id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
23504223|NCT00982137|65587774|FG000|Overall Study|Lost to Follow-up|0|||
23504224|NCT00982137|65587775|FG001|Overall Study|Lost to Follow-up|0|||
23504225|NCT00982137|65587776|FG002|Overall Study|Lost to Follow-up|0|||
23504226|NCT00982137|65587777|FG003|Overall Study|Lost to Follow-up|1|||
23201521|NCT01921257|64479890|FG000|Overall Study|Adverse Event|1|||
23504227|NCT00982137|65587774|FG000|Overall Study|Withdrawal by Subject|0|||
23504228|NCT00982137|65587775|FG001|Overall Study|Withdrawal by Subject|1|||
23504229|NCT00982137|65587776|FG002|Overall Study|Withdrawal by Subject|0|||
23504230|NCT00982137|65587777|FG003|Overall Study|Withdrawal by Subject|0|||
23504231|NCT02717611|65587778|FG000|Overall Study|Death|13|||
23504232|NCT02717611|65587778|FG000|Overall Study|Withdrawal by Subject|6|||
23504233|NCT02717611|65587778|FG000|Overall Study|Active, not recruiting|40|||
23504234|NCT02717611|65587778|FG000|Overall Study|Complicating disease|1|||
23504235|NCT03766581|65587779|FG000|Randomization|Other reasons|2|||
23504236|NCT03766581|65587780|FG001|Randomization|Other reasons|1|||
23201522|NCT01921257|64479890|FG000|Overall Study|Protocol Violation|1|||
23201523|NCT01921257|64479890|FG000|Overall Study|Withdrawal by Subject|1|||
23201524|NCT03799718|64479894|FG000|Overall Study|Adverse Event|2|||
23201525|NCT03136185|64479895|FG000|Overall Study|Adverse Event|0|||
23201526|NCT03136185|64479896|FG001|Overall Study|Adverse Event|1|||
23201527|NCT03136185|64479897|FG002|Overall Study|Adverse Event|3|||
23201528|NCT03136185|64479898|FG003|Overall Study|Adverse Event|1|||
23201529|NCT03136185|64479899|FG004|Overall Study|Adverse Event|2|||
23201530|NCT03136185|64479900|FG005|Overall Study|Adverse Event|2|||
23201531|NCT03136185|64479901|FG006|Overall Study|Adverse Event|5|||
23201532|NCT03136185|64479902|FG007|Overall Study|Adverse Event|1|||
23201533|NCT03136185|64479903|FG008|Overall Study|Adverse Event|1|||
23504237|NCT03766581|65587781|FG002|Randomization|Other reasons|0|||
23504238|NCT03766581|65587782|FG003|Randomization|Other reasons|1|||
23504239|NCT03766581|65587783|FG004|Randomization|Other reasons|0|||
23504240|NCT03766581|65587784|FG005|Randomization|Other reasons|0|||
23504241|NCT03766581|65587785|FG006|Randomization|Other reasons|0|||
23504242|NCT03766581|65587786|FG007|Randomization|Other reasons|0|||
23504243|NCT03766581|65587779|FG000|Randomization|Participant no longer meets study criteria|5|||
23504244|NCT03766581|65587780|FG001|Randomization|Participant no longer meets study criteria|3|||
23504245|NCT03766581|65587781|FG002|Randomization|Participant no longer meets study criteria|4|||
23504246|NCT03766581|65587782|FG003|Randomization|Participant no longer meets study criteria|0|||
23504247|NCT03766581|65587783|FG004|Randomization|Participant no longer meets study criteria|2|||
23504248|NCT03766581|65587784|FG005|Randomization|Participant no longer meets study criteria|3|||
23504249|NCT03766581|65587785|FG006|Randomization|Participant no longer meets study criteria|0|||
23504250|NCT03766581|65587786|FG007|Randomization|Participant no longer meets study criteria|1|||
23504251|NCT03766581|65587779|FG000|Randomization|Participant request to discontinue study treatment|1|||
23504252|NCT03766581|65587780|FG001|Randomization|Participant request to discontinue study treatment|0|||
23504253|NCT03766581|65587781|FG002|Randomization|Participant request to discontinue study treatment|0|||
23504254|NCT03766581|65587782|FG003|Randomization|Participant request to discontinue study treatment|0|||
23504255|NCT03766581|65587783|FG004|Randomization|Participant request to discontinue study treatment|1|||
23504256|NCT03766581|65587784|FG005|Randomization|Participant request to discontinue study treatment|2|||
23504257|NCT03766581|65587785|FG006|Randomization|Participant request to discontinue study treatment|0|||
23504258|NCT03766581|65587786|FG007|Randomization|Participant request to discontinue study treatment|0|||
23504259|NCT03766581|65587779|FG000|Randomization|Participant withdrew consent|1|||
23504260|NCT03766581|65587780|FG001|Randomization|Participant withdrew consent|0|||
23504261|NCT03766581|65587781|FG002|Randomization|Participant withdrew consent|1|||
23504262|NCT03766581|65587782|FG003|Randomization|Participant withdrew consent|2|||
23504263|NCT03766581|65587783|FG004|Randomization|Participant withdrew consent|1|||
23403148|NCT02534883|65223171|FG000|Overall Study|Early Termination|8|||
23504264|NCT03766581|65587784|FG005|Randomization|Participant withdrew consent|1|||
23504265|NCT03766581|65587785|FG006|Randomization|Participant withdrew consent|0|||
23504266|NCT03766581|65587786|FG007|Randomization|Participant withdrew consent|0|||
23504267|NCT03766581|65587779|FG000|Treatment|Adverse Event|82|||
23504268|NCT03766581|65587780|FG001|Treatment|Adverse Event|44|||
23201534|NCT03136185|64479895|FG000|Overall Study|Death|0|||
23201535|NCT03136185|64479896|FG001|Overall Study|Death|0|||
23201536|NCT03136185|64479897|FG002|Overall Study|Death|0|||
23201537|NCT03136185|64479898|FG003|Overall Study|Death|1|||
23201538|NCT03136185|64479899|FG004|Overall Study|Death|1|||
23201539|NCT03136185|64479900|FG005|Overall Study|Death|0|||
23302331|NCT01144364|64850677|FG000|Induction Phase|Disease progression|14|||
23201540|NCT03136185|64479901|FG006|Overall Study|Death|1|||
23403149|NCT02534883|65223172|FG001|Overall Study|Early Termination|3|||
23403150|NCT00132301|65223175|FG000|Overall Study|Death|7|||
23201541|NCT03136185|64479902|FG007|Overall Study|Death|0|||
23302332|NCT01144364|64850678|FG001|Induction Phase|Disease progression|0|||
23302333|NCT01144364|64850679|FG002|Induction Phase|Disease progression|0|||
23504269|NCT03766581|65587781|FG002|Treatment|Adverse Event|47|||
23504270|NCT03766581|65587782|FG003|Treatment|Adverse Event|46|||
23504271|NCT03766581|65587783|FG004|Treatment|Adverse Event|50|||
23201542|NCT03136185|64479903|FG008|Overall Study|Death|0|||
23201543|NCT03136185|64479895|FG000|Overall Study|Physician Decision|3|||
23201544|NCT03136185|64479896|FG001|Overall Study|Physician Decision|1|||
23201545|NCT03136185|64479897|FG002|Overall Study|Physician Decision|1|||
23201546|NCT03136185|64479898|FG003|Overall Study|Physician Decision|2|||
23201547|NCT03136185|64479899|FG004|Overall Study|Physician Decision|1|||
23201548|NCT03136185|64479900|FG005|Overall Study|Physician Decision|2|||
23201549|NCT03136185|64479901|FG006|Overall Study|Physician Decision|1|||
23201550|NCT03136185|64479902|FG007|Overall Study|Physician Decision|0|||
23201551|NCT03136185|64479903|FG008|Overall Study|Physician Decision|1|||
23201552|NCT03136185|64479895|FG000|Overall Study|Protocol Defined Disease Progression|0|||
23201553|NCT03136185|64479896|FG001|Overall Study|Protocol Defined Disease Progression|0|||
23201554|NCT03136185|64479897|FG002|Overall Study|Protocol Defined Disease Progression|1|||
23201555|NCT03136185|64479898|FG003|Overall Study|Protocol Defined Disease Progression|0|||
23201556|NCT03136185|64479899|FG004|Overall Study|Protocol Defined Disease Progression|0|||
23201557|NCT03136185|64479900|FG005|Overall Study|Protocol Defined Disease Progression|1|||
23201558|NCT03136185|64479901|FG006|Overall Study|Protocol Defined Disease Progression|0|||
23201559|NCT03136185|64479902|FG007|Overall Study|Protocol Defined Disease Progression|1|||
23201560|NCT03136185|64479903|FG008|Overall Study|Protocol Defined Disease Progression|1|||
23201561|NCT03136185|64479895|FG000|Overall Study|Withdrawal by Subject|1|||
23201562|NCT03136185|64479896|FG001|Overall Study|Withdrawal by Subject|0|||
23201563|NCT03136185|64479897|FG002|Overall Study|Withdrawal by Subject|1|||
23201564|NCT03136185|64479898|FG003|Overall Study|Withdrawal by Subject|1|||
23201565|NCT03136185|64479899|FG004|Overall Study|Withdrawal by Subject|1|||
23201566|NCT03136185|64479900|FG005|Overall Study|Withdrawal by Subject|1|||
23504272|NCT03766581|65587784|FG005|Treatment|Adverse Event|77|||
23504273|NCT03766581|65587785|FG006|Treatment|Adverse Event|5|||
23504274|NCT03766581|65587786|FG007|Treatment|Adverse Event|2|||
23504275|NCT03766581|65587779|FG000|Treatment|Participant request to discontinue treatment|34|||
23504276|NCT03766581|65587780|FG001|Treatment|Participant request to discontinue treatment|6|||
23201567|NCT03136185|64479901|FG006|Overall Study|Withdrawal by Subject|2|||
23201568|NCT03136185|64479902|FG007|Overall Study|Withdrawal by Subject|3|||
23201569|NCT03136185|64479903|FG008|Overall Study|Withdrawal by Subject|3|||
23201570|NCT03136185|64479895|FG000|Overall Study|Not Reported|4|||
23201571|NCT03136185|64479896|FG001|Overall Study|Not Reported|1|||
23504277|NCT03766581|65587781|FG002|Treatment|Participant request to discontinue treatment|10|||
23201572|NCT03136185|64479897|FG002|Overall Study|Not Reported|0|||
23201573|NCT03136185|64479898|FG003|Overall Study|Not Reported|1|||
23201574|NCT03136185|64479899|FG004|Overall Study|Not Reported|0|||
23201575|NCT03136185|64479900|FG005|Overall Study|Not Reported|2|||
23201576|NCT03136185|64479901|FG006|Overall Study|Not Reported|1|||
23201577|NCT03136185|64479902|FG007|Overall Study|Not Reported|1|||
23201578|NCT03136185|64479903|FG008|Overall Study|Not Reported|0|||
23201579|NCT04369430|64479906|FG000|Overall Study|Adverse Event|2|||
23201580|NCT04369430|64479907|FG001|Overall Study|Adverse Event|3|||
23201581|NCT04369430|64479906|FG000|Overall Study|Death|1|||
23201582|NCT04369430|64479907|FG001|Overall Study|Death|0|||
23201583|NCT04369430|64479906|FG000|Overall Study|Withdrawal by Subject|4|||
23201584|NCT04369430|64479907|FG001|Overall Study|Withdrawal by Subject|3|||
23201585|NCT04369430|64479906|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
23504278|NCT03766581|65587782|FG003|Treatment|Participant request to discontinue treatment|10|||
23504279|NCT03766581|65587783|FG004|Treatment|Participant request to discontinue treatment|14|||
23504280|NCT03766581|65587784|FG005|Treatment|Participant request to discontinue treatment|15|||
23504281|NCT03766581|65587785|FG006|Treatment|Participant request to discontinue treatment|0|||
23504282|NCT03766581|65587786|FG007|Treatment|Participant request to discontinue treatment|1|||
23504283|NCT03766581|65587779|FG000|Treatment|Participant withdrew consent|11|||
23504284|NCT03766581|65587780|FG001|Treatment|Participant withdrew consent|4|||
23403151|NCT00132301|65223176|FG001|Overall Study|Death|6|||
23403152|NCT00132301|65223175|FG000|Overall Study|Withdrawal by Subject|5|||
23403153|NCT00132301|65223176|FG001|Overall Study|Withdrawal by Subject|2|||
23403154|NCT00132301|65223175|FG000|Overall Study|Physician Decision|1|||
23403155|NCT00132301|65223176|FG001|Overall Study|Physician Decision|1|||
23403156|NCT00132301|65223175|FG000|Overall Study|Lost to Follow-up|5|||
23403157|NCT00132301|65223176|FG001|Overall Study|Lost to Follow-up|3|||
23403158|NCT00132301|65223175|FG000|Overall Study|Other|1|||
23403159|NCT00132301|65223176|FG001|Overall Study|Other|1|||
23403160|NCT00132301|65223175|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
23403161|NCT00132301|65223176|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
23403162|NCT01402869|65223177|FG000|Overall Study|Required Tooth Extraction|0|||
23403163|NCT01402869|65223178|FG001|Overall Study|Required Tooth Extraction|0|||
23403164|NCT01402869|65223179|FG002|Overall Study|Required Tooth Extraction|1|||
23403165|NCT00553631|65223184|FG000|Overall Study|Withdrawal by Subject|0|||
23403166|NCT00553631|65223185|FG001|Overall Study|Withdrawal by Subject|1|||
23403167|NCT00553631|65223184|FG000|Overall Study|Lost to Follow-up|1|||
23201586|NCT04369430|64479907|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
23201587|NCT04369430|64479906|FG000|Overall Study|Lost to Follow-up|0|||
23201588|NCT04369430|64479907|FG001|Overall Study|Lost to Follow-up|1|||
23201589|NCT03123354|64479908|FG000|Overall Study|Physician Decision|6|||
23201590|NCT01597622|64479911|FG000|Overall Study|Adverse Event|7|||
23201591|NCT01597622|64479911|FG000|Overall Study|Lack of Efficacy|3|||
23201592|NCT01597622|64479911|FG000|Overall Study|Protocol Violation|1|||
23201593|NCT01597622|64479911|FG000|Overall Study|Lost to Follow-up|1|||
23201594|NCT01597622|64479911|FG000|Overall Study|Investigator Discretion|5|||
23201595|NCT01597622|64479911|FG000|Overall Study|Withdrawal by Subject|20|||
23201596|NCT01597622|64479911|FG000|Overall Study|Death|1|||
23201597|NCT01746732|64479912|FG000|Lead-In Period|Withdrawal by Subject|1|||
23201598|NCT01746732|64479913|FG001|Lead-In Period|Withdrawal by Subject|0|||
23201599|NCT01746732|64479914|FG002|Lead-In Period|Withdrawal by Subject|0|||
23201600|NCT01746732|64479912|FG000|Period 1|Physician Decision|0|||
23201601|NCT01746732|64479913|FG001|Period 1|Physician Decision|1|||
23201602|NCT01746732|64479914|FG002|Period 1|Physician Decision|0|||
23201603|NCT01746732|64479912|FG000|Period 2|Withdrawal by Subject|0|||
23201604|NCT01746732|64479913|FG001|Period 2|Withdrawal by Subject|0|||
23201605|NCT01746732|64479914|FG002|Period 2|Withdrawal by Subject|2|||
23403168|NCT00553631|65223185|FG001|Overall Study|Lost to Follow-up|0|||
23403169|NCT00950651|65223186|FG000|Overall Study|Adverse Event|17|||
23201606|NCT01746732|64479912|FG000|Period 2|Adverse Event|0|||
23201607|NCT01746732|64479913|FG001|Period 2|Adverse Event|0|||
23201608|NCT01746732|64479914|FG002|Period 2|Adverse Event|1|||
23302334|NCT01144364|64850677|FG000|Induction Phase|Adverse Event|9|||
23403170|NCT00950651|65223187|FG001|Overall Study|Adverse Event|20|||
23403171|NCT00950651|65223186|FG000|Overall Study|Death|1|||
23201609|NCT01746732|64479912|FG000|Period 2|Lost to Follow-up|0|||
23201610|NCT01746732|64479913|FG001|Period 2|Lost to Follow-up|0|||
23201611|NCT01746732|64479914|FG002|Period 2|Lost to Follow-up|1|||
23302335|NCT01144364|64850678|FG001|Induction Phase|Adverse Event|0|||
23201612|NCT00316303|64479917|FG000|Overall Study|Lost to Follow-up|11|||
23201613|NCT00316303|64479918|FG001|Overall Study|Lost to Follow-up|16|||
23201614|NCT01425190|64479919|FG000|Overall Study|Full dose not consumed.|1|||
23201615|NCT01425190|64479920|FG001|Overall Study|Full dose not consumed.|0|||
23201616|NCT01425190|64479921|FG002|Overall Study|Full dose not consumed.|0|||
23201617|NCT01638000|64479926|FG000|Overall Study|Randomized but Never Received Drug|7|||
23201618|NCT01638000|64479927|FG001|Overall Study|Randomized but Never Received Drug|10|||
23201619|NCT01638000|64479926|FG000|Overall Study|Adverse Event|14|||
23201620|NCT01638000|64479927|FG001|Overall Study|Adverse Event|16|||
23201621|NCT01638000|64479926|FG000|Overall Study|Lack of Efficacy|5|||
23201622|NCT01638000|64479927|FG001|Overall Study|Lack of Efficacy|6|||
23201623|NCT01638000|64479926|FG000|Overall Study|Protocol Violation|11|||
23201624|NCT01638000|64479927|FG001|Overall Study|Protocol Violation|13|||
23201625|NCT01638000|64479926|FG000|Overall Study|Withdrawal by Subject|21|||
23201626|NCT01638000|64479927|FG001|Overall Study|Withdrawal by Subject|24|||
23201627|NCT01638000|64479926|FG000|Overall Study|Miscellaneous|2|||
23201628|NCT01638000|64479927|FG001|Overall Study|Miscellaneous|2|||
23504285|NCT03766581|65587781|FG002|Treatment|Participant withdrew consent|5|||
23504286|NCT03766581|65587782|FG003|Treatment|Participant withdrew consent|5|||
23201629|NCT01426425|64479928|FG000|Overall Study|Exited prior to EP study|22|||
23201630|NCT01426425|64479928|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
23504287|NCT03766581|65587783|FG004|Treatment|Participant withdrew consent|4|||
23504288|NCT03766581|65587784|FG005|Treatment|Participant withdrew consent|4|||
23201631|NCT01426425|64479928|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
23201632|NCT03442829|64479931|FG000|Overall Study|Scheduling clash|3|||
23201633|NCT03442829|64479932|FG001|Overall Study|Scheduling clash|1|||
23201634|NCT03442829|64479931|FG000|Overall Study|Illness unrelated to study|1|||
23201635|NCT03442829|64479932|FG001|Overall Study|Illness unrelated to study|1|||
23201636|NCT01740440|64479933|FG000|Overall Study|Lost to Follow-up|3|||
23201637|NCT01675531|64479936|FG000|Overall Study|Adverse Event|9|||
23201638|NCT01675531|64479936|FG000|Overall Study|Withdrawal by Subject|7|||
23201639|NCT01675531|64479936|FG000|Overall Study|Lack of Efficacy|1|||
23201640|NCT01675531|64479936|FG000|Overall Study|Protocol Violation|8|||
23201641|NCT04045613|64479942|FG000|Overall Study|Adverse Event|2|||
23201642|NCT04045613|64479943|FG001|Overall Study|Adverse Event|2|||
23201643|NCT04045613|64479944|FG002|Overall Study|Adverse Event|1|||
23201644|NCT04045613|64479945|FG003|Overall Study|Adverse Event|1|||
23201645|NCT04045613|64479946|FG004|Overall Study|Adverse Event|0|||
23201646|NCT04045613|64479947|FG005|Overall Study|Adverse Event|0|||
23201647|NCT04045613|64479948|FG006|Overall Study|Adverse Event|1|||
23201648|NCT04045613|64479942|FG000|Overall Study|Withdrawal by Subject|0|||
23201649|NCT04045613|64479943|FG001|Overall Study|Withdrawal by Subject|5|||
23201650|NCT04045613|64479944|FG002|Overall Study|Withdrawal by Subject|0|||
23201651|NCT04045613|64479945|FG003|Overall Study|Withdrawal by Subject|0|||
23201652|NCT04045613|64479946|FG004|Overall Study|Withdrawal by Subject|0|||
23201653|NCT04045613|64479947|FG005|Overall Study|Withdrawal by Subject|1|||
23201654|NCT04045613|64479948|FG006|Overall Study|Withdrawal by Subject|0|||
23201655|NCT04045613|64479942|FG000|Overall Study|Physician Decision|2|||
23201656|NCT04045613|64479943|FG001|Overall Study|Physician Decision|0|||
23201657|NCT04045613|64479944|FG002|Overall Study|Physician Decision|0|||
23201658|NCT04045613|64479945|FG003|Overall Study|Physician Decision|0|||
23201659|NCT04045613|64479946|FG004|Overall Study|Physician Decision|1|||
23201660|NCT04045613|64479947|FG005|Overall Study|Physician Decision|0|||
23201661|NCT04045613|64479948|FG006|Overall Study|Physician Decision|0|||
23201662|NCT04045613|64479942|FG000|Overall Study|Death|3|||
23201663|NCT04045613|64479943|FG001|Overall Study|Death|0|||
23201664|NCT04045613|64479944|FG002|Overall Study|Death|0|||
23201665|NCT04045613|64479945|FG003|Overall Study|Death|0|||
23201666|NCT04045613|64479946|FG004|Overall Study|Death|0|||
23201667|NCT04045613|64479947|FG005|Overall Study|Death|0|||
23201668|NCT04045613|64479948|FG006|Overall Study|Death|1|||
23201669|NCT04045613|64479942|FG000|Overall Study|Other reasons|0|||
23201670|NCT04045613|64479943|FG001|Overall Study|Other reasons|1|||
23201671|NCT04045613|64479944|FG002|Overall Study|Other reasons|0|||
23201672|NCT04045613|64479945|FG003|Overall Study|Other reasons|0|||
23403172|NCT00950651|65223187|FG001|Overall Study|Death|0|||
23403173|NCT00950651|65223186|FG000|Overall Study|Lack of Efficacy|2|||
23403174|NCT00950651|65223187|FG001|Overall Study|Lack of Efficacy|2|||
23403175|NCT00950651|65223186|FG000|Overall Study|Protocol Violation|3|||
23201673|NCT04045613|64479946|FG004|Overall Study|Other reasons|0|||
23201674|NCT04045613|64479947|FG005|Overall Study|Other reasons|0|||
23403176|NCT00950651|65223187|FG001|Overall Study|Protocol Violation|4|||
23201675|NCT04045613|64479948|FG006|Overall Study|Other reasons|1|||
23201676|NCT04045613|64479942|FG000|Overall Study|Progressive disease: Clinical progression|1|||
23201677|NCT04045613|64479943|FG001|Overall Study|Progressive disease: Clinical progression|0|||
23201678|NCT04045613|64479944|FG002|Overall Study|Progressive disease: Clinical progression|3|||
23201679|NCT04045613|64479945|FG003|Overall Study|Progressive disease: Clinical progression|1|||
23201680|NCT04045613|64479946|FG004|Overall Study|Progressive disease: Clinical progression|1|||
23201681|NCT04045613|64479947|FG005|Overall Study|Progressive disease: Clinical progression|3|||
23236635|NCT00280059|64608259|FG000|Efficacy Assessment Phase|Other|7|||
23504289|NCT03766581|65587785|FG006|Treatment|Participant withdrew consent|0|||
23403177|NCT00950651|65223186|FG000|Overall Study|Withdrawal by Subject|8|||
23201682|NCT04045613|64479948|FG006|Overall Study|Progressive disease: Clinical progression|3|||
23201683|NCT04045613|64479942|FG000|Overall Study|Progressive disease: Radiological progression|24|||
23201684|NCT04045613|64479943|FG001|Overall Study|Progressive disease: Radiological progression|6|||
23201685|NCT04045613|64479944|FG002|Overall Study|Progressive disease: Radiological progression|8|||
23201686|NCT04045613|64479945|FG003|Overall Study|Progressive disease: Radiological progression|0|||
23201687|NCT04045613|64479946|FG004|Overall Study|Progressive disease: Radiological progression|6|||
23403178|NCT00950651|65223187|FG001|Overall Study|Withdrawal by Subject|9|||
23403179|NCT04179305|65223190|FG000|Overall Study|Death|1|||
23403180|NCT04179305|65223191|FG001|Overall Study|Death|1|||
23403181|NCT04179305|65223192|FG002|Overall Study|Death|0|||
23403182|NCT04179305|65223193|FG003|Overall Study|Death|0|||
23403183|NCT04179305|65223190|FG000|Overall Study|Lost to Follow-up|1|||
23403184|NCT04179305|65223191|FG001|Overall Study|Lost to Follow-up|1|||
23403185|NCT04179305|65223192|FG002|Overall Study|Lost to Follow-up|0|||
23403186|NCT04179305|65223193|FG003|Overall Study|Lost to Follow-up|0|||
23403187|NCT04179305|65223190|FG000|Overall Study|Withdrawal by Subject|0|||
23403188|NCT04179305|65223191|FG001|Overall Study|Withdrawal by Subject|1|||
23403189|NCT04179305|65223192|FG002|Overall Study|Withdrawal by Subject|0|||
23403190|NCT04179305|65223193|FG003|Overall Study|Withdrawal by Subject|0|||
23403191|NCT04179305|65223190|FG000|Overall Study|Did not have scan|1|||
23403192|NCT04179305|65223191|FG001|Overall Study|Did not have scan|0|||
23403193|NCT04179305|65223192|FG002|Overall Study|Did not have scan|0|||
23403194|NCT04179305|65223193|FG003|Overall Study|Did not have scan|0|||
23403195|NCT04179305|65223190|FG000|Overall Study|In hospice care|3|||
23403196|NCT04179305|65223191|FG001|Overall Study|In hospice care|0|||
23403197|NCT04179305|65223192|FG002|Overall Study|In hospice care|0|||
23201688|NCT04045613|64479947|FG005|Overall Study|Progressive disease: Radiological progression|6|||
23201689|NCT04045613|64479948|FG006|Overall Study|Progressive disease: Radiological progression|11|||
23201690|NCT02202031|64479949|FG000|Overall Study|Lost to Follow-up|1|||
23201691|NCT02202031|64479950|FG001|Overall Study|Lost to Follow-up|0|||
23201692|NCT02202031|64479949|FG000|Overall Study|Too Busy|1|||
23201693|NCT02202031|64479950|FG001|Overall Study|Too Busy|3|||
23201694|NCT02202031|64479949|FG000|Overall Study|Illness/Medical Reason|0|||
23201695|NCT02202031|64479950|FG001|Overall Study|Illness/Medical Reason|2|||
23201696|NCT02202031|64479949|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
23201697|NCT02202031|64479950|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
23201698|NCT00002663|64479952|FG000|Overall Study|Death|4|||
23403198|NCT04179305|65223193|FG003|Overall Study|In hospice care|0|||
23403199|NCT03389308|65223200|FG000|Overall Study|Withdrawal by Subject|5|||
23403200|NCT03389308|65223200|FG000|Overall Study|Lost to Follow-up|3|||
23403201|NCT03389308|65223200|FG000|Overall Study|Adverse Event|2|||
23403202|NCT03389308|65223200|FG000|Overall Study|Sponsor Request|2|||
23403203|NCT00038948|65223201|FG000|Overall Study|Adverse Event|131|||
23403204|NCT00038948|65223202|FG001|Overall Study|Adverse Event|43|||
23403205|NCT00038948|65223201|FG000|Overall Study|Lost to Follow-up|4|||
23403206|NCT00038948|65223202|FG001|Overall Study|Lost to Follow-up|4|||
23403207|NCT00038948|65223201|FG000|Overall Study|Nonmedical event|5|||
23403208|NCT00038948|65223202|FG001|Overall Study|Nonmedical event|7|||
23403209|NCT00038948|65223201|FG000|Overall Study|Withdrawal by Subject|23|||
23403210|NCT00038948|65223202|FG001|Overall Study|Withdrawal by Subject|10|||
23403211|NCT00038948|65223201|FG000|Overall Study|Protocol Violation|3|||
23403212|NCT00038948|65223202|FG001|Overall Study|Protocol Violation|7|||
23403213|NCT00038948|65223201|FG000|Overall Study|Lack of Efficacy|3|||
23403214|NCT00038948|65223202|FG001|Overall Study|Lack of Efficacy|6|||
23403215|NCT04774380|65223203|FG000|Overall Study|Patients ongoing study at data cut-off|75|||
23403216|NCT00881894|65223204|FG000|Overall Study|Consent withdrawn|0|||
23403217|NCT00881894|65223205|FG001|Overall Study|Consent withdrawn|1|||
23403218|NCT00881894|65223204|FG000|Overall Study|Other reasons for premature termination|1|||
23403219|NCT00881894|65223205|FG001|Overall Study|Other reasons for premature termination|2|||
23403220|NCT00142792|65223206|FG000|Overall Study|Death|0|||
23403221|NCT00142792|65223207|FG001|Overall Study|Death|0|||
23403222|NCT00142792|65223208|FG002|Overall Study|Death|1|||
23403223|NCT00142792|65223206|FG000|Overall Study|Withdrawal by Subject|3|||
23403224|NCT00142792|65223207|FG001|Overall Study|Withdrawal by Subject|2|||
23403225|NCT00142792|65223208|FG002|Overall Study|Withdrawal by Subject|3|||
23403226|NCT00142792|65223206|FG000|Overall Study|Lost to Follow-up|8|||
23403227|NCT00142792|65223207|FG001|Overall Study|Lost to Follow-up|11|||
23403228|NCT00142792|65223208|FG002|Overall Study|Lost to Follow-up|7|||
23403229|NCT00142792|65223206|FG000|Overall Study|No category|1|||
23403230|NCT00142792|65223207|FG001|Overall Study|No category|2|||
23403231|NCT00142792|65223208|FG002|Overall Study|No category|1|||
23403232|NCT02897115|65223209|FG000|Overall Study|Early termination of study by sponsor|11|||
23403233|NCT02897115|65223210|FG001|Overall Study|Early termination of study by sponsor|8|||
23403234|NCT01544348|65223211|FG000|Overall Study|Lost to Follow-up|1|||
23403235|NCT01544348|65223212|FG001|Overall Study|Lost to Follow-up|0|||
23403236|NCT01544348|65223213|FG002|Overall Study|Lost to Follow-up|0|||
23403237|NCT01544348|65223214|FG003|Overall Study|Lost to Follow-up|0|||
23403238|NCT01544348|65223215|FG004|Overall Study|Lost to Follow-up|0|||
23403239|NCT01544348|65223216|FG005|Overall Study|Lost to Follow-up|0|||
23403240|NCT01544348|65223217|FG006|Overall Study|Lost to Follow-up|1|||
23403241|NCT01544348|65223218|FG007|Overall Study|Lost to Follow-up|0|||
23403242|NCT01544348|65223211|FG000|Overall Study|Withdrawal by Subject|1|||
23403243|NCT01544348|65223212|FG001|Overall Study|Withdrawal by Subject|0|||
23403244|NCT01544348|65223213|FG002|Overall Study|Withdrawal by Subject|0|||
23403245|NCT01544348|65223214|FG003|Overall Study|Withdrawal by Subject|0|||
23403246|NCT01544348|65223215|FG004|Overall Study|Withdrawal by Subject|1|||
23403247|NCT01544348|65223216|FG005|Overall Study|Withdrawal by Subject|2|||
23403248|NCT01544348|65223217|FG006|Overall Study|Withdrawal by Subject|1|||
23403249|NCT01544348|65223218|FG007|Overall Study|Withdrawal by Subject|0|||
23403250|NCT01544348|65223211|FG000|Overall Study|Physician Decision|0|||
23403251|NCT01544348|65223212|FG001|Overall Study|Physician Decision|0|||
23403252|NCT01544348|65223213|FG002|Overall Study|Physician Decision|0|||
23403253|NCT01544348|65223214|FG003|Overall Study|Physician Decision|0|||
23403254|NCT01544348|65223215|FG004|Overall Study|Physician Decision|0|||
23403255|NCT01544348|65223216|FG005|Overall Study|Physician Decision|1|||
23403256|NCT01544348|65223217|FG006|Overall Study|Physician Decision|0|||
23403257|NCT01544348|65223218|FG007|Overall Study|Physician Decision|0|||
23403258|NCT01070979|65223219|FG000|Overall Study|Adverse Event|2|||
23403259|NCT01070979|65223220|FG001|Overall Study|Adverse Event|3|||
23403260|NCT01070979|65223221|FG002|Overall Study|Adverse Event|3|||
23403261|NCT01070979|65223219|FG000|Overall Study|Lost to Follow-up|2|||
23403262|NCT01070979|65223220|FG001|Overall Study|Lost to Follow-up|1|||
23403263|NCT01070979|65223221|FG002|Overall Study|Lost to Follow-up|1|||
23403264|NCT01070979|65223219|FG000|Overall Study|Protocol Violation|0|||
23403265|NCT01070979|65223220|FG001|Overall Study|Protocol Violation|2|||
23403266|NCT01070979|65223221|FG002|Overall Study|Protocol Violation|6|||
23403267|NCT01070979|65223219|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
23403268|NCT01070979|65223220|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
23403269|NCT01070979|65223221|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
23403270|NCT01070979|65223219|FG000|Overall Study|Withdrawal by Subject|3|||
23403271|NCT01070979|65223220|FG001|Overall Study|Withdrawal by Subject|1|||
23403272|NCT01070979|65223221|FG002|Overall Study|Withdrawal by Subject|1|||
23403273|NCT01070979|65223219|FG000|Overall Study|No study drug taken|0|||
23403274|NCT01070979|65223220|FG001|Overall Study|No study drug taken|1|||
23403275|NCT01070979|65223221|FG002|Overall Study|No study drug taken|0|||
23403276|NCT01119287|65223228|FG000|Overall Study|Patient Decision, not related to AE|0|||
23403277|NCT01119287|65223229|FG001|Overall Study|Patient Decision, not related to AE|0|||
23403278|NCT01119287|65223230|FG002|Overall Study|Patient Decision, not related to AE|2|||
23403279|NCT01119287|65223231|FG003|Overall Study|Patient Decision, not related to AE|2|||
23403280|NCT01119287|65223232|FG004|Overall Study|Patient Decision, not related to AE|1|||
23403281|NCT01119287|65223233|FG005|Overall Study|Patient Decision, not related to AE|0|||
23403282|NCT02078752|65223234|FG000|Overall Study|Death|0|||
23403283|NCT02078752|65223235|FG001|Overall Study|Death|3|||
23403284|NCT02078752|65223236|FG002|Overall Study|Death|0|||
23403285|NCT02078752|65223237|FG003|Overall Study|Death|0|||
23403286|NCT02078752|65223238|FG004|Overall Study|Death|0|||
23403287|NCT02078752|65223239|FG005|Overall Study|Death|1|||
23403288|NCT02078752|65223240|FG006|Overall Study|Death|0|||
23403289|NCT02078752|65223241|FG007|Overall Study|Death|1|||
23403290|NCT02078752|65223242|FG008|Overall Study|Death|0|||
23403291|NCT02078752|65223243|FG009|Overall Study|Death|4|||
23403292|NCT02078752|65223234|FG000|Overall Study|Lost to Follow-up|1|||
23403293|NCT02078752|65223235|FG001|Overall Study|Lost to Follow-up|0|||
23403294|NCT02078752|65223236|FG002|Overall Study|Lost to Follow-up|0|||
23504290|NCT03766581|65587786|FG007|Treatment|Participant withdrew consent|0|||
23504291|NCT03766581|65587779|FG000|Treatment|Death|1|||
23504292|NCT03766581|65587780|FG001|Treatment|Death|0|||
23504293|NCT03766581|65587781|FG002|Treatment|Death|0|||
23504294|NCT03766581|65587782|FG003|Treatment|Death|0|||
23504295|NCT03766581|65587783|FG004|Treatment|Death|0|||
23504296|NCT03766581|65587784|FG005|Treatment|Death|0|||
23403295|NCT02078752|65223237|FG003|Overall Study|Lost to Follow-up|1|||
23403296|NCT02078752|65223238|FG004|Overall Study|Lost to Follow-up|0|||
23403297|NCT02078752|65223239|FG005|Overall Study|Lost to Follow-up|0|||
23403298|NCT02078752|65223240|FG006|Overall Study|Lost to Follow-up|0|||
23403299|NCT02078752|65223241|FG007|Overall Study|Lost to Follow-up|0|||
23403300|NCT02078752|65223242|FG008|Overall Study|Lost to Follow-up|0|||
23403301|NCT02078752|65223243|FG009|Overall Study|Lost to Follow-up|0|||
23403302|NCT02078752|65223234|FG000|Overall Study|Withdrawal by Subject|1|||
23403303|NCT02078752|65223235|FG001|Overall Study|Withdrawal by Subject|1|||
23403304|NCT02078752|65223236|FG002|Overall Study|Withdrawal by Subject|1|||
23403305|NCT02078752|65223237|FG003|Overall Study|Withdrawal by Subject|1|||
23403306|NCT02078752|65223238|FG004|Overall Study|Withdrawal by Subject|0|||
23403307|NCT02078752|65223239|FG005|Overall Study|Withdrawal by Subject|3|||
23403308|NCT02078752|65223240|FG006|Overall Study|Withdrawal by Subject|2|||
23403309|NCT02078752|65223241|FG007|Overall Study|Withdrawal by Subject|1|||
23403310|NCT02078752|65223242|FG008|Overall Study|Withdrawal by Subject|0|||
23403311|NCT02078752|65223243|FG009|Overall Study|Withdrawal by Subject|1|||
23403312|NCT02078752|65223234|FG000|Overall Study|Other|0|||
23403313|NCT02078752|65223235|FG001|Overall Study|Other|3|||
23403314|NCT02078752|65223236|FG002|Overall Study|Other|0|||
23403315|NCT02078752|65223237|FG003|Overall Study|Other|0|||
23403316|NCT02078752|65223238|FG004|Overall Study|Other|1|||
23403317|NCT02078752|65223239|FG005|Overall Study|Other|0|||
23403318|NCT02078752|65223240|FG006|Overall Study|Other|0|||
23403319|NCT02078752|65223241|FG007|Overall Study|Other|1|||
23403320|NCT02078752|65223242|FG008|Overall Study|Other|0|||
23403321|NCT02078752|65223243|FG009|Overall Study|Other|0|||
23403322|NCT02078752|65223234|FG000|Overall Study|Study terminated by sponsor|0|||
23504297|NCT03766581|65587785|FG006|Treatment|Death|0|||
23504298|NCT03766581|65587786|FG007|Treatment|Death|0|||
23504299|NCT03766581|65587779|FG000|Treatment|Lost to Follow-up|1|||
23175774|NCT01790503|64386547|FG007|Overall Study|Other|0|||
23302336|NCT01144364|64850679|FG002|Induction Phase|Adverse Event|0|||
23403323|NCT02078752|65223235|FG001|Overall Study|Study terminated by sponsor|0|||
23403324|NCT02078752|65223236|FG002|Overall Study|Study terminated by sponsor|0|||
23403325|NCT02078752|65223237|FG003|Overall Study|Study terminated by sponsor|0|||
23403326|NCT02078752|65223238|FG004|Overall Study|Study terminated by sponsor|0|||
23403327|NCT02078752|65223239|FG005|Overall Study|Study terminated by sponsor|0|||
23403328|NCT02078752|65223240|FG006|Overall Study|Study terminated by sponsor|0|||
23403329|NCT02078752|65223241|FG007|Overall Study|Study terminated by sponsor|0|||
23403330|NCT02078752|65223242|FG008|Overall Study|Study terminated by sponsor|0|||
23403331|NCT02078752|65223243|FG009|Overall Study|Study terminated by sponsor|5|||
23403332|NCT05525910|65223272|FG000|Period 4|Per sponsor due to study timelines|0|||
23403333|NCT05525910|65223273|FG001|Period 4|Per sponsor due to study timelines|0|||
23403334|NCT05525910|65223274|FG002|Period 4|Per sponsor due to study timelines|1|||
23403335|NCT05525910|65223275|FG003|Period 4|Per sponsor due to study timelines|1|||
23403336|NCT05525910|65223276|FG004|Period 4|Per sponsor due to study timelines|1|||
23403337|NCT03594110|65223277|FG000|Overall Study|Participant concerned about study treatment|23|||
23403338|NCT03594110|65223278|FG001|Overall Study|Participant concerned about study treatment|28|||
23403339|NCT03594110|65223277|FG000|Overall Study|Doctor advice|38|||
23403340|NCT03594110|65223278|FG001|Overall Study|Doctor advice|40|||
23403341|NCT03594110|65223277|FG000|Overall Study|Participants' wish|89|||
23403342|NCT03594110|65223278|FG001|Overall Study|Participants' wish|68|||
23403343|NCT03594110|65223277|FG000|Overall Study|Adverse Event|119|||
23403344|NCT03594110|65223278|FG001|Overall Study|Adverse Event|116|||
23403345|NCT03594110|65223277|FG000|Overall Study|Study drug stopped, reason missing|337|||
23403346|NCT03594110|65223278|FG001|Overall Study|Study drug stopped, reason missing|295|||
23403347|NCT03594110|65223277|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
23403348|NCT03594110|65223278|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
23403349|NCT03594110|65223277|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
23403350|NCT03594110|65223278|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
23403351|NCT03594110|65223277|FG000|Overall Study|Contraindicated drug started|32|||
23403352|NCT03594110|65223278|FG001|Overall Study|Contraindicated drug started|18|||
23403353|NCT03594110|65223277|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
23403354|NCT03594110|65223278|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
23403355|NCT03594110|65223277|FG000|Overall Study|Death|129|||
23403356|NCT03594110|65223278|FG001|Overall Study|Death|120|||
23403357|NCT04240886|65223279|FG000|Treatment Phase|Death|4|||
23403358|NCT04240886|65223279|FG000|Treatment Phase|Discontinuation by Subject|1|||
23403359|NCT04240886|65223279|FG000|Treatment Phase|Adverse Event|5|||
23175775|NCT01790503|64386548|FG008|Overall Study|Other|1|||
23175776|NCT01790503|64386549|FG009|Overall Study|Other|2|||
23175777|NCT01790503|64386550|FG010|Overall Study|Other|0|||
23175778|NCT02411747|64386551|FG000|Overall Study|Withdrawal by Subject|1|||
23175779|NCT02411747|64386552|FG001|Overall Study|Withdrawal by Subject|0|||
23175780|NCT02411747|64386551|FG000|Overall Study|Protocol Violation|2|||
23175781|NCT02411747|64386552|FG001|Overall Study|Protocol Violation|4|||
23175782|NCT03430986|64386554|FG000|24-week Control Period|Adverse Event|1|||
23175783|NCT03430986|64386555|FG001|24-week Control Period|Adverse Event|0|||
23175784|NCT03430986|64386554|FG000|24-week Control Period|Lost to Follow-up|2|||
23175785|NCT03430986|64386555|FG001|24-week Control Period|Lost to Follow-up|2|||
23175786|NCT03430986|64386554|FG000|24-week Control Period|Withdrawal by Participant|5|||
23175787|NCT03430986|64386555|FG001|24-week Control Period|Withdrawal by Participant|0|||
23175788|NCT03430986|64386554|FG000|24-week Control Period|Protocol Deviation|0|||
23175789|NCT03430986|64386555|FG001|24-week Control Period|Protocol Deviation|2|||
23175790|NCT03430986|64386554|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
23175791|NCT03430986|64386555|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
23175792|NCT03430986|64386554|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
23175793|NCT03430986|64386555|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
23175794|NCT02354703|64386559|FG000|Overall Study|Withdrawal by Subject|1|||
23175795|NCT02354703|64386560|FG001|Overall Study|Withdrawal by Subject|1|||
23175796|NCT02354703|64386561|FG002|Overall Study|Withdrawal by Subject|1|||
23175797|NCT02354703|64386562|FG003|Overall Study|Withdrawal by Subject|1|||
23175798|NCT02354703|64386559|FG000|Overall Study|Lost to Follow-up|2|||
23175799|NCT02354703|64386560|FG001|Overall Study|Lost to Follow-up|7|||
23175800|NCT02354703|64386561|FG002|Overall Study|Lost to Follow-up|9|||
23175801|NCT02354703|64386562|FG003|Overall Study|Lost to Follow-up|2|||
23175802|NCT02354703|64386559|FG000|Overall Study|Adverse Event|0|||
23175803|NCT02354703|64386560|FG001|Overall Study|Adverse Event|0|||
23175804|NCT02354703|64386561|FG002|Overall Study|Adverse Event|1|||
23175805|NCT02354703|64386562|FG003|Overall Study|Adverse Event|0|||
23403360|NCT04240886|65223279|FG000|Follow-up Phase|Withdrawal by Subject|1|||
23403361|NCT04240886|65223279|FG000|Follow-up Phase|Discontinuation by Subject|1|||
23403362|NCT04240886|65223279|FG000|Follow-up Phase|Death|2|||
23403363|NCT01908140|65223284|FG000|Overall Study|Other or Progressive Disease|5|||
23403364|NCT01908140|65223285|FG001|Overall Study|Other or Progressive Disease|12|||
23403365|NCT01908140|65223284|FG000|Overall Study|Lack of Efficacy|7|||
23403366|NCT01908140|65223285|FG001|Overall Study|Lack of Efficacy|5|||
23403367|NCT01908140|65223284|FG000|Overall Study|Withdrawal by Subject|23|||
23403368|NCT01908140|65223285|FG001|Overall Study|Withdrawal by Subject|24|||
23403369|NCT01908140|65223284|FG000|Overall Study|Lost to Follow-up|1|||
23403370|NCT01908140|65223285|FG001|Overall Study|Lost to Follow-up|6|||
23403371|NCT01908140|65223284|FG000|Overall Study|Protocol Violation|8|||
23403372|NCT01908140|65223285|FG001|Overall Study|Protocol Violation|9|||
23403373|NCT01908140|65223284|FG000|Overall Study|Adverse Event|22|||
23403374|NCT01908140|65223285|FG001|Overall Study|Adverse Event|23|||
23403375|NCT04865289|65223288|FG000|Overall Study|Participant ongoing in study|47|||
23201699|NCT00002663|64479953|FG001|Overall Study|Death|1|||
23403376|NCT04865289|65223289|FG001|Overall Study|Participant ongoing in study|35|||
23403377|NCT04865289|65223288|FG000|Overall Study|Death|27|||
23403378|NCT04865289|65223289|FG001|Overall Study|Death|21|||
23403379|NCT00087698|65223291|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
23403380|NCT00087698|65223291|FG000|Overall Study|Death from Other Causes|3|||
23403381|NCT00087698|65223291|FG000|Overall Study|Adverse Event|4|||
23403382|NCT00087698|65223291|FG000|Overall Study|Withdrawal by Subject|4|||
23403383|NCT00087698|65223291|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
23403384|NCT00087698|65223291|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
23403385|NCT00087698|65223291|FG000|Overall Study|Clinical Relapse|1|||
23403386|NCT00087698|65223291|FG000|Overall Study|Death from Study Disease|2|||
23403387|NCT00087698|65223291|FG000|Overall Study|Death from Study Drug Toxicity|2|||
23403388|NCT00087698|65223291|FG000|Overall Study|Protocol Violation|1|||
23403389|NCT00889707|65223293|FG000|Overall Study|Adverse Event|1|||
23403390|NCT00889707|65223294|FG001|Overall Study|Adverse Event|0|||
23403391|NCT00889707|65223293|FG000|Overall Study|Withdrawal by Subject|4|||
23403392|NCT00889707|65223294|FG001|Overall Study|Withdrawal by Subject|3|||
23403393|NCT00889707|65223293|FG000|Overall Study|Lost to Follow-up|0|||
23403394|NCT00889707|65223294|FG001|Overall Study|Lost to Follow-up|2|||
23403395|NCT00889707|65223293|FG000|Overall Study|Lack of Efficacy|2|||
23403396|NCT00889707|65223294|FG001|Overall Study|Lack of Efficacy|5|||
23403397|NCT00784368|65223299|FG000|Overall Study|Physician Decision|0|||
23403398|NCT00784368|65223300|FG001|Overall Study|Physician Decision|0|||
23403399|NCT00784368|65223301|FG002|Overall Study|Physician Decision|6|||
23403400|NCT00784368|65223299|FG000|Overall Study|Lack of Efficacy|2|||
23403401|NCT00784368|65223300|FG001|Overall Study|Lack of Efficacy|0|||
23403402|NCT00784368|65223301|FG002|Overall Study|Lack of Efficacy|1|||
23403403|NCT00784368|65223299|FG000|Overall Study|Adverse Event|6|||
23403404|NCT00784368|65223300|FG001|Overall Study|Adverse Event|9|||
23403405|NCT00784368|65223301|FG002|Overall Study|Adverse Event|2|||
23403406|NCT00784368|65223299|FG000|Overall Study|Diagnosis of fever|0|||
23403407|NCT00784368|65223300|FG001|Overall Study|Diagnosis of fever|0|||
23403408|NCT00784368|65223301|FG002|Overall Study|Diagnosis of fever|1|||
23403409|NCT00784368|65223299|FG000|Overall Study|Worsening of complications|0|||
23403410|NCT00784368|65223300|FG001|Overall Study|Worsening of complications|0|||
23201700|NCT00002663|64479954|FG002|Overall Study|Death|1|||
23201701|NCT00002663|64479955|FG003|Overall Study|Death|0|||
23201702|NCT00002663|64479956|FG004|Overall Study|Death|0|||
23201703|NCT00002663|64479957|FG005|Overall Study|Death|13|||
23201704|NCT00002663|64479958|FG006|Overall Study|Death|0|||
23201705|NCT00002663|64479959|FG007|Overall Study|Death|1|||
23201706|NCT00002663|64479960|FG008|Overall Study|Death|1|||
23201707|NCT00002663|64479961|FG009|Overall Study|Death|1|||
23201708|NCT00002663|64479952|FG000|Overall Study|Lost to Follow-up|3|||
23201709|NCT00002663|64479953|FG001|Overall Study|Lost to Follow-up|0|||
23403411|NCT00784368|65223301|FG002|Overall Study|Worsening of complications|1|||
23403412|NCT00784368|65223299|FG000|Overall Study|Worsening of symptoms|0|||
23403413|NCT00784368|65223300|FG001|Overall Study|Worsening of symptoms|1|||
23201710|NCT00002663|64479954|FG002|Overall Study|Lost to Follow-up|0|||
23403414|NCT00784368|65223301|FG002|Overall Study|Worsening of symptoms|0|||
23403415|NCT00784368|65223299|FG000|Overall Study|Withdrawal of informed consent|0|||
23403416|NCT00784368|65223300|FG001|Overall Study|Withdrawal of informed consent|1|||
23403417|NCT00784368|65223301|FG002|Overall Study|Withdrawal of informed consent|0|||
23403418|NCT00811720|65223302|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
23403419|NCT00811720|65223303|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
23403420|NCT00811720|65223302|FG000|All Treated Patients|Adverse Event|20|||
23403421|NCT00811720|65223303|FG001|All Treated Patients|Adverse Event|62|||
23504300|NCT03766581|65587780|FG001|Treatment|Lost to Follow-up|0|||
23504301|NCT03766581|65587781|FG002|Treatment|Lost to Follow-up|0|||
23201711|NCT00002663|64479955|FG003|Overall Study|Lost to Follow-up|1|||
23201712|NCT00002663|64479956|FG004|Overall Study|Lost to Follow-up|0|||
23201713|NCT00002663|64479957|FG005|Overall Study|Lost to Follow-up|1|||
23201714|NCT00002663|64479958|FG006|Overall Study|Lost to Follow-up|0|||
23201715|NCT00002663|64479959|FG007|Overall Study|Lost to Follow-up|0|||
23201716|NCT00002663|64479960|FG008|Overall Study|Lost to Follow-up|0|||
23201717|NCT00002663|64479961|FG009|Overall Study|Lost to Follow-up|0|||
23504302|NCT03766581|65587782|FG003|Treatment|Lost to Follow-up|1|||
23504303|NCT03766581|65587783|FG004|Treatment|Lost to Follow-up|0|||
23504304|NCT03766581|65587784|FG005|Treatment|Lost to Follow-up|0|||
23504305|NCT03766581|65587785|FG006|Treatment|Lost to Follow-up|0|||
23504306|NCT03766581|65587786|FG007|Treatment|Lost to Follow-up|0|||
23504307|NCT03766581|65587779|FG000|Treatment|Poor/Non compliance|2|||
23504308|NCT03766581|65587780|FG001|Treatment|Poor/Non compliance|2|||
23504309|NCT03766581|65587781|FG002|Treatment|Poor/Non compliance|1|||
23504310|NCT03766581|65587782|FG003|Treatment|Poor/Non compliance|1|||
23504311|NCT03766581|65587783|FG004|Treatment|Poor/Non compliance|1|||
23504312|NCT03766581|65587784|FG005|Treatment|Poor/Non compliance|1|||
23504313|NCT03766581|65587785|FG006|Treatment|Poor/Non compliance|0|||
23504314|NCT03766581|65587786|FG007|Treatment|Poor/Non compliance|0|||
23504315|NCT03766581|65587779|FG000|Treatment|Participant no longer meets study criteria|9|||
23504316|NCT03766581|65587780|FG001|Treatment|Participant no longer meets study criteria|1|||
23504317|NCT03766581|65587781|FG002|Treatment|Participant no longer meets study criteria|5|||
23504318|NCT03766581|65587782|FG003|Treatment|Participant no longer meets study criteria|4|||
23504319|NCT03766581|65587783|FG004|Treatment|Participant no longer meets study criteria|4|||
23504320|NCT03766581|65587784|FG005|Treatment|Participant no longer meets study criteria|4|||
23504321|NCT03766581|65587785|FG006|Treatment|Participant no longer meets study criteria|2|||
23504322|NCT03766581|65587786|FG007|Treatment|Participant no longer meets study criteria|0|||
23504323|NCT03766581|65587779|FG000|Treatment|Other reasons|13|||
23504324|NCT03766581|65587780|FG001|Treatment|Other reasons|8|||
23504325|NCT03766581|65587781|FG002|Treatment|Other reasons|3|||
23504326|NCT03766581|65587782|FG003|Treatment|Other reasons|7|||
23504327|NCT03766581|65587783|FG004|Treatment|Other reasons|3|||
23504328|NCT03766581|65587784|FG005|Treatment|Other reasons|3|||
23504329|NCT03766581|65587785|FG006|Treatment|Other reasons|0|||
23504330|NCT03766581|65587786|FG007|Treatment|Other reasons|0|||
23504331|NCT03798483|65587787|FG000|Overall Study|Lost to Follow-up|2|||
23504332|NCT00587054|65587788|FG000|Overall Study|Patient not treated|9|||
23504333|NCT01897454|65587789|FG000|Overall Study|Withdrawal by Subject|1|||
23504334|NCT00381485|65587790|FG000|Open-Label Run-In Period|Adverse Event|9|||
23504335|NCT00381485|65587791|FG001|Open-Label Run-In Period|Adverse Event|0|||
23504336|NCT00381485|65587792|FG002|Open-Label Run-In Period|Adverse Event|0|||
23504337|NCT00381485|65587793|FG003|Open-Label Run-In Period|Adverse Event|0|||
23504338|NCT00381485|65587790|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
23504339|NCT00381485|65587791|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
23504340|NCT00381485|65587792|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
23504341|NCT00381485|65587793|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
23504342|NCT00381485|65587790|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
23504343|NCT00381485|65587791|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
23504344|NCT00381485|65587792|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
23504345|NCT00381485|65587793|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
23504346|NCT00381485|65587790|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
23504347|NCT00381485|65587791|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
23201718|NCT00002663|64479952|FG000|Overall Study|Other|0|||
23201719|NCT00002663|64479953|FG001|Overall Study|Other|1|||
23201720|NCT00002663|64479954|FG002|Overall Study|Other|0|||
23201721|NCT00002663|64479955|FG003|Overall Study|Other|0|||
23201722|NCT00002663|64479956|FG004|Overall Study|Other|0|||
23201723|NCT00002663|64479957|FG005|Overall Study|Other|1|||
23201724|NCT00002663|64479958|FG006|Overall Study|Other|1|||
23201725|NCT00002663|64479959|FG007|Overall Study|Other|0|||
23201726|NCT00002663|64479960|FG008|Overall Study|Other|0|||
23201727|NCT00002663|64479961|FG009|Overall Study|Other|0|||
23201728|NCT00002663|64479952|FG000|Overall Study|Physician Decision|0|||
23201729|NCT00002663|64479953|FG001|Overall Study|Physician Decision|0|||
23201730|NCT00002663|64479954|FG002|Overall Study|Physician Decision|0|||
23504348|NCT00381485|65587792|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
23504349|NCT00381485|65587793|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
23504350|NCT00381485|65587790|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
23201731|NCT00002663|64479955|FG003|Overall Study|Physician Decision|0|||
23201732|NCT00002663|64479956|FG004|Overall Study|Physician Decision|1|||
23201733|NCT00002663|64479957|FG005|Overall Study|Physician Decision|0|||
23504351|NCT00381485|65587791|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
23504352|NCT00381485|65587792|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
23504353|NCT00381485|65587793|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
23504354|NCT00381485|65587790|FG000|Open-Label Run-In Period|Treatment failure|1|||
23504355|NCT00381485|65587791|FG001|Open-Label Run-In Period|Treatment failure|0|||
23504356|NCT00381485|65587792|FG002|Open-Label Run-In Period|Treatment failure|0|||
23504357|NCT00381485|65587793|FG003|Open-Label Run-In Period|Treatment failure|0|||
23504358|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23504359|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Adverse Event|2|||
23504360|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Adverse Event|2|||
23504361|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Adverse Event|5|||
23504362|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23504363|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
23504364|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
23504365|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
23504366|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23504367|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
23504368|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
23504369|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
23504370|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
23504371|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
23504372|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
23504373|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
23504374|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
23504375|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
23504376|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
23504377|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
23504378|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
23403422|NCT00811720|65223302|FG000|All Treated Patients|Lack of Efficacy|22|||
23403423|NCT00811720|65223303|FG001|All Treated Patients|Lack of Efficacy|18|||
23403424|NCT00811720|65223302|FG000|All Treated Patients|Non-compliance|0|||
23403425|NCT00811720|65223303|FG001|All Treated Patients|Non-compliance|14|||
23403426|NCT00811720|65223302|FG000|All Treated Patients|Protocol Violation|9|||
23403427|NCT00811720|65223303|FG001|All Treated Patients|Protocol Violation|16|||
23403428|NCT00811720|65223302|FG000|All Treated Patients|Withdrawal by Subject|28|||
23403429|NCT00811720|65223303|FG001|All Treated Patients|Withdrawal by Subject|34|||
23403430|NCT00811720|65223302|FG000|All Treated Patients|Lost to Follow-up|10|||
23403431|NCT00811720|65223303|FG001|All Treated Patients|Lost to Follow-up|16|||
23403432|NCT00811720|65223302|FG000|All Treated Patients|Other Reason|7|||
23403433|NCT00811720|65223303|FG001|All Treated Patients|Other Reason|4|||
23403434|NCT00107276|65223305|FG000|Overall Study|Progression|46|||
23403435|NCT00107276|65223305|FG000|Overall Study|Adverse Event|6|||
23403436|NCT00107276|65223305|FG000|Overall Study|M.D. decision|2|||
23403437|NCT00107276|65223305|FG000|Overall Study|Patient refusal|1|||
23403438|NCT00107276|65223305|FG000|Overall Study|Death|1|||
23403439|NCT00107276|65223305|FG000|Overall Study|Ineligible|16|||
23403440|NCT00488514|65223306|FG000|Overall Study|Adverse Event|41|||
23201734|NCT00002663|64479958|FG006|Overall Study|Physician Decision|0|||
23201735|NCT00002663|64479959|FG007|Overall Study|Physician Decision|0|||
23201736|NCT00002663|64479960|FG008|Overall Study|Physician Decision|1|||
23201737|NCT00002663|64479961|FG009|Overall Study|Physician Decision|1|||
23201738|NCT00002663|64479952|FG000|Overall Study|Adverse Event|0|||
23201739|NCT00002663|64479953|FG001|Overall Study|Adverse Event|0|||
23201740|NCT00002663|64479954|FG002|Overall Study|Adverse Event|0|||
23201741|NCT00002663|64479955|FG003|Overall Study|Adverse Event|1|||
23201742|NCT00002663|64479956|FG004|Overall Study|Adverse Event|0|||
23201743|NCT00002663|64479957|FG005|Overall Study|Adverse Event|0|||
23201744|NCT00002663|64479958|FG006|Overall Study|Adverse Event|0|||
23403441|NCT00488514|65223306|FG000|Overall Study|Lost to Follow-up|44|||
23403442|NCT00488514|65223306|FG000|Overall Study|Protocol Violation|32|||
23403443|NCT00488514|65223306|FG000|Overall Study|Withdrawal by Subject|106|||
23403444|NCT00488514|65223306|FG000|Overall Study|Lack of Efficacy|28|||
23403445|NCT00488514|65223306|FG000|Overall Study|Did not meet criteria for treatment|30|||
23403446|NCT00488514|65223306|FG000|Overall Study|Postive drug screen|1|||
23403447|NCT00488514|65223306|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
23403448|NCT00488514|65223306|FG000|Overall Study|Investigator decision|1|||
23403449|NCT00488514|65223306|FG000|Overall Study|Participant had too few migraines|5|||
23403450|NCT00488514|65223306|FG000|Overall Study|Increase in number of migraines|2|||
23403451|NCT00488514|65223306|FG000|Overall Study|Increased use of concomitant medication|1|||
23403452|NCT02949024|65223307|FG000|Overall Study|Withdrawal by Subject|0|||
23403453|NCT02949024|65223308|FG001|Overall Study|Withdrawal by Subject|1|||
23403454|NCT02230189|65223309|FG000|Overall Study|Withdrawal by Subject|3|||
23403455|NCT02230189|65223310|FG001|Overall Study|Withdrawal by Subject|0|||
23403456|NCT02230189|65223311|FG002|Overall Study|Withdrawal by Subject|1|||
23403457|NCT02230189|65223309|FG000|Overall Study|Lost to Follow-up|1|||
23403458|NCT02230189|65223310|FG001|Overall Study|Lost to Follow-up|0|||
23403459|NCT02230189|65223311|FG002|Overall Study|Lost to Follow-up|0|||
23403460|NCT02230189|65223309|FG000|Overall Study|Physician Decision|1|||
23403461|NCT02230189|65223310|FG001|Overall Study|Physician Decision|0|||
23403462|NCT02230189|65223311|FG002|Overall Study|Physician Decision|0|||
23403463|NCT02954458|65223319|FG000|Overall Study|Adverse Event|0|||
23403464|NCT02954458|65223320|FG001|Overall Study|Adverse Event|0|||
23403465|NCT02954458|65223321|FG002|Overall Study|Adverse Event|0|||
23403466|NCT02954458|65223322|FG003|Overall Study|Adverse Event|1|||
23403467|NCT02954458|65223319|FG000|Overall Study|Withdrawal by Subject|0|||
23403468|NCT02954458|65223320|FG001|Overall Study|Withdrawal by Subject|0|||
23403469|NCT02954458|65223321|FG002|Overall Study|Withdrawal by Subject|0|||
23403470|NCT02954458|65223322|FG003|Overall Study|Withdrawal by Subject|1|||
23403471|NCT02954458|65223319|FG000|Overall Study|Physician Decision|0|||
23403472|NCT02954458|65223320|FG001|Overall Study|Physician Decision|0|||
23403473|NCT02954458|65223321|FG002|Overall Study|Physician Decision|1|||
23403474|NCT02954458|65223322|FG003|Overall Study|Physician Decision|1|||
23403475|NCT02954458|65223319|FG000|Overall Study|Lost to Follow-up|1|||
23403476|NCT02954458|65223320|FG001|Overall Study|Lost to Follow-up|0|||
23403477|NCT02954458|65223321|FG002|Overall Study|Lost to Follow-up|0|||
23403478|NCT02954458|65223322|FG003|Overall Study|Lost to Follow-up|1|||
23403479|NCT02954458|65223319|FG000|Overall Study|Death|0|||
23403480|NCT02954458|65223320|FG001|Overall Study|Death|0|||
23403481|NCT02954458|65223321|FG002|Overall Study|Death|0|||
23403482|NCT02954458|65223322|FG003|Overall Study|Death|1|||
23403483|NCT02954458|65223319|FG000|Overall Study|Other|0|||
23403484|NCT02954458|65223320|FG001|Overall Study|Other|0|||
23403485|NCT02954458|65223321|FG002|Overall Study|Other|0|||
23403486|NCT02954458|65223322|FG003|Overall Study|Other|7|||
23403487|NCT01345929|65223323|FG000|Overall Study|Withdrawal by Subject|9|||
23403488|NCT01345929|65223324|FG001|Overall Study|Withdrawal by Subject|8|||
23403489|NCT01345929|65223323|FG000|Overall Study|Lost to Follow-up|9|||
23403490|NCT01345929|65223324|FG001|Overall Study|Lost to Follow-up|9|||
23403491|NCT01345929|65223323|FG000|Overall Study|Adverse Event|0|||
23403492|NCT01345929|65223324|FG001|Overall Study|Adverse Event|1|||
23403493|NCT01345929|65223323|FG000|Overall Study|Didn't meet eligibility criteria|2|||
23403494|NCT01345929|65223324|FG001|Overall Study|Didn't meet eligibility criteria|0|||
23403495|NCT01345929|65223323|FG000|Overall Study|40,000 CFU/ML|1|||
23403496|NCT01345929|65223324|FG001|Overall Study|40,000 CFU/ML|0|||
23403497|NCT01345929|65223323|FG000|Overall Study|Patient withdrawal|0|||
23403498|NCT01345929|65223324|FG001|Overall Study|Patient withdrawal|1|||
23403499|NCT01603043|65223331|FG000|Overall Study|Study Futility|7|||
23403500|NCT01603043|65223332|FG001|Overall Study|Study Futility|3|||
23403501|NCT03381287|65223333|FG000|Overall Study|Withdrawal by Subject|0|||
23403502|NCT03381287|65223334|FG001|Overall Study|Withdrawal by Subject|1|||
23403503|NCT03381287|65223335|FG002|Overall Study|Withdrawal by Subject|0|||
23403504|NCT03381287|65223336|FG003|Overall Study|Withdrawal by Subject|0|||
23403505|NCT03381287|65223333|FG000|Overall Study|Adverse Event|0|||
23403506|NCT03381287|65223334|FG001|Overall Study|Adverse Event|0|||
23403507|NCT03381287|65223335|FG002|Overall Study|Adverse Event|0|||
23403508|NCT03381287|65223336|FG003|Overall Study|Adverse Event|1|||
23403509|NCT03381287|65223333|FG000|Overall Study|Physician Decision|0|||
23403510|NCT03381287|65223334|FG001|Overall Study|Physician Decision|0|||
23403511|NCT03381287|65223335|FG002|Overall Study|Physician Decision|0|||
23403512|NCT03381287|65223336|FG003|Overall Study|Physician Decision|1|||
23403513|NCT03654274|65223337|FG000|Overall Study|Adverse Event|19|||
23403514|NCT03654274|65223338|FG001|Overall Study|Adverse Event|23|||
23403515|NCT03654274|65223339|FG002|Overall Study|Adverse Event|24|||
23403516|NCT03654274|65223337|FG000|Overall Study|Protocol Deviation|0|||
23403517|NCT03654274|65223338|FG001|Overall Study|Protocol Deviation|2|||
23403518|NCT03654274|65223339|FG002|Overall Study|Protocol Deviation|0|||
23403519|NCT03654274|65223337|FG000|Overall Study|Lost to Follow-up|8|||
23403520|NCT03654274|65223338|FG001|Overall Study|Lost to Follow-up|6|||
23403521|NCT03654274|65223339|FG002|Overall Study|Lost to Follow-up|5|||
23403522|NCT03654274|65223337|FG000|Overall Study|Withdrawal by Subject|46|||
23403523|NCT03654274|65223338|FG001|Overall Study|Withdrawal by Subject|25|||
23403524|NCT03654274|65223339|FG002|Overall Study|Withdrawal by Subject|33|||
23403525|NCT03654274|65223337|FG000|Overall Study|Lack of Efficacy|4|||
23403526|NCT03654274|65223338|FG001|Overall Study|Lack of Efficacy|5|||
23403527|NCT03654274|65223339|FG002|Overall Study|Lack of Efficacy|7|||
23403528|NCT03654274|65223337|FG000|Overall Study|Pregnancy|2|||
23403529|NCT03654274|65223338|FG001|Overall Study|Pregnancy|2|||
23403530|NCT03654274|65223339|FG002|Overall Study|Pregnancy|1|||
23403531|NCT03654274|65223337|FG000|Overall Study|Other|27|||
23403532|NCT03654274|65223338|FG001|Overall Study|Other|29|||
23403533|NCT03654274|65223339|FG002|Overall Study|Other|32|||
23403534|NCT03654274|65223337|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
23403535|NCT03654274|65223338|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
23403536|NCT03654274|65223339|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
23403537|NCT00972517|65223344|FG000|Overall Study|Adverse Event|0|||
23403538|NCT00972517|65223345|FG001|Overall Study|Adverse Event|0|||
23403539|NCT00972517|65223346|FG002|Overall Study|Adverse Event|0|||
23403540|NCT00972517|65223347|FG003|Overall Study|Adverse Event|1|||
23403541|NCT00972517|65223348|FG004|Overall Study|Adverse Event|0|||
23403542|NCT00972517|65223349|FG005|Overall Study|Adverse Event|0|||
23403543|NCT00972517|65223344|FG000|Overall Study|Withdrawal by Subject|0|||
23403544|NCT00972517|65223345|FG001|Overall Study|Withdrawal by Subject|1|||
23403545|NCT00972517|65223346|FG002|Overall Study|Withdrawal by Subject|0|||
23403546|NCT00972517|65223347|FG003|Overall Study|Withdrawal by Subject|2|||
23403547|NCT00972517|65223348|FG004|Overall Study|Withdrawal by Subject|1|||
23403548|NCT00972517|65223349|FG005|Overall Study|Withdrawal by Subject|0|||
23403549|NCT00636181|65223350|FG000|Overall Study|Withdrawal by Subject|8|||
23403550|NCT00636181|65223351|FG001|Overall Study|Withdrawal by Subject|6|||
23403551|NCT00636181|65223352|FG002|Overall Study|Withdrawal by Subject|10|||
23403552|NCT02850978|65223361|FG000|Overall Study|Uncollectable CRF|27|||
23403553|NCT02850978|65223361|FG000|Overall Study|No visit since the first visit|35|||
23403554|NCT02850978|65223361|FG000|Overall Study|Adverse Event|81|||
23403555|NCT02850978|65223361|FG000|Overall Study|Lack of Efficacy|40|||
23403556|NCT02850978|65223361|FG000|Overall Study|Improvement in condition|34|||
23302337|NCT01144364|64850677|FG000|Induction Phase|Death|1|||
23403557|NCT02850978|65223361|FG000|Overall Study|Lost to Follow-up|121|||
23403558|NCT02850978|65223361|FG000|Overall Study|Reason not listed|88|||
23403559|NCT03519997|65223363|FG000|Overall Study|Adverse Event|4|||
23403560|NCT03519997|65223363|FG000|Overall Study|Withdrawal by Subject|2|||
23403561|NCT03519997|65223363|FG000|Overall Study|Protocol Violation|1|||
23403562|NCT00443118|65223364|FG000|Overall Study|unknown primary outcome|3|||
23403563|NCT00443118|65223365|FG001|Overall Study|unknown primary outcome|1|||
23403564|NCT00443118|65223366|FG002|Overall Study|unknown primary outcome|0|||
23403565|NCT00443118|65223364|FG000|Overall Study|Withdrawal by Subject|1|||
23403566|NCT00443118|65223365|FG001|Overall Study|Withdrawal by Subject|0|||
23403567|NCT00443118|65223366|FG002|Overall Study|Withdrawal by Subject|0|||
23403568|NCT02012218|65223367|FG000|Overall Study|Withdrawal by Subject|1|||
23403569|NCT02012218|65223368|FG001|Overall Study|Withdrawal by Subject|0|||
23403570|NCT02012218|65223369|FG002|Overall Study|Withdrawal by Subject|1|||
23403571|NCT02012218|65223370|FG003|Overall Study|Withdrawal by Subject|1|||
23403572|NCT02012218|65223371|FG004|Overall Study|Withdrawal by Subject|1|||
23403573|NCT02012218|65223367|FG000|Overall Study|Adverse Event|1|||
23403574|NCT02012218|65223368|FG001|Overall Study|Adverse Event|0|||
23403575|NCT02012218|65223369|FG002|Overall Study|Adverse Event|0|||
23403576|NCT02012218|65223370|FG003|Overall Study|Adverse Event|1|||
23403577|NCT02012218|65223371|FG004|Overall Study|Adverse Event|0|||
23403578|NCT02012218|65223367|FG000|Overall Study|Lost to Follow-up|0|||
23403579|NCT02012218|65223368|FG001|Overall Study|Lost to Follow-up|1|||
23403580|NCT02012218|65223369|FG002|Overall Study|Lost to Follow-up|1|||
23403581|NCT02012218|65223370|FG003|Overall Study|Lost to Follow-up|0|||
23403582|NCT02012218|65223371|FG004|Overall Study|Lost to Follow-up|0|||
23403583|NCT02012218|65223367|FG000|Overall Study|Protocol Specified|1|||
23403584|NCT02012218|65223368|FG001|Overall Study|Protocol Specified|0|||
23403585|NCT02012218|65223369|FG002|Overall Study|Protocol Specified|0|||
23302338|NCT01144364|64850678|FG001|Induction Phase|Death|0|||
23403586|NCT02012218|65223370|FG003|Overall Study|Protocol Specified|0|||
23403587|NCT02012218|65223371|FG004|Overall Study|Protocol Specified|0|||
23403588|NCT02012218|65223367|FG000|Overall Study|Protocol Deviation|1|||
23403589|NCT02012218|65223368|FG001|Overall Study|Protocol Deviation|0|||
23403590|NCT02012218|65223369|FG002|Overall Study|Protocol Deviation|0|||
23403591|NCT02012218|65223370|FG003|Overall Study|Protocol Deviation|0|||
23403592|NCT02012218|65223371|FG004|Overall Study|Protocol Deviation|0|||
23403593|NCT01490918|65223372|FG000|Overall Study|Lost to Follow-up|2|||
23403594|NCT01490918|65223373|FG001|Overall Study|Lost to Follow-up|1|||
23403595|NCT01490918|65223374|FG002|Overall Study|Lost to Follow-up|0|||
23403596|NCT01490918|65223372|FG000|Overall Study|Withdrawal by Subject|7|||
23403597|NCT01490918|65223373|FG001|Overall Study|Withdrawal by Subject|8|||
23403598|NCT01490918|65223374|FG002|Overall Study|Withdrawal by Subject|3|||
23403599|NCT01490918|65223372|FG000|Overall Study|Adverse Event|0|||
23403600|NCT01490918|65223373|FG001|Overall Study|Adverse Event|0|||
23403601|NCT01490918|65223374|FG002|Overall Study|Adverse Event|1|||
23403602|NCT01490918|65223372|FG000|Overall Study|other cause|4|||
23403603|NCT01490918|65223373|FG001|Overall Study|other cause|5|||
23403604|NCT01490918|65223374|FG002|Overall Study|other cause|8|||
23403605|NCT03073525|65223375|FG000|Overall Study|Withdrawal by Subject|0|||
23403606|NCT03073525|65223376|FG001|Overall Study|Withdrawal by Subject|0|||
23403607|NCT03073525|65223377|FG002|Overall Study|Withdrawal by Subject|3|||
23403608|NCT01465386|65223382|FG000|Overall Study|Lack of Efficacy|3|||
23403609|NCT01465386|65223382|FG000|Overall Study|Adverse Event|1|||
23403610|NCT00429182|65223387|FG000|Overall Study|Not evaluable, Disease Progression|2|||
23403611|NCT00429182|65223387|FG000|Overall Study|Not eligible|5|||
23403612|NCT02347085|65223388|FG000|Overall Study|Adverse Event|2|||
23403613|NCT02347085|65223388|FG000|Overall Study|Lack of Efficacy|1|||
23403614|NCT02347085|65223388|FG000|Overall Study|Withdrawal by Subject|4|||
23403615|NCT02347085|65223388|FG000|Overall Study|Lost to Follow-up|1|||
23403616|NCT02347085|65223388|FG000|Overall Study|Protocol Criteria|2|||
23403617|NCT03533660|65223391|FG000|Overall Study|Withdrawal by Subject|2|||
23403618|NCT03533660|65223392|FG001|Overall Study|Withdrawal by Subject|2|||
23403619|NCT03533660|65223391|FG000|Overall Study|Death|2|||
23403620|NCT03533660|65223392|FG001|Overall Study|Death|4|||
23403621|NCT03533660|65223391|FG000|Overall Study|Adverse Event|0|||
23403622|NCT03533660|65223392|FG001|Overall Study|Adverse Event|2|||
23403623|NCT01206517|65223393|FG000|Overall Study|Withdrawal by Subject|0|||
23403624|NCT01206517|65223394|FG001|Overall Study|Withdrawal by Subject|0|||
23403625|NCT01206517|65223395|FG002|Overall Study|Withdrawal by Subject|2|||
23403626|NCT01206517|65223396|FG003|Overall Study|Withdrawal by Subject|0|||
23403627|NCT01206517|65223397|FG004|Overall Study|Withdrawal by Subject|1|||
23403628|NCT01206517|65223398|FG005|Overall Study|Withdrawal by Subject|0|||
23403629|NCT00295646|65223399|FG000|Overall Study|Protocol Violation|18|||
23403630|NCT00295646|65223400|FG001|Overall Study|Protocol Violation|20|||
23403631|NCT00295646|65223401|FG002|Overall Study|Protocol Violation|20|||
23403632|NCT00295646|65223402|FG003|Overall Study|Protocol Violation|18|||
23403633|NCT00295646|65223399|FG000|Overall Study|Withdrawal by Subject|8|||
23403634|NCT00295646|65223400|FG001|Overall Study|Withdrawal by Subject|9|||
23403635|NCT00295646|65223401|FG002|Overall Study|Withdrawal by Subject|11|||
23403636|NCT00295646|65223402|FG003|Overall Study|Withdrawal by Subject|14|||
23403637|NCT00295646|65223399|FG000|Overall Study|Lost to Follow-up|0|||
23403638|NCT00295646|65223400|FG001|Overall Study|Lost to Follow-up|5|||
23403639|NCT00295646|65223401|FG002|Overall Study|Lost to Follow-up|1|||
23403640|NCT00295646|65223402|FG003|Overall Study|Lost to Follow-up|5|||
23403641|NCT00295646|65223399|FG000|Overall Study|Death|9|||
23403642|NCT00295646|65223400|FG001|Overall Study|Death|7|||
23403643|NCT00295646|65223401|FG002|Overall Study|Death|18|||
23403644|NCT00295646|65223402|FG003|Overall Study|Death|8|||
23403645|NCT02473471|65223405|FG000|Overall Study|poor oral hygiene|2|||
23403646|NCT02473471|65223405|FG000|Overall Study|Lost to Follow-up|1|||
23403647|NCT00783432|65223416|FG000|Overall Study|Adverse Event|22|||
23403648|NCT00783432|65223417|FG001|Overall Study|Adverse Event|17|||
23403649|NCT00783432|65223416|FG000|Overall Study|Lack of Efficacy|20|||
23403650|NCT00783432|65223417|FG001|Overall Study|Lack of Efficacy|21|||
23403651|NCT00783432|65223416|FG000|Overall Study|Lost to Follow-up|11|||
23403652|NCT00783432|65223417|FG001|Overall Study|Lost to Follow-up|6|||
23403653|NCT00783432|65223416|FG000|Overall Study|Withdrawal by Subject|23|||
23403654|NCT00783432|65223417|FG001|Overall Study|Withdrawal by Subject|20|||
23403655|NCT00783432|65223416|FG000|Overall Study|subject moved|3|||
23403656|NCT00783432|65223417|FG001|Overall Study|subject moved|5|||
23403657|NCT00783432|65223416|FG000|Overall Study|Protocol Violation|6|||
23403658|NCT00783432|65223417|FG001|Overall Study|Protocol Violation|9|||
23403659|NCT00972023|65223418|FG000|Overall Study|Withdrawal by Subject|1|||
23403660|NCT03710889|65223422|FG000|Overall Study|Adverse Event|2|||
23403661|NCT03710889|65223422|FG000|Overall Study|Protocol Deviation|1|||
23403662|NCT00442416|65223423|FG000|Overall Study|Adverse Event|4|||
23403663|NCT00442416|65223424|FG001|Overall Study|Adverse Event|1|||
23403664|NCT00442416|65223423|FG000|Overall Study|Death|1|||
23403665|NCT00442416|65223424|FG001|Overall Study|Death|0|||
23403666|NCT00442416|65223423|FG000|Overall Study|Lack of Efficacy|2|||
23403667|NCT00442416|65223424|FG001|Overall Study|Lack of Efficacy|0|||
23403668|NCT00442416|65223423|FG000|Overall Study|Protocol Violation|2|||
23403669|NCT00442416|65223424|FG001|Overall Study|Protocol Violation|3|||
23403670|NCT00442416|65223423|FG000|Overall Study|Withdrew consent|1|||
23403671|NCT00442416|65223424|FG001|Overall Study|Withdrew consent|2|||
23403672|NCT00442416|65223423|FG000|Overall Study|Administrative/Other|27|||
23403673|NCT00442416|65223424|FG001|Overall Study|Administrative/Other|33|||
23403674|NCT03082677|65223427|FG000|Overall Study|Not Treated|2|||
23403675|NCT00305877|65223428|FG000|Overall Study|Lack of Efficacy|6|||
23403676|NCT00305877|65223429|FG001|Overall Study|Lack of Efficacy|9|||
23403677|NCT00305877|65223428|FG000|Overall Study|Adverse Event|9|||
23403678|NCT00305877|65223429|FG001|Overall Study|Adverse Event|14|||
23403679|NCT00305877|65223428|FG000|Overall Study|Death|0|||
23403680|NCT00305877|65223429|FG001|Overall Study|Death|1|||
23403681|NCT00305877|65223428|FG000|Overall Study|Withdrawal by Subject|4|||
23403682|NCT00305877|65223429|FG001|Overall Study|Withdrawal by Subject|2|||
23403683|NCT00305877|65223428|FG000|Overall Study|Physician Decision|1|||
23403684|NCT00305877|65223429|FG001|Overall Study|Physician Decision|1|||
23403685|NCT00305877|65223428|FG000|Overall Study|Never start treatment|2|||
23403686|NCT00305877|65223429|FG001|Overall Study|Never start treatment|5|||
23403687|NCT00305877|65223428|FG000|Overall Study|Ineligible|2|||
23403688|NCT00305877|65223429|FG001|Overall Study|Ineligible|1|||
23403689|NCT00305877|65223428|FG000|Overall Study|Transportation issue with daily RT|0|||
23403690|NCT00305877|65223429|FG001|Overall Study|Transportation issue with daily RT|1|||
23403691|NCT00165789|65223430|FG000|Overall Study|Adverse Event|0|||
23403692|NCT00165789|65223431|FG001|Overall Study|Adverse Event|3|||
23403693|NCT00165789|65223432|FG002|Overall Study|Adverse Event|0|||
23403694|NCT00165789|65223433|FG003|Overall Study|Adverse Event|12|||
23403695|NCT00165789|65223430|FG000|Overall Study|Withdrawal by Subject|0|||
23403696|NCT00165789|65223431|FG001|Overall Study|Withdrawal by Subject|1|||
23403697|NCT00165789|65223432|FG002|Overall Study|Withdrawal by Subject|1|||
23403698|NCT00165789|65223433|FG003|Overall Study|Withdrawal by Subject|2|||
23403699|NCT02271529|65223434|FG000|Overall Study|Withdrawal by Subject|1|||
23403700|NCT00570713|65223435|FG000|Overall Study|Adverse Event|16|||
23403701|NCT00570713|65223436|FG001|Overall Study|Adverse Event|9|||
23403702|NCT00570713|65223435|FG000|Overall Study|Death|7|||
23403703|NCT00570713|65223436|FG001|Overall Study|Death|7|||
23403704|NCT00570713|65223435|FG000|Overall Study|Lack of Efficacy|40|||
23403705|NCT00570713|65223436|FG001|Overall Study|Lack of Efficacy|49|||
23403706|NCT00570713|65223435|FG000|Overall Study|Physician Decision|2|||
23403707|NCT00570713|65223436|FG001|Overall Study|Physician Decision|2|||
23403708|NCT00570713|65223435|FG000|Overall Study|Withdrawal by Subject|3|||
23403709|NCT00570713|65223436|FG001|Overall Study|Withdrawal by Subject|3|||
23403710|NCT00570713|65223435|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
23403711|NCT00570713|65223436|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
23403712|NCT01628913|65223439|FG000|Overall Study|Adverse Event|12|||
23403713|NCT01628913|65223440|FG001|Overall Study|Adverse Event|5|||
23403714|NCT01628913|65223439|FG000|Overall Study|Disease Progression|11|||
23403715|NCT01628913|65223440|FG001|Overall Study|Disease Progression|14|||
23403716|NCT01628913|65223439|FG000|Overall Study|Protocol Violation|1|||
23403717|NCT01628913|65223440|FG001|Overall Study|Protocol Violation|0|||
23403718|NCT01628913|65223439|FG000|Overall Study|Death|1|||
23403719|NCT01628913|65223440|FG001|Overall Study|Death|0|||
23403720|NCT01628913|65223439|FG000|Overall Study|study terminated by Sponsor|4|||
23403721|NCT01628913|65223440|FG001|Overall Study|study terminated by Sponsor|9|||
23403722|NCT01628913|65223439|FG000|Overall Study|Withdrawal by Subject|1|||
23403723|NCT01628913|65223440|FG001|Overall Study|Withdrawal by Subject|0|||
23403724|NCT01628913|65223439|FG000|Overall Study|Physician Decision|1|||
23403725|NCT01628913|65223440|FG001|Overall Study|Physician Decision|3|||
23403726|NCT00524121|65223443|FG000|Overall Study|Disease progression|6|||
23403727|NCT00524121|65223443|FG000|Overall Study|Adverse Event|4|||
23403728|NCT00524121|65223443|FG000|Overall Study|Patient refused|2|||
23403729|NCT00524121|65223443|FG000|Overall Study|Other|1|||
23403730|NCT00524121|65223443|FG000|Overall Study|Death|1|||
23403731|NCT00524121|65223443|FG000|Overall Study|Not treated (became ineligible)|4|||
23403732|NCT00524121|65223443|FG000|Overall Study|Not treated (changed mind)|1|||
23403733|NCT01261975|65223448|FG000|Overall Study|Surgical complication|1|||
23403734|NCT01840943|65223449|FG000|Overall Study|Withdrawal by Subject|5|||
23403735|NCT01840943|65223450|FG001|Overall Study|Withdrawal by Subject|6|||
23403736|NCT01840943|65223449|FG000|Overall Study|Physician Decision|4|||
23403737|NCT01840943|65223450|FG001|Overall Study|Physician Decision|2|||
23403738|NCT01840943|65223449|FG000|Overall Study|Lost to Follow-up|4|||
23403739|NCT01840943|65223450|FG001|Overall Study|Lost to Follow-up|4|||
23403740|NCT00272792|65223451|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
23403741|NCT00272792|65223452|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
23403742|NCT00272792|65223451|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
23403743|NCT00272792|65223452|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
23403744|NCT00272792|65223451|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
23403745|NCT00272792|65223452|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
23403746|NCT00272792|65223451|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
23403747|NCT00272792|65223452|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
23403748|NCT01192126|65223453|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
23403749|NCT01192126|65223454|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
23403750|NCT01192126|65223453|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
23403751|NCT01192126|65223454|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
23403752|NCT00421148|65223464|FG000|Overall Study|Lost to Follow-up|0|||
23175806|NCT00560755|64386565|FG000|Overall Study|Protocol Violation|15|||
23403753|NCT00421148|65223465|FG001|Overall Study|Lost to Follow-up|0|||
23403754|NCT00421148|65223466|FG002|Overall Study|Lost to Follow-up|0|||
23403755|NCT00421148|65223467|FG003|Overall Study|Lost to Follow-up|0|||
23403756|NCT00421148|65223468|FG004|Overall Study|Lost to Follow-up|0|||
23403757|NCT00421148|65223469|FG005|Overall Study|Lost to Follow-up|0|||
23403758|NCT00421148|65223470|FG006|Overall Study|Lost to Follow-up|0|||
23403759|NCT00421148|65223471|FG007|Overall Study|Lost to Follow-up|0|||
23403760|NCT00421148|65223472|FG008|Overall Study|Lost to Follow-up|0|||
23403761|NCT00421148|65223473|FG009|Overall Study|Lost to Follow-up|0|||
23403762|NCT00421148|65223474|FG010|Overall Study|Lost to Follow-up|0|||
23403763|NCT00421148|65223475|FG011|Overall Study|Lost to Follow-up|0|||
23403764|NCT00421148|65223476|FG012|Overall Study|Lost to Follow-up|0|||
23403765|NCT00421148|65223477|FG013|Overall Study|Lost to Follow-up|0|||
23403766|NCT00421148|65223478|FG014|Overall Study|Lost to Follow-up|0|||
23403767|NCT00421148|65223479|FG015|Overall Study|Lost to Follow-up|0|||
23403768|NCT00421148|65223480|FG016|Overall Study|Lost to Follow-up|0|||
23403769|NCT00421148|65223481|FG017|Overall Study|Lost to Follow-up|1|||
23403770|NCT00421148|65223482|FG018|Overall Study|Lost to Follow-up|0|||
23403771|NCT00421148|65223483|FG019|Overall Study|Lost to Follow-up|0|||
23403772|NCT00421148|65223464|FG000|Overall Study|Withdrawal by Subject|0|||
23403773|NCT00421148|65223465|FG001|Overall Study|Withdrawal by Subject|0|||
23403774|NCT00421148|65223466|FG002|Overall Study|Withdrawal by Subject|0|||
23403775|NCT00421148|65223467|FG003|Overall Study|Withdrawal by Subject|0|||
23403776|NCT00421148|65223468|FG004|Overall Study|Withdrawal by Subject|0|||
23403777|NCT00421148|65223469|FG005|Overall Study|Withdrawal by Subject|0|||
23403778|NCT00421148|65223470|FG006|Overall Study|Withdrawal by Subject|0|||
23403779|NCT00421148|65223471|FG007|Overall Study|Withdrawal by Subject|0|||
23403780|NCT00421148|65223472|FG008|Overall Study|Withdrawal by Subject|0|||
23403781|NCT00421148|65223473|FG009|Overall Study|Withdrawal by Subject|0|||
23403782|NCT00421148|65223474|FG010|Overall Study|Withdrawal by Subject|0|||
23403783|NCT00421148|65223475|FG011|Overall Study|Withdrawal by Subject|0|||
23403784|NCT00421148|65223476|FG012|Overall Study|Withdrawal by Subject|0|||
23403785|NCT00421148|65223477|FG013|Overall Study|Withdrawal by Subject|0|||
23403786|NCT00421148|65223478|FG014|Overall Study|Withdrawal by Subject|0|||
23403787|NCT00421148|65223479|FG015|Overall Study|Withdrawal by Subject|0|||
23403788|NCT00421148|65223480|FG016|Overall Study|Withdrawal by Subject|0|||
23403789|NCT00421148|65223481|FG017|Overall Study|Withdrawal by Subject|1|||
23403790|NCT00421148|65223482|FG018|Overall Study|Withdrawal by Subject|0|||
23403791|NCT00421148|65223483|FG019|Overall Study|Withdrawal by Subject|0|||
23403792|NCT00421148|65223464|FG000|Overall Study|Protocol Violation|0|||
23403793|NCT00421148|65223465|FG001|Overall Study|Protocol Violation|0|||
23403794|NCT00421148|65223466|FG002|Overall Study|Protocol Violation|0|||
23403795|NCT00421148|65223467|FG003|Overall Study|Protocol Violation|0|||
23403796|NCT00421148|65223468|FG004|Overall Study|Protocol Violation|0|||
23403797|NCT00421148|65223469|FG005|Overall Study|Protocol Violation|1|||
23403798|NCT00421148|65223470|FG006|Overall Study|Protocol Violation|0|||
23403799|NCT00421148|65223471|FG007|Overall Study|Protocol Violation|0|||
23403800|NCT00421148|65223472|FG008|Overall Study|Protocol Violation|0|||
23201745|NCT00002663|64479959|FG007|Overall Study|Adverse Event|1|||
23201746|NCT00002663|64479960|FG008|Overall Study|Adverse Event|0|||
23201747|NCT00002663|64479961|FG009|Overall Study|Adverse Event|0|||
23201748|NCT00372190|64479962|FG000|Overall Study|Lost to Follow-up|3|||
23201749|NCT00372190|64479963|FG001|Overall Study|Lost to Follow-up|1|||
23201750|NCT01469013|64479964|FG000|Part A (Treatment Period)|Adverse Event|1|||
23201751|NCT01469013|64479965|FG001|Part A (Treatment Period)|Adverse Event|0|||
23201752|NCT01469013|64479966|FG002|Part A (Treatment Period)|Adverse Event|0|||
23201753|NCT01469013|64479967|FG003|Part A (Treatment Period)|Adverse Event|0|||
23201754|NCT01469013|64479968|FG004|Part A (Treatment Period)|Adverse Event|1|||
23201755|NCT01469013|64479969|FG005|Part A (Treatment Period)|Adverse Event|0|||
23201756|NCT01469013|64479970|FG006|Part A (Treatment Period)|Adverse Event|0|||
23201757|NCT01469013|64479971|FG007|Part A (Treatment Period)|Adverse Event|0|||
23403801|NCT00421148|65223473|FG009|Overall Study|Protocol Violation|0|||
23403802|NCT00421148|65223474|FG010|Overall Study|Protocol Violation|0|||
23403803|NCT00421148|65223475|FG011|Overall Study|Protocol Violation|0|||
23403804|NCT00421148|65223476|FG012|Overall Study|Protocol Violation|0|||
23403805|NCT00421148|65223477|FG013|Overall Study|Protocol Violation|0|||
23403806|NCT00421148|65223478|FG014|Overall Study|Protocol Violation|0|||
23403807|NCT00421148|65223479|FG015|Overall Study|Protocol Violation|0|||
23201758|NCT01469013|64479972|FG008|Part A (Treatment Period)|Adverse Event|0|||
23201759|NCT01469013|64479973|FG009|Part A (Treatment Period)|Adverse Event|0|||
23403808|NCT00421148|65223480|FG016|Overall Study|Protocol Violation|0|||
23201760|NCT01469013|64479974|FG010|Part A (Treatment Period)|Adverse Event|0|||
23403809|NCT00421148|65223481|FG017|Overall Study|Protocol Violation|0|||
23403810|NCT00421148|65223482|FG018|Overall Study|Protocol Violation|1|||
23403811|NCT00421148|65223483|FG019|Overall Study|Protocol Violation|0|||
23403812|NCT00181844|65223484|FG000|Signed Consent|Withdrawal by Subject|5|||
23403813|NCT00181844|65223484|FG000|Signed Consent|Did not meet entrance criteria|7|||
23403814|NCT00181844|65223484|FG000|Exposed to Study Medication|Adverse Event|10|||
23403815|NCT00181844|65223484|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
23201761|NCT01469013|64479975|FG011|Part A (Treatment Period)|Adverse Event|0|||
23201762|NCT01469013|64479976|FG012|Part A (Treatment Period)|Adverse Event|0|||
23201763|NCT01469013|64479964|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201764|NCT01469013|64479965|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201765|NCT01469013|64479966|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
23201766|NCT01469013|64479967|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201767|NCT01469013|64479968|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201768|NCT01469013|64479969|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201769|NCT01469013|64479970|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
23403816|NCT00181844|65223484|FG000|Exposed to Study Medication|Non-compliance|2|||
23403817|NCT00181844|65223484|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
23403818|NCT00181844|65223484|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
23403819|NCT02580877|65223486|FG000|Overall Study|Withdrawal by Subject|1|||
23403820|NCT02580877|65223487|FG001|Overall Study|Withdrawal by Subject|3|||
23403821|NCT02580877|65223486|FG000|Overall Study|Adverse Event|0|||
23201770|NCT01469013|64479971|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201771|NCT01469013|64479972|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201772|NCT01469013|64479973|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201773|NCT01469013|64479974|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201774|NCT01469013|64479975|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201775|NCT01469013|64479976|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
23201776|NCT01469013|64479964|FG000|Part B (Extension Period)|Adverse Event|0|||
23201777|NCT01469013|64479965|FG001|Part B (Extension Period)|Adverse Event|0|||
23201778|NCT01469013|64479966|FG002|Part B (Extension Period)|Adverse Event|0|||
23201779|NCT01469013|64479967|FG003|Part B (Extension Period)|Adverse Event|0|||
23201780|NCT01469013|64479968|FG004|Part B (Extension Period)|Adverse Event|0|||
23201781|NCT01469013|64479969|FG005|Part B (Extension Period)|Adverse Event|2|||
23201782|NCT01469013|64479970|FG006|Part B (Extension Period)|Adverse Event|5|||
23201783|NCT01469013|64479971|FG007|Part B (Extension Period)|Adverse Event|5|||
23201784|NCT01469013|64479972|FG008|Part B (Extension Period)|Adverse Event|3|||
23201785|NCT01469013|64479973|FG009|Part B (Extension Period)|Adverse Event|3|||
23201786|NCT01469013|64479974|FG010|Part B (Extension Period)|Adverse Event|1|||
23201787|NCT01469013|64479975|FG011|Part B (Extension Period)|Adverse Event|6|||
23201788|NCT01469013|64479976|FG012|Part B (Extension Period)|Adverse Event|3|||
23201789|NCT01469013|64479964|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
23201790|NCT01469013|64479965|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
23201791|NCT01469013|64479966|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
23201792|NCT01469013|64479967|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
23201793|NCT01469013|64479968|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
23201794|NCT01469013|64479969|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
23201795|NCT01469013|64479970|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
23201796|NCT01469013|64479971|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
23201797|NCT01469013|64479972|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
23201798|NCT01469013|64479973|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
23201799|NCT01469013|64479974|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
23201800|NCT01469013|64479975|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
23201801|NCT01469013|64479976|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
23201802|NCT00408421|64479977|FG000|Treatment Initial Randomization|Adverse Event|5|||
23201803|NCT00408421|64479978|FG001|Treatment Initial Randomization|Adverse Event|9|||
23201804|NCT00408421|64479979|FG002|Treatment Initial Randomization|Adverse Event|0|||
23201805|NCT00408421|64479977|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
23201806|NCT00408421|64479978|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
23201807|NCT00408421|64479979|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
23302339|NCT01144364|64850679|FG002|Induction Phase|Death|0|||
23201808|NCT00408421|64479977|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
23201809|NCT00408421|64479978|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
23201810|NCT00408421|64479979|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
23201811|NCT00408421|64479977|FG000|Treatment Initial Randomization|Physician Decision|1|||
23201812|NCT00408421|64479978|FG001|Treatment Initial Randomization|Physician Decision|0|||
23302340|NCT01144364|64850677|FG000|Induction Phase|Withdrawal by Subject|1|||
23403822|NCT02580877|65223487|FG001|Overall Study|Adverse Event|1|||
23504379|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
23201813|NCT00408421|64479979|FG002|Treatment Initial Randomization|Physician Decision|0|||
23201814|NCT00408421|64479977|FG000|Treatment Initial Randomization|Protocol Violation|0|||
23403823|NCT01436110|65223488|FG000|Overall Study|Lack of Efficacy|23|||
23403824|NCT01436110|65223489|FG001|Overall Study|Lack of Efficacy|14|||
23403825|NCT01436110|65223490|FG002|Overall Study|Lack of Efficacy|9|||
23403826|NCT01436110|65223488|FG000|Overall Study|Withdrawal by Subject|6|||
23403827|NCT01436110|65223489|FG001|Overall Study|Withdrawal by Subject|8|||
23403828|NCT01436110|65223490|FG002|Overall Study|Withdrawal by Subject|4|||
23403829|NCT01436110|65223488|FG000|Overall Study|Adverse Event|2|||
23403830|NCT01436110|65223489|FG001|Overall Study|Adverse Event|1|||
23403831|NCT01436110|65223490|FG002|Overall Study|Adverse Event|2|||
23403832|NCT01436110|65223488|FG000|Overall Study|Physician Decision|3|||
23403833|NCT01436110|65223489|FG001|Overall Study|Physician Decision|1|||
23403834|NCT01436110|65223490|FG002|Overall Study|Physician Decision|1|||
23403835|NCT01436110|65223488|FG000|Overall Study|Lost to Follow-up|1|||
23403836|NCT01436110|65223489|FG001|Overall Study|Lost to Follow-up|1|||
23403837|NCT01436110|65223490|FG002|Overall Study|Lost to Follow-up|3|||
23403838|NCT01436110|65223488|FG000|Overall Study|Protocol Violation|3|||
23403839|NCT01436110|65223489|FG001|Overall Study|Protocol Violation|1|||
23403840|NCT01436110|65223490|FG002|Overall Study|Protocol Violation|1|||
23403841|NCT01436110|65223488|FG000|Overall Study|Did Not Receive Trial Medication|1|||
23403842|NCT01436110|65223489|FG001|Overall Study|Did Not Receive Trial Medication|0|||
23403843|NCT01436110|65223490|FG002|Overall Study|Did Not Receive Trial Medication|3|||
23403844|NCT00846846|65223497|FG000|Overall Study|Death|56|||
23403845|NCT00846846|65223497|FG000|Overall Study|Withdrawal by Subject|19|||
23201815|NCT00408421|64479978|FG001|Treatment Initial Randomization|Protocol Violation|1|||
23302341|NCT01144364|64850678|FG001|Induction Phase|Withdrawal by Subject|0|||
23403846|NCT01306643|65223498|FG000|Overall Study|Adverse Event|5|||
23403847|NCT01306643|65223498|FG000|Overall Study|Disease Progression|7|||
23403848|NCT01306643|65223498|FG000|Overall Study|Other: Change in Eligibility Status|1|||
23403849|NCT05219253|65226426|FG000|Overall Study|Withdrawal by Subject|1|||
23403850|NCT05219253|65226427|FG001|Overall Study|Withdrawal by Subject|2|||
23403851|NCT00955474|65226428|FG000|Overall Study|Physician Decision|7|||
23403852|NCT00955474|65226429|FG001|Overall Study|Physician Decision|5|||
23403853|NCT03364231|65226430|FG000|Overall Study|Adverse Event|1|||
23403854|NCT03364231|65226431|FG001|Overall Study|Adverse Event|4|||
23403855|NCT03364231|65226430|FG000|Overall Study|Death|1|||
23403856|NCT03364231|65226431|FG001|Overall Study|Death|0|||
23403857|NCT03364231|65226430|FG000|Overall Study|Investigator Decision|2|||
23403858|NCT03364231|65226431|FG001|Overall Study|Investigator Decision|2|||
23403859|NCT03364231|65226430|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
23403860|NCT03364231|65226431|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
23403861|NCT03364231|65226430|FG000|Overall Study|Withdrawal of Subject Consent|1|||
23403862|NCT03364231|65226431|FG001|Overall Study|Withdrawal of Subject Consent|0|||
23403863|NCT03364231|65226430|FG000|Overall Study|Reason Not Specified|1|||
23403864|NCT03364231|65226431|FG001|Overall Study|Reason Not Specified|0|||
23403865|NCT03364231|65226430|FG000|Overall Study|Disease Progression|0|||
23403866|NCT03364231|65226431|FG001|Overall Study|Disease Progression|6|||
23403867|NCT00003645|65226432|FG000|Overall Study|Death|4|||
23403868|NCT00003645|65226433|FG001|Overall Study|Death|1|||
23403869|NCT00003645|65226432|FG000|Overall Study|Lost to Follow-up|7|||
23403870|NCT00003645|65226433|FG001|Overall Study|Lost to Follow-up|8|||
23403871|NCT00003645|65226432|FG000|Overall Study|Withdrawal by Subject|1|||
23403872|NCT00003645|65226433|FG001|Overall Study|Withdrawal by Subject|3|||
23403873|NCT03306433|65226434|FG000|Overall Study|Lost to Follow-up|3|||
23403874|NCT03306433|65226434|FG000|Overall Study|Patient did not have teeth extracted|1|||
23403875|NCT03306433|65226434|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
23403876|NCT01331681|65226435|FG000|Overall Study|Adverse Event|10|||
23403877|NCT01331681|65226436|FG001|Overall Study|Adverse Event|13|||
23403878|NCT01331681|65226437|FG002|Overall Study|Adverse Event|10|||
23403879|NCT01331681|65226435|FG000|Overall Study|Death|6|||
23403880|NCT01331681|65226436|FG001|Overall Study|Death|6|||
23403881|NCT01331681|65226437|FG002|Overall Study|Death|2|||
23403882|NCT01331681|65226435|FG000|Overall Study|Lack of Efficacy|0|||
23403883|NCT01331681|65226436|FG001|Overall Study|Lack of Efficacy|1|||
23403884|NCT01331681|65226437|FG002|Overall Study|Lack of Efficacy|0|||
23403885|NCT01331681|65226435|FG000|Overall Study|Withdrawal by Subject|12|||
23403886|NCT01331681|65226436|FG001|Overall Study|Withdrawal by Subject|8|||
23403887|NCT01331681|65226437|FG002|Overall Study|Withdrawal by Subject|15|||
23302342|NCT01144364|64850679|FG002|Induction Phase|Withdrawal by Subject|0|||
23403888|NCT01331681|65226435|FG000|Overall Study|Protocol Violation|1|||
23302343|NCT01144364|64850677|FG000|Induction Phase|Lost to Follow-up|2|||
23403889|NCT01331681|65226436|FG001|Overall Study|Protocol Violation|1|||
23403890|NCT01331681|65226437|FG002|Overall Study|Protocol Violation|0|||
23403891|NCT01331681|65226435|FG000|Overall Study|Lost to Follow-up|2|||
23403892|NCT01331681|65226436|FG001|Overall Study|Lost to Follow-up|4|||
23403893|NCT01331681|65226437|FG002|Overall Study|Lost to Follow-up|1|||
23403894|NCT01331681|65226435|FG000|Overall Study|Physician Decision|2|||
23403895|NCT01331681|65226436|FG001|Overall Study|Physician Decision|0|||
23403896|NCT01331681|65226437|FG002|Overall Study|Physician Decision|4|||
23201816|NCT00408421|64479979|FG002|Treatment Initial Randomization|Protocol Violation|0|||
23403897|NCT01331681|65226435|FG000|Overall Study|Therapeutic procedure required|1|||
23403898|NCT01331681|65226436|FG001|Overall Study|Therapeutic procedure required|0|||
23403899|NCT01331681|65226437|FG002|Overall Study|Therapeutic procedure required|0|||
23403900|NCT01331681|65226435|FG000|Overall Study|Sponsor decision|1|||
23403901|NCT01331681|65226436|FG001|Overall Study|Sponsor decision|1|||
23403902|NCT01331681|65226437|FG002|Overall Study|Sponsor decision|0|||
23403903|NCT01331681|65226435|FG000|Overall Study|Switching to other therapy|0|||
23403904|NCT01331681|65226436|FG001|Overall Study|Switching to other therapy|0|||
23403905|NCT01331681|65226437|FG002|Overall Study|Switching to other therapy|1|||
23403906|NCT01331681|65226435|FG000|Overall Study|Not Received Study Treatment|0|||
23201817|NCT00408421|64479977|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
23403907|NCT01331681|65226436|FG001|Overall Study|Not Received Study Treatment|0|||
23403908|NCT01331681|65226437|FG002|Overall Study|Not Received Study Treatment|2|||
23504380|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
23504381|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
23504382|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
23504383|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
23504384|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
23504385|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
23504386|NCT00381485|65587790|FG000|Double-Blind Treatment Period|Administrative|0|||
23504387|NCT00381485|65587791|FG001|Double-Blind Treatment Period|Administrative|1|||
23504388|NCT00381485|65587792|FG002|Double-Blind Treatment Period|Administrative|0|||
23504389|NCT00381485|65587793|FG003|Double-Blind Treatment Period|Administrative|1|||
23504390|NCT00299975|65587796|FG000|Overall Study|Adverse Event|1|||
23504391|NCT00299975|65587797|FG001|Overall Study|Adverse Event|0|||
23504392|NCT00299975|65587798|FG002|Overall Study|Adverse Event|2|||
23504393|NCT00299975|65587796|FG000|Overall Study|Pregnancy|0|||
23504394|NCT00299975|65587797|FG001|Overall Study|Pregnancy|0|||
23504395|NCT00299975|65587798|FG002|Overall Study|Pregnancy|1|||
23504396|NCT00299975|65587796|FG000|Overall Study|Lack of Efficacy|1|||
23504397|NCT00299975|65587797|FG001|Overall Study|Lack of Efficacy|0|||
23504398|NCT00299975|65587798|FG002|Overall Study|Lack of Efficacy|1|||
23201818|NCT00408421|64479978|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
23201819|NCT00408421|64479979|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
23201820|NCT00408421|64479977|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
23201821|NCT00408421|64479978|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
23201822|NCT00408421|64479979|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
23201823|NCT00408421|64479977|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
23201824|NCT00408421|64479978|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
23201825|NCT00408421|64479979|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
23201826|NCT00408421|64479977|FG000|Treatment Re-Randomization|Adverse Event|2|||
23201827|NCT00408421|64479978|FG001|Treatment Re-Randomization|Adverse Event|2|||
23201828|NCT00408421|64479979|FG002|Treatment Re-Randomization|Adverse Event|4|||
23201829|NCT00408421|64479977|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
23201830|NCT00408421|64479978|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
23201831|NCT00408421|64479979|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
23201832|NCT00408421|64479977|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
23201833|NCT00408421|64479978|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
23201834|NCT00408421|64479979|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
23201835|NCT00408421|64479977|FG000|Treatment Re-Randomization|Physician Decision|1|||
23201836|NCT00408421|64479978|FG001|Treatment Re-Randomization|Physician Decision|3|||
23201837|NCT00408421|64479979|FG002|Treatment Re-Randomization|Physician Decision|0|||
23201838|NCT00408421|64479977|FG000|Treatment Re-Randomization|Protocol Violation|1|||
23201839|NCT00408421|64479978|FG001|Treatment Re-Randomization|Protocol Violation|1|||
23201840|NCT00408421|64479979|FG002|Treatment Re-Randomization|Protocol Violation|0|||
23201841|NCT00408421|64479977|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
23201842|NCT00408421|64479978|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
23201843|NCT00408421|64479979|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
23504399|NCT00299975|65587796|FG000|Overall Study|Lost to Follow-up|1|||
23504400|NCT00299975|65587797|FG001|Overall Study|Lost to Follow-up|0|||
23504401|NCT00299975|65587798|FG002|Overall Study|Lost to Follow-up|0|||
23504402|NCT00299975|65587796|FG000|Overall Study|Withdrawal by Subject|0|||
23504403|NCT00299975|65587797|FG001|Overall Study|Withdrawal by Subject|1|||
23504404|NCT00299975|65587798|FG002|Overall Study|Withdrawal by Subject|3|||
23504405|NCT00299975|65587796|FG000|Overall Study|Physician Decision|0|||
23201844|NCT01104584|64479980|FG000|Overall Study|Study drug never administered|21|||
23201845|NCT01104584|64479980|FG000|Overall Study|Study prematurely discontinued|2|||
23201846|NCT01276457|64479981|FG000|Core Study|Adverse Event|6|||
23201847|NCT01276457|64479982|FG001|Core Study|Adverse Event|3|||
23201848|NCT01276457|64479981|FG000|Core Study|Lost to Follow-up|1|||
23504406|NCT00299975|65587797|FG001|Overall Study|Physician Decision|0|||
23201849|NCT01276457|64479982|FG001|Core Study|Lost to Follow-up|2|||
23201850|NCT01276457|64479981|FG000|Core Study|Administrative problems|1|||
23504407|NCT00299975|65587798|FG002|Overall Study|Physician Decision|1|||
23504408|NCT02170298|65587799|FG000|Overall Study|Withdrawal by Subject|0|||
23504409|NCT02170298|65587800|FG001|Overall Study|Withdrawal by Subject|1|||
23504410|NCT02170298|65587799|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
23504411|NCT02170298|65587800|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
23504412|NCT05228132|65587801|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
23504413|NCT05228132|65587801|FG000|Overall Study|Adverse Event|3|||
23504414|NCT05228132|65587801|FG000|Overall Study|Lost to Follow-up|1|||
23201851|NCT01276457|64479982|FG001|Core Study|Administrative problems|1|||
23201852|NCT01276457|64479981|FG000|Core Study|Death|2|||
23201853|NCT01276457|64479982|FG001|Core Study|Death|2|||
23201854|NCT01276457|64479981|FG000|Core Study|Lack of Efficacy|3|||
23201855|NCT01276457|64479982|FG001|Core Study|Lack of Efficacy|12|||
23201856|NCT01276457|64479981|FG000|Extension Study|Lost to Follow-up|3|||
23201857|NCT01276457|64479982|FG001|Extension Study|Lost to Follow-up|0|||
23201858|NCT01276457|64479981|FG000|Extension Study|Death|0|||
23201859|NCT01276457|64479982|FG001|Extension Study|Death|1|||
23201860|NCT01276457|64479981|FG000|Extension Study|Lack of Efficacy|3|||
23504415|NCT05228132|65587801|FG000|Overall Study|Arteriovenous-fistula mature|1|||
23504416|NCT00662012|65587802|FG000|Overall Study|Lost to Follow-up|85|||
23504417|NCT00662012|65587802|FG000|Overall Study|Death|1|||
23201861|NCT01276457|64479982|FG001|Extension Study|Lack of Efficacy|1|||
23201862|NCT01745393|64479983|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
23201863|NCT01745393|64479984|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
23201864|NCT01745393|64479983|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
23201865|NCT01745393|64479984|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
23201866|NCT01745393|64479983|FG000|12-month Follow-up|Lost to Follow-up|6|||
23201867|NCT01745393|64479984|FG001|12-month Follow-up|Lost to Follow-up|5|||
23201868|NCT04191577|64479985|FG000|Overall Study|Withdrawal by Subject|2|||
23201869|NCT04191577|64479986|FG001|Overall Study|Withdrawal by Subject|2|||
23201870|NCT04191577|64479987|FG002|Overall Study|Withdrawal by Subject|1|||
23201871|NCT04191577|64479985|FG000|Overall Study|Physician Decision|1|||
23201872|NCT04191577|64479986|FG001|Overall Study|Physician Decision|1|||
23201873|NCT04191577|64479987|FG002|Overall Study|Physician Decision|0|||
23201874|NCT04191577|64479985|FG000|Overall Study|Adverse Event|0|||
23201875|NCT04191577|64479986|FG001|Overall Study|Adverse Event|0|||
23201876|NCT04191577|64479987|FG002|Overall Study|Adverse Event|1|||
23201877|NCT04191577|64479985|FG000|Overall Study|Death|0|||
23201878|NCT04191577|64479986|FG001|Overall Study|Death|0|||
23201879|NCT04191577|64479987|FG002|Overall Study|Death|1|||
23201880|NCT02108951|64479988|FG000|Overall Study|Lost to Follow-up|1|||
23201881|NCT02108951|64479988|FG000|Overall Study|Patient's/guardian's decision|1|||
23201882|NCT02108951|64479988|FG000|Overall Study|Study Terminated by Sponsor|14|||
23201883|NCT02149836|64479989|FG000|Overall Study|Withdrawal by Subject|1|||
23201884|NCT00610935|64479991|FG000|Overall Study|Lost to Follow-up|0|||
23201885|NCT00610935|64479992|FG001|Overall Study|Lost to Follow-up|1|||
23201886|NCT00610935|64479991|FG000|Overall Study|Withdrawal by Subject|0|||
23201887|NCT00610935|64479992|FG001|Overall Study|Withdrawal by Subject|2|||
23201888|NCT00610935|64479991|FG000|Overall Study|Sponsor Discontinuation|1|||
23201889|NCT00610935|64479992|FG001|Overall Study|Sponsor Discontinuation|0|||
23201890|NCT01737840|64479993|FG000|Overall Study|Diagnosed with an other pathology|2|||
23201891|NCT01737840|64479994|FG001|Overall Study|Diagnosed with an other pathology|2|||
23201892|NCT00411788|64479999|FG000|Overall Study|Protocol Violation|1|||
23201893|NCT00411788|64479999|FG000|Overall Study|Adverse Event|1|||
23201894|NCT00968253|64480000|FG000|Overall Study|Death|0|||
23201895|NCT00968253|64480001|FG001|Overall Study|Death|0|||
23201896|NCT00968253|64480002|FG002|Overall Study|Death|2|||
23201897|NCT00968253|64480000|FG000|Overall Study|Withdrawal by Subject|0|||
23201898|NCT00968253|64480001|FG001|Overall Study|Withdrawal by Subject|0|||
23201899|NCT00968253|64480002|FG002|Overall Study|Withdrawal by Subject|1|||
23201900|NCT00968253|64480000|FG000|Overall Study|Disease Progression|0|||
23201901|NCT00968253|64480001|FG001|Overall Study|Disease Progression|3|||
23201902|NCT00968253|64480002|FG002|Overall Study|Disease Progression|3|||
23201903|NCT00968253|64480000|FG000|Overall Study|Adverse Event|0|||
23201904|NCT00968253|64480001|FG001|Overall Study|Adverse Event|0|||
23201905|NCT00968253|64480002|FG002|Overall Study|Adverse Event|1|||
23201906|NCT00786838|64480003|FG000|Overall Study|Physician Decision|4|||
23201907|NCT00786838|64480003|FG000|Overall Study|Death|4|||
23201908|NCT00786838|64480003|FG000|Overall Study|Adverse Event|6|||
23201909|NCT00786838|64480003|FG000|Overall Study|Progressive disease|31|||
23201910|NCT00786838|64480003|FG000|Overall Study|Withdrawal by Subject|4|||
23201911|NCT02280291|64480004|FG000|Overall Study|Lost to Follow-up|2|||
23201912|NCT02280291|64480005|FG001|Overall Study|Lost to Follow-up|1|||
23201913|NCT02280291|64480006|FG002|Overall Study|Lost to Follow-up|3|||
23201914|NCT02280291|64480007|FG003|Overall Study|Lost to Follow-up|8|||
23201915|NCT02280291|64480004|FG000|Overall Study|Protocol Violation|1|||
23504418|NCT00662012|65587802|FG000|Overall Study|Withdrawal by Subject|1|||
23504419|NCT01558271|65587803|FG000|Overall Study|Adverse Event|6|||
23504420|NCT01558271|65587804|FG001|Overall Study|Adverse Event|3|||
23201916|NCT02280291|64480005|FG001|Overall Study|Protocol Violation|0|||
23201917|NCT02280291|64480006|FG002|Overall Study|Protocol Violation|0|||
23201918|NCT02280291|64480007|FG003|Overall Study|Protocol Violation|0|||
23201919|NCT02280291|64480004|FG000|Overall Study|Other|1|||
23201920|NCT02280291|64480005|FG001|Overall Study|Other|1|||
23201921|NCT02280291|64480006|FG002|Overall Study|Other|0|||
23201922|NCT02280291|64480007|FG003|Overall Study|Other|0|||
23201923|NCT01994226|64480008|FG000|Overall Study|Protocol Violation|13|||
23201924|NCT01994226|64480009|FG001|Overall Study|Protocol Violation|10|||
23201925|NCT01994226|64480008|FG000|Overall Study|Early Cessation of treatment|6|||
23201926|NCT01994226|64480009|FG001|Overall Study|Early Cessation of treatment|11|||
23201927|NCT00488618|64480012|FG000|Overall Study|Adverse Event|13|||
23201928|NCT00488618|64480013|FG001|Overall Study|Adverse Event|17|||
23201929|NCT00488618|64480012|FG000|Overall Study|Insufficient Therapeutic Response|18|||
23201930|NCT00488618|64480013|FG001|Overall Study|Insufficient Therapeutic Response|11|||
23201931|NCT00488618|64480012|FG000|Overall Study|Protocol Violation|0|||
23201932|NCT00488618|64480013|FG001|Overall Study|Protocol Violation|2|||
23201933|NCT00488618|64480012|FG000|Overall Study|Withdrawal of Consent|15|||
23201934|NCT00488618|64480013|FG001|Overall Study|Withdrawal of Consent|13|||
23201935|NCT00488618|64480012|FG000|Overall Study|Lost to Follow-up|1|||
23201936|NCT00488618|64480013|FG001|Overall Study|Lost to Follow-up|0|||
23504421|NCT01558271|65587805|FG002|Overall Study|Adverse Event|4|||
23504422|NCT01558271|65587803|FG000|Overall Study|Lost to Follow-up|1|||
23504423|NCT01558271|65587804|FG001|Overall Study|Lost to Follow-up|0|||
23504424|NCT01558271|65587805|FG002|Overall Study|Lost to Follow-up|0|||
23504425|NCT01558271|65587803|FG000|Overall Study|Protocol Violation|1|||
23504426|NCT01558271|65587804|FG001|Overall Study|Protocol Violation|0|||
23504427|NCT01558271|65587805|FG002|Overall Study|Protocol Violation|0|||
23504428|NCT01558271|65587803|FG000|Overall Study|Withdrawal by Subject|10|||
23201937|NCT00414310|64480014|FG000|Overall Study|Not treated|1|||
23504429|NCT01558271|65587804|FG001|Overall Study|Withdrawal by Subject|6|||
23504430|NCT01558271|65587805|FG002|Overall Study|Withdrawal by Subject|12|||
23504431|NCT01558271|65587803|FG000|Overall Study|Physician Decision|0|||
23201938|NCT00414310|64480015|FG001|Overall Study|Not treated|0|||
23201939|NCT02773238|64480016|FG000|Overall Study|Lack of Efficacy|4|||
23504432|NCT01558271|65587804|FG001|Overall Study|Physician Decision|2|||
23201940|NCT00678587|64480019|FG000|Overall Study|Adverse Event|3|||
23201941|NCT00678587|64480020|FG001|Overall Study|Adverse Event|3|||
23201942|NCT00678587|64480019|FG000|Overall Study|Lack of Efficacy|1|||
23201943|NCT00678587|64480020|FG001|Overall Study|Lack of Efficacy|0|||
23201944|NCT00678587|64480019|FG000|Overall Study|Protocol Violation|2|||
23201945|NCT00678587|64480020|FG001|Overall Study|Protocol Violation|1|||
23201946|NCT00678587|64480019|FG000|Overall Study|Study Closed/Terminated|1|||
23201947|NCT00678587|64480020|FG001|Overall Study|Study Closed/Terminated|0|||
23201948|NCT00678587|64480019|FG000|Overall Study|Lost to Follow-up|3|||
23201949|NCT00678587|64480020|FG001|Overall Study|Lost to Follow-up|5|||
23201950|NCT00678587|64480019|FG000|Overall Study|Investigator Discretion|2|||
23504433|NCT01558271|65587805|FG002|Overall Study|Physician Decision|1|||
23504434|NCT02615145|65587806|FG000|Overall Study|Did Not Start Treatment|0|||
23504435|NCT02615145|65587807|FG001|Overall Study|Did Not Start Treatment|0|||
23201951|NCT00678587|64480020|FG001|Overall Study|Investigator Discretion|6|||
23504436|NCT02615145|65587808|FG002|Overall Study|Did Not Start Treatment|1|||
23504437|NCT02615145|65587809|FG003|Overall Study|Did Not Start Treatment|1|||
23504438|NCT02615145|65587806|FG000|Overall Study|Failure to Return|20|||
23504439|NCT02615145|65587807|FG001|Overall Study|Failure to Return|10|||
23504440|NCT02615145|65587808|FG002|Overall Study|Failure to Return|7|||
23504441|NCT02615145|65587809|FG003|Overall Study|Failure to Return|0|||
23504442|NCT02615145|65587806|FG000|Overall Study|Death|2|||
23504443|NCT02615145|65587807|FG001|Overall Study|Death|3|||
23504444|NCT02615145|65587808|FG002|Overall Study|Death|0|||
23504445|NCT02615145|65587809|FG003|Overall Study|Death|0|||
23504446|NCT02615145|65587806|FG000|Overall Study|Other, Not Specified|5|||
23504447|NCT02615145|65587807|FG001|Overall Study|Other, Not Specified|2|||
23504448|NCT02615145|65587808|FG002|Overall Study|Other, Not Specified|0|||
23504449|NCT02615145|65587809|FG003|Overall Study|Other, Not Specified|0|||
23201952|NCT00678587|64480019|FG000|Overall Study|Withdrew Consent|8|||
23504450|NCT01192516|65587810|FG000|Overall Study|Lost to Follow-up|7|||
23504451|NCT01192516|65587811|FG001|Overall Study|Lost to Follow-up|10|||
23504452|NCT01192516|65587812|FG002|Overall Study|Lost to Follow-up|7|||
23504453|NCT01192516|65587810|FG000|Overall Study|Withdrawal by Subject|4|||
23504454|NCT01192516|65587811|FG001|Overall Study|Withdrawal by Subject|4|||
23201953|NCT00678587|64480020|FG001|Overall Study|Withdrew Consent|3|||
23201954|NCT01683071|64480021|FG000|Part 1|Lack of Efficacy|1|||
23201955|NCT01683071|64480022|FG001|Part 1|Lack of Efficacy|0|||
23201956|NCT01683071|64480023|FG002|Part 1|Lack of Efficacy|0|||
23201957|NCT01683071|64480024|FG003|Part 1|Lack of Efficacy|3|||
23201958|NCT01683071|64480025|FG004|Part 1|Lack of Efficacy|0|||
23201959|NCT01683071|64480026|FG005|Part 1|Lack of Efficacy|0|||
23201960|NCT01683071|64480021|FG000|Part 1|Withdrawal by Subject|1|||
23201961|NCT01683071|64480022|FG001|Part 1|Withdrawal by Subject|2|||
23201962|NCT01683071|64480023|FG002|Part 1|Withdrawal by Subject|2|||
23201963|NCT01683071|64480024|FG003|Part 1|Withdrawal by Subject|1|||
23201964|NCT01683071|64480025|FG004|Part 1|Withdrawal by Subject|0|||
23201965|NCT01683071|64480026|FG005|Part 1|Withdrawal by Subject|0|||
23201966|NCT01683071|64480021|FG000|Part 1|Surgery Cancelled|1|||
23201967|NCT01683071|64480022|FG001|Part 1|Surgery Cancelled|0|||
23201968|NCT01683071|64480023|FG002|Part 1|Surgery Cancelled|0|||
23201969|NCT01683071|64480024|FG003|Part 1|Surgery Cancelled|0|||
23201970|NCT01683071|64480025|FG004|Part 1|Surgery Cancelled|0|||
23201971|NCT01683071|64480026|FG005|Part 1|Surgery Cancelled|0|||
23201972|NCT01683071|64480021|FG000|Part 1|Did not receive study drug|1|||
23201973|NCT01683071|64480022|FG001|Part 1|Did not receive study drug|0|||
23201974|NCT01683071|64480023|FG002|Part 1|Did not receive study drug|0|||
23201975|NCT01683071|64480024|FG003|Part 1|Did not receive study drug|1|||
23201976|NCT01683071|64480025|FG004|Part 1|Did not receive study drug|0|||
23201977|NCT01683071|64480026|FG005|Part 1|Did not receive study drug|0|||
23201978|NCT01683071|64480021|FG000|Part 1|Early termination; met exclusion criteria|0|||
23201979|NCT01683071|64480022|FG001|Part 1|Early termination; met exclusion criteria|2|||
23201980|NCT01683071|64480023|FG002|Part 1|Early termination; met exclusion criteria|1|||
23201981|NCT01683071|64480024|FG003|Part 1|Early termination; met exclusion criteria|0|||
23201982|NCT01683071|64480025|FG004|Part 1|Early termination; met exclusion criteria|0|||
23201983|NCT01683071|64480026|FG005|Part 1|Early termination; met exclusion criteria|0|||
23201984|NCT01683071|64480021|FG000|Part 2|Lack of Efficacy|0|||
23201985|NCT01683071|64480022|FG001|Part 2|Lack of Efficacy|0|||
23201986|NCT01683071|64480023|FG002|Part 2|Lack of Efficacy|0|||
23201987|NCT01683071|64480024|FG003|Part 2|Lack of Efficacy|0|||
23201988|NCT01683071|64480025|FG004|Part 2|Lack of Efficacy|3|||
23201989|NCT01683071|64480026|FG005|Part 2|Lack of Efficacy|4|||
23201990|NCT01683071|64480021|FG000|Part 2|Lost to Follow-up|0|||
23201991|NCT01683071|64480022|FG001|Part 2|Lost to Follow-up|0|||
23201992|NCT01683071|64480023|FG002|Part 2|Lost to Follow-up|0|||
23201993|NCT01683071|64480024|FG003|Part 2|Lost to Follow-up|0|||
23201994|NCT01683071|64480025|FG004|Part 2|Lost to Follow-up|2|||
23201995|NCT01683071|64480026|FG005|Part 2|Lost to Follow-up|0|||
23201996|NCT01683071|64480021|FG000|Part 2|Withdrawal by Subject|0|||
23504455|NCT01192516|65587812|FG002|Overall Study|Withdrawal by Subject|1|||
23504456|NCT01192516|65587810|FG000|Overall Study|started new treatment|5|||
23504457|NCT01192516|65587811|FG001|Overall Study|started new treatment|1|||
23201997|NCT01683071|64480022|FG001|Part 2|Withdrawal by Subject|0|||
23302344|NCT01144364|64850678|FG001|Induction Phase|Lost to Follow-up|0|||
23201998|NCT01683071|64480023|FG002|Part 2|Withdrawal by Subject|0|||
23201999|NCT01683071|64480024|FG003|Part 2|Withdrawal by Subject|0|||
23202000|NCT01683071|64480025|FG004|Part 2|Withdrawal by Subject|3|||
23202001|NCT01683071|64480026|FG005|Part 2|Withdrawal by Subject|3|||
23202002|NCT01683071|64480021|FG000|Part 2|Surgery cancelled|0|||
23202003|NCT01683071|64480022|FG001|Part 2|Surgery cancelled|0|||
23202004|NCT01683071|64480023|FG002|Part 2|Surgery cancelled|0|||
23202005|NCT01683071|64480024|FG003|Part 2|Surgery cancelled|0|||
23504458|NCT01192516|65587812|FG002|Overall Study|started new treatment|0|||
23504459|NCT01192516|65587810|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
23202006|NCT01683071|64480025|FG004|Part 2|Surgery cancelled|4|||
23202007|NCT01683071|64480026|FG005|Part 2|Surgery cancelled|2|||
23202008|NCT01683071|64480021|FG000|Part 2|Did not receive study drug|0|||
23202009|NCT01683071|64480022|FG001|Part 2|Did not receive study drug|0|||
23202010|NCT01683071|64480023|FG002|Part 2|Did not receive study drug|0|||
23202011|NCT01683071|64480024|FG003|Part 2|Did not receive study drug|0|||
23202012|NCT01683071|64480025|FG004|Part 2|Did not receive study drug|2|||
23202013|NCT01683071|64480026|FG005|Part 2|Did not receive study drug|1|||
23202014|NCT01683071|64480021|FG000|Part 2|Met exclusion criterion|0|||
23202015|NCT01683071|64480022|FG001|Part 2|Met exclusion criterion|0|||
23202016|NCT01683071|64480023|FG002|Part 2|Met exclusion criterion|0|||
23202017|NCT01683071|64480024|FG003|Part 2|Met exclusion criterion|0|||
23202018|NCT01683071|64480025|FG004|Part 2|Met exclusion criterion|1|||
23202019|NCT01683071|64480026|FG005|Part 2|Met exclusion criterion|1|||
23202020|NCT01683071|64480021|FG000|Part 2|Protocol deviation|0|||
23202021|NCT01683071|64480022|FG001|Part 2|Protocol deviation|0|||
23202022|NCT01683071|64480023|FG002|Part 2|Protocol deviation|0|||
23202023|NCT01683071|64480024|FG003|Part 2|Protocol deviation|0|||
23202024|NCT01683071|64480025|FG004|Part 2|Protocol deviation|1|||
23202025|NCT01683071|64480026|FG005|Part 2|Protocol deviation|2|||
23202026|NCT01683071|64480021|FG000|Part 2|Withdrawal by investigator decision|0|||
23202027|NCT01683071|64480022|FG001|Part 2|Withdrawal by investigator decision|0|||
23202028|NCT01683071|64480023|FG002|Part 2|Withdrawal by investigator decision|0|||
23202029|NCT01683071|64480024|FG003|Part 2|Withdrawal by investigator decision|0|||
23202030|NCT01683071|64480025|FG004|Part 2|Withdrawal by investigator decision|1|||
23202031|NCT01683071|64480026|FG005|Part 2|Withdrawal by investigator decision|2|||
23202032|NCT00986258|64480027|FG000|Observation Period|Not eligible to be dosed|11|||
23202033|NCT00986258|64480027|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
23202034|NCT00986258|64480027|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
23202035|NCT00986258|64480027|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
23202036|NCT00986258|64480027|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
23202037|NCT00986258|64480027|FG000|Titration and Optimal Dose Period|Other|1|||
23202038|NCT00986258|64480027|FG000|Maintenance Period|Adverse Event|5|||
23202039|NCT00986258|64480027|FG000|Maintenance Period|Lack of Efficacy|2|||
23202040|NCT00986258|64480027|FG000|Maintenance Period|Withdrawal by Subject|2|||
23202041|NCT03699631|64480030|FG000|Overall Study|Adverse Event|3|||
23202042|NCT01586156|64480031|FG000|Overall Study|Pregnancy|0|||
23202043|NCT01586156|64480032|FG001|Overall Study|Pregnancy|1|||
23202044|NCT01586156|64480033|FG002|Overall Study|Pregnancy|0|||
23202045|NCT01515306|64480034|FG000|Overall Study|Adverse Event|3|||
23202046|NCT01515306|64480035|FG001|Overall Study|Adverse Event|2|||
23202047|NCT01515306|64480034|FG000|Overall Study|Progressive Disease|19|||
23202048|NCT01515306|64480035|FG001|Overall Study|Progressive Disease|9|||
23202049|NCT01515306|64480034|FG000|Overall Study|Withdrawal by Subject|1|||
23202050|NCT01515306|64480035|FG001|Overall Study|Withdrawal by Subject|2|||
23202051|NCT01515306|64480034|FG000|Overall Study|Physician Decision|1|||
23202052|NCT01515306|64480035|FG001|Overall Study|Physician Decision|1|||
23202053|NCT00516269|64480036|FG000|Overall Study|Adverse Event|2|||
23202054|NCT00516269|64480037|FG001|Overall Study|Adverse Event|1|||
23202055|NCT00516269|64480036|FG000|Overall Study|Lost to Follow-up|0|||
23202056|NCT00516269|64480037|FG001|Overall Study|Lost to Follow-up|1|||
23202057|NCT00516269|64480036|FG000|Overall Study|Protocol Violation|0|||
23202058|NCT00516269|64480037|FG001|Overall Study|Protocol Violation|1|||
23202059|NCT02433288|64480038|FG000|Overall Study|Severe non-compliance to protocol|13|||
23202060|NCT02433288|64480039|FG001|Overall Study|Severe non-compliance to protocol|7|||
23202061|NCT02433288|64480038|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
23202062|NCT02433288|64480039|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
23202063|NCT02433288|64480038|FG000|Overall Study|Withdrawal by Subject|101|||
23202064|NCT02433288|64480039|FG001|Overall Study|Withdrawal by Subject|99|||
23202065|NCT02433288|64480038|FG000|Overall Study|Lost to Follow-up|2|||
23202066|NCT02433288|64480039|FG001|Overall Study|Lost to Follow-up|14|||
23202067|NCT02433288|64480038|FG000|Overall Study|Death|0|||
23202068|NCT02433288|64480039|FG001|Overall Study|Death|3|||
23202069|NCT03439748|64480046|FG000|Overall Study|Withdrawal by Subject|11|||
23202070|NCT03439748|64480047|FG001|Overall Study|Withdrawal by Subject|17|||
23202071|NCT03628508|64480048|FG000|Overall Study|Lost to Follow-up|1|||
23202072|NCT02433379|64480049|FG000|Overall Study|Screen Failures|55|||
23202073|NCT02433379|64480049|FG000|Overall Study|Death|57|||
23202074|NCT02433379|64480049|FG000|Overall Study|Total Withdrawals|209|||
23202075|NCT01934192|64480050|FG000|Overall Study|Protocol Violation|0|||
23202076|NCT01934192|64480051|FG001|Overall Study|Protocol Violation|0|||
23202077|NCT01934192|64480052|FG002|Overall Study|Protocol Violation|0|||
23302345|NCT01144364|64850679|FG002|Induction Phase|Lost to Follow-up|0|||
23202078|NCT01934192|64480053|FG003|Overall Study|Protocol Violation|1|||
23202079|NCT01934192|64480050|FG000|Overall Study|Other: reached stopping criteria|6|||
23202080|NCT01934192|64480051|FG001|Overall Study|Other: reached stopping criteria|5|||
23202081|NCT01934192|64480052|FG002|Overall Study|Other: reached stopping criteria|1|||
23202082|NCT01934192|64480053|FG003|Overall Study|Other: reached stopping criteria|0|||
23202083|NCT01934192|64480050|FG000|Overall Study|Physician Decision|3|||
23202084|NCT01934192|64480051|FG001|Overall Study|Physician Decision|2|||
23202085|NCT01934192|64480052|FG002|Overall Study|Physician Decision|0|||
23403909|NCT00833027|65226438|FG000|Overall Study|Adverse Event|33|||
23202086|NCT01934192|64480053|FG003|Overall Study|Physician Decision|0|||
23202087|NCT00115349|64480056|FG000|Overall Study|Study closed due to low enrollment.|11|||
23202088|NCT00115349|64480057|FG001|Overall Study|Study closed due to low enrollment.|9|||
23202089|NCT01496430|64480058|FG000|Overall Study|Adverse Event|0|||
23202090|NCT01496430|64480059|FG001|Overall Study|Adverse Event|0|||
23202091|NCT01496430|64480060|FG002|Overall Study|Adverse Event|1|||
23202092|NCT01496430|64480058|FG000|Overall Study|Major Protocol Deviation|0|||
23202093|NCT01496430|64480059|FG001|Overall Study|Major Protocol Deviation|0|||
23202094|NCT01496430|64480060|FG002|Overall Study|Major Protocol Deviation|1|||
23202095|NCT01496430|64480058|FG000|Overall Study|Lost to Follow-up|2|||
23202096|NCT01496430|64480059|FG001|Overall Study|Lost to Follow-up|3|||
23202097|NCT01496430|64480060|FG002|Overall Study|Lost to Follow-up|1|||
23202098|NCT01496430|64480058|FG000|Overall Study|Voluntary Withdrawal|2|||
23202099|NCT01496430|64480059|FG001|Overall Study|Voluntary Withdrawal|1|||
23504460|NCT01192516|65587811|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
23504461|NCT01192516|65587812|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
23504462|NCT03334903|65587813|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
23504463|NCT03334903|65587814|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
23504464|NCT03334903|65587813|FG000|Overall Study|Protocol Violation|1|||
23504465|NCT03334903|65587814|FG001|Overall Study|Protocol Violation|3|||
23504466|NCT03334903|65587813|FG000|Overall Study|Surgery postponed|1|||
23504467|NCT03334903|65587814|FG001|Overall Study|Surgery postponed|0|||
23504468|NCT03334903|65587813|FG000|Overall Study|Adverse Event|1|||
23504469|NCT03334903|65587814|FG001|Overall Study|Adverse Event|1|||
23504470|NCT03334903|65587813|FG000|Overall Study|Withdrawal by Subject|0|||
23202100|NCT01496430|64480060|FG002|Overall Study|Voluntary Withdrawal|6|||
23504471|NCT03334903|65587814|FG001|Overall Study|Withdrawal by Subject|1|||
23202101|NCT01496430|64480058|FG000|Overall Study|Principal Investigator Discretion|0|||
23202102|NCT01496430|64480059|FG001|Overall Study|Principal Investigator Discretion|1|||
23202103|NCT01496430|64480060|FG002|Overall Study|Principal Investigator Discretion|1|||
23202104|NCT01496430|64480058|FG000|Overall Study|Other|2|||
23202105|NCT01496430|64480059|FG001|Overall Study|Other|0|||
23202106|NCT01496430|64480060|FG002|Overall Study|Other|0|||
23202107|NCT00527111|64480066|FG000|Overall Study|Adverse Event|14|||
23202108|NCT00527111|64480067|FG001|Overall Study|Adverse Event|13|||
23202109|NCT00527111|64480066|FG000|Overall Study|Death|0|||
23202110|NCT00527111|64480067|FG001|Overall Study|Death|1|||
23202111|NCT00527111|64480066|FG000|Overall Study|Investigator Request|2|||
23202112|NCT00527111|64480067|FG001|Overall Study|Investigator Request|1|||
23202113|NCT00527111|64480066|FG000|Overall Study|Patient Request|2|||
23202114|NCT00527111|64480067|FG001|Overall Study|Patient Request|5|||
23202115|NCT00527111|64480066|FG000|Overall Study|Other|2|||
23504472|NCT04851314|65587817|FG000|Overall Study|Unable to complete research set-up procedures|0|||
23504473|NCT04851314|65587818|FG001|Overall Study|Unable to complete research set-up procedures|2|||
23504474|NCT04851314|65587817|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
23504475|NCT04851314|65587818|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
23504476|NCT01484197|65587819|FG000|Treatment Period 1|Adverse Event|1|||
23504477|NCT01484197|65587820|FG001|Treatment Period 1|Adverse Event|0|||
23504478|NCT01484197|65587821|FG002|Treatment Period 1|Adverse Event|0|||
23202116|NCT00527111|64480067|FG001|Overall Study|Other|2|||
23202117|NCT01153763|64480068|FG000|Overall Study|Study Closed|16|||
23202118|NCT01153763|64480068|FG000|Overall Study|Lost to Follow-up|1|||
23202119|NCT01153763|64480068|FG000|Overall Study|Physician Decision|2|||
23202120|NCT01153763|64480068|FG000|Overall Study|Withdrawal by Subject|2|||
23504479|NCT01484197|65587822|FG003|Treatment Period 1|Adverse Event|0|||
23504480|NCT01484197|65587819|FG000|Treatment Period 2|Subject withdrew consent|0|||
23504481|NCT01484197|65587820|FG001|Treatment Period 2|Subject withdrew consent|0|||
23504482|NCT01484197|65587821|FG002|Treatment Period 2|Subject withdrew consent|0|||
23504483|NCT01484197|65587822|FG003|Treatment Period 2|Subject withdrew consent|1|||
23504484|NCT01500694|65587831|FG000|Overall Study|Adverse Event|4|||
23504485|NCT01500694|65587832|FG001|Overall Study|Adverse Event|3|||
23504486|NCT01500694|65587831|FG000|Overall Study|Protocol Violation|0|||
23504487|NCT01500694|65587832|FG001|Overall Study|Protocol Violation|1|||
23202121|NCT00305006|64480069|FG000|Overall Study|Withdrawal by Subject|1|||
23202122|NCT00305006|64480070|FG001|Overall Study|Withdrawal by Subject|0|||
23504488|NCT01500694|65587831|FG000|Overall Study|Withdrawal by Subject|23|||
23504489|NCT01500694|65587832|FG001|Overall Study|Withdrawal by Subject|14|||
23504490|NCT01500694|65587831|FG000|Overall Study|Lost to Follow-up|2|||
23202123|NCT00305006|64480069|FG000|Overall Study|Failure to complete pretest|0|||
23202124|NCT00305006|64480070|FG001|Overall Study|Failure to complete pretest|1|||
23202125|NCT01252134|64480071|FG000|Period 1, 8 Hours|Personal Reasons|0|||
23202126|NCT01252134|64480072|FG001|Period 1, 8 Hours|Personal Reasons|1|||
23202127|NCT01252134|64480073|FG002|Period 1, 8 Hours|Personal Reasons|1|||
23202128|NCT01252134|64480074|FG003|Period 1, 8 Hours|Personal Reasons|0|||
23202129|NCT01252134|64480075|FG004|Period 1, 8 Hours|Personal Reasons|0|||
23202130|NCT01252134|64480076|FG005|Period 1, 8 Hours|Personal Reasons|0|||
23202131|NCT03100942|64480077|FG000|Randomized Treatment Period|Withdrew Consent|4|||
23202132|NCT03100942|64480078|FG001|Randomized Treatment Period|Withdrew Consent|5|||
23202133|NCT03100942|64480079|FG002|Randomized Treatment Period|Withdrew Consent|3|||
23202134|NCT03100942|64480080|FG003|Randomized Treatment Period|Withdrew Consent|3|||
23202135|NCT03100942|64480081|FG004|Randomized Treatment Period|Withdrew Consent|0|||
23504491|NCT01500694|65587832|FG001|Overall Study|Lost to Follow-up|3|||
23504492|NCT01500694|65587831|FG000|Overall Study|Lack of Efficacy|14|||
23504493|NCT01500694|65587832|FG001|Overall Study|Lack of Efficacy|5|||
23504494|NCT01500694|65587831|FG000|Overall Study|Other|9|||
23504495|NCT01500694|65587832|FG001|Overall Study|Other|3|||
23504496|NCT00382252|65587833|FG000|Overall Study|Death|4|||
23504497|NCT00382252|65587833|FG000|Overall Study|Protocol Violation|8|||
23504498|NCT00382252|65587833|FG000|Overall Study|Not treated by RFA|1|||
23504499|NCT02025621|65587840|FG000|Overall Study|Withdrawal by Subject|1|||
23504500|NCT02025621|65587841|FG001|Overall Study|Withdrawal by Subject|0|||
23504501|NCT02025621|65587840|FG000|Overall Study|Death|0|||
23504502|NCT02025621|65587841|FG001|Overall Study|Death|1|||
23504503|NCT02025621|65587840|FG000|Overall Study|No longer eligible|10|||
23202136|NCT03100942|64480082|FG005|Randomized Treatment Period|Withdrew Consent|0|||
23202137|NCT03100942|64480083|FG006|Randomized Treatment Period|Withdrew Consent|0|||
23202138|NCT03100942|64480077|FG000|Randomized Treatment Period|Adverse Event|5|||
23202139|NCT03100942|64480078|FG001|Randomized Treatment Period|Adverse Event|2|||
23202140|NCT03100942|64480079|FG002|Randomized Treatment Period|Adverse Event|1|||
23202141|NCT03100942|64480080|FG003|Randomized Treatment Period|Adverse Event|0|||
23202142|NCT03100942|64480081|FG004|Randomized Treatment Period|Adverse Event|0|||
23202143|NCT03100942|64480082|FG005|Randomized Treatment Period|Adverse Event|0|||
23202144|NCT03100942|64480083|FG006|Randomized Treatment Period|Adverse Event|0|||
23202145|NCT03100942|64480077|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
23202146|NCT03100942|64480078|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
23202147|NCT03100942|64480079|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
23202148|NCT03100942|64480080|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
23202149|NCT03100942|64480081|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
23202150|NCT03100942|64480082|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
23202151|NCT03100942|64480083|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
23202152|NCT03100942|64480077|FG000|Randomized Treatment Period|Protocol Violation|0|||
23202153|NCT03100942|64480078|FG001|Randomized Treatment Period|Protocol Violation|1|||
23202154|NCT03100942|64480079|FG002|Randomized Treatment Period|Protocol Violation|1|||
23202155|NCT03100942|64480080|FG003|Randomized Treatment Period|Protocol Violation|1|||
23202156|NCT03100942|64480081|FG004|Randomized Treatment Period|Protocol Violation|0|||
23202157|NCT03100942|64480082|FG005|Randomized Treatment Period|Protocol Violation|0|||
23202158|NCT03100942|64480083|FG006|Randomized Treatment Period|Protocol Violation|0|||
23202159|NCT03100942|64480077|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
23202160|NCT03100942|64480078|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
23202161|NCT03100942|64480079|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
23202162|NCT03100942|64480080|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
23202163|NCT03100942|64480081|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
23202164|NCT03100942|64480082|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
23202165|NCT03100942|64480083|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
23202166|NCT03100942|64480077|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
23202167|NCT03100942|64480078|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23202168|NCT03100942|64480079|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23202169|NCT03100942|64480080|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
23202170|NCT03100942|64480081|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23202171|NCT03100942|64480082|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23202172|NCT03100942|64480083|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
23504504|NCT02025621|65587841|FG001|Overall Study|No longer eligible|15|||
23504505|NCT02025621|65587840|FG000|Overall Study|Surgery initiated before infusion|3|||
23504506|NCT02025621|65587841|FG001|Overall Study|Surgery initiated before infusion|3|||
23504507|NCT01594762|65587854|FG000|Overall Study|Withdrawal by Subject|1|||
23504508|NCT01594762|65587855|FG001|Overall Study|Withdrawal by Subject|0|||
23504509|NCT01594762|65587854|FG000|Overall Study|Lost to Follow-up|10|||
23202173|NCT03100942|64480077|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23202174|NCT03100942|64480078|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23202175|NCT03100942|64480079|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23202176|NCT03100942|64480080|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23504510|NCT01594762|65587855|FG001|Overall Study|Lost to Follow-up|10|||
23504511|NCT03208244|65587860|FG000|Overall Study|Death|1|||
23236636|NCT00280059|64608260|FG001|Efficacy Assessment Phase|Other|8|||
23504512|NCT03032705|65587861|FG000|Overall Study|Lost to Follow-up|16|||
23504513|NCT03032705|65587862|FG001|Overall Study|Lost to Follow-up|17|||
23504514|NCT03032705|65587861|FG000|Overall Study|did not quality|6|||
23202177|NCT03100942|64480081|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23202178|NCT03100942|64480082|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
23202179|NCT03100942|64480083|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
23202180|NCT02020031|64480084|FG000|Overall Study|Physician Decision|1|||
23202181|NCT02020031|64480085|FG001|Overall Study|Physician Decision|1|||
23202182|NCT01599754|64480086|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
23202183|NCT01599754|64480087|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
23202184|NCT01599754|64480086|FG000|Overall Study|Participant noncompliance|4|||
23202185|NCT01599754|64480087|FG001|Overall Study|Participant noncompliance|4|||
23202186|NCT01599754|64480086|FG000|Overall Study|Lost to Follow-up|13|||
23202187|NCT01599754|64480087|FG001|Overall Study|Lost to Follow-up|6|||
23202188|NCT01599754|64480086|FG000|Overall Study|Death|31|||
23202189|NCT01599754|64480087|FG001|Overall Study|Death|33|||
23202190|NCT01599754|64480086|FG000|Overall Study|Adverse Event|3|||
23202191|NCT01599754|64480087|FG001|Overall Study|Adverse Event|2|||
23202192|NCT01599754|64480086|FG000|Overall Study|Investigator decision|1|||
23202193|NCT01599754|64480087|FG001|Overall Study|Investigator decision|3|||
23202194|NCT01599754|64480086|FG000|Overall Study|Withdrawal by Subject|24|||
23202195|NCT01599754|64480087|FG001|Overall Study|Withdrawal by Subject|25|||
23202196|NCT01599754|64480086|FG000|Overall Study|Study terminated by sponsor|282|||
23202197|NCT01599754|64480087|FG001|Overall Study|Study terminated by sponsor|285|||
23202198|NCT03132805|64480088|FG000|Overall Study|Lost to Follow-up|142|||
23202199|NCT03132805|64480089|FG001|Overall Study|Lost to Follow-up|141|||
23202200|NCT03132805|64480090|FG002|Overall Study|Lost to Follow-up|113|||
23202201|NCT00926796|64480093|FG000|Overall Study|Did not receive randomized treatment|4|||
23202202|NCT00926796|64480094|FG001|Overall Study|Did not receive randomized treatment|7|||
23202203|NCT00926796|64480093|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
23202204|NCT00926796|64480094|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
23202205|NCT00926796|64480093|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
23202206|NCT00926796|64480094|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
23202207|NCT00926796|64480093|FG000|Overall Study|Adverse Event|7|||
23202208|NCT00926796|64480094|FG001|Overall Study|Adverse Event|14|||
23202209|NCT00926796|64480093|FG000|Overall Study|Lost to Follow-up|22|||
23202210|NCT00926796|64480094|FG001|Overall Study|Lost to Follow-up|13|||
23202211|NCT00926796|64480093|FG000|Overall Study|Protocol Violation|15|||
23202212|NCT00926796|64480094|FG001|Overall Study|Protocol Violation|11|||
23202213|NCT00926796|64480093|FG000|Overall Study|Withdrawal by Subject|1|||
23202214|NCT00926796|64480094|FG001|Overall Study|Withdrawal by Subject|0|||
23202215|NCT01345123|64480098|FG000|Overall Study|participants no longer with health plan|79|||
23202216|NCT01345123|64480099|FG001|Overall Study|participants no longer with health plan|85|||
23202217|NCT01345123|64480100|FG002|Overall Study|participants no longer with health plan|88|||
23202218|NCT02108600|64480106|FG000|Overall Study|Withdrawal by Subject|2|||
23202219|NCT02108600|64480107|FG001|Overall Study|Withdrawal by Subject|0|||
23202220|NCT02108600|64480106|FG000|Overall Study|Lost to Follow-up|1|||
23202221|NCT02108600|64480107|FG001|Overall Study|Lost to Follow-up|1|||
23202222|NCT01096849|64480112|FG000|Overall Study|Consent Withdrawn|1|||
23202223|NCT01096849|64480113|FG001|Overall Study|Consent Withdrawn|4|||
23202224|NCT01096849|64480114|FG002|Overall Study|Consent Withdrawn|2|||
23202225|NCT01096849|64480112|FG000|Overall Study|Lack of Efficacy|0|||
23202226|NCT01096849|64480113|FG001|Overall Study|Lack of Efficacy|2|||
23202227|NCT01096849|64480114|FG002|Overall Study|Lack of Efficacy|0|||
23202228|NCT01096849|64480112|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
23202229|NCT01096849|64480113|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
23202230|NCT01096849|64480114|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
23202231|NCT01096849|64480112|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
23202232|NCT01096849|64480113|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
23202233|NCT01096849|64480114|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
23202234|NCT01096849|64480112|FG000|Overall Study|Administrative Reasons|0|||
23202235|NCT01096849|64480113|FG001|Overall Study|Administrative Reasons|1|||
23202236|NCT01096849|64480114|FG002|Overall Study|Administrative Reasons|2|||
23202237|NCT01096849|64480112|FG000|Overall Study|Lost to Follow-up|1|||
23202238|NCT01096849|64480113|FG001|Overall Study|Lost to Follow-up|3|||
23202239|NCT01096849|64480114|FG002|Overall Study|Lost to Follow-up|1|||
23202240|NCT00532948|64480115|FG000|Overall Study|Protocol Violation|1|||
23202241|NCT00532948|64480116|FG001|Overall Study|Protocol Violation|0|||
23302346|NCT01144364|64850677|FG000|Induction Phase|Physician Decision|1|||
23202242|NCT00532948|64480117|FG002|Overall Study|Protocol Violation|0|||
23202243|NCT00532948|64480115|FG000|Overall Study|Death|3|||
23202244|NCT00532948|64480116|FG001|Overall Study|Death|3|||
23202245|NCT00532948|64480117|FG002|Overall Study|Death|4|||
23202246|NCT00532948|64480115|FG000|Overall Study|Violation of selection criteria at entry|0|||
23202247|NCT00532948|64480116|FG001|Overall Study|Violation of selection criteria at entry|1|||
23202248|NCT00532948|64480117|FG002|Overall Study|Violation of selection criteria at entry|0|||
23202249|NCT00532948|64480115|FG000|Overall Study|Failure to return|0|||
23202250|NCT00532948|64480116|FG001|Overall Study|Failure to return|1|||
23202251|NCT00532948|64480117|FG002|Overall Study|Failure to return|0|||
23202252|NCT01189435|64480118|FG000|Overall Study|Withdrawal by Subject|1|||
23202253|NCT01189435|64480118|FG000|Overall Study|Physician Decision|1|||
23202254|NCT02115815|64480121|FG000|Overall Study|Withdrawal by Subject|2|||
23202255|NCT02115815|64480122|FG001|Overall Study|Withdrawal by Subject|0|||
23202256|NCT02115815|64480123|FG002|Overall Study|Withdrawal by Subject|0|||
23202257|NCT02115815|64480124|FG003|Overall Study|Withdrawal by Subject|0|||
23202258|NCT02115815|64480125|FG004|Overall Study|Withdrawal by Subject|0|||
23202259|NCT02115815|64480126|FG005|Overall Study|Withdrawal by Subject|0|||
23202260|NCT02115815|64480127|FG006|Overall Study|Withdrawal by Subject|0|||
23202261|NCT02115815|64480121|FG000|Overall Study|Not enough drug to dose participant|0|||
23202262|NCT02115815|64480122|FG001|Overall Study|Not enough drug to dose participant|0|||
23202263|NCT02115815|64480123|FG002|Overall Study|Not enough drug to dose participant|0|||
23202264|NCT02115815|64480124|FG003|Overall Study|Not enough drug to dose participant|0|||
23202265|NCT02115815|64480125|FG004|Overall Study|Not enough drug to dose participant|0|||
23202266|NCT02115815|64480126|FG005|Overall Study|Not enough drug to dose participant|1|||
23202267|NCT02115815|64480127|FG006|Overall Study|Not enough drug to dose participant|0|||
23202268|NCT02115815|64480121|FG000|Overall Study|Missed appointment, randomized in error|0|||
23202269|NCT02115815|64480122|FG001|Overall Study|Missed appointment, randomized in error|0|||
23202270|NCT02115815|64480123|FG002|Overall Study|Missed appointment, randomized in error|0|||
23202271|NCT02115815|64480124|FG003|Overall Study|Missed appointment, randomized in error|0|||
23202272|NCT02115815|64480125|FG004|Overall Study|Missed appointment, randomized in error|0|||
23202273|NCT02115815|64480126|FG005|Overall Study|Missed appointment, randomized in error|1|||
23202274|NCT02115815|64480127|FG006|Overall Study|Missed appointment, randomized in error|0|||
23202275|NCT01810042|64480130|FG000|Overall Study|Lost to Follow-up|10|||
23202276|NCT01028651|64480139|FG000|Overall Study|Death|2|||
23202277|NCT01028651|64480139|FG000|Overall Study|Adverse Event|1|||
23202278|NCT01477892|64480140|FG000|Overall Study|Withdrawal by Subject|0|||
23202279|NCT01477892|64480141|FG001|Overall Study|Withdrawal by Subject|2|||
23202280|NCT03554005|64480142|FG000|Overall Study|Not in participant's best interest|0|||
23202281|NCT03554005|64480143|FG001|Overall Study|Not in participant's best interest|0|||
23202282|NCT03554005|64480144|FG002|Overall Study|Not in participant's best interest|0|||
23202283|NCT03554005|64480145|FG003|Overall Study|Not in participant's best interest|0|||
23202284|NCT03554005|64480146|FG004|Overall Study|Not in participant's best interest|0|||
23202285|NCT03554005|64480147|FG005|Overall Study|Not in participant's best interest|1|||
23202286|NCT03554005|64480142|FG000|Overall Study|Disease Progression|1|||
23202287|NCT03554005|64480143|FG001|Overall Study|Disease Progression|1|||
23202288|NCT03554005|64480144|FG002|Overall Study|Disease Progression|1|||
23202289|NCT03554005|64480145|FG003|Overall Study|Disease Progression|1|||
23202290|NCT03554005|64480146|FG004|Overall Study|Disease Progression|5|||
23202291|NCT03554005|64480147|FG005|Overall Study|Disease Progression|6|||
23202292|NCT03554005|64480142|FG000|Overall Study|Adverse Event|0|||
23202293|NCT03554005|64480143|FG001|Overall Study|Adverse Event|0|||
23202294|NCT03554005|64480144|FG002|Overall Study|Adverse Event|0|||
23202295|NCT03554005|64480145|FG003|Overall Study|Adverse Event|0|||
23202296|NCT03554005|64480146|FG004|Overall Study|Adverse Event|0|||
23202297|NCT03554005|64480147|FG005|Overall Study|Adverse Event|3|||
23202298|NCT03554005|64480142|FG000|Overall Study|Physician Decision|0|||
23202299|NCT03554005|64480143|FG001|Overall Study|Physician Decision|0|||
23202300|NCT03554005|64480144|FG002|Overall Study|Physician Decision|0|||
23202301|NCT03554005|64480145|FG003|Overall Study|Physician Decision|0|||
23202302|NCT03554005|64480146|FG004|Overall Study|Physician Decision|1|||
23202303|NCT03554005|64480147|FG005|Overall Study|Physician Decision|0|||
23202304|NCT03554005|64480142|FG000|Overall Study|Other|0|||
23202305|NCT03554005|64480143|FG001|Overall Study|Other|0|||
23202306|NCT03554005|64480144|FG002|Overall Study|Other|0|||
23202307|NCT03554005|64480145|FG003|Overall Study|Other|0|||
23202308|NCT03554005|64480146|FG004|Overall Study|Other|0|||
23202309|NCT03554005|64480147|FG005|Overall Study|Other|1|||
23202310|NCT03116399|64480149|FG000|Overall Study|Death|8|||
23202311|NCT03116399|64480150|FG001|Overall Study|Death|3|||
23202312|NCT03116399|64480149|FG000|Overall Study|Lost to Follow-up|7|||
23202313|NCT03116399|64480150|FG001|Overall Study|Lost to Follow-up|11|||
23202314|NCT03116399|64480149|FG000|Overall Study|Investigator Decision|1|||
23202315|NCT03116399|64480150|FG001|Overall Study|Investigator Decision|1|||
23202316|NCT03116399|64480149|FG000|Overall Study|Withdrawal by Subject|24|||
23202317|NCT03116399|64480150|FG001|Overall Study|Withdrawal by Subject|9|||
23202318|NCT00603980|64480151|FG000|Study Qualification|Protocol Violation|3|||
23202319|NCT00603980|64480151|FG000|Study Qualification|Inconsistent data reporting|13|||
23202320|NCT00603980|64480151|FG000|Main Study|14th subject completed trial|1|||
23504515|NCT03032705|65587862|FG001|Overall Study|did not quality|6|||
23202321|NCT00089843|64480156|FG000|Overall Study|Withdrawal by Subject|1|||
23202322|NCT00089843|64480157|FG001|Overall Study|Withdrawal by Subject|4|||
23202323|NCT00089843|64480158|FG002|Overall Study|Withdrawal by Subject|5|||
23202324|NCT00089843|64480159|FG003|Overall Study|Withdrawal by Subject|6|||
23202325|NCT00089843|64480156|FG000|Overall Study|Physician Decision|1|||
23202326|NCT00089843|64480157|FG001|Overall Study|Physician Decision|0|||
23202327|NCT00089843|64480158|FG002|Overall Study|Physician Decision|0|||
23202328|NCT00089843|64480159|FG003|Overall Study|Physician Decision|1|||
23202329|NCT00138151|64480163|FG000|Overall Study|Withdrawal by Subject|3|||
23202330|NCT00138151|64480163|FG000|Overall Study|Physician Decision|1|||
23202331|NCT02756650|64480171|FG000|Overall Study|Physician Decision|1|||
23202332|NCT02756650|64480171|FG000|Overall Study|Adverse Event|1|||
23202333|NCT04737031|64480172|FG000|Overall Study|Patients who did not have a treatment visit|0|||
23202334|NCT04737031|64480173|FG001|Overall Study|Patients who did not have a treatment visit|31|||
23202335|NCT04737031|64480174|FG002|Overall Study|Patients who did not have a treatment visit|93|||
23202336|NCT04737031|64480175|FG003|Overall Study|Patients who did not have a treatment visit|227|||
23202337|NCT00771030|64480178|FG000|Overall Study|Adverse Event|0|||
23202338|NCT00771030|64480179|FG001|Overall Study|Adverse Event|1|||
23202339|NCT00771030|64480180|FG002|Overall Study|Adverse Event|0|||
23202340|NCT00771030|64480181|FG003|Overall Study|Adverse Event|0|||
23202341|NCT00771030|64480182|FG004|Overall Study|Adverse Event|0|||
23202342|NCT00771030|64480183|FG005|Overall Study|Adverse Event|0|||
23202343|NCT00771030|64480184|FG006|Overall Study|Adverse Event|0|||
23202344|NCT02043301|64480185|FG000|Overall Study|Discontinued|0|||
23202345|NCT02043301|64480186|FG001|Overall Study|Discontinued|1|||
23202346|NCT02043301|64480187|FG002|Overall Study|Discontinued|0|||
23202347|NCT03648476|64480188|FG000|Overall Study|Withdrawal by Subject|2|||
23202348|NCT03648476|64480189|FG001|Overall Study|Withdrawal by Subject|1|||
23202349|NCT01401010|64480190|FG000|Overall Study|Could not interpret assay results|1|||
23202350|NCT01401010|64480191|FG001|Overall Study|Could not interpret assay results|0|||
23202351|NCT00943319|64480192|FG000|Overall Study|Death|1|||
23202352|NCT00631488|64480193|FG000|Overall Study|Adverse Event|1|||
23202353|NCT00631488|64480194|FG001|Overall Study|Adverse Event|0|||
23202354|NCT00631488|64480195|FG002|Overall Study|Adverse Event|0|||
23202355|NCT00631488|64480193|FG000|Overall Study|Lost to Follow-up|2|||
23202356|NCT00631488|64480194|FG001|Overall Study|Lost to Follow-up|2|||
23202357|NCT00631488|64480195|FG002|Overall Study|Lost to Follow-up|0|||
23202358|NCT00631488|64480193|FG000|Overall Study|Physician Decision|1|||
23202359|NCT00631488|64480194|FG001|Overall Study|Physician Decision|0|||
23202360|NCT00631488|64480195|FG002|Overall Study|Physician Decision|1|||
23202361|NCT00631488|64480193|FG000|Overall Study|Protocol Violation|0|||
23202362|NCT00631488|64480194|FG001|Overall Study|Protocol Violation|0|||
23202363|NCT00631488|64480195|FG002|Overall Study|Protocol Violation|1|||
23202364|NCT00525148|64480196|FG000|Overall Study|Other Adverse Event|3|||
23202365|NCT00525148|64480197|FG001|Overall Study|Other Adverse Event|5|||
23202366|NCT00525148|64480198|FG002|Overall Study|Other Adverse Event|1|||
23202367|NCT00525148|64480199|FG003|Overall Study|Other Adverse Event|8|||
23202368|NCT00525148|64480196|FG000|Overall Study|Progressive disease|18|||
23202369|NCT00525148|64480197|FG001|Overall Study|Progressive disease|30|||
23202370|NCT00525148|64480198|FG002|Overall Study|Progressive disease|6|||
23202371|NCT00525148|64480199|FG003|Overall Study|Progressive disease|49|||
23202372|NCT00525148|64480196|FG000|Overall Study|Refused continuation of study medication|0|||
23202373|NCT00525148|64480197|FG001|Overall Study|Refused continuation of study medication|2|||
23202374|NCT00525148|64480198|FG002|Overall Study|Refused continuation of study medication|0|||
23202375|NCT00525148|64480199|FG003|Overall Study|Refused continuation of study medication|1|||
23202376|NCT00525148|64480196|FG000|Overall Study|Other than stated|2|||
23202377|NCT00525148|64480197|FG001|Overall Study|Other than stated|1|||
23202378|NCT00525148|64480198|FG002|Overall Study|Other than stated|0|||
23202379|NCT00525148|64480199|FG003|Overall Study|Other than stated|3|||
23202380|NCT01781429|64480204|FG000|Overall Study|Death|0|||
23202381|NCT01781429|64480205|FG001|Overall Study|Death|0|||
23202382|NCT01781429|64480206|FG002|Overall Study|Death|0|||
23202383|NCT01781429|64480207|FG003|Overall Study|Death|0|||
23202384|NCT01781429|64480208|FG004|Overall Study|Death|0|||
23202385|NCT01781429|64480209|FG005|Overall Study|Death|0|||
23202386|NCT01781429|64480210|FG006|Overall Study|Death|0|||
23202387|NCT01781429|64480211|FG007|Overall Study|Death|0|||
23202388|NCT01781429|64480212|FG008|Overall Study|Death|0|||
23202389|NCT01781429|64480213|FG009|Overall Study|Death|1|||
23202390|NCT01781429|64480214|FG010|Overall Study|Death|0|||
23202391|NCT01781429|64480215|FG011|Overall Study|Death|0|||
23202392|NCT01781429|64480216|FG012|Overall Study|Death|1|||
23202393|NCT01781429|64480217|FG013|Overall Study|Death|0|||
23202394|NCT01781429|64480218|FG014|Overall Study|Death|1|||
23202395|NCT01781429|64480219|FG015|Overall Study|Death|0|||
23202396|NCT01781429|64480204|FG000|Overall Study|Withdrawal by Subject|0|||
23202397|NCT01781429|64480205|FG001|Overall Study|Withdrawal by Subject|0|||
23202398|NCT01781429|64480206|FG002|Overall Study|Withdrawal by Subject|0|||
23202399|NCT01781429|64480207|FG003|Overall Study|Withdrawal by Subject|0|||
23202400|NCT01781429|64480208|FG004|Overall Study|Withdrawal by Subject|0|||
23202401|NCT01781429|64480209|FG005|Overall Study|Withdrawal by Subject|0|||
23202402|NCT01781429|64480210|FG006|Overall Study|Withdrawal by Subject|0|||
23202403|NCT01781429|64480211|FG007|Overall Study|Withdrawal by Subject|0|||
23202404|NCT01781429|64480212|FG008|Overall Study|Withdrawal by Subject|1|||
23202405|NCT01781429|64480213|FG009|Overall Study|Withdrawal by Subject|3|||
23202406|NCT01781429|64480214|FG010|Overall Study|Withdrawal by Subject|1|||
23202407|NCT01781429|64480215|FG011|Overall Study|Withdrawal by Subject|1|||
23202408|NCT01781429|64480216|FG012|Overall Study|Withdrawal by Subject|5|||
23202409|NCT01781429|64480217|FG013|Overall Study|Withdrawal by Subject|2|||
23202410|NCT01781429|64480218|FG014|Overall Study|Withdrawal by Subject|3|||
23202411|NCT01781429|64480219|FG015|Overall Study|Withdrawal by Subject|0|||
23202412|NCT01781429|64480204|FG000|Overall Study|Disease Progression|1|||
23202413|NCT01781429|64480205|FG001|Overall Study|Disease Progression|0|||
23202414|NCT01781429|64480206|FG002|Overall Study|Disease Progression|1|||
23202415|NCT01781429|64480207|FG003|Overall Study|Disease Progression|1|||
23202416|NCT01781429|64480208|FG004|Overall Study|Disease Progression|1|||
23202417|NCT01781429|64480209|FG005|Overall Study|Disease Progression|4|||
23202418|NCT01781429|64480210|FG006|Overall Study|Disease Progression|7|||
23202419|NCT01781429|64480211|FG007|Overall Study|Disease Progression|4|||
23202420|NCT01781429|64480212|FG008|Overall Study|Disease Progression|6|||
23202421|NCT01781429|64480213|FG009|Overall Study|Disease Progression|15|||
23202422|NCT01781429|64480214|FG010|Overall Study|Disease Progression|15|||
23202423|NCT01781429|64480215|FG011|Overall Study|Disease Progression|15|||
23202424|NCT01781429|64480216|FG012|Overall Study|Disease Progression|15|||
23202425|NCT01781429|64480217|FG013|Overall Study|Disease Progression|4|||
23202426|NCT01781429|64480218|FG014|Overall Study|Disease Progression|11|||
23202427|NCT01781429|64480219|FG015|Overall Study|Disease Progression|0|||
23202428|NCT01781429|64480204|FG000|Overall Study|Unacceptable Toxicity|0|||
23202429|NCT01781429|64480205|FG001|Overall Study|Unacceptable Toxicity|0|||
23202430|NCT01781429|64480206|FG002|Overall Study|Unacceptable Toxicity|0|||
23202431|NCT01781429|64480207|FG003|Overall Study|Unacceptable Toxicity|0|||
23202432|NCT01781429|64480208|FG004|Overall Study|Unacceptable Toxicity|0|||
23202433|NCT01781429|64480209|FG005|Overall Study|Unacceptable Toxicity|0|||
23202434|NCT01781429|64480210|FG006|Overall Study|Unacceptable Toxicity|0|||
23202435|NCT01781429|64480211|FG007|Overall Study|Unacceptable Toxicity|0|||
23202436|NCT01781429|64480212|FG008|Overall Study|Unacceptable Toxicity|0|||
23202437|NCT01781429|64480213|FG009|Overall Study|Unacceptable Toxicity|0|||
23202438|NCT01781429|64480214|FG010|Overall Study|Unacceptable Toxicity|0|||
23202439|NCT01781429|64480215|FG011|Overall Study|Unacceptable Toxicity|2|||
23202440|NCT01781429|64480216|FG012|Overall Study|Unacceptable Toxicity|0|||
23202441|NCT01781429|64480217|FG013|Overall Study|Unacceptable Toxicity|0|||
23202442|NCT01781429|64480218|FG014|Overall Study|Unacceptable Toxicity|0|||
23202443|NCT01781429|64480219|FG015|Overall Study|Unacceptable Toxicity|0|||
23202444|NCT01781429|64480204|FG000|Overall Study|Patient Condition Changed|0|||
23202445|NCT01781429|64480205|FG001|Overall Study|Patient Condition Changed|0|||
23202446|NCT01781429|64480206|FG002|Overall Study|Patient Condition Changed|0|||
23202447|NCT01781429|64480207|FG003|Overall Study|Patient Condition Changed|0|||
23202448|NCT01781429|64480208|FG004|Overall Study|Patient Condition Changed|0|||
23202449|NCT01781429|64480209|FG005|Overall Study|Patient Condition Changed|0|||
23202450|NCT01781429|64480210|FG006|Overall Study|Patient Condition Changed|0|||
23202451|NCT01781429|64480211|FG007|Overall Study|Patient Condition Changed|0|||
23202452|NCT01781429|64480212|FG008|Overall Study|Patient Condition Changed|0|||
23202453|NCT01781429|64480213|FG009|Overall Study|Patient Condition Changed|4|||
23202454|NCT01781429|64480214|FG010|Overall Study|Patient Condition Changed|0|||
23202455|NCT01781429|64480215|FG011|Overall Study|Patient Condition Changed|1|||
23202456|NCT01781429|64480216|FG012|Overall Study|Patient Condition Changed|0|||
23202457|NCT01781429|64480217|FG013|Overall Study|Patient Condition Changed|1|||
23202458|NCT01781429|64480218|FG014|Overall Study|Patient Condition Changed|0|||
23202459|NCT01781429|64480219|FG015|Overall Study|Patient Condition Changed|0|||
23202460|NCT01781429|64480204|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
23202461|NCT01781429|64480205|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
23202462|NCT01781429|64480206|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
23202463|NCT01781429|64480207|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
23202464|NCT01781429|64480208|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
23202465|NCT01781429|64480209|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
23202466|NCT01781429|64480210|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
23202467|NCT01781429|64480211|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
23202468|NCT01781429|64480212|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
23202469|NCT01781429|64480213|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
23202470|NCT01781429|64480214|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
23202471|NCT01781429|64480215|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
23202472|NCT01781429|64480216|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
23202473|NCT01781429|64480217|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
23202474|NCT01781429|64480218|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
23202475|NCT01781429|64480219|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
23202476|NCT01781429|64480204|FG000|Overall Study|Enrolled, but not treated|0|||
23202477|NCT01781429|64480205|FG001|Overall Study|Enrolled, but not treated|0|||
23202478|NCT01781429|64480206|FG002|Overall Study|Enrolled, but not treated|0|||
23202479|NCT01781429|64480207|FG003|Overall Study|Enrolled, but not treated|0|||
23202480|NCT01781429|64480208|FG004|Overall Study|Enrolled, but not treated|0|||
23202481|NCT01781429|64480209|FG005|Overall Study|Enrolled, but not treated|0|||
23202482|NCT01781429|64480210|FG006|Overall Study|Enrolled, but not treated|0|||
23202483|NCT01781429|64480211|FG007|Overall Study|Enrolled, but not treated|0|||
23202484|NCT01781429|64480212|FG008|Overall Study|Enrolled, but not treated|0|||
23202485|NCT01781429|64480213|FG009|Overall Study|Enrolled, but not treated|0|||
23202486|NCT01781429|64480214|FG010|Overall Study|Enrolled, but not treated|1|||
23202487|NCT01781429|64480215|FG011|Overall Study|Enrolled, but not treated|0|||
23504516|NCT00471328|65587865|FG000|Core Phase|Adverse Event|18|||
23504517|NCT00471328|65587866|FG001|Core Phase|Adverse Event|6|||
23504518|NCT00471328|65587865|FG000|Core Phase|Death|8|||
23202488|NCT01781429|64480216|FG012|Overall Study|Enrolled, but not treated|0|||
23202489|NCT01781429|64480217|FG013|Overall Study|Enrolled, but not treated|0|||
23202490|NCT01781429|64480218|FG014|Overall Study|Enrolled, but not treated|0|||
23202491|NCT01781429|64480219|FG015|Overall Study|Enrolled, but not treated|0|||
23202492|NCT03029650|64480220|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
23504519|NCT00471328|65587866|FG001|Core Phase|Death|4|||
23504520|NCT00471328|65587865|FG000|Core Phase|Withdrawal by Subject|2|||
23504521|NCT00471328|65587866|FG001|Core Phase|Withdrawal by Subject|2|||
23504522|NCT00471328|65587865|FG000|Core Phase|Abnormal laboratory value|1|||
23504523|NCT00471328|65587866|FG001|Core Phase|Abnormal laboratory value|0|||
23504524|NCT00471328|65587865|FG000|Core Phase|Disease Progression|78|||
23504525|NCT00471328|65587866|FG001|Core Phase|Disease Progression|53|||
23504526|NCT00471328|65587865|FG000|Core Phase|Administrative Problem|0|||
23504527|NCT00471328|65587866|FG001|Core Phase|Administrative Problem|1|||
23202493|NCT03029650|64480221|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
23202494|NCT03029650|64480220|FG000|Washout (1 Week)|Physician Decision|0|||
23202495|NCT03029650|64480221|FG001|Washout (1 Week)|Physician Decision|1|||
23202496|NCT03215264|64480223|FG000|Dose Level 2|Adverse Event|0|||
23202497|NCT03215264|64480224|FG001|Dose Level 2|Adverse Event|1|||
23202498|NCT03215264|64480225|FG002|Dose Level 2|Adverse Event|0|||
23202499|NCT03215264|64480223|FG000|Dose Level 3|Withdrawal by Subject|0|||
23202500|NCT03215264|64480224|FG001|Dose Level 3|Withdrawal by Subject|0|||
23202501|NCT03215264|64480225|FG002|Dose Level 3|Withdrawal by Subject|1|||
23202502|NCT01202227|64480226|FG000|Overall Study|Adverse Event|16|||
23202503|NCT01202227|64480226|FG000|Overall Study|Withdrawal by Subject|2|||
23202504|NCT01202227|64480226|FG000|Overall Study|Lack of Efficacy|1|||
23202505|NCT00615290|64480231|FG000|Overall Study|Adverse Event|2|||
23202506|NCT00615290|64480231|FG000|Overall Study|Lost to Follow-up|3|||
23202507|NCT00615290|64480231|FG000|Overall Study|Withdrawal by Subject|1|||
23202508|NCT00615290|64480231|FG000|Overall Study|Other|2|||
23202509|NCT03504774|64480232|FG000|Overall Study|Adverse Event|2|||
23202510|NCT03504774|64480233|FG001|Overall Study|Adverse Event|0|||
23202511|NCT03504774|64480232|FG000|Overall Study|Lost to Follow-up|0|||
23202512|NCT03504774|64480233|FG001|Overall Study|Lost to Follow-up|1|||
23202513|NCT03504774|64480232|FG000|Overall Study|Protocol Violation|11|||
23202514|NCT03504774|64480233|FG001|Overall Study|Protocol Violation|3|||
23202515|NCT03504774|64480232|FG000|Overall Study|failed wk 52 DBPCFC|1|||
23202516|NCT03504774|64480233|FG001|Overall Study|failed wk 52 DBPCFC|0|||
23202517|NCT02651194|64483556|FG000|Overall Study|Lost to Follow-up|3|||
23202518|NCT02651194|64483556|FG000|Overall Study|Other|2|||
23202519|NCT04146467|64483559|FG000|Overall Study|Adverse Event|0|||
23202520|NCT04146467|64483560|FG001|Overall Study|Adverse Event|1|||
23202521|NCT04146467|64483559|FG000|Overall Study|Lost to Follow-up|0|||
23202522|NCT04146467|64483560|FG001|Overall Study|Lost to Follow-up|2|||
23202523|NCT05127421|64483561|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
23202524|NCT05127421|64483562|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
23202525|NCT05127421|64483563|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
23202526|NCT05127421|64483564|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
23202527|NCT05127421|64483561|FG000|4-Week Double-Blind Period|Physician Decision|1|||
23202528|NCT05127421|64483562|FG001|4-Week Double-Blind Period|Physician Decision|0|||
23202529|NCT05127421|64483563|FG002|4-Week Double-Blind Period|Physician Decision|0|||
23202530|NCT05127421|64483564|FG003|4-Week Double-Blind Period|Physician Decision|0|||
23202531|NCT05127421|64483561|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
23202532|NCT05127421|64483562|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
23202533|NCT05127421|64483563|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
23202534|NCT05127421|64483564|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
23202535|NCT05127421|64483561|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
23202536|NCT05127421|64483562|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
23202537|NCT05127421|64483563|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
23202538|NCT05127421|64483564|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
23504528|NCT00471328|65587865|FG000|Core Phase|Protocol Deviation|0|||
23504529|NCT00471328|65587866|FG001|Core Phase|Protocol Deviation|1|||
23504530|NCT00471328|65587865|FG000|Extension Phase|Adverse Event|3|||
23202539|NCT05127421|64483561|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
23202540|NCT05127421|64483562|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
23504531|NCT00471328|65587866|FG001|Extension Phase|Adverse Event|12|||
23202541|NCT05127421|64483563|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
23202542|NCT05127421|64483564|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
23202543|NCT05127421|64483561|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
23202544|NCT05127421|64483562|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
23202545|NCT05127421|64483563|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
23202546|NCT05127421|64483564|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
23202547|NCT05127421|64483561|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
23202548|NCT05127421|64483562|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
23202549|NCT05127421|64483563|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
23202550|NCT05127421|64483564|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
23202551|NCT05127421|64483561|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
23202552|NCT05127421|64483562|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
23202553|NCT05127421|64483563|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
23202554|NCT05127421|64483564|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
23202555|NCT01035255|64483567|FG000|Overall Study|Death|724|||
23202556|NCT01035255|64483568|FG001|Overall Study|Death|844|||
23202557|NCT01035255|64483567|FG000|Overall Study|Lost to Follow-up|2|||
23504532|NCT00471328|65587865|FG000|Extension Phase|Withdrawal by Subject|0|||
23504533|NCT00471328|65587866|FG001|Extension Phase|Withdrawal by Subject|2|||
23504534|NCT00471328|65587865|FG000|Extension Phase|Death|1|||
23504535|NCT00471328|65587866|FG001|Extension Phase|Death|7|||
23504536|NCT00471328|65587865|FG000|Extension Phase|Protocol Deviation|3|||
23504537|NCT00471328|65587866|FG001|Extension Phase|Protocol Deviation|1|||
23504538|NCT00471328|65587865|FG000|Extension Phase|Treatment duration as per protocol|0|||
23504539|NCT00471328|65587866|FG001|Extension Phase|Treatment duration as per protocol|1|||
23504540|NCT00471328|65587865|FG000|Extension Phase|Disease Progression|32|||
23504541|NCT00471328|65587866|FG001|Extension Phase|Disease Progression|44|||
23202558|NCT01035255|64483568|FG001|Overall Study|Lost to Follow-up|5|||
23202559|NCT01035255|64483567|FG000|Overall Study|patient's request|15|||
23202560|NCT01035255|64483568|FG001|Overall Study|patient's request|13|||
23202561|NCT01468909|64483570|FG000|Overall Study|Never Treated|2|||
23202562|NCT01468909|64483571|FG001|Overall Study|Never Treated|2|||
23202563|NCT02849990|64483573|FG000|Overall Study|Adverse Event|1|||
23202564|NCT02849990|64483573|FG000|Overall Study|Withdrawal by Subject|1|||
23202565|NCT02357849|64483574|FG000|Overall Study|Withdrawal by Subject|2|||
23202566|NCT02357849|64483575|FG001|Overall Study|Withdrawal by Subject|3|||
23202567|NCT00586924|64483576|FG000|Overall Study|Adverse event/serious adverse event|0|||
23202568|NCT00586924|64483577|FG001|Overall Study|Adverse event/serious adverse event|0|||
23202569|NCT00586924|64483578|FG002|Overall Study|Adverse event/serious adverse event|0|||
23202570|NCT00586924|64483579|FG003|Overall Study|Adverse event/serious adverse event|1|||
23202571|NCT00586924|64483580|FG004|Overall Study|Adverse event/serious adverse event|0|||
23202572|NCT00586924|64483581|FG005|Overall Study|Adverse event/serious adverse event|2|||
23202573|NCT00586924|64483576|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
23202574|NCT00586924|64483577|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
23202575|NCT00586924|64483578|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
23202576|NCT00586924|64483579|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
23202577|NCT00586924|64483580|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
23202578|NCT00586924|64483581|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
23202579|NCT00586924|64483576|FG000|Overall Study|Disease progression|0|||
23202580|NCT00586924|64483577|FG001|Overall Study|Disease progression|0|||
23202581|NCT00586924|64483578|FG002|Overall Study|Disease progression|0|||
23202582|NCT00586924|64483579|FG003|Overall Study|Disease progression|1|||
23202583|NCT00586924|64483580|FG004|Overall Study|Disease progression|1|||
23202584|NCT00586924|64483581|FG005|Overall Study|Disease progression|0|||
23202585|NCT00586924|64483576|FG000|Overall Study|Development of neutralizing antibodies|2|||
23202586|NCT00586924|64483577|FG001|Overall Study|Development of neutralizing antibodies|2|||
23202587|NCT00586924|64483578|FG002|Overall Study|Development of neutralizing antibodies|2|||
23202588|NCT00586924|64483579|FG003|Overall Study|Development of neutralizing antibodies|0|||
23202589|NCT00586924|64483580|FG004|Overall Study|Development of neutralizing antibodies|0|||
23202590|NCT00586924|64483581|FG005|Overall Study|Development of neutralizing antibodies|22|||
23202591|NCT00586924|64483576|FG000|Overall Study|Complete response|0|||
23202592|NCT00586924|64483577|FG001|Overall Study|Complete response|1|||
23202593|NCT00586924|64483578|FG002|Overall Study|Complete response|0|||
23202594|NCT00586924|64483579|FG003|Overall Study|Complete response|0|||
23202595|NCT00586924|64483580|FG004|Overall Study|Complete response|2|||
23202596|NCT00586924|64483581|FG005|Overall Study|Complete response|2|||
23202597|NCT00586924|64483576|FG000|Overall Study|Other|1|||
23202598|NCT00586924|64483577|FG001|Overall Study|Other|0|||
23202599|NCT00586924|64483578|FG002|Overall Study|Other|1|||
23202600|NCT00586924|64483579|FG003|Overall Study|Other|1|||
23202601|NCT00586924|64483580|FG004|Overall Study|Other|1|||
23202602|NCT00586924|64483581|FG005|Overall Study|Other|6|||
23202603|NCT01822691|64483582|FG000|Overall Study|Withdrawal by Subject|2|||
23403910|NCT00833027|65226438|FG000|Overall Study|Death|1|||
23202604|NCT02044159|64483583|FG000|Overall Study|Consent declined (deferred consent)|2|||
23202605|NCT02044159|64483584|FG001|Overall Study|Consent declined (deferred consent)|4|||
23202606|NCT02044159|64483583|FG000|Overall Study|No longer eligible, drug not given|1|||
23202607|NCT02044159|64483584|FG001|Overall Study|No longer eligible, drug not given|0|||
23202608|NCT02044159|64483583|FG000|Overall Study|Nurse declined to give study drug|1|||
23202609|NCT02044159|64483584|FG001|Overall Study|Nurse declined to give study drug|0|||
23202610|NCT00137436|64483591|FG000|Overall Study|Adverse Event|13|||
23202611|NCT00137436|64483591|FG000|Overall Study|Death|2|||
23202612|NCT00137436|64483591|FG000|Overall Study|Lack of Efficacy|17|||
23202613|NCT00137436|64483591|FG000|Overall Study|Withdrawal by Subject|6|||
23202614|NCT00137436|64483591|FG000|Overall Study|Other|5|||
23202615|NCT00777491|64483592|FG000|Overall Study|Protocol Violation|0|||
23202616|NCT00777491|64483593|FG001|Overall Study|Protocol Violation|2|||
23202617|NCT00777491|64483592|FG000|Overall Study|Did not receive any protocol treatment|2|||
23202618|NCT00777491|64483593|FG001|Overall Study|Did not receive any protocol treatment|0|||
23202619|NCT01263691|64483594|FG000|Overall Study|Lost to Follow-up|1|||
23202620|NCT01263691|64483595|FG001|Overall Study|Lost to Follow-up|0|||
23202621|NCT01263691|64483596|FG002|Overall Study|Lost to Follow-up|1|||
23202622|NCT01263691|64483597|FG003|Overall Study|Lost to Follow-up|1|||
23202623|NCT01263691|64483598|FG004|Overall Study|Lost to Follow-up|0|||
23202624|NCT01263691|64483599|FG005|Overall Study|Lost to Follow-up|0|||
23202625|NCT01263691|64483594|FG000|Overall Study|Withdrawal by Subject|1|||
23202626|NCT01263691|64483595|FG001|Overall Study|Withdrawal by Subject|0|||
23202627|NCT01263691|64483596|FG002|Overall Study|Withdrawal by Subject|0|||
23202628|NCT01263691|64483597|FG003|Overall Study|Withdrawal by Subject|0|||
23202629|NCT01263691|64483598|FG004|Overall Study|Withdrawal by Subject|0|||
23202630|NCT01263691|64483599|FG005|Overall Study|Withdrawal by Subject|0|||
23504542|NCT00471328|65587865|FG000|Extension Phase|New cancer Therapy|1|||
23202631|NCT01263691|64483594|FG000|Overall Study|Adverse Event|1|||
23202632|NCT01263691|64483595|FG001|Overall Study|Adverse Event|0|||
23202633|NCT01263691|64483596|FG002|Overall Study|Adverse Event|0|||
23202634|NCT01263691|64483597|FG003|Overall Study|Adverse Event|0|||
23202635|NCT01263691|64483598|FG004|Overall Study|Adverse Event|0|||
23202636|NCT01263691|64483599|FG005|Overall Study|Adverse Event|0|||
23202637|NCT00487084|64483606|FG000|Overall Study|Did not receive intervention|4|||
23202638|NCT00487084|64483607|FG001|Overall Study|Did not receive intervention|3|||
23202639|NCT00487084|64483608|FG002|Overall Study|Did not receive intervention|5|||
23202640|NCT02245568|64483612|FG000|Overall Study|Study terminated by Sponsor|346|||
23202641|NCT02245568|64483612|FG000|Overall Study|Adverse Event|144|||
23202642|NCT02245568|64483612|FG000|Overall Study|Lack of Efficacy|98|||
23202643|NCT02245568|64483612|FG000|Overall Study|Withdrawal by Caregiver|85|||
23202644|NCT02245568|64483612|FG000|Overall Study|Withdrawal by Subject|77|||
23202645|NCT02245568|64483612|FG000|Overall Study|Withdrawal by Legal Representative|31|||
23202646|NCT02245568|64483612|FG000|Overall Study|Missing (Site closure)|16|||
23202647|NCT02245568|64483612|FG000|Overall Study|Physician Decision|14|||
23504543|NCT00471328|65587866|FG001|Extension Phase|New cancer Therapy|0|||
23504544|NCT00471328|65587865|FG000|Extension Phase|Administrative Problem|1|||
23504545|NCT00471328|65587866|FG001|Extension Phase|Administrative Problem|0|||
23504546|NCT03052725|65587867|FG000|Overall Study|Adverse Event|2|||
23504547|NCT03052725|65587868|FG001|Overall Study|Adverse Event|0|||
23504548|NCT03052725|65587867|FG000|Overall Study|Withdrawal by Subject|3|||
23504549|NCT03052725|65587868|FG001|Overall Study|Withdrawal by Subject|4|||
23504550|NCT03052725|65587867|FG000|Overall Study|Pregnancy|0|||
23504551|NCT03052725|65587868|FG001|Overall Study|Pregnancy|1|||
23504552|NCT03052725|65587867|FG000|Overall Study|Site closure|0|||
23504553|NCT03052725|65587868|FG001|Overall Study|Site closure|1|||
23504554|NCT03052725|65587867|FG000|Overall Study|Study terminated by sponsor|143|||
23504555|NCT03052725|65587868|FG001|Overall Study|Study terminated by sponsor|144|||
23504556|NCT02927431|65587870|FG000|Overall Study|Withdrawal by Subject|0|||
23202648|NCT02245568|64483612|FG000|Overall Study|Non-compliance with study drug|11|||
23504557|NCT02927431|65587871|FG001|Overall Study|Withdrawal by Subject|0|||
23504558|NCT02927431|65587872|FG002|Overall Study|Withdrawal by Subject|1|||
23504559|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
23504560|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
23504561|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
23504562|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
23504563|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
23504564|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
23202649|NCT02245568|64483612|FG000|Overall Study|Death|9|||
23202650|NCT02245568|64483612|FG000|Overall Study|Blue staining|6|||
23202651|NCT02245568|64483612|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
23202652|NCT02245568|64483612|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
23202653|NCT02245568|64483612|FG000|Overall Study|Lost to Follow-up|5|||
23202654|NCT00367640|64483613|FG000|Overall Study|Adverse Event|3|||
23202655|NCT00367640|64483614|FG001|Overall Study|Adverse Event|6|||
23202656|NCT00367640|64483615|FG002|Overall Study|Adverse Event|8|||
23202657|NCT00367640|64483616|FG003|Overall Study|Adverse Event|0|||
23504565|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
23504566|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
23504567|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
23504568|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
23504569|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
23202658|NCT00367640|64483613|FG000|Overall Study|Withdrawal by Subject|8|||
23504570|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
23504571|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
23504572|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
23504573|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
23202659|NCT00367640|64483614|FG001|Overall Study|Withdrawal by Subject|11|||
23202660|NCT00367640|64483615|FG002|Overall Study|Withdrawal by Subject|8|||
23202661|NCT00367640|64483616|FG003|Overall Study|Withdrawal by Subject|6|||
23202662|NCT00367640|64483613|FG000|Overall Study|Any other reason not above-mentioned|7|||
23202663|NCT00367640|64483614|FG001|Overall Study|Any other reason not above-mentioned|5|||
23202664|NCT00367640|64483615|FG002|Overall Study|Any other reason not above-mentioned|3|||
23202665|NCT00367640|64483616|FG003|Overall Study|Any other reason not above-mentioned|4|||
23202666|NCT01952834|64483617|FG000|Overall Study|Adverse Event|1|||
23202667|NCT01871896|64483618|FG000|Overall Study|Lost to Follow-up|1|||
23202668|NCT00403559|64483625|FG000|Overall Study|Adverse Event|0|||
23202669|NCT00403559|64483626|FG001|Overall Study|Adverse Event|1|||
23202670|NCT00403559|64483625|FG000|Overall Study|Lost to Follow-up|3|||
23202671|NCT00403559|64483626|FG001|Overall Study|Lost to Follow-up|3|||
23202672|NCT00403559|64483625|FG000|Overall Study|Withdrawal by Subject|1|||
23202673|NCT00403559|64483626|FG001|Overall Study|Withdrawal by Subject|0|||
23302347|NCT01144364|64850678|FG001|Induction Phase|Physician Decision|0|||
23302348|NCT01144364|64850679|FG002|Induction Phase|Physician Decision|0|||
23302349|NCT01144364|64850677|FG000|Induction Phase|Stable disease|2|||
23302350|NCT01144364|64850678|FG001|Induction Phase|Stable disease|0|||
23302351|NCT01144364|64850679|FG002|Induction Phase|Stable disease|0|||
23302352|NCT01144364|64850677|FG000|Induction Phase|Secondary neoplasia|1|||
23202674|NCT02389816|64483627|FG000|Overall Study|Randomized but Not Treated|1|||
23202675|NCT02389816|64483628|FG001|Overall Study|Randomized but Not Treated|0|||
23202676|NCT02389816|64483629|FG002|Overall Study|Randomized but Not Treated|0|||
23202677|NCT02389816|64483627|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
23202678|NCT02389816|64483628|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
23202679|NCT02389816|64483629|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
23202680|NCT02389816|64483627|FG000|Overall Study|Major Protocol Deviation|1|||
23202681|NCT02389816|64483628|FG001|Overall Study|Major Protocol Deviation|0|||
23202682|NCT02389816|64483629|FG002|Overall Study|Major Protocol Deviation|0|||
23202683|NCT02389816|64483627|FG000|Overall Study|Lost to Follow-up|1|||
23202684|NCT02389816|64483628|FG001|Overall Study|Lost to Follow-up|0|||
23202685|NCT02389816|64483629|FG002|Overall Study|Lost to Follow-up|0|||
23202686|NCT02389816|64483627|FG000|Overall Study|Withdrawal of Consent|6|||
23202687|NCT02389816|64483628|FG001|Overall Study|Withdrawal of Consent|4|||
23202688|NCT02389816|64483629|FG002|Overall Study|Withdrawal of Consent|4|||
23202689|NCT02389816|64483627|FG000|Overall Study|Lack of Efficacy|1|||
23202690|NCT02389816|64483628|FG001|Overall Study|Lack of Efficacy|0|||
23202691|NCT02389816|64483629|FG002|Overall Study|Lack of Efficacy|0|||
23202692|NCT02389816|64483627|FG000|Overall Study|Non Compliance with Study Drug|1|||
23202693|NCT02389816|64483628|FG001|Overall Study|Non Compliance with Study Drug|1|||
23202694|NCT02389816|64483629|FG002|Overall Study|Non Compliance with Study Drug|1|||
23202695|NCT02389816|64483627|FG000|Overall Study|Reason not Specified|0|||
23202696|NCT02389816|64483628|FG001|Overall Study|Reason not Specified|2|||
23202697|NCT02389816|64483629|FG002|Overall Study|Reason not Specified|0|||
23202698|NCT02273752|64483630|FG000|Overall Study|Trial was terminated early|2|||
23202699|NCT00745368|64483632|FG000|Overall Study|Unable to provide sample|3|||
23202700|NCT00568958|64483633|FG000|Allocation|Withdrawal by Subject|7|||
23202701|NCT00568958|64483634|FG001|Allocation|Withdrawal by Subject|3|||
23202702|NCT00568958|64483633|FG000|Allocation|Physician Decision|2|||
23202703|NCT00568958|64483634|FG001|Allocation|Physician Decision|0|||
23202704|NCT00568958|64483633|FG000|Follow-Up|Withdrawal by Subject|6|||
23202705|NCT00568958|64483634|FG001|Follow-Up|Withdrawal by Subject|6|||
23202706|NCT00568958|64483633|FG000|Follow-Up|Physician Decision|1|||
23202707|NCT00568958|64483634|FG001|Follow-Up|Physician Decision|1|||
23202708|NCT00568958|64483633|FG000|Follow-Up|Family Emergency|1|||
23202709|NCT00568958|64483634|FG001|Follow-Up|Family Emergency|0|||
23202710|NCT00568958|64483633|FG000|Follow-Up|Adverse Event|1|||
23202711|NCT00568958|64483634|FG001|Follow-Up|Adverse Event|0|||
23302353|NCT01144364|64850678|FG001|Induction Phase|Secondary neoplasia|0|||
23504574|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
23202712|NCT01395368|64483635|FG000|Overall Study|Physician Decision|14|||
23202713|NCT01395368|64483635|FG000|Overall Study|Withdrawal by Subject|2|||
23202714|NCT02940626|64483638|FG000|Overall Study|Death|40|||
23202715|NCT02940626|64483639|FG001|Overall Study|Death|32|||
23202716|NCT02940626|64483638|FG000|Overall Study|Lost to Follow-up|5|||
23202717|NCT02940626|64483639|FG001|Overall Study|Lost to Follow-up|2|||
23202718|NCT02940626|64483638|FG000|Overall Study|Withdrawal by Subject|1|||
23202719|NCT02940626|64483639|FG001|Overall Study|Withdrawal by Subject|0|||
23202720|NCT02940626|64483638|FG000|Overall Study|Transfer to Hospice Care|1|||
23202721|NCT02940626|64483639|FG001|Overall Study|Transfer to Hospice Care|0|||
23302354|NCT01144364|64850679|FG002|Induction Phase|Secondary neoplasia|0|||
23302355|NCT01144364|64850677|FG000|Induction Phase|Protocol Violation|1|||
23202722|NCT02940626|64483638|FG000|Overall Study|Prohibited Concomitant Medication|0|||
23202723|NCT02940626|64483639|FG001|Overall Study|Prohibited Concomitant Medication|1|||
23202724|NCT02531373|64483640|FG000|Overall Study|Lack of Efficacy|0|||
23504575|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
23504576|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
23504577|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
23504578|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
23504579|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
23504580|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
23504581|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
23504582|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
23504583|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
23504584|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
23504585|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
23504586|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504587|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504588|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504589|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504590|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504591|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504592|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504593|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504594|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504595|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504596|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504597|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504598|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504599|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504600|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504601|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504602|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23202725|NCT02531373|64483641|FG001|Overall Study|Lack of Efficacy|0|||
23202726|NCT02531373|64483642|FG002|Overall Study|Lack of Efficacy|0|||
23202727|NCT02531373|64483643|FG003|Overall Study|Lack of Efficacy|0|||
23202728|NCT02531373|64483644|FG004|Overall Study|Lack of Efficacy|3|||
23202729|NCT02531373|64483645|FG005|Overall Study|Lack of Efficacy|2|||
23202730|NCT02531373|64483646|FG006|Overall Study|Lack of Efficacy|4|||
23202731|NCT02531373|64483647|FG007|Overall Study|Lack of Efficacy|8|||
23202732|NCT02531373|64483648|FG008|Overall Study|Lack of Efficacy|5|||
23202733|NCT02531373|64483640|FG000|Overall Study|Lost to Follow-up|0|||
23202734|NCT02531373|64483641|FG001|Overall Study|Lost to Follow-up|0|||
23202735|NCT02531373|64483642|FG002|Overall Study|Lost to Follow-up|0|||
23202736|NCT02531373|64483643|FG003|Overall Study|Lost to Follow-up|0|||
23202737|NCT02531373|64483644|FG004|Overall Study|Lost to Follow-up|0|||
23202738|NCT02531373|64483645|FG005|Overall Study|Lost to Follow-up|2|||
23202739|NCT02531373|64483646|FG006|Overall Study|Lost to Follow-up|2|||
23202740|NCT02531373|64483647|FG007|Overall Study|Lost to Follow-up|0|||
23202741|NCT02531373|64483648|FG008|Overall Study|Lost to Follow-up|0|||
23202742|NCT02531373|64483640|FG000|Overall Study|Physician Decision|0|||
23202743|NCT02531373|64483641|FG001|Overall Study|Physician Decision|0|||
23202744|NCT02531373|64483642|FG002|Overall Study|Physician Decision|0|||
23202745|NCT02531373|64483643|FG003|Overall Study|Physician Decision|0|||
23202746|NCT02531373|64483644|FG004|Overall Study|Physician Decision|2|||
23202747|NCT02531373|64483645|FG005|Overall Study|Physician Decision|1|||
23202748|NCT02531373|64483646|FG006|Overall Study|Physician Decision|0|||
23202749|NCT02531373|64483647|FG007|Overall Study|Physician Decision|0|||
23202750|NCT02531373|64483648|FG008|Overall Study|Physician Decision|0|||
23202751|NCT02531373|64483640|FG000|Overall Study|Protocol Violation|0|||
23202752|NCT02531373|64483641|FG001|Overall Study|Protocol Violation|0|||
23202753|NCT02531373|64483642|FG002|Overall Study|Protocol Violation|0|||
23504603|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23202754|NCT02531373|64483643|FG003|Overall Study|Protocol Violation|0|||
23202755|NCT02531373|64483644|FG004|Overall Study|Protocol Violation|0|||
23202756|NCT02531373|64483645|FG005|Overall Study|Protocol Violation|1|||
23202757|NCT02531373|64483646|FG006|Overall Study|Protocol Violation|1|||
23202758|NCT02531373|64483647|FG007|Overall Study|Protocol Violation|0|||
23202759|NCT02531373|64483648|FG008|Overall Study|Protocol Violation|1|||
23202760|NCT02531373|64483640|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23202761|NCT02531373|64483641|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23504604|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504605|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504606|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504607|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504608|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504609|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504610|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
23504611|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
23504612|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
23504613|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504614|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504615|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504616|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23202762|NCT02531373|64483642|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23202763|NCT02531373|64483643|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23202764|NCT02531373|64483644|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23202765|NCT02531373|64483645|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
23202766|NCT02531373|64483646|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
23202767|NCT02531373|64483647|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
23504617|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504618|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504619|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504620|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23202768|NCT02531373|64483648|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
23504621|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504622|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23202769|NCT02531373|64483640|FG000|Overall Study|Withdrawal by Subject|0|||
23202770|NCT02531373|64483641|FG001|Overall Study|Withdrawal by Subject|0|||
23202771|NCT02531373|64483642|FG002|Overall Study|Withdrawal by Subject|0|||
23202772|NCT02531373|64483643|FG003|Overall Study|Withdrawal by Subject|0|||
23202773|NCT02531373|64483644|FG004|Overall Study|Withdrawal by Subject|3|||
23202774|NCT02531373|64483645|FG005|Overall Study|Withdrawal by Subject|0|||
23202775|NCT02531373|64483646|FG006|Overall Study|Withdrawal by Subject|0|||
23202776|NCT02531373|64483647|FG007|Overall Study|Withdrawal by Subject|0|||
23202777|NCT02531373|64483648|FG008|Overall Study|Withdrawal by Subject|0|||
23202778|NCT05460871|64483652|FG000|Overall Study|Withdrawal by Subject|1|||
23202779|NCT05460871|64483653|FG001|Overall Study|Withdrawal by Subject|2|||
23202780|NCT03703375|64483657|FG000|Randomization Period|Withdrawal by Subject|0|||
23202781|NCT03703375|64483658|FG001|Randomization Period|Withdrawal by Subject|0|||
23202782|NCT03703375|64483659|FG002|Randomization Period|Withdrawal by Subject|0|||
23202783|NCT03703375|64483660|FG003|Randomization Period|Withdrawal by Subject|1|||
23202784|NCT03703375|64483657|FG000|Randomization Period|Completed safety run-in treatment|7|||
23202785|NCT03703375|64483658|FG001|Randomization Period|Completed safety run-in treatment|0|||
23202786|NCT03703375|64483659|FG002|Randomization Period|Completed safety run-in treatment|0|||
23202787|NCT03703375|64483660|FG003|Randomization Period|Completed safety run-in treatment|0|||
23202788|NCT03703375|64483657|FG000|Treatment Period|Other Reasons|0|||
23202789|NCT03703375|64483658|FG001|Treatment Period|Other Reasons|1|||
23202790|NCT03703375|64483659|FG002|Treatment Period|Other Reasons|0|||
23202791|NCT03703375|64483660|FG003|Treatment Period|Other Reasons|3|||
23202792|NCT03703375|64483657|FG000|Treatment Period|Consent Withdrawal|0|||
23202793|NCT03703375|64483658|FG001|Treatment Period|Consent Withdrawal|0|||
23202794|NCT03703375|64483659|FG002|Treatment Period|Consent Withdrawal|0|||
23202795|NCT03703375|64483660|FG003|Treatment Period|Consent Withdrawal|1|||
23202796|NCT03703375|64483657|FG000|Treatment Period|Death|1|||
23202797|NCT03703375|64483658|FG001|Treatment Period|Death|0|||
23202798|NCT03703375|64483659|FG002|Treatment Period|Death|1|||
23202799|NCT03703375|64483660|FG003|Treatment Period|Death|2|||
23202800|NCT03703375|64483657|FG000|Treatment Period|Toxicity of Study Treatment|2|||
23202801|NCT03703375|64483658|FG001|Treatment Period|Toxicity of Study Treatment|0|||
23504623|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504624|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504625|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504626|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504627|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504628|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504629|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23202802|NCT03703375|64483659|FG002|Treatment Period|Toxicity of Study Treatment|4|||
23202803|NCT03703375|64483660|FG003|Treatment Period|Toxicity of Study Treatment|1|||
23202804|NCT03703375|64483657|FG000|Treatment Period|Progression|32|||
23202805|NCT03703375|64483658|FG001|Treatment Period|Progression|1|||
23202806|NCT03703375|64483659|FG002|Treatment Period|Progression|7|||
23202807|NCT03703375|64483660|FG003|Treatment Period|Progression|11|||
23202808|NCT03703375|64483657|FG000|Treatment Period|Completed treatment|7|||
23504630|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504631|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504632|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504633|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504634|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504635|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504636|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
23504637|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
23504638|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
23504639|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504640|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504641|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504642|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504643|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504644|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504645|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504646|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504647|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504648|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504649|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504650|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504651|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504652|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504653|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504654|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504655|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504656|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504657|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504658|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504659|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504660|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504661|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504662|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
23504663|NCT03129100|65587876|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504664|NCT03129100|65587877|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
23504665|NCT03129100|65587878|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504666|NCT03129100|65587879|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504667|NCT03129100|65587880|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504668|NCT03129100|65587881|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504669|NCT03129100|65587882|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504670|NCT03129100|65587883|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504671|NCT03129100|65587884|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504672|NCT03129100|65587885|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504673|NCT03129100|65587886|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504674|NCT03129100|65587887|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504675|NCT03129100|65587888|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504676|NCT03129100|65587889|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504677|NCT03129100|65587890|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504678|NCT03129100|65587891|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504679|NCT03129100|65587892|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504680|NCT03129100|65587893|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504681|NCT03129100|65587894|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504682|NCT03129100|65587895|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504683|NCT03129100|65587896|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504684|NCT03129100|65587897|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504685|NCT03129100|65587898|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504686|NCT03129100|65587899|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504687|NCT03129100|65587900|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
23504688|NCT03129100|65587901|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
23202809|NCT03703375|64483658|FG001|Treatment Period|Completed treatment|2|||
23202810|NCT03703375|64483659|FG002|Treatment Period|Completed treatment|0|||
23504689|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504690|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504691|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
23504692|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
23504693|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23202811|NCT03703375|64483660|FG003|Treatment Period|Completed treatment|0|||
23202812|NCT00506077|64483661|FG000|Treatment Period 1|Adverse Event|2|||
23202813|NCT00506077|64483662|FG001|Treatment Period 1|Adverse Event|1|||
23403911|NCT00833027|65226438|FG000|Overall Study|Lack of Efficacy|12|||
23504694|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
23504695|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504696|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23202814|NCT00506077|64483661|FG000|Treatment Period 1|Lost to Follow-up|0|||
23202815|NCT00506077|64483662|FG001|Treatment Period 1|Lost to Follow-up|2|||
23202816|NCT00506077|64483661|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23202817|NCT00506077|64483662|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23202818|NCT00506077|64483661|FG000|Treatment Period 2|Adverse Event|0|||
23202819|NCT00506077|64483662|FG001|Treatment Period 2|Adverse Event|1|||
23202820|NCT00506077|64483661|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23202821|NCT00506077|64483662|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23202822|NCT03670641|64483666|FG000|Overall Study|Lost to Follow-up|3|||
23202823|NCT01346371|64483667|FG000|Overall Study|Lost to Follow-up|2|||
23202824|NCT01346371|64483668|FG001|Overall Study|Lost to Follow-up|0|||
23202825|NCT00905021|64483669|FG000|Overall Study|Adverse Event|2|||
23202826|NCT00339183|64483670|FG000|Overall Study|Adverse Event|5|||
23202827|NCT00339183|64483671|FG001|Overall Study|Adverse Event|3|||
23202828|NCT00339183|64483670|FG000|Overall Study|Withdrawal by Subject|16|||
23202829|NCT00339183|64483671|FG001|Overall Study|Withdrawal by Subject|19|||
23202830|NCT00339183|64483670|FG000|Overall Study|Physician Decision|2|||
23202831|NCT00339183|64483671|FG001|Overall Study|Physician Decision|4|||
23202832|NCT00339183|64483670|FG000|Overall Study|Lost to Follow-up|17|||
23202833|NCT00339183|64483671|FG001|Overall Study|Lost to Follow-up|17|||
23202834|NCT00339183|64483670|FG000|Overall Study|Protocol-specified criteria|12|||
23202835|NCT00339183|64483671|FG001|Overall Study|Protocol-specified criteria|8|||
23202836|NCT00339183|64483670|FG000|Overall Study|Missing reason|3|||
23202837|NCT00339183|64483671|FG001|Overall Study|Missing reason|1|||
23202838|NCT00339183|64483670|FG000|Overall Study|Other|46|||
23202839|NCT00339183|64483671|FG001|Overall Study|Other|40|||
23202840|NCT00339183|64483670|FG000|Overall Study|Ongoing|20|||
23202841|NCT00339183|64483671|FG001|Overall Study|Ongoing|13|||
23202842|NCT02273050|64483672|FG000|Overall Study|Adverse Event|4|||
23202843|NCT02273050|64483673|FG001|Overall Study|Adverse Event|3|||
23202844|NCT02273050|64483674|FG002|Overall Study|Adverse Event|3|||
23202845|NCT02273050|64483672|FG000|Overall Study|Death|0|||
23202846|NCT02273050|64483673|FG001|Overall Study|Death|0|||
23202847|NCT02273050|64483674|FG002|Overall Study|Death|1|||
23202848|NCT02273050|64483672|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
23202849|NCT02273050|64483673|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
23202850|NCT02273050|64483674|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
23202851|NCT02273050|64483672|FG000|Overall Study|Lack of Efficacy|0|||
23202852|NCT02273050|64483673|FG001|Overall Study|Lack of Efficacy|1|||
23202853|NCT02273050|64483674|FG002|Overall Study|Lack of Efficacy|1|||
23202854|NCT02273050|64483672|FG000|Overall Study|Withdrawal by Subject|17|||
23202855|NCT02273050|64483673|FG001|Overall Study|Withdrawal by Subject|14|||
23202856|NCT02273050|64483674|FG002|Overall Study|Withdrawal by Subject|16|||
23504697|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23202857|NCT02273050|64483672|FG000|Overall Study|Lost to Follow-up|0|||
23202858|NCT02273050|64483673|FG001|Overall Study|Lost to Follow-up|2|||
23202859|NCT02273050|64483674|FG002|Overall Study|Lost to Follow-up|3|||
23202860|NCT02273050|64483672|FG000|Overall Study|Protocol Violation|3|||
23202861|NCT02273050|64483673|FG001|Overall Study|Protocol Violation|1|||
23202862|NCT02273050|64483674|FG002|Overall Study|Protocol Violation|4|||
23202863|NCT00937560|64483675|FG000|Initial Treatment|Death|6|||
23202864|NCT00937560|64483675|FG000|Initial Treatment|Withdraw consent|3|||
23202865|NCT00937560|64483675|FG000|Initial Treatment|Adverse Event|1|||
23202866|NCT00937560|64483675|FG000|Initial Treatment|Lost to Follow-up|1|||
23202867|NCT00937560|64483675|FG000|Initial Treatment|No end of study page|10|||
23202868|NCT00937560|64483675|FG000|Maintenance Treatment|Death|12|||
23202869|NCT00937560|64483675|FG000|Maintenance Treatment|Withdraw consent|5|||
23504698|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504699|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23202870|NCT00937560|64483675|FG000|Maintenance Treatment|According to protocol|1|||
23202871|NCT02618928|64483676|FG000|Overall Study|Failure to Return|28|||
23202872|NCT02618928|64483676|FG000|Overall Study|Insufficient Virological Response|1|||
23202873|NCT02618928|64483676|FG000|Overall Study|Withdrawal by Subject|2|||
23202874|NCT02618928|64483676|FG000|Overall Study|Death|3|||
23202875|NCT02618928|64483676|FG000|Overall Study|Other|11|||
23202876|NCT02618928|64483676|FG000|Overall Study|Missing|6|||
23202877|NCT02618928|64483676|FG000|Overall Study|Treatment Never Started|7|||
23202878|NCT02322892|64483677|FG000|Overall Study|Surgery cancelled|1|||
23202879|NCT02322892|64483678|FG001|Overall Study|Surgery cancelled|2|||
23202880|NCT02322892|64483677|FG000|Overall Study|Met exclusion criteria|0|||
23202881|NCT02322892|64483678|FG001|Overall Study|Met exclusion criteria|1|||
23202882|NCT02322892|64483677|FG000|Overall Study|Protocol Violation|1|||
23202883|NCT02322892|64483678|FG001|Overall Study|Protocol Violation|0|||
23202884|NCT04633473|64483679|FG000|Overall Study|Withdrawal by Subject|6|||
23202885|NCT01687413|64483680|FG000|Overall Study|Withdrawal by Subject|0|||
23202886|NCT01687413|64483681|FG001|Overall Study|Withdrawal by Subject|2|||
23202887|NCT01687413|64483680|FG000|Overall Study|Not eligible|0|||
23202888|NCT01687413|64483681|FG001|Overall Study|Not eligible|2|||
23202889|NCT01687413|64483680|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
23202890|NCT01687413|64483681|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
23202891|NCT01830543|64483706|FG000|Overall Study|Subject Decision|19|||
23202892|NCT01830543|64483707|FG001|Overall Study|Subject Decision|21|||
23202893|NCT01830543|64483708|FG002|Overall Study|Subject Decision|57|||
23202894|NCT01830543|64483706|FG000|Overall Study|Adverse Event|91|||
23202895|NCT01830543|64483707|FG001|Overall Study|Adverse Event|77|||
23202896|NCT01830543|64483708|FG002|Overall Study|Adverse Event|76|||
23202897|NCT01830543|64483706|FG000|Overall Study|Death|20|||
23202898|NCT01830543|64483707|FG001|Overall Study|Death|22|||
23202899|NCT01830543|64483708|FG002|Overall Study|Death|22|||
23202900|NCT01830543|64483706|FG000|Overall Study|Protocol Violation|3|||
23202901|NCT01830543|64483707|FG001|Overall Study|Protocol Violation|7|||
23202902|NCT01830543|64483708|FG002|Overall Study|Protocol Violation|7|||
23202903|NCT01830543|64483706|FG000|Overall Study|Physician Decision|11|||
23202904|NCT01830543|64483707|FG001|Overall Study|Physician Decision|5|||
23202905|NCT01830543|64483708|FG002|Overall Study|Physician Decision|12|||
23202906|NCT01830543|64483706|FG000|Overall Study|Withdrawal by consent|3|||
23202907|NCT01830543|64483707|FG001|Overall Study|Withdrawal by consent|3|||
23302356|NCT01144364|64850678|FG001|Induction Phase|Protocol Violation|0|||
23302357|NCT01144364|64850679|FG002|Induction Phase|Protocol Violation|0|||
23302358|NCT01144364|64850677|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
23302359|NCT01144364|64850678|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
23302360|NCT01144364|64850679|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
23302361|NCT01144364|64850677|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
23302362|NCT01144364|64850678|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
23302363|NCT01144364|64850679|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
23302364|NCT01144364|64850677|FG000|Follow-Up/Maintenance Phase|Death|0|||
23302365|NCT01144364|64850678|FG001|Follow-Up/Maintenance Phase|Death|2|||
23302366|NCT01144364|64850679|FG002|Follow-Up/Maintenance Phase|Death|0|||
23302367|NCT01144364|64850677|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
23302368|NCT01144364|64850678|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
23302369|NCT01144364|64850679|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
23302370|NCT01144364|64850677|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
23302371|NCT01144364|64850678|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
23202908|NCT01830543|64483708|FG002|Overall Study|Withdrawal by consent|3|||
23202909|NCT01830543|64483706|FG000|Overall Study|Other|12|||
23202910|NCT01830543|64483707|FG001|Overall Study|Other|17|||
23202911|NCT01830543|64483708|FG002|Overall Study|Other|37|||
23202912|NCT02653976|64483709|FG000|Overall Study|Withdrawal by Subject|5|||
23202913|NCT02653976|64483709|FG000|Overall Study|Death|4|||
23202914|NCT03011034|64483710|FG000|Overall Study|Adverse Event|1|||
23202915|NCT03011034|64483711|FG001|Overall Study|Adverse Event|0|||
23202916|NCT02006667|64483719|FG000|Overall Study|Adverse Event|3|||
23202917|NCT02006667|64483719|FG000|Overall Study|Death|2|||
23202918|NCT02006667|64483719|FG000|Overall Study|Withdrawal by Subject|1|||
23202919|NCT04056455|64483724|FG000|Overall Study|Adverse Event|1|||
23202920|NCT04056455|64483725|FG001|Overall Study|Adverse Event|0|||
23202921|NCT00937768|64483727|FG000|Overall Study|Refused Further Treatment|3|||
23202922|NCT00937768|64483728|FG001|Overall Study|Refused Further Treatment|2|||
23202923|NCT00937768|64483727|FG000|Overall Study|Disease Progression|1|||
23202924|NCT00937768|64483728|FG001|Overall Study|Disease Progression|1|||
23202925|NCT00937768|64483727|FG000|Overall Study|Alternate Treatment|0|||
23202926|NCT00937768|64483728|FG001|Overall Study|Alternate Treatment|1|||
23202927|NCT00937768|64483727|FG000|Overall Study|No Further Funding|4|||
23202928|NCT00937768|64483728|FG001|Overall Study|No Further Funding|4|||
23202929|NCT02935634|64483730|FG000|Randomization|Participant withdrew consent|0|||
23202930|NCT02935634|64483731|FG001|Randomization|Participant withdrew consent|1|||
23202931|NCT02935634|64483732|FG002|Randomization|Participant withdrew consent|0|||
23202932|NCT02935634|64483733|FG003|Randomization|Participant withdrew consent|0|||
23302372|NCT01144364|64850679|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
23302373|NCT01144364|64850677|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
23302374|NCT01144364|64850678|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
23302375|NCT01144364|64850679|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
23202933|NCT02935634|64483734|FG004|Randomization|Participant withdrew consent|0|||
23202934|NCT02935634|64483735|FG005|Randomization|Participant withdrew consent|0|||
23202935|NCT02935634|64483730|FG000|Randomization|Death|2|||
23202936|NCT02935634|64483731|FG001|Randomization|Death|1|||
23202937|NCT02935634|64483732|FG002|Randomization|Death|1|||
23202938|NCT02935634|64483733|FG003|Randomization|Death|0|||
23202939|NCT02935634|64483734|FG004|Randomization|Death|0|||
23202940|NCT02935634|64483735|FG005|Randomization|Death|0|||
23202941|NCT02935634|64483730|FG000|Randomization|Other reasons|0|||
23202942|NCT02935634|64483731|FG001|Randomization|Other reasons|2|||
23202943|NCT02935634|64483732|FG002|Randomization|Other reasons|2|||
23202944|NCT02935634|64483733|FG003|Randomization|Other reasons|0|||
23202945|NCT02935634|64483734|FG004|Randomization|Other reasons|0|||
23202946|NCT02935634|64483735|FG005|Randomization|Other reasons|0|||
23202947|NCT02935634|64483730|FG000|Treatment: Track 1|Disease progression|15|||
23202948|NCT02935634|64483731|FG001|Treatment: Track 1|Disease progression|17|||
23202949|NCT02935634|64483732|FG002|Treatment: Track 1|Disease progression|28|||
23202950|NCT02935634|64483733|FG003|Treatment: Track 1|Disease progression|4|||
23202951|NCT02935634|64483734|FG004|Treatment: Track 1|Disease progression|6|||
23202952|NCT02935634|64483735|FG005|Treatment: Track 1|Disease progression|2|||
23202953|NCT02935634|64483730|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
23202954|NCT02935634|64483731|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
23202955|NCT02935634|64483732|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
23202956|NCT02935634|64483733|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
23202957|NCT02935634|64483734|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
23202958|NCT02935634|64483735|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
23302376|NCT01144364|64850677|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
23302377|NCT01144364|64850678|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
23302378|NCT01144364|64850679|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
23302379|NCT00655850|64850680|FG000|Overall Study|Death|2|||
23302380|NCT00655850|64850680|FG000|Overall Study|Withdrawal by Subject|1|||
23302381|NCT04556552|64850681|FG000|Overall Study|Lost to Follow-up|1|||
23302382|NCT04556552|64850682|FG001|Overall Study|Lost to Follow-up|0|||
23504700|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504701|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504702|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504703|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504704|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504705|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504706|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504707|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504708|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504709|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504710|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504711|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504712|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504713|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504714|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
23504715|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Death|0|||
23504716|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Death|0|||
23504717|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Death|1|||
23202959|NCT02935634|64483730|FG000|Treatment: Track 1|Lost to Follow-up|1|||
23202960|NCT02935634|64483731|FG001|Treatment: Track 1|Lost to Follow-up|0|||
23202961|NCT02935634|64483732|FG002|Treatment: Track 1|Lost to Follow-up|0|||
23202962|NCT02935634|64483733|FG003|Treatment: Track 1|Lost to Follow-up|0|||
23202963|NCT02935634|64483734|FG004|Treatment: Track 1|Lost to Follow-up|0|||
23202964|NCT02935634|64483735|FG005|Treatment: Track 1|Lost to Follow-up|0|||
23202965|NCT02935634|64483730|FG000|Treatment: Track 1|Study drug toxicity|2|||
23202966|NCT02935634|64483731|FG001|Treatment: Track 1|Study drug toxicity|1|||
23202967|NCT02935634|64483732|FG002|Treatment: Track 1|Study drug toxicity|3|||
23202968|NCT02935634|64483733|FG003|Treatment: Track 1|Study drug toxicity|0|||
23202969|NCT02935634|64483734|FG004|Treatment: Track 1|Study drug toxicity|0|||
23202970|NCT02935634|64483735|FG005|Treatment: Track 1|Study drug toxicity|1|||
23202971|NCT02935634|64483730|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
23202972|NCT02935634|64483731|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
23202973|NCT02935634|64483732|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
23202974|NCT02935634|64483733|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
23202975|NCT02935634|64483734|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
23504718|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Death|0|||
23202976|NCT02935634|64483735|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
23202977|NCT02935634|64483730|FG000|Treatment: Track 1|Participant withdrew consent|2|||
23202978|NCT02935634|64483731|FG001|Treatment: Track 1|Participant withdrew consent|0|||
23202979|NCT02935634|64483732|FG002|Treatment: Track 1|Participant withdrew consent|1|||
23302383|NCT04556552|64850681|FG000|Overall Study|Claustrophobia|0|||
23302384|NCT04556552|64850682|FG001|Overall Study|Claustrophobia|1|||
23302385|NCT04556552|64850681|FG000|Overall Study|Inability to continue|0|||
23504719|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Death|0|||
23504720|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Death|0|||
23202980|NCT02935634|64483733|FG003|Treatment: Track 1|Participant withdrew consent|0|||
23202981|NCT02935634|64483734|FG004|Treatment: Track 1|Participant withdrew consent|1|||
23202982|NCT02935634|64483735|FG005|Treatment: Track 1|Participant withdrew consent|0|||
23202983|NCT02935634|64483730|FG000|Treatment: Track 1|Other reasons|0|||
23202984|NCT02935634|64483731|FG001|Treatment: Track 1|Other reasons|0|||
23202985|NCT02935634|64483732|FG002|Treatment: Track 1|Other reasons|2|||
23202986|NCT02935634|64483733|FG003|Treatment: Track 1|Other reasons|0|||
23202987|NCT02935634|64483734|FG004|Treatment: Track 1|Other reasons|0|||
23202988|NCT02935634|64483735|FG005|Treatment: Track 1|Other reasons|0|||
23202989|NCT02935634|64483730|FG000|Treatment: Track 2|Disease progression|13|||
23202990|NCT02935634|64483731|FG001|Treatment: Track 2|Disease progression|26|||
23202991|NCT02935634|64483732|FG002|Treatment: Track 2|Disease progression|20|||
23202992|NCT02935634|64483733|FG003|Treatment: Track 2|Disease progression|5|||
23202993|NCT02935634|64483734|FG004|Treatment: Track 2|Disease progression|1|||
23202994|NCT02935634|64483735|FG005|Treatment: Track 2|Disease progression|4|||
23202995|NCT02935634|64483730|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
23202996|NCT02935634|64483731|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
23202997|NCT02935634|64483732|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
23202998|NCT02935634|64483733|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
23202999|NCT02935634|64483734|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
23302386|NCT04556552|64850682|FG001|Overall Study|Inability to continue|1|||
23302387|NCT03212521|64850683|FG000|Overall Study|Adverse Event|1|||
23302388|NCT03212521|64850683|FG000|Overall Study|Lost to Follow-up|4|||
23302389|NCT03212521|64850683|FG000|Overall Study|Withdrawal by Subject|1|||
23302390|NCT03212521|64850683|FG000|Overall Study|Other|1|||
23302391|NCT01304693|64850685|FG000|Overall Study|Adverse Event|0|||
23302392|NCT01304693|64850686|FG001|Overall Study|Adverse Event|0|||
23302393|NCT01304693|64850687|FG002|Overall Study|Adverse Event|0|||
23302394|NCT01304693|64850688|FG003|Overall Study|Adverse Event|0|||
23302395|NCT01304693|64850689|FG004|Overall Study|Adverse Event|1|||
23302396|NCT01304693|64850685|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
23302397|NCT01304693|64850686|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
23302398|NCT01304693|64850687|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
23302399|NCT01304693|64850688|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
23302400|NCT01304693|64850689|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
23302401|NCT03578237|64850690|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
23302402|NCT03578237|64850691|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
23302403|NCT01641133|64850692|FG000|Overall Study|Protocol Violation|0|||
23302404|NCT01641133|64850693|FG001|Overall Study|Protocol Violation|1|||
23302405|NCT01641133|64850694|FG002|Overall Study|Protocol Violation|1|||
23302406|NCT01641133|64850692|FG000|Overall Study|Migrated/moved from study area|5|||
23302407|NCT01641133|64850693|FG001|Overall Study|Migrated/moved from study area|3|||
23302408|NCT01641133|64850694|FG002|Overall Study|Migrated/moved from study area|1|||
23302409|NCT01641133|64850692|FG000|Overall Study|Adverse Event|0|||
23302410|NCT01641133|64850693|FG001|Overall Study|Adverse Event|0|||
23302411|NCT01641133|64850694|FG002|Overall Study|Adverse Event|1|||
23302412|NCT01641133|64850692|FG000|Overall Study|Withdrawal by Subject|5|||
23302413|NCT01641133|64850693|FG001|Overall Study|Withdrawal by Subject|3|||
23302414|NCT01641133|64850694|FG002|Overall Study|Withdrawal by Subject|3|||
23302415|NCT01641133|64850692|FG000|Overall Study|Lost to Follow-up|0|||
23302416|NCT01641133|64850693|FG001|Overall Study|Lost to Follow-up|2|||
23302417|NCT01641133|64850694|FG002|Overall Study|Lost to Follow-up|2|||
23302418|NCT01195272|64850695|FG000|Overall Study|Adverse Event|1|||
23302419|NCT01195272|64850695|FG000|Overall Study|Lack of Efficacy|3|||
23302420|NCT04135196|64850698|FG000|Overall Study|Lost to Follow-up|8|||
23302421|NCT04135196|64850699|FG001|Overall Study|Lost to Follow-up|7|||
23302422|NCT04135196|64850700|FG002|Overall Study|Lost to Follow-up|8|||
23302423|NCT04135196|64850701|FG003|Overall Study|Lost to Follow-up|9|||
23302424|NCT04135196|64850702|FG004|Overall Study|Lost to Follow-up|1|||
23302425|NCT04135196|64850698|FG000|Overall Study|Pregnancy|0|||
23302426|NCT04135196|64850699|FG001|Overall Study|Pregnancy|0|||
23302427|NCT04135196|64850700|FG002|Overall Study|Pregnancy|1|||
23302428|NCT04135196|64850701|FG003|Overall Study|Pregnancy|0|||
23302429|NCT04135196|64850702|FG004|Overall Study|Pregnancy|0|||
23302430|NCT04135196|64850698|FG000|Overall Study|Withdrawal by Subject|0|||
23302431|NCT04135196|64850699|FG001|Overall Study|Withdrawal by Subject|0|||
23203000|NCT02935634|64483735|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
23302432|NCT04135196|64850700|FG002|Overall Study|Withdrawal by Subject|0|||
23302433|NCT04135196|64850701|FG003|Overall Study|Withdrawal by Subject|0|||
23203001|NCT02935634|64483730|FG000|Treatment: Track 2|Study drug toxicity|7|||
23203002|NCT02935634|64483731|FG001|Treatment: Track 2|Study drug toxicity|3|||
23203003|NCT02935634|64483732|FG002|Treatment: Track 2|Study drug toxicity|0|||
23203004|NCT02935634|64483733|FG003|Treatment: Track 2|Study drug toxicity|0|||
23203005|NCT02935634|64483734|FG004|Treatment: Track 2|Study drug toxicity|0|||
23203006|NCT02935634|64483735|FG005|Treatment: Track 2|Study drug toxicity|0|||
23203007|NCT02935634|64483730|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
23203008|NCT02935634|64483731|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
23203009|NCT02935634|64483732|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
23203010|NCT02935634|64483733|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
23203011|NCT02935634|64483734|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
23203012|NCT02935634|64483735|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
23203013|NCT02935634|64483730|FG000|Treatment: Track 2|Participant withdrew consent|0|||
23203014|NCT02935634|64483731|FG001|Treatment: Track 2|Participant withdrew consent|1|||
23203015|NCT02935634|64483732|FG002|Treatment: Track 2|Participant withdrew consent|1|||
23203016|NCT02935634|64483733|FG003|Treatment: Track 2|Participant withdrew consent|0|||
23203017|NCT02935634|64483734|FG004|Treatment: Track 2|Participant withdrew consent|1|||
23203018|NCT02935634|64483735|FG005|Treatment: Track 2|Participant withdrew consent|0|||
23203019|NCT00905307|64483736|FG000|Overall Study|Switched to Open Label Rescue|7|||
23203020|NCT00905307|64483737|FG001|Overall Study|Switched to Open Label Rescue|17|||
23203021|NCT00905307|64483738|FG002|Overall Study|Switched to Open Label Rescue|11|||
23203022|NCT00905307|64483739|FG003|Overall Study|Switched to Open Label Rescue|11|||
23203023|NCT00905307|64483740|FG004|Overall Study|Switched to Open Label Rescue|4|||
23203024|NCT00905307|64483741|FG005|Overall Study|Switched to Open Label Rescue|15|||
23203025|NCT00905307|64483736|FG000|Overall Study|Lost to Follow-up|0|||
23203026|NCT00905307|64483737|FG001|Overall Study|Lost to Follow-up|0|||
23203027|NCT00905307|64483738|FG002|Overall Study|Lost to Follow-up|0|||
23203028|NCT00905307|64483739|FG003|Overall Study|Lost to Follow-up|0|||
23203029|NCT00905307|64483740|FG004|Overall Study|Lost to Follow-up|1|||
23203030|NCT00905307|64483741|FG005|Overall Study|Lost to Follow-up|1|||
23203031|NCT00905307|64483736|FG000|Overall Study|Adverse Event|3|||
23203032|NCT00905307|64483737|FG001|Overall Study|Adverse Event|4|||
23203033|NCT00905307|64483738|FG002|Overall Study|Adverse Event|5|||
23203034|NCT00905307|64483739|FG003|Overall Study|Adverse Event|11|||
23203035|NCT00905307|64483740|FG004|Overall Study|Adverse Event|3|||
23203036|NCT00905307|64483741|FG005|Overall Study|Adverse Event|5|||
23203037|NCT00905307|64483736|FG000|Overall Study|Withdrawal by Subject|5|||
23203038|NCT00905307|64483737|FG001|Overall Study|Withdrawal by Subject|13|||
23203039|NCT00905307|64483738|FG002|Overall Study|Withdrawal by Subject|15|||
23203040|NCT00905307|64483739|FG003|Overall Study|Withdrawal by Subject|11|||
23203041|NCT00905307|64483740|FG004|Overall Study|Withdrawal by Subject|4|||
23203042|NCT00905307|64483741|FG005|Overall Study|Withdrawal by Subject|13|||
23203043|NCT00905307|64483736|FG000|Overall Study|Protocol Violation|1|||
23203044|NCT00905307|64483737|FG001|Overall Study|Protocol Violation|0|||
23203045|NCT00905307|64483738|FG002|Overall Study|Protocol Violation|1|||
23203046|NCT00905307|64483739|FG003|Overall Study|Protocol Violation|0|||
23203047|NCT00905307|64483740|FG004|Overall Study|Protocol Violation|0|||
23203048|NCT00905307|64483741|FG005|Overall Study|Protocol Violation|0|||
23203049|NCT00905307|64483736|FG000|Overall Study|Lack of Efficacy|6|||
23203050|NCT00905307|64483737|FG001|Overall Study|Lack of Efficacy|3|||
23203051|NCT00905307|64483738|FG002|Overall Study|Lack of Efficacy|5|||
23203052|NCT00905307|64483739|FG003|Overall Study|Lack of Efficacy|4|||
23203053|NCT00905307|64483740|FG004|Overall Study|Lack of Efficacy|4|||
23203054|NCT00905307|64483741|FG005|Overall Study|Lack of Efficacy|8|||
23203055|NCT04863014|64483743|FG000|Overall Study|Lost to Follow-up|3|||
23203056|NCT04863014|64483744|FG001|Overall Study|Lost to Follow-up|2|||
23203057|NCT04863014|64483743|FG000|Overall Study|Subject Decision|0|||
23203058|NCT04863014|64483744|FG001|Overall Study|Subject Decision|4|||
23203059|NCT02330549|64483745|FG000|Overall Study|Adverse Event|1|||
23203060|NCT02330549|64483746|FG001|Overall Study|Adverse Event|0|||
23203061|NCT02330549|64483745|FG000|Overall Study|Subject withdrew consent|2|||
23302434|NCT04135196|64850702|FG004|Overall Study|Withdrawal by Subject|1|||
23203062|NCT02330549|64483746|FG001|Overall Study|Subject withdrew consent|1|||
23203063|NCT02330549|64483745|FG000|Overall Study|Failure to meet randomization criteria|1|||
23203064|NCT02330549|64483746|FG001|Overall Study|Failure to meet randomization criteria|0|||
23203065|NCT02938585|64483753|FG000|Overall Study|Withdrawal by parent or guardian|0|||
23203066|NCT02938585|64483754|FG001|Overall Study|Withdrawal by parent or guardian|1|||
23203067|NCT02938585|64483755|FG002|Overall Study|Withdrawal by parent or guardian|0|||
23203068|NCT02938585|64483756|FG003|Overall Study|Withdrawal by parent or guardian|0|||
23203069|NCT02938585|64483753|FG000|Overall Study|Withdrawal by Subject|0|||
23203070|NCT02938585|64483754|FG001|Overall Study|Withdrawal by Subject|0|||
23203071|NCT02938585|64483755|FG002|Overall Study|Withdrawal by Subject|0|||
23302435|NCT00448136|64850703|FG000|Overall Study|Death|3|||
23203072|NCT02938585|64483756|FG003|Overall Study|Withdrawal by Subject|5|||
23203073|NCT04426825|64483760|FG000|Overall Study|Death|17|||
23203074|NCT04426825|64483760|FG000|Overall Study|Lost to Follow-up|1|||
23203075|NCT04426825|64483760|FG000|Overall Study|Study terminated by sponsor|5|||
23203076|NCT02768194|64483763|FG000|Period 1|Adverse Event|0|||
23203077|NCT02768194|64483764|FG001|Period 1|Adverse Event|0|||
23203078|NCT02768194|64483765|FG002|Period 1|Adverse Event|0|||
23203079|NCT02768194|64483766|FG003|Period 1|Adverse Event|1|||
23203080|NCT02768194|64483767|FG004|Period 1|Adverse Event|0|||
23203081|NCT02768194|64483768|FG005|Period 1|Adverse Event|0|||
23203082|NCT02768194|64483763|FG000|Period 2|Other (Reason not specified)|1|||
23203083|NCT02768194|64483764|FG001|Period 2|Other (Reason not specified)|0|||
23203084|NCT02768194|64483765|FG002|Period 2|Other (Reason not specified)|0|||
23203085|NCT02768194|64483766|FG003|Period 2|Other (Reason not specified)|0|||
23203086|NCT02768194|64483767|FG004|Period 2|Other (Reason not specified)|0|||
23203087|NCT02768194|64483768|FG005|Period 2|Other (Reason not specified)|0|||
23203088|NCT02768194|64483763|FG000|Period 3|Other (Reason not specified)|0|||
23203089|NCT02768194|64483764|FG001|Period 3|Other (Reason not specified)|1|||
23203090|NCT02768194|64483765|FG002|Period 3|Other (Reason not specified)|0|||
23203091|NCT02768194|64483766|FG003|Period 3|Other (Reason not specified)|0|||
23203092|NCT02768194|64483767|FG004|Period 3|Other (Reason not specified)|0|||
23203093|NCT02768194|64483768|FG005|Period 3|Other (Reason not specified)|0|||
23203094|NCT01763905|64483769|FG000|Overall Study|Withdrawal by Subject|1|||
23203095|NCT01763905|64483770|FG001|Overall Study|Withdrawal by Subject|1|||
23203096|NCT01763905|64483771|FG002|Overall Study|Withdrawal by Subject|0|||
23203097|NCT01763905|64483772|FG003|Overall Study|Withdrawal by Subject|1|||
23203098|NCT01763905|64483769|FG000|Overall Study|Decision by sponsor|5|||
23203099|NCT01763905|64483770|FG001|Overall Study|Decision by sponsor|0|||
23203100|NCT01763905|64483771|FG002|Overall Study|Decision by sponsor|8|||
23203101|NCT01763905|64483772|FG003|Overall Study|Decision by sponsor|0|||
23203102|NCT01763905|64483769|FG000|Overall Study|Lost to Follow-up|0|||
23203103|NCT01763905|64483770|FG001|Overall Study|Lost to Follow-up|0|||
23203104|NCT01763905|64483771|FG002|Overall Study|Lost to Follow-up|1|||
23203105|NCT01763905|64483772|FG003|Overall Study|Lost to Follow-up|0|||
23203106|NCT02554253|64483773|FG000|Overall Study|ineligible after enrollment|1|||
23203107|NCT02554253|64483774|FG001|Overall Study|ineligible after enrollment|0|||
23203108|NCT02554253|64483773|FG000|Overall Study|converted to transcatheter procedure|0|||
23203109|NCT02554253|64483774|FG001|Overall Study|converted to transcatheter procedure|1|||
23203110|NCT02554253|64483773|FG000|Overall Study|received both drugs|0|||
23203111|NCT02554253|64483774|FG001|Overall Study|received both drugs|1|||
23203112|NCT04263142|64483776|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
23203113|NCT04263142|64483777|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
23203114|NCT04263142|64483778|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
23203115|NCT04263142|64483779|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
23203116|NCT04263142|64483780|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
23203117|NCT04263142|64483776|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
23203118|NCT04263142|64483777|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
23203119|NCT04263142|64483778|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
23203120|NCT04263142|64483779|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
23203121|NCT04263142|64483780|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
23203122|NCT02509598|64483781|FG000|Overall Study|Withdrawal by Subject|1|||
23203123|NCT00436566|64483784|FG000|Overall Study|Withdrawal by Subject|2|||
23203124|NCT00436566|64483784|FG000|Overall Study|Protocol Violation|1|||
23203125|NCT02340819|64483787|FG000|Overall Study|Adverse Event|1|||
23203126|NCT02340819|64483787|FG000|Overall Study|Withdrawal by Subject|2|||
23203127|NCT02340819|64483787|FG000|Overall Study|Discontinued with other reason|1|||
23203128|NCT00242580|64483793|FG000|Overall Study|Adverse Event|3|||
23203129|NCT00242580|64483794|FG001|Overall Study|Adverse Event|0|||
23203130|NCT00242580|64483795|FG002|Overall Study|Adverse Event|2|||
23203131|NCT00242580|64483793|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23203132|NCT00242580|64483794|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
23203133|NCT00242580|64483795|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
23203134|NCT00242580|64483793|FG000|Overall Study|Protocol Violation|0|||
23203135|NCT00242580|64483794|FG001|Overall Study|Protocol Violation|0|||
23203136|NCT00242580|64483795|FG002|Overall Study|Protocol Violation|1|||
23203137|NCT00242580|64483793|FG000|Overall Study|Subject withdrew consent|2|||
23203138|NCT00242580|64483794|FG001|Overall Study|Subject withdrew consent|2|||
23203139|NCT00242580|64483795|FG002|Overall Study|Subject withdrew consent|5|||
23203140|NCT00242580|64483793|FG000|Overall Study|Lost to Follow-up|0|||
23203141|NCT00242580|64483794|FG001|Overall Study|Lost to Follow-up|3|||
23203142|NCT00242580|64483795|FG002|Overall Study|Lost to Follow-up|0|||
23504721|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Death|0|||
23504722|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Death|0|||
23203143|NCT00242580|64483793|FG000|Overall Study|Death|1|||
23203144|NCT00242580|64483794|FG001|Overall Study|Death|2|||
23203145|NCT00242580|64483795|FG002|Overall Study|Death|1|||
23203146|NCT02488551|64483796|FG000|Overall Study|Lost to Follow-up|4|||
23203147|NCT02488551|64483797|FG001|Overall Study|Lost to Follow-up|7|||
23504723|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Death|0|||
23504724|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Death|0|||
23203148|NCT02488551|64483798|FG002|Overall Study|Lost to Follow-up|0|||
23203149|NCT02488551|64483799|FG003|Overall Study|Lost to Follow-up|0|||
23203150|NCT02488551|64483796|FG000|Overall Study|Military Deployment|1|||
23203151|NCT02488551|64483797|FG001|Overall Study|Military Deployment|1|||
23203152|NCT02488551|64483798|FG002|Overall Study|Military Deployment|0|||
23203153|NCT02488551|64483799|FG003|Overall Study|Military Deployment|0|||
23203154|NCT01008995|64483800|FG000|Controlled Period|Adverse Event|1|||
23203155|NCT01008995|64483801|FG001|Controlled Period|Adverse Event|2|||
23203156|NCT01008995|64483802|FG002|Controlled Period|Adverse Event|0|||
23203157|NCT01008995|64483803|FG003|Controlled Period|Adverse Event|0|||
23203158|NCT01008995|64483800|FG000|Controlled Period|Other|2|||
23203159|NCT01008995|64483801|FG001|Controlled Period|Other|1|||
23203160|NCT01008995|64483802|FG002|Controlled Period|Other|0|||
23203161|NCT01008995|64483803|FG003|Controlled Period|Other|0|||
23203162|NCT01008995|64483800|FG000|After Controlled Period|Adverse Event|0|||
23203163|NCT01008995|64483801|FG001|After Controlled Period|Adverse Event|0|||
23203164|NCT01008995|64483802|FG002|After Controlled Period|Adverse Event|1|||
23203165|NCT01008995|64483803|FG003|After Controlled Period|Adverse Event|1|||
23203166|NCT01008995|64483800|FG000|After Controlled Period|Other|0|||
23203167|NCT01008995|64483801|FG001|After Controlled Period|Other|0|||
23203168|NCT01008995|64483802|FG002|After Controlled Period|Other|1|||
23203169|NCT01008995|64483803|FG003|After Controlled Period|Other|0|||
23203170|NCT02436577|64483804|FG000|Overall Study|Protocol Deviation|0|||
23203171|NCT02436577|64483805|FG001|Overall Study|Protocol Deviation|1|||
23203172|NCT02436577|64483806|FG002|Overall Study|Protocol Deviation|0|||
23203173|NCT02436577|64483807|FG003|Overall Study|Protocol Deviation|0|||
23203174|NCT02436577|64483808|FG004|Overall Study|Protocol Deviation|0|||
23203175|NCT02436577|64483809|FG005|Overall Study|Protocol Deviation|0|||
23203176|NCT04439344|64483812|FG000|Overall Study|Never started threapy|3|||
23203177|NCT04439344|64483812|FG000|Overall Study|Ineligible|3|||
23203178|NCT04439344|64483812|FG000|Overall Study|Adverse Event|13|||
23203179|NCT04439344|64483812|FG000|Overall Study|Death|2|||
23203180|NCT04439344|64483812|FG000|Overall Study|Disease progression|29|||
23203181|NCT04439344|64483812|FG000|Overall Study|Withdrawal by Subject|2|||
23203182|NCT04439344|64483812|FG000|Overall Study|Alternative therapy|1|||
23203183|NCT01952730|64483814|FG000|Overall Study|FDA shut down core lab used by study|1|||
23203184|NCT01005719|64483821|FG000|Period 1|Adverse Event|0|||
23203185|NCT01005719|64483822|FG001|Period 1|Adverse Event|0|||
23203186|NCT01005719|64483823|FG002|Period 1|Adverse Event|0|||
23203187|NCT01005719|64483824|FG003|Period 1|Adverse Event|1|||
23203188|NCT01005719|64483825|FG004|Period 1|Adverse Event|0|||
23203189|NCT01005719|64483826|FG005|Period 1|Adverse Event|0|||
23203190|NCT01005719|64483821|FG000|Period 1|Delay in completing study procedures|0|||
23203191|NCT01005719|64483822|FG001|Period 1|Delay in completing study procedures|0|||
23203192|NCT01005719|64483823|FG002|Period 1|Delay in completing study procedures|0|||
23203193|NCT01005719|64483824|FG003|Period 1|Delay in completing study procedures|0|||
23203194|NCT01005719|64483825|FG004|Period 1|Delay in completing study procedures|0|||
23203195|NCT01005719|64483826|FG005|Period 1|Delay in completing study procedures|1|||
23203196|NCT01005719|64483821|FG000|Period 2|Adverse Event|0|||
23203197|NCT01005719|64483822|FG001|Period 2|Adverse Event|0|||
23203198|NCT01005719|64483823|FG002|Period 2|Adverse Event|0|||
23203199|NCT01005719|64483824|FG003|Period 2|Adverse Event|0|||
23203200|NCT01005719|64483825|FG004|Period 2|Adverse Event|1|||
23203201|NCT01005719|64483826|FG005|Period 2|Adverse Event|1|||
23203202|NCT01251276|64483827|FG000|Overall Study|Protocol Violation|1|||
23203203|NCT01251276|64483828|FG001|Overall Study|Protocol Violation|0|||
23203204|NCT01251276|64483827|FG000|Overall Study|Lost to Follow-up|0|||
23203205|NCT01251276|64483828|FG001|Overall Study|Lost to Follow-up|1|||
23203206|NCT01364233|64483833|FG000|Overall Study|Lost to Follow-up|1|||
23203207|NCT00069576|64483838|FG000|Original Trial|Lost to Follow-up|25|||
23203208|NCT00069576|64483839|FG001|Original Trial|Lost to Follow-up|33|||
23203209|NCT00069576|64483838|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
23203210|NCT00069576|64483839|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
23203211|NCT01725152|64483840|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
23203212|NCT01725152|64483841|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
23203213|NCT01725152|64483840|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
23203214|NCT01725152|64483841|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
23203215|NCT01725152|64483840|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
23203216|NCT01725152|64483841|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
23203217|NCT01725152|64483840|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
23203218|NCT01725152|64483841|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
23203219|NCT02130427|64483842|FG000|Overall Study|Imaging results not interpretable|30|||
23203220|NCT00077610|64483843|FG000|Overall Study|Adverse Event|9|||
23203221|NCT00077610|64483844|FG001|Overall Study|Adverse Event|7|||
23504725|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Death|0|||
23504726|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Death|0|||
23203222|NCT00077610|64483845|FG002|Overall Study|Adverse Event|1|||
23203223|NCT00077610|64483843|FG000|Overall Study|Lost to Follow-up|0|||
23203224|NCT00077610|64483844|FG001|Overall Study|Lost to Follow-up|1|||
23203225|NCT00077610|64483845|FG002|Overall Study|Lost to Follow-up|2|||
23203226|NCT00077610|64483843|FG000|Overall Study|Withdrawal by Subject|4|||
23203227|NCT00077610|64483844|FG001|Overall Study|Withdrawal by Subject|10|||
23203228|NCT00077610|64483845|FG002|Overall Study|Withdrawal by Subject|6|||
23203229|NCT00077610|64483843|FG000|Overall Study|Death|17|||
23203230|NCT00077610|64483844|FG001|Overall Study|Death|13|||
23203231|NCT00077610|64483845|FG002|Overall Study|Death|13|||
23203232|NCT00077610|64483843|FG000|Overall Study|Renal transplant|12|||
23203233|NCT00077610|64483844|FG001|Overall Study|Renal transplant|15|||
23203234|NCT00077610|64483845|FG002|Overall Study|Renal transplant|11|||
23203235|NCT00077610|64483843|FG000|Overall Study|Withdrew from dialysis care|5|||
23203236|NCT00077610|64483844|FG001|Overall Study|Withdrew from dialysis care|0|||
23203237|NCT00077610|64483845|FG002|Overall Study|Withdrew from dialysis care|3|||
23203238|NCT00077610|64483843|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23203239|NCT00077610|64483844|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23203240|NCT00077610|64483845|FG002|Overall Study|Insufficient Therapeutic Response|0|||
23203241|NCT00077610|64483843|FG000|Overall Study|Multiple blood transfusions|0|||
23203242|NCT00077610|64483844|FG001|Overall Study|Multiple blood transfusions|0|||
23203243|NCT00077610|64483845|FG002|Overall Study|Multiple blood transfusions|1|||
23203244|NCT00077610|64483843|FG000|Overall Study|Principal Investigator's decision|1|||
23203245|NCT00077610|64483844|FG001|Overall Study|Principal Investigator's decision|0|||
23203246|NCT00077610|64483845|FG002|Overall Study|Principal Investigator's decision|1|||
23203247|NCT00077610|64483843|FG000|Overall Study|Worsening of health condition|1|||
23203248|NCT00077610|64483844|FG001|Overall Study|Worsening of health condition|1|||
23203249|NCT00077610|64483845|FG002|Overall Study|Worsening of health condition|0|||
23203250|NCT00077610|64483843|FG000|Overall Study|Given Epogen in hospital|1|||
23203251|NCT00077610|64483844|FG001|Overall Study|Given Epogen in hospital|0|||
23203252|NCT00077610|64483845|FG002|Overall Study|Given Epogen in hospital|0|||
23203253|NCT00077610|64483843|FG000|Overall Study|Transferred to other unit|0|||
23203254|NCT00077610|64483844|FG001|Overall Study|Transferred to other unit|0|||
23203255|NCT00077610|64483845|FG002|Overall Study|Transferred to other unit|1|||
23203256|NCT00077610|64483843|FG000|Overall Study|Transferred to nursing home|0|||
23203257|NCT00077610|64483844|FG001|Overall Study|Transferred to nursing home|0|||
23203258|NCT00077610|64483845|FG002|Overall Study|Transferred to nursing home|1|||
23203259|NCT00077610|64483843|FG000|Overall Study|Transfer to satellite unit|1|||
23203260|NCT00077610|64483844|FG001|Overall Study|Transfer to satellite unit|0|||
23203261|NCT00077610|64483845|FG002|Overall Study|Transfer to satellite unit|0|||
23203262|NCT00077610|64483843|FG000|Overall Study|Transfer to other center for surgery|1|||
23203263|NCT00077610|64483844|FG001|Overall Study|Transfer to other center for surgery|0|||
23203264|NCT00077610|64483845|FG002|Overall Study|Transfer to other center for surgery|0|||
23203265|NCT00077610|64483843|FG000|Overall Study|Change in dialysis modality|1|||
23203266|NCT00077610|64483844|FG001|Overall Study|Change in dialysis modality|0|||
23203267|NCT00077610|64483845|FG002|Overall Study|Change in dialysis modality|0|||
23203268|NCT00077610|64483843|FG000|Overall Study|Relocation|0|||
23203269|NCT00077610|64483844|FG001|Overall Study|Relocation|8|||
23203270|NCT00077610|64483845|FG002|Overall Study|Relocation|5|||
23203271|NCT00077610|64483843|FG000|Overall Study|Financial issues|0|||
23203272|NCT00077610|64483844|FG001|Overall Study|Financial issues|1|||
23203273|NCT00077610|64483845|FG002|Overall Study|Financial issues|0|||
23203274|NCT00077610|64483843|FG000|Overall Study|Sponsors decision to withdraw|0|||
23203275|NCT00077610|64483844|FG001|Overall Study|Sponsors decision to withdraw|0|||
23203276|NCT00077610|64483845|FG002|Overall Study|Sponsors decision to withdraw|1|||
23203277|NCT02023164|64483848|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
23203278|NCT02023164|64483849|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
23203279|NCT03855137|64483850|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
23203280|NCT03855137|64483851|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
23203281|NCT03855137|64483852|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
23203282|NCT03855137|64483850|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
23203283|NCT03855137|64483851|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
23203284|NCT03855137|64483852|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
23203285|NCT03855137|64483850|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
23203286|NCT03855137|64483851|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
23203287|NCT03855137|64483852|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
23203288|NCT03855137|64483850|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
23203289|NCT03855137|64483851|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
23203290|NCT03855137|64483852|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
23203291|NCT03855137|64483850|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
23203292|NCT03855137|64483851|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
23203293|NCT03855137|64483852|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
23203294|NCT03855137|64483850|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
23203295|NCT03855137|64483851|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
23203296|NCT03855137|64483852|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
23203297|NCT03855137|64483850|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
23203298|NCT03855137|64483851|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
23203299|NCT03855137|64483852|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
23203300|NCT03855137|64483850|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
23203301|NCT03855137|64483851|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
23203302|NCT03855137|64483852|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
23203303|NCT03855137|64483850|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
23203304|NCT03855137|64483851|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
23203305|NCT03855137|64483852|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
23203306|NCT03855137|64483850|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
23203307|NCT03855137|64483851|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
23203308|NCT03855137|64483852|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
23203309|NCT02370498|64487441|FG000|Overall Study|Adverse Event|10|||
23203310|NCT02370498|64487442|FG001|Overall Study|Adverse Event|8|||
23203311|NCT02370498|64487441|FG000|Overall Study|Death|263|||
23203312|NCT02370498|64487442|FG001|Overall Study|Death|265|||
23203313|NCT02370498|64487441|FG000|Overall Study|Protocol Violation|1|||
23203314|NCT02370498|64487442|FG001|Overall Study|Protocol Violation|2|||
23203315|NCT02370498|64487441|FG000|Overall Study|Withdrawal by Subject|7|||
23203316|NCT02370498|64487442|FG001|Overall Study|Withdrawal by Subject|12|||
23203317|NCT02370498|64487441|FG000|Overall Study|Sponsor's decision|15|||
23203318|NCT02370498|64487442|FG001|Overall Study|Sponsor's decision|9|||
23203319|NCT02104804|64487443|FG000|Overall Study|Did not take study medication|0|||
23203320|NCT02104804|64487444|FG001|Overall Study|Did not take study medication|1|||
23203321|NCT02104804|64487443|FG000|Overall Study|Study specific discontinuation criteria|6|||
23203322|NCT02104804|64487444|FG001|Overall Study|Study specific discontinuation criteria|1|||
23203323|NCT02104804|64487443|FG000|Overall Study|Other listed|2|||
23203324|NCT02104804|64487444|FG001|Overall Study|Other listed|1|||
23203325|NCT02104804|64487443|FG000|Overall Study|Protocol Violation|0|||
23203326|NCT02104804|64487444|FG001|Overall Study|Protocol Violation|1|||
23203327|NCT02104804|64487443|FG000|Overall Study|Adverse Event|4|||
23203328|NCT02104804|64487444|FG001|Overall Study|Adverse Event|3|||
23203329|NCT02104804|64487443|FG000|Overall Study|Withdrawal by Subject|4|||
23203330|NCT02104804|64487444|FG001|Overall Study|Withdrawal by Subject|12|||
23203331|NCT03245723|64487449|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
23203332|NCT03245723|64487450|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
23203333|NCT03245723|64487449|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
23203334|NCT03245723|64487450|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
23203335|NCT03245723|64487449|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
23203336|NCT03245723|64487450|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
23203337|NCT03245723|64487449|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
23203338|NCT03245723|64487450|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
23203339|NCT02078713|64487460|FG000|Overall Study|Lost to Follow-up|49|||
23203340|NCT02078713|64487461|FG001|Overall Study|Lost to Follow-up|55|||
23203341|NCT02078713|64487462|FG002|Overall Study|Lost to Follow-up|0|||
23203342|NCT02078713|64487463|FG003|Overall Study|Lost to Follow-up|0|||
23203343|NCT02078713|64487460|FG000|Overall Study|Pregnant at baseline|3|||
23203344|NCT02078713|64487461|FG001|Overall Study|Pregnant at baseline|5|||
23203345|NCT02078713|64487462|FG002|Overall Study|Pregnant at baseline|0|||
23203346|NCT02078713|64487463|FG003|Overall Study|Pregnant at baseline|0|||
23203347|NCT02078713|64487460|FG000|Overall Study|Enrolled twice|0|||
23203348|NCT02078713|64487461|FG001|Overall Study|Enrolled twice|1|||
23203349|NCT02078713|64487462|FG002|Overall Study|Enrolled twice|0|||
23203350|NCT02078713|64487463|FG003|Overall Study|Enrolled twice|0|||
23203351|NCT00625365|64487464|FG000|Overall Study|Withdrawal by Subject|1|||
23203352|NCT00625365|64487464|FG000|Overall Study|No IV access|5|||
23203353|NCT00625365|64487464|FG000|Overall Study|VSD|1|||
23203354|NCT04580394|64487465|FG000|First Intervention|Incorrectly Randomized|1|||
23203355|NCT04580394|64487465|FG000|First Intervention|Physician Decision|1|||
23203356|NCT04580394|64487465|FG000|First Intervention|Lost to Follow-up|1|||
23203357|NCT04580394|64487465|FG000|Washout (One Week)|Withdrawal by Subject|1|||
23203358|NCT04580394|64487465|FG000|Washout (One Week)|Adverse Event|1|||
23203359|NCT04580394|64487465|FG000|Washout (One Week)|Withdrawal by Subject|2|||
23203360|NCT04580394|64487465|FG000|Third Intervention|Adverse Event|1|||
23203361|NCT04580394|64487465|FG000|Third Intervention|Withdrawal by Subject|1|||
23203362|NCT04580394|64487465|FG000|Washout (One Week)|Withdrawal by Subject|2|||
23203363|NCT00099359|64487471|FG000|Overall Study|Death|11|||
23203364|NCT00099359|64487472|FG001|Overall Study|Death|15|||
23203365|NCT00099359|64487473|FG002|Overall Study|Death|17|||
23203366|NCT00099359|64487471|FG000|Overall Study|Withdrawal by Subject|19|||
23203367|NCT00099359|64487472|FG001|Overall Study|Withdrawal by Subject|19|||
23203368|NCT00099359|64487473|FG002|Overall Study|Withdrawal by Subject|23|||
23203369|NCT00099359|64487471|FG000|Overall Study|Lost to Follow-up|15|||
23203370|NCT00099359|64487472|FG001|Overall Study|Lost to Follow-up|24|||
23203371|NCT00099359|64487473|FG002|Overall Study|Lost to Follow-up|24|||
23203372|NCT00099359|64487471|FG000|Overall Study|moved out of area|9|||
23203373|NCT00099359|64487472|FG001|Overall Study|moved out of area|7|||
23203374|NCT00099359|64487473|FG002|Overall Study|moved out of area|4|||
23203375|NCT00074412|64487476|FG000|Overall Study|Death|30|||
23203376|NCT00074412|64487477|FG001|Overall Study|Death|26|||
23203377|NCT00074412|64487476|FG000|Overall Study|Lost to Follow-up|52|||
23203378|NCT00074412|64487477|FG001|Overall Study|Lost to Follow-up|58|||
23606542|NCT00498797|65950440|FG000|Overall Study|Withdrawal by Subject|4|||
23606543|NCT00498797|65950441|FG001|Overall Study|Withdrawal by Subject|2|||
23606544|NCT00498797|65950440|FG000|Overall Study|Adverse Event|12|||
23606545|NCT00498797|65950441|FG001|Overall Study|Adverse Event|5|||
23606546|NCT00498797|65950440|FG000|Overall Study|Condition under investigation worsened|19|||
23203384|NCT03331666|64487484|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
23203385|NCT03331666|64487485|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
23203386|NCT00953043|64487492|FG000|Overall Study|Withdrawal by Subject|4|||
23203387|NCT00953043|64487493|FG001|Overall Study|Withdrawal by Subject|0|||
23203388|NCT00953043|64487492|FG000|Overall Study|Physician Decision|0|||
23203389|NCT00953043|64487493|FG001|Overall Study|Physician Decision|2|||
23203390|NCT00121992|64487494|FG000|Overall Study|Treatment not received|2|||
23203391|NCT00121992|64487495|FG001|Overall Study|Treatment not received|11|||
23203392|NCT00547378|64487496|FG000|Randomized Cohort|Withdrawal by Subject|7|||
23203393|NCT00547378|64487497|FG001|Randomized Cohort|Withdrawal by Subject|5|||
23203394|NCT00547378|64487498|FG002|Randomized Cohort|Withdrawal by Subject|0|||
23203395|NCT00547378|64487496|FG000|Randomized Cohort|Death|0|||
23203396|NCT00547378|64487497|FG001|Randomized Cohort|Death|1|||
23203397|NCT00547378|64487498|FG002|Randomized Cohort|Death|0|||
23203398|NCT00547378|64487496|FG000|Randomized Cohort|Lost to Follow-up|1|||
23203399|NCT00547378|64487497|FG001|Randomized Cohort|Lost to Follow-up|0|||
23203400|NCT00547378|64487498|FG002|Randomized Cohort|Lost to Follow-up|0|||
23203401|NCT00547378|64487496|FG000|Randomized Cohort|Adverse Event|1|||
23203402|NCT00547378|64487497|FG001|Randomized Cohort|Adverse Event|0|||
23203403|NCT00547378|64487498|FG002|Randomized Cohort|Adverse Event|0|||
23203404|NCT00547378|64487496|FG000|Randomized Cohort|Other reasons|2|||
23203405|NCT00547378|64487497|FG001|Randomized Cohort|Other reasons|0|||
23203406|NCT00547378|64487498|FG002|Randomized Cohort|Other reasons|0|||
23203407|NCT00547378|64487496|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
23203408|NCT00547378|64487497|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
23203409|NCT00547378|64487498|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
23203410|NCT00547378|64487496|FG000|All Implanted Cohort|Adverse Event|4|||
23203411|NCT00547378|64487497|FG001|All Implanted Cohort|Adverse Event|10|||
23203412|NCT00547378|64487498|FG002|All Implanted Cohort|Adverse Event|17|||
23203413|NCT00547378|64487496|FG000|All Implanted Cohort|Lost to Follow-up|0|||
23203414|NCT00547378|64487497|FG001|All Implanted Cohort|Lost to Follow-up|1|||
23203415|NCT00547378|64487498|FG002|All Implanted Cohort|Lost to Follow-up|14|||
23302436|NCT00448136|64850704|FG001|Overall Study|Death|8|||
23302437|NCT00448136|64850703|FG000|Overall Study|Investigator's decision (progression)|1|||
23302438|NCT00448136|64850704|FG001|Overall Study|Investigator's decision (progression)|0|||
23302439|NCT03493542|64850705|FG000|Overall Study|Ongoing|2|||
23302440|NCT03493542|64850706|FG001|Overall Study|Ongoing|3|||
23203416|NCT00547378|64487496|FG000|All Implanted Cohort|Death|3|||
23203417|NCT00547378|64487497|FG001|All Implanted Cohort|Death|1|||
23203418|NCT00547378|64487498|FG002|All Implanted Cohort|Death|4|||
23203419|NCT00547378|64487496|FG000|All Implanted Cohort|Physician Decision|0|||
23203420|NCT00547378|64487497|FG001|All Implanted Cohort|Physician Decision|2|||
23203421|NCT00547378|64487498|FG002|All Implanted Cohort|Physician Decision|6|||
23203422|NCT00547378|64487496|FG000|All Implanted Cohort|Site closure|2|||
23203423|NCT00547378|64487497|FG001|All Implanted Cohort|Site closure|0|||
23203424|NCT00547378|64487498|FG002|All Implanted Cohort|Site closure|1|||
23203425|NCT00547378|64487496|FG000|All Implanted Cohort|Other reasons|1|||
23203426|NCT00547378|64487497|FG001|All Implanted Cohort|Other reasons|0|||
23302441|NCT03493542|64850705|FG000|Overall Study|Withdrawal by parent or guardian|3|||
23203427|NCT00547378|64487498|FG002|All Implanted Cohort|Other reasons|1|||
23203428|NCT01975272|64487499|FG000|Overall Study|Excluded after protocol amendment|1|||
23203429|NCT01975272|64487500|FG001|Overall Study|Excluded after protocol amendment|1|||
23203430|NCT01975272|64487501|FG002|Overall Study|Excluded after protocol amendment|2|||
23203431|NCT01043185|64487502|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
23203432|NCT01043185|64487503|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
23203433|NCT01043185|64487504|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
23203434|NCT01043185|64487505|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
23203435|NCT01043185|64487506|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
23302442|NCT03493542|64850706|FG001|Overall Study|Withdrawal by parent or guardian|0|||
23203436|NCT01043185|64487507|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
23203437|NCT01043185|64487508|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
23203438|NCT01043185|64487509|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
23203439|NCT01043185|64487510|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
23203440|NCT01043185|64487511|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
23203441|NCT02491073|64487516|FG000|Overall Study|screen failure|1|||
23203442|NCT02491073|64487517|FG001|Overall Study|screen failure|0|||
23203443|NCT02034474|64487523|FG000|Overall Study|Adverse Event|3|||
23302443|NCT03493542|64850705|FG000|Overall Study|Withdrawal by Subject|2|||
23203444|NCT02034474|64487524|FG001|Overall Study|Adverse Event|2|||
23203445|NCT02034474|64487523|FG000|Overall Study|Withdrawal by Subject|1|||
23203446|NCT02034474|64487524|FG001|Overall Study|Withdrawal by Subject|2|||
23203447|NCT01627067|64487525|FG000|Overall Study|Screen Failure|1|||
23203448|NCT03282357|64487527|FG000|Overall Study|Lost to Follow-up|3|||
23203449|NCT03282357|64487527|FG000|Overall Study|Withdrawal by Subject|4|||
23203450|NCT03282357|64487527|FG000|Overall Study|Adverse Event|1|||
23203451|NCT03282357|64487527|FG000|Overall Study|Other|9|||
23203452|NCT01232894|64487528|FG000|Overall Study|Lost to Follow-up|0|||
23203453|NCT01232894|64487529|FG001|Overall Study|Lost to Follow-up|1|||
23203454|NCT01232894|64487528|FG000|Overall Study|Death|1|||
23203455|NCT01232894|64487529|FG001|Overall Study|Death|0|||
23203456|NCT01232894|64487528|FG000|Overall Study|Protocol Violation|1|||
23203457|NCT01232894|64487529|FG001|Overall Study|Protocol Violation|1|||
23203458|NCT01232894|64487528|FG000|Overall Study|Withdrawal by Subject|8|||
23203459|NCT01232894|64487529|FG001|Overall Study|Withdrawal by Subject|5|||
23203460|NCT01232894|64487528|FG000|Overall Study|Physician Decision|2|||
23203461|NCT01232894|64487529|FG001|Overall Study|Physician Decision|1|||
23203462|NCT00028002|64487530|FG000|Overall Study|Withdrawal by Subject|3|||
23203463|NCT00028002|64487530|FG000|Overall Study|Ineligible|8|||
23203464|NCT01774344|64487533|FG000|Overall Study|Withdrawal by Subject|3|||
23203465|NCT01774344|64487534|FG001|Overall Study|Withdrawal by Subject|10|||
23203466|NCT01774344|64487533|FG000|Overall Study|Protocol Violation|0|||
23203467|NCT01774344|64487534|FG001|Overall Study|Protocol Violation|1|||
23203468|NCT01774344|64487533|FG000|Overall Study|Lost to Follow-up|4|||
23203469|NCT01774344|64487534|FG001|Overall Study|Lost to Follow-up|10|||
23203470|NCT01774344|64487533|FG000|Overall Study|End of survival follow-up not available|2|||
23203471|NCT01774344|64487534|FG001|Overall Study|End of survival follow-up not available|2|||
23203472|NCT01774344|64487533|FG000|Overall Study|Data collection finished|4|||
23203473|NCT01774344|64487534|FG001|Overall Study|Data collection finished|14|||
23504727|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Death|0|||
23504728|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Death|0|||
23504729|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Death|0|||
23203474|NCT01774344|64487533|FG000|Overall Study|Other|0|||
23203475|NCT01774344|64487534|FG001|Overall Study|Other|1|||
23302444|NCT03493542|64850706|FG001|Overall Study|Withdrawal by Subject|6|||
23302445|NCT01524913|64850707|FG000|Overall Study|Lost to Follow-up|4|||
23302446|NCT01524913|64850708|FG001|Overall Study|Lost to Follow-up|0|||
23302447|NCT01524913|64850709|FG002|Overall Study|Lost to Follow-up|0|||
23302448|NCT00073021|64850713|FG000|Overall Study|Protocol Violation|2|||
23302449|NCT00073021|64850714|FG001|Overall Study|Protocol Violation|1|||
23302450|NCT00073021|64850713|FG000|Overall Study|Adverse Event|4|||
23302451|NCT00073021|64850714|FG001|Overall Study|Adverse Event|4|||
23302452|NCT00073021|64850713|FG000|Overall Study|Withdrawal by Subject|6|||
23302453|NCT00073021|64850714|FG001|Overall Study|Withdrawal by Subject|5|||
23302454|NCT00073021|64850713|FG000|Overall Study|Physician Decision|3|||
23302455|NCT00073021|64850714|FG001|Overall Study|Physician Decision|1|||
23504730|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Death|0|||
23504731|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Death|0|||
23504732|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Death|0|||
23504733|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Death|0|||
23504734|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Death|0|||
23504735|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Death|0|||
23504736|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Death|0|||
23504737|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Death|0|||
23504738|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Death|0|||
23504739|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Death|0|||
23504740|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Death|0|||
23504741|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504742|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504743|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
23504744|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
23504745|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
23504746|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
23504747|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
23504748|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23302456|NCT00073021|64850713|FG000|Overall Study|Lack of Efficacy|11|||
23302457|NCT00073021|64850714|FG001|Overall Study|Lack of Efficacy|5|||
23302458|NCT03476343|64850715|FG000|Overall Study|Clinical exam moved to another scanner|7|||
23302459|NCT03476343|64850715|FG000|Overall Study|Clinical order cancelled|4|||
23302460|NCT03476343|64850715|FG000|Overall Study|Neonate did not settle down for the scan|1|||
23302461|NCT01753336|64850716|FG000|Overall Study|Patient decision|12|||
23504749|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23203476|NCT01774344|64487533|FG000|Overall Study|Did not enter Survival Follow up|49|||
23203477|NCT01774344|64487534|FG001|Overall Study|Did not enter Survival Follow up|83|||
23203478|NCT01328249|64487540|FG000|Overall Study|Adverse Event|3|||
23203479|NCT01328249|64487541|FG001|Overall Study|Adverse Event|0|||
23203480|NCT01328249|64487540|FG000|Overall Study|Disease progression|1|||
23203481|NCT01328249|64487541|FG001|Overall Study|Disease progression|0|||
23203482|NCT01328249|64487540|FG000|Overall Study|Withdrawal by Subject|1|||
23203483|NCT01328249|64487541|FG001|Overall Study|Withdrawal by Subject|1|||
23203484|NCT01328249|64487540|FG000|Overall Study|Moved before end of treatment visit|1|||
23203485|NCT01328249|64487541|FG001|Overall Study|Moved before end of treatment visit|0|||
23203486|NCT01328249|64487540|FG000|Overall Study|Subject choice|1|||
23203487|NCT01328249|64487541|FG001|Overall Study|Subject choice|1|||
23203488|NCT01328249|64487540|FG000|Overall Study|Protocol Violation|0|||
23203489|NCT01328249|64487541|FG001|Overall Study|Protocol Violation|1|||
23504750|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504751|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504752|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504753|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504754|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504755|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504756|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23403912|NCT00833027|65226438|FG000|Overall Study|Lost to Follow-up|24|||
23504757|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504758|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504759|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504760|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23203490|NCT01553916|64487542|FG000|Overall Study|Withdrawal by Subject|2|||
23203491|NCT01553916|64487542|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
23203492|NCT03509207|64487543|FG000|Overall Study|Death|2|||
23203493|NCT00358917|64487544|FG000|Overall Study|Adverse Event|14|||
23203494|NCT00358917|64487545|FG001|Overall Study|Adverse Event|21|||
23203495|NCT00358917|64487544|FG000|Overall Study|Withdrawal by Subject|5|||
23203496|NCT00358917|64487545|FG001|Overall Study|Withdrawal by Subject|7|||
23203497|NCT00358917|64487544|FG000|Overall Study|Lost to Follow-up|20|||
23203498|NCT00358917|64487545|FG001|Overall Study|Lost to Follow-up|17|||
23203499|NCT00358917|64487544|FG000|Overall Study|Noncompliance|12|||
23203500|NCT00358917|64487545|FG001|Overall Study|Noncompliance|11|||
23203501|NCT00358917|64487544|FG000|Overall Study|Death|2|||
23203502|NCT00358917|64487545|FG001|Overall Study|Death|3|||
23203503|NCT00358917|64487544|FG000|Overall Study|Virologic failure|11|||
23203504|NCT00358917|64487545|FG001|Overall Study|Virologic failure|8|||
23203505|NCT00358917|64487544|FG000|Overall Study|Unable to Continue Participation|2|||
23203506|NCT00358917|64487545|FG001|Overall Study|Unable to Continue Participation|2|||
23203507|NCT03009539|64487546|FG000|Overall Study|Lost to Follow-up|132|||
23203508|NCT03009539|64487547|FG001|Overall Study|Lost to Follow-up|113|||
23203509|NCT03009539|64487548|FG002|Overall Study|Lost to Follow-up|132|||
23203510|NCT03009539|64487549|FG003|Overall Study|Lost to Follow-up|113|||
23203511|NCT01163253|64487550|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
23203512|NCT01163253|64487551|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
23203513|NCT01163253|64487550|FG000|Overall Study|Study Terminated by Sponsor|978|||
23203514|NCT01163253|64487551|FG001|Overall Study|Study Terminated by Sponsor|349|||
23203515|NCT01163253|64487550|FG000|Overall Study|Protocol Violation|43|||
23203516|NCT01163253|64487551|FG001|Overall Study|Protocol Violation|12|||
23203517|NCT01163253|64487550|FG000|Overall Study|Withdrawal by Subject|199|||
23203518|NCT01163253|64487551|FG001|Overall Study|Withdrawal by Subject|50|||
23203519|NCT01163253|64487550|FG000|Overall Study|Medication Error|1|||
23203520|NCT01163253|64487551|FG001|Overall Study|Medication Error|0|||
23203521|NCT01163253|64487550|FG000|Overall Study|Lost to Follow-up|125|||
23203522|NCT01163253|64487551|FG001|Overall Study|Lost to Follow-up|23|||
23203523|NCT01163253|64487550|FG000|Overall Study|Insufficient Clinical Response|423|||
23203524|NCT01163253|64487551|FG001|Overall Study|Insufficient Clinical Response|29|||
23203525|NCT01163253|64487550|FG000|Overall Study|Adverse Event|300|||
23203526|NCT01163253|64487551|FG001|Overall Study|Adverse Event|78|||
23203527|NCT01163253|64487550|FG000|Overall Study|Death|17|||
23203528|NCT01163253|64487551|FG001|Overall Study|Death|5|||
23504761|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504762|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23203529|NCT01163253|64487550|FG000|Overall Study|Ongoing|13|||
23504763|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23203530|NCT01163253|64487551|FG001|Overall Study|Ongoing|4|||
23203531|NCT01163253|64487550|FG000|Overall Study|Other Unspecified|170|||
23203532|NCT01163253|64487551|FG001|Overall Study|Other Unspecified|34|||
23203533|NCT00696657|64487552|FG000|Overall Study|Protocol Violation|0|||
23203534|NCT00696657|64487553|FG001|Overall Study|Protocol Violation|0|||
23203535|NCT00696657|64487554|FG002|Overall Study|Protocol Violation|0|||
23203536|NCT00696657|64487555|FG003|Overall Study|Protocol Violation|0|||
23203537|NCT00696657|64487556|FG004|Overall Study|Protocol Violation|0|||
23203538|NCT00696657|64487557|FG005|Overall Study|Protocol Violation|1|||
23203539|NCT00696657|64487558|FG006|Overall Study|Protocol Violation|0|||
23203540|NCT00696657|64487559|FG007|Overall Study|Protocol Violation|0|||
23203541|NCT00696657|64487560|FG008|Overall Study|Protocol Violation|1|||
23203542|NCT00696657|64487552|FG000|Overall Study|Lack of Efficacy|0|||
23203543|NCT00696657|64487553|FG001|Overall Study|Lack of Efficacy|1|||
23203544|NCT00696657|64487554|FG002|Overall Study|Lack of Efficacy|0|||
23203545|NCT00696657|64487555|FG003|Overall Study|Lack of Efficacy|0|||
23203546|NCT00696657|64487556|FG004|Overall Study|Lack of Efficacy|0|||
23203547|NCT00696657|64487557|FG005|Overall Study|Lack of Efficacy|0|||
23203548|NCT00696657|64487558|FG006|Overall Study|Lack of Efficacy|0|||
23203549|NCT00696657|64487559|FG007|Overall Study|Lack of Efficacy|0|||
23203550|NCT00696657|64487560|FG008|Overall Study|Lack of Efficacy|0|||
23203551|NCT00696657|64487552|FG000|Overall Study|Withdrawal criteria|1|||
23203552|NCT00696657|64487553|FG001|Overall Study|Withdrawal criteria|3|||
23203553|NCT00696657|64487554|FG002|Overall Study|Withdrawal criteria|2|||
23203554|NCT00696657|64487555|FG003|Overall Study|Withdrawal criteria|2|||
23203555|NCT00696657|64487556|FG004|Overall Study|Withdrawal criteria|0|||
23203556|NCT00696657|64487557|FG005|Overall Study|Withdrawal criteria|0|||
23302462|NCT01753336|64850716|FG000|Overall Study|Lost to Follow-up|3|||
23203557|NCT00696657|64487558|FG006|Overall Study|Withdrawal criteria|1|||
23203558|NCT00696657|64487559|FG007|Overall Study|Withdrawal criteria|1|||
23203559|NCT00696657|64487560|FG008|Overall Study|Withdrawal criteria|2|||
23203560|NCT00696657|64487552|FG000|Overall Study|Unclassified|0|||
23203561|NCT00696657|64487553|FG001|Overall Study|Unclassified|1|||
23203562|NCT00696657|64487554|FG002|Overall Study|Unclassified|3|||
23203563|NCT00696657|64487555|FG003|Overall Study|Unclassified|2|||
23203564|NCT00696657|64487556|FG004|Overall Study|Unclassified|4|||
23203565|NCT00696657|64487557|FG005|Overall Study|Unclassified|2|||
23203566|NCT00696657|64487558|FG006|Overall Study|Unclassified|0|||
23203567|NCT00696657|64487559|FG007|Overall Study|Unclassified|0|||
23203568|NCT00696657|64487560|FG008|Overall Study|Unclassified|1|||
23203569|NCT00696657|64487552|FG000|Overall Study|Adverse Event|0|||
23203570|NCT00696657|64487553|FG001|Overall Study|Adverse Event|0|||
23203571|NCT00696657|64487554|FG002|Overall Study|Adverse Event|3|||
23203572|NCT00696657|64487555|FG003|Overall Study|Adverse Event|7|||
23203573|NCT00696657|64487556|FG004|Overall Study|Adverse Event|6|||
23203574|NCT00696657|64487557|FG005|Overall Study|Adverse Event|9|||
23203575|NCT00696657|64487558|FG006|Overall Study|Adverse Event|14|||
23203576|NCT00696657|64487559|FG007|Overall Study|Adverse Event|2|||
23203577|NCT00696657|64487560|FG008|Overall Study|Adverse Event|5|||
23203578|NCT03298412|64487568|FG000|Run-in Period|Other, Not Specified|1|||
23203579|NCT03298412|64487568|FG000|Run-in Period|Disease Progression|1|||
23203580|NCT03298412|64487568|FG000|Run-in Period|Ineligibility Determined|1|||
23203581|NCT03298412|64487568|FG000|Run-in Period|Decision by Sponsor|6|||
23203582|NCT03150095|64487571|FG000|Overall Study|Death|0|||
23203583|NCT03150095|64487572|FG001|Overall Study|Death|1|||
23203584|NCT03150095|64487571|FG000|Overall Study|Lost to Follow-up|1|||
23203585|NCT03150095|64487572|FG001|Overall Study|Lost to Follow-up|1|||
23203586|NCT03150095|64487571|FG000|Overall Study|Withdrawal by Subject|4|||
23203587|NCT03150095|64487572|FG001|Overall Study|Withdrawal by Subject|0|||
23203588|NCT03150095|64487571|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
23203589|NCT03150095|64487572|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
23203590|NCT00879814|64487573|FG000|Overall Study|Adverse Event|0|||
23203591|NCT00879814|64487574|FG001|Overall Study|Adverse Event|1|||
23203592|NCT00879814|64487575|FG002|Overall Study|Adverse Event|0|||
23203593|NCT00879814|64487576|FG003|Overall Study|Adverse Event|0|||
23203594|NCT00879814|64487573|FG000|Overall Study|Lost to Follow-up|1|||
23203595|NCT00879814|64487574|FG001|Overall Study|Lost to Follow-up|0|||
23203596|NCT00879814|64487575|FG002|Overall Study|Lost to Follow-up|0|||
23203597|NCT00879814|64487576|FG003|Overall Study|Lost to Follow-up|2|||
23302463|NCT01753336|64850716|FG000|Overall Study|Physician Decision|2|||
23302464|NCT01753336|64850716|FG000|Overall Study|Sponsor's decision|2|||
23302465|NCT01753336|64850716|FG000|Overall Study|Withdrawal by Subject|1|||
23302466|NCT00914459|64850717|FG000|Overall Study|Protocol Violation|0|||
23302467|NCT00914459|64850718|FG001|Overall Study|Protocol Violation|1|||
23302468|NCT00914459|64850717|FG000|Overall Study|Parent/Legal guardian request|1|||
23203598|NCT00879814|64487573|FG000|Overall Study|Participant Failed to Return|0|||
23203599|NCT00879814|64487574|FG001|Overall Study|Participant Failed to Return|0|||
23203600|NCT00879814|64487575|FG002|Overall Study|Participant Failed to Return|0|||
23203601|NCT00879814|64487576|FG003|Overall Study|Participant Failed to Return|1|||
23203602|NCT00879814|64487573|FG000|Overall Study|Withdrawal by Subject|3|||
23203603|NCT00879814|64487574|FG001|Overall Study|Withdrawal by Subject|1|||
23203604|NCT00879814|64487575|FG002|Overall Study|Withdrawal by Subject|1|||
23203605|NCT00879814|64487576|FG003|Overall Study|Withdrawal by Subject|2|||
23203606|NCT00879814|64487573|FG000|Overall Study|Physician Decision|0|||
23203607|NCT00879814|64487574|FG001|Overall Study|Physician Decision|0|||
23302469|NCT00914459|64850718|FG001|Overall Study|Parent/Legal guardian request|0|||
23302470|NCT01449279|64850719|FG000|Overall Study|Lack of Efficacy|5|||
23302471|NCT01449279|64850719|FG000|Overall Study|Toxicity|2|||
23302472|NCT02558231|64850720|FG000|Overall Study|Death|4|||
23302473|NCT02558231|64850721|FG001|Overall Study|Death|12|||
23302474|NCT02558231|64850720|FG000|Overall Study|Lost to Follow-up|7|||
23302475|NCT02558231|64850721|FG001|Overall Study|Lost to Follow-up|4|||
23302476|NCT02558231|64850720|FG000|Overall Study|Withdrawal by Subject|7|||
23302477|NCT02558231|64850721|FG001|Overall Study|Withdrawal by Subject|4|||
23302478|NCT02558231|64850720|FG000|Overall Study|Physician Decision|7|||
23302479|NCT02558231|64850721|FG001|Overall Study|Physician Decision|5|||
23302480|NCT02558231|64850720|FG000|Overall Study|Sponsor Decision|0|||
23302481|NCT02558231|64850721|FG001|Overall Study|Sponsor Decision|1|||
23302482|NCT00499174|64850723|FG000|Overall Study|Physician Decision|78|||
23302483|NCT00499174|64850724|FG001|Overall Study|Physician Decision|9|||
23302484|NCT02192164|64850729|FG000|Overall Study|Other|8|||
23302485|NCT02192164|64850729|FG000|Overall Study|Withdrawal by Subject|1|||
23302486|NCT02192164|64850729|FG000|Overall Study|Physician Decision|4|||
23302487|NCT02192164|64850729|FG000|Overall Study|Did not meet the exclusion criteria|1|||
23302488|NCT00855803|64850730|FG000|Overall Study|Death|2|||
23302489|NCT00855803|64850730|FG000|Overall Study|Lost to Follow-up|2|||
23302490|NCT00855803|64850730|FG000|Overall Study|Technical inability to undergo procedure|2|||
23302491|NCT00855803|64850730|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
23302492|NCT00855803|64850730|FG000|Overall Study|Withdrawal by Subject|3|||
23302493|NCT00855803|64850730|FG000|Overall Study|Physician Decision|3|||
23302494|NCT00704730|64850731|FG000|Overall Study|Adverse Event|35|||
23302495|NCT00704730|64850732|FG001|Overall Study|Adverse Event|9|||
23302496|NCT00704730|64850731|FG000|Overall Study|Death|11|||
23302497|NCT00704730|64850732|FG001|Overall Study|Death|5|||
23302498|NCT00704730|64850731|FG000|Overall Study|Physician Decision|2|||
23302499|NCT00704730|64850732|FG001|Overall Study|Physician Decision|0|||
23302500|NCT00704730|64850731|FG000|Overall Study|Did not receive drug|5|||
23302501|NCT00704730|64850732|FG001|Overall Study|Did not receive drug|2|||
23302502|NCT00704730|64850731|FG000|Overall Study|Disease progression per PI|58|||
23302503|NCT00704730|64850732|FG001|Overall Study|Disease progression per PI|67|||
23302504|NCT00704730|64850731|FG000|Overall Study|data unavailable|1|||
23302505|NCT00704730|64850732|FG001|Overall Study|data unavailable|0|||
23302506|NCT00704730|64850731|FG000|Overall Study|Withdrawal by Subject|9|||
23302507|NCT00704730|64850732|FG001|Overall Study|Withdrawal by Subject|13|||
23302508|NCT03347422|64850739|FG000|Part A (26 Weeks)|Adverse Event|3|||
23302509|NCT03347422|64850740|FG001|Part A (26 Weeks)|Adverse Event|0|||
23302510|NCT03347422|64850739|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
23302511|NCT03347422|64850740|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
23302512|NCT03347422|64850739|FG000|Part B (149 Weeks)|Adverse Event|0|||
23302513|NCT03347422|64850740|FG001|Part B (149 Weeks)|Adverse Event|1|||
23302514|NCT03347422|64850739|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
23302515|NCT03347422|64850740|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
23302516|NCT03347422|64850739|FG000|Part B (149 Weeks)|Other|1|||
23302517|NCT03347422|64850740|FG001|Part B (149 Weeks)|Other|0|||
23302518|NCT02377063|64850741|FG000|Overall Study|Non-compliance|5|||
23302519|NCT00706381|64850742|FG000|Overall Study|Lost to Follow-up|0|||
23302520|NCT00706381|64850743|FG001|Overall Study|Lost to Follow-up|1|||
23302521|NCT00706381|64850744|FG002|Overall Study|Lost to Follow-up|1|||
23302522|NCT00706381|64850745|FG003|Overall Study|Lost to Follow-up|0|||
23302523|NCT02566993|64850748|FG000|Overall Study|Randomized but not treated|5|||
23302524|NCT02566993|64850749|FG001|Overall Study|Randomized but not treated|16|||
23203608|NCT00879814|64487575|FG002|Overall Study|Physician Decision|1|||
23203609|NCT00879814|64487576|FG003|Overall Study|Physician Decision|0|||
23203610|NCT00879814|64487573|FG000|Overall Study|Other|0|||
23504764|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504765|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504766|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
23504767|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23302525|NCT02566993|64850748|FG000|Overall Study|Progressive disease|213|||
23302526|NCT02566993|64850749|FG001|Overall Study|Progressive disease|152|||
23302527|NCT02566993|64850748|FG000|Overall Study|Withdrawal by Subject|12|||
23302528|NCT02566993|64850749|FG001|Overall Study|Withdrawal by Subject|28|||
23203611|NCT00879814|64487574|FG001|Overall Study|Other|0|||
23302529|NCT02566993|64850748|FG000|Overall Study|Death|17|||
23504768|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23302530|NCT02566993|64850749|FG001|Overall Study|Death|23|||
23302531|NCT02566993|64850748|FG000|Overall Study|Physician Decision|10|||
23302532|NCT02566993|64850749|FG001|Overall Study|Physician Decision|17|||
23302533|NCT02566993|64850748|FG000|Overall Study|Study drug-related adverse event|20|||
23302534|NCT02566993|64850749|FG001|Overall Study|Study drug-related adverse event|41|||
23302535|NCT02566993|64850748|FG000|Overall Study|Non study drug-related adverse event|9|||
23302536|NCT02566993|64850749|FG001|Overall Study|Non study drug-related adverse event|9|||
23302537|NCT02566993|64850748|FG000|Overall Study|Symptomatic deterioration|9|||
23302538|NCT02566993|64850749|FG001|Overall Study|Symptomatic deterioration|16|||
23504769|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
23504770|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504771|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504772|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504773|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23203612|NCT00879814|64487575|FG002|Overall Study|Other|1|||
23203613|NCT00879814|64487576|FG003|Overall Study|Other|0|||
23203614|NCT00752609|64487580|FG000|Overall Study|Adverse Event|2|||
23203615|NCT00752609|64487581|FG001|Overall Study|Adverse Event|2|||
23203616|NCT00752609|64487580|FG000|Overall Study|Withdrawal by Subject|3|||
23203617|NCT00752609|64487581|FG001|Overall Study|Withdrawal by Subject|0|||
23203618|NCT00752609|64487580|FG000|Overall Study|Physician Decision|1|||
23203619|NCT00752609|64487581|FG001|Overall Study|Physician Decision|0|||
23203620|NCT00752609|64487580|FG000|Overall Study|Death|1|||
23203621|NCT00752609|64487581|FG001|Overall Study|Death|0|||
23203622|NCT00752609|64487580|FG000|Overall Study|Met exclusion criteria|1|||
23203623|NCT00752609|64487581|FG001|Overall Study|Met exclusion criteria|0|||
23203624|NCT00752609|64487580|FG000|Overall Study|Received Aranesp in error|1|||
23203625|NCT00752609|64487581|FG001|Overall Study|Received Aranesp in error|0|||
23203626|NCT02175771|64487582|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
23203627|NCT02175771|64487583|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23203628|NCT02175771|64487584|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23203629|NCT02175771|64487585|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23203630|NCT02175771|64487586|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23203631|NCT02175771|64487587|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23203632|NCT02175771|64487588|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23203633|NCT02175771|64487589|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23203634|NCT02175771|64487590|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23302539|NCT02566993|64850748|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
23302540|NCT02566993|64850749|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
23203635|NCT02175771|64487582|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
23203636|NCT02175771|64487583|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23302541|NCT02566993|64850748|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
23302542|NCT02566993|64850749|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
23302543|NCT02566993|64850748|FG000|Overall Study|Screening failure|2|||
23302544|NCT02566993|64850749|FG001|Overall Study|Screening failure|0|||
23302545|NCT02566993|64850748|FG000|Overall Study|Lost to Follow-up|0|||
23302546|NCT02566993|64850749|FG001|Overall Study|Lost to Follow-up|1|||
23302547|NCT02566993|64850748|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
23302548|NCT02566993|64850749|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
23302549|NCT02177136|64850752|FG000|DB Phase|Withdrawal by Subject|2|||
23302550|NCT02177136|64850753|FG001|DB Phase|Withdrawal by Subject|0|||
23302551|NCT02177136|64850754|FG002|DB Phase|Withdrawal by Subject|0|||
23302552|NCT02177136|64850755|FG003|DB Phase|Withdrawal by Subject|0|||
23302553|NCT02177136|64850752|FG000|DB Phase|Discontinued Due to Pruritus|1|||
23302554|NCT02177136|64850753|FG001|DB Phase|Discontinued Due to Pruritus|3|||
23302555|NCT02177136|64850754|FG002|DB Phase|Discontinued Due to Pruritus|0|||
23302556|NCT02177136|64850755|FG003|DB Phase|Discontinued Due to Pruritus|0|||
23302557|NCT02177136|64850752|FG000|DB Phase|Adverse Event|3|||
23302558|NCT02177136|64850753|FG001|DB Phase|Adverse Event|2|||
23302559|NCT02177136|64850754|FG002|DB Phase|Adverse Event|3|||
23302560|NCT02177136|64850755|FG003|DB Phase|Adverse Event|0|||
23302561|NCT02177136|64850752|FG000|DB Phase|Protocol Violation|0|||
23302562|NCT02177136|64850753|FG001|DB Phase|Protocol Violation|0|||
23302563|NCT02177136|64850754|FG002|DB Phase|Protocol Violation|1|||
23302564|NCT02177136|64850755|FG003|DB Phase|Protocol Violation|0|||
23302565|NCT02177136|64850752|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
23504774|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504775|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23203637|NCT02175771|64487584|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23203638|NCT02175771|64487585|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23203639|NCT02175771|64487586|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23203640|NCT02175771|64487587|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23203641|NCT02175771|64487588|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23203642|NCT02175771|64487589|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23203643|NCT02175771|64487590|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23203644|NCT02175771|64487582|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
23203645|NCT02175771|64487583|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23203646|NCT02175771|64487584|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23203647|NCT02175771|64487585|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23203648|NCT02175771|64487586|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23203649|NCT02175771|64487587|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23203650|NCT02175771|64487588|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23203651|NCT02175771|64487589|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23203652|NCT02175771|64487590|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23203653|NCT02175771|64487582|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
23203654|NCT02175771|64487583|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
23203655|NCT02175771|64487584|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
23203656|NCT02175771|64487585|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
23203657|NCT02175771|64487586|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
23203658|NCT02175771|64487587|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
23203659|NCT02175771|64487588|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
23203660|NCT02175771|64487589|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
23203661|NCT02175771|64487590|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
23203662|NCT02175771|64487582|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
23203663|NCT02175771|64487583|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23203664|NCT02175771|64487584|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23203665|NCT02175771|64487585|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23203666|NCT02175771|64487586|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23203667|NCT02175771|64487587|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23203668|NCT02175771|64487588|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23203669|NCT02175771|64487589|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23203670|NCT02175771|64487590|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23203671|NCT02175771|64487582|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
23203672|NCT02175771|64487583|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23203673|NCT02175771|64487584|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23203674|NCT02175771|64487585|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23203675|NCT02175771|64487586|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23203676|NCT02175771|64487587|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23203677|NCT02175771|64487588|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23203678|NCT02175771|64487589|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23203679|NCT02175771|64487590|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23203680|NCT02175771|64487582|FG000|Run-In Period (Pre-assignment)|Other|8|||
23203681|NCT02175771|64487583|FG001|Run-In Period (Pre-assignment)|Other|0|||
23203682|NCT02175771|64487584|FG002|Run-In Period (Pre-assignment)|Other|0|||
23203683|NCT02175771|64487585|FG003|Run-In Period (Pre-assignment)|Other|0|||
23203684|NCT02175771|64487586|FG004|Run-In Period (Pre-assignment)|Other|0|||
23203685|NCT02175771|64487587|FG005|Run-In Period (Pre-assignment)|Other|0|||
23203686|NCT02175771|64487588|FG006|Run-In Period (Pre-assignment)|Other|0|||
23203687|NCT02175771|64487589|FG007|Run-In Period (Pre-assignment)|Other|0|||
23203688|NCT02175771|64487590|FG008|Run-In Period (Pre-assignment)|Other|0|||
23203689|NCT02175771|64487582|FG000|Treatment Period|Adverse Event|0|||
23203690|NCT02175771|64487583|FG001|Treatment Period|Adverse Event|2|||
23203691|NCT02175771|64487584|FG002|Treatment Period|Adverse Event|1|||
23203692|NCT02175771|64487585|FG003|Treatment Period|Adverse Event|1|||
23203693|NCT02175771|64487586|FG004|Treatment Period|Adverse Event|1|||
23203694|NCT02175771|64487587|FG005|Treatment Period|Adverse Event|3|||
23203695|NCT02175771|64487588|FG006|Treatment Period|Adverse Event|2|||
23203696|NCT02175771|64487589|FG007|Treatment Period|Adverse Event|0|||
23203697|NCT02175771|64487590|FG008|Treatment Period|Adverse Event|1|||
23203698|NCT02175771|64487582|FG000|Treatment Period|Withdrawal by Subject|0|||
23203699|NCT02175771|64487583|FG001|Treatment Period|Withdrawal by Subject|9|||
23203700|NCT02175771|64487584|FG002|Treatment Period|Withdrawal by Subject|3|||
23203701|NCT02175771|64487585|FG003|Treatment Period|Withdrawal by Subject|6|||
23203702|NCT02175771|64487586|FG004|Treatment Period|Withdrawal by Subject|2|||
23203703|NCT02175771|64487587|FG005|Treatment Period|Withdrawal by Subject|4|||
23203704|NCT02175771|64487588|FG006|Treatment Period|Withdrawal by Subject|2|||
23203705|NCT02175771|64487589|FG007|Treatment Period|Withdrawal by Subject|9|||
23203706|NCT02175771|64487590|FG008|Treatment Period|Withdrawal by Subject|2|||
23203707|NCT02175771|64487582|FG000|Treatment Period|Noncompliance|0|||
23203708|NCT02175771|64487583|FG001|Treatment Period|Noncompliance|1|||
23203709|NCT02175771|64487584|FG002|Treatment Period|Noncompliance|2|||
23203710|NCT02175771|64487585|FG003|Treatment Period|Noncompliance|0|||
23203711|NCT02175771|64487586|FG004|Treatment Period|Noncompliance|0|||
23203712|NCT02175771|64487587|FG005|Treatment Period|Noncompliance|0|||
23203713|NCT02175771|64487588|FG006|Treatment Period|Noncompliance|0|||
23203714|NCT02175771|64487589|FG007|Treatment Period|Noncompliance|0|||
23203715|NCT02175771|64487590|FG008|Treatment Period|Noncompliance|1|||
23203716|NCT02175771|64487582|FG000|Treatment Period|Protocol Violation|0|||
23203717|NCT02175771|64487583|FG001|Treatment Period|Protocol Violation|0|||
23203718|NCT02175771|64487584|FG002|Treatment Period|Protocol Violation|0|||
23203719|NCT02175771|64487585|FG003|Treatment Period|Protocol Violation|0|||
23203720|NCT02175771|64487586|FG004|Treatment Period|Protocol Violation|0|||
23203721|NCT02175771|64487587|FG005|Treatment Period|Protocol Violation|0|||
23203722|NCT02175771|64487588|FG006|Treatment Period|Protocol Violation|0|||
23203723|NCT02175771|64487589|FG007|Treatment Period|Protocol Violation|1|||
23203724|NCT02175771|64487590|FG008|Treatment Period|Protocol Violation|0|||
23203725|NCT02175771|64487582|FG000|Treatment Period|Disease progression|0|||
23203726|NCT02175771|64487583|FG001|Treatment Period|Disease progression|0|||
23203727|NCT02175771|64487584|FG002|Treatment Period|Disease progression|0|||
23203728|NCT02175771|64487585|FG003|Treatment Period|Disease progression|0|||
23203729|NCT02175771|64487586|FG004|Treatment Period|Disease progression|0|||
23203730|NCT02175771|64487587|FG005|Treatment Period|Disease progression|0|||
23203731|NCT02175771|64487588|FG006|Treatment Period|Disease progression|0|||
23203732|NCT02175771|64487589|FG007|Treatment Period|Disease progression|2|||
23203733|NCT02175771|64487590|FG008|Treatment Period|Disease progression|0|||
23203734|NCT02175771|64487582|FG000|Treatment Period|Lost to Follow-up|0|||
23203735|NCT02175771|64487583|FG001|Treatment Period|Lost to Follow-up|3|||
23203736|NCT02175771|64487584|FG002|Treatment Period|Lost to Follow-up|1|||
23203737|NCT02175771|64487585|FG003|Treatment Period|Lost to Follow-up|3|||
23203738|NCT02175771|64487586|FG004|Treatment Period|Lost to Follow-up|1|||
23203739|NCT02175771|64487587|FG005|Treatment Period|Lost to Follow-up|2|||
23203740|NCT02175771|64487588|FG006|Treatment Period|Lost to Follow-up|1|||
23203741|NCT02175771|64487589|FG007|Treatment Period|Lost to Follow-up|2|||
23203742|NCT02175771|64487590|FG008|Treatment Period|Lost to Follow-up|2|||
23203743|NCT02175771|64487582|FG000|Treatment Period|Lack of Efficacy|0|||
23203744|NCT02175771|64487583|FG001|Treatment Period|Lack of Efficacy|0|||
23203745|NCT02175771|64487584|FG002|Treatment Period|Lack of Efficacy|0|||
23203746|NCT02175771|64487585|FG003|Treatment Period|Lack of Efficacy|0|||
23203747|NCT02175771|64487586|FG004|Treatment Period|Lack of Efficacy|0|||
23203748|NCT02175771|64487587|FG005|Treatment Period|Lack of Efficacy|1|||
23203749|NCT02175771|64487588|FG006|Treatment Period|Lack of Efficacy|0|||
23203750|NCT02175771|64487589|FG007|Treatment Period|Lack of Efficacy|1|||
23203751|NCT02175771|64487590|FG008|Treatment Period|Lack of Efficacy|0|||
23203752|NCT02175771|64487582|FG000|Treatment Period|Other|0|||
23203753|NCT02175771|64487583|FG001|Treatment Period|Other|1|||
23302566|NCT02177136|64850753|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
23302567|NCT02177136|64850754|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
23302568|NCT02177136|64850755|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
23302569|NCT02177136|64850752|FG000|LTSE Phase|Withdrawal by Subject|0|||
23302570|NCT02177136|64850753|FG001|LTSE Phase|Withdrawal by Subject|0|||
23302571|NCT02177136|64850754|FG002|LTSE Phase|Withdrawal by Subject|0|||
23302572|NCT02177136|64850755|FG003|LTSE Phase|Withdrawal by Subject|6|||
23302573|NCT02177136|64850752|FG000|LTSE Phase|Adverse Event|0|||
23302574|NCT02177136|64850753|FG001|LTSE Phase|Adverse Event|0|||
23302575|NCT02177136|64850754|FG002|LTSE Phase|Adverse Event|0|||
23302576|NCT02177136|64850755|FG003|LTSE Phase|Adverse Event|10|||
23302577|NCT02177136|64850752|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
23302578|NCT02177136|64850753|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
23302579|NCT02177136|64850754|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
23203754|NCT02175771|64487584|FG002|Treatment Period|Other|0|||
23203755|NCT02175771|64487585|FG003|Treatment Period|Other|3|||
23203756|NCT02175771|64487586|FG004|Treatment Period|Other|1|||
23203757|NCT02175771|64487587|FG005|Treatment Period|Other|0|||
23203758|NCT02175771|64487588|FG006|Treatment Period|Other|0|||
23203759|NCT02175771|64487589|FG007|Treatment Period|Other|2|||
23203760|NCT02175771|64487590|FG008|Treatment Period|Other|0|||
23203761|NCT01201798|64487591|FG000|Overall Study|Adverse Event|2|||
23203762|NCT01201798|64487592|FG001|Overall Study|Adverse Event|0|||
23203763|NCT01201798|64487591|FG000|Overall Study|Lost to Follow-up|3|||
23203764|NCT01201798|64487592|FG001|Overall Study|Lost to Follow-up|5|||
23203765|NCT01201798|64487591|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
23203766|NCT01201798|64487592|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
23203767|NCT01201798|64487591|FG000|Overall Study|Noncompliance|1|||
23302580|NCT02177136|64850755|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
23302581|NCT02177136|64850752|FG000|LTSE Phase|Physician Decision|0|||
23302582|NCT02177136|64850753|FG001|LTSE Phase|Physician Decision|0|||
23302583|NCT02177136|64850754|FG002|LTSE Phase|Physician Decision|0|||
23302584|NCT02177136|64850755|FG003|LTSE Phase|Physician Decision|2|||
23302585|NCT02177136|64850752|FG000|LTSE Phase|Lost to Follow-up|0|||
23302586|NCT02177136|64850753|FG001|LTSE Phase|Lost to Follow-up|0|||
23302587|NCT02177136|64850754|FG002|LTSE Phase|Lost to Follow-up|0|||
23302588|NCT02177136|64850755|FG003|LTSE Phase|Lost to Follow-up|1|||
23302589|NCT02177136|64850752|FG000|LTSE Phase|Participant Moved|0|||
23203768|NCT01201798|64487592|FG001|Overall Study|Noncompliance|0|||
23302590|NCT02177136|64850753|FG001|LTSE Phase|Participant Moved|0|||
23302591|NCT02177136|64850754|FG002|LTSE Phase|Participant Moved|0|||
23302592|NCT02177136|64850755|FG003|LTSE Phase|Participant Moved|1|||
23203769|NCT01201798|64487591|FG000|Overall Study|Protocol Violation|1|||
23203770|NCT01201798|64487592|FG001|Overall Study|Protocol Violation|1|||
23203771|NCT01201798|64487591|FG000|Overall Study|Treatment Failure|1|||
23203772|NCT01201798|64487592|FG001|Overall Study|Treatment Failure|8|||
23203773|NCT00578864|64487593|FG000|Overall Study|Death|1|||
23203774|NCT00578864|64487594|FG001|Overall Study|Death|0|||
23203775|NCT02678741|64487598|FG000|Overall Study|Death|4|||
23203776|NCT02678741|64487598|FG000|Overall Study|Withdrawal by Subject|1|||
23203777|NCT02678741|64487598|FG000|Overall Study|ineligible|3|||
23203778|NCT02678741|64487598|FG000|Overall Study|Not RECIST Measurable|2|||
23203779|NCT02678741|64487598|FG000|Overall Study|Lack of Efficacy|10|||
23203780|NCT00995345|64487600|FG000|Overall Study|Withdrawal by Subject|4|||
23203781|NCT00995345|64487601|FG001|Overall Study|Withdrawal by Subject|2|||
23203782|NCT00995345|64487602|FG002|Overall Study|Withdrawal by Subject|1|||
23302593|NCT01393730|64850758|FG000|Overall Study|Withdrawal by Subject|3|||
23302594|NCT01393730|64850758|FG000|Overall Study|Other|2|||
23302595|NCT01393730|64850758|FG000|Overall Study|Adverse Event|1|||
23302596|NCT00912093|64850759|FG000|The Controlled Phase|Death|0|||
23302597|NCT00912093|64850760|FG001|The Controlled Phase|Death|1|||
23302598|NCT00912093|64850761|FG002|The Controlled Phase|Death|0|||
23302599|NCT00912093|64850762|FG003|The Controlled Phase|Death|0|||
23302600|NCT00912093|64850763|FG004|The Controlled Phase|Death|0|||
23302601|NCT00912093|64850759|FG000|The Controlled Phase|Medical Condition|0|||
23302602|NCT00912093|64850760|FG001|The Controlled Phase|Medical Condition|1|||
23302603|NCT00912093|64850761|FG002|The Controlled Phase|Medical Condition|0|||
23302604|NCT00912093|64850762|FG003|The Controlled Phase|Medical Condition|0|||
23302605|NCT00912093|64850763|FG004|The Controlled Phase|Medical Condition|0|||
23302606|NCT00912093|64850759|FG000|The Controlled Phase|Lost to Follow-up|0|||
23302607|NCT00912093|64850760|FG001|The Controlled Phase|Lost to Follow-up|0|||
23302608|NCT00912093|64850761|FG002|The Controlled Phase|Lost to Follow-up|0|||
23302609|NCT00912093|64850762|FG003|The Controlled Phase|Lost to Follow-up|0|||
23302610|NCT00912093|64850763|FG004|The Controlled Phase|Lost to Follow-up|1|||
23302611|NCT01460901|64850764|FG000|Overall Study|Withdrawal by Subject|2|||
23302612|NCT03575871|64850771|FG000|Overall Study|Adverse Event|5|||
23302613|NCT03575871|64850772|FG001|Overall Study|Adverse Event|5|||
23302614|NCT03575871|64850773|FG002|Overall Study|Adverse Event|8|||
23302615|NCT03575871|64850771|FG000|Overall Study|Death|1|||
23302616|NCT03575871|64850772|FG001|Overall Study|Death|0|||
23302617|NCT03575871|64850773|FG002|Overall Study|Death|0|||
23302618|NCT03575871|64850771|FG000|Overall Study|Lack of Efficacy|5|||
23203783|NCT00995345|64487603|FG003|Overall Study|Withdrawal by Subject|3|||
23203784|NCT00995345|64487604|FG004|Overall Study|Withdrawal by Subject|1|||
23203785|NCT00995345|64487600|FG000|Overall Study|Adverse Event|3|||
23203786|NCT00995345|64487601|FG001|Overall Study|Adverse Event|1|||
23203787|NCT00995345|64487602|FG002|Overall Study|Adverse Event|2|||
23203788|NCT00995345|64487603|FG003|Overall Study|Adverse Event|0|||
23203789|NCT00995345|64487604|FG004|Overall Study|Adverse Event|1|||
23203790|NCT00995345|64487600|FG000|Overall Study|Lost to Follow-up|2|||
23203791|NCT00995345|64487601|FG001|Overall Study|Lost to Follow-up|2|||
23203792|NCT00995345|64487602|FG002|Overall Study|Lost to Follow-up|2|||
23203793|NCT00995345|64487603|FG003|Overall Study|Lost to Follow-up|1|||
23203794|NCT00995345|64487604|FG004|Overall Study|Lost to Follow-up|0|||
23203795|NCT00995345|64487600|FG000|Overall Study|all other reasons combined|2|||
23203796|NCT00995345|64487601|FG001|Overall Study|all other reasons combined|2|||
23203797|NCT00995345|64487602|FG002|Overall Study|all other reasons combined|2|||
23203798|NCT00995345|64487603|FG003|Overall Study|all other reasons combined|1|||
23203799|NCT00995345|64487604|FG004|Overall Study|all other reasons combined|3|||
23203800|NCT01029886|64487605|FG000|Overall Study|Adverse Event|12|||
23203801|NCT01029886|64487606|FG001|Overall Study|Adverse Event|25|||
23203802|NCT01029886|64487605|FG000|Overall Study|Lost to Follow-up|1|||
23203803|NCT01029886|64487606|FG001|Overall Study|Lost to Follow-up|0|||
23203804|NCT01029886|64487605|FG000|Overall Study|Physician Decision|2|||
23203805|NCT01029886|64487606|FG001|Overall Study|Physician Decision|6|||
23203806|NCT01029886|64487605|FG000|Overall Study|Protocol Violation|17|||
23203807|NCT01029886|64487606|FG001|Overall Study|Protocol Violation|5|||
23203808|NCT01029886|64487605|FG000|Overall Study|Withdrawal by Subject|8|||
23203809|NCT01029886|64487606|FG001|Overall Study|Withdrawal by Subject|18|||
23203810|NCT01029886|64487605|FG000|Overall Study|Entry Criteria Not Met|13|||
23203811|NCT01029886|64487606|FG001|Overall Study|Entry Criteria Not Met|5|||
23302619|NCT03575871|64850772|FG001|Overall Study|Lack of Efficacy|4|||
23203812|NCT01029886|64487605|FG000|Overall Study|Sponsor Decision|1|||
23302620|NCT03575871|64850773|FG002|Overall Study|Lack of Efficacy|7|||
23302621|NCT03575871|64850771|FG000|Overall Study|Lost to Follow-up|1|||
23302622|NCT03575871|64850772|FG001|Overall Study|Lost to Follow-up|1|||
23203813|NCT01029886|64487606|FG001|Overall Study|Sponsor Decision|0|||
23203814|NCT01029886|64487605|FG000|Overall Study|Loss Glucose Control|7|||
23203815|NCT01029886|64487606|FG001|Overall Study|Loss Glucose Control|1|||
23203816|NCT02410902|64487607|FG000|Overall Study|Adverse Event|2|||
23203817|NCT02410902|64487608|FG001|Overall Study|Adverse Event|3|||
23203818|NCT02410902|64487607|FG000|Overall Study|Lost to Follow-up|4|||
23203819|NCT02410902|64487608|FG001|Overall Study|Lost to Follow-up|1|||
23302623|NCT03575871|64850773|FG002|Overall Study|Lost to Follow-up|1|||
23203820|NCT02410902|64487607|FG000|Overall Study|Protocol Violation|1|||
23203821|NCT02410902|64487608|FG001|Overall Study|Protocol Violation|4|||
23203822|NCT02410902|64487607|FG000|Overall Study|Withdrawal by Subject|6|||
23203823|NCT02410902|64487608|FG001|Overall Study|Withdrawal by Subject|8|||
23203824|NCT02410902|64487607|FG000|Overall Study|Non-Compliance|8|||
23203825|NCT02410902|64487608|FG001|Overall Study|Non-Compliance|2|||
23504776|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504777|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504778|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504779|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504780|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23203832|NCT00142519|64487612|FG000|Overall Study|Not Treated|7|||
23203833|NCT00142519|64487613|FG001|Overall Study|Not Treated|9|||
23203834|NCT00142519|64487612|FG000|Overall Study|Protocol Violation|1|||
23203835|NCT00142519|64487613|FG001|Overall Study|Protocol Violation|0|||
23203836|NCT00142519|64487612|FG000|Overall Study|Withdrawal by Subject|10|||
23203837|NCT00142519|64487613|FG001|Overall Study|Withdrawal by Subject|7|||
23203838|NCT00406783|64487614|FG000|Overall Study|Adverse Event|4|||
23203839|NCT00406783|64487615|FG001|Overall Study|Adverse Event|4|||
23302624|NCT03575871|64850771|FG000|Overall Study|Protocol Deviation|1|||
23302625|NCT03575871|64850772|FG001|Overall Study|Protocol Deviation|1|||
23302626|NCT03575871|64850773|FG002|Overall Study|Protocol Deviation|1|||
23302627|NCT03575871|64850771|FG000|Overall Study|Withdrawal by Subject|6|||
23302628|NCT03575871|64850772|FG001|Overall Study|Withdrawal by Subject|1|||
23302629|NCT03575871|64850773|FG002|Overall Study|Withdrawal by Subject|9|||
23302630|NCT03575871|64850771|FG000|Overall Study|Other than specified|2|||
23203840|NCT00406783|64487614|FG000|Overall Study|Treatment Failure|2|||
23203841|NCT00406783|64487615|FG001|Overall Study|Treatment Failure|3|||
23203842|NCT00406783|64487614|FG000|Overall Study|Lost to Follow-up|3|||
23203843|NCT00406783|64487615|FG001|Overall Study|Lost to Follow-up|0|||
23203844|NCT00406783|64487614|FG000|Overall Study|Withdrawal by Subject|1|||
23203845|NCT00406783|64487615|FG001|Overall Study|Withdrawal by Subject|4|||
23203846|NCT00406783|64487614|FG000|Overall Study|Protocol Violation|4|||
23203847|NCT00406783|64487615|FG001|Overall Study|Protocol Violation|4|||
23203848|NCT03314519|64487616|FG000|Overall Study|Protocol Violation|3|||
23203849|NCT03314519|64487617|FG001|Overall Study|Protocol Violation|2|||
23203850|NCT00986427|64487618|FG000|Overall Study|Lost to Follow-up|2|||
23203851|NCT00986427|64487619|FG001|Overall Study|Lost to Follow-up|0|||
23203852|NCT00986427|64487618|FG000|Overall Study|Lack of Efficacy|1|||
23203853|NCT00986427|64487619|FG001|Overall Study|Lack of Efficacy|0|||
23203854|NCT00986427|64487618|FG000|Overall Study|Withdrawal by Subject|1|||
23203855|NCT00986427|64487619|FG001|Overall Study|Withdrawal by Subject|0|||
23203856|NCT00364845|64487620|FG000|Overall Study|Adverse Event|1|||
23203857|NCT00364845|64487621|FG001|Overall Study|Adverse Event|0|||
23203858|NCT00364845|64487620|FG000|Overall Study|Withdrawal by Subject|2|||
23203859|NCT00364845|64487621|FG001|Overall Study|Withdrawal by Subject|1|||
23203860|NCT00364845|64487620|FG000|Overall Study|Physician Decision|8|||
23203861|NCT00364845|64487621|FG001|Overall Study|Physician Decision|8|||
23203862|NCT00364845|64487620|FG000|Overall Study|Lost to Follow-up|0|||
23203863|NCT00364845|64487621|FG001|Overall Study|Lost to Follow-up|1|||
23203864|NCT00364845|64487620|FG000|Overall Study|Death|0|||
23203865|NCT00364845|64487621|FG001|Overall Study|Death|1|||
23203866|NCT03050359|64487622|FG000|Overall Study|Randomized But Not Treated|2|||
23203867|NCT03050359|64487623|FG001|Overall Study|Randomized But Not Treated|0|||
23203868|NCT03050359|64487622|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
23203869|NCT03050359|64487623|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
23203870|NCT03050359|64487622|FG000|Overall Study|Significant Protocol Deviation|2|||
23203871|NCT03050359|64487623|FG001|Overall Study|Significant Protocol Deviation|3|||
23203872|NCT03050359|64487622|FG000|Overall Study|Lost to Follow-up|2|||
23203873|NCT03050359|64487623|FG001|Overall Study|Lost to Follow-up|1|||
23203874|NCT03050359|64487622|FG000|Overall Study|Voluntary Withdrawal|4|||
23203875|NCT03050359|64487623|FG001|Overall Study|Voluntary Withdrawal|6|||
23203876|NCT03050359|64487622|FG000|Overall Study|Pregnancy|1|||
23203877|NCT03050359|64487623|FG001|Overall Study|Pregnancy|0|||
23203878|NCT03050359|64487622|FG000|Overall Study|Reason Not Specified|1|||
23203879|NCT03050359|64487623|FG001|Overall Study|Reason Not Specified|0|||
23203880|NCT03666858|64487624|FG000|Cohort 1|Adverse Event|1|||
23203881|NCT03666858|64487625|FG001|Cohort 1|Adverse Event|0|||
23203882|NCT03666858|64487624|FG000|Cohort 2|Adverse Event|0|||
23203883|NCT03666858|64487625|FG001|Cohort 2|Adverse Event|1|||
23203884|NCT00717366|64487626|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
23203885|NCT00717366|64487627|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
23203886|NCT00717366|64487626|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
23203887|NCT00717366|64487627|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
23203888|NCT00717366|64487626|FG000|Core Study Period (20 Weeks)|Death|0|||
23203889|NCT00717366|64487627|FG001|Core Study Period (20 Weeks)|Death|1|||
23403913|NCT00833027|65226438|FG000|Overall Study|Protocol Violation|115|||
23203890|NCT00717366|64487626|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
23203891|NCT00717366|64487627|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
23203892|NCT00717366|64487626|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
23203893|NCT00717366|64487627|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
23203894|NCT00717366|64487626|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
23203895|NCT00717366|64487627|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
23203896|NCT00717366|64487626|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
23203897|NCT00717366|64487627|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
23203898|NCT01603641|64487628|FG000|Overall Study|Did not Receive Treatment|3|||
23203899|NCT01603641|64487628|FG000|Overall Study|Adverse Event|1|||
23203900|NCT01603641|64487628|FG000|Overall Study|Lack of Efficacy|1|||
23302631|NCT03575871|64850772|FG001|Overall Study|Other than specified|2|||
23302632|NCT03575871|64850773|FG002|Overall Study|Other than specified|0|||
23203901|NCT01603641|64487628|FG000|Overall Study|Lost to Follow-up|6|||
23203902|NCT01603641|64487628|FG000|Overall Study|Personal Reasons|18|||
23203903|NCT01603641|64487628|FG000|Overall Study|Other Miscellaneous Reasons|6|||
23203904|NCT00543569|64487629|FG000|Overall Study|Death|2|||
23203905|NCT00543569|64487630|FG001|Overall Study|Death|2|||
23203906|NCT00543569|64487631|FG002|Overall Study|Death|3|||
23203907|NCT00543569|64487632|FG003|Overall Study|Death|1|||
23203908|NCT00543569|64487629|FG000|Overall Study|Lost to Follow-up|0|||
23203909|NCT00543569|64487630|FG001|Overall Study|Lost to Follow-up|0|||
23203910|NCT00543569|64487631|FG002|Overall Study|Lost to Follow-up|1|||
23203911|NCT00543569|64487632|FG003|Overall Study|Lost to Follow-up|1|||
23203912|NCT00543569|64487629|FG000|Overall Study|Miscellaneous Reasons|7|||
23203913|NCT00543569|64487630|FG001|Overall Study|Miscellaneous Reasons|3|||
23203914|NCT00543569|64487631|FG002|Overall Study|Miscellaneous Reasons|11|||
23203915|NCT00543569|64487632|FG003|Overall Study|Miscellaneous Reasons|4|||
23203916|NCT00543569|64487629|FG000|Overall Study|Randomized but never received study drug|3|||
23203917|NCT00543569|64487630|FG001|Overall Study|Randomized but never received study drug|3|||
23203918|NCT00543569|64487631|FG002|Overall Study|Randomized but never received study drug|5|||
23203919|NCT00543569|64487632|FG003|Overall Study|Randomized but never received study drug|3|||
23203920|NCT00592852|64487633|FG000|Overall Study|Non-compliance|1|||
23203921|NCT00592852|64487633|FG000|Overall Study|Adverse Event|3|||
23203922|NCT00592852|64487633|FG000|Overall Study|Found ineligible|1|||
23203923|NCT00592852|64487633|FG000|Overall Study|Withdrawal by Subject|1|||
23203924|NCT01409031|64487634|FG000|Overall Study|transferred to other hosp|1|||
23203925|NCT01409031|64487635|FG001|Overall Study|transferred to other hosp|0|||
23203926|NCT00366548|64487638|FG000|Infant Series|Adverse Event|1|||
23203927|NCT00366548|64487639|FG001|Infant Series|Adverse Event|3|||
23203928|NCT00366548|64487638|FG000|Infant Series|Protocol Violation|0|||
23203929|NCT00366548|64487639|FG001|Infant Series|Protocol Violation|1|||
23203930|NCT00366548|64487638|FG000|Infant Series|Withdrawal by Subject|3|||
23203931|NCT00366548|64487639|FG001|Infant Series|Withdrawal by Subject|1|||
23203932|NCT00366548|64487638|FG000|After Infant Series|Withdrawal by Subject|3|||
23203933|NCT00366548|64487639|FG001|After Infant Series|Withdrawal by Subject|1|||
23203934|NCT00366548|64487638|FG000|After Infant Series|Adverse Event|2|||
23203935|NCT00366548|64487639|FG001|After Infant Series|Adverse Event|0|||
23203936|NCT00366548|64487638|FG000|After Infant Series|Lost to Follow-up|1|||
23203937|NCT00366548|64487639|FG001|After Infant Series|Lost to Follow-up|0|||
23203938|NCT00195260|64487643|FG000|Part 1: Dose Escalation|Adverse Event|0|||
23203939|NCT00195260|64487644|FG001|Part 1: Dose Escalation|Adverse Event|1|||
23203940|NCT00195260|64487645|FG002|Part 1: Dose Escalation|Adverse Event|0|||
23203941|NCT00195260|64487646|FG003|Part 1: Dose Escalation|Adverse Event|1|||
23203942|NCT00195260|64487647|FG004|Part 1: Dose Escalation|Adverse Event|1|||
23203943|NCT00195260|64487648|FG005|Part 1: Dose Escalation|Adverse Event|0|||
23203944|NCT00195260|64487649|FG006|Part 1: Dose Escalation|Adverse Event|3|||
23203945|NCT00195260|64487650|FG007|Part 1: Dose Escalation|Adverse Event|0|||
23203946|NCT00195260|64487651|FG008|Part 1: Dose Escalation|Adverse Event|0|||
23203947|NCT00195260|64487652|FG009|Part 1: Dose Escalation|Adverse Event|0|||
23203948|NCT00195260|64487653|FG010|Part 1: Dose Escalation|Adverse Event|0|||
23203949|NCT00195260|64487643|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23203950|NCT00195260|64487644|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23302633|NCT02973321|64850774|FG000|Overall Study|Other than specified|0|||
23302634|NCT02973321|64850775|FG001|Overall Study|Other than specified|5|||
23203951|NCT00195260|64487645|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23203952|NCT00195260|64487646|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23203953|NCT00195260|64487647|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
23203954|NCT00195260|64487648|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23203955|NCT00195260|64487649|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23203956|NCT00195260|64487650|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
23203957|NCT00195260|64487651|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23203958|NCT00195260|64487652|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23203959|NCT00195260|64487653|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23203960|NCT00195260|64487643|FG000|Part 1: Dose Escalation|Death|0|||
23203961|NCT00195260|64487644|FG001|Part 1: Dose Escalation|Death|0|||
23203962|NCT00195260|64487645|FG002|Part 1: Dose Escalation|Death|0|||
23203963|NCT00195260|64487646|FG003|Part 1: Dose Escalation|Death|0|||
23203964|NCT00195260|64487647|FG004|Part 1: Dose Escalation|Death|0|||
23203965|NCT00195260|64487648|FG005|Part 1: Dose Escalation|Death|0|||
23203966|NCT00195260|64487649|FG006|Part 1: Dose Escalation|Death|0|||
23302635|NCT02973321|64850776|FG002|Overall Study|Other than specified|3|||
23203967|NCT00195260|64487650|FG007|Part 1: Dose Escalation|Death|1|||
23203968|NCT00195260|64487651|FG008|Part 1: Dose Escalation|Death|0|||
23203969|NCT00195260|64487652|FG009|Part 1: Dose Escalation|Death|0|||
23203970|NCT00195260|64487653|FG010|Part 1: Dose Escalation|Death|0|||
23203971|NCT00195260|64487643|FG000|Part 1: Dose Escalation|Disease Progression|3|||
23203972|NCT00195260|64487644|FG001|Part 1: Dose Escalation|Disease Progression|2|||
23203973|NCT00195260|64487645|FG002|Part 1: Dose Escalation|Disease Progression|5|||
23203974|NCT00195260|64487646|FG003|Part 1: Dose Escalation|Disease Progression|6|||
23203975|NCT00195260|64487647|FG004|Part 1: Dose Escalation|Disease Progression|4|||
23203976|NCT00195260|64487648|FG005|Part 1: Dose Escalation|Disease Progression|6|||
23203977|NCT00195260|64487649|FG006|Part 1: Dose Escalation|Disease Progression|7|||
23203978|NCT00195260|64487650|FG007|Part 1: Dose Escalation|Disease Progression|4|||
23203979|NCT00195260|64487651|FG008|Part 1: Dose Escalation|Disease Progression|0|||
23203980|NCT00195260|64487652|FG009|Part 1: Dose Escalation|Disease Progression|0|||
23203981|NCT00195260|64487653|FG010|Part 1: Dose Escalation|Disease Progression|0|||
23203982|NCT00195260|64487643|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
23203983|NCT00195260|64487644|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
23203984|NCT00195260|64487645|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
23203985|NCT00195260|64487646|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23203986|NCT00195260|64487647|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23203987|NCT00195260|64487648|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
23203988|NCT00195260|64487649|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23203989|NCT00195260|64487650|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23203990|NCT00195260|64487651|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23203991|NCT00195260|64487652|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23203992|NCT00195260|64487653|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
23203993|NCT00195260|64487643|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23203994|NCT00195260|64487644|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23203995|NCT00195260|64487645|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23203996|NCT00195260|64487646|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23203997|NCT00195260|64487647|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23203998|NCT00195260|64487648|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23302636|NCT02973321|64850777|FG003|Overall Study|Other than specified|3|||
23302637|NCT02973321|64850778|FG004|Overall Study|Other than specified|1|||
23203999|NCT00195260|64487649|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23204000|NCT00195260|64487650|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
23204001|NCT00195260|64487651|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
23204002|NCT00195260|64487652|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
23204003|NCT00195260|64487653|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
23204004|NCT00195260|64487643|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23204005|NCT00195260|64487644|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23204006|NCT00195260|64487645|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23204007|NCT00195260|64487646|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23204008|NCT00195260|64487647|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23204009|NCT00195260|64487648|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23204010|NCT00195260|64487649|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23204011|NCT00195260|64487650|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
23204012|NCT00195260|64487651|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
23204013|NCT00195260|64487652|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
23204014|NCT00195260|64487653|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
23204015|NCT00195260|64487643|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23204016|NCT00195260|64487644|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23204017|NCT00195260|64487645|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23204018|NCT00195260|64487646|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23204019|NCT00195260|64487647|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23204020|NCT00195260|64487648|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23204021|NCT00195260|64487649|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23302638|NCT02973321|64850774|FG000|Overall Study|Lack of Efficacy|0|||
23204022|NCT00195260|64487650|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
23204023|NCT00195260|64487651|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
23204024|NCT00195260|64487652|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
23204025|NCT00195260|64487653|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
23302639|NCT02973321|64850775|FG001|Overall Study|Lack of Efficacy|0|||
23204026|NCT00195260|64487643|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23204027|NCT00195260|64487644|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23204028|NCT00195260|64487645|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23204029|NCT00195260|64487646|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23204030|NCT00195260|64487647|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23204031|NCT00195260|64487648|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23204032|NCT00195260|64487649|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23204033|NCT00195260|64487650|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
23204034|NCT00195260|64487651|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
23204035|NCT00195260|64487652|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
23204036|NCT00195260|64487653|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
23204037|NCT01525849|64487654|FG000|Overall Study|Lost to Follow-up|3|||
23204038|NCT01525849|64487655|FG001|Overall Study|Lost to Follow-up|2|||
23204039|NCT01525849|64487654|FG000|Overall Study|Withdrawal by Subject|1|||
23204040|NCT01525849|64487655|FG001|Overall Study|Withdrawal by Subject|9|||
23204041|NCT01525849|64487654|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
23204042|NCT01525849|64487655|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
23204043|NCT01525849|64487654|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
23204044|NCT01525849|64487655|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
23204045|NCT03731364|64487656|FG000|Overall Study|Adverse Event|0|||
23204046|NCT03731364|64487657|FG001|Overall Study|Adverse Event|0|||
23204047|NCT03731364|64487658|FG002|Overall Study|Adverse Event|1|||
23204048|NCT03731364|64487659|FG003|Overall Study|Adverse Event|2|||
23204049|NCT03731364|64487660|FG004|Overall Study|Adverse Event|1|||
23302640|NCT02973321|64850776|FG002|Overall Study|Lack of Efficacy|0|||
23302641|NCT02973321|64850777|FG003|Overall Study|Lack of Efficacy|0|||
23302642|NCT02973321|64850778|FG004|Overall Study|Lack of Efficacy|1|||
23302643|NCT02973321|64850774|FG000|Overall Study|Adverse Event|1|||
23302644|NCT02973321|64850775|FG001|Overall Study|Adverse Event|10|||
23204050|NCT02723604|64487668|FG000|Overall Study|ineligible|1|||
23204051|NCT02723604|64487668|FG000|Overall Study|never received treatment|1|||
23204052|NCT00912015|64487671|FG000|Overall Study|Lack of Efficacy|1|||
23204053|NCT00912015|64487672|FG001|Overall Study|Lack of Efficacy|0|||
23204054|NCT00912015|64487673|FG002|Overall Study|Lack of Efficacy|0|||
23204055|NCT00912015|64487674|FG003|Overall Study|Lack of Efficacy|0|||
23204056|NCT00912015|64487671|FG000|Overall Study|Withdrawal by Subject|8|||
23204057|NCT00912015|64487672|FG001|Overall Study|Withdrawal by Subject|8|||
23204058|NCT00912015|64487673|FG002|Overall Study|Withdrawal by Subject|3|||
23204059|NCT00912015|64487674|FG003|Overall Study|Withdrawal by Subject|0|||
23204060|NCT00912015|64487671|FG000|Overall Study|Protocol Violation|1|||
23204061|NCT00912015|64487672|FG001|Overall Study|Protocol Violation|0|||
23204062|NCT00912015|64487673|FG002|Overall Study|Protocol Violation|0|||
23204063|NCT00912015|64487674|FG003|Overall Study|Protocol Violation|1|||
23204064|NCT00912015|64487671|FG000|Overall Study|Adverse Event|6|||
23204065|NCT00912015|64487672|FG001|Overall Study|Adverse Event|0|||
23204066|NCT00912015|64487673|FG002|Overall Study|Adverse Event|0|||
23204067|NCT00912015|64487674|FG003|Overall Study|Adverse Event|1|||
23204068|NCT04032171|64487682|FG000|Overall Study|Study Termination|1|||
23204069|NCT04032171|64487683|FG001|Overall Study|Study Termination|0|||
23204070|NCT03448224|64487686|FG000|Overall Study|Provided same answer to every question|1|||
23204071|NCT03448224|64487687|FG001|Overall Study|Provided same answer to every question|0|||
23204072|NCT02128763|64487692|FG000|Overall Study|Death|1|||
23204073|NCT02128763|64487693|FG001|Overall Study|Death|0|||
23204074|NCT02128763|64487692|FG000|Overall Study|Lost to Follow-up|19|||
23204075|NCT02128763|64487693|FG001|Overall Study|Lost to Follow-up|16|||
23204076|NCT01842308|64487694|FG000|Overall Study|Withdrawal by Subject|0|||
23204077|NCT01842308|64487695|FG001|Overall Study|Withdrawal by Subject|0|||
23204078|NCT01842308|64487696|FG002|Overall Study|Withdrawal by Subject|0|||
23204079|NCT01842308|64487697|FG003|Overall Study|Withdrawal by Subject|0|||
23204080|NCT01842308|64487698|FG004|Overall Study|Withdrawal by Subject|1|||
23204081|NCT00916370|64487701|FG000|Overall Study|Death|3|||
23204082|NCT00916370|64487702|FG001|Overall Study|Death|1|||
23204083|NCT00916370|64487701|FG000|Overall Study|Withdrawal by Subject|2|||
23204084|NCT00916370|64487702|FG001|Overall Study|Withdrawal by Subject|0|||
23204085|NCT00916370|64487701|FG000|Overall Study|Physician Decision|0|||
23204086|NCT00916370|64487702|FG001|Overall Study|Physician Decision|1|||
23204087|NCT01079962|64487709|FG000|Overall Study|Adverse Event|2|||
23204088|NCT01079962|64487710|FG001|Overall Study|Adverse Event|2|||
23204089|NCT01079962|64487709|FG000|Overall Study|Withdrawal by Subject|5|||
23204090|NCT01079962|64487710|FG001|Overall Study|Withdrawal by Subject|7|||
23204091|NCT01079962|64487709|FG000|Overall Study|Protocol Violation|2|||
23204092|NCT01079962|64487710|FG001|Overall Study|Protocol Violation|2|||
23204093|NCT01079962|64487709|FG000|Overall Study|No blood pressure (BP) control|3|||
23204094|NCT01079962|64487710|FG001|Overall Study|No blood pressure (BP) control|0|||
23204095|NCT01079962|64487709|FG000|Overall Study|Inclusion/exclusion criteria|1|||
23204096|NCT01079962|64487710|FG001|Overall Study|Inclusion/exclusion criteria|3|||
23204097|NCT01079962|64487709|FG000|Overall Study|Participant not returning for next visit|1|||
23204098|NCT01079962|64487710|FG001|Overall Study|Participant not returning for next visit|0|||
23204099|NCT01079962|64487709|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
23204100|NCT01079962|64487710|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
23204101|NCT03364608|64487713|FG000|Overall Study|Withdrawal by Subject|4|||
23204102|NCT03364608|64487713|FG000|Overall Study|Protocol Violation|2|||
23204103|NCT03364608|64487713|FG000|Overall Study|Lost to Follow-up|2|||
23204104|NCT02626533|64487714|FG000|Overall Study|Protocol Violation|14|||
23204105|NCT02626533|64487714|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
23204106|NCT02626533|64487714|FG000|Overall Study|Withdrawal by Subject|1|||
23204107|NCT00617409|64487715|FG000|Overall Study|Withdrawal by Subject|4|||
23204108|NCT00617409|64487716|FG001|Overall Study|Withdrawal by Subject|1|||
23204109|NCT00617409|64487717|FG002|Overall Study|Withdrawal by Subject|2|||
23204110|NCT00617409|64487715|FG000|Overall Study|Adverse Event|0|||
23204111|NCT00617409|64487716|FG001|Overall Study|Adverse Event|2|||
23204112|NCT00617409|64487717|FG002|Overall Study|Adverse Event|3|||
23204113|NCT00617409|64487715|FG000|Overall Study|Disease Progression|8|||
23204114|NCT00617409|64487716|FG001|Overall Study|Disease Progression|8|||
23204115|NCT00617409|64487717|FG002|Overall Study|Disease Progression|18|||
23204116|NCT00617409|64487715|FG000|Overall Study|Death|3|||
23204117|NCT00617409|64487716|FG001|Overall Study|Death|5|||
23204118|NCT00617409|64487717|FG002|Overall Study|Death|4|||
23204119|NCT00617409|64487715|FG000|Overall Study|Alternative Therapy|1|||
23204120|NCT00617409|64487716|FG001|Overall Study|Alternative Therapy|2|||
23204121|NCT00617409|64487717|FG002|Overall Study|Alternative Therapy|0|||
23204122|NCT01716533|64487718|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
23204123|NCT01716533|64487719|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
23204124|NCT01716533|64487720|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
23204125|NCT01716533|64487721|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
23204126|NCT01716533|64487718|FG000|Overall Study|Withdrawal by Subject|0|||
23204127|NCT01716533|64487719|FG001|Overall Study|Withdrawal by Subject|0|||
23204128|NCT01716533|64487720|FG002|Overall Study|Withdrawal by Subject|0|||
23204129|NCT01716533|64487721|FG003|Overall Study|Withdrawal by Subject|5|||
23204130|NCT01716533|64487718|FG000|Overall Study|Death|0|||
23204131|NCT01716533|64487719|FG001|Overall Study|Death|0|||
23204132|NCT01716533|64487720|FG002|Overall Study|Death|0|||
23204133|NCT01716533|64487721|FG003|Overall Study|Death|2|||
23204134|NCT01716533|64487718|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
23204135|NCT01716533|64487719|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
23204136|NCT01716533|64487720|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
23204137|NCT01716533|64487721|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
23204138|NCT02121756|64487722|FG000|Overall Study|Adverse Event|3|||
23204139|NCT02121756|64487723|FG001|Overall Study|Adverse Event|0|||
23204140|NCT02121756|64487722|FG000|Overall Study|Protocol Violation|1|||
23204141|NCT02121756|64487723|FG001|Overall Study|Protocol Violation|1|||
23204142|NCT02121756|64487722|FG000|Overall Study|Physician Decision|2|||
23204143|NCT02121756|64487723|FG001|Overall Study|Physician Decision|1|||
23204144|NCT00882999|64487724|FG000|Overall Study|Adverse Event|0|||
23204145|NCT00882999|64487725|FG001|Overall Study|Adverse Event|0|||
23302645|NCT02973321|64850776|FG002|Overall Study|Adverse Event|11|||
23302646|NCT02973321|64850777|FG003|Overall Study|Adverse Event|13|||
23204146|NCT00882999|64487726|FG002|Overall Study|Adverse Event|0|||
23204147|NCT00882999|64487727|FG003|Overall Study|Adverse Event|0|||
23204148|NCT00882999|64487728|FG004|Overall Study|Adverse Event|1|||
23204149|NCT00882999|64487729|FG005|Overall Study|Adverse Event|0|||
23204150|NCT00882999|64487730|FG006|Overall Study|Adverse Event|0|||
23204151|NCT00882999|64487724|FG000|Overall Study|Death|0|||
23204152|NCT00882999|64487725|FG001|Overall Study|Death|1|||
23204153|NCT00882999|64487726|FG002|Overall Study|Death|0|||
23204154|NCT00882999|64487727|FG003|Overall Study|Death|0|||
23204155|NCT00882999|64487728|FG004|Overall Study|Death|0|||
23204156|NCT00882999|64487729|FG005|Overall Study|Death|0|||
23204157|NCT00882999|64487730|FG006|Overall Study|Death|0|||
23204158|NCT00882999|64487724|FG000|Overall Study|Withdrawal by Subject|7|||
23204159|NCT00882999|64487725|FG001|Overall Study|Withdrawal by Subject|6|||
23204160|NCT00882999|64487726|FG002|Overall Study|Withdrawal by Subject|3|||
23204161|NCT00882999|64487727|FG003|Overall Study|Withdrawal by Subject|3|||
23204162|NCT00882999|64487728|FG004|Overall Study|Withdrawal by Subject|6|||
23204163|NCT00882999|64487729|FG005|Overall Study|Withdrawal by Subject|5|||
23204164|NCT00882999|64487730|FG006|Overall Study|Withdrawal by Subject|5|||
23204165|NCT00882999|64487724|FG000|Overall Study|Lost to Follow-up|0|||
23204166|NCT00882999|64487725|FG001|Overall Study|Lost to Follow-up|1|||
23204167|NCT00882999|64487726|FG002|Overall Study|Lost to Follow-up|1|||
23204168|NCT00882999|64487727|FG003|Overall Study|Lost to Follow-up|2|||
23204169|NCT00882999|64487728|FG004|Overall Study|Lost to Follow-up|1|||
23204170|NCT00882999|64487729|FG005|Overall Study|Lost to Follow-up|1|||
23204171|NCT00882999|64487730|FG006|Overall Study|Lost to Follow-up|2|||
23302647|NCT02973321|64850778|FG004|Overall Study|Adverse Event|3|||
23204172|NCT00882999|64487724|FG000|Overall Study|Physician Decision|1|||
23204173|NCT00882999|64487725|FG001|Overall Study|Physician Decision|0|||
23204174|NCT00882999|64487726|FG002|Overall Study|Physician Decision|0|||
23204175|NCT00882999|64487727|FG003|Overall Study|Physician Decision|0|||
23204176|NCT00882999|64487728|FG004|Overall Study|Physician Decision|0|||
23204177|NCT00882999|64487729|FG005|Overall Study|Physician Decision|1|||
23204178|NCT00882999|64487730|FG006|Overall Study|Physician Decision|1|||
23302648|NCT03285308|64850779|FG000|Overall Study|Adverse Event|3|||
23302649|NCT03285308|64850780|FG001|Overall Study|Adverse Event|7|||
23302650|NCT03285308|64850779|FG000|Overall Study|Withdrawal by Subject|8|||
23204179|NCT02112994|64487731|FG000|Overall Study|Progressive Disease|0|||
23302651|NCT03285308|64850780|FG001|Overall Study|Withdrawal by Subject|9|||
23204180|NCT02112994|64487732|FG001|Overall Study|Progressive Disease|0|||
23204181|NCT02112994|64487733|FG002|Overall Study|Progressive Disease|1|||
23204182|NCT02112994|64487731|FG000|Overall Study|Pregnancy|0|||
23204183|NCT02112994|64487732|FG001|Overall Study|Pregnancy|1|||
23204184|NCT02112994|64487733|FG002|Overall Study|Pregnancy|1|||
23204185|NCT02112994|64487731|FG000|Overall Study|Liver Transplant|0|||
23204186|NCT02112994|64487732|FG001|Overall Study|Liver Transplant|1|||
23204187|NCT02112994|64487733|FG002|Overall Study|Liver Transplant|0|||
23204188|NCT02112994|64487731|FG000|Overall Study|Withdrawal by Subject|0|||
23204189|NCT02112994|64487732|FG001|Overall Study|Withdrawal by Subject|0|||
23204190|NCT02112994|64487733|FG002|Overall Study|Withdrawal by Subject|1|||
23204191|NCT03453151|64487734|FG000|Overall Study|Withdrawal by Subject|1|||
23204192|NCT03453151|64487734|FG000|Overall Study|Physician Decision|3|||
23204193|NCT02364947|64487735|FG000|Overall Study|Withdrawal by Subject|10|||
23204194|NCT02364947|64487736|FG001|Overall Study|Withdrawal by Subject|8|||
23204195|NCT02364947|64487737|FG002|Overall Study|Withdrawal by Subject|9|||
23204196|NCT02364947|64487735|FG000|Overall Study|Adverse Event|45|||
23204197|NCT02364947|64487736|FG001|Overall Study|Adverse Event|33|||
23204198|NCT02364947|64487737|FG002|Overall Study|Adverse Event|11|||
23204199|NCT02364947|64487735|FG000|Overall Study|Protocol Violation|1|||
23204200|NCT02364947|64487736|FG001|Overall Study|Protocol Violation|1|||
23204201|NCT02364947|64487737|FG002|Overall Study|Protocol Violation|1|||
23204202|NCT02364947|64487735|FG000|Overall Study|Physician Decision|3|||
23204203|NCT02364947|64487736|FG001|Overall Study|Physician Decision|2|||
23204204|NCT02364947|64487737|FG002|Overall Study|Physician Decision|5|||
23204205|NCT02364947|64487735|FG000|Overall Study|Death|0|||
23204206|NCT02364947|64487736|FG001|Overall Study|Death|1|||
23204207|NCT02364947|64487737|FG002|Overall Study|Death|0|||
23204208|NCT02410772|64487744|FG000|Overall Study|Death|3|||
23204209|NCT02410772|64487745|FG001|Overall Study|Death|4|||
23204210|NCT02410772|64487746|FG002|Overall Study|Death|8|||
23204211|NCT02410772|64487744|FG000|Overall Study|Lost to Follow-up|31|||
23204212|NCT02410772|64487745|FG001|Overall Study|Lost to Follow-up|23|||
23204213|NCT02410772|64487746|FG002|Overall Study|Lost to Follow-up|22|||
23204214|NCT02410772|64487744|FG000|Overall Study|Pregnancy|8|||
23204215|NCT02410772|64487745|FG001|Overall Study|Pregnancy|4|||
23204216|NCT02410772|64487746|FG002|Overall Study|Pregnancy|5|||
23204217|NCT02410772|64487744|FG000|Overall Study|Protocol Violation|8|||
23204218|NCT02410772|64487745|FG001|Overall Study|Protocol Violation|8|||
23204219|NCT02410772|64487746|FG002|Overall Study|Protocol Violation|4|||
23204220|NCT02410772|64487744|FG000|Overall Study|Baseline Drug Resistance|49|||
23204221|NCT02410772|64487745|FG001|Overall Study|Baseline Drug Resistance|40|||
23204222|NCT02410772|64487746|FG002|Overall Study|Baseline Drug Resistance|51|||
23204223|NCT02410772|64487744|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
23204224|NCT02410772|64487745|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
23204225|NCT02410772|64487746|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
23204226|NCT02410772|64487744|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
23204227|NCT02410772|64487745|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
23204228|NCT02410772|64487746|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
23204229|NCT00621855|64487747|FG000|Overall Study|Adverse Event|32|||
23204230|NCT00621855|64487748|FG001|Overall Study|Adverse Event|31|||
23504781|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23204231|NCT00621855|64487749|FG002|Overall Study|Adverse Event|48|||
23204232|NCT00621855|64487750|FG003|Overall Study|Adverse Event|34|||
23204233|NCT00621855|64487751|FG004|Overall Study|Adverse Event|31|||
23204234|NCT00621855|64487747|FG000|Overall Study|Lost to Follow-up|0|||
23204235|NCT00621855|64487748|FG001|Overall Study|Lost to Follow-up|1|||
23204236|NCT00621855|64487749|FG002|Overall Study|Lost to Follow-up|3|||
23204237|NCT00621855|64487750|FG003|Overall Study|Lost to Follow-up|4|||
23204238|NCT00621855|64487751|FG004|Overall Study|Lost to Follow-up|1|||
23204239|NCT00621855|64487747|FG000|Overall Study|Protocol Violation|16|||
23204240|NCT00621855|64487748|FG001|Overall Study|Protocol Violation|8|||
23204241|NCT00621855|64487749|FG002|Overall Study|Protocol Violation|6|||
23204242|NCT00621855|64487750|FG003|Overall Study|Protocol Violation|7|||
23204243|NCT00621855|64487751|FG004|Overall Study|Protocol Violation|8|||
23204244|NCT00621855|64487747|FG000|Overall Study|Withdrawal by Subject|16|||
23204245|NCT00621855|64487748|FG001|Overall Study|Withdrawal by Subject|11|||
23204246|NCT00621855|64487749|FG002|Overall Study|Withdrawal by Subject|13|||
23204247|NCT00621855|64487750|FG003|Overall Study|Withdrawal by Subject|13|||
23204248|NCT00621855|64487751|FG004|Overall Study|Withdrawal by Subject|9|||
23204249|NCT00621855|64487747|FG000|Overall Study|Other|9|||
23204250|NCT00621855|64487748|FG001|Overall Study|Other|7|||
23204251|NCT00621855|64487749|FG002|Overall Study|Other|6|||
23204252|NCT00621855|64487750|FG003|Overall Study|Other|5|||
23204253|NCT00621855|64487751|FG004|Overall Study|Other|4|||
23204254|NCT00621855|64487747|FG000|Overall Study|Patients did not receive study drug|3|||
23204255|NCT00621855|64487748|FG001|Overall Study|Patients did not receive study drug|3|||
23204256|NCT00621855|64487749|FG002|Overall Study|Patients did not receive study drug|5|||
23204257|NCT00621855|64487750|FG003|Overall Study|Patients did not receive study drug|4|||
23204258|NCT00621855|64487751|FG004|Overall Study|Patients did not receive study drug|2|||
23204259|NCT00502307|64487752|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
23204260|NCT00502307|64487753|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
23204261|NCT00502307|64487754|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
23204262|NCT00502307|64487752|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
23204263|NCT00502307|64487753|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
23204264|NCT00502307|64487754|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
23204265|NCT00502307|64487752|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
23204266|NCT00502307|64487753|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
23204267|NCT00502307|64487754|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
23204268|NCT00502307|64487752|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
23204269|NCT00502307|64487753|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
23204270|NCT00502307|64487754|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
23204271|NCT00502307|64487752|FG000|Maintenance Period|Progressive disease|80|||
23204272|NCT00502307|64487753|FG001|Maintenance Period|Progressive disease|0|||
23204273|NCT00502307|64487754|FG002|Maintenance Period|Progressive disease|0|||
23204274|NCT00502307|64487752|FG000|Maintenance Period|Discontinued due to other reasons|68|||
23204275|NCT00502307|64487753|FG001|Maintenance Period|Discontinued due to other reasons|0|||
23204276|NCT00502307|64487754|FG002|Maintenance Period|Discontinued due to other reasons|0|||
23204277|NCT00782418|64487755|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
23504782|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504783|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504784|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504785|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504786|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504787|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504788|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504789|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504790|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504791|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504792|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
23504793|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504794|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504795|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
23504796|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504797|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504798|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504799|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504800|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504801|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504802|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504803|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504804|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504805|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504806|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504807|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504808|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504809|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504810|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504811|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504812|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23204278|NCT00782418|64487756|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23204279|NCT00782418|64487757|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23204280|NCT00782418|64487758|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23504813|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504814|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504815|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504816|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504817|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504818|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
23504819|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504820|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504821|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
23504822|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504823|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504824|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504825|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504826|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504827|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504828|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504829|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504830|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504831|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504832|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504833|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504834|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504835|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504836|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504837|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504838|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504839|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504840|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504841|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504842|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504843|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504844|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
23504845|NCT03129100|65587876|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504846|NCT03129100|65587877|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504847|NCT03129100|65587878|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504848|NCT03129100|65587879|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504849|NCT03129100|65587880|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
23504850|NCT03129100|65587881|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
23504851|NCT03129100|65587882|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
23504852|NCT03129100|65587883|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504853|NCT03129100|65587884|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504854|NCT03129100|65587885|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504855|NCT03129100|65587886|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504856|NCT03129100|65587887|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504857|NCT03129100|65587888|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504858|NCT03129100|65587889|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504859|NCT03129100|65587890|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504860|NCT03129100|65587891|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504861|NCT03129100|65587892|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504862|NCT03129100|65587893|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504863|NCT03129100|65587894|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504864|NCT03129100|65587895|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504865|NCT03129100|65587896|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504866|NCT03129100|65587897|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504867|NCT03129100|65587898|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504868|NCT03129100|65587899|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504869|NCT03129100|65587900|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504870|NCT03129100|65587901|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
23504871|NCT03129100|65587876|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23204281|NCT00782418|64487759|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23504872|NCT03129100|65587877|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504873|NCT03129100|65587878|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23204282|NCT00782418|64487760|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23504874|NCT03129100|65587879|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504875|NCT03129100|65587880|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23204283|NCT00782418|64487761|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
23204284|NCT00782418|64487755|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
23204285|NCT00782418|64487756|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
23204286|NCT00782418|64487757|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
23204287|NCT00782418|64487758|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
23204288|NCT00782418|64487759|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
23204289|NCT00782418|64487760|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
23204290|NCT00782418|64487761|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
23204291|NCT00444626|64490999|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
23204292|NCT00444626|64490999|FG000|Initial Treatment Period|Adverse Event|1|||
23204293|NCT00444626|64490999|FG000|Initial Treatment Period|Lost to Follow-up|9|||
23204294|NCT02868216|64491002|FG000|Overall Study|Death|0|||
23204295|NCT02868216|64491003|FG001|Overall Study|Death|1|||
23204296|NCT02868216|64491002|FG000|Overall Study|coronary artery bypass|1|||
23204297|NCT02868216|64491003|FG001|Overall Study|coronary artery bypass|0|||
23204298|NCT02868216|64491002|FG000|Overall Study|Withdrawal by Subject|7|||
23204299|NCT02868216|64491003|FG001|Overall Study|Withdrawal by Subject|5|||
23204300|NCT01115738|64491014|FG000|Overall Study|Death|1|||
23204301|NCT01115738|64491015|FG001|Overall Study|Death|0|||
23204302|NCT01115738|64491016|FG002|Overall Study|Death|0|||
23204303|NCT01115738|64491014|FG000|Overall Study|Lost to Follow-up|0|||
23204304|NCT01115738|64491015|FG001|Overall Study|Lost to Follow-up|0|||
23204305|NCT01115738|64491016|FG002|Overall Study|Lost to Follow-up|1|||
23204306|NCT01115738|64491014|FG000|Overall Study|Physician Decision|18|||
23204307|NCT01115738|64491015|FG001|Overall Study|Physician Decision|15|||
23204308|NCT01115738|64491016|FG002|Overall Study|Physician Decision|17|||
23204309|NCT01115738|64491014|FG000|Overall Study|Withdrawal by Subject|6|||
23204310|NCT01115738|64491015|FG001|Overall Study|Withdrawal by Subject|6|||
23204311|NCT01115738|64491016|FG002|Overall Study|Withdrawal by Subject|9|||
23204312|NCT01449682|64491017|FG000|Overall Study|Death|0|||
23204313|NCT01449682|64491018|FG001|Overall Study|Death|1|||
23204314|NCT01449682|64491017|FG000|Overall Study|Adverse Event|1|||
23204315|NCT01449682|64491018|FG001|Overall Study|Adverse Event|0|||
23204316|NCT04937816|64491019|FG000|Overall Study|Study drug stopped, reason missing|5|||
23204317|NCT04937816|64491020|FG001|Overall Study|Study drug stopped, reason missing|3|||
23204318|NCT04937816|64491021|FG002|Overall Study|Study drug stopped, reason missing|4|||
23204319|NCT04937816|64491022|FG003|Overall Study|Study drug stopped, reason missing|6|||
23204320|NCT04937816|64491023|FG004|Overall Study|Study drug stopped, reason missing|1|||
23504876|NCT03129100|65587881|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504877|NCT03129100|65587882|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504878|NCT03129100|65587883|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504879|NCT03129100|65587884|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504880|NCT03129100|65587885|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
23504881|NCT03129100|65587886|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504882|NCT03129100|65587887|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504883|NCT03129100|65587888|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504884|NCT03129100|65587889|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504885|NCT03129100|65587890|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504886|NCT03129100|65587891|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504887|NCT03129100|65587892|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504888|NCT03129100|65587893|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504889|NCT03129100|65587894|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504890|NCT03129100|65587895|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504891|NCT03129100|65587896|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504892|NCT03129100|65587897|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504893|NCT03129100|65587898|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23204321|NCT04937816|64491024|FG005|Overall Study|Study drug stopped, reason missing|0|||
23204322|NCT04937816|64491025|FG006|Overall Study|Study drug stopped, reason missing|0|||
23204323|NCT04937816|64491019|FG000|Overall Study|Other than stated below|173|||
23204324|NCT04937816|64491020|FG001|Overall Study|Other than stated below|143|||
23204325|NCT04937816|64491021|FG002|Overall Study|Other than stated below|125|||
23204326|NCT04937816|64491022|FG003|Overall Study|Other than stated below|44|||
23204327|NCT04937816|64491023|FG004|Overall Study|Other than stated below|45|||
23204328|NCT04937816|64491024|FG005|Overall Study|Other than stated below|28|||
23204329|NCT04937816|64491025|FG006|Overall Study|Other than stated below|31|||
23204330|NCT04937816|64491019|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
23204331|NCT04937816|64491020|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
23504894|NCT03129100|65587899|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504895|NCT03129100|65587900|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504896|NCT03129100|65587901|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
23504897|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23204332|NCT04937816|64491021|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
23204333|NCT04937816|64491022|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
23204334|NCT04937816|64491023|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
23204335|NCT04937816|64491024|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
23204336|NCT04937816|64491025|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
23204337|NCT04937816|64491019|FG000|Overall Study|Lost to Follow-up|15|||
23504898|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504899|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23204338|NCT04937816|64491020|FG001|Overall Study|Lost to Follow-up|9|||
23204339|NCT04937816|64491021|FG002|Overall Study|Lost to Follow-up|6|||
23204340|NCT04937816|64491022|FG003|Overall Study|Lost to Follow-up|6|||
23504900|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504901|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504902|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504903|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504904|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504905|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504906|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504907|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504908|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
23204341|NCT04937816|64491023|FG004|Overall Study|Lost to Follow-up|16|||
23204342|NCT04937816|64491024|FG005|Overall Study|Lost to Follow-up|11|||
23204343|NCT04937816|64491025|FG006|Overall Study|Lost to Follow-up|17|||
23204344|NCT04937816|64491019|FG000|Overall Study|Protocol Violation|15|||
23204345|NCT04937816|64491020|FG001|Overall Study|Protocol Violation|15|||
23204346|NCT04937816|64491021|FG002|Overall Study|Protocol Violation|12|||
23204347|NCT04937816|64491022|FG003|Overall Study|Protocol Violation|30|||
23204348|NCT04937816|64491023|FG004|Overall Study|Protocol Violation|24|||
23204349|NCT04937816|64491024|FG005|Overall Study|Protocol Violation|5|||
23204350|NCT04937816|64491025|FG006|Overall Study|Protocol Violation|5|||
23504909|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504910|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504911|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504912|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504913|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504914|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504915|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504916|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504917|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504918|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504919|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504920|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504921|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504922|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
23504923|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504924|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504925|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504926|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504927|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504928|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504929|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504930|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23204351|NCT04937816|64491019|FG000|Overall Study|Adverse Event|303|||
23204352|NCT04937816|64491020|FG001|Overall Study|Adverse Event|267|||
23204353|NCT04937816|64491021|FG002|Overall Study|Adverse Event|273|||
23204354|NCT04937816|64491022|FG003|Overall Study|Adverse Event|553|||
23204355|NCT04937816|64491023|FG004|Overall Study|Adverse Event|575|||
23204356|NCT04937816|64491024|FG005|Overall Study|Adverse Event|343|||
23204357|NCT04937816|64491025|FG006|Overall Study|Adverse Event|337|||
23204358|NCT04937816|64491019|FG000|Overall Study|Not treated|4|||
23204359|NCT04937816|64491020|FG001|Overall Study|Not treated|2|||
23302652|NCT03285308|64850779|FG000|Overall Study|Lost to Follow-up|3|||
23204360|NCT04937816|64491021|FG002|Overall Study|Not treated|2|||
23204361|NCT04937816|64491022|FG003|Overall Study|Not treated|2|||
23504931|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504932|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23204362|NCT04937816|64491023|FG004|Overall Study|Not treated|1|||
23204363|NCT04937816|64491024|FG005|Overall Study|Not treated|4|||
23204364|NCT04937816|64491025|FG006|Overall Study|Not treated|0|||
23204365|NCT02417233|64491026|FG000|Overall Study|Death|4|||
23204366|NCT02417233|64491027|FG001|Overall Study|Death|10|||
23204367|NCT02417233|64491028|FG002|Overall Study|Death|14|||
23204368|NCT02417233|64491026|FG000|Overall Study|Lost to Follow-up|27|||
23204369|NCT02417233|64491027|FG001|Overall Study|Lost to Follow-up|39|||
23204370|NCT02417233|64491028|FG002|Overall Study|Lost to Follow-up|34|||
23204371|NCT02417233|64491026|FG000|Overall Study|Protocol Violation|2|||
23204372|NCT02417233|64491027|FG001|Overall Study|Protocol Violation|0|||
23504933|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504934|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
23504935|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
23504936|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
23504937|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
23504938|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504939|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504940|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504941|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504942|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504943|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504944|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504945|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504946|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504947|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23204373|NCT02417233|64491028|FG002|Overall Study|Protocol Violation|2|||
23204374|NCT02417233|64491026|FG000|Overall Study|Withdrawal by Subject|2|||
23204375|NCT02417233|64491027|FG001|Overall Study|Withdrawal by Subject|1|||
23204376|NCT02417233|64491028|FG002|Overall Study|Withdrawal by Subject|8|||
23504948|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
23504949|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504950|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504951|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504952|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504953|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23204377|NCT02417233|64491026|FG000|Overall Study|Relocation out of study area|1|||
23204378|NCT02417233|64491027|FG001|Overall Study|Relocation out of study area|0|||
23204379|NCT02417233|64491028|FG002|Overall Study|Relocation out of study area|1|||
23204380|NCT02417233|64491026|FG000|Overall Study|Mentally unstable|0|||
23204381|NCT02417233|64491027|FG001|Overall Study|Mentally unstable|1|||
23204382|NCT02417233|64491028|FG002|Overall Study|Mentally unstable|0|||
23204383|NCT00712322|64491029|FG000|Overall Study|Protocol deviation|0|||
23204384|NCT00712322|64491030|FG001|Overall Study|Protocol deviation|1|||
23204385|NCT00712322|64491031|FG002|Overall Study|Protocol deviation|0|||
23204386|NCT00910429|64491036|FG000|Overall Study|Death|18|||
23204387|NCT00910429|64491037|FG001|Overall Study|Death|12|||
23504954|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504955|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504956|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504957|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23204388|NCT00910429|64491036|FG000|Overall Study|Withdrawal by Subject|3|||
23204389|NCT00910429|64491037|FG001|Overall Study|Withdrawal by Subject|2|||
23302653|NCT03285308|64850780|FG001|Overall Study|Lost to Follow-up|1|||
23302654|NCT03285308|64850779|FG000|Overall Study|Protocol Deviation|6|||
23302655|NCT03285308|64850780|FG001|Overall Study|Protocol Deviation|5|||
23302656|NCT03285308|64850779|FG000|Overall Study|Reason not Specified|0|||
23302657|NCT03285308|64850780|FG001|Overall Study|Reason not Specified|1|||
23302658|NCT01558297|64850784|FG000|Overall Study|Withdrawal by Subject|2|||
23302659|NCT01558297|64850785|FG001|Overall Study|Withdrawal by Subject|2|||
23302660|NCT01558297|64850786|FG002|Overall Study|Withdrawal by Subject|1|||
23302661|NCT04322149|64850787|FG000|Overall Study|Adverse Event|1|||
23302662|NCT04322149|64850788|FG001|Overall Study|Adverse Event|1|||
23302663|NCT04322149|64850789|FG002|Overall Study|Adverse Event|0|||
23302664|NCT04322149|64850790|FG003|Overall Study|Adverse Event|0|||
23302665|NCT04322149|64850787|FG000|Overall Study|Withdrawal by Subject|0|||
23302666|NCT04322149|64850788|FG001|Overall Study|Withdrawal by Subject|0|||
23302667|NCT04322149|64850789|FG002|Overall Study|Withdrawal by Subject|0|||
23302668|NCT04322149|64850790|FG003|Overall Study|Withdrawal by Subject|2|||
23302669|NCT04322149|64850787|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
23340849|NCT01936181|64992870|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
23504958|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504959|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504960|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
23504961|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504962|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
23504963|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
23504964|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504965|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504966|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504967|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504968|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504969|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504970|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504971|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504972|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504973|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504974|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
23504975|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504976|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504977|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504978|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504979|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504980|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504981|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504982|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504983|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504984|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23302670|NCT04322149|64850788|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
23302671|NCT04322149|64850789|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
23302672|NCT04322149|64850790|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
23302673|NCT03365011|64850791|FG000|Overall Study|Withdrawal by Subject|1|||
23302674|NCT03365011|64850792|FG001|Overall Study|Withdrawal by Subject|2|||
23302675|NCT03512262|64850798|FG000|Overall Study|Adverse Event|8|||
23302676|NCT03512262|64850799|FG001|Overall Study|Adverse Event|3|||
23302677|NCT03512262|64850798|FG000|Overall Study|Death (non-treatment emergent)|1|||
23302678|NCT03512262|64850799|FG001|Overall Study|Death (non-treatment emergent)|0|||
23302679|NCT03512262|64850798|FG000|Overall Study|Withdrawal by Subject|17|||
23302680|NCT03512262|64850799|FG001|Overall Study|Withdrawal by Subject|9|||
23302681|NCT03512262|64850798|FG000|Overall Study|Lost to Follow-up|7|||
23302682|NCT03512262|64850799|FG001|Overall Study|Lost to Follow-up|1|||
23302683|NCT03512262|64850798|FG000|Overall Study|Other than Specified|2|||
23302684|NCT03512262|64850799|FG001|Overall Study|Other than Specified|2|||
23302685|NCT03567382|64850800|FG000|Overall Study|Lost to Follow-up|1|||
23302686|NCT03567382|64850801|FG001|Overall Study|Lost to Follow-up|21|||
23302687|NCT03567382|64850802|FG002|Overall Study|Lost to Follow-up|1|||
23302688|NCT03567382|64850803|FG003|Overall Study|Lost to Follow-up|21|||
23302689|NCT03567382|64850800|FG000|Overall Study|Withdrawal by Subject|2|||
23302690|NCT03567382|64850801|FG001|Overall Study|Withdrawal by Subject|14|||
23302691|NCT03567382|64850802|FG002|Overall Study|Withdrawal by Subject|1|||
23302692|NCT03567382|64850803|FG003|Overall Study|Withdrawal by Subject|12|||
23302693|NCT01117766|64850804|FG000|First Intervention|Adverse Event|0|||
23302694|NCT01117766|64850805|FG001|First Intervention|Adverse Event|1|||
23302695|NCT01117766|64850804|FG000|First Intervention|Protocol Violation|1|||
23302696|NCT01117766|64850805|FG001|First Intervention|Protocol Violation|0|||
23302697|NCT01117766|64850804|FG000|Washout Period|Protocol Violation|0|||
23302698|NCT01117766|64850805|FG001|Washout Period|Protocol Violation|2|||
23302699|NCT01117766|64850804|FG000|Second Intervention|Lost to Follow-up|1|||
23302700|NCT01117766|64850805|FG001|Second Intervention|Lost to Follow-up|0|||
23302701|NCT01117766|64850804|FG000|Second Intervention|Other|1|||
23302702|NCT01117766|64850805|FG001|Second Intervention|Other|2|||
23302703|NCT01117766|64850804|FG000|Second Intervention|Adverse Event|0|||
23302704|NCT01117766|64850805|FG001|Second Intervention|Adverse Event|2|||
23302705|NCT01117766|64850804|FG000|Second Intervention|Withdrawal by Subject|0|||
23302706|NCT01117766|64850805|FG001|Second Intervention|Withdrawal by Subject|1|||
23302707|NCT01855048|64850810|FG000|Overall Study|Withdrawal by Subject|0|||
23302708|NCT01855048|64850811|FG001|Overall Study|Withdrawal by Subject|1|||
23302709|NCT01855048|64850812|FG002|Overall Study|Withdrawal by Subject|0|||
23302710|NCT01855048|64850813|FG003|Overall Study|Withdrawal by Subject|0|||
23504985|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23302711|NCT01855048|64850814|FG004|Overall Study|Withdrawal by Subject|1|||
23302712|NCT01855048|64850815|FG005|Overall Study|Withdrawal by Subject|0|||
23302713|NCT01705236|64850816|FG000|Overall Study|Lost to Follow-up|1|||
23302714|NCT01705236|64850816|FG000|Overall Study|Administrative problems|2|||
23302715|NCT01705236|64850816|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23302716|NCT01705236|64850816|FG000|Overall Study|Protocol Violation|3|||
23302717|NCT01705236|64850816|FG000|Overall Study|Abnormal test procedure result(s)|4|||
23302718|NCT01705236|64850816|FG000|Overall Study|Abnormal laboratory value(s)|4|||
23302719|NCT01705236|64850816|FG000|Overall Study|Withdrawal by Subject|5|||
23302720|NCT01705236|64850816|FG000|Overall Study|Adverse Event|5|||
23504986|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504987|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23302721|NCT02091141|64850817|FG000|Overall Study|Death|280|||
23504988|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504989|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504990|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
23504991|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504992|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504993|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504994|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23302722|NCT02091141|64850818|FG001|Overall Study|Death|118|||
23302723|NCT02091141|64850819|FG002|Overall Study|Death|46|||
23302724|NCT02091141|64850820|FG003|Overall Study|Death|13|||
23302725|NCT02091141|64850821|FG004|Overall Study|Death|31|||
23302726|NCT02091141|64850822|FG005|Overall Study|Death|16|||
23302727|NCT02091141|64850823|FG006|Overall Study|Death|12|||
23302728|NCT02091141|64850817|FG000|Overall Study|Withdrawal by Subject|21|||
23302729|NCT02091141|64850818|FG001|Overall Study|Withdrawal by Subject|13|||
23302730|NCT02091141|64850819|FG002|Overall Study|Withdrawal by Subject|3|||
23302731|NCT02091141|64850820|FG003|Overall Study|Withdrawal by Subject|2|||
23302732|NCT02091141|64850821|FG004|Overall Study|Withdrawal by Subject|2|||
23302733|NCT02091141|64850822|FG005|Overall Study|Withdrawal by Subject|3|||
23302734|NCT02091141|64850823|FG006|Overall Study|Withdrawal by Subject|0|||
23302735|NCT02091141|64850817|FG000|Overall Study|Lost to Follow-up|21|||
23302736|NCT02091141|64850818|FG001|Overall Study|Lost to Follow-up|5|||
23302737|NCT02091141|64850819|FG002|Overall Study|Lost to Follow-up|1|||
23302738|NCT02091141|64850820|FG003|Overall Study|Lost to Follow-up|0|||
23302739|NCT02091141|64850821|FG004|Overall Study|Lost to Follow-up|1|||
23302740|NCT02091141|64850822|FG005|Overall Study|Lost to Follow-up|2|||
23302741|NCT02091141|64850823|FG006|Overall Study|Lost to Follow-up|0|||
23302742|NCT02091141|64850817|FG000|Overall Study|Reason Not Specified|6|||
23302743|NCT02091141|64850818|FG001|Overall Study|Reason Not Specified|5|||
23504995|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504996|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504997|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504998|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23504999|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23505000|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
23505001|NCT03129100|65587876|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505002|NCT03129100|65587877|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505003|NCT03129100|65587878|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505004|NCT03129100|65587879|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505005|NCT03129100|65587880|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505006|NCT03129100|65587881|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505007|NCT03129100|65587882|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505008|NCT03129100|65587883|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23302744|NCT02091141|64850819|FG002|Overall Study|Reason Not Specified|2|||
23302745|NCT02091141|64850820|FG003|Overall Study|Reason Not Specified|0|||
23302746|NCT02091141|64850821|FG004|Overall Study|Reason Not Specified|0|||
23302747|NCT02091141|64850822|FG005|Overall Study|Reason Not Specified|0|||
23302748|NCT02091141|64850823|FG006|Overall Study|Reason Not Specified|1|||
23302749|NCT02091141|64850817|FG000|Overall Study|Study Ended by Sponsor|1|||
23302750|NCT02091141|64850818|FG001|Overall Study|Study Ended by Sponsor|9|||
23302751|NCT02091141|64850819|FG002|Overall Study|Study Ended by Sponsor|0|||
23302752|NCT02091141|64850820|FG003|Overall Study|Study Ended by Sponsor|0|||
23302753|NCT02091141|64850821|FG004|Overall Study|Study Ended by Sponsor|0|||
23302754|NCT02091141|64850822|FG005|Overall Study|Study Ended by Sponsor|0|||
23302755|NCT02091141|64850823|FG006|Overall Study|Study Ended by Sponsor|0|||
23302756|NCT02091141|64850817|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
23302757|NCT02091141|64850818|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
23302758|NCT02091141|64850819|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
23505009|NCT03129100|65587884|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505010|NCT03129100|65587885|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23302759|NCT02091141|64850820|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
23302760|NCT02091141|64850821|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
23302761|NCT02091141|64850822|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
23302762|NCT02091141|64850823|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
23505011|NCT03129100|65587886|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505012|NCT03129100|65587887|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505013|NCT03129100|65587888|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
23302763|NCT00974974|64850824|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
23302764|NCT00974974|64850825|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
23302765|NCT00974974|64850824|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
23302766|NCT00974974|64850825|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
23302767|NCT00974974|64850824|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
23302768|NCT00974974|64850825|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
23302769|NCT00974974|64850824|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
23302770|NCT00974974|64850825|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
23302771|NCT00974974|64850824|FG000|IR CD-LD Dose Adjustment|Various|0|||
23302772|NCT00974974|64850825|FG001|IR CD-LD Dose Adjustment|Various|9|||
23302773|NCT00974974|64850824|FG000|IPX066 Dose Conversion|Adverse Event|23|||
23505014|NCT03129100|65587889|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505015|NCT03129100|65587890|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
23505016|NCT03129100|65587891|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
23505017|NCT03129100|65587892|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505018|NCT03129100|65587893|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505019|NCT03129100|65587894|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23302774|NCT00974974|64850825|FG001|IPX066 Dose Conversion|Adverse Event|0|||
23505020|NCT03129100|65587895|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505021|NCT03129100|65587896|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23204390|NCT00910429|64491036|FG000|Overall Study|Protocol Violation|1|||
23302775|NCT00974974|64850824|FG000|IPX066 Dose Conversion|Death|2|||
23302776|NCT00974974|64850825|FG001|IPX066 Dose Conversion|Death|0|||
23302777|NCT00974974|64850824|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
23302778|NCT00974974|64850825|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
23302779|NCT00974974|64850824|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
23302780|NCT00974974|64850825|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
23302781|NCT00974974|64850824|FG000|IPX066 Dose Conversion|Various|3|||
23302782|NCT00974974|64850825|FG001|IPX066 Dose Conversion|Various|0|||
23302783|NCT00974974|64850824|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
23302784|NCT00974974|64850825|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
23302785|NCT00974974|64850824|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
23302786|NCT00974974|64850825|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
23302787|NCT00974974|64850824|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
23302788|NCT00974974|64850825|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
23302789|NCT00974974|64850824|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
23302790|NCT00974974|64850825|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
23302791|NCT00974974|64850824|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
23302792|NCT00974974|64850825|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
23302793|NCT00974974|64850824|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
23302794|NCT00974974|64850825|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
23302795|NCT00974974|64850824|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
23302796|NCT00974974|64850825|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
23302797|NCT00974974|64850824|FG000|Maintenance - Double Blind Treatment|Various|4|||
23302798|NCT00974974|64850825|FG001|Maintenance - Double Blind Treatment|Various|0|||
23302799|NCT00262041|64850826|FG000|Overall Study|Withdrawal by Subject|0|||
23505022|NCT03129100|65587897|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23302800|NCT00262041|64850827|FG001|Overall Study|Withdrawal by Subject|3|||
23302801|NCT00262041|64850828|FG002|Overall Study|Withdrawal by Subject|1|||
23302802|NCT00262041|64850826|FG000|Overall Study|Lost to Follow-up|1|||
23302803|NCT00262041|64850827|FG001|Overall Study|Lost to Follow-up|1|||
23302804|NCT00262041|64850828|FG002|Overall Study|Lost to Follow-up|5|||
23302805|NCT00262041|64850826|FG000|Overall Study|Unable to classify|1|||
23302806|NCT00262041|64850827|FG001|Overall Study|Unable to classify|0|||
23302807|NCT00262041|64850828|FG002|Overall Study|Unable to classify|0|||
23302808|NCT01197417|64850829|FG000|Overall Study|Physician Decision|3|||
23302809|NCT01197417|64850830|FG001|Overall Study|Physician Decision|2|||
23302810|NCT01197417|64850829|FG000|Overall Study|Withdrawal by Subject|2|||
23302811|NCT01197417|64850830|FG001|Overall Study|Withdrawal by Subject|4|||
23302812|NCT01197417|64850829|FG000|Overall Study|Site miscommunication|0|||
23302813|NCT01197417|64850830|FG001|Overall Study|Site miscommunication|1|||
23302814|NCT01197417|64850829|FG000|Overall Study|Subject transferred to intensive care|0|||
23302815|NCT01197417|64850830|FG001|Overall Study|Subject transferred to intensive care|1|||
23302816|NCT01197417|64850829|FG000|Overall Study|Not consented in time to receive drug|0|||
23302817|NCT01197417|64850830|FG001|Overall Study|Not consented in time to receive drug|1|||
23302818|NCT01197417|64850829|FG000|Overall Study|Hypotension|1|||
23505023|NCT03129100|65587898|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505024|NCT03129100|65587899|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505025|NCT03129100|65587900|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505026|NCT03129100|65587901|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
23505027|NCT03129100|65587876|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23302819|NCT01197417|64850830|FG001|Overall Study|Hypotension|2|||
23302820|NCT01197417|64850829|FG000|Overall Study|Found to be ineligible|2|||
23302821|NCT01197417|64850830|FG001|Overall Study|Found to be ineligible|5|||
23302822|NCT01197417|64850829|FG000|Overall Study|No 25-hour magnesium level|0|||
23302823|NCT01197417|64850830|FG001|Overall Study|No 25-hour magnesium level|2|||
23302824|NCT03197558|64850831|FG000|Overall Study|Tubes not placed|1|||
23302825|NCT02269163|64850845|FG000|Overall Study|Lost to Follow-up|1|||
23302826|NCT02269163|64850846|FG001|Overall Study|Lost to Follow-up|0|||
23302827|NCT02269163|64850845|FG000|Overall Study|Major protocol violation|0|||
23302828|NCT02269163|64850846|FG001|Overall Study|Major protocol violation|1|||
23302829|NCT02269163|64850845|FG000|Overall Study|Other|2|||
23302830|NCT02269163|64850846|FG001|Overall Study|Other|2|||
23302831|NCT02269163|64850845|FG000|Overall Study|Withdrawal by Subject|0|||
23302832|NCT02269163|64850846|FG001|Overall Study|Withdrawal by Subject|3|||
23302833|NCT02269163|64850845|FG000|Overall Study|Physician Decision|0|||
23302834|NCT02269163|64850846|FG001|Overall Study|Physician Decision|1|||
23302835|NCT02618408|64850848|FG000|Overall Study|Withdrawal by Subject|1|||
23302836|NCT02618408|64850849|FG001|Overall Study|Withdrawal by Subject|0|||
23302837|NCT02618408|64850850|FG002|Overall Study|Withdrawal by Subject|4|||
23302838|NCT02618408|64850848|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
23302839|NCT02618408|64850849|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
23302840|NCT02618408|64850850|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
23302841|NCT02618408|64850848|FG000|Overall Study|Lost to Follow-up|4|||
23302842|NCT02618408|64850849|FG001|Overall Study|Lost to Follow-up|2|||
23302843|NCT02618408|64850850|FG002|Overall Study|Lost to Follow-up|6|||
23302844|NCT02618408|64850848|FG000|Overall Study|Adverse Event|4|||
23302845|NCT02618408|64850849|FG001|Overall Study|Adverse Event|0|||
23302846|NCT02618408|64850850|FG002|Overall Study|Adverse Event|10|||
23302847|NCT02618408|64850848|FG000|Overall Study|Physician Decision|1|||
23302848|NCT02618408|64850849|FG001|Overall Study|Physician Decision|1|||
23302849|NCT02618408|64850850|FG002|Overall Study|Physician Decision|2|||
23302850|NCT02618408|64850848|FG000|Overall Study|Protocol Violation|1|||
23302851|NCT02618408|64850849|FG001|Overall Study|Protocol Violation|1|||
23302852|NCT02618408|64850850|FG002|Overall Study|Protocol Violation|2|||
23302853|NCT02618408|64850848|FG000|Overall Study|Other, Multiple Categories|0|||
23302854|NCT02618408|64850849|FG001|Overall Study|Other, Multiple Categories|0|||
23302855|NCT02618408|64850850|FG002|Overall Study|Other, Multiple Categories|4|||
23302856|NCT00891839|64850851|FG000|Overall Study|Adverse Event|2|||
23302857|NCT00891839|64850851|FG000|Overall Study|Withdrawal by Subject|2|||
23302858|NCT00891839|64850851|FG000|Overall Study|Disease progression|3|||
23302859|NCT00325195|64850852|FG000|Randomized|Not dosed|5|||
23302860|NCT00325195|64850853|FG001|Randomized|Not dosed|5|||
23302861|NCT00325195|64850854|FG002|Randomized|Not dosed|3|||
23302862|NCT00325195|64850852|FG000|Received Intervention: ITT Population|Adverse Event|15|||
23302863|NCT00325195|64850853|FG001|Received Intervention: ITT Population|Adverse Event|17|||
23302864|NCT00325195|64850854|FG002|Received Intervention: ITT Population|Adverse Event|1|||
23302865|NCT00325195|64850852|FG000|Received Intervention: ITT Population|Death|3|||
23302866|NCT00325195|64850853|FG001|Received Intervention: ITT Population|Death|1|||
23302867|NCT00325195|64850854|FG002|Received Intervention: ITT Population|Death|0|||
23302868|NCT00325195|64850852|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
23302869|NCT00325195|64850853|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
23302870|NCT00325195|64850854|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
23302871|NCT00325195|64850852|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
23302872|NCT00325195|64850853|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
23302873|NCT00325195|64850854|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
23302874|NCT00325195|64850852|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
23302875|NCT00325195|64850853|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
23302876|NCT00325195|64850854|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
23505028|NCT03129100|65587877|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505029|NCT03129100|65587878|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23302877|NCT01829113|64850855|FG000|Overall Study|Disease Progression|37|||
23302878|NCT01829113|64850856|FG001|Overall Study|Disease Progression|48|||
23302879|NCT01829113|64850855|FG000|Overall Study|Adverse Event|14|||
23302880|NCT01829113|64850856|FG001|Overall Study|Adverse Event|10|||
23302881|NCT01829113|64850855|FG000|Overall Study|Withdrawal by Subject|17|||
23302882|NCT01829113|64850856|FG001|Overall Study|Withdrawal by Subject|10|||
23302883|NCT01829113|64850855|FG000|Overall Study|Death|4|||
23302884|NCT01829113|64850856|FG001|Overall Study|Death|6|||
23302885|NCT01829113|64850855|FG000|Overall Study|Sponsor Decision|1|||
23302886|NCT01829113|64850856|FG001|Overall Study|Sponsor Decision|1|||
23302887|NCT01829113|64850855|FG000|Overall Study|No Study Treatment Received|3|||
23302888|NCT01829113|64850856|FG001|Overall Study|No Study Treatment Received|2|||
23302889|NCT01829113|64850855|FG000|Overall Study|Physician Decision|1|||
23302890|NCT01829113|64850856|FG001|Overall Study|Physician Decision|1|||
23302891|NCT00560937|64850857|FG000|Overall Study|Withdrawal by Subject|0|||
23302892|NCT00560937|64850858|FG001|Overall Study|Withdrawal by Subject|1|||
23302893|NCT00560937|64850857|FG000|Overall Study|Physician Decision|1|||
23302894|NCT00560937|64850858|FG001|Overall Study|Physician Decision|1|||
23302895|NCT01660334|64850861|FG000|Overall Study|Lost to Follow-up|1|||
23302896|NCT01102374|64850862|FG000|Overall Study|Death|9|||
23302897|NCT01102374|64850863|FG001|Overall Study|Death|13|||
23302898|NCT01102374|64850862|FG000|Overall Study|Lost to Follow-up|7|||
23302899|NCT01102374|64850863|FG001|Overall Study|Lost to Follow-up|6|||
23302900|NCT02238626|64850864|FG000|Overall Study|Adverse Event|3|||
23302901|NCT02238626|64850865|FG001|Overall Study|Adverse Event|5|||
23302902|NCT02238626|64850866|FG002|Overall Study|Adverse Event|0|||
23302903|NCT02238626|64850867|FG003|Overall Study|Adverse Event|3|||
23302904|NCT02238626|64850864|FG000|Overall Study|Lost to Follow-up|2|||
23302905|NCT02238626|64850865|FG001|Overall Study|Lost to Follow-up|4|||
23302906|NCT02238626|64850866|FG002|Overall Study|Lost to Follow-up|2|||
23302907|NCT02238626|64850867|FG003|Overall Study|Lost to Follow-up|2|||
23302908|NCT02238626|64850864|FG000|Overall Study|Withdrawal by Subject|0|||
23302909|NCT02238626|64850865|FG001|Overall Study|Withdrawal by Subject|3|||
23302910|NCT02238626|64850866|FG002|Overall Study|Withdrawal by Subject|0|||
23302911|NCT02238626|64850867|FG003|Overall Study|Withdrawal by Subject|1|||
23302912|NCT02238626|64850864|FG000|Overall Study|Death|0|||
23302913|NCT02238626|64850865|FG001|Overall Study|Death|0|||
23302914|NCT02238626|64850866|FG002|Overall Study|Death|1|||
23302915|NCT02238626|64850867|FG003|Overall Study|Death|1|||
23302916|NCT02238626|64850864|FG000|Overall Study|Other|0|||
23302917|NCT02238626|64850865|FG001|Overall Study|Other|2|||
23302918|NCT02238626|64850866|FG002|Overall Study|Other|0|||
23302919|NCT02238626|64850867|FG003|Overall Study|Other|0|||
23302920|NCT02500641|64850870|FG000|Overall Study|Adverse Event|0|||
23302921|NCT02500641|64850871|FG001|Overall Study|Adverse Event|2|||
23302922|NCT02500641|64850870|FG000|Overall Study|Withdrawal by Subject|4|||
23302923|NCT02500641|64850871|FG001|Overall Study|Withdrawal by Subject|5|||
23302924|NCT02500641|64850870|FG000|Overall Study|Unable to follow study procedures|3|||
23302925|NCT02500641|64850871|FG001|Overall Study|Unable to follow study procedures|2|||
23302926|NCT02500641|64850870|FG000|Overall Study|Protocol Violation|1|||
23302927|NCT02500641|64850871|FG001|Overall Study|Protocol Violation|2|||
23302928|NCT02500641|64850870|FG000|Overall Study|Lost to Follow-up|1|||
23302929|NCT02500641|64850871|FG001|Overall Study|Lost to Follow-up|0|||
23302930|NCT02500641|64850870|FG000|Overall Study|Sponsor decision|1|||
23302931|NCT02500641|64850871|FG001|Overall Study|Sponsor decision|0|||
23302932|NCT02500641|64850870|FG000|Overall Study|Non compliance to study drug|0|||
23302933|NCT02500641|64850871|FG001|Overall Study|Non compliance to study drug|1|||
23302934|NCT04397445|64850875|FG000|Overall Study|Withdrawal by Subject|1|||
23302935|NCT04397445|64850876|FG001|Overall Study|Withdrawal by Subject|0|||
23302936|NCT04397445|64850877|FG002|Overall Study|Withdrawal by Subject|0|||
23302937|NCT04397445|64850878|FG003|Overall Study|Withdrawal by Subject|0|||
23302938|NCT00986570|64850889|FG000|Overall Study|Lost to Follow-up|6|||
23302939|NCT00986570|64850889|FG000|Overall Study|Potential bias for objective assessment|1|||
23302940|NCT02722148|64850904|FG000|Overall Study|Lost to Follow-up|2|||
23302941|NCT02722148|64850904|FG000|Overall Study|Non compliant with treatment regimen|3|||
23302942|NCT04700280|64850905|FG000|Overall Study|Adverse Event|4|||
23302943|NCT04700280|64850906|FG001|Overall Study|Adverse Event|0|||
23302944|NCT04700280|64850905|FG000|Overall Study|Lack of Efficacy|1|||
23302945|NCT04700280|64850906|FG001|Overall Study|Lack of Efficacy|0|||
23302946|NCT04700280|64850905|FG000|Overall Study|Study terminated by sponsor|5|||
23302947|NCT04700280|64850906|FG001|Overall Study|Study terminated by sponsor|3|||
23302948|NCT04700280|64850905|FG000|Overall Study|Other than specified|1|||
23302949|NCT04700280|64850906|FG001|Overall Study|Other than specified|0|||
23302950|NCT01215513|64850909|FG000|Overall Study|Not completed CS42|9|||
23302951|NCT01215513|64850909|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
23302952|NCT01215513|64850909|FG000|Overall Study|Adverse event (CS42A)|2|||
23302953|NCT01215513|64850909|FG000|Overall Study|Physician decision (CS42A)|6|||
23302954|NCT01215513|64850909|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
23302955|NCT01215513|64850909|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
23204391|NCT00910429|64491037|FG001|Overall Study|Protocol Violation|0|||
23302956|NCT01661179|64850910|FG000|Overall Study|Death|1|||
23302957|NCT01661179|64850910|FG000|Overall Study|Withdrawal by Subject|1|||
23302958|NCT01661179|64850910|FG000|Overall Study|Other Eligibility criteria|4|||
23302959|NCT00423319|64850912|FG000|Overall Study|Death|2|||
23302960|NCT00423319|64850913|FG001|Overall Study|Death|0|||
23302961|NCT00423319|64850912|FG000|Overall Study|Adverse Event|93|||
23302962|NCT00423319|64850913|FG001|Overall Study|Adverse Event|112|||
23302963|NCT00423319|64850912|FG000|Overall Study|Withdrawal by Subject|86|||
23302964|NCT00423319|64850913|FG001|Overall Study|Withdrawal by Subject|99|||
23302965|NCT00423319|64850912|FG000|Overall Study|Lost to Follow-up|4|||
23302966|NCT00423319|64850913|FG001|Overall Study|Lost to Follow-up|3|||
23302967|NCT00423319|64850912|FG000|Overall Study|Poor compliance or noncompliance|1|||
23302968|NCT00423319|64850913|FG001|Overall Study|Poor compliance or noncompliance|1|||
23302969|NCT00423319|64850912|FG000|Overall Study|No longer meets study criteria|15|||
23302970|NCT00423319|64850913|FG001|Overall Study|No longer meets study criteria|15|||
23302971|NCT00423319|64850912|FG000|Overall Study|Other|23|||
23302972|NCT00423319|64850913|FG001|Overall Study|Other|22|||
23302973|NCT01000493|64850920|FG000|Overall Study|Adverse Event|3|||
23302974|NCT01000493|64850921|FG001|Overall Study|Adverse Event|6|||
23302975|NCT01000493|64850920|FG000|Overall Study|Lack of Efficacy|1|||
23302976|NCT01000493|64850921|FG001|Overall Study|Lack of Efficacy|1|||
23302977|NCT01000493|64850920|FG000|Overall Study|Protocol Violation|1|||
23302978|NCT01000493|64850921|FG001|Overall Study|Protocol Violation|8|||
23302979|NCT01000493|64850920|FG000|Overall Study|Study closed/terminated|25|||
23302980|NCT01000493|64850921|FG001|Overall Study|Study closed/terminated|23|||
23302981|NCT01000493|64850920|FG000|Overall Study|Lost to Follow-up|5|||
23302982|NCT01000493|64850921|FG001|Overall Study|Lost to Follow-up|9|||
23302983|NCT01000493|64850920|FG000|Overall Study|Physician Decision|1|||
23302984|NCT01000493|64850921|FG001|Overall Study|Physician Decision|1|||
23302985|NCT01000493|64850920|FG000|Overall Study|Withdrawal by Subject|3|||
23302986|NCT01000493|64850921|FG001|Overall Study|Withdrawal by Subject|7|||
23302987|NCT01334710|64850928|FG000|Overall Study|Trial was terminated|3|||
23302988|NCT02980874|64850929|FG000|Overall Study|Adverse Event|2|||
23302989|NCT02980874|64850930|FG001|Overall Study|Adverse Event|7|||
23302990|NCT02980874|64850929|FG000|Overall Study|Withdrawal by Subject|7|||
23302991|NCT02980874|64850930|FG001|Overall Study|Withdrawal by Subject|2|||
23302992|NCT02980874|64850929|FG000|Overall Study|Lost to Follow-up|5|||
23302993|NCT02980874|64850930|FG001|Overall Study|Lost to Follow-up|5|||
23302994|NCT02980874|64850929|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
23302995|NCT02980874|64850930|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
23302996|NCT02980874|64850929|FG000|Overall Study|Unknown study completion status|1|||
23302997|NCT02980874|64850930|FG001|Overall Study|Unknown study completion status|0|||
23302998|NCT00922987|64850931|FG000|Overall Study|Insufficient clinical response|1|||
23302999|NCT00922987|64850931|FG000|Overall Study|Protocol Violation|2|||
23303000|NCT00922987|64850931|FG000|Overall Study|Adverse Event|1|||
23303001|NCT03796039|64850934|FG000|Overall Study|Death|2|||
23303002|NCT03796039|64850935|FG001|Overall Study|Death|1|||
23303003|NCT03796039|64850934|FG000|Overall Study|Withdrawal by Subject|7|||
23303004|NCT03796039|64850935|FG001|Overall Study|Withdrawal by Subject|4|||
23303005|NCT03828448|64850938|FG000|Overall Study|Sponsor's Discretion|34|||
23303006|NCT00468650|64850939|FG000|Overall Study|Lost to Follow-up|4|||
23303007|NCT00468650|64850939|FG000|Overall Study|Withdrawal by Subject|2|||
23303008|NCT00468650|64850939|FG000|Overall Study|Protocol Violation|1|||
23303009|NCT02932228|64850940|FG000|Overall Study|Death|8|||
23505030|NCT03129100|65587879|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505031|NCT03129100|65587880|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505032|NCT03129100|65587881|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505033|NCT03129100|65587882|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505034|NCT03129100|65587883|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505035|NCT03129100|65587884|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505036|NCT03129100|65587885|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505037|NCT03129100|65587886|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505038|NCT03129100|65587887|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505039|NCT03129100|65587888|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505040|NCT03129100|65587889|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23303010|NCT02932228|64850941|FG001|Overall Study|Death|23|||
23505041|NCT03129100|65587890|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505042|NCT03129100|65587891|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505043|NCT03129100|65587892|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23303011|NCT02932228|64850940|FG000|Overall Study|not eligible upon chart review|2|||
23303012|NCT02932228|64850941|FG001|Overall Study|not eligible upon chart review|5|||
23505044|NCT03129100|65587893|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
23303013|NCT02516410|64850942|FG000|Overall Study|Adverse Event|0|||
23303014|NCT02516410|64850943|FG001|Overall Study|Adverse Event|1|||
23303015|NCT02516410|64850942|FG000|Overall Study|Withdrawal by Subject|0|||
23303016|NCT02516410|64850943|FG001|Overall Study|Withdrawal by Subject|1|||
23505045|NCT03129100|65587894|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505046|NCT03129100|65587895|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
23505047|NCT03129100|65587896|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505048|NCT03129100|65587897|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505049|NCT03129100|65587898|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505050|NCT03129100|65587899|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505051|NCT03129100|65587900|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505052|NCT03129100|65587901|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
23505053|NCT03129100|65587876|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505054|NCT03129100|65587877|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505055|NCT03129100|65587878|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505056|NCT03129100|65587879|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505057|NCT03129100|65587880|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505058|NCT03129100|65587881|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505059|NCT03129100|65587882|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505060|NCT03129100|65587883|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23303017|NCT00851643|64850944|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
23303018|NCT00851643|64850945|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23303019|NCT00851643|64850946|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23303020|NCT00851643|64850947|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23303021|NCT00851643|64850948|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23303022|NCT00851643|64850949|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
23505061|NCT03129100|65587884|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505062|NCT03129100|65587885|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505063|NCT03129100|65587886|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505064|NCT03129100|65587887|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505065|NCT03129100|65587888|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505066|NCT03129100|65587889|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505067|NCT03129100|65587890|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505068|NCT03129100|65587891|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505069|NCT03129100|65587892|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505070|NCT03129100|65587893|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505071|NCT03129100|65587894|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505072|NCT03129100|65587895|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505073|NCT03129100|65587896|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
23505074|NCT03129100|65587897|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505075|NCT03129100|65587898|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505076|NCT03129100|65587899|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505077|NCT03129100|65587900|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505078|NCT03129100|65587901|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
23505079|NCT03129100|65587876|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
23505080|NCT03129100|65587877|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
23505081|NCT03129100|65587878|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
23505082|NCT03129100|65587879|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
23505083|NCT03129100|65587880|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
23505084|NCT03129100|65587881|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
23505085|NCT03129100|65587882|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
23505086|NCT03129100|65587883|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
23505087|NCT03129100|65587884|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
23505088|NCT03129100|65587885|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
23505089|NCT03129100|65587886|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
23505090|NCT03129100|65587887|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
23505091|NCT03129100|65587888|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
23505092|NCT03129100|65587889|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
23505093|NCT03129100|65587890|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
23505094|NCT03129100|65587891|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
23505095|NCT03129100|65587892|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
23505096|NCT03129100|65587893|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
23505097|NCT03129100|65587894|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
23505098|NCT03129100|65587895|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
23505099|NCT03129100|65587896|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
23303023|NCT00851643|64850944|FG000|Base Study (Up to 12 Months)|Other|0|||
23303024|NCT00851643|64850945|FG001|Base Study (Up to 12 Months)|Other|0|||
23303025|NCT00851643|64850946|FG002|Base Study (Up to 12 Months)|Other|0|||
23505100|NCT03129100|65587897|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
23505101|NCT03129100|65587898|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
23505102|NCT03129100|65587899|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
23505103|NCT03129100|65587900|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
23505104|NCT03129100|65587901|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
23505105|NCT03129100|65587876|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505106|NCT03129100|65587877|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505107|NCT03129100|65587878|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505108|NCT03129100|65587879|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505109|NCT03129100|65587880|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505110|NCT03129100|65587881|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505111|NCT03129100|65587882|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505112|NCT03129100|65587883|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505113|NCT03129100|65587884|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505114|NCT03129100|65587885|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505115|NCT03129100|65587886|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505116|NCT03129100|65587887|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505117|NCT03129100|65587888|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505118|NCT03129100|65587889|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505119|NCT03129100|65587890|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505120|NCT03129100|65587891|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505121|NCT03129100|65587892|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505122|NCT03129100|65587893|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505123|NCT03129100|65587894|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505124|NCT03129100|65587895|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505125|NCT03129100|65587896|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
23505126|NCT03129100|65587897|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505127|NCT03129100|65587898|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505128|NCT03129100|65587899|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505129|NCT03129100|65587900|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505130|NCT03129100|65587901|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
23505131|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
23505132|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
23505133|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
23505134|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
23505135|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
23505136|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
23303026|NCT00851643|64850947|FG003|Base Study (Up to 12 Months)|Other|0|||
23303027|NCT00851643|64850948|FG004|Base Study (Up to 12 Months)|Other|0|||
23303028|NCT00851643|64850949|FG005|Base Study (Up to 12 Months)|Other|1|||
23303029|NCT00851643|64850944|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
23303030|NCT00851643|64850945|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
23303031|NCT00851643|64850946|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
23303032|NCT00851643|64850947|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
23303033|NCT00851643|64850948|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
23303034|NCT00851643|64850949|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
23505137|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
23505138|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
23505139|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
23303035|NCT00851643|64850944|FG000|Extension Study (Up to 36 Months)|Moved|0|||
23303036|NCT00851643|64850945|FG001|Extension Study (Up to 36 Months)|Moved|2|||
23303037|NCT00851643|64850946|FG002|Extension Study (Up to 36 Months)|Moved|1|||
23303038|NCT00851643|64850947|FG003|Extension Study (Up to 36 Months)|Moved|1|||
23303039|NCT00851643|64850948|FG004|Extension Study (Up to 36 Months)|Moved|0|||
23303040|NCT00851643|64850949|FG005|Extension Study (Up to 36 Months)|Moved|1|||
23303041|NCT02206620|64850950|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23505140|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
23505141|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
23303042|NCT02206620|64850951|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23303043|NCT02206620|64850950|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
23303044|NCT02206620|64850951|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
23303045|NCT00622466|64850954|FG000|Overall Study|Death|1|||
23505142|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
23505143|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
23505144|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
23505145|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
23505146|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
23505147|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
23505148|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
23505149|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
23505150|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
23505151|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
23303046|NCT00622466|64850954|FG000|Overall Study|Adverse Event|1|||
23303047|NCT00622466|64850954|FG000|Overall Study|Withdrawal by Subject|2|||
23505152|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
23505153|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
23505154|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
23204392|NCT00910429|64491036|FG000|Overall Study|Lost to Follow-up|2|||
23204393|NCT00910429|64491037|FG001|Overall Study|Lost to Follow-up|1|||
23505155|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
23505156|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
23303048|NCT01698775|64850961|FG000|Phase A|Adverse Event|2|||
23303049|NCT01698775|64850962|FG001|Phase A|Adverse Event|1|||
23303050|NCT01698775|64850961|FG000|Phase A|Death|1|||
23303051|NCT01698775|64850962|FG001|Phase A|Death|1|||
23303052|NCT01698775|64850961|FG000|Phase A|Lack of Efficacy|1|||
23303053|NCT01698775|64850962|FG001|Phase A|Lack of Efficacy|0|||
23303054|NCT01698775|64850961|FG000|Phase A|Lost to Follow-up|1|||
23505157|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505158|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505159|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23303055|NCT01698775|64850962|FG001|Phase A|Lost to Follow-up|2|||
23303056|NCT01698775|64850961|FG000|Phase A|Protocol Violation|1|||
23505160|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505161|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505162|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505163|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505164|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23303057|NCT01698775|64850962|FG001|Phase A|Protocol Violation|0|||
23303058|NCT01698775|64850961|FG000|Phase A|Withdrawal by Subject|3|||
23303059|NCT01698775|64850962|FG001|Phase A|Withdrawal by Subject|4|||
23303060|NCT01698775|64850961|FG000|Phase A|Kidney [transplant]|0|||
23303061|NCT01698775|64850962|FG001|Phase A|Kidney [transplant]|1|||
23303062|NCT01698775|64850961|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
23303063|NCT01698775|64850962|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
23303064|NCT01698775|64850961|FG000|Phase B|Adverse Event|6|||
23303065|NCT01698775|64850962|FG001|Phase B|Adverse Event|3|||
23303066|NCT01698775|64850961|FG000|Phase B|Death|0|||
23303067|NCT01698775|64850962|FG001|Phase B|Death|1|||
23303068|NCT01698775|64850961|FG000|Phase B|Lack of Efficacy|0|||
23303069|NCT01698775|64850962|FG001|Phase B|Lack of Efficacy|1|||
23303070|NCT01698775|64850961|FG000|Phase B|Lost to Follow-up|0|||
23303071|NCT01698775|64850962|FG001|Phase B|Lost to Follow-up|1|||
23303072|NCT01698775|64850961|FG000|Phase B|Physician Decision|1|||
23303073|NCT01698775|64850962|FG001|Phase B|Physician Decision|1|||
23505165|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505166|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505167|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505168|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23303074|NCT01698775|64850961|FG000|Phase B|Protocol Violation|1|||
23303075|NCT01698775|64850962|FG001|Phase B|Protocol Violation|1|||
23303076|NCT01698775|64850961|FG000|Phase B|Withdrawal by Subject|6|||
23303077|NCT01698775|64850962|FG001|Phase B|Withdrawal by Subject|2|||
23303078|NCT03176459|64850963|FG000|Overall Study|Lost to Follow-up|5|||
23505169|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23303079|NCT03176459|64850964|FG001|Overall Study|Lost to Follow-up|7|||
23303080|NCT00871741|64850965|FG000|Overall Study|Premature study termination|9|||
23303081|NCT00871741|64850966|FG001|Overall Study|Premature study termination|7|||
23303082|NCT03970837|64850967|FG000|Overall Study|Adverse Event|23|||
23303083|NCT03970837|64850968|FG001|Overall Study|Adverse Event|20|||
23303084|NCT03970837|64850969|FG002|Overall Study|Adverse Event|16|||
23303085|NCT03970837|64850970|FG003|Overall Study|Adverse Event|6|||
23303086|NCT03970837|64850971|FG004|Overall Study|Adverse Event|4|||
23303087|NCT03970837|64850972|FG005|Overall Study|Adverse Event|5|||
23303088|NCT03970837|64850973|FG006|Overall Study|Adverse Event|1|||
23303089|NCT03970837|64850974|FG007|Overall Study|Adverse Event|5|||
23303090|NCT03970837|64850975|FG008|Overall Study|Adverse Event|0|||
23303091|NCT03970837|64850976|FG009|Overall Study|Adverse Event|0|||
23303092|NCT03970837|64850977|FG010|Overall Study|Adverse Event|1|||
23303093|NCT03970837|64850978|FG011|Overall Study|Adverse Event|1|||
23303094|NCT03970837|64850967|FG000|Overall Study|Lack of Efficacy|14|||
23303095|NCT03970837|64850968|FG001|Overall Study|Lack of Efficacy|12|||
23303096|NCT03970837|64850969|FG002|Overall Study|Lack of Efficacy|1|||
23303097|NCT03970837|64850970|FG003|Overall Study|Lack of Efficacy|2|||
23303098|NCT03970837|64850971|FG004|Overall Study|Lack of Efficacy|3|||
23303099|NCT03970837|64850972|FG005|Overall Study|Lack of Efficacy|4|||
23303100|NCT03970837|64850973|FG006|Overall Study|Lack of Efficacy|6|||
23505170|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505171|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505172|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23303101|NCT03970837|64850974|FG007|Overall Study|Lack of Efficacy|1|||
23303102|NCT03970837|64850975|FG008|Overall Study|Lack of Efficacy|1|||
23303103|NCT03970837|64850976|FG009|Overall Study|Lack of Efficacy|0|||
23303104|NCT03970837|64850977|FG010|Overall Study|Lack of Efficacy|0|||
23303105|NCT03970837|64850978|FG011|Overall Study|Lack of Efficacy|0|||
23303106|NCT03970837|64850967|FG000|Overall Study|Lost to Follow-up|6|||
23303107|NCT03970837|64850968|FG001|Overall Study|Lost to Follow-up|5|||
23303108|NCT03970837|64850969|FG002|Overall Study|Lost to Follow-up|5|||
23303109|NCT03970837|64850970|FG003|Overall Study|Lost to Follow-up|1|||
23505173|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505174|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505175|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505176|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505177|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505178|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23303110|NCT03970837|64850971|FG004|Overall Study|Lost to Follow-up|0|||
23303111|NCT03970837|64850972|FG005|Overall Study|Lost to Follow-up|2|||
23303112|NCT03970837|64850973|FG006|Overall Study|Lost to Follow-up|0|||
23303113|NCT03970837|64850974|FG007|Overall Study|Lost to Follow-up|0|||
23303114|NCT03970837|64850975|FG008|Overall Study|Lost to Follow-up|0|||
23505179|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23505180|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
23303115|NCT03970837|64850976|FG009|Overall Study|Lost to Follow-up|0|||
23303116|NCT03970837|64850977|FG010|Overall Study|Lost to Follow-up|0|||
23303117|NCT03970837|64850978|FG011|Overall Study|Lost to Follow-up|0|||
23303118|NCT03970837|64850967|FG000|Overall Study|Protocol Violation|1|||
23303119|NCT03970837|64850968|FG001|Overall Study|Protocol Violation|0|||
23303120|NCT03970837|64850969|FG002|Overall Study|Protocol Violation|0|||
23303121|NCT03970837|64850970|FG003|Overall Study|Protocol Violation|0|||
23505181|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
23505182|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
23505183|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505184|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505185|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505186|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505187|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505188|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505189|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23303122|NCT03970837|64850971|FG004|Overall Study|Protocol Violation|0|||
23303123|NCT03970837|64850972|FG005|Overall Study|Protocol Violation|0|||
23303124|NCT03970837|64850973|FG006|Overall Study|Protocol Violation|0|||
23303125|NCT03970837|64850974|FG007|Overall Study|Protocol Violation|0|||
23303126|NCT03970837|64850975|FG008|Overall Study|Protocol Violation|0|||
23303127|NCT03970837|64850976|FG009|Overall Study|Protocol Violation|0|||
23303128|NCT03970837|64850977|FG010|Overall Study|Protocol Violation|0|||
23303129|NCT03970837|64850978|FG011|Overall Study|Protocol Violation|0|||
23303130|NCT03970837|64850967|FG000|Overall Study|Physician Decision|5|||
23303131|NCT03970837|64850968|FG001|Overall Study|Physician Decision|8|||
23303132|NCT03970837|64850969|FG002|Overall Study|Physician Decision|4|||
23303133|NCT03970837|64850970|FG003|Overall Study|Physician Decision|1|||
23303134|NCT03970837|64850971|FG004|Overall Study|Physician Decision|5|||
23303135|NCT03970837|64850972|FG005|Overall Study|Physician Decision|2|||
23303136|NCT03970837|64850973|FG006|Overall Study|Physician Decision|4|||
23303137|NCT03970837|64850974|FG007|Overall Study|Physician Decision|5|||
23303138|NCT03970837|64850975|FG008|Overall Study|Physician Decision|0|||
23303139|NCT03970837|64850976|FG009|Overall Study|Physician Decision|1|||
23303140|NCT03970837|64850977|FG010|Overall Study|Physician Decision|0|||
23303141|NCT03970837|64850978|FG011|Overall Study|Physician Decision|0|||
23303142|NCT03970837|64850967|FG000|Overall Study|Withdrawal by Subject|32|||
23303143|NCT03970837|64850968|FG001|Overall Study|Withdrawal by Subject|35|||
23303144|NCT03970837|64850969|FG002|Overall Study|Withdrawal by Subject|12|||
23303145|NCT03970837|64850970|FG003|Overall Study|Withdrawal by Subject|8|||
23303146|NCT03970837|64850971|FG004|Overall Study|Withdrawal by Subject|6|||
23303147|NCT03970837|64850972|FG005|Overall Study|Withdrawal by Subject|8|||
23505190|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505191|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505192|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23303148|NCT03970837|64850973|FG006|Overall Study|Withdrawal by Subject|2|||
23505193|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505194|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505195|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505196|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23204394|NCT00910429|64491036|FG000|Overall Study|Adverse Event|10|||
23303149|NCT03970837|64850974|FG007|Overall Study|Withdrawal by Subject|3|||
23303150|NCT03970837|64850975|FG008|Overall Study|Withdrawal by Subject|0|||
23303151|NCT03970837|64850976|FG009|Overall Study|Withdrawal by Subject|0|||
23303152|NCT03970837|64850977|FG010|Overall Study|Withdrawal by Subject|0|||
23303153|NCT03970837|64850978|FG011|Overall Study|Withdrawal by Subject|1|||
23303154|NCT03970837|64850967|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
23303155|NCT03970837|64850968|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
23303156|NCT03970837|64850969|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
23303157|NCT03970837|64850970|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23505197|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505198|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505199|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505200|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505201|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505202|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505203|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505204|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23303158|NCT03970837|64850971|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
23303159|NCT03970837|64850972|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23303160|NCT03970837|64850973|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23303161|NCT03970837|64850974|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23303162|NCT03970837|64850975|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23303163|NCT03970837|64850976|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23303164|NCT03970837|64850977|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23303165|NCT03970837|64850978|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23303166|NCT03970837|64850967|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23303167|NCT03970837|64850968|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23303168|NCT03970837|64850969|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23303169|NCT03970837|64850970|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23303170|NCT03970837|64850971|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23303171|NCT03970837|64850972|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23303172|NCT03970837|64850973|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
23303173|NCT03970837|64850974|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
23303174|NCT03970837|64850975|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
23303175|NCT03970837|64850976|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
23303176|NCT03970837|64850977|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
23303177|NCT03970837|64850978|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
23303178|NCT00761865|64854580|FG000|Overall Study|Lost to Follow-up|8|||
23303179|NCT00761865|64854581|FG001|Overall Study|Lost to Follow-up|7|||
23303180|NCT02823652|64854589|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
23303181|NCT02823652|64854590|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
23303182|NCT02823652|64854591|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
23303183|NCT02823652|64854589|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
23303184|NCT02823652|64854590|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
23303185|NCT02823652|64854591|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
23303186|NCT02823652|64854589|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
23303187|NCT02823652|64854590|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
23303188|NCT02823652|64854591|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
23303189|NCT02823652|64854589|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
23303190|NCT02823652|64854590|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
23303191|NCT02823652|64854591|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
23303192|NCT01570283|64854592|FG000|Cohort 1: Dose Level 1|Death|0|||
23303193|NCT01570283|64854593|FG001|Cohort 1: Dose Level 1|Death|1|||
23303194|NCT01570283|64854594|FG002|Cohort 1: Dose Level 1|Death|0|||
23303195|NCT01570283|64854595|FG003|Cohort 1: Dose Level 1|Death|0|||
23303196|NCT01570283|64854596|FG004|Cohort 1: Dose Level 1|Death|0|||
23303197|NCT01570283|64854597|FG005|Cohort 1: Dose Level 1|Death|0|||
23303198|NCT01570283|64854592|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23303199|NCT01570283|64854593|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
23303200|NCT01570283|64854594|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23303201|NCT01570283|64854595|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23303202|NCT01570283|64854596|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23303203|NCT01570283|64854597|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
23303204|NCT01570283|64854592|FG000|Cohort 2: Dose Level 2|Death|0|||
23303205|NCT01570283|64854593|FG001|Cohort 2: Dose Level 2|Death|0|||
23303206|NCT01570283|64854594|FG002|Cohort 2: Dose Level 2|Death|1|||
23303207|NCT01570283|64854595|FG003|Cohort 2: Dose Level 2|Death|0|||
23303208|NCT01570283|64854596|FG004|Cohort 2: Dose Level 2|Death|0|||
23303209|NCT01570283|64854597|FG005|Cohort 2: Dose Level 2|Death|0|||
23303210|NCT01570283|64854592|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23303211|NCT01570283|64854593|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23303212|NCT01570283|64854594|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23303213|NCT01570283|64854595|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
23303214|NCT01570283|64854596|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23303215|NCT01570283|64854597|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
23303216|NCT01570283|64854592|FG000|Cohort 3: Dose Level 3|Death|0|||
23303217|NCT01570283|64854593|FG001|Cohort 3: Dose Level 3|Death|0|||
23303218|NCT01570283|64854594|FG002|Cohort 3: Dose Level 3|Death|0|||
23303219|NCT01570283|64854595|FG003|Cohort 3: Dose Level 3|Death|0|||
23204395|NCT00910429|64491037|FG001|Overall Study|Adverse Event|5|||
23303220|NCT01570283|64854596|FG004|Cohort 3: Dose Level 3|Death|0|||
23303221|NCT01570283|64854597|FG005|Cohort 3: Dose Level 3|Death|1|||
23303222|NCT01570283|64854592|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23303223|NCT01570283|64854593|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23303224|NCT01570283|64854594|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23303225|NCT01570283|64854595|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23303226|NCT01570283|64854596|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
23303227|NCT01570283|64854597|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
23303228|NCT01181271|64854598|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
23303229|NCT01181271|64854598|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
23303230|NCT01181271|64854598|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
23303231|NCT01181271|64854598|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
23303232|NCT01765582|64854599|FG000|Overall Study|Other|3|||
23303233|NCT01765582|64854600|FG001|Overall Study|Other|6|||
23303234|NCT01765582|64854601|FG002|Overall Study|Other|9|||
23303235|NCT01765582|64854599|FG000|Overall Study|Lost to Follow-up|2|||
23303236|NCT01765582|64854600|FG001|Overall Study|Lost to Follow-up|2|||
23303237|NCT01765582|64854601|FG002|Overall Study|Lost to Follow-up|1|||
23303238|NCT01765582|64854599|FG000|Overall Study|Death|31|||
23303239|NCT01765582|64854600|FG001|Overall Study|Death|36|||
23303240|NCT01765582|64854601|FG002|Overall Study|Death|33|||
23303241|NCT01765582|64854599|FG000|Overall Study|Sponsor Decision|46|||
23303242|NCT01765582|64854600|FG001|Overall Study|Sponsor Decision|42|||
23303243|NCT01765582|64854601|FG002|Overall Study|Sponsor Decision|42|||
23303244|NCT01765582|64854599|FG000|Overall Study|Withdrawal of Consent|11|||
23303245|NCT01765582|64854600|FG001|Overall Study|Withdrawal of Consent|6|||
23303246|NCT01765582|64854601|FG002|Overall Study|Withdrawal of Consent|10|||
23303247|NCT00629265|64854606|FG000|Overall Study|Lost to Follow-up|4|||
23303248|NCT00629265|64854607|FG001|Overall Study|Lost to Follow-up|5|||
23303249|NCT00629265|64854606|FG000|Overall Study|Withdrawal by Subject|11|||
23303250|NCT00629265|64854607|FG001|Overall Study|Withdrawal by Subject|8|||
23303251|NCT00629265|64854606|FG000|Overall Study|Death|1|||
23303252|NCT00629265|64854607|FG001|Overall Study|Death|0|||
23303253|NCT00629265|64854606|FG000|Overall Study|Adverse Event|2|||
23303254|NCT00629265|64854607|FG001|Overall Study|Adverse Event|0|||
23303255|NCT00629265|64854606|FG000|Overall Study|HNC Recurrence|4|||
23303256|NCT00629265|64854607|FG001|Overall Study|HNC Recurrence|0|||
23303257|NCT00629265|64854606|FG000|Overall Study|Other CA Requiring Treatment|1|||
23303258|NCT00629265|64854607|FG001|Overall Study|Other CA Requiring Treatment|3|||
23303259|NCT00629265|64854606|FG000|Overall Study|Needed Esophageal Dilation|4|||
23303260|NCT00629265|64854607|FG001|Overall Study|Needed Esophageal Dilation|1|||
23303261|NCT00629265|64854606|FG000|Overall Study|Unrelated Medical Complications|3|||
23303262|NCT00629265|64854607|FG001|Overall Study|Unrelated Medical Complications|1|||
23303263|NCT00629265|64854606|FG000|Overall Study|Unknown Reason|2|||
23303264|NCT00629265|64854607|FG001|Overall Study|Unknown Reason|2|||
23303265|NCT00321737|64854608|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
23303266|NCT00321737|64854609|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
23303267|NCT00321737|64854610|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
23403914|NCT00833027|65226438|FG000|Overall Study|Withdrawal by Subject|16|||
23403915|NCT00833027|65226438|FG000|Overall Study|Missing|10|||
23403916|NCT02146131|65226439|FG000|Overall Study|Physician Decision|61|||
23403917|NCT02146131|65226440|FG001|Overall Study|Physician Decision|56|||
23403918|NCT01964378|65226441|FG000|Overall Study|Disc. due to death before first dosing|0|||
23403919|NCT01964378|65226442|FG001|Overall Study|Disc. due to death before first dosing|1|||
23403920|NCT01964378|65226441|FG000|Overall Study|Disc. due to AE before first dosing|1|||
23403921|NCT01964378|65226442|FG001|Overall Study|Disc. due to AE before first dosing|0|||
23403922|NCT01964378|65226441|FG000|Overall Study|Death|3|||
23403923|NCT01964378|65226442|FG001|Overall Study|Death|2|||
23403924|NCT01964378|65226441|FG000|Overall Study|Adverse Event|12|||
23403925|NCT01964378|65226442|FG001|Overall Study|Adverse Event|5|||
23403926|NCT01964378|65226441|FG000|Overall Study|Lack of Efficacy|0|||
23403927|NCT01964378|65226442|FG001|Overall Study|Lack of Efficacy|1|||
23403928|NCT01964378|65226441|FG000|Overall Study|Protocol Violation|0|||
23403929|NCT01964378|65226442|FG001|Overall Study|Protocol Violation|1|||
23403930|NCT01964378|65226441|FG000|Overall Study|Lost to Follow-up|0|||
23403931|NCT01964378|65226442|FG001|Overall Study|Lost to Follow-up|1|||
23403932|NCT01964378|65226441|FG000|Overall Study|Withdrawal by Subject|7|||
23403933|NCT01964378|65226442|FG001|Overall Study|Withdrawal by Subject|5|||
23403934|NCT01964378|65226441|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
23403935|NCT01964378|65226442|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
23403936|NCT01964378|65226441|FG000|Overall Study|Other|1|||
23403937|NCT01964378|65226442|FG001|Overall Study|Other|2|||
23403938|NCT02903823|65226450|FG000|Overall Study|Physician Decision|5|||
23403939|NCT02903823|65226450|FG000|Overall Study|Could not advance catheter|1|||
23403940|NCT02903823|65226450|FG000|Overall Study|Catheter dislodgement|1|||
23303268|NCT00321737|64854608|FG000|Overall Study|Adverse Event|11|||
23403941|NCT01023217|65226451|FG000|Overall Study|Withdrawal by Subject|1|||
23403942|NCT01023217|65226452|FG001|Overall Study|Withdrawal by Subject|0|||
23403943|NCT00503425|65226455|FG000|Overall Study|Participant files lost|6|||
23403944|NCT00503425|65226455|FG000|Overall Study|Adverse Event|5|||
23403945|NCT00503425|65226455|FG000|Overall Study|Lack of Efficacy|25|||
23403946|NCT00503425|65226455|FG000|Overall Study|Withdrawal by Subject|8|||
23403947|NCT00503425|65226455|FG000|Overall Study|Lost to Follow-up|3|||
23403948|NCT00503425|65226455|FG000|Overall Study|Death|3|||
23403949|NCT00503425|65226455|FG000|Overall Study|Missing Data/Unknown|4|||
23403950|NCT02931838|65226464|FG000|Overall Study|Reason not provided by investigator|1|||
23403951|NCT02931838|65226465|FG001|Overall Study|Reason not provided by investigator|0|||
23403952|NCT02931838|65226466|FG002|Overall Study|Reason not provided by investigator|1|||
23403953|NCT02931838|65226467|FG003|Overall Study|Reason not provided by investigator|0|||
23403954|NCT02931838|65226468|FG004|Overall Study|Reason not provided by investigator|0|||
23403955|NCT02931838|65226469|FG005|Overall Study|Reason not provided by investigator|0|||
23505205|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
23505206|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
23505207|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
23505208|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
23505209|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505210|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23403956|NCT02931838|65226464|FG000|Overall Study|Poor/non-compliance|0|||
23403957|NCT02931838|65226465|FG001|Overall Study|Poor/non-compliance|0|||
23403958|NCT02931838|65226466|FG002|Overall Study|Poor/non-compliance|1|||
23403959|NCT02931838|65226467|FG003|Overall Study|Poor/non-compliance|0|||
23403960|NCT02931838|65226468|FG004|Overall Study|Poor/non-compliance|0|||
23403961|NCT02931838|65226469|FG005|Overall Study|Poor/non-compliance|0|||
23403962|NCT02931838|65226464|FG000|Overall Study|Lack of Efficacy|5|||
23403963|NCT02931838|65226465|FG001|Overall Study|Lack of Efficacy|4|||
23403964|NCT02931838|65226466|FG002|Overall Study|Lack of Efficacy|0|||
23403965|NCT02931838|65226467|FG003|Overall Study|Lack of Efficacy|0|||
23403966|NCT02931838|65226468|FG004|Overall Study|Lack of Efficacy|0|||
23403967|NCT02931838|65226469|FG005|Overall Study|Lack of Efficacy|1|||
23403968|NCT02931838|65226464|FG000|Overall Study|Lost to Follow-up|1|||
23403969|NCT02931838|65226465|FG001|Overall Study|Lost to Follow-up|0|||
23403970|NCT02931838|65226466|FG002|Overall Study|Lost to Follow-up|1|||
23403971|NCT02931838|65226467|FG003|Overall Study|Lost to Follow-up|1|||
23303269|NCT00321737|64854609|FG001|Overall Study|Adverse Event|3|||
23303270|NCT00321737|64854610|FG002|Overall Study|Adverse Event|6|||
23303271|NCT00321737|64854608|FG000|Overall Study|Lost to Follow-up|5|||
23303272|NCT00321737|64854609|FG001|Overall Study|Lost to Follow-up|5|||
23303273|NCT00321737|64854610|FG002|Overall Study|Lost to Follow-up|6|||
23303274|NCT00321737|64854608|FG000|Overall Study|Withdrawal by Subject|19|||
23303275|NCT00321737|64854609|FG001|Overall Study|Withdrawal by Subject|12|||
23303276|NCT00321737|64854610|FG002|Overall Study|Withdrawal by Subject|17|||
23403972|NCT02931838|65226468|FG004|Overall Study|Lost to Follow-up|2|||
23403973|NCT02931838|65226469|FG005|Overall Study|Lost to Follow-up|0|||
23403974|NCT02931838|65226464|FG000|Overall Study|Subject request to discontinue treatment|4|||
23403975|NCT02931838|65226465|FG001|Overall Study|Subject request to discontinue treatment|3|||
23403976|NCT02931838|65226466|FG002|Overall Study|Subject request to discontinue treatment|3|||
23403977|NCT02931838|65226467|FG003|Overall Study|Subject request to discontinue treatment|0|||
23403978|NCT02931838|65226468|FG004|Overall Study|Subject request to discontinue treatment|1|||
23403979|NCT02931838|65226469|FG005|Overall Study|Subject request to discontinue treatment|0|||
23403980|NCT02931838|65226464|FG000|Overall Study|Withdrawal by Subject|1|||
23403981|NCT02931838|65226465|FG001|Overall Study|Withdrawal by Subject|2|||
23403982|NCT02931838|65226466|FG002|Overall Study|Withdrawal by Subject|0|||
23403983|NCT02931838|65226467|FG003|Overall Study|Withdrawal by Subject|1|||
23403984|NCT02931838|65226468|FG004|Overall Study|Withdrawal by Subject|0|||
23403985|NCT02931838|65226469|FG005|Overall Study|Withdrawal by Subject|0|||
23303277|NCT00321737|64854608|FG000|Overall Study|Protocol Violation|0|||
23303278|NCT00321737|64854609|FG001|Overall Study|Protocol Violation|0|||
23303279|NCT00321737|64854610|FG002|Overall Study|Protocol Violation|1|||
23303280|NCT00321737|64854608|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
23403986|NCT02931838|65226464|FG000|Overall Study|Adverse Event|2|||
23403987|NCT02931838|65226465|FG001|Overall Study|Adverse Event|1|||
23403988|NCT02931838|65226466|FG002|Overall Study|Adverse Event|2|||
23403989|NCT02931838|65226467|FG003|Overall Study|Adverse Event|1|||
23403990|NCT02931838|65226468|FG004|Overall Study|Adverse Event|3|||
23403991|NCT02931838|65226469|FG005|Overall Study|Adverse Event|1|||
23403992|NCT02949011|65226472|FG000|Overall Study|Adverse Event|6|||
23403993|NCT02949011|65226473|FG001|Overall Study|Adverse Event|7|||
23403994|NCT02949011|65226474|FG002|Overall Study|Adverse Event|3|||
23403995|NCT02949011|65226472|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
23403996|NCT02949011|65226473|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
23403997|NCT02949011|65226474|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
23403998|NCT02949011|65226472|FG000|Overall Study|Protocol Deviation|5|||
23403999|NCT02949011|65226473|FG001|Overall Study|Protocol Deviation|3|||
23404000|NCT02949011|65226474|FG002|Overall Study|Protocol Deviation|3|||
23404001|NCT02949011|65226472|FG000|Overall Study|Lack of Efficacy|0|||
23404002|NCT02949011|65226473|FG001|Overall Study|Lack of Efficacy|2|||
23404003|NCT02949011|65226474|FG002|Overall Study|Lack of Efficacy|0|||
23404004|NCT02949011|65226472|FG000|Overall Study|Withdrawal by Subject|13|||
23404005|NCT02949011|65226473|FG001|Overall Study|Withdrawal by Subject|13|||
23404006|NCT02949011|65226474|FG002|Overall Study|Withdrawal by Subject|21|||
23404007|NCT02949011|65226472|FG000|Overall Study|Lost to Follow-up|7|||
23404008|NCT02949011|65226473|FG001|Overall Study|Lost to Follow-up|5|||
23404009|NCT02949011|65226474|FG002|Overall Study|Lost to Follow-up|5|||
23404010|NCT02949011|65226472|FG000|Overall Study|Death|0|||
23404011|NCT02949011|65226473|FG001|Overall Study|Death|0|||
23404012|NCT02949011|65226474|FG002|Overall Study|Death|1|||
23404013|NCT02949011|65226472|FG000|Overall Study|Miscellaneous|2|||
23404014|NCT02949011|65226473|FG001|Overall Study|Miscellaneous|4|||
23404015|NCT02949011|65226474|FG002|Overall Study|Miscellaneous|6|||
23404016|NCT00912782|65226479|FG000|Overall Study|Death|2|||
23404017|NCT00912782|65226480|FG001|Overall Study|Death|1|||
23404018|NCT00912782|65226479|FG000|Overall Study|Lost to Follow-up|0|||
23404019|NCT00912782|65226480|FG001|Overall Study|Lost to Follow-up|1|||
23303281|NCT00321737|64854609|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
23303282|NCT00321737|64854610|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
23303283|NCT00321737|64854608|FG000|Overall Study|Possible Barrett's Esophagus|2|||
23303284|NCT00321737|64854609|FG001|Overall Study|Possible Barrett's Esophagus|1|||
23303285|NCT00321737|64854610|FG002|Overall Study|Possible Barrett's Esophagus|1|||
23303286|NCT00321737|64854608|FG000|Overall Study|Therapeutic Failure|6|||
23303287|NCT00321737|64854609|FG001|Overall Study|Therapeutic Failure|0|||
23303288|NCT00321737|64854610|FG002|Overall Study|Therapeutic Failure|2|||
23303289|NCT00321737|64854608|FG000|Overall Study|Pregnancy|0|||
23303290|NCT00321737|64854609|FG001|Overall Study|Pregnancy|2|||
23303291|NCT00321737|64854610|FG002|Overall Study|Pregnancy|0|||
23303292|NCT00321737|64854608|FG000|Overall Study|Noncompliance|2|||
23303293|NCT00321737|64854609|FG001|Overall Study|Noncompliance|0|||
23303294|NCT00321737|64854610|FG002|Overall Study|Noncompliance|0|||
23303295|NCT00321737|64854608|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
23303296|NCT00321737|64854609|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
23303297|NCT00321737|64854610|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
23303298|NCT00468728|64854613|FG000|Treatment|criteria for mITT population|4|||
23303299|NCT00468728|64854614|FG001|Treatment|criteria for mITT population|11|||
23303300|NCT00468728|64854613|FG000|Follow-up|mITT failure|34|||
23303301|NCT00468728|64854614|FG001|Follow-up|mITT failure|31|||
23303302|NCT05065983|64854617|FG000|Overall Study|Lost to Follow-up|2|||
23303303|NCT01007942|64854623|FG000|Overall Study|Adverse Event|29|||
23303304|NCT01007942|64854624|FG001|Overall Study|Adverse Event|14|||
23303305|NCT01007942|64854623|FG000|Overall Study|Abnormal test procedure|0|||
23303306|NCT01007942|64854624|FG001|Overall Study|Abnormal test procedure|1|||
23303307|NCT01007942|64854623|FG000|Overall Study|Disease progression|217|||
23303308|NCT01007942|64854624|FG001|Overall Study|Disease progression|242|||
23303309|NCT01007942|64854623|FG000|Overall Study|New cancer therapy|5|||
23303310|NCT01007942|64854624|FG001|Overall Study|New cancer therapy|1|||
23303311|NCT01007942|64854623|FG000|Overall Study|Protocol Violation|1|||
23303312|NCT01007942|64854624|FG001|Overall Study|Protocol Violation|1|||
23303313|NCT01007942|64854623|FG000|Overall Study|Withdrawal by Subject|19|||
23404020|NCT00912782|65226479|FG000|Overall Study|Did not receive vascular access type|1|||
23404021|NCT00912782|65226480|FG001|Overall Study|Did not receive vascular access type|2|||
23404022|NCT00912782|65226479|FG000|Overall Study|Relocated before study completion|0|||
23404023|NCT00912782|65226480|FG001|Overall Study|Relocated before study completion|1|||
23404024|NCT02765399|65226481|FG000|Overall Study|Nausea|1|||
23404025|NCT02765399|65226482|FG001|Overall Study|Nausea|0|||
23404026|NCT03257358|65226483|FG000|Overall Study|Adverse Event|25|||
23404027|NCT03257358|65226484|FG001|Overall Study|Adverse Event|12|||
23404028|NCT03257358|65226483|FG000|Overall Study|Lack of Efficacy|1|||
23404029|NCT03257358|65226484|FG001|Overall Study|Lack of Efficacy|1|||
23404030|NCT03257358|65226483|FG000|Overall Study|Lost to Follow-up|12|||
23404031|NCT03257358|65226484|FG001|Overall Study|Lost to Follow-up|4|||
23404032|NCT03257358|65226483|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
23404033|NCT03257358|65226484|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
23404034|NCT03257358|65226483|FG000|Overall Study|Physician Decision|2|||
23404035|NCT03257358|65226484|FG001|Overall Study|Physician Decision|2|||
23404036|NCT03257358|65226483|FG000|Overall Study|Protocol Violation|5|||
23404037|NCT03257358|65226484|FG001|Overall Study|Protocol Violation|3|||
23404038|NCT03257358|65226483|FG000|Overall Study|Technical problems|4|||
23404039|NCT03257358|65226484|FG001|Overall Study|Technical problems|1|||
23303314|NCT01007942|64854624|FG001|Overall Study|Withdrawal by Subject|14|||
23303315|NCT01007942|64854623|FG000|Overall Study|Lost to Follow-up|1|||
23303316|NCT01007942|64854624|FG001|Overall Study|Lost to Follow-up|0|||
23404040|NCT03257358|65226483|FG000|Overall Study|Withdrawal by Subject|8|||
23404041|NCT03257358|65226484|FG001|Overall Study|Withdrawal by Subject|3|||
23404042|NCT03257358|65226483|FG000|Overall Study|Withdrawal of informed consent|9|||
23404043|NCT03257358|65226484|FG001|Overall Study|Withdrawal of informed consent|5|||
23404044|NCT03257358|65226483|FG000|Overall Study|New therapy for study indication|1|||
23404045|NCT03257358|65226484|FG001|Overall Study|New therapy for study indication|0|||
23404046|NCT03257358|65226483|FG000|Overall Study|No longer requires treatment|0|||
23404047|NCT03257358|65226484|FG001|Overall Study|No longer requires treatment|1|||
23404048|NCT00506779|65226485|FG000|Overall Study|Withdrawal by Subject|1|||
23303317|NCT01007942|64854623|FG000|Overall Study|Administrative problems|2|||
23303318|NCT01007942|64854624|FG001|Overall Study|Administrative problems|0|||
23303319|NCT01007942|64854623|FG000|Overall Study|Death|3|||
23303320|NCT01007942|64854624|FG001|Overall Study|Death|2|||
23303321|NCT01007942|64854623|FG000|Overall Study|Patients untreated|4|||
23303322|NCT01007942|64854624|FG001|Overall Study|Patients untreated|3|||
23303323|NCT00838435|64854625|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
23303324|NCT00838435|64854625|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
23303325|NCT00838435|64854625|FG000|Part 2 (7 Years)|Adverse Event|2|||
23303326|NCT00838435|64854625|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
23303327|NCT00838435|64854625|FG000|Part 2 (7 Years)|Physician Decision|1|||
23303328|NCT00838435|64854625|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
23303329|NCT00838435|64854625|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
23303330|NCT01691820|64854626|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
23303331|NCT01691820|64854627|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
23303332|NCT01691820|64854626|FG000|Overall Study|Migrated/moved from study area|7|||
23303333|NCT01691820|64854627|FG001|Overall Study|Migrated/moved from study area|4|||
23303334|NCT01691820|64854626|FG000|Overall Study|Lost to Follow-up|6|||
23303335|NCT01691820|64854627|FG001|Overall Study|Lost to Follow-up|17|||
23303336|NCT01691820|64854626|FG000|Overall Study|Other (unspecified)|4|||
23303337|NCT01691820|64854627|FG001|Overall Study|Other (unspecified)|1|||
23303338|NCT02751359|64854632|FG000|Overall Study|Lost to Follow-up|1|||
23303339|NCT03118570|64854633|FG000|Overall Study|Adverse Event|2|||
23303340|NCT03118570|64854634|FG001|Overall Study|Adverse Event|0|||
23303341|NCT03118570|64854635|FG002|Overall Study|Adverse Event|0|||
23303342|NCT03118570|64854636|FG003|Overall Study|Adverse Event|0|||
23303343|NCT03118570|64854637|FG004|Overall Study|Adverse Event|3|||
23505211|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505212|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505213|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505214|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505215|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505216|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505217|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505218|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23404049|NCT00506779|65226486|FG001|Overall Study|Withdrawal by Subject|0|||
23404050|NCT00506779|65226487|FG002|Overall Study|Withdrawal by Subject|1|||
23404051|NCT00506779|65226488|FG003|Overall Study|Withdrawal by Subject|0|||
23404052|NCT00506779|65226485|FG000|Overall Study|Adverse Event|0|||
23404053|NCT00506779|65226486|FG001|Overall Study|Adverse Event|1|||
23404054|NCT00506779|65226487|FG002|Overall Study|Adverse Event|1|||
23404055|NCT00506779|65226488|FG003|Overall Study|Adverse Event|1|||
23404056|NCT03465722|65226489|FG000|Overall Study|Withdrawal by Subject|21|||
23404057|NCT03465722|65226490|FG001|Overall Study|Withdrawal by Subject|14|||
23404058|NCT03465722|65226489|FG000|Overall Study|Death|89|||
23404059|NCT03465722|65226490|FG001|Overall Study|Death|87|||
23404060|NCT03465722|65226489|FG000|Overall Study|Lost to Follow-up|5|||
23404061|NCT03465722|65226490|FG001|Overall Study|Lost to Follow-up|3|||
23404062|NCT03465722|65226489|FG000|Overall Study|Administrative/Other|33|||
23404063|NCT03465722|65226490|FG001|Overall Study|Administrative/Other|32|||
23404064|NCT03465722|65226489|FG000|Overall Study|Not treated|1|||
23404065|NCT03465722|65226490|FG001|Overall Study|Not treated|2|||
23404066|NCT03465722|65226489|FG000|Overall Study|Sponsor decision|91|||
23505219|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505220|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23404067|NCT03465722|65226490|FG001|Overall Study|Sponsor decision|98|||
23404068|NCT00539240|65226492|FG000|Overall Study|Withdrawal by Subject|0|||
23404069|NCT00539240|65226493|FG001|Overall Study|Withdrawal by Subject|2|||
23404070|NCT00539240|65226494|FG002|Overall Study|Withdrawal by Subject|0|||
23404071|NCT00539240|65226492|FG000|Overall Study|Protocol Violation|1|||
23404072|NCT00539240|65226493|FG001|Overall Study|Protocol Violation|1|||
23404073|NCT00539240|65226494|FG002|Overall Study|Protocol Violation|4|||
23404074|NCT00539240|65226492|FG000|Overall Study|Lost to Follow-up|2|||
23404075|NCT00539240|65226493|FG001|Overall Study|Lost to Follow-up|3|||
23404076|NCT00539240|65226494|FG002|Overall Study|Lost to Follow-up|1|||
23404077|NCT00539240|65226492|FG000|Overall Study|Adverse Event|3|||
23404078|NCT00539240|65226493|FG001|Overall Study|Adverse Event|1|||
23404079|NCT00539240|65226494|FG002|Overall Study|Adverse Event|10|||
23404080|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Physician Decision|2|||
23404081|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Physician Decision|0|||
23404082|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Physician Decision|0|||
23404083|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Adverse Event|33|||
23404084|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Adverse Event|0|||
23404085|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Adverse Event|0|||
23404086|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
23404087|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
23404088|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
23404089|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
23404090|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
23404091|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
23404092|NCT01008618|65226495|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
23404093|NCT01008618|65226496|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
23505221|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505222|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505223|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505224|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505225|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505226|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505227|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505228|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505229|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505230|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505231|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505232|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23505233|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
23505234|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
23404094|NCT01008618|65226497|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
23404095|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
23404096|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
23404097|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
23505235|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505236|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505237|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505238|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505239|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505240|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505241|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505242|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505243|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23404098|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
23404099|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
23404100|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
23404101|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
23404102|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
23505244|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505245|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505246|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505247|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505248|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505249|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505250|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505251|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505252|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505253|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505254|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23404103|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
23404104|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
23404105|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
23404106|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
23404107|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
23404108|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
23404109|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
23404110|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
23404111|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
23404112|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
23404113|NCT01008618|65226495|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
23404114|NCT01008618|65226496|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
23404115|NCT01008618|65226497|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
23404116|NCT01466491|65226500|FG000|Overall Study|Protocol Violation|0|||
23404117|NCT01466491|65226501|FG001|Overall Study|Protocol Violation|3|||
23404118|NCT01466491|65226502|FG002|Overall Study|Protocol Violation|2|||
23404119|NCT01466491|65226503|FG003|Overall Study|Protocol Violation|0|||
23404120|NCT01466491|65226500|FG000|Overall Study|Missing Data|0|||
23404121|NCT01466491|65226501|FG001|Overall Study|Missing Data|0|||
23404122|NCT01466491|65226502|FG002|Overall Study|Missing Data|1|||
23404123|NCT01466491|65226503|FG003|Overall Study|Missing Data|0|||
23404124|NCT00803361|65226504|FG000|Overall Study|Adverse Event|13|||
23404125|NCT00803361|65226505|FG001|Overall Study|Adverse Event|3|||
23404126|NCT00803361|65226504|FG000|Overall Study|Lack of Efficacy|4|||
23404127|NCT00803361|65226505|FG001|Overall Study|Lack of Efficacy|13|||
23404128|NCT00803361|65226504|FG000|Overall Study|Lost to Follow-up|1|||
23404129|NCT00803361|65226505|FG001|Overall Study|Lost to Follow-up|2|||
23404130|NCT00803361|65226504|FG000|Overall Study|Physician Decision|1|||
23404131|NCT00803361|65226505|FG001|Overall Study|Physician Decision|0|||
23404132|NCT00803361|65226504|FG000|Overall Study|Protocol Violation|2|||
23404133|NCT00803361|65226505|FG001|Overall Study|Protocol Violation|4|||
23404134|NCT00803361|65226504|FG000|Overall Study|Withdrawal by Subject|5|||
23404135|NCT00803361|65226505|FG001|Overall Study|Withdrawal by Subject|6|||
23404136|NCT02311881|65226506|FG000|Overall Study|Did not meet the study criteria|2|||
23404137|NCT02311881|65226507|FG001|Overall Study|Did not meet the study criteria|2|||
23404138|NCT02311881|65226508|FG002|Overall Study|Did not meet the study criteria|0|||
23404139|NCT02311881|65226506|FG000|Overall Study|Adverse Event|7|||
23404140|NCT02311881|65226507|FG001|Overall Study|Adverse Event|15|||
23404141|NCT02311881|65226508|FG002|Overall Study|Adverse Event|8|||
23404142|NCT02311881|65226506|FG000|Overall Study|Lost to Follow-up|3|||
23404143|NCT02311881|65226507|FG001|Overall Study|Lost to Follow-up|3|||
23505255|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505256|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505257|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505258|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505259|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
23505260|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
23505261|NCT03129100|65587876|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
23204396|NCT00910429|64491036|FG000|Overall Study|Drug non-compliance|1|||
23204397|NCT00910429|64491037|FG001|Overall Study|Drug non-compliance|0|||
23303344|NCT03118570|64854633|FG000|Overall Study|Withdrawal by Subject|0|||
23303345|NCT03118570|64854634|FG001|Overall Study|Withdrawal by Subject|1|||
23303346|NCT03118570|64854635|FG002|Overall Study|Withdrawal by Subject|4|||
23303347|NCT03118570|64854636|FG003|Overall Study|Withdrawal by Subject|0|||
23303348|NCT03118570|64854637|FG004|Overall Study|Withdrawal by Subject|1|||
23303349|NCT03118570|64854633|FG000|Overall Study|Lost to Follow-up|2|||
23303350|NCT03118570|64854634|FG001|Overall Study|Lost to Follow-up|3|||
23303351|NCT03118570|64854635|FG002|Overall Study|Lost to Follow-up|1|||
23303352|NCT03118570|64854636|FG003|Overall Study|Lost to Follow-up|0|||
23303353|NCT03118570|64854637|FG004|Overall Study|Lost to Follow-up|1|||
23303354|NCT03118570|64854633|FG000|Overall Study|Other, Not Specified|1|||
23303355|NCT03118570|64854634|FG001|Overall Study|Other, Not Specified|3|||
23303356|NCT03118570|64854635|FG002|Overall Study|Other, Not Specified|0|||
23303357|NCT03118570|64854636|FG003|Overall Study|Other, Not Specified|0|||
23303358|NCT03118570|64854637|FG004|Overall Study|Other, Not Specified|0|||
23303359|NCT01649271|64854638|FG000|Overall Study|Progressive disease|4|||
23303360|NCT01649271|64854639|FG001|Overall Study|Progressive disease|5|||
23303361|NCT01649271|64854638|FG000|Overall Study|Other Adverse Event|0|||
23303362|NCT01649271|64854639|FG001|Overall Study|Other Adverse Event|2|||
23303363|NCT01649271|64854638|FG000|Overall Study|Withdrawal by Subject|1|||
23303364|NCT01649271|64854639|FG001|Overall Study|Withdrawal by Subject|0|||
23303365|NCT01649271|64854638|FG000|Overall Study|Other than stated above|1|||
23303366|NCT01649271|64854639|FG001|Overall Study|Other than stated above|0|||
23303367|NCT02546362|64854640|FG000|4-week Treatment Period|Lost to Follow-up|1|||
23303368|NCT02546362|64854640|FG000|4-week Treatment Period|Change in medication|2|||
23303369|NCT02546362|64854640|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
23303370|NCT02546362|64854640|FG000|12-week Treatment Period|Lost to Follow-up|2|||
23303371|NCT02546362|64854640|FG000|12-week Treatment Period|Change in medication|1|||
23303372|NCT00541970|64854641|FG000|Month 7|Protocol Violation|9|||
23303373|NCT00541970|64854642|FG001|Month 7|Protocol Violation|13|||
23303374|NCT00541970|64854643|FG002|Month 7|Protocol Violation|11|||
23303375|NCT00541970|64854644|FG003|Month 7|Protocol Violation|5|||
23303376|NCT00541970|64854641|FG000|Month 12|Adverse Event|0|||
23303377|NCT00541970|64854642|FG001|Month 12|Adverse Event|1|||
23303378|NCT00541970|64854643|FG002|Month 12|Adverse Event|1|||
23303379|NCT00541970|64854644|FG003|Month 12|Adverse Event|1|||
23303380|NCT00541970|64854641|FG000|Month 12|Protocol Violation|12|||
23303381|NCT00541970|64854642|FG001|Month 12|Protocol Violation|21|||
23303382|NCT00541970|64854643|FG002|Month 12|Protocol Violation|20|||
23303383|NCT00541970|64854644|FG003|Month 12|Protocol Violation|15|||
23303384|NCT00541970|64854641|FG000|Month 18|Adverse Event|0|||
23303385|NCT00541970|64854642|FG001|Month 18|Adverse Event|1|||
23303386|NCT00541970|64854643|FG002|Month 18|Adverse Event|1|||
23303387|NCT00541970|64854644|FG003|Month 18|Adverse Event|1|||
23303388|NCT00541970|64854641|FG000|Month 18|Protocol Violation|14|||
23303389|NCT00541970|64854642|FG001|Month 18|Protocol Violation|23|||
23303390|NCT00541970|64854643|FG002|Month 18|Protocol Violation|24|||
23303391|NCT00541970|64854644|FG003|Month 18|Protocol Violation|16|||
23303392|NCT00541970|64854641|FG000|Month 24|Adverse Event|0|||
23303393|NCT00541970|64854642|FG001|Month 24|Adverse Event|1|||
23303394|NCT00541970|64854643|FG002|Month 24|Adverse Event|1|||
23303395|NCT00541970|64854644|FG003|Month 24|Adverse Event|1|||
23303396|NCT00541970|64854641|FG000|Month 24|Protocol Violation|29|||
23303397|NCT00541970|64854642|FG001|Month 24|Protocol Violation|31|||
23303398|NCT00541970|64854643|FG002|Month 24|Protocol Violation|31|||
23303399|NCT00541970|64854644|FG003|Month 24|Protocol Violation|21|||
23303400|NCT00541970|64854641|FG000|Month 36|Protocol Violation|61|||
23303401|NCT00541970|64854642|FG001|Month 36|Protocol Violation|66|||
23303402|NCT00541970|64854643|FG002|Month 36|Protocol Violation|66|||
23303403|NCT00541970|64854644|FG003|Month 36|Protocol Violation|60|||
23303404|NCT00541970|64854641|FG000|Month 48|Withdrawal by Subject|2|||
23303405|NCT00541970|64854642|FG001|Month 48|Withdrawal by Subject|4|||
23303406|NCT00541970|64854643|FG002|Month 48|Withdrawal by Subject|4|||
23303407|NCT00541970|64854644|FG003|Month 48|Withdrawal by Subject|2|||
23303408|NCT00541970|64854641|FG000|Month 48|Other|3|||
23303409|NCT00541970|64854642|FG001|Month 48|Other|1|||
23303410|NCT00541970|64854643|FG002|Month 48|Other|1|||
23303411|NCT00541970|64854644|FG003|Month 48|Other|0|||
23303412|NCT00541970|64854641|FG000|Month 48|Lost to Follow-up|66|||
23303413|NCT00541970|64854642|FG001|Month 48|Lost to Follow-up|68|||
23303414|NCT00541970|64854643|FG002|Month 48|Lost to Follow-up|68|||
23303415|NCT00541970|64854644|FG003|Month 48|Lost to Follow-up|73|||
23303416|NCT00541970|64854641|FG000|Month 60|Protocol Violation|78|||
23303417|NCT00541970|64854642|FG001|Month 60|Protocol Violation|77|||
23303418|NCT00541970|64854643|FG002|Month 60|Protocol Violation|82|||
23303419|NCT00541970|64854644|FG003|Month 60|Protocol Violation|72|||
23303420|NCT01117337|64854647|FG000|Overall Study|Lost to Follow-up|4|||
23303421|NCT01117337|64854648|FG001|Overall Study|Lost to Follow-up|0|||
23303422|NCT03923530|64854649|FG000|Overall Study|Withdrawal by Subject|1|||
23303423|NCT03923530|64854649|FG000|Overall Study|screen failure|3|||
23303424|NCT01490866|64854650|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
23303425|NCT01490866|64854650|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
23303426|NCT01490866|64854650|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
23303427|NCT01490866|64854650|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
23303428|NCT01490866|64854650|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
23303429|NCT01490866|64854650|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
23303430|NCT01490866|64854650|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
23303431|NCT01490866|64854650|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
23303432|NCT01490866|64854650|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
23303433|NCT01490866|64854650|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
23303434|NCT01490866|64854650|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
23303435|NCT01936623|64854651|FG000|Overall Study|Lost to Follow-up|0|||
23303436|NCT01936623|64854652|FG001|Overall Study|Lost to Follow-up|5|||
23303437|NCT02667288|64854660|FG000|Overall Study|Protocol Violation|5|||
23404144|NCT02311881|65226508|FG002|Overall Study|Lost to Follow-up|2|||
23404145|NCT02311881|65226506|FG000|Overall Study|Protocol Violation|1|||
23404146|NCT02311881|65226507|FG001|Overall Study|Protocol Violation|2|||
23404147|NCT02311881|65226508|FG002|Overall Study|Protocol Violation|3|||
23404148|NCT02311881|65226506|FG000|Overall Study|Withdrawal of consent|14|||
23404149|NCT02311881|65226507|FG001|Overall Study|Withdrawal of consent|16|||
23404150|NCT02311881|65226508|FG002|Overall Study|Withdrawal of consent|17|||
23404151|NCT02311881|65226506|FG000|Overall Study|Other|0|||
23404152|NCT02311881|65226507|FG001|Overall Study|Other|0|||
23404153|NCT02311881|65226508|FG002|Overall Study|Other|1|||
23404154|NCT02311881|65226506|FG000|Overall Study|Lack of Efficacy|1|||
23404155|NCT02311881|65226507|FG001|Overall Study|Lack of Efficacy|2|||
23404156|NCT02311881|65226508|FG002|Overall Study|Lack of Efficacy|0|||
23404157|NCT02311881|65226506|FG000|Overall Study|Subject has border line pregnancy test|1|||
23404158|NCT02311881|65226507|FG001|Overall Study|Subject has border line pregnancy test|0|||
23303438|NCT02667288|64854660|FG000|Overall Study|Lost to Follow-up|3|||
23303439|NCT02667288|64854660|FG000|Overall Study|Withdrawal by Subject|5|||
23303440|NCT02435836|64854661|FG000|Overall Study|Lost to Follow-up|21|||
23303441|NCT02435836|64854661|FG000|Overall Study|Lack of Efficacy|1|||
23404159|NCT02311881|65226508|FG002|Overall Study|Subject has border line pregnancy test|0|||
23404160|NCT02311881|65226506|FG000|Overall Study|Withdrawal by Subject|3|||
23404161|NCT02311881|65226507|FG001|Overall Study|Withdrawal by Subject|1|||
23404162|NCT02311881|65226508|FG002|Overall Study|Withdrawal by Subject|4|||
23404163|NCT02311881|65226506|FG000|Overall Study|Sponsor Decision|1|||
23404164|NCT02311881|65226507|FG001|Overall Study|Sponsor Decision|1|||
23404165|NCT02311881|65226508|FG002|Overall Study|Sponsor Decision|1|||
23404166|NCT02311881|65226506|FG000|Overall Study|Protocol Deviation|1|||
23404167|NCT02311881|65226507|FG001|Overall Study|Protocol Deviation|0|||
23404168|NCT02311881|65226508|FG002|Overall Study|Protocol Deviation|0|||
23404169|NCT02311881|65226506|FG000|Overall Study|Non-Compliance|1|||
23404170|NCT02311881|65226507|FG001|Overall Study|Non-Compliance|0|||
23404171|NCT02311881|65226508|FG002|Overall Study|Non-Compliance|2|||
23404172|NCT02311881|65226506|FG000|Overall Study|Physician Decision|0|||
23404173|NCT02311881|65226507|FG001|Overall Study|Physician Decision|0|||
23404174|NCT02311881|65226508|FG002|Overall Study|Physician Decision|1|||
23404175|NCT02311881|65226506|FG000|Overall Study|Medical Monitor Discretion|0|||
23404176|NCT02311881|65226507|FG001|Overall Study|Medical Monitor Discretion|0|||
23404177|NCT02311881|65226508|FG002|Overall Study|Medical Monitor Discretion|1|||
23404178|NCT02311881|65226506|FG000|Overall Study|Participant taking another medication|0|||
23404179|NCT02311881|65226507|FG001|Overall Study|Participant taking another medication|0|||
23404180|NCT02311881|65226508|FG002|Overall Study|Participant taking another medication|1|||
23404181|NCT02311881|65226506|FG000|Overall Study|Serious Adverse Event|0|||
23404182|NCT02311881|65226507|FG001|Overall Study|Serious Adverse Event|1|||
23404183|NCT02311881|65226508|FG002|Overall Study|Serious Adverse Event|0|||
23404184|NCT00339040|65226511|FG000|Stage I|Not able to attend clinic|1|||
23404185|NCT00339040|65226512|FG001|Stage I|Not able to attend clinic|0|||
23404186|NCT00339040|65226511|FG000|Stage I|Protocol Violation|1|||
23404187|NCT00339040|65226512|FG001|Stage I|Protocol Violation|1|||
23404188|NCT00339040|65226511|FG000|Stage II|Lost to Follow-up|3|||
23404189|NCT00339040|65226512|FG001|Stage II|Lost to Follow-up|0|||
23404190|NCT00339040|65226511|FG000|Stage II|Withdrawal by Subject|1|||
23404191|NCT00339040|65226512|FG001|Stage II|Withdrawal by Subject|2|||
23404192|NCT00339040|65226511|FG000|Stage II|Protocol Violation|3|||
23404193|NCT00339040|65226512|FG001|Stage II|Protocol Violation|0|||
23404194|NCT00339040|65226511|FG000|Stage II|Not able to attend clinic|1|||
23404195|NCT00339040|65226512|FG001|Stage II|Not able to attend clinic|0|||
23404196|NCT00339040|65226511|FG000|Stage II|Site closing|2|||
23404197|NCT00339040|65226512|FG001|Stage II|Site closing|0|||
23404198|NCT01119443|65226513|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
23404199|NCT01119443|65226514|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
23404200|NCT00886769|65226515|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
23404201|NCT00886769|65226516|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
23404202|NCT01082081|65226522|FG000|Overall Study|Lost to Follow-up|0|||
23404203|NCT01082081|65226523|FG001|Overall Study|Lost to Follow-up|0|||
23404204|NCT01082081|65226524|FG002|Overall Study|Lost to Follow-up|1|||
23404205|NCT01082081|65226522|FG000|Overall Study|Withdrawal by Subject|0|||
23404206|NCT01082081|65226523|FG001|Overall Study|Withdrawal by Subject|0|||
23404207|NCT01082081|65226524|FG002|Overall Study|Withdrawal by Subject|1|||
23404208|NCT01082081|65226522|FG000|Overall Study|Other Reason|0|||
23404209|NCT01082081|65226523|FG001|Overall Study|Other Reason|1|||
23404210|NCT01082081|65226524|FG002|Overall Study|Other Reason|0|||
23404211|NCT00678288|65226525|FG000|Overall Study|Adverse Event|0|||
23404212|NCT00678288|65226526|FG001|Overall Study|Adverse Event|2|||
23404213|NCT00678288|65226525|FG000|Overall Study|Withdrawal by Subject|1|||
23404214|NCT00678288|65226526|FG001|Overall Study|Withdrawal by Subject|1|||
23404215|NCT00678288|65226525|FG000|Overall Study|Study terminated by the sponsor|2|||
23404216|NCT00678288|65226526|FG001|Overall Study|Study terminated by the sponsor|0|||
23404217|NCT00678288|65226525|FG000|Overall Study|Not compliant with study medication|0|||
23404218|NCT00678288|65226526|FG001|Overall Study|Not compliant with study medication|1|||
23404219|NCT00678288|65226525|FG000|Overall Study|Switch to commercial drug|0|||
23404220|NCT00678288|65226526|FG001|Overall Study|Switch to commercial drug|1|||
23404221|NCT00678288|65226525|FG000|Overall Study|Reason not reported|1|||
23404222|NCT00678288|65226526|FG001|Overall Study|Reason not reported|0|||
23404223|NCT00678288|65226525|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
23404224|NCT00678288|65226526|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
23505262|NCT03129100|65587877|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
23404225|NCT00363142|65226527|FG000|Overall Study|Adverse Event|2|||
23404226|NCT00363142|65226528|FG001|Overall Study|Adverse Event|0|||
23505263|NCT03129100|65587878|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
23404227|NCT00363142|65226527|FG000|Overall Study|Lack of Efficacy|0|||
23404228|NCT00363142|65226528|FG001|Overall Study|Lack of Efficacy|1|||
23404229|NCT00363142|65226527|FG000|Overall Study|Lost to Follow-up|1|||
23404230|NCT00363142|65226528|FG001|Overall Study|Lost to Follow-up|0|||
23404231|NCT00363142|65226527|FG000|Overall Study|Non-compliance|1|||
23404232|NCT00363142|65226528|FG001|Overall Study|Non-compliance|1|||
23404233|NCT00363142|65226527|FG000|Overall Study|Withdrawal by Subject|3|||
23505264|NCT03129100|65587879|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
23505265|NCT03129100|65587880|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
23505266|NCT03129100|65587881|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
23505267|NCT03129100|65587882|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
23505268|NCT03129100|65587883|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
23505269|NCT03129100|65587884|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
23505270|NCT03129100|65587885|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
23505271|NCT03129100|65587886|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
23505272|NCT03129100|65587887|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
23505273|NCT03129100|65587888|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
23505274|NCT03129100|65587889|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
23505275|NCT03129100|65587890|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
23505276|NCT03129100|65587891|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
23505277|NCT03129100|65587892|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
23505278|NCT03129100|65587893|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
23505279|NCT03129100|65587894|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
23505280|NCT03129100|65587895|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
23505281|NCT03129100|65587896|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
23505282|NCT03129100|65587897|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
23505283|NCT03129100|65587898|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
23505284|NCT03129100|65587899|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
23505285|NCT03129100|65587900|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
23505286|NCT03129100|65587901|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
23505287|NCT00291577|65587902|FG000|Overall Study|Adverse Event|1|||
23505288|NCT00291577|65587902|FG000|Overall Study|Other|4|||
23505289|NCT00291577|65587902|FG000|Overall Study|Withdrawal by Subject|2|||
23505290|NCT00291577|65587902|FG000|Overall Study|Lack of Efficacy|14|||
23505291|NCT00601458|65587903|FG000|Overall Study|Dosing Error|1|||
23505292|NCT00601458|65587904|FG001|Overall Study|Dosing Error|0|||
23505293|NCT00601458|65587905|FG002|Overall Study|Dosing Error|0|||
23505294|NCT00601458|65587903|FG000|Overall Study|Incomplete Data|0|||
23505295|NCT00601458|65587904|FG001|Overall Study|Incomplete Data|2|||
23505296|NCT00601458|65587905|FG002|Overall Study|Incomplete Data|0|||
23505297|NCT00601458|65587903|FG000|Overall Study|Protocol Violation|3|||
23505298|NCT00601458|65587904|FG001|Overall Study|Protocol Violation|2|||
23505299|NCT00601458|65587905|FG002|Overall Study|Protocol Violation|1|||
23505300|NCT00601458|65587903|FG000|Overall Study|Early Termination|0|||
23505301|NCT00601458|65587904|FG001|Overall Study|Early Termination|1|||
23505302|NCT00601458|65587905|FG002|Overall Study|Early Termination|1|||
23505303|NCT04706091|65587906|FG000|Treatment 2|Withdrawal by Subject|1|||
23505304|NCT04706091|65587907|FG001|Treatment 2|Withdrawal by Subject|0|||
23505305|NCT03098550|65587908|FG000|Overall Study|Disease Progression|30|||
23505306|NCT03098550|65587909|FG001|Overall Study|Disease Progression|19|||
23505307|NCT03098550|65587910|FG002|Overall Study|Disease Progression|41|||
23505308|NCT03098550|65587908|FG000|Overall Study|Study Drug Toxicity|2|||
23505309|NCT03098550|65587909|FG001|Overall Study|Study Drug Toxicity|1|||
23505310|NCT03098550|65587910|FG002|Overall Study|Study Drug Toxicity|0|||
23505311|NCT03098550|65587908|FG000|Overall Study|Death|1|||
23505312|NCT03098550|65587909|FG001|Overall Study|Death|0|||
23505313|NCT03098550|65587910|FG002|Overall Study|Death|0|||
23505314|NCT03098550|65587908|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
23505315|NCT03098550|65587909|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
23505316|NCT03098550|65587910|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
23505317|NCT03098550|65587908|FG000|Overall Study|Administrative reason by sponsor|0|||
23505318|NCT03098550|65587909|FG001|Overall Study|Administrative reason by sponsor|0|||
23505319|NCT03098550|65587910|FG002|Overall Study|Administrative reason by sponsor|1|||
23505320|NCT03098550|65587908|FG000|Overall Study|Other reasons|2|||
23505321|NCT03098550|65587909|FG001|Overall Study|Other reasons|0|||
23505322|NCT03098550|65587910|FG002|Overall Study|Other reasons|0|||
23505323|NCT00520936|65587913|FG000|Overall Study|Physician Decision|0|||
23505324|NCT00520936|65587914|FG001|Overall Study|Physician Decision|2|||
23505325|NCT00520936|65587915|FG002|Overall Study|Physician Decision|1|||
23505326|NCT00520936|65587916|FG003|Overall Study|Physician Decision|0|||
23505327|NCT00520936|65587917|FG004|Overall Study|Physician Decision|0|||
23505328|NCT00520936|65587918|FG005|Overall Study|Physician Decision|0|||
23505329|NCT00520936|65587919|FG006|Overall Study|Physician Decision|0|||
23505330|NCT00520936|65587920|FG007|Overall Study|Physician Decision|0|||
23505331|NCT00520936|65587913|FG000|Overall Study|Withdrawal by Subject|0|||
23505332|NCT00520936|65587914|FG001|Overall Study|Withdrawal by Subject|0|||
23505333|NCT00520936|65587915|FG002|Overall Study|Withdrawal by Subject|0|||
23505334|NCT00520936|65587916|FG003|Overall Study|Withdrawal by Subject|0|||
23505335|NCT00520936|65587917|FG004|Overall Study|Withdrawal by Subject|0|||
23505336|NCT00520936|65587918|FG005|Overall Study|Withdrawal by Subject|0|||
23505337|NCT00520936|65587919|FG006|Overall Study|Withdrawal by Subject|0|||
23505338|NCT00520936|65587920|FG007|Overall Study|Withdrawal by Subject|1|||
23505339|NCT00520936|65587913|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
23505340|NCT00520936|65587914|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
23505341|NCT00520936|65587915|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
23505342|NCT00520936|65587916|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
23505343|NCT00520936|65587917|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
23505344|NCT00520936|65587918|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
23505345|NCT00520936|65587919|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
23505346|NCT00520936|65587920|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
23505347|NCT00520936|65587913|FG000|Overall Study|Death|0|||
23505348|NCT00520936|65587914|FG001|Overall Study|Death|0|||
23505349|NCT00520936|65587915|FG002|Overall Study|Death|0|||
23505350|NCT00520936|65587916|FG003|Overall Study|Death|0|||
23505351|NCT00520936|65587917|FG004|Overall Study|Death|0|||
23505352|NCT00520936|65587918|FG005|Overall Study|Death|0|||
23505353|NCT00520936|65587919|FG006|Overall Study|Death|1|||
23505354|NCT00520936|65587920|FG007|Overall Study|Death|0|||
23505355|NCT00520936|65587913|FG000|Overall Study|Protocol Violation|0|||
23505356|NCT00520936|65587914|FG001|Overall Study|Protocol Violation|1|||
23505357|NCT00520936|65587915|FG002|Overall Study|Protocol Violation|1|||
23505358|NCT00520936|65587916|FG003|Overall Study|Protocol Violation|0|||
23505359|NCT00520936|65587917|FG004|Overall Study|Protocol Violation|1|||
23505360|NCT00520936|65587918|FG005|Overall Study|Protocol Violation|0|||
23505361|NCT00520936|65587919|FG006|Overall Study|Protocol Violation|1|||
23505362|NCT00520936|65587920|FG007|Overall Study|Protocol Violation|0|||
23505363|NCT00827502|65587921|FG000|Overall Study|randomized but not treated|11|||
23505364|NCT00827502|65587921|FG000|Overall Study|Adverse Event|1|||
23505365|NCT00827502|65587921|FG000|Overall Study|Lost to Follow-up|4|||
23505366|NCT00827502|65587921|FG000|Overall Study|Withdrawal by Subject|5|||
23505367|NCT00621985|65587922|FG000|Dexamethasone Admission|Adverse Event|1|||
23505368|NCT00056316|65587926|FG000|Overall Study|Withdrawal by Subject|2|||
23505369|NCT00056316|65587927|FG001|Overall Study|Withdrawal by Subject|2|||
23505370|NCT00056316|65587926|FG000|Overall Study|Death/NH placement of pt|1|||
23404234|NCT00363142|65226528|FG001|Overall Study|Withdrawal by Subject|1|||
23404235|NCT01558596|65226529|FG000|Overall Study|Withdrawal by Subject|1|||
23303442|NCT02435836|64854661|FG000|Overall Study|Withdrawal by Subject|236|||
23303443|NCT02435836|64854661|FG000|Overall Study|Insufficient Clinical Response|26|||
23404236|NCT01558596|65226530|FG001|Overall Study|Withdrawal by Subject|0|||
23404237|NCT01558596|65226529|FG000|Overall Study|surgery elsewhere or cancelled|1|||
23404238|NCT01558596|65226530|FG001|Overall Study|surgery elsewhere or cancelled|1|||
23404239|NCT01558596|65226529|FG000|Overall Study|Protocol Violation|1|||
23404240|NCT01558596|65226530|FG001|Overall Study|Protocol Violation|0|||
23404241|NCT03273907|65226531|FG000|Overall Study|Death|1|||
23404242|NCT03273907|65226531|FG000|Overall Study|Lost to Follow-up|4|||
23404243|NCT03273907|65226531|FG000|Overall Study|Withdrawal by Subject|2|||
23404244|NCT03273907|65226531|FG000|Overall Study|COVID 19|2|||
23404245|NCT00517699|65226532|FG000|Overall Study|Withdrawal by Subject|1|||
23404246|NCT00517699|65226532|FG000|Overall Study|Lack of Efficacy|1|||
23404247|NCT00517699|65226532|FG000|Overall Study|Administrative error|1|||
23404248|NCT00517699|65226532|FG000|Overall Study|Study terminated by Sponsor|2|||
23404249|NCT00800982|65226536|FG000|Overall Study|Lost to Follow-up|1|||
23404250|NCT00800982|65226537|FG001|Overall Study|Lost to Follow-up|2|||
23404251|NCT00800982|65226536|FG000|Overall Study|Withdrawal by Subject|0|||
23404252|NCT00800982|65226537|FG001|Overall Study|Withdrawal by Subject|1|||
23404253|NCT00800982|65226536|FG000|Overall Study|Patient moved out of state|1|||
23404254|NCT00800982|65226537|FG001|Overall Study|Patient moved out of state|0|||
23404255|NCT04419467|65226545|FG000|Overall Study|Not treated with IP|0|||
23404256|NCT04419467|65226546|FG001|Overall Study|Not treated with IP|0|||
23404257|NCT04419467|65226547|FG002|Overall Study|Not treated with IP|2|||
23404258|NCT04419467|65226545|FG000|Overall Study|Adverse Event|0|||
23404259|NCT04419467|65226546|FG001|Overall Study|Adverse Event|2|||
23404260|NCT04419467|65226547|FG002|Overall Study|Adverse Event|0|||
23404261|NCT04419467|65226545|FG000|Overall Study|Death|1|||
23404262|NCT04419467|65226546|FG001|Overall Study|Death|0|||
23404263|NCT04419467|65226547|FG002|Overall Study|Death|0|||
23404264|NCT04419467|65226545|FG000|Overall Study|Lost to Follow-up|0|||
23404265|NCT04419467|65226546|FG001|Overall Study|Lost to Follow-up|1|||
23404266|NCT04419467|65226547|FG002|Overall Study|Lost to Follow-up|2|||
23404267|NCT04419467|65226545|FG000|Overall Study|Withdrawal by Subject|0|||
23404268|NCT04419467|65226546|FG001|Overall Study|Withdrawal by Subject|0|||
23404269|NCT04419467|65226547|FG002|Overall Study|Withdrawal by Subject|4|||
23404270|NCT04419467|65226545|FG000|Overall Study|Pandemic related|0|||
23404271|NCT04419467|65226546|FG001|Overall Study|Pandemic related|0|||
23404272|NCT04419467|65226547|FG002|Overall Study|Pandemic related|1|||
23404273|NCT04419467|65226545|FG000|Overall Study|Reason not known|1|||
23404274|NCT04419467|65226546|FG001|Overall Study|Reason not known|0|||
23505371|NCT00056316|65587927|FG001|Overall Study|Death/NH placement of pt|1|||
23505372|NCT00838578|65587928|FG000|Overall Study|Protocol Violation|2|||
23505373|NCT01433991|65587929|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
23505374|NCT01433991|65587930|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
23404275|NCT04419467|65226547|FG002|Overall Study|Reason not known|0|||
23404276|NCT00952705|65226556|FG000|Overall Study|Lost to Follow-up|24|||
23404277|NCT00952705|65226557|FG001|Overall Study|Lost to Follow-up|8|||
23404278|NCT00952705|65226558|FG002|Overall Study|Lost to Follow-up|9|||
23404279|NCT00952705|65226556|FG000|Overall Study|Withdrawal by Subject|2|||
23404280|NCT00952705|65226557|FG001|Overall Study|Withdrawal by Subject|1|||
23404281|NCT00952705|65226558|FG002|Overall Study|Withdrawal by Subject|1|||
23404282|NCT00952705|65226556|FG000|Overall Study|Death|2|||
23404283|NCT00952705|65226557|FG001|Overall Study|Death|0|||
23404284|NCT00952705|65226558|FG002|Overall Study|Death|0|||
23404285|NCT00952705|65226556|FG000|Overall Study|Incarcerated post dose|5|||
23606547|NCT00498797|65950441|FG001|Overall Study|Condition under investigation worsened|21|||
23404286|NCT00952705|65226557|FG001|Overall Study|Incarcerated post dose|0|||
23404287|NCT00952705|65226558|FG002|Overall Study|Incarcerated post dose|0|||
23404288|NCT00952705|65226556|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
23404289|NCT00952705|65226557|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
23404290|NCT00952705|65226558|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
23404291|NCT00186628|65226559|FG000|Overall Study|Death|2|||
23505375|NCT01433991|65587931|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
23505376|NCT01433991|65587932|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
23505377|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
23505378|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
23505379|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
23505380|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
23505381|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
23505382|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
23404292|NCT00186628|65226559|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
23404293|NCT02175277|65226560|FG000|Overall Study|Protocol-specified Criteria|1|||
23404294|NCT01479764|65226562|FG000|Randomized|Adverse Event|1|||
23404295|NCT01479764|65226563|FG001|Randomized|Adverse Event|1|||
23404296|NCT01479764|65226562|FG000|Randomized|Withdrawal by Subject|1|||
23404297|NCT01479764|65226563|FG001|Randomized|Withdrawal by Subject|0|||
23404298|NCT01479764|65226562|FG000|Treated|Lost to Follow-up|0|||
23404299|NCT01479764|65226563|FG001|Treated|Lost to Follow-up|2|||
23404300|NCT01027650|65226566|FG000|Overall Study|Personal Reasons|0|||
23404301|NCT01027650|65226567|FG001|Overall Study|Personal Reasons|0|||
23404302|NCT01027650|65226568|FG002|Overall Study|Personal Reasons|0|||
23404303|NCT01027650|65226569|FG003|Overall Study|Personal Reasons|0|||
23404304|NCT01027650|65226570|FG004|Overall Study|Personal Reasons|2|||
23404305|NCT01027650|65226571|FG005|Overall Study|Personal Reasons|1|||
23404306|NCT01027650|65226572|FG006|Overall Study|Personal Reasons|0|||
23404307|NCT01027650|65226573|FG007|Overall Study|Personal Reasons|0|||
23404308|NCT01027650|65226566|FG000|Overall Study|Lost to Follow-up|0|||
23404309|NCT01027650|65226567|FG001|Overall Study|Lost to Follow-up|0|||
23404310|NCT01027650|65226568|FG002|Overall Study|Lost to Follow-up|0|||
23404311|NCT01027650|65226569|FG003|Overall Study|Lost to Follow-up|0|||
23404312|NCT01027650|65226570|FG004|Overall Study|Lost to Follow-up|0|||
23404313|NCT01027650|65226571|FG005|Overall Study|Lost to Follow-up|0|||
23404314|NCT01027650|65226572|FG006|Overall Study|Lost to Follow-up|1|||
23404315|NCT01027650|65226573|FG007|Overall Study|Lost to Follow-up|0|||
23404316|NCT01027650|65226566|FG000|Overall Study|Lack of Efficacy|0|||
23404317|NCT01027650|65226567|FG001|Overall Study|Lack of Efficacy|0|||
23404318|NCT01027650|65226568|FG002|Overall Study|Lack of Efficacy|0|||
23404319|NCT01027650|65226569|FG003|Overall Study|Lack of Efficacy|0|||
23505383|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
23505384|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
23505385|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
23505386|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
23505387|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
23505388|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
23505389|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
23505390|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
23606548|NCT00498797|65950440|FG000|Overall Study|Other|3|||
23606549|NCT00498797|65950441|FG001|Overall Study|Other|1|||
23606550|NCT04693637|65950445|FG000|Overall Study|Death|4|||
23606551|NCT04693637|65950445|FG000|Overall Study|Withdrawal by Subject|3|||
23606552|NCT04693637|65950445|FG000|Overall Study|Physician Decision|2|||
23404320|NCT01027650|65226570|FG004|Overall Study|Lack of Efficacy|0|||
23404321|NCT01027650|65226571|FG005|Overall Study|Lack of Efficacy|1|||
23404322|NCT01027650|65226572|FG006|Overall Study|Lack of Efficacy|0|||
23404323|NCT01027650|65226573|FG007|Overall Study|Lack of Efficacy|0|||
23404324|NCT00200967|65226574|FG000|First Treatment Period|Withdrawal by Subject|5|||
23404325|NCT00200967|65226575|FG001|First Treatment Period|Withdrawal by Subject|1|||
23404326|NCT00200967|65226574|FG000|First Treatment Period|Pregnancy|1|||
23606553|NCT04693637|65950445|FG000|Overall Study|Lost to Follow-up|1|||
23404327|NCT00200967|65226575|FG001|First Treatment Period|Pregnancy|0|||
23606554|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
23606555|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
23606556|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
23606557|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
23606558|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
23606559|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Adverse Event|0|||
23606560|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Adverse Event|1|||
23606561|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Adverse Event|1|||
23606562|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Adverse Event|0|||
23606563|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Adverse Event|0|||
23606564|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
23606565|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
23606566|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
23606567|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
23606568|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
23606569|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Physician Decision|1|||
23606570|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Physician Decision|0|||
23606571|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Physician Decision|0|||
23606572|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Physician Decision|0|||
23606573|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Physician Decision|0|||
23606574|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
23606575|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
23606576|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
23606577|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
23606578|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
23606579|NCT00446095|65950446|FG000|Phase II (8 Weeks)|Ongoing|0|||
23606580|NCT00446095|65950447|FG001|Phase II (8 Weeks)|Ongoing|0|||
23606581|NCT00446095|65950448|FG002|Phase II (8 Weeks)|Ongoing|1|||
23606582|NCT00446095|65950449|FG003|Phase II (8 Weeks)|Ongoing|0|||
23606583|NCT00446095|65950450|FG004|Phase II (8 Weeks)|Ongoing|0|||
23606584|NCT00446095|65950446|FG000|Phase I (28 Days)|Adverse Event|0|||
23606585|NCT00446095|65950447|FG001|Phase I (28 Days)|Adverse Event|0|||
23404328|NCT00200967|65226574|FG000|Wash-out Period|Lost to Follow-up|0|||
23404329|NCT00200967|65226575|FG001|Wash-out Period|Lost to Follow-up|1|||
23404330|NCT00200967|65226574|FG000|Second Treatment Period|Withdrawal by Subject|1|||
23404331|NCT00200967|65226575|FG001|Second Treatment Period|Withdrawal by Subject|2|||
23606586|NCT00446095|65950448|FG002|Phase I (28 Days)|Adverse Event|0|||
23606587|NCT00446095|65950449|FG003|Phase I (28 Days)|Adverse Event|1|||
23606588|NCT00446095|65950450|FG004|Phase I (28 Days)|Adverse Event|0|||
23606589|NCT00446095|65950446|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
23404332|NCT00200967|65226574|FG000|Run-out Period|Lost to Follow-up|1|||
23606590|NCT00446095|65950447|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
23606591|NCT00446095|65950448|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
23606592|NCT00446095|65950449|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
23606593|NCT00446095|65950450|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
23606594|NCT02007070|65950451|FG000|Overall Study|Adverse Event|4|||
23606595|NCT02007070|65950451|FG000|Overall Study|Clinical Progression|4|||
23606596|NCT02007070|65950451|FG000|Overall Study|Death|1|||
23606597|NCT02007070|65950451|FG000|Overall Study|Protocol Violation|2|||
23606598|NCT02007070|65950451|FG000|Overall Study|Physician Decision|1|||
23606599|NCT02007070|65950451|FG000|Overall Study|Progressive Disease|21|||
23606600|NCT00048932|65950452|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
23606601|NCT00048932|65950453|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
23606602|NCT00048932|65950454|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
23606603|NCT00048932|65950452|FG000|Double Blind Period (DB)|Adverse Event|51|||
23505391|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
23505392|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
23505393|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
23505394|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
23505395|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
23505396|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
23505397|NCT01433991|65587929|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
23505398|NCT01433991|65587930|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
23606604|NCT00048932|65950453|FG001|Double Blind Period (DB)|Adverse Event|19|||
23606605|NCT00048932|65950454|FG002|Double Blind Period (DB)|Adverse Event|0|||
23606606|NCT00048932|65950452|FG000|Double Blind Period (DB)|Death|5|||
23606607|NCT00048932|65950453|FG001|Double Blind Period (DB)|Death|3|||
23606608|NCT00048932|65950454|FG002|Double Blind Period (DB)|Death|0|||
23606609|NCT00048932|65950452|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
23404333|NCT00200967|65226575|FG001|Run-out Period|Lost to Follow-up|0|||
23606610|NCT00048932|65950453|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
23606611|NCT00048932|65950454|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
23606612|NCT00048932|65950452|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
23606613|NCT00048932|65950453|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
23404334|NCT01824290|65226578|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
23606614|NCT00048932|65950454|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
23606615|NCT00048932|65950452|FG000|Double Blind Period (DB)|Relocation|1|||
23606616|NCT00048932|65950453|FG001|Double Blind Period (DB)|Relocation|0|||
23606617|NCT00048932|65950454|FG002|Double Blind Period (DB)|Relocation|0|||
23606618|NCT00048932|65950452|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
23606619|NCT00048932|65950453|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
23606620|NCT00048932|65950454|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
23606621|NCT00048932|65950452|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
23606622|NCT00048932|65950453|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
23606623|NCT00048932|65950454|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
23606624|NCT00048932|65950452|FG000|Double Blind Period (DB)|Pregnancy|1|||
23606625|NCT00048932|65950453|FG001|Double Blind Period (DB)|Pregnancy|0|||
23606626|NCT00048932|65950454|FG002|Double Blind Period (DB)|Pregnancy|0|||
23606627|NCT00048932|65950452|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
23606628|NCT00048932|65950453|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
23606629|NCT00048932|65950454|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
23606630|NCT00048932|65950452|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
23606631|NCT00048932|65950453|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
23606632|NCT00048932|65950454|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
23606633|NCT00048932|65950452|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
23606634|NCT00048932|65950453|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
23606635|NCT00048932|65950454|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
23606636|NCT00048932|65950452|FG000|Open Label Period (OL)|Death|0|||
23606637|NCT00048932|65950453|FG001|Open Label Period (OL)|Death|0|||
23404335|NCT01824290|65226579|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
23404336|NCT01824290|65226580|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
23404337|NCT01824290|65226581|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
23404338|NCT01824290|65226578|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
23404339|NCT01824290|65226579|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
23404340|NCT01824290|65226580|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
23404341|NCT01824290|65226581|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
23303444|NCT02435836|64854661|FG000|Overall Study|Adverse Event|44|||
23303445|NCT02435836|64854661|FG000|Overall Study|Sponsor discontinued trial|167|||
23303446|NCT02435836|64854661|FG000|Overall Study|Noncompliance|27|||
23303447|NCT02435836|64854661|FG000|Overall Study|Protocol Violation|6|||
23303448|NCT02435836|64854661|FG000|Overall Study|Met Withdrawal Criteria|7|||
23303449|NCT02435836|64854661|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
23303450|NCT01806506|64854662|FG000|Overall Study|Lost to Follow-up|2|||
23303451|NCT01806506|64854663|FG001|Overall Study|Lost to Follow-up|1|||
23303452|NCT02914236|64854664|FG000|Overall Study|Lost to Follow-up|1|||
23606638|NCT00048932|65950454|FG002|Open Label Period (OL)|Death|25|||
23606639|NCT00048932|65950452|FG000|Open Label Period (OL)|Adverse Event|0|||
23606640|NCT00048932|65950453|FG001|Open Label Period (OL)|Adverse Event|0|||
23606641|NCT00048932|65950454|FG002|Open Label Period (OL)|Adverse Event|103|||
23606642|NCT00048932|65950452|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
23606643|NCT00048932|65950453|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
23606644|NCT00048932|65950454|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
23606645|NCT00048932|65950452|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
23606646|NCT00048932|65950453|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
23606647|NCT00048932|65950454|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
23606648|NCT00048932|65950452|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
23606649|NCT00048932|65950453|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
23606650|NCT00048932|65950454|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
23606651|NCT00048932|65950452|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
23606652|NCT00048932|65950453|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
23606653|NCT00048932|65950454|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
23606654|NCT00048932|65950452|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
23606655|NCT00048932|65950453|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
23606656|NCT00048932|65950454|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
23606657|NCT00048932|65950452|FG000|Open Label Period (OL)|Pregnancy|0|||
23303453|NCT01968694|64854666|FG000|Washout (1 Month)|Lost to Follow-up|0|||
23303454|NCT01968694|64854667|FG001|Washout (1 Month)|Lost to Follow-up|1|||
23303455|NCT03096847|64854668|FG000|Overall Study|Other|2|||
23303456|NCT03096847|64854669|FG001|Overall Study|Other|1|||
23303457|NCT03096847|64854670|FG002|Overall Study|Other|2|||
23303458|NCT03096847|64854668|FG000|Overall Study|Lost to Follow-up|1|||
23303459|NCT03096847|64854669|FG001|Overall Study|Lost to Follow-up|0|||
23303460|NCT03096847|64854670|FG002|Overall Study|Lost to Follow-up|1|||
23303461|NCT03096847|64854668|FG000|Overall Study|Death|6|||
23204398|NCT00910429|64491036|FG000|Overall Study|Lack of Efficacy|4|||
23404342|NCT01824290|65226578|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
23303462|NCT03096847|64854669|FG001|Overall Study|Death|0|||
23303463|NCT03096847|64854670|FG002|Overall Study|Death|2|||
23404343|NCT01824290|65226579|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
23404344|NCT01824290|65226580|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
23404345|NCT01824290|65226581|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
23404346|NCT01824290|65226578|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
23404347|NCT01824290|65226579|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
23404348|NCT01824290|65226580|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
23404349|NCT01824290|65226581|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
23404350|NCT01824290|65226578|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
23404351|NCT01824290|65226579|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
23404352|NCT01824290|65226580|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
23404353|NCT01824290|65226581|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
23404354|NCT01824290|65226578|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
23404355|NCT01824290|65226579|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
23404356|NCT01824290|65226580|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
23404357|NCT01824290|65226581|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
23404358|NCT03801928|65226586|FG000|Overall Study|Adverse Event|1|||
23404359|NCT03801928|65226587|FG001|Overall Study|Adverse Event|0|||
23404360|NCT03801928|65226588|FG002|Overall Study|Adverse Event|1|||
23404361|NCT03801928|65226589|FG003|Overall Study|Adverse Event|2|||
23404362|NCT03801928|65226590|FG004|Overall Study|Adverse Event|0|||
23404363|NCT03801928|65226591|FG005|Overall Study|Adverse Event|2|||
23404364|NCT03801928|65226586|FG000|Overall Study|Lack of Efficacy|0|||
23404365|NCT03801928|65226587|FG001|Overall Study|Lack of Efficacy|0|||
23404366|NCT03801928|65226588|FG002|Overall Study|Lack of Efficacy|1|||
23404367|NCT03801928|65226589|FG003|Overall Study|Lack of Efficacy|0|||
23404368|NCT03801928|65226590|FG004|Overall Study|Lack of Efficacy|0|||
23404369|NCT03801928|65226591|FG005|Overall Study|Lack of Efficacy|0|||
23404370|NCT03801928|65226586|FG000|Overall Study|Lost to Follow-up|5|||
23404371|NCT03801928|65226587|FG001|Overall Study|Lost to Follow-up|1|||
23404372|NCT03801928|65226588|FG002|Overall Study|Lost to Follow-up|1|||
23404373|NCT03801928|65226589|FG003|Overall Study|Lost to Follow-up|4|||
23404374|NCT03801928|65226590|FG004|Overall Study|Lost to Follow-up|4|||
23404375|NCT03801928|65226591|FG005|Overall Study|Lost to Follow-up|2|||
23404376|NCT03801928|65226586|FG000|Overall Study|Withdrawal by Subject|0|||
23404377|NCT03801928|65226587|FG001|Overall Study|Withdrawal by Subject|0|||
23404378|NCT03801928|65226588|FG002|Overall Study|Withdrawal by Subject|2|||
23404379|NCT03801928|65226589|FG003|Overall Study|Withdrawal by Subject|1|||
23404380|NCT03801928|65226590|FG004|Overall Study|Withdrawal by Subject|0|||
23404381|NCT03801928|65226591|FG005|Overall Study|Withdrawal by Subject|0|||
23404382|NCT03801928|65226586|FG000|Overall Study|Other|0|||
23404383|NCT03801928|65226587|FG001|Overall Study|Other|2|||
23404384|NCT03801928|65226588|FG002|Overall Study|Other|0|||
23404385|NCT03801928|65226589|FG003|Overall Study|Other|1|||
23404386|NCT03801928|65226590|FG004|Overall Study|Other|0|||
23404387|NCT03801928|65226591|FG005|Overall Study|Other|1|||
23404388|NCT00856635|65226594|FG000|Overall Study|Lost to Follow-up|2|||
23404389|NCT00856635|65226595|FG001|Overall Study|Lost to Follow-up|5|||
23404390|NCT00856635|65226594|FG000|Overall Study|Pregnancy|1|||
23404391|NCT00856635|65226595|FG001|Overall Study|Pregnancy|0|||
23404392|NCT00856635|65226594|FG000|Overall Study|Withdrawal by Subject|3|||
23404393|NCT00856635|65226595|FG001|Overall Study|Withdrawal by Subject|1|||
23404394|NCT00856635|65226594|FG000|Overall Study|Serious Adverse Event|1|||
23404395|NCT00856635|65226595|FG001|Overall Study|Serious Adverse Event|0|||
23404396|NCT00856635|65226594|FG000|Overall Study|Other|1|||
23404397|NCT00856635|65226595|FG001|Overall Study|Other|0|||
23404398|NCT00856635|65226594|FG000|Overall Study|Discontinued at Randomization|2|||
23404399|NCT00856635|65226595|FG001|Overall Study|Discontinued at Randomization|2|||
23404400|NCT02777086|65226598|FG000|Overall Study|Lost to Follow-up|96|||
23404401|NCT02777086|65226599|FG001|Overall Study|Lost to Follow-up|99|||
23404402|NCT00856609|65226600|FG000|Overall Study|Adverse Event|1|||
23404403|NCT00856609|65226601|FG001|Overall Study|Adverse Event|0|||
23404404|NCT00856323|65226602|FG000|Overall Study|Withdrawal by Subject|2|||
23404405|NCT03759600|65226603|FG000|Overall Study|Adverse Event|2|||
23404406|NCT03759600|65226603|FG000|Overall Study|Progressive Disease|15|||
23404407|NCT03759600|65226603|FG000|Overall Study|Site Terminated by Sponsor|3|||
23404408|NCT00540592|65226604|FG000|Overall Study|Adverse Event|0|||
23404409|NCT00540592|65226605|FG001|Overall Study|Adverse Event|1|||
23404410|NCT00540592|65226606|FG002|Overall Study|Adverse Event|0|||
23404411|NCT00540592|65226607|FG003|Overall Study|Adverse Event|0|||
23404412|NCT00540592|65226608|FG004|Overall Study|Adverse Event|1|||
23404413|NCT00540592|65226609|FG005|Overall Study|Adverse Event|0|||
23204399|NCT00910429|64491037|FG001|Overall Study|Lack of Efficacy|1|||
23404414|NCT00540592|65226610|FG006|Overall Study|Adverse Event|0|||
23404415|NCT00540592|65226611|FG007|Overall Study|Adverse Event|1|||
23404416|NCT00540592|65226612|FG008|Overall Study|Adverse Event|1|||
23404417|NCT00540592|65226613|FG009|Overall Study|Adverse Event|2|||
23404418|NCT00540592|65226604|FG000|Overall Study|Lost to Follow-up|2|||
23404419|NCT00540592|65226605|FG001|Overall Study|Lost to Follow-up|0|||
23404420|NCT00540592|65226606|FG002|Overall Study|Lost to Follow-up|0|||
23404421|NCT00540592|65226607|FG003|Overall Study|Lost to Follow-up|0|||
23404422|NCT00540592|65226608|FG004|Overall Study|Lost to Follow-up|0|||
23404423|NCT00540592|65226609|FG005|Overall Study|Lost to Follow-up|0|||
23404424|NCT00540592|65226610|FG006|Overall Study|Lost to Follow-up|0|||
23404425|NCT00540592|65226611|FG007|Overall Study|Lost to Follow-up|0|||
23404426|NCT00540592|65226612|FG008|Overall Study|Lost to Follow-up|0|||
23404427|NCT00540592|65226613|FG009|Overall Study|Lost to Follow-up|0|||
23404428|NCT00540592|65226604|FG000|Overall Study|Withdrawal by Subject|0|||
23404429|NCT00540592|65226605|FG001|Overall Study|Withdrawal by Subject|0|||
23404430|NCT00540592|65226606|FG002|Overall Study|Withdrawal by Subject|1|||
23404431|NCT00540592|65226607|FG003|Overall Study|Withdrawal by Subject|1|||
23404432|NCT00540592|65226608|FG004|Overall Study|Withdrawal by Subject|0|||
23404433|NCT00540592|65226609|FG005|Overall Study|Withdrawal by Subject|0|||
23404434|NCT00540592|65226610|FG006|Overall Study|Withdrawal by Subject|0|||
23404435|NCT00540592|65226611|FG007|Overall Study|Withdrawal by Subject|0|||
23404436|NCT00540592|65226612|FG008|Overall Study|Withdrawal by Subject|0|||
23404437|NCT00540592|65226613|FG009|Overall Study|Withdrawal by Subject|0|||
23404438|NCT00928187|65226617|FG000|Overall Study|Death|1|||
23404439|NCT00928187|65226618|FG001|Overall Study|Death|2|||
23404440|NCT00928187|65226619|FG002|Overall Study|Death|3|||
23404441|NCT00928187|65226617|FG000|Overall Study|Lost to Follow-up|1|||
23404442|NCT00928187|65226618|FG001|Overall Study|Lost to Follow-up|2|||
23404443|NCT00928187|65226619|FG002|Overall Study|Lost to Follow-up|1|||
23404444|NCT00928187|65226617|FG000|Overall Study|Withdrawal by Subject|0|||
23404445|NCT00928187|65226618|FG001|Overall Study|Withdrawal by Subject|1|||
23404446|NCT00928187|65226619|FG002|Overall Study|Withdrawal by Subject|1|||
23404447|NCT00928187|65226617|FG000|Overall Study|Protocol Violation|0|||
23404448|NCT00928187|65226618|FG001|Overall Study|Protocol Violation|1|||
23404449|NCT00928187|65226619|FG002|Overall Study|Protocol Violation|0|||
23404450|NCT04749745|65226620|FG000|Overall Study|Withdrawal by Subject|1|||
23404451|NCT04749745|65226621|FG001|Overall Study|Withdrawal by Subject|0|||
23404452|NCT01182298|65226622|FG000|Overall Study|Lack of Efficacy|4|||
23404453|NCT01182298|65226622|FG000|Overall Study|Withdrawal by Subject|2|||
23404454|NCT00375674|65226623|FG000|Overall Study|Other|26|||
23404455|NCT00375674|65226624|FG001|Overall Study|Other|18|||
23404456|NCT00375674|65226623|FG000|Overall Study|Death|67|||
23404457|NCT00375674|65226624|FG001|Overall Study|Death|76|||
23404458|NCT00375674|65226623|FG000|Overall Study|Participants refused further follow-up|31|||
23606658|NCT00048932|65950453|FG001|Open Label Period (OL)|Pregnancy|0|||
23606659|NCT00048932|65950454|FG002|Open Label Period (OL)|Pregnancy|6|||
23606660|NCT00048932|65950452|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
23606661|NCT00048932|65950453|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
23606662|NCT00048932|65950454|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
23606663|NCT00048932|65950452|FG000|Open Label Period (OL)|Investigator Retiring|0|||
23606664|NCT00048932|65950453|FG001|Open Label Period (OL)|Investigator Retiring|0|||
23606665|NCT00048932|65950454|FG002|Open Label Period (OL)|Investigator Retiring|2|||
23606666|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
23606667|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
23606668|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
23606669|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Relocated|0|||
23606670|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Relocated|0|||
23606671|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Relocated|6|||
23606672|NCT00048932|65950452|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
23606673|NCT00048932|65950453|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
23606674|NCT00048932|65950454|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
23606675|NCT00048932|65950452|FG000|Open Label Period (OL)|Site Closure|0|||
23606676|NCT00048932|65950453|FG001|Open Label Period (OL)|Site Closure|0|||
23404459|NCT00375674|65226624|FG001|Overall Study|Participants refused further follow-up|30|||
23404460|NCT00375674|65226623|FG000|Overall Study|Lost to Follow-up|17|||
23404461|NCT00375674|65226624|FG001|Overall Study|Lost to Follow-up|15|||
23404462|NCT00375674|65226623|FG000|Overall Study|Enrolled but not treated|3|||
23404463|NCT00375674|65226624|FG001|Overall Study|Enrolled but not treated|2|||
23404464|NCT01484496|65226625|FG000|Period 1|Protocol Violation|3|||
23404465|NCT01484496|65226626|FG001|Period 1|Protocol Violation|4|||
23404466|NCT01484496|65226627|FG002|Period 1|Protocol Violation|0|||
23404467|NCT01484496|65226628|FG003|Period 1|Protocol Violation|0|||
23404468|NCT01484496|65226625|FG000|Period 1|Physician Decision|5|||
23404469|NCT01484496|65226626|FG001|Period 1|Physician Decision|1|||
23404470|NCT01484496|65226627|FG002|Period 1|Physician Decision|0|||
23404471|NCT01484496|65226628|FG003|Period 1|Physician Decision|0|||
23404472|NCT01484496|65226625|FG000|Period 1|Lack of Efficacy|10|||
23404473|NCT01484496|65226626|FG001|Period 1|Lack of Efficacy|15|||
23404474|NCT01484496|65226627|FG002|Period 1|Lack of Efficacy|0|||
23404475|NCT01484496|65226628|FG003|Period 1|Lack of Efficacy|0|||
23606677|NCT00048932|65950454|FG002|Open Label Period (OL)|Site Closure|3|||
23404476|NCT01484496|65226625|FG000|Period 1|Adverse Event|25|||
23404477|NCT01484496|65226626|FG001|Period 1|Adverse Event|40|||
23404478|NCT01484496|65226627|FG002|Period 1|Adverse Event|0|||
23404479|NCT01484496|65226628|FG003|Period 1|Adverse Event|0|||
23404480|NCT01484496|65226625|FG000|Period 1|Withdrawal by Subject|15|||
23404481|NCT01484496|65226626|FG001|Period 1|Withdrawal by Subject|12|||
23404482|NCT01484496|65226627|FG002|Period 1|Withdrawal by Subject|0|||
23404483|NCT01484496|65226628|FG003|Period 1|Withdrawal by Subject|0|||
23404484|NCT01484496|65226625|FG000|Period 1|Lost to Follow-up|2|||
23404485|NCT01484496|65226626|FG001|Period 1|Lost to Follow-up|6|||
23404486|NCT01484496|65226627|FG002|Period 1|Lost to Follow-up|0|||
23404487|NCT01484496|65226628|FG003|Period 1|Lost to Follow-up|0|||
23404488|NCT01484496|65226625|FG000|Period 1|Positive Pregnancy|1|||
23404489|NCT01484496|65226626|FG001|Period 1|Positive Pregnancy|6|||
23404490|NCT01484496|65226627|FG002|Period 1|Positive Pregnancy|0|||
23404491|NCT01484496|65226628|FG003|Period 1|Positive Pregnancy|0|||
23404492|NCT01484496|65226625|FG000|Period 1|Treatment Failure|3|||
23404493|NCT01484496|65226626|FG001|Period 1|Treatment Failure|6|||
23404494|NCT01484496|65226627|FG002|Period 1|Treatment Failure|0|||
23404495|NCT01484496|65226628|FG003|Period 1|Treatment Failure|0|||
23404496|NCT01484496|65226625|FG000|Period 1|Lack of Compliance|2|||
23404497|NCT01484496|65226626|FG001|Period 1|Lack of Compliance|1|||
23404498|NCT01484496|65226627|FG002|Period 1|Lack of Compliance|0|||
23404499|NCT01484496|65226628|FG003|Period 1|Lack of Compliance|0|||
23404500|NCT01484496|65226625|FG000|Period 1|Unable to Visit Site|0|||
23404501|NCT01484496|65226626|FG001|Period 1|Unable to Visit Site|2|||
23404502|NCT01484496|65226627|FG002|Period 1|Unable to Visit Site|0|||
23404503|NCT01484496|65226628|FG003|Period 1|Unable to Visit Site|0|||
23404504|NCT01484496|65226625|FG000|Period 2|Lack of Efficacy|0|||
23404505|NCT01484496|65226626|FG001|Period 2|Lack of Efficacy|0|||
23404506|NCT01484496|65226627|FG002|Period 2|Lack of Efficacy|1|||
23404507|NCT01484496|65226628|FG003|Period 2|Lack of Efficacy|3|||
23404508|NCT01484496|65226625|FG000|Period 2|Adverse Event|0|||
23404509|NCT01484496|65226626|FG001|Period 2|Adverse Event|0|||
23404510|NCT01484496|65226627|FG002|Period 2|Adverse Event|5|||
23404511|NCT01484496|65226628|FG003|Period 2|Adverse Event|13|||
23404512|NCT01484496|65226625|FG000|Period 2|Other|0|||
23404513|NCT01484496|65226626|FG001|Period 2|Other|0|||
23404514|NCT01484496|65226627|FG002|Period 2|Other|9|||
23404515|NCT01484496|65226628|FG003|Period 2|Other|6|||
23404516|NCT00730756|65226629|FG000|Overall Study|Adverse Event|2|||
23404517|NCT00730756|65226630|FG001|Overall Study|Adverse Event|0|||
23404518|NCT00730756|65226629|FG000|Overall Study|Lack of Efficacy|1|||
23404519|NCT00730756|65226630|FG001|Overall Study|Lack of Efficacy|1|||
23404520|NCT00730756|65226629|FG000|Overall Study|Protocol Deviation|1|||
23404521|NCT00730756|65226630|FG001|Overall Study|Protocol Deviation|2|||
23404522|NCT00730756|65226629|FG000|Overall Study|Lost to Follow-up|0|||
23404523|NCT00730756|65226630|FG001|Overall Study|Lost to Follow-up|1|||
23404524|NCT00730756|65226629|FG000|Overall Study|Withdrew Consent|0|||
23404525|NCT00730756|65226630|FG001|Overall Study|Withdrew Consent|1|||
23404526|NCT04828707|65226634|FG000|Overall Study|Lost to Follow-up|3|||
23404527|NCT04828707|65226635|FG001|Overall Study|Lost to Follow-up|2|||
23404528|NCT04828707|65226634|FG000|Overall Study|Withdrawal by Subject|2|||
23404529|NCT04828707|65226635|FG001|Overall Study|Withdrawal by Subject|1|||
23404530|NCT00825994|65226643|FG000|Overall Study|Withdrawal by Subject|2|||
23404531|NCT00825994|65226643|FG000|Overall Study|Lost to Follow-up|1|||
23404532|NCT00825994|65226643|FG000|Overall Study|Protocol Violation|1|||
23404533|NCT00825994|65226643|FG000|Overall Study|Placebo Responder at V2|1|||
23404534|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404535|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404536|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404537|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
23404538|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
23404539|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404540|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
23404541|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
23404542|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
23404543|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
23404544|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
23404545|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
23404546|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
23404547|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
23404548|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
23404549|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
23404550|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404551|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404552|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404553|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404554|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404555|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
23404556|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
23404557|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
23404558|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404559|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404560|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404561|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404562|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404563|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404564|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
23404565|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
23404566|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
23404567|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
23404568|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
23404569|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
23404570|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
23404571|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
23404572|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
23404573|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
23404574|NCT02315703|65226644|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
23404575|NCT02315703|65226645|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
23404576|NCT02315703|65226646|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
23404577|NCT02315703|65226647|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
23404578|NCT02315703|65226648|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
23404579|NCT02315703|65226649|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
23404580|NCT02315703|65226650|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
23404581|NCT02315703|65226651|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
23404582|NCT02315703|65226644|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
23404583|NCT02315703|65226645|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
23404584|NCT02315703|65226646|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404585|NCT02315703|65226647|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404586|NCT02315703|65226648|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404587|NCT02315703|65226649|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404588|NCT02315703|65226650|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404589|NCT02315703|65226651|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
23404590|NCT02315703|65226644|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404591|NCT02315703|65226645|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
23404592|NCT02315703|65226646|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404593|NCT02315703|65226647|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404594|NCT02315703|65226648|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404595|NCT02315703|65226649|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404596|NCT02315703|65226650|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404597|NCT02315703|65226651|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
23404598|NCT02315703|65226644|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
23404599|NCT02315703|65226645|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
23404600|NCT02315703|65226646|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
23404601|NCT02315703|65226647|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
23404602|NCT02315703|65226648|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
23404603|NCT02315703|65226649|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
23404604|NCT02315703|65226650|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
23404605|NCT02315703|65226651|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
23404606|NCT03328832|65226652|FG000|Overall Study|Lost to Follow-up|0|||
23404607|NCT03328832|65226653|FG001|Overall Study|Lost to Follow-up|1|||
23404608|NCT00980148|65226654|FG000|Overall Study|Discharged from facility|89|||
23404609|NCT00980148|65226655|FG001|Overall Study|Discharged from facility|96|||
23404610|NCT00980148|65226654|FG000|Overall Study|Received other antichlamydia treatment|20|||
23404611|NCT00980148|65226655|FG001|Overall Study|Received other antichlamydia treatment|14|||
23404612|NCT00980148|65226654|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
23404613|NCT00980148|65226655|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
23404614|NCT00980148|65226654|FG000|Overall Study|Various other reasons|8|||
23404615|NCT00980148|65226655|FG001|Overall Study|Various other reasons|9|||
23404616|NCT00374595|65226665|FG000|Overall Study|Death|23|||
23404617|NCT00374595|65226665|FG000|Overall Study|Withdrawal by Subject|39|||
23404618|NCT00374595|65226665|FG000|Overall Study|Lost to Follow-up|3|||
23404619|NCT00374595|65226665|FG000|Overall Study|too much time commitment|1|||
23303464|NCT03096847|64854668|FG000|Overall Study|Protocol Violation|3|||
23404620|NCT00374595|65226665|FG000|Overall Study|transfer care to other clinical site|1|||
23404621|NCT00374595|65226665|FG000|Overall Study|relocation|3|||
23404622|NCT00551031|65226667|FG000|Overall Study|Adverse Event|0|||
23404623|NCT00551031|65226668|FG001|Overall Study|Adverse Event|1|||
23404624|NCT00551031|65226669|FG002|Overall Study|Adverse Event|0|||
23404625|NCT00551031|65226670|FG003|Overall Study|Adverse Event|0|||
23404626|NCT00551031|65226671|FG004|Overall Study|Adverse Event|0|||
23404627|NCT00551031|65226667|FG000|Overall Study|Protocol Violation|1|||
23404628|NCT00551031|65226668|FG001|Overall Study|Protocol Violation|1|||
23404629|NCT00551031|65226669|FG002|Overall Study|Protocol Violation|0|||
23404630|NCT00551031|65226670|FG003|Overall Study|Protocol Violation|0|||
23404631|NCT00551031|65226671|FG004|Overall Study|Protocol Violation|0|||
23404632|NCT00551031|65226667|FG000|Overall Study|Lost to Follow-up|0|||
23404633|NCT00551031|65226668|FG001|Overall Study|Lost to Follow-up|1|||
23404634|NCT00551031|65226669|FG002|Overall Study|Lost to Follow-up|0|||
23404635|NCT00551031|65226670|FG003|Overall Study|Lost to Follow-up|1|||
23404636|NCT00551031|65226671|FG004|Overall Study|Lost to Follow-up|1|||
23404637|NCT00551031|65226667|FG000|Overall Study|Withdrawal by Subject|0|||
23404638|NCT00551031|65226668|FG001|Overall Study|Withdrawal by Subject|4|||
23404639|NCT00551031|65226669|FG002|Overall Study|Withdrawal by Subject|1|||
23404640|NCT00551031|65226670|FG003|Overall Study|Withdrawal by Subject|2|||
23404641|NCT00551031|65226671|FG004|Overall Study|Withdrawal by Subject|0|||
23404642|NCT00551031|65226667|FG000|Overall Study|Serious Adverse Event|0|||
23404643|NCT00551031|65226668|FG001|Overall Study|Serious Adverse Event|2|||
23404644|NCT00551031|65226669|FG002|Overall Study|Serious Adverse Event|1|||
23404645|NCT00551031|65226670|FG003|Overall Study|Serious Adverse Event|0|||
23404646|NCT00551031|65226671|FG004|Overall Study|Serious Adverse Event|0|||
23404647|NCT00551031|65226667|FG000|Overall Study|Did not receive vaccine|1|||
23404648|NCT00551031|65226668|FG001|Overall Study|Did not receive vaccine|2|||
23404649|NCT00551031|65226669|FG002|Overall Study|Did not receive vaccine|0|||
23404650|NCT00551031|65226670|FG003|Overall Study|Did not receive vaccine|0|||
23404651|NCT00551031|65226671|FG004|Overall Study|Did not receive vaccine|0|||
23404652|NCT00600067|65226673|FG000|Overall Study|Adverse Event|0|||
23404653|NCT00600067|65226674|FG001|Overall Study|Adverse Event|1|||
23404654|NCT00600067|65226673|FG000|Overall Study|Lost to Follow-up|2|||
23404655|NCT00600067|65226674|FG001|Overall Study|Lost to Follow-up|3|||
23404656|NCT00600067|65226673|FG000|Overall Study|protocol non-compliance|0|||
23404657|NCT00600067|65226674|FG001|Overall Study|protocol non-compliance|3|||
23404658|NCT00600067|65226673|FG000|Overall Study|Lack of Efficacy|1|||
23404659|NCT00600067|65226674|FG001|Overall Study|Lack of Efficacy|0|||
23404660|NCT01581684|65226675|FG000|Overall Study|Other reason not defined|0|||
23404661|NCT01581684|65226676|FG001|Overall Study|Other reason not defined|0|||
23404662|NCT01581684|65226677|FG002|Overall Study|Other reason not defined|0|||
23404663|NCT01581684|65226678|FG003|Overall Study|Other reason not defined|0|||
23404664|NCT01581684|65226679|FG004|Overall Study|Other reason not defined|0|||
23404665|NCT01581684|65226680|FG005|Overall Study|Other reason not defined|0|||
23404666|NCT01581684|65226681|FG006|Overall Study|Other reason not defined|0|||
23404667|NCT01581684|65226682|FG007|Overall Study|Other reason not defined|0|||
23404668|NCT01581684|65226683|FG008|Overall Study|Other reason not defined|1|||
23404669|NCT01581684|65226684|FG009|Overall Study|Other reason not defined|0|||
23404670|NCT01451749|65226685|FG000|Overall Study|Protocol Violation|14|||
23404671|NCT01451749|65226686|FG001|Overall Study|Protocol Violation|7|||
23404672|NCT01451749|65226685|FG000|Overall Study|Lost to Follow-up|15|||
23404673|NCT01451749|65226686|FG001|Overall Study|Lost to Follow-up|5|||
23404674|NCT01451749|65226685|FG000|Overall Study|Meet the exclusion criteria,and|1|||
23404675|NCT01451749|65226686|FG001|Overall Study|Meet the exclusion criteria,and|1|||
23404676|NCT01451749|65226685|FG000|Overall Study|Adverse Event|2|||
23404677|NCT01451749|65226686|FG001|Overall Study|Adverse Event|0|||
23404678|NCT01451749|65226685|FG000|Overall Study|Withdrawal by Subject|0|||
23404679|NCT01451749|65226686|FG001|Overall Study|Withdrawal by Subject|1|||
23404680|NCT04011735|65226687|FG000|Overall Study|Withdrawal by Subject|1|||
23404681|NCT04011735|65226688|FG001|Overall Study|Withdrawal by Subject|0|||
23404682|NCT04011735|65226689|FG002|Overall Study|Withdrawal by Subject|1|||
23404683|NCT04011735|65226687|FG000|Overall Study|Met exclusion criteria after study entry|0|||
23404684|NCT04011735|65226688|FG001|Overall Study|Met exclusion criteria after study entry|1|||
23404685|NCT04011735|65226689|FG002|Overall Study|Met exclusion criteria after study entry|0|||
23404686|NCT00473889|65226690|FG000|Overall Study|Did not receive study medication|1|||
23404687|NCT00473889|65226691|FG001|Overall Study|Did not receive study medication|4|||
23404688|NCT00473889|65226690|FG000|Overall Study|Adverse Event|30|||
23404689|NCT00473889|65226691|FG001|Overall Study|Adverse Event|17|||
23404690|NCT00473889|65226690|FG000|Overall Study|Protocol Violation|4|||
23404691|NCT00473889|65226691|FG001|Overall Study|Protocol Violation|2|||
23404692|NCT00473889|65226690|FG000|Overall Study|Lack of Efficacy|28|||
23404693|NCT00473889|65226691|FG001|Overall Study|Lack of Efficacy|29|||
23404694|NCT00473889|65226690|FG000|Overall Study|Lost to Follow-up|2|||
23404695|NCT00473889|65226691|FG001|Overall Study|Lost to Follow-up|1|||
23404696|NCT00473889|65226690|FG000|Overall Study|Physician Decision|10|||
23404697|NCT00473889|65226691|FG001|Overall Study|Physician Decision|5|||
23404698|NCT00473889|65226690|FG000|Overall Study|Trial Terminated|3|||
23404699|NCT00473889|65226691|FG001|Overall Study|Trial Terminated|6|||
23404700|NCT00473889|65226690|FG000|Overall Study|Withdrawal by Subject|5|||
23404701|NCT00473889|65226691|FG001|Overall Study|Withdrawal by Subject|0|||
23404702|NCT04263766|65226692|FG000|Overall Study|Withdrawal by Subject|6|||
23404703|NCT04263766|65226693|FG001|Overall Study|Withdrawal by Subject|4|||
23404704|NCT04263766|65226692|FG000|Overall Study|Lack of Efficacy|1|||
23404705|NCT04263766|65226693|FG001|Overall Study|Lack of Efficacy|3|||
23404706|NCT00937495|65226695|FG000|Overall Study|Protocol Violation|2|||
23404707|NCT02852967|65226697|FG000|Overall Study|Adverse Event|3|||
23404708|NCT02852967|65226698|FG001|Overall Study|Adverse Event|1|||
23404709|NCT02852967|65226699|FG002|Overall Study|Adverse Event|0|||
23404710|NCT02852967|65226700|FG003|Overall Study|Adverse Event|1|||
23404711|NCT02852967|65226701|FG004|Overall Study|Adverse Event|0|||
23404712|NCT02852967|65226697|FG000|Overall Study|Death|1|||
23404713|NCT02852967|65226698|FG001|Overall Study|Death|0|||
23606678|NCT00048932|65950452|FG000|Open Label Period (OL)|Trial Terminated|0|||
23606679|NCT00048932|65950453|FG001|Open Label Period (OL)|Trial Terminated|0|||
23606680|NCT00048932|65950454|FG002|Open Label Period (OL)|Trial Terminated|1|||
23606681|NCT00048932|65950452|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
23606682|NCT00048932|65950453|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
23606683|NCT00048932|65950454|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
23606684|NCT00048932|65950452|FG000|Open Label Period (OL)|Patient Decision|0|||
23606685|NCT00048932|65950453|FG001|Open Label Period (OL)|Patient Decision|0|||
23606686|NCT00048932|65950454|FG002|Open Label Period (OL)|Patient Decision|4|||
23606687|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
23606688|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
23606689|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
23606690|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
23606691|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
23606692|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
23606693|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
23606694|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
23606695|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
23606696|NCT00048932|65950452|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
23606697|NCT00048932|65950453|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
23606698|NCT00048932|65950454|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
23606699|NCT00048932|65950452|FG000|Open Label Period (OL)|Investigator Decision|0|||
23606700|NCT00048932|65950453|FG001|Open Label Period (OL)|Investigator Decision|0|||
23606701|NCT00048932|65950454|FG002|Open Label Period (OL)|Investigator Decision|4|||
23606702|NCT00048932|65950452|FG000|Open Label Period (OL)|Site Staff Issues|0|||
23606703|NCT00048932|65950453|FG001|Open Label Period (OL)|Site Staff Issues|0|||
23606704|NCT00048932|65950454|FG002|Open Label Period (OL)|Site Staff Issues|2|||
23606705|NCT00048932|65950452|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
23606706|NCT00048932|65950453|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
23606707|NCT00048932|65950454|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
23606708|NCT00048932|65950452|FG000|Open Label Period (OL)|Participant Surgery|0|||
23606709|NCT00048932|65950453|FG001|Open Label Period (OL)|Participant Surgery|0|||
23606710|NCT00048932|65950454|FG002|Open Label Period (OL)|Participant Surgery|1|||
23606711|NCT02924051|65950455|FG000|Overall Study|Withdrawal by Subject|1|||
23606712|NCT02924051|65950456|FG001|Overall Study|Withdrawal by Subject|9|||
23606713|NCT03560206|65950458|FG000|Overall Study|Lost to Follow-up|19|||
23606714|NCT03560206|65950459|FG001|Overall Study|Lost to Follow-up|11|||
23606715|NCT03560206|65950458|FG000|Overall Study|Withdrawal by Subject|2|||
23606716|NCT03560206|65950459|FG001|Overall Study|Withdrawal by Subject|4|||
23606717|NCT03560206|65950458|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
23606718|NCT03560206|65950459|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
23606719|NCT03560206|65950458|FG000|Overall Study|Busy schedule|14|||
23606720|NCT03560206|65950459|FG001|Overall Study|Busy schedule|2|||
23606721|NCT03560206|65950458|FG000|Overall Study|patients' new health condition such as cancer|10|||
23303465|NCT03096847|64854669|FG001|Overall Study|Protocol Violation|0|||
23404714|NCT02852967|65226699|FG002|Overall Study|Death|0|||
23404715|NCT02852967|65226700|FG003|Overall Study|Death|0|||
23404716|NCT02852967|65226701|FG004|Overall Study|Death|0|||
23404717|NCT02852967|65226697|FG000|Overall Study|Lost to Follow-up|1|||
23404718|NCT02852967|65226698|FG001|Overall Study|Lost to Follow-up|2|||
23404719|NCT02852967|65226699|FG002|Overall Study|Lost to Follow-up|3|||
23404720|NCT02852967|65226700|FG003|Overall Study|Lost to Follow-up|4|||
23404721|NCT02852967|65226701|FG004|Overall Study|Lost to Follow-up|4|||
23404722|NCT02852967|65226697|FG000|Overall Study|Withdrawal by Subject|6|||
23404723|NCT02852967|65226698|FG001|Overall Study|Withdrawal by Subject|12|||
23606722|NCT03560206|65950459|FG001|Overall Study|patients' new health condition such as cancer|1|||
23606723|NCT00237809|65950460|FG000|Overall Study|Lost to Follow-up|11|||
23606724|NCT00237809|65950461|FG001|Overall Study|Lost to Follow-up|10|||
23404724|NCT02852967|65226699|FG002|Overall Study|Withdrawal by Subject|7|||
23404725|NCT02852967|65226700|FG003|Overall Study|Withdrawal by Subject|10|||
23404726|NCT02852967|65226701|FG004|Overall Study|Withdrawal by Subject|10|||
23404727|NCT02852967|65226697|FG000|Overall Study|SAE|0|||
23404728|NCT02852967|65226698|FG001|Overall Study|SAE|0|||
23404729|NCT02852967|65226699|FG002|Overall Study|SAE|0|||
23404730|NCT02852967|65226700|FG003|Overall Study|SAE|3|||
23404731|NCT02852967|65226701|FG004|Overall Study|SAE|0|||
23404732|NCT02852967|65226697|FG000|Overall Study|Elevated Liver Enzymes|2|||
23404733|NCT02852967|65226698|FG001|Overall Study|Elevated Liver Enzymes|0|||
23404734|NCT02852967|65226699|FG002|Overall Study|Elevated Liver Enzymes|0|||
23404735|NCT02852967|65226700|FG003|Overall Study|Elevated Liver Enzymes|2|||
23606725|NCT00237809|65950462|FG002|Overall Study|Lost to Follow-up|9|||
23606726|NCT00237809|65950463|FG003|Overall Study|Lost to Follow-up|9|||
23606727|NCT00458783|65950464|FG000|Overall Study|Protocol Violation|1228|||
23606728|NCT00458783|65950465|FG001|Overall Study|Protocol Violation|1220|||
23404736|NCT02852967|65226701|FG004|Overall Study|Elevated Liver Enzymes|2|||
23404737|NCT02852967|65226697|FG000|Overall Study|Physician Decision|0|||
23404738|NCT02852967|65226698|FG001|Overall Study|Physician Decision|0|||
23404739|NCT02852967|65226699|FG002|Overall Study|Physician Decision|0|||
23404740|NCT02852967|65226700|FG003|Overall Study|Physician Decision|1|||
23404741|NCT02852967|65226701|FG004|Overall Study|Physician Decision|0|||
23404742|NCT02852967|65226697|FG000|Overall Study|Lack of Efficacy|0|||
23606729|NCT04497415|65950468|FG000|Overall Study|Lost to Follow-up|43|||
23606730|NCT04497415|65950469|FG001|Overall Study|Lost to Follow-up|27|||
23606731|NCT00990184|65950474|FG000|Overall Study|Physician Decision|1|||
23606732|NCT02514824|65950480|FG000|Overall Study|Withdrawal by Subject|1|||
23606733|NCT02514824|65950481|FG001|Overall Study|Withdrawal by Subject|0|||
23606734|NCT02514824|65950482|FG002|Overall Study|Withdrawal by Subject|0|||
23606735|NCT02514824|65950483|FG003|Overall Study|Withdrawal by Subject|0|||
23606736|NCT02514824|65950480|FG000|Overall Study|Dose-Limiting Toxicity|0|||
23606737|NCT02514824|65950481|FG001|Overall Study|Dose-Limiting Toxicity|1|||
23606738|NCT02514824|65950482|FG002|Overall Study|Dose-Limiting Toxicity|0|||
23606739|NCT02514824|65950483|FG003|Overall Study|Dose-Limiting Toxicity|0|||
23606740|NCT03611556|65950484|FG000|Overall Study|Death|7|||
23606741|NCT03611556|65950485|FG001|Overall Study|Death|7|||
23606742|NCT03611556|65950486|FG002|Overall Study|Death|3|||
23606743|NCT03611556|65950487|FG003|Overall Study|Death|8|||
23606744|NCT03611556|65950488|FG004|Overall Study|Death|47|||
23606745|NCT03611556|65950489|FG005|Overall Study|Death|32|||
23606746|NCT03611556|65950490|FG006|Overall Study|Death|53|||
23606747|NCT03611556|65950484|FG000|Overall Study|Withdrawal by Subject|0|||
23606748|NCT03611556|65950485|FG001|Overall Study|Withdrawal by Subject|0|||
23606749|NCT03611556|65950486|FG002|Overall Study|Withdrawal by Subject|0|||
23606750|NCT03611556|65950487|FG003|Overall Study|Withdrawal by Subject|0|||
23606751|NCT03611556|65950488|FG004|Overall Study|Withdrawal by Subject|4|||
23606752|NCT03611556|65950489|FG005|Overall Study|Withdrawal by Subject|2|||
23606753|NCT03611556|65950490|FG006|Overall Study|Withdrawal by Subject|4|||
23606754|NCT03611556|65950484|FG000|Overall Study|Sponsor decision|0|||
23606755|NCT03611556|65950485|FG001|Overall Study|Sponsor decision|0|||
23606756|NCT03611556|65950486|FG002|Overall Study|Sponsor decision|0|||
23606757|NCT03611556|65950487|FG003|Overall Study|Sponsor decision|0|||
23606758|NCT03611556|65950488|FG004|Overall Study|Sponsor decision|9|||
23606759|NCT03611556|65950489|FG005|Overall Study|Sponsor decision|4|||
23606760|NCT03611556|65950490|FG006|Overall Study|Sponsor decision|12|||
23606761|NCT03611556|65950484|FG000|Overall Study|Reasons|0|||
23606762|NCT03611556|65950485|FG001|Overall Study|Reasons|0|||
23606763|NCT03611556|65950486|FG002|Overall Study|Reasons|0|||
23606764|NCT03611556|65950487|FG003|Overall Study|Reasons|0|||
23606765|NCT03611556|65950488|FG004|Overall Study|Reasons|2|||
23606766|NCT03611556|65950489|FG005|Overall Study|Reasons|0|||
23606767|NCT03611556|65950490|FG006|Overall Study|Reasons|1|||
23606768|NCT01052714|65950491|FG000|Overall Study|Adverse Event|6|||
23606769|NCT01052714|65950492|FG001|Overall Study|Adverse Event|3|||
23606770|NCT01052714|65950493|FG002|Overall Study|Adverse Event|0|||
23606771|NCT01052714|65950491|FG000|Overall Study|Death|1|||
23606772|NCT01052714|65950492|FG001|Overall Study|Death|2|||
23606773|NCT01052714|65950493|FG002|Overall Study|Death|0|||
23303466|NCT03096847|64854670|FG002|Overall Study|Protocol Violation|6|||
23404743|NCT02852967|65226698|FG001|Overall Study|Lack of Efficacy|1|||
23606774|NCT01052714|65950491|FG000|Overall Study|Lost to Follow-up|2|||
23606775|NCT01052714|65950492|FG001|Overall Study|Lost to Follow-up|3|||
23606776|NCT01052714|65950493|FG002|Overall Study|Lost to Follow-up|0|||
23606777|NCT01052714|65950491|FG000|Overall Study|Physician Decision|9|||
23606778|NCT01052714|65950492|FG001|Overall Study|Physician Decision|9|||
23606779|NCT01052714|65950493|FG002|Overall Study|Physician Decision|1|||
23606780|NCT01052714|65950491|FG000|Overall Study|Withdrawal by Subject|7|||
23606781|NCT01052714|65950492|FG001|Overall Study|Withdrawal by Subject|12|||
23606782|NCT01052714|65950493|FG002|Overall Study|Withdrawal by Subject|1|||
23606783|NCT03142932|65950495|FG000|Overall Study|Lost to Follow-up|2|||
23606784|NCT03142932|65950496|FG001|Overall Study|Lost to Follow-up|11|||
23606785|NCT01480258|65950497|FG000|Infant Series|Protocol Violation|2|||
23606786|NCT01480258|65950498|FG001|Infant Series|Protocol Violation|0|||
23606787|NCT01480258|65950497|FG000|Infant Series|Physician Decision|0|||
23606788|NCT01480258|65950498|FG001|Infant Series|Physician Decision|1|||
23606789|NCT01480258|65950497|FG000|Infant Series|Not Vaccinated|3|||
23606790|NCT01480258|65950498|FG001|Infant Series|Not Vaccinated|0|||
23606791|NCT01480258|65950497|FG000|Infant Series|Adverse Event|1|||
23606792|NCT01480258|65950498|FG001|Infant Series|Adverse Event|1|||
23606793|NCT01480258|65950497|FG000|Infant Series|Withdrawal by Subject|1|||
23606794|NCT01480258|65950498|FG001|Infant Series|Withdrawal by Subject|6|||
23606795|NCT01480258|65950497|FG000|Interim Period|Lost to Follow-up|0|||
23606796|NCT01480258|65950498|FG001|Interim Period|Lost to Follow-up|2|||
23606797|NCT01480258|65950497|FG000|Interim Period|Physician Decision|1|||
23606798|NCT01480258|65950498|FG001|Interim Period|Physician Decision|0|||
23606799|NCT01480258|65950497|FG000|Interim Period|Protocol Violation|0|||
23606800|NCT01480258|65950498|FG001|Interim Period|Protocol Violation|1|||
23606801|NCT01480258|65950497|FG000|Interim Period|Withdrawal by Subject|9|||
23606802|NCT01480258|65950498|FG001|Interim Period|Withdrawal by Subject|6|||
23606803|NCT01829711|65950499|FG000|Overall Study|Lost to Follow-up|2|||
23606804|NCT01829711|65950499|FG000|Overall Study|Withdrawal by Subject|3|||
23606805|NCT01829711|65950499|FG000|Overall Study|Death|4|||
23606806|NCT01829711|65950499|FG000|Overall Study|Started new therapies|17|||
23606807|NCT01829711|65950499|FG000|Overall Study|Adverse Event|3|||
23606808|NCT01829711|65950499|FG000|Overall Study|Due to progression of disease|13|||
23606809|NCT01829711|65950499|FG000|Overall Study|Due to lack of response|1|||
23606810|NCT03979040|65950500|FG000|Overall Study|Withdrawal by Subject|24|||
23606811|NCT03979040|65950501|FG001|Overall Study|Withdrawal by Subject|32|||
23606812|NCT03979040|65950500|FG000|Overall Study|randomized but never started treatment|32|||
23606813|NCT03979040|65950501|FG001|Overall Study|randomized but never started treatment|39|||
23606814|NCT03979040|65950500|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
23606815|NCT03979040|65950501|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
23606816|NCT03002194|65950510|FG000|Overall Study|Lost to Follow-up|6|||
23606817|NCT03002194|65950510|FG000|Overall Study|Adverse Event|1|||
23606818|NCT03002194|65950510|FG000|Overall Study|Lack of Efficacy|1|||
23606819|NCT03002194|65950510|FG000|Overall Study|Withdrawal by Subject|2|||
23606820|NCT03953079|65950511|FG000|Core Study|Withdrawal by Subject|1|||
23606821|NCT03953079|65950512|FG001|Core Study|Withdrawal by Subject|2|||
23606822|NCT03953079|65950513|FG002|Core Study|Withdrawal by Subject|1|||
23606823|NCT03953079|65950511|FG000|Core Study|COVID-19|0|||
23606824|NCT03953079|65950512|FG001|Core Study|COVID-19|1|||
23606825|NCT03953079|65950513|FG002|Core Study|COVID-19|0|||
23606826|NCT03953079|65950511|FG000|Core Study|Difficulties leaving the house|0|||
23606827|NCT03953079|65950512|FG001|Core Study|Difficulties leaving the house|1|||
23606828|NCT03953079|65950513|FG002|Core Study|Difficulties leaving the house|0|||
23606829|NCT03953079|65950511|FG000|Extension Study|Withdrawal by Subject|1|||
23606830|NCT03953079|65950512|FG001|Extension Study|Withdrawal by Subject|0|||
23606831|NCT03953079|65950513|FG002|Extension Study|Withdrawal by Subject|0|||
23606832|NCT03953079|65950511|FG000|Extension Study|Received Rescue Treatment|5|||
23606833|NCT03953079|65950512|FG001|Extension Study|Received Rescue Treatment|6|||
23606834|NCT03953079|65950513|FG002|Extension Study|Received Rescue Treatment|5|||
23606835|NCT03654326|65950514|FG000|Overall Study|Withdrawal by Subject|5|||
23606836|NCT03654326|65950515|FG001|Overall Study|Withdrawal by Subject|3|||
23606837|NCT03654326|65950514|FG000|Overall Study|Physician Decision|0|||
23606838|NCT03654326|65950515|FG001|Overall Study|Physician Decision|1|||
23606839|NCT03654326|65950514|FG000|Overall Study|Unable to adhere to study schedule|0|||
23606840|NCT03654326|65950515|FG001|Overall Study|Unable to adhere to study schedule|1|||
23606841|NCT03654326|65950514|FG000|Overall Study|Lost to Follow-up|1|||
23606842|NCT03654326|65950515|FG001|Overall Study|Lost to Follow-up|1|||
23606843|NCT01419184|65950516|FG000|Overall Study|Site data not available|3|||
23606844|NCT01419184|65950517|FG001|Overall Study|Site data not available|2|||
23606845|NCT01419184|65950516|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
23606846|NCT01419184|65950517|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
23606847|NCT01419184|65950516|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
23606848|NCT01419184|65950517|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
23204400|NCT04191967|64491038|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
23404744|NCT02852967|65226699|FG002|Overall Study|Lack of Efficacy|0|||
23606849|NCT01419184|65950516|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
23606850|NCT01419184|65950517|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
23606851|NCT01419184|65950516|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
23606852|NCT01419184|65950517|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
23606853|NCT01419184|65950516|FG000|Overall Study|Participant randomized, not treated|1|||
23606854|NCT01419184|65950517|FG001|Overall Study|Participant randomized, not treated|0|||
23606855|NCT03176407|65950520|FG000|Overall Study|Protocol Violation|1|||
23606856|NCT03176407|65950520|FG000|Overall Study|human failure|1|||
23606857|NCT03176407|65950520|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
23606858|NCT02950961|65950522|FG000|Overall Study|Study had to stop due to COVID.|7|||
23606859|NCT00963924|65950523|FG000|Overall Study|Adverse Event|1|||
23606860|NCT00963924|65950524|FG001|Overall Study|Adverse Event|0|||
23606861|NCT00963924|65950523|FG000|Overall Study|Withdrawal by Subject|0|||
23606862|NCT00963924|65950524|FG001|Overall Study|Withdrawal by Subject|1|||
23606863|NCT00963924|65950523|FG000|Overall Study|Changed antipsychotic|0|||
23606864|NCT00963924|65950524|FG001|Overall Study|Changed antipsychotic|1|||
23606865|NCT00963924|65950523|FG000|Overall Study|Lost to Follow-up|0|||
23606866|NCT00963924|65950524|FG001|Overall Study|Lost to Follow-up|1|||
23606867|NCT00346398|65950525|FG000|Overall Study|Lost to Follow-up|3|||
23606868|NCT00346398|65950526|FG001|Overall Study|Lost to Follow-up|0|||
23404745|NCT02852967|65226700|FG003|Overall Study|Lack of Efficacy|0|||
23404746|NCT02852967|65226701|FG004|Overall Study|Lack of Efficacy|0|||
23404747|NCT02852967|65226697|FG000|Overall Study|Non-compliance|0|||
23404748|NCT02852967|65226698|FG001|Overall Study|Non-compliance|0|||
23404749|NCT02852967|65226699|FG002|Overall Study|Non-compliance|1|||
23404750|NCT02852967|65226700|FG003|Overall Study|Non-compliance|1|||
23404751|NCT02852967|65226701|FG004|Overall Study|Non-compliance|0|||
23404752|NCT02852967|65226697|FG000|Overall Study|Dispensing Drug Violation|0|||
23404753|NCT02852967|65226698|FG001|Overall Study|Dispensing Drug Violation|0|||
23404754|NCT02852967|65226699|FG002|Overall Study|Dispensing Drug Violation|1|||
23404755|NCT02852967|65226700|FG003|Overall Study|Dispensing Drug Violation|0|||
23404756|NCT02852967|65226701|FG004|Overall Study|Dispensing Drug Violation|0|||
23404757|NCT02852967|65226697|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
23404758|NCT02852967|65226698|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
23404759|NCT02852967|65226699|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
23404760|NCT02852967|65226700|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
23404761|NCT02852967|65226701|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
23404762|NCT00310375|65226702|FG000|Primary Reporting Phase|Adverse Event|28|||
23404763|NCT00310375|65226703|FG001|Primary Reporting Phase|Adverse Event|22|||
23404764|NCT00310375|65226704|FG002|Primary Reporting Phase|Adverse Event|0|||
23404765|NCT00310375|65226702|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
23404766|NCT00310375|65226703|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
23404767|NCT00310375|65226704|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
23404768|NCT00310375|65226702|FG000|Primary Reporting Phase|Pregnancy|2|||
23404769|NCT00310375|65226703|FG001|Primary Reporting Phase|Pregnancy|2|||
23404770|NCT00310375|65226704|FG002|Primary Reporting Phase|Pregnancy|0|||
23404771|NCT00310375|65226702|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
23404772|NCT00310375|65226703|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
23404773|NCT00310375|65226704|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
23404774|NCT00310375|65226702|FG000|Primary Reporting Phase|Protocol Violation|8|||
23404775|NCT00310375|65226703|FG001|Primary Reporting Phase|Protocol Violation|5|||
23404776|NCT00310375|65226704|FG002|Primary Reporting Phase|Protocol Violation|0|||
23404777|NCT00310375|65226702|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
23404778|NCT00310375|65226703|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
23404779|NCT00310375|65226704|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
23404780|NCT00310375|65226702|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
23404781|NCT00310375|65226703|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
23404782|NCT00310375|65226704|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
23404783|NCT00310375|65226702|FG000|Primary Reporting Phase|Physician Decision|5|||
23404784|NCT00310375|65226703|FG001|Primary Reporting Phase|Physician Decision|3|||
23404785|NCT00310375|65226704|FG002|Primary Reporting Phase|Physician Decision|0|||
23404786|NCT00310375|65226702|FG000|Primary Reporting Phase|Request of the sponsor|2|||
23404787|NCT00310375|65226703|FG001|Primary Reporting Phase|Request of the sponsor|2|||
23404788|NCT00310375|65226704|FG002|Primary Reporting Phase|Request of the sponsor|0|||
23404789|NCT00310375|65226702|FG000|Primary Reporting Phase|Failed to return|1|||
23404790|NCT00310375|65226703|FG001|Primary Reporting Phase|Failed to return|3|||
23404791|NCT00310375|65226704|FG002|Primary Reporting Phase|Failed to return|0|||
23404792|NCT00310375|65226702|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
23404793|NCT00310375|65226703|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
23404794|NCT00310375|65226704|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
23404795|NCT00310375|65226702|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
23404796|NCT00310375|65226703|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
23404797|NCT00310375|65226704|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
23404798|NCT00310375|65226702|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
23404799|NCT00310375|65226703|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
23404800|NCT00310375|65226704|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
23404801|NCT00310375|65226702|FG000|Primary Reporting Phase|Site closure|3|||
23404802|NCT00310375|65226703|FG001|Primary Reporting Phase|Site closure|0|||
23404803|NCT00310375|65226704|FG002|Primary Reporting Phase|Site closure|0|||
23606869|NCT00346398|65950525|FG000|Overall Study|Withdrawal by Subject|0|||
23606870|NCT00346398|65950526|FG001|Overall Study|Withdrawal by Subject|2|||
23606871|NCT02699099|65950529|FG000|Overall Study|Adverse Event|1|||
23404804|NCT00310375|65226702|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
23404805|NCT00310375|65226703|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
23404806|NCT00310375|65226704|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
23404807|NCT00310375|65226702|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
23404808|NCT00310375|65226703|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
23404809|NCT00310375|65226704|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
23404810|NCT00310375|65226702|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
23404811|NCT00310375|65226703|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
23404812|NCT00310375|65226704|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
23404813|NCT00310375|65226702|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
23404814|NCT00310375|65226703|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
23404815|NCT00310375|65226704|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
23404816|NCT00628446|65226706|FG000|Overall Study|Lost to Follow-up|3|||
23404817|NCT00628446|65226706|FG000|Overall Study|Withdrawal by Subject|1|||
23404818|NCT00628446|65226706|FG000|Overall Study|Protocol Violation|3|||
23404819|NCT01531998|65226710|FG000|Overall Study|Withdrawal by Subject|3|||
23404820|NCT00420381|65226712|FG000|Overall Study|Protocol Violation|1|||
23404821|NCT00645840|65226715|FG000|Overall Study|Protocol Violation|3|||
23404822|NCT02240121|65226716|FG000|Overall Study|Protocol Violation|1|||
23404823|NCT02240121|65226717|FG001|Overall Study|Protocol Violation|2|||
23404824|NCT02240121|65226716|FG000|Overall Study|Physician Decision|0|||
23404825|NCT02240121|65226717|FG001|Overall Study|Physician Decision|1|||
23404826|NCT02240121|65226716|FG000|Overall Study|Change in protocol interpretation|1|||
23404827|NCT02240121|65226717|FG001|Overall Study|Change in protocol interpretation|0|||
23404828|NCT02240121|65226716|FG000|Overall Study|Lack of Efficacy|2|||
23404829|NCT02240121|65226717|FG001|Overall Study|Lack of Efficacy|3|||
23404830|NCT02240121|65226716|FG000|Overall Study|Site closed|1|||
23404831|NCT02240121|65226717|FG001|Overall Study|Site closed|1|||
23404832|NCT02240121|65226716|FG000|Overall Study|Pregnancy|1|||
23404833|NCT02240121|65226717|FG001|Overall Study|Pregnancy|0|||
23404834|NCT02240121|65226716|FG000|Overall Study|Adverse Event|2|||
23404835|NCT02240121|65226717|FG001|Overall Study|Adverse Event|4|||
23404836|NCT02240121|65226716|FG000|Overall Study|Withdrawal by Subject|6|||
23404837|NCT02240121|65226717|FG001|Overall Study|Withdrawal by Subject|2|||
23606872|NCT02699099|65950530|FG001|Overall Study|Adverse Event|0|||
23606873|NCT02699099|65950531|FG002|Overall Study|Adverse Event|2|||
23606874|NCT02699099|65950529|FG000|Overall Study|Lost to Follow-up|0|||
23606875|NCT02699099|65950530|FG001|Overall Study|Lost to Follow-up|1|||
23404838|NCT02240121|65226716|FG000|Overall Study|Lost to Follow-up|3|||
23404839|NCT02240121|65226717|FG001|Overall Study|Lost to Follow-up|4|||
23404840|NCT02240121|65226716|FG000|Overall Study|Other than specified|1|||
23404841|NCT02240121|65226717|FG001|Overall Study|Other than specified|3|||
23404842|NCT03894891|65226718|FG000|Overall Study|Withdrawal by Subject|1|||
23404843|NCT03894891|65226718|FG000|Overall Study|Completed protocol treatment per protocol|5|||
23404844|NCT01055613|65226719|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
23404845|NCT01055613|65226720|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23404846|NCT01055613|65226719|FG000|Overall Study|Unacceptable lens fit|1|||
23404847|NCT01055613|65226720|FG001|Overall Study|Unacceptable lens fit|0|||
23404848|NCT01055613|65226719|FG000|Overall Study|Discomfort|2|||
23404849|NCT01055613|65226720|FG001|Overall Study|Discomfort|1|||
23404850|NCT01055613|65226719|FG000|Overall Study|Lost to Follow-up|1|||
23404851|NCT01055613|65226720|FG001|Overall Study|Lost to Follow-up|1|||
23404852|NCT01055613|65226719|FG000|Overall Study|Protocol Violation|1|||
23404853|NCT01055613|65226720|FG001|Overall Study|Protocol Violation|1|||
23404854|NCT01055613|65226719|FG000|Overall Study|Subject Disinterest|1|||
23404855|NCT01055613|65226720|FG001|Overall Study|Subject Disinterest|1|||
23404856|NCT02131311|65226721|FG000|Overall Study|Adverse Event|2|||
23404857|NCT02131311|65226721|FG000|Overall Study|Protocol Violation|1|||
23404858|NCT02131311|65226721|FG000|Overall Study|Lost to Follow-up|1|||
23404859|NCT00363311|65226726|FG000|Overall Study|Adverse Event|6|||
23404860|NCT00363311|65226727|FG001|Overall Study|Adverse Event|4|||
23404861|NCT00363311|65226726|FG000|Overall Study|Lost to Follow-up|3|||
23404862|NCT00363311|65226727|FG001|Overall Study|Lost to Follow-up|0|||
23404863|NCT00363311|65226726|FG000|Overall Study|Protocol Violation|1|||
23404864|NCT00363311|65226727|FG001|Overall Study|Protocol Violation|2|||
23404865|NCT00363311|65226726|FG000|Overall Study|Withdrawal by Subject|12|||
23404866|NCT00363311|65226727|FG001|Overall Study|Withdrawal by Subject|6|||
23404867|NCT00363311|65226726|FG000|Overall Study|Physician Decision|1|||
23404868|NCT00363311|65226727|FG001|Overall Study|Physician Decision|1|||
23404869|NCT00363311|65226726|FG000|Overall Study|Sponsor Terminated Study|2|||
23404870|NCT00363311|65226727|FG001|Overall Study|Sponsor Terminated Study|2|||
23404871|NCT00363311|65226726|FG000|Overall Study|Disease Progression|46|||
23404872|NCT00363311|65226727|FG001|Overall Study|Disease Progression|26|||
23404873|NCT00363311|65226726|FG000|Overall Study|Non-Compliance|1|||
23404874|NCT00363311|65226727|FG001|Overall Study|Non-Compliance|1|||
23606876|NCT02699099|65950531|FG002|Overall Study|Lost to Follow-up|0|||
23404875|NCT00363311|65226726|FG000|Overall Study|Participant Refused Biopsy|1|||
23404876|NCT00363311|65226727|FG001|Overall Study|Participant Refused Biopsy|0|||
23404877|NCT00363311|65226726|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
23404878|NCT00363311|65226727|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
23404879|NCT00363311|65226726|FG000|Overall Study|Participant Opted for Treatment|1|||
23404880|NCT00363311|65226727|FG001|Overall Study|Participant Opted for Treatment|0|||
23404881|NCT00363311|65226726|FG000|Overall Study|Participant Moved to Another Country|1|||
23404882|NCT00363311|65226727|FG001|Overall Study|Participant Moved to Another Country|0|||
23404883|NCT00363311|65226726|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
23404884|NCT00363311|65226727|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
23404885|NCT00363311|65226726|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
23404886|NCT00363311|65226727|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
23404887|NCT00363311|65226726|FG000|Overall Study|Participant Moved to Louisiana|0|||
23404888|NCT00363311|65226727|FG001|Overall Study|Participant Moved to Louisiana|1|||
23404889|NCT00570323|65229982|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
23404890|NCT00570323|65229983|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
23404891|NCT00570323|65229982|FG000|Started Treatment After Randomization|Protocol Violation|1|||
23404892|NCT00570323|65229983|FG001|Started Treatment After Randomization|Protocol Violation|0|||
23404893|NCT00570323|65229982|FG000|Started Treatment After Randomization|Physician Decision|1|||
23404894|NCT00570323|65229983|FG001|Started Treatment After Randomization|Physician Decision|0|||
23404895|NCT00570323|65229982|FG000|Complete Study After Start|Lost to Follow-up|0|||
23404896|NCT00570323|65229983|FG001|Complete Study After Start|Lost to Follow-up|1|||
23404897|NCT00570323|65229982|FG000|Complete Study After Start|Withdrawal by Subject|2|||
23404898|NCT00570323|65229983|FG001|Complete Study After Start|Withdrawal by Subject|0|||
23404899|NCT00570323|65229982|FG000|Complete Study After Start|Physician Decision|1|||
23404900|NCT00570323|65229983|FG001|Complete Study After Start|Physician Decision|0|||
23404901|NCT03810014|65229984|FG000|Overall Study|Pregnancy|2|||
23404902|NCT03810014|65229985|FG001|Overall Study|Pregnancy|2|||
23404903|NCT03810014|65229986|FG002|Overall Study|Pregnancy|0|||
23404904|NCT03810014|65229987|FG003|Overall Study|Pregnancy|2|||
23404905|NCT00443703|65229989|FG000|Overall Study|Never Treated|3|||
23404906|NCT00443703|65229990|FG001|Overall Study|Never Treated|1|||
23404907|NCT00443703|65229989|FG000|Overall Study|Adverse Event|7|||
23404908|NCT00443703|65229990|FG001|Overall Study|Adverse Event|3|||
23404909|NCT00443703|65229989|FG000|Overall Study|Lack of Efficacy|3|||
23404910|NCT00443703|65229990|FG001|Overall Study|Lack of Efficacy|1|||
23404911|NCT00443703|65229989|FG000|Overall Study|Lost to Follow-up|0|||
23404912|NCT00443703|65229990|FG001|Overall Study|Lost to Follow-up|4|||
23404913|NCT00443703|65229989|FG000|Overall Study|Physician Decision|4|||
23404914|NCT00443703|65229990|FG001|Overall Study|Physician Decision|2|||
23404915|NCT00443703|65229989|FG000|Overall Study|Protocol Violation|1|||
23404916|NCT00443703|65229990|FG001|Overall Study|Protocol Violation|1|||
23404917|NCT00443703|65229989|FG000|Overall Study|Withdrawal by Subject|9|||
23404918|NCT00443703|65229990|FG001|Overall Study|Withdrawal by Subject|6|||
23404919|NCT00443703|65229989|FG000|Overall Study|Progressive Disease|1|||
23404920|NCT00443703|65229990|FG001|Overall Study|Progressive Disease|0|||
23404921|NCT00619918|65229991|FG000|Overall Study|Withdrawal by Subject|4|||
23404922|NCT00619918|65229992|FG001|Overall Study|Withdrawal by Subject|3|||
23404923|NCT00619918|65229991|FG000|Overall Study|Physician Decision|8|||
23404924|NCT00619918|65229992|FG001|Overall Study|Physician Decision|8|||
23404925|NCT00619918|65229991|FG000|Overall Study|Transfer to outside facility|3|||
23404926|NCT00619918|65229992|FG001|Overall Study|Transfer to outside facility|3|||
23404927|NCT00619918|65229991|FG000|Overall Study|Left before receiving first dose|5|||
23404928|NCT00619918|65229992|FG001|Overall Study|Left before receiving first dose|8|||
23404929|NCT00444925|65229993|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
23404930|NCT00444925|65229994|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
23404931|NCT00444925|65229995|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
23404932|NCT00444925|65229993|FG000|Double-blind Treatment Period|Death|2|||
23404933|NCT00444925|65229994|FG001|Double-blind Treatment Period|Death|0|||
23404934|NCT00444925|65229995|FG002|Double-blind Treatment Period|Death|0|||
23404935|NCT00444925|65229993|FG000|Double-blind Treatment Period|Adverse Event|6|||
23404936|NCT00444925|65229994|FG001|Double-blind Treatment Period|Adverse Event|28|||
23404937|NCT00444925|65229995|FG002|Double-blind Treatment Period|Adverse Event|44|||
23404938|NCT00444925|65229993|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
23404939|NCT00444925|65229994|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
23404940|NCT00444925|65229995|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
23404941|NCT00444925|65229993|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
23404942|NCT00444925|65229994|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
23404943|NCT00444925|65229995|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
23404944|NCT00444925|65229993|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
23404945|NCT00444925|65229994|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
23404946|NCT00444925|65229995|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
23404947|NCT00444925|65229993|FG000|Double-blind Treatment Period|Other|7|||
23404948|NCT00444925|65229994|FG001|Double-blind Treatment Period|Other|7|||
23404949|NCT00444925|65229995|FG002|Double-blind Treatment Period|Other|12|||
23404950|NCT01963767|65229998|FG000|Overall Study|Withdrawal by Subject|4|||
23404951|NCT01963767|65229999|FG001|Overall Study|Withdrawal by Subject|2|||
23404952|NCT01963767|65229998|FG000|Overall Study|Adverse Event|2|||
23404953|NCT01963767|65229999|FG001|Overall Study|Adverse Event|0|||
23404954|NCT01396187|65230000|FG000|Overall Study|Adverse Event|0|||
23404955|NCT01396187|65230001|FG001|Overall Study|Adverse Event|1|||
23404956|NCT01396187|65230002|FG002|Overall Study|Adverse Event|0|||
23404957|NCT01396187|65230003|FG003|Overall Study|Adverse Event|0|||
23404958|NCT01396187|65230004|FG004|Overall Study|Adverse Event|0|||
23404959|NCT01396187|65230000|FG000|Overall Study|Withdrawal by Subject|0|||
23404960|NCT01396187|65230001|FG001|Overall Study|Withdrawal by Subject|1|||
23404961|NCT01396187|65230002|FG002|Overall Study|Withdrawal by Subject|1|||
23404962|NCT01396187|65230003|FG003|Overall Study|Withdrawal by Subject|0|||
23404963|NCT01396187|65230004|FG004|Overall Study|Withdrawal by Subject|0|||
23404964|NCT01396187|65230000|FG000|Overall Study|Other|1|||
23404965|NCT01396187|65230001|FG001|Overall Study|Other|1|||
23404966|NCT01396187|65230002|FG002|Overall Study|Other|0|||
23404967|NCT01396187|65230003|FG003|Overall Study|Other|0|||
23404968|NCT01396187|65230004|FG004|Overall Study|Other|1|||
23404969|NCT00130039|65230006|FG000|Overall Study|Withdrawal by Subject|15|||
23404970|NCT00130039|65230007|FG001|Overall Study|Withdrawal by Subject|11|||
23404971|NCT00130039|65230006|FG000|Overall Study|Lost to Follow-up|3|||
23404972|NCT00130039|65230007|FG001|Overall Study|Lost to Follow-up|1|||
23404973|NCT00130039|65230006|FG000|Overall Study|Adverse Event|4|||
23404974|NCT00130039|65230007|FG001|Overall Study|Adverse Event|2|||
23404975|NCT00130039|65230006|FG000|Overall Study|Physician Decision|3|||
23404976|NCT00130039|65230007|FG001|Overall Study|Physician Decision|0|||
23404977|NCT00130039|65230006|FG000|Overall Study|clinical events without follow up MRI|5|||
23404978|NCT00130039|65230007|FG001|Overall Study|clinical events without follow up MRI|4|||
23404979|NCT00400517|65230008|FG000|Overall Study|Withdrawal by Subject|1|||
23404980|NCT00400517|65230008|FG000|Overall Study|Physician Decision|1|||
23404981|NCT00837161|65230009|FG000|Overall Study|refused hysterectomy|2|||
23404982|NCT01016067|65230011|FG000|Overall Study|Lost to Follow-up|1|||
23404983|NCT01016067|65230012|FG001|Overall Study|Lost to Follow-up|2|||
23404984|NCT01016067|65230011|FG000|Overall Study|Physician Decision|1|||
23404985|NCT01016067|65230012|FG001|Overall Study|Physician Decision|1|||
23404986|NCT01016067|65230011|FG000|Overall Study|Withdrew due to Relocation|0|||
23404987|NCT01016067|65230012|FG001|Overall Study|Withdrew due to Relocation|1|||
23404988|NCT03547908|65230013|FG000|Overall Study|Still On Study|115|||
23404989|NCT03547908|65230014|FG001|Overall Study|Still On Study|118|||
23404990|NCT03547908|65230013|FG000|Overall Study|Lost to Follow-up|2|||
23404991|NCT03547908|65230014|FG001|Overall Study|Lost to Follow-up|2|||
23404992|NCT03547908|65230013|FG000|Overall Study|Withdrew Consent|2|||
23404993|NCT03547908|65230014|FG001|Overall Study|Withdrew Consent|1|||
23404994|NCT03547908|65230013|FG000|Overall Study|Adverse Event|1|||
23404995|NCT03547908|65230014|FG001|Overall Study|Adverse Event|0|||
23404996|NCT03547908|65230013|FG000|Overall Study|Death|1|||
23404997|NCT03547908|65230014|FG001|Overall Study|Death|0|||
23404998|NCT03547908|65230013|FG000|Overall Study|Investigator's Discretion|0|||
23404999|NCT03547908|65230014|FG001|Overall Study|Investigator's Discretion|1|||
23405000|NCT03547908|65230013|FG000|Overall Study|Randomized But Never Treated|1|||
23405001|NCT03547908|65230014|FG001|Overall Study|Randomized But Never Treated|0|||
23405002|NCT02382991|65230019|FG000|Overall Study|Adverse Event|1|||
23405003|NCT02382991|65230020|FG001|Overall Study|Adverse Event|2|||
23405004|NCT02382991|65230019|FG000|Overall Study|Lost to Follow-up|1|||
23405005|NCT02382991|65230020|FG001|Overall Study|Lost to Follow-up|0|||
23405006|NCT02382991|65230019|FG000|Overall Study|Withdrawal by Subject|0|||
23405007|NCT02382991|65230020|FG001|Overall Study|Withdrawal by Subject|1|||
23405008|NCT00003869|65230021|FG000|Overall Study|Adverse Event|14|||
23405009|NCT00003869|65230022|FG001|Overall Study|Adverse Event|3|||
23405010|NCT00003869|65230021|FG000|Overall Study|Withdrawal by Subject|21|||
23405011|NCT00003869|65230022|FG001|Overall Study|Withdrawal by Subject|3|||
23405012|NCT00003869|65230021|FG000|Overall Study|Death|1|||
23405013|NCT00003869|65230022|FG001|Overall Study|Death|2|||
23405014|NCT00003869|65230021|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
23405015|NCT00003869|65230022|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
23405016|NCT01770743|65230025|FG000|Overall Study|Adverse Event|1|||
23405017|NCT01770743|65230026|FG001|Overall Study|Adverse Event|0|||
23405018|NCT01770743|65230027|FG002|Overall Study|Adverse Event|0|||
23405019|NCT01770743|65230028|FG003|Overall Study|Adverse Event|0|||
23405020|NCT01770743|65230029|FG004|Overall Study|Adverse Event|0|||
23405021|NCT01770743|65230025|FG000|Overall Study|Withdrawal by Subject|0|||
23405022|NCT01770743|65230026|FG001|Overall Study|Withdrawal by Subject|0|||
23405023|NCT01770743|65230027|FG002|Overall Study|Withdrawal by Subject|1|||
23405024|NCT01770743|65230028|FG003|Overall Study|Withdrawal by Subject|1|||
23405025|NCT01770743|65230029|FG004|Overall Study|Withdrawal by Subject|1|||
23405026|NCT01770743|65230025|FG000|Overall Study|Lost to Follow-up|0|||
23405027|NCT01770743|65230026|FG001|Overall Study|Lost to Follow-up|2|||
23405028|NCT01770743|65230027|FG002|Overall Study|Lost to Follow-up|0|||
23405029|NCT01770743|65230028|FG003|Overall Study|Lost to Follow-up|0|||
23405030|NCT01770743|65230029|FG004|Overall Study|Lost to Follow-up|1|||
23405031|NCT01770743|65230025|FG000|Overall Study|Sponsor Terminated Subject|1|||
23405032|NCT01770743|65230026|FG001|Overall Study|Sponsor Terminated Subject|0|||
23405033|NCT01770743|65230027|FG002|Overall Study|Sponsor Terminated Subject|0|||
23405034|NCT01770743|65230028|FG003|Overall Study|Sponsor Terminated Subject|1|||
23405035|NCT01770743|65230029|FG004|Overall Study|Sponsor Terminated Subject|0|||
23405036|NCT01770743|65230025|FG000|Overall Study|Moving Out of State|0|||
23405037|NCT01770743|65230026|FG001|Overall Study|Moving Out of State|1|||
23405038|NCT01770743|65230027|FG002|Overall Study|Moving Out of State|0|||
23405039|NCT01770743|65230028|FG003|Overall Study|Moving Out of State|0|||
23405040|NCT01770743|65230029|FG004|Overall Study|Moving Out of State|0|||
23405041|NCT03542266|65230030|FG000|Treatment Phase|Withdrawal by Subject|1|||
23405042|NCT03542266|65230030|FG000|Treatment Phase|Adverse Event|1|||
23405043|NCT03542266|65230030|FG000|Treatment Phase|PD|1|||
23405044|NCT04389866|65230031|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
23405045|NCT04389866|65230032|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
23405046|NCT01030822|65230034|FG000|Overall Study|Moved/migrated from study area|6|||
23405047|NCT01030822|65230035|FG001|Overall Study|Moved/migrated from study area|7|||
23405048|NCT01030822|65230036|FG002|Overall Study|Moved/migrated from study area|3|||
23405049|NCT01030822|65230034|FG000|Overall Study|Withdrawal by Subject|16|||
23405050|NCT01030822|65230035|FG001|Overall Study|Withdrawal by Subject|13|||
23405051|NCT01030822|65230036|FG002|Overall Study|Withdrawal by Subject|16|||
23405052|NCT01030822|65230034|FG000|Overall Study|Lost to Follow-up|9|||
23405053|NCT01030822|65230035|FG001|Overall Study|Lost to Follow-up|4|||
23405054|NCT01030822|65230036|FG002|Overall Study|Lost to Follow-up|7|||
23405055|NCT01721486|65230041|FG000|Overall Study|Protocol Violation|1|||
23405056|NCT01721486|65230042|FG001|Overall Study|Protocol Violation|0|||
23405057|NCT01721486|65230041|FG000|Overall Study|Physician Decision|0|||
23405058|NCT01721486|65230042|FG001|Overall Study|Physician Decision|1|||
23405059|NCT00355030|65230043|FG000|Study Period 1 Treatment|Adverse Event|1|||
23405060|NCT00355030|65230044|FG001|Study Period 1 Treatment|Adverse Event|1|||
23405061|NCT00355030|65230043|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
23405062|NCT00355030|65230044|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
23405063|NCT00355030|65230043|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
23405064|NCT00355030|65230044|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
23405065|NCT00355030|65230043|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
23405066|NCT00355030|65230044|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
23405067|NCT00355030|65230043|FG000|Study Period 1 Treatment|Physician Decision|0|||
23405068|NCT00355030|65230044|FG001|Study Period 1 Treatment|Physician Decision|1|||
23405069|NCT00355030|65230043|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
23405070|NCT00355030|65230044|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
23405071|NCT00355030|65230043|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
23405072|NCT00355030|65230044|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
23405073|NCT00355030|65230043|FG000|Study Period 1 Treatment|Other|2|||
23405074|NCT00355030|65230044|FG001|Study Period 1 Treatment|Other|6|||
23405075|NCT00355030|65230043|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
23405076|NCT00355030|65230044|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
23405077|NCT00355030|65230043|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
23405078|NCT00355030|65230044|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
23405079|NCT00049322|65230045|FG000|Overall Study|disease burden|0|||
23405080|NCT00049322|65230046|FG001|Overall Study|disease burden|3|||
23405081|NCT00049322|65230045|FG000|Overall Study|Adverse Event|1|||
23405082|NCT00049322|65230046|FG001|Overall Study|Adverse Event|0|||
23405083|NCT00049322|65230045|FG000|Overall Study|refused angio|0|||
23405084|NCT00049322|65230046|FG001|Overall Study|refused angio|3|||
23405085|NCT02375373|65230047|FG000|Overall Study|Withdrawal by Subject|11|||
23405086|NCT02776683|65230049|FG000|Pre-switch Period|Protocol Violation|1|||
23405087|NCT02776683|65230050|FG001|Pre-switch Period|Protocol Violation|0|||
23405088|NCT02776683|65230049|FG000|Pre-switch Period|Adverse Event|21|||
23405089|NCT02776683|65230050|FG001|Pre-switch Period|Adverse Event|0|||
23405090|NCT02776683|65230049|FG000|Pre-switch Period|Withdrawal by Subject|9|||
23405091|NCT02776683|65230050|FG001|Pre-switch Period|Withdrawal by Subject|0|||
23405092|NCT02776683|65230049|FG000|Pre-switch Period|Physician Decision|7|||
23405093|NCT02776683|65230050|FG001|Pre-switch Period|Physician Decision|0|||
23405094|NCT02776683|65230049|FG000|Pre-switch Period|Progressive disease|39|||
23405095|NCT02776683|65230050|FG001|Pre-switch Period|Progressive disease|0|||
23405096|NCT02776683|65230049|FG000|Pre-switch Period|Other than listed|3|||
23405097|NCT02776683|65230050|FG001|Pre-switch Period|Other than listed|0|||
23405098|NCT02776683|65230049|FG000|Post-switch Period|Adverse Event|0|||
23303467|NCT03096847|64854668|FG000|Overall Study|Physician Decision|12|||
23405099|NCT02776683|65230050|FG001|Post-switch Period|Adverse Event|3|||
23405100|NCT02776683|65230049|FG000|Post-switch Period|Withdrawal by Subject|0|||
23405101|NCT02776683|65230050|FG001|Post-switch Period|Withdrawal by Subject|2|||
23405102|NCT02776683|65230049|FG000|Post-switch Period|Physician Decision|0|||
23405103|NCT02776683|65230050|FG001|Post-switch Period|Physician Decision|3|||
23405104|NCT02776683|65230049|FG000|Post-switch Period|Progressive disease|0|||
23405105|NCT02776683|65230050|FG001|Post-switch Period|Progressive disease|20|||
23405106|NCT02776683|65230049|FG000|Post-switch Period|Other than listed|0|||
23405107|NCT02776683|65230050|FG001|Post-switch Period|Other than listed|15|||
23405108|NCT01354223|65230051|FG000|Overall Study|Withdrawal by Subject|3|||
23405109|NCT01354223|65230052|FG001|Overall Study|Withdrawal by Subject|1|||
23405110|NCT01102491|65230053|FG000|Overall Study|Protocol Violation|11|||
23405111|NCT01102491|65230054|FG001|Overall Study|Protocol Violation|12|||
23405112|NCT00700622|65230055|FG000|Overall Study|Adverse Event|4|||
23405113|NCT00700622|65230056|FG001|Overall Study|Adverse Event|0|||
23405114|NCT00700622|65230055|FG000|Overall Study|Lost to Follow-up|0|||
23405115|NCT00700622|65230056|FG001|Overall Study|Lost to Follow-up|1|||
23405116|NCT00700622|65230055|FG000|Overall Study|Physician Decision|2|||
23405117|NCT00700622|65230056|FG001|Overall Study|Physician Decision|1|||
23405118|NCT00700622|65230055|FG000|Overall Study|Protocol Violation|0|||
23606877|NCT02699099|65950529|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
23606878|NCT02699099|65950530|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
23606879|NCT02699099|65950531|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
23606880|NCT03875729|65950532|FG000|Overall Study|Adverse Event|0|||
23405119|NCT00700622|65230056|FG001|Overall Study|Protocol Violation|1|||
23405120|NCT00700622|65230055|FG000|Overall Study|Withdrawal by Subject|4|||
23405121|NCT00700622|65230056|FG001|Overall Study|Withdrawal by Subject|1|||
23405122|NCT00700622|65230055|FG000|Overall Study|Other|3|||
23405123|NCT00700622|65230056|FG001|Overall Study|Other|1|||
23405124|NCT00976716|65230057|FG000|Overall Study|Adverse Event|1|||
23405125|NCT04677543|65230058|FG000|Overall Study|Withdrawal by Subject|4|||
23405126|NCT04677543|65230059|FG001|Overall Study|Withdrawal by Subject|1|||
23405127|NCT04677543|65230058|FG000|Overall Study|Physician Decision|0|||
23405128|NCT04677543|65230059|FG001|Overall Study|Physician Decision|1|||
23405129|NCT04677543|65230058|FG000|Overall Study|Adverse Event|0|||
23405130|NCT04677543|65230059|FG001|Overall Study|Adverse Event|1|||
23405131|NCT03432494|65230069|FG000|Overall Study|Death|1|||
23405132|NCT03432494|65230069|FG000|Overall Study|Noncompliance|1|||
23405133|NCT01898286|65230070|FG000|Overall Study|Withdrawal by Subject|1|||
23405134|NCT01898286|65230070|FG000|Overall Study|Protocol Violation|1|||
23405135|NCT01898286|65230070|FG000|Overall Study|Lost to Follow-up|1|||
23405136|NCT04232943|65230073|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
23405137|NCT04232943|65230074|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
23405138|NCT04232943|65230075|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
23405139|NCT04232943|65230073|FG000|Overall Study|Withdrawal by Subject|1|||
23405140|NCT04232943|65230074|FG001|Overall Study|Withdrawal by Subject|1|||
23405141|NCT04232943|65230075|FG002|Overall Study|Withdrawal by Subject|0|||
23405142|NCT01456130|65230082|FG000|Overall Study|Adverse Event|4|||
23405143|NCT01456130|65230082|FG000|Overall Study|Voluntary Withdrawal|1|||
23405144|NCT01456130|65230082|FG000|Overall Study|Lack of Efficacy|4|||
23405145|NCT01456130|65230082|FG000|Overall Study|Other|1|||
23405146|NCT02639247|65230083|FG000|Overall Study|Lost to Follow-up|2|||
23405147|NCT02639247|65230084|FG001|Overall Study|Lost to Follow-up|1|||
23405148|NCT02639247|65230083|FG000|Overall Study|Death|2|||
23606881|NCT03875729|65950533|FG001|Overall Study|Adverse Event|5|||
23606882|NCT03875729|65950532|FG000|Overall Study|Withdrawal by Subject|8|||
23606883|NCT03875729|65950533|FG001|Overall Study|Withdrawal by Subject|11|||
23606884|NCT03875729|65950532|FG000|Overall Study|Pregnancy|0|||
23606885|NCT03875729|65950533|FG001|Overall Study|Pregnancy|1|||
23606886|NCT03875729|65950532|FG000|Overall Study|Lost to Follow-up|0|||
23606887|NCT03875729|65950533|FG001|Overall Study|Lost to Follow-up|5|||
23606888|NCT03875729|65950532|FG000|Overall Study|Personal reasons|2|||
23606889|NCT03875729|65950533|FG001|Overall Study|Personal reasons|0|||
23606890|NCT04749797|65950534|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
23606891|NCT04749797|65950535|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
23606892|NCT04749797|65950536|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
23606893|NCT03820024|65950537|FG000|Overall Study|Physician Decision|1|||
23606894|NCT03820024|65950538|FG001|Overall Study|Physician Decision|2|||
23606895|NCT03042767|65950539|FG000|Overall Study|Lost to Follow-up|1|||
23405149|NCT02639247|65230084|FG001|Overall Study|Death|0|||
23405150|NCT02639247|65230083|FG000|Overall Study|Withdrew Consent|0|||
23405151|NCT02639247|65230084|FG001|Overall Study|Withdrew Consent|1|||
23405152|NCT02639247|65230083|FG000|Overall Study|Protocol Violation|1|||
23606896|NCT03042767|65950540|FG001|Overall Study|Lost to Follow-up|2|||
23606897|NCT00687297|65950542|FG000|Randomization|Withdrawal by Subject|2|||
23606898|NCT00687297|65950543|FG001|Randomization|Withdrawal by Subject|0|||
23606899|NCT00687297|65950542|FG000|Randomization|Withdrew before treatment, ineligible|1|||
23606900|NCT00687297|65950543|FG001|Randomization|Withdrew before treatment, ineligible|1|||
23606901|NCT00687297|65950542|FG000|Induction|Withdrawal by Subject|4|||
23606902|NCT00687297|65950543|FG001|Induction|Withdrawal by Subject|4|||
23606903|NCT00687297|65950542|FG000|Induction|Adverse Event|16|||
23606904|NCT00687297|65950543|FG001|Induction|Adverse Event|15|||
23606905|NCT00687297|65950542|FG000|Induction|Death|7|||
23606906|NCT00687297|65950543|FG001|Induction|Death|11|||
23606907|NCT00687297|65950542|FG000|Induction|Lack of Efficacy|17|||
23606908|NCT00687297|65950543|FG001|Induction|Lack of Efficacy|21|||
23606909|NCT00687297|65950542|FG000|Induction|Ineligible|0|||
23405153|NCT02639247|65230084|FG001|Overall Study|Protocol Violation|0|||
23405154|NCT01147393|65230085|FG000|Dose Level 1|Dose limiting Toxicity|2|||
23405155|NCT01147393|65230085|FG000|Dose Level -1|Dose Limited Toxicity|1|||
23405156|NCT01856322|65230086|FG000|Overall Study|off study due to lack of accrual|0|||
23405157|NCT01856322|65230087|FG001|Overall Study|off study due to lack of accrual|0|||
23405158|NCT01856322|65230088|FG002|Overall Study|off study due to lack of accrual|3|||
23405159|NCT01265992|65230089|FG000|Overall Study|Lost to Follow-up|1|||
23405160|NCT01265992|65230089|FG000|Overall Study|Withdrawal by Subject|1|||
23405161|NCT01265992|65230089|FG000|Overall Study|Adverse Event|1|||
23405162|NCT01265992|65230089|FG000|Overall Study|Administrative reasons|2|||
23405163|NCT01265992|65230089|FG000|Overall Study|Stopped treatment|3|||
23405164|NCT01265992|65230089|FG000|Overall Study|Did not receive treatment|1|||
23405165|NCT02041299|65230091|FG000|Overall Study|Adverse Event|9|||
23405166|NCT02041299|65230092|FG001|Overall Study|Adverse Event|3|||
23405167|NCT02041299|65230091|FG000|Overall Study|Lost to Follow-up|4|||
23405168|NCT02041299|65230092|FG001|Overall Study|Lost to Follow-up|1|||
23405169|NCT02041299|65230091|FG000|Overall Study|Physician Decision|1|||
23405170|NCT02041299|65230092|FG001|Overall Study|Physician Decision|1|||
23405171|NCT02041299|65230091|FG000|Overall Study|Withdrawal by Subject|13|||
23405172|NCT02041299|65230092|FG001|Overall Study|Withdrawal by Subject|7|||
23405173|NCT02041299|65230091|FG000|Overall Study|Protocol Violation|11|||
23405174|NCT02041299|65230092|FG001|Overall Study|Protocol Violation|4|||
23405175|NCT02041299|65230091|FG000|Overall Study|Termination of the study|7|||
23405176|NCT02041299|65230092|FG001|Overall Study|Termination of the study|3|||
23405177|NCT02041299|65230091|FG000|Overall Study|Required bone marrow transplant|0|||
23405178|NCT02041299|65230092|FG001|Overall Study|Required bone marrow transplant|1|||
23405179|NCT02041299|65230091|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
23405180|NCT02041299|65230092|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
23405181|NCT00945659|65230093|FG000|Overall Study|Lost to Follow-up|7|||
23405182|NCT00945659|65230094|FG001|Overall Study|Lost to Follow-up|20|||
23405183|NCT00945659|65230095|FG002|Overall Study|Lost to Follow-up|17|||
23405184|NCT01123148|65230096|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
23405185|NCT01123148|65230096|FG000|Overall Study|Didn't meet milestone criteria|1|||
23405186|NCT03688919|65230099|FG000|Overall Study|Lost to Follow-up|2|||
23405187|NCT03688919|65230100|FG001|Overall Study|Lost to Follow-up|1|||
23405188|NCT03688919|65230099|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
23405189|NCT03688919|65230100|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
23405190|NCT00590122|65230101|FG000|Overall Study|swallowed oral dissolving dose|1|||
23405191|NCT00590122|65230102|FG001|Overall Study|swallowed oral dissolving dose|0|||
23405192|NCT03382912|65230107|FG000|Overall Study|Physician Decision|0|||
23405193|NCT03382912|65230108|FG001|Overall Study|Physician Decision|1|||
23405194|NCT03382912|65230107|FG000|Overall Study|Sponsor Decision|6|||
23405195|NCT03382912|65230108|FG001|Overall Study|Sponsor Decision|6|||
23405196|NCT03382912|65230107|FG000|Overall Study|Withdrawal by Subject|0|||
23405197|NCT03382912|65230108|FG001|Overall Study|Withdrawal by Subject|5|||
23405198|NCT01775553|65230110|FG000|Overall Study|Adverse Event|1|||
23405199|NCT01775553|65230110|FG000|Overall Study|Disease Progression|12|||
23405200|NCT00670930|65230111|FG000|Overall Study|Adminstrative Problem|0|||
23405201|NCT00670930|65230112|FG001|Overall Study|Adminstrative Problem|1|||
23405202|NCT00670930|65230111|FG000|Overall Study|Lost to Follow-up|1|||
23405203|NCT00670930|65230112|FG001|Overall Study|Lost to Follow-up|0|||
23405204|NCT02457247|65230113|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
23405205|NCT02457247|65230114|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
23405206|NCT02457247|65230115|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
23405207|NCT02457247|65230116|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
23405208|NCT02457247|65230113|FG000|Period 1|Significant Protocol Deviation|1|||
23405209|NCT02457247|65230114|FG001|Period 1|Significant Protocol Deviation|1|||
23405210|NCT02457247|65230115|FG002|Period 1|Significant Protocol Deviation|0|||
23405211|NCT02457247|65230116|FG003|Period 1|Significant Protocol Deviation|0|||
23405212|NCT02457247|65230113|FG000|Period 1|Voluntary Withdrawal|1|||
23405213|NCT02457247|65230114|FG001|Period 1|Voluntary Withdrawal|0|||
23405214|NCT02457247|65230115|FG002|Period 1|Voluntary Withdrawal|0|||
23405215|NCT02457247|65230116|FG003|Period 1|Voluntary Withdrawal|0|||
23405216|NCT02457247|65230113|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
23606910|NCT00687297|65950543|FG001|Induction|Ineligible|1|||
23606911|NCT00687297|65950542|FG000|Induction|Patient Noncompliance|1|||
23606912|NCT00687297|65950543|FG001|Induction|Patient Noncompliance|0|||
23405217|NCT02457247|65230114|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
23405218|NCT02457247|65230115|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
23405219|NCT02457247|65230116|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
23405220|NCT02457247|65230113|FG000|Period 2|Significant Protocol Deviation|1|||
23405221|NCT02457247|65230114|FG001|Period 2|Significant Protocol Deviation|0|||
23405222|NCT02457247|65230115|FG002|Period 2|Significant Protocol Deviation|0|||
23405223|NCT02457247|65230116|FG003|Period 2|Significant Protocol Deviation|0|||
23405224|NCT02457247|65230113|FG000|Period 2|Lost to Follow-up|0|||
23405225|NCT02457247|65230114|FG001|Period 2|Lost to Follow-up|1|||
23405226|NCT02457247|65230115|FG002|Period 2|Lost to Follow-up|0|||
23405227|NCT02457247|65230116|FG003|Period 2|Lost to Follow-up|0|||
23405228|NCT02457247|65230113|FG000|Period 2|Voluntary Withdrawal|1|||
23405229|NCT02457247|65230114|FG001|Period 2|Voluntary Withdrawal|1|||
23405230|NCT02457247|65230115|FG002|Period 2|Voluntary Withdrawal|0|||
23405231|NCT02457247|65230116|FG003|Period 2|Voluntary Withdrawal|0|||
23405232|NCT00658541|65230119|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
23405233|NCT00658541|65230120|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23405234|NCT00658541|65230119|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23405235|NCT00658541|65230120|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23405236|NCT01977898|65230121|FG000|Overall Study|Non functioning catheter|1|||
23405237|NCT01977898|65230122|FG001|Overall Study|Non functioning catheter|1|||
23405238|NCT00756275|65230123|FG000|Overall Study|Lost to Follow-up|25|||
23405239|NCT00756275|65230124|FG001|Overall Study|Lost to Follow-up|21|||
23405240|NCT00756275|65230123|FG000|Overall Study|Withdrawal by Subject|4|||
23405241|NCT00756275|65230124|FG001|Overall Study|Withdrawal by Subject|7|||
23405242|NCT00811954|65230125|FG000|Overall Study|Death|10|||
23405243|NCT00811954|65230126|FG001|Overall Study|Death|6|||
23405244|NCT00811954|65230127|FG002|Overall Study|Death|13|||
23405245|NCT00811954|65230125|FG000|Overall Study|Lost to Follow-up|29|||
23405246|NCT00811954|65230126|FG001|Overall Study|Lost to Follow-up|23|||
23606913|NCT00687297|65950542|FG000|Induction|Physician Decision|0|||
23606914|NCT00687297|65950543|FG001|Induction|Physician Decision|2|||
23606915|NCT00687297|65950542|FG000|Induction|Other|0|||
23606916|NCT00687297|65950543|FG001|Induction|Other|1|||
23606917|NCT01029704|65950545|FG000|Overall Study|Adverse Event|0|||
23606918|NCT01029704|65950546|FG001|Overall Study|Adverse Event|0|||
23606919|NCT01029704|65950547|FG002|Overall Study|Adverse Event|0|||
23606920|NCT01029704|65950548|FG003|Overall Study|Adverse Event|0|||
23606921|NCT01029704|65950549|FG004|Overall Study|Adverse Event|0|||
23606922|NCT01029704|65950550|FG005|Overall Study|Adverse Event|0|||
23606923|NCT01029704|65950551|FG006|Overall Study|Adverse Event|1|||
23606924|NCT01029704|65950552|FG007|Overall Study|Adverse Event|1|||
23606925|NCT01029704|65950553|FG008|Overall Study|Adverse Event|0|||
23606926|NCT01029704|65950545|FG000|Overall Study|Withdrawal by Subject|0|||
23606927|NCT01029704|65950546|FG001|Overall Study|Withdrawal by Subject|0|||
23606928|NCT01029704|65950547|FG002|Overall Study|Withdrawal by Subject|0|||
23606929|NCT01029704|65950548|FG003|Overall Study|Withdrawal by Subject|0|||
23606930|NCT01029704|65950549|FG004|Overall Study|Withdrawal by Subject|2|||
23606931|NCT01029704|65950550|FG005|Overall Study|Withdrawal by Subject|1|||
23606932|NCT01029704|65950551|FG006|Overall Study|Withdrawal by Subject|1|||
23606933|NCT01029704|65950552|FG007|Overall Study|Withdrawal by Subject|1|||
23606934|NCT01029704|65950553|FG008|Overall Study|Withdrawal by Subject|0|||
23606935|NCT01029704|65950545|FG000|Overall Study|Lost to Follow-up|0|||
23606936|NCT01029704|65950546|FG001|Overall Study|Lost to Follow-up|0|||
23606937|NCT01029704|65950547|FG002|Overall Study|Lost to Follow-up|0|||
23606938|NCT01029704|65950548|FG003|Overall Study|Lost to Follow-up|0|||
23606939|NCT01029704|65950549|FG004|Overall Study|Lost to Follow-up|0|||
23606940|NCT01029704|65950550|FG005|Overall Study|Lost to Follow-up|0|||
23606941|NCT01029704|65950551|FG006|Overall Study|Lost to Follow-up|1|||
23606942|NCT01029704|65950552|FG007|Overall Study|Lost to Follow-up|1|||
23606943|NCT01029704|65950553|FG008|Overall Study|Lost to Follow-up|1|||
23606944|NCT01029704|65950545|FG000|Overall Study|Lack of Efficacy|0|||
23606945|NCT01029704|65950546|FG001|Overall Study|Lack of Efficacy|0|||
23606946|NCT01029704|65950547|FG002|Overall Study|Lack of Efficacy|0|||
23606947|NCT01029704|65950548|FG003|Overall Study|Lack of Efficacy|0|||
23606948|NCT01029704|65950549|FG004|Overall Study|Lack of Efficacy|2|||
23606949|NCT01029704|65950550|FG005|Overall Study|Lack of Efficacy|3|||
23606950|NCT01029704|65950551|FG006|Overall Study|Lack of Efficacy|1|||
23606951|NCT01029704|65950552|FG007|Overall Study|Lack of Efficacy|2|||
23606952|NCT01029704|65950553|FG008|Overall Study|Lack of Efficacy|0|||
23606953|NCT01029704|65950545|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
23606954|NCT01029704|65950546|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
23606955|NCT01029704|65950547|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
23606956|NCT01029704|65950548|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
23606957|NCT01029704|65950549|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
23606958|NCT01029704|65950550|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
23606959|NCT01029704|65950551|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
23606960|NCT01029704|65950552|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
23606961|NCT01029704|65950553|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
23606962|NCT00321672|65950556|FG000|Overall Study|Withdrawal by Subject|5|||
23606963|NCT00321672|65950557|FG001|Overall Study|Withdrawal by Subject|1|||
23606964|NCT00321672|65950558|FG002|Overall Study|Withdrawal by Subject|2|||
23606965|NCT00321672|65950559|FG003|Overall Study|Withdrawal by Subject|0|||
23606966|NCT00321672|65950556|FG000|Overall Study|Noncompliance|1|||
23606967|NCT00321672|65950557|FG001|Overall Study|Noncompliance|2|||
23606968|NCT00321672|65950558|FG002|Overall Study|Noncompliance|1|||
23606969|NCT00321672|65950559|FG003|Overall Study|Noncompliance|0|||
23606970|NCT00321672|65950556|FG000|Overall Study|Adverse Event|1|||
23606971|NCT00321672|65950557|FG001|Overall Study|Adverse Event|1|||
23606972|NCT00321672|65950558|FG002|Overall Study|Adverse Event|0|||
23606973|NCT00321672|65950559|FG003|Overall Study|Adverse Event|0|||
23606974|NCT00321672|65950556|FG000|Overall Study|Lack of Efficacy|1|||
23606975|NCT00321672|65950557|FG001|Overall Study|Lack of Efficacy|1|||
23606976|NCT00321672|65950558|FG002|Overall Study|Lack of Efficacy|0|||
23606977|NCT00321672|65950559|FG003|Overall Study|Lack of Efficacy|0|||
23606978|NCT00321672|65950556|FG000|Overall Study|Lost to Follow-up|2|||
23606979|NCT00321672|65950557|FG001|Overall Study|Lost to Follow-up|0|||
23606980|NCT00321672|65950558|FG002|Overall Study|Lost to Follow-up|4|||
23606981|NCT00321672|65950559|FG003|Overall Study|Lost to Follow-up|2|||
23606982|NCT00321672|65950556|FG000|Overall Study|Death|1|||
23606983|NCT00321672|65950557|FG001|Overall Study|Death|0|||
23606984|NCT00321672|65950558|FG002|Overall Study|Death|0|||
23204401|NCT04191967|64491038|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
23204402|NCT00138424|64491039|FG000|Overall Study|Physician Decision|0|||
23204403|NCT00138424|64491040|FG001|Overall Study|Physician Decision|1|||
23204404|NCT00138424|64491041|FG002|Overall Study|Physician Decision|0|||
23204405|NCT00138424|64491042|FG003|Overall Study|Physician Decision|0|||
23204406|NCT04664855|64491047|FG000|Overall Study|Withdrawal by Subject|0|||
23204407|NCT04664855|64491048|FG001|Overall Study|Withdrawal by Subject|2|||
23204408|NCT01753076|64491049|FG000|Overall Study|Adverse Event|17|||
23204409|NCT01753076|64491050|FG001|Overall Study|Adverse Event|18|||
23204410|NCT01753076|64491049|FG000|Overall Study|Lack of Efficacy|3|||
23303468|NCT03096847|64854669|FG001|Overall Study|Physician Decision|2|||
23303469|NCT03096847|64854670|FG002|Overall Study|Physician Decision|8|||
23303470|NCT03096847|64854668|FG000|Overall Study|Withdrawal by Subject|24|||
23303471|NCT03096847|64854669|FG001|Overall Study|Withdrawal by Subject|1|||
23303472|NCT03096847|64854670|FG002|Overall Study|Withdrawal by Subject|12|||
23303473|NCT03096847|64854668|FG000|Overall Study|Adverse Event|72|||
23303474|NCT03096847|64854669|FG001|Overall Study|Adverse Event|6|||
23303475|NCT03096847|64854670|FG002|Overall Study|Adverse Event|28|||
23303476|NCT03096847|64854668|FG000|Overall Study|Progressive disease|97|||
23303477|NCT03096847|64854669|FG001|Overall Study|Progressive disease|10|||
23303478|NCT03096847|64854670|FG002|Overall Study|Progressive disease|78|||
23303479|NCT03096847|64854668|FG000|Overall Study|Non-compliance with study medication|1|||
23303480|NCT03096847|64854669|FG001|Overall Study|Non-compliance with study medication|0|||
23303481|NCT03096847|64854670|FG002|Overall Study|Non-compliance with study medication|0|||
23303482|NCT03096847|64854668|FG000|Overall Study|New therapy for study indication|1|||
23303483|NCT03096847|64854669|FG001|Overall Study|New therapy for study indication|0|||
23303484|NCT03096847|64854670|FG002|Overall Study|New therapy for study indication|1|||
23303485|NCT04053465|64854673|FG000|Overall Study|Withdrawal by Subject|4|||
23303486|NCT04053465|64854674|FG001|Overall Study|Withdrawal by Subject|4|||
23303487|NCT04874636|64854677|FG000|Overall Study|Adverse Event|17|||
23303488|NCT04874636|64854678|FG001|Overall Study|Adverse Event|7|||
23405247|NCT00811954|65230127|FG002|Overall Study|Lost to Follow-up|34|||
23405248|NCT00811954|65230125|FG000|Overall Study|Not able to get to clinic|28|||
23405249|NCT00811954|65230126|FG001|Overall Study|Not able to get to clinic|35|||
23405250|NCT00811954|65230127|FG002|Overall Study|Not able to get to clinic|30|||
23405251|NCT00811954|65230125|FG000|Overall Study|Not willing to adhere to requirements|12|||
23405252|NCT00811954|65230126|FG001|Overall Study|Not willing to adhere to requirements|2|||
23405253|NCT00811954|65230127|FG002|Overall Study|Not willing to adhere to requirements|16|||
23405254|NCT00811954|65230125|FG000|Overall Study|Withdraw consent prior study completion|4|||
23405255|NCT00811954|65230126|FG001|Overall Study|Withdraw consent prior study completion|6|||
23405256|NCT00811954|65230127|FG002|Overall Study|Withdraw consent prior study completion|5|||
23405257|NCT00811954|65230125|FG000|Overall Study|Site Closure|4|||
23405258|NCT00811954|65230126|FG001|Overall Study|Site Closure|0|||
23405259|NCT00811954|65230127|FG002|Overall Study|Site Closure|1|||
23606985|NCT00321672|65950559|FG003|Overall Study|Death|0|||
23303489|NCT04874636|64854677|FG000|Overall Study|Lost to Follow-up|1|||
23303490|NCT04874636|64854678|FG001|Overall Study|Lost to Follow-up|0|||
23606986|NCT00321672|65950556|FG000|Overall Study|Too far to travel for visits|1|||
23606987|NCT00321672|65950557|FG001|Overall Study|Too far to travel for visits|0|||
23606988|NCT00321672|65950558|FG002|Overall Study|Too far to travel for visits|0|||
23606989|NCT00321672|65950559|FG003|Overall Study|Too far to travel for visits|0|||
23606990|NCT00321672|65950556|FG000|Overall Study|Incarcerated|0|||
23606991|NCT00321672|65950557|FG001|Overall Study|Incarcerated|0|||
23606992|NCT00321672|65950558|FG002|Overall Study|Incarcerated|2|||
23606993|NCT00321672|65950559|FG003|Overall Study|Incarcerated|0|||
23606994|NCT00321672|65950556|FG000|Overall Study|Moved out of state|0|||
23606995|NCT00321672|65950557|FG001|Overall Study|Moved out of state|1|||
23606996|NCT00321672|65950558|FG002|Overall Study|Moved out of state|1|||
23606997|NCT00321672|65950559|FG003|Overall Study|Moved out of state|0|||
23606998|NCT00321672|65950556|FG000|Overall Study|Protocol Violation|0|||
23606999|NCT00321672|65950557|FG001|Overall Study|Protocol Violation|0|||
23607000|NCT00321672|65950558|FG002|Overall Study|Protocol Violation|1|||
23607001|NCT00321672|65950559|FG003|Overall Study|Protocol Violation|0|||
23607002|NCT00321672|65950556|FG000|Overall Study|Diagnosis of testicular cancer|0|||
23607003|NCT00321672|65950557|FG001|Overall Study|Diagnosis of testicular cancer|1|||
23607004|NCT00321672|65950558|FG002|Overall Study|Diagnosis of testicular cancer|0|||
23607005|NCT00321672|65950559|FG003|Overall Study|Diagnosis of testicular cancer|0|||
23607006|NCT00321672|65950556|FG000|Overall Study|Extensive travel required for new job|0|||
23607007|NCT00321672|65950557|FG001|Overall Study|Extensive travel required for new job|1|||
23607008|NCT00321672|65950558|FG002|Overall Study|Extensive travel required for new job|0|||
23607009|NCT00321672|65950559|FG003|Overall Study|Extensive travel required for new job|0|||
23607010|NCT00512902|65950561|FG000|Overall Study|Adverse Event|7|||
23607011|NCT00512902|65950561|FG000|Overall Study|Lost to Follow-up|1|||
23607012|NCT02138838|65950567|FG000|Overall Study|Study Closure|7|||
23607013|NCT02138838|65950568|FG001|Overall Study|Study Closure|6|||
23607014|NCT02138838|65950567|FG000|Overall Study|Withdrawal by Subject|1|||
23607015|NCT02138838|65950568|FG001|Overall Study|Withdrawal by Subject|5|||
23607016|NCT00240994|65950569|FG000|Overall Study|Lost to Follow-up|1|||
23607017|NCT00240994|65950569|FG000|Overall Study|Protocol Violation|1|||
23607018|NCT00240994|65950569|FG000|Overall Study|Graft failure|1|||
23607019|NCT04571944|65950570|FG000|Overall Study|Death|1|||
23607020|NCT04571944|65950571|FG001|Overall Study|Death|0|||
23607021|NCT04571944|65950570|FG000|Overall Study|Withdrawal by Subject|3|||
23607022|NCT04571944|65950571|FG001|Overall Study|Withdrawal by Subject|0|||
23607023|NCT04571944|65950570|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
23607024|NCT04571944|65950571|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
23607025|NCT02325154|65950579|FG000|Overall Study|Physician Decision|1|||
23607026|NCT03678688|65950581|FG000|Overall Study|Reason not Specified|0|||
23607027|NCT03678688|65950582|FG001|Overall Study|Reason not Specified|0|||
23607028|NCT03678688|65950583|FG002|Overall Study|Reason not Specified|3|||
23607029|NCT03678688|65950584|FG003|Overall Study|Reason not Specified|0|||
23607030|NCT03678688|65950585|FG004|Overall Study|Reason not Specified|1|||
23607031|NCT03678688|65950586|FG005|Overall Study|Reason not Specified|0|||
23607032|NCT03678688|65950587|FG006|Overall Study|Reason not Specified|0|||
23607033|NCT03678688|65950588|FG007|Overall Study|Reason not Specified|0|||
23607034|NCT03678688|65950589|FG008|Overall Study|Reason not Specified|0|||
23607035|NCT03678688|65950581|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
23607036|NCT03678688|65950582|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
23607037|NCT03678688|65950583|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
23607038|NCT03678688|65950584|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
23607039|NCT03678688|65950585|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
23607040|NCT03678688|65950586|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
23607041|NCT03678688|65950587|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
23607042|NCT03678688|65950588|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
23607043|NCT03678688|65950589|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
23607044|NCT03678688|65950581|FG000|Overall Study|Covid Related Adverse Event|0|||
23607045|NCT03678688|65950582|FG001|Overall Study|Covid Related Adverse Event|0|||
23607046|NCT03678688|65950583|FG002|Overall Study|Covid Related Adverse Event|0|||
23607047|NCT03678688|65950584|FG003|Overall Study|Covid Related Adverse Event|0|||
23607048|NCT03678688|65950585|FG004|Overall Study|Covid Related Adverse Event|0|||
23607049|NCT03678688|65950586|FG005|Overall Study|Covid Related Adverse Event|3|||
23607050|NCT03678688|65950587|FG006|Overall Study|Covid Related Adverse Event|1|||
23607051|NCT03678688|65950588|FG007|Overall Study|Covid Related Adverse Event|1|||
23607052|NCT03678688|65950589|FG008|Overall Study|Covid Related Adverse Event|0|||
23607053|NCT03678688|65950581|FG000|Overall Study|Physician Decision|0|||
23607054|NCT03678688|65950582|FG001|Overall Study|Physician Decision|0|||
23607055|NCT03678688|65950583|FG002|Overall Study|Physician Decision|0|||
23303491|NCT04874636|64854677|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23303492|NCT04874636|64854678|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23303493|NCT04874636|64854677|FG000|Overall Study|Physician Decision|1|||
23303494|NCT04874636|64854678|FG001|Overall Study|Physician Decision|0|||
23303495|NCT04874636|64854677|FG000|Overall Study|Withdrawal by Subject|6|||
23303496|NCT04874636|64854678|FG001|Overall Study|Withdrawal by Subject|5|||
23303497|NCT00384176|64854682|FG000|Overall Study|Death|239|||
23607056|NCT03678688|65950584|FG003|Overall Study|Physician Decision|0|||
23303498|NCT00384176|64854683|FG001|Overall Study|Death|247|||
23303499|NCT00384176|64854684|FG002|Overall Study|Death|105|||
23303500|NCT00384176|64854682|FG000|Overall Study|Withdrawal by Subject|52|||
23303501|NCT00384176|64854683|FG001|Overall Study|Withdrawal by Subject|48|||
23303502|NCT00384176|64854684|FG002|Overall Study|Withdrawal by Subject|22|||
23303503|NCT00384176|64854682|FG000|Overall Study|Lost to Follow-up|16|||
23303504|NCT00384176|64854683|FG001|Overall Study|Lost to Follow-up|18|||
23303505|NCT00384176|64854684|FG002|Overall Study|Lost to Follow-up|4|||
23303506|NCT00384176|64854682|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
23303507|NCT00384176|64854683|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
23303508|NCT00384176|64854684|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
23303509|NCT00384176|64854682|FG000|Overall Study|Longer QTC as Visit 1|1|||
23303510|NCT00384176|64854683|FG001|Overall Study|Longer QTC as Visit 1|0|||
23303511|NCT00384176|64854684|FG002|Overall Study|Longer QTC as Visit 1|0|||
23303512|NCT00384176|64854682|FG000|Overall Study|Toxicity of treatment|1|||
23303513|NCT00384176|64854683|FG001|Overall Study|Toxicity of treatment|0|||
23303514|NCT00384176|64854684|FG002|Overall Study|Toxicity of treatment|0|||
23303515|NCT00384176|64854682|FG000|Overall Study|Did not receive study treatment|0|||
23303516|NCT00384176|64854683|FG001|Overall Study|Did not receive study treatment|1|||
23303517|NCT00384176|64854684|FG002|Overall Study|Did not receive study treatment|1|||
23303518|NCT00384176|64854682|FG000|Overall Study|Physician Decision|0|||
23303519|NCT00384176|64854683|FG001|Overall Study|Physician Decision|2|||
23303520|NCT00384176|64854684|FG002|Overall Study|Physician Decision|0|||
23303521|NCT00384176|64854682|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
23303522|NCT00384176|64854683|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
23303523|NCT00384176|64854684|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
23303524|NCT04442490|64854685|FG000|Overall Study|Withdrawal by Subject|18|||
23303525|NCT04442490|64854686|FG001|Overall Study|Withdrawal by Subject|10|||
23303526|NCT04442490|64854685|FG000|Overall Study|Lost to Follow-up|7|||
23303527|NCT04442490|64854686|FG001|Overall Study|Lost to Follow-up|7|||
23303528|NCT04442490|64854685|FG000|Overall Study|Adverse Event|2|||
23303529|NCT04442490|64854686|FG001|Overall Study|Adverse Event|6|||
23303530|NCT04442490|64854685|FG000|Overall Study|Noncompliance|3|||
23303531|NCT04442490|64854686|FG001|Overall Study|Noncompliance|1|||
23303532|NCT04442490|64854685|FG000|Overall Study|Physician Decision|2|||
23303533|NCT04442490|64854686|FG001|Overall Study|Physician Decision|1|||
23303534|NCT04442490|64854685|FG000|Overall Study|Reason not Specified|2|||
23303535|NCT04442490|64854686|FG001|Overall Study|Reason not Specified|1|||
23303536|NCT04442490|64854685|FG000|Overall Study|Randomized but not Treated|3|||
23303537|NCT04442490|64854686|FG001|Overall Study|Randomized but not Treated|3|||
23303538|NCT01429051|64854687|FG000|Titration Phase|Death|1|||
23303539|NCT01429051|64854687|FG000|Titration Phase|Withdrawal by Subject|7|||
23303540|NCT01429051|64854687|FG000|Titration Phase|Physician Decision|1|||
23303541|NCT01429051|64854687|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
23303542|NCT01429051|64854687|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
23303543|NCT01429051|64854687|FG000|Efficacy Phase|Adverse Event|1|||
23303544|NCT01429051|64854687|FG000|Efficacy Phase|Death|1|||
23303545|NCT01429051|64854687|FG000|Tolerability Phase|Death|5|||
23303546|NCT01429051|64854687|FG000|Tolerability Phase|Adverse Event|2|||
23303547|NCT01429051|64854687|FG000|Tolerability Phase|Withdrawal by Subject|5|||
23303548|NCT01429051|64854687|FG000|Tolerability Phase|Physician Decision|1|||
23303549|NCT01429051|64854687|FG000|Tolerability Phase|Other|2|||
23303550|NCT01597479|64854689|FG000|Overall Study|Protocol Violation|1|||
23303551|NCT01597479|64854690|FG001|Overall Study|Protocol Violation|0|||
23303552|NCT01597479|64854689|FG000|Overall Study|Lost to Follow-up|1|||
23303553|NCT01597479|64854690|FG001|Overall Study|Lost to Follow-up|0|||
23303554|NCT00741936|64854696|FG000|Overall Study|Lost to Follow-up|1|||
23303555|NCT00741936|64854697|FG001|Overall Study|Lost to Follow-up|1|||
23303556|NCT00741936|64854696|FG000|Overall Study|Adverse Event|3|||
23303557|NCT00741936|64854697|FG001|Overall Study|Adverse Event|4|||
23303558|NCT00741936|64854696|FG000|Overall Study|Pregnancy|0|||
23303559|NCT00741936|64854697|FG001|Overall Study|Pregnancy|1|||
23303560|NCT00741936|64854696|FG000|Overall Study|Protocol Violation|2|||
23303561|NCT00741936|64854697|FG001|Overall Study|Protocol Violation|0|||
23303562|NCT00741936|64854696|FG000|Overall Study|Lack of Efficacy|0|||
23303563|NCT00741936|64854697|FG001|Overall Study|Lack of Efficacy|2|||
23303564|NCT00741936|64854696|FG000|Overall Study|Low compliance|3|||
23303565|NCT00741936|64854697|FG001|Overall Study|Low compliance|0|||
23303566|NCT01408628|64854698|FG000|Consented|Withdrawal by Subject|12|||
23303567|NCT01408628|64854698|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
23303568|NCT01408628|64854698|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
23303569|NCT01408628|64854698|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
23303570|NCT03334721|64854699|FG000|Overall Study|Withdrawal by Subject|1|||
23303571|NCT03334721|64854700|FG001|Overall Study|Withdrawal by Subject|0|||
23303572|NCT03334721|64854699|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
23303573|NCT03334721|64854700|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
23303574|NCT04355663|64854701|FG000|Overall Study|Physician Decision|2|||
23303575|NCT04355663|64854702|FG001|Overall Study|Physician Decision|7|||
23303576|NCT04355663|64854703|FG002|Overall Study|Physician Decision|0|||
23303577|NCT04355663|64854701|FG000|Overall Study|Adverse Event|0|||
23303578|NCT04355663|64854702|FG001|Overall Study|Adverse Event|0|||
23303579|NCT04355663|64854703|FG002|Overall Study|Adverse Event|1|||
23303580|NCT04355663|64854701|FG000|Overall Study|Withdrawal by Subject|0|||
23303581|NCT04355663|64854702|FG001|Overall Study|Withdrawal by Subject|8|||
23303582|NCT04355663|64854703|FG002|Overall Study|Withdrawal by Subject|3|||
23303583|NCT03649412|64854704|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
23303584|NCT03649412|64854705|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
23303585|NCT03649412|64854704|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
23303586|NCT03649412|64854705|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
23303587|NCT03649412|64854704|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
23303588|NCT03649412|64854705|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23303589|NCT03649412|64854704|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
23303590|NCT03649412|64854705|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
23303591|NCT03649412|64854704|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
23303592|NCT03649412|64854705|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
23303593|NCT03649412|64854704|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
23303594|NCT03649412|64854705|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
23303595|NCT02746471|64854710|FG000|Overall Study|Death|43|||
23303596|NCT02746471|64854710|FG000|Overall Study|Exited before 36 months|1119|||
23303597|NCT03014180|64854712|FG000|Overall Study|Protocol Violation|2|||
23303598|NCT01568320|64854713|FG000|Overall Study|Death|20|||
23303599|NCT01568320|64854713|FG000|Overall Study|Lost to Follow-up|9|||
23303600|NCT01568320|64854713|FG000|Overall Study|Withdrawal by Subject|10|||
23303601|NCT01568320|64854713|FG000|Overall Study|Conversion to open repair|1|||
23303602|NCT01568320|64854713|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
23303603|NCT00102687|64854715|FG000|Initial Period|Withdrawal by Subject|6|||
23303604|NCT00102687|64854716|FG001|Initial Period|Withdrawal by Subject|3|||
23303605|NCT00102687|64854717|FG002|Initial Period|Withdrawal by Subject|5|||
23303606|NCT00102687|64854718|FG003|Initial Period|Withdrawal by Subject|0|||
23303607|NCT00102687|64854719|FG004|Initial Period|Withdrawal by Subject|0|||
23303608|NCT00102687|64854715|FG000|Initial Period|Adverse Event|4|||
23303609|NCT00102687|64854716|FG001|Initial Period|Adverse Event|7|||
23303610|NCT00102687|64854717|FG002|Initial Period|Adverse Event|9|||
23303611|NCT00102687|64854718|FG003|Initial Period|Adverse Event|0|||
23303612|NCT00102687|64854719|FG004|Initial Period|Adverse Event|0|||
23303613|NCT00102687|64854715|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
23303614|NCT00102687|64854716|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
23303615|NCT00102687|64854717|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
23303616|NCT00102687|64854718|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
23303617|NCT00102687|64854719|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
23303618|NCT00102687|64854715|FG000|Initial Period|Protocol Violation|0|||
23303619|NCT00102687|64854716|FG001|Initial Period|Protocol Violation|0|||
23303620|NCT00102687|64854717|FG002|Initial Period|Protocol Violation|2|||
23303621|NCT00102687|64854718|FG003|Initial Period|Protocol Violation|0|||
23303622|NCT00102687|64854719|FG004|Initial Period|Protocol Violation|0|||
23303623|NCT00102687|64854715|FG000|Initial Period|Physician Decision|2|||
23303624|NCT00102687|64854716|FG001|Initial Period|Physician Decision|9|||
23303625|NCT00102687|64854717|FG002|Initial Period|Physician Decision|6|||
23303626|NCT00102687|64854718|FG003|Initial Period|Physician Decision|0|||
23303627|NCT00102687|64854719|FG004|Initial Period|Physician Decision|0|||
23303628|NCT00102687|64854715|FG000|Initial Period|Sponsor's decision|0|||
23303629|NCT00102687|64854716|FG001|Initial Period|Sponsor's decision|1|||
23303630|NCT00102687|64854717|FG002|Initial Period|Sponsor's decision|1|||
23303631|NCT00102687|64854718|FG003|Initial Period|Sponsor's decision|0|||
23303632|NCT00102687|64854719|FG004|Initial Period|Sponsor's decision|0|||
23303633|NCT00102687|64854715|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
23303634|NCT00102687|64854716|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
23303635|NCT00102687|64854717|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
23303636|NCT00102687|64854718|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
23303637|NCT00102687|64854719|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
23303638|NCT00102687|64854715|FG000|Initial Period|Death|1|||
23303639|NCT00102687|64854716|FG001|Initial Period|Death|1|||
23303640|NCT00102687|64854717|FG002|Initial Period|Death|1|||
23303641|NCT00102687|64854718|FG003|Initial Period|Death|0|||
23607057|NCT03678688|65950585|FG004|Overall Study|Physician Decision|0|||
23303642|NCT00102687|64854719|FG004|Initial Period|Death|0|||
23303643|NCT00102687|64854715|FG000|Maintenance Period|Withdrawal by Subject|4|||
23303644|NCT00102687|64854716|FG001|Maintenance Period|Withdrawal by Subject|0|||
23303645|NCT00102687|64854717|FG002|Maintenance Period|Withdrawal by Subject|2|||
23303646|NCT00102687|64854718|FG003|Maintenance Period|Withdrawal by Subject|3|||
23303647|NCT00102687|64854719|FG004|Maintenance Period|Withdrawal by Subject|1|||
23607058|NCT03678688|65950586|FG005|Overall Study|Physician Decision|1|||
23607059|NCT03678688|65950587|FG006|Overall Study|Physician Decision|0|||
23303648|NCT00102687|64854715|FG000|Maintenance Period|Adverse Event|1|||
23303649|NCT00102687|64854716|FG001|Maintenance Period|Adverse Event|0|||
23303650|NCT00102687|64854717|FG002|Maintenance Period|Adverse Event|0|||
23303651|NCT00102687|64854718|FG003|Maintenance Period|Adverse Event|1|||
23303652|NCT00102687|64854719|FG004|Maintenance Period|Adverse Event|3|||
23303653|NCT00102687|64854715|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
23303654|NCT00102687|64854716|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
23303655|NCT00102687|64854717|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
23303656|NCT00102687|64854718|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
23303657|NCT00102687|64854719|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
23303658|NCT00102687|64854715|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
23303659|NCT00102687|64854716|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
23303660|NCT00102687|64854717|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
23303661|NCT00102687|64854718|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
23303662|NCT00102687|64854719|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
23607060|NCT03678688|65950588|FG007|Overall Study|Physician Decision|0|||
23607061|NCT03678688|65950589|FG008|Overall Study|Physician Decision|0|||
23607062|NCT03678688|65950581|FG000|Overall Study|Withdrawal by Subject|0|||
23607063|NCT03678688|65950582|FG001|Overall Study|Withdrawal by Subject|0|||
23607064|NCT03678688|65950583|FG002|Overall Study|Withdrawal by Subject|0|||
23607065|NCT03678688|65950584|FG003|Overall Study|Withdrawal by Subject|0|||
23303663|NCT00102687|64854715|FG000|Maintenance Period|Death|0|||
23303664|NCT00102687|64854716|FG001|Maintenance Period|Death|0|||
23303665|NCT00102687|64854717|FG002|Maintenance Period|Death|0|||
23303666|NCT00102687|64854718|FG003|Maintenance Period|Death|1|||
23303667|NCT00102687|64854719|FG004|Maintenance Period|Death|1|||
23303668|NCT00102687|64854715|FG000|Maintenance Period|Physician Decision|1|||
23303669|NCT00102687|64854716|FG001|Maintenance Period|Physician Decision|2|||
23303670|NCT00102687|64854717|FG002|Maintenance Period|Physician Decision|3|||
23303671|NCT00102687|64854718|FG003|Maintenance Period|Physician Decision|0|||
23303672|NCT00102687|64854719|FG004|Maintenance Period|Physician Decision|4|||
23303673|NCT02581163|64854720|FG000|Overall Study|Failure to return|15|||
23303674|NCT02581163|64854720|FG000|Overall Study|Insufficient virological response|3|||
23303675|NCT02581163|64854720|FG000|Overall Study|Withdrew consent|1|||
23303676|NCT02581163|64854720|FG000|Overall Study|Death|1|||
23303677|NCT02581163|64854720|FG000|Overall Study|Other, not specified|9|||
23303678|NCT02054130|64854723|FG000|Overall Study|Withdrawal by Subject|4|||
23303679|NCT02054130|64854724|FG001|Overall Study|Withdrawal by Subject|4|||
23303680|NCT02054130|64854725|FG002|Overall Study|Withdrawal by Subject|7|||
23303681|NCT02054130|64854726|FG003|Overall Study|Withdrawal by Subject|10|||
23303682|NCT02054130|64854723|FG000|Overall Study|Death|0|||
23303683|NCT02054130|64854724|FG001|Overall Study|Death|1|||
23303684|NCT02054130|64854725|FG002|Overall Study|Death|0|||
23303685|NCT02054130|64854726|FG003|Overall Study|Death|0|||
23303686|NCT02054130|64854723|FG000|Overall Study|Lost to Follow-up|0|||
23303687|NCT02054130|64854724|FG001|Overall Study|Lost to Follow-up|0|||
23303688|NCT02054130|64854725|FG002|Overall Study|Lost to Follow-up|1|||
23303689|NCT02054130|64854726|FG003|Overall Study|Lost to Follow-up|2|||
23303690|NCT02054130|64854723|FG000|Overall Study|Missed dose|4|||
23303691|NCT02054130|64854724|FG001|Overall Study|Missed dose|6|||
23303692|NCT02054130|64854725|FG002|Overall Study|Missed dose|7|||
23303693|NCT02054130|64854726|FG003|Overall Study|Missed dose|10|||
23303694|NCT02296684|64854727|FG000|Overall Study|Withdrawal by Subject|0|||
23303695|NCT02296684|64854728|FG001|Overall Study|Withdrawal by Subject|1|||
23303696|NCT02296684|64854729|FG002|Overall Study|Withdrawal by Subject|1|||
23303697|NCT02296684|64854727|FG000|Overall Study|Death|2|||
23303698|NCT02296684|64854728|FG001|Overall Study|Death|0|||
23303699|NCT02296684|64854729|FG002|Overall Study|Death|0|||
23303700|NCT01744093|64854731|FG000|Overall Study|Withdrawal by Subject|6|||
23303701|NCT01744093|64854732|FG001|Overall Study|Withdrawal by Subject|1|||
23303702|NCT01150890|64854733|FG000|Overall Study|Other|0|||
23303703|NCT01150890|64854734|FG001|Overall Study|Other|1|||
23303704|NCT01150890|64854735|FG002|Overall Study|Other|0|||
23303705|NCT01150890|64854736|FG003|Overall Study|Other|2|||
23303706|NCT01150890|64854733|FG000|Overall Study|Pregnancy|0|||
23405260|NCT00811954|65230125|FG000|Overall Study|Severe Debilitation|2|||
23607066|NCT03678688|65950585|FG004|Overall Study|Withdrawal by Subject|0|||
23607067|NCT03678688|65950586|FG005|Overall Study|Withdrawal by Subject|0|||
23607068|NCT03678688|65950587|FG006|Overall Study|Withdrawal by Subject|2|||
23505399|NCT01433991|65587931|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
23505400|NCT01433991|65587932|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
23505401|NCT03033394|65587933|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
23505402|NCT03033394|65587933|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
23505403|NCT03033394|65587933|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
23303707|NCT01150890|64854734|FG001|Overall Study|Pregnancy|0|||
23405261|NCT00811954|65230126|FG001|Overall Study|Severe Debilitation|0|||
23303708|NCT01150890|64854735|FG002|Overall Study|Pregnancy|0|||
23303709|NCT01150890|64854736|FG003|Overall Study|Pregnancy|1|||
23505404|NCT03033394|65587933|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
23505405|NCT03033394|65587933|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
23505406|NCT02495168|65587934|FG000|Overall Study|Other than Specified|18|||
23505407|NCT02495168|65587935|FG001|Overall Study|Other than Specified|22|||
23505408|NCT02495168|65587936|FG002|Overall Study|Other than Specified|5|||
23505409|NCT02495168|65587934|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
23505410|NCT02495168|65587935|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
23505411|NCT02495168|65587936|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
23505412|NCT02495168|65587934|FG000|Overall Study|Physician Decision|1|||
23505413|NCT02495168|65587935|FG001|Overall Study|Physician Decision|1|||
23505414|NCT02495168|65587936|FG002|Overall Study|Physician Decision|0|||
23505415|NCT02495168|65587934|FG000|Overall Study|Lost to Follow-up|10|||
23505416|NCT02495168|65587935|FG001|Overall Study|Lost to Follow-up|6|||
23505417|NCT02495168|65587936|FG002|Overall Study|Lost to Follow-up|1|||
23505418|NCT02495168|65587934|FG000|Overall Study|Withdrawal by Subject|1|||
23505419|NCT02495168|65587935|FG001|Overall Study|Withdrawal by Subject|4|||
23505420|NCT02495168|65587936|FG002|Overall Study|Withdrawal by Subject|2|||
23505421|NCT02495168|65587934|FG000|Overall Study|Protocol Violation|0|||
23505422|NCT02495168|65587935|FG001|Overall Study|Protocol Violation|10|||
23505423|NCT02495168|65587936|FG002|Overall Study|Protocol Violation|1|||
23505424|NCT02495168|65587934|FG000|Overall Study|Adverse Event|4|||
23505425|NCT02495168|65587935|FG001|Overall Study|Adverse Event|8|||
23505426|NCT02495168|65587936|FG002|Overall Study|Adverse Event|3|||
23505427|NCT02495168|65587934|FG000|Overall Study|Lack of Efficacy|0|||
23505428|NCT02495168|65587935|FG001|Overall Study|Lack of Efficacy|0|||
23505429|NCT02495168|65587936|FG002|Overall Study|Lack of Efficacy|3|||
23505430|NCT04051008|65587946|FG000|Overall Study|Withdrawal by Subject|2|||
23505431|NCT04051008|65587947|FG001|Overall Study|Withdrawal by Subject|0|||
23505432|NCT04051008|65587948|FG002|Overall Study|Withdrawal by Subject|1|||
23505433|NCT02254486|65587949|FG000|Overall Study|Adverse Event|1|||
23505434|NCT02254486|65587950|FG001|Overall Study|Adverse Event|1|||
23505435|NCT02254486|65587949|FG000|Overall Study|Lack of Efficacy|1|||
23505436|NCT02254486|65587950|FG001|Overall Study|Lack of Efficacy|0|||
23505437|NCT02254486|65587949|FG000|Overall Study|Lost to Follow-up|2|||
23505438|NCT02254486|65587950|FG001|Overall Study|Lost to Follow-up|4|||
23505439|NCT02254486|65587949|FG000|Overall Study|Protocol Violation|1|||
23505440|NCT02254486|65587950|FG001|Overall Study|Protocol Violation|2|||
23505441|NCT02254486|65587949|FG000|Overall Study|Withdrawal by Subject|17|||
23505442|NCT02254486|65587950|FG001|Overall Study|Withdrawal by Subject|15|||
23505443|NCT02254486|65587949|FG000|Overall Study|GFR<60mL/min|16|||
23505444|NCT02254486|65587950|FG001|Overall Study|GFR<60mL/min|21|||
23505445|NCT02254486|65587949|FG000|Overall Study|Various|12|||
23303710|NCT01150890|64854733|FG000|Overall Study|Administrative Decision|4|||
23303711|NCT01150890|64854734|FG001|Overall Study|Administrative Decision|4|||
23303712|NCT01150890|64854735|FG002|Overall Study|Administrative Decision|5|||
23303713|NCT01150890|64854736|FG003|Overall Study|Administrative Decision|6|||
23303714|NCT01150890|64854733|FG000|Overall Study|Ineligibility determined|0|||
23303715|NCT01150890|64854734|FG001|Overall Study|Ineligibility determined|1|||
23303716|NCT01150890|64854735|FG002|Overall Study|Ineligibility determined|0|||
23303717|NCT01150890|64854736|FG003|Overall Study|Ineligibility determined|0|||
23303718|NCT01150890|64854733|FG000|Overall Study|Adverse Event|0|||
23303719|NCT01150890|64854734|FG001|Overall Study|Adverse Event|0|||
23303720|NCT01150890|64854735|FG002|Overall Study|Adverse Event|2|||
23303721|NCT01150890|64854736|FG003|Overall Study|Adverse Event|0|||
23303722|NCT01150890|64854733|FG000|Overall Study|Withdrawal by Subject|0|||
23303723|NCT01150890|64854734|FG001|Overall Study|Withdrawal by Subject|0|||
23303724|NCT01150890|64854735|FG002|Overall Study|Withdrawal by Subject|2|||
23303725|NCT01150890|64854736|FG003|Overall Study|Withdrawal by Subject|1|||
23303726|NCT01150890|64854733|FG000|Overall Study|Disease progression|0|||
23303727|NCT01150890|64854734|FG001|Overall Study|Disease progression|7|||
23303728|NCT01150890|64854735|FG002|Overall Study|Disease progression|3|||
23303729|NCT01150890|64854736|FG003|Overall Study|Disease progression|7|||
23303730|NCT00759902|64854737|FG000|Overall Study|Adverse Event|0|||
23303731|NCT00759902|64854738|FG001|Overall Study|Adverse Event|1|||
23303732|NCT00754013|64854740|FG000|Overall Study|Lost to Follow-up|1|||
23303733|NCT00754013|64854741|FG001|Overall Study|Lost to Follow-up|1|||
23303734|NCT00754013|64854740|FG000|Overall Study|didn't return after study termed|3|||
23303735|NCT00754013|64854741|FG001|Overall Study|didn't return after study termed|4|||
23303736|NCT04156620|64854742|FG000|Overall Study|Adverse event - TP 1|5|||
23303737|NCT04156620|64854743|FG001|Overall Study|Adverse event - TP 1|2|||
23303738|NCT04156620|64854742|FG000|Overall Study|Lost to follow-up TP 1|1|||
23303739|NCT04156620|64854743|FG001|Overall Study|Lost to follow-up TP 1|1|||
23303740|NCT04156620|64854742|FG000|Overall Study|Progressive disease - TP 1|0|||
23303741|NCT04156620|64854743|FG001|Overall Study|Progressive disease - TP 1|1|||
23303742|NCT04156620|64854742|FG000|Overall Study|Subject decision - TP 1|3|||
23505446|NCT02254486|65587950|FG001|Overall Study|Various|12|||
23303743|NCT04156620|64854743|FG001|Overall Study|Subject decision - TP 1|5|||
23303744|NCT04156620|64854742|FG000|Overall Study|Adverse event - TP 2|5|||
23303745|NCT04156620|64854743|FG001|Overall Study|Adverse event - TP 2|6|||
23303746|NCT04156620|64854742|FG000|Overall Study|Death - TP 2|1|||
23303747|NCT04156620|64854743|FG001|Overall Study|Death - TP 2|0|||
23303748|NCT04156620|64854742|FG000|Overall Study|Lost to follow-up - TP 2|5|||
23303749|NCT04156620|64854743|FG001|Overall Study|Lost to follow-up - TP 2|2|||
23303750|NCT04156620|64854742|FG000|Overall Study|Physician decision - TP 2|4|||
23303751|NCT04156620|64854743|FG001|Overall Study|Physician decision - TP 2|2|||
23303752|NCT04156620|64854742|FG000|Overall Study|Pregnancy - TP 2|1|||
23303753|NCT04156620|64854743|FG001|Overall Study|Pregnancy - TP 2|1|||
23303754|NCT04156620|64854742|FG000|Overall Study|Subject decision - TP 2|11|||
23303755|NCT04156620|64854743|FG001|Overall Study|Subject decision - TP 2|9|||
23303756|NCT04156620|64854742|FG000|Overall Study|New therapy for study indication - TP 2|1|||
23303757|NCT04156620|64854743|FG001|Overall Study|New therapy for study indication - TP 2|0|||
23303758|NCT01995266|64854746|FG000|Overall Study|Death|1|||
23303759|NCT01995266|64854746|FG000|Overall Study|Lack of Efficacy|6|||
23303760|NCT01995266|64854746|FG000|Overall Study|Adverse Event|2|||
23303761|NCT00667810|64854751|FG000|Overall Study|Adverse Event|13|||
23303762|NCT00667810|64854752|FG001|Overall Study|Adverse Event|14|||
23303763|NCT00667810|64854753|FG002|Overall Study|Adverse Event|19|||
23303764|NCT00667810|64854754|FG003|Overall Study|Adverse Event|1|||
23303765|NCT00667810|64854751|FG000|Overall Study|Death|1|||
23303766|NCT00667810|64854752|FG001|Overall Study|Death|1|||
23505447|NCT00317356|65587952|FG000|Overall Study|Adverse Event|0|||
23505448|NCT00317356|65587953|FG001|Overall Study|Adverse Event|0|||
23505449|NCT00317356|65587954|FG002|Overall Study|Adverse Event|1|||
23505450|NCT00317356|65587955|FG003|Overall Study|Adverse Event|0|||
23505451|NCT00317356|65587952|FG000|Overall Study|Lack of Efficacy|1|||
23505452|NCT00317356|65587953|FG001|Overall Study|Lack of Efficacy|1|||
23303767|NCT00667810|64854753|FG002|Overall Study|Death|3|||
23303768|NCT00667810|64854754|FG003|Overall Study|Death|0|||
23204411|NCT01753076|64491050|FG001|Overall Study|Lack of Efficacy|1|||
23505453|NCT00317356|65587954|FG002|Overall Study|Lack of Efficacy|0|||
23505454|NCT00317356|65587955|FG003|Overall Study|Lack of Efficacy|3|||
23505455|NCT00317356|65587952|FG000|Overall Study|Physician Decision|0|||
23505456|NCT00317356|65587953|FG001|Overall Study|Physician Decision|1|||
23505457|NCT00317356|65587954|FG002|Overall Study|Physician Decision|0|||
23505458|NCT00317356|65587955|FG003|Overall Study|Physician Decision|0|||
23505459|NCT01397084|65587956|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
23505460|NCT01397084|65587956|FG000|Overall Study|Protocol Violation|2|||
23505461|NCT01397084|65587956|FG000|Overall Study|Adverse Event|2|||
23505462|NCT01397084|65587956|FG000|Overall Study|Withdrawal by Subject|1|||
23204412|NCT01753076|64491049|FG000|Overall Study|Lost to Follow-up|2|||
23204413|NCT01753076|64491050|FG001|Overall Study|Lost to Follow-up|1|||
23204414|NCT01753076|64491049|FG000|Overall Study|Physician Decision|4|||
23204415|NCT01753076|64491050|FG001|Overall Study|Physician Decision|2|||
23204416|NCT01753076|64491049|FG000|Overall Study|Withdrawal by Subject|14|||
23204417|NCT01753076|64491050|FG001|Overall Study|Withdrawal by Subject|24|||
23204418|NCT01753076|64491049|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
23204419|NCT01753076|64491050|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
23204420|NCT01151579|64491051|FG000|Overall Study|Physician Decision|3|||
23204421|NCT01151579|64491052|FG001|Overall Study|Physician Decision|1|||
23204422|NCT01151579|64491051|FG000|Overall Study|Withdrawal by Subject|3|||
23204423|NCT01151579|64491052|FG001|Overall Study|Withdrawal by Subject|2|||
23505463|NCT01397084|65587956|FG000|Overall Study|Lost to Follow-up|1|||
23505464|NCT01397084|65587956|FG000|Overall Study|Used other proton pump inhibitor|1|||
23505465|NCT01056653|65587959|FG000|Overall Study|Lost to Follow-up|0|||
23505466|NCT01056653|65587960|FG001|Overall Study|Lost to Follow-up|0|||
23505467|NCT01056653|65587961|FG002|Overall Study|Lost to Follow-up|2|||
23505468|NCT00897104|65587962|FG000|Overall Study|Lost to Follow-up|12|||
23505469|NCT00897104|65587963|FG001|Overall Study|Lost to Follow-up|17|||
23505470|NCT00897104|65587964|FG002|Overall Study|Lost to Follow-up|2|||
23505471|NCT00897104|65587962|FG000|Overall Study|Pregnancy|0|||
23505472|NCT00897104|65587963|FG001|Overall Study|Pregnancy|1|||
23505473|NCT00897104|65587964|FG002|Overall Study|Pregnancy|0|||
23505474|NCT00897104|65587962|FG000|Overall Study|Protocol Violation|0|||
23505475|NCT00897104|65587963|FG001|Overall Study|Protocol Violation|1|||
23505476|NCT00897104|65587964|FG002|Overall Study|Protocol Violation|0|||
23505477|NCT00897104|65587962|FG000|Overall Study|Withdrawal by Subject|23|||
23505478|NCT00897104|65587963|FG001|Overall Study|Withdrawal by Subject|27|||
23204424|NCT01151579|64491051|FG000|Overall Study|Not meet inclusion criteria|6|||
23204425|NCT01151579|64491052|FG001|Overall Study|Not meet inclusion criteria|4|||
23204426|NCT02509494|64491053|FG000|Overall Study|Lost to Follow-up|8|||
23204427|NCT02509494|64491054|FG001|Overall Study|Lost to Follow-up|47|||
23505479|NCT00897104|65587964|FG002|Overall Study|Withdrawal by Subject|3|||
23505480|NCT00897104|65587962|FG000|Overall Study|Abnormal Prestudy Labs|2|||
23505481|NCT00897104|65587963|FG001|Overall Study|Abnormal Prestudy Labs|0|||
23505482|NCT00897104|65587964|FG002|Overall Study|Abnormal Prestudy Labs|0|||
23204428|NCT02509494|64491055|FG002|Overall Study|Lost to Follow-up|19|||
23204429|NCT02509494|64491056|FG003|Overall Study|Lost to Follow-up|6|||
23204430|NCT02509494|64491057|FG004|Overall Study|Lost to Follow-up|3|||
23204431|NCT02509494|64491058|FG005|Overall Study|Lost to Follow-up|3|||
23204432|NCT02509494|64491059|FG006|Overall Study|Lost to Follow-up|1|||
23204433|NCT02509494|64491060|FG007|Overall Study|Lost to Follow-up|3|||
23204434|NCT02509494|64491061|FG008|Overall Study|Lost to Follow-up|1|||
23204435|NCT02509494|64491053|FG000|Overall Study|Physician Decision|2|||
23204436|NCT02509494|64491054|FG001|Overall Study|Physician Decision|1|||
23204437|NCT02509494|64491055|FG002|Overall Study|Physician Decision|0|||
23204438|NCT02509494|64491056|FG003|Overall Study|Physician Decision|0|||
23204439|NCT02509494|64491057|FG004|Overall Study|Physician Decision|0|||
23204440|NCT02509494|64491058|FG005|Overall Study|Physician Decision|0|||
23204441|NCT02509494|64491059|FG006|Overall Study|Physician Decision|0|||
23204442|NCT02509494|64491060|FG007|Overall Study|Physician Decision|0|||
23204443|NCT02509494|64491061|FG008|Overall Study|Physician Decision|0|||
23204444|NCT02509494|64491053|FG000|Overall Study|Withdrawal by Subject|4|||
23204445|NCT02509494|64491054|FG001|Overall Study|Withdrawal by Subject|17|||
23204446|NCT02509494|64491055|FG002|Overall Study|Withdrawal by Subject|7|||
23204447|NCT02509494|64491056|FG003|Overall Study|Withdrawal by Subject|5|||
23204448|NCT02509494|64491057|FG004|Overall Study|Withdrawal by Subject|0|||
23204449|NCT02509494|64491058|FG005|Overall Study|Withdrawal by Subject|6|||
23204450|NCT02509494|64491059|FG006|Overall Study|Withdrawal by Subject|1|||
23204451|NCT02509494|64491060|FG007|Overall Study|Withdrawal by Subject|2|||
23204452|NCT02509494|64491061|FG008|Overall Study|Withdrawal by Subject|1|||
23204453|NCT02509494|64491053|FG000|Overall Study|Death|0|||
23405262|NCT00811954|65230127|FG002|Overall Study|Severe Debilitation|1|||
23405263|NCT00811954|65230125|FG000|Overall Study|Complete Protocol: No follow-up|0|||
23405264|NCT00811954|65230126|FG001|Overall Study|Complete Protocol: No follow-up|0|||
23405265|NCT00811954|65230127|FG002|Overall Study|Complete Protocol: No follow-up|1|||
23405266|NCT02504372|65230130|FG000|Overall Study|Death|136|||
23405267|NCT02504372|65230131|FG001|Overall Study|Death|154|||
23405268|NCT02504372|65230130|FG000|Overall Study|Lost to Follow-up|0|||
23405269|NCT02504372|65230131|FG001|Overall Study|Lost to Follow-up|2|||
23405270|NCT02504372|65230130|FG000|Overall Study|Withdrawal of consent|25|||
23405271|NCT02504372|65230131|FG001|Overall Study|Withdrawal of consent|16|||
23405272|NCT02504372|65230130|FG000|Overall Study|Participants ongoing|429|||
23405273|NCT02504372|65230131|FG001|Overall Study|Participants ongoing|415|||
23405274|NCT02549989|65230132|FG000|Overall Study|Adverse Event|4|||
23405275|NCT02549989|65230132|FG000|Overall Study|Death|1|||
23405276|NCT02549989|65230132|FG000|Overall Study|Lack of Efficacy|19|||
23405277|NCT02549989|65230132|FG000|Overall Study|Withdrawal by Subject|3|||
23405278|NCT01151020|65230136|FG000|Overall Study|Death|25|||
23405279|NCT01151020|65230136|FG000|Overall Study|Conversion to open repair|1|||
23405280|NCT01151020|65230136|FG000|Overall Study|Lost to Follow-up|4|||
23405281|NCT01151020|65230136|FG000|Overall Study|Withdrawal by Subject|22|||
23405282|NCT01151020|65230136|FG000|Overall Study|Patients did not receive the device|2|||
23405283|NCT01369199|65230137|FG000|Overall Study|Withdrawal by Subject|1|||
23405284|NCT01369199|65230137|FG000|Overall Study|Lost to Follow-up|2|||
23405285|NCT02122146|65230138|FG000|Part 1: Dose Escalation|Death|0|||
23405286|NCT02122146|65230139|FG001|Part 1: Dose Escalation|Death|1|||
23405287|NCT02122146|65230140|FG002|Part 1: Dose Escalation|Death|1|||
23405288|NCT02122146|65230141|FG003|Part 1: Dose Escalation|Death|0|||
23405289|NCT02122146|65230142|FG004|Part 1: Dose Escalation|Death|0|||
23405290|NCT02122146|65230143|FG005|Part 1: Dose Escalation|Death|0|||
23505483|NCT00897104|65587962|FG000|Overall Study|Abnormal Baseline ECG|2|||
23505484|NCT00897104|65587963|FG001|Overall Study|Abnormal Baseline ECG|2|||
23505485|NCT00897104|65587964|FG002|Overall Study|Abnormal Baseline ECG|0|||
23505486|NCT00897104|65587962|FG000|Overall Study|Need for Concom. Med.|0|||
23405291|NCT02122146|65230144|FG006|Part 1: Dose Escalation|Death|0|||
23405292|NCT02122146|65230145|FG007|Part 1: Dose Escalation|Death|0|||
23405293|NCT02122146|65230138|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405294|NCT02122146|65230139|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405295|NCT02122146|65230140|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
23405296|NCT02122146|65230141|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405297|NCT02122146|65230142|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
23405298|NCT02122146|65230143|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405299|NCT02122146|65230144|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405300|NCT02122146|65230145|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
23405301|NCT02122146|65230138|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23204454|NCT02509494|64491054|FG001|Overall Study|Death|1|||
23204455|NCT02509494|64491055|FG002|Overall Study|Death|0|||
23505487|NCT00897104|65587963|FG001|Overall Study|Need for Concom. Med.|1|||
23204456|NCT02509494|64491056|FG003|Overall Study|Death|0|||
23505488|NCT00897104|65587964|FG002|Overall Study|Need for Concom. Med.|1|||
23505489|NCT00897104|65587962|FG000|Overall Study|Lack of Migraine Attack|20|||
23204457|NCT02509494|64491057|FG004|Overall Study|Death|1|||
23405302|NCT02122146|65230139|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405303|NCT02122146|65230140|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405304|NCT02122146|65230141|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
23405305|NCT02122146|65230142|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405306|NCT02122146|65230143|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405307|NCT02122146|65230144|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405308|NCT02122146|65230145|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
23405309|NCT02122146|65230138|FG000|Part 1: Dose Escalation|Other|1|||
23405310|NCT02122146|65230139|FG001|Part 1: Dose Escalation|Other|0|||
23405311|NCT02122146|65230140|FG002|Part 1: Dose Escalation|Other|0|||
23405312|NCT02122146|65230141|FG003|Part 1: Dose Escalation|Other|0|||
23405313|NCT02122146|65230142|FG004|Part 1: Dose Escalation|Other|0|||
23405314|NCT02122146|65230143|FG005|Part 1: Dose Escalation|Other|1|||
23204458|NCT02509494|64491058|FG005|Overall Study|Death|0|||
23405315|NCT02122146|65230144|FG006|Part 1: Dose Escalation|Other|1|||
23405316|NCT02122146|65230145|FG007|Part 1: Dose Escalation|Other|2|||
23204459|NCT02509494|64491059|FG006|Overall Study|Death|0|||
23204460|NCT02509494|64491060|FG007|Overall Study|Death|1|||
23204461|NCT02509494|64491061|FG008|Overall Study|Death|0|||
23204462|NCT02509494|64491053|FG000|Overall Study|Other|0|||
23204463|NCT02509494|64491054|FG001|Overall Study|Other|4|||
23204464|NCT02509494|64491055|FG002|Overall Study|Other|5|||
23204465|NCT02509494|64491056|FG003|Overall Study|Other|0|||
23204466|NCT02509494|64491057|FG004|Overall Study|Other|0|||
23204467|NCT02509494|64491058|FG005|Overall Study|Other|0|||
23204468|NCT02509494|64491059|FG006|Overall Study|Other|0|||
23204469|NCT02509494|64491060|FG007|Overall Study|Other|0|||
23204470|NCT02509494|64491061|FG008|Overall Study|Other|0|||
23405317|NCT02948582|65230146|FG000|Washout Period 1|Adverse Event|0|||
23204471|NCT02509494|64491053|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23204472|NCT02509494|64491054|FG001|Overall Study|Non-Compliance With Study Drug|11|||
23204473|NCT02509494|64491055|FG002|Overall Study|Non-Compliance With Study Drug|7|||
23204474|NCT02509494|64491056|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23204475|NCT02509494|64491057|FG004|Overall Study|Non-Compliance With Study Drug|1|||
23204476|NCT02509494|64491058|FG005|Overall Study|Non-Compliance With Study Drug|2|||
23204477|NCT02509494|64491059|FG006|Overall Study|Non-Compliance With Study Drug|1|||
23204478|NCT02509494|64491060|FG007|Overall Study|Non-Compliance With Study Drug|1|||
23405318|NCT02948582|65230147|FG001|Washout Period 1|Adverse Event|2|||
23204479|NCT02509494|64491061|FG008|Overall Study|Non-Compliance With Study Drug|0|||
23204480|NCT01259856|64491067|FG000|Overall Study|Adverse Event|12|||
23204481|NCT01259856|64491068|FG001|Overall Study|Adverse Event|9|||
23204482|NCT01259856|64491067|FG000|Overall Study|Death|0|||
23204483|NCT01259856|64491068|FG001|Overall Study|Death|1|||
23204484|NCT01259856|64491067|FG000|Overall Study|Lack of Efficacy|3|||
23204485|NCT01259856|64491068|FG001|Overall Study|Lack of Efficacy|1|||
23204486|NCT01259856|64491067|FG000|Overall Study|Lost to Follow-up|1|||
23204487|NCT01259856|64491068|FG001|Overall Study|Lost to Follow-up|1|||
23204488|NCT01259856|64491067|FG000|Overall Study|Physician Decision|2|||
23204489|NCT01259856|64491068|FG001|Overall Study|Physician Decision|1|||
23204490|NCT01259856|64491067|FG000|Overall Study|Withdrawal by Subject|9|||
23204491|NCT01259856|64491068|FG001|Overall Study|Withdrawal by Subject|10|||
23204492|NCT01259856|64491067|FG000|Overall Study|Treatment never started|0|||
23204493|NCT01259856|64491068|FG001|Overall Study|Treatment never started|6|||
23204494|NCT01259856|64491067|FG000|Overall Study|Study closure by sponsor|40|||
23204495|NCT01259856|64491068|FG001|Overall Study|Study closure by sponsor|41|||
23204496|NCT01259856|64491067|FG000|Overall Study|Patient developed other disease|0|||
23204497|NCT01259856|64491068|FG001|Overall Study|Patient developed other disease|1|||
23204498|NCT01259856|64491067|FG000|Overall Study|Transfer to another study|0|||
23204499|NCT01259856|64491068|FG001|Overall Study|Transfer to another study|1|||
23204500|NCT01259856|64491067|FG000|Overall Study|Unknown/missing|2|||
23204501|NCT01259856|64491068|FG001|Overall Study|Unknown/missing|2|||
23204502|NCT02683525|64491069|FG000|Overall Study|Lost to Follow-up|1|||
23204503|NCT02683525|64491069|FG000|Overall Study|Physician Decision|1|||
23204504|NCT02683525|64491069|FG000|Overall Study|Disease Progression|6|||
23204505|NCT00848549|64491070|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
23204506|NCT00848549|64491071|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
23204507|NCT00848549|64491070|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
23405319|NCT02948582|65230148|FG002|Washout Period 1|Adverse Event|0|||
23405320|NCT02948582|65230149|FG003|Washout Period 1|Adverse Event|0|||
23405321|NCT02948582|65230150|FG004|Washout Period 1|Adverse Event|0|||
23405322|NCT02948582|65230151|FG005|Washout Period 1|Adverse Event|0|||
23204508|NCT00848549|64491071|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
23204509|NCT00848549|64491070|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
23204510|NCT00848549|64491071|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
23204511|NCT00848549|64491070|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
23204512|NCT00848549|64491071|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
23303769|NCT00667810|64854751|FG000|Overall Study|Lack of Efficacy|1|||
23405323|NCT02948582|65230146|FG000|Washout Period 1|Protocol Violation|0|||
23204513|NCT00848549|64491070|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
23204514|NCT00848549|64491071|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
23204515|NCT00848549|64491070|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
23204516|NCT00848549|64491071|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
23204517|NCT00848549|64491070|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
23204518|NCT00848549|64491071|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
23204519|NCT00848549|64491070|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
23204520|NCT00848549|64491071|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
23204521|NCT00848549|64491070|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
23204522|NCT00848549|64491071|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
23204523|NCT00848549|64491070|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
23204524|NCT00848549|64491071|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
23204525|NCT00848549|64491070|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
23204526|NCT00848549|64491071|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
23204527|NCT00848549|64491070|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
23204528|NCT00848549|64491071|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
23204529|NCT00848549|64491070|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
23204530|NCT00848549|64491071|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
23204531|NCT00848549|64491070|FG000|E2090-E044-314 (Extension Study)|Other|5|||
23204532|NCT00848549|64491071|FG001|E2090-E044-314 (Extension Study)|Other|6|||
23204533|NCT01669811|64491076|FG000|Overall Study|Investigator decision|0|||
23204534|NCT01669811|64491077|FG001|Overall Study|Investigator decision|1|||
23204535|NCT01669811|64491076|FG000|Overall Study|Withdrawal by Subject|1|||
23204536|NCT01669811|64491077|FG001|Overall Study|Withdrawal by Subject|2|||
23204537|NCT01669811|64491076|FG000|Overall Study|Adverse Event|2|||
23204538|NCT01669811|64491077|FG001|Overall Study|Adverse Event|6|||
23204539|NCT01669811|64491076|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23405324|NCT02948582|65230147|FG001|Washout Period 1|Protocol Violation|0|||
23405325|NCT02948582|65230148|FG002|Washout Period 1|Protocol Violation|0|||
23405326|NCT02948582|65230149|FG003|Washout Period 1|Protocol Violation|0|||
23405327|NCT02948582|65230150|FG004|Washout Period 1|Protocol Violation|0|||
23505490|NCT00897104|65587963|FG001|Overall Study|Lack of Migraine Attack|22|||
23204540|NCT01669811|64491077|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
23303770|NCT00667810|64854752|FG001|Overall Study|Lack of Efficacy|0|||
23303771|NCT00667810|64854753|FG002|Overall Study|Lack of Efficacy|2|||
23303772|NCT00667810|64854754|FG003|Overall Study|Lack of Efficacy|0|||
23303773|NCT00667810|64854751|FG000|Overall Study|Lost to Follow-up|1|||
23303774|NCT00667810|64854752|FG001|Overall Study|Lost to Follow-up|4|||
23303775|NCT00667810|64854753|FG002|Overall Study|Lost to Follow-up|2|||
23303776|NCT00667810|64854754|FG003|Overall Study|Lost to Follow-up|0|||
23303777|NCT00667810|64854751|FG000|Overall Study|Physician Decision|1|||
23303778|NCT00667810|64854752|FG001|Overall Study|Physician Decision|1|||
23303779|NCT00667810|64854753|FG002|Overall Study|Physician Decision|2|||
23303780|NCT00667810|64854754|FG003|Overall Study|Physician Decision|0|||
23303781|NCT00667810|64854751|FG000|Overall Study|Protocol Violation|0|||
23303782|NCT00667810|64854752|FG001|Overall Study|Protocol Violation|2|||
23303783|NCT00667810|64854753|FG002|Overall Study|Protocol Violation|0|||
23303784|NCT00667810|64854754|FG003|Overall Study|Protocol Violation|0|||
23303785|NCT00667810|64854751|FG000|Overall Study|Withdrawal by Subject|14|||
23303786|NCT00667810|64854752|FG001|Overall Study|Withdrawal by Subject|20|||
23303787|NCT00667810|64854753|FG002|Overall Study|Withdrawal by Subject|29|||
23303788|NCT00667810|64854754|FG003|Overall Study|Withdrawal by Subject|1|||
23303789|NCT00667810|64854751|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
23303790|NCT00667810|64854752|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
23303791|NCT00667810|64854753|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
23303792|NCT00667810|64854754|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
23303793|NCT00667810|64854751|FG000|Overall Study|Failed to Return|0|||
23303794|NCT00667810|64854752|FG001|Overall Study|Failed to Return|0|||
23303795|NCT00667810|64854753|FG002|Overall Study|Failed to Return|2|||
23303796|NCT00667810|64854754|FG003|Overall Study|Failed to Return|0|||
23303797|NCT00667810|64854751|FG000|Overall Study|Loss of Caregiver|0|||
23303798|NCT00667810|64854752|FG001|Overall Study|Loss of Caregiver|1|||
23303799|NCT00667810|64854753|FG002|Overall Study|Loss of Caregiver|3|||
23303800|NCT00667810|64854754|FG003|Overall Study|Loss of Caregiver|0|||
23303801|NCT00667810|64854751|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
23303802|NCT00667810|64854752|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
23303803|NCT00667810|64854753|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
23303804|NCT00667810|64854754|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
23303805|NCT00667810|64854751|FG000|Overall Study|Other|6|||
23303806|NCT00667810|64854752|FG001|Overall Study|Other|6|||
23303807|NCT00667810|64854753|FG002|Overall Study|Other|5|||
23303808|NCT00667810|64854754|FG003|Overall Study|Other|0|||
23405328|NCT02948582|65230151|FG005|Washout Period 1|Protocol Violation|1|||
23405329|NCT02948582|65230146|FG000|Washout Period 2|Adverse Event|0|||
23303809|NCT04465630|64854757|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
23303810|NCT04465630|64854757|FG000|Overall Study|Screen failure|8|||
23303811|NCT04465630|64854757|FG000|Overall Study|Baseline failure|16|||
23505491|NCT00897104|65587964|FG002|Overall Study|Lack of Migraine Attack|1|||
23505492|NCT00897104|65587962|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23505493|NCT00897104|65587963|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23505494|NCT00897104|65587964|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23505495|NCT00897104|65587962|FG000|Overall Study|Other|3|||
23505496|NCT00897104|65587963|FG001|Overall Study|Other|0|||
23505497|NCT00897104|65587964|FG002|Overall Study|Other|0|||
23505498|NCT00897104|65587962|FG000|Overall Study|Protocol Violation|1|||
23505499|NCT00897104|65587963|FG001|Overall Study|Protocol Violation|0|||
23303812|NCT01458106|64854758|FG000|Overall Study|Withdrawal by Subject|2|||
23303813|NCT01458106|64854759|FG001|Overall Study|Withdrawal by Subject|0|||
23303814|NCT01458106|64854758|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
23303815|NCT01458106|64854759|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
23303816|NCT01458106|64854758|FG000|Overall Study|Withdrawn Per Protocol|0|||
23303817|NCT01458106|64854759|FG001|Overall Study|Withdrawn Per Protocol|1|||
23303818|NCT01249365|64854762|FG000|Overall Study|Lost to Follow-up|1|||
23303819|NCT02639052|64854763|FG000|Overall Study|Lost to Follow-up|1|||
23303820|NCT01940497|64854764|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
23303821|NCT01940497|64854765|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
23303822|NCT01940497|64854764|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
23303823|NCT01940497|64854765|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
23303824|NCT01940497|64854764|FG000|Overall Study|Violation of Entry Criteria|1|||
23303825|NCT01940497|64854765|FG001|Overall Study|Violation of Entry Criteria|1|||
23303826|NCT01940497|64854764|FG000|Overall Study|Refused Treatment|1|||
23303827|NCT01940497|64854765|FG001|Overall Study|Refused Treatment|3|||
23505500|NCT00897104|65587964|FG002|Overall Study|Protocol Violation|0|||
23505501|NCT00897104|65587962|FG000|Overall Study|Withdrawal by Subject|0|||
23505502|NCT00897104|65587963|FG001|Overall Study|Withdrawal by Subject|0|||
23505503|NCT00897104|65587964|FG002|Overall Study|Withdrawal by Subject|1|||
23204541|NCT03105700|64491078|FG000|Overall Study|screen fail|3|||
23204542|NCT03105700|64491078|FG000|Overall Study|Lost to Follow-up|4|||
23204543|NCT00585923|64491089|FG000|Overall Study|Physician decided not to continue|31|||
23303828|NCT01940497|64854764|FG000|Overall Study|Withdrew Consent|6|||
23303829|NCT01940497|64854765|FG001|Overall Study|Withdrew Consent|2|||
23303830|NCT01940497|64854764|FG000|Overall Study|Administrative/Other|1|||
23303831|NCT01940497|64854765|FG001|Overall Study|Administrative/Other|1|||
23303832|NCT03955471|64854771|FG000|Overall Study|Death|22|||
23303833|NCT03955471|64854771|FG000|Overall Study|Lost to Follow-up|1|||
23303834|NCT03955471|64854771|FG000|Overall Study|Withdrawal by Subject|6|||
23303835|NCT03955471|64854771|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
23303836|NCT00673933|64854772|FG000|Overall Study|Withdrawal by Subject|2|||
23303837|NCT00673933|64854772|FG000|Overall Study|Lost to Follow-up|1|||
23303838|NCT02444793|64854773|FG000|Overall Study|Lost to Follow-up|2|||
23303839|NCT02444793|64854774|FG001|Overall Study|Lost to Follow-up|2|||
23303840|NCT02444793|64854775|FG002|Overall Study|Lost to Follow-up|0|||
23303841|NCT02444793|64854776|FG003|Overall Study|Lost to Follow-up|0|||
23303842|NCT02444793|64854773|FG000|Overall Study|Death|0|||
23303843|NCT02444793|64854774|FG001|Overall Study|Death|3|||
23303844|NCT02444793|64854775|FG002|Overall Study|Death|0|||
23303845|NCT02444793|64854776|FG003|Overall Study|Death|0|||
23303846|NCT02444793|64854773|FG000|Overall Study|Other|0|||
23303847|NCT02444793|64854774|FG001|Overall Study|Other|0|||
23303848|NCT02444793|64854775|FG002|Overall Study|Other|2|||
23303849|NCT02444793|64854776|FG003|Overall Study|Other|0|||
23303850|NCT02444793|64854773|FG000|Overall Study|Objective progression or relapse|9|||
23303851|NCT02444793|64854774|FG001|Overall Study|Objective progression or relapse|1|||
23303852|NCT02444793|64854775|FG002|Overall Study|Objective progression or relapse|2|||
23303853|NCT02444793|64854776|FG003|Overall Study|Objective progression or relapse|3|||
23303854|NCT02707861|64854777|FG000|Overall Study|Went onto commercial drug|30|||
23405330|NCT02948582|65230147|FG001|Washout Period 2|Adverse Event|1|||
23204544|NCT00585923|64491090|FG001|Overall Study|Physician decided not to continue|33|||
23204545|NCT00608530|64491091|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
23204546|NCT00608530|64491092|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
23204547|NCT00608530|64491093|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
23204548|NCT00608530|64491094|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
23204549|NCT00608530|64491091|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
23204550|NCT00608530|64491092|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
23303855|NCT02707861|64854778|FG001|Overall Study|Went onto commercial drug|23|||
23303856|NCT02707861|64854777|FG000|Overall Study|Adverse Event|2|||
23303857|NCT02707861|64854778|FG001|Overall Study|Adverse Event|3|||
23505504|NCT02161731|65587965|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
23505505|NCT02161731|65587966|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
23505506|NCT02161731|65587965|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
23405331|NCT02948582|65230148|FG002|Washout Period 2|Adverse Event|0|||
23405332|NCT02948582|65230149|FG003|Washout Period 2|Adverse Event|0|||
23405333|NCT02948582|65230150|FG004|Washout Period 2|Adverse Event|0|||
23405334|NCT02948582|65230151|FG005|Washout Period 2|Adverse Event|0|||
23405335|NCT02948582|65230146|FG000|Washout Period 2|personal reasons|0|||
23405336|NCT02948582|65230147|FG001|Washout Period 2|personal reasons|0|||
23405337|NCT02948582|65230148|FG002|Washout Period 2|personal reasons|0|||
23405338|NCT02948582|65230149|FG003|Washout Period 2|personal reasons|1|||
23405339|NCT02948582|65230150|FG004|Washout Period 2|personal reasons|0|||
23405340|NCT02948582|65230151|FG005|Washout Period 2|personal reasons|0|||
23405341|NCT02948582|65230146|FG000|Washout Period 4|Adverse Event|1|||
23405342|NCT02948582|65230147|FG001|Washout Period 4|Adverse Event|0|||
23405343|NCT02948582|65230148|FG002|Washout Period 4|Adverse Event|1|||
23405344|NCT02948582|65230149|FG003|Washout Period 4|Adverse Event|0|||
23405345|NCT02948582|65230150|FG004|Washout Period 4|Adverse Event|0|||
23405346|NCT02948582|65230151|FG005|Washout Period 4|Adverse Event|0|||
23405347|NCT00335738|65230152|FG000|Overall Study|Physician Decision|6|||
23405348|NCT00335738|65230153|FG001|Overall Study|Physician Decision|0|||
23405349|NCT00335738|65230152|FG000|Overall Study|Withdrawal by Subject|2|||
23405350|NCT00335738|65230153|FG001|Overall Study|Withdrawal by Subject|0|||
23405351|NCT00335738|65230152|FG000|Overall Study|Ineligible|3|||
23405352|NCT00335738|65230153|FG001|Overall Study|Ineligible|4|||
23405353|NCT02441101|65230155|FG000|Overall Study|Withdrawal by Subject|1|||
23405354|NCT02441101|65230156|FG001|Overall Study|Withdrawal by Subject|0|||
23405355|NCT02441101|65230155|FG000|Overall Study|Lost to Follow-up|1|||
23405356|NCT02441101|65230156|FG001|Overall Study|Lost to Follow-up|0|||
23405357|NCT02441101|65230155|FG000|Overall Study|PI relocated and study terminated|1|||
23405358|NCT02441101|65230156|FG001|Overall Study|PI relocated and study terminated|0|||
23405359|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
23405360|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
23405361|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
23405362|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
23405363|NCT02735421|65230157|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
23405364|NCT02735421|65230157|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
23405365|NCT02735421|65230157|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
23405366|NCT00427011|65230160|FG000|Overall Study|Adverse Event|10|||
23405367|NCT00427011|65230160|FG000|Overall Study|Withdrawal by Subject|1|||
23405368|NCT00427011|65230160|FG000|Overall Study|Lack of Efficacy|2|||
23405369|NCT00427011|65230160|FG000|Overall Study|Other|12|||
23405370|NCT00803595|65230164|FG000|Overall Study|Adverse Event|3|||
23405371|NCT00803595|65230165|FG001|Overall Study|Adverse Event|4|||
23405372|NCT00803595|65230166|FG002|Overall Study|Adverse Event|1|||
23405373|NCT00803595|65230164|FG000|Overall Study|Protocol Violation|7|||
23405374|NCT00803595|65230165|FG001|Overall Study|Protocol Violation|2|||
23405375|NCT00803595|65230166|FG002|Overall Study|Protocol Violation|12|||
23405376|NCT00803595|65230164|FG000|Overall Study|Withdrawal by Subject|5|||
23405377|NCT00803595|65230165|FG001|Overall Study|Withdrawal by Subject|2|||
23405378|NCT00803595|65230166|FG002|Overall Study|Withdrawal by Subject|3|||
23405379|NCT01534481|65230167|FG000|Overall Study|Lost to Follow-up|29|||
23405380|NCT01534481|65230168|FG001|Overall Study|Lost to Follow-up|24|||
23405381|NCT01534481|65230167|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
23405382|NCT01534481|65230168|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
23405383|NCT00790582|65230169|FG000|Overall Study|Death|14|||
23405384|NCT00790582|65230170|FG001|Overall Study|Death|32|||
23405385|NCT00790582|65230169|FG000|Overall Study|Physician Decision|7|||
23405386|NCT00790582|65230170|FG001|Overall Study|Physician Decision|1|||
23405387|NCT00790582|65230169|FG000|Overall Study|Lost to Follow-up|3|||
23405388|NCT00790582|65230170|FG001|Overall Study|Lost to Follow-up|3|||
23405389|NCT00790582|65230169|FG000|Overall Study|Withdrawal by Subject|7|||
23405390|NCT00790582|65230170|FG001|Overall Study|Withdrawal by Subject|51|||
23405391|NCT01198574|65230174|FG000|Overall Study|Resigned from schools|4|||
23405392|NCT01198574|65230175|FG001|Overall Study|Resigned from schools|1|||
23405393|NCT01198574|65230176|FG002|Overall Study|Resigned from schools|1|||
23405394|NCT01198574|65230177|FG003|Overall Study|Resigned from schools|4|||
23405395|NCT03289533|65230178|FG000|Overall Study|Death|12|||
23405396|NCT03289533|65230178|FG000|Overall Study|Terminated from study by sponsor|10|||
23405397|NCT00661830|65230189|FG000|Overall Study|Death|37|||
23405398|NCT00661830|65230190|FG001|Overall Study|Death|33|||
23405399|NCT00661830|65230189|FG000|Overall Study|Lost to Follow-up|1|||
23405400|NCT00661830|65230190|FG001|Overall Study|Lost to Follow-up|3|||
23405401|NCT00661830|65230189|FG000|Overall Study|Withdrawal by Subject|1|||
23405402|NCT00661830|65230190|FG001|Overall Study|Withdrawal by Subject|1|||
23405403|NCT00661830|65230189|FG000|Overall Study|Other reason|1|||
23405404|NCT00661830|65230190|FG001|Overall Study|Other reason|5|||
23405405|NCT04403919|65230191|FG000|Overall Study|Lost to Follow-up|0|||
23405406|NCT04403919|65230192|FG001|Overall Study|Lost to Follow-up|0|||
23405407|NCT04403919|65230193|FG002|Overall Study|Lost to Follow-up|0|||
23405408|NCT04403919|65230194|FG003|Overall Study|Lost to Follow-up|1|||
23405409|NCT03599518|65230195|FG000|Overall Study|Clinical progression|0|||
23405410|NCT03599518|65230196|FG001|Overall Study|Clinical progression|0|||
23405411|NCT03599518|65230197|FG002|Overall Study|Clinical progression|0|||
23405412|NCT03599518|65230198|FG003|Overall Study|Clinical progression|0|||
23405413|NCT03599518|65230199|FG004|Overall Study|Clinical progression|1|||
23405414|NCT03599518|65230195|FG000|Overall Study|Adverse Event|0|||
23405415|NCT03599518|65230196|FG001|Overall Study|Adverse Event|0|||
23405416|NCT03599518|65230197|FG002|Overall Study|Adverse Event|0|||
23405417|NCT03599518|65230198|FG003|Overall Study|Adverse Event|0|||
23405418|NCT03599518|65230199|FG004|Overall Study|Adverse Event|1|||
23405419|NCT03599518|65230195|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
23405420|NCT03599518|65230196|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
23405421|NCT03599518|65230197|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
23405422|NCT03599518|65230198|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
23405423|NCT03599518|65230199|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
23405424|NCT03599518|65230195|FG000|Overall Study|Participant withdrawal from study treatment|0|||
23405425|NCT03599518|65230196|FG001|Overall Study|Participant withdrawal from study treatment|0|||
23505507|NCT02161731|65587966|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
23505508|NCT04115839|65587969|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
23505509|NCT04115839|65587970|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
23505510|NCT04115839|65587971|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
23505511|NCT04115839|65587972|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
23505512|NCT04115839|65587973|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
23505513|NCT04115839|65587974|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
23505514|NCT04115839|65587975|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
23505515|NCT04115839|65587969|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
23505516|NCT04115839|65587970|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
23505517|NCT04115839|65587971|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
23505518|NCT04115839|65587972|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
23505519|NCT04115839|65587973|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
23505520|NCT04115839|65587974|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
23505521|NCT04115839|65587975|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
23505522|NCT04115839|65587969|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
23505523|NCT04115839|65587970|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505524|NCT04115839|65587971|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505525|NCT04115839|65587972|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505526|NCT04115839|65587973|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505527|NCT04115839|65587974|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23405426|NCT03599518|65230197|FG002|Overall Study|Participant withdrawal from study treatment|1|||
23405427|NCT03599518|65230198|FG003|Overall Study|Participant withdrawal from study treatment|0|||
23405428|NCT03599518|65230199|FG004|Overall Study|Participant withdrawal from study treatment|0|||
23405429|NCT02477527|65230200|FG000|Overall Study|Lost to Follow-up|2|||
23405430|NCT02477527|65230200|FG000|Overall Study|Withdrawal by Subject|1|||
23405431|NCT02477527|65230200|FG000|Overall Study|Screen Failure|3|||
23405432|NCT00997984|65230201|FG000|Overall Study|Adverse Event|1|||
23405433|NCT00997984|65230202|FG001|Overall Study|Adverse Event|8|||
23405434|NCT00997984|65230203|FG002|Overall Study|Adverse Event|8|||
23505528|NCT04115839|65587975|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
23505529|NCT04115839|65587969|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505530|NCT04115839|65587970|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505531|NCT04115839|65587971|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
23505532|NCT04115839|65587972|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505533|NCT04115839|65587973|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505534|NCT04115839|65587974|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505535|NCT04115839|65587975|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
23505536|NCT04115839|65587969|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
23505537|NCT04115839|65587970|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
23505538|NCT04115839|65587971|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
23505539|NCT04115839|65587972|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
23505540|NCT04115839|65587973|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
23505541|NCT04115839|65587974|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
23505542|NCT04115839|65587975|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
23505543|NCT04115839|65587969|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505544|NCT04115839|65587970|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505545|NCT04115839|65587971|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505546|NCT04115839|65587972|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
23505547|NCT04115839|65587973|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
23303858|NCT02707861|64854777|FG000|Overall Study|Death|5|||
23405435|NCT00997984|65230201|FG000|Overall Study|Protocol Violation|1|||
23405436|NCT00997984|65230202|FG001|Overall Study|Protocol Violation|3|||
23505548|NCT04115839|65587974|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505549|NCT04115839|65587975|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
23505550|NCT03930797|65587976|FG000|Overall Study|Lost to Follow-up|3|||
23505551|NCT03930797|65587977|FG001|Overall Study|Lost to Follow-up|10|||
23505552|NCT01594281|65587978|FG000|Interventional Core Phase|Protocol Deviation|1|||
23505553|NCT01594281|65587979|FG001|Interventional Core Phase|Protocol Deviation|0|||
23505554|NCT01594281|65587980|FG002|Interventional Core Phase|Protocol Deviation|0|||
23505555|NCT01594281|65587978|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
23505556|NCT01594281|65587979|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
23505557|NCT01594281|65587980|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
23505558|NCT01594281|65587978|FG000|Interventional Core Phase|Death|1|||
23505559|NCT01594281|65587979|FG001|Interventional Core Phase|Death|1|||
23505560|NCT01594281|65587980|FG002|Interventional Core Phase|Death|2|||
23505561|NCT01594281|65587978|FG000|Interventional Core Phase|Lost to Follow-up|1|||
23505562|NCT01594281|65587979|FG001|Interventional Core Phase|Lost to Follow-up|4|||
23505563|NCT01594281|65587980|FG002|Interventional Core Phase|Lost to Follow-up|1|||
23505564|NCT01594281|65587978|FG000|Interventional Core Phase|Adverse Event|4|||
23505565|NCT01594281|65587979|FG001|Interventional Core Phase|Adverse Event|4|||
23505566|NCT01594281|65587980|FG002|Interventional Core Phase|Adverse Event|4|||
23505567|NCT01594281|65587978|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
23303859|NCT02707861|64854778|FG001|Overall Study|Death|2|||
23303860|NCT02707861|64854777|FG000|Overall Study|Lack of Efficacy|0|||
23505568|NCT01594281|65587979|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
23505569|NCT01594281|65587980|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
23505570|NCT01594281|65587978|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
23505571|NCT01594281|65587979|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
23505572|NCT01594281|65587980|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
23505573|NCT01594281|65587978|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
23405437|NCT00997984|65230203|FG002|Overall Study|Protocol Violation|0|||
23405438|NCT00997984|65230201|FG000|Overall Study|Withdrawal by Subject|6|||
23405439|NCT00997984|65230202|FG001|Overall Study|Withdrawal by Subject|9|||
23405440|NCT00997984|65230203|FG002|Overall Study|Withdrawal by Subject|5|||
23505574|NCT01594281|65587979|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
23505575|NCT01594281|65587980|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
23505576|NCT02496611|65587983|FG000|Overall Study|Lost to Follow-up|2|||
23505577|NCT02496611|65587984|FG001|Overall Study|Lost to Follow-up|1|||
23505578|NCT02496611|65587983|FG000|Overall Study|Withdrawal by Subject|5|||
23505579|NCT02496611|65587984|FG001|Overall Study|Withdrawal by Subject|2|||
23505580|NCT00370032|65587985|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
23505581|NCT00370032|65587986|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
23505582|NCT00370032|65587985|FG000|Washout Period|Withdrawal by Subject|0|||
23405441|NCT00997984|65230201|FG000|Overall Study|Lost to Follow-up|8|||
23405442|NCT00997984|65230202|FG001|Overall Study|Lost to Follow-up|5|||
23405443|NCT00997984|65230203|FG002|Overall Study|Lost to Follow-up|4|||
23405444|NCT00997984|65230201|FG000|Overall Study|Lack of Efficacy|20|||
23405445|NCT00997984|65230202|FG001|Overall Study|Lack of Efficacy|6|||
23405446|NCT00997984|65230203|FG002|Overall Study|Lack of Efficacy|3|||
23405447|NCT00997984|65230201|FG000|Overall Study|Met exclusion criteria|1|||
23405448|NCT00997984|65230202|FG001|Overall Study|Met exclusion criteria|0|||
23405449|NCT00997984|65230203|FG002|Overall Study|Met exclusion criteria|0|||
23405450|NCT00997984|65230201|FG000|Overall Study|non-compliance|0|||
23405451|NCT00997984|65230202|FG001|Overall Study|non-compliance|2|||
23405452|NCT00997984|65230203|FG002|Overall Study|non-compliance|3|||
23405453|NCT00997984|65230201|FG000|Overall Study|Wrong medication dispensed|0|||
23405454|NCT00997984|65230202|FG001|Overall Study|Wrong medication dispensed|1|||
23405455|NCT00997984|65230203|FG002|Overall Study|Wrong medication dispensed|0|||
23405456|NCT00997984|65230201|FG000|Overall Study|Suicidal ideation|0|||
23405457|NCT00997984|65230202|FG001|Overall Study|Suicidal ideation|0|||
23405458|NCT00997984|65230203|FG002|Overall Study|Suicidal ideation|1|||
23405459|NCT00997984|65230201|FG000|Overall Study|Work schedule|0|||
23405460|NCT00997984|65230202|FG001|Overall Study|Work schedule|0|||
23405461|NCT00997984|65230203|FG002|Overall Study|Work schedule|2|||
23405462|NCT00326599|65230204|FG000|Overall Study|Withdrawal by Subject|1|||
23405463|NCT00326599|65230205|FG001|Overall Study|Withdrawal by Subject|0|||
23405464|NCT00326599|65230206|FG002|Overall Study|Withdrawal by Subject|5|||
23405465|NCT00326599|65230207|FG003|Overall Study|Withdrawal by Subject|2|||
23405466|NCT00326599|65230204|FG000|Overall Study|Adverse Event|1|||
23405467|NCT00326599|65230205|FG001|Overall Study|Adverse Event|0|||
23505583|NCT00370032|65587986|FG001|Washout Period|Withdrawal by Subject|1|||
23505584|NCT00370032|65587985|FG000|Washout Period|Lost to Follow-up|0|||
23505585|NCT00370032|65587986|FG001|Washout Period|Lost to Follow-up|1|||
23505586|NCT00370032|65587985|FG000|Washout Period|Adverse Event|1|||
23303861|NCT02707861|64854778|FG001|Overall Study|Lack of Efficacy|2|||
23405468|NCT00326599|65230206|FG002|Overall Study|Adverse Event|32|||
23505587|NCT00370032|65587986|FG001|Washout Period|Adverse Event|0|||
23303862|NCT02707861|64854777|FG000|Overall Study|Physician Decision|1|||
23505588|NCT00370032|65587985|FG000|Follow-up Period|Withdrawal by Subject|1|||
23505589|NCT00370032|65587986|FG001|Follow-up Period|Withdrawal by Subject|0|||
23505590|NCT01947582|65587987|FG000|Overall Study|Withdrawal by Subject|1|||
23405469|NCT00326599|65230207|FG003|Overall Study|Adverse Event|3|||
23405470|NCT00326599|65230204|FG000|Overall Study|Disease Progression|3|||
23405471|NCT00326599|65230205|FG001|Overall Study|Disease Progression|1|||
23505591|NCT01806298|65587989|FG000|Overall Study|Adverse Event|3|||
23505592|NCT01806298|65587989|FG000|Overall Study|Protocol Non-compliance|1|||
23505593|NCT01806298|65587989|FG000|Overall Study|Withdrawal by Subject|1|||
23505594|NCT01806298|65587989|FG000|Overall Study|Other|5|||
23505595|NCT05059600|65587990|FG000|Overall Study|Enrolled but not Treated|10|||
23505596|NCT01812174|65587991|FG000|Overall Study|Death|1|||
23303863|NCT02707861|64854778|FG001|Overall Study|Physician Decision|4|||
23303864|NCT02707861|64854777|FG000|Overall Study|Withdrawal by Subject|2|||
23303865|NCT02707861|64854778|FG001|Overall Study|Withdrawal by Subject|1|||
23303866|NCT02707861|64854777|FG000|Overall Study|Lost to Follow-up|1|||
23303867|NCT02707861|64854778|FG001|Overall Study|Lost to Follow-up|3|||
23303868|NCT02149121|64854781|FG000|Main Study Period|Lack of Efficacy|2|||
23303869|NCT02149121|64854782|FG001|Main Study Period|Lack of Efficacy|2|||
23303870|NCT02149121|64854783|FG002|Main Study Period|Lack of Efficacy|1|||
23303871|NCT02149121|64854784|FG003|Main Study Period|Lack of Efficacy|0|||
23303872|NCT02149121|64854785|FG004|Main Study Period|Lack of Efficacy|0|||
23303873|NCT02149121|64854786|FG005|Main Study Period|Lack of Efficacy|0|||
23303874|NCT02149121|64854787|FG006|Main Study Period|Lack of Efficacy|0|||
23303875|NCT02149121|64854781|FG000|Main Study Period|Withdrawal by Subject|9|||
23303876|NCT02149121|64854782|FG001|Main Study Period|Withdrawal by Subject|5|||
23303877|NCT02149121|64854783|FG002|Main Study Period|Withdrawal by Subject|1|||
23303878|NCT02149121|64854784|FG003|Main Study Period|Withdrawal by Subject|0|||
23303879|NCT02149121|64854785|FG004|Main Study Period|Withdrawal by Subject|0|||
23303880|NCT02149121|64854786|FG005|Main Study Period|Withdrawal by Subject|0|||
23303881|NCT02149121|64854787|FG006|Main Study Period|Withdrawal by Subject|0|||
23303882|NCT02149121|64854781|FG000|Main Study Period|Adverse Event|2|||
23303883|NCT02149121|64854782|FG001|Main Study Period|Adverse Event|5|||
23303884|NCT02149121|64854783|FG002|Main Study Period|Adverse Event|1|||
23303885|NCT02149121|64854784|FG003|Main Study Period|Adverse Event|0|||
23303886|NCT02149121|64854785|FG004|Main Study Period|Adverse Event|0|||
23303887|NCT02149121|64854786|FG005|Main Study Period|Adverse Event|0|||
23303888|NCT02149121|64854787|FG006|Main Study Period|Adverse Event|0|||
23303889|NCT02149121|64854781|FG000|Main Study Period|Protocol Violation|2|||
23303890|NCT02149121|64854782|FG001|Main Study Period|Protocol Violation|0|||
23303891|NCT02149121|64854783|FG002|Main Study Period|Protocol Violation|0|||
23303892|NCT02149121|64854784|FG003|Main Study Period|Protocol Violation|0|||
23303893|NCT02149121|64854785|FG004|Main Study Period|Protocol Violation|0|||
23505597|NCT01812174|65587992|FG001|Overall Study|Death|0|||
23505598|NCT01812174|65587991|FG000|Overall Study|Protocol Violation|2|||
23505599|NCT01812174|65587992|FG001|Overall Study|Protocol Violation|0|||
23505600|NCT00630396|65587993|FG000|Overall Study|Death|4|||
23505601|NCT00630396|65587993|FG000|Overall Study|Lost to Follow-up|3|||
23505602|NCT00598832|65587994|FG000|Overall Study|Lack of Efficacy|3|||
23505603|NCT00598832|65587995|FG001|Overall Study|Lack of Efficacy|7|||
23505604|NCT00598832|65587994|FG000|Overall Study|Adverse Event|6|||
23505605|NCT00598832|65587995|FG001|Overall Study|Adverse Event|2|||
23505606|NCT00598832|65587994|FG000|Overall Study|Withdrawal by Subject|25|||
23505607|NCT00598832|65587995|FG001|Overall Study|Withdrawal by Subject|36|||
23505608|NCT00598832|65587994|FG000|Overall Study|Protocol Violation|0|||
23505609|NCT00598832|65587995|FG001|Overall Study|Protocol Violation|2|||
23505610|NCT00598832|65587994|FG000|Overall Study|Lost to Follow-up|24|||
23505611|NCT00598832|65587995|FG001|Overall Study|Lost to Follow-up|29|||
23505612|NCT00598832|65587994|FG000|Overall Study|Pregnancy|2|||
23505613|NCT00598832|65587995|FG001|Overall Study|Pregnancy|2|||
23505614|NCT00598832|65587994|FG000|Overall Study|Physician Decision|1|||
23505615|NCT00598832|65587995|FG001|Overall Study|Physician Decision|4|||
23505616|NCT00598832|65587994|FG000|Overall Study|Non compliance|1|||
23505617|NCT00598832|65587995|FG001|Overall Study|Non compliance|0|||
23505618|NCT04160195|65587998|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
23303894|NCT02149121|64854786|FG005|Main Study Period|Protocol Violation|0|||
23505619|NCT04160195|65587999|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
23505620|NCT04584645|65588002|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
23505621|NCT04584645|65588003|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
23505622|NCT01496807|65588004|FG000|Overall Study|Progressive Disease|21|||
23505623|NCT01496807|65588004|FG000|Overall Study|Participant preference/toxicity|8|||
23505624|NCT01496807|65588004|FG000|Overall Study|Change in diagnosis|1|||
23303895|NCT02149121|64854787|FG006|Main Study Period|Protocol Violation|0|||
23303896|NCT02149121|64854781|FG000|Main Study Period|Lost to Follow-up|2|||
23505625|NCT00980057|65588007|FG000|Overall Study|Death|13|||
23607069|NCT03678688|65950588|FG007|Overall Study|Withdrawal by Subject|1|||
23505626|NCT00980057|65588008|FG001|Overall Study|Death|3|||
23505627|NCT00980057|65588007|FG000|Overall Study|Adverse Event|0|||
23505628|NCT00980057|65588008|FG001|Overall Study|Adverse Event|1|||
23505629|NCT00980057|65588007|FG000|Overall Study|Physician Decision|4|||
23505630|NCT00980057|65588008|FG001|Overall Study|Physician Decision|0|||
23505631|NCT00980057|65588007|FG000|Overall Study|Lost to Follow-up|1|||
23505632|NCT00980057|65588008|FG001|Overall Study|Lost to Follow-up|0|||
23505633|NCT00980057|65588007|FG000|Overall Study|Withdrawal by Subject|1|||
23505634|NCT00980057|65588008|FG001|Overall Study|Withdrawal by Subject|1|||
23505635|NCT02966028|65588009|FG000|Overall Study|Adverse Event|7|||
23505636|NCT02966028|65588010|FG001|Overall Study|Adverse Event|13|||
23505637|NCT02966028|65588011|FG002|Overall Study|Adverse Event|10|||
23505638|NCT02966028|65588009|FG000|Overall Study|Physician Decision|1|||
23505639|NCT02966028|65588010|FG001|Overall Study|Physician Decision|0|||
23607070|NCT03678688|65950589|FG008|Overall Study|Withdrawal by Subject|0|||
23607071|NCT03150589|65950590|FG000|Overall Study|Withdrawal by Subject|16|||
23607072|NCT03150589|65950591|FG001|Overall Study|Withdrawal by Subject|9|||
23607073|NCT03150589|65950590|FG000|Overall Study|Adverse Event|7|||
23607074|NCT03150589|65950591|FG001|Overall Study|Adverse Event|6|||
23607075|NCT03150589|65950590|FG000|Overall Study|Protocol Violation|4|||
23607076|NCT03150589|65950591|FG001|Overall Study|Protocol Violation|3|||
23607077|NCT03150589|65950590|FG000|Overall Study|Lost to Follow-up|3|||
23607078|NCT03150589|65950591|FG001|Overall Study|Lost to Follow-up|3|||
23607079|NCT03150589|65950590|FG000|Overall Study|Death|2|||
23607080|NCT03150589|65950591|FG001|Overall Study|Death|3|||
23607081|NCT03150589|65950590|FG000|Overall Study|IP non-compliance and other reasons|12|||
23607082|NCT03150589|65950591|FG001|Overall Study|IP non-compliance and other reasons|3|||
23607083|NCT00603798|65950595|FG000|Overall Study|Adverse Event|4|||
23607084|NCT00603798|65950596|FG001|Overall Study|Adverse Event|2|||
23607085|NCT00603798|65950597|FG002|Overall Study|Adverse Event|1|||
23607086|NCT00603798|65950595|FG000|Overall Study|Withdrawal by Subject|4|||
23607087|NCT00603798|65950596|FG001|Overall Study|Withdrawal by Subject|3|||
23607088|NCT00603798|65950597|FG002|Overall Study|Withdrawal by Subject|4|||
23607089|NCT00603798|65950595|FG000|Overall Study|Lost to Follow-up|1|||
23607090|NCT00603798|65950596|FG001|Overall Study|Lost to Follow-up|0|||
23607091|NCT00603798|65950597|FG002|Overall Study|Lost to Follow-up|1|||
23607092|NCT00603798|65950595|FG000|Overall Study|Non-compliance with study procedures|0|||
23607093|NCT00603798|65950596|FG001|Overall Study|Non-compliance with study procedures|1|||
23607094|NCT00603798|65950597|FG002|Overall Study|Non-compliance with study procedures|0|||
23607095|NCT00603798|65950595|FG000|Overall Study|Not due to AE|1|||
23607096|NCT00603798|65950596|FG001|Overall Study|Not due to AE|1|||
23607097|NCT00603798|65950597|FG002|Overall Study|Not due to AE|4|||
23607098|NCT01248715|65950598|FG000|Overall Study|Not influenza positive|501|||
23607099|NCT01248715|65950599|FG001|Overall Study|Not influenza positive|510|||
23607100|NCT00658632|65950600|FG000|Overall Study|Adverse Event|13|||
23607101|NCT00658632|65950601|FG001|Overall Study|Adverse Event|11|||
23607102|NCT00658632|65950600|FG000|Overall Study|Lost to Follow-up|25|||
23607103|NCT00658632|65950601|FG001|Overall Study|Lost to Follow-up|23|||
23607104|NCT00658632|65950600|FG000|Overall Study|Withdrawal by Subject|10|||
23607105|NCT00658632|65950601|FG001|Overall Study|Withdrawal by Subject|7|||
23607106|NCT00658632|65950600|FG000|Overall Study|Lack of Efficacy|0|||
23607107|NCT00658632|65950601|FG001|Overall Study|Lack of Efficacy|1|||
23607108|NCT00658632|65950600|FG000|Overall Study|Withdrawal of consent|8|||
23607109|NCT00658632|65950601|FG001|Overall Study|Withdrawal of consent|14|||
23607110|NCT00658632|65950600|FG000|Overall Study|Pregnancy|1|||
23303897|NCT02149121|64854782|FG001|Main Study Period|Lost to Follow-up|1|||
23303898|NCT02149121|64854783|FG002|Main Study Period|Lost to Follow-up|0|||
23303899|NCT02149121|64854784|FG003|Main Study Period|Lost to Follow-up|0|||
23303900|NCT02149121|64854785|FG004|Main Study Period|Lost to Follow-up|0|||
23303901|NCT02149121|64854786|FG005|Main Study Period|Lost to Follow-up|0|||
23303902|NCT02149121|64854787|FG006|Main Study Period|Lost to Follow-up|0|||
23607111|NCT00658632|65950601|FG001|Overall Study|Pregnancy|1|||
23607112|NCT00658632|65950600|FG000|Overall Study|Other|7|||
23607113|NCT00658632|65950601|FG001|Overall Study|Other|8|||
23607114|NCT00990314|65950602|FG000|Overall Study|Death|2|||
23607115|NCT00990314|65950602|FG000|Overall Study|Adverse Event|2|||
23607116|NCT00990314|65950602|FG000|Overall Study|Withdrawal by Subject|3|||
23607117|NCT00990314|65950602|FG000|Overall Study|Non-Compliance|1|||
23607118|NCT00990314|65950602|FG000|Overall Study|Physician Decision|3|||
23607119|NCT00990314|65950602|FG000|Overall Study|Lack of Efficacy|1|||
23607120|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
23303903|NCT02149121|64854781|FG000|Main Study Period|Death|1|||
23505640|NCT02966028|65588011|FG002|Overall Study|Physician Decision|2|||
23607121|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
23607122|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
23607123|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
23303904|NCT02149121|64854782|FG001|Main Study Period|Death|0|||
23303905|NCT02149121|64854783|FG002|Main Study Period|Death|0|||
23303906|NCT02149121|64854784|FG003|Main Study Period|Death|0|||
23303907|NCT02149121|64854785|FG004|Main Study Period|Death|0|||
23607124|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
23607125|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
23607126|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
23607127|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
23607128|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
23607129|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
23607130|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
23607131|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
23607132|NCT01494467|65950603|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
23607133|NCT01494467|65950604|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
23607134|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
23607135|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
23607136|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
23607137|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
23607138|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
23607139|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
23303908|NCT02149121|64854786|FG005|Main Study Period|Death|0|||
23303909|NCT02149121|64854787|FG006|Main Study Period|Death|0|||
23303910|NCT02149121|64854781|FG000|Main Study Period|Physician Decision|1|||
23303911|NCT02149121|64854782|FG001|Main Study Period|Physician Decision|0|||
23204551|NCT00608530|64491093|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
23204552|NCT00608530|64491094|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
23204553|NCT00608530|64491091|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
23303912|NCT02149121|64854783|FG002|Main Study Period|Physician Decision|0|||
23303913|NCT02149121|64854784|FG003|Main Study Period|Physician Decision|0|||
23303914|NCT02149121|64854785|FG004|Main Study Period|Physician Decision|0|||
23303915|NCT02149121|64854786|FG005|Main Study Period|Physician Decision|0|||
23303916|NCT02149121|64854787|FG006|Main Study Period|Physician Decision|0|||
23303917|NCT02149121|64854781|FG000|Main Study Period|Developed any malignancy|0|||
23303918|NCT02149121|64854782|FG001|Main Study Period|Developed any malignancy|1|||
23303919|NCT02149121|64854783|FG002|Main Study Period|Developed any malignancy|1|||
23303920|NCT02149121|64854784|FG003|Main Study Period|Developed any malignancy|0|||
23303921|NCT02149121|64854785|FG004|Main Study Period|Developed any malignancy|0|||
23303922|NCT02149121|64854786|FG005|Main Study Period|Developed any malignancy|0|||
23303923|NCT02149121|64854787|FG006|Main Study Period|Developed any malignancy|0|||
23303924|NCT02149121|64854781|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
23303925|NCT02149121|64854782|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
23303926|NCT02149121|64854783|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
23303927|NCT02149121|64854784|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
23303928|NCT02149121|64854785|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
23303929|NCT02149121|64854786|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
23303930|NCT02149121|64854787|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
23303931|NCT02149121|64854781|FG000|Main Study Period|Disease progression|0|||
23303932|NCT02149121|64854782|FG001|Main Study Period|Disease progression|1|||
23303933|NCT02149121|64854783|FG002|Main Study Period|Disease progression|0|||
23303934|NCT02149121|64854784|FG003|Main Study Period|Disease progression|0|||
23607140|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
23607141|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
23607142|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
23607143|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
23607144|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
23607145|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
23607146|NCT01494467|65950603|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
23607147|NCT01494467|65950604|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
23607148|NCT02009332|65950605|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23303935|NCT02149121|64854785|FG004|Main Study Period|Disease progression|0|||
23303936|NCT02149121|64854786|FG005|Main Study Period|Disease progression|0|||
23303937|NCT02149121|64854787|FG006|Main Study Period|Disease progression|0|||
23303938|NCT02149121|64854781|FG000|Extension Study Period|Withdrawal by Subject|0|||
23303939|NCT02149121|64854782|FG001|Extension Study Period|Withdrawal by Subject|0|||
23303940|NCT02149121|64854783|FG002|Extension Study Period|Withdrawal by Subject|0|||
23303941|NCT02149121|64854784|FG003|Extension Study Period|Withdrawal by Subject|1|||
23303942|NCT02149121|64854785|FG004|Extension Study Period|Withdrawal by Subject|0|||
23303943|NCT02149121|64854786|FG005|Extension Study Period|Withdrawal by Subject|2|||
23303944|NCT02149121|64854787|FG006|Extension Study Period|Withdrawal by Subject|0|||
23303945|NCT00080938|64854789|FG000|Overall Study|Adverse Event|3|||
23607149|NCT02009332|65950606|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
23607150|NCT02009332|65950607|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23607151|NCT02009332|65950608|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23607152|NCT02009332|65950609|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23607153|NCT02009332|65950610|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
23607154|NCT02009332|65950605|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607155|NCT02009332|65950606|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607156|NCT02009332|65950607|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607157|NCT02009332|65950608|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607158|NCT02009332|65950609|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
23607159|NCT02009332|65950610|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
23607160|NCT02009332|65950605|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607161|NCT02009332|65950606|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607162|NCT02009332|65950607|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607163|NCT02009332|65950608|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607164|NCT02009332|65950609|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
23607165|NCT02009332|65950610|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
23607166|NCT00508144|65950611|FG000|Overall Study|Not eligible|6|||
23607167|NCT00508144|65950611|FG000|Overall Study|Death|5|||
23607168|NCT00388726|65950612|FG000|Overall Study|Adverse Event|50|||
23607169|NCT00388726|65950613|FG001|Overall Study|Adverse Event|24|||
23607170|NCT00388726|65950612|FG000|Overall Study|Progressive Disease|336|||
23607171|NCT00388726|65950613|FG001|Overall Study|Progressive Disease|153|||
23607172|NCT00388726|65950612|FG000|Overall Study|Clinical Progression|61|||
23607173|NCT00388726|65950613|FG001|Overall Study|Clinical Progression|36|||
23607174|NCT00388726|65950612|FG000|Overall Study|Withdrawal by Subject|10|||
23607175|NCT00388726|65950613|FG001|Overall Study|Withdrawal by Subject|7|||
23607176|NCT00388726|65950612|FG000|Overall Study|Administrative|6|||
23607177|NCT00388726|65950613|FG001|Overall Study|Administrative|9|||
23607178|NCT00388726|65950612|FG000|Overall Study|Physician Decision|18|||
23607179|NCT00388726|65950613|FG001|Overall Study|Physician Decision|13|||
23607180|NCT00388726|65950612|FG000|Overall Study|Death|3|||
23607181|NCT00388726|65950613|FG001|Overall Study|Death|2|||
23607182|NCT02584257|65950616|FG000|Period 1|Withdrawal by Subject|0|||
23303946|NCT00080938|64854789|FG000|Overall Study|Withdrawal by Subject|6|||
23303947|NCT00080938|64854789|FG000|Overall Study|Death|2|||
23303948|NCT00080938|64854789|FG000|Overall Study|Lack of Efficacy|7|||
23303949|NCT00080938|64854789|FG000|Overall Study|other disease|1|||
23303950|NCT00080938|64854789|FG000|Overall Study|Not started protocol therapy|1|||
23303951|NCT00080938|64854789|FG000|Overall Study|Ineligible|4|||
23303952|NCT00605865|64854790|FG000|Overall Study|Protocol Violation|115|||
23303953|NCT00669071|64854791|FG000|Overall Study|Lost to Follow-up|3|||
23303954|NCT00669071|64854791|FG000|Overall Study|Final visit 40 days out of window|1|||
23303955|NCT03733210|64854793|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
23303956|NCT03733210|64854794|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
23303957|NCT02312063|64854798|FG000|Overall Study|Withdrawal by Subject|0|||
23303958|NCT02312063|64854799|FG001|Overall Study|Withdrawal by Subject|1|||
23303959|NCT00931268|64854800|FG000|Overall Study|Lost to Follow-up|6|||
23303960|NCT00750308|64854802|FG000|First Treatment|Adverse Event|0|||
23303961|NCT00750308|64854803|FG001|First Treatment|Adverse Event|1|||
23303962|NCT00750308|64854804|FG002|First Treatment|Adverse Event|0|||
23607183|NCT02584257|65950617|FG001|Period 1|Withdrawal by Subject|0|||
23303963|NCT00750308|64854805|FG003|First Treatment|Adverse Event|0|||
23303964|NCT00750308|64854806|FG004|First Treatment|Adverse Event|0|||
23303965|NCT00750308|64854807|FG005|First Treatment|Adverse Event|0|||
23303966|NCT00750308|64854808|FG006|First Treatment|Adverse Event|0|||
23204554|NCT00608530|64491092|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
23204555|NCT00608530|64491093|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
23204556|NCT00608530|64491094|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
23204557|NCT00608530|64491091|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
23204558|NCT00608530|64491092|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
23204559|NCT00608530|64491093|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
23204560|NCT00608530|64491094|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
23204561|NCT00608530|64491091|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
23303967|NCT00750308|64854809|FG007|First Treatment|Adverse Event|0|||
23405472|NCT00326599|65230206|FG002|Overall Study|Disease Progression|13|||
23505641|NCT02966028|65588009|FG000|Overall Study|Withdrawal by Subject|7|||
23505642|NCT02966028|65588010|FG001|Overall Study|Withdrawal by Subject|5|||
23505643|NCT02966028|65588011|FG002|Overall Study|Withdrawal by Subject|5|||
23505644|NCT02966028|65588009|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
23607184|NCT02584257|65950618|FG002|Period 1|Withdrawal by Subject|0|||
23607185|NCT02584257|65950619|FG003|Period 1|Withdrawal by Subject|0|||
23607186|NCT02584257|65950620|FG004|Period 1|Withdrawal by Subject|0|||
23607187|NCT02584257|65950621|FG005|Period 1|Withdrawal by Subject|0|||
23204562|NCT00608530|64491092|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
23204563|NCT00608530|64491093|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
23204564|NCT00608530|64491094|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
23204565|NCT00608530|64491091|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
23204566|NCT00608530|64491092|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
23204567|NCT00608530|64491093|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
23505645|NCT02966028|65588010|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
23505646|NCT02966028|65588011|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
23505647|NCT00907777|65588019|FG000|Overall Study|Withdrawal by Subject|0|||
23505648|NCT00907777|65588020|FG001|Overall Study|Withdrawal by Subject|1|||
23505649|NCT01425281|65588021|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
23607188|NCT02584257|65950622|FG006|Period 1|Withdrawal by Subject|1|||
23204568|NCT00608530|64491094|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
23204569|NCT04504032|64491095|FG000|Overall Study|Adverse Event|1|||
23204570|NCT04504032|64491096|FG001|Overall Study|Adverse Event|2|||
23204571|NCT04504032|64491095|FG000|Overall Study|Lost to Follow-up|6|||
23204572|NCT04504032|64491096|FG001|Overall Study|Lost to Follow-up|9|||
23204573|NCT04504032|64491095|FG000|Overall Study|Protocol Violation|2|||
23204574|NCT04504032|64491096|FG001|Overall Study|Protocol Violation|0|||
23204575|NCT04504032|64491095|FG000|Overall Study|Study terminated by sponsor|1|||
23204576|NCT04504032|64491096|FG001|Overall Study|Study terminated by sponsor|2|||
23204577|NCT04504032|64491095|FG000|Overall Study|Withdrawal by Subject|9|||
23204578|NCT04504032|64491096|FG001|Overall Study|Withdrawal by Subject|11|||
23204579|NCT04504032|64491095|FG000|Overall Study|Disease progression prior to dosing|15|||
23204580|NCT04504032|64491096|FG001|Overall Study|Disease progression prior to dosing|3|||
23204581|NCT04504032|64491095|FG000|Overall Study|Drug supply issues|1|||
23204582|NCT04504032|64491096|FG001|Overall Study|Drug supply issues|1|||
23204583|NCT04504032|64491095|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
23204584|NCT04504032|64491096|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
23204585|NCT03544268|64491098|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
23204586|NCT03544268|64491099|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
23204587|NCT02512068|64491100|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
23204588|NCT02512068|64491101|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
23204589|NCT02512068|64491100|FG000|Overall Study|Major Protocol Deviation|1|||
23204590|NCT02512068|64491101|FG001|Overall Study|Major Protocol Deviation|0|||
23204591|NCT02512068|64491100|FG000|Overall Study|Voluntary Withdrawal|0|||
23204592|NCT02512068|64491101|FG001|Overall Study|Voluntary Withdrawal|1|||
23204593|NCT02512068|64491100|FG000|Overall Study|Lack of Efficacy|0|||
23204594|NCT02512068|64491101|FG001|Overall Study|Lack of Efficacy|1|||
23204595|NCT02512068|64491100|FG000|Overall Study|Reason Not Specified|3|||
23204596|NCT02512068|64491101|FG001|Overall Study|Reason Not Specified|5|||
23204597|NCT01718509|64491102|FG000|Overall Study|Lost to Follow-up|18|||
23204598|NCT01718509|64491103|FG001|Overall Study|Lost to Follow-up|15|||
23303968|NCT00750308|64854810|FG008|First Treatment|Adverse Event|0|||
23303969|NCT00750308|64854811|FG009|First Treatment|Adverse Event|0|||
23303970|NCT00750308|64854812|FG010|First Treatment|Adverse Event|1|||
23303971|NCT00750308|64854813|FG011|First Treatment|Adverse Event|1|||
23303972|NCT00750308|64854802|FG000|First Treatment|Withdrawal by Subject|0|||
23303973|NCT00750308|64854803|FG001|First Treatment|Withdrawal by Subject|0|||
23303974|NCT00750308|64854804|FG002|First Treatment|Withdrawal by Subject|0|||
23303975|NCT00750308|64854805|FG003|First Treatment|Withdrawal by Subject|1|||
23303976|NCT00750308|64854806|FG004|First Treatment|Withdrawal by Subject|0|||
23303977|NCT00750308|64854807|FG005|First Treatment|Withdrawal by Subject|0|||
23303978|NCT00750308|64854808|FG006|First Treatment|Withdrawal by Subject|0|||
23303979|NCT00750308|64854809|FG007|First Treatment|Withdrawal by Subject|1|||
23303980|NCT00750308|64854810|FG008|First Treatment|Withdrawal by Subject|0|||
23303981|NCT00750308|64854811|FG009|First Treatment|Withdrawal by Subject|0|||
23303982|NCT00750308|64854812|FG010|First Treatment|Withdrawal by Subject|0|||
23303983|NCT00750308|64854813|FG011|First Treatment|Withdrawal by Subject|0|||
23303984|NCT00750308|64854802|FG000|Second Treatment|Adverse Event|0|||
23303985|NCT00750308|64854803|FG001|Second Treatment|Adverse Event|0|||
23303986|NCT00750308|64854804|FG002|Second Treatment|Adverse Event|0|||
23303987|NCT00750308|64854805|FG003|Second Treatment|Adverse Event|0|||
23303988|NCT00750308|64854806|FG004|Second Treatment|Adverse Event|0|||
23303989|NCT00750308|64854807|FG005|Second Treatment|Adverse Event|1|||
23607189|NCT02584257|65950623|FG007|Period 1|Withdrawal by Subject|0|||
23303990|NCT00750308|64854808|FG006|Second Treatment|Adverse Event|0|||
23303991|NCT00750308|64854809|FG007|Second Treatment|Adverse Event|0|||
23303992|NCT00750308|64854810|FG008|Second Treatment|Adverse Event|1|||
23303993|NCT00750308|64854811|FG009|Second Treatment|Adverse Event|0|||
23303994|NCT00750308|64854812|FG010|Second Treatment|Adverse Event|0|||
23303995|NCT00750308|64854813|FG011|Second Treatment|Adverse Event|0|||
23303996|NCT00750308|64854802|FG000|Second Treatment|Withdrawal by Subject|0|||
23303997|NCT00750308|64854803|FG001|Second Treatment|Withdrawal by Subject|0|||
23303998|NCT00750308|64854804|FG002|Second Treatment|Withdrawal by Subject|0|||
23303999|NCT00750308|64854805|FG003|Second Treatment|Withdrawal by Subject|0|||
23304000|NCT00750308|64854806|FG004|Second Treatment|Withdrawal by Subject|1|||
23304001|NCT00750308|64854807|FG005|Second Treatment|Withdrawal by Subject|0|||
23304002|NCT00750308|64854808|FG006|Second Treatment|Withdrawal by Subject|0|||
23304003|NCT00750308|64854809|FG007|Second Treatment|Withdrawal by Subject|0|||
23304004|NCT00750308|64854810|FG008|Second Treatment|Withdrawal by Subject|0|||
23304005|NCT00750308|64854811|FG009|Second Treatment|Withdrawal by Subject|0|||
23304006|NCT00750308|64854812|FG010|Second Treatment|Withdrawal by Subject|0|||
23304007|NCT00750308|64854813|FG011|Second Treatment|Withdrawal by Subject|0|||
23304008|NCT00750308|64854802|FG000|Third Treatment|Withdrawal by Subject|0|||
23304009|NCT00750308|64854803|FG001|Third Treatment|Withdrawal by Subject|1|||
23304010|NCT00750308|64854804|FG002|Third Treatment|Withdrawal by Subject|0|||
23304011|NCT00750308|64854805|FG003|Third Treatment|Withdrawal by Subject|0|||
23304012|NCT00750308|64854806|FG004|Third Treatment|Withdrawal by Subject|0|||
23304013|NCT00750308|64854807|FG005|Third Treatment|Withdrawal by Subject|0|||
23304014|NCT00750308|64854808|FG006|Third Treatment|Withdrawal by Subject|0|||
23304015|NCT00750308|64854809|FG007|Third Treatment|Withdrawal by Subject|0|||
23607190|NCT02584257|65950624|FG008|Period 1|Withdrawal by Subject|0|||
23607191|NCT02584257|65950616|FG000|Period 2|Physician Decision|1|||
23505650|NCT01425281|65588022|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
23505651|NCT01425281|65588021|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
23505652|NCT01425281|65588022|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
23304016|NCT00750308|64854810|FG008|Third Treatment|Withdrawal by Subject|0|||
23304017|NCT00750308|64854811|FG009|Third Treatment|Withdrawal by Subject|0|||
23505653|NCT01425281|65588021|FG000|At 180-day Clinical Follow-up|Death|0|||
23505654|NCT01425281|65588022|FG001|At 180-day Clinical Follow-up|Death|1|||
23505655|NCT01425281|65588021|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
23505656|NCT01425281|65588022|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
23505657|NCT01425281|65588021|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
23505658|NCT01425281|65588022|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
23505659|NCT01425281|65588021|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
23505660|NCT01425281|65588022|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
23505661|NCT01425281|65588021|FG000|At 2-year Clinical Follow-up|Death|2|||
23505662|NCT01425281|65588022|FG001|At 2-year Clinical Follow-up|Death|0|||
23505663|NCT01425281|65588021|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
23505664|NCT01425281|65588022|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
23505665|NCT01425281|65588021|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
23505666|NCT01425281|65588022|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
23505667|NCT01425281|65588021|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
23505668|NCT01425281|65588022|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
23505669|NCT01425281|65588021|FG000|At 3-year Clinical Follow-up|Death|2|||
23505670|NCT01425281|65588022|FG001|At 3-year Clinical Follow-up|Death|3|||
23505671|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Death|7|||
23505672|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Death|3|||
23505673|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
23505674|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
23505675|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
23505676|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
23505677|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
23505678|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
23505679|NCT01425281|65588021|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
23505680|NCT01425281|65588022|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
23505681|NCT01425281|65588021|FG000|At 5-year Clinical Follow-up|Death|2|||
23505682|NCT01425281|65588022|FG001|At 5-year Clinical Follow-up|Death|0|||
23505683|NCT01425281|65588021|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
23505684|NCT01425281|65588022|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
23505685|NCT01425281|65588021|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
23505686|NCT01425281|65588022|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
23505687|NCT01425281|65588021|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
23505688|NCT01425281|65588022|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
23607192|NCT02584257|65950617|FG001|Period 2|Physician Decision|0|||
23607193|NCT02584257|65950618|FG002|Period 2|Physician Decision|0|||
23204599|NCT01718509|64491102|FG000|Overall Study|Withdrawal by Subject|7|||
23304018|NCT00750308|64854812|FG010|Third Treatment|Withdrawal by Subject|0|||
23304019|NCT00750308|64854813|FG011|Third Treatment|Withdrawal by Subject|0|||
23304020|NCT02071849|64854814|FG000|6-month Primary Endpoint|Did not receive device|4|||
23607194|NCT02584257|65950619|FG003|Period 2|Physician Decision|0|||
23304021|NCT02071849|64854814|FG000|6-month Primary Endpoint|Adverse Event|1|||
23304022|NCT02071849|64854814|FG000|2-year Extended Follow-up|Adverse Event|1|||
23304023|NCT00038649|64854815|FG000|Overall Study|Adverse Event|9|||
23505689|NCT00612040|65588025|FG000|Overall Study|Adverse Event|0|||
23607195|NCT02584257|65950620|FG004|Period 2|Physician Decision|0|||
23607196|NCT02584257|65950621|FG005|Period 2|Physician Decision|0|||
23607197|NCT02584257|65950622|FG006|Period 2|Physician Decision|0|||
23607198|NCT02584257|65950623|FG007|Period 2|Physician Decision|0|||
23304024|NCT02939950|64854821|FG000|Overall Study|Lost to Follow-up|13|||
23304025|NCT02939950|64854822|FG001|Overall Study|Lost to Follow-up|16|||
23304026|NCT02939950|64854821|FG000|Overall Study|Positive slit lamp findings|0|||
23304027|NCT02939950|64854822|FG001|Overall Study|Positive slit lamp findings|1|||
23304028|NCT02939950|64854821|FG000|Overall Study|Chalazion upper lid|0|||
23304029|NCT02939950|64854822|FG001|Overall Study|Chalazion upper lid|1|||
23304030|NCT02939950|64854821|FG000|Overall Study|Lack of motivation|0|||
23304031|NCT02939950|64854822|FG001|Overall Study|Lack of motivation|2|||
23304032|NCT02939950|64854821|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
23304033|NCT02939950|64854822|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
23304034|NCT02939950|64854821|FG000|Overall Study|Military orders|1|||
23304035|NCT02939950|64854822|FG001|Overall Study|Military orders|0|||
23304036|NCT02939950|64854821|FG000|Overall Study|Participant Relocated|5|||
23304037|NCT02939950|64854822|FG001|Overall Study|Participant Relocated|3|||
23304038|NCT02939950|64854821|FG000|Overall Study|Study related symptoms|8|||
23304039|NCT02939950|64854822|FG001|Overall Study|Study related symptoms|8|||
23304040|NCT02939950|64854821|FG000|Overall Study|Unacceptable lens movement|2|||
23304041|NCT02939950|64854822|FG001|Overall Study|Unacceptable lens movement|0|||
23304042|NCT02939950|64854821|FG000|Overall Study|Protocol Violation|6|||
23304043|NCT02939950|64854822|FG001|Overall Study|Protocol Violation|3|||
23304044|NCT02939950|64854821|FG000|Overall Study|Physician Decision|2|||
23304045|NCT02939950|64854822|FG001|Overall Study|Physician Decision|0|||
23304046|NCT02939950|64854821|FG000|Overall Study|Pregnancy|6|||
23304047|NCT02939950|64854822|FG001|Overall Study|Pregnancy|7|||
23304048|NCT02939950|64854821|FG000|Overall Study|Withdrawal by Subject|12|||
23304049|NCT02939950|64854822|FG001|Overall Study|Withdrawal by Subject|28|||
23304050|NCT02939950|64854821|FG000|Overall Study|Adverse Event|7|||
23304051|NCT02939950|64854822|FG001|Overall Study|Adverse Event|3|||
23304052|NCT02939950|64854821|FG000|Overall Study|Randomized, not dispensed|1|||
23304053|NCT02939950|64854822|FG001|Overall Study|Randomized, not dispensed|0|||
23304054|NCT02939950|64854821|FG000|Overall Study|Ineligible at Baseline|2|||
23304055|NCT02939950|64854822|FG001|Overall Study|Ineligible at Baseline|8|||
23304056|NCT02963311|64854823|FG000|Overall Study|Withdrawal by Subject|1|||
23304057|NCT02963311|64854823|FG000|Overall Study|Screen Failure|4|||
23304058|NCT01970865|64854824|FG000|Overall Study|Death|3|||
23304059|NCT01970865|64854825|FG001|Overall Study|Death|2|||
23304060|NCT01970865|64854826|FG002|Overall Study|Death|3|||
23304061|NCT01970865|64854827|FG003|Overall Study|Death|6|||
23304062|NCT01970865|64854828|FG004|Overall Study|Death|9|||
23304063|NCT01970865|64854829|FG005|Overall Study|Death|3|||
23304064|NCT01970865|64854830|FG006|Overall Study|Death|2|||
23304065|NCT01970865|64854831|FG007|Overall Study|Death|3|||
23304066|NCT01970865|64854832|FG008|Overall Study|Death|2|||
23304067|NCT01970865|64854833|FG009|Overall Study|Death|2|||
23304068|NCT01970865|64854834|FG010|Overall Study|Death|8|||
23304069|NCT01970865|64854835|FG011|Overall Study|Death|13|||
23304070|NCT01970865|64854836|FG012|Overall Study|Death|25|||
23304071|NCT01970865|64854837|FG013|Overall Study|Death|46|||
23304072|NCT01970865|64854838|FG014|Overall Study|Death|37|||
23304073|NCT01970865|64854839|FG015|Overall Study|Death|22|||
23304074|NCT01970865|64854840|FG016|Overall Study|Death|1|||
23304075|NCT01970865|64854841|FG017|Overall Study|Death|17|||
23304076|NCT01970865|64854824|FG000|Overall Study|Lost to Follow-up|0|||
23304077|NCT01970865|64854825|FG001|Overall Study|Lost to Follow-up|0|||
23607199|NCT02584257|65950624|FG008|Period 2|Physician Decision|0|||
23607200|NCT02584257|65950616|FG000|Period 2|Adverse Event|0|||
23607201|NCT02584257|65950617|FG001|Period 2|Adverse Event|1|||
23607202|NCT02584257|65950618|FG002|Period 2|Adverse Event|0|||
23607203|NCT02584257|65950619|FG003|Period 2|Adverse Event|0|||
23607204|NCT02584257|65950620|FG004|Period 2|Adverse Event|0|||
23607205|NCT02584257|65950621|FG005|Period 2|Adverse Event|0|||
23607206|NCT02584257|65950622|FG006|Period 2|Adverse Event|0|||
23607207|NCT02584257|65950623|FG007|Period 2|Adverse Event|0|||
23304078|NCT01970865|64854826|FG002|Overall Study|Lost to Follow-up|0|||
23304079|NCT01970865|64854827|FG003|Overall Study|Lost to Follow-up|1|||
23304080|NCT01970865|64854828|FG004|Overall Study|Lost to Follow-up|1|||
23304081|NCT01970865|64854829|FG005|Overall Study|Lost to Follow-up|0|||
23304082|NCT01970865|64854830|FG006|Overall Study|Lost to Follow-up|0|||
23304083|NCT01970865|64854831|FG007|Overall Study|Lost to Follow-up|0|||
23304084|NCT01970865|64854832|FG008|Overall Study|Lost to Follow-up|0|||
23304085|NCT01970865|64854833|FG009|Overall Study|Lost to Follow-up|0|||
23304086|NCT01970865|64854834|FG010|Overall Study|Lost to Follow-up|1|||
23304087|NCT01970865|64854835|FG011|Overall Study|Lost to Follow-up|0|||
23304088|NCT01970865|64854836|FG012|Overall Study|Lost to Follow-up|2|||
23304089|NCT01970865|64854837|FG013|Overall Study|Lost to Follow-up|0|||
23304090|NCT01970865|64854838|FG014|Overall Study|Lost to Follow-up|1|||
23607208|NCT02584257|65950624|FG008|Period 2|Adverse Event|0|||
23607209|NCT02106325|65950625|FG000|Phase 1|Lost to Follow-up|2|||
23505690|NCT00612040|65588026|FG001|Overall Study|Adverse Event|2|||
23505691|NCT00612040|65588027|FG002|Overall Study|Adverse Event|1|||
23505692|NCT00612040|65588025|FG000|Overall Study|Protocol Violation|1|||
23505693|NCT00612040|65588026|FG001|Overall Study|Protocol Violation|2|||
23505694|NCT00612040|65588027|FG002|Overall Study|Protocol Violation|1|||
23505695|NCT00612040|65588025|FG000|Overall Study|Lack of Efficacy|2|||
23505696|NCT00612040|65588026|FG001|Overall Study|Lack of Efficacy|1|||
23505697|NCT00612040|65588027|FG002|Overall Study|Lack of Efficacy|0|||
23505698|NCT00612040|65588025|FG000|Overall Study|Unclassified|2|||
23505699|NCT00612040|65588026|FG001|Overall Study|Unclassified|2|||
23505700|NCT00612040|65588027|FG002|Overall Study|Unclassified|5|||
23505701|NCT03539081|65588030|FG000|Overall Study|Withdrawal by Subject|2|||
23505702|NCT03539081|65588031|FG001|Overall Study|Withdrawal by Subject|3|||
23505703|NCT03539081|65588032|FG002|Overall Study|Withdrawal by Subject|0|||
23505704|NCT03539081|65588030|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
23304091|NCT01970865|64854839|FG015|Overall Study|Lost to Follow-up|4|||
23304092|NCT01970865|64854840|FG016|Overall Study|Lost to Follow-up|0|||
23304093|NCT01970865|64854841|FG017|Overall Study|Lost to Follow-up|1|||
23304094|NCT01970865|64854824|FG000|Overall Study|Other|0|||
23304095|NCT01970865|64854825|FG001|Overall Study|Other|1|||
23304096|NCT01970865|64854826|FG002|Overall Study|Other|0|||
23304097|NCT01970865|64854827|FG003|Overall Study|Other|1|||
23304098|NCT01970865|64854828|FG004|Overall Study|Other|1|||
23304099|NCT01970865|64854829|FG005|Overall Study|Other|0|||
23304100|NCT01970865|64854830|FG006|Overall Study|Other|1|||
23304101|NCT01970865|64854831|FG007|Overall Study|Other|0|||
23304102|NCT01970865|64854832|FG008|Overall Study|Other|0|||
23304103|NCT01970865|64854833|FG009|Overall Study|Other|0|||
23304104|NCT01970865|64854834|FG010|Overall Study|Other|2|||
23304105|NCT01970865|64854835|FG011|Overall Study|Other|3|||
23304106|NCT01970865|64854836|FG012|Overall Study|Other|8|||
23304107|NCT01970865|64854837|FG013|Overall Study|Other|3|||
23304108|NCT01970865|64854838|FG014|Overall Study|Other|2|||
23304109|NCT01970865|64854839|FG015|Overall Study|Other|3|||
23304110|NCT01970865|64854840|FG016|Overall Study|Other|0|||
23304111|NCT01970865|64854841|FG017|Overall Study|Other|2|||
23304112|NCT01970865|64854824|FG000|Overall Study|Participant refused further follow-up|0|||
23304113|NCT01970865|64854825|FG001|Overall Study|Participant refused further follow-up|0|||
23304114|NCT01970865|64854826|FG002|Overall Study|Participant refused further follow-up|0|||
23304115|NCT01970865|64854827|FG003|Overall Study|Participant refused further follow-up|2|||
23304116|NCT01970865|64854828|FG004|Overall Study|Participant refused further follow-up|3|||
23304117|NCT01970865|64854829|FG005|Overall Study|Participant refused further follow-up|0|||
23304118|NCT01970865|64854830|FG006|Overall Study|Participant refused further follow-up|0|||
23304119|NCT01970865|64854831|FG007|Overall Study|Participant refused further follow-up|0|||
23304120|NCT01970865|64854832|FG008|Overall Study|Participant refused further follow-up|0|||
23304121|NCT01970865|64854833|FG009|Overall Study|Participant refused further follow-up|0|||
23304122|NCT01970865|64854834|FG010|Overall Study|Participant refused further follow-up|1|||
23304123|NCT01970865|64854835|FG011|Overall Study|Participant refused further follow-up|4|||
23304124|NCT01970865|64854836|FG012|Overall Study|Participant refused further follow-up|7|||
23304125|NCT01970865|64854837|FG013|Overall Study|Participant refused further follow-up|8|||
23304126|NCT01970865|64854838|FG014|Overall Study|Participant refused further follow-up|3|||
23304127|NCT01970865|64854839|FG015|Overall Study|Participant refused further follow-up|11|||
23304128|NCT01970865|64854840|FG016|Overall Study|Participant refused further follow-up|0|||
23304129|NCT01970865|64854841|FG017|Overall Study|Participant refused further follow-up|6|||
23304130|NCT02989168|64854843|FG000|Overall Study|Withdrawal by Subject|2|||
23304131|NCT02989168|64854844|FG001|Overall Study|Withdrawal by Subject|0|||
23304132|NCT02989168|64854843|FG000|Overall Study|Physician Decision|0|||
23304133|NCT02989168|64854844|FG001|Overall Study|Physician Decision|1|||
23304134|NCT02989168|64854843|FG000|Overall Study|Adverse Event|1|||
23304135|NCT02989168|64854844|FG001|Overall Study|Adverse Event|2|||
23304136|NCT02989168|64854843|FG000|Overall Study|Sponsor stopped study.|1|||
23505705|NCT03539081|65588031|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
23304137|NCT02989168|64854844|FG001|Overall Study|Sponsor stopped study.|0|||
23304138|NCT00324649|64854855|FG000|Overall Study|Adverse Event|1|||
23505706|NCT03539081|65588032|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
23304139|NCT00324649|64854856|FG001|Overall Study|Adverse Event|4|||
23304140|NCT00324649|64854855|FG000|Overall Study|Withdrawal by Subject|0|||
23304141|NCT00324649|64854856|FG001|Overall Study|Withdrawal by Subject|1|||
23304142|NCT00324649|64854855|FG000|Overall Study|Noncompliance|1|||
23304143|NCT00324649|64854856|FG001|Overall Study|Noncompliance|0|||
23304144|NCT02981303|64854857|FG000|Overall Study|Progressive Disease|17|||
23304145|NCT02981303|64854858|FG001|Overall Study|Progressive Disease|37|||
23304146|NCT02981303|64854857|FG000|Overall Study|Adverse Event|1|||
23304147|NCT02981303|64854858|FG001|Overall Study|Adverse Event|4|||
23505707|NCT01826604|65588034|FG000|Overall Study|Lost to Follow-up|8|||
23304148|NCT02981303|64854857|FG000|Overall Study|Withdrawal by Subject|0|||
23304149|NCT02981303|64854858|FG001|Overall Study|Withdrawal by Subject|1|||
23304150|NCT01111019|64854859|FG000|Overall Study|Withdrew Prematurely|2|||
23304151|NCT01111019|64854859|FG000|Overall Study|Other|1|||
23304152|NCT04619992|64854860|FG000|Overall Study|Withdrawal by Subject|1|||
23304153|NCT04619992|64854861|FG001|Overall Study|Withdrawal by Subject|0|||
23304154|NCT04049617|64854862|FG000|Overall Study|Adverse Event|0|||
23304155|NCT04049617|64854863|FG001|Overall Study|Adverse Event|0|||
23304156|NCT04049617|64854864|FG002|Overall Study|Adverse Event|0|||
23304157|NCT04049617|64854865|FG003|Overall Study|Adverse Event|1|||
23304158|NCT04049617|64854866|FG004|Overall Study|Adverse Event|0|||
23304159|NCT04049617|64854867|FG005|Overall Study|Adverse Event|0|||
23304160|NCT04049617|64854862|FG000|Overall Study|Death|0|||
23304161|NCT04049617|64854863|FG001|Overall Study|Death|0|||
23304162|NCT04049617|64854864|FG002|Overall Study|Death|0|||
23304163|NCT04049617|64854865|FG003|Overall Study|Death|0|||
23304164|NCT04049617|64854866|FG004|Overall Study|Death|0|||
23304165|NCT04049617|64854867|FG005|Overall Study|Death|1|||
23304166|NCT04049617|64854862|FG000|Overall Study|Lost to Follow-up|0|||
23304167|NCT04049617|64854863|FG001|Overall Study|Lost to Follow-up|0|||
23304168|NCT04049617|64854864|FG002|Overall Study|Lost to Follow-up|0|||
23405473|NCT00326599|65230207|FG003|Overall Study|Disease Progression|11|||
23405474|NCT00326599|65230204|FG000|Overall Study|Alternate Treatment|1|||
23405475|NCT00326599|65230205|FG001|Overall Study|Alternate Treatment|0|||
23405476|NCT00326599|65230206|FG002|Overall Study|Alternate Treatment|0|||
23405477|NCT00326599|65230207|FG003|Overall Study|Alternate Treatment|0|||
23405478|NCT00326599|65230204|FG000|Overall Study|Death|0|||
23405479|NCT00326599|65230205|FG001|Overall Study|Death|0|||
23405480|NCT00326599|65230206|FG002|Overall Study|Death|1|||
23405481|NCT00326599|65230207|FG003|Overall Study|Death|2|||
23405482|NCT00326599|65230204|FG000|Overall Study|Other Unspecified Reason|0|||
23405483|NCT00326599|65230205|FG001|Overall Study|Other Unspecified Reason|0|||
23405484|NCT00326599|65230206|FG002|Overall Study|Other Unspecified Reason|2|||
23405485|NCT00326599|65230207|FG003|Overall Study|Other Unspecified Reason|1|||
23405486|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
23405487|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
23405488|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
23405489|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
23405490|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
23405491|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
23405492|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
23405493|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
23405494|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
23405495|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
23405496|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
23405497|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
23405498|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405499|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
23405500|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405501|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405502|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405503|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
23405504|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
23405505|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
23405506|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
23405507|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
23405508|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
23405509|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
23405510|NCT02820844|65230208|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
23405511|NCT02820844|65230209|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23405512|NCT02820844|65230210|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23405513|NCT02820844|65230211|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23607210|NCT02106325|65950626|FG001|Phase 1|Lost to Follow-up|2|||
23505708|NCT01826604|65588035|FG001|Overall Study|Lost to Follow-up|9|||
23304169|NCT04049617|64854865|FG003|Overall Study|Lost to Follow-up|1|||
23304170|NCT04049617|64854866|FG004|Overall Study|Lost to Follow-up|0|||
23304171|NCT04049617|64854867|FG005|Overall Study|Lost to Follow-up|0|||
23405514|NCT02820844|65230212|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23405515|NCT02820844|65230213|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
23405516|NCT02820844|65230208|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
23405517|NCT02820844|65230209|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
23405518|NCT02820844|65230210|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
23505709|NCT01408485|65588036|FG000|Overall Study|Withdrawal by Subject|21|||
23304172|NCT04049617|64854862|FG000|Overall Study|Withdrew consent|0|||
23304173|NCT04049617|64854863|FG001|Overall Study|Withdrew consent|0|||
23304174|NCT04049617|64854864|FG002|Overall Study|Withdrew consent|1|||
23304175|NCT04049617|64854865|FG003|Overall Study|Withdrew consent|0|||
23405519|NCT02820844|65230211|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
23405520|NCT02820844|65230212|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
23405521|NCT02820844|65230213|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
23405522|NCT02820844|65230208|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405523|NCT02820844|65230209|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405524|NCT02820844|65230210|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
23405525|NCT02820844|65230211|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405526|NCT02820844|65230212|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405527|NCT02820844|65230213|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
23405528|NCT02820844|65230208|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405529|NCT02820844|65230209|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405530|NCT02820844|65230210|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
23405531|NCT02820844|65230211|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
23304176|NCT04049617|64854866|FG004|Overall Study|Withdrew consent|0|||
23304177|NCT04049617|64854867|FG005|Overall Study|Withdrew consent|0|||
23405532|NCT02820844|65230212|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405533|NCT02820844|65230213|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405534|NCT02820844|65230208|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23505710|NCT03547583|65588042|FG000|Overall Study|Adverse Event|16|||
23505711|NCT03547583|65588043|FG001|Overall Study|Adverse Event|11|||
23505712|NCT03547583|65588044|FG002|Overall Study|Adverse Event|10|||
23505713|NCT03547583|65588042|FG000|Overall Study|Death|11|||
23505714|NCT03547583|65588043|FG001|Overall Study|Death|7|||
23304178|NCT04032158|64854871|FG000|Overall Study|Study Termination|2|||
23405535|NCT02820844|65230209|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23405536|NCT02820844|65230210|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23405537|NCT02820844|65230211|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23304179|NCT04032158|64854872|FG001|Overall Study|Study Termination|1|||
23304180|NCT00062010|64854873|FG000|Overall Study|Ineligible|3|||
23304181|NCT03734666|64854874|FG000|Overall Study|Other|7|||
23304182|NCT03734666|64854875|FG001|Overall Study|Other|4|||
23304183|NCT03734666|64854874|FG000|Overall Study|Lost to Follow-up|12|||
23304184|NCT03734666|64854875|FG001|Overall Study|Lost to Follow-up|12|||
23304185|NCT00857584|64854876|FG000|Overall Study|Lack of Efficacy|1|||
23304186|NCT00857584|64854877|FG001|Overall Study|Lack of Efficacy|2|||
23304187|NCT00857584|64854876|FG000|Overall Study|Adverse Event|2|||
23304188|NCT00857584|64854877|FG001|Overall Study|Adverse Event|2|||
23304189|NCT00857584|64854876|FG000|Overall Study|Physician Decision|1|||
23304190|NCT00857584|64854877|FG001|Overall Study|Physician Decision|1|||
23304191|NCT00809159|64854880|FG000|Part 1|Adverse Event|1|||
23304192|NCT00809159|64854881|FG001|Part 1|Adverse Event|1|||
23304193|NCT00809159|64854882|FG002|Part 1|Adverse Event|0|||
23304194|NCT00809159|64854883|FG003|Part 1|Adverse Event|0|||
23304195|NCT00809159|64854884|FG004|Part 1|Adverse Event|0|||
23304196|NCT00809159|64854885|FG005|Part 1|Adverse Event|0|||
23405538|NCT02820844|65230212|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
23405539|NCT02820844|65230213|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
23405540|NCT02820844|65230208|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405541|NCT02820844|65230209|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405542|NCT02820844|65230210|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405543|NCT02820844|65230211|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405544|NCT02820844|65230212|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
23405545|NCT02820844|65230213|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
23405546|NCT00616642|65230214|FG000|Overall Study|Withdrawal by Subject|0|||
23405547|NCT00616642|65230215|FG001|Overall Study|Withdrawal by Subject|1|||
23405548|NCT02973997|65230218|FG000|Overall Study|Withdrawal by Subject|4|||
23405549|NCT02973997|65230219|FG001|Overall Study|Withdrawal by Subject|0|||
23405550|NCT02973997|65230218|FG000|Overall Study|Adverse Event|4|||
23405551|NCT02973997|65230219|FG001|Overall Study|Adverse Event|1|||
23405552|NCT02973997|65230218|FG000|Overall Study|Disease Progression|11|||
23405553|NCT02973997|65230219|FG001|Overall Study|Disease Progression|20|||
23405554|NCT02973997|65230218|FG000|Overall Study|Alternative Therapy|3|||
23405555|NCT02973997|65230219|FG001|Overall Study|Alternative Therapy|0|||
23405556|NCT02973997|65230218|FG000|Overall Study|Other complicating disease|0|||
23405557|NCT02973997|65230219|FG001|Overall Study|Other complicating disease|1|||
23505715|NCT03547583|65588044|FG002|Overall Study|Death|4|||
23304197|NCT00809159|64854880|FG000|Part 1|Lost to Follow-up|1|||
23304198|NCT00809159|64854881|FG001|Part 1|Lost to Follow-up|0|||
23304199|NCT00809159|64854882|FG002|Part 1|Lost to Follow-up|0|||
23304200|NCT00809159|64854883|FG003|Part 1|Lost to Follow-up|0|||
23405558|NCT02973997|65230218|FG000|Overall Study|Death|0|||
23405559|NCT02973997|65230219|FG001|Overall Study|Death|1|||
23405560|NCT03606486|65230220|FG000|Overall Study|Unable to collect sample|5|||
23405561|NCT00763256|65230228|FG000|Overall Study|Didn't return for appointments|7|||
23405562|NCT00763256|65230229|FG001|Overall Study|Didn't return for appointments|10|||
23405563|NCT05384834|65230233|FG000|Overall Study|Lost to Follow-up|43|||
23405564|NCT05384834|65230233|FG000|Overall Study|Withdrawal by Subject|5|||
23405565|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
23405566|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405567|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405568|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405569|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405570|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405571|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405572|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405573|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
23405574|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405575|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
23304201|NCT00809159|64854884|FG004|Part 1|Lost to Follow-up|0|||
23304202|NCT00809159|64854885|FG005|Part 1|Lost to Follow-up|0|||
23304203|NCT00809159|64854880|FG000|Part 1|Withdrawal by Subject|3|||
23304204|NCT00809159|64854881|FG001|Part 1|Withdrawal by Subject|1|||
23405576|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
23405577|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405578|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405579|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405580|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405581|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405582|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
23405583|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
23304205|NCT00809159|64854882|FG002|Part 1|Withdrawal by Subject|0|||
23304206|NCT00809159|64854883|FG003|Part 1|Withdrawal by Subject|0|||
23304207|NCT00809159|64854884|FG004|Part 1|Withdrawal by Subject|0|||
23304208|NCT00809159|64854885|FG005|Part 1|Withdrawal by Subject|0|||
23304209|NCT00809159|64854880|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
23405584|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
23405585|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
23405586|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405587|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23304210|NCT00809159|64854881|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
23304211|NCT00809159|64854882|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
23304212|NCT00809159|64854883|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
23304213|NCT00809159|64854884|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
23304214|NCT00809159|64854885|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
23304215|NCT00809159|64854880|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
23304216|NCT00809159|64854881|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
23304217|NCT00809159|64854882|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
23304218|NCT00809159|64854883|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
23405588|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405589|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405590|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405591|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
23304219|NCT00809159|64854884|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
23304220|NCT00809159|64854885|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
23304221|NCT00809159|64854880|FG000|Part 1 and 2|Administrative problems|0|||
23304222|NCT00809159|64854881|FG001|Part 1 and 2|Administrative problems|0|||
23304223|NCT00809159|64854882|FG002|Part 1 and 2|Administrative problems|0|||
23304224|NCT00809159|64854883|FG003|Part 1 and 2|Administrative problems|1|||
23304225|NCT00809159|64854884|FG004|Part 1 and 2|Administrative problems|0|||
23405592|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
23405593|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
23505716|NCT03547583|65588042|FG000|Overall Study|Lost to Follow-up|1|||
23304226|NCT00809159|64854885|FG005|Part 1 and 2|Administrative problems|0|||
23304227|NCT00809159|64854880|FG000|Part 1 and 2|Adverse Event|0|||
23304228|NCT00809159|64854881|FG001|Part 1 and 2|Adverse Event|0|||
23304229|NCT00809159|64854882|FG002|Part 1 and 2|Adverse Event|1|||
23405594|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
23405595|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405596|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405597|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405598|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405599|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405600|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
23405601|NCT02628444|65230234|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
23405602|NCT02628444|65230235|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
23405603|NCT02628444|65230236|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
23405604|NCT02628444|65230237|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405605|NCT02628444|65230238|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405606|NCT02628444|65230239|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405607|NCT02628444|65230240|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405608|NCT02628444|65230241|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405609|NCT02628444|65230242|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
23405610|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405611|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405612|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405613|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
23405614|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405615|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405616|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405617|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405618|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
23405619|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
23405620|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
23405621|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
23405622|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
23405623|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
23405624|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
23405625|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
23405626|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
23405627|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
23405628|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405629|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405630|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
23405631|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
23405632|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
23405633|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
23405634|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
23405635|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
23405636|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
23405637|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405638|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405639|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405640|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405641|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
23405642|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405643|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
23405644|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
23405645|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
23405646|NCT02628444|65230234|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
23405647|NCT02628444|65230235|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
23405648|NCT02628444|65230236|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
23405649|NCT02628444|65230237|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
23405650|NCT02628444|65230238|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
23405651|NCT02628444|65230239|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
23405652|NCT02628444|65230240|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
23405653|NCT02628444|65230241|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
23405654|NCT02628444|65230242|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
23405655|NCT00003631|65230243|FG000|Overall Study|Patient not treated|1|||
23405656|NCT00003631|65230244|FG001|Overall Study|Patient not treated|0|||
23405657|NCT00003631|65230245|FG002|Overall Study|Patient not treated|1|||
23405658|NCT00003631|65230243|FG000|Overall Study|Protocol Violation|1|||
23405659|NCT00003631|65230244|FG001|Overall Study|Protocol Violation|0|||
23405660|NCT00003631|65230245|FG002|Overall Study|Protocol Violation|0|||
23405661|NCT00003631|65230243|FG000|Overall Study|Adverse Event|1|||
23405662|NCT00003631|65230244|FG001|Overall Study|Adverse Event|1|||
23405663|NCT00003631|65230245|FG002|Overall Study|Adverse Event|5|||
23405664|NCT00003631|65230243|FG000|Overall Study|Death|0|||
23405665|NCT00003631|65230244|FG001|Overall Study|Death|0|||
23405666|NCT00003631|65230245|FG002|Overall Study|Death|1|||
23405667|NCT00003631|65230243|FG000|Overall Study|Evaluable for toxicity only|0|||
23405668|NCT00003631|65230244|FG001|Overall Study|Evaluable for toxicity only|0|||
23405669|NCT00003631|65230245|FG002|Overall Study|Evaluable for toxicity only|2|||
23405670|NCT03335150|65230247|FG000|Overall Study|Withdrawal by Subject|10|||
23405671|NCT03335150|65230248|FG001|Overall Study|Withdrawal by Subject|4|||
23405672|NCT03335150|65230247|FG000|Overall Study|Adverse Event|0|||
23405673|NCT03335150|65230248|FG001|Overall Study|Adverse Event|1|||
23405674|NCT01133665|65230250|FG000|Overall Study|Physician Decision|2|||
23405675|NCT03341637|65230251|FG000|Overall Study|Lost to Follow-up|1|||
23405676|NCT03341637|65230252|FG001|Overall Study|Lost to Follow-up|0|||
23405677|NCT03341637|65230251|FG000|Overall Study|Withdrawal by Subject|3|||
23405678|NCT03341637|65230252|FG001|Overall Study|Withdrawal by Subject|3|||
23405679|NCT03341637|65230251|FG000|Overall Study|Reason not Specified|1|||
23405680|NCT03341637|65230252|FG001|Overall Study|Reason not Specified|1|||
23405681|NCT02503085|65230264|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
23405682|NCT02503085|65230265|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
23405683|NCT02503085|65230266|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
23405684|NCT02503085|65230267|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
23405685|NCT01444430|65230268|FG000|Overall Study|Withdrawal by Subject|53|||
23405686|NCT01444430|65230269|FG001|Overall Study|Withdrawal by Subject|72|||
23405687|NCT01444430|65230268|FG000|Overall Study|Death|6|||
23405688|NCT01444430|65230269|FG001|Overall Study|Death|8|||
23405689|NCT01444430|65230268|FG000|Overall Study|Lost to Follow-up|2|||
23405690|NCT01444430|65230269|FG001|Overall Study|Lost to Follow-up|0|||
23405691|NCT01444430|65230268|FG000|Overall Study|CRF termination module not completed.|0|||
23405692|NCT01444430|65230269|FG001|Overall Study|CRF termination module not completed.|1|||
23405693|NCT04339413|65230270|FG000|Overall Study|Reason Not Specified|2|||
23405694|NCT04339413|65230271|FG001|Overall Study|Reason Not Specified|7|||
23405695|NCT04339413|65230270|FG000|Overall Study|Study Terminated by Sponsor|30|||
23405696|NCT04339413|65230271|FG001|Overall Study|Study Terminated by Sponsor|33|||
23405697|NCT04339413|65230270|FG000|Overall Study|Progressive Disease|9|||
23405698|NCT04339413|65230271|FG001|Overall Study|Progressive Disease|6|||
23405699|NCT04339413|65230270|FG000|Overall Study|Withdrawal by Subject|9|||
23405700|NCT04339413|65230271|FG001|Overall Study|Withdrawal by Subject|10|||
23405701|NCT04339413|65230270|FG000|Overall Study|Physician Decision|3|||
23405702|NCT04339413|65230271|FG001|Overall Study|Physician Decision|1|||
23405703|NCT04339413|65230270|FG000|Overall Study|Death|2|||
23405704|NCT04339413|65230271|FG001|Overall Study|Death|0|||
23405705|NCT04339413|65230270|FG000|Overall Study|Adverse Event|3|||
23304230|NCT00809159|64854883|FG003|Part 1 and 2|Adverse Event|0|||
23304231|NCT00809159|64854884|FG004|Part 1 and 2|Adverse Event|1|||
23304232|NCT00809159|64854885|FG005|Part 1 and 2|Adverse Event|1|||
23304233|NCT00809159|64854880|FG000|Part 1 and 2|Lost to Follow-up|0|||
23304234|NCT00809159|64854881|FG001|Part 1 and 2|Lost to Follow-up|0|||
23304235|NCT00809159|64854882|FG002|Part 1 and 2|Lost to Follow-up|1|||
23304236|NCT00809159|64854883|FG003|Part 1 and 2|Lost to Follow-up|1|||
23304237|NCT00809159|64854884|FG004|Part 1 and 2|Lost to Follow-up|0|||
23304238|NCT00809159|64854885|FG005|Part 1 and 2|Lost to Follow-up|0|||
23304239|NCT00809159|64854880|FG000|Part 1 and 2|Withdrawal by Subject|0|||
23304240|NCT00809159|64854881|FG001|Part 1 and 2|Withdrawal by Subject|0|||
23304241|NCT00809159|64854882|FG002|Part 1 and 2|Withdrawal by Subject|4|||
23304242|NCT00809159|64854883|FG003|Part 1 and 2|Withdrawal by Subject|0|||
23304243|NCT00809159|64854884|FG004|Part 1 and 2|Withdrawal by Subject|0|||
23304244|NCT00809159|64854885|FG005|Part 1 and 2|Withdrawal by Subject|1|||
23304245|NCT03439852|64854886|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
23304246|NCT03439852|64854887|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
23304247|NCT03439852|64854886|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
23304248|NCT03439852|64854887|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
23405706|NCT04339413|65230271|FG001|Overall Study|Adverse Event|0|||
23405707|NCT02140970|65233577|FG000|Overall Study|Lost to Follow-up|1|||
23304249|NCT03439852|64854886|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
23304250|NCT03439852|64854887|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
23304251|NCT01359644|64854888|FG000|Treatment Period|Lack of Efficacy|0|||
23304252|NCT01359644|64854889|FG001|Treatment Period|Lack of Efficacy|1|||
23405708|NCT02140970|65233578|FG001|Overall Study|Lost to Follow-up|2|||
23405709|NCT02140970|65233577|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
23304253|NCT01359644|64854890|FG002|Treatment Period|Lack of Efficacy|0|||
23304254|NCT01359644|64854891|FG003|Treatment Period|Lack of Efficacy|0|||
23304255|NCT01359644|64854892|FG004|Treatment Period|Lack of Efficacy|0|||
23304256|NCT01359644|64854893|FG005|Treatment Period|Lack of Efficacy|0|||
23304257|NCT01359644|64854894|FG006|Treatment Period|Lack of Efficacy|0|||
23304258|NCT01359644|64854895|FG007|Treatment Period|Lack of Efficacy|0|||
23304259|NCT01359644|64854896|FG008|Treatment Period|Lack of Efficacy|0|||
23304260|NCT01359644|64854897|FG009|Treatment Period|Lack of Efficacy|0|||
23304261|NCT01359644|64854888|FG000|Treatment Period|Adverse Event|0|||
23304262|NCT01359644|64854889|FG001|Treatment Period|Adverse Event|0|||
23304263|NCT01359644|64854890|FG002|Treatment Period|Adverse Event|1|||
23304264|NCT01359644|64854891|FG003|Treatment Period|Adverse Event|0|||
23304265|NCT01359644|64854892|FG004|Treatment Period|Adverse Event|0|||
23304266|NCT01359644|64854893|FG005|Treatment Period|Adverse Event|1|||
23304267|NCT01359644|64854894|FG006|Treatment Period|Adverse Event|0|||
23304268|NCT01359644|64854895|FG007|Treatment Period|Adverse Event|0|||
23304269|NCT01359644|64854896|FG008|Treatment Period|Adverse Event|0|||
23304270|NCT01359644|64854897|FG009|Treatment Period|Adverse Event|0|||
23304271|NCT01359644|64854888|FG000|Treatment Period|Lost to Follow-up|0|||
23304272|NCT01359644|64854889|FG001|Treatment Period|Lost to Follow-up|0|||
23304273|NCT01359644|64854890|FG002|Treatment Period|Lost to Follow-up|0|||
23304274|NCT01359644|64854891|FG003|Treatment Period|Lost to Follow-up|0|||
23304275|NCT01359644|64854892|FG004|Treatment Period|Lost to Follow-up|0|||
23304276|NCT01359644|64854893|FG005|Treatment Period|Lost to Follow-up|1|||
23304277|NCT01359644|64854894|FG006|Treatment Period|Lost to Follow-up|0|||
23304278|NCT01359644|64854895|FG007|Treatment Period|Lost to Follow-up|0|||
23304279|NCT01359644|64854896|FG008|Treatment Period|Lost to Follow-up|0|||
23304280|NCT01359644|64854897|FG009|Treatment Period|Lost to Follow-up|0|||
23304281|NCT01359644|64854888|FG000|Follow-up Period|Withdrawal by Subject|0|||
23304282|NCT01359644|64854889|FG001|Follow-up Period|Withdrawal by Subject|0|||
23304283|NCT01359644|64854890|FG002|Follow-up Period|Withdrawal by Subject|0|||
23304284|NCT01359644|64854891|FG003|Follow-up Period|Withdrawal by Subject|0|||
23304285|NCT01359644|64854892|FG004|Follow-up Period|Withdrawal by Subject|0|||
23304286|NCT01359644|64854893|FG005|Follow-up Period|Withdrawal by Subject|1|||
23405710|NCT02140970|65233578|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
23405711|NCT02140970|65233577|FG000|Overall Study|Did not meet inclusion criteria|0|||
23405712|NCT02140970|65233578|FG001|Overall Study|Did not meet inclusion criteria|1|||
23405713|NCT03554018|65233579|FG000|Overall Study|Lost to Follow-up|3|||
23405714|NCT03554018|65233580|FG001|Overall Study|Lost to Follow-up|7|||
23405715|NCT00984594|65233581|FG000|Overall Study|Lost to Follow-up|1|||
23405716|NCT00984594|65233582|FG001|Overall Study|Lost to Follow-up|0|||
23405717|NCT00984594|65233581|FG000|Overall Study|Withdrawal by Subject|0|||
23405718|NCT00984594|65233582|FG001|Overall Study|Withdrawal by Subject|1|||
23405719|NCT02625220|65233583|FG000|Overall Study|Adverse Event|2|||
23405720|NCT02625220|65233583|FG000|Overall Study|Lost to Follow-up|2|||
23405721|NCT02625220|65233583|FG000|Overall Study|Protocol Violation|1|||
23405722|NCT02625220|65233583|FG000|Overall Study|Study discontinued at site|2|||
23405723|NCT01170273|65233584|FG000|Overall Study|Lost to Follow-up|6|||
23405724|NCT01170273|65233585|FG001|Overall Study|Lost to Follow-up|8|||
23405725|NCT01170273|65233584|FG000|Overall Study|Protocol Violation|1|||
23405726|NCT01170273|65233585|FG001|Overall Study|Protocol Violation|0|||
23405727|NCT01170273|65233584|FG000|Overall Study|Death|1|||
23405728|NCT01170273|65233585|FG001|Overall Study|Death|0|||
23405729|NCT01170273|65233584|FG000|Overall Study|Adverse Event|0|||
23405730|NCT01170273|65233585|FG001|Overall Study|Adverse Event|1|||
23405731|NCT00787839|65233588|FG000|Overall Study|Failure to have the OGTT was most common|404|||
23405732|NCT00573391|65233595|FG000|Overall Study|study stopped|2|||
23405733|NCT00573391|65233596|FG001|Overall Study|study stopped|2|||
23405734|NCT00573391|65233595|FG000|Overall Study|Death|1|||
23405735|NCT00573391|65233596|FG001|Overall Study|Death|0|||
23405736|NCT01747915|65233597|FG000|Overall Study|Other|1|||
23405737|NCT01747915|65233598|FG001|Overall Study|Other|1|||
23405738|NCT01747915|65233599|FG002|Overall Study|Other|1|||
23405739|NCT01747915|65233597|FG000|Overall Study|Adverse Event|8|||
23405740|NCT01747915|65233598|FG001|Overall Study|Adverse Event|5|||
23405741|NCT01747915|65233599|FG002|Overall Study|Adverse Event|2|||
23405742|NCT01747915|65233597|FG000|Overall Study|Death|0|||
23405743|NCT01747915|65233598|FG001|Overall Study|Death|0|||
23405744|NCT01747915|65233599|FG002|Overall Study|Death|1|||
23304287|NCT01359644|64854894|FG006|Follow-up Period|Withdrawal by Subject|0|||
23304288|NCT01359644|64854895|FG007|Follow-up Period|Withdrawal by Subject|0|||
23304289|NCT01359644|64854896|FG008|Follow-up Period|Withdrawal by Subject|0|||
23304290|NCT01359644|64854897|FG009|Follow-up Period|Withdrawal by Subject|0|||
23304291|NCT01359644|64854888|FG000|Follow-up Period|Lost to Follow-up|0|||
23304292|NCT01359644|64854889|FG001|Follow-up Period|Lost to Follow-up|0|||
23304293|NCT01359644|64854890|FG002|Follow-up Period|Lost to Follow-up|0|||
23304294|NCT01359644|64854891|FG003|Follow-up Period|Lost to Follow-up|0|||
23304295|NCT01359644|64854892|FG004|Follow-up Period|Lost to Follow-up|0|||
23405745|NCT01747915|65233597|FG000|Overall Study|Lack of Efficacy|0|||
23405746|NCT01747915|65233598|FG001|Overall Study|Lack of Efficacy|1|||
23405747|NCT01747915|65233599|FG002|Overall Study|Lack of Efficacy|0|||
23405748|NCT01747915|65233597|FG000|Overall Study|Lost to Follow-up|1|||
23405749|NCT01747915|65233598|FG001|Overall Study|Lost to Follow-up|0|||
23405750|NCT01747915|65233599|FG002|Overall Study|Lost to Follow-up|0|||
23405751|NCT01747915|65233597|FG000|Overall Study|Withdrawal by Subject|4|||
23405752|NCT01747915|65233598|FG001|Overall Study|Withdrawal by Subject|4|||
23405753|NCT01747915|65233599|FG002|Overall Study|Withdrawal by Subject|1|||
23405754|NCT01747915|65233597|FG000|Overall Study|Protocol Violation|1|||
23405755|NCT01747915|65233598|FG001|Overall Study|Protocol Violation|0|||
23405756|NCT01747915|65233599|FG002|Overall Study|Protocol Violation|0|||
23405757|NCT01747915|65233597|FG000|Overall Study|Pregnancy|0|||
23405758|NCT01747915|65233598|FG001|Overall Study|Pregnancy|0|||
23405759|NCT01747915|65233599|FG002|Overall Study|Pregnancy|1|||
23405760|NCT01244035|65233600|FG000|Part 1: Period 1|Adverse Event|0|||
23405761|NCT01244035|65233601|FG001|Part 1: Period 1|Adverse Event|0|||
23304296|NCT01359644|64854893|FG005|Follow-up Period|Lost to Follow-up|0|||
23304297|NCT01359644|64854894|FG006|Follow-up Period|Lost to Follow-up|1|||
23304298|NCT01359644|64854895|FG007|Follow-up Period|Lost to Follow-up|2|||
23304299|NCT01359644|64854896|FG008|Follow-up Period|Lost to Follow-up|0|||
23304300|NCT01359644|64854897|FG009|Follow-up Period|Lost to Follow-up|0|||
23304301|NCT00311311|64854898|FG000|Overall Study|Adverse Event|3|||
23304302|NCT00311311|64854899|FG001|Overall Study|Adverse Event|2|||
23304303|NCT00311311|64854898|FG000|Overall Study|Withdrawal by Subject|1|||
23304304|NCT00311311|64854899|FG001|Overall Study|Withdrawal by Subject|1|||
23304305|NCT00311311|64854898|FG000|Overall Study|Noncompliance|0|||
23304306|NCT00311311|64854899|FG001|Overall Study|Noncompliance|1|||
23304307|NCT00311311|64854898|FG000|Overall Study|Study Termination by Sponsor|3|||
23304308|NCT00311311|64854899|FG001|Overall Study|Study Termination by Sponsor|4|||
23304309|NCT00311311|64854898|FG000|Overall Study|Death|1|||
23304310|NCT00311311|64854899|FG001|Overall Study|Death|0|||
23304311|NCT00311311|64854898|FG000|Overall Study|Lack of ancillary assistance|0|||
23304312|NCT00311311|64854899|FG001|Overall Study|Lack of ancillary assistance|1|||
23304313|NCT01769339|64854903|FG000|Overall Study|Lost to Follow-up|42|||
23304314|NCT01769339|64854903|FG000|Overall Study|Adverse Event|1|||
23304315|NCT00103311|64858312|FG000|Overall Study|Lost to Follow-up|1|||
23304316|NCT00103311|64858313|FG001|Overall Study|Lost to Follow-up|0|||
23304317|NCT00103311|64858312|FG000|Overall Study|Withdrawal by Subject|2|||
23304318|NCT00103311|64858313|FG001|Overall Study|Withdrawal by Subject|1|||
23304319|NCT00103311|64858312|FG000|Overall Study|Adverse Event|1|||
23304320|NCT00103311|64858313|FG001|Overall Study|Adverse Event|0|||
23405762|NCT01244035|65233602|FG002|Part 1: Period 1|Adverse Event|0|||
23405763|NCT01244035|65233603|FG003|Part 1: Period 1|Adverse Event|0|||
23405764|NCT01244035|65233604|FG004|Part 1: Period 1|Adverse Event|0|||
23405765|NCT01244035|65233605|FG005|Part 1: Period 1|Adverse Event|1|||
23304321|NCT03340064|64858316|FG000|First Period|Adverse Event, non-fatal|2|||
23304322|NCT03340064|64858317|FG001|First Period|Adverse Event, non-fatal|0|||
23405766|NCT01244035|65233600|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
23405767|NCT01244035|65233601|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
23405768|NCT01244035|65233602|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
23405769|NCT01244035|65233603|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
23405770|NCT01244035|65233604|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
23405771|NCT01244035|65233605|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
23405772|NCT01244035|65233600|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
23405773|NCT01244035|65233601|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
23405774|NCT01244035|65233602|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
23405775|NCT01244035|65233603|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
23405776|NCT01244035|65233604|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
23405777|NCT01244035|65233605|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
23405778|NCT01244035|65233600|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405779|NCT01244035|65233601|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405780|NCT01244035|65233602|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
23405781|NCT01244035|65233603|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405782|NCT01244035|65233604|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405783|NCT01244035|65233605|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
23405784|NCT01244035|65233600|FG000|Part 1: Period 3|Adverse Event|0|||
23405785|NCT01244035|65233601|FG001|Part 1: Period 3|Adverse Event|0|||
23405786|NCT01244035|65233602|FG002|Part 1: Period 3|Adverse Event|0|||
23304323|NCT03340064|64858316|FG000|First Period|Lack of Efficacy|3|||
23304324|NCT03340064|64858317|FG001|First Period|Lack of Efficacy|0|||
23304325|NCT03340064|64858316|FG000|Second Period|Adverse Event, non-fatal|1|||
23304326|NCT03340064|64858317|FG001|Second Period|Adverse Event, non-fatal|1|||
23304327|NCT03340064|64858316|FG000|Second Period|Lack of Efficacy|11|||
23405787|NCT01244035|65233603|FG003|Part 1: Period 3|Adverse Event|0|||
23405788|NCT01244035|65233604|FG004|Part 1: Period 3|Adverse Event|0|||
23405789|NCT01244035|65233605|FG005|Part 1: Period 3|Adverse Event|1|||
23405790|NCT01244035|65233600|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
23405791|NCT01244035|65233601|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
23405792|NCT01244035|65233602|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
23405793|NCT01244035|65233603|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
23405794|NCT01244035|65233604|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
23405795|NCT01244035|65233605|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
23405796|NCT01244035|65233600|FG000|Part 1: Period 3|Protocol Deviation|0|||
23405797|NCT01244035|65233601|FG001|Part 1: Period 3|Protocol Deviation|1|||
23405798|NCT01244035|65233602|FG002|Part 1: Period 3|Protocol Deviation|0|||
23405799|NCT01244035|65233603|FG003|Part 1: Period 3|Protocol Deviation|0|||
23405800|NCT01244035|65233604|FG004|Part 1: Period 3|Protocol Deviation|0|||
23405801|NCT01244035|65233605|FG005|Part 1: Period 3|Protocol Deviation|0|||
23405802|NCT00131352|65233606|FG000|Initial Treatment Period|Adverse Event|1|||
23405803|NCT00131352|65233607|FG001|Initial Treatment Period|Adverse Event|3|||
23405804|NCT00131352|65233606|FG000|Initial Treatment Period|Non-compliant|1|||
23405805|NCT00131352|65233607|FG001|Initial Treatment Period|Non-compliant|2|||
23405806|NCT00131352|65233606|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
23405807|NCT00131352|65233607|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
23405808|NCT00131352|65233606|FG000|Initial Treatment Period|Lack of Efficacy|6|||
23405809|NCT00131352|65233607|FG001|Initial Treatment Period|Lack of Efficacy|4|||
23405810|NCT00131352|65233606|FG000|Initial Treatment Period|Other|0|||
23405811|NCT00131352|65233607|FG001|Initial Treatment Period|Other|2|||
23405812|NCT00131352|65233606|FG000|Repeat Treatment Period|Adverse Event|1|||
23405813|NCT00131352|65233607|FG001|Repeat Treatment Period|Adverse Event|0|||
23405814|NCT00131352|65233606|FG000|Repeat Treatment Period|Other|1|||
23405815|NCT00131352|65233607|FG001|Repeat Treatment Period|Other|0|||
23405816|NCT03896477|65233608|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
23405817|NCT03896477|65233609|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
23405818|NCT03896477|65233610|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
23405819|NCT03896477|65233608|FG000|Overall Study|Parent Requested Withdrawal|8|||
23405820|NCT03896477|65233609|FG001|Overall Study|Parent Requested Withdrawal|12|||
23405821|NCT03896477|65233610|FG002|Overall Study|Parent Requested Withdrawal|9|||
23405822|NCT03896477|65233608|FG000|Overall Study|Adverse Event|0|||
23405823|NCT03896477|65233609|FG001|Overall Study|Adverse Event|0|||
23405824|NCT03896477|65233610|FG002|Overall Study|Adverse Event|1|||
23405825|NCT03896477|65233608|FG000|Overall Study|Death|1|||
23405826|NCT03896477|65233609|FG001|Overall Study|Death|0|||
23405827|NCT03896477|65233610|FG002|Overall Study|Death|0|||
23405828|NCT03896477|65233608|FG000|Overall Study|Other|5|||
23405829|NCT03896477|65233609|FG001|Overall Study|Other|6|||
23405830|NCT03896477|65233610|FG002|Overall Study|Other|7|||
23405831|NCT03896477|65233608|FG000|Overall Study|Lost to Follow-up|2|||
23405832|NCT03896477|65233609|FG001|Overall Study|Lost to Follow-up|1|||
23405833|NCT03896477|65233610|FG002|Overall Study|Lost to Follow-up|1|||
23405834|NCT01042158|65233611|FG000|Overall Study|Physician Decision|1|||
23405835|NCT00938912|65233612|FG000|Overall Study|Withdrawal by Subject|28|||
23405836|NCT00938912|65233612|FG000|Overall Study|Lost to Follow-up|4|||
23405837|NCT00938912|65233612|FG000|Overall Study|Lack of Efficacy|43|||
23405838|NCT00938912|65233612|FG000|Overall Study|Adverse event, non-fatal|24|||
23405839|NCT00938912|65233612|FG000|Overall Study|Adverse event, fatal|1|||
23405840|NCT00938912|65233612|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
23405841|NCT00938912|65233612|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
23405842|NCT00938912|65233612|FG000|Overall Study|Participant needed prohibit medication|1|||
23405843|NCT00938912|65233612|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
23405844|NCT00938912|65233612|FG000|Overall Study|Did not meet Eligibility criteria|1|||
23405845|NCT00938912|65233612|FG000|Overall Study|Participant relocated not related to AE|1|||
23405846|NCT00938912|65233612|FG000|Overall Study|Participant moved to another city|1|||
23405847|NCT00938912|65233612|FG000|Overall Study|Participant experienced break through seizures|1|||
23405848|NCT00938912|65233612|FG000|Overall Study|No longer wished to participate in the study|1|||
23405849|NCT00938912|65233612|FG000|Overall Study|Protocol Deviation|2|||
23405850|NCT02967679|65233633|FG000|Overall Study|Adverse Event|1|||
23405851|NCT01492426|65233634|FG000|Treatment|Death|0|||
23405852|NCT01492426|65233635|FG001|Treatment|Death|1|||
23405853|NCT01492426|65233634|FG000|Treatment|Other|1|||
23405854|NCT01492426|65233635|FG001|Treatment|Other|0|||
23405855|NCT01492426|65233634|FG000|Treatment|Adverse Event|25|||
23405856|NCT01492426|65233635|FG001|Treatment|Adverse Event|25|||
23405857|NCT01492426|65233634|FG000|Treatment|Lack of Efficacy|38|||
23405858|NCT01492426|65233635|FG001|Treatment|Lack of Efficacy|5|||
23405859|NCT01492426|65233634|FG000|Treatment|Participant withdrew consent|1|||
23405860|NCT01492426|65233635|FG001|Treatment|Participant withdrew consent|2|||
23405861|NCT01492426|65233634|FG000|Treatment|Poor compliance/noncompliance|1|||
23405862|NCT01492426|65233635|FG001|Treatment|Poor compliance/noncompliance|0|||
23405863|NCT01492426|65233634|FG000|Treatment|Subject requested discontinue study drug|7|||
23505717|NCT03547583|65588043|FG001|Overall Study|Lost to Follow-up|0|||
23405864|NCT01492426|65233635|FG001|Treatment|Subject requested discontinue study drug|3|||
23405865|NCT01492426|65233634|FG000|Treatment|Lost to Follow-up|9|||
23405866|NCT01492426|65233635|FG001|Treatment|Lost to Follow-up|4|||
23405867|NCT01492426|65233634|FG000|Treatment|Participant does not meet study criteria|1|||
23405868|NCT01492426|65233635|FG001|Treatment|Participant does not meet study criteria|0|||
23405869|NCT01492426|65233634|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
23405870|NCT01492426|65233635|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
23405871|NCT01492426|65233634|FG000|Follow-Up|Death|1|||
23405872|NCT01492426|65233635|FG001|Follow-Up|Death|0|||
23405873|NCT01492426|65233634|FG000|Follow-Up|Other|4|||
23405874|NCT01492426|65233635|FG001|Follow-Up|Other|2|||
23405875|NCT01492426|65233634|FG000|Follow-Up|Participant Withdrew Consent|6|||
23405876|NCT01492426|65233635|FG001|Follow-Up|Participant Withdrew Consent|1|||
23405877|NCT01492426|65233634|FG000|Follow-Up|Lost to Follow-up|12|||
23405878|NCT01492426|65233635|FG001|Follow-Up|Lost to Follow-up|6|||
23405879|NCT03484429|65233638|FG000|Overall Study|Withdrawal by Subject|1|||
23405880|NCT03484429|65233639|FG001|Overall Study|Withdrawal by Subject|0|||
23405881|NCT03484429|65233638|FG000|Overall Study|Adverse Event|2|||
23405882|NCT03484429|65233639|FG001|Overall Study|Adverse Event|0|||
23405883|NCT00355368|65233640|FG000|Overall Study|Protocol Violation|8|||
23405884|NCT00355368|65233641|FG001|Overall Study|Protocol Violation|7|||
23405885|NCT00355368|65233640|FG000|Overall Study|cardiac arrest prior to intubation|2|||
23405886|NCT00355368|65233641|FG001|Overall Study|cardiac arrest prior to intubation|2|||
23405887|NCT00690430|65233642|FG000|Core Phase|Abnormal Laboratory value|0|||
23405888|NCT00690430|65233643|FG001|Core Phase|Abnormal Laboratory value|1|||
23405889|NCT00690430|65233644|FG002|Core Phase|Abnormal Laboratory value|0|||
23405890|NCT00690430|65233642|FG000|Core Phase|Adverse Event|5|||
23405891|NCT00690430|65233643|FG001|Core Phase|Adverse Event|1|||
23405892|NCT00690430|65233644|FG002|Core Phase|Adverse Event|0|||
23405893|NCT00690430|65233642|FG000|Core Phase|Death|0|||
23405894|NCT00690430|65233643|FG001|Core Phase|Death|2|||
23405895|NCT00690430|65233644|FG002|Core Phase|Death|0|||
23405896|NCT00690430|65233642|FG000|Core Phase|Protocol Violation|1|||
23405897|NCT00690430|65233643|FG001|Core Phase|Protocol Violation|0|||
23405898|NCT00690430|65233644|FG002|Core Phase|Protocol Violation|0|||
23405899|NCT00690430|65233642|FG000|Core Phase|Withdrawal by Subject|3|||
23405900|NCT00690430|65233643|FG001|Core Phase|Withdrawal by Subject|3|||
23405901|NCT00690430|65233644|FG002|Core Phase|Withdrawal by Subject|0|||
23405902|NCT00690430|65233642|FG000|Core Phase|Subject no longer requires study drug|1|||
23405903|NCT00690430|65233643|FG001|Core Phase|Subject no longer requires study drug|0|||
23405904|NCT00690430|65233644|FG002|Core Phase|Subject no longer requires study drug|0|||
23405905|NCT00690430|65233642|FG000|Core Phase|Lack of Efficacy|8|||
23405906|NCT00690430|65233643|FG001|Core Phase|Lack of Efficacy|10|||
23405907|NCT00690430|65233644|FG002|Core Phase|Lack of Efficacy|0|||
23405908|NCT00690430|65233642|FG000|Core Phase|Administrative Problems|0|||
23405909|NCT00690430|65233643|FG001|Core Phase|Administrative Problems|1|||
23405910|NCT00690430|65233644|FG002|Core Phase|Administrative Problems|0|||
23405911|NCT00690430|65233642|FG000|Core Phase|Early Termination|0|||
23405912|NCT00690430|65233643|FG001|Core Phase|Early Termination|5|||
23405913|NCT00690430|65233644|FG002|Core Phase|Early Termination|0|||
23405914|NCT00690430|65233642|FG000|Extension Phase|Lack of Efficacy|3|||
23405915|NCT00690430|65233643|FG001|Extension Phase|Lack of Efficacy|1|||
23405916|NCT00690430|65233644|FG002|Extension Phase|Lack of Efficacy|4|||
23405917|NCT00690430|65233642|FG000|Extension Phase|Abnormal Lab Values|1|||
23405918|NCT00690430|65233643|FG001|Extension Phase|Abnormal Lab Values|0|||
23405919|NCT00690430|65233644|FG002|Extension Phase|Abnormal Lab Values|0|||
23405920|NCT00690430|65233642|FG000|Extension Phase|Abnormal test procedure results|1|||
23405921|NCT00690430|65233643|FG001|Extension Phase|Abnormal test procedure results|0|||
23405922|NCT00690430|65233644|FG002|Extension Phase|Abnormal test procedure results|0|||
23405923|NCT00690430|65233642|FG000|Extension Phase|Administrative Problems|0|||
23405924|NCT00690430|65233643|FG001|Extension Phase|Administrative Problems|1|||
23405925|NCT00690430|65233644|FG002|Extension Phase|Administrative Problems|1|||
23405926|NCT00690430|65233642|FG000|Extension Phase|Adverse Event|2|||
23405927|NCT00690430|65233643|FG001|Extension Phase|Adverse Event|1|||
23405928|NCT00690430|65233644|FG002|Extension Phase|Adverse Event|2|||
23405929|NCT00690430|65233642|FG000|Extension Phase|Death|1|||
23405930|NCT00690430|65233643|FG001|Extension Phase|Death|1|||
23405931|NCT00690430|65233644|FG002|Extension Phase|Death|1|||
23405932|NCT00690430|65233642|FG000|Extension Phase|Withdrawal by Subject|0|||
23405933|NCT00690430|65233643|FG001|Extension Phase|Withdrawal by Subject|0|||
23405934|NCT00690430|65233644|FG002|Extension Phase|Withdrawal by Subject|2|||
23405935|NCT00690430|65233642|FG000|Extension Phase|Early Termination|10|||
23405936|NCT00690430|65233643|FG001|Extension Phase|Early Termination|1|||
23405937|NCT00690430|65233644|FG002|Extension Phase|Early Termination|3|||
23405938|NCT02980107|65233645|FG000|Overall Study|Withdrawal by Subject|51|||
23405939|NCT02980107|65233646|FG001|Overall Study|Withdrawal by Subject|62|||
23405940|NCT01945996|65233647|FG000|Overall Study|Lost to Follow-up|3|||
23405941|NCT01945996|65233648|FG001|Overall Study|Lost to Follow-up|5|||
23405942|NCT01408277|65233654|FG000|Overall Study|Adverse Event|3|||
23405943|NCT01408277|65233655|FG001|Overall Study|Adverse Event|4|||
23405944|NCT01408277|65233654|FG000|Overall Study|Lost to Follow-up|1|||
23405945|NCT01408277|65233655|FG001|Overall Study|Lost to Follow-up|0|||
23405946|NCT01408277|65233654|FG000|Overall Study|Withdrawal by Subject|2|||
23405947|NCT01408277|65233655|FG001|Overall Study|Withdrawal by Subject|0|||
23405948|NCT01408277|65233654|FG000|Overall Study|Protocol Violation|2|||
23405949|NCT01408277|65233655|FG001|Overall Study|Protocol Violation|0|||
23405950|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
23405951|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
23405952|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
23405953|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
23405954|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
23405955|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
23405956|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Other|0|||
23405957|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Other|1|||
23405958|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Other|1|||
23405959|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Other|0|||
23405960|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Other|0|||
23405961|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Other|0|||
23405962|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
23405963|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
23405964|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
23405965|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
23405966|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
23405967|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
23405968|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405969|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405970|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
23405971|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405972|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405973|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
23405974|NCT03666988|65233656|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
23405975|NCT03666988|65233657|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405976|NCT03666988|65233658|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405977|NCT03666988|65233659|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405978|NCT03666988|65233660|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405979|NCT03666988|65233661|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
23405980|NCT02707965|65233679|FG000|Overall Study|Withdrawal by Subject|0|||
23405981|NCT02707965|65233680|FG001|Overall Study|Withdrawal by Subject|0|||
23405982|NCT02707965|65233681|FG002|Overall Study|Withdrawal by Subject|1|||
23405983|NCT02707965|65233682|FG003|Overall Study|Withdrawal by Subject|0|||
23405984|NCT02707965|65233683|FG004|Overall Study|Withdrawal by Subject|0|||
23405985|NCT02707965|65233684|FG005|Overall Study|Withdrawal by Subject|0|||
23405986|NCT02707965|65233685|FG006|Overall Study|Withdrawal by Subject|0|||
23405987|NCT02707965|65233686|FG007|Overall Study|Withdrawal by Subject|2|||
23405988|NCT02707965|65233687|FG008|Overall Study|Withdrawal by Subject|0|||
23405989|NCT02707965|65233688|FG009|Overall Study|Withdrawal by Subject|0|||
23405990|NCT02707965|65233689|FG010|Overall Study|Withdrawal by Subject|0|||
23405991|NCT02707965|65233690|FG011|Overall Study|Withdrawal by Subject|0|||
23405992|NCT02707965|65233691|FG012|Overall Study|Withdrawal by Subject|0|||
23405993|NCT02707965|65233692|FG013|Overall Study|Withdrawal by Subject|0|||
23405994|NCT02707965|65233693|FG014|Overall Study|Withdrawal by Subject|0|||
23405995|NCT02707965|65233694|FG015|Overall Study|Withdrawal by Subject|0|||
23405996|NCT02707965|65233679|FG000|Overall Study|PI decisions|0|||
23405997|NCT02707965|65233680|FG001|Overall Study|PI decisions|0|||
23405998|NCT02707965|65233681|FG002|Overall Study|PI decisions|0|||
23405999|NCT02707965|65233682|FG003|Overall Study|PI decisions|0|||
23406000|NCT02707965|65233683|FG004|Overall Study|PI decisions|0|||
23406001|NCT02707965|65233684|FG005|Overall Study|PI decisions|0|||
23406002|NCT02707965|65233685|FG006|Overall Study|PI decisions|0|||
23406003|NCT02707965|65233686|FG007|Overall Study|PI decisions|0|||
23406004|NCT02707965|65233687|FG008|Overall Study|PI decisions|0|||
23406005|NCT02707965|65233688|FG009|Overall Study|PI decisions|0|||
23406006|NCT02707965|65233689|FG010|Overall Study|PI decisions|0|||
23406007|NCT02707965|65233690|FG011|Overall Study|PI decisions|0|||
23406008|NCT02707965|65233691|FG012|Overall Study|PI decisions|0|||
23406009|NCT02707965|65233692|FG013|Overall Study|PI decisions|0|||
23406010|NCT02707965|65233693|FG014|Overall Study|PI decisions|2|||
23406011|NCT02707965|65233694|FG015|Overall Study|PI decisions|0|||
23406012|NCT02707965|65233679|FG000|Overall Study|Protocol deviation|1|||
23406013|NCT02707965|65233680|FG001|Overall Study|Protocol deviation|1|||
23406014|NCT02707965|65233681|FG002|Overall Study|Protocol deviation|0|||
23406015|NCT02707965|65233682|FG003|Overall Study|Protocol deviation|0|||
23505718|NCT03547583|65588044|FG002|Overall Study|Lost to Follow-up|0|||
23505719|NCT03547583|65588042|FG000|Overall Study|Non-compliance with study drug|0|||
23406016|NCT02707965|65233683|FG004|Overall Study|Protocol deviation|0|||
23406017|NCT02707965|65233684|FG005|Overall Study|Protocol deviation|0|||
23406018|NCT02707965|65233685|FG006|Overall Study|Protocol deviation|0|||
23406019|NCT02707965|65233686|FG007|Overall Study|Protocol deviation|1|||
23406020|NCT02707965|65233687|FG008|Overall Study|Protocol deviation|0|||
23406021|NCT02707965|65233688|FG009|Overall Study|Protocol deviation|0|||
23406022|NCT02707965|65233689|FG010|Overall Study|Protocol deviation|0|||
23406023|NCT02707965|65233690|FG011|Overall Study|Protocol deviation|0|||
23406024|NCT02707965|65233691|FG012|Overall Study|Protocol deviation|0|||
23406025|NCT02707965|65233692|FG013|Overall Study|Protocol deviation|0|||
23406026|NCT02707965|65233693|FG014|Overall Study|Protocol deviation|0|||
23406027|NCT02707965|65233694|FG015|Overall Study|Protocol deviation|0|||
23406028|NCT02840253|65233695|FG000|Overall Study|Unsuccessful block|4|||
23406029|NCT00589797|65233697|FG000|Overall Study|Death|1|||
23406030|NCT00589797|65233698|FG001|Overall Study|Death|0|||
23406031|NCT00589797|65233697|FG000|Overall Study|Lost to Follow-up|12|||
23607211|NCT02106325|65950625|FG000|Phase 2|Lost to Follow-up|2|||
23406032|NCT00589797|65233698|FG001|Overall Study|Lost to Follow-up|9|||
23406033|NCT00589797|65233697|FG000|Overall Study|Physician Decision|8|||
23406034|NCT00589797|65233698|FG001|Overall Study|Physician Decision|3|||
23406035|NCT00589797|65233697|FG000|Overall Study|Withdrawal by Subject|6|||
23406036|NCT00589797|65233698|FG001|Overall Study|Withdrawal by Subject|5|||
23406037|NCT00589797|65233697|FG000|Overall Study|Non-Randomized Training Subjects|46|||
23406038|NCT00589797|65233698|FG001|Overall Study|Non-Randomized Training Subjects|6|||
23406039|NCT00881530|65233701|FG000|Overall Study|Adverse Event|5|||
23406040|NCT00881530|65233702|FG001|Overall Study|Adverse Event|1|||
23406041|NCT00881530|65233703|FG002|Overall Study|Adverse Event|1|||
23406042|NCT00881530|65233704|FG003|Overall Study|Adverse Event|4|||
23406043|NCT00881530|65233705|FG004|Overall Study|Adverse Event|10|||
23406044|NCT00881530|65233706|FG005|Overall Study|Adverse Event|2|||
23406045|NCT00881530|65233701|FG000|Overall Study|Lack of Efficacy|1|||
23406046|NCT00881530|65233702|FG001|Overall Study|Lack of Efficacy|0|||
23406047|NCT00881530|65233703|FG002|Overall Study|Lack of Efficacy|0|||
23406048|NCT00881530|65233704|FG003|Overall Study|Lack of Efficacy|0|||
23406049|NCT00881530|65233705|FG004|Overall Study|Lack of Efficacy|1|||
23406050|NCT00881530|65233706|FG005|Overall Study|Lack of Efficacy|1|||
23406051|NCT00881530|65233701|FG000|Overall Study|Not compliant with the protocol|0|||
23406052|NCT00881530|65233702|FG001|Overall Study|Not compliant with the protocol|0|||
23406053|NCT00881530|65233703|FG002|Overall Study|Not compliant with the protocol|0|||
23406054|NCT00881530|65233704|FG003|Overall Study|Not compliant with the protocol|0|||
23406055|NCT00881530|65233705|FG004|Overall Study|Not compliant with the protocol|2|||
23406056|NCT00881530|65233706|FG005|Overall Study|Not compliant with the protocol|0|||
23406057|NCT00881530|65233701|FG000|Overall Study|Lost to Follow-up|0|||
23406058|NCT00881530|65233702|FG001|Overall Study|Lost to Follow-up|1|||
23406059|NCT00881530|65233703|FG002|Overall Study|Lost to Follow-up|1|||
23406060|NCT00881530|65233704|FG003|Overall Study|Lost to Follow-up|3|||
23406061|NCT00881530|65233705|FG004|Overall Study|Lost to Follow-up|1|||
23406062|NCT00881530|65233706|FG005|Overall Study|Lost to Follow-up|0|||
23406063|NCT00881530|65233701|FG000|Overall Study|Refused to continue medication|7|||
23406064|NCT00881530|65233702|FG001|Overall Study|Refused to continue medication|2|||
23406065|NCT00881530|65233703|FG002|Overall Study|Refused to continue medication|1|||
23406066|NCT00881530|65233704|FG003|Overall Study|Refused to continue medication|2|||
23406067|NCT00881530|65233705|FG004|Overall Study|Refused to continue medication|0|||
23406068|NCT00881530|65233706|FG005|Overall Study|Refused to continue medication|0|||
23406069|NCT00881530|65233701|FG000|Overall Study|Other reason not defined above|1|||
23406070|NCT00881530|65233702|FG001|Overall Study|Other reason not defined above|1|||
23406071|NCT00881530|65233703|FG002|Overall Study|Other reason not defined above|2|||
23406072|NCT00881530|65233704|FG003|Overall Study|Other reason not defined above|0|||
23406073|NCT00881530|65233705|FG004|Overall Study|Other reason not defined above|0|||
23406074|NCT00881530|65233706|FG005|Overall Study|Other reason not defined above|2|||
23406075|NCT00466947|65233707|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
23406076|NCT00466947|65233708|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
23406077|NCT00466947|65233707|FG000|Study End Analysis Period|Adverse Event|35|||
23406078|NCT00466947|65233708|FG001|Study End Analysis Period|Adverse Event|43|||
23406079|NCT00466947|65233707|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
23406080|NCT00466947|65233708|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
23406081|NCT00466947|65233707|FG000|Study End Analysis Period|Physician Decision|29|||
23406082|NCT00466947|65233708|FG001|Study End Analysis Period|Physician Decision|29|||
23406083|NCT00466947|65233707|FG000|Study End Analysis Period|Protocol Violation|9|||
23406084|NCT00466947|65233708|FG001|Study End Analysis Period|Protocol Violation|17|||
23406085|NCT00466947|65233707|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
23406086|NCT00466947|65233708|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
23406087|NCT00466947|65233707|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
23406088|NCT00466947|65233708|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
23406089|NCT00466947|65233707|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
23304328|NCT03340064|64858317|FG001|Second Period|Lack of Efficacy|0|||
23304329|NCT03340064|64858316|FG000|Second Period|Physician Decision|3|||
23406090|NCT00466947|65233708|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
23406091|NCT00466947|65233707|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
23406092|NCT00466947|65233708|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
23406093|NCT01853462|65233709|FG000|Overall Study|Withdrawal by Subject|1|||
23406094|NCT01853462|65233710|FG001|Overall Study|Withdrawal by Subject|1|||
23406095|NCT00582712|65233711|FG000|Overall Study|Adverse Event|1|||
23406096|NCT00582712|65233711|FG000|Overall Study|Lack of Efficacy|1|||
23406097|NCT00582712|65233711|FG000|Overall Study|Withdrawal by Subject|1|||
23406098|NCT00582712|65233711|FG000|Overall Study|Complicating disease requiring treatment|1|||
23406099|NCT01791517|65233712|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
23406100|NCT01791517|65233713|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
23406101|NCT01791517|65233714|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
23406102|NCT01791517|65233715|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
23406103|NCT01791517|65233716|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
23406104|NCT01791517|65233717|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
23406105|NCT01791517|65233718|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
23406106|NCT01791517|65233719|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
23406107|NCT01791517|65233720|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
23406108|NCT01791517|65233721|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
23505720|NCT03547583|65588043|FG001|Overall Study|Non-compliance with study drug|0|||
23505721|NCT03547583|65588044|FG002|Overall Study|Non-compliance with study drug|1|||
23505722|NCT03547583|65588042|FG000|Overall Study|Physician Decision|1|||
23505723|NCT03547583|65588043|FG001|Overall Study|Physician Decision|0|||
23505724|NCT03547583|65588044|FG002|Overall Study|Physician Decision|3|||
23505725|NCT03547583|65588042|FG000|Overall Study|Protocol Violation|2|||
23505726|NCT03547583|65588043|FG001|Overall Study|Protocol Violation|1|||
23505727|NCT03547583|65588044|FG002|Overall Study|Protocol Violation|1|||
23505728|NCT03547583|65588042|FG000|Overall Study|Withdrawal by Subject|12|||
23505729|NCT03547583|65588043|FG001|Overall Study|Withdrawal by Subject|19|||
23505730|NCT03547583|65588044|FG002|Overall Study|Withdrawal by Subject|10|||
23505731|NCT03547583|65588042|FG000|Overall Study|Other|2|||
23505732|NCT03547583|65588043|FG001|Overall Study|Other|2|||
23505733|NCT03547583|65588044|FG002|Overall Study|Other|3|||
23505734|NCT03066804|65588045|FG000|Overall Study|Physician Decision|0|||
23505735|NCT03066804|65588046|FG001|Overall Study|Physician Decision|4|||
23505736|NCT03066804|65588045|FG000|Overall Study|Death|23|||
23505737|NCT03066804|65588046|FG001|Overall Study|Death|17|||
23505738|NCT03066804|65588045|FG000|Overall Study|Withdrawal by Subject|19|||
23505739|NCT03066804|65588046|FG001|Overall Study|Withdrawal by Subject|25|||
23505740|NCT03066804|65588045|FG000|Overall Study|Lost to Follow-up|2|||
23505741|NCT03066804|65588046|FG001|Overall Study|Lost to Follow-up|0|||
23406109|NCT01791517|65233722|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
23406110|NCT01791517|65233723|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
23406111|NCT01791517|65233712|FG000|Phase I: Period 1|Adverse Event|0|||
23406112|NCT01791517|65233713|FG001|Phase I: Period 1|Adverse Event|0|||
23406113|NCT01791517|65233714|FG002|Phase I: Period 1|Adverse Event|1|||
23406114|NCT01791517|65233715|FG003|Phase I: Period 1|Adverse Event|1|||
23406115|NCT01791517|65233716|FG004|Phase I: Period 1|Adverse Event|0|||
23505742|NCT03066804|65588045|FG000|Overall Study|Adverse Event|2|||
23505743|NCT03066804|65588046|FG001|Overall Study|Adverse Event|3|||
23505744|NCT03066804|65588045|FG000|Overall Study|Technical problems|5|||
23505745|NCT03066804|65588046|FG001|Overall Study|Technical problems|1|||
23505746|NCT02601469|65588050|FG000|Overall Study|Enrolled in Error|1|||
23505747|NCT02601469|65588051|FG001|Overall Study|Enrolled in Error|0|||
23505748|NCT00217620|65588052|FG000|Overall Study|Adverse Event|2|||
23505749|NCT00217620|65588052|FG000|Overall Study|Progression|31|||
23505750|NCT00217620|65588052|FG000|Overall Study|Not Protocol Specified|4|||
23505751|NCT00217620|65588052|FG000|Overall Study|Ineligible|13|||
23406116|NCT01791517|65233717|FG005|Phase I: Period 1|Adverse Event|0|||
23406117|NCT01791517|65233718|FG006|Phase I: Period 1|Adverse Event|0|||
23406118|NCT01791517|65233719|FG007|Phase I: Period 1|Adverse Event|0|||
23406119|NCT01791517|65233720|FG008|Phase I: Period 1|Adverse Event|0|||
23406120|NCT01791517|65233721|FG009|Phase I: Period 1|Adverse Event|0|||
23406121|NCT01791517|65233722|FG010|Phase I: Period 1|Adverse Event|0|||
23406122|NCT01791517|65233723|FG011|Phase I: Period 1|Adverse Event|0|||
23406123|NCT01791517|65233712|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
23406124|NCT01791517|65233713|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406125|NCT01791517|65233714|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406126|NCT01791517|65233715|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406127|NCT01791517|65233716|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406128|NCT01791517|65233717|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406129|NCT01791517|65233718|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406130|NCT01791517|65233719|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406131|NCT01791517|65233720|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406132|NCT01791517|65233721|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23505752|NCT00217620|65588052|FG000|Overall Study|Never received treatment|1|||
23505753|NCT01709513|65588058|FG000|Overall Study|Randomized but not treated|0|||
23505754|NCT01709513|65588059|FG001|Overall Study|Randomized but not treated|1|||
23406133|NCT01791517|65233722|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406134|NCT01791517|65233723|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
23406135|NCT01791517|65233712|FG000|Phase I: Period 1|Protocol Violation|0|||
23406136|NCT01791517|65233713|FG001|Phase I: Period 1|Protocol Violation|1|||
23406137|NCT01791517|65233714|FG002|Phase I: Period 1|Protocol Violation|0|||
23406138|NCT01791517|65233715|FG003|Phase I: Period 1|Protocol Violation|0|||
23406139|NCT01791517|65233716|FG004|Phase I: Period 1|Protocol Violation|0|||
23406140|NCT01791517|65233717|FG005|Phase I: Period 1|Protocol Violation|0|||
23406141|NCT01791517|65233718|FG006|Phase I: Period 1|Protocol Violation|0|||
23406142|NCT01791517|65233719|FG007|Phase I: Period 1|Protocol Violation|0|||
23406143|NCT01791517|65233720|FG008|Phase I: Period 1|Protocol Violation|0|||
23406144|NCT01791517|65233721|FG009|Phase I: Period 1|Protocol Violation|0|||
23406145|NCT01791517|65233722|FG010|Phase I: Period 1|Protocol Violation|0|||
23406146|NCT01791517|65233723|FG011|Phase I: Period 1|Protocol Violation|0|||
23406147|NCT01791517|65233712|FG000|Phase I: Period 1|Lost to Follow-up|0|||
23406148|NCT01791517|65233713|FG001|Phase I: Period 1|Lost to Follow-up|0|||
23406149|NCT01791517|65233714|FG002|Phase I: Period 1|Lost to Follow-up|0|||
23406150|NCT01791517|65233715|FG003|Phase I: Period 1|Lost to Follow-up|1|||
23406151|NCT01791517|65233716|FG004|Phase I: Period 1|Lost to Follow-up|0|||
23406152|NCT01791517|65233717|FG005|Phase I: Period 1|Lost to Follow-up|0|||
23406153|NCT01791517|65233718|FG006|Phase I: Period 1|Lost to Follow-up|1|||
23406154|NCT01791517|65233719|FG007|Phase I: Period 1|Lost to Follow-up|0|||
23406155|NCT01791517|65233720|FG008|Phase I: Period 1|Lost to Follow-up|1|||
23406156|NCT01791517|65233721|FG009|Phase I: Period 1|Lost to Follow-up|1|||
23406157|NCT01791517|65233722|FG010|Phase I: Period 1|Lost to Follow-up|0|||
23406158|NCT01791517|65233723|FG011|Phase I: Period 1|Lost to Follow-up|0|||
23406159|NCT01791517|65233712|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406160|NCT01791517|65233713|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406161|NCT01791517|65233714|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406162|NCT01791517|65233715|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406163|NCT01791517|65233716|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406164|NCT01791517|65233717|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406165|NCT01791517|65233718|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406166|NCT01791517|65233719|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406167|NCT01791517|65233720|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406168|NCT01791517|65233721|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406169|NCT01791517|65233722|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
23406170|NCT01791517|65233723|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
23406171|NCT01791517|65233712|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
23406172|NCT01791517|65233713|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406173|NCT01791517|65233714|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406174|NCT01791517|65233715|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406175|NCT01791517|65233716|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23505755|NCT01709513|65588060|FG002|Overall Study|Randomized but not treated|0|||
23505756|NCT01709513|65588058|FG000|Overall Study|Adverse Event|16|||
23505757|NCT01709513|65588059|FG001|Overall Study|Adverse Event|31|||
23505758|NCT01709513|65588060|FG002|Overall Study|Adverse Event|23|||
23505759|NCT01709513|65588058|FG000|Overall Study|Poor compliance to protocol|2|||
23505760|NCT01709513|65588059|FG001|Overall Study|Poor compliance to protocol|0|||
23505761|NCT01709513|65588060|FG002|Overall Study|Poor compliance to protocol|0|||
23505762|NCT01709513|65588058|FG000|Overall Study|Other|3|||
23505763|NCT01709513|65588059|FG001|Overall Study|Other|11|||
23406176|NCT01791517|65233717|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406177|NCT01791517|65233718|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406178|NCT01791517|65233719|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406179|NCT01791517|65233720|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406180|NCT01791517|65233721|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406181|NCT01791517|65233722|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406182|NCT01791517|65233723|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
23406183|NCT01791517|65233712|FG000|Phase I: Period 2|Protocol Violation|0|||
23406184|NCT01791517|65233713|FG001|Phase I: Period 2|Protocol Violation|0|||
23406185|NCT01791517|65233714|FG002|Phase I: Period 2|Protocol Violation|0|||
23406186|NCT01791517|65233715|FG003|Phase I: Period 2|Protocol Violation|1|||
23406187|NCT01791517|65233716|FG004|Phase I: Period 2|Protocol Violation|0|||
23406188|NCT01791517|65233717|FG005|Phase I: Period 2|Protocol Violation|0|||
23406189|NCT01791517|65233718|FG006|Phase I: Period 2|Protocol Violation|0|||
23406190|NCT01791517|65233719|FG007|Phase I: Period 2|Protocol Violation|0|||
23406191|NCT01791517|65233720|FG008|Phase I: Period 2|Protocol Violation|0|||
23406192|NCT01791517|65233721|FG009|Phase I: Period 2|Protocol Violation|0|||
23406193|NCT01791517|65233722|FG010|Phase I: Period 2|Protocol Violation|0|||
23406194|NCT01791517|65233723|FG011|Phase I: Period 2|Protocol Violation|0|||
23505764|NCT01709513|65588060|FG002|Overall Study|Other|7|||
23505765|NCT04221009|65588061|FG000|Overall Study|Withdrawal by Subject|4|||
23406195|NCT01791517|65233712|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
23505766|NCT03329573|65588062|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
23406196|NCT01791517|65233713|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
23505767|NCT03329573|65588063|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
23505768|NCT03329573|65588064|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
23505769|NCT03329573|65588065|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
23505770|NCT03329573|65588062|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
23505771|NCT03329573|65588063|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
23505772|NCT03329573|65588064|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23505773|NCT03329573|65588065|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23505774|NCT03329573|65588062|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
23505775|NCT03329573|65588063|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
23505776|NCT03329573|65588064|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
23505777|NCT03329573|65588065|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
23505778|NCT03329573|65588062|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
23505779|NCT03329573|65588063|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
23505780|NCT03329573|65588064|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
23505781|NCT03329573|65588065|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
23505782|NCT01977794|65588072|FG000|Overall Study|Adverse Event|2|||
23505783|NCT01977794|65588073|FG001|Overall Study|Adverse Event|2|||
23505784|NCT01977794|65588072|FG000|Overall Study|Lost to Follow-up|2|||
23505785|NCT01977794|65588073|FG001|Overall Study|Lost to Follow-up|1|||
23505786|NCT01977794|65588072|FG000|Overall Study|Protocol Violation|1|||
23505787|NCT01977794|65588073|FG001|Overall Study|Protocol Violation|0|||
23505788|NCT01977794|65588072|FG000|Overall Study|Death|1|||
23505789|NCT01977794|65588073|FG001|Overall Study|Death|1|||
23505790|NCT01977794|65588072|FG000|Overall Study|Withdrew consent|2|||
23505791|NCT01977794|65588073|FG001|Overall Study|Withdrew consent|1|||
23505792|NCT01977794|65588072|FG000|Overall Study|Other|0|||
23505793|NCT01977794|65588073|FG001|Overall Study|Other|1|||
23505794|NCT00165776|65588074|FG000|Overall Study|Lack of Efficacy|0|||
23505795|NCT00165776|65588075|FG001|Overall Study|Lack of Efficacy|0|||
23505796|NCT00165776|65588076|FG002|Overall Study|Lack of Efficacy|0|||
23505797|NCT00165776|65588077|FG003|Overall Study|Lack of Efficacy|1|||
23505798|NCT00165776|65588074|FG000|Overall Study|Withdrawal by Subject|4|||
23505799|NCT00165776|65588075|FG001|Overall Study|Withdrawal by Subject|1|||
23505800|NCT00165776|65588076|FG002|Overall Study|Withdrawal by Subject|2|||
23505801|NCT00165776|65588077|FG003|Overall Study|Withdrawal by Subject|0|||
23505802|NCT00165776|65588074|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
23505803|NCT00165776|65588075|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
23505804|NCT00165776|65588076|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
23505805|NCT00165776|65588077|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
23505806|NCT02706691|65588078|FG000|Overall Study|Adverse Event|1|||
23505807|NCT00289991|65588081|FG000|Overall Study|Death|35|||
23505808|NCT00289991|65588082|FG001|Overall Study|Death|38|||
23505809|NCT00289991|65588081|FG000|Overall Study|Adverse Event|15|||
23505810|NCT00289991|65588082|FG001|Overall Study|Adverse Event|13|||
23505811|NCT00289991|65588081|FG000|Overall Study|Failure of prophylaxis|1|||
23505812|NCT00289991|65588082|FG001|Overall Study|Failure of prophylaxis|1|||
23505813|NCT00289991|65588081|FG000|Overall Study|Fungal breakthrough infection|0|||
23505814|NCT00289991|65588082|FG001|Overall Study|Fungal breakthrough infection|1|||
23505815|NCT00289991|65588081|FG000|Overall Study|Lost to Follow-up|0|||
23505816|NCT00289991|65588082|FG001|Overall Study|Lost to Follow-up|1|||
23505817|NCT00289991|65588081|FG000|Overall Study|Withdrawal by Subject|2|||
23505818|NCT00289991|65588082|FG001|Overall Study|Withdrawal by Subject|12|||
23505819|NCT00289991|65588081|FG000|Overall Study|Other|5|||
23505820|NCT00289991|65588082|FG001|Overall Study|Other|14|||
23505821|NCT01007812|65588083|FG000|Period 1, One Week|Lost to Follow-up|0|||
23505822|NCT01007812|65588084|FG001|Period 1, One Week|Lost to Follow-up|1|||
23505823|NCT01007812|65588083|FG000|Period 1, One Week|Discomfort|1|||
23505824|NCT01007812|65588084|FG001|Period 1, One Week|Discomfort|0|||
23406197|NCT01791517|65233714|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
23406198|NCT01791517|65233715|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
23406199|NCT01791517|65233716|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
23406200|NCT01791517|65233717|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
23406201|NCT01791517|65233718|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
23406202|NCT01791517|65233719|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
23406203|NCT01791517|65233720|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
23406204|NCT01791517|65233721|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
23406205|NCT01791517|65233722|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
23505825|NCT01673867|65588085|FG000|Randomization|Adverse event unrelated to study drug|1|||
23406206|NCT01791517|65233723|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
23505826|NCT01673867|65588086|FG001|Randomization|Adverse event unrelated to study drug|0|||
23505827|NCT01673867|65588085|FG000|Randomization|Participant request to discontinue study treatment|0|||
23505828|NCT01673867|65588086|FG001|Randomization|Participant request to discontinue study treatment|4|||
23505829|NCT01673867|65588085|FG000|Randomization|Withdrawal by participant|0|||
23406207|NCT01791517|65233712|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406208|NCT01791517|65233713|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23505830|NCT01673867|65588086|FG001|Randomization|Withdrawal by participant|12|||
23505831|NCT01673867|65588085|FG000|Randomization|Lost to Follow-up|0|||
23505832|NCT01673867|65588086|FG001|Randomization|Lost to Follow-up|1|||
23505833|NCT01673867|65588085|FG000|Randomization|Participant no longer meets study criteria|4|||
23505834|NCT01673867|65588086|FG001|Randomization|Participant no longer meets study criteria|5|||
23505835|NCT01673867|65588085|FG000|Treatment|Disease Progression|208|||
23505836|NCT01673867|65588086|FG001|Treatment|Disease Progression|178|||
23505837|NCT01673867|65588085|FG000|Treatment|Study Drug Toxicity|23|||
23505838|NCT01673867|65588086|FG001|Treatment|Study Drug Toxicity|43|||
23505839|NCT01673867|65588085|FG000|Treatment|Death|2|||
23505840|NCT01673867|65588086|FG001|Treatment|Death|3|||
23505841|NCT01673867|65588085|FG000|Treatment|Adverse event unrelated to study drug|23|||
23505842|NCT01673867|65588086|FG001|Treatment|Adverse event unrelated to study drug|10|||
23505843|NCT01673867|65588085|FG000|Treatment|Participant request to discontinue study treatment|7|||
23505844|NCT01673867|65588086|FG001|Treatment|Participant request to discontinue study treatment|17|||
23505845|NCT01673867|65588085|FG000|Treatment|Withdrawal by participant|5|||
23505846|NCT01673867|65588086|FG001|Treatment|Withdrawal by participant|5|||
23505847|NCT01673867|65588085|FG000|Treatment|Maximum clinical benefit|1|||
23505848|NCT01673867|65588086|FG001|Treatment|Maximum clinical benefit|10|||
23505849|NCT01673867|65588085|FG000|Treatment|Participant no longer meets study criteria|2|||
23505850|NCT01673867|65588086|FG001|Treatment|Participant no longer meets study criteria|0|||
23505851|NCT01673867|65588085|FG000|Treatment|Administrative reason by sponsor|3|||
23505852|NCT01673867|65588086|FG001|Treatment|Administrative reason by sponsor|0|||
23505853|NCT01673867|65588085|FG000|Treatment|Other reason|11|||
23505854|NCT01673867|65588086|FG001|Treatment|Other reason|2|||
23505855|NCT00541931|65588092|FG000|Overall Study|Adverse Event|1|||
23505856|NCT00541931|65588093|FG001|Overall Study|Adverse Event|0|||
23505857|NCT00541931|65588092|FG000|Overall Study|Lost to Follow-up|3|||
23505858|NCT00541931|65588093|FG001|Overall Study|Lost to Follow-up|3|||
23505859|NCT00541931|65588092|FG000|Overall Study|Withdrawal by Subject|1|||
23505860|NCT00541931|65588093|FG001|Overall Study|Withdrawal by Subject|0|||
23505861|NCT00541931|65588092|FG000|Overall Study|Transportation Issue|0|||
23505862|NCT00541931|65588093|FG001|Overall Study|Transportation Issue|1|||
23505863|NCT00790023|65588094|FG000|Overall Study|Adverse Event|2|||
23505864|NCT00790023|65588095|FG001|Overall Study|Adverse Event|1|||
23505865|NCT00790023|65588096|FG002|Overall Study|Adverse Event|4|||
23505866|NCT00790023|65588094|FG000|Overall Study|Protocol Violation|2|||
23505867|NCT00790023|65588095|FG001|Overall Study|Protocol Violation|4|||
23505868|NCT00790023|65588096|FG002|Overall Study|Protocol Violation|2|||
23505869|NCT00790023|65588094|FG000|Overall Study|Withdrawal by Subject|2|||
23505870|NCT00790023|65588095|FG001|Overall Study|Withdrawal by Subject|0|||
23505871|NCT00790023|65588096|FG002|Overall Study|Withdrawal by Subject|6|||
23505872|NCT00790023|65588094|FG000|Overall Study|Lost to Follow-up|0|||
23505873|NCT00790023|65588095|FG001|Overall Study|Lost to Follow-up|0|||
23505874|NCT00790023|65588096|FG002|Overall Study|Lost to Follow-up|1|||
23505875|NCT00790023|65588094|FG000|Overall Study|Other|5|||
23505876|NCT00790023|65588095|FG001|Overall Study|Other|5|||
23505877|NCT00790023|65588096|FG002|Overall Study|Other|8|||
23505878|NCT02144012|65588097|FG000|Overall Study|Adverse Event|1|||
23505879|NCT02144012|65588098|FG001|Overall Study|Adverse Event|0|||
23505880|NCT02144012|65588097|FG000|Overall Study|Death|1|||
23505881|NCT02144012|65588098|FG001|Overall Study|Death|0|||
23406209|NCT01791517|65233714|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406210|NCT01791517|65233715|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406211|NCT01791517|65233716|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406212|NCT01791517|65233717|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406213|NCT01791517|65233718|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406214|NCT01791517|65233719|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406215|NCT01791517|65233720|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406216|NCT01791517|65233721|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406217|NCT01791517|65233722|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
23505882|NCT02144012|65588097|FG000|Overall Study|Withdrawal by Subject|11|||
23505883|NCT02144012|65588098|FG001|Overall Study|Withdrawal by Subject|3|||
23505884|NCT02144012|65588097|FG000|Overall Study|Study Terminated by Sponsor|18|||
23505885|NCT02144012|65588098|FG001|Overall Study|Study Terminated by Sponsor|12|||
23505886|NCT02144012|65588097|FG000|Overall Study|Other|3|||
23505887|NCT02144012|65588098|FG001|Overall Study|Other|0|||
23505888|NCT03648541|65588106|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
23505889|NCT03648541|65588107|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
23505890|NCT03648541|65588106|FG000|Re-induction Period Only|Lack of Efficacy|7|||
23505891|NCT03648541|65588107|FG001|Re-induction Period Only|Lack of Efficacy|0|||
23505892|NCT03648541|65588106|FG000|Maintenance Period Only|Missing|0|||
23505893|NCT03648541|65588107|FG001|Maintenance Period Only|Missing|1|||
23505894|NCT03648541|65588106|FG000|Maintenance Period Only|Other not listed below|0|||
23406218|NCT01791517|65233723|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
23406219|NCT01791517|65233712|FG000|Phase I: Period 2|Lens Discomfort|0|||
23406220|NCT01791517|65233713|FG001|Phase I: Period 2|Lens Discomfort|0|||
23406221|NCT01791517|65233714|FG002|Phase I: Period 2|Lens Discomfort|0|||
23406222|NCT01791517|65233715|FG003|Phase I: Period 2|Lens Discomfort|0|||
23406223|NCT01791517|65233716|FG004|Phase I: Period 2|Lens Discomfort|0|||
23406224|NCT01791517|65233717|FG005|Phase I: Period 2|Lens Discomfort|1|||
23406225|NCT01791517|65233718|FG006|Phase I: Period 2|Lens Discomfort|0|||
23406226|NCT01791517|65233719|FG007|Phase I: Period 2|Lens Discomfort|0|||
23406227|NCT01791517|65233720|FG008|Phase I: Period 2|Lens Discomfort|0|||
23406228|NCT01791517|65233721|FG009|Phase I: Period 2|Lens Discomfort|0|||
23406229|NCT01791517|65233722|FG010|Phase I: Period 2|Lens Discomfort|0|||
23406230|NCT01791517|65233723|FG011|Phase I: Period 2|Lens Discomfort|0|||
23406231|NCT01791517|65233712|FG000|Phase I: Period 2|Lost to Follow-up|0|||
23406232|NCT01791517|65233713|FG001|Phase I: Period 2|Lost to Follow-up|3|||
23406233|NCT01791517|65233714|FG002|Phase I: Period 2|Lost to Follow-up|2|||
23406234|NCT01791517|65233715|FG003|Phase I: Period 2|Lost to Follow-up|0|||
23406235|NCT01791517|65233716|FG004|Phase I: Period 2|Lost to Follow-up|0|||
23406236|NCT01791517|65233717|FG005|Phase I: Period 2|Lost to Follow-up|0|||
23406237|NCT01791517|65233718|FG006|Phase I: Period 2|Lost to Follow-up|0|||
23406238|NCT01791517|65233719|FG007|Phase I: Period 2|Lost to Follow-up|0|||
23406239|NCT01791517|65233720|FG008|Phase I: Period 2|Lost to Follow-up|0|||
23406240|NCT01791517|65233721|FG009|Phase I: Period 2|Lost to Follow-up|0|||
23505895|NCT03648541|65588107|FG001|Maintenance Period Only|Other not listed below|4|||
23505896|NCT03648541|65588106|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
23505897|NCT03648541|65588107|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
23505898|NCT03648541|65588106|FG000|Maintenance Period Only|Protocol Violation|0|||
23505899|NCT03648541|65588107|FG001|Maintenance Period Only|Protocol Violation|1|||
23505900|NCT03648541|65588106|FG000|Maintenance Period Only|Lack of Efficacy|0|||
23505901|NCT03648541|65588107|FG001|Maintenance Period Only|Lack of Efficacy|18|||
23505902|NCT03648541|65588106|FG000|Maintenance Period Only|Adverse Event|0|||
23505903|NCT03648541|65588107|FG001|Maintenance Period Only|Adverse Event|4|||
23505904|NCT03648541|65588106|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
23505905|NCT03648541|65588107|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
23505906|NCT01919723|65588108|FG000|Overall Study|Blood Samples Hemolyzed|2|||
23505907|NCT01919723|65588109|FG001|Overall Study|Blood Samples Hemolyzed|2|||
23505908|NCT01844518|65588110|FG000|Overall Study|Adverse Event|7|||
23505909|NCT01844518|65588111|FG001|Overall Study|Adverse Event|1|||
23505910|NCT01844518|65588110|FG000|Overall Study|Lack of Efficacy|17|||
23505911|NCT01844518|65588111|FG001|Overall Study|Lack of Efficacy|5|||
23505912|NCT01844518|65588110|FG000|Overall Study|Participant's request to discontinue|4|||
23406241|NCT01791517|65233722|FG010|Phase I: Period 2|Lost to Follow-up|0|||
23406242|NCT01791517|65233723|FG011|Phase I: Period 2|Lost to Follow-up|0|||
23406243|NCT01791517|65233712|FG000|Phase I: Period 3|Lens Discomfort|0|||
23406244|NCT01791517|65233713|FG001|Phase I: Period 3|Lens Discomfort|0|||
23406245|NCT01791517|65233714|FG002|Phase I: Period 3|Lens Discomfort|0|||
23406246|NCT01791517|65233715|FG003|Phase I: Period 3|Lens Discomfort|0|||
23406247|NCT01791517|65233716|FG004|Phase I: Period 3|Lens Discomfort|0|||
23406248|NCT01791517|65233717|FG005|Phase I: Period 3|Lens Discomfort|0|||
23406249|NCT01791517|65233718|FG006|Phase I: Period 3|Lens Discomfort|0|||
23406250|NCT01791517|65233719|FG007|Phase I: Period 3|Lens Discomfort|0|||
23406251|NCT01791517|65233720|FG008|Phase I: Period 3|Lens Discomfort|0|||
23406252|NCT01791517|65233721|FG009|Phase I: Period 3|Lens Discomfort|0|||
23505913|NCT01844518|65588111|FG001|Overall Study|Participant's request to discontinue|1|||
23505914|NCT01844518|65588110|FG000|Overall Study|Poor/Non-compliance|1|||
23505915|NCT01844518|65588111|FG001|Overall Study|Poor/Non-compliance|0|||
23505916|NCT01844518|65588110|FG000|Overall Study|No Longer Met Study Criteria|2|||
23505917|NCT01844518|65588111|FG001|Overall Study|No Longer Met Study Criteria|0|||
23505918|NCT01844518|65588110|FG000|Overall Study|Withdrawal by Subject|9|||
23505919|NCT01844518|65588111|FG001|Overall Study|Withdrawal by Subject|0|||
23505920|NCT01844518|65588110|FG000|Overall Study|Pregnancy|1|||
23505921|NCT01844518|65588111|FG001|Overall Study|Pregnancy|0|||
23505922|NCT00855920|65590993|FG000|Overall Study|Protocol Violation|0|||
23505923|NCT00855920|65590994|FG001|Overall Study|Protocol Violation|0|||
23505924|NCT00855920|65590995|FG002|Overall Study|Protocol Violation|2|||
23505925|NCT00855920|65590993|FG000|Overall Study|Adverse Event|2|||
23406253|NCT01791517|65233722|FG010|Phase I: Period 3|Lens Discomfort|0|||
23406254|NCT01791517|65233723|FG011|Phase I: Period 3|Lens Discomfort|1|||
23406255|NCT01791517|65233712|FG000|Phase I: Period 3|Lost to Follow-up|0|||
23505926|NCT00855920|65590994|FG001|Overall Study|Adverse Event|1|||
23505927|NCT00855920|65590995|FG002|Overall Study|Adverse Event|1|||
23406256|NCT01791517|65233713|FG001|Phase I: Period 3|Lost to Follow-up|1|||
23406257|NCT01791517|65233714|FG002|Phase I: Period 3|Lost to Follow-up|0|||
23406258|NCT01791517|65233715|FG003|Phase I: Period 3|Lost to Follow-up|0|||
23406259|NCT01791517|65233716|FG004|Phase I: Period 3|Lost to Follow-up|1|||
23406260|NCT01791517|65233717|FG005|Phase I: Period 3|Lost to Follow-up|0|||
23406261|NCT01791517|65233718|FG006|Phase I: Period 3|Lost to Follow-up|0|||
23505928|NCT00855920|65590993|FG000|Overall Study|Lack of Efficacy|2|||
23505929|NCT00855920|65590994|FG001|Overall Study|Lack of Efficacy|2|||
23505930|NCT00855920|65590995|FG002|Overall Study|Lack of Efficacy|2|||
23505931|NCT00855920|65590993|FG000|Overall Study|Withdrawal by Subject|2|||
23505932|NCT00855920|65590994|FG001|Overall Study|Withdrawal by Subject|3|||
23505933|NCT00855920|65590995|FG002|Overall Study|Withdrawal by Subject|2|||
23505934|NCT00855920|65590993|FG000|Overall Study|Lost to Follow-up|1|||
23505935|NCT00855920|65590994|FG001|Overall Study|Lost to Follow-up|0|||
23505936|NCT00855920|65590995|FG002|Overall Study|Lost to Follow-up|2|||
23505937|NCT00855920|65590993|FG000|Overall Study|Death|0|||
23505938|NCT00855920|65590994|FG001|Overall Study|Death|1|||
23505939|NCT00855920|65590995|FG002|Overall Study|Death|0|||
23505940|NCT00855920|65590993|FG000|Overall Study|Decision by the sponsor|0|||
23505941|NCT00855920|65590994|FG001|Overall Study|Decision by the sponsor|1|||
23505942|NCT00855920|65590995|FG002|Overall Study|Decision by the sponsor|1|||
23505943|NCT00855920|65590993|FG000|Overall Study|Other than specified above|1|||
23505944|NCT00855920|65590994|FG001|Overall Study|Other than specified above|1|||
23505945|NCT00855920|65590995|FG002|Overall Study|Other than specified above|1|||
23505946|NCT00160693|65590996|FG000|Overall Study|Adverse Event|97|||
23505947|NCT00160693|65590996|FG000|Overall Study|Lack of Efficacy|30|||
23505948|NCT00160693|65590996|FG000|Overall Study|Protocol Violation|24|||
23505949|NCT00160693|65590996|FG000|Overall Study|Lost to Follow-up|15|||
23406262|NCT01791517|65233719|FG007|Phase I: Period 3|Lost to Follow-up|0|||
23505950|NCT00160693|65590996|FG000|Overall Study|Withdrawal by Subject|54|||
23505951|NCT00160693|65590996|FG000|Overall Study|Study terminated by sponsor|15|||
23505952|NCT02216591|65590997|FG000|Overall Study|Lost to Follow-up|0|||
23505953|NCT02216591|65590998|FG001|Overall Study|Lost to Follow-up|1|||
23505954|NCT04212650|65590999|FG000|Overall Study|Withdrawal by Subject|1|||
23505955|NCT04212650|65591000|FG001|Overall Study|Withdrawal by Subject|0|||
23406263|NCT01791517|65233720|FG008|Phase I: Period 3|Lost to Follow-up|0|||
23406264|NCT01791517|65233721|FG009|Phase I: Period 3|Lost to Follow-up|0|||
23406265|NCT01791517|65233722|FG010|Phase I: Period 3|Lost to Follow-up|0|||
23406266|NCT01791517|65233723|FG011|Phase I: Period 3|Lost to Follow-up|0|||
23406267|NCT01791517|65233712|FG000|Phase I: Period 3|Adverse Event|0|||
23505956|NCT01606436|65591005|FG000|Overall Study|Withdrawal by Subject|0|||
23505957|NCT01606436|65591006|FG001|Overall Study|Withdrawal by Subject|0|||
23505958|NCT01606436|65591007|FG002|Overall Study|Withdrawal by Subject|1|||
23505959|NCT01606436|65591008|FG003|Overall Study|Withdrawal by Subject|1|||
23505960|NCT01606436|65591009|FG004|Overall Study|Withdrawal by Subject|1|||
23505961|NCT01606436|65591010|FG005|Overall Study|Withdrawal by Subject|0|||
23505962|NCT01606436|65591005|FG000|Overall Study|Adverse Event|0|||
23505963|NCT01606436|65591006|FG001|Overall Study|Adverse Event|0|||
23505964|NCT01606436|65591007|FG002|Overall Study|Adverse Event|1|||
23505965|NCT01606436|65591008|FG003|Overall Study|Adverse Event|0|||
23505966|NCT01606436|65591009|FG004|Overall Study|Adverse Event|0|||
23505967|NCT01606436|65591010|FG005|Overall Study|Adverse Event|0|||
23505968|NCT01606436|65591005|FG000|Overall Study|Sponsor Decision|0|||
23505969|NCT01606436|65591006|FG001|Overall Study|Sponsor Decision|0|||
23505970|NCT01606436|65591007|FG002|Overall Study|Sponsor Decision|0|||
23505971|NCT01606436|65591008|FG003|Overall Study|Sponsor Decision|1|||
23505972|NCT01606436|65591009|FG004|Overall Study|Sponsor Decision|0|||
23505973|NCT01606436|65591010|FG005|Overall Study|Sponsor Decision|0|||
23505974|NCT00496054|65591011|FG000|Overall Study|Adverse Event|1|||
23505975|NCT00496054|65591011|FG000|Overall Study|Lost to Follow-up|7|||
23505976|NCT00687323|65591012|FG000|Overall Study|Death|25|||
23505977|NCT00687323|65591012|FG000|Overall Study|Withdrawal by Subject|1|||
23505978|NCT00687323|65591012|FG000|Overall Study|Excluded from efficacy evaluations|6|||
23505979|NCT00687323|65591012|FG000|Overall Study|Screen failure|148|||
23505980|NCT01949506|65591016|FG000|Overall Study|Physician Decision|1|||
23505981|NCT00737282|65591028|FG000|Overall Study|Study prematurely terminated|175|||
23505982|NCT01819831|65591029|FG000|Overall Study|Withdrawal by Subject|1|||
23505983|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
23505984|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
23505985|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
23505986|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505987|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505988|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505989|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505990|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505991|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505992|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505993|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
23505994|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
23505995|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23505996|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
23505997|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23505998|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23505999|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506000|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506001|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506002|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506003|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506004|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
23506005|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
23506006|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
23506007|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
23506008|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506009|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23406268|NCT01791517|65233713|FG001|Phase I: Period 3|Adverse Event|0|||
23406269|NCT01791517|65233714|FG002|Phase I: Period 3|Adverse Event|0|||
23406270|NCT01791517|65233715|FG003|Phase I: Period 3|Adverse Event|1|||
23406271|NCT01791517|65233716|FG004|Phase I: Period 3|Adverse Event|0|||
23406272|NCT01791517|65233717|FG005|Phase I: Period 3|Adverse Event|0|||
23506010|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506011|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506012|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506013|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506014|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23506015|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
23607212|NCT02106325|65950626|FG001|Phase 2|Lost to Follow-up|3|||
23506016|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
23506017|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
23506018|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506019|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506020|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506021|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506022|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506023|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506024|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506025|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506026|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
23506027|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
23506028|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
23506029|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
23506030|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506031|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506032|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506033|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506034|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506035|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506036|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23406273|NCT01791517|65233718|FG006|Phase I: Period 3|Adverse Event|0|||
23406274|NCT01791517|65233719|FG007|Phase I: Period 3|Adverse Event|0|||
23406275|NCT01791517|65233720|FG008|Phase I: Period 3|Adverse Event|0|||
23406276|NCT01791517|65233721|FG009|Phase I: Period 3|Adverse Event|0|||
23406277|NCT01791517|65233722|FG010|Phase I: Period 3|Adverse Event|0|||
23406278|NCT01791517|65233723|FG011|Phase I: Period 3|Adverse Event|0|||
23406279|NCT01791517|65233712|FG000|Phase II|Lost to Follow-up|1|||
23406280|NCT01791517|65233713|FG001|Phase II|Lost to Follow-up|0|||
23406281|NCT01791517|65233714|FG002|Phase II|Lost to Follow-up|1|||
23406282|NCT01791517|65233715|FG003|Phase II|Lost to Follow-up|0|||
23406283|NCT01791517|65233716|FG004|Phase II|Lost to Follow-up|1|||
23406284|NCT01791517|65233717|FG005|Phase II|Lost to Follow-up|2|||
23406285|NCT01791517|65233718|FG006|Phase II|Lost to Follow-up|0|||
23406286|NCT01791517|65233719|FG007|Phase II|Lost to Follow-up|1|||
23406287|NCT01791517|65233720|FG008|Phase II|Lost to Follow-up|1|||
23406288|NCT01791517|65233721|FG009|Phase II|Lost to Follow-up|1|||
23406289|NCT01791517|65233722|FG010|Phase II|Lost to Follow-up|0|||
23406290|NCT01791517|65233723|FG011|Phase II|Lost to Follow-up|0|||
23406291|NCT01791517|65233712|FG000|Phase II|Withdrawal by Subject|1|||
23406292|NCT01791517|65233713|FG001|Phase II|Withdrawal by Subject|0|||
23406293|NCT01791517|65233714|FG002|Phase II|Withdrawal by Subject|0|||
23406294|NCT01791517|65233715|FG003|Phase II|Withdrawal by Subject|0|||
23406295|NCT01791517|65233716|FG004|Phase II|Withdrawal by Subject|0|||
23406296|NCT01791517|65233717|FG005|Phase II|Withdrawal by Subject|2|||
23406297|NCT01791517|65233718|FG006|Phase II|Withdrawal by Subject|0|||
23406298|NCT01791517|65233719|FG007|Phase II|Withdrawal by Subject|1|||
23506037|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
23506038|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506039|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
23506040|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
23506041|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506042|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506043|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506044|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506045|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506046|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506047|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506048|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
23506049|NCT02207244|65591032|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506050|NCT02207244|65591033|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
23506051|NCT02207244|65591034|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506052|NCT02207244|65591035|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506053|NCT02207244|65591036|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506054|NCT02207244|65591037|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506055|NCT02207244|65591038|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506056|NCT02207244|65591039|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506057|NCT02207244|65591040|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506058|NCT02207244|65591041|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506059|NCT02207244|65591042|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
23506060|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506061|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506062|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506063|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506064|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
23607213|NCT02106325|65950625|FG000|Phase 3|Lost to Follow-up|2|||
23607214|NCT02106325|65950626|FG001|Phase 3|Lost to Follow-up|1|||
23607215|NCT02268851|65950627|FG000|Overall Study|Death|0|||
23607216|NCT02268851|65950628|FG001|Overall Study|Death|0|||
23607217|NCT02268851|65950629|FG002|Overall Study|Death|0|||
23607218|NCT02268851|65950630|FG003|Overall Study|Death|1|||
23607219|NCT02268851|65950631|FG004|Overall Study|Death|2|||
23607220|NCT02268851|65950632|FG005|Overall Study|Death|1|||
23607221|NCT02268851|65950627|FG000|Overall Study|Adverse Event|0|||
23607222|NCT02268851|65950628|FG001|Overall Study|Adverse Event|0|||
23607223|NCT02268851|65950629|FG002|Overall Study|Adverse Event|0|||
23607224|NCT02268851|65950630|FG003|Overall Study|Adverse Event|0|||
23607225|NCT02268851|65950631|FG004|Overall Study|Adverse Event|2|||
23607226|NCT02268851|65950632|FG005|Overall Study|Adverse Event|2|||
23607227|NCT02268851|65950627|FG000|Overall Study|Withdrawal by Subject|0|||
23607228|NCT02268851|65950628|FG001|Overall Study|Withdrawal by Subject|0|||
23607229|NCT02268851|65950629|FG002|Overall Study|Withdrawal by Subject|0|||
23607230|NCT02268851|65950630|FG003|Overall Study|Withdrawal by Subject|2|||
23607231|NCT02268851|65950631|FG004|Overall Study|Withdrawal by Subject|0|||
23607232|NCT02268851|65950632|FG005|Overall Study|Withdrawal by Subject|1|||
23607233|NCT02268851|65950627|FG000|Overall Study|Progressive Disease|1|||
23607234|NCT02268851|65950628|FG001|Overall Study|Progressive Disease|3|||
23607235|NCT02268851|65950629|FG002|Overall Study|Progressive Disease|0|||
23607236|NCT02268851|65950630|FG003|Overall Study|Progressive Disease|0|||
23607237|NCT02268851|65950631|FG004|Overall Study|Progressive Disease|1|||
23607238|NCT02268851|65950632|FG005|Overall Study|Progressive Disease|4|||
23607239|NCT02268851|65950627|FG000|Overall Study|Physician Decision|0|||
23607240|NCT02268851|65950628|FG001|Overall Study|Physician Decision|0|||
23607241|NCT02268851|65950629|FG002|Overall Study|Physician Decision|1|||
23607242|NCT02268851|65950630|FG003|Overall Study|Physician Decision|0|||
23607243|NCT02268851|65950631|FG004|Overall Study|Physician Decision|0|||
23607244|NCT02268851|65950632|FG005|Overall Study|Physician Decision|1|||
23607245|NCT02268851|65950627|FG000|Overall Study|Patient Compliance|0|||
23607246|NCT02268851|65950628|FG001|Overall Study|Patient Compliance|0|||
23607247|NCT02268851|65950629|FG002|Overall Study|Patient Compliance|0|||
23607248|NCT02268851|65950630|FG003|Overall Study|Patient Compliance|0|||
23607249|NCT02268851|65950631|FG004|Overall Study|Patient Compliance|1|||
23607250|NCT02268851|65950632|FG005|Overall Study|Patient Compliance|1|||
23607251|NCT02268851|65950627|FG000|Overall Study|Co-Morbid Condition|0|||
23607252|NCT02268851|65950628|FG001|Overall Study|Co-Morbid Condition|0|||
23607253|NCT02268851|65950629|FG002|Overall Study|Co-Morbid Condition|0|||
23607254|NCT02268851|65950630|FG003|Overall Study|Co-Morbid Condition|0|||
23607255|NCT02268851|65950631|FG004|Overall Study|Co-Morbid Condition|1|||
23607256|NCT02268851|65950632|FG005|Overall Study|Co-Morbid Condition|1|||
23607257|NCT01084772|65950633|FG000|Baseline|Withdrawal by Subject|7|||
23607258|NCT01084772|65950634|FG001|Baseline|Withdrawal by Subject|6|||
23607259|NCT01084772|65950633|FG000|3 Months|Death|1|||
23607260|NCT01084772|65950634|FG001|3 Months|Death|0|||
23607261|NCT01084772|65950633|FG000|3 Months|Study Termination|2|||
23607262|NCT01084772|65950634|FG001|3 Months|Study Termination|2|||
23607263|NCT01084772|65950633|FG000|1 Year|Withdrawal by Subject|0|||
23607264|NCT01084772|65950634|FG001|1 Year|Withdrawal by Subject|1|||
23607265|NCT01084772|65950633|FG000|1 Year|Lost to Follow-up|3|||
23607266|NCT01084772|65950634|FG001|1 Year|Lost to Follow-up|0|||
23607267|NCT01084772|65950633|FG000|1 Year|Study Termination|0|||
23607268|NCT01084772|65950634|FG001|1 Year|Study Termination|7|||
23607269|NCT01084772|65950633|FG000|2 Years|Withdrawal by Subject|1|||
23607270|NCT01084772|65950634|FG001|2 Years|Withdrawal by Subject|0|||
23607271|NCT01084772|65950633|FG000|2 Years|Lost to Follow-up|5|||
23607272|NCT01084772|65950634|FG001|2 Years|Lost to Follow-up|2|||
23607273|NCT01084772|65950633|FG000|2 Years|Study Termination|3|||
23607274|NCT01084772|65950634|FG001|2 Years|Study Termination|2|||
23607275|NCT00799409|65950638|FG000|Overall Study|Withdrawal by Subject|1|||
23607276|NCT00799409|65950639|FG001|Overall Study|Withdrawal by Subject|0|||
23607277|NCT00799409|65950640|FG002|Overall Study|Withdrawal by Subject|0|||
23607278|NCT00799409|65950638|FG000|Overall Study|Lost to Follow-up|1|||
23607279|NCT00799409|65950639|FG001|Overall Study|Lost to Follow-up|0|||
23607280|NCT00799409|65950640|FG002|Overall Study|Lost to Follow-up|0|||
23607281|NCT00799409|65950638|FG000|Overall Study|Optimal Dose Not Achieved|2|||
23607282|NCT00799409|65950639|FG001|Overall Study|Optimal Dose Not Achieved|0|||
23607283|NCT00799409|65950640|FG002|Overall Study|Optimal Dose Not Achieved|0|||
23607284|NCT00799409|65950638|FG000|Overall Study|Failure to follow study protocol)|1|||
23607285|NCT00799409|65950639|FG001|Overall Study|Failure to follow study protocol)|0|||
23607286|NCT00799409|65950640|FG002|Overall Study|Failure to follow study protocol)|0|||
23607287|NCT00799409|65950638|FG000|Overall Study|Did not attend lab school day 1|1|||
23607288|NCT00799409|65950639|FG001|Overall Study|Did not attend lab school day 1|0|||
23607289|NCT00799409|65950640|FG002|Overall Study|Did not attend lab school day 1|0|||
23607290|NCT00799409|65950638|FG000|Overall Study|medication compliance|1|||
23607291|NCT00799409|65950639|FG001|Overall Study|medication compliance|0|||
23607292|NCT00799409|65950640|FG002|Overall Study|medication compliance|0|||
23607293|NCT01220999|65950647|FG000|Overall Study|Progressive disease|0|||
23607294|NCT01220999|65950648|FG001|Overall Study|Progressive disease|0|||
23607295|NCT01220999|65950649|FG002|Overall Study|Progressive disease|1|||
23607296|NCT01220999|65950650|FG003|Overall Study|Progressive disease|0|||
23607297|NCT01220999|65950651|FG004|Overall Study|Progressive disease|0|||
23607298|NCT00413283|65950652|FG000|Overall Study|Withdrawal by Subject|1|||
23607299|NCT00413283|65950653|FG001|Overall Study|Withdrawal by Subject|0|||
23506065|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
23506066|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506067|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506068|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23607300|NCT00413283|65950654|FG002|Overall Study|Withdrawal by Subject|0|||
23607301|NCT00413283|65950655|FG003|Overall Study|Withdrawal by Subject|1|||
23607302|NCT00413283|65950652|FG000|Overall Study|Death|0|||
23607303|NCT00413283|65950653|FG001|Overall Study|Death|0|||
23607304|NCT00413283|65950654|FG002|Overall Study|Death|1|||
23607305|NCT00413283|65950655|FG003|Overall Study|Death|1|||
23506069|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506070|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
23506071|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506072|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506073|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506074|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506075|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506076|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
23506077|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506078|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506079|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506080|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506081|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
23506082|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506083|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506084|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506085|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
23607306|NCT00413283|65950652|FG000|Overall Study|Adverse Event|0|||
23607307|NCT00413283|65950653|FG001|Overall Study|Adverse Event|0|||
23607308|NCT00413283|65950654|FG002|Overall Study|Adverse Event|0|||
23607309|NCT00413283|65950655|FG003|Overall Study|Adverse Event|1|||
23607310|NCT00413283|65950652|FG000|Overall Study|Ineligibility determined|0|||
23304330|NCT03340064|64858317|FG001|Second Period|Physician Decision|0|||
23607311|NCT00413283|65950653|FG001|Overall Study|Ineligibility determined|0|||
23607312|NCT00413283|65950654|FG002|Overall Study|Ineligibility determined|0|||
23607313|NCT00413283|65950655|FG003|Overall Study|Ineligibility determined|1|||
23506086|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
23304331|NCT03340064|64858316|FG000|Second Period|Withdrawal by Subject|2|||
23304332|NCT03340064|64858317|FG001|Second Period|Withdrawal by Subject|1|||
23304333|NCT03340064|64858316|FG000|Second Period|Approved Drug Available For Indication|1|||
23304334|NCT03340064|64858317|FG001|Second Period|Approved Drug Available For Indication|0|||
23304335|NCT03340064|64858316|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
23304336|NCT03340064|64858317|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
23304337|NCT02791893|64858318|FG000|Blinded Phase|Lost to Follow-up|2|||
23304338|NCT02791893|64858319|FG001|Blinded Phase|Lost to Follow-up|2|||
23304339|NCT02791893|64858318|FG000|Blinded Phase|Withdrawal by Subject|1|||
23304340|NCT02791893|64858319|FG001|Blinded Phase|Withdrawal by Subject|2|||
23304341|NCT02791893|64858318|FG000|Open Label Phase|Lost to Follow-up|3|||
23304342|NCT02791893|64858319|FG001|Open Label Phase|Lost to Follow-up|0|||
23304343|NCT02791893|64858318|FG000|Open Label Phase|Withdrawal by Subject|0|||
23304344|NCT02791893|64858319|FG001|Open Label Phase|Withdrawal by Subject|2|||
23304345|NCT00354341|64858320|FG000|Overall Study|Adverse Event|1|||
23304346|NCT00354341|64858321|FG001|Overall Study|Adverse Event|0|||
23304347|NCT00354341|64858320|FG000|Overall Study|Death|0|||
23304348|NCT00354341|64858321|FG001|Overall Study|Death|2|||
23304349|NCT00354341|64858320|FG000|Overall Study|Refused treatment|1|||
23304350|NCT00354341|64858321|FG001|Overall Study|Refused treatment|2|||
23304351|NCT00354341|64858320|FG000|Overall Study|Failure to return|0|||
23304352|NCT00354341|64858321|FG001|Overall Study|Failure to return|1|||
23304353|NCT00354341|64858320|FG000|Overall Study|Other|1|||
23304354|NCT00354341|64858321|FG001|Overall Study|Other|2|||
23304355|NCT00614926|64858322|FG000|Overall Study|Burden of travel|1|||
23304356|NCT00614926|64858323|FG001|Overall Study|Burden of travel|0|||
23304357|NCT00614926|64858322|FG000|Overall Study|Adverse Event|3|||
23304358|NCT00614926|64858323|FG001|Overall Study|Adverse Event|0|||
23304359|NCT00505375|64858324|FG000|Overall Study|Death|1|||
23304360|NCT00505375|64858325|FG001|Overall Study|Death|0|||
23304361|NCT00505375|64858324|FG000|Overall Study|Withdrawal by Subject|2|||
23304362|NCT00505375|64858325|FG001|Overall Study|Withdrawal by Subject|2|||
23304363|NCT00505375|64858324|FG000|Overall Study|Lost to Follow-up|0|||
23304364|NCT00505375|64858325|FG001|Overall Study|Lost to Follow-up|2|||
23304365|NCT00505375|64858324|FG000|Overall Study|Pregnancy|1|||
23304366|NCT00505375|64858325|FG001|Overall Study|Pregnancy|0|||
23304367|NCT00505375|64858324|FG000|Overall Study|Travel issues|0|||
23304368|NCT00505375|64858325|FG001|Overall Study|Travel issues|1|||
23304369|NCT01763684|64858326|FG000|Overall Study|Study terminated early due to low enrollment|126|||
23304370|NCT01763684|64858327|FG001|Overall Study|Study terminated early due to low enrollment|127|||
23506087|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
23506088|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506089|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506090|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506091|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506092|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
23506093|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506094|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506095|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506096|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
23506097|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
23506098|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
23506099|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506100|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506101|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506102|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506103|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
23506104|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23304371|NCT01763684|64858326|FG000|Overall Study|Study surgery not performed|7|||
23304372|NCT01763684|64858327|FG001|Overall Study|Study surgery not performed|6|||
23304373|NCT01059539|64858328|FG000|Overall Study|Adverse Event|66|||
23304374|NCT01059539|64858328|FG000|Overall Study|Insufficient Therapeutic Response|26|||
23304375|NCT01059539|64858328|FG000|Overall Study|Protocol Violation|55|||
23304376|NCT01059539|64858328|FG000|Overall Study|Withdrawal of Consent|80|||
23304377|NCT01059539|64858328|FG000|Overall Study|Lost to Follow-up|42|||
23304378|NCT01059539|64858328|FG000|Overall Study|Reason Not Specified|2|||
23304379|NCT03914950|64858334|FG000|Overall Study|Physician Decision|54|||
23304380|NCT02551666|64858335|FG000|Overall Study|Withdrawal by Subject|1|||
23304381|NCT02551666|64858336|FG001|Overall Study|Withdrawal by Subject|3|||
23304382|NCT03835221|64858337|FG000|Methafilcon A|Withdrawal by Subject|1|||
23304383|NCT00477295|64858338|FG000|Overall Study|Adverse Event|31|||
23304384|NCT00477295|64858339|FG001|Overall Study|Adverse Event|35|||
23304385|NCT00477295|64858338|FG000|Overall Study|Withdrawal by Subject|35|||
23304386|NCT00477295|64858339|FG001|Overall Study|Withdrawal by Subject|24|||
23304387|NCT00477295|64858338|FG000|Overall Study|Lack of Efficacy|23|||
23304388|NCT00477295|64858339|FG001|Overall Study|Lack of Efficacy|23|||
23304389|NCT00477295|64858338|FG000|Overall Study|Protocol Violation|3|||
23304390|NCT00477295|64858339|FG001|Overall Study|Protocol Violation|8|||
23304391|NCT00477295|64858338|FG000|Overall Study|Physician Decision|4|||
23304392|NCT00477295|64858339|FG001|Overall Study|Physician Decision|5|||
23304393|NCT00477295|64858338|FG000|Overall Study|Lost to Follow-up|21|||
23304394|NCT00477295|64858339|FG001|Overall Study|Lost to Follow-up|11|||
23304395|NCT00477295|64858338|FG000|Overall Study|Other|4|||
23304396|NCT00477295|64858339|FG001|Overall Study|Other|3|||
23304397|NCT00415194|64858340|FG000|Overall Study|Adverse Event|37|||
23304398|NCT00415194|64858341|FG001|Overall Study|Adverse Event|32|||
23304399|NCT00415194|64858340|FG000|Overall Study|Entry Criteria Not Met|4|||
23304400|NCT00415194|64858341|FG001|Overall Study|Entry Criteria Not Met|8|||
23304401|NCT00415194|64858340|FG000|Overall Study|Lost to Follow-up|1|||
23304402|NCT00415194|64858341|FG001|Overall Study|Lost to Follow-up|0|||
23304403|NCT00415194|64858340|FG000|Overall Study|Physician Decision|10|||
23304404|NCT00415194|64858341|FG001|Overall Study|Physician Decision|16|||
23304405|NCT00415194|64858340|FG000|Overall Study|Progressive Disease|180|||
23304406|NCT00415194|64858341|FG001|Overall Study|Progressive Disease|217|||
23304407|NCT00415194|64858340|FG000|Overall Study|Protocol Violation|4|||
23304408|NCT00415194|64858341|FG001|Overall Study|Protocol Violation|2|||
23304409|NCT00415194|64858340|FG000|Overall Study|Withdrawal by Subject|28|||
23304410|NCT00415194|64858341|FG001|Overall Study|Withdrawal by Subject|21|||
23304411|NCT00415194|64858340|FG000|Overall Study|Death Due to Study Disease|26|||
23304412|NCT00415194|64858341|FG001|Overall Study|Death Due to Study Disease|29|||
23304413|NCT00415194|64858340|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
23304414|NCT00415194|64858341|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
23304415|NCT00415194|64858340|FG000|Overall Study|Death Due to Procedural Related AE|0|||
23304416|NCT00415194|64858341|FG001|Overall Study|Death Due to Procedural Related AE|1|||
23304417|NCT00415194|64858340|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
23304418|NCT00415194|64858341|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
23304419|NCT01700049|64858344|FG000|Overall Study|Withdrawal by Subject|1|||
23304420|NCT02674061|64858346|FG000|Overall Study|Death|229|||
23304421|NCT02674061|64858347|FG001|Overall Study|Death|77|||
23304422|NCT02674061|64858346|FG000|Overall Study|Lost to Follow-up|3|||
23304423|NCT02674061|64858347|FG001|Overall Study|Lost to Follow-up|3|||
23304424|NCT02674061|64858346|FG000|Overall Study|Withdrawal by Subject|9|||
23304425|NCT02674061|64858347|FG001|Overall Study|Withdrawal by Subject|1|||
23304426|NCT02674061|64858346|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
23304427|NCT02674061|64858347|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
23304428|NCT00289874|64858348|FG000|Overall Study|Adverse Event|1|||
23304429|NCT00289874|64858349|FG001|Overall Study|Adverse Event|5|||
23304430|NCT00289874|64858348|FG000|Overall Study|Lost to Follow-up|1|||
23304431|NCT00289874|64858349|FG001|Overall Study|Lost to Follow-up|1|||
23304432|NCT00289874|64858348|FG000|Overall Study|Protocol Violation|3|||
23304433|NCT00289874|64858349|FG001|Overall Study|Protocol Violation|2|||
23304434|NCT00289874|64858348|FG000|Overall Study|Did not meet eligibility|1|||
23304435|NCT00289874|64858349|FG001|Overall Study|Did not meet eligibility|0|||
23304436|NCT02570113|64858351|FG000|Overall Study|Withdrawal by Subject|3|||
23304437|NCT00910091|64858352|FG000|Pre-assignment|Withdrawal by Subject|0|||
23304438|NCT00910091|64858353|FG001|Pre-assignment|Withdrawal by Subject|2|||
23304439|NCT00910091|64858352|FG000|Treatment and Survival|Withdrawal by Subject|3|||
23304440|NCT00910091|64858353|FG001|Treatment and Survival|Withdrawal by Subject|4|||
23304441|NCT00910091|64858352|FG000|Treatment and Survival|Adverse Event|1|||
23304442|NCT00910091|64858353|FG001|Treatment and Survival|Adverse Event|0|||
23304443|NCT00418821|64858354|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
23304444|NCT00609466|64858357|FG000|Overall Study|Withdrawal by Subject|0|||
23304445|NCT00609466|64858358|FG001|Overall Study|Withdrawal by Subject|1|||
23304446|NCT00609466|64858359|FG002|Overall Study|Withdrawal by Subject|1|||
23304447|NCT00609466|64858357|FG000|Overall Study|Adverse Event|2|||
23304448|NCT00609466|64858358|FG001|Overall Study|Adverse Event|3|||
23304449|NCT00609466|64858359|FG002|Overall Study|Adverse Event|1|||
23304450|NCT00609466|64858357|FG000|Overall Study|Lack of Efficacy|0|||
23304451|NCT00609466|64858358|FG001|Overall Study|Lack of Efficacy|2|||
23304452|NCT00609466|64858359|FG002|Overall Study|Lack of Efficacy|2|||
23304453|NCT03258853|64858364|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
23304454|NCT03258853|64858365|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
23304455|NCT01780987|64858366|FG000|Overall Study|Adverse Event|0|||
23304456|NCT01780987|64858367|FG001|Overall Study|Adverse Event|4|||
23304457|NCT01780987|64858366|FG000|Overall Study|Withdrawal by Subject|2|||
23304458|NCT01780987|64858367|FG001|Overall Study|Withdrawal by Subject|0|||
23304459|NCT01780987|64858366|FG000|Overall Study|Request of Changing Hospital|0|||
23304460|NCT01780987|64858367|FG001|Overall Study|Request of Changing Hospital|1|||
23304461|NCT01780987|64858366|FG000|Overall Study|Changing Residence|1|||
23304462|NCT01780987|64858367|FG001|Overall Study|Changing Residence|0|||
23304463|NCT01780987|64858366|FG000|Overall Study|Not Receiving any Study Medication|0|||
23304464|NCT01780987|64858367|FG001|Overall Study|Not Receiving any Study Medication|1|||
23304465|NCT03918109|64858369|FG000|Overall Study|Withdrawal by Subject|0|||
23304466|NCT03918109|64858370|FG001|Overall Study|Withdrawal by Subject|0|||
23304467|NCT03918109|64858371|FG002|Overall Study|Withdrawal by Subject|2|||
23304468|NCT03918109|64858372|FG003|Overall Study|Withdrawal by Subject|1|||
23304469|NCT03918109|64858369|FG000|Overall Study|Lost to Follow-up|0|||
23304470|NCT03918109|64858370|FG001|Overall Study|Lost to Follow-up|0|||
23304471|NCT03918109|64858371|FG002|Overall Study|Lost to Follow-up|0|||
23304472|NCT03918109|64858372|FG003|Overall Study|Lost to Follow-up|1|||
23304473|NCT03760250|64858376|FG000|Overall Study|Withdrawal by Subject|1|||
23607314|NCT00413283|65950652|FG000|Overall Study|Protocol deviation|0|||
23607315|NCT00413283|65950653|FG001|Overall Study|Protocol deviation|1|||
23607316|NCT00413283|65950654|FG002|Overall Study|Protocol deviation|0|||
23607317|NCT00413283|65950655|FG003|Overall Study|Protocol deviation|0|||
23607318|NCT00413283|65950652|FG000|Overall Study|Requirement for alternative therapy|0|||
23607319|NCT00413283|65950653|FG001|Overall Study|Requirement for alternative therapy|2|||
23607320|NCT00413283|65950654|FG002|Overall Study|Requirement for alternative therapy|0|||
23607321|NCT00413283|65950655|FG003|Overall Study|Requirement for alternative therapy|0|||
23607322|NCT00413283|65950652|FG000|Overall Study|Other|0|||
23607323|NCT00413283|65950653|FG001|Overall Study|Other|0|||
23607324|NCT00413283|65950654|FG002|Overall Study|Other|1|||
23607325|NCT00413283|65950655|FG003|Overall Study|Other|0|||
23607326|NCT00886834|65950658|FG000|Overall Study|Protocol Violation|0|||
23607327|NCT00886834|65950659|FG001|Overall Study|Protocol Violation|3|||
23607328|NCT02002689|65950660|FG000|Overall Study|Disease Progression|7|||
23607329|NCT02002689|65950660|FG000|Overall Study|Adverse Event|3|||
23607330|NCT01000649|65950661|FG000|Overall Study|Adverse Event|5|||
23607331|NCT01000649|65950662|FG001|Overall Study|Adverse Event|1|||
23607332|NCT01000649|65950663|FG002|Overall Study|Adverse Event|2|||
23607333|NCT01000649|65950664|FG003|Overall Study|Adverse Event|4|||
23506105|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506106|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506107|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
23607334|NCT01000649|65950661|FG000|Overall Study|Lost to Follow-up|0|||
23607335|NCT01000649|65950662|FG001|Overall Study|Lost to Follow-up|2|||
23607336|NCT01000649|65950663|FG002|Overall Study|Lost to Follow-up|0|||
23607337|NCT01000649|65950664|FG003|Overall Study|Lost to Follow-up|2|||
23607338|NCT02442622|65950666|FG000|Overall Study|Withdrawal by Subject|3|||
23607339|NCT02442622|65950667|FG001|Overall Study|Withdrawal by Subject|1|||
23607340|NCT04131556|65950678|FG000|Overall Study|Adverse Event|1|||
23607341|NCT04131556|65950678|FG000|Overall Study|Withdrawal by Subject|1|||
23607342|NCT03031782|65950679|FG000|Treatment Period 1|Lack of Efficacy|3|||
23607343|NCT03031782|65950680|FG001|Treatment Period 1|Lack of Efficacy|0|||
23607344|NCT03031782|65950681|FG002|Treatment Period 1|Lack of Efficacy|0|||
23607345|NCT03031782|65950682|FG003|Treatment Period 1|Lack of Efficacy|0|||
23607346|NCT03031782|65950683|FG004|Treatment Period 1|Lack of Efficacy|0|||
23607347|NCT03031782|65950679|FG000|Treatment Period 2|Physician Decision|0|||
23607348|NCT03031782|65950680|FG001|Treatment Period 2|Physician Decision|1|||
23607349|NCT03031782|65950681|FG002|Treatment Period 2|Physician Decision|0|||
23607350|NCT03031782|65950682|FG003|Treatment Period 2|Physician Decision|0|||
23506108|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506109|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
23506110|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506111|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506112|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506113|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506114|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
23506115|NCT02207244|65591032|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506116|NCT02207244|65591033|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506117|NCT02207244|65591034|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506118|NCT02207244|65591035|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
23506119|NCT02207244|65591036|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506120|NCT02207244|65591037|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506121|NCT02207244|65591038|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506122|NCT02207244|65591039|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506123|NCT02207244|65591040|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506124|NCT02207244|65591041|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
23607351|NCT03031782|65950683|FG004|Treatment Period 2|Physician Decision|3|||
23607352|NCT03031782|65950679|FG000|Treatment Period 2|Lack of Efficacy|0|||
23607353|NCT03031782|65950680|FG001|Treatment Period 2|Lack of Efficacy|1|||
23607354|NCT03031782|65950681|FG002|Treatment Period 2|Lack of Efficacy|0|||
23607355|NCT03031782|65950682|FG003|Treatment Period 2|Lack of Efficacy|0|||
23304474|NCT03760250|64858376|FG000|Overall Study|Physician Decision|1|||
23304475|NCT00380692|64858377|FG000|Study Period II - Double Blind|Adverse Event|1|||
23304476|NCT00380692|64858378|FG001|Study Period II - Double Blind|Adverse Event|0|||
23304477|NCT00380692|64858377|FG000|Study Period II - Double Blind|Protocol Violation|2|||
23304478|NCT00380692|64858378|FG001|Study Period II - Double Blind|Protocol Violation|2|||
23304479|NCT00380692|64858377|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
23304480|NCT00380692|64858378|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
23304481|NCT00380692|64858377|FG000|Study Period II - Double Blind|Physician Decision|0|||
23304482|NCT00380692|64858378|FG001|Study Period II - Double Blind|Physician Decision|1|||
23304483|NCT00380692|64858377|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
23304484|NCT00380692|64858378|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
23304485|NCT00380692|64858377|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
23304486|NCT00380692|64858378|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
23304487|NCT00380692|64858377|FG000|Study Period III - Open Label|Adverse Event|5|||
23304488|NCT00380692|64858378|FG001|Study Period III - Open Label|Adverse Event|3|||
23304489|NCT00380692|64858377|FG000|Study Period III - Open Label|Protocol Violation|0|||
23304490|NCT00380692|64858378|FG001|Study Period III - Open Label|Protocol Violation|0|||
23304491|NCT00380692|64858377|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
23304492|NCT00380692|64858378|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
23304493|NCT00380692|64858377|FG000|Study Period III - Open Label|Physician Decision|0|||
23304494|NCT00380692|64858378|FG001|Study Period III - Open Label|Physician Decision|3|||
23304495|NCT00380692|64858377|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
23304496|NCT00380692|64858378|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
23304497|NCT00380692|64858377|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
23304498|NCT00380692|64858378|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
23304499|NCT00121134|64858379|FG000|Overall Study|Progression of Disease|5|||
23304500|NCT00121134|64858380|FG001|Overall Study|Progression of Disease|3|||
23304501|NCT00121134|64858381|FG002|Overall Study|Progression of Disease|4|||
23304502|NCT00121134|64858382|FG003|Overall Study|Progression of Disease|2|||
23304503|NCT00121134|64858379|FG000|Overall Study|Toxicity|4|||
23304504|NCT00121134|64858380|FG001|Overall Study|Toxicity|7|||
23304505|NCT00121134|64858381|FG002|Overall Study|Toxicity|13|||
23304506|NCT00121134|64858382|FG003|Overall Study|Toxicity|5|||
23304507|NCT00121134|64858379|FG000|Overall Study|Physician Decision|6|||
23304508|NCT00121134|64858380|FG001|Overall Study|Physician Decision|4|||
23304509|NCT00121134|64858381|FG002|Overall Study|Physician Decision|4|||
23304510|NCT00121134|64858382|FG003|Overall Study|Physician Decision|1|||
23304511|NCT00121134|64858379|FG000|Overall Study|Treatment Delay|1|||
23304512|NCT00121134|64858380|FG001|Overall Study|Treatment Delay|0|||
23304513|NCT00121134|64858381|FG002|Overall Study|Treatment Delay|0|||
23304514|NCT00121134|64858382|FG003|Overall Study|Treatment Delay|0|||
23304515|NCT00121134|64858379|FG000|Overall Study|Intercurrent Illness|0|||
23304516|NCT00121134|64858380|FG001|Overall Study|Intercurrent Illness|0|||
23304517|NCT00121134|64858381|FG002|Overall Study|Intercurrent Illness|0|||
23304518|NCT00121134|64858382|FG003|Overall Study|Intercurrent Illness|1|||
23304519|NCT00121134|64858379|FG000|Overall Study|Patient Personal Reasons|0|||
23304520|NCT00121134|64858380|FG001|Overall Study|Patient Personal Reasons|1|||
23304521|NCT00121134|64858381|FG002|Overall Study|Patient Personal Reasons|0|||
23304522|NCT00121134|64858382|FG003|Overall Study|Patient Personal Reasons|0|||
23506125|NCT02207244|65591042|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
23506126|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506127|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506128|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506129|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506130|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506131|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506132|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
23506133|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
23506134|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
23506135|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
23506136|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
23506137|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506138|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506139|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506140|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506141|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506142|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506143|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23506144|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
23506145|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23607356|NCT03031782|65950683|FG004|Treatment Period 2|Lack of Efficacy|1|||
23607357|NCT03031782|65950679|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23607358|NCT03031782|65950680|FG001|Treatment Period 2|Withdrawal by Subject|3|||
23304523|NCT02802631|64858383|FG000|Overall Study|Withdrawal by Subject|1|||
23304524|NCT02802631|64858384|FG001|Overall Study|Withdrawal by Subject|0|||
23304525|NCT02802631|64858385|FG002|Overall Study|Withdrawal by Subject|0|||
23304526|NCT02802631|64858386|FG003|Overall Study|Withdrawal by Subject|0|||
23304527|NCT02802631|64858387|FG004|Overall Study|Withdrawal by Subject|0|||
23304528|NCT02802631|64858388|FG005|Overall Study|Withdrawal by Subject|0|||
23304529|NCT02802631|64858389|FG006|Overall Study|Withdrawal by Subject|0|||
23304530|NCT02802631|64858390|FG007|Overall Study|Withdrawal by Subject|0|||
23304531|NCT02802631|64858383|FG000|Overall Study|Physician Decision|1|||
23304532|NCT02802631|64858384|FG001|Overall Study|Physician Decision|0|||
23304533|NCT02802631|64858385|FG002|Overall Study|Physician Decision|0|||
23304534|NCT02802631|64858386|FG003|Overall Study|Physician Decision|0|||
23304535|NCT02802631|64858387|FG004|Overall Study|Physician Decision|0|||
23304536|NCT02802631|64858388|FG005|Overall Study|Physician Decision|0|||
23304537|NCT02802631|64858389|FG006|Overall Study|Physician Decision|1|||
23304538|NCT02802631|64858390|FG007|Overall Study|Physician Decision|0|||
23304539|NCT02802631|64858383|FG000|Overall Study|Adverse Event|0|||
23304540|NCT02802631|64858384|FG001|Overall Study|Adverse Event|2|||
23304541|NCT02802631|64858385|FG002|Overall Study|Adverse Event|0|||
23304542|NCT02802631|64858386|FG003|Overall Study|Adverse Event|1|||
23304543|NCT02802631|64858387|FG004|Overall Study|Adverse Event|6|||
23304544|NCT02802631|64858388|FG005|Overall Study|Adverse Event|1|||
23304545|NCT02802631|64858389|FG006|Overall Study|Adverse Event|4|||
23304546|NCT02802631|64858390|FG007|Overall Study|Adverse Event|0|||
23304547|NCT02802631|64858383|FG000|Overall Study|Sponsor Decision|0|||
23304548|NCT02802631|64858384|FG001|Overall Study|Sponsor Decision|0|||
23304549|NCT02802631|64858385|FG002|Overall Study|Sponsor Decision|6|||
23304550|NCT02802631|64858386|FG003|Overall Study|Sponsor Decision|0|||
23304551|NCT02802631|64858387|FG004|Overall Study|Sponsor Decision|2|||
23304552|NCT02802631|64858388|FG005|Overall Study|Sponsor Decision|0|||
23304553|NCT02802631|64858389|FG006|Overall Study|Sponsor Decision|0|||
23304554|NCT02802631|64858390|FG007|Overall Study|Sponsor Decision|4|||
23304555|NCT02348723|64858391|FG000|Overall Study|No ablation|21|||
23304556|NCT02348723|64858392|FG001|Overall Study|No ablation|20|||
23304557|NCT02348723|64858391|FG000|Overall Study|Non-compliant with Protocol|1|||
23304558|NCT02348723|64858392|FG001|Overall Study|Non-compliant with Protocol|0|||
23304559|NCT02348723|64858391|FG000|Overall Study|Lost to Follow-up|1|||
23304560|NCT02348723|64858392|FG001|Overall Study|Lost to Follow-up|1|||
23304561|NCT02348723|64858391|FG000|Overall Study|Consent withdrawn|1|||
23304562|NCT02348723|64858392|FG001|Overall Study|Consent withdrawn|3|||
23304563|NCT02348723|64858391|FG000|Overall Study|Reason other than specified|1|||
23304564|NCT02348723|64858392|FG001|Overall Study|Reason other than specified|1|||
23304565|NCT02348723|64858391|FG000|Overall Study|Adverse Event|3|||
23304566|NCT02348723|64858392|FG001|Overall Study|Adverse Event|1|||
23304567|NCT01946191|64858400|FG000|Allocation|Did not complete orientation|1|||
23304568|NCT01946191|64858401|FG001|Allocation|Did not complete orientation|1|||
23304569|NCT01946191|64858400|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
23304570|NCT01946191|64858401|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
23304571|NCT01946191|64858400|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
23304572|NCT01946191|64858401|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
23304573|NCT01946191|64858400|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
23304574|NCT01946191|64858401|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
23304575|NCT02128217|64858402|FG000|Overall Study|Lost to Follow-up|0|||
23304576|NCT02128217|64858403|FG001|Overall Study|Lost to Follow-up|1|||
23304577|NCT03484117|64858405|FG000|Overall Study|Lost to Follow-up|1|||
23304578|NCT03484117|64858406|FG001|Overall Study|Lost to Follow-up|3|||
23304579|NCT03484117|64858405|FG000|Overall Study|Declined participation in exit assess|1|||
23304580|NCT03484117|64858406|FG001|Overall Study|Declined participation in exit assess|1|||
23304581|NCT00793780|64858413|FG000|Overall Study|Withdrawal by Subject|2|||
23304582|NCT00793780|64858414|FG001|Overall Study|Withdrawal by Subject|1|||
23304583|NCT02856880|64858415|FG000|Overall Study|Withdrawal of consent|1|||
23304584|NCT02699684|64858416|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
23304585|NCT02699684|64858417|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
23304586|NCT03514641|64858420|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
23304587|NCT03514641|64858421|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
23304588|NCT03514641|64858422|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
23304589|NCT03514641|64858423|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
23304590|NCT03514641|64858420|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
23304591|NCT03514641|64858421|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
23304592|NCT03514641|64858422|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
23304593|NCT03514641|64858423|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
23304594|NCT03514641|64858420|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
23304595|NCT03514641|64858421|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
23304596|NCT03514641|64858422|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
23304597|NCT03514641|64858423|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
23304598|NCT03514641|64858420|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
23304599|NCT03514641|64858421|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
23304600|NCT03514641|64858422|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
23304601|NCT03514641|64858423|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
23304602|NCT03514641|64858420|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
23304603|NCT03514641|64858421|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
23304604|NCT03514641|64858422|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
23304605|NCT03514641|64858423|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
23304606|NCT03514641|64858420|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
23304607|NCT03514641|64858421|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
23304608|NCT03514641|64858422|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
23304609|NCT03514641|64858423|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
23304610|NCT03514641|64858420|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
23304611|NCT03514641|64858421|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
23304612|NCT03514641|64858422|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
23304613|NCT03514641|64858423|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
23304614|NCT03514641|64858420|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
23304615|NCT03514641|64858421|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
23304616|NCT03514641|64858422|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
23304617|NCT03514641|64858423|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
23304618|NCT03514641|64858420|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
23304619|NCT03514641|64858421|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
23304620|NCT03514641|64858422|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
23304621|NCT03514641|64858423|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
23304622|NCT03514641|64858420|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
23304623|NCT03514641|64858421|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
23304624|NCT03514641|64858422|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
23304625|NCT03514641|64858423|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
23304626|NCT03514641|64858420|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
23304627|NCT03514641|64858421|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
23304628|NCT03514641|64858422|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
23304629|NCT03514641|64858423|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
23304630|NCT03514641|64858420|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
23304631|NCT03514641|64858421|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
23304632|NCT03514641|64858422|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
23304633|NCT03514641|64858423|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
23304634|NCT03582826|64858424|FG000|Overall Study|Lost to Follow-up|39|||
23304635|NCT03582826|64858425|FG001|Overall Study|Lost to Follow-up|0|||
23304636|NCT03582826|64858424|FG000|Overall Study|Withdrawal by Subject|2|||
23304637|NCT03582826|64858425|FG001|Overall Study|Withdrawal by Subject|0|||
23304638|NCT04319159|64858428|FG000|Overall Study|Screening failure|13|||
23304639|NCT04319159|64858428|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
23304640|NCT04319159|64858428|FG000|Overall Study|Withdrawal by Subject|1|||
23304641|NCT00678041|64858440|FG000|Overall Study|Physician Decision|5|||
23304642|NCT00678041|64858441|FG001|Overall Study|Physician Decision|5|||
23304643|NCT01951885|64858442|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
23304644|NCT01951885|64858443|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
23304645|NCT01951885|64858442|FG000|Overall Study|Adverse Event|1|||
23304646|NCT01951885|64858443|FG001|Overall Study|Adverse Event|0|||
23304647|NCT01951885|64858442|FG000|Overall Study|Withdrawal by Subject|0|||
23304648|NCT01951885|64858443|FG001|Overall Study|Withdrawal by Subject|1|||
23304649|NCT01951885|64858442|FG000|Overall Study|ineligible due to a change in donor|0|||
23304650|NCT01951885|64858443|FG001|Overall Study|ineligible due to a change in donor|1|||
23304651|NCT01951885|64858442|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
23304652|NCT01951885|64858443|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
23304653|NCT02533375|64858444|FG000|Overall Study|Lack of Efficacy|3|||
23304654|NCT02533375|64858444|FG000|Overall Study|Adverse Event|2|||
23304655|NCT02358343|64858445|FG000|Screening Intervention|Death|0|||
23304656|NCT02358343|64858446|FG001|Screening Intervention|Death|2|||
23304657|NCT02358343|64858447|FG002|Screening Intervention|Death|0|||
23304658|NCT02358343|64858448|FG003|Screening Intervention|Death|0|||
23304659|NCT02358343|64858449|FG004|Screening Intervention|Death|0|||
23304660|NCT02358343|64858445|FG000|Screening Intervention|Withdrawal by Subject|1|||
23304661|NCT02358343|64858446|FG001|Screening Intervention|Withdrawal by Subject|0|||
23304662|NCT02358343|64858447|FG002|Screening Intervention|Withdrawal by Subject|0|||
23304663|NCT02358343|64858448|FG003|Screening Intervention|Withdrawal by Subject|0|||
23304664|NCT02358343|64858449|FG004|Screening Intervention|Withdrawal by Subject|0|||
23406299|NCT01791517|65233720|FG008|Phase II|Withdrawal by Subject|0|||
23406300|NCT01791517|65233721|FG009|Phase II|Withdrawal by Subject|0|||
23304665|NCT02358343|64858445|FG000|Screening Intervention|Determined Ineligible|5|||
23304666|NCT02358343|64858446|FG001|Screening Intervention|Determined Ineligible|6|||
23406301|NCT01791517|65233722|FG010|Phase II|Withdrawal by Subject|1|||
23304667|NCT02358343|64858447|FG002|Screening Intervention|Determined Ineligible|0|||
23304668|NCT02358343|64858448|FG003|Screening Intervention|Determined Ineligible|0|||
23304669|NCT02358343|64858449|FG004|Screening Intervention|Determined Ineligible|0|||
23304670|NCT02358343|64858445|FG000|Comparative Efficacy Trial / Observation|Death|0|||
23304671|NCT02358343|64858446|FG001|Comparative Efficacy Trial / Observation|Death|0|||
23304672|NCT02358343|64858447|FG002|Comparative Efficacy Trial / Observation|Death|2|||
23304673|NCT02358343|64858448|FG003|Comparative Efficacy Trial / Observation|Death|0|||
23304674|NCT02358343|64858449|FG004|Comparative Efficacy Trial / Observation|Death|0|||
23304675|NCT02358343|64858445|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
23304676|NCT02358343|64858446|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
23304677|NCT02358343|64858447|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
23304678|NCT02358343|64858448|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
23304679|NCT02358343|64858449|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
23304680|NCT02358343|64858445|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
23304681|NCT02358343|64858446|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
23304682|NCT02358343|64858447|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
23304683|NCT02358343|64858448|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
23304684|NCT02358343|64858449|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
23304685|NCT00846521|64858452|FG000|Overall Study|Withdrawal by Subject|5|||
23304686|NCT00846521|64858452|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
23304687|NCT00846521|64858452|FG000|Overall Study|Protocol Violation|1|||
23304688|NCT00123474|64858453|FG000|Randomized to Treatment|Randomized, never treated|1|||
23304689|NCT00123474|64858454|FG001|Randomized to Treatment|Randomized, never treated|4|||
23304690|NCT00123474|64858455|FG002|Randomized to Treatment|Randomized, never treated|2|||
23304691|NCT00123474|64858456|FG003|Randomized to Treatment|Randomized, never treated|1|||
23304692|NCT00123474|64858453|FG000|As Treated at Study Closure|not reported when site closed|1|||
23304693|NCT00123474|64858454|FG001|As Treated at Study Closure|not reported when site closed|0|||
23304694|NCT00123474|64858455|FG002|As Treated at Study Closure|not reported when site closed|1|||
23304695|NCT00123474|64858456|FG003|As Treated at Study Closure|not reported when site closed|0|||
23304696|NCT00123474|64858453|FG000|As Treated at Study Closure|Adverse Event|10|||
23304697|NCT00123474|64858454|FG001|As Treated at Study Closure|Adverse Event|4|||
23304698|NCT00123474|64858455|FG002|As Treated at Study Closure|Adverse Event|10|||
23304699|NCT00123474|64858456|FG003|As Treated at Study Closure|Adverse Event|8|||
23304700|NCT00123474|64858453|FG000|As Treated at Study Closure|Disease Progression|35|||
23304701|NCT00123474|64858454|FG001|As Treated at Study Closure|Disease Progression|42|||
23304702|NCT00123474|64858455|FG002|As Treated at Study Closure|Disease Progression|29|||
23304703|NCT00123474|64858456|FG003|As Treated at Study Closure|Disease Progression|27|||
23304704|NCT00123474|64858453|FG000|As Treated at Study Closure|Investigator Request|12|||
23304705|NCT00123474|64858454|FG001|As Treated at Study Closure|Investigator Request|6|||
23304706|NCT00123474|64858455|FG002|As Treated at Study Closure|Investigator Request|7|||
23304707|NCT00123474|64858456|FG003|As Treated at Study Closure|Investigator Request|5|||
23304708|NCT00123474|64858453|FG000|As Treated at Study Closure|non-specified|54|||
23304709|NCT00123474|64858454|FG001|As Treated at Study Closure|non-specified|47|||
23304710|NCT00123474|64858455|FG002|As Treated at Study Closure|non-specified|57|||
23304711|NCT00123474|64858456|FG003|As Treated at Study Closure|non-specified|60|||
23304712|NCT00123474|64858453|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
23304713|NCT00123474|64858454|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
23304714|NCT00123474|64858455|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
23304715|NCT00123474|64858456|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
23304716|NCT00123474|64858453|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
23304717|NCT00123474|64858454|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
23304718|NCT00123474|64858455|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
23304719|NCT00123474|64858456|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
23304720|NCT02603393|64858461|FG000|Overall Study|Patient/guardian decision|32|||
23304721|NCT02603393|64858462|FG001|Overall Study|Patient/guardian decision|18|||
23304722|NCT02603393|64858461|FG000|Overall Study|Adverse Event|17|||
23304723|NCT02603393|64858462|FG001|Overall Study|Adverse Event|15|||
23304724|NCT02603393|64858461|FG000|Overall Study|Technical problems|4|||
23304725|NCT02603393|64858462|FG001|Overall Study|Technical problems|7|||
23304726|NCT02603393|64858461|FG000|Overall Study|Lack of Efficacy|7|||
23304727|NCT02603393|64858462|FG001|Overall Study|Lack of Efficacy|2|||
23304728|NCT02603393|64858461|FG000|Overall Study|Death|3|||
23304729|NCT02603393|64858462|FG001|Overall Study|Death|4|||
23304730|NCT02603393|64858461|FG000|Overall Study|Physician Decision|3|||
23304731|NCT02603393|64858462|FG001|Overall Study|Physician Decision|3|||
23304732|NCT02603393|64858461|FG000|Overall Study|Protocol deviation|2|||
23304733|NCT02603393|64858462|FG001|Overall Study|Protocol deviation|3|||
23304734|NCT02603393|64858461|FG000|Overall Study|Lost to Follow-up|1|||
23304735|NCT02603393|64858462|FG001|Overall Study|Lost to Follow-up|2|||
23304736|NCT02603393|64858461|FG000|Overall Study|Non-compliance with study treatment|1|||
23304737|NCT02603393|64858462|FG001|Overall Study|Non-compliance with study treatment|0|||
23304738|NCT02603393|64858461|FG000|Overall Study|Sponsor decision|1|||
23304739|NCT02603393|64858462|FG001|Overall Study|Sponsor decision|0|||
23304740|NCT04430855|64858463|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
23304741|NCT04430855|64858464|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
23304742|NCT04430855|64858463|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
23304743|NCT04430855|64858464|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
23304744|NCT04430855|64858463|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
23304745|NCT04430855|64858464|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
23304746|NCT04430855|64858463|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
23304747|NCT04430855|64858464|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
23304748|NCT04430855|64858463|FG000|Period 1 (Weeks 1-12)|Other|0|||
23304749|NCT04430855|64858464|FG001|Period 1 (Weeks 1-12)|Other|1|||
23304750|NCT04430855|64858463|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
23304751|NCT04430855|64858464|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
23304752|NCT04430855|64858463|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
23304753|NCT04430855|64858464|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
23304754|NCT04430855|64858463|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
23304755|NCT04430855|64858464|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
23304756|NCT01345175|64858467|FG000|Overall Study|Physician Decision|0|||
23304757|NCT01345175|64858468|FG001|Overall Study|Physician Decision|1|||
23304758|NCT01345175|64858467|FG000|Overall Study|Withdrawal by Subject|1|||
23304759|NCT01345175|64858468|FG001|Overall Study|Withdrawal by Subject|1|||
23304760|NCT01345175|64858467|FG000|Overall Study|Failed to complete BFI|3|||
23304761|NCT01345175|64858468|FG001|Overall Study|Failed to complete BFI|2|||
23304762|NCT01345175|64858467|FG000|Overall Study|Stopped taking medication|2|||
23304763|NCT01345175|64858468|FG001|Overall Study|Stopped taking medication|2|||
23304764|NCT01892657|64858469|FG000|Overall Study|Withdrawal by Subject|6|||
23304765|NCT01892657|64858469|FG000|Overall Study|Protocol Violation|12|||
23304766|NCT00444457|64858473|FG000|Infant Series|Other|0|||
23304767|NCT00444457|64858474|FG001|Infant Series|Other|1|||
23304768|NCT00444457|64858475|FG002|Infant Series|Other|0|||
23304769|NCT00444457|64858476|FG003|Infant Series|Other|0|||
23304770|NCT00444457|64858473|FG000|Infant Series|Parent or legal guardian request|18|||
23304771|NCT00444457|64858474|FG001|Infant Series|Parent or legal guardian request|29|||
23304772|NCT00444457|64858475|FG002|Infant Series|Parent or legal guardian request|34|||
23304773|NCT00444457|64858476|FG003|Infant Series|Parent or legal guardian request|14|||
23304774|NCT00444457|64858473|FG000|Infant Series|Lost to Follow-up|10|||
23304775|NCT00444457|64858474|FG001|Infant Series|Lost to Follow-up|11|||
23304776|NCT00444457|64858475|FG002|Infant Series|Lost to Follow-up|7|||
23304777|NCT00444457|64858476|FG003|Infant Series|Lost to Follow-up|6|||
23304778|NCT00444457|64858473|FG000|Infant Series|Protocol Violation|16|||
23304779|NCT00444457|64858474|FG001|Infant Series|Protocol Violation|8|||
23304780|NCT00444457|64858475|FG002|Infant Series|Protocol Violation|6|||
23304781|NCT00444457|64858476|FG003|Infant Series|Protocol Violation|3|||
23304782|NCT00444457|64858473|FG000|Infant Series|Failed to return|5|||
23304783|NCT00444457|64858474|FG001|Infant Series|Failed to return|4|||
23304784|NCT00444457|64858475|FG002|Infant Series|Failed to return|4|||
23304785|NCT00444457|64858476|FG003|Infant Series|Failed to return|2|||
23304786|NCT00444457|64858473|FG000|Infant Series|Investigator request|4|||
23304787|NCT00444457|64858474|FG001|Infant Series|Investigator request|3|||
23304788|NCT00444457|64858475|FG002|Infant Series|Investigator request|3|||
23304789|NCT00444457|64858476|FG003|Infant Series|Investigator request|2|||
23304790|NCT00444457|64858473|FG000|Infant Series|Other|0|||
23304791|NCT00444457|64858474|FG001|Infant Series|Other|2|||
23304792|NCT00444457|64858475|FG002|Infant Series|Other|4|||
23304793|NCT00444457|64858476|FG003|Infant Series|Other|0|||
23304794|NCT00444457|64858473|FG000|Infant Series|Adverse Event|1|||
23304795|NCT00444457|64858474|FG001|Infant Series|Adverse Event|2|||
23304796|NCT00444457|64858475|FG002|Infant Series|Adverse Event|2|||
23304797|NCT00444457|64858476|FG003|Infant Series|Adverse Event|0|||
23304798|NCT00444457|64858473|FG000|Infant Series|Death|0|||
23304799|NCT00444457|64858474|FG001|Infant Series|Death|1|||
23304800|NCT00444457|64858475|FG002|Infant Series|Death|1|||
23304801|NCT00444457|64858476|FG003|Infant Series|Death|1|||
23304802|NCT00444457|64858473|FG000|After Infant Series|Other|0|||
23304803|NCT00444457|64858474|FG001|After Infant Series|Other|1|||
23304804|NCT00444457|64858475|FG002|After Infant Series|Other|1|||
23304805|NCT00444457|64858476|FG003|After Infant Series|Other|1|||
23304806|NCT00444457|64858473|FG000|After Infant Series|Parent or legal guardian request|4|||
23304807|NCT00444457|64858474|FG001|After Infant Series|Parent or legal guardian request|11|||
23304808|NCT00444457|64858475|FG002|After Infant Series|Parent or legal guardian request|6|||
23304809|NCT00444457|64858476|FG003|After Infant Series|Parent or legal guardian request|3|||
23304810|NCT00444457|64858473|FG000|After Infant Series|Failed to return|7|||
23304811|NCT00444457|64858474|FG001|After Infant Series|Failed to return|6|||
23304812|NCT00444457|64858475|FG002|After Infant Series|Failed to return|5|||
23304813|NCT00444457|64858476|FG003|After Infant Series|Failed to return|1|||
23304814|NCT00444457|64858473|FG000|After Infant Series|Lost to Follow-up|5|||
23304815|NCT00444457|64858474|FG001|After Infant Series|Lost to Follow-up|5|||
23304816|NCT00444457|64858475|FG002|After Infant Series|Lost to Follow-up|5|||
23304817|NCT00444457|64858476|FG003|After Infant Series|Lost to Follow-up|2|||
23304818|NCT00444457|64858473|FG000|After Infant Series|Protocol Violation|2|||
23304819|NCT00444457|64858474|FG001|After Infant Series|Protocol Violation|4|||
23304820|NCT00444457|64858475|FG002|After Infant Series|Protocol Violation|2|||
23304821|NCT00444457|64858476|FG003|After Infant Series|Protocol Violation|2|||
23304822|NCT00444457|64858473|FG000|After Infant Series|Adverse Event|2|||
23304823|NCT00444457|64858474|FG001|After Infant Series|Adverse Event|2|||
23304824|NCT00444457|64858475|FG002|After Infant Series|Adverse Event|0|||
23304825|NCT00444457|64858476|FG003|After Infant Series|Adverse Event|0|||
23304826|NCT00444457|64858473|FG000|After Infant Series|Investigator request|0|||
23304827|NCT00444457|64858474|FG001|After Infant Series|Investigator request|0|||
23304828|NCT00444457|64858475|FG002|After Infant Series|Investigator request|0|||
23304829|NCT00444457|64858476|FG003|After Infant Series|Investigator request|1|||
23304830|NCT00444457|64858473|FG000|After Infant Series|Other|0|||
23304831|NCT00444457|64858474|FG001|After Infant Series|Other|1|||
23304832|NCT00444457|64858475|FG002|After Infant Series|Other|0|||
23304833|NCT00444457|64858476|FG003|After Infant Series|Other|0|||
23304834|NCT00444457|64858473|FG000|Toddler Dose|Lost to Follow-up|4|||
23304835|NCT00444457|64858474|FG001|Toddler Dose|Lost to Follow-up|1|||
23304836|NCT00444457|64858475|FG002|Toddler Dose|Lost to Follow-up|1|||
23304837|NCT00444457|64858476|FG003|Toddler Dose|Lost to Follow-up|3|||
23304838|NCT00444457|64858473|FG000|Toddler Dose|Failed to return|2|||
23304839|NCT00444457|64858474|FG001|Toddler Dose|Failed to return|2|||
23304840|NCT00444457|64858475|FG002|Toddler Dose|Failed to return|1|||
23304841|NCT00444457|64858476|FG003|Toddler Dose|Failed to return|3|||
23304842|NCT00444457|64858473|FG000|Toddler Dose|Parent or legal guardian request|0|||
23304843|NCT00444457|64858474|FG001|Toddler Dose|Parent or legal guardian request|3|||
23304844|NCT00444457|64858475|FG002|Toddler Dose|Parent or legal guardian request|2|||
23304845|NCT00444457|64858476|FG003|Toddler Dose|Parent or legal guardian request|1|||
23304846|NCT00444457|64858473|FG000|Toddler Dose|Protocol Violation|1|||
23304847|NCT00444457|64858474|FG001|Toddler Dose|Protocol Violation|0|||
23304848|NCT00444457|64858475|FG002|Toddler Dose|Protocol Violation|0|||
23304849|NCT00444457|64858476|FG003|Toddler Dose|Protocol Violation|1|||
23304850|NCT03573505|64858477|FG000|Overall Study|Adverse Event|1|||
23304851|NCT03573505|64858478|FG001|Overall Study|Adverse Event|1|||
23304852|NCT03573505|64858477|FG000|Overall Study|Consent withdrawn|0|||
23304853|NCT03573505|64858478|FG001|Overall Study|Consent withdrawn|1|||
23304854|NCT03573505|64858477|FG000|Overall Study|Disease progression|0|||
23304855|NCT03573505|64858478|FG001|Overall Study|Disease progression|1|||
23304856|NCT03573505|64858477|FG000|Overall Study|Site Terminated by Sponsor|1|||
23304857|NCT03573505|64858478|FG001|Overall Study|Site Terminated by Sponsor|1|||
23304858|NCT03573505|64858477|FG000|Overall Study|Study terminated by sponsor|50|||
23304859|NCT03573505|64858478|FG001|Overall Study|Study terminated by sponsor|45|||
23304860|NCT03573505|64858477|FG000|Overall Study|Reason not specified|0|||
23304861|NCT03573505|64858478|FG001|Overall Study|Reason not specified|1|||
23304862|NCT03573505|64858477|FG000|Overall Study|Death|0|||
23304863|NCT03573505|64858478|FG001|Overall Study|Death|4|||
23304864|NCT02534844|64858479|FG000|Part B|Withdrawal by Subject|0|||
23304865|NCT02534844|64858480|FG001|Part B|Withdrawal by Subject|0|||
23304866|NCT02534844|64858481|FG002|Part B|Withdrawal by Subject|0|||
23304867|NCT02534844|64858482|FG003|Part B|Withdrawal by Subject|0|||
23304868|NCT02534844|64858483|FG004|Part B|Withdrawal by Subject|2|||
23304869|NCT02534844|64858484|FG005|Part B|Withdrawal by Subject|1|||
23304870|NCT02987959|64858485|FG000|Overall Study|Grantor stopped supply of drugs|6|||
23304871|NCT00968799|64858486|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
23304872|NCT02093221|64858487|FG000|Overall Study|Adverse Event|1|||
23304873|NCT02093221|64858488|FG001|Overall Study|Adverse Event|0|||
23304874|NCT02093221|64858489|FG002|Overall Study|Adverse Event|0|||
23304875|NCT02093221|64858490|FG003|Overall Study|Adverse Event|0|||
23304876|NCT02093221|64858491|FG004|Overall Study|Adverse Event|0|||
23304877|NCT02093221|64858487|FG000|Overall Study|Withdrawal by Subject|1|||
23304878|NCT02093221|64858488|FG001|Overall Study|Withdrawal by Subject|1|||
23304879|NCT02093221|64858489|FG002|Overall Study|Withdrawal by Subject|4|||
23304880|NCT02093221|64858490|FG003|Overall Study|Withdrawal by Subject|1|||
23304881|NCT02093221|64858491|FG004|Overall Study|Withdrawal by Subject|1|||
23304882|NCT02093221|64858487|FG000|Overall Study|Lost to Follow-up|2|||
23304883|NCT02093221|64858488|FG001|Overall Study|Lost to Follow-up|0|||
23304884|NCT02093221|64858489|FG002|Overall Study|Lost to Follow-up|1|||
23304885|NCT02093221|64858490|FG003|Overall Study|Lost to Follow-up|1|||
23304886|NCT02093221|64858491|FG004|Overall Study|Lost to Follow-up|0|||
23304887|NCT02093221|64858487|FG000|Overall Study|Death|0|||
23506146|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23304888|NCT02093221|64858488|FG001|Overall Study|Death|1|||
23304889|NCT02093221|64858489|FG002|Overall Study|Death|0|||
23304890|NCT02093221|64858490|FG003|Overall Study|Death|0|||
23304891|NCT02093221|64858491|FG004|Overall Study|Death|0|||
23304892|NCT02093221|64858487|FG000|Overall Study|Protocol Violation|0|||
23304893|NCT02093221|64858488|FG001|Overall Study|Protocol Violation|1|||
23304894|NCT02093221|64858489|FG002|Overall Study|Protocol Violation|0|||
23304895|NCT02093221|64858490|FG003|Overall Study|Protocol Violation|0|||
23304896|NCT02093221|64858491|FG004|Overall Study|Protocol Violation|0|||
23304897|NCT02093221|64858487|FG000|Overall Study|Study termination|6|||
23304898|NCT02093221|64858488|FG001|Overall Study|Study termination|5|||
23304899|NCT02093221|64858489|FG002|Overall Study|Study termination|4|||
23304900|NCT02093221|64858490|FG003|Overall Study|Study termination|6|||
23304901|NCT02093221|64858491|FG004|Overall Study|Study termination|7|||
23304902|NCT00719849|64858494|FG000|Overall Study|Death|0|||
23304903|NCT00719849|64858495|FG001|Overall Study|Death|1|||
23304904|NCT02072148|64858496|FG000|Overall Study|withdrew prior to surgery|23|||
23304905|NCT02072148|64858497|FG001|Overall Study|withdrew prior to surgery|0|||
23304906|NCT02072148|64858498|FG002|Overall Study|withdrew prior to surgery|0|||
23304907|NCT02072148|64858496|FG000|Overall Study|Death|0|||
23304908|NCT02072148|64858497|FG001|Overall Study|Death|0|||
23304909|NCT02072148|64858498|FG002|Overall Study|Death|1|||
23304910|NCT02072148|64858496|FG000|Overall Study|Withdrawal by Subject|0|||
23304911|NCT02072148|64858497|FG001|Overall Study|Withdrawal by Subject|13|||
23304912|NCT02072148|64858498|FG002|Overall Study|Withdrawal by Subject|12|||
23304913|NCT02400671|64858501|FG000|Overall Study|Death|5|||
23304914|NCT02400671|64858502|FG001|Overall Study|Death|3|||
23304915|NCT02400671|64858503|FG002|Overall Study|Death|4|||
23304916|NCT02400671|64858501|FG000|Overall Study|Lost to Follow-up|20|||
23304917|NCT02400671|64858502|FG001|Overall Study|Lost to Follow-up|27|||
23304918|NCT02400671|64858503|FG002|Overall Study|Lost to Follow-up|24|||
23304919|NCT02400671|64858501|FG000|Overall Study|Withdrawal by Subject|2|||
23304920|NCT02400671|64858502|FG001|Overall Study|Withdrawal by Subject|2|||
23304921|NCT02400671|64858503|FG002|Overall Study|Withdrawal by Subject|0|||
23304922|NCT00848107|64858504|FG000|Overall Study|Lost to Follow-up|2|||
23304923|NCT00848107|64858504|FG000|Overall Study|Withdrawal by Subject|8|||
23304924|NCT00848107|64858504|FG000|Overall Study|Adverse Event|9|||
23304925|NCT00848107|64858504|FG000|Overall Study|Death|1|||
23304926|NCT00848107|64858504|FG000|Overall Study|Pregnancy|1|||
23304927|NCT01929031|64858505|FG000|Overall Study|Adverse Event|3|||
23304928|NCT01929031|64858506|FG001|Overall Study|Adverse Event|1|||
23304929|NCT01929031|64858507|FG002|Overall Study|Adverse Event|1|||
23304930|NCT01929031|64858508|FG003|Overall Study|Adverse Event|0|||
23304931|NCT01929031|64858509|FG004|Overall Study|Adverse Event|0|||
23304932|NCT01929031|64858510|FG005|Overall Study|Adverse Event|0|||
23304933|NCT01929031|64858505|FG000|Overall Study|Protocol Violation|1|||
23304934|NCT01929031|64858506|FG001|Overall Study|Protocol Violation|0|||
23304935|NCT01929031|64858507|FG002|Overall Study|Protocol Violation|0|||
23304936|NCT01929031|64858508|FG003|Overall Study|Protocol Violation|0|||
23304937|NCT01929031|64858509|FG004|Overall Study|Protocol Violation|0|||
23304938|NCT01929031|64858510|FG005|Overall Study|Protocol Violation|1|||
23304939|NCT01929031|64858505|FG000|Overall Study|Reason other than specified above|0|||
23304940|NCT01929031|64858506|FG001|Overall Study|Reason other than specified above|1|||
23304941|NCT01929031|64858507|FG002|Overall Study|Reason other than specified above|0|||
23304942|NCT01929031|64858508|FG003|Overall Study|Reason other than specified above|0|||
23304943|NCT01929031|64858509|FG004|Overall Study|Reason other than specified above|1|||
23304944|NCT01929031|64858510|FG005|Overall Study|Reason other than specified above|0|||
23304945|NCT02749292|64858513|FG000|Overall Study|Physician Decision|1|||
23304946|NCT02749292|64858514|FG001|Overall Study|Physician Decision|0|||
23304947|NCT02749292|64858513|FG000|Overall Study|Withdrawal by Subject|5|||
23304948|NCT02749292|64858514|FG001|Overall Study|Withdrawal by Subject|7|||
23304949|NCT02749292|64858513|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
23304950|NCT02749292|64858514|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
23304951|NCT02749292|64858513|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
23304952|NCT02749292|64858514|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
23304953|NCT02749292|64858513|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
23304954|NCT02749292|64858514|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
23304955|NCT02749292|64858513|FG000|Overall Study|Adverse Event|4|||
23304956|NCT02749292|64858514|FG001|Overall Study|Adverse Event|1|||
23304957|NCT02749292|64858513|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
23304958|NCT02749292|64858514|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
23304959|NCT02749292|64858513|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
23304960|NCT02749292|64858514|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
23304961|NCT02749292|64858513|FG000|Overall Study|Requiring glucocorticoids|0|||
23304962|NCT02749292|64858514|FG001|Overall Study|Requiring glucocorticoids|3|||
23304963|NCT02749292|64858513|FG000|Overall Study|Cancer|1|||
23304964|NCT02749292|64858514|FG001|Overall Study|Cancer|0|||
23304965|NCT01777620|64858515|FG000|Overall Study|Subject Withdrawal|1|||
23304966|NCT01777620|64858516|FG001|Overall Study|Subject Withdrawal|0|||
23506147|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
23304967|NCT03247517|64858523|FG000|Overall Study|Adverse Event|0|||
23304968|NCT03247517|64858524|FG001|Overall Study|Adverse Event|4|||
23304969|NCT03247517|64858525|FG002|Overall Study|Adverse Event|2|||
23304970|NCT03247517|64858523|FG000|Overall Study|Lost to Follow-up|2|||
23304971|NCT03247517|64858524|FG001|Overall Study|Lost to Follow-up|6|||
23304972|NCT03247517|64858525|FG002|Overall Study|Lost to Follow-up|4|||
23304973|NCT03247517|64858523|FG000|Overall Study|Consent withdrawn by caregiver|1|||
23304974|NCT03247517|64858524|FG001|Overall Study|Consent withdrawn by caregiver|4|||
23304975|NCT03247517|64858525|FG002|Overall Study|Consent withdrawn by caregiver|7|||
23304976|NCT03247517|64858523|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
23304977|NCT03247517|64858524|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
23304978|NCT03247517|64858525|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
23304979|NCT03247517|64858523|FG000|Overall Study|Protocol Violation|0|||
23304980|NCT03247517|64858524|FG001|Overall Study|Protocol Violation|2|||
23304981|NCT03247517|64858525|FG002|Overall Study|Protocol Violation|0|||
23304982|NCT03247517|64858523|FG000|Overall Study|Multiple reasons|3|||
23304983|NCT03247517|64858524|FG001|Overall Study|Multiple reasons|1|||
23304984|NCT03247517|64858525|FG002|Overall Study|Multiple reasons|0|||
23304985|NCT00986180|64858526|FG000|Overall Study|Adverse Event|21|||
23304986|NCT00986180|64858527|FG001|Overall Study|Adverse Event|23|||
23304987|NCT00986180|64858526|FG000|Overall Study|Lack of Efficacy|4|||
23304988|NCT00986180|64858527|FG001|Overall Study|Lack of Efficacy|3|||
23304989|NCT00986180|64858526|FG000|Overall Study|Lost to Follow-up|5|||
23304990|NCT00986180|64858527|FG001|Overall Study|Lost to Follow-up|7|||
23304991|NCT00986180|64858526|FG000|Overall Study|Physician Decision|1|||
23304992|NCT00986180|64858527|FG001|Overall Study|Physician Decision|3|||
23304993|NCT00986180|64858526|FG000|Overall Study|Protocol Violation|2|||
23304994|NCT00986180|64858527|FG001|Overall Study|Protocol Violation|0|||
23304995|NCT00986180|64858526|FG000|Overall Study|Withdrawal by Subject|1|||
23304996|NCT00986180|64858527|FG001|Overall Study|Withdrawal by Subject|9|||
23304997|NCT00986180|64858526|FG000|Overall Study|Miscellanies|10|||
23304998|NCT00986180|64858527|FG001|Overall Study|Miscellanies|11|||
23304999|NCT00076804|64858528|FG000|Overall Study|Death|9|||
23305000|NCT00076804|64858529|FG001|Overall Study|Death|20|||
23305001|NCT00076804|64858528|FG000|Overall Study|Lost to Follow-up|9|||
23305002|NCT00076804|64858529|FG001|Overall Study|Lost to Follow-up|9|||
23305003|NCT00076804|64858528|FG000|Overall Study|Withdrawal by Subject|10|||
23305004|NCT00076804|64858529|FG001|Overall Study|Withdrawal by Subject|8|||
23305005|NCT00076804|64858528|FG000|Overall Study|Early study Closure|32|||
23305006|NCT00076804|64858529|FG001|Overall Study|Early study Closure|32|||
23305007|NCT00197496|64858531|FG000|Baseline to Discharge|not interested|1|||
23305008|NCT00197496|64858532|FG001|Baseline to Discharge|not interested|0|||
23305009|NCT00197496|64858531|FG000|Baseline to Discharge|MRSA|1|||
23305010|NCT00197496|64858532|FG001|Baseline to Discharge|MRSA|0|||
23305011|NCT00197496|64858531|FG000|Baseline to Discharge|Physician Decision|0|||
23305012|NCT00197496|64858532|FG001|Baseline to Discharge|Physician Decision|1|||
23305013|NCT00197496|64858531|FG000|Baseline to Discharge|Protocol Violation|0|||
23305014|NCT00197496|64858532|FG001|Baseline to Discharge|Protocol Violation|1|||
23305015|NCT00197496|64858531|FG000|Follow-up|Lost to Follow-up|2|||
23305016|NCT00197496|64858532|FG001|Follow-up|Lost to Follow-up|1|||
23305017|NCT01347866|64858533|FG000|Overall Study|Death|0|||
23305018|NCT01347866|64858534|FG001|Overall Study|Death|0|||
23305019|NCT01347866|64858535|FG002|Overall Study|Death|0|||
23305020|NCT01347866|64858536|FG003|Overall Study|Death|1|||
23305021|NCT01347866|64858537|FG004|Overall Study|Death|2|||
23305022|NCT01347866|64858538|FG005|Overall Study|Death|2|||
23305023|NCT01347866|64858539|FG006|Overall Study|Death|1|||
23305024|NCT01347866|64858540|FG007|Overall Study|Death|0|||
23305025|NCT01347866|64858541|FG008|Overall Study|Death|4|||
23305026|NCT01347866|64858542|FG009|Overall Study|Death|1|||
23305027|NCT01347866|64858543|FG010|Overall Study|Death|3|||
23305028|NCT01347866|64858544|FG011|Overall Study|Death|1|||
23305029|NCT01347866|64858545|FG012|Overall Study|Death|2|||
23305030|NCT01347866|64858546|FG013|Overall Study|Death|0|||
23305031|NCT01347866|64858547|FG014|Overall Study|Death|0|||
23305032|NCT01347866|64858548|FG015|Overall Study|Death|1|||
23305033|NCT01347866|64858549|FG016|Overall Study|Death|0|||
23305034|NCT01347866|64858533|FG000|Overall Study|Lost to Follow-up|0|||
23305035|NCT01347866|64858534|FG001|Overall Study|Lost to Follow-up|0|||
23406302|NCT01791517|65233723|FG011|Phase II|Withdrawal by Subject|0|||
23506148|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23305036|NCT01347866|64858535|FG002|Overall Study|Lost to Follow-up|0|||
23305037|NCT01347866|64858536|FG003|Overall Study|Lost to Follow-up|0|||
23305038|NCT01347866|64858537|FG004|Overall Study|Lost to Follow-up|0|||
23305039|NCT01347866|64858538|FG005|Overall Study|Lost to Follow-up|0|||
23305040|NCT01347866|64858539|FG006|Overall Study|Lost to Follow-up|0|||
23305041|NCT01347866|64858540|FG007|Overall Study|Lost to Follow-up|1|||
23305042|NCT01347866|64858541|FG008|Overall Study|Lost to Follow-up|1|||
23305043|NCT01347866|64858542|FG009|Overall Study|Lost to Follow-up|0|||
23305044|NCT01347866|64858543|FG010|Overall Study|Lost to Follow-up|0|||
23305045|NCT01347866|64858544|FG011|Overall Study|Lost to Follow-up|0|||
23305046|NCT01347866|64858545|FG012|Overall Study|Lost to Follow-up|0|||
23305047|NCT01347866|64858546|FG013|Overall Study|Lost to Follow-up|0|||
23305048|NCT01347866|64858547|FG014|Overall Study|Lost to Follow-up|0|||
23305049|NCT01347866|64858548|FG015|Overall Study|Lost to Follow-up|0|||
23305050|NCT01347866|64858549|FG016|Overall Study|Lost to Follow-up|0|||
23305051|NCT01347866|64858533|FG000|Overall Study|Other|3|||
23305052|NCT01347866|64858534|FG001|Overall Study|Other|1|||
23305053|NCT01347866|64858535|FG002|Overall Study|Other|1|||
23305054|NCT01347866|64858536|FG003|Overall Study|Other|4|||
23305055|NCT01347866|64858537|FG004|Overall Study|Other|5|||
23305056|NCT01347866|64858538|FG005|Overall Study|Other|0|||
23305057|NCT01347866|64858539|FG006|Overall Study|Other|5|||
23305058|NCT01347866|64858540|FG007|Overall Study|Other|3|||
23305059|NCT01347866|64858541|FG008|Overall Study|Other|22|||
23305060|NCT01347866|64858542|FG009|Overall Study|Other|5|||
23305061|NCT01347866|64858543|FG010|Overall Study|Other|0|||
23305062|NCT01347866|64858544|FG011|Overall Study|Other|3|||
23305063|NCT01347866|64858545|FG012|Overall Study|Other|4|||
23305064|NCT01347866|64858546|FG013|Overall Study|Other|4|||
23305065|NCT01347866|64858547|FG014|Overall Study|Other|2|||
23305066|NCT01347866|64858548|FG015|Overall Study|Other|3|||
23305067|NCT01347866|64858549|FG016|Overall Study|Other|0|||
23305068|NCT01347866|64858533|FG000|Overall Study|Subject refused further follow-up|2|||
23305069|NCT01347866|64858534|FG001|Overall Study|Subject refused further follow-up|0|||
23305070|NCT01347866|64858535|FG002|Overall Study|Subject refused further follow-up|0|||
23305071|NCT01347866|64858536|FG003|Overall Study|Subject refused further follow-up|2|||
23305072|NCT01347866|64858537|FG004|Overall Study|Subject refused further follow-up|0|||
23305073|NCT01347866|64858538|FG005|Overall Study|Subject refused further follow-up|1|||
23305074|NCT01347866|64858539|FG006|Overall Study|Subject refused further follow-up|0|||
23305075|NCT01347866|64858540|FG007|Overall Study|Subject refused further follow-up|0|||
23305076|NCT01347866|64858541|FG008|Overall Study|Subject refused further follow-up|4|||
23305077|NCT01347866|64858542|FG009|Overall Study|Subject refused further follow-up|1|||
23305078|NCT01347866|64858543|FG010|Overall Study|Subject refused further follow-up|0|||
23305079|NCT01347866|64858544|FG011|Overall Study|Subject refused further follow-up|0|||
23305080|NCT01347866|64858545|FG012|Overall Study|Subject refused further follow-up|1|||
23305081|NCT01347866|64858546|FG013|Overall Study|Subject refused further follow-up|3|||
23305082|NCT01347866|64858547|FG014|Overall Study|Subject refused further follow-up|1|||
23305083|NCT01347866|64858548|FG015|Overall Study|Subject refused further follow-up|0|||
23305084|NCT01347866|64858549|FG016|Overall Study|Subject refused further follow-up|2|||
23305085|NCT03028740|64858560|FG000|Overall Study|Did not Receive Study Drug|4|||
23305086|NCT03028740|64858561|FG001|Overall Study|Did not Receive Study Drug|5|||
23305087|NCT03028740|64858560|FG000|Overall Study|Adverse Event|8|||
23305088|NCT03028740|64858561|FG001|Overall Study|Adverse Event|26|||
23305089|NCT03028740|64858560|FG000|Overall Study|Lack of Efficacy|0|||
23305090|NCT03028740|64858561|FG001|Overall Study|Lack of Efficacy|1|||
23305091|NCT03028740|64858560|FG000|Overall Study|Withdrawal by Subject|48|||
23305092|NCT03028740|64858561|FG001|Overall Study|Withdrawal by Subject|101|||
23305093|NCT03028740|64858560|FG000|Overall Study|Lost to Follow-up|30|||
23305094|NCT03028740|64858561|FG001|Overall Study|Lost to Follow-up|54|||
23305095|NCT03028740|64858560|FG000|Overall Study|Physician Decision|4|||
23305096|NCT03028740|64858561|FG001|Overall Study|Physician Decision|11|||
23305097|NCT03028740|64858560|FG000|Overall Study|Protocol Violation|4|||
23305098|NCT03028740|64858561|FG001|Overall Study|Protocol Violation|8|||
23305099|NCT03028740|64858560|FG000|Overall Study|Non-compliance with Study Drug|0|||
23305100|NCT03028740|64858561|FG001|Overall Study|Non-compliance with Study Drug|2|||
23305101|NCT03028740|64858560|FG000|Overall Study|Study Terminated by Sponsor|467|||
23305102|NCT03028740|64858561|FG001|Overall Study|Study Terminated by Sponsor|917|||
23305103|NCT03028740|64858560|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
23305104|NCT03028740|64858561|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
23305105|NCT03028740|64858560|FG000|Overall Study|Reason not Specified|1|||
23305106|NCT03028740|64858561|FG001|Overall Study|Reason not Specified|5|||
23305107|NCT02304458|64858562|FG000|Overall Study|Adverse Event|0|||
23305108|NCT02304458|64858563|FG001|Overall Study|Adverse Event|0|||
23305109|NCT02304458|64858564|FG002|Overall Study|Adverse Event|7|||
23305110|NCT02304458|64858565|FG003|Overall Study|Adverse Event|0|||
23305111|NCT02304458|64858566|FG004|Overall Study|Adverse Event|0|||
23305112|NCT02304458|64858567|FG005|Overall Study|Adverse Event|0|||
23406303|NCT01791517|65233712|FG000|Phase II|Lack of Efficacy|0|||
23406304|NCT01791517|65233713|FG001|Phase II|Lack of Efficacy|0|||
23406305|NCT01791517|65233714|FG002|Phase II|Lack of Efficacy|0|||
23406306|NCT01791517|65233715|FG003|Phase II|Lack of Efficacy|0|||
23305113|NCT02304458|64858568|FG006|Overall Study|Adverse Event|3|||
23305114|NCT02304458|64858569|FG007|Overall Study|Adverse Event|4|||
23506149|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23305115|NCT02304458|64858562|FG000|Overall Study|Death|0|||
23305116|NCT02304458|64858563|FG001|Overall Study|Death|0|||
23305117|NCT02304458|64858564|FG002|Overall Study|Death|2|||
23305118|NCT02304458|64858565|FG003|Overall Study|Death|0|||
23305119|NCT02304458|64858566|FG004|Overall Study|Death|0|||
23305120|NCT02304458|64858567|FG005|Overall Study|Death|0|||
23406307|NCT01791517|65233716|FG004|Phase II|Lack of Efficacy|1|||
23305121|NCT02304458|64858568|FG006|Overall Study|Death|1|||
23305122|NCT02304458|64858569|FG007|Overall Study|Death|0|||
23305123|NCT02304458|64858562|FG000|Overall Study|Lack of Efficacy|4|||
23305124|NCT02304458|64858563|FG001|Overall Study|Lack of Efficacy|6|||
23305125|NCT02304458|64858564|FG002|Overall Study|Lack of Efficacy|38|||
23305126|NCT02304458|64858565|FG003|Overall Study|Lack of Efficacy|5|||
23305127|NCT02304458|64858566|FG004|Overall Study|Lack of Efficacy|6|||
23305128|NCT02304458|64858567|FG005|Overall Study|Lack of Efficacy|6|||
23305129|NCT02304458|64858568|FG006|Overall Study|Lack of Efficacy|21|||
23305130|NCT02304458|64858569|FG007|Overall Study|Lack of Efficacy|4|||
23305131|NCT02304458|64858562|FG000|Overall Study|Physician Decision|2|||
23305132|NCT02304458|64858563|FG001|Overall Study|Physician Decision|0|||
23305133|NCT02304458|64858564|FG002|Overall Study|Physician Decision|16|||
23305134|NCT02304458|64858565|FG003|Overall Study|Physician Decision|1|||
23305135|NCT02304458|64858566|FG004|Overall Study|Physician Decision|0|||
23305136|NCT02304458|64858567|FG005|Overall Study|Physician Decision|0|||
23305137|NCT02304458|64858568|FG006|Overall Study|Physician Decision|3|||
23305138|NCT02304458|64858569|FG007|Overall Study|Physician Decision|0|||
23305139|NCT02304458|64858562|FG000|Overall Study|Protocol Violation|0|||
23305140|NCT02304458|64858563|FG001|Overall Study|Protocol Violation|0|||
23305141|NCT02304458|64858564|FG002|Overall Study|Protocol Violation|1|||
23305142|NCT02304458|64858565|FG003|Overall Study|Protocol Violation|0|||
23305143|NCT02304458|64858566|FG004|Overall Study|Protocol Violation|0|||
23305144|NCT02304458|64858567|FG005|Overall Study|Protocol Violation|0|||
23305145|NCT02304458|64858568|FG006|Overall Study|Protocol Violation|0|||
23305146|NCT02304458|64858569|FG007|Overall Study|Protocol Violation|0|||
23305147|NCT02304458|64858562|FG000|Overall Study|Withdrawal by Subject|1|||
23305148|NCT02304458|64858563|FG001|Overall Study|Withdrawal by Subject|0|||
23305149|NCT02304458|64858564|FG002|Overall Study|Withdrawal by Subject|7|||
23305150|NCT02304458|64858565|FG003|Overall Study|Withdrawal by Subject|0|||
23305151|NCT02304458|64858566|FG004|Overall Study|Withdrawal by Subject|0|||
23305152|NCT02304458|64858567|FG005|Overall Study|Withdrawal by Subject|0|||
23305153|NCT02304458|64858568|FG006|Overall Study|Withdrawal by Subject|1|||
23305154|NCT02304458|64858569|FG007|Overall Study|Withdrawal by Subject|0|||
23305155|NCT00319982|64858576|FG000|Overall Study|Withdrawal by Subject|1|||
23305156|NCT00319982|64858577|FG001|Overall Study|Withdrawal by Subject|0|||
23305157|NCT01565850|64858578|FG000|Overall Study|Adverse Event|0|||
23305158|NCT01565850|64858579|FG001|Overall Study|Adverse Event|1|||
23305159|NCT01565850|64858578|FG000|Overall Study|Lost to Follow-up|12|||
23305160|NCT01565850|64858579|FG001|Overall Study|Lost to Follow-up|4|||
23305161|NCT01565850|64858578|FG000|Overall Study|Investigator's Discretion|2|||
23305162|NCT01565850|64858579|FG001|Overall Study|Investigator's Discretion|1|||
23305163|NCT01565850|64858578|FG000|Overall Study|Participant noncompliance|2|||
23305164|NCT01565850|64858579|FG001|Overall Study|Participant noncompliance|0|||
23305165|NCT01565850|64858578|FG000|Overall Study|Withdrew Consent|4|||
23305166|NCT01565850|64858579|FG001|Overall Study|Withdrew Consent|2|||
23305167|NCT00361335|64858580|FG000|IV Period: Baseline to E0|Adverse Event|9|||
23305168|NCT00361335|64858581|FG001|IV Period: Baseline to E0|Adverse Event|4|||
23305169|NCT00361335|64858582|FG002|IV Period: Baseline to E0|Adverse Event|5|||
23305170|NCT00361335|64858583|FG003|IV Period: Baseline to E0|Adverse Event|9|||
23305171|NCT00361335|64858584|FG004|IV Period: Baseline to E0|Adverse Event|8|||
23305172|NCT00361335|64858585|FG005|IV Period: Baseline to E0|Adverse Event|0|||
23305173|NCT00361335|64858586|FG006|IV Period: Baseline to E0|Adverse Event|0|||
23305174|NCT00361335|64858580|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
23305175|NCT00361335|64858581|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
23305176|NCT00361335|64858582|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
23305177|NCT00361335|64858583|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
23305178|NCT00361335|64858584|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
23305179|NCT00361335|64858585|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
23305180|NCT00361335|64858586|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
23305181|NCT00361335|64858580|FG000|IV Period: Baseline to E0|Death|1|||
23305182|NCT00361335|64858581|FG001|IV Period: Baseline to E0|Death|1|||
23305183|NCT00361335|64858582|FG002|IV Period: Baseline to E0|Death|1|||
23305184|NCT00361335|64858583|FG003|IV Period: Baseline to E0|Death|1|||
23305185|NCT00361335|64858584|FG004|IV Period: Baseline to E0|Death|0|||
23305186|NCT00361335|64858585|FG005|IV Period: Baseline to E0|Death|0|||
23406308|NCT01791517|65233717|FG005|Phase II|Lack of Efficacy|0|||
23305187|NCT00361335|64858586|FG006|IV Period: Baseline to E0|Death|0|||
23305188|NCT00361335|64858580|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
23305189|NCT00361335|64858581|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
23305190|NCT00361335|64858582|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
23305191|NCT00361335|64858583|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
23305192|NCT00361335|64858584|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
23305193|NCT00361335|64858585|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
23305194|NCT00361335|64858586|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
23305195|NCT00361335|64858580|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23406309|NCT01791517|65233718|FG006|Phase II|Lack of Efficacy|0|||
23305196|NCT00361335|64858581|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23305197|NCT00361335|64858582|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
23305198|NCT00361335|64858583|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23305199|NCT00361335|64858584|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23305200|NCT00361335|64858585|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23305201|NCT00361335|64858586|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
23305202|NCT00361335|64858580|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
23305203|NCT00361335|64858581|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
23305204|NCT00361335|64858582|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
23305205|NCT00361335|64858583|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
23305206|NCT00361335|64858584|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
23305207|NCT00361335|64858585|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
23305208|NCT00361335|64858586|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
23305209|NCT00361335|64858580|FG000|IV Period: Baseline to E0|Other|2|||
23305210|NCT00361335|64858581|FG001|IV Period: Baseline to E0|Other|9|||
23305211|NCT00361335|64858582|FG002|IV Period: Baseline to E0|Other|9|||
23305212|NCT00361335|64858583|FG003|IV Period: Baseline to E0|Other|3|||
23305213|NCT00361335|64858584|FG004|IV Period: Baseline to E0|Other|2|||
23305214|NCT00361335|64858585|FG005|IV Period: Baseline to E0|Other|0|||
23305215|NCT00361335|64858586|FG006|IV Period: Baseline to E0|Other|0|||
23305216|NCT00361335|64858580|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
23305217|NCT00361335|64858581|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
23506150|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23506151|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23305218|NCT00361335|64858582|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
23305219|NCT00361335|64858583|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
23305220|NCT00361335|64858584|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
23305221|NCT00361335|64858585|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
23305222|NCT00361335|64858586|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
23305223|NCT00361335|64858580|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
23305224|NCT00361335|64858581|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
23305225|NCT00361335|64858582|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
23305226|NCT00361335|64858583|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
23305227|NCT00361335|64858584|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
23305228|NCT00361335|64858585|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
23305229|NCT00361335|64858586|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
23305230|NCT00361335|64858580|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
23305231|NCT00361335|64858581|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
23305232|NCT00361335|64858582|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
23305233|NCT00361335|64858583|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
23305234|NCT00361335|64858584|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
23305235|NCT00361335|64858585|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
23305236|NCT00361335|64858586|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
23305237|NCT00361335|64858580|FG000|SC Period: Week E0 to Week E24|Death|0|||
23305238|NCT00361335|64858581|FG001|SC Period: Week E0 to Week E24|Death|0|||
23305239|NCT00361335|64858582|FG002|SC Period: Week E0 to Week E24|Death|0|||
23305240|NCT00361335|64858583|FG003|SC Period: Week E0 to Week E24|Death|0|||
23305241|NCT00361335|64858584|FG004|SC Period: Week E0 to Week E24|Death|0|||
23305242|NCT00361335|64858585|FG005|SC Period: Week E0 to Week E24|Death|0|||
23305243|NCT00361335|64858586|FG006|SC Period: Week E0 to Week E24|Death|1|||
23305244|NCT00361335|64858580|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
23305245|NCT00361335|64858581|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
23305246|NCT00361335|64858582|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
23305247|NCT00361335|64858583|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
23305248|NCT00361335|64858584|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
23305249|NCT00361335|64858585|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
23305250|NCT00361335|64858586|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
23305251|NCT00361335|64858580|FG000|SC Period: Week E0 to Week E24|Other|1|||
23305252|NCT00361335|64858581|FG001|SC Period: Week E0 to Week E24|Other|0|||
23305253|NCT00361335|64858582|FG002|SC Period: Week E0 to Week E24|Other|0|||
23305254|NCT00361335|64858583|FG003|SC Period: Week E0 to Week E24|Other|1|||
23305255|NCT00361335|64858584|FG004|SC Period: Week E0 to Week E24|Other|0|||
23305256|NCT00361335|64858585|FG005|SC Period: Week E0 to Week E24|Other|1|||
23305257|NCT00361335|64858586|FG006|SC Period: Week E0 to Week E24|Other|2|||
23305258|NCT00361335|64858580|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23305259|NCT00361335|64858581|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23305260|NCT00361335|64858582|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
23305261|NCT00361335|64858583|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23305262|NCT00361335|64858584|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23305263|NCT00361335|64858585|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
23607359|NCT03031782|65950681|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23607360|NCT03031782|65950682|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23305264|NCT00361335|64858586|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
23305265|NCT01902628|64858587|FG000|Overall Study|Withdrawal of participant's consent|7|||
23305266|NCT01902628|64858587|FG000|Overall Study|Adverse Event|41|||
23305267|NCT01902628|64858587|FG000|Overall Study|Lost to Follow-up|35|||
23406310|NCT01791517|65233719|FG007|Phase II|Lack of Efficacy|0|||
23406311|NCT01791517|65233720|FG008|Phase II|Lack of Efficacy|0|||
23406312|NCT01791517|65233721|FG009|Phase II|Lack of Efficacy|0|||
23406313|NCT01791517|65233722|FG010|Phase II|Lack of Efficacy|0|||
23406314|NCT01791517|65233723|FG011|Phase II|Lack of Efficacy|0|||
23406315|NCT01791517|65233712|FG000|Phase II|Adverse Event|0|||
23406316|NCT01791517|65233713|FG001|Phase II|Adverse Event|0|||
23406317|NCT01791517|65233714|FG002|Phase II|Adverse Event|0|||
23406318|NCT01791517|65233715|FG003|Phase II|Adverse Event|0|||
23406319|NCT01791517|65233716|FG004|Phase II|Adverse Event|0|||
23406320|NCT01791517|65233717|FG005|Phase II|Adverse Event|0|||
23406321|NCT01791517|65233718|FG006|Phase II|Adverse Event|2|||
23406322|NCT01791517|65233719|FG007|Phase II|Adverse Event|1|||
23406323|NCT01791517|65233720|FG008|Phase II|Adverse Event|0|||
23305268|NCT00856830|64858590|FG000|Irinotecan & Bendamustine|Death|0|||
23305269|NCT00856830|64858591|FG001|Irinotecan & Bendamustine|Death|0|||
23305270|NCT00856830|64858592|FG002|Irinotecan & Bendamustine|Death|0|||
23305271|NCT00856830|64858593|FG003|Irinotecan & Bendamustine|Death|2|||
23305272|NCT00856830|64858590|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
23305273|NCT00856830|64858591|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
23305274|NCT00856830|64858592|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
23305275|NCT00856830|64858593|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
23305276|NCT01971970|64858594|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
23305277|NCT01971970|64858595|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
23305278|NCT01971970|64858594|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
23305279|NCT01971970|64858595|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
23305280|NCT01971970|64858594|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
23305281|NCT01971970|64858595|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
23305282|NCT01971970|64858594|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
23305283|NCT01971970|64858595|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
23305284|NCT01971970|64858594|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
23305285|NCT01971970|64858595|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
23305286|NCT01971970|64858594|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
23305287|NCT01971970|64858595|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
23305288|NCT01971970|64858594|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
23305289|NCT01971970|64858595|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
23305290|NCT00123955|64858600|FG000|Overall Study|Adverse Event|1|||
23305291|NCT00123955|64858601|FG001|Overall Study|Adverse Event|0|||
23305292|NCT00123955|64858600|FG000|Overall Study|Withdrawal by Subject|4|||
23305293|NCT00123955|64858601|FG001|Overall Study|Withdrawal by Subject|3|||
23305294|NCT00123955|64858600|FG000|Overall Study|Death|0|||
23305295|NCT00123955|64858601|FG001|Overall Study|Death|1|||
23305296|NCT01030341|64858602|FG000|Overall Study|Withdrawal by Subject|1|||
23305297|NCT01030341|64858602|FG000|Overall Study|Lost to Follow-up|2|||
23305298|NCT02372071|64858603|FG000|Overall Study|Protocol Violation|18|||
23305299|NCT02858492|64858606|FG000|Overall Study|Withdrawal by Subject|0|||
23305300|NCT02858492|64858607|FG001|Overall Study|Withdrawal by Subject|1|||
23305301|NCT02858492|64858608|FG002|Overall Study|Withdrawal by Subject|0|||
23305302|NCT02858492|64858609|FG003|Overall Study|Withdrawal by Subject|1|||
23305303|NCT02858492|64858606|FG000|Overall Study|Adverse Event|0|||
23305304|NCT02858492|64858607|FG001|Overall Study|Adverse Event|0|||
23305305|NCT02858492|64858608|FG002|Overall Study|Adverse Event|0|||
23305306|NCT02858492|64858609|FG003|Overall Study|Adverse Event|3|||
23305307|NCT02858492|64858606|FG000|Overall Study|Lack of Efficacy|0|||
23305308|NCT02858492|64858607|FG001|Overall Study|Lack of Efficacy|0|||
23305309|NCT02858492|64858608|FG002|Overall Study|Lack of Efficacy|0|||
23305310|NCT02858492|64858609|FG003|Overall Study|Lack of Efficacy|1|||
23305311|NCT02858492|64858606|FG000|Overall Study|Protocol defined stopping criteria|0|||
23305312|NCT02858492|64858607|FG001|Overall Study|Protocol defined stopping criteria|0|||
23305313|NCT02858492|64858608|FG002|Overall Study|Protocol defined stopping criteria|0|||
23305314|NCT02858492|64858609|FG003|Overall Study|Protocol defined stopping criteria|1|||
23305315|NCT01470612|64858610|FG000|Overall Study|Adverse Event|20|||
23305316|NCT01470612|64858611|FG001|Overall Study|Adverse Event|80|||
23305317|NCT01470612|64858610|FG000|Overall Study|Death|0|||
23305318|NCT01470612|64858611|FG001|Overall Study|Death|1|||
23305319|NCT01470612|64858610|FG000|Overall Study|Lack of Efficacy|20|||
23406324|NCT01791517|65233721|FG009|Phase II|Adverse Event|1|||
23406325|NCT01791517|65233722|FG010|Phase II|Adverse Event|0|||
23305320|NCT01470612|64858611|FG001|Overall Study|Lack of Efficacy|326|||
23406326|NCT01791517|65233723|FG011|Phase II|Adverse Event|0|||
23406327|NCT01791517|65233712|FG000|Phase II|Lens Handling Difficulties|0|||
23406328|NCT01791517|65233713|FG001|Phase II|Lens Handling Difficulties|0|||
23305321|NCT01470612|64858610|FG000|Overall Study|Lost to Follow-up|2|||
23305322|NCT01470612|64858611|FG001|Overall Study|Lost to Follow-up|5|||
23305323|NCT01470612|64858610|FG000|Overall Study|Did not meet entrance criteria|0|||
23305324|NCT01470612|64858611|FG001|Overall Study|Did not meet entrance criteria|1|||
23305325|NCT01470612|64858610|FG000|Overall Study|Pregnancy|2|||
23305326|NCT01470612|64858611|FG001|Overall Study|Pregnancy|10|||
23305327|NCT01470612|64858610|FG000|Overall Study|Protocol Violation|2|||
23305328|NCT01470612|64858611|FG001|Overall Study|Protocol Violation|7|||
23305329|NCT01470612|64858610|FG000|Overall Study|Withdrawal by Subject|24|||
23305330|NCT01470612|64858611|FG001|Overall Study|Withdrawal by Subject|79|||
23305331|NCT01470612|64858610|FG000|Overall Study|Other|14|||
23305332|NCT01470612|64858611|FG001|Overall Study|Other|156|||
23305333|NCT01335997|64858612|FG000|Period I and II|Adverse Event|63|||
23305334|NCT01335997|64858613|FG001|Period I and II|Adverse Event|43|||
23305335|NCT01335997|64858612|FG000|Period I and II|Noncompliance with Study Drug|1|||
23305336|NCT01335997|64858613|FG001|Period I and II|Noncompliance with Study Drug|1|||
23305337|NCT01335997|64858612|FG000|Period I and II|Lost to Follow-up|3|||
23305338|NCT01335997|64858613|FG001|Period I and II|Lost to Follow-up|5|||
23305339|NCT01335997|64858612|FG000|Period I and II|Withdrawal by Subject|9|||
23305340|NCT01335997|64858613|FG001|Period I and II|Withdrawal by Subject|4|||
23305341|NCT01335997|64858612|FG000|Period I and II|Study Terminated by Sponsor|406|||
23305342|NCT01335997|64858613|FG001|Period I and II|Study Terminated by Sponsor|415|||
23305343|NCT01335997|64858612|FG000|Period I and II|Protocol Violation|9|||
23305344|NCT01335997|64858613|FG001|Period I and II|Protocol Violation|10|||
23305345|NCT01335997|64858612|FG000|Period I and II|Physician Decision|2|||
23305346|NCT01335997|64858613|FG001|Period I and II|Physician Decision|1|||
23305347|NCT01335997|64858612|FG000|Period III|Adverse Event|0|||
23305348|NCT01335997|64858613|FG001|Period III|Adverse Event|2|||
23305349|NCT01335997|64858612|FG000|Period III|Study Terminated by Sponsor|77|||
23305350|NCT01335997|64858613|FG001|Period III|Study Terminated by Sponsor|76|||
23305351|NCT01335997|64858612|FG000|Period III|Protocol Violation|0|||
23305352|NCT01335997|64858613|FG001|Period III|Protocol Violation|1|||
23305353|NCT01335997|64858612|FG000|Period III|Lost to Follow-up|1|||
23305354|NCT01335997|64858613|FG001|Period III|Lost to Follow-up|0|||
23305355|NCT00643565|64858615|FG000|Overall Study|Death|12|||
23305356|NCT00643565|64858616|FG001|Overall Study|Death|11|||
23305357|NCT00643565|64858615|FG000|Overall Study|Withdrawal by Subject|4|||
23305358|NCT00643565|64858616|FG001|Overall Study|Withdrawal by Subject|1|||
23305359|NCT00643565|64858615|FG000|Overall Study|Lost to Follow-up|0|||
23305360|NCT00643565|64858616|FG001|Overall Study|Lost to Follow-up|6|||
23305361|NCT00643565|64858615|FG000|Overall Study|Other|7|||
23305362|NCT00643565|64858616|FG001|Overall Study|Other|8|||
23305363|NCT00643565|64858615|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
23305364|NCT00643565|64858616|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
23305365|NCT00643565|64858615|FG000|Overall Study|Recurrence of Disease|2|||
23305366|NCT00643565|64858616|FG001|Overall Study|Recurrence of Disease|1|||
23305367|NCT00643565|64858615|FG000|Overall Study|Progression of Disease|18|||
23305368|NCT00643565|64858616|FG001|Overall Study|Progression of Disease|14|||
23305369|NCT00643565|64858615|FG000|Overall Study|Protocol Violation|3|||
23305370|NCT00643565|64858616|FG001|Overall Study|Protocol Violation|0|||
23305371|NCT00643565|64858615|FG000|Overall Study|Did Not Cooperate|0|||
23305372|NCT00643565|64858616|FG001|Overall Study|Did Not Cooperate|1|||
23305373|NCT00643565|64858615|FG000|Overall Study|Administrative|22|||
23305374|NCT00643565|64858616|FG001|Overall Study|Administrative|16|||
23305375|NCT00643565|64858615|FG000|Overall Study|Adverse Event|5|||
23305376|NCT00643565|64858616|FG001|Overall Study|Adverse Event|8|||
23305377|NCT02229539|64858617|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
23305378|NCT02229539|64858618|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
23305379|NCT02229539|64858619|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
23305380|NCT02229539|64858617|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
23305381|NCT02229539|64858618|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
23305382|NCT02229539|64858619|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
23305383|NCT02229539|64858617|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
23305384|NCT02229539|64858618|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
23305385|NCT02229539|64858619|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
23305386|NCT02229539|64858617|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
23305387|NCT02229539|64858618|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
23305388|NCT02229539|64858619|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
23305389|NCT02229539|64858617|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
23305390|NCT02229539|64858618|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
23406329|NCT01791517|65233714|FG002|Phase II|Lens Handling Difficulties|0|||
23406330|NCT01791517|65233715|FG003|Phase II|Lens Handling Difficulties|0|||
23305391|NCT02229539|64858619|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
23305392|NCT02229539|64858617|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
23305393|NCT02229539|64858618|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
23305394|NCT02229539|64858619|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
23305395|NCT02229539|64858617|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
23305396|NCT02229539|64858618|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
23305397|NCT02229539|64858619|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
23305398|NCT02229539|64858617|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
23305399|NCT02229539|64858618|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
23305400|NCT02229539|64858619|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
23305401|NCT02229539|64858617|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
23305402|NCT02229539|64858618|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
23305403|NCT02229539|64858619|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
23305404|NCT03071094|64862285|FG000|Overall Study|Death|1|||
23305405|NCT03071094|64862286|FG001|Overall Study|Death|1|||
23305406|NCT03071094|64862285|FG000|Overall Study|Adverse Event|1|||
23305407|NCT03071094|64862286|FG001|Overall Study|Adverse Event|0|||
23305408|NCT01173471|64862287|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23305409|NCT01173471|64862288|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23305410|NCT01173471|64862289|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23305411|NCT01173471|64862290|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23305412|NCT01173471|64862287|FG000|Overall Study|Condition under investigation worsened|2|||
23305413|NCT01173471|64862288|FG001|Overall Study|Condition under investigation worsened|0|||
23305414|NCT01173471|64862289|FG002|Overall Study|Condition under investigation worsened|0|||
23305415|NCT01173471|64862290|FG003|Overall Study|Condition under investigation worsened|0|||
23305416|NCT01173471|64862287|FG000|Overall Study|Lost to Follow-up|0|||
23305417|NCT01173471|64862288|FG001|Overall Study|Lost to Follow-up|0|||
23305418|NCT01173471|64862289|FG002|Overall Study|Lost to Follow-up|1|||
23305419|NCT01173471|64862290|FG003|Overall Study|Lost to Follow-up|0|||
23305420|NCT01173471|64862287|FG000|Overall Study|Reason given as Other|0|||
23305421|NCT01173471|64862288|FG001|Overall Study|Reason given as Other|0|||
23305422|NCT01173471|64862289|FG002|Overall Study|Reason given as Other|1|||
23305423|NCT01173471|64862290|FG003|Overall Study|Reason given as Other|0|||
23305424|NCT02034058|64862291|FG000|Overall Study|Death|3|||
23305425|NCT00270257|64862294|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
23305426|NCT00270257|64862295|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
23305427|NCT01732874|64862296|FG000|Overall Study|Withdrawal by Subject|5|||
23305428|NCT01732874|64862297|FG001|Overall Study|Withdrawal by Subject|1|||
23305429|NCT01732874|64862296|FG000|Overall Study|Death of Infant|3|||
23305430|NCT01732874|64862297|FG001|Overall Study|Death of Infant|2|||
23305431|NCT02582866|64862298|FG000|Overall Study|Death|1|||
23305432|NCT02582866|64862298|FG000|Overall Study|Lack of Efficacy|2|||
23305433|NCT02582866|64862298|FG000|Overall Study|Lost to Follow-up|2|||
23305434|NCT02582866|64862298|FG000|Overall Study|Withdrawal by Subject|7|||
23305435|NCT02582866|64862298|FG000|Overall Study|Investigator decision|5|||
23305436|NCT02582866|64862298|FG000|Overall Study|Participant wants to get pregnant|1|||
23305437|NCT02582866|64862298|FG000|Overall Study|Pregnancy|2|||
23305438|NCT02582866|64862298|FG000|Overall Study|Sponsor decision|1|||
23305439|NCT02582866|64862298|FG000|Overall Study|Withdrawal due to personal reasons|1|||
23305440|NCT01553279|64862299|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
23305441|NCT01553279|64862300|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
23305442|NCT01553279|64862299|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
23305443|NCT01553279|64862300|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
23305444|NCT01553279|64862299|FG000|Interim Period|Withdrawal by Subject|2|||
23305445|NCT01553279|64862300|FG001|Interim Period|Withdrawal by Subject|2|||
23305446|NCT01553279|64862299|FG000|Interim Period|Lost to Follow-up|1|||
23305447|NCT01553279|64862300|FG001|Interim Period|Lost to Follow-up|0|||
23305448|NCT01553279|64862299|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
23305449|NCT01553279|64862300|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
23305450|NCT01553279|64862299|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
23305451|NCT01553279|64862300|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
23305452|NCT02338193|64862312|FG000|Overall Study|Withdrawal by Subject|0|||
23305453|NCT02338193|64862313|FG001|Overall Study|Withdrawal by Subject|0|||
23305454|NCT02338193|64862314|FG002|Overall Study|Withdrawal by Subject|2|||
23305455|NCT02338193|64862312|FG000|Overall Study|Pregnancy|0|||
23305456|NCT02338193|64862313|FG001|Overall Study|Pregnancy|1|||
23305457|NCT02338193|64862314|FG002|Overall Study|Pregnancy|1|||
23305458|NCT02338193|64862312|FG000|Overall Study|Noncompliant with visits|2|||
23305459|NCT02338193|64862313|FG001|Overall Study|Noncompliant with visits|2|||
23305460|NCT02338193|64862314|FG002|Overall Study|Noncompliant with visits|7|||
23305461|NCT02338193|64862312|FG000|Overall Study|moved out of state|0|||
23305462|NCT02338193|64862313|FG001|Overall Study|moved out of state|1|||
23305463|NCT02338193|64862314|FG002|Overall Study|moved out of state|0|||
23305464|NCT02338193|64862312|FG000|Overall Study|intolerant of side effects|1|||
23305465|NCT02338193|64862313|FG001|Overall Study|intolerant of side effects|0|||
23305466|NCT02338193|64862314|FG002|Overall Study|intolerant of side effects|0|||
23305467|NCT01855074|64862323|FG000|Overall Study|Adverse Event|1|||
23305468|NCT01855074|64862323|FG000|Overall Study|Lost to Follow-up|4|||
23305469|NCT01855074|64862323|FG000|Overall Study|Withdrawal by Subject|8|||
23305470|NCT01855074|64862323|FG000|Overall Study|Started but not treated|1|||
23305471|NCT01642914|64862325|FG000|Overall Study|Adverse Event|11|||
23305472|NCT01642914|64862326|FG001|Overall Study|Adverse Event|7|||
23305473|NCT01642914|64862327|FG002|Overall Study|Adverse Event|15|||
23305474|NCT01642914|64862325|FG000|Overall Study|Lack of Efficacy|9|||
23305475|NCT01642914|64862326|FG001|Overall Study|Lack of Efficacy|4|||
23305476|NCT01642914|64862327|FG002|Overall Study|Lack of Efficacy|2|||
23305477|NCT01642914|64862325|FG000|Overall Study|Protocol Violation|15|||
23305478|NCT01642914|64862326|FG001|Overall Study|Protocol Violation|13|||
23406331|NCT01791517|65233716|FG004|Phase II|Lens Handling Difficulties|0|||
23406332|NCT01791517|65233717|FG005|Phase II|Lens Handling Difficulties|0|||
23406333|NCT01791517|65233718|FG006|Phase II|Lens Handling Difficulties|0|||
23406334|NCT01791517|65233719|FG007|Phase II|Lens Handling Difficulties|0|||
23406335|NCT01791517|65233720|FG008|Phase II|Lens Handling Difficulties|1|||
23406336|NCT01791517|65233721|FG009|Phase II|Lens Handling Difficulties|0|||
23406337|NCT01791517|65233722|FG010|Phase II|Lens Handling Difficulties|0|||
23406338|NCT01791517|65233723|FG011|Phase II|Lens Handling Difficulties|0|||
23305479|NCT01642914|64862327|FG002|Overall Study|Protocol Violation|6|||
23406339|NCT01791517|65233712|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
23406340|NCT01791517|65233713|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
23305480|NCT01642914|64862325|FG000|Overall Study|Withdrawal by Subject|5|||
23305481|NCT01642914|64862326|FG001|Overall Study|Withdrawal by Subject|5|||
23305482|NCT01642914|64862327|FG002|Overall Study|Withdrawal by Subject|10|||
23305483|NCT01642914|64862325|FG000|Overall Study|Lost to Follow-up|5|||
23305484|NCT01642914|64862326|FG001|Overall Study|Lost to Follow-up|3|||
23305485|NCT01642914|64862327|FG002|Overall Study|Lost to Follow-up|7|||
23305486|NCT01642914|64862325|FG000|Overall Study|Other Reason|1|||
23305487|NCT01642914|64862326|FG001|Overall Study|Other Reason|0|||
23305488|NCT01642914|64862327|FG002|Overall Study|Other Reason|0|||
23305489|NCT00450619|64862329|FG000|Overall Study|refused treatment after randomization|2|||
23305490|NCT00450619|64862330|FG001|Overall Study|refused treatment after randomization|0|||
23305491|NCT00450619|64862329|FG000|Overall Study|did not progress; refused further trmt|1|||
23305492|NCT00450619|64862330|FG001|Overall Study|did not progress; refused further trmt|1|||
23305493|NCT00450619|64862329|FG000|Overall Study|Adverse Event|1|||
23406341|NCT01791517|65233714|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
23406342|NCT01791517|65233715|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
23305494|NCT00450619|64862330|FG001|Overall Study|Adverse Event|0|||
23305495|NCT04639713|64862331|FG000|Overall Study|Protocol Noncompliance|2|||
23305496|NCT04639713|64862331|FG000|Overall Study|Withdrawal by Subject|1|||
23305497|NCT01403064|64862332|FG000|Overall Study|Death|0|||
23305498|NCT01403064|64862333|FG001|Overall Study|Death|0|||
23305499|NCT01403064|64862334|FG002|Overall Study|Death|1|||
23305500|NCT01403064|64862335|FG003|Overall Study|Death|1|||
23305501|NCT01403064|64862332|FG000|Overall Study|Withdrawal by Subject|0|||
23406343|NCT01791517|65233716|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
23406344|NCT01791517|65233717|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
23406345|NCT01791517|65233718|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
23406346|NCT01791517|65233719|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
23406347|NCT01791517|65233720|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
23406348|NCT01791517|65233721|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
23406349|NCT01791517|65233722|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
23406350|NCT01791517|65233723|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
23406351|NCT01791517|65233712|FG000|Phase II|Pre-Existing Ocular Issue|0|||
23406352|NCT01791517|65233713|FG001|Phase II|Pre-Existing Ocular Issue|0|||
23406353|NCT01791517|65233714|FG002|Phase II|Pre-Existing Ocular Issue|0|||
23406354|NCT01791517|65233715|FG003|Phase II|Pre-Existing Ocular Issue|0|||
23406355|NCT01791517|65233716|FG004|Phase II|Pre-Existing Ocular Issue|0|||
23406356|NCT01791517|65233717|FG005|Phase II|Pre-Existing Ocular Issue|0|||
23406357|NCT01791517|65233718|FG006|Phase II|Pre-Existing Ocular Issue|0|||
23406358|NCT01791517|65233719|FG007|Phase II|Pre-Existing Ocular Issue|0|||
23406359|NCT01791517|65233720|FG008|Phase II|Pre-Existing Ocular Issue|0|||
23406360|NCT01791517|65233721|FG009|Phase II|Pre-Existing Ocular Issue|0|||
23406361|NCT01791517|65233722|FG010|Phase II|Pre-Existing Ocular Issue|0|||
23406362|NCT01791517|65233723|FG011|Phase II|Pre-Existing Ocular Issue|1|||
23406363|NCT01694433|65233724|FG000|Overall Study|Adverse Event|7|||
23406364|NCT01694433|65233725|FG001|Overall Study|Adverse Event|0|||
23406365|NCT01694433|65233724|FG000|Overall Study|Physician Decision|1|||
23406366|NCT01694433|65233725|FG001|Overall Study|Physician Decision|0|||
23406367|NCT01694433|65233724|FG000|Overall Study|Withdrawal by Subject|3|||
23406368|NCT01694433|65233725|FG001|Overall Study|Withdrawal by Subject|4|||
23406369|NCT03456700|65233726|FG000|Overall Study|Withdrawal by Subject|1|||
23406370|NCT02336815|65233727|FG000|Overall Study|Disease Progression|45|||
23305502|NCT01403064|64862333|FG001|Overall Study|Withdrawal by Subject|0|||
23406371|NCT02336815|65233728|FG001|Overall Study|Disease Progression|70|||
23406372|NCT02336815|65233727|FG000|Overall Study|Adverse Event|18|||
23406373|NCT02336815|65233728|FG001|Overall Study|Adverse Event|39|||
23406374|NCT02336815|65233727|FG000|Overall Study|Physician Decision|11|||
23406375|NCT02336815|65233728|FG001|Overall Study|Physician Decision|4|||
23406376|NCT02336815|65233727|FG000|Overall Study|Withdrawal by Subject|3|||
23406377|NCT02336815|65233728|FG001|Overall Study|Withdrawal by Subject|2|||
23406378|NCT02336815|65233727|FG000|Overall Study|Lost to Follow-up|1|||
23406379|NCT02336815|65233728|FG001|Overall Study|Lost to Follow-up|3|||
23406380|NCT02336815|65233727|FG000|Overall Study|Other|1|||
23406381|NCT02336815|65233728|FG001|Overall Study|Other|5|||
23406382|NCT02131662|65233729|FG000|Overall Study|Protocol Violation|1|||
23406383|NCT02131662|65233730|FG001|Overall Study|Protocol Violation|0|||
23406384|NCT02131662|65233731|FG002|Overall Study|Protocol Violation|0|||
23406385|NCT02131662|65233732|FG003|Overall Study|Protocol Violation|0|||
23406386|NCT02131662|65233733|FG004|Overall Study|Protocol Violation|0|||
23406387|NCT02131662|65233729|FG000|Overall Study|Other|2|||
23406388|NCT02131662|65233730|FG001|Overall Study|Other|4|||
23406389|NCT02131662|65233731|FG002|Overall Study|Other|3|||
23406390|NCT02131662|65233732|FG003|Overall Study|Other|3|||
23406391|NCT02131662|65233733|FG004|Overall Study|Other|4|||
23305503|NCT01403064|64862334|FG002|Overall Study|Withdrawal by Subject|1|||
23305504|NCT01403064|64862335|FG003|Overall Study|Withdrawal by Subject|1|||
23305505|NCT01403064|64862332|FG000|Overall Study|Other|1|||
23305506|NCT01403064|64862333|FG001|Overall Study|Other|0|||
23305507|NCT01403064|64862334|FG002|Overall Study|Other|2|||
23305508|NCT01403064|64862335|FG003|Overall Study|Other|1|||
23305509|NCT01287039|64862336|FG000|Overall Study|Noncompliance with study procedures|0|||
23305510|NCT01287039|64862337|FG001|Overall Study|Noncompliance with study procedures|1|||
23305511|NCT01287039|64862336|FG000|Overall Study|Change of location/residence|0|||
23305512|NCT01287039|64862337|FG001|Overall Study|Change of location/residence|3|||
23305513|NCT01287039|64862336|FG000|Overall Study|Elective surgery|0|||
23305514|NCT01287039|64862337|FG001|Overall Study|Elective surgery|1|||
23305515|NCT01287039|64862336|FG000|Overall Study|Protocol Violation|2|||
23305516|NCT01287039|64862337|FG001|Overall Study|Protocol Violation|3|||
23305517|NCT01287039|64862336|FG000|Overall Study|Excluded medication taken|1|||
23305518|NCT01287039|64862337|FG001|Overall Study|Excluded medication taken|0|||
23305519|NCT01287039|64862336|FG000|Overall Study|Noncompliance with study medication|0|||
23305520|NCT01287039|64862337|FG001|Overall Study|Noncompliance with study medication|1|||
23305521|NCT01287039|64862336|FG000|Overall Study|Problem with travel|0|||
23305522|NCT01287039|64862337|FG001|Overall Study|Problem with travel|1|||
23305523|NCT01287039|64862336|FG000|Overall Study|Death|1|||
23305524|NCT01287039|64862337|FG001|Overall Study|Death|0|||
23305525|NCT01287039|64862336|FG000|Overall Study|Change of residence|1|||
23305526|NCT01287039|64862337|FG001|Overall Study|Change of residence|0|||
23305527|NCT01287039|64862336|FG000|Overall Study|Adverse Event|7|||
23305528|NCT01287039|64862337|FG001|Overall Study|Adverse Event|4|||
23305529|NCT01287039|64862336|FG000|Overall Study|Withdrawal by Subject|14|||
23305530|NCT01287039|64862337|FG001|Overall Study|Withdrawal by Subject|11|||
23305531|NCT01287039|64862336|FG000|Overall Study|Lost to Follow-up|3|||
23305532|NCT01287039|64862337|FG001|Overall Study|Lost to Follow-up|2|||
23305533|NCT02006628|64862338|FG000|Overall Study|Adverse Event|1|||
23305534|NCT02006628|64862339|FG001|Overall Study|Adverse Event|1|||
23305535|NCT02006628|64862338|FG000|Overall Study|Withdrawal by Subject|2|||
23305536|NCT02006628|64862339|FG001|Overall Study|Withdrawal by Subject|1|||
23305537|NCT03276221|64862340|FG000|Overall Study|Lost to Follow-up|6|||
23305538|NCT03276221|64862341|FG001|Overall Study|Lost to Follow-up|2|||
23305539|NCT03276221|64862342|FG002|Overall Study|Lost to Follow-up|0|||
23305540|NCT03276221|64862340|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
23305541|NCT03276221|64862341|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
23305542|NCT03276221|64862342|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
23305543|NCT01346774|64862344|FG000|Overall Study|Did not take a single dose|6|||
23305544|NCT01346774|64862345|FG001|Overall Study|Did not take a single dose|4|||
23305545|NCT01346774|64862344|FG000|Overall Study|Lost to Follow-up|3|||
23305546|NCT01346774|64862345|FG001|Overall Study|Lost to Follow-up|4|||
23305547|NCT01346774|64862344|FG000|Overall Study|Withdrawal by Subject|1|||
23305548|NCT01346774|64862345|FG001|Overall Study|Withdrawal by Subject|4|||
23305549|NCT01346774|64862344|FG000|Overall Study|Protocol Violation|2|||
23305550|NCT01346774|64862345|FG001|Overall Study|Protocol Violation|3|||
23406392|NCT02131662|65233729|FG000|Overall Study|Adverse Event|0|||
23406393|NCT02131662|65233730|FG001|Overall Study|Adverse Event|1|||
23406394|NCT02131662|65233731|FG002|Overall Study|Adverse Event|1|||
23406395|NCT02131662|65233732|FG003|Overall Study|Adverse Event|1|||
23406396|NCT02131662|65233733|FG004|Overall Study|Adverse Event|3|||
23406397|NCT02131662|65233729|FG000|Overall Study|Pregnancy|0|||
23406398|NCT02131662|65233730|FG001|Overall Study|Pregnancy|1|||
23406399|NCT02131662|65233731|FG002|Overall Study|Pregnancy|0|||
23305551|NCT01346774|64862344|FG000|Overall Study|Adverse Event|1|||
23406400|NCT02131662|65233732|FG003|Overall Study|Pregnancy|1|||
23406401|NCT02131662|65233733|FG004|Overall Study|Pregnancy|0|||
23406402|NCT02131662|65233729|FG000|Overall Study|Wish for pregnancy|0|||
23406403|NCT02131662|65233730|FG001|Overall Study|Wish for pregnancy|0|||
23406404|NCT02131662|65233731|FG002|Overall Study|Wish for pregnancy|0|||
23406405|NCT02131662|65233732|FG003|Overall Study|Wish for pregnancy|0|||
23406406|NCT02131662|65233733|FG004|Overall Study|Wish for pregnancy|1|||
23406407|NCT02131662|65233729|FG000|Overall Study|Lack of Efficacy|1|||
23406408|NCT02131662|65233730|FG001|Overall Study|Lack of Efficacy|0|||
23406409|NCT02131662|65233731|FG002|Overall Study|Lack of Efficacy|0|||
23406410|NCT02131662|65233732|FG003|Overall Study|Lack of Efficacy|0|||
23406411|NCT02131662|65233733|FG004|Overall Study|Lack of Efficacy|1|||
23406412|NCT02131662|65233729|FG000|Overall Study|Withdrawal by Subject|1|||
23406413|NCT02131662|65233730|FG001|Overall Study|Withdrawal by Subject|5|||
23406414|NCT02131662|65233731|FG002|Overall Study|Withdrawal by Subject|1|||
23406415|NCT02131662|65233732|FG003|Overall Study|Withdrawal by Subject|5|||
23406416|NCT02131662|65233733|FG004|Overall Study|Withdrawal by Subject|6|||
23406417|NCT02131662|65233729|FG000|Overall Study|Lost to Follow-up|1|||
23406418|NCT02131662|65233730|FG001|Overall Study|Lost to Follow-up|3|||
23406419|NCT02131662|65233731|FG002|Overall Study|Lost to Follow-up|0|||
23406420|NCT02131662|65233732|FG003|Overall Study|Lost to Follow-up|9|||
23406421|NCT02131662|65233733|FG004|Overall Study|Lost to Follow-up|0|||
23406422|NCT02131662|65233729|FG000|Overall Study|Not treated|2|||
23406423|NCT02131662|65233730|FG001|Overall Study|Not treated|0|||
23406424|NCT02131662|65233731|FG002|Overall Study|Not treated|2|||
23406425|NCT02131662|65233732|FG003|Overall Study|Not treated|2|||
23406426|NCT02131662|65233733|FG004|Overall Study|Not treated|3|||
23406427|NCT03943290|65233734|FG000|Overall Study|Sponsor Terminated Study|6|||
23406428|NCT03943290|65233735|FG001|Overall Study|Sponsor Terminated Study|1|||
23406429|NCT03943290|65233736|FG002|Overall Study|Sponsor Terminated Study|11|||
23406430|NCT03943290|65233737|FG003|Overall Study|Sponsor Terminated Study|6|||
23406431|NCT03943290|65233738|FG004|Overall Study|Sponsor Terminated Study|7|||
23406432|NCT03943290|65233739|FG005|Overall Study|Sponsor Terminated Study|6|||
23406433|NCT03943290|65233740|FG006|Overall Study|Sponsor Terminated Study|6|||
23406434|NCT03943290|65233741|FG007|Overall Study|Sponsor Terminated Study|7|||
23406435|NCT03943290|65233742|FG008|Overall Study|Sponsor Terminated Study|8|||
23406436|NCT03943290|65233734|FG000|Overall Study|Lost to Follow-up|1|||
23406437|NCT03943290|65233735|FG001|Overall Study|Lost to Follow-up|0|||
23406438|NCT03943290|65233736|FG002|Overall Study|Lost to Follow-up|1|||
23406439|NCT03943290|65233737|FG003|Overall Study|Lost to Follow-up|0|||
23406440|NCT03943290|65233738|FG004|Overall Study|Lost to Follow-up|0|||
23406441|NCT03943290|65233739|FG005|Overall Study|Lost to Follow-up|0|||
23406442|NCT03943290|65233740|FG006|Overall Study|Lost to Follow-up|0|||
23406443|NCT03943290|65233741|FG007|Overall Study|Lost to Follow-up|1|||
23406444|NCT03943290|65233742|FG008|Overall Study|Lost to Follow-up|0|||
23406445|NCT03943290|65233734|FG000|Overall Study|Withdrawal by Subject|0|||
23406446|NCT03943290|65233735|FG001|Overall Study|Withdrawal by Subject|0|||
23406447|NCT03943290|65233736|FG002|Overall Study|Withdrawal by Subject|1|||
23406448|NCT03943290|65233737|FG003|Overall Study|Withdrawal by Subject|0|||
23406449|NCT03943290|65233738|FG004|Overall Study|Withdrawal by Subject|0|||
23406450|NCT03943290|65233739|FG005|Overall Study|Withdrawal by Subject|0|||
23406451|NCT03943290|65233740|FG006|Overall Study|Withdrawal by Subject|0|||
23406452|NCT03943290|65233741|FG007|Overall Study|Withdrawal by Subject|0|||
23406453|NCT03943290|65233742|FG008|Overall Study|Withdrawal by Subject|0|||
23406454|NCT03154476|65233743|FG000|Overall Study|Lost to Follow-up|4|||
23406455|NCT03154476|65233744|FG001|Overall Study|Lost to Follow-up|4|||
23406456|NCT00120627|65233748|FG000|Overall Study|Withdrawal by Subject|5|||
23406457|NCT00120627|65233749|FG001|Overall Study|Withdrawal by Subject|5|||
23406458|NCT01637584|65233750|FG000|Overall Study|Withdrawal by Subject|1|||
23406459|NCT01637584|65233751|FG001|Overall Study|Withdrawal by Subject|3|||
23406460|NCT00925002|65233755|FG000|Overall Study|Other|1|||
23406461|NCT00925002|65233756|FG001|Overall Study|Other|4|||
23406462|NCT00925002|65233757|FG002|Overall Study|Other|0|||
23406463|NCT00925002|65233755|FG000|Overall Study|Death|1|||
23406464|NCT00925002|65233756|FG001|Overall Study|Death|1|||
23406465|NCT00925002|65233757|FG002|Overall Study|Death|5|||
23406466|NCT00925002|65233755|FG000|Overall Study|Adverse Event|3|||
23406467|NCT00925002|65233756|FG001|Overall Study|Adverse Event|1|||
23406468|NCT00925002|65233757|FG002|Overall Study|Adverse Event|2|||
23406469|NCT00925002|65233755|FG000|Overall Study|Participant withdrew consent|1|||
23406470|NCT00925002|65233756|FG001|Overall Study|Participant withdrew consent|3|||
23406471|NCT00925002|65233757|FG002|Overall Study|Participant withdrew consent|3|||
23406472|NCT01277822|65233761|FG000|Overall Study|Adverse Event|2|||
23406473|NCT01277822|65233762|FG001|Overall Study|Adverse Event|1|||
23406474|NCT01277822|65233761|FG000|Overall Study|Withdrawal by Subject|6|||
23406475|NCT01277822|65233762|FG001|Overall Study|Withdrawal by Subject|7|||
23406476|NCT01277822|65233761|FG000|Overall Study|Physician Decision|1|||
23406477|NCT01277822|65233762|FG001|Overall Study|Physician Decision|1|||
23406478|NCT01277822|65233761|FG000|Overall Study|Protocol Violation|1|||
23406479|NCT01277822|65233762|FG001|Overall Study|Protocol Violation|0|||
23406480|NCT01277822|65233761|FG000|Overall Study|Lost to Follow-up|2|||
23406481|NCT01277822|65233762|FG001|Overall Study|Lost to Follow-up|1|||
23406482|NCT01277822|65233761|FG000|Overall Study|Contraindicated medication used|2|||
23406483|NCT01277822|65233762|FG001|Overall Study|Contraindicated medication used|1|||
23406484|NCT01277822|65233761|FG000|Overall Study|Participant moved|1|||
23406485|NCT01277822|65233762|FG001|Overall Study|Participant moved|0|||
23406486|NCT01737762|65233767|FG000|Overall Study|Adverse Event|2|||
23406487|NCT01737762|65233768|FG001|Overall Study|Adverse Event|2|||
23406488|NCT01737762|65233767|FG000|Overall Study|Lost to Follow-up|1|||
23406489|NCT01737762|65233768|FG001|Overall Study|Lost to Follow-up|0|||
23406490|NCT01737762|65233767|FG000|Overall Study|Withdrawal by Subject|2|||
23406491|NCT01737762|65233768|FG001|Overall Study|Withdrawal by Subject|2|||
23406492|NCT01737762|65233767|FG000|Overall Study|Progressive disease|1|||
23406493|NCT01737762|65233768|FG001|Overall Study|Progressive disease|2|||
23406494|NCT01737762|65233767|FG000|Overall Study|Physician Decision|1|||
23406495|NCT01737762|65233768|FG001|Overall Study|Physician Decision|1|||
23406496|NCT01737762|65233767|FG000|Overall Study|Moved from area|2|||
23406497|NCT01737762|65233768|FG001|Overall Study|Moved from area|1|||
23406498|NCT01737762|65233767|FG000|Overall Study|Trial termination|11|||
23406499|NCT01737762|65233768|FG001|Overall Study|Trial termination|9|||
23406500|NCT00819156|65233769|FG000|Overall Study|Adverse Event|1|||
23406501|NCT00819156|65233770|FG001|Overall Study|Adverse Event|4|||
23406502|NCT00819156|65233771|FG002|Overall Study|Adverse Event|2|||
23406503|NCT00819156|65233772|FG003|Overall Study|Adverse Event|1|||
23406504|NCT00819156|65233773|FG004|Overall Study|Adverse Event|2|||
23406505|NCT00819156|65233774|FG005|Overall Study|Adverse Event|3|||
23406506|NCT00819156|65233769|FG000|Overall Study|Withdrawal by Subject|0|||
23406507|NCT00819156|65233770|FG001|Overall Study|Withdrawal by Subject|3|||
23406508|NCT00819156|65233771|FG002|Overall Study|Withdrawal by Subject|2|||
23406509|NCT00819156|65233772|FG003|Overall Study|Withdrawal by Subject|0|||
23406510|NCT00819156|65233773|FG004|Overall Study|Withdrawal by Subject|1|||
23406511|NCT00819156|65233774|FG005|Overall Study|Withdrawal by Subject|0|||
23406512|NCT00819156|65233769|FG000|Overall Study|Protocol Violation|1|||
23406513|NCT00819156|65233770|FG001|Overall Study|Protocol Violation|0|||
23406514|NCT00819156|65233771|FG002|Overall Study|Protocol Violation|1|||
23406515|NCT00819156|65233772|FG003|Overall Study|Protocol Violation|0|||
23406516|NCT00819156|65233773|FG004|Overall Study|Protocol Violation|0|||
23406517|NCT00819156|65233774|FG005|Overall Study|Protocol Violation|1|||
23406518|NCT00819156|65233769|FG000|Overall Study|Lost to Follow-up|0|||
23406519|NCT00819156|65233770|FG001|Overall Study|Lost to Follow-up|1|||
23406520|NCT00819156|65233771|FG002|Overall Study|Lost to Follow-up|0|||
23406521|NCT00819156|65233772|FG003|Overall Study|Lost to Follow-up|0|||
23406522|NCT00819156|65233773|FG004|Overall Study|Lost to Follow-up|0|||
23406523|NCT00819156|65233774|FG005|Overall Study|Lost to Follow-up|2|||
23406524|NCT00819156|65233769|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
23406525|NCT00819156|65233770|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
23406526|NCT00819156|65233771|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
23406527|NCT00819156|65233772|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
23406528|NCT00819156|65233773|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
23406529|NCT00819156|65233774|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
23406530|NCT00819156|65233769|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
23406531|NCT00819156|65233770|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
23406532|NCT00819156|65233771|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
23406533|NCT00819156|65233772|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
23406534|NCT00819156|65233773|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
23406535|NCT00819156|65233774|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
23406536|NCT00819156|65233769|FG000|Overall Study|Prostate-specific antigen progression|0|||
23406537|NCT00819156|65233770|FG001|Overall Study|Prostate-specific antigen progression|0|||
23406538|NCT00819156|65233771|FG002|Overall Study|Prostate-specific antigen progression|0|||
23406539|NCT00819156|65233772|FG003|Overall Study|Prostate-specific antigen progression|0|||
23406540|NCT00819156|65233773|FG004|Overall Study|Prostate-specific antigen progression|1|||
23406541|NCT00819156|65233774|FG005|Overall Study|Prostate-specific antigen progression|0|||
23406542|NCT03886493|65233775|FG000|Overall Study|Adverse Event|1|||
23406543|NCT01284959|65233782|FG000|Overall Study|Withdrawal by Subject|1|||
23406544|NCT01284959|65233783|FG001|Overall Study|Withdrawal by Subject|0|||
23406545|NCT01284959|65233784|FG002|Overall Study|Withdrawal by Subject|0|||
23406546|NCT01284959|65233782|FG000|Overall Study|Adverse Event|0|||
23406547|NCT01284959|65233783|FG001|Overall Study|Adverse Event|0|||
23406548|NCT01284959|65233784|FG002|Overall Study|Adverse Event|1|||
23406549|NCT00792740|65233787|FG000|Overall Study|Disease Worsening|3|||
23607361|NCT03031782|65950683|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23406550|NCT00792740|65233788|FG001|Overall Study|Disease Worsening|2|||
23406551|NCT00792740|65233787|FG000|Overall Study|Personal Reason|1|||
23406552|NCT00792740|65233788|FG001|Overall Study|Personal Reason|0|||
23406553|NCT00792740|65233787|FG000|Overall Study|Adverse Event|1|||
23406554|NCT00792740|65233788|FG001|Overall Study|Adverse Event|3|||
23406555|NCT00792740|65233787|FG000|Overall Study|Patient's withdrawal of consent|0|||
23406556|NCT00792740|65233788|FG001|Overall Study|Patient's withdrawal of consent|1|||
23406557|NCT00792740|65233787|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
23406558|NCT00792740|65233788|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
23406559|NCT00792740|65233787|FG000|Overall Study|Other reasons|0|||
23406560|NCT00792740|65233788|FG001|Overall Study|Other reasons|1|||
23406561|NCT01135992|65233789|FG000|Overall Study|Adverse Event|1|||
23406562|NCT01135992|65233789|FG000|Overall Study|Lack of Efficacy|1|||
23406563|NCT01135992|65233789|FG000|Overall Study|Protocol Violation|2|||
23406564|NCT01135992|65233789|FG000|Overall Study|Withdrawal criteria|10|||
23406565|NCT01135992|65233789|FG000|Overall Study|Unclassified|7|||
23406566|NCT00556439|65233790|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
23406567|NCT00556439|65233791|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
23406568|NCT00556439|65233792|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
23406569|NCT00556439|65233793|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
23406570|NCT00556439|65233790|FG000|Study Entry to Week 12|Physician Decision|1|||
23406571|NCT00556439|65233791|FG001|Study Entry to Week 12|Physician Decision|0|||
23406572|NCT00556439|65233792|FG002|Study Entry to Week 12|Physician Decision|0|||
23406573|NCT00556439|65233793|FG003|Study Entry to Week 12|Physician Decision|0|||
23406574|NCT00556439|65233790|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
23406575|NCT00556439|65233791|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
23406576|NCT00556439|65233792|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
23406577|NCT00556439|65233793|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
23406578|NCT00556439|65233790|FG000|Study Entry to Week 12|Recurrent infection|1|||
23406579|NCT00556439|65233791|FG001|Study Entry to Week 12|Recurrent infection|0|||
23406580|NCT00556439|65233792|FG002|Study Entry to Week 12|Recurrent infection|0|||
23406581|NCT00556439|65233793|FG003|Study Entry to Week 12|Recurrent infection|0|||
23406582|NCT00556439|65233790|FG000|Study Entry to Week 12|Malignancy|0|||
23406583|NCT00556439|65233791|FG001|Study Entry to Week 12|Malignancy|0|||
23406584|NCT00556439|65233792|FG002|Study Entry to Week 12|Malignancy|1|||
23406585|NCT00556439|65233793|FG003|Study Entry to Week 12|Malignancy|0|||
23406586|NCT00556439|65233790|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
23406587|NCT00556439|65233791|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
23406588|NCT00556439|65233792|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
23406589|NCT00556439|65233793|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
23406590|NCT00556439|65233790|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
23406591|NCT00556439|65233791|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
23406592|NCT00556439|65233792|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
23406593|NCT00556439|65233793|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
23406594|NCT00556439|65233790|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
23406595|NCT00556439|65233791|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
23406596|NCT00556439|65233792|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
23406597|NCT00556439|65233793|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
23406598|NCT00556439|65233790|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
23406599|NCT00556439|65233791|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
23406600|NCT00556439|65233792|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
23406601|NCT00556439|65233793|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
23406602|NCT01340664|65233794|FG000|Overall Study|Adverse Event|0|||
23406603|NCT01340664|65233795|FG001|Overall Study|Adverse Event|1|||
23406604|NCT01340664|65233796|FG002|Overall Study|Adverse Event|7|||
23406605|NCT01340664|65233794|FG000|Overall Study|Lost to Follow-up|2|||
23406606|NCT01340664|65233795|FG001|Overall Study|Lost to Follow-up|0|||
23607362|NCT03031782|65950679|FG000|Treatment Period 2|Adverse Event|0|||
23305552|NCT01346774|64862345|FG001|Overall Study|Adverse Event|2|||
23305553|NCT02518919|64862346|FG000|Overall Study|Protocol Violation|1|||
23305554|NCT02518919|64862347|FG001|Overall Study|Protocol Violation|1|||
23305555|NCT02518919|64862348|FG002|Overall Study|Protocol Violation|2|||
23305556|NCT01196078|64862349|FG000|Overall Study|Withdrawal by Subject|3|||
23305557|NCT01196078|64862350|FG001|Overall Study|Withdrawal by Subject|5|||
23305558|NCT01196078|64862349|FG000|Overall Study|Adverse Event|4|||
23305559|NCT01196078|64862350|FG001|Overall Study|Adverse Event|4|||
23305560|NCT01196078|64862349|FG000|Overall Study|Protocol Violation|2|||
23305561|NCT01196078|64862350|FG001|Overall Study|Protocol Violation|1|||
23305562|NCT01196078|64862349|FG000|Overall Study|Lack of Efficacy|17|||
23305563|NCT01196078|64862350|FG001|Overall Study|Lack of Efficacy|23|||
23305564|NCT01196078|64862349|FG000|Overall Study|Lost to Follow-up|1|||
23305565|NCT01196078|64862350|FG001|Overall Study|Lost to Follow-up|0|||
23305566|NCT01196078|64862349|FG000|Overall Study|Death|6|||
23305567|NCT01196078|64862350|FG001|Overall Study|Death|4|||
23305568|NCT01321008|64862357|FG000|Overall Study|Early Study Termination|1|||
23305569|NCT03052322|64862358|FG000|Overall Study|Other un-specified|1|||
23305570|NCT03052322|64862359|FG001|Overall Study|Other un-specified|2|||
23305571|NCT03052322|64862358|FG000|Overall Study|Withdrawal by Subject|10|||
23305572|NCT03052322|64862359|FG001|Overall Study|Withdrawal by Subject|9|||
23305573|NCT03052322|64862358|FG000|Overall Study|Death|0|||
23305574|NCT03052322|64862359|FG001|Overall Study|Death|2|||
23305575|NCT03052322|64862358|FG000|Overall Study|Lack of Efficacy|1|||
23305576|NCT03052322|64862359|FG001|Overall Study|Lack of Efficacy|2|||
23305577|NCT03052322|64862358|FG000|Overall Study|Protocol Violation|1|||
23305578|NCT03052322|64862359|FG001|Overall Study|Protocol Violation|0|||
23305579|NCT03052322|64862358|FG000|Overall Study|Lost to Follow-up|2|||
23305580|NCT03052322|64862359|FG001|Overall Study|Lost to Follow-up|4|||
23305581|NCT03052322|64862358|FG000|Overall Study|Adverse Event|6|||
23305582|NCT03052322|64862359|FG001|Overall Study|Adverse Event|13|||
23305583|NCT03123861|64862361|FG000|Overall Study|Protocol Violation|1|||
23305584|NCT03123861|64862362|FG001|Overall Study|Protocol Violation|1|||
23305585|NCT03123861|64862361|FG000|Overall Study|Withdrawal by Subject|2|||
23305586|NCT03123861|64862362|FG001|Overall Study|Withdrawal by Subject|2|||
23305587|NCT00988065|64862363|FG000|Overall Study|Adverse Event|4|||
23305588|NCT00988065|64862364|FG001|Overall Study|Adverse Event|10|||
23305589|NCT00988065|64862365|FG002|Overall Study|Adverse Event|2|||
23305590|NCT00988065|64862363|FG000|Overall Study|Lost to Follow-up|1|||
23305591|NCT00988065|64862364|FG001|Overall Study|Lost to Follow-up|2|||
23305592|NCT00988065|64862365|FG002|Overall Study|Lost to Follow-up|2|||
23305593|NCT00988065|64862363|FG000|Overall Study|Subject withdrew consent|3|||
23305594|NCT00988065|64862364|FG001|Overall Study|Subject withdrew consent|5|||
23305595|NCT00988065|64862365|FG002|Overall Study|Subject withdrew consent|2|||
23305596|NCT00988065|64862363|FG000|Overall Study|Noncompliance with protocol|5|||
23305597|NCT00988065|64862364|FG001|Overall Study|Noncompliance with protocol|6|||
23305598|NCT00988065|64862365|FG002|Overall Study|Noncompliance with protocol|9|||
23305599|NCT00857792|64862369|FG000|Overall Study|inadequate image quality for analysis|12|||
23305600|NCT04614246|64862370|FG000|Overall Study|Adverse Event|0|||
23305601|NCT04614246|64862371|FG001|Overall Study|Adverse Event|1|||
23305602|NCT04614246|64862372|FG002|Overall Study|Adverse Event|1|||
23305603|NCT04614246|64862373|FG003|Overall Study|Adverse Event|2|||
23305604|NCT04614246|64862374|FG004|Overall Study|Adverse Event|1|||
23305605|NCT04614246|64862370|FG000|Overall Study|Lost to Follow-up|0|||
23305606|NCT04614246|64862371|FG001|Overall Study|Lost to Follow-up|1|||
23305607|NCT04614246|64862372|FG002|Overall Study|Lost to Follow-up|0|||
23406607|NCT01340664|65233796|FG002|Overall Study|Lost to Follow-up|2|||
23406608|NCT01340664|65233794|FG000|Overall Study|Withdrawal by Subject|2|||
23305608|NCT04614246|64862373|FG003|Overall Study|Lost to Follow-up|1|||
23305609|NCT04614246|64862374|FG004|Overall Study|Lost to Follow-up|3|||
23305610|NCT04614246|64862370|FG000|Overall Study|Other reason|0|||
23305611|NCT04614246|64862371|FG001|Overall Study|Other reason|1|||
23305612|NCT04614246|64862372|FG002|Overall Study|Other reason|2|||
23305613|NCT04614246|64862373|FG003|Overall Study|Other reason|0|||
23305614|NCT04614246|64862374|FG004|Overall Study|Other reason|0|||
23305615|NCT04614246|64862370|FG000|Overall Study|Withdrawal by Subject|4|||
23305616|NCT04614246|64862371|FG001|Overall Study|Withdrawal by Subject|2|||
23305617|NCT04614246|64862372|FG002|Overall Study|Withdrawal by Subject|4|||
23305618|NCT04614246|64862373|FG003|Overall Study|Withdrawal by Subject|3|||
23305619|NCT04614246|64862374|FG004|Overall Study|Withdrawal by Subject|4|||
23305620|NCT04614246|64862370|FG000|Overall Study|Physician Decision|0|||
23305621|NCT04614246|64862371|FG001|Overall Study|Physician Decision|2|||
23305622|NCT04614246|64862372|FG002|Overall Study|Physician Decision|1|||
23305623|NCT04614246|64862373|FG003|Overall Study|Physician Decision|0|||
23305624|NCT04614246|64862374|FG004|Overall Study|Physician Decision|0|||
23305625|NCT04614246|64862370|FG000|Overall Study|Study terminated by sponsor|10|||
23305626|NCT04614246|64862371|FG001|Overall Study|Study terminated by sponsor|15|||
23305627|NCT04614246|64862372|FG002|Overall Study|Study terminated by sponsor|12|||
23305628|NCT04614246|64862373|FG003|Overall Study|Study terminated by sponsor|13|||
23305629|NCT04614246|64862374|FG004|Overall Study|Study terminated by sponsor|9|||
23305630|NCT04614246|64862370|FG000|Overall Study|Pregnancy|2|||
23305631|NCT04614246|64862371|FG001|Overall Study|Pregnancy|0|||
23305632|NCT04614246|64862372|FG002|Overall Study|Pregnancy|1|||
23305633|NCT04614246|64862373|FG003|Overall Study|Pregnancy|0|||
23305634|NCT04614246|64862374|FG004|Overall Study|Pregnancy|0|||
23305635|NCT02771795|64862375|FG000|Overall Study|Withdrawal by Subject|47|||
23305636|NCT02771795|64862376|FG001|Overall Study|Withdrawal by Subject|37|||
23305637|NCT02771795|64862375|FG000|Overall Study|Termination by premature discontinuation of study|168|||
23305638|NCT02771795|64862376|FG001|Overall Study|Termination by premature discontinuation of study|185|||
23406609|NCT01340664|65233795|FG001|Overall Study|Withdrawal by Subject|4|||
23406610|NCT01340664|65233796|FG002|Overall Study|Withdrawal by Subject|0|||
23406611|NCT01340664|65233794|FG000|Overall Study|Glycemic withdrawal criteria|2|||
23406612|NCT01340664|65233795|FG001|Overall Study|Glycemic withdrawal criteria|0|||
23406613|NCT01340664|65233796|FG002|Overall Study|Glycemic withdrawal criteria|0|||
23607363|NCT03031782|65950680|FG001|Treatment Period 2|Adverse Event|1|||
23305639|NCT02923674|64862378|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
23305640|NCT02923674|64862379|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
23305641|NCT02923674|64862380|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
23305642|NCT02923674|64862378|FG000|Overall Study|Lost to Follow-up|7|||
23406614|NCT01340664|65233794|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
23406615|NCT01340664|65233795|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
23406616|NCT01340664|65233796|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
23305643|NCT02923674|64862379|FG001|Overall Study|Lost to Follow-up|12|||
23305644|NCT02923674|64862380|FG002|Overall Study|Lost to Follow-up|7|||
23305645|NCT02923674|64862378|FG000|Overall Study|Problem with intervention|2|||
23305646|NCT02923674|64862379|FG001|Overall Study|Problem with intervention|2|||
23305647|NCT02923674|64862380|FG002|Overall Study|Problem with intervention|1|||
23305648|NCT02923674|64862378|FG000|Overall Study|Adverse Event|3|||
23305649|NCT02923674|64862379|FG001|Overall Study|Adverse Event|1|||
23305650|NCT02923674|64862380|FG002|Overall Study|Adverse Event|1|||
23305651|NCT02923674|64862378|FG000|Overall Study|Withdrawal by Subject|2|||
23305652|NCT02923674|64862379|FG001|Overall Study|Withdrawal by Subject|2|||
23305653|NCT02923674|64862380|FG002|Overall Study|Withdrawal by Subject|2|||
23305654|NCT00278889|64862386|FG000|Overall Study|Withdrawal by Subject|0|||
23305655|NCT00278889|64862387|FG001|Overall Study|Withdrawal by Subject|5|||
23305656|NCT00278889|64862388|FG002|Overall Study|Withdrawal by Subject|3|||
23305657|NCT00278889|64862386|FG000|Overall Study|Lost to Follow-up|1|||
23305658|NCT00278889|64862387|FG001|Overall Study|Lost to Follow-up|1|||
23305659|NCT00278889|64862388|FG002|Overall Study|Lost to Follow-up|0|||
23305660|NCT00278889|64862386|FG000|Overall Study|Death|24|||
23305661|NCT00278889|64862387|FG001|Overall Study|Death|21|||
23305662|NCT00278889|64862388|FG002|Overall Study|Death|17|||
23305663|NCT02005887|64862393|FG000|Overall Study|Protocol Violation|0|||
23305664|NCT02005887|64862394|FG001|Overall Study|Protocol Violation|2|||
23305665|NCT01229735|64862395|FG000|Overall Study|Lack of Efficacy|8|||
23305666|NCT01229735|64862396|FG001|Overall Study|Lack of Efficacy|8|||
23305667|NCT01229735|64862395|FG000|Overall Study|Protocol Violation|13|||
23305668|NCT01229735|64862396|FG001|Overall Study|Protocol Violation|8|||
23305669|NCT01229735|64862395|FG000|Overall Study|Lost to Follow-up|0|||
23305670|NCT01229735|64862396|FG001|Overall Study|Lost to Follow-up|2|||
23305671|NCT01229735|64862395|FG000|Overall Study|Withdrawal by Subject|18|||
23305672|NCT01229735|64862396|FG001|Overall Study|Withdrawal by Subject|17|||
23305673|NCT01229735|64862395|FG000|Overall Study|Other Reason|13|||
23305674|NCT01229735|64862396|FG001|Overall Study|Other Reason|10|||
23305675|NCT01229735|64862395|FG000|Overall Study|SAE, non-fatal|0|||
23305676|NCT01229735|64862396|FG001|Overall Study|SAE, non-fatal|4|||
23305677|NCT01229735|64862395|FG000|Overall Study|AE, non-serious non-fatal|13|||
23305678|NCT01229735|64862396|FG001|Overall Study|AE, non-serious non-fatal|17|||
23305679|NCT01229735|64862395|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23305680|NCT01229735|64862396|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23305681|NCT01175811|64862397|FG000|Overall Study|Adverse Event|1|||
23305682|NCT01175811|64862398|FG001|Overall Study|Adverse Event|1|||
23305683|NCT01175811|64862397|FG000|Overall Study|Entry criteria not met|3|||
23305684|NCT01175811|64862398|FG001|Overall Study|Entry criteria not met|1|||
23305685|NCT01175811|64862397|FG000|Overall Study|Lack of Efficacy|1|||
23305686|NCT01175811|64862398|FG001|Overall Study|Lack of Efficacy|0|||
23305687|NCT01175811|64862397|FG000|Overall Study|Lost to Follow-up|3|||
23305688|NCT01175811|64862398|FG001|Overall Study|Lost to Follow-up|2|||
23305689|NCT01175811|64862397|FG000|Overall Study|Physician Decision|1|||
23305690|NCT01175811|64862398|FG001|Overall Study|Physician Decision|1|||
23305691|NCT01175811|64862397|FG000|Overall Study|Protocol Violation|1|||
23406617|NCT01340664|65233794|FG000|Overall Study|Other|1|||
23406618|NCT01340664|65233795|FG001|Overall Study|Other|2|||
23406619|NCT01340664|65233796|FG002|Overall Study|Other|2|||
23406620|NCT03981744|65233797|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
23406621|NCT03981744|65233798|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
23406622|NCT03981744|65233799|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
23406623|NCT03981744|65233800|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
23406624|NCT03981744|65233797|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
23406625|NCT03981744|65233798|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
23406626|NCT03981744|65233799|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
23406627|NCT03981744|65233800|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
23406628|NCT03981744|65233797|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
23406629|NCT03981744|65233798|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
23406630|NCT03981744|65233799|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
23406631|NCT03981744|65233800|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
23406632|NCT01991483|65233810|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
23406633|NCT01991483|65233811|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
23607364|NCT03031782|65950681|FG002|Treatment Period 2|Adverse Event|2|||
23406634|NCT01991483|65233812|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
23305692|NCT01175811|64862398|FG001|Overall Study|Protocol Violation|2|||
23305693|NCT01175811|64862397|FG000|Overall Study|Withdrawal by Subject|6|||
23305694|NCT01175811|64862398|FG001|Overall Study|Withdrawal by Subject|7|||
23305695|NCT00515541|64862399|FG000|Overall Study|Physician Decision|0|||
23406635|NCT01991483|65233813|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
23607365|NCT03031782|65950682|FG003|Treatment Period 2|Adverse Event|0|||
23406636|NCT01991483|65233810|FG000|Dose Level 600 mg|Physician Decision|0|||
23406637|NCT01991483|65233811|FG001|Dose Level 600 mg|Physician Decision|0|||
23406638|NCT01991483|65233812|FG002|Dose Level 600 mg|Physician Decision|1|||
23406639|NCT01991483|65233813|FG003|Dose Level 600 mg|Physician Decision|0|||
23406640|NCT01991483|65233810|FG000|Dose Level 1000 mg|Protocol Violation|0|||
23406641|NCT01991483|65233811|FG001|Dose Level 1000 mg|Protocol Violation|0|||
23406642|NCT01991483|65233812|FG002|Dose Level 1000 mg|Protocol Violation|0|||
23406643|NCT01991483|65233813|FG003|Dose Level 1000 mg|Protocol Violation|1|||
23406644|NCT00532129|65233814|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
23406645|NCT00532129|65233814|FG000|Treatment Period|Physician Decision|15|||
23406646|NCT00532129|65233814|FG000|Treatment Period|Disease progression|3|||
23406647|NCT00532129|65233814|FG000|Treatment Period|Protocol Violation|1|||
23406648|NCT00532129|65233814|FG000|Treatment Period|Other|5|||
23406649|NCT00532129|65233814|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
23406650|NCT00532129|65233814|FG000|Follow-up Period|Disease progression|57|||
23406651|NCT00532129|65233814|FG000|Follow-up Period|Lost to Follow-up|1|||
23406652|NCT00532129|65233814|FG000|Follow-up Period|Other|6|||
23406653|NCT03768089|65233817|FG000|Part A|Lost to Follow-up|0|||
23406654|NCT03768089|65233818|FG001|Part A|Lost to Follow-up|0|||
23406655|NCT03768089|65233819|FG002|Part A|Lost to Follow-up|0|||
23406656|NCT03768089|65233820|FG003|Part A|Lost to Follow-up|0|||
23406657|NCT03768089|65233821|FG004|Part A|Lost to Follow-up|1|||
23406658|NCT03768089|65233822|FG005|Part A|Lost to Follow-up|0|||
23406659|NCT03768089|65233823|FG006|Part A|Lost to Follow-up|0|||
23406660|NCT03768089|65233824|FG007|Part A|Lost to Follow-up|0|||
23406661|NCT03768089|65233825|FG008|Part A|Lost to Follow-up|0|||
23406662|NCT03768089|65233826|FG009|Part A|Lost to Follow-up|0|||
23406663|NCT03768089|65233827|FG010|Part A|Lost to Follow-up|0|||
23406664|NCT03768089|65233828|FG011|Part A|Lost to Follow-up|0|||
23406665|NCT03768089|65233829|FG012|Part A|Lost to Follow-up|0|||
23406666|NCT03768089|65233830|FG013|Part A|Lost to Follow-up|0|||
23406667|NCT03768089|65233831|FG014|Part A|Lost to Follow-up|0|||
23406668|NCT03768089|65233832|FG015|Part A|Lost to Follow-up|0|||
23406669|NCT03768089|65233833|FG016|Part A|Lost to Follow-up|0|||
23406670|NCT03768089|65233834|FG017|Part A|Lost to Follow-up|0|||
23406671|NCT03768089|65233817|FG000|Part C|Randomized, Never Dosed|0|||
23406672|NCT03768089|65233818|FG001|Part C|Randomized, Never Dosed|0|||
23406673|NCT03768089|65233819|FG002|Part C|Randomized, Never Dosed|0|||
23406674|NCT03768089|65233820|FG003|Part C|Randomized, Never Dosed|0|||
23406675|NCT03768089|65233821|FG004|Part C|Randomized, Never Dosed|0|||
23406676|NCT03768089|65233822|FG005|Part C|Randomized, Never Dosed|0|||
23406677|NCT03768089|65233823|FG006|Part C|Randomized, Never Dosed|0|||
23406678|NCT03768089|65233824|FG007|Part C|Randomized, Never Dosed|0|||
23406679|NCT03768089|65233825|FG008|Part C|Randomized, Never Dosed|0|||
23406680|NCT03768089|65233826|FG009|Part C|Randomized, Never Dosed|0|||
23406681|NCT03768089|65233827|FG010|Part C|Randomized, Never Dosed|0|||
23406682|NCT03768089|65233828|FG011|Part C|Randomized, Never Dosed|0|||
23406683|NCT03768089|65233829|FG012|Part C|Randomized, Never Dosed|0|||
23406684|NCT03768089|65233830|FG013|Part C|Randomized, Never Dosed|0|||
23406685|NCT03768089|65233831|FG014|Part C|Randomized, Never Dosed|1|||
23406686|NCT03768089|65233832|FG015|Part C|Randomized, Never Dosed|0|||
23406687|NCT03768089|65233833|FG016|Part C|Randomized, Never Dosed|0|||
23406688|NCT03768089|65233834|FG017|Part C|Randomized, Never Dosed|0|||
23406689|NCT03008070|65233835|FG000|Overall Study|Adverse Event|3|||
23406690|NCT03008070|65233836|FG001|Overall Study|Adverse Event|3|||
23406691|NCT03008070|65233837|FG002|Overall Study|Adverse Event|3|||
23406692|NCT03008070|65233835|FG000|Overall Study|Lost to Follow-up|1|||
23406693|NCT03008070|65233836|FG001|Overall Study|Lost to Follow-up|1|||
23406694|NCT03008070|65233837|FG002|Overall Study|Lost to Follow-up|0|||
23406695|NCT03008070|65233835|FG000|Overall Study|Non compliance|0|||
23406696|NCT03008070|65233836|FG001|Overall Study|Non compliance|1|||
23406697|NCT03008070|65233837|FG002|Overall Study|Non compliance|1|||
23406698|NCT03008070|65233835|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
23406699|NCT03008070|65233836|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
23406700|NCT03008070|65233837|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
23406701|NCT03008070|65233835|FG000|Overall Study|Withdrawal by Subject|2|||
23406702|NCT03008070|65233836|FG001|Overall Study|Withdrawal by Subject|0|||
23406703|NCT03008070|65233837|FG002|Overall Study|Withdrawal by Subject|1|||
23406704|NCT03008070|65233835|FG000|Overall Study|Use of prohibited drug|0|||
23406705|NCT03008070|65233836|FG001|Overall Study|Use of prohibited drug|0|||
23406706|NCT03008070|65233837|FG002|Overall Study|Use of prohibited drug|2|||
23406707|NCT03497039|65233838|FG000|Overall Study|Withdrawal by Subject|1|||
23406708|NCT03497039|65233839|FG001|Overall Study|Withdrawal by Subject|0|||
23406709|NCT03497039|65233838|FG000|Overall Study|Protocol Violation|0|||
23406710|NCT03497039|65233839|FG001|Overall Study|Protocol Violation|1|||
23406711|NCT01509846|65233840|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
23406712|NCT01509846|65233841|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
23406713|NCT01509846|65233842|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
23406714|NCT01509846|65233843|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
23406715|NCT01509846|65233844|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
23406716|NCT01509846|65233840|FG000|Received Vaccination 2|Illness|0|||
23406717|NCT01509846|65233841|FG001|Received Vaccination 2|Illness|0|||
23406718|NCT01509846|65233842|FG002|Received Vaccination 2|Illness|0|||
23406719|NCT01509846|65233843|FG003|Received Vaccination 2|Illness|0|||
23406720|NCT01509846|65233844|FG004|Received Vaccination 2|Illness|1|||
23406721|NCT01509846|65233840|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
23406722|NCT01509846|65233841|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
23406723|NCT01509846|65233842|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
23406724|NCT01509846|65233843|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
23406725|NCT01509846|65233844|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
23406726|NCT01509846|65233840|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
23406727|NCT01509846|65233841|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
23406728|NCT01509846|65233842|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
23406729|NCT01509846|65233843|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
23406730|NCT01509846|65233844|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
23406731|NCT01509846|65233840|FG000|Received Vaccination 3|Pregnancy|0|||
23406732|NCT01509846|65233841|FG001|Received Vaccination 3|Pregnancy|0|||
23406733|NCT01509846|65233842|FG002|Received Vaccination 3|Pregnancy|0|||
23406734|NCT01509846|65233843|FG003|Received Vaccination 3|Pregnancy|1|||
23406735|NCT01509846|65233844|FG004|Received Vaccination 3|Pregnancy|0|||
23406736|NCT01509846|65233840|FG000|Received Vaccination 3|Lost to Follow-up|0|||
23406737|NCT01509846|65233841|FG001|Received Vaccination 3|Lost to Follow-up|0|||
23406738|NCT01509846|65233842|FG002|Received Vaccination 3|Lost to Follow-up|1|||
23406739|NCT01509846|65233843|FG003|Received Vaccination 3|Lost to Follow-up|0|||
23406740|NCT01509846|65233844|FG004|Received Vaccination 3|Lost to Follow-up|0|||
23406741|NCT01978145|65233845|FG000|Treatment Period 1|Adverse Event|1|||
23406742|NCT01978145|65233846|FG001|Treatment Period 1|Adverse Event|9|||
23406743|NCT01978145|65233845|FG000|Treatment Period 1|Physician Decision|1|||
23406744|NCT01978145|65233846|FG001|Treatment Period 1|Physician Decision|0|||
23406745|NCT01978145|65233845|FG000|Treatment Period 1|Withdrawal by Subject|5|||
23406746|NCT01978145|65233846|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23406747|NCT01978145|65233845|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
23406748|NCT01978145|65233846|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
23406749|NCT01978145|65233845|FG000|Washout Period 1|Adverse Event|0|||
23406750|NCT01978145|65233846|FG001|Washout Period 1|Adverse Event|1|||
23406751|NCT01978145|65233845|FG000|Washout Period 1|Withdrawal by Subject|1|||
23406752|NCT01978145|65233846|FG001|Washout Period 1|Withdrawal by Subject|1|||
23406753|NCT01978145|65233845|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
23406754|NCT01978145|65233846|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
23406755|NCT01978145|65233845|FG000|Treatment Period 2|Adverse Event|3|||
23406756|NCT01978145|65233846|FG001|Treatment Period 2|Adverse Event|3|||
23406757|NCT01978145|65233845|FG000|Treatment Period 2|Protocol Violation|0|||
23406758|NCT01978145|65233846|FG001|Treatment Period 2|Protocol Violation|1|||
23406759|NCT01978145|65233845|FG000|Treatment Period 2|Lost to Follow-up|1|||
23406760|NCT01978145|65233846|FG001|Treatment Period 2|Lost to Follow-up|1|||
23406761|NCT01978145|65233845|FG000|Treatment Period 2|Withdrawal by Subject|7|||
23406762|NCT01978145|65233846|FG001|Treatment Period 2|Withdrawal by Subject|4|||
23406763|NCT01978145|65233845|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
23406764|NCT01978145|65233846|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
23406765|NCT01558115|65233850|FG000|Overall Study|Withdrawal by Subject|3|||
23406766|NCT01558115|65233850|FG000|Overall Study|Study closed due to poor enrollment|4|||
23406767|NCT02528942|65233851|FG000|Overall Study|Did not meet imaging criteria|9|||
23406768|NCT02528942|65233851|FG000|Overall Study|Lost to Follow-up|25|||
23406769|NCT00413660|65233852|FG000|Up To Week 12|Adverse Event|1|||
23406770|NCT00413660|65233853|FG001|Up To Week 12|Adverse Event|3|||
23406771|NCT00413660|65233854|FG002|Up To Week 12|Adverse Event|1|||
23406772|NCT00413660|65233855|FG003|Up To Week 12|Adverse Event|4|||
23406773|NCT00413660|65233856|FG004|Up To Week 12|Adverse Event|6|||
23406774|NCT00413660|65233857|FG005|Up To Week 12|Adverse Event|4|||
23406775|NCT00413660|65233858|FG006|Up To Week 12|Adverse Event|1|||
23406776|NCT00413660|65233859|FG007|Up To Week 12|Adverse Event|0|||
23406777|NCT00413660|65233860|FG008|Up To Week 12|Adverse Event|0|||
23406778|NCT00413660|65233861|FG009|Up To Week 12|Adverse Event|0|||
23406779|NCT00413660|65233862|FG010|Up To Week 12|Adverse Event|0|||
23406780|NCT00413660|65233852|FG000|Up To Week 12|Lack of Efficacy|2|||
23406781|NCT00413660|65233853|FG001|Up To Week 12|Lack of Efficacy|0|||
23406782|NCT00413660|65233854|FG002|Up To Week 12|Lack of Efficacy|0|||
23406783|NCT00413660|65233855|FG003|Up To Week 12|Lack of Efficacy|0|||
23406784|NCT00413660|65233856|FG004|Up To Week 12|Lack of Efficacy|0|||
23406785|NCT00413660|65233857|FG005|Up To Week 12|Lack of Efficacy|0|||
23406786|NCT00413660|65233858|FG006|Up To Week 12|Lack of Efficacy|5|||
23406787|NCT00413660|65233859|FG007|Up To Week 12|Lack of Efficacy|0|||
23607366|NCT03031782|65950683|FG004|Treatment Period 2|Adverse Event|0|||
23406788|NCT00413660|65233860|FG008|Up To Week 12|Lack of Efficacy|0|||
23406789|NCT00413660|65233861|FG009|Up To Week 12|Lack of Efficacy|0|||
23406790|NCT00413660|65233862|FG010|Up To Week 12|Lack of Efficacy|0|||
23406791|NCT00413660|65233852|FG000|Up To Week 12|Lost to Follow-up|0|||
23406792|NCT00413660|65233853|FG001|Up To Week 12|Lost to Follow-up|1|||
23406793|NCT00413660|65233854|FG002|Up To Week 12|Lost to Follow-up|0|||
23406794|NCT00413660|65233855|FG003|Up To Week 12|Lost to Follow-up|0|||
23406795|NCT00413660|65233856|FG004|Up To Week 12|Lost to Follow-up|1|||
23406796|NCT00413660|65233857|FG005|Up To Week 12|Lost to Follow-up|0|||
23406797|NCT00413660|65233858|FG006|Up To Week 12|Lost to Follow-up|0|||
23406798|NCT00413660|65233859|FG007|Up To Week 12|Lost to Follow-up|0|||
23406799|NCT00413660|65233860|FG008|Up To Week 12|Lost to Follow-up|0|||
23406800|NCT00413660|65233861|FG009|Up To Week 12|Lost to Follow-up|0|||
23406801|NCT00413660|65233862|FG010|Up To Week 12|Lost to Follow-up|0|||
23406802|NCT00413660|65233852|FG000|Up To Week 12|Withdrawal by Subject|0|||
23406803|NCT00413660|65233853|FG001|Up To Week 12|Withdrawal by Subject|2|||
23406804|NCT00413660|65233854|FG002|Up To Week 12|Withdrawal by Subject|0|||
23406805|NCT00413660|65233855|FG003|Up To Week 12|Withdrawal by Subject|2|||
23406806|NCT00413660|65233856|FG004|Up To Week 12|Withdrawal by Subject|0|||
23406807|NCT00413660|65233857|FG005|Up To Week 12|Withdrawal by Subject|2|||
23406808|NCT00413660|65233858|FG006|Up To Week 12|Withdrawal by Subject|2|||
23406809|NCT00413660|65233859|FG007|Up To Week 12|Withdrawal by Subject|0|||
23406810|NCT00413660|65233860|FG008|Up To Week 12|Withdrawal by Subject|0|||
23406811|NCT00413660|65233861|FG009|Up To Week 12|Withdrawal by Subject|0|||
23406812|NCT00413660|65233862|FG010|Up To Week 12|Withdrawal by Subject|0|||
23406813|NCT00413660|65233852|FG000|Up To Week 12|Randomized, Not Treated|1|||
23406814|NCT00413660|65233853|FG001|Up To Week 12|Randomized, Not Treated|0|||
23406815|NCT00413660|65233854|FG002|Up To Week 12|Randomized, Not Treated|0|||
23406816|NCT00413660|65233855|FG003|Up To Week 12|Randomized, Not Treated|1|||
23406817|NCT00413660|65233856|FG004|Up To Week 12|Randomized, Not Treated|0|||
23406818|NCT00413660|65233857|FG005|Up To Week 12|Randomized, Not Treated|0|||
23406819|NCT00413660|65233858|FG006|Up To Week 12|Randomized, Not Treated|0|||
23406820|NCT00413660|65233859|FG007|Up To Week 12|Randomized, Not Treated|0|||
23406821|NCT00413660|65233860|FG008|Up To Week 12|Randomized, Not Treated|0|||
23406822|NCT00413660|65233861|FG009|Up To Week 12|Randomized, Not Treated|0|||
23406823|NCT00413660|65233862|FG010|Up To Week 12|Randomized, Not Treated|0|||
23406824|NCT00413660|65233852|FG000|Up To Week 12|Other|3|||
23406825|NCT00413660|65233853|FG001|Up To Week 12|Other|1|||
23406826|NCT00413660|65233854|FG002|Up To Week 12|Other|6|||
23406827|NCT00413660|65233855|FG003|Up To Week 12|Other|1|||
23406828|NCT00413660|65233856|FG004|Up To Week 12|Other|2|||
23406829|NCT00413660|65233857|FG005|Up To Week 12|Other|4|||
23406830|NCT00413660|65233858|FG006|Up To Week 12|Other|3|||
23406831|NCT00413660|65233859|FG007|Up To Week 12|Other|0|||
23406832|NCT00413660|65233860|FG008|Up To Week 12|Other|0|||
23406833|NCT00413660|65233861|FG009|Up To Week 12|Other|0|||
23406834|NCT00413660|65233862|FG010|Up To Week 12|Other|0|||
23406835|NCT00413660|65233852|FG000|Post Week 12|Adverse Event|2|||
23406836|NCT00413660|65233853|FG001|Post Week 12|Adverse Event|0|||
23406837|NCT00413660|65233854|FG002|Post Week 12|Adverse Event|2|||
23406838|NCT00413660|65233855|FG003|Post Week 12|Adverse Event|1|||
23406839|NCT00413660|65233856|FG004|Post Week 12|Adverse Event|4|||
23406840|NCT00413660|65233857|FG005|Post Week 12|Adverse Event|2|||
23406841|NCT00413660|65233858|FG006|Post Week 12|Adverse Event|2|||
23406842|NCT00413660|65233859|FG007|Post Week 12|Adverse Event|0|||
23406843|NCT00413660|65233860|FG008|Post Week 12|Adverse Event|0|||
23406844|NCT00413660|65233861|FG009|Post Week 12|Adverse Event|0|||
23406845|NCT00413660|65233862|FG010|Post Week 12|Adverse Event|0|||
23406846|NCT00413660|65233852|FG000|Post Week 12|Lack of Efficacy|0|||
23406847|NCT00413660|65233853|FG001|Post Week 12|Lack of Efficacy|0|||
23406848|NCT00413660|65233854|FG002|Post Week 12|Lack of Efficacy|1|||
23406849|NCT00413660|65233855|FG003|Post Week 12|Lack of Efficacy|0|||
23406850|NCT00413660|65233856|FG004|Post Week 12|Lack of Efficacy|0|||
23406851|NCT00413660|65233857|FG005|Post Week 12|Lack of Efficacy|0|||
23406852|NCT00413660|65233858|FG006|Post Week 12|Lack of Efficacy|0|||
23406853|NCT00413660|65233859|FG007|Post Week 12|Lack of Efficacy|0|||
23406854|NCT00413660|65233860|FG008|Post Week 12|Lack of Efficacy|0|||
23406855|NCT00413660|65233861|FG009|Post Week 12|Lack of Efficacy|1|||
23406856|NCT00413660|65233862|FG010|Post Week 12|Lack of Efficacy|0|||
23406857|NCT00413660|65233852|FG000|Post Week 12|Lost to Follow-up|0|||
23406858|NCT00413660|65233853|FG001|Post Week 12|Lost to Follow-up|1|||
23406859|NCT00413660|65233854|FG002|Post Week 12|Lost to Follow-up|1|||
23406860|NCT00413660|65233855|FG003|Post Week 12|Lost to Follow-up|0|||
23406861|NCT00413660|65233856|FG004|Post Week 12|Lost to Follow-up|0|||
23406862|NCT00413660|65233857|FG005|Post Week 12|Lost to Follow-up|0|||
23406863|NCT00413660|65233858|FG006|Post Week 12|Lost to Follow-up|0|||
23406864|NCT00413660|65233859|FG007|Post Week 12|Lost to Follow-up|0|||
23406865|NCT00413660|65233860|FG008|Post Week 12|Lost to Follow-up|0|||
23406866|NCT00413660|65233861|FG009|Post Week 12|Lost to Follow-up|0|||
23406867|NCT00413660|65233862|FG010|Post Week 12|Lost to Follow-up|0|||
23406868|NCT00413660|65233852|FG000|Post Week 12|Withdrawal by Subject|0|||
23406869|NCT00413660|65233853|FG001|Post Week 12|Withdrawal by Subject|1|||
23406870|NCT00413660|65233854|FG002|Post Week 12|Withdrawal by Subject|1|||
23406871|NCT00413660|65233855|FG003|Post Week 12|Withdrawal by Subject|0|||
23406872|NCT00413660|65233856|FG004|Post Week 12|Withdrawal by Subject|1|||
23406873|NCT00413660|65233857|FG005|Post Week 12|Withdrawal by Subject|0|||
23406874|NCT00413660|65233858|FG006|Post Week 12|Withdrawal by Subject|0|||
23406875|NCT00413660|65233859|FG007|Post Week 12|Withdrawal by Subject|0|||
23406876|NCT00413660|65233860|FG008|Post Week 12|Withdrawal by Subject|0|||
23406877|NCT00413660|65233861|FG009|Post Week 12|Withdrawal by Subject|0|||
23406878|NCT00413660|65233862|FG010|Post Week 12|Withdrawal by Subject|1|||
23406879|NCT00413660|65233852|FG000|Post Week 12|Other|1|||
23406880|NCT00413660|65233853|FG001|Post Week 12|Other|2|||
23406881|NCT00413660|65233854|FG002|Post Week 12|Other|3|||
23406882|NCT00413660|65233855|FG003|Post Week 12|Other|0|||
23406883|NCT00413660|65233856|FG004|Post Week 12|Other|1|||
23406884|NCT00413660|65233857|FG005|Post Week 12|Other|1|||
23406885|NCT00413660|65233858|FG006|Post Week 12|Other|1|||
23406886|NCT00413660|65233859|FG007|Post Week 12|Other|0|||
23406887|NCT00413660|65233860|FG008|Post Week 12|Other|0|||
23406888|NCT00413660|65233861|FG009|Post Week 12|Other|0|||
23406889|NCT00413660|65233862|FG010|Post Week 12|Other|0|||
23406890|NCT02316353|65233863|FG000|Overall Study|Pregnancy|1|||
23406891|NCT02316353|65233864|FG001|Overall Study|Pregnancy|3|||
23406892|NCT02316353|65233863|FG000|Overall Study|Adverse Event|1|||
23406893|NCT02316353|65233864|FG001|Overall Study|Adverse Event|3|||
23406894|NCT02316353|65233863|FG000|Overall Study|Withdrawal by Subject|6|||
23406895|NCT02316353|65233864|FG001|Overall Study|Withdrawal by Subject|2|||
23406896|NCT00592631|65233865|FG000|Overall Study|Lost to Follow-up|0|||
23406897|NCT00592631|65233866|FG001|Overall Study|Lost to Follow-up|2|||
23406898|NCT00892008|65233867|FG000|Overall Study|Death|5|||
23406899|NCT00892008|65233867|FG000|Overall Study|Lack of Efficacy|3|||
23406900|NCT00892008|65233867|FG000|Overall Study|Lost to Follow-up|142|||
23406901|NCT00892008|65233867|FG000|Overall Study|Other|378|||
23406902|NCT00892008|65233867|FG000|Overall Study|Adverse Event|37|||
23406903|NCT01847092|65233868|FG000|Overall Study|Adverse Event|12|||
23406904|NCT01847092|65233869|FG001|Overall Study|Adverse Event|3|||
23406905|NCT01847092|65233868|FG000|Overall Study|Withdrawal by Subject|5|||
23406906|NCT01847092|65233869|FG001|Overall Study|Withdrawal by Subject|5|||
23406907|NCT01847092|65233868|FG000|Overall Study|Protocol Specified|8|||
23406908|NCT01847092|65233869|FG001|Overall Study|Protocol Specified|0|||
23406909|NCT01847092|65233868|FG000|Overall Study|Physician Decision|1|||
23406910|NCT01847092|65233869|FG001|Overall Study|Physician Decision|1|||
23406911|NCT01847092|65233868|FG000|Overall Study|Protocol Violation|0|||
23406912|NCT01847092|65233869|FG001|Overall Study|Protocol Violation|2|||
23406913|NCT03462758|65233870|FG000|Overall Study|Chose no or other method of contraception|20|||
23406914|NCT03462758|65233871|FG001|Overall Study|Chose no or other method of contraception|23|||
23406915|NCT03462758|65233870|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
23406916|NCT03462758|65233871|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
23406917|NCT03462758|65233870|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
23406918|NCT03462758|65233871|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
23406919|NCT03462758|65233870|FG000|Overall Study|Medical contraindication|2|||
23406920|NCT03462758|65233871|FG001|Overall Study|Medical contraindication|2|||
23406921|NCT03462758|65233870|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
23406922|NCT03462758|65233871|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
23406923|NCT02389465|65233872|FG000|Overall Study|Lost to Follow-up|1|||
23406924|NCT02389465|65233873|FG001|Overall Study|Lost to Follow-up|3|||
23406925|NCT02389465|65233874|FG002|Overall Study|Lost to Follow-up|3|||
23406926|NCT02389465|65233875|FG003|Overall Study|Lost to Follow-up|0|||
23406927|NCT02389465|65233872|FG000|Overall Study|Physician Decision|0|||
23406928|NCT02389465|65233873|FG001|Overall Study|Physician Decision|0|||
23406929|NCT02389465|65233874|FG002|Overall Study|Physician Decision|0|||
23406930|NCT02389465|65233875|FG003|Overall Study|Physician Decision|1|||
23406931|NCT02389465|65233872|FG000|Overall Study|Withdrawal by Subject|0|||
23406932|NCT02389465|65233873|FG001|Overall Study|Withdrawal by Subject|1|||
23406933|NCT02389465|65233874|FG002|Overall Study|Withdrawal by Subject|2|||
23406934|NCT02389465|65233875|FG003|Overall Study|Withdrawal by Subject|2|||
23406935|NCT00347932|65233876|FG000|Overall Study|Adverse Event|4|||
23406936|NCT00347932|65233877|FG001|Overall Study|Adverse Event|5|||
23406937|NCT00347932|65233876|FG000|Overall Study|Lack of Efficacy|3|||
23406938|NCT00347932|65233877|FG001|Overall Study|Lack of Efficacy|14|||
23406939|NCT00347932|65233876|FG000|Overall Study|Lost to Follow-up|10|||
23406940|NCT00347932|65233877|FG001|Overall Study|Lost to Follow-up|9|||
23406941|NCT00347932|65233876|FG000|Overall Study|Withdrawal by Subject|10|||
23406942|NCT00347932|65233877|FG001|Overall Study|Withdrawal by Subject|16|||
23406943|NCT00347932|65233876|FG000|Overall Study|Did not meet inclusion criteria|4|||
23406944|NCT00347932|65233877|FG001|Overall Study|Did not meet inclusion criteria|8|||
23406945|NCT02151786|65233880|FG000|Overall Study|Unavailability of Case Report Form|26|||
23607367|NCT03031782|65950679|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23406946|NCT02151786|65233880|FG000|Overall Study|Outside the Contract Period|1|||
23406947|NCT02151786|65233880|FG000|Overall Study|Randomized, not Treated|1|||
23406948|NCT02151786|65233880|FG000|Overall Study|Unavailability of Information|8|||
23406949|NCT02727322|65233881|FG000|Overall Study|Withdrawal by Subject|1|||
23406950|NCT02727322|65233882|FG001|Overall Study|Withdrawal by Subject|1|||
23406951|NCT02727322|65233881|FG000|Overall Study|Protocol Violation|1|||
23406952|NCT02727322|65233882|FG001|Overall Study|Protocol Violation|0|||
23406953|NCT04971967|65233883|FG000|Overall Study|Lost to Follow-up|6|||
23406954|NCT04971967|65233884|FG001|Overall Study|Lost to Follow-up|7|||
23406955|NCT01837680|65233885|FG000|Overall Study|Lost to Follow-up|2|||
23406956|NCT01837680|65233886|FG001|Overall Study|Lost to Follow-up|2|||
23406957|NCT01837680|65233885|FG000|Overall Study|lack of insurance|0|||
23406958|NCT01837680|65233886|FG001|Overall Study|lack of insurance|2|||
23406959|NCT01837680|65233885|FG000|Overall Study|allergic reaction|6|||
23406960|NCT01837680|65233886|FG001|Overall Study|allergic reaction|0|||
23406961|NCT01837680|65233885|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
23406962|NCT01837680|65233886|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
23406963|NCT00251693|65233887|FG000|Overall Study|Adverse Event|17|||
23406964|NCT00251693|65233888|FG001|Overall Study|Adverse Event|9|||
23406965|NCT00251693|65233889|FG002|Overall Study|Adverse Event|9|||
23406966|NCT00251693|65233887|FG000|Overall Study|Protocol Violation|2|||
23406967|NCT00251693|65233888|FG001|Overall Study|Protocol Violation|0|||
23406968|NCT00251693|65233889|FG002|Overall Study|Protocol Violation|2|||
23406969|NCT00251693|65233887|FG000|Overall Study|Lost to Follow-up|12|||
23406970|NCT00251693|65233888|FG001|Overall Study|Lost to Follow-up|7|||
23406971|NCT00251693|65233889|FG002|Overall Study|Lost to Follow-up|8|||
23406972|NCT00251693|65233887|FG000|Overall Study|Withdrawal by Subject|11|||
23406973|NCT00251693|65233888|FG001|Overall Study|Withdrawal by Subject|17|||
23406974|NCT00251693|65233889|FG002|Overall Study|Withdrawal by Subject|14|||
23406975|NCT00251693|65233887|FG000|Overall Study|Lack of Efficacy|0|||
23406976|NCT00251693|65233888|FG001|Overall Study|Lack of Efficacy|1|||
23406977|NCT00251693|65233889|FG002|Overall Study|Lack of Efficacy|0|||
23406978|NCT00251693|65233887|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
23406979|NCT00251693|65233888|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
23406980|NCT00251693|65233889|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
23406981|NCT00251693|65233887|FG000|Overall Study|Noncompliant|0|||
23406982|NCT00251693|65233888|FG001|Overall Study|Noncompliant|0|||
23406983|NCT00251693|65233889|FG002|Overall Study|Noncompliant|2|||
23406984|NCT00251693|65233887|FG000|Overall Study|Possible Barrett's esophagus|3|||
23406985|NCT00251693|65233888|FG001|Overall Study|Possible Barrett's esophagus|5|||
23406986|NCT00251693|65233889|FG002|Overall Study|Possible Barrett's esophagus|2|||
23406987|NCT00251693|65233887|FG000|Overall Study|Subject request/subject unavailable|1|||
23406988|NCT00251693|65233888|FG001|Overall Study|Subject request/subject unavailable|2|||
23406989|NCT00251693|65233889|FG002|Overall Study|Subject request/subject unavailable|0|||
23406990|NCT00251693|65233887|FG000|Overall Study|Abnormal laboratory findings|0|||
23406991|NCT00251693|65233888|FG001|Overall Study|Abnormal laboratory findings|0|||
23406992|NCT00251693|65233889|FG002|Overall Study|Abnormal laboratory findings|1|||
23406993|NCT01333722|65233890|FG000|Overall Study|Lack of Efficacy|0|||
23406994|NCT01333722|65233891|FG001|Overall Study|Lack of Efficacy|2|||
23406995|NCT01333722|65233890|FG000|Overall Study|Withdrawal by Subject|0|||
23406996|NCT01333722|65233891|FG001|Overall Study|Withdrawal by Subject|1|||
23406997|NCT00465972|65233894|FG000|Overall Study|Withdrawal by Subject|2|||
23406998|NCT00465972|65233895|FG001|Overall Study|Withdrawal by Subject|1|||
23406999|NCT01582009|65233896|FG000|Overall Study|Withdrawal by Subject|1|||
23407000|NCT01582009|65233896|FG000|Overall Study|Physician Decision|1|||
23407001|NCT03338400|65233897|FG000|Overall Study|Lost to Follow-up|1|||
23407002|NCT03338400|65233898|FG001|Overall Study|Lost to Follow-up|2|||
23407003|NCT02015481|65233906|FG000|Overall Study|Death|1|||
23407004|NCT03386435|65233914|FG000|Overall Study|Protocol Violation|5|||
23407005|NCT03386435|65233915|FG001|Overall Study|Protocol Violation|7|||
23407006|NCT01146613|65233916|FG000|Overall Study|Lost to Follow-up|3|||
23407007|NCT01146613|65233917|FG001|Overall Study|Lost to Follow-up|8|||
23407008|NCT01146613|65233916|FG000|Overall Study|Lack of Efficacy|0|||
23407009|NCT01146613|65233917|FG001|Overall Study|Lack of Efficacy|1|||
23407010|NCT01146613|65233916|FG000|Overall Study|Death|1|||
23407011|NCT01146613|65233917|FG001|Overall Study|Death|0|||
23407012|NCT01146613|65233916|FG000|Overall Study|Physician Decision|1|||
23407013|NCT01146613|65233917|FG001|Overall Study|Physician Decision|0|||
23407014|NCT01146613|65233916|FG000|Overall Study|Withdrawal by Subject|0|||
23407015|NCT01146613|65233917|FG001|Overall Study|Withdrawal by Subject|3|||
23407016|NCT01146613|65233916|FG000|Overall Study|schedule conflict|1|||
23407017|NCT01146613|65233917|FG001|Overall Study|schedule conflict|0|||
23407018|NCT01146613|65233916|FG000|Overall Study|Outpatient detox|1|||
23407019|NCT01146613|65233917|FG001|Overall Study|Outpatient detox|0|||
23407020|NCT01696773|65236730|FG000|Days 15-27, Washout|Adverse Event|1|||
23407021|NCT01696773|65236731|FG001|Days 15-27, Washout|Adverse Event|0|||
23407022|NCT01127633|65236732|FG000|Overall Study|Adverse Event|74|||
23407023|NCT01127633|65236733|FG001|Overall Study|Adverse Event|73|||
23407024|NCT01127633|65236732|FG000|Overall Study|Death|40|||
23407025|NCT01127633|65236733|FG001|Overall Study|Death|43|||
23407026|NCT01127633|65236732|FG000|Overall Study|Lost to Follow-up|4|||
23407027|NCT01127633|65236733|FG001|Overall Study|Lost to Follow-up|0|||
23407028|NCT01127633|65236732|FG000|Overall Study|Parent/Caregiver Decision|246|||
23407029|NCT01127633|65236733|FG001|Overall Study|Parent/Caregiver Decision|228|||
23407030|NCT01127633|65236732|FG000|Overall Study|Physician Decision|60|||
23407031|NCT01127633|65236733|FG001|Overall Study|Physician Decision|45|||
23407032|NCT01127633|65236732|FG000|Overall Study|Withdrawal by Subject|57|||
23407033|NCT01127633|65236733|FG001|Overall Study|Withdrawal by Subject|72|||
23407034|NCT01127633|65236732|FG000|Overall Study|Sponsor Decision|163|||
23407035|NCT01127633|65236733|FG001|Overall Study|Sponsor Decision|195|||
23407036|NCT01127633|65236732|FG000|Overall Study|Protocol Violation|8|||
23407037|NCT01127633|65236733|FG001|Overall Study|Protocol Violation|16|||
23407038|NCT01127633|65236732|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
23407039|NCT01127633|65236733|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
23407040|NCT01127633|65236732|FG000|Overall Study|Not treated|1|||
23407041|NCT01127633|65236733|FG001|Overall Study|Not treated|0|||
23407042|NCT01063348|65236738|FG000|Overall Study|Lost to Follow-up|3|||
23407043|NCT01063348|65236739|FG001|Overall Study|Lost to Follow-up|10|||
23407044|NCT03276728|65236740|FG000|Overall Study|Lost to Follow-up|0|||
23407045|NCT03276728|65236741|FG001|Overall Study|Lost to Follow-up|0|||
23407046|NCT03276728|65236742|FG002|Overall Study|Lost to Follow-up|2|||
23407047|NCT03276728|65236743|FG003|Overall Study|Lost to Follow-up|2|||
23407048|NCT03276728|65236744|FG004|Overall Study|Lost to Follow-up|0|||
23407049|NCT03276728|65236745|FG005|Overall Study|Lost to Follow-up|0|||
23407050|NCT03276728|65236746|FG006|Overall Study|Lost to Follow-up|0|||
23407051|NCT03276728|65236747|FG007|Overall Study|Lost to Follow-up|0|||
23407052|NCT03276728|65236740|FG000|Overall Study|Withdrawal by Subject|0|||
23407053|NCT03276728|65236741|FG001|Overall Study|Withdrawal by Subject|0|||
23407054|NCT03276728|65236742|FG002|Overall Study|Withdrawal by Subject|0|||
23407055|NCT03276728|65236743|FG003|Overall Study|Withdrawal by Subject|3|||
23407056|NCT03276728|65236744|FG004|Overall Study|Withdrawal by Subject|0|||
23407057|NCT03276728|65236745|FG005|Overall Study|Withdrawal by Subject|0|||
23407058|NCT03276728|65236746|FG006|Overall Study|Withdrawal by Subject|0|||
23407059|NCT03276728|65236747|FG007|Overall Study|Withdrawal by Subject|0|||
23407060|NCT03276728|65236740|FG000|Overall Study|Decision by sponsor|0|||
23407061|NCT03276728|65236741|FG001|Overall Study|Decision by sponsor|0|||
23407062|NCT03276728|65236742|FG002|Overall Study|Decision by sponsor|0|||
23407063|NCT03276728|65236743|FG003|Overall Study|Decision by sponsor|0|||
23407064|NCT03276728|65236744|FG004|Overall Study|Decision by sponsor|1|||
23407065|NCT03276728|65236745|FG005|Overall Study|Decision by sponsor|0|||
23407066|NCT03276728|65236746|FG006|Overall Study|Decision by sponsor|2|||
23407067|NCT03276728|65236747|FG007|Overall Study|Decision by sponsor|1|||
23407068|NCT02720523|65236749|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407069|NCT02720523|65236750|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407070|NCT02720523|65236751|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
23407071|NCT02720523|65236752|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
23407072|NCT02720523|65236753|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407073|NCT02720523|65236754|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407074|NCT02720523|65236755|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
23407075|NCT02720523|65236749|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
23407076|NCT02720523|65236750|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407077|NCT02720523|65236751|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407078|NCT02720523|65236752|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407079|NCT02720523|65236753|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407080|NCT02720523|65236754|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407081|NCT02720523|65236755|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23407082|NCT02720523|65236749|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
23407083|NCT02720523|65236750|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407084|NCT02720523|65236751|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407085|NCT02720523|65236752|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407086|NCT02720523|65236753|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407087|NCT02720523|65236754|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407088|NCT02720523|65236755|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
23407089|NCT02720523|65236749|FG000|Period 1: Placebo-controlled Period|Other|0|||
23407090|NCT02720523|65236750|FG001|Period 1: Placebo-controlled Period|Other|0|||
23407091|NCT02720523|65236751|FG002|Period 1: Placebo-controlled Period|Other|1|||
23407092|NCT02720523|65236752|FG003|Period 1: Placebo-controlled Period|Other|1|||
23407093|NCT02720523|65236753|FG004|Period 1: Placebo-controlled Period|Other|0|||
23407094|NCT02720523|65236754|FG005|Period 1: Placebo-controlled Period|Other|0|||
23407095|NCT02720523|65236755|FG006|Period 1: Placebo-controlled Period|Other|0|||
23407096|NCT02720523|65236749|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
23407097|NCT02720523|65236750|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
23407098|NCT02720523|65236751|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
23407099|NCT02720523|65236752|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
23407100|NCT02720523|65236753|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
23407101|NCT02720523|65236754|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
23407102|NCT02720523|65236755|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
23407103|NCT02720523|65236749|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
23407104|NCT02720523|65236750|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
23407105|NCT02720523|65236751|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
23407106|NCT02720523|65236752|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
23407107|NCT02720523|65236753|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
23407108|NCT02720523|65236754|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
23407109|NCT02720523|65236755|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
23407110|NCT02720523|65236749|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
23407111|NCT02720523|65236750|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
23407112|NCT02720523|65236751|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
23407113|NCT02720523|65236752|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
23407114|NCT02720523|65236753|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
23407115|NCT02720523|65236754|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
23407116|NCT02720523|65236755|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
23407117|NCT02720523|65236749|FG000|Period 2: Long-term Extension Period|Other|0|||
23407118|NCT02720523|65236750|FG001|Period 2: Long-term Extension Period|Other|0|||
23407119|NCT02720523|65236751|FG002|Period 2: Long-term Extension Period|Other|0|||
23407120|NCT02720523|65236752|FG003|Period 2: Long-term Extension Period|Other|0|||
23407121|NCT02720523|65236753|FG004|Period 2: Long-term Extension Period|Other|2|||
23407122|NCT02720523|65236754|FG005|Period 2: Long-term Extension Period|Other|0|||
23407123|NCT02720523|65236755|FG006|Period 2: Long-term Extension Period|Other|3|||
23407124|NCT00992056|65236756|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
23407125|NCT00992056|65236757|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
23407126|NCT00992056|65236756|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
23407127|NCT00992056|65236757|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
23407128|NCT02685826|65236758|FG000|Overall Study|Adverse Event|2|||
23407129|NCT02685826|65236759|FG001|Overall Study|Adverse Event|0|||
23407130|NCT02685826|65236760|FG002|Overall Study|Adverse Event|1|||
23407131|NCT02685826|65236758|FG000|Overall Study|Progressive Disease|2|||
23407132|NCT02685826|65236759|FG001|Overall Study|Progressive Disease|1|||
23407133|NCT02685826|65236760|FG002|Overall Study|Progressive Disease|0|||
23407134|NCT02685826|65236758|FG000|Overall Study|Withdrawal by Subject|2|||
23407135|NCT02685826|65236759|FG001|Overall Study|Withdrawal by Subject|0|||
23407136|NCT02685826|65236760|FG002|Overall Study|Withdrawal by Subject|0|||
23407137|NCT02685826|65236758|FG000|Overall Study|Full Clinical Hold by FDA|19|||
23407138|NCT02685826|65236759|FG001|Overall Study|Full Clinical Hold by FDA|9|||
23407139|NCT02685826|65236760|FG002|Overall Study|Full Clinical Hold by FDA|20|||
23407140|NCT00401843|65236763|FG000|Overall Study|Achieved Complete Response|1|||
23407141|NCT00401843|65236764|FG001|Overall Study|Achieved Complete Response|5|||
23407142|NCT00401843|65236765|FG002|Overall Study|Achieved Complete Response|11|||
23407143|NCT00401843|65236763|FG000|Overall Study|Adverse Event|7|||
23407144|NCT00401843|65236764|FG001|Overall Study|Adverse Event|26|||
23407145|NCT00401843|65236765|FG002|Overall Study|Adverse Event|27|||
23407146|NCT00401843|65236763|FG000|Overall Study|Death|0|||
23407147|NCT00401843|65236764|FG001|Overall Study|Death|8|||
23407148|NCT00401843|65236765|FG002|Overall Study|Death|10|||
23407149|NCT00401843|65236763|FG000|Overall Study|Disease progression|10|||
23407150|NCT00401843|65236764|FG001|Overall Study|Disease progression|60|||
23407151|NCT00401843|65236765|FG002|Overall Study|Disease progression|49|||
23407152|NCT00401843|65236763|FG000|Overall Study|End of Study|1|||
23407153|NCT00401843|65236764|FG001|Overall Study|End of Study|1|||
23407154|NCT00401843|65236765|FG002|Overall Study|End of Study|2|||
23407155|NCT00401843|65236763|FG000|Overall Study|Lost to Follow-up|0|||
23407156|NCT00401843|65236764|FG001|Overall Study|Lost to Follow-up|0|||
23407157|NCT00401843|65236765|FG002|Overall Study|Lost to Follow-up|2|||
23407158|NCT00401843|65236763|FG000|Overall Study|Other Unspecified|0|||
23407159|NCT00401843|65236764|FG001|Overall Study|Other Unspecified|3|||
23407160|NCT00401843|65236765|FG002|Overall Study|Other Unspecified|5|||
23407161|NCT00401843|65236763|FG000|Overall Study|Physician Decision|0|||
23407162|NCT00401843|65236764|FG001|Overall Study|Physician Decision|16|||
23407163|NCT00401843|65236765|FG002|Overall Study|Physician Decision|10|||
23407164|NCT00401843|65236763|FG000|Overall Study|Protocol Violation|0|||
23407165|NCT00401843|65236764|FG001|Overall Study|Protocol Violation|0|||
23407166|NCT00401843|65236765|FG002|Overall Study|Protocol Violation|1|||
23407167|NCT00401843|65236763|FG000|Overall Study|Withdrawal by Subject|1|||
23407168|NCT00401843|65236764|FG001|Overall Study|Withdrawal by Subject|5|||
23407169|NCT00401843|65236765|FG002|Overall Study|Withdrawal by Subject|5|||
23407170|NCT00401843|65236763|FG000|Overall Study|Withdrawal of consent to study agent|1|||
23407171|NCT00401843|65236764|FG001|Overall Study|Withdrawal of consent to study agent|15|||
23407172|NCT00401843|65236765|FG002|Overall Study|Withdrawal of consent to study agent|17|||
23407173|NCT00401843|65236763|FG000|Overall Study|Randomized but not Treated|0|||
23407174|NCT00401843|65236764|FG001|Overall Study|Randomized but not Treated|2|||
23407175|NCT00401843|65236765|FG002|Overall Study|Randomized but not Treated|3|||
23407176|NCT00401843|65236763|FG000|Overall Study|Received incorrect treatment|0|||
23407177|NCT00401843|65236764|FG001|Overall Study|Received incorrect treatment|3|||
23407178|NCT00401843|65236765|FG002|Overall Study|Received incorrect treatment|0|||
23407179|NCT01485796|65236766|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
23407180|NCT01485796|65236766|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
23407181|NCT01485796|65236766|FG000|Period 2: Epoch 2|Adverse Event|3|||
23407182|NCT01485796|65236766|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
23407183|NCT01485796|65236766|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
23407184|NCT01485796|65236766|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
23407185|NCT01485796|65236766|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
23407186|NCT01485796|65236766|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
23407187|NCT00603941|65236770|FG000|Overall Study|Disease progression|6|||
23407188|NCT00603941|65236771|FG001|Overall Study|Disease progression|7|||
23407189|NCT00603941|65236772|FG002|Overall Study|Disease progression|1|||
23407190|NCT00603941|65236770|FG000|Overall Study|Adverse Event|1|||
23407191|NCT00603941|65236771|FG001|Overall Study|Adverse Event|0|||
23407192|NCT00603941|65236772|FG002|Overall Study|Adverse Event|1|||
23407193|NCT00603941|65236770|FG000|Overall Study|Physician Decision|0|||
23407194|NCT00603941|65236771|FG001|Overall Study|Physician Decision|1|||
23407195|NCT00603941|65236772|FG002|Overall Study|Physician Decision|0|||
23407196|NCT00603941|65236770|FG000|Overall Study|Withdrawal by Subject|0|||
23407197|NCT00603941|65236771|FG001|Overall Study|Withdrawal by Subject|2|||
23407198|NCT00603941|65236772|FG002|Overall Study|Withdrawal by Subject|0|||
23407199|NCT02278341|65236773|FG000|Overall Study|Randomized but never received study drug|1|||
23407200|NCT02278341|65236774|FG001|Overall Study|Randomized but never received study drug|1|||
23407201|NCT02278341|65236773|FG000|Overall Study|Adverse Event|3|||
23407202|NCT02278341|65236774|FG001|Overall Study|Adverse Event|0|||
23407203|NCT02278341|65236773|FG000|Overall Study|Death|68|||
23407204|NCT02278341|65236774|FG001|Overall Study|Death|56|||
23407205|NCT02278341|65236773|FG000|Overall Study|Withdrawal by Subject|30|||
23407206|NCT02278341|65236774|FG001|Overall Study|Withdrawal by Subject|19|||
23407207|NCT02278341|65236773|FG000|Overall Study|Lost to Follow-up|0|||
23407208|NCT02278341|65236774|FG001|Overall Study|Lost to Follow-up|1|||
23407209|NCT02278341|65236773|FG000|Overall Study|Physician Decision|1|||
23407210|NCT02278341|65236774|FG001|Overall Study|Physician Decision|1|||
23407211|NCT02278341|65236773|FG000|Overall Study|Miscellaneous|15|||
23407212|NCT02278341|65236774|FG001|Overall Study|Miscellaneous|14|||
23407213|NCT02454530|65236781|FG000|Overall Study|Other|8|||
23407214|NCT02454530|65236782|FG001|Overall Study|Other|13|||
23407215|NCT02454530|65236781|FG000|Overall Study|Missing information|56|||
23407216|NCT02454530|65236782|FG001|Overall Study|Missing information|69|||
23407217|NCT02454530|65236781|FG000|Overall Study|Death|2|||
23407218|NCT02454530|65236782|FG001|Overall Study|Death|41|||
23407219|NCT02454530|65236781|FG000|Overall Study|Lost to Follow-up|4|||
23407220|NCT02454530|65236782|FG001|Overall Study|Lost to Follow-up|4|||
23407221|NCT04194944|65236783|FG000|Overall Study|Lost to Follow-up|3|||
23407222|NCT04194944|65236784|FG001|Overall Study|Lost to Follow-up|0|||
23407223|NCT04194944|65236783|FG000|Overall Study|Withdrawal by Subject|2|||
23407224|NCT04194944|65236784|FG001|Overall Study|Withdrawal by Subject|2|||
23407225|NCT04194944|65236783|FG000|Overall Study|On Treatment|93|||
23407226|NCT04194944|65236784|FG001|Overall Study|On Treatment|30|||
23407227|NCT03369665|65236785|FG000|Overall Study|Adverse Event|3|||
23407228|NCT03369665|65236785|FG000|Overall Study|Lost to Follow-up|7|||
23407229|NCT03369665|65236785|FG000|Overall Study|Withdrawal by Subject|15|||
23407230|NCT03369665|65236785|FG000|Overall Study|Progression Disease|2|||
23407231|NCT03369665|65236785|FG000|Overall Study|Not classified|3|||
23407232|NCT01970241|65236788|FG000|Overall Study|Withdrawal by Subject|2|||
23407233|NCT01970241|65236789|FG001|Overall Study|Withdrawal by Subject|0|||
23407234|NCT01970241|65236788|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
23407235|NCT01970241|65236789|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
23407236|NCT00114127|65236790|FG000|Overall Study|Adverse Event|2|||
23407237|NCT00114127|65236791|FG001|Overall Study|Adverse Event|1|||
23407238|NCT00114127|65236790|FG000|Overall Study|Lost to Follow-up|1|||
23407239|NCT00114127|65236791|FG001|Overall Study|Lost to Follow-up|0|||
23407240|NCT00114127|65236790|FG000|Overall Study|Withdrawal by Subject|1|||
23407241|NCT00114127|65236791|FG001|Overall Study|Withdrawal by Subject|3|||
23407242|NCT01135459|65236792|FG000|Overall Study|Adverse Event|8|||
23407243|NCT01135459|65236793|FG001|Overall Study|Adverse Event|10|||
23407244|NCT01135459|65236792|FG000|Overall Study|Lack of Efficacy|3|||
23407245|NCT01135459|65236793|FG001|Overall Study|Lack of Efficacy|1|||
23407246|NCT01135459|65236792|FG000|Overall Study|Withdrawal by Subject|2|||
23407247|NCT01135459|65236793|FG001|Overall Study|Withdrawal by Subject|3|||
23407248|NCT01135459|65236792|FG000|Overall Study|Protocol Violation|5|||
23407249|NCT01135459|65236793|FG001|Overall Study|Protocol Violation|3|||
23407250|NCT01135459|65236792|FG000|Overall Study|Lost to Follow-up|2|||
23407251|NCT01135459|65236793|FG001|Overall Study|Lost to Follow-up|1|||
23407252|NCT01135459|65236792|FG000|Overall Study|Non-compliance to study procedures|0|||
23407253|NCT01135459|65236793|FG001|Overall Study|Non-compliance to study procedures|1|||
23407254|NCT01135459|65236792|FG000|Overall Study|Other than specified|1|||
23407255|NCT01135459|65236793|FG001|Overall Study|Other than specified|1|||
23407256|NCT02257242|65236802|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
23407257|NCT02257242|65236803|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407258|NCT02257242|65236804|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407259|NCT02257242|65236805|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407260|NCT02257242|65236806|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407261|NCT02257242|65236807|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407262|NCT02257242|65236808|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407263|NCT02257242|65236809|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407264|NCT02257242|65236810|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
23407265|NCT01000506|65236814|FG000|Overall Study|Adverse Event|6|||
23407266|NCT01000506|65236815|FG001|Overall Study|Adverse Event|5|||
23407267|NCT01000506|65236816|FG002|Overall Study|Adverse Event|8|||
23407268|NCT01000506|65236817|FG003|Overall Study|Adverse Event|9|||
23407269|NCT01000506|65236814|FG000|Overall Study|Lack of Efficacy|8|||
23407270|NCT01000506|65236815|FG001|Overall Study|Lack of Efficacy|6|||
23407271|NCT01000506|65236816|FG002|Overall Study|Lack of Efficacy|4|||
23407272|NCT01000506|65236817|FG003|Overall Study|Lack of Efficacy|4|||
23407273|NCT01000506|65236814|FG000|Overall Study|Protocol Violation|1|||
23407274|NCT01000506|65236815|FG001|Overall Study|Protocol Violation|1|||
23407275|NCT01000506|65236816|FG002|Overall Study|Protocol Violation|0|||
23407276|NCT01000506|65236817|FG003|Overall Study|Protocol Violation|0|||
23407277|NCT01000506|65236814|FG000|Overall Study|Lost to Follow-up|1|||
23407278|NCT01000506|65236815|FG001|Overall Study|Lost to Follow-up|1|||
23407279|NCT01000506|65236816|FG002|Overall Study|Lost to Follow-up|4|||
23407280|NCT01000506|65236817|FG003|Overall Study|Lost to Follow-up|0|||
23407281|NCT01000506|65236814|FG000|Overall Study|Physician Decision|1|||
23407282|NCT01000506|65236815|FG001|Overall Study|Physician Decision|3|||
23407283|NCT01000506|65236816|FG002|Overall Study|Physician Decision|3|||
23407284|NCT01000506|65236817|FG003|Overall Study|Physician Decision|3|||
23407285|NCT01000506|65236814|FG000|Overall Study|Withdrawal by Subject|11|||
23407286|NCT01000506|65236815|FG001|Overall Study|Withdrawal by Subject|8|||
23407287|NCT01000506|65236816|FG002|Overall Study|Withdrawal by Subject|2|||
23407288|NCT01000506|65236817|FG003|Overall Study|Withdrawal by Subject|7|||
23407289|NCT01393899|65236818|FG000|Overall Study|Study terminated by sponsor|1|||
23407290|NCT01393899|65236819|FG001|Overall Study|Study terminated by sponsor|0|||
23407291|NCT01393899|65236820|FG002|Overall Study|Study terminated by sponsor|1|||
23407292|NCT01393899|65236818|FG000|Overall Study|Other|1|||
23407293|NCT01393899|65236819|FG001|Overall Study|Other|0|||
23407294|NCT01393899|65236820|FG002|Overall Study|Other|0|||
23407295|NCT01393899|65236818|FG000|Overall Study|Withdrawal by Subject|2|||
23407296|NCT01393899|65236819|FG001|Overall Study|Withdrawal by Subject|2|||
23407297|NCT01393899|65236820|FG002|Overall Study|Withdrawal by Subject|1|||
23407298|NCT01393899|65236818|FG000|Overall Study|Lost to Follow-up|0|||
23407299|NCT01393899|65236819|FG001|Overall Study|Lost to Follow-up|0|||
23407300|NCT01393899|65236820|FG002|Overall Study|Lost to Follow-up|1|||
23407301|NCT01393899|65236818|FG000|Overall Study|Does not meet entrance criteria|1|||
23407302|NCT01393899|65236819|FG001|Overall Study|Does not meet entrance criteria|0|||
23407303|NCT01393899|65236820|FG002|Overall Study|Does not meet entrance criteria|1|||
23407304|NCT01393899|65236818|FG000|Overall Study|Lack of Efficacy|26|||
23407305|NCT01393899|65236819|FG001|Overall Study|Lack of Efficacy|21|||
23407306|NCT01393899|65236820|FG002|Overall Study|Lack of Efficacy|16|||
23407307|NCT01393899|65236818|FG000|Overall Study|Adverse Event|1|||
23407308|NCT01393899|65236819|FG001|Overall Study|Adverse Event|5|||
23407309|NCT01393899|65236820|FG002|Overall Study|Adverse Event|3|||
23407310|NCT03159468|65236821|FG000|Overall Study|Withdrawal by Subject|0|||
23407311|NCT03159468|65236822|FG001|Overall Study|Withdrawal by Subject|0|||
23407312|NCT03159468|65236823|FG002|Overall Study|Withdrawal by Subject|3|||
23407313|NCT03159468|65236824|FG003|Overall Study|Withdrawal by Subject|0|||
23407314|NCT03159468|65236825|FG004|Overall Study|Withdrawal by Subject|0|||
23407315|NCT03159468|65236826|FG005|Overall Study|Withdrawal by Subject|0|||
23407316|NCT02819297|65236827|FG000|Overall Study|Withdrawal by Subject|25|||
23407317|NCT02819297|65236828|FG001|Overall Study|Withdrawal by Subject|13|||
23407318|NCT02819297|65236827|FG000|Overall Study|Lost to Follow-up|12|||
23407319|NCT02819297|65236828|FG001|Overall Study|Lost to Follow-up|14|||
23407320|NCT02819297|65236827|FG000|Overall Study|Adverse Event|12|||
23607368|NCT03031782|65950680|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23407321|NCT02819297|65236828|FG001|Overall Study|Adverse Event|10|||
23407322|NCT02819297|65236827|FG000|Overall Study|Physician Decision|5|||
23407323|NCT02819297|65236828|FG001|Overall Study|Physician Decision|5|||
23407324|NCT02819297|65236827|FG000|Overall Study|Lack of Efficacy|5|||
23407325|NCT02819297|65236828|FG001|Overall Study|Lack of Efficacy|8|||
23407326|NCT02819297|65236827|FG000|Overall Study|Protocol Violation|1|||
23407327|NCT02819297|65236828|FG001|Overall Study|Protocol Violation|2|||
23407328|NCT01462929|65236831|FG000|Overall Study|Adverse Event|3|||
23407329|NCT01462929|65236832|FG001|Overall Study|Adverse Event|3|||
23407330|NCT01462929|65236833|FG002|Overall Study|Adverse Event|4|||
23407331|NCT01462929|65236831|FG000|Overall Study|Withdrawal by Subject|2|||
23407332|NCT01462929|65236832|FG001|Overall Study|Withdrawal by Subject|1|||
23407333|NCT01462929|65236833|FG002|Overall Study|Withdrawal by Subject|0|||
23407334|NCT01462929|65236831|FG000|Overall Study|Lack of Efficacy|0|||
23407335|NCT01462929|65236832|FG001|Overall Study|Lack of Efficacy|0|||
23407336|NCT01462929|65236833|FG002|Overall Study|Lack of Efficacy|1|||
23407337|NCT04162470|65236843|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
23407338|NCT02524145|65236844|FG000|Overall Study|Withdrawal by Subject|2|||
23407339|NCT02524145|65236845|FG001|Overall Study|Withdrawal by Subject|2|||
23407340|NCT02524145|65236846|FG002|Overall Study|Withdrawal by Subject|3|||
23407341|NCT03549338|65236847|FG000|Overall Study|Progressive Disease|1|||
23407342|NCT03549338|65236848|FG001|Overall Study|Progressive Disease|0|||
23407343|NCT03549338|65236849|FG002|Overall Study|Progressive Disease|0|||
23407344|NCT03549338|65236847|FG000|Overall Study|Clinical Progression|0|||
23407345|NCT03549338|65236848|FG001|Overall Study|Clinical Progression|1|||
23407346|NCT03549338|65236849|FG002|Overall Study|Clinical Progression|0|||
23407347|NCT03902392|65236850|FG000|Overall Study|Lost to Follow-up|7|||
23407348|NCT03902392|65236851|FG001|Overall Study|Lost to Follow-up|7|||
23407349|NCT00625586|65236856|FG000|Overall Study|Adverse Event|1|||
23407350|NCT00625586|65236856|FG000|Overall Study|Progressive disease|1|||
23407351|NCT02581891|65236857|FG000|Overall Study|Adverse Event|4|||
23407352|NCT02581891|65236858|FG001|Overall Study|Adverse Event|6|||
23407353|NCT02581891|65236857|FG000|Overall Study|Death|3|||
23407354|NCT02581891|65236858|FG001|Overall Study|Death|4|||
23407355|NCT02581891|65236857|FG000|Overall Study|Lost to Follow-up|1|||
23407356|NCT02581891|65236858|FG001|Overall Study|Lost to Follow-up|2|||
23407357|NCT02581891|65236857|FG000|Overall Study|Physician Decision|0|||
23407358|NCT02581891|65236858|FG001|Overall Study|Physician Decision|1|||
23407359|NCT02581891|65236857|FG000|Overall Study|Withdrawal by Subject|4|||
23407360|NCT02581891|65236858|FG001|Overall Study|Withdrawal by Subject|5|||
23407361|NCT02581891|65236857|FG000|Overall Study|Other Reasons|3|||
23407362|NCT02581891|65236858|FG001|Overall Study|Other Reasons|1|||
23407363|NCT02581891|65236857|FG000|Overall Study|Discontinued during followup|1|||
23407364|NCT02581891|65236858|FG001|Overall Study|Discontinued during followup|0|||
23407365|NCT03783962|65236860|FG000|Overall Study|Lost to Follow-up|3|||
23407366|NCT03783962|65236861|FG001|Overall Study|Lost to Follow-up|6|||
23407367|NCT03783962|65236860|FG000|Overall Study|Protocol Violation|0|||
23407368|NCT03783962|65236861|FG001|Overall Study|Protocol Violation|1|||
23407369|NCT00469833|65236866|FG000|Overall Study|No IV access|2|||
23407370|NCT01194245|65236867|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
23407371|NCT01194245|65236868|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
23407372|NCT01194245|65236869|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
23407373|NCT01194245|65236870|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
23407374|NCT01194245|65236871|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
23407375|NCT01194245|65236867|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
23407376|NCT01194245|65236868|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
23407377|NCT01194245|65236869|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
23407378|NCT01194245|65236870|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
23407379|NCT01194245|65236871|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
23407380|NCT01194245|65236867|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
23407381|NCT01194245|65236868|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
23407382|NCT01194245|65236869|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
23407383|NCT01194245|65236870|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
23407384|NCT01194245|65236871|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
23407385|NCT01194245|65236867|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
23407386|NCT01194245|65236868|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
23506152|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23407387|NCT01194245|65236869|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
23407388|NCT01194245|65236870|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
23407389|NCT01194245|65236871|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
23506153|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23506154|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
23407390|NCT01194245|65236867|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23607369|NCT03031782|65950681|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23407391|NCT01194245|65236868|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23407392|NCT01194245|65236869|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23407393|NCT01194245|65236870|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23407394|NCT01194245|65236871|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
23407395|NCT01194245|65236867|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23407396|NCT01194245|65236868|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23407397|NCT01194245|65236869|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
23407398|NCT01194245|65236870|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
23407399|NCT01194245|65236871|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
23407400|NCT02484443|65236872|FG000|Overall Study|Lack of Efficacy|28|||
23407401|NCT02484443|65236872|FG000|Overall Study|Physician Decision|2|||
23407402|NCT02484443|65236872|FG000|Overall Study|Ineligible|2|||
23407403|NCT06164691|65236873|FG000|Overall Study|Withdrawal by Subject|2|||
23407404|NCT06164691|65236874|FG001|Overall Study|Withdrawal by Subject|0|||
23407405|NCT06164691|65236875|FG002|Overall Study|Withdrawal by Subject|0|||
23407406|NCT03230318|65236876|FG000|Overall Study|Radiographic disease progression|72|||
23407407|NCT03230318|65236877|FG001|Overall Study|Radiographic disease progression|19|||
23407408|NCT03230318|65236876|FG000|Overall Study|Clinical progression|17|||
23407409|NCT03230318|65236877|FG001|Overall Study|Clinical progression|7|||
23407410|NCT03230318|65236876|FG000|Overall Study|Adverse Event|5|||
23407411|NCT03230318|65236877|FG001|Overall Study|Adverse Event|3|||
23407412|NCT03230318|65236876|FG000|Overall Study|Physician Decision|2|||
23407413|NCT03230318|65236877|FG001|Overall Study|Physician Decision|3|||
23407414|NCT03230318|65236876|FG000|Overall Study|Death|3|||
23407415|NCT03230318|65236877|FG001|Overall Study|Death|2|||
23407416|NCT03230318|65236876|FG000|Overall Study|Lost to Follow-up|1|||
23407417|NCT03230318|65236877|FG001|Overall Study|Lost to Follow-up|0|||
23407418|NCT03230318|65236876|FG000|Overall Study|Withdrawal by Subject|1|||
23407419|NCT03230318|65236877|FG001|Overall Study|Withdrawal by Subject|3|||
23407420|NCT03230318|65236876|FG000|Overall Study|Other|3|||
23407421|NCT03230318|65236877|FG001|Overall Study|Other|7|||
23407422|NCT01664247|65236882|FG000|Overall Study|Adverse Event|5|||
23407423|NCT01664247|65236883|FG001|Overall Study|Adverse Event|3|||
23407424|NCT01664247|65236882|FG000|Overall Study|Protocol Violation|3|||
23407425|NCT01664247|65236883|FG001|Overall Study|Protocol Violation|5|||
23407426|NCT01664247|65236882|FG000|Overall Study|Withdrawal Criteria|1|||
23407427|NCT01664247|65236883|FG001|Overall Study|Withdrawal Criteria|4|||
23407428|NCT01664247|65236882|FG000|Overall Study|Unclassified|5|||
23407429|NCT01664247|65236883|FG001|Overall Study|Unclassified|29|||
23407430|NCT01508910|65236891|FG000|Treatment|Death|2|||
23407431|NCT01508910|65236892|FG001|Treatment|Death|3|||
23407432|NCT01508910|65236893|FG002|Treatment|Death|2|||
23407433|NCT01508910|65236894|FG003|Treatment|Death|0|||
23407434|NCT01508910|65236891|FG000|Treatment|Lost to Follow-up|0|||
23407435|NCT01508910|65236892|FG001|Treatment|Lost to Follow-up|0|||
23407436|NCT01508910|65236893|FG002|Treatment|Lost to Follow-up|2|||
23407437|NCT01508910|65236894|FG003|Treatment|Lost to Follow-up|1|||
23407438|NCT01508910|65236891|FG000|Treatment|Withdrawal by Subject|0|||
23407439|NCT01508910|65236892|FG001|Treatment|Withdrawal by Subject|1|||
23407440|NCT01508910|65236893|FG002|Treatment|Withdrawal by Subject|6|||
23407441|NCT01508910|65236894|FG003|Treatment|Withdrawal by Subject|1|||
23407442|NCT01508910|65236891|FG000|Treatment|Sponsor Decision|0|||
23407443|NCT01508910|65236892|FG001|Treatment|Sponsor Decision|0|||
23407444|NCT01508910|65236893|FG002|Treatment|Sponsor Decision|0|||
23407445|NCT01508910|65236894|FG003|Treatment|Sponsor Decision|1|||
23407446|NCT00996658|65236895|FG000|Overall Study|Adverse Event|2|||
23407447|NCT00996658|65236896|FG001|Overall Study|Adverse Event|5|||
23407448|NCT00996658|65236895|FG000|Overall Study|Protocol Violation|0|||
23407449|NCT00996658|65236896|FG001|Overall Study|Protocol Violation|1|||
23407450|NCT00996658|65236895|FG000|Overall Study|Lost to Follow-up|2|||
23407451|NCT00996658|65236896|FG001|Overall Study|Lost to Follow-up|5|||
23407452|NCT00996658|65236895|FG000|Overall Study|Non-compliance issues|3|||
23407453|NCT00996658|65236896|FG001|Overall Study|Non-compliance issues|3|||
23506155|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
23407454|NCT00996658|65236895|FG000|Overall Study|Other|9|||
23407455|NCT00996658|65236896|FG001|Overall Study|Other|7|||
23407456|NCT01648023|65236900|FG000|Overall Study|Screen Fail Post Randomization|1|||
23407457|NCT01648023|65236901|FG001|Overall Study|Screen Fail Post Randomization|2|||
23407458|NCT01106157|65236902|FG000|Overall Study|Withdrawal by Subject|1|||
23407459|NCT01106157|65236903|FG001|Overall Study|Withdrawal by Subject|0|||
23407460|NCT00642707|65236904|FG000|Overall Study|Adverse Event|0|||
23407461|NCT00642707|65236905|FG001|Overall Study|Adverse Event|0|||
23407462|NCT00642707|65236906|FG002|Overall Study|Adverse Event|0|||
23407463|NCT00642707|65236907|FG003|Overall Study|Adverse Event|2|||
23407464|NCT00642707|65236904|FG000|Overall Study|Withdrawal by Subject|1|||
23607370|NCT03031782|65950682|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23407465|NCT00642707|65236905|FG001|Overall Study|Withdrawal by Subject|0|||
23407466|NCT00642707|65236906|FG002|Overall Study|Withdrawal by Subject|0|||
23407467|NCT00642707|65236907|FG003|Overall Study|Withdrawal by Subject|0|||
23407468|NCT01881009|65236912|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
23407469|NCT01881009|65236913|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
23407470|NCT01722994|65236915|FG000|Overall Study|Missing data|25|||
23407471|NCT01722994|65236916|FG001|Overall Study|Missing data|17|||
23407472|NCT02148263|65236917|FG000|Overall Study|Withdrawal by Subject|3|||
23407473|NCT02148263|65236918|FG001|Overall Study|Withdrawal by Subject|2|||
23407474|NCT00470262|65236919|FG000|Overall Study|Withdrawal by Subject|2|||
23407475|NCT00470262|65236920|FG001|Overall Study|Withdrawal by Subject|0|||
23407476|NCT00699413|65236921|FG000|Overall Study|Withdrawal by Subject|0|||
23407477|NCT00699413|65236922|FG001|Overall Study|Withdrawal by Subject|2|||
23407478|NCT00699413|65236921|FG000|Overall Study|Study terminated by sponsor|4|||
23407479|NCT00699413|65236922|FG001|Overall Study|Study terminated by sponsor|2|||
23407480|NCT03135431|65236923|FG000|Overall Study|Study Surgeon not available|2|||
23407481|NCT03135431|65236924|FG001|Overall Study|Study Surgeon not available|0|||
23407482|NCT02779777|65236925|FG000|Overall Study|Disease Progression|1|||
23407483|NCT02779777|65236926|FG001|Overall Study|Disease Progression|0|||
23407484|NCT02779777|65236927|FG002|Overall Study|Disease Progression|0|||
23407485|NCT02779777|65236925|FG000|Overall Study|Adverse Event|3|||
23407486|NCT02779777|65236926|FG001|Overall Study|Adverse Event|1|||
23407487|NCT02779777|65236927|FG002|Overall Study|Adverse Event|0|||
23407488|NCT02779777|65236925|FG000|Overall Study|Physician Decision|9|||
23407489|NCT02779777|65236926|FG001|Overall Study|Physician Decision|0|||
23407490|NCT02779777|65236927|FG002|Overall Study|Physician Decision|1|||
23407491|NCT02779777|65236925|FG000|Overall Study|Withdrawal by Subject|1|||
23407492|NCT02779777|65236926|FG001|Overall Study|Withdrawal by Subject|0|||
23407493|NCT02779777|65236927|FG002|Overall Study|Withdrawal by Subject|0|||
23407494|NCT00809926|65236928|FG000|Overall Study|Adverse Event|18|||
23407495|NCT00809926|65236929|FG001|Overall Study|Adverse Event|10|||
23407496|NCT00809926|65236928|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23407497|NCT00809926|65236929|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23407498|NCT00809926|65236928|FG000|Overall Study|Patient withdrew consent|8|||
23407499|NCT00809926|65236929|FG001|Overall Study|Patient withdrew consent|6|||
23407500|NCT00809926|65236928|FG000|Overall Study|Lost to Follow-up|2|||
23407501|NCT00809926|65236929|FG001|Overall Study|Lost to Follow-up|1|||
23407502|NCT00809926|65236928|FG000|Overall Study|Administrative Problems|0|||
23407503|NCT00809926|65236929|FG001|Overall Study|Administrative Problems|1|||
23407504|NCT00809926|65236928|FG000|Overall Study|Protocol deviation|0|||
23407505|NCT00809926|65236929|FG001|Overall Study|Protocol deviation|2|||
23407506|NCT00803738|65236933|FG000|Overall Study|Adverse Event|3|||
23407507|NCT00803738|65236934|FG001|Overall Study|Adverse Event|5|||
23407508|NCT00803738|65236933|FG000|Overall Study|Lost to Follow-up|4|||
23407509|NCT00803738|65236934|FG001|Overall Study|Lost to Follow-up|4|||
23407510|NCT00803738|65236933|FG000|Overall Study|Protocol Violation|18|||
23407511|NCT00803738|65236934|FG001|Overall Study|Protocol Violation|10|||
23407512|NCT00803738|65236933|FG000|Overall Study|Withdrawal by Subject|1|||
23407513|NCT00803738|65236934|FG001|Overall Study|Withdrawal by Subject|4|||
23407514|NCT00803738|65236933|FG000|Overall Study|Lack of Efficacy|10|||
23407515|NCT00803738|65236934|FG001|Overall Study|Lack of Efficacy|16|||
23407516|NCT00803738|65236933|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
23407517|NCT00803738|65236934|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
23407518|NCT00803738|65236933|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
23407519|NCT00803738|65236934|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
23407520|NCT02676895|65236938|FG000|Overall Study|Administrative reason|1|||
23407521|NCT02676895|65236939|FG001|Overall Study|Administrative reason|0|||
23407522|NCT02676895|65236940|FG002|Overall Study|Administrative reason|0|||
23407523|NCT02676895|65236938|FG000|Overall Study|Protocol Violation|1|||
23407524|NCT02676895|65236939|FG001|Overall Study|Protocol Violation|0|||
23407525|NCT02676895|65236940|FG002|Overall Study|Protocol Violation|0|||
23407526|NCT02676895|65236938|FG000|Overall Study|Adverse Event|0|||
23407527|NCT02676895|65236939|FG001|Overall Study|Adverse Event|3|||
23407528|NCT02676895|65236940|FG002|Overall Study|Adverse Event|1|||
23407529|NCT02676895|65236938|FG000|Overall Study|Lost to Follow-up|0|||
23407530|NCT02676895|65236939|FG001|Overall Study|Lost to Follow-up|0|||
23407531|NCT02676895|65236940|FG002|Overall Study|Lost to Follow-up|1|||
23407532|NCT02676895|65236938|FG000|Overall Study|Withdrawal by Subject|0|||
23407533|NCT02676895|65236939|FG001|Overall Study|Withdrawal by Subject|0|||
23407534|NCT02676895|65236940|FG002|Overall Study|Withdrawal by Subject|1|||
23407535|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
23407536|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
23407537|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407538|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407539|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407540|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407541|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407542|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407543|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407544|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
23407545|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
23407546|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
23407547|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407548|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407549|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407550|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407551|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407552|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407553|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407554|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
23407555|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
23407556|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407557|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407558|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407559|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407560|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407561|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407562|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407563|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407564|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
23407565|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
23407566|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
23407567|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407568|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407569|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407570|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407571|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407572|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407573|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407574|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
23407575|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407576|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
23407577|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407578|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407579|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407580|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407581|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407582|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407583|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407584|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
23407585|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
23407586|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
23407587|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407588|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407589|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407590|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407591|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407592|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407593|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407594|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
23407595|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
23407596|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
23407597|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407598|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407599|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407600|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407601|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407602|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407603|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407604|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
23407605|NCT01194219|65236941|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
23407606|NCT01194219|65236942|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
23407607|NCT01194219|65236943|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407608|NCT01194219|65236944|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407609|NCT01194219|65236945|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407610|NCT01194219|65236946|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407611|NCT01194219|65236947|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407612|NCT01194219|65236948|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407613|NCT01194219|65236949|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407614|NCT01194219|65236950|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
23407615|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407616|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407617|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
23407618|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
23407619|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407620|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407621|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407622|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407623|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407624|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
23407625|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407626|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407627|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
23407628|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
23407629|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407630|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407631|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407632|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407633|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407634|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
23407635|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407636|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407637|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
23407638|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
23407639|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407640|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407641|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407642|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407643|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407644|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
23407645|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407646|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407647|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
23407648|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
23407649|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407650|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407651|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407652|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407653|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407654|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
23407655|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407656|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407657|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
23407658|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407659|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407660|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407661|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407662|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407663|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407664|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
23407665|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407666|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407667|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407668|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
23407669|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407670|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407671|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407672|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407673|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23506156|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
23506157|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
23607371|NCT03031782|65950683|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23407674|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
23407675|NCT01194219|65236941|FG000|Maintenance Phase Weeks16-32|Other|0|||
23407676|NCT01194219|65236942|FG001|Maintenance Phase Weeks16-32|Other|0|||
23407677|NCT01194219|65236943|FG002|Maintenance Phase Weeks16-32|Other|2|||
23407678|NCT01194219|65236944|FG003|Maintenance Phase Weeks16-32|Other|1|||
23407679|NCT01194219|65236945|FG004|Maintenance Phase Weeks16-32|Other|0|||
23407680|NCT01194219|65236946|FG005|Maintenance Phase Weeks16-32|Other|0|||
23407681|NCT01194219|65236947|FG006|Maintenance Phase Weeks16-32|Other|0|||
23407682|NCT01194219|65236948|FG007|Maintenance Phase Weeks16-32|Other|0|||
23407683|NCT01194219|65236949|FG008|Maintenance Phase Weeks16-32|Other|0|||
23407684|NCT01194219|65236950|FG009|Maintenance Phase Weeks16-32|Other|0|||
23407685|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407686|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407687|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407688|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407689|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407690|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
23407691|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
23407692|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
23407693|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407694|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
23407695|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407696|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407697|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407698|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407699|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
23407700|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
23407701|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
23407702|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
23407703|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407704|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
23407705|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407706|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407707|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407708|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407709|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
23407710|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407711|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
23407712|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407713|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407714|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
23407715|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407716|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407717|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407718|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407719|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
23407720|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407721|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
23407722|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
23407723|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407724|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
23407725|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407726|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407727|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407728|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407729|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
23407730|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
23407731|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
23407732|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407733|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407734|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
23407735|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407736|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407737|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407738|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407739|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407740|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407741|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407742|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
23407743|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407744|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
23407745|NCT01194219|65236941|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407746|NCT01194219|65236942|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407747|NCT01194219|65236943|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407748|NCT01194219|65236944|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407749|NCT01194219|65236945|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407750|NCT01194219|65236946|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407751|NCT01194219|65236947|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
23407752|NCT01194219|65236948|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407753|NCT01194219|65236949|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407754|NCT01194219|65236950|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
23407755|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407756|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407757|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407758|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407759|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407760|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407761|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407762|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
23407763|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
23407764|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
23407765|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407766|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407767|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407768|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407769|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407770|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407771|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407772|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
23407773|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
23407774|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
23407775|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407776|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407777|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407778|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407779|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407780|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407781|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407782|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
23407783|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
23407784|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
23407785|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407786|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407787|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407788|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407789|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407790|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407791|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407792|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
23407793|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
23407794|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
23407795|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
23407796|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
23407797|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
23407798|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
23407799|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
23407800|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
23407801|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
23407802|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
23407803|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
23407804|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
23506158|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
23506159|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23407805|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407806|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407807|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407808|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407809|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407810|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407811|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407812|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
23407813|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
23407814|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
23407815|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407816|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407817|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407818|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407819|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407820|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407821|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407822|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407823|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
23407824|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
23407825|NCT01194219|65236941|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407826|NCT01194219|65236942|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407827|NCT01194219|65236943|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407828|NCT01194219|65236944|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407829|NCT01194219|65236945|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407830|NCT01194219|65236946|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407831|NCT01194219|65236947|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407832|NCT01194219|65236948|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
23407833|NCT01194219|65236949|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
23407834|NCT01194219|65236950|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
23407835|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
23407836|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
23407837|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
23407838|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
23407839|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Death|58|||
23407840|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Death|65|||
23407841|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Adverse Event|28|||
23407842|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Adverse Event|40|||
23407843|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Disease Progression|22|||
23407844|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Disease Progression|35|||
23407845|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Other|25|||
23407846|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Other|33|||
23407847|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
23407848|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
23407849|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Noncompliance|8|||
23407850|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Noncompliance|8|||
23407851|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
23407852|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
23407853|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
23407854|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
23407855|NCT00286091|65236959|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
23407856|NCT00286091|65236960|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
23407857|NCT00286091|65236959|FG000|Open-label Treatment Phase|Physician Decision|24|||
23407858|NCT00286091|65236960|FG001|Open-label Treatment Phase|Physician Decision|21|||
23407859|NCT00286091|65236959|FG000|Open-label Treatment Phase|Adverse Event|5|||
23407860|NCT00286091|65236960|FG001|Open-label Treatment Phase|Adverse Event|16|||
23407861|NCT00286091|65236959|FG000|Open-label Treatment Phase|Other|11|||
23407862|NCT00286091|65236960|FG001|Open-label Treatment Phase|Other|11|||
23407863|NCT00286091|65236959|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
23407864|NCT00286091|65236960|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
23407865|NCT00286091|65236959|FG000|Open-label Treatment Phase|Death|10|||
23407866|NCT00286091|65236960|FG001|Open-label Treatment Phase|Death|7|||
23407867|NCT00286091|65236959|FG000|Open-label Treatment Phase|Disease Progression|9|||
23407868|NCT00286091|65236960|FG001|Open-label Treatment Phase|Disease Progression|3|||
23407869|NCT00286091|65236959|FG000|Open-label Treatment Phase|Noncompliance|3|||
23407870|NCT00286091|65236960|FG001|Open-label Treatment Phase|Noncompliance|1|||
23407871|NCT00286091|65236959|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
23407872|NCT00286091|65236960|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
23407873|NCT00286091|65236959|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
23407874|NCT00286091|65236960|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
23407875|NCT00286091|65236959|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
23407876|NCT00286091|65236960|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
23407877|NCT00414076|65236963|FG000|Overall Study|Progression|1|||
23407878|NCT00414076|65236964|FG001|Overall Study|Progression|2|||
23407879|NCT00414076|65236963|FG000|Overall Study|Withdrawal by Subject|1|||
23407880|NCT00414076|65236964|FG001|Overall Study|Withdrawal by Subject|3|||
23407881|NCT00414076|65236963|FG000|Overall Study|Adverse Event|1|||
23407882|NCT00414076|65236964|FG001|Overall Study|Adverse Event|0|||
23407883|NCT01595529|65236965|FG000|Overall Study|Adverse Event|2|||
23407884|NCT01595529|65236966|FG001|Overall Study|Adverse Event|0|||
23407885|NCT01595529|65236965|FG000|Overall Study|Subject Non-Compliant|2|||
23407886|NCT01595529|65236966|FG001|Overall Study|Subject Non-Compliant|0|||
23407887|NCT01595529|65236965|FG000|Overall Study|Lost to Follow-up|8|||
23407888|NCT01595529|65236966|FG001|Overall Study|Lost to Follow-up|14|||
23407889|NCT01595529|65236965|FG000|Overall Study|Protocol Violation|1|||
23407890|NCT01595529|65236966|FG001|Overall Study|Protocol Violation|2|||
23407891|NCT01595529|65236965|FG000|Overall Study|Physician Decision|1|||
23407892|NCT01595529|65236966|FG001|Overall Study|Physician Decision|0|||
23407893|NCT01595529|65236965|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
23407894|NCT01595529|65236966|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
23407895|NCT01595529|65236965|FG000|Overall Study|Administrative Decision|1|||
23407896|NCT01595529|65236966|FG001|Overall Study|Administrative Decision|0|||
23407897|NCT01595529|65236965|FG000|Overall Study|Entry Failure/Screening Failure|6|||
23407898|NCT01595529|65236966|FG001|Overall Study|Entry Failure/Screening Failure|1|||
23407899|NCT01162473|65236967|FG000|Overall Study|Adverse Event|2|||
23407900|NCT01162473|65236968|FG001|Overall Study|Adverse Event|1|||
23407901|NCT01162473|65236967|FG000|Overall Study|Withdrawal by Subject|0|||
23407902|NCT01162473|65236968|FG001|Overall Study|Withdrawal by Subject|4|||
23407903|NCT02517398|65236969|FG000|Overall Study|Death|2|||
23407904|NCT02517398|65236970|FG001|Overall Study|Death|3|||
23407905|NCT02517398|65236971|FG002|Overall Study|Death|4|||
23407906|NCT02517398|65236972|FG003|Overall Study|Death|2|||
23407907|NCT02517398|65236973|FG004|Overall Study|Death|3|||
23407908|NCT02517398|65236974|FG005|Overall Study|Death|8|||
23407909|NCT02517398|65236975|FG006|Overall Study|Death|3|||
23407910|NCT02517398|65236976|FG007|Overall Study|Death|2|||
23407911|NCT02517398|65236977|FG008|Overall Study|Death|6|||
23407912|NCT02517398|65236978|FG009|Overall Study|Death|24|||
23407913|NCT02517398|65236979|FG010|Overall Study|Death|53|||
23407914|NCT02517398|65236980|FG011|Overall Study|Death|25|||
23407915|NCT02517398|65236981|FG012|Overall Study|Death|73|||
23407916|NCT02517398|65236982|FG013|Overall Study|Death|29|||
23407917|NCT02517398|65236983|FG014|Overall Study|Death|26|||
23407918|NCT02517398|65236984|FG015|Overall Study|Death|23|||
23407919|NCT02517398|65236985|FG016|Overall Study|Death|26|||
23407920|NCT02517398|65236986|FG017|Overall Study|Death|25|||
23407921|NCT02517398|65236987|FG018|Overall Study|Death|22|||
23407922|NCT02517398|65236988|FG019|Overall Study|Death|7|||
23407923|NCT02517398|65236989|FG020|Overall Study|Death|26|||
23407924|NCT02517398|65236990|FG021|Overall Study|Death|30|||
23407925|NCT02517398|65236991|FG022|Overall Study|Death|20|||
23407926|NCT02517398|65236969|FG000|Overall Study|Other|0|||
23407927|NCT02517398|65236970|FG001|Overall Study|Other|0|||
23407928|NCT02517398|65236971|FG002|Overall Study|Other|0|||
23407929|NCT02517398|65236972|FG003|Overall Study|Other|1|||
23407930|NCT02517398|65236973|FG004|Overall Study|Other|0|||
23407931|NCT02517398|65236974|FG005|Overall Study|Other|0|||
23407932|NCT02517398|65236975|FG006|Overall Study|Other|0|||
23407933|NCT02517398|65236976|FG007|Overall Study|Other|0|||
23407934|NCT02517398|65236977|FG008|Overall Study|Other|0|||
23407935|NCT02517398|65236978|FG009|Overall Study|Other|1|||
23407936|NCT02517398|65236979|FG010|Overall Study|Other|0|||
23407937|NCT02517398|65236980|FG011|Overall Study|Other|0|||
23407938|NCT02517398|65236981|FG012|Overall Study|Other|0|||
23407939|NCT02517398|65236982|FG013|Overall Study|Other|1|||
23407940|NCT02517398|65236983|FG014|Overall Study|Other|0|||
23407941|NCT02517398|65236984|FG015|Overall Study|Other|1|||
23407942|NCT02517398|65236985|FG016|Overall Study|Other|1|||
23407943|NCT02517398|65236986|FG017|Overall Study|Other|0|||
23407944|NCT02517398|65236987|FG018|Overall Study|Other|0|||
23407945|NCT02517398|65236988|FG019|Overall Study|Other|1|||
23407946|NCT02517398|65236989|FG020|Overall Study|Other|0|||
23407947|NCT02517398|65236990|FG021|Overall Study|Other|0|||
23407948|NCT02517398|65236991|FG022|Overall Study|Other|0|||
23407949|NCT02517398|65236969|FG000|Overall Study|Lost to Follow-up|0|||
23407950|NCT02517398|65236970|FG001|Overall Study|Lost to Follow-up|0|||
23407951|NCT02517398|65236971|FG002|Overall Study|Lost to Follow-up|0|||
23407952|NCT02517398|65236972|FG003|Overall Study|Lost to Follow-up|0|||
23407953|NCT02517398|65236973|FG004|Overall Study|Lost to Follow-up|0|||
23407954|NCT02517398|65236974|FG005|Overall Study|Lost to Follow-up|0|||
23407955|NCT02517398|65236975|FG006|Overall Study|Lost to Follow-up|0|||
23407956|NCT02517398|65236976|FG007|Overall Study|Lost to Follow-up|0|||
23407957|NCT02517398|65236977|FG008|Overall Study|Lost to Follow-up|0|||
23407958|NCT02517398|65236978|FG009|Overall Study|Lost to Follow-up|1|||
23407959|NCT02517398|65236979|FG010|Overall Study|Lost to Follow-up|0|||
23407960|NCT02517398|65236980|FG011|Overall Study|Lost to Follow-up|2|||
23407961|NCT02517398|65236981|FG012|Overall Study|Lost to Follow-up|2|||
23407962|NCT02517398|65236982|FG013|Overall Study|Lost to Follow-up|0|||
23407963|NCT02517398|65236983|FG014|Overall Study|Lost to Follow-up|1|||
23407964|NCT02517398|65236984|FG015|Overall Study|Lost to Follow-up|1|||
23407965|NCT02517398|65236985|FG016|Overall Study|Lost to Follow-up|0|||
23407966|NCT02517398|65236986|FG017|Overall Study|Lost to Follow-up|3|||
23407967|NCT02517398|65236987|FG018|Overall Study|Lost to Follow-up|1|||
23407968|NCT02517398|65236988|FG019|Overall Study|Lost to Follow-up|0|||
23407969|NCT02517398|65236989|FG020|Overall Study|Lost to Follow-up|1|||
23407970|NCT02517398|65236990|FG021|Overall Study|Lost to Follow-up|0|||
23407971|NCT02517398|65236991|FG022|Overall Study|Lost to Follow-up|2|||
23407972|NCT02517398|65236969|FG000|Overall Study|Withdrew Consent|0|||
23407973|NCT02517398|65236970|FG001|Overall Study|Withdrew Consent|0|||
23407974|NCT02517398|65236971|FG002|Overall Study|Withdrew Consent|0|||
23407975|NCT02517398|65236972|FG003|Overall Study|Withdrew Consent|0|||
23407976|NCT02517398|65236973|FG004|Overall Study|Withdrew Consent|0|||
23407977|NCT02517398|65236974|FG005|Overall Study|Withdrew Consent|0|||
23407978|NCT02517398|65236975|FG006|Overall Study|Withdrew Consent|1|||
23407979|NCT02517398|65236976|FG007|Overall Study|Withdrew Consent|0|||
23407980|NCT02517398|65236977|FG008|Overall Study|Withdrew Consent|0|||
23407981|NCT02517398|65236978|FG009|Overall Study|Withdrew Consent|2|||
23407982|NCT02517398|65236979|FG010|Overall Study|Withdrew Consent|7|||
23407983|NCT02517398|65236980|FG011|Overall Study|Withdrew Consent|1|||
23407984|NCT02517398|65236981|FG012|Overall Study|Withdrew Consent|5|||
23407985|NCT02517398|65236982|FG013|Overall Study|Withdrew Consent|4|||
23407986|NCT02517398|65236983|FG014|Overall Study|Withdrew Consent|2|||
23407987|NCT02517398|65236984|FG015|Overall Study|Withdrew Consent|5|||
23407988|NCT02517398|65236985|FG016|Overall Study|Withdrew Consent|4|||
23407989|NCT02517398|65236986|FG017|Overall Study|Withdrew Consent|2|||
23407990|NCT02517398|65236987|FG018|Overall Study|Withdrew Consent|3|||
23407991|NCT02517398|65236988|FG019|Overall Study|Withdrew Consent|2|||
23407992|NCT02517398|65236989|FG020|Overall Study|Withdrew Consent|9|||
23407993|NCT02517398|65236990|FG021|Overall Study|Withdrew Consent|3|||
23407994|NCT02517398|65236991|FG022|Overall Study|Withdrew Consent|1|||
23407995|NCT00755807|65236992|FG000|Acute Phase|Adverse Event|16|||
23407996|NCT00755807|65236993|FG001|Acute Phase|Adverse Event|5|||
23407997|NCT00755807|65236992|FG000|Acute Phase|Protocol Violation|1|||
23407998|NCT00755807|65236993|FG001|Acute Phase|Protocol Violation|3|||
23407999|NCT00755807|65236992|FG000|Acute Phase|Withdrawal by Subject|1|||
23408000|NCT00755807|65236993|FG001|Acute Phase|Withdrawal by Subject|2|||
23408001|NCT00755807|65236992|FG000|Acute Phase|Lack of Efficacy|0|||
23408002|NCT00755807|65236993|FG001|Acute Phase|Lack of Efficacy|1|||
23607372|NCT00264576|65950684|FG000|Overall Study|Lost to Follow-up|1|||
23305696|NCT00515541|64862400|FG001|Overall Study|Physician Decision|2|||
23305697|NCT00515541|64862401|FG002|Overall Study|Physician Decision|0|||
23305698|NCT00515541|64862402|FG003|Overall Study|Physician Decision|1|||
23305699|NCT00515541|64862399|FG000|Overall Study|No show for appointments|0|||
23305700|NCT00515541|64862400|FG001|Overall Study|No show for appointments|1|||
23305701|NCT00515541|64862401|FG002|Overall Study|No show for appointments|0|||
23305702|NCT00515541|64862402|FG003|Overall Study|No show for appointments|2|||
23305703|NCT00515541|64862399|FG000|Overall Study|Withdrawal by Subject|0|||
23305704|NCT00515541|64862400|FG001|Overall Study|Withdrawal by Subject|2|||
23305705|NCT00515541|64862401|FG002|Overall Study|Withdrawal by Subject|0|||
23305706|NCT00515541|64862402|FG003|Overall Study|Withdrawal by Subject|2|||
23305707|NCT02227147|64862403|FG000|Controlled Treatment Period|Adverse Event|4|||
23305708|NCT02227147|64862404|FG001|Controlled Treatment Period|Adverse Event|3|||
23305709|NCT02227147|64862403|FG000|Controlled Treatment Period|Other|2|||
23305710|NCT02227147|64862404|FG001|Controlled Treatment Period|Other|0|||
23305711|NCT02227147|64862403|FG000|Follow-up Period|Other|3|||
23305712|NCT02227147|64862404|FG001|Follow-up Period|Other|5|||
23305713|NCT01103466|64862405|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
23305714|NCT01103466|64862406|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
23408003|NCT00755807|65236992|FG000|Acute Phase|Physician Decision|0|||
23408004|NCT00755807|65236993|FG001|Acute Phase|Physician Decision|1|||
23408005|NCT00755807|65236992|FG000|Open-label Extension Phase|Adverse Event|7|||
23408006|NCT00755807|65236993|FG001|Open-label Extension Phase|Adverse Event|7|||
23408007|NCT00755807|65236992|FG000|Open-label Extension Phase|Protocol Violation|5|||
23408008|NCT00755807|65236993|FG001|Open-label Extension Phase|Protocol Violation|2|||
23408009|NCT00755807|65236992|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
23408010|NCT00755807|65236993|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
23408011|NCT00755807|65236992|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
23408012|NCT00755807|65236993|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
23408013|NCT00755807|65236992|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
23408014|NCT00755807|65236993|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
23408015|NCT00755807|65236992|FG000|Open-label Extension Phase|Sponsor Decision|0|||
23408016|NCT00755807|65236993|FG001|Open-label Extension Phase|Sponsor Decision|1|||
23408017|NCT00375427|65236994|FG000|Overall Study|Adverse Event|21|||
23408018|NCT00375427|65236995|FG001|Overall Study|Adverse Event|27|||
23408019|NCT00375427|65236994|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23408020|NCT00375427|65236995|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23408021|NCT00375427|65236994|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23408022|NCT00375427|65236995|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23408023|NCT00375427|65236994|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23408024|NCT00375427|65236995|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23408025|NCT00375427|65236994|FG000|Overall Study|Patient no longer requires study drug|3|||
23408026|NCT00375427|65236995|FG001|Overall Study|Patient no longer requires study drug|7|||
23408027|NCT00375427|65236994|FG000|Overall Study|Protocol Violation|10|||
23408028|NCT00375427|65236995|FG001|Overall Study|Protocol Violation|8|||
23408029|NCT00375427|65236994|FG000|Overall Study|Withdrawal by Subject|9|||
23408030|NCT00375427|65236995|FG001|Overall Study|Withdrawal by Subject|13|||
23408031|NCT00375427|65236994|FG000|Overall Study|Lost to Follow-up|1|||
23408032|NCT00375427|65236995|FG001|Overall Study|Lost to Follow-up|1|||
23408033|NCT00375427|65236994|FG000|Overall Study|Administrative reasons|0|||
23408034|NCT00375427|65236995|FG001|Overall Study|Administrative reasons|1|||
23408035|NCT00375427|65236994|FG000|Overall Study|Death|11|||
23408036|NCT00375427|65236995|FG001|Overall Study|Death|10|||
23408037|NCT02383862|65236996|FG000|3 Month Follow up|Lost to Follow-up|23|||
23408038|NCT02383862|65236997|FG001|3 Month Follow up|Lost to Follow-up|21|||
23408039|NCT03592771|65236998|FG000|Overall Study|Adverse Event|2|||
23408040|NCT03592771|65236999|FG001|Overall Study|Adverse Event|0|||
23408041|NCT03592771|65237000|FG002|Overall Study|Adverse Event|1|||
23408042|NCT03592771|65236998|FG000|Overall Study|Death|0|||
23408043|NCT03592771|65236999|FG001|Overall Study|Death|1|||
23408044|NCT03592771|65237000|FG002|Overall Study|Death|1|||
23408045|NCT03592771|65236998|FG000|Overall Study|Lost to Follow-up|5|||
23408046|NCT03592771|65236999|FG001|Overall Study|Lost to Follow-up|11|||
23408047|NCT03592771|65237000|FG002|Overall Study|Lost to Follow-up|15|||
23408048|NCT03592771|65236998|FG000|Overall Study|Withdrawal by Subject|0|||
23408049|NCT03592771|65236999|FG001|Overall Study|Withdrawal by Subject|2|||
23408050|NCT03592771|65237000|FG002|Overall Study|Withdrawal by Subject|0|||
23408051|NCT04571060|65237006|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
23408052|NCT04571060|65237007|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
23408053|NCT04571060|65237006|FG000|Overall Study|Never treated migraine|47|||
23408054|NCT04571060|65237007|FG001|Overall Study|Never treated migraine|36|||
23408055|NCT04571060|65237006|FG000|Overall Study|Protocol Violation|4|||
23408056|NCT04571060|65237007|FG001|Overall Study|Protocol Violation|2|||
23408057|NCT04571060|65237006|FG000|Overall Study|Withdrawal by Subject|6|||
23408058|NCT04571060|65237007|FG001|Overall Study|Withdrawal by Subject|2|||
23408059|NCT04571060|65237006|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
23408060|NCT04571060|65237007|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
23408061|NCT02969915|65237008|FG000|Overall Study|Death|104|||
23408062|NCT02969915|65237009|FG001|Overall Study|Death|125|||
23408063|NCT02969915|65237008|FG000|Overall Study|Lost to Follow-up|108|||
23408064|NCT02969915|65237009|FG001|Overall Study|Lost to Follow-up|112|||
23408065|NCT02969915|65237008|FG000|Overall Study|Censored due to COVID-19|481|||
23408066|NCT02969915|65237009|FG001|Overall Study|Censored due to COVID-19|471|||
23408067|NCT00194077|65237012|FG000|Overall Study|Lack of Efficacy|22|||
23408068|NCT00194077|65237013|FG001|Overall Study|Lack of Efficacy|29|||
23408069|NCT00194077|65237012|FG000|Overall Study|Study nonadherence|1|||
23408070|NCT00194077|65237013|FG001|Overall Study|Study nonadherence|0|||
23408071|NCT00194077|65237012|FG000|Overall Study|Withdrawal by Subject|1|||
23408072|NCT00194077|65237013|FG001|Overall Study|Withdrawal by Subject|1|||
23408073|NCT00506454|65237016|FG000|Overall Study|Withdrawal by Subject|1|||
23408074|NCT00506454|65237017|FG001|Overall Study|Withdrawal by Subject|1|||
23408075|NCT00703963|65237022|FG000|Overall Study|Withdrawal by Subject|7|||
23408076|NCT00703963|65237023|FG001|Overall Study|Withdrawal by Subject|13|||
23408077|NCT00703963|65237022|FG000|Overall Study|Physician Decision|0|||
23408078|NCT00703963|65237023|FG001|Overall Study|Physician Decision|1|||
23408079|NCT01815424|65237026|FG000|Week 0 to 16|Adverse Event|1|||
23408080|NCT01815424|65237027|FG001|Week 0 to 16|Adverse Event|3|||
23408081|NCT01815424|65237028|FG002|Week 0 to 16|Adverse Event|3|||
23408082|NCT01815424|65237029|FG003|Week 0 to 16|Adverse Event|0|||
23408083|NCT01815424|65237030|FG004|Week 0 to 16|Adverse Event|0|||
23408084|NCT01815424|65237026|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
23408085|NCT01815424|65237027|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
23408086|NCT01815424|65237028|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
23408087|NCT01815424|65237029|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
23408088|NCT01815424|65237030|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
23408089|NCT01815424|65237026|FG000|Week 0 to 16|Lost to Follow-up|0|||
23408090|NCT01815424|65237027|FG001|Week 0 to 16|Lost to Follow-up|1|||
23408091|NCT01815424|65237028|FG002|Week 0 to 16|Lost to Follow-up|0|||
23408092|NCT01815424|65237029|FG003|Week 0 to 16|Lost to Follow-up|0|||
23408093|NCT01815424|65237030|FG004|Week 0 to 16|Lost to Follow-up|0|||
23408094|NCT01815424|65237026|FG000|Week 0 to 16|Withdrawal by Subject|0|||
23408095|NCT01815424|65237027|FG001|Week 0 to 16|Withdrawal by Subject|0|||
23408096|NCT01815424|65237028|FG002|Week 0 to 16|Withdrawal by Subject|1|||
23408097|NCT01815424|65237029|FG003|Week 0 to 16|Withdrawal by Subject|0|||
23408098|NCT01815424|65237030|FG004|Week 0 to 16|Withdrawal by Subject|0|||
23408099|NCT01815424|65237026|FG000|Week 0 to 16|Other|1|||
23408100|NCT01815424|65237027|FG001|Week 0 to 16|Other|0|||
23408101|NCT01815424|65237028|FG002|Week 0 to 16|Other|3|||
23408102|NCT01815424|65237029|FG003|Week 0 to 16|Other|0|||
23408103|NCT01815424|65237030|FG004|Week 0 to 16|Other|0|||
23408104|NCT01815424|65237026|FG000|Week 0 to 16|Protocol Violation|1|||
23408105|NCT01815424|65237027|FG001|Week 0 to 16|Protocol Violation|0|||
23408106|NCT01815424|65237028|FG002|Week 0 to 16|Protocol Violation|0|||
23408107|NCT01815424|65237029|FG003|Week 0 to 16|Protocol Violation|0|||
23408108|NCT01815424|65237030|FG004|Week 0 to 16|Protocol Violation|0|||
23408109|NCT01815424|65237026|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
23408110|NCT01815424|65237027|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
23408111|NCT01815424|65237028|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
23408112|NCT01815424|65237029|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
23408113|NCT01815424|65237030|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
23408114|NCT01815424|65237026|FG000|Week 16 to 52|Other|0|||
23408115|NCT01815424|65237027|FG001|Week 16 to 52|Other|1|||
23408116|NCT01815424|65237028|FG002|Week 16 to 52|Other|0|||
23408117|NCT01815424|65237029|FG003|Week 16 to 52|Other|0|||
23408118|NCT01815424|65237030|FG004|Week 16 to 52|Other|0|||
23408119|NCT01815424|65237026|FG000|Week 16 to 52|Adverse Event|0|||
23408120|NCT01815424|65237027|FG001|Week 16 to 52|Adverse Event|0|||
23408121|NCT01815424|65237028|FG002|Week 16 to 52|Adverse Event|0|||
23408122|NCT01815424|65237029|FG003|Week 16 to 52|Adverse Event|0|||
23408123|NCT01815424|65237030|FG004|Week 16 to 52|Adverse Event|1|||
23408124|NCT01815424|65237026|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
23408125|NCT01815424|65237027|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
23408126|NCT01815424|65237028|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
23408127|NCT01815424|65237029|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
23408128|NCT01815424|65237030|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
23408129|NCT01815424|65237026|FG000|Week 16 to 52|Lost to Follow-up|0|||
23408130|NCT01815424|65237027|FG001|Week 16 to 52|Lost to Follow-up|2|||
23408131|NCT01815424|65237028|FG002|Week 16 to 52|Lost to Follow-up|0|||
23408132|NCT01815424|65237029|FG003|Week 16 to 52|Lost to Follow-up|2|||
23408133|NCT01815424|65237030|FG004|Week 16 to 52|Lost to Follow-up|1|||
23408134|NCT01815424|65237026|FG000|Week 16 to 52|Withdrawal by Subject|1|||
23408135|NCT01815424|65237027|FG001|Week 16 to 52|Withdrawal by Subject|2|||
23408136|NCT01815424|65237028|FG002|Week 16 to 52|Withdrawal by Subject|0|||
23408137|NCT01815424|65237029|FG003|Week 16 to 52|Withdrawal by Subject|0|||
23408138|NCT01815424|65237030|FG004|Week 16 to 52|Withdrawal by Subject|0|||
23408139|NCT02079909|65237031|FG000|Overall Study|Adverse Event|23|||
23408140|NCT02079909|65237032|FG001|Overall Study|Adverse Event|23|||
23408141|NCT02079909|65237033|FG002|Overall Study|Adverse Event|7|||
23408142|NCT02079909|65237031|FG000|Overall Study|Withdrawal by Subject|9|||
23408143|NCT02079909|65237032|FG001|Overall Study|Withdrawal by Subject|17|||
23408144|NCT02079909|65237033|FG002|Overall Study|Withdrawal by Subject|4|||
23408145|NCT02079909|65237031|FG000|Overall Study|Lost to Follow-up|2|||
23408146|NCT02079909|65237032|FG001|Overall Study|Lost to Follow-up|3|||
23408147|NCT02079909|65237033|FG002|Overall Study|Lost to Follow-up|1|||
23408148|NCT02079909|65237031|FG000|Overall Study|Death|2|||
23408149|NCT02079909|65237032|FG001|Overall Study|Death|2|||
23408150|NCT02079909|65237033|FG002|Overall Study|Death|0|||
23408151|NCT02079909|65237031|FG000|Overall Study|Lack of Efficacy|0|||
23408152|NCT02079909|65237032|FG001|Overall Study|Lack of Efficacy|0|||
23408153|NCT02079909|65237033|FG002|Overall Study|Lack of Efficacy|1|||
23408154|NCT02079909|65237031|FG000|Overall Study|Protocol Violation|0|||
23408155|NCT02079909|65237032|FG001|Overall Study|Protocol Violation|1|||
23408156|NCT02079909|65237033|FG002|Overall Study|Protocol Violation|1|||
23408157|NCT02079909|65237031|FG000|Overall Study|Physician Decision|0|||
23408158|NCT02079909|65237032|FG001|Overall Study|Physician Decision|1|||
23607373|NCT00264576|65950685|FG001|Overall Study|Lost to Follow-up|1|||
23408159|NCT02079909|65237033|FG002|Overall Study|Physician Decision|1|||
23408160|NCT02079909|65237031|FG000|Overall Study|Relocation etc.|2|||
23408161|NCT02079909|65237032|FG001|Overall Study|Relocation etc.|2|||
23408162|NCT02079909|65237033|FG002|Overall Study|Relocation etc.|3|||
23408163|NCT00407602|65237034|FG000|Overall Study|Death - unrelated to device|1|||
23408164|NCT00407602|65237034|FG000|Overall Study|Device explanted|5|||
23408165|NCT00407602|65237034|FG000|Overall Study|Withdrawal by Subject|1|||
23408166|NCT00402324|65237037|FG000|Overall Study|Lost to Follow-up|11|||
23408167|NCT00402324|65237038|FG001|Overall Study|Lost to Follow-up|11|||
23408168|NCT00402324|65237037|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
23408169|NCT00402324|65237038|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
23408170|NCT00402324|65237037|FG000|Overall Study|Protocol Violation|8|||
23408171|NCT00402324|65237038|FG001|Overall Study|Protocol Violation|7|||
23408172|NCT00402324|65237037|FG000|Overall Study|Withdrawal by Subject|5|||
23408173|NCT00402324|65237038|FG001|Overall Study|Withdrawal by Subject|2|||
23408174|NCT00402324|65237037|FG000|Overall Study|Physician Decision|2|||
23506160|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23408175|NCT00402324|65237038|FG001|Overall Study|Physician Decision|4|||
23408176|NCT00402324|65237037|FG000|Overall Study|Sponsor Decision|4|||
23408177|NCT00402324|65237038|FG001|Overall Study|Sponsor Decision|5|||
23408178|NCT00402324|65237037|FG000|Overall Study|Lack of Efficacy|1|||
23408179|NCT00402324|65237038|FG001|Overall Study|Lack of Efficacy|4|||
23408180|NCT00402324|65237037|FG000|Overall Study|Adverse Event|6|||
23408181|NCT00402324|65237038|FG001|Overall Study|Adverse Event|4|||
23408182|NCT00402324|65237037|FG000|Overall Study|Death|1|||
23408183|NCT00402324|65237038|FG001|Overall Study|Death|0|||
23408184|NCT00529243|65239817|FG000|Overall Study|Adverse Event|1|||
23408185|NCT00529243|65239817|FG000|Overall Study|Death|1|||
23408186|NCT00529243|65239817|FG000|Overall Study|Relocated|1|||
23408187|NCT00851890|65239820|FG000|Overall Study|Lost to Follow-up|0|||
23408188|NCT00851890|65239821|FG001|Overall Study|Lost to Follow-up|1|||
23408189|NCT00851890|65239822|FG002|Overall Study|Lost to Follow-up|0|||
23408190|NCT00851890|65239823|FG003|Overall Study|Lost to Follow-up|1|||
23408191|NCT00075764|65239824|FG000|Overall Study|Adverse Event|5|||
23408192|NCT00075764|65239825|FG001|Overall Study|Adverse Event|12|||
23408193|NCT00075764|65239824|FG000|Overall Study|Death|4|||
23408194|NCT00075764|65239825|FG001|Overall Study|Death|8|||
23408195|NCT00075764|65239824|FG000|Overall Study|Withdrawal by Subject|28|||
23408196|NCT00075764|65239825|FG001|Overall Study|Withdrawal by Subject|18|||
23408197|NCT00075764|65239824|FG000|Overall Study|Progression|269|||
23408198|NCT00075764|65239825|FG001|Overall Study|Progression|274|||
23408199|NCT00075764|65239824|FG000|Overall Study|Still on treatment|8|||
23408200|NCT00075764|65239825|FG001|Overall Study|Still on treatment|15|||
23408201|NCT00075764|65239824|FG000|Overall Study|Delinquent|4|||
23408202|NCT00075764|65239825|FG001|Overall Study|Delinquent|2|||
23408203|NCT00075764|65239824|FG000|Overall Study|Not protocol specified|27|||
23408204|NCT00075764|65239825|FG001|Overall Study|Not protocol specified|19|||
23408205|NCT00075764|65239824|FG000|Overall Study|Under review|0|||
23408206|NCT00075764|65239825|FG001|Overall Study|Under review|1|||
23408207|NCT02565147|65239828|FG000|Overall Study|Withdrawal by Subject|5|||
23408208|NCT02565147|65239829|FG001|Overall Study|Withdrawal by Subject|1|||
23408209|NCT02565147|65239828|FG000|Overall Study|Lost to Follow-up|0|||
23408210|NCT02565147|65239829|FG001|Overall Study|Lost to Follow-up|1|||
23408211|NCT02565147|65239828|FG000|Overall Study|Death|1|||
23408212|NCT02565147|65239829|FG001|Overall Study|Death|1|||
23408213|NCT04703192|65239830|FG000|Overall Study|Withdrawal by Subject|2|||
23408214|NCT04703192|65239831|FG001|Overall Study|Withdrawal by Subject|0|||
23408215|NCT04703192|65239830|FG000|Overall Study|Death|3|||
23506161|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23408216|NCT04703192|65239831|FG001|Overall Study|Death|1|||
23408217|NCT04703192|65239830|FG000|Overall Study|Adverse Event|13|||
23408218|NCT04703192|65239831|FG001|Overall Study|Adverse Event|2|||
23408219|NCT04703192|65239830|FG000|Overall Study|Progressive or Relapsed Disease|46|||
23408220|NCT04703192|65239831|FG001|Overall Study|Progressive or Relapsed Disease|7|||
23408221|NCT04703192|65239830|FG000|Overall Study|Clinical Progression|19|||
23408222|NCT04703192|65239831|FG001|Overall Study|Clinical Progression|8|||
23408223|NCT04703192|65239830|FG000|Overall Study|Lost to Follow-up|1|||
23408224|NCT04703192|65239831|FG001|Overall Study|Lost to Follow-up|0|||
23408225|NCT04703192|65239830|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
23408226|NCT04703192|65239831|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
23408227|NCT04703192|65239830|FG000|Overall Study|Other|5|||
23408228|NCT04703192|65239831|FG001|Overall Study|Other|1|||
23408229|NCT00244725|65239832|FG000|Overall Study|Lost to Follow-up|3|||
23408230|NCT00244725|65239833|FG001|Overall Study|Lost to Follow-up|4|||
23408231|NCT00244725|65239834|FG002|Overall Study|Lost to Follow-up|9|||
23506162|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23408232|NCT00244725|65239835|FG003|Overall Study|Lost to Follow-up|2|||
23408233|NCT00244725|65239832|FG000|Overall Study|Withdrawal by Subject|9|||
23408234|NCT00244725|65239833|FG001|Overall Study|Withdrawal by Subject|7|||
23408235|NCT00244725|65239834|FG002|Overall Study|Withdrawal by Subject|7|||
23408236|NCT00244725|65239835|FG003|Overall Study|Withdrawal by Subject|8|||
23408237|NCT00244725|65239832|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
23408238|NCT00244725|65239833|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
23408239|NCT00244725|65239834|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
23408240|NCT00244725|65239835|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
23408241|NCT00244725|65239832|FG000|Overall Study|Physician Decision|3|||
23408242|NCT00244725|65239833|FG001|Overall Study|Physician Decision|0|||
23408243|NCT00244725|65239834|FG002|Overall Study|Physician Decision|1|||
23408244|NCT00244725|65239835|FG003|Overall Study|Physician Decision|2|||
23408245|NCT00244725|65239832|FG000|Overall Study|Adverse Events|3|||
23408246|NCT00244725|65239833|FG001|Overall Study|Adverse Events|1|||
23408247|NCT00244725|65239834|FG002|Overall Study|Adverse Events|4|||
23408248|NCT00244725|65239835|FG003|Overall Study|Adverse Events|4|||
23408249|NCT00244725|65239832|FG000|Overall Study|Withdrwal by participant|1|||
23408250|NCT00244725|65239833|FG001|Overall Study|Withdrwal by participant|0|||
23408251|NCT00244725|65239834|FG002|Overall Study|Withdrwal by participant|0|||
23408252|NCT00244725|65239835|FG003|Overall Study|Withdrwal by participant|1|||
23408253|NCT00244725|65239832|FG000|Overall Study|Liver function test abnormality|2|||
23408254|NCT00244725|65239833|FG001|Overall Study|Liver function test abnormality|0|||
23408255|NCT00244725|65239834|FG002|Overall Study|Liver function test abnormality|0|||
23408256|NCT00244725|65239835|FG003|Overall Study|Liver function test abnormality|1|||
23408257|NCT00244725|65239832|FG000|Overall Study|Sponsor withdrew the participant|1|||
23408258|NCT00244725|65239833|FG001|Overall Study|Sponsor withdrew the participant|0|||
23408259|NCT00244725|65239834|FG002|Overall Study|Sponsor withdrew the participant|0|||
23408260|NCT00244725|65239835|FG003|Overall Study|Sponsor withdrew the participant|1|||
23408261|NCT00244725|65239832|FG000|Overall Study|Mediciation Error|0|||
23408262|NCT00244725|65239833|FG001|Overall Study|Mediciation Error|1|||
23408263|NCT00244725|65239834|FG002|Overall Study|Mediciation Error|0|||
23408264|NCT00244725|65239835|FG003|Overall Study|Mediciation Error|0|||
23408265|NCT00244725|65239832|FG000|Overall Study|Rehab Refused to allow participantion|0|||
23408266|NCT00244725|65239833|FG001|Overall Study|Rehab Refused to allow participantion|1|||
23408267|NCT00244725|65239834|FG002|Overall Study|Rehab Refused to allow participantion|0|||
23408268|NCT00244725|65239835|FG003|Overall Study|Rehab Refused to allow participantion|0|||
23408269|NCT00244725|65239832|FG000|Overall Study|Headache|0|||
23408270|NCT00244725|65239833|FG001|Overall Study|Headache|1|||
23408271|NCT00244725|65239834|FG002|Overall Study|Headache|0|||
23408272|NCT00244725|65239835|FG003|Overall Study|Headache|0|||
23408273|NCT00244725|65239832|FG000|Overall Study|Received prohibited medication|0|||
23408274|NCT00244725|65239833|FG001|Overall Study|Received prohibited medication|1|||
23408275|NCT00244725|65239834|FG002|Overall Study|Received prohibited medication|0|||
23408276|NCT00244725|65239835|FG003|Overall Study|Received prohibited medication|1|||
23408277|NCT00244725|65239832|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
23408278|NCT00244725|65239833|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
23408279|NCT00244725|65239834|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
23408280|NCT00244725|65239835|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
23408281|NCT00244725|65239832|FG000|Overall Study|Administrative reason|0|||
23408282|NCT00244725|65239833|FG001|Overall Study|Administrative reason|0|||
23408283|NCT00244725|65239834|FG002|Overall Study|Administrative reason|1|||
23408284|NCT00244725|65239835|FG003|Overall Study|Administrative reason|0|||
23408285|NCT00244725|65239832|FG000|Overall Study|Vomit|0|||
23408286|NCT00244725|65239833|FG001|Overall Study|Vomit|0|||
23408287|NCT00244725|65239834|FG002|Overall Study|Vomit|1|||
23408288|NCT00244725|65239835|FG003|Overall Study|Vomit|0|||
23408289|NCT00244725|65239832|FG000|Overall Study|Failed to follow-up|0|||
23408290|NCT00244725|65239833|FG001|Overall Study|Failed to follow-up|0|||
23408291|NCT00244725|65239834|FG002|Overall Study|Failed to follow-up|1|||
23408292|NCT00244725|65239835|FG003|Overall Study|Failed to follow-up|1|||
23408293|NCT01107392|65239837|FG000|Overall Study|Adverse Event|2|||
23408294|NCT01107392|65239838|FG001|Overall Study|Adverse Event|0|||
23408295|NCT01107392|65239837|FG000|Overall Study|Personal Reasons|2|||
23408296|NCT01107392|65239838|FG001|Overall Study|Personal Reasons|3|||
23408297|NCT01107392|65239837|FG000|Overall Study|Administrative decision|1|||
23408298|NCT01107392|65239838|FG001|Overall Study|Administrative decision|0|||
23506163|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23506164|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23506165|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
23408299|NCT02446769|65239840|FG000|Screening Period|Screen Failure|11|||
23408300|NCT02446769|65239841|FG001|Screening Period|Screen Failure|0|||
23408301|NCT02446769|65239842|FG002|Screening Period|Screen Failure|0|||
23408302|NCT02446769|65239840|FG000|Study Period|Randomized in Error|0|||
23408303|NCT02446769|65239841|FG001|Study Period|Randomized in Error|2|||
23408304|NCT02446769|65239842|FG002|Study Period|Randomized in Error|0|||
23408305|NCT00322049|65239843|FG000|Overall Study|Moved out of area|0|||
23408306|NCT00322049|65239844|FG001|Overall Study|Moved out of area|0|||
23408307|NCT00322049|65239845|FG002|Overall Study|Moved out of area|0|||
23408308|NCT00322049|65239846|FG003|Overall Study|Moved out of area|1|||
23408309|NCT00322049|65239843|FG000|Overall Study|Infected with Dengue during study|0|||
23408310|NCT00322049|65239844|FG001|Overall Study|Infected with Dengue during study|1|||
23408311|NCT00322049|65239845|FG002|Overall Study|Infected with Dengue during study|0|||
23408312|NCT00322049|65239846|FG003|Overall Study|Infected with Dengue during study|0|||
23408313|NCT02553928|65239847|FG000|Overall Study|Adverse Event|2|||
23408314|NCT02553928|65239848|FG001|Overall Study|Adverse Event|1|||
23408315|NCT02553928|65239847|FG000|Overall Study|Lost to Follow-up|0|||
23408316|NCT02553928|65239848|FG001|Overall Study|Lost to Follow-up|1|||
23408317|NCT02553928|65239847|FG000|Overall Study|Administrative reason(s)|0|||
23408318|NCT02553928|65239848|FG001|Overall Study|Administrative reason(s)|1|||
23408319|NCT03012828|65239849|FG000|Overall Study|Lost to Follow-up|1|||
23408320|NCT03012828|65239850|FG001|Overall Study|Lost to Follow-up|0|||
23408321|NCT03012828|65239851|FG002|Overall Study|Lost to Follow-up|1|||
23408322|NCT03012828|65239852|FG003|Overall Study|Lost to Follow-up|0|||
23408323|NCT03012828|65239853|FG004|Overall Study|Lost to Follow-up|1|||
23408324|NCT03012828|65239854|FG005|Overall Study|Lost to Follow-up|0|||
23408325|NCT03012828|65239849|FG000|Overall Study|Withdrawal by Subject|0|||
23506166|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
23506167|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23506168|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
23506169|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
23408326|NCT03012828|65239850|FG001|Overall Study|Withdrawal by Subject|0|||
23408327|NCT03012828|65239851|FG002|Overall Study|Withdrawal by Subject|1|||
23408328|NCT03012828|65239852|FG003|Overall Study|Withdrawal by Subject|0|||
23408329|NCT03012828|65239853|FG004|Overall Study|Withdrawal by Subject|0|||
23408330|NCT03012828|65239854|FG005|Overall Study|Withdrawal by Subject|1|||
23408331|NCT03012828|65239849|FG000|Overall Study|Non-compliance with protocol|0|||
23408332|NCT03012828|65239850|FG001|Overall Study|Non-compliance with protocol|0|||
23408333|NCT03012828|65239851|FG002|Overall Study|Non-compliance with protocol|0|||
23408334|NCT03012828|65239852|FG003|Overall Study|Non-compliance with protocol|0|||
23408335|NCT03012828|65239853|FG004|Overall Study|Non-compliance with protocol|1|||
23408336|NCT03012828|65239854|FG005|Overall Study|Non-compliance with protocol|0|||
23408337|NCT03012828|65239849|FG000|Overall Study|Delay to last visit would delay DBL|0|||
23408338|NCT03012828|65239850|FG001|Overall Study|Delay to last visit would delay DBL|0|||
23408339|NCT03012828|65239851|FG002|Overall Study|Delay to last visit would delay DBL|0|||
23408340|NCT03012828|65239852|FG003|Overall Study|Delay to last visit would delay DBL|0|||
23408341|NCT03012828|65239853|FG004|Overall Study|Delay to last visit would delay DBL|0|||
23408342|NCT03012828|65239854|FG005|Overall Study|Delay to last visit would delay DBL|1|||
23408343|NCT01673646|65239855|FG000|Overall Study|Adverse Event|2|||
23408344|NCT01673646|65239856|FG001|Overall Study|Adverse Event|1|||
23408345|NCT01673646|65239857|FG002|Overall Study|Adverse Event|1|||
23408346|NCT01673646|65239855|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23408347|NCT01673646|65239856|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23408348|NCT01673646|65239857|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23408349|NCT01673646|65239855|FG000|Overall Study|Condition no longer requires study drug|0|||
23408350|NCT01673646|65239856|FG001|Overall Study|Condition no longer requires study drug|1|||
23408351|NCT01673646|65239857|FG002|Overall Study|Condition no longer requires study drug|0|||
23408352|NCT01673646|65239855|FG000|Overall Study|Withdrawal by Subject|0|||
23408353|NCT01673646|65239856|FG001|Overall Study|Withdrawal by Subject|2|||
23408354|NCT01673646|65239857|FG002|Overall Study|Withdrawal by Subject|2|||
23408355|NCT01673646|65239855|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
23408356|NCT01673646|65239856|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
23408357|NCT01673646|65239857|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
23408358|NCT03835481|65239859|FG000|Double-blind Period|Other not stated below|0|||
23408359|NCT03835481|65239860|FG001|Double-blind Period|Other not stated below|0|||
23408360|NCT03835481|65239861|FG002|Double-blind Period|Other not stated below|0|||
23408361|NCT03835481|65239862|FG003|Double-blind Period|Other not stated below|1|||
23408362|NCT03835481|65239863|FG004|Double-blind Period|Other not stated below|1|||
23408363|NCT03835481|65239859|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
23408364|NCT03835481|65239860|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
23408365|NCT03835481|65239861|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
23408366|NCT03835481|65239862|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
23408367|NCT03835481|65239863|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
23408368|NCT03835481|65239859|FG000|Double-blind Period|Withdrawal by Subject|0|||
23408369|NCT03835481|65239860|FG001|Double-blind Period|Withdrawal by Subject|0|||
23408370|NCT03835481|65239861|FG002|Double-blind Period|Withdrawal by Subject|1|||
23408371|NCT03835481|65239862|FG003|Double-blind Period|Withdrawal by Subject|0|||
23408372|NCT03835481|65239863|FG004|Double-blind Period|Withdrawal by Subject|5|||
23408373|NCT03835481|65239859|FG000|Double-blind Period|Lost to Follow-up|0|||
23408374|NCT03835481|65239860|FG001|Double-blind Period|Lost to Follow-up|0|||
23408375|NCT03835481|65239861|FG002|Double-blind Period|Lost to Follow-up|0|||
23408376|NCT03835481|65239862|FG003|Double-blind Period|Lost to Follow-up|1|||
23408377|NCT03835481|65239863|FG004|Double-blind Period|Lost to Follow-up|0|||
23408378|NCT03835481|65239859|FG000|Double-blind Period|Protocol Violation|0|||
23408379|NCT03835481|65239860|FG001|Double-blind Period|Protocol Violation|2|||
23408380|NCT03835481|65239861|FG002|Double-blind Period|Protocol Violation|0|||
23408381|NCT03835481|65239862|FG003|Double-blind Period|Protocol Violation|1|||
23408382|NCT03835481|65239863|FG004|Double-blind Period|Protocol Violation|0|||
23408383|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
23408384|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
23408385|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
23408386|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
23408387|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
23408388|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
23408389|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
23408390|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
23408391|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
23408392|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
23408393|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
23408394|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
23408395|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
23408396|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
23408397|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
23408398|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
23408399|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
23408400|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
23408401|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
23408402|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
23408403|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
23408404|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
23408405|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
23408406|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
23408407|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
23408408|NCT03835481|65239859|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
23408409|NCT03835481|65239860|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
23408410|NCT03835481|65239861|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
23408411|NCT03835481|65239862|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
23408412|NCT03835481|65239863|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
23408413|NCT03188263|65239864|FG000|Overall Study|Withdrawal by Subject|3|||
23408414|NCT03188263|65239865|FG001|Overall Study|Withdrawal by Subject|0|||
23408415|NCT03188263|65239864|FG000|Overall Study|Physician Decision|1|||
23408416|NCT03188263|65239865|FG001|Overall Study|Physician Decision|0|||
23408417|NCT01890265|65239866|FG000|Overall Study|Other (Unspecified reason)|0|||
23408418|NCT01890265|65239867|FG001|Overall Study|Other (Unspecified reason)|1|||
23408419|NCT01890265|65239868|FG002|Overall Study|Other (Unspecified reason)|0|||
23408420|NCT01890265|65239869|FG003|Overall Study|Other (Unspecified reason)|0|||
23506170|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506171|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506172|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506173|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506174|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506175|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506176|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
23506177|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
23506178|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
23506179|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
23506180|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
23506181|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506182|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506183|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506184|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506185|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506186|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506187|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506188|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
23408421|NCT01890265|65239870|FG004|Overall Study|Other (Unspecified reason)|0|||
23408422|NCT01890265|65239871|FG005|Overall Study|Other (Unspecified reason)|0|||
23408423|NCT01890265|65239866|FG000|Overall Study|Progressive disease|6|||
23408424|NCT01890265|65239867|FG001|Overall Study|Progressive disease|6|||
23408425|NCT01890265|65239868|FG002|Overall Study|Progressive disease|0|||
23408426|NCT01890265|65239869|FG003|Overall Study|Progressive disease|0|||
23408427|NCT01890265|65239870|FG004|Overall Study|Progressive disease|0|||
23408428|NCT01890265|65239871|FG005|Overall Study|Progressive disease|0|||
23408429|NCT01890265|65239866|FG000|Overall Study|Adverse Event|2|||
23408430|NCT01890265|65239867|FG001|Overall Study|Adverse Event|1|||
23506189|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
23408431|NCT01890265|65239868|FG002|Overall Study|Adverse Event|0|||
23408432|NCT01890265|65239869|FG003|Overall Study|Adverse Event|0|||
23408433|NCT01890265|65239870|FG004|Overall Study|Adverse Event|0|||
23408434|NCT01890265|65239871|FG005|Overall Study|Adverse Event|0|||
23506190|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506191|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
23506192|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506193|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506194|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506195|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506196|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506197|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506198|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506199|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23408435|NCT01890265|65239866|FG000|Overall Study|Death|2|||
23408436|NCT01890265|65239867|FG001|Overall Study|Death|3|||
23408437|NCT01890265|65239868|FG002|Overall Study|Death|1|||
23408438|NCT01890265|65239869|FG003|Overall Study|Death|0|||
23408439|NCT01890265|65239870|FG004|Overall Study|Death|0|||
23408440|NCT01890265|65239871|FG005|Overall Study|Death|0|||
23408441|NCT01890265|65239866|FG000|Overall Study|Withdrawal by Subject|0|||
23408442|NCT01890265|65239867|FG001|Overall Study|Withdrawal by Subject|2|||
23408443|NCT01890265|65239868|FG002|Overall Study|Withdrawal by Subject|3|||
23408444|NCT01890265|65239869|FG003|Overall Study|Withdrawal by Subject|0|||
23506200|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
23506201|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23408445|NCT01890265|65239870|FG004|Overall Study|Withdrawal by Subject|2|||
23408446|NCT01890265|65239871|FG005|Overall Study|Withdrawal by Subject|0|||
23408447|NCT00673231|65239872|FG000|Overall Study|Withdrawal by Subject|14|||
23408448|NCT00673231|65239873|FG001|Overall Study|Withdrawal by Subject|10|||
23408449|NCT00673231|65239874|FG002|Overall Study|Withdrawal by Subject|8|||
23506202|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
23506203|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506204|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506205|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506206|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506207|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23408450|NCT00673231|65239875|FG003|Overall Study|Withdrawal by Subject|6|||
23408451|NCT00673231|65239872|FG000|Overall Study|Adverse Event|6|||
23408452|NCT00673231|65239873|FG001|Overall Study|Adverse Event|5|||
23408453|NCT00673231|65239874|FG002|Overall Study|Adverse Event|9|||
23408454|NCT00673231|65239875|FG003|Overall Study|Adverse Event|6|||
23408455|NCT00673231|65239872|FG000|Overall Study|Lost to Follow-up|1|||
23408456|NCT00673231|65239873|FG001|Overall Study|Lost to Follow-up|2|||
23408457|NCT00673231|65239874|FG002|Overall Study|Lost to Follow-up|1|||
23408458|NCT00673231|65239875|FG003|Overall Study|Lost to Follow-up|2|||
23408459|NCT00673231|65239872|FG000|Overall Study|Death|0|||
23408460|NCT00673231|65239873|FG001|Overall Study|Death|0|||
23408461|NCT00673231|65239874|FG002|Overall Study|Death|1|||
23408462|NCT00673231|65239875|FG003|Overall Study|Death|0|||
23408463|NCT00673231|65239872|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
23408464|NCT00673231|65239873|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
23408465|NCT00673231|65239874|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
23408466|NCT00673231|65239875|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
23408467|NCT01804049|65239876|FG000|Overall Study|Adverse Event|2|||
23408468|NCT01804049|65239877|FG001|Overall Study|Adverse Event|10|||
23408469|NCT01804049|65239876|FG000|Overall Study|Lost to Follow-up|2|||
23408470|NCT01804049|65239877|FG001|Overall Study|Lost to Follow-up|1|||
23408471|NCT01804049|65239876|FG000|Overall Study|Decreased interest/personal|4|||
23408472|NCT01804049|65239877|FG001|Overall Study|Decreased interest/personal|5|||
23408473|NCT01804049|65239876|FG000|Overall Study|Other health concerns|2|||
23408474|NCT01804049|65239877|FG001|Overall Study|Other health concerns|7|||
23408475|NCT01804049|65239876|FG000|Overall Study|Moved out of area|0|||
23408476|NCT01804049|65239877|FG001|Overall Study|Moved out of area|7|||
23408477|NCT01804049|65239876|FG000|Overall Study|other MD recommended|1|||
23408478|NCT01804049|65239877|FG001|Overall Study|other MD recommended|1|||
23408479|NCT01804049|65239876|FG000|Overall Study|Enrollment in dual studies|0|||
23408480|NCT01804049|65239877|FG001|Overall Study|Enrollment in dual studies|1|||
23408481|NCT01309204|65239879|FG000|Overall Study|Adverse Event|48|||
23408482|NCT01309204|65239880|FG001|Overall Study|Adverse Event|58|||
23408483|NCT01309204|65239879|FG000|Overall Study|Lost to Follow-up|2|||
23408484|NCT01309204|65239880|FG001|Overall Study|Lost to Follow-up|2|||
23408485|NCT01309204|65239879|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
23408486|NCT01309204|65239880|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
23506208|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23408487|NCT01309204|65239879|FG000|Overall Study|Inadequate control of IOP|4|||
23408488|NCT01309204|65239880|FG001|Overall Study|Inadequate control of IOP|4|||
23408489|NCT01309204|65239879|FG000|Overall Study|Other|4|||
23506209|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506210|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
23506211|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506212|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506213|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
23506214|NCT02207244|65591032|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506215|NCT02207244|65591033|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506216|NCT02207244|65591034|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506217|NCT02207244|65591035|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506218|NCT02207244|65591036|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506219|NCT02207244|65591037|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506220|NCT02207244|65591038|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
23506221|NCT02207244|65591039|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506222|NCT02207244|65591040|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506223|NCT02207244|65591041|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506224|NCT02207244|65591042|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
23506225|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506226|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506227|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506228|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506229|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506230|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506231|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506232|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506233|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
23506234|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
23506235|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
23506236|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506237|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506238|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506239|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506240|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506241|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506242|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506243|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506244|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
23506245|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
23506246|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
23506247|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506248|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506249|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506250|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506251|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506252|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506253|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506254|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506255|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
23506256|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
23506257|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
23506258|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506259|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506260|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23607374|NCT00195819|65950686|FG000|Double-Blind|Withdrawal by Subject|1|||
23408490|NCT01309204|65239880|FG001|Overall Study|Other|1|||
23408491|NCT02817776|65239881|FG000|Overall Study|Excluded|33|||
23408492|NCT02817776|65239881|FG000|Overall Study|Lost to Follow-up|20|||
23408493|NCT02817776|65239881|FG000|Overall Study|Withdrawal by Subject|33|||
23408494|NCT02817776|65239881|FG000|Overall Study|Death|2|||
23408495|NCT02522429|65239884|FG000|Overall Study|Lost to Follow-up|8|||
23408496|NCT02522429|65239884|FG000|Overall Study|Adverse Event|2|||
23408497|NCT02522429|65239884|FG000|Overall Study|Death|1|||
23408498|NCT02522429|65239884|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
23506261|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506262|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506263|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506264|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506265|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506266|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
23506267|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
23506268|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
23506269|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
23506270|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
23506271|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
23506272|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
23506273|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
23506274|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
23506275|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
23506276|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
23506277|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
23506278|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
23506279|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
23506280|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
23506281|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
23506282|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
23506283|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
23506284|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
23506285|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
23506286|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
23506287|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
23506288|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
23506289|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
23506290|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
23506291|NCT02207244|65591032|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506292|NCT02207244|65591033|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506293|NCT02207244|65591034|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506294|NCT02207244|65591035|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506295|NCT02207244|65591036|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506296|NCT02207244|65591037|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506297|NCT02207244|65591038|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506298|NCT02207244|65591039|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506299|NCT02207244|65591040|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506300|NCT02207244|65591041|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
23506301|NCT02207244|65591042|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
23506302|NCT02627144|65591045|FG000|Overall Study|Serious adverse event|32|||
23506303|NCT02627144|65591045|FG000|Overall Study|Cancer progression|171|||
23506304|NCT02627144|65591045|FG000|Overall Study|Death from cancer|20|||
23506305|NCT02627144|65591045|FG000|Overall Study|Death from other cause|8|||
23506306|NCT02627144|65591045|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
23506307|NCT02627144|65591045|FG000|Overall Study|Administrative reasons|65|||
23506308|NCT02627144|65591045|FG000|Overall Study|Lost to Follow-up|8|||
23506309|NCT02627144|65591045|FG000|Overall Study|Enrolled, not treated|6|||
23506310|NCT02627144|65591045|FG000|Overall Study|Other|17|||
23506311|NCT00660023|65591046|FG000|Overall Study|Adverse Event|2|||
23506312|NCT00660023|65591046|FG000|Overall Study|Death|8|||
23506313|NCT00660023|65591046|FG000|Overall Study|Blood Transfusion|5|||
23506314|NCT00660023|65591046|FG000|Overall Study|Renal Transplantation|3|||
23506315|NCT00660023|65591046|FG000|Overall Study|Withdrawal by Subject|1|||
23506316|NCT00660023|65591046|FG000|Overall Study|Missed Pregnancy Test|1|||
23506317|NCT00660023|65591046|FG000|Overall Study|Other Screening Failure|9|||
23506318|NCT03851705|65591052|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
23506319|NCT03851705|65591053|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
23506320|NCT03851705|65591054|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
23506321|NCT03851705|65591055|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
23506322|NCT03851705|65591052|FG000|Part 1: Double-Blind Period|Other reason|1|||
23506323|NCT03851705|65591053|FG001|Part 1: Double-Blind Period|Other reason|0|||
23506324|NCT03851705|65591054|FG002|Part 1: Double-Blind Period|Other reason|0|||
23506325|NCT03851705|65591055|FG003|Part 1: Double-Blind Period|Other reason|0|||
23506326|NCT03851705|65591052|FG000|Part 2: Open-Label Period|Other reason|0|||
23506327|NCT03851705|65591053|FG001|Part 2: Open-Label Period|Other reason|0|||
23506328|NCT03851705|65591054|FG002|Part 2: Open-Label Period|Other reason|0|||
23506329|NCT03851705|65591055|FG003|Part 2: Open-Label Period|Other reason|1|||
23506330|NCT03851705|65591052|FG000|Part 2: Open-Label Period|Death|0|||
23506331|NCT03851705|65591053|FG001|Part 2: Open-Label Period|Death|0|||
23506332|NCT03851705|65591054|FG002|Part 2: Open-Label Period|Death|3|||
23506333|NCT03851705|65591055|FG003|Part 2: Open-Label Period|Death|0|||
23506334|NCT03851705|65591052|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
23506335|NCT03851705|65591053|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
23506336|NCT03851705|65591054|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
23506337|NCT03851705|65591055|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
23506338|NCT02651922|65591057|FG000|Overall Study|due to exclusion criteria|2|||
23506339|NCT00618072|65591058|FG000|Overall Study|Lost to Follow-up|2|||
23506340|NCT00618072|65591059|FG001|Overall Study|Lost to Follow-up|0|||
23506341|NCT00618072|65591060|FG002|Overall Study|Lost to Follow-up|3|||
23506342|NCT00618072|65591058|FG000|Overall Study|Physician Decision|0|||
23506343|NCT00618072|65591059|FG001|Overall Study|Physician Decision|1|||
23506344|NCT00618072|65591060|FG002|Overall Study|Physician Decision|1|||
23506345|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
23506346|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
23506347|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
23506348|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
23506349|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
23506350|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
23506351|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
23506352|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
23506353|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
23506354|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
23506355|NCT00787891|65591074|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
23506356|NCT00787891|65591075|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
23506357|NCT00787891|65591074|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
23506358|NCT00787891|65591075|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
23506359|NCT00787891|65591074|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
23506360|NCT00787891|65591075|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
23506361|NCT00787891|65591074|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
23506362|NCT00787891|65591075|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
23506363|NCT00787891|65591074|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
23506364|NCT00787891|65591075|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
23506365|NCT03020160|65591076|FG000|Overall Study|Withdrawal by Subject|1|||
23506366|NCT03020160|65591077|FG001|Overall Study|Withdrawal by Subject|0|||
23506367|NCT02010775|65591078|FG000|Overall Study|Adverse Event|0|||
23506368|NCT02010775|65591079|FG001|Overall Study|Adverse Event|0|||
23506369|NCT02010775|65591080|FG002|Overall Study|Adverse Event|0|||
23506370|NCT02010775|65591081|FG003|Overall Study|Adverse Event|0|||
23506371|NCT02010775|65591082|FG004|Overall Study|Adverse Event|1|||
23506372|NCT02010775|65591078|FG000|Overall Study|Pregnancy|0|||
23506373|NCT02010775|65591079|FG001|Overall Study|Pregnancy|0|||
23506374|NCT02010775|65591080|FG002|Overall Study|Pregnancy|2|||
23506375|NCT02010775|65591081|FG003|Overall Study|Pregnancy|0|||
23506376|NCT02010775|65591082|FG004|Overall Study|Pregnancy|0|||
23408499|NCT00211172|65239885|FG000|Overall Study|Died or lost health plan eligibility|39|||
23408500|NCT00211172|65239886|FG001|Overall Study|Died or lost health plan eligibility|32|||
23408501|NCT02567799|65239890|FG000|Concurrent Chemoradiotherapy|Death|1|||
23408502|NCT02567799|65239891|FG001|Concurrent Chemoradiotherapy|Death|0|||
23408503|NCT02567799|65239892|FG002|Concurrent Chemoradiotherapy|Death|0|||
23408504|NCT02567799|65239890|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
23408505|NCT02567799|65239891|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
23408506|NCT02567799|65239892|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
23408507|NCT02567799|65239890|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
23408508|NCT02567799|65239891|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
23408509|NCT02567799|65239892|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
23408510|NCT02567799|65239890|FG000|Follow-up|Death|1|||
23408511|NCT02567799|65239891|FG001|Follow-up|Death|0|||
23408512|NCT02567799|65239892|FG002|Follow-up|Death|1|||
23408513|NCT02567799|65239890|FG000|Follow-up|Progressive Disease|1|||
23408514|NCT02567799|65239891|FG001|Follow-up|Progressive Disease|1|||
23408515|NCT02567799|65239892|FG002|Follow-up|Progressive Disease|3|||
23408516|NCT00833469|65239893|FG000|Overall Study|Withdrawal by Subject|1|||
23408517|NCT00833469|65239893|FG000|Overall Study|Lost to Follow-up|1|||
23408518|NCT04466384|65239899|FG000|First Phase|Protocol Violation|1|||
23408519|NCT04466384|65239900|FG001|First Phase|Protocol Violation|0|||
23408520|NCT04466384|65239899|FG000|First Phase|Missing data|1|||
23408521|NCT04466384|65239900|FG001|First Phase|Missing data|0|||
23408522|NCT04466384|65239899|FG000|Cross Over Phase|Physician Decision|1|||
23408523|NCT04466384|65239900|FG001|Cross Over Phase|Physician Decision|0|||
23408524|NCT04466384|65239899|FG000|Cross Over Phase|Withdrawal by Subject|0|||
23408525|NCT04466384|65239900|FG001|Cross Over Phase|Withdrawal by Subject|1|||
23408526|NCT02366923|65239903|FG000|Overall Study|Withdrawal by Subject|1|||
23408527|NCT02366923|65239903|FG000|Overall Study|Positive Slit Lamp Findings|2|||
23506377|NCT02010775|65591078|FG000|Overall Study|Lost to Follow-up|2|||
23506378|NCT02010775|65591079|FG001|Overall Study|Lost to Follow-up|0|||
23506379|NCT02010775|65591080|FG002|Overall Study|Lost to Follow-up|0|||
23408528|NCT02366923|65239903|FG000|Overall Study|High Astigmatism|3|||
23408529|NCT01635998|65239906|FG000|Overall Study|Death|1|||
23408530|NCT01635998|65239907|FG001|Overall Study|Death|1|||
23408531|NCT01635998|65239906|FG000|Overall Study|Lost to Follow-up|2|||
23408532|NCT01635998|65239907|FG001|Overall Study|Lost to Follow-up|1|||
23408533|NCT01635998|65239906|FG000|Overall Study|Withdrawal by Subject|1|||
23408534|NCT01635998|65239907|FG001|Overall Study|Withdrawal by Subject|5|||
23408535|NCT00910910|65239908|FG000|Overall Study|Adverse Event|63|||
23408536|NCT00910910|65239909|FG001|Overall Study|Adverse Event|35|||
23408537|NCT00910910|65239908|FG000|Overall Study|PD without histologic change|27|||
23408538|NCT00910910|65239909|FG001|Overall Study|PD without histologic change|23|||
23408539|NCT00910910|65239908|FG000|Overall Study|PD with histologic change|0|||
23408540|NCT00910910|65239909|FG001|Overall Study|PD with histologic change|2|||
23408541|NCT00910910|65239908|FG000|Overall Study|Withdrawal by Subject|7|||
23408542|NCT00910910|65239909|FG001|Overall Study|Withdrawal by Subject|5|||
23408543|NCT00910910|65239908|FG000|Overall Study|Lost to Follow-up|2|||
23408544|NCT00910910|65239909|FG001|Overall Study|Lost to Follow-up|2|||
23408545|NCT00910910|65239908|FG000|Overall Study|Death|9|||
23408546|NCT00910910|65239909|FG001|Overall Study|Death|3|||
23408547|NCT00910910|65239908|FG000|Overall Study|Protocol Violation|2|||
23408548|NCT00910910|65239909|FG001|Overall Study|Protocol Violation|2|||
23408549|NCT00910910|65239908|FG000|Overall Study|Completed 13 cycles of treatment|0|||
23408550|NCT00910910|65239909|FG001|Overall Study|Completed 13 cycles of treatment|118|||
23408551|NCT00910910|65239908|FG000|Overall Study|Other|114|||
23408552|NCT00910910|65239909|FG001|Overall Study|Other|32|||
23408553|NCT00910910|65239908|FG000|Overall Study|Untreated before cycle 1|1|||
23408554|NCT00910910|65239909|FG001|Overall Study|Untreated before cycle 1|2|||
23408555|NCT03072043|65239919|FG000|Overall Study|Death|0|||
23408556|NCT03072043|65239920|FG001|Overall Study|Death|0|||
23408557|NCT03072043|65239921|FG002|Overall Study|Death|3|||
23506380|NCT02010775|65591081|FG003|Overall Study|Lost to Follow-up|1|||
23506381|NCT02010775|65591082|FG004|Overall Study|Lost to Follow-up|1|||
23506382|NCT02010775|65591078|FG000|Overall Study|Personal Reasons|3|||
23506383|NCT02010775|65591079|FG001|Overall Study|Personal Reasons|3|||
23506384|NCT02010775|65591080|FG002|Overall Study|Personal Reasons|1|||
23506385|NCT02010775|65591081|FG003|Overall Study|Personal Reasons|2|||
23506386|NCT02010775|65591082|FG004|Overall Study|Personal Reasons|4|||
23506387|NCT01605877|65591083|FG000|Overall Study|Withdrawal by Subject|1|||
23506388|NCT02088047|65591087|FG000|Overall Study|Withdrawal by Subject|1|||
23506389|NCT02088047|65591088|FG001|Overall Study|Withdrawal by Subject|0|||
23506390|NCT03281577|65591089|FG000|Overall Study|Adverse Event|0|||
23506391|NCT03281577|65591090|FG001|Overall Study|Adverse Event|0|||
23506392|NCT03281577|65591091|FG002|Overall Study|Adverse Event|0|||
23506393|NCT03281577|65591092|FG003|Overall Study|Adverse Event|1|||
23506394|NCT03281577|65591089|FG000|Overall Study|Withdrawal by Subject|1|||
23506395|NCT03281577|65591090|FG001|Overall Study|Withdrawal by Subject|0|||
23506396|NCT03281577|65591091|FG002|Overall Study|Withdrawal by Subject|0|||
23506397|NCT03281577|65591092|FG003|Overall Study|Withdrawal by Subject|0|||
23506398|NCT01731990|65591104|FG000|Overall Study|Adverse Event|1|||
23506399|NCT01731990|65591105|FG001|Overall Study|Adverse Event|5|||
23506400|NCT01731990|65591104|FG000|Overall Study|Withdrawal by Subject|1|||
23506401|NCT01731990|65591105|FG001|Overall Study|Withdrawal by Subject|1|||
23506402|NCT01731990|65591104|FG000|Overall Study|Protocol deviation|1|||
23506403|NCT01731990|65591105|FG001|Overall Study|Protocol deviation|2|||
23506404|NCT01731990|65591104|FG000|Overall Study|Death|1|||
23506405|NCT01731990|65591105|FG001|Overall Study|Death|0|||
23506406|NCT00673465|65591106|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506407|NCT00673465|65591107|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506408|NCT00673465|65591108|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506409|NCT00673465|65591109|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506410|NCT00673465|65591110|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
23506411|NCT00673465|65591111|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
23506412|NCT00673465|65591112|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506413|NCT00673465|65591113|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506414|NCT00673465|65591114|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506415|NCT00673465|65591115|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506416|NCT00673465|65591116|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506417|NCT00673465|65591117|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
23506418|NCT00673465|65591106|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506419|NCT00673465|65591107|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506420|NCT00673465|65591108|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506421|NCT00673465|65591109|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506422|NCT00673465|65591110|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
23506423|NCT00673465|65591111|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506424|NCT00673465|65591112|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506425|NCT00673465|65591113|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506426|NCT00673465|65591114|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506427|NCT00673465|65591115|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506428|NCT00673465|65591116|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506429|NCT00673465|65591117|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
23506430|NCT01365910|65591118|FG000|Overall Study|Withdrawal by Subject|7|||
23506431|NCT01365910|65591118|FG000|Overall Study|disease progression|18|||
23506432|NCT01365910|65591118|FG000|Overall Study|Adverse Event|3|||
23506433|NCT01365910|65591118|FG000|Overall Study|other complicating disease|1|||
23506434|NCT01365910|65591118|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
23506435|NCT01654536|65591133|FG000|Overall Study|Lost to Follow-up|5|||
23506436|NCT01654536|65591134|FG001|Overall Study|Lost to Follow-up|5|||
23506437|NCT01654536|65591133|FG000|Overall Study|Physician Decision|12|||
23506438|NCT01654536|65591134|FG001|Overall Study|Physician Decision|8|||
23506439|NCT01654536|65591133|FG000|Overall Study|Withdrawal by Subject|27|||
23506440|NCT01654536|65591134|FG001|Overall Study|Withdrawal by Subject|25|||
23506441|NCT00553644|65591135|FG000|Overall Study|Adverse Event|17|||
23506442|NCT00553644|65591135|FG000|Overall Study|Withdrawal by Subject|4|||
23506443|NCT00553644|65591135|FG000|Overall Study|Physician Decision|1|||
23506444|NCT00553644|65591135|FG000|Overall Study|Alternative therapy|6|||
23506445|NCT01603355|65591138|FG000|Overall Study|Lack of Efficacy|2|||
23506446|NCT03130257|65591140|FG000|Overall Study|Withdrawal by Subject|1|||
23506447|NCT03130257|65591141|FG001|Overall Study|Withdrawal by Subject|0|||
23506448|NCT03130257|65591142|FG002|Overall Study|Withdrawal by Subject|2|||
23506449|NCT01336764|65591143|FG000|Overall Study|Withdrawal by Subject|5|||
23506450|NCT01336764|65591144|FG001|Overall Study|Withdrawal by Subject|5|||
23506451|NCT01129960|65591148|FG000|Overall Study|Withdrawal by Subject|3|||
23506452|NCT01129960|65591149|FG001|Overall Study|Withdrawal by Subject|0|||
23506453|NCT01129960|65591150|FG002|Overall Study|Withdrawal by Subject|3|||
23506454|NCT01129960|65591151|FG003|Overall Study|Withdrawal by Subject|2|||
23506455|NCT01129960|65591148|FG000|Overall Study|Lack of Efficacy|1|||
23506456|NCT01129960|65591149|FG001|Overall Study|Lack of Efficacy|1|||
23506457|NCT01129960|65591150|FG002|Overall Study|Lack of Efficacy|1|||
23506458|NCT01129960|65591151|FG003|Overall Study|Lack of Efficacy|1|||
23506459|NCT01129960|65591148|FG000|Overall Study|Adverse Event|23|||
23506460|NCT01129960|65591149|FG001|Overall Study|Adverse Event|16|||
23506461|NCT01129960|65591150|FG002|Overall Study|Adverse Event|16|||
23506462|NCT01129960|65591151|FG003|Overall Study|Adverse Event|7|||
23506463|NCT01129960|65591148|FG000|Overall Study|Protocol Violation|1|||
23506464|NCT01129960|65591149|FG001|Overall Study|Protocol Violation|2|||
23506465|NCT01129960|65591150|FG002|Overall Study|Protocol Violation|3|||
23506466|NCT01129960|65591151|FG003|Overall Study|Protocol Violation|0|||
23506467|NCT01129960|65591148|FG000|Overall Study|Lost to Follow-up|0|||
23506468|NCT01129960|65591149|FG001|Overall Study|Lost to Follow-up|2|||
23506469|NCT01129960|65591150|FG002|Overall Study|Lost to Follow-up|3|||
23506470|NCT01129960|65591151|FG003|Overall Study|Lost to Follow-up|3|||
23506471|NCT01129960|65591148|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
23506472|NCT01129960|65591149|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
23506473|NCT01129960|65591150|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
23506474|NCT01129960|65591151|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
23506475|NCT01129960|65591148|FG000|Overall Study|Physician Decision|1|||
23506476|NCT01129960|65591149|FG001|Overall Study|Physician Decision|0|||
23506477|NCT01129960|65591150|FG002|Overall Study|Physician Decision|0|||
23506478|NCT01129960|65591151|FG003|Overall Study|Physician Decision|0|||
23506479|NCT01129960|65591148|FG000|Overall Study|Pregnancy|1|||
23506480|NCT01129960|65591149|FG001|Overall Study|Pregnancy|0|||
23506481|NCT01129960|65591150|FG002|Overall Study|Pregnancy|0|||
23506482|NCT01129960|65591151|FG003|Overall Study|Pregnancy|0|||
23506483|NCT02505867|65591153|FG000|Overall Study|Lack of Efficacy|6|||
23506484|NCT02505867|65591154|FG001|Overall Study|Lack of Efficacy|6|||
23506485|NCT00003499|65591156|FG000|Overall Study|Not evaluable|8|||
23506486|NCT00739674|65591161|FG000|Overall Study|Screening failures|19|||
23506487|NCT00739674|65591162|FG001|Overall Study|Screening failures|17|||
23506488|NCT00739674|65591161|FG000|Overall Study|Site 212 removal|19|||
23506489|NCT00739674|65591162|FG001|Overall Study|Site 212 removal|13|||
23506490|NCT00739674|65591161|FG000|Overall Study|No follow-up data|33|||
23506491|NCT00739674|65591162|FG001|Overall Study|No follow-up data|18|||
23506492|NCT00739674|65591161|FG000|Overall Study|Dietician consultation >30 days|1|||
23506493|NCT00739674|65591162|FG001|Overall Study|Dietician consultation >30 days|9|||
23506494|NCT00739674|65591161|FG000|Overall Study|Adverse Event|22|||
23506495|NCT00739674|65591162|FG001|Overall Study|Adverse Event|13|||
23506496|NCT00739674|65591161|FG000|Overall Study|Death|1|||
23506497|NCT00739674|65591162|FG001|Overall Study|Death|0|||
23506498|NCT00739674|65591161|FG000|Overall Study|Lack of Efficacy|1|||
23506499|NCT00739674|65591162|FG001|Overall Study|Lack of Efficacy|0|||
23506500|NCT00739674|65591161|FG000|Overall Study|Lost to Follow-up|52|||
23506501|NCT00739674|65591162|FG001|Overall Study|Lost to Follow-up|30|||
23506502|NCT00739674|65591161|FG000|Overall Study|Protocol Violation|5|||
23506503|NCT00739674|65591162|FG001|Overall Study|Protocol Violation|5|||
23506504|NCT00739674|65591161|FG000|Overall Study|Withdrawal by Subject|9|||
23506505|NCT00739674|65591162|FG001|Overall Study|Withdrawal by Subject|9|||
23506506|NCT00739674|65591161|FG000|Overall Study|Reason missing|2|||
23506507|NCT00739674|65591162|FG001|Overall Study|Reason missing|0|||
23506508|NCT00739674|65591161|FG000|Overall Study|Clinic closed|6|||
23506509|NCT00739674|65591162|FG001|Overall Study|Clinic closed|4|||
23506510|NCT00739674|65591161|FG000|Overall Study|Patient moved|3|||
23506511|NCT00739674|65591162|FG001|Overall Study|Patient moved|2|||
23506512|NCT00739674|65591161|FG000|Overall Study|Non compliant|4|||
23506513|NCT00739674|65591162|FG001|Overall Study|Non compliant|0|||
23506514|NCT00739674|65591161|FG000|Overall Study|Unable to attend visit|3|||
23506515|NCT00739674|65591162|FG001|Overall Study|Unable to attend visit|1|||
23506516|NCT00739674|65591161|FG000|Overall Study|Home monitoring off meds|1|||
23506517|NCT00739674|65591162|FG001|Overall Study|Home monitoring off meds|0|||
23506518|NCT00739674|65591161|FG000|Overall Study|Erectile dysfunction|0|||
23506519|NCT00739674|65591162|FG001|Overall Study|Erectile dysfunction|1|||
23506520|NCT04015336|65591163|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
23506521|NCT02014597|65591164|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
23506522|NCT02014597|65591165|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
23506523|NCT00730132|65591166|FG000|Overall Study|Protocol Violation|154|||
23506524|NCT00730132|65591166|FG000|Overall Study|Death|1|||
23506525|NCT02289898|65591167|FG000|Overall Study|Death|5|||
23506526|NCT02289898|65591168|FG001|Overall Study|Death|4|||
23506527|NCT02289898|65591169|FG002|Overall Study|Death|3|||
23506528|NCT02289898|65591167|FG000|Overall Study|Physician Decision|2|||
23506529|NCT02289898|65591168|FG001|Overall Study|Physician Decision|5|||
23506530|NCT02289898|65591169|FG002|Overall Study|Physician Decision|2|||
23506531|NCT02289898|65591167|FG000|Overall Study|Withdrawal by Subject|0|||
23506532|NCT02289898|65591168|FG001|Overall Study|Withdrawal by Subject|4|||
23506533|NCT02289898|65591169|FG002|Overall Study|Withdrawal by Subject|1|||
23506534|NCT02289898|65591167|FG000|Overall Study|Adverse Event|3|||
23506535|NCT02289898|65591168|FG001|Overall Study|Adverse Event|5|||
23506536|NCT02289898|65591169|FG002|Overall Study|Adverse Event|5|||
23506537|NCT02289898|65591167|FG000|Overall Study|Disease progression|34|||
23506538|NCT02289898|65591168|FG001|Overall Study|Disease progression|28|||
23506539|NCT02289898|65591169|FG002|Overall Study|Disease progression|34|||
23506540|NCT02289898|65591167|FG000|Overall Study|Use of another anticancer therapy|0|||
23506541|NCT02289898|65591168|FG001|Overall Study|Use of another anticancer therapy|0|||
23506542|NCT02289898|65591169|FG002|Overall Study|Use of another anticancer therapy|1|||
23506543|NCT02289898|65591167|FG000|Overall Study|Other|8|||
23506544|NCT02289898|65591168|FG001|Overall Study|Other|7|||
23506545|NCT02289898|65591169|FG002|Overall Study|Other|10|||
23506546|NCT02151591|65591184|FG000|Overall Study|Lost to Follow-up|6|||
23506547|NCT02151591|65591185|FG001|Overall Study|Lost to Follow-up|3|||
23506548|NCT00887978|65591186|FG000|Overall Study|Adverse Event|18|||
23506549|NCT00887978|65591187|FG001|Overall Study|Adverse Event|5|||
23506550|NCT00887978|65591186|FG000|Overall Study|Clinical Worsening|4|||
23506551|NCT00887978|65591187|FG001|Overall Study|Clinical Worsening|4|||
23506552|NCT00887978|65591186|FG000|Overall Study|Death|2|||
23506553|NCT00887978|65591187|FG001|Overall Study|Death|3|||
23506554|NCT00887978|65591186|FG000|Overall Study|Withdrawal by Subject|1|||
23506555|NCT00887978|65591187|FG001|Overall Study|Withdrawal by Subject|2|||
23506556|NCT00887978|65591186|FG000|Overall Study|Lost to Follow-up|0|||
23506557|NCT00887978|65591187|FG001|Overall Study|Lost to Follow-up|1|||
23506558|NCT00573534|65591188|FG000|Overall Study|oppositional behavior|3|||
23506559|NCT01402492|65591189|FG000|Overall Study|Withdrawal by Subject|17|||
23506560|NCT01402492|65591190|FG001|Overall Study|Withdrawal by Subject|11|||
23506561|NCT01402492|65591191|FG002|Overall Study|Withdrawal by Subject|11|||
23506562|NCT01402492|65591189|FG000|Overall Study|Adverse Event|2|||
23506563|NCT01402492|65591190|FG001|Overall Study|Adverse Event|3|||
23506564|NCT01402492|65591191|FG002|Overall Study|Adverse Event|4|||
23506565|NCT01402492|65591189|FG000|Overall Study|Physician Decision|0|||
23506566|NCT01402492|65591190|FG001|Overall Study|Physician Decision|3|||
23506567|NCT01402492|65591191|FG002|Overall Study|Physician Decision|0|||
23506568|NCT01402492|65591189|FG000|Overall Study|Incarcerated (N=3)|2|||
23506569|NCT01402492|65591190|FG001|Overall Study|Incarcerated (N=3)|0|||
23506570|NCT01402492|65591191|FG002|Overall Study|Incarcerated (N=3)|1|||
23506571|NCT02007109|65591192|FG000|Overall Study|Diary not returned or excluded|102|||
23506572|NCT02007109|65591192|FG000|Overall Study|Excluded - Age<7yo|9|||
23506573|NCT01835587|65591196|FG000|Overall Study|Disease Recurrence or Relapse|0|||
23506574|NCT01835587|65591197|FG001|Overall Study|Disease Recurrence or Relapse|3|||
23506575|NCT01835587|65591198|FG002|Overall Study|Disease Recurrence or Relapse|0|||
23506576|NCT01835587|65591199|FG003|Overall Study|Disease Recurrence or Relapse|3|||
23506577|NCT01835587|65591196|FG000|Overall Study|Withdrawal by Subject|2|||
23506578|NCT01835587|65591197|FG001|Overall Study|Withdrawal by Subject|0|||
23506579|NCT01835587|65591198|FG002|Overall Study|Withdrawal by Subject|0|||
23506580|NCT01835587|65591199|FG003|Overall Study|Withdrawal by Subject|3|||
23506581|NCT01835587|65591196|FG000|Overall Study|Adverse Event|0|||
23506582|NCT01835587|65591197|FG001|Overall Study|Adverse Event|0|||
23506583|NCT01835587|65591198|FG002|Overall Study|Adverse Event|2|||
23506584|NCT01835587|65591199|FG003|Overall Study|Adverse Event|2|||
23506585|NCT01835587|65591196|FG000|Overall Study|Death|0|||
23506586|NCT01835587|65591197|FG001|Overall Study|Death|0|||
23506587|NCT01835587|65591198|FG002|Overall Study|Death|0|||
23506588|NCT01835587|65591199|FG003|Overall Study|Death|1|||
23506589|NCT01835587|65591196|FG000|Overall Study|Miscellaneous|0|||
23506590|NCT01835587|65591197|FG001|Overall Study|Miscellaneous|1|||
23506591|NCT01835587|65591198|FG002|Overall Study|Miscellaneous|0|||
23506592|NCT01835587|65591199|FG003|Overall Study|Miscellaneous|0|||
23506593|NCT03064451|65591200|FG000|Overall Study|Lost to Follow-up|1|||
23506594|NCT03064451|65591200|FG000|Overall Study|Mapping Failure|4|||
23506595|NCT03064451|65591200|FG000|Overall Study|Exited prior to procedure|8|||
23506596|NCT03064451|65591200|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
23506597|NCT01385566|65591207|FG000|Overall Study|Lost to Follow-up|1|||
23506598|NCT01385566|65591208|FG001|Overall Study|Lost to Follow-up|0|||
23506599|NCT01385566|65591209|FG002|Overall Study|Lost to Follow-up|0|||
23506600|NCT01385566|65591210|FG003|Overall Study|Lost to Follow-up|0|||
23506601|NCT01385566|65591211|FG004|Overall Study|Lost to Follow-up|0|||
23506602|NCT01385566|65591212|FG005|Overall Study|Lost to Follow-up|0|||
23506603|NCT01385566|65591207|FG000|Overall Study|Withdrawal by Subject|0|||
23506604|NCT01385566|65591208|FG001|Overall Study|Withdrawal by Subject|0|||
23506605|NCT01385566|65591209|FG002|Overall Study|Withdrawal by Subject|0|||
23506606|NCT01385566|65591210|FG003|Overall Study|Withdrawal by Subject|1|||
23506607|NCT01385566|65591211|FG004|Overall Study|Withdrawal by Subject|0|||
23506608|NCT01385566|65591212|FG005|Overall Study|Withdrawal by Subject|0|||
23506609|NCT03715764|65591213|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
23506610|NCT03715764|65591214|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
23506611|NCT03715764|65591213|FG000|3 Month Follow-up|Lost to Follow-up|2|||
23506612|NCT03715764|65591214|FG001|3 Month Follow-up|Lost to Follow-up|2|||
23506613|NCT03715764|65591213|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
23506614|NCT03715764|65591214|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
23506615|NCT03715764|65591213|FG000|6 Month Follow-up|Lost to Follow-up|3|||
23506616|NCT03715764|65591214|FG001|6 Month Follow-up|Lost to Follow-up|0|||
23506617|NCT03715764|65591213|FG000|12 Month Follow-up|Lost to Follow-up|2|||
23506618|NCT03715764|65591214|FG001|12 Month Follow-up|Lost to Follow-up|3|||
23506619|NCT03715764|65591213|FG000|12 Month Follow-up|Pregnancy|0|||
23506620|NCT03715764|65591214|FG001|12 Month Follow-up|Pregnancy|1|||
23506621|NCT03715764|65591213|FG000|12 Month Follow-up|Surgery|2|||
23506622|NCT03715764|65591214|FG001|12 Month Follow-up|Surgery|0|||
23506623|NCT03715764|65591213|FG000|12 Month Follow-up|Wrong address|1|||
23506624|NCT03715764|65591214|FG001|12 Month Follow-up|Wrong address|0|||
23506625|NCT03715764|65591213|FG000|12 Month Follow-up|No symptoms|1|||
23506626|NCT03715764|65591214|FG001|12 Month Follow-up|No symptoms|0|||
23506627|NCT03715764|65591213|FG000|12 Month Follow-up|Changed primary care centre|0|||
23506628|NCT03715764|65591214|FG001|12 Month Follow-up|Changed primary care centre|1|||
23506629|NCT00867568|65591215|FG000|Overall Study|Lack of Efficacy|10|||
23506630|NCT00867568|65591215|FG000|Overall Study|Adverse Event|4|||
23506631|NCT00867568|65591215|FG000|Overall Study|Withdrawal by Subject|1|||
23506632|NCT00390468|65591217|FG000|Overall Study|Protocol Violation|2|||
23506633|NCT00390468|65591217|FG000|Overall Study|Lack of Efficacy|1|||
23506634|NCT03428360|65591218|FG000|Overall Study|Informed consent withdrawn|5|||
23506635|NCT03428360|65591218|FG000|Overall Study|Withdrawal by Subject|4|||
23506636|NCT03428360|65591218|FG000|Overall Study|Lost to Follow-up|5|||
23506637|NCT03428360|65591218|FG000|Overall Study|Physician Decision|2|||
23506638|NCT03428360|65591218|FG000|Overall Study|Informed consent withdrawn|5|||
23506639|NCT03428360|65591218|FG000|Overall Study|Study terminated by sponsor|10|||
23506640|NCT03428360|65591218|FG000|Overall Study|Non-compliant with study|1|||
23506641|NCT03428360|65591218|FG000|Overall Study|Non-compliant with study drug|3|||
23506642|NCT03428360|65591218|FG000|Overall Study|Death|3|||
23506643|NCT03428360|65591218|FG000|Overall Study|Adverse Event|1|||
23506644|NCT03428360|65591218|FG000|Overall Study|Not on antiepileptic drug|1|||
23506645|NCT02550106|65591226|FG000|Overall Study|Adverse Event|1|||
23506646|NCT02550106|65591226|FG000|Overall Study|Lack of Efficacy|3|||
23506647|NCT02550106|65591226|FG000|Overall Study|Protocol Violation|6|||
23506648|NCT02550106|65591226|FG000|Overall Study|Withdrawal by Subject|2|||
23506649|NCT03672747|65591231|FG000|Overall Study|Lost to Follow-up|1|||
23506650|NCT03672747|65591232|FG001|Overall Study|Lost to Follow-up|1|||
23506651|NCT03672747|65591233|FG002|Overall Study|Lost to Follow-up|2|||
23506652|NCT03672747|65591234|FG003|Overall Study|Lost to Follow-up|2|||
23506653|NCT03672747|65591235|FG004|Overall Study|Lost to Follow-up|2|||
23506654|NCT03672747|65591236|FG005|Overall Study|Lost to Follow-up|1|||
23506655|NCT00982878|65591240|FG000|Overall Study|Physician Decision|1|||
23506656|NCT02130570|65591241|FG000|Overall Study|Death|3|||
23506657|NCT02130570|65591242|FG001|Overall Study|Death|5|||
23506658|NCT02130570|65591241|FG000|Overall Study|Withdrawal by Subject|6|||
23506659|NCT02130570|65591242|FG001|Overall Study|Withdrawal by Subject|3|||
23506660|NCT02130570|65591241|FG000|Overall Study|Part of practice that discontinued study|0|||
23506661|NCT02130570|65591242|FG001|Overall Study|Part of practice that discontinued study|5|||
23506662|NCT04997161|65591244|FG000|Overall Study|Study terminated by sponsor|3|||
23506663|NCT02233647|65591245|FG000|Overall Study|Adverse Event|1|||
23506664|NCT04502589|65591246|FG000|Overall Study|Physician Decision|1|||
23506665|NCT04502589|65591247|FG001|Overall Study|Physician Decision|0|||
23506666|NCT00688753|65591248|FG000|Overall Study|Disease progression|55|||
23506667|NCT00688753|65591248|FG000|Overall Study|Missing|1|||
23506668|NCT00688753|65591248|FG000|Overall Study|Death|9|||
23506669|NCT00688753|65591248|FG000|Overall Study|Withdrawal by Subject|3|||
23506670|NCT00688753|65591248|FG000|Overall Study|Adverse Event|20|||
23506671|NCT00688753|65591248|FG000|Overall Study|Protocol Violation|1|||
23506672|NCT00688753|65591248|FG000|Overall Study|Lost to Follow-up|3|||
23506673|NCT01830972|65591249|FG000|Part II|Withdrawal by Subject|2|||
23506674|NCT01830972|65591250|FG001|Part II|Withdrawal by Subject|2|||
23506675|NCT01830972|65591249|FG000|Part III|Withdrawal by Subject|1|||
23506676|NCT01830972|65591250|FG001|Part III|Withdrawal by Subject|0|||
23506677|NCT01830972|65591249|FG000|Part III|Noncompliance|1|||
23506678|NCT01830972|65591250|FG001|Part III|Noncompliance|0|||
23506679|NCT01830972|65591249|FG000|Part IV|Withdrawal by Subject|2|||
23506680|NCT01830972|65591250|FG001|Part IV|Withdrawal by Subject|1|||
23506681|NCT01830972|65591249|FG000|Part IV|Non-Compliance|1|||
23506682|NCT01830972|65591250|FG001|Part IV|Non-Compliance|0|||
23506683|NCT00297830|65591251|FG000|6 Month Visit|Death|1|||
23506684|NCT00297830|65591252|FG001|6 Month Visit|Death|0|||
23506685|NCT00297830|65591253|FG002|6 Month Visit|Death|2|||
23506686|NCT00297830|65591251|FG000|6 Month Visit|Withdrawal by Subject|2|||
23506687|NCT00297830|65591252|FG001|6 Month Visit|Withdrawal by Subject|1|||
23506688|NCT00297830|65591253|FG002|6 Month Visit|Withdrawal by Subject|1|||
23506689|NCT00297830|65591251|FG000|6 Month Visit|Adverse Event|0|||
23506690|NCT00297830|65591252|FG001|6 Month Visit|Adverse Event|1|||
23506691|NCT00297830|65591253|FG002|6 Month Visit|Adverse Event|0|||
23506692|NCT00297830|65591251|FG000|12 Month Visit|Lost to Follow-up|1|||
23506693|NCT00297830|65591252|FG001|12 Month Visit|Lost to Follow-up|0|||
23506694|NCT00297830|65591253|FG002|12 Month Visit|Lost to Follow-up|0|||
23506695|NCT00297830|65591251|FG000|12 Month Visit|Adverse Event|0|||
23506696|NCT00297830|65591252|FG001|12 Month Visit|Adverse Event|3|||
23506697|NCT00297830|65591253|FG002|12 Month Visit|Adverse Event|0|||
23506698|NCT00297830|65591251|FG000|12 Month Visit|Withdrawal by Subject|0|||
23506699|NCT00297830|65591252|FG001|12 Month Visit|Withdrawal by Subject|3|||
23506700|NCT00297830|65591253|FG002|12 Month Visit|Withdrawal by Subject|0|||
23506701|NCT01442675|65591254|FG000|Overall Study|Protocol Violation|6|||
23506702|NCT01442675|65591254|FG000|Overall Study|Lost to Follow-up|2|||
23506703|NCT01442675|65591254|FG000|Overall Study|Withdrawal by Subject|4|||
23506704|NCT02220205|65591259|FG000|Overall Study|Withdrawal by Subject|1|||
23506705|NCT02220205|65591260|FG001|Overall Study|Withdrawal by Subject|0|||
23506706|NCT03217175|65591265|FG000|Overall Study|Physician Decision|4|||
23506707|NCT03217175|65591266|FG001|Overall Study|Physician Decision|1|||
23506708|NCT01537393|65591267|FG000|Overall Study|Exclude prior to study|32|||
23506709|NCT01537393|65591268|FG001|Overall Study|Exclude prior to study|44|||
23506710|NCT01537393|65591267|FG000|Overall Study|Death|20|||
23506711|NCT01537393|65591268|FG001|Overall Study|Death|32|||
23506712|NCT01537393|65591267|FG000|Overall Study|Withdrawal by Subject|18|||
23506713|NCT01537393|65591268|FG001|Overall Study|Withdrawal by Subject|17|||
23506714|NCT01537393|65591267|FG000|Overall Study|Lost to Follow-up|53|||
23506715|NCT01537393|65591268|FG001|Overall Study|Lost to Follow-up|48|||
23506716|NCT01537393|65591267|FG000|Overall Study|Failure - Regrafted|28|||
23506717|NCT01537393|65591268|FG001|Overall Study|Failure - Regrafted|43|||
23506718|NCT01537393|65591267|FG000|Overall Study|Failure - Not regrafted|2|||
23506719|NCT01537393|65591268|FG001|Overall Study|Failure - Not regrafted|6|||
23506720|NCT01537393|65591267|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
23506721|NCT01537393|65591268|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
23506722|NCT02837783|65591269|FG000|Overall Study|Adverse Event|1|||
23506723|NCT02837783|65591270|FG001|Overall Study|Adverse Event|0|||
23506724|NCT02837783|65591269|FG000|Overall Study|Other, Not Specified|1|||
23506725|NCT02837783|65591270|FG001|Overall Study|Other, Not Specified|2|||
23506726|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
23506727|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
23506728|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
23506729|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
23506730|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
23506731|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23506732|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
23506733|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
23506734|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Other|1|||
23506735|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Other|4|||
23506736|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Other|3|||
23506737|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Other|6|||
23506738|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
23506739|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
23506740|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
23506741|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
23506742|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
23506743|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
23506744|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
23506745|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
23506746|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23506747|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23506748|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
23506749|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
23506750|NCT02925494|65591271|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
23506751|NCT02925494|65591272|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
23506752|NCT02925494|65591273|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
23506753|NCT02925494|65591274|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
23506754|NCT01384760|65591275|FG000|Overall Study|Lost to Follow-up|0|||
23506755|NCT01384760|65591276|FG001|Overall Study|Lost to Follow-up|6|||
23506756|NCT01384760|65591275|FG000|Overall Study|Protocol Violation|16|||
23506757|NCT01384760|65591276|FG001|Overall Study|Protocol Violation|0|||
23506758|NCT02980601|65591277|FG000|Overall Study|Lost to Follow-up|2|||
23506759|NCT02980601|65591278|FG001|Overall Study|Lost to Follow-up|2|||
23506760|NCT02980601|65591277|FG000|Overall Study|Death|0|||
23506761|NCT02980601|65591278|FG001|Overall Study|Death|1|||
23506762|NCT02980601|65591277|FG000|Overall Study|Graft loss|1|||
23506763|NCT02980601|65591278|FG001|Overall Study|Graft loss|0|||
23506764|NCT02980601|65591277|FG000|Overall Study|Failed to sign consent|2|||
23506765|NCT02980601|65591278|FG001|Overall Study|Failed to sign consent|0|||
23506766|NCT00491075|65591307|FG000|Overall Study|Withdrawal by Subject|1|||
23506767|NCT00491075|65591307|FG000|Overall Study|Physician Decision|1|||
23506768|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
23506769|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
23506770|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
23506771|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
23506772|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
23506773|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
23506774|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
23506775|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
23506776|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
23506777|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
23506778|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Other|1|||
23506779|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Other|1|||
23506780|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Other|0|||
23506781|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Other|0|||
23506782|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Other|0|||
23506783|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
23506784|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
23506785|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
23506786|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
23506787|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
23506788|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
23506789|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
23506790|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
23506791|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
23506792|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
23506793|NCT02310568|65591310|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
23506794|NCT02310568|65591311|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
23506795|NCT02310568|65591312|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
23506796|NCT02310568|65591313|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
23506797|NCT02310568|65591314|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
23506798|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
23506799|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
23506800|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
23506801|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
23506802|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
23506803|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Other|0|||
23506804|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Other|1|||
23506805|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Other|1|||
23506806|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Other|0|||
23506807|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Other|0|||
23506808|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
23506809|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
23607375|NCT00195819|65950687|FG001|Double-Blind|Withdrawal by Subject|0|||
23506810|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
23506811|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
23506812|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
23506813|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
23506814|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
23506815|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
23506816|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
23506817|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
23506818|NCT02310568|65591310|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
23506819|NCT02310568|65591311|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
23506820|NCT02310568|65591312|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
23506821|NCT02310568|65591313|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
23506822|NCT02310568|65591314|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
23506823|NCT04404361|65591315|FG000|Overall Study|Death|12|||
23506824|NCT04404361|65591316|FG001|Overall Study|Death|12|||
23506825|NCT04404361|65591315|FG000|Overall Study|Withdrawal by Subject|13|||
23506826|NCT04404361|65591316|FG001|Overall Study|Withdrawal by Subject|5|||
23506827|NCT04404361|65591315|FG000|Overall Study|Lost to Follow-up|6|||
23506828|NCT04404361|65591316|FG001|Overall Study|Lost to Follow-up|3|||
23506829|NCT04404361|65591315|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
23506830|NCT04404361|65591316|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
23506831|NCT01664533|65591317|FG000|Overall Study|Death|42|||
23506832|NCT01664533|65591317|FG000|Overall Study|Lost to Follow-up|3|||
23506833|NCT01664533|65591317|FG000|Overall Study|Study termination|9|||
23506834|NCT01664533|65591317|FG000|Overall Study|Protocol Violation|3|||
23506835|NCT01473836|65591318|FG000|Overall Study|Adverse Event|4|||
23506836|NCT01473836|65591318|FG000|Overall Study|Lack of Efficacy|1|||
23506837|NCT01473836|65591318|FG000|Overall Study|Does not meet entrance criteria|1|||
23506838|NCT01530997|65591323|FG000|Overall Study|Physician Decision|1|||
23506839|NCT01530997|65591323|FG000|Overall Study|Withdrawal by Subject|1|||
23506840|NCT03667924|65591329|FG000|Baseline Completed|Lost to Follow-up|0|||
23506841|NCT03667924|65591330|FG001|Baseline Completed|Lost to Follow-up|2|||
23506842|NCT03667924|65591331|FG002|Baseline Completed|Lost to Follow-up|0|||
23506843|NCT03667924|65591329|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
23506844|NCT03667924|65591330|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
23506845|NCT03667924|65591331|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
23506846|NCT03667924|65591329|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
23506847|NCT03667924|65591330|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
23506848|NCT03667924|65591331|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
23506849|NCT03667924|65591329|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
23506850|NCT03667924|65591330|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
23506851|NCT03667924|65591331|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
23506852|NCT03667924|65591329|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
23506853|NCT03667924|65591330|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
23506854|NCT03667924|65591331|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
23506855|NCT03667924|65591329|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
23506856|NCT03667924|65591330|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
23506857|NCT03667924|65591331|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
23506858|NCT03667924|65591329|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
23506859|NCT03667924|65591330|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
23506860|NCT03667924|65591331|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
23506861|NCT00563381|65591332|FG000|Overall Study|Adverse Event|264|||
23506862|NCT00563381|65591333|FG001|Overall Study|Adverse Event|292|||
23506863|NCT00563381|65591332|FG000|Overall Study|Protocol Violation|66|||
23506864|NCT00563381|65591333|FG001|Overall Study|Protocol Violation|74|||
23506865|NCT00563381|65591332|FG000|Overall Study|Lost to Follow-up|7|||
23506866|NCT00563381|65591333|FG001|Overall Study|Lost to Follow-up|15|||
23506867|NCT00563381|65591332|FG000|Overall Study|Withdrawal by Subject|192|||
23506868|NCT00563381|65591333|FG001|Overall Study|Withdrawal by Subject|209|||
23506869|NCT00563381|65591332|FG000|Overall Study|Lack of Efficacy|32|||
23506870|NCT00563381|65591333|FG001|Overall Study|Lack of Efficacy|24|||
23506871|NCT00563381|65591332|FG000|Overall Study|Individual different reasons|24|||
23506872|NCT00563381|65591333|FG001|Overall Study|Individual different reasons|34|||
23506873|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
23506874|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
23506875|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
23506876|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
23506877|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
23506878|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
23506879|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
23506880|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
23506881|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Patient Request|1|||
23506882|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Patient Request|0|||
23506883|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
23506884|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
23506885|NCT04649060|65591334|FG000|Arm A/Arm B Treatment|Other|1|||
23506886|NCT04649060|65591335|FG001|Arm A/Arm B Treatment|Other|0|||
23506887|NCT04649060|65591334|FG000|Crossover (Arm B)|Adverse Event|0|||
23506888|NCT04649060|65591335|FG001|Crossover (Arm B)|Adverse Event|1|||
23506889|NCT04649060|65591334|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
23506890|NCT04649060|65591335|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
23506891|NCT01663532|65591336|FG000|Overall Study|Lost to Follow-up|9|||
23506892|NCT01663532|65591337|FG001|Overall Study|Lost to Follow-up|10|||
23506893|NCT01663532|65591336|FG000|Overall Study|Adverse Event|7|||
23506894|NCT01663532|65591337|FG001|Overall Study|Adverse Event|13|||
23506895|NCT01663532|65591336|FG000|Overall Study|Met Withdrawal Criteria|7|||
23506896|NCT01663532|65591337|FG001|Overall Study|Met Withdrawal Criteria|6|||
23506897|NCT01663532|65591336|FG000|Overall Study|Physician Decision|1|||
23506898|NCT01663532|65591337|FG001|Overall Study|Physician Decision|1|||
23506899|NCT01663532|65591336|FG000|Overall Study|Withdrawal by Subject|35|||
23506900|NCT01663532|65591337|FG001|Overall Study|Withdrawal by Subject|17|||
23506901|NCT01663532|65591336|FG000|Overall Study|Lack of Efficacy|15|||
23506902|NCT01663532|65591337|FG001|Overall Study|Lack of Efficacy|60|||
23506903|NCT01854710|65594572|FG000|Overall Study|Withdrawal by Subject|2|||
23506904|NCT01854710|65594573|FG001|Overall Study|Withdrawal by Subject|1|||
23506905|NCT01854710|65594574|FG002|Overall Study|Withdrawal by Subject|0|||
23506906|NCT01854710|65594575|FG003|Overall Study|Withdrawal by Subject|0|||
23506907|NCT01854710|65594576|FG004|Overall Study|Withdrawal by Subject|0|||
23506908|NCT01854710|65594577|FG005|Overall Study|Withdrawal by Subject|0|||
23506909|NCT01854710|65594572|FG000|Overall Study|CRI procedural error|2|||
23506910|NCT01854710|65594573|FG001|Overall Study|CRI procedural error|2|||
23506911|NCT01854710|65594574|FG002|Overall Study|CRI procedural error|2|||
23506912|NCT01854710|65594575|FG003|Overall Study|CRI procedural error|2|||
23506913|NCT01854710|65594576|FG004|Overall Study|CRI procedural error|2|||
23506914|NCT01854710|65594577|FG005|Overall Study|CRI procedural error|2|||
23506915|NCT01713686|65594578|FG000|Overall Study|Lost to Follow-up|9|||
23506916|NCT01713686|65594578|FG000|Overall Study|Withdrawal by Subject|6|||
23506917|NCT00840450|65594579|FG000|Overall Study|Adverse Event|1|||
23506918|NCT00840450|65594579|FG000|Overall Study|Lack of Efficacy|2|||
23506919|NCT04203238|65594580|FG000|Overall Study|Withdrawal by Subject|1|||
23506920|NCT04203238|65594581|FG001|Overall Study|Withdrawal by Subject|1|||
23506921|NCT04203238|65594580|FG000|Overall Study|Covid-19|3|||
23506922|NCT04203238|65594581|FG001|Overall Study|Covid-19|0|||
23506923|NCT03132220|65594582|FG000|Overall Study|Lost to Follow-up|17|||
23506924|NCT03132220|65594583|FG001|Overall Study|Lost to Follow-up|8|||
23506925|NCT03132220|65594582|FG000|Overall Study|Withdrawal by Subject|1|||
23506926|NCT03132220|65594583|FG001|Overall Study|Withdrawal by Subject|4|||
23506927|NCT04669600|65594584|FG000|Overall Study|Withdrawal by Subject|1|||
23506928|NCT04669600|65594584|FG000|Overall Study|Other|6|||
23506929|NCT02732119|65594585|FG000|Phase I|Adverse Event|1|||
23506930|NCT02732119|65594586|FG001|Phase I|Adverse Event|3|||
23506931|NCT02732119|65594587|FG002|Phase I|Adverse Event|1|||
23506932|NCT02732119|65594588|FG003|Phase I|Adverse Event|0|||
23506933|NCT02732119|65594589|FG004|Phase I|Adverse Event|0|||
23506934|NCT02732119|65594585|FG000|Phase I|Progressive disease|7|||
23506935|NCT02732119|65594586|FG001|Phase I|Progressive disease|3|||
23506936|NCT02732119|65594587|FG002|Phase I|Progressive disease|2|||
23506937|NCT02732119|65594588|FG003|Phase I|Progressive disease|0|||
23506938|NCT02732119|65594589|FG004|Phase I|Progressive disease|0|||
23408558|NCT03072043|65239919|FG000|Overall Study|Adverse Event|0|||
23408559|NCT03072043|65239920|FG001|Overall Study|Adverse Event|0|||
23408560|NCT03072043|65239921|FG002|Overall Study|Adverse Event|2|||
23408561|NCT03072043|65239919|FG000|Overall Study|Withdrawal by Subject|0|||
23408562|NCT03072043|65239920|FG001|Overall Study|Withdrawal by Subject|0|||
23506939|NCT02732119|65594585|FG000|Phase I|Protocol deviation|0|||
23506940|NCT02732119|65594586|FG001|Phase I|Protocol deviation|1|||
23506941|NCT02732119|65594587|FG002|Phase I|Protocol deviation|0|||
23506942|NCT02732119|65594588|FG003|Phase I|Protocol deviation|0|||
23506943|NCT02732119|65594589|FG004|Phase I|Protocol deviation|0|||
23506944|NCT02732119|65594585|FG000|Phase I|Physician Decision|0|||
23408563|NCT03072043|65239921|FG002|Overall Study|Withdrawal by Subject|4|||
23506945|NCT02732119|65594586|FG001|Phase I|Physician Decision|3|||
23506946|NCT02732119|65594587|FG002|Phase I|Physician Decision|4|||
23506947|NCT02732119|65594588|FG003|Phase I|Physician Decision|0|||
23506948|NCT02732119|65594589|FG004|Phase I|Physician Decision|0|||
23506949|NCT02732119|65594585|FG000|Phase II|Adverse Event|0|||
23506950|NCT02732119|65594586|FG001|Phase II|Adverse Event|0|||
23506951|NCT02732119|65594587|FG002|Phase II|Adverse Event|0|||
23506952|NCT02732119|65594588|FG003|Phase II|Adverse Event|3|||
23506953|NCT02732119|65594589|FG004|Phase II|Adverse Event|3|||
23506954|NCT02732119|65594585|FG000|Phase II|Death|0|||
23506955|NCT02732119|65594586|FG001|Phase II|Death|0|||
23506956|NCT02732119|65594587|FG002|Phase II|Death|0|||
23506957|NCT02732119|65594588|FG003|Phase II|Death|1|||
23506958|NCT02732119|65594589|FG004|Phase II|Death|0|||
23506959|NCT02732119|65594585|FG000|Phase II|Progressive dissease|0|||
23506960|NCT02732119|65594586|FG001|Phase II|Progressive dissease|0|||
23506961|NCT02732119|65594587|FG002|Phase II|Progressive dissease|0|||
23506962|NCT02732119|65594588|FG003|Phase II|Progressive dissease|30|||
23506963|NCT02732119|65594589|FG004|Phase II|Progressive dissease|23|||
23506964|NCT02732119|65594585|FG000|Phase II|Study terminated by sponsor|0|||
23506965|NCT02732119|65594586|FG001|Phase II|Study terminated by sponsor|0|||
23506966|NCT02732119|65594587|FG002|Phase II|Study terminated by sponsor|0|||
23506967|NCT02732119|65594588|FG003|Phase II|Study terminated by sponsor|2|||
23506968|NCT02732119|65594589|FG004|Phase II|Study terminated by sponsor|2|||
23506969|NCT02732119|65594585|FG000|Phase II|Other|0|||
23506970|NCT02732119|65594586|FG001|Phase II|Other|0|||
23506971|NCT02732119|65594587|FG002|Phase II|Other|0|||
23506972|NCT02732119|65594588|FG003|Phase II|Other|2|||
23506973|NCT02732119|65594589|FG004|Phase II|Other|0|||
23506974|NCT02732119|65594585|FG000|Phase II|Physician Decision|0|||
23506975|NCT02732119|65594586|FG001|Phase II|Physician Decision|0|||
23506976|NCT02732119|65594587|FG002|Phase II|Physician Decision|0|||
23506977|NCT02732119|65594588|FG003|Phase II|Physician Decision|8|||
23506978|NCT02732119|65594589|FG004|Phase II|Physician Decision|5|||
23506979|NCT03519932|65594590|FG000|First Intervention|Adverse Event|1|||
23506980|NCT03519932|65594591|FG001|First Intervention|Adverse Event|3|||
23506981|NCT02269241|65594593|FG000|Overall Study|Lost to Follow-up|269|||
23506982|NCT02269241|65594593|FG000|Overall Study|Withdrawal by Subject|155|||
23506983|NCT02269241|65594593|FG000|Overall Study|Protocol Violation|1|||
23506984|NCT02269241|65594593|FG000|Overall Study|Physician Decision|7|||
23506985|NCT02269241|65594593|FG000|Overall Study|Pregnancy|15|||
23506986|NCT02269241|65594593|FG000|Overall Study|Wish for pregnancy|5|||
23506987|NCT02269241|65594593|FG000|Overall Study|Development of an exclusion criteria|16|||
23506988|NCT02269241|65594593|FG000|Overall Study|Adverse Event|113|||
23506989|NCT02269241|65594593|FG000|Overall Study|At the specific request of the sponsor|20|||
23506990|NCT02269241|65594593|FG000|Overall Study|Several reasons not classified|53|||
23506991|NCT02269241|65594593|FG000|Overall Study|Screening failures|546|||
23506992|NCT01340898|65594594|FG000|Primary Phase|Serious Adverse Events|0|||
23506993|NCT01340898|65594595|FG001|Primary Phase|Serious Adverse Events|0|||
23506994|NCT01340898|65594596|FG002|Primary Phase|Serious Adverse Events|1|||
23506995|NCT01340898|65594594|FG000|Primary Phase|Withdrawal by Subject|8|||
23506996|NCT01340898|65594595|FG001|Primary Phase|Withdrawal by Subject|7|||
23506997|NCT01340898|65594596|FG002|Primary Phase|Withdrawal by Subject|5|||
23506998|NCT01340898|65594594|FG000|Primary Phase|Migrated/moved from study area|4|||
23506999|NCT01340898|65594595|FG001|Primary Phase|Migrated/moved from study area|1|||
23507000|NCT01340898|65594596|FG002|Primary Phase|Migrated/moved from study area|0|||
23507001|NCT01340898|65594594|FG000|Primary Phase|Lost to Follow-up|4|||
23507002|NCT01340898|65594595|FG001|Primary Phase|Lost to Follow-up|1|||
23507003|NCT01340898|65594596|FG002|Primary Phase|Lost to Follow-up|0|||
23507004|NCT01340898|65594594|FG000|Booster Phase|Withdrawal by Subject|3|||
23507005|NCT01340898|65594595|FG001|Booster Phase|Withdrawal by Subject|0|||
23507006|NCT01340898|65594596|FG002|Booster Phase|Withdrawal by Subject|4|||
23507007|NCT01340898|65594594|FG000|Booster Phase|Migrated/moved from study area|3|||
23507008|NCT01340898|65594595|FG001|Booster Phase|Migrated/moved from study area|0|||
23507009|NCT01340898|65594596|FG002|Booster Phase|Migrated/moved from study area|0|||
23507010|NCT01340898|65594594|FG000|Booster Phase|Lost to Follow-up|4|||
23507011|NCT01340898|65594595|FG001|Booster Phase|Lost to Follow-up|2|||
23507012|NCT01340898|65594596|FG002|Booster Phase|Lost to Follow-up|3|||
23507013|NCT01315678|65594597|FG000|Overall Study|Withdrawal by Subject|7|||
23507014|NCT01315678|65594598|FG001|Overall Study|Withdrawal by Subject|3|||
23507015|NCT01315678|65594597|FG000|Overall Study|Adverse Event|3|||
23507016|NCT01315678|65594598|FG001|Overall Study|Adverse Event|1|||
23507017|NCT01315678|65594597|FG000|Overall Study|Lost to Follow-up|1|||
23507018|NCT01315678|65594598|FG001|Overall Study|Lost to Follow-up|0|||
23507019|NCT01315678|65594597|FG000|Overall Study|similar reason to those listed above|3|||
23507020|NCT01315678|65594598|FG001|Overall Study|similar reason to those listed above|2|||
23507021|NCT01846416|65594603|FG000|Treatment Phase|Death|2|||
23507022|NCT01846416|65594604|FG001|Treatment Phase|Death|9|||
23507023|NCT01846416|65594605|FG002|Treatment Phase|Death|1|||
23507024|NCT01846416|65594603|FG000|Treatment Phase|Withdrawal by Subject|2|||
23507025|NCT01846416|65594604|FG001|Treatment Phase|Withdrawal by Subject|4|||
23507026|NCT01846416|65594605|FG002|Treatment Phase|Withdrawal by Subject|2|||
23507027|NCT01846416|65594603|FG000|Treatment Phase|Other|1|||
23607376|NCT00195819|65950686|FG000|Double-Blind|Moved|1|||
23507028|NCT01846416|65594604|FG001|Treatment Phase|Other|5|||
23507029|NCT01846416|65594605|FG002|Treatment Phase|Other|1|||
23507030|NCT01846416|65594603|FG000|Treatment Phase|Physician Decision|1|||
23507031|NCT01846416|65594604|FG001|Treatment Phase|Physician Decision|2|||
23507032|NCT01846416|65594605|FG002|Treatment Phase|Physician Decision|0|||
23507033|NCT01846416|65594603|FG000|Treatment Phase|Adverse Event|3|||
23507034|NCT01846416|65594604|FG001|Treatment Phase|Adverse Event|4|||
23507035|NCT01846416|65594605|FG002|Treatment Phase|Adverse Event|0|||
23507036|NCT01846416|65594603|FG000|Treatment Phase|Non-compliance|0|||
23507037|NCT01846416|65594604|FG001|Treatment Phase|Non-compliance|2|||
23507038|NCT01846416|65594605|FG002|Treatment Phase|Non-compliance|0|||
23507039|NCT01846416|65594603|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
23507040|NCT01846416|65594604|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
23507041|NCT01846416|65594605|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
23507042|NCT01846416|65594603|FG000|Treatment Phase|Progressive Disease|21|||
23507043|NCT01846416|65594604|FG001|Treatment Phase|Progressive Disease|63|||
23507044|NCT01846416|65594605|FG002|Treatment Phase|Progressive Disease|9|||
23507045|NCT01846416|65594603|FG000|Survival Follow-up|Death|21|||
23507046|NCT01846416|65594604|FG001|Survival Follow-up|Death|62|||
23507047|NCT01846416|65594605|FG002|Survival Follow-up|Death|9|||
23507048|NCT01846416|65594603|FG000|Survival Follow-up|Lost to Follow-up|0|||
23507049|NCT01846416|65594604|FG001|Survival Follow-up|Lost to Follow-up|2|||
23507050|NCT01846416|65594605|FG002|Survival Follow-up|Lost to Follow-up|2|||
23507051|NCT01846416|65594603|FG000|Survival Follow-up|Withdrawal by Subject|2|||
23507052|NCT01846416|65594604|FG001|Survival Follow-up|Withdrawal by Subject|7|||
23507053|NCT01846416|65594605|FG002|Survival Follow-up|Withdrawal by Subject|0|||
23507054|NCT01846416|65594603|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
23507055|NCT01846416|65594604|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
23507056|NCT01846416|65594605|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
23507057|NCT01846416|65594603|FG000|Survival Follow-up|Other|3|||
23507058|NCT01846416|65594604|FG001|Survival Follow-up|Other|1|||
23507059|NCT01846416|65594605|FG002|Survival Follow-up|Other|1|||
23507060|NCT00646776|65594608|FG000|Overall Study|Adverse Event|1|||
23507061|NCT00646776|65594609|FG001|Overall Study|Adverse Event|9|||
23507062|NCT00646776|65594608|FG000|Overall Study|Investigator discretion|0|||
23507063|NCT00646776|65594609|FG001|Overall Study|Investigator discretion|4|||
23507064|NCT03470441|65594610|FG000|Overall Study|Death|0|||
23507065|NCT03470441|65594611|FG001|Overall Study|Death|1|||
23507066|NCT03470441|65594612|FG002|Overall Study|Death|1|||
23507067|NCT03470441|65594613|FG003|Overall Study|Death|0|||
23507068|NCT03470441|65594610|FG000|Overall Study|Adverse Event|0|||
23507069|NCT03470441|65594611|FG001|Overall Study|Adverse Event|0|||
23507070|NCT03470441|65594612|FG002|Overall Study|Adverse Event|0|||
23507071|NCT03470441|65594613|FG003|Overall Study|Adverse Event|1|||
23507072|NCT03470441|65594610|FG000|Overall Study|Withdrawal by Subject|1|||
23507073|NCT03470441|65594611|FG001|Overall Study|Withdrawal by Subject|4|||
23507074|NCT03470441|65594612|FG002|Overall Study|Withdrawal by Subject|1|||
23507075|NCT03470441|65594613|FG003|Overall Study|Withdrawal by Subject|3|||
23507076|NCT00371137|65594614|FG000|Overall Study|Adverse Event|20|||
23507077|NCT00371137|65594615|FG001|Overall Study|Adverse Event|35|||
23507078|NCT00371137|65594616|FG002|Overall Study|Adverse Event|42|||
23507079|NCT00371137|65594614|FG000|Overall Study|Withdrawal by Subject|11|||
23507080|NCT00371137|65594615|FG001|Overall Study|Withdrawal by Subject|10|||
23507081|NCT00371137|65594616|FG002|Overall Study|Withdrawal by Subject|15|||
23507082|NCT00371137|65594614|FG000|Overall Study|Lost to Follow-up|6|||
23507083|NCT00371137|65594615|FG001|Overall Study|Lost to Follow-up|3|||
23507084|NCT00371137|65594616|FG002|Overall Study|Lost to Follow-up|5|||
23507085|NCT00371137|65594614|FG000|Overall Study|Lack of Efficacy|30|||
23507086|NCT00371137|65594615|FG001|Overall Study|Lack of Efficacy|12|||
23507087|NCT00371137|65594616|FG002|Overall Study|Lack of Efficacy|13|||
23507088|NCT00371137|65594614|FG000|Overall Study|Sponsor Decision|2|||
23507089|NCT00371137|65594615|FG001|Overall Study|Sponsor Decision|1|||
23507090|NCT00371137|65594616|FG002|Overall Study|Sponsor Decision|2|||
23507091|NCT00371137|65594614|FG000|Overall Study|Physician Decision|1|||
23507092|NCT00371137|65594615|FG001|Overall Study|Physician Decision|1|||
23507093|NCT00371137|65594616|FG002|Overall Study|Physician Decision|1|||
23507094|NCT00371137|65594614|FG000|Overall Study|Protocol Violation|2|||
23507095|NCT00371137|65594615|FG001|Overall Study|Protocol Violation|1|||
23507096|NCT00371137|65594616|FG002|Overall Study|Protocol Violation|1|||
23507097|NCT03965962|65594617|FG000|Overall Study|Adverse Event|1|||
23507098|NCT03965962|65594618|FG001|Overall Study|Adverse Event|0|||
23507099|NCT03965962|65594619|FG002|Overall Study|Adverse Event|0|||
23507100|NCT03965962|65594620|FG003|Overall Study|Adverse Event|0|||
23507101|NCT03965962|65594617|FG000|Overall Study|Protocol Violation|21|||
23507102|NCT03965962|65594618|FG001|Overall Study|Protocol Violation|4|||
23507103|NCT03965962|65594619|FG002|Overall Study|Protocol Violation|10|||
23507104|NCT03965962|65594620|FG003|Overall Study|Protocol Violation|5|||
23507105|NCT03965962|65594617|FG000|Overall Study|Lost to Follow-up|0|||
23507106|NCT03965962|65594618|FG001|Overall Study|Lost to Follow-up|1|||
23507107|NCT03965962|65594619|FG002|Overall Study|Lost to Follow-up|0|||
23507108|NCT03965962|65594620|FG003|Overall Study|Lost to Follow-up|0|||
23507109|NCT03965962|65594617|FG000|Overall Study|Withdrawal by Subject|3|||
23507110|NCT03965962|65594618|FG001|Overall Study|Withdrawal by Subject|0|||
23507111|NCT03965962|65594619|FG002|Overall Study|Withdrawal by Subject|0|||
23507112|NCT03965962|65594620|FG003|Overall Study|Withdrawal by Subject|1|||
23507113|NCT00733408|65594621|FG000|Overall Study|Adverse Event|4|||
23507114|NCT01516437|65594622|FG000|Overall Study|Reason not specified|0|||
23507115|NCT01516437|65594623|FG001|Overall Study|Reason not specified|0|||
23507116|NCT01516437|65594624|FG002|Overall Study|Reason not specified|1|||
23507117|NCT01516437|65594625|FG003|Overall Study|Reason not specified|1|||
23507118|NCT02848651|65594626|FG000|Overall Study|Death|85|||
23507119|NCT02848651|65594626|FG000|Overall Study|Lost to Follow-up|1|||
23507120|NCT02848651|65594626|FG000|Overall Study|Non-Compliance|1|||
23507121|NCT02848651|65594626|FG000|Overall Study|Symptomatic Deterioration|1|||
23507122|NCT02848651|65594626|FG000|Overall Study|Physician Decision|4|||
23507123|NCT02848651|65594626|FG000|Overall Study|Withdrawal by Subject|14|||
23507124|NCT00793598|65594627|FG000|Overall Study|Patient Request|0|||
23507125|NCT00793598|65594628|FG001|Overall Study|Patient Request|1|||
23507126|NCT00793598|65594629|FG002|Overall Study|Patient Request|0|||
23507127|NCT00793598|65594630|FG003|Overall Study|Patient Request|0|||
23507128|NCT00793598|65594631|FG004|Overall Study|Patient Request|0|||
23507129|NCT00793598|65594632|FG005|Overall Study|Patient Request|0|||
23507130|NCT00793598|65594633|FG006|Overall Study|Patient Request|0|||
23507131|NCT00793598|65594634|FG007|Overall Study|Patient Request|0|||
23507132|NCT00793598|65594627|FG000|Overall Study|Protocol Violation|0|||
23507133|NCT00793598|65594628|FG001|Overall Study|Protocol Violation|0|||
23507134|NCT00793598|65594629|FG002|Overall Study|Protocol Violation|0|||
23507135|NCT00793598|65594630|FG003|Overall Study|Protocol Violation|0|||
23507136|NCT00793598|65594631|FG004|Overall Study|Protocol Violation|0|||
23507137|NCT00793598|65594632|FG005|Overall Study|Protocol Violation|0|||
23507138|NCT00793598|65594633|FG006|Overall Study|Protocol Violation|0|||
23507139|NCT00793598|65594634|FG007|Overall Study|Protocol Violation|1|||
23507140|NCT00793598|65594627|FG000|Overall Study|Subject not dosed|0|||
23507141|NCT00793598|65594628|FG001|Overall Study|Subject not dosed|0|||
23507142|NCT00793598|65594629|FG002|Overall Study|Subject not dosed|0|||
23507143|NCT00793598|65594630|FG003|Overall Study|Subject not dosed|0|||
23507144|NCT00793598|65594631|FG004|Overall Study|Subject not dosed|0|||
23507145|NCT00793598|65594632|FG005|Overall Study|Subject not dosed|1|||
23507146|NCT00793598|65594633|FG006|Overall Study|Subject not dosed|0|||
23507147|NCT00793598|65594634|FG007|Overall Study|Subject not dosed|0|||
23507148|NCT01652703|65594636|FG000|Overall Study|Withdrawal by Subject|0|||
23507149|NCT01652703|65594637|FG001|Overall Study|Withdrawal by Subject|1|||
23507150|NCT01652703|65594638|FG002|Overall Study|Withdrawal by Subject|3|||
23507151|NCT01652703|65594639|FG003|Overall Study|Withdrawal by Subject|1|||
23507152|NCT01652703|65594640|FG004|Overall Study|Withdrawal by Subject|0|||
23507153|NCT01652703|65594641|FG005|Overall Study|Withdrawal by Subject|1|||
23507154|NCT01652703|65594636|FG000|Overall Study|Other|0|||
23507155|NCT01652703|65594637|FG001|Overall Study|Other|0|||
23507156|NCT01652703|65594638|FG002|Overall Study|Other|0|||
23507157|NCT01652703|65594639|FG003|Overall Study|Other|1|||
23507158|NCT01652703|65594640|FG004|Overall Study|Other|1|||
23507159|NCT01652703|65594641|FG005|Overall Study|Other|1|||
23507160|NCT01438424|65594642|FG000|Overall Study|Continuing treatment|29|||
23507161|NCT01438424|65594642|FG000|Overall Study|Minimal virologic response|95|||
23507162|NCT01438424|65594642|FG000|Overall Study|Not identified|55|||
23507163|NCT01438424|65594642|FG000|Overall Study|Withdrawal by Subject|104|||
23507164|NCT01438424|65594642|FG000|Overall Study|Progression of chronic hepatitis B|22|||
23507165|NCT01438424|65594642|FG000|Overall Study|Death|22|||
23507166|NCT01438424|65594642|FG000|Overall Study|Adverse Event|17|||
23507167|NCT01438424|65594642|FG000|Overall Study|Lost to Follow-up|17|||
23507168|NCT01438424|65594642|FG000|Overall Study|Abnormal laboratory test result|14|||
23507169|NCT01438424|65594642|FG000|Overall Study|Need for drug prohibited by protocol|14|||
23507170|NCT01438424|65594642|FG000|Overall Study|Pregnancy|7|||
23507171|NCT01438424|65594642|FG000|Overall Study|No longer met inclusion criteria|1|||
23507172|NCT01438424|65594642|FG000|Overall Study|Participant noncompliance|20|||
23507173|NCT00599924|65594643|FG000|Overall Study|Lack of Efficacy|3|||
23507174|NCT00599924|65594644|FG001|Overall Study|Lack of Efficacy|5|||
23507175|NCT00599924|65594645|FG002|Overall Study|Lack of Efficacy|1|||
23507176|NCT00599924|65594646|FG003|Overall Study|Lack of Efficacy|2|||
23507177|NCT00599924|65594647|FG004|Overall Study|Lack of Efficacy|3|||
23507178|NCT00599924|65594648|FG005|Overall Study|Lack of Efficacy|2|||
23507179|NCT00599924|65594649|FG006|Overall Study|Lack of Efficacy|0|||
23507180|NCT00599924|65594643|FG000|Overall Study|Adverse Event|0|||
23507181|NCT00599924|65594644|FG001|Overall Study|Adverse Event|0|||
23507182|NCT00599924|65594645|FG002|Overall Study|Adverse Event|0|||
23507183|NCT00599924|65594646|FG003|Overall Study|Adverse Event|2|||
23507184|NCT00599924|65594647|FG004|Overall Study|Adverse Event|0|||
23507185|NCT00599924|65594648|FG005|Overall Study|Adverse Event|0|||
23507186|NCT00599924|65594649|FG006|Overall Study|Adverse Event|2|||
23507187|NCT00599924|65594643|FG000|Overall Study|Death|0|||
23507188|NCT00599924|65594644|FG001|Overall Study|Death|0|||
23507189|NCT00599924|65594645|FG002|Overall Study|Death|0|||
23507190|NCT00599924|65594646|FG003|Overall Study|Death|2|||
23507191|NCT00599924|65594647|FG004|Overall Study|Death|0|||
23507192|NCT00599924|65594648|FG005|Overall Study|Death|2|||
23507193|NCT00599924|65594649|FG006|Overall Study|Death|1|||
23507194|NCT00599924|65594643|FG000|Overall Study|Protocol Violation|0|||
23507195|NCT00599924|65594644|FG001|Overall Study|Protocol Violation|0|||
23507196|NCT00599924|65594645|FG002|Overall Study|Protocol Violation|0|||
23507197|NCT00599924|65594646|FG003|Overall Study|Protocol Violation|1|||
23507198|NCT00599924|65594647|FG004|Overall Study|Protocol Violation|0|||
23507199|NCT00599924|65594648|FG005|Overall Study|Protocol Violation|0|||
23507200|NCT00599924|65594649|FG006|Overall Study|Protocol Violation|0|||
23507201|NCT00599924|65594643|FG000|Overall Study|Withdrawal by Subject|0|||
23507202|NCT00599924|65594644|FG001|Overall Study|Withdrawal by Subject|0|||
23507203|NCT00599924|65594645|FG002|Overall Study|Withdrawal by Subject|1|||
23507204|NCT00599924|65594646|FG003|Overall Study|Withdrawal by Subject|0|||
23507205|NCT00599924|65594647|FG004|Overall Study|Withdrawal by Subject|1|||
23507206|NCT00599924|65594648|FG005|Overall Study|Withdrawal by Subject|0|||
23507207|NCT00599924|65594649|FG006|Overall Study|Withdrawal by Subject|0|||
23507208|NCT00599924|65594643|FG000|Overall Study|Other|0|||
23507209|NCT00599924|65594644|FG001|Overall Study|Other|0|||
23507210|NCT00599924|65594645|FG002|Overall Study|Other|0|||
23507211|NCT00599924|65594646|FG003|Overall Study|Other|1|||
23507212|NCT00599924|65594647|FG004|Overall Study|Other|2|||
23507213|NCT00599924|65594648|FG005|Overall Study|Other|0|||
23507214|NCT00599924|65594649|FG006|Overall Study|Other|2|||
23507215|NCT00001723|65594652|FG000|Overall Study|Lack of Efficacy|6|||
23507216|NCT00001723|65594653|FG001|Overall Study|Lack of Efficacy|7|||
23607377|NCT00195819|65950687|FG001|Double-Blind|Moved|0|||
23507217|NCT00001723|65594652|FG000|Overall Study|Lack of family interest|4|||
23507218|NCT00001723|65594653|FG001|Overall Study|Lack of family interest|5|||
23507219|NCT00001723|65594652|FG000|Overall Study|Lost to Follow-up|2|||
23507220|NCT00001723|65594653|FG001|Overall Study|Lost to Follow-up|2|||
23507221|NCT00001723|65594652|FG000|Overall Study|medication intolerance|1|||
23507222|NCT00001723|65594653|FG001|Overall Study|medication intolerance|2|||
23507223|NCT01411774|65594654|FG000|Overall Study|Withdrawal by Subject|0|||
23507224|NCT01411774|65594655|FG001|Overall Study|Withdrawal by Subject|3|||
23507225|NCT02501473|65594656|FG000|Overall Study|Study Terminated|2|||
23507226|NCT02501473|65594657|FG001|Overall Study|Study Terminated|3|||
23507227|NCT02501473|65594658|FG002|Overall Study|Study Terminated|7|||
23507228|NCT02501473|65594659|FG003|Overall Study|Study Terminated|9|||
23507229|NCT02501473|65594660|FG004|Overall Study|Study Terminated|2|||
23507230|NCT02501473|65594661|FG005|Overall Study|Study Terminated|10|||
23507231|NCT02501473|65594662|FG006|Overall Study|Study Terminated|1|||
23507232|NCT02501473|65594663|FG007|Overall Study|Study Terminated|0|||
23507233|NCT02501473|65594656|FG000|Overall Study|Withdrawal by Subject|0|||
23507234|NCT02501473|65594657|FG001|Overall Study|Withdrawal by Subject|0|||
23507235|NCT02501473|65594658|FG002|Overall Study|Withdrawal by Subject|3|||
23507236|NCT02501473|65594659|FG003|Overall Study|Withdrawal by Subject|3|||
23507237|NCT02501473|65594660|FG004|Overall Study|Withdrawal by Subject|2|||
23507238|NCT02501473|65594661|FG005|Overall Study|Withdrawal by Subject|2|||
23507239|NCT02501473|65594662|FG006|Overall Study|Withdrawal by Subject|0|||
23507240|NCT02501473|65594663|FG007|Overall Study|Withdrawal by Subject|0|||
23507241|NCT02501473|65594656|FG000|Overall Study|Death|0|||
23507242|NCT02501473|65594657|FG001|Overall Study|Death|0|||
23507243|NCT02501473|65594658|FG002|Overall Study|Death|1|||
23507244|NCT02501473|65594659|FG003|Overall Study|Death|1|||
23507245|NCT02501473|65594660|FG004|Overall Study|Death|0|||
23507246|NCT02501473|65594661|FG005|Overall Study|Death|1|||
23507247|NCT02501473|65594662|FG006|Overall Study|Death|0|||
23507248|NCT02501473|65594663|FG007|Overall Study|Death|0|||
23507249|NCT02501473|65594656|FG000|Overall Study|Lost to Follow-up|1|||
23507250|NCT02501473|65594657|FG001|Overall Study|Lost to Follow-up|0|||
23507251|NCT02501473|65594658|FG002|Overall Study|Lost to Follow-up|1|||
23507252|NCT02501473|65594659|FG003|Overall Study|Lost to Follow-up|0|||
23507253|NCT02501473|65594660|FG004|Overall Study|Lost to Follow-up|0|||
23507254|NCT02501473|65594661|FG005|Overall Study|Lost to Follow-up|1|||
23507255|NCT02501473|65594662|FG006|Overall Study|Lost to Follow-up|0|||
23507256|NCT02501473|65594663|FG007|Overall Study|Lost to Follow-up|0|||
23507257|NCT02501473|65594656|FG000|Overall Study|Reason not specified|0|||
23507258|NCT02501473|65594657|FG001|Overall Study|Reason not specified|0|||
23507259|NCT02501473|65594658|FG002|Overall Study|Reason not specified|1|||
23507260|NCT02501473|65594659|FG003|Overall Study|Reason not specified|1|||
23507261|NCT02501473|65594660|FG004|Overall Study|Reason not specified|0|||
23507262|NCT02501473|65594661|FG005|Overall Study|Reason not specified|0|||
23507263|NCT02501473|65594662|FG006|Overall Study|Reason not specified|0|||
23507264|NCT02501473|65594663|FG007|Overall Study|Reason not specified|0|||
23507265|NCT00309387|65594664|FG000|Overall Study|Death|72|||
23607378|NCT00195819|65950686|FG000|Open-label|Adverse Event|0|||
23507266|NCT00309387|65594665|FG001|Overall Study|Death|73|||
23507267|NCT00309387|65594664|FG000|Overall Study|Lost to Follow-up|70|||
23507268|NCT00309387|65594665|FG001|Overall Study|Lost to Follow-up|86|||
23507269|NCT04016285|65594666|FG000|Overall Study|Did not progress to surgery|2|||
23607379|NCT00195819|65950687|FG001|Open-label|Adverse Event|9|||
23507270|NCT04016285|65594667|FG001|Overall Study|Did not progress to surgery|5|||
23507271|NCT04016285|65594666|FG000|Overall Study|Failed to collect outcome data|5|||
23507272|NCT04016285|65594667|FG001|Overall Study|Failed to collect outcome data|3|||
23507273|NCT00844831|65594668|FG000|Overall Study|Withdrawal by Subject|4|||
23507274|NCT00844831|65594668|FG000|Overall Study|Adverse Event|1|||
23507275|NCT00844831|65594668|FG000|Overall Study|Physician Decision|1|||
23507276|NCT02820753|65594669|FG000|2 Month|Withdrawal by Subject|3|||
23507277|NCT02820753|65594670|FG001|2 Month|Withdrawal by Subject|3|||
23507278|NCT02820753|65594669|FG000|2 Month|Lost to Follow-up|24|||
23507279|NCT02820753|65594670|FG001|2 Month|Lost to Follow-up|26|||
23507280|NCT02820753|65594669|FG000|2 Month|Stopped per NIH Hold|51|||
23507281|NCT02820753|65594670|FG001|2 Month|Stopped per NIH Hold|13|||
23507282|NCT02820753|65594669|FG000|6 Month|Withdrawal by Subject|2|||
23507283|NCT02820753|65594670|FG001|6 Month|Withdrawal by Subject|2|||
23507284|NCT02820753|65594669|FG000|6 Month|Lost to Follow-up|20|||
23507285|NCT02820753|65594670|FG001|6 Month|Lost to Follow-up|27|||
23507286|NCT02820753|65594669|FG000|6 Month|Stopped per NIH Hold|81|||
23507287|NCT02820753|65594670|FG001|6 Month|Stopped per NIH Hold|81|||
23507288|NCT02820753|65594669|FG000|6 Month|Death|0|||
23507289|NCT02820753|65594670|FG001|6 Month|Death|1|||
23507290|NCT01524692|65594671|FG000|Overall Study|Withdrawal by Subject|3|||
23507291|NCT02028065|65594672|FG000|Randomization Through Start Treatment|Not treated|1|||
23507292|NCT02028065|65594673|FG001|Randomization Through Start Treatment|Not treated|3|||
23507293|NCT02028065|65594674|FG002|Randomization Through Start Treatment|Not treated|3|||
23507294|NCT02028065|65594672|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
23507295|NCT02028065|65594673|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
23507296|NCT02028065|65594674|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
23507297|NCT02028065|65594672|FG000|Treatment Through Study Completion|Physician Decision|1|||
23507298|NCT02028065|65594673|FG001|Treatment Through Study Completion|Physician Decision|0|||
23507299|NCT02028065|65594674|FG002|Treatment Through Study Completion|Physician Decision|0|||
23507300|NCT02028065|65594672|FG000|Treatment Through Study Completion|Protocol Violation|1|||
23507301|NCT02028065|65594673|FG001|Treatment Through Study Completion|Protocol Violation|4|||
23507302|NCT02028065|65594674|FG002|Treatment Through Study Completion|Protocol Violation|0|||
23507303|NCT02028065|65594672|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
23507304|NCT02028065|65594673|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
23507305|NCT02028065|65594674|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
23507306|NCT02028065|65594672|FG000|Treatment Through Study Completion|Adverse Event|3|||
23507307|NCT02028065|65594673|FG001|Treatment Through Study Completion|Adverse Event|3|||
23507308|NCT02028065|65594674|FG002|Treatment Through Study Completion|Adverse Event|5|||
23507309|NCT00801632|65594676|FG000|Overall Study|Re-transplant|1|||
23507310|NCT04983264|65594677|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
23507311|NCT04983264|65594678|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
23507312|NCT04983264|65594679|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
23507313|NCT04983264|65594677|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
23507314|NCT04983264|65594678|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
23507315|NCT04983264|65594679|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
23507316|NCT02532972|65594680|FG000|Overall Study|Withdrawal by Subject|1|||
23507317|NCT00230607|65594681|FG000|Overall Study|Other|3|||
23507318|NCT04980040|65594682|FG000|Overall Study|Violated the Inclusion Criteria|260|||
23507319|NCT04980040|65594682|FG000|Overall Study|Violated the Administration & Dosage|225|||
23507320|NCT04980040|65594682|FG000|Overall Study|Lost to Safety-Follow-up|4|||
23507321|NCT04980040|65594682|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
23507322|NCT01918085|65594683|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
23507323|NCT01918085|65594684|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
23507324|NCT01828281|65594691|FG000|Overall Study|Withdrawal by Subject|1|||
23507325|NCT01828281|65594692|FG001|Overall Study|Withdrawal by Subject|0|||
23507326|NCT00127660|65594693|FG000|Overall Study|Protocol Violation|3|||
23507327|NCT00127660|65594694|FG001|Overall Study|Protocol Violation|3|||
23507328|NCT00127660|65594695|FG002|Overall Study|Protocol Violation|5|||
23507329|NCT00127660|65594696|FG003|Overall Study|Protocol Violation|0|||
23507330|NCT02380677|65594703|FG000|Overall Study|Adverse Event|0|||
23507331|NCT02380677|65594704|FG001|Overall Study|Adverse Event|0|||
23507332|NCT02380677|65594705|FG002|Overall Study|Adverse Event|0|||
23507333|NCT02380677|65594706|FG003|Overall Study|Adverse Event|1|||
23507334|NCT02380677|65594707|FG004|Overall Study|Adverse Event|1|||
23507335|NCT02380677|65594708|FG005|Overall Study|Adverse Event|4|||
23507336|NCT02380677|65594709|FG006|Overall Study|Adverse Event|2|||
23507337|NCT02380677|65594710|FG007|Overall Study|Adverse Event|2|||
23507338|NCT02380677|65594711|FG008|Overall Study|Adverse Event|2|||
23507339|NCT02380677|65594712|FG009|Overall Study|Adverse Event|1|||
23507340|NCT02380677|65594713|FG010|Overall Study|Adverse Event|2|||
23507341|NCT02380677|65594714|FG011|Overall Study|Adverse Event|1|||
23507342|NCT02380677|65594703|FG000|Overall Study|Physician Decision|1|||
23507343|NCT02380677|65594704|FG001|Overall Study|Physician Decision|0|||
23507344|NCT02380677|65594705|FG002|Overall Study|Physician Decision|1|||
23507345|NCT02380677|65594706|FG003|Overall Study|Physician Decision|1|||
23507346|NCT02380677|65594707|FG004|Overall Study|Physician Decision|0|||
23507347|NCT02380677|65594708|FG005|Overall Study|Physician Decision|0|||
23507348|NCT02380677|65594709|FG006|Overall Study|Physician Decision|0|||
23507349|NCT02380677|65594710|FG007|Overall Study|Physician Decision|0|||
23507350|NCT02380677|65594711|FG008|Overall Study|Physician Decision|0|||
23507351|NCT02380677|65594712|FG009|Overall Study|Physician Decision|0|||
23507352|NCT02380677|65594713|FG010|Overall Study|Physician Decision|0|||
23507353|NCT02380677|65594714|FG011|Overall Study|Physician Decision|0|||
23507354|NCT02380677|65594703|FG000|Overall Study|Lack of Efficacy|0|||
23507355|NCT02380677|65594704|FG001|Overall Study|Lack of Efficacy|1|||
23507356|NCT02380677|65594705|FG002|Overall Study|Lack of Efficacy|2|||
23507357|NCT02380677|65594706|FG003|Overall Study|Lack of Efficacy|0|||
23507358|NCT02380677|65594707|FG004|Overall Study|Lack of Efficacy|4|||
23507359|NCT02380677|65594708|FG005|Overall Study|Lack of Efficacy|1|||
23507360|NCT02380677|65594709|FG006|Overall Study|Lack of Efficacy|1|||
23507361|NCT02380677|65594710|FG007|Overall Study|Lack of Efficacy|2|||
23507362|NCT02380677|65594711|FG008|Overall Study|Lack of Efficacy|2|||
23507363|NCT02380677|65594712|FG009|Overall Study|Lack of Efficacy|0|||
23507364|NCT02380677|65594713|FG010|Overall Study|Lack of Efficacy|2|||
23507365|NCT02380677|65594714|FG011|Overall Study|Lack of Efficacy|1|||
23507366|NCT02380677|65594703|FG000|Overall Study|Withdrawal by Subject|0|||
23507367|NCT02380677|65594704|FG001|Overall Study|Withdrawal by Subject|0|||
23507368|NCT02380677|65594705|FG002|Overall Study|Withdrawal by Subject|0|||
23507369|NCT02380677|65594706|FG003|Overall Study|Withdrawal by Subject|0|||
23507370|NCT02380677|65594707|FG004|Overall Study|Withdrawal by Subject|0|||
23507371|NCT02380677|65594708|FG005|Overall Study|Withdrawal by Subject|0|||
23507372|NCT02380677|65594709|FG006|Overall Study|Withdrawal by Subject|0|||
23507373|NCT02380677|65594710|FG007|Overall Study|Withdrawal by Subject|0|||
23507374|NCT02380677|65594711|FG008|Overall Study|Withdrawal by Subject|0|||
23507375|NCT02380677|65594712|FG009|Overall Study|Withdrawal by Subject|1|||
23507376|NCT02380677|65594713|FG010|Overall Study|Withdrawal by Subject|0|||
23507377|NCT02380677|65594714|FG011|Overall Study|Withdrawal by Subject|3|||
23507378|NCT02380677|65594703|FG000|Overall Study|Other|0|||
23507379|NCT02380677|65594704|FG001|Overall Study|Other|0|||
23507380|NCT02380677|65594705|FG002|Overall Study|Other|0|||
23507381|NCT02380677|65594706|FG003|Overall Study|Other|1|||
23507382|NCT02380677|65594707|FG004|Overall Study|Other|1|||
23507383|NCT02380677|65594708|FG005|Overall Study|Other|1|||
23507384|NCT02380677|65594709|FG006|Overall Study|Other|0|||
23507385|NCT02380677|65594710|FG007|Overall Study|Other|0|||
23507386|NCT02380677|65594711|FG008|Overall Study|Other|0|||
23507387|NCT02380677|65594712|FG009|Overall Study|Other|0|||
23507388|NCT02380677|65594713|FG010|Overall Study|Other|0|||
23507389|NCT02380677|65594714|FG011|Overall Study|Other|0|||
23507390|NCT01877265|65594724|FG000|Treatment Period 1|Sponsor Decision|0|||
23507391|NCT01877265|65594725|FG001|Treatment Period 1|Sponsor Decision|0|||
23507392|NCT01877265|65594726|FG002|Treatment Period 1|Sponsor Decision|1|||
23507393|NCT01877265|65594727|FG003|Treatment Period 1|Sponsor Decision|0|||
23507394|NCT01877265|65594728|FG004|Treatment Period 1|Sponsor Decision|0|||
23507395|NCT01877265|65594729|FG005|Treatment Period 1|Sponsor Decision|0|||
23507396|NCT01877265|65594724|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507397|NCT01877265|65594725|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507398|NCT01877265|65594726|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507399|NCT01877265|65594727|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507400|NCT01877265|65594728|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
23507401|NCT01877265|65594729|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
23507402|NCT01877265|65594724|FG000|Treatment Period 3|Lost to Follow-up|1|||
23507403|NCT01877265|65594725|FG001|Treatment Period 3|Lost to Follow-up|0|||
23507404|NCT01877265|65594726|FG002|Treatment Period 3|Lost to Follow-up|0|||
23507405|NCT01877265|65594727|FG003|Treatment Period 3|Lost to Follow-up|0|||
23507406|NCT01877265|65594728|FG004|Treatment Period 3|Lost to Follow-up|0|||
23507407|NCT01877265|65594729|FG005|Treatment Period 3|Lost to Follow-up|0|||
23507408|NCT05466682|65594730|FG000|Overall Study|Withdrawal by Subject|0|||
23507409|NCT05466682|65594731|FG001|Overall Study|Withdrawal by Subject|2|||
23507410|NCT05466682|65594730|FG000|Overall Study|Lost to Follow-up|2|||
23507411|NCT05466682|65594731|FG001|Overall Study|Lost to Follow-up|1|||
23507412|NCT02743871|65594734|FG000|Overall Study|Lost to Follow-up|0|||
23507413|NCT02743871|65594735|FG001|Overall Study|Lost to Follow-up|0|||
23507414|NCT02743871|65594736|FG002|Overall Study|Lost to Follow-up|0|||
23507415|NCT02743871|65594737|FG003|Overall Study|Lost to Follow-up|1|||
23507416|NCT02743871|65594738|FG004|Overall Study|Lost to Follow-up|0|||
23507417|NCT02743871|65594739|FG005|Overall Study|Lost to Follow-up|0|||
23507418|NCT02743871|65594740|FG006|Overall Study|Lost to Follow-up|1|||
23507419|NCT02743871|65594741|FG007|Overall Study|Lost to Follow-up|0|||
23507420|NCT02743871|65594742|FG008|Overall Study|Lost to Follow-up|0|||
23507421|NCT02743871|65594743|FG009|Overall Study|Lost to Follow-up|0|||
23507422|NCT02743871|65594744|FG010|Overall Study|Lost to Follow-up|0|||
23507423|NCT02743871|65594745|FG011|Overall Study|Lost to Follow-up|2|||
23507424|NCT02743871|65594746|FG012|Overall Study|Lost to Follow-up|0|||
23507425|NCT02743871|65594747|FG013|Overall Study|Lost to Follow-up|0|||
23507426|NCT02743871|65594734|FG000|Overall Study|Withdrawal by Subject|0|||
23507427|NCT02743871|65594735|FG001|Overall Study|Withdrawal by Subject|0|||
23507428|NCT02743871|65594736|FG002|Overall Study|Withdrawal by Subject|0|||
23507429|NCT02743871|65594737|FG003|Overall Study|Withdrawal by Subject|0|||
23507430|NCT02743871|65594738|FG004|Overall Study|Withdrawal by Subject|0|||
23507431|NCT02743871|65594739|FG005|Overall Study|Withdrawal by Subject|0|||
23507432|NCT02743871|65594740|FG006|Overall Study|Withdrawal by Subject|0|||
23507433|NCT02743871|65594741|FG007|Overall Study|Withdrawal by Subject|0|||
23507434|NCT02743871|65594742|FG008|Overall Study|Withdrawal by Subject|0|||
23507435|NCT02743871|65594743|FG009|Overall Study|Withdrawal by Subject|0|||
23507436|NCT02743871|65594744|FG010|Overall Study|Withdrawal by Subject|1|||
23507437|NCT02743871|65594745|FG011|Overall Study|Withdrawal by Subject|0|||
23507438|NCT02743871|65594746|FG012|Overall Study|Withdrawal by Subject|12|||
23507439|NCT02743871|65594747|FG013|Overall Study|Withdrawal by Subject|6|||
23507440|NCT02743871|65594734|FG000|Overall Study|Adverse Event|1|||
23507441|NCT02743871|65594735|FG001|Overall Study|Adverse Event|0|||
23507442|NCT02743871|65594736|FG002|Overall Study|Adverse Event|0|||
23507443|NCT02743871|65594737|FG003|Overall Study|Adverse Event|0|||
23507444|NCT02743871|65594738|FG004|Overall Study|Adverse Event|0|||
23507445|NCT02743871|65594739|FG005|Overall Study|Adverse Event|0|||
23507446|NCT02743871|65594740|FG006|Overall Study|Adverse Event|0|||
23507447|NCT02743871|65594741|FG007|Overall Study|Adverse Event|0|||
23507448|NCT02743871|65594742|FG008|Overall Study|Adverse Event|0|||
23507449|NCT02743871|65594743|FG009|Overall Study|Adverse Event|0|||
23507450|NCT02743871|65594744|FG010|Overall Study|Adverse Event|0|||
23507451|NCT02743871|65594745|FG011|Overall Study|Adverse Event|0|||
23507452|NCT02743871|65594746|FG012|Overall Study|Adverse Event|0|||
23507453|NCT02743871|65594747|FG013|Overall Study|Adverse Event|0|||
23507454|NCT02743871|65594734|FG000|Overall Study|Other|0|||
23507455|NCT02743871|65594735|FG001|Overall Study|Other|0|||
23507456|NCT02743871|65594736|FG002|Overall Study|Other|0|||
23507457|NCT02743871|65594737|FG003|Overall Study|Other|0|||
23507458|NCT02743871|65594738|FG004|Overall Study|Other|0|||
23507459|NCT02743871|65594739|FG005|Overall Study|Other|0|||
23507460|NCT02743871|65594740|FG006|Overall Study|Other|0|||
23507461|NCT02743871|65594741|FG007|Overall Study|Other|0|||
23507462|NCT02743871|65594742|FG008|Overall Study|Other|0|||
23507463|NCT02743871|65594743|FG009|Overall Study|Other|0|||
23507464|NCT02743871|65594744|FG010|Overall Study|Other|0|||
23507465|NCT02743871|65594745|FG011|Overall Study|Other|1|||
23507466|NCT02743871|65594746|FG012|Overall Study|Other|1|||
23507467|NCT02743871|65594747|FG013|Overall Study|Other|1|||
23507468|NCT02743871|65594734|FG000|Overall Study|Protocol Violation|0|||
23507469|NCT02743871|65594735|FG001|Overall Study|Protocol Violation|0|||
23507470|NCT02743871|65594736|FG002|Overall Study|Protocol Violation|0|||
23507471|NCT02743871|65594737|FG003|Overall Study|Protocol Violation|0|||
23507472|NCT02743871|65594738|FG004|Overall Study|Protocol Violation|0|||
23507473|NCT02743871|65594739|FG005|Overall Study|Protocol Violation|0|||
23507474|NCT02743871|65594740|FG006|Overall Study|Protocol Violation|0|||
23507475|NCT02743871|65594741|FG007|Overall Study|Protocol Violation|0|||
23507476|NCT02743871|65594742|FG008|Overall Study|Protocol Violation|0|||
23507477|NCT02743871|65594743|FG009|Overall Study|Protocol Violation|0|||
23507478|NCT02743871|65594744|FG010|Overall Study|Protocol Violation|0|||
23507479|NCT02743871|65594745|FG011|Overall Study|Protocol Violation|0|||
23507480|NCT02743871|65594746|FG012|Overall Study|Protocol Violation|2|||
23507481|NCT02743871|65594747|FG013|Overall Study|Protocol Violation|0|||
23507482|NCT01366209|65594750|FG000|Overall Study|Adverse Event|6|||
23507483|NCT01366209|65594751|FG001|Overall Study|Adverse Event|7|||
23507484|NCT01366209|65594750|FG000|Overall Study|Withdrawal by Subject|4|||
23507485|NCT01366209|65594751|FG001|Overall Study|Withdrawal by Subject|4|||
23507486|NCT01366209|65594750|FG000|Overall Study|Death|12|||
23507487|NCT01366209|65594751|FG001|Overall Study|Death|19|||
23507488|NCT01366209|65594750|FG000|Overall Study|Lung transplantation|6|||
23507489|NCT01366209|65594751|FG001|Overall Study|Lung transplantation|1|||
23507490|NCT01366209|65594750|FG000|Overall Study|Lost to Follow-up|2|||
23507491|NCT01366209|65594751|FG001|Overall Study|Lost to Follow-up|1|||
23507492|NCT01366209|65594750|FG000|Overall Study|Physician Decision|1|||
23507493|NCT01366209|65594751|FG001|Overall Study|Physician Decision|0|||
23507494|NCT01366209|65594750|FG000|Overall Study|Sponsors decision|0|||
23507495|NCT01366209|65594751|FG001|Overall Study|Sponsors decision|1|||
23507496|NCT01366209|65594750|FG000|Overall Study|Withdrew consent|4|||
23507497|NCT01366209|65594751|FG001|Overall Study|Withdrew consent|3|||
23507498|NCT02324569|65594752|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23607380|NCT00195819|65950686|FG000|Open-label|Lack of Efficacy|0|||
23507499|NCT02324569|65594753|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
23507500|NCT02324569|65594752|FG000|Overall Study|Voluntary Withdrawal|3|||
23507501|NCT02324569|65594753|FG001|Overall Study|Voluntary Withdrawal|6|||
23507502|NCT02324569|65594752|FG000|Overall Study|Lack of Efficacy|2|||
23507503|NCT02324569|65594753|FG001|Overall Study|Lack of Efficacy|3|||
23507504|NCT02324569|65594752|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
23507505|NCT02324569|65594753|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
23507506|NCT02324569|65594752|FG000|Overall Study|Inconvenient Schedule|2|||
23507507|NCT02324569|65594753|FG001|Overall Study|Inconvenient Schedule|0|||
23507508|NCT00576927|65594754|FG000|Clinical Assessment|Lack of Efficacy|24|||
23507509|NCT00576927|65594754|FG000|Clinical Assessment|Death|1|||
23507510|NCT00576927|65594754|FG000|Clinical Assessment|Withdrawal by Subject|10|||
23507511|NCT00576927|65594754|FG000|Clinical Assessment|Physician Decision|1|||
23507512|NCT00576927|65594754|FG000|Baseline|Physician Decision|9|||
23507513|NCT00576927|65594754|FG000|Baseline|Medication Change by PCP of subject|1|||
23507514|NCT00576927|65594754|FG000|Baseline|Withdrawal by Subject|3|||
23507515|NCT00576927|65594754|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
23507516|NCT00576927|65594754|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
23507517|NCT00576927|65594754|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
23507518|NCT00576927|65594754|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
23507519|NCT00576927|65594754|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
23507520|NCT02547649|65594755|FG000|Overall Study|Lost to Follow-up|3|||
23507521|NCT02547649|65594756|FG001|Overall Study|Lost to Follow-up|1|||
23507522|NCT02547649|65594757|FG002|Overall Study|Lost to Follow-up|1|||
23507523|NCT02547649|65594755|FG000|Overall Study|Not vaccinated|0|||
23507524|NCT02547649|65594756|FG001|Overall Study|Not vaccinated|0|||
23507525|NCT02547649|65594757|FG002|Overall Study|Not vaccinated|1|||
23507526|NCT02547649|65594755|FG000|Overall Study|Withdrawal by Subject|0|||
23507527|NCT02547649|65594756|FG001|Overall Study|Withdrawal by Subject|4|||
23507528|NCT02547649|65594757|FG002|Overall Study|Withdrawal by Subject|2|||
23507529|NCT00403234|65594758|FG000|Overall Study|Withdrawal by Subject|0|||
23507530|NCT00403234|65594759|FG001|Overall Study|Withdrawal by Subject|1|||
23507531|NCT00403234|65594760|FG002|Overall Study|Withdrawal by Subject|0|||
23507532|NCT00403234|65594761|FG003|Overall Study|Withdrawal by Subject|0|||
23507533|NCT00403234|65594758|FG000|Overall Study|Adverse Event|1|||
23507534|NCT00403234|65594759|FG001|Overall Study|Adverse Event|0|||
23507535|NCT00403234|65594760|FG002|Overall Study|Adverse Event|1|||
23507536|NCT00403234|65594761|FG003|Overall Study|Adverse Event|0|||
23507537|NCT01658072|65594762|FG000|Overall Study|Protocol Violation|4|||
23507538|NCT01658072|65594763|FG001|Overall Study|Protocol Violation|2|||
23507539|NCT00612690|65594766|FG000|Overall Study|Lost to Follow-up|72|||
23507540|NCT00612690|65594767|FG001|Overall Study|Lost to Follow-up|98|||
23507541|NCT00612690|65594766|FG000|Overall Study|Withdrawal by Subject|32|||
23507542|NCT00612690|65594767|FG001|Overall Study|Withdrawal by Subject|20|||
23507543|NCT00612690|65594766|FG000|Overall Study|Withdrawal by Site|11|||
23507544|NCT00612690|65594767|FG001|Overall Study|Withdrawal by Site|0|||
23507545|NCT02622321|65594768|FG000|Overall Study|Withdrawal by Subject|2|||
23507546|NCT02622321|65594769|FG001|Overall Study|Withdrawal by Subject|0|||
23507547|NCT02622321|65594770|FG002|Overall Study|Withdrawal by Subject|0|||
23507548|NCT02622321|65594771|FG003|Overall Study|Withdrawal by Subject|0|||
23507549|NCT02622321|65594768|FG000|Overall Study|Death|0|||
23507550|NCT02622321|65594769|FG001|Overall Study|Death|0|||
23507551|NCT02622321|65594770|FG002|Overall Study|Death|1|||
23507552|NCT02622321|65594771|FG003|Overall Study|Death|0|||
23507553|NCT02622321|65594768|FG000|Overall Study|Physician Decision|1|||
23507554|NCT02622321|65594769|FG001|Overall Study|Physician Decision|0|||
23507555|NCT02622321|65594770|FG002|Overall Study|Physician Decision|0|||
23507556|NCT02622321|65594771|FG003|Overall Study|Physician Decision|0|||
23507557|NCT03198234|65594772|FG000|Overall Study|Relapse of primary disease|0|||
23507558|NCT03198234|65594773|FG001|Overall Study|Relapse of primary disease|1|||
23507559|NCT03198234|65594774|FG002|Overall Study|Relapse of primary disease|0|||
23507560|NCT01648101|65594777|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
23507561|NCT01648101|65594778|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
23507562|NCT01648101|65594779|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
23507563|NCT01648101|65594777|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
23507564|NCT01648101|65594778|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
23507565|NCT01648101|65594779|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
23507566|NCT01648101|65594777|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
23507567|NCT01648101|65594778|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
23507568|NCT01648101|65594779|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
23507569|NCT01648101|65594777|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
23507570|NCT01648101|65594778|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
23507571|NCT01648101|65594779|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
23507572|NCT01648101|65594777|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
23507573|NCT01648101|65594778|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
23507574|NCT01648101|65594779|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
23507575|NCT01648101|65594777|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
23507576|NCT01648101|65594778|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
23507577|NCT01648101|65594779|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
23507578|NCT01648101|65594777|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
23507579|NCT01648101|65594778|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
23507580|NCT01648101|65594779|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
23507581|NCT01648101|65594777|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
23507582|NCT01648101|65594778|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
23507583|NCT01648101|65594779|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
23507584|NCT01648101|65594777|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
23507585|NCT01648101|65594778|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
23507586|NCT01648101|65594779|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
23507587|NCT01648101|65594777|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
23507588|NCT01648101|65594778|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
23507589|NCT01648101|65594779|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
23507590|NCT01648101|65594777|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
23507591|NCT01648101|65594778|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
23507592|NCT01648101|65594779|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
23507593|NCT01749514|65594780|FG000|Overall Study|Lost to Follow-up|0|||
23507594|NCT01749514|65594781|FG001|Overall Study|Lost to Follow-up|0|||
23507595|NCT01749514|65594782|FG002|Overall Study|Lost to Follow-up|0|||
23507596|NCT01749514|65594783|FG003|Overall Study|Lost to Follow-up|0|||
23507597|NCT01749514|65594784|FG004|Overall Study|Lost to Follow-up|0|||
23507598|NCT01749514|65594785|FG005|Overall Study|Lost to Follow-up|0|||
23507599|NCT01749514|65594786|FG006|Overall Study|Lost to Follow-up|0|||
23507600|NCT01749514|65594787|FG007|Overall Study|Lost to Follow-up|1|||
23507601|NCT01749514|65594780|FG000|Overall Study|Withdrawal by Subject|0|||
23507602|NCT01749514|65594781|FG001|Overall Study|Withdrawal by Subject|0|||
23507603|NCT01749514|65594782|FG002|Overall Study|Withdrawal by Subject|0|||
23507604|NCT01749514|65594783|FG003|Overall Study|Withdrawal by Subject|0|||
23507605|NCT01749514|65594784|FG004|Overall Study|Withdrawal by Subject|0|||
23507606|NCT01749514|65594785|FG005|Overall Study|Withdrawal by Subject|1|||
23507607|NCT01749514|65594786|FG006|Overall Study|Withdrawal by Subject|0|||
23507608|NCT01749514|65594787|FG007|Overall Study|Withdrawal by Subject|1|||
23507609|NCT01749514|65594780|FG000|Overall Study|Not Reported|0|||
23507610|NCT01749514|65594781|FG001|Overall Study|Not Reported|0|||
23507611|NCT01749514|65594782|FG002|Overall Study|Not Reported|0|||
23507612|NCT01749514|65594783|FG003|Overall Study|Not Reported|0|||
23507613|NCT01749514|65594784|FG004|Overall Study|Not Reported|0|||
23507614|NCT01749514|65594785|FG005|Overall Study|Not Reported|0|||
23507615|NCT01749514|65594786|FG006|Overall Study|Not Reported|0|||
23507616|NCT01749514|65594787|FG007|Overall Study|Not Reported|5|||
23507617|NCT03978520|65594789|FG000|Overall Study|Adverse Event|2|||
23507618|NCT03978520|65594790|FG001|Overall Study|Adverse Event|5|||
23507619|NCT03978520|65594791|FG002|Overall Study|Adverse Event|3|||
23507620|NCT03978520|65594792|FG003|Overall Study|Adverse Event|5|||
23507621|NCT03978520|65594793|FG004|Overall Study|Adverse Event|6|||
23507622|NCT03978520|65594789|FG000|Overall Study|Withdrawal by Subject|10|||
23507623|NCT03978520|65594790|FG001|Overall Study|Withdrawal by Subject|4|||
23507624|NCT03978520|65594791|FG002|Overall Study|Withdrawal by Subject|5|||
23507625|NCT03978520|65594792|FG003|Overall Study|Withdrawal by Subject|6|||
23507626|NCT03978520|65594793|FG004|Overall Study|Withdrawal by Subject|5|||
23507627|NCT03978520|65594789|FG000|Overall Study|Lost to Follow-up|2|||
23507628|NCT03978520|65594790|FG001|Overall Study|Lost to Follow-up|2|||
23507629|NCT03978520|65594791|FG002|Overall Study|Lost to Follow-up|2|||
23507630|NCT03978520|65594792|FG003|Overall Study|Lost to Follow-up|0|||
23507631|NCT03978520|65594793|FG004|Overall Study|Lost to Follow-up|1|||
23507632|NCT03978520|65594789|FG000|Overall Study|COVID-19 infection|0|||
23507633|NCT03978520|65594790|FG001|Overall Study|COVID-19 infection|1|||
23507634|NCT03978520|65594791|FG002|Overall Study|COVID-19 infection|0|||
23507635|NCT03978520|65594792|FG003|Overall Study|COVID-19 infection|0|||
23507636|NCT03978520|65594793|FG004|Overall Study|COVID-19 infection|0|||
23507637|NCT03978520|65594789|FG000|Overall Study|Other, not specified|9|||
23507638|NCT03978520|65594790|FG001|Overall Study|Other, not specified|4|||
23507639|NCT03978520|65594791|FG002|Overall Study|Other, not specified|1|||
23507640|NCT03978520|65594792|FG003|Overall Study|Other, not specified|1|||
23507641|NCT03978520|65594793|FG004|Overall Study|Other, not specified|2|||
23507642|NCT03978520|65594789|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
23507643|NCT03978520|65594790|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
23507644|NCT03978520|65594791|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
23507645|NCT03978520|65594792|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
23507646|NCT03978520|65594793|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
23507647|NCT01987505|65594795|FG000|Overall Study|Other|9|||
23507648|NCT01987505|65594795|FG000|Overall Study|Withdrawal by Subject|2|||
23507649|NCT01987505|65594795|FG000|Overall Study|Other Reason|2|||
23507650|NCT01987505|65594795|FG000|Overall Study|Lost to Follow-up|15|||
23507651|NCT01987505|65594795|FG000|Overall Study|Investigator Decision|2|||
23507652|NCT01987505|65594795|FG000|Overall Study|Death|4|||
23507653|NCT02101060|65594799|FG000|Overall Study|Adverse Event|1|||
23507654|NCT02101060|65594800|FG001|Overall Study|Adverse Event|0|||
23507655|NCT02101060|65594799|FG000|Overall Study|Withdrawal by Subject|1|||
23507656|NCT02101060|65594800|FG001|Overall Study|Withdrawal by Subject|1|||
23507657|NCT02101060|65594799|FG000|Overall Study|Lost to Follow-up|3|||
23507658|NCT02101060|65594800|FG001|Overall Study|Lost to Follow-up|3|||
23507659|NCT00171730|65594801|FG000|Overall Study|Adverse Event|3|||
23507660|NCT00171730|65594801|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
23507661|NCT00171730|65594801|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
23507662|NCT00171730|65594801|FG000|Overall Study|Withdrawal by Subject|3|||
23507663|NCT00727025|65594802|FG000|Overall Study|Physician Decision|23|||
23507664|NCT02181413|65594805|FG000|Overall Study|Adverse Event|7|||
23507665|NCT02181413|65594806|FG001|Overall Study|Adverse Event|24|||
23507666|NCT02181413|65594805|FG000|Overall Study|Progressive Disease|121|||
23507667|NCT02181413|65594806|FG001|Overall Study|Progressive Disease|143|||
23507668|NCT02181413|65594805|FG000|Overall Study|Withdrawal by Subject|5|||
23507669|NCT02181413|65594806|FG001|Overall Study|Withdrawal by Subject|8|||
23507670|NCT02181413|65594805|FG000|Overall Study|Reason Not Specified|19|||
23507671|NCT02181413|65594806|FG001|Overall Study|Reason Not Specified|20|||
23507672|NCT02181413|65594805|FG000|Overall Study|Ongoing Study Treatment|0|||
23507673|NCT02181413|65594806|FG001|Overall Study|Ongoing Study Treatment|1|||
23507674|NCT02181413|65594805|FG000|Overall Study|Lost to Follow-up|0|||
23507675|NCT02181413|65594806|FG001|Overall Study|Lost to Follow-up|1|||
23507676|NCT03633695|65594807|FG000|Overall Study|Lost to Follow-up|4|||
23507677|NCT03633695|65594808|FG001|Overall Study|Lost to Follow-up|5|||
23507678|NCT03633695|65594807|FG000|Overall Study|Discontinued|8|||
23507679|NCT03633695|65594808|FG001|Overall Study|Discontinued|4|||
23507680|NCT00691015|65594809|FG000|Overall Study|Refused further treatment|1|||
23507681|NCT03031678|65594812|FG000|Overall Study|Study closed prior to completion|1|||
23507682|NCT03761277|65594819|FG000|Enrollment to Implant|Screen Failure|17|||
23507683|NCT03761277|65594819|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
23507684|NCT03761277|65594819|FG000|Enrollment to Implant|Physician Decision|2|||
23507685|NCT03761277|65594819|FG000|Enrollment to Implant|Site Closure|3|||
23507686|NCT03761277|65594819|FG000|Enrollment to Implant|Sponsor Request|2|||
23507687|NCT03761277|65594819|FG000|Post-Implant to 6 Months|Adverse Event|2|||
23507688|NCT03761277|65594819|FG000|Post-Implant to 6 Months|Death|1|||
23507689|NCT03761277|65594819|FG000|Post-Implant to 6 Months|Site Closure|2|||
23507690|NCT03761277|65594819|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
23507691|NCT03761277|65594819|FG000|6 Months to 12 Months|Physician Decision|2|||
23507692|NCT03761277|65594819|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
23507693|NCT00191789|65594820|FG000|Overall Study|Adverse Event|5|||
23507694|NCT00191789|65594820|FG000|Overall Study|Patient: Satisfactory Response|5|||
23507695|NCT00191789|65594820|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
23507696|NCT00191789|65594820|FG000|Overall Study|Withdrawal by Subject|4|||
23507697|NCT00191789|65594820|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
23507698|NCT00191789|65594820|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
23507699|NCT00191789|65594820|FG000|Overall Study|Death - Not Study-Drug Related|1|||
23507700|NCT00482612|65594821|FG000|In-treatment Period|No study medication administered|0|||
23507701|NCT00482612|65594822|FG001|In-treatment Period|No study medication administered|0|||
23507702|NCT00482612|65594823|FG002|In-treatment Period|No study medication administered|1|||
23507703|NCT00482612|65594824|FG003|In-treatment Period|No study medication administered|0|||
23507704|NCT00482612|65594821|FG000|Follow-up Period|Other|4|||
23507705|NCT00482612|65594822|FG001|Follow-up Period|Other|2|||
23507706|NCT00482612|65594823|FG002|Follow-up Period|Other|1|||
23507707|NCT00482612|65594824|FG003|Follow-up Period|Other|2|||
23507708|NCT00482612|65594821|FG000|Follow-up Period|Lack of compliance|0|||
23507709|NCT00482612|65594822|FG001|Follow-up Period|Lack of compliance|0|||
23507710|NCT00482612|65594823|FG002|Follow-up Period|Lack of compliance|1|||
23507711|NCT00482612|65594824|FG003|Follow-up Period|Lack of compliance|0|||
23507712|NCT00482612|65594821|FG000|Follow-up Period|Lost to Follow-up|0|||
23507713|NCT00482612|65594822|FG001|Follow-up Period|Lost to Follow-up|4|||
23507714|NCT00482612|65594823|FG002|Follow-up Period|Lost to Follow-up|2|||
23507715|NCT00482612|65594824|FG003|Follow-up Period|Lost to Follow-up|1|||
23507716|NCT00482612|65594821|FG000|Follow-up Period|Adverse Event|4|||
23507717|NCT00482612|65594822|FG001|Follow-up Period|Adverse Event|7|||
23507718|NCT00482612|65594823|FG002|Follow-up Period|Adverse Event|9|||
23507719|NCT00482612|65594824|FG003|Follow-up Period|Adverse Event|0|||
23507720|NCT00482612|65594821|FG000|Follow-up Period|Lack of Efficacy|2|||
23507721|NCT00482612|65594822|FG001|Follow-up Period|Lack of Efficacy|0|||
23507722|NCT00482612|65594823|FG002|Follow-up Period|Lack of Efficacy|1|||
23507723|NCT00482612|65594824|FG003|Follow-up Period|Lack of Efficacy|0|||
23507724|NCT00482612|65594821|FG000|Follow-up Period|Withdrawal by Subject|3|||
23507725|NCT00482612|65594822|FG001|Follow-up Period|Withdrawal by Subject|5|||
23507726|NCT00482612|65594823|FG002|Follow-up Period|Withdrawal by Subject|7|||
23507727|NCT00482612|65594824|FG003|Follow-up Period|Withdrawal by Subject|2|||
23507728|NCT00482612|65594821|FG000|Follow-up Period|Reasons not related to trial|1|||
23507729|NCT00482612|65594822|FG001|Follow-up Period|Reasons not related to trial|0|||
23507730|NCT00482612|65594823|FG002|Follow-up Period|Reasons not related to trial|1|||
23507731|NCT00482612|65594824|FG003|Follow-up Period|Reasons not related to trial|3|||
23507732|NCT03462082|65594825|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507733|NCT03462082|65594826|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507734|NCT03462082|65594827|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507735|NCT03462082|65594828|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507736|NCT03462082|65594829|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507737|NCT03462082|65594830|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
23507738|NCT03462082|65594831|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
23507739|NCT03462082|65594832|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
23507740|NCT01350414|65594835|FG000|Overall Study|Lost to Follow-up|13|||
23507741|NCT01350414|65594835|FG000|Overall Study|Withdrawal by Subject|4|||
23507742|NCT01350414|65594835|FG000|Overall Study|Physician Decision|2|||
23507743|NCT01575769|65594855|FG000|Overall Study|Adverse Event|1|||
23507744|NCT01575769|65594855|FG000|Overall Study|Study terminated by sponsor|40|||
23507745|NCT00001596|65594856|FG000|Overall Study|Death|1|||
23507746|NCT00001596|65594857|FG001|Overall Study|Death|0|||
23507747|NCT00001596|65594856|FG000|Overall Study|Withdrawal by Subject|3|||
23507748|NCT00001596|65594857|FG001|Overall Study|Withdrawal by Subject|1|||
23507749|NCT00001596|65594856|FG000|Overall Study|Study Termination|12|||
23507750|NCT00001596|65594857|FG001|Overall Study|Study Termination|9|||
23507751|NCT00001596|65594856|FG000|Overall Study|Adverse Event|1|||
23507752|NCT00001596|65594857|FG001|Overall Study|Adverse Event|0|||
23507753|NCT00644995|65594858|FG000|Overall Study|Lost to Follow-up|1|||
23507754|NCT00644995|65594859|FG001|Overall Study|Lost to Follow-up|4|||
23507755|NCT00644995|65594858|FG000|Overall Study|Refused|1|||
23507756|NCT00644995|65594859|FG001|Overall Study|Refused|0|||
23507757|NCT04656691|65597878|FG000|Overall Study|Adverse Event|1|||
23507758|NCT00489541|65597879|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
23507759|NCT00489541|65597880|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
23507760|NCT00489541|65597879|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
23507761|NCT00489541|65597880|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
23507762|NCT00489541|65597879|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
23507763|NCT00489541|65597880|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
23507764|NCT00489541|65597879|FG000|12-Month Clinical Follow-up|Death|3|||
23507765|NCT00489541|65597880|FG001|12-Month Clinical Follow-up|Death|2|||
23507766|NCT00489541|65597879|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
23507767|NCT00489541|65597880|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
23507768|NCT00489541|65597879|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
23507769|NCT00489541|65597880|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
23507770|NCT01276353|65597881|FG000|Double-blind|Adverse Event|2|||
23507771|NCT01276353|65597882|FG001|Double-blind|Adverse Event|0|||
23507772|NCT01276353|65597881|FG000|Double-blind|Withdrawal by Subject|1|||
23507773|NCT01276353|65597882|FG001|Double-blind|Withdrawal by Subject|0|||
23507774|NCT01276353|65597881|FG000|Extension|Adverse Event|2|||
23507775|NCT01276353|65597882|FG001|Extension|Adverse Event|5|||
23507776|NCT01276353|65597881|FG000|Extension|Withdrawal by Subject|1|||
23507777|NCT01276353|65597882|FG001|Extension|Withdrawal by Subject|2|||
23507778|NCT01276353|65597881|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
23507779|NCT01276353|65597882|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
23507780|NCT01276353|65597881|FG000|Extension|Physician Decision|1|||
23507781|NCT01276353|65597882|FG001|Extension|Physician Decision|0|||
23507782|NCT01276353|65597881|FG000|Extension|Prohibited concomitant medications|0|||
23507783|NCT01276353|65597882|FG001|Extension|Prohibited concomitant medications|1|||
23507784|NCT00071513|65597883|FG000|Intervention Component|Withdrawal by Subject|2|||
23507785|NCT00071513|65597884|FG001|Intervention Component|Withdrawal by Subject|3|||
23507786|NCT00071513|65597883|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
23507787|NCT00071513|65597884|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
23507788|NCT00752232|65597885|FG000|Overall Study|Protocol Violation|0|||
23507789|NCT00752232|65597886|FG001|Overall Study|Protocol Violation|0|||
23507790|NCT00752232|65597887|FG002|Overall Study|Protocol Violation|0|||
23507791|NCT00752232|65597888|FG003|Overall Study|Protocol Violation|0|||
23507792|NCT00752232|65597889|FG004|Overall Study|Protocol Violation|0|||
23507793|NCT00752232|65597890|FG005|Overall Study|Protocol Violation|1|||
23507794|NCT00752232|65597891|FG006|Overall Study|Protocol Violation|0|||
23507795|NCT00752232|65597885|FG000|Overall Study|Caregiver request|2|||
23507796|NCT00752232|65597886|FG001|Overall Study|Caregiver request|0|||
23507797|NCT00752232|65597887|FG002|Overall Study|Caregiver request|0|||
23507798|NCT00752232|65597888|FG003|Overall Study|Caregiver request|0|||
23507799|NCT00752232|65597889|FG004|Overall Study|Caregiver request|1|||
23507800|NCT00752232|65597890|FG005|Overall Study|Caregiver request|0|||
23507801|NCT00752232|65597891|FG006|Overall Study|Caregiver request|0|||
23507802|NCT00752232|65597885|FG000|Overall Study|Investigator request|0|||
23507803|NCT00752232|65597886|FG001|Overall Study|Investigator request|0|||
23507804|NCT00752232|65597887|FG002|Overall Study|Investigator request|0|||
23507805|NCT00752232|65597888|FG003|Overall Study|Investigator request|0|||
23507806|NCT00752232|65597889|FG004|Overall Study|Investigator request|1|||
23507807|NCT00752232|65597890|FG005|Overall Study|Investigator request|0|||
23507808|NCT00752232|65597891|FG006|Overall Study|Investigator request|0|||
23507809|NCT00752232|65597885|FG000|Overall Study|Subject request|0|||
23507810|NCT00752232|65597886|FG001|Overall Study|Subject request|0|||
23507811|NCT00752232|65597887|FG002|Overall Study|Subject request|1|||
23507812|NCT00752232|65597888|FG003|Overall Study|Subject request|0|||
23507813|NCT00752232|65597889|FG004|Overall Study|Subject request|0|||
23507814|NCT00752232|65597890|FG005|Overall Study|Subject request|0|||
23507815|NCT00752232|65597891|FG006|Overall Study|Subject request|0|||
23507816|NCT00752232|65597885|FG000|Overall Study|Group home admission|0|||
23507817|NCT00752232|65597886|FG001|Overall Study|Group home admission|0|||
23507818|NCT00752232|65597887|FG002|Overall Study|Group home admission|0|||
23507819|NCT00752232|65597888|FG003|Overall Study|Group home admission|1|||
23507820|NCT00752232|65597889|FG004|Overall Study|Group home admission|0|||
23507821|NCT00752232|65597890|FG005|Overall Study|Group home admission|0|||
23507822|NCT00752232|65597891|FG006|Overall Study|Group home admission|0|||
23607381|NCT00195819|65950687|FG001|Open-label|Lack of Efficacy|2|||
23607382|NCT00195819|65950686|FG000|Open-label|Pregnancy|0|||
23607383|NCT00195819|65950687|FG001|Open-label|Pregnancy|1|||
23607384|NCT00195819|65950686|FG000|Open-label|Protocol Violation|0|||
23607385|NCT00195819|65950687|FG001|Open-label|Protocol Violation|2|||
23607386|NCT00195819|65950686|FG000|Open-label|Moved|0|||
23607387|NCT00195819|65950687|FG001|Open-label|Moved|1|||
23607388|NCT00195819|65950686|FG000|Open-label|Withdrawal by Subject|0|||
23607389|NCT00195819|65950687|FG001|Open-label|Withdrawal by Subject|5|||
23507823|NCT00752232|65597885|FG000|Overall Study|Caregiver could not attend the subject|0|||
23507824|NCT00752232|65597886|FG001|Overall Study|Caregiver could not attend the subject|0|||
23507825|NCT00752232|65597887|FG002|Overall Study|Caregiver could not attend the subject|0|||
23507826|NCT00752232|65597888|FG003|Overall Study|Caregiver could not attend the subject|0|||
23507827|NCT00752232|65597889|FG004|Overall Study|Caregiver could not attend the subject|1|||
23507828|NCT00752232|65597890|FG005|Overall Study|Caregiver could not attend the subject|0|||
23507829|NCT00752232|65597891|FG006|Overall Study|Caregiver could not attend the subject|0|||
23507830|NCT01928394|65597892|FG000|Treatment Period|Disease progression|17|||
23507831|NCT01928394|65597893|FG001|Treatment Period|Disease progression|2|||
23507832|NCT01928394|65597894|FG002|Treatment Period|Disease progression|12|||
23507833|NCT01928394|65597895|FG003|Treatment Period|Disease progression|48|||
23507834|NCT01928394|65597896|FG004|Treatment Period|Disease progression|3|||
23507835|NCT01928394|65597897|FG005|Treatment Period|Disease progression|25|||
23507836|NCT01928394|65597898|FG006|Treatment Period|Disease progression|38|||
23507837|NCT01928394|65597899|FG007|Treatment Period|Disease progression|16|||
23507838|NCT01928394|65597900|FG008|Treatment Period|Disease progression|3|||
23507839|NCT01928394|65597901|FG009|Treatment Period|Disease progression|11|||
23507840|NCT01928394|65597902|FG010|Treatment Period|Disease progression|22|||
23507841|NCT01928394|65597903|FG011|Treatment Period|Disease progression|73|||
23507842|NCT01928394|65597904|FG012|Treatment Period|Disease progression|38|||
23507843|NCT01928394|65597905|FG013|Treatment Period|Disease progression|118|||
23507844|NCT01928394|65597906|FG014|Treatment Period|Disease progression|59|||
23507845|NCT01928394|65597907|FG015|Treatment Period|Disease progression|1|||
23507846|NCT01928394|65597908|FG016|Treatment Period|Disease progression|43|||
23507847|NCT01928394|65597909|FG017|Treatment Period|Disease progression|56|||
23507848|NCT01928394|65597910|FG018|Treatment Period|Disease progression|50|||
23507849|NCT01928394|65597911|FG019|Treatment Period|Disease progression|71|||
23507850|NCT01928394|65597912|FG020|Treatment Period|Disease progression|30|||
23507851|NCT01928394|65597913|FG021|Treatment Period|Disease progression|31|||
23507852|NCT01928394|65597914|FG022|Treatment Period|Disease progression|31|||
23507853|NCT01928394|65597892|FG000|Treatment Period|Study drug toxicity|1|||
23507854|NCT01928394|65597893|FG001|Treatment Period|Study drug toxicity|1|||
23507855|NCT01928394|65597894|FG002|Treatment Period|Study drug toxicity|3|||
23507856|NCT01928394|65597895|FG003|Treatment Period|Study drug toxicity|3|||
23507857|NCT01928394|65597896|FG004|Treatment Period|Study drug toxicity|0|||
23507858|NCT01928394|65597897|FG005|Treatment Period|Study drug toxicity|9|||
23507859|NCT01928394|65597898|FG006|Treatment Period|Study drug toxicity|7|||
23507860|NCT01928394|65597899|FG007|Treatment Period|Study drug toxicity|1|||
23507861|NCT01928394|65597900|FG008|Treatment Period|Study drug toxicity|0|||
23507862|NCT01928394|65597901|FG009|Treatment Period|Study drug toxicity|5|||
23507863|NCT01928394|65597902|FG010|Treatment Period|Study drug toxicity|2|||
23507864|NCT01928394|65597903|FG011|Treatment Period|Study drug toxicity|3|||
23507865|NCT01928394|65597904|FG012|Treatment Period|Study drug toxicity|7|||
23507866|NCT01928394|65597905|FG013|Treatment Period|Study drug toxicity|5|||
23507867|NCT01928394|65597906|FG014|Treatment Period|Study drug toxicity|12|||
23507868|NCT01928394|65597907|FG015|Treatment Period|Study drug toxicity|0|||
23507869|NCT01928394|65597908|FG016|Treatment Period|Study drug toxicity|3|||
23507870|NCT01928394|65597909|FG017|Treatment Period|Study drug toxicity|3|||
23607390|NCT00696241|65950688|FG000|Overall Study|Adverse Event|11|||
23607391|NCT00696241|65950689|FG001|Overall Study|Adverse Event|3|||
23507871|NCT01928394|65597910|FG018|Treatment Period|Study drug toxicity|12|||
23507872|NCT01928394|65597911|FG019|Treatment Period|Study drug toxicity|15|||
23507873|NCT01928394|65597912|FG020|Treatment Period|Study drug toxicity|4|||
23507874|NCT01928394|65597913|FG021|Treatment Period|Study drug toxicity|7|||
23507875|NCT01928394|65597914|FG022|Treatment Period|Study drug toxicity|4|||
23507876|NCT01928394|65597892|FG000|Treatment Period|AE unrelated to study drug|0|||
23507877|NCT01928394|65597893|FG001|Treatment Period|AE unrelated to study drug|0|||
23507878|NCT01928394|65597894|FG002|Treatment Period|AE unrelated to study drug|2|||
23507879|NCT01928394|65597895|FG003|Treatment Period|AE unrelated to study drug|3|||
23507880|NCT01928394|65597896|FG004|Treatment Period|AE unrelated to study drug|0|||
23507881|NCT01928394|65597897|FG005|Treatment Period|AE unrelated to study drug|5|||
23507882|NCT01928394|65597898|FG006|Treatment Period|AE unrelated to study drug|1|||
23507883|NCT01928394|65597899|FG007|Treatment Period|AE unrelated to study drug|0|||
23507884|NCT01928394|65597900|FG008|Treatment Period|AE unrelated to study drug|0|||
23507885|NCT01928394|65597901|FG009|Treatment Period|AE unrelated to study drug|2|||
23507886|NCT01928394|65597902|FG010|Treatment Period|AE unrelated to study drug|0|||
23507887|NCT01928394|65597903|FG011|Treatment Period|AE unrelated to study drug|12|||
23507888|NCT01928394|65597904|FG012|Treatment Period|AE unrelated to study drug|6|||
23507889|NCT01928394|65597905|FG013|Treatment Period|AE unrelated to study drug|13|||
23507890|NCT01928394|65597906|FG014|Treatment Period|AE unrelated to study drug|6|||
23507891|NCT01928394|65597907|FG015|Treatment Period|AE unrelated to study drug|1|||
23507892|NCT01928394|65597908|FG016|Treatment Period|AE unrelated to study drug|1|||
23507893|NCT01928394|65597909|FG017|Treatment Period|AE unrelated to study drug|6|||
23507894|NCT01928394|65597910|FG018|Treatment Period|AE unrelated to study drug|3|||
23507895|NCT01928394|65597911|FG019|Treatment Period|AE unrelated to study drug|5|||
23507896|NCT01928394|65597912|FG020|Treatment Period|AE unrelated to study drug|1|||
23507897|NCT01928394|65597913|FG021|Treatment Period|AE unrelated to study drug|1|||
23507898|NCT01928394|65597914|FG022|Treatment Period|AE unrelated to study drug|0|||
23507899|NCT01928394|65597892|FG000|Treatment Period|Participant request to stop therapy|0|||
23507900|NCT01928394|65597893|FG001|Treatment Period|Participant request to stop therapy|0|||
23507901|NCT01928394|65597894|FG002|Treatment Period|Participant request to stop therapy|0|||
23507902|NCT01928394|65597895|FG003|Treatment Period|Participant request to stop therapy|0|||
23507903|NCT01928394|65597896|FG004|Treatment Period|Participant request to stop therapy|0|||
23507904|NCT01928394|65597897|FG005|Treatment Period|Participant request to stop therapy|3|||
23507905|NCT01928394|65597898|FG006|Treatment Period|Participant request to stop therapy|3|||
23507906|NCT01928394|65597899|FG007|Treatment Period|Participant request to stop therapy|0|||
23507907|NCT01928394|65597900|FG008|Treatment Period|Participant request to stop therapy|0|||
23507908|NCT01928394|65597901|FG009|Treatment Period|Participant request to stop therapy|0|||
23507909|NCT01928394|65597902|FG010|Treatment Period|Participant request to stop therapy|3|||
23507910|NCT01928394|65597903|FG011|Treatment Period|Participant request to stop therapy|2|||
23507911|NCT01928394|65597904|FG012|Treatment Period|Participant request to stop therapy|1|||
23507912|NCT01928394|65597905|FG013|Treatment Period|Participant request to stop therapy|2|||
23507913|NCT01928394|65597906|FG014|Treatment Period|Participant request to stop therapy|4|||
23507914|NCT01928394|65597907|FG015|Treatment Period|Participant request to stop therapy|0|||
23507915|NCT01928394|65597908|FG016|Treatment Period|Participant request to stop therapy|1|||
23507916|NCT01928394|65597909|FG017|Treatment Period|Participant request to stop therapy|3|||
23507917|NCT01928394|65597910|FG018|Treatment Period|Participant request to stop therapy|1|||
23507918|NCT01928394|65597911|FG019|Treatment Period|Participant request to stop therapy|1|||
23507919|NCT01928394|65597912|FG020|Treatment Period|Participant request to stop therapy|3|||
23507920|NCT01928394|65597913|FG021|Treatment Period|Participant request to stop therapy|1|||
23507921|NCT01928394|65597914|FG022|Treatment Period|Participant request to stop therapy|3|||
23507922|NCT01928394|65597892|FG000|Treatment Period|Participant withdrew consent|0|||
23507923|NCT01928394|65597893|FG001|Treatment Period|Participant withdrew consent|0|||
23507924|NCT01928394|65597894|FG002|Treatment Period|Participant withdrew consent|1|||
23507925|NCT01928394|65597895|FG003|Treatment Period|Participant withdrew consent|1|||
23507926|NCT01928394|65597896|FG004|Treatment Period|Participant withdrew consent|0|||
23507927|NCT01928394|65597897|FG005|Treatment Period|Participant withdrew consent|1|||
23507928|NCT01928394|65597898|FG006|Treatment Period|Participant withdrew consent|0|||
23507929|NCT01928394|65597899|FG007|Treatment Period|Participant withdrew consent|1|||
23507930|NCT01928394|65597900|FG008|Treatment Period|Participant withdrew consent|0|||
23507931|NCT01928394|65597901|FG009|Treatment Period|Participant withdrew consent|0|||
23507932|NCT01928394|65597902|FG010|Treatment Period|Participant withdrew consent|1|||
23507933|NCT01928394|65597903|FG011|Treatment Period|Participant withdrew consent|1|||
23507934|NCT01928394|65597904|FG012|Treatment Period|Participant withdrew consent|1|||
23507935|NCT01928394|65597905|FG013|Treatment Period|Participant withdrew consent|0|||
23507936|NCT01928394|65597906|FG014|Treatment Period|Participant withdrew consent|2|||
23507937|NCT01928394|65597907|FG015|Treatment Period|Participant withdrew consent|0|||
23507938|NCT01928394|65597908|FG016|Treatment Period|Participant withdrew consent|2|||
23507939|NCT01928394|65597909|FG017|Treatment Period|Participant withdrew consent|1|||
23507940|NCT01928394|65597910|FG018|Treatment Period|Participant withdrew consent|1|||
23507941|NCT01928394|65597911|FG019|Treatment Period|Participant withdrew consent|1|||
23507942|NCT01928394|65597912|FG020|Treatment Period|Participant withdrew consent|0|||
23507943|NCT01928394|65597913|FG021|Treatment Period|Participant withdrew consent|2|||
23507944|NCT01928394|65597914|FG022|Treatment Period|Participant withdrew consent|0|||
23507945|NCT01928394|65597892|FG000|Treatment Period|Poor/non-compliance|0|||
23507946|NCT01928394|65597893|FG001|Treatment Period|Poor/non-compliance|0|||
23507947|NCT01928394|65597894|FG002|Treatment Period|Poor/non-compliance|0|||
23507948|NCT01928394|65597895|FG003|Treatment Period|Poor/non-compliance|1|||
23507949|NCT01928394|65597896|FG004|Treatment Period|Poor/non-compliance|0|||
23507950|NCT01928394|65597897|FG005|Treatment Period|Poor/non-compliance|0|||
23507951|NCT01928394|65597898|FG006|Treatment Period|Poor/non-compliance|0|||
23507952|NCT01928394|65597899|FG007|Treatment Period|Poor/non-compliance|0|||
23507953|NCT01928394|65597900|FG008|Treatment Period|Poor/non-compliance|0|||
23507954|NCT01928394|65597901|FG009|Treatment Period|Poor/non-compliance|0|||
23507955|NCT01928394|65597902|FG010|Treatment Period|Poor/non-compliance|0|||
23507956|NCT01928394|65597903|FG011|Treatment Period|Poor/non-compliance|0|||
23507957|NCT01928394|65597904|FG012|Treatment Period|Poor/non-compliance|1|||
23507958|NCT01928394|65597905|FG013|Treatment Period|Poor/non-compliance|0|||
23507959|NCT01928394|65597906|FG014|Treatment Period|Poor/non-compliance|1|||
23507960|NCT01928394|65597907|FG015|Treatment Period|Poor/non-compliance|0|||
23507961|NCT01928394|65597908|FG016|Treatment Period|Poor/non-compliance|0|||
23507962|NCT01928394|65597909|FG017|Treatment Period|Poor/non-compliance|1|||
23507963|NCT01928394|65597910|FG018|Treatment Period|Poor/non-compliance|0|||
23507964|NCT01928394|65597911|FG019|Treatment Period|Poor/non-compliance|1|||
23507965|NCT01928394|65597912|FG020|Treatment Period|Poor/non-compliance|0|||
23507966|NCT01928394|65597913|FG021|Treatment Period|Poor/non-compliance|0|||
23507967|NCT01928394|65597914|FG022|Treatment Period|Poor/non-compliance|0|||
23507968|NCT01928394|65597892|FG000|Treatment Period|other reason|0|||
23507969|NCT01928394|65597893|FG001|Treatment Period|other reason|0|||
23507970|NCT01928394|65597894|FG002|Treatment Period|other reason|0|||
23507971|NCT01928394|65597895|FG003|Treatment Period|other reason|0|||
23507972|NCT01928394|65597896|FG004|Treatment Period|other reason|0|||
23507973|NCT01928394|65597897|FG005|Treatment Period|other reason|0|||
23507974|NCT01928394|65597898|FG006|Treatment Period|other reason|0|||
23507975|NCT01928394|65597899|FG007|Treatment Period|other reason|0|||
23507976|NCT01928394|65597900|FG008|Treatment Period|other reason|0|||
23507977|NCT01928394|65597901|FG009|Treatment Period|other reason|0|||
23507978|NCT01928394|65597902|FG010|Treatment Period|other reason|1|||
23507979|NCT01928394|65597903|FG011|Treatment Period|other reason|1|||
23507980|NCT01928394|65597904|FG012|Treatment Period|other reason|1|||
23507981|NCT01928394|65597905|FG013|Treatment Period|other reason|0|||
23507982|NCT01928394|65597906|FG014|Treatment Period|other reason|1|||
23507983|NCT01928394|65597907|FG015|Treatment Period|other reason|0|||
23507984|NCT01928394|65597908|FG016|Treatment Period|other reason|0|||
23507985|NCT01928394|65597909|FG017|Treatment Period|other reason|0|||
23507986|NCT01928394|65597910|FG018|Treatment Period|other reason|2|||
23507987|NCT01928394|65597911|FG019|Treatment Period|other reason|2|||
23507988|NCT01928394|65597912|FG020|Treatment Period|other reason|0|||
23507989|NCT01928394|65597913|FG021|Treatment Period|other reason|0|||
23507990|NCT01928394|65597914|FG022|Treatment Period|other reason|0|||
23507991|NCT01928394|65597892|FG000|Treatment Period|Maximum clinical benefit|0|||
23507992|NCT01928394|65597893|FG001|Treatment Period|Maximum clinical benefit|0|||
23507993|NCT01928394|65597894|FG002|Treatment Period|Maximum clinical benefit|0|||
23507994|NCT01928394|65597895|FG003|Treatment Period|Maximum clinical benefit|0|||
23507995|NCT01928394|65597896|FG004|Treatment Period|Maximum clinical benefit|0|||
23507996|NCT01928394|65597897|FG005|Treatment Period|Maximum clinical benefit|0|||
23507997|NCT01928394|65597898|FG006|Treatment Period|Maximum clinical benefit|0|||
23507998|NCT01928394|65597899|FG007|Treatment Period|Maximum clinical benefit|0|||
23507999|NCT01928394|65597900|FG008|Treatment Period|Maximum clinical benefit|0|||
23508000|NCT01928394|65597901|FG009|Treatment Period|Maximum clinical benefit|0|||
23508001|NCT01928394|65597902|FG010|Treatment Period|Maximum clinical benefit|1|||
23508002|NCT01928394|65597903|FG011|Treatment Period|Maximum clinical benefit|1|||
23508003|NCT01928394|65597904|FG012|Treatment Period|Maximum clinical benefit|0|||
23508004|NCT01928394|65597905|FG013|Treatment Period|Maximum clinical benefit|0|||
23508005|NCT01928394|65597906|FG014|Treatment Period|Maximum clinical benefit|1|||
23508006|NCT01928394|65597907|FG015|Treatment Period|Maximum clinical benefit|0|||
23508007|NCT01928394|65597908|FG016|Treatment Period|Maximum clinical benefit|0|||
23508008|NCT01928394|65597909|FG017|Treatment Period|Maximum clinical benefit|1|||
23508009|NCT01928394|65597910|FG018|Treatment Period|Maximum clinical benefit|1|||
23508010|NCT01928394|65597911|FG019|Treatment Period|Maximum clinical benefit|0|||
23508011|NCT01928394|65597912|FG020|Treatment Period|Maximum clinical benefit|2|||
23508012|NCT01928394|65597913|FG021|Treatment Period|Maximum clinical benefit|0|||
23508013|NCT01928394|65597914|FG022|Treatment Period|Maximum clinical benefit|0|||
23508014|NCT01928394|65597892|FG000|Treatment Period|Lost to Follow-up|0|||
23508015|NCT01928394|65597893|FG001|Treatment Period|Lost to Follow-up|0|||
23607392|NCT00696241|65950690|FG002|Overall Study|Adverse Event|6|||
23508016|NCT01928394|65597894|FG002|Treatment Period|Lost to Follow-up|0|||
23508017|NCT01928394|65597895|FG003|Treatment Period|Lost to Follow-up|0|||
23508018|NCT01928394|65597896|FG004|Treatment Period|Lost to Follow-up|0|||
23508019|NCT01928394|65597897|FG005|Treatment Period|Lost to Follow-up|0|||
23508020|NCT01928394|65597898|FG006|Treatment Period|Lost to Follow-up|0|||
23508021|NCT01928394|65597899|FG007|Treatment Period|Lost to Follow-up|0|||
23508022|NCT01928394|65597900|FG008|Treatment Period|Lost to Follow-up|0|||
23508023|NCT01928394|65597901|FG009|Treatment Period|Lost to Follow-up|0|||
23508024|NCT01928394|65597902|FG010|Treatment Period|Lost to Follow-up|0|||
23508025|NCT01928394|65597903|FG011|Treatment Period|Lost to Follow-up|0|||
23508026|NCT01928394|65597904|FG012|Treatment Period|Lost to Follow-up|0|||
23508027|NCT01928394|65597905|FG013|Treatment Period|Lost to Follow-up|0|||
23508028|NCT01928394|65597906|FG014|Treatment Period|Lost to Follow-up|0|||
23508029|NCT01928394|65597907|FG015|Treatment Period|Lost to Follow-up|0|||
23508030|NCT01928394|65597908|FG016|Treatment Period|Lost to Follow-up|0|||
23508031|NCT01928394|65597909|FG017|Treatment Period|Lost to Follow-up|0|||
23508032|NCT01928394|65597910|FG018|Treatment Period|Lost to Follow-up|0|||
23508033|NCT01928394|65597911|FG019|Treatment Period|Lost to Follow-up|0|||
23508034|NCT01928394|65597912|FG020|Treatment Period|Lost to Follow-up|0|||
23508035|NCT01928394|65597913|FG021|Treatment Period|Lost to Follow-up|0|||
23508036|NCT01928394|65597914|FG022|Treatment Period|Lost to Follow-up|1|||
23508037|NCT01928394|65597892|FG000|Treatment Period|Death|0|||
23508038|NCT01928394|65597893|FG001|Treatment Period|Death|0|||
23508039|NCT01928394|65597894|FG002|Treatment Period|Death|0|||
23508040|NCT01928394|65597895|FG003|Treatment Period|Death|0|||
23508041|NCT01928394|65597896|FG004|Treatment Period|Death|0|||
23508042|NCT01928394|65597897|FG005|Treatment Period|Death|0|||
23508043|NCT01928394|65597898|FG006|Treatment Period|Death|0|||
23508044|NCT01928394|65597899|FG007|Treatment Period|Death|0|||
23508045|NCT01928394|65597900|FG008|Treatment Period|Death|0|||
23508046|NCT01928394|65597901|FG009|Treatment Period|Death|0|||
23508047|NCT01928394|65597902|FG010|Treatment Period|Death|0|||
23508048|NCT01928394|65597903|FG011|Treatment Period|Death|0|||
23508049|NCT01928394|65597904|FG012|Treatment Period|Death|0|||
23508050|NCT01928394|65597905|FG013|Treatment Period|Death|1|||
23508051|NCT01928394|65597906|FG014|Treatment Period|Death|2|||
23508052|NCT01928394|65597907|FG015|Treatment Period|Death|0|||
23508053|NCT01928394|65597908|FG016|Treatment Period|Death|0|||
23508054|NCT01928394|65597909|FG017|Treatment Period|Death|0|||
23508055|NCT01928394|65597910|FG018|Treatment Period|Death|0|||
23508056|NCT01928394|65597911|FG019|Treatment Period|Death|0|||
23508057|NCT01928394|65597912|FG020|Treatment Period|Death|0|||
23508058|NCT01928394|65597913|FG021|Treatment Period|Death|0|||
23508059|NCT01928394|65597914|FG022|Treatment Period|Death|0|||
23508060|NCT01928394|65597892|FG000|Follow-up Period|Participant withdrew consent|3|||
23508061|NCT01928394|65597893|FG001|Follow-up Period|Participant withdrew consent|0|||
23508062|NCT01928394|65597894|FG002|Follow-up Period|Participant withdrew consent|1|||
23508063|NCT01928394|65597895|FG003|Follow-up Period|Participant withdrew consent|4|||
23508064|NCT01928394|65597896|FG004|Follow-up Period|Participant withdrew consent|0|||
23508065|NCT01928394|65597897|FG005|Follow-up Period|Participant withdrew consent|2|||
23508066|NCT01928394|65597898|FG006|Follow-up Period|Participant withdrew consent|5|||
23508067|NCT01928394|65597899|FG007|Follow-up Period|Participant withdrew consent|1|||
23508068|NCT01928394|65597900|FG008|Follow-up Period|Participant withdrew consent|0|||
23508069|NCT01928394|65597901|FG009|Follow-up Period|Participant withdrew consent|0|||
23508070|NCT01928394|65597902|FG010|Follow-up Period|Participant withdrew consent|5|||
23508071|NCT01928394|65597903|FG011|Follow-up Period|Participant withdrew consent|8|||
23508072|NCT01928394|65597904|FG012|Follow-up Period|Participant withdrew consent|2|||
23508073|NCT01928394|65597905|FG013|Follow-up Period|Participant withdrew consent|12|||
23508074|NCT01928394|65597906|FG014|Follow-up Period|Participant withdrew consent|7|||
23508075|NCT01928394|65597907|FG015|Follow-up Period|Participant withdrew consent|0|||
23508076|NCT01928394|65597908|FG016|Follow-up Period|Participant withdrew consent|5|||
23508077|NCT01928394|65597909|FG017|Follow-up Period|Participant withdrew consent|3|||
23508078|NCT01928394|65597910|FG018|Follow-up Period|Participant withdrew consent|2|||
23508079|NCT01928394|65597911|FG019|Follow-up Period|Participant withdrew consent|7|||
23508080|NCT01928394|65597912|FG020|Follow-up Period|Participant withdrew consent|4|||
23508081|NCT01928394|65597913|FG021|Follow-up Period|Participant withdrew consent|6|||
23508082|NCT01928394|65597914|FG022|Follow-up Period|Participant withdrew consent|2|||
23508083|NCT01928394|65597892|FG000|Follow-up Period|Death|0|||
23508084|NCT01928394|65597893|FG001|Follow-up Period|Death|0|||
23508085|NCT01928394|65597894|FG002|Follow-up Period|Death|2|||
23508086|NCT01928394|65597895|FG003|Follow-up Period|Death|6|||
23508087|NCT01928394|65597896|FG004|Follow-up Period|Death|0|||
23508088|NCT01928394|65597897|FG005|Follow-up Period|Death|6|||
23508089|NCT01928394|65597898|FG006|Follow-up Period|Death|6|||
23508090|NCT01928394|65597899|FG007|Follow-up Period|Death|2|||
23508091|NCT01928394|65597900|FG008|Follow-up Period|Death|1|||
23508092|NCT01928394|65597901|FG009|Follow-up Period|Death|2|||
23508093|NCT01928394|65597902|FG010|Follow-up Period|Death|4|||
23508094|NCT01928394|65597903|FG011|Follow-up Period|Death|12|||
23508095|NCT01928394|65597904|FG012|Follow-up Period|Death|11|||
23508096|NCT01928394|65597905|FG013|Follow-up Period|Death|25|||
23508097|NCT01928394|65597906|FG014|Follow-up Period|Death|18|||
23508098|NCT01928394|65597907|FG015|Follow-up Period|Death|0|||
23508099|NCT01928394|65597908|FG016|Follow-up Period|Death|6|||
23508100|NCT01928394|65597909|FG017|Follow-up Period|Death|5|||
23508101|NCT01928394|65597910|FG018|Follow-up Period|Death|13|||
23508102|NCT01928394|65597911|FG019|Follow-up Period|Death|13|||
23508103|NCT01928394|65597912|FG020|Follow-up Period|Death|5|||
23508104|NCT01928394|65597913|FG021|Follow-up Period|Death|3|||
23508105|NCT01928394|65597914|FG022|Follow-up Period|Death|2|||
23508106|NCT01928394|65597892|FG000|Follow-up Period|other reason|0|||
23508107|NCT01928394|65597893|FG001|Follow-up Period|other reason|0|||
23508108|NCT01928394|65597894|FG002|Follow-up Period|other reason|0|||
23508109|NCT01928394|65597895|FG003|Follow-up Period|other reason|0|||
23508110|NCT01928394|65597896|FG004|Follow-up Period|other reason|0|||
23508111|NCT01928394|65597897|FG005|Follow-up Period|other reason|0|||
23508112|NCT01928394|65597898|FG006|Follow-up Period|other reason|1|||
23508113|NCT01928394|65597899|FG007|Follow-up Period|other reason|3|||
23508114|NCT01928394|65597900|FG008|Follow-up Period|other reason|0|||
23508115|NCT01928394|65597901|FG009|Follow-up Period|other reason|0|||
23508116|NCT01928394|65597902|FG010|Follow-up Period|other reason|2|||
23508117|NCT01928394|65597903|FG011|Follow-up Period|other reason|1|||
23508118|NCT01928394|65597904|FG012|Follow-up Period|other reason|0|||
23508119|NCT01928394|65597905|FG013|Follow-up Period|other reason|1|||
23508120|NCT01928394|65597906|FG014|Follow-up Period|other reason|4|||
23508121|NCT01928394|65597907|FG015|Follow-up Period|other reason|0|||
23508122|NCT01928394|65597908|FG016|Follow-up Period|other reason|2|||
23508123|NCT01928394|65597909|FG017|Follow-up Period|other reason|0|||
23508124|NCT01928394|65597910|FG018|Follow-up Period|other reason|1|||
23508125|NCT01928394|65597911|FG019|Follow-up Period|other reason|1|||
23508126|NCT01928394|65597912|FG020|Follow-up Period|other reason|0|||
23508127|NCT01928394|65597913|FG021|Follow-up Period|other reason|0|||
23508128|NCT01928394|65597914|FG022|Follow-up Period|other reason|1|||
23508129|NCT01928394|65597892|FG000|Follow-up Period|Lost to Follow-up|0|||
23508130|NCT01928394|65597893|FG001|Follow-up Period|Lost to Follow-up|0|||
23508131|NCT01928394|65597894|FG002|Follow-up Period|Lost to Follow-up|0|||
23508132|NCT01928394|65597895|FG003|Follow-up Period|Lost to Follow-up|0|||
23508133|NCT01928394|65597896|FG004|Follow-up Period|Lost to Follow-up|0|||
23508134|NCT01928394|65597897|FG005|Follow-up Period|Lost to Follow-up|0|||
23508135|NCT01928394|65597898|FG006|Follow-up Period|Lost to Follow-up|0|||
23508136|NCT01928394|65597899|FG007|Follow-up Period|Lost to Follow-up|0|||
23508137|NCT01928394|65597900|FG008|Follow-up Period|Lost to Follow-up|0|||
23508138|NCT01928394|65597901|FG009|Follow-up Period|Lost to Follow-up|0|||
23508139|NCT01928394|65597902|FG010|Follow-up Period|Lost to Follow-up|0|||
23508140|NCT01928394|65597903|FG011|Follow-up Period|Lost to Follow-up|1|||
23508141|NCT01928394|65597904|FG012|Follow-up Period|Lost to Follow-up|1|||
23508142|NCT01928394|65597905|FG013|Follow-up Period|Lost to Follow-up|0|||
23508143|NCT01928394|65597906|FG014|Follow-up Period|Lost to Follow-up|1|||
23508144|NCT01928394|65597907|FG015|Follow-up Period|Lost to Follow-up|0|||
23508145|NCT01928394|65597908|FG016|Follow-up Period|Lost to Follow-up|1|||
23508146|NCT01928394|65597909|FG017|Follow-up Period|Lost to Follow-up|0|||
23508147|NCT01928394|65597910|FG018|Follow-up Period|Lost to Follow-up|0|||
23508148|NCT01928394|65597911|FG019|Follow-up Period|Lost to Follow-up|0|||
23508149|NCT01928394|65597912|FG020|Follow-up Period|Lost to Follow-up|0|||
23508150|NCT01928394|65597913|FG021|Follow-up Period|Lost to Follow-up|0|||
23508151|NCT01928394|65597914|FG022|Follow-up Period|Lost to Follow-up|1|||
23508152|NCT02155608|65597915|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
23508153|NCT02155608|65597916|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
23508154|NCT02155608|65597915|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
23508155|NCT02155608|65597916|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
23508156|NCT01153347|65597919|FG000|Overall Study|Withdrawal by Subject|7|||
23508157|NCT01153347|65597920|FG001|Overall Study|Withdrawal by Subject|7|||
23508158|NCT01153347|65597921|FG002|Overall Study|Withdrawal by Subject|7|||
23508159|NCT01153347|65597922|FG003|Overall Study|Withdrawal by Subject|7|||
23508160|NCT01153347|65597919|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23508161|NCT01153347|65597920|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23508162|NCT01153347|65597921|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
23508163|NCT01153347|65597922|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23508164|NCT01153347|65597919|FG000|Overall Study|Adverse Event|3|||
23508165|NCT01153347|65597920|FG001|Overall Study|Adverse Event|9|||
23508166|NCT01153347|65597921|FG002|Overall Study|Adverse Event|21|||
23508167|NCT01153347|65597922|FG003|Overall Study|Adverse Event|7|||
23508168|NCT01153347|65597919|FG000|Overall Study|Severe non-compliance to protocol|6|||
23508169|NCT01153347|65597920|FG001|Overall Study|Severe non-compliance to protocol|7|||
23508170|NCT01153347|65597921|FG002|Overall Study|Severe non-compliance to protocol|4|||
23508171|NCT01153347|65597922|FG003|Overall Study|Severe non-compliance to protocol|3|||
23607393|NCT00696241|65950691|FG003|Overall Study|Adverse Event|4|||
23508172|NCT01153347|65597919|FG000|Overall Study|Condition under investigation worsened|1|||
23508173|NCT01153347|65597920|FG001|Overall Study|Condition under investigation worsened|1|||
23508174|NCT01153347|65597921|FG002|Overall Study|Condition under investigation worsened|0|||
23508175|NCT01153347|65597922|FG003|Overall Study|Condition under investigation worsened|0|||
23508176|NCT01153347|65597919|FG000|Overall Study|Lack of Efficacy|2|||
23508177|NCT01153347|65597920|FG001|Overall Study|Lack of Efficacy|2|||
23508178|NCT01153347|65597921|FG002|Overall Study|Lack of Efficacy|0|||
23508179|NCT01153347|65597922|FG003|Overall Study|Lack of Efficacy|4|||
23508180|NCT01153347|65597919|FG000|Overall Study|Study-specific withdrawal criteria|4|||
23508181|NCT01153347|65597920|FG001|Overall Study|Study-specific withdrawal criteria|3|||
23508182|NCT01153347|65597921|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23508183|NCT01153347|65597922|FG003|Overall Study|Study-specific withdrawal criteria|2|||
23508184|NCT01153347|65597919|FG000|Overall Study|Lost to Follow-up|4|||
23508185|NCT01153347|65597920|FG001|Overall Study|Lost to Follow-up|9|||
23508186|NCT01153347|65597921|FG002|Overall Study|Lost to Follow-up|11|||
23508187|NCT01153347|65597922|FG003|Overall Study|Lost to Follow-up|8|||
23508188|NCT01153347|65597919|FG000|Overall Study|Other|5|||
23508189|NCT01153347|65597920|FG001|Overall Study|Other|5|||
23508190|NCT01153347|65597921|FG002|Overall Study|Other|4|||
23508191|NCT01153347|65597922|FG003|Overall Study|Other|0|||
23508192|NCT01153347|65597919|FG000|Overall Study|Death|1|||
23508193|NCT01153347|65597920|FG001|Overall Study|Death|0|||
23508194|NCT01153347|65597921|FG002|Overall Study|Death|0|||
23508195|NCT01153347|65597922|FG003|Overall Study|Death|0|||
23508196|NCT02728076|65597923|FG000|Overall Study|Physician Decision|4|||
23508197|NCT00357968|65597928|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
23508198|NCT00357968|65597929|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
23508199|NCT00357968|65597928|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
23508200|NCT00357968|65597929|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
23508201|NCT00543140|65597930|FG000|Overall Study|Lost to Follow-up|33|||
23508202|NCT00543140|65597930|FG000|Overall Study|Withdrawal by Subject|13|||
23508203|NCT00543140|65597930|FG000|Overall Study|Protocol Violation|10|||
23508204|NCT00543140|65597930|FG000|Overall Study|Insufficient weight loss|10|||
23508205|NCT00543140|65597930|FG000|Overall Study|SAE leading to explant of SAGB|3|||
23508206|NCT00543140|65597930|FG000|Overall Study|Death|1|||
23508207|NCT00543140|65597930|FG000|Overall Study|Subject moved|1|||
23508208|NCT00543140|65597930|FG000|Overall Study|Conversion to different procedure|1|||
23508209|NCT01871532|65597932|FG000|Overall Study|Withdrawal by Subject|1|||
23508210|NCT01871532|65597933|FG001|Overall Study|Withdrawal by Subject|2|||
23508211|NCT02788357|65597936|FG000|Overall Study|Lost to Follow-up|3|||
23508212|NCT02788357|65597937|FG001|Overall Study|Lost to Follow-up|0|||
23508213|NCT02266225|65597938|FG000|Overall Study|Lost to Follow-up|2|||
23508214|NCT02266225|65597938|FG000|Overall Study|Death|1|||
23508215|NCT02266225|65597938|FG000|Overall Study|Withdrawal by Subject|13|||
23508216|NCT01339429|65597943|FG000|Overall Study|Withdrawal by Subject|1|||
23508217|NCT01339429|65597943|FG000|Overall Study|Physician Decision|3|||
23508218|NCT01025752|65597944|FG000|Overall Study|Lost to Follow-up|7|||
23508219|NCT01025752|65597945|FG001|Overall Study|Lost to Follow-up|10|||
23508220|NCT01025752|65597944|FG000|Overall Study|Physician Decision|1|||
23508221|NCT01025752|65597945|FG001|Overall Study|Physician Decision|3|||
23508222|NCT02507505|65597946|FG000|Overall Study|Withdrawal by Subject|13|||
23508223|NCT02507505|65597947|FG001|Overall Study|Withdrawal by Subject|11|||
23508224|NCT02507505|65597946|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
23508225|NCT02507505|65597947|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
23508226|NCT02507505|65597946|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
23508227|NCT02507505|65597947|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
23508228|NCT02507505|65597946|FG000|Overall Study|Death before receipt of anesthesia|0|||
23508229|NCT02507505|65597947|FG001|Overall Study|Death before receipt of anesthesia|1|||
23508230|NCT02860169|65597948|FG000|Part A|Withdrawal by Subject|1|||
23508231|NCT02860169|65597948|FG000|Part A|Other (Screening failure)|6|||
23508232|NCT02860169|65597948|FG000|Part A|Other (Survey not completed)|3|||
23508233|NCT02860169|65597948|FG000|Part A|Other (did not completed consent)|1|||
23508234|NCT02860169|65597948|FG000|Part B|Other (Screening failure)|10|||
23508235|NCT02860169|65597948|FG000|Part B|Withdrawal by Subject|1|||
23508236|NCT02860169|65597948|FG000|Part C|Other (Screening failure)|1|||
23508237|NCT00307294|65597949|FG000|Overall Study|Withdrawal by Subject|1|||
23508238|NCT04285879|65597950|FG000|Overall Study|Lost to Follow-up|1|||
23508239|NCT04285879|65597951|FG001|Overall Study|Lost to Follow-up|8|||
23508240|NCT04285879|65597950|FG000|Overall Study|medical/surgical exclusion|16|||
23508241|NCT04285879|65597951|FG001|Overall Study|medical/surgical exclusion|0|||
23508242|NCT04232124|65597952|FG000|Overall Study|Lost to Follow-up|3|||
23508243|NCT02239978|65597953|FG000|Overall Study|Withdrawal by Subject|2|||
23508244|NCT02239978|65597954|FG001|Overall Study|Withdrawal by Subject|0|||
23508245|NCT00600483|65597955|FG000|Overall Study|Lost to Follow-up|26|||
23508246|NCT00600483|65597956|FG001|Overall Study|Lost to Follow-up|47|||
23408564|NCT00041470|65239922|FG000|Overall Study|Loss of Funding|38|||
23508247|NCT00600483|65597955|FG000|Overall Study|Randomized but not treated|10|||
23508248|NCT00600483|65597956|FG001|Overall Study|Randomized but not treated|0|||
23508249|NCT01244425|65597957|FG000|Overall Study|Withdrawal by Subject|2|||
23508250|NCT01244425|65597958|FG001|Overall Study|Withdrawal by Subject|2|||
23508251|NCT01244425|65597957|FG000|Overall Study|Adverse Event|1|||
23508252|NCT01244425|65597958|FG001|Overall Study|Adverse Event|1|||
23508253|NCT03535844|65597959|FG000|Overall Study|Withdrawal by Subject|0|||
23508254|NCT03535844|65597960|FG001|Overall Study|Withdrawal by Subject|1|||
23508255|NCT02323113|65597963|FG000|Overall Study|Adverse Event|3|||
23508256|NCT02323113|65597964|FG001|Overall Study|Adverse Event|3|||
23508257|NCT02323113|65597965|FG002|Overall Study|Adverse Event|2|||
23508258|NCT02323113|65597966|FG003|Overall Study|Adverse Event|5|||
23508259|NCT02323113|65597967|FG004|Overall Study|Adverse Event|8|||
23508260|NCT02323113|65597968|FG005|Overall Study|Adverse Event|3|||
23508261|NCT02323113|65597969|FG006|Overall Study|Adverse Event|6|||
23508262|NCT02323113|65597970|FG007|Overall Study|Adverse Event|0|||
23508263|NCT02323113|65597963|FG000|Overall Study|Progressive Disease|0|||
23508264|NCT02323113|65597964|FG001|Overall Study|Progressive Disease|1|||
23508265|NCT02323113|65597965|FG002|Overall Study|Progressive Disease|1|||
23508266|NCT02323113|65597966|FG003|Overall Study|Progressive Disease|0|||
23508267|NCT02323113|65597967|FG004|Overall Study|Progressive Disease|0|||
23508268|NCT02323113|65597968|FG005|Overall Study|Progressive Disease|3|||
23508269|NCT02323113|65597969|FG006|Overall Study|Progressive Disease|0|||
23508270|NCT02323113|65597970|FG007|Overall Study|Progressive Disease|0|||
23508271|NCT02323113|65597963|FG000|Overall Study|Symptomatic Deterioration|0|||
23508272|NCT02323113|65597964|FG001|Overall Study|Symptomatic Deterioration|0|||
23508273|NCT02323113|65597965|FG002|Overall Study|Symptomatic Deterioration|1|||
23508274|NCT02323113|65597966|FG003|Overall Study|Symptomatic Deterioration|0|||
23508275|NCT02323113|65597967|FG004|Overall Study|Symptomatic Deterioration|1|||
23508276|NCT02323113|65597968|FG005|Overall Study|Symptomatic Deterioration|0|||
23508277|NCT02323113|65597969|FG006|Overall Study|Symptomatic Deterioration|0|||
23607394|NCT00696241|65950692|FG004|Overall Study|Adverse Event|5|||
23508278|NCT02323113|65597970|FG007|Overall Study|Symptomatic Deterioration|0|||
23508279|NCT02323113|65597963|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
23508280|NCT02323113|65597964|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
23508281|NCT02323113|65597965|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508282|NCT02323113|65597966|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508283|NCT02323113|65597967|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508284|NCT02323113|65597968|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
23508285|NCT02323113|65597969|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508286|NCT02323113|65597970|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
23508287|NCT02323113|65597963|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508288|NCT02323113|65597964|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
23508289|NCT02323113|65597965|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508290|NCT02323113|65597966|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508291|NCT02323113|65597967|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508292|NCT02323113|65597968|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508293|NCT02323113|65597969|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508294|NCT02323113|65597970|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
23508295|NCT01979016|65597971|FG000|Overall Study|Withdrawal by Subject|2|||
23508296|NCT01979016|65597972|FG001|Overall Study|Withdrawal by Subject|0|||
23508297|NCT01979016|65597971|FG000|Overall Study|Adverse Event|0|||
23508298|NCT01979016|65597972|FG001|Overall Study|Adverse Event|1|||
23508299|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508300|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
23508301|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508302|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508303|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508304|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
23508305|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
23508306|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
23508307|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
23508308|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
23508309|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
23508310|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
23508311|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
23508312|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
23508313|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
23607395|NCT00696241|65950688|FG000|Overall Study|Protocol Violation|1|||
23508314|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
23508315|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
23508316|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
23508317|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508318|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508319|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508320|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508321|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
23508322|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
23508323|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508324|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
23508325|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508326|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508327|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508328|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
23508329|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
23508330|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
23508331|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
23508332|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
23508333|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
23508334|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
23508335|NCT02603419|65597975|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508336|NCT02603419|65597976|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508337|NCT02603419|65597977|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508338|NCT02603419|65597978|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
23508339|NCT02603419|65597979|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508340|NCT02603419|65597980|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
23508341|NCT02603419|65597975|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508342|NCT02603419|65597976|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508343|NCT02603419|65597977|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508344|NCT02603419|65597978|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508345|NCT02603419|65597979|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
23508346|NCT02603419|65597980|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
23508347|NCT02603419|65597975|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508348|NCT02603419|65597976|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508349|NCT02603419|65597977|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508350|NCT02603419|65597978|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508351|NCT02603419|65597979|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
23508352|NCT02603419|65597980|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
23508353|NCT02603419|65597975|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508354|NCT02603419|65597976|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508355|NCT02603419|65597977|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508356|NCT02603419|65597978|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508357|NCT02603419|65597979|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
23508358|NCT02603419|65597980|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
23508359|NCT01906008|65597981|FG000|Overall Study|Lost to Follow-up|2|||
23508360|NCT01906008|65597982|FG001|Overall Study|Lost to Follow-up|0|||
23508361|NCT01906008|65597981|FG000|Overall Study|Oxaliplatin toxicity|2|||
23508362|NCT01906008|65597982|FG001|Overall Study|Oxaliplatin toxicity|0|||
23508363|NCT01906008|65597981|FG000|Overall Study|Protocol Violation|0|||
23508364|NCT01906008|65597982|FG001|Overall Study|Protocol Violation|1|||
23508365|NCT01906008|65597981|FG000|Overall Study|Withdrawal by Subject|1|||
23508366|NCT01906008|65597982|FG001|Overall Study|Withdrawal by Subject|5|||
23508367|NCT01906008|65597981|FG000|Overall Study|Did not start study med|3|||
23508368|NCT01906008|65597982|FG001|Overall Study|Did not start study med|4|||
23508369|NCT01906008|65597981|FG000|Overall Study|Oxaliplatin stops|10|||
23508370|NCT01906008|65597982|FG001|Overall Study|Oxaliplatin stops|8|||
23508371|NCT01906008|65597981|FG000|Overall Study|Hospice|1|||
23508372|NCT01906008|65597982|FG001|Overall Study|Hospice|0|||
23508373|NCT01906008|65597981|FG000|Overall Study|Physician Decision|3|||
23508374|NCT01906008|65597982|FG001|Overall Study|Physician Decision|3|||
23508375|NCT01906008|65597981|FG000|Overall Study|Lack of compliance of study med|5|||
23508376|NCT01906008|65597982|FG001|Overall Study|Lack of compliance of study med|3|||
23508377|NCT01906008|65597981|FG000|Overall Study|Adverse Event|0|||
23508378|NCT01906008|65597982|FG001|Overall Study|Adverse Event|3|||
23508379|NCT02167893|65597983|FG000|Overall Study|Investigator transferred|85|||
23508380|NCT02167893|65597983|FG000|Overall Study|Investigator health reasons|10|||
23508381|NCT02167893|65597983|FG000|Overall Study|Case report forms not collected|68|||
23508382|NCT01892293|65597984|FG000|Overall Study|Apheresed but not treated|4|||
23508383|NCT02760069|65597989|FG000|Overall Study|Withdrawal by Subject|0|||
23508384|NCT02760069|65597990|FG001|Overall Study|Withdrawal by Subject|1|||
23508385|NCT02760069|65597991|FG002|Overall Study|Withdrawal by Subject|1|||
23508386|NCT01385202|65597992|FG000|Overall Study|Lost to Follow-up|6|||
23508387|NCT01385202|65597992|FG000|Overall Study|Not Eligible|11|||
23508388|NCT01385202|65597992|FG000|Overall Study|Withdrawn|1|||
23508389|NCT00203996|65598000|FG000|Overall Study|Lost to Follow-up|0|||
23508390|NCT00203996|65598001|FG001|Overall Study|Lost to Follow-up|0|||
23508391|NCT00203996|65598002|FG002|Overall Study|Lost to Follow-up|0|||
23508392|NCT00203996|65598003|FG003|Overall Study|Lost to Follow-up|1|||
23508393|NCT00203996|65598004|FG004|Overall Study|Lost to Follow-up|0|||
23508394|NCT00203996|65598005|FG005|Overall Study|Lost to Follow-up|0|||
23508395|NCT00203996|65598006|FG006|Overall Study|Lost to Follow-up|0|||
23508396|NCT00203996|65598007|FG007|Overall Study|Lost to Follow-up|0|||
23508397|NCT00203996|65598008|FG008|Overall Study|Lost to Follow-up|0|||
23508398|NCT00203996|65598009|FG009|Overall Study|Lost to Follow-up|0|||
23508399|NCT00203996|65598000|FG000|Overall Study|Protocol Violation|0|||
23508400|NCT00203996|65598001|FG001|Overall Study|Protocol Violation|0|||
23508401|NCT00203996|65598002|FG002|Overall Study|Protocol Violation|0|||
23508402|NCT00203996|65598003|FG003|Overall Study|Protocol Violation|6|||
23508403|NCT00203996|65598004|FG004|Overall Study|Protocol Violation|1|||
23508404|NCT00203996|65598005|FG005|Overall Study|Protocol Violation|0|||
23508405|NCT00203996|65598006|FG006|Overall Study|Protocol Violation|0|||
23508406|NCT00203996|65598007|FG007|Overall Study|Protocol Violation|0|||
23508407|NCT00203996|65598008|FG008|Overall Study|Protocol Violation|0|||
23508408|NCT00203996|65598009|FG009|Overall Study|Protocol Violation|0|||
23508409|NCT00203996|65598000|FG000|Overall Study|Physician Decision|0|||
23508410|NCT00203996|65598001|FG001|Overall Study|Physician Decision|0|||
23508411|NCT00203996|65598002|FG002|Overall Study|Physician Decision|0|||
23508412|NCT00203996|65598003|FG003|Overall Study|Physician Decision|2|||
23508413|NCT00203996|65598004|FG004|Overall Study|Physician Decision|0|||
23508414|NCT00203996|65598005|FG005|Overall Study|Physician Decision|0|||
23508415|NCT00203996|65598006|FG006|Overall Study|Physician Decision|0|||
23508416|NCT00203996|65598007|FG007|Overall Study|Physician Decision|0|||
23508417|NCT00203996|65598008|FG008|Overall Study|Physician Decision|0|||
23508418|NCT00203996|65598009|FG009|Overall Study|Physician Decision|1|||
23508419|NCT00203996|65598000|FG000|Overall Study|CPAP machine malfunction|0|||
23508420|NCT00203996|65598001|FG001|Overall Study|CPAP machine malfunction|0|||
23508421|NCT00203996|65598002|FG002|Overall Study|CPAP machine malfunction|0|||
23508422|NCT00203996|65598003|FG003|Overall Study|CPAP machine malfunction|1|||
23508423|NCT00203996|65598004|FG004|Overall Study|CPAP machine malfunction|0|||
23508424|NCT00203996|65598005|FG005|Overall Study|CPAP machine malfunction|0|||
23508425|NCT00203996|65598006|FG006|Overall Study|CPAP machine malfunction|0|||
23508426|NCT00203996|65598007|FG007|Overall Study|CPAP machine malfunction|0|||
23508427|NCT00203996|65598008|FG008|Overall Study|CPAP machine malfunction|0|||
23508428|NCT00203996|65598009|FG009|Overall Study|CPAP machine malfunction|0|||
23508429|NCT00203996|65598000|FG000|Overall Study|Scheduling issue|0|||
23508430|NCT00203996|65598001|FG001|Overall Study|Scheduling issue|0|||
23508431|NCT00203996|65598002|FG002|Overall Study|Scheduling issue|0|||
23508432|NCT00203996|65598003|FG003|Overall Study|Scheduling issue|0|||
23508433|NCT00203996|65598004|FG004|Overall Study|Scheduling issue|0|||
23508434|NCT00203996|65598005|FG005|Overall Study|Scheduling issue|0|||
23508435|NCT00203996|65598006|FG006|Overall Study|Scheduling issue|0|||
23508436|NCT00203996|65598007|FG007|Overall Study|Scheduling issue|2|||
23508437|NCT00203996|65598008|FG008|Overall Study|Scheduling issue|0|||
23508438|NCT00203996|65598009|FG009|Overall Study|Scheduling issue|0|||
23508439|NCT00160251|65598010|FG000|Prior to Amendment 2|Adverse Event|2|||
23508440|NCT00160251|65598011|FG001|Prior to Amendment 2|Adverse Event|1|||
23508441|NCT00160251|65598012|FG002|Prior to Amendment 2|Adverse Event|3|||
23508442|NCT00160251|65598013|FG003|Prior to Amendment 2|Adverse Event|1|||
23508443|NCT00160251|65598014|FG004|Prior to Amendment 2|Adverse Event|1|||
23508444|NCT00160251|65598015|FG005|Prior to Amendment 2|Adverse Event|1|||
23508445|NCT00160251|65598016|FG006|Prior to Amendment 2|Adverse Event|1|||
23508446|NCT00160251|65598017|FG007|Prior to Amendment 2|Adverse Event|0|||
23508447|NCT00160251|65598010|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
23508448|NCT00160251|65598011|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
23508449|NCT00160251|65598012|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
23508450|NCT00160251|65598013|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
23508451|NCT00160251|65598014|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
23508452|NCT00160251|65598015|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
23508453|NCT00160251|65598016|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
23508454|NCT00160251|65598017|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
23508455|NCT00160251|65598010|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
23508456|NCT00160251|65598011|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
23508457|NCT00160251|65598012|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
23508458|NCT00160251|65598013|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
23508459|NCT00160251|65598014|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
23508460|NCT00160251|65598015|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
23508461|NCT00160251|65598016|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
23508462|NCT00160251|65598017|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
23508463|NCT00160251|65598010|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
23508464|NCT00160251|65598011|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
23508465|NCT00160251|65598012|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
23508466|NCT00160251|65598013|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
23508467|NCT00160251|65598014|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
23508468|NCT00160251|65598015|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
23508469|NCT00160251|65598016|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
23508470|NCT00160251|65598017|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
23508471|NCT00160251|65598010|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
23508472|NCT00160251|65598011|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
23508473|NCT00160251|65598012|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
23508474|NCT00160251|65598013|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
23508475|NCT00160251|65598014|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
23508476|NCT00160251|65598015|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
23508477|NCT00160251|65598016|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
23508478|NCT00160251|65598017|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
23508479|NCT00160251|65598010|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
23508480|NCT00160251|65598011|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
23508481|NCT00160251|65598012|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
23508482|NCT00160251|65598013|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
23508483|NCT00160251|65598014|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
23508484|NCT00160251|65598015|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
23508485|NCT00160251|65598016|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
23508486|NCT00160251|65598017|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
23508487|NCT00160251|65598010|FG000|Post-amendment 2|Adverse Event|0|||
23508488|NCT00160251|65598011|FG001|Post-amendment 2|Adverse Event|0|||
23508489|NCT00160251|65598012|FG002|Post-amendment 2|Adverse Event|0|||
23508490|NCT00160251|65598013|FG003|Post-amendment 2|Adverse Event|0|||
23508491|NCT00160251|65598014|FG004|Post-amendment 2|Adverse Event|0|||
23508492|NCT00160251|65598015|FG005|Post-amendment 2|Adverse Event|0|||
23508493|NCT00160251|65598016|FG006|Post-amendment 2|Adverse Event|0|||
23508494|NCT00160251|65598017|FG007|Post-amendment 2|Adverse Event|20|||
23508495|NCT00160251|65598010|FG000|Post-amendment 2|Lack of Efficacy|0|||
23508496|NCT00160251|65598011|FG001|Post-amendment 2|Lack of Efficacy|0|||
23508497|NCT00160251|65598012|FG002|Post-amendment 2|Lack of Efficacy|0|||
23508498|NCT00160251|65598013|FG003|Post-amendment 2|Lack of Efficacy|0|||
23508499|NCT00160251|65598014|FG004|Post-amendment 2|Lack of Efficacy|0|||
23508500|NCT00160251|65598015|FG005|Post-amendment 2|Lack of Efficacy|0|||
23508501|NCT00160251|65598016|FG006|Post-amendment 2|Lack of Efficacy|0|||
23508502|NCT00160251|65598017|FG007|Post-amendment 2|Lack of Efficacy|24|||
23508503|NCT00160251|65598010|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508504|NCT00160251|65598011|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508505|NCT00160251|65598012|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508506|NCT00160251|65598013|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508507|NCT00160251|65598014|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508508|NCT00160251|65598015|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508509|NCT00160251|65598016|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
23508510|NCT00160251|65598017|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
23508511|NCT02547454|65598018|FG000|Overall Study|Due to hemodialysis|53|||
23508512|NCT02547454|65598018|FG000|Overall Study|Due to transplantation|1|||
23508513|NCT02547454|65598018|FG000|Overall Study|Due to no further need to treat|4|||
23508514|NCT02547454|65598018|FG000|Overall Study|Death|38|||
23508515|NCT02547454|65598018|FG000|Overall Study|Lost to Follow-up|26|||
23508516|NCT02547454|65598018|FG000|Overall Study|Other|39|||
23508517|NCT02547454|65598018|FG000|Overall Study|No data|11|||
23508518|NCT05255068|65598019|FG000|Overall Study|Lost to Follow-up|0|||
23508519|NCT05255068|65598020|FG001|Overall Study|Lost to Follow-up|1|||
23508520|NCT02573350|65598023|FG000|Overall Study|Lost to Follow-up|2|||
23508521|NCT02573350|65598024|FG001|Overall Study|Lost to Follow-up|1|||
23508522|NCT02573350|65598023|FG000|Overall Study|Adverse Event|3|||
23508523|NCT02573350|65598024|FG001|Overall Study|Adverse Event|4|||
23508524|NCT02573350|65598023|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
23508525|NCT02573350|65598024|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
23508526|NCT02573350|65598023|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
23508527|NCT02573350|65598024|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
23508528|NCT02573350|65598023|FG000|Overall Study|Subject withdrew consent to participate|6|||
23508529|NCT02573350|65598024|FG001|Overall Study|Subject withdrew consent to participate|1|||
23508530|NCT02573350|65598023|FG000|Overall Study|Protocol Deviation|1|||
23508531|NCT02573350|65598024|FG001|Overall Study|Protocol Deviation|1|||
23508532|NCT03547687|65598025|FG000|Overall Study|Withdrawal by Subject|1|||
23508533|NCT03547687|65598025|FG000|Overall Study|Death|1|||
23508534|NCT05227027|65598040|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
23508535|NCT05227027|65598041|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
23508536|NCT02480114|65598042|FG000|Overall Study|Not completing surveys|3|||
23508537|NCT02480114|65598043|FG001|Overall Study|Not completing surveys|2|||
23508538|NCT02480114|65598042|FG000|Overall Study|Withdrawal by Subject|2|||
23508539|NCT02480114|65598043|FG001|Overall Study|Withdrawal by Subject|4|||
23508540|NCT02480114|65598042|FG000|Overall Study|Disease progression|3|||
23508541|NCT02480114|65598043|FG001|Overall Study|Disease progression|0|||
23508542|NCT02480114|65598042|FG000|Overall Study|Improper completion of survey|1|||
23508543|NCT02480114|65598043|FG001|Overall Study|Improper completion of survey|1|||
23508544|NCT02480114|65598042|FG000|Overall Study|Not eligible|0|||
23508545|NCT02480114|65598043|FG001|Overall Study|Not eligible|1|||
23508546|NCT01029795|65598044|FG000|Overall Study|Entry Criteria Not Met|2|||
23508547|NCT01029795|65598045|FG001|Overall Study|Entry Criteria Not Met|1|||
23508548|NCT01029795|65598044|FG000|Overall Study|Physician Decision|2|||
23508549|NCT01029795|65598045|FG001|Overall Study|Physician Decision|1|||
23508550|NCT01029795|65598044|FG000|Overall Study|Sponsor Decision|11|||
23508551|NCT01029795|65598045|FG001|Overall Study|Sponsor Decision|17|||
23508552|NCT01029795|65598044|FG000|Overall Study|Withdrawal by Subject|1|||
23508553|NCT01029795|65598045|FG001|Overall Study|Withdrawal by Subject|3|||
23508554|NCT02375113|65598046|FG000|Overall Study|Undisclosed Reason(s).|1|||
23508555|NCT02375113|65598047|FG001|Overall Study|Undisclosed Reason(s).|1|||
23508556|NCT02375113|65598046|FG000|Overall Study|Poor adherence (<70%).|1|||
23508557|NCT02375113|65598047|FG001|Overall Study|Poor adherence (<70%).|0|||
23508558|NCT02375113|65598046|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
23508559|NCT02375113|65598047|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
23508560|NCT03292588|65598048|FG000|Overall Study|Death|1|||
23508561|NCT03292588|65598049|FG001|Overall Study|Death|0|||
23508562|NCT03292588|65598048|FG000|Overall Study|Lost to Follow-up|12|||
23508563|NCT03292588|65598049|FG001|Overall Study|Lost to Follow-up|16|||
23508564|NCT03292588|65598048|FG000|Overall Study|Physician Decision|0|||
23508565|NCT03292588|65598049|FG001|Overall Study|Physician Decision|1|||
23508566|NCT03292588|65598048|FG000|Overall Study|Withdrawal by Subject|4|||
23508567|NCT03292588|65598049|FG001|Overall Study|Withdrawal by Subject|4|||
23508568|NCT03292588|65598048|FG000|Overall Study|Move out of town|1|||
23508569|NCT03292588|65598049|FG001|Overall Study|Move out of town|0|||
23508570|NCT03292588|65598048|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
23508571|NCT03292588|65598049|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
23508572|NCT04868890|65598050|FG000|Overall Study|Death|2|||
23508573|NCT04868890|65598051|FG001|Overall Study|Death|1|||
23508574|NCT04868890|65598050|FG000|Overall Study|Withdrawal by Subject|1|||
23508575|NCT04868890|65598051|FG001|Overall Study|Withdrawal by Subject|5|||
23508576|NCT03694821|65598064|FG000|Overall Study|Study terminated|4|||
23508577|NCT03694821|65598065|FG001|Overall Study|Study terminated|8|||
23508578|NCT03694821|65598066|FG002|Overall Study|Study terminated|4|||
23508579|NCT03018704|65598069|FG000|Overall Study|Lost to Follow-up|1|||
23508580|NCT03018704|65598070|FG001|Overall Study|Lost to Follow-up|1|||
23508581|NCT00439244|65598072|FG000|Overall Study|Adverse Event|5|||
23508582|NCT00439244|65598073|FG001|Overall Study|Adverse Event|2|||
23508583|NCT00439244|65598074|FG002|Overall Study|Adverse Event|3|||
23508584|NCT00439244|65598072|FG000|Overall Study|Withdrawal by Subject|3|||
23508585|NCT00439244|65598073|FG001|Overall Study|Withdrawal by Subject|1|||
23508586|NCT00439244|65598074|FG002|Overall Study|Withdrawal by Subject|2|||
23508587|NCT00439244|65598072|FG000|Overall Study|Lost to Follow-up|2|||
23508588|NCT00439244|65598073|FG001|Overall Study|Lost to Follow-up|1|||
23508589|NCT00439244|65598074|FG002|Overall Study|Lost to Follow-up|2|||
23508590|NCT00439244|65598072|FG000|Overall Study|Death|0|||
23508591|NCT00439244|65598073|FG001|Overall Study|Death|1|||
23508592|NCT00439244|65598074|FG002|Overall Study|Death|0|||
23508593|NCT00439244|65598072|FG000|Overall Study|Protocol Violation|0|||
23508594|NCT00439244|65598073|FG001|Overall Study|Protocol Violation|1|||
23508595|NCT00439244|65598074|FG002|Overall Study|Protocol Violation|0|||
23508596|NCT00439244|65598072|FG000|Overall Study|Administrative problems|1|||
23508597|NCT00439244|65598073|FG001|Overall Study|Administrative problems|0|||
23508598|NCT00439244|65598074|FG002|Overall Study|Administrative problems|0|||
23508599|NCT00965718|65598075|FG000|Overall Study|Withdrawal by Subject|4|||
23508600|NCT00004978|65598085|FG000|Overall Study|Death|107|||
23508601|NCT00004978|65598086|FG001|Overall Study|Death|116|||
23508602|NCT00004978|65598085|FG000|Overall Study|Lost to Follow-up|101|||
23508603|NCT00004978|65598086|FG001|Overall Study|Lost to Follow-up|108|||
23508604|NCT00004978|65598085|FG000|Overall Study|Withdrawal by Subject|17|||
23508605|NCT00004978|65598086|FG001|Overall Study|Withdrawal by Subject|26|||
23508606|NCT00004978|65598085|FG000|Overall Study|site closure - not in analysis cohort|19|||
23607396|NCT00696241|65950689|FG001|Overall Study|Protocol Violation|1|||
23508607|NCT00004978|65598086|FG001|Overall Study|site closure - not in analysis cohort|20|||
23508608|NCT02670837|65598087|FG000|Overall Study|Death|2|||
23508609|NCT02670837|65598088|FG001|Overall Study|Death|0|||
23508610|NCT02670837|65598089|FG002|Overall Study|Death|0|||
23508611|NCT01985867|65598090|FG000|Overall Study|Lost to Follow-up|3|||
23508612|NCT01985867|65598091|FG001|Overall Study|Lost to Follow-up|4|||
23508613|NCT01985867|65598090|FG000|Overall Study|Adverse Event|3|||
23508614|NCT01985867|65598091|FG001|Overall Study|Adverse Event|2|||
23508615|NCT01985867|65598090|FG000|Overall Study|Lack of Efficacy|1|||
23508616|NCT01985867|65598091|FG001|Overall Study|Lack of Efficacy|0|||
23508617|NCT02132130|65598092|FG000|Overall Study|Lost to Follow-up|0|||
23508618|NCT02132130|65598093|FG001|Overall Study|Lost to Follow-up|2|||
23508619|NCT02132130|65598094|FG002|Overall Study|Lost to Follow-up|0|||
23508620|NCT02132130|65598095|FG003|Overall Study|Lost to Follow-up|0|||
23508621|NCT02132130|65598092|FG000|Overall Study|Withdrawal by Subject|0|||
23508622|NCT02132130|65598093|FG001|Overall Study|Withdrawal by Subject|0|||
23508623|NCT02132130|65598094|FG002|Overall Study|Withdrawal by Subject|0|||
23508624|NCT02132130|65598095|FG003|Overall Study|Withdrawal by Subject|1|||
23508625|NCT00023764|65598096|FG000|Overall Study|Other|1|||
23508626|NCT00023764|65598096|FG000|Overall Study|Adverse Event|4|||
23508627|NCT00023764|65598096|FG000|Overall Study|Withdrawal by Subject|1|||
23508628|NCT00023764|65598096|FG000|Overall Study|Progression of disease|6|||
23508629|NCT00023764|65598096|FG000|Overall Study|patient received other treatment|1|||
23508630|NCT00023764|65598096|FG000|Overall Study|delay in obtaining staging images|1|||
23508631|NCT04342897|65598097|FG000|Overall Study|Death|7|||
23508632|NCT04342897|65598098|FG001|Overall Study|Death|4|||
23508633|NCT04342897|65598097|FG000|Overall Study|Lost to Follow-up|6|||
23508634|NCT04342897|65598098|FG001|Overall Study|Lost to Follow-up|6|||
23508635|NCT04342897|65598097|FG000|Overall Study|Withdrawal by Subject|1|||
23508636|NCT04342897|65598098|FG001|Overall Study|Withdrawal by Subject|2|||
23508637|NCT01833520|65598101|FG000|Overall Study|Lack of Efficacy|3|||
23508638|NCT01833520|65598102|FG001|Overall Study|Lack of Efficacy|3|||
23508639|NCT01833520|65598103|FG002|Overall Study|Lack of Efficacy|8|||
23508640|NCT01833520|65598104|FG003|Overall Study|Lack of Efficacy|3|||
23508641|NCT04605484|65598105|FG000|Overall Study|Lost to Follow-up|0|||
23508642|NCT04605484|65598106|FG001|Overall Study|Lost to Follow-up|1|||
23508643|NCT04605484|65598107|FG002|Overall Study|Lost to Follow-up|1|||
23508644|NCT04605484|65598105|FG000|Overall Study|Other|0|||
23508645|NCT04605484|65598106|FG001|Overall Study|Other|1|||
23508646|NCT04605484|65598107|FG002|Overall Study|Other|0|||
23508647|NCT00642460|65598108|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
23508648|NCT00642460|65598109|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
23508649|NCT00642460|65598110|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
23508650|NCT00642460|65598111|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
23508651|NCT00642460|65598112|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
23508652|NCT00642460|65598113|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
23508653|NCT00642460|65598108|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
23508654|NCT00642460|65598109|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508655|NCT00642460|65598110|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508656|NCT00642460|65598111|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508657|NCT00642460|65598112|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508658|NCT00642460|65598113|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
23508659|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
23508660|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
23508661|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
23508662|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
23508663|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
23508664|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
23508665|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Death|0|||
23508666|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Death|1|||
23508667|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Death|0|||
23508668|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Death|2|||
23508669|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Death|0|||
23508670|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Death|0|||
23508671|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
23508672|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
23508673|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
23508674|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
23508675|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
23508676|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
23508677|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
23508678|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
23508679|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
23508680|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
23508681|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
23508682|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
23508683|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508684|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
23508685|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508686|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508687|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508688|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
23508689|NCT00642460|65598108|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508690|NCT00642460|65598109|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508691|NCT00642460|65598110|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508692|NCT00642460|65598111|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
23508693|NCT00642460|65598112|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508694|NCT00642460|65598113|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
23508695|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
23508696|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
23508697|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
23508698|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
23508699|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
23508700|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
23508701|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
23508702|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
23508703|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
23508704|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
23508705|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
23508706|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
23508707|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
23508708|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
23508709|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
23508710|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
23508711|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
23508712|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
23508713|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
23508714|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
23508715|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
23508716|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
23508717|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
23508718|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
23508719|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Other|0|||
23508720|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Other|0|||
23508721|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Other|0|||
23508722|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Other|0|||
23508723|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Other|2|||
23508724|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Other|2|||
23508725|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Death|0|||
23508726|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Death|0|||
23508727|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Death|0|||
23508728|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Death|0|||
23508729|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Death|0|||
23508730|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Death|3|||
23508731|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508732|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508733|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508734|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508735|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
23508736|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
23508737|NCT00642460|65598108|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
23508738|NCT00642460|65598109|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
23508739|NCT00642460|65598110|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
23508740|NCT00642460|65598111|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
23508741|NCT00642460|65598112|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
23508742|NCT00642460|65598113|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
23508743|NCT01958008|65598114|FG000|Overall Study|Worsening of disease under study|0|||
23508744|NCT01958008|65598115|FG001|Overall Study|Worsening of disease under study|0|||
23508745|NCT01958008|65598116|FG002|Overall Study|Worsening of disease under study|1|||
23508746|NCT01958008|65598117|FG003|Overall Study|Worsening of disease under study|0|||
23508747|NCT01958008|65598114|FG000|Overall Study|Other adverse event|1|||
23508748|NCT01958008|65598115|FG001|Overall Study|Other adverse event|0|||
23508749|NCT01958008|65598116|FG002|Overall Study|Other adverse event|0|||
23508750|NCT01958008|65598117|FG003|Overall Study|Other adverse event|0|||
23508751|NCT04952402|65598118|FG000|Overall Study|Lost to Follow-up|1|||
23508752|NCT04952402|65598119|FG001|Overall Study|Lost to Follow-up|3|||
23508753|NCT04952402|65598118|FG000|Overall Study|Lack Of Venous Access|0|||
23508754|NCT04952402|65598119|FG001|Overall Study|Lack Of Venous Access|1|||
23508755|NCT02450903|65598122|FG000|Overall Study|Adverse Event|3|||
23508756|NCT02450903|65598122|FG000|Overall Study|Progressive disease|15|||
23508757|NCT02450903|65598122|FG000|Overall Study|Switched to commercial drug|1|||
23508758|NCT02450903|65598122|FG000|Overall Study|Subject/guardian decision|1|||
23508759|NCT01053221|65598123|FG000|Overall Study|The study was closed prematurely|5|||
23508760|NCT01053221|65598124|FG001|Overall Study|The study was closed prematurely|9|||
23508761|NCT04118166|65598132|FG000|Overall Study|Adverse Event|1|||
23508762|NCT00420927|65598137|FG000|Period 1|Adverse Event|19|||
23508763|NCT00420927|65598138|FG001|Period 1|Adverse Event|15|||
23508764|NCT00420927|65598139|FG002|Period 1|Adverse Event|0|||
23508765|NCT00420927|65598140|FG003|Period 1|Adverse Event|0|||
23508766|NCT00420927|65598141|FG004|Period 1|Adverse Event|0|||
23508767|NCT00420927|65598142|FG005|Period 1|Adverse Event|0|||
23508768|NCT00420927|65598143|FG006|Period 1|Adverse Event|0|||
23508769|NCT00420927|65598137|FG000|Period 1|Withdrawal by Subject|7|||
23508770|NCT00420927|65598138|FG001|Period 1|Withdrawal by Subject|12|||
23508771|NCT00420927|65598139|FG002|Period 1|Withdrawal by Subject|0|||
23508772|NCT00420927|65598140|FG003|Period 1|Withdrawal by Subject|0|||
23508773|NCT00420927|65598141|FG004|Period 1|Withdrawal by Subject|0|||
23508774|NCT00420927|65598142|FG005|Period 1|Withdrawal by Subject|0|||
23508775|NCT00420927|65598143|FG006|Period 1|Withdrawal by Subject|0|||
23508776|NCT00420927|65598137|FG000|Period 1|Lost to Follow-up|8|||
23508777|NCT00420927|65598138|FG001|Period 1|Lost to Follow-up|6|||
23508778|NCT00420927|65598139|FG002|Period 1|Lost to Follow-up|0|||
23508779|NCT00420927|65598140|FG003|Period 1|Lost to Follow-up|0|||
23508780|NCT00420927|65598141|FG004|Period 1|Lost to Follow-up|0|||
23508781|NCT00420927|65598142|FG005|Period 1|Lost to Follow-up|0|||
23508782|NCT00420927|65598143|FG006|Period 1|Lost to Follow-up|0|||
23508783|NCT00420927|65598137|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
23508784|NCT00420927|65598138|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
23508785|NCT00420927|65598139|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508786|NCT00420927|65598140|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508787|NCT00420927|65598141|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508788|NCT00420927|65598142|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508789|NCT00420927|65598143|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
23508790|NCT00420927|65598137|FG000|Period 1|Death|2|||
23508791|NCT00420927|65598138|FG001|Period 1|Death|0|||
23508792|NCT00420927|65598139|FG002|Period 1|Death|0|||
23508793|NCT00420927|65598140|FG003|Period 1|Death|0|||
23508794|NCT00420927|65598141|FG004|Period 1|Death|0|||
23508795|NCT00420927|65598142|FG005|Period 1|Death|0|||
23508796|NCT00420927|65598143|FG006|Period 1|Death|0|||
23508797|NCT00420927|65598137|FG000|Period 1|Subject moved/relocated|0|||
23508798|NCT00420927|65598138|FG001|Period 1|Subject moved/relocated|2|||
23508799|NCT00420927|65598139|FG002|Period 1|Subject moved/relocated|0|||
23508800|NCT00420927|65598140|FG003|Period 1|Subject moved/relocated|0|||
23508801|NCT00420927|65598141|FG004|Period 1|Subject moved/relocated|0|||
23508802|NCT00420927|65598142|FG005|Period 1|Subject moved/relocated|0|||
23508803|NCT00420927|65598143|FG006|Period 1|Subject moved/relocated|0|||
23508804|NCT00420927|65598137|FG000|Period 1|Noncompliant with study drug|1|||
23508805|NCT00420927|65598138|FG001|Period 1|Noncompliant with study drug|1|||
23508806|NCT00420927|65598139|FG002|Period 1|Noncompliant with study drug|0|||
23508807|NCT00420927|65598140|FG003|Period 1|Noncompliant with study drug|0|||
23508808|NCT00420927|65598141|FG004|Period 1|Noncompliant with study drug|0|||
23508809|NCT00420927|65598142|FG005|Period 1|Noncompliant with study drug|0|||
23508810|NCT00420927|65598143|FG006|Period 1|Noncompliant with study drug|0|||
23508811|NCT00420927|65598137|FG000|Period 1|Randomization error|1|||
23508812|NCT00420927|65598138|FG001|Period 1|Randomization error|0|||
23508813|NCT00420927|65598139|FG002|Period 1|Randomization error|0|||
23508814|NCT00420927|65598140|FG003|Period 1|Randomization error|0|||
23508815|NCT00420927|65598141|FG004|Period 1|Randomization error|0|||
23508816|NCT00420927|65598142|FG005|Period 1|Randomization error|0|||
23508817|NCT00420927|65598143|FG006|Period 1|Randomization error|0|||
23508818|NCT00420927|65598137|FG000|Period 1|Suspected tuberculosis/positive test|1|||
23508819|NCT00420927|65598138|FG001|Period 1|Suspected tuberculosis/positive test|1|||
23508820|NCT00420927|65598139|FG002|Period 1|Suspected tuberculosis/positive test|0|||
23508821|NCT00420927|65598140|FG003|Period 1|Suspected tuberculosis/positive test|0|||
23508822|NCT00420927|65598141|FG004|Period 1|Suspected tuberculosis/positive test|0|||
23508823|NCT00420927|65598142|FG005|Period 1|Suspected tuberculosis/positive test|0|||
23508824|NCT00420927|65598143|FG006|Period 1|Suspected tuberculosis/positive test|0|||
23508825|NCT00420927|65598137|FG000|Period 1|Study site closure|0|||
23508826|NCT00420927|65598138|FG001|Period 1|Study site closure|1|||
23508827|NCT00420927|65598139|FG002|Period 1|Study site closure|0|||
23508828|NCT00420927|65598140|FG003|Period 1|Study site closure|0|||
23508829|NCT00420927|65598141|FG004|Period 1|Study site closure|0|||
23508830|NCT00420927|65598142|FG005|Period 1|Study site closure|0|||
23508831|NCT00420927|65598143|FG006|Period 1|Study site closure|0|||
23508832|NCT00420927|65598137|FG000|Period 1|Subject received new diagnosis|0|||
23508833|NCT00420927|65598138|FG001|Period 1|Subject received new diagnosis|2|||
23508834|NCT00420927|65598139|FG002|Period 1|Subject received new diagnosis|0|||
23508835|NCT00420927|65598140|FG003|Period 1|Subject received new diagnosis|0|||
23508836|NCT00420927|65598141|FG004|Period 1|Subject received new diagnosis|0|||
23508837|NCT00420927|65598142|FG005|Period 1|Subject received new diagnosis|0|||
23508838|NCT00420927|65598143|FG006|Period 1|Subject received new diagnosis|0|||
23508839|NCT00420927|65598137|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
23508840|NCT00420927|65598138|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
23508841|NCT00420927|65598139|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
23508842|NCT00420927|65598140|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
23508843|NCT00420927|65598141|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
23508844|NCT00420927|65598142|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
23508845|NCT00420927|65598143|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
23508846|NCT00420927|65598137|FG000|Period 1|Failed to meet entry criteria|8|||
23508847|NCT00420927|65598138|FG001|Period 1|Failed to meet entry criteria|7|||
23508848|NCT00420927|65598139|FG002|Period 1|Failed to meet entry criteria|0|||
23508849|NCT00420927|65598140|FG003|Period 1|Failed to meet entry criteria|0|||
23508850|NCT00420927|65598141|FG004|Period 1|Failed to meet entry criteria|0|||
23508851|NCT00420927|65598142|FG005|Period 1|Failed to meet entry criteria|0|||
23508852|NCT00420927|65598143|FG006|Period 1|Failed to meet entry criteria|0|||
23508853|NCT00420927|65598137|FG000|Period 1|Took prohibited medication|1|||
23508854|NCT00420927|65598138|FG001|Period 1|Took prohibited medication|3|||
23508855|NCT00420927|65598139|FG002|Period 1|Took prohibited medication|0|||
23508856|NCT00420927|65598140|FG003|Period 1|Took prohibited medication|0|||
23508857|NCT00420927|65598141|FG004|Period 1|Took prohibited medication|0|||
23508858|NCT00420927|65598142|FG005|Period 1|Took prohibited medication|0|||
23508859|NCT00420927|65598143|FG006|Period 1|Took prohibited medication|0|||
23508860|NCT00420927|65598137|FG000|Period 2|Adverse Event|0|||
23508861|NCT00420927|65598138|FG001|Period 2|Adverse Event|0|||
23508862|NCT00420927|65598139|FG002|Period 2|Adverse Event|7|||
23508863|NCT00420927|65598140|FG003|Period 2|Adverse Event|3|||
23508864|NCT00420927|65598141|FG004|Period 2|Adverse Event|17|||
23508865|NCT00420927|65598142|FG005|Period 2|Adverse Event|6|||
23508866|NCT00420927|65598143|FG006|Period 2|Adverse Event|20|||
23508867|NCT00420927|65598137|FG000|Period 2|Withdrawal by Subject|0|||
23508868|NCT00420927|65598138|FG001|Period 2|Withdrawal by Subject|0|||
23508869|NCT00420927|65598139|FG002|Period 2|Withdrawal by Subject|1|||
23508870|NCT00420927|65598140|FG003|Period 2|Withdrawal by Subject|3|||
23508871|NCT00420927|65598141|FG004|Period 2|Withdrawal by Subject|11|||
23508872|NCT00420927|65598142|FG005|Period 2|Withdrawal by Subject|2|||
23508873|NCT00420927|65598143|FG006|Period 2|Withdrawal by Subject|12|||
23508874|NCT00420927|65598137|FG000|Period 2|Lost to Follow-up|0|||
23508875|NCT00420927|65598138|FG001|Period 2|Lost to Follow-up|0|||
23508876|NCT00420927|65598139|FG002|Period 2|Lost to Follow-up|2|||
23508877|NCT00420927|65598140|FG003|Period 2|Lost to Follow-up|2|||
23508878|NCT00420927|65598141|FG004|Period 2|Lost to Follow-up|6|||
23508879|NCT00420927|65598142|FG005|Period 2|Lost to Follow-up|3|||
23508880|NCT00420927|65598143|FG006|Period 2|Lost to Follow-up|9|||
23508881|NCT00420927|65598137|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
23508882|NCT00420927|65598138|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
23508883|NCT00420927|65598139|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
23508884|NCT00420927|65598140|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
23508885|NCT00420927|65598141|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
23508886|NCT00420927|65598142|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
23508887|NCT00420927|65598143|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
23508888|NCT00420927|65598137|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
23508889|NCT00420927|65598138|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
23508890|NCT00420927|65598139|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
23508891|NCT00420927|65598140|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
23508892|NCT00420927|65598141|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
23408565|NCT03782259|65239923|FG000|Overall Study|Lost to Follow-up|1|||
23508893|NCT00420927|65598142|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
23508894|NCT00420927|65598143|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
23508895|NCT00420927|65598137|FG000|Period 2|Subject unable to find transportation|0|||
23508896|NCT00420927|65598138|FG001|Period 2|Subject unable to find transportation|0|||
23508897|NCT00420927|65598139|FG002|Period 2|Subject unable to find transportation|0|||
23508898|NCT00420927|65598140|FG003|Period 2|Subject unable to find transportation|0|||
23508899|NCT00420927|65598141|FG004|Period 2|Subject unable to find transportation|0|||
23508900|NCT00420927|65598142|FG005|Period 2|Subject unable to find transportation|0|||
23508901|NCT00420927|65598143|FG006|Period 2|Subject unable to find transportation|1|||
23508902|NCT00420927|65598137|FG000|Period 2|Physician Decision|0|||
23508903|NCT00420927|65598138|FG001|Period 2|Physician Decision|0|||
23508904|NCT00420927|65598139|FG002|Period 2|Physician Decision|0|||
23508905|NCT00420927|65598140|FG003|Period 2|Physician Decision|0|||
23508906|NCT00420927|65598141|FG004|Period 2|Physician Decision|1|||
23508907|NCT00420927|65598142|FG005|Period 2|Physician Decision|1|||
23508908|NCT00420927|65598143|FG006|Period 2|Physician Decision|0|||
23508909|NCT00420927|65598137|FG000|Period 2|Sponsor decision|0|||
23508910|NCT00420927|65598138|FG001|Period 2|Sponsor decision|0|||
23508911|NCT00420927|65598139|FG002|Period 2|Sponsor decision|1|||
23508912|NCT00420927|65598140|FG003|Period 2|Sponsor decision|0|||
23508913|NCT00420927|65598141|FG004|Period 2|Sponsor decision|0|||
23508914|NCT00420927|65598142|FG005|Period 2|Sponsor decision|0|||
23508915|NCT00420927|65598143|FG006|Period 2|Sponsor decision|1|||
23508916|NCT00420927|65598137|FG000|Period 2|Randomization error|0|||
23508917|NCT00420927|65598138|FG001|Period 2|Randomization error|0|||
23508918|NCT00420927|65598139|FG002|Period 2|Randomization error|0|||
23508919|NCT00420927|65598140|FG003|Period 2|Randomization error|0|||
23508920|NCT00420927|65598141|FG004|Period 2|Randomization error|1|||
23508921|NCT00420927|65598142|FG005|Period 2|Randomization error|1|||
23508922|NCT00420927|65598143|FG006|Period 2|Randomization error|0|||
23508923|NCT00420927|65598137|FG000|Period 2|Noncompliant with study drug|0|||
23508924|NCT00420927|65598138|FG001|Period 2|Noncompliant with study drug|0|||
23508925|NCT00420927|65598139|FG002|Period 2|Noncompliant with study drug|0|||
23508926|NCT00420927|65598140|FG003|Period 2|Noncompliant with study drug|1|||
23508927|NCT00420927|65598141|FG004|Period 2|Noncompliant with study drug|0|||
23508928|NCT00420927|65598142|FG005|Period 2|Noncompliant with study drug|0|||
23508929|NCT00420927|65598143|FG006|Period 2|Noncompliant with study drug|2|||
23508930|NCT00420927|65598137|FG000|Period 2|Methotrexate intolerance|0|||
23508931|NCT00420927|65598138|FG001|Period 2|Methotrexate intolerance|0|||
23508932|NCT00420927|65598139|FG002|Period 2|Methotrexate intolerance|0|||
23508933|NCT00420927|65598140|FG003|Period 2|Methotrexate intolerance|0|||
23508934|NCT00420927|65598141|FG004|Period 2|Methotrexate intolerance|0|||
23508935|NCT00420927|65598142|FG005|Period 2|Methotrexate intolerance|0|||
23508936|NCT00420927|65598143|FG006|Period 2|Methotrexate intolerance|1|||
23508937|NCT00420927|65598137|FG000|Period 2|Took prohibited medication|0|||
23508938|NCT00420927|65598138|FG001|Period 2|Took prohibited medication|0|||
23508939|NCT00420927|65598139|FG002|Period 2|Took prohibited medication|0|||
23508940|NCT00420927|65598140|FG003|Period 2|Took prohibited medication|0|||
23508941|NCT00420927|65598141|FG004|Period 2|Took prohibited medication|1|||
23508942|NCT00420927|65598142|FG005|Period 2|Took prohibited medication|0|||
23508943|NCT00420927|65598143|FG006|Period 2|Took prohibited medication|0|||
23508944|NCT00211809|65598151|FG000|Overall Study|Lack of Efficacy|1|||
23508945|NCT00211809|65598151|FG000|Overall Study|Lost to Follow-up|2|||
23508946|NCT00211809|65598151|FG000|Overall Study|Pregnancy|1|||
23508947|NCT00211809|65598151|FG000|Overall Study|side effects|2|||
23508948|NCT03982368|65598152|FG000|Overall Study|Adverse Event|6|||
23508949|NCT03982368|65598153|FG001|Overall Study|Adverse Event|4|||
23508950|NCT03982368|65598154|FG002|Overall Study|Adverse Event|3|||
23508951|NCT03982368|65598152|FG000|Overall Study|Lost to Follow-up|2|||
23508952|NCT03982368|65598153|FG001|Overall Study|Lost to Follow-up|1|||
23508953|NCT03982368|65598154|FG002|Overall Study|Lost to Follow-up|0|||
23508954|NCT03982368|65598152|FG000|Overall Study|Withdrawal by Subject|1|||
23508955|NCT03982368|65598153|FG001|Overall Study|Withdrawal by Subject|2|||
23508956|NCT03982368|65598154|FG002|Overall Study|Withdrawal by Subject|0|||
23508957|NCT03982368|65598152|FG000|Overall Study|unknow|4|||
23508958|NCT03982368|65598153|FG001|Overall Study|unknow|0|||
23508959|NCT03982368|65598154|FG002|Overall Study|unknow|2|||
23508960|NCT01850524|65598160|FG000|Overall Study|Lost to Follow-up|5|||
23508961|NCT01850524|65598161|FG001|Overall Study|Lost to Follow-up|10|||
23508962|NCT01850524|65598160|FG000|Overall Study|Withdrawal by Subject|24|||
23508963|NCT01850524|65598161|FG001|Overall Study|Withdrawal by Subject|22|||
23508964|NCT01850524|65598160|FG000|Overall Study|Reason not Specified|142|||
23508965|NCT01850524|65598161|FG001|Overall Study|Reason not Specified|141|||
23508966|NCT02193867|65598164|FG000|Overall Study|Death|2|||
23508967|NCT02193867|65598164|FG000|Overall Study|Sponsor Study Termination|2|||
23508968|NCT02034110|65598173|FG000|Overall Study|Physician Decision|0|||
23508969|NCT02034110|65598174|FG001|Overall Study|Physician Decision|0|||
23508970|NCT02034110|65598175|FG002|Overall Study|Physician Decision|0|||
23508971|NCT02034110|65598176|FG003|Overall Study|Physician Decision|0|||
23508972|NCT02034110|65598177|FG004|Overall Study|Physician Decision|2|||
23508973|NCT02034110|65598178|FG005|Overall Study|Physician Decision|0|||
23508974|NCT02034110|65598179|FG006|Overall Study|Physician Decision|1|||
23508975|NCT02034110|65598180|FG007|Overall Study|Physician Decision|0|||
23508976|NCT02034110|65598173|FG000|Overall Study|Lost to Follow-up|1|||
23508977|NCT02034110|65598174|FG001|Overall Study|Lost to Follow-up|0|||
23508978|NCT02034110|65598175|FG002|Overall Study|Lost to Follow-up|0|||
23508979|NCT02034110|65598176|FG003|Overall Study|Lost to Follow-up|0|||
23508980|NCT02034110|65598177|FG004|Overall Study|Lost to Follow-up|1|||
23508981|NCT02034110|65598178|FG005|Overall Study|Lost to Follow-up|0|||
23508982|NCT02034110|65598179|FG006|Overall Study|Lost to Follow-up|1|||
23508983|NCT02034110|65598180|FG007|Overall Study|Lost to Follow-up|0|||
23508984|NCT02034110|65598173|FG000|Overall Study|Withdrawal by Subject|5|||
23508985|NCT02034110|65598174|FG001|Overall Study|Withdrawal by Subject|7|||
23508986|NCT02034110|65598175|FG002|Overall Study|Withdrawal by Subject|0|||
23508987|NCT02034110|65598176|FG003|Overall Study|Withdrawal by Subject|3|||
23508988|NCT02034110|65598177|FG004|Overall Study|Withdrawal by Subject|7|||
23508989|NCT02034110|65598178|FG005|Overall Study|Withdrawal by Subject|0|||
23508990|NCT02034110|65598179|FG006|Overall Study|Withdrawal by Subject|3|||
23508991|NCT02034110|65598180|FG007|Overall Study|Withdrawal by Subject|1|||
23508992|NCT02034110|65598173|FG000|Overall Study|Study closed by sponsor|6|||
23508993|NCT02034110|65598174|FG001|Overall Study|Study closed by sponsor|2|||
23508994|NCT02034110|65598175|FG002|Overall Study|Study closed by sponsor|0|||
23508995|NCT02034110|65598176|FG003|Overall Study|Study closed by sponsor|6|||
23508996|NCT02034110|65598177|FG004|Overall Study|Study closed by sponsor|7|||
23508997|NCT02034110|65598178|FG005|Overall Study|Study closed by sponsor|0|||
23508998|NCT02034110|65598179|FG006|Overall Study|Study closed by sponsor|42|||
23508999|NCT02034110|65598180|FG007|Overall Study|Study closed by sponsor|0|||
23509000|NCT02692703|65598182|FG000|Overall Study|Lost to Follow-up|1|||
23509001|NCT02692703|65598182|FG000|Overall Study|Other|1|||
23509002|NCT00546637|65598183|FG000|Overall Study|Adverse Event|46|||
23509003|NCT00546637|65598184|FG001|Overall Study|Adverse Event|20|||
23509004|NCT00546637|65598183|FG000|Overall Study|Lack of Efficacy|5|||
23509005|NCT00546637|65598184|FG001|Overall Study|Lack of Efficacy|5|||
23509006|NCT00546637|65598183|FG000|Overall Study|Lost to Follow-up|2|||
23509007|NCT00546637|65598184|FG001|Overall Study|Lost to Follow-up|2|||
23509008|NCT00546637|65598183|FG000|Overall Study|Other|10|||
23509009|NCT00546637|65598184|FG001|Overall Study|Other|12|||
23509010|NCT00546637|65598183|FG000|Overall Study|Withdrawal by Subject|7|||
23509011|NCT00546637|65598184|FG001|Overall Study|Withdrawal by Subject|9|||
23509012|NCT00546637|65598183|FG000|Overall Study|Randomized, but not treated|3|||
23509013|NCT00546637|65598184|FG001|Overall Study|Randomized, but not treated|1|||
23509014|NCT02170051|65598185|FG000|Overall Study|Withdrawal by Subject|10|||
23509015|NCT02170051|65598186|FG001|Overall Study|Withdrawal by Subject|10|||
23509016|NCT02170051|65598185|FG000|Overall Study|Lost to Follow-up|1|||
23509017|NCT02170051|65598186|FG001|Overall Study|Lost to Follow-up|3|||
23509018|NCT04967443|65598187|FG000|Open Label Treatment|Death|1|||
23509019|NCT04967443|65598188|FG001|Open Label Treatment|Death|0|||
23509020|NCT04967443|65598189|FG002|Open Label Treatment|Death|0|||
23509021|NCT04967443|65598190|FG003|Open Label Treatment|Death|0|||
23509022|NCT04967443|65598191|FG004|Open Label Treatment|Death|0|||
23509023|NCT04967443|65598192|FG005|Open Label Treatment|Death|0|||
23509024|NCT04967443|65598193|FG006|Open Label Treatment|Death|0|||
23509025|NCT04967443|65598194|FG007|Open Label Treatment|Death|0|||
23509026|NCT04967443|65598187|FG000|Open Label Treatment|Lost to Follow-up|0|||
23509027|NCT04967443|65598188|FG001|Open Label Treatment|Lost to Follow-up|0|||
23509028|NCT04967443|65598189|FG002|Open Label Treatment|Lost to Follow-up|1|||
23509029|NCT04967443|65598190|FG003|Open Label Treatment|Lost to Follow-up|0|||
23509030|NCT04967443|65598191|FG004|Open Label Treatment|Lost to Follow-up|0|||
23509031|NCT04967443|65598192|FG005|Open Label Treatment|Lost to Follow-up|0|||
23509032|NCT04967443|65598193|FG006|Open Label Treatment|Lost to Follow-up|0|||
23509033|NCT04967443|65598194|FG007|Open Label Treatment|Lost to Follow-up|0|||
23509034|NCT04967443|65598187|FG000|Open Label Treatment|Withdrawal by Subject|0|||
23509035|NCT04967443|65598188|FG001|Open Label Treatment|Withdrawal by Subject|1|||
23509036|NCT04967443|65598189|FG002|Open Label Treatment|Withdrawal by Subject|0|||
23509037|NCT04967443|65598190|FG003|Open Label Treatment|Withdrawal by Subject|1|||
23509038|NCT04967443|65598191|FG004|Open Label Treatment|Withdrawal by Subject|0|||
23509039|NCT04967443|65598192|FG005|Open Label Treatment|Withdrawal by Subject|1|||
23509040|NCT04967443|65598193|FG006|Open Label Treatment|Withdrawal by Subject|2|||
23509041|NCT04967443|65598194|FG007|Open Label Treatment|Withdrawal by Subject|3|||
23509042|NCT04967443|65598187|FG000|Follow-Up|Death|1|||
23509043|NCT04967443|65598188|FG001|Follow-Up|Death|0|||
23509044|NCT04967443|65598189|FG002|Follow-Up|Death|0|||
23509045|NCT04967443|65598190|FG003|Follow-Up|Death|0|||
23509046|NCT04967443|65598191|FG004|Follow-Up|Death|0|||
23509047|NCT04967443|65598192|FG005|Follow-Up|Death|0|||
23509048|NCT04967443|65598193|FG006|Follow-Up|Death|0|||
23509049|NCT04967443|65598194|FG007|Follow-Up|Death|0|||
23509050|NCT04967443|65598187|FG000|Follow-Up|Lost to Follow-up|0|||
23509051|NCT04967443|65598188|FG001|Follow-Up|Lost to Follow-up|0|||
23509052|NCT04967443|65598189|FG002|Follow-Up|Lost to Follow-up|1|||
23509053|NCT04967443|65598190|FG003|Follow-Up|Lost to Follow-up|1|||
23509054|NCT04967443|65598191|FG004|Follow-Up|Lost to Follow-up|0|||
23509055|NCT04967443|65598192|FG005|Follow-Up|Lost to Follow-up|0|||
23509056|NCT04967443|65598193|FG006|Follow-Up|Lost to Follow-up|0|||
23509057|NCT04967443|65598194|FG007|Follow-Up|Lost to Follow-up|0|||
23509058|NCT04967443|65598187|FG000|Follow-Up|Withdrawal by Subject|0|||
23509059|NCT04967443|65598188|FG001|Follow-Up|Withdrawal by Subject|1|||
23509060|NCT04967443|65598189|FG002|Follow-Up|Withdrawal by Subject|0|||
23509061|NCT04967443|65598190|FG003|Follow-Up|Withdrawal by Subject|1|||
23509062|NCT04967443|65598191|FG004|Follow-Up|Withdrawal by Subject|0|||
23509063|NCT04967443|65598192|FG005|Follow-Up|Withdrawal by Subject|1|||
23509064|NCT04967443|65598193|FG006|Follow-Up|Withdrawal by Subject|2|||
23509065|NCT04967443|65598194|FG007|Follow-Up|Withdrawal by Subject|3|||
23509066|NCT02990910|65598195|FG000|Overall Study|Lack of Efficacy|6|||
23509067|NCT02990910|65598196|FG001|Overall Study|Lack of Efficacy|10|||
23509068|NCT01426373|65598198|FG000|Overall Study|Adverse Event|6|||
23509069|NCT01426373|65598198|FG000|Overall Study|Lost to Follow-up|14|||
23509070|NCT01426373|65598198|FG000|Overall Study|Participant Convenience|10|||
23509071|NCT01426373|65598198|FG000|Overall Study|Miscellaneous Reasons|4|||
23509072|NCT02246660|65598199|FG000|Overall Study|Withdrawal by Subject|0|||
23509073|NCT02246660|65598200|FG001|Overall Study|Withdrawal by Subject|1|||
23509074|NCT02246660|65598201|FG002|Overall Study|Withdrawal by Subject|0|||
23509075|NCT02246660|65598199|FG000|Overall Study|Death|0|||
23509076|NCT02246660|65598200|FG001|Overall Study|Death|0|||
23509077|NCT02246660|65598201|FG002|Overall Study|Death|1|||
23509078|NCT01465997|65598202|FG000|Overall Study|Adverse Event|12|||
23509079|NCT01465997|65598203|FG001|Overall Study|Adverse Event|22|||
23509080|NCT01465997|65598202|FG000|Overall Study|Lack of Efficacy|13|||
23509081|NCT01465997|65598203|FG001|Overall Study|Lack of Efficacy|1|||
23509082|NCT01465997|65598202|FG000|Overall Study|Protocol Violation|1|||
23509083|NCT01465997|65598203|FG001|Overall Study|Protocol Violation|4|||
23509084|NCT01465997|65598202|FG000|Overall Study|Lost to Follow-up|6|||
23509085|NCT01465997|65598203|FG001|Overall Study|Lost to Follow-up|9|||
23509086|NCT01465997|65598202|FG000|Overall Study|Withdrawal by Subject|32|||
23509087|NCT01465997|65598203|FG001|Overall Study|Withdrawal by Subject|35|||
23509088|NCT01465997|65598202|FG000|Overall Study|investigator's decision|1|||
23509089|NCT01465997|65598203|FG001|Overall Study|investigator's decision|1|||
23509090|NCT01465997|65598202|FG000|Overall Study|Death|0|||
23509091|NCT01465997|65598203|FG001|Overall Study|Death|1|||
23509092|NCT01465997|65598202|FG000|Overall Study|sponsor's decision|1|||
23509093|NCT01465997|65598203|FG001|Overall Study|sponsor's decision|1|||
23509094|NCT01465997|65598202|FG000|Overall Study|subject withdrew consent|1|||
23509095|NCT01465997|65598203|FG001|Overall Study|subject withdrew consent|0|||
23509096|NCT01465997|65598202|FG000|Overall Study|local lab unblinded site|1|||
23509097|NCT01465997|65598203|FG001|Overall Study|local lab unblinded site|0|||
23509098|NCT01465997|65598202|FG000|Overall Study|withdrew before follow-up|0|||
23509099|NCT01465997|65598203|FG001|Overall Study|withdrew before follow-up|13|||
23509100|NCT01465997|65598202|FG000|Overall Study|decision by site staff|0|||
23509101|NCT01465997|65598203|FG001|Overall Study|decision by site staff|1|||
23509102|NCT01465997|65598202|FG000|Overall Study|subject left participation SP0993|0|||
23509103|NCT01465997|65598203|FG001|Overall Study|subject left participation SP0993|1|||
23509104|NCT01927367|65598204|FG000|Overall Study|Withdrawal by Subject|7|||
23509105|NCT01927367|65598205|FG001|Overall Study|Withdrawal by Subject|4|||
23509106|NCT01927367|65598204|FG000|Overall Study|No baseline data|0|||
23509107|NCT01927367|65598205|FG001|Overall Study|No baseline data|1|||
23509108|NCT02954237|65598212|FG000|Overall Study|Withdrawal by Subject|25|||
23509109|NCT02954237|65598212|FG000|Overall Study|Missed visit|16|||
23509110|NCT02954237|65598212|FG000|Overall Study|Death|2|||
23509111|NCT00743340|65598213|FG000|Overall Study|Study medication non-compliance|1|||
23509112|NCT00743340|65598213|FG000|Overall Study|Lost to Follow-up|1|||
23509113|NCT00743340|65598213|FG000|Overall Study|Withdrawal from the Study|5|||
23509114|NCT00743340|65598213|FG000|Overall Study|Protocol Violation|1|||
23509115|NCT00743340|65598213|FG000|Overall Study|Virologic failure|8|||
23509116|NCT00743340|65598213|FG000|Overall Study|Pregnancy|1|||
23509117|NCT00743340|65598213|FG000|Overall Study|Rolled over to other Gilead Study|23|||
23509118|NCT00743340|65598213|FG000|Overall Study|Participant Relocated|1|||
23509119|NCT00187486|65598214|FG000|Overall Study|Protocol Violation|1|||
23509120|NCT02270957|65598215|FG000|Overall Study|Lack of Efficacy|2|||
23509121|NCT02270957|65598216|FG001|Overall Study|Lack of Efficacy|4|||
23509122|NCT02270957|65598215|FG000|Overall Study|Adverse Event|2|||
23509123|NCT02270957|65598216|FG001|Overall Study|Adverse Event|0|||
23509124|NCT00320411|65601782|FG000|Overall Study|No investigational product admin.|4|||
23509125|NCT00726661|65601785|FG000|Overall Study|Lost to Follow-up|36|||
23509126|NCT00726661|65601786|FG001|Overall Study|Lost to Follow-up|11|||
23509127|NCT00726661|65601785|FG000|Overall Study|Withdrawal by Subject|17|||
23509128|NCT00726661|65601786|FG001|Overall Study|Withdrawal by Subject|13|||
23509129|NCT00726661|65601785|FG000|Overall Study|Trial terminated by sponsor|214|||
23509130|NCT00726661|65601786|FG001|Overall Study|Trial terminated by sponsor|187|||
23509131|NCT00726661|65601785|FG000|Overall Study|Death|475|||
23509132|NCT00726661|65601786|FG001|Overall Study|Death|159|||
23509133|NCT00726661|65601785|FG000|Overall Study|Physician Decision|25|||
23509134|NCT00726661|65601786|FG001|Overall Study|Physician Decision|13|||
23509135|NCT00726661|65601785|FG000|Overall Study|Other|47|||
23509136|NCT00726661|65601786|FG001|Overall Study|Other|35|||
23509137|NCT04900220|65601789|FG000|Overall Study|Lost to Follow-up|1|||
23509138|NCT04900220|65601790|FG001|Overall Study|Lost to Follow-up|1|||
23509139|NCT02196558|65601791|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
23509140|NCT02196558|65601792|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
23509141|NCT02196558|65601793|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
23509142|NCT02196558|65601791|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
23509143|NCT02196558|65601792|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
23509144|NCT02196558|65601793|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
23509145|NCT02196558|65601791|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
23509146|NCT02196558|65601792|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
23509147|NCT02196558|65601793|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
23509148|NCT02196558|65601791|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
23509149|NCT02196558|65601792|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
23509150|NCT02196558|65601793|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
23509151|NCT02196558|65601791|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
23509152|NCT02196558|65601792|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
23509153|NCT02196558|65601793|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
23509154|NCT01867424|65601797|FG000|Overall Study|Patient noncompliance|2|||
23509155|NCT01867424|65601798|FG001|Overall Study|Patient noncompliance|1|||
23509156|NCT01829191|65601801|FG000|Overall Study|Relocation|0|||
23509157|NCT01829191|65601802|FG001|Overall Study|Relocation|1|||
23509158|NCT01829191|65601801|FG000|Overall Study|Lens discomfort|0|||
23509159|NCT01829191|65601802|FG001|Overall Study|Lens discomfort|3|||
23509160|NCT01829191|65601801|FG000|Overall Study|Lens handling difficulty|1|||
23509161|NCT01829191|65601802|FG001|Overall Study|Lens handling difficulty|4|||
23509162|NCT01829191|65601801|FG000|Overall Study|Protocol Violation|4|||
23509163|NCT01829191|65601802|FG001|Overall Study|Protocol Violation|1|||
23509164|NCT01829191|65601801|FG000|Overall Study|Withdrawal by Subject|2|||
23509165|NCT01829191|65601802|FG001|Overall Study|Withdrawal by Subject|3|||
23509166|NCT01829191|65601801|FG000|Overall Study|Lost to Follow-up|0|||
23509167|NCT01829191|65601802|FG001|Overall Study|Lost to Follow-up|1|||
23509168|NCT01829191|65601801|FG000|Overall Study|Subject was fit for ortho - k|0|||
23509169|NCT01829191|65601802|FG001|Overall Study|Subject was fit for ortho - k|1|||
23509170|NCT00720434|65601806|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
23509171|NCT00720434|65601807|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
23509172|NCT00720434|65601808|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
23509173|NCT00720434|65601809|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
23509174|NCT00720434|65601806|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
23509175|NCT00720434|65601807|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
23509176|NCT00720434|65601808|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
23509177|NCT00720434|65601809|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
23509178|NCT00720434|65601806|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
23509179|NCT00720434|65601807|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
23509180|NCT00720434|65601808|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
23509181|NCT00720434|65601809|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
23509182|NCT00720434|65601806|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
23509183|NCT00720434|65601807|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
23509184|NCT00720434|65601808|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
23509185|NCT00720434|65601809|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
23509186|NCT00720434|65601806|FG000|Open-Label Period (Week 5-72)|Other|4|||
23509187|NCT00720434|65601807|FG001|Open-Label Period (Week 5-72)|Other|3|||
23509188|NCT00720434|65601808|FG002|Open-Label Period (Week 5-72)|Other|3|||
23509189|NCT00720434|65601809|FG003|Open-Label Period (Week 5-72)|Other|2|||
23509190|NCT01907815|65601811|FG000|Overall Study|Withdrawal by Subject|1|||
23509191|NCT01907815|65601812|FG001|Overall Study|Withdrawal by Subject|0|||
23509192|NCT03266094|65601813|FG000|Overall Study|Lost to Follow-up|1|||
23509193|NCT03266094|65601813|FG000|Overall Study|Withdrawal by Subject|1|||
23509194|NCT01214629|65601814|FG000|Overall Study|Progressive Disease|1|||
23509195|NCT01214629|65601815|FG001|Overall Study|Progressive Disease|1|||
23509196|NCT01214629|65601816|FG002|Overall Study|Progressive Disease|0|||
23509197|NCT01214629|65601817|FG003|Overall Study|Progressive Disease|1|||
23509198|NCT01214629|65601818|FG004|Overall Study|Progressive Disease|2|||
23509199|NCT01214629|65601819|FG005|Overall Study|Progressive Disease|3|||
23509200|NCT01214629|65601820|FG006|Overall Study|Progressive Disease|1|||
23509201|NCT01214629|65601821|FG007|Overall Study|Progressive Disease|1|||
23509202|NCT01214629|65601822|FG008|Overall Study|Progressive Disease|1|||
23509203|NCT01214629|65601823|FG009|Overall Study|Progressive Disease|5|||
23509204|NCT01214629|65601824|FG010|Overall Study|Progressive Disease|1|||
23509205|NCT01214629|65601814|FG000|Overall Study|Adverse Event|0|||
23509206|NCT01214629|65601815|FG001|Overall Study|Adverse Event|0|||
23509207|NCT01214629|65601816|FG002|Overall Study|Adverse Event|0|||
23509208|NCT01214629|65601817|FG003|Overall Study|Adverse Event|1|||
23509209|NCT01214629|65601818|FG004|Overall Study|Adverse Event|0|||
23509210|NCT01214629|65601819|FG005|Overall Study|Adverse Event|1|||
23509211|NCT01214629|65601820|FG006|Overall Study|Adverse Event|0|||
23509212|NCT01214629|65601821|FG007|Overall Study|Adverse Event|0|||
23509213|NCT01214629|65601822|FG008|Overall Study|Adverse Event|0|||
23509214|NCT01214629|65601823|FG009|Overall Study|Adverse Event|1|||
23509215|NCT01214629|65601824|FG010|Overall Study|Adverse Event|0|||
23509216|NCT01214629|65601814|FG000|Overall Study|Physician Decision|0|||
23509217|NCT01214629|65601815|FG001|Overall Study|Physician Decision|0|||
23509218|NCT01214629|65601816|FG002|Overall Study|Physician Decision|0|||
23509219|NCT01214629|65601817|FG003|Overall Study|Physician Decision|0|||
23509220|NCT01214629|65601818|FG004|Overall Study|Physician Decision|0|||
23509221|NCT01214629|65601819|FG005|Overall Study|Physician Decision|0|||
23509222|NCT01214629|65601820|FG006|Overall Study|Physician Decision|0|||
23509223|NCT01214629|65601821|FG007|Overall Study|Physician Decision|0|||
23509224|NCT01214629|65601822|FG008|Overall Study|Physician Decision|0|||
23509225|NCT01214629|65601823|FG009|Overall Study|Physician Decision|0|||
23509226|NCT01214629|65601824|FG010|Overall Study|Physician Decision|1|||
23509227|NCT01214629|65601814|FG000|Overall Study|Withdrawal by Subject|0|||
23509228|NCT01214629|65601815|FG001|Overall Study|Withdrawal by Subject|0|||
23509229|NCT01214629|65601816|FG002|Overall Study|Withdrawal by Subject|0|||
23509230|NCT01214629|65601817|FG003|Overall Study|Withdrawal by Subject|0|||
23509231|NCT01214629|65601818|FG004|Overall Study|Withdrawal by Subject|0|||
23509232|NCT01214629|65601819|FG005|Overall Study|Withdrawal by Subject|0|||
23509233|NCT01214629|65601820|FG006|Overall Study|Withdrawal by Subject|0|||
23509234|NCT01214629|65601821|FG007|Overall Study|Withdrawal by Subject|0|||
23509235|NCT01214629|65601822|FG008|Overall Study|Withdrawal by Subject|0|||
23509236|NCT01214629|65601823|FG009|Overall Study|Withdrawal by Subject|1|||
23509237|NCT01214629|65601824|FG010|Overall Study|Withdrawal by Subject|0|||
23509238|NCT01634360|65601825|FG000|Overall Study|Adverse Event|10|||
23509239|NCT01634360|65601826|FG001|Overall Study|Adverse Event|34|||
23509240|NCT01634360|65601825|FG000|Overall Study|subject withdrew consent|13|||
23509241|NCT01634360|65601826|FG001|Overall Study|subject withdrew consent|23|||
23509242|NCT01634360|65601825|FG000|Overall Study|Protocol Violation|1|||
23509243|NCT01634360|65601826|FG001|Overall Study|Protocol Violation|1|||
23509244|NCT01634360|65601825|FG000|Overall Study|Lack of Efficacy|4|||
23509245|NCT01634360|65601826|FG001|Overall Study|Lack of Efficacy|14|||
23509246|NCT01634360|65601825|FG000|Overall Study|Other|3|||
23509247|NCT01634360|65601826|FG001|Overall Study|Other|20|||
23509248|NCT01634360|65601825|FG000|Overall Study|Study termination by sponsor|18|||
23509249|NCT01634360|65601826|FG001|Overall Study|Study termination by sponsor|44|||
23509250|NCT02326025|65601828|FG000|Overall Study|Adverse Event|3|||
23509251|NCT02326025|65601829|FG001|Overall Study|Adverse Event|0|||
23509252|NCT02326025|65601828|FG000|Overall Study|Physician Decision|1|||
23509253|NCT02326025|65601829|FG001|Overall Study|Physician Decision|2|||
23509254|NCT02326025|65601828|FG000|Overall Study|Physician and Participant Decision|1|||
23509255|NCT02326025|65601829|FG001|Overall Study|Physician and Participant Decision|0|||
23509256|NCT02326025|65601828|FG000|Overall Study|Withdrawal by Subject|0|||
23509257|NCT02326025|65601829|FG001|Overall Study|Withdrawal by Subject|2|||
23509258|NCT02326025|65601828|FG000|Overall Study|Protocol Violation|0|||
23509259|NCT02326025|65601829|FG001|Overall Study|Protocol Violation|1|||
23509260|NCT00867009|65601830|FG000|Induction Period|Nonserious Adverse Event|5|||
23509261|NCT00867009|65601830|FG000|Induction Period|Serious Adverse Event|10|||
23509262|NCT00867009|65601830|FG000|Induction Period|Death due to serious adverse event|6|||
23509263|NCT00867009|65601830|FG000|Induction Period|Death due to Study Disease|4|||
23509264|NCT00867009|65601830|FG000|Induction Period|Protocol Violation|1|||
23509265|NCT00867009|65601830|FG000|Induction Period|Withdrawal by Subject|8|||
23509266|NCT00867009|65601830|FG000|Induction Period|Physician Decision|3|||
23509267|NCT00867009|65601830|FG000|Induction Period|Progressive Disease (PD)|25|||
23509268|NCT00867009|65601830|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
23509269|NCT00696696|65601833|FG000|Overall Study|Adverse Event|5|||
23509270|NCT00696696|65601833|FG000|Overall Study|Withdrawal by Subject|8|||
23509271|NCT00696696|65601833|FG000|Overall Study|Physician Decision|2|||
23509272|NCT00696696|65601833|FG000|Overall Study|Death|3|||
23509273|NCT00885105|65601836|FG000|Overall Study|Withdrawal by Subject|0|||
23509274|NCT00885105|65601837|FG001|Overall Study|Withdrawal by Subject|8|||
23509275|NCT00885105|65601836|FG000|Overall Study|Adverse Event|1|||
23509276|NCT00885105|65601837|FG001|Overall Study|Adverse Event|0|||
23509277|NCT00885105|65601836|FG000|Overall Study|Protocol Violation|0|||
23509278|NCT00885105|65601837|FG001|Overall Study|Protocol Violation|2|||
23509279|NCT02205814|65601840|FG000|Overall Study|Lost to Follow-up|0|||
23509280|NCT02205814|65601841|FG001|Overall Study|Lost to Follow-up|0|||
23509281|NCT02205814|65601842|FG002|Overall Study|Lost to Follow-up|0|||
23509282|NCT02205814|65601843|FG003|Overall Study|Lost to Follow-up|1|||
23509283|NCT02205814|65601840|FG000|Overall Study|Lack of Efficacy|1|||
23509284|NCT02205814|65601841|FG001|Overall Study|Lack of Efficacy|0|||
23509285|NCT02205814|65601842|FG002|Overall Study|Lack of Efficacy|1|||
23509286|NCT02205814|65601843|FG003|Overall Study|Lack of Efficacy|1|||
23509287|NCT02205814|65601840|FG000|Overall Study|Physician Decision|0|||
23509288|NCT02205814|65601841|FG001|Overall Study|Physician Decision|0|||
23509289|NCT02205814|65601842|FG002|Overall Study|Physician Decision|1|||
23509290|NCT02205814|65601843|FG003|Overall Study|Physician Decision|0|||
23509291|NCT02205814|65601840|FG000|Overall Study|Protocol Violation|1|||
23509292|NCT02205814|65601841|FG001|Overall Study|Protocol Violation|0|||
23509293|NCT02205814|65601842|FG002|Overall Study|Protocol Violation|0|||
23509294|NCT02205814|65601843|FG003|Overall Study|Protocol Violation|1|||
23509295|NCT02205814|65601840|FG000|Overall Study|Withdrawal by Subject|0|||
23509296|NCT02205814|65601841|FG001|Overall Study|Withdrawal by Subject|1|||
23509297|NCT02205814|65601842|FG002|Overall Study|Withdrawal by Subject|2|||
23509298|NCT02205814|65601843|FG003|Overall Study|Withdrawal by Subject|1|||
23509299|NCT02205814|65601840|FG000|Overall Study|not compliant with study procedures|0|||
23509300|NCT02205814|65601841|FG001|Overall Study|not compliant with study procedures|0|||
23509301|NCT02205814|65601842|FG002|Overall Study|not compliant with study procedures|1|||
23509302|NCT02205814|65601843|FG003|Overall Study|not compliant with study procedures|0|||
23509303|NCT03402386|65601844|FG000|Overall Study|Adverse Event|3|||
23509304|NCT03402386|65601844|FG000|Overall Study|Physician Decision|1|||
23509305|NCT03402386|65601844|FG000|Overall Study|Difficult to control Hb|2|||
23509306|NCT03902574|65601848|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
23509307|NCT03902574|65601849|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
23509308|NCT03902574|65601850|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
23509309|NCT00573469|65601853|FG000|Overall Study|Adverse Event|1|||
23509310|NCT00573469|65601854|FG001|Overall Study|Adverse Event|1|||
23509311|NCT00573469|65601855|FG002|Overall Study|Adverse Event|1|||
23509312|NCT00573469|65601853|FG000|Overall Study|Withdrawal by Subject|0|||
23509313|NCT00573469|65601854|FG001|Overall Study|Withdrawal by Subject|2|||
23509314|NCT00573469|65601855|FG002|Overall Study|Withdrawal by Subject|0|||
23509315|NCT00573469|65601853|FG000|Overall Study|Other|5|||
23509316|NCT00573469|65601854|FG001|Overall Study|Other|1|||
23509317|NCT00573469|65601855|FG002|Overall Study|Other|3|||
23509318|NCT00837811|65601856|FG000|Overall Study|Adverse Event|4|||
23509319|NCT00837811|65601857|FG001|Overall Study|Adverse Event|6|||
23509320|NCT00837811|65601858|FG002|Overall Study|Adverse Event|0|||
23509321|NCT00837811|65601856|FG000|Overall Study|Death|1|||
23509322|NCT00837811|65601857|FG001|Overall Study|Death|1|||
23509323|NCT00837811|65601858|FG002|Overall Study|Death|0|||
23509324|NCT00837811|65601856|FG000|Overall Study|Lack of Efficacy|0|||
23509325|NCT00837811|65601857|FG001|Overall Study|Lack of Efficacy|11|||
23509326|NCT00837811|65601858|FG002|Overall Study|Lack of Efficacy|0|||
23509327|NCT00837811|65601856|FG000|Overall Study|Lost to Follow-up|1|||
23607397|NCT00696241|65950690|FG002|Overall Study|Protocol Violation|2|||
23607398|NCT00696241|65950691|FG003|Overall Study|Protocol Violation|0|||
23607399|NCT00696241|65950692|FG004|Overall Study|Protocol Violation|3|||
23607400|NCT00696241|65950688|FG000|Overall Study|Lost to Follow-up|1|||
23607401|NCT00696241|65950689|FG001|Overall Study|Lost to Follow-up|4|||
23607402|NCT00696241|65950690|FG002|Overall Study|Lost to Follow-up|1|||
23607403|NCT00696241|65950691|FG003|Overall Study|Lost to Follow-up|2|||
23607404|NCT00696241|65950692|FG004|Overall Study|Lost to Follow-up|0|||
23607405|NCT00696241|65950688|FG000|Overall Study|Withdrawal by Subject|4|||
23607406|NCT00696241|65950689|FG001|Overall Study|Withdrawal by Subject|8|||
23607407|NCT00696241|65950690|FG002|Overall Study|Withdrawal by Subject|6|||
23607408|NCT00696241|65950691|FG003|Overall Study|Withdrawal by Subject|1|||
23607409|NCT00696241|65950692|FG004|Overall Study|Withdrawal by Subject|0|||
23607410|NCT00696241|65950688|FG000|Overall Study|Lack of Efficacy|1|||
23607411|NCT00696241|65950689|FG001|Overall Study|Lack of Efficacy|5|||
23607412|NCT00696241|65950690|FG002|Overall Study|Lack of Efficacy|4|||
23607413|NCT00696241|65950691|FG003|Overall Study|Lack of Efficacy|5|||
23607414|NCT00696241|65950692|FG004|Overall Study|Lack of Efficacy|3|||
23607415|NCT00696241|65950688|FG000|Overall Study|Other|6|||
23607416|NCT00696241|65950689|FG001|Overall Study|Other|1|||
23607417|NCT00696241|65950690|FG002|Overall Study|Other|5|||
23607418|NCT00696241|65950691|FG003|Overall Study|Other|2|||
23607419|NCT00696241|65950692|FG004|Overall Study|Other|1|||
23607420|NCT02006641|65950694|FG000|Overall Study|Withdrawal before treatment|2|||
23607421|NCT02006641|65950695|FG001|Overall Study|Withdrawal before treatment|5|||
23607422|NCT02006641|65950696|FG002|Overall Study|Withdrawal before treatment|3|||
23607423|NCT02006641|65950694|FG000|Overall Study|Adverse Event|15|||
23607424|NCT02006641|65950695|FG001|Overall Study|Adverse Event|11|||
23607425|NCT02006641|65950696|FG002|Overall Study|Adverse Event|15|||
23509328|NCT00837811|65601857|FG001|Overall Study|Lost to Follow-up|3|||
23509329|NCT00837811|65601858|FG002|Overall Study|Lost to Follow-up|0|||
23509330|NCT00837811|65601856|FG000|Overall Study|Physician Decision|0|||
23509331|NCT00837811|65601857|FG001|Overall Study|Physician Decision|2|||
23509332|NCT00837811|65601858|FG002|Overall Study|Physician Decision|1|||
23509333|NCT00837811|65601856|FG000|Overall Study|Withdrawal by Subject|1|||
23509334|NCT00837811|65601857|FG001|Overall Study|Withdrawal by Subject|9|||
23509335|NCT00837811|65601858|FG002|Overall Study|Withdrawal by Subject|0|||
23509336|NCT00837811|65601856|FG000|Overall Study|Sponsor Decision|0|||
23607426|NCT02006641|65950694|FG000|Overall Study|Protocol Violation|0|||
23607427|NCT02006641|65950695|FG001|Overall Study|Protocol Violation|2|||
23607428|NCT02006641|65950696|FG002|Overall Study|Protocol Violation|2|||
23607429|NCT02006641|65950694|FG000|Overall Study|Lost to Follow-up|0|||
23607430|NCT02006641|65950695|FG001|Overall Study|Lost to Follow-up|1|||
23607431|NCT02006641|65950696|FG002|Overall Study|Lost to Follow-up|0|||
23509337|NCT00837811|65601857|FG001|Overall Study|Sponsor Decision|2|||
23509338|NCT00837811|65601858|FG002|Overall Study|Sponsor Decision|0|||
23509339|NCT01366521|65601859|FG000|Overall Study|Adverse Event|1|||
23509340|NCT01366521|65601860|FG001|Overall Study|Adverse Event|0|||
23509341|NCT01366521|65601861|FG002|Overall Study|Adverse Event|0|||
23509342|NCT01366521|65601862|FG003|Overall Study|Adverse Event|0|||
23509343|NCT01366521|65601859|FG000|Overall Study|Protocol Violation|0|||
23607432|NCT02006641|65950694|FG000|Overall Study|Withdrawal by Subject|7|||
23607433|NCT02006641|65950695|FG001|Overall Study|Withdrawal by Subject|12|||
23607434|NCT02006641|65950696|FG002|Overall Study|Withdrawal by Subject|11|||
23607435|NCT02006641|65950694|FG000|Overall Study|Other reason: patient didn't show up|1|||
23607436|NCT02006641|65950695|FG001|Overall Study|Other reason: patient didn't show up|0|||
23607437|NCT02006641|65950696|FG002|Overall Study|Other reason: patient didn't show up|0|||
23607438|NCT02006641|65950694|FG000|Overall Study|Other reason:patient didn't want to come|0|||
23509344|NCT01366521|65601860|FG001|Overall Study|Protocol Violation|0|||
23509345|NCT01366521|65601861|FG002|Overall Study|Protocol Violation|1|||
23509346|NCT01366521|65601862|FG003|Overall Study|Protocol Violation|0|||
23509347|NCT01366521|65601859|FG000|Overall Study|Physician Decision|0|||
23509348|NCT01366521|65601860|FG001|Overall Study|Physician Decision|0|||
23509349|NCT01366521|65601861|FG002|Overall Study|Physician Decision|1|||
23509350|NCT01366521|65601862|FG003|Overall Study|Physician Decision|0|||
23509351|NCT01366521|65601859|FG000|Overall Study|Withdrawal by Subject|0|||
23509352|NCT01366521|65601860|FG001|Overall Study|Withdrawal by Subject|1|||
23509353|NCT01366521|65601861|FG002|Overall Study|Withdrawal by Subject|0|||
23509354|NCT01366521|65601862|FG003|Overall Study|Withdrawal by Subject|0|||
23509355|NCT01291173|65601863|FG000|Overall Study|Adverse Event|0|||
23607439|NCT02006641|65950695|FG001|Overall Study|Other reason:patient didn't want to come|0|||
23607440|NCT02006641|65950696|FG002|Overall Study|Other reason:patient didn't want to come|1|||
23607441|NCT02006641|65950694|FG000|Overall Study|Other reason: patient has moved|1|||
23607442|NCT02006641|65950695|FG001|Overall Study|Other reason: patient has moved|0|||
23607443|NCT02006641|65950696|FG002|Overall Study|Other reason: patient has moved|1|||
23607444|NCT02006641|65950694|FG000|Overall Study|Other reason: caregiver in hospital|0|||
23607445|NCT02006641|65950695|FG001|Overall Study|Other reason: caregiver in hospital|1|||
23607446|NCT02006641|65950696|FG002|Overall Study|Other reason: caregiver in hospital|0|||
23607447|NCT02006641|65950694|FG000|Overall Study|Other reason: patient's wife has died|0|||
23607448|NCT02006641|65950695|FG001|Overall Study|Other reason: patient's wife has died|0|||
23607449|NCT02006641|65950696|FG002|Overall Study|Other reason: patient's wife has died|1|||
23607450|NCT02006641|65950694|FG000|Overall Study|Other reason: hospitalisation|0|||
23607451|NCT02006641|65950695|FG001|Overall Study|Other reason: hospitalisation|1|||
23607452|NCT02006641|65950696|FG002|Overall Study|Other reason: hospitalisation|0|||
23607453|NCT02006641|65950694|FG000|Overall Study|Other reason: caregiver impossibility|0|||
23607454|NCT02006641|65950695|FG001|Overall Study|Other reason: caregiver impossibility|0|||
23607455|NCT02006641|65950696|FG002|Overall Study|Other reason: caregiver impossibility|1|||
23607456|NCT02006641|65950694|FG000|Overall Study|Other reason: protocol non-compliance|0|||
23607457|NCT02006641|65950695|FG001|Overall Study|Other reason: protocol non-compliance|0|||
23607458|NCT02006641|65950696|FG002|Overall Study|Other reason: protocol non-compliance|1|||
23607459|NCT03456856|65950699|FG000|Overall Study|Lost to Follow-up|2|||
23607460|NCT03456856|65950699|FG000|Overall Study|Withdrawal by Subject|1|||
23607461|NCT03065400|65950704|FG000|Overall Study|Adverse Event|1|||
23607462|NCT03065400|65950704|FG000|Overall Study|Physician Decision|3|||
23607463|NCT03065400|65950704|FG000|Overall Study|Withdrawal by Subject|1|||
23607464|NCT03065400|65950704|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
23607465|NCT02106884|65950715|FG000|Overall Study|Change of diagnosis/exclusion|0|||
23607466|NCT02106884|65950716|FG001|Overall Study|Change of diagnosis/exclusion|1|||
23607467|NCT03442777|65950719|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
23607468|NCT03442777|65950720|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
23607469|NCT03442777|65950721|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
23607470|NCT00878189|65950722|FG000|Overall Study|Death|0|||
23607471|NCT00878189|65950723|FG001|Overall Study|Death|1|||
23607472|NCT00878189|65950724|FG002|Overall Study|Death|0|||
23607473|NCT00878189|65950725|FG003|Overall Study|Death|1|||
23607474|NCT00878189|65950726|FG004|Overall Study|Death|0|||
23607475|NCT00878189|65950727|FG005|Overall Study|Death|0|||
23607476|NCT00878189|65950728|FG006|Overall Study|Death|0|||
23607477|NCT00878189|65950729|FG007|Overall Study|Death|0|||
23607478|NCT00878189|65950730|FG008|Overall Study|Death|1|||
23408566|NCT03782259|65239924|FG001|Overall Study|Lost to Follow-up|1|||
23509356|NCT01291173|65601864|FG001|Overall Study|Adverse Event|3|||
23509357|NCT01291173|65601865|FG002|Overall Study|Adverse Event|1|||
23509358|NCT01291173|65601866|FG003|Overall Study|Adverse Event|3|||
23509359|NCT01291173|65601863|FG000|Overall Study|Protocol Violation|7|||
23509360|NCT01291173|65601864|FG001|Overall Study|Protocol Violation|2|||
23509361|NCT01291173|65601865|FG002|Overall Study|Protocol Violation|2|||
23509362|NCT01291173|65601866|FG003|Overall Study|Protocol Violation|5|||
23509363|NCT01291173|65601863|FG000|Overall Study|Withdrawal by Subject|6|||
23509364|NCT01291173|65601864|FG001|Overall Study|Withdrawal by Subject|4|||
23509365|NCT01291173|65601865|FG002|Overall Study|Withdrawal by Subject|4|||
23509366|NCT01291173|65601866|FG003|Overall Study|Withdrawal by Subject|2|||
23509367|NCT01291173|65601863|FG000|Overall Study|Lost to Follow-up|4|||
23509368|NCT01291173|65601864|FG001|Overall Study|Lost to Follow-up|6|||
23607479|NCT00878189|65950722|FG000|Overall Study|Participant Refused to Follow-up|0|||
23607480|NCT00878189|65950723|FG001|Overall Study|Participant Refused to Follow-up|0|||
23607481|NCT00878189|65950724|FG002|Overall Study|Participant Refused to Follow-up|0|||
23607482|NCT00878189|65950725|FG003|Overall Study|Participant Refused to Follow-up|0|||
23607483|NCT00878189|65950726|FG004|Overall Study|Participant Refused to Follow-up|0|||
23607484|NCT00878189|65950727|FG005|Overall Study|Participant Refused to Follow-up|4|||
23607485|NCT00878189|65950728|FG006|Overall Study|Participant Refused to Follow-up|0|||
23607486|NCT00878189|65950729|FG007|Overall Study|Participant Refused to Follow-up|0|||
23607487|NCT00878189|65950730|FG008|Overall Study|Participant Refused to Follow-up|0|||
23607488|NCT00878189|65950722|FG000|Overall Study|Other|3|||
23607489|NCT00878189|65950723|FG001|Overall Study|Other|2|||
23607490|NCT00878189|65950724|FG002|Overall Study|Other|4|||
23607491|NCT00878189|65950725|FG003|Overall Study|Other|7|||
23607492|NCT00878189|65950726|FG004|Overall Study|Other|4|||
23607493|NCT00878189|65950727|FG005|Overall Study|Other|18|||
23607494|NCT00878189|65950728|FG006|Overall Study|Other|15|||
23607495|NCT00878189|65950729|FG007|Overall Study|Other|3|||
23607496|NCT00878189|65950730|FG008|Overall Study|Other|4|||
23607497|NCT00878189|65950722|FG000|Overall Study|Lost to Follow-up|0|||
23607498|NCT00878189|65950723|FG001|Overall Study|Lost to Follow-up|0|||
23607499|NCT00878189|65950724|FG002|Overall Study|Lost to Follow-up|0|||
23607500|NCT00878189|65950725|FG003|Overall Study|Lost to Follow-up|0|||
23607501|NCT00878189|65950726|FG004|Overall Study|Lost to Follow-up|0|||
23607502|NCT00878189|65950727|FG005|Overall Study|Lost to Follow-up|1|||
23607503|NCT00878189|65950728|FG006|Overall Study|Lost to Follow-up|1|||
23607504|NCT00878189|65950729|FG007|Overall Study|Lost to Follow-up|0|||
23607505|NCT00878189|65950730|FG008|Overall Study|Lost to Follow-up|0|||
23607506|NCT00878189|65950722|FG000|Overall Study|Objection Progression or Relapse|0|||
23607507|NCT00878189|65950723|FG001|Overall Study|Objection Progression or Relapse|0|||
23607508|NCT00878189|65950724|FG002|Overall Study|Objection Progression or Relapse|0|||
23607509|NCT00878189|65950725|FG003|Overall Study|Objection Progression or Relapse|0|||
23607510|NCT00878189|65950726|FG004|Overall Study|Objection Progression or Relapse|0|||
23607511|NCT00878189|65950727|FG005|Overall Study|Objection Progression or Relapse|0|||
23607512|NCT00878189|65950728|FG006|Overall Study|Objection Progression or Relapse|0|||
23607513|NCT00878189|65950729|FG007|Overall Study|Objection Progression or Relapse|0|||
23607514|NCT00878189|65950730|FG008|Overall Study|Objection Progression or Relapse|3|||
23607515|NCT01380145|65950732|FG000|Overall Study|Progressive disease|4|||
23607516|NCT01661972|65950733|FG000|Overall Study|Adverse Event|1|||
23607517|NCT01661972|65950734|FG001|Overall Study|Adverse Event|2|||
23607518|NCT01661972|65950733|FG000|Overall Study|Death during Treatment period|1|||
23607519|NCT01661972|65950734|FG001|Overall Study|Death during Treatment period|1|||
23607520|NCT01661972|65950733|FG000|Overall Study|Withdrawal by Subject|0|||
23607521|NCT01661972|65950734|FG001|Overall Study|Withdrawal by Subject|1|||
23607522|NCT01186809|65950738|FG000|Overall Study|Death|30|||
23607523|NCT01019135|65950739|FG000|Overall Study|Did not receive allocated intervention|12|||
23607524|NCT01019135|65950740|FG001|Overall Study|Did not receive allocated intervention|6|||
23607525|NCT01019135|65950741|FG002|Overall Study|Did not receive allocated intervention|25|||
23607526|NCT01019135|65950739|FG000|Overall Study|Did not attend CR|8|||
23607527|NCT01019135|65950740|FG001|Overall Study|Did not attend CR|13|||
23607528|NCT01019135|65950741|FG002|Overall Study|Did not attend CR|6|||
23607529|NCT00448344|65953390|FG000|Overall Study|Lost to Follow-up|20|||
23607530|NCT00448344|65953391|FG001|Overall Study|Lost to Follow-up|22|||
23607531|NCT00448344|65953390|FG000|Overall Study|Withdrawal by Subject|6|||
23607532|NCT00448344|65953391|FG001|Overall Study|Withdrawal by Subject|8|||
23607533|NCT00448344|65953390|FG000|Overall Study|Death|3|||
23607534|NCT00448344|65953391|FG001|Overall Study|Death|4|||
23607535|NCT00448344|65953390|FG000|Overall Study|Physician Decision|1|||
23509369|NCT01291173|65601865|FG002|Overall Study|Lost to Follow-up|3|||
23509370|NCT01291173|65601866|FG003|Overall Study|Lost to Follow-up|2|||
23607536|NCT00448344|65953391|FG001|Overall Study|Physician Decision|2|||
23607537|NCT00442559|65953393|FG000|Overall Study|Lost to Follow-up|32|||
23607538|NCT00442559|65953394|FG001|Overall Study|Lost to Follow-up|34|||
23607539|NCT00442559|65953393|FG000|Overall Study|Protocol Violation|1|||
23607540|NCT00442559|65953394|FG001|Overall Study|Protocol Violation|1|||
23607541|NCT00442559|65953393|FG000|Overall Study|Withdrawal by Subject|1|||
23509371|NCT01291173|65601863|FG000|Overall Study|Unable to meet visit schedule|0|||
23607542|NCT00442559|65953394|FG001|Overall Study|Withdrawal by Subject|0|||
23509372|NCT01291173|65601864|FG001|Overall Study|Unable to meet visit schedule|0|||
23509373|NCT01291173|65601865|FG002|Overall Study|Unable to meet visit schedule|1|||
23607543|NCT02095145|65953395|FG000|Overall Study|Withdrawal by Subject|1|||
23607544|NCT02095145|65953396|FG001|Overall Study|Withdrawal by Subject|0|||
23607545|NCT04237792|65953400|FG000|Treatment (Day 1)|Adverse Event|1|||
23607546|NCT04237792|65953401|FG001|Treatment (Day 1)|Adverse Event|0|||
23607547|NCT04237792|65953402|FG002|Treatment (Day 1)|Adverse Event|0|||
23607548|NCT04237792|65953403|FG003|Treatment (Day 1)|Adverse Event|0|||
23607549|NCT04237792|65953404|FG004|Treatment (Day 1)|Adverse Event|1|||
23607550|NCT04237792|65953405|FG005|Treatment (Day 1)|Adverse Event|1|||
23607551|NCT04237792|65953400|FG000|Treatment (Day 1)|Other|0|||
23607552|NCT04237792|65953401|FG001|Treatment (Day 1)|Other|0|||
23607553|NCT04237792|65953402|FG002|Treatment (Day 1)|Other|1|||
23607554|NCT04237792|65953403|FG003|Treatment (Day 1)|Other|0|||
23607555|NCT04237792|65953404|FG004|Treatment (Day 1)|Other|0|||
23607556|NCT04237792|65953405|FG005|Treatment (Day 1)|Other|1|||
23607557|NCT04237792|65953400|FG000|Treatment (Day 1)|Not treated|1|||
23607558|NCT04237792|65953401|FG001|Treatment (Day 1)|Not treated|1|||
23607559|NCT04237792|65953402|FG002|Treatment (Day 1)|Not treated|2|||
23607560|NCT04237792|65953403|FG003|Treatment (Day 1)|Not treated|1|||
23607561|NCT04237792|65953404|FG004|Treatment (Day 1)|Not treated|0|||
23607562|NCT04237792|65953405|FG005|Treatment (Day 1)|Not treated|1|||
23607563|NCT01294644|65953406|FG000|Overall Study|Adverse Event|2|||
23607564|NCT01294644|65953407|FG001|Overall Study|Adverse Event|0|||
23607565|NCT01294644|65953408|FG002|Overall Study|Adverse Event|1|||
23607566|NCT01294644|65953406|FG000|Overall Study|Withdrawal by Subject|3|||
23607567|NCT01294644|65953407|FG001|Overall Study|Withdrawal by Subject|7|||
23607568|NCT01294644|65953408|FG002|Overall Study|Withdrawal by Subject|4|||
23607569|NCT01294644|65953406|FG000|Overall Study|Lost to Follow-up|3|||
23509374|NCT01291173|65601866|FG003|Overall Study|Unable to meet visit schedule|0|||
23509375|NCT01291173|65601863|FG000|Overall Study|Lack of compliance|0|||
23509376|NCT01291173|65601864|FG001|Overall Study|Lack of compliance|0|||
23509377|NCT01291173|65601865|FG002|Overall Study|Lack of compliance|0|||
23509378|NCT01291173|65601866|FG003|Overall Study|Lack of compliance|1|||
23509379|NCT01291173|65601863|FG000|Overall Study|Subject was unblinded|0|||
23509380|NCT01291173|65601864|FG001|Overall Study|Subject was unblinded|0|||
23509381|NCT01291173|65601865|FG002|Overall Study|Subject was unblinded|1|||
23509382|NCT01291173|65601866|FG003|Overall Study|Subject was unblinded|0|||
23509383|NCT01291173|65601863|FG000|Overall Study|Excluded therapy|0|||
23509384|NCT01291173|65601864|FG001|Overall Study|Excluded therapy|0|||
23509385|NCT01291173|65601865|FG002|Overall Study|Excluded therapy|1|||
23509386|NCT01291173|65601866|FG003|Overall Study|Excluded therapy|0|||
23509387|NCT01532414|65601869|FG000|Overall Study|Lost to Follow-up|3|||
23509388|NCT01532414|65601870|FG001|Overall Study|Lost to Follow-up|0|||
23509389|NCT01532414|65601871|FG002|Overall Study|Lost to Follow-up|1|||
23509390|NCT01532414|65601869|FG000|Overall Study|Withdrawal by Subject|3|||
23509391|NCT01532414|65601870|FG001|Overall Study|Withdrawal by Subject|0|||
23509392|NCT01532414|65601871|FG002|Overall Study|Withdrawal by Subject|0|||
23509393|NCT01532414|65601869|FG000|Overall Study|No V6 semen sample|0|||
23509394|NCT01532414|65601870|FG001|Overall Study|No V6 semen sample|1|||
23509395|NCT01532414|65601871|FG002|Overall Study|No V6 semen sample|0|||
23509396|NCT01532414|65601869|FG000|Overall Study|Adverse Event|0|||
23509397|NCT01532414|65601870|FG001|Overall Study|Adverse Event|1|||
23509398|NCT01532414|65601871|FG002|Overall Study|Adverse Event|1|||
23509399|NCT01532414|65601869|FG000|Overall Study|Unable to complete 24 hour PK|0|||
23509400|NCT01532414|65601870|FG001|Overall Study|Unable to complete 24 hour PK|0|||
23509401|NCT01532414|65601871|FG002|Overall Study|Unable to complete 24 hour PK|1|||
23509402|NCT01532414|65601869|FG000|Overall Study|Withdrawn by sponsor|1|||
23509403|NCT01532414|65601870|FG001|Overall Study|Withdrawn by sponsor|0|||
23509404|NCT01532414|65601871|FG002|Overall Study|Withdrawn by sponsor|0|||
23509405|NCT02056340|65601872|FG000|Overall Study|Lost to Follow-up|5|||
23509406|NCT02056340|65601873|FG001|Overall Study|Lost to Follow-up|5|||
23509407|NCT02056340|65601872|FG000|Overall Study|Withdrawal by Subject|2|||
23607570|NCT01294644|65953407|FG001|Overall Study|Lost to Follow-up|2|||
23607571|NCT01294644|65953408|FG002|Overall Study|Lost to Follow-up|5|||
23607572|NCT01294644|65953406|FG000|Overall Study|Miscellaneous Reason|2|||
23607573|NCT01294644|65953407|FG001|Overall Study|Miscellaneous Reason|1|||
23509408|NCT02056340|65601873|FG001|Overall Study|Withdrawal by Subject|6|||
23509409|NCT01482884|65601874|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
23509410|NCT01482884|65601875|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
23607574|NCT01294644|65953408|FG002|Overall Study|Miscellaneous Reason|4|||
23607575|NCT00392197|65953409|FG000|Overall Study|Adverse Event|4|||
23509411|NCT01482884|65601874|FG000|Overall Study|Protocol Violation|1|||
23509412|NCT01482884|65601875|FG001|Overall Study|Protocol Violation|0|||
23509413|NCT01482884|65601874|FG000|Overall Study|Lost to Follow-up|2|||
23509414|NCT01482884|65601875|FG001|Overall Study|Lost to Follow-up|2|||
23509415|NCT01482884|65601874|FG000|Overall Study|Lack of Efficacy|0|||
23509416|NCT01482884|65601875|FG001|Overall Study|Lack of Efficacy|1|||
23607576|NCT00392197|65953410|FG001|Overall Study|Adverse Event|12|||
23607577|NCT00392197|65953409|FG000|Overall Study|Lack of Efficacy|3|||
23607578|NCT00392197|65953410|FG001|Overall Study|Lack of Efficacy|4|||
23607579|NCT00392197|65953409|FG000|Overall Study|Lost to Follow-up|0|||
23607580|NCT00392197|65953410|FG001|Overall Study|Lost to Follow-up|1|||
23607581|NCT00392197|65953409|FG000|Overall Study|Physician Decision|3|||
23607582|NCT00392197|65953410|FG001|Overall Study|Physician Decision|2|||
23607583|NCT00392197|65953409|FG000|Overall Study|Protocol Violation|7|||
23607584|NCT00392197|65953410|FG001|Overall Study|Protocol Violation|5|||
23607585|NCT00392197|65953409|FG000|Overall Study|Withdrawal by Subject|4|||
23607586|NCT00392197|65953410|FG001|Overall Study|Withdrawal by Subject|6|||
23607587|NCT00824850|65953411|FG000|Overall Study|Withdrawal by Subject|0|||
23607588|NCT00824850|65953412|FG001|Overall Study|Withdrawal by Subject|1|||
23607589|NCT02713594|65953413|FG000|Overall Study|Withdrawal by Subject|32|||
23607590|NCT02713594|65953414|FG001|Overall Study|Withdrawal by Subject|22|||
23509417|NCT01482884|65601874|FG000|Overall Study|Adverse Event|2|||
23509418|NCT01482884|65601875|FG001|Overall Study|Adverse Event|1|||
23509419|NCT01482884|65601874|FG000|Overall Study|Withdrawal by Subject|8|||
23509420|NCT01482884|65601875|FG001|Overall Study|Withdrawal by Subject|13|||
23509421|NCT00684593|65601876|FG000|Overall Study|Adverse Event|0|||
23509422|NCT00684593|65601877|FG001|Overall Study|Adverse Event|2|||
23607591|NCT02713594|65953413|FG000|Overall Study|Lost to Follow-up|358|||
23607592|NCT02713594|65953414|FG001|Overall Study|Lost to Follow-up|374|||
23607593|NCT01190436|65953415|FG000|Overall Study|Lost to Follow-up|35|||
23607594|NCT01190436|65953415|FG000|Overall Study|Other|4|||
23607595|NCT00220805|65953422|FG000|Overall Study|Adverse Event|1|||
23607596|NCT00220805|65953423|FG001|Overall Study|Adverse Event|3|||
23607597|NCT00220805|65953422|FG000|Overall Study|Withdrawal by Subject|3|||
23607598|NCT00220805|65953423|FG001|Overall Study|Withdrawal by Subject|0|||
23607599|NCT00220805|65953422|FG000|Overall Study|Lack of Efficacy|1|||
23607600|NCT00220805|65953423|FG001|Overall Study|Lack of Efficacy|0|||
23607601|NCT00220805|65953422|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
23607602|NCT00220805|65953423|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
23607603|NCT04710576|65953424|FG000|Overall Study|Participants still in the study|73|||
23607604|NCT04710576|65953425|FG001|Overall Study|Participants still in the study|70|||
23509423|NCT02468414|65601878|FG000|Overall Study|Early Study Termination by Sponsor|1|||
23607605|NCT04710576|65953426|FG002|Overall Study|Participants still in the study|60|||
23607606|NCT04710576|65953424|FG000|Overall Study|Death|2|||
23607607|NCT04710576|65953425|FG001|Overall Study|Death|7|||
23607608|NCT04710576|65953426|FG002|Overall Study|Death|12|||
23607609|NCT04710576|65953424|FG000|Overall Study|Withdrawal by Subject|4|||
23607610|NCT04710576|65953425|FG001|Overall Study|Withdrawal by Subject|3|||
23607611|NCT04710576|65953426|FG002|Overall Study|Withdrawal by Subject|7|||
23607612|NCT04710576|65953424|FG000|Overall Study|Sponsor decision|1|||
23607613|NCT04710576|65953425|FG001|Overall Study|Sponsor decision|0|||
23607614|NCT04710576|65953426|FG002|Overall Study|Sponsor decision|0|||
23607615|NCT01613599|65953427|FG000|Overall Study|Death|9|||
23607616|NCT01613599|65953427|FG000|Overall Study|Lost to Follow-up|5|||
23607617|NCT01613599|65953427|FG000|Overall Study|Withdrawal by Subject|8|||
23607618|NCT01613599|65953427|FG000|Overall Study|Reason not specified|3|||
23607619|NCT01640288|65953428|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
23607620|NCT01640288|65953429|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
23607621|NCT01640288|65953428|FG000|Overall Study|Screen Failure|20|||
23607622|NCT01640288|65953429|FG001|Overall Study|Screen Failure|18|||
23607623|NCT01640288|65953428|FG000|Overall Study|Withdrawn by PI|5|||
23607624|NCT01640288|65953429|FG001|Overall Study|Withdrawn by PI|0|||
23607625|NCT01640288|65953428|FG000|Overall Study|Withdrawal by Subject|1|||
23607626|NCT01640288|65953429|FG001|Overall Study|Withdrawal by Subject|0|||
23607627|NCT01334606|65953432|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
23607628|NCT01428583|65953435|FG000|Overall Study|Adverse Event|75|||
23607629|NCT01428583|65953435|FG000|Overall Study|Withdrawal by Subject|51|||
23607630|NCT01428583|65953435|FG000|Overall Study|Lack of Efficacy|37|||
23607631|NCT01428583|65953435|FG000|Overall Study|Lost to Follow-up|17|||
23607632|NCT01428583|65953435|FG000|Overall Study|Death|1|||
23607633|NCT01428583|65953435|FG000|Overall Study|Pregnancy|1|||
23607634|NCT01428583|65953435|FG000|Overall Study|Protocol Violation|1|||
23607635|NCT01428583|65953435|FG000|Overall Study|Physician Decision|12|||
23607636|NCT01428583|65953435|FG000|Overall Study|Non-compliant|25|||
23607637|NCT01428583|65953435|FG000|Overall Study|Confirmed positive urine drug test|8|||
23607638|NCT01428583|65953435|FG000|Overall Study|Sponsor's request|3|||
23607639|NCT01428583|65953435|FG000|Overall Study|Other|6|||
23607640|NCT05260437|65953443|FG000|Overall Study|Lost to Follow-up|5|||
23509424|NCT02468414|65601879|FG001|Overall Study|Early Study Termination by Sponsor|0|||
23509425|NCT02468414|65601878|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
23607641|NCT05260437|65953444|FG001|Overall Study|Lost to Follow-up|2|||
23607642|NCT05260437|65953445|FG002|Overall Study|Lost to Follow-up|1|||
23607643|NCT05260437|65953446|FG003|Overall Study|Lost to Follow-up|2|||
23607644|NCT05260437|65953447|FG004|Overall Study|Lost to Follow-up|2|||
23607645|NCT05260437|65953443|FG000|Overall Study|Withdrawal by Subject|3|||
23607646|NCT05260437|65953444|FG001|Overall Study|Withdrawal by Subject|0|||
23607647|NCT05260437|65953445|FG002|Overall Study|Withdrawal by Subject|4|||
23607648|NCT05260437|65953446|FG003|Overall Study|Withdrawal by Subject|5|||
23607649|NCT05260437|65953447|FG004|Overall Study|Withdrawal by Subject|0|||
23607650|NCT05260437|65953443|FG000|Overall Study|Vaccine Not Administered|0|||
23607651|NCT05260437|65953444|FG001|Overall Study|Vaccine Not Administered|1|||
23607652|NCT05260437|65953445|FG002|Overall Study|Vaccine Not Administered|0|||
23607653|NCT05260437|65953446|FG003|Overall Study|Vaccine Not Administered|0|||
23607654|NCT05260437|65953447|FG004|Overall Study|Vaccine Not Administered|0|||
23607655|NCT03006393|65953450|FG000|Overall Study|Withdrawal by Subject|1|||
23607656|NCT03006393|65953451|FG001|Overall Study|Withdrawal by Subject|1|||
23607657|NCT03006393|65953450|FG000|Overall Study|Pregnancy|0|||
23607658|NCT03006393|65953451|FG001|Overall Study|Pregnancy|1|||
23607659|NCT03006393|65953450|FG000|Overall Study|Lost to Follow-up|0|||
23607660|NCT03006393|65953451|FG001|Overall Study|Lost to Follow-up|1|||
23607661|NCT00308308|65953452|FG000|Overall Study|Adverse Event|17|||
23607662|NCT00308308|65953453|FG001|Overall Study|Adverse Event|2|||
23607663|NCT00308308|65953452|FG000|Overall Study|Lost to Follow-up|5|||
23607664|NCT00308308|65953453|FG001|Overall Study|Lost to Follow-up|5|||
23607665|NCT00308308|65953452|FG000|Overall Study|Physician Decision|15|||
23607666|NCT00308308|65953453|FG001|Overall Study|Physician Decision|7|||
23607667|NCT00308308|65953452|FG000|Overall Study|Protocol Violation|3|||
23607668|NCT00308308|65953453|FG001|Overall Study|Protocol Violation|14|||
23607669|NCT00308308|65953452|FG000|Overall Study|Withdrawal by Subject|47|||
23607670|NCT00308308|65953453|FG001|Overall Study|Withdrawal by Subject|19|||
23607671|NCT00308308|65953452|FG000|Overall Study|Various|7|||
23607672|NCT00308308|65953453|FG001|Overall Study|Various|5|||
23607673|NCT00308308|65953452|FG000|Overall Study|Randomized but not dosed|8|||
23607674|NCT00308308|65953453|FG001|Overall Study|Randomized but not dosed|16|||
23509426|NCT02468414|65601879|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
23509427|NCT02468414|65601878|FG000|Overall Study|Screen Failure|1|||
23509428|NCT02468414|65601879|FG001|Overall Study|Screen Failure|0|||
23509429|NCT00578812|65601881|FG000|Overall Study|Not treated|6|||
23607675|NCT00308308|65953452|FG000|Overall Study|Other|1|||
23607676|NCT00308308|65953453|FG001|Overall Study|Other|0|||
23509430|NCT00578812|65601882|FG001|Overall Study|Not treated|7|||
23509431|NCT03998189|65601883|FG000|Overall Study|Lack of Efficacy|0|||
23509432|NCT03998189|65601884|FG001|Overall Study|Lack of Efficacy|1|||
23509433|NCT04532164|65601893|FG000|Overall Study|Adverse Event|1|||
23509434|NCT04532164|65601893|FG000|Overall Study|Protocol Violation|5|||
23509435|NCT04532164|65601893|FG000|Overall Study|Lost to Follow-up|1|||
23509436|NCT04532164|65601893|FG000|Overall Study|Found to be Ineligible|3|||
23509437|NCT04532164|65601893|FG000|Overall Study|Withdrawal by Subject|14|||
23509438|NCT00434330|65601894|FG000|Overall Study|Adverse Event|0|||
23509439|NCT00434330|65601895|FG001|Overall Study|Adverse Event|0|||
23509440|NCT00434330|65601896|FG002|Overall Study|Adverse Event|1|||
23509441|NCT00434330|65601897|FG003|Overall Study|Adverse Event|0|||
23509442|NCT00434330|65601898|FG004|Overall Study|Adverse Event|0|||
23509443|NCT00434330|65601899|FG005|Overall Study|Adverse Event|0|||
23509444|NCT00434330|65601894|FG000|Overall Study|Death|1|||
23509445|NCT00434330|65601895|FG001|Overall Study|Death|0|||
23509446|NCT00434330|65601896|FG002|Overall Study|Death|0|||
23509447|NCT00434330|65601897|FG003|Overall Study|Death|0|||
23509448|NCT00434330|65601898|FG004|Overall Study|Death|1|||
23509449|NCT00434330|65601899|FG005|Overall Study|Death|1|||
23509450|NCT00434330|65601894|FG000|Overall Study|Withdrawal by Subject|0|||
23509451|NCT00434330|65601895|FG001|Overall Study|Withdrawal by Subject|0|||
23509452|NCT00434330|65601896|FG002|Overall Study|Withdrawal by Subject|1|||
23509453|NCT00434330|65601897|FG003|Overall Study|Withdrawal by Subject|1|||
23509454|NCT00434330|65601898|FG004|Overall Study|Withdrawal by Subject|0|||
23509455|NCT00434330|65601899|FG005|Overall Study|Withdrawal by Subject|0|||
23509456|NCT00434330|65601894|FG000|Overall Study|Renal transplant|0|||
23607677|NCT00638456|65953454|FG000|Overall Study|Withdrawal by Subject|6|||
23607678|NCT00638456|65953455|FG001|Overall Study|Withdrawal by Subject|2|||
23607679|NCT00489554|65953458|FG000|Overall Study|Adverse Event|2|||
23607680|NCT00489554|65953458|FG000|Overall Study|Withdrawal by Subject|1|||
23607681|NCT00489554|65953458|FG000|Overall Study|Lost to Follow-up|1|||
23607682|NCT04323800|65953460|FG000|Overall Study|Withdrawal by Subject|4|||
23607683|NCT04323800|65953461|FG001|Overall Study|Withdrawal by Subject|4|||
23509457|NCT00434330|65601895|FG001|Overall Study|Renal transplant|0|||
23509458|NCT00434330|65601896|FG002|Overall Study|Renal transplant|0|||
23509459|NCT00434330|65601897|FG003|Overall Study|Renal transplant|1|||
23509460|NCT00434330|65601898|FG004|Overall Study|Renal transplant|0|||
23509461|NCT00434330|65601899|FG005|Overall Study|Renal transplant|0|||
23509462|NCT00434330|65601894|FG000|Overall Study|Subject Not Compliant With Study|0|||
23509463|NCT00434330|65601895|FG001|Overall Study|Subject Not Compliant With Study|0|||
23607684|NCT04323800|65953460|FG000|Overall Study|Incomplete transfusion|1|||
23607685|NCT04323800|65953461|FG001|Overall Study|Incomplete transfusion|0|||
23607686|NCT04323800|65953460|FG000|Overall Study|Other|0|||
23607687|NCT04323800|65953461|FG001|Overall Study|Other|1|||
23509464|NCT00434330|65601896|FG002|Overall Study|Subject Not Compliant With Study|1|||
23509465|NCT00434330|65601897|FG003|Overall Study|Subject Not Compliant With Study|0|||
23509466|NCT00434330|65601898|FG004|Overall Study|Subject Not Compliant With Study|0|||
23607688|NCT04323800|65953460|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
23607689|NCT04323800|65953461|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
23607690|NCT02232737|65953462|FG000|Overall Study|Lost to Follow-up|18|||
23607691|NCT02232737|65953463|FG001|Overall Study|Lost to Follow-up|28|||
23607692|NCT02232737|65953464|FG002|Overall Study|Lost to Follow-up|33|||
23607693|NCT02232737|65953462|FG000|Overall Study|Personal reasons|7|||
23607694|NCT02232737|65953463|FG001|Overall Study|Personal reasons|8|||
23607695|NCT02232737|65953464|FG002|Overall Study|Personal reasons|14|||
23607696|NCT02232737|65953462|FG000|Overall Study|Adverse Event|6|||
23509467|NCT00434330|65601899|FG005|Overall Study|Subject Not Compliant With Study|0|||
23509468|NCT01224431|65601900|FG000|Overall Study|not randomized|0|||
23509469|NCT01224431|65601901|FG001|Overall Study|not randomized|4|||
23509470|NCT01224431|65601900|FG000|Overall Study|no video record|0|||
23607697|NCT02232737|65953463|FG001|Overall Study|Adverse Event|3|||
23607698|NCT02232737|65953464|FG002|Overall Study|Adverse Event|8|||
23607699|NCT02232737|65953462|FG000|Overall Study|Incarcerated|2|||
23607700|NCT02232737|65953463|FG001|Overall Study|Incarcerated|1|||
23607701|NCT02232737|65953464|FG002|Overall Study|Incarcerated|2|||
23607702|NCT02232737|65953462|FG000|Overall Study|Withdrawal by Subject|0|||
23607703|NCT02232737|65953463|FG001|Overall Study|Withdrawal by Subject|1|||
23607704|NCT02232737|65953464|FG002|Overall Study|Withdrawal by Subject|2|||
23607705|NCT02232737|65953462|FG000|Overall Study|Death|0|||
23607706|NCT02232737|65953463|FG001|Overall Study|Death|1|||
23607707|NCT02232737|65953464|FG002|Overall Study|Death|1|||
23607708|NCT02232737|65953462|FG000|Overall Study|Physician Decision|1|||
23607709|NCT02232737|65953463|FG001|Overall Study|Physician Decision|3|||
23607710|NCT02232737|65953464|FG002|Overall Study|Physician Decision|1|||
23607711|NCT02232737|65953462|FG000|Overall Study|Protocol Violation|1|||
23607712|NCT02232737|65953463|FG001|Overall Study|Protocol Violation|0|||
23607713|NCT02232737|65953464|FG002|Overall Study|Protocol Violation|1|||
23607714|NCT02232737|65953462|FG000|Overall Study|Reason unknown|1|||
23607715|NCT02232737|65953463|FG001|Overall Study|Reason unknown|0|||
23607716|NCT02232737|65953464|FG002|Overall Study|Reason unknown|0|||
23607717|NCT03005106|65953465|FG000|Overall Study|Lost to Follow-up|16|||
23607718|NCT03005106|65953465|FG000|Overall Study|Adverse Event|1|||
23607719|NCT03005106|65953465|FG000|Overall Study|Physician Decision|1|||
23607720|NCT03005106|65953465|FG000|Overall Study|Death|2|||
23607721|NCT01124045|65953468|FG000|Overall Study|Lost to Follow-up|0|||
23607722|NCT01124045|65953469|FG001|Overall Study|Lost to Follow-up|1|||
23607723|NCT01124045|65953468|FG000|Overall Study|Physician Decision|0|||
23607724|NCT01124045|65953469|FG001|Overall Study|Physician Decision|2|||
23607725|NCT03693989|65953471|FG000|Overall Study|Protocol Violation|3|||
23607726|NCT03693989|65953472|FG001|Overall Study|Protocol Violation|4|||
23607727|NCT04766996|65953473|FG000|Overall Study|Withdrawal by Subject|1|||
23607728|NCT04766996|65953474|FG001|Overall Study|Withdrawal by Subject|0|||
23607729|NCT04766996|65953475|FG002|Overall Study|Withdrawal by Subject|13|||
23607730|NCT00754325|65953476|FG000|Initial Treatment|Continuing Active Treatment|4|||
23607731|NCT00754325|65953477|FG001|Initial Treatment|Continuing Active Treatment|5|||
23607732|NCT00754325|65953476|FG000|Initial Treatment|Adverse Event|7|||
23607733|NCT00754325|65953477|FG001|Initial Treatment|Adverse Event|6|||
23607734|NCT00754325|65953476|FG000|Initial Treatment|Withdrawal by Subject|2|||
23607735|NCT00754325|65953477|FG001|Initial Treatment|Withdrawal by Subject|2|||
23607736|NCT00754325|65953476|FG000|Initial Treatment|Physician Decision|2|||
23607737|NCT00754325|65953477|FG001|Initial Treatment|Physician Decision|0|||
23607738|NCT00754325|65953476|FG000|Initial Treatment|Sponsor Request|0|||
23607739|NCT00754325|65953477|FG001|Initial Treatment|Sponsor Request|1|||
23607740|NCT00754325|65953476|FG000|Initial Treatment|Disease Progression|35|||
23607741|NCT00754325|65953477|FG001|Initial Treatment|Disease Progression|35|||
23607742|NCT03122548|65953478|FG000|Overall Study|Death|2|||
23607743|NCT03122548|65953478|FG000|Overall Study|Progression - subject went into hospice|1|||
23509471|NCT01224431|65601901|FG001|Overall Study|no video record|1|||
23509472|NCT01543698|65601902|FG000|Phase 1b|Disease progression|2|||
23607744|NCT03122548|65953478|FG000|Overall Study|Study Terminated by Sponsor|2|||
23509473|NCT01543698|65601903|FG001|Phase 1b|Disease progression|4|||
23607745|NCT00942266|65953479|FG000|Overall Study|Withdrawal by Subject|1|||
23607746|NCT00942266|65953480|FG001|Overall Study|Withdrawal by Subject|0|||
23607747|NCT00942266|65953479|FG000|Overall Study|Adverse Event|2|||
23607748|NCT00942266|65953480|FG001|Overall Study|Adverse Event|1|||
23607749|NCT00942266|65953479|FG000|Overall Study|Disease Progression|38|||
23607750|NCT00942266|65953480|FG001|Overall Study|Disease Progression|11|||
23607751|NCT00942266|65953479|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
23607752|NCT00942266|65953480|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
23607753|NCT00942266|65953479|FG000|Overall Study|Intercurrent illness|0|||
23607754|NCT00942266|65953480|FG001|Overall Study|Intercurrent illness|1|||
23607755|NCT00942266|65953479|FG000|Overall Study|Physician Decision|2|||
23509474|NCT01543698|65601904|FG002|Phase 1b|Disease progression|3|||
23509475|NCT01543698|65601905|FG003|Phase 1b|Disease progression|2|||
23607756|NCT00942266|65953480|FG001|Overall Study|Physician Decision|0|||
23607757|NCT00942266|65953479|FG000|Overall Study|medical deterioration (pneumonia)|0|||
23607758|NCT00942266|65953480|FG001|Overall Study|medical deterioration (pneumonia)|1|||
23607759|NCT00595764|65953481|FG000|Overall Study|Protocol Violation|24|||
23607760|NCT00595764|65953482|FG001|Overall Study|Protocol Violation|19|||
23607761|NCT00595764|65953481|FG000|Overall Study|Missed Medication >1 week|10|||
23607762|NCT00595764|65953482|FG001|Overall Study|Missed Medication >1 week|17|||
23607763|NCT00595764|65953481|FG000|Overall Study|Missed 3 PM visits|1|||
23607764|NCT00595764|65953482|FG001|Overall Study|Missed 3 PM visits|7|||
23607765|NCT00595764|65953481|FG000|Overall Study|Withdrawal by Subject|4|||
23607766|NCT00595764|65953482|FG001|Overall Study|Withdrawal by Subject|0|||
23607767|NCT02706483|65953483|FG000|Overall Study|Adverse Event|97|||
23607768|NCT02706483|65953483|FG000|Overall Study|Death|1|||
23607769|NCT02706483|65953483|FG000|Overall Study|Lack of Efficacy|39|||
23607770|NCT02706483|65953483|FG000|Overall Study|Lost to Follow-up|101|||
23607771|NCT02706483|65953483|FG000|Overall Study|Non-compliance with study drug|15|||
23607772|NCT02706483|65953483|FG000|Overall Study|Physician Decision|6|||
23607773|NCT02706483|65953483|FG000|Overall Study|Pregnancy|6|||
23607774|NCT02706483|65953483|FG000|Overall Study|Protocol Violation|18|||
23607775|NCT02706483|65953483|FG000|Overall Study|Withdrawal by Subject|136|||
23607776|NCT02706483|65953483|FG000|Overall Study|Non-compliance with visits|6|||
23607777|NCT02706483|65953483|FG000|Overall Study|Site closure|4|||
23607778|NCT02706483|65953483|FG000|Overall Study|Subject moved|1|||
23607779|NCT00484198|65953486|FG000|Overall Study|Participant Withdrew Consent|12|||
23607780|NCT00484198|65953487|FG001|Overall Study|Participant Withdrew Consent|21|||
23607781|NCT00484198|65953488|FG002|Overall Study|Participant Withdrew Consent|47|||
23607782|NCT00484198|65953489|FG003|Overall Study|Participant Withdrew Consent|59|||
23607783|NCT00484198|65953486|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
23607784|NCT00484198|65953487|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
23607785|NCT00484198|65953488|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
23607786|NCT00484198|65953489|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
23607787|NCT00484198|65953486|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
23607788|NCT00484198|65953487|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
23607789|NCT00484198|65953488|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
23607790|NCT00484198|65953489|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
23607791|NCT00484198|65953486|FG000|Overall Study|Adverse Event|3|||
23607792|NCT00484198|65953487|FG001|Overall Study|Adverse Event|11|||
23607793|NCT00484198|65953488|FG002|Overall Study|Adverse Event|32|||
23607794|NCT00484198|65953489|FG003|Overall Study|Adverse Event|31|||
23607795|NCT00484198|65953486|FG000|Overall Study|Protocol Violation|0|||
23607796|NCT00484198|65953487|FG001|Overall Study|Protocol Violation|5|||
23607797|NCT00484198|65953488|FG002|Overall Study|Protocol Violation|6|||
23607798|NCT00484198|65953489|FG003|Overall Study|Protocol Violation|8|||
23607799|NCT00484198|65953486|FG000|Overall Study|Other|7|||
23607800|NCT00484198|65953487|FG001|Overall Study|Other|10|||
23607801|NCT00484198|65953488|FG002|Overall Study|Other|31|||
23607802|NCT00484198|65953489|FG003|Overall Study|Other|28|||
23607803|NCT00768755|65953490|FG000|Phase 1|Death|6|||
23607804|NCT00768755|65953491|FG001|Phase 1|Death|0|||
23607805|NCT00768755|65953492|FG002|Phase 1|Death|0|||
23607806|NCT00768755|65953493|FG003|Phase 1|Death|0|||
23607807|NCT00768755|65953490|FG000|Phase 1|Other|4|||
23607808|NCT00768755|65953491|FG001|Phase 1|Other|0|||
23607809|NCT00768755|65953492|FG002|Phase 1|Other|0|||
23607810|NCT00768755|65953493|FG003|Phase 1|Other|0|||
23607811|NCT00768755|65953490|FG000|Phase 2|Death|0|||
23607812|NCT00768755|65953491|FG001|Phase 2|Death|37|||
23607813|NCT00768755|65953492|FG002|Phase 2|Death|48|||
23607814|NCT00768755|65953493|FG003|Phase 2|Death|31|||
23509476|NCT01543698|65601906|FG004|Phase 1b|Disease progression|10|||
23607815|NCT00768755|65953490|FG000|Phase 2|Protocol Violation|0|||
23607816|NCT00768755|65953491|FG001|Phase 2|Protocol Violation|2|||
23607817|NCT00768755|65953492|FG002|Phase 2|Protocol Violation|0|||
23607818|NCT00768755|65953493|FG003|Phase 2|Protocol Violation|1|||
23607819|NCT00768755|65953490|FG000|Phase 2|Lost to Follow-up|0|||
23607820|NCT00768755|65953491|FG001|Phase 2|Lost to Follow-up|1|||
23607821|NCT00768755|65953492|FG002|Phase 2|Lost to Follow-up|1|||
23607822|NCT00768755|65953493|FG003|Phase 2|Lost to Follow-up|4|||
23607823|NCT00768755|65953490|FG000|Phase 2|Withdrawal by Subject|0|||
23607824|NCT00768755|65953491|FG001|Phase 2|Withdrawal by Subject|1|||
23607825|NCT00768755|65953492|FG002|Phase 2|Withdrawal by Subject|0|||
23607826|NCT00768755|65953493|FG003|Phase 2|Withdrawal by Subject|1|||
23607827|NCT00768755|65953490|FG000|Phase 2|Other|0|||
23607828|NCT00768755|65953491|FG001|Phase 2|Other|1|||
23607829|NCT00768755|65953492|FG002|Phase 2|Other|2|||
23607830|NCT00768755|65953493|FG003|Phase 2|Other|4|||
23607831|NCT00768755|65953490|FG000|Phase 2|Study Terminated by Sponsor|0|||
23607832|NCT00768755|65953491|FG001|Phase 2|Study Terminated by Sponsor|13|||
23607833|NCT00768755|65953492|FG002|Phase 2|Study Terminated by Sponsor|7|||
23607834|NCT00768755|65953493|FG003|Phase 2|Study Terminated by Sponsor|14|||
23607835|NCT00768755|65953490|FG000|Phase 2|Randomized but not treated|0|||
23607836|NCT00768755|65953491|FG001|Phase 2|Randomized but not treated|0|||
23607837|NCT00768755|65953492|FG002|Phase 2|Randomized but not treated|0|||
23607838|NCT00768755|65953493|FG003|Phase 2|Randomized but not treated|2|||
23607839|NCT00486954|65953497|FG000|Pilot Part|Adverse Event|4|||
23607840|NCT00486954|65953498|FG001|Pilot Part|Adverse Event|0|||
23607841|NCT00486954|65953499|FG002|Pilot Part|Adverse Event|5|||
23607842|NCT00486954|65953500|FG003|Pilot Part|Adverse Event|0|||
23607843|NCT00486954|65953501|FG004|Pilot Part|Adverse Event|0|||
23607844|NCT00486954|65953497|FG000|Pilot Part|Disease Progression|2|||
23607845|NCT00486954|65953498|FG001|Pilot Part|Disease Progression|0|||
23607846|NCT00486954|65953499|FG002|Pilot Part|Disease Progression|1|||
23607847|NCT00486954|65953500|FG003|Pilot Part|Disease Progression|0|||
23607848|NCT00486954|65953501|FG004|Pilot Part|Disease Progression|0|||
23607849|NCT00486954|65953497|FG000|Randomized Part|Lost to Follow-up|0|||
23607850|NCT00486954|65953498|FG001|Randomized Part|Lost to Follow-up|0|||
23607851|NCT00486954|65953499|FG002|Randomized Part|Lost to Follow-up|0|||
23607852|NCT00486954|65953500|FG003|Randomized Part|Lost to Follow-up|0|||
23607853|NCT00486954|65953501|FG004|Randomized Part|Lost to Follow-up|1|||
23607854|NCT00486954|65953497|FG000|Randomized Part|Withdrawal by Subject|0|||
23607855|NCT00486954|65953498|FG001|Randomized Part|Withdrawal by Subject|0|||
23607856|NCT00486954|65953499|FG002|Randomized Part|Withdrawal by Subject|0|||
23607857|NCT00486954|65953500|FG003|Randomized Part|Withdrawal by Subject|1|||
23607858|NCT00486954|65953501|FG004|Randomized Part|Withdrawal by Subject|0|||
23607859|NCT00486954|65953497|FG000|Randomized Part|Sponsor Terminated Study|0|||
23607860|NCT00486954|65953498|FG001|Randomized Part|Sponsor Terminated Study|0|||
23607861|NCT00486954|65953499|FG002|Randomized Part|Sponsor Terminated Study|0|||
23607862|NCT00486954|65953500|FG003|Randomized Part|Sponsor Terminated Study|19|||
23607863|NCT00486954|65953501|FG004|Randomized Part|Sponsor Terminated Study|13|||
23607864|NCT01681511|65953503|FG000|Overall Study|No Treatment Received|1|||
23607865|NCT01681511|65953504|FG001|Overall Study|No Treatment Received|3|||
23607866|NCT01681511|65953503|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
23509477|NCT01543698|65601907|FG005|Phase 1b|Disease progression|6|||
23509478|NCT01543698|65601908|FG006|Phase 1b|Disease progression|5|||
23509479|NCT01543698|65601909|FG007|Phase 1b|Disease progression|3|||
23509480|NCT01543698|65601910|FG008|Phase 1b|Disease progression|4|||
23607867|NCT01681511|65953504|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
23607868|NCT01681511|65953503|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
23607869|NCT01681511|65953504|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
23607870|NCT01681511|65953503|FG000|Overall Study|No Daily Urine Sample Collected|0|||
23607871|NCT01681511|65953504|FG001|Overall Study|No Daily Urine Sample Collected|1|||
23607872|NCT01681511|65953503|FG000|Overall Study|No post-catheter sample collected|11|||
23607873|NCT01681511|65953504|FG001|Overall Study|No post-catheter sample collected|4|||
23607874|NCT02674399|65953505|FG000|Overall Study|Lost to Follow-up|2|||
23607875|NCT02674399|65953506|FG001|Overall Study|Lost to Follow-up|0|||
23509481|NCT01543698|65601911|FG009|Phase 1b|Disease progression|5|||
23509482|NCT01543698|65601912|FG010|Phase 1b|Disease progression|1|||
23509483|NCT01543698|65601913|FG011|Phase 1b|Disease progression|0|||
23509484|NCT01543698|65601914|FG012|Phase 1b|Disease progression|0|||
23509485|NCT01543698|65601915|FG013|Phase 1b|Disease progression|0|||
23607876|NCT03029585|65953509|FG000|Overall Study|Death|1|||
23607877|NCT03029585|65953510|FG001|Overall Study|Death|1|||
23607878|NCT03029585|65953509|FG000|Overall Study|Withdrawal by Subject|1|||
23607879|NCT03029585|65953510|FG001|Overall Study|Withdrawal by Subject|0|||
23607880|NCT02574286|65953511|FG000|Overall Study|Adverse Event|3|||
23607881|NCT02574286|65953511|FG000|Overall Study|Withdrawal by Subject|2|||
23607882|NCT00813709|65953514|FG000|Double Blind Period|Adverse Event|4|||
23607883|NCT00813709|65953515|FG001|Double Blind Period|Adverse Event|1|||
23607884|NCT00813709|65953516|FG002|Double Blind Period|Adverse Event|4|||
23607885|NCT00813709|65953517|FG003|Double Blind Period|Adverse Event|0|||
23607886|NCT00813709|65953518|FG004|Double Blind Period|Adverse Event|0|||
23607887|NCT00813709|65953519|FG005|Double Blind Period|Adverse Event|0|||
23607888|NCT00813709|65953514|FG000|Double Blind Period|Lost to Follow-up|3|||
23607889|NCT00813709|65953515|FG001|Double Blind Period|Lost to Follow-up|2|||
23607890|NCT00813709|65953516|FG002|Double Blind Period|Lost to Follow-up|2|||
23607891|NCT00813709|65953517|FG003|Double Blind Period|Lost to Follow-up|0|||
23607892|NCT00813709|65953518|FG004|Double Blind Period|Lost to Follow-up|0|||
23607893|NCT00813709|65953519|FG005|Double Blind Period|Lost to Follow-up|0|||
23607894|NCT00813709|65953514|FG000|Double Blind Period|Switched to open label phase|9|||
23607895|NCT00813709|65953515|FG001|Double Blind Period|Switched to open label phase|26|||
23607896|NCT00813709|65953516|FG002|Double Blind Period|Switched to open label phase|18|||
23607897|NCT00813709|65953517|FG003|Double Blind Period|Switched to open label phase|0|||
23607898|NCT00813709|65953518|FG004|Double Blind Period|Switched to open label phase|0|||
23607899|NCT00813709|65953519|FG005|Double Blind Period|Switched to open label phase|0|||
23509486|NCT01543698|65601916|FG014|Phase 1b|Disease progression|0|||
23607900|NCT00813709|65953514|FG000|Double Blind Period|Randomized but not treated|1|||
23509487|NCT01543698|65601902|FG000|Phase 1b|Death|0|||
23607901|NCT00813709|65953515|FG001|Double Blind Period|Randomized but not treated|3|||
23607902|NCT00813709|65953516|FG002|Double Blind Period|Randomized but not treated|1|||
23607903|NCT00813709|65953517|FG003|Double Blind Period|Randomized but not treated|0|||
23607904|NCT00813709|65953518|FG004|Double Blind Period|Randomized but not treated|0|||
23607905|NCT00813709|65953519|FG005|Double Blind Period|Randomized but not treated|0|||
23607906|NCT00813709|65953514|FG000|Double Blind Period|Other|14|||
23607907|NCT00813709|65953515|FG001|Double Blind Period|Other|9|||
23607908|NCT00813709|65953516|FG002|Double Blind Period|Other|6|||
23607909|NCT00813709|65953517|FG003|Double Blind Period|Other|0|||
23607910|NCT00813709|65953518|FG004|Double Blind Period|Other|0|||
23607911|NCT00813709|65953519|FG005|Double Blind Period|Other|0|||
23607912|NCT00813709|65953514|FG000|Open Label Period|Adverse Event|0|||
23607913|NCT00813709|65953515|FG001|Open Label Period|Adverse Event|0|||
23607914|NCT00813709|65953516|FG002|Open Label Period|Adverse Event|0|||
23607915|NCT00813709|65953517|FG003|Open Label Period|Adverse Event|5|||
23607916|NCT00813709|65953518|FG004|Open Label Period|Adverse Event|4|||
23607917|NCT00813709|65953519|FG005|Open Label Period|Adverse Event|3|||
23607918|NCT00813709|65953514|FG000|Open Label Period|Lack of Efficacy|0|||
23607919|NCT00813709|65953515|FG001|Open Label Period|Lack of Efficacy|0|||
23607920|NCT00813709|65953516|FG002|Open Label Period|Lack of Efficacy|0|||
23607921|NCT00813709|65953517|FG003|Open Label Period|Lack of Efficacy|3|||
23607922|NCT00813709|65953518|FG004|Open Label Period|Lack of Efficacy|1|||
23607923|NCT00813709|65953519|FG005|Open Label Period|Lack of Efficacy|1|||
23607924|NCT00813709|65953514|FG000|Open Label Period|Randomized but not treated|0|||
23607925|NCT00813709|65953515|FG001|Open Label Period|Randomized but not treated|0|||
23607926|NCT00813709|65953516|FG002|Open Label Period|Randomized but not treated|0|||
23607927|NCT00813709|65953517|FG003|Open Label Period|Randomized but not treated|1|||
23607928|NCT00813709|65953518|FG004|Open Label Period|Randomized but not treated|0|||
23607929|NCT00813709|65953519|FG005|Open Label Period|Randomized but not treated|1|||
23607930|NCT00813709|65953514|FG000|Open Label Period|Other|0|||
23607931|NCT00813709|65953515|FG001|Open Label Period|Other|0|||
23607932|NCT00813709|65953516|FG002|Open Label Period|Other|0|||
23607933|NCT00813709|65953517|FG003|Open Label Period|Other|11|||
23607934|NCT00813709|65953518|FG004|Open Label Period|Other|5|||
23607935|NCT00813709|65953519|FG005|Open Label Period|Other|6|||
23607936|NCT01760876|65953520|FG000|Overall Study|Non-cardiac death (head injury)|1|||
23607937|NCT01760876|65953520|FG000|Overall Study|Carcinoma of prostate|1|||
23607938|NCT01760876|65953520|FG000|Overall Study|Impaired renal function|1|||
23607939|NCT01760876|65953520|FG000|Overall Study|Major depression|1|||
23607940|NCT01760876|65953520|FG000|Overall Study|Very poor baseline OCT quality|2|||
23607941|NCT04633200|65953523|FG000|Overall Study|Lost to Follow-up|3|||
23607942|NCT04633200|65953524|FG001|Overall Study|Lost to Follow-up|5|||
23607943|NCT03431350|65953525|FG000|Overall Study|ONGOING|0|||
23607944|NCT03431350|65953526|FG001|Overall Study|ONGOING|0|||
23607945|NCT03431350|65953527|FG002|Overall Study|ONGOING|2|||
23607946|NCT03431350|65953528|FG003|Overall Study|ONGOING|0|||
23607947|NCT03431350|65953529|FG004|Overall Study|ONGOING|1|||
23607948|NCT03431350|65953530|FG005|Overall Study|ONGOING|3|||
23607949|NCT03431350|65953531|FG006|Overall Study|ONGOING|0|||
23607950|NCT03431350|65953532|FG007|Overall Study|ONGOING|1|||
23607951|NCT03431350|65953533|FG008|Overall Study|ONGOING|3|||
23607952|NCT03431350|65953534|FG009|Overall Study|ONGOING|4|||
23607953|NCT03431350|65953535|FG010|Overall Study|ONGOING|2|||
23607954|NCT03431350|65953536|FG011|Overall Study|ONGOING|1|||
23607955|NCT03431350|65953525|FG000|Overall Study|Death|6|||
23607956|NCT03431350|65953526|FG001|Overall Study|Death|5|||
23607957|NCT03431350|65953527|FG002|Overall Study|Death|18|||
23607958|NCT03431350|65953528|FG003|Overall Study|Death|7|||
23607959|NCT03431350|65953529|FG004|Overall Study|Death|4|||
23607960|NCT03431350|65953530|FG005|Overall Study|Death|3|||
23607961|NCT03431350|65953531|FG006|Overall Study|Death|2|||
23607962|NCT03431350|65953532|FG007|Overall Study|Death|0|||
23607963|NCT03431350|65953533|FG008|Overall Study|Death|0|||
23607964|NCT03431350|65953534|FG009|Overall Study|Death|0|||
23607965|NCT03431350|65953535|FG010|Overall Study|Death|4|||
23607966|NCT03431350|65953536|FG011|Overall Study|Death|0|||
23607967|NCT03431350|65953525|FG000|Overall Study|Lost to Follow-up|0|||
23607968|NCT03431350|65953526|FG001|Overall Study|Lost to Follow-up|1|||
23607969|NCT03431350|65953527|FG002|Overall Study|Lost to Follow-up|0|||
23607970|NCT03431350|65953528|FG003|Overall Study|Lost to Follow-up|0|||
23607971|NCT03431350|65953529|FG004|Overall Study|Lost to Follow-up|0|||
23607972|NCT03431350|65953530|FG005|Overall Study|Lost to Follow-up|0|||
23607973|NCT03431350|65953531|FG006|Overall Study|Lost to Follow-up|0|||
23607974|NCT03431350|65953532|FG007|Overall Study|Lost to Follow-up|0|||
23607975|NCT03431350|65953533|FG008|Overall Study|Lost to Follow-up|0|||
23607976|NCT03431350|65953534|FG009|Overall Study|Lost to Follow-up|0|||
23607977|NCT03431350|65953535|FG010|Overall Study|Lost to Follow-up|0|||
23607978|NCT03431350|65953536|FG011|Overall Study|Lost to Follow-up|0|||
23607979|NCT03431350|65953525|FG000|Overall Study|Withdrawal by Subject|0|||
23607980|NCT03431350|65953526|FG001|Overall Study|Withdrawal by Subject|0|||
23607981|NCT03431350|65953527|FG002|Overall Study|Withdrawal by Subject|0|||
23607982|NCT03431350|65953528|FG003|Overall Study|Withdrawal by Subject|1|||
23607983|NCT03431350|65953529|FG004|Overall Study|Withdrawal by Subject|1|||
23607984|NCT03431350|65953530|FG005|Overall Study|Withdrawal by Subject|1|||
23607985|NCT03431350|65953531|FG006|Overall Study|Withdrawal by Subject|0|||
23607986|NCT03431350|65953532|FG007|Overall Study|Withdrawal by Subject|0|||
23607987|NCT03431350|65953533|FG008|Overall Study|Withdrawal by Subject|0|||
23607988|NCT03431350|65953534|FG009|Overall Study|Withdrawal by Subject|2|||
23607989|NCT03431350|65953535|FG010|Overall Study|Withdrawal by Subject|0|||
23607990|NCT03431350|65953536|FG011|Overall Study|Withdrawal by Subject|1|||
23509488|NCT01543698|65601903|FG001|Phase 1b|Death|0|||
23509489|NCT01543698|65601904|FG002|Phase 1b|Death|1|||
23509490|NCT01543698|65601905|FG003|Phase 1b|Death|1|||
23509491|NCT01543698|65601906|FG004|Phase 1b|Death|0|||
23509492|NCT01543698|65601907|FG005|Phase 1b|Death|0|||
23509493|NCT01543698|65601908|FG006|Phase 1b|Death|0|||
23607991|NCT03431350|65953525|FG000|Overall Study|Other|0|||
23607992|NCT03431350|65953526|FG001|Overall Study|Other|0|||
23607993|NCT03431350|65953527|FG002|Overall Study|Other|1|||
23607994|NCT03431350|65953528|FG003|Overall Study|Other|3|||
23607995|NCT03431350|65953529|FG004|Overall Study|Other|2|||
23607996|NCT03431350|65953530|FG005|Overall Study|Other|2|||
23607997|NCT03431350|65953531|FG006|Overall Study|Other|4|||
23607998|NCT03431350|65953532|FG007|Overall Study|Other|0|||
23607999|NCT03431350|65953533|FG008|Overall Study|Other|14|||
23608000|NCT03431350|65953534|FG009|Overall Study|Other|11|||
23608001|NCT03431350|65953535|FG010|Overall Study|Other|11|||
23608002|NCT03431350|65953536|FG011|Overall Study|Other|15|||
23608003|NCT02332889|65953541|FG000|Overall Study|Physician Decision|1|||
23608004|NCT01316913|65953542|FG000|Overall Study|Adverse Event|17|||
23608005|NCT01316913|65953543|FG001|Overall Study|Adverse Event|20|||
23608006|NCT01316913|65953544|FG002|Overall Study|Adverse Event|15|||
23608007|NCT01316913|65953545|FG003|Overall Study|Adverse Event|11|||
23608008|NCT01316913|65953542|FG000|Overall Study|Lack of Efficacy|22|||
23608009|NCT01316913|65953543|FG001|Overall Study|Lack of Efficacy|12|||
23608010|NCT01316913|65953544|FG002|Overall Study|Lack of Efficacy|9|||
23608011|NCT01316913|65953545|FG003|Overall Study|Lack of Efficacy|13|||
23608012|NCT01316913|65953542|FG000|Overall Study|Protocol Violation|1|||
23608013|NCT01316913|65953543|FG001|Overall Study|Protocol Violation|4|||
23608014|NCT01316913|65953544|FG002|Overall Study|Protocol Violation|4|||
23608015|NCT01316913|65953545|FG003|Overall Study|Protocol Violation|1|||
23608016|NCT01316913|65953542|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
23608017|NCT01316913|65953543|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
23608018|NCT01316913|65953544|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
23608019|NCT01316913|65953545|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
23608020|NCT01316913|65953542|FG000|Overall Study|Lost to Follow-up|0|||
23608021|NCT01316913|65953543|FG001|Overall Study|Lost to Follow-up|1|||
23608022|NCT01316913|65953544|FG002|Overall Study|Lost to Follow-up|0|||
23608023|NCT01316913|65953545|FG003|Overall Study|Lost to Follow-up|2|||
23608024|NCT01316913|65953542|FG000|Overall Study|Withdrawal by Subject|10|||
23608025|NCT01316913|65953543|FG001|Overall Study|Withdrawal by Subject|9|||
23608026|NCT01316913|65953544|FG002|Overall Study|Withdrawal by Subject|10|||
23608027|NCT01316913|65953545|FG003|Overall Study|Withdrawal by Subject|6|||
23608028|NCT01214200|65953546|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
23608029|NCT01214200|65953546|FG000|Overall Study|Withdrawal by Subject|2|||
23608030|NCT04212299|65953547|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
23608031|NCT02721147|65953548|FG000|Overall Study|Lost to Follow-up|2|||
23608032|NCT02721147|65953549|FG001|Overall Study|Lost to Follow-up|0|||
23608033|NCT02721147|65953550|FG002|Overall Study|Lost to Follow-up|0|||
23509494|NCT01543698|65601909|FG007|Phase 1b|Death|0|||
23509495|NCT01543698|65601910|FG008|Phase 1b|Death|0|||
23608034|NCT00617708|65953551|FG000|Overall Study|Adverse Event|0|||
23608035|NCT00617708|65953552|FG001|Overall Study|Adverse Event|6|||
23608036|NCT00617708|65953553|FG002|Overall Study|Adverse Event|9|||
23608037|NCT00617708|65953551|FG000|Overall Study|Withdrawal by Subject|1|||
23608038|NCT00617708|65953552|FG001|Overall Study|Withdrawal by Subject|1|||
23608039|NCT00617708|65953553|FG002|Overall Study|Withdrawal by Subject|7|||
23608040|NCT00617708|65953551|FG000|Overall Study|Death|0|||
23608041|NCT00617708|65953552|FG001|Overall Study|Death|6|||
23608042|NCT00617708|65953553|FG002|Overall Study|Death|5|||
23608043|NCT00617708|65953551|FG000|Overall Study|Progression/Relapse|7|||
23608044|NCT00617708|65953552|FG001|Overall Study|Progression/Relapse|40|||
23608045|NCT00617708|65953553|FG002|Overall Study|Progression/Relapse|36|||
23509496|NCT01543698|65601911|FG009|Phase 1b|Death|0|||
23608046|NCT00617708|65953551|FG000|Overall Study|Not protocol specified|1|||
23608047|NCT00617708|65953552|FG001|Overall Study|Not protocol specified|4|||
23509497|NCT01543698|65601912|FG010|Phase 1b|Death|1|||
23509498|NCT01543698|65601913|FG011|Phase 1b|Death|0|||
23509499|NCT01543698|65601914|FG012|Phase 1b|Death|0|||
23608048|NCT00617708|65953553|FG002|Overall Study|Not protocol specified|2|||
23608049|NCT00617708|65953551|FG000|Overall Study|Not eligible|1|||
23608050|NCT00617708|65953552|FG001|Overall Study|Not eligible|3|||
23509500|NCT01543698|65601915|FG013|Phase 1b|Death|0|||
23608051|NCT00617708|65953553|FG002|Overall Study|Not eligible|5|||
23608052|NCT00670488|65953554|FG000|Overall Study|Adverse Event|0|||
23608053|NCT00670488|65953555|FG001|Overall Study|Adverse Event|7|||
23608054|NCT00670488|65953556|FG002|Overall Study|Adverse Event|0|||
23608055|NCT00670488|65953557|FG003|Overall Study|Adverse Event|3|||
23608056|NCT00670488|65953558|FG004|Overall Study|Adverse Event|1|||
23608057|NCT00670488|65953559|FG005|Overall Study|Adverse Event|1|||
23608058|NCT00670488|65953560|FG006|Overall Study|Adverse Event|5|||
23608059|NCT00670488|65953561|FG007|Overall Study|Adverse Event|1|||
23608060|NCT00670488|65953562|FG008|Overall Study|Adverse Event|0|||
23509501|NCT01543698|65601916|FG014|Phase 1b|Death|0|||
23509502|NCT01543698|65601902|FG000|Phase 1b|Withdrawal by Subject|0|||
23509503|NCT01543698|65601903|FG001|Phase 1b|Withdrawal by Subject|1|||
23509504|NCT01543698|65601904|FG002|Phase 1b|Withdrawal by Subject|0|||
23509505|NCT01543698|65601905|FG003|Phase 1b|Withdrawal by Subject|1|||
23509506|NCT01543698|65601906|FG004|Phase 1b|Withdrawal by Subject|0|||
23509507|NCT01543698|65601907|FG005|Phase 1b|Withdrawal by Subject|0|||
23509508|NCT01543698|65601908|FG006|Phase 1b|Withdrawal by Subject|1|||
23509509|NCT01543698|65601909|FG007|Phase 1b|Withdrawal by Subject|0|||
23509510|NCT01543698|65601910|FG008|Phase 1b|Withdrawal by Subject|0|||
23509511|NCT01543698|65601911|FG009|Phase 1b|Withdrawal by Subject|0|||
23509512|NCT01543698|65601912|FG010|Phase 1b|Withdrawal by Subject|0|||
23509513|NCT01543698|65601913|FG011|Phase 1b|Withdrawal by Subject|0|||
23509514|NCT01543698|65601914|FG012|Phase 1b|Withdrawal by Subject|0|||
23509515|NCT01543698|65601915|FG013|Phase 1b|Withdrawal by Subject|0|||
23509516|NCT01543698|65601916|FG014|Phase 1b|Withdrawal by Subject|0|||
23509517|NCT01543698|65601902|FG000|Phase 1b|Adverse Event|1|||
23509518|NCT01543698|65601903|FG001|Phase 1b|Adverse Event|0|||
23509519|NCT01543698|65601904|FG002|Phase 1b|Adverse Event|0|||
23509520|NCT01543698|65601905|FG003|Phase 1b|Adverse Event|1|||
23509521|NCT01543698|65601906|FG004|Phase 1b|Adverse Event|2|||
23509522|NCT01543698|65601907|FG005|Phase 1b|Adverse Event|2|||
23509523|NCT01543698|65601908|FG006|Phase 1b|Adverse Event|0|||
23509524|NCT01543698|65601909|FG007|Phase 1b|Adverse Event|0|||
23509525|NCT01543698|65601910|FG008|Phase 1b|Adverse Event|1|||
23509526|NCT01543698|65601911|FG009|Phase 1b|Adverse Event|1|||
23509527|NCT01543698|65601912|FG010|Phase 1b|Adverse Event|2|||
23509528|NCT01543698|65601913|FG011|Phase 1b|Adverse Event|0|||
23509529|NCT01543698|65601914|FG012|Phase 1b|Adverse Event|0|||
23509530|NCT01543698|65601915|FG013|Phase 1b|Adverse Event|0|||
23509531|NCT01543698|65601916|FG014|Phase 1b|Adverse Event|0|||
23509532|NCT01543698|65601902|FG000|Phase 1b|Administrative problems|1|||
23509533|NCT01543698|65601903|FG001|Phase 1b|Administrative problems|0|||
23509534|NCT01543698|65601904|FG002|Phase 1b|Administrative problems|0|||
23509535|NCT01543698|65601905|FG003|Phase 1b|Administrative problems|0|||
23509536|NCT01543698|65601906|FG004|Phase 1b|Administrative problems|1|||
23509537|NCT01543698|65601907|FG005|Phase 1b|Administrative problems|0|||
23509538|NCT01543698|65601908|FG006|Phase 1b|Administrative problems|0|||
23509539|NCT01543698|65601909|FG007|Phase 1b|Administrative problems|1|||
23509540|NCT01543698|65601910|FG008|Phase 1b|Administrative problems|0|||
23509541|NCT01543698|65601911|FG009|Phase 1b|Administrative problems|0|||
23509542|NCT01543698|65601912|FG010|Phase 1b|Administrative problems|2|||
23509543|NCT01543698|65601913|FG011|Phase 1b|Administrative problems|0|||
23509544|NCT01543698|65601914|FG012|Phase 1b|Administrative problems|0|||
23509545|NCT01543698|65601915|FG013|Phase 1b|Administrative problems|0|||
23509546|NCT01543698|65601916|FG014|Phase 1b|Administrative problems|0|||
23509547|NCT01543698|65601902|FG000|Phase 1b|Protocol Violation|2|||
23509548|NCT01543698|65601903|FG001|Phase 1b|Protocol Violation|0|||
23509549|NCT01543698|65601904|FG002|Phase 1b|Protocol Violation|0|||
23509550|NCT01543698|65601905|FG003|Phase 1b|Protocol Violation|0|||
23509551|NCT01543698|65601906|FG004|Phase 1b|Protocol Violation|0|||
23509552|NCT01543698|65601907|FG005|Phase 1b|Protocol Violation|0|||
23509553|NCT01543698|65601908|FG006|Phase 1b|Protocol Violation|0|||
23509554|NCT01543698|65601909|FG007|Phase 1b|Protocol Violation|0|||
23509555|NCT01543698|65601910|FG008|Phase 1b|Protocol Violation|0|||
23509556|NCT01543698|65601911|FG009|Phase 1b|Protocol Violation|0|||
23509557|NCT01543698|65601912|FG010|Phase 1b|Protocol Violation|0|||
23509558|NCT01543698|65601913|FG011|Phase 1b|Protocol Violation|0|||
23509559|NCT01543698|65601914|FG012|Phase 1b|Protocol Violation|0|||
23509560|NCT01543698|65601915|FG013|Phase 1b|Protocol Violation|0|||
23509561|NCT01543698|65601916|FG014|Phase 1b|Protocol Violation|0|||
23509562|NCT01543698|65601902|FG000|Phase 2|Protocol Violation|0|||
23509563|NCT01543698|65601903|FG001|Phase 2|Protocol Violation|0|||
23509564|NCT01543698|65601904|FG002|Phase 2|Protocol Violation|0|||
23509565|NCT01543698|65601905|FG003|Phase 2|Protocol Violation|0|||
23509566|NCT01543698|65601906|FG004|Phase 2|Protocol Violation|0|||
23509567|NCT01543698|65601907|FG005|Phase 2|Protocol Violation|0|||
23509568|NCT01543698|65601908|FG006|Phase 2|Protocol Violation|0|||
23509569|NCT01543698|65601909|FG007|Phase 2|Protocol Violation|0|||
23509570|NCT01543698|65601910|FG008|Phase 2|Protocol Violation|0|||
23509571|NCT01543698|65601911|FG009|Phase 2|Protocol Violation|0|||
23608061|NCT00670488|65953563|FG009|Overall Study|Adverse Event|1|||
23608062|NCT00670488|65953554|FG000|Overall Study|Physician Decision|1|||
23608063|NCT00670488|65953555|FG001|Overall Study|Physician Decision|9|||
23608064|NCT00670488|65953556|FG002|Overall Study|Physician Decision|0|||
23608065|NCT00670488|65953557|FG003|Overall Study|Physician Decision|1|||
23608066|NCT00670488|65953558|FG004|Overall Study|Physician Decision|0|||
23608067|NCT00670488|65953559|FG005|Overall Study|Physician Decision|0|||
23608068|NCT00670488|65953560|FG006|Overall Study|Physician Decision|0|||
23608069|NCT00670488|65953561|FG007|Overall Study|Physician Decision|0|||
23608070|NCT00670488|65953562|FG008|Overall Study|Physician Decision|0|||
23608071|NCT00670488|65953563|FG009|Overall Study|Physician Decision|0|||
23608072|NCT00670488|65953554|FG000|Overall Study|Progressive Disease|2|||
23608073|NCT00670488|65953555|FG001|Overall Study|Progressive Disease|41|||
23608074|NCT00670488|65953556|FG002|Overall Study|Progressive Disease|3|||
23608075|NCT00670488|65953557|FG003|Overall Study|Progressive Disease|2|||
23608076|NCT00670488|65953558|FG004|Overall Study|Progressive Disease|2|||
23608077|NCT00670488|65953559|FG005|Overall Study|Progressive Disease|4|||
23608078|NCT00670488|65953560|FG006|Overall Study|Progressive Disease|11|||
23608079|NCT00670488|65953561|FG007|Overall Study|Progressive Disease|2|||
23608080|NCT00670488|65953562|FG008|Overall Study|Progressive Disease|2|||
23608081|NCT00670488|65953563|FG009|Overall Study|Progressive Disease|1|||
23608082|NCT00670488|65953554|FG000|Overall Study|Withdrawal by Subject|0|||
23608083|NCT00670488|65953555|FG001|Overall Study|Withdrawal by Subject|1|||
23608084|NCT00670488|65953556|FG002|Overall Study|Withdrawal by Subject|0|||
23608085|NCT00670488|65953557|FG003|Overall Study|Withdrawal by Subject|1|||
23608086|NCT00670488|65953558|FG004|Overall Study|Withdrawal by Subject|0|||
23608087|NCT00670488|65953559|FG005|Overall Study|Withdrawal by Subject|0|||
23608088|NCT00670488|65953560|FG006|Overall Study|Withdrawal by Subject|1|||
23608089|NCT00670488|65953561|FG007|Overall Study|Withdrawal by Subject|0|||
23608090|NCT00670488|65953562|FG008|Overall Study|Withdrawal by Subject|1|||
23608091|NCT00670488|65953563|FG009|Overall Study|Withdrawal by Subject|0|||
23608092|NCT02555397|65953564|FG000|Overall Study|Withdrawal by Subject|1|||
23608093|NCT02555397|65953565|FG001|Overall Study|Withdrawal by Subject|0|||
23608094|NCT02555397|65953566|FG002|Overall Study|Withdrawal by Subject|0|||
23608095|NCT02555397|65953567|FG003|Overall Study|Withdrawal by Subject|0|||
23608096|NCT02555397|65953568|FG004|Overall Study|Withdrawal by Subject|0|||
23608097|NCT02382640|65953569|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
23608098|NCT02382640|65953570|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
23608099|NCT02382640|65953571|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
23608100|NCT02382640|65953572|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
23608101|NCT01986348|65953573|FG000|Overall Study|Death|8|||
23608102|NCT01986348|65953574|FG001|Overall Study|Death|22|||
23608103|NCT01986348|65953575|FG002|Overall Study|Death|10|||
23608104|NCT01986348|65953576|FG003|Overall Study|Death|21|||
23608105|NCT01986348|65953573|FG000|Overall Study|Lost to Follow-up|0|||
23608106|NCT01986348|65953574|FG001|Overall Study|Lost to Follow-up|0|||
23608107|NCT01986348|65953575|FG002|Overall Study|Lost to Follow-up|0|||
23509572|NCT01543698|65601912|FG010|Phase 2|Protocol Violation|0|||
23509573|NCT01543698|65601913|FG011|Phase 2|Protocol Violation|0|||
23509574|NCT01543698|65601914|FG012|Phase 2|Protocol Violation|1|||
23509575|NCT01543698|65601915|FG013|Phase 2|Protocol Violation|0|||
23509576|NCT01543698|65601916|FG014|Phase 2|Protocol Violation|0|||
23509577|NCT01543698|65601902|FG000|Phase 2|Disease progression|0|||
23509578|NCT01543698|65601903|FG001|Phase 2|Disease progression|0|||
23509579|NCT01543698|65601904|FG002|Phase 2|Disease progression|0|||
23509580|NCT01543698|65601905|FG003|Phase 2|Disease progression|0|||
23509581|NCT01543698|65601906|FG004|Phase 2|Disease progression|0|||
23509582|NCT01543698|65601907|FG005|Phase 2|Disease progression|0|||
23509583|NCT01543698|65601908|FG006|Phase 2|Disease progression|0|||
23509584|NCT01543698|65601909|FG007|Phase 2|Disease progression|0|||
23509585|NCT01543698|65601910|FG008|Phase 2|Disease progression|0|||
23509586|NCT01543698|65601911|FG009|Phase 2|Disease progression|0|||
23509587|NCT01543698|65601912|FG010|Phase 2|Disease progression|0|||
23509588|NCT01543698|65601913|FG011|Phase 2|Disease progression|10|||
23509589|NCT01543698|65601914|FG012|Phase 2|Disease progression|21|||
23509590|NCT01543698|65601915|FG013|Phase 2|Disease progression|30|||
23509591|NCT01543698|65601916|FG014|Phase 2|Disease progression|25|||
23608108|NCT01986348|65953576|FG003|Overall Study|Lost to Follow-up|2|||
23608109|NCT01986348|65953573|FG000|Overall Study|Physician Decision|0|||
23608110|NCT01986348|65953574|FG001|Overall Study|Physician Decision|0|||
23608111|NCT01986348|65953575|FG002|Overall Study|Physician Decision|0|||
23608112|NCT01986348|65953576|FG003|Overall Study|Physician Decision|1|||
23509592|NCT01543698|65601902|FG000|Phase 2|Death|0|||
23509593|NCT01543698|65601903|FG001|Phase 2|Death|0|||
23509594|NCT01543698|65601904|FG002|Phase 2|Death|0|||
23509595|NCT01543698|65601905|FG003|Phase 2|Death|0|||
23509596|NCT01543698|65601906|FG004|Phase 2|Death|0|||
23509597|NCT01543698|65601907|FG005|Phase 2|Death|0|||
23509598|NCT01543698|65601908|FG006|Phase 2|Death|0|||
23509599|NCT01543698|65601909|FG007|Phase 2|Death|0|||
23509600|NCT01543698|65601910|FG008|Phase 2|Death|0|||
23608113|NCT01986348|65953573|FG000|Overall Study|Progressive Disease|0|||
23509601|NCT01543698|65601911|FG009|Phase 2|Death|0|||
23509602|NCT01543698|65601912|FG010|Phase 2|Death|0|||
23509603|NCT01543698|65601913|FG011|Phase 2|Death|0|||
23509604|NCT01543698|65601914|FG012|Phase 2|Death|1|||
23509605|NCT01543698|65601915|FG013|Phase 2|Death|1|||
23509606|NCT01543698|65601916|FG014|Phase 2|Death|1|||
23509607|NCT01543698|65601902|FG000|Phase 2|Administrative problems|0|||
23509608|NCT01543698|65601903|FG001|Phase 2|Administrative problems|0|||
23509609|NCT01543698|65601904|FG002|Phase 2|Administrative problems|0|||
23509610|NCT01543698|65601905|FG003|Phase 2|Administrative problems|0|||
23509611|NCT01543698|65601906|FG004|Phase 2|Administrative problems|0|||
23509612|NCT01543698|65601907|FG005|Phase 2|Administrative problems|0|||
23509613|NCT01543698|65601908|FG006|Phase 2|Administrative problems|0|||
23509614|NCT01543698|65601909|FG007|Phase 2|Administrative problems|0|||
23509615|NCT01543698|65601910|FG008|Phase 2|Administrative problems|0|||
23509616|NCT01543698|65601911|FG009|Phase 2|Administrative problems|0|||
23509617|NCT01543698|65601912|FG010|Phase 2|Administrative problems|0|||
23509618|NCT01543698|65601913|FG011|Phase 2|Administrative problems|0|||
23509619|NCT01543698|65601914|FG012|Phase 2|Administrative problems|0|||
23509620|NCT01543698|65601915|FG013|Phase 2|Administrative problems|3|||
23509621|NCT01543698|65601916|FG014|Phase 2|Administrative problems|1|||
23509622|NCT01543698|65601902|FG000|Phase 2|Withdrawal by Subject|0|||
23509623|NCT01543698|65601903|FG001|Phase 2|Withdrawal by Subject|0|||
23509624|NCT01543698|65601904|FG002|Phase 2|Withdrawal by Subject|0|||
23509625|NCT01543698|65601905|FG003|Phase 2|Withdrawal by Subject|0|||
23509626|NCT01543698|65601906|FG004|Phase 2|Withdrawal by Subject|0|||
23509627|NCT01543698|65601907|FG005|Phase 2|Withdrawal by Subject|0|||
23509628|NCT01543698|65601908|FG006|Phase 2|Withdrawal by Subject|0|||
23509629|NCT01543698|65601909|FG007|Phase 2|Withdrawal by Subject|0|||
23509630|NCT01543698|65601910|FG008|Phase 2|Withdrawal by Subject|0|||
23509631|NCT01543698|65601911|FG009|Phase 2|Withdrawal by Subject|0|||
23509632|NCT01543698|65601912|FG010|Phase 2|Withdrawal by Subject|0|||
23509633|NCT01543698|65601913|FG011|Phase 2|Withdrawal by Subject|0|||
23509634|NCT01543698|65601914|FG012|Phase 2|Withdrawal by Subject|0|||
23509635|NCT01543698|65601915|FG013|Phase 2|Withdrawal by Subject|3|||
23509636|NCT01543698|65601916|FG014|Phase 2|Withdrawal by Subject|1|||
23509637|NCT01543698|65601902|FG000|Phase 2|Adverse Event|0|||
23509638|NCT01543698|65601903|FG001|Phase 2|Adverse Event|0|||
23509639|NCT01543698|65601904|FG002|Phase 2|Adverse Event|0|||
23509640|NCT01543698|65601905|FG003|Phase 2|Adverse Event|0|||
23509641|NCT01543698|65601906|FG004|Phase 2|Adverse Event|0|||
23509642|NCT01543698|65601907|FG005|Phase 2|Adverse Event|0|||
23509643|NCT01543698|65601908|FG006|Phase 2|Adverse Event|0|||
23509644|NCT01543698|65601909|FG007|Phase 2|Adverse Event|0|||
23509645|NCT01543698|65601910|FG008|Phase 2|Adverse Event|0|||
23509646|NCT01543698|65601911|FG009|Phase 2|Adverse Event|0|||
23509647|NCT01543698|65601912|FG010|Phase 2|Adverse Event|0|||
23509648|NCT01543698|65601913|FG011|Phase 2|Adverse Event|1|||
23509649|NCT01543698|65601914|FG012|Phase 2|Adverse Event|3|||
23509650|NCT01543698|65601915|FG013|Phase 2|Adverse Event|5|||
23509651|NCT01543698|65601916|FG014|Phase 2|Adverse Event|14|||
23509652|NCT01874054|65601917|FG000|Overall Study|Withdrawal by Subject|3|||
23509653|NCT01874054|65601917|FG000|Overall Study|Study Termination by Sponsor|42|||
23509654|NCT01874054|65601917|FG000|Overall Study|Lost to Follow-up|5|||
23509655|NCT01874054|65601917|FG000|Overall Study|Death|5|||
23509656|NCT02279420|65601918|FG000|Overall Study|Lost to Follow-up|23|||
23509657|NCT02599129|65601921|FG000|Overall Study|Lack of Efficacy|2|||
23509658|NCT02599129|65601922|FG001|Overall Study|Lack of Efficacy|2|||
23509659|NCT02599129|65601921|FG000|Overall Study|Lost to Follow-up|1|||
23509660|NCT02599129|65601922|FG001|Overall Study|Lost to Follow-up|0|||
23509661|NCT02599129|65601921|FG000|Overall Study|Withdrawal by Subject|2|||
23509662|NCT02599129|65601922|FG001|Overall Study|Withdrawal by Subject|1|||
23509663|NCT02370160|65601926|FG000|Overall Study|Death|3|||
23509664|NCT02370160|65601927|FG001|Overall Study|Death|4|||
23509665|NCT02370160|65601928|FG002|Overall Study|Death|1|||
23509666|NCT00850564|65601929|FG000|Overall Study|Withdrawal by Subject|2|||
23509667|NCT01338792|65601933|FG000|Overall Study|Adverse Event|2|||
23509668|NCT01338792|65601933|FG000|Overall Study|Death|1|||
23509669|NCT01338792|65601933|FG000|Overall Study|Withdrawal by Subject|1|||
23509670|NCT00276744|65601934|FG000|PART A|Reason unknown|98|||
23509671|NCT02268084|65601936|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
23509672|NCT02268084|65601937|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
23509673|NCT02268084|65601936|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
23509674|NCT02268084|65601937|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
23509675|NCT02329730|65601938|FG000|Overall Study|Protocol Violation|0|||
23509676|NCT02329730|65601939|FG001|Overall Study|Protocol Violation|0|||
23509677|NCT02329730|65601940|FG002|Overall Study|Protocol Violation|0|||
23509678|NCT02329730|65601941|FG003|Overall Study|Protocol Violation|0|||
23509679|NCT02329730|65601942|FG004|Overall Study|Protocol Violation|2|||
23509680|NCT02329730|65601943|FG005|Overall Study|Protocol Violation|2|||
23509681|NCT02329730|65601944|FG006|Overall Study|Protocol Violation|0|||
23509682|NCT02329730|65601945|FG007|Overall Study|Protocol Violation|0|||
23608114|NCT01986348|65953574|FG001|Overall Study|Progressive Disease|0|||
23608115|NCT01986348|65953575|FG002|Overall Study|Progressive Disease|2|||
23608116|NCT01986348|65953576|FG003|Overall Study|Progressive Disease|0|||
23608117|NCT01986348|65953573|FG000|Overall Study|Withdrawal by Participant|0|||
23408567|NCT03782259|65239923|FG000|Overall Study|Moved out of state|0|||
23509683|NCT02329730|65601946|FG008|Overall Study|Protocol Violation|0|||
23509684|NCT02329730|65601947|FG009|Overall Study|Protocol Violation|0|||
23509685|NCT02329730|65601948|FG010|Overall Study|Protocol Violation|0|||
23509686|NCT02329730|65601949|FG011|Overall Study|Protocol Violation|0|||
23509687|NCT02329730|65601938|FG000|Overall Study|Withdrawal by Subject|0|||
23509688|NCT02329730|65601939|FG001|Overall Study|Withdrawal by Subject|0|||
23509689|NCT02329730|65601940|FG002|Overall Study|Withdrawal by Subject|0|||
23509690|NCT02329730|65601941|FG003|Overall Study|Withdrawal by Subject|0|||
23509691|NCT02329730|65601942|FG004|Overall Study|Withdrawal by Subject|1|||
23509692|NCT02329730|65601943|FG005|Overall Study|Withdrawal by Subject|0|||
23509693|NCT02329730|65601944|FG006|Overall Study|Withdrawal by Subject|1|||
23509694|NCT02329730|65601945|FG007|Overall Study|Withdrawal by Subject|1|||
23509695|NCT02329730|65601946|FG008|Overall Study|Withdrawal by Subject|1|||
23509696|NCT02329730|65601947|FG009|Overall Study|Withdrawal by Subject|1|||
23509697|NCT02329730|65601948|FG010|Overall Study|Withdrawal by Subject|0|||
23509698|NCT02329730|65601949|FG011|Overall Study|Withdrawal by Subject|0|||
23509699|NCT00296374|65601952|FG000|Overall Study|Adverse Event|14|||
23509700|NCT00296374|65601953|FG001|Overall Study|Adverse Event|10|||
23509701|NCT00296374|65601954|FG002|Overall Study|Adverse Event|7|||
23509702|NCT00296374|65601952|FG000|Overall Study|Withdrawal by Subject|3|||
23509703|NCT00296374|65601953|FG001|Overall Study|Withdrawal by Subject|5|||
23509704|NCT00296374|65601954|FG002|Overall Study|Withdrawal by Subject|11|||
23509705|NCT00296374|65601952|FG000|Overall Study|Incorrect enrollment|3|||
23509706|NCT00296374|65601953|FG001|Overall Study|Incorrect enrollment|3|||
23509707|NCT00296374|65601954|FG002|Overall Study|Incorrect enrollment|4|||
23509708|NCT00296374|65601952|FG000|Overall Study|Protocol Violation|1|||
23509709|NCT00296374|65601953|FG001|Overall Study|Protocol Violation|2|||
23509710|NCT00296374|65601954|FG002|Overall Study|Protocol Violation|3|||
23509711|NCT00296374|65601952|FG000|Overall Study|Lost to Follow-up|3|||
23509712|NCT00296374|65601953|FG001|Overall Study|Lost to Follow-up|1|||
23509713|NCT00296374|65601954|FG002|Overall Study|Lost to Follow-up|1|||
23509714|NCT00296374|65601952|FG000|Overall Study|Relocated to another state|1|||
23509715|NCT00296374|65601953|FG001|Overall Study|Relocated to another state|0|||
23509716|NCT00296374|65601954|FG002|Overall Study|Relocated to another state|0|||
23509717|NCT00296374|65601952|FG000|Overall Study|Stopped drug before end of study visit|0|||
23509718|NCT00296374|65601953|FG001|Overall Study|Stopped drug before end of study visit|1|||
23509719|NCT00296374|65601954|FG002|Overall Study|Stopped drug before end of study visit|0|||
23509720|NCT00296374|65601952|FG000|Overall Study|Nephrologist introduced ACE|0|||
23509721|NCT00296374|65601953|FG001|Overall Study|Nephrologist introduced ACE|1|||
23509722|NCT00296374|65601954|FG002|Overall Study|Nephrologist introduced ACE|0|||
23509723|NCT00296374|65601952|FG000|Overall Study|Pregnancy|0|||
23509724|NCT00296374|65601953|FG001|Overall Study|Pregnancy|0|||
23509725|NCT00296374|65601954|FG002|Overall Study|Pregnancy|2|||
23509726|NCT00296374|65601952|FG000|Overall Study|Other|0|||
23509727|NCT00296374|65601953|FG001|Overall Study|Other|0|||
23509728|NCT00296374|65601954|FG002|Overall Study|Other|1|||
23509729|NCT02483520|65601955|FG000|Overall Study|Lost to Follow-up|3|||
23509730|NCT02483520|65601956|FG001|Overall Study|Lost to Follow-up|4|||
23509731|NCT02483520|65601955|FG000|Overall Study|Withdrawal by Subject|4|||
23509732|NCT02483520|65601956|FG001|Overall Study|Withdrawal by Subject|14|||
23509733|NCT02483520|65601955|FG000|Overall Study|Hospitalized|2|||
23509734|NCT02483520|65601956|FG001|Overall Study|Hospitalized|3|||
23509735|NCT02483520|65601955|FG000|Overall Study|Moved to LTC|2|||
23509736|NCT02483520|65601956|FG001|Overall Study|Moved to LTC|3|||
23509737|NCT00331682|65601957|FG000|Overall Study|Adverse Event|1|||
23509738|NCT00459953|65601958|FG000|Overall Study|not analyzed-household member in study|1|||
23509739|NCT00459953|65601959|FG001|Overall Study|not analyzed-household member in study|1|||
23509740|NCT01074450|65601960|FG000|First Intervention|Emesis in Dosing Interval|0|||
23509741|NCT01074450|65601961|FG001|First Intervention|Emesis in Dosing Interval|2|||
23509742|NCT01074450|65601960|FG000|Second Intervention|Protocol Violation|1|||
23509743|NCT01074450|65601961|FG001|Second Intervention|Protocol Violation|0|||
23509744|NCT01074450|65601960|FG000|Second Intervention|Physician Decision|0|||
23509745|NCT01074450|65601961|FG001|Second Intervention|Physician Decision|1|||
23509746|NCT01134783|65601964|FG000|Overall Study|Pregnancy|16|||
23509747|NCT01134783|65601965|FG001|Overall Study|Pregnancy|8|||
23509748|NCT01134783|65601964|FG000|Overall Study|Withdrawal by Subject|15|||
23509749|NCT01134783|65601965|FG001|Overall Study|Withdrawal by Subject|9|||
23509750|NCT01134783|65601964|FG000|Overall Study|Lost to Follow-up|5|||
23608118|NCT01986348|65953574|FG001|Overall Study|Withdrawal by Participant|1|||
23608119|NCT01986348|65953575|FG002|Overall Study|Withdrawal by Participant|2|||
23608120|NCT01986348|65953576|FG003|Overall Study|Withdrawal by Participant|1|||
23608121|NCT01986348|65953573|FG000|Overall Study|Study Terminated by Sponsor|0|||
23608122|NCT01986348|65953574|FG001|Overall Study|Study Terminated by Sponsor|0|||
23608123|NCT01986348|65953575|FG002|Overall Study|Study Terminated by Sponsor|0|||
23608124|NCT01986348|65953576|FG003|Overall Study|Study Terminated by Sponsor|3|||
23608125|NCT01986348|65953573|FG000|Overall Study|Other-unspecified|0|||
23608126|NCT01986348|65953574|FG001|Overall Study|Other-unspecified|1|||
23608127|NCT01986348|65953575|FG002|Overall Study|Other-unspecified|0|||
23608128|NCT01986348|65953576|FG003|Overall Study|Other-unspecified|2|||
23608129|NCT01071317|65953577|FG000|Overall Study|Lost to Follow-up|2|||
23608130|NCT01071317|65953578|FG001|Overall Study|Lost to Follow-up|2|||
23608131|NCT03390166|65953581|FG000|Overall Study|Death|0|||
23608132|NCT03390166|65953582|FG001|Overall Study|Death|1|||
23608133|NCT03390166|65953581|FG000|Overall Study|Lost to Follow-up|6|||
23608134|NCT03390166|65953582|FG001|Overall Study|Lost to Follow-up|4|||
23608135|NCT03390166|65953581|FG000|Overall Study|Physician Decision|2|||
23608136|NCT03390166|65953582|FG001|Overall Study|Physician Decision|1|||
23608137|NCT03390166|65953581|FG000|Overall Study|Move from study area|3|||
23608138|NCT03390166|65953582|FG001|Overall Study|Move from study area|2|||
23608139|NCT03390166|65953581|FG000|Overall Study|To militarycamp for conscript|1|||
23608140|NCT03390166|65953582|FG001|Overall Study|To militarycamp for conscript|0|||
23608141|NCT03390166|65953581|FG000|Overall Study|To drug therapy course|0|||
23608142|NCT03390166|65953582|FG001|Overall Study|To drug therapy course|1|||
23608143|NCT03390166|65953581|FG000|Overall Study|Move to work oversea|0|||
23608144|NCT03390166|65953582|FG001|Overall Study|Move to work oversea|1|||
23608145|NCT01029925|65953583|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
23608146|NCT01029925|65953583|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
23608147|NCT01029925|65953583|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
23608148|NCT00925548|65953588|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
23608149|NCT00925548|65953589|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
23608150|NCT02245620|65953592|FG000|Overall Study|Physician Decision|1|||
23608151|NCT02245620|65953593|FG001|Overall Study|Physician Decision|1|||
23608152|NCT02085941|65953598|FG000|Overall Study|Lack of Efficacy|1|||
23608153|NCT02085941|65953599|FG001|Overall Study|Lack of Efficacy|0|||
23608154|NCT02085941|65953598|FG000|Overall Study|Death|6|||
23608155|NCT02085941|65953599|FG001|Overall Study|Death|1|||
23608156|NCT02085941|65953598|FG000|Overall Study|Lost to Follow-up|1|||
23608157|NCT02085941|65953599|FG001|Overall Study|Lost to Follow-up|0|||
23608158|NCT02085941|65953598|FG000|Overall Study|Physician Decision|0|||
23608159|NCT02085941|65953599|FG001|Overall Study|Physician Decision|2|||
23608160|NCT01836523|65953600|FG000|Overall Study|Adverse Event|15|||
23608161|NCT01836523|65953601|FG001|Overall Study|Adverse Event|41|||
23608162|NCT01836523|65953602|FG002|Overall Study|Adverse Event|49|||
23608163|NCT01836523|65953603|FG003|Overall Study|Adverse Event|14|||
23608164|NCT01836523|65953600|FG000|Overall Study|Protocol Violation|6|||
23608165|NCT01836523|65953601|FG001|Overall Study|Protocol Violation|3|||
23608166|NCT01836523|65953602|FG002|Overall Study|Protocol Violation|2|||
23608167|NCT01836523|65953603|FG003|Overall Study|Protocol Violation|4|||
23608168|NCT01836523|65953600|FG000|Overall Study|Met Withdrawal Criteria|13|||
23608169|NCT01836523|65953601|FG001|Overall Study|Met Withdrawal Criteria|13|||
23608170|NCT01836523|65953602|FG002|Overall Study|Met Withdrawal Criteria|21|||
23608171|NCT01836523|65953603|FG003|Overall Study|Met Withdrawal Criteria|27|||
23608172|NCT01836523|65953600|FG000|Overall Study|Unclassified|17|||
23608173|NCT01836523|65953601|FG001|Overall Study|Unclassified|28|||
23608174|NCT01836523|65953602|FG002|Overall Study|Unclassified|19|||
23608175|NCT01836523|65953603|FG003|Overall Study|Unclassified|29|||
23608176|NCT03122860|65953604|FG000|Overall Study|Discontinued Before Treatment|1|||
23608177|NCT03122860|65953605|FG001|Overall Study|Discontinued Before Treatment|1|||
23608178|NCT03122860|65953606|FG002|Overall Study|Discontinued Before Treatment|2|||
23608179|NCT03122860|65953607|FG003|Overall Study|Discontinued Before Treatment|0|||
23608180|NCT03122860|65953608|FG004|Overall Study|Discontinued Before Treatment|1|||
23608181|NCT03122860|65953609|FG005|Overall Study|Discontinued Before Treatment|0|||
23608182|NCT03122860|65953604|FG000|Overall Study|Adverse Event|1|||
23608183|NCT03122860|65953605|FG001|Overall Study|Adverse Event|0|||
23608184|NCT03122860|65953606|FG002|Overall Study|Adverse Event|1|||
23608185|NCT03122860|65953607|FG003|Overall Study|Adverse Event|1|||
23608186|NCT03122860|65953608|FG004|Overall Study|Adverse Event|0|||
23608187|NCT03122860|65953609|FG005|Overall Study|Adverse Event|0|||
23608188|NCT03122860|65953604|FG000|Overall Study|Lost to Follow-up|5|||
23608189|NCT03122860|65953605|FG001|Overall Study|Lost to Follow-up|2|||
23608190|NCT03122860|65953606|FG002|Overall Study|Lost to Follow-up|3|||
23608191|NCT03122860|65953607|FG003|Overall Study|Lost to Follow-up|3|||
23608192|NCT03122860|65953608|FG004|Overall Study|Lost to Follow-up|5|||
23608193|NCT03122860|65953609|FG005|Overall Study|Lost to Follow-up|4|||
23608194|NCT03122860|65953604|FG000|Overall Study|Subject Non-Compliance|0|||
23608195|NCT03122860|65953605|FG001|Overall Study|Subject Non-Compliance|0|||
23509751|NCT01134783|65601965|FG001|Overall Study|Lost to Follow-up|20|||
23608196|NCT03122860|65953606|FG002|Overall Study|Subject Non-Compliance|1|||
23608197|NCT03122860|65953607|FG003|Overall Study|Subject Non-Compliance|0|||
23608198|NCT03122860|65953608|FG004|Overall Study|Subject Non-Compliance|0|||
23608199|NCT03122860|65953609|FG005|Overall Study|Subject Non-Compliance|0|||
23608200|NCT03122860|65953604|FG000|Overall Study|Withdrawal by Subject|3|||
23608201|NCT03122860|65953605|FG001|Overall Study|Withdrawal by Subject|2|||
23608202|NCT03122860|65953606|FG002|Overall Study|Withdrawal by Subject|5|||
23608203|NCT03122860|65953607|FG003|Overall Study|Withdrawal by Subject|7|||
23608204|NCT03122860|65953608|FG004|Overall Study|Withdrawal by Subject|9|||
23608205|NCT03122860|65953609|FG005|Overall Study|Withdrawal by Subject|8|||
23608206|NCT01858688|65953610|FG000|Overall Study|Withdrawal by Subject|8|||
23608207|NCT01858688|65953610|FG000|Overall Study|Participant began another therapy|3|||
23608208|NCT01858688|65953610|FG000|Overall Study|Physician Decision|2|||
23608209|NCT01858688|65953610|FG000|Overall Study|Progressive Disease|2|||
23608210|NCT01858688|65953610|FG000|Overall Study|Reason not reproted|5|||
23608211|NCT03137459|65953615|FG000|2-month Assessment|Withdrawal by Subject|13|||
23608212|NCT03137459|65953616|FG001|2-month Assessment|Withdrawal by Subject|3|||
23608213|NCT03137459|65953615|FG000|2-month Assessment|Unable to reach|42|||
23608214|NCT03137459|65953616|FG001|2-month Assessment|Unable to reach|32|||
23608215|NCT03137459|65953615|FG000|2-month Assessment|Refused assessment|7|||
23608216|NCT03137459|65953616|FG001|2-month Assessment|Refused assessment|5|||
23608217|NCT03137459|65953615|FG000|2-month Assessment|Acutely ill|6|||
23608218|NCT03137459|65953616|FG001|2-month Assessment|Acutely ill|2|||
23608219|NCT03137459|65953615|FG000|4-month Assessment|Death|4|||
23608220|NCT03137459|65953616|FG001|4-month Assessment|Death|2|||
23608221|NCT03137459|65953615|FG000|4-month Assessment|Withdrawal by Subject|4|||
23608222|NCT03137459|65953616|FG001|4-month Assessment|Withdrawal by Subject|2|||
23608223|NCT03137459|65953615|FG000|4-month Assessment|Unable to reach|44|||
23608224|NCT03137459|65953616|FG001|4-month Assessment|Unable to reach|29|||
23608225|NCT03137459|65953615|FG000|4-month Assessment|Refused assessment|24|||
23608226|NCT03137459|65953616|FG001|4-month Assessment|Refused assessment|10|||
23608227|NCT03137459|65953615|FG000|4-month Assessment|Acutely ill|2|||
23608228|NCT03137459|65953616|FG001|4-month Assessment|Acutely ill|3|||
23608229|NCT03137459|65953615|FG000|6-months|Lost to Follow-up|14|||
23608230|NCT03137459|65953616|FG001|6-months|Lost to Follow-up|11|||
23608231|NCT03137459|65953615|FG000|6-months|Death|0|||
23608232|NCT03137459|65953616|FG001|6-months|Death|2|||
23608233|NCT03137459|65953615|FG000|6-months|Refused assessment|6|||
23509752|NCT03247530|65601966|FG000|Overall Study|Withdrawal by caregiver|19|||
23509753|NCT03247530|65601967|FG001|Overall Study|Withdrawal by caregiver|8|||
23509754|NCT03247530|65601968|FG002|Overall Study|Withdrawal by caregiver|10|||
23509755|NCT03247530|65601966|FG000|Overall Study|Lost to Follow-up|3|||
23509756|NCT03247530|65601967|FG001|Overall Study|Lost to Follow-up|9|||
23509757|NCT03247530|65601968|FG002|Overall Study|Lost to Follow-up|6|||
23509758|NCT03247530|65601966|FG000|Overall Study|Adverse Event|2|||
23509759|NCT03247530|65601967|FG001|Overall Study|Adverse Event|5|||
23509760|NCT03247530|65601968|FG002|Overall Study|Adverse Event|2|||
23509761|NCT03247530|65601966|FG000|Overall Study|Failure to follow procedure|1|||
23509762|NCT03247530|65601967|FG001|Overall Study|Failure to follow procedure|1|||
23509763|NCT03247530|65601968|FG002|Overall Study|Failure to follow procedure|1|||
23509764|NCT03247530|65601966|FG000|Overall Study|Withdrawal by Subject|1|||
23509765|NCT03247530|65601967|FG001|Overall Study|Withdrawal by Subject|1|||
23509766|NCT03247530|65601968|FG002|Overall Study|Withdrawal by Subject|0|||
23509767|NCT03247530|65601966|FG000|Overall Study|Study medication misuse|0|||
23509768|NCT03247530|65601967|FG001|Overall Study|Study medication misuse|1|||
23509769|NCT03247530|65601968|FG002|Overall Study|Study medication misuse|0|||
23509770|NCT03247530|65601966|FG000|Overall Study|Other, multiple categories|1|||
23509771|NCT03247530|65601967|FG001|Overall Study|Other, multiple categories|3|||
23509772|NCT03247530|65601968|FG002|Overall Study|Other, multiple categories|1|||
23509773|NCT02989194|65601969|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
23509774|NCT02989194|65601970|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
23509775|NCT02989194|65601971|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
23509776|NCT02989194|65601969|FG000|Overall Study|Lost to Follow-up|0|||
23509777|NCT02989194|65601970|FG001|Overall Study|Lost to Follow-up|1|||
23509778|NCT02989194|65601971|FG002|Overall Study|Lost to Follow-up|0|||
23509779|NCT02989194|65601969|FG000|Overall Study|Withdrawal by Subject|0|||
23509780|NCT02989194|65601970|FG001|Overall Study|Withdrawal by Subject|1|||
23509781|NCT02989194|65601971|FG002|Overall Study|Withdrawal by Subject|0|||
23509782|NCT03171415|65601974|FG000|Overall Study|Lost to Follow-up|0|||
23509783|NCT03171415|65601975|FG001|Overall Study|Lost to Follow-up|0|||
23509784|NCT03171415|65601976|FG002|Overall Study|Lost to Follow-up|0|||
23509785|NCT03171415|65601977|FG003|Overall Study|Lost to Follow-up|0|||
23509786|NCT03171415|65601978|FG004|Overall Study|Lost to Follow-up|2|||
23509787|NCT01937559|65601981|FG000|Overall Study|Physician Decision|3|||
23509788|NCT01937559|65601982|FG001|Overall Study|Physician Decision|3|||
23608234|NCT03137459|65953616|FG001|6-months|Refused assessment|3|||
23608235|NCT03137459|65953615|FG000|6-months|Acutely ill|1|||
23608236|NCT03137459|65953616|FG001|6-months|Acutely ill|1|||
23608237|NCT02365597|65953617|FG000|Overall Study|Lost to Follow-up|0|||
23608238|NCT02365597|65953618|FG001|Overall Study|Lost to Follow-up|1|||
23608239|NCT02365597|65953619|FG002|Overall Study|Lost to Follow-up|0|||
23608240|NCT02365597|65953620|FG003|Overall Study|Lost to Follow-up|1|||
23608241|NCT02365597|65953617|FG000|Overall Study|Withdrawal by Subject|1|||
23608242|NCT02365597|65953618|FG001|Overall Study|Withdrawal by Subject|8|||
23608243|NCT02365597|65953619|FG002|Overall Study|Withdrawal by Subject|5|||
23608244|NCT02365597|65953620|FG003|Overall Study|Withdrawal by Subject|1|||
23608245|NCT02365597|65953617|FG000|Overall Study|Sponsor's decision|1|||
23608246|NCT02365597|65953618|FG001|Overall Study|Sponsor's decision|3|||
23608247|NCT02365597|65953619|FG002|Overall Study|Sponsor's decision|13|||
23608248|NCT02365597|65953620|FG003|Overall Study|Sponsor's decision|0|||
23608249|NCT02365597|65953617|FG000|Overall Study|Other|0|||
23608250|NCT02365597|65953618|FG001|Overall Study|Other|4|||
23608251|NCT02365597|65953619|FG002|Overall Study|Other|0|||
23608252|NCT02365597|65953620|FG003|Overall Study|Other|0|||
23608253|NCT02365597|65953617|FG000|Overall Study|Enrolled but not treated|0|||
23608254|NCT02365597|65953618|FG001|Overall Study|Enrolled but not treated|1|||
23608255|NCT02365597|65953619|FG002|Overall Study|Enrolled but not treated|1|||
23608256|NCT02365597|65953620|FG003|Overall Study|Enrolled but not treated|0|||
23608257|NCT02365597|65953617|FG000|Overall Study|Ongoing|0|||
23608258|NCT02365597|65953618|FG001|Overall Study|Ongoing|0|||
23608259|NCT02365597|65953619|FG002|Overall Study|Ongoing|0|||
23608260|NCT02365597|65953620|FG003|Overall Study|Ongoing|17|||
23608261|NCT01065779|65953622|FG000|Overall Study|Duplicate Investigation|1|||
23608262|NCT01065779|65953622|FG000|Overall Study|Investigation Before Contract Date|37|||
23608263|NCT01065779|65953622|FG000|Overall Study|Non-enrollment Period Administration|10|||
23608264|NCT01065779|65953622|FG000|Overall Study|Not Administered With Study Drug|17|||
23608265|NCT01065779|65953622|FG000|Overall Study|Failed to Follow-up|10|||
23608266|NCT01065779|65953622|FG000|Overall Study|Inclusion Criteria Violation|7|||
23608267|NCT01884571|65953627|FG000|Overall Study|Adverse Event|1|||
23608268|NCT01884571|65953627|FG000|Overall Study|Death|2|||
23608269|NCT01884571|65953627|FG000|Overall Study|Withdrawal by Subject|2|||
23608270|NCT01884571|65953627|FG000|Overall Study|Disease progression|3|||
23608271|NCT00663923|65953628|FG000|Overall Study|Lost to Follow-up|2|||
23608272|NCT02133131|65953629|FG000|Overall Study|Adverse Event|0|||
23608273|NCT02133131|65953630|FG001|Overall Study|Adverse Event|0|||
23608274|NCT02133131|65953631|FG002|Overall Study|Adverse Event|0|||
23608275|NCT02133131|65953632|FG003|Overall Study|Adverse Event|1|||
23608276|NCT02133131|65953633|FG004|Overall Study|Adverse Event|0|||
23608277|NCT02133131|65953634|FG005|Overall Study|Adverse Event|0|||
23608278|NCT02133131|65953635|FG006|Overall Study|Adverse Event|0|||
23608279|NCT02133131|65953629|FG000|Overall Study|Lost to Follow-up|1|||
23608280|NCT02133131|65953630|FG001|Overall Study|Lost to Follow-up|0|||
23608281|NCT02133131|65953631|FG002|Overall Study|Lost to Follow-up|0|||
23608282|NCT02133131|65953632|FG003|Overall Study|Lost to Follow-up|1|||
23608283|NCT02133131|65953633|FG004|Overall Study|Lost to Follow-up|0|||
23608284|NCT02133131|65953634|FG005|Overall Study|Lost to Follow-up|0|||
23608285|NCT02133131|65953635|FG006|Overall Study|Lost to Follow-up|0|||
23608286|NCT02133131|65953629|FG000|Overall Study|Status not recorded|4|||
23608287|NCT02133131|65953630|FG001|Overall Study|Status not recorded|5|||
23608288|NCT02133131|65953631|FG002|Overall Study|Status not recorded|1|||
23608289|NCT02133131|65953632|FG003|Overall Study|Status not recorded|4|||
23608290|NCT02133131|65953633|FG004|Overall Study|Status not recorded|0|||
23608291|NCT02133131|65953634|FG005|Overall Study|Status not recorded|0|||
23608292|NCT02133131|65953635|FG006|Overall Study|Status not recorded|0|||
23608293|NCT02133131|65953629|FG000|Overall Study|Ongoing in study|0|||
23608294|NCT02133131|65953630|FG001|Overall Study|Ongoing in study|0|||
23608295|NCT02133131|65953631|FG002|Overall Study|Ongoing in study|0|||
23608296|NCT02133131|65953632|FG003|Overall Study|Ongoing in study|0|||
23608297|NCT02133131|65953633|FG004|Overall Study|Ongoing in study|15|||
23408568|NCT03782259|65239924|FG001|Overall Study|Moved out of state|2|||
23608298|NCT02133131|65953634|FG005|Overall Study|Ongoing in study|14|||
23608299|NCT02133131|65953635|FG006|Overall Study|Ongoing in study|11|||
23608300|NCT02133131|65953629|FG000|Overall Study|Protocol Violation|0|||
23608301|NCT02133131|65953630|FG001|Overall Study|Protocol Violation|0|||
23608302|NCT02133131|65953631|FG002|Overall Study|Protocol Violation|0|||
23608303|NCT02133131|65953632|FG003|Overall Study|Protocol Violation|0|||
23608304|NCT02133131|65953633|FG004|Overall Study|Protocol Violation|0|||
23608305|NCT02133131|65953634|FG005|Overall Study|Protocol Violation|0|||
23608306|NCT02133131|65953635|FG006|Overall Study|Protocol Violation|1|||
23608307|NCT03162614|65953637|FG000|Overall Study|Lost to Follow-up|2|||
23608308|NCT03162614|65953638|FG001|Overall Study|Lost to Follow-up|1|||
23608309|NCT03162614|65953639|FG002|Overall Study|Lost to Follow-up|1|||
23608310|NCT03162614|65953640|FG003|Overall Study|Lost to Follow-up|1|||
23608311|NCT03162614|65953641|FG004|Overall Study|Lost to Follow-up|2|||
23608312|NCT03162614|65953642|FG005|Overall Study|Lost to Follow-up|0|||
23608313|NCT03162614|65953637|FG000|Overall Study|Protocol Violation|0|||
23608314|NCT03162614|65953638|FG001|Overall Study|Protocol Violation|1|||
23608315|NCT03162614|65953639|FG002|Overall Study|Protocol Violation|0|||
23608316|NCT03162614|65953640|FG003|Overall Study|Protocol Violation|1|||
23608317|NCT03162614|65953641|FG004|Overall Study|Protocol Violation|0|||
23608318|NCT03162614|65953642|FG005|Overall Study|Protocol Violation|0|||
23608319|NCT03162614|65953637|FG000|Overall Study|Withdrawal by Subject|2|||
23608320|NCT03162614|65953638|FG001|Overall Study|Withdrawal by Subject|1|||
23608321|NCT03162614|65953639|FG002|Overall Study|Withdrawal by Subject|1|||
23608322|NCT03162614|65953640|FG003|Overall Study|Withdrawal by Subject|1|||
23608323|NCT03162614|65953641|FG004|Overall Study|Withdrawal by Subject|0|||
23608324|NCT03162614|65953642|FG005|Overall Study|Withdrawal by Subject|0|||
23608325|NCT03162614|65953637|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
23608326|NCT03162614|65953638|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
23608327|NCT03162614|65953639|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
23608328|NCT03162614|65953640|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
23608329|NCT03162614|65953641|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
23608330|NCT03162614|65953642|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
23608331|NCT00805792|65953643|FG000|Overall Study|Death|3|||
23608332|NCT00805792|65953643|FG000|Overall Study|Lost to Follow-up|2|||
23608333|NCT01970527|65953644|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
23608334|NCT01970527|65953645|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
23608335|NCT01970527|65953644|FG000|Treatment|Disease progression|0|||
23608336|NCT01970527|65953645|FG001|Treatment|Disease progression|1|||
23608337|NCT01970527|65953644|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
23608338|NCT01970527|65953645|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
23608339|NCT01970527|65953644|FG000|Treatment|Death|0|||
23608340|NCT01970527|65953645|FG001|Treatment|Death|1|||
23608341|NCT01970527|65953644|FG000|Follow-up Clinic Visit|Disease progression|1|||
23608342|NCT01970527|65953645|FG001|Follow-up Clinic Visit|Disease progression|1|||
23608343|NCT01970527|65953644|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
23608344|NCT01970527|65953645|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
23608345|NCT01970527|65953644|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
23608346|NCT01970527|65953645|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
23608347|NCT01721109|65953646|FG000|Overall Study|Lack of Efficacy|1|||
23608348|NCT01721109|65953646|FG000|Overall Study|Non- Compliance with Study Drug|3|||
23608349|NCT01721109|65953646|FG000|Overall Study|Withdrew Consent|1|||
23608350|NCT01721109|65953646|FG000|Overall Study|Lost to Follow-up|2|||
23608351|NCT01722097|65953647|FG000|Overall Study|Patient sheets not returned|6|||
23608352|NCT01722097|65953648|FG001|Overall Study|Patient sheets not returned|5|||
23608353|NCT02132195|65953649|FG000|Initial Assignment|Relapsed|14|||
23608354|NCT02132195|65953650|FG001|Initial Assignment|Relapsed|0|||
23608355|NCT02132195|65953651|FG002|Initial Assignment|Relapsed|0|||
23608356|NCT02132195|65953649|FG000|Rescue Therapy|Relapsed|0|||
23608357|NCT02132195|65953650|FG001|Rescue Therapy|Relapsed|0|||
23608358|NCT02132195|65953651|FG002|Rescue Therapy|Relapsed|7|||
23608359|NCT02132195|65953649|FG000|Rescue Therapy|Physician Decision|0|||
23608360|NCT02132195|65953650|FG001|Rescue Therapy|Physician Decision|0|||
23608361|NCT02132195|65953651|FG002|Rescue Therapy|Physician Decision|1|||
23608362|NCT02132195|65953649|FG000|Rescue Therapy|Withdrawal by Subject|0|||
23608363|NCT02132195|65953650|FG001|Rescue Therapy|Withdrawal by Subject|0|||
23608364|NCT02132195|65953651|FG002|Rescue Therapy|Withdrawal by Subject|1|||
23608365|NCT02132195|65953649|FG000|Rescue Therapy|Adverse Event|0|||
23608366|NCT02132195|65953650|FG001|Rescue Therapy|Adverse Event|0|||
23608367|NCT02132195|65953651|FG002|Rescue Therapy|Adverse Event|2|||
23608368|NCT00910962|65953652|FG000|Overall Study|Adverse Event|5|||
23608369|NCT00910962|65953653|FG001|Overall Study|Adverse Event|20|||
23608370|NCT00910962|65953654|FG002|Overall Study|Adverse Event|17|||
23608371|NCT00910962|65953652|FG000|Overall Study|Protocol Violation|1|||
23608372|NCT00910962|65953653|FG001|Overall Study|Protocol Violation|3|||
23608373|NCT00910962|65953654|FG002|Overall Study|Protocol Violation|3|||
23608374|NCT00910962|65953652|FG000|Overall Study|Lost to Follow-up|0|||
23608375|NCT00910962|65953653|FG001|Overall Study|Lost to Follow-up|3|||
23608376|NCT00910962|65953654|FG002|Overall Study|Lost to Follow-up|1|||
23608377|NCT00910962|65953652|FG000|Overall Study|Physician Decision|0|||
23608378|NCT00910962|65953653|FG001|Overall Study|Physician Decision|6|||
23608379|NCT00910962|65953654|FG002|Overall Study|Physician Decision|6|||
23608380|NCT00910962|65953652|FG000|Overall Study|Withdrawal by Subject|25|||
23608381|NCT00910962|65953653|FG001|Overall Study|Withdrawal by Subject|32|||
23608382|NCT00910962|65953654|FG002|Overall Study|Withdrawal by Subject|32|||
23608383|NCT00910962|65953652|FG000|Overall Study|Reached defined stopping criteria|12|||
23608384|NCT00910962|65953653|FG001|Overall Study|Reached defined stopping criteria|14|||
23608385|NCT00910962|65953654|FG002|Overall Study|Reached defined stopping criteria|17|||
23608386|NCT02128269|65953655|FG000|Treatment Period|Adverse Event|1|||
23608387|NCT02128269|65953655|FG000|Treatment Period|Physician Decision|1|||
23608388|NCT02170207|65953656|FG000|Overall Study|Case report forms unavailable|5|||
23608389|NCT03236779|65953657|FG000|Overall Study|Lost to Follow-up|13|||
23608390|NCT03236779|65953658|FG001|Overall Study|Lost to Follow-up|21|||
23608391|NCT01802333|65953659|FG000|Overall Study|Ineligible|2|||
23608392|NCT01802333|65953660|FG001|Overall Study|Ineligible|6|||
23608393|NCT01802333|65953661|FG002|Overall Study|Ineligible|8|||
23608394|NCT01802333|65953659|FG000|Overall Study|Adverse Event|1|||
23608395|NCT01802333|65953660|FG001|Overall Study|Adverse Event|8|||
23608396|NCT01802333|65953661|FG002|Overall Study|Adverse Event|8|||
23608397|NCT01802333|65953659|FG000|Overall Study|Withdrawal by Subject|6|||
23608398|NCT01802333|65953660|FG001|Overall Study|Withdrawal by Subject|6|||
23608399|NCT01802333|65953661|FG002|Overall Study|Withdrawal by Subject|5|||
23608400|NCT01802333|65953659|FG000|Overall Study|Progression/relapse|1|||
23608401|NCT01802333|65953660|FG001|Overall Study|Progression/relapse|3|||
23608402|NCT01802333|65953661|FG002|Overall Study|Progression/relapse|0|||
23608403|NCT01802333|65953659|FG000|Overall Study|Death|7|||
23608404|NCT01802333|65953660|FG001|Overall Study|Death|14|||
23608405|NCT01802333|65953661|FG002|Overall Study|Death|13|||
23608406|NCT01802333|65953659|FG000|Overall Study|Other - not protocol specified|32|||
23608407|NCT01802333|65953660|FG001|Overall Study|Other - not protocol specified|22|||
23608408|NCT01802333|65953661|FG002|Overall Study|Other - not protocol specified|24|||
23608409|NCT01802333|65953659|FG000|Overall Study|Did not start treatment|0|||
23608410|NCT01802333|65953660|FG001|Overall Study|Did not start treatment|2|||
23608411|NCT01802333|65953661|FG002|Overall Study|Did not start treatment|5|||
23608412|NCT05124210|65953664|FG000|Overall Study|Lost to Follow-up|1|||
23608413|NCT05124210|65953665|FG001|Overall Study|Lost to Follow-up|0|||
23608414|NCT05124210|65953664|FG000|Overall Study|Withdrawal by Subject|1|||
23608415|NCT05124210|65953665|FG001|Overall Study|Withdrawal by Subject|0|||
23608416|NCT00257556|65953666|FG000|Overall Study|Adverse Event|1|||
23608417|NCT00257556|65953667|FG001|Overall Study|Adverse Event|4|||
23608418|NCT00257556|65953666|FG000|Overall Study|Physician Decision|6|||
23608419|NCT00257556|65953667|FG001|Overall Study|Physician Decision|0|||
23608420|NCT00257556|65953666|FG000|Overall Study|Did not meet hCG criterion|3|||
23608421|NCT00257556|65953667|FG001|Overall Study|Did not meet hCG criterion|0|||
23608422|NCT00257556|65953666|FG000|Overall Study|other reason|4|||
23608423|NCT00257556|65953667|FG001|Overall Study|other reason|6|||
23608424|NCT00578344|65953668|FG000|Overall Study|Insurance problems|1|||
23608425|NCT00578344|65953668|FG000|Overall Study|Graft failure|1|||
23608426|NCT02981953|65953669|FG000|Overall Study|Death|9|||
23608427|NCT02981953|65953669|FG000|Overall Study|Withdrawal by Subject|1|||
23608428|NCT02981953|65953669|FG000|Overall Study|Withdrawal to non-compliance|1|||
23608429|NCT00424476|65956274|FG000|Overall Study|Withdrawal by Subject|7|||
23608430|NCT00424476|65956275|FG001|Overall Study|Withdrawal by Subject|6|||
23608431|NCT00424476|65956276|FG002|Overall Study|Withdrawal by Subject|3|||
23608432|NCT00424476|65956274|FG000|Overall Study|Adverse Event|19|||
23608433|NCT00424476|65956275|FG001|Overall Study|Adverse Event|16|||
23608434|NCT00424476|65956276|FG002|Overall Study|Adverse Event|15|||
23608435|NCT00424476|65956274|FG000|Overall Study|Lack of Efficacy|16|||
23608436|NCT00424476|65956275|FG001|Overall Study|Lack of Efficacy|12|||
23608437|NCT00424476|65956276|FG002|Overall Study|Lack of Efficacy|12|||
23608438|NCT00424476|65956274|FG000|Overall Study|Lack of Compliance|1|||
23608439|NCT00424476|65956275|FG001|Overall Study|Lack of Compliance|1|||
23608440|NCT00424476|65956276|FG002|Overall Study|Lack of Compliance|1|||
23608441|NCT00424476|65956274|FG000|Overall Study|Lost to Follow-up|4|||
23608442|NCT00424476|65956275|FG001|Overall Study|Lost to Follow-up|6|||
23608443|NCT00424476|65956276|FG002|Overall Study|Lost to Follow-up|3|||
23608444|NCT00424476|65956274|FG000|Overall Study|Protocol Violation|7|||
23608445|NCT00424476|65956275|FG001|Overall Study|Protocol Violation|2|||
23608446|NCT00424476|65956276|FG002|Overall Study|Protocol Violation|3|||
23608447|NCT00424476|65956274|FG000|Overall Study|Physician Decision|3|||
23608448|NCT00424476|65956275|FG001|Overall Study|Physician Decision|2|||
23608449|NCT00424476|65956276|FG002|Overall Study|Physician Decision|3|||
23608450|NCT00424476|65956274|FG000|Overall Study|Other|4|||
23608451|NCT00424476|65956275|FG001|Overall Study|Other|3|||
23608452|NCT00424476|65956276|FG002|Overall Study|Other|9|||
23608453|NCT03316170|65956277|FG000|Overall Study|Death|1|||
23608454|NCT03316170|65956278|FG001|Overall Study|Death|0|||
23608455|NCT03316170|65956277|FG000|Overall Study|Lost to Follow-up|6|||
23608456|NCT03316170|65956278|FG001|Overall Study|Lost to Follow-up|7|||
23608457|NCT03262389|65956279|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
23608458|NCT03262389|65956279|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
23608459|NCT03262389|65956279|FG000|Overall Study|opted out of PET/MR|1|||
23608460|NCT02764320|65956280|FG000|Overall Study|Withdrawal by Subject|35|||
23608461|NCT02764320|65956281|FG001|Overall Study|Withdrawal by Subject|38|||
23608462|NCT02764320|65956280|FG000|Overall Study|Protocol Violation|11|||
23608463|NCT02764320|65956281|FG001|Overall Study|Protocol Violation|6|||
23608464|NCT02764320|65956280|FG000|Overall Study|Adverse Event|2|||
23608465|NCT02764320|65956281|FG001|Overall Study|Adverse Event|0|||
23509789|NCT01937559|65601983|FG002|Overall Study|Physician Decision|0|||
23608466|NCT02764320|65956280|FG000|Overall Study|Health Issues unable to continue|2|||
23608467|NCT02764320|65956281|FG001|Overall Study|Health Issues unable to continue|0|||
23608468|NCT02764320|65956280|FG000|Overall Study|Did not meet inclusion criteria|1|||
23509790|NCT01937559|65601981|FG000|Overall Study|Withdrawal by Subject|6|||
23509791|NCT01937559|65601982|FG001|Overall Study|Withdrawal by Subject|4|||
23509792|NCT01937559|65601983|FG002|Overall Study|Withdrawal by Subject|0|||
23509793|NCT01937559|65601981|FG000|Overall Study|screen fail|2|||
23509794|NCT01937559|65601982|FG001|Overall Study|screen fail|4|||
23509795|NCT01937559|65601983|FG002|Overall Study|screen fail|0|||
23509796|NCT02707991|65601984|FG000|Overall Study|Protocol Violation|1|||
23509797|NCT02707991|65601985|FG001|Overall Study|Protocol Violation|0|||
23509798|NCT02707991|65601984|FG000|Overall Study|Became ineligible|0|||
23509799|NCT02707991|65601985|FG001|Overall Study|Became ineligible|1|||
23509800|NCT02064868|65601986|FG000|Overall Study|Lost to Follow-up|14|||
23509801|NCT02064868|65601987|FG001|Overall Study|Lost to Follow-up|8|||
23509802|NCT02064868|65601986|FG000|Overall Study|Physician Decision|1|||
23509803|NCT02064868|65601987|FG001|Overall Study|Physician Decision|0|||
23509804|NCT02064868|65601986|FG000|Overall Study|Withdrawal by Subject|14|||
23509805|NCT02064868|65601987|FG001|Overall Study|Withdrawal by Subject|3|||
23509806|NCT02064868|65601986|FG000|Overall Study|Technical Problems or Missing|5|||
23509807|NCT02064868|65601987|FG001|Overall Study|Technical Problems or Missing|2|||
23509808|NCT01513473|65601992|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
23509809|NCT01513473|65601993|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
23509810|NCT01513473|65601992|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
23509811|NCT01513473|65601993|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
23509812|NCT01513473|65601992|FG000|Main Trial (26 Weeks)|Unclassified|0|||
23509813|NCT01513473|65601993|FG001|Main Trial (26 Weeks)|Unclassified|2|||
23509814|NCT01513473|65601992|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
23509815|NCT01513473|65601993|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
23509816|NCT01513473|65601992|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
23509817|NCT01513473|65601993|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
23509818|NCT01085591|65601994|FG000|Overall Study|Adverse Event|0|||
23509819|NCT01085591|65601995|FG001|Overall Study|Adverse Event|1|||
23509820|NCT01085591|65601996|FG002|Overall Study|Adverse Event|3|||
23509821|NCT01085591|65601994|FG000|Overall Study|Physician Decision|1|||
23509822|NCT01085591|65601995|FG001|Overall Study|Physician Decision|0|||
23608469|NCT02764320|65956281|FG001|Overall Study|Did not meet inclusion criteria|0|||
23608470|NCT02764320|65956280|FG000|Overall Study|Subject moved|0|||
23608471|NCT02764320|65956281|FG001|Overall Study|Subject moved|2|||
23608472|NCT02764320|65956280|FG000|Overall Study|Overused medication unavailable|0|||
23509823|NCT01085591|65601996|FG002|Overall Study|Physician Decision|1|||
23509824|NCT01085591|65601994|FG000|Overall Study|Withdrawal by Subject|0|||
23509825|NCT01085591|65601995|FG001|Overall Study|Withdrawal by Subject|2|||
23509826|NCT01085591|65601996|FG002|Overall Study|Withdrawal by Subject|1|||
23509827|NCT01085591|65601994|FG000|Overall Study|Lost to Follow-up|0|||
23509828|NCT01085591|65601995|FG001|Overall Study|Lost to Follow-up|1|||
23509829|NCT01085591|65601996|FG002|Overall Study|Lost to Follow-up|1|||
23509830|NCT01085591|65601994|FG000|Overall Study|Protocol Violation|1|||
23608473|NCT02764320|65956281|FG001|Overall Study|Overused medication unavailable|1|||
23608474|NCT02764320|65956280|FG000|Overall Study|Seeking care outside site|0|||
23608475|NCT02764320|65956281|FG001|Overall Study|Seeking care outside site|1|||
23608476|NCT02764320|65956280|FG000|Overall Study|Technology barriers|0|||
23608477|NCT02764320|65956281|FG001|Overall Study|Technology barriers|1|||
23608478|NCT02362789|65956282|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
23608479|NCT02362789|65956283|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
23608480|NCT02362789|65956284|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
23608481|NCT02362789|65956282|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
23608482|NCT02362789|65956283|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
23608483|NCT02362789|65956284|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
23608484|NCT02362789|65956282|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
23608485|NCT02362789|65956283|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
23608486|NCT02362789|65956284|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
23608487|NCT02362789|65956282|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
23608488|NCT02362789|65956283|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
23608489|NCT02362789|65956284|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
23608490|NCT02362789|65956282|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
23509831|NCT01085591|65601995|FG001|Overall Study|Protocol Violation|1|||
23509832|NCT01085591|65601996|FG002|Overall Study|Protocol Violation|1|||
23509833|NCT01085591|65601994|FG000|Overall Study|Other|0|||
23509834|NCT01085591|65601995|FG001|Overall Study|Other|1|||
23509835|NCT01085591|65601996|FG002|Overall Study|Other|0|||
23509836|NCT01085591|65601994|FG000|Overall Study|Not Properly Consented|1|||
23509837|NCT01085591|65601995|FG001|Overall Study|Not Properly Consented|0|||
23509838|NCT01085591|65601996|FG002|Overall Study|Not Properly Consented|0|||
23509839|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
23509840|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
23509841|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
23509842|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
23509843|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
23509844|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
23509845|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
23509846|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
23509847|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
23509848|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
23509849|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
23509850|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
23509851|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
23509852|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
23509853|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
23509854|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
23509855|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
23608491|NCT02362789|65956283|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
23608492|NCT02362789|65956284|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
23608493|NCT03541369|65956285|FG000|Overall Study|Death|0|||
23608494|NCT03541369|65956286|FG001|Overall Study|Death|0|||
23608495|NCT03541369|65956287|FG002|Overall Study|Death|0|||
23608496|NCT03541369|65956288|FG003|Overall Study|Death|0|||
23608497|NCT03541369|65956289|FG004|Overall Study|Death|1|||
23608498|NCT03541369|65956290|FG005|Overall Study|Death|1|||
23608499|NCT03541369|65956291|FG006|Overall Study|Death|0|||
23608500|NCT03541369|65956292|FG007|Overall Study|Death|2|||
23608501|NCT03541369|65956293|FG008|Overall Study|Death|1|||
23608502|NCT03541369|65956294|FG009|Overall Study|Death|2|||
23608503|NCT03541369|65956295|FG010|Overall Study|Death|1|||
23608504|NCT03541369|65956296|FG011|Overall Study|Death|0|||
23608505|NCT03541369|65956297|FG012|Overall Study|Death|2|||
23608506|NCT03541369|65956298|FG013|Overall Study|Death|1|||
23608507|NCT03541369|65956299|FG014|Overall Study|Death|1|||
23608508|NCT03541369|65956300|FG015|Overall Study|Death|1|||
23608509|NCT03541369|65956301|FG016|Overall Study|Death|0|||
23608510|NCT03541369|65956302|FG017|Overall Study|Death|1|||
23608511|NCT03541369|65956285|FG000|Overall Study|Decision by sponsor|0|||
23608512|NCT03541369|65956286|FG001|Overall Study|Decision by sponsor|0|||
23608513|NCT03541369|65956287|FG002|Overall Study|Decision by sponsor|0|||
23608514|NCT03541369|65956288|FG003|Overall Study|Decision by sponsor|1|||
23608515|NCT03541369|65956289|FG004|Overall Study|Decision by sponsor|0|||
23608516|NCT03541369|65956290|FG005|Overall Study|Decision by sponsor|2|||
23608517|NCT03541369|65956291|FG006|Overall Study|Decision by sponsor|0|||
23608518|NCT03541369|65956292|FG007|Overall Study|Decision by sponsor|1|||
23608519|NCT03541369|65956293|FG008|Overall Study|Decision by sponsor|2|||
23608520|NCT03541369|65956294|FG009|Overall Study|Decision by sponsor|0|||
23608521|NCT03541369|65956295|FG010|Overall Study|Decision by sponsor|0|||
23608522|NCT03541369|65956296|FG011|Overall Study|Decision by sponsor|0|||
23608523|NCT03541369|65956297|FG012|Overall Study|Decision by sponsor|2|||
23608524|NCT03541369|65956298|FG013|Overall Study|Decision by sponsor|2|||
23608525|NCT03541369|65956299|FG014|Overall Study|Decision by sponsor|0|||
23608526|NCT03541369|65956300|FG015|Overall Study|Decision by sponsor|1|||
23608527|NCT03541369|65956301|FG016|Overall Study|Decision by sponsor|1|||
23608528|NCT03541369|65956302|FG017|Overall Study|Decision by sponsor|1|||
23608529|NCT03541369|65956285|FG000|Overall Study|Withdrawal by Subject|0|||
23608530|NCT03541369|65956286|FG001|Overall Study|Withdrawal by Subject|0|||
23608531|NCT03541369|65956287|FG002|Overall Study|Withdrawal by Subject|0|||
23608532|NCT03541369|65956288|FG003|Overall Study|Withdrawal by Subject|0|||
23608533|NCT03541369|65956289|FG004|Overall Study|Withdrawal by Subject|0|||
23608534|NCT03541369|65956290|FG005|Overall Study|Withdrawal by Subject|0|||
23608535|NCT03541369|65956291|FG006|Overall Study|Withdrawal by Subject|1|||
23608536|NCT03541369|65956292|FG007|Overall Study|Withdrawal by Subject|0|||
23608537|NCT03541369|65956293|FG008|Overall Study|Withdrawal by Subject|0|||
23608538|NCT03541369|65956294|FG009|Overall Study|Withdrawal by Subject|0|||
23608539|NCT03541369|65956295|FG010|Overall Study|Withdrawal by Subject|0|||
23608540|NCT03541369|65956296|FG011|Overall Study|Withdrawal by Subject|1|||
23608541|NCT03541369|65956297|FG012|Overall Study|Withdrawal by Subject|0|||
23608542|NCT03541369|65956298|FG013|Overall Study|Withdrawal by Subject|0|||
23608543|NCT03541369|65956299|FG014|Overall Study|Withdrawal by Subject|3|||
23608544|NCT03541369|65956300|FG015|Overall Study|Withdrawal by Subject|0|||
23608545|NCT03541369|65956301|FG016|Overall Study|Withdrawal by Subject|4|||
23608546|NCT03541369|65956302|FG017|Overall Study|Withdrawal by Subject|2|||
23608547|NCT03541369|65956285|FG000|Overall Study|Lost to Follow-up|0|||
23608548|NCT03541369|65956286|FG001|Overall Study|Lost to Follow-up|0|||
23608549|NCT03541369|65956287|FG002|Overall Study|Lost to Follow-up|0|||
23608550|NCT03541369|65956288|FG003|Overall Study|Lost to Follow-up|0|||
23608551|NCT03541369|65956289|FG004|Overall Study|Lost to Follow-up|1|||
23608552|NCT03541369|65956290|FG005|Overall Study|Lost to Follow-up|0|||
23608553|NCT03541369|65956291|FG006|Overall Study|Lost to Follow-up|0|||
23608554|NCT03541369|65956292|FG007|Overall Study|Lost to Follow-up|0|||
23608555|NCT03541369|65956293|FG008|Overall Study|Lost to Follow-up|1|||
23608556|NCT03541369|65956294|FG009|Overall Study|Lost to Follow-up|0|||
23608557|NCT03541369|65956295|FG010|Overall Study|Lost to Follow-up|0|||
23608558|NCT03541369|65956296|FG011|Overall Study|Lost to Follow-up|0|||
23608559|NCT03541369|65956297|FG012|Overall Study|Lost to Follow-up|1|||
23608560|NCT03541369|65956298|FG013|Overall Study|Lost to Follow-up|0|||
23608561|NCT03541369|65956299|FG014|Overall Study|Lost to Follow-up|0|||
23608562|NCT03541369|65956300|FG015|Overall Study|Lost to Follow-up|0|||
23608563|NCT03541369|65956301|FG016|Overall Study|Lost to Follow-up|0|||
23608564|NCT03541369|65956302|FG017|Overall Study|Lost to Follow-up|0|||
23608565|NCT01381549|65956303|FG000|Overall Study|Ineligible: No organisms isolated|0|||
23608566|NCT01381549|65956304|FG001|Overall Study|Ineligible: No organisms isolated|0|||
23608567|NCT01381549|65956305|FG002|Overall Study|Ineligible: No organisms isolated|1|||
23608568|NCT01416285|65956308|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
23608569|NCT01416285|65956309|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
23608570|NCT03989232|65956310|FG000|Overall Study|Lost to Follow-up|3|||
23608571|NCT03989232|65956311|FG001|Overall Study|Lost to Follow-up|10|||
23608572|NCT03989232|65956310|FG000|Overall Study|Withdrawal by Subject|6|||
23608573|NCT03989232|65956311|FG001|Overall Study|Withdrawal by Subject|6|||
23608574|NCT03989232|65956310|FG000|Overall Study|Death|1|||
23608575|NCT03989232|65956311|FG001|Overall Study|Death|2|||
23608576|NCT01137682|65956312|FG000|Overall Study|Adverse Event-CORE|2|||
23608577|NCT01137682|65956313|FG001|Overall Study|Adverse Event-CORE|4|||
23608578|NCT01137682|65956314|FG002|Overall Study|Adverse Event-CORE|0|||
23509856|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
23509857|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
23509858|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
23509859|NCT01962207|65601997|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
23509860|NCT01962207|65601998|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
23509861|NCT01962207|65601999|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
23509862|NCT01962207|65602000|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
23509863|NCT03789318|65602001|FG000|Overall Study|Adverse Event|0|||
23509864|NCT03789318|65602002|FG001|Overall Study|Adverse Event|0|||
23509865|NCT03789318|65602003|FG002|Overall Study|Adverse Event|1|||
23509866|NCT03789318|65602004|FG003|Overall Study|Adverse Event|1|||
23509867|NCT03789318|65602005|FG004|Overall Study|Adverse Event|0|||
23509868|NCT03789318|65602001|FG000|Overall Study|Lost to Follow-up|0|||
23509869|NCT03789318|65602002|FG001|Overall Study|Lost to Follow-up|0|||
23509870|NCT03789318|65602003|FG002|Overall Study|Lost to Follow-up|1|||
23509871|NCT03789318|65602004|FG003|Overall Study|Lost to Follow-up|0|||
23509872|NCT03789318|65602005|FG004|Overall Study|Lost to Follow-up|0|||
23509873|NCT03789318|65602001|FG000|Overall Study|Withdrawal by Subject|0|||
23509874|NCT03789318|65602002|FG001|Overall Study|Withdrawal by Subject|0|||
23509875|NCT03789318|65602003|FG002|Overall Study|Withdrawal by Subject|1|||
23509876|NCT03789318|65602004|FG003|Overall Study|Withdrawal by Subject|0|||
23509877|NCT03789318|65602005|FG004|Overall Study|Withdrawal by Subject|0|||
23509878|NCT00679302|65602006|FG000|Overall Study|Lost to Follow-up|8|||
23509879|NCT00679302|65602007|FG001|Overall Study|Lost to Follow-up|4|||
23509880|NCT00459667|65602008|FG000|Overall Study|Adverse Event|9|||
23509881|NCT00459667|65602009|FG001|Overall Study|Adverse Event|12|||
23509882|NCT00459667|65602010|FG002|Overall Study|Adverse Event|8|||
23509883|NCT00459667|65602008|FG000|Overall Study|Lost to Follow-up|5|||
23509884|NCT00459667|65602009|FG001|Overall Study|Lost to Follow-up|9|||
23509885|NCT00459667|65602010|FG002|Overall Study|Lost to Follow-up|3|||
23509886|NCT00459667|65602008|FG000|Overall Study|Pregnancy|1|||
23509887|NCT00459667|65602009|FG001|Overall Study|Pregnancy|1|||
23608579|NCT01137682|65956312|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
23608580|NCT01137682|65956313|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
23608581|NCT01137682|65956314|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
23608582|NCT01137682|65956312|FG000|Overall Study|Administrative problems-CORE|2|||
23608583|NCT01137682|65956313|FG001|Overall Study|Administrative problems-CORE|1|||
23608584|NCT01137682|65956314|FG002|Overall Study|Administrative problems-CORE|0|||
23608585|NCT01137682|65956312|FG000|Overall Study|Protocol Violation-CORE|0|||
23608586|NCT01137682|65956313|FG001|Overall Study|Protocol Violation-CORE|1|||
23608587|NCT01137682|65956314|FG002|Overall Study|Protocol Violation-CORE|1|||
23608588|NCT01137682|65956312|FG000|Overall Study|Adverse Event-Extension|4|||
23608589|NCT01137682|65956313|FG001|Overall Study|Adverse Event-Extension|8|||
23509888|NCT00459667|65602010|FG002|Overall Study|Pregnancy|1|||
23509889|NCT00459667|65602008|FG000|Overall Study|Protocol Violation|1|||
23509890|NCT00459667|65602009|FG001|Overall Study|Protocol Violation|0|||
23509891|NCT00459667|65602010|FG002|Overall Study|Protocol Violation|0|||
23509892|NCT00459667|65602008|FG000|Overall Study|Withdrawal by Subject|3|||
23608590|NCT01137682|65956314|FG002|Overall Study|Adverse Event-Extension|7|||
23509893|NCT00459667|65602009|FG001|Overall Study|Withdrawal by Subject|5|||
23509894|NCT00459667|65602010|FG002|Overall Study|Withdrawal by Subject|5|||
23509895|NCT00459667|65602008|FG000|Overall Study|Other disease modifying treatment|1|||
23608591|NCT01137682|65956312|FG000|Overall Study|Lack of Efficacy-Extension|15|||
23608592|NCT01137682|65956313|FG001|Overall Study|Lack of Efficacy-Extension|9|||
23453415|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
23509896|NCT00459667|65602009|FG001|Overall Study|Other disease modifying treatment|2|||
23509897|NCT00459667|65602010|FG002|Overall Study|Other disease modifying treatment|1|||
23509898|NCT00459667|65602008|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
23509899|NCT00459667|65602009|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
23509900|NCT00459667|65602010|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
23509901|NCT00459667|65602008|FG000|Overall Study|No treatment administered|6|||
23509902|NCT00459667|65602009|FG001|Overall Study|No treatment administered|3|||
23509903|NCT00459667|65602010|FG002|Overall Study|No treatment administered|1|||
23509904|NCT00429104|65602012|FG000|Overall Study|Protocol Violation|1|||
23509905|NCT01342796|65602015|FG000|Overall Study|Withdrawal by Subject|2|||
23509906|NCT01342796|65602016|FG001|Overall Study|Withdrawal by Subject|0|||
23509907|NCT01342796|65602015|FG000|Overall Study|Lost to Follow-up|0|||
23509908|NCT01342796|65602016|FG001|Overall Study|Lost to Follow-up|3|||
23453416|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453417|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
23453418|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
23453419|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
23453420|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
23453421|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
23453422|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
23453423|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
23453424|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
23453425|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
23453426|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
23453427|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
23453428|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
23453429|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
23453430|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
23453431|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
23453432|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
23453433|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453434|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453435|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453436|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453437|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
23453438|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
23453439|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
23453440|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
23453441|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453442|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
23453443|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453444|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453445|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
23453446|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
23453447|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
23453448|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453449|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453450|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453451|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
23453452|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453453|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453454|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453455|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453456|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453457|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453458|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453459|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453460|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453461|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453462|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
23453463|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453464|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453465|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453466|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23608593|NCT01137682|65956314|FG002|Overall Study|Lack of Efficacy-Extension|13|||
23608594|NCT01137682|65956312|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
23608595|NCT01137682|65956313|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
23608596|NCT01137682|65956314|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
23608597|NCT01137682|65956312|FG000|Overall Study|Lost to Follow Up-Extension|0|||
23608598|NCT01137682|65956313|FG001|Overall Study|Lost to Follow Up-Extension|1|||
23608599|NCT01137682|65956314|FG002|Overall Study|Lost to Follow Up-Extension|0|||
23608600|NCT01137682|65956312|FG000|Overall Study|Administrative problems-Extension|0|||
23608601|NCT01137682|65956313|FG001|Overall Study|Administrative problems-Extension|2|||
23608602|NCT01137682|65956314|FG002|Overall Study|Administrative problems-Extension|0|||
23608603|NCT01137682|65956312|FG000|Overall Study|Death-Extension|2|||
23608604|NCT01137682|65956313|FG001|Overall Study|Death-Extension|0|||
23608605|NCT01137682|65956314|FG002|Overall Study|Death-Extension|0|||
23608606|NCT01137682|65956312|FG000|Overall Study|Protocol Violation-Extension|2|||
23608607|NCT01137682|65956313|FG001|Overall Study|Protocol Violation-Extension|1|||
23608608|NCT01137682|65956314|FG002|Overall Study|Protocol Violation-Extension|0|||
23608609|NCT01137682|65956312|FG000|Overall Study|Did not enter extension|2|||
23608610|NCT01137682|65956313|FG001|Overall Study|Did not enter extension|3|||
23608611|NCT01137682|65956314|FG002|Overall Study|Did not enter extension|2|||
23608612|NCT01137682|65956312|FG000|Overall Study|Did not receive treatment in extension|0|||
23608613|NCT01137682|65956313|FG001|Overall Study|Did not receive treatment in extension|0|||
23608614|NCT01137682|65956314|FG002|Overall Study|Did not receive treatment in extension|1|||
23608615|NCT02144285|65956315|FG000|Overall Study|Withdrawal by Subject|0|||
23608616|NCT02144285|65956316|FG001|Overall Study|Withdrawal by Subject|0|||
23608617|NCT02144285|65956317|FG002|Overall Study|Withdrawal by Subject|0|||
23608618|NCT02144285|65956318|FG003|Overall Study|Withdrawal by Subject|0|||
23509909|NCT01342796|65602015|FG000|Overall Study|Inappropriate enrollment|1|||
23509910|NCT01342796|65602016|FG001|Overall Study|Inappropriate enrollment|0|||
23608619|NCT02144285|65956319|FG004|Overall Study|Withdrawal by Subject|1|||
23608620|NCT02144285|65956320|FG005|Overall Study|Withdrawal by Subject|0|||
23608621|NCT02144285|65956321|FG006|Overall Study|Withdrawal by Subject|0|||
23608622|NCT02144285|65956322|FG007|Overall Study|Withdrawal by Subject|0|||
23608623|NCT02144285|65956323|FG008|Overall Study|Withdrawal by Subject|0|||
23608624|NCT02144285|65956324|FG009|Overall Study|Withdrawal by Subject|0|||
23608625|NCT00439218|65956325|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
23608626|NCT04311983|65956326|FG000|Overall Study|Lost to Follow-up|421|||
23509911|NCT02117648|65602017|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
23608627|NCT04311983|65956327|FG001|Overall Study|Lost to Follow-up|456|||
23608628|NCT04311983|65956326|FG000|Overall Study|Incomplete survey|7|||
23608629|NCT04311983|65956327|FG001|Overall Study|Incomplete survey|9|||
23608630|NCT04311983|65956326|FG000|Overall Study|Death|1|||
23608631|NCT04311983|65956327|FG001|Overall Study|Death|0|||
23608632|NCT04328467|65956330|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
23608633|NCT04328467|65956331|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
23608634|NCT04328467|65956332|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
23608635|NCT02354417|65956333|FG000|Overall Study|Physician Decision|1|||
23608636|NCT02637063|65956334|FG000|Overall Study|Lost to Follow-up|3|||
23608637|NCT02637063|65956335|FG001|Overall Study|Lost to Follow-up|2|||
23608638|NCT02637063|65956336|FG002|Overall Study|Lost to Follow-up|3|||
23608639|NCT02637063|65956334|FG000|Overall Study|Withdrawal by Subject|2|||
23608640|NCT02637063|65956335|FG001|Overall Study|Withdrawal by Subject|2|||
23608641|NCT02637063|65956336|FG002|Overall Study|Withdrawal by Subject|3|||
23608642|NCT00901459|65956339|FG000|Overall Study|Withdrawal by Subject|6|||
23608643|NCT01205126|65956343|FG000|Titration Phase|Adverse Event|5|||
23608644|NCT01205126|65956344|FG001|Titration Phase|Adverse Event|3|||
23608645|NCT01205126|65956343|FG000|Titration Phase|Withdrawal by Subject|5|||
23608646|NCT01205126|65956344|FG001|Titration Phase|Withdrawal by Subject|5|||
23608647|NCT01205126|65956343|FG000|Titration Phase|Lost to Follow-up|2|||
23608648|NCT01205126|65956344|FG001|Titration Phase|Lost to Follow-up|2|||
23608649|NCT01205126|65956343|FG000|Titration Phase|No stable titration dose|1|||
23608650|NCT01205126|65956344|FG001|Titration Phase|No stable titration dose|0|||
23608651|NCT01205126|65956343|FG000|Titration Phase|More than maximum dosage required|2|||
23608652|NCT01205126|65956344|FG001|Titration Phase|More than maximum dosage required|3|||
23608653|NCT01205126|65956343|FG000|Titration Phase|Other|8|||
23408569|NCT03782259|65239923|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
23509912|NCT02117648|65602017|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
23509913|NCT02117648|65602017|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
23509914|NCT02117648|65602017|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
23509915|NCT02117648|65602017|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
23509916|NCT02117648|65602017|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
23509917|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
23509918|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
23509919|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
23608654|NCT01205126|65956344|FG001|Titration Phase|Other|6|||
23608655|NCT01205126|65956343|FG000|Between Titration & Maintenance Phase|Other|0|||
23608656|NCT01205126|65956344|FG001|Between Titration & Maintenance Phase|Other|4|||
23608657|NCT01205126|65956343|FG000|Maintenance Phase|Adverse Event|3|||
23608658|NCT01205126|65956344|FG001|Maintenance Phase|Adverse Event|7|||
23608659|NCT01205126|65956343|FG000|Maintenance Phase|Death|4|||
23608660|NCT01205126|65956344|FG001|Maintenance Phase|Death|4|||
23608661|NCT01205126|65956343|FG000|Maintenance Phase|More than the maximum dosage required|5|||
23608662|NCT01205126|65956344|FG001|Maintenance Phase|More than the maximum dosage required|5|||
23608663|NCT01205126|65956343|FG000|Maintenance Phase|Prohibited drugs used|1|||
23509920|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
23509921|NCT02117648|65602017|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
23509922|NCT01414855|65602018|FG000|Overall Study|Death|17|||
23509923|NCT01414855|65602018|FG000|Overall Study|Lost to Follow-up|5|||
23509924|NCT01414855|65602018|FG000|Overall Study|Withdrawal by Subject|7|||
23509925|NCT01104493|65602019|FG000|Overall Study|Lost to Follow-up|0|||
23509926|NCT01104493|65602020|FG001|Overall Study|Lost to Follow-up|2|||
23509927|NCT00617773|65602022|FG000|Overall Study|Physician Decision|1|||
23509928|NCT00617773|65602022|FG000|Overall Study|Lack of compliance with the protocol|1|||
23509929|NCT00617773|65602022|FG000|Overall Study|Withdrawal by Subject|1|||
23509930|NCT00617773|65602022|FG000|Overall Study|Death|1|||
23509931|NCT00617773|65602022|FG000|Overall Study|Progressive disease|19|||
23509932|NCT00617773|65602022|FG000|Overall Study|Protocol Violation|1|||
23509933|NCT03211416|65602023|FG000|Overall Study|Adverse Event|7|||
23509934|NCT03211416|65602023|FG000|Overall Study|Lack of Efficacy|2|||
23509935|NCT03211416|65602023|FG000|Overall Study|Physician Decision|1|||
23509936|NCT00062374|65602024|FG000|Overall Study|Not treated|12|||
23509937|NCT02670083|65602025|FG000|Overall Study|Adverse Event|16|||
23509938|NCT02670083|65602026|FG001|Overall Study|Adverse Event|13|||
23509939|NCT02670083|65602025|FG000|Overall Study|Death|4|||
23509940|NCT02670083|65602026|FG001|Overall Study|Death|6|||
23509941|NCT02670083|65602025|FG000|Overall Study|Lost to Follow-up|2|||
23509942|NCT02670083|65602026|FG001|Overall Study|Lost to Follow-up|2|||
23509943|NCT02670083|65602025|FG000|Overall Study|Multiple Reasons|9|||
23509944|NCT02670083|65602026|FG001|Overall Study|Multiple Reasons|9|||
23509945|NCT02670083|65602025|FG000|Overall Study|Physician Decision|0|||
23509946|NCT02670083|65602026|FG001|Overall Study|Physician Decision|2|||
23509947|NCT02670083|65602025|FG000|Overall Study|Study Terminated By Sponsor|257|||
23509948|NCT02670083|65602026|FG001|Overall Study|Study Terminated By Sponsor|254|||
23509949|NCT02670083|65602025|FG000|Overall Study|Symptomatic Deterioration|0|||
23509950|NCT02670083|65602026|FG001|Overall Study|Symptomatic Deterioration|2|||
23509951|NCT02670083|65602025|FG000|Overall Study|Withdrawal by Subject|32|||
23509952|NCT02670083|65602026|FG001|Overall Study|Withdrawal by Subject|31|||
23509953|NCT02670083|65602025|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23509954|NCT02670083|65602026|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23509955|NCT01417234|65602029|FG000|Overall Study|Subject non-compliant|3|||
23509956|NCT02573311|65602030|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
23509957|NCT02573311|65602031|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
23509958|NCT02573311|65602030|FG000|Disposition for Part 2|Physician Decision|25|||
23509959|NCT02573311|65602031|FG001|Disposition for Part 2|Physician Decision|7|||
23509960|NCT02573311|65602030|FG000|Disposition for Part 2|Adverse Event|36|||
23509961|NCT02573311|65602031|FG001|Disposition for Part 2|Adverse Event|5|||
23509962|NCT02573311|65602030|FG000|Disposition for Part 2|Lost to Follow-up|76|||
23509963|NCT02573311|65602031|FG001|Disposition for Part 2|Lost to Follow-up|7|||
23509964|NCT02573311|65602030|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
23509965|NCT02573311|65602031|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
23509966|NCT02573311|65602030|FG000|Disposition for Part 2|Investigator decision|0|||
23509967|NCT02573311|65602031|FG001|Disposition for Part 2|Investigator decision|1|||
23509968|NCT02573311|65602030|FG000|Disposition for Part 2|Other than specified above|13|||
23509969|NCT02573311|65602031|FG001|Disposition for Part 2|Other than specified above|3|||
23509970|NCT03068130|65602032|FG000|Overall Study|Adverse Event|19|||
23509971|NCT03068130|65602032|FG000|Overall Study|Death|14|||
23509972|NCT03068130|65602032|FG000|Overall Study|Lost to Follow-up|4|||
23509973|NCT03068130|65602032|FG000|Overall Study|Withdrawal by Subject|26|||
23509974|NCT03068130|65602032|FG000|Overall Study|Administrative Reasons|3|||
23509975|NCT03068130|65602032|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
23509976|NCT03068130|65602032|FG000|Overall Study|Study terminated by sponsor|194|||
23509977|NCT00587639|65602033|FG000|Overall Study|Withdrawal by Subject|1|||
23509978|NCT01401283|65602034|FG000|Overall Study|surgery cancelled|5|||
23509979|NCT01401283|65602035|FG001|Overall Study|surgery cancelled|8|||
23509980|NCT01401283|65602034|FG000|Overall Study|preoperative arrhythmia|5|||
23509981|NCT01401283|65602035|FG001|Overall Study|preoperative arrhythmia|0|||
23509982|NCT01401283|65602034|FG000|Overall Study|no central venous access|0|||
23509983|NCT01401283|65602035|FG001|Overall Study|no central venous access|1|||
23509984|NCT01401283|65602034|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
23509985|NCT01401283|65602035|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
23608664|NCT01205126|65956344|FG001|Maintenance Phase|Prohibited drugs used|0|||
23608665|NCT01205126|65956343|FG000|Maintenance Phase|Other|11|||
23608666|NCT01205126|65956344|FG001|Maintenance Phase|Other|8|||
23608667|NCT01205126|65956343|FG000|Maintenance Phase|Lost to Follow-up|5|||
23608668|NCT01205126|65956344|FG001|Maintenance Phase|Lost to Follow-up|5|||
23608669|NCT01205126|65956343|FG000|Maintenance Phase|Withdrawal by Subject|8|||
23608670|NCT01205126|65956344|FG001|Maintenance Phase|Withdrawal by Subject|11|||
23608671|NCT00952523|65956348|FG000|Overall Study|Withdrawal by Subject|7|||
23608672|NCT01560429|65956349|FG000|Overall Study|Protocol Violation|3|||
23608673|NCT01560429|65956350|FG001|Overall Study|Protocol Violation|6|||
23608674|NCT04938453|65956351|FG000|Washout Period 1|Adverse Event|1|||
23608675|NCT04938453|65956352|FG001|Washout Period 1|Adverse Event|0|||
23608676|NCT04938453|65956351|FG000|Washout Period 1|Physician Decision|0|||
23608677|NCT04938453|65956352|FG001|Washout Period 1|Physician Decision|1|||
23608678|NCT00537914|65956355|FG000|Overall Study|Death|1|||
23608679|NCT00537914|65956355|FG000|Overall Study|Adverse Event|7|||
23608680|NCT00537914|65956355|FG000|Overall Study|Treatment failure|10|||
23608681|NCT00537914|65956355|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
23608682|NCT00537914|65956355|FG000|Overall Study|Lost to Follow-up|19|||
23608683|NCT00537914|65956355|FG000|Overall Study|Withdrawal of informed consent|59|||
23608684|NCT00417885|65956360|FG000|Overall Study|Adverse Event|1|||
23608685|NCT00417885|65956360|FG000|Overall Study|Objective Progression or Relapse|3|||
23608686|NCT00417885|65956360|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
23608687|NCT02607956|65956367|FG000|Double-Blinded Phase|Withdrew Consent|17|||
23608688|NCT02607956|65956368|FG001|Double-Blinded Phase|Withdrew Consent|19|||
23608689|NCT02607956|65956369|FG002|Double-Blinded Phase|Withdrew Consent|0|||
23608690|NCT02607956|65956370|FG003|Double-Blinded Phase|Withdrew Consent|0|||
23608691|NCT02607956|65956367|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
23608692|NCT02607956|65956368|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
23608693|NCT02607956|65956369|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
23608694|NCT02607956|65956370|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
23608695|NCT02607956|65956367|FG000|Double-Blinded Phase|Randomized but never treated|7|||
23608696|NCT02607956|65956368|FG001|Double-Blinded Phase|Randomized but never treated|5|||
23608697|NCT02607956|65956369|FG002|Double-Blinded Phase|Randomized but never treated|0|||
23608698|NCT02607956|65956370|FG003|Double-Blinded Phase|Randomized but never treated|0|||
23608699|NCT02607956|65956367|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
23608700|NCT02607956|65956368|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
23608701|NCT02607956|65956369|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
23608702|NCT02607956|65956370|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
23608703|NCT02607956|65956367|FG000|Double-Blinded Phase|Death|4|||
23608704|NCT02607956|65956368|FG001|Double-Blinded Phase|Death|4|||
23608705|NCT02607956|65956369|FG002|Double-Blinded Phase|Death|0|||
23608706|NCT02607956|65956370|FG003|Double-Blinded Phase|Death|0|||
23608707|NCT02607956|65956367|FG000|Double-Blinded Phase|Adverse Event|4|||
23608708|NCT02607956|65956368|FG001|Double-Blinded Phase|Adverse Event|3|||
23608709|NCT02607956|65956369|FG002|Double-Blinded Phase|Adverse Event|0|||
23608710|NCT02607956|65956370|FG003|Double-Blinded Phase|Adverse Event|0|||
23608711|NCT02607956|65956367|FG000|Double-Blinded Phase|Protocol Violation|3|||
23608712|NCT02607956|65956368|FG001|Double-Blinded Phase|Protocol Violation|1|||
23608713|NCT02607956|65956369|FG002|Double-Blinded Phase|Protocol Violation|0|||
23608714|NCT02607956|65956370|FG003|Double-Blinded Phase|Protocol Violation|0|||
23608715|NCT02607956|65956367|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
23608716|NCT02607956|65956368|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
23608717|NCT02607956|65956369|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
23608718|NCT02607956|65956370|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
23608719|NCT02607956|65956367|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
23608720|NCT02607956|65956368|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
23608721|NCT02607956|65956369|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
23608722|NCT02607956|65956370|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
23608723|NCT02607956|65956367|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23608724|NCT02607956|65956368|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23608725|NCT02607956|65956369|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
23608726|NCT02607956|65956370|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
23608727|NCT02607956|65956367|FG000|Open-Label Extension Phase|Death|0|||
23608728|NCT02607956|65956368|FG001|Open-Label Extension Phase|Death|0|||
23608729|NCT02607956|65956369|FG002|Open-Label Extension Phase|Death|1|||
23608730|NCT02607956|65956370|FG003|Open-Label Extension Phase|Death|3|||
23608731|NCT02607956|65956367|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
23608732|NCT02607956|65956368|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
23608733|NCT02607956|65956369|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
23608734|NCT02607956|65956370|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
23608735|NCT02607956|65956367|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
23608736|NCT02607956|65956368|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
23608737|NCT02607956|65956369|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
23608738|NCT02607956|65956370|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
23608739|NCT02607956|65956367|FG000|Open-Label Extension Phase|Protocol Violation|0|||
23608740|NCT02607956|65956368|FG001|Open-Label Extension Phase|Protocol Violation|0|||
23608741|NCT02607956|65956369|FG002|Open-Label Extension Phase|Protocol Violation|0|||
23608742|NCT02607956|65956370|FG003|Open-Label Extension Phase|Protocol Violation|2|||
23608743|NCT02607956|65956367|FG000|Open-Label Extension Phase|Pregnancy|0|||
23608744|NCT02607956|65956368|FG001|Open-Label Extension Phase|Pregnancy|0|||
23608745|NCT02607956|65956369|FG002|Open-Label Extension Phase|Pregnancy|0|||
23608746|NCT02607956|65956370|FG003|Open-Label Extension Phase|Pregnancy|1|||
23608747|NCT01911819|65956373|FG000|Overall Study|Adverse Event|0|||
23608748|NCT01911819|65956374|FG001|Overall Study|Adverse Event|1|||
23608749|NCT01911819|65956375|FG002|Overall Study|Adverse Event|0|||
23608750|NCT01911819|65956373|FG000|Overall Study|Withdrawal by Subject|1|||
23608751|NCT01911819|65956374|FG001|Overall Study|Withdrawal by Subject|1|||
23608752|NCT01911819|65956375|FG002|Overall Study|Withdrawal by Subject|0|||
23608753|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
23608754|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
23608755|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
23608756|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
23608757|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
23608758|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
23509986|NCT00964860|65602042|FG000|Overall Study|Withdrawal by Subject|0|||
23608759|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
23608760|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
23608761|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
23608762|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
23608763|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
23608764|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
23608765|NCT03928743|65956376|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
23608766|NCT03928743|65956377|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
23608767|NCT03928743|65956378|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
23608768|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
23608769|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
23608770|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
23608771|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
23608772|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
23608773|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
23608774|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
23608775|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
23608776|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
23608777|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
23608778|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
23608779|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
23608780|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
23608781|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
23608782|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
23608783|NCT03928743|65956376|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
23608784|NCT03928743|65956377|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
23608785|NCT03928743|65956378|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
23608786|NCT03602053|65956381|FG000|Overall Study|Withdrawal by Subject|7|||
23608787|NCT03602053|65956382|FG001|Overall Study|Withdrawal by Subject|9|||
23608788|NCT03602053|65956383|FG002|Overall Study|Withdrawal by Subject|7|||
23608789|NCT03602053|65956381|FG000|Overall Study|Lost to Follow-up|5|||
23608790|NCT03602053|65956382|FG001|Overall Study|Lost to Follow-up|6|||
23608791|NCT03602053|65956383|FG002|Overall Study|Lost to Follow-up|0|||
23608792|NCT03602053|65956381|FG000|Overall Study|Protocol Violation|3|||
23608793|NCT03602053|65956382|FG001|Overall Study|Protocol Violation|0|||
23608794|NCT03602053|65956383|FG002|Overall Study|Protocol Violation|4|||
23608795|NCT03602053|65956381|FG000|Overall Study|Physician Decision|1|||
23608796|NCT03602053|65956382|FG001|Overall Study|Physician Decision|0|||
23608797|NCT03602053|65956383|FG002|Overall Study|Physician Decision|0|||
23608798|NCT03602053|65956381|FG000|Overall Study|migration|2|||
23608799|NCT03602053|65956382|FG001|Overall Study|migration|3|||
23608800|NCT03602053|65956383|FG002|Overall Study|migration|0|||
23608801|NCT03602053|65956381|FG000|Overall Study|Other|1|||
23608802|NCT03602053|65956382|FG001|Overall Study|Other|0|||
23608803|NCT03602053|65956383|FG002|Overall Study|Other|0|||
23608804|NCT00787176|65956387|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
23608805|NCT00787176|65956388|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
23608806|NCT00787176|65956389|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
23608807|NCT00787176|65956390|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
23608808|NCT01328756|65956391|FG000|Overall Study|Protocol Violation|4|||
23509987|NCT00964860|65602043|FG001|Overall Study|Withdrawal by Subject|1|||
23509988|NCT00638378|65602047|FG000|Overall Study|Death|2|||
23509989|NCT00638378|65602047|FG000|Overall Study|Adverse Event|1|||
23509990|NCT00638378|65602047|FG000|Overall Study|Disease progression|15|||
23509991|NCT00638378|65602047|FG000|Overall Study|Physician Decision|4|||
23509992|NCT03555591|65602048|FG000|Overall Study|Protocol Violation|77|||
23509993|NCT00040664|65602054|FG000|Overall Study|Adverse Event|12|||
23509994|NCT00040664|65602055|FG001|Overall Study|Adverse Event|3|||
23509995|NCT00040664|65602056|FG002|Overall Study|Adverse Event|2|||
23509996|NCT00040664|65602057|FG003|Overall Study|Adverse Event|7|||
23509997|NCT00040664|65602054|FG000|Overall Study|Lack of Efficacy|9|||
23509998|NCT00040664|65602055|FG001|Overall Study|Lack of Efficacy|2|||
23509999|NCT00040664|65602056|FG002|Overall Study|Lack of Efficacy|3|||
23510000|NCT00040664|65602057|FG003|Overall Study|Lack of Efficacy|4|||
23510001|NCT00040664|65602054|FG000|Overall Study|Insufficient CD4 response|1|||
23510002|NCT00040664|65602055|FG001|Overall Study|Insufficient CD4 response|0|||
23510003|NCT00040664|65602056|FG002|Overall Study|Insufficient CD4 response|1|||
23510004|NCT00040664|65602057|FG003|Overall Study|Insufficient CD4 response|0|||
23510005|NCT00040664|65602054|FG000|Overall Study|Lost to Follow-up|4|||
23510006|NCT00040664|65602055|FG001|Overall Study|Lost to Follow-up|2|||
23510007|NCT00040664|65602056|FG002|Overall Study|Lost to Follow-up|0|||
23608809|NCT01328756|65956391|FG000|Overall Study|Adverse Event|39|||
23608810|NCT01328756|65956391|FG000|Overall Study|Lack of Efficacy|5|||
23608811|NCT01328756|65956391|FG000|Overall Study|Withdrawal by Subject|41|||
23608812|NCT01328756|65956391|FG000|Overall Study|Lost to Follow-up|5|||
23608813|NCT01328756|65956391|FG000|Overall Study|Other|29|||
23608814|NCT00923078|65956392|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
23608815|NCT00923078|65956393|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
23608816|NCT00923078|65956394|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
23608817|NCT00923078|65956392|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
23608818|NCT00923078|65956393|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
23608819|NCT00923078|65956394|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
23608820|NCT02291549|65956397|FG000|Overall Study|Lost to Follow-up|1|||
23608821|NCT02291549|65956398|FG001|Overall Study|Lost to Follow-up|0|||
23608822|NCT02291549|65956397|FG000|Overall Study|Withdrawal by Subject|0|||
23608823|NCT02291549|65956398|FG001|Overall Study|Withdrawal by Subject|1|||
23608824|NCT00980538|65956400|FG000|Overall Study|Lost to Follow-up|20|||
23608825|NCT00980538|65956400|FG000|Overall Study|Sponsor's Decision|4|||
23608826|NCT00980538|65956400|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
23608827|NCT00980538|65956400|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
23608828|NCT00980538|65956400|FG000|Overall Study|Switch to Commercially Available Medication|25|||
23608829|NCT00980538|65956400|FG000|Overall Study|Participant Non-Compliant|9|||
23608830|NCT00980538|65956400|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
23608831|NCT00980538|65956400|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
23608832|NCT00980538|65956400|FG000|Overall Study|Other|60|||
23608833|NCT00980538|65956400|FG000|Overall Study|Other|1|||
23608834|NCT00632736|65956402|FG000|Overall Study|Adverse Event|104|||
23608835|NCT00632736|65956402|FG000|Overall Study|Lost to Follow-up|15|||
23608836|NCT00632736|65956402|FG000|Overall Study|Protocol Violation|14|||
23608837|NCT00632736|65956402|FG000|Overall Study|Withdrawal by Subject|99|||
23608838|NCT00632736|65956402|FG000|Overall Study|Lack of Efficacy|5|||
23608839|NCT00632736|65956402|FG000|Overall Study|Sponsor terminated study|5|||
23608840|NCT00632736|65956402|FG000|Overall Study|Non-compliance|10|||
23608841|NCT00632736|65956402|FG000|Overall Study|Other|16|||
23608842|NCT01945086|65956403|FG000|Overall Study|Withdrawal by Subject|1|||
23608843|NCT01945086|65956404|FG001|Overall Study|Withdrawal by Subject|0|||
23608844|NCT01945086|65956405|FG002|Overall Study|Withdrawal by Subject|1|||
23608845|NCT01945086|65956403|FG000|Overall Study|Adverse Event|0|||
23608846|NCT01945086|65956404|FG001|Overall Study|Adverse Event|0|||
23608847|NCT01945086|65956405|FG002|Overall Study|Adverse Event|1|||
23608848|NCT00103857|65956414|FG000|54-Week Base Study|Adverse Event|12|||
23510008|NCT00040664|65602057|FG003|Overall Study|Lost to Follow-up|2|||
23510009|NCT00040664|65602054|FG000|Overall Study|Protocol Violation|2|||
23510010|NCT00040664|65602055|FG001|Overall Study|Protocol Violation|1|||
23608849|NCT00103857|65956415|FG001|54-Week Base Study|Adverse Event|9|||
23608850|NCT00103857|65956416|FG002|54-Week Base Study|Adverse Event|11|||
23608851|NCT00103857|65956417|FG003|54-Week Base Study|Adverse Event|6|||
23608852|NCT00103857|65956418|FG004|54-Week Base Study|Adverse Event|5|||
23510011|NCT00040664|65602056|FG002|Overall Study|Protocol Violation|0|||
23510012|NCT00040664|65602057|FG003|Overall Study|Protocol Violation|1|||
23510013|NCT00040664|65602054|FG000|Overall Study|Withdrawal by Subject|7|||
23510014|NCT00040664|65602055|FG001|Overall Study|Withdrawal by Subject|0|||
23608853|NCT00103857|65956419|FG005|54-Week Base Study|Adverse Event|11|||
23608854|NCT00103857|65956420|FG006|54-Week Base Study|Adverse Event|3|||
23608855|NCT00103857|65956414|FG000|54-Week Base Study|Death|0|||
23608856|NCT00103857|65956415|FG001|54-Week Base Study|Death|0|||
23608857|NCT00103857|65956416|FG002|54-Week Base Study|Death|0|||
23608858|NCT00103857|65956417|FG003|54-Week Base Study|Death|0|||
23608859|NCT00103857|65956418|FG004|54-Week Base Study|Death|1|||
23608860|NCT00103857|65956419|FG005|54-Week Base Study|Death|1|||
23608861|NCT00103857|65956420|FG006|54-Week Base Study|Death|0|||
23608862|NCT00103857|65956414|FG000|54-Week Base Study|Lack of Efficacy|11|||
23608863|NCT00103857|65956415|FG001|54-Week Base Study|Lack of Efficacy|14|||
23608864|NCT00103857|65956416|FG002|54-Week Base Study|Lack of Efficacy|8|||
23608865|NCT00103857|65956417|FG003|54-Week Base Study|Lack of Efficacy|4|||
23608866|NCT00103857|65956418|FG004|54-Week Base Study|Lack of Efficacy|3|||
23608867|NCT00103857|65956419|FG005|54-Week Base Study|Lack of Efficacy|14|||
23608868|NCT00103857|65956420|FG006|54-Week Base Study|Lack of Efficacy|19|||
23608869|NCT00103857|65956414|FG000|54-Week Base Study|Lost to Follow-up|5|||
23608870|NCT00103857|65956415|FG001|54-Week Base Study|Lost to Follow-up|4|||
23608871|NCT00103857|65956416|FG002|54-Week Base Study|Lost to Follow-up|7|||
23608872|NCT00103857|65956417|FG003|54-Week Base Study|Lost to Follow-up|5|||
23608873|NCT00103857|65956418|FG004|54-Week Base Study|Lost to Follow-up|10|||
23608874|NCT00103857|65956419|FG005|54-Week Base Study|Lost to Follow-up|9|||
23608875|NCT00103857|65956420|FG006|54-Week Base Study|Lost to Follow-up|3|||
23608876|NCT00103857|65956414|FG000|54-Week Base Study|Physician Decision|1|||
23608877|NCT00103857|65956415|FG001|54-Week Base Study|Physician Decision|1|||
23608878|NCT00103857|65956416|FG002|54-Week Base Study|Physician Decision|0|||
23608879|NCT00103857|65956417|FG003|54-Week Base Study|Physician Decision|0|||
23608880|NCT00103857|65956418|FG004|54-Week Base Study|Physician Decision|1|||
23608881|NCT00103857|65956419|FG005|54-Week Base Study|Physician Decision|0|||
23608882|NCT00103857|65956420|FG006|54-Week Base Study|Physician Decision|0|||
23608883|NCT00103857|65956414|FG000|54-Week Base Study|Pregnancy|1|||
23608884|NCT00103857|65956415|FG001|54-Week Base Study|Pregnancy|0|||
23608885|NCT00103857|65956416|FG002|54-Week Base Study|Pregnancy|0|||
23608886|NCT00103857|65956417|FG003|54-Week Base Study|Pregnancy|0|||
23608887|NCT00103857|65956418|FG004|54-Week Base Study|Pregnancy|1|||
23608888|NCT00103857|65956419|FG005|54-Week Base Study|Pregnancy|0|||
23608889|NCT00103857|65956420|FG006|54-Week Base Study|Pregnancy|1|||
23608890|NCT00103857|65956414|FG000|54-Week Base Study|Protocol Violation|6|||
23608891|NCT00103857|65956415|FG001|54-Week Base Study|Protocol Violation|4|||
23608892|NCT00103857|65956416|FG002|54-Week Base Study|Protocol Violation|2|||
23608893|NCT00103857|65956417|FG003|54-Week Base Study|Protocol Violation|4|||
23608894|NCT00103857|65956418|FG004|54-Week Base Study|Protocol Violation|0|||
23608895|NCT00103857|65956419|FG005|54-Week Base Study|Protocol Violation|3|||
23608896|NCT00103857|65956420|FG006|54-Week Base Study|Protocol Violation|3|||
23608897|NCT00103857|65956414|FG000|54-Week Base Study|Withdrawal by Subject|17|||
23608898|NCT00103857|65956415|FG001|54-Week Base Study|Withdrawal by Subject|16|||
23608899|NCT00103857|65956416|FG002|54-Week Base Study|Withdrawal by Subject|16|||
23608900|NCT00103857|65956417|FG003|54-Week Base Study|Withdrawal by Subject|15|||
23608901|NCT00103857|65956418|FG004|54-Week Base Study|Withdrawal by Subject|10|||
23608902|NCT00103857|65956419|FG005|54-Week Base Study|Withdrawal by Subject|15|||
23608903|NCT00103857|65956420|FG006|54-Week Base Study|Withdrawal by Subject|4|||
23608904|NCT00103857|65956414|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
23608905|NCT00103857|65956415|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
23608906|NCT00103857|65956416|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
23608907|NCT00103857|65956417|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
23608908|NCT00103857|65956418|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
23608909|NCT00103857|65956419|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
23608910|NCT00103857|65956420|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
23608911|NCT00103857|65956414|FG000|54-Week Base Study|patient moved|0|||
23608912|NCT00103857|65956415|FG001|54-Week Base Study|patient moved|1|||
23608913|NCT00103857|65956416|FG002|54-Week Base Study|patient moved|1|||
23608914|NCT00103857|65956417|FG003|54-Week Base Study|patient moved|2|||
23608915|NCT00103857|65956418|FG004|54-Week Base Study|patient moved|3|||
23608916|NCT00103857|65956419|FG005|54-Week Base Study|patient moved|1|||
23608917|NCT00103857|65956420|FG006|54-Week Base Study|patient moved|0|||
23608918|NCT00103857|65956414|FG000|54-Week Base Study|non-compliance with study procedures|1|||
23608919|NCT00103857|65956415|FG001|54-Week Base Study|non-compliance with study procedures|2|||
23608920|NCT00103857|65956416|FG002|54-Week Base Study|non-compliance with study procedures|0|||
23608921|NCT00103857|65956417|FG003|54-Week Base Study|non-compliance with study procedures|0|||
23608922|NCT00103857|65956418|FG004|54-Week Base Study|non-compliance with study procedures|0|||
23608923|NCT00103857|65956419|FG005|54-Week Base Study|non-compliance with study procedures|2|||
23608924|NCT00103857|65956420|FG006|54-Week Base Study|non-compliance with study procedures|0|||
23608925|NCT00103857|65956414|FG000|54-Week Base Study|patient incarcerated|0|||
23608926|NCT00103857|65956415|FG001|54-Week Base Study|patient incarcerated|0|||
23608927|NCT00103857|65956416|FG002|54-Week Base Study|patient incarcerated|0|||
23608928|NCT00103857|65956417|FG003|54-Week Base Study|patient incarcerated|0|||
23608929|NCT00103857|65956418|FG004|54-Week Base Study|patient incarcerated|1|||
23608930|NCT00103857|65956419|FG005|54-Week Base Study|patient incarcerated|1|||
23608931|NCT00103857|65956420|FG006|54-Week Base Study|patient incarcerated|0|||
23608932|NCT00103857|65956414|FG000|54-Week Base Study|laboratory reporting error|0|||
23608933|NCT00103857|65956415|FG001|54-Week Base Study|laboratory reporting error|0|||
23608934|NCT00103857|65956416|FG002|54-Week Base Study|laboratory reporting error|0|||
23608935|NCT00103857|65956417|FG003|54-Week Base Study|laboratory reporting error|0|||
23608936|NCT00103857|65956418|FG004|54-Week Base Study|laboratory reporting error|1|||
23608937|NCT00103857|65956419|FG005|54-Week Base Study|laboratory reporting error|0|||
23608938|NCT00103857|65956420|FG006|54-Week Base Study|laboratory reporting error|0|||
23608939|NCT00103857|65956414|FG000|54-Week Base Study|site error|0|||
23608940|NCT00103857|65956415|FG001|54-Week Base Study|site error|0|||
23608941|NCT00103857|65956416|FG002|54-Week Base Study|site error|0|||
23608942|NCT00103857|65956417|FG003|54-Week Base Study|site error|0|||
23608943|NCT00103857|65956418|FG004|54-Week Base Study|site error|0|||
23608944|NCT00103857|65956419|FG005|54-Week Base Study|site error|1|||
23608945|NCT00103857|65956420|FG006|54-Week Base Study|site error|0|||
23608946|NCT00103857|65956414|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
23608947|NCT00103857|65956415|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608948|NCT00103857|65956416|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608949|NCT00103857|65956417|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608950|NCT00103857|65956418|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608951|NCT00103857|65956419|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608952|NCT00103857|65956420|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
23608953|NCT00103857|65956414|FG000|50-Week Extension Study|Adverse Event|2|||
23608954|NCT00103857|65956415|FG001|50-Week Extension Study|Adverse Event|3|||
23608955|NCT00103857|65956416|FG002|50-Week Extension Study|Adverse Event|2|||
23608956|NCT00103857|65956417|FG003|50-Week Extension Study|Adverse Event|0|||
23608957|NCT00103857|65956418|FG004|50-Week Extension Study|Adverse Event|1|||
23608958|NCT00103857|65956419|FG005|50-Week Extension Study|Adverse Event|1|||
23608959|NCT00103857|65956420|FG006|50-Week Extension Study|Adverse Event|0|||
23608960|NCT00103857|65956414|FG000|50-Week Extension Study|Death|0|||
23608961|NCT00103857|65956415|FG001|50-Week Extension Study|Death|0|||
23608962|NCT00103857|65956416|FG002|50-Week Extension Study|Death|0|||
23608963|NCT00103857|65956417|FG003|50-Week Extension Study|Death|1|||
23608964|NCT00103857|65956418|FG004|50-Week Extension Study|Death|0|||
23608965|NCT00103857|65956419|FG005|50-Week Extension Study|Death|1|||
23608966|NCT00103857|65956420|FG006|50-Week Extension Study|Death|0|||
23608967|NCT00103857|65956414|FG000|50-Week Extension Study|Lack of Efficacy|26|||
23608968|NCT00103857|65956415|FG001|50-Week Extension Study|Lack of Efficacy|15|||
23608969|NCT00103857|65956416|FG002|50-Week Extension Study|Lack of Efficacy|13|||
23608970|NCT00103857|65956417|FG003|50-Week Extension Study|Lack of Efficacy|16|||
23608971|NCT00103857|65956418|FG004|50-Week Extension Study|Lack of Efficacy|8|||
23608972|NCT00103857|65956419|FG005|50-Week Extension Study|Lack of Efficacy|8|||
23608973|NCT00103857|65956420|FG006|50-Week Extension Study|Lack of Efficacy|0|||
23608974|NCT00103857|65956414|FG000|50-Week Extension Study|Lost to Follow-up|4|||
23608975|NCT00103857|65956415|FG001|50-Week Extension Study|Lost to Follow-up|0|||
23608976|NCT00103857|65956416|FG002|50-Week Extension Study|Lost to Follow-up|1|||
23608977|NCT00103857|65956417|FG003|50-Week Extension Study|Lost to Follow-up|4|||
23608978|NCT00103857|65956418|FG004|50-Week Extension Study|Lost to Follow-up|3|||
23608979|NCT00103857|65956419|FG005|50-Week Extension Study|Lost to Follow-up|3|||
23608980|NCT00103857|65956420|FG006|50-Week Extension Study|Lost to Follow-up|0|||
23608981|NCT00103857|65956414|FG000|50-Week Extension Study|Physician Decision|0|||
23608982|NCT00103857|65956415|FG001|50-Week Extension Study|Physician Decision|1|||
23608983|NCT00103857|65956416|FG002|50-Week Extension Study|Physician Decision|1|||
23608984|NCT00103857|65956417|FG003|50-Week Extension Study|Physician Decision|0|||
23608985|NCT00103857|65956418|FG004|50-Week Extension Study|Physician Decision|0|||
23608986|NCT00103857|65956419|FG005|50-Week Extension Study|Physician Decision|0|||
23608987|NCT00103857|65956420|FG006|50-Week Extension Study|Physician Decision|0|||
23608988|NCT00103857|65956414|FG000|50-Week Extension Study|Pregnancy|0|||
23608989|NCT00103857|65956415|FG001|50-Week Extension Study|Pregnancy|0|||
23608990|NCT00103857|65956416|FG002|50-Week Extension Study|Pregnancy|1|||
23608991|NCT00103857|65956417|FG003|50-Week Extension Study|Pregnancy|0|||
23608992|NCT00103857|65956418|FG004|50-Week Extension Study|Pregnancy|1|||
23608993|NCT00103857|65956419|FG005|50-Week Extension Study|Pregnancy|0|||
23608994|NCT00103857|65956420|FG006|50-Week Extension Study|Pregnancy|0|||
23608995|NCT00103857|65956414|FG000|50-Week Extension Study|Protocol Violation|1|||
23608996|NCT00103857|65956415|FG001|50-Week Extension Study|Protocol Violation|1|||
23608997|NCT00103857|65956416|FG002|50-Week Extension Study|Protocol Violation|1|||
23608998|NCT00103857|65956417|FG003|50-Week Extension Study|Protocol Violation|2|||
23608999|NCT00103857|65956418|FG004|50-Week Extension Study|Protocol Violation|0|||
23609000|NCT00103857|65956419|FG005|50-Week Extension Study|Protocol Violation|1|||
23609001|NCT00103857|65956420|FG006|50-Week Extension Study|Protocol Violation|0|||
23609002|NCT00103857|65956414|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
23609003|NCT00103857|65956415|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
23510015|NCT00040664|65602056|FG002|Overall Study|Withdrawal by Subject|3|||
23510016|NCT00040664|65602057|FG003|Overall Study|Withdrawal by Subject|4|||
23510017|NCT00040664|65602054|FG000|Overall Study|Pregnancy|3|||
23510018|NCT00040664|65602055|FG001|Overall Study|Pregnancy|0|||
23510019|NCT00040664|65602056|FG002|Overall Study|Pregnancy|0|||
23510020|NCT00040664|65602057|FG003|Overall Study|Pregnancy|3|||
23510021|NCT00040664|65602054|FG000|Overall Study|Medication adherence/compliance problems|8|||
23510022|NCT00040664|65602055|FG001|Overall Study|Medication adherence/compliance problems|2|||
23510023|NCT00040664|65602056|FG002|Overall Study|Medication adherence/compliance problems|1|||
23510024|NCT00040664|65602057|FG003|Overall Study|Medication adherence/compliance problems|5|||
23510025|NCT00040664|65602054|FG000|Overall Study|Poor taste|2|||
23510026|NCT00040664|65602055|FG001|Overall Study|Poor taste|0|||
23510027|NCT00040664|65602056|FG002|Overall Study|Poor taste|2|||
23609004|NCT00103857|65956416|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
23609005|NCT00103857|65956417|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
23609006|NCT00103857|65956418|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
23609007|NCT00103857|65956419|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
23609008|NCT00103857|65956420|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
23609009|NCT00103857|65956414|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
23609010|NCT00103857|65956415|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
23609011|NCT00103857|65956416|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
23609012|NCT00103857|65956417|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
23609013|NCT00103857|65956418|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
23609014|NCT00103857|65956419|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
23609015|NCT00103857|65956420|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
23609016|NCT00103857|65956414|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
23609017|NCT00103857|65956415|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
23609018|NCT00103857|65956416|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
23609019|NCT00103857|65956417|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
23609020|NCT00103857|65956418|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
23609021|NCT00103857|65956419|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
23609022|NCT00103857|65956420|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
23609023|NCT00103857|65956414|FG000|50-Week Extension Study|patient moved|0|||
23609024|NCT00103857|65956415|FG001|50-Week Extension Study|patient moved|0|||
23609025|NCT00103857|65956416|FG002|50-Week Extension Study|patient moved|1|||
23609026|NCT00103857|65956417|FG003|50-Week Extension Study|patient moved|2|||
23609027|NCT00103857|65956418|FG004|50-Week Extension Study|patient moved|0|||
23609028|NCT00103857|65956419|FG005|50-Week Extension Study|patient moved|0|||
23609029|NCT00103857|65956420|FG006|50-Week Extension Study|patient moved|0|||
23609030|NCT00103857|65956414|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609031|NCT00103857|65956415|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609032|NCT00103857|65956416|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
23609033|NCT00103857|65956417|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609034|NCT00103857|65956418|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609035|NCT00103857|65956419|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609036|NCT00103857|65956420|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
23609037|NCT00103857|65956414|FG000|50-Week Extension Study|reason unspecified|0|||
23609038|NCT00103857|65956415|FG001|50-Week Extension Study|reason unspecified|0|||
23609039|NCT00103857|65956416|FG002|50-Week Extension Study|reason unspecified|0|||
23609040|NCT00103857|65956417|FG003|50-Week Extension Study|reason unspecified|0|||
23609041|NCT00103857|65956418|FG004|50-Week Extension Study|reason unspecified|1|||
23609042|NCT00103857|65956419|FG005|50-Week Extension Study|reason unspecified|0|||
23609043|NCT00103857|65956420|FG006|50-Week Extension Study|reason unspecified|0|||
23609044|NCT00113529|65956427|FG000|Overall Study|Adverse Event|4|||
23609045|NCT00113529|65956427|FG000|Overall Study|Lack of Efficacy|20|||
23609046|NCT00113529|65956427|FG000|Overall Study|Decision of sponsor|6|||
23609047|NCT00113529|65956427|FG000|Overall Study|Withdrawal by Subject|4|||
23609048|NCT00732498|65956428|FG000|Overall Study|Ineligible|1|||
23609049|NCT00732498|65956428|FG000|Overall Study|Adverse Event|2|||
23609050|NCT00732498|65956428|FG000|Overall Study|Physician Decision|3|||
23609051|NCT00608959|65956429|FG000|Part 1|Did not meet eligibility criteria|1|||
23609052|NCT00355784|65956430|FG000|Overall Study|Withdrawal by Subject|0|||
23609053|NCT00355784|65956431|FG001|Overall Study|Withdrawal by Subject|0|||
23609054|NCT00355784|65956432|FG002|Overall Study|Withdrawal by Subject|2|||
23609055|NCT03746015|65956433|FG000|Overall Study|Withdrawal of Consent|1|||
23609056|NCT03746015|65956434|FG001|Overall Study|Withdrawal of Consent|0|||
23609057|NCT03746015|65956435|FG002|Overall Study|Withdrawal of Consent|0|||
23510028|NCT00040664|65602057|FG003|Overall Study|Poor taste|0|||
23510029|NCT00040664|65602054|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
23609058|NCT00403845|65956438|FG000|Treatment Period 1|Subject withdrew consent|1|||
23510030|NCT00040664|65602055|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
23510031|NCT00040664|65602056|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
23510032|NCT00040664|65602057|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
23510033|NCT00040664|65602054|FG000|Overall Study|Change of formulation|2|||
23510034|NCT00040664|65602055|FG001|Overall Study|Change of formulation|2|||
23510035|NCT00040664|65602056|FG002|Overall Study|Change of formulation|0|||
23510036|NCT00040664|65602057|FG003|Overall Study|Change of formulation|0|||
23510037|NCT00040664|65602054|FG000|Overall Study|Non-viability of oral suspension|1|||
23510038|NCT00040664|65602055|FG001|Overall Study|Non-viability of oral suspension|0|||
23510039|NCT00040664|65602056|FG002|Overall Study|Non-viability of oral suspension|1|||
23510040|NCT00040664|65602057|FG003|Overall Study|Non-viability of oral suspension|0|||
23510041|NCT01402544|65602058|FG000|Overall Study|Withdrawal by Subject|6|||
23510042|NCT02899988|65602059|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
23510043|NCT02899988|65602060|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
23510044|NCT02899988|65602061|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510045|NCT02899988|65602062|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510046|NCT02899988|65602063|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510047|NCT02899988|65602064|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510048|NCT02899988|65602065|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510049|NCT02899988|65602066|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510050|NCT02899988|65602067|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510051|NCT02899988|65602068|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510052|NCT02899988|65602069|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23510053|NCT02899988|65602059|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
23510054|NCT02899988|65602060|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
23510055|NCT02899988|65602061|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
23510056|NCT02899988|65602062|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
23510057|NCT02899988|65602063|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
23510058|NCT02899988|65602064|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
23510059|NCT02899988|65602065|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
23510060|NCT02899988|65602066|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
23510061|NCT02899988|65602067|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
23510062|NCT02899988|65602068|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
23510063|NCT02899988|65602069|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
23510064|NCT02899988|65602059|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
23510065|NCT02899988|65602060|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
23510066|NCT02899988|65602061|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
23510067|NCT02899988|65602062|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
23510068|NCT02899988|65602063|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
23510069|NCT02899988|65602064|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
23510070|NCT02899988|65602065|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
23510071|NCT02899988|65602066|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
23510072|NCT02899988|65602067|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
23510073|NCT02899988|65602068|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
23510074|NCT02899988|65602069|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
23510075|NCT02899988|65602059|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
23510076|NCT02899988|65602060|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
23510077|NCT02899988|65602061|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
23510078|NCT02899988|65602062|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
23510079|NCT02899988|65602063|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
23510080|NCT02899988|65602064|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
23510081|NCT02899988|65602065|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
23510082|NCT02899988|65602066|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
23510083|NCT02899988|65602067|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
23510084|NCT02899988|65602068|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
23510085|NCT02899988|65602069|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
23609059|NCT00403845|65956439|FG001|Treatment Period 1|Subject withdrew consent|0|||
23609060|NCT00403845|65956440|FG002|Treatment Period 1|Subject withdrew consent|0|||
23609061|NCT00403845|65956441|FG003|Treatment Period 1|Subject withdrew consent|0|||
23609062|NCT00403845|65956438|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
23609063|NCT00403845|65956439|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
23609064|NCT00403845|65956440|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
23609065|NCT00403845|65956441|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
23609066|NCT00403845|65956438|FG000|Treatment Period 2|Subject withdrew consent|1|||
23609067|NCT00403845|65956439|FG001|Treatment Period 2|Subject withdrew consent|0|||
23609068|NCT00403845|65956440|FG002|Treatment Period 2|Subject withdrew consent|0|||
23609069|NCT00403845|65956441|FG003|Treatment Period 2|Subject withdrew consent|0|||
23609070|NCT00403845|65956438|FG000|Treatment Period 3|Subject withdrew consent|0|||
23609071|NCT00403845|65956439|FG001|Treatment Period 3|Subject withdrew consent|0|||
23609072|NCT00403845|65956440|FG002|Treatment Period 3|Subject withdrew consent|0|||
23609073|NCT00403845|65956441|FG003|Treatment Period 3|Subject withdrew consent|1|||
23609074|NCT00403845|65956438|FG000|Treatment Period 3|Adverse Event|0|||
23609075|NCT00403845|65956439|FG001|Treatment Period 3|Adverse Event|0|||
23609076|NCT00403845|65956440|FG002|Treatment Period 3|Adverse Event|0|||
23609077|NCT00403845|65956441|FG003|Treatment Period 3|Adverse Event|1|||
23609078|NCT05005247|65956443|FG000|Overall Study|Withdrawal by Subject|0|||
23609079|NCT05005247|65956444|FG001|Overall Study|Withdrawal by Subject|1|||
23609080|NCT05005247|65956445|FG002|Overall Study|Withdrawal by Subject|0|||
23609081|NCT01123200|65956446|FG000|Overall Study|Withdrawal by Subject|1|||
23609082|NCT04222088|65956447|FG000|Overall Study|Lost to Follow-up|5|||
23609083|NCT04222088|65956448|FG001|Overall Study|Lost to Follow-up|1|||
23609084|NCT04222088|65956447|FG000|Overall Study|Withdrawal by Subject|4|||
23609085|NCT04222088|65956448|FG001|Overall Study|Withdrawal by Subject|0|||
23609086|NCT01156675|65956449|FG000|Overall Study|Death|5|||
23609087|NCT01156675|65956450|FG001|Overall Study|Death|3|||
23609088|NCT01156675|65956451|FG002|Overall Study|Death|0|||
23609089|NCT01156675|65956449|FG000|Overall Study|No data|29|||
23609090|NCT01156675|65956450|FG001|Overall Study|No data|22|||
23609091|NCT01156675|65956451|FG002|Overall Study|No data|2|||
23609092|NCT02010684|65956456|FG000|Overall Study|Lost to Follow-up|8|||
23609093|NCT02010684|65956457|FG001|Overall Study|Lost to Follow-up|18|||
23510086|NCT02899988|65602059|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510087|NCT02899988|65602060|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510088|NCT02899988|65602061|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510089|NCT02899988|65602062|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510090|NCT02899988|65602063|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510091|NCT02899988|65602064|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
23510092|NCT02899988|65602065|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510093|NCT02899988|65602066|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
23510094|NCT02899988|65602067|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510095|NCT02899988|65602068|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510096|NCT02899988|65602069|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
23510097|NCT02899988|65602059|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510098|NCT02899988|65602060|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510099|NCT02899988|65602061|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510100|NCT02899988|65602062|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510101|NCT02899988|65602063|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
23510102|NCT02899988|65602064|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23510103|NCT02899988|65602065|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
23510104|NCT02899988|65602066|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
23510105|NCT02899988|65602067|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
23510106|NCT02899988|65602068|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
23609094|NCT02010684|65956456|FG000|Overall Study|Withdrawal by Subject|4|||
23609095|NCT02010684|65956457|FG001|Overall Study|Withdrawal by Subject|5|||
23609096|NCT02009865|65956458|FG000|Overall Study|Adverse Event|0|||
23609097|NCT02009865|65956459|FG001|Overall Study|Adverse Event|2|||
23609098|NCT02009865|65956458|FG000|Overall Study|Protocol Violation|0|||
23609099|NCT02009865|65956459|FG001|Overall Study|Protocol Violation|2|||
23609100|NCT02009865|65956458|FG000|Overall Study|Withdrawal by Subject|1|||
23609101|NCT02009865|65956459|FG001|Overall Study|Withdrawal by Subject|1|||
23609102|NCT01517282|65956463|FG000|Overall Study|Consent withdrawn|0|||
23609103|NCT01517282|65956464|FG001|Overall Study|Consent withdrawn|1|||
23609104|NCT01517282|65956465|FG002|Overall Study|Consent withdrawn|1|||
23609105|NCT01517282|65956466|FG003|Overall Study|Consent withdrawn|1|||
23609106|NCT01517282|65956463|FG000|Overall Study|Physician Decision|1|||
23609107|NCT01517282|65956464|FG001|Overall Study|Physician Decision|0|||
23609108|NCT01517282|65956465|FG002|Overall Study|Physician Decision|0|||
23609109|NCT01517282|65956466|FG003|Overall Study|Physician Decision|0|||
23609110|NCT00703092|65956467|FG000|Overall Study|Withdrawal by Subject|2|||
23609111|NCT00671853|65956468|FG000|Overall Study|Lack of Efficacy|3|||
23609112|NCT00671853|65956469|FG001|Overall Study|Lack of Efficacy|7|||
23609113|NCT00671853|65956468|FG000|Overall Study|Adverse Event|7|||
23609114|NCT00671853|65956469|FG001|Overall Study|Adverse Event|1|||
23609115|NCT00671853|65956468|FG000|Overall Study|Withdrawal by Subject|1|||
23609116|NCT00671853|65956469|FG001|Overall Study|Withdrawal by Subject|5|||
23609117|NCT00671853|65956468|FG000|Overall Study|Lost to Follow-up|8|||
23510107|NCT02899988|65602069|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
23510108|NCT00590720|65602072|FG000|Overall Study|Lost to Follow-up|1|||
23510109|NCT00590720|65602073|FG001|Overall Study|Lost to Follow-up|0|||
23510110|NCT00590720|65602072|FG000|Overall Study|Withdrawal by Subject|0|||
23609118|NCT00671853|65956469|FG001|Overall Study|Lost to Follow-up|8|||
23609119|NCT00671853|65956468|FG000|Overall Study|Physician Decision|0|||
23609120|NCT00671853|65956469|FG001|Overall Study|Physician Decision|2|||
23609121|NCT00671853|65956468|FG000|Overall Study|Non-adherence with study procedures|1|||
23609122|NCT00671853|65956469|FG001|Overall Study|Non-adherence with study procedures|4|||
23609123|NCT01322386|65956470|FG000|Overall Study|Protocol Violation|0|||
23510111|NCT00590720|65602073|FG001|Overall Study|Withdrawal by Subject|1|||
23510112|NCT03364023|65602074|FG000|Overall Study|Lost to Follow-up|3|||
23510113|NCT03364023|65602074|FG000|Overall Study|Death|14|||
23510114|NCT00368355|65602075|FG000|Overall Study|Adverse Event|1|||
23510115|NCT00368355|65602076|FG001|Overall Study|Adverse Event|0|||
23510116|NCT00368355|65602075|FG000|Overall Study|Death|2|||
23510117|NCT00368355|65602076|FG001|Overall Study|Death|4|||
23510118|NCT00368355|65602075|FG000|Overall Study|Relapse|6|||
23510119|NCT00368355|65602076|FG001|Overall Study|Relapse|10|||
23510120|NCT00368355|65602075|FG000|Overall Study|Subsequent transplant|0|||
23510121|NCT00368355|65602076|FG001|Overall Study|Subsequent transplant|3|||
23510122|NCT00368355|65602075|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
23510123|NCT00368355|65602076|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
23510124|NCT00290888|65602078|FG000|Overall Study|Physician Decision|3|||
23510125|NCT00290888|65602079|FG001|Overall Study|Physician Decision|1|||
23510126|NCT00284050|65602080|FG000|Overall Study|Adverse Event|1|||
23510127|NCT00284050|65602081|FG001|Overall Study|Adverse Event|1|||
23510128|NCT00284050|65602082|FG002|Overall Study|Adverse Event|1|||
23510129|NCT00284050|65602080|FG000|Overall Study|Lack of Efficacy|0|||
23510130|NCT00284050|65602081|FG001|Overall Study|Lack of Efficacy|1|||
23510131|NCT00284050|65602082|FG002|Overall Study|Lack of Efficacy|3|||
23510132|NCT00284050|65602080|FG000|Overall Study|Protocol Violation|0|||
23510133|NCT00284050|65602081|FG001|Overall Study|Protocol Violation|1|||
23510134|NCT00284050|65602082|FG002|Overall Study|Protocol Violation|2|||
23510135|NCT00284050|65602080|FG000|Overall Study|Withdrawal by Subject|2|||
23510136|NCT00284050|65602081|FG001|Overall Study|Withdrawal by Subject|2|||
23510137|NCT00284050|65602082|FG002|Overall Study|Withdrawal by Subject|2|||
23510138|NCT00284050|65602080|FG000|Overall Study|Lost to Follow-up|1|||
23510139|NCT00284050|65602081|FG001|Overall Study|Lost to Follow-up|0|||
23510140|NCT00284050|65602082|FG002|Overall Study|Lost to Follow-up|1|||
23510141|NCT00284050|65602080|FG000|Overall Study|Death|1|||
23510142|NCT00284050|65602081|FG001|Overall Study|Death|0|||
23510143|NCT00284050|65602082|FG002|Overall Study|Death|0|||
23510144|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Death|3|||
23510145|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Death|3|||
23510146|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Death|0|||
23510147|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Death|0|||
23510148|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
23510149|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
23510150|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
23510151|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
23510152|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
23510153|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
23510154|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
23510155|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
23510156|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
23510157|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
23510158|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
23510159|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
23510160|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
23510161|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
23510162|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
23510163|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
23510164|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
23510165|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
23510166|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
23510167|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
23510168|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
23510169|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
23510170|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
23510171|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
23510172|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Other|6|||
23510173|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Other|3|||
23510174|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Other|0|||
23510175|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Other|0|||
23510176|NCT02051608|65602089|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
23510177|NCT02051608|65602090|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
23510178|NCT02051608|65602091|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
23510179|NCT02051608|65602092|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
23510180|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Adverse Event|0|||
23510181|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Adverse Event|0|||
23510182|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Adverse Event|6|||
23510183|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Adverse Event|8|||
23510184|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Death|0|||
23510185|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Death|0|||
23510186|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Death|7|||
23510187|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Death|4|||
23510188|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
23510189|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
23510190|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
23510191|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
23510192|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
23510193|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
23510194|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
23510195|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
23510196|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
23510197|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
23510198|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
23510199|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
23510200|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
23510201|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
23510202|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
23510203|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
23510204|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Physician Decision|0|||
23510205|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Physician Decision|0|||
23510206|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Physician Decision|8|||
23510207|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Physician Decision|5|||
23510208|NCT02051608|65602089|FG000|Part 2: Open-label Extension|Other|0|||
23510209|NCT02051608|65602090|FG001|Part 2: Open-label Extension|Other|0|||
23510210|NCT02051608|65602091|FG002|Part 2: Open-label Extension|Other|9|||
23510211|NCT02051608|65602092|FG003|Part 2: Open-label Extension|Other|9|||
23510212|NCT03716024|65602093|FG000|Overall Study|Randomized, not Treated|7|||
23510213|NCT03716024|65602094|FG001|Overall Study|Randomized, not Treated|8|||
23510214|NCT03716024|65602093|FG000|Overall Study|Adverse Event|1|||
23510215|NCT03716024|65602094|FG001|Overall Study|Adverse Event|2|||
23510216|NCT03716024|65602093|FG000|Overall Study|Treatment Failure|1|||
23510217|NCT03716024|65602094|FG001|Overall Study|Treatment Failure|0|||
23510218|NCT03716024|65602093|FG000|Overall Study|Lost to Follow-up|2|||
23510219|NCT03716024|65602094|FG001|Overall Study|Lost to Follow-up|6|||
23510220|NCT03716024|65602093|FG000|Overall Study|Withdrawal by Subject|0|||
23510221|NCT03716024|65602094|FG001|Overall Study|Withdrawal by Subject|1|||
23510222|NCT03716024|65602093|FG000|Overall Study|Missing Reason|0|||
23510223|NCT03716024|65602094|FG001|Overall Study|Missing Reason|1|||
23510224|NCT02385045|65605942|FG000|Overall Study|Endoscopy could not be completed|4|||
23510225|NCT00715078|65605943|FG000|Overall Study|Death|29|||
23510226|NCT00715078|65605944|FG001|Overall Study|Death|36|||
23510227|NCT00715078|65605945|FG002|Overall Study|Death|36|||
23510228|NCT00715078|65605943|FG000|Overall Study|Withdrawal by Subject|1|||
23510229|NCT00715078|65605944|FG001|Overall Study|Withdrawal by Subject|0|||
23510230|NCT00715078|65605945|FG002|Overall Study|Withdrawal by Subject|1|||
23510231|NCT00715078|65605943|FG000|Overall Study|Unable to start due to disease prog.|0|||
23510232|NCT00715078|65605944|FG001|Overall Study|Unable to start due to disease prog.|0|||
23510233|NCT00715078|65605945|FG002|Overall Study|Unable to start due to disease prog.|1|||
23510234|NCT00779467|65605946|FG000|Overall Study|Lack of Efficacy|11|||
23510235|NCT00779467|65605947|FG001|Overall Study|Lack of Efficacy|2|||
23510236|NCT00779467|65605948|FG002|Overall Study|Lack of Efficacy|6|||
23510237|NCT00779467|65605949|FG003|Overall Study|Lack of Efficacy|11|||
23510238|NCT00779467|65605946|FG000|Overall Study|failed inclusion criteria|3|||
23510239|NCT00779467|65605947|FG001|Overall Study|failed inclusion criteria|3|||
23510240|NCT00779467|65605948|FG002|Overall Study|failed inclusion criteria|1|||
23510241|NCT00779467|65605949|FG003|Overall Study|failed inclusion criteria|2|||
23510242|NCT00779467|65605946|FG000|Overall Study|missing data|1|||
23510243|NCT00779467|65605947|FG001|Overall Study|missing data|0|||
23510244|NCT00779467|65605948|FG002|Overall Study|missing data|1|||
23510245|NCT00779467|65605949|FG003|Overall Study|missing data|4|||
23510246|NCT00779467|65605946|FG000|Overall Study|technical issue|0|||
23510247|NCT00779467|65605947|FG001|Overall Study|technical issue|0|||
23510248|NCT00779467|65605948|FG002|Overall Study|technical issue|2|||
23510249|NCT00779467|65605949|FG003|Overall Study|technical issue|1|||
23510250|NCT00779467|65605946|FG000|Overall Study|unavailable research staff|0|||
23510251|NCT00779467|65605947|FG001|Overall Study|unavailable research staff|0|||
23510252|NCT00779467|65605948|FG002|Overall Study|unavailable research staff|0|||
23510253|NCT00779467|65605949|FG003|Overall Study|unavailable research staff|1|||
23510254|NCT03915496|65605959|FG000|Overall Study|Adverse Event|2|||
23510255|NCT03915496|65605960|FG001|Overall Study|Adverse Event|1|||
23510256|NCT03915496|65605961|FG002|Overall Study|Adverse Event|2|||
23510257|NCT01005745|65605962|FG000|Overall Study|No TIL growth|1|||
23510258|NCT01005745|65605962|FG000|Overall Study|Disease progressed during TIL growth|3|||
23510259|NCT01005745|65605962|FG000|Overall Study|Death prior to treatment|1|||
23510260|NCT01005745|65605962|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
23510261|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
23510262|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
23510263|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
23510264|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
23510265|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
23510266|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
23510267|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
23510268|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
23510269|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
23510270|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
23510271|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Death|2|||
23609124|NCT01322386|65956471|FG001|Overall Study|Protocol Violation|1|||
23609125|NCT01322386|65956470|FG000|Overall Study|Physician Decision|0|||
23609126|NCT01322386|65956471|FG001|Overall Study|Physician Decision|1|||
23609127|NCT02312258|65956472|FG000|Overall Study|Lost to Follow-up|8|||
23609128|NCT02312258|65956473|FG001|Overall Study|Lost to Follow-up|8|||
23609129|NCT02312258|65956472|FG000|Overall Study|Withdrawal by Patient|49|||
23609130|NCT02312258|65956473|FG001|Overall Study|Withdrawal by Patient|76|||
23609131|NCT02312258|65956472|FG000|Overall Study|Reason not Specified|107|||
23609132|NCT02312258|65956473|FG001|Overall Study|Reason not Specified|159|||
23609133|NCT02312258|65956472|FG000|Overall Study|Missing|2|||
23609134|NCT02312258|65956473|FG001|Overall Study|Missing|1|||
23609135|NCT02312258|65956472|FG000|Overall Study|Death|115|||
23609136|NCT02312258|65956473|FG001|Overall Study|Death|181|||
23609137|NCT01020435|65956474|FG000|Overall Study|Lost to Follow-up|0|||
23609138|NCT01020435|65956475|FG001|Overall Study|Lost to Follow-up|1|||
23609139|NCT01090739|65956476|FG000|Enrollment|Withdrawal by Subject|24|||
23609140|NCT01090739|65956476|FG000|Enrollment|Protocol Violation|14|||
23609141|NCT01090739|65956476|FG000|Enrollment|Lost to Follow-up|5|||
23609142|NCT01090739|65956476|FG000|Enrollment|Physician Decision|5|||
23609143|NCT01090739|65956476|FG000|Enrollment|Sponsor termination of site|4|||
23609144|NCT01090739|65956476|FG000|Enrollment|Study implant limit reached|2|||
23609145|NCT01090739|65956476|FG000|Enrollment|Adverse Event|1|||
23609146|NCT01090739|65956476|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
23609147|NCT01090739|65956476|FG000|12 Month Follow-up|Lost to Follow-up|1|||
23609148|NCT01090739|65956476|FG000|12 Month Follow-up|Physician Decision|1|||
23609149|NCT01090739|65956476|FG000|12 Month Follow-up|Death|1|||
23609150|NCT01090739|65956476|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
23609151|NCT01090739|65956476|FG000|24 Month Follow-up|Lost to Follow-up|1|||
23609152|NCT01090739|65956476|FG000|24 Month Follow-up|Death|1|||
23609153|NCT01090739|65956476|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
23609154|NCT01090739|65956476|FG000|36 Month Follow-up|Visit still pending|17|||
23609155|NCT02548585|65956477|FG000|Overall Study|Withdrawal by Subject|0|||
23609156|NCT02548585|65956478|FG001|Overall Study|Withdrawal by Subject|0|||
23609157|NCT02548585|65956479|FG002|Overall Study|Withdrawal by Subject|0|||
23609158|NCT02548585|65956480|FG003|Overall Study|Withdrawal by Subject|0|||
23609159|NCT02548585|65956481|FG004|Overall Study|Withdrawal by Subject|0|||
23609160|NCT02548585|65956482|FG005|Overall Study|Withdrawal by Subject|1|||
23609161|NCT02548585|65956483|FG006|Overall Study|Withdrawal by Subject|0|||
23609162|NCT02548585|65956477|FG000|Overall Study|Lost to Follow-up|1|||
23609163|NCT02548585|65956478|FG001|Overall Study|Lost to Follow-up|0|||
23609164|NCT02548585|65956479|FG002|Overall Study|Lost to Follow-up|0|||
23609165|NCT02548585|65956480|FG003|Overall Study|Lost to Follow-up|0|||
23609166|NCT02548585|65956481|FG004|Overall Study|Lost to Follow-up|0|||
23609167|NCT02548585|65956482|FG005|Overall Study|Lost to Follow-up|0|||
23609168|NCT02548585|65956483|FG006|Overall Study|Lost to Follow-up|0|||
23609169|NCT02548585|65956477|FG000|Overall Study|Other|1|||
23609170|NCT02548585|65956478|FG001|Overall Study|Other|0|||
23609171|NCT02548585|65956479|FG002|Overall Study|Other|0|||
23609172|NCT02548585|65956480|FG003|Overall Study|Other|2|||
23609173|NCT02548585|65956481|FG004|Overall Study|Other|3|||
23609174|NCT02548585|65956482|FG005|Overall Study|Other|0|||
23609175|NCT02548585|65956483|FG006|Overall Study|Other|1|||
23609176|NCT02548585|65956477|FG000|Overall Study|Randomized but not treated|0|||
23609177|NCT02548585|65956478|FG001|Overall Study|Randomized but not treated|0|||
23609178|NCT02548585|65956479|FG002|Overall Study|Randomized but not treated|0|||
23609179|NCT02548585|65956480|FG003|Overall Study|Randomized but not treated|0|||
23609180|NCT02548585|65956481|FG004|Overall Study|Randomized but not treated|0|||
23609181|NCT02548585|65956482|FG005|Overall Study|Randomized but not treated|1|||
23609182|NCT02548585|65956483|FG006|Overall Study|Randomized but not treated|0|||
23609183|NCT02279732|65956484|FG000|Overall Study|Death|23|||
23609184|NCT02279732|65956485|FG001|Overall Study|Death|20|||
23609185|NCT02279732|65956484|FG000|Overall Study|Disease Progression|13|||
23609186|NCT02279732|65956485|FG001|Overall Study|Disease Progression|3|||
23609187|NCT02279732|65956484|FG000|Overall Study|Withdrawal by Subject|2|||
23609188|NCT02279732|65956485|FG001|Overall Study|Withdrawal by Subject|7|||
23609189|NCT02279732|65956484|FG000|Overall Study|Adverse Event|1|||
23609190|NCT02279732|65956485|FG001|Overall Study|Adverse Event|2|||
23609191|NCT02279732|65956484|FG000|Overall Study|Administrative Reason By Sponsor|0|||
23609192|NCT02279732|65956485|FG001|Overall Study|Administrative Reason By Sponsor|2|||
23609193|NCT02279732|65956484|FG000|Overall Study|Study Drug Toxicity|2|||
23609194|NCT02279732|65956485|FG001|Overall Study|Study Drug Toxicity|0|||
23609195|NCT02279732|65956484|FG000|Overall Study|Lost to Follow-up|0|||
23609196|NCT02279732|65956485|FG001|Overall Study|Lost to Follow-up|1|||
23609197|NCT02279732|65956484|FG000|Overall Study|Maximum Clinical Benefit|1|||
23609198|NCT02279732|65956485|FG001|Overall Study|Maximum Clinical Benefit|0|||
23609199|NCT02279732|65956484|FG000|Overall Study|Subject Requested to Discontinue|0|||
23609200|NCT02279732|65956485|FG001|Overall Study|Subject Requested to Discontinue|1|||
23609201|NCT02279732|65956484|FG000|Overall Study|Other|53|||
23609202|NCT02279732|65956485|FG001|Overall Study|Other|67|||
23609203|NCT02279732|65956484|FG000|Overall Study|Other|3|||
23609204|NCT02279732|65956485|FG001|Overall Study|Other|3|||
23609205|NCT02598388|65956488|FG000|Overall Study|Lost to Follow-up|1|||
23609206|NCT02598388|65956489|FG001|Overall Study|Lost to Follow-up|0|||
23609207|NCT02598388|65956490|FG002|Overall Study|Lost to Follow-up|1|||
23609208|NCT02598388|65956491|FG003|Overall Study|Lost to Follow-up|0|||
23609209|NCT02598388|65956492|FG004|Overall Study|Lost to Follow-up|5|||
23609210|NCT02598388|65956493|FG005|Overall Study|Lost to Follow-up|1|||
23609211|NCT02598388|65956494|FG006|Overall Study|Lost to Follow-up|2|||
23609212|NCT02598388|65956495|FG007|Overall Study|Lost to Follow-up|1|||
23609213|NCT02598388|65956496|FG008|Overall Study|Lost to Follow-up|0|||
23609214|NCT02598388|65956497|FG009|Overall Study|Lost to Follow-up|0|||
23609215|NCT02598388|65956498|FG010|Overall Study|Lost to Follow-up|1|||
23609216|NCT02598388|65956499|FG011|Overall Study|Lost to Follow-up|0|||
23609217|NCT02598388|65956488|FG000|Overall Study|Withdrawal by Subject|0|||
23609218|NCT02598388|65956489|FG001|Overall Study|Withdrawal by Subject|0|||
23609219|NCT02598388|65956490|FG002|Overall Study|Withdrawal by Subject|0|||
23609220|NCT02598388|65956491|FG003|Overall Study|Withdrawal by Subject|0|||
23609221|NCT02598388|65956492|FG004|Overall Study|Withdrawal by Subject|2|||
23609222|NCT02598388|65956493|FG005|Overall Study|Withdrawal by Subject|0|||
23609223|NCT02598388|65956494|FG006|Overall Study|Withdrawal by Subject|2|||
23609224|NCT02598388|65956495|FG007|Overall Study|Withdrawal by Subject|0|||
23609225|NCT02598388|65956496|FG008|Overall Study|Withdrawal by Subject|0|||
23609226|NCT02598388|65956497|FG009|Overall Study|Withdrawal by Subject|1|||
23609227|NCT02598388|65956498|FG010|Overall Study|Withdrawal by Subject|0|||
23609228|NCT02598388|65956499|FG011|Overall Study|Withdrawal by Subject|0|||
23609229|NCT02598388|65956488|FG000|Overall Study|Other|0|||
23609230|NCT02598388|65956489|FG001|Overall Study|Other|0|||
23609231|NCT02598388|65956490|FG002|Overall Study|Other|1|||
23609232|NCT02598388|65956491|FG003|Overall Study|Other|0|||
23609233|NCT02598388|65956492|FG004|Overall Study|Other|3|||
23609234|NCT02598388|65956493|FG005|Overall Study|Other|0|||
23609235|NCT02598388|65956494|FG006|Overall Study|Other|1|||
23609236|NCT02598388|65956495|FG007|Overall Study|Other|0|||
23609237|NCT02598388|65956496|FG008|Overall Study|Other|0|||
23609238|NCT02598388|65956497|FG009|Overall Study|Other|0|||
23510272|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Death|1|||
23510273|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Death|4|||
23609239|NCT02598388|65956498|FG010|Overall Study|Other|0|||
23609240|NCT02598388|65956499|FG011|Overall Study|Other|0|||
23609241|NCT01102426|65956500|FG000|Overall Study|Randomized but not treated|4|||
23609242|NCT01102426|65956501|FG001|Overall Study|Randomized but not treated|1|||
23609243|NCT01102426|65956500|FG000|Overall Study|Adverse Events (treatment-related)|15|||
23609244|NCT01102426|65956501|FG001|Overall Study|Adverse Events (treatment-related)|8|||
23609245|NCT01102426|65956500|FG000|Overall Study|Physician Decision|9|||
23609246|NCT01102426|65956501|FG001|Overall Study|Physician Decision|6|||
23609247|NCT01102426|65956500|FG000|Overall Study|Progressive Disease|85|||
23510274|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Death|0|||
23510275|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Death|0|||
23609248|NCT01102426|65956501|FG001|Overall Study|Progressive Disease|44|||
23609249|NCT01102426|65956500|FG000|Overall Study|Adverse Events (unrelated to|9|||
23609250|NCT01102426|65956501|FG001|Overall Study|Adverse Events (unrelated to|1|||
23609251|NCT01102426|65956500|FG000|Overall Study|Patient Refusal|24|||
23510276|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
23609252|NCT01102426|65956501|FG001|Overall Study|Patient Refusal|12|||
23609253|NCT01102426|65956500|FG000|Overall Study|Death (due to adverse events|0|||
23609254|NCT01102426|65956501|FG001|Overall Study|Death (due to adverse events|1|||
23609255|NCT01102426|65956500|FG000|Overall Study|Death (non-related to the study|19|||
23609256|NCT01102426|65956501|FG001|Overall Study|Death (non-related to the study|8|||
23609257|NCT00603278|65956502|FG000|Overall Study|Lack of Efficacy|35|||
23609258|NCT00603278|65956503|FG001|Overall Study|Lack of Efficacy|10|||
23609259|NCT00603278|65956504|FG002|Overall Study|Lack of Efficacy|11|||
23609260|NCT00603278|65956505|FG003|Overall Study|Lack of Efficacy|8|||
23609261|NCT00603278|65956506|FG004|Overall Study|Lack of Efficacy|7|||
23609262|NCT00603278|65956507|FG005|Overall Study|Lack of Efficacy|14|||
23609263|NCT00603278|65956502|FG000|Overall Study|Adverse Event|0|||
23609264|NCT00603278|65956503|FG001|Overall Study|Adverse Event|3|||
23609265|NCT00603278|65956504|FG002|Overall Study|Adverse Event|1|||
23609266|NCT00603278|65956505|FG003|Overall Study|Adverse Event|0|||
23609267|NCT00603278|65956506|FG004|Overall Study|Adverse Event|2|||
23609268|NCT00603278|65956507|FG005|Overall Study|Adverse Event|1|||
23609269|NCT00603278|65956502|FG000|Overall Study|Withdrawal by Subject|2|||
23609270|NCT00603278|65956503|FG001|Overall Study|Withdrawal by Subject|3|||
23609271|NCT00603278|65956504|FG002|Overall Study|Withdrawal by Subject|1|||
23609272|NCT00603278|65956505|FG003|Overall Study|Withdrawal by Subject|2|||
23609273|NCT00603278|65956506|FG004|Overall Study|Withdrawal by Subject|1|||
23609274|NCT00603278|65956507|FG005|Overall Study|Withdrawal by Subject|2|||
23609275|NCT00603278|65956502|FG000|Overall Study|Protocol Violation|3|||
23609276|NCT00603278|65956503|FG001|Overall Study|Protocol Violation|0|||
23609277|NCT00603278|65956504|FG002|Overall Study|Protocol Violation|1|||
23609278|NCT00603278|65956505|FG003|Overall Study|Protocol Violation|1|||
23609279|NCT00603278|65956506|FG004|Overall Study|Protocol Violation|0|||
23609280|NCT00603278|65956507|FG005|Overall Study|Protocol Violation|1|||
23609281|NCT00603278|65956502|FG000|Overall Study|Physician Decision|0|||
23609282|NCT00603278|65956503|FG001|Overall Study|Physician Decision|1|||
23609283|NCT00603278|65956504|FG002|Overall Study|Physician Decision|0|||
23609284|NCT00603278|65956505|FG003|Overall Study|Physician Decision|0|||
23609285|NCT00603278|65956506|FG004|Overall Study|Physician Decision|2|||
23609286|NCT00603278|65956507|FG005|Overall Study|Physician Decision|1|||
23609287|NCT00603278|65956502|FG000|Overall Study|Lost to Follow-up|1|||
23609288|NCT00603278|65956503|FG001|Overall Study|Lost to Follow-up|0|||
23609289|NCT00603278|65956504|FG002|Overall Study|Lost to Follow-up|0|||
23510277|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
23510278|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
23510279|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
23510280|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
23510281|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Other Reason|1|||
23510282|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Other Reason|3|||
23510283|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Other Reason|2|||
23510284|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Other Reason|0|||
23510285|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Other Reason|0|||
23510286|NCT00555321|65605963|FG000|Treatment Phase up to 12-months|Never treated|2|||
23510287|NCT00555321|65605964|FG001|Treatment Phase up to 12-months|Never treated|3|||
23510288|NCT00555321|65605965|FG002|Treatment Phase up to 12-months|Never treated|1|||
23510289|NCT00555321|65605966|FG003|Treatment Phase up to 12-months|Never treated|0|||
23510290|NCT00555321|65605967|FG004|Treatment Phase up to 12-months|Never treated|4|||
23510291|NCT00555321|65605963|FG000|Long-term Extension Phase|Adverse Event|2|||
23510292|NCT00555321|65605964|FG001|Long-term Extension Phase|Adverse Event|5|||
23510293|NCT00555321|65605965|FG002|Long-term Extension Phase|Adverse Event|2|||
23510294|NCT00555321|65605966|FG003|Long-term Extension Phase|Adverse Event|1|||
23510295|NCT00555321|65605967|FG004|Long-term Extension Phase|Adverse Event|0|||
23510296|NCT00555321|65605963|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
23510297|NCT00555321|65605964|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
23510298|NCT00555321|65605965|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
23510299|NCT00555321|65605966|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
23510300|NCT00555321|65605967|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
23510301|NCT00555321|65605963|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
23510302|NCT00555321|65605964|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
23510303|NCT00555321|65605965|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
23510304|NCT00555321|65605966|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
23510305|NCT00555321|65605967|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
23510306|NCT00555321|65605963|FG000|Long-term Extension Phase|Death|2|||
23510307|NCT00555321|65605964|FG001|Long-term Extension Phase|Death|0|||
23510308|NCT00555321|65605965|FG002|Long-term Extension Phase|Death|0|||
23510309|NCT00555321|65605966|FG003|Long-term Extension Phase|Death|3|||
23510310|NCT00555321|65605967|FG004|Long-term Extension Phase|Death|0|||
23510311|NCT00555321|65605963|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
23510312|NCT00555321|65605964|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
23510313|NCT00555321|65605965|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
23609290|NCT00603278|65956505|FG003|Overall Study|Lost to Follow-up|0|||
23609291|NCT00603278|65956506|FG004|Overall Study|Lost to Follow-up|1|||
23609292|NCT00603278|65956507|FG005|Overall Study|Lost to Follow-up|0|||
23609293|NCT04765046|65956508|FG000|Overall Study|Screen Failure|2|||
23609294|NCT04765046|65956508|FG000|Overall Study|Withdrawal by Subject|4|||
23510314|NCT00555321|65605966|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
23609295|NCT04765046|65956508|FG000|Overall Study|Physician Decision|4|||
23609296|NCT04765046|65956508|FG000|Overall Study|Surgery Cancelled|8|||
23609297|NCT03492177|65956512|FG000|Overall Study|Adverse Event|1|||
23609298|NCT03492177|65956513|FG001|Overall Study|Adverse Event|0|||
23609299|NCT03492177|65956514|FG002|Overall Study|Adverse Event|0|||
23510315|NCT00555321|65605967|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
23510316|NCT00555321|65605963|FG000|Long-term Extension Phase|Other Reason|1|||
23510317|NCT00555321|65605964|FG001|Long-term Extension Phase|Other Reason|0|||
23510318|NCT00555321|65605965|FG002|Long-term Extension Phase|Other Reason|2|||
23510319|NCT00555321|65605966|FG003|Long-term Extension Phase|Other Reason|0|||
23510320|NCT00555321|65605967|FG004|Long-term Extension Phase|Other Reason|0|||
23510321|NCT03562481|65605968|FG000|First Intervention|Lost to Follow-up|1|||
23510322|NCT03562481|65605969|FG001|First Intervention|Lost to Follow-up|0|||
23510323|NCT01955733|65605971|FG000|Period 1|Lost to Follow-up|1|||
23510324|NCT01955733|65605972|FG001|Period 1|Lost to Follow-up|0|||
23510325|NCT01955733|65605973|FG002|Period 1|Lost to Follow-up|0|||
23510326|NCT01955733|65605971|FG000|Period 2|Adverse Event|1|||
23510327|NCT01955733|65605972|FG001|Period 2|Adverse Event|0|||
23510328|NCT01955733|65605973|FG002|Period 2|Adverse Event|0|||
23609300|NCT03492177|65956512|FG000|Overall Study|Death|3|||
23609301|NCT03492177|65956513|FG001|Overall Study|Death|0|||
23609302|NCT03492177|65956514|FG002|Overall Study|Death|3|||
23609303|NCT03492177|65956512|FG000|Overall Study|Lack of Efficacy|1|||
23609304|NCT03492177|65956513|FG001|Overall Study|Lack of Efficacy|2|||
23609305|NCT03492177|65956514|FG002|Overall Study|Lack of Efficacy|0|||
23609306|NCT03492177|65956512|FG000|Overall Study|Other|1|||
23609307|NCT03492177|65956513|FG001|Overall Study|Other|0|||
23609308|NCT03492177|65956514|FG002|Overall Study|Other|0|||
23609309|NCT03492177|65956512|FG000|Overall Study|Ongoing|16|||
23609310|NCT03492177|65956513|FG001|Overall Study|Ongoing|19|||
23609311|NCT03492177|65956514|FG002|Overall Study|Ongoing|17|||
23609312|NCT01794689|65956517|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
23609313|NCT01794689|65956518|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
23609314|NCT01794689|65956519|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
23609315|NCT01794689|65956520|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
23609316|NCT01794689|65956517|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
23609317|NCT01794689|65956518|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
23609318|NCT01794689|65956519|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
23609319|NCT01794689|65956520|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
23609320|NCT01794689|65956517|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
23609321|NCT01794689|65956518|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
23609322|NCT01794689|65956519|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
23609323|NCT01794689|65956520|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
23609324|NCT01794689|65956517|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
23609325|NCT01794689|65956518|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
23609326|NCT01794689|65956519|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
23609327|NCT01794689|65956520|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
23609328|NCT02058992|65956521|FG000|Overall Study|Lost to Follow-up|4|||
23609329|NCT02058992|65956521|FG000|Overall Study|Protocol Violation|92|||
23609330|NCT02058992|65956521|FG000|Overall Study|CRF Uncollected|20|||
23609331|NCT01697956|65956525|FG000|Overall Study|Protocol Violation|1|||
23609332|NCT01697956|65956526|FG001|Overall Study|Protocol Violation|1|||
23609333|NCT00882050|65956527|FG000|Overall Study|Physician Decision|1|||
23609334|NCT00882050|65956528|FG001|Overall Study|Physician Decision|0|||
23609335|NCT00882050|65956529|FG002|Overall Study|Physician Decision|0|||
23609336|NCT00589628|65956530|FG000|Overall Study|Lost to Follow-up|0|||
23609337|NCT00589628|65956531|FG001|Overall Study|Lost to Follow-up|1|||
23609338|NCT03070301|65956532|FG000|Overall Study|Progression of disease|16|||
23609339|NCT03070301|65956532|FG000|Overall Study|Physician Decision|3|||
23609340|NCT03070301|65956532|FG000|Overall Study|Withdrawal by Subject|1|||
23609341|NCT00460434|65959405|FG000|Overall Study|Lost to Follow-up|3|||
23609342|NCT00460434|65959406|FG001|Overall Study|Lost to Follow-up|7|||
23609343|NCT02710669|65959407|FG000|Overall Study|Physician Decision|2|||
23609344|NCT02710669|65959408|FG001|Overall Study|Physician Decision|1|||
23609345|NCT02710669|65959409|FG002|Overall Study|Physician Decision|0|||
23609346|NCT02710669|65959407|FG000|Overall Study|Institutional delays (including COVID)|2|||
23510329|NCT01955733|65605971|FG000|Period 2|Physician Decision|0|||
23510330|NCT01955733|65605972|FG001|Period 2|Physician Decision|0|||
23510331|NCT01955733|65605973|FG002|Period 2|Physician Decision|1|||
23510332|NCT01955733|65605971|FG000|Period 2|Withdrawal by Subject|1|||
23510333|NCT01955733|65605972|FG001|Period 2|Withdrawal by Subject|3|||
23609347|NCT02710669|65959408|FG001|Overall Study|Institutional delays (including COVID)|2|||
23609348|NCT02710669|65959409|FG002|Overall Study|Institutional delays (including COVID)|0|||
23609349|NCT02710669|65959407|FG000|Overall Study|arrived in afib/aflutter|10|||
23609350|NCT02710669|65959408|FG001|Overall Study|arrived in afib/aflutter|8|||
23609351|NCT02710669|65959409|FG002|Overall Study|arrived in afib/aflutter|2|||
23609352|NCT01393600|65959411|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
23609353|NCT01393600|65959412|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
23609354|NCT01393600|65959413|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
23609355|NCT01393600|65959414|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
23609356|NCT01393600|65959411|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
23510334|NCT01955733|65605973|FG002|Period 2|Withdrawal by Subject|2|||
23510335|NCT01955733|65605971|FG000|Period 2|Study terminated by sponsor|8|||
23510336|NCT01955733|65605972|FG001|Period 2|Study terminated by sponsor|14|||
23609357|NCT01393600|65959412|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
23609358|NCT01393600|65959413|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
23609359|NCT01393600|65959414|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
23609360|NCT01393600|65959411|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
23609361|NCT01393600|65959412|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
23609362|NCT01393600|65959413|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
23609363|NCT01393600|65959414|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
23609364|NCT01393600|65959411|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
23609365|NCT01393600|65959412|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
23609366|NCT01393600|65959413|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
23609367|NCT01393600|65959414|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
23609368|NCT01393600|65959411|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
23609369|NCT01393600|65959412|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
23609370|NCT01393600|65959413|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
23609371|NCT01393600|65959414|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
23609372|NCT01393600|65959411|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
23609373|NCT01393600|65959412|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
23609374|NCT01393600|65959413|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
23609375|NCT01393600|65959414|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
23609376|NCT01393600|65959411|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
23609377|NCT01393600|65959412|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
23609378|NCT01393600|65959413|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
23609379|NCT01393600|65959414|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
23609380|NCT03166215|65959415|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
23609381|NCT03166215|65959416|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
23408570|NCT03782259|65239924|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
23609382|NCT03166215|65959417|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
23609383|NCT03166215|65959415|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
23609384|NCT03166215|65959416|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
23609385|NCT03166215|65959417|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
23609386|NCT02753075|65959419|FG000|Overall Study|Adverse Event|2|||
23609387|NCT02753075|65959420|FG001|Overall Study|Adverse Event|1|||
23609388|NCT02753075|65959421|FG002|Overall Study|Adverse Event|0|||
23609389|NCT02753075|65959419|FG000|Overall Study|Lost to Follow-up|2|||
23609390|NCT02753075|65959420|FG001|Overall Study|Lost to Follow-up|0|||
23609391|NCT02753075|65959421|FG002|Overall Study|Lost to Follow-up|0|||
23609392|NCT02753075|65959419|FG000|Overall Study|Withdrawal of Consent|1|||
23609393|NCT02753075|65959420|FG001|Overall Study|Withdrawal of Consent|1|||
23408571|NCT03782259|65239923|FG000|Overall Study|Subject discontinued intervention|1|||
23408572|NCT03782259|65239924|FG001|Overall Study|Subject discontinued intervention|0|||
23408573|NCT02100423|65239929|FG000|Overall Study|Death|1|||
23408574|NCT02100423|65239929|FG000|Overall Study|Withdrawal by Subject|3|||
23408575|NCT02100423|65239929|FG000|Overall Study|Adverse Event|1|||
23408576|NCT02100423|65239929|FG000|Overall Study|Physician Decision|1|||
23408577|NCT02141672|65239930|FG000|Overall Study|Adverse Event|0|||
23408578|NCT02141672|65239931|FG001|Overall Study|Adverse Event|1|||
23408579|NCT02141672|65239932|FG002|Overall Study|Adverse Event|0|||
23408580|NCT02141672|65239930|FG000|Overall Study|Death|10|||
23408581|NCT02141672|65239931|FG001|Overall Study|Death|2|||
23408582|NCT02141672|65239932|FG002|Overall Study|Death|1|||
23408583|NCT02141672|65239930|FG000|Overall Study|Lack of Efficacy|0|||
23408584|NCT02141672|65239931|FG001|Overall Study|Lack of Efficacy|0|||
23408585|NCT02141672|65239932|FG002|Overall Study|Lack of Efficacy|2|||
23408586|NCT02141672|65239930|FG000|Overall Study|Lost to Follow-up|1|||
23408587|NCT02141672|65239931|FG001|Overall Study|Lost to Follow-up|1|||
23408588|NCT02141672|65239932|FG002|Overall Study|Lost to Follow-up|3|||
23408589|NCT02141672|65239930|FG000|Overall Study|Physician Decision|1|||
23408590|NCT02141672|65239931|FG001|Overall Study|Physician Decision|2|||
23408591|NCT02141672|65239932|FG002|Overall Study|Physician Decision|5|||
23408592|NCT02141672|65239930|FG000|Overall Study|Protocol Violation|0|||
23609394|NCT02753075|65959421|FG002|Overall Study|Withdrawal of Consent|3|||
23408593|NCT02141672|65239931|FG001|Overall Study|Protocol Violation|0|||
23408594|NCT02141672|65239932|FG002|Overall Study|Protocol Violation|1|||
23408595|NCT02141672|65239930|FG000|Overall Study|Withdrawal by Subject|3|||
23408596|NCT02141672|65239931|FG001|Overall Study|Withdrawal by Subject|2|||
23408597|NCT02141672|65239932|FG002|Overall Study|Withdrawal by Subject|5|||
23408598|NCT02141672|65239930|FG000|Overall Study|refused to follow-up|1|||
23609395|NCT02753075|65959419|FG000|Overall Study|Physician Decision|3|||
23609396|NCT02753075|65959420|FG001|Overall Study|Physician Decision|1|||
23609397|NCT02753075|65959421|FG002|Overall Study|Physician Decision|0|||
23609398|NCT03840993|65959422|FG000|Overall Study|Adverse Event|1|||
23609399|NCT03840993|65959423|FG001|Overall Study|Adverse Event|0|||
23609400|NCT03840993|65959422|FG000|Overall Study|Lost to Follow-up|4|||
23609401|NCT03840993|65959423|FG001|Overall Study|Lost to Follow-up|0|||
23609402|NCT03840993|65959422|FG000|Overall Study|Physician Decision|0|||
23609403|NCT03840993|65959423|FG001|Overall Study|Physician Decision|1|||
23609404|NCT03840993|65959422|FG000|Overall Study|Pregnancy|0|||
23609405|NCT03840993|65959423|FG001|Overall Study|Pregnancy|1|||
23609406|NCT03840993|65959422|FG000|Overall Study|Withdrawal by Subject|1|||
23609407|NCT03840993|65959423|FG001|Overall Study|Withdrawal by Subject|3|||
23609408|NCT03840993|65959422|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
23609409|NCT03840993|65959423|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
23609410|NCT03242863|65959424|FG000|Study Week 1|Withdrawal by Subject|0|||
23609411|NCT03242863|65959425|FG001|Study Week 1|Withdrawal by Subject|1|||
23609412|NCT03242863|65959426|FG002|Study Week 1|Withdrawal by Subject|0|||
23609413|NCT03242863|65959427|FG003|Study Week 1|Withdrawal by Subject|0|||
23609414|NCT03242863|65959428|FG004|Study Week 1|Withdrawal by Subject|3|||
23609415|NCT03242863|65959429|FG005|Study Week 1|Withdrawal by Subject|0|||
23609416|NCT01944774|65959432|FG000|Overall Study|Withdrawal by Subject|2|||
23609417|NCT01944774|65959433|FG001|Overall Study|Withdrawal by Subject|3|||
23609418|NCT01944774|65959434|FG002|Overall Study|Withdrawal by Subject|3|||
23609419|NCT01944774|65959432|FG000|Overall Study|Adverse Event|3|||
23609420|NCT01944774|65959433|FG001|Overall Study|Adverse Event|2|||
23609421|NCT01944774|65959434|FG002|Overall Study|Adverse Event|3|||
23609422|NCT01944774|65959432|FG000|Overall Study|Lack of Efficacy|1|||
23609423|NCT01944774|65959433|FG001|Overall Study|Lack of Efficacy|2|||
23609424|NCT01944774|65959434|FG002|Overall Study|Lack of Efficacy|2|||
23609425|NCT01944774|65959432|FG000|Overall Study|Lost to Follow-up|0|||
23609426|NCT01944774|65959433|FG001|Overall Study|Lost to Follow-up|1|||
23609427|NCT01944774|65959434|FG002|Overall Study|Lost to Follow-up|0|||
23609428|NCT02935894|65959441|FG000|Overall Study|Subject dismissed|1|||
23510337|NCT01955733|65605973|FG002|Period 2|Study terminated by sponsor|16|||
23510338|NCT01955733|65605971|FG000|Period 2|Lost to Follow-up|2|||
23510339|NCT01955733|65605972|FG001|Period 2|Lost to Follow-up|0|||
23510340|NCT01955733|65605973|FG002|Period 2|Lost to Follow-up|0|||
23609429|NCT02109172|65959445|FG000|Overall Study|Withdrawal by Subject|1|||
23609430|NCT02109172|65959446|FG001|Overall Study|Withdrawal by Subject|0|||
23609431|NCT02109172|65959447|FG002|Overall Study|Withdrawal by Subject|0|||
23609432|NCT02109172|65959448|FG003|Overall Study|Withdrawal by Subject|1|||
23609433|NCT02109172|65959449|FG004|Overall Study|Withdrawal by Subject|0|||
23609434|NCT02109172|65959450|FG005|Overall Study|Withdrawal by Subject|0|||
23609435|NCT02109172|65959445|FG000|Overall Study|Adverse Event|0|||
23609436|NCT02109172|65959446|FG001|Overall Study|Adverse Event|0|||
23609437|NCT02109172|65959447|FG002|Overall Study|Adverse Event|1|||
23609438|NCT02109172|65959448|FG003|Overall Study|Adverse Event|0|||
23609439|NCT02109172|65959449|FG004|Overall Study|Adverse Event|0|||
23609440|NCT02109172|65959450|FG005|Overall Study|Adverse Event|1|||
23609441|NCT02109172|65959445|FG000|Overall Study|Death|0|||
23609442|NCT02109172|65959446|FG001|Overall Study|Death|0|||
23609443|NCT02109172|65959447|FG002|Overall Study|Death|0|||
23609444|NCT02109172|65959448|FG003|Overall Study|Death|0|||
23609445|NCT02109172|65959449|FG004|Overall Study|Death|1|||
23609446|NCT02109172|65959450|FG005|Overall Study|Death|0|||
23609447|NCT01528605|65959453|FG000|Overall Study|Lost to Follow-up|1|||
23609448|NCT01528605|65959454|FG001|Overall Study|Lost to Follow-up|0|||
23609449|NCT01528605|65959455|FG002|Overall Study|Lost to Follow-up|1|||
23609450|NCT01528605|65959456|FG003|Overall Study|Lost to Follow-up|1|||
23609451|NCT01528605|65959457|FG004|Overall Study|Lost to Follow-up|0|||
23609452|NCT01528605|65959458|FG005|Overall Study|Lost to Follow-up|0|||
23609453|NCT01528605|65959453|FG000|Overall Study|Death|1|||
23609454|NCT01528605|65959454|FG001|Overall Study|Death|0|||
23609455|NCT01528605|65959455|FG002|Overall Study|Death|0|||
23609456|NCT01528605|65959456|FG003|Overall Study|Death|0|||
23609457|NCT01528605|65959457|FG004|Overall Study|Death|0|||
23510341|NCT01955733|65605971|FG000|Period 2|Other not defined above|0|||
23609458|NCT01528605|65959458|FG005|Overall Study|Death|0|||
23609459|NCT02367794|65959459|FG000|Overall Study|Death|252|||
23609460|NCT02367794|65959460|FG001|Overall Study|Death|245|||
23609461|NCT02367794|65959461|FG002|Overall Study|Death|243|||
23609462|NCT02367794|65959459|FG000|Overall Study|Lost to Follow-up|1|||
23609463|NCT02367794|65959460|FG001|Overall Study|Lost to Follow-up|2|||
23609464|NCT02367794|65959461|FG002|Overall Study|Lost to Follow-up|2|||
23609465|NCT02367794|65959459|FG000|Overall Study|Physician Decision|0|||
23609466|NCT02367794|65959460|FG001|Overall Study|Physician Decision|5|||
23609467|NCT02367794|65959461|FG002|Overall Study|Physician Decision|3|||
23609468|NCT02367794|65959459|FG000|Overall Study|Protocol Violation|1|||
23609469|NCT02367794|65959460|FG001|Overall Study|Protocol Violation|0|||
23609470|NCT02367794|65959461|FG002|Overall Study|Protocol Violation|1|||
23609471|NCT02367794|65959459|FG000|Overall Study|Withdrawal by Subject|25|||
23609472|NCT02367794|65959460|FG001|Overall Study|Withdrawal by Subject|12|||
23609473|NCT02367794|65959461|FG002|Overall Study|Withdrawal by Subject|20|||
23609474|NCT02367794|65959459|FG000|Overall Study|Brain metastasis|1|||
23609475|NCT02367794|65959460|FG001|Overall Study|Brain metastasis|0|||
23609476|NCT02367794|65959461|FG002|Overall Study|Brain metastasis|0|||
23609477|NCT02367794|65959459|FG000|Overall Study|Randomized in error|0|||
23609478|NCT02367794|65959460|FG001|Overall Study|Randomized in error|0|||
23609479|NCT02367794|65959461|FG002|Overall Study|Randomized in error|1|||
23609480|NCT02367794|65959459|FG000|Overall Study|Patient unable to receive carboplatin|0|||
23510342|NCT01955733|65605972|FG001|Period 2|Other not defined above|2|||
23609481|NCT02367794|65959460|FG001|Overall Study|Patient unable to receive carboplatin|0|||
23609482|NCT02367794|65959461|FG002|Overall Study|Patient unable to receive carboplatin|1|||
23609483|NCT02367794|65959459|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
23609484|NCT02367794|65959460|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
23609485|NCT02367794|65959461|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
23609486|NCT02367794|65959459|FG000|Overall Study|Adverse Event|0|||
23609487|NCT02367794|65959460|FG001|Overall Study|Adverse Event|0|||
23609488|NCT02367794|65959461|FG002|Overall Study|Adverse Event|2|||
23609489|NCT02367794|65959459|FG000|Overall Study|Study Terminated By Sponsor|0|||
23609490|NCT02367794|65959460|FG001|Overall Study|Study Terminated By Sponsor|1|||
23609491|NCT02367794|65959461|FG002|Overall Study|Study Terminated By Sponsor|1|||
23609492|NCT02367794|65959459|FG000|Overall Study|Moved to Roll-Over Study|0|||
23609493|NCT02367794|65959460|FG001|Overall Study|Moved to Roll-Over Study|15|||
23609494|NCT02367794|65959461|FG002|Overall Study|Moved to Roll-Over Study|13|||
23609495|NCT02367794|65959459|FG000|Overall Study|Sponsor Request|60|||
23609496|NCT02367794|65959460|FG001|Overall Study|Sponsor Request|57|||
23609497|NCT02367794|65959461|FG002|Overall Study|Sponsor Request|45|||
23609498|NCT02367794|65959459|FG000|Overall Study|Moved into PTAP Study|0|||
23609499|NCT02367794|65959460|FG001|Overall Study|Moved into PTAP Study|2|||
23609500|NCT02367794|65959461|FG002|Overall Study|Moved into PTAP Study|3|||
23609501|NCT02367794|65959459|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
23609502|NCT02367794|65959460|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
23609503|NCT02367794|65959461|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
23609504|NCT02367794|65959459|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
23609505|NCT02367794|65959460|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
23609506|NCT02367794|65959461|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
23609507|NCT02367794|65959459|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
23609508|NCT02367794|65959460|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
23609509|NCT02367794|65959461|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
23609510|NCT02367794|65959459|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
23609511|NCT02367794|65959460|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
23609512|NCT02367794|65959461|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
23609513|NCT03708744|65959464|FG000|Overall Study|Withdrawal by Subject|0|||
23609514|NCT03708744|65959465|FG001|Overall Study|Withdrawal by Subject|0|||
23609515|NCT03708744|65959466|FG002|Overall Study|Withdrawal by Subject|1|||
23609516|NCT03708744|65959467|FG003|Overall Study|Withdrawal by Subject|0|||
23609517|NCT02935673|65959470|FG000|Overall Study|Adverse Event|0|||
23609518|NCT02935673|65959471|FG001|Overall Study|Adverse Event|1|||
23609519|NCT02935673|65959472|FG002|Overall Study|Adverse Event|0|||
23609520|NCT02935673|65959470|FG000|Overall Study|Withdrawal by Subject|1|||
23609521|NCT02935673|65959471|FG001|Overall Study|Withdrawal by Subject|2|||
23609522|NCT02935673|65959472|FG002|Overall Study|Withdrawal by Subject|0|||
23609523|NCT03326856|65959477|FG000|Overall Study|Lost to Follow-up|1|||
23609524|NCT03326856|65959478|FG001|Overall Study|Lost to Follow-up|1|||
23609525|NCT03326856|65959479|FG002|Overall Study|Lost to Follow-up|0|||
23609526|NCT03326856|65959480|FG003|Overall Study|Lost to Follow-up|0|||
23609527|NCT03326856|65959481|FG004|Overall Study|Lost to Follow-up|0|||
23609528|NCT01535261|65959482|FG000|Overall Study|Physician Decision|8|||
23609529|NCT01535261|65959482|FG000|Overall Study|Protocol Violation|3|||
23609530|NCT01535261|65959482|FG000|Overall Study|Death|5|||
23609531|NCT01535261|65959482|FG000|Overall Study|Lost to Follow-up|8|||
23609532|NCT01535261|65959482|FG000|Overall Study|Withdrawal by Subject|14|||
23609533|NCT01535261|65959482|FG000|Overall Study|Adverse Event|12|||
23609534|NCT01441596|65959483|FG000|Overall Study|Other reason not defined below|0|||
23609535|NCT01441596|65959484|FG001|Overall Study|Other reason not defined below|2|||
23609536|NCT01441596|65959485|FG002|Overall Study|Other reason not defined below|1|||
23609537|NCT01441596|65959483|FG000|Overall Study|Withdrawal by Subject|4|||
23609538|NCT01441596|65959484|FG001|Overall Study|Withdrawal by Subject|0|||
23609539|NCT01441596|65959485|FG002|Overall Study|Withdrawal by Subject|2|||
23609540|NCT01441596|65959483|FG000|Overall Study|Not treated|0|||
23609541|NCT01441596|65959484|FG001|Overall Study|Not treated|1|||
23609542|NCT01441596|65959485|FG002|Overall Study|Not treated|1|||
23609543|NCT02152384|65959486|FG000|Period 1|Withdrawal by Subject|0|||
23609544|NCT02152384|65959487|FG001|Period 1|Withdrawal by Subject|1|||
23609545|NCT02152384|65959486|FG000|Period 1|Adverse Event|1|||
23609546|NCT02152384|65959487|FG001|Period 1|Adverse Event|1|||
23609547|NCT00749944|65959491|FG000|Overall Study|Lost to Follow-up|2|||
23609548|NCT00749944|65959492|FG001|Overall Study|Lost to Follow-up|1|||
23609549|NCT00749944|65959491|FG000|Overall Study|Other|1|||
23609550|NCT00749944|65959492|FG001|Overall Study|Other|0|||
23609551|NCT00749944|65959491|FG000|Overall Study|Withdrawal by Subject|2|||
23609552|NCT00749944|65959492|FG001|Overall Study|Withdrawal by Subject|0|||
23609553|NCT01437540|65959493|FG000|Overall Study|Not listed below|7|||
23609554|NCT01437540|65959494|FG001|Overall Study|Not listed below|6|||
23609555|NCT01437540|65959493|FG000|Overall Study|COPD exacerbation|13|||
23609556|NCT01437540|65959494|FG001|Overall Study|COPD exacerbation|3|||
23609557|NCT01437540|65959493|FG000|Overall Study|Lost to Follow-up|3|||
23609558|NCT01437540|65959494|FG001|Overall Study|Lost to Follow-up|5|||
23510343|NCT01955733|65605973|FG002|Period 2|Other not defined above|2|||
23609559|NCT01437540|65959493|FG000|Overall Study|Lack of Efficacy|23|||
23609560|NCT01437540|65959494|FG001|Overall Study|Lack of Efficacy|11|||
23609561|NCT01437540|65959493|FG000|Overall Study|Protocol Violation|24|||
23609562|NCT01437540|65959494|FG001|Overall Study|Protocol Violation|12|||
23609563|NCT01437540|65959493|FG000|Overall Study|Adverse Event|26|||
23609564|NCT01437540|65959494|FG001|Overall Study|Adverse Event|13|||
23609565|NCT01437540|65959493|FG000|Overall Study|Withdrawal by Subject|31|||
23609566|NCT01437540|65959494|FG001|Overall Study|Withdrawal by Subject|15|||
23609567|NCT04739306|65959495|FG000|Main Study Period|Adverse Event|6|||
23609568|NCT04739306|65959496|FG001|Main Study Period|Adverse Event|7|||
23609569|NCT04739306|65959495|FG000|Main Study Period|Lost to Follow-up|4|||
23609570|NCT04739306|65959496|FG001|Main Study Period|Lost to Follow-up|6|||
23609571|NCT04739306|65959495|FG000|Main Study Period|Physician Decision|1|||
23609572|NCT04739306|65959496|FG001|Main Study Period|Physician Decision|1|||
23609573|NCT04739306|65959495|FG000|Main Study Period|Withdrawal by Subject|8|||
23609574|NCT04739306|65959496|FG001|Main Study Period|Withdrawal by Subject|6|||
23609575|NCT04739306|65959495|FG000|Main Study Period|Protocol Violation|0|||
23609576|NCT04739306|65959496|FG001|Main Study Period|Protocol Violation|1|||
23609577|NCT04739306|65959495|FG000|Main Study Period|War in Ukraine|1|||
23609578|NCT04739306|65959496|FG001|Main Study Period|War in Ukraine|1|||
23609579|NCT00134056|65959501|FG000|Randomization|Not eligible for assigned treatment|22|||
23609580|NCT00134056|65959502|FG001|Randomization|Not eligible for assigned treatment|20|||
23510344|NCT00883116|65605974|FG000|Overall Study|Adverse event unrelated to study drug|5|||
23510345|NCT00883116|65605975|FG001|Overall Study|Adverse event unrelated to study drug|10|||
23510346|NCT00883116|65605974|FG000|Overall Study|Death|6|||
23609581|NCT00134056|65959501|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
23609582|NCT00134056|65959502|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
23609583|NCT00134056|65959501|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
23609584|NCT00134056|65959502|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
23609585|NCT00134056|65959501|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
23609586|NCT00134056|65959502|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
23609587|NCT00134056|65959501|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
23609588|NCT00134056|65959502|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
23609589|NCT02889900|65959506|FG000|Overall Study|Adverse Event|11|||
23609590|NCT02889900|65959506|FG000|Overall Study|Condition under investigation worsened|32|||
23609591|NCT02889900|65959506|FG000|Overall Study|Other|5|||
23609592|NCT02889900|65959506|FG000|Overall Study|Withdrawal by Subject|7|||
23609593|NCT02889900|65959506|FG000|Overall Study|Not treated|2|||
23609594|NCT02449902|65959507|FG000|Overall Study|Adverse Event|0|||
23609595|NCT02449902|65959508|FG001|Overall Study|Adverse Event|1|||
23609596|NCT02449902|65959507|FG000|Overall Study|Withdrawal by Subject|0|||
23609597|NCT02449902|65959508|FG001|Overall Study|Withdrawal by Subject|1|||
23609598|NCT00535626|65959509|FG000|Overall Study|Death|15|||
23609599|NCT00535626|65959509|FG000|Overall Study|Lost to Follow-up|29|||
23609600|NCT00535626|65959509|FG000|Overall Study|Withdrawal by Subject|20|||
23609601|NCT00535626|65959509|FG000|Overall Study|Removal/revision of study component|8|||
23609602|NCT00535626|65959509|FG000|Overall Study|Subject terminated|31|||
23609603|NCT00535626|65959509|FG000|Overall Study|Unable to return|2|||
23609604|NCT02203513|65959510|FG000|Overall Study|Refused further treatment|2|||
23609605|NCT02203513|65959511|FG001|Overall Study|Refused further treatment|0|||
23609606|NCT02203513|65959512|FG002|Overall Study|Refused further treatment|1|||
23609607|NCT02203513|65959513|FG003|Overall Study|Refused further treatment|0|||
23609608|NCT02203513|65959514|FG004|Overall Study|Refused further treatment|0|||
23510347|NCT00883116|65605975|FG001|Overall Study|Death|2|||
23609609|NCT02203513|65959510|FG000|Overall Study|Switched to alternative treatment|3|||
23609610|NCT02203513|65959511|FG001|Overall Study|Switched to alternative treatment|4|||
23609611|NCT02203513|65959512|FG002|Overall Study|Switched to alternative treatment|0|||
23609612|NCT02203513|65959513|FG003|Overall Study|Switched to alternative treatment|0|||
23609613|NCT02203513|65959514|FG004|Overall Study|Switched to alternative treatment|4|||
23609614|NCT02203513|65959510|FG000|Overall Study|Did not receive investigational product (IP)|0|||
23609615|NCT02203513|65959511|FG001|Overall Study|Did not receive investigational product (IP)|1|||
23609616|NCT02203513|65959512|FG002|Overall Study|Did not receive investigational product (IP)|0|||
23609617|NCT02203513|65959513|FG003|Overall Study|Did not receive investigational product (IP)|0|||
23609618|NCT02203513|65959514|FG004|Overall Study|Did not receive investigational product (IP)|0|||
23609619|NCT02203513|65959510|FG000|Overall Study|Death (unrelated to study therapy)|1|||
23609620|NCT02203513|65959511|FG001|Overall Study|Death (unrelated to study therapy)|3|||
23609621|NCT02203513|65959512|FG002|Overall Study|Death (unrelated to study therapy)|1|||
23609622|NCT02203513|65959513|FG003|Overall Study|Death (unrelated to study therapy)|0|||
23609623|NCT02203513|65959514|FG004|Overall Study|Death (unrelated to study therapy)|2|||
23609624|NCT02203513|65959510|FG000|Overall Study|Lost to Follow-up|0|||
23609625|NCT02203513|65959511|FG001|Overall Study|Lost to Follow-up|0|||
23609626|NCT02203513|65959512|FG002|Overall Study|Lost to Follow-up|1|||
23609627|NCT02203513|65959513|FG003|Overall Study|Lost to Follow-up|1|||
23609628|NCT02203513|65959514|FG004|Overall Study|Lost to Follow-up|0|||
23609629|NCT00141271|65959515|FG000|Overall Study|Adverse Event|31|||
23609630|NCT00141271|65959516|FG001|Overall Study|Adverse Event|19|||
23609631|NCT00141271|65959517|FG002|Overall Study|Adverse Event|17|||
23609632|NCT00141271|65959515|FG000|Overall Study|Laboratory Abnormality|2|||
23609633|NCT00141271|65959516|FG001|Overall Study|Laboratory Abnormality|1|||
23609634|NCT00141271|65959517|FG002|Overall Study|Laboratory Abnormality|1|||
23609635|NCT00141271|65959515|FG000|Overall Study|Lack of Efficacy|7|||
23609636|NCT00141271|65959516|FG001|Overall Study|Lack of Efficacy|7|||
23609637|NCT00141271|65959517|FG002|Overall Study|Lack of Efficacy|3|||
23609638|NCT00141271|65959515|FG000|Overall Study|Lost to Follow-up|15|||
23609639|NCT00141271|65959516|FG001|Overall Study|Lost to Follow-up|15|||
23609640|NCT00141271|65959517|FG002|Overall Study|Lost to Follow-up|21|||
23609641|NCT00141271|65959515|FG000|Overall Study|Withdrawal by Subject|14|||
23609642|NCT00141271|65959516|FG001|Overall Study|Withdrawal by Subject|9|||
23609643|NCT00141271|65959517|FG002|Overall Study|Withdrawal by Subject|10|||
23609644|NCT00141271|65959515|FG000|Overall Study|Other|11|||
23609645|NCT00141271|65959516|FG001|Overall Study|Other|12|||
23609646|NCT00141271|65959517|FG002|Overall Study|Other|5|||
23609647|NCT02256553|65959532|FG000|Period I|Adverse Event|5|||
23609648|NCT02256553|65959532|FG000|Period I|Protocol Violation|1|||
23609649|NCT02256553|65959532|FG000|Period II|Adverse Event|1|||
23609650|NCT02256553|65959532|FG000|Period II|Subject Moved|1|||
23609651|NCT02256553|65959532|FG000|Period III|Adverse Event|3|||
23609652|NCT03406507|65959534|FG000|Extension Period|Lack of Efficacy|0|||
23609653|NCT03406507|65959535|FG001|Extension Period|Lack of Efficacy|1|||
23609654|NCT00091572|65959536|FG000|Overall Study|Lost to Follow-up|1|||
23609655|NCT00091572|65959537|FG001|Overall Study|Lost to Follow-up|1|||
23609656|NCT00091572|65959536|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
23609657|NCT00091572|65959537|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
23609658|NCT00091572|65959536|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
23609659|NCT00091572|65959537|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
23609660|NCT00091572|65959536|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
23609661|NCT00091572|65959537|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
23609662|NCT00091572|65959536|FG000|Overall Study|Other Reason|6|||
23609663|NCT00091572|65959537|FG001|Overall Study|Other Reason|13|||
23609664|NCT00091572|65959536|FG000|Overall Study|Ongoing (still on treatment)|8|||
23609665|NCT00091572|65959537|FG001|Overall Study|Ongoing (still on treatment)|12|||
23609666|NCT00091572|65959536|FG000|Overall Study|Major Protocol Violation|2|||
23609667|NCT00091572|65959537|FG001|Overall Study|Major Protocol Violation|0|||
23609668|NCT00091572|65959536|FG000|Overall Study|Toxicity (Related AE)|53|||
23609669|NCT00091572|65959537|FG001|Overall Study|Toxicity (Related AE)|9|||
23609670|NCT00648895|65959538|FG000|Overall Study|Lack of Efficacy|0|||
23609671|NCT00648895|65959539|FG001|Overall Study|Lack of Efficacy|1|||
23609672|NCT01757288|65959542|FG000|Overall Study|Consent withdrawal|0|||
23609673|NCT01757288|65959543|FG001|Overall Study|Consent withdrawal|4|||
23609674|NCT01757288|65959544|FG002|Overall Study|Consent withdrawal|4|||
23609675|NCT01757288|65959542|FG000|Overall Study|Patient off study, IRB hold.|0|||
23609676|NCT01757288|65959543|FG001|Overall Study|Patient off study, IRB hold.|0|||
23609677|NCT01757288|65959544|FG002|Overall Study|Patient off study, IRB hold.|1|||
23609678|NCT01757288|65959542|FG000|Overall Study|Patient death prior to starting treatment|0|||
23609679|NCT01757288|65959543|FG001|Overall Study|Patient death prior to starting treatment|0|||
23609680|NCT01757288|65959544|FG002|Overall Study|Patient death prior to starting treatment|1|||
23609681|NCT01757288|65959542|FG000|Overall Study|Wrong medication administered|0|||
23609682|NCT01757288|65959543|FG001|Overall Study|Wrong medication administered|1|||
23609683|NCT01757288|65959544|FG002|Overall Study|Wrong medication administered|0|||
23609684|NCT01757288|65959542|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
23609685|NCT01757288|65959543|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
23609686|NCT01757288|65959544|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
23609687|NCT01757288|65959542|FG000|Overall Study|Not meeting protocol constraints|0|||
23609688|NCT01757288|65959543|FG001|Overall Study|Not meeting protocol constraints|1|||
23609689|NCT01757288|65959544|FG002|Overall Study|Not meeting protocol constraints|1|||
23609690|NCT01757288|65959542|FG000|Overall Study|Multiple missed appointments|0|||
23609691|NCT01757288|65959543|FG001|Overall Study|Multiple missed appointments|1|||
23609692|NCT01757288|65959544|FG002|Overall Study|Multiple missed appointments|0|||
23510348|NCT00883116|65605974|FG000|Overall Study|Disease progression|130|||
23609693|NCT01757288|65959542|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
23609694|NCT01757288|65959543|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
23609695|NCT01757288|65959544|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
23609696|NCT01757288|65959542|FG000|Overall Study|>2 weeks treatment break|0|||
23609697|NCT01757288|65959543|FG001|Overall Study|>2 weeks treatment break|0|||
23609698|NCT01757288|65959544|FG002|Overall Study|>2 weeks treatment break|1|||
23609699|NCT00818519|65959545|FG000|Overall Study|Adverse Event|2|||
23609700|NCT00818519|65959546|FG001|Overall Study|Adverse Event|2|||
23609701|NCT00818519|65959545|FG000|Overall Study|Lost to Follow-up|4|||
23609702|NCT00818519|65959546|FG001|Overall Study|Lost to Follow-up|6|||
23609703|NCT00818519|65959545|FG000|Overall Study|Protocol Violation|2|||
23609704|NCT00818519|65959546|FG001|Overall Study|Protocol Violation|1|||
23609705|NCT00818519|65959545|FG000|Overall Study|Pregnancy|0|||
23609706|NCT00818519|65959546|FG001|Overall Study|Pregnancy|1|||
23609707|NCT00818519|65959545|FG000|Overall Study|Withdrawal by Subject|4|||
23609708|NCT00818519|65959546|FG001|Overall Study|Withdrawal by Subject|9|||
23609709|NCT00818519|65959545|FG000|Overall Study|participant recovered completely|1|||
23609710|NCT00818519|65959546|FG001|Overall Study|participant recovered completely|0|||
23609711|NCT00818519|65959545|FG000|Overall Study|participant will leave for long tme|1|||
23609712|NCT00818519|65959546|FG001|Overall Study|participant will leave for long tme|0|||
23609713|NCT03884478|65959547|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
23609714|NCT03884478|65959548|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
23609715|NCT03884478|65959549|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
23609716|NCT03884478|65959547|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
23609717|NCT03884478|65959548|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
23609718|NCT03884478|65959549|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
23609719|NCT03884478|65959547|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
23609720|NCT03884478|65959548|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
23609721|NCT03884478|65959549|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
23609722|NCT03884478|65959547|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
23609723|NCT03884478|65959548|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
23609724|NCT03884478|65959549|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
23609725|NCT01377844|65959550|FG000|Overall Study|Withdrawal by Subject|25|||
23609726|NCT01377844|65959551|FG001|Overall Study|Withdrawal by Subject|28|||
23609727|NCT01377844|65959550|FG000|Overall Study|Protocol Violation|2|||
23609728|NCT01377844|65959551|FG001|Overall Study|Protocol Violation|3|||
23609729|NCT01377844|65959550|FG000|Overall Study|Adverse Event|3|||
23609730|NCT01377844|65959551|FG001|Overall Study|Adverse Event|0|||
23609731|NCT01377844|65959550|FG000|Overall Study|Physician Decision|6|||
23609732|NCT01377844|65959551|FG001|Overall Study|Physician Decision|3|||
23609733|NCT01377844|65959550|FG000|Overall Study|Study terminated by Sponsor|0|||
23609734|NCT01377844|65959551|FG001|Overall Study|Study terminated by Sponsor|1|||
23609735|NCT04410445|65959553|FG000|Overall Study|Lost to Follow-up|3|||
23609736|NCT04410445|65959554|FG001|Overall Study|Lost to Follow-up|9|||
23609737|NCT04410445|65959553|FG000|Overall Study|Withdrawal by Subject|27|||
23609738|NCT04410445|65959554|FG001|Overall Study|Withdrawal by Subject|15|||
23609739|NCT01468597|65959555|FG000|Overall Study|Found ineligible|17|||
23609740|NCT01468597|65959555|FG000|Overall Study|concomitant valves|12|||
23609741|NCT01468597|65959555|FG000|Overall Study|off-pump CABG|1|||
23609742|NCT01468597|65959555|FG000|Overall Study|no platelet function data|5|||
23609743|NCT04382053|65959556|FG000|Overall Study|Death|6|||
23510349|NCT00883116|65605975|FG001|Overall Study|Disease progression|128|||
23510350|NCT00883116|65605974|FG000|Overall Study|Lost to Follow-up|0|||
23510351|NCT00883116|65605975|FG001|Overall Study|Lost to Follow-up|1|||
23510352|NCT00883116|65605974|FG000|Overall Study|Maximum clinical benefit|13|||
23609744|NCT04382053|65959557|FG001|Overall Study|Death|8|||
23609745|NCT04382053|65959556|FG000|Overall Study|Lost to Follow-up|0|||
23609746|NCT04382053|65959557|FG001|Overall Study|Lost to Follow-up|2|||
23609747|NCT04382053|65959556|FG000|Overall Study|Protocol Deviation|1|||
23609748|NCT04382053|65959557|FG001|Overall Study|Protocol Deviation|2|||
23609749|NCT04382053|65959556|FG000|Overall Study|Withdrawal by Subject|2|||
23609750|NCT04382053|65959557|FG001|Overall Study|Withdrawal by Subject|1|||
23609751|NCT03349476|65959562|FG000|Overall Study|Physician Decision|3|||
23609752|NCT00316121|65959563|FG000|Overall Study|Death|1|||
23609753|NCT00316121|65959564|FG001|Overall Study|Death|0|||
23609754|NCT00316121|65959563|FG000|Overall Study|Lost to Follow-up|14|||
23609755|NCT00316121|65959564|FG001|Overall Study|Lost to Follow-up|8|||
23609756|NCT00316121|65959563|FG000|Overall Study|Withdrawal by Subject|2|||
23609757|NCT00316121|65959564|FG001|Overall Study|Withdrawal by Subject|0|||
23609758|NCT00316121|65959563|FG000|Overall Study|Reason is missing|1|||
23510353|NCT00883116|65605975|FG001|Overall Study|Maximum clinical benefit|46|||
23609759|NCT00316121|65959564|FG001|Overall Study|Reason is missing|0|||
23609760|NCT00316121|65959563|FG000|Overall Study|Subject relocated|1|||
23609761|NCT00316121|65959564|FG001|Overall Study|Subject relocated|1|||
23609762|NCT00316121|65959563|FG000|Overall Study|Subject refused to return|1|||
23609763|NCT00316121|65959564|FG001|Overall Study|Subject refused to return|0|||
23609764|NCT00316121|65959563|FG000|Overall Study|Subject no show for visit x 3|1|||
23609765|NCT00316121|65959564|FG001|Overall Study|Subject no show for visit x 3|0|||
23609766|NCT00316121|65959563|FG000|Overall Study|Subject did not have 24 month visit|1|||
23609767|NCT00316121|65959564|FG001|Overall Study|Subject did not have 24 month visit|0|||
23609768|NCT00096278|65959565|FG000|Overall Study|No follow-up data|15|||
23609769|NCT00096278|65959566|FG001|Overall Study|No follow-up data|18|||
23609770|NCT00096278|65959565|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
23609771|NCT00096278|65959566|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
23609772|NCT01543204|65959567|FG000|Overall Study|Non-compliance|1|||
23609773|NCT01543204|65959567|FG000|Overall Study|Adverse Event|1|||
23609774|NCT01543204|65959567|FG000|Overall Study|Withdrawal by Subject|4|||
23609775|NCT01543204|65959567|FG000|Overall Study|Requirement for Alternative Therapy|1|||
23609776|NCT01543204|65959567|FG000|Overall Study|Lost to Follow-up|1|||
23609777|NCT00721734|65959568|FG000|Overall Study|Progressive Disease|3|||
23609778|NCT00721734|65959569|FG001|Overall Study|Progressive Disease|10|||
23609779|NCT00721734|65959570|FG002|Overall Study|Progressive Disease|4|||
23609780|NCT00721734|65959571|FG003|Overall Study|Progressive Disease|5|||
23609781|NCT00721734|65959572|FG004|Overall Study|Progressive Disease|2|||
23609782|NCT00721734|65959568|FG000|Overall Study|Adverse Event|3|||
23609783|NCT00721734|65959569|FG001|Overall Study|Adverse Event|1|||
23609784|NCT00721734|65959570|FG002|Overall Study|Adverse Event|4|||
23609785|NCT00721734|65959571|FG003|Overall Study|Adverse Event|0|||
23609786|NCT00721734|65959572|FG004|Overall Study|Adverse Event|3|||
23609787|NCT00721734|65959568|FG000|Overall Study|Withdrawal by Subject|2|||
23609788|NCT00721734|65959569|FG001|Overall Study|Withdrawal by Subject|1|||
23609789|NCT00721734|65959570|FG002|Overall Study|Withdrawal by Subject|0|||
23609790|NCT00721734|65959571|FG003|Overall Study|Withdrawal by Subject|0|||
23609791|NCT00721734|65959572|FG004|Overall Study|Withdrawal by Subject|1|||
23609792|NCT00721734|65959568|FG000|Overall Study|Other|0|||
23609793|NCT00721734|65959569|FG001|Overall Study|Other|0|||
23609794|NCT00721734|65959570|FG002|Overall Study|Other|0|||
23609795|NCT00721734|65959571|FG003|Overall Study|Other|1|||
23609796|NCT00721734|65959572|FG004|Overall Study|Other|0|||
23609797|NCT01768572|65959573|FG000|Overall Study|Adverse Event|7|||
23609798|NCT01768572|65959574|FG001|Overall Study|Adverse Event|8|||
23609799|NCT01768572|65959575|FG002|Overall Study|Adverse Event|4|||
23609800|NCT01768572|65959573|FG000|Overall Study|Lack of Efficacy|1|||
23609801|NCT01768572|65959574|FG001|Overall Study|Lack of Efficacy|3|||
23609802|NCT01768572|65959575|FG002|Overall Study|Lack of Efficacy|1|||
23609803|NCT01768572|65959573|FG000|Overall Study|Other, Not due to an adverse event|1|||
23609804|NCT01768572|65959574|FG001|Overall Study|Other, Not due to an adverse event|1|||
23609805|NCT01768572|65959575|FG002|Overall Study|Other, Not due to an adverse event|1|||
23609806|NCT04184622|65959576|FG000|Overall Study|Adverse Event|7|||
23609807|NCT04184622|65959577|FG001|Overall Study|Adverse Event|7|||
23609808|NCT04184622|65959578|FG002|Overall Study|Adverse Event|11|||
23609809|NCT04184622|65959579|FG003|Overall Study|Adverse Event|8|||
23609810|NCT04184622|65959576|FG000|Overall Study|Death|4|||
23609811|NCT04184622|65959577|FG001|Overall Study|Death|4|||
23609812|NCT04184622|65959578|FG002|Overall Study|Death|2|||
23609813|NCT04184622|65959579|FG003|Overall Study|Death|1|||
23609814|NCT04184622|65959576|FG000|Overall Study|Lost to Follow-up|41|||
23609815|NCT04184622|65959577|FG001|Overall Study|Lost to Follow-up|19|||
23510354|NCT00883116|65605974|FG000|Overall Study|Not identified|3|||
23510355|NCT00883116|65605975|FG001|Overall Study|Not identified|6|||
23609816|NCT04184622|65959578|FG002|Overall Study|Lost to Follow-up|20|||
23609817|NCT04184622|65959579|FG003|Overall Study|Lost to Follow-up|15|||
23609818|NCT04184622|65959576|FG000|Overall Study|Missing Weight at Week 72|1|||
23510356|NCT00883116|65605974|FG000|Overall Study|Study drug toxicity|36|||
23510357|NCT00883116|65605975|FG001|Overall Study|Study drug toxicity|16|||
23510358|NCT00883116|65605974|FG000|Overall Study|Withdrawal by Subject|14|||
23510359|NCT00883116|65605975|FG001|Overall Study|Withdrawal by Subject|8|||
23510360|NCT00883116|65605974|FG000|Overall Study|No longer meets study criteria|2|||
23510361|NCT00883116|65605975|FG001|Overall Study|No longer meets study criteria|2|||
23510362|NCT03855280|65605980|FG000|Treatment Phase|Adverse Event|1|||
23510363|NCT03855280|65605980|FG000|Treatment Phase|Withdrawal by Subject|1|||
23510364|NCT03855280|65605980|FG000|Continuation Phase|Protocol Violation|1|||
23609819|NCT04184622|65959577|FG001|Overall Study|Missing Weight at Week 72|0|||
23609820|NCT04184622|65959578|FG002|Overall Study|Missing Weight at Week 72|1|||
23609821|NCT04184622|65959579|FG003|Overall Study|Missing Weight at Week 72|0|||
23609822|NCT04184622|65959576|FG000|Overall Study|Other - as reported by the investigator|22|||
23609823|NCT04184622|65959577|FG001|Overall Study|Other - as reported by the investigator|7|||
23609824|NCT04184622|65959578|FG002|Overall Study|Other - as reported by the investigator|5|||
23609825|NCT04184622|65959579|FG003|Overall Study|Other - as reported by the investigator|12|||
23609826|NCT04184622|65959576|FG000|Overall Study|Physician Decision|0|||
23609827|NCT04184622|65959577|FG001|Overall Study|Physician Decision|0|||
23609828|NCT04184622|65959578|FG002|Overall Study|Physician Decision|3|||
23609829|NCT04184622|65959579|FG003|Overall Study|Physician Decision|1|||
23510365|NCT03855280|65605980|FG000|Continuation Phase|Adverse Event|1|||
23510366|NCT03855280|65605980|FG000|Continuation Phase|Sponsor Concluded Study|1|||
23510367|NCT03049280|65605993|FG000|Overall Study|Physician Decision|1|||
23510368|NCT00166114|65605998|FG000|Overall Study|Protocol Violation|2|||
23510369|NCT00166114|65605999|FG001|Overall Study|Protocol Violation|1|||
23609830|NCT04184622|65959576|FG000|Overall Study|Pregnancy|4|||
23609831|NCT04184622|65959577|FG001|Overall Study|Pregnancy|4|||
23609832|NCT04184622|65959578|FG002|Overall Study|Pregnancy|3|||
23609833|NCT04184622|65959579|FG003|Overall Study|Pregnancy|5|||
23510370|NCT00166114|65605998|FG000|Overall Study|Withdrawal by Subject|10|||
23510371|NCT00166114|65605999|FG001|Overall Study|Withdrawal by Subject|4|||
23510372|NCT00166114|65605998|FG000|Overall Study|Adverse Event|2|||
23609834|NCT04184622|65959576|FG000|Overall Study|Protocol Deviation|1|||
23609835|NCT04184622|65959577|FG001|Overall Study|Protocol Deviation|0|||
23609836|NCT04184622|65959578|FG002|Overall Study|Protocol Deviation|0|||
23609837|NCT04184622|65959579|FG003|Overall Study|Protocol Deviation|0|||
23609838|NCT04184622|65959576|FG000|Overall Study|Withdrawal by Subject|68|||
23609839|NCT04184622|65959577|FG001|Overall Study|Withdrawal by Subject|28|||
23609840|NCT04184622|65959578|FG002|Overall Study|Withdrawal by Subject|29|||
23609841|NCT04184622|65959579|FG003|Overall Study|Withdrawal by Subject|22|||
23609842|NCT02830893|65959581|FG000|Overall Study|Relocation to out of the country|1|||
23609843|NCT02830893|65959582|FG001|Overall Study|Relocation to out of the country|0|||
23609844|NCT02830893|65959581|FG000|Overall Study|Lost to Follow-up|0|||
23609845|NCT02830893|65959582|FG001|Overall Study|Lost to Follow-up|2|||
23609846|NCT02830893|65959581|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
23609847|NCT02830893|65959582|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
23609848|NCT02708498|65959583|FG000|Overall Study|Death|20|||
23609849|NCT02708498|65959584|FG001|Overall Study|Death|19|||
23609850|NCT02708498|65959585|FG002|Overall Study|Death|0|||
23609851|NCT02708498|65959586|FG003|Overall Study|Death|0|||
23609852|NCT02708498|65959587|FG004|Overall Study|Death|1|||
23609853|NCT02708498|65959588|FG005|Overall Study|Death|0|||
23609854|NCT02708498|65959589|FG006|Overall Study|Death|0|||
23609855|NCT02708498|65959590|FG007|Overall Study|Death|0|||
23609856|NCT02708498|65959583|FG000|Overall Study|Unknown reason, missing data|0|||
23609857|NCT02708498|65959584|FG001|Overall Study|Unknown reason, missing data|0|||
23609858|NCT02708498|65959585|FG002|Overall Study|Unknown reason, missing data|62|||
23609859|NCT02708498|65959586|FG003|Overall Study|Unknown reason, missing data|51|||
23609860|NCT02708498|65959587|FG004|Overall Study|Unknown reason, missing data|195|||
23609861|NCT02708498|65959588|FG005|Overall Study|Unknown reason, missing data|132|||
23609862|NCT02708498|65959589|FG006|Overall Study|Unknown reason, missing data|0|||
23609863|NCT02708498|65959590|FG007|Overall Study|Unknown reason, missing data|0|||
23609864|NCT02865083|65959591|FG000|Overall Study|Early Termination|3|||
23609865|NCT02865083|65959592|FG001|Overall Study|Early Termination|1|||
23609866|NCT01287832|65959600|FG000|Overall Study|Adverse Event|1|||
23609867|NCT01287832|65959601|FG001|Overall Study|Adverse Event|0|||
23609868|NCT01287832|65959600|FG000|Overall Study|Death|0|||
23609869|NCT01287832|65959601|FG001|Overall Study|Death|1|||
23609870|NCT00936065|65959602|FG000|Overall Study|Adverse Event|1|||
23609871|NCT00936065|65959603|FG001|Overall Study|Adverse Event|0|||
23609872|NCT00936065|65959604|FG002|Overall Study|Adverse Event|1|||
23609873|NCT00936065|65959602|FG000|Overall Study|Lack of Efficacy|1|||
23609874|NCT00936065|65959603|FG001|Overall Study|Lack of Efficacy|0|||
23609875|NCT00936065|65959604|FG002|Overall Study|Lack of Efficacy|1|||
23609876|NCT00936065|65959602|FG000|Overall Study|Lost to Follow-up|1|||
23609877|NCT00936065|65959603|FG001|Overall Study|Lost to Follow-up|0|||
23510373|NCT00166114|65605999|FG001|Overall Study|Adverse Event|1|||
23609878|NCT00936065|65959604|FG002|Overall Study|Lost to Follow-up|0|||
23609879|NCT00936065|65959602|FG000|Overall Study|Protocol Violation|1|||
23609880|NCT00936065|65959603|FG001|Overall Study|Protocol Violation|2|||
23609881|NCT00936065|65959604|FG002|Overall Study|Protocol Violation|1|||
23609882|NCT00936065|65959602|FG000|Overall Study|Withdrawal by Subject|0|||
23609883|NCT00936065|65959603|FG001|Overall Study|Withdrawal by Subject|2|||
23609884|NCT00936065|65959604|FG002|Overall Study|Withdrawal by Subject|4|||
23609885|NCT03849300|65959610|FG000|Overall Study|move out to different area|1|||
23609886|NCT03849300|65959611|FG001|Overall Study|move out to different area|3|||
23609887|NCT03849300|65959612|FG002|Overall Study|move out to different area|1|||
23609888|NCT03849300|65959613|FG003|Overall Study|move out to different area|4|||
23609889|NCT03849300|65959610|FG000|Overall Study|scheduling/transportation conflict|4|||
23510374|NCT03194321|65606000|FG000|Overall Study|Withdrawal by Subject|1|||
23609890|NCT03849300|65959611|FG001|Overall Study|scheduling/transportation conflict|4|||
23609891|NCT03849300|65959612|FG002|Overall Study|scheduling/transportation conflict|3|||
23609892|NCT03849300|65959613|FG003|Overall Study|scheduling/transportation conflict|2|||
23609893|NCT00383500|65959614|FG000|Overall Study|Withdrawal by Subject|8|||
23609894|NCT00383500|65959615|FG001|Overall Study|Withdrawal by Subject|3|||
23609895|NCT00383500|65959616|FG002|Overall Study|Withdrawal by Subject|0|||
23609896|NCT00383500|65959614|FG000|Overall Study|Lost to Follow-up|0|||
23609897|NCT00383500|65959615|FG001|Overall Study|Lost to Follow-up|0|||
23609898|NCT00383500|65959616|FG002|Overall Study|Lost to Follow-up|2|||
23609899|NCT02547974|65959620|FG000|Overall Study|Withdrawal by Subject|1|||
23609900|NCT02547974|65959621|FG001|Overall Study|Withdrawal by Subject|0|||
23609901|NCT02547974|65959622|FG002|Overall Study|Withdrawal by Subject|0|||
23609902|NCT02547974|65959623|FG003|Overall Study|Withdrawal by Subject|0|||
23609903|NCT03823703|65959627|FG000|Overall Study|Sponsor request|0|||
23609904|NCT03823703|65959628|FG001|Overall Study|Sponsor request|3|||
23609905|NCT03823703|65959629|FG002|Overall Study|Sponsor request|4|||
23609906|NCT03823703|65959627|FG000|Overall Study|Adverse Event|3|||
23609907|NCT03823703|65959628|FG001|Overall Study|Adverse Event|1|||
23609908|NCT03823703|65959629|FG002|Overall Study|Adverse Event|0|||
23510375|NCT03194321|65606000|FG000|Overall Study|Lost to Follow-up|1|||
23510376|NCT03194321|65606000|FG000|Overall Study|Travel for Follow-up|1|||
23510377|NCT02260921|65606001|FG000|Overall Study|Adverse Event|1|||
23510378|NCT02260921|65606002|FG001|Overall Study|Adverse Event|0|||
23510379|NCT02260921|65606001|FG000|Overall Study|Lost to Follow-up|4|||
23510380|NCT02260921|65606002|FG001|Overall Study|Lost to Follow-up|3|||
23510381|NCT02260921|65606001|FG000|Overall Study|Withdraw Consent|4|||
23510382|NCT02260921|65606002|FG001|Overall Study|Withdraw Consent|1|||
23510383|NCT02260921|65606001|FG000|Overall Study|Death|1|||
23510384|NCT02260921|65606002|FG001|Overall Study|Death|0|||
23510385|NCT02260921|65606001|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
23510386|NCT02260921|65606002|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
23510387|NCT01798004|65606007|FG000|Overall Study|Death|2|||
23510388|NCT01798004|65606007|FG000|Overall Study|Lack of Efficacy|8|||
23510389|NCT01798004|65606007|FG000|Overall Study|Physician Decision|25|||
23510390|NCT01798004|65606007|FG000|Overall Study|Withdrawal by Subject|4|||
23609909|NCT03823703|65959627|FG000|Overall Study|Withdrawal by Subject|0|||
23609910|NCT03823703|65959628|FG001|Overall Study|Withdrawal by Subject|1|||
23609911|NCT03823703|65959629|FG002|Overall Study|Withdrawal by Subject|0|||
23204600|NCT01718509|64491103|FG001|Overall Study|Withdrawal by Subject|13|||
23204601|NCT01718509|64491102|FG000|Overall Study|Adverse Event|5|||
23204602|NCT01718509|64491103|FG001|Overall Study|Adverse Event|7|||
23204603|NCT01718509|64491102|FG000|Overall Study|Other|13|||
23204604|NCT01718509|64491103|FG001|Overall Study|Other|11|||
23204605|NCT01718509|64491102|FG000|Overall Study|Protocol Violation|4|||
23609912|NCT01115309|65959630|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
23609913|NCT01115309|65959630|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
23204606|NCT01718509|64491103|FG001|Overall Study|Protocol Violation|2|||
23204607|NCT01718509|64491102|FG000|Overall Study|Lack of Efficacy|1|||
23204608|NCT01718509|64491103|FG001|Overall Study|Lack of Efficacy|0|||
23204609|NCT04715230|64491104|FG000|Overall Study|Withdrawal by Subject|1|||
23204610|NCT04715230|64491105|FG001|Overall Study|Withdrawal by Subject|0|||
23204611|NCT04715230|64491106|FG002|Overall Study|Withdrawal by Subject|0|||
23204612|NCT04715230|64491104|FG000|Overall Study|Lost to Follow-up|0|||
23204613|NCT04715230|64491105|FG001|Overall Study|Lost to Follow-up|5|||
23204614|NCT04715230|64491106|FG002|Overall Study|Lost to Follow-up|1|||
23204615|NCT03456713|64491107|FG000|Overall Study|Lost to Follow-up|1|||
23204616|NCT03456713|64491108|FG001|Overall Study|Lost to Follow-up|0|||
23204617|NCT03456713|64491109|FG002|Overall Study|Lost to Follow-up|0|||
23204618|NCT03456713|64491110|FG003|Overall Study|Lost to Follow-up|0|||
23204619|NCT02176291|64491111|FG000|Overall Study|Death|1|||
23204620|NCT02176291|64491112|FG001|Overall Study|Death|0|||
23204621|NCT02176291|64491111|FG000|Overall Study|non compliance with protocol|2|||
23204622|NCT02176291|64491112|FG001|Overall Study|non compliance with protocol|0|||
23204623|NCT02176291|64491111|FG000|Overall Study|Withdrawal by Subject|2|||
23204624|NCT02176291|64491112|FG001|Overall Study|Withdrawal by Subject|0|||
23204625|NCT02855411|64491118|FG000|Overall Study|Study terminated by sponsor|21|||
23204626|NCT02855411|64491118|FG000|Overall Study|Does not meet entrance criteria|14|||
23204627|NCT03571256|64491119|FG000|Overall Study|Adverse Event|3|||
23204628|NCT03571256|64491120|FG001|Overall Study|Adverse Event|0|||
23204629|NCT03571256|64491121|FG002|Overall Study|Adverse Event|1|||
23204630|NCT03571256|64491119|FG000|Overall Study|Withdrawal by Subject|3|||
23510391|NCT01798004|65606007|FG000|Overall Study|Ineligible|4|||
23510392|NCT01798004|65606007|FG000|Overall Study|Patient/parent refusal|7|||
23510393|NCT01798004|65606007|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
23510394|NCT01798004|65606007|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
23510395|NCT04294472|65606008|FG000|Overall Study|Adverse Event|0|||
23510396|NCT04294472|65606009|FG001|Overall Study|Adverse Event|1|||
23609914|NCT01115309|65959630|FG000|Long-term Follow-up|Lost to Follow-up|6|||
23204631|NCT03571256|64491120|FG001|Overall Study|Withdrawal by Subject|1|||
23609915|NCT00795639|65959631|FG000|Overall Study|Death|1|||
23609916|NCT00795639|65959632|FG001|Overall Study|Death|6|||
23609917|NCT00795639|65959631|FG000|Overall Study|Withdrawal by Subject|1|||
23204632|NCT03571256|64491121|FG002|Overall Study|Withdrawal by Subject|1|||
23204633|NCT03571256|64491119|FG000|Overall Study|Other than specified|0|||
23510397|NCT04294472|65606010|FG002|Overall Study|Adverse Event|1|||
23609918|NCT00795639|65959632|FG001|Overall Study|Withdrawal by Subject|3|||
23609919|NCT00795639|65959631|FG000|Overall Study|Pregnancy|1|||
23204634|NCT03571256|64491120|FG001|Overall Study|Other than specified|1|||
23204635|NCT03571256|64491121|FG002|Overall Study|Other than specified|1|||
23204636|NCT03571256|64491119|FG000|Overall Study|Protocol Violation|0|||
23204637|NCT03571256|64491120|FG001|Overall Study|Protocol Violation|1|||
23204638|NCT03571256|64491121|FG002|Overall Study|Protocol Violation|1|||
23204639|NCT01826422|64491122|FG000|Overall Study|Withdrawal by Subject|1|||
23204640|NCT01826422|64491123|FG001|Overall Study|Withdrawal by Subject|3|||
23204641|NCT01944969|64491124|FG000|Overall Study|Adverse Event|1|||
23204642|NCT01944969|64491124|FG000|Overall Study|Lack of Efficacy|1|||
23204643|NCT01944969|64491124|FG000|Overall Study|Non-compliance with IMP|1|||
23204644|NCT01944969|64491124|FG000|Overall Study|Administrative or other reasons|23|||
23204645|NCT00903032|64491132|FG000|Overall Study|Withdrawal by Subject|5|||
23204646|NCT00903032|64491133|FG001|Overall Study|Withdrawal by Subject|3|||
23204647|NCT00903032|64491132|FG000|Overall Study|Lost to Follow-up|2|||
23204648|NCT00903032|64491133|FG001|Overall Study|Lost to Follow-up|2|||
23204649|NCT03622593|64491134|FG000|Overall Study|Withdrawal by Subject|11|||
23204650|NCT03622593|64491135|FG001|Overall Study|Withdrawal by Subject|9|||
23204651|NCT03622593|64491136|FG002|Overall Study|Withdrawal by Subject|13|||
23204652|NCT03622593|64491134|FG000|Overall Study|Death|12|||
23204653|NCT03622593|64491135|FG001|Overall Study|Death|9|||
23204654|NCT03622593|64491136|FG002|Overall Study|Death|10|||
23204655|NCT03622593|64491134|FG000|Overall Study|Lost to Follow-up|11|||
23204656|NCT03622593|64491135|FG001|Overall Study|Lost to Follow-up|5|||
23204657|NCT03622593|64491136|FG002|Overall Study|Lost to Follow-up|8|||
23204658|NCT03622593|64491134|FG000|Overall Study|Adverse Event|4|||
23204659|NCT03622593|64491135|FG001|Overall Study|Adverse Event|5|||
23204660|NCT03622593|64491136|FG002|Overall Study|Adverse Event|6|||
23204661|NCT03622593|64491134|FG000|Overall Study|Physician Decision|2|||
23204662|NCT03622593|64491135|FG001|Overall Study|Physician Decision|1|||
23204663|NCT03622593|64491136|FG002|Overall Study|Physician Decision|6|||
23204664|NCT03622593|64491134|FG000|Overall Study|Other|2|||
23204665|NCT03622593|64491135|FG001|Overall Study|Other|2|||
23204666|NCT03622593|64491136|FG002|Overall Study|Other|3|||
23204667|NCT03622593|64491134|FG000|Overall Study|Protocol Violation|0|||
23204668|NCT03622593|64491135|FG001|Overall Study|Protocol Violation|0|||
23204669|NCT03622593|64491136|FG002|Overall Study|Protocol Violation|1|||
23204670|NCT03622593|64491134|FG000|Overall Study|Pregnancy|0|||
23204671|NCT03622593|64491135|FG001|Overall Study|Pregnancy|0|||
23204672|NCT03622593|64491136|FG002|Overall Study|Pregnancy|1|||
23204673|NCT01640925|64491139|FG000|Overall Study|Withdrawal by Subject|1|||
23204674|NCT01640925|64491140|FG001|Overall Study|Withdrawal by Subject|0|||
23204675|NCT01640925|64491139|FG000|Overall Study|Previously enrolled in this trial|13|||
23204676|NCT01640925|64491140|FG001|Overall Study|Previously enrolled in this trial|11|||
23204677|NCT01842607|64491141|FG000|Overall Study|Adverse Event|11|||
23204678|NCT01842607|64491141|FG000|Overall Study|Lack of Efficacy|19|||
23204679|NCT01842607|64491141|FG000|Overall Study|Protocol Violation|8|||
23204680|NCT01842607|64491141|FG000|Overall Study|Protocol defined stopping criteria|2|||
23204681|NCT01842607|64491141|FG000|Overall Study|Lost to Follow-up|3|||
23204682|NCT01842607|64491141|FG000|Overall Study|Physician Decision|9|||
23204683|NCT01842607|64491141|FG000|Overall Study|Withdrawal by Subject|14|||
23204684|NCT03629041|64491142|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
23204685|NCT03629041|64491143|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
23204686|NCT03629041|64491144|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
23204687|NCT03629041|64491145|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
23204688|NCT01727713|64491150|FG000|Overall Study|Lost to Follow-up|5|||
23204689|NCT01727713|64491150|FG000|Overall Study|Adverse Event|10|||
23204690|NCT01727713|64491150|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
23204691|NCT01727713|64491150|FG000|Overall Study|Withdrawal by Subject|13|||
23204692|NCT01727713|64491150|FG000|Overall Study|Protocol Deviation|2|||
23609920|NCT00795639|65959632|FG001|Overall Study|Pregnancy|0|||
23609921|NCT00795639|65959631|FG000|Overall Study|Adverse Event|5|||
23609922|NCT00795639|65959632|FG001|Overall Study|Adverse Event|2|||
23609923|NCT00795639|65959631|FG000|Overall Study|Other|0|||
23609924|NCT00795639|65959632|FG001|Overall Study|Other|2|||
23609925|NCT00795639|65959631|FG000|Overall Study|Terminated by sponsor|13|||
23609926|NCT00795639|65959632|FG001|Overall Study|Terminated by sponsor|12|||
23609927|NCT00795639|65959631|FG000|Overall Study|Randomized and not treated|0|||
23609928|NCT00795639|65959632|FG001|Overall Study|Randomized and not treated|1|||
23609929|NCT00853957|65959633|FG000|Overall Study|Adverse Event|9|||
23609930|NCT00853957|65959634|FG001|Overall Study|Adverse Event|3|||
23204693|NCT00115804|64491153|FG000|Overall Study|Adverse Event|2|||
23204694|NCT01432262|64491154|FG000|Overall Study|Withdrawal by Subject|2|||
23204695|NCT01432262|64491155|FG001|Overall Study|Withdrawal by Subject|1|||
23204696|NCT03025217|64491156|FG000|Overall Study|Pregnancy|1|||
23204697|NCT03025217|64491156|FG000|Overall Study|Lost to Follow-up|1|||
23204698|NCT03025217|64491156|FG000|Overall Study|Not eligible, poor English|2|||
23204699|NCT03888391|64491159|FG000|Overall Study|Lost to Follow-up|15|||
23609931|NCT00853957|65959633|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23609932|NCT00853957|65959634|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23609933|NCT00853957|65959633|FG000|Overall Study|Subject withdrew consent|4|||
23609934|NCT00853957|65959634|FG001|Overall Study|Subject withdrew consent|5|||
23204700|NCT01767194|64491162|FG000|Overall Study|Adverse Event|1|||
23204701|NCT01767194|64491163|FG001|Overall Study|Adverse Event|1|||
23609935|NCT00853957|65959633|FG000|Overall Study|Lost to Follow-up|1|||
23204702|NCT01767194|64491162|FG000|Overall Study|Death|0|||
23408599|NCT02141672|65239931|FG001|Overall Study|refused to follow-up|0|||
23609936|NCT00853957|65959634|FG001|Overall Study|Lost to Follow-up|6|||
23609937|NCT00853957|65959633|FG000|Overall Study|Protocol deviation|0|||
23609938|NCT00853957|65959634|FG001|Overall Study|Protocol deviation|3|||
23609939|NCT00267865|65959635|FG000|Induction Treatment|Died before completing.|2|||
23609940|NCT00267865|65959635|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
23609941|NCT01261793|65959638|FG000|Overall Study|Lack of Efficacy|44|||
23609942|NCT01261793|65959639|FG001|Overall Study|Lack of Efficacy|37|||
23609943|NCT01261793|65959640|FG002|Overall Study|Lack of Efficacy|32|||
23609944|NCT01261793|65959638|FG000|Overall Study|Protocol Violation|3|||
23609945|NCT01261793|65959639|FG001|Overall Study|Protocol Violation|5|||
23609946|NCT01261793|65959640|FG002|Overall Study|Protocol Violation|6|||
23609947|NCT01261793|65959638|FG000|Overall Study|Lost to Follow-up|10|||
23510398|NCT04294472|65606008|FG000|Overall Study|Randomized but not treated|0|||
23204703|NCT01767194|64491163|FG001|Overall Study|Death|1|||
23510399|NCT04294472|65606009|FG001|Overall Study|Randomized but not treated|1|||
23510400|NCT04294472|65606010|FG002|Overall Study|Randomized but not treated|1|||
23609948|NCT01261793|65959639|FG001|Overall Study|Lost to Follow-up|3|||
23609949|NCT01261793|65959640|FG002|Overall Study|Lost to Follow-up|7|||
23609950|NCT01261793|65959638|FG000|Overall Study|Withdrawal by Subject|12|||
23609951|NCT01261793|65959639|FG001|Overall Study|Withdrawal by Subject|14|||
23609952|NCT01261793|65959640|FG002|Overall Study|Withdrawal by Subject|14|||
23609953|NCT01261793|65959638|FG000|Overall Study|Death|3|||
23609954|NCT01261793|65959639|FG001|Overall Study|Death|1|||
23609955|NCT01261793|65959640|FG002|Overall Study|Death|0|||
23609956|NCT01261793|65959638|FG000|Overall Study|Adverse Event|9|||
23609957|NCT01261793|65959639|FG001|Overall Study|Adverse Event|24|||
23510401|NCT00617123|65606011|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
23609958|NCT01261793|65959640|FG002|Overall Study|Adverse Event|19|||
23609959|NCT01261793|65959638|FG000|Overall Study|Patient non-availability|1|||
23609960|NCT01261793|65959639|FG001|Overall Study|Patient non-availability|1|||
23609961|NCT01261793|65959640|FG002|Overall Study|Patient non-availability|1|||
23609962|NCT01261793|65959638|FG000|Overall Study|Suspected pregnancy|1|||
23609963|NCT01261793|65959639|FG001|Overall Study|Suspected pregnancy|1|||
23609964|NCT01261793|65959640|FG002|Overall Study|Suspected pregnancy|0|||
23609965|NCT01261793|65959638|FG000|Overall Study|Patient non-compliance|1|||
23609966|NCT01261793|65959639|FG001|Overall Study|Patient non-compliance|0|||
23609967|NCT01261793|65959640|FG002|Overall Study|Patient non-compliance|1|||
23609968|NCT01261793|65959638|FG000|Overall Study|Patient pregnant|1|||
23609969|NCT01261793|65959639|FG001|Overall Study|Patient pregnant|0|||
23609970|NCT01261793|65959640|FG002|Overall Study|Patient pregnant|0|||
23609971|NCT01261793|65959638|FG000|Overall Study|Outside the study area|0|||
23609972|NCT01261793|65959639|FG001|Overall Study|Outside the study area|2|||
23609973|NCT01261793|65959640|FG002|Overall Study|Outside the study area|1|||
23609974|NCT01261793|65959638|FG000|Overall Study|Lack of efficacy & patient not available|0|||
23609975|NCT01261793|65959639|FG001|Overall Study|Lack of efficacy & patient not available|1|||
23609976|NCT01261793|65959640|FG002|Overall Study|Lack of efficacy & patient not available|0|||
23609977|NCT01261793|65959638|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
23609978|NCT01261793|65959639|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
23609979|NCT01261793|65959640|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
23609980|NCT01261793|65959638|FG000|Overall Study|Randomization error|0|||
23609981|NCT01261793|65959639|FG001|Overall Study|Randomization error|1|||
23609982|NCT01261793|65959640|FG002|Overall Study|Randomization error|0|||
23609983|NCT01261793|65959638|FG000|Overall Study|Patient unable to start IV line|0|||
23609984|NCT01261793|65959639|FG001|Overall Study|Patient unable to start IV line|0|||
23609985|NCT01261793|65959640|FG002|Overall Study|Patient unable to start IV line|1|||
23609986|NCT00529529|65959641|FG000|Overall Study|Adverse Event|12|||
23609987|NCT00529529|65959642|FG001|Overall Study|Adverse Event|17|||
23609988|NCT00529529|65959643|FG002|Overall Study|Adverse Event|8|||
23609989|NCT00529529|65959641|FG000|Overall Study|Subject withdrew consent|12|||
23609990|NCT00529529|65959642|FG001|Overall Study|Subject withdrew consent|9|||
23609991|NCT00529529|65959643|FG002|Overall Study|Subject withdrew consent|12|||
23609992|NCT00529529|65959641|FG000|Overall Study|Protocol deviation|8|||
23609993|NCT00529529|65959642|FG001|Overall Study|Protocol deviation|12|||
23609994|NCT00529529|65959643|FG002|Overall Study|Protocol deviation|5|||
23609995|NCT00529529|65959641|FG000|Overall Study|Lost to Follow-up|5|||
23609996|NCT00529529|65959642|FG001|Overall Study|Lost to Follow-up|3|||
23609997|NCT00529529|65959643|FG002|Overall Study|Lost to Follow-up|1|||
23609998|NCT00529529|65959641|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23609999|NCT00529529|65959642|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23610000|NCT00529529|65959643|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23610001|NCT00529529|65959641|FG000|Overall Study|Death|2|||
23610002|NCT00529529|65959642|FG001|Overall Study|Death|0|||
23610003|NCT00529529|65959643|FG002|Overall Study|Death|0|||
23510402|NCT00617123|65606012|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
23610004|NCT00529529|65959641|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23610005|NCT00529529|65959642|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23610006|NCT00529529|65959643|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23610007|NCT00529529|65959641|FG000|Overall Study|Administrative problems|1|||
23610008|NCT00529529|65959642|FG001|Overall Study|Administrative problems|0|||
23610009|NCT00529529|65959643|FG002|Overall Study|Administrative problems|3|||
23610010|NCT03060525|65959646|FG000|Overall Study|moved out of state|1|||
23510403|NCT00617123|65606011|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
23510404|NCT00617123|65606012|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
23510405|NCT00617123|65606011|FG000|Referral Screening Period|Adverse Event|0|||
23510406|NCT00617123|65606012|FG001|Referral Screening Period|Adverse Event|1|||
23510407|NCT00617123|65606011|FG000|Study Treatment Period|Withdrawal by Subject|8|||
23510408|NCT00617123|65606012|FG001|Study Treatment Period|Withdrawal by Subject|12|||
23510409|NCT00617123|65606011|FG000|Study Treatment Period|Adverse Event|7|||
23610011|NCT03060525|65959647|FG001|Overall Study|moved out of state|1|||
23610012|NCT03060525|65959648|FG002|Overall Study|moved out of state|1|||
23610013|NCT03060525|65959649|FG003|Overall Study|moved out of state|1|||
23610014|NCT03060525|65959646|FG000|Overall Study|unable to meet time commitment required of study|2|||
23610015|NCT03060525|65959647|FG001|Overall Study|unable to meet time commitment required of study|3|||
23610016|NCT03060525|65959648|FG002|Overall Study|unable to meet time commitment required of study|3|||
23610017|NCT03060525|65959649|FG003|Overall Study|unable to meet time commitment required of study|1|||
23610018|NCT03060525|65959646|FG000|Overall Study|no longer interested in doing intervention|0|||
23610019|NCT03060525|65959647|FG001|Overall Study|no longer interested in doing intervention|0|||
23610020|NCT03060525|65959648|FG002|Overall Study|no longer interested in doing intervention|0|||
23610021|NCT03060525|65959649|FG003|Overall Study|no longer interested in doing intervention|1|||
23610022|NCT00742560|65959650|FG000|Overall Study|Adverse Event|0|||
23610023|NCT00742560|65959651|FG001|Overall Study|Adverse Event|0|||
23610024|NCT00742560|65959652|FG002|Overall Study|Adverse Event|1|||
23610025|NCT00742560|65959653|FG003|Overall Study|Adverse Event|1|||
23610026|NCT00742560|65959654|FG004|Overall Study|Adverse Event|1|||
23610027|NCT00742560|65959650|FG000|Overall Study|Death|0|||
23610028|NCT00742560|65959651|FG001|Overall Study|Death|2|||
23610029|NCT00742560|65959652|FG002|Overall Study|Death|0|||
23610030|NCT00742560|65959653|FG003|Overall Study|Death|2|||
23610031|NCT00742560|65959654|FG004|Overall Study|Death|3|||
23610032|NCT00742560|65959650|FG000|Overall Study|Subject's Decision|1|||
23510410|NCT00617123|65606012|FG001|Study Treatment Period|Adverse Event|3|||
23510411|NCT00617123|65606011|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
23610033|NCT00742560|65959651|FG001|Overall Study|Subject's Decision|0|||
23610034|NCT00742560|65959652|FG002|Overall Study|Subject's Decision|2|||
23610035|NCT00742560|65959653|FG003|Overall Study|Subject's Decision|3|||
23510412|NCT00617123|65606012|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
23610036|NCT00742560|65959654|FG004|Overall Study|Subject's Decision|3|||
23610037|NCT00742560|65959650|FG000|Overall Study|Investigator's Decision|0|||
23610038|NCT00742560|65959651|FG001|Overall Study|Investigator's Decision|0|||
23610039|NCT00742560|65959652|FG002|Overall Study|Investigator's Decision|4|||
23610040|NCT00742560|65959653|FG003|Overall Study|Investigator's Decision|1|||
23610041|NCT00742560|65959654|FG004|Overall Study|Investigator's Decision|0|||
23610042|NCT00742560|65959650|FG000|Overall Study|Disease Progression|1|||
23610043|NCT00742560|65959651|FG001|Overall Study|Disease Progression|0|||
23610044|NCT00742560|65959652|FG002|Overall Study|Disease Progression|5|||
23610045|NCT00742560|65959653|FG003|Overall Study|Disease Progression|17|||
23610046|NCT00742560|65959654|FG004|Overall Study|Disease Progression|16|||
23610047|NCT00742560|65959650|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
23610048|NCT00742560|65959651|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
23610049|NCT00742560|65959652|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
23610050|NCT00742560|65959653|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
23610051|NCT00742560|65959654|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
23610052|NCT00742560|65959650|FG000|Overall Study|Other|0|||
23610053|NCT00742560|65959651|FG001|Overall Study|Other|1|||
23610054|NCT00742560|65959652|FG002|Overall Study|Other|8|||
23610055|NCT00742560|65959653|FG003|Overall Study|Other|9|||
23610056|NCT00742560|65959654|FG004|Overall Study|Other|9|||
23610057|NCT00742560|65959650|FG000|Overall Study|MIssing|0|||
23610058|NCT00742560|65959651|FG001|Overall Study|MIssing|0|||
23610059|NCT00742560|65959652|FG002|Overall Study|MIssing|0|||
23610060|NCT00742560|65959653|FG003|Overall Study|MIssing|0|||
23610061|NCT00742560|65959654|FG004|Overall Study|MIssing|1|||
23610062|NCT00584909|65959655|FG000|Overall Study|Adverse Event|4|||
23610063|NCT01737398|65959658|FG000|Overall Study|Adverse event or SAE|16|||
23610064|NCT01737398|65959659|FG001|Overall Study|Adverse event or SAE|1|||
23610065|NCT01737398|65959658|FG000|Overall Study|Stopping rule met|2|||
23610066|NCT01737398|65959659|FG001|Overall Study|Stopping rule met|1|||
23610067|NCT01737398|65959658|FG000|Overall Study|Voluntary withdrawal|2|||
23610068|NCT01737398|65959659|FG001|Overall Study|Voluntary withdrawal|3|||
23610069|NCT01737398|65959658|FG000|Overall Study|Ineligibility|1|||
23610070|NCT01737398|65959659|FG001|Overall Study|Ineligibility|0|||
23610071|NCT01737398|65959658|FG000|Overall Study|Liver transplant|1|||
23610072|NCT01737398|65959659|FG001|Overall Study|Liver transplant|0|||
23610073|NCT01737398|65959658|FG000|Overall Study|Disease progression|2|||
23610074|NCT01737398|65959659|FG001|Overall Study|Disease progression|3|||
23610075|NCT01737398|65959658|FG000|Overall Study|Sponsor's decision|2|||
23610076|NCT01737398|65959659|FG001|Overall Study|Sponsor's decision|0|||
23610077|NCT00832650|65959660|FG000|Overall Study|Randomized but not treated|0|||
23610078|NCT00832650|65959661|FG001|Overall Study|Randomized but not treated|0|||
23610079|NCT00832650|65959662|FG002|Overall Study|Randomized but not treated|1|||
23610080|NCT01999335|65959663|FG000|Overall Study|Discontinued before receiving treatment|0|||
23610081|NCT01999335|65959664|FG001|Overall Study|Discontinued before receiving treatment|0|||
23610082|NCT01999335|65959665|FG002|Overall Study|Discontinued before receiving treatment|0|||
23610083|NCT01999335|65959666|FG003|Overall Study|Discontinued before receiving treatment|0|||
23610084|NCT01999335|65959667|FG004|Overall Study|Discontinued before receiving treatment|2|||
23610085|NCT00307489|65959673|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
23610086|NCT00307489|65959674|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
23610087|NCT00307489|65959673|FG000|Baseline Through Week 48|Physician Decision|1|||
23610088|NCT00307489|65959674|FG001|Baseline Through Week 48|Physician Decision|0|||
23610089|NCT00307489|65959673|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
23610090|NCT00307489|65959674|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
23610091|NCT00307489|65959673|FG000|Week 48 Through Week 168|Adverse Event|1|||
23610092|NCT00307489|65959674|FG001|Week 48 Through Week 168|Adverse Event|0|||
23610093|NCT00307489|65959673|FG000|Week 48 Through Week 168|Physician Decision|1|||
23610094|NCT00307489|65959674|FG001|Week 48 Through Week 168|Physician Decision|0|||
23610095|NCT00307489|65959673|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
23610096|NCT00307489|65959674|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
23610097|NCT00307489|65959673|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
23610098|NCT00307489|65959674|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
23610099|NCT00307489|65959673|FG000|Week 48 Through Week 168|Death|0|||
23610100|NCT00307489|65959674|FG001|Week 48 Through Week 168|Death|1|||
23610101|NCT00307489|65959673|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
23610102|NCT00307489|65959674|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
23610103|NCT00307489|65959673|FG000|Week 48 Through Week 168|Seroconversion|1|||
23610104|NCT00307489|65959674|FG001|Week 48 Through Week 168|Seroconversion|0|||
23610105|NCT03747575|65959675|FG000|Overall Study|Withdrawal by Subject|6|||
23610106|NCT03747575|65959676|FG001|Overall Study|Withdrawal by Subject|3|||
23610107|NCT03747575|65959675|FG000|Overall Study|Lost to Follow-up|3|||
23610108|NCT03747575|65959676|FG001|Overall Study|Lost to Follow-up|3|||
23610109|NCT03747575|65959675|FG000|Overall Study|Adverse Event|0|||
23610110|NCT03747575|65959676|FG001|Overall Study|Adverse Event|1|||
23610111|NCT02481934|65959677|FG000|Overall Study|Death|2|||
23610112|NCT00441168|65959678|FG000|Treatment Period|Death|3|||
23610113|NCT00441168|65959679|FG001|Treatment Period|Death|0|||
23610114|NCT00441168|65959678|FG000|Treatment Period|Adverse Event|1|||
23610115|NCT00441168|65959679|FG001|Treatment Period|Adverse Event|2|||
23610116|NCT00441168|65959678|FG000|Treatment Period|Progressive Disease|0|||
23610117|NCT00441168|65959679|FG001|Treatment Period|Progressive Disease|2|||
23610118|NCT00441168|65959678|FG000|Treatment Period|Protocol Violation|0|||
23610119|NCT00441168|65959679|FG001|Treatment Period|Protocol Violation|1|||
23610120|NCT00441168|65959678|FG000|Treatment Period|Lost to Follow-up|0|||
23610121|NCT00441168|65959679|FG001|Treatment Period|Lost to Follow-up|1|||
23610122|NCT00441168|65959678|FG000|Treatment Period|Withdrawal by Subject|3|||
23610123|NCT00441168|65959679|FG001|Treatment Period|Withdrawal by Subject|0|||
23610124|NCT00441168|65959678|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
23610125|NCT00441168|65959679|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
23610126|NCT00441168|65959678|FG000|Treatment Period|refractory disease|1|||
23610127|NCT00441168|65959679|FG001|Treatment Period|refractory disease|0|||
23610128|NCT00441168|65959678|FG000|Follow-up Period|Death|3|||
23610129|NCT00441168|65959679|FG001|Follow-up Period|Death|0|||
23610130|NCT00441168|65959678|FG000|Follow-up Period|Lost to Follow-up|5|||
23610131|NCT00441168|65959679|FG001|Follow-up Period|Lost to Follow-up|6|||
23610132|NCT00441168|65959678|FG000|Follow-up Period|Withdrawal by Subject|3|||
23610133|NCT00441168|65959679|FG001|Follow-up Period|Withdrawal by Subject|0|||
23610134|NCT00441168|65959678|FG000|Follow-up Period|Other|1|||
23610135|NCT00441168|65959679|FG001|Follow-up Period|Other|3|||
23610136|NCT03769090|65959680|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
23610137|NCT03769090|65959681|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
23610138|NCT03769090|65959682|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
23510413|NCT00617123|65606011|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
23510414|NCT00617123|65606012|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
23510415|NCT02825992|65606013|FG000|Overall Study|Withdrawal by Subject|4|||
23510416|NCT02825992|65606013|FG000|Overall Study|Lost to Follow-up|2|||
23510417|NCT02825992|65606013|FG000|Overall Study|Procedure terminated|2|||
23510418|NCT02057406|65606015|FG000|Overall Study|Physician Decision|0|||
23510419|NCT02057406|65606016|FG001|Overall Study|Physician Decision|0|||
23510420|NCT02057406|65606017|FG002|Overall Study|Physician Decision|2|||
23510421|NCT02057406|65606015|FG000|Overall Study|Withdrawal by Subject|0|||
23510422|NCT02057406|65606016|FG001|Overall Study|Withdrawal by Subject|2|||
23510423|NCT02057406|65606017|FG002|Overall Study|Withdrawal by Subject|0|||
23510424|NCT02057406|65606015|FG000|Overall Study|Lost to Follow-up|0|||
23510425|NCT02057406|65606016|FG001|Overall Study|Lost to Follow-up|0|||
23510426|NCT02057406|65606017|FG002|Overall Study|Lost to Follow-up|1|||
23510427|NCT02057406|65606015|FG000|Overall Study|Death|1|||
23510428|NCT02057406|65606016|FG001|Overall Study|Death|0|||
23510429|NCT02057406|65606017|FG002|Overall Study|Death|0|||
23510430|NCT02057406|65606015|FG000|Overall Study|Protocol Violation|0|||
23510431|NCT02057406|65606016|FG001|Overall Study|Protocol Violation|1|||
23510432|NCT02057406|65606017|FG002|Overall Study|Protocol Violation|0|||
23510433|NCT02057406|65606015|FG000|Overall Study|Patient transportation issues|0|||
23510434|NCT02057406|65606016|FG001|Overall Study|Patient transportation issues|0|||
23510435|NCT02057406|65606017|FG002|Overall Study|Patient transportation issues|1|||
23610139|NCT03769090|65959680|FG000|Overall Study|Withdrawal by Subject|52|||
23610140|NCT03769090|65959681|FG001|Overall Study|Withdrawal by Subject|62|||
23610141|NCT03769090|65959682|FG002|Overall Study|Withdrawal by Subject|74|||
23610142|NCT03769090|65959680|FG000|Overall Study|Death|4|||
23610143|NCT03769090|65959681|FG001|Overall Study|Death|2|||
23610144|NCT03769090|65959682|FG002|Overall Study|Death|2|||
23510436|NCT02268864|65606021|FG000|Overall Study|Withdrawal by Subject|2|||
23510437|NCT02268864|65606022|FG001|Overall Study|Withdrawal by Subject|0|||
23510438|NCT02268864|65606023|FG002|Overall Study|Withdrawal by Subject|0|||
23510439|NCT02268864|65606021|FG000|Overall Study|Death|0|||
23610145|NCT03769090|65959680|FG000|Overall Study|Adverse Event|7|||
23510440|NCT02268864|65606022|FG001|Overall Study|Death|1|||
23510441|NCT02268864|65606023|FG002|Overall Study|Death|0|||
23610146|NCT03769090|65959681|FG001|Overall Study|Adverse Event|7|||
23610147|NCT03769090|65959682|FG002|Overall Study|Adverse Event|8|||
23610148|NCT03769090|65959680|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
23610149|NCT03769090|65959681|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
23610150|NCT03769090|65959682|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
23610151|NCT03769090|65959680|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
23610152|NCT03769090|65959681|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
23610153|NCT03769090|65959682|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
23610154|NCT03769090|65959680|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
23610155|NCT03769090|65959681|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
23610156|NCT03769090|65959682|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
23610157|NCT03769090|65959680|FG000|Overall Study|Protocol Violation|5|||
23610158|NCT03769090|65959681|FG001|Overall Study|Protocol Violation|6|||
23610159|NCT03769090|65959682|FG002|Overall Study|Protocol Violation|8|||
23610160|NCT03769090|65959680|FG000|Overall Study|Pregnancy|1|||
23610161|NCT03769090|65959681|FG001|Overall Study|Pregnancy|0|||
23610162|NCT03769090|65959682|FG002|Overall Study|Pregnancy|3|||
23610163|NCT03769090|65959680|FG000|Overall Study|Lost to Follow-up|19|||
23610164|NCT03769090|65959681|FG001|Overall Study|Lost to Follow-up|25|||
23610165|NCT03769090|65959682|FG002|Overall Study|Lost to Follow-up|21|||
23610166|NCT03769090|65959680|FG000|Overall Study|Condition under investigation worsened|2|||
23610167|NCT03769090|65959681|FG001|Overall Study|Condition under investigation worsened|0|||
23610168|NCT03769090|65959682|FG002|Overall Study|Condition under investigation worsened|1|||
23610169|NCT03769090|65959680|FG000|Overall Study|Lack of Efficacy|1|||
23610170|NCT03769090|65959681|FG001|Overall Study|Lack of Efficacy|2|||
23610171|NCT03769090|65959682|FG002|Overall Study|Lack of Efficacy|2|||
23610172|NCT03769090|65959680|FG000|Overall Study|Other reasons|8|||
23610173|NCT03769090|65959681|FG001|Overall Study|Other reasons|12|||
23610174|NCT03769090|65959682|FG002|Overall Study|Other reasons|15|||
23610175|NCT03873038|65962671|FG000|Part 2|Withdrawal by Subject|0|||
23610176|NCT03873038|65962672|FG001|Part 2|Withdrawal by Subject|0|||
23610177|NCT03873038|65962673|FG002|Part 2|Withdrawal by Subject|0|||
23610178|NCT03873038|65962674|FG003|Part 2|Withdrawal by Subject|0|||
23610179|NCT03873038|65962675|FG004|Part 2|Withdrawal by Subject|0|||
23610180|NCT03873038|65962676|FG005|Part 2|Withdrawal by Subject|1|||
23610181|NCT03873038|65962671|FG000|Part 2|Unknon|0|||
23610182|NCT03873038|65962672|FG001|Part 2|Unknon|0|||
23610183|NCT03873038|65962673|FG002|Part 2|Unknon|0|||
23610184|NCT03873038|65962674|FG003|Part 2|Unknon|0|||
23610185|NCT03873038|65962675|FG004|Part 2|Unknon|1|||
23610186|NCT03873038|65962676|FG005|Part 2|Unknon|0|||
23610187|NCT01204775|65962680|FG000|Overall Study|Poor/non-compliance|0|||
23610188|NCT01204775|65962681|FG001|Overall Study|Poor/non-compliance|1|||
23610189|NCT01204775|65962680|FG000|Overall Study|Withdrawal by Subject|1|||
23610190|NCT01204775|65962681|FG001|Overall Study|Withdrawal by Subject|0|||
23610191|NCT01405508|65962682|FG000|Overall Study|AE, non-serious non-fatal|1|||
23610192|NCT01405508|65962683|FG001|Overall Study|AE, non-serious non-fatal|1|||
23610193|NCT01405508|65962684|FG002|Overall Study|AE, non-serious non-fatal|0|||
23610194|NCT01405508|65962685|FG003|Overall Study|AE, non-serious non-fatal|0|||
23610195|NCT03605745|65962686|FG000|Overall Study|Study was terminated for business reasons|47|||
23610196|NCT02418819|65962687|FG000|Overall Study|Adverse Event|0|||
23610197|NCT02418819|65962688|FG001|Overall Study|Adverse Event|0|||
23610198|NCT02418819|65962689|FG002|Overall Study|Adverse Event|1|||
23510442|NCT02669433|65606024|FG000|Overall Study|Protocol Violation|0|||
23510443|NCT02669433|65606025|FG001|Overall Study|Protocol Violation|4|||
23510444|NCT02669433|65606026|FG002|Overall Study|Protocol Violation|1|||
23510445|NCT02669433|65606024|FG000|Overall Study|Disease Progression|1|||
23610199|NCT02418819|65962690|FG003|Overall Study|Adverse Event|0|||
23610200|NCT02418819|65962687|FG000|Overall Study|Lost to Follow-up|1|||
23610201|NCT02418819|65962688|FG001|Overall Study|Lost to Follow-up|0|||
23610202|NCT02418819|65962689|FG002|Overall Study|Lost to Follow-up|0|||
23610203|NCT02418819|65962690|FG003|Overall Study|Lost to Follow-up|0|||
23610204|NCT02418819|65962687|FG000|Overall Study|No longer meets eligibility criteria|0|||
23610205|NCT02418819|65962688|FG001|Overall Study|No longer meets eligibility criteria|0|||
23610206|NCT02418819|65962689|FG002|Overall Study|No longer meets eligibility criteria|1|||
23610207|NCT02418819|65962690|FG003|Overall Study|No longer meets eligibility criteria|0|||
23610208|NCT02418819|65962687|FG000|Overall Study|No longer willing to participate|0|||
23610209|NCT02418819|65962688|FG001|Overall Study|No longer willing to participate|0|||
23610210|NCT02418819|65962689|FG002|Overall Study|No longer willing to participate|2|||
23510446|NCT02669433|65606025|FG001|Overall Study|Disease Progression|0|||
23610211|NCT02418819|65962690|FG003|Overall Study|No longer willing to participate|1|||
23610212|NCT02660086|65962691|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
23610213|NCT02660086|65962692|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
23610214|NCT02660086|65962691|FG000|Overall Study- 12-month|Left full-time employment|12|||
23610215|NCT02660086|65962692|FG001|Overall Study- 12-month|Left full-time employment|20|||
23610216|NCT02660086|65962691|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
23610217|NCT02660086|65962692|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
23610218|NCT02660086|65962691|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
23610219|NCT02660086|65962692|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
23610220|NCT02660086|65962691|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
23610221|NCT02660086|65962692|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
23610222|NCT02660086|65962691|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
23610223|NCT02660086|65962692|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
23610224|NCT04743999|65962693|FG000|3-month Questionnaire|Death|1|||
23610225|NCT04743999|65962693|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
23610226|NCT04743999|65962693|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
23610227|NCT04743999|65962693|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
23610228|NCT01279447|65962694|FG000|Overall Study|Lost to Follow-up|3|||
23610229|NCT01279447|65962695|FG001|Overall Study|Lost to Follow-up|1|||
23610230|NCT01894620|65962697|FG000|Overall Study|Withdrawal by Subject|0|||
23610231|NCT01894620|65962698|FG001|Overall Study|Withdrawal by Subject|1|||
23610232|NCT03689452|65962699|FG000|Overall Study|Lost to Follow-up|1|||
23610233|NCT03689452|65962700|FG001|Overall Study|Lost to Follow-up|1|||
23610234|NCT02612285|65962701|FG000|Overall Study|Withdrawal by Subject|1|||
23610235|NCT01699178|65962702|FG000|Overall Study|Adverse Event|1|||
23610236|NCT01699178|65962703|FG001|Overall Study|Adverse Event|5|||
23610237|NCT01699178|65962702|FG000|Overall Study|Lost to Follow-up|1|||
23610238|NCT01699178|65962703|FG001|Overall Study|Lost to Follow-up|6|||
23610239|NCT01699178|65962702|FG000|Overall Study|Non-compliance with Study Drug|3|||
23610240|NCT01699178|65962703|FG001|Overall Study|Non-compliance with Study Drug|1|||
23610241|NCT01699178|65962702|FG000|Overall Study|Physician Decision|1|||
23610242|NCT01699178|65962703|FG001|Overall Study|Physician Decision|0|||
23610243|NCT01699178|65962702|FG000|Overall Study|Withdrawal by Subject|4|||
23610244|NCT01699178|65962703|FG001|Overall Study|Withdrawal by Subject|12|||
23610245|NCT01699178|65962702|FG000|Overall Study|Hematocrit >54%|1|||
23610246|NCT01699178|65962703|FG001|Overall Study|Hematocrit >54%|1|||
23610247|NCT01699178|65962702|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
23610248|NCT01699178|65962703|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
23610249|NCT01699178|65962702|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
23610250|NCT01699178|65962703|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
23610251|NCT03503188|65962704|FG000|Overall Study|Non eligible in the sub study|0|||
23510447|NCT02669433|65606026|FG002|Overall Study|Disease Progression|0|||
23510448|NCT02669433|65606024|FG000|Overall Study|Physician Decision|1|||
23510449|NCT02669433|65606025|FG001|Overall Study|Physician Decision|1|||
23510450|NCT02669433|65606026|FG002|Overall Study|Physician Decision|0|||
23510451|NCT02669433|65606024|FG000|Overall Study|Adverse Event|6|||
23510452|NCT02669433|65606025|FG001|Overall Study|Adverse Event|7|||
23510453|NCT02669433|65606026|FG002|Overall Study|Adverse Event|10|||
23510454|NCT02669433|65606024|FG000|Overall Study|Sponsor Termination|1|||
23510455|NCT02669433|65606025|FG001|Overall Study|Sponsor Termination|0|||
23510456|NCT02669433|65606026|FG002|Overall Study|Sponsor Termination|1|||
23510457|NCT02669433|65606024|FG000|Overall Study|Withdrawal by Subject|5|||
23510458|NCT02669433|65606025|FG001|Overall Study|Withdrawal by Subject|1|||
23510459|NCT02669433|65606026|FG002|Overall Study|Withdrawal by Subject|0|||
23510460|NCT02669433|65606024|FG000|Overall Study|Withdrawal by Caregiver|1|||
23510461|NCT02669433|65606025|FG001|Overall Study|Withdrawal by Caregiver|0|||
23510462|NCT02669433|65606026|FG002|Overall Study|Withdrawal by Caregiver|2|||
23510463|NCT02669433|65606024|FG000|Overall Study|Death|0|||
23510464|NCT02669433|65606025|FG001|Overall Study|Death|1|||
23510465|NCT02669433|65606026|FG002|Overall Study|Death|1|||
23510466|NCT01824394|65606027|FG000|Overall Study|Early Termination|1|||
23510467|NCT01824394|65606028|FG001|Overall Study|Early Termination|1|||
23510468|NCT01824394|65606029|FG002|Overall Study|Early Termination|3|||
23510469|NCT01824394|65606027|FG000|Overall Study|Withdrawn due to Study Termination|91|||
23510470|NCT01824394|65606028|FG001|Overall Study|Withdrawn due to Study Termination|83|||
23510471|NCT01824394|65606029|FG002|Overall Study|Withdrawn due to Study Termination|41|||
23510472|NCT01824394|65606027|FG000|Overall Study|Lost to Follow-up|0|||
23510473|NCT01824394|65606028|FG001|Overall Study|Lost to Follow-up|9|||
23510474|NCT01824394|65606029|FG002|Overall Study|Lost to Follow-up|3|||
23510475|NCT01824394|65606027|FG000|Overall Study|Death|3|||
23510476|NCT01824394|65606028|FG001|Overall Study|Death|2|||
23510477|NCT01824394|65606029|FG002|Overall Study|Death|4|||
23510478|NCT01824394|65606027|FG000|Overall Study|Discontinued Subjects|1|||
23510479|NCT01824394|65606028|FG001|Overall Study|Discontinued Subjects|1|||
23510480|NCT01824394|65606029|FG002|Overall Study|Discontinued Subjects|2|||
23510481|NCT01824394|65606027|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
23510482|NCT01824394|65606028|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
23510483|NCT01824394|65606029|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
23510484|NCT00545168|65606030|FG000|Overall Study|Lost to Follow-up|5|||
23510485|NCT00545168|65606031|FG001|Overall Study|Lost to Follow-up|5|||
23510486|NCT00545168|65606032|FG002|Overall Study|Lost to Follow-up|5|||
23510487|NCT00545168|65606030|FG000|Overall Study|Withdrawal by Subject|9|||
23510488|NCT00545168|65606031|FG001|Overall Study|Withdrawal by Subject|0|||
23610252|NCT03503188|65962705|FG001|Overall Study|Non eligible in the sub study|1|||
23610253|NCT01562275|65962706|FG000|Stage 1|Adverse Event|0|||
23610254|NCT01562275|65962707|FG001|Stage 1|Adverse Event|0|||
23610255|NCT01562275|65962708|FG002|Stage 1|Adverse Event|0|||
23610256|NCT01562275|65962709|FG003|Stage 1|Adverse Event|1|||
23610257|NCT01562275|65962710|FG004|Stage 1|Adverse Event|1|||
23610258|NCT01562275|65962711|FG005|Stage 1|Adverse Event|0|||
23610259|NCT01562275|65962712|FG006|Stage 1|Adverse Event|0|||
23610260|NCT01562275|65962713|FG007|Stage 1|Adverse Event|0|||
23610261|NCT01562275|65962714|FG008|Stage 1|Adverse Event|0|||
23610262|NCT01562275|65962715|FG009|Stage 1|Adverse Event|1|||
23510489|NCT00545168|65606032|FG002|Overall Study|Withdrawal by Subject|13|||
23510490|NCT00545168|65606030|FG000|Overall Study|Protocol Violation|1|||
23510491|NCT00545168|65606031|FG001|Overall Study|Protocol Violation|0|||
23510492|NCT00545168|65606032|FG002|Overall Study|Protocol Violation|1|||
23510493|NCT00545168|65606030|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
23510494|NCT00545168|65606031|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
23510495|NCT00545168|65606032|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
23510496|NCT02617628|65606033|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
23510497|NCT02617628|65606034|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
23510498|NCT00848081|65606035|FG000|Overall Study|Adverse Event|6|||
23510499|NCT00848081|65606036|FG001|Overall Study|Adverse Event|7|||
23510500|NCT00848081|65606035|FG000|Overall Study|Protocol Violation|8|||
23610263|NCT01562275|65962716|FG010|Stage 1|Adverse Event|0|||
23610264|NCT01562275|65962717|FG011|Stage 1|Adverse Event|0|||
23610265|NCT01562275|65962718|FG012|Stage 1|Adverse Event|0|||
23610266|NCT01562275|65962706|FG000|Stage 1|Death|1|||
23610267|NCT01562275|65962707|FG001|Stage 1|Death|0|||
23610268|NCT01562275|65962708|FG002|Stage 1|Death|0|||
23610269|NCT01562275|65962709|FG003|Stage 1|Death|0|||
23610270|NCT01562275|65962710|FG004|Stage 1|Death|0|||
23610271|NCT01562275|65962711|FG005|Stage 1|Death|0|||
23610272|NCT01562275|65962712|FG006|Stage 1|Death|0|||
23610273|NCT01562275|65962713|FG007|Stage 1|Death|0|||
23610274|NCT01562275|65962714|FG008|Stage 1|Death|0|||
23610275|NCT01562275|65962715|FG009|Stage 1|Death|0|||
23610276|NCT01562275|65962716|FG010|Stage 1|Death|0|||
23510501|NCT00848081|65606036|FG001|Overall Study|Protocol Violation|5|||
23510502|NCT00848081|65606035|FG000|Overall Study|Lost to Follow-up|1|||
23610277|NCT01562275|65962717|FG011|Stage 1|Death|0|||
23610278|NCT01562275|65962718|FG012|Stage 1|Death|0|||
23610279|NCT01562275|65962706|FG000|Stage 1|Non Compliance|0|||
23610280|NCT01562275|65962707|FG001|Stage 1|Non Compliance|0|||
23610281|NCT01562275|65962708|FG002|Stage 1|Non Compliance|1|||
23610282|NCT01562275|65962709|FG003|Stage 1|Non Compliance|0|||
23610283|NCT01562275|65962710|FG004|Stage 1|Non Compliance|0|||
23610284|NCT01562275|65962711|FG005|Stage 1|Non Compliance|0|||
23610285|NCT01562275|65962712|FG006|Stage 1|Non Compliance|0|||
23610286|NCT01562275|65962713|FG007|Stage 1|Non Compliance|0|||
23610287|NCT01562275|65962714|FG008|Stage 1|Non Compliance|0|||
23610288|NCT01562275|65962715|FG009|Stage 1|Non Compliance|0|||
23610289|NCT01562275|65962716|FG010|Stage 1|Non Compliance|0|||
23610290|NCT01562275|65962717|FG011|Stage 1|Non Compliance|0|||
23610291|NCT01562275|65962718|FG012|Stage 1|Non Compliance|0|||
23610292|NCT01562275|65962706|FG000|Stage 1|Physician Decision|0|||
23610293|NCT01562275|65962707|FG001|Stage 1|Physician Decision|0|||
23610294|NCT01562275|65962708|FG002|Stage 1|Physician Decision|0|||
23610295|NCT01562275|65962709|FG003|Stage 1|Physician Decision|0|||
23610296|NCT01562275|65962710|FG004|Stage 1|Physician Decision|1|||
23610297|NCT01562275|65962711|FG005|Stage 1|Physician Decision|0|||
23610298|NCT01562275|65962712|FG006|Stage 1|Physician Decision|1|||
23610299|NCT01562275|65962713|FG007|Stage 1|Physician Decision|0|||
23610300|NCT01562275|65962714|FG008|Stage 1|Physician Decision|1|||
23610301|NCT01562275|65962715|FG009|Stage 1|Physician Decision|0|||
23610302|NCT01562275|65962716|FG010|Stage 1|Physician Decision|0|||
23610303|NCT01562275|65962717|FG011|Stage 1|Physician Decision|0|||
23610304|NCT01562275|65962718|FG012|Stage 1|Physician Decision|0|||
23610305|NCT01562275|65962706|FG000|Stage 1|Progression of Disease|2|||
23610306|NCT01562275|65962707|FG001|Stage 1|Progression of Disease|6|||
23610307|NCT01562275|65962708|FG002|Stage 1|Progression of Disease|2|||
23610308|NCT01562275|65962709|FG003|Stage 1|Progression of Disease|1|||
23610309|NCT01562275|65962710|FG004|Stage 1|Progression of Disease|2|||
23610310|NCT01562275|65962711|FG005|Stage 1|Progression of Disease|4|||
23610311|NCT01562275|65962712|FG006|Stage 1|Progression of Disease|1|||
23610312|NCT01562275|65962713|FG007|Stage 1|Progression of Disease|7|||
23610313|NCT01562275|65962714|FG008|Stage 1|Progression of Disease|2|||
23610314|NCT01562275|65962715|FG009|Stage 1|Progression of Disease|5|||
23610315|NCT01562275|65962716|FG010|Stage 1|Progression of Disease|3|||
23610316|NCT01562275|65962717|FG011|Stage 1|Progression of Disease|0|||
23610317|NCT01562275|65962718|FG012|Stage 1|Progression of Disease|0|||
23610318|NCT01562275|65962706|FG000|Stage 1|Withdrawal by Subject|0|||
23610319|NCT01562275|65962707|FG001|Stage 1|Withdrawal by Subject|1|||
23610320|NCT01562275|65962708|FG002|Stage 1|Withdrawal by Subject|0|||
23610321|NCT01562275|65962709|FG003|Stage 1|Withdrawal by Subject|2|||
23610322|NCT01562275|65962710|FG004|Stage 1|Withdrawal by Subject|0|||
23610323|NCT01562275|65962711|FG005|Stage 1|Withdrawal by Subject|0|||
23610324|NCT01562275|65962712|FG006|Stage 1|Withdrawal by Subject|1|||
23610325|NCT01562275|65962713|FG007|Stage 1|Withdrawal by Subject|0|||
23610326|NCT01562275|65962714|FG008|Stage 1|Withdrawal by Subject|0|||
23610327|NCT01562275|65962715|FG009|Stage 1|Withdrawal by Subject|1|||
23610328|NCT01562275|65962716|FG010|Stage 1|Withdrawal by Subject|0|||
23610329|NCT01562275|65962717|FG011|Stage 1|Withdrawal by Subject|0|||
23610330|NCT01562275|65962718|FG012|Stage 1|Withdrawal by Subject|0|||
23610331|NCT01562275|65962706|FG000|Stage 2|Death|0|||
23610332|NCT01562275|65962707|FG001|Stage 2|Death|0|||
23610333|NCT01562275|65962708|FG002|Stage 2|Death|0|||
23610334|NCT01562275|65962709|FG003|Stage 2|Death|0|||
23610335|NCT01562275|65962710|FG004|Stage 2|Death|0|||
23610336|NCT01562275|65962711|FG005|Stage 2|Death|0|||
23610337|NCT01562275|65962712|FG006|Stage 2|Death|0|||
23610338|NCT01562275|65962713|FG007|Stage 2|Death|0|||
23610339|NCT01562275|65962714|FG008|Stage 2|Death|0|||
23610340|NCT01562275|65962715|FG009|Stage 2|Death|0|||
23610341|NCT01562275|65962716|FG010|Stage 2|Death|0|||
23610342|NCT01562275|65962717|FG011|Stage 2|Death|2|||
23610343|NCT01562275|65962718|FG012|Stage 2|Death|1|||
23610344|NCT01562275|65962706|FG000|Stage 2|Progression of Disease|0|||
23610345|NCT01562275|65962707|FG001|Stage 2|Progression of Disease|0|||
23610346|NCT01562275|65962708|FG002|Stage 2|Progression of Disease|0|||
23610347|NCT01562275|65962709|FG003|Stage 2|Progression of Disease|0|||
23610348|NCT01562275|65962710|FG004|Stage 2|Progression of Disease|0|||
23610349|NCT01562275|65962711|FG005|Stage 2|Progression of Disease|0|||
23610350|NCT01562275|65962712|FG006|Stage 2|Progression of Disease|0|||
23610351|NCT01562275|65962713|FG007|Stage 2|Progression of Disease|0|||
23610352|NCT01562275|65962714|FG008|Stage 2|Progression of Disease|0|||
23610353|NCT01562275|65962715|FG009|Stage 2|Progression of Disease|0|||
23610354|NCT01562275|65962716|FG010|Stage 2|Progression of Disease|0|||
23610355|NCT01562275|65962717|FG011|Stage 2|Progression of Disease|12|||
23610356|NCT01562275|65962718|FG012|Stage 2|Progression of Disease|4|||
23610357|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
23610358|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
23610359|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
23610360|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
23610361|NCT02163499|65962729|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
23610362|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
23610363|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
23610364|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
23610365|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
23610366|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
23610367|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
23610368|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
23610369|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
23610370|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
23610371|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Death|8|||
23610372|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
23610373|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
23610374|NCT02163499|65962729|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
23610375|NCT00042939|65962733|FG000|Overall Study|Adverse Event|6|||
23610376|NCT00042939|65962734|FG001|Overall Study|Adverse Event|7|||
23610377|NCT00042939|65962733|FG000|Overall Study|Death|3|||
23610378|NCT00042939|65962734|FG001|Overall Study|Death|2|||
23510503|NCT00848081|65606036|FG001|Overall Study|Lost to Follow-up|0|||
23610379|NCT00042939|65962733|FG000|Overall Study|Withdrawal by Subject|3|||
23610380|NCT00042939|65962734|FG001|Overall Study|Withdrawal by Subject|4|||
23610381|NCT00042939|65962733|FG000|Overall Study|Other disease|1|||
23610382|NCT00042939|65962734|FG001|Overall Study|Other disease|0|||
23408600|NCT02141672|65239932|FG002|Overall Study|refused to follow-up|1|||
23610383|NCT00042939|65962733|FG000|Overall Study|Ineligible|2|||
23610384|NCT00042939|65962734|FG001|Overall Study|Ineligible|2|||
23610385|NCT00042939|65962733|FG000|Overall Study|Deterioration of health|3|||
23610386|NCT00042939|65962734|FG001|Overall Study|Deterioration of health|4|||
23610387|NCT00042939|65962733|FG000|Overall Study|QOL diminished|1|||
23610388|NCT00042939|65962734|FG001|Overall Study|QOL diminished|0|||
23610389|NCT00042939|65962733|FG000|Overall Study|Rising ca 19-9|1|||
23408601|NCT01766037|65239938|FG000|Overall Study|Adverse Event|1|||
23610390|NCT00042939|65962734|FG001|Overall Study|Rising ca 19-9|0|||
23610391|NCT00042939|65962733|FG000|Overall Study|Patient non-compliance|1|||
23610392|NCT00042939|65962734|FG001|Overall Study|Patient non-compliance|0|||
23610393|NCT00042939|65962733|FG000|Overall Study|Still on treatment|1|||
23610394|NCT00042939|65962734|FG001|Overall Study|Still on treatment|0|||
23610395|NCT00042939|65962733|FG000|Overall Study|Treatment break > 4 weeks|0|||
23610396|NCT00042939|65962734|FG001|Overall Study|Treatment break > 4 weeks|1|||
23610397|NCT00042939|65962733|FG000|Overall Study|Did not start treatment|2|||
23610398|NCT00042939|65962734|FG001|Overall Study|Did not start treatment|1|||
23610399|NCT00905255|65962735|FG000|Overall Study|Adverse Event|7|||
23610400|NCT00905255|65962736|FG001|Overall Study|Adverse Event|5|||
23610401|NCT00905255|65962735|FG000|Overall Study|Withdrawal by Subject|5|||
23610402|NCT00905255|65962736|FG001|Overall Study|Withdrawal by Subject|4|||
23510504|NCT00848081|65606035|FG000|Overall Study|Physician Decision|0|||
23610403|NCT00905255|65962735|FG000|Overall Study|Familial and Personal Reasons|1|||
23610404|NCT00905255|65962736|FG001|Overall Study|Familial and Personal Reasons|0|||
23610405|NCT01241448|65962737|FG000|Overall Study|Adverse Event|1|||
23510505|NCT00848081|65606036|FG001|Overall Study|Physician Decision|3|||
23510506|NCT00848081|65606035|FG000|Overall Study|Withdrawal by Subject|5|||
23510507|NCT00848081|65606036|FG001|Overall Study|Withdrawal by Subject|3|||
23510508|NCT01995825|65606041|FG000|Overall Study|Withdrawal by Subject|1|||
23510509|NCT01995825|65606042|FG001|Overall Study|Withdrawal by Subject|0|||
23510510|NCT01648205|65606043|FG000|Placebo|Pregnancy|1|||
23510511|NCT01648205|65606043|FG000|Placebo|Withdrawal by Subject|1|||
23510512|NCT01648205|65606043|FG000|Placebo|Protocol Violation|2|||
23510513|NCT01648205|65606043|FG000|Ranolazine|Death|1|||
23510514|NCT01648205|65606043|FG000|Ranolazine|Withdrawal by Subject|1|||
23510515|NCT01648205|65606043|FG000|Ranolazine|Protocol Violation|3|||
23510516|NCT00477971|65606044|FG000|Overall Study|Disease progression|6|||
23510517|NCT00477971|65606045|FG001|Overall Study|Disease progression|0|||
23610406|NCT01241448|65962738|FG001|Overall Study|Adverse Event|0|||
23610407|NCT01241448|65962739|FG002|Overall Study|Adverse Event|2|||
23610408|NCT01241448|65962740|FG003|Overall Study|Adverse Event|2|||
23610409|NCT01241448|65962737|FG000|Overall Study|Lost to Follow-up|2|||
23610410|NCT01241448|65962738|FG001|Overall Study|Lost to Follow-up|1|||
23610411|NCT01241448|65962739|FG002|Overall Study|Lost to Follow-up|1|||
23610412|NCT01241448|65962740|FG003|Overall Study|Lost to Follow-up|1|||
23610413|NCT01241448|65962737|FG000|Overall Study|Physician Decision|0|||
23610414|NCT01241448|65962738|FG001|Overall Study|Physician Decision|2|||
23610415|NCT01241448|65962739|FG002|Overall Study|Physician Decision|0|||
23510518|NCT00477971|65606044|FG000|Overall Study|Withdrawal by Subject|3|||
23510519|NCT00477971|65606045|FG001|Overall Study|Withdrawal by Subject|1|||
23510520|NCT00477971|65606044|FG000|Overall Study|Adverse Event|3|||
23510521|NCT00477971|65606045|FG001|Overall Study|Adverse Event|0|||
23510522|NCT00477971|65606044|FG000|Overall Study|Death|2|||
23510523|NCT00477971|65606045|FG001|Overall Study|Death|4|||
23510524|NCT00477971|65606044|FG000|Overall Study|Alternative treatment|3|||
23510525|NCT00477971|65606045|FG001|Overall Study|Alternative treatment|1|||
23510526|NCT03055260|65606057|FG000|Overall Study|Withdrawal by Subject|1|||
23510527|NCT03055260|65606058|FG001|Overall Study|Withdrawal by Subject|0|||
23510528|NCT02674529|65606059|FG000|Overall Study|Lost to Follow-up|1|||
23510529|NCT02674529|65606060|FG001|Overall Study|Lost to Follow-up|2|||
23510530|NCT02674529|65606059|FG000|Overall Study|Withdrawal by Subject|2|||
23510531|NCT02674529|65606060|FG001|Overall Study|Withdrawal by Subject|1|||
23510532|NCT02674529|65606059|FG000|Overall Study|Physician Decision|0|||
23510533|NCT02674529|65606060|FG001|Overall Study|Physician Decision|1|||
23510534|NCT02674529|65606059|FG000|Overall Study|Protocol Violation|0|||
23510535|NCT02674529|65606060|FG001|Overall Study|Protocol Violation|1|||
23510536|NCT00390858|65606066|FG000|Overall Study|Adverse Event|6|||
23510537|NCT00390858|65606067|FG001|Overall Study|Adverse Event|2|||
23510538|NCT00390858|65606066|FG000|Overall Study|Lack of Efficacy|0|||
23510539|NCT00390858|65606067|FG001|Overall Study|Lack of Efficacy|1|||
23510540|NCT00390858|65606066|FG000|Overall Study|Withdrawal by Subject|3|||
23510541|NCT00390858|65606067|FG001|Overall Study|Withdrawal by Subject|4|||
23510542|NCT00667368|65606076|FG000|Overall Study|Lost to Follow-up|176|||
23510543|NCT00667368|65606077|FG001|Overall Study|Lost to Follow-up|155|||
23510544|NCT00667368|65606076|FG000|Overall Study|Discontinued early|24|||
23510545|NCT00667368|65606077|FG001|Overall Study|Discontinued early|17|||
23510546|NCT01782495|65606078|FG000|Overall Study|Adverse Event|0|||
23510547|NCT01782495|65606079|FG001|Overall Study|Adverse Event|0|||
23510548|NCT01782495|65606080|FG002|Overall Study|Adverse Event|0|||
23510549|NCT01782495|65606081|FG003|Overall Study|Adverse Event|0|||
23510550|NCT01782495|65606082|FG004|Overall Study|Adverse Event|0|||
23510551|NCT01782495|65606083|FG005|Overall Study|Adverse Event|0|||
23510552|NCT01782495|65606084|FG006|Overall Study|Adverse Event|0|||
23510553|NCT01782495|65606085|FG007|Overall Study|Adverse Event|2|||
23510554|NCT01782495|65606086|FG008|Overall Study|Adverse Event|0|||
23510555|NCT01782495|65606087|FG009|Overall Study|Adverse Event|0|||
23510556|NCT01782495|65606088|FG010|Overall Study|Adverse Event|0|||
23510557|NCT01782495|65606078|FG000|Overall Study|Withdrew Consent|0|||
23510558|NCT01782495|65606079|FG001|Overall Study|Withdrew Consent|1|||
23510559|NCT01782495|65606080|FG002|Overall Study|Withdrew Consent|0|||
23510560|NCT01782495|65606081|FG003|Overall Study|Withdrew Consent|0|||
23510561|NCT01782495|65606082|FG004|Overall Study|Withdrew Consent|0|||
23610416|NCT01241448|65962740|FG003|Overall Study|Physician Decision|0|||
23610417|NCT01241448|65962737|FG000|Overall Study|Protocol Violation|10|||
23610418|NCT01241448|65962738|FG001|Overall Study|Protocol Violation|5|||
23610419|NCT01241448|65962739|FG002|Overall Study|Protocol Violation|3|||
23610420|NCT01241448|65962740|FG003|Overall Study|Protocol Violation|6|||
23610421|NCT01241448|65962737|FG000|Overall Study|Sponsor Decision|17|||
23610422|NCT01241448|65962738|FG001|Overall Study|Sponsor Decision|14|||
23610423|NCT01241448|65962739|FG002|Overall Study|Sponsor Decision|12|||
23610424|NCT01241448|65962740|FG003|Overall Study|Sponsor Decision|6|||
23610425|NCT01241448|65962737|FG000|Overall Study|Withdrawal by Subject|4|||
23610426|NCT01241448|65962738|FG001|Overall Study|Withdrawal by Subject|5|||
23610427|NCT01241448|65962739|FG002|Overall Study|Withdrawal by Subject|3|||
23610428|NCT01241448|65962740|FG003|Overall Study|Withdrawal by Subject|6|||
23610429|NCT01241448|65962737|FG000|Overall Study|Excluded due to data integrity issues|3|||
23610430|NCT01241448|65962738|FG001|Overall Study|Excluded due to data integrity issues|2|||
23610431|NCT01241448|65962739|FG002|Overall Study|Excluded due to data integrity issues|2|||
23610432|NCT01241448|65962740|FG003|Overall Study|Excluded due to data integrity issues|2|||
23610433|NCT02691702|65962741|FG000|Overall Study|Adverse Event|1|||
23610434|NCT02691702|65962742|FG001|Overall Study|Adverse Event|0|||
23610435|NCT02691702|65962743|FG002|Overall Study|Adverse Event|0|||
23610436|NCT02691702|65962744|FG003|Overall Study|Adverse Event|0|||
23610437|NCT02691702|65962745|FG004|Overall Study|Adverse Event|0|||
23610438|NCT02691702|65962746|FG005|Overall Study|Adverse Event|0|||
23610439|NCT02691702|65962747|FG006|Overall Study|Adverse Event|0|||
23610440|NCT02691702|65962748|FG007|Overall Study|Adverse Event|0|||
23610441|NCT02691702|65962749|FG008|Overall Study|Adverse Event|1|||
23610442|NCT02691702|65962750|FG009|Overall Study|Adverse Event|0|||
23610443|NCT02691702|65962751|FG010|Overall Study|Adverse Event|1|||
23610444|NCT02691702|65962741|FG000|Overall Study|Lost to Follow-up|0|||
23610445|NCT02691702|65962742|FG001|Overall Study|Lost to Follow-up|0|||
23610446|NCT02691702|65962743|FG002|Overall Study|Lost to Follow-up|1|||
23610447|NCT02691702|65962744|FG003|Overall Study|Lost to Follow-up|0|||
23610448|NCT02691702|65962745|FG004|Overall Study|Lost to Follow-up|0|||
23610449|NCT02691702|65962746|FG005|Overall Study|Lost to Follow-up|2|||
23610450|NCT02691702|65962747|FG006|Overall Study|Lost to Follow-up|0|||
23610451|NCT02691702|65962748|FG007|Overall Study|Lost to Follow-up|0|||
23610452|NCT02691702|65962749|FG008|Overall Study|Lost to Follow-up|0|||
23610453|NCT02691702|65962750|FG009|Overall Study|Lost to Follow-up|0|||
23610454|NCT02691702|65962751|FG010|Overall Study|Lost to Follow-up|1|||
23610455|NCT02691702|65962741|FG000|Overall Study|Withdrawal by Subject|1|||
23610456|NCT02691702|65962742|FG001|Overall Study|Withdrawal by Subject|1|||
23610457|NCT02691702|65962743|FG002|Overall Study|Withdrawal by Subject|0|||
23510562|NCT01782495|65606083|FG005|Overall Study|Withdrew Consent|0|||
23510563|NCT01782495|65606084|FG006|Overall Study|Withdrew Consent|0|||
23510564|NCT01782495|65606085|FG007|Overall Study|Withdrew Consent|1|||
23510565|NCT01782495|65606086|FG008|Overall Study|Withdrew Consent|0|||
23510566|NCT01782495|65606087|FG009|Overall Study|Withdrew Consent|0|||
23510567|NCT01782495|65606088|FG010|Overall Study|Withdrew Consent|0|||
23510568|NCT00005937|65606092|FG000|Overall Study|Lack of Efficacy|5|||
23510569|NCT00609492|65606094|FG000|Overall Study|Withdrawal by Subject|0|||
23510570|NCT00609492|65606095|FG001|Overall Study|Withdrawal by Subject|2|||
23510571|NCT00609492|65606096|FG002|Overall Study|Withdrawal by Subject|3|||
23510572|NCT00609492|65606094|FG000|Overall Study|Lost to Follow-up|1|||
23510573|NCT00609492|65606095|FG001|Overall Study|Lost to Follow-up|1|||
23510574|NCT00609492|65606096|FG002|Overall Study|Lost to Follow-up|4|||
23510575|NCT00759031|65606097|FG000|First Intervention (1 Day)|Physician Decision|1|||
23510576|NCT00759031|65606098|FG001|First Intervention (1 Day)|Physician Decision|0|||
23510577|NCT00759031|65606097|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
23510578|NCT00759031|65606098|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
23510579|NCT00759031|65606097|FG000|First Intervention (1 Day)|Screening failure|1|||
23510580|NCT00759031|65606098|FG001|First Intervention (1 Day)|Screening failure|0|||
23510581|NCT00911820|65606105|FG000|Overall Study|RECIST progression|12|||
23510582|NCT00911820|65606106|FG001|Overall Study|RECIST progression|8|||
23510583|NCT00911820|65606105|FG000|Overall Study|Adverse Event|8|||
23510584|NCT00911820|65606106|FG001|Overall Study|Adverse Event|8|||
23510585|NCT00911820|65606105|FG000|Overall Study|Clinical Progression|7|||
23510586|NCT00911820|65606106|FG001|Overall Study|Clinical Progression|5|||
23510587|NCT00911820|65606105|FG000|Overall Study|Physician Decision|5|||
23510588|NCT00911820|65606106|FG001|Overall Study|Physician Decision|9|||
23510589|NCT00911820|65606105|FG000|Overall Study|Decline in Performance Status|4|||
23510590|NCT00911820|65606106|FG001|Overall Study|Decline in Performance Status|2|||
23510591|NCT00911820|65606105|FG000|Overall Study|Withdrawal by Subject|3|||
23510592|NCT00911820|65606106|FG001|Overall Study|Withdrawal by Subject|4|||
23510593|NCT00911820|65606105|FG000|Overall Study|Death|1|||
23610458|NCT02691702|65962744|FG003|Overall Study|Withdrawal by Subject|0|||
23610459|NCT02691702|65962745|FG004|Overall Study|Withdrawal by Subject|0|||
23610460|NCT02691702|65962746|FG005|Overall Study|Withdrawal by Subject|1|||
23610461|NCT02691702|65962747|FG006|Overall Study|Withdrawal by Subject|2|||
23610462|NCT02691702|65962748|FG007|Overall Study|Withdrawal by Subject|0|||
23610463|NCT02691702|65962749|FG008|Overall Study|Withdrawal by Subject|0|||
23610464|NCT02691702|65962750|FG009|Overall Study|Withdrawal by Subject|0|||
23610465|NCT02691702|65962751|FG010|Overall Study|Withdrawal by Subject|0|||
23510594|NCT00911820|65606106|FG001|Overall Study|Death|2|||
23510595|NCT00911820|65606105|FG000|Overall Study|Pursue surgery|1|||
23510596|NCT00911820|65606106|FG001|Overall Study|Pursue surgery|1|||
23510597|NCT00911820|65606105|FG000|Overall Study|Pursue Radiation|1|||
23510598|NCT00911820|65606106|FG001|Overall Study|Pursue Radiation|0|||
23510599|NCT00911820|65606105|FG000|Overall Study|Still on Therapy|2|||
23510600|NCT00911820|65606106|FG001|Overall Study|Still on Therapy|2|||
23510601|NCT00911820|65606105|FG000|Overall Study|Pathology Not Confirmed|1|||
23510602|NCT00911820|65606106|FG001|Overall Study|Pathology Not Confirmed|0|||
23510603|NCT00911820|65606105|FG000|Overall Study|Withdraw before Receive Treatment|0|||
23510604|NCT00911820|65606106|FG001|Overall Study|Withdraw before Receive Treatment|2|||
23610466|NCT02691702|65962741|FG000|Overall Study|Other|0|||
23610467|NCT02691702|65962742|FG001|Overall Study|Other|0|||
23610468|NCT02691702|65962743|FG002|Overall Study|Other|0|||
23610469|NCT02691702|65962744|FG003|Overall Study|Other|0|||
23610470|NCT02691702|65962745|FG004|Overall Study|Other|0|||
23610471|NCT02691702|65962746|FG005|Overall Study|Other|0|||
23610472|NCT02691702|65962747|FG006|Overall Study|Other|1|||
23610473|NCT02691702|65962748|FG007|Overall Study|Other|0|||
23610474|NCT02691702|65962749|FG008|Overall Study|Other|1|||
23610475|NCT02691702|65962750|FG009|Overall Study|Other|0|||
23610476|NCT02691702|65962751|FG010|Overall Study|Other|0|||
23610477|NCT02691702|65962741|FG000|Overall Study|Protocol Violation|0|||
23610478|NCT02691702|65962742|FG001|Overall Study|Protocol Violation|0|||
23610479|NCT02691702|65962743|FG002|Overall Study|Protocol Violation|0|||
23610480|NCT02691702|65962744|FG003|Overall Study|Protocol Violation|0|||
23610481|NCT02691702|65962745|FG004|Overall Study|Protocol Violation|0|||
23610482|NCT02691702|65962746|FG005|Overall Study|Protocol Violation|0|||
23610483|NCT02691702|65962747|FG006|Overall Study|Protocol Violation|0|||
23610484|NCT02691702|65962748|FG007|Overall Study|Protocol Violation|0|||
23610485|NCT02691702|65962749|FG008|Overall Study|Protocol Violation|0|||
23610486|NCT02691702|65962750|FG009|Overall Study|Protocol Violation|2|||
23610487|NCT02691702|65962751|FG010|Overall Study|Protocol Violation|0|||
23610488|NCT02659059|65962757|FG000|Overall Study|Other reasons|6|||
23610489|NCT02659059|65962758|FG001|Overall Study|Other reasons|1|||
23610490|NCT02659059|65962757|FG000|Overall Study|Disease Progression|143|||
23610491|NCT02659059|65962758|FG001|Overall Study|Disease Progression|16|||
23610492|NCT02659059|65962757|FG000|Overall Study|Study Drug toxicity|56|||
23610493|NCT02659059|65962758|FG001|Overall Study|Study Drug toxicity|9|||
23610494|NCT02659059|65962757|FG000|Overall Study|Death|3|||
23610495|NCT02659059|65962758|FG001|Overall Study|Death|1|||
23610496|NCT02659059|65962757|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
23610497|NCT02659059|65962758|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
23610498|NCT02659059|65962757|FG000|Overall Study|Participant request to discontinue study treatment|5|||
23610499|NCT02659059|65962758|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23610500|NCT02659059|65962757|FG000|Overall Study|Participant withdrew consent|6|||
23610501|NCT02659059|65962758|FG001|Overall Study|Participant withdrew consent|1|||
23610502|NCT03928821|65962768|FG000|Overall Study|Death|0|||
23610503|NCT03928821|65962769|FG001|Overall Study|Death|1|||
23610504|NCT03928821|65962770|FG002|Overall Study|Death|0|||
23610505|NCT03928821|65962771|FG003|Overall Study|Death|0|||
23610506|NCT03928821|65962768|FG000|Overall Study|Lost to Follow-up|0|||
23610507|NCT03928821|65962769|FG001|Overall Study|Lost to Follow-up|2|||
23610508|NCT03928821|65962770|FG002|Overall Study|Lost to Follow-up|3|||
23610509|NCT03928821|65962771|FG003|Overall Study|Lost to Follow-up|0|||
23610510|NCT03928821|65962768|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23610511|NCT03928821|65962769|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23610512|NCT03928821|65962770|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23610513|NCT03928821|65962771|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
23610514|NCT02889809|65962772|FG000|Overall Study|Withdrawal by Subject|30|||
23610515|NCT02889809|65962773|FG001|Overall Study|Withdrawal by Subject|21|||
23610516|NCT02889809|65962772|FG000|Overall Study|Lost to Follow-up|1|||
23610517|NCT02889809|65962773|FG001|Overall Study|Lost to Follow-up|1|||
23610518|NCT02889809|65962772|FG000|Overall Study|Site Closed|12|||
23610519|NCT02889809|65962773|FG001|Overall Study|Site Closed|11|||
23610520|NCT00396409|65962774|FG000|Period 1 - 2007|Adverse Event|0|||
23610521|NCT00396409|65962775|FG001|Period 1 - 2007|Adverse Event|1|||
23510605|NCT01581931|65606108|FG000|Washout|Adverse Event|0|||
23510606|NCT01581931|65606109|FG001|Washout|Adverse Event|1|||
23510607|NCT02835820|65606110|FG000|Overall Study|Baseline Screen Failure|0|||
23610522|NCT00396409|65962774|FG000|Period 1 - 2007|Lack of Efficacy|0|||
23610523|NCT00396409|65962775|FG001|Period 1 - 2007|Lack of Efficacy|1|||
23610524|NCT00396409|65962774|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
23610525|NCT00396409|65962775|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
23610526|NCT00396409|65962774|FG000|Period 1 - 2007|Lost to Follow-up|2|||
23610527|NCT00396409|65962775|FG001|Period 1 - 2007|Lost to Follow-up|3|||
23610528|NCT00396409|65962774|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
23610529|NCT00396409|65962775|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
23610530|NCT00396409|65962774|FG000|Period 2 - 2008|Protocol Violation|1|||
23510608|NCT02835820|65606111|FG001|Overall Study|Baseline Screen Failure|3|||
23510609|NCT00938639|65606123|FG000|Overall Study|Moved away from study area|0|||
23510610|NCT00938639|65606124|FG001|Overall Study|Moved away from study area|1|||
23510611|NCT00938639|65606123|FG000|Overall Study|Lost to Follow-up|1|||
23510612|NCT00938639|65606124|FG001|Overall Study|Lost to Follow-up|2|||
23510613|NCT00938639|65606123|FG000|Overall Study|Family issues|1|||
23510614|NCT00938639|65606124|FG001|Overall Study|Family issues|1|||
23510615|NCT00938639|65606123|FG000|Overall Study|Participant noncompliance|1|||
23510616|NCT00938639|65606124|FG001|Overall Study|Participant noncompliance|0|||
23510617|NCT04557371|65606125|FG000|Overall Study|Covid-19-related|0|||
23510618|NCT04557371|65606126|FG001|Overall Study|Covid-19-related|1|||
23510619|NCT04557371|65606127|FG002|Overall Study|Covid-19-related|0|||
23510620|NCT04557371|65606125|FG000|Overall Study|Withdrawal by Subject|0|||
23510621|NCT04557371|65606126|FG001|Overall Study|Withdrawal by Subject|1|||
23510622|NCT04557371|65606127|FG002|Overall Study|Withdrawal by Subject|0|||
23510623|NCT04557371|65606125|FG000|Overall Study|Adverse Event|1|||
23510624|NCT04557371|65606126|FG001|Overall Study|Adverse Event|0|||
23510625|NCT04557371|65606127|FG002|Overall Study|Adverse Event|0|||
23510626|NCT02407704|65606128|FG000|Overall Study|Lost to Follow-up|0|||
23510627|NCT02407704|65606129|FG001|Overall Study|Lost to Follow-up|0|||
23510628|NCT02407704|65606130|FG002|Overall Study|Lost to Follow-up|0|||
23510629|NCT02407704|65606131|FG003|Overall Study|Lost to Follow-up|2|||
23510630|NCT02407704|65606128|FG000|Overall Study|Protocol Violation|0|||
23510631|NCT02407704|65606129|FG001|Overall Study|Protocol Violation|0|||
23510632|NCT02407704|65606130|FG002|Overall Study|Protocol Violation|0|||
23510633|NCT02407704|65606131|FG003|Overall Study|Protocol Violation|1|||
23610531|NCT00396409|65962775|FG001|Period 2 - 2008|Protocol Violation|0|||
23610532|NCT00396409|65962774|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
23510634|NCT02407704|65606128|FG000|Overall Study|Withdrawal by Subject|0|||
23510635|NCT02407704|65606129|FG001|Overall Study|Withdrawal by Subject|0|||
23510636|NCT02407704|65606130|FG002|Overall Study|Withdrawal by Subject|1|||
23510637|NCT02407704|65606131|FG003|Overall Study|Withdrawal by Subject|0|||
23510638|NCT00553514|65606132|FG000|Overall Study|Protocol deviation|0|||
23510639|NCT00553514|65606133|FG001|Overall Study|Protocol deviation|0|||
23510640|NCT00553514|65606134|FG002|Overall Study|Protocol deviation|0|||
23510641|NCT00553514|65606135|FG003|Overall Study|Protocol deviation|1|||
23510642|NCT00553514|65606136|FG004|Overall Study|Protocol deviation|0|||
23510643|NCT00553514|65606132|FG000|Overall Study|Lack of ovarian response|4|||
23510644|NCT00553514|65606133|FG001|Overall Study|Lack of ovarian response|5|||
23510645|NCT00553514|65606134|FG002|Overall Study|Lack of ovarian response|5|||
23510646|NCT00553514|65606135|FG003|Overall Study|Lack of ovarian response|5|||
23510647|NCT00553514|65606136|FG004|Overall Study|Lack of ovarian response|6|||
23510648|NCT00553514|65606132|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
23510649|NCT00553514|65606133|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
23510650|NCT00553514|65606134|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23510651|NCT00553514|65606135|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
23510652|NCT00553514|65606136|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
23510653|NCT00553514|65606132|FG000|Overall Study|Risk of multiple pregnancy|0|||
23510654|NCT00553514|65606133|FG001|Overall Study|Risk of multiple pregnancy|2|||
23510655|NCT00553514|65606134|FG002|Overall Study|Risk of multiple pregnancy|0|||
23610533|NCT00396409|65962775|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
23510656|NCT00553514|65606135|FG003|Overall Study|Risk of multiple pregnancy|1|||
23610534|NCT00396409|65962774|FG000|Period 2 - 2008|Lost to Follow-up|3|||
23610535|NCT00396409|65962775|FG001|Period 2 - 2008|Lost to Follow-up|1|||
23610536|NCT04454125|65962776|FG000|Overall Study|Lost to Follow-up|0|||
23610537|NCT04454125|65962777|FG001|Overall Study|Lost to Follow-up|1|||
23610538|NCT03508830|65962778|FG000|Overall Study|Withdrawal by Subject|3|||
23610539|NCT03508830|65962779|FG001|Overall Study|Withdrawal by Subject|4|||
23610540|NCT03508830|65962778|FG000|Overall Study|Physician Decision|2|||
23610541|NCT03508830|65962779|FG001|Overall Study|Physician Decision|2|||
23510657|NCT00553514|65606136|FG004|Overall Study|Risk of multiple pregnancy|0|||
23510658|NCT00553514|65606132|FG000|Overall Study|Other|1|||
23510659|NCT00553514|65606133|FG001|Overall Study|Other|1|||
23510660|NCT00553514|65606134|FG002|Overall Study|Other|0|||
23510661|NCT00553514|65606135|FG003|Overall Study|Other|0|||
23510662|NCT00553514|65606136|FG004|Overall Study|Other|1|||
23510663|NCT01320085|65606137|FG000|Overall Study|Disease Progression|26|||
23510664|NCT01320085|65606138|FG001|Overall Study|Disease Progression|93|||
23610542|NCT01215253|65962784|FG000|Overall Study|Withdrawal by Subject|57|||
23610543|NCT01215253|65962785|FG001|Overall Study|Withdrawal by Subject|35|||
23610544|NCT01215253|65962784|FG000|Overall Study|Physician Decision|9|||
23610545|NCT01215253|65962785|FG001|Overall Study|Physician Decision|12|||
23510665|NCT01320085|65606139|FG002|Overall Study|Disease Progression|17|||
23510666|NCT01320085|65606137|FG000|Overall Study|Adverse Event|12|||
23610546|NCT01215253|65962784|FG000|Overall Study|Lost to Follow-up|6|||
23510667|NCT01320085|65606138|FG001|Overall Study|Adverse Event|20|||
23610547|NCT01215253|65962785|FG001|Overall Study|Lost to Follow-up|4|||
23610548|NCT01215253|65962784|FG000|Overall Study|Other|14|||
23610549|NCT01215253|65962785|FG001|Overall Study|Other|12|||
23610550|NCT02135445|65962792|FG000|Overall Study|Lost to Follow-up|1|||
23610551|NCT02135445|65962793|FG001|Overall Study|Lost to Follow-up|0|||
23610552|NCT02135445|65962792|FG000|Overall Study|Withdrawal by Subject|1|||
23610553|NCT02135445|65962793|FG001|Overall Study|Withdrawal by Subject|0|||
23610554|NCT02335242|65962795|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
23610555|NCT02335242|65962796|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
23610556|NCT02335242|65962795|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
23610557|NCT02335242|65962796|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23610558|NCT02335242|65962795|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
23610559|NCT02335242|65962796|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
23510668|NCT01320085|65606139|FG002|Overall Study|Adverse Event|5|||
23510669|NCT01320085|65606137|FG000|Overall Study|Withdrawal by Subject|2|||
23610560|NCT04626128|65962797|FG000|Overall Study|Withdrawal by Subject|0|||
23610561|NCT04626128|65962798|FG001|Overall Study|Withdrawal by Subject|1|||
23610562|NCT04626128|65962799|FG002|Overall Study|Withdrawal by Subject|0|||
23510670|NCT01320085|65606138|FG001|Overall Study|Withdrawal by Subject|4|||
23510671|NCT01320085|65606139|FG002|Overall Study|Withdrawal by Subject|1|||
23510672|NCT01320085|65606137|FG000|Overall Study|Protocol Deviation|1|||
23510673|NCT01320085|65606138|FG001|Overall Study|Protocol Deviation|0|||
23510674|NCT01320085|65606139|FG002|Overall Study|Protocol Deviation|1|||
23510675|NCT01320085|65606137|FG000|Overall Study|Administrative problems|0|||
23510676|NCT01320085|65606138|FG001|Overall Study|Administrative problems|0|||
23510677|NCT01320085|65606139|FG002|Overall Study|Administrative problems|1|||
23510678|NCT00967798|65606142|FG000|Overall Study|Withdrawal by Subject|5|||
23510679|NCT00967798|65606143|FG001|Overall Study|Withdrawal by Subject|2|||
23510680|NCT00967798|65606142|FG000|Overall Study|Lost to Follow-up|4|||
23510681|NCT00967798|65606143|FG001|Overall Study|Lost to Follow-up|1|||
23510682|NCT01018186|65606144|FG000|2-week Run-in Period|Protocol Violation|1|||
23510683|NCT01018186|65606145|FG001|2-week Run-in Period|Protocol Violation|0|||
23510684|NCT01018186|65606146|FG002|2-week Run-in Period|Protocol Violation|0|||
23510685|NCT01018186|65606147|FG003|2-week Run-in Period|Protocol Violation|0|||
23510686|NCT01018186|65606144|FG000|2-week Run-in Period|Lost to Follow-up|2|||
23510687|NCT01018186|65606145|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23610563|NCT04626128|65962800|FG003|Overall Study|Withdrawal by Subject|0|||
23610564|NCT01426217|65962801|FG000|Overall Study|lost sample|8|||
23610565|NCT01426217|65962802|FG001|Overall Study|lost sample|14|||
23610566|NCT01964547|65962804|FG000|Overall Study|Adverse Event|8|||
23204704|NCT01767194|64491162|FG000|Overall Study|Lack of Efficacy|12|||
23204705|NCT01767194|64491163|FG001|Overall Study|Lack of Efficacy|11|||
23204706|NCT01767194|64491162|FG000|Overall Study|Physician Decision|2|||
23204707|NCT01767194|64491163|FG001|Overall Study|Physician Decision|23|||
23204708|NCT01767194|64491162|FG000|Overall Study|Withdrawal by Subject|0|||
23204709|NCT01767194|64491163|FG001|Overall Study|Withdrawal by Subject|1|||
23204710|NCT01767194|64491162|FG000|Overall Study|Ineligible|1|||
23204711|NCT01767194|64491163|FG001|Overall Study|Ineligible|1|||
23204712|NCT01767194|64491162|FG000|Overall Study|Refusal by patient/parent|2|||
23204713|NCT01767194|64491163|FG001|Overall Study|Refusal by patient/parent|4|||
23204714|NCT01767194|64491162|FG000|Overall Study|Criteria not met on time for next cycle|0|||
23204715|NCT01767194|64491163|FG001|Overall Study|Criteria not met on time for next cycle|1|||
23204716|NCT03591146|64491164|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
23204717|NCT03591146|64491165|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
23204718|NCT03591146|64491166|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
23204719|NCT03591146|64491167|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
23204720|NCT03591146|64491168|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
23204721|NCT03591146|64491164|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
23204722|NCT03591146|64491165|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
23204723|NCT03591146|64491166|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
23204724|NCT03591146|64491167|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
23204725|NCT03591146|64491168|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
23204726|NCT03591146|64491164|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
23204727|NCT03591146|64491165|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
23204728|NCT03591146|64491166|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
23204729|NCT03591146|64491167|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
23204730|NCT03591146|64491168|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
23204731|NCT03591146|64491164|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
23204732|NCT03591146|64491165|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
23204733|NCT03591146|64491166|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
23204734|NCT03591146|64491167|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
23204735|NCT03591146|64491168|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
23204736|NCT00239837|64491169|FG000|Overall Study|Lost to Follow-up|3|||
23204737|NCT00239837|64491170|FG001|Overall Study|Lost to Follow-up|7|||
23204738|NCT00798694|64491171|FG000|Overall Study|Lost to Follow-up|1|||
23204739|NCT00798694|64491172|FG001|Overall Study|Lost to Follow-up|1|||
23204740|NCT00798694|64491171|FG000|Overall Study|Physician Decision|1|||
23204741|NCT00798694|64491172|FG001|Overall Study|Physician Decision|0|||
23204742|NCT02486952|64491177|FG000|Overall Study|Not Started Induction Therapy|3|||
23204743|NCT02486952|64491177|FG000|Overall Study|Adverse Event|1|||
23204744|NCT02486952|64491177|FG000|Overall Study|Death|15|||
23204745|NCT02486952|64491177|FG000|Overall Study|Lack of Efficacy|3|||
23204746|NCT02486952|64491177|FG000|Overall Study|Lost to Follow-up|26|||
23204747|NCT02486952|64491177|FG000|Overall Study|Other|2|||
23204748|NCT02125331|64491178|FG000|Overall Study|Protocol Violation|1|||
23204749|NCT02125331|64491179|FG001|Overall Study|Protocol Violation|0|||
23204750|NCT02125331|64491178|FG000|Overall Study|technical problem|2|||
23204751|NCT02125331|64491179|FG001|Overall Study|technical problem|0|||
23204752|NCT02125331|64491178|FG000|Overall Study|screen failure|2|||
23204753|NCT02125331|64491179|FG001|Overall Study|screen failure|0|||
23204754|NCT00418834|64491180|FG000|Overall Study|Adverse Event|16|||
23204755|NCT00418834|64491181|FG001|Overall Study|Adverse Event|9|||
23204756|NCT00418834|64491180|FG000|Overall Study|Lost to Follow-up|0|||
23204757|NCT00418834|64491181|FG001|Overall Study|Lost to Follow-up|1|||
23204758|NCT00418834|64491180|FG000|Overall Study|Protocol Violation|4|||
23204759|NCT00418834|64491181|FG001|Overall Study|Protocol Violation|3|||
23204760|NCT00418834|64491180|FG000|Overall Study|Withdrawal by Subject|3|||
23204761|NCT00418834|64491181|FG001|Overall Study|Withdrawal by Subject|7|||
23204762|NCT00788775|64491182|FG000|Overall Study|Progressive Disease|8|||
23204763|NCT00788775|64491183|FG001|Overall Study|Progressive Disease|6|||
23204764|NCT00788775|64491182|FG000|Overall Study|Withdrawal by Subject|0|||
23204765|NCT00788775|64491183|FG001|Overall Study|Withdrawal by Subject|2|||
23204766|NCT00788775|64491182|FG000|Overall Study|Patient Non-Compliance|1|||
23204767|NCT00788775|64491183|FG001|Overall Study|Patient Non-Compliance|0|||
23204768|NCT00788775|64491182|FG000|Overall Study|Patient's measurable disease resected.|1|||
23204769|NCT00788775|64491183|FG001|Overall Study|Patient's measurable disease resected.|0|||
23204770|NCT02586233|64491190|FG000|Overall Study|Randomized but did not receive treatment|0|||
23204771|NCT02586233|64491191|FG001|Overall Study|Randomized but did not receive treatment|1|||
23204772|NCT02586233|64491192|FG002|Overall Study|Randomized but did not receive treatment|0|||
23204773|NCT02586233|64491193|FG003|Overall Study|Randomized but did not receive treatment|0|||
23204774|NCT02586233|64491194|FG004|Overall Study|Randomized but did not receive treatment|0|||
23204775|NCT02586233|64491195|FG005|Overall Study|Randomized but did not receive treatment|2|||
23204776|NCT02586233|64491196|FG006|Overall Study|Randomized but did not receive treatment|2|||
23204777|NCT02586233|64491190|FG000|Overall Study|Death|0|||
23204778|NCT02586233|64491191|FG001|Overall Study|Death|1|||
23204779|NCT02586233|64491192|FG002|Overall Study|Death|0|||
23204780|NCT02586233|64491193|FG003|Overall Study|Death|0|||
23204781|NCT02586233|64491194|FG004|Overall Study|Death|2|||
23204782|NCT02586233|64491195|FG005|Overall Study|Death|0|||
23204783|NCT02586233|64491196|FG006|Overall Study|Death|0|||
23204784|NCT02918266|64491200|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
23204785|NCT02918266|64491201|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23204786|NCT02918266|64491202|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23204787|NCT02918266|64491203|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23204788|NCT02918266|64491204|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23204789|NCT02918266|64491205|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23204790|NCT02918266|64491206|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
23204791|NCT02918266|64491207|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23204792|NCT02918266|64491208|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
23204793|NCT02918266|64491209|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23204794|NCT02918266|64491210|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
23204795|NCT02625324|64491214|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
23204796|NCT02625324|64491214|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
23204797|NCT02625324|64491214|FG000|6-Month Follow-up Subject Accountability|Death|5|||
23204798|NCT02625324|64491214|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
23204799|NCT02625324|64491214|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
23204800|NCT02625324|64491214|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
23204801|NCT02625324|64491214|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
23204802|NCT02625324|64491214|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
23204803|NCT02625324|64491214|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
23204804|NCT02625324|64491214|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
23204805|NCT02625324|64491214|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
23204806|NCT02625324|64491214|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
23204807|NCT02625324|64491214|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
23204808|NCT02625324|64491214|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
23204809|NCT02625324|64491214|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
23204810|NCT02625324|64491214|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
23204811|NCT02625324|64491214|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
23204812|NCT00077376|64491215|FG000|Overall Study|Adverse Event|8|||
23204813|NCT00077376|64491215|FG000|Overall Study|Withdrawal by Subject|2|||
23204814|NCT00077376|64491215|FG000|Overall Study|Death|1|||
23204815|NCT00077376|64491215|FG000|Overall Study|Physician Decision|1|||
23204816|NCT00077376|64491215|FG000|Overall Study|Alternative therapy|5|||
23204817|NCT00077376|64491215|FG000|Overall Study|Complicating disease|1|||
23204818|NCT00077376|64491215|FG000|Overall Study|Still on treatment|1|||
23204819|NCT00077376|64491215|FG000|Overall Study|Symptomatic deterioration|1|||
23204820|NCT00077376|64491215|FG000|Overall Study|Surgery|1|||
23204821|NCT00077376|64491215|FG000|Overall Study|Insurance ran out|1|||
23204822|NCT02921919|64491216|FG000|Overall Study|Other|5|||
23204823|NCT02921919|64491217|FG001|Overall Study|Other|6|||
23204824|NCT02921919|64491216|FG000|Overall Study|Lost to Follow-up|0|||
23204825|NCT02921919|64491217|FG001|Overall Study|Lost to Follow-up|1|||
23204826|NCT02921919|64491216|FG000|Overall Study|Withdrawal by Subject|5|||
23204827|NCT02921919|64491217|FG001|Overall Study|Withdrawal by Subject|1|||
23204828|NCT02921919|64491216|FG000|Overall Study|Disease Progression|47|||
23305715|NCT01103466|64862407|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
23305716|NCT01103466|64862405|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
23305717|NCT01103466|64862406|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
23305718|NCT01103466|64862407|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
23305719|NCT01103466|64862405|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
23305720|NCT01103466|64862406|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
23305721|NCT01103466|64862407|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
23305722|NCT01103466|64862405|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
23305723|NCT01103466|64862406|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
23305724|NCT01103466|64862407|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
23305725|NCT01103466|64862405|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
23305726|NCT01103466|64862406|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
23305727|NCT01103466|64862407|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
23305728|NCT01103466|64862405|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
23305729|NCT01103466|64862406|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
23305730|NCT01103466|64862407|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
23204829|NCT02921919|64491217|FG001|Overall Study|Disease Progression|38|||
23204830|NCT02921919|64491216|FG000|Overall Study|Physician Decision|3|||
23204831|NCT02921919|64491217|FG001|Overall Study|Physician Decision|2|||
23204832|NCT02921919|64491216|FG000|Overall Study|Adverse Event|6|||
23204833|NCT02921919|64491217|FG001|Overall Study|Adverse Event|4|||
23204834|NCT01766817|64491218|FG000|Overall Study|Drug-related adverse event|1|||
23204835|NCT01766817|64491219|FG001|Overall Study|Drug-related adverse event|2|||
23204836|NCT01766817|64491220|FG002|Overall Study|Drug-related adverse event|1|||
23204837|NCT01766817|64491218|FG000|Overall Study|Drug-unrelated adverse event|3|||
23204838|NCT01766817|64491219|FG001|Overall Study|Drug-unrelated adverse event|3|||
23204839|NCT01766817|64491220|FG002|Overall Study|Drug-unrelated adverse event|3|||
23204840|NCT01766817|64491218|FG000|Overall Study|Death|1|||
23204841|NCT01766817|64491219|FG001|Overall Study|Death|1|||
23204842|NCT01766817|64491220|FG002|Overall Study|Death|0|||
23204843|NCT01766817|64491218|FG000|Overall Study|Unable to take study drug|0|||
23204844|NCT01766817|64491219|FG001|Overall Study|Unable to take study drug|1|||
23204845|NCT01766817|64491220|FG002|Overall Study|Unable to take study drug|0|||
23204846|NCT01766817|64491218|FG000|Overall Study|Withdrawal by Subject|2|||
23204847|NCT01766817|64491219|FG001|Overall Study|Withdrawal by Subject|0|||
23204848|NCT01766817|64491220|FG002|Overall Study|Withdrawal by Subject|3|||
23204849|NCT01766817|64491218|FG000|Overall Study|Subject non-compliance|0|||
23204850|NCT01766817|64491219|FG001|Overall Study|Subject non-compliance|1|||
23204851|NCT01766817|64491220|FG002|Overall Study|Subject non-compliance|2|||
23204852|NCT01766817|64491218|FG000|Overall Study|Physician Decision|3|||
23204853|NCT01766817|64491219|FG001|Overall Study|Physician Decision|3|||
23204854|NCT01766817|64491220|FG002|Overall Study|Physician Decision|4|||
23204855|NCT01766817|64491218|FG000|Overall Study|Other|1|||
23204856|NCT01766817|64491219|FG001|Overall Study|Other|0|||
23305731|NCT03469336|64862408|FG000|Overall Study|Adverse Event|1|||
23305732|NCT02387983|64862409|FG000|Overall Study|Adverse Event|4|||
23305733|NCT02387983|64862409|FG000|Overall Study|Protocol Violation|1|||
23305734|NCT02387983|64862409|FG000|Overall Study|Withdrawal by Subject|2|||
23305735|NCT01315132|64862410|FG000|Overall Study|not treated due to disease progression|1|||
23305736|NCT03246126|64862413|FG000|Overall Study|Withdrawal by Subject|0|||
23305737|NCT03246126|64862414|FG001|Overall Study|Withdrawal by Subject|1|||
23305738|NCT00673387|64862415|FG000|Overall Study|Withdrawal by Subject|15|||
23305739|NCT00673387|64862416|FG001|Overall Study|Withdrawal by Subject|16|||
23305740|NCT00673387|64862417|FG002|Overall Study|Withdrawal by Subject|20|||
23305741|NCT00673387|64862418|FG003|Overall Study|Withdrawal by Subject|16|||
23305742|NCT00673387|64862419|FG004|Overall Study|Withdrawal by Subject|18|||
23305743|NCT00673387|64862420|FG005|Overall Study|Withdrawal by Subject|21|||
23305744|NCT00673387|64862421|FG006|Overall Study|Withdrawal by Subject|15|||
23305745|NCT00673387|64862422|FG007|Overall Study|Withdrawal by Subject|21|||
23305746|NCT00673387|64862415|FG000|Overall Study|Adverse Event|3|||
23305747|NCT00673387|64862416|FG001|Overall Study|Adverse Event|1|||
23305748|NCT00673387|64862417|FG002|Overall Study|Adverse Event|5|||
23305749|NCT00673387|64862418|FG003|Overall Study|Adverse Event|2|||
23510688|NCT01018186|65606146|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23204857|NCT01766817|64491220|FG002|Overall Study|Other|0|||
23204858|NCT00006604|64491221|FG000|Overall Study|Met study objective - no further FU|1|||
23204859|NCT00006604|64491222|FG001|Overall Study|Met study objective - no further FU|0|||
23305750|NCT00673387|64862419|FG004|Overall Study|Adverse Event|6|||
23305751|NCT00673387|64862420|FG005|Overall Study|Adverse Event|2|||
23305752|NCT00673387|64862421|FG006|Overall Study|Adverse Event|5|||
23305753|NCT00673387|64862422|FG007|Overall Study|Adverse Event|5|||
23305754|NCT00673387|64862415|FG000|Overall Study|Physician Decision|0|||
23305755|NCT00673387|64862416|FG001|Overall Study|Physician Decision|0|||
23305756|NCT00673387|64862417|FG002|Overall Study|Physician Decision|0|||
23305757|NCT00673387|64862418|FG003|Overall Study|Physician Decision|0|||
23305758|NCT00673387|64862419|FG004|Overall Study|Physician Decision|0|||
23305759|NCT00673387|64862420|FG005|Overall Study|Physician Decision|5|||
23305760|NCT00673387|64862421|FG006|Overall Study|Physician Decision|1|||
23305761|NCT00673387|64862422|FG007|Overall Study|Physician Decision|1|||
23305762|NCT00673387|64862415|FG000|Overall Study|Protocol Violation|3|||
23305763|NCT00673387|64862416|FG001|Overall Study|Protocol Violation|0|||
23305764|NCT00673387|64862417|FG002|Overall Study|Protocol Violation|1|||
23305765|NCT00673387|64862418|FG003|Overall Study|Protocol Violation|2|||
23305766|NCT00673387|64862419|FG004|Overall Study|Protocol Violation|0|||
23305767|NCT00673387|64862420|FG005|Overall Study|Protocol Violation|1|||
23305768|NCT00673387|64862421|FG006|Overall Study|Protocol Violation|1|||
23305769|NCT00673387|64862422|FG007|Overall Study|Protocol Violation|3|||
23305770|NCT00673387|64862415|FG000|Overall Study|Lost to Follow-up|8|||
23305771|NCT00673387|64862416|FG001|Overall Study|Lost to Follow-up|6|||
23305772|NCT00673387|64862417|FG002|Overall Study|Lost to Follow-up|5|||
23305773|NCT00673387|64862418|FG003|Overall Study|Lost to Follow-up|6|||
23305774|NCT00673387|64862419|FG004|Overall Study|Lost to Follow-up|6|||
23305775|NCT00673387|64862420|FG005|Overall Study|Lost to Follow-up|5|||
23305776|NCT00673387|64862421|FG006|Overall Study|Lost to Follow-up|8|||
23510689|NCT01018186|65606147|FG003|2-week Run-in Period|Lost to Follow-up|0|||
23510690|NCT01018186|65606144|FG000|2-week Run-in Period|Physician Decision|3|||
23510691|NCT01018186|65606145|FG001|2-week Run-in Period|Physician Decision|0|||
23204860|NCT00006604|64491223|FG002|Overall Study|Met study objective - no further FU|0|||
23204861|NCT00006604|64491224|FG003|Overall Study|Met study objective - no further FU|0|||
23204862|NCT00006604|64491225|FG004|Overall Study|Met study objective - no further FU|0|||
23204863|NCT00006604|64491226|FG005|Overall Study|Met study objective - no further FU|0|||
23204864|NCT00006604|64491227|FG006|Overall Study|Met study objective - no further FU|0|||
23204865|NCT00006604|64491228|FG007|Overall Study|Met study objective - no further FU|0|||
23204866|NCT00006604|64491229|FG008|Overall Study|Met study objective - no further FU|0|||
23204867|NCT00006604|64491230|FG009|Overall Study|Met study objective - no further FU|0|||
23204868|NCT00006604|64491231|FG010|Overall Study|Met study objective - no further FU|0|||
23204869|NCT00006604|64491232|FG011|Overall Study|Met study objective - no further FU|0|||
23204870|NCT00006604|64491233|FG012|Overall Study|Met study objective - no further FU|0|||
23204871|NCT00006604|64491234|FG013|Overall Study|Met study objective - no further FU|0|||
23204872|NCT00006604|64491235|FG014|Overall Study|Met study objective - no further FU|1|||
23204873|NCT00006604|64491236|FG015|Overall Study|Met study objective - no further FU|1|||
23204874|NCT00006604|64491237|FG016|Overall Study|Met study objective - no further FU|0|||
23204875|NCT00006604|64491221|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
23204876|NCT00006604|64491222|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
23204877|NCT00006604|64491223|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
23204878|NCT00006604|64491224|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
23204879|NCT00006604|64491225|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
23204880|NCT00006604|64491226|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
23204881|NCT00006604|64491227|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
23204882|NCT00006604|64491228|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
23204883|NCT00006604|64491229|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
23204884|NCT00006604|64491230|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
23204885|NCT00006604|64491231|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
23204886|NCT00006604|64491232|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
23204887|NCT00006604|64491233|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
23204888|NCT00006604|64491234|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
23204889|NCT00006604|64491235|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
23204890|NCT00006604|64491236|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
23204891|NCT00006604|64491237|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
23204892|NCT00006604|64491221|FG000|Overall Study|Death|0|||
23204893|NCT00006604|64491222|FG001|Overall Study|Death|0|||
23204894|NCT00006604|64491223|FG002|Overall Study|Death|0|||
23204895|NCT00006604|64491224|FG003|Overall Study|Death|0|||
23204896|NCT00006604|64491225|FG004|Overall Study|Death|0|||
23204897|NCT00006604|64491226|FG005|Overall Study|Death|0|||
23204898|NCT00006604|64491227|FG006|Overall Study|Death|0|||
23204899|NCT00006604|64491228|FG007|Overall Study|Death|0|||
23204900|NCT00006604|64491229|FG008|Overall Study|Death|0|||
23204901|NCT00006604|64491230|FG009|Overall Study|Death|1|||
23204902|NCT00006604|64491231|FG010|Overall Study|Death|1|||
23305777|NCT00673387|64862422|FG007|Overall Study|Lost to Follow-up|5|||
23305778|NCT01055132|64862423|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
23305779|NCT01055132|64862424|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
23204903|NCT00006604|64491232|FG011|Overall Study|Death|1|||
23204904|NCT00006604|64491233|FG012|Overall Study|Death|0|||
23204905|NCT00006604|64491234|FG013|Overall Study|Death|0|||
23204906|NCT00006604|64491235|FG014|Overall Study|Death|0|||
23204907|NCT00006604|64491236|FG015|Overall Study|Death|0|||
23204908|NCT00006604|64491237|FG016|Overall Study|Death|0|||
23204909|NCT00006604|64491221|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23204910|NCT00006604|64491222|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23204911|NCT00006604|64491223|FG002|Overall Study|Severe debilitation, unable to continue|0|||
23204912|NCT00006604|64491224|FG003|Overall Study|Severe debilitation, unable to continue|0|||
23204913|NCT00006604|64491225|FG004|Overall Study|Severe debilitation, unable to continue|0|||
23204914|NCT00006604|64491226|FG005|Overall Study|Severe debilitation, unable to continue|0|||
23204915|NCT00006604|64491227|FG006|Overall Study|Severe debilitation, unable to continue|3|||
23204916|NCT00006604|64491228|FG007|Overall Study|Severe debilitation, unable to continue|0|||
23204917|NCT00006604|64491229|FG008|Overall Study|Severe debilitation, unable to continue|0|||
23204918|NCT00006604|64491230|FG009|Overall Study|Severe debilitation, unable to continue|5|||
23204919|NCT00006604|64491231|FG010|Overall Study|Severe debilitation, unable to continue|0|||
23204920|NCT00006604|64491232|FG011|Overall Study|Severe debilitation, unable to continue|2|||
23204921|NCT00006604|64491233|FG012|Overall Study|Severe debilitation, unable to continue|1|||
23204922|NCT00006604|64491234|FG013|Overall Study|Severe debilitation, unable to continue|0|||
23510692|NCT01018186|65606146|FG002|2-week Run-in Period|Physician Decision|0|||
23510693|NCT01018186|65606147|FG003|2-week Run-in Period|Physician Decision|0|||
23510694|NCT01018186|65606144|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
23510695|NCT01018186|65606145|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23510696|NCT01018186|65606146|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23510697|NCT01018186|65606147|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
23510698|NCT01018186|65606144|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
23510699|NCT01018186|65606145|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23510700|NCT01018186|65606146|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23510701|NCT01018186|65606147|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23510702|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
23510703|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
23204923|NCT00006604|64491235|FG014|Overall Study|Severe debilitation, unable to continue|2|||
23204924|NCT00006604|64491236|FG015|Overall Study|Severe debilitation, unable to continue|0|||
23204925|NCT00006604|64491237|FG016|Overall Study|Severe debilitation, unable to continue|0|||
23204926|NCT00006604|64491221|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
23204927|NCT00006604|64491222|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
23204928|NCT00006604|64491223|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
23204929|NCT00006604|64491224|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
23204930|NCT00006604|64491225|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
23204931|NCT00006604|64491226|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
23204932|NCT00006604|64491227|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
23204933|NCT00006604|64491228|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
23204934|NCT00006604|64491229|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
23204935|NCT00006604|64491230|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
23204936|NCT00006604|64491231|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
23204937|NCT00006604|64491232|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
23204938|NCT00006604|64491233|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
23204939|NCT00006604|64491234|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
23204940|NCT00006604|64491235|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
23204941|NCT00006604|64491236|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
23204942|NCT00006604|64491237|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
23204943|NCT00006604|64491221|FG000|Overall Study|Site closing|0|||
23204944|NCT00006604|64491222|FG001|Overall Study|Site closing|0|||
23204945|NCT00006604|64491223|FG002|Overall Study|Site closing|1|||
23204946|NCT00006604|64491224|FG003|Overall Study|Site closing|1|||
23204947|NCT00006604|64491225|FG004|Overall Study|Site closing|0|||
23204948|NCT00006604|64491226|FG005|Overall Study|Site closing|0|||
23204949|NCT00006604|64491227|FG006|Overall Study|Site closing|0|||
23204950|NCT00006604|64491228|FG007|Overall Study|Site closing|1|||
23204951|NCT00006604|64491229|FG008|Overall Study|Site closing|0|||
23204952|NCT00006604|64491230|FG009|Overall Study|Site closing|0|||
23204953|NCT00006604|64491231|FG010|Overall Study|Site closing|0|||
23204954|NCT00006604|64491232|FG011|Overall Study|Site closing|1|||
23204955|NCT00006604|64491233|FG012|Overall Study|Site closing|1|||
23204956|NCT00006604|64491234|FG013|Overall Study|Site closing|1|||
23204957|NCT00006604|64491235|FG014|Overall Study|Site closing|0|||
23204958|NCT00006604|64491236|FG015|Overall Study|Site closing|0|||
23204959|NCT00006604|64491237|FG016|Overall Study|Site closing|1|||
23510704|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
23510705|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
23510706|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
23510707|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
23510708|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
23510709|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
23510710|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
23510711|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
23510712|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
23510713|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
23510714|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
23510715|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
23510716|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
23510717|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
23510718|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
23510719|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
23510720|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
23510721|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
23204960|NCT00006604|64491221|FG000|Overall Study|Withdrawal by Subject|1|||
23204961|NCT00006604|64491222|FG001|Overall Study|Withdrawal by Subject|0|||
23204962|NCT00006604|64491223|FG002|Overall Study|Withdrawal by Subject|2|||
23204963|NCT00006604|64491224|FG003|Overall Study|Withdrawal by Subject|0|||
23204964|NCT00006604|64491225|FG004|Overall Study|Withdrawal by Subject|1|||
23204965|NCT00006604|64491226|FG005|Overall Study|Withdrawal by Subject|2|||
23204966|NCT00006604|64491227|FG006|Overall Study|Withdrawal by Subject|2|||
23204967|NCT00006604|64491228|FG007|Overall Study|Withdrawal by Subject|0|||
23204968|NCT00006604|64491229|FG008|Overall Study|Withdrawal by Subject|1|||
23204969|NCT00006604|64491230|FG009|Overall Study|Withdrawal by Subject|3|||
23204970|NCT00006604|64491231|FG010|Overall Study|Withdrawal by Subject|2|||
23204971|NCT00006604|64491232|FG011|Overall Study|Withdrawal by Subject|0|||
23204972|NCT00006604|64491233|FG012|Overall Study|Withdrawal by Subject|1|||
23204973|NCT00006604|64491234|FG013|Overall Study|Withdrawal by Subject|2|||
23204974|NCT00006604|64491235|FG014|Overall Study|Withdrawal by Subject|1|||
23204975|NCT00006604|64491236|FG015|Overall Study|Withdrawal by Subject|0|||
23204976|NCT00006604|64491237|FG016|Overall Study|Withdrawal by Subject|1|||
23204977|NCT00006604|64491221|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
23204978|NCT00006604|64491222|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
23204979|NCT00006604|64491223|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
23204980|NCT00006604|64491224|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
23204981|NCT00006604|64491225|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
23204982|NCT00006604|64491226|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
23204983|NCT00006604|64491227|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
23204984|NCT00006604|64491228|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
23204985|NCT00006604|64491229|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
23204986|NCT00006604|64491230|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
23204987|NCT00006604|64491231|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
23204988|NCT00006604|64491232|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
23204989|NCT00006604|64491233|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
23204990|NCT00006604|64491234|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
23204991|NCT00006604|64491235|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
23204992|NCT00006604|64491236|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
23305780|NCT01055132|64862423|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
23305781|NCT01055132|64862424|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
23305782|NCT00228423|64862425|FG000|Overall Study|Adverse Event|2|||
23305783|NCT00228423|64862426|FG001|Overall Study|Adverse Event|5|||
23305784|NCT00228423|64862425|FG000|Overall Study|Withdrawal by Subject|7|||
23305785|NCT00228423|64862426|FG001|Overall Study|Withdrawal by Subject|3|||
23305786|NCT00228423|64862425|FG000|Overall Study|Protocol Violation|1|||
23510722|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
23510723|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
23510724|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
23305787|NCT00228423|64862426|FG001|Overall Study|Protocol Violation|3|||
23510725|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
23305788|NCT00228423|64862425|FG000|Overall Study|Physician Decision|0|||
23305789|NCT00228423|64862426|FG001|Overall Study|Physician Decision|1|||
23305790|NCT00686075|64862427|FG000|Overall Study|Withdrawal by Subject|4|||
23305791|NCT00686075|64862428|FG001|Overall Study|Withdrawal by Subject|3|||
23408602|NCT01766037|65239939|FG001|Overall Study|Adverse Event|0|||
23510726|NCT01018186|65606144|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23510727|NCT01018186|65606145|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
23510728|NCT01018186|65606146|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
23510729|NCT01018186|65606147|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
23305792|NCT00686075|64862429|FG002|Overall Study|Withdrawal by Subject|3|||
23305793|NCT00686075|64862430|FG003|Overall Study|Withdrawal by Subject|7|||
23305794|NCT00686075|64862431|FG004|Overall Study|Withdrawal by Subject|1|||
23305795|NCT00686075|64862432|FG005|Overall Study|Withdrawal by Subject|0|||
23305796|NCT00686075|64862433|FG006|Overall Study|Withdrawal by Subject|0|||
23305797|NCT00686075|64862434|FG007|Overall Study|Withdrawal by Subject|2|||
23510730|NCT01386554|65606148|FG000|Overall Study|Lost to Follow-up|0|||
23510731|NCT01386554|65606149|FG001|Overall Study|Lost to Follow-up|0|||
23510732|NCT01386554|65606150|FG002|Overall Study|Lost to Follow-up|1|||
23510733|NCT01386554|65606148|FG000|Overall Study|Adverse Event|2|||
23510734|NCT01386554|65606149|FG001|Overall Study|Adverse Event|5|||
23510735|NCT01386554|65606150|FG002|Overall Study|Adverse Event|2|||
23510736|NCT01386554|65606148|FG000|Overall Study|Progressive disease|1|||
23510737|NCT01386554|65606149|FG001|Overall Study|Progressive disease|2|||
23510738|NCT01386554|65606150|FG002|Overall Study|Progressive disease|2|||
23510739|NCT01386554|65606148|FG000|Overall Study|Administration of live vaccines|0|||
23510740|NCT01386554|65606149|FG001|Overall Study|Administration of live vaccines|1|||
23510741|NCT01386554|65606150|FG002|Overall Study|Administration of live vaccines|0|||
23510742|NCT01386554|65606148|FG000|Overall Study|Investigator discretion|0|||
23510743|NCT01386554|65606149|FG001|Overall Study|Investigator discretion|0|||
23510744|NCT01386554|65606150|FG002|Overall Study|Investigator discretion|1|||
23510745|NCT01386554|65606148|FG000|Overall Study|Reason not collected|0|||
23510746|NCT01386554|65606149|FG001|Overall Study|Reason not collected|1|||
23510747|NCT01386554|65606150|FG002|Overall Study|Reason not collected|0|||
23510748|NCT03187197|65606151|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
23510749|NCT03187197|65606152|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
23510750|NCT03187197|65606153|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
23510751|NCT03187197|65606151|FG000|Overall Study|Withdrawal by Subject|8|||
23510752|NCT03187197|65606152|FG001|Overall Study|Withdrawal by Subject|63|||
23510753|NCT03187197|65606153|FG002|Overall Study|Withdrawal by Subject|4|||
23510754|NCT03187197|65606151|FG000|Overall Study|Lost to Follow-up|1|||
23510755|NCT03187197|65606152|FG001|Overall Study|Lost to Follow-up|60|||
23510756|NCT03187197|65606153|FG002|Overall Study|Lost to Follow-up|7|||
23510757|NCT03187197|65606151|FG000|Overall Study|Adverse Event|6|||
23510758|NCT03187197|65606152|FG001|Overall Study|Adverse Event|29|||
23510759|NCT03187197|65606153|FG002|Overall Study|Adverse Event|0|||
23510760|NCT03187197|65606151|FG000|Overall Study|Death|0|||
23510761|NCT03187197|65606152|FG001|Overall Study|Death|11|||
23510762|NCT03187197|65606153|FG002|Overall Study|Death|0|||
23510763|NCT03187197|65606151|FG000|Overall Study|Administrative problem|1|||
23510764|NCT03187197|65606152|FG001|Overall Study|Administrative problem|1|||
23510765|NCT03187197|65606153|FG002|Overall Study|Administrative problem|0|||
23510766|NCT03187197|65606151|FG000|Overall Study|Reason not listed|2|||
23510767|NCT03187197|65606152|FG001|Overall Study|Reason not listed|54|||
23510768|NCT03187197|65606153|FG002|Overall Study|Reason not listed|1|||
23510769|NCT03187197|65606151|FG000|Overall Study|Missing|1|||
23510770|NCT03187197|65606152|FG001|Overall Study|Missing|32|||
23510771|NCT03187197|65606153|FG002|Overall Study|Missing|3|||
23510772|NCT03187197|65606151|FG000|Overall Study|Status missing|2|||
23510773|NCT03187197|65606152|FG001|Overall Study|Status missing|33|||
23510774|NCT03187197|65606153|FG002|Overall Study|Status missing|3|||
23510775|NCT03187197|65606151|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
23510776|NCT03187197|65606152|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
23510777|NCT03187197|65606153|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
23510778|NCT03552198|65606154|FG000|Overall Study|Lost to Follow-up|42|||
23510779|NCT03552198|65606155|FG001|Overall Study|Lost to Follow-up|48|||
23510780|NCT03552198|65606156|FG002|Overall Study|Lost to Follow-up|15|||
23510781|NCT03552198|65606157|FG003|Overall Study|Lost to Follow-up|19|||
23510782|NCT03552198|65606154|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
23510783|NCT03552198|65606155|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
23510784|NCT03552198|65606156|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
23510785|NCT03552198|65606157|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
23510786|NCT03552198|65606154|FG000|Overall Study|Did not receive air alerts|1|||
23510787|NCT03552198|65606155|FG001|Overall Study|Did not receive air alerts|0|||
23510788|NCT03552198|65606156|FG002|Overall Study|Did not receive air alerts|0|||
23510789|NCT03552198|65606157|FG003|Overall Study|Did not receive air alerts|1|||
23510790|NCT02692716|65606158|FG000|Overall Study|Lost to Follow-up|2|||
23510791|NCT02692716|65606159|FG001|Overall Study|Lost to Follow-up|5|||
23510792|NCT02692716|65606158|FG000|Overall Study|Withdrawal by Subject|3|||
23510793|NCT02692716|65606159|FG001|Overall Study|Withdrawal by Subject|1|||
23510794|NCT00936910|65606161|FG000|Overall Study|Lack of Efficacy|3|||
23510795|NCT00903695|65606162|FG000|Overall Study|medical exclusion after 1st testing|1|||
23510796|NCT00903695|65606163|FG001|Overall Study|medical exclusion after 1st testing|0|||
23510797|NCT00903695|65606162|FG000|Overall Study|lung cancer|1|||
23510798|NCT00903695|65606163|FG001|Overall Study|lung cancer|0|||
23510799|NCT01535053|65606164|FG000|Overall Study|Ineligible|1|||
23510800|NCT01535053|65606165|FG001|Overall Study|Ineligible|2|||
23510801|NCT01957553|65606166|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
23510802|NCT01957553|65606167|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
23510803|NCT01957553|65606166|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
23510804|NCT01957553|65606167|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
23510805|NCT01957553|65606166|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
23510806|NCT01957553|65606167|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
23510807|NCT01957553|65606166|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
23510808|NCT01957553|65606167|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
23305798|NCT00686075|64862435|FG008|Overall Study|Withdrawal by Subject|4|||
23305799|NCT00686075|64862436|FG009|Overall Study|Withdrawal by Subject|6|||
23305800|NCT00686075|64862427|FG000|Overall Study|Lost to Follow-up|3|||
23305801|NCT00686075|64862428|FG001|Overall Study|Lost to Follow-up|6|||
23305802|NCT00686075|64862429|FG002|Overall Study|Lost to Follow-up|3|||
23305803|NCT00686075|64862430|FG003|Overall Study|Lost to Follow-up|2|||
23305804|NCT00686075|64862431|FG004|Overall Study|Lost to Follow-up|3|||
23305805|NCT00686075|64862432|FG005|Overall Study|Lost to Follow-up|3|||
23305806|NCT00686075|64862433|FG006|Overall Study|Lost to Follow-up|0|||
23305807|NCT00686075|64862434|FG007|Overall Study|Lost to Follow-up|0|||
23305808|NCT00686075|64862435|FG008|Overall Study|Lost to Follow-up|2|||
23305809|NCT00686075|64862436|FG009|Overall Study|Lost to Follow-up|3|||
23305810|NCT00686075|64862427|FG000|Overall Study|Other|1|||
23305811|NCT00686075|64862428|FG001|Overall Study|Other|1|||
23305812|NCT00686075|64862429|FG002|Overall Study|Other|0|||
23305813|NCT00686075|64862430|FG003|Overall Study|Other|0|||
23305814|NCT00686075|64862431|FG004|Overall Study|Other|0|||
23305815|NCT00686075|64862432|FG005|Overall Study|Other|0|||
23305816|NCT00686075|64862433|FG006|Overall Study|Other|0|||
23305817|NCT00686075|64862434|FG007|Overall Study|Other|0|||
23305818|NCT00686075|64862435|FG008|Overall Study|Other|0|||
23305819|NCT00686075|64862436|FG009|Overall Study|Other|1|||
23305820|NCT00127036|64862440|FG000|Overall Study|Insufficient Data for Analysis|6|||
23305821|NCT00127036|64862441|FG001|Overall Study|Insufficient Data for Analysis|11|||
23305822|NCT00127036|64862440|FG000|Overall Study|Screen Failure|2|||
23305823|NCT00127036|64862441|FG001|Overall Study|Screen Failure|0|||
23305824|NCT05142566|64862446|FG000|Overall Study|Protocol Violation|1|||
23305825|NCT04498403|64862453|FG000|Overall Study|Adverse Event|1|||
23305826|NCT04498403|64862454|FG001|Overall Study|Adverse Event|0|||
23305827|NCT04498403|64862453|FG000|Overall Study|Study Terminated By Sponsor|29|||
23305828|NCT04498403|64862454|FG001|Overall Study|Study Terminated By Sponsor|10|||
23305829|NCT02593773|64862460|FG000|Overall Study|Voluntary Withdrawal|3|||
23305830|NCT02593773|64862460|FG000|Overall Study|Study Terminated by Sponsor|31|||
23305831|NCT02593773|64862460|FG000|Overall Study|Death|1|||
23305832|NCT01193127|64862461|FG000|Randomized|Surgery Cancelled|0|||
23305833|NCT01193127|64862462|FG001|Randomized|Surgery Cancelled|0|||
23305834|NCT01193127|64862463|FG002|Randomized|Surgery Cancelled|0|||
23305835|NCT01193127|64862464|FG003|Randomized|Surgery Cancelled|1|||
23305836|NCT01193127|64862461|FG000|Treated|Withdrawal by Subject|0|||
23305837|NCT01193127|64862462|FG001|Treated|Withdrawal by Subject|0|||
23305838|NCT01193127|64862463|FG002|Treated|Withdrawal by Subject|0|||
23305839|NCT01193127|64862464|FG003|Treated|Withdrawal by Subject|1|||
23305840|NCT05256134|64862465|FG000|Overall Study|Study Terminated by Sponsor|11|||
23510809|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
23510810|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
23510811|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
23204993|NCT00006604|64491237|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
23204994|NCT00006604|64491221|FG000|Overall Study|Lost to Follow-up|0|||
23204995|NCT00006604|64491222|FG001|Overall Study|Lost to Follow-up|0|||
23204996|NCT00006604|64491223|FG002|Overall Study|Lost to Follow-up|0|||
23204997|NCT00006604|64491224|FG003|Overall Study|Lost to Follow-up|0|||
23204998|NCT00006604|64491225|FG004|Overall Study|Lost to Follow-up|0|||
23204999|NCT00006604|64491226|FG005|Overall Study|Lost to Follow-up|0|||
23205000|NCT00006604|64491227|FG006|Overall Study|Lost to Follow-up|0|||
23205001|NCT00006604|64491228|FG007|Overall Study|Lost to Follow-up|1|||
23205002|NCT00006604|64491229|FG008|Overall Study|Lost to Follow-up|0|||
23205003|NCT00006604|64491230|FG009|Overall Study|Lost to Follow-up|2|||
23205004|NCT00006604|64491231|FG010|Overall Study|Lost to Follow-up|0|||
23205005|NCT00006604|64491232|FG011|Overall Study|Lost to Follow-up|0|||
23205006|NCT00006604|64491233|FG012|Overall Study|Lost to Follow-up|0|||
23205007|NCT00006604|64491234|FG013|Overall Study|Lost to Follow-up|0|||
23205008|NCT00006604|64491235|FG014|Overall Study|Lost to Follow-up|0|||
23205009|NCT00006604|64491236|FG015|Overall Study|Lost to Follow-up|1|||
23205010|NCT00006604|64491237|FG016|Overall Study|Lost to Follow-up|3|||
23205011|NCT00006604|64491221|FG000|Overall Study|Other Reason|0|||
23205012|NCT00006604|64491222|FG001|Overall Study|Other Reason|0|||
23205013|NCT00006604|64491223|FG002|Overall Study|Other Reason|0|||
23205014|NCT00006604|64491224|FG003|Overall Study|Other Reason|0|||
23205015|NCT00006604|64491225|FG004|Overall Study|Other Reason|0|||
23205016|NCT00006604|64491226|FG005|Overall Study|Other Reason|1|||
23205017|NCT00006604|64491227|FG006|Overall Study|Other Reason|0|||
23205018|NCT00006604|64491228|FG007|Overall Study|Other Reason|0|||
23205019|NCT00006604|64491229|FG008|Overall Study|Other Reason|0|||
23205020|NCT00006604|64491230|FG009|Overall Study|Other Reason|1|||
23205021|NCT00006604|64491231|FG010|Overall Study|Other Reason|0|||
23205022|NCT00006604|64491232|FG011|Overall Study|Other Reason|0|||
23205023|NCT00006604|64491233|FG012|Overall Study|Other Reason|0|||
23510812|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
23510813|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
23510814|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
23510815|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
23205024|NCT00006604|64491234|FG013|Overall Study|Other Reason|0|||
23205025|NCT00006604|64491235|FG014|Overall Study|Other Reason|0|||
23205026|NCT00006604|64491236|FG015|Overall Study|Other Reason|0|||
23205027|NCT00006604|64491237|FG016|Overall Study|Other Reason|0|||
23205028|NCT00805545|64491241|FG000|Overall Study|Protocol Violation|3|||
23205029|NCT00805545|64491242|FG001|Overall Study|Protocol Violation|2|||
23205030|NCT00805545|64491241|FG000|Overall Study|Protocol Violation|3|||
23205031|NCT00805545|64491242|FG001|Overall Study|Protocol Violation|1|||
23205032|NCT02279524|64491243|FG000|Overall Study|Withdrawal by Subject|3|||
23205033|NCT02279524|64491244|FG001|Overall Study|Withdrawal by Subject|6|||
23205034|NCT02279524|64491245|FG002|Overall Study|Withdrawal by Subject|3|||
23205035|NCT02279524|64491243|FG000|Overall Study|Adverse Event|4|||
23205036|NCT02279524|64491244|FG001|Overall Study|Adverse Event|3|||
23205037|NCT02279524|64491245|FG002|Overall Study|Adverse Event|2|||
23205038|NCT02279524|64491243|FG000|Overall Study|Lost to Follow-up|1|||
23205039|NCT02279524|64491244|FG001|Overall Study|Lost to Follow-up|1|||
23205040|NCT02279524|64491245|FG002|Overall Study|Lost to Follow-up|0|||
23205041|NCT02279524|64491243|FG000|Overall Study|Disallowed medication|1|||
23205042|NCT02279524|64491244|FG001|Overall Study|Disallowed medication|1|||
23205043|NCT02279524|64491245|FG002|Overall Study|Disallowed medication|2|||
23205044|NCT02279524|64491243|FG000|Overall Study|Bariatric surgery|1|||
23205045|NCT02279524|64491244|FG001|Overall Study|Bariatric surgery|0|||
23205046|NCT02279524|64491245|FG002|Overall Study|Bariatric surgery|0|||
23205047|NCT00414960|64491247|FG000|Overall Study|Adverse Event|4|||
23205048|NCT00414960|64491248|FG001|Overall Study|Adverse Event|0|||
23205049|NCT00414960|64491247|FG000|Overall Study|Withdrawal by Subject|3|||
23205050|NCT00414960|64491248|FG001|Overall Study|Withdrawal by Subject|0|||
23205051|NCT00414960|64491247|FG000|Overall Study|Physician Decision|0|||
23205052|NCT00414960|64491248|FG001|Overall Study|Physician Decision|1|||
23305841|NCT05256134|64862466|FG001|Overall Study|Study Terminated by Sponsor|10|||
23305842|NCT05256134|64862465|FG000|Overall Study|Withdrawal by Subject|1|||
23305843|NCT05256134|64862466|FG001|Overall Study|Withdrawal by Subject|3|||
23305844|NCT00975286|64862467|FG000|Overall Study|Adverse Event|9|||
23305845|NCT00975286|64862468|FG001|Overall Study|Adverse Event|19|||
23305846|NCT00975286|64862467|FG000|Overall Study|Protocol Violation|1|||
23305847|NCT00975286|64862468|FG001|Overall Study|Protocol Violation|2|||
23305848|NCT00975286|64862467|FG000|Overall Study|Withdrawal by Subject|0|||
23305849|NCT00975286|64862468|FG001|Overall Study|Withdrawal by Subject|2|||
23305850|NCT00975286|64862467|FG000|Overall Study|Familial and Personal Reasons|2|||
23305851|NCT00975286|64862468|FG001|Overall Study|Familial and Personal Reasons|2|||
23305852|NCT00975286|64862467|FG000|Overall Study|Poor Compliance to Protocol|0|||
23305853|NCT00975286|64862468|FG001|Overall Study|Poor Compliance to Protocol|2|||
23305854|NCT00975286|64862467|FG000|Overall Study|Sponsor Decision|0|||
23510816|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
23510817|NCT01957553|65606166|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
23510818|NCT01957553|65606167|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
23510819|NCT03291808|65606170|FG000|Overall Study|Lost to Follow-up|6|||
23305855|NCT00975286|64862468|FG001|Overall Study|Sponsor Decision|2|||
23305856|NCT00158600|64862469|FG000|Overall Study|unable to commit time to study|0|||
23305857|NCT00158600|64862470|FG001|Overall Study|unable to commit time to study|1|||
23305858|NCT00158600|64862469|FG000|Overall Study|Adverse Event|2|||
23305859|NCT00158600|64862470|FG001|Overall Study|Adverse Event|1|||
23510820|NCT03291808|65606170|FG000|Overall Study|Research burden|4|||
23510821|NCT04840615|65606172|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
23205053|NCT00793819|64491249|FG000|Overall Study|Adverse Event|8|||
23205054|NCT00793819|64491250|FG001|Overall Study|Adverse Event|4|||
23205055|NCT00793819|64491249|FG000|Overall Study|Lack of Efficacy|1|||
23205056|NCT00793819|64491250|FG001|Overall Study|Lack of Efficacy|1|||
23305860|NCT00158600|64862469|FG000|Overall Study|Death|1|||
23305861|NCT00158600|64862470|FG001|Overall Study|Death|0|||
23305862|NCT00158600|64862469|FG000|Overall Study|Withdrawal by Subject|2|||
23510822|NCT04840615|65606173|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
23305863|NCT00158600|64862470|FG001|Overall Study|Withdrawal by Subject|2|||
23305864|NCT04168190|64862471|FG000|Overall Study|Lost to Follow-up|0|||
23305865|NCT04168190|64862472|FG001|Overall Study|Lost to Follow-up|1|||
23305866|NCT04168190|64862473|FG002|Overall Study|Lost to Follow-up|0|||
23305867|NCT04168190|64862474|FG003|Overall Study|Lost to Follow-up|7|||
23305868|NCT04168190|64862475|FG004|Overall Study|Lost to Follow-up|5|||
23305869|NCT04168190|64862471|FG000|Overall Study|Withdrawal by Subject|1|||
23305870|NCT04168190|64862472|FG001|Overall Study|Withdrawal by Subject|0|||
23408603|NCT01766037|65239938|FG000|Overall Study|Lack of Efficacy|1|||
23408604|NCT01766037|65239939|FG001|Overall Study|Lack of Efficacy|0|||
23408605|NCT01766037|65239938|FG000|Overall Study|Lost to Follow-up|0|||
23408606|NCT01766037|65239939|FG001|Overall Study|Lost to Follow-up|10|||
23408607|NCT01766037|65239938|FG000|Overall Study|Physician Decision|0|||
23408608|NCT01766037|65239939|FG001|Overall Study|Physician Decision|1|||
23408609|NCT01766037|65239938|FG000|Overall Study|Withdrawal by Subject|18|||
23408610|NCT01766037|65239939|FG001|Overall Study|Withdrawal by Subject|16|||
23408611|NCT01766037|65239938|FG000|Overall Study|Moved from area|5|||
23408612|NCT01766037|65239939|FG001|Overall Study|Moved from area|0|||
23408613|NCT01766037|65239938|FG000|Overall Study|medical - unrelated|1|||
23408614|NCT01766037|65239939|FG001|Overall Study|medical - unrelated|2|||
23408615|NCT01766037|65239938|FG000|Overall Study|nausea / discomfort|3|||
23408616|NCT01766037|65239939|FG001|Overall Study|nausea / discomfort|0|||
23408617|NCT01575808|65239940|FG000|Overall Study|Death|2|||
23408618|NCT01575808|65239941|FG001|Overall Study|Death|0|||
23408619|NCT01575808|65239940|FG000|Overall Study|Withdrawal by Subject|1|||
23408620|NCT01575808|65239941|FG001|Overall Study|Withdrawal by Subject|0|||
23408621|NCT01279044|65239949|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
23408622|NCT01279044|65239950|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
23408623|NCT01279044|65239951|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
23408624|NCT01279044|65239949|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
23408625|NCT01279044|65239950|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
23408626|NCT01279044|65239951|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
23408627|NCT01279044|65239949|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
23408628|NCT01279044|65239950|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
23408629|NCT01279044|65239951|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
23408630|NCT00662831|65239952|FG000|Overall Study|Death|4|||
23408631|NCT00662831|65239953|FG001|Overall Study|Death|1|||
23408632|NCT00662831|65239952|FG000|Overall Study|Lack of Efficacy|6|||
23408633|NCT00662831|65239953|FG001|Overall Study|Lack of Efficacy|6|||
23408634|NCT00662831|65239952|FG000|Overall Study|Lost to Follow-up|1|||
23408635|NCT00662831|65239953|FG001|Overall Study|Lost to Follow-up|0|||
23408636|NCT00662831|65239952|FG000|Overall Study|Withdrawal by Subject|2|||
23408637|NCT00662831|65239953|FG001|Overall Study|Withdrawal by Subject|1|||
23408638|NCT00662831|65239952|FG000|Overall Study|Other|62|||
23408639|NCT00662831|65239953|FG001|Overall Study|Other|31|||
23408640|NCT00662831|65239952|FG000|Overall Study|Protocol Violation|8|||
23408641|NCT00662831|65239953|FG001|Overall Study|Protocol Violation|4|||
23408642|NCT00662831|65239952|FG000|Overall Study|Adverse Event|23|||
23408643|NCT00662831|65239953|FG001|Overall Study|Adverse Event|16|||
23408644|NCT02038946|65239957|FG000|Overall Study|Death|5|||
23408645|NCT02038946|65239957|FG000|Overall Study|Withdrawal by Subject|3|||
23408646|NCT02038946|65239957|FG000|Overall Study|Lost to Follow-up|2|||
23408647|NCT02038946|65239957|FG000|Overall Study|Other reasons|2|||
23408648|NCT01119066|65239961|FG000|Overall Study|Withdrawal by Subject|4|||
23408649|NCT01119066|65239962|FG001|Overall Study|Withdrawal by Subject|6|||
23408650|NCT01119066|65239963|FG002|Overall Study|Withdrawal by Subject|0|||
23408651|NCT01119066|65239964|FG003|Overall Study|Withdrawal by Subject|0|||
23408652|NCT01119066|65239961|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
23408653|NCT01119066|65239962|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
23408654|NCT01119066|65239963|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
23408655|NCT01119066|65239964|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
23408656|NCT01119066|65239961|FG000|Overall Study|Relapse identified before transplant|1|||
23408657|NCT01119066|65239962|FG001|Overall Study|Relapse identified before transplant|0|||
23408658|NCT01119066|65239963|FG002|Overall Study|Relapse identified before transplant|0|||
23408659|NCT01119066|65239964|FG003|Overall Study|Relapse identified before transplant|0|||
23408660|NCT01119066|65239961|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
23408661|NCT01119066|65239962|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
23408662|NCT01119066|65239963|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
23408663|NCT01119066|65239964|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
23408664|NCT01119066|65239961|FG000|Overall Study|Relapse identified before transplant|0|||
23408665|NCT01119066|65239962|FG001|Overall Study|Relapse identified before transplant|4|||
23610567|NCT01964547|65962805|FG001|Overall Study|Adverse Event|2|||
23610568|NCT01964547|65962804|FG000|Overall Study|Withdrawal by Subject|4|||
23305871|NCT04168190|64862473|FG002|Overall Study|Withdrawal by Subject|0|||
23408666|NCT01119066|65239963|FG002|Overall Study|Relapse identified before transplant|0|||
23408667|NCT01119066|65239964|FG003|Overall Study|Relapse identified before transplant|0|||
23408668|NCT01833494|65239967|FG000|Overall Study|Adverse Event|24|||
23408669|NCT01833494|65239967|FG000|Overall Study|Physician Decision|6|||
23408670|NCT01833494|65239967|FG000|Overall Study|Withdrawal by Subject|6|||
23408671|NCT01833494|65239967|FG000|Overall Study|Decrease in serum phosphorus|4|||
23408672|NCT01833494|65239967|FG000|Overall Study|Decrease in serum calcium|4|||
23408673|NCT01833494|65239967|FG000|Overall Study|Increase in serum ferritin|1|||
23408674|NCT00326001|65239968|FG000|Overall Study|Adverse Event|4|||
23408675|NCT00326001|65239969|FG001|Overall Study|Adverse Event|5|||
23408676|NCT00326001|65239968|FG000|Overall Study|Physician Decision|3|||
23408677|NCT00326001|65239969|FG001|Overall Study|Physician Decision|3|||
23408678|NCT05332392|65239970|FG000|Overall Study|Did not meet inclusion criteria|25|||
23408679|NCT05332392|65239970|FG000|Overall Study|Principal Investigator's decision|17|||
23408680|NCT05332392|65239970|FG000|Overall Study|Adverse Event|1|||
23408681|NCT05332392|65239970|FG000|Overall Study|Subject's decision|1|||
23408682|NCT00334737|65239971|FG000|Hospital Phase|Death|1|||
23408683|NCT00334737|65239972|FG001|Hospital Phase|Death|2|||
23408684|NCT00334737|65239973|FG002|Hospital Phase|Death|3|||
23408685|NCT00334737|65239971|FG000|Hospital Phase|Withdrawal by Subject|0|||
23408686|NCT00334737|65239972|FG001|Hospital Phase|Withdrawal by Subject|0|||
23408687|NCT00334737|65239973|FG002|Hospital Phase|Withdrawal by Subject|1|||
23408688|NCT00334737|65239971|FG000|Hospital Phase|Did not receive study drug|1|||
23408689|NCT00334737|65239972|FG001|Hospital Phase|Did not receive study drug|0|||
23408690|NCT00334737|65239973|FG002|Hospital Phase|Did not receive study drug|0|||
23408691|NCT00334737|65239971|FG000|Follow up Phase|Lost to Follow-up|5|||
23408692|NCT00334737|65239972|FG001|Follow up Phase|Lost to Follow-up|3|||
23408693|NCT00334737|65239973|FG002|Follow up Phase|Lost to Follow-up|6|||
23408694|NCT02168101|65239978|FG000|Overall Study|Death|2|||
23408695|NCT02168101|65239979|FG001|Overall Study|Death|2|||
23510823|NCT04840615|65606174|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
23510824|NCT01442493|65606175|FG000|Overall Study|withdrawn from study|3|||
23510825|NCT01442493|65606176|FG001|Overall Study|withdrawn from study|2|||
23510826|NCT02049957|65606183|FG000|Overall Study|Progressive Disease|5|||
23510827|NCT02049957|65606184|FG001|Overall Study|Progressive Disease|4|||
23510828|NCT02049957|65606185|FG002|Overall Study|Progressive Disease|2|||
23510829|NCT02049957|65606186|FG003|Overall Study|Progressive Disease|2|||
23305872|NCT04168190|64862474|FG003|Overall Study|Withdrawal by Subject|2|||
23205057|NCT00793819|64491249|FG000|Overall Study|Withdrawal by Subject|4|||
23205058|NCT00793819|64491250|FG001|Overall Study|Withdrawal by Subject|3|||
23205059|NCT00793819|64491249|FG000|Overall Study|Lost to Follow-up|1|||
23305873|NCT04168190|64862475|FG004|Overall Study|Withdrawal by Subject|4|||
23305874|NCT04168190|64862471|FG000|Overall Study|Death|0|||
23305875|NCT04168190|64862472|FG001|Overall Study|Death|0|||
23408696|NCT02168101|65239980|FG002|Overall Study|Death|1|||
23408697|NCT01995526|65239981|FG000|Overall Study|Physician Decision|1|||
23408698|NCT00383331|65239982|FG000|Overall Study|Protocol Violation|0|||
23408699|NCT00383331|65239983|FG001|Overall Study|Protocol Violation|1|||
23510830|NCT02049957|65606187|FG004|Overall Study|Progressive Disease|6|||
23305876|NCT04168190|64862473|FG002|Overall Study|Death|0|||
23305877|NCT04168190|64862474|FG003|Overall Study|Death|1|||
23305878|NCT04168190|64862475|FG004|Overall Study|Death|0|||
23305879|NCT03551496|64862476|FG000|Overall Study|Death|11|||
23305880|NCT03551496|64862477|FG001|Overall Study|Death|7|||
23305881|NCT03551496|64862476|FG000|Overall Study|Withdrawal by Subject|4|||
23305882|NCT03551496|64862477|FG001|Overall Study|Withdrawal by Subject|3|||
23305883|NCT03551496|64862476|FG000|Overall Study|Other Reasons|1|||
23305884|NCT03551496|64862477|FG001|Overall Study|Other Reasons|0|||
23305885|NCT00712985|64862482|FG000|Overall Study|1 withdrew prior to start of drug|1|||
23305886|NCT00712985|64862482|FG000|Overall Study|1 patient moved out of state|1|||
23305887|NCT00712985|64862482|FG000|Overall Study|Lack of Efficacy|3|||
23305888|NCT00390221|64862483|FG000|Overall Study|Lost to Follow-up|0|||
23305889|NCT00390221|64862484|FG001|Overall Study|Lost to Follow-up|3|||
23305890|NCT00390221|64862485|FG002|Overall Study|Lost to Follow-up|0|||
23205060|NCT00793819|64491250|FG001|Overall Study|Lost to Follow-up|1|||
23408700|NCT00682929|65239984|FG000|Overall Study|Adverse Event|4|||
23305891|NCT00390221|64862483|FG000|Overall Study|Adverse Event|1|||
23305892|NCT00390221|64862484|FG001|Overall Study|Adverse Event|4|||
23510831|NCT02049957|65606188|FG005|Overall Study|Progressive Disease|35|||
23510832|NCT02049957|65606189|FG006|Overall Study|Progressive Disease|7|||
23305893|NCT00390221|64862485|FG002|Overall Study|Adverse Event|3|||
23305894|NCT00390221|64862483|FG000|Overall Study|Investigator Decision|0|||
23305895|NCT00390221|64862484|FG001|Overall Study|Investigator Decision|0|||
23305896|NCT00390221|64862485|FG002|Overall Study|Investigator Decision|1|||
23305897|NCT00390221|64862483|FG000|Overall Study|Withdrawal by Subject|13|||
23305898|NCT00390221|64862484|FG001|Overall Study|Withdrawal by Subject|9|||
23305899|NCT00390221|64862485|FG002|Overall Study|Withdrawal by Subject|7|||
23305900|NCT00390221|64862483|FG000|Overall Study|Subject Non-compliance|1|||
23305901|NCT00390221|64862484|FG001|Overall Study|Subject Non-compliance|0|||
23305902|NCT00390221|64862485|FG002|Overall Study|Subject Non-compliance|2|||
23305903|NCT00390221|64862483|FG000|Overall Study|Other|3|||
23305904|NCT00390221|64862484|FG001|Overall Study|Other|4|||
23305905|NCT00390221|64862485|FG002|Overall Study|Other|2|||
23305906|NCT04078126|64862490|FG000|Washout|Study put on hold due to COVID-19|0|||
23305907|NCT04078126|64862491|FG001|Washout|Study put on hold due to COVID-19|2|||
23305908|NCT04078126|64862490|FG000|Period 2|Study put on hold due to COVID-19|1|||
23305909|NCT04078126|64862491|FG001|Period 2|Study put on hold due to COVID-19|1|||
23305910|NCT05304611|64862497|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
23305911|NCT05304611|64862498|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
23305912|NCT05304611|64862499|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
23305913|NCT05304611|64862500|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
23305914|NCT05304611|64862501|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
23305915|NCT05304611|64862502|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
23305916|NCT05304611|64862503|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
23305917|NCT05304611|64862504|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
23305918|NCT05304611|64862505|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
23305919|NCT05304611|64862497|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
23305920|NCT05304611|64862498|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
23305921|NCT05304611|64862499|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
23305922|NCT05304611|64862500|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
23305923|NCT05304611|64862501|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
23305924|NCT05304611|64862502|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
23408701|NCT00682929|65239985|FG001|Overall Study|Adverse Event|1|||
23408702|NCT00682929|65239986|FG002|Overall Study|Adverse Event|1|||
23408703|NCT00682929|65239984|FG000|Overall Study|Withdrawal by Subject|1|||
23408704|NCT00682929|65239985|FG001|Overall Study|Withdrawal by Subject|2|||
23408705|NCT00682929|65239986|FG002|Overall Study|Withdrawal by Subject|1|||
23408706|NCT00682929|65239984|FG000|Overall Study|dosing compliance < 80%|0|||
23408707|NCT00682929|65239985|FG001|Overall Study|dosing compliance < 80%|2|||
23408708|NCT00682929|65239986|FG002|Overall Study|dosing compliance < 80%|0|||
23408709|NCT00682929|65239984|FG000|Overall Study|lag in DEA renewal|1|||
23305925|NCT05304611|64862503|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
23305926|NCT05304611|64862504|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
23305927|NCT05304611|64862505|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
23305928|NCT02065700|64862506|FG000|Overall Study|Adverse Event|165|||
23305929|NCT02065700|64862507|FG001|Overall Study|Adverse Event|101|||
23305930|NCT02065700|64862506|FG000|Overall Study|Withdrawal by Subject|90|||
23408710|NCT00682929|65239985|FG001|Overall Study|lag in DEA renewal|0|||
23408711|NCT00682929|65239986|FG002|Overall Study|lag in DEA renewal|0|||
23408712|NCT01453036|65239987|FG000|Overall Study|Lost to Follow-up|26|||
23408713|NCT01453036|65239988|FG001|Overall Study|Lost to Follow-up|115|||
23408714|NCT01453036|65239989|FG002|Overall Study|Lost to Follow-up|31|||
23408715|NCT03035864|65239993|FG000|Treatment Period|Adverse Event|1|||
23408716|NCT03035864|65239994|FG001|Treatment Period|Adverse Event|0|||
23305931|NCT02065700|64862507|FG001|Overall Study|Withdrawal by Subject|29|||
23305932|NCT02065700|64862506|FG000|Overall Study|Lost to Follow-up|12|||
23305933|NCT02065700|64862507|FG001|Overall Study|Lost to Follow-up|9|||
23305934|NCT02065700|64862506|FG000|Overall Study|Physician Decision|2|||
23305935|NCT02065700|64862507|FG001|Overall Study|Physician Decision|0|||
23305936|NCT02065700|64862506|FG000|Overall Study|Sponsor Request|38|||
23305937|NCT02065700|64862507|FG001|Overall Study|Sponsor Request|15|||
23305938|NCT02065700|64862506|FG000|Overall Study|Treatment Failure|3|||
23305939|NCT02065700|64862507|FG001|Overall Study|Treatment Failure|2|||
23305940|NCT02065700|64862506|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
23305941|NCT02065700|64862507|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
23305942|NCT02065700|64862506|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
23305943|NCT02065700|64862507|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
23305944|NCT02065700|64862506|FG000|Overall Study|Non-compliance with Study Procedures|2|||
23305945|NCT02065700|64862507|FG001|Overall Study|Non-compliance with Study Procedures|0|||
23305946|NCT02065700|64862506|FG000|Overall Study|Not Defined|21|||
23305947|NCT02065700|64862507|FG001|Overall Study|Not Defined|3|||
23305948|NCT02575911|64862509|FG000|Overall Study|Lost to Follow-up|1|||
23305949|NCT01672970|64862510|FG000|Overall Study|Lack of Efficacy|12|||
23305950|NCT01672970|64862510|FG000|Overall Study|Adverse Event|18|||
23305951|NCT01672970|64862510|FG000|Overall Study|Withdrawal by Subject|2|||
23305952|NCT01672970|64862510|FG000|Overall Study|Lost to Follow-up|5|||
23305953|NCT01672970|64862510|FG000|Overall Study|Other|9|||
23305954|NCT01672970|64862510|FG000|Overall Study|Enrolled but not treated|1|||
23305955|NCT04853992|64862511|FG000|Treatment Period A|Adverse Event|0|||
23305956|NCT04853992|64862512|FG001|Treatment Period A|Adverse Event|1|||
23305957|NCT04853992|64862511|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
23305958|NCT04853992|64862512|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
23305959|NCT01685073|64862515|FG000|Overall Study|Lost to Follow-up|6|||
23305960|NCT01685073|64862516|FG001|Overall Study|Lost to Follow-up|8|||
23305961|NCT01685073|64862515|FG000|Overall Study|Withdrawal by Subject|24|||
23305962|NCT01685073|64862516|FG001|Overall Study|Withdrawal by Subject|24|||
23305963|NCT02288182|64862517|FG000|Overall Study|Adverse Event|0|||
23305964|NCT02288182|64862518|FG001|Overall Study|Adverse Event|1|||
23305965|NCT02288182|64862517|FG000|Overall Study|Lost to Follow-up|0|||
23305966|NCT02288182|64862518|FG001|Overall Study|Lost to Follow-up|1|||
23305967|NCT02139124|64862521|FG000|Overall Study|Adverse Event|2|||
23305968|NCT02139124|64862522|FG001|Overall Study|Adverse Event|0|||
23305969|NCT02139124|64862523|FG002|Overall Study|Adverse Event|1|||
23305970|NCT02139124|64862524|FG003|Overall Study|Adverse Event|2|||
23305971|NCT02139124|64862525|FG004|Overall Study|Adverse Event|5|||
23305972|NCT02139124|64862521|FG000|Overall Study|Withdrawal by Subject|2|||
23305973|NCT02139124|64862522|FG001|Overall Study|Withdrawal by Subject|2|||
23305974|NCT02139124|64862523|FG002|Overall Study|Withdrawal by Subject|2|||
23305975|NCT02139124|64862524|FG003|Overall Study|Withdrawal by Subject|2|||
23305976|NCT02139124|64862525|FG004|Overall Study|Withdrawal by Subject|3|||
23408717|NCT03035864|65239993|FG000|Treatment Period|Other|3|||
23305977|NCT02139124|64862521|FG000|Overall Study|Protocol Violation|0|||
23305978|NCT02139124|64862522|FG001|Overall Study|Protocol Violation|0|||
23305979|NCT02139124|64862523|FG002|Overall Study|Protocol Violation|0|||
23305980|NCT02139124|64862524|FG003|Overall Study|Protocol Violation|1|||
23305981|NCT02139124|64862525|FG004|Overall Study|Protocol Violation|1|||
23305982|NCT02139124|64862521|FG000|Overall Study|non-compliant|1|||
23305983|NCT02139124|64862522|FG001|Overall Study|non-compliant|0|||
23305984|NCT02139124|64862523|FG002|Overall Study|non-compliant|0|||
23305985|NCT02139124|64862524|FG003|Overall Study|non-compliant|2|||
23305986|NCT02139124|64862525|FG004|Overall Study|non-compliant|0|||
23408718|NCT03035864|65239994|FG001|Treatment Period|Other|1|||
23408719|NCT03035864|65239993|FG000|Follow-up Period|Adverse Event|1|||
23408720|NCT03035864|65239994|FG001|Follow-up Period|Adverse Event|0|||
23408721|NCT03035864|65239993|FG000|Follow-up Period|Lost to Follow-up|6|||
23408722|NCT03035864|65239994|FG001|Follow-up Period|Lost to Follow-up|2|||
23408723|NCT03035864|65239993|FG000|Follow-up Period|Physician Decision|1|||
23408724|NCT03035864|65239994|FG001|Follow-up Period|Physician Decision|0|||
23408725|NCT03035864|65239993|FG000|Follow-up Period|Other|3|||
23408726|NCT03035864|65239994|FG001|Follow-up Period|Other|2|||
23408727|NCT00288015|65239995|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
23408728|NCT00288015|65239995|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
23305987|NCT02139124|64862521|FG000|Overall Study|incarceration|0|||
23305988|NCT02139124|64862522|FG001|Overall Study|incarceration|0|||
23305989|NCT02139124|64862523|FG002|Overall Study|incarceration|1|||
23305990|NCT02139124|64862524|FG003|Overall Study|incarceration|0|||
23305991|NCT02139124|64862525|FG004|Overall Study|incarceration|0|||
23305992|NCT02139124|64862521|FG000|Overall Study|subject moved|1|||
23305993|NCT02139124|64862522|FG001|Overall Study|subject moved|0|||
23305994|NCT02139124|64862523|FG002|Overall Study|subject moved|0|||
23305995|NCT02139124|64862524|FG003|Overall Study|subject moved|0|||
23305996|NCT02139124|64862525|FG004|Overall Study|subject moved|0|||
23305997|NCT02139124|64862521|FG000|Overall Study|Lost to Follow-up|3|||
23305998|NCT02139124|64862522|FG001|Overall Study|Lost to Follow-up|2|||
23305999|NCT02139124|64862523|FG002|Overall Study|Lost to Follow-up|0|||
23306000|NCT02139124|64862524|FG003|Overall Study|Lost to Follow-up|5|||
23306001|NCT02139124|64862525|FG004|Overall Study|Lost to Follow-up|4|||
23306002|NCT01797835|64862526|FG000|Overall Study|Lost to Follow-up|31|||
23306003|NCT01797835|64862527|FG001|Overall Study|Lost to Follow-up|27|||
23306004|NCT03188666|64862535|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
23306005|NCT03188666|64862536|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
23306006|NCT03188666|64862537|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
23408729|NCT00288015|65239995|FG000|First Response Assessment|Withdrawal by Subject|1|||
23408730|NCT00288015|65239995|FG000|First Response Assessment|Death|1|||
23408731|NCT00288015|65239995|FG000|First Response Assessment|Physician Decision|2|||
23408732|NCT00288015|65239995|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
23408733|NCT00288015|65239995|FG000|Follow up for Survival x 2 Years|Death|13|||
23408734|NCT00288015|65239995|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
23408735|NCT00288015|65239995|FG000|Follow up for Survival x 2 Years|Other|9|||
23408736|NCT03663569|65239998|FG000|Overall Study|Discontinuation of study|11|||
23408737|NCT03663569|65239998|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
23408738|NCT03663569|65239998|FG000|Overall Study|Deceased patient|6|||
23408739|NCT03663569|65239998|FG000|Overall Study|Lost to Follow-up|18|||
23408740|NCT03663569|65239998|FG000|Overall Study|Withdrawal of consent|5|||
23408741|NCT03663569|65239998|FG000|Overall Study|Patient's request|11|||
23408742|NCT03663569|65239998|FG000|Overall Study|Adverse Event|4|||
23408743|NCT03663569|65239998|FG000|Overall Study|Not come to second visit|3|||
23306007|NCT03188666|64862538|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
23306008|NCT03188666|64862535|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
23408744|NCT03663569|65239998|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
23306009|NCT03188666|64862536|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
23306010|NCT03188666|64862537|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
23408745|NCT03663569|65239998|FG000|Overall Study|Serious adverse event|1|||
23408746|NCT00078806|65239999|FG000|Part 1A|Adverse Event|2|||
23408747|NCT00078806|65240000|FG001|Part 1A|Adverse Event|0|||
23408748|NCT00078806|65240001|FG002|Part 1A|Adverse Event|0|||
23306011|NCT03188666|64862538|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
23306012|NCT03188666|64862535|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
23408749|NCT00078806|65240002|FG003|Part 1A|Adverse Event|0|||
23306013|NCT03188666|64862536|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
23408750|NCT00078806|65239999|FG000|Part 1A|Lack of Efficacy|7|||
23205061|NCT01511419|64491253|FG000|Dose 2|Physician Decision|1|||
23408751|NCT00078806|65240000|FG001|Part 1A|Lack of Efficacy|0|||
23408752|NCT00078806|65240001|FG002|Part 1A|Lack of Efficacy|0|||
23408753|NCT00078806|65240002|FG003|Part 1A|Lack of Efficacy|0|||
23408754|NCT00078806|65239999|FG000|Part 1A|Other|1|||
23408755|NCT00078806|65240000|FG001|Part 1A|Other|0|||
23408756|NCT00078806|65240001|FG002|Part 1A|Other|0|||
23408757|NCT00078806|65240002|FG003|Part 1A|Other|0|||
23408758|NCT00078806|65239999|FG000|Part 1B|Adverse Event|1|||
23408759|NCT00078806|65240000|FG001|Part 1B|Adverse Event|0|||
23408760|NCT00078806|65240001|FG002|Part 1B|Adverse Event|0|||
23408761|NCT00078806|65240002|FG003|Part 1B|Adverse Event|0|||
23408762|NCT00078806|65239999|FG000|Part 1B|Lack of Efficacy|7|||
23408763|NCT00078806|65240000|FG001|Part 1B|Lack of Efficacy|0|||
23408764|NCT00078806|65240001|FG002|Part 1B|Lack of Efficacy|0|||
23306014|NCT03188666|64862537|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
23306015|NCT03188666|64862538|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
23408765|NCT00078806|65240002|FG003|Part 1B|Lack of Efficacy|0|||
23408766|NCT00078806|65239999|FG000|Part 2|Adverse Event|0|||
23408767|NCT00078806|65240000|FG001|Part 2|Adverse Event|1|||
23408768|NCT00078806|65240001|FG002|Part 2|Adverse Event|0|||
23408769|NCT00078806|65240002|FG003|Part 2|Adverse Event|0|||
23408770|NCT03367403|65240003|FG000|Overall Study|Adverse Event|20|||
23408771|NCT03367403|65240004|FG001|Overall Study|Adverse Event|6|||
23408772|NCT03367403|65240005|FG002|Overall Study|Adverse Event|2|||
23408773|NCT03367403|65240003|FG000|Overall Study|Withdrawal by Subject|12|||
23408774|NCT03367403|65240004|FG001|Overall Study|Withdrawal by Subject|13|||
23408775|NCT03367403|65240005|FG002|Overall Study|Withdrawal by Subject|1|||
23408776|NCT03367403|65240003|FG000|Overall Study|Death|1|||
23408777|NCT03367403|65240004|FG001|Overall Study|Death|2|||
23408778|NCT03367403|65240005|FG002|Overall Study|Death|0|||
23408779|NCT03367403|65240003|FG000|Overall Study|Physician Decision|0|||
23408780|NCT03367403|65240004|FG001|Overall Study|Physician Decision|1|||
23408781|NCT03367403|65240005|FG002|Overall Study|Physician Decision|0|||
23408782|NCT03367403|65240003|FG000|Overall Study|Protocol Violation|1|||
23408783|NCT03367403|65240004|FG001|Overall Study|Protocol Violation|1|||
23408784|NCT03367403|65240005|FG002|Overall Study|Protocol Violation|0|||
23408785|NCT03367403|65240003|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
23408786|NCT03367403|65240004|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
23408787|NCT03367403|65240005|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
23408788|NCT03367403|65240003|FG000|Overall Study|COVID-19|3|||
23408789|NCT03367403|65240004|FG001|Overall Study|COVID-19|6|||
23408790|NCT03367403|65240005|FG002|Overall Study|COVID-19|0|||
23306016|NCT03188666|64862535|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
23306017|NCT03188666|64862536|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
23306018|NCT03188666|64862537|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
23306019|NCT03188666|64862538|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
23306020|NCT02056392|64862541|FG000|Overall Study|Lost to Follow-up|0|||
23306021|NCT02056392|64862542|FG001|Overall Study|Lost to Follow-up|1|||
23306022|NCT02056392|64862543|FG002|Overall Study|Lost to Follow-up|2|||
23306023|NCT02056392|64862544|FG003|Overall Study|Lost to Follow-up|0|||
23306024|NCT02056392|64862545|FG004|Overall Study|Lost to Follow-up|0|||
23306025|NCT02056392|64862546|FG005|Overall Study|Lost to Follow-up|0|||
23306026|NCT02056392|64862541|FG000|Overall Study|Protocol Violation|1|||
23306027|NCT02056392|64862542|FG001|Overall Study|Protocol Violation|0|||
23306028|NCT02056392|64862543|FG002|Overall Study|Protocol Violation|1|||
23306029|NCT02056392|64862544|FG003|Overall Study|Protocol Violation|0|||
23306030|NCT02056392|64862545|FG004|Overall Study|Protocol Violation|0|||
23306031|NCT02056392|64862546|FG005|Overall Study|Protocol Violation|0|||
23306032|NCT02056392|64862541|FG000|Overall Study|Withdrawal by Subject|1|||
23306033|NCT02056392|64862542|FG001|Overall Study|Withdrawal by Subject|0|||
23306034|NCT02056392|64862543|FG002|Overall Study|Withdrawal by Subject|0|||
23306035|NCT02056392|64862544|FG003|Overall Study|Withdrawal by Subject|0|||
23306036|NCT02056392|64862545|FG004|Overall Study|Withdrawal by Subject|1|||
23306037|NCT02056392|64862546|FG005|Overall Study|Withdrawal by Subject|0|||
23306038|NCT00302081|64862547|FG000|Overall Study|Adverse Event|6|||
23306039|NCT00302081|64862548|FG001|Overall Study|Adverse Event|5|||
23408791|NCT03367403|65240003|FG000|Overall Study|Abuse of Alcohol Intake|0|||
23408792|NCT03367403|65240004|FG001|Overall Study|Abuse of Alcohol Intake|1|||
23408793|NCT03367403|65240005|FG002|Overall Study|Abuse of Alcohol Intake|0|||
23408794|NCT03367403|65240003|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
23408795|NCT03367403|65240004|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
23408796|NCT03367403|65240005|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
23306040|NCT00302081|64862549|FG002|Overall Study|Adverse Event|4|||
23306041|NCT00302081|64862547|FG000|Overall Study|Lost to Follow-up|21|||
23306042|NCT00302081|64862548|FG001|Overall Study|Lost to Follow-up|18|||
23306043|NCT00302081|64862549|FG002|Overall Study|Lost to Follow-up|28|||
23408797|NCT01772550|65240006|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
23306044|NCT00302081|64862547|FG000|Overall Study|Withdrawal by Subject|8|||
23306045|NCT00302081|64862548|FG001|Overall Study|Withdrawal by Subject|12|||
23306046|NCT00302081|64862549|FG002|Overall Study|Withdrawal by Subject|8|||
23306047|NCT00302081|64862547|FG000|Overall Study|Protocol Violation|5|||
23306048|NCT00302081|64862548|FG001|Overall Study|Protocol Violation|1|||
23306049|NCT00302081|64862549|FG002|Overall Study|Protocol Violation|2|||
23306050|NCT00302081|64862547|FG000|Overall Study|Lack of Efficacy|1|||
23306051|NCT00302081|64862548|FG001|Overall Study|Lack of Efficacy|0|||
23306052|NCT00302081|64862549|FG002|Overall Study|Lack of Efficacy|5|||
23306053|NCT00302081|64862547|FG000|Overall Study|Death|2|||
23306054|NCT00302081|64862548|FG001|Overall Study|Death|1|||
23306055|NCT00302081|64862549|FG002|Overall Study|Death|0|||
23306056|NCT00302081|64862547|FG000|Overall Study|Other|13|||
23306057|NCT00302081|64862548|FG001|Overall Study|Other|6|||
23306058|NCT00302081|64862549|FG002|Overall Study|Other|5|||
23306059|NCT01941940|64862550|FG000|Overall Study|Adverse Event|11|||
23306060|NCT01941940|64862550|FG000|Overall Study|Lost to Follow-up|2|||
23306061|NCT01941940|64862550|FG000|Overall Study|Physician Decision|2|||
23306062|NCT01941940|64862550|FG000|Overall Study|Withdrawal by Subject|15|||
23306063|NCT01941940|64862550|FG000|Overall Study|Death|1|||
23306064|NCT01941940|64862550|FG000|Overall Study|Other|1|||
23306065|NCT01941940|64862550|FG000|Overall Study|Other|1|||
23306066|NCT01300052|64862551|FG000|Overall Study|Adverse Event|3|||
23306067|NCT01300052|64862552|FG001|Overall Study|Adverse Event|0|||
23306068|NCT01300052|64862551|FG000|Overall Study|Withdrawal by Subject|2|||
23306069|NCT01300052|64862552|FG001|Overall Study|Withdrawal by Subject|2|||
23306070|NCT01300052|64862551|FG000|Overall Study|Protocol Violation|1|||
23306071|NCT01300052|64862552|FG001|Overall Study|Protocol Violation|1|||
23306072|NCT02493777|64862556|FG000|Overall Study|Lost to Follow-up|0|||
23306073|NCT02493777|64862557|FG001|Overall Study|Lost to Follow-up|1|||
23306074|NCT00557076|64862559|FG000|Overall Study|Unblinding|0|||
23306075|NCT00557076|64862560|FG001|Overall Study|Unblinding|1|||
23306076|NCT02685202|64862567|FG000|Overall Study|Lost to Follow-up|9|||
23306077|NCT02331368|64862571|FG000|Overall Study|Withdrawal by Subject|3|||
23306078|NCT02384941|64862572|FG000|Overall Study|Adverse Event|11|||
23306079|NCT02384941|64862573|FG001|Overall Study|Adverse Event|13|||
23306080|NCT02384941|64862574|FG002|Overall Study|Adverse Event|17|||
23306081|NCT02384941|64862572|FG000|Overall Study|Lost to Follow-up|3|||
23306082|NCT02384941|64862573|FG001|Overall Study|Lost to Follow-up|2|||
23306083|NCT02384941|64862574|FG002|Overall Study|Lost to Follow-up|1|||
23306084|NCT02384941|64862572|FG000|Overall Study|Non-Compliance With Study Drug|2|||
23306085|NCT02384941|64862573|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23306086|NCT02384941|64862574|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23306087|NCT02384941|64862572|FG000|Overall Study|Physician Decision|1|||
23306088|NCT02384941|64862573|FG001|Overall Study|Physician Decision|1|||
23306089|NCT02384941|64862574|FG002|Overall Study|Physician Decision|0|||
23306090|NCT02384941|64862572|FG000|Overall Study|Protocol Violation|3|||
23306091|NCT02384941|64862573|FG001|Overall Study|Protocol Violation|0|||
23306092|NCT02384941|64862574|FG002|Overall Study|Protocol Violation|0|||
23306093|NCT02384941|64862572|FG000|Overall Study|Withdrawal by Subject|26|||
23306094|NCT02384941|64862573|FG001|Overall Study|Withdrawal by Subject|19|||
23306095|NCT02384941|64862574|FG002|Overall Study|Withdrawal by Subject|20|||
23306096|NCT02384941|64862572|FG000|Overall Study|Pregnancy|0|||
23306097|NCT02384941|64862573|FG001|Overall Study|Pregnancy|0|||
23306098|NCT02384941|64862574|FG002|Overall Study|Pregnancy|1|||
23306099|NCT02384941|64862572|FG000|Overall Study|Other than specified above|4|||
23306100|NCT02384941|64862573|FG001|Overall Study|Other than specified above|0|||
23306101|NCT02384941|64862574|FG002|Overall Study|Other than specified above|1|||
23306102|NCT01172821|64862575|FG000|Overall Study|Adverse Event|5|||
23306103|NCT01172821|64862576|FG001|Overall Study|Adverse Event|2|||
23306104|NCT01172821|64862577|FG002|Overall Study|Adverse Event|2|||
23306105|NCT01172821|64862578|FG003|Overall Study|Adverse Event|7|||
23306106|NCT01172821|64862575|FG000|Overall Study|Protocol Violation|0|||
23306107|NCT01172821|64862576|FG001|Overall Study|Protocol Violation|2|||
23306108|NCT01172821|64862577|FG002|Overall Study|Protocol Violation|1|||
23306109|NCT01172821|64862578|FG003|Overall Study|Protocol Violation|2|||
23306110|NCT01172821|64862575|FG000|Overall Study|Lost to Follow-up|4|||
23306111|NCT01172821|64862576|FG001|Overall Study|Lost to Follow-up|1|||
23306112|NCT01172821|64862577|FG002|Overall Study|Lost to Follow-up|2|||
23306113|NCT01172821|64862578|FG003|Overall Study|Lost to Follow-up|2|||
23306114|NCT01172821|64862575|FG000|Overall Study|Withdrawal by Subject|2|||
23306115|NCT01172821|64862576|FG001|Overall Study|Withdrawal by Subject|3|||
23306116|NCT01172821|64862577|FG002|Overall Study|Withdrawal by Subject|3|||
23306117|NCT01172821|64862578|FG003|Overall Study|Withdrawal by Subject|3|||
23306118|NCT01172821|64862575|FG000|Overall Study|Other|3|||
23306119|NCT01172821|64862576|FG001|Overall Study|Other|4|||
23306120|NCT01172821|64862577|FG002|Overall Study|Other|5|||
23306121|NCT01172821|64862578|FG003|Overall Study|Other|3|||
23306122|NCT01167257|64862579|FG000|Overall Study|Lost to Follow-up|2|||
23306123|NCT01167257|64862580|FG001|Overall Study|Lost to Follow-up|2|||
23306124|NCT01167257|64862579|FG000|Overall Study|Withdrew consent|1|||
23306125|NCT01167257|64862580|FG001|Overall Study|Withdrew consent|1|||
23306126|NCT00430495|64862581|FG000|Overall Study|Adverse Event|2|||
23306127|NCT00430495|64862582|FG001|Overall Study|Adverse Event|3|||
23306128|NCT00430495|64862583|FG002|Overall Study|Adverse Event|2|||
23306129|NCT00430495|64862584|FG003|Overall Study|Adverse Event|0|||
23306130|NCT00430495|64862581|FG000|Overall Study|Death|0|||
23306131|NCT00430495|64862582|FG001|Overall Study|Death|0|||
23306132|NCT00430495|64862583|FG002|Overall Study|Death|1|||
23306133|NCT00430495|64862584|FG003|Overall Study|Death|0|||
23306134|NCT00430495|64862581|FG000|Overall Study|Lost to Follow-up|0|||
23306135|NCT00430495|64862582|FG001|Overall Study|Lost to Follow-up|1|||
23306136|NCT00430495|64862583|FG002|Overall Study|Lost to Follow-up|4|||
23510833|NCT02049957|65606190|FG007|Overall Study|Progressive Disease|26|||
23306137|NCT00430495|64862584|FG003|Overall Study|Lost to Follow-up|0|||
23306138|NCT00430495|64862581|FG000|Overall Study|Protocol Violation|1|||
23306139|NCT00430495|64862582|FG001|Overall Study|Protocol Violation|0|||
23306140|NCT00430495|64862583|FG002|Overall Study|Protocol Violation|1|||
23306141|NCT00430495|64862584|FG003|Overall Study|Protocol Violation|0|||
23306142|NCT00430495|64862581|FG000|Overall Study|Disease Progression|1|||
23306143|NCT00430495|64862582|FG001|Overall Study|Disease Progression|1|||
23306144|NCT00430495|64862583|FG002|Overall Study|Disease Progression|0|||
23306145|NCT00430495|64862584|FG003|Overall Study|Disease Progression|0|||
23510834|NCT02049957|65606191|FG008|Overall Study|Progressive Disease|6|||
23306146|NCT00430495|64862581|FG000|Overall Study|Other|8|||
23306147|NCT00430495|64862582|FG001|Overall Study|Other|2|||
23306148|NCT00430495|64862583|FG002|Overall Study|Other|5|||
23306149|NCT00430495|64862584|FG003|Overall Study|Other|4|||
23306150|NCT00430495|64862581|FG000|Overall Study|Randomized but not Treated|2|||
23306151|NCT00430495|64862582|FG001|Overall Study|Randomized but not Treated|0|||
23306152|NCT00430495|64862583|FG002|Overall Study|Randomized but not Treated|0|||
23510835|NCT02049957|65606183|FG000|Overall Study|Adverse Event|1|||
23306153|NCT00430495|64862584|FG003|Overall Study|Randomized but not Treated|0|||
23306154|NCT00112866|64862585|FG000|Overall Study|Protocol Violation|1|||
23306155|NCT00112866|64862586|FG001|Overall Study|Protocol Violation|0|||
23306156|NCT00112866|64862585|FG000|Overall Study|did not start treatment post-op|1|||
23306157|NCT00112866|64862586|FG001|Overall Study|did not start treatment post-op|2|||
23306158|NCT01732484|64862587|FG000|Overall Study|Death|7|||
23306159|NCT01732484|64862587|FG000|Overall Study|Lost to Follow-up|14|||
23306160|NCT01732484|64862587|FG000|Overall Study|chronical illness|5|||
23306161|NCT02528123|64862599|FG000|Overall Study|Lost to Follow-up|1|||
23306162|NCT00440466|64866280|FG000|Overall Study|Death|3|||
23306163|NCT00440466|64866281|FG001|Overall Study|Death|2|||
23306164|NCT00440466|64866282|FG002|Overall Study|Death|9|||
23306165|NCT00440466|64866280|FG000|Overall Study|Adverse Event|3|||
23306166|NCT00440466|64866281|FG001|Overall Study|Adverse Event|4|||
23306167|NCT00440466|64866282|FG002|Overall Study|Adverse Event|11|||
23306168|NCT00440466|64866280|FG000|Overall Study|Lost to Follow-up|1|||
23306169|NCT00440466|64866281|FG001|Overall Study|Lost to Follow-up|0|||
23306170|NCT00440466|64866282|FG002|Overall Study|Lost to Follow-up|2|||
23306171|NCT00440466|64866280|FG000|Overall Study|Physician Decision|2|||
23306172|NCT00440466|64866281|FG001|Overall Study|Physician Decision|0|||
23306173|NCT00440466|64866282|FG002|Overall Study|Physician Decision|1|||
23306174|NCT00440466|64866280|FG000|Overall Study|Protocol Violation|2|||
23306175|NCT00440466|64866281|FG001|Overall Study|Protocol Violation|0|||
23306176|NCT00440466|64866282|FG002|Overall Study|Protocol Violation|4|||
23306177|NCT00440466|64866280|FG000|Overall Study|Withdrawal by Subject|2|||
23306178|NCT00440466|64866281|FG001|Overall Study|Withdrawal by Subject|5|||
23306179|NCT00440466|64866282|FG002|Overall Study|Withdrawal by Subject|9|||
23306180|NCT00440466|64866280|FG000|Overall Study|Began Dialysis|0|||
23306181|NCT00440466|64866281|FG001|Overall Study|Began Dialysis|0|||
23306182|NCT00440466|64866282|FG002|Overall Study|Began Dialysis|1|||
23306183|NCT00440466|64866280|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
23306184|NCT00440466|64866281|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
23306185|NCT00440466|64866282|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
23306186|NCT03251963|64866283|FG000|Overall Study|inappropriate Xa level timing|6|||
23306187|NCT03251963|64866284|FG001|Overall Study|inappropriate Xa level timing|3|||
23306188|NCT03251963|64866283|FG000|Overall Study|no peak Xa level drawn|2|||
23306189|NCT03251963|64866284|FG001|Overall Study|no peak Xa level drawn|0|||
23306190|NCT03251963|64866283|FG000|Overall Study|bled prior to Xa level|1|||
23306191|NCT03251963|64866284|FG001|Overall Study|bled prior to Xa level|2|||
23306192|NCT02906930|64866285|FG000|Overall Study|Withdrawal by Subject|0|||
23306193|NCT02906930|64866286|FG001|Overall Study|Withdrawal by Subject|5|||
23306194|NCT02906930|64866287|FG002|Overall Study|Withdrawal by Subject|5|||
23306195|NCT02906930|64866288|FG003|Overall Study|Withdrawal by Subject|4|||
23306196|NCT02906930|64866285|FG000|Overall Study|Lost to Follow-up|5|||
23306197|NCT02906930|64866286|FG001|Overall Study|Lost to Follow-up|7|||
23306198|NCT02906930|64866287|FG002|Overall Study|Lost to Follow-up|5|||
23306199|NCT02906930|64866288|FG003|Overall Study|Lost to Follow-up|2|||
23306200|NCT02906930|64866285|FG000|Overall Study|Death|0|||
23306201|NCT02906930|64866286|FG001|Overall Study|Death|0|||
23306202|NCT02906930|64866287|FG002|Overall Study|Death|1|||
23306203|NCT02906930|64866288|FG003|Overall Study|Death|0|||
23306204|NCT02906930|64866285|FG000|Overall Study|Other|1|||
23306205|NCT02906930|64866286|FG001|Overall Study|Other|2|||
23306206|NCT02906930|64866287|FG002|Overall Study|Other|1|||
23306207|NCT02906930|64866288|FG003|Overall Study|Other|2|||
23306208|NCT04688931|64866289|FG000|Overall Study|Adverse Event|4|||
23306209|NCT04688931|64866290|FG001|Overall Study|Adverse Event|1|||
23306210|NCT04688931|64866289|FG000|Overall Study|Withdrawal by Subject|5|||
23306211|NCT04688931|64866290|FG001|Overall Study|Withdrawal by Subject|16|||
23306212|NCT04688931|64866289|FG000|Overall Study|Physician Decision|3|||
23306213|NCT04688931|64866290|FG001|Overall Study|Physician Decision|5|||
23306214|NCT04688931|64866289|FG000|Overall Study|Noncompliance|0|||
23306215|NCT04688931|64866290|FG001|Overall Study|Noncompliance|1|||
23306216|NCT04688931|64866289|FG000|Overall Study|Lost to Follow-up|1|||
23306217|NCT04688931|64866290|FG001|Overall Study|Lost to Follow-up|3|||
23306218|NCT04688931|64866289|FG000|Overall Study|Randomization Error|3|||
23306219|NCT04688931|64866290|FG001|Overall Study|Randomization Error|0|||
23306220|NCT04688931|64866289|FG000|Overall Study|Not Eligible|1|||
23306221|NCT04688931|64866290|FG001|Overall Study|Not Eligible|3|||
23306222|NCT04688931|64866289|FG000|Overall Study|Disease Progression|0|||
23306223|NCT04688931|64866290|FG001|Overall Study|Disease Progression|2|||
23306224|NCT04688931|64866289|FG000|Overall Study|Sponsor Requirement|1|||
23306225|NCT04688931|64866290|FG001|Overall Study|Sponsor Requirement|1|||
23306226|NCT04688931|64866289|FG000|Overall Study|Other Reason|1|||
23306227|NCT04688931|64866290|FG001|Overall Study|Other Reason|2|||
23306228|NCT02408068|64866291|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
23306229|NCT02408068|64866292|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
23306230|NCT02408068|64866293|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
23306231|NCT02408068|64866294|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
23306232|NCT02408068|64866295|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
23306233|NCT02408068|64866296|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
23306234|NCT01183221|64866299|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
23306235|NCT01183221|64866300|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
23306236|NCT00826449|64866309|FG000|Overall Study|Disease Progression|4|||
23306237|NCT00826449|64866309|FG000|Overall Study|Withdrawal by Subject|1|||
23306238|NCT01433549|64866310|FG000|Phase 2: Second Study Product|Adverse Event|0|||
23306239|NCT01433549|64866311|FG001|Phase 2: Second Study Product|Adverse Event|1|||
23306240|NCT03052959|64866313|FG000|Overall Study|Lost to Follow-up|4|||
23306241|NCT03052959|64866314|FG001|Overall Study|Lost to Follow-up|5|||
23306242|NCT00158756|64866315|FG000|Overall Study|Withdrawal by Subject|5|||
23306243|NCT00158756|64866316|FG001|Overall Study|Withdrawal by Subject|0|||
23306244|NCT00158756|64866317|FG002|Overall Study|Withdrawal by Subject|6|||
23306245|NCT00158756|64866318|FG003|Overall Study|Withdrawal by Subject|1|||
23306246|NCT00158756|64866319|FG004|Overall Study|Withdrawal by Subject|3|||
23306247|NCT00158756|64866315|FG000|Overall Study|Adverse Event|0|||
23306248|NCT00158756|64866316|FG001|Overall Study|Adverse Event|0|||
23306249|NCT00158756|64866317|FG002|Overall Study|Adverse Event|1|||
23306250|NCT00158756|64866318|FG003|Overall Study|Adverse Event|0|||
23306251|NCT00158756|64866319|FG004|Overall Study|Adverse Event|0|||
23306252|NCT00158756|64866315|FG000|Overall Study|Serious adverse event|0|||
23306253|NCT00158756|64866316|FG001|Overall Study|Serious adverse event|0|||
23306254|NCT00158756|64866317|FG002|Overall Study|Serious adverse event|1|||
23306255|NCT00158756|64866318|FG003|Overall Study|Serious adverse event|0|||
23306256|NCT00158756|64866319|FG004|Overall Study|Serious adverse event|0|||
23306257|NCT02307266|64866321|FG000|Overall Study|Adverse Event|3|||
23306258|NCT02307266|64866322|FG001|Overall Study|Adverse Event|1|||
23306259|NCT02307266|64866323|FG002|Overall Study|Adverse Event|5|||
23306260|NCT02307266|64866321|FG000|Overall Study|Withdrawal by Subject|2|||
23306261|NCT02307266|64866322|FG001|Overall Study|Withdrawal by Subject|0|||
23306262|NCT02307266|64866323|FG002|Overall Study|Withdrawal by Subject|1|||
23306263|NCT02307266|64866321|FG000|Overall Study|Lost to Follow-up|3|||
23306264|NCT02307266|64866322|FG001|Overall Study|Lost to Follow-up|0|||
23306265|NCT02307266|64866323|FG002|Overall Study|Lost to Follow-up|0|||
23306266|NCT00251719|64866324|FG000|Overall Study|Adverse Event|14|||
23306267|NCT00251719|64866325|FG001|Overall Study|Adverse Event|8|||
23306268|NCT00251719|64866326|FG002|Overall Study|Adverse Event|7|||
23306269|NCT00251719|64866324|FG000|Overall Study|Protocol Violation|1|||
23306270|NCT00251719|64866325|FG001|Overall Study|Protocol Violation|1|||
23306271|NCT00251719|64866326|FG002|Overall Study|Protocol Violation|1|||
23306272|NCT00251719|64866324|FG000|Overall Study|Lost to Follow-up|5|||
23306273|NCT00251719|64866325|FG001|Overall Study|Lost to Follow-up|11|||
23306274|NCT00251719|64866326|FG002|Overall Study|Lost to Follow-up|8|||
23306275|NCT00251719|64866324|FG000|Overall Study|Withdrawal by Subject|14|||
23306276|NCT00251719|64866325|FG001|Overall Study|Withdrawal by Subject|12|||
23306277|NCT00251719|64866326|FG002|Overall Study|Withdrawal by Subject|11|||
23306278|NCT00251719|64866324|FG000|Overall Study|Lack of Efficacy|2|||
23306279|NCT00251719|64866325|FG001|Overall Study|Lack of Efficacy|1|||
23306280|NCT00251719|64866326|FG002|Overall Study|Lack of Efficacy|0|||
23306281|NCT00251719|64866324|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
23306282|NCT00251719|64866325|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
23306283|NCT00251719|64866326|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
23306284|NCT00251719|64866324|FG000|Overall Study|Investigator decision|1|||
23306285|NCT00251719|64866325|FG001|Overall Study|Investigator decision|1|||
23306286|NCT00251719|64866326|FG002|Overall Study|Investigator decision|0|||
23510836|NCT02049957|65606184|FG001|Overall Study|Adverse Event|1|||
23510837|NCT02049957|65606185|FG002|Overall Study|Adverse Event|1|||
23510838|NCT02049957|65606186|FG003|Overall Study|Adverse Event|0|||
23510839|NCT02049957|65606187|FG004|Overall Study|Adverse Event|0|||
23510840|NCT02049957|65606188|FG005|Overall Study|Adverse Event|5|||
23510841|NCT02049957|65606189|FG006|Overall Study|Adverse Event|0|||
23510842|NCT02049957|65606190|FG007|Overall Study|Adverse Event|6|||
23510843|NCT02049957|65606191|FG008|Overall Study|Adverse Event|1|||
23510844|NCT02049957|65606183|FG000|Overall Study|Study Terminated by Sponsor|0|||
23510845|NCT02049957|65606184|FG001|Overall Study|Study Terminated by Sponsor|1|||
23510846|NCT02049957|65606185|FG002|Overall Study|Study Terminated by Sponsor|0|||
23510847|NCT02049957|65606186|FG003|Overall Study|Study Terminated by Sponsor|0|||
23510848|NCT02049957|65606187|FG004|Overall Study|Study Terminated by Sponsor|0|||
23510849|NCT02049957|65606188|FG005|Overall Study|Study Terminated by Sponsor|0|||
23510850|NCT02049957|65606189|FG006|Overall Study|Study Terminated by Sponsor|1|||
23510851|NCT02049957|65606190|FG007|Overall Study|Study Terminated by Sponsor|0|||
23510852|NCT02049957|65606191|FG008|Overall Study|Study Terminated by Sponsor|0|||
23510853|NCT02049957|65606183|FG000|Overall Study|Withdrawal by Subject|0|||
23510854|NCT02049957|65606184|FG001|Overall Study|Withdrawal by Subject|0|||
23510855|NCT02049957|65606185|FG002|Overall Study|Withdrawal by Subject|0|||
23510856|NCT02049957|65606186|FG003|Overall Study|Withdrawal by Subject|1|||
23510857|NCT02049957|65606187|FG004|Overall Study|Withdrawal by Subject|0|||
23510858|NCT02049957|65606188|FG005|Overall Study|Withdrawal by Subject|2|||
23510859|NCT02049957|65606189|FG006|Overall Study|Withdrawal by Subject|0|||
23510860|NCT02049957|65606190|FG007|Overall Study|Withdrawal by Subject|3|||
23510861|NCT02049957|65606191|FG008|Overall Study|Withdrawal by Subject|1|||
23510862|NCT02049957|65606183|FG000|Overall Study|Physician Decision|0|||
23510863|NCT02049957|65606184|FG001|Overall Study|Physician Decision|0|||
23510864|NCT02049957|65606185|FG002|Overall Study|Physician Decision|0|||
23510865|NCT02049957|65606186|FG003|Overall Study|Physician Decision|0|||
23510866|NCT02049957|65606187|FG004|Overall Study|Physician Decision|0|||
23510867|NCT02049957|65606188|FG005|Overall Study|Physician Decision|1|||
23306287|NCT00251719|64866324|FG000|Overall Study|Noncompliance|2|||
23306288|NCT00251719|64866325|FG001|Overall Study|Noncompliance|3|||
23306289|NCT00251719|64866326|FG002|Overall Study|Noncompliance|1|||
23306290|NCT00251719|64866324|FG000|Overall Study|Barrett's esophagus|2|||
23306291|NCT00251719|64866325|FG001|Overall Study|Barrett's esophagus|2|||
23306292|NCT00251719|64866326|FG002|Overall Study|Barrett's esophagus|0|||
23306293|NCT01367665|64866327|FG000|Overall Study|Death|102|||
23306294|NCT01367665|64866328|FG001|Overall Study|Death|19|||
23306295|NCT01367665|64866327|FG000|Overall Study|Lost to Follow-up|222|||
23306296|NCT01367665|64866328|FG001|Overall Study|Lost to Follow-up|22|||
23306297|NCT01367665|64866327|FG000|Overall Study|Not Done|118|||
23306298|NCT01367665|64866328|FG001|Overall Study|Not Done|14|||
23306299|NCT00321828|64866335|FG000|Overall Study|Ineligible|3|||
23306300|NCT00321828|64866335|FG000|Overall Study|No follow up data|1|||
23306301|NCT02145026|64866336|FG000|Overall Study|Adverse Event|2|||
23306302|NCT02145026|64866336|FG000|Overall Study|Death|4|||
23306303|NCT02145026|64866336|FG000|Overall Study|Withdrawal by Subject|2|||
23306304|NCT02145026|64866336|FG000|Overall Study|Physician Decision|4|||
23306305|NCT00895947|64866337|FG000|Overall Study|Adverse Event|3|||
23306306|NCT00895947|64866338|FG001|Overall Study|Adverse Event|4|||
23306307|NCT00895947|64866337|FG000|Overall Study|Lost to Follow-up|3|||
23306308|NCT00895947|64866338|FG001|Overall Study|Lost to Follow-up|4|||
23306309|NCT00895947|64866337|FG000|Overall Study|Protocol Violation|4|||
23306310|NCT00895947|64866338|FG001|Overall Study|Protocol Violation|2|||
23306311|NCT00895947|64866337|FG000|Overall Study|Withdrawal by Subject|2|||
23306312|NCT00895947|64866338|FG001|Overall Study|Withdrawal by Subject|0|||
23306313|NCT01550744|64866343|FG000|Open-Label|Lost to Follow-up|7|||
23306314|NCT01550744|64866344|FG001|Open-Label|Lost to Follow-up|0|||
23306315|NCT01550744|64866345|FG002|Open-Label|Lost to Follow-up|0|||
23306316|NCT01550744|64866343|FG000|Open-Label|Withdrawal by Subject|13|||
23306317|NCT01550744|64866344|FG001|Open-Label|Withdrawal by Subject|0|||
23306318|NCT01550744|64866345|FG002|Open-Label|Withdrawal by Subject|0|||
23306319|NCT01550744|64866343|FG000|Open-Label|Adverse Event|11|||
23306320|NCT01550744|64866344|FG001|Open-Label|Adverse Event|0|||
23306321|NCT01550744|64866345|FG002|Open-Label|Adverse Event|0|||
23306322|NCT01550744|64866343|FG000|Open-Label|Lack of Efficacy|4|||
23610569|NCT01964547|65962805|FG001|Overall Study|Withdrawal by Subject|7|||
23205062|NCT01511419|64491254|FG001|Dose 2|Physician Decision|0|||
23205063|NCT01617187|64491255|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
23205064|NCT01617187|64491256|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
23205065|NCT01617187|64491257|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
23205066|NCT01617187|64491258|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
23205067|NCT01617187|64491255|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
23205068|NCT01617187|64491256|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
23205069|NCT01617187|64491257|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
23205070|NCT01617187|64491258|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
23205071|NCT01617187|64491255|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
23205072|NCT01617187|64491256|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
23306323|NCT01550744|64866344|FG001|Open-Label|Lack of Efficacy|0|||
23306324|NCT01550744|64866345|FG002|Open-Label|Lack of Efficacy|0|||
23306325|NCT01550744|64866343|FG000|Open-Label|Protocol Violation|4|||
23306326|NCT01550744|64866344|FG001|Open-Label|Protocol Violation|0|||
23205073|NCT01617187|64491257|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
23205074|NCT01617187|64491258|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
23205075|NCT01617187|64491255|FG000|Treatment Through Study Completion|Adverse Event|1|||
23205076|NCT01617187|64491256|FG001|Treatment Through Study Completion|Adverse Event|1|||
23205077|NCT01617187|64491257|FG002|Treatment Through Study Completion|Adverse Event|0|||
23205078|NCT01617187|64491258|FG003|Treatment Through Study Completion|Adverse Event|1|||
23205079|NCT01617187|64491255|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
23205080|NCT01617187|64491256|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
23205081|NCT01617187|64491257|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
23205082|NCT01617187|64491258|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
23205083|NCT01617187|64491255|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
23205084|NCT01617187|64491256|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
23205085|NCT01617187|64491257|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
23205086|NCT01617187|64491258|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
23205087|NCT01617187|64491255|FG000|Treatment Through Study Completion|Protocol Violation|1|||
23205088|NCT01617187|64491256|FG001|Treatment Through Study Completion|Protocol Violation|0|||
23205089|NCT01617187|64491257|FG002|Treatment Through Study Completion|Protocol Violation|0|||
23205090|NCT01617187|64491258|FG003|Treatment Through Study Completion|Protocol Violation|1|||
23205091|NCT02365584|64491259|FG000|Overall Study|Adverse Event|2|||
23205092|NCT02365584|64491260|FG001|Overall Study|Adverse Event|2|||
23205093|NCT02365584|64491259|FG000|Overall Study|Withdrawal by Subject|1|||
23205094|NCT02365584|64491260|FG001|Overall Study|Withdrawal by Subject|0|||
23205095|NCT02365584|64491259|FG000|Overall Study|Disease Progression|9|||
23205096|NCT02365584|64491260|FG001|Overall Study|Disease Progression|12|||
23205097|NCT00862849|64491261|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23205098|NCT00862849|64491262|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
23205099|NCT00862849|64491263|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23205100|NCT00862849|64491264|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23205101|NCT00862849|64491265|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23205102|NCT00862849|64491266|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
23205103|NCT00862849|64491261|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23205104|NCT00862849|64491262|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
23205105|NCT00862849|64491263|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23205106|NCT00862849|64491264|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23205107|NCT00862849|64491265|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23205108|NCT00862849|64491266|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
23205109|NCT00125190|64491267|FG000|Overall Study|Subject/Parent Decision|7|||
23205110|NCT00125190|64491267|FG000|Overall Study|Non-compliance|2|||
23205111|NCT00125190|64491267|FG000|Overall Study|Adverse Event|1|||
23205112|NCT00125190|64491267|FG000|Overall Study|Other|1|||
23205113|NCT00125190|64491267|FG000|Overall Study|Lost to Follow-up|4|||
23205114|NCT04501679|64491271|FG000|Overall Study|Pregnancy|0|||
23205115|NCT04501679|64491272|FG001|Overall Study|Pregnancy|1|||
23205116|NCT04501679|64491271|FG000|Overall Study|Adverse Event|4|||
23205117|NCT04501679|64491272|FG001|Overall Study|Adverse Event|2|||
23205118|NCT04501679|64491271|FG000|Overall Study|Withdrawal by Subject|2|||
23205119|NCT04501679|64491272|FG001|Overall Study|Withdrawal by Subject|0|||
23205120|NCT04501679|64491271|FG000|Overall Study|Physician Decision|1|||
23205121|NCT04501679|64491272|FG001|Overall Study|Physician Decision|0|||
23205122|NCT04501679|64491271|FG000|Overall Study|Lost to Follow-up|2|||
23205123|NCT04501679|64491272|FG001|Overall Study|Lost to Follow-up|0|||
23205124|NCT00471536|64491273|FG000|Overall Study|Withdrawal by Subject|1|||
23205125|NCT03095521|64491276|FG000|Overall Study|Withdrawal by Subject|0|||
23205126|NCT03095521|64491277|FG001|Overall Study|Withdrawal by Subject|1|||
23205127|NCT03095521|64491276|FG000|Overall Study|Lost to Follow-up|0|||
23205128|NCT03095521|64491277|FG001|Overall Study|Lost to Follow-up|1|||
23205129|NCT04167306|64491279|FG000|Overall Study|Lost to Follow-up|2|||
23205130|NCT04167306|64491280|FG001|Overall Study|Lost to Follow-up|2|||
23205131|NCT04167306|64491281|FG002|Overall Study|Lost to Follow-up|5|||
23205132|NCT04167306|64491282|FG003|Overall Study|Lost to Follow-up|5|||
23205133|NCT04167306|64491279|FG000|Overall Study|Adverse Event|13|||
23205134|NCT04167306|64491280|FG001|Overall Study|Adverse Event|14|||
23205135|NCT04167306|64491281|FG002|Overall Study|Adverse Event|5|||
23205136|NCT04167306|64491282|FG003|Overall Study|Adverse Event|4|||
23205137|NCT04167306|64491279|FG000|Overall Study|Withdrawal by Subject|4|||
23205138|NCT04167306|64491280|FG001|Overall Study|Withdrawal by Subject|6|||
23205139|NCT04167306|64491281|FG002|Overall Study|Withdrawal by Subject|8|||
23205140|NCT04167306|64491282|FG003|Overall Study|Withdrawal by Subject|3|||
23205141|NCT04167306|64491279|FG000|Overall Study|covid|1|||
23205142|NCT04167306|64491280|FG001|Overall Study|covid|1|||
23205143|NCT04167306|64491281|FG002|Overall Study|covid|2|||
23205144|NCT04167306|64491282|FG003|Overall Study|covid|1|||
23306327|NCT01550744|64866345|FG002|Open-Label|Protocol Violation|0|||
23306328|NCT01550744|64866343|FG000|Open-Label|Not all 3 study drug injections received|2|||
23205145|NCT04167306|64491279|FG000|Overall Study|concomitant medication|0|||
23205146|NCT04167306|64491280|FG001|Overall Study|concomitant medication|0|||
23205147|NCT04167306|64491281|FG002|Overall Study|concomitant medication|0|||
23205148|NCT04167306|64491282|FG003|Overall Study|concomitant medication|1|||
23205149|NCT04167306|64491279|FG000|Overall Study|Alcohol treatment|0|||
23205150|NCT04167306|64491280|FG001|Overall Study|Alcohol treatment|4|||
23205151|NCT04167306|64491281|FG002|Overall Study|Alcohol treatment|3|||
23205152|NCT04167306|64491282|FG003|Overall Study|Alcohol treatment|2|||
23205153|NCT04167306|64491279|FG000|Overall Study|non-compliance|0|||
23205154|NCT04167306|64491280|FG001|Overall Study|non-compliance|0|||
23205155|NCT04167306|64491281|FG002|Overall Study|non-compliance|1|||
23205156|NCT04167306|64491282|FG003|Overall Study|non-compliance|0|||
23205157|NCT04167306|64491279|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
23205158|NCT04167306|64491280|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
23205159|NCT04167306|64491281|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
23205160|NCT04167306|64491282|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
23205161|NCT03053427|64491283|FG000|Overall Study|Adverse Event|4|||
23205162|NCT03053427|64491284|FG001|Overall Study|Adverse Event|4|||
23205163|NCT03053427|64491283|FG000|Overall Study|Lack of Efficacy|1|||
23205164|NCT03053427|64491284|FG001|Overall Study|Lack of Efficacy|3|||
23205165|NCT03053427|64491283|FG000|Overall Study|Lost to Follow-up|2|||
23205166|NCT03053427|64491284|FG001|Overall Study|Lost to Follow-up|2|||
23205167|NCT03053427|64491283|FG000|Overall Study|Worsening of the target disease|0|||
23205168|NCT03053427|64491284|FG001|Overall Study|Worsening of the target disease|1|||
23205169|NCT03053427|64491283|FG000|Overall Study|Protocol Deviation|3|||
23205170|NCT03053427|64491284|FG001|Overall Study|Protocol Deviation|3|||
23205171|NCT03053427|64491283|FG000|Overall Study|Withdrawal by Subject|3|||
23205172|NCT03053427|64491284|FG001|Overall Study|Withdrawal by Subject|2|||
23205173|NCT03053427|64491283|FG000|Overall Study|Miscellaneous|0|||
23205174|NCT03053427|64491284|FG001|Overall Study|Miscellaneous|1|||
23205175|NCT00492856|64491285|FG000|Induction|Adverse Event|2|||
23205176|NCT00492856|64491286|FG001|Induction|Adverse Event|0|||
23205177|NCT00492856|64491287|FG002|Induction|Adverse Event|0|||
23205178|NCT00492856|64491288|FG003|Induction|Adverse Event|0|||
23306329|NCT01550744|64866344|FG001|Open-Label|Not all 3 study drug injections received|0|||
23306330|NCT01550744|64866345|FG002|Open-Label|Not all 3 study drug injections received|0|||
23306331|NCT01550744|64866343|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
23306332|NCT01550744|64866344|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
23306333|NCT01550744|64866345|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
23306334|NCT01550744|64866343|FG000|Open-Label|Other|1|||
23306335|NCT01550744|64866344|FG001|Open-Label|Other|0|||
23306336|NCT01550744|64866345|FG002|Open-Label|Other|0|||
23306337|NCT01550744|64866343|FG000|Double-Blind|Lost to Follow-up|0|||
23306338|NCT01550744|64866344|FG001|Double-Blind|Lost to Follow-up|6|||
23306339|NCT01550744|64866345|FG002|Double-Blind|Lost to Follow-up|12|||
23306340|NCT01550744|64866343|FG000|Double-Blind|Withdrawal by Subject|0|||
23306341|NCT01550744|64866344|FG001|Double-Blind|Withdrawal by Subject|2|||
23306342|NCT01550744|64866345|FG002|Double-Blind|Withdrawal by Subject|15|||
23306343|NCT01550744|64866343|FG000|Double-Blind|Adverse Event|0|||
23306344|NCT01550744|64866344|FG001|Double-Blind|Adverse Event|4|||
23306345|NCT01550744|64866345|FG002|Double-Blind|Adverse Event|15|||
23306346|NCT01550744|64866343|FG000|Double-Blind|Death|0|||
23306347|NCT01550744|64866344|FG001|Double-Blind|Death|1|||
23306348|NCT01550744|64866345|FG002|Double-Blind|Death|0|||
23306349|NCT01550744|64866343|FG000|Double-Blind|Lack of Efficacy|0|||
23306350|NCT01550744|64866344|FG001|Double-Blind|Lack of Efficacy|2|||
23306351|NCT01550744|64866345|FG002|Double-Blind|Lack of Efficacy|8|||
23306352|NCT01550744|64866343|FG000|Double-Blind|Protocol Violation|0|||
23306353|NCT01550744|64866344|FG001|Double-Blind|Protocol Violation|0|||
23306354|NCT01550744|64866345|FG002|Double-Blind|Protocol Violation|4|||
23306355|NCT01550744|64866343|FG000|Double-Blind|Pregnancy|0|||
23306356|NCT01550744|64866344|FG001|Double-Blind|Pregnancy|0|||
23306357|NCT01550744|64866345|FG002|Double-Blind|Pregnancy|3|||
23306358|NCT01550744|64866343|FG000|Double-Blind|Other|0|||
23306359|NCT01550744|64866344|FG001|Double-Blind|Other|2|||
23306360|NCT01550744|64866345|FG002|Double-Blind|Other|10|||
23306361|NCT01939496|64866346|FG000|Overall Study|Adverse Event|2|||
23306362|NCT01939496|64866347|FG001|Overall Study|Adverse Event|0|||
23306363|NCT01939496|64866348|FG002|Overall Study|Adverse Event|0|||
23205179|NCT00492856|64491285|FG000|Induction|Withdrawal by Subject|1|||
23306364|NCT01939496|64866346|FG000|Overall Study|Lost to Follow-up|1|||
23306365|NCT01939496|64866347|FG001|Overall Study|Lost to Follow-up|1|||
23306366|NCT01939496|64866348|FG002|Overall Study|Lost to Follow-up|0|||
23306367|NCT01939496|64866346|FG000|Overall Study|Physician Decision|1|||
23306368|NCT01939496|64866347|FG001|Overall Study|Physician Decision|0|||
23306369|NCT01939496|64866348|FG002|Overall Study|Physician Decision|0|||
23306370|NCT01939496|64866346|FG000|Overall Study|Protocol Violation|3|||
23306371|NCT01939496|64866347|FG001|Overall Study|Protocol Violation|0|||
23306372|NCT01939496|64866348|FG002|Overall Study|Protocol Violation|0|||
23306373|NCT01939496|64866346|FG000|Overall Study|Withdrawal by Subject|0|||
23306374|NCT01939496|64866347|FG001|Overall Study|Withdrawal by Subject|1|||
23306375|NCT01939496|64866348|FG002|Overall Study|Withdrawal by Subject|1|||
23306376|NCT01939496|64866346|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
23306377|NCT01939496|64866347|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
23306378|NCT01939496|64866348|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
23306379|NCT01939496|64866346|FG000|Overall Study|Other|2|||
23306380|NCT01939496|64866347|FG001|Overall Study|Other|0|||
23306381|NCT01939496|64866348|FG002|Overall Study|Other|1|||
23306382|NCT02119819|64866349|FG000|Overall Study|Adverse Event|3|||
23306383|NCT02119819|64866350|FG001|Overall Study|Adverse Event|1|||
23306384|NCT02119819|64866351|FG002|Overall Study|Adverse Event|2|||
23306385|NCT02119819|64866352|FG003|Overall Study|Adverse Event|3|||
23306386|NCT02119819|64866353|FG004|Overall Study|Adverse Event|0|||
23306387|NCT02119819|64866354|FG005|Overall Study|Adverse Event|1|||
23306388|NCT02119819|64866349|FG000|Overall Study|Lack of Efficacy|0|||
23306389|NCT02119819|64866350|FG001|Overall Study|Lack of Efficacy|0|||
23306390|NCT02119819|64866351|FG002|Overall Study|Lack of Efficacy|0|||
23306391|NCT02119819|64866352|FG003|Overall Study|Lack of Efficacy|0|||
23306392|NCT02119819|64866353|FG004|Overall Study|Lack of Efficacy|0|||
23306393|NCT02119819|64866354|FG005|Overall Study|Lack of Efficacy|1|||
23306394|NCT02119819|64866349|FG000|Overall Study|Lost to Follow-up|0|||
23306395|NCT02119819|64866350|FG001|Overall Study|Lost to Follow-up|0|||
23306396|NCT02119819|64866351|FG002|Overall Study|Lost to Follow-up|1|||
23306397|NCT02119819|64866352|FG003|Overall Study|Lost to Follow-up|2|||
23306398|NCT02119819|64866353|FG004|Overall Study|Lost to Follow-up|1|||
23306399|NCT02119819|64866354|FG005|Overall Study|Lost to Follow-up|2|||
23306400|NCT02119819|64866349|FG000|Overall Study|Physician Decision|1|||
23306401|NCT02119819|64866350|FG001|Overall Study|Physician Decision|1|||
23306402|NCT02119819|64866351|FG002|Overall Study|Physician Decision|0|||
23306403|NCT02119819|64866352|FG003|Overall Study|Physician Decision|0|||
23306404|NCT02119819|64866353|FG004|Overall Study|Physician Decision|0|||
23306405|NCT02119819|64866354|FG005|Overall Study|Physician Decision|1|||
23306406|NCT02119819|64866349|FG000|Overall Study|Withdrawal by Subject|5|||
23306407|NCT02119819|64866350|FG001|Overall Study|Withdrawal by Subject|3|||
23306408|NCT02119819|64866351|FG002|Overall Study|Withdrawal by Subject|0|||
23306409|NCT02119819|64866352|FG003|Overall Study|Withdrawal by Subject|0|||
23306410|NCT02119819|64866353|FG004|Overall Study|Withdrawal by Subject|6|||
23306411|NCT02119819|64866354|FG005|Overall Study|Withdrawal by Subject|10|||
23306412|NCT02119819|64866349|FG000|Overall Study|Jury Duty|0|||
23306413|NCT02119819|64866350|FG001|Overall Study|Jury Duty|0|||
23306414|NCT02119819|64866351|FG002|Overall Study|Jury Duty|1|||
23306415|NCT02119819|64866352|FG003|Overall Study|Jury Duty|0|||
23306416|NCT02119819|64866353|FG004|Overall Study|Jury Duty|0|||
23306417|NCT02119819|64866354|FG005|Overall Study|Jury Duty|0|||
23306418|NCT02119819|64866349|FG000|Overall Study|Protocol Violation|0|||
23306419|NCT02119819|64866350|FG001|Overall Study|Protocol Violation|0|||
23306420|NCT02119819|64866351|FG002|Overall Study|Protocol Violation|0|||
23306421|NCT02119819|64866352|FG003|Overall Study|Protocol Violation|1|||
23306422|NCT02119819|64866353|FG004|Overall Study|Protocol Violation|0|||
23306423|NCT02119819|64866354|FG005|Overall Study|Protocol Violation|0|||
23306424|NCT02119819|64866349|FG000|Overall Study|Left the city to get a job|0|||
23306425|NCT02119819|64866350|FG001|Overall Study|Left the city to get a job|0|||
23306426|NCT02119819|64866351|FG002|Overall Study|Left the city to get a job|0|||
23306427|NCT02119819|64866352|FG003|Overall Study|Left the city to get a job|1|||
23306428|NCT02119819|64866353|FG004|Overall Study|Left the city to get a job|0|||
23306429|NCT02119819|64866354|FG005|Overall Study|Left the city to get a job|0|||
23306430|NCT01910389|64866355|FG000|Overall Study|Withdrawal by Subject|2|||
23306431|NCT01910389|64866356|FG001|Overall Study|Withdrawal by Subject|0|||
23306432|NCT01910389|64866355|FG000|Overall Study|Study Closed|13|||
23306433|NCT01910389|64866356|FG001|Overall Study|Study Closed|8|||
23306434|NCT00424775|64866357|FG000|Overall Study|Adverse Event|2|||
23306435|NCT00424775|64866358|FG001|Overall Study|Adverse Event|0|||
23306436|NCT00424775|64866357|FG000|Overall Study|Lack of Efficacy|1|||
23306437|NCT00424775|64866358|FG001|Overall Study|Lack of Efficacy|0|||
23306438|NCT03402750|64866365|FG000|Overall Study|Lost to Follow-up|2|||
23306439|NCT03402750|64866366|FG001|Overall Study|Lost to Follow-up|1|||
23510868|NCT02049957|65606189|FG006|Overall Study|Physician Decision|0|||
23306440|NCT02655666|64866370|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
23306441|NCT00584844|64866371|FG000|Overall Study|Withdrawal by Subject|59|||
23306442|NCT00584844|64866371|FG000|Overall Study|Screen Failure|20|||
23306443|NCT02032706|64866372|FG000|Overall Study|Did not qualify|5|||
23306444|NCT02032706|64866372|FG000|Overall Study|Protocol Violation|1|||
23306445|NCT04126213|64866374|FG000|Overall Study|Lost to Follow-up|9|||
23306446|NCT04126213|64866375|FG001|Overall Study|Lost to Follow-up|1|||
23306447|NCT04126213|64866376|FG002|Overall Study|Lost to Follow-up|5|||
23306448|NCT04126213|64866377|FG003|Overall Study|Lost to Follow-up|10|||
23306449|NCT04126213|64866378|FG004|Overall Study|Lost to Follow-up|4|||
23306450|NCT04126213|64866379|FG005|Overall Study|Lost to Follow-up|7|||
23306451|NCT04126213|64866374|FG000|Overall Study|Withdrawal by Subject|3|||
23306452|NCT04126213|64866375|FG001|Overall Study|Withdrawal by Subject|2|||
23306453|NCT04126213|64866376|FG002|Overall Study|Withdrawal by Subject|1|||
23306454|NCT04126213|64866377|FG003|Overall Study|Withdrawal by Subject|1|||
23306455|NCT04126213|64866378|FG004|Overall Study|Withdrawal by Subject|1|||
23306456|NCT04126213|64866379|FG005|Overall Study|Withdrawal by Subject|1|||
23306457|NCT04126213|64866374|FG000|Overall Study|Other|0|||
23306458|NCT04126213|64866375|FG001|Overall Study|Other|0|||
23306459|NCT04126213|64866376|FG002|Overall Study|Other|2|||
23306460|NCT04126213|64866377|FG003|Overall Study|Other|2|||
23306461|NCT04126213|64866378|FG004|Overall Study|Other|0|||
23306462|NCT04126213|64866379|FG005|Overall Study|Other|1|||
23306463|NCT04126213|64866374|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23306464|NCT04126213|64866375|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23306465|NCT04126213|64866376|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23306466|NCT04126213|64866377|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23306467|NCT04126213|64866378|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23306468|NCT04126213|64866379|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23306469|NCT00599521|64866380|FG000|Overall Study|Lack of Efficacy|4|||
23306470|NCT00599521|64866381|FG001|Overall Study|Lack of Efficacy|8|||
23306471|NCT00599521|64866380|FG000|Overall Study|Adverse Event|4|||
23306472|NCT00599521|64866381|FG001|Overall Study|Adverse Event|1|||
23306473|NCT00599521|64866380|FG000|Overall Study|Withdrawal by Subject|28|||
23306474|NCT00599521|64866381|FG001|Overall Study|Withdrawal by Subject|34|||
23306475|NCT00599521|64866380|FG000|Overall Study|Protocol Violation|1|||
23306476|NCT00599521|64866381|FG001|Overall Study|Protocol Violation|1|||
23306477|NCT00599521|64866380|FG000|Overall Study|Lost to Follow-up|23|||
23306478|NCT00599521|64866381|FG001|Overall Study|Lost to Follow-up|23|||
23306479|NCT00599521|64866380|FG000|Overall Study|Pregnancy|0|||
23306480|NCT00599521|64866381|FG001|Overall Study|Pregnancy|2|||
23306481|NCT02038907|64866382|FG000|Overall Study|Protocol Violation|0|||
23306482|NCT02038907|64866383|FG001|Overall Study|Protocol Violation|0|||
23306483|NCT02038907|64866384|FG002|Overall Study|Protocol Violation|0|||
23306484|NCT02038907|64866385|FG003|Overall Study|Protocol Violation|0|||
23306485|NCT02038907|64866386|FG004|Overall Study|Protocol Violation|0|||
23306486|NCT02038907|64866387|FG005|Overall Study|Protocol Violation|0|||
23306487|NCT02038907|64866388|FG006|Overall Study|Protocol Violation|0|||
23306488|NCT02038907|64866389|FG007|Overall Study|Protocol Violation|0|||
23306489|NCT02038907|64866390|FG008|Overall Study|Protocol Violation|0|||
23306490|NCT02038907|64866391|FG009|Overall Study|Protocol Violation|0|||
23306491|NCT02038907|64866392|FG010|Overall Study|Protocol Violation|1|||
23306492|NCT02038907|64866393|FG011|Overall Study|Protocol Violation|0|||
23306493|NCT02038907|64866394|FG012|Overall Study|Protocol Violation|0|||
23306494|NCT02038907|64866395|FG013|Overall Study|Protocol Violation|0|||
23306495|NCT02038907|64866382|FG000|Overall Study|Withdrawal by Subject|0|||
23306496|NCT02038907|64866383|FG001|Overall Study|Withdrawal by Subject|0|||
23306497|NCT02038907|64866384|FG002|Overall Study|Withdrawal by Subject|0|||
23306498|NCT02038907|64866385|FG003|Overall Study|Withdrawal by Subject|0|||
23306499|NCT02038907|64866386|FG004|Overall Study|Withdrawal by Subject|0|||
23306500|NCT02038907|64866387|FG005|Overall Study|Withdrawal by Subject|0|||
23306501|NCT02038907|64866388|FG006|Overall Study|Withdrawal by Subject|0|||
23306502|NCT02038907|64866389|FG007|Overall Study|Withdrawal by Subject|0|||
23306503|NCT02038907|64866390|FG008|Overall Study|Withdrawal by Subject|0|||
23306504|NCT02038907|64866391|FG009|Overall Study|Withdrawal by Subject|0|||
23306505|NCT02038907|64866392|FG010|Overall Study|Withdrawal by Subject|1|||
23306506|NCT02038907|64866393|FG011|Overall Study|Withdrawal by Subject|0|||
23306507|NCT02038907|64866394|FG012|Overall Study|Withdrawal by Subject|0|||
23306508|NCT02038907|64866395|FG013|Overall Study|Withdrawal by Subject|0|||
23306509|NCT02944383|64866396|FG000|Overall Study|Lost to Follow-up|0|||
23306510|NCT02944383|64866397|FG001|Overall Study|Lost to Follow-up|0|||
23306511|NCT02944383|64866398|FG002|Overall Study|Lost to Follow-up|1|||
23306512|NCT02944383|64866396|FG000|Overall Study|Withdrawal by Subject|1|||
23306513|NCT02944383|64866397|FG001|Overall Study|Withdrawal by Subject|0|||
23306514|NCT02944383|64866398|FG002|Overall Study|Withdrawal by Subject|0|||
23306515|NCT02394730|64866401|FG000|Overall Study|Lost to Follow-up|1|||
23306516|NCT02394730|64866402|FG001|Overall Study|Lost to Follow-up|0|||
23306517|NCT02394730|64866401|FG000|Overall Study|Withdrawal by Subject|0|||
23306518|NCT02394730|64866402|FG001|Overall Study|Withdrawal by Subject|1|||
23306519|NCT00658658|64866410|FG000|Overall Study|Withdrawal by Subject|0|||
23306520|NCT00658658|64866411|FG001|Overall Study|Withdrawal by Subject|1|||
23306521|NCT00658658|64866412|FG002|Overall Study|Withdrawal by Subject|0|||
23306522|NCT00658658|64866413|FG003|Overall Study|Withdrawal by Subject|0|||
23306523|NCT00658658|64866414|FG004|Overall Study|Withdrawal by Subject|0|||
23306524|NCT00658658|64866410|FG000|Overall Study|Death|4|||
23306525|NCT00658658|64866411|FG001|Overall Study|Death|0|||
23306526|NCT00658658|64866412|FG002|Overall Study|Death|0|||
23306527|NCT00658658|64866413|FG003|Overall Study|Death|1|||
23306528|NCT00658658|64866414|FG004|Overall Study|Death|1|||
23306529|NCT00658658|64866410|FG000|Overall Study|Disease Progression|0|||
23306530|NCT00658658|64866411|FG001|Overall Study|Disease Progression|1|||
23306531|NCT00658658|64866412|FG002|Overall Study|Disease Progression|0|||
23306532|NCT00658658|64866413|FG003|Overall Study|Disease Progression|1|||
23306533|NCT00658658|64866414|FG004|Overall Study|Disease Progression|3|||
23306534|NCT00658658|64866410|FG000|Overall Study|Protocol-specified Criteria|1|||
23306535|NCT00658658|64866411|FG001|Overall Study|Protocol-specified Criteria|0|||
23306536|NCT00658658|64866412|FG002|Overall Study|Protocol-specified Criteria|0|||
23306537|NCT00658658|64866413|FG003|Overall Study|Protocol-specified Criteria|0|||
23306538|NCT00658658|64866414|FG004|Overall Study|Protocol-specified Criteria|0|||
23306539|NCT00658658|64866410|FG000|Overall Study|Other|0|||
23306540|NCT00658658|64866411|FG001|Overall Study|Other|0|||
23306541|NCT00658658|64866412|FG002|Overall Study|Other|0|||
23306542|NCT00658658|64866413|FG003|Overall Study|Other|0|||
23306543|NCT00658658|64866414|FG004|Overall Study|Other|1|||
23306544|NCT00714493|64866415|FG000|Overall Study|Adverse Event|11|||
23306545|NCT00714493|64866415|FG000|Overall Study|Death|3|||
23306546|NCT00714493|64866415|FG000|Overall Study|Lack of Efficacy|10|||
23306547|NCT00714493|64866415|FG000|Overall Study|Lost to Follow-up|3|||
23306548|NCT00714493|64866415|FG000|Overall Study|Protocol Violation|12|||
23306549|NCT00714493|64866415|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
23306550|NCT00714493|64866415|FG000|Overall Study|OTHER|2|||
23306551|NCT02640053|64866416|FG000|Overall Study|Withdrawal by Subject|2|||
23306552|NCT02640053|64866417|FG001|Overall Study|Withdrawal by Subject|1|||
23306553|NCT02640053|64866416|FG000|Overall Study|Adverse Event|1|||
23306554|NCT02640053|64866417|FG001|Overall Study|Adverse Event|1|||
23306555|NCT02640053|64866416|FG000|Overall Study|Alternative Therapy|1|||
23306556|NCT02640053|64866417|FG001|Overall Study|Alternative Therapy|1|||
23306557|NCT02640053|64866416|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
23306558|NCT02640053|64866417|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
23306559|NCT00085423|64866418|FG000|Overall Study|Withdrawal by Subject|1|||
23306560|NCT00085423|64866418|FG000|Overall Study|screen failure|1|||
23306561|NCT00757848|64866419|FG000|Overall Study|Voluntary discontinuation|1|||
23306562|NCT00757848|64866420|FG001|Overall Study|Voluntary discontinuation|0|||
23306563|NCT00757848|64866419|FG000|Overall Study|Adverse Event|1|||
23306564|NCT00757848|64866420|FG001|Overall Study|Adverse Event|2|||
23306565|NCT00757848|64866419|FG000|Overall Study|Incorrect enrolment|1|||
23306566|NCT00757848|64866420|FG001|Overall Study|Incorrect enrolment|0|||
23306567|NCT01675661|64866421|FG000|Overall Study|Lost to Follow-up|22|||
23306568|NCT01675661|64866422|FG001|Overall Study|Lost to Follow-up|23|||
23306569|NCT01675661|64866421|FG000|Overall Study|Practical problems|9|||
23306570|NCT01675661|64866422|FG001|Overall Study|Practical problems|5|||
23306571|NCT01675661|64866421|FG000|Overall Study|Moved away|5|||
23306572|NCT01675661|64866422|FG001|Overall Study|Moved away|6|||
23306573|NCT01675661|64866421|FG000|Overall Study|Withdrawal by Subject|3|||
23306574|NCT01675661|64866422|FG001|Overall Study|Withdrawal by Subject|7|||
23306575|NCT01675661|64866421|FG000|Overall Study|Physician Decision|0|||
23306576|NCT01675661|64866422|FG001|Overall Study|Physician Decision|2|||
23510869|NCT02049957|65606190|FG007|Overall Study|Physician Decision|0|||
23510870|NCT02049957|65606191|FG008|Overall Study|Physician Decision|0|||
23510871|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Physician Decision|0|||
23306577|NCT01675661|64866421|FG000|Overall Study|Death|0|||
23306578|NCT01675661|64866422|FG001|Overall Study|Death|1|||
23306579|NCT01675661|64866421|FG000|Overall Study|Other reason|1|||
23306580|NCT01675661|64866422|FG001|Overall Study|Other reason|2|||
23306581|NCT02828241|64866423|FG000|Overall Study|Adverse Event|7|||
23306582|NCT02828241|64866424|FG001|Overall Study|Adverse Event|2|||
23306583|NCT02828241|64866423|FG000|Overall Study|Protocol Violation|1|||
23306584|NCT02828241|64866424|FG001|Overall Study|Protocol Violation|0|||
23306585|NCT02105974|64866427|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
23306586|NCT02105974|64866428|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
23306587|NCT02105974|64866429|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
23510872|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Physician Decision|1|||
23306588|NCT02105974|64866427|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
23306589|NCT02105974|64866428|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
23306590|NCT02105974|64866429|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
23306591|NCT02105974|64866427|FG000|2 Week Run-in Period|Adverse Event|6|||
23306592|NCT02105974|64866428|FG001|2 Week Run-in Period|Adverse Event|0|||
23306593|NCT02105974|64866429|FG002|2 Week Run-in Period|Adverse Event|0|||
23306594|NCT02105974|64866427|FG000|2 Week Run-in Period|Study closed/terminated|1|||
23306595|NCT02105974|64866428|FG001|2 Week Run-in Period|Study closed/terminated|0|||
23306596|NCT02105974|64866429|FG002|2 Week Run-in Period|Study closed/terminated|0|||
23510873|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Physician Decision|0|||
23306597|NCT02105974|64866427|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
23306598|NCT02105974|64866428|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
23306599|NCT02105974|64866429|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
23306600|NCT02105974|64866427|FG000|2 Week Run-in Period|Withdrew consent|23|||
23306601|NCT02105974|64866428|FG001|2 Week Run-in Period|Withdrew consent|0|||
23306602|NCT02105974|64866429|FG002|2 Week Run-in Period|Withdrew consent|0|||
23306603|NCT02105974|64866427|FG000|2 Week Run-in Period|Investigator discretion|8|||
23306604|NCT02105974|64866428|FG001|2 Week Run-in Period|Investigator discretion|0|||
23306605|NCT02105974|64866429|FG002|2 Week Run-in Period|Investigator discretion|0|||
23306606|NCT02105974|64866427|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
23306607|NCT02105974|64866428|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
23306608|NCT02105974|64866429|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
23306609|NCT02105974|64866427|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
23306610|NCT02105974|64866428|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
23306611|NCT02105974|64866429|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
23306612|NCT02105974|64866427|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
23306613|NCT02105974|64866428|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
23306614|NCT02105974|64866429|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
23306615|NCT02105974|64866427|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
23306616|NCT02105974|64866428|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
23306617|NCT02105974|64866429|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
23306618|NCT02105974|64866427|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
23306619|NCT02105974|64866428|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
23306620|NCT02105974|64866429|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
23306621|NCT02105974|64866427|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
23306622|NCT02105974|64866428|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
23306623|NCT02105974|64866429|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
23306624|NCT02105974|64866427|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
23306625|NCT02105974|64866428|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
23306626|NCT02105974|64866429|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
23306627|NCT03151408|64866430|FG000|Overall Study|Adverse Event|24|||
23306628|NCT03151408|64866431|FG001|Overall Study|Adverse Event|23|||
23306629|NCT03151408|64866430|FG000|Overall Study|Death|46|||
23306630|NCT03151408|64866431|FG001|Overall Study|Death|26|||
23306631|NCT03151408|64866430|FG000|Overall Study|Physician Decision|13|||
23306632|NCT03151408|64866431|FG001|Overall Study|Physician Decision|19|||
23306633|NCT03151408|64866430|FG000|Overall Study|Withdrawal by Subject|16|||
23306634|NCT03151408|64866431|FG001|Overall Study|Withdrawal by Subject|20|||
23306635|NCT03151408|64866430|FG000|Overall Study|Progressive disease|45|||
23306636|NCT03151408|64866431|FG001|Overall Study|Progressive disease|61|||
23306637|NCT03151408|64866430|FG000|Overall Study|non-compliance by patient|1|||
23306638|NCT03151408|64866431|FG001|Overall Study|non-compliance by patient|0|||
23306639|NCT03151408|64866430|FG000|Overall Study|other reasons|56|||
23306640|NCT03151408|64866431|FG001|Overall Study|other reasons|52|||
23306641|NCT03151408|64866430|FG000|Overall Study|randomized and not treated|2|||
23306642|NCT03151408|64866431|FG001|Overall Study|randomized and not treated|2|||
23306643|NCT00918138|64866432|FG000|Overall Study|Subject withdrew consent|1|||
23306644|NCT00918138|64866433|FG001|Overall Study|Subject withdrew consent|1|||
23306645|NCT00918138|64866432|FG000|Overall Study|Death|1|||
23306646|NCT00918138|64866433|FG001|Overall Study|Death|0|||
23306647|NCT02605993|64866436|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
23306648|NCT02605993|64866437|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
23306649|NCT02605993|64866438|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
23306650|NCT02605993|64866439|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
23306651|NCT01447420|64866440|FG000|Overall Study|Adverse Event|2|||
23408798|NCT01772550|65240007|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
23510874|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
23610570|NCT01964547|65962804|FG000|Overall Study|Lost to Follow-up|0|||
23306652|NCT01447420|64866441|FG001|Overall Study|Adverse Event|4|||
23306653|NCT01447420|64866442|FG002|Overall Study|Adverse Event|2|||
23306654|NCT01447420|64866440|FG000|Overall Study|Protocol Violation|3|||
23306655|NCT01447420|64866441|FG001|Overall Study|Protocol Violation|3|||
23306656|NCT01447420|64866442|FG002|Overall Study|Protocol Violation|0|||
23306657|NCT01447420|64866440|FG000|Overall Study|Withdrawal by Subject|4|||
23306658|NCT01447420|64866441|FG001|Overall Study|Withdrawal by Subject|1|||
23306659|NCT01447420|64866442|FG002|Overall Study|Withdrawal by Subject|0|||
23306660|NCT01447420|64866440|FG000|Overall Study|Lack of Efficacy|1|||
23306661|NCT01447420|64866441|FG001|Overall Study|Lack of Efficacy|19|||
23306662|NCT01447420|64866442|FG002|Overall Study|Lack of Efficacy|8|||
23306663|NCT00706511|64866445|FG000|Overall Study|Withdrawal by Subject|1|||
23306664|NCT00706511|64866446|FG001|Overall Study|Withdrawal by Subject|0|||
23306665|NCT00706511|64866447|FG002|Overall Study|Withdrawal by Subject|0|||
23306666|NCT00706511|64866448|FG003|Overall Study|Withdrawal by Subject|0|||
23306667|NCT04730349|64866449|FG000|Overall Study|Participant withdrew consent|1|||
23306668|NCT04730349|64866450|FG001|Overall Study|Participant withdrew consent|0|||
23306669|NCT04730349|64866449|FG000|Overall Study|Disease progression|6|||
23306670|NCT04730349|64866450|FG001|Overall Study|Disease progression|4|||
23306671|NCT04730349|64866449|FG000|Overall Study|Study drug toxicity|0|||
23306672|NCT04730349|64866450|FG001|Overall Study|Study drug toxicity|1|||
23306673|NCT02440568|64866451|FG000|Overall Study|Death|1|||
23306674|NCT02440568|64866452|FG001|Overall Study|Death|3|||
23306675|NCT02440568|64866453|FG002|Overall Study|Death|4|||
23306676|NCT02440568|64866454|FG003|Overall Study|Death|2|||
23306677|NCT02440568|64866451|FG000|Overall Study|Lack of Efficacy|2|||
23306678|NCT02440568|64866452|FG001|Overall Study|Lack of Efficacy|0|||
23306679|NCT02440568|64866453|FG002|Overall Study|Lack of Efficacy|1|||
23306680|NCT02440568|64866454|FG003|Overall Study|Lack of Efficacy|0|||
23306681|NCT02440568|64866451|FG000|Overall Study|Lost to Follow-up|1|||
23306682|NCT02440568|64866452|FG001|Overall Study|Lost to Follow-up|0|||
23306683|NCT02440568|64866453|FG002|Overall Study|Lost to Follow-up|0|||
23408799|NCT01772550|65240008|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
23408800|NCT01772550|65240006|FG000|Overall Study|Adverse Event|0|||
23408801|NCT01772550|65240007|FG001|Overall Study|Adverse Event|0|||
23408802|NCT01772550|65240008|FG002|Overall Study|Adverse Event|1|||
23408803|NCT00902850|65240016|FG000|Overall Study|Physician Decision|2|||
23408804|NCT00902850|65240017|FG001|Overall Study|Physician Decision|2|||
23408805|NCT01467466|65240018|FG000|Overall Study|Withdrawal by Subject|15|||
23408806|NCT01467466|65240019|FG001|Overall Study|Withdrawal by Subject|18|||
23408807|NCT01467466|65240020|FG002|Overall Study|Withdrawal by Subject|13|||
23408808|NCT01467466|65240021|FG003|Overall Study|Withdrawal by Subject|11|||
23408809|NCT01467466|65240018|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
23408810|NCT01467466|65240019|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
23408811|NCT01467466|65240020|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
23408812|NCT01467466|65240021|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
23510875|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
23510876|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
23510877|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
23510878|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
23510879|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
23510880|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Other|4|||
23510881|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Other|4|||
23510882|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Other|0|||
23510883|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
23510884|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
23510885|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
23510886|NCT02585960|65606194|FG000|PK/Safety Assessment Period|Screen Failure|0|||
23510887|NCT02585960|65606195|FG001|PK/Safety Assessment Period|Screen Failure|0|||
23510888|NCT02585960|65606196|FG002|PK/Safety Assessment Period|Screen Failure|1|||
23510889|NCT02585960|65606194|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
23510890|NCT02585960|65606195|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
23510891|NCT02585960|65606196|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
23510892|NCT02585960|65606194|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
23510893|NCT02585960|65606195|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
23408813|NCT01467466|65240018|FG000|Overall Study|Procedure Cancelled|46|||
23408814|NCT01467466|65240019|FG001|Overall Study|Procedure Cancelled|45|||
23306684|NCT02440568|64866454|FG003|Overall Study|Lost to Follow-up|0|||
23306685|NCT01680497|64866455|FG000|Overall Study|Lost to Follow-up|2|||
23306686|NCT02351960|64866457|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
23306687|NCT02351960|64866458|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
23306688|NCT02351960|64866457|FG000|Overall Study|Voluntary Withdrawal|5|||
23306689|NCT02351960|64866458|FG001|Overall Study|Voluntary Withdrawal|4|||
23306690|NCT02351960|64866457|FG000|Overall Study|Significant Protocol Deviation|0|||
23510894|NCT02585960|65606196|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
23510895|NCT00241280|65606197|FG000|Overall Study|Adverse Event|2|||
23510896|NCT00241280|65606198|FG001|Overall Study|Adverse Event|6|||
23510897|NCT00241280|65606197|FG000|Overall Study|Discomfort|11|||
23510898|NCT00241280|65606198|FG001|Overall Study|Discomfort|16|||
23510899|NCT00241280|65606197|FG000|Overall Study|Pregnancy|1|||
23510900|NCT00241280|65606198|FG001|Overall Study|Pregnancy|5|||
23510901|NCT00241280|65606197|FG000|Overall Study|Lost to Follow-up|5|||
23510902|NCT00241280|65606198|FG001|Overall Study|Lost to Follow-up|8|||
23510903|NCT00241280|65606197|FG000|Overall Study|Withdrawal by Subject|7|||
23510904|NCT00241280|65606198|FG001|Overall Study|Withdrawal by Subject|4|||
23510905|NCT00241280|65606197|FG000|Overall Study|Protocol Violation|4|||
23510906|NCT00241280|65606198|FG001|Overall Study|Protocol Violation|10|||
23510907|NCT00241280|65606197|FG000|Overall Study|Relocation|4|||
23510908|NCT00241280|65606198|FG001|Overall Study|Relocation|4|||
23510909|NCT00241280|65606197|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
23510910|NCT00241280|65606198|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
23510911|NCT00241280|65606197|FG000|Overall Study|Unsatisfactory Visual Response|1|||
23510912|NCT00241280|65606198|FG001|Overall Study|Unsatisfactory Visual Response|1|||
23510913|NCT00241280|65606197|FG000|Overall Study|Diabetic|1|||
23510914|NCT00241280|65606198|FG001|Overall Study|Diabetic|0|||
23510915|NCT00241280|65606197|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
23510916|NCT00241280|65606198|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
23510917|NCT00241280|65606197|FG000|Overall Study|Dispensed incorrect test article|1|||
23510918|NCT00241280|65606198|FG001|Overall Study|Dispensed incorrect test article|2|||
23510919|NCT00241280|65606197|FG000|Overall Study|Unacceptable Fit|0|||
23510920|NCT00241280|65606198|FG001|Overall Study|Unacceptable Fit|1|||
23510921|NCT00241280|65606197|FG000|Overall Study|Scheduling Conflict|0|||
23510922|NCT00241280|65606198|FG001|Overall Study|Scheduling Conflict|2|||
23510923|NCT00241280|65606197|FG000|Overall Study|History of Ocular Surgery|0|||
23510924|NCT00241280|65606198|FG001|Overall Study|History of Ocular Surgery|1|||
23510925|NCT00241280|65606197|FG000|Overall Study|Coating on Lens|1|||
23510926|NCT00241280|65606198|FG001|Overall Study|Coating on Lens|0|||
23510927|NCT00241280|65606197|FG000|Overall Study|Excessive Dryness|0|||
23510928|NCT00241280|65606198|FG001|Overall Study|Excessive Dryness|1|||
23510929|NCT00464087|65606199|FG000|Overall Study|No PCI per inclusion criteria|0|||
23510930|NCT00464087|65606200|FG001|Overall Study|No PCI per inclusion criteria|0|||
23510931|NCT00464087|65606201|FG002|Overall Study|No PCI per inclusion criteria|29|||
23510932|NCT00126568|65606208|FG000|Overall Study|Death|2|||
23510933|NCT00674700|65606209|FG000|Year 1|Adverse Event|17|||
23510934|NCT00674700|65606210|FG001|Year 1|Adverse Event|20|||
23510935|NCT00674700|65606211|FG002|Year 1|Adverse Event|5|||
23510936|NCT00674700|65606209|FG000|Year 1|Withdrawal by Subject|7|||
23510937|NCT00674700|65606210|FG001|Year 1|Withdrawal by Subject|7|||
23510938|NCT00674700|65606211|FG002|Year 1|Withdrawal by Subject|6|||
23510939|NCT00674700|65606209|FG000|Year 1|Any other reason not above-mentioned|7|||
23510940|NCT00674700|65606210|FG001|Year 1|Any other reason not above-mentioned|7|||
23510941|NCT00674700|65606211|FG002|Year 1|Any other reason not above-mentioned|6|||
23510942|NCT00674700|65606209|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
23510943|NCT00674700|65606210|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
23510944|NCT00674700|65606211|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
23510945|NCT00674700|65606209|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
23510946|NCT00674700|65606210|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
23510947|NCT00674700|65606211|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
23510948|NCT00674700|65606209|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
23510949|NCT00674700|65606210|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
23510950|NCT00674700|65606211|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
23510951|NCT01709162|65606212|FG000|Overall Study|Disease progression|3|||
23510952|NCT01709162|65606213|FG001|Overall Study|Disease progression|3|||
23510953|NCT01709162|65606212|FG000|Overall Study|Study drug toxicity|2|||
23306691|NCT02351960|64866458|FG001|Overall Study|Significant Protocol Deviation|5|||
23510954|NCT01709162|65606213|FG001|Overall Study|Study drug toxicity|0|||
23510955|NCT01709162|65606212|FG000|Overall Study|Administrative reason by sponsor|0|||
23510956|NCT01709162|65606213|FG001|Overall Study|Administrative reason by sponsor|1|||
23510957|NCT01709162|65606212|FG000|Overall Study|Other|1|||
23510958|NCT01709162|65606213|FG001|Overall Study|Other|0|||
23510959|NCT01709162|65606212|FG000|Overall Study|Withdrawal by Subject|0|||
23510960|NCT01709162|65606213|FG001|Overall Study|Withdrawal by Subject|1|||
23510961|NCT00381095|65606214|FG000|Overall Study|Death|3|||
23510962|NCT00381095|65606215|FG001|Overall Study|Death|4|||
23510963|NCT00381095|65606214|FG000|Overall Study|Lack of Efficacy|2|||
23510964|NCT00381095|65606215|FG001|Overall Study|Lack of Efficacy|4|||
23510965|NCT00381095|65606214|FG000|Overall Study|Other|2|||
23510966|NCT00381095|65606215|FG001|Overall Study|Other|2|||
23510967|NCT00381095|65606214|FG000|Overall Study|Protocol Violation|1|||
23510968|NCT00381095|65606215|FG001|Overall Study|Protocol Violation|1|||
23510969|NCT00381095|65606214|FG000|Overall Study|Withdrawal by Subject|3|||
23510970|NCT00381095|65606215|FG001|Overall Study|Withdrawal by Subject|3|||
23510971|NCT00381095|65606214|FG000|Overall Study|Adverse Event|2|||
23510972|NCT00381095|65606215|FG001|Overall Study|Adverse Event|7|||
23510973|NCT01191801|65606218|FG000|Overall Study|Death|36|||
23510974|NCT01191801|65606219|FG001|Overall Study|Death|12|||
23510975|NCT01191801|65606218|FG000|Overall Study|Lack of Efficacy|176|||
23510976|NCT01191801|65606219|FG001|Overall Study|Lack of Efficacy|258|||
23510977|NCT01191801|65606218|FG000|Overall Study|Adverse Event|9|||
23510978|NCT01191801|65606219|FG001|Overall Study|Adverse Event|8|||
23510979|NCT01191801|65606218|FG000|Overall Study|Protocol Violation|2|||
23510980|NCT01191801|65606219|FG001|Overall Study|Protocol Violation|4|||
23510981|NCT01191801|65606218|FG000|Overall Study|Physician Decision|47|||
23510982|NCT01191801|65606219|FG001|Overall Study|Physician Decision|24|||
23510983|NCT01191801|65606218|FG000|Overall Study|Withdrawal by Subject|1|||
23510984|NCT01191801|65606219|FG001|Overall Study|Withdrawal by Subject|4|||
23510985|NCT01191801|65606218|FG000|Overall Study|Not Provided|45|||
23510986|NCT01191801|65606219|FG001|Overall Study|Not Provided|27|||
23510987|NCT02782780|65606220|FG000|Overall Study|dropped out after randomization.|7|||
23510988|NCT02782780|65606221|FG001|Overall Study|dropped out after randomization.|5|||
23510989|NCT02782780|65606220|FG000|Overall Study|Protocol Violation|0|||
23510990|NCT02782780|65606221|FG001|Overall Study|Protocol Violation|2|||
23510991|NCT01001377|65606222|FG000|Overall Study|Ineligibility determined|2|||
23510992|NCT01001377|65606223|FG001|Overall Study|Ineligibility determined|0|||
23510993|NCT01001377|65606222|FG000|Overall Study|Withdrawal by Subject|19|||
23510994|NCT01001377|65606223|FG001|Overall Study|Withdrawal by Subject|20|||
23510995|NCT01001377|65606222|FG000|Overall Study|Lost to Follow-up|14|||
23510996|NCT01001377|65606223|FG001|Overall Study|Lost to Follow-up|17|||
23510997|NCT01001377|65606222|FG000|Overall Study|Death|391|||
23510998|NCT01001377|65606223|FG001|Overall Study|Death|384|||
23510999|NCT05131646|65606227|FG000|Overall Study|Withdrawal by Subject|1|||
23511000|NCT05131646|65606228|FG001|Overall Study|Withdrawal by Subject|0|||
23511001|NCT05131646|65606229|FG002|Overall Study|Withdrawal by Subject|0|||
23511002|NCT03334448|65606232|FG000|Washout|Personal Reason|0|||
23511003|NCT03334448|65606233|FG001|Washout|Personal Reason|1|||
23511004|NCT03334448|65606234|FG002|Washout|Personal Reason|0|||
23511005|NCT03334448|65606235|FG003|Washout|Personal Reason|0|||
23511006|NCT03334448|65606232|FG000|Washout|Protocol Violation|0|||
23511007|NCT03334448|65606233|FG001|Washout|Protocol Violation|0|||
23511008|NCT03334448|65606234|FG002|Washout|Protocol Violation|0|||
23511009|NCT03334448|65606235|FG003|Washout|Protocol Violation|1|||
23511010|NCT02664441|65606238|FG000|Randomization|Withdrawal by Subject|0|||
23511011|NCT02664441|65606239|FG001|Randomization|Withdrawal by Subject|1|||
23511012|NCT02664441|65606238|FG000|36-week Randomized Trial|Adverse Event|2|||
23511013|NCT02664441|65606239|FG001|36-week Randomized Trial|Adverse Event|0|||
23511014|NCT02664441|65606238|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
23511015|NCT02664441|65606239|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
23511016|NCT02664441|65606238|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
23511017|NCT02664441|65606239|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
23511018|NCT02664441|65606238|FG000|18-week Open Label Extension|Adverse Event|1|||
23511019|NCT02664441|65606239|FG001|18-week Open Label Extension|Adverse Event|0|||
23511020|NCT02664441|65606238|FG000|18-week Open Label Extension|Physician Decision|1|||
23511021|NCT02664441|65606239|FG001|18-week Open Label Extension|Physician Decision|0|||
23511022|NCT02664441|65606238|FG000|18-week Open Label Extension|Death|1|||
23511023|NCT02664441|65606239|FG001|18-week Open Label Extension|Death|0|||
23511024|NCT02664441|65606238|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
23511025|NCT02664441|65606239|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
23511026|NCT03156543|65606241|FG000|Overall Study|Withdrawal by Subject|1|||
23511027|NCT03156543|65606242|FG001|Overall Study|Withdrawal by Subject|0|||
23511028|NCT02763189|65606245|FG000|Overall Study|Device failure|0|||
23511029|NCT02763189|65606246|FG001|Overall Study|Device failure|2|||
23511030|NCT04140292|65606247|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
23306692|NCT00616941|64866461|FG000|Overall Study|Progressive Disease|1|||
23511031|NCT04140292|65606248|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
23511032|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
23511033|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
23511034|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
23511035|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
23511036|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
23511037|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
23511038|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
23511039|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
23511040|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
23511041|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
23511042|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
23511043|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
23511044|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
23511045|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
23511046|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
23511047|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
23511048|NCT03510884|65606249|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
23511049|NCT03510884|65606250|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
23511050|NCT03510884|65606251|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
23511051|NCT03510884|65606252|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
23511052|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
23511053|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
23511054|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
23511055|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
23511056|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
23511057|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
23511058|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
23511059|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
23511060|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
23511061|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
23511062|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
23511063|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
23511064|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
23610571|NCT01964547|65962805|FG001|Overall Study|Lost to Follow-up|1|||
23306693|NCT00616941|64866462|FG001|Overall Study|Progressive Disease|2|||
23306694|NCT00616941|64866463|FG002|Overall Study|Progressive Disease|1|||
23306695|NCT00616941|64866461|FG000|Overall Study|Adverse Event|0|||
23306696|NCT00616941|64866462|FG001|Overall Study|Adverse Event|1|||
23306697|NCT00616941|64866463|FG002|Overall Study|Adverse Event|1|||
23306698|NCT00616941|64866461|FG000|Overall Study|Subject Non-compliance|0|||
23306699|NCT00616941|64866462|FG001|Overall Study|Subject Non-compliance|0|||
23306700|NCT00616941|64866463|FG002|Overall Study|Subject Non-compliance|1|||
23306701|NCT00616941|64866461|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
23306702|NCT00616941|64866462|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
23306703|NCT00616941|64866463|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
23306704|NCT00616941|64866461|FG000|Overall Study|Vaccination Suspended|0|||
23306705|NCT00616941|64866462|FG001|Overall Study|Vaccination Suspended|0|||
23306706|NCT00616941|64866463|FG002|Overall Study|Vaccination Suspended|3|||
23306707|NCT00861198|64866466|FG000|Overall Study|SpyGlass Failed|5|||
23306708|NCT04112173|64866467|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
23306709|NCT01394952|64866468|FG000|Overall Study|Lost to Follow-up|0|||
23306710|NCT01394952|64866469|FG001|Overall Study|Lost to Follow-up|5|||
23306711|NCT01394952|64866468|FG000|Overall Study|Withdrawal by Subject|10|||
23306712|NCT01394952|64866469|FG001|Overall Study|Withdrawal by Subject|5|||
23306713|NCT01394952|64866468|FG000|Overall Study|Physician Decision|2|||
23306714|NCT01394952|64866469|FG001|Overall Study|Physician Decision|0|||
23306715|NCT01394952|64866468|FG000|Overall Study|Sponsor Decision|5|||
23306716|NCT01394952|64866469|FG001|Overall Study|Sponsor Decision|7|||
23306717|NCT00114166|64866473|FG000|Overall Study|Wrong primary|0|||
23306718|NCT00114166|64866474|FG001|Overall Study|Wrong primary|1|||
23306719|NCT04421586|64866475|FG000|Overall Study|Death|0|||
23306720|NCT04421586|64866476|FG001|Overall Study|Death|1|||
23306721|NCT04421586|64866475|FG000|Overall Study|Lost to Follow-up|2|||
23306722|NCT04421586|64866476|FG001|Overall Study|Lost to Follow-up|2|||
23306723|NCT04421586|64866475|FG000|Overall Study|Withdrawn by PI|1|||
23306724|NCT04421586|64866476|FG001|Overall Study|Withdrawn by PI|0|||
23306725|NCT04421586|64866475|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
23306726|NCT04421586|64866476|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
23306727|NCT04234984|64866477|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
23306728|NCT04234984|64866477|FG000|Follow-up at the Second Time Point|Death|1|||
23306729|NCT04234984|64866477|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
23306730|NCT02669758|64866478|FG000|Overall Study|Withdrawal by Subject|43|||
23306731|NCT02669758|64866478|FG000|Overall Study|Lost to Follow-up|19|||
23306732|NCT02669758|64866478|FG000|Overall Study|Adverse Event|16|||
23511065|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
23511066|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
23511067|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
23511068|NCT03510884|65606249|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
23511069|NCT03510884|65606250|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
23511070|NCT03510884|65606251|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
23511071|NCT03510884|65606252|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
23511072|NCT02709785|65606253|FG000|Overall Study|Withdrawal by Subject|1|||
23511073|NCT02709785|65606254|FG001|Overall Study|Withdrawal by Subject|2|||
23511074|NCT02709785|65606255|FG002|Overall Study|Withdrawal by Subject|1|||
23511075|NCT02846779|65606258|FG000|Overall Study|Lost Enrollment|83|||
23511076|NCT02846779|65606259|FG001|Overall Study|Lost Enrollment|82|||
23511077|NCT02846779|65606260|FG002|Overall Study|Lost Enrollment|86|||
23511078|NCT02846779|65606258|FG000|Overall Study|Less than 31 days of follow-up|56|||
23511079|NCT02846779|65606259|FG001|Overall Study|Less than 31 days of follow-up|45|||
23511080|NCT02846779|65606260|FG002|Overall Study|Less than 31 days of follow-up|52|||
23511081|NCT03454893|65606261|FG000|Overall Study|Study Terminated by the Sponsor|5|||
23511082|NCT03454893|65606261|FG000|Overall Study|Did not pass screening|4|||
23511083|NCT03274440|65606262|FG000|Overall Study|Time commitment too great|1|||
23511084|NCT03274440|65606263|FG001|Overall Study|Time commitment too great|0|||
23511085|NCT03274440|65606264|FG002|Overall Study|Time commitment too great|0|||
23511086|NCT03274440|65606265|FG003|Overall Study|Time commitment too great|1|||
23511087|NCT03274440|65606266|FG004|Overall Study|Time commitment too great|0|||
23511088|NCT03274440|65606267|FG005|Overall Study|Time commitment too great|0|||
23511089|NCT02509156|65606268|FG000|Randomized Phase|Death|1|||
23511090|NCT02509156|65606269|FG001|Randomized Phase|Death|0|||
23511091|NCT02509156|65606268|FG000|Randomized Phase|Withdrawal by Subject|1|||
23511092|NCT02509156|65606269|FG001|Randomized Phase|Withdrawal by Subject|1|||
23511093|NCT03700671|65606274|FG000|Overall Study|Lack of Efficacy|1|||
23511094|NCT03700671|65606275|FG001|Overall Study|Lack of Efficacy|2|||
23511095|NCT02708121|65606276|FG000|Overall Study|Withdrawn by Study Team|1|||
23511096|NCT02708121|65606277|FG001|Overall Study|Withdrawn by Study Team|1|||
23511097|NCT02708121|65606276|FG000|Overall Study|Withdrawal by Subject|0|||
23511098|NCT02708121|65606277|FG001|Overall Study|Withdrawal by Subject|4|||
23511099|NCT02041286|65606279|FG000|Overall Study|Adverse Event|1|||
23511100|NCT00456521|65606282|FG000|Overall Study|Adverse Event|150|||
23511101|NCT00456521|65606283|FG001|Overall Study|Adverse Event|25|||
23511102|NCT00456521|65606282|FG000|Overall Study|Withdrawal by Subject|43|||
23511103|NCT00456521|65606283|FG001|Overall Study|Withdrawal by Subject|24|||
23511104|NCT00456521|65606282|FG000|Overall Study|Lost to Follow-up|22|||
23511105|NCT00456521|65606283|FG001|Overall Study|Lost to Follow-up|17|||
23511106|NCT00456521|65606282|FG000|Overall Study|Lack of Efficacy|3|||
23511107|NCT00456521|65606283|FG001|Overall Study|Lack of Efficacy|6|||
23511108|NCT00456521|65606282|FG000|Overall Study|Protocol Violation|4|||
23511109|NCT00456521|65606283|FG001|Overall Study|Protocol Violation|0|||
23511110|NCT00456521|65606282|FG000|Overall Study|Pregnancy|1|||
23511111|NCT00456521|65606283|FG001|Overall Study|Pregnancy|1|||
23306733|NCT02669758|64866478|FG000|Overall Study|Non-Compliance with Study Drug|8|||
23306734|NCT02669758|64866478|FG000|Overall Study|Lack of Efficacy|5|||
23306735|NCT02669758|64866478|FG000|Overall Study|Pregnancy|1|||
23306736|NCT02669758|64866478|FG000|Overall Study|Study noncompliance|1|||
23306737|NCT02669758|64866478|FG000|Overall Study|Protocol Violation|1|||
23306738|NCT02669940|64866485|FG000|Overall Study|Failure to return|0|||
23306739|NCT02669940|64866486|FG001|Overall Study|Failure to return|3|||
23306740|NCT02669940|64866485|FG000|Overall Study|Insufficient follow-up data|1|||
23306741|NCT02669940|64866486|FG001|Overall Study|Insufficient follow-up data|0|||
23306742|NCT00616629|64866487|FG000|Overall Study|Protocol Violation|1|||
23306743|NCT00616629|64866488|FG001|Overall Study|Protocol Violation|2|||
23306744|NCT00616629|64866489|FG002|Overall Study|Protocol Violation|1|||
23306745|NCT00616629|64866490|FG003|Overall Study|Protocol Violation|0|||
23306746|NCT00616629|64866491|FG004|Overall Study|Protocol Violation|0|||
23306747|NCT00616629|64866487|FG000|Overall Study|AV-block|1|||
23408815|NCT01467466|65240020|FG002|Overall Study|Procedure Cancelled|25|||
23408816|NCT01467466|65240021|FG003|Overall Study|Procedure Cancelled|29|||
23511112|NCT00456521|65606282|FG000|Overall Study|Drug non-compliance, moved, other|26|||
23511113|NCT00456521|65606283|FG001|Overall Study|Drug non-compliance, moved, other|11|||
23511114|NCT02433483|65606286|FG000|Overall Study|Unacceptable toxicity|1|||
23511115|NCT02433483|65606286|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
23511116|NCT01340027|65606287|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
23511117|NCT01340027|65606288|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
23306748|NCT00616629|64866488|FG001|Overall Study|AV-block|0|||
23306749|NCT00616629|64866489|FG002|Overall Study|AV-block|0|||
23408817|NCT01467466|65240018|FG000|Overall Study|No Endpoint Blood Draw|38|||
23306750|NCT00616629|64866490|FG003|Overall Study|AV-block|0|||
23306751|NCT00616629|64866491|FG004|Overall Study|AV-block|0|||
23511118|NCT01340027|65606289|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
23511119|NCT01340027|65606290|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
23511120|NCT01340027|65606291|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
23511121|NCT01340027|65606292|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
23511122|NCT01340027|65606293|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
23511123|NCT01340027|65606294|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
23511124|NCT01340027|65606295|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
23511125|NCT01340027|65606296|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
23511126|NCT01340027|65606297|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
23511127|NCT01340027|65606298|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
23511128|NCT01340027|65606287|FG000|Overall Study|Adverse Event|0|||
23511129|NCT01340027|65606288|FG001|Overall Study|Adverse Event|1|||
23511130|NCT01340027|65606289|FG002|Overall Study|Adverse Event|2|||
23511131|NCT01340027|65606290|FG003|Overall Study|Adverse Event|0|||
23511132|NCT01340027|65606291|FG004|Overall Study|Adverse Event|1|||
23511133|NCT01340027|65606292|FG005|Overall Study|Adverse Event|2|||
23511134|NCT01340027|65606293|FG006|Overall Study|Adverse Event|2|||
23511135|NCT01340027|65606294|FG007|Overall Study|Adverse Event|1|||
23511136|NCT01340027|65606295|FG008|Overall Study|Adverse Event|4|||
23511137|NCT01340027|65606296|FG009|Overall Study|Adverse Event|1|||
23511138|NCT01340027|65606297|FG010|Overall Study|Adverse Event|1|||
23511139|NCT01340027|65606298|FG011|Overall Study|Adverse Event|3|||
23511140|NCT01340027|65606287|FG000|Overall Study|Lack of Efficacy|0|||
23511141|NCT01340027|65606288|FG001|Overall Study|Lack of Efficacy|0|||
23511142|NCT01340027|65606289|FG002|Overall Study|Lack of Efficacy|0|||
23511143|NCT01340027|65606290|FG003|Overall Study|Lack of Efficacy|0|||
23511144|NCT01340027|65606291|FG004|Overall Study|Lack of Efficacy|0|||
23511145|NCT01340027|65606292|FG005|Overall Study|Lack of Efficacy|0|||
23511146|NCT01340027|65606293|FG006|Overall Study|Lack of Efficacy|1|||
23511147|NCT01340027|65606294|FG007|Overall Study|Lack of Efficacy|1|||
23511148|NCT01340027|65606295|FG008|Overall Study|Lack of Efficacy|1|||
23511149|NCT01340027|65606296|FG009|Overall Study|Lack of Efficacy|0|||
23511150|NCT01340027|65606297|FG010|Overall Study|Lack of Efficacy|0|||
23511151|NCT01340027|65606298|FG011|Overall Study|Lack of Efficacy|0|||
23511152|NCT01340027|65606287|FG000|Overall Study|Lost to Follow-up|0|||
23511153|NCT01340027|65606288|FG001|Overall Study|Lost to Follow-up|1|||
23511154|NCT01340027|65606289|FG002|Overall Study|Lost to Follow-up|0|||
23511155|NCT01340027|65606290|FG003|Overall Study|Lost to Follow-up|0|||
23511156|NCT01340027|65606291|FG004|Overall Study|Lost to Follow-up|0|||
23511157|NCT01340027|65606292|FG005|Overall Study|Lost to Follow-up|0|||
23511158|NCT01340027|65606293|FG006|Overall Study|Lost to Follow-up|1|||
23511159|NCT01340027|65606294|FG007|Overall Study|Lost to Follow-up|0|||
23511160|NCT01340027|65606295|FG008|Overall Study|Lost to Follow-up|0|||
23511161|NCT01340027|65606296|FG009|Overall Study|Lost to Follow-up|1|||
23511162|NCT01340027|65606297|FG010|Overall Study|Lost to Follow-up|0|||
23511163|NCT01340027|65606298|FG011|Overall Study|Lost to Follow-up|0|||
23511164|NCT01340027|65606287|FG000|Overall Study|Protocol Violation|1|||
23511165|NCT01340027|65606288|FG001|Overall Study|Protocol Violation|2|||
23511166|NCT01340027|65606289|FG002|Overall Study|Protocol Violation|0|||
23511167|NCT01340027|65606290|FG003|Overall Study|Protocol Violation|0|||
23511168|NCT01340027|65606291|FG004|Overall Study|Protocol Violation|6|||
23511169|NCT01340027|65606292|FG005|Overall Study|Protocol Violation|0|||
23511170|NCT01340027|65606293|FG006|Overall Study|Protocol Violation|0|||
23511171|NCT01340027|65606294|FG007|Overall Study|Protocol Violation|1|||
23511172|NCT01340027|65606295|FG008|Overall Study|Protocol Violation|2|||
23511173|NCT01340027|65606296|FG009|Overall Study|Protocol Violation|2|||
23511174|NCT01340027|65606297|FG010|Overall Study|Protocol Violation|0|||
23511175|NCT01340027|65606298|FG011|Overall Study|Protocol Violation|0|||
23511176|NCT01340027|65606287|FG000|Overall Study|Withdrawal by Subject|4|||
23511177|NCT01340027|65606288|FG001|Overall Study|Withdrawal by Subject|3|||
23511178|NCT01340027|65606289|FG002|Overall Study|Withdrawal by Subject|1|||
23511179|NCT01340027|65606290|FG003|Overall Study|Withdrawal by Subject|3|||
23511180|NCT01340027|65606291|FG004|Overall Study|Withdrawal by Subject|3|||
23511181|NCT01340027|65606292|FG005|Overall Study|Withdrawal by Subject|2|||
23511182|NCT01340027|65606293|FG006|Overall Study|Withdrawal by Subject|3|||
23511183|NCT01340027|65606294|FG007|Overall Study|Withdrawal by Subject|4|||
23511184|NCT01340027|65606295|FG008|Overall Study|Withdrawal by Subject|1|||
23511185|NCT01340027|65606296|FG009|Overall Study|Withdrawal by Subject|2|||
23511186|NCT01340027|65606297|FG010|Overall Study|Withdrawal by Subject|0|||
23511187|NCT01340027|65606298|FG011|Overall Study|Withdrawal by Subject|1|||
23511188|NCT01340027|65606287|FG000|Overall Study|Miscellaneous|0|||
23511189|NCT01340027|65606288|FG001|Overall Study|Miscellaneous|0|||
23511190|NCT01340027|65606289|FG002|Overall Study|Miscellaneous|0|||
23511191|NCT01340027|65606290|FG003|Overall Study|Miscellaneous|1|||
23511192|NCT01340027|65606291|FG004|Overall Study|Miscellaneous|0|||
23511193|NCT01340027|65606292|FG005|Overall Study|Miscellaneous|0|||
23511194|NCT01340027|65606293|FG006|Overall Study|Miscellaneous|0|||
23511195|NCT01340027|65606294|FG007|Overall Study|Miscellaneous|0|||
23511196|NCT01340027|65606295|FG008|Overall Study|Miscellaneous|0|||
23511197|NCT01340027|65606296|FG009|Overall Study|Miscellaneous|0|||
23511198|NCT01340027|65606297|FG010|Overall Study|Miscellaneous|1|||
23511199|NCT01340027|65606298|FG011|Overall Study|Miscellaneous|0|||
23511200|NCT00137046|65606303|FG000|Overall Study|Death|2|||
23511201|NCT00137046|65606304|FG001|Overall Study|Death|1|||
23511202|NCT00137046|65606303|FG000|Overall Study|Adverse Event|16|||
23511203|NCT00137046|65606304|FG001|Overall Study|Adverse Event|5|||
23511204|NCT00137046|65606303|FG000|Overall Study|Laboratory Abnormality|2|||
23511205|NCT00137046|65606304|FG001|Overall Study|Laboratory Abnormality|0|||
23511206|NCT00137046|65606303|FG000|Overall Study|Lack of Efficacy|13|||
23511207|NCT00137046|65606304|FG001|Overall Study|Lack of Efficacy|1|||
23511208|NCT00137046|65606303|FG000|Overall Study|Lost to Follow-up|8|||
23511209|NCT00137046|65606304|FG001|Overall Study|Lost to Follow-up|24|||
23511210|NCT00137046|65606303|FG000|Overall Study|Other|23|||
23511211|NCT00137046|65606304|FG001|Overall Study|Other|19|||
23511212|NCT00137046|65606303|FG000|Overall Study|Withdrawal by Subject|33|||
23511213|NCT00137046|65606304|FG001|Overall Study|Withdrawal by Subject|42|||
23511214|NCT00137046|65606303|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
23511215|NCT00137046|65606304|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
23511216|NCT00137046|65606303|FG000|Overall Study|Withdrew prior to study treatment|1|||
23511217|NCT00137046|65606304|FG001|Overall Study|Withdrew prior to study treatment|1|||
23511218|NCT03070782|65606310|FG000|Overall Study|Adverse Event|3|||
23511219|NCT03070782|65606311|FG001|Overall Study|Adverse Event|0|||
23511220|NCT03070782|65606312|FG002|Overall Study|Adverse Event|3|||
23511221|NCT03070782|65606313|FG003|Overall Study|Adverse Event|1|||
23511222|NCT03070782|65606314|FG004|Overall Study|Adverse Event|6|||
23511223|NCT03070782|65606315|FG005|Overall Study|Adverse Event|2|||
23511224|NCT03070782|65606310|FG000|Overall Study|Withdrawal by Subject|2|||
23511225|NCT03070782|65606311|FG001|Overall Study|Withdrawal by Subject|1|||
23511226|NCT03070782|65606312|FG002|Overall Study|Withdrawal by Subject|1|||
23511227|NCT03070782|65606313|FG003|Overall Study|Withdrawal by Subject|0|||
23511228|NCT03070782|65606314|FG004|Overall Study|Withdrawal by Subject|4|||
23511229|NCT03070782|65606315|FG005|Overall Study|Withdrawal by Subject|3|||
23511230|NCT03070782|65606310|FG000|Overall Study|Reason Not Specified|2|||
23511231|NCT03070782|65606311|FG001|Overall Study|Reason Not Specified|0|||
23511232|NCT03070782|65606312|FG002|Overall Study|Reason Not Specified|0|||
23511233|NCT03070782|65606313|FG003|Overall Study|Reason Not Specified|1|||
23511234|NCT03070782|65606314|FG004|Overall Study|Reason Not Specified|2|||
23511235|NCT03070782|65606315|FG005|Overall Study|Reason Not Specified|1|||
23511236|NCT03070782|65606310|FG000|Overall Study|Ineligibility|0|||
23511237|NCT03070782|65606311|FG001|Overall Study|Ineligibility|0|||
23511238|NCT03070782|65606312|FG002|Overall Study|Ineligibility|0|||
23511239|NCT03070782|65606313|FG003|Overall Study|Ineligibility|1|||
23511240|NCT03070782|65606314|FG004|Overall Study|Ineligibility|0|||
23511241|NCT03070782|65606315|FG005|Overall Study|Ineligibility|1|||
23511242|NCT03070782|65606310|FG000|Overall Study|Pregnancy|0|||
23511243|NCT03070782|65606311|FG001|Overall Study|Pregnancy|0|||
23511244|NCT03070782|65606312|FG002|Overall Study|Pregnancy|0|||
23511245|NCT03070782|65606313|FG003|Overall Study|Pregnancy|1|||
23511246|NCT03070782|65606314|FG004|Overall Study|Pregnancy|0|||
23511247|NCT03070782|65606315|FG005|Overall Study|Pregnancy|0|||
23511248|NCT03070782|65606310|FG000|Overall Study|Investigator Judgement|0|||
23511249|NCT03070782|65606311|FG001|Overall Study|Investigator Judgement|0|||
23511250|NCT03070782|65606312|FG002|Overall Study|Investigator Judgement|0|||
23511251|NCT03070782|65606313|FG003|Overall Study|Investigator Judgement|1|||
23511252|NCT03070782|65606314|FG004|Overall Study|Investigator Judgement|0|||
23511253|NCT03070782|65606315|FG005|Overall Study|Investigator Judgement|0|||
23511254|NCT03406104|65609258|FG000|Overall Study|Lost to Follow-up|2|||
23511255|NCT03406104|65609258|FG000|Overall Study|Withdrawal by Subject|2|||
23511256|NCT03406104|65609258|FG000|Overall Study|due to Covid patient did not want to travel|1|||
23511257|NCT03406104|65609258|FG000|Overall Study|Death|2|||
23511258|NCT02425046|65609260|FG000|Overall Study|Lost to Follow-up|52|||
23511259|NCT02425046|65609261|FG001|Overall Study|Lost to Follow-up|50|||
23511260|NCT02425046|65609262|FG002|Overall Study|Lost to Follow-up|56|||
23511261|NCT02425046|65609260|FG000|Overall Study|Withdrawal by Subject|16|||
23511262|NCT02425046|65609261|FG001|Overall Study|Withdrawal by Subject|12|||
23511263|NCT02425046|65609262|FG002|Overall Study|Withdrawal by Subject|0|||
23511264|NCT00931762|65609272|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
23511265|NCT00931762|65609272|FG000|Overall Study|Administrative Problems|5|||
23511266|NCT00931762|65609272|FG000|Overall Study|Death|1|||
23511267|NCT00931762|65609272|FG000|Overall Study|Disease Progression|3|||
23511268|NCT00931762|65609272|FG000|Overall Study|Adverse Event (s)|11|||
23511269|NCT00931762|65609272|FG000|Overall Study|Subject withdrew consent|13|||
23511270|NCT01113801|65609274|FG000|Overall Study|Adverse Event|4|||
23511271|NCT01113801|65609275|FG001|Overall Study|Adverse Event|0|||
23511272|NCT01113801|65609276|FG002|Overall Study|Adverse Event|2|||
23511273|NCT01113801|65609277|FG003|Overall Study|Adverse Event|6|||
23511274|NCT01113801|65609274|FG000|Overall Study|Death|4|||
23511275|NCT01113801|65609275|FG001|Overall Study|Death|5|||
23511276|NCT01113801|65609276|FG002|Overall Study|Death|3|||
23511277|NCT01113801|65609277|FG003|Overall Study|Death|4|||
23511278|NCT01113801|65609274|FG000|Overall Study|Protocol Violation|0|||
23511279|NCT01113801|65609275|FG001|Overall Study|Protocol Violation|1|||
23511280|NCT01113801|65609276|FG002|Overall Study|Protocol Violation|0|||
23511281|NCT01113801|65609277|FG003|Overall Study|Protocol Violation|0|||
23511282|NCT01113801|65609274|FG000|Overall Study|Withdrawal by Subject|9|||
23511283|NCT01113801|65609275|FG001|Overall Study|Withdrawal by Subject|7|||
23511284|NCT01113801|65609276|FG002|Overall Study|Withdrawal by Subject|7|||
23511285|NCT01113801|65609277|FG003|Overall Study|Withdrawal by Subject|8|||
23511286|NCT01113801|65609274|FG000|Overall Study|Physician Decision|2|||
23511287|NCT01113801|65609275|FG001|Overall Study|Physician Decision|2|||
23511288|NCT01113801|65609276|FG002|Overall Study|Physician Decision|3|||
23511289|NCT01113801|65609277|FG003|Overall Study|Physician Decision|3|||
23511290|NCT01113801|65609274|FG000|Overall Study|Sponsor Decision|15|||
23511291|NCT01113801|65609275|FG001|Overall Study|Sponsor Decision|21|||
23511292|NCT01113801|65609276|FG002|Overall Study|Sponsor Decision|20|||
23511293|NCT01113801|65609277|FG003|Overall Study|Sponsor Decision|15|||
23511294|NCT01113801|65609274|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
23511295|NCT01113801|65609275|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
23511296|NCT01113801|65609276|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
23511297|NCT01113801|65609277|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
23511298|NCT00418314|65609278|FG000|Overall Study|Withdrawal by Subject|1|||
23511299|NCT00418314|65609279|FG001|Overall Study|Withdrawal by Subject|2|||
23511300|NCT00142584|65609283|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
23511301|NCT00142584|65609284|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
23511302|NCT00142584|65609283|FG000|Overall Study|Withdrawal by Subject|30|||
23511303|NCT00142584|65609284|FG001|Overall Study|Withdrawal by Subject|16|||
23511304|NCT00142584|65609283|FG000|Overall Study|Lost to Follow-up|22|||
23511305|NCT00142584|65609284|FG001|Overall Study|Lost to Follow-up|12|||
23511306|NCT00142584|65609283|FG000|Overall Study|Adverse Event|14|||
23511307|NCT00142584|65609284|FG001|Overall Study|Adverse Event|5|||
23511308|NCT00142584|65609283|FG000|Overall Study|Protocol Violation|4|||
23511309|NCT00142584|65609284|FG001|Overall Study|Protocol Violation|7|||
23511310|NCT00142584|65609283|FG000|Overall Study|Treatment Failure|2|||
23511311|NCT00142584|65609284|FG001|Overall Study|Treatment Failure|0|||
23511312|NCT04977583|65609285|FG000|Overall Study|Lost to Follow-up|8|||
23511313|NCT04977583|65609286|FG001|Overall Study|Lost to Follow-up|4|||
23511314|NCT04977583|65609287|FG002|Overall Study|Lost to Follow-up|13|||
23511315|NCT04977583|65609285|FG000|Overall Study|Withdrawal by Subject|3|||
23511316|NCT04977583|65609286|FG001|Overall Study|Withdrawal by Subject|2|||
23511317|NCT04977583|65609287|FG002|Overall Study|Withdrawal by Subject|1|||
23511318|NCT00416078|65609288|FG000|Overall Study|Death|3|||
23511319|NCT00416078|65609289|FG001|Overall Study|Death|4|||
23511320|NCT00416078|65609288|FG000|Overall Study|Withdrawal by Subject|3|||
23511321|NCT00416078|65609289|FG001|Overall Study|Withdrawal by Subject|2|||
23511322|NCT00416078|65609288|FG000|Overall Study|Physician Decision|1|||
23511323|NCT00416078|65609289|FG001|Overall Study|Physician Decision|0|||
23511324|NCT00416078|65609288|FG000|Overall Study|Lost to Follow-up|4|||
23511325|NCT00416078|65609289|FG001|Overall Study|Lost to Follow-up|2|||
23511326|NCT00514540|65609290|FG000|First-Line Chemo|Withdrawal by Subject|1|||
23511327|NCT00514540|65609290|FG000|First-Line Chemo|Protocol Violation|7|||
23511328|NCT00514540|65609290|FG000|Second-Line|Physician/Patient Decision|31|||
23511329|NCT01852110|65609291|FG000|Overall Study|Adverse Event|12|||
23511330|NCT01852110|65609292|FG001|Overall Study|Adverse Event|5|||
23511331|NCT01852110|65609293|FG002|Overall Study|Adverse Event|0|||
23511332|NCT01852110|65609294|FG003|Overall Study|Adverse Event|0|||
23511333|NCT01852110|65609295|FG004|Overall Study|Adverse Event|0|||
23511334|NCT01852110|65609296|FG005|Overall Study|Adverse Event|0|||
23511335|NCT01852110|65609291|FG000|Overall Study|Lost to Follow-up|1|||
23511336|NCT01852110|65609292|FG001|Overall Study|Lost to Follow-up|3|||
23511337|NCT01852110|65609293|FG002|Overall Study|Lost to Follow-up|0|||
23511338|NCT01852110|65609294|FG003|Overall Study|Lost to Follow-up|0|||
23511339|NCT01852110|65609295|FG004|Overall Study|Lost to Follow-up|0|||
23511340|NCT01852110|65609296|FG005|Overall Study|Lost to Follow-up|0|||
23511341|NCT01852110|65609291|FG000|Overall Study|Non-compliance with Study Drug|2|||
23511342|NCT01852110|65609292|FG001|Overall Study|Non-compliance with Study Drug|1|||
23511343|NCT01852110|65609293|FG002|Overall Study|Non-compliance with Study Drug|0|||
23511344|NCT01852110|65609294|FG003|Overall Study|Non-compliance with Study Drug|0|||
23511345|NCT01852110|65609295|FG004|Overall Study|Non-compliance with Study Drug|0|||
23511346|NCT01852110|65609296|FG005|Overall Study|Non-compliance with Study Drug|0|||
23511347|NCT01852110|65609291|FG000|Overall Study|Physician Decision|1|||
23511348|NCT01852110|65609292|FG001|Overall Study|Physician Decision|0|||
23511349|NCT01852110|65609293|FG002|Overall Study|Physician Decision|0|||
23511350|NCT01852110|65609294|FG003|Overall Study|Physician Decision|0|||
23511351|NCT01852110|65609295|FG004|Overall Study|Physician Decision|0|||
23511352|NCT01852110|65609296|FG005|Overall Study|Physician Decision|0|||
23511353|NCT01852110|65609291|FG000|Overall Study|Protocol Violation|0|||
23511354|NCT01852110|65609292|FG001|Overall Study|Protocol Violation|1|||
23511355|NCT01852110|65609293|FG002|Overall Study|Protocol Violation|0|||
23511356|NCT01852110|65609294|FG003|Overall Study|Protocol Violation|0|||
23511357|NCT01852110|65609295|FG004|Overall Study|Protocol Violation|0|||
23511358|NCT01852110|65609296|FG005|Overall Study|Protocol Violation|0|||
23511359|NCT01852110|65609291|FG000|Overall Study|Study Terminated by Sponsor|30|||
23511360|NCT01852110|65609292|FG001|Overall Study|Study Terminated by Sponsor|32|||
23511361|NCT01852110|65609293|FG002|Overall Study|Study Terminated by Sponsor|0|||
23511362|NCT01852110|65609294|FG003|Overall Study|Study Terminated by Sponsor|0|||
23511363|NCT01852110|65609295|FG004|Overall Study|Study Terminated by Sponsor|0|||
23511364|NCT01852110|65609296|FG005|Overall Study|Study Terminated by Sponsor|0|||
23511365|NCT01852110|65609291|FG000|Overall Study|Withdrawal by Subject|4|||
23511366|NCT01852110|65609292|FG001|Overall Study|Withdrawal by Subject|4|||
23511367|NCT01852110|65609293|FG002|Overall Study|Withdrawal by Subject|0|||
23511368|NCT01852110|65609294|FG003|Overall Study|Withdrawal by Subject|0|||
23511369|NCT01852110|65609295|FG004|Overall Study|Withdrawal by Subject|0|||
23511370|NCT01852110|65609296|FG005|Overall Study|Withdrawal by Subject|0|||
23511371|NCT03506815|65609297|FG000|Overall Study|Adverse Event|8|||
23511372|NCT03506815|65609298|FG001|Overall Study|Adverse Event|0|||
23511373|NCT03506815|65609297|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
23511374|NCT03506815|65609298|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
23511375|NCT03506815|65609297|FG000|Overall Study|Protocol Violation|1|||
23511376|NCT03506815|65609298|FG001|Overall Study|Protocol Violation|0|||
23511377|NCT03506815|65609297|FG000|Overall Study|Elective Surgery|1|||
23340850|NCT01936181|64992871|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
23511378|NCT03506815|65609298|FG001|Overall Study|Elective Surgery|0|||
23511379|NCT02496533|65609299|FG000|Overall Study|Lack of data on outcome|3|||
23511380|NCT02496533|65609300|FG001|Overall Study|Lack of data on outcome|0|||
23511381|NCT02496533|65609299|FG000|Overall Study|Patient did not complete all measures|0|||
23511382|NCT02496533|65609300|FG001|Overall Study|Patient did not complete all measures|4|||
23511383|NCT02496533|65609299|FG000|Overall Study|Late for radiologic testing|0|||
23511384|NCT02496533|65609300|FG001|Overall Study|Late for radiologic testing|2|||
23511385|NCT04533438|65609316|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
23511386|NCT04533438|65609317|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
23511387|NCT03128892|65609318|FG000|Overall Study|Withdrawal by Subject|2|||
23511388|NCT03128892|65609318|FG000|Overall Study|Physician Decision|1|||
23511389|NCT03557151|65609319|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
23511390|NCT03557151|65609320|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
23511391|NCT03557151|65609319|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
23511392|NCT03557151|65609320|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
23511393|NCT03557151|65609319|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
23408818|NCT01467466|65240019|FG001|Overall Study|No Endpoint Blood Draw|32|||
23408819|NCT01467466|65240020|FG002|Overall Study|No Endpoint Blood Draw|51|||
23408820|NCT01467466|65240021|FG003|Overall Study|No Endpoint Blood Draw|43|||
23408821|NCT04644276|65240022|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
23408822|NCT04644276|65240023|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
23408823|NCT04644276|65240024|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
23408824|NCT01063062|65240025|FG000|Overall Study|Patient withdrew consent|0|||
23306752|NCT01155024|64866492|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
23306753|NCT01155024|64866493|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
23306754|NCT01155024|64866492|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
23306755|NCT01155024|64866493|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
23306756|NCT01155024|64866492|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
23306757|NCT01155024|64866493|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
23306758|NCT03050060|64866494|FG000|Overall Study|Adverse Event|7|||
23306759|NCT03050060|64866494|FG000|Overall Study|Withdrawal by Subject|1|||
23306760|NCT03050060|64866494|FG000|Overall Study|Progression|7|||
23306761|NCT00548093|64866495|FG000|Overall Study|Death|33|||
23306762|NCT00548093|64866496|FG001|Overall Study|Death|13|||
23306763|NCT00548093|64866495|FG000|Overall Study|Lost to Follow-up|3|||
23306764|NCT00548093|64866496|FG001|Overall Study|Lost to Follow-up|1|||
23306765|NCT00548093|64866495|FG000|Overall Study|Objective progression or relapse|1|||
23306766|NCT00548093|64866496|FG001|Overall Study|Objective progression or relapse|1|||
23306767|NCT00548093|64866495|FG000|Overall Study|Other|11|||
23408825|NCT01063062|65240026|FG001|Overall Study|Patient withdrew consent|1|||
23408826|NCT01063062|65240025|FG000|Overall Study|Adverse Event|2|||
23408827|NCT01063062|65240026|FG001|Overall Study|Adverse Event|4|||
23408828|NCT01063062|65240025|FG000|Overall Study|Protocol Violation|5|||
23408829|NCT01063062|65240026|FG001|Overall Study|Protocol Violation|4|||
23408830|NCT01063062|65240025|FG000|Overall Study|Investigator's request|1|||
23408831|NCT01063062|65240026|FG001|Overall Study|Investigator's request|0|||
23408832|NCT01063062|65240025|FG000|Overall Study|Lost to Follow-up|0|||
23408833|NCT01063062|65240026|FG001|Overall Study|Lost to Follow-up|2|||
23408834|NCT01063062|65240025|FG000|Overall Study|Miscellaneous reason|0|||
23408835|NCT01063062|65240026|FG001|Overall Study|Miscellaneous reason|1|||
23408836|NCT01665911|65240027|FG000|Overall Study|Protocol Violation|4|||
23408837|NCT01665911|65240027|FG000|Overall Study|Withdrawal by Subject|1|||
23408838|NCT01665911|65240027|FG000|Overall Study|Adverse Event|1|||
23408839|NCT04396795|65240028|FG000|Month 1|Lost to Follow-up|2|||
23408840|NCT04396795|65240029|FG001|Month 1|Lost to Follow-up|3|||
23408841|NCT04396795|65240028|FG000|Month 3|Lost to Follow-up|1|||
23408842|NCT04396795|65240029|FG001|Month 3|Lost to Follow-up|3|||
23408843|NCT04396795|65240028|FG000|Month 6|Lost to Follow-up|3|||
23408844|NCT04396795|65240029|FG001|Month 6|Lost to Follow-up|3|||
23408845|NCT02010593|65240032|FG000|Overall Study|Lost to Follow-up|1|||
23408846|NCT02010593|65240033|FG001|Overall Study|Lost to Follow-up|0|||
23408847|NCT02010593|65240032|FG000|Overall Study|Physician Decision|1|||
23408848|NCT02010593|65240033|FG001|Overall Study|Physician Decision|0|||
23408849|NCT02010593|65240032|FG000|Overall Study|Unable to adhere to visit schedule|0|||
23408850|NCT02010593|65240033|FG001|Overall Study|Unable to adhere to visit schedule|2|||
23408851|NCT01253369|65240034|FG000|Overall Study|Adverse Event|4|||
23408852|NCT01253369|65240034|FG000|Overall Study|Withdrawal by Subject|2|||
23408853|NCT01253369|65240034|FG000|Overall Study|Death|1|||
23511394|NCT03557151|65609320|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
23511395|NCT01829230|65609321|FG000|Overall Study|Protocol Violation|0|||
23306768|NCT00548093|64866496|FG001|Overall Study|Other|1|||
23306769|NCT00548093|64866495|FG000|Overall Study|Withdrawal by Subject|1|||
23408854|NCT01253369|65240034|FG000|Overall Study|Progressive disease|23|||
23408855|NCT01253369|65240034|FG000|Overall Study|Not Evaluable|3|||
23408856|NCT03900728|65240035|FG000|Overall Study|No text responses|0|||
23408857|NCT03900728|65240036|FG001|Overall Study|No text responses|0|||
23408858|NCT03900728|65240037|FG002|Overall Study|No text responses|4|||
23306770|NCT00548093|64866496|FG001|Overall Study|Withdrawal by Subject|0|||
23408859|NCT00690794|65240038|FG000|Overall Study|Adverse Event|12|||
23408860|NCT00690794|65240039|FG001|Overall Study|Adverse Event|10|||
23408861|NCT00690794|65240038|FG000|Overall Study|Lost to Follow-up|1|||
23408862|NCT00690794|65240039|FG001|Overall Study|Lost to Follow-up|4|||
23408863|NCT00690794|65240038|FG000|Overall Study|Withdrawal by Subject|0|||
23408864|NCT00690794|65240039|FG001|Overall Study|Withdrawal by Subject|9|||
23408865|NCT00690794|65240038|FG000|Overall Study|Protocol Violation|6|||
23408866|NCT00690794|65240039|FG001|Overall Study|Protocol Violation|7|||
23408867|NCT00690794|65240038|FG000|Overall Study|Noncompliance|1|||
23408868|NCT00690794|65240039|FG001|Overall Study|Noncompliance|2|||
23408869|NCT00690794|65240038|FG000|Overall Study|Other not specified|1|||
23408870|NCT00690794|65240039|FG001|Overall Study|Other not specified|3|||
23408871|NCT02595866|65240041|FG000|Overall Study|Adverse Event|2|||
23408872|NCT02595866|65240042|FG001|Overall Study|Adverse Event|5|||
23408873|NCT02595866|65240041|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
23408874|NCT02595866|65240042|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
23408875|NCT02595866|65240041|FG000|Overall Study|Death|0|||
23408876|NCT02595866|65240042|FG001|Overall Study|Death|1|||
23408877|NCT02595866|65240041|FG000|Overall Study|Incarceration|1|||
23408878|NCT02595866|65240042|FG001|Overall Study|Incarceration|0|||
23408879|NCT02595866|65240041|FG000|Overall Study|Lack of Efficacy|17|||
23408880|NCT02595866|65240042|FG001|Overall Study|Lack of Efficacy|7|||
23408881|NCT02595866|65240041|FG000|Overall Study|Physician Decision|4|||
23408882|NCT02595866|65240042|FG001|Overall Study|Physician Decision|3|||
23408883|NCT02595866|65240041|FG000|Overall Study|Switched to Alternative Treatment|1|||
23408884|NCT02595866|65240042|FG001|Overall Study|Switched to Alternative Treatment|0|||
23408885|NCT02595866|65240041|FG000|Overall Study|Study Terminated|0|||
23408886|NCT02595866|65240042|FG001|Overall Study|Study Terminated|4|||
23408887|NCT02595866|65240041|FG000|Overall Study|Withdrawal by Subject|6|||
23408888|NCT02595866|65240042|FG001|Overall Study|Withdrawal by Subject|1|||
23408889|NCT00430989|65240048|FG000|Overall Study|Lost to Follow-up|2|||
23408890|NCT00430989|65240049|FG001|Overall Study|Lost to Follow-up|3|||
23408891|NCT00430989|65240048|FG000|Overall Study|Withdrawal by Subject|15|||
23408892|NCT00430989|65240049|FG001|Overall Study|Withdrawal by Subject|14|||
23408893|NCT00430989|65240048|FG000|Overall Study|Protocol Violation|30|||
23408894|NCT00430989|65240049|FG001|Overall Study|Protocol Violation|37|||
23408895|NCT00430989|65240048|FG000|Overall Study|Not eligible|13|||
23408896|NCT00430989|65240049|FG001|Overall Study|Not eligible|6|||
23408897|NCT03559517|65240050|FG000|Overall Study|Withdrawal by Subject|1|||
23408898|NCT03559517|65240051|FG001|Overall Study|Withdrawal by Subject|0|||
23408899|NCT03559517|65240052|FG002|Overall Study|Withdrawal by Subject|0|||
23408900|NCT02229825|65240053|FG000|Overall Study|Personal Reasons|0|||
23306771|NCT00548093|64866495|FG000|Overall Study|Completed post-treatment follow-up|1|||
23306772|NCT00548093|64866496|FG001|Overall Study|Completed post-treatment follow-up|0|||
23306773|NCT01629966|64866503|FG000|Overall Study|Pregnancy|0|||
23306774|NCT01629966|64866504|FG001|Overall Study|Pregnancy|1|||
23306775|NCT01629966|64866505|FG002|Overall Study|Pregnancy|0|||
23306776|NCT01629966|64866503|FG000|Overall Study|Lost to Follow-up|10|||
23306777|NCT01629966|64866504|FG001|Overall Study|Lost to Follow-up|13|||
23306778|NCT01629966|64866505|FG002|Overall Study|Lost to Follow-up|9|||
23306779|NCT01629966|64866503|FG000|Overall Study|Withdrawal by Subject|8|||
23306780|NCT01629966|64866504|FG001|Overall Study|Withdrawal by Subject|9|||
23306781|NCT01629966|64866505|FG002|Overall Study|Withdrawal by Subject|16|||
23306782|NCT01629966|64866503|FG000|Overall Study|Protocol Violation|7|||
23306783|NCT01629966|64866504|FG001|Overall Study|Protocol Violation|9|||
23306784|NCT01629966|64866505|FG002|Overall Study|Protocol Violation|7|||
23306785|NCT01629966|64866503|FG000|Overall Study|Lack of Efficacy|5|||
23408901|NCT02229825|65240054|FG001|Overall Study|Personal Reasons|1|||
23408902|NCT02229825|65240053|FG000|Overall Study|Refused continuing medication|7|||
23408903|NCT02229825|65240054|FG001|Overall Study|Refused continuing medication|6|||
23408904|NCT02229825|65240053|FG000|Overall Study|Lost to Follow-up|1|||
23408905|NCT02229825|65240054|FG001|Overall Study|Lost to Follow-up|2|||
23408906|NCT02229825|65240053|FG000|Overall Study|Protocol Violation|1|||
23306786|NCT01629966|64866504|FG001|Overall Study|Lack of Efficacy|2|||
23306787|NCT01629966|64866505|FG002|Overall Study|Lack of Efficacy|4|||
23408907|NCT02229825|65240054|FG001|Overall Study|Protocol Violation|1|||
23306788|NCT01629966|64866503|FG000|Overall Study|Adverse Event|11|||
23306789|NCT01629966|64866504|FG001|Overall Study|Adverse Event|18|||
23306790|NCT01629966|64866505|FG002|Overall Study|Adverse Event|30|||
23306791|NCT00725205|64866506|FG000|Overall Study|Adverse Event|22|||
23306792|NCT00725205|64866506|FG000|Overall Study|Investigator Discontinued|1|||
23306793|NCT00725205|64866506|FG000|Overall Study|Non-compliance With Protocol|14|||
23306794|NCT00725205|64866506|FG000|Overall Study|Other|8|||
23306795|NCT00725205|64866506|FG000|Overall Study|Protocol Defined Clinical Event|1|||
23306796|NCT00725205|64866506|FG000|Overall Study|Treatment Failure|41|||
23306797|NCT02924727|64866508|FG000|Overall Study|Withdrawal by Subject|2|||
23306798|NCT02924727|64866509|FG001|Overall Study|Withdrawal by Subject|4|||
23306799|NCT02924727|64866508|FG000|Overall Study|Lost to Follow-up|2|||
23306800|NCT02924727|64866509|FG001|Overall Study|Lost to Follow-up|5|||
23306801|NCT02924727|64866508|FG000|Overall Study|Death|221|||
23306802|NCT02924727|64866509|FG001|Overall Study|Death|247|||
23306803|NCT02924727|64866508|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
23306804|NCT02924727|64866509|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
23306805|NCT03623386|64866510|FG000|Overall Study|Protocol Violation|3|||
23306806|NCT03623386|64866511|FG001|Overall Study|Protocol Violation|2|||
23306807|NCT03623386|64866512|FG002|Overall Study|Protocol Violation|0|||
23306808|NCT03623386|64866510|FG000|Overall Study|Physician Decision|1|||
23306809|NCT03623386|64866511|FG001|Overall Study|Physician Decision|1|||
23306810|NCT03623386|64866512|FG002|Overall Study|Physician Decision|0|||
23306811|NCT03623386|64866510|FG000|Overall Study|Lost to Follow-up|0|||
23306812|NCT03623386|64866511|FG001|Overall Study|Lost to Follow-up|2|||
23306813|NCT03623386|64866512|FG002|Overall Study|Lost to Follow-up|0|||
23306814|NCT03623386|64866510|FG000|Overall Study|COVID-19|0|||
23306815|NCT03623386|64866511|FG001|Overall Study|COVID-19|1|||
23306816|NCT03623386|64866512|FG002|Overall Study|COVID-19|0|||
23306817|NCT00816361|64866522|FG000|Overall Study|Withdrawal by Subject|0|||
23306818|NCT00816361|64866523|FG001|Overall Study|Withdrawal by Subject|0|||
23306819|NCT00816361|64866524|FG002|Overall Study|Withdrawal by Subject|0|||
23306820|NCT00816361|64866525|FG003|Overall Study|Withdrawal by Subject|0|||
23306821|NCT00816361|64866526|FG004|Overall Study|Withdrawal by Subject|1|||
23306822|NCT00816361|64866527|FG005|Overall Study|Withdrawal by Subject|2|||
23306823|NCT00816361|64866528|FG006|Overall Study|Withdrawal by Subject|0|||
23306824|NCT00816361|64866529|FG007|Overall Study|Withdrawal by Subject|2|||
23306825|NCT00816361|64866530|FG008|Overall Study|Withdrawal by Subject|1|||
23306826|NCT00816361|64866522|FG000|Overall Study|Death|4|||
23306827|NCT00816361|64866523|FG001|Overall Study|Death|3|||
23306828|NCT00816361|64866524|FG002|Overall Study|Death|3|||
23306829|NCT00816361|64866525|FG003|Overall Study|Death|3|||
23306830|NCT00816361|64866526|FG004|Overall Study|Death|1|||
23306831|NCT00816361|64866527|FG005|Overall Study|Death|1|||
23306832|NCT00816361|64866528|FG006|Overall Study|Death|3|||
23306833|NCT00816361|64866529|FG007|Overall Study|Death|7|||
23306834|NCT00816361|64866530|FG008|Overall Study|Death|8|||
23306835|NCT00816361|64866522|FG000|Overall Study|Other|0|||
23306836|NCT00816361|64866523|FG001|Overall Study|Other|0|||
23306837|NCT00816361|64866524|FG002|Overall Study|Other|0|||
23306838|NCT00816361|64866525|FG003|Overall Study|Other|0|||
23306839|NCT00816361|64866526|FG004|Overall Study|Other|0|||
23306840|NCT00816361|64866527|FG005|Overall Study|Other|0|||
23306841|NCT00816361|64866528|FG006|Overall Study|Other|0|||
23306842|NCT00816361|64866529|FG007|Overall Study|Other|0|||
23306843|NCT00816361|64866530|FG008|Overall Study|Other|1|||
23306844|NCT01959035|64866531|FG000|Overall Study|Adverse Event|5|||
23306845|NCT01959035|64866531|FG000|Overall Study|Withdrawal by Subject|4|||
23306846|NCT01959035|64866531|FG000|Overall Study|Lost to Follow-up|1|||
23306847|NCT01959035|64866531|FG000|Overall Study|Other (no primary reason given)|1|||
23306848|NCT02588950|64866532|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
23306849|NCT02588950|64866533|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
23306850|NCT02588950|64866534|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
23306851|NCT02588950|64866535|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
23306852|NCT02588950|64866532|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
23306853|NCT02588950|64866533|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
23306854|NCT02588950|64866534|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
23306855|NCT02588950|64866535|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
23306856|NCT01831765|64866539|FG000|Overall Study|Lack of Efficacy|1|||
23306857|NCT01831765|64866540|FG001|Overall Study|Lack of Efficacy|0|||
23306858|NCT01831765|64866541|FG002|Overall Study|Lack of Efficacy|0|||
23306859|NCT01831765|64866539|FG000|Overall Study|Other, sponsor withdrew subject|0|||
23306860|NCT01831765|64866540|FG001|Overall Study|Other, sponsor withdrew subject|1|||
23306861|NCT01831765|64866541|FG002|Overall Study|Other, sponsor withdrew subject|0|||
23306862|NCT01831765|64866539|FG000|Overall Study|Pregnancy|1|||
23306863|NCT01831765|64866540|FG001|Overall Study|Pregnancy|1|||
23306864|NCT01831765|64866541|FG002|Overall Study|Pregnancy|2|||
23306865|NCT01831765|64866539|FG000|Overall Study|Death|0|||
23306866|NCT01831765|64866540|FG001|Overall Study|Death|1|||
23306867|NCT01831765|64866541|FG002|Overall Study|Death|1|||
23306868|NCT01831765|64866539|FG000|Overall Study|Other, site closed|1|||
23306869|NCT01831765|64866540|FG001|Overall Study|Other, site closed|1|||
23306870|NCT01831765|64866541|FG002|Overall Study|Other, site closed|0|||
23306871|NCT01831765|64866539|FG000|Overall Study|Adverse Event|5|||
23306872|NCT01831765|64866540|FG001|Overall Study|Adverse Event|3|||
23306873|NCT01831765|64866541|FG002|Overall Study|Adverse Event|3|||
23306874|NCT01831765|64866539|FG000|Overall Study|Withdrawal by Subject|22|||
23306875|NCT01831765|64866540|FG001|Overall Study|Withdrawal by Subject|7|||
23306876|NCT01831765|64866541|FG002|Overall Study|Withdrawal by Subject|17|||
23306877|NCT01831765|64866539|FG000|Overall Study|Withdrawal criteria|12|||
23306878|NCT01831765|64866540|FG001|Overall Study|Withdrawal criteria|10|||
23306879|NCT01831765|64866541|FG002|Overall Study|Withdrawal criteria|16|||
23306880|NCT01831765|64866539|FG000|Overall Study|Lost to Follow-up|2|||
23306881|NCT01831765|64866540|FG001|Overall Study|Lost to Follow-up|3|||
23306882|NCT01831765|64866541|FG002|Overall Study|Lost to Follow-up|3|||
23306883|NCT02731326|64866542|FG000|Overall Study|Withdrawal by Subject|4|||
23306884|NCT02731326|64866543|FG001|Overall Study|Withdrawal by Subject|1|||
23306885|NCT02731326|64866542|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
23306886|NCT02731326|64866543|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
23306887|NCT02731326|64866542|FG000|Overall Study|Discharged without AliveCor|10|||
23306888|NCT02731326|64866543|FG001|Overall Study|Discharged without AliveCor|0|||
23306889|NCT02731326|64866542|FG000|Overall Study|Duplicate Participant|1|||
23306890|NCT02731326|64866543|FG001|Overall Study|Duplicate Participant|1|||
23306891|NCT01169532|64866547|FG000|Overall Study|Withdrawal by Subject|1|||
23306892|NCT00706095|64866550|FG000|Overall Study|Progressive Disease|4|||
23306893|NCT00706095|64866551|FG001|Overall Study|Progressive Disease|5|||
23306894|NCT00706095|64866552|FG002|Overall Study|Progressive Disease|3|||
23306895|NCT00706095|64866550|FG000|Overall Study|Clinical Progression|1|||
23306896|NCT00706095|64866551|FG001|Overall Study|Clinical Progression|2|||
23306897|NCT00706095|64866552|FG002|Overall Study|Clinical Progression|2|||
23306898|NCT00706095|64866550|FG000|Overall Study|Withdrawal by Subject|1|||
23408908|NCT02229825|65240053|FG000|Overall Study|Lack of Efficacy|4|||
23408909|NCT02229825|65240054|FG001|Overall Study|Lack of Efficacy|10|||
23306899|NCT00706095|64866551|FG001|Overall Study|Withdrawal by Subject|0|||
23306900|NCT00706095|64866552|FG002|Overall Study|Withdrawal by Subject|0|||
23306901|NCT02448706|64866555|FG000|Overall Study|Withdrawal by Subject|4|||
23306902|NCT02448706|64866556|FG001|Overall Study|Withdrawal by Subject|3|||
23408910|NCT02229825|65240053|FG000|Overall Study|Adverse Event|11|||
23408911|NCT02229825|65240054|FG001|Overall Study|Adverse Event|9|||
23408912|NCT02229825|65240053|FG000|Overall Study|Not treated|0|||
23408913|NCT02229825|65240054|FG001|Overall Study|Not treated|1|||
23408914|NCT00049257|65240055|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
23408915|NCT00049257|65240055|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
23408916|NCT00049257|65240055|FG000|Carboplatin, Paclitaxel|Death|2|||
23408917|NCT00049257|65240055|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
23408918|NCT00135330|65240056|FG000|Overall Study|Adverse Event|2|||
23408919|NCT00135330|65240057|FG001|Overall Study|Adverse Event|5|||
23408920|NCT00135330|65240058|FG002|Overall Study|Adverse Event|1|||
23408921|NCT00135330|65240056|FG000|Overall Study|Lost to Follow-up|0|||
23408922|NCT00135330|65240057|FG001|Overall Study|Lost to Follow-up|2|||
23306903|NCT02448706|64866555|FG000|Overall Study|Protocol Violation|1|||
23306904|NCT02448706|64866556|FG001|Overall Study|Protocol Violation|1|||
23306905|NCT02196701|64866559|FG000|Overall Study|Adverse Event|1|||
23408923|NCT00135330|65240058|FG002|Overall Study|Lost to Follow-up|3|||
23408924|NCT00135330|65240056|FG000|Overall Study|Physician Decision|1|||
23408925|NCT00135330|65240057|FG001|Overall Study|Physician Decision|1|||
23408926|NCT00135330|65240058|FG002|Overall Study|Physician Decision|0|||
23408927|NCT00135330|65240056|FG000|Overall Study|Protocol Violation|4|||
23408928|NCT00135330|65240057|FG001|Overall Study|Protocol Violation|3|||
23306906|NCT02196701|64866559|FG000|Overall Study|Lost to Follow-up|1|||
23306907|NCT02196701|64866559|FG000|Overall Study|Non-adherence to Protocol|1|||
23306908|NCT00977379|64866560|FG000|Overall Study|Withdrawal by Subject|1|||
23306909|NCT00977379|64866561|FG001|Overall Study|Withdrawal by Subject|1|||
23408929|NCT00135330|65240058|FG002|Overall Study|Protocol Violation|3|||
23408930|NCT00135330|65240056|FG000|Overall Study|Patient Decision|5|||
23408931|NCT00135330|65240057|FG001|Overall Study|Patient Decision|1|||
23408932|NCT00135330|65240058|FG002|Overall Study|Patient Decision|4|||
23408933|NCT00135330|65240056|FG000|Overall Study|Sponsor Decision|0|||
23408934|NCT00135330|65240057|FG001|Overall Study|Sponsor Decision|1|||
23408935|NCT00135330|65240058|FG002|Overall Study|Sponsor Decision|0|||
23408936|NCT01248728|65240059|FG000|Overall Study|Adverse Event|1|||
23408937|NCT01248728|65240060|FG001|Overall Study|Adverse Event|1|||
23408938|NCT01248728|65240059|FG000|Overall Study|Withdrawal by Subject|2|||
23408939|NCT01248728|65240060|FG001|Overall Study|Withdrawal by Subject|1|||
23408940|NCT01248728|65240059|FG000|Overall Study|Lack of Efficacy|1|||
23408941|NCT01248728|65240060|FG001|Overall Study|Lack of Efficacy|0|||
23408942|NCT00923351|65242483|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
23408943|NCT00923351|65242484|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
23408944|NCT00923351|65242485|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
23408945|NCT00887159|65242486|FG000|Overall Study|Disease progression|6|||
23408946|NCT00887159|65242487|FG001|Overall Study|Disease progression|39|||
23408947|NCT00887159|65242488|FG002|Overall Study|Disease progression|33|||
23408948|NCT00887159|65242486|FG000|Overall Study|Adverse Event|3|||
23408949|NCT00887159|65242487|FG001|Overall Study|Adverse Event|4|||
23408950|NCT00887159|65242488|FG002|Overall Study|Adverse Event|17|||
23408951|NCT00887159|65242486|FG000|Overall Study|Death|2|||
23408952|NCT00887159|65242487|FG001|Overall Study|Death|2|||
23408953|NCT00887159|65242488|FG002|Overall Study|Death|0|||
23408954|NCT00887159|65242486|FG000|Overall Study|Withdrawal by Subject|4|||
23408955|NCT00887159|65242487|FG001|Overall Study|Withdrawal by Subject|4|||
23408956|NCT00887159|65242488|FG002|Overall Study|Withdrawal by Subject|2|||
23408957|NCT00887159|65242486|FG000|Overall Study|Alternative therapy|2|||
23408958|NCT00887159|65242487|FG001|Overall Study|Alternative therapy|0|||
23408959|NCT00887159|65242488|FG002|Overall Study|Alternative therapy|0|||
23408960|NCT00887159|65242486|FG000|Overall Study|Physician Decision|1|||
23408961|NCT00887159|65242487|FG001|Overall Study|Physician Decision|1|||
23408962|NCT00887159|65242488|FG002|Overall Study|Physician Decision|0|||
23408963|NCT00887159|65242486|FG000|Overall Study|Sympomatic deterioration|1|||
23408964|NCT00887159|65242487|FG001|Overall Study|Sympomatic deterioration|0|||
23408965|NCT00887159|65242488|FG002|Overall Study|Sympomatic deterioration|0|||
23408966|NCT00887159|65242486|FG000|Overall Study|Treatment delayed|1|||
23408967|NCT00887159|65242487|FG001|Overall Study|Treatment delayed|1|||
23408968|NCT00887159|65242488|FG002|Overall Study|Treatment delayed|0|||
23408969|NCT00887159|65242486|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
23408970|NCT00887159|65242487|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
23306910|NCT00977379|64866560|FG000|Overall Study|Death|7|||
23306911|NCT00977379|64866561|FG001|Overall Study|Death|9|||
23306912|NCT00977379|64866560|FG000|Overall Study|Premature Study Termination|4|||
23306913|NCT00977379|64866561|FG001|Overall Study|Premature Study Termination|0|||
23306914|NCT00977379|64866560|FG000|Overall Study|Participant Moving House|0|||
23306915|NCT00977379|64866561|FG001|Overall Study|Participant Moving House|1|||
23306916|NCT00977379|64866560|FG000|Overall Study|Randomization Error|0|||
23306917|NCT00977379|64866561|FG001|Overall Study|Randomization Error|1|||
23306918|NCT00960115|64866562|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
23306919|NCT00960115|64866563|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
23408971|NCT00887159|65242488|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
23408972|NCT00887159|65242486|FG000|Overall Study|Received more tx instead of observation|1|||
23408973|NCT00887159|65242487|FG001|Overall Study|Received more tx instead of observation|0|||
23408974|NCT00887159|65242488|FG002|Overall Study|Received more tx instead of observation|0|||
23408975|NCT00887159|65242486|FG000|Overall Study|Ineligible|5|||
23408976|NCT00887159|65242487|FG001|Overall Study|Ineligible|1|||
23408977|NCT00887159|65242488|FG002|Overall Study|Ineligible|0|||
23408978|NCT00887159|65242486|FG000|Overall Study|Never started assigned therapy|3|||
23306920|NCT00536263|64866564|FG000|Overall Study|Adverse Event|5|||
23306921|NCT00536263|64866565|FG001|Overall Study|Adverse Event|5|||
23306922|NCT00536263|64866566|FG002|Overall Study|Adverse Event|7|||
23408979|NCT00887159|65242487|FG001|Overall Study|Never started assigned therapy|3|||
23408980|NCT00887159|65242488|FG002|Overall Study|Never started assigned therapy|4|||
23408981|NCT00375505|65242489|FG000|Overall Study|Adverse Event|1|||
23408982|NCT00375505|65242490|FG001|Overall Study|Adverse Event|2|||
23408983|NCT01846299|65242497|FG000|Overall Study|Physician Decision|4|||
23408984|NCT01846299|65242498|FG001|Overall Study|Physician Decision|2|||
23408985|NCT01846299|65242497|FG000|Overall Study|Protocol deviation|1|||
23408986|NCT01846299|65242498|FG001|Overall Study|Protocol deviation|0|||
23408987|NCT01846299|65242497|FG000|Overall Study|Death|1|||
23408988|NCT01846299|65242498|FG001|Overall Study|Death|2|||
23408989|NCT01846299|65242497|FG000|Overall Study|Lost to Follow-up|3|||
23408990|NCT01846299|65242498|FG001|Overall Study|Lost to Follow-up|0|||
23408991|NCT01846299|65242497|FG000|Overall Study|Withdrawal by Subject|1|||
23408992|NCT01846299|65242498|FG001|Overall Study|Withdrawal by Subject|6|||
23408993|NCT01846299|65242497|FG000|Overall Study|Adverse Event|2|||
23408994|NCT01846299|65242498|FG001|Overall Study|Adverse Event|0|||
23408995|NCT01234480|65242499|FG000|Overall Study|Pregnancy|88|||
23408996|NCT01234480|65242499|FG000|Overall Study|>36/Normal History|50|||
23408997|NCT01234480|65242499|FG000|Overall Study|Age|3|||
23408998|NCT01234480|65242499|FG000|Overall Study|HPV Vaccine History|28|||
23408999|NCT01234480|65242499|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
23409000|NCT01234480|65242499|FG000|Overall Study|Hysterectomy|2|||
23409001|NCT01234480|65242499|FG000|Overall Study|Hysterectomy post enrollment|1|||
23409002|NCT01234480|65242499|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
23409003|NCT01234480|65242499|FG000|Overall Study|Informed Consent Form Violation|30|||
23409004|NCT01234480|65242499|FG000|Overall Study|Incorrect Visit|3|||
23409005|NCT01234480|65242499|FG000|Overall Study|No Florida Lab License|20|||
23409006|NCT01234480|65242499|FG000|Overall Study|Out of Window|42|||
23409007|NCT01234480|65242499|FG000|Overall Study|Sample Processing/Storage|92|||
23409008|NCT01234480|65242499|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
23409009|NCT01234480|65242499|FG000|Overall Study|Site/Subject non-compliance|44|||
23409010|NCT01234480|65242499|FG000|Overall Study|Missing Sample|9|||
23409011|NCT01118780|65242500|FG000|Overall Study|Adverse Event|15|||
23409012|NCT01118780|65242501|FG001|Overall Study|Adverse Event|15|||
23409013|NCT01118780|65242500|FG000|Overall Study|Death|1|||
23409014|NCT01118780|65242501|FG001|Overall Study|Death|0|||
23409015|NCT01118780|65242500|FG000|Overall Study|Lack of Efficacy|2|||
23409016|NCT01118780|65242501|FG001|Overall Study|Lack of Efficacy|6|||
23409017|NCT01118780|65242500|FG000|Overall Study|Physician Decision|2|||
23409018|NCT01118780|65242501|FG001|Overall Study|Physician Decision|0|||
23409019|NCT01118780|65242500|FG000|Overall Study|Protocol Violation|3|||
23409020|NCT01118780|65242501|FG001|Overall Study|Protocol Violation|6|||
23409021|NCT01118780|65242500|FG000|Overall Study|Withdrawal by Subject|13|||
23409022|NCT01118780|65242501|FG001|Overall Study|Withdrawal by Subject|8|||
23409023|NCT01295944|65242502|FG000|Overall Study|Switched to alternative treatment|1|||
23409024|NCT01295944|65242502|FG000|Overall Study|Ineligible|9|||
23409025|NCT01295944|65242502|FG000|Overall Study|Withdrawal by Subject|4|||
23409026|NCT01295944|65242502|FG000|Overall Study|Participant chose to be treated in Peru|1|||
23409027|NCT01295944|65242502|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
23409028|NCT01295944|65242502|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
23409029|NCT01295944|65242502|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
23409030|NCT02151903|65242503|FG000|Overall Study|Withdrawal by Subject|1|||
23409031|NCT02151903|65242504|FG001|Overall Study|Withdrawal by Subject|0|||
23409032|NCT02151903|65242503|FG000|Overall Study|Progressive disease|2|||
23409033|NCT02151903|65242504|FG001|Overall Study|Progressive disease|1|||
23409034|NCT01916824|65242505|FG000|Overall Study|Lost to Follow-up|3|||
23409035|NCT01916824|65242506|FG001|Overall Study|Lost to Follow-up|6|||
23409036|NCT01916824|65242505|FG000|Overall Study|Physician Decision|2|||
23409037|NCT01916824|65242506|FG001|Overall Study|Physician Decision|0|||
23409038|NCT01916824|65242505|FG000|Overall Study|Withdrawal by Subject|2|||
23409039|NCT01916824|65242506|FG001|Overall Study|Withdrawal by Subject|3|||
23409040|NCT00349349|65242509|FG000|Overall Study|Adverse Event|5|||
23409041|NCT00349349|65242510|FG001|Overall Study|Adverse Event|6|||
23409042|NCT00349349|65242511|FG002|Overall Study|Adverse Event|2|||
23409043|NCT00349349|65242509|FG000|Overall Study|Withdrawal by Subject|5|||
23409044|NCT00349349|65242510|FG001|Overall Study|Withdrawal by Subject|2|||
23409045|NCT00349349|65242511|FG002|Overall Study|Withdrawal by Subject|1|||
23409046|NCT00349349|65242509|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
23409047|NCT00349349|65242510|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
23409048|NCT00349349|65242511|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
23409049|NCT00349349|65242509|FG000|Overall Study|Death|13|||
23409050|NCT00349349|65242510|FG001|Overall Study|Death|10|||
23409051|NCT00349349|65242511|FG002|Overall Study|Death|1|||
23409052|NCT00349349|65242509|FG000|Overall Study|Other Treatment Selected|2|||
23409053|NCT00349349|65242510|FG001|Overall Study|Other Treatment Selected|0|||
23409054|NCT00349349|65242511|FG002|Overall Study|Other Treatment Selected|0|||
23409055|NCT00349349|65242509|FG000|Overall Study|Participant Reduced General Condition|0|||
23409056|NCT00349349|65242510|FG001|Overall Study|Participant Reduced General Condition|1|||
23409057|NCT00349349|65242511|FG002|Overall Study|Participant Reduced General Condition|0|||
23409058|NCT00349349|65242509|FG000|Overall Study|Physician Decision|1|||
23409059|NCT00349349|65242510|FG001|Overall Study|Physician Decision|2|||
23409060|NCT00349349|65242511|FG002|Overall Study|Physician Decision|1|||
23409061|NCT00349349|65242509|FG000|Overall Study|No Response|0|||
23409062|NCT00349349|65242510|FG001|Overall Study|No Response|3|||
23409063|NCT00349349|65242511|FG002|Overall Study|No Response|0|||
23409064|NCT00349349|65242509|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
23409065|NCT00349349|65242510|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
23409066|NCT00349349|65242511|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
23409067|NCT03583359|65242517|FG000|Overall Study|Withdrawal by Subject|15|||
23409068|NCT03583359|65242518|FG001|Overall Study|Withdrawal by Subject|6|||
23409069|NCT03583359|65242517|FG000|Overall Study|Lost to Follow-up|12|||
23409070|NCT03583359|65242518|FG001|Overall Study|Lost to Follow-up|3|||
23409071|NCT03583359|65242517|FG000|Overall Study|Adverse Event|0|||
23409072|NCT03583359|65242518|FG001|Overall Study|Adverse Event|1|||
23409073|NCT03583359|65242517|FG000|Overall Study|Protocol Violation|0|||
23409074|NCT03583359|65242518|FG001|Overall Study|Protocol Violation|1|||
23409075|NCT03583359|65242517|FG000|Overall Study|Other|2|||
23409076|NCT03583359|65242518|FG001|Overall Study|Other|1|||
23409077|NCT02466425|65242519|FG000|Overall Study|Adverse Event|3|||
23409078|NCT02466425|65242520|FG001|Overall Study|Adverse Event|11|||
23409079|NCT02466425|65242519|FG000|Overall Study|Lack of Efficacy|4|||
23409080|NCT02466425|65242520|FG001|Overall Study|Lack of Efficacy|1|||
23409081|NCT02466425|65242519|FG000|Overall Study|Lost to Follow-up|3|||
23511396|NCT01829230|65609322|FG001|Overall Study|Protocol Violation|2|||
23409082|NCT02466425|65242520|FG001|Overall Study|Lost to Follow-up|0|||
23409083|NCT02466425|65242519|FG000|Overall Study|Protocol Violation|1|||
23511397|NCT01829230|65609321|FG000|Overall Study|Withdrawal by Subject|0|||
23409084|NCT02466425|65242520|FG001|Overall Study|Protocol Violation|0|||
23409085|NCT02466425|65242519|FG000|Overall Study|Withdrawal by Subject|0|||
23409086|NCT02466425|65242520|FG001|Overall Study|Withdrawal by Subject|1|||
23409087|NCT02466425|65242519|FG000|Overall Study|Other|1|||
23409088|NCT02466425|65242520|FG001|Overall Study|Other|3|||
23409089|NCT02466425|65242519|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23409090|NCT02466425|65242520|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23409091|NCT01144416|65242525|FG000|Intervention Period|Adverse Event|5|||
23409092|NCT01144416|65242526|FG001|Intervention Period|Adverse Event|6|||
23409093|NCT01144416|65242525|FG000|Intervention Period|Insufficient ovarian response|11|||
23409094|NCT01144416|65242526|FG001|Intervention Period|Insufficient ovarian response|17|||
23409095|NCT01144416|65242525|FG000|Intervention Period|Risk of OHSS|0|||
23409096|NCT01144416|65242526|FG001|Intervention Period|Risk of OHSS|1|||
23409097|NCT01144416|65242525|FG000|Intervention Period|Too high ovarian response|4|||
23409098|NCT01144416|65242526|FG001|Intervention Period|Too high ovarian response|2|||
23409099|NCT01144416|65242525|FG000|Intervention Period|No/too few/bad oocytes|7|||
23409100|NCT01144416|65242526|FG001|Intervention Period|No/too few/bad oocytes|5|||
23409101|NCT01144416|65242525|FG000|Intervention Period|No or abnormal fertilization|25|||
23409102|NCT01144416|65242526|FG001|Intervention Period|No or abnormal fertilization|10|||
23409103|NCT01144416|65242525|FG000|Intervention Period|No/too few/bad quality embryos|3|||
23409104|NCT01144416|65242526|FG001|Intervention Period|No/too few/bad quality embryos|3|||
23409105|NCT01144416|65242525|FG000|Intervention Period|Other|7|||
23409106|NCT01144416|65242526|FG001|Intervention Period|Other|5|||
23409107|NCT00437268|65242527|FG000|Overall Study|Adverse Event|1|||
23409108|NCT00437268|65242528|FG001|Overall Study|Adverse Event|1|||
23409109|NCT00437268|65242527|FG000|Overall Study|Withdrawal by Subject|2|||
23409110|NCT00437268|65242528|FG001|Overall Study|Withdrawal by Subject|2|||
23409111|NCT00437268|65242527|FG000|Overall Study|Progressive disease|9|||
23409112|NCT00437268|65242528|FG001|Overall Study|Progressive disease|9|||
23409113|NCT00437268|65242527|FG000|Overall Study|Physician Decision|1|||
23409114|NCT00437268|65242528|FG001|Overall Study|Physician Decision|0|||
23409115|NCT00437268|65242527|FG000|Overall Study|Death|0|||
23409116|NCT00437268|65242528|FG001|Overall Study|Death|1|||
23409117|NCT02063984|65242529|FG000|Overall Study|Lost to Follow-up|6|||
23409118|NCT02063984|65242530|FG001|Overall Study|Lost to Follow-up|5|||
23409119|NCT00124072|65242531|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
23409120|NCT00124072|65242532|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
23409121|NCT00124072|65242533|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
23409122|NCT00124072|65242534|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
23409123|NCT00124072|65242531|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
23409124|NCT00124072|65242532|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
23409125|NCT00124072|65242533|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
23409126|NCT00124072|65242534|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
23409127|NCT00124072|65242531|FG000|Overall Study|Death|499|||
23409128|NCT00124072|65242532|FG001|Overall Study|Death|484|||
23409129|NCT00124072|65242533|FG002|Overall Study|Death|471|||
23409130|NCT00124072|65242534|FG003|Overall Study|Death|480|||
23409131|NCT00040742|65242535|FG000|Overall Study|Death|0|||
23409132|NCT00040742|65242536|FG001|Overall Study|Death|0|||
23409133|NCT00040742|65242537|FG002|Overall Study|Death|1|||
23409134|NCT00040742|65242538|FG003|Overall Study|Death|0|||
23409135|NCT00040742|65242535|FG000|Overall Study|Adverse Event|15|||
23306923|NCT00536263|64866564|FG000|Overall Study|Lost to Follow-up|3|||
23409136|NCT00040742|65242536|FG001|Overall Study|Adverse Event|16|||
23409137|NCT00040742|65242537|FG002|Overall Study|Adverse Event|21|||
23409138|NCT00040742|65242538|FG003|Overall Study|Adverse Event|9|||
23409139|NCT00040742|65242535|FG000|Overall Study|Withdrawal by Subject|7|||
23409140|NCT00040742|65242536|FG001|Overall Study|Withdrawal by Subject|15|||
23409141|NCT00040742|65242537|FG002|Overall Study|Withdrawal by Subject|10|||
23409142|NCT00040742|65242538|FG003|Overall Study|Withdrawal by Subject|13|||
23409143|NCT00040742|65242535|FG000|Overall Study|Chemotoxicity|4|||
23409144|NCT00040742|65242536|FG001|Overall Study|Chemotoxicity|3|||
23409145|NCT00040742|65242537|FG002|Overall Study|Chemotoxicity|5|||
23306924|NCT00536263|64866565|FG001|Overall Study|Lost to Follow-up|4|||
23306925|NCT00536263|64866566|FG002|Overall Study|Lost to Follow-up|4|||
23306926|NCT00536263|64866564|FG000|Overall Study|Subject withdrew - not treatment related|2|||
23306927|NCT00536263|64866565|FG001|Overall Study|Subject withdrew - not treatment related|0|||
23306928|NCT00536263|64866566|FG002|Overall Study|Subject withdrew - not treatment related|5|||
23306929|NCT00536263|64866564|FG000|Overall Study|Subject withdrew - treatment related|0|||
23306930|NCT00536263|64866565|FG001|Overall Study|Subject withdrew - treatment related|3|||
23306931|NCT00536263|64866566|FG002|Overall Study|Subject withdrew - treatment related|2|||
23409146|NCT00040742|65242538|FG003|Overall Study|Chemotoxicity|2|||
23409147|NCT00040742|65242535|FG000|Overall Study|Incomplete Forms|6|||
23409148|NCT00040742|65242536|FG001|Overall Study|Incomplete Forms|10|||
23409149|NCT00040742|65242537|FG002|Overall Study|Incomplete Forms|4|||
23409150|NCT00040742|65242538|FG003|Overall Study|Incomplete Forms|5|||
23409151|NCT00040742|65242535|FG000|Overall Study|Other medical|7|||
23409152|NCT00040742|65242536|FG001|Overall Study|Other medical|5|||
23409153|NCT00040742|65242537|FG002|Overall Study|Other medical|5|||
23409154|NCT00040742|65242538|FG003|Overall Study|Other medical|5|||
23409155|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
23409156|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
23409157|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
23409158|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
23409159|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
23409160|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
23409161|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
23409162|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
23409163|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
23409164|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
23409165|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
23409166|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
23409167|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
23409168|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
23409169|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
23409170|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
23409171|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
23409172|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
23409173|NCT02831855|65242539|FG000|Open Label Phase (24 Weeks)|Other|4|||
23409174|NCT02831855|65242540|FG001|Open Label Phase (24 Weeks)|Other|0|||
23409175|NCT02831855|65242541|FG002|Open Label Phase (24 Weeks)|Other|0|||
23409176|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
23409177|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
23409178|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
23409179|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Death|0|||
23409180|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Death|0|||
23409181|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Death|2|||
23409182|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
23409183|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
23409184|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
23409185|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
23409186|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
23409187|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
23409188|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
23409189|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
23409190|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
23409191|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Other|0|||
23409192|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Other|2|||
23409193|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Other|5|||
23409194|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
23409195|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
23409196|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
23409197|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
23409198|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
23409199|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
23409200|NCT02831855|65242539|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
23409201|NCT02831855|65242540|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
23409202|NCT02831855|65242541|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
23409203|NCT01206140|65242542|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
23409204|NCT01206140|65242543|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
23409205|NCT02195700|65242544|FG000|Overall Study|Protocol Violation|0|||
23409206|NCT02195700|65242545|FG001|Overall Study|Protocol Violation|2|||
23409207|NCT02195700|65242544|FG000|Overall Study|Noncompliance|1|||
23409208|NCT02195700|65242545|FG001|Overall Study|Noncompliance|0|||
23409209|NCT02195700|65242544|FG000|Overall Study|Adverse Event|1|||
23409210|NCT02195700|65242545|FG001|Overall Study|Adverse Event|2|||
23409211|NCT02195700|65242544|FG000|Overall Study|Withdrawal by Subject|3|||
23409212|NCT02195700|65242545|FG001|Overall Study|Withdrawal by Subject|2|||
23409213|NCT02195700|65242544|FG000|Overall Study|Lost to Follow-up|1|||
23409214|NCT02195700|65242545|FG001|Overall Study|Lost to Follow-up|1|||
23409215|NCT01498692|65242551|FG000|Overall Study|Death|4|||
23409216|NCT01498692|65242551|FG000|Overall Study|Withdrawal by Subject|1|||
23409217|NCT01498692|65242551|FG000|Overall Study|Missed 12-month visit|3|||
23409218|NCT00399568|65242554|FG000|Overall Study|Adverse Event|1|||
23409219|NCT00399568|65242555|FG001|Overall Study|Adverse Event|2|||
23409220|NCT00399568|65242554|FG000|Overall Study|Withdrawal by Subject|7|||
23409221|NCT00399568|65242555|FG001|Overall Study|Withdrawal by Subject|3|||
23409222|NCT00399568|65242554|FG000|Overall Study|Protocol non-compliance|2|||
23409223|NCT00399568|65242555|FG001|Overall Study|Protocol non-compliance|2|||
23409224|NCT00399568|65242554|FG000|Overall Study|Lost to Follow-up|2|||
23409225|NCT00399568|65242555|FG001|Overall Study|Lost to Follow-up|2|||
23409226|NCT02036580|65242556|FG000|Overall Study|Withdrawal by Subject|0|||
23409227|NCT02036580|65242557|FG001|Overall Study|Withdrawal by Subject|1|||
23409228|NCT02036580|65242558|FG002|Overall Study|Withdrawal by Subject|0|||
23409229|NCT02036580|65242556|FG000|Overall Study|Adverse Event|1|||
23409230|NCT02036580|65242557|FG001|Overall Study|Adverse Event|0|||
23409231|NCT02036580|65242558|FG002|Overall Study|Adverse Event|0|||
23409232|NCT02709577|65242569|FG000|Overall Study|non-accommodating anatomy|0|||
23409233|NCT02709577|65242570|FG001|Overall Study|non-accommodating anatomy|1|||
23409234|NCT02709577|65242571|FG002|Overall Study|non-accommodating anatomy|0|||
23409235|NCT02709577|65242572|FG003|Overall Study|non-accommodating anatomy|0|||
23409236|NCT02709577|65242569|FG000|Overall Study|procedural complication|0|||
23409237|NCT02709577|65242570|FG001|Overall Study|procedural complication|1|||
23409238|NCT02709577|65242571|FG002|Overall Study|procedural complication|0|||
23409239|NCT02709577|65242572|FG003|Overall Study|procedural complication|0|||
23409240|NCT02709577|65242569|FG000|Overall Study|Withdrawal by Subject|2|||
23409241|NCT02709577|65242570|FG001|Overall Study|Withdrawal by Subject|3|||
23409242|NCT02709577|65242571|FG002|Overall Study|Withdrawal by Subject|2|||
23409243|NCT02709577|65242572|FG003|Overall Study|Withdrawal by Subject|0|||
23409244|NCT05010070|65242573|FG000|Overall Study|Lost to Follow-up|1|||
23409245|NCT05010070|65242573|FG000|Overall Study|Withdrawal by Subject|1|||
23409246|NCT02998671|65242575|FG000|Period 1|Study Terminated By Sponsor|2|||
23409247|NCT02998671|65242576|FG001|Period 1|Study Terminated By Sponsor|1|||
23409248|NCT02998671|65242577|FG002|Period 1|Study Terminated By Sponsor|0|||
23409249|NCT02998671|65242578|FG003|Period 1|Study Terminated By Sponsor|0|||
23409250|NCT02998671|65242579|FG004|Period 1|Study Terminated By Sponsor|1|||
23409251|NCT02998671|65242575|FG000|Period 1|Withdrawal by Subject|1|||
23409252|NCT02998671|65242576|FG001|Period 1|Withdrawal by Subject|2|||
23409253|NCT02998671|65242577|FG002|Period 1|Withdrawal by Subject|0|||
23409254|NCT02998671|65242578|FG003|Period 1|Withdrawal by Subject|0|||
23409255|NCT02998671|65242579|FG004|Period 1|Withdrawal by Subject|2|||
23409256|NCT02998671|65242575|FG000|Period 1|Pregnancy|1|||
23409257|NCT02998671|65242576|FG001|Period 1|Pregnancy|0|||
23409258|NCT02998671|65242577|FG002|Period 1|Pregnancy|0|||
23409259|NCT02998671|65242578|FG003|Period 1|Pregnancy|0|||
23409260|NCT02998671|65242579|FG004|Period 1|Pregnancy|0|||
23409261|NCT02998671|65242575|FG000|Period 1|Adverse Event|0|||
23409262|NCT02998671|65242576|FG001|Period 1|Adverse Event|0|||
23409263|NCT02998671|65242577|FG002|Period 1|Adverse Event|0|||
23409264|NCT02998671|65242578|FG003|Period 1|Adverse Event|0|||
23409265|NCT02998671|65242579|FG004|Period 1|Adverse Event|1|||
23409266|NCT02998671|65242575|FG000|Period 2|Adverse Event|0|||
23409267|NCT02998671|65242576|FG001|Period 2|Adverse Event|1|||
23409268|NCT02998671|65242577|FG002|Period 2|Adverse Event|0|||
23409269|NCT02998671|65242578|FG003|Period 2|Adverse Event|0|||
23409270|NCT02998671|65242579|FG004|Period 2|Adverse Event|0|||
23409271|NCT02998671|65242575|FG000|Period 2|Study Terminated By Sponsor|3|||
23409272|NCT02998671|65242576|FG001|Period 2|Study Terminated By Sponsor|5|||
23409273|NCT02998671|65242577|FG002|Period 2|Study Terminated By Sponsor|1|||
23409274|NCT02998671|65242578|FG003|Period 2|Study Terminated By Sponsor|3|||
23409275|NCT02998671|65242579|FG004|Period 2|Study Terminated By Sponsor|0|||
23409276|NCT02998671|65242575|FG000|Period 2|Withdrawal by Subject|0|||
23409277|NCT02998671|65242576|FG001|Period 2|Withdrawal by Subject|1|||
23409278|NCT02998671|65242577|FG002|Period 2|Withdrawal by Subject|0|||
23409279|NCT02998671|65242578|FG003|Period 2|Withdrawal by Subject|0|||
23409280|NCT02998671|65242579|FG004|Period 2|Withdrawal by Subject|0|||
23409281|NCT02998671|65242575|FG000|Period 2|Lost to Follow-up|0|||
23409282|NCT02998671|65242576|FG001|Period 2|Lost to Follow-up|0|||
23409283|NCT02998671|65242577|FG002|Period 2|Lost to Follow-up|0|||
23409284|NCT02998671|65242578|FG003|Period 2|Lost to Follow-up|1|||
23409285|NCT02998671|65242579|FG004|Period 2|Lost to Follow-up|0|||
23409286|NCT01823107|65242580|FG000|Overall Study|Withdrawal by Subject|1|||
23409287|NCT02623205|65242581|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
23409288|NCT02623205|65242582|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
23409289|NCT00570778|65242583|FG000|Overall Study|Protocol deviation|2|||
23409290|NCT00570778|65242584|FG001|Overall Study|Protocol deviation|1|||
23511398|NCT01829230|65609322|FG001|Overall Study|Withdrawal by Subject|1|||
23409291|NCT00570778|65242585|FG002|Overall Study|Protocol deviation|2|||
23409292|NCT00570778|65242586|FG003|Overall Study|Protocol deviation|2|||
23610572|NCT01964547|65962804|FG000|Overall Study|Withdrawal by Investigator|0|||
23409293|NCT00570778|65242583|FG000|Overall Study|Adverse Event|0|||
23409294|NCT00570778|65242584|FG001|Overall Study|Adverse Event|1|||
23409295|NCT00570778|65242585|FG002|Overall Study|Adverse Event|4|||
23409296|NCT00570778|65242586|FG003|Overall Study|Adverse Event|1|||
23409297|NCT00570778|65242583|FG000|Overall Study|Subject withdrew consent|0|||
23409298|NCT00570778|65242584|FG001|Overall Study|Subject withdrew consent|1|||
23409299|NCT00570778|65242585|FG002|Overall Study|Subject withdrew consent|0|||
23409300|NCT00570778|65242586|FG003|Overall Study|Subject withdrew consent|1|||
23409301|NCT00570778|65242583|FG000|Overall Study|Abnormal test procedure|1|||
23409302|NCT00570778|65242584|FG001|Overall Study|Abnormal test procedure|0|||
23409303|NCT00570778|65242585|FG002|Overall Study|Abnormal test procedure|0|||
23409304|NCT00570778|65242586|FG003|Overall Study|Abnormal test procedure|0|||
23409305|NCT00570778|65242583|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23409306|NCT00570778|65242584|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23409307|NCT00570778|65242585|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23409308|NCT00570778|65242586|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23409309|NCT00570778|65242583|FG000|Overall Study|Lost to Follow-up|0|||
23409310|NCT00570778|65242584|FG001|Overall Study|Lost to Follow-up|0|||
23409311|NCT00570778|65242585|FG002|Overall Study|Lost to Follow-up|1|||
23409312|NCT00570778|65242586|FG003|Overall Study|Lost to Follow-up|0|||
23409313|NCT00570778|65242583|FG000|Overall Study|Subject no longer requires study drug|0|||
23409314|NCT00570778|65242584|FG001|Overall Study|Subject no longer requires study drug|1|||
23409315|NCT00570778|65242585|FG002|Overall Study|Subject no longer requires study drug|0|||
23409316|NCT00570778|65242586|FG003|Overall Study|Subject no longer requires study drug|0|||
23409317|NCT03083665|65242587|FG000|Double-Blind Period|Adverse Event|5|||
23409318|NCT03083665|65242588|FG001|Double-Blind Period|Adverse Event|4|||
23409319|NCT03083665|65242589|FG002|Double-Blind Period|Adverse Event|5|||
23409320|NCT03083665|65242590|FG003|Double-Blind Period|Adverse Event|0|||
23409321|NCT03083665|65242591|FG004|Double-Blind Period|Adverse Event|0|||
23409322|NCT03083665|65242592|FG005|Double-Blind Period|Adverse Event|0|||
23409323|NCT03083665|65242587|FG000|Double-Blind Period|Lack of Efficacy|0|||
23409324|NCT03083665|65242588|FG001|Double-Blind Period|Lack of Efficacy|0|||
23409325|NCT03083665|65242589|FG002|Double-Blind Period|Lack of Efficacy|1|||
23409326|NCT03083665|65242590|FG003|Double-Blind Period|Lack of Efficacy|0|||
23409327|NCT03083665|65242591|FG004|Double-Blind Period|Lack of Efficacy|0|||
23409328|NCT03083665|65242592|FG005|Double-Blind Period|Lack of Efficacy|0|||
23409329|NCT03083665|65242587|FG000|Double-Blind Period|Protocol Violation|1|||
23409330|NCT03083665|65242588|FG001|Double-Blind Period|Protocol Violation|0|||
23409331|NCT03083665|65242589|FG002|Double-Blind Period|Protocol Violation|1|||
23409332|NCT03083665|65242590|FG003|Double-Blind Period|Protocol Violation|0|||
23409333|NCT03083665|65242591|FG004|Double-Blind Period|Protocol Violation|0|||
23409334|NCT03083665|65242592|FG005|Double-Blind Period|Protocol Violation|0|||
23409335|NCT03083665|65242587|FG000|Double-Blind Period|Lost to Follow-up|1|||
23409336|NCT03083665|65242588|FG001|Double-Blind Period|Lost to Follow-up|0|||
23409337|NCT03083665|65242589|FG002|Double-Blind Period|Lost to Follow-up|1|||
23409338|NCT03083665|65242590|FG003|Double-Blind Period|Lost to Follow-up|0|||
23409339|NCT03083665|65242591|FG004|Double-Blind Period|Lost to Follow-up|0|||
23409340|NCT03083665|65242592|FG005|Double-Blind Period|Lost to Follow-up|0|||
23409341|NCT03083665|65242587|FG000|Double-Blind Period|Withdrawal by Subject|3|||
23409342|NCT03083665|65242588|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23409343|NCT03083665|65242589|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23409344|NCT03083665|65242590|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23409345|NCT03083665|65242591|FG004|Double-Blind Period|Withdrawal by Subject|0|||
23409346|NCT03083665|65242592|FG005|Double-Blind Period|Withdrawal by Subject|0|||
23409347|NCT03083665|65242587|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
23409348|NCT03083665|65242588|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409349|NCT03083665|65242589|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409350|NCT03083665|65242590|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409351|NCT03083665|65242591|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409352|NCT03083665|65242592|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
23409353|NCT03083665|65242587|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409354|NCT03083665|65242588|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
23409355|NCT03083665|65242589|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409356|NCT03083665|65242590|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409357|NCT03083665|65242591|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409358|NCT03083665|65242592|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
23409359|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409360|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409361|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409362|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
23409363|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409364|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
23409365|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409366|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409367|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409368|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409369|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
23409370|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
23409371|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
23409372|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
23409373|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
23409374|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
23409375|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
23409376|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
23409377|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409378|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409379|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409380|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409381|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
23409382|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
23409383|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409384|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409385|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409386|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
23409387|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409388|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
23409389|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409390|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409391|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409392|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409393|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
23409394|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
23409395|NCT03083665|65242587|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409396|NCT03083665|65242588|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409397|NCT03083665|65242589|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409398|NCT03083665|65242590|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409399|NCT03083665|65242591|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
23409400|NCT03083665|65242592|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
23409401|NCT00709319|65242593|FG000|Overall Study|Death|4|||
23409402|NCT00709319|65242593|FG000|Overall Study|Withdrawal by Subject|2|||
23409403|NCT05141175|65242602|FG000|Overall Study|Withdrawal by Subject|1|||
23409404|NCT03183063|65242605|FG000|Overall Study|Withdrawal by Subject|2|||
23409405|NCT03183063|65242606|FG001|Overall Study|Withdrawal by Subject|0|||
23409406|NCT03183063|65242607|FG002|Overall Study|Withdrawal by Subject|0|||
23409407|NCT03183063|65242605|FG000|Overall Study|Physician Decision|3|||
23409408|NCT03183063|65242606|FG001|Overall Study|Physician Decision|4|||
23409409|NCT03183063|65242607|FG002|Overall Study|Physician Decision|4|||
23409410|NCT03525600|65242614|FG000|Overall Study|Adverse Event|9|||
23409411|NCT03525600|65242615|FG001|Overall Study|Adverse Event|6|||
23409412|NCT03525600|65242616|FG002|Overall Study|Adverse Event|5|||
23409413|NCT03525600|65242617|FG003|Overall Study|Adverse Event|3|||
23409414|NCT03525600|65242614|FG000|Overall Study|Lost to Follow-up|2|||
23409415|NCT03525600|65242615|FG001|Overall Study|Lost to Follow-up|4|||
23409416|NCT03525600|65242616|FG002|Overall Study|Lost to Follow-up|4|||
23409417|NCT03525600|65242617|FG003|Overall Study|Lost to Follow-up|0|||
23409418|NCT03525600|65242614|FG000|Overall Study|Physician Decision|1|||
23409419|NCT03525600|65242615|FG001|Overall Study|Physician Decision|0|||
23409420|NCT03525600|65242616|FG002|Overall Study|Physician Decision|2|||
23409421|NCT03525600|65242617|FG003|Overall Study|Physician Decision|0|||
23409422|NCT03525600|65242614|FG000|Overall Study|Consent withdrawal|36|||
23409423|NCT03525600|65242615|FG001|Overall Study|Consent withdrawal|20|||
23409424|NCT03525600|65242616|FG002|Overall Study|Consent withdrawal|6|||
23409425|NCT03525600|65242617|FG003|Overall Study|Consent withdrawal|13|||
23409426|NCT03525600|65242614|FG000|Overall Study|Death|7|||
23409427|NCT03525600|65242615|FG001|Overall Study|Death|6|||
23409428|NCT03525600|65242616|FG002|Overall Study|Death|4|||
23409429|NCT03525600|65242617|FG003|Overall Study|Death|3|||
23409430|NCT03525600|65242614|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
23409431|NCT03525600|65242615|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
23409432|NCT03525600|65242616|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
23409433|NCT03525600|65242617|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
23409434|NCT03525600|65242614|FG000|Overall Study|Other|0|||
23409435|NCT03525600|65242615|FG001|Overall Study|Other|1|||
23409436|NCT03525600|65242616|FG002|Overall Study|Other|0|||
23409437|NCT03525600|65242617|FG003|Overall Study|Other|0|||
23409438|NCT03470194|65242618|FG000|Overall Study|Lost to Follow-up|11|||
23409439|NCT03470194|65242619|FG001|Overall Study|Lost to Follow-up|17|||
23409440|NCT01977729|65242620|FG000|Overall Study|Study terminated|1|||
23409441|NCT03036852|65242621|FG000|Overall Study|Death|2|||
23409442|NCT03036852|65242621|FG000|Overall Study|Lack of Efficacy|2|||
23409443|NCT03036852|65242621|FG000|Overall Study|Adverse Event|1|||
23409444|NCT03036852|65242621|FG000|Overall Study|Lost to Follow-up|1|||
23409445|NCT01336712|65242622|FG000|Overall Study|Death|2|||
23409446|NCT01336712|65242622|FG000|Overall Study|Lack of Efficacy|1|||
23409447|NCT02923531|65242623|FG000|Overall Study|Adverse Event|4|||
23409448|NCT02923531|65242623|FG000|Overall Study|Clinical Deterioration|1|||
23409449|NCT02923531|65242623|FG000|Overall Study|Disease Progression|3|||
23409450|NCT02923531|65242623|FG000|Overall Study|Study Termination|1|||
23409451|NCT00104728|65242625|FG000|Overall Study|screen failures|19|||
23409452|NCT01532921|65242626|FG000|Overall Study|Death|3|||
23409453|NCT01532921|65242626|FG000|Overall Study|Withdrawal by Subject|2|||
23409454|NCT01532921|65242626|FG000|Overall Study|Lost to Follow-up|3|||
23409455|NCT01532921|65242626|FG000|Overall Study|Physician Decision|7|||
23409456|NCT01532921|65242626|FG000|Overall Study|Device was explanted during procedure|1|||
23409457|NCT02997865|65242628|FG000|Overall Study|Death|2|||
23409458|NCT02997865|65242629|FG001|Overall Study|Death|1|||
23409459|NCT02997865|65242628|FG000|Overall Study|Lost to Follow-up|6|||
23409460|NCT02997865|65242629|FG001|Overall Study|Lost to Follow-up|3|||
23409461|NCT02997865|65242628|FG000|Overall Study|Withdrawal by Subject|5|||
23409462|NCT02997865|65242629|FG001|Overall Study|Withdrawal by Subject|0|||
23409463|NCT03265145|65242630|FG000|Overall Study|Protocol Violation|2|||
23409464|NCT03265145|65242631|FG001|Overall Study|Protocol Violation|0|||
23409465|NCT03265145|65242630|FG000|Overall Study|Adverse Event|1|||
23409466|NCT03265145|65242631|FG001|Overall Study|Adverse Event|0|||
23409467|NCT03265145|65242630|FG000|Overall Study|Withdrawal by Subject|23|||
23409468|NCT03265145|65242631|FG001|Overall Study|Withdrawal by Subject|19|||
23409469|NCT03265145|65242630|FG000|Overall Study|Death|12|||
23409470|NCT03265145|65242631|FG001|Overall Study|Death|12|||
23409471|NCT03265145|65242630|FG000|Overall Study|Lost to Follow-up|13|||
23409472|NCT03265145|65242631|FG001|Overall Study|Lost to Follow-up|9|||
23409473|NCT03265145|65242630|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
23409474|NCT03265145|65242631|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
23409475|NCT03265145|65242630|FG000|Overall Study|Switched back to previous medication|1|||
23409476|NCT03265145|65242631|FG001|Overall Study|Switched back to previous medication|0|||
23409477|NCT03265145|65242630|FG000|Overall Study|Did not want to take medication|1|||
23409478|NCT03265145|65242631|FG001|Overall Study|Did not want to take medication|0|||
23409479|NCT03265145|65242630|FG000|Overall Study|Subject could not afford medication|0|||
23409480|NCT03265145|65242631|FG001|Overall Study|Subject could not afford medication|1|||
23409481|NCT03265145|65242630|FG000|Overall Study|Site closed|2|||
23409482|NCT03265145|65242631|FG001|Overall Study|Site closed|3|||
23409483|NCT03265145|65242630|FG000|Overall Study|Incorrectly randomized|16|||
23409484|NCT03265145|65242631|FG001|Overall Study|Incorrectly randomized|6|||
23409485|NCT03265145|65242630|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
23409486|NCT03265145|65242631|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
23409487|NCT03265145|65242630|FG000|Overall Study|Physician Decision|0|||
23409488|NCT03265145|65242631|FG001|Overall Study|Physician Decision|3|||
23409489|NCT03265145|65242630|FG000|Overall Study|Subject transferred to another facility|0|||
23409490|NCT03265145|65242631|FG001|Overall Study|Subject transferred to another facility|1|||
23409491|NCT02318368|65242632|FG000|Overall Study|Withdrawal by Subject|2|||
23409492|NCT02318368|65242633|FG001|Overall Study|Withdrawal by Subject|0|||
23409493|NCT02318368|65242632|FG000|Overall Study|Study terminated by the sponsor|5|||
23409494|NCT02318368|65242633|FG001|Overall Study|Study terminated by the sponsor|2|||
23409495|NCT02318368|65242632|FG000|Overall Study|Death|0|||
23409496|NCT02318368|65242633|FG001|Overall Study|Death|1|||
23409497|NCT00770562|65242634|FG000|Overall Study|Did not take treatment|1|||
23409498|NCT00770562|65242635|FG001|Overall Study|Did not take treatment|1|||
23409499|NCT00735553|65242639|FG000|Overall Study|Study prematurely terminated|77|||
23409500|NCT03799952|65242643|FG000|Overall Study|Program was too easy, discontinued|1|||
23409501|NCT03799952|65242644|FG001|Overall Study|Program was too easy, discontinued|0|||
23409502|NCT03799952|65242643|FG000|Overall Study|Lost to Follow-up|0|||
23409503|NCT03799952|65242644|FG001|Overall Study|Lost to Follow-up|2|||
23409504|NCT03146663|65242645|FG000|Overall Study|Did not receive study treatment|1|||
23409505|NCT03146663|65242646|FG001|Overall Study|Did not receive study treatment|1|||
23409506|NCT04721158|65242653|FG000|Overall Study|Lost to Follow-up|4|||
23409507|NCT04721158|65242653|FG000|Overall Study|Device did not connect|1|||
23409508|NCT03374358|65242654|FG000|Overall Study|Withdrawal by Subject|0|||
23409509|NCT03374358|65242655|FG001|Overall Study|Withdrawal by Subject|2|||
23409510|NCT02688192|65242659|FG000|Overall Study|Lost to Follow-up|11|||
23409511|NCT02688192|65242660|FG001|Overall Study|Lost to Follow-up|5|||
23409512|NCT02688192|65242659|FG000|Overall Study|Physician Decision|1|||
23409513|NCT02688192|65242660|FG001|Overall Study|Physician Decision|0|||
23409514|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23511399|NCT01829230|65609321|FG000|Overall Study|Lost to Follow-up|1|||
23409515|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23409516|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23409517|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
23409518|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
23409519|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
23409520|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
23409521|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
23409522|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
23409523|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
23409524|NCT01925768|65242663|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
23409525|NCT01925768|65242664|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
23409526|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
23409527|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
23409528|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
23409529|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
23409530|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
23409531|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
23409532|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
23409533|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
23409534|NCT01925768|65242663|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
23409535|NCT01925768|65242664|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
23409536|NCT03122145|65242665|FG000|Overall Study|Concurrent respiratory disease|3|||
23409537|NCT03122145|65242666|FG001|Overall Study|Concurrent respiratory disease|0|||
23409538|NCT01104545|65242667|FG000|Overall Study|Adverse Event|0|||
23409539|NCT01104545|65242668|FG001|Overall Study|Adverse Event|1|||
23409540|NCT01104545|65242669|FG002|Overall Study|Adverse Event|2|||
23409541|NCT01973231|65242670|FG000|Overall Study|Protocol Violation|1|||
23409542|NCT01973231|65242671|FG001|Overall Study|Protocol Violation|1|||
23409543|NCT01973231|65242670|FG000|Overall Study|Lost to Follow-up|1|||
23409544|NCT01973231|65242671|FG001|Overall Study|Lost to Follow-up|1|||
23409545|NCT01973231|65242670|FG000|Overall Study|unclassified|2|||
23409546|NCT01973231|65242671|FG001|Overall Study|unclassified|1|||
23409547|NCT01973231|65242670|FG000|Overall Study|Withdrawal by Subject|7|||
23409548|NCT01973231|65242671|FG001|Overall Study|Withdrawal by Subject|9|||
23409549|NCT02388165|65242672|FG000|Overall Study|Study terminated by sponsor|5|||
23409550|NCT02388165|65242673|FG001|Overall Study|Study terminated by sponsor|5|||
23409551|NCT02388165|65242672|FG000|Overall Study|Other|11|||
23409552|NCT02388165|65242673|FG001|Overall Study|Other|13|||
23409553|NCT02388165|65242672|FG000|Overall Study|No longer meet eligibility criteria|40|||
23409554|NCT02388165|65242673|FG001|Overall Study|No longer meet eligibility criteria|43|||
23409555|NCT02388165|65242672|FG000|Overall Study|Withdrawal of consent|31|||
23409556|NCT02388165|65242673|FG001|Overall Study|Withdrawal of consent|32|||
23409557|NCT02388165|65242672|FG000|Overall Study|Lost to Follow-up|19|||
23409558|NCT02388165|65242673|FG001|Overall Study|Lost to Follow-up|20|||
23409559|NCT02388165|65242672|FG000|Overall Study|Death|13|||
23409560|NCT02388165|65242673|FG001|Overall Study|Death|10|||
23409561|NCT02388165|65242672|FG000|Overall Study|Adverse Event|3|||
23409562|NCT02388165|65242673|FG001|Overall Study|Adverse Event|5|||
23409563|NCT02388165|65242672|FG000|Overall Study|Did not meet entrance criteria|5|||
23409564|NCT02388165|65242673|FG001|Overall Study|Did not meet entrance criteria|2|||
23409565|NCT03050450|65242675|FG000|Overall Study|Physician Decision|1|||
23409566|NCT03050450|65242676|FG001|Overall Study|Physician Decision|0|||
23409567|NCT03050450|65242677|FG002|Overall Study|Physician Decision|0|||
23409568|NCT03050450|65242678|FG003|Overall Study|Physician Decision|0|||
23409569|NCT03050450|65242679|FG004|Overall Study|Physician Decision|0|||
23409570|NCT01642901|65242689|FG000|12-month Follow-up|Withdrawal by Subject|1|||
23409571|NCT01642901|65242690|FG001|12-month Follow-up|Withdrawal by Subject|0|||
23409572|NCT02544750|65242691|FG000|Overall Study|Physician Decision|3|||
23409573|NCT02544750|65242692|FG001|Overall Study|Physician Decision|1|||
23409574|NCT02544750|65242691|FG000|Overall Study|Other reasons|69|||
23409575|NCT02544750|65242692|FG001|Overall Study|Other reasons|39|||
23409576|NCT02544750|65242691|FG000|Overall Study|Met withdrawal criteria|2|||
23409577|NCT02544750|65242692|FG001|Overall Study|Met withdrawal criteria|2|||
23409578|NCT02544750|65242691|FG000|Overall Study|Transition To Commercial Product|1|||
23409579|NCT02544750|65242692|FG001|Overall Study|Transition To Commercial Product|0|||
23409580|NCT02544750|65242691|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
23409581|NCT02544750|65242692|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
23205180|NCT00492856|64491286|FG001|Induction|Withdrawal by Subject|0|||
23409582|NCT02544750|65242691|FG000|Overall Study|Adverse Event|8|||
23409583|NCT02544750|65242692|FG001|Overall Study|Adverse Event|10|||
23409584|NCT02544750|65242691|FG000|Overall Study|Withdrawal by Subject|10|||
23409585|NCT02544750|65242692|FG001|Overall Study|Withdrawal by Subject|4|||
23409586|NCT02544750|65242691|FG000|Overall Study|Lost to Follow-up|1|||
23409587|NCT02544750|65242692|FG001|Overall Study|Lost to Follow-up|0|||
23409588|NCT01871545|65242696|FG000|Overall Study|Death|2|||
23409589|NCT01871545|65242697|FG001|Overall Study|Death|0|||
23409590|NCT01871545|65242696|FG000|Overall Study|Lack of Efficacy|11|||
23409591|NCT01871545|65242697|FG001|Overall Study|Lack of Efficacy|2|||
23409592|NCT01871545|65242696|FG000|Overall Study|Physician Decision|4|||
23409593|NCT01871545|65242697|FG001|Overall Study|Physician Decision|0|||
23409594|NCT01871545|65242696|FG000|Overall Study|Withdrawal by Subject|0|||
23409595|NCT01871545|65242697|FG001|Overall Study|Withdrawal by Subject|1|||
23409596|NCT01901614|65242698|FG000|Overall Study|Adverse Event|0|||
23409597|NCT01901614|65242699|FG001|Overall Study|Adverse Event|1|||
23409598|NCT01901614|65242698|FG000|Overall Study|Lost to Follow-up|1|||
23409599|NCT01901614|65242699|FG001|Overall Study|Lost to Follow-up|0|||
23409600|NCT01901614|65242698|FG000|Overall Study|Screen Fail|1|||
23409601|NCT01901614|65242699|FG001|Overall Study|Screen Fail|0|||
23409602|NCT02964273|65242701|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
23409603|NCT02964273|65242702|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
23409604|NCT02964273|65242703|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
23409605|NCT02964273|65242704|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
23409606|NCT02964273|65242701|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
23409607|NCT02964273|65242702|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
23409608|NCT02964273|65242703|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
23409609|NCT02964273|65242704|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
23409610|NCT02964273|65242701|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
23409611|NCT02964273|65242702|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
23409612|NCT02964273|65242703|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
23409613|NCT02964273|65242704|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
23409614|NCT02964273|65242701|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
23409615|NCT02964273|65242702|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
23409616|NCT02964273|65242703|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
23409617|NCT02964273|65242704|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
23409618|NCT02964273|65242701|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
23409619|NCT02964273|65242702|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
23409620|NCT02964273|65242703|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
23409621|NCT02964273|65242704|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
23409622|NCT02964273|65242701|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
23409623|NCT02964273|65242702|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
23409624|NCT02964273|65242703|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
23409625|NCT02964273|65242704|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
23409626|NCT03462641|65242708|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
23409627|NCT03462641|65242709|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
23409628|NCT03462641|65242708|FG000|Visit 2|Withdrawal by Subject|0|||
23409629|NCT03462641|65242709|FG001|Visit 2|Withdrawal by Subject|1|||
23409630|NCT00814580|65242710|FG000|Overall Study|Adverse Event|6|||
23409631|NCT00814580|65242711|FG001|Overall Study|Adverse Event|15|||
23409632|NCT00814580|65242710|FG000|Overall Study|Lack of Efficacy|18|||
23409633|NCT00814580|65242711|FG001|Overall Study|Lack of Efficacy|25|||
23409634|NCT00814580|65242710|FG000|Overall Study|Protocol Violation|2|||
23409635|NCT00814580|65242711|FG001|Overall Study|Protocol Violation|0|||
23409636|NCT00814580|65242710|FG000|Overall Study|Withdrawal by Subject|2|||
23409637|NCT00814580|65242711|FG001|Overall Study|Withdrawal by Subject|2|||
23409638|NCT00814580|65242710|FG000|Overall Study|Other|1|||
23409639|NCT00814580|65242711|FG001|Overall Study|Other|3|||
23409640|NCT00814580|65242710|FG000|Overall Study|Did Not Take Drug|2|||
23409641|NCT00814580|65242711|FG001|Overall Study|Did Not Take Drug|2|||
23306932|NCT00536263|64866564|FG000|Overall Study|Noncompliance with protocol|0|||
23306933|NCT00536263|64866565|FG001|Overall Study|Noncompliance with protocol|0|||
23306934|NCT00536263|64866566|FG002|Overall Study|Noncompliance with protocol|1|||
23306935|NCT00536263|64866564|FG000|Overall Study|Did not meet protocol eligibility|1|||
23306936|NCT00536263|64866565|FG001|Overall Study|Did not meet protocol eligibility|2|||
23306937|NCT00536263|64866566|FG002|Overall Study|Did not meet protocol eligibility|2|||
23306938|NCT00742924|64870336|FG000|Overall Study|Adverse Event|0|||
23306939|NCT00742924|64870337|FG001|Overall Study|Adverse Event|0|||
23409642|NCT04072835|65242715|FG000|Overall Study|Overall trial ended|603|||
23409643|NCT04072835|65242715|FG000|Overall Study|Ablation|97|||
23409644|NCT04072835|65242715|FG000|Overall Study|Withdrawal of consent|66|||
23409645|NCT04072835|65242715|FG000|Overall Study|Physician Decision|50|||
23409646|NCT04072835|65242715|FG000|Overall Study|Lost to Follow-up|39|||
23409647|NCT04072835|65242715|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
23409648|NCT04072835|65242715|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
23409649|NCT04072835|65242715|FG000|Overall Study|Adverse Event|25|||
23306940|NCT00742924|64870338|FG002|Overall Study|Adverse Event|1|||
23409650|NCT04072835|65242715|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
23409651|NCT04072835|65242715|FG000|Overall Study|Death|11|||
23409652|NCT04072835|65242715|FG000|Overall Study|Participant felt the drug did not work|8|||
23409653|NCT04072835|65242715|FG000|Overall Study|Participant tolerability|5|||
23409654|NCT04072835|65242715|FG000|Overall Study|Missing|5|||
23409655|NCT04072835|65242715|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
23409656|NCT04072835|65242715|FG000|Overall Study|Pregnancy|3|||
23409657|NCT02236572|65242718|FG000|Overall Study|Withdrawal by Subject|1|||
23409658|NCT02236572|65242718|FG000|Overall Study|Protocol Violation|1|||
23409659|NCT02236572|65242718|FG000|Overall Study|Lost to Follow-up|1|||
23409660|NCT02725476|65242721|FG000|Overall Study|Physician Decision|2|||
23409661|NCT02725476|65242722|FG001|Overall Study|Physician Decision|0|||
23409662|NCT02725476|65242721|FG000|Overall Study|Adverse Event|1|||
23409663|NCT02725476|65242722|FG001|Overall Study|Adverse Event|1|||
23409664|NCT01926444|65242723|FG000|Overall Study|Colonoscopy not performed|0|||
23409665|NCT01926444|65242724|FG001|Overall Study|Colonoscopy not performed|0|||
23409666|NCT01926444|65242725|FG002|Overall Study|Colonoscopy not performed|4|||
23409667|NCT01926444|65242726|FG003|Overall Study|Colonoscopy not performed|2|||
23409668|NCT00988052|65242729|FG000|Overall Study|Missing|1|||
23409669|NCT00988052|65242730|FG001|Overall Study|Missing|0|||
23409670|NCT00988052|65242729|FG000|Overall Study|Teva requested subject withdrawal|3|||
23409671|NCT00988052|65242730|FG001|Overall Study|Teva requested subject withdrawal|1|||
23409672|NCT00988052|65242729|FG000|Overall Study|Death|1|||
23306941|NCT00742924|64870339|FG003|Overall Study|Adverse Event|1|||
23306942|NCT00742924|64870336|FG000|Overall Study|Lack of Efficacy|5|||
23306943|NCT00742924|64870337|FG001|Overall Study|Lack of Efficacy|1|||
23306944|NCT00742924|64870338|FG002|Overall Study|Lack of Efficacy|2|||
23306945|NCT00742924|64870339|FG003|Overall Study|Lack of Efficacy|4|||
23306946|NCT00742924|64870336|FG000|Overall Study|Physician Decision|0|||
23306947|NCT00742924|64870337|FG001|Overall Study|Physician Decision|0|||
23306948|NCT00742924|64870338|FG002|Overall Study|Physician Decision|0|||
23306949|NCT00742924|64870339|FG003|Overall Study|Physician Decision|1|||
23306950|NCT00742924|64870336|FG000|Overall Study|Withdrawal by Subject|0|||
23306951|NCT00742924|64870337|FG001|Overall Study|Withdrawal by Subject|1|||
23205181|NCT00492856|64491287|FG002|Induction|Withdrawal by Subject|0|||
23306952|NCT00742924|64870338|FG002|Overall Study|Withdrawal by Subject|1|||
23409673|NCT00988052|65242730|FG001|Overall Study|Death|3|||
23409674|NCT00988052|65242729|FG000|Overall Study|Protocol Violation|6|||
23409675|NCT00988052|65242730|FG001|Overall Study|Protocol Violation|5|||
23409676|NCT00988052|65242729|FG000|Overall Study|Pregnancy|6|||
23409677|NCT00988052|65242730|FG001|Overall Study|Pregnancy|6|||
23409678|NCT00988052|65242729|FG000|Overall Study|Lack of Efficacy|8|||
23409679|NCT00988052|65242730|FG001|Overall Study|Lack of Efficacy|7|||
23409680|NCT00988052|65242729|FG000|Overall Study|Lost to Follow-up|6|||
23409681|NCT00988052|65242730|FG001|Overall Study|Lost to Follow-up|11|||
23409682|NCT00988052|65242729|FG000|Overall Study|Physician Decision|27|||
23409683|NCT00988052|65242730|FG001|Overall Study|Physician Decision|28|||
23306953|NCT00742924|64870339|FG003|Overall Study|Withdrawal by Subject|0|||
23306954|NCT00372411|64870340|FG000|Overall Study|Withdrawal by Subject|3|||
23306955|NCT00372411|64870341|FG001|Overall Study|Withdrawal by Subject|4|||
23306956|NCT00372411|64870342|FG002|Overall Study|Withdrawal by Subject|1|||
23306957|NCT00372411|64870340|FG000|Overall Study|Death|0|||
23306958|NCT00372411|64870341|FG001|Overall Study|Death|2|||
23306959|NCT00372411|64870342|FG002|Overall Study|Death|1|||
23306960|NCT00372411|64870340|FG000|Overall Study|Lost to Follow-up|1|||
23306961|NCT00372411|64870341|FG001|Overall Study|Lost to Follow-up|1|||
23306962|NCT00372411|64870342|FG002|Overall Study|Lost to Follow-up|1|||
23306963|NCT00372411|64870340|FG000|Overall Study|Adverse Event|1|||
23306964|NCT00372411|64870341|FG001|Overall Study|Adverse Event|1|||
23306965|NCT00372411|64870342|FG002|Overall Study|Adverse Event|0|||
23306966|NCT01584843|64870343|FG000|First Treatment Period|Adverse Event|0|||
23306967|NCT01584843|64870344|FG001|First Treatment Period|Adverse Event|0|||
23306968|NCT01584843|64870345|FG002|First Treatment Period|Adverse Event|1|||
23306969|NCT01584843|64870346|FG003|First Treatment Period|Adverse Event|0|||
23306970|NCT01584843|64870347|FG004|First Treatment Period|Adverse Event|0|||
23306971|NCT01584843|64870348|FG005|First Treatment Period|Adverse Event|0|||
23306972|NCT01584843|64870343|FG000|First Treatment Period|Protocol Violation|0|||
23306973|NCT01584843|64870344|FG001|First Treatment Period|Protocol Violation|0|||
23306974|NCT01584843|64870345|FG002|First Treatment Period|Protocol Violation|0|||
23306975|NCT01584843|64870346|FG003|First Treatment Period|Protocol Violation|0|||
23306976|NCT01584843|64870347|FG004|First Treatment Period|Protocol Violation|0|||
23306977|NCT01584843|64870348|FG005|First Treatment Period|Protocol Violation|1|||
23306978|NCT01584843|64870343|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23306979|NCT01584843|64870344|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23306980|NCT01584843|64870345|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23306981|NCT01584843|64870346|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23306982|NCT01584843|64870347|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
23306983|NCT01584843|64870348|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
23306984|NCT01584843|64870343|FG000|Second Treatment Period|Withdrawal by Subject|0|||
23306985|NCT01584843|64870344|FG001|Second Treatment Period|Withdrawal by Subject|0|||
23306986|NCT01584843|64870345|FG002|Second Treatment Period|Withdrawal by Subject|0|||
23306987|NCT01584843|64870346|FG003|Second Treatment Period|Withdrawal by Subject|0|||
23306988|NCT01584843|64870347|FG004|Second Treatment Period|Withdrawal by Subject|0|||
23306989|NCT01584843|64870348|FG005|Second Treatment Period|Withdrawal by Subject|1|||
23306990|NCT04516759|64870349|FG000|Overall Study|Withdrawal by Subject|1|||
23306991|NCT04516759|64870350|FG001|Overall Study|Withdrawal by Subject|1|||
23306992|NCT04516759|64870349|FG000|Overall Study|Other|0|||
23306993|NCT04516759|64870350|FG001|Overall Study|Other|1|||
23306994|NCT00807248|64870351|FG000|Overall Study|Adverse Event|1|||
23306995|NCT00807248|64870352|FG001|Overall Study|Adverse Event|2|||
23306996|NCT00807248|64870353|FG002|Overall Study|Adverse Event|2|||
23306997|NCT00807248|64870354|FG003|Overall Study|Adverse Event|6|||
23306998|NCT00807248|64870351|FG000|Overall Study|Lack of Efficacy|14|||
23306999|NCT00807248|64870352|FG001|Overall Study|Lack of Efficacy|4|||
23307000|NCT00807248|64870353|FG002|Overall Study|Lack of Efficacy|8|||
23409684|NCT00988052|65242729|FG000|Overall Study|Adverse Event|35|||
23409685|NCT00988052|65242730|FG001|Overall Study|Adverse Event|28|||
23409686|NCT00988052|65242729|FG000|Overall Study|Withdrawal by Subject|90|||
23409687|NCT00988052|65242730|FG001|Overall Study|Withdrawal by Subject|91|||
23409688|NCT00988052|65242729|FG000|Overall Study|Study terminated by sponsor|240|||
23409689|NCT00988052|65242730|FG001|Overall Study|Study terminated by sponsor|236|||
23409690|NCT01445613|65242731|FG000|30-day Follow-up|Withdrawal by Subject|6|||
23409691|NCT01445613|65242731|FG000|30-day Follow-up|Physician Decision|3|||
23409692|NCT01445613|65242731|FG000|30-day Follow-up|Missed visit|23|||
23409693|NCT01445613|65242731|FG000|30-day Follow-up|Death|3|||
23409694|NCT01445613|65242731|FG000|1-year Follow-up|Withdrawal by Subject|12|||
23409695|NCT01445613|65242731|FG000|1-year Follow-up|Missed visit|29|||
23409696|NCT01445613|65242731|FG000|1-year Follow-up|Lost to Follow-up|2|||
23409697|NCT01445613|65242731|FG000|1-year Follow-up|Death|30|||
23409698|NCT01445613|65242731|FG000|1-year Follow-up|Physician Decision|2|||
23409699|NCT01445613|65242731|FG000|1-year Follow-up|Received a non-study stent|2|||
23409700|NCT03046446|65242732|FG000|Overall Study|Lack of Efficacy|7|||
23409701|NCT03046446|65242732|FG000|Overall Study|Adverse Event|6|||
23409702|NCT03046446|65242732|FG000|Overall Study|Lost to Follow-up|3|||
23409703|NCT03046446|65242732|FG000|Overall Study|Withdrawal by Subject|14|||
23409704|NCT03046446|65242732|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
23409705|NCT03046446|65242732|FG000|Overall Study|Disease Progression (see caveats)|25|||
23409706|NCT03046446|65242732|FG000|Overall Study|Non OA related knee surgery|1|||
23409707|NCT03850093|65242733|FG000|Overall Study|Withdrawal by Subject|1|||
23409708|NCT03850093|65242734|FG001|Overall Study|Withdrawal by Subject|0|||
23409709|NCT03850093|65242735|FG002|Overall Study|Withdrawal by Subject|2|||
23409710|NCT00995436|65242737|FG000|Overall Study|Withdrawal by Subject|2|||
23409711|NCT00995436|65242738|FG001|Overall Study|Withdrawal by Subject|5|||
23409712|NCT00995436|65242739|FG002|Overall Study|Withdrawal by Subject|0|||
23409713|NCT00325130|65242741|FG000|Overall Study|Lost to Follow-up|6|||
23409714|NCT00325130|65242742|FG001|Overall Study|Lost to Follow-up|14|||
23409715|NCT00325130|65242741|FG000|Overall Study|Withdrawal by Subject|12|||
23409716|NCT00325130|65242742|FG001|Overall Study|Withdrawal by Subject|14|||
23409717|NCT00325130|65242741|FG000|Overall Study|Protocol Deviation|0|||
23409718|NCT00325130|65242742|FG001|Overall Study|Protocol Deviation|1|||
23409719|NCT00325130|65242741|FG000|Overall Study|Moved|0|||
23409720|NCT00325130|65242742|FG001|Overall Study|Moved|1|||
23409721|NCT00325130|65242741|FG000|Overall Study|Patient Discontinued for Other|1|||
23409722|NCT00325130|65242742|FG001|Overall Study|Patient Discontinued for Other|0|||
23409723|NCT01232127|65242744|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
23409724|NCT01232127|65242745|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
23409725|NCT01232127|65242746|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
23409726|NCT00438360|65245561|FG000|Overall Study|Adverse Event|6|||
23409727|NCT00438360|65245562|FG001|Overall Study|Adverse Event|1|||
23409728|NCT00438360|65245561|FG000|Overall Study|Lack of Efficacy|42|||
23511400|NCT01829230|65609322|FG001|Overall Study|Lost to Follow-up|1|||
23511401|NCT03227029|65609327|FG000|Overall Study|Child Wheezed (no treatment)|0|||
23511402|NCT03227029|65609328|FG001|Overall Study|Child Wheezed (no treatment)|1|||
23307001|NCT00807248|64870354|FG003|Overall Study|Lack of Efficacy|3|||
23409729|NCT00438360|65245562|FG001|Overall Study|Lack of Efficacy|27|||
23409730|NCT00438360|65245561|FG000|Overall Study|Other|24|||
23409731|NCT00438360|65245562|FG001|Overall Study|Other|15|||
23409732|NCT02526212|65245563|FG000|Overall Study|Incarceration|1|||
23409733|NCT02526212|65245564|FG001|Overall Study|Incarceration|0|||
23307002|NCT00807248|64870351|FG000|Overall Study|Protocol Violation|0|||
23307003|NCT00807248|64870352|FG001|Overall Study|Protocol Violation|1|||
23307004|NCT00807248|64870353|FG002|Overall Study|Protocol Violation|1|||
23307005|NCT00807248|64870354|FG003|Overall Study|Protocol Violation|0|||
23307006|NCT00807248|64870351|FG000|Overall Study|Withdrawal of Consent|5|||
23307007|NCT00807248|64870352|FG001|Overall Study|Withdrawal of Consent|5|||
23307008|NCT00807248|64870353|FG002|Overall Study|Withdrawal of Consent|5|||
23307009|NCT00807248|64870354|FG003|Overall Study|Withdrawal of Consent|5|||
23307010|NCT00807248|64870351|FG000|Overall Study|Lost to Follow-up|1|||
23307011|NCT00807248|64870352|FG001|Overall Study|Lost to Follow-up|0|||
23307012|NCT00807248|64870353|FG002|Overall Study|Lost to Follow-up|0|||
23307013|NCT00807248|64870354|FG003|Overall Study|Lost to Follow-up|0|||
23307014|NCT00807248|64870351|FG000|Overall Study|Other Reason|0|||
23307015|NCT00807248|64870352|FG001|Overall Study|Other Reason|0|||
23307016|NCT00807248|64870353|FG002|Overall Study|Other Reason|2|||
23409734|NCT02526212|65245563|FG000|Overall Study|Lost to Follow-up|1|||
23409735|NCT02526212|65245564|FG001|Overall Study|Lost to Follow-up|0|||
23409736|NCT02526212|65245563|FG000|Overall Study|Death|0|||
23409737|NCT02526212|65245564|FG001|Overall Study|Death|1|||
23409738|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
23409739|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
23409740|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
23409741|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
23409742|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
23409743|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
23409744|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
23409745|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
23409746|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
23409747|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
23409748|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
23409749|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
23409750|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
23409751|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
23409752|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
23409753|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
23409754|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
23409755|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
23409756|NCT03162796|65245565|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
23409757|NCT03162796|65245566|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
23409758|NCT03162796|65245567|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
23409759|NCT03162796|65245565|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
23409760|NCT03162796|65245566|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
23409761|NCT03162796|65245567|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
23409762|NCT03162796|65245565|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
23409763|NCT03162796|65245566|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
23409764|NCT03162796|65245567|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
23409765|NCT03162796|65245565|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
23409766|NCT03162796|65245566|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
23409767|NCT03162796|65245567|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
23409768|NCT03162796|65245565|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
23409769|NCT03162796|65245566|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
23409770|NCT03162796|65245567|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
23409771|NCT01437111|65245568|FG000|Overall Study|Adverse Event|2|||
23409772|NCT01437111|65245568|FG000|Overall Study|Withdrawal by Subject|4|||
23409773|NCT01437111|65245568|FG000|Overall Study|Not reported|5|||
23409774|NCT01437111|65245568|FG000|Overall Study|Physician Decision|1|||
23409775|NCT01437111|65245568|FG000|Overall Study|Lost to Follow-up|5|||
23409776|NCT01437111|65245568|FG000|Overall Study|Protocol Violation|1|||
23409777|NCT02263326|65245572|FG000|Overall Study|Lost to Follow-up|1|||
23409778|NCT02263326|65245573|FG001|Overall Study|Lost to Follow-up|1|||
23409779|NCT00880269|65245574|FG000|Overall Study|Protocol Violation|1|||
23409780|NCT00880269|65245575|FG001|Overall Study|Protocol Violation|0|||
23409781|NCT00880269|65245574|FG000|Overall Study|Disease Progression|13|||
23409782|NCT00880269|65245575|FG001|Overall Study|Disease Progression|11|||
23409783|NCT00880269|65245574|FG000|Overall Study|New Cancer Therapy|1|||
23409784|NCT00880269|65245575|FG001|Overall Study|New Cancer Therapy|0|||
23409785|NCT00880269|65245574|FG000|Overall Study|Death|4|||
23409786|NCT00880269|65245575|FG001|Overall Study|Death|2|||
23409787|NCT00880269|65245574|FG000|Overall Study|Lost to Follow-up|0|||
23409788|NCT00880269|65245575|FG001|Overall Study|Lost to Follow-up|1|||
23409789|NCT00880269|65245574|FG000|Overall Study|Withdrawal by Subject|3|||
23511403|NCT03227029|65609329|FG002|Overall Study|Child Wheezed (no treatment)|0|||
23511404|NCT03227029|65609327|FG000|Overall Study|No post RSV season visit due to COVID|3|||
23409790|NCT00880269|65245575|FG001|Overall Study|Withdrawal by Subject|4|||
23409791|NCT00880269|65245574|FG000|Overall Study|Adverse Event|10|||
23409792|NCT00880269|65245575|FG001|Overall Study|Adverse Event|9|||
23409793|NCT00739310|65245580|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
23409794|NCT00739310|65245580|FG000|Overall Study|Withdrawal by Subject|1|||
23409795|NCT00739310|65245580|FG000|Overall Study|Lost to Follow-up|2|||
23409796|NCT01048242|65245591|FG000|Overall Study|See study flow chart|4|||
23511405|NCT03227029|65609328|FG001|Overall Study|No post RSV season visit due to COVID|3|||
23409797|NCT01048242|65245592|FG001|Overall Study|See study flow chart|2|||
23409798|NCT00161616|65245593|FG000|Overall Study|Withdrawal by Subject|6|||
23409799|NCT00161616|65245594|FG001|Overall Study|Withdrawal by Subject|5|||
23409800|NCT00161616|65245593|FG000|Overall Study|Physician Decision|1|||
23409801|NCT00161616|65245594|FG001|Overall Study|Physician Decision|0|||
23409802|NCT00161616|65245593|FG000|Overall Study|Death|1|||
23409803|NCT00161616|65245594|FG001|Overall Study|Death|1|||
23409804|NCT00161616|65245593|FG000|Overall Study|Lost to Follow-up|17|||
23409805|NCT00161616|65245594|FG001|Overall Study|Lost to Follow-up|13|||
23409806|NCT00161616|65245593|FG000|Overall Study|Protocol deviation|1|||
23409807|NCT00161616|65245594|FG001|Overall Study|Protocol deviation|0|||
23409808|NCT00780143|65245595|FG000|Overall Study|Progressive disease|1|||
23409809|NCT00780143|65245595|FG000|Overall Study|Toxicity|1|||
23409810|NCT00780143|65245595|FG000|Overall Study|Adverse Event|1|||
23307017|NCT00807248|64870354|FG003|Overall Study|Other Reason|0|||
23307018|NCT01284621|64870357|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23307019|NCT01284621|64870358|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23307020|NCT01284621|64870359|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23307021|NCT01284621|64870360|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23307022|NCT01284621|64870361|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
23307023|NCT01284621|64870362|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
23307024|NCT03596151|64870367|FG000|Overall Study|Withdrawal by Subject|1|||
23307025|NCT01259115|64870370|FG000|Period 1|Adverse Event|1|||
23307026|NCT01259115|64870371|FG001|Period 1|Adverse Event|0|||
23307027|NCT01259115|64870370|FG000|Period 1|Protocol Violation|2|||
23307028|NCT01259115|64870371|FG001|Period 1|Protocol Violation|0|||
23307029|NCT01259115|64870370|FG000|Period 1|Lost to Follow-up|0|||
23307030|NCT01259115|64870371|FG001|Period 1|Lost to Follow-up|1|||
23307031|NCT01259115|64870370|FG000|Period 2|Adverse Event|1|||
23307032|NCT01259115|64870371|FG001|Period 2|Adverse Event|0|||
23307033|NCT02303041|64870372|FG000|Overall Study|Adverse Event|1|||
23307034|NCT02303041|64870373|FG001|Overall Study|Adverse Event|2|||
23307035|NCT04319718|64870374|FG000|Overall Study|Adverse Event|0|||
23307036|NCT04319718|64870375|FG001|Overall Study|Adverse Event|2|||
23307037|NCT04319718|64870374|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
23307038|NCT04319718|64870375|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
23307039|NCT02272634|64870386|FG000|Overall Study|Adverse Event|1|||
23307040|NCT02272634|64870387|FG001|Overall Study|Adverse Event|0|||
23307041|NCT02272634|64870388|FG002|Overall Study|Adverse Event|0|||
23307042|NCT02272634|64870386|FG000|Overall Study|Protocol Violation|0|||
23307043|NCT02272634|64870387|FG001|Overall Study|Protocol Violation|0|||
23307044|NCT02272634|64870388|FG002|Overall Study|Protocol Violation|1|||
23307045|NCT02272634|64870386|FG000|Overall Study|Withdrawal by Subject|0|||
23307046|NCT02272634|64870387|FG001|Overall Study|Withdrawal by Subject|1|||
23307047|NCT02272634|64870388|FG002|Overall Study|Withdrawal by Subject|0|||
23307048|NCT00895414|64870391|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
23307049|NCT00895414|64870392|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
23307050|NCT00895414|64870391|FG000|First Intervention (14 Days)|Physician Decision|0|||
23307051|NCT00895414|64870392|FG001|First Intervention (14 Days)|Physician Decision|1|||
23307052|NCT01177059|64870398|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
23307053|NCT01177059|64870398|FG000|Overall Study|Withdrew consent|2|||
23307054|NCT01177059|64870398|FG000|Overall Study|Lost to Follow-up|18|||
23307055|NCT01561430|64870399|FG000|Overall Study|Adverse Event|0|||
23307056|NCT01561430|64870400|FG001|Overall Study|Adverse Event|0|||
23307057|NCT01561430|64870401|FG002|Overall Study|Adverse Event|3|||
23307058|NCT01561430|64870402|FG003|Overall Study|Adverse Event|1|||
23307059|NCT01561430|64870399|FG000|Overall Study|Withdrawal by Subject|0|||
23307060|NCT01561430|64870400|FG001|Overall Study|Withdrawal by Subject|0|||
23307061|NCT01561430|64870401|FG002|Overall Study|Withdrawal by Subject|1|||
23409811|NCT01650831|65245600|FG000|Overall Study|Screen failure|1|||
23307062|NCT01561430|64870402|FG003|Overall Study|Withdrawal by Subject|0|||
23307063|NCT01561430|64870399|FG000|Overall Study|Physician Decision|0|||
23307064|NCT01561430|64870400|FG001|Overall Study|Physician Decision|1|||
23307065|NCT01561430|64870401|FG002|Overall Study|Physician Decision|0|||
23307066|NCT01561430|64870402|FG003|Overall Study|Physician Decision|0|||
23307067|NCT01561430|64870399|FG000|Overall Study|Sponsor Decision|1|||
23307068|NCT01561430|64870400|FG001|Overall Study|Sponsor Decision|14|||
23307069|NCT01561430|64870401|FG002|Overall Study|Sponsor Decision|13|||
23307070|NCT01561430|64870402|FG003|Overall Study|Sponsor Decision|12|||
23307071|NCT01267994|64870404|FG000|Overall Study|Adverse Event|2|||
23307072|NCT03246646|64870407|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
23409812|NCT00255723|65245601|FG000|Overall Study|Adverse Event|1|||
23409813|NCT00255723|65245602|FG001|Overall Study|Adverse Event|1|||
23409814|NCT00255723|65245601|FG000|Overall Study|Death|0|||
23409815|NCT00255723|65245602|FG001|Overall Study|Death|1|||
23409816|NCT00255723|65245601|FG000|Overall Study|Response Data Not Available|1|||
23409817|NCT00255723|65245602|FG001|Overall Study|Response Data Not Available|0|||
23409818|NCT04830215|65245603|FG000|Overall Study|Adverse Event|6|||
23409819|NCT04830215|65245603|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
23409820|NCT04830215|65245603|FG000|Overall Study|Withdrawal by Subject|3|||
23409821|NCT04830215|65245603|FG000|Overall Study|Protocol Deviation|1|||
23409822|NCT00600106|65245604|FG000|Overall Study|Withdrawal by Subject|1|||
23409823|NCT00600106|65245605|FG001|Overall Study|Withdrawal by Subject|1|||
23409824|NCT00583752|65245607|FG000|Overall Study|Lost to Follow-up|5|||
23409825|NCT00583752|65245608|FG001|Overall Study|Lost to Follow-up|5|||
23409826|NCT01693250|65245609|FG000|Overall Study|Lost to Follow-up|2|||
23409827|NCT01693250|65245610|FG001|Overall Study|Lost to Follow-up|2|||
23409828|NCT04474197|65245612|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
23409829|NCT04474197|65245613|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
23409830|NCT04474197|65245614|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
23409831|NCT04474197|65245615|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
23409832|NCT02974140|65245616|FG000|Overall Study|Adverse Event|2|||
23409833|NCT02974140|65245616|FG000|Overall Study|Lost to Follow-up|1|||
23409834|NCT02974140|65245616|FG000|Overall Study|Study Terminated by Sponsor|36|||
23409835|NCT01732510|65245617|FG000|Overall Study|Adverse Event|0|||
23409836|NCT01732510|65245618|FG001|Overall Study|Adverse Event|1|||
23409837|NCT01732510|65245619|FG002|Overall Study|Adverse Event|1|||
23409838|NCT01732510|65245620|FG003|Overall Study|Adverse Event|0|||
23409839|NCT01732510|65245621|FG004|Overall Study|Adverse Event|0|||
23409840|NCT01732510|65245622|FG005|Overall Study|Adverse Event|0|||
23409841|NCT01732510|65245623|FG006|Overall Study|Adverse Event|1|||
23409842|NCT01732510|65245617|FG000|Overall Study|Protocol Violation|0|||
23409843|NCT01732510|65245618|FG001|Overall Study|Protocol Violation|0|||
23409844|NCT01732510|65245619|FG002|Overall Study|Protocol Violation|0|||
23409845|NCT01732510|65245620|FG003|Overall Study|Protocol Violation|1|||
23409846|NCT01732510|65245621|FG004|Overall Study|Protocol Violation|0|||
23409847|NCT01732510|65245622|FG005|Overall Study|Protocol Violation|0|||
23409848|NCT01732510|65245623|FG006|Overall Study|Protocol Violation|0|||
23409849|NCT01732510|65245617|FG000|Overall Study|Withdrawal by Subject|1|||
23409850|NCT01732510|65245618|FG001|Overall Study|Withdrawal by Subject|3|||
23409851|NCT01732510|65245619|FG002|Overall Study|Withdrawal by Subject|2|||
23409852|NCT01732510|65245620|FG003|Overall Study|Withdrawal by Subject|1|||
23409853|NCT01732510|65245621|FG004|Overall Study|Withdrawal by Subject|5|||
23409854|NCT01732510|65245622|FG005|Overall Study|Withdrawal by Subject|0|||
23409855|NCT01732510|65245623|FG006|Overall Study|Withdrawal by Subject|1|||
23409856|NCT01732510|65245617|FG000|Overall Study|Lost to Follow-up|0|||
23409857|NCT01732510|65245618|FG001|Overall Study|Lost to Follow-up|0|||
23409858|NCT01732510|65245619|FG002|Overall Study|Lost to Follow-up|1|||
23409859|NCT01732510|65245620|FG003|Overall Study|Lost to Follow-up|1|||
23409860|NCT01732510|65245621|FG004|Overall Study|Lost to Follow-up|0|||
23409861|NCT01732510|65245622|FG005|Overall Study|Lost to Follow-up|1|||
23409862|NCT01732510|65245623|FG006|Overall Study|Lost to Follow-up|0|||
23409863|NCT01732510|65245617|FG000|Overall Study|Physician Decision|0|||
23409864|NCT01732510|65245618|FG001|Overall Study|Physician Decision|1|||
23409865|NCT01732510|65245619|FG002|Overall Study|Physician Decision|0|||
23409866|NCT01732510|65245620|FG003|Overall Study|Physician Decision|0|||
23409867|NCT01732510|65245621|FG004|Overall Study|Physician Decision|0|||
23409868|NCT01732510|65245622|FG005|Overall Study|Physician Decision|0|||
23409869|NCT01732510|65245623|FG006|Overall Study|Physician Decision|0|||
23409870|NCT01732510|65245617|FG000|Overall Study|Pregnancy|0|||
23409871|NCT01732510|65245618|FG001|Overall Study|Pregnancy|0|||
23409872|NCT01732510|65245619|FG002|Overall Study|Pregnancy|0|||
23409873|NCT01732510|65245620|FG003|Overall Study|Pregnancy|1|||
23409874|NCT01732510|65245621|FG004|Overall Study|Pregnancy|0|||
23409875|NCT01732510|65245622|FG005|Overall Study|Pregnancy|0|||
23409876|NCT01732510|65245623|FG006|Overall Study|Pregnancy|0|||
23409877|NCT01732510|65245617|FG000|Overall Study|Study Terminated By Sponsor|0|||
23409878|NCT01732510|65245618|FG001|Overall Study|Study Terminated By Sponsor|0|||
23409879|NCT01732510|65245619|FG002|Overall Study|Study Terminated By Sponsor|0|||
23409880|NCT01732510|65245620|FG003|Overall Study|Study Terminated By Sponsor|1|||
23409881|NCT01732510|65245621|FG004|Overall Study|Study Terminated By Sponsor|0|||
23409882|NCT01732510|65245622|FG005|Overall Study|Study Terminated By Sponsor|12|||
23409883|NCT01732510|65245623|FG006|Overall Study|Study Terminated By Sponsor|6|||
23409884|NCT02201329|65245626|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
23409885|NCT02201329|65245626|FG000|Overall Study|Withdrawal by Subject|2|||
23409886|NCT01500252|65245627|FG000|Overall Study|Death|4|||
23409887|NCT01500252|65245628|FG001|Overall Study|Death|2|||
23409888|NCT01500252|65245627|FG000|Overall Study|Lost to Follow-up|5|||
23409889|NCT01500252|65245628|FG001|Overall Study|Lost to Follow-up|4|||
23409890|NCT02298868|65245633|FG000|Overall Study|Adverse Event|1|||
23409891|NCT02298868|65245633|FG000|Overall Study|Death|1|||
23409892|NCT02298868|65245633|FG000|Overall Study|Patient underwent transplant|1|||
23409893|NCT01262560|65245634|FG000|Overall Study|Protocol Violation|0|||
23409894|NCT01262560|65245635|FG001|Overall Study|Protocol Violation|1|||
23409895|NCT01262560|65245636|FG002|Overall Study|Protocol Violation|2|||
23409896|NCT02364037|65245640|FG000|Overall Study|Withdrawal by Subject|7|||
23409897|NCT02364037|65245641|FG001|Overall Study|Withdrawal by Subject|4|||
23409898|NCT02364037|65245640|FG000|Overall Study|Lost to Follow-up|37|||
23409899|NCT02364037|65245641|FG001|Overall Study|Lost to Follow-up|49|||
23409900|NCT00460655|65245642|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
23409901|NCT00460655|65245643|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23409902|NCT00460655|65245644|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23409903|NCT00460655|65245645|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23409904|NCT00460655|65245642|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
23409905|NCT00460655|65245643|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23409906|NCT00460655|65245644|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23409907|NCT00460655|65245645|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23409908|NCT00460655|65245642|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
23409909|NCT00460655|65245643|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
23409910|NCT00460655|65245644|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
23409911|NCT00460655|65245645|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
23409912|NCT00460655|65245642|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23409913|NCT00460655|65245643|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23409914|NCT00460655|65245644|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
23409915|NCT00460655|65245645|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
23409916|NCT00460655|65245642|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23409917|NCT00460655|65245643|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23409918|NCT00460655|65245644|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
23409919|NCT00460655|65245645|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
23409920|NCT00460655|65245642|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
23409921|NCT00460655|65245643|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
23409922|NCT00460655|65245644|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
23409923|NCT00460655|65245645|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
23409924|NCT01947283|65245649|FG000|Overall Study|Death|1|||
23409925|NCT01947283|65245650|FG001|Overall Study|Death|1|||
23409926|NCT01947283|65245651|FG002|Overall Study|Death|1|||
23409927|NCT01947283|65245652|FG003|Overall Study|Death|0|||
23409928|NCT01947283|65245653|FG004|Overall Study|Death|0|||
23409929|NCT01947283|65245654|FG005|Overall Study|Death|0|||
23409930|NCT01947283|65245655|FG006|Overall Study|Death|0|||
23409931|NCT01947283|65245649|FG000|Overall Study|Lost to Follow-up|4|||
23409932|NCT01947283|65245650|FG001|Overall Study|Lost to Follow-up|6|||
23409933|NCT01947283|65245651|FG002|Overall Study|Lost to Follow-up|5|||
23409934|NCT01947283|65245652|FG003|Overall Study|Lost to Follow-up|5|||
23409935|NCT01947283|65245653|FG004|Overall Study|Lost to Follow-up|0|||
23409936|NCT01947283|65245654|FG005|Overall Study|Lost to Follow-up|2|||
23409937|NCT01947283|65245655|FG006|Overall Study|Lost to Follow-up|5|||
23409938|NCT01947283|65245649|FG000|Overall Study|Withdrawal by Subject|10|||
23409939|NCT01947283|65245650|FG001|Overall Study|Withdrawal by Subject|8|||
23409940|NCT01947283|65245651|FG002|Overall Study|Withdrawal by Subject|4|||
23409941|NCT01947283|65245652|FG003|Overall Study|Withdrawal by Subject|1|||
23409942|NCT01947283|65245653|FG004|Overall Study|Withdrawal by Subject|0|||
23409943|NCT01947283|65245654|FG005|Overall Study|Withdrawal by Subject|0|||
23409944|NCT01947283|65245655|FG006|Overall Study|Withdrawal by Subject|2|||
23409945|NCT01947283|65245649|FG000|Overall Study|No Clinical Recording|12|||
23409946|NCT01947283|65245650|FG001|Overall Study|No Clinical Recording|6|||
23409947|NCT01947283|65245651|FG002|Overall Study|No Clinical Recording|8|||
23409948|NCT01947283|65245652|FG003|Overall Study|No Clinical Recording|10|||
23409949|NCT01947283|65245653|FG004|Overall Study|No Clinical Recording|0|||
23409950|NCT01947283|65245654|FG005|Overall Study|No Clinical Recording|0|||
23409951|NCT01947283|65245655|FG006|Overall Study|No Clinical Recording|0|||
23409952|NCT01947283|65245649|FG000|Overall Study|Non-coding Clinical Recording language|0|||
23409953|NCT01947283|65245650|FG001|Overall Study|Non-coding Clinical Recording language|0|||
23409954|NCT01947283|65245651|FG002|Overall Study|Non-coding Clinical Recording language|0|||
23409955|NCT01947283|65245652|FG003|Overall Study|Non-coding Clinical Recording language|1|||
23409956|NCT01947283|65245653|FG004|Overall Study|Non-coding Clinical Recording language|0|||
23409957|NCT01947283|65245654|FG005|Overall Study|Non-coding Clinical Recording language|0|||
23409958|NCT01947283|65245655|FG006|Overall Study|Non-coding Clinical Recording language|0|||
23409959|NCT01947283|65245649|FG000|Overall Study|Missing Follow-up Assessment|2|||
23409960|NCT01947283|65245650|FG001|Overall Study|Missing Follow-up Assessment|2|||
23409961|NCT01947283|65245651|FG002|Overall Study|Missing Follow-up Assessment|3|||
23409962|NCT01947283|65245652|FG003|Overall Study|Missing Follow-up Assessment|0|||
23409963|NCT01947283|65245653|FG004|Overall Study|Missing Follow-up Assessment|0|||
23409964|NCT01947283|65245654|FG005|Overall Study|Missing Follow-up Assessment|2|||
23307073|NCT03246646|64870408|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
23307074|NCT03246646|64870407|FG000|Overall Study|Withdrawal by Subject|3|||
23307075|NCT03246646|64870408|FG001|Overall Study|Withdrawal by Subject|0|||
23307076|NCT03246646|64870407|FG000|Overall Study|Lost to Follow-up|7|||
23307077|NCT03246646|64870408|FG001|Overall Study|Lost to Follow-up|0|||
23307078|NCT01957176|64870409|FG000|Overall Study|Adverse Event|2|||
23409965|NCT01947283|65245655|FG006|Overall Study|Missing Follow-up Assessment|0|||
23409966|NCT01947283|65245649|FG000|Overall Study|No patients were enrolled in study|0|||
23409967|NCT01947283|65245650|FG001|Overall Study|No patients were enrolled in study|0|||
23409968|NCT01947283|65245651|FG002|Overall Study|No patients were enrolled in study|0|||
23409969|NCT01947283|65245652|FG003|Overall Study|No patients were enrolled in study|0|||
23409970|NCT01947283|65245653|FG004|Overall Study|No patients were enrolled in study|0|||
23409971|NCT01947283|65245654|FG005|Overall Study|No patients were enrolled in study|3|||
23409972|NCT01947283|65245655|FG006|Overall Study|No patients were enrolled in study|1|||
23409973|NCT04560816|65245656|FG000|Overall Study|Withdrawal by Subject|1|||
23307079|NCT01957176|64870410|FG001|Overall Study|Adverse Event|0|||
23307080|NCT01957176|64870409|FG000|Overall Study|Physician Decision|2|||
23409974|NCT04560816|65245657|FG001|Overall Study|Withdrawal by Subject|1|||
23409975|NCT04560816|65245658|FG002|Overall Study|Withdrawal by Subject|1|||
23409976|NCT04560816|65245659|FG003|Overall Study|Withdrawal by Subject|0|||
23307081|NCT01957176|64870410|FG001|Overall Study|Physician Decision|1|||
23409977|NCT04560816|65245660|FG004|Overall Study|Withdrawal by Subject|3|||
23409978|NCT04560816|65245661|FG005|Overall Study|Withdrawal by Subject|0|||
23409979|NCT04560816|65245656|FG000|Overall Study|Lost to Follow-up|1|||
23409980|NCT04560816|65245657|FG001|Overall Study|Lost to Follow-up|0|||
23409981|NCT04560816|65245658|FG002|Overall Study|Lost to Follow-up|0|||
23409982|NCT04560816|65245659|FG003|Overall Study|Lost to Follow-up|0|||
23409983|NCT04560816|65245660|FG004|Overall Study|Lost to Follow-up|0|||
23409984|NCT04560816|65245661|FG005|Overall Study|Lost to Follow-up|0|||
23409985|NCT04560816|65245656|FG000|Overall Study|Protocol Violation|1|||
23409986|NCT04560816|65245657|FG001|Overall Study|Protocol Violation|0|||
23409987|NCT04560816|65245658|FG002|Overall Study|Protocol Violation|0|||
23409988|NCT04560816|65245659|FG003|Overall Study|Protocol Violation|0|||
23409989|NCT04560816|65245660|FG004|Overall Study|Protocol Violation|0|||
23409990|NCT04560816|65245661|FG005|Overall Study|Protocol Violation|0|||
23409991|NCT02689206|65245665|FG000|Overall Study|Adverse Event|0|||
23409992|NCT02689206|65245666|FG001|Overall Study|Adverse Event|0|||
23409993|NCT02689206|65245667|FG002|Overall Study|Adverse Event|1|||
23409994|NCT02689206|65245668|FG003|Overall Study|Adverse Event|0|||
23409995|NCT02689206|65245669|FG004|Overall Study|Adverse Event|2|||
23409996|NCT02689206|65245665|FG000|Overall Study|Protocol Violation|1|||
23409997|NCT02689206|65245666|FG001|Overall Study|Protocol Violation|0|||
23409998|NCT02689206|65245667|FG002|Overall Study|Protocol Violation|0|||
23409999|NCT02689206|65245668|FG003|Overall Study|Protocol Violation|1|||
23410000|NCT02689206|65245669|FG004|Overall Study|Protocol Violation|2|||
23410001|NCT02689206|65245665|FG000|Overall Study|Other: Reached stopping criteria|0|||
23410002|NCT02689206|65245666|FG001|Overall Study|Other: Reached stopping criteria|1|||
23410003|NCT02689206|65245667|FG002|Overall Study|Other: Reached stopping criteria|2|||
23410004|NCT02689206|65245668|FG003|Overall Study|Other: Reached stopping criteria|3|||
23410005|NCT02689206|65245669|FG004|Overall Study|Other: Reached stopping criteria|4|||
23410006|NCT02689206|65245665|FG000|Overall Study|Physician Decision|1|||
23410007|NCT02689206|65245666|FG001|Overall Study|Physician Decision|0|||
23410008|NCT02689206|65245667|FG002|Overall Study|Physician Decision|0|||
23410009|NCT02689206|65245668|FG003|Overall Study|Physician Decision|0|||
23410010|NCT02689206|65245669|FG004|Overall Study|Physician Decision|0|||
23410011|NCT02689206|65245665|FG000|Overall Study|Withdrawal by Subject|1|||
23410012|NCT02689206|65245666|FG001|Overall Study|Withdrawal by Subject|0|||
23410013|NCT02689206|65245667|FG002|Overall Study|Withdrawal by Subject|1|||
23410014|NCT02689206|65245668|FG003|Overall Study|Withdrawal by Subject|0|||
23410015|NCT02689206|65245669|FG004|Overall Study|Withdrawal by Subject|0|||
23410016|NCT05002985|65245670|FG000|Overall Study|Withdrawal by Subject|1|||
23410017|NCT01270880|65245671|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
23410018|NCT00661726|65245672|FG000|Overall Study|Adverse Event|1|||
23410019|NCT02702609|65245673|FG000|Overall Study|Lost to Follow-up|8|||
23410020|NCT02702609|65245674|FG001|Overall Study|Lost to Follow-up|4|||
23410021|NCT02702609|65245673|FG000|Overall Study|Physician Decision|1|||
23410022|NCT02702609|65245674|FG001|Overall Study|Physician Decision|0|||
23410023|NCT02253433|65245675|FG000|Overall Study|Unable to Contact|9|||
23410024|NCT02253433|65245676|FG001|Overall Study|Unable to Contact|16|||
23410025|NCT02253433|65245675|FG000|Overall Study|Death|1|||
23410026|NCT02253433|65245676|FG001|Overall Study|Death|1|||
23410027|NCT02253433|65245675|FG000|Overall Study|No Longer Interested|3|||
23410028|NCT02253433|65245676|FG001|Overall Study|No Longer Interested|15|||
23410029|NCT02253433|65245675|FG000|Overall Study|Out of Study Area|2|||
23410030|NCT02253433|65245676|FG001|Overall Study|Out of Study Area|7|||
23410031|NCT02253433|65245675|FG000|Overall Study|Uncomfortable with home visitors|0|||
23410032|NCT02253433|65245676|FG001|Overall Study|Uncomfortable with home visitors|3|||
23410033|NCT02253433|65245675|FG000|Overall Study|Unstable Housing/Homeless|0|||
23410034|NCT02253433|65245676|FG001|Overall Study|Unstable Housing/Homeless|7|||
23410035|NCT02253433|65245675|FG000|Overall Study|Too Busy|0|||
23410036|NCT02253433|65245676|FG001|Overall Study|Too Busy|4|||
23410037|NCT02253433|65245675|FG000|Overall Study|Medical or Other Concerns|1|||
23410038|NCT02253433|65245676|FG001|Overall Study|Medical or Other Concerns|2|||
23410039|NCT00224120|65245679|FG000|Overall Study|Adverse Event|10|||
23410040|NCT00224120|65245680|FG001|Overall Study|Adverse Event|4|||
23410041|NCT00224120|65245679|FG000|Overall Study|Protocol Violation|1|||
23511406|NCT03227029|65609329|FG002|Overall Study|No post RSV season visit due to COVID|2|||
23511407|NCT03227029|65609327|FG000|Overall Study|Not able to get to clinic|0|||
23511408|NCT03227029|65609328|FG001|Overall Study|Not able to get to clinic|0|||
23410042|NCT00224120|65245680|FG001|Overall Study|Protocol Violation|0|||
23410043|NCT00224120|65245679|FG000|Overall Study|Withdrawal by Subject|5|||
23410044|NCT00224120|65245680|FG001|Overall Study|Withdrawal by Subject|10|||
23410045|NCT00224120|65245679|FG000|Overall Study|Lack of Efficacy|0|||
23410046|NCT00224120|65245680|FG001|Overall Study|Lack of Efficacy|2|||
23410047|NCT00224120|65245679|FG000|Overall Study|Lost to Follow-up|2|||
23410048|NCT00224120|65245680|FG001|Overall Study|Lost to Follow-up|3|||
23410049|NCT00224120|65245679|FG000|Overall Study|Other|4|||
23410050|NCT00224120|65245680|FG001|Overall Study|Other|5|||
23410051|NCT01643408|65245681|FG000|Overall Study|Adverse Event|12|||
23410052|NCT01643408|65245681|FG000|Overall Study|Other|2|||
23410053|NCT01864148|65245689|FG000|Overall Study|Other|2|||
23410054|NCT01864148|65245690|FG001|Overall Study|Other|1|||
23410055|NCT01864148|65245691|FG002|Overall Study|Other|1|||
23410056|NCT01864148|65245692|FG003|Overall Study|Other|3|||
23410057|NCT01864148|65245693|FG004|Overall Study|Other|1|||
23410058|NCT01864148|65245689|FG000|Overall Study|Death|0|||
23410059|NCT01864148|65245690|FG001|Overall Study|Death|0|||
23410060|NCT01864148|65245691|FG002|Overall Study|Death|0|||
23410061|NCT01864148|65245692|FG003|Overall Study|Death|1|||
23410062|NCT01864148|65245693|FG004|Overall Study|Death|0|||
23410063|NCT01864148|65245689|FG000|Overall Study|Investigator Decision|5|||
23307082|NCT01957176|64870409|FG000|Overall Study|Withdrawal by Subject|1|||
23307083|NCT01957176|64870410|FG001|Overall Study|Withdrawal by Subject|0|||
23307084|NCT04505293|64870412|FG000|Overall Study|Lost to Follow-up|2|||
23307085|NCT04505293|64870412|FG000|Overall Study|Withdrawal by Subject|6|||
23307086|NCT04505293|64870412|FG000|Overall Study|CT scan unreadable|277|||
23307087|NCT00699374|64870414|FG000|Overall Study|Death|93|||
23307088|NCT00699374|64870415|FG001|Overall Study|Death|83|||
23307089|NCT00699374|64870414|FG000|Overall Study|Adverse Event|70|||
23307090|NCT00699374|64870415|FG001|Overall Study|Adverse Event|67|||
23307091|NCT00699374|64870414|FG000|Overall Study|Global deterioration of health status|7|||
23307092|NCT00699374|64870415|FG001|Overall Study|Global deterioration of health status|8|||
23307093|NCT00699374|64870414|FG000|Overall Study|Lost to Follow-up|3|||
23307094|NCT00699374|64870415|FG001|Overall Study|Lost to Follow-up|5|||
23307095|NCT00699374|64870414|FG000|Overall Study|Withdrawal by Subject|34|||
23307096|NCT00699374|64870415|FG001|Overall Study|Withdrawal by Subject|44|||
23307097|NCT00699374|64870414|FG000|Overall Study|Objective progression or relapse|281|||
23307098|NCT00699374|64870415|FG001|Overall Study|Objective progression or relapse|277|||
23307099|NCT00699374|64870414|FG000|Overall Study|Other|18|||
23307100|NCT00699374|64870415|FG001|Overall Study|Other|15|||
23307101|NCT00699374|64870414|FG000|Overall Study|Protocol Violation|2|||
23307102|NCT00699374|64870415|FG001|Overall Study|Protocol Violation|6|||
23307103|NCT00699374|64870414|FG000|Overall Study|Study terminated by sponsor|13|||
23307104|NCT00699374|64870415|FG001|Overall Study|Study terminated by sponsor|28|||
23307105|NCT00699374|64870414|FG000|Overall Study|Randomized but not treated|4|||
23307106|NCT00699374|64870415|FG001|Overall Study|Randomized but not treated|2|||
23307107|NCT00699374|64870414|FG000|Overall Study|Died 28 days after last dose|5|||
23307108|NCT00699374|64870415|FG001|Overall Study|Died 28 days after last dose|9|||
23307109|NCT04295135|64870418|FG000|Overall Study|Withdrawal by Subject|2|||
23307110|NCT04295135|64870419|FG001|Overall Study|Withdrawal by Subject|1|||
23307111|NCT04295135|64870418|FG000|Overall Study|Subject left organization|8|||
23307112|NCT04295135|64870419|FG001|Overall Study|Subject left organization|4|||
23307113|NCT04188301|64870420|FG000|Month 3|Lost to Follow-up|0|||
23307114|NCT04188301|64870421|FG001|Month 3|Lost to Follow-up|0|||
23307115|NCT04188301|64870422|FG002|Month 3|Lost to Follow-up|1|||
23307116|NCT04188301|64870420|FG000|Month 12|Lost to Follow-up|0|||
23410064|NCT01864148|65245690|FG001|Overall Study|Investigator Decision|0|||
23410065|NCT01864148|65245691|FG002|Overall Study|Investigator Decision|0|||
23410066|NCT01864148|65245692|FG003|Overall Study|Investigator Decision|4|||
23307117|NCT04188301|64870421|FG001|Month 12|Lost to Follow-up|0|||
23307118|NCT04188301|64870422|FG002|Month 12|Lost to Follow-up|2|||
23307119|NCT04188301|64870420|FG000|Month 12|Death|1|||
23307120|NCT04188301|64870421|FG001|Month 12|Death|1|||
23307121|NCT04188301|64870422|FG002|Month 12|Death|0|||
23307122|NCT04188301|64870420|FG000|Month 18|Lost to Follow-up|6|||
23307123|NCT04188301|64870421|FG001|Month 18|Lost to Follow-up|0|||
23307124|NCT04188301|64870422|FG002|Month 18|Lost to Follow-up|0|||
23410067|NCT01864148|65245693|FG004|Overall Study|Investigator Decision|6|||
23410068|NCT01864148|65245689|FG000|Overall Study|Withdrawal by Subject|9|||
23410069|NCT01864148|65245690|FG001|Overall Study|Withdrawal by Subject|2|||
23410070|NCT01864148|65245691|FG002|Overall Study|Withdrawal by Subject|6|||
23410071|NCT01864148|65245692|FG003|Overall Study|Withdrawal by Subject|8|||
23410072|NCT01864148|65245693|FG004|Overall Study|Withdrawal by Subject|8|||
23410073|NCT01864148|65245689|FG000|Overall Study|Lost to Follow-up|0|||
23410074|NCT01864148|65245690|FG001|Overall Study|Lost to Follow-up|0|||
23410075|NCT01864148|65245691|FG002|Overall Study|Lost to Follow-up|0|||
23410076|NCT01864148|65245692|FG003|Overall Study|Lost to Follow-up|2|||
23410077|NCT01864148|65245693|FG004|Overall Study|Lost to Follow-up|1|||
23410078|NCT01864148|65245689|FG000|Overall Study|Adverse Event|4|||
23410079|NCT01864148|65245690|FG001|Overall Study|Adverse Event|2|||
23410080|NCT01864148|65245691|FG002|Overall Study|Adverse Event|4|||
23410081|NCT01864148|65245692|FG003|Overall Study|Adverse Event|7|||
23410082|NCT01864148|65245693|FG004|Overall Study|Adverse Event|7|||
23410083|NCT01864148|65245689|FG000|Overall Study|Not Dosed|0|||
23410084|NCT01864148|65245690|FG001|Overall Study|Not Dosed|0|||
23410085|NCT01864148|65245691|FG002|Overall Study|Not Dosed|0|||
23410086|NCT01864148|65245692|FG003|Overall Study|Not Dosed|1|||
23410087|NCT01864148|65245693|FG004|Overall Study|Not Dosed|0|||
23410088|NCT01803880|65245694|FG000|Overall Study|Adverse Event|1|||
23410089|NCT01803880|65245695|FG001|Overall Study|Adverse Event|0|||
23410090|NCT01803880|65245696|FG002|Overall Study|Adverse Event|0|||
23410091|NCT01803880|65245694|FG000|Overall Study|Withdrawal by Subject|1|||
23410092|NCT01803880|65245695|FG001|Overall Study|Withdrawal by Subject|1|||
23410093|NCT01803880|65245696|FG002|Overall Study|Withdrawal by Subject|4|||
23410094|NCT01803880|65245694|FG000|Overall Study|Physician Decision|0|||
23410095|NCT01803880|65245695|FG001|Overall Study|Physician Decision|0|||
23410096|NCT01803880|65245696|FG002|Overall Study|Physician Decision|1|||
23410097|NCT01803880|65245694|FG000|Overall Study|Unable to return for follow-up visits|0|||
23410098|NCT01803880|65245695|FG001|Overall Study|Unable to return for follow-up visits|1|||
23410099|NCT01803880|65245696|FG002|Overall Study|Unable to return for follow-up visits|2|||
23410100|NCT01803880|65245694|FG000|Overall Study|Lost to Follow-up|1|||
23410101|NCT01803880|65245695|FG001|Overall Study|Lost to Follow-up|2|||
23410102|NCT01803880|65245696|FG002|Overall Study|Lost to Follow-up|3|||
23410103|NCT01803880|65245694|FG000|Overall Study|Protocol Violation|1|||
23410104|NCT01803880|65245695|FG001|Overall Study|Protocol Violation|0|||
23410105|NCT01803880|65245696|FG002|Overall Study|Protocol Violation|0|||
23410106|NCT01803880|65245694|FG000|Overall Study|Early study termination|0|||
23410107|NCT01803880|65245695|FG001|Overall Study|Early study termination|6|||
23410108|NCT01803880|65245696|FG002|Overall Study|Early study termination|5|||
23410109|NCT01803880|65245694|FG000|Overall Study|Incomplete data entry by sites|2|||
23410110|NCT01803880|65245695|FG001|Overall Study|Incomplete data entry by sites|0|||
23410111|NCT01803880|65245696|FG002|Overall Study|Incomplete data entry by sites|0|||
23410112|NCT03248167|65245697|FG000|Overall Study|Withdrawal by Subject|2|||
23410113|NCT03248167|65245698|FG001|Overall Study|Withdrawal by Subject|2|||
23410114|NCT03248167|65245697|FG000|Overall Study|Physician Decision|0|||
23410115|NCT03248167|65245698|FG001|Overall Study|Physician Decision|1|||
23410116|NCT03248167|65245697|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
23410117|NCT03248167|65245698|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
23410118|NCT03248167|65245697|FG000|Overall Study|Lost to Follow-up|1|||
23410119|NCT03248167|65245698|FG001|Overall Study|Lost to Follow-up|0|||
23410120|NCT02674464|65245701|FG000|Overall Study|Death|10|||
23410121|NCT02674464|65245702|FG001|Overall Study|Death|21|||
23410122|NCT02674464|65245701|FG000|Overall Study|Withdrawal by Subject|24|||
23410123|NCT02674464|65245702|FG001|Overall Study|Withdrawal by Subject|44|||
23410124|NCT02674464|65245701|FG000|Overall Study|Lost to Follow-up|97|||
23410125|NCT02674464|65245702|FG001|Overall Study|Lost to Follow-up|92|||
23410126|NCT02674464|65245701|FG000|Overall Study|Outside survey window|6|||
23410127|NCT02674464|65245702|FG001|Overall Study|Outside survey window|3|||
23410128|NCT00082368|65245703|FG000|Overall Study|Not treated-pt had poor IV access|1|||
23410129|NCT02277691|65245704|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
23410130|NCT02277691|65245704|FG000|Overall Study|Voluntary Withdrawal|7|||
23410131|NCT02277691|65245704|FG000|Overall Study|Lack of Efficacy|5|||
23410132|NCT02277691|65245704|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
23410133|NCT00294671|65245705|FG000|Overall Study|Lack of Efficacy|11|||
23410134|NCT00294671|65245706|FG001|Overall Study|Lack of Efficacy|23|||
23511409|NCT03227029|65609329|FG002|Overall Study|Not able to get to clinic|1|||
23511410|NCT03227029|65609327|FG000|Overall Study|Withdrawal by Subject|1|||
23410135|NCT00294671|65245705|FG000|Overall Study|Liver transplant|7|||
23410136|NCT00294671|65245706|FG001|Overall Study|Liver transplant|9|||
23410137|NCT00294671|65245705|FG000|Overall Study|Drug related adverse event (AE)|4|||
23410138|NCT00294671|65245706|FG001|Overall Study|Drug related adverse event (AE)|2|||
23410139|NCT00294671|65245705|FG000|Overall Study|Non-drug related AE|3|||
23410140|NCT00294671|65245706|FG001|Overall Study|Non-drug related AE|2|||
23410141|NCT00294671|65245705|FG000|Overall Study|Lost to Follow-up|1|||
23410142|NCT00294671|65245706|FG001|Overall Study|Lost to Follow-up|3|||
23410143|NCT00294671|65245705|FG000|Overall Study|Non-compliance|1|||
23410144|NCT00294671|65245706|FG001|Overall Study|Non-compliance|0|||
23410145|NCT00294671|65245705|FG000|Overall Study|Death|0|||
23410146|NCT00294671|65245706|FG001|Overall Study|Death|1|||
23410147|NCT01901289|65245709|FG000|Overall Study|Death|32|||
23410148|NCT01901289|65245709|FG000|Overall Study|Lost to Follow-up|16|||
23410149|NCT01901289|65245709|FG000|Overall Study|Withdrawal by Subject|35|||
23410150|NCT01901289|65245709|FG000|Overall Study|Other type of endpoint met|2|||
23410151|NCT00620373|65245710|FG000|Overall Study|Unverified cancer status|33|||
23410152|NCT00107900|65245711|FG000|Overall Study|Adverse Event|3|||
23410153|NCT00107900|65245712|FG001|Overall Study|Adverse Event|2|||
23511411|NCT03227029|65609328|FG001|Overall Study|Withdrawal by Subject|0|||
23410154|NCT00107900|65245713|FG002|Overall Study|Adverse Event|10|||
23410155|NCT00107900|65245714|FG003|Overall Study|Adverse Event|3|||
23410156|NCT00107900|65245715|FG004|Overall Study|Adverse Event|5|||
23410157|NCT00107900|65245716|FG005|Overall Study|Adverse Event|3|||
23410158|NCT00107900|65245711|FG000|Overall Study|Death|0|||
23410159|NCT00107900|65245712|FG001|Overall Study|Death|0|||
23410160|NCT00107900|65245713|FG002|Overall Study|Death|0|||
23410161|NCT00107900|65245714|FG003|Overall Study|Death|0|||
23410162|NCT00107900|65245715|FG004|Overall Study|Death|1|||
23410163|NCT00107900|65245716|FG005|Overall Study|Death|0|||
23410164|NCT00107900|65245711|FG000|Overall Study|Lost to Follow-up|4|||
23410165|NCT00107900|65245712|FG001|Overall Study|Lost to Follow-up|1|||
23410166|NCT00107900|65245713|FG002|Overall Study|Lost to Follow-up|3|||
23410167|NCT00107900|65245714|FG003|Overall Study|Lost to Follow-up|2|||
23410168|NCT00107900|65245715|FG004|Overall Study|Lost to Follow-up|5|||
23410169|NCT00107900|65245716|FG005|Overall Study|Lost to Follow-up|5|||
23410170|NCT00107900|65245711|FG000|Overall Study|Protocol Violation|1|||
23410171|NCT00107900|65245712|FG001|Overall Study|Protocol Violation|0|||
23410172|NCT00107900|65245713|FG002|Overall Study|Protocol Violation|5|||
23410173|NCT00107900|65245714|FG003|Overall Study|Protocol Violation|5|||
23410174|NCT00107900|65245715|FG004|Overall Study|Protocol Violation|7|||
23410175|NCT00107900|65245716|FG005|Overall Study|Protocol Violation|0|||
23410176|NCT00107900|65245711|FG000|Overall Study|Withdrawal by Subject|1|||
23410177|NCT00107900|65245712|FG001|Overall Study|Withdrawal by Subject|0|||
23410178|NCT00107900|65245713|FG002|Overall Study|Withdrawal by Subject|5|||
23410179|NCT00107900|65245714|FG003|Overall Study|Withdrawal by Subject|0|||
23410180|NCT00107900|65245715|FG004|Overall Study|Withdrawal by Subject|1|||
23410181|NCT00107900|65245716|FG005|Overall Study|Withdrawal by Subject|1|||
23410182|NCT00107900|65245711|FG000|Overall Study|Administrative Reasons|1|||
23410183|NCT00107900|65245712|FG001|Overall Study|Administrative Reasons|0|||
23410184|NCT00107900|65245713|FG002|Overall Study|Administrative Reasons|2|||
23410185|NCT00107900|65245714|FG003|Overall Study|Administrative Reasons|2|||
23410186|NCT00107900|65245715|FG004|Overall Study|Administrative Reasons|2|||
23410187|NCT00107900|65245716|FG005|Overall Study|Administrative Reasons|0|||
23410188|NCT01030952|65245717|FG000|Overall Study|Protocol Violation|0|||
23410189|NCT01030952|65245718|FG001|Overall Study|Protocol Violation|1|||
23410190|NCT01030952|65245717|FG000|Overall Study|Informed consent withdrawal|1|||
23410191|NCT01030952|65245718|FG001|Overall Study|Informed consent withdrawal|0|||
23410192|NCT01030952|65245717|FG000|Overall Study|Lost to Follow-up|0|||
23410193|NCT01030952|65245718|FG001|Overall Study|Lost to Follow-up|1|||
23410194|NCT01030952|65245717|FG000|Overall Study|Unexplained|1|||
23410195|NCT01030952|65245718|FG001|Overall Study|Unexplained|1|||
23410196|NCT00282087|65245719|FG000|Overall Study|Death|1|||
23410197|NCT02125838|65245720|FG000|Overall Study|Lost to Follow-up|4|||
23410198|NCT02125838|65245721|FG001|Overall Study|Lost to Follow-up|4|||
23410199|NCT04294459|65245722|FG000|Overall Study|Adverse Event|0|||
23410200|NCT04294459|65245723|FG001|Overall Study|Adverse Event|1|||
23410201|NCT00771927|65245730|FG000|Overall Study|Adverse Event|100|||
23410202|NCT00771927|65245731|FG001|Overall Study|Adverse Event|105|||
23410203|NCT00771927|65245730|FG000|Overall Study|Lack of Efficacy|70|||
23410204|NCT00771927|65245731|FG001|Overall Study|Lack of Efficacy|42|||
23410205|NCT00771927|65245730|FG000|Overall Study|Lost to Follow-up|46|||
23410206|NCT00771927|65245731|FG001|Overall Study|Lost to Follow-up|46|||
23410207|NCT00771927|65245730|FG000|Overall Study|Withdrawal by Subject|16|||
23410208|NCT00771927|65245731|FG001|Overall Study|Withdrawal by Subject|17|||
23410209|NCT00771927|65245730|FG000|Overall Study|Other reason|23|||
23410210|NCT00771927|65245731|FG001|Overall Study|Other reason|27|||
23410211|NCT02413996|65245733|FG000|Overall Study|not comfortable with the intervention|9|||
23410212|NCT02413996|65245734|FG001|Overall Study|not comfortable with the intervention|2|||
23410213|NCT03472495|65245735|FG000|Overall Study|Treatment no longer indicated|1|||
23410214|NCT03472495|65245736|FG001|Overall Study|Treatment no longer indicated|2|||
23410215|NCT03472495|65245735|FG000|Overall Study|Physician Decision|0|||
23511412|NCT03227029|65609329|FG002|Overall Study|Withdrawal by Subject|0|||
23511413|NCT03227029|65609327|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
23511414|NCT03227029|65609328|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
23610573|NCT01964547|65962805|FG001|Overall Study|Withdrawal by Investigator|1|||
23610574|NCT03562117|65962806|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
23610575|NCT03562117|65962807|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
23610576|NCT03562117|65962808|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
23610577|NCT02676778|65962809|FG000|Overall Study|Disease Progression|7|||
23610578|NCT02676778|65962810|FG001|Overall Study|Disease Progression|3|||
23410216|NCT03472495|65245736|FG001|Overall Study|Physician Decision|2|||
23410217|NCT01208324|65245737|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
23410218|NCT01208324|65245738|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
23410219|NCT01208324|65245739|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
23410220|NCT01208324|65245740|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
23410221|NCT00456755|65245746|FG000|Overall Study|Lost to Follow-up|2|||
23410222|NCT00456755|65245747|FG001|Overall Study|Lost to Follow-up|1|||
23410223|NCT00391053|65245750|FG000|Overall Study|Serious Adverse Events|1|||
23410224|NCT00391053|65245751|FG001|Overall Study|Serious Adverse Events|0|||
23410225|NCT00391053|65245752|FG002|Overall Study|Serious Adverse Events|1|||
23410226|NCT00391053|65245753|FG003|Overall Study|Serious Adverse Events|4|||
23410227|NCT00391053|65245750|FG000|Overall Study|Protocol Violation|2|||
23410228|NCT00391053|65245751|FG001|Overall Study|Protocol Violation|0|||
23410229|NCT00391053|65245752|FG002|Overall Study|Protocol Violation|0|||
23410230|NCT00391053|65245753|FG003|Overall Study|Protocol Violation|0|||
23410231|NCT00391053|65245750|FG000|Overall Study|Lost to Follow-up|1|||
23410232|NCT00391053|65245751|FG001|Overall Study|Lost to Follow-up|0|||
23410233|NCT00391053|65245752|FG002|Overall Study|Lost to Follow-up|0|||
23410234|NCT00391053|65245753|FG003|Overall Study|Lost to Follow-up|5|||
23410235|NCT00391053|65245750|FG000|Overall Study|Withdrawal by Subject|5|||
23410236|NCT00391053|65245751|FG001|Overall Study|Withdrawal by Subject|1|||
23410237|NCT00391053|65245752|FG002|Overall Study|Withdrawal by Subject|1|||
23410238|NCT00391053|65245753|FG003|Overall Study|Withdrawal by Subject|1|||
23410239|NCT00703846|65245754|FG000|Overall Study|Adverse Event|8|||
23410240|NCT00703846|65245754|FG000|Overall Study|Lost to Follow-up|55|||
23410241|NCT00703846|65245754|FG000|Overall Study|Lack of Efficacy|15|||
23410242|NCT00703846|65245754|FG000|Overall Study|Noncompliance with Study Treatment|2|||
23410243|NCT00703846|65245754|FG000|Overall Study|Withdrawal by Subject|40|||
23410244|NCT00703846|65245754|FG000|Overall Study|Death|1|||
23410245|NCT00703846|65245754|FG000|Overall Study|Other|14|||
23410246|NCT00703846|65245754|FG000|Overall Study|Did Not Receive Study Drug|2|||
23410247|NCT02391311|65245755|FG000|Overall Study|Lost to Follow-up|2|||
23410248|NCT02391311|65245756|FG001|Overall Study|Lost to Follow-up|1|||
23410249|NCT02391311|65245755|FG000|Overall Study|deemed ineligible after baseline|1|||
23410250|NCT02391311|65245756|FG001|Overall Study|deemed ineligible after baseline|1|||
23410251|NCT04512001|65245760|FG000|Week 0 to Week 24|Adverse Event|14|||
23410252|NCT04512001|65245761|FG001|Week 0 to Week 24|Adverse Event|10|||
23410253|NCT04512001|65245762|FG002|Week 0 to Week 24|Adverse Event|0|||
23410254|NCT04512001|65245763|FG003|Week 0 to Week 24|Adverse Event|0|||
23410255|NCT04512001|65245764|FG004|Week 0 to Week 24|Adverse Event|0|||
23511415|NCT03227029|65609329|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
23410256|NCT04512001|65245760|FG000|Week 0 to Week 24|Death|0|||
23410257|NCT04512001|65245761|FG001|Week 0 to Week 24|Death|2|||
23410258|NCT04512001|65245762|FG002|Week 0 to Week 24|Death|0|||
23410259|NCT04512001|65245763|FG003|Week 0 to Week 24|Death|0|||
23410260|NCT04512001|65245764|FG004|Week 0 to Week 24|Death|0|||
23511416|NCT01195415|65609330|FG000|Overall Study|No repeat biopsy due to progression|2|||
23511417|NCT04343261|65609333|FG000|Overall Study|Adverse Event|1|||
23205182|NCT00492856|64491288|FG003|Induction|Withdrawal by Subject|0|||
23410261|NCT04512001|65245760|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
23410262|NCT04512001|65245761|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
23410263|NCT04512001|65245762|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
23410264|NCT04512001|65245763|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
23410265|NCT04512001|65245764|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
23410266|NCT04512001|65245760|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
23410267|NCT04512001|65245761|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
23410268|NCT04512001|65245762|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
23410269|NCT04512001|65245763|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
23410270|NCT04512001|65245764|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
23410271|NCT04512001|65245760|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
23410272|NCT04512001|65245761|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
23410273|NCT04512001|65245762|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
23410274|NCT04512001|65245763|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
23410275|NCT04512001|65245764|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
23410276|NCT04512001|65245760|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
23410277|NCT04512001|65245761|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
23410278|NCT04512001|65245762|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
23410279|NCT04512001|65245763|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
23410280|NCT04512001|65245764|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
23410281|NCT04512001|65245760|FG000|Week 24 to Week 63|Adverse Event|0|||
23410282|NCT04512001|65245761|FG001|Week 24 to Week 63|Adverse Event|0|||
23410283|NCT04512001|65245762|FG002|Week 24 to Week 63|Adverse Event|13|||
23410284|NCT04512001|65245763|FG003|Week 24 to Week 63|Adverse Event|8|||
23410285|NCT04512001|65245764|FG004|Week 24 to Week 63|Adverse Event|6|||
23410286|NCT04512001|65245760|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
23410287|NCT04512001|65245761|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
23410288|NCT04512001|65245762|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
23410289|NCT04512001|65245763|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
23410290|NCT04512001|65245764|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
23410291|NCT04512001|65245760|FG000|Week 24 to Week 63|Death|0|||
23410292|NCT04512001|65245761|FG001|Week 24 to Week 63|Death|0|||
23410293|NCT04512001|65245762|FG002|Week 24 to Week 63|Death|0|||
23410294|NCT04512001|65245763|FG003|Week 24 to Week 63|Death|1|||
23410295|NCT04512001|65245764|FG004|Week 24 to Week 63|Death|1|||
23410296|NCT04512001|65245760|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
23410297|NCT04512001|65245761|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
23410298|NCT04512001|65245762|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
23410299|NCT04512001|65245763|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
23410300|NCT04512001|65245764|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
23410301|NCT04512001|65245760|FG000|Week 24 to Week 63|Miscellaneous|0|||
23410302|NCT04512001|65245761|FG001|Week 24 to Week 63|Miscellaneous|0|||
23410303|NCT04512001|65245762|FG002|Week 24 to Week 63|Miscellaneous|3|||
23410304|NCT04512001|65245763|FG003|Week 24 to Week 63|Miscellaneous|2|||
23410305|NCT04512001|65245764|FG004|Week 24 to Week 63|Miscellaneous|1|||
23410306|NCT02013778|65245767|FG000|Overall Study|Death|4|||
23410307|NCT02013778|65245767|FG000|Overall Study|Withdrawal by Subject|1|||
23410308|NCT02013778|65245767|FG000|Overall Study|Physician Decision|1|||
23410309|NCT02013778|65245767|FG000|Overall Study|Adverse Event|1|||
23410310|NCT03604497|65245772|FG000|Overall Study|Protocol Violation|52|||
23410311|NCT04482439|65245773|FG000|Overall Study|Lost to Follow-up|1|||
23410312|NCT04482439|65245773|FG000|Overall Study|Unrelated illness|1|||
23410313|NCT01773967|65245774|FG000|Overall Study|Lost to Follow-up|15|||
23410314|NCT01773967|65245775|FG001|Overall Study|Lost to Follow-up|13|||
23410315|NCT01670279|65245776|FG000|Overall Study|Adverse Event|0|||
23410316|NCT01670279|65245777|FG001|Overall Study|Adverse Event|1|||
23410317|NCT01670279|65245778|FG002|Overall Study|Adverse Event|0|||
23410318|NCT01670279|65245779|FG003|Overall Study|Adverse Event|0|||
23410319|NCT01670279|65245776|FG000|Overall Study|Physician Decision|0|||
23410320|NCT01670279|65245777|FG001|Overall Study|Physician Decision|1|||
23410321|NCT01670279|65245778|FG002|Overall Study|Physician Decision|0|||
23410322|NCT01670279|65245779|FG003|Overall Study|Physician Decision|0|||
23410323|NCT01670279|65245776|FG000|Overall Study|Participant met withdrawal criteria|0|||
23410324|NCT01670279|65245777|FG001|Overall Study|Participant met withdrawal criteria|0|||
23410325|NCT01670279|65245778|FG002|Overall Study|Participant met withdrawal criteria|0|||
23410326|NCT01670279|65245779|FG003|Overall Study|Participant met withdrawal criteria|1|||
23410327|NCT02936869|65245780|FG000|Overall Study|Lost to Follow-up|1|||
23410328|NCT02936869|65245781|FG001|Overall Study|Lost to Follow-up|3|||
23410329|NCT02936869|65245780|FG000|Overall Study|Death|0|||
23410330|NCT02936869|65245781|FG001|Overall Study|Death|1|||
23410331|NCT02936869|65245780|FG000|Overall Study|Legal Case|0|||
23410332|NCT02936869|65245781|FG001|Overall Study|Legal Case|1|||
23410333|NCT02936869|65245780|FG000|Overall Study|Protocol Violation|1|||
23410334|NCT02936869|65245781|FG001|Overall Study|Protocol Violation|0|||
23410335|NCT00606411|65245783|FG000|Overall Study|Adverse Event|1|||
23410336|NCT00606411|65245784|FG001|Overall Study|Adverse Event|2|||
23410337|NCT00606411|65245783|FG000|Overall Study|Lack of Adherence|1|||
23410338|NCT00606411|65245784|FG001|Overall Study|Lack of Adherence|1|||
23410339|NCT00606411|65245783|FG000|Overall Study|Lack of Efficacy|1|||
23410340|NCT00606411|65245784|FG001|Overall Study|Lack of Efficacy|1|||
23410341|NCT00606411|65245783|FG000|Overall Study|Withdrawal by Subject|2|||
23410342|NCT00606411|65245784|FG001|Overall Study|Withdrawal by Subject|0|||
23410343|NCT00606411|65245783|FG000|Overall Study|Lost to Follow-up|1|||
23410344|NCT00606411|65245784|FG001|Overall Study|Lost to Follow-up|2|||
23410345|NCT00606411|65245783|FG000|Overall Study|Move out of state|0|||
23307125|NCT01268501|64870423|FG000|Overall Study|Lost to Follow-up|1|||
23307126|NCT01268501|64870423|FG000|Overall Study|Withdrawal by Subject|3|||
23410346|NCT00606411|65245784|FG001|Overall Study|Move out of state|1|||
23410347|NCT04262882|65245786|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
23410348|NCT04262882|65245787|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
23410349|NCT04262882|65245786|FG000|Overall Study|Lost to Follow-up|1|||
23410350|NCT04262882|65245787|FG001|Overall Study|Lost to Follow-up|0|||
23410351|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Adverse Event|1|||
23410352|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Adverse Event|0|||
23410353|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
23410354|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
23511418|NCT04343261|65609333|FG000|Overall Study|received inadequate amount of antibodies|7|||
23511419|NCT01549860|65609337|FG000|Overall Study|Withdrawal by Subject|1|||
23511420|NCT01549860|65609338|FG001|Overall Study|Withdrawal by Subject|0|||
23511421|NCT01549860|65609337|FG000|Overall Study|Physician Decision|1|||
23307127|NCT01268501|64870423|FG000|Overall Study|Unacceptable Subjective Vision|3|||
23307128|NCT01268501|64870423|FG000|Overall Study|Handling Difficulties|2|||
23307129|NCT02912650|64870424|FG000|Overall Study|Withdrawal by Subject|1|||
23307130|NCT02912650|64870425|FG001|Overall Study|Withdrawal by Subject|0|||
23307131|NCT02912650|64870426|FG002|Overall Study|Withdrawal by Subject|1|||
23307132|NCT02912650|64870427|FG003|Overall Study|Withdrawal by Subject|5|||
23307133|NCT02912650|64870424|FG000|Overall Study|Adverse Event|0|||
23307134|NCT02912650|64870425|FG001|Overall Study|Adverse Event|0|||
23307135|NCT02912650|64870426|FG002|Overall Study|Adverse Event|1|||
23307136|NCT02912650|64870427|FG003|Overall Study|Adverse Event|0|||
23307137|NCT02516553|64870428|FG000|Overall Study|Progressive disease|2|||
23307138|NCT02516553|64870429|FG001|Overall Study|Progressive disease|2|||
23307139|NCT02516553|64870430|FG002|Overall Study|Progressive disease|3|||
23307140|NCT02516553|64870431|FG003|Overall Study|Progressive disease|5|||
23307141|NCT02516553|64870432|FG004|Overall Study|Progressive disease|3|||
23307142|NCT02516553|64870433|FG005|Overall Study|Progressive disease|0|||
23307143|NCT02516553|64870434|FG006|Overall Study|Progressive disease|5|||
23307144|NCT02516553|64870435|FG007|Overall Study|Progressive disease|5|||
23307145|NCT02516553|64870436|FG008|Overall Study|Progressive disease|11|||
23307146|NCT02516553|64870437|FG009|Overall Study|Progressive disease|3|||
23307147|NCT02516553|64870438|FG010|Overall Study|Progressive disease|10|||
23307148|NCT02516553|64870439|FG011|Overall Study|Progressive disease|8|||
23307149|NCT02516553|64870440|FG012|Overall Study|Progressive disease|8|||
23307150|NCT02516553|64870441|FG013|Overall Study|Progressive disease|2|||
23307151|NCT02516553|64870442|FG014|Overall Study|Progressive disease|2|||
23307152|NCT02516553|64870443|FG015|Overall Study|Progressive disease|2|||
23307153|NCT02516553|64870444|FG016|Overall Study|Progressive disease|1|||
23307154|NCT02516553|64870445|FG017|Overall Study|Progressive disease|9|||
23307155|NCT02516553|64870446|FG018|Overall Study|Progressive disease|12|||
23307156|NCT02516553|64870447|FG019|Overall Study|Progressive disease|7|||
23307157|NCT02516553|64870448|FG020|Overall Study|Progressive disease|16|||
23307158|NCT02516553|64870449|FG021|Overall Study|Progressive disease|18|||
23307159|NCT02516553|64870428|FG000|Overall Study|Dose limiting toxicity|0|||
23205183|NCT00492856|64491285|FG000|Induction|Death|3|||
23307160|NCT02516553|64870429|FG001|Overall Study|Dose limiting toxicity|0|||
23307161|NCT02516553|64870430|FG002|Overall Study|Dose limiting toxicity|0|||
23307162|NCT02516553|64870431|FG003|Overall Study|Dose limiting toxicity|0|||
23205184|NCT00492856|64491286|FG001|Induction|Death|0|||
23410355|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
23410356|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
23410357|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
23410358|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
23410359|NCT00301262|65245788|FG000|Double Blind Phase (DB)|Other|1|||
23410360|NCT00301262|65245789|FG001|Double Blind Phase (DB)|Other|4|||
23410361|NCT00301262|65245788|FG000|Open Label Phase (OL)|Adverse Event|1|||
23410362|NCT00301262|65245789|FG001|Open Label Phase (OL)|Adverse Event|0|||
23410363|NCT00301262|65245788|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
23410364|NCT00301262|65245789|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
23410365|NCT00301262|65245788|FG000|Open Label Phase (OL)|Other|2|||
23410366|NCT00301262|65245789|FG001|Open Label Phase (OL)|Other|0|||
23410367|NCT00292045|65245793|FG000|Core Study (Through Week 13)|Adverse Event|1|||
23410368|NCT00292045|65245793|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
23410369|NCT02016716|65245798|FG000|Overall Study|Withdrawal by Subject|5|||
23410370|NCT02016716|65245799|FG001|Overall Study|Withdrawal by Subject|5|||
23410371|NCT02016716|65245800|FG002|Overall Study|Withdrawal by Subject|5|||
23410372|NCT02016716|65245798|FG000|Overall Study|Protocol-specified Criteria|0|||
23410373|NCT02016716|65245799|FG001|Overall Study|Protocol-specified Criteria|1|||
23410374|NCT02016716|65245800|FG002|Overall Study|Protocol-specified Criteria|0|||
23410375|NCT02016716|65245798|FG000|Overall Study|Lost to Follow-up|1|||
23410376|NCT02016716|65245799|FG001|Overall Study|Lost to Follow-up|2|||
23410377|NCT02016716|65245800|FG002|Overall Study|Lost to Follow-up|1|||
23410378|NCT01032070|65245803|FG000|Overall Study|Disease progression|13|||
23410379|NCT01032070|65245804|FG001|Overall Study|Disease progression|8|||
23410380|NCT01032070|65245803|FG000|Overall Study|Medical or ethical reasons|0|||
23410381|NCT01032070|65245804|FG001|Overall Study|Medical or ethical reasons|2|||
23410382|NCT01032070|65245803|FG000|Overall Study|Withdrawal by Subject|0|||
23410383|NCT01032070|65245804|FG001|Overall Study|Withdrawal by Subject|2|||
23410384|NCT01496287|65245805|FG000|Overall Study|Lost to Follow-up|1|||
23410385|NCT01496287|65245805|FG000|Overall Study|Incomplete anesthesia|5|||
23410386|NCT00967694|65245806|FG000|Overall Study|Withdrawal by Subject|6|||
23410387|NCT00705250|65245807|FG000|Overall Study|Withdrawal by Subject|1|||
23410388|NCT00705250|65245807|FG000|Overall Study|Patient died in car accident|1|||
23410389|NCT04493424|65245808|FG000|Overall Study|Termination of the trial by the sponsor|89|||
23410390|NCT04493424|65245808|FG000|Overall Study|Withdrawal by Subject|9|||
23410391|NCT04493424|65245808|FG000|Overall Study|Lost to Follow-up|2|||
23410392|NCT04493424|65245808|FG000|Overall Study|Lack of Efficacy|3|||
23410393|NCT04493424|65245808|FG000|Overall Study|Adverse Event|5|||
23410394|NCT01823198|65245809|FG000|Overall Study|Physician Decision|0|||
23410395|NCT01823198|65245810|FG001|Overall Study|Physician Decision|1|||
23410396|NCT01823198|65245811|FG002|Overall Study|Physician Decision|0|||
23410397|NCT01823198|65245812|FG003|Overall Study|Physician Decision|0|||
23410398|NCT01823198|65245813|FG004|Overall Study|Physician Decision|0|||
23410399|NCT01823198|65245814|FG005|Overall Study|Physician Decision|3|||
23410400|NCT01823198|65245815|FG006|Overall Study|Physician Decision|3|||
23410401|NCT03370419|65245818|FG000|Overall Study|Lost to Follow-up|16|||
23511422|NCT01549860|65609338|FG001|Overall Study|Physician Decision|1|||
23410402|NCT03198767|65245820|FG000|Overall Study|Protocol Violation|0|||
23410403|NCT03198767|65245821|FG001|Overall Study|Protocol Violation|0|||
23410404|NCT03198767|65245822|FG002|Overall Study|Protocol Violation|0|||
23410405|NCT03198767|65245823|FG003|Overall Study|Protocol Violation|6|||
23410406|NCT03198767|65245824|FG004|Overall Study|Protocol Violation|0|||
23205185|NCT00492856|64491287|FG002|Induction|Death|0|||
23410407|NCT03198767|65245825|FG005|Overall Study|Protocol Violation|0|||
23410408|NCT03198767|65245826|FG006|Overall Study|Protocol Violation|0|||
23410409|NCT00778336|65245827|FG000|Index Procedure-Discharge|Death|6|||
23410410|NCT00778336|65245828|FG001|Index Procedure-Discharge|Death|3|||
23410411|NCT00778336|65245829|FG002|Index Procedure-Discharge|Death|2|||
23410412|NCT00778336|65245830|FG003|Index Procedure-Discharge|Death|0|||
23410413|NCT00778336|65245827|FG000|3 Month Follow Up|Lost to Follow-up|15|||
23410414|NCT00778336|65245828|FG001|3 Month Follow Up|Lost to Follow-up|20|||
23410415|NCT00778336|65245829|FG002|3 Month Follow Up|Lost to Follow-up|3|||
23410416|NCT00778336|65245830|FG003|3 Month Follow Up|Lost to Follow-up|0|||
23410417|NCT00778336|65245827|FG000|3 Month Follow Up|Death|8|||
23410418|NCT00778336|65245828|FG001|3 Month Follow Up|Death|3|||
23410419|NCT00778336|65245829|FG002|3 Month Follow Up|Death|2|||
23410420|NCT00778336|65245830|FG003|3 Month Follow Up|Death|0|||
23410421|NCT02520388|65245831|FG000|Overall Study|Physician Decision|1|||
23410422|NCT02520388|65245832|FG001|Overall Study|Physician Decision|0|||
23410423|NCT02520388|65245831|FG000|Overall Study|Subject or parent/guardian request|0|||
23410424|NCT02520388|65245832|FG001|Overall Study|Subject or parent/guardian request|6|||
23410425|NCT02520388|65245831|FG000|Overall Study|Adverse Event|1|||
23410426|NCT02520388|65245832|FG001|Overall Study|Adverse Event|4|||
23410427|NCT02520388|65245831|FG000|Overall Study|Lost to Follow-up|3|||
23410428|NCT02520388|65245832|FG001|Overall Study|Lost to Follow-up|2|||
23410429|NCT02520388|65245831|FG000|Overall Study|Other (reason not defined)|4|||
23410430|NCT02520388|65245832|FG001|Overall Study|Other (reason not defined)|4|||
23410431|NCT01713582|65245833|FG000|Overall Study|Disease progression|3|||
23410432|NCT01713582|65245834|FG001|Overall Study|Disease progression|3|||
23410433|NCT01713582|65245835|FG002|Overall Study|Disease progression|3|||
23511423|NCT00450450|65609340|FG000|Overall Study|Death|1|||
23205186|NCT00492856|64491288|FG003|Induction|Death|0|||
23307163|NCT02516553|64870432|FG004|Overall Study|Dose limiting toxicity|3|||
23410434|NCT01713582|65245836|FG003|Overall Study|Disease progression|2|||
23410435|NCT01713582|65245837|FG004|Overall Study|Disease progression|3|||
23410436|NCT01713582|65245838|FG005|Overall Study|Disease progression|3|||
23410437|NCT01713582|65245839|FG006|Overall Study|Disease progression|3|||
23410438|NCT01713582|65245840|FG007|Overall Study|Disease progression|3|||
23410439|NCT01713582|65245841|FG008|Overall Study|Disease progression|3|||
23410440|NCT01713582|65245842|FG009|Overall Study|Disease progression|11|||
23410441|NCT01713582|65245843|FG010|Overall Study|Disease progression|10|||
23410442|NCT01713582|65245844|FG011|Overall Study|Disease progression|5|||
23410443|NCT01713582|65245845|FG012|Overall Study|Disease progression|3|||
23410444|NCT01713582|65245846|FG013|Overall Study|Disease progression|3|||
23410445|NCT01713582|65245847|FG014|Overall Study|Disease progression|6|||
23410446|NCT01713582|65245848|FG015|Overall Study|Disease progression|6|||
23410447|NCT01713582|65245849|FG016|Overall Study|Disease progression|5|||
23410448|NCT01713582|65245850|FG017|Overall Study|Disease progression|2|||
23410449|NCT01713582|65245851|FG018|Overall Study|Disease progression|3|||
23410450|NCT01713582|65245852|FG019|Overall Study|Disease progression|5|||
23410451|NCT01713582|65245853|FG020|Overall Study|Disease progression|15|||
23410452|NCT01713582|65245833|FG000|Overall Study|Death|0|||
23410453|NCT01713582|65245834|FG001|Overall Study|Death|0|||
23410454|NCT01713582|65245835|FG002|Overall Study|Death|0|||
23410455|NCT01713582|65245836|FG003|Overall Study|Death|1|||
23410456|NCT01713582|65245837|FG004|Overall Study|Death|1|||
23410457|NCT01713582|65245838|FG005|Overall Study|Death|3|||
23410458|NCT01713582|65245839|FG006|Overall Study|Death|3|||
23410459|NCT01713582|65245840|FG007|Overall Study|Death|2|||
23410460|NCT01713582|65245841|FG008|Overall Study|Death|3|||
23410461|NCT01713582|65245842|FG009|Overall Study|Death|4|||
23410462|NCT01713582|65245843|FG010|Overall Study|Death|3|||
23410463|NCT01713582|65245844|FG011|Overall Study|Death|0|||
23410464|NCT01713582|65245845|FG012|Overall Study|Death|0|||
23410465|NCT01713582|65245846|FG013|Overall Study|Death|0|||
23410466|NCT01713582|65245847|FG014|Overall Study|Death|0|||
23410467|NCT01713582|65245848|FG015|Overall Study|Death|0|||
23410468|NCT01713582|65245849|FG016|Overall Study|Death|0|||
23410469|NCT01713582|65245850|FG017|Overall Study|Death|0|||
23410470|NCT01713582|65245851|FG018|Overall Study|Death|0|||
23410471|NCT01713582|65245852|FG019|Overall Study|Death|0|||
23410472|NCT01713582|65245853|FG020|Overall Study|Death|0|||
23410473|NCT01713582|65245833|FG000|Overall Study|Adverse event-related|0|||
23410474|NCT01713582|65245834|FG001|Overall Study|Adverse event-related|0|||
23410475|NCT01713582|65245835|FG002|Overall Study|Adverse event-related|0|||
23410476|NCT01713582|65245836|FG003|Overall Study|Adverse event-related|0|||
23410477|NCT01713582|65245837|FG004|Overall Study|Adverse event-related|0|||
23410478|NCT01713582|65245838|FG005|Overall Study|Adverse event-related|0|||
23410479|NCT01713582|65245839|FG006|Overall Study|Adverse event-related|0|||
23410480|NCT01713582|65245840|FG007|Overall Study|Adverse event-related|0|||
23410481|NCT01713582|65245841|FG008|Overall Study|Adverse event-related|0|||
23410482|NCT01713582|65245842|FG009|Overall Study|Adverse event-related|1|||
23410483|NCT01713582|65245843|FG010|Overall Study|Adverse event-related|1|||
23511424|NCT00450450|65609341|FG001|Overall Study|Death|3|||
23511425|NCT00450450|65609340|FG000|Overall Study|Relapse|2|||
23511426|NCT00450450|65609341|FG001|Overall Study|Relapse|0|||
23410484|NCT01713582|65245844|FG011|Overall Study|Adverse event-related|0|||
23410485|NCT01713582|65245845|FG012|Overall Study|Adverse event-related|0|||
23410486|NCT01713582|65245846|FG013|Overall Study|Adverse event-related|0|||
23410487|NCT01713582|65245847|FG014|Overall Study|Adverse event-related|0|||
23410488|NCT01713582|65245848|FG015|Overall Study|Adverse event-related|0|||
23410489|NCT01713582|65245849|FG016|Overall Study|Adverse event-related|0|||
23410490|NCT01713582|65245850|FG017|Overall Study|Adverse event-related|0|||
23410491|NCT01713582|65245851|FG018|Overall Study|Adverse event-related|1|||
23410492|NCT01713582|65245852|FG019|Overall Study|Adverse event-related|0|||
23410493|NCT01713582|65245853|FG020|Overall Study|Adverse event-related|0|||
23410494|NCT01713582|65245833|FG000|Overall Study|Adverse event-unrelated|0|||
23410495|NCT01713582|65245834|FG001|Overall Study|Adverse event-unrelated|0|||
23410496|NCT01713582|65245835|FG002|Overall Study|Adverse event-unrelated|0|||
23410497|NCT01713582|65245836|FG003|Overall Study|Adverse event-unrelated|0|||
23410498|NCT01713582|65245837|FG004|Overall Study|Adverse event-unrelated|0|||
23410499|NCT01713582|65245838|FG005|Overall Study|Adverse event-unrelated|1|||
23410500|NCT01713582|65245839|FG006|Overall Study|Adverse event-unrelated|1|||
23511427|NCT00450450|65609340|FG000|Overall Study|Missing Data|2|||
23511428|NCT00450450|65609341|FG001|Overall Study|Missing Data|0|||
23511429|NCT00085631|65609342|FG000|Overall Study|Missing Data|4|||
23511430|NCT00085631|65609343|FG001|Overall Study|Missing Data|11|||
23511431|NCT00085631|65609344|FG002|Overall Study|Missing Data|7|||
23511432|NCT02373202|65609349|FG000|Overall Study|Adverse Event|2|||
23511433|NCT02373202|65609350|FG001|Overall Study|Adverse Event|5|||
23511434|NCT02373202|65609351|FG002|Overall Study|Adverse Event|2|||
23511435|NCT02373202|65609352|FG003|Overall Study|Adverse Event|1|||
23511436|NCT02373202|65609349|FG000|Overall Study|Lack of Efficacy|0|||
23511437|NCT02373202|65609350|FG001|Overall Study|Lack of Efficacy|0|||
23511438|NCT02373202|65609351|FG002|Overall Study|Lack of Efficacy|1|||
23511439|NCT02373202|65609352|FG003|Overall Study|Lack of Efficacy|0|||
23511440|NCT02373202|65609349|FG000|Overall Study|Other|0|||
23307164|NCT02516553|64870433|FG005|Overall Study|Dose limiting toxicity|1|||
23307165|NCT02516553|64870434|FG006|Overall Study|Dose limiting toxicity|1|||
23307166|NCT02516553|64870435|FG007|Overall Study|Dose limiting toxicity|0|||
23307167|NCT02516553|64870436|FG008|Overall Study|Dose limiting toxicity|1|||
23307168|NCT02516553|64870437|FG009|Overall Study|Dose limiting toxicity|0|||
23307169|NCT02516553|64870438|FG010|Overall Study|Dose limiting toxicity|0|||
23307170|NCT02516553|64870439|FG011|Overall Study|Dose limiting toxicity|1|||
23307171|NCT02516553|64870440|FG012|Overall Study|Dose limiting toxicity|0|||
23307172|NCT02516553|64870441|FG013|Overall Study|Dose limiting toxicity|1|||
23307173|NCT02516553|64870442|FG014|Overall Study|Dose limiting toxicity|0|||
23307174|NCT02516553|64870443|FG015|Overall Study|Dose limiting toxicity|0|||
23307175|NCT02516553|64870444|FG016|Overall Study|Dose limiting toxicity|1|||
23307176|NCT02516553|64870445|FG017|Overall Study|Dose limiting toxicity|1|||
23307177|NCT02516553|64870446|FG018|Overall Study|Dose limiting toxicity|0|||
23307178|NCT02516553|64870447|FG019|Overall Study|Dose limiting toxicity|2|||
23307179|NCT02516553|64870448|FG020|Overall Study|Dose limiting toxicity|0|||
23307180|NCT02516553|64870449|FG021|Overall Study|Dose limiting toxicity|0|||
23307181|NCT02516553|64870428|FG000|Overall Study|Other Adverse Events|0|||
23307182|NCT02516553|64870429|FG001|Overall Study|Other Adverse Events|0|||
23307183|NCT02516553|64870430|FG002|Overall Study|Other Adverse Events|0|||
23307184|NCT02516553|64870431|FG003|Overall Study|Other Adverse Events|1|||
23307185|NCT02516553|64870432|FG004|Overall Study|Other Adverse Events|0|||
23307186|NCT02516553|64870433|FG005|Overall Study|Other Adverse Events|1|||
23307187|NCT02516553|64870434|FG006|Overall Study|Other Adverse Events|0|||
23307188|NCT02516553|64870435|FG007|Overall Study|Other Adverse Events|0|||
23307189|NCT02516553|64870436|FG008|Overall Study|Other Adverse Events|0|||
23307190|NCT02516553|64870437|FG009|Overall Study|Other Adverse Events|1|||
23307191|NCT02516553|64870438|FG010|Overall Study|Other Adverse Events|3|||
23307192|NCT02516553|64870439|FG011|Overall Study|Other Adverse Events|2|||
23307193|NCT02516553|64870440|FG012|Overall Study|Other Adverse Events|0|||
23307194|NCT02516553|64870441|FG013|Overall Study|Other Adverse Events|1|||
23307195|NCT02516553|64870442|FG014|Overall Study|Other Adverse Events|0|||
23307196|NCT02516553|64870443|FG015|Overall Study|Other Adverse Events|0|||
23307197|NCT02516553|64870444|FG016|Overall Study|Other Adverse Events|0|||
23307198|NCT02516553|64870445|FG017|Overall Study|Other Adverse Events|2|||
23307199|NCT02516553|64870446|FG018|Overall Study|Other Adverse Events|1|||
23307200|NCT02516553|64870447|FG019|Overall Study|Other Adverse Events|2|||
23307201|NCT02516553|64870448|FG020|Overall Study|Other Adverse Events|2|||
23307202|NCT02516553|64870449|FG021|Overall Study|Other Adverse Events|1|||
23307203|NCT02516553|64870428|FG000|Overall Study|Refused to continue trial medication|0|||
23307204|NCT02516553|64870429|FG001|Overall Study|Refused to continue trial medication|0|||
23307205|NCT02516553|64870430|FG002|Overall Study|Refused to continue trial medication|0|||
23307206|NCT02516553|64870431|FG003|Overall Study|Refused to continue trial medication|0|||
23307207|NCT02516553|64870432|FG004|Overall Study|Refused to continue trial medication|0|||
23307208|NCT02516553|64870433|FG005|Overall Study|Refused to continue trial medication|0|||
23307209|NCT02516553|64870434|FG006|Overall Study|Refused to continue trial medication|0|||
23307210|NCT02516553|64870435|FG007|Overall Study|Refused to continue trial medication|0|||
23307211|NCT02516553|64870436|FG008|Overall Study|Refused to continue trial medication|0|||
23410501|NCT01713582|65245840|FG007|Overall Study|Adverse event-unrelated|1|||
23410502|NCT01713582|65245841|FG008|Overall Study|Adverse event-unrelated|0|||
23410503|NCT01713582|65245842|FG009|Overall Study|Adverse event-unrelated|0|||
23511441|NCT02373202|65609350|FG001|Overall Study|Other|1|||
23410504|NCT01713582|65245843|FG010|Overall Study|Adverse event-unrelated|0|||
23410505|NCT01713582|65245844|FG011|Overall Study|Adverse event-unrelated|0|||
23410506|NCT01713582|65245845|FG012|Overall Study|Adverse event-unrelated|0|||
23410507|NCT01713582|65245846|FG013|Overall Study|Adverse event-unrelated|1|||
23410508|NCT01713582|65245847|FG014|Overall Study|Adverse event-unrelated|1|||
23410509|NCT01713582|65245848|FG015|Overall Study|Adverse event-unrelated|0|||
23410510|NCT01713582|65245849|FG016|Overall Study|Adverse event-unrelated|0|||
23410511|NCT01713582|65245850|FG017|Overall Study|Adverse event-unrelated|0|||
23410512|NCT01713582|65245851|FG018|Overall Study|Adverse event-unrelated|0|||
23410513|NCT01713582|65245852|FG019|Overall Study|Adverse event-unrelated|0|||
23410514|NCT01713582|65245853|FG020|Overall Study|Adverse event-unrelated|0|||
23410515|NCT01713582|65245833|FG000|Overall Study|Withdrawal of consent|0|||
23307212|NCT02516553|64870437|FG009|Overall Study|Refused to continue trial medication|0|||
23307213|NCT02516553|64870438|FG010|Overall Study|Refused to continue trial medication|1|||
23307214|NCT02516553|64870439|FG011|Overall Study|Refused to continue trial medication|0|||
23307215|NCT02516553|64870440|FG012|Overall Study|Refused to continue trial medication|0|||
23307216|NCT02516553|64870441|FG013|Overall Study|Refused to continue trial medication|0|||
23307217|NCT02516553|64870442|FG014|Overall Study|Refused to continue trial medication|0|||
23307218|NCT02516553|64870443|FG015|Overall Study|Refused to continue trial medication|0|||
23307219|NCT02516553|64870444|FG016|Overall Study|Refused to continue trial medication|0|||
23307220|NCT02516553|64870445|FG017|Overall Study|Refused to continue trial medication|0|||
23307221|NCT02516553|64870446|FG018|Overall Study|Refused to continue trial medication|1|||
23307222|NCT02516553|64870447|FG019|Overall Study|Refused to continue trial medication|0|||
23307223|NCT02516553|64870448|FG020|Overall Study|Refused to continue trial medication|0|||
23307224|NCT02516553|64870449|FG021|Overall Study|Refused to continue trial medication|1|||
23307225|NCT02516553|64870428|FG000|Overall Study|other reasons than listed|0|||
23307226|NCT02516553|64870429|FG001|Overall Study|other reasons than listed|0|||
23307227|NCT02516553|64870430|FG002|Overall Study|other reasons than listed|0|||
23307228|NCT02516553|64870431|FG003|Overall Study|other reasons than listed|0|||
23307229|NCT02516553|64870432|FG004|Overall Study|other reasons than listed|0|||
23307230|NCT02516553|64870433|FG005|Overall Study|other reasons than listed|0|||
23307231|NCT02516553|64870434|FG006|Overall Study|other reasons than listed|0|||
23307232|NCT02516553|64870435|FG007|Overall Study|other reasons than listed|1|||
23307233|NCT02516553|64870436|FG008|Overall Study|other reasons than listed|1|||
23307234|NCT02516553|64870437|FG009|Overall Study|other reasons than listed|0|||
23307235|NCT02516553|64870438|FG010|Overall Study|other reasons than listed|1|||
23307236|NCT02516553|64870439|FG011|Overall Study|other reasons than listed|1|||
23307237|NCT02516553|64870440|FG012|Overall Study|other reasons than listed|0|||
23307238|NCT02516553|64870441|FG013|Overall Study|other reasons than listed|0|||
23307239|NCT02516553|64870442|FG014|Overall Study|other reasons than listed|0|||
23307240|NCT02516553|64870443|FG015|Overall Study|other reasons than listed|0|||
23307241|NCT02516553|64870444|FG016|Overall Study|other reasons than listed|0|||
23307242|NCT02516553|64870445|FG017|Overall Study|other reasons than listed|0|||
23307243|NCT02516553|64870446|FG018|Overall Study|other reasons than listed|0|||
23307244|NCT02516553|64870447|FG019|Overall Study|other reasons than listed|0|||
23307245|NCT02516553|64870448|FG020|Overall Study|other reasons than listed|2|||
23307246|NCT02516553|64870449|FG021|Overall Study|other reasons than listed|2|||
23307247|NCT00160641|64870452|FG000|Overall Study|Adverse Event|102|||
23307248|NCT00160641|64870452|FG000|Overall Study|Withdrawal by Subject|87|||
23307249|NCT00160641|64870452|FG000|Overall Study|Lost to Follow-up|8|||
23307250|NCT00160641|64870452|FG000|Overall Study|Lack of Efficacy|12|||
23307251|NCT00160641|64870452|FG000|Overall Study|Protocol Violation|3|||
23307252|NCT00160641|64870452|FG000|Overall Study|Other|9|||
23340851|NCT01936181|64992872|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
23410516|NCT01713582|65245834|FG001|Overall Study|Withdrawal of consent|0|||
23205187|NCT00492856|64491285|FG000|Consolidation|Adverse Event|6|||
23410517|NCT01713582|65245835|FG002|Overall Study|Withdrawal of consent|1|||
23410518|NCT01713582|65245836|FG003|Overall Study|Withdrawal of consent|0|||
23410519|NCT01713582|65245837|FG004|Overall Study|Withdrawal of consent|0|||
23410520|NCT01713582|65245838|FG005|Overall Study|Withdrawal of consent|1|||
23410521|NCT01713582|65245839|FG006|Overall Study|Withdrawal of consent|0|||
23410522|NCT01713582|65245840|FG007|Overall Study|Withdrawal of consent|0|||
23410523|NCT01713582|65245841|FG008|Overall Study|Withdrawal of consent|0|||
23410524|NCT01713582|65245842|FG009|Overall Study|Withdrawal of consent|1|||
23410525|NCT01713582|65245843|FG010|Overall Study|Withdrawal of consent|0|||
23410526|NCT01713582|65245844|FG011|Overall Study|Withdrawal of consent|0|||
23410527|NCT01713582|65245845|FG012|Overall Study|Withdrawal of consent|0|||
23410528|NCT01713582|65245846|FG013|Overall Study|Withdrawal of consent|0|||
23410529|NCT01713582|65245847|FG014|Overall Study|Withdrawal of consent|0|||
23410530|NCT01713582|65245848|FG015|Overall Study|Withdrawal of consent|0|||
23511442|NCT02373202|65609351|FG002|Overall Study|Other|0|||
23511443|NCT02373202|65609352|FG003|Overall Study|Other|0|||
23410531|NCT01713582|65245849|FG016|Overall Study|Withdrawal of consent|0|||
23410532|NCT01713582|65245850|FG017|Overall Study|Withdrawal of consent|0|||
23511444|NCT01170091|65609353|FG000|Overall Study|Missing efficacy evaluation|3|||
23205188|NCT00492856|64491286|FG001|Consolidation|Adverse Event|0|||
23410533|NCT01713582|65245851|FG018|Overall Study|Withdrawal of consent|1|||
23410534|NCT01713582|65245852|FG019|Overall Study|Withdrawal of consent|0|||
23410535|NCT01713582|65245853|FG020|Overall Study|Withdrawal of consent|0|||
23410536|NCT01713582|65245833|FG000|Overall Study|Lack of Efficacy|0|||
23410537|NCT01713582|65245834|FG001|Overall Study|Lack of Efficacy|0|||
23410538|NCT01713582|65245835|FG002|Overall Study|Lack of Efficacy|0|||
23410539|NCT01713582|65245836|FG003|Overall Study|Lack of Efficacy|0|||
23410540|NCT01713582|65245837|FG004|Overall Study|Lack of Efficacy|0|||
23410541|NCT01713582|65245838|FG005|Overall Study|Lack of Efficacy|0|||
23410542|NCT01713582|65245839|FG006|Overall Study|Lack of Efficacy|0|||
23410543|NCT01713582|65245840|FG007|Overall Study|Lack of Efficacy|0|||
23410544|NCT01713582|65245841|FG008|Overall Study|Lack of Efficacy|0|||
23410545|NCT01713582|65245842|FG009|Overall Study|Lack of Efficacy|1|||
23410546|NCT01713582|65245843|FG010|Overall Study|Lack of Efficacy|2|||
23410547|NCT01713582|65245844|FG011|Overall Study|Lack of Efficacy|0|||
23410548|NCT01713582|65245845|FG012|Overall Study|Lack of Efficacy|0|||
23410549|NCT01713582|65245846|FG013|Overall Study|Lack of Efficacy|0|||
23410550|NCT01713582|65245847|FG014|Overall Study|Lack of Efficacy|0|||
23410551|NCT01713582|65245848|FG015|Overall Study|Lack of Efficacy|0|||
23410552|NCT01713582|65245849|FG016|Overall Study|Lack of Efficacy|0|||
23410553|NCT01713582|65245850|FG017|Overall Study|Lack of Efficacy|0|||
23410554|NCT01713582|65245851|FG018|Overall Study|Lack of Efficacy|0|||
23410555|NCT01713582|65245852|FG019|Overall Study|Lack of Efficacy|0|||
23410556|NCT01713582|65245853|FG020|Overall Study|Lack of Efficacy|0|||
23410557|NCT01713582|65245833|FG000|Overall Study|Withdrawal by Subject|0|||
23410558|NCT01713582|65245834|FG001|Overall Study|Withdrawal by Subject|0|||
23410559|NCT01713582|65245835|FG002|Overall Study|Withdrawal by Subject|0|||
23410560|NCT01713582|65245836|FG003|Overall Study|Withdrawal by Subject|0|||
23410561|NCT01713582|65245837|FG004|Overall Study|Withdrawal by Subject|0|||
23410562|NCT01713582|65245838|FG005|Overall Study|Withdrawal by Subject|0|||
23410563|NCT01713582|65245839|FG006|Overall Study|Withdrawal by Subject|0|||
23410564|NCT01713582|65245840|FG007|Overall Study|Withdrawal by Subject|0|||
23410565|NCT01713582|65245841|FG008|Overall Study|Withdrawal by Subject|0|||
23410566|NCT01713582|65245842|FG009|Overall Study|Withdrawal by Subject|0|||
23410567|NCT01713582|65245843|FG010|Overall Study|Withdrawal by Subject|0|||
23410568|NCT01713582|65245844|FG011|Overall Study|Withdrawal by Subject|0|||
23410569|NCT01713582|65245845|FG012|Overall Study|Withdrawal by Subject|0|||
23410570|NCT01713582|65245846|FG013|Overall Study|Withdrawal by Subject|0|||
23410571|NCT01713582|65245847|FG014|Overall Study|Withdrawal by Subject|0|||
23410572|NCT01713582|65245848|FG015|Overall Study|Withdrawal by Subject|0|||
23410573|NCT01713582|65245849|FG016|Overall Study|Withdrawal by Subject|0|||
23410574|NCT01713582|65245850|FG017|Overall Study|Withdrawal by Subject|1|||
23410575|NCT01713582|65245851|FG018|Overall Study|Withdrawal by Subject|0|||
23410576|NCT01713582|65245852|FG019|Overall Study|Withdrawal by Subject|0|||
23307253|NCT04771403|64870453|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
23307254|NCT04771403|64870454|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
23307255|NCT04771403|64870453|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
23307256|NCT04771403|64870454|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
23307257|NCT04771403|64870453|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
23307258|NCT04771403|64870454|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
23307259|NCT04771403|64870453|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
23307260|NCT04771403|64870454|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
23410577|NCT01713582|65245853|FG020|Overall Study|Withdrawal by Subject|0|||
23410578|NCT01713582|65245833|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
23410579|NCT01713582|65245834|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
23410580|NCT01713582|65245835|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
23410581|NCT01713582|65245836|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
23410582|NCT01713582|65245837|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
23410583|NCT01713582|65245838|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
23410584|NCT01713582|65245839|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
23610579|NCT02676778|65962811|FG002|Overall Study|Disease Progression|1|||
23610580|NCT02676778|65962809|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
23610581|NCT02676778|65962810|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
23610582|NCT02676778|65962811|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
23410585|NCT01713582|65245840|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
23410586|NCT01713582|65245841|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
23410587|NCT01713582|65245842|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
23410588|NCT01713582|65245843|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
23410589|NCT01713582|65245844|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
23410590|NCT01713582|65245845|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
23410591|NCT01713582|65245846|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
23410592|NCT01713582|65245847|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
23410593|NCT01713582|65245848|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
23410594|NCT01713582|65245849|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
23410595|NCT01713582|65245850|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
23410596|NCT01713582|65245851|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
23410597|NCT01713582|65245852|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
23410598|NCT01713582|65245853|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
23410599|NCT01713582|65245833|FG000|Overall Study|Disease progression and adverse event|0|||
23410600|NCT01713582|65245834|FG001|Overall Study|Disease progression and adverse event|0|||
23410601|NCT01713582|65245835|FG002|Overall Study|Disease progression and adverse event|0|||
23410602|NCT01713582|65245836|FG003|Overall Study|Disease progression and adverse event|0|||
23410603|NCT01713582|65245837|FG004|Overall Study|Disease progression and adverse event|0|||
23410604|NCT01713582|65245838|FG005|Overall Study|Disease progression and adverse event|0|||
23410605|NCT01713582|65245839|FG006|Overall Study|Disease progression and adverse event|0|||
23410606|NCT01713582|65245840|FG007|Overall Study|Disease progression and adverse event|0|||
23410607|NCT01713582|65245841|FG008|Overall Study|Disease progression and adverse event|0|||
23410608|NCT01713582|65245842|FG009|Overall Study|Disease progression and adverse event|0|||
23410609|NCT01713582|65245843|FG010|Overall Study|Disease progression and adverse event|0|||
23410610|NCT01713582|65245844|FG011|Overall Study|Disease progression and adverse event|0|||
23410611|NCT01713582|65245845|FG012|Overall Study|Disease progression and adverse event|0|||
23410612|NCT01713582|65245846|FG013|Overall Study|Disease progression and adverse event|0|||
23410613|NCT01713582|65245847|FG014|Overall Study|Disease progression and adverse event|0|||
23410614|NCT01713582|65245848|FG015|Overall Study|Disease progression and adverse event|0|||
23410615|NCT01713582|65245849|FG016|Overall Study|Disease progression and adverse event|1|||
23410616|NCT01713582|65245850|FG017|Overall Study|Disease progression and adverse event|0|||
23410617|NCT01713582|65245851|FG018|Overall Study|Disease progression and adverse event|0|||
23410618|NCT01713582|65245852|FG019|Overall Study|Disease progression and adverse event|0|||
23410619|NCT01713582|65245853|FG020|Overall Study|Disease progression and adverse event|0|||
23410620|NCT02147197|65245854|FG000|Overall Study|Adverse Event|1|||
23410621|NCT02147197|65245855|FG001|Overall Study|Adverse Event|0|||
23410622|NCT02147197|65245856|FG002|Overall Study|Adverse Event|0|||
23410623|NCT02147197|65245854|FG000|Overall Study|Withdrawal of Consent|4|||
23410624|NCT02147197|65245855|FG001|Overall Study|Withdrawal of Consent|3|||
23410625|NCT02147197|65245856|FG002|Overall Study|Withdrawal of Consent|2|||
23410626|NCT02147197|65245854|FG000|Overall Study|Lost to Follow-up|2|||
23410627|NCT02147197|65245855|FG001|Overall Study|Lost to Follow-up|3|||
23410628|NCT02147197|65245856|FG002|Overall Study|Lost to Follow-up|1|||
23410629|NCT02147197|65245854|FG000|Overall Study|Protocol Violation|1|||
23410630|NCT02147197|65245855|FG001|Overall Study|Protocol Violation|0|||
23410631|NCT02147197|65245856|FG002|Overall Study|Protocol Violation|3|||
23410632|NCT02147197|65245854|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23410633|NCT02147197|65245855|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23410634|NCT02147197|65245856|FG002|Overall Study|Other Miscellaneous Reasons|3|||
23410635|NCT01534351|65245857|FG000|Overall Study|Study Terminated Early|1|||
23410636|NCT01534351|65245858|FG001|Overall Study|Study Terminated Early|0|||
23410637|NCT01534351|65245859|FG002|Overall Study|Study Terminated Early|0|||
23410638|NCT02097719|65248870|FG000|Overall Study|Subject Withdrew Consent|1|||
23410639|NCT02097719|65248871|FG001|Overall Study|Subject Withdrew Consent|0|||
23410640|NCT02097719|65248870|FG000|Overall Study|Lost to Follow-up|0|||
23410641|NCT02097719|65248871|FG001|Overall Study|Lost to Follow-up|1|||
23410642|NCT02097719|65248870|FG000|Overall Study|Adverse Event|2|||
23410643|NCT02097719|65248871|FG001|Overall Study|Adverse Event|0|||
23410644|NCT02323126|65248872|FG000|Overall Study|Patient / guardian decision|0|||
23410645|NCT02323126|65248873|FG001|Overall Study|Patient / guardian decision|1|||
23410646|NCT02323126|65248874|FG002|Overall Study|Patient / guardian decision|2|||
23410647|NCT02323126|65248872|FG000|Overall Study|Progressive disease|14|||
23410648|NCT02323126|65248873|FG001|Overall Study|Progressive disease|8|||
23410649|NCT02323126|65248874|FG002|Overall Study|Progressive disease|14|||
23410650|NCT02323126|65248872|FG000|Overall Study|Physician Decision|0|||
23410651|NCT02323126|65248873|FG001|Overall Study|Physician Decision|1|||
23410652|NCT02323126|65248874|FG002|Overall Study|Physician Decision|3|||
23410653|NCT02323126|65248872|FG000|Overall Study|Death|1|||
23410654|NCT02323126|65248873|FG001|Overall Study|Death|1|||
23410655|NCT02323126|65248874|FG002|Overall Study|Death|4|||
23410656|NCT02323126|65248872|FG000|Overall Study|Adverse Event|3|||
23410657|NCT02323126|65248873|FG001|Overall Study|Adverse Event|5|||
23410658|NCT02323126|65248874|FG002|Overall Study|Adverse Event|7|||
23410659|NCT00783835|65248875|FG000|Overall Study|Adverse Event|3|||
23410660|NCT00783835|65248875|FG000|Overall Study|Medical Criteria|1|||
23410661|NCT00783835|65248875|FG000|Overall Study|Withdrawal by Subject|2|||
23410662|NCT00783835|65248875|FG000|Overall Study|Lost to Follow-up|1|||
23410663|NCT00783835|65248875|FG000|Overall Study|Participant not Adherent|3|||
23410664|NCT01463696|65248878|FG000|Overall Study|Adverse Event|0|||
23410665|NCT01463696|65248879|FG001|Overall Study|Adverse Event|1|||
23410666|NCT01463696|65248880|FG002|Overall Study|Adverse Event|0|||
23410667|NCT01463696|65248881|FG003|Overall Study|Adverse Event|2|||
23410668|NCT01463696|65248882|FG004|Overall Study|Adverse Event|0|||
23410669|NCT01463696|65248883|FG005|Overall Study|Adverse Event|1|||
23410670|NCT01463696|65248884|FG006|Overall Study|Adverse Event|3|||
23410671|NCT01463696|65248885|FG007|Overall Study|Adverse Event|2|||
23410672|NCT01463696|65248878|FG000|Overall Study|Lost to Follow-up|0|||
23410673|NCT01463696|65248879|FG001|Overall Study|Lost to Follow-up|0|||
23410674|NCT01463696|65248880|FG002|Overall Study|Lost to Follow-up|1|||
23410675|NCT01463696|65248881|FG003|Overall Study|Lost to Follow-up|0|||
23410676|NCT01463696|65248882|FG004|Overall Study|Lost to Follow-up|0|||
23410677|NCT01463696|65248883|FG005|Overall Study|Lost to Follow-up|0|||
23410678|NCT01463696|65248884|FG006|Overall Study|Lost to Follow-up|0|||
23410679|NCT01463696|65248885|FG007|Overall Study|Lost to Follow-up|0|||
23410680|NCT01463696|65248878|FG000|Overall Study|Progressive Disease|0|||
23410681|NCT01463696|65248879|FG001|Overall Study|Progressive Disease|1|||
23410682|NCT01463696|65248880|FG002|Overall Study|Progressive Disease|0|||
23410683|NCT01463696|65248881|FG003|Overall Study|Progressive Disease|1|||
23410684|NCT01463696|65248882|FG004|Overall Study|Progressive Disease|0|||
23410685|NCT01463696|65248883|FG005|Overall Study|Progressive Disease|1|||
23410686|NCT01463696|65248884|FG006|Overall Study|Progressive Disease|4|||
23410687|NCT01463696|65248885|FG007|Overall Study|Progressive Disease|2|||
23410688|NCT01463696|65248878|FG000|Overall Study|Withdrawal by Subject|0|||
23410689|NCT01463696|65248879|FG001|Overall Study|Withdrawal by Subject|0|||
23410690|NCT01463696|65248880|FG002|Overall Study|Withdrawal by Subject|0|||
23410691|NCT01463696|65248881|FG003|Overall Study|Withdrawal by Subject|1|||
23410692|NCT01463696|65248882|FG004|Overall Study|Withdrawal by Subject|1|||
23410693|NCT01463696|65248883|FG005|Overall Study|Withdrawal by Subject|1|||
23410694|NCT01463696|65248884|FG006|Overall Study|Withdrawal by Subject|2|||
23410695|NCT01463696|65248885|FG007|Overall Study|Withdrawal by Subject|0|||
23410696|NCT01463696|65248878|FG000|Overall Study|Not Treated|0|||
23410697|NCT01463696|65248879|FG001|Overall Study|Not Treated|0|||
23410698|NCT01463696|65248880|FG002|Overall Study|Not Treated|0|||
23410699|NCT01463696|65248881|FG003|Overall Study|Not Treated|0|||
23410700|NCT01463696|65248882|FG004|Overall Study|Not Treated|0|||
23410701|NCT01463696|65248883|FG005|Overall Study|Not Treated|0|||
23410702|NCT01463696|65248884|FG006|Overall Study|Not Treated|1|||
23410703|NCT01463696|65248885|FG007|Overall Study|Not Treated|0|||
23410704|NCT01169701|65248886|FG000|Overall Study|Lost to Follow-up|1|||
23410705|NCT01169701|65248887|FG001|Overall Study|Lost to Follow-up|1|||
23410706|NCT01169701|65248886|FG000|Overall Study|Withdrawal by Subject|1|||
23410707|NCT01169701|65248887|FG001|Overall Study|Withdrawal by Subject|3|||
23410708|NCT01169701|65248886|FG000|Overall Study|Adverse Event|1|||
23410709|NCT01169701|65248887|FG001|Overall Study|Adverse Event|2|||
23410710|NCT01169701|65248886|FG000|Overall Study|Exclusion criteria|2|||
23410711|NCT01169701|65248887|FG001|Overall Study|Exclusion criteria|0|||
23410712|NCT01169701|65248886|FG000|Overall Study|Death|0|||
23410713|NCT01169701|65248887|FG001|Overall Study|Death|1|||
23410714|NCT01169701|65248886|FG000|Overall Study|Administrative problems|0|||
23410715|NCT01169701|65248887|FG001|Overall Study|Administrative problems|1|||
23410716|NCT01169701|65248886|FG000|Overall Study|Serious adverse event|0|||
23410717|NCT01169701|65248887|FG001|Overall Study|Serious adverse event|1|||
23410718|NCT01169701|65248886|FG000|Overall Study|Sponsor decision|0|||
23410719|NCT01169701|65248887|FG001|Overall Study|Sponsor decision|1|||
23410720|NCT02314156|65248889|FG000|Overall Study|Adverse Event|1|||
23511445|NCT01170091|65609353|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
23511446|NCT02485574|65609354|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
23410721|NCT02314156|65248890|FG001|Overall Study|Adverse Event|0|||
23410722|NCT02314156|65248889|FG000|Overall Study|Withdrawal by Subject|1|||
23410723|NCT02314156|65248890|FG001|Overall Study|Withdrawal by Subject|0|||
23410724|NCT02644096|65248893|FG000|Overall Study|Withdrawal by Subject|28|||
23410725|NCT02644096|65248894|FG001|Overall Study|Withdrawal by Subject|25|||
23410726|NCT02342288|65248895|FG000|Overall Study|no protocol anesthesiologist available|3|||
23410727|NCT02342288|65248896|FG001|Overall Study|no protocol anesthesiologist available|2|||
23410728|NCT02342288|65248895|FG000|Overall Study|anesthesia leak in system|1|||
23410729|NCT02342288|65248896|FG001|Overall Study|anesthesia leak in system|0|||
23410730|NCT02342288|65248895|FG000|Overall Study|Withdrawal by Subject|1|||
23410731|NCT02342288|65248896|FG001|Overall Study|Withdrawal by Subject|0|||
23410732|NCT02342288|65248895|FG000|Overall Study|coordinator contaminated with blood|0|||
23410733|NCT02342288|65248896|FG001|Overall Study|coordinator contaminated with blood|1|||
23410734|NCT02342288|65248895|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
23410735|NCT02342288|65248896|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
23410736|NCT02342288|65248895|FG000|Overall Study|coordinator not available|0|||
23410737|NCT02342288|65248896|FG001|Overall Study|coordinator not available|2|||
23410738|NCT03820986|65248898|FG000|Overall Study|Death|177|||
23410739|NCT03820986|65248899|FG001|Overall Study|Death|156|||
23410740|NCT03820986|65248898|FG000|Overall Study|Lost to Follow-up|0|||
23410741|NCT03820986|65248899|FG001|Overall Study|Lost to Follow-up|1|||
23410742|NCT03820986|65248898|FG000|Overall Study|Withdrawal by Subject|8|||
23410743|NCT03820986|65248899|FG001|Overall Study|Withdrawal by Subject|3|||
23410744|NCT03820986|65248898|FG000|Overall Study|Ongoing|149|||
23410745|NCT03820986|65248899|FG001|Overall Study|Ongoing|180|||
23410746|NCT00182078|65248900|FG000|Overall Study|Withdrawal by Subject|1|||
23410747|NCT00182078|65248901|FG001|Overall Study|Withdrawal by Subject|0|||
23410748|NCT02297815|65248906|FG000|Overall Study|Lost to Follow-up|236|||
23410749|NCT02297815|65248907|FG001|Overall Study|Lost to Follow-up|140|||
23410750|NCT02817594|65248910|FG000|Overall Study|Withdrawal by Subject|1|||
23410751|NCT02817594|65248910|FG000|Overall Study|Other|1|||
23410752|NCT02817594|65248910|FG000|Overall Study|Did Not Receive Treatment|1|||
23410753|NCT00293813|65248911|FG000|Overall Study|Physician Decision|0|||
23410754|NCT00293813|65248912|FG001|Overall Study|Physician Decision|1|||
23410755|NCT00293813|65248913|FG002|Overall Study|Physician Decision|0|||
23410756|NCT00293813|65248911|FG000|Overall Study|Adverse Event|3|||
23410757|NCT00293813|65248912|FG001|Overall Study|Adverse Event|1|||
23410758|NCT00293813|65248913|FG002|Overall Study|Adverse Event|1|||
23410759|NCT00293813|65248911|FG000|Overall Study|Withdrawal by Subject|7|||
23410760|NCT00293813|65248912|FG001|Overall Study|Withdrawal by Subject|4|||
23410761|NCT00293813|65248913|FG002|Overall Study|Withdrawal by Subject|4|||
23410762|NCT00293813|65248911|FG000|Overall Study|Lost to Follow-up|3|||
23410763|NCT00293813|65248912|FG001|Overall Study|Lost to Follow-up|2|||
23410764|NCT00293813|65248913|FG002|Overall Study|Lost to Follow-up|3|||
23410765|NCT00293813|65248911|FG000|Overall Study|Noncompliance|0|||
23410766|NCT00293813|65248912|FG001|Overall Study|Noncompliance|1|||
23410767|NCT00293813|65248913|FG002|Overall Study|Noncompliance|0|||
23410768|NCT01061723|65248914|FG000|Overall Study|Adverse Event|0|||
23410769|NCT01061723|65248915|FG001|Overall Study|Adverse Event|2|||
23410770|NCT01061723|65248916|FG002|Overall Study|Adverse Event|5|||
23410771|NCT01061723|65248917|FG003|Overall Study|Adverse Event|5|||
23410772|NCT01061723|65248918|FG004|Overall Study|Adverse Event|2|||
23410773|NCT01061723|65248919|FG005|Overall Study|Adverse Event|6|||
23410774|NCT01061723|65248914|FG000|Overall Study|Lack of Efficacy|2|||
23410775|NCT01061723|65248915|FG001|Overall Study|Lack of Efficacy|3|||
23410776|NCT01061723|65248916|FG002|Overall Study|Lack of Efficacy|4|||
23410777|NCT01061723|65248917|FG003|Overall Study|Lack of Efficacy|2|||
23410778|NCT01061723|65248918|FG004|Overall Study|Lack of Efficacy|1|||
23410779|NCT01061723|65248919|FG005|Overall Study|Lack of Efficacy|1|||
23410780|NCT01061723|65248914|FG000|Overall Study|Randomized but not treated|0|||
23410781|NCT01061723|65248915|FG001|Overall Study|Randomized but not treated|0|||
23410782|NCT01061723|65248916|FG002|Overall Study|Randomized but not treated|0|||
23410783|NCT01061723|65248917|FG003|Overall Study|Randomized but not treated|0|||
23410784|NCT01061723|65248918|FG004|Overall Study|Randomized but not treated|0|||
23410785|NCT01061723|65248919|FG005|Overall Study|Randomized but not treated|1|||
23410786|NCT01061723|65248914|FG000|Overall Study|Other than specified above|2|||
23410787|NCT01061723|65248915|FG001|Overall Study|Other than specified above|1|||
23410788|NCT01061723|65248916|FG002|Overall Study|Other than specified above|1|||
23410789|NCT01061723|65248917|FG003|Overall Study|Other than specified above|1|||
23410790|NCT01061723|65248918|FG004|Overall Study|Other than specified above|0|||
23410791|NCT01061723|65248919|FG005|Overall Study|Other than specified above|1|||
23410792|NCT03726658|65248920|FG000|Overall Study|Lost to Follow-up|0|||
23410793|NCT03726658|65248921|FG001|Overall Study|Lost to Follow-up|0|||
23410794|NCT03726658|65248922|FG002|Overall Study|Lost to Follow-up|2|||
23410795|NCT03726658|65248923|FG003|Overall Study|Lost to Follow-up|0|||
23410796|NCT03726658|65248924|FG004|Overall Study|Lost to Follow-up|0|||
23410797|NCT03726658|65248925|FG005|Overall Study|Lost to Follow-up|1|||
23410798|NCT03726658|65248926|FG006|Overall Study|Lost to Follow-up|1|||
23410799|NCT03726658|65248920|FG000|Overall Study|Withdrawal by Subject|1|||
23410800|NCT03726658|65248921|FG001|Overall Study|Withdrawal by Subject|0|||
23410801|NCT03726658|65248922|FG002|Overall Study|Withdrawal by Subject|0|||
23410802|NCT03726658|65248923|FG003|Overall Study|Withdrawal by Subject|0|||
23410803|NCT03726658|65248924|FG004|Overall Study|Withdrawal by Subject|6|||
23410804|NCT03726658|65248925|FG005|Overall Study|Withdrawal by Subject|4|||
23410805|NCT03726658|65248926|FG006|Overall Study|Withdrawal by Subject|2|||
23410806|NCT03726658|65248920|FG000|Overall Study|Pregnancy|0|||
23410807|NCT03726658|65248921|FG001|Overall Study|Pregnancy|0|||
23410808|NCT03726658|65248922|FG002|Overall Study|Pregnancy|0|||
23410809|NCT03726658|65248923|FG003|Overall Study|Pregnancy|0|||
23410810|NCT03726658|65248924|FG004|Overall Study|Pregnancy|0|||
23410811|NCT03726658|65248925|FG005|Overall Study|Pregnancy|0|||
23410812|NCT03726658|65248926|FG006|Overall Study|Pregnancy|1|||
23410813|NCT03726658|65248920|FG000|Overall Study|Not Reported|0|||
23410814|NCT03726658|65248921|FG001|Overall Study|Not Reported|0|||
23410815|NCT03726658|65248922|FG002|Overall Study|Not Reported|0|||
23410816|NCT03726658|65248923|FG003|Overall Study|Not Reported|0|||
23410817|NCT03726658|65248924|FG004|Overall Study|Not Reported|0|||
23307261|NCT04771403|64870453|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
23307262|NCT04771403|64870454|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
23410818|NCT03726658|65248925|FG005|Overall Study|Not Reported|0|||
23410819|NCT03726658|65248926|FG006|Overall Study|Not Reported|1|||
23410820|NCT00260832|65248927|FG000|Overall Study|Adverse Event|26|||
23410821|NCT00260832|65248928|FG001|Overall Study|Adverse Event|19|||
23410822|NCT00260832|65248927|FG000|Overall Study|Progression|116|||
23410823|NCT00260832|65248928|FG001|Overall Study|Progression|96|||
23410824|NCT00260832|65248927|FG000|Overall Study|Withdrawal by Subject|15|||
23410825|NCT00260832|65248928|FG001|Overall Study|Withdrawal by Subject|17|||
23410826|NCT00260832|65248927|FG000|Overall Study|Physician Decision|15|||
23410827|NCT00260832|65248928|FG001|Overall Study|Physician Decision|9|||
23410828|NCT00260832|65248927|FG000|Overall Study|Death|43|||
23410829|NCT00260832|65248928|FG001|Overall Study|Death|62|||
23410830|NCT00260832|65248927|FG000|Overall Study|Other|10|||
23410831|NCT00260832|65248928|FG001|Overall Study|Other|7|||
23410832|NCT00260832|65248927|FG000|Overall Study|Protocol Violation|3|||
23410833|NCT00260832|65248928|FG001|Overall Study|Protocol Violation|1|||
23410834|NCT00851552|65248929|FG000|Overall Study|Death|2|||
23410835|NCT00851552|65248929|FG000|Overall Study|Adverse Event|1|||
23410836|NCT00851552|65248929|FG000|Overall Study|Disease Progression|4|||
23410837|NCT02982772|65248930|FG000|Intervention|Lost to Follow-up|19|||
23410838|NCT02982772|65248931|FG001|Intervention|Lost to Follow-up|13|||
23410839|NCT02982772|65248930|FG000|1M Follow-Up|Lost to Follow-up|21|||
23410840|NCT02982772|65248931|FG001|1M Follow-Up|Lost to Follow-up|18|||
23410841|NCT02982772|65248930|FG000|3M Follow-Up|Lost to Follow-up|17|||
23410842|NCT02982772|65248931|FG001|3M Follow-Up|Lost to Follow-up|11|||
23410843|NCT02982772|65248930|FG000|6M Follow-Up|Lost to Follow-up|11|||
23410844|NCT02982772|65248931|FG001|6M Follow-Up|Lost to Follow-up|9|||
23410845|NCT02982772|65248930|FG000|12M Follow-Up|Lost to Follow-up|11|||
23410846|NCT02982772|65248931|FG001|12M Follow-Up|Lost to Follow-up|5|||
23410847|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
23410848|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
23410849|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
23410850|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
23410851|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
23307263|NCT04771403|64870453|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
23307264|NCT04771403|64870454|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
23307265|NCT04771403|64870453|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
23307266|NCT04771403|64870454|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
23307267|NCT04771403|64870453|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
23307268|NCT04771403|64870454|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
23307269|NCT00311402|64870455|FG000|Overall Study|Adverse Event|118|||
23307270|NCT00311402|64870456|FG001|Overall Study|Adverse Event|105|||
23307271|NCT00311402|64870455|FG000|Overall Study|Lost to Follow-up|0|||
23307272|NCT00311402|64870456|FG001|Overall Study|Lost to Follow-up|3|||
23307273|NCT00311402|64870455|FG000|Overall Study|Withdrawal by Subject|17|||
23307274|NCT00311402|64870456|FG001|Overall Study|Withdrawal by Subject|18|||
23307275|NCT00311402|64870455|FG000|Overall Study|Lack of Efficacy|58|||
23307276|NCT00311402|64870456|FG001|Overall Study|Lack of Efficacy|42|||
23307277|NCT00311402|64870455|FG000|Overall Study|Protocol Violation|7|||
23307278|NCT00311402|64870456|FG001|Overall Study|Protocol Violation|6|||
23307279|NCT00311402|64870455|FG000|Overall Study|IRB's rejection etc.|10|||
23307280|NCT00311402|64870456|FG001|Overall Study|IRB's rejection etc.|3|||
23307281|NCT03127644|64870459|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23307282|NCT03127644|64870460|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23307283|NCT03127644|64870461|FG002|Overall Study|Study-specific withdrawal criteria|2|||
23307284|NCT00315731|64870462|FG000|Overall Study|Lost to Follow-up|1|||
23307285|NCT00315731|64870462|FG000|Overall Study|Death|5|||
23307286|NCT05012163|64870463|FG000|Overall Study|Protocol Violation|0|||
23410852|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
23410853|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
23410854|NCT01673854|65248932|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
23410855|NCT01673854|65248932|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
23410856|NCT01673854|65248932|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
23410857|NCT01673854|65248932|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
23410858|NCT01673854|65248932|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
23410859|NCT01681186|65248933|FG000|Washout Period From Second Intervention|Adverse Event|0|||
23410860|NCT01681186|65248934|FG001|Washout Period From Second Intervention|Adverse Event|0|||
23410861|NCT01681186|65248935|FG002|Washout Period From Second Intervention|Adverse Event|0|||
23410862|NCT01681186|65248936|FG003|Washout Period From Second Intervention|Adverse Event|0|||
23410863|NCT01681186|65248937|FG004|Washout Period From Second Intervention|Adverse Event|0|||
23410864|NCT01681186|65248938|FG005|Washout Period From Second Intervention|Adverse Event|0|||
23410865|NCT01681186|65248939|FG006|Washout Period From Second Intervention|Adverse Event|1|||
23410866|NCT01681186|65248940|FG007|Washout Period From Second Intervention|Adverse Event|0|||
23410867|NCT01681186|65248933|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
23410868|NCT01681186|65248934|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
23410869|NCT01681186|65248935|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
23410870|NCT01681186|65248936|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
23410871|NCT01681186|65248937|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
23410872|NCT01681186|65248938|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
23410873|NCT01681186|65248939|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
23410874|NCT01681186|65248940|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
23410875|NCT01681186|65248933|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410876|NCT01681186|65248934|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410877|NCT01681186|65248935|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410878|NCT01681186|65248936|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410879|NCT01681186|65248937|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410880|NCT01681186|65248938|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410881|NCT01681186|65248939|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
23410882|NCT01681186|65248940|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
23410883|NCT01681186|65248933|FG000|Fourth Intervention|Protocol Violation|0|||
23410884|NCT01681186|65248934|FG001|Fourth Intervention|Protocol Violation|0|||
23410885|NCT01681186|65248935|FG002|Fourth Intervention|Protocol Violation|0|||
23410886|NCT01681186|65248936|FG003|Fourth Intervention|Protocol Violation|0|||
23410887|NCT01681186|65248937|FG004|Fourth Intervention|Protocol Violation|0|||
23410888|NCT01681186|65248938|FG005|Fourth Intervention|Protocol Violation|0|||
23410889|NCT01681186|65248939|FG006|Fourth Intervention|Protocol Violation|0|||
23410890|NCT01681186|65248940|FG007|Fourth Intervention|Protocol Violation|1|||
23410891|NCT02836717|65248941|FG000|Test Phase|Lack of Efficacy|14|||
23410892|NCT02836717|65248942|FG001|Test Phase|Lack of Efficacy|8|||
23410893|NCT02836717|65248943|FG002|Test Phase|Lack of Efficacy|0|||
23410894|NCT02836717|65248941|FG000|Study Phase|Adverse Event|2|||
23410895|NCT02836717|65248942|FG001|Study Phase|Adverse Event|0|||
23410896|NCT02836717|65248943|FG002|Study Phase|Adverse Event|0|||
23410897|NCT02836717|65248941|FG000|Study Phase|Lack of Efficacy|8|||
23410898|NCT02836717|65248942|FG001|Study Phase|Lack of Efficacy|6|||
23410899|NCT02836717|65248943|FG002|Study Phase|Lack of Efficacy|1|||
23410900|NCT02836717|65248941|FG000|Study Phase|Withdrawal by Subject|1|||
23410901|NCT02836717|65248942|FG001|Study Phase|Withdrawal by Subject|0|||
23410902|NCT02836717|65248943|FG002|Study Phase|Withdrawal by Subject|0|||
23410903|NCT02836717|65248941|FG000|Study Phase|Death|1|||
23410904|NCT02836717|65248942|FG001|Study Phase|Death|0|||
23410905|NCT02836717|65248943|FG002|Study Phase|Death|0|||
23410906|NCT02836717|65248941|FG000|Study Phase|abdominal surgeries|2|||
23410907|NCT02836717|65248942|FG001|Study Phase|abdominal surgeries|1|||
23410908|NCT02836717|65248943|FG002|Study Phase|abdominal surgeries|0|||
23410909|NCT01014767|65248944|FG000|Overall Study|PI left institution, data unavailable|12|||
23410910|NCT01014767|65248945|FG001|Overall Study|PI left institution, data unavailable|1|||
23410911|NCT01014767|65248946|FG002|Overall Study|PI left institution, data unavailable|4|||
23410912|NCT01014767|65248947|FG003|Overall Study|PI left institution, data unavailable|1|||
23410913|NCT03423238|65248958|FG000|Overall Study|Lost to Follow-up|1|||
23410914|NCT03423238|65248959|FG001|Overall Study|Lost to Follow-up|0|||
23410915|NCT03423238|65248958|FG000|Overall Study|Withdrawal by Subject|1|||
23410916|NCT03423238|65248959|FG001|Overall Study|Withdrawal by Subject|0|||
23410917|NCT00615719|65248960|FG000|Overall Study|Physician Decision|5|||
23511447|NCT01396148|65609355|FG000|Overall Study|Patient Decision|1|||
23511448|NCT04128267|65609358|FG000|Overall Study|Withdrawal by Subject|6|||
23511449|NCT04128267|65609358|FG000|Overall Study|Death|2|||
23511450|NCT04128267|65609358|FG000|Overall Study|Disease progression|1|||
23511451|NCT04128267|65609358|FG000|Overall Study|Participant had other medical issues|4|||
23511452|NCT04128267|65609358|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
23410918|NCT01268046|65248961|FG000|Overall Study|Withdrawal by Subject|1|||
23410919|NCT01268046|65248962|FG001|Overall Study|Withdrawal by Subject|0|||
23511453|NCT02013791|65609359|FG000|Period 1|Lost to Follow-up|0|||
23511454|NCT02013791|65609360|FG001|Period 1|Lost to Follow-up|0|||
23410920|NCT01268046|65248963|FG002|Overall Study|Withdrawal by Subject|0|||
23410921|NCT01268046|65248964|FG003|Overall Study|Withdrawal by Subject|1|||
23410922|NCT01268046|65248961|FG000|Overall Study|Lost to Follow-up|0|||
23410923|NCT01268046|65248962|FG001|Overall Study|Lost to Follow-up|0|||
23410924|NCT01268046|65248963|FG002|Overall Study|Lost to Follow-up|1|||
23410925|NCT01268046|65248964|FG003|Overall Study|Lost to Follow-up|0|||
23410926|NCT02597452|65248965|FG000|Overall Study|testing incomplete|30|||
23410927|NCT00861757|65248966|FG000|Overall Study|Adverse Event|1|||
23410928|NCT00861757|65248967|FG001|Overall Study|Adverse Event|5|||
23410929|NCT00861757|65248968|FG002|Overall Study|Adverse Event|7|||
23410930|NCT00861757|65248969|FG003|Overall Study|Adverse Event|2|||
23410931|NCT00861757|65248966|FG000|Overall Study|Entry Criteria Not Met|1|||
23410932|NCT00861757|65248967|FG001|Overall Study|Entry Criteria Not Met|2|||
23410933|NCT00861757|65248968|FG002|Overall Study|Entry Criteria Not Met|1|||
23410934|NCT00861757|65248969|FG003|Overall Study|Entry Criteria Not Met|1|||
23410935|NCT00861757|65248966|FG000|Overall Study|Lack of Efficacy|3|||
23410936|NCT00861757|65248967|FG001|Overall Study|Lack of Efficacy|1|||
23410937|NCT00861757|65248968|FG002|Overall Study|Lack of Efficacy|0|||
23410938|NCT00861757|65248969|FG003|Overall Study|Lack of Efficacy|1|||
23410939|NCT00861757|65248966|FG000|Overall Study|Lost to Follow-up|1|||
23410940|NCT00861757|65248967|FG001|Overall Study|Lost to Follow-up|0|||
23410941|NCT00861757|65248968|FG002|Overall Study|Lost to Follow-up|1|||
23410942|NCT00861757|65248969|FG003|Overall Study|Lost to Follow-up|1|||
23410943|NCT00861757|65248966|FG000|Overall Study|Physician Decision|0|||
23410944|NCT00861757|65248967|FG001|Overall Study|Physician Decision|0|||
23410945|NCT00861757|65248968|FG002|Overall Study|Physician Decision|0|||
23410946|NCT00861757|65248969|FG003|Overall Study|Physician Decision|1|||
23410947|NCT00861757|65248966|FG000|Overall Study|Protocol Violation|2|||
23410948|NCT00861757|65248967|FG001|Overall Study|Protocol Violation|2|||
23410949|NCT00861757|65248968|FG002|Overall Study|Protocol Violation|4|||
23410950|NCT00861757|65248969|FG003|Overall Study|Protocol Violation|1|||
23410951|NCT00861757|65248966|FG000|Overall Study|Withdrawal by Subject|1|||
23410952|NCT00861757|65248967|FG001|Overall Study|Withdrawal by Subject|5|||
23410953|NCT00861757|65248968|FG002|Overall Study|Withdrawal by Subject|5|||
23410954|NCT00861757|65248969|FG003|Overall Study|Withdrawal by Subject|2|||
23410955|NCT03458325|65248971|FG000|Overall Study|Withdrawal by Subject|1|||
23410956|NCT02243371|65248982|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
23307287|NCT05012163|64870464|FG001|Overall Study|Protocol Violation|0|||
23307288|NCT05012163|64870465|FG002|Overall Study|Protocol Violation|1|||
23410957|NCT02243371|65248983|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
23410958|NCT02243371|65248982|FG000|Overall Study|Death (unrelated)|2|||
23410959|NCT02243371|65248983|FG001|Overall Study|Death (unrelated)|4|||
23410960|NCT02243371|65248982|FG000|Overall Study|Adverse Event (unrelated)|0|||
23410961|NCT02243371|65248983|FG001|Overall Study|Adverse Event (unrelated)|1|||
23410962|NCT02243371|65248982|FG000|Overall Study|Lack of Clinical Benefit|0|||
23410963|NCT02243371|65248983|FG001|Overall Study|Lack of Clinical Benefit|1|||
23410964|NCT02243371|65248982|FG000|Overall Study|Withdrawal by Subject|0|||
23410965|NCT02243371|65248983|FG001|Overall Study|Withdrawal by Subject|2|||
23453467|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453468|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453469|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453470|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453471|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453472|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453473|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453474|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453475|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453476|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
23453477|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
23453478|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453479|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453480|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453481|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
23453482|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453483|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453484|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453485|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453486|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453487|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453488|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
23453489|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453490|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453491|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23511455|NCT02013791|65609361|FG002|Period 1|Lost to Follow-up|0|||
23511456|NCT02013791|65609362|FG003|Period 1|Lost to Follow-up|1|||
23511457|NCT02013791|65609363|FG004|Period 1|Lost to Follow-up|0|||
23511458|NCT02013791|65609364|FG005|Period 1|Lost to Follow-up|0|||
23511459|NCT02013791|65609365|FG006|Period 1|Lost to Follow-up|1|||
23511460|NCT02013791|65609366|FG007|Period 1|Lost to Follow-up|1|||
23511461|NCT02013791|65609367|FG008|Period 1|Lost to Follow-up|0|||
23511462|NCT02013791|65609359|FG000|Period 1|Other Miscellaneous Reasons|0|||
23511463|NCT02013791|65609360|FG001|Period 1|Other Miscellaneous Reasons|2|||
23511464|NCT02013791|65609361|FG002|Period 1|Other Miscellaneous Reasons|0|||
23511465|NCT02013791|65609362|FG003|Period 1|Other Miscellaneous Reasons|0|||
23511466|NCT02013791|65609363|FG004|Period 1|Other Miscellaneous Reasons|0|||
23511467|NCT02013791|65609364|FG005|Period 1|Other Miscellaneous Reasons|0|||
23511468|NCT02013791|65609365|FG006|Period 1|Other Miscellaneous Reasons|0|||
23511469|NCT02013791|65609366|FG007|Period 1|Other Miscellaneous Reasons|0|||
23511470|NCT02013791|65609367|FG008|Period 1|Other Miscellaneous Reasons|0|||
23511471|NCT02279173|65609371|FG000|Overall Study|Protocol-specified Criteria|67|||
23511472|NCT02279173|65609371|FG000|Overall Study|Withdrawal by Subject|20|||
23511473|NCT02279173|65609371|FG000|Overall Study|Decision by Sponsor|4|||
23511474|NCT02279173|65609371|FG000|Overall Study|Lost to Follow-up|3|||
23511475|NCT01896531|65609372|FG000|Overall Study|Death|57|||
23511476|NCT01896531|65609373|FG001|Overall Study|Death|59|||
23511477|NCT01896531|65609372|FG000|Overall Study|Lost to Follow-up|3|||
23511478|NCT01896531|65609373|FG001|Overall Study|Lost to Follow-up|0|||
23511479|NCT01896531|65609372|FG000|Overall Study|Non-compliance|0|||
23511480|NCT01896531|65609373|FG001|Overall Study|Non-compliance|1|||
23511481|NCT01896531|65609372|FG000|Overall Study|Study Ended by Sponsor|7|||
23511482|NCT01896531|65609373|FG001|Overall Study|Study Ended by Sponsor|20|||
23511483|NCT01896531|65609372|FG000|Overall Study|Withdrawal by Subject|3|||
23511484|NCT01896531|65609373|FG001|Overall Study|Withdrawal by Subject|2|||
23511485|NCT01896531|65609372|FG000|Overall Study|Death Prior to Treatment|1|||
23511486|NCT01896531|65609373|FG001|Overall Study|Death Prior to Treatment|0|||
23511487|NCT02157298|65609376|FG000|Overall Study|Adverse Event|1|||
23511488|NCT02157298|65609377|FG001|Overall Study|Adverse Event|0|||
23511489|NCT02157298|65609376|FG000|Overall Study|Subject no longer meets study criteria|1|||
23511490|NCT02157298|65609377|FG001|Overall Study|Subject no longer meets study criteria|2|||
23511491|NCT02157298|65609376|FG000|Overall Study|Poor/Non-compliance|1|||
23511492|NCT02157298|65609377|FG001|Overall Study|Poor/Non-compliance|0|||
23511493|NCT02157298|65609376|FG000|Overall Study|Withdrawal by Subject|1|||
23511494|NCT02157298|65609377|FG001|Overall Study|Withdrawal by Subject|0|||
23511495|NCT01721330|65609378|FG000|Overall Study|Withdrawal by Subject|0|||
23511496|NCT01721330|65609379|FG001|Overall Study|Withdrawal by Subject|1|||
23511497|NCT01698801|65609384|FG000|Treatment Phase|Adverse Event|4|||
23511498|NCT01698801|65609384|FG000|Treatment Phase|Protocol Violation|1|||
23511499|NCT01698801|65609384|FG000|Treatment Phase|Other|4|||
23511500|NCT01698801|65609384|FG000|Treatment Phase|Withdrawal by Subject|1|||
23511501|NCT01698801|65609384|FG000|Treatment Phase|Disease progression|1|||
23511502|NCT01698801|65609384|FG000|Follow Up Phase|Withdrawal by Subject|1|||
23511503|NCT01698801|65609384|FG000|Follow Up Phase|Death|4|||
23511504|NCT01986985|65609385|FG000|Overall Study|Withdrawal by Subject|4|||
23511505|NCT01986985|65609385|FG000|Overall Study|Scan not completed due to malfunction|3|||
23511506|NCT00856284|65609389|FG000|Overall Study|Hyperglycemic rescue|231|||
23511507|NCT00856284|65609390|FG001|Overall Study|Hyperglycemic rescue|201|||
23511508|NCT00856284|65609391|FG002|Overall Study|Hyperglycemic rescue|235|||
23511509|NCT00856284|65609389|FG000|Overall Study|Adverse Event|60|||
23511510|NCT00856284|65609390|FG001|Overall Study|Adverse Event|74|||
23511511|NCT00856284|65609391|FG002|Overall Study|Adverse Event|82|||
23511512|NCT00856284|65609389|FG000|Overall Study|Major protocol deviation|24|||
23511513|NCT00856284|65609390|FG001|Overall Study|Major protocol deviation|16|||
23511514|NCT00856284|65609391|FG002|Overall Study|Major protocol deviation|15|||
23511515|NCT00856284|65609389|FG000|Overall Study|Lost to Follow-up|20|||
23511516|NCT00856284|65609390|FG001|Overall Study|Lost to Follow-up|22|||
23511517|NCT00856284|65609391|FG002|Overall Study|Lost to Follow-up|28|||
23511518|NCT00856284|65609389|FG000|Overall Study|Voluntary withdrawal|48|||
23511519|NCT00856284|65609390|FG001|Overall Study|Voluntary withdrawal|52|||
23511520|NCT00856284|65609391|FG002|Overall Study|Voluntary withdrawal|62|||
23511521|NCT00856284|65609389|FG000|Overall Study|Pregnancy|1|||
23511522|NCT00856284|65609390|FG001|Overall Study|Pregnancy|2|||
23511523|NCT00856284|65609391|FG002|Overall Study|Pregnancy|0|||
23511524|NCT00856284|65609389|FG000|Overall Study|Investigator discretion|9|||
23511525|NCT00856284|65609390|FG001|Overall Study|Investigator discretion|8|||
23511526|NCT00856284|65609391|FG002|Overall Study|Investigator discretion|10|||
23511527|NCT00856284|65609389|FG000|Overall Study|Other|15|||
23511528|NCT00856284|65609390|FG001|Overall Study|Other|17|||
23511529|NCT00856284|65609391|FG002|Overall Study|Other|14|||
23511530|NCT00856284|65609389|FG000|Overall Study|Randomized in error|0|||
23511531|NCT00856284|65609390|FG001|Overall Study|Randomized in error|0|||
23511532|NCT00856284|65609391|FG002|Overall Study|Randomized in error|1|||
23511533|NCT02891850|65609392|FG000|Overall Study|Adverse Event|3|||
23511534|NCT02891850|65609393|FG001|Overall Study|Adverse Event|0|||
23511535|NCT02891850|65609392|FG000|Overall Study|Death|0|||
23511536|NCT02891850|65609393|FG001|Overall Study|Death|4|||
23511537|NCT02891850|65609392|FG000|Overall Study|Physician Decision|1|||
23511538|NCT02891850|65609393|FG001|Overall Study|Physician Decision|0|||
23511539|NCT02891850|65609392|FG000|Overall Study|Pregnancy|1|||
23511540|NCT02891850|65609393|FG001|Overall Study|Pregnancy|0|||
23511541|NCT02891850|65609392|FG000|Overall Study|Withdrawal by Subject|2|||
23511542|NCT02891850|65609393|FG001|Overall Study|Withdrawal by Subject|3|||
23511543|NCT00556712|65609394|FG000|Overall Study|Adverse Event|7|||
23511544|NCT00556712|65609395|FG001|Overall Study|Adverse Event|19|||
23410966|NCT02485639|65248987|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
23410967|NCT02485639|65248987|FG000|Overall Study|Early termination|4|||
23410968|NCT02485639|65248987|FG000|Overall Study|Withdrawal by Subject|4|||
23410969|NCT02684617|65248988|FG000|Overall Study|Adverse Event|1|||
23410970|NCT02684617|65248989|FG001|Overall Study|Adverse Event|0|||
23410971|NCT02684617|65248990|FG002|Overall Study|Adverse Event|1|||
23410972|NCT02684617|65248988|FG000|Overall Study|Death|8|||
23410973|NCT02684617|65248989|FG001|Overall Study|Death|16|||
23410974|NCT02684617|65248990|FG002|Overall Study|Death|28|||
23410975|NCT02684617|65248988|FG000|Overall Study|Withdrawal by Subject|2|||
23410976|NCT02684617|65248989|FG001|Overall Study|Withdrawal by Subject|0|||
23410977|NCT02684617|65248990|FG002|Overall Study|Withdrawal by Subject|4|||
23410978|NCT02684617|65248988|FG000|Overall Study|Screen Failure|1|||
23410979|NCT02684617|65248989|FG001|Overall Study|Screen Failure|0|||
23410980|NCT02684617|65248990|FG002|Overall Study|Screen Failure|2|||
23410981|NCT02684617|65248988|FG000|Overall Study|Study Terminated by Sponsor|6|||
23410982|NCT02684617|65248989|FG001|Overall Study|Study Terminated by Sponsor|1|||
23410983|NCT02684617|65248990|FG002|Overall Study|Study Terminated by Sponsor|5|||
23410984|NCT00656058|65248991|FG000|Overall Study|Withdrawal by Subject|2|||
23410985|NCT00656058|65248991|FG000|Overall Study|Withdrawal by Subject|4|||
23410986|NCT00005947|65248992|FG000|Overall Study|Death|54|||
23410987|NCT00005947|65248993|FG001|Overall Study|Death|40|||
23410988|NCT00005947|65248992|FG000|Overall Study|Patient Refused to Continue|2|||
23410989|NCT00005947|65248993|FG001|Overall Study|Patient Refused to Continue|1|||
23410990|NCT00005947|65248992|FG000|Overall Study|Site Closure|1|||
23410991|NCT00005947|65248993|FG001|Overall Study|Site Closure|0|||
23410992|NCT02103062|65248999|FG000|Overall Study|Adverse Event|1|||
23410993|NCT02103062|65249000|FG001|Overall Study|Adverse Event|2|||
23410994|NCT02103062|65248999|FG000|Overall Study|Progressive Disease|17|||
23410995|NCT02103062|65249000|FG001|Overall Study|Progressive Disease|20|||
23410996|NCT02103062|65248999|FG000|Overall Study|Death|0|||
23410997|NCT02103062|65249000|FG001|Overall Study|Death|1|||
23410998|NCT01843673|65249001|FG000|Overall Study|Lack of Efficacy|2|||
23410999|NCT01843673|65249001|FG000|Overall Study|Withdrawal by Subject|4|||
23411000|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Adverse Event|21|||
23411001|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Adverse Event|34|||
23411002|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Adverse Event|14|||
23411003|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Adverse Event|17|||
23411004|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Adverse Event|0|||
23411005|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
23411006|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
23411007|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
23411008|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
23411009|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
23411010|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
23411011|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
23411012|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
23411013|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
23411014|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
23411015|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Physician Decision|2|||
23411016|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Physician Decision|4|||
23411017|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Physician Decision|4|||
23411018|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Physician Decision|4|||
23411019|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Physician Decision|0|||
23411020|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
23411021|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
23411022|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
23411023|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
23411024|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
23411025|NCT00451958|65249002|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
23411026|NCT00451958|65249003|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
23411027|NCT00451958|65249004|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
23411028|NCT00451958|65249005|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
23411029|NCT00451958|65249006|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
23511545|NCT00556712|65609394|FG000|Overall Study|Death|5|||
23511546|NCT00556712|65609395|FG001|Overall Study|Death|10|||
23411030|NCT00564733|65249010|FG000|Overall Study|Withdrawal by Subject|4|||
23411031|NCT00564733|65249010|FG000|Overall Study|Ineligible|5|||
23411032|NCT00652743|65249011|FG000|Months 12-18|Lost to Follow-up|1|||
23411033|NCT00652743|65249012|FG001|Months 12-18|Lost to Follow-up|2|||
23411034|NCT00652743|65249013|FG002|Months 12-18|Lost to Follow-up|7|||
23411035|NCT00652743|65249011|FG000|Months 24-30|Other|5|||
23411036|NCT00652743|65249012|FG001|Months 24-30|Other|1|||
23411037|NCT00652743|65249013|FG002|Months 24-30|Other|11|||
23411038|NCT00652743|65249011|FG000|Months 36-42|Serious Adverse Events|0|||
23411039|NCT00652743|65249012|FG001|Months 36-42|Serious Adverse Events|1|||
23411040|NCT00652743|65249013|FG002|Months 36-42|Serious Adverse Events|1|||
23411041|NCT00652743|65249011|FG000|Months 36-42|Withdrawal by Subject|1|||
23411042|NCT00652743|65249012|FG001|Months 36-42|Withdrawal by Subject|1|||
23411043|NCT00652743|65249013|FG002|Months 36-42|Withdrawal by Subject|0|||
23411044|NCT00652743|65249011|FG000|Months 36-42|Lost to Follow-up|0|||
23411045|NCT00652743|65249012|FG001|Months 36-42|Lost to Follow-up|1|||
23411046|NCT00652743|65249013|FG002|Months 36-42|Lost to Follow-up|0|||
23411047|NCT00652743|65249011|FG000|Months 36-42|Migrated/moved from study area|1|||
23411048|NCT00652743|65249012|FG001|Months 36-42|Migrated/moved from study area|0|||
23411049|NCT00652743|65249013|FG002|Months 36-42|Migrated/moved from study area|0|||
23411050|NCT00652743|65249011|FG000|Months 36-42|Other|4|||
23411051|NCT00652743|65249012|FG001|Months 36-42|Other|2|||
23411052|NCT00652743|65249013|FG002|Months 36-42|Other|8|||
23411053|NCT00368745|65249016|FG000|Double-blind Treatment Period|Adverse Event|6|||
23411054|NCT00368745|65249017|FG001|Double-blind Treatment Period|Adverse Event|6|||
23411055|NCT00368745|65249016|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
23411056|NCT00368745|65249017|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
23411057|NCT00368745|65249016|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
23411058|NCT00368745|65249017|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23411059|NCT00368745|65249016|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
23411060|NCT00368745|65249017|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
23411061|NCT00368745|65249016|FG000|Double-blind Treatment Period|Other|7|||
23411062|NCT00368745|65249017|FG001|Double-blind Treatment Period|Other|6|||
23411063|NCT04601532|65249018|FG000|Overall Study|Lost to Follow-up|1|||
23411064|NCT04601532|65249019|FG001|Overall Study|Lost to Follow-up|2|||
23411065|NCT04601532|65249018|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
23411066|NCT04601532|65249019|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
23411067|NCT03275246|65249020|FG000|Overall Study|Protocol Violation|5|||
23411068|NCT03275246|65249020|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
23411069|NCT02943070|65249021|FG000|Overall Study|Physician Decision|1|||
23411070|NCT02943070|65249021|FG000|Overall Study|Adverse Event|2|||
23411071|NCT02943070|65249021|FG000|Overall Study|Death|2|||
23411072|NCT02943070|65249021|FG000|Overall Study|Withdrawal by Subject|3|||
23411073|NCT02943070|65249021|FG000|Overall Study|Lost to Follow-up|4|||
23411074|NCT02943070|65249021|FG000|Overall Study|Retreatment or TURP|13|||
23411075|NCT02943070|65249021|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
23411076|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
23411077|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411078|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411079|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411080|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411081|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23411082|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
23411083|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
23411084|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23411085|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23411086|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23411087|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23411088|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
23411089|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
23411090|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
23411091|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
23411092|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
23411093|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
23411094|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
23411095|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
23411096|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23411097|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23411098|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23411099|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23411100|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
23411101|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
23411102|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
23411103|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
23411104|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
23411105|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
23411106|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
23411107|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411108|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411109|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411110|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411111|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
23411112|NCT03989349|65249027|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
23411113|NCT03989349|65249028|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
23411114|NCT03989349|65249029|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
23411115|NCT03989349|65249030|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
23411116|NCT03989349|65249031|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
23411117|NCT03989349|65249032|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
23411118|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23411119|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23411120|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
23411121|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
23411122|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
23411123|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
23411124|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23411125|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23411126|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
23411127|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
23411128|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
23411129|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
23411130|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23411131|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23411132|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
23411133|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
23411134|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
23411135|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
23411136|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23411137|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23411138|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23411139|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23411140|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
23411141|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23411142|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23411143|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23411144|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
23411145|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
23411146|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23411147|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
23411148|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
23411149|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
23411150|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
23411151|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
23411152|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
23411153|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
23411154|NCT03989349|65249027|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
23411155|NCT03989349|65249028|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
23411156|NCT03989349|65249029|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
23411157|NCT03989349|65249030|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
23411158|NCT03989349|65249031|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
23411159|NCT03989349|65249032|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
23411160|NCT02808897|65249033|FG000|Overall Study|Lost to Follow-up|9|||
23411161|NCT02808897|65249034|FG001|Overall Study|Lost to Follow-up|11|||
23411162|NCT03941964|65249035|FG000|Overall Study|Adverse Event|1|||
23411163|NCT03941964|65249036|FG001|Overall Study|Adverse Event|8|||
23411164|NCT03941964|65249035|FG000|Overall Study|Progressive disease|7|||
23411165|NCT03941964|65249036|FG001|Overall Study|Progressive disease|3|||
23411166|NCT03941964|65249035|FG000|Overall Study|Lack of Efficacy|0|||
23411167|NCT03941964|65249036|FG001|Overall Study|Lack of Efficacy|1|||
23411168|NCT03941964|65249035|FG000|Overall Study|Death|3|||
23411169|NCT03941964|65249036|FG001|Overall Study|Death|1|||
23411170|NCT03941964|65249035|FG000|Overall Study|Withdrew consent|1|||
23411171|NCT03941964|65249036|FG001|Overall Study|Withdrew consent|3|||
23411172|NCT03941964|65249035|FG000|Overall Study|Physician Decision|9|||
23411173|NCT03941964|65249036|FG001|Overall Study|Physician Decision|2|||
23411174|NCT03941964|65249035|FG000|Overall Study|Other, not specified|2|||
23411175|NCT03941964|65249036|FG001|Overall Study|Other, not specified|1|||
23411176|NCT02038777|65249037|FG000|Overall Study|Death|0|||
23411177|NCT02038777|65249038|FG001|Overall Study|Death|2|||
23411178|NCT02038777|65249039|FG002|Overall Study|Death|0|||
23411179|NCT02038777|65249040|FG003|Overall Study|Death|1|||
23411180|NCT02038777|65249041|FG004|Overall Study|Death|2|||
23411181|NCT02038777|65249042|FG005|Overall Study|Death|4|||
23411182|NCT02038777|65249043|FG006|Overall Study|Death|0|||
23411183|NCT02038777|65249044|FG007|Overall Study|Death|10|||
23411184|NCT02038777|65249037|FG000|Overall Study|Lost to Follow-up|0|||
23411185|NCT02038777|65249038|FG001|Overall Study|Lost to Follow-up|0|||
23411186|NCT02038777|65249039|FG002|Overall Study|Lost to Follow-up|0|||
23411187|NCT02038777|65249040|FG003|Overall Study|Lost to Follow-up|1|||
23411188|NCT02038777|65249041|FG004|Overall Study|Lost to Follow-up|0|||
23411189|NCT02038777|65249042|FG005|Overall Study|Lost to Follow-up|0|||
23411190|NCT02038777|65249043|FG006|Overall Study|Lost to Follow-up|0|||
23411191|NCT02038777|65249044|FG007|Overall Study|Lost to Follow-up|0|||
23411192|NCT02038777|65249037|FG000|Overall Study|Other|0|||
23411193|NCT02038777|65249038|FG001|Overall Study|Other|1|||
23411194|NCT02038777|65249039|FG002|Overall Study|Other|0|||
23411195|NCT02038777|65249040|FG003|Overall Study|Other|2|||
23411196|NCT02038777|65249041|FG004|Overall Study|Other|1|||
23411197|NCT02038777|65249042|FG005|Overall Study|Other|0|||
23411198|NCT02038777|65249043|FG006|Overall Study|Other|0|||
23411199|NCT02038777|65249044|FG007|Overall Study|Other|0|||
23411200|NCT02038777|65249037|FG000|Overall Study|Randomized but not treated|0|||
23411201|NCT02038777|65249038|FG001|Overall Study|Randomized but not treated|1|||
23411202|NCT02038777|65249039|FG002|Overall Study|Randomized but not treated|0|||
23411203|NCT02038777|65249040|FG003|Overall Study|Randomized but not treated|0|||
23411204|NCT02038777|65249041|FG004|Overall Study|Randomized but not treated|0|||
23411205|NCT02038777|65249042|FG005|Overall Study|Randomized but not treated|0|||
23411206|NCT02038777|65249043|FG006|Overall Study|Randomized but not treated|0|||
23411207|NCT02038777|65249044|FG007|Overall Study|Randomized but not treated|0|||
23411208|NCT02038777|65249037|FG000|Overall Study|Started Chemotherapy|1|||
23411209|NCT02038777|65249038|FG001|Overall Study|Started Chemotherapy|0|||
23411210|NCT02038777|65249039|FG002|Overall Study|Started Chemotherapy|3|||
23411211|NCT02038777|65249040|FG003|Overall Study|Started Chemotherapy|0|||
23411212|NCT02038777|65249041|FG004|Overall Study|Started Chemotherapy|0|||
23411213|NCT02038777|65249042|FG005|Overall Study|Started Chemotherapy|0|||
23411214|NCT02038777|65249043|FG006|Overall Study|Started Chemotherapy|0|||
23411215|NCT02038777|65249044|FG007|Overall Study|Started Chemotherapy|0|||
23411216|NCT00758069|65249045|FG000|Overall Study|Lack of Efficacy|0|||
23411217|NCT00758069|65249046|FG001|Overall Study|Lack of Efficacy|0|||
23411218|NCT00758069|65249047|FG002|Overall Study|Lack of Efficacy|1|||
23411219|NCT00758069|65249045|FG000|Overall Study|Incorrect Study Drug|1|||
23411220|NCT00758069|65249046|FG001|Overall Study|Incorrect Study Drug|0|||
23411221|NCT00758069|65249047|FG002|Overall Study|Incorrect Study Drug|0|||
23411222|NCT05059301|65249050|FG000|Overall Study|Adverse Event|0|||
23411223|NCT05059301|65249051|FG001|Overall Study|Adverse Event|2|||
23411224|NCT05059301|65249052|FG002|Overall Study|Adverse Event|2|||
23411225|NCT05059301|65249050|FG000|Overall Study|Lost to Follow-up|2|||
23411226|NCT05059301|65249051|FG001|Overall Study|Lost to Follow-up|3|||
23411227|NCT05059301|65249052|FG002|Overall Study|Lost to Follow-up|3|||
23411228|NCT05069597|65249053|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
23411229|NCT05069597|65249054|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
23411230|NCT02628600|65249055|FG000|Overall Study|Death|2|||
23411231|NCT02628600|65249056|FG001|Overall Study|Death|1|||
23411232|NCT02628600|65249055|FG000|Overall Study|Adverse Event|3|||
23411233|NCT02628600|65249056|FG001|Overall Study|Adverse Event|20|||
23411234|NCT02628600|65249055|FG000|Overall Study|Protocol Violation|0|||
23411235|NCT02628600|65249056|FG001|Overall Study|Protocol Violation|1|||
23411236|NCT02628600|65249055|FG000|Overall Study|Lack of Efficacy|2|||
23411237|NCT02628600|65249056|FG001|Overall Study|Lack of Efficacy|0|||
23411238|NCT02628600|65249055|FG000|Overall Study|Withdrawal by Subject|13|||
23411239|NCT02628600|65249056|FG001|Overall Study|Withdrawal by Subject|8|||
23411240|NCT02628600|65249055|FG000|Overall Study|Lost to Follow-up|1|||
23411241|NCT02628600|65249056|FG001|Overall Study|Lost to Follow-up|0|||
23411242|NCT02628600|65249055|FG000|Overall Study|Physician Decision|2|||
23411243|NCT02628600|65249056|FG001|Overall Study|Physician Decision|2|||
23411244|NCT02628600|65249055|FG000|Overall Study|Other not specified|1|||
23411245|NCT02628600|65249056|FG001|Overall Study|Other not specified|0|||
23411246|NCT02858440|65249057|FG000|Overall Study|Lost to Follow-up|3|||
23411247|NCT02858440|65249057|FG000|Overall Study|Protocol Violation|2|||
23411248|NCT02858440|65249057|FG000|Overall Study|Consent withdrawal|3|||
23411249|NCT02858440|65249057|FG000|Overall Study|Migrated/moved from study area|4|||
23411250|NCT00720356|65249058|FG000|Registration to Study|Determined to have methylated MGMT|67|||
23411251|NCT00720356|65249058|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
23411252|NCT00720356|65249058|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
23411253|NCT00720356|65249058|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
23411254|NCT00720356|65249058|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
23411255|NCT00720356|65249058|FG000|Follow up Until Death|Withdrawal by Subject|1|||
23411256|NCT00720356|65249058|FG000|Follow up Until Death|Alive at last data collection|4|||
23411257|NCT00958360|65249060|FG000|Overall Study|Withdrawal by Subject|3|||
23411258|NCT00958360|65249061|FG001|Overall Study|Withdrawal by Subject|1|||
23411259|NCT00958360|65249060|FG000|Overall Study|Death|6|||
23411260|NCT00958360|65249061|FG001|Overall Study|Death|7|||
23411261|NCT00958360|65249060|FG000|Overall Study|Physician Decision|2|||
23411262|NCT00958360|65249061|FG001|Overall Study|Physician Decision|1|||
23411263|NCT00958360|65249060|FG000|Overall Study|Lost to Follow-up|0|||
23411264|NCT00958360|65249061|FG001|Overall Study|Lost to Follow-up|1|||
23411265|NCT03028129|65249066|FG000|Overall Study|Adverse Event|13|||
23411266|NCT03028129|65249067|FG001|Overall Study|Adverse Event|2|||
23411267|NCT03028129|65249066|FG000|Overall Study|Lost to Follow-up|50|||
23511547|NCT00556712|65609394|FG000|Overall Study|Progressive Disease|383|||
23411268|NCT03028129|65249067|FG001|Overall Study|Lost to Follow-up|38|||
23411269|NCT03028129|65249066|FG000|Overall Study|Physician Decision|0|||
23411270|NCT03028129|65249067|FG001|Overall Study|Physician Decision|1|||
23411271|NCT03028129|65249066|FG000|Overall Study|Protocol Violation|1|||
23411272|NCT03028129|65249067|FG001|Overall Study|Protocol Violation|1|||
23411273|NCT03028129|65249066|FG000|Overall Study|Withdrawal by Subject|62|||
23411274|NCT03028129|65249067|FG001|Overall Study|Withdrawal by Subject|45|||
23411275|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
23411276|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
23411277|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
23411278|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
23411279|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
23411280|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
23411281|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
23411282|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
23411283|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
23411284|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
23411285|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
23411286|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
23411287|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
23411288|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
23411289|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
23411290|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
23411291|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
23411292|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
23411293|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
23411294|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
23411295|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
23411296|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
23411297|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
23411298|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
23411299|NCT01672879|65249068|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
23411300|NCT01672879|65249069|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
23411301|NCT01672879|65249070|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
23411302|NCT01672879|65249068|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
23411303|NCT01672879|65249069|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
23411304|NCT01672879|65249070|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
23411305|NCT01672879|65249068|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
23411306|NCT01672879|65249069|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
23411307|NCT01672879|65249070|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
23411308|NCT01672879|65249068|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
23411309|NCT01672879|65249069|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
23411310|NCT01672879|65249070|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
23411311|NCT01672879|65249068|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
23411312|NCT01672879|65249069|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
23411313|NCT01672879|65249070|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
23411314|NCT01047007|65249071|FG000|Overall Study|Adverse Event|0|||
23411315|NCT01047007|65249072|FG001|Overall Study|Adverse Event|2|||
23411316|NCT01047007|65249073|FG002|Overall Study|Adverse Event|1|||
23411317|NCT01047007|65249074|FG003|Overall Study|Adverse Event|0|||
23411318|NCT01047007|65249071|FG000|Overall Study|Progressive Disease|2|||
23411319|NCT01047007|65249072|FG001|Overall Study|Progressive Disease|4|||
23411320|NCT01047007|65249073|FG002|Overall Study|Progressive Disease|1|||
23411321|NCT01047007|65249074|FG003|Overall Study|Progressive Disease|0|||
23411322|NCT00809835|65249075|FG000|Overall Study|Lost to Follow-up|7|||
23411323|NCT00809835|65249076|FG001|Overall Study|Lost to Follow-up|6|||
23411324|NCT00809835|65249077|FG002|Overall Study|Lost to Follow-up|10|||
23411325|NCT00809835|65249078|FG003|Overall Study|Lost to Follow-up|2|||
23411326|NCT00809835|65249075|FG000|Overall Study|Withdrawal by Subject|1|||
23411327|NCT00809835|65249076|FG001|Overall Study|Withdrawal by Subject|1|||
23411328|NCT00809835|65249077|FG002|Overall Study|Withdrawal by Subject|1|||
23411329|NCT00809835|65249078|FG003|Overall Study|Withdrawal by Subject|0|||
23411330|NCT05559905|65249079|FG000|Overall Study|Withdrawal by Subject|1|||
23411331|NCT05559905|65249080|FG001|Overall Study|Withdrawal by Subject|0|||
23411332|NCT05559905|65249081|FG002|Overall Study|Withdrawal by Subject|0|||
23411333|NCT05559905|65249079|FG000|Overall Study|Not Reported|1|||
23411334|NCT05559905|65249080|FG001|Overall Study|Not Reported|0|||
23411335|NCT05559905|65249081|FG002|Overall Study|Not Reported|0|||
23411336|NCT01667133|65249085|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
23411337|NCT01667133|65249086|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
23411338|NCT01667133|65249087|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
23411339|NCT01667133|65249088|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
23411340|NCT01667133|65249089|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
23411341|NCT01667133|65249090|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
23411342|NCT01667133|65249091|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
23411343|NCT01667133|65249092|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
23411344|NCT01667133|65249093|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
23411345|NCT01667133|65249094|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
23411346|NCT01667133|65249095|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
23411347|NCT01667133|65249096|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
23411348|NCT01667133|65249085|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411349|NCT01667133|65249086|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411350|NCT01667133|65249087|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
23411351|NCT01667133|65249088|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411352|NCT01667133|65249089|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411353|NCT01667133|65249090|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411354|NCT01667133|65249091|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411355|NCT01667133|65249092|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411356|NCT01667133|65249093|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411357|NCT01667133|65249094|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411358|NCT01667133|65249095|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411359|NCT01667133|65249096|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
23411360|NCT01667133|65249085|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
23411361|NCT01667133|65249086|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
23411362|NCT01667133|65249087|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
23411363|NCT01667133|65249088|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
23411364|NCT01667133|65249089|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
23411365|NCT01667133|65249090|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
23411366|NCT01667133|65249091|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
23411367|NCT01667133|65249092|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
23411368|NCT01667133|65249093|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
23411369|NCT01667133|65249094|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
23411370|NCT01667133|65249095|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
23511548|NCT00556712|65609395|FG001|Overall Study|Progressive Disease|320|||
23411371|NCT01667133|65249096|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
23511549|NCT00556712|65609394|FG000|Overall Study|Protocol Violation|3|||
23205189|NCT00492856|64491287|FG002|Consolidation|Adverse Event|0|||
23411372|NCT01667133|65249085|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411373|NCT01667133|65249086|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411374|NCT01667133|65249087|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411375|NCT01667133|65249088|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
23411376|NCT01667133|65249089|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411377|NCT01667133|65249090|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411378|NCT01667133|65249091|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411379|NCT01667133|65249092|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411380|NCT01667133|65249093|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411381|NCT01667133|65249094|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411382|NCT01667133|65249095|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411383|NCT01667133|65249096|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
23411384|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
23411385|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
23411386|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
23411387|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
23411388|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
23411389|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
23411390|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
23411391|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
23411392|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
23411393|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
23411394|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
23411395|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
23411396|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411397|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411398|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411399|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411400|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411401|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411402|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411403|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411404|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411405|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
23411406|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411407|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
23411408|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
23411409|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
23411410|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
23411411|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
23411412|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
23411413|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
23411414|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
23411415|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
23411416|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
23411417|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
23411418|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
23411419|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
23511550|NCT00556712|65609395|FG001|Overall Study|Protocol Violation|2|||
23411420|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411421|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411422|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411423|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411424|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411425|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411426|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411427|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411428|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411429|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
23411430|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411431|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
23411432|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Death|0|||
23411433|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Death|0|||
23411434|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Death|0|||
23411435|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Death|0|||
23411436|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Death|0|||
23411437|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Death|0|||
23411438|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Death|0|||
23411439|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Death|0|||
23511551|NCT00556712|65609394|FG000|Overall Study|Refused Treatment|17|||
23411440|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Death|0|||
23411441|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Death|1|||
23411442|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Death|0|||
23411443|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Death|0|||
23411444|NCT01667133|65249085|FG000|Phase 2: Dose-expansion|Other|0|||
23411445|NCT01667133|65249086|FG001|Phase 2: Dose-expansion|Other|0|||
23411446|NCT01667133|65249087|FG002|Phase 2: Dose-expansion|Other|0|||
23411447|NCT01667133|65249088|FG003|Phase 2: Dose-expansion|Other|0|||
23411448|NCT01667133|65249089|FG004|Phase 2: Dose-expansion|Other|0|||
23411449|NCT01667133|65249090|FG005|Phase 2: Dose-expansion|Other|0|||
23411450|NCT01667133|65249091|FG006|Phase 2: Dose-expansion|Other|0|||
23411451|NCT01667133|65249092|FG007|Phase 2: Dose-expansion|Other|0|||
23411452|NCT01667133|65249093|FG008|Phase 2: Dose-expansion|Other|0|||
23411453|NCT01667133|65249094|FG009|Phase 2: Dose-expansion|Other|0|||
23411454|NCT01667133|65249095|FG010|Phase 2: Dose-expansion|Other|0|||
23411455|NCT01667133|65249096|FG011|Phase 2: Dose-expansion|Other|1|||
23411456|NCT00269113|65249099|FG000|Overall Study|Adverse Event|14|||
23411457|NCT00269113|65249100|FG001|Overall Study|Adverse Event|7|||
23411458|NCT00269113|65249099|FG000|Overall Study|Lack of Efficacy|35|||
23411459|NCT00269113|65249100|FG001|Overall Study|Lack of Efficacy|18|||
23411460|NCT00269113|65249099|FG000|Overall Study|Early Improvement|2|||
23411461|NCT00269113|65249100|FG001|Overall Study|Early Improvement|0|||
23411462|NCT00269113|65249099|FG000|Overall Study|Withdrawal by Subject|0|||
23411463|NCT00269113|65249100|FG001|Overall Study|Withdrawal by Subject|2|||
23411464|NCT00269113|65249099|FG000|Overall Study|Death|6|||
23411465|NCT00269113|65249100|FG001|Overall Study|Death|2|||
23411466|NCT00269113|65249099|FG000|Overall Study|Lost to Follow-up|2|||
23411467|NCT00269113|65249100|FG001|Overall Study|Lost to Follow-up|1|||
23411468|NCT00269113|65249099|FG000|Overall Study|Protocol Violation|15|||
23411469|NCT00269113|65249100|FG001|Overall Study|Protocol Violation|5|||
23411470|NCT00269113|65249099|FG000|Overall Study|Other|0|||
23411471|NCT00269113|65249100|FG001|Overall Study|Other|2|||
23411472|NCT01309997|65249108|FG000|Overall Study|Adverse Event|1|||
23411473|NCT01309997|65249109|FG001|Overall Study|Adverse Event|0|||
23411474|NCT01309997|65249108|FG000|Overall Study|Death|1|||
23411475|NCT01309997|65249109|FG001|Overall Study|Death|3|||
23411476|NCT01309997|65249108|FG000|Overall Study|Lack of Efficacy|2|||
23411477|NCT01309997|65249109|FG001|Overall Study|Lack of Efficacy|2|||
23411478|NCT01309997|65249108|FG000|Overall Study|Withdrawal by Subject|1|||
23411479|NCT01309997|65249109|FG001|Overall Study|Withdrawal by Subject|1|||
23411480|NCT00935493|65249110|FG000|Overall Study|Lost to Follow-up|1|||
23411481|NCT00935493|65249111|FG001|Overall Study|Lost to Follow-up|1|||
23411482|NCT00935493|65249112|FG002|Overall Study|Lost to Follow-up|1|||
23411483|NCT00935493|65249110|FG000|Overall Study|Treatment Discontinued|0|||
23411484|NCT00935493|65249111|FG001|Overall Study|Treatment Discontinued|1|||
23411485|NCT00935493|65249112|FG002|Overall Study|Treatment Discontinued|0|||
23411486|NCT03107052|65249114|FG000|Overall Study|Adverse Event|6|||
23411487|NCT03107052|65249115|FG001|Overall Study|Adverse Event|1|||
23411488|NCT03107052|65249116|FG002|Overall Study|Adverse Event|2|||
23511552|NCT00556712|65609395|FG001|Overall Study|Refused Treatment|16|||
23411489|NCT03107052|65249114|FG000|Overall Study|Withdrawal by Subject|9|||
23411490|NCT03107052|65249115|FG001|Overall Study|Withdrawal by Subject|5|||
23411491|NCT03107052|65249116|FG002|Overall Study|Withdrawal by Subject|8|||
23411492|NCT03107052|65249114|FG000|Overall Study|Protocol Violation|6|||
23411493|NCT03107052|65249115|FG001|Overall Study|Protocol Violation|0|||
23411494|NCT03107052|65249116|FG002|Overall Study|Protocol Violation|3|||
23411495|NCT03107052|65249114|FG000|Overall Study|Lost to Follow-up|4|||
23411496|NCT03107052|65249115|FG001|Overall Study|Lost to Follow-up|0|||
23411497|NCT03107052|65249116|FG002|Overall Study|Lost to Follow-up|1|||
23411498|NCT03107052|65249114|FG000|Overall Study|Lack of Efficacy|23|||
23411499|NCT03107052|65249115|FG001|Overall Study|Lack of Efficacy|7|||
23411500|NCT03107052|65249116|FG002|Overall Study|Lack of Efficacy|4|||
23411501|NCT03107052|65249114|FG000|Overall Study|Other than specified|4|||
23511553|NCT00556712|65609394|FG000|Overall Study|Failure to Return|2|||
23511554|NCT00556712|65609395|FG001|Overall Study|Failure to Return|3|||
23511555|NCT00556712|65609394|FG000|Overall Study|Other|2|||
23511556|NCT00556712|65609395|FG001|Overall Study|Other|2|||
23511557|NCT00556712|65609394|FG000|Overall Study|Ongoing at Data Cutoff|32|||
23511558|NCT00556712|65609395|FG001|Overall Study|Ongoing at Data Cutoff|66|||
23511559|NCT02663674|65609396|FG000|Overall Study|Lost to Follow-up|5|||
23511560|NCT02663674|65609397|FG001|Overall Study|Lost to Follow-up|4|||
23511561|NCT02663674|65609396|FG000|Overall Study|Withdrawal by Subject|1|||
23511562|NCT02663674|65609397|FG001|Overall Study|Withdrawal by Subject|4|||
23511563|NCT02663674|65609396|FG000|Overall Study|Physician Decision|1|||
23511564|NCT02663674|65609397|FG001|Overall Study|Physician Decision|1|||
23511565|NCT02663674|65609396|FG000|Overall Study|Other Event (Health Related)|0|||
23511566|NCT02663674|65609397|FG001|Overall Study|Other Event (Health Related)|1|||
23511567|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
23511568|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
23511569|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
23511570|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
23511571|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|Death|7|||
23511572|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|Death|5|||
23511573|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
23511574|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
23511575|NCT02999854|65609398|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
23511576|NCT02999854|65609399|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
23511577|NCT02999854|65609398|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
23511578|NCT02999854|65609399|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
23511579|NCT02999854|65609398|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
23511580|NCT02999854|65609399|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
23411502|NCT03107052|65249115|FG001|Overall Study|Other than specified|2|||
23411503|NCT03107052|65249116|FG002|Overall Study|Other than specified|0|||
23411504|NCT03107052|65249114|FG000|Overall Study|Study terminated due to futility|67|||
23411505|NCT03107052|65249115|FG001|Overall Study|Study terminated due to futility|31|||
23411506|NCT03107052|65249116|FG002|Overall Study|Study terminated due to futility|23|||
23411507|NCT03951766|65249117|FG000|Treatment Phase|Lost to Follow-up|1|||
23411508|NCT03951766|65249117|FG000|Follow-up Phase|Lost to Follow-up|10|||
23411509|NCT02467192|65249118|FG000|Overall Study|Death|1|||
23411510|NCT02467192|65249118|FG000|Overall Study|revealed to have pneumonia before|2|||
23411511|NCT02920528|65249119|FG000|Overall Study|Incomplete Data|1|||
23411512|NCT02920528|65249120|FG001|Overall Study|Incomplete Data|1|||
23411513|NCT02920528|65249121|FG002|Overall Study|Incomplete Data|1|||
23411514|NCT02920528|65249119|FG000|Overall Study|Adverse Event|0|||
23411515|NCT02920528|65249120|FG001|Overall Study|Adverse Event|0|||
23411516|NCT02920528|65249121|FG002|Overall Study|Adverse Event|3|||
23411517|NCT02920528|65249119|FG000|Overall Study|Did not meet inclusion criteria|2|||
23411518|NCT02920528|65249120|FG001|Overall Study|Did not meet inclusion criteria|0|||
23411519|NCT02920528|65249121|FG002|Overall Study|Did not meet inclusion criteria|1|||
23411520|NCT05005273|65249124|FG000|Overall Study|Study Terminated|1|||
23411521|NCT05005273|65249125|FG001|Overall Study|Study Terminated|0|||
23411522|NCT02443337|65249126|FG000|Overall Study|Adverse Event|0|||
23411523|NCT02443337|65249127|FG001|Overall Study|Adverse Event|1|||
23411524|NCT02443337|65249126|FG000|Overall Study|Clinical Progressive Disease|3|||
23411525|NCT02443337|65249127|FG001|Overall Study|Clinical Progressive Disease|0|||
23411526|NCT02443337|65249126|FG000|Overall Study|Withdrawal by Subject|2|||
23411527|NCT02443337|65249127|FG001|Overall Study|Withdrawal by Subject|1|||
23411528|NCT03748706|65249128|FG000|Overall Study|Lost to Follow-up|1|||
23411529|NCT03098433|65249134|FG000|Overall Study|Withdrawal by Subject|10|||
23411530|NCT04660552|65249135|FG000|Overall Study|Withdrawal by Subject|3|||
23411531|NCT04660552|65249136|FG001|Overall Study|Withdrawal by Subject|1|||
23411532|NCT00579553|65249137|FG000|Overall Study|Lost to Follow-up|16|||
23411533|NCT00579553|65249138|FG001|Overall Study|Lost to Follow-up|13|||
23411534|NCT00861692|65249139|FG000|Overall Study|Death|6|||
23511581|NCT02999854|65609398|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
23511582|NCT02999854|65609399|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
23511583|NCT02743520|65609409|FG000|Overall Study|Withdrawal by Subject|1|||
23511584|NCT02733991|65609415|FG000|Overall Study|Adverse Event|1|||
23511585|NCT02733991|65609416|FG001|Overall Study|Adverse Event|0|||
23411535|NCT04153981|65249140|FG000|Overall Study|Death|1|||
23411536|NCT04153981|65249140|FG000|Overall Study|Withdrawal by Subject|24|||
23411537|NCT04153981|65249140|FG000|Overall Study|Lost to Follow-up|1|||
23411538|NCT04153981|65249140|FG000|Overall Study|Physician Decision|1|||
23411539|NCT04153981|65249140|FG000|Overall Study|Due to Unavailable Glucometer|1|||
23411540|NCT04153981|65249140|FG000|Overall Study|Covid 19|52|||
23511586|NCT02733991|65609415|FG000|Overall Study|Withdrawal by Subject|0|||
23511587|NCT02733991|65609416|FG001|Overall Study|Withdrawal by Subject|5|||
23411541|NCT04153981|65249140|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
23411542|NCT04153981|65249140|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
23411543|NCT04776161|65249141|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
23411544|NCT04776161|65249142|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
23411545|NCT04776161|65249143|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
23411546|NCT04776161|65249141|FG000|Overall Study|Withdrawal by Subject|1|||
23411547|NCT04776161|65249142|FG001|Overall Study|Withdrawal by Subject|0|||
23411548|NCT04776161|65249143|FG002|Overall Study|Withdrawal by Subject|1|||
23411549|NCT04776161|65249141|FG000|Overall Study|Adverse Event|0|||
23411550|NCT04776161|65249142|FG001|Overall Study|Adverse Event|1|||
23411551|NCT04776161|65249143|FG002|Overall Study|Adverse Event|1|||
23411552|NCT00711594|65249146|FG000|Overall Study|Progressive disease|2|||
23411553|NCT00711594|65249147|FG001|Overall Study|Progressive disease|2|||
23411554|NCT00711594|65249148|FG002|Overall Study|Progressive disease|6|||
23411555|NCT00711594|65249149|FG003|Overall Study|Progressive disease|44|||
23411556|NCT00711594|65249146|FG000|Overall Study|Other Adverse Event|1|||
23411557|NCT00711594|65249147|FG001|Overall Study|Other Adverse Event|0|||
23411558|NCT00711594|65249148|FG002|Overall Study|Other Adverse Event|0|||
23411559|NCT00711594|65249149|FG003|Overall Study|Other Adverse Event|16|||
23411560|NCT00711594|65249146|FG000|Overall Study|Withdrawal by Subject|0|||
23411561|NCT00711594|65249147|FG001|Overall Study|Withdrawal by Subject|1|||
23411562|NCT00711594|65249148|FG002|Overall Study|Withdrawal by Subject|0|||
23411563|NCT00711594|65249149|FG003|Overall Study|Withdrawal by Subject|2|||
23411564|NCT01831466|65249150|FG000|Overall Study|Protocol Violation|1|||
23411565|NCT01831466|65249151|FG001|Overall Study|Protocol Violation|1|||
23411566|NCT01831466|65249152|FG002|Overall Study|Protocol Violation|2|||
23411567|NCT01831466|65249153|FG003|Overall Study|Protocol Violation|0|||
23411568|NCT01831466|65249154|FG004|Overall Study|Protocol Violation|0|||
23411569|NCT01831466|65249155|FG005|Overall Study|Protocol Violation|1|||
23411570|NCT01831466|65249156|FG006|Overall Study|Protocol Violation|0|||
23411571|NCT01831466|65249157|FG007|Overall Study|Protocol Violation|0|||
23411572|NCT01831466|65249158|FG008|Overall Study|Protocol Violation|0|||
23411573|NCT01831466|65249159|FG009|Overall Study|Protocol Violation|0|||
23411574|NCT01831466|65249160|FG010|Overall Study|Protocol Violation|0|||
23411575|NCT01831466|65249161|FG011|Overall Study|Protocol Violation|0|||
23411576|NCT01831466|65249150|FG000|Overall Study|Other|2|||
23411577|NCT01831466|65249151|FG001|Overall Study|Other|3|||
23411578|NCT01831466|65249152|FG002|Overall Study|Other|2|||
23411579|NCT01831466|65249153|FG003|Overall Study|Other|2|||
23411580|NCT01831466|65249154|FG004|Overall Study|Other|2|||
23411581|NCT01831466|65249155|FG005|Overall Study|Other|1|||
23411582|NCT01831466|65249156|FG006|Overall Study|Other|0|||
23411583|NCT01831466|65249157|FG007|Overall Study|Other|0|||
23411584|NCT01831466|65249158|FG008|Overall Study|Other|0|||
23411585|NCT01831466|65249159|FG009|Overall Study|Other|0|||
23511588|NCT01031069|65609422|FG000|Overall Study|Serious Adverse Event|0|||
23511589|NCT01031069|65609423|FG001|Overall Study|Serious Adverse Event|1|||
23511590|NCT01031069|65609424|FG002|Overall Study|Serious Adverse Event|0|||
23511591|NCT01031069|65609425|FG003|Overall Study|Serious Adverse Event|0|||
23511592|NCT01031069|65609422|FG000|Overall Study|Withdrawal by Subject|2|||
23511593|NCT01031069|65609423|FG001|Overall Study|Withdrawal by Subject|3|||
23511594|NCT01031069|65609424|FG002|Overall Study|Withdrawal by Subject|18|||
23511595|NCT01031069|65609425|FG003|Overall Study|Withdrawal by Subject|18|||
23511596|NCT01031069|65609422|FG000|Overall Study|Migrated/moved from study area|1|||
23511597|NCT01031069|65609423|FG001|Overall Study|Migrated/moved from study area|2|||
23511598|NCT01031069|65609424|FG002|Overall Study|Migrated/moved from study area|1|||
23511599|NCT01031069|65609425|FG003|Overall Study|Migrated/moved from study area|1|||
23511600|NCT01031069|65609422|FG000|Overall Study|Lost to Follow-up|9|||
23511601|NCT01031069|65609423|FG001|Overall Study|Lost to Follow-up|5|||
23511602|NCT01031069|65609424|FG002|Overall Study|Lost to Follow-up|21|||
23511603|NCT01031069|65609425|FG003|Overall Study|Lost to Follow-up|15|||
23511604|NCT01031069|65609422|FG000|Overall Study|Other|0|||
23511605|NCT01031069|65609423|FG001|Overall Study|Other|0|||
23511606|NCT01031069|65609424|FG002|Overall Study|Other|1|||
23511607|NCT01031069|65609425|FG003|Overall Study|Other|0|||
23411586|NCT01831466|65249160|FG010|Overall Study|Other|0|||
23411587|NCT01831466|65249161|FG011|Overall Study|Other|0|||
23411588|NCT01831466|65249150|FG000|Overall Study|Non-compliance with study treatment|2|||
23411589|NCT01831466|65249151|FG001|Overall Study|Non-compliance with study treatment|1|||
23411590|NCT01831466|65249152|FG002|Overall Study|Non-compliance with study treatment|1|||
23411591|NCT01831466|65249153|FG003|Overall Study|Non-compliance with study treatment|0|||
23411592|NCT01831466|65249154|FG004|Overall Study|Non-compliance with study treatment|0|||
23511608|NCT02511184|65609426|FG000|Overall Study|Death|1|||
23511609|NCT02511184|65609427|FG001|Overall Study|Death|0|||
23511610|NCT02511184|65609426|FG000|Overall Study|Lost to Follow-up|0|||
23511611|NCT02511184|65609427|FG001|Overall Study|Lost to Follow-up|1|||
23511612|NCT02511184|65609426|FG000|Overall Study|Study terminated by sponsor|1|||
23511613|NCT02511184|65609427|FG001|Overall Study|Study terminated by sponsor|5|||
23511614|NCT02511184|65609426|FG000|Overall Study|Withdrawal by Subject|0|||
23511615|NCT02511184|65609427|FG001|Overall Study|Withdrawal by Subject|1|||
23511616|NCT03559257|65609430|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
23511617|NCT03559257|65609431|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
23511618|NCT03559257|65609430|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23511619|NCT03559257|65609431|FG001|Double Blind Treatment Period|Protocol Violation|4|||
23511620|NCT03559257|65609430|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
23511621|NCT03559257|65609431|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
23511622|NCT03559257|65609430|FG000|Double Blind Treatment Period|Adverse Event|0|||
23511623|NCT03559257|65609431|FG001|Double Blind Treatment Period|Adverse Event|1|||
23511624|NCT03559257|65609430|FG000|Double Blind Treatment Period|Screen Failure|0|||
23511625|NCT03559257|65609431|FG001|Double Blind Treatment Period|Screen Failure|1|||
23511626|NCT03559257|65609430|FG000|Open-label Treatment Period|Adverse Event|1|||
23511627|NCT03559257|65609431|FG001|Open-label Treatment Period|Adverse Event|4|||
23511628|NCT03559257|65609430|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
23511629|NCT03559257|65609431|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
23511630|NCT03559257|65609430|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
23511631|NCT03559257|65609431|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23511632|NCT03559257|65609430|FG000|Open-label Treatment Period|Protocol Violation|2|||
23411593|NCT01831466|65249155|FG005|Overall Study|Non-compliance with study treatment|1|||
23411594|NCT01831466|65249156|FG006|Overall Study|Non-compliance with study treatment|0|||
23511633|NCT03559257|65609431|FG001|Open-label Treatment Period|Protocol Violation|0|||
23511634|NCT03559257|65609430|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
23511635|NCT03559257|65609431|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
23511636|NCT03559257|65609430|FG000|Open-label Treatment Period|Physician Decision|0|||
23511637|NCT03559257|65609431|FG001|Open-label Treatment Period|Physician Decision|1|||
23511638|NCT01327885|65609435|FG000|Overall Study|Disease progression-according to RECIST|173|||
23511639|NCT01327885|65609436|FG001|Overall Study|Disease progression-according to RECIST|165|||
23511640|NCT01327885|65609435|FG000|Overall Study|Clinical progression|24|||
23511641|NCT01327885|65609436|FG001|Overall Study|Clinical progression|27|||
23511642|NCT01327885|65609435|FG000|Overall Study|Adverse Event|14|||
23511643|NCT01327885|65609436|FG001|Overall Study|Adverse Event|10|||
23511644|NCT01327885|65609435|FG000|Overall Study|Subject choice|5|||
23511645|NCT01327885|65609436|FG001|Overall Study|Subject choice|10|||
23511646|NCT01327885|65609435|FG000|Overall Study|Other|8|||
23511647|NCT01327885|65609436|FG001|Overall Study|Other|6|||
23511648|NCT01327885|65609435|FG000|Overall Study|Withdrawal of consent from study|3|||
23610583|NCT02676778|65962809|FG000|Overall Study|Withdrawal by Subject|3|||
23411595|NCT01831466|65249157|FG007|Overall Study|Non-compliance with study treatment|0|||
23411596|NCT01831466|65249158|FG008|Overall Study|Non-compliance with study treatment|0|||
23411597|NCT01831466|65249159|FG009|Overall Study|Non-compliance with study treatment|0|||
23411598|NCT01831466|65249160|FG010|Overall Study|Non-compliance with study treatment|0|||
23411599|NCT01831466|65249161|FG011|Overall Study|Non-compliance with study treatment|0|||
23411600|NCT01831466|65249150|FG000|Overall Study|Death|0|||
23411601|NCT01831466|65249151|FG001|Overall Study|Death|1|||
23411602|NCT01831466|65249152|FG002|Overall Study|Death|0|||
23411603|NCT01831466|65249153|FG003|Overall Study|Death|0|||
23411604|NCT01831466|65249154|FG004|Overall Study|Death|0|||
23411605|NCT01831466|65249155|FG005|Overall Study|Death|0|||
23411606|NCT01831466|65249156|FG006|Overall Study|Death|0|||
23411607|NCT01831466|65249157|FG007|Overall Study|Death|0|||
23411608|NCT01831466|65249158|FG008|Overall Study|Death|0|||
23411609|NCT01831466|65249159|FG009|Overall Study|Death|0|||
23411610|NCT01831466|65249160|FG010|Overall Study|Death|0|||
23411611|NCT01831466|65249161|FG011|Overall Study|Death|0|||
23411612|NCT01831466|65249150|FG000|Overall Study|Withdrawal by Subject|6|||
23411613|NCT01831466|65249151|FG001|Overall Study|Withdrawal by Subject|3|||
23411614|NCT01831466|65249152|FG002|Overall Study|Withdrawal by Subject|3|||
23411615|NCT01831466|65249153|FG003|Overall Study|Withdrawal by Subject|3|||
23411616|NCT01831466|65249154|FG004|Overall Study|Withdrawal by Subject|3|||
23411617|NCT01831466|65249155|FG005|Overall Study|Withdrawal by Subject|5|||
23411618|NCT01831466|65249156|FG006|Overall Study|Withdrawal by Subject|0|||
23411619|NCT01831466|65249157|FG007|Overall Study|Withdrawal by Subject|0|||
23411620|NCT01831466|65249158|FG008|Overall Study|Withdrawal by Subject|0|||
23411621|NCT01831466|65249159|FG009|Overall Study|Withdrawal by Subject|1|||
23411622|NCT01831466|65249160|FG010|Overall Study|Withdrawal by Subject|0|||
23411623|NCT01831466|65249161|FG011|Overall Study|Withdrawal by Subject|1|||
23411624|NCT01831466|65249150|FG000|Overall Study|Lost to Follow-up|0|||
23411625|NCT01831466|65249151|FG001|Overall Study|Lost to Follow-up|1|||
23411626|NCT01831466|65249152|FG002|Overall Study|Lost to Follow-up|4|||
23411627|NCT01831466|65249153|FG003|Overall Study|Lost to Follow-up|2|||
23411628|NCT01831466|65249154|FG004|Overall Study|Lost to Follow-up|0|||
23411629|NCT01831466|65249155|FG005|Overall Study|Lost to Follow-up|3|||
23411630|NCT01831466|65249156|FG006|Overall Study|Lost to Follow-up|0|||
23411631|NCT01831466|65249157|FG007|Overall Study|Lost to Follow-up|0|||
23411632|NCT01831466|65249158|FG008|Overall Study|Lost to Follow-up|0|||
23411633|NCT01831466|65249159|FG009|Overall Study|Lost to Follow-up|1|||
23411634|NCT01831466|65249160|FG010|Overall Study|Lost to Follow-up|0|||
23411635|NCT01831466|65249161|FG011|Overall Study|Lost to Follow-up|1|||
23411636|NCT01831466|65249150|FG000|Overall Study|Lack of Efficacy|5|||
23411637|NCT01831466|65249151|FG001|Overall Study|Lack of Efficacy|8|||
23411638|NCT01831466|65249152|FG002|Overall Study|Lack of Efficacy|7|||
23411639|NCT01831466|65249153|FG003|Overall Study|Lack of Efficacy|6|||
23411640|NCT01831466|65249154|FG004|Overall Study|Lack of Efficacy|9|||
23411641|NCT01831466|65249155|FG005|Overall Study|Lack of Efficacy|8|||
23411642|NCT01831466|65249156|FG006|Overall Study|Lack of Efficacy|1|||
23411643|NCT01831466|65249157|FG007|Overall Study|Lack of Efficacy|1|||
23411644|NCT01831466|65249158|FG008|Overall Study|Lack of Efficacy|2|||
23411645|NCT01831466|65249159|FG009|Overall Study|Lack of Efficacy|2|||
23411646|NCT01831466|65249160|FG010|Overall Study|Lack of Efficacy|2|||
23411647|NCT01831466|65249161|FG011|Overall Study|Lack of Efficacy|0|||
23411648|NCT01831466|65249150|FG000|Overall Study|Adverse Event|0|||
23411649|NCT01831466|65249151|FG001|Overall Study|Adverse Event|0|||
23411650|NCT01831466|65249152|FG002|Overall Study|Adverse Event|4|||
23411651|NCT01831466|65249153|FG003|Overall Study|Adverse Event|6|||
23411652|NCT01831466|65249154|FG004|Overall Study|Adverse Event|3|||
23411653|NCT01831466|65249155|FG005|Overall Study|Adverse Event|7|||
23411654|NCT01831466|65249156|FG006|Overall Study|Adverse Event|0|||
23411655|NCT01831466|65249157|FG007|Overall Study|Adverse Event|1|||
23411656|NCT01831466|65249158|FG008|Overall Study|Adverse Event|1|||
23411657|NCT01831466|65249159|FG009|Overall Study|Adverse Event|1|||
23411658|NCT01831466|65249160|FG010|Overall Study|Adverse Event|0|||
23411659|NCT01831466|65249161|FG011|Overall Study|Adverse Event|2|||
23411660|NCT03604172|65249162|FG000|Overall Study|Lost to Follow-up|1|||
23411661|NCT03604172|65249163|FG001|Overall Study|Lost to Follow-up|2|||
23411662|NCT02370368|65252234|FG000|Overall Study|Adverse Event|1|||
23411663|NCT02370368|65252235|FG001|Overall Study|Adverse Event|2|||
23411664|NCT02370368|65252234|FG000|Overall Study|Withdrawal by Subject|5|||
23411665|NCT02370368|65252235|FG001|Overall Study|Withdrawal by Subject|4|||
23411666|NCT01700959|65252239|FG000|Overall Study|Adverse Event|0|||
23411667|NCT01700959|65252240|FG001|Overall Study|Adverse Event|1|||
23411668|NCT01700959|65252241|FG002|Overall Study|Adverse Event|1|||
23411669|NCT01700959|65252242|FG003|Overall Study|Adverse Event|2|||
23411670|NCT01700959|65252243|FG004|Overall Study|Adverse Event|0|||
23411671|NCT01700959|65252244|FG005|Overall Study|Adverse Event|2|||
23411672|NCT01700959|65252239|FG000|Overall Study|Withdrawal by Subject|15|||
23411673|NCT01700959|65252240|FG001|Overall Study|Withdrawal by Subject|9|||
23411674|NCT01700959|65252241|FG002|Overall Study|Withdrawal by Subject|12|||
23411675|NCT01700959|65252242|FG003|Overall Study|Withdrawal by Subject|11|||
23411676|NCT01700959|65252243|FG004|Overall Study|Withdrawal by Subject|8|||
23411677|NCT01700959|65252244|FG005|Overall Study|Withdrawal by Subject|12|||
23411678|NCT01700959|65252239|FG000|Overall Study|Ineligible|2|||
23411679|NCT01700959|65252240|FG001|Overall Study|Ineligible|1|||
23411680|NCT01700959|65252241|FG002|Overall Study|Ineligible|2|||
23411681|NCT01700959|65252242|FG003|Overall Study|Ineligible|0|||
23411682|NCT01700959|65252243|FG004|Overall Study|Ineligible|0|||
23411683|NCT01700959|65252244|FG005|Overall Study|Ineligible|1|||
23411684|NCT01700959|65252239|FG000|Overall Study|Noncompliant|9|||
23411685|NCT01700959|65252240|FG001|Overall Study|Noncompliant|9|||
23411686|NCT01700959|65252241|FG002|Overall Study|Noncompliant|17|||
23411687|NCT01700959|65252242|FG003|Overall Study|Noncompliant|18|||
23411688|NCT01700959|65252243|FG004|Overall Study|Noncompliant|15|||
23411689|NCT01700959|65252244|FG005|Overall Study|Noncompliant|9|||
23411690|NCT01700959|65252239|FG000|Overall Study|Side effects|1|||
23411691|NCT01700959|65252240|FG001|Overall Study|Side effects|4|||
23511649|NCT01327885|65609436|FG001|Overall Study|Withdrawal of consent from study|4|||
23511650|NCT01327885|65609435|FG000|Overall Study|Not treated|1|||
23511651|NCT01327885|65609436|FG001|Overall Study|Not treated|1|||
23511652|NCT01327885|65609435|FG000|Overall Study|Administrative decision|0|||
23511653|NCT01327885|65609436|FG001|Overall Study|Administrative decision|1|||
23511654|NCT03090152|65609437|FG000|Overall Study|Withdrawal by Subject|0|||
23511655|NCT03090152|65609438|FG001|Overall Study|Withdrawal by Subject|2|||
23511656|NCT03090152|65609439|FG002|Overall Study|Withdrawal by Subject|1|||
23511657|NCT03090152|65609437|FG000|Overall Study|Surgery Canceled|1|||
23511658|NCT03090152|65609438|FG001|Overall Study|Surgery Canceled|0|||
23411692|NCT01700959|65252241|FG002|Overall Study|Side effects|8|||
23411693|NCT01700959|65252242|FG003|Overall Study|Side effects|4|||
23511659|NCT03090152|65609439|FG002|Overall Study|Surgery Canceled|0|||
23511660|NCT03090152|65609437|FG000|Overall Study|Epidural catheter could not be placed|0|||
23610584|NCT02676778|65962810|FG001|Overall Study|Withdrawal by Subject|2|||
23205190|NCT00492856|64491288|FG003|Consolidation|Adverse Event|0|||
23411694|NCT01700959|65252243|FG004|Overall Study|Side effects|4|||
23411695|NCT01700959|65252244|FG005|Overall Study|Side effects|1|||
23411696|NCT01188551|65252245|FG000|Overall Study|Pharmacy issues|1|||
23411697|NCT01188551|65252246|FG001|Overall Study|Pharmacy issues|0|||
23411698|NCT01188551|65252247|FG002|Overall Study|Pharmacy issues|0|||
23411699|NCT01188551|65252248|FG003|Overall Study|Pharmacy issues|0|||
23511661|NCT03090152|65609438|FG001|Overall Study|Epidural catheter could not be placed|2|||
23511662|NCT03090152|65609439|FG002|Overall Study|Epidural catheter could not be placed|0|||
23511663|NCT01059799|65609446|FG000|Overall Study|Adverse Event|2|||
23511664|NCT01059799|65609447|FG001|Overall Study|Adverse Event|3|||
23511665|NCT01059799|65609446|FG000|Overall Study|Lack of Efficacy|1|||
23511666|NCT01059799|65609447|FG001|Overall Study|Lack of Efficacy|0|||
23411700|NCT02120781|65252258|FG000|Overall Study|Physician Decision|2|||
23411701|NCT02120781|65252259|FG001|Overall Study|Physician Decision|0|||
23411702|NCT02120781|65252258|FG000|Overall Study|Completion not documented|2|||
23411703|NCT02120781|65252259|FG001|Overall Study|Completion not documented|1|||
23411704|NCT00249808|65252260|FG000|Overall Study|Other|27|||
23411705|NCT00249808|65252260|FG000|Overall Study|Protocol Violation|3|||
23411706|NCT00249808|65252260|FG000|Overall Study|Lost to Follow-up|8|||
23411707|NCT00249808|65252260|FG000|Overall Study|Adverse Event|81|||
23411708|NCT00249808|65252260|FG000|Overall Study|Lack of Efficacy|52|||
23411709|NCT00249808|65252260|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
23411710|NCT03711370|65252261|FG000|Overall Study|Lost to Follow-up|16|||
23411711|NCT03711370|65252262|FG001|Overall Study|Lost to Follow-up|10|||
23411712|NCT03711370|65252261|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
23411713|NCT03711370|65252262|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
23411714|NCT04245449|65252263|FG000|Overall Study|COVID shutdown|7|||
23411715|NCT04470050|65252269|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23411716|NCT04470050|65252270|FG001|Double-blind Treatment Phase|Adverse Event|0|||
23511667|NCT01059799|65609446|FG000|Overall Study|Protocol Violation|3|||
23511668|NCT01059799|65609447|FG001|Overall Study|Protocol Violation|2|||
23511669|NCT01059799|65609446|FG000|Overall Study|Withdrawal criteria|13|||
23511670|NCT01059799|65609447|FG001|Overall Study|Withdrawal criteria|2|||
23511671|NCT01059799|65609446|FG000|Overall Study|Other|12|||
23511672|NCT01059799|65609447|FG001|Overall Study|Other|3|||
23511673|NCT01996982|65609459|FG000|Overall Study|PI/team left institution|7|||
23511674|NCT00750204|65609460|FG000|Overall Study|study halted prematurely|1|||
23511675|NCT00750204|65609461|FG001|Overall Study|study halted prematurely|1|||
23511676|NCT04626297|65609473|FG000|Overall Study|Adverse Event|5|||
23511677|NCT04626297|65609474|FG001|Overall Study|Adverse Event|3|||
23511678|NCT04626297|65609473|FG000|Overall Study|Lost to Follow-up|7|||
23511679|NCT04626297|65609474|FG001|Overall Study|Lost to Follow-up|3|||
23511680|NCT04626297|65609473|FG000|Overall Study|Protocol Violation|5|||
23511681|NCT04626297|65609474|FG001|Overall Study|Protocol Violation|1|||
23511682|NCT04626297|65609473|FG000|Overall Study|Withdrawal by Subject|20|||
23511683|NCT04626297|65609474|FG001|Overall Study|Withdrawal by Subject|6|||
23511684|NCT04626297|65609473|FG000|Overall Study|Sponsor decision|2|||
23511685|NCT04626297|65609474|FG001|Overall Study|Sponsor decision|1|||
23511686|NCT04876274|65609475|FG000|Overall Study|Lost to Follow-up|9|||
23511687|NCT04876274|65609476|FG001|Overall Study|Lost to Follow-up|12|||
23511688|NCT01314443|65609477|FG000|Overall Study|Withdrawal by Subject|2|||
23511689|NCT01314443|65609478|FG001|Overall Study|Withdrawal by Subject|1|||
23511690|NCT01314443|65609479|FG002|Overall Study|Withdrawal by Subject|1|||
23511691|NCT01314443|65609480|FG003|Overall Study|Withdrawal by Subject|1|||
23511692|NCT01314443|65609477|FG000|Overall Study|Protocol Violation|2|||
23511693|NCT01314443|65609478|FG001|Overall Study|Protocol Violation|2|||
23411717|NCT04470050|65252271|FG002|Double-blind Treatment Phase|Adverse Event|0|||
23411718|NCT04470050|65252272|FG003|Double-blind Treatment Phase|Adverse Event|1|||
23511694|NCT01314443|65609479|FG002|Overall Study|Protocol Violation|1|||
23511695|NCT01314443|65609480|FG003|Overall Study|Protocol Violation|1|||
23411719|NCT04470050|65252273|FG004|Double-blind Treatment Phase|Adverse Event|0|||
23411720|NCT04470050|65252274|FG005|Double-blind Treatment Phase|Adverse Event|0|||
23411721|NCT04470050|65252275|FG006|Double-blind Treatment Phase|Adverse Event|0|||
23411722|NCT04470050|65252269|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23511696|NCT02282020|65609485|FG000|Overall Study|Objective Disease Progression|128|||
23411723|NCT04470050|65252270|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411724|NCT04470050|65252271|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411725|NCT04470050|65252272|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411726|NCT04470050|65252273|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
23411727|NCT04470050|65252274|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411728|NCT04470050|65252275|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
23411729|NCT04470050|65252269|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
23411730|NCT04470050|65252270|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
23411731|NCT04470050|65252271|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
23411732|NCT04470050|65252272|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
23411733|NCT04470050|65252273|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
23411734|NCT04470050|65252274|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
23411735|NCT04470050|65252275|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
23411736|NCT01147250|65252276|FG000|Overall Study|Lost to Follow-up|14|||
23411737|NCT01147250|65252277|FG001|Overall Study|Lost to Follow-up|11|||
23411738|NCT01147250|65252276|FG000|Overall Study|Withdrawal by Subject|83|||
23411739|NCT01147250|65252277|FG001|Overall Study|Withdrawal by Subject|88|||
23411740|NCT01147250|65252276|FG000|Overall Study|Site termination by sponsor|13|||
23411741|NCT01147250|65252277|FG001|Overall Study|Site termination by sponsor|5|||
23411742|NCT01147250|65252276|FG000|Overall Study|Other than specified|0|||
23411743|NCT01147250|65252277|FG001|Overall Study|Other than specified|1|||
23411744|NCT02574078|65252286|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411745|NCT02574078|65252287|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411746|NCT02574078|65252288|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411747|NCT02574078|65252289|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411748|NCT02574078|65252290|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411749|NCT02574078|65252291|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23411750|NCT02574078|65252292|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
23411751|NCT02574078|65252293|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411752|NCT02574078|65252294|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23411753|NCT02574078|65252295|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411754|NCT02574078|65252296|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411755|NCT02574078|65252297|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411756|NCT02574078|65252298|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23411757|NCT02574078|65252286|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
23411758|NCT02574078|65252287|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23411759|NCT02574078|65252288|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
23411760|NCT02574078|65252289|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
23411761|NCT02574078|65252290|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
23411762|NCT02574078|65252291|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
23411763|NCT02574078|65252292|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
23411764|NCT02574078|65252293|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
23411765|NCT02574078|65252294|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
23411766|NCT02574078|65252295|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
23511697|NCT02282020|65609486|FG001|Overall Study|Objective Disease Progression|30|||
23511698|NCT02282020|65609485|FG000|Overall Study|Adverse Event|18|||
23511699|NCT02282020|65609486|FG001|Overall Study|Adverse Event|15|||
23511700|NCT02282020|65609485|FG000|Overall Study|Withdrawal by Subject|7|||
23511701|NCT02282020|65609486|FG001|Overall Study|Withdrawal by Subject|10|||
23511702|NCT02282020|65609485|FG000|Overall Study|Miscellaneous|5|||
23511703|NCT02282020|65609486|FG001|Overall Study|Miscellaneous|19|||
23511704|NCT02282020|65609485|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
23511705|NCT02282020|65609486|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
23511706|NCT02282020|65609485|FG000|Overall Study|Developed Discontinuation Criteria|0|||
23511707|NCT02282020|65609486|FG001|Overall Study|Developed Discontinuation Criteria|2|||
23511708|NCT02282020|65609485|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
23511709|NCT02282020|65609486|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
23511710|NCT01585194|65609487|FG000|Overall Study|Withdrawal by Subject|1|||
23511711|NCT01585194|65609487|FG000|Overall Study|Physician Decision|2|||
23511712|NCT01585194|65609487|FG000|Overall Study|Lack of insurance|1|||
23411767|NCT02574078|65252296|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
23411768|NCT02574078|65252297|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
23411769|NCT02574078|65252298|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
23411770|NCT02574078|65252286|FG000|Pre-Treatment Period|Other reasons|0|||
23411771|NCT02574078|65252287|FG001|Pre-Treatment Period|Other reasons|0|||
23411772|NCT02574078|65252288|FG002|Pre-Treatment Period|Other reasons|0|||
23411773|NCT02574078|65252289|FG003|Pre-Treatment Period|Other reasons|0|||
23411774|NCT02574078|65252290|FG004|Pre-Treatment Period|Other reasons|0|||
23511713|NCT00877383|65609491|FG000|Overall Study|Adverse Event|13|||
23411775|NCT02574078|65252291|FG005|Pre-Treatment Period|Other reasons|0|||
23411776|NCT02574078|65252292|FG006|Pre-Treatment Period|Other reasons|2|||
23411777|NCT02574078|65252293|FG007|Pre-Treatment Period|Other reasons|0|||
23411778|NCT02574078|65252294|FG008|Pre-Treatment Period|Other reasons|0|||
23411779|NCT02574078|65252295|FG009|Pre-Treatment Period|Other reasons|0|||
23411780|NCT02574078|65252296|FG010|Pre-Treatment Period|Other reasons|2|||
23411781|NCT02574078|65252297|FG011|Pre-Treatment Period|Other reasons|0|||
23411782|NCT02574078|65252298|FG012|Pre-Treatment Period|Other reasons|0|||
23411783|NCT02574078|65252286|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
23411784|NCT02574078|65252287|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
23411785|NCT02574078|65252288|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
23411786|NCT02574078|65252289|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
23411787|NCT02574078|65252290|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
23411788|NCT02574078|65252291|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
23411789|NCT02574078|65252292|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
23411790|NCT02574078|65252293|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
23411791|NCT02574078|65252294|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
23411792|NCT02574078|65252295|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
23411793|NCT02574078|65252296|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
23411794|NCT02574078|65252297|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
23411795|NCT02574078|65252298|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
23411796|NCT02574078|65252286|FG000|Treatment Period|Disease progression|6|||
23411797|NCT02574078|65252287|FG001|Treatment Period|Disease progression|4|||
23411798|NCT02574078|65252288|FG002|Treatment Period|Disease progression|7|||
23411799|NCT02574078|65252289|FG003|Treatment Period|Disease progression|18|||
23411800|NCT02574078|65252290|FG004|Treatment Period|Disease progression|16|||
23411801|NCT02574078|65252291|FG005|Treatment Period|Disease progression|26|||
23411802|NCT02574078|65252292|FG006|Treatment Period|Disease progression|5|||
23411803|NCT02574078|65252293|FG007|Treatment Period|Disease progression|9|||
23411804|NCT02574078|65252294|FG008|Treatment Period|Disease progression|8|||
23411805|NCT02574078|65252295|FG009|Treatment Period|Disease progression|5|||
23411806|NCT02574078|65252296|FG010|Treatment Period|Disease progression|20|||
23411807|NCT02574078|65252297|FG011|Treatment Period|Disease progression|29|||
23411808|NCT02574078|65252298|FG012|Treatment Period|Disease progression|2|||
23411809|NCT02574078|65252286|FG000|Treatment Period|Study drug toxicity|1|||
23411810|NCT02574078|65252287|FG001|Treatment Period|Study drug toxicity|1|||
23411811|NCT02574078|65252288|FG002|Treatment Period|Study drug toxicity|0|||
23411812|NCT02574078|65252289|FG003|Treatment Period|Study drug toxicity|5|||
23411813|NCT02574078|65252290|FG004|Treatment Period|Study drug toxicity|3|||
23411814|NCT02574078|65252291|FG005|Treatment Period|Study drug toxicity|1|||
23411815|NCT02574078|65252292|FG006|Treatment Period|Study drug toxicity|2|||
23411816|NCT02574078|65252293|FG007|Treatment Period|Study drug toxicity|0|||
23411817|NCT02574078|65252294|FG008|Treatment Period|Study drug toxicity|2|||
23411818|NCT02574078|65252295|FG009|Treatment Period|Study drug toxicity|1|||
23411819|NCT02574078|65252296|FG010|Treatment Period|Study drug toxicity|16|||
23411820|NCT02574078|65252297|FG011|Treatment Period|Study drug toxicity|2|||
23411821|NCT02574078|65252298|FG012|Treatment Period|Study drug toxicity|4|||
23411822|NCT02574078|65252286|FG000|Treatment Period|Death|2|||
23411823|NCT02574078|65252287|FG001|Treatment Period|Death|0|||
23411824|NCT02574078|65252288|FG002|Treatment Period|Death|0|||
23411825|NCT02574078|65252289|FG003|Treatment Period|Death|0|||
23411826|NCT02574078|65252290|FG004|Treatment Period|Death|1|||
23411827|NCT02574078|65252291|FG005|Treatment Period|Death|1|||
23411828|NCT02574078|65252292|FG006|Treatment Period|Death|1|||
23411829|NCT02574078|65252293|FG007|Treatment Period|Death|1|||
23411830|NCT02574078|65252294|FG008|Treatment Period|Death|7|||
23411831|NCT02574078|65252295|FG009|Treatment Period|Death|1|||
23411832|NCT02574078|65252296|FG010|Treatment Period|Death|0|||
23411833|NCT02574078|65252297|FG011|Treatment Period|Death|2|||
23411834|NCT02574078|65252298|FG012|Treatment Period|Death|1|||
23411835|NCT02574078|65252286|FG000|Treatment Period|Adverse event unrelated to drug|0|||
23411836|NCT02574078|65252287|FG001|Treatment Period|Adverse event unrelated to drug|0|||
23411837|NCT02574078|65252288|FG002|Treatment Period|Adverse event unrelated to drug|1|||
23411838|NCT02574078|65252289|FG003|Treatment Period|Adverse event unrelated to drug|0|||
23411839|NCT02574078|65252290|FG004|Treatment Period|Adverse event unrelated to drug|2|||
23511714|NCT00877383|65609492|FG001|Overall Study|Adverse Event|14|||
23511715|NCT00877383|65609491|FG000|Overall Study|Lost to Follow-up|5|||
23411840|NCT02574078|65252291|FG005|Treatment Period|Adverse event unrelated to drug|3|||
23411841|NCT02574078|65252292|FG006|Treatment Period|Adverse event unrelated to drug|0|||
23411842|NCT02574078|65252293|FG007|Treatment Period|Adverse event unrelated to drug|0|||
23411843|NCT02574078|65252294|FG008|Treatment Period|Adverse event unrelated to drug|1|||
23411844|NCT02574078|65252295|FG009|Treatment Period|Adverse event unrelated to drug|2|||
23411845|NCT02574078|65252296|FG010|Treatment Period|Adverse event unrelated to drug|4|||
23411846|NCT02574078|65252297|FG011|Treatment Period|Adverse event unrelated to drug|1|||
23411847|NCT02574078|65252298|FG012|Treatment Period|Adverse event unrelated to drug|0|||
23411848|NCT02574078|65252286|FG000|Treatment Period|Administrative reason by Sponsor|0|||
23411849|NCT02574078|65252287|FG001|Treatment Period|Administrative reason by Sponsor|1|||
23411850|NCT02574078|65252288|FG002|Treatment Period|Administrative reason by Sponsor|0|||
23411851|NCT02574078|65252289|FG003|Treatment Period|Administrative reason by Sponsor|0|||
23411852|NCT02574078|65252290|FG004|Treatment Period|Administrative reason by Sponsor|0|||
23411853|NCT02574078|65252291|FG005|Treatment Period|Administrative reason by Sponsor|0|||
23411854|NCT02574078|65252292|FG006|Treatment Period|Administrative reason by Sponsor|1|||
23411855|NCT02574078|65252293|FG007|Treatment Period|Administrative reason by Sponsor|0|||
23411856|NCT02574078|65252294|FG008|Treatment Period|Administrative reason by Sponsor|0|||
23411857|NCT02574078|65252295|FG009|Treatment Period|Administrative reason by Sponsor|0|||
23411858|NCT02574078|65252296|FG010|Treatment Period|Administrative reason by Sponsor|0|||
23411859|NCT02574078|65252297|FG011|Treatment Period|Administrative reason by Sponsor|0|||
23411860|NCT02574078|65252298|FG012|Treatment Period|Administrative reason by Sponsor|3|||
23411861|NCT02574078|65252286|FG000|Treatment Period|Other reasons|1|||
23411862|NCT02574078|65252287|FG001|Treatment Period|Other reasons|0|||
23411863|NCT02574078|65252288|FG002|Treatment Period|Other reasons|1|||
23411864|NCT02574078|65252289|FG003|Treatment Period|Other reasons|3|||
23411865|NCT02574078|65252290|FG004|Treatment Period|Other reasons|3|||
23411866|NCT02574078|65252291|FG005|Treatment Period|Other reasons|1|||
23411867|NCT02574078|65252292|FG006|Treatment Period|Other reasons|2|||
23411868|NCT02574078|65252293|FG007|Treatment Period|Other reasons|1|||
23411869|NCT02574078|65252294|FG008|Treatment Period|Other reasons|3|||
23411870|NCT02574078|65252295|FG009|Treatment Period|Other reasons|1|||
23411871|NCT02574078|65252296|FG010|Treatment Period|Other reasons|1|||
23411872|NCT02574078|65252297|FG011|Treatment Period|Other reasons|3|||
23411873|NCT02574078|65252298|FG012|Treatment Period|Other reasons|1|||
23411874|NCT02574078|65252286|FG000|Treatment Period|Participant request to stop drug|0|||
23411875|NCT02574078|65252287|FG001|Treatment Period|Participant request to stop drug|0|||
23411876|NCT02574078|65252288|FG002|Treatment Period|Participant request to stop drug|0|||
23411877|NCT02574078|65252289|FG003|Treatment Period|Participant request to stop drug|2|||
23411878|NCT02574078|65252290|FG004|Treatment Period|Participant request to stop drug|4|||
23411879|NCT02574078|65252291|FG005|Treatment Period|Participant request to stop drug|0|||
23411880|NCT02574078|65252292|FG006|Treatment Period|Participant request to stop drug|1|||
23411881|NCT02574078|65252293|FG007|Treatment Period|Participant request to stop drug|0|||
23411882|NCT02574078|65252294|FG008|Treatment Period|Participant request to stop drug|3|||
23411883|NCT02574078|65252295|FG009|Treatment Period|Participant request to stop drug|2|||
23411884|NCT02574078|65252296|FG010|Treatment Period|Participant request to stop drug|2|||
23411885|NCT02574078|65252297|FG011|Treatment Period|Participant request to stop drug|4|||
23411886|NCT02574078|65252298|FG012|Treatment Period|Participant request to stop drug|1|||
23411887|NCT02574078|65252286|FG000|Treatment Period|Participant withdrew consent|0|||
23411888|NCT02574078|65252287|FG001|Treatment Period|Participant withdrew consent|0|||
23411889|NCT02574078|65252288|FG002|Treatment Period|Participant withdrew consent|0|||
23411890|NCT02574078|65252289|FG003|Treatment Period|Participant withdrew consent|0|||
23411891|NCT02574078|65252290|FG004|Treatment Period|Participant withdrew consent|1|||
23411892|NCT02574078|65252291|FG005|Treatment Period|Participant withdrew consent|1|||
23411893|NCT02574078|65252292|FG006|Treatment Period|Participant withdrew consent|0|||
23411894|NCT02574078|65252293|FG007|Treatment Period|Participant withdrew consent|1|||
23411895|NCT02574078|65252294|FG008|Treatment Period|Participant withdrew consent|0|||
23411896|NCT02574078|65252295|FG009|Treatment Period|Participant withdrew consent|2|||
23411897|NCT02574078|65252296|FG010|Treatment Period|Participant withdrew consent|1|||
23411898|NCT02574078|65252297|FG011|Treatment Period|Participant withdrew consent|4|||
23411899|NCT02574078|65252298|FG012|Treatment Period|Participant withdrew consent|1|||
23411900|NCT02574078|65252286|FG000|Treatment Period|Participant no longer meets criteria|0|||
23411901|NCT02574078|65252287|FG001|Treatment Period|Participant no longer meets criteria|0|||
23411902|NCT02574078|65252288|FG002|Treatment Period|Participant no longer meets criteria|0|||
23411903|NCT02574078|65252289|FG003|Treatment Period|Participant no longer meets criteria|0|||
23411904|NCT02574078|65252290|FG004|Treatment Period|Participant no longer meets criteria|1|||
23411905|NCT02574078|65252291|FG005|Treatment Period|Participant no longer meets criteria|0|||
23411906|NCT02574078|65252292|FG006|Treatment Period|Participant no longer meets criteria|0|||
23411907|NCT02574078|65252293|FG007|Treatment Period|Participant no longer meets criteria|0|||
23411908|NCT02574078|65252294|FG008|Treatment Period|Participant no longer meets criteria|0|||
23411909|NCT02574078|65252295|FG009|Treatment Period|Participant no longer meets criteria|1|||
23411910|NCT02574078|65252296|FG010|Treatment Period|Participant no longer meets criteria|1|||
23411911|NCT02574078|65252297|FG011|Treatment Period|Participant no longer meets criteria|1|||
23411912|NCT02574078|65252298|FG012|Treatment Period|Participant no longer meets criteria|0|||
23411913|NCT02574078|65252286|FG000|Treatment Period|Lost to Follow-up|0|||
23411914|NCT02574078|65252287|FG001|Treatment Period|Lost to Follow-up|0|||
23411915|NCT02574078|65252288|FG002|Treatment Period|Lost to Follow-up|0|||
23411916|NCT02574078|65252289|FG003|Treatment Period|Lost to Follow-up|0|||
23411917|NCT02574078|65252290|FG004|Treatment Period|Lost to Follow-up|0|||
23411918|NCT02574078|65252291|FG005|Treatment Period|Lost to Follow-up|0|||
23411919|NCT02574078|65252292|FG006|Treatment Period|Lost to Follow-up|0|||
23411920|NCT02574078|65252293|FG007|Treatment Period|Lost to Follow-up|0|||
23411921|NCT02574078|65252294|FG008|Treatment Period|Lost to Follow-up|0|||
23411922|NCT02574078|65252295|FG009|Treatment Period|Lost to Follow-up|1|||
23307289|NCT05012163|64870466|FG003|Overall Study|Protocol Violation|1|||
23307290|NCT03233230|64870473|FG000|Overall Study|Adverse Event|6|||
23411923|NCT02574078|65252296|FG010|Treatment Period|Lost to Follow-up|0|||
23411924|NCT02574078|65252297|FG011|Treatment Period|Lost to Follow-up|1|||
23411925|NCT02574078|65252298|FG012|Treatment Period|Lost to Follow-up|0|||
23307291|NCT03233230|64870474|FG001|Overall Study|Adverse Event|3|||
23307292|NCT03233230|64870475|FG002|Overall Study|Adverse Event|6|||
23307293|NCT03233230|64870476|FG003|Overall Study|Adverse Event|3|||
23307294|NCT03233230|64870473|FG000|Overall Study|Protocol Violation|1|||
23307295|NCT03233230|64870474|FG001|Overall Study|Protocol Violation|2|||
23307296|NCT03233230|64870475|FG002|Overall Study|Protocol Violation|1|||
23307297|NCT03233230|64870476|FG003|Overall Study|Protocol Violation|1|||
23307298|NCT03233230|64870473|FG000|Overall Study|Lack of Efficacy|1|||
23307299|NCT03233230|64870474|FG001|Overall Study|Lack of Efficacy|0|||
23307300|NCT03233230|64870475|FG002|Overall Study|Lack of Efficacy|0|||
23307301|NCT03233230|64870476|FG003|Overall Study|Lack of Efficacy|0|||
23307302|NCT03233230|64870473|FG000|Overall Study|Other|5|||
23307303|NCT03233230|64870474|FG001|Overall Study|Other|5|||
23307304|NCT03233230|64870475|FG002|Overall Study|Other|5|||
23307305|NCT03233230|64870476|FG003|Overall Study|Other|3|||
23307306|NCT03233230|64870473|FG000|Overall Study|Withdrawal by Subject|2|||
23307307|NCT03233230|64870474|FG001|Overall Study|Withdrawal by Subject|2|||
23307308|NCT03233230|64870475|FG002|Overall Study|Withdrawal by Subject|0|||
23307309|NCT03233230|64870476|FG003|Overall Study|Withdrawal by Subject|1|||
23307310|NCT03233230|64870473|FG000|Overall Study|Lost to Follow-up|0|||
23307311|NCT03233230|64870474|FG001|Overall Study|Lost to Follow-up|3|||
23307312|NCT03233230|64870475|FG002|Overall Study|Lost to Follow-up|0|||
23307313|NCT03233230|64870476|FG003|Overall Study|Lost to Follow-up|0|||
23307314|NCT00688376|64870477|FG000|Double-Blind Phase|Adverse Event|4|||
23307315|NCT00688376|64870478|FG001|Double-Blind Phase|Adverse Event|4|||
23307316|NCT00688376|64870477|FG000|Double-Blind Phase|Protocol Violation|1|||
23307317|NCT00688376|64870478|FG001|Double-Blind Phase|Protocol Violation|2|||
23307318|NCT00688376|64870477|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
23307319|NCT00688376|64870478|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
23307320|NCT00688376|64870477|FG000|Double-Blind Phase|Not treated|0|||
23307321|NCT00688376|64870478|FG001|Double-Blind Phase|Not treated|1|||
23307322|NCT00688376|64870477|FG000|Blinded Extension Phase|Adverse Event|3|||
23307323|NCT00688376|64870478|FG001|Blinded Extension Phase|Adverse Event|4|||
23307324|NCT00688376|64870477|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
23307325|NCT00688376|64870478|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
23307326|NCT00688376|64870477|FG000|Blinded Extension Phase|Physician Decision|1|||
23307327|NCT00688376|64870478|FG001|Blinded Extension Phase|Physician Decision|0|||
23307328|NCT00688376|64870477|FG000|Blinded Extension Phase|Other|1|||
23307329|NCT00688376|64870478|FG001|Blinded Extension Phase|Other|0|||
23307330|NCT03579966|64870479|FG000|Overall Study|Adverse Event|6|||
23307331|NCT03579966|64870479|FG000|Overall Study|Lost to Follow-up|4|||
23307332|NCT03579966|64870479|FG000|Overall Study|Physician Decision|10|||
23307333|NCT03579966|64870479|FG000|Overall Study|Pregnancy|1|||
23307334|NCT03579966|64870479|FG000|Overall Study|Withdrawal by Subject|16|||
23307335|NCT03579966|64870479|FG000|Overall Study|Study terminated by Sponsor|22|||
23307336|NCT03579966|64870479|FG000|Overall Study|Protocol Violation|1|||
23307337|NCT01297465|64870480|FG000|Overall Study|Lack of Ovarian Response|1|||
23307338|NCT01297465|64870481|FG001|Overall Study|Lack of Ovarian Response|1|||
23307339|NCT01297465|64870480|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
23307340|NCT01297465|64870481|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23307341|NCT01297465|64870480|FG000|Overall Study|No Oocytes Retrieved|1|||
23307342|NCT01297465|64870481|FG001|Overall Study|No Oocytes Retrieved|1|||
23307343|NCT01297465|64870480|FG000|Overall Study|Poor oocyte quality|0|||
23307344|NCT01297465|64870481|FG001|Overall Study|Poor oocyte quality|1|||
23307345|NCT01297465|64870480|FG000|Overall Study|No Fertilization|6|||
23307346|NCT01297465|64870481|FG001|Overall Study|No Fertilization|4|||
23307347|NCT01297465|64870480|FG000|Overall Study|All Embryos Discarded|0|||
23307348|NCT01297465|64870481|FG001|Overall Study|All Embryos Discarded|1|||
23307349|NCT01297465|64870480|FG000|Overall Study|Intention to Freeze all Embryos|0|||
23307350|NCT01297465|64870481|FG001|Overall Study|Intention to Freeze all Embryos|1|||
23307351|NCT03107026|64870482|FG000|Overall Study|Adverse Event|2|||
23307352|NCT03107026|64870483|FG001|Overall Study|Adverse Event|14|||
23307353|NCT03107026|64870484|FG002|Overall Study|Adverse Event|23|||
23307354|NCT03107026|64870482|FG000|Overall Study|Lost to Follow-up|12|||
23307355|NCT03107026|64870483|FG001|Overall Study|Lost to Follow-up|12|||
23411926|NCT02574078|65252286|FG000|Treatment Period|Maximum clinical benefit|0|||
23411927|NCT02574078|65252287|FG001|Treatment Period|Maximum clinical benefit|0|||
23411928|NCT02574078|65252288|FG002|Treatment Period|Maximum clinical benefit|0|||
23411929|NCT02574078|65252289|FG003|Treatment Period|Maximum clinical benefit|0|||
23411930|NCT02574078|65252290|FG004|Treatment Period|Maximum clinical benefit|0|||
23411931|NCT02574078|65252291|FG005|Treatment Period|Maximum clinical benefit|0|||
23411932|NCT02574078|65252292|FG006|Treatment Period|Maximum clinical benefit|0|||
23411933|NCT02574078|65252293|FG007|Treatment Period|Maximum clinical benefit|0|||
23411934|NCT02574078|65252294|FG008|Treatment Period|Maximum clinical benefit|0|||
23411935|NCT02574078|65252295|FG009|Treatment Period|Maximum clinical benefit|1|||
23411936|NCT02574078|65252296|FG010|Treatment Period|Maximum clinical benefit|0|||
23411937|NCT02574078|65252297|FG011|Treatment Period|Maximum clinical benefit|0|||
23411938|NCT02574078|65252298|FG012|Treatment Period|Maximum clinical benefit|0|||
23411939|NCT03292874|65252299|FG000|Overall Study|Due to pandemic|5|||
23411940|NCT00553436|65252300|FG000|Overall Study|Conversion to another procedure|1|||
23411941|NCT01054560|65252303|FG000|Overall Study|Death|10|||
23411942|NCT01054560|65252304|FG001|Overall Study|Death|21|||
23411943|NCT01054560|65252303|FG000|Overall Study|Lost to Follow-up|2|||
23411944|NCT01054560|65252304|FG001|Overall Study|Lost to Follow-up|5|||
23411945|NCT01054560|65252303|FG000|Overall Study|Withdrawal by Subject|0|||
23411946|NCT01054560|65252304|FG001|Overall Study|Withdrawal by Subject|2|||
23411947|NCT01054560|65252303|FG000|Overall Study|Physician Decision|1|||
23411948|NCT01054560|65252304|FG001|Overall Study|Physician Decision|0|||
23411949|NCT03818607|65252305|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
23411950|NCT03818607|65252306|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
23411951|NCT03818607|65252305|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
23411952|NCT03818607|65252306|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
23411953|NCT03818607|65252305|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
23411954|NCT03818607|65252306|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
23411955|NCT02231892|65252312|FG000|Overall Study|Lost to Follow-up|1|||
23411956|NCT02231892|65252313|FG001|Overall Study|Lost to Follow-up|0|||
23411957|NCT02231892|65252314|FG002|Overall Study|Lost to Follow-up|3|||
23411958|NCT02231892|65252312|FG000|Overall Study|Withdrawal by Subject|4|||
23411959|NCT02231892|65252313|FG001|Overall Study|Withdrawal by Subject|3|||
23411960|NCT02231892|65252314|FG002|Overall Study|Withdrawal by Subject|15|||
23411961|NCT02231892|65252312|FG000|Overall Study|Physician Decision|0|||
23411962|NCT02231892|65252313|FG001|Overall Study|Physician Decision|2|||
23411963|NCT02231892|65252314|FG002|Overall Study|Physician Decision|4|||
23411964|NCT02231892|65252312|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
23411965|NCT02231892|65252313|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
23411966|NCT02231892|65252314|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
23411967|NCT02231892|65252312|FG000|Overall Study|Participant motor threshold was >83%|0|||
23411968|NCT02231892|65252313|FG001|Overall Study|Participant motor threshold was >83%|0|||
23411969|NCT02231892|65252314|FG002|Overall Study|Participant motor threshold was >83%|9|||
23411970|NCT02231892|65252312|FG000|Overall Study|Could not find motor threshold|2|||
23411971|NCT02231892|65252313|FG001|Overall Study|Could not find motor threshold|0|||
23411972|NCT02231892|65252314|FG002|Overall Study|Could not find motor threshold|1|||
23411973|NCT02231892|65252312|FG000|Overall Study|Could not find reliable motor hotspot|0|||
23411974|NCT02231892|65252313|FG001|Overall Study|Could not find reliable motor hotspot|0|||
23411975|NCT02231892|65252314|FG002|Overall Study|Could not find reliable motor hotspot|1|||
23411976|NCT01562314|65252315|FG000|Overall Study|Adverse Event|10|||
23411977|NCT01562314|65252316|FG001|Overall Study|Adverse Event|5|||
23411978|NCT01562314|65252315|FG000|Overall Study|Met Withdrawal Criteria|3|||
23411979|NCT01562314|65252316|FG001|Overall Study|Met Withdrawal Criteria|2|||
23411980|NCT01562314|65252315|FG000|Overall Study|Withdrawal by Subject|0|||
23411981|NCT01562314|65252316|FG001|Overall Study|Withdrawal by Subject|1|||
23411982|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
23411983|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
23411984|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
23411985|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
23411986|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
23411987|NCT01536561|65252317|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
23411988|NCT01202188|65252318|FG000|Overall Study|Protocol deviation|14|||
23411989|NCT01202188|65252319|FG001|Overall Study|Protocol deviation|8|||
23411990|NCT01202188|65252320|FG002|Overall Study|Protocol deviation|12|||
23411991|NCT01202188|65252321|FG003|Overall Study|Protocol deviation|10|||
23411992|NCT01202188|65252322|FG004|Overall Study|Protocol deviation|11|||
23411993|NCT01202188|65252318|FG000|Overall Study|Subject withdrew consent|12|||
23411994|NCT01202188|65252319|FG001|Overall Study|Subject withdrew consent|13|||
23411995|NCT01202188|65252320|FG002|Overall Study|Subject withdrew consent|22|||
23411996|NCT01202188|65252321|FG003|Overall Study|Subject withdrew consent|11|||
23411997|NCT01202188|65252322|FG004|Overall Study|Subject withdrew consent|13|||
23411998|NCT01202188|65252318|FG000|Overall Study|Adverse Event|5|||
23411999|NCT01202188|65252319|FG001|Overall Study|Adverse Event|23|||
23412000|NCT01202188|65252320|FG002|Overall Study|Adverse Event|13|||
23412001|NCT01202188|65252321|FG003|Overall Study|Adverse Event|10|||
23412002|NCT01202188|65252322|FG004|Overall Study|Adverse Event|10|||
23412003|NCT01202188|65252318|FG000|Overall Study|Administrative problems|3|||
23412004|NCT01202188|65252319|FG001|Overall Study|Administrative problems|2|||
23412005|NCT01202188|65252320|FG002|Overall Study|Administrative problems|1|||
23412006|NCT01202188|65252321|FG003|Overall Study|Administrative problems|1|||
23412007|NCT01202188|65252322|FG004|Overall Study|Administrative problems|2|||
23412008|NCT01202188|65252318|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23412009|NCT01202188|65252319|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23412010|NCT01202188|65252320|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23412011|NCT01202188|65252321|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
23412012|NCT01202188|65252322|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
23412013|NCT01202188|65252318|FG000|Overall Study|Lost to Follow-up|1|||
23412014|NCT01202188|65252319|FG001|Overall Study|Lost to Follow-up|1|||
23412015|NCT01202188|65252320|FG002|Overall Study|Lost to Follow-up|0|||
23412016|NCT01202188|65252321|FG003|Overall Study|Lost to Follow-up|4|||
23412017|NCT01202188|65252322|FG004|Overall Study|Lost to Follow-up|1|||
23412018|NCT01202188|65252318|FG000|Overall Study|Death|1|||
23412019|NCT01202188|65252319|FG001|Overall Study|Death|1|||
23412020|NCT01202188|65252320|FG002|Overall Study|Death|1|||
23412021|NCT01202188|65252321|FG003|Overall Study|Death|1|||
23412022|NCT01202188|65252322|FG004|Overall Study|Death|0|||
23412023|NCT01202188|65252318|FG000|Overall Study|Abnormal test procedure result (s)|0|||
23412024|NCT01202188|65252319|FG001|Overall Study|Abnormal test procedure result (s)|0|||
23412025|NCT01202188|65252320|FG002|Overall Study|Abnormal test procedure result (s)|2|||
23412026|NCT01202188|65252321|FG003|Overall Study|Abnormal test procedure result (s)|0|||
23412027|NCT01202188|65252322|FG004|Overall Study|Abnormal test procedure result (s)|0|||
23412028|NCT04154293|65252323|FG000|Overall Study|Withdrawal by Subject|2|||
23412029|NCT04154293|65252324|FG001|Overall Study|Withdrawal by Subject|3|||
23412030|NCT04154293|65252325|FG002|Overall Study|Withdrawal by Subject|1|||
23412031|NCT04154293|65252323|FG000|Overall Study|Physician Decision|0|||
23412032|NCT04154293|65252324|FG001|Overall Study|Physician Decision|0|||
23412033|NCT04154293|65252325|FG002|Overall Study|Physician Decision|1|||
23412034|NCT03028415|65252329|FG000|Overall Study|Lost to Follow-up|6|||
23412035|NCT03028415|65252330|FG001|Overall Study|Lost to Follow-up|3|||
23412036|NCT03028415|65252329|FG000|Overall Study|Withdrawal by Subject|1|||
23412037|NCT03028415|65252330|FG001|Overall Study|Withdrawal by Subject|0|||
23412038|NCT03028415|65252329|FG000|Overall Study|Discontinued due to COVID-19|1|||
23412039|NCT03028415|65252330|FG001|Overall Study|Discontinued due to COVID-19|0|||
23412040|NCT00964002|65252331|FG000|Overall Study|Protocol Violation|8|||
23412041|NCT03286543|65252332|FG000|Consented|Screen failure before randomization|2|||
23412042|NCT03286543|65252333|FG001|Consented|Screen failure before randomization|0|||
23412043|NCT03286543|65252334|FG002|Consented|Screen failure before randomization|0|||
23412044|NCT03286543|65252332|FG000|Consented|Screen failure before enrollment|4|||
23412045|NCT03286543|65252333|FG001|Consented|Screen failure before enrollment|0|||
23412046|NCT03286543|65252334|FG002|Consented|Screen failure before enrollment|0|||
23412047|NCT03286543|65252332|FG000|Consented|TKA cancelled after enrollment|1|||
23412048|NCT03286543|65252333|FG001|Consented|TKA cancelled after enrollment|0|||
23307356|NCT03107026|64870484|FG002|Overall Study|Lost to Follow-up|13|||
23412049|NCT03286543|65252334|FG002|Consented|TKA cancelled after enrollment|0|||
23307357|NCT03107026|64870482|FG000|Overall Study|Protocol Violation|1|||
23412050|NCT03286543|65252332|FG000|Consented|Withdrawn from study|12|||
23412051|NCT03286543|65252333|FG001|Consented|Withdrawn from study|0|||
23412052|NCT03286543|65252334|FG002|Consented|Withdrawn from study|0|||
23412053|NCT03286543|65252332|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
23412054|NCT03286543|65252333|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
23412055|NCT03286543|65252334|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
23412056|NCT03286543|65252332|FG000|Study Enrollment|Withdrawn from study|0|||
23412057|NCT03286543|65252333|FG001|Study Enrollment|Withdrawn from study|6|||
23412058|NCT03286543|65252334|FG002|Study Enrollment|Withdrawn from study|6|||
23412059|NCT01001767|65252335|FG000|Overall Study|no baseline study performed|1|||
23412060|NCT01001767|65252336|FG001|Overall Study|no baseline study performed|0|||
23412061|NCT01001767|65252335|FG000|Overall Study|Protocol Violation|1|||
23412062|NCT01001767|65252336|FG001|Overall Study|Protocol Violation|0|||
23412063|NCT01001767|65252335|FG000|Overall Study|Lost to Follow-up|1|||
23412064|NCT01001767|65252336|FG001|Overall Study|Lost to Follow-up|0|||
23412065|NCT01001767|65252335|FG000|Overall Study|Physician Decision|1|||
23412066|NCT01001767|65252336|FG001|Overall Study|Physician Decision|0|||
23412067|NCT03640507|65252337|FG000|Overall Study|Withdrawal by Subject|0|||
23412068|NCT03640507|65252338|FG001|Overall Study|Withdrawal by Subject|0|||
23412069|NCT03640507|65252339|FG002|Overall Study|Withdrawal by Subject|1|||
23412070|NCT02516982|65252340|FG000|Overall Study|Called in to antenatal appointment|32|||
23412071|NCT02516982|65252341|FG001|Overall Study|Called in to antenatal appointment|35|||
23412072|NCT02516982|65252342|FG002|Overall Study|Called in to antenatal appointment|0|||
23412073|NCT02516982|65252343|FG003|Overall Study|Called in to antenatal appointment|0|||
23412074|NCT02516982|65252340|FG000|Overall Study|Withdrawal by Subject|0|||
23412075|NCT02516982|65252341|FG001|Overall Study|Withdrawal by Subject|0|||
23412076|NCT02516982|65252342|FG002|Overall Study|Withdrawal by Subject|1|||
23412077|NCT02516982|65252343|FG003|Overall Study|Withdrawal by Subject|2|||
23412078|NCT02516982|65252340|FG000|Overall Study|Protocol Violation|0|||
23412079|NCT02516982|65252341|FG001|Overall Study|Protocol Violation|0|||
23412080|NCT02516982|65252342|FG002|Overall Study|Protocol Violation|1|||
23412081|NCT02516982|65252343|FG003|Overall Study|Protocol Violation|1|||
23412082|NCT02516982|65252340|FG000|Overall Study|Did not install the app|0|||
23412083|NCT02516982|65252341|FG001|Overall Study|Did not install the app|0|||
23412084|NCT02516982|65252342|FG002|Overall Study|Did not install the app|46|||
23412085|NCT02516982|65252343|FG003|Overall Study|Did not install the app|47|||
23412086|NCT00500357|65252351|FG000|Overall Study|Death|1|||
23412087|NCT04209634|65252352|FG000|Overall Study|Ongoing|10|||
23412088|NCT00688467|65252355|FG000|Treatment Period 1|Adverse Event|2|||
23412089|NCT00688467|65252356|FG001|Treatment Period 1|Adverse Event|1|||
23412090|NCT00688467|65252355|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
23412091|NCT00688467|65252356|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
23412092|NCT00688467|65252355|FG000|Treatment Period 2|Protocol Violation|0|||
23412093|NCT00688467|65252356|FG001|Treatment Period 2|Protocol Violation|1|||
23412094|NCT00688467|65252355|FG000|Treatment Period 2|Adverse Event|0|||
23412095|NCT00688467|65252356|FG001|Treatment Period 2|Adverse Event|1|||
23412096|NCT02798315|65252357|FG000|Overall Study|Failure to return|1|||
23412097|NCT00577707|65252358|FG000|Overall Study|Withdrawal by Subject|3|||
23412098|NCT04188834|65252363|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
23412099|NCT03326063|65252364|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
23412100|NCT03326063|65252365|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
23412101|NCT02582814|65252366|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23412102|NCT02582814|65252367|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23412103|NCT02582814|65252366|FG000|Overall Study|Withdrawal by Subject|4|||
23412104|NCT02582814|65252367|FG001|Overall Study|Withdrawal by Subject|3|||
23412105|NCT02582814|65252366|FG000|Overall Study|Adverse Event|4|||
23412106|NCT02582814|65252367|FG001|Overall Study|Adverse Event|4|||
23412107|NCT00610857|65252368|FG000|Overall Study|Not evaluable for response|2|||
23412108|NCT00104416|65252371|FG000|Double-Blind Phase|Adverse Event|2|||
23412109|NCT00104416|65252372|FG001|Double-Blind Phase|Adverse Event|1|||
23412110|NCT00104416|65252373|FG002|Double-Blind Phase|Adverse Event|0|||
23412111|NCT00104416|65252374|FG003|Double-Blind Phase|Adverse Event|0|||
23412112|NCT00104416|65252375|FG004|Double-Blind Phase|Adverse Event|0|||
23412113|NCT00104416|65252371|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23412114|NCT00104416|65252372|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23412115|NCT00104416|65252373|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23511716|NCT00877383|65609492|FG001|Overall Study|Lost to Follow-up|3|||
23511717|NCT00877383|65609491|FG000|Overall Study|Subject withdrew consent|3|||
23511718|NCT00877383|65609492|FG001|Overall Study|Subject withdrew consent|12|||
23511719|NCT00877383|65609491|FG000|Overall Study|Subject no longer requires study drug|2|||
23511720|NCT00877383|65609492|FG001|Overall Study|Subject no longer requires study drug|0|||
23511721|NCT00877383|65609491|FG000|Overall Study|Administrative problems|2|||
23511722|NCT00877383|65609492|FG001|Overall Study|Administrative problems|0|||
23511723|NCT00877383|65609491|FG000|Overall Study|Protocol deviation|2|||
23412116|NCT00104416|65252374|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23412117|NCT00104416|65252375|FG004|Double-Blind Phase|Lost to Follow-up|0|||
23412118|NCT00104416|65252371|FG000|Double-Blind Phase|Protocol Violation|0|||
23412119|NCT00104416|65252372|FG001|Double-Blind Phase|Protocol Violation|1|||
23412120|NCT00104416|65252373|FG002|Double-Blind Phase|Protocol Violation|0|||
23412121|NCT00104416|65252374|FG003|Double-Blind Phase|Protocol Violation|0|||
23511724|NCT00877383|65609492|FG001|Overall Study|Protocol deviation|6|||
23511725|NCT00877383|65609491|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23511726|NCT00877383|65609492|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23511727|NCT00877383|65609491|FG000|Overall Study|Death|1|||
23511728|NCT00877383|65609492|FG001|Overall Study|Death|2|||
23511729|NCT01943292|65609493|FG000|Overall Study|Withdrawal by Subject|1|||
23412122|NCT00104416|65252375|FG004|Double-Blind Phase|Protocol Violation|0|||
23412123|NCT00104416|65252371|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
23412124|NCT00104416|65252372|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
23511730|NCT01943292|65609494|FG001|Overall Study|Withdrawal by Subject|0|||
23511731|NCT01943292|65609495|FG002|Overall Study|Withdrawal by Subject|0|||
23511732|NCT00110149|65609498|FG000|Overall Study|Physician Decision|3|||
23511733|NCT01722071|65609499|FG000|Overall Study|Protocol Violation|1|||
23511734|NCT01722071|65609500|FG001|Overall Study|Protocol Violation|0|||
23511735|NCT03473808|65609504|FG000|Overall Study|Withdrawal by Subject|1|||
23511736|NCT00684307|65609505|FG000|Overall Study|Adverse Event|11|||
23511737|NCT00684307|65609506|FG001|Overall Study|Adverse Event|6|||
23511738|NCT00684307|65609507|FG002|Overall Study|Adverse Event|15|||
23511739|NCT00684307|65609508|FG003|Overall Study|Adverse Event|16|||
23511740|NCT00684307|65609509|FG004|Overall Study|Adverse Event|8|||
23511741|NCT00684307|65609505|FG000|Overall Study|Development of increasing Liver Function|0|||
23511742|NCT00684307|65609506|FG001|Overall Study|Development of increasing Liver Function|2|||
23511743|NCT00684307|65609507|FG002|Overall Study|Development of increasing Liver Function|0|||
23511744|NCT00684307|65609508|FG003|Overall Study|Development of increasing Liver Function|1|||
23511745|NCT00684307|65609509|FG004|Overall Study|Development of increasing Liver Function|0|||
23511746|NCT00684307|65609505|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
23511747|NCT00684307|65609506|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
23511748|NCT00684307|65609507|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
23511749|NCT00684307|65609508|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
23511750|NCT00684307|65609509|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
23511751|NCT00684307|65609505|FG000|Overall Study|Incorrect enrolment or randomization|4|||
23511752|NCT00684307|65609506|FG001|Overall Study|Incorrect enrolment or randomization|0|||
23511753|NCT00684307|65609507|FG002|Overall Study|Incorrect enrolment or randomization|0|||
23511754|NCT00684307|65609508|FG003|Overall Study|Incorrect enrolment or randomization|0|||
23511755|NCT00684307|65609509|FG004|Overall Study|Incorrect enrolment or randomization|0|||
23511756|NCT00684307|65609505|FG000|Overall Study|Interupted IP for more than 7 days|0|||
23511757|NCT00684307|65609506|FG001|Overall Study|Interupted IP for more than 7 days|4|||
23511758|NCT00684307|65609507|FG002|Overall Study|Interupted IP for more than 7 days|1|||
23412125|NCT00104416|65252373|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23412126|NCT00104416|65252374|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23412127|NCT00104416|65252375|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23412128|NCT00104416|65252371|FG000|Double-Blind Phase|Pregnancy|1|||
23412129|NCT00104416|65252372|FG001|Double-Blind Phase|Pregnancy|0|||
23412130|NCT00104416|65252373|FG002|Double-Blind Phase|Pregnancy|0|||
23412131|NCT00104416|65252374|FG003|Double-Blind Phase|Pregnancy|0|||
23412132|NCT00104416|65252375|FG004|Double-Blind Phase|Pregnancy|0|||
23412133|NCT00104416|65252371|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
23412134|NCT00104416|65252372|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
23412135|NCT00104416|65252373|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
23412136|NCT00104416|65252374|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
23412137|NCT00104416|65252375|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
23412138|NCT00104416|65252371|FG000|Continuation Phase|Adverse Event|0|||
23412139|NCT00104416|65252372|FG001|Continuation Phase|Adverse Event|0|||
23412140|NCT00104416|65252373|FG002|Continuation Phase|Adverse Event|2|||
23412141|NCT00104416|65252374|FG003|Continuation Phase|Adverse Event|0|||
23412142|NCT00104416|65252375|FG004|Continuation Phase|Adverse Event|2|||
23412143|NCT00104416|65252371|FG000|Continuation Phase|Lost to Follow-up|0|||
23412144|NCT00104416|65252372|FG001|Continuation Phase|Lost to Follow-up|0|||
23412145|NCT00104416|65252373|FG002|Continuation Phase|Lost to Follow-up|1|||
23412146|NCT00104416|65252374|FG003|Continuation Phase|Lost to Follow-up|0|||
23412147|NCT00104416|65252375|FG004|Continuation Phase|Lost to Follow-up|1|||
23412148|NCT00104416|65252371|FG000|Continuation Phase|Withdrawal by Subject|0|||
23412149|NCT00104416|65252372|FG001|Continuation Phase|Withdrawal by Subject|0|||
23511759|NCT00684307|65609508|FG003|Overall Study|Interupted IP for more than 7 days|3|||
23511760|NCT00684307|65609509|FG004|Overall Study|Interupted IP for more than 7 days|3|||
23511761|NCT00684307|65609505|FG000|Overall Study|Severe non compliance to protocol|1|||
23511762|NCT00684307|65609506|FG001|Overall Study|Severe non compliance to protocol|0|||
23511763|NCT00684307|65609507|FG002|Overall Study|Severe non compliance to protocol|0|||
23511764|NCT00684307|65609508|FG003|Overall Study|Severe non compliance to protocol|1|||
23511765|NCT00684307|65609509|FG004|Overall Study|Severe non compliance to protocol|2|||
23412150|NCT00104416|65252373|FG002|Continuation Phase|Withdrawal by Subject|2|||
23412151|NCT00104416|65252374|FG003|Continuation Phase|Withdrawal by Subject|1|||
23412152|NCT00104416|65252375|FG004|Continuation Phase|Withdrawal by Subject|1|||
23412153|NCT00104416|65252371|FG000|Continuation Phase|Pregnancy|0|||
23412154|NCT00104416|65252372|FG001|Continuation Phase|Pregnancy|0|||
23412155|NCT00104416|65252373|FG002|Continuation Phase|Pregnancy|1|||
23412156|NCT00104416|65252374|FG003|Continuation Phase|Pregnancy|1|||
23412157|NCT00104416|65252375|FG004|Continuation Phase|Pregnancy|0|||
23412158|NCT00104416|65252371|FG000|Continuation Phase|Non-compliance|0|||
23412159|NCT00104416|65252372|FG001|Continuation Phase|Non-compliance|0|||
23412160|NCT00104416|65252373|FG002|Continuation Phase|Non-compliance|0|||
23412161|NCT00104416|65252374|FG003|Continuation Phase|Non-compliance|0|||
23412162|NCT00104416|65252375|FG004|Continuation Phase|Non-compliance|1|||
23412163|NCT03015363|65252376|FG000|Overall Study|Physician Decision|14|||
23412164|NCT03015363|65252376|FG000|Overall Study|Withdrawal by Subject|3|||
23412165|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
23412166|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
23412167|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
23412168|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
23412169|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
23412170|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
23412171|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
23412172|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
23412173|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
23412174|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
23412175|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
23412176|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
23412177|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
23412178|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
23412179|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
23412180|NCT01057693|65252377|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
23412181|NCT01057693|65252378|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
23412182|NCT01057693|65252379|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
23412183|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
23412184|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
23412185|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
23412186|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
23412187|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
23412188|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
23412189|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
23412190|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
23412191|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
23412192|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
23412193|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
23412194|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
23412195|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
23412196|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
23412197|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
23412198|NCT01057693|65252377|FG000|Between Single-Blind and Double-Blind|Other|6|||
23412199|NCT01057693|65252378|FG001|Between Single-Blind and Double-Blind|Other|0|||
23412200|NCT01057693|65252379|FG002|Between Single-Blind and Double-Blind|Other|0|||
23412201|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
23412202|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
23412203|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
23412204|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
23412205|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
23610585|NCT02676778|65962811|FG002|Overall Study|Withdrawal by Subject|0|||
23412206|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
23412207|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
23412208|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
23412209|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
23412210|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
23412211|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
23412212|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
23412213|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
23412214|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
23412215|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
23412216|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
23412217|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
23412218|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
23412219|NCT01057693|65252377|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
23412220|NCT01057693|65252378|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
23412221|NCT01057693|65252379|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
23412222|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412223|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
23412224|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412225|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412226|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412227|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
23412228|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
23412229|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
23412230|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23412231|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23412232|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23412233|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
23412234|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
23412235|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
23412236|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23412237|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23412238|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23412239|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
23412240|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
23412241|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
23412242|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
23412243|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
23412244|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
23412245|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
23412246|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412247|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
23412248|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412249|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412250|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412251|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
23412252|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
23412253|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
23412254|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
23412255|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
23412256|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
23412257|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
23412258|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412259|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
23412260|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412261|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412262|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412263|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
23412264|NCT03985943|65252380|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23412265|NCT03985943|65252381|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
23412266|NCT03985943|65252382|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23610586|NCT02676778|65962809|FG000|Overall Study|Other|4|||
23412267|NCT03985943|65252383|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23412268|NCT03985943|65252384|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23412269|NCT03985943|65252385|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
23412270|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23412271|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23412272|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
23412273|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
23412274|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
23412275|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
23412276|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23412277|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23412278|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
23412279|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
23412280|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
23412281|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
23412282|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
23412283|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
23412284|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
23412285|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
23412286|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
23412287|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
23412288|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23412289|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23412290|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23412291|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23412292|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23412293|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23412294|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
23412295|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
23412296|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
23412297|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
23412298|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
23412299|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
23412300|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
23412301|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
23412302|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
23412303|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
23412304|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
23412305|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
23412306|NCT03985943|65252380|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
23412307|NCT03985943|65252381|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
23412308|NCT03985943|65252382|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
23412309|NCT03985943|65252383|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
23412310|NCT03985943|65252384|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
23412311|NCT03985943|65252385|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
23412312|NCT00269087|65252388|FG000|Overall Study|Adverse Event|20|||
23412313|NCT00269087|65252388|FG000|Overall Study|Withdrawal by Subject|1|||
23412314|NCT00269087|65252388|FG000|Overall Study|Exacerbation of COPD|13|||
23412315|NCT01701362|65252389|FG000|Overall Study|Adverse events not related to study drug|1|||
23412316|NCT01701362|65252390|FG001|Overall Study|Adverse events not related to study drug|6|||
23412317|NCT01701362|65252389|FG000|Overall Study|Adverse events related to study drug|12|||
23412318|NCT01701362|65252390|FG001|Overall Study|Adverse events related to study drug|10|||
23412319|NCT01701362|65252389|FG000|Overall Study|Protocol Violation|5|||
23412320|NCT01701362|65252390|FG001|Overall Study|Protocol Violation|3|||
23412321|NCT01701362|65252389|FG000|Overall Study|No longer willing to participate|8|||
23412322|NCT01701362|65252390|FG001|Overall Study|No longer willing to participate|14|||
23412323|NCT01701362|65252389|FG000|Overall Study|Lost to Follow-up|6|||
23412324|NCT01701362|65252390|FG001|Overall Study|Lost to Follow-up|9|||
23412325|NCT01701362|65252389|FG000|Overall Study|Insufficient clinical response|6|||
23412326|NCT01701362|65252390|FG001|Overall Study|Insufficient clinical response|6|||
23412327|NCT01701362|65252389|FG000|Overall Study|Death|0|||
23412328|NCT01701362|65252390|FG001|Overall Study|Death|1|||
23610587|NCT02676778|65962810|FG001|Overall Study|Other|3|||
23412329|NCT01701362|65252389|FG000|Overall Study|Randomized but not treated|1|||
23412330|NCT01701362|65252390|FG001|Overall Study|Randomized but not treated|2|||
23412331|NCT01701362|65252389|FG000|Overall Study|Reasons other than those mentioned above|3|||
23412332|NCT01701362|65252390|FG001|Overall Study|Reasons other than those mentioned above|5|||
23412333|NCT01734785|65252398|FG000|Open-Label Period|Adverse Event|0|||
23412334|NCT01734785|65252399|FG001|Open-Label Period|Adverse Event|0|||
23412335|NCT01734785|65252400|FG002|Open-Label Period|Adverse Event|0|||
23412336|NCT01734785|65252401|FG003|Open-Label Period|Adverse Event|9|||
23412337|NCT01734785|65252398|FG000|Open-Label Period|Lack of Efficacy|0|||
23412338|NCT01734785|65252399|FG001|Open-Label Period|Lack of Efficacy|0|||
23412339|NCT01734785|65252400|FG002|Open-Label Period|Lack of Efficacy|0|||
23412340|NCT01734785|65252401|FG003|Open-Label Period|Lack of Efficacy|1|||
23412341|NCT01734785|65252398|FG000|Open-Label Period|Protocol Violation|0|||
23412342|NCT01734785|65252399|FG001|Open-Label Period|Protocol Violation|0|||
23412343|NCT01734785|65252400|FG002|Open-Label Period|Protocol Violation|0|||
23412344|NCT01734785|65252401|FG003|Open-Label Period|Protocol Violation|13|||
23412345|NCT01734785|65252398|FG000|Open-Label Period|Lost to Follow-up|0|||
23412346|NCT01734785|65252399|FG001|Open-Label Period|Lost to Follow-up|0|||
23412347|NCT01734785|65252400|FG002|Open-Label Period|Lost to Follow-up|0|||
23412348|NCT01734785|65252401|FG003|Open-Label Period|Lost to Follow-up|14|||
23412349|NCT01734785|65252398|FG000|Open-Label Period|Withdrawal by Subject|0|||
23412350|NCT01734785|65252399|FG001|Open-Label Period|Withdrawal by Subject|0|||
23412351|NCT01734785|65252400|FG002|Open-Label Period|Withdrawal by Subject|0|||
23412352|NCT01734785|65252401|FG003|Open-Label Period|Withdrawal by Subject|12|||
23412353|NCT01734785|65252398|FG000|Open-Label Period|Other Reasons|0|||
23412354|NCT01734785|65252399|FG001|Open-Label Period|Other Reasons|0|||
23412355|NCT01734785|65252400|FG002|Open-Label Period|Other Reasons|0|||
23412356|NCT01734785|65252401|FG003|Open-Label Period|Other Reasons|224|||
23412357|NCT01734785|65252398|FG000|Double-Blind Period|Adverse Event|0|||
23412358|NCT01734785|65252399|FG001|Double-Blind Period|Adverse Event|3|||
23412359|NCT01734785|65252400|FG002|Double-Blind Period|Adverse Event|2|||
23412360|NCT01734785|65252401|FG003|Double-Blind Period|Adverse Event|0|||
23412361|NCT01734785|65252398|FG000|Double-Blind Period|Lack of Efficacy|0|||
23412362|NCT01734785|65252399|FG001|Double-Blind Period|Lack of Efficacy|1|||
23412363|NCT01734785|65252400|FG002|Double-Blind Period|Lack of Efficacy|0|||
23412364|NCT01734785|65252401|FG003|Double-Blind Period|Lack of Efficacy|0|||
23412365|NCT01734785|65252398|FG000|Double-Blind Period|Protocol Violation|0|||
23412366|NCT01734785|65252399|FG001|Double-Blind Period|Protocol Violation|1|||
23412367|NCT01734785|65252400|FG002|Double-Blind Period|Protocol Violation|1|||
23412368|NCT01734785|65252401|FG003|Double-Blind Period|Protocol Violation|0|||
23412369|NCT01734785|65252398|FG000|Double-Blind Period|Lost to Follow-up|2|||
23412370|NCT01734785|65252399|FG001|Double-Blind Period|Lost to Follow-up|4|||
23412371|NCT01734785|65252400|FG002|Double-Blind Period|Lost to Follow-up|2|||
23412372|NCT01734785|65252401|FG003|Double-Blind Period|Lost to Follow-up|0|||
23412373|NCT01734785|65252398|FG000|Double-Blind Period|Withdrawal by Subject|2|||
23412374|NCT01734785|65252399|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23412375|NCT01734785|65252400|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23412376|NCT01734785|65252401|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23412377|NCT01734785|65252398|FG000|Double-Blind Period|Not treated|1|||
23511766|NCT00684307|65609505|FG000|Overall Study|Participant not willing to continue|7|||
23412378|NCT01734785|65252399|FG001|Double-Blind Period|Not treated|0|||
23412379|NCT01734785|65252400|FG002|Double-Blind Period|Not treated|0|||
23412380|NCT01734785|65252401|FG003|Double-Blind Period|Not treated|0|||
23412381|NCT03333928|65252402|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
23412382|NCT03333928|65252403|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
23412383|NCT03333928|65252404|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
23412384|NCT03333928|65252402|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
23412385|NCT03333928|65252403|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
23412386|NCT03333928|65252404|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
23511767|NCT00684307|65609506|FG001|Overall Study|Participant not willing to continue|10|||
23511768|NCT00684307|65609507|FG002|Overall Study|Participant not willing to continue|11|||
23511769|NCT00684307|65609508|FG003|Overall Study|Participant not willing to continue|5|||
23511770|NCT00684307|65609509|FG004|Overall Study|Participant not willing to continue|8|||
23511771|NCT00684307|65609505|FG000|Overall Study|Criteria from the CSR|0|||
23511772|NCT00684307|65609506|FG001|Overall Study|Criteria from the CSR|0|||
23511773|NCT00684307|65609507|FG002|Overall Study|Criteria from the CSR|1|||
23511774|NCT00684307|65609508|FG003|Overall Study|Criteria from the CSR|3|||
23511775|NCT00684307|65609509|FG004|Overall Study|Criteria from the CSR|3|||
23511776|NCT04492618|65609510|FG000|Overall Study|Withdrawal by Subject|1|||
23511777|NCT00592384|65609511|FG000|Overall Study|Withdrawal by Subject|5|||
23511778|NCT00592384|65609512|FG001|Overall Study|Withdrawal by Subject|6|||
23511779|NCT02107482|65609513|FG000|Overall Study|inconveinence|2|||
23511780|NCT02107482|65609513|FG000|Overall Study|Lost to Follow-up|1|||
23511781|NCT02107482|65609513|FG000|Overall Study|Lack of Efficacy|1|||
23511782|NCT04166435|65609518|FG000|Overall Study|2 patients ineligible for response|2|||
23511783|NCT00937157|65609521|FG000|Overall Study|Pregnancy|1|||
23511784|NCT00937157|65609521|FG000|Overall Study|Lost to Follow-up|3|||
23511785|NCT02548650|65609522|FG000|Triple Therapy|Adverse Event|1|||
23511786|NCT02548650|65609523|FG001|Triple Therapy|Adverse Event|0|||
23511787|NCT02548650|65609522|FG000|Triple Therapy|Withdrawal by Subject|0|||
23511788|NCT02548650|65609523|FG001|Triple Therapy|Withdrawal by Subject|4|||
23511789|NCT02548650|65609522|FG000|Double Therapy|Adverse Event|1|||
23511790|NCT02548650|65609523|FG001|Double Therapy|Adverse Event|1|||
23511791|NCT02548650|65609522|FG000|Double Therapy|Withdrawal by Subject|0|||
23511792|NCT02548650|65609523|FG001|Double Therapy|Withdrawal by Subject|1|||
23412387|NCT03333928|65252402|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
23412388|NCT03333928|65252403|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
23511793|NCT00754624|65609524|FG000|Overall Study|Adverse Event|16|||
23511794|NCT00754624|65609524|FG000|Overall Study|Death|1|||
23511795|NCT00754624|65609524|FG000|Overall Study|Physician Decision|8|||
23511796|NCT00754624|65609524|FG000|Overall Study|Protocol Violation|1|||
23511797|NCT00754624|65609524|FG000|Overall Study|Withdrawal by Subject|28|||
23511798|NCT00754624|65609524|FG000|Overall Study|Various|12|||
23511799|NCT00754624|65609524|FG000|Overall Study|Lost to Follow-up|3|||
23511800|NCT04481750|65609527|FG000|Period 1 (Fasted)|Adverse Event|0|||
23511801|NCT04481750|65609528|FG001|Period 1 (Fasted)|Adverse Event|0|||
23511802|NCT04481750|65609529|FG002|Period 1 (Fasted)|Adverse Event|1|||
23511803|NCT04481750|65609530|FG003|Period 1 (Fasted)|Adverse Event|0|||
23511804|NCT04481750|65609531|FG004|Period 1 (Fasted)|Adverse Event|0|||
23511805|NCT04481750|65609532|FG005|Period 1 (Fasted)|Adverse Event|0|||
23511806|NCT04481750|65609533|FG006|Period 1 (Fasted)|Adverse Event|0|||
23511807|NCT04481750|65609534|FG007|Period 1 (Fasted)|Adverse Event|0|||
23511808|NCT04481750|65609535|FG008|Period 1 (Fasted)|Adverse Event|0|||
23511809|NCT04481750|65609536|FG009|Period 1 (Fasted)|Adverse Event|0|||
23511810|NCT04481750|65609537|FG010|Period 1 (Fasted)|Adverse Event|0|||
23511811|NCT02005445|65609538|FG000|Overall Study|Dual study enrollment|0|||
23511812|NCT02005445|65609539|FG001|Overall Study|Dual study enrollment|1|||
23511813|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
23511814|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
23511815|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
23412389|NCT03333928|65252404|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
23412390|NCT03333928|65252402|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
23412391|NCT03333928|65252403|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
23412392|NCT03333928|65252404|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
23412393|NCT03333928|65252402|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
23412394|NCT03333928|65252403|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
23412395|NCT03333928|65252404|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
23412396|NCT03333928|65252402|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
23412397|NCT03333928|65252403|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
23412398|NCT03333928|65252404|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
23412399|NCT03333928|65252402|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
23412400|NCT03333928|65252403|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
23412401|NCT03333928|65252404|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
23412402|NCT03333928|65252402|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
23412403|NCT03333928|65252403|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
23412404|NCT03333928|65252404|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
23412405|NCT00889603|65252409|FG000|Overall Study|Adverse Event|7|||
23412406|NCT00889603|65252409|FG000|Overall Study|Death|3|||
23412407|NCT00889603|65252409|FG000|Overall Study|Lost to Follow-up|19|||
23412408|NCT00889603|65252409|FG000|Overall Study|No longer willing to participant in stud|4|||
23412409|NCT00889603|65252409|FG000|Overall Study|Other|4|||
23412410|NCT00854724|65252410|FG000|First Intervention|Withdrawal by Subject|1|||
23412411|NCT00854724|65252411|FG001|First Intervention|Withdrawal by Subject|1|||
23412412|NCT00854724|65252410|FG000|Washout|Protocol Violation|1|||
23412413|NCT00854724|65252411|FG001|Washout|Protocol Violation|0|||
23412414|NCT00854724|65252410|FG000|Washout|Withdrawal by Subject|0|||
23412415|NCT00854724|65252411|FG001|Washout|Withdrawal by Subject|1|||
23412416|NCT00854724|65252410|FG000|Second Intervention|Protocol Violation|1|||
23412417|NCT00854724|65252411|FG001|Second Intervention|Protocol Violation|0|||
23412418|NCT00854724|65252410|FG000|Second Intervention|Physician Decision|0|||
23412419|NCT00854724|65252411|FG001|Second Intervention|Physician Decision|1|||
23412420|NCT01606176|65252414|FG000|Overall Study|Adverse Event|2|||
23511816|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
23511817|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
23511818|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
23511819|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
23511820|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
23511821|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
23511822|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
23511823|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
23511824|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
23511825|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
23511826|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
23511827|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
23511828|NCT01124422|65609542|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
23511829|NCT01124422|65609543|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
23412421|NCT01606176|65252415|FG001|Overall Study|Adverse Event|3|||
23412422|NCT01606176|65252414|FG000|Overall Study|Disease progression|1|||
23412423|NCT01606176|65252415|FG001|Overall Study|Disease progression|0|||
23412424|NCT01606176|65252414|FG000|Overall Study|Withdrawal by Subject|1|||
23412425|NCT01606176|65252415|FG001|Overall Study|Withdrawal by Subject|0|||
23412426|NCT01523743|65252416|FG000|Period 1|Adverse Event|1|||
23412427|NCT01523743|65252417|FG001|Period 1|Adverse Event|0|||
23412428|NCT01523743|65252416|FG000|Period 1|Withdrawal by Subject|6|||
23412429|NCT01523743|65252417|FG001|Period 1|Withdrawal by Subject|2|||
23412430|NCT01523743|65252416|FG000|Period 1|Lost to Follow-up|1|||
23412431|NCT01523743|65252417|FG001|Period 1|Lost to Follow-up|0|||
23412432|NCT01523743|65252416|FG000|Period 1|Lack of Efficacy|1|||
23412433|NCT01523743|65252417|FG001|Period 1|Lack of Efficacy|0|||
23412434|NCT01523743|65252416|FG000|Period 1|Felt unable to empty bladder|1|||
23412435|NCT01523743|65252417|FG001|Period 1|Felt unable to empty bladder|0|||
23412436|NCT01523743|65252416|FG000|Period 2|Withdrawal by Subject|0|||
23412437|NCT01523743|65252417|FG001|Period 2|Withdrawal by Subject|2|||
23412438|NCT01523743|65252416|FG000|Period 2|Adverse Event|1|||
23511830|NCT01124422|65609544|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
23610588|NCT02676778|65962811|FG002|Overall Study|Other|0|||
23412439|NCT01523743|65252417|FG001|Period 2|Adverse Event|0|||
23412440|NCT01220401|65252428|FG000|Overall Study|Withdrawal by Subject|2|||
23412441|NCT01220401|65252428|FG000|Overall Study|Protocol Violation|1|||
23412442|NCT01262638|65252429|FG000|Overall Study|Adverse Event|3|||
23412443|NCT01262638|65252430|FG001|Overall Study|Adverse Event|4|||
23412444|NCT01262638|65252431|FG002|Overall Study|Adverse Event|3|||
23511831|NCT01124422|65609542|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
23511832|NCT01124422|65609543|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
23511833|NCT01124422|65609544|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
23511834|NCT01124422|65609542|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
23511835|NCT01124422|65609543|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
23511836|NCT01124422|65609544|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
23511837|NCT01124422|65609542|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
23511838|NCT01124422|65609543|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
23511839|NCT01124422|65609544|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
23511840|NCT01124422|65609542|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
23511841|NCT01124422|65609543|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
23511842|NCT01124422|65609544|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
23511843|NCT01714635|65609547|FG000|Overall Study|Discontinued|1|||
23511844|NCT01714635|65609548|FG001|Overall Study|Discontinued|0|||
23511845|NCT01714635|65609549|FG002|Overall Study|Discontinued|2|||
23511846|NCT01714635|65609547|FG000|Overall Study|Missed 6-month exam|1|||
23511847|NCT01714635|65609548|FG001|Overall Study|Missed 6-month exam|0|||
23511848|NCT01714635|65609549|FG002|Overall Study|Missed 6-month exam|0|||
23511849|NCT01324999|65609550|FG000|Overall Study|Adverse Event|3|||
23511850|NCT01324999|65609550|FG000|Overall Study|Withdrawal by Subject|2|||
23511851|NCT03241342|65609551|FG000|Overall Study|Adverse Event|5|||
23511852|NCT03241342|65609552|FG001|Overall Study|Adverse Event|8|||
23511853|NCT03241342|65609553|FG002|Overall Study|Adverse Event|4|||
23511854|NCT03241342|65609551|FG000|Overall Study|Lack of Efficacy|0|||
23511855|NCT03241342|65609552|FG001|Overall Study|Lack of Efficacy|0|||
23511856|NCT03241342|65609553|FG002|Overall Study|Lack of Efficacy|1|||
23511857|NCT03241342|65609551|FG000|Overall Study|noncompliance with study drug|2|||
23511858|NCT03241342|65609552|FG001|Overall Study|noncompliance with study drug|1|||
23511859|NCT03241342|65609553|FG002|Overall Study|noncompliance with study drug|1|||
23511860|NCT03241342|65609551|FG000|Overall Study|sponsor decision|0|||
23511861|NCT03241342|65609552|FG001|Overall Study|sponsor decision|1|||
23511862|NCT03241342|65609553|FG002|Overall Study|sponsor decision|2|||
23511863|NCT03241342|65609551|FG000|Overall Study|not reported|15|||
23511864|NCT03241342|65609552|FG001|Overall Study|not reported|21|||
23511865|NCT03241342|65609553|FG002|Overall Study|not reported|19|||
23511866|NCT02887521|65612539|FG000|Overall Study|Withdrawal by Subject|0|||
23511867|NCT02887521|65612540|FG001|Overall Study|Withdrawal by Subject|3|||
23511868|NCT01948050|65612541|FG000|Overall Study|Withdrawal by Subject|0|||
23511869|NCT01948050|65612542|FG001|Overall Study|Withdrawal by Subject|1|||
23511870|NCT02557646|65612543|FG000|Overall Study|Adverse Event|40|||
23511871|NCT02557646|65612543|FG000|Overall Study|Death|1|||
23511872|NCT02557646|65612543|FG000|Overall Study|Lack of Efficacy|186|||
23511873|NCT02557646|65612543|FG000|Overall Study|Withdrawal by Subject|18|||
23412445|NCT01262638|65252432|FG003|Overall Study|Adverse Event|4|||
23412446|NCT01262638|65252429|FG000|Overall Study|Protocol Violation|1|||
23412447|NCT01262638|65252430|FG001|Overall Study|Protocol Violation|0|||
23412448|NCT01262638|65252431|FG002|Overall Study|Protocol Violation|0|||
23412449|NCT01262638|65252432|FG003|Overall Study|Protocol Violation|1|||
23412450|NCT01262638|65252429|FG000|Overall Study|Withdrawal by Subject|2|||
23412451|NCT01262638|65252430|FG001|Overall Study|Withdrawal by Subject|1|||
23412452|NCT01262638|65252431|FG002|Overall Study|Withdrawal by Subject|0|||
23412453|NCT01262638|65252432|FG003|Overall Study|Withdrawal by Subject|1|||
23412454|NCT01262638|65252429|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
23412455|NCT01262638|65252430|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
23412456|NCT01262638|65252431|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
23412457|NCT01262638|65252432|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
23412458|NCT01262638|65252429|FG000|Overall Study|Lost to Follow-up|1|||
23412459|NCT01262638|65252430|FG001|Overall Study|Lost to Follow-up|1|||
23412460|NCT01262638|65252431|FG002|Overall Study|Lost to Follow-up|1|||
23412461|NCT01262638|65252432|FG003|Overall Study|Lost to Follow-up|1|||
23412462|NCT01262638|65252429|FG000|Overall Study|Participant Went Out of Town|0|||
23412463|NCT01262638|65252430|FG001|Overall Study|Participant Went Out of Town|0|||
23412464|NCT01262638|65252431|FG002|Overall Study|Participant Went Out of Town|1|||
23511874|NCT02557646|65612543|FG000|Overall Study|Lost to Follow-up|17|||
23511875|NCT02557646|65612543|FG000|Overall Study|Other|14|||
23511876|NCT01083576|65612544|FG000|Overall Study|Treatment Failure|6|||
23511877|NCT01083576|65612545|FG001|Overall Study|Treatment Failure|1|||
23511878|NCT02066233|65612546|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
23511879|NCT02066233|65612547|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
23511880|NCT01753856|65612548|FG000|Overall Study|Adverse Event|1|||
23511881|NCT01753856|65612549|FG001|Overall Study|Adverse Event|0|||
23412465|NCT01262638|65252432|FG003|Overall Study|Participant Went Out of Town|0|||
23412466|NCT02455336|65252433|FG000|Overall Study|Withdrawal by Subject|0|||
23412467|NCT02455336|65252434|FG001|Overall Study|Withdrawal by Subject|2|||
23412468|NCT02455336|65252433|FG000|Overall Study|Adverse Event|3|||
23412469|NCT02455336|65252434|FG001|Overall Study|Adverse Event|0|||
23412470|NCT02455336|65252433|FG000|Overall Study|Non-responder to treatment|2|||
23412471|NCT02455336|65252434|FG001|Overall Study|Non-responder to treatment|0|||
23412472|NCT01905943|65252435|FG000|Overall Study|Withdrawal of consent|90|||
23412473|NCT01905943|65252435|FG000|Overall Study|Lost to Follow-up|16|||
23412474|NCT01905943|65252435|FG000|Overall Study|Investigator discretion|7|||
23412475|NCT01905943|65252435|FG000|Overall Study|Death|186|||
23412476|NCT01905943|65252435|FG000|Overall Study|Adverse Event|3|||
23412477|NCT01905943|65252435|FG000|Overall Study|Other|12|||
23412478|NCT01140867|65252436|FG000|Overall Study|Adverse Event|22|||
23412479|NCT01140867|65252436|FG000|Overall Study|Lack of Efficacy|3|||
23412480|NCT01140867|65252436|FG000|Overall Study|Lost to Follow-up|2|||
23412481|NCT01140867|65252436|FG000|Overall Study|Withdrawal by Subject|1|||
23412482|NCT01140867|65252436|FG000|Overall Study|Protocol Violation|1|||
23412483|NCT01140867|65252436|FG000|Overall Study|Uncooperative patient|2|||
23412484|NCT01140867|65252436|FG000|Overall Study|Medication Noncompliance|2|||
23412485|NCT03530995|65252437|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
23412486|NCT03530995|65252438|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
23412487|NCT03530995|65252437|FG000|Part 1 Period 3|Protocol Violation|1|||
23412488|NCT03530995|65252438|FG001|Part 1 Period 3|Protocol Violation|0|||
23412489|NCT03530995|65252437|FG000|Part 1 Period 4|Physician Decision|1|||
23412490|NCT03530995|65252438|FG001|Part 1 Period 4|Physician Decision|0|||
23412491|NCT03530995|65252437|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
23412492|NCT03530995|65252438|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
23412493|NCT00289289|65252439|FG000|Overall Study|Withdrawal by Subject|5|||
23412494|NCT00289289|65252440|FG001|Overall Study|Withdrawal by Subject|3|||
23412495|NCT00289289|65252441|FG002|Overall Study|Withdrawal by Subject|15|||
23412496|NCT00289289|65252439|FG000|Overall Study|Lost to Follow-up|1|||
23412497|NCT00289289|65252440|FG001|Overall Study|Lost to Follow-up|0|||
23412498|NCT00289289|65252441|FG002|Overall Study|Lost to Follow-up|1|||
23412499|NCT00289289|65252439|FG000|Overall Study|Death|4|||
23412500|NCT00289289|65252440|FG001|Overall Study|Death|2|||
23412501|NCT00289289|65252441|FG002|Overall Study|Death|5|||
23412502|NCT00289289|65252439|FG000|Overall Study|No implant attempted|0|||
23412503|NCT00289289|65252440|FG001|Overall Study|No implant attempted|0|||
23412504|NCT00289289|65252441|FG002|Overall Study|No implant attempted|1|||
23412505|NCT00289289|65252439|FG000|Overall Study|Physician Decision|1|||
23412506|NCT00289289|65252440|FG001|Overall Study|Physician Decision|0|||
23412507|NCT00289289|65252441|FG002|Overall Study|Physician Decision|6|||
23412508|NCT00289289|65252439|FG000|Overall Study|Non-study device implanted|2|||
23412509|NCT00289289|65252440|FG001|Overall Study|Non-study device implanted|1|||
23412510|NCT00289289|65252441|FG002|Overall Study|Non-study device implanted|3|||
23412511|NCT00289289|65252439|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
23412512|NCT00289289|65252440|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
23412513|NCT00289289|65252441|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
23412514|NCT00289289|65252439|FG000|Overall Study|Other Exit Reason|6|||
23412515|NCT00289289|65252440|FG001|Overall Study|Other Exit Reason|4|||
23412516|NCT00289289|65252441|FG002|Overall Study|Other Exit Reason|12|||
23412517|NCT00759876|65252443|FG000|Overall Study|Sponsor terminated study early|36|||
23412518|NCT03802630|65252444|FG000|Overall Study|Study terminated by sponsor|130|||
23412519|NCT03802630|65252445|FG001|Overall Study|Study terminated by sponsor|134|||
23412520|NCT03802630|65252444|FG000|Overall Study|Subject decision|16|||
23412521|NCT03802630|65252445|FG001|Overall Study|Subject decision|9|||
23412522|NCT03802630|65252444|FG000|Overall Study|Adverse Event|3|||
23412523|NCT03802630|65252445|FG001|Overall Study|Adverse Event|1|||
23412524|NCT03802630|65252444|FG000|Overall Study|Lost to Follow-up|2|||
23412525|NCT03802630|65252445|FG001|Overall Study|Lost to Follow-up|2|||
23412526|NCT03802630|65252444|FG000|Overall Study|Physician Decision|2|||
23412527|NCT03802630|65252445|FG001|Overall Study|Physician Decision|0|||
23412528|NCT03802630|65252444|FG000|Overall Study|Death|0|||
23412529|NCT03802630|65252445|FG001|Overall Study|Death|2|||
23412530|NCT03226249|65252454|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
23412531|NCT03226249|65252454|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
23412532|NCT03226249|65252454|FG000|Survival Follow-up|Patients still in follow-up.|30|||
23412533|NCT00559104|65252456|FG000|Overall Study|Lack of Efficacy|9|||
23412534|NCT00559104|65252457|FG001|Overall Study|Lack of Efficacy|0|||
23412535|NCT04097028|65252458|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
23412536|NCT04097028|65252458|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
23412537|NCT04097028|65252458|FG000|Overall Study|Disease Progression prior to Surgery|2|||
23412538|NCT04097028|65252458|FG000|Overall Study|Adverse Event prior to Surgery|1|||
23412539|NCT00613327|65252459|FG000|Overall Study|Adverse Event|38|||
23412540|NCT00613327|65252459|FG000|Overall Study|Lost to Follow-up|8|||
23412541|NCT00613327|65252459|FG000|Overall Study|Withdrawal by Subject|6|||
23412542|NCT00613327|65252459|FG000|Overall Study|Protocol Violation|2|||
23412543|NCT00613327|65252459|FG000|Overall Study|Other|47|||
23412544|NCT01221753|65252460|FG000|Overall Study|Adverse Event|1|||
23412545|NCT01802580|65252461|FG000|Overall Study|Physician Decision|1|||
23412546|NCT01802580|65252462|FG001|Overall Study|Physician Decision|0|||
23412547|NCT01802580|65252461|FG000|Overall Study|Protocol Violation|2|||
23412548|NCT01802580|65252462|FG001|Overall Study|Protocol Violation|0|||
23511882|NCT01753856|65612548|FG000|Overall Study|Withdrawal by Subject|0|||
23511883|NCT01753856|65612549|FG001|Overall Study|Withdrawal by Subject|2|||
23511884|NCT01753856|65612548|FG000|Overall Study|Sponsor Decision|2|||
23511885|NCT01753856|65612549|FG001|Overall Study|Sponsor Decision|0|||
23511886|NCT03045328|65612550|FG000|Overall Study|Withdrawal by Subject|2|||
23412549|NCT01802580|65252461|FG000|Overall Study|Withdrawal by Subject|5|||
23412550|NCT01802580|65252462|FG001|Overall Study|Withdrawal by Subject|6|||
23511887|NCT00461682|65612561|FG000|Overall Study|Protocol Violation|1|||
23511888|NCT03061331|65612567|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
23511889|NCT03061331|65612568|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
23511890|NCT04160091|65612569|FG000|Overall Study|Terminated by Sponsor|7|||
23307358|NCT03107026|64870483|FG001|Overall Study|Protocol Violation|2|||
23412551|NCT01802580|65252461|FG000|Overall Study|Other|1|||
23412552|NCT01802580|65252462|FG001|Overall Study|Other|3|||
23412553|NCT01802580|65252461|FG000|Overall Study|Lack of Efficacy|0|||
23412554|NCT01802580|65252462|FG001|Overall Study|Lack of Efficacy|2|||
23412555|NCT02237001|65252463|FG000|Overall Study|Lost to Follow-up|2|||
23412556|NCT02237001|65252463|FG000|Overall Study|Withdrawal by Subject|1|||
23412557|NCT02237001|65252463|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
23412558|NCT02237001|65252463|FG000|Overall Study|Re-operation|4|||
23412559|NCT02237001|65252463|FG000|Overall Study|Incarceration|1|||
23412560|NCT02752633|65252464|FG000|Overall Study|Withdrawal by Subject|1|||
23412561|NCT00175916|65252468|FG000|Overall Study|Death|19|||
23412562|NCT00175916|65252468|FG000|Overall Study|Adverse Event|81|||
23412563|NCT00175916|65252468|FG000|Overall Study|Lack of Efficacy|354|||
23412564|NCT00175916|65252468|FG000|Overall Study|Lost to Follow-up|17|||
23412565|NCT00175916|65252468|FG000|Overall Study|Subject Choice|98|||
23412566|NCT00175916|65252468|FG000|Overall Study|Lack of compliance|8|||
23412567|NCT00175916|65252468|FG000|Overall Study|Patient cannot record seizures|1|||
23412568|NCT00175916|65252468|FG000|Overall Study|Sponsor decision|17|||
23412569|NCT00175916|65252468|FG000|Overall Study|Vigabatrin intake|1|||
23412570|NCT00175916|65252468|FG000|Overall Study|Suicidal behaviour|1|||
23412571|NCT00175916|65252468|FG000|Overall Study|Withdrawal by Subject|1|||
23412572|NCT00175916|65252468|FG000|Overall Study|Seizure - free|4|||
23412573|NCT00175916|65252468|FG000|Overall Study|Administrative reason|1|||
23412574|NCT00175916|65252468|FG000|Overall Study|Pregnancy|1|||
23412575|NCT00175916|65252468|FG000|Overall Study|Patient's request|2|||
23412576|NCT00175916|65252468|FG000|Overall Study|Treating physiciant's choice|1|||
23412577|NCT00175916|65252468|FG000|Overall Study|Moved overseas|1|||
23412578|NCT00175916|65252468|FG000|Overall Study|Loss of job and economic burden|1|||
23412579|NCT00175916|65252468|FG000|Overall Study|Site was closed|9|||
23412580|NCT00175916|65252468|FG000|Overall Study|Patient went to prison|1|||
23412581|NCT00588237|65252469|FG000|Overall Study|Evaluable for toxicity only|3|||
23412582|NCT00588237|65252469|FG000|Overall Study|Patien not treated|1|||
23412583|NCT01071252|65252470|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
23412584|NCT01071252|65252471|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
23412585|NCT01071252|65252472|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
23412586|NCT01071252|65252473|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
23412587|NCT01071252|65252474|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
23412588|NCT01071252|65252470|FG000|Overall Study|Withdrawal by Subject|8|||
23412589|NCT01071252|65252471|FG001|Overall Study|Withdrawal by Subject|2|||
23412590|NCT01071252|65252472|FG002|Overall Study|Withdrawal by Subject|1|||
23412591|NCT01071252|65252473|FG003|Overall Study|Withdrawal by Subject|2|||
23412592|NCT01071252|65252474|FG004|Overall Study|Withdrawal by Subject|3|||
23412593|NCT01071252|65252470|FG000|Overall Study|administrative problems|1|||
23412594|NCT01071252|65252471|FG001|Overall Study|administrative problems|1|||
23412595|NCT01071252|65252472|FG002|Overall Study|administrative problems|0|||
23412596|NCT01071252|65252473|FG003|Overall Study|administrative problems|2|||
23412597|NCT01071252|65252474|FG004|Overall Study|administrative problems|1|||
23412598|NCT01071252|65252470|FG000|Overall Study|Lost to Follow-up|1|||
23412599|NCT01071252|65252471|FG001|Overall Study|Lost to Follow-up|0|||
23412600|NCT01071252|65252472|FG002|Overall Study|Lost to Follow-up|1|||
23412601|NCT01071252|65252473|FG003|Overall Study|Lost to Follow-up|2|||
23412602|NCT01071252|65252474|FG004|Overall Study|Lost to Follow-up|0|||
23412603|NCT01071252|65252470|FG000|Overall Study|Adverse Event|1|||
23412604|NCT01071252|65252471|FG001|Overall Study|Adverse Event|1|||
23412605|NCT01071252|65252472|FG002|Overall Study|Adverse Event|0|||
23412606|NCT01071252|65252473|FG003|Overall Study|Adverse Event|1|||
23412607|NCT01071252|65252474|FG004|Overall Study|Adverse Event|0|||
23511891|NCT04160091|65612570|FG001|Overall Study|Terminated by Sponsor|3|||
23307359|NCT03107026|64870484|FG002|Overall Study|Protocol Violation|0|||
23412608|NCT01071252|65252470|FG000|Overall Study|Death|0|||
23412609|NCT01071252|65252471|FG001|Overall Study|Death|0|||
23412610|NCT01071252|65252472|FG002|Overall Study|Death|0|||
23412611|NCT01071252|65252473|FG003|Overall Study|Death|0|||
23412612|NCT01071252|65252474|FG004|Overall Study|Death|1|||
23412613|NCT00344318|65252475|FG000|Overall Study|Adverse Event|0|||
23412614|NCT00344318|65252476|FG001|Overall Study|Adverse Event|3|||
23412615|NCT00344318|65252477|FG002|Overall Study|Adverse Event|0|||
23412616|NCT00344318|65252478|FG003|Overall Study|Adverse Event|1|||
23412617|NCT00344318|65252475|FG000|Overall Study|Withdrawal by Subject|2|||
23412618|NCT00344318|65252476|FG001|Overall Study|Withdrawal by Subject|2|||
23412619|NCT00344318|65252477|FG002|Overall Study|Withdrawal by Subject|0|||
23412620|NCT00344318|65252478|FG003|Overall Study|Withdrawal by Subject|2|||
23412621|NCT00344318|65252475|FG000|Overall Study|Lost to Follow-up|2|||
23412622|NCT00344318|65252476|FG001|Overall Study|Lost to Follow-up|0|||
23412623|NCT00344318|65252477|FG002|Overall Study|Lost to Follow-up|1|||
23412624|NCT00344318|65252478|FG003|Overall Study|Lost to Follow-up|0|||
23412625|NCT02907216|65252479|FG000|Overall Study|No benefit to be obtained by continuing|0|||
23412626|NCT02907216|65252480|FG001|Overall Study|No benefit to be obtained by continuing|1|||
23412627|NCT02907216|65252479|FG000|Overall Study|Withdrawal by Subject|1|||
23412628|NCT02907216|65252480|FG001|Overall Study|Withdrawal by Subject|0|||
23412629|NCT01897727|65252484|FG000|Overall Study|Exclusion: central sleep apnea|0|||
23412630|NCT01897727|65252485|FG001|Overall Study|Exclusion: central sleep apnea|1|||
23412631|NCT03490292|65252486|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
23412632|NCT03490292|65252487|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
23412633|NCT03490292|65252486|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
23412634|NCT03490292|65252487|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
23412635|NCT03490292|65252486|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
23412636|NCT03490292|65252487|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
23412637|NCT03490292|65252486|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
23412638|NCT03490292|65252487|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
23412639|NCT03490292|65252486|FG000|1 Year Follow Up Post Last Dose|Death|1|||
23412640|NCT03490292|65252487|FG001|1 Year Follow Up Post Last Dose|Death|1|||
23412641|NCT01691105|65252488|FG000|1 Month Follow-up|Lost to Follow-up|41|||
23412642|NCT01691105|65252489|FG001|1 Month Follow-up|Lost to Follow-up|38|||
23412643|NCT01691105|65252488|FG000|1 Month Follow-up|Death|2|||
23412644|NCT01691105|65252489|FG001|1 Month Follow-up|Death|3|||
23511892|NCT04160091|65612571|FG002|Overall Study|Terminated by Sponsor|5|||
23511893|NCT04160091|65612572|FG003|Overall Study|Terminated by Sponsor|2|||
23511894|NCT04160091|65612569|FG000|Overall Study|Noncompliance|0|||
23511895|NCT04160091|65612570|FG001|Overall Study|Noncompliance|0|||
23511896|NCT04160091|65612571|FG002|Overall Study|Noncompliance|0|||
23511897|NCT04160091|65612572|FG003|Overall Study|Noncompliance|1|||
23511898|NCT04160091|65612569|FG000|Overall Study|Withdrawal by Subject|0|||
23511899|NCT04160091|65612570|FG001|Overall Study|Withdrawal by Subject|0|||
23511900|NCT04160091|65612571|FG002|Overall Study|Withdrawal by Subject|0|||
23511901|NCT04160091|65612572|FG003|Overall Study|Withdrawal by Subject|1|||
23511902|NCT03585504|65612573|FG000|Overall Study|Lost to Follow-up|26|||
23511903|NCT03585504|65612574|FG001|Overall Study|Lost to Follow-up|29|||
23511904|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
23511905|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
23511906|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
23511907|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
23511908|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
23511909|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
23511910|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
23511911|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
23412645|NCT01691105|65252488|FG000|6 Month Follow-up|Lost to Follow-up|39|||
23412646|NCT01691105|65252489|FG001|6 Month Follow-up|Lost to Follow-up|58|||
23412647|NCT01691105|65252488|FG000|6 Month Follow-up|Death|13|||
23412648|NCT01691105|65252489|FG001|6 Month Follow-up|Death|13|||
23412649|NCT01691105|65252488|FG000|12 Month Follow-up|Lost to Follow-up|50|||
23412650|NCT01691105|65252489|FG001|12 Month Follow-up|Lost to Follow-up|71|||
23412651|NCT01691105|65252488|FG000|12 Month Follow-up|Death|22|||
23412652|NCT01691105|65252489|FG001|12 Month Follow-up|Death|30|||
23412653|NCT01691105|65252488|FG000|12 Month Biochemical Verification|Death|22|||
23511912|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
23511913|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
23511914|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
23412654|NCT01691105|65252489|FG001|12 Month Biochemical Verification|Death|30|||
23412655|NCT01691105|65252488|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
23412656|NCT01691105|65252489|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
23412657|NCT01691105|65252488|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
23412658|NCT01691105|65252489|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
23412659|NCT00342628|65252490|FG000|Overall Study|Withdrawal by Subject|19|||
23412660|NCT00342628|65252491|FG001|Overall Study|Withdrawal by Subject|19|||
23412661|NCT00342628|65252492|FG002|Overall Study|Withdrawal by Subject|18|||
23412662|NCT00342628|65252490|FG000|Overall Study|Death|1|||
23412663|NCT00342628|65252491|FG001|Overall Study|Death|1|||
23412664|NCT00342628|65252492|FG002|Overall Study|Death|0|||
23412665|NCT00342628|65252490|FG000|Overall Study|moved residence|0|||
23412666|NCT00342628|65252491|FG001|Overall Study|moved residence|1|||
23412667|NCT00342628|65252492|FG002|Overall Study|moved residence|1|||
23412668|NCT02249091|65252495|FG000|Overall Study|Lack of Efficacy|8|||
23412669|NCT02249091|65252496|FG001|Overall Study|Lack of Efficacy|3|||
23412670|NCT02249091|65252495|FG000|Overall Study|Physician Decision|4|||
23412671|NCT02249091|65252496|FG001|Overall Study|Physician Decision|1|||
23412672|NCT02249091|65252495|FG000|Overall Study|Withdrawal by Subject|2|||
23412673|NCT02249091|65252496|FG001|Overall Study|Withdrawal by Subject|2|||
23412674|NCT02249091|65252495|FG000|Overall Study|Death|3|||
23412675|NCT02249091|65252496|FG001|Overall Study|Death|4|||
23412676|NCT02249091|65252495|FG000|Overall Study|Adverse Event|1|||
23412677|NCT02249091|65252496|FG001|Overall Study|Adverse Event|0|||
23412678|NCT02249091|65252495|FG000|Overall Study|Stable disease with following SCT|0|||
23412679|NCT02249091|65252496|FG001|Overall Study|Stable disease with following SCT|1|||
23412680|NCT02249091|65252495|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
23412681|NCT02249091|65252496|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
23412682|NCT02249091|65252495|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
23412683|NCT02249091|65252496|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
23412684|NCT02249091|65252495|FG000|Overall Study|Refractory AML|1|||
23412685|NCT02249091|65252496|FG001|Overall Study|Refractory AML|1|||
23412686|NCT00830375|65252498|FG000|Overall Study|Lost to Follow-up|1|||
23412687|NCT00090779|65252499|FG000|Step 1|Withdrawal by Subject|4|||
23412688|NCT00090779|65252500|FG001|Step 1|Withdrawal by Subject|2|||
23412689|NCT00090779|65252499|FG000|Step 1|Lost to Follow-up|3|||
23412690|NCT00090779|65252500|FG001|Step 1|Lost to Follow-up|2|||
23412691|NCT00090779|65252499|FG000|Step 1|Death|0|||
23412692|NCT00090779|65252500|FG001|Step 1|Death|2|||
23412693|NCT00090779|65252499|FG000|Step 1|Physician Decision|1|||
23412694|NCT00090779|65252500|FG001|Step 1|Physician Decision|0|||
23412695|NCT00090779|65252499|FG000|Step 1|Pregnancy|1|||
23412696|NCT00090779|65252500|FG001|Step 1|Pregnancy|0|||
23412697|NCT00090779|65252499|FG000|Step 1|Non-compliance to study requirements|0|||
23412698|NCT00090779|65252500|FG001|Step 1|Non-compliance to study requirements|1|||
23412699|NCT00090779|65252499|FG000|Step 1|Subject relocated|2|||
23412700|NCT00090779|65252500|FG001|Step 1|Subject relocated|8|||
23412701|NCT00090779|65252499|FG000|Step 2|Off study per study closure|6|||
23412702|NCT00090779|65252500|FG001|Step 2|Off study per study closure|16|||
23412703|NCT00090779|65252499|FG000|Step 2|Subject relocated|0|||
23412704|NCT00090779|65252500|FG001|Step 2|Subject relocated|1|||
23412705|NCT00090779|65252499|FG000|Step 2|Non-compliance to study requirements|0|||
23412706|NCT00090779|65252500|FG001|Step 2|Non-compliance to study requirements|1|||
23412707|NCT00090779|65252499|FG000|Step 3|Initiation of ART and off extended study|3|||
23412708|NCT00090779|65252500|FG001|Step 3|Initiation of ART and off extended study|2|||
23412709|NCT00090779|65252499|FG000|Step 3|Off extended study due to study closure|4|||
23412710|NCT00090779|65252500|FG001|Step 3|Off extended study due to study closure|3|||
23412711|NCT01238991|65252504|FG000|Overall Study|Adverse Event|1|||
23412712|NCT01238991|65252505|FG001|Overall Study|Adverse Event|0|||
23412713|NCT01238991|65252506|FG002|Overall Study|Adverse Event|3|||
23412714|NCT01238991|65252507|FG003|Overall Study|Adverse Event|1|||
23412715|NCT01238991|65252508|FG004|Overall Study|Adverse Event|1|||
23412716|NCT01238991|65252509|FG005|Overall Study|Adverse Event|0|||
23412717|NCT01238991|65252510|FG006|Overall Study|Adverse Event|1|||
23412718|NCT01238991|65252511|FG007|Overall Study|Adverse Event|1|||
23412719|NCT01238991|65252512|FG008|Overall Study|Adverse Event|0|||
23412720|NCT01238991|65252513|FG009|Overall Study|Adverse Event|0|||
23412721|NCT01238991|65252504|FG000|Overall Study|Death|0|||
23412722|NCT01238991|65252505|FG001|Overall Study|Death|0|||
23412723|NCT01238991|65252506|FG002|Overall Study|Death|0|||
23412724|NCT01238991|65252507|FG003|Overall Study|Death|1|||
23412725|NCT01238991|65252508|FG004|Overall Study|Death|0|||
23412726|NCT01238991|65252509|FG005|Overall Study|Death|0|||
23412727|NCT01238991|65252510|FG006|Overall Study|Death|0|||
23412728|NCT01238991|65252511|FG007|Overall Study|Death|0|||
23412729|NCT01238991|65252512|FG008|Overall Study|Death|0|||
23412730|NCT01238991|65252513|FG009|Overall Study|Death|0|||
23412731|NCT01238991|65252504|FG000|Overall Study|Lack of Efficacy|0|||
23412732|NCT01238991|65252505|FG001|Overall Study|Lack of Efficacy|0|||
23412733|NCT01238991|65252506|FG002|Overall Study|Lack of Efficacy|1|||
23412734|NCT01238991|65252507|FG003|Overall Study|Lack of Efficacy|0|||
23412735|NCT01238991|65252508|FG004|Overall Study|Lack of Efficacy|0|||
23412736|NCT01238991|65252509|FG005|Overall Study|Lack of Efficacy|0|||
23412737|NCT01238991|65252510|FG006|Overall Study|Lack of Efficacy|0|||
23412738|NCT01238991|65252511|FG007|Overall Study|Lack of Efficacy|0|||
23412739|NCT01238991|65252512|FG008|Overall Study|Lack of Efficacy|1|||
23412740|NCT01238991|65252513|FG009|Overall Study|Lack of Efficacy|0|||
23412741|NCT01238991|65252504|FG000|Overall Study|Withdrawal by Subject|0|||
23412742|NCT01238991|65252505|FG001|Overall Study|Withdrawal by Subject|0|||
23412743|NCT01238991|65252506|FG002|Overall Study|Withdrawal by Subject|1|||
23412744|NCT01238991|65252507|FG003|Overall Study|Withdrawal by Subject|0|||
23412745|NCT01238991|65252508|FG004|Overall Study|Withdrawal by Subject|0|||
23412746|NCT01238991|65252509|FG005|Overall Study|Withdrawal by Subject|0|||
23412747|NCT01238991|65252510|FG006|Overall Study|Withdrawal by Subject|0|||
23412748|NCT01238991|65252511|FG007|Overall Study|Withdrawal by Subject|0|||
23412749|NCT01238991|65252512|FG008|Overall Study|Withdrawal by Subject|0|||
23412750|NCT01238991|65252513|FG009|Overall Study|Withdrawal by Subject|0|||
23412751|NCT01238991|65252504|FG000|Overall Study|Study Terminated by Sponsor|0|||
23412752|NCT01238991|65252505|FG001|Overall Study|Study Terminated by Sponsor|0|||
23412753|NCT01238991|65252506|FG002|Overall Study|Study Terminated by Sponsor|0|||
23412754|NCT01238991|65252507|FG003|Overall Study|Study Terminated by Sponsor|0|||
23412755|NCT01238991|65252508|FG004|Overall Study|Study Terminated by Sponsor|1|||
23412756|NCT01238991|65252509|FG005|Overall Study|Study Terminated by Sponsor|0|||
23412757|NCT01238991|65252510|FG006|Overall Study|Study Terminated by Sponsor|7|||
23412758|NCT01238991|65252511|FG007|Overall Study|Study Terminated by Sponsor|4|||
23412759|NCT01238991|65252512|FG008|Overall Study|Study Terminated by Sponsor|2|||
23412760|NCT01238991|65252513|FG009|Overall Study|Study Terminated by Sponsor|2|||
23412761|NCT01238991|65252504|FG000|Overall Study|Caregiver's request|0|||
23412762|NCT01238991|65252505|FG001|Overall Study|Caregiver's request|0|||
23412763|NCT01238991|65252506|FG002|Overall Study|Caregiver's request|0|||
23412764|NCT01238991|65252507|FG003|Overall Study|Caregiver's request|0|||
23412765|NCT01238991|65252508|FG004|Overall Study|Caregiver's request|0|||
23412766|NCT01238991|65252509|FG005|Overall Study|Caregiver's request|0|||
23412767|NCT01238991|65252510|FG006|Overall Study|Caregiver's request|0|||
23412768|NCT01238991|65252511|FG007|Overall Study|Caregiver's request|0|||
23412769|NCT01238991|65252512|FG008|Overall Study|Caregiver's request|1|||
23412770|NCT01238991|65252513|FG009|Overall Study|Caregiver's request|0|||
23412771|NCT01238991|65252504|FG000|Overall Study|Admission to a nursing home|1|||
23412772|NCT01238991|65252505|FG001|Overall Study|Admission to a nursing home|0|||
23412773|NCT01238991|65252506|FG002|Overall Study|Admission to a nursing home|1|||
23412774|NCT01238991|65252507|FG003|Overall Study|Admission to a nursing home|0|||
23412775|NCT01238991|65252508|FG004|Overall Study|Admission to a nursing home|0|||
23412776|NCT01238991|65252509|FG005|Overall Study|Admission to a nursing home|0|||
23412777|NCT01238991|65252510|FG006|Overall Study|Admission to a nursing home|0|||
23412778|NCT01238991|65252511|FG007|Overall Study|Admission to a nursing home|0|||
23412779|NCT01238991|65252512|FG008|Overall Study|Admission to a nursing home|0|||
23412780|NCT01238991|65252513|FG009|Overall Study|Admission to a nursing home|0|||
23412781|NCT00526656|65252514|FG000|Overall Study|Death|1|||
23412782|NCT00526656|65252514|FG000|Overall Study|Refused surgery|1|||
23412783|NCT03248531|65252515|FG000|Overall Study|Adverse Event|0|||
23412784|NCT03248531|65252516|FG001|Overall Study|Adverse Event|0|||
23412785|NCT03248531|65252517|FG002|Overall Study|Adverse Event|1|||
23412786|NCT03248531|65252515|FG000|Overall Study|Lost to Follow-up|1|||
23412787|NCT03248531|65252516|FG001|Overall Study|Lost to Follow-up|0|||
23412788|NCT03248531|65252517|FG002|Overall Study|Lost to Follow-up|5|||
23412789|NCT03248531|65252515|FG000|Overall Study|Withdrawal by Subject|3|||
23412790|NCT03248531|65252516|FG001|Overall Study|Withdrawal by Subject|3|||
23412791|NCT03248531|65252517|FG002|Overall Study|Withdrawal by Subject|2|||
23412792|NCT03248531|65252515|FG000|Overall Study|Sponsor Request|0|||
23412793|NCT03248531|65252516|FG001|Overall Study|Sponsor Request|2|||
23412794|NCT03248531|65252517|FG002|Overall Study|Sponsor Request|0|||
23412795|NCT04075513|65252518|FG000|Overall Study|Withdrawal by Subject|2|||
23412796|NCT04075513|65252519|FG001|Overall Study|Withdrawal by Subject|2|||
23412797|NCT04075513|65252518|FG000|Overall Study|Lack of Efficacy|1|||
23412798|NCT04075513|65252519|FG001|Overall Study|Lack of Efficacy|0|||
23412799|NCT04075513|65252518|FG000|Overall Study|Lost to Follow-up|4|||
23412800|NCT04075513|65252519|FG001|Overall Study|Lost to Follow-up|2|||
23412801|NCT04075513|65252518|FG000|Overall Study|Switch to insulin pump|1|||
23412802|NCT04075513|65252519|FG001|Overall Study|Switch to insulin pump|0|||
23412803|NCT02482298|65252523|FG000|Overall Study|Withdrawal by Subject|2|||
23412804|NCT02482298|65252524|FG001|Overall Study|Withdrawal by Subject|1|||
23412805|NCT02482298|65252525|FG002|Overall Study|Withdrawal by Subject|2|||
23412806|NCT02482298|65252523|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
23412807|NCT02482298|65252524|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
23412808|NCT02482298|65252525|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
23412809|NCT02482298|65252523|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
23412810|NCT02482298|65252524|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
23412811|NCT02482298|65252525|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
23412812|NCT02482298|65252523|FG000|Overall Study|Lost to Follow-up|0|||
23412813|NCT02482298|65252524|FG001|Overall Study|Lost to Follow-up|1|||
23412814|NCT02482298|65252525|FG002|Overall Study|Lost to Follow-up|0|||
23412815|NCT02241733|65252526|FG000|Overall Study|Lost to Follow-up|9|||
23412816|NCT02241733|65252527|FG001|Overall Study|Lost to Follow-up|4|||
23412817|NCT02241733|65252526|FG000|Overall Study|Physician Decision|6|||
23412818|NCT02241733|65252527|FG001|Overall Study|Physician Decision|2|||
23412819|NCT02241733|65252526|FG000|Overall Study|Withdrawal by Subject|0|||
23412820|NCT02241733|65252527|FG001|Overall Study|Withdrawal by Subject|2|||
23412821|NCT02241733|65252526|FG000|Overall Study|Death|0|||
23412822|NCT02241733|65252527|FG001|Overall Study|Death|2|||
23412823|NCT01521923|65252528|FG000|Overall Study|AE, serious fatal|1|||
23412824|NCT01521923|65252529|FG001|Overall Study|AE, serious fatal|0|||
23412825|NCT01521923|65252530|FG002|Overall Study|AE, serious fatal|0|||
23412826|NCT01521923|65252531|FG003|Overall Study|AE, serious fatal|0|||
23412827|NCT01521923|65252528|FG000|Overall Study|SAE, non-fatal|0|||
23412828|NCT01521923|65252529|FG001|Overall Study|SAE, non-fatal|2|||
23412829|NCT01521923|65252530|FG002|Overall Study|SAE, non-fatal|2|||
23412830|NCT01521923|65252531|FG003|Overall Study|SAE, non-fatal|0|||
23412831|NCT01521923|65252528|FG000|Overall Study|AE, non-serious, non-fatal|1|||
23412832|NCT01521923|65252529|FG001|Overall Study|AE, non-serious, non-fatal|3|||
23412833|NCT01521923|65252530|FG002|Overall Study|AE, non-serious, non-fatal|6|||
23412834|NCT01521923|65252531|FG003|Overall Study|AE, non-serious, non-fatal|2|||
23412835|NCT01521923|65252528|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
23412836|NCT01521923|65252529|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
23412837|NCT01521923|65252530|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
23412838|NCT01521923|65252531|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
23412839|NCT01521923|65252528|FG000|Overall Study|Lack of Efficacy|1|||
23412840|NCT01521923|65252529|FG001|Overall Study|Lack of Efficacy|1|||
23412841|NCT01521923|65252530|FG002|Overall Study|Lack of Efficacy|0|||
23412842|NCT01521923|65252531|FG003|Overall Study|Lack of Efficacy|0|||
23412843|NCT01521923|65252528|FG000|Overall Study|Protocol Violation|0|||
23412844|NCT01521923|65252529|FG001|Overall Study|Protocol Violation|0|||
23412845|NCT01521923|65252530|FG002|Overall Study|Protocol Violation|1|||
23412846|NCT01521923|65252531|FG003|Overall Study|Protocol Violation|0|||
23412847|NCT01521923|65252528|FG000|Overall Study|Lost to Follow-up|1|||
23412848|NCT01521923|65252529|FG001|Overall Study|Lost to Follow-up|0|||
23307360|NCT03107026|64870482|FG000|Overall Study|Pregnancy|1|||
23307361|NCT03107026|64870483|FG001|Overall Study|Pregnancy|0|||
23307362|NCT03107026|64870484|FG002|Overall Study|Pregnancy|0|||
23307363|NCT03107026|64870482|FG000|Overall Study|Withdrawal by Subject|13|||
23307364|NCT03107026|64870483|FG001|Overall Study|Withdrawal by Subject|5|||
23307365|NCT03107026|64870484|FG002|Overall Study|Withdrawal by Subject|17|||
23307366|NCT03107026|64870482|FG000|Overall Study|non compliance with study visits|1|||
23307367|NCT03107026|64870483|FG001|Overall Study|non compliance with study visits|2|||
23307368|NCT03107026|64870484|FG002|Overall Study|non compliance with study visits|0|||
23307369|NCT03107026|64870482|FG000|Overall Study|non-compliance with study drug|2|||
23412849|NCT01521923|65252530|FG002|Overall Study|Lost to Follow-up|2|||
23412850|NCT01521923|65252531|FG003|Overall Study|Lost to Follow-up|1|||
23412851|NCT01521923|65252528|FG000|Overall Study|Withdrawal by Subject|1|||
23412852|NCT01521923|65252529|FG001|Overall Study|Withdrawal by Subject|1|||
23412853|NCT01521923|65252530|FG002|Overall Study|Withdrawal by Subject|1|||
23412854|NCT01521923|65252531|FG003|Overall Study|Withdrawal by Subject|2|||
23412855|NCT01521923|65252528|FG000|Overall Study|Other|2|||
23412856|NCT01521923|65252529|FG001|Overall Study|Other|1|||
23412857|NCT01521923|65252530|FG002|Overall Study|Other|3|||
23412858|NCT01521923|65252531|FG003|Overall Study|Other|6|||
23412859|NCT01521923|65252528|FG000|Overall Study|AE, captured in Period 1|0|||
23412860|NCT01521923|65252529|FG001|Overall Study|AE, captured in Period 1|1|||
23412861|NCT01521923|65252530|FG002|Overall Study|AE, captured in Period 1|0|||
23412862|NCT01521923|65252531|FG003|Overall Study|AE, captured in Period 1|1|||
23307370|NCT03107026|64870483|FG001|Overall Study|non-compliance with study drug|2|||
23412863|NCT00904670|65252533|FG000|Open Label Phase|Withdrawal by Subject|2|||
23412864|NCT00904670|65252534|FG001|Open Label Phase|Withdrawal by Subject|0|||
23412865|NCT00904670|65252533|FG000|Open Label Phase|Adverse Event|2|||
23412866|NCT00904670|65252534|FG001|Open Label Phase|Adverse Event|0|||
23412867|NCT00904670|65252533|FG000|Open Label Phase|Lack of Efficacy|1|||
23412868|NCT00904670|65252534|FG001|Open Label Phase|Lack of Efficacy|0|||
23412869|NCT00904670|65252533|FG000|Open Label Phase|Lost to Follow-up|1|||
23412870|NCT00904670|65252534|FG001|Open Label Phase|Lost to Follow-up|0|||
23412871|NCT03650413|65252537|FG000|Overall Study|Adverse Event|1|||
23412872|NCT03650413|65252537|FG000|Overall Study|Lack of Efficacy|17|||
23412873|NCT03650413|65252537|FG000|Overall Study|Other|9|||
23307371|NCT03107026|64870484|FG002|Overall Study|non-compliance with study drug|3|||
23307372|NCT03107026|64870482|FG000|Overall Study|Physician Decision|0|||
23412874|NCT03650413|65252537|FG000|Overall Study|Physician Decision|2|||
23412875|NCT03650413|65252537|FG000|Overall Study|Study Terminated By Sponsor|16|||
23412876|NCT03650413|65252537|FG000|Overall Study|Withdrawal by Subject|16|||
23412877|NCT02266147|65252540|FG000|PART 1: Dose Escalation|Physician Decision|0|||
23412878|NCT02266147|65252541|FG001|PART 1: Dose Escalation|Physician Decision|0|||
23412879|NCT02266147|65252542|FG002|PART 1: Dose Escalation|Physician Decision|1|||
23412880|NCT02266147|65252543|FG003|PART 1: Dose Escalation|Physician Decision|0|||
23412881|NCT02266147|65252540|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
23412882|NCT02266147|65252541|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
23412883|NCT02266147|65252542|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
23412884|NCT02266147|65252543|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
23412885|NCT02266147|65252540|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
23412886|NCT02266147|65252541|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
23412887|NCT02266147|65252542|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
23412888|NCT02266147|65252543|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
23412889|NCT02266147|65252540|FG000|PART 1: Dose Escalation|Other|1|||
23412890|NCT02266147|65252541|FG001|PART 1: Dose Escalation|Other|1|||
23412891|NCT02266147|65252542|FG002|PART 1: Dose Escalation|Other|0|||
23412892|NCT02266147|65252543|FG003|PART 1: Dose Escalation|Other|0|||
23412893|NCT02266147|65252540|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
23412894|NCT02266147|65252541|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
23412895|NCT02266147|65252542|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
23412896|NCT02266147|65252543|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
23412897|NCT02266147|65252540|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
23412898|NCT02266147|65252541|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
23412899|NCT02266147|65252542|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
23412900|NCT02266147|65252543|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
23412901|NCT01221623|65252544|FG000|Overall Study|Withdrawal by Subject|19|||
23412902|NCT01221623|65252545|FG001|Overall Study|Withdrawal by Subject|8|||
23412903|NCT01221623|65252544|FG000|Overall Study|Lost to Follow-up|7|||
23412904|NCT01221623|65252545|FG001|Overall Study|Lost to Follow-up|1|||
23412905|NCT01221623|65252544|FG000|Overall Study|Adverse Event|6|||
23412906|NCT01221623|65252545|FG001|Overall Study|Adverse Event|3|||
23412907|NCT01221623|65252544|FG000|Overall Study|Death|1|||
23412908|NCT01221623|65252545|FG001|Overall Study|Death|0|||
23412909|NCT01221623|65252544|FG000|Overall Study|Other|5|||
23412910|NCT01221623|65252545|FG001|Overall Study|Other|2|||
23412911|NCT01076205|65252546|FG000|Overall Study|Adverse Drug Reaction|299|||
23412912|NCT01076205|65252546|FG000|Overall Study|Lack of Effectiveness|1423|||
23412913|NCT01076205|65252546|FG000|Overall Study|Other Reason|1075|||
23412914|NCT01076205|65252546|FG000|Overall Study|Unknown Reason|71|||
23412915|NCT01076205|65252546|FG000|Overall Study|Lost to Follow-up|3151|||
23412916|NCT00635349|65255228|FG000|Overall Study|Other|8|||
23412917|NCT00635349|65255229|FG001|Overall Study|Other|6|||
23412918|NCT00635349|65255228|FG000|Overall Study|Protocol Violation|18|||
23412919|NCT00635349|65255229|FG001|Overall Study|Protocol Violation|22|||
23412920|NCT00635349|65255228|FG000|Overall Study|Withdrawal by Subject|3|||
23412921|NCT00635349|65255229|FG001|Overall Study|Withdrawal by Subject|8|||
23412922|NCT00635349|65255228|FG000|Overall Study|Lost to Follow-up|4|||
23412923|NCT00635349|65255229|FG001|Overall Study|Lost to Follow-up|3|||
23412924|NCT00635349|65255228|FG000|Overall Study|Adverse Event|11|||
23412925|NCT00635349|65255229|FG001|Overall Study|Adverse Event|9|||
23412926|NCT00372619|65255230|FG000|Overall Study|Ineligible|0|||
23412927|NCT00372619|65255231|FG001|Overall Study|Ineligible|0|||
23412928|NCT00372619|65255232|FG002|Overall Study|Ineligible|0|||
23412929|NCT00372619|65255233|FG003|Overall Study|Ineligible|0|||
23412930|NCT00372619|65255234|FG004|Overall Study|Ineligible|0|||
23412931|NCT00372619|65255235|FG005|Overall Study|Ineligible|2|||
23412932|NCT00372619|65255236|FG006|Overall Study|Ineligible|0|||
23412933|NCT00372619|65255230|FG000|Overall Study|Inevaluable|0|||
23412934|NCT00372619|65255231|FG001|Overall Study|Inevaluable|0|||
23412935|NCT00372619|65255232|FG002|Overall Study|Inevaluable|0|||
23412936|NCT00372619|65255233|FG003|Overall Study|Inevaluable|0|||
23412937|NCT00372619|65255234|FG004|Overall Study|Inevaluable|0|||
23412938|NCT00372619|65255235|FG005|Overall Study|Inevaluable|1|||
23412939|NCT00372619|65255236|FG006|Overall Study|Inevaluable|0|||
23412940|NCT01555073|65255237|FG000|Overall Study|Lost to Follow-up|1|||
23412941|NCT01555073|65255238|FG001|Overall Study|Lost to Follow-up|2|||
23412942|NCT01555073|65255239|FG002|Overall Study|Lost to Follow-up|0|||
23412943|NCT01555073|65255240|FG003|Overall Study|Lost to Follow-up|5|||
23412944|NCT00361231|65255241|FG000|Overall Study|Physician Decision|3|||
23412945|NCT00361231|65255241|FG000|Overall Study|Symptomatic deterioration|5|||
23412946|NCT00361231|65255241|FG000|Overall Study|Radiographic disease progression|16|||
23412947|NCT00361231|65255241|FG000|Overall Study|Withdrawal by Subject|4|||
23412948|NCT00361231|65255241|FG000|Overall Study|Adverse Event|6|||
23412949|NCT02096952|65255244|FG000|Overall Study|Adverse Event|1|||
23412950|NCT01390298|65255246|FG000|Overall Study|Death|1|||
23412951|NCT01390298|65255246|FG000|Overall Study|long term ICU admission|1|||
23412952|NCT01390298|65255246|FG000|Overall Study|Withdrawal by Subject|14|||
23412953|NCT01390298|65255246|FG000|Overall Study|Lost to Follow-up|7|||
23412954|NCT01390298|65255246|FG000|Overall Study|Surgery cancelled|1|||
23412955|NCT02675751|65255252|FG000|Overall Study|Lost to Follow-up|16|||
23412956|NCT03143153|65255253|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
23412957|NCT03143153|65255254|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
23412958|NCT03143153|65255255|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
23412959|NCT03143153|65255253|FG000|Pre-Treatment|Participant withdrew consent|0|||
23412960|NCT03143153|65255254|FG001|Pre-Treatment|Participant withdrew consent|1|||
23412961|NCT03143153|65255255|FG002|Pre-Treatment|Participant withdrew consent|12|||
23412962|NCT03143153|65255253|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
23412963|NCT03143153|65255254|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
23412964|NCT03143153|65255255|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
23412965|NCT03143153|65255253|FG000|Pre-Treatment|Other Reasons|1|||
23412966|NCT03143153|65255254|FG001|Pre-Treatment|Other Reasons|2|||
23412967|NCT03143153|65255255|FG002|Pre-Treatment|Other Reasons|1|||
23412968|NCT03143153|65255253|FG000|Pre-Treatment|Disease Progression|1|||
23412969|NCT03143153|65255254|FG001|Pre-Treatment|Disease Progression|1|||
23412970|NCT03143153|65255255|FG002|Pre-Treatment|Disease Progression|2|||
23412971|NCT03143153|65255253|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
23412972|NCT03143153|65255254|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
23412973|NCT03143153|65255255|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
23412974|NCT03143153|65255253|FG000|Treatment|Disease progression|174|||
23412975|NCT03143153|65255254|FG001|Treatment|Disease progression|184|||
23412976|NCT03143153|65255255|FG002|Treatment|Disease progression|193|||
23412977|NCT03143153|65255253|FG000|Treatment|Study drug toxicity|59|||
23412978|NCT03143153|65255254|FG001|Treatment|Study drug toxicity|33|||
23412979|NCT03143153|65255255|FG002|Treatment|Study drug toxicity|40|||
23412980|NCT03143153|65255253|FG000|Treatment|Death|5|||
23412981|NCT03143153|65255254|FG001|Treatment|Death|3|||
23412982|NCT03143153|65255255|FG002|Treatment|Death|4|||
23412983|NCT03143153|65255253|FG000|Treatment|Adverse event unrelated to study drug|19|||
23412984|NCT03143153|65255254|FG001|Treatment|Adverse event unrelated to study drug|28|||
23412985|NCT03143153|65255255|FG002|Treatment|Adverse event unrelated to study drug|12|||
23412986|NCT03143153|65255253|FG000|Treatment|Participant request to discontinue study treatment|13|||
23412987|NCT03143153|65255254|FG001|Treatment|Participant request to discontinue study treatment|15|||
23412988|NCT03143153|65255255|FG002|Treatment|Participant request to discontinue study treatment|20|||
23412989|NCT03143153|65255253|FG000|Treatment|Participant withdrew consent|3|||
23412990|NCT03143153|65255254|FG001|Treatment|Participant withdrew consent|4|||
23511915|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
23511916|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
23511917|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
23511918|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
23511919|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
23511920|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
23511921|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
23511922|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
23511923|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
23511924|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
23511925|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
23511926|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
23412991|NCT03143153|65255255|FG002|Treatment|Participant withdrew consent|12|||
23412992|NCT03143153|65255253|FG000|Treatment|Pregnancy|1|||
23412993|NCT03143153|65255254|FG001|Treatment|Pregnancy|0|||
23412994|NCT03143153|65255255|FG002|Treatment|Pregnancy|0|||
23412995|NCT03143153|65255253|FG000|Treatment|Maximum clinical benefit|1|||
23412996|NCT03143153|65255254|FG001|Treatment|Maximum clinical benefit|3|||
23412997|NCT03143153|65255255|FG002|Treatment|Maximum clinical benefit|4|||
23511927|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
23412998|NCT03143153|65255253|FG000|Treatment|Completed treatment as per Protocol|13|||
23412999|NCT03143153|65255254|FG001|Treatment|Completed treatment as per Protocol|8|||
23413000|NCT03143153|65255255|FG002|Treatment|Completed treatment as per Protocol|0|||
23413001|NCT03143153|65255253|FG000|Treatment|Other reasons|12|||
23413002|NCT03143153|65255254|FG001|Treatment|Other reasons|7|||
23413003|NCT03143153|65255255|FG002|Treatment|Other reasons|15|||
23413004|NCT03143153|65255253|FG000|Treatment|Not reported|1|||
23413005|NCT03143153|65255254|FG001|Treatment|Not reported|0|||
23413006|NCT03143153|65255255|FG002|Treatment|Not reported|0|||
23413007|NCT02482428|65255256|FG000|Overall Study|Lost to Follow-up|4|||
23413008|NCT02482428|65255257|FG001|Overall Study|Lost to Follow-up|9|||
23413009|NCT02482428|65255258|FG002|Overall Study|Lost to Follow-up|1|||
23413010|NCT02482428|65255259|FG003|Overall Study|Lost to Follow-up|2|||
23413011|NCT02482428|65255260|FG004|Overall Study|Lost to Follow-up|4|||
23413012|NCT02482428|65255256|FG000|Overall Study|Physician Decision|0|||
23413013|NCT02482428|65255257|FG001|Overall Study|Physician Decision|0|||
23413014|NCT02482428|65255258|FG002|Overall Study|Physician Decision|0|||
23413015|NCT02482428|65255259|FG003|Overall Study|Physician Decision|0|||
23413016|NCT02482428|65255260|FG004|Overall Study|Physician Decision|1|||
23413017|NCT02482428|65255256|FG000|Overall Study|protocol deviation|1|||
23413018|NCT02482428|65255257|FG001|Overall Study|protocol deviation|1|||
23413019|NCT02482428|65255258|FG002|Overall Study|protocol deviation|0|||
23413020|NCT02482428|65255259|FG003|Overall Study|protocol deviation|0|||
23413021|NCT02482428|65255260|FG004|Overall Study|protocol deviation|0|||
23413022|NCT02482428|65255256|FG000|Overall Study|subject/guardian decision|4|||
23413023|NCT02482428|65255257|FG001|Overall Study|subject/guardian decision|2|||
23413024|NCT02482428|65255258|FG002|Overall Study|subject/guardian decision|0|||
23413025|NCT02482428|65255259|FG003|Overall Study|subject/guardian decision|0|||
23413026|NCT02482428|65255260|FG004|Overall Study|subject/guardian decision|2|||
23413027|NCT03292640|65255272|FG000|Overall Study|Withdrawal by Subject|17|||
23413028|NCT03292640|65255273|FG001|Overall Study|Withdrawal by Subject|16|||
23413029|NCT03292640|65255272|FG000|Overall Study|Adverse Event|20|||
23511928|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
23511929|NCT01285310|65612575|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
23511930|NCT01285310|65612576|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
23511931|NCT01285310|65612577|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
23511932|NCT01285310|65612578|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
23511933|NCT01285310|65612579|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
23413030|NCT03292640|65255273|FG001|Overall Study|Adverse Event|2|||
23413031|NCT03292640|65255272|FG000|Overall Study|Lost to Follow-up|24|||
23413032|NCT03292640|65255273|FG001|Overall Study|Lost to Follow-up|24|||
23413033|NCT02993822|65255278|FG000|Overall Study|Lack of Efficacy|1|||
23413034|NCT02993822|65255279|FG001|Overall Study|Lack of Efficacy|1|||
23413035|NCT02993822|65255280|FG002|Overall Study|Lack of Efficacy|0|||
23511934|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
23511935|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
23511936|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
23511937|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
23511938|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
23413036|NCT02993822|65255281|FG003|Overall Study|Lack of Efficacy|0|||
23413037|NCT02993822|65255278|FG000|Overall Study|Protocol Violation|1|||
23511939|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
23511940|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
23413038|NCT02993822|65255279|FG001|Overall Study|Protocol Violation|0|||
23413039|NCT02993822|65255280|FG002|Overall Study|Protocol Violation|0|||
23413040|NCT02993822|65255281|FG003|Overall Study|Protocol Violation|0|||
23413041|NCT02993822|65255278|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
23413042|NCT02993822|65255279|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
23413043|NCT02993822|65255280|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
23511941|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
23413044|NCT02993822|65255281|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
23413045|NCT02993822|65255278|FG000|Overall Study|Adverse Event|3|||
23413046|NCT02993822|65255279|FG001|Overall Study|Adverse Event|1|||
23413047|NCT02993822|65255280|FG002|Overall Study|Adverse Event|7|||
23413048|NCT02993822|65255281|FG003|Overall Study|Adverse Event|0|||
23413049|NCT02993822|65255278|FG000|Overall Study|Withdrawal by Subject|4|||
23413050|NCT02993822|65255279|FG001|Overall Study|Withdrawal by Subject|2|||
23413051|NCT02993822|65255280|FG002|Overall Study|Withdrawal by Subject|2|||
23413052|NCT02993822|65255281|FG003|Overall Study|Withdrawal by Subject|3|||
23413053|NCT02993822|65255278|FG000|Overall Study|Lost to Follow-up|1|||
23413054|NCT02993822|65255279|FG001|Overall Study|Lost to Follow-up|0|||
23413055|NCT02993822|65255280|FG002|Overall Study|Lost to Follow-up|1|||
23413056|NCT02993822|65255281|FG003|Overall Study|Lost to Follow-up|0|||
23413057|NCT00191945|65255283|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
23413058|NCT00191945|65255284|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
23413059|NCT00191945|65255283|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
23413060|NCT00191945|65255284|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
23413061|NCT00191945|65255283|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
23413062|NCT00191945|65255284|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
23413063|NCT00191945|65255283|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
23413064|NCT00191945|65255284|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
23413065|NCT00810277|65255285|FG000|Overall Study|Adverse Event|1|||
23413066|NCT03832322|65255286|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
23413067|NCT03832322|65255287|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
23413068|NCT01681069|65255288|FG000|Overall Study|Withdrawal by Subject|4|||
23413069|NCT01681069|65255289|FG001|Overall Study|Withdrawal by Subject|5|||
23413070|NCT01681069|65255288|FG000|Overall Study|Protocol Violation|1|||
23413071|NCT01681069|65255289|FG001|Overall Study|Protocol Violation|1|||
23413072|NCT01681069|65255288|FG000|Overall Study|Adverse Event|0|||
23413073|NCT01681069|65255289|FG001|Overall Study|Adverse Event|1|||
23413074|NCT01832493|65255290|FG000|Overall Study|Physician Decision|2|||
23413075|NCT01832493|65255290|FG000|Overall Study|Protocol Violation|4|||
23413076|NCT01832493|65255290|FG000|Overall Study|Unable to place LV lead|2|||
23413077|NCT00958347|65255291|FG000|Overall Study|Death|43|||
23511942|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
23511943|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
23413078|NCT00958347|65255291|FG000|Overall Study|Withdrawal by Subject|23|||
23413079|NCT00958347|65255291|FG000|Overall Study|Lost to Follow-up|15|||
23413080|NCT00958347|65255291|FG000|Overall Study|revision/removal|10|||
23413081|NCT00958347|65255291|FG000|Overall Study|study termination|135|||
23413082|NCT00956007|65255298|FG000|Overall Study|Protocol Violation|27|||
23413083|NCT00956007|65255299|FG001|Overall Study|Protocol Violation|23|||
23413084|NCT00624468|65255300|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
23413085|NCT00624468|65255301|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
23413086|NCT00624468|65255302|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
23413087|NCT00624468|65255303|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
23413088|NCT00624468|65255300|FG000|Double-blind Period|Withdrew Prematurely|1|||
23413089|NCT00624468|65255301|FG001|Double-blind Period|Withdrew Prematurely|1|||
23413090|NCT00624468|65255302|FG002|Double-blind Period|Withdrew Prematurely|0|||
23413091|NCT00624468|65255303|FG003|Double-blind Period|Withdrew Prematurely|0|||
23413092|NCT00624468|65255300|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
23413093|NCT00624468|65255301|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
23413094|NCT00624468|65255302|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
23413095|NCT00624468|65255303|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
23413096|NCT00624468|65255300|FG000|Safety Follow-up (SFU) Period|Other|0|||
23413097|NCT00624468|65255301|FG001|Safety Follow-up (SFU) Period|Other|0|||
23413098|NCT00624468|65255302|FG002|Safety Follow-up (SFU) Period|Other|1|||
23413099|NCT00624468|65255303|FG003|Safety Follow-up (SFU) Period|Other|1|||
23413100|NCT03350035|65255304|FG000|Overall Study|Lack of Efficacy|2|||
23413101|NCT03350035|65255305|FG001|Overall Study|Lack of Efficacy|0|||
23511944|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
23413102|NCT03350035|65255306|FG002|Overall Study|Lack of Efficacy|0|||
23413103|NCT03350035|65255304|FG000|Overall Study|Subject discharged to hospice|0|||
23413104|NCT03350035|65255305|FG001|Overall Study|Subject discharged to hospice|0|||
23413105|NCT03350035|65255306|FG002|Overall Study|Subject discharged to hospice|1|||
23413106|NCT03718884|65255307|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
23413107|NCT03718884|65255308|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
23413108|NCT03718884|65255307|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
23413109|NCT03718884|65255308|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
23413110|NCT00425698|65255309|FG000|Overall Study|Adverse Event|3|||
23413111|NCT00425698|65255310|FG001|Overall Study|Adverse Event|1|||
23413112|NCT00425698|65255309|FG000|Overall Study|Withdrawal by Subject|0|||
23413113|NCT00425698|65255310|FG001|Overall Study|Withdrawal by Subject|1|||
23413114|NCT02222688|65255311|FG000|Overall Study|Withdrawal by Subject|0|||
23413115|NCT02222688|65255312|FG001|Overall Study|Withdrawal by Subject|0|||
23413116|NCT02222688|65255313|FG002|Overall Study|Withdrawal by Subject|0|||
23413117|NCT02222688|65255314|FG003|Overall Study|Withdrawal by Subject|2|||
23413118|NCT02222688|65255315|FG004|Overall Study|Withdrawal by Subject|1|||
23413119|NCT02222688|65255316|FG005|Overall Study|Withdrawal by Subject|0|||
23413120|NCT02222688|65255317|FG006|Overall Study|Withdrawal by Subject|1|||
23413121|NCT02222688|65255311|FG000|Overall Study|Disease progression|1|||
23413122|NCT02222688|65255312|FG001|Overall Study|Disease progression|0|||
23413123|NCT02222688|65255313|FG002|Overall Study|Disease progression|0|||
23413124|NCT02222688|65255314|FG003|Overall Study|Disease progression|0|||
23413125|NCT02222688|65255315|FG004|Overall Study|Disease progression|0|||
23413126|NCT02222688|65255316|FG005|Overall Study|Disease progression|0|||
23413127|NCT02222688|65255317|FG006|Overall Study|Disease progression|0|||
23413128|NCT02957747|65255321|FG000|Overall Study|Withdrawal by Subject|0|||
23413129|NCT02957747|65255322|FG001|Overall Study|Withdrawal by Subject|3|||
23413130|NCT02957747|65255321|FG000|Overall Study|Lost to Follow-up|10|||
23413131|NCT02957747|65255322|FG001|Overall Study|Lost to Follow-up|5|||
23413132|NCT02248649|65255323|FG000|Overall Study|Death|7|||
23413133|NCT02248649|65255324|FG001|Overall Study|Death|11|||
23413134|NCT02248649|65255323|FG000|Overall Study|Lost to Follow-up|14|||
23413135|NCT02248649|65255324|FG001|Overall Study|Lost to Follow-up|10|||
23413136|NCT00700882|65255325|FG000|Overall Study|Never received treatment|6|||
23413137|NCT00700882|65255325|FG000|Overall Study|Ineligible|2|||
23413138|NCT00700882|65255325|FG000|Overall Study|No KIT mutation|51|||
23413139|NCT04091581|65255328|FG000|Overall Study|Lost to Follow-up|0|||
23413140|NCT04091581|65255329|FG001|Overall Study|Lost to Follow-up|1|||
23413141|NCT01951586|65255330|FG000|Overall Study|Death|61|||
23413142|NCT01951586|65255331|FG001|Overall Study|Death|120|||
23413143|NCT01951586|65255330|FG000|Overall Study|Withdrawal by Subject|8|||
23413144|NCT01951586|65255331|FG001|Overall Study|Withdrawal by Subject|17|||
23413145|NCT01951586|65255330|FG000|Overall Study|Lost to Follow-up|0|||
23413146|NCT01951586|65255331|FG001|Overall Study|Lost to Follow-up|1|||
23413147|NCT01951586|65255330|FG000|Overall Study|Sponsor Decision|9|||
23413148|NCT01951586|65255331|FG001|Overall Study|Sponsor Decision|10|||
23413149|NCT01891396|65255332|FG000|Overall Study|Withdrawal by Subject|4|||
23413150|NCT01891396|65255333|FG001|Overall Study|Withdrawal by Subject|4|||
23413151|NCT01891396|65255334|FG002|Overall Study|Withdrawal by Subject|3|||
23413152|NCT01891396|65255332|FG000|Overall Study|Lost to Follow-up|0|||
23413153|NCT01891396|65255333|FG001|Overall Study|Lost to Follow-up|1|||
23413154|NCT01891396|65255334|FG002|Overall Study|Lost to Follow-up|0|||
23413155|NCT00177294|65255335|FG000|Overall Study|Withdrawal by Subject|7|||
23413156|NCT00177294|65255336|FG001|Overall Study|Withdrawal by Subject|5|||
23413157|NCT04599803|65255341|FG000|Overall Study|Withdrawal by Subject|5|||
23413158|NCT04599803|65255341|FG000|Overall Study|Lost to Follow-up|26|||
23413159|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Adverse Event|7|||
23413160|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Adverse Event|0|||
23413161|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Adverse Event|0|||
23413162|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
23413163|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
23413164|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
23413165|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
23413166|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
23413167|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
23413168|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
23413169|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
23413170|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
23413171|NCT01059864|65255342|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
23413172|NCT01059864|65255343|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
23413173|NCT01059864|65255344|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
23413174|NCT01059864|65255342|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23413175|NCT01059864|65255343|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
23413176|NCT01059864|65255344|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
23413177|NCT00070109|65255353|FG000|Overall Study|Death|1|||
23413178|NCT00070109|65255354|FG001|Overall Study|Death|1|||
23413179|NCT00070109|65255355|FG002|Overall Study|Death|0|||
23511945|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
23413180|NCT00070109|65255356|FG003|Overall Study|Death|0|||
23413181|NCT00070109|65255357|FG004|Overall Study|Death|1|||
23413182|NCT00070109|65255353|FG000|Overall Study|Lack of Efficacy|6|||
23413183|NCT00070109|65255354|FG001|Overall Study|Lack of Efficacy|4|||
23413184|NCT00070109|65255355|FG002|Overall Study|Lack of Efficacy|5|||
23413185|NCT00070109|65255356|FG003|Overall Study|Lack of Efficacy|15|||
23413186|NCT00070109|65255357|FG004|Overall Study|Lack of Efficacy|5|||
23511946|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
23413187|NCT00070109|65255353|FG000|Overall Study|Physician Decision|1|||
23413188|NCT00070109|65255354|FG001|Overall Study|Physician Decision|0|||
23413189|NCT00070109|65255355|FG002|Overall Study|Physician Decision|0|||
23413190|NCT00070109|65255356|FG003|Overall Study|Physician Decision|0|||
23413191|NCT00070109|65255357|FG004|Overall Study|Physician Decision|0|||
23413192|NCT00070109|65255353|FG000|Overall Study|Withdrawal by Subject|0|||
23413193|NCT00070109|65255354|FG001|Overall Study|Withdrawal by Subject|1|||
23413194|NCT00070109|65255355|FG002|Overall Study|Withdrawal by Subject|1|||
23413195|NCT00070109|65255356|FG003|Overall Study|Withdrawal by Subject|0|||
23413196|NCT00070109|65255357|FG004|Overall Study|Withdrawal by Subject|0|||
23413197|NCT00070109|65255353|FG000|Overall Study|Adverse Event|0|||
23413198|NCT00070109|65255354|FG001|Overall Study|Adverse Event|0|||
23413199|NCT00070109|65255355|FG002|Overall Study|Adverse Event|2|||
23413200|NCT00070109|65255356|FG003|Overall Study|Adverse Event|4|||
23413201|NCT00070109|65255357|FG004|Overall Study|Adverse Event|2|||
23413202|NCT00070109|65255353|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
23413203|NCT00070109|65255354|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
23413204|NCT00070109|65255355|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
23413205|NCT00070109|65255356|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
23413206|NCT00070109|65255357|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
23413207|NCT02712983|65255358|FG000|Treatment Phase|Adverse Event|3|||
23413208|NCT02712983|65255359|FG001|Treatment Phase|Adverse Event|1|||
23413209|NCT02712983|65255360|FG002|Treatment Phase|Adverse Event|1|||
23413210|NCT02712983|65255361|FG003|Treatment Phase|Adverse Event|4|||
23413211|NCT02712983|65255362|FG004|Treatment Phase|Adverse Event|3|||
23413212|NCT02712983|65255363|FG005|Treatment Phase|Adverse Event|0|||
23413213|NCT02712983|65255364|FG006|Treatment Phase|Adverse Event|6|||
23413214|NCT02712983|65255365|FG007|Treatment Phase|Adverse Event|6|||
23413215|NCT02712983|65255366|FG008|Treatment Phase|Adverse Event|1|||
23413216|NCT02712983|65255358|FG000|Treatment Phase|Protocol Deviation|0|||
23413217|NCT02712983|65255359|FG001|Treatment Phase|Protocol Deviation|0|||
23413218|NCT02712983|65255360|FG002|Treatment Phase|Protocol Deviation|0|||
23413219|NCT02712983|65255361|FG003|Treatment Phase|Protocol Deviation|2|||
23413220|NCT02712983|65255362|FG004|Treatment Phase|Protocol Deviation|0|||
23413221|NCT02712983|65255363|FG005|Treatment Phase|Protocol Deviation|0|||
23413222|NCT02712983|65255364|FG006|Treatment Phase|Protocol Deviation|1|||
23413223|NCT02712983|65255365|FG007|Treatment Phase|Protocol Deviation|0|||
23413224|NCT02712983|65255366|FG008|Treatment Phase|Protocol Deviation|0|||
23413225|NCT02712983|65255358|FG000|Treatment Phase|Technical Problems|0|||
23413226|NCT02712983|65255359|FG001|Treatment Phase|Technical Problems|0|||
23413227|NCT02712983|65255360|FG002|Treatment Phase|Technical Problems|0|||
23413228|NCT02712983|65255361|FG003|Treatment Phase|Technical Problems|0|||
23413229|NCT02712983|65255362|FG004|Treatment Phase|Technical Problems|0|||
23413230|NCT02712983|65255363|FG005|Treatment Phase|Technical Problems|0|||
23413231|NCT02712983|65255364|FG006|Treatment Phase|Technical Problems|1|||
23413232|NCT02712983|65255365|FG007|Treatment Phase|Technical Problems|0|||
23413233|NCT02712983|65255366|FG008|Treatment Phase|Technical Problems|0|||
23413234|NCT02712983|65255358|FG000|Treatment Phase|Physician Decision|0|||
23413235|NCT02712983|65255359|FG001|Treatment Phase|Physician Decision|0|||
23413236|NCT02712983|65255360|FG002|Treatment Phase|Physician Decision|0|||
23413237|NCT02712983|65255361|FG003|Treatment Phase|Physician Decision|0|||
23413238|NCT02712983|65255362|FG004|Treatment Phase|Physician Decision|0|||
23413239|NCT02712983|65255363|FG005|Treatment Phase|Physician Decision|0|||
23413240|NCT02712983|65255364|FG006|Treatment Phase|Physician Decision|0|||
23413241|NCT02712983|65255365|FG007|Treatment Phase|Physician Decision|1|||
23413242|NCT02712983|65255366|FG008|Treatment Phase|Physician Decision|1|||
23413243|NCT02712983|65255358|FG000|Treatment Phase|Subject Decision|2|||
23413244|NCT02712983|65255359|FG001|Treatment Phase|Subject Decision|0|||
23413245|NCT02712983|65255360|FG002|Treatment Phase|Subject Decision|0|||
23413246|NCT02712983|65255361|FG003|Treatment Phase|Subject Decision|2|||
23413247|NCT02712983|65255362|FG004|Treatment Phase|Subject Decision|1|||
23413248|NCT02712983|65255363|FG005|Treatment Phase|Subject Decision|0|||
23413249|NCT02712983|65255364|FG006|Treatment Phase|Subject Decision|1|||
23413250|NCT02712983|65255365|FG007|Treatment Phase|Subject Decision|2|||
23413251|NCT02712983|65255366|FG008|Treatment Phase|Subject Decision|0|||
23413252|NCT02712983|65255358|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413253|NCT02712983|65255359|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
23413254|NCT02712983|65255360|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413255|NCT02712983|65255361|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413256|NCT02712983|65255362|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23307373|NCT03107026|64870483|FG001|Overall Study|Physician Decision|1|||
23413257|NCT02712983|65255363|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413258|NCT02712983|65255364|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
23413259|NCT02712983|65255365|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
23413260|NCT02712983|65255366|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23413261|NCT02712983|65255358|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413262|NCT02712983|65255359|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413263|NCT02712983|65255360|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413264|NCT02712983|65255361|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
23413265|NCT02712983|65255362|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413266|NCT02712983|65255363|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413267|NCT02712983|65255364|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413268|NCT02712983|65255365|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413269|NCT02712983|65255366|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
23413270|NCT02712983|65255358|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413271|NCT02712983|65255359|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413272|NCT02712983|65255360|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413273|NCT02712983|65255361|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413274|NCT02712983|65255362|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
23413275|NCT02712983|65255363|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
23413276|NCT02712983|65255364|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
23413277|NCT02712983|65255365|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
23413278|NCT02712983|65255366|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
23413279|NCT02584452|65255367|FG000|Overall Study|Physician Decision|1|||
23413280|NCT02584452|65255368|FG001|Overall Study|Physician Decision|1|||
23413281|NCT02584452|65255367|FG000|Overall Study|Lost to Follow-up|1|||
23413282|NCT02584452|65255368|FG001|Overall Study|Lost to Follow-up|1|||
23413283|NCT03629223|65255369|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413284|NCT03629223|65255370|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413285|NCT03629223|65255371|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413286|NCT03629223|65255372|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
23413287|NCT03629223|65255373|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413288|NCT03629223|65255374|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
23413289|NCT03629223|65255369|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413290|NCT03629223|65255370|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413291|NCT03629223|65255371|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413292|NCT03629223|65255372|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
23413293|NCT03629223|65255373|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413294|NCT03629223|65255374|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
23413295|NCT03629223|65255369|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413296|NCT03629223|65255370|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
23413297|NCT03629223|65255371|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413298|NCT03629223|65255372|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413299|NCT03629223|65255373|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413300|NCT03629223|65255374|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
23413301|NCT03629223|65255369|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413302|NCT03629223|65255370|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
23413303|NCT03629223|65255371|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413304|NCT03629223|65255372|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413305|NCT03629223|65255373|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413306|NCT03629223|65255374|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
23413307|NCT03629223|65255369|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
23413308|NCT03629223|65255370|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23413309|NCT03629223|65255371|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23511947|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
23511948|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
23511949|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
23511950|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
23413310|NCT03629223|65255372|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23413311|NCT03629223|65255373|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23413312|NCT03629223|65255374|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
23413313|NCT00933608|65255377|FG000|Overall Study|Adverse Event|4|||
23413314|NCT00933608|65255378|FG001|Overall Study|Adverse Event|2|||
23413315|NCT00933608|65255377|FG000|Overall Study|Physician Decision|1|||
23413316|NCT00933608|65255378|FG001|Overall Study|Physician Decision|0|||
23413317|NCT00412958|65255380|FG000|Overall Study|Withdrawal by Subject|3|||
23413318|NCT00412958|65255381|FG001|Overall Study|Withdrawal by Subject|0|||
23413319|NCT00412958|65255382|FG002|Overall Study|Withdrawal by Subject|0|||
23511951|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
23413320|NCT00412958|65255383|FG003|Overall Study|Withdrawal by Subject|1|||
23413321|NCT00412958|65255380|FG000|Overall Study|Adverse Event|0|||
23511952|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
23511953|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
23511954|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
23511955|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
23511956|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
23511957|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
23511958|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
23511959|NCT01285310|65612575|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
23511960|NCT01285310|65612576|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
23511961|NCT01285310|65612577|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
23511962|NCT01285310|65612578|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
23511963|NCT01285310|65612579|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
23511964|NCT01164956|65612581|FG000|Overall Study|Side Effects|1|||
23511965|NCT01164956|65612582|FG001|Overall Study|Side Effects|0|||
23511966|NCT01164956|65612583|FG002|Overall Study|Side Effects|1|||
23413322|NCT00412958|65255381|FG001|Overall Study|Adverse Event|1|||
23413323|NCT00412958|65255382|FG002|Overall Study|Adverse Event|0|||
23413324|NCT00412958|65255383|FG003|Overall Study|Adverse Event|0|||
23413325|NCT00412958|65255380|FG000|Overall Study|Lost to Follow-up|0|||
23413326|NCT00412958|65255381|FG001|Overall Study|Lost to Follow-up|1|||
23413327|NCT00412958|65255382|FG002|Overall Study|Lost to Follow-up|0|||
23413328|NCT00412958|65255383|FG003|Overall Study|Lost to Follow-up|0|||
23413329|NCT00412958|65255380|FG000|Overall Study|Death|0|||
23511967|NCT00969150|65612585|FG000|Overall Study|Adverse Event|4|||
23511968|NCT00969150|65612586|FG001|Overall Study|Adverse Event|14|||
23511969|NCT00969150|65612585|FG000|Overall Study|Lack of Efficacy|1|||
23511970|NCT00969150|65612586|FG001|Overall Study|Lack of Efficacy|1|||
23511971|NCT00969150|65612585|FG000|Overall Study|Protocol Violation|9|||
23511972|NCT00969150|65612586|FG001|Overall Study|Protocol Violation|12|||
23511973|NCT00969150|65612585|FG000|Overall Study|Withdrawal by Subject|13|||
23511974|NCT00969150|65612586|FG001|Overall Study|Withdrawal by Subject|9|||
23511975|NCT00969150|65612585|FG000|Overall Study|Lost to Follow-up|5|||
23511976|NCT00969150|65612586|FG001|Overall Study|Lost to Follow-up|4|||
23511977|NCT00969150|65612585|FG000|Overall Study|Other reasons|1|||
23511978|NCT00969150|65612586|FG001|Overall Study|Other reasons|0|||
23511979|NCT00643682|65612588|FG000|Overall Study|did not keep appointment|522|||
23511980|NCT00643682|65612589|FG001|Overall Study|did not keep appointment|509|||
23511981|NCT02446990|65612590|FG000|Overall Study|Death|485|||
23511982|NCT02446990|65612591|FG001|Overall Study|Death|458|||
23511983|NCT02446990|65612590|FG000|Overall Study|Lost to Follow-up|3|||
23511984|NCT02446990|65612591|FG001|Overall Study|Lost to Follow-up|1|||
23511985|NCT02446990|65612590|FG000|Overall Study|Physician Decision|1|||
23511986|NCT02446990|65612591|FG001|Overall Study|Physician Decision|0|||
23511987|NCT02446990|65612590|FG000|Overall Study|Withdrawal by Subject|231|||
23511988|NCT02446990|65612591|FG001|Overall Study|Withdrawal by Subject|199|||
23511989|NCT03944954|65612592|FG000|Overall Study|Withdrawal by Subject|22|||
23511990|NCT03944954|65612593|FG001|Overall Study|Withdrawal by Subject|4|||
23511991|NCT03944954|65612592|FG000|Overall Study|Lost to Follow-up|18|||
23511992|NCT03944954|65612593|FG001|Overall Study|Lost to Follow-up|0|||
23511993|NCT03944954|65612592|FG000|Overall Study|Failed Medical Screening|7|||
23511994|NCT03944954|65612593|FG001|Overall Study|Failed Medical Screening|0|||
23511995|NCT01957644|65612594|FG000|Overall Study|Adverse Event|4|||
23511996|NCT01957644|65612595|FG001|Overall Study|Adverse Event|2|||
23511997|NCT01957644|65612596|FG002|Overall Study|Adverse Event|0|||
23511998|NCT01957644|65612597|FG003|Overall Study|Adverse Event|0|||
23307374|NCT03107026|64870484|FG002|Overall Study|Physician Decision|0|||
23413330|NCT00412958|65255381|FG001|Overall Study|Death|1|||
23413331|NCT00412958|65255382|FG002|Overall Study|Death|0|||
23511999|NCT01957644|65612598|FG004|Overall Study|Adverse Event|1|||
23512000|NCT01957644|65612594|FG000|Overall Study|Progressive disease / relapse|0|||
23512001|NCT01957644|65612595|FG001|Overall Study|Progressive disease / relapse|1|||
23512002|NCT01957644|65612596|FG002|Overall Study|Progressive disease / relapse|0|||
23512003|NCT01957644|65612597|FG003|Overall Study|Progressive disease / relapse|1|||
23610589|NCT02676778|65962809|FG000|Overall Study|Adverse Event|2|||
23413332|NCT00412958|65255383|FG003|Overall Study|Death|0|||
23512004|NCT01957644|65612598|FG004|Overall Study|Progressive disease / relapse|0|||
23512005|NCT01957644|65612594|FG000|Overall Study|Other reason|1|||
23512006|NCT01957644|65612595|FG001|Overall Study|Other reason|2|||
23512007|NCT01957644|65612596|FG002|Overall Study|Other reason|1|||
23512008|NCT01957644|65612597|FG003|Overall Study|Other reason|1|||
23512009|NCT01957644|65612598|FG004|Overall Study|Other reason|0|||
23512010|NCT01957644|65612594|FG000|Overall Study|Withdrawal by Subject|1|||
23512011|NCT01957644|65612595|FG001|Overall Study|Withdrawal by Subject|0|||
23512012|NCT01957644|65612596|FG002|Overall Study|Withdrawal by Subject|0|||
23512013|NCT01957644|65612597|FG003|Overall Study|Withdrawal by Subject|0|||
23512014|NCT01957644|65612598|FG004|Overall Study|Withdrawal by Subject|0|||
23512015|NCT01957644|65612594|FG000|Overall Study|Protocol Violation|0|||
23512016|NCT01957644|65612595|FG001|Overall Study|Protocol Violation|1|||
23512017|NCT01957644|65612596|FG002|Overall Study|Protocol Violation|0|||
23512018|NCT01957644|65612597|FG003|Overall Study|Protocol Violation|0|||
23512019|NCT01957644|65612598|FG004|Overall Study|Protocol Violation|0|||
23512020|NCT01252940|65612600|FG000|Main Study Phase|Randomized but not treated|4|||
23512021|NCT01252940|65612601|FG001|Main Study Phase|Randomized but not treated|2|||
23512022|NCT01252940|65612600|FG000|Main Study Phase|Adverse Event|3|||
23512023|NCT01252940|65612601|FG001|Main Study Phase|Adverse Event|1|||
23512024|NCT01252940|65612600|FG000|Main Study Phase|Lack of Efficacy|1|||
23512025|NCT01252940|65612601|FG001|Main Study Phase|Lack of Efficacy|0|||
23512026|NCT01252940|65612600|FG000|Main Study Phase|Lost to Follow-up|6|||
23512027|NCT01252940|65612601|FG001|Main Study Phase|Lost to Follow-up|1|||
23512028|NCT01252940|65612600|FG000|Main Study Phase|Physician Decision|1|||
23512029|NCT01252940|65612601|FG001|Main Study Phase|Physician Decision|0|||
23512030|NCT01252940|65612600|FG000|Main Study Phase|Protocol Violation|4|||
23512031|NCT01252940|65612601|FG001|Main Study Phase|Protocol Violation|2|||
23512032|NCT01252940|65612600|FG000|Main Study Phase|Withdrawal by Subject|6|||
23512033|NCT01252940|65612601|FG001|Main Study Phase|Withdrawal by Subject|5|||
23512034|NCT01252940|65612600|FG000|Main Study Phase|Subject Non-compliance|1|||
23512035|NCT01252940|65612601|FG001|Main Study Phase|Subject Non-compliance|1|||
23512036|NCT01252940|65612600|FG000|Extension Phase|Adverse Event|2|||
23512037|NCT01252940|65612601|FG001|Extension Phase|Adverse Event|1|||
23512038|NCT01252940|65612600|FG000|Extension Phase|Lack of Efficacy|1|||
23512039|NCT01252940|65612601|FG001|Extension Phase|Lack of Efficacy|0|||
23512040|NCT01252940|65612600|FG000|Extension Phase|Lost to Follow-up|5|||
23512041|NCT01252940|65612601|FG001|Extension Phase|Lost to Follow-up|0|||
23512042|NCT01252940|65612600|FG000|Extension Phase|Physician Decision|0|||
23512043|NCT01252940|65612601|FG001|Extension Phase|Physician Decision|1|||
23512044|NCT01252940|65612600|FG000|Extension Phase|Subject Non-compliance|1|||
23512045|NCT01252940|65612601|FG001|Extension Phase|Subject Non-compliance|0|||
23512046|NCT01252940|65612600|FG000|Extension Phase|Withdrawal by Subject|1|||
23512047|NCT01252940|65612601|FG001|Extension Phase|Withdrawal by Subject|1|||
23512048|NCT02057198|65612602|FG000|Overall Study|Death|0|||
23512049|NCT02057198|65612603|FG001|Overall Study|Death|0|||
23512050|NCT02057198|65612604|FG002|Overall Study|Death|1|||
23512051|NCT02057198|65612602|FG000|Overall Study|Discharged early; lost to followup|0|||
23512052|NCT02057198|65612603|FG001|Overall Study|Discharged early; lost to followup|1|||
23512053|NCT02057198|65612604|FG002|Overall Study|Discharged early; lost to followup|0|||
23512054|NCT04690751|65612605|FG000|Overall Study|Protocol Violation|0|||
23512055|NCT04690751|65612606|FG001|Overall Study|Protocol Violation|1|||
23512056|NCT04690751|65612607|FG002|Overall Study|Protocol Violation|0|||
23512057|NCT04690751|65612608|FG003|Overall Study|Protocol Violation|1|||
23512058|NCT04690751|65612609|FG004|Overall Study|Protocol Violation|2|||
23512059|NCT04690751|65612610|FG005|Overall Study|Protocol Violation|0|||
23512060|NCT04690751|65612605|FG000|Overall Study|Adverse Event|0|||
23413333|NCT00412958|65255380|FG000|Overall Study|Transport issue|0|||
23413334|NCT00412958|65255381|FG001|Overall Study|Transport issue|1|||
23413335|NCT00412958|65255382|FG002|Overall Study|Transport issue|0|||
23413336|NCT00412958|65255383|FG003|Overall Study|Transport issue|0|||
23413337|NCT02954887|65255387|FG000|Overall Study|Withdrawal by Subject|3|||
23512061|NCT04690751|65612606|FG001|Overall Study|Adverse Event|0|||
23512062|NCT04690751|65612607|FG002|Overall Study|Adverse Event|1|||
23512063|NCT04690751|65612608|FG003|Overall Study|Adverse Event|0|||
23512064|NCT04690751|65612609|FG004|Overall Study|Adverse Event|0|||
23512065|NCT04690751|65612610|FG005|Overall Study|Adverse Event|0|||
23512066|NCT04690751|65612605|FG000|Overall Study|Positive urine drug screen test|0|||
23512067|NCT04690751|65612606|FG001|Overall Study|Positive urine drug screen test|0|||
23512068|NCT04690751|65612607|FG002|Overall Study|Positive urine drug screen test|0|||
23512069|NCT04690751|65612608|FG003|Overall Study|Positive urine drug screen test|0|||
23307375|NCT00837473|64870485|FG000|Overall Study|Lost to Follow-up|1|||
23413338|NCT02954887|65255387|FG000|Overall Study|Lack of Efficacy|3|||
23413339|NCT02954887|65255387|FG000|Overall Study|Other|1|||
23413340|NCT00617084|65255393|FG000|Overall Study|Withdrawal by Subject|5|||
23413341|NCT00617084|65255394|FG001|Overall Study|Withdrawal by Subject|7|||
23413342|NCT00617084|65255393|FG000|Overall Study|Missed 12 Months visit|16|||
23512070|NCT04690751|65612609|FG004|Overall Study|Positive urine drug screen test|1|||
23512071|NCT04690751|65612610|FG005|Overall Study|Positive urine drug screen test|0|||
23512072|NCT03527966|65612611|FG000|Overall Study|Lost to Follow-up|3|||
23512073|NCT03527966|65612612|FG001|Overall Study|Lost to Follow-up|0|||
23413343|NCT00617084|65255394|FG001|Overall Study|Missed 12 Months visit|19|||
23413344|NCT04908384|65255399|FG000|Overall Study|Lost to Follow-up|4|||
23413345|NCT04908384|65255400|FG001|Overall Study|Lost to Follow-up|4|||
23512074|NCT02865187|65612613|FG000|Overall Study|Lost to Follow-up|12|||
23512075|NCT02865187|65612614|FG001|Overall Study|Lost to Follow-up|7|||
23512076|NCT02865187|65612613|FG000|Overall Study|Adverse Event|1|||
23512077|NCT02865187|65612614|FG001|Overall Study|Adverse Event|0|||
23512078|NCT00180414|65612615|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
23512079|NCT00180414|65612616|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
23512080|NCT02642614|65612617|FG000|Overall Study|Adverse Event|1|||
23512081|NCT02642614|65612618|FG001|Overall Study|Adverse Event|1|||
23512082|NCT02642614|65612619|FG002|Overall Study|Adverse Event|2|||
23413346|NCT04908384|65255401|FG002|Overall Study|Lost to Follow-up|0|||
23413347|NCT04908384|65255402|FG003|Overall Study|Lost to Follow-up|0|||
23413348|NCT02397915|65255403|FG000|Period 1|Protocol Violation|0|||
23413349|NCT02397915|65255404|FG001|Period 1|Protocol Violation|1|||
23413350|NCT02397915|65255405|FG002|Period 1|Protocol Violation|0|||
23413351|NCT02397915|65255406|FG003|Period 1|Protocol Violation|0|||
23413352|NCT02397915|65255403|FG000|Period 1|Physician Decision|1|||
23413353|NCT02397915|65255404|FG001|Period 1|Physician Decision|0|||
23413354|NCT02397915|65255405|FG002|Period 1|Physician Decision|0|||
23413355|NCT02397915|65255406|FG003|Period 1|Physician Decision|0|||
23413356|NCT05479097|65255409|FG000|Overall Study|Withdrawal by Subject|2|||
23413357|NCT01318135|65255410|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
23413358|NCT01318135|65255411|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413359|NCT01318135|65255412|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413360|NCT01318135|65255413|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413361|NCT01318135|65255414|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413362|NCT01318135|65255415|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413363|NCT01318135|65255416|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413364|NCT01318135|65255417|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23413365|NCT01318135|65255410|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
23413366|NCT01318135|65255411|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413367|NCT01318135|65255412|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413368|NCT01318135|65255413|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413369|NCT01318135|65255414|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413370|NCT01318135|65255415|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413371|NCT01318135|65255416|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413372|NCT01318135|65255417|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
23413373|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
23413374|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
23413375|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
23413376|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
23413377|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
23413378|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
23413379|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
23413380|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
23413381|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
23413382|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
23413383|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413384|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413385|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
23413386|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413387|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413388|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
23413389|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23413390|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23413391|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23413392|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23413393|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23413394|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23413395|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23512083|NCT02642614|65612620|FG003|Overall Study|Adverse Event|2|||
23307376|NCT00837473|64870485|FG000|Overall Study|Withdrawal by Subject|2|||
23413396|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23413397|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
23413398|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
23413399|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
23413400|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
23512084|NCT02642614|65612617|FG000|Overall Study|Lost to Follow-up|1|||
23512085|NCT02642614|65612618|FG001|Overall Study|Lost to Follow-up|0|||
23512086|NCT02642614|65612619|FG002|Overall Study|Lost to Follow-up|0|||
23512087|NCT02642614|65612620|FG003|Overall Study|Lost to Follow-up|0|||
23413401|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
23413402|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
23413403|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23413404|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23413405|NCT01318135|65255410|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413406|NCT01318135|65255411|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413407|NCT01318135|65255412|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413408|NCT01318135|65255413|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413409|NCT01318135|65255414|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413410|NCT01318135|65255415|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413411|NCT01318135|65255416|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
23413412|NCT01318135|65255417|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
23413413|NCT01703091|65255420|FG000|Overall Study|Adverse Event|5|||
23413414|NCT01703091|65255421|FG001|Overall Study|Adverse Event|3|||
23413415|NCT01703091|65255420|FG000|Overall Study|Physician Decision|2|||
23413416|NCT01703091|65255421|FG001|Overall Study|Physician Decision|1|||
23413417|NCT01703091|65255420|FG000|Overall Study|Withdrawal by Subject|1|||
23413418|NCT01703091|65255421|FG001|Overall Study|Withdrawal by Subject|0|||
23413419|NCT01703091|65255420|FG000|Overall Study|Sponsor Decision|1|||
23413420|NCT01703091|65255421|FG001|Overall Study|Sponsor Decision|0|||
23413421|NCT00576628|65255422|FG000|Overall Study|Adverse Event|11|||
23413422|NCT00576628|65255422|FG000|Overall Study|Death|2|||
23413423|NCT00576628|65255422|FG000|Overall Study|Failure to return|1|||
23413424|NCT00576628|65255422|FG000|Overall Study|Refused Treatment|8|||
23413425|NCT00576628|65255422|FG000|Overall Study|Pregnancy|1|||
23413426|NCT00576628|65255422|FG000|Overall Study|RBC transfusion|1|||
23413427|NCT00576628|65255422|FG000|Overall Study|Progression of Kidney Disease|1|||
23413428|NCT00576628|65255422|FG000|Overall Study|Progression of Renal Failure|1|||
23413429|NCT00576628|65255422|FG000|Overall Study|The patient move into other town|1|||
23413430|NCT00576628|65255422|FG000|Overall Study|Transplantation|1|||
23413431|NCT00576628|65255422|FG000|Overall Study|Dialysis|15|||
23413432|NCT01814397|65255423|FG000|Overall Study|Adverse Event|7|||
23413433|NCT01814397|65255423|FG000|Overall Study|Withdrawal by Subject|7|||
23413434|NCT01814046|65255425|FG000|Drug Administration|Death due to complications of RSV|1|||
23413435|NCT01814046|65255426|FG001|Drug Administration|Death due to complications of RSV|0|||
23413436|NCT01814046|65255427|FG002|Drug Administration|Death due to complications of RSV|0|||
23413437|NCT01709110|65255430|FG000|Overall Study|Adverse Event|56|||
23413438|NCT01709110|65255431|FG001|Overall Study|Adverse Event|48|||
23413439|NCT01709110|65255430|FG000|Overall Study|Death|14|||
23413440|NCT01709110|65255431|FG001|Overall Study|Death|6|||
23413441|NCT01709110|65255430|FG000|Overall Study|Lost to Follow-up|7|||
23413442|NCT01709110|65255431|FG001|Overall Study|Lost to Follow-up|5|||
23413443|NCT01709110|65255430|FG000|Overall Study|Protocol Violation|4|||
23413444|NCT01709110|65255431|FG001|Overall Study|Protocol Violation|6|||
23413445|NCT01709110|65255430|FG000|Overall Study|Withdrawal by Subject|96|||
23413446|NCT01709110|65255431|FG001|Overall Study|Withdrawal by Subject|89|||
23413447|NCT01709110|65255430|FG000|Overall Study|Physician Decision|4|||
23413448|NCT01709110|65255431|FG001|Overall Study|Physician Decision|10|||
23413449|NCT01709110|65255430|FG000|Overall Study|Sponsor Decision|2|||
23413450|NCT01709110|65255431|FG001|Overall Study|Sponsor Decision|2|||
23413451|NCT01709110|65255430|FG000|Overall Study|Lack of Efficacy|1|||
23413452|NCT01709110|65255431|FG001|Overall Study|Lack of Efficacy|1|||
23413453|NCT01709110|65255430|FG000|Overall Study|Caregiver Decision|1|||
23413454|NCT01709110|65255431|FG001|Overall Study|Caregiver Decision|1|||
23413455|NCT02952313|65255439|FG000|Primary Endpoint|Lost to Follow-up|4|||
23413456|NCT02952313|65255439|FG000|Primary Endpoint|Withdrawal by Subject|1|||
23413457|NCT02952313|65255439|FG000|Primary Endpoint|Lack of Efficacy|1|||
23413458|NCT02952313|65255439|FG000|Primary Endpoint|Missed visit|1|||
23413459|NCT02952313|65255439|FG000|Long-term Follow-up|Lost to Follow-up|12|||
23413460|NCT02952313|65255439|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
23413461|NCT02952313|65255439|FG000|Long-term Follow-up|Lack of Efficacy|6|||
23413462|NCT02952313|65255439|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
23413463|NCT02952313|65255439|FG000|Long-term Follow-up|Physician Decision|1|||
23413464|NCT02952313|65255439|FG000|Long-term Follow-up|Death|1|||
23413465|NCT01108731|65255446|FG000|Overall Study|Withdrawal by Subject|1|||
23413466|NCT01108731|65255447|FG001|Overall Study|Withdrawal by Subject|1|||
23413467|NCT01108731|65255446|FG000|Overall Study|Adverse Event|3|||
23413468|NCT01108731|65255447|FG001|Overall Study|Adverse Event|3|||
23413469|NCT00395486|65255448|FG000|Overall Study|Adverse Event|1|||
23413470|NCT00395486|65255449|FG001|Overall Study|Adverse Event|2|||
23413471|NCT00395486|65255448|FG000|Overall Study|Withdrawal by Subject|5|||
23413472|NCT00395486|65255449|FG001|Overall Study|Withdrawal by Subject|2|||
23413473|NCT00395486|65255448|FG000|Overall Study|Lost to Follow-up|0|||
23413474|NCT00395486|65255449|FG001|Overall Study|Lost to Follow-up|1|||
23413475|NCT01822899|65255450|FG000|Overall Study|Adverse Event|6|||
23413476|NCT01822899|65255451|FG001|Overall Study|Adverse Event|5|||
23413477|NCT01822899|65255450|FG000|Overall Study|Lack of Efficacy|6|||
23413478|NCT01822899|65255451|FG001|Overall Study|Lack of Efficacy|3|||
23413479|NCT01822899|65255450|FG000|Overall Study|Protocol Violation|6|||
23413480|NCT01822899|65255451|FG001|Overall Study|Protocol Violation|3|||
23413481|NCT01822899|65255450|FG000|Overall Study|Lost to Follow-up|1|||
23413482|NCT01822899|65255451|FG001|Overall Study|Lost to Follow-up|0|||
23512088|NCT02642614|65612617|FG000|Overall Study|Withdrawal by Subject|1|||
23512089|NCT02642614|65612618|FG001|Overall Study|Withdrawal by Subject|1|||
23512090|NCT02642614|65612619|FG002|Overall Study|Withdrawal by Subject|0|||
23512091|NCT02642614|65612620|FG003|Overall Study|Withdrawal by Subject|0|||
23512092|NCT04271605|65612621|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
23512093|NCT00884312|65612623|FG000|Overall Study|Non-fatal Progressive Disease|0|||
23512094|NCT00884312|65612624|FG001|Overall Study|Non-fatal Progressive Disease|8|||
23512095|NCT00884312|65612623|FG000|Overall Study|Fatal Progressive Disease|0|||
23307377|NCT00856973|64870486|FG000|Overall Study|Adverse Event|5|||
23307378|NCT00856973|64870487|FG001|Overall Study|Adverse Event|5|||
23307379|NCT00856973|64870488|FG002|Overall Study|Adverse Event|3|||
23307380|NCT00856973|64870486|FG000|Overall Study|Lost to Follow-up|6|||
23307381|NCT00856973|64870487|FG001|Overall Study|Lost to Follow-up|3|||
23307382|NCT00856973|64870488|FG002|Overall Study|Lost to Follow-up|5|||
23307383|NCT00856973|64870486|FG000|Overall Study|Physician Decision|0|||
23307384|NCT00856973|64870487|FG001|Overall Study|Physician Decision|3|||
23307385|NCT00856973|64870488|FG002|Overall Study|Physician Decision|1|||
23307386|NCT00856973|64870486|FG000|Overall Study|Protocol Violation|1|||
23307387|NCT00856973|64870487|FG001|Overall Study|Protocol Violation|2|||
23307388|NCT00856973|64870488|FG002|Overall Study|Protocol Violation|1|||
23307389|NCT00856973|64870486|FG000|Overall Study|Withdrawal by Subject|13|||
23307390|NCT00856973|64870487|FG001|Overall Study|Withdrawal by Subject|16|||
23307391|NCT00856973|64870488|FG002|Overall Study|Withdrawal by Subject|15|||
23307392|NCT00856973|64870486|FG000|Overall Study|Other|11|||
23307393|NCT00856973|64870487|FG001|Overall Study|Other|12|||
23307394|NCT00856973|64870488|FG002|Overall Study|Other|13|||
23307395|NCT01388166|64870489|FG000|Overall Study|Adverse Event|16|||
23307396|NCT01388166|64870489|FG000|Overall Study|Lost to Follow-up|30|||
23307397|NCT01388166|64870489|FG000|Overall Study|Others than specified above|13|||
23307398|NCT02266134|64870490|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
23307399|NCT02266134|64870491|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
23307400|NCT02266134|64870492|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
23307401|NCT02266134|64870493|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
23307402|NCT02266134|64870490|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
23307403|NCT02266134|64870491|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
23307404|NCT02266134|64870492|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
23307405|NCT02266134|64870493|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
23307406|NCT02266134|64870490|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
23307407|NCT02266134|64870491|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
23307408|NCT02266134|64870492|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
23307409|NCT02266134|64870493|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
23307410|NCT02266134|64870490|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
23307411|NCT02266134|64870491|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
23307412|NCT02266134|64870492|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
23307413|NCT02266134|64870493|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
23307414|NCT02266134|64870490|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
23307415|NCT02266134|64870491|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
23307416|NCT02266134|64870492|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
23413483|NCT01822899|65255450|FG000|Overall Study|Withdrawal by Subject|5|||
23307417|NCT02266134|64870493|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
23413484|NCT01822899|65255451|FG001|Overall Study|Withdrawal by Subject|7|||
23413485|NCT02027311|65255453|FG000|Overall Study|Protocol Violation|3|||
23413486|NCT02027311|65255454|FG001|Overall Study|Protocol Violation|2|||
23413487|NCT04222699|65255455|FG000|Overall Study|Lost to Follow-up|2|||
23413488|NCT01645735|65255462|FG000|Overall Study|Physician Decision|2|||
23413489|NCT01645735|65255463|FG001|Overall Study|Physician Decision|0|||
23413490|NCT01645735|65255462|FG000|Overall Study|Withdrawal by Subject|1|||
23413491|NCT01645735|65255463|FG001|Overall Study|Withdrawal by Subject|0|||
23413492|NCT01645735|65255462|FG000|Overall Study|Protocol Violation|1|||
23413493|NCT01645735|65255463|FG001|Overall Study|Protocol Violation|0|||
23413494|NCT01645735|65255462|FG000|Overall Study|Adverse Event|0|||
23413495|NCT01645735|65255463|FG001|Overall Study|Adverse Event|1|||
23413496|NCT03299244|65255464|FG000|Overall Study|Withdrawal by Subject|34|||
23413497|NCT03299244|65255465|FG001|Overall Study|Withdrawal by Subject|29|||
23413498|NCT03299244|65255464|FG000|Overall Study|Decision by Sponsor|4|||
23413499|NCT03299244|65255465|FG001|Overall Study|Decision by Sponsor|5|||
23413500|NCT03299244|65255464|FG000|Overall Study|Death|9|||
23413501|NCT03299244|65255465|FG001|Overall Study|Death|4|||
23413502|NCT02705105|65255467|FG000|Treatment|Objective Disease Progression|1|||
23413503|NCT02705105|65255468|FG001|Treatment|Objective Disease Progression|50|||
23413504|NCT02705105|65255467|FG000|Treatment|Withdrawal by Subject|3|||
23413505|NCT02705105|65255468|FG001|Treatment|Withdrawal by Subject|5|||
23413506|NCT02705105|65255467|FG000|Treatment|Adverse Event|0|||
23413507|NCT02705105|65255468|FG001|Treatment|Adverse Event|17|||
23413508|NCT02705105|65255467|FG000|Treatment|Clinical Disease Progression|0|||
23413509|NCT02705105|65255468|FG001|Treatment|Clinical Disease Progression|32|||
23413510|NCT02705105|65255467|FG000|Treatment|Physician Decision|0|||
23413511|NCT02705105|65255468|FG001|Treatment|Physician Decision|3|||
23413512|NCT02705105|65255467|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
23413513|NCT02705105|65255468|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
23413514|NCT02705105|65255467|FG000|Follow-Up|Death|3|||
23413515|NCT02705105|65255468|FG001|Follow-Up|Death|68|||
23413516|NCT02705105|65255467|FG000|Follow-Up|Withdrawal by Subject|1|||
23413517|NCT02705105|65255468|FG001|Follow-Up|Withdrawal by Subject|14|||
23413518|NCT02705105|65255467|FG000|Follow-Up|Study Terminated|0|||
23413519|NCT02705105|65255468|FG001|Follow-Up|Study Terminated|26|||
23413520|NCT02705105|65255467|FG000|Follow-Up|Discontinued per Amendment 3|0|||
23413521|NCT02705105|65255468|FG001|Follow-Up|Discontinued per Amendment 3|2|||
23413522|NCT01301066|65255469|FG000|Overall Study|Lost to Follow-up|5|||
23413523|NCT01301066|65255470|FG001|Overall Study|Lost to Follow-up|11|||
23413524|NCT01301066|65255469|FG000|Overall Study|Protocol Violation|8|||
23413525|NCT01301066|65255470|FG001|Overall Study|Protocol Violation|7|||
23413526|NCT01301066|65255469|FG000|Overall Study|Withdrawal by Subject|4|||
23413527|NCT01301066|65255470|FG001|Overall Study|Withdrawal by Subject|9|||
23413528|NCT01301066|65255469|FG000|Overall Study|Adverse Event|6|||
23413529|NCT01301066|65255470|FG001|Overall Study|Adverse Event|6|||
23413530|NCT01301066|65255469|FG000|Overall Study|Sponsor Decision|2|||
23413531|NCT01301066|65255470|FG001|Overall Study|Sponsor Decision|1|||
23413532|NCT01301066|65255469|FG000|Overall Study|Physician Decision|0|||
23413533|NCT01301066|65255470|FG001|Overall Study|Physician Decision|1|||
23413534|NCT01301066|65255469|FG000|Overall Study|Other|2|||
23413535|NCT01301066|65255470|FG001|Overall Study|Other|0|||
23413536|NCT00632827|65255475|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
23413537|NCT00632827|65255475|FG000|Overall Study|Death|2|||
23413538|NCT00632827|65255475|FG000|Overall Study|Adverse Event|5|||
23413539|NCT00632827|65255475|FG000|Overall Study|Lost to Follow-up|1|||
23413540|NCT04003207|65255477|FG000|Overall Study|Protocol Violation|1|||
23413541|NCT02091362|65255478|FG000|Period 1|Protocol Violation|1|||
23413542|NCT02091362|65255479|FG001|Period 1|Protocol Violation|0|||
23413543|NCT02091362|65255478|FG000|Period 1|Withdrawal by Subject|2|||
23413544|NCT02091362|65255479|FG001|Period 1|Withdrawal by Subject|3|||
23413545|NCT02091362|65255478|FG000|Period 1|Lost to Follow-up|0|||
23413546|NCT02091362|65255479|FG001|Period 1|Lost to Follow-up|1|||
23413547|NCT02091362|65255478|FG000|Period 1|Adverse Event|2|||
23413548|NCT02091362|65255479|FG001|Period 1|Adverse Event|0|||
23413549|NCT02091362|65255478|FG000|Wash-out|Lost to Follow-up|1|||
23413550|NCT02091362|65255479|FG001|Wash-out|Lost to Follow-up|1|||
23413551|NCT02091362|65255478|FG000|Wash-out|Withdrawal by Subject|0|||
23413552|NCT02091362|65255479|FG001|Wash-out|Withdrawal by Subject|2|||
23413553|NCT02091362|65255478|FG000|Period 2|Adverse Event|1|||
23413554|NCT02091362|65255479|FG001|Period 2|Adverse Event|0|||
23413555|NCT02091362|65255478|FG000|Period 2|Lost to Follow-up|0|||
23413556|NCT02091362|65255479|FG001|Period 2|Lost to Follow-up|1|||
23413557|NCT02091362|65255478|FG000|Period 2|Withdrawal by Subject|1|||
23413558|NCT02091362|65255479|FG001|Period 2|Withdrawal by Subject|1|||
23413559|NCT01811485|65255490|FG000|Overall Study|Adverse Event|1|||
23413560|NCT01811485|65255491|FG001|Overall Study|Adverse Event|3|||
23413561|NCT01811485|65255492|FG002|Overall Study|Adverse Event|2|||
23413562|NCT01811485|65255490|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23413563|NCT01811485|65255491|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23413564|NCT01811485|65255492|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
23413565|NCT01811485|65255490|FG000|Overall Study|Administrative problems|1|||
23413566|NCT01811485|65255491|FG001|Overall Study|Administrative problems|0|||
23413567|NCT01811485|65255492|FG002|Overall Study|Administrative problems|0|||
23413568|NCT01811485|65255490|FG000|Overall Study|Protocol Deviation|0|||
23413569|NCT01811485|65255491|FG001|Overall Study|Protocol Deviation|1|||
23413570|NCT01811485|65255492|FG002|Overall Study|Protocol Deviation|0|||
23413571|NCT03300024|65255493|FG000|Overall Study|Physician Decision|4|||
23413572|NCT03300024|65255494|FG001|Overall Study|Physician Decision|6|||
23413573|NCT02547038|65255495|FG000|Overall Study|Lost to Follow-up|3|||
23413574|NCT02547038|65255496|FG001|Overall Study|Lost to Follow-up|2|||
23413575|NCT00313144|65255497|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
23413576|NCT00313144|65255497|FG000|Overall Study|Death|7|||
23413577|NCT00313144|65255497|FG000|Overall Study|Lost to Follow-up|5|||
23413578|NCT00313144|65255497|FG000|Overall Study|Withdrawal by Subject|4|||
23413579|NCT00313144|65255497|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
23413580|NCT00313144|65255497|FG000|Overall Study|Physician Decision|4|||
23413581|NCT00313144|65255497|FG000|Overall Study|Adverse event - transient|5|||
23413582|NCT00313144|65255497|FG000|Overall Study|Liver transplant|1|||
23413583|NCT00313144|65255497|FG000|Overall Study|Insurance (homecare provider) change|1|||
23413584|NCT00313144|65255497|FG000|Overall Study|Change to different product|1|||
23413585|NCT00313144|65255497|FG000|Overall Study|Due to termination of the study|66|||
23413586|NCT01939977|65255498|FG000|Overall Study|Adverse Event|4|||
23413587|NCT01939977|65255499|FG001|Overall Study|Adverse Event|3|||
23413588|NCT01939977|65255498|FG000|Overall Study|Lack of Efficacy|3|||
23413589|NCT01939977|65255499|FG001|Overall Study|Lack of Efficacy|0|||
23413590|NCT01939977|65255498|FG000|Overall Study|Physician Decision|1|||
23413591|NCT01939977|65255499|FG001|Overall Study|Physician Decision|1|||
23413592|NCT01939977|65255498|FG000|Overall Study|Withdrawal by Subject|0|||
23413593|NCT01939977|65255499|FG001|Overall Study|Withdrawal by Subject|2|||
23413594|NCT01939977|65255498|FG000|Overall Study|Did not meet inclusion criteria|1|||
23413595|NCT01939977|65255499|FG001|Overall Study|Did not meet inclusion criteria|0|||
23413596|NCT01939977|65255498|FG000|Overall Study|Did not receive study medication|0|||
23413597|NCT01939977|65255499|FG001|Overall Study|Did not receive study medication|1|||
23413598|NCT01581021|65255500|FG000|Overall Study|Lost to Follow-up|4|||
23413599|NCT01581021|65255501|FG001|Overall Study|Lost to Follow-up|6|||
23413600|NCT01581021|65255500|FG000|Overall Study|More than 2 hooks in thoracic|3|||
23413601|NCT01581021|65255501|FG001|Overall Study|More than 2 hooks in thoracic|0|||
23413602|NCT01581021|65255500|FG000|Overall Study|Neuromuscular|2|||
23413603|NCT01581021|65255501|FG001|Overall Study|Neuromuscular|1|||
23413604|NCT01581021|65255500|FG000|Overall Study|Not Randomized|1|||
23413605|NCT01581021|65255501|FG001|Overall Study|Not Randomized|2|||
23413606|NCT01581021|65255500|FG000|Overall Study|Lenke 6 Classification|0|||
23413607|NCT01581021|65255501|FG001|Overall Study|Lenke 6 Classification|1|||
23413608|NCT01581021|65255500|FG000|Overall Study|Lack of Efficacy|0|||
23413609|NCT01581021|65255501|FG001|Overall Study|Lack of Efficacy|1|||
23413610|NCT01450696|65255505|FG000|Overall Study|Never Treated|1|||
23413611|NCT01450696|65255506|FG001|Overall Study|Never Treated|1|||
23413612|NCT01450696|65255505|FG000|Overall Study|Death|77|||
23413613|NCT01450696|65255506|FG001|Overall Study|Death|84|||
23413614|NCT01450696|65255505|FG000|Overall Study|Lost to Follow-up|3|||
23413615|NCT01450696|65255506|FG001|Overall Study|Lost to Follow-up|3|||
23413616|NCT01450696|65255505|FG000|Overall Study|Non-Compliance|1|||
23413617|NCT01450696|65255506|FG001|Overall Study|Non-Compliance|0|||
23413618|NCT01450696|65255505|FG000|Overall Study|Withdrawal by Subject|13|||
23413619|NCT01450696|65255506|FG001|Overall Study|Withdrawal by Subject|2|||
23413620|NCT01450696|65255505|FG000|Overall Study|Study Terminated by Sponsor|53|||
23413621|NCT01450696|65255506|FG001|Overall Study|Study Terminated by Sponsor|58|||
23413622|NCT00841776|65255509|FG000|Overall Study|Lack of Efficacy|0|||
23413623|NCT00841776|65255510|FG001|Overall Study|Lack of Efficacy|1|||
23413624|NCT00841776|65255509|FG000|Overall Study|Lost to Follow-up|2|||
23413625|NCT00841776|65255510|FG001|Overall Study|Lost to Follow-up|1|||
23413626|NCT00841776|65255509|FG000|Overall Study|Withdrawal by Subject|0|||
23413627|NCT00841776|65255510|FG001|Overall Study|Withdrawal by Subject|1|||
23413628|NCT00566982|65255511|FG000|Overall Study|Adverse Event|6|||
23413629|NCT00566982|65255512|FG001|Overall Study|Adverse Event|48|||
23413630|NCT00566982|65255511|FG000|Overall Study|Withdrawal by Subject|1|||
23413631|NCT00566982|65255512|FG001|Overall Study|Withdrawal by Subject|14|||
23413632|NCT00566982|65255511|FG000|Overall Study|Protocol Violation|1|||
23413633|NCT00566982|65255512|FG001|Overall Study|Protocol Violation|4|||
23413634|NCT00566982|65255511|FG000|Overall Study|Lost to Follow-up|0|||
23413635|NCT00566982|65255512|FG001|Overall Study|Lost to Follow-up|1|||
23413636|NCT00566982|65255511|FG000|Overall Study|Other-family problems & doctor's request|0|||
23413637|NCT00566982|65255512|FG001|Overall Study|Other-family problems & doctor's request|2|||
23453492|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
23453493|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453494|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453495|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453496|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453497|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453498|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453499|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453500|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453501|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453502|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453503|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453504|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453505|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
23453506|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23453507|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
23307418|NCT02266134|64870490|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
23307419|NCT02266134|64870491|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
23307420|NCT02266134|64870492|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
23307421|NCT02266134|64870493|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
23307422|NCT02317614|64870494|FG000|Overall Study|Lost to Follow-up|1|||
23307423|NCT02317614|64870495|FG001|Overall Study|Lost to Follow-up|1|||
23307424|NCT02317614|64870494|FG000|Overall Study|Withdrawal by Subject|1|||
23307425|NCT02317614|64870495|FG001|Overall Study|Withdrawal by Subject|0|||
23307426|NCT02317614|64870494|FG000|Overall Study|Death|1|||
23307427|NCT02317614|64870495|FG001|Overall Study|Death|1|||
23307428|NCT01121666|64870498|FG000|Overall Study|Protocol Violation|29|||
23307429|NCT01121666|64870499|FG001|Overall Study|Protocol Violation|10|||
23307430|NCT02149108|64870502|FG000|Overall Study|Not treated|1|||
23307431|NCT02149108|64870503|FG001|Overall Study|Not treated|2|||
23307432|NCT02149108|64870502|FG000|Overall Study|Progressive Disease (PD)|324|||
23307433|NCT02149108|64870503|FG001|Overall Study|Progressive Disease (PD)|318|||
23307434|NCT02149108|64870502|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
23307435|NCT02149108|64870503|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
23307436|NCT02149108|64870502|FG000|Overall Study|Other Adverse Event (AE)|8|||
23307437|NCT02149108|64870503|FG001|Overall Study|Other Adverse Event (AE)|18|||
23307438|NCT02149108|64870502|FG000|Overall Study|Other not defined above|0|||
23307439|NCT02149108|64870503|FG001|Overall Study|Other not defined above|2|||
23307440|NCT02149108|64870502|FG000|Overall Study|Refusal to continue trial medication|15|||
23307441|NCT02149108|64870503|FG001|Overall Study|Refusal to continue trial medication|11|||
23307442|NCT02149108|64870502|FG000|Overall Study|Lost to Follow-up|1|||
23307443|NCT02149108|64870503|FG001|Overall Study|Lost to Follow-up|0|||
23453508|NCT01147666|65403331|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453509|NCT01147666|65403332|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23610590|NCT02676778|65962810|FG001|Overall Study|Adverse Event|3|||
23307444|NCT01156142|64870504|FG000|Overall Study|Withdrawal by Subject|8|||
23307445|NCT01156142|64870505|FG001|Overall Study|Withdrawal by Subject|6|||
23413638|NCT02489318|65258190|FG000|Randomized|Withdrawal by Subject|0|||
23413639|NCT02489318|65258191|FG001|Randomized|Withdrawal by Subject|1|||
23413640|NCT02489318|65258190|FG000|Treated|Adverse Event|19|||
23413641|NCT02489318|65258191|FG001|Treated|Adverse Event|62|||
23413642|NCT02489318|65258190|FG000|Treated|Death|13|||
23413643|NCT02489318|65258191|FG001|Treated|Death|11|||
23413644|NCT02489318|65258190|FG000|Treated|Physician Decision|4|||
23413645|NCT02489318|65258191|FG001|Treated|Physician Decision|6|||
23413646|NCT02489318|65258190|FG000|Treated|Protocol Violation|1|||
23413647|NCT02489318|65258191|FG001|Treated|Protocol Violation|2|||
23413648|NCT02489318|65258190|FG000|Treated|Withdrawal by Subject|37|||
23413649|NCT02489318|65258191|FG001|Treated|Withdrawal by Subject|36|||
23413650|NCT02489318|65258190|FG000|Treated|Other: Progressive Disease|245|||
23413651|NCT02489318|65258191|FG001|Treated|Other: Progressive Disease|138|||
23413652|NCT02489318|65258190|FG000|Treated|Other|0|||
23413653|NCT02489318|65258191|FG001|Treated|Other|2|||
23413654|NCT02489318|65258190|FG000|Treated|Ongoing|0|||
23413655|NCT02489318|65258191|FG001|Treated|Ongoing|267|||
23610591|NCT02676778|65962811|FG002|Overall Study|Adverse Event|0|||
23610592|NCT02604199|65962812|FG000|Overall Study|Pregnancy|0|||
23610593|NCT02604199|65962813|FG001|Overall Study|Pregnancy|0|||
23610594|NCT02604199|65962814|FG002|Overall Study|Pregnancy|0|||
23413660|NCT04551898|65258211|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
23413661|NCT04551898|65258212|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
23413662|NCT04551898|65258213|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
23413663|NCT04551898|65258214|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
23413664|NCT04551898|65258211|FG000|Overall Study|Withdrawal by Subject|5|||
23413665|NCT04551898|65258212|FG001|Overall Study|Withdrawal by Subject|1|||
23413666|NCT04551898|65258213|FG002|Overall Study|Withdrawal by Subject|2|||
23413667|NCT04551898|65258214|FG003|Overall Study|Withdrawal by Subject|2|||
23413668|NCT04551898|65258211|FG000|Overall Study|Lost to Follow-up|2|||
23413669|NCT04551898|65258212|FG001|Overall Study|Lost to Follow-up|1|||
23413670|NCT04551898|65258213|FG002|Overall Study|Lost to Follow-up|2|||
23413671|NCT04551898|65258214|FG003|Overall Study|Lost to Follow-up|2|||
23413672|NCT04551898|65258211|FG000|Overall Study|Death|1|||
23413673|NCT04551898|65258212|FG001|Overall Study|Death|0|||
23413674|NCT04551898|65258213|FG002|Overall Study|Death|0|||
23413675|NCT04551898|65258214|FG003|Overall Study|Death|0|||
23413676|NCT04551898|65258211|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
23413677|NCT04551898|65258212|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
23413678|NCT04551898|65258213|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
23413679|NCT04551898|65258214|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
23413680|NCT05425732|65258215|FG000|Overall Study|Death|4|||
23413681|NCT05425732|65258216|FG001|Overall Study|Death|2|||
23413682|NCT05425732|65258217|FG002|Overall Study|Death|0|||
23413683|NCT05425732|65258218|FG003|Overall Study|Death|0|||
23413684|NCT05425732|65258215|FG000|Overall Study|Lost to Follow-up|10|||
23413685|NCT05425732|65258216|FG001|Overall Study|Lost to Follow-up|15|||
23413686|NCT05425732|65258217|FG002|Overall Study|Lost to Follow-up|5|||
23413687|NCT05425732|65258218|FG003|Overall Study|Lost to Follow-up|3|||
23413688|NCT05425732|65258215|FG000|Overall Study|Physician Decision|0|||
23413689|NCT05425732|65258216|FG001|Overall Study|Physician Decision|2|||
23413690|NCT05425732|65258217|FG002|Overall Study|Physician Decision|0|||
23413691|NCT05425732|65258218|FG003|Overall Study|Physician Decision|0|||
23413692|NCT05425732|65258215|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
23413693|NCT05425732|65258216|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
23413694|NCT05425732|65258217|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23413695|NCT05425732|65258218|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23413696|NCT05425732|65258215|FG000|Overall Study|Withdrawal by Subject|4|||
23413697|NCT05425732|65258216|FG001|Overall Study|Withdrawal by Subject|8|||
23413698|NCT05425732|65258217|FG002|Overall Study|Withdrawal by Subject|1|||
23413699|NCT05425732|65258218|FG003|Overall Study|Withdrawal by Subject|1|||
23413700|NCT05425732|65258215|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
23413701|NCT05425732|65258216|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
23413702|NCT05425732|65258217|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
23413703|NCT05425732|65258218|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
23413704|NCT02506153|65258219|FG000|Overall Study|Adverse Event|359|||
23413705|NCT02506153|65258220|FG001|Overall Study|Adverse Event|114|||
23413706|NCT02506153|65258219|FG000|Overall Study|Refused unrelated to adverse event|127|||
23413707|NCT02506153|65258220|FG001|Overall Study|Refused unrelated to adverse event|18|||
23413708|NCT02506153|65258219|FG000|Overall Study|Progression/relapse|91|||
23413709|NCT02506153|65258220|FG001|Overall Study|Progression/relapse|136|||
23413710|NCT02506153|65258219|FG000|Overall Study|Death|2|||
23413711|NCT02506153|65258220|FG001|Overall Study|Death|1|||
23610595|NCT02604199|65962815|FG003|Overall Study|Pregnancy|1|||
23413712|NCT02506153|65258219|FG000|Overall Study|Other - not protocol specified|23|||
23413713|NCT02506153|65258220|FG001|Overall Study|Other - not protocol specified|12|||
23413714|NCT00861705|65258221|FG000|Overall Study|Never Began Treatment|7|||
23413715|NCT00861705|65258222|FG001|Overall Study|Never Began Treatment|3|||
23413716|NCT00861705|65258223|FG002|Overall Study|Never Began Treatment|0|||
23413717|NCT00861705|65258224|FG003|Overall Study|Never Began Treatment|1|||
23610596|NCT02604199|65962812|FG000|Overall Study|Study terminated by sponsor|0|||
23413719|NCT03427814|65258234|FG000|Overall Study|Withdrawal by Subject|4|||
23413720|NCT03427814|65258235|FG001|Overall Study|Withdrawal by Subject|4|||
23413721|NCT03427814|65258234|FG000|Overall Study|Lost to Follow-up|0|||
23413722|NCT03427814|65258235|FG001|Overall Study|Lost to Follow-up|2|||
23413723|NCT03427814|65258234|FG000|Overall Study|Death|42|||
23413724|NCT03427814|65258235|FG001|Overall Study|Death|31|||
23413725|NCT03427814|65258234|FG000|Overall Study|Sponsor's Decision|1|||
23413726|NCT03427814|65258235|FG001|Overall Study|Sponsor's Decision|0|||
23413727|NCT03427814|65258234|FG000|Overall Study|Investigator's Decision|1|||
23413728|NCT03427814|65258235|FG001|Overall Study|Investigator's Decision|2|||
23413729|NCT03427814|65258234|FG000|Overall Study|Disease progression|1|||
23413730|NCT03427814|65258235|FG001|Overall Study|Disease progression|0|||
23413731|NCT03427814|65258234|FG000|Overall Study|Treatment Completed|0|||
23413732|NCT03427814|65258235|FG001|Overall Study|Treatment Completed|1|||
23413733|NCT03427814|65258234|FG000|Overall Study|Sponsor's Decision to End study|21|||
23413734|NCT03427814|65258235|FG001|Overall Study|Sponsor's Decision to End study|25|||
23413735|NCT03427814|65258234|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
23413736|NCT03427814|65258235|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
23413737|NCT03145064|65258236|FG000|Overall Study|Death|24|||
23413738|NCT03145064|65258236|FG000|Overall Study|Lost to Follow-up|3|||
23413739|NCT03145064|65258236|FG000|Overall Study|Withdrawal by Subject|6|||
23413740|NCT03145064|65258236|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
23413741|NCT03145064|65258236|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
23413742|NCT03846427|65258237|FG000|Overall Study|Death|13|||
23413743|NCT03846427|65258237|FG000|Overall Study|Withdrawal by Subject|3|||
23413744|NCT03846427|65258237|FG000|Overall Study|Physician Decision|1|||
23413745|NCT04723355|65258241|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
23413746|NCT04723355|65258241|FG000|Overall Study|Errors in the informed consent form|2|||
23610597|NCT02604199|65962813|FG001|Overall Study|Study terminated by sponsor|2|||
23610598|NCT02604199|65962814|FG002|Overall Study|Study terminated by sponsor|0|||
23610599|NCT02604199|65962815|FG003|Overall Study|Study terminated by sponsor|2|||
23610600|NCT02604199|65962812|FG000|Overall Study|Withdrawal by Subject|0|||
23610601|NCT02604199|65962813|FG001|Overall Study|Withdrawal by Subject|1|||
23610602|NCT02604199|65962814|FG002|Overall Study|Withdrawal by Subject|0|||
23610603|NCT02604199|65962815|FG003|Overall Study|Withdrawal by Subject|0|||
23610604|NCT00321555|65962816|FG000|Overall Study|Developed antibodies|1|||
23610605|NCT00321555|65962816|FG000|Overall Study|Switched to alternative treatment|3|||
23610606|NCT00321555|65962816|FG000|Overall Study|Physician Decision|1|||
23610607|NCT00321555|65962816|FG000|Overall Study|Disease progression on study|1|||
23610608|NCT00409747|65962829|FG000|Overall Study|Withdrawal by Subject|1|||
23610609|NCT04930263|65962833|FG000|Overall Study|Withdrawal by Subject|3|||
23610610|NCT04930263|65962834|FG001|Overall Study|Withdrawal by Subject|5|||
23610611|NCT00731692|65962835|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
23610612|NCT00731692|65962836|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
23610613|NCT00731692|65962837|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
23610614|NCT00731692|65962835|FG000|Core Study (36 Months)|Physician Decision|1|||
23610615|NCT00731692|65962836|FG001|Core Study (36 Months)|Physician Decision|0|||
23610616|NCT00731692|65962837|FG002|Core Study (36 Months)|Physician Decision|2|||
23610617|NCT00731692|65962835|FG000|Core Study (36 Months)|Death|2|||
23610618|NCT00731692|65962836|FG001|Core Study (36 Months)|Death|1|||
23610619|NCT00731692|65962837|FG002|Core Study (36 Months)|Death|2|||
23610620|NCT00731692|65962835|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
23610621|NCT00731692|65962836|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
23610622|NCT00731692|65962837|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
23610623|NCT00731692|65962835|FG000|Core Study (36 Months)|Administrative|2|||
23610624|NCT00731692|65962836|FG001|Core Study (36 Months)|Administrative|2|||
23610625|NCT00731692|65962837|FG002|Core Study (36 Months)|Administrative|6|||
23610626|NCT00731692|65962835|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
23610627|NCT00731692|65962836|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
23610628|NCT00731692|65962837|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
23610629|NCT00731692|65962835|FG000|Core Study (36 Months)|Protocol Violation|4|||
23610630|NCT00731692|65962836|FG001|Core Study (36 Months)|Protocol Violation|5|||
23610631|NCT00731692|65962837|FG002|Core Study (36 Months)|Protocol Violation|8|||
23610632|NCT00731692|65962835|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
23512096|NCT00884312|65612624|FG001|Overall Study|Fatal Progressive Disease|1|||
23512097|NCT00884312|65612623|FG000|Overall Study|Non-fatal Adverse Event|1|||
23610633|NCT00731692|65962836|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
23610634|NCT00731692|65962837|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
23413787|NCT03053440|65258250|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
23413788|NCT03053440|65258251|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
23413789|NCT03053440|65258250|FG000|Overall Study|Death|18|||
23413790|NCT03053440|65258251|FG001|Overall Study|Death|14|||
23413791|NCT03053440|65258250|FG000|Overall Study|Withdrawal by Subject|9|||
23413792|NCT03053440|65258251|FG001|Overall Study|Withdrawal by Subject|8|||
23413793|NCT03053440|65258250|FG000|Overall Study|Lost to Follow-up|1|||
23413794|NCT03053440|65258251|FG001|Overall Study|Lost to Follow-up|0|||
23413795|NCT03053440|65258250|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
23413796|NCT03053440|65258251|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
23413797|NCT03053440|65258250|FG000|Overall Study|Physician Decision|2|||
23413798|NCT03053440|65258251|FG001|Overall Study|Physician Decision|1|||
23413799|NCT03053440|65258250|FG000|Overall Study|Participant Randomized but died before dosing|1|||
23413800|NCT03053440|65258251|FG001|Overall Study|Participant Randomized but died before dosing|0|||
23413801|NCT02890355|65258254|FG000|Overall Study|Adverse Event|5|||
23413802|NCT02890355|65258255|FG001|Overall Study|Adverse Event|5|||
23413803|NCT02890355|65258254|FG000|Overall Study|Refusal unrelated to adverse event|5|||
23413804|NCT02890355|65258255|FG001|Overall Study|Refusal unrelated to adverse event|10|||
23413805|NCT02890355|65258254|FG000|Overall Study|Progression/relapse|46|||
23413806|NCT02890355|65258255|FG001|Overall Study|Progression/relapse|39|||
23413807|NCT02890355|65258254|FG000|Overall Study|Not protocol specified|3|||
23413808|NCT02890355|65258255|FG001|Overall Study|Not protocol specified|4|||
23610635|NCT00731692|65962835|FG000|Core Study (36 Months)|Adverse Event|25|||
23413810|NCT03332017|65258257|FG000|Overall Study|Lost to Follow-up|1|||
23413811|NCT03332017|65258258|FG001|Overall Study|Lost to Follow-up|2|||
23413812|NCT03332017|65258257|FG000|Overall Study|Death|17|||
23413813|NCT03332017|65258258|FG001|Overall Study|Death|16|||
23413814|NCT03332017|65258257|FG000|Overall Study|Withdrawal by Subject|6|||
23413815|NCT03332017|65258258|FG001|Overall Study|Withdrawal by Subject|14|||
23413816|NCT03332017|65258257|FG000|Overall Study|Other|1|||
23413817|NCT03332017|65258258|FG001|Overall Study|Other|3|||
23413818|NCT03332017|65258257|FG000|Overall Study|Remained in Study (Ongoing)|47|||
23413819|NCT03332017|65258258|FG001|Overall Study|Remained in Study (Ongoing)|110|||
23610636|NCT00731692|65962836|FG001|Core Study (36 Months)|Adverse Event|28|||
23610637|NCT00731692|65962837|FG002|Core Study (36 Months)|Adverse Event|29|||
23610638|NCT00731692|65962835|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
23610639|NCT00731692|65962836|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
23610640|NCT00731692|65962837|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
23610641|NCT00731692|65962835|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
23610642|NCT00731692|65962836|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
23610643|NCT00731692|65962837|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
23610644|NCT00731692|65962835|FG000|Extension Phase|Abnormal test procedure|0|||
23610645|NCT00731692|65962836|FG001|Extension Phase|Abnormal test procedure|0|||
23610646|NCT00731692|65962837|FG002|Extension Phase|Abnormal test procedure|1|||
23610647|NCT00731692|65962835|FG000|Extension Phase|Abnormal lab values|0|||
23610648|NCT00731692|65962836|FG001|Extension Phase|Abnormal lab values|0|||
23610649|NCT00731692|65962837|FG002|Extension Phase|Abnormal lab values|1|||
23610650|NCT00731692|65962835|FG000|Extension Phase|Lost to Follow-up|0|||
23610651|NCT00731692|65962836|FG001|Extension Phase|Lost to Follow-up|1|||
23610652|NCT00731692|65962837|FG002|Extension Phase|Lost to Follow-up|4|||
23610653|NCT00731692|65962835|FG000|Extension Phase|Withdrawal by Subject|4|||
23610654|NCT00731692|65962836|FG001|Extension Phase|Withdrawal by Subject|5|||
23610655|NCT00731692|65962837|FG002|Extension Phase|Withdrawal by Subject|3|||
23610656|NCT00731692|65962835|FG000|Extension Phase|Adverse Event|1|||
23610657|NCT00731692|65962836|FG001|Extension Phase|Adverse Event|1|||
23610658|NCT00731692|65962837|FG002|Extension Phase|Adverse Event|15|||
23610659|NCT04425252|65962842|FG000|Overall Study|Withdrawal by Subject|2|||
23610660|NCT04425252|65962843|FG001|Overall Study|Withdrawal by Subject|1|||
23610661|NCT04425252|65962842|FG000|Overall Study|Lost to Follow-up|1|||
23610662|NCT04425252|65962843|FG001|Overall Study|Lost to Follow-up|0|||
23610663|NCT04425252|65962842|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
23610664|NCT04425252|65962843|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
23610665|NCT00596960|65962849|FG000|Overall Study|Death|1|||
23610666|NCT00596960|65962850|FG001|Overall Study|Death|2|||
23610667|NCT00596960|65962849|FG000|Overall Study|Lost to Follow-up|6|||
23610668|NCT00596960|65962850|FG001|Overall Study|Lost to Follow-up|5|||
23610669|NCT00596960|65962849|FG000|Overall Study|Withdrawal by Subject|1|||
23413852|NCT05784129|65258267|FG000|Overall Study|Study terminated by sponsor|2|||
23413853|NCT05784129|65258268|FG001|Overall Study|Study terminated by sponsor|2|||
23413854|NCT01436656|65258269|FG000|Dose Escalation|Death|1|||
23413855|NCT01436656|65258270|FG001|Dose Escalation|Death|3|||
23413856|NCT01436656|65258271|FG002|Dose Escalation|Death|1|||
23413857|NCT01436656|65258272|FG003|Dose Escalation|Death|0|||
23413858|NCT01436656|65258273|FG004|Dose Escalation|Death|2|||
23413859|NCT01436656|65258274|FG005|Dose Escalation|Death|1|||
23413860|NCT01436656|65258275|FG006|Dose Escalation|Death|1|||
23413861|NCT01436656|65258276|FG007|Dose Escalation|Death|1|||
23413862|NCT01436656|65258277|FG008|Dose Escalation|Death|1|||
23413863|NCT01436656|65258278|FG009|Dose Escalation|Death|0|||
23413864|NCT01436656|65258279|FG010|Dose Escalation|Death|0|||
23413865|NCT01436656|65258280|FG011|Dose Escalation|Death|0|||
23413866|NCT01436656|65258281|FG012|Dose Escalation|Death|0|||
23413867|NCT01436656|65258282|FG013|Dose Escalation|Death|0|||
23413868|NCT01436656|65258283|FG014|Dose Escalation|Death|0|||
23413869|NCT01436656|65258284|FG015|Dose Escalation|Death|0|||
23413870|NCT01436656|65258285|FG016|Dose Escalation|Death|0|||
23413871|NCT01436656|65258286|FG017|Dose Escalation|Death|0|||
23413872|NCT01436656|65258269|FG000|Dose Escalation|Protocol Violation|0|||
23413873|NCT01436656|65258270|FG001|Dose Escalation|Protocol Violation|0|||
23413874|NCT01436656|65258271|FG002|Dose Escalation|Protocol Violation|0|||
23413875|NCT01436656|65258272|FG003|Dose Escalation|Protocol Violation|0|||
23413876|NCT01436656|65258273|FG004|Dose Escalation|Protocol Violation|0|||
23413877|NCT01436656|65258274|FG005|Dose Escalation|Protocol Violation|1|||
23413878|NCT01436656|65258275|FG006|Dose Escalation|Protocol Violation|0|||
23413879|NCT01436656|65258276|FG007|Dose Escalation|Protocol Violation|0|||
23413880|NCT01436656|65258277|FG008|Dose Escalation|Protocol Violation|0|||
23413881|NCT01436656|65258278|FG009|Dose Escalation|Protocol Violation|0|||
23413882|NCT01436656|65258279|FG010|Dose Escalation|Protocol Violation|0|||
23413883|NCT01436656|65258280|FG011|Dose Escalation|Protocol Violation|0|||
23413884|NCT01436656|65258281|FG012|Dose Escalation|Protocol Violation|0|||
23413885|NCT01436656|65258282|FG013|Dose Escalation|Protocol Violation|0|||
23413886|NCT01436656|65258283|FG014|Dose Escalation|Protocol Violation|0|||
23413887|NCT01436656|65258284|FG015|Dose Escalation|Protocol Violation|0|||
23413888|NCT01436656|65258285|FG016|Dose Escalation|Protocol Violation|0|||
23413889|NCT01436656|65258286|FG017|Dose Escalation|Protocol Violation|0|||
23413890|NCT01436656|65258269|FG000|Dose Escalation|Withdrawal by Subject|0|||
23413891|NCT01436656|65258270|FG001|Dose Escalation|Withdrawal by Subject|0|||
23413892|NCT01436656|65258271|FG002|Dose Escalation|Withdrawal by Subject|0|||
23413893|NCT01436656|65258272|FG003|Dose Escalation|Withdrawal by Subject|0|||
23413894|NCT01436656|65258273|FG004|Dose Escalation|Withdrawal by Subject|1|||
23413895|NCT01436656|65258274|FG005|Dose Escalation|Withdrawal by Subject|0|||
23413896|NCT01436656|65258275|FG006|Dose Escalation|Withdrawal by Subject|0|||
23413897|NCT01436656|65258276|FG007|Dose Escalation|Withdrawal by Subject|2|||
23413898|NCT01436656|65258277|FG008|Dose Escalation|Withdrawal by Subject|0|||
23413899|NCT01436656|65258278|FG009|Dose Escalation|Withdrawal by Subject|1|||
23413900|NCT01436656|65258279|FG010|Dose Escalation|Withdrawal by Subject|1|||
23413901|NCT01436656|65258280|FG011|Dose Escalation|Withdrawal by Subject|0|||
23413902|NCT01436656|65258281|FG012|Dose Escalation|Withdrawal by Subject|0|||
23413903|NCT01436656|65258282|FG013|Dose Escalation|Withdrawal by Subject|0|||
23413904|NCT01436656|65258283|FG014|Dose Escalation|Withdrawal by Subject|0|||
23413905|NCT01436656|65258284|FG015|Dose Escalation|Withdrawal by Subject|0|||
23413906|NCT01436656|65258285|FG016|Dose Escalation|Withdrawal by Subject|0|||
23413907|NCT01436656|65258286|FG017|Dose Escalation|Withdrawal by Subject|0|||
23413908|NCT01436656|65258269|FG000|Dose Escalation|Administrative problems|0|||
23413909|NCT01436656|65258270|FG001|Dose Escalation|Administrative problems|1|||
23413910|NCT01436656|65258271|FG002|Dose Escalation|Administrative problems|0|||
23413911|NCT01436656|65258272|FG003|Dose Escalation|Administrative problems|0|||
23413912|NCT01436656|65258273|FG004|Dose Escalation|Administrative problems|0|||
23413913|NCT01436656|65258274|FG005|Dose Escalation|Administrative problems|0|||
23610670|NCT00596960|65962850|FG001|Overall Study|Withdrawal by Subject|0|||
23610671|NCT00596960|65962849|FG000|Overall Study|Incarcerated|2|||
23413914|NCT01436656|65258275|FG006|Dose Escalation|Administrative problems|0|||
23413915|NCT01436656|65258276|FG007|Dose Escalation|Administrative problems|0|||
23413916|NCT01436656|65258277|FG008|Dose Escalation|Administrative problems|0|||
23413917|NCT01436656|65258278|FG009|Dose Escalation|Administrative problems|0|||
23413918|NCT01436656|65258279|FG010|Dose Escalation|Administrative problems|0|||
23413919|NCT01436656|65258280|FG011|Dose Escalation|Administrative problems|0|||
23413920|NCT01436656|65258281|FG012|Dose Escalation|Administrative problems|0|||
23413921|NCT01436656|65258282|FG013|Dose Escalation|Administrative problems|0|||
23413922|NCT01436656|65258283|FG014|Dose Escalation|Administrative problems|0|||
23413923|NCT01436656|65258284|FG015|Dose Escalation|Administrative problems|0|||
23413924|NCT01436656|65258285|FG016|Dose Escalation|Administrative problems|0|||
23413925|NCT01436656|65258286|FG017|Dose Escalation|Administrative problems|0|||
23413926|NCT01436656|65258269|FG000|Dose Escalation|Lost to Follow-up|1|||
23413927|NCT01436656|65258270|FG001|Dose Escalation|Lost to Follow-up|0|||
23413928|NCT01436656|65258271|FG002|Dose Escalation|Lost to Follow-up|0|||
23413929|NCT01436656|65258272|FG003|Dose Escalation|Lost to Follow-up|0|||
23413930|NCT01436656|65258273|FG004|Dose Escalation|Lost to Follow-up|1|||
23413931|NCT01436656|65258274|FG005|Dose Escalation|Lost to Follow-up|0|||
23413932|NCT01436656|65258275|FG006|Dose Escalation|Lost to Follow-up|0|||
23413933|NCT01436656|65258276|FG007|Dose Escalation|Lost to Follow-up|0|||
23413934|NCT01436656|65258277|FG008|Dose Escalation|Lost to Follow-up|0|||
23413935|NCT01436656|65258278|FG009|Dose Escalation|Lost to Follow-up|0|||
23413936|NCT01436656|65258279|FG010|Dose Escalation|Lost to Follow-up|0|||
23413937|NCT01436656|65258280|FG011|Dose Escalation|Lost to Follow-up|0|||
23413938|NCT01436656|65258281|FG012|Dose Escalation|Lost to Follow-up|0|||
23413939|NCT01436656|65258282|FG013|Dose Escalation|Lost to Follow-up|0|||
23413940|NCT01436656|65258283|FG014|Dose Escalation|Lost to Follow-up|0|||
23413941|NCT01436656|65258284|FG015|Dose Escalation|Lost to Follow-up|0|||
23413942|NCT01436656|65258285|FG016|Dose Escalation|Lost to Follow-up|0|||
23413943|NCT01436656|65258286|FG017|Dose Escalation|Lost to Follow-up|0|||
23413944|NCT01436656|65258269|FG000|Dose Escalation|New anti-cancer therapy|1|||
23413945|NCT01436656|65258270|FG001|Dose Escalation|New anti-cancer therapy|0|||
23413946|NCT01436656|65258271|FG002|Dose Escalation|New anti-cancer therapy|0|||
23413947|NCT01436656|65258272|FG003|Dose Escalation|New anti-cancer therapy|0|||
23413948|NCT01436656|65258273|FG004|Dose Escalation|New anti-cancer therapy|0|||
23413949|NCT01436656|65258274|FG005|Dose Escalation|New anti-cancer therapy|0|||
23413950|NCT01436656|65258275|FG006|Dose Escalation|New anti-cancer therapy|0|||
23413951|NCT01436656|65258276|FG007|Dose Escalation|New anti-cancer therapy|0|||
23413952|NCT01436656|65258277|FG008|Dose Escalation|New anti-cancer therapy|1|||
23413953|NCT01436656|65258278|FG009|Dose Escalation|New anti-cancer therapy|1|||
23413954|NCT01436656|65258279|FG010|Dose Escalation|New anti-cancer therapy|0|||
23413955|NCT01436656|65258280|FG011|Dose Escalation|New anti-cancer therapy|0|||
23413956|NCT01436656|65258281|FG012|Dose Escalation|New anti-cancer therapy|0|||
23413957|NCT01436656|65258282|FG013|Dose Escalation|New anti-cancer therapy|0|||
23413958|NCT01436656|65258283|FG014|Dose Escalation|New anti-cancer therapy|0|||
23413959|NCT01436656|65258284|FG015|Dose Escalation|New anti-cancer therapy|0|||
23413960|NCT01436656|65258285|FG016|Dose Escalation|New anti-cancer therapy|0|||
23413961|NCT01436656|65258286|FG017|Dose Escalation|New anti-cancer therapy|0|||
23413962|NCT01436656|65258269|FG000|Dose Expansion|Adverse Event|0|||
23413963|NCT01436656|65258270|FG001|Dose Expansion|Adverse Event|0|||
23413964|NCT01436656|65258271|FG002|Dose Expansion|Adverse Event|0|||
23413965|NCT01436656|65258272|FG003|Dose Expansion|Adverse Event|0|||
23413966|NCT01436656|65258273|FG004|Dose Expansion|Adverse Event|0|||
23413967|NCT01436656|65258274|FG005|Dose Expansion|Adverse Event|0|||
23413968|NCT01436656|65258275|FG006|Dose Expansion|Adverse Event|0|||
23413969|NCT01436656|65258276|FG007|Dose Expansion|Adverse Event|0|||
23413970|NCT01436656|65258277|FG008|Dose Expansion|Adverse Event|0|||
23413971|NCT01436656|65258278|FG009|Dose Expansion|Adverse Event|0|||
23413972|NCT01436656|65258279|FG010|Dose Expansion|Adverse Event|0|||
23413973|NCT01436656|65258280|FG011|Dose Expansion|Adverse Event|1|||
23413974|NCT01436656|65258281|FG012|Dose Expansion|Adverse Event|0|||
23413975|NCT01436656|65258282|FG013|Dose Expansion|Adverse Event|0|||
23413976|NCT01436656|65258283|FG014|Dose Expansion|Adverse Event|0|||
23413977|NCT01436656|65258284|FG015|Dose Expansion|Adverse Event|0|||
23413978|NCT01436656|65258285|FG016|Dose Expansion|Adverse Event|0|||
23413979|NCT01436656|65258286|FG017|Dose Expansion|Adverse Event|0|||
23413980|NCT01436656|65258269|FG000|Dose Expansion|Withdrawal by Subject|0|||
23413981|NCT01436656|65258270|FG001|Dose Expansion|Withdrawal by Subject|0|||
23413982|NCT01436656|65258271|FG002|Dose Expansion|Withdrawal by Subject|0|||
23413983|NCT01436656|65258272|FG003|Dose Expansion|Withdrawal by Subject|0|||
23413984|NCT01436656|65258273|FG004|Dose Expansion|Withdrawal by Subject|0|||
23413985|NCT01436656|65258274|FG005|Dose Expansion|Withdrawal by Subject|0|||
23413986|NCT01436656|65258275|FG006|Dose Expansion|Withdrawal by Subject|0|||
23413987|NCT01436656|65258276|FG007|Dose Expansion|Withdrawal by Subject|0|||
23413988|NCT01436656|65258277|FG008|Dose Expansion|Withdrawal by Subject|0|||
23413989|NCT01436656|65258278|FG009|Dose Expansion|Withdrawal by Subject|0|||
23413990|NCT01436656|65258279|FG010|Dose Expansion|Withdrawal by Subject|0|||
23413991|NCT01436656|65258280|FG011|Dose Expansion|Withdrawal by Subject|1|||
23413992|NCT01436656|65258281|FG012|Dose Expansion|Withdrawal by Subject|3|||
23413993|NCT01436656|65258282|FG013|Dose Expansion|Withdrawal by Subject|1|||
23413994|NCT01436656|65258283|FG014|Dose Expansion|Withdrawal by Subject|2|||
23413995|NCT01436656|65258284|FG015|Dose Expansion|Withdrawal by Subject|0|||
23413996|NCT01436656|65258285|FG016|Dose Expansion|Withdrawal by Subject|1|||
23413997|NCT01436656|65258286|FG017|Dose Expansion|Withdrawal by Subject|1|||
23413998|NCT01436656|65258269|FG000|Dose Expansion|Death|0|||
23413999|NCT01436656|65258270|FG001|Dose Expansion|Death|0|||
23414000|NCT01436656|65258271|FG002|Dose Expansion|Death|0|||
23414001|NCT01436656|65258272|FG003|Dose Expansion|Death|0|||
23414002|NCT01436656|65258273|FG004|Dose Expansion|Death|0|||
23414003|NCT01436656|65258274|FG005|Dose Expansion|Death|0|||
23414004|NCT01436656|65258275|FG006|Dose Expansion|Death|0|||
23414005|NCT01436656|65258276|FG007|Dose Expansion|Death|0|||
23414006|NCT01436656|65258277|FG008|Dose Expansion|Death|0|||
23414007|NCT01436656|65258278|FG009|Dose Expansion|Death|0|||
23414008|NCT01436656|65258279|FG010|Dose Expansion|Death|0|||
23414009|NCT01436656|65258280|FG011|Dose Expansion|Death|0|||
23414010|NCT01436656|65258281|FG012|Dose Expansion|Death|1|||
23414011|NCT01436656|65258282|FG013|Dose Expansion|Death|0|||
23414012|NCT01436656|65258283|FG014|Dose Expansion|Death|3|||
23414013|NCT01436656|65258284|FG015|Dose Expansion|Death|0|||
23414014|NCT01436656|65258285|FG016|Dose Expansion|Death|3|||
23414015|NCT01436656|65258286|FG017|Dose Expansion|Death|3|||
23414016|NCT01436656|65258269|FG000|Dose Expansion|Lost to Follow-up|0|||
23414017|NCT01436656|65258270|FG001|Dose Expansion|Lost to Follow-up|0|||
23414018|NCT01436656|65258271|FG002|Dose Expansion|Lost to Follow-up|0|||
23414019|NCT01436656|65258272|FG003|Dose Expansion|Lost to Follow-up|0|||
23414020|NCT01436656|65258273|FG004|Dose Expansion|Lost to Follow-up|0|||
23414021|NCT01436656|65258274|FG005|Dose Expansion|Lost to Follow-up|0|||
23414022|NCT01436656|65258275|FG006|Dose Expansion|Lost to Follow-up|0|||
23414023|NCT01436656|65258276|FG007|Dose Expansion|Lost to Follow-up|0|||
23414024|NCT01436656|65258277|FG008|Dose Expansion|Lost to Follow-up|0|||
23414025|NCT01436656|65258278|FG009|Dose Expansion|Lost to Follow-up|0|||
23414026|NCT01436656|65258279|FG010|Dose Expansion|Lost to Follow-up|0|||
23414027|NCT01436656|65258280|FG011|Dose Expansion|Lost to Follow-up|0|||
23414028|NCT01436656|65258281|FG012|Dose Expansion|Lost to Follow-up|0|||
23414029|NCT01436656|65258282|FG013|Dose Expansion|Lost to Follow-up|0|||
23414030|NCT01436656|65258283|FG014|Dose Expansion|Lost to Follow-up|0|||
23414031|NCT01436656|65258284|FG015|Dose Expansion|Lost to Follow-up|0|||
23414032|NCT01436656|65258285|FG016|Dose Expansion|Lost to Follow-up|0|||
23414033|NCT01436656|65258286|FG017|Dose Expansion|Lost to Follow-up|3|||
23414034|NCT01436656|65258269|FG000|Dose Expansion|Disease progression|0|||
23414035|NCT01436656|65258270|FG001|Dose Expansion|Disease progression|0|||
23414036|NCT01436656|65258271|FG002|Dose Expansion|Disease progression|0|||
23414037|NCT01436656|65258272|FG003|Dose Expansion|Disease progression|0|||
23414038|NCT01436656|65258273|FG004|Dose Expansion|Disease progression|0|||
23414039|NCT01436656|65258274|FG005|Dose Expansion|Disease progression|0|||
23414040|NCT01436656|65258275|FG006|Dose Expansion|Disease progression|0|||
23414041|NCT01436656|65258276|FG007|Dose Expansion|Disease progression|0|||
23414042|NCT01436656|65258277|FG008|Dose Expansion|Disease progression|0|||
23414043|NCT01436656|65258278|FG009|Dose Expansion|Disease progression|0|||
23414044|NCT01436656|65258279|FG010|Dose Expansion|Disease progression|0|||
23414045|NCT01436656|65258280|FG011|Dose Expansion|Disease progression|3|||
23414046|NCT01436656|65258281|FG012|Dose Expansion|Disease progression|1|||
23414047|NCT01436656|65258282|FG013|Dose Expansion|Disease progression|0|||
23414048|NCT01436656|65258283|FG014|Dose Expansion|Disease progression|1|||
23414049|NCT01436656|65258284|FG015|Dose Expansion|Disease progression|0|||
23414050|NCT01436656|65258285|FG016|Dose Expansion|Disease progression|0|||
23414051|NCT01436656|65258286|FG017|Dose Expansion|Disease progression|1|||
23414052|NCT01436656|65258269|FG000|Dose Expansion|New cancer therapy|0|||
23414053|NCT01436656|65258270|FG001|Dose Expansion|New cancer therapy|0|||
23414054|NCT01436656|65258271|FG002|Dose Expansion|New cancer therapy|0|||
23414055|NCT01436656|65258272|FG003|Dose Expansion|New cancer therapy|0|||
23414056|NCT01436656|65258273|FG004|Dose Expansion|New cancer therapy|0|||
23414057|NCT01436656|65258274|FG005|Dose Expansion|New cancer therapy|0|||
23414058|NCT01436656|65258275|FG006|Dose Expansion|New cancer therapy|0|||
23414059|NCT01436656|65258276|FG007|Dose Expansion|New cancer therapy|0|||
23414060|NCT01436656|65258277|FG008|Dose Expansion|New cancer therapy|0|||
23512098|NCT00884312|65612624|FG001|Overall Study|Non-fatal Adverse Event|0|||
23307446|NCT01156142|64870504|FG000|Overall Study|Ineligible|0|||
23414061|NCT01436656|65258278|FG009|Dose Expansion|New cancer therapy|0|||
23414062|NCT01436656|65258279|FG010|Dose Expansion|New cancer therapy|0|||
23414063|NCT01436656|65258280|FG011|Dose Expansion|New cancer therapy|1|||
23414064|NCT01436656|65258281|FG012|Dose Expansion|New cancer therapy|1|||
23414065|NCT01436656|65258282|FG013|Dose Expansion|New cancer therapy|0|||
23414066|NCT01436656|65258283|FG014|Dose Expansion|New cancer therapy|2|||
23414067|NCT01436656|65258284|FG015|Dose Expansion|New cancer therapy|0|||
23414068|NCT01436656|65258285|FG016|Dose Expansion|New cancer therapy|0|||
23414069|NCT01436656|65258286|FG017|Dose Expansion|New cancer therapy|0|||
23414070|NCT03206970|65258302|FG000|Overall Study|Death|21|||
23414071|NCT03206970|65258302|FG000|Overall Study|Withdrawal by Subject|13|||
23414072|NCT03206970|65258302|FG000|Overall Study|Lost to Follow-up|3|||
23414073|NCT03206970|65258302|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
23610672|NCT00596960|65962850|FG001|Overall Study|Incarcerated|0|||
23610673|NCT00596960|65962849|FG000|Overall Study|Physician Decision|1|||
23610674|NCT00596960|65962850|FG001|Overall Study|Physician Decision|0|||
23610675|NCT00596960|65962849|FG000|Overall Study|Protocol Violation|0|||
23610676|NCT00596960|65962850|FG001|Overall Study|Protocol Violation|1|||
23610677|NCT00596960|65962849|FG000|Overall Study|No alcohol use data|0|||
23610678|NCT00596960|65962850|FG001|Overall Study|No alcohol use data|1|||
23610679|NCT01399905|65962851|FG000|Overall Study|Withdrawal by Subject|1|||
23610680|NCT01399905|65962852|FG001|Overall Study|Withdrawal by Subject|1|||
23610681|NCT02092909|65962870|FG000|Overall Study|Adverse Event|0|||
23610682|NCT02092909|65962871|FG001|Overall Study|Adverse Event|0|||
23610683|NCT02092909|65962872|FG002|Overall Study|Adverse Event|4|||
23610684|NCT02092909|65962873|FG003|Overall Study|Adverse Event|2|||
23610685|NCT02092909|65962870|FG000|Overall Study|Lack of Efficacy|0|||
23610686|NCT02092909|65962871|FG001|Overall Study|Lack of Efficacy|2|||
23610687|NCT02092909|65962872|FG002|Overall Study|Lack of Efficacy|1|||
23610688|NCT02092909|65962873|FG003|Overall Study|Lack of Efficacy|0|||
23610689|NCT02092909|65962870|FG000|Overall Study|Withdrawal by Subject|0|||
23610690|NCT02092909|65962871|FG001|Overall Study|Withdrawal by Subject|0|||
23610691|NCT02092909|65962872|FG002|Overall Study|Withdrawal by Subject|2|||
23610692|NCT02092909|65962873|FG003|Overall Study|Withdrawal by Subject|1|||
23610693|NCT02092909|65962870|FG000|Overall Study|Study terminated by Sponsor|0|||
23414096|NCT04551963|65258305|FG000|Overall Study|Physician Decision|1|||
23414097|NCT04551963|65258306|FG001|Overall Study|Physician Decision|1|||
23414098|NCT04551963|65258305|FG000|Overall Study|Death|1|||
23414099|NCT04551963|65258306|FG001|Overall Study|Death|0|||
23414100|NCT03379259|65258307|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
23414101|NCT03379259|65258308|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
23414102|NCT03379259|65258309|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
23414103|NCT03379259|65258310|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
23414104|NCT03379259|65258311|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
23414105|NCT03379259|65258312|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
23414106|NCT03379259|65258307|FG000|Overall Study|Death|0|||
23414107|NCT03379259|65258308|FG001|Overall Study|Death|1|||
23414108|NCT03379259|65258309|FG002|Overall Study|Death|2|||
23414109|NCT03379259|65258310|FG003|Overall Study|Death|1|||
23414110|NCT03379259|65258311|FG004|Overall Study|Death|4|||
23414111|NCT03379259|65258312|FG005|Overall Study|Death|2|||
23414112|NCT03379259|65258307|FG000|Overall Study|Withdrawal by Subject|0|||
23414113|NCT03379259|65258308|FG001|Overall Study|Withdrawal by Subject|0|||
23414114|NCT03379259|65258309|FG002|Overall Study|Withdrawal by Subject|1|||
23414115|NCT03379259|65258310|FG003|Overall Study|Withdrawal by Subject|0|||
23414116|NCT03379259|65258311|FG004|Overall Study|Withdrawal by Subject|2|||
23414117|NCT03379259|65258312|FG005|Overall Study|Withdrawal by Subject|0|||
23414118|NCT03379259|65258307|FG000|Overall Study|Study terminated by sponsor|0|||
23414119|NCT03379259|65258308|FG001|Overall Study|Study terminated by sponsor|0|||
23414120|NCT03379259|65258309|FG002|Overall Study|Study terminated by sponsor|0|||
23414121|NCT03379259|65258310|FG003|Overall Study|Study terminated by sponsor|1|||
23414122|NCT03379259|65258311|FG004|Overall Study|Study terminated by sponsor|1|||
23414123|NCT03379259|65258312|FG005|Overall Study|Study terminated by sponsor|4|||
23414124|NCT03379259|65258307|FG000|Overall Study|Disease progression|0|||
23414125|NCT03379259|65258308|FG001|Overall Study|Disease progression|0|||
23414126|NCT03379259|65258309|FG002|Overall Study|Disease progression|0|||
23414127|NCT03379259|65258310|FG003|Overall Study|Disease progression|1|||
23414128|NCT03379259|65258311|FG004|Overall Study|Disease progression|0|||
23414129|NCT03379259|65258312|FG005|Overall Study|Disease progression|1|||
23512099|NCT00884312|65612623|FG000|Overall Study|Fatal Adverse Event|1|||
23512100|NCT00884312|65612624|FG001|Overall Study|Fatal Adverse Event|4|||
23414130|NCT03379259|65258307|FG000|Overall Study|Lost to Follow-up|0|||
23414131|NCT03379259|65258308|FG001|Overall Study|Lost to Follow-up|0|||
23414132|NCT03379259|65258309|FG002|Overall Study|Lost to Follow-up|0|||
23414133|NCT03379259|65258310|FG003|Overall Study|Lost to Follow-up|0|||
23414134|NCT03379259|65258311|FG004|Overall Study|Lost to Follow-up|1|||
23414135|NCT03379259|65258312|FG005|Overall Study|Lost to Follow-up|0|||
23414136|NCT03379259|65258307|FG000|Overall Study|Deteriorating condition|0|||
23610694|NCT02092909|65962871|FG001|Overall Study|Study terminated by Sponsor|0|||
23610695|NCT02092909|65962872|FG002|Overall Study|Study terminated by Sponsor|0|||
23610696|NCT02092909|65962873|FG003|Overall Study|Study terminated by Sponsor|2|||
23610697|NCT02092909|65962870|FG000|Overall Study|Miscellaneous|1|||
23414137|NCT03379259|65258308|FG001|Overall Study|Deteriorating condition|0|||
23307447|NCT01156142|64870505|FG001|Overall Study|Ineligible|1|||
23307448|NCT01602965|64870507|FG000|Overall Study|Lost to Follow-up|4|||
23307449|NCT01602965|64870508|FG001|Overall Study|Lost to Follow-up|2|||
23307450|NCT00540293|64870509|FG000|Overall Study|Adverse event related to study drug|10|||
23307451|NCT00540293|64870509|FG000|Overall Study|Adverse event not related to study drug|7|||
23307452|NCT00540293|64870509|FG000|Overall Study|Withdrawal by Subject|6|||
23307453|NCT00540293|64870509|FG000|Overall Study|Protocol violation, & subject schedule|12|||
23307454|NCT04625725|64870510|FG000|Overall Study|Adverse Event|2|||
23307455|NCT04625725|64870511|FG001|Overall Study|Adverse Event|1|||
23307456|NCT04625725|64870510|FG000|Overall Study|Death|22|||
23307457|NCT04625725|64870511|FG001|Overall Study|Death|10|||
23307458|NCT04625725|64870510|FG000|Overall Study|Lost to Follow-up|357|||
23307459|NCT04625725|64870511|FG001|Overall Study|Lost to Follow-up|200|||
23307460|NCT04625725|64870510|FG000|Overall Study|Dosed in sub-study|310|||
23307461|NCT04625725|64870511|FG001|Overall Study|Dosed in sub-study|193|||
23307462|NCT04625725|64870510|FG000|Overall Study|Physician Decision|5|||
23307463|NCT04625725|64870511|FG001|Overall Study|Physician Decision|0|||
23307464|NCT04625725|64870510|FG000|Overall Study|Protocol Violation|1|||
23307465|NCT04625725|64870511|FG001|Overall Study|Protocol Violation|0|||
23307466|NCT04625725|64870510|FG000|Overall Study|Withdrawal by Subject|242|||
23307467|NCT04625725|64870511|FG001|Overall Study|Withdrawal by Subject|144|||
23307468|NCT04625725|64870510|FG000|Overall Study|Not specified otherwise|31|||
23307469|NCT04625725|64870511|FG001|Overall Study|Not specified otherwise|9|||
23307470|NCT04625725|64870510|FG000|Overall Study|Missing|0|||
23307471|NCT04625725|64870511|FG001|Overall Study|Missing|1|||
23307472|NCT01996332|64870512|FG000|Overall Study|Adverse Event|117|||
23307473|NCT01996332|64870512|FG000|Overall Study|Lack of Efficacy|1245|||
23307474|NCT01996332|64870512|FG000|Overall Study|Death|264|||
23307475|NCT01996332|64870512|FG000|Overall Study|Protocol Violation|9|||
23307476|NCT01996332|64870512|FG000|Overall Study|Withdrawal by Subject|71|||
23307477|NCT01996332|64870512|FG000|Overall Study|Other|20|||
23307478|NCT01996332|64870512|FG000|Overall Study|Clinical Deterioration|28|||
23307479|NCT01996332|64870512|FG000|Overall Study|Physician Decision|17|||
23307480|NCT01996332|64870512|FG000|Overall Study|Lost to Follow-up|34|||
23307481|NCT03321630|64870513|FG000|Overall Study|Adverse Event|1|||
23307482|NCT03321630|64870513|FG000|Overall Study|Investigator Discretion|2|||
23307483|NCT03321630|64870513|FG000|Overall Study|Withdrawal by Subject|1|||
23307484|NCT04663295|64870514|FG000|Run-in Period|Withdrawal by Subject|3|||
23307485|NCT04663295|64870514|FG000|Overall Study Period|Pregnancy|1|||
23307486|NCT04663295|64870514|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
23307487|NCT03255655|64870516|FG000|Overall Study|Lost to Follow-up|7|||
23307488|NCT03255655|64870517|FG001|Overall Study|Lost to Follow-up|4|||
23307489|NCT02585934|64870529|FG000|Overall Study|Lost to Follow-up|2|||
23307490|NCT02585934|64870530|FG001|Overall Study|Lost to Follow-up|2|||
23307491|NCT02585934|64870529|FG000|Overall Study|Protocol Violation|14|||
23307492|NCT02585934|64870530|FG001|Overall Study|Protocol Violation|11|||
23307493|NCT02585934|64870529|FG000|Overall Study|Adverse Event|21|||
23307494|NCT02585934|64870530|FG001|Overall Study|Adverse Event|22|||
23307495|NCT02585934|64870529|FG000|Overall Study|Physician Decision|3|||
23307496|NCT02585934|64870530|FG001|Overall Study|Physician Decision|2|||
23307497|NCT02585934|64870529|FG000|Overall Study|Withdrawal by Subject|7|||
23307498|NCT02585934|64870530|FG001|Overall Study|Withdrawal by Subject|21|||
23307499|NCT02585934|64870529|FG000|Overall Study|Lack of Efficacy|2|||
23414138|NCT03379259|65258309|FG002|Overall Study|Deteriorating condition|0|||
23307500|NCT02585934|64870530|FG001|Overall Study|Lack of Efficacy|1|||
23307501|NCT02585934|64870529|FG000|Overall Study|Death|2|||
23307502|NCT02585934|64870530|FG001|Overall Study|Death|0|||
23307503|NCT02585934|64870529|FG000|Overall Study|Caregiver Withdrew Consent|7|||
23307504|NCT02585934|64870530|FG001|Overall Study|Caregiver Withdrew Consent|7|||
23307505|NCT02585934|64870529|FG000|Overall Study|Sponsor Termination|1|||
23307506|NCT02585934|64870530|FG001|Overall Study|Sponsor Termination|2|||
23307507|NCT02585934|64870529|FG000|Overall Study|Another Reason|10|||
23414139|NCT03379259|65258310|FG003|Overall Study|Deteriorating condition|0|||
23414140|NCT03379259|65258311|FG004|Overall Study|Deteriorating condition|1|||
23414141|NCT03379259|65258312|FG005|Overall Study|Deteriorating condition|0|||
23414142|NCT03332173|65258313|FG000|Overall Study|Death|7|||
23414143|NCT03332173|65258313|FG000|Overall Study|Withdrawal by Subject|6|||
23414144|NCT03332173|65258313|FG000|Overall Study|Lost to Follow-up|2|||
23414145|NCT03332173|65258313|FG000|Overall Study|Transferred to long-term extension study|29|||
23414146|NCT02152982|65258314|FG000|Overall Study|Ineligible|4|||
23414147|NCT02152982|65258315|FG001|Overall Study|Ineligible|4|||
23414148|NCT02152982|65258314|FG000|Overall Study|Did not start treatment|12|||
23414149|NCT02152982|65258315|FG001|Overall Study|Did not start treatment|6|||
23414150|NCT00748618|65258318|FG000|Overall Study|Adverse Event|1|||
23414151|NCT00748618|65258319|FG001|Overall Study|Adverse Event|0|||
23414152|NCT05507567|65258322|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
23414153|NCT05507567|65258323|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
23414154|NCT05507567|65258324|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
23414155|NCT05507567|65258322|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
23414156|NCT05507567|65258323|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
23414157|NCT05507567|65258324|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
23414158|NCT05507567|65258322|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
23414159|NCT05507567|65258323|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
23414160|NCT05507567|65258324|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
23512101|NCT00884312|65612623|FG000|Overall Study|Withdrawal by Subject|0|||
23512102|NCT00884312|65612624|FG001|Overall Study|Withdrawal by Subject|6|||
23512103|NCT00884312|65612623|FG000|Overall Study|Physician Decision|0|||
23512104|NCT00884312|65612624|FG001|Overall Study|Physician Decision|1|||
23512105|NCT00884312|65612623|FG000|Overall Study|Other|0|||
23512106|NCT00884312|65612624|FG001|Overall Study|Other|4|||
23512107|NCT00884312|65612623|FG000|Overall Study|Did Not Receive Study Drug|0|||
23512108|NCT00884312|65612624|FG001|Overall Study|Did Not Receive Study Drug|1|||
23512109|NCT04044716|65612627|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
23512110|NCT04044716|65612628|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
23512111|NCT04044716|65612629|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
23512112|NCT04044716|65612627|FG000|Overall Study|Lost to Follow-up|2|||
23512113|NCT04044716|65612628|FG001|Overall Study|Lost to Follow-up|3|||
23512114|NCT04044716|65612629|FG002|Overall Study|Lost to Follow-up|0|||
23512115|NCT03358290|65612636|FG000|Overall Study|Study discontinued by Sponsor|0|||
23512116|NCT03358290|65612637|FG001|Overall Study|Study discontinued by Sponsor|1|||
23512117|NCT03358290|65612638|FG002|Overall Study|Study discontinued by Sponsor|1|||
23512118|NCT03358290|65612639|FG003|Overall Study|Study discontinued by Sponsor|0|||
23512119|NCT03358290|65612640|FG004|Overall Study|Study discontinued by Sponsor|0|||
23512120|NCT03358290|65612636|FG000|Overall Study|Adverse Event|0|||
23512121|NCT03358290|65612637|FG001|Overall Study|Adverse Event|0|||
23512122|NCT03358290|65612638|FG002|Overall Study|Adverse Event|1|||
23512123|NCT03358290|65612639|FG003|Overall Study|Adverse Event|2|||
23512124|NCT03358290|65612640|FG004|Overall Study|Adverse Event|0|||
23512125|NCT03358290|65612636|FG000|Overall Study|Withdrawal by Subject|0|||
23512126|NCT03358290|65612637|FG001|Overall Study|Withdrawal by Subject|0|||
23512127|NCT03358290|65612638|FG002|Overall Study|Withdrawal by Subject|0|||
23512128|NCT03358290|65612639|FG003|Overall Study|Withdrawal by Subject|0|||
23512129|NCT03358290|65612640|FG004|Overall Study|Withdrawal by Subject|1|||
23512130|NCT00710710|65612641|FG000|Overall Study|Consent withdrawn|2|||
23512131|NCT00710710|65612642|FG001|Overall Study|Consent withdrawn|2|||
23512132|NCT00710710|65612641|FG000|Overall Study|Protocol Violation|0|||
23512133|NCT00710710|65612642|FG001|Overall Study|Protocol Violation|1|||
23512134|NCT00710710|65612641|FG000|Overall Study|Adverse Event|3|||
23512135|NCT00710710|65612642|FG001|Overall Study|Adverse Event|3|||
23512136|NCT00710710|65612641|FG000|Overall Study|Progressive disease|40|||
23512137|NCT00710710|65612642|FG001|Overall Study|Progressive disease|38|||
23414161|NCT05507567|65258322|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
23414162|NCT05507567|65258323|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
23414163|NCT05507567|65258324|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
23414164|NCT02921230|65258325|FG000|Overall Study|Withdrawal by Subject|20|||
23414165|NCT02921230|65258326|FG001|Overall Study|Withdrawal by Subject|8|||
23414166|NCT02921230|65258325|FG000|Overall Study|Death|12|||
23414167|NCT02921230|65258326|FG001|Overall Study|Death|3|||
23414168|NCT02921230|65258325|FG000|Overall Study|Protocol Violation|17|||
23414169|NCT02921230|65258326|FG001|Overall Study|Protocol Violation|6|||
23414170|NCT02921230|65258325|FG000|Overall Study|Early completion|5|||
23414171|NCT02921230|65258326|FG001|Overall Study|Early completion|1|||
23414172|NCT02921230|65258325|FG000|Overall Study|Pending data entry|1|||
23414173|NCT02921230|65258326|FG001|Overall Study|Pending data entry|0|||
23414174|NCT03520920|65258337|FG000|Overall Study|Death|13|||
23414175|NCT03520920|65258338|FG001|Overall Study|Death|1|||
23414176|NCT03520920|65258339|FG002|Overall Study|Death|0|||
23414177|NCT03520920|65258337|FG000|Overall Study|Withdrawal by Subject|2|||
23414178|NCT03520920|65258338|FG001|Overall Study|Withdrawal by Subject|1|||
23414179|NCT03520920|65258339|FG002|Overall Study|Withdrawal by Subject|0|||
23414180|NCT03520920|65258337|FG000|Overall Study|Study Terminated by the Sponsor|5|||
23414181|NCT03520920|65258338|FG001|Overall Study|Study Terminated by the Sponsor|14|||
23414182|NCT03520920|65258339|FG002|Overall Study|Study Terminated by the Sponsor|5|||
23414183|NCT01708941|65258341|FG000|Overall Study|Adverse Event|4|||
23414184|NCT01708941|65258342|FG001|Overall Study|Adverse Event|6|||
23414185|NCT01708941|65258343|FG002|Overall Study|Adverse Event|1|||
23414186|NCT01708941|65258344|FG003|Overall Study|Adverse Event|0|||
23414187|NCT01708941|65258341|FG000|Overall Study|Death|1|||
23414188|NCT01708941|65258342|FG001|Overall Study|Death|1|||
23414189|NCT01708941|65258343|FG002|Overall Study|Death|2|||
23414190|NCT01708941|65258344|FG003|Overall Study|Death|14|||
23414191|NCT01708941|65258341|FG000|Overall Study|Withdrawal by Subject|1|||
23414192|NCT01708941|65258342|FG001|Overall Study|Withdrawal by Subject|0|||
23414193|NCT01708941|65258343|FG002|Overall Study|Withdrawal by Subject|3|||
23414194|NCT01708941|65258344|FG003|Overall Study|Withdrawal by Subject|4|||
23414195|NCT01708941|65258341|FG000|Overall Study|Disease progression|9|||
23414196|NCT01708941|65258342|FG001|Overall Study|Disease progression|10|||
23414197|NCT01708941|65258343|FG002|Overall Study|Disease progression|8|||
23414198|NCT01708941|65258344|FG003|Overall Study|Disease progression|0|||
23414199|NCT01708941|65258341|FG000|Overall Study|Alternative therapy|0|||
23414200|NCT01708941|65258342|FG001|Overall Study|Alternative therapy|0|||
23414201|NCT01708941|65258343|FG002|Overall Study|Alternative therapy|2|||
23414202|NCT01708941|65258344|FG003|Overall Study|Alternative therapy|0|||
23414203|NCT01708941|65258341|FG000|Overall Study|Ineligible and never started treatment|1|||
23414204|NCT01708941|65258342|FG001|Overall Study|Ineligible and never started treatment|0|||
23414205|NCT01708941|65258343|FG002|Overall Study|Ineligible and never started treatment|1|||
23414206|NCT01708941|65258344|FG003|Overall Study|Ineligible and never started treatment|0|||
23414207|NCT01708941|65258341|FG000|Overall Study|Never started treatment|2|||
23414208|NCT01708941|65258342|FG001|Overall Study|Never started treatment|1|||
23414209|NCT01708941|65258343|FG002|Overall Study|Never started treatment|0|||
23414210|NCT01708941|65258344|FG003|Overall Study|Never started treatment|0|||
23414211|NCT01708941|65258341|FG000|Overall Study|Ineligible|0|||
23414212|NCT01708941|65258342|FG001|Overall Study|Ineligible|0|||
23414213|NCT01708941|65258343|FG002|Overall Study|Ineligible|2|||
23414214|NCT01708941|65258344|FG003|Overall Study|Ineligible|0|||
23414215|NCT01575548|65258345|FG000|Overall Study|Adverse Event|15|||
23414216|NCT01575548|65258346|FG001|Overall Study|Adverse Event|2|||
23414217|NCT01575548|65258345|FG000|Overall Study|Disease progression|12|||
23414218|NCT01575548|65258346|FG001|Overall Study|Disease progression|25|||
23414219|NCT01575548|65258345|FG000|Overall Study|Death|1|||
23414220|NCT01575548|65258346|FG001|Overall Study|Death|0|||
23414221|NCT01575548|65258345|FG000|Overall Study|Other complicating disease|1|||
23414222|NCT01575548|65258346|FG001|Overall Study|Other complicating disease|0|||
23414223|NCT01575548|65258345|FG000|Overall Study|Withdrawal by Subject|7|||
23414224|NCT01575548|65258346|FG001|Overall Study|Withdrawal by Subject|3|||
23414225|NCT01575548|65258345|FG000|Overall Study|Noncompliance|1|||
23414226|NCT01575548|65258346|FG001|Overall Study|Noncompliance|0|||
23414227|NCT01575548|65258345|FG000|Overall Study|Anticipated surgery|0|||
23414228|NCT01575548|65258346|FG001|Overall Study|Anticipated surgery|1|||
23414229|NCT01575548|65258345|FG000|Overall Study|Never started protocol therapy|3|||
23414230|NCT01575548|65258346|FG001|Overall Study|Never started protocol therapy|2|||
23414231|NCT05027971|65258347|FG000|Overall Study|Physician Decision|7|||
23414232|NCT05027971|65258348|FG001|Overall Study|Physician Decision|3|||
23414233|NCT05027971|65258347|FG000|Overall Study|Lost to Follow-up|1|||
23414234|NCT05027971|65258348|FG001|Overall Study|Lost to Follow-up|1|||
23414235|NCT05027971|65258347|FG000|Overall Study|Withdrawal by Subject|0|||
23414236|NCT05027971|65258348|FG001|Overall Study|Withdrawal by Subject|2|||
23414237|NCT05027971|65258347|FG000|Overall Study|Non-study fiber used.|0|||
23414238|NCT05027971|65258348|FG001|Overall Study|Non-study fiber used.|1|||
23414239|NCT05027971|65258347|FG000|Overall Study|Protocol Violation|0|||
23414240|NCT05027971|65258348|FG001|Overall Study|Protocol Violation|2|||
23414241|NCT04952597|65258349|FG000|Overall Study|Death|12|||
23414242|NCT04952597|65258350|FG001|Overall Study|Death|13|||
23414243|NCT04952597|65258351|FG002|Overall Study|Death|14|||
23414244|NCT04952597|65258349|FG000|Overall Study|Withdrawal by Subject|1|||
23414245|NCT04952597|65258350|FG001|Overall Study|Withdrawal by Subject|0|||
23414246|NCT04952597|65258351|FG002|Overall Study|Withdrawal by Subject|3|||
23414247|NCT04952597|65258349|FG000|Overall Study|Lost to Follow-up|0|||
23414248|NCT04952597|65258350|FG001|Overall Study|Lost to Follow-up|1|||
23414249|NCT04952597|65258351|FG002|Overall Study|Lost to Follow-up|1|||
23414250|NCT03983382|65258355|FG000|Overall Study|Death|1|||
23414251|NCT03983382|65258355|FG000|Overall Study|Lost to Follow-up|3|||
23414252|NCT03983382|65258355|FG000|Overall Study|Physician Decision|2|||
23414253|NCT03983382|65258355|FG000|Overall Study|Withdrawal by Subject|10|||
23414254|NCT03983382|65258355|FG000|Overall Study|Change in cancer treatment|2|||
23610698|NCT02092909|65962871|FG001|Overall Study|Miscellaneous|1|||
23610699|NCT02092909|65962872|FG002|Overall Study|Miscellaneous|2|||
23610700|NCT02092909|65962873|FG003|Overall Study|Miscellaneous|1|||
23610701|NCT00157209|65962874|FG000|Overall Study|Ongoing at data cut-off|10|||
23610702|NCT00157209|65962875|FG001|Overall Study|Ongoing at data cut-off|0|||
23610703|NCT00390806|65962876|FG000|Overall Study|Lost to Follow-up|7|||
23610704|NCT00390806|65962877|FG001|Overall Study|Lost to Follow-up|6|||
23512138|NCT03266107|65612643|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
23512139|NCT03266107|65612643|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
23512140|NCT03266107|65612643|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
23512141|NCT03266107|65612643|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
23512142|NCT01601626|65612646|FG000|Overall Study|Death|1|||
23512143|NCT01601626|65612647|FG001|Overall Study|Death|1|||
23512144|NCT01601626|65612648|FG002|Overall Study|Death|1|||
23512145|NCT01601626|65612646|FG000|Overall Study|Lost to Follow-up|1|||
23512146|NCT01601626|65612647|FG001|Overall Study|Lost to Follow-up|2|||
23512147|NCT01601626|65612648|FG002|Overall Study|Lost to Follow-up|0|||
23610705|NCT00390806|65962876|FG000|Overall Study|Protocol Violation|2|||
23610706|NCT00390806|65962877|FG001|Overall Study|Protocol Violation|2|||
23610707|NCT00390806|65962876|FG000|Overall Study|Withdrawal by Subject|12|||
23610708|NCT00390806|65962877|FG001|Overall Study|Withdrawal by Subject|15|||
23610709|NCT00390806|65962876|FG000|Overall Study|Investigator Decision|4|||
23610710|NCT00390806|65962877|FG001|Overall Study|Investigator Decision|6|||
23610711|NCT00390806|65962876|FG000|Overall Study|Death|1|||
23610712|NCT00390806|65962877|FG001|Overall Study|Death|0|||
23610713|NCT00390806|65962876|FG000|Overall Study|Physician Decision|0|||
23610714|NCT00390806|65962877|FG001|Overall Study|Physician Decision|1|||
23610715|NCT00390806|65962876|FG000|Overall Study|Ongoing|4|||
23610716|NCT00390806|65962877|FG001|Overall Study|Ongoing|2|||
23610717|NCT01207453|65962883|FG000|First Intervention|Adverse Event|2|||
23610718|NCT01207453|65962884|FG001|First Intervention|Adverse Event|1|||
23610719|NCT01207453|65962883|FG000|Washout|Adverse Event|1|||
23610720|NCT01207453|65962884|FG001|Washout|Adverse Event|0|||
23610721|NCT01207453|65962883|FG000|Washout|Lost to Follow-up|1|||
23610722|NCT01207453|65962884|FG001|Washout|Lost to Follow-up|0|||
23610723|NCT01207453|65962883|FG000|2nd Intervention|Adverse Event|1|||
23610724|NCT01207453|65962884|FG001|2nd Intervention|Adverse Event|2|||
23610725|NCT01207453|65962883|FG000|2nd Intervention|Lost to Follow-up|1|||
23610726|NCT01207453|65962884|FG001|2nd Intervention|Lost to Follow-up|0|||
23610727|NCT02037568|65962888|FG000|Overall Study|Withdrawal by Subject|17|||
23610728|NCT02037568|65962889|FG001|Overall Study|Withdrawal by Subject|24|||
23610729|NCT02037568|65962888|FG000|Overall Study|Lost to Follow-up|16|||
23512148|NCT01601626|65612646|FG000|Overall Study|Unable to Get to Clinic|0|||
23512149|NCT01601626|65612647|FG001|Overall Study|Unable to Get to Clinic|1|||
23610730|NCT02037568|65962889|FG001|Overall Study|Lost to Follow-up|13|||
23610731|NCT02037568|65962888|FG000|Overall Study|Screen Failure|3|||
23610732|NCT02037568|65962889|FG001|Overall Study|Screen Failure|1|||
23610733|NCT02037568|65962888|FG000|Overall Study|Patient did not receive transplant|0|||
23610734|NCT02037568|65962889|FG001|Overall Study|Patient did not receive transplant|1|||
23610735|NCT01732757|65962890|FG000|Overall Study|Lost to Follow-up|1|||
23610736|NCT01732757|65962891|FG001|Overall Study|Lost to Follow-up|0|||
23610737|NCT01732757|65962892|FG002|Overall Study|Lost to Follow-up|0|||
23414295|NCT01708954|65258360|FG000|Step 1|Disease progression|26|||
23414296|NCT01708954|65258361|FG001|Step 1|Disease progression|17|||
23414297|NCT01708954|65258362|FG002|Step 1|Disease progression|14|||
23414298|NCT01708954|65258360|FG000|Step 1|Adverse Event|3|||
23414299|NCT01708954|65258361|FG001|Step 1|Adverse Event|11|||
23414300|NCT01708954|65258362|FG002|Step 1|Adverse Event|13|||
23414301|NCT01708954|65258360|FG000|Step 1|Death|3|||
23414302|NCT01708954|65258361|FG001|Step 1|Death|2|||
23414303|NCT01708954|65258362|FG002|Step 1|Death|3|||
23512150|NCT01601626|65612648|FG002|Overall Study|Unable to Get to Clinic|0|||
23512151|NCT01601626|65612646|FG000|Overall Study|Withdrawal by Subject|0|||
23512152|NCT01601626|65612647|FG001|Overall Study|Withdrawal by Subject|1|||
23414304|NCT01708954|65258360|FG000|Step 1|Withdrawal by Subject|2|||
23414305|NCT01708954|65258361|FG001|Step 1|Withdrawal by Subject|5|||
23414306|NCT01708954|65258362|FG002|Step 1|Withdrawal by Subject|3|||
23414307|NCT01708954|65258360|FG000|Step 1|Other complicating disease|0|||
23414308|NCT01708954|65258361|FG001|Step 1|Other complicating disease|2|||
23414309|NCT01708954|65258362|FG002|Step 1|Other complicating disease|0|||
23414310|NCT01708954|65258360|FG000|Step 1|Crossed over to Step 2|2|||
23414311|NCT01708954|65258361|FG001|Step 1|Crossed over to Step 2|0|||
23414312|NCT01708954|65258362|FG002|Step 1|Crossed over to Step 2|0|||
23414313|NCT01708954|65258360|FG000|Step 1|Symptomatic deterioration|1|||
23414314|NCT01708954|65258361|FG001|Step 1|Symptomatic deterioration|0|||
23414315|NCT01708954|65258362|FG002|Step 1|Symptomatic deterioration|1|||
23414316|NCT01708954|65258360|FG000|Step 1|Off-treatment reason not submitted|1|||
23414317|NCT01708954|65258361|FG001|Step 1|Off-treatment reason not submitted|1|||
23414318|NCT01708954|65258362|FG002|Step 1|Off-treatment reason not submitted|1|||
23414319|NCT01708954|65258360|FG000|Step 1|Ineligible or never received treatment|4|||
23414320|NCT01708954|65258361|FG001|Step 1|Ineligible or never received treatment|2|||
23414321|NCT01708954|65258362|FG002|Step 1|Ineligible or never received treatment|8|||
23414322|NCT01708954|65258360|FG000|Step 2|Disease progression|9|||
23414323|NCT01708954|65258361|FG001|Step 2|Disease progression|4|||
23414324|NCT01708954|65258362|FG002|Step 2|Disease progression|0|||
23414325|NCT01708954|65258360|FG000|Step 2|Adverse Event|3|||
23414326|NCT01708954|65258361|FG001|Step 2|Adverse Event|2|||
23414327|NCT01708954|65258362|FG002|Step 2|Adverse Event|0|||
23414328|NCT01708954|65258360|FG000|Step 2|Withdrawal by Subject|1|||
23414329|NCT01708954|65258361|FG001|Step 2|Withdrawal by Subject|1|||
23414330|NCT01708954|65258362|FG002|Step 2|Withdrawal by Subject|0|||
23610738|NCT01288729|65962897|FG000|Overall Study|Withdrawal by Subject|1|||
23610739|NCT01288729|65962898|FG001|Overall Study|Withdrawal by Subject|0|||
23610740|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
23610741|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23610742|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23610743|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23610744|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
23610745|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23610746|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23610747|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23512153|NCT01601626|65612648|FG002|Overall Study|Withdrawal by Subject|1|||
23512154|NCT01601626|65612646|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
23512155|NCT01601626|65612647|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
23512156|NCT01601626|65612648|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
23512157|NCT03235154|65612649|FG000|Overall Study|Withdrawal by Subject|1|||
23512158|NCT03235154|65612649|FG000|Overall Study|Adverse Event|1|||
23512159|NCT03235154|65612649|FG000|Overall Study|Lost to Follow-up|2|||
23512160|NCT02759471|65612654|FG000|Overall Study|discomfort|2|||
23512161|NCT04350788|65612657|FG000|Overall Study|Lost to Follow-up|6|||
23512162|NCT04350788|65612658|FG001|Overall Study|Lost to Follow-up|2|||
23512163|NCT04350788|65612657|FG000|Overall Study|Withdrawal by Subject|2|||
23512164|NCT04350788|65612658|FG001|Overall Study|Withdrawal by Subject|4|||
23512165|NCT04350788|65612657|FG000|Overall Study|Protocol Violation|4|||
23512166|NCT04350788|65612658|FG001|Overall Study|Protocol Violation|0|||
23512167|NCT03489720|65612659|FG000|Overall Study|Withdrawal by Subject|2|||
23512168|NCT03489720|65612660|FG001|Overall Study|Withdrawal by Subject|0|||
23512169|NCT02154490|65612661|FG000|Overall Study|No tissue submitted|23|||
23512170|NCT02154490|65612661|FG000|Overall Study|No biomarker results|167|||
23512171|NCT02154490|65612661|FG000|Overall Study|Not assigned to a sub-study|270|||
23512172|NCT02154490|65612661|FG000|Overall Study|Did not register to a sub-study|749|||
23610748|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
23610749|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23610750|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23610751|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23610752|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
23610753|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23512173|NCT03934931|65612663|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
23512174|NCT03934931|65612664|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
23307508|NCT02585934|64870530|FG001|Overall Study|Another Reason|5|||
23610754|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23610755|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23610756|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
23610757|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23610758|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23512175|NCT03934931|65612665|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
23512176|NCT04059094|65612666|FG000|Overall Study|Adverse Event|0|||
23512177|NCT04059094|65612667|FG001|Overall Study|Adverse Event|0|||
23610759|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23610760|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
23610761|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23610762|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23610763|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23610764|NCT01185340|65962899|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
23610765|NCT01185340|65962900|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23610766|NCT01185340|65962901|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23610767|NCT01185340|65962902|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23610768|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
23610769|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
23610770|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
23610771|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
23610772|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
23610773|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
23512178|NCT04059094|65612668|FG002|Overall Study|Adverse Event|0|||
23512179|NCT04059094|65612669|FG003|Overall Study|Adverse Event|0|||
23512180|NCT04059094|65612670|FG004|Overall Study|Adverse Event|1|||
23512181|NCT04059094|65612666|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
23512182|NCT04059094|65612667|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
23512183|NCT04059094|65612668|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
23512184|NCT04059094|65612669|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
23512185|NCT04059094|65612670|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
23610774|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
23610775|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
23610776|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
23610777|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
23610778|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
23610779|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
23610780|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23610781|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
23610782|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23610783|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
23610784|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
23610785|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23610786|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
23610787|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23610788|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
23610789|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
23610790|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
23610791|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
23610792|NCT01185340|65962899|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23610793|NCT01185340|65962900|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23610794|NCT01185340|65962901|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
23610795|NCT01185340|65962902|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
23610796|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
23610797|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
23610798|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
23610799|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
23512186|NCT01463878|65612671|FG000|Overall Study|no longer met criteria for tube feed|2|||
23512187|NCT01463878|65612672|FG001|Overall Study|no longer met criteria for tube feed|2|||
23512188|NCT03182829|65612673|FG000|Overall Study|Protocol Violation|12|||
23512189|NCT03182829|65612674|FG001|Overall Study|Protocol Violation|12|||
23512190|NCT03182829|65612673|FG000|Overall Study|Other|4|||
23512191|NCT03182829|65612674|FG001|Overall Study|Other|3|||
23512192|NCT02772081|65612682|FG000|Overall Study|Physician Decision|1|||
23512193|NCT02772081|65612683|FG001|Overall Study|Physician Decision|1|||
23512194|NCT02772081|65612682|FG000|Overall Study|Death|1|||
23512195|NCT02772081|65612683|FG001|Overall Study|Death|1|||
23610800|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Adverse Event|7|||
23610801|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Adverse Event|8|||
23512196|NCT00330616|65612688|FG000|Overall Study|Adverse Event|13|||
23512197|NCT00330616|65612688|FG000|Overall Study|Lack of Efficacy|1|||
23512198|NCT00330616|65612688|FG000|Overall Study|Lost to Follow-up|2|||
23610802|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Adverse Event|8|||
23610803|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Adverse Event|9|||
23610804|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
23307509|NCT03493386|64870531|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23610805|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
23610806|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
23610807|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
23610808|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
23610809|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
23610810|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
23610811|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
23610812|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Pregnancy|0|||
23610813|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Pregnancy|2|||
23610814|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Pregnancy|2|||
23610815|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Pregnancy|0|||
23610816|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Non-compliance|1|||
23610817|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Non-compliance|0|||
23610818|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Non-compliance|0|||
23610819|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Non-compliance|3|||
23610820|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Other|3|||
23610821|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Other|0|||
23610822|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Other|3|||
23610823|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Other|2|||
23610824|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
23610825|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
23610826|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
23610827|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
23610828|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
23610829|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
23610830|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
23610831|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
23610832|NCT02143713|65962906|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
23610833|NCT02143713|65962907|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
23610834|NCT02143713|65962908|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
23610835|NCT02143713|65962909|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
23610836|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
23610837|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
23610838|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
23610839|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
23610840|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
23610841|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
23610842|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
23610843|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
23610844|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
23610845|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
23610846|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
23610847|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
23610848|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
23512199|NCT00330616|65612688|FG000|Overall Study|Withdrawal by Subject|4|||
23512200|NCT00330616|65612688|FG000|Overall Study|Other|1|||
23512201|NCT03226392|65612689|FG000|Overall Study|Protocol Deviation|1|||
23512202|NCT03226392|65612690|FG001|Overall Study|Protocol Deviation|0|||
23512203|NCT03226392|65612689|FG000|Overall Study|Physician Decision|1|||
23512204|NCT03226392|65612690|FG001|Overall Study|Physician Decision|0|||
23512205|NCT03226392|65612689|FG000|Overall Study|Lost to Follow-up|1|||
23512206|NCT03226392|65612690|FG001|Overall Study|Lost to Follow-up|0|||
23512207|NCT03226392|65612689|FG000|Overall Study|Adverse Event|1|||
23512208|NCT03226392|65612690|FG001|Overall Study|Adverse Event|0|||
23512209|NCT03226392|65612689|FG000|Overall Study|Technical Problems|0|||
23512210|NCT03226392|65612690|FG001|Overall Study|Technical Problems|2|||
23512211|NCT03226392|65612689|FG000|Overall Study|Subject/Guardian Decision|7|||
23512212|NCT03226392|65612690|FG001|Overall Study|Subject/Guardian Decision|6|||
23512213|NCT02259582|65612691|FG000|Overall Study|Physician Decision|0|||
23512214|NCT02259582|65612692|FG001|Overall Study|Physician Decision|1|||
23512215|NCT02259582|65612693|FG002|Overall Study|Physician Decision|0|||
23512216|NCT02259582|65612691|FG000|Overall Study|Death|0|||
23512217|NCT02259582|65612692|FG001|Overall Study|Death|0|||
23512218|NCT02259582|65612693|FG002|Overall Study|Death|1|||
23610849|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
23512219|NCT02259582|65612691|FG000|Overall Study|Adverse Event|1|||
23512220|NCT02259582|65612692|FG001|Overall Study|Adverse Event|0|||
23512221|NCT02259582|65612693|FG002|Overall Study|Adverse Event|1|||
23512222|NCT02259582|65612691|FG000|Overall Study|Withdrawal by Subject|0|||
23610850|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
23610851|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
23610852|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
23610853|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
23610854|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
23610855|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
23610856|NCT02143713|65962906|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
23610857|NCT02143713|65962907|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
23610858|NCT02143713|65962908|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
23610859|NCT02143713|65962909|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
23610860|NCT02727998|65962910|FG000|Overall Study|Lost to Follow-up|3|||
23610861|NCT02727998|65962911|FG001|Overall Study|Lost to Follow-up|3|||
23610862|NCT02727998|65962910|FG000|Overall Study|Withdrawal by Subject|0|||
23610863|NCT02727998|65962911|FG001|Overall Study|Withdrawal by Subject|1|||
23610864|NCT02825550|65962913|FG000|Overall Study|Physician Decision|1|||
23610865|NCT01668355|65962914|FG000|Overall Study|Death|3|||
23414459|NCT04489771|65258380|FG000|Overall Study|Death|27|||
23414460|NCT04489771|65258381|FG001|Overall Study|Death|25|||
23414461|NCT04489771|65258380|FG000|Overall Study|Withdrawal by Subject|1|||
23414462|NCT04489771|65258381|FG001|Overall Study|Withdrawal by Subject|0|||
23414463|NCT04489771|65258380|FG000|Overall Study|Participants Ongoing in Study|50|||
23414464|NCT04489771|65258381|FG001|Overall Study|Participants Ongoing in Study|51|||
23414465|NCT04860869|65258382|FG000|Overall Study|Withdrawal by Subject|1|||
23414466|NCT04860869|65258383|FG001|Overall Study|Withdrawal by Subject|0|||
23610866|NCT01668355|65962915|FG001|Overall Study|Death|1|||
23610867|NCT01668355|65962914|FG000|Overall Study|Withdrawal by Subject|6|||
23610868|NCT01668355|65962915|FG001|Overall Study|Withdrawal by Subject|1|||
23610869|NCT00636168|65962917|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
23610870|NCT00636168|65962918|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
23610871|NCT00636168|65962917|FG000|Randomized to Study Drug|Adverse Event|1|||
23610872|NCT00636168|65962918|FG001|Randomized to Study Drug|Adverse Event|0|||
23610873|NCT00636168|65962917|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
23610874|NCT00636168|65962918|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
23610875|NCT00636168|65962917|FG000|Treated With Study Drug|Recurrence of disease|135|||
23610876|NCT00636168|65962918|FG001|Treated With Study Drug|Recurrence of disease|282|||
23610877|NCT00636168|65962917|FG000|Treated With Study Drug|Adverse Event|250|||
23610878|NCT00636168|65962918|FG001|Treated With Study Drug|Adverse Event|22|||
23610879|NCT00636168|65962917|FG000|Treated With Study Drug|Participant withdrew consent|16|||
23610880|NCT00636168|65962918|FG001|Treated With Study Drug|Participant withdrew consent|21|||
23610881|NCT00636168|65962917|FG000|Treated With Study Drug|Poor/non-compliance|1|||
23610882|NCT00636168|65962918|FG001|Treated With Study Drug|Poor/non-compliance|3|||
23610883|NCT00636168|65962917|FG000|Treated With Study Drug|Death|3|||
23610884|NCT00636168|65962918|FG001|Treated With Study Drug|Death|0|||
23414487|NCT05040971|65258391|FG000|Overall Study|Withdrawal by Subject|0|||
23414488|NCT05040971|65258392|FG001|Overall Study|Withdrawal by Subject|2|||
23414489|NCT05040971|65258391|FG000|Overall Study|Lost to Follow-up|8|||
23414490|NCT05040971|65258392|FG001|Overall Study|Lost to Follow-up|3|||
23414491|NCT05040971|65258391|FG000|Overall Study|Death|2|||
23414492|NCT05040971|65258392|FG001|Overall Study|Death|0|||
23414493|NCT01522976|65258393|FG000|Overall Study|Ineligible|4|||
23414494|NCT01522976|65258394|FG001|Overall Study|Ineligible|0|||
23414495|NCT01522976|65258395|FG002|Overall Study|Ineligible|1|||
23414496|NCT01522976|65258393|FG000|Overall Study|Death|7|||
23414497|NCT01522976|65258394|FG001|Overall Study|Death|6|||
23414498|NCT01522976|65258395|FG002|Overall Study|Death|2|||
23414499|NCT01522976|65258393|FG000|Overall Study|Still on treatment|9|||
23414500|NCT01522976|65258394|FG001|Overall Study|Still on treatment|9|||
23414501|NCT01522976|65258395|FG002|Overall Study|Still on treatment|6|||
23512223|NCT02259582|65612692|FG001|Overall Study|Withdrawal by Subject|0|||
23414502|NCT01522976|65258393|FG000|Overall Study|Disease progression|28|||
23414503|NCT01522976|65258394|FG001|Overall Study|Disease progression|30|||
23414504|NCT01522976|65258395|FG002|Overall Study|Disease progression|25|||
23414505|NCT01522976|65258393|FG000|Overall Study|Adverse Event|17|||
23414506|NCT01522976|65258394|FG001|Overall Study|Adverse Event|7|||
23414507|NCT01522976|65258395|FG002|Overall Study|Adverse Event|18|||
23414508|NCT01522976|65258393|FG000|Overall Study|Refusal unrelated to adverse event|10|||
23414509|NCT01522976|65258394|FG001|Overall Study|Refusal unrelated to adverse event|13|||
23414510|NCT01522976|65258395|FG002|Overall Study|Refusal unrelated to adverse event|14|||
23414511|NCT01522976|65258393|FG000|Overall Study|Not protocol specified|22|||
23414512|NCT01522976|65258394|FG001|Overall Study|Not protocol specified|27|||
23414513|NCT01522976|65258395|FG002|Overall Study|Not protocol specified|27|||
23414514|NCT01013649|65258396|FG000|First Step|Withdrawal by Subject|36|||
23414515|NCT01013649|65258397|FG001|First Step|Withdrawal by Subject|19|||
23414516|NCT01013649|65258398|FG002|First Step|Withdrawal by Subject|0|||
23414517|NCT01013649|65258399|FG003|First Step|Withdrawal by Subject|0|||
23414518|NCT01013649|65258396|FG000|First Step|Progression|58|||
23414519|NCT01013649|65258397|FG001|First Step|Progression|23|||
23414520|NCT01013649|65258398|FG002|First Step|Progression|0|||
23414521|NCT01013649|65258399|FG003|First Step|Progression|0|||
23414522|NCT01013649|65258396|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
23414523|NCT01013649|65258397|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
23414524|NCT01013649|65258398|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
23414525|NCT01013649|65258399|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
23414526|NCT01013649|65258396|FG000|First Step|Death|3|||
23414527|NCT01013649|65258397|FG001|First Step|Death|4|||
23414528|NCT01013649|65258398|FG002|First Step|Death|0|||
23414529|NCT01013649|65258399|FG003|First Step|Death|0|||
23414530|NCT01013649|65258396|FG000|First Step|Adverse Event|9|||
23414531|NCT01013649|65258397|FG001|First Step|Adverse Event|5|||
23414532|NCT01013649|65258398|FG002|First Step|Adverse Event|0|||
23414533|NCT01013649|65258399|FG003|First Step|Adverse Event|0|||
23414534|NCT01013649|65258396|FG000|First Step|Other|4|||
23414535|NCT01013649|65258397|FG001|First Step|Other|6|||
23414536|NCT01013649|65258398|FG002|First Step|Other|0|||
23414537|NCT01013649|65258399|FG003|First Step|Other|0|||
23414538|NCT04550832|65258400|FG000|Overall Study|Adverse Event|0|||
23414539|NCT04550832|65258401|FG001|Overall Study|Adverse Event|0|||
23414540|NCT04550832|65258402|FG002|Overall Study|Adverse Event|2|||
23414541|NCT04550832|65258403|FG003|Overall Study|Adverse Event|0|||
23414542|NCT04550832|65258404|FG004|Overall Study|Adverse Event|1|||
23610885|NCT00636168|65962917|FG000|Treated With Study Drug|Pregnancy|1|||
23610886|NCT00636168|65962918|FG001|Treated With Study Drug|Pregnancy|0|||
23610887|NCT00636168|65962917|FG000|Treated With Study Drug|No longer meets study criteria|1|||
23610888|NCT00636168|65962918|FG001|Treated With Study Drug|No longer meets study criteria|0|||
23610889|NCT00636168|65962917|FG000|Treated With Study Drug|Other reason|1|||
23610890|NCT00636168|65962918|FG001|Treated With Study Drug|Other reason|3|||
23610891|NCT00636168|65962917|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
23610892|NCT00636168|65962918|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
23610893|NCT00636168|65962917|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
23610894|NCT00636168|65962918|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
23610895|NCT00636168|65962917|FG000|Long Term Follow-Up|Death|8|||
23610896|NCT00636168|65962918|FG001|Long Term Follow-Up|Death|9|||
23610897|NCT02991456|65962923|FG000|Overall Study|Adverse Event|2|||
23610898|NCT02991456|65962924|FG001|Overall Study|Adverse Event|0|||
23610899|NCT02991456|65962923|FG000|Overall Study|Lost to Follow-up|0|||
23610900|NCT02991456|65962924|FG001|Overall Study|Lost to Follow-up|2|||
23610901|NCT02991456|65962923|FG000|Overall Study|Withdrawal by Subject|1|||
23610902|NCT02991456|65962924|FG001|Overall Study|Withdrawal by Subject|0|||
23610903|NCT02784834|65962927|FG000|Overall Study|Lack of Efficacy|1|||
23610904|NCT02964234|65962931|FG000|Overall Study|Lost to Follow-up|22|||
23610905|NCT02964234|65962932|FG001|Overall Study|Lost to Follow-up|13|||
23610906|NCT00828139|65962935|FG000|Overall Study|Adverse Event|8|||
23512224|NCT02259582|65612693|FG002|Overall Study|Withdrawal by Subject|1|||
23512225|NCT02259582|65612691|FG000|Overall Study|Disease progression|14|||
23512226|NCT02259582|65612692|FG001|Overall Study|Disease progression|15|||
23512227|NCT02259582|65612693|FG002|Overall Study|Disease progression|17|||
23512228|NCT02259582|65612691|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
23610907|NCT00828139|65962936|FG001|Overall Study|Adverse Event|1|||
23610908|NCT00828139|65962937|FG002|Overall Study|Adverse Event|10|||
23414567|NCT03594747|65258407|FG000|Overall Study|Death|78|||
23414568|NCT03594747|65258408|FG001|Overall Study|Death|86|||
23414569|NCT03594747|65258409|FG002|Overall Study|Death|87|||
23414570|NCT03594747|65258407|FG000|Overall Study|Withdrawal by Subject|5|||
23414571|NCT03594747|65258408|FG001|Overall Study|Withdrawal by Subject|2|||
23414572|NCT03594747|65258409|FG002|Overall Study|Withdrawal by Subject|11|||
23414573|NCT03594747|65258407|FG000|Overall Study|Lost to Follow-up|4|||
23414574|NCT03594747|65258408|FG001|Overall Study|Lost to Follow-up|1|||
23414575|NCT03594747|65258409|FG002|Overall Study|Lost to Follow-up|1|||
23414576|NCT03594747|65258407|FG000|Overall Study|Physician Decision|0|||
23414577|NCT03594747|65258408|FG001|Overall Study|Physician Decision|1|||
23414578|NCT03594747|65258409|FG002|Overall Study|Physician Decision|0|||
23414579|NCT03594747|65258407|FG000|Overall Study|Sponsor decision|23|||
23414580|NCT03594747|65258408|FG001|Overall Study|Sponsor decision|17|||
23414581|NCT03594747|65258409|FG002|Overall Study|Sponsor decision|16|||
23414582|NCT03594747|65258407|FG000|Overall Study|Did not meet inclusion criteria|0|||
23414583|NCT03594747|65258408|FG001|Overall Study|Did not meet inclusion criteria|0|||
23414584|NCT03594747|65258409|FG002|Overall Study|Did not meet inclusion criteria|1|||
23414585|NCT03594747|65258407|FG000|Overall Study|Transfer to long term extension study|10|||
23414586|NCT03594747|65258408|FG001|Overall Study|Transfer to long term extension study|12|||
23414587|NCT03594747|65258409|FG002|Overall Study|Transfer to long term extension study|5|||
23414588|NCT04295681|65258411|FG000|Overall Study|Eligibility error|1|||
23414589|NCT04295681|65258412|FG001|Overall Study|Eligibility error|3|||
23512229|NCT02259582|65612692|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
23512230|NCT02259582|65612693|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
23414590|NCT02569476|65258415|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
23414591|NCT02569476|65258415|FG000|Overall Study|Death|33|||
23414592|NCT02569476|65258415|FG000|Overall Study|Withdrawal by Subject|9|||
23414593|NCT02569476|65258415|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
23414594|NCT02569476|65258415|FG000|Overall Study|Palliative care|1|||
23414595|NCT02569476|65258415|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
23414596|NCT02569476|65258415|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
23610909|NCT00828139|65962938|FG003|Overall Study|Adverse Event|5|||
23610910|NCT00828139|65962935|FG000|Overall Study|Death|2|||
23610911|NCT00828139|65962936|FG001|Overall Study|Death|1|||
23610912|NCT00828139|65962937|FG002|Overall Study|Death|0|||
23610913|NCT00828139|65962938|FG003|Overall Study|Death|2|||
23610914|NCT00828139|65962935|FG000|Overall Study|Refusal unrelated to toxicity|3|||
23610915|NCT00828139|65962936|FG001|Overall Study|Refusal unrelated to toxicity|4|||
23610916|NCT00828139|65962937|FG002|Overall Study|Refusal unrelated to toxicity|5|||
23610917|NCT00828139|65962938|FG003|Overall Study|Refusal unrelated to toxicity|3|||
23610918|NCT00828139|65962935|FG000|Overall Study|Disease Progression|24|||
23610919|NCT00828139|65962936|FG001|Overall Study|Disease Progression|33|||
23610920|NCT00828139|65962937|FG002|Overall Study|Disease Progression|35|||
23610921|NCT00828139|65962938|FG003|Overall Study|Disease Progression|39|||
23610922|NCT00828139|65962935|FG000|Overall Study|Other|4|||
23610923|NCT00828139|65962936|FG001|Overall Study|Other|2|||
23610924|NCT00828139|65962937|FG002|Overall Study|Other|5|||
23610925|NCT00828139|65962938|FG003|Overall Study|Other|2|||
23610926|NCT03344458|65962942|FG000|Overall Study|Physician Decision|1|||
23610927|NCT03344458|65962942|FG000|Overall Study|Withdrawal by Subject|16|||
23610928|NCT03344458|65962942|FG000|Overall Study|Other reasons|10|||
23414617|NCT05420961|65258427|FG000|Overall Study|Withdrawal by Subject|2|||
23414618|NCT05420961|65258428|FG001|Overall Study|Withdrawal by Subject|1|||
23414619|NCT05420961|65258429|FG002|Overall Study|Withdrawal by Subject|1|||
23414620|NCT05420961|65258430|FG003|Overall Study|Withdrawal by Subject|0|||
23414621|NCT05420961|65258431|FG004|Overall Study|Withdrawal by Subject|0|||
23414622|NCT05420961|65258427|FG000|Overall Study|Lost to Follow-up|0|||
23414623|NCT05420961|65258428|FG001|Overall Study|Lost to Follow-up|0|||
23414624|NCT05420961|65258429|FG002|Overall Study|Lost to Follow-up|1|||
23414625|NCT05420961|65258430|FG003|Overall Study|Lost to Follow-up|0|||
23414626|NCT05420961|65258431|FG004|Overall Study|Lost to Follow-up|0|||
23414627|NCT05420961|65258427|FG000|Overall Study|Randomized by mistake without study treatment|0|||
23414628|NCT05420961|65258428|FG001|Overall Study|Randomized by mistake without study treatment|0|||
23414629|NCT05420961|65258429|FG002|Overall Study|Randomized by mistake without study treatment|1|||
23414630|NCT05420961|65258430|FG003|Overall Study|Randomized by mistake without study treatment|0|||
23414631|NCT05420961|65258431|FG004|Overall Study|Randomized by mistake without study treatment|1|||
23610929|NCT03344458|65962942|FG000|Overall Study|Lost to Follow-up|9|||
23610930|NCT03344458|65962942|FG000|Overall Study|Protocol Violation|3|||
23610931|NCT00889863|65962944|FG000|Part I: Open Label|Death|1|||
23610932|NCT00889863|65962945|FG001|Part I: Open Label|Death|0|||
23610933|NCT00889863|65962944|FG000|Part I: Open Label|Adverse Event|4|||
23610934|NCT00889863|65962945|FG001|Part I: Open Label|Adverse Event|0|||
23610935|NCT00889863|65962944|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
23512231|NCT00105482|65612694|FG000|Overall Study|Adverse Event|1|||
23610936|NCT00889863|65962945|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
23610937|NCT00889863|65962944|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
23414640|NCT04790279|65260697|FG000|Overall Study|Did not meet medication start criteria|27|||
23414641|NCT04790279|65260698|FG001|Overall Study|Did not meet medication start criteria|15|||
23414642|NCT04790279|65260697|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
23414643|NCT04790279|65260698|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
23414644|NCT04790279|65260697|FG000|Overall Study|Protocol Violation|8|||
23414645|NCT04790279|65260698|FG001|Overall Study|Protocol Violation|3|||
23414646|NCT04790279|65260697|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
23414647|NCT04790279|65260698|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
23610938|NCT00889863|65962945|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
23414650|NCT01274338|65260701|FG000|Overall Study|Lack of Efficacy|72|||
23414651|NCT01274338|65260702|FG001|Overall Study|Lack of Efficacy|108|||
23414652|NCT01274338|65260703|FG002|Overall Study|Lack of Efficacy|116|||
23414653|NCT01274338|65260704|FG003|Overall Study|Lack of Efficacy|0|||
23414654|NCT01274338|65260705|FG004|Overall Study|Lack of Efficacy|0|||
23414655|NCT01274338|65260706|FG005|Overall Study|Lack of Efficacy|0|||
23414656|NCT01274338|65260701|FG000|Overall Study|Adverse Event|272|||
23414657|NCT01274338|65260702|FG001|Overall Study|Adverse Event|105|||
23414658|NCT01274338|65260703|FG002|Overall Study|Adverse Event|180|||
23414659|NCT01274338|65260704|FG003|Overall Study|Adverse Event|1|||
23414660|NCT01274338|65260705|FG004|Overall Study|Adverse Event|0|||
23414661|NCT01274338|65260706|FG005|Overall Study|Adverse Event|0|||
23414662|NCT01274338|65260701|FG000|Overall Study|Death|8|||
23414663|NCT01274338|65260702|FG001|Overall Study|Death|1|||
23414664|NCT01274338|65260703|FG002|Overall Study|Death|0|||
23414665|NCT01274338|65260704|FG003|Overall Study|Death|0|||
23414666|NCT01274338|65260705|FG004|Overall Study|Death|0|||
23414667|NCT01274338|65260706|FG005|Overall Study|Death|0|||
23414668|NCT01274338|65260701|FG000|Overall Study|Withdrawal by Subject|27|||
23414669|NCT01274338|65260702|FG001|Overall Study|Withdrawal by Subject|99|||
23414670|NCT01274338|65260703|FG002|Overall Study|Withdrawal by Subject|17|||
23414671|NCT01274338|65260704|FG003|Overall Study|Withdrawal by Subject|0|||
23414672|NCT01274338|65260705|FG004|Overall Study|Withdrawal by Subject|0|||
23414673|NCT01274338|65260706|FG005|Overall Study|Withdrawal by Subject|0|||
23414674|NCT01274338|65260701|FG000|Overall Study|Did not start treatment|8|||
23414675|NCT01274338|65260702|FG001|Overall Study|Did not start treatment|116|||
23414676|NCT01274338|65260703|FG002|Overall Study|Did not start treatment|7|||
23414677|NCT01274338|65260704|FG003|Overall Study|Did not start treatment|0|||
23414678|NCT01274338|65260705|FG004|Overall Study|Did not start treatment|0|||
23414679|NCT01274338|65260706|FG005|Overall Study|Did not start treatment|0|||
23414680|NCT01274338|65260701|FG000|Overall Study|Alternative therapy|0|||
23414681|NCT01274338|65260702|FG001|Overall Study|Alternative therapy|1|||
23414682|NCT01274338|65260703|FG002|Overall Study|Alternative therapy|0|||
23414683|NCT01274338|65260704|FG003|Overall Study|Alternative therapy|0|||
23414684|NCT01274338|65260705|FG004|Overall Study|Alternative therapy|0|||
23414685|NCT01274338|65260706|FG005|Overall Study|Alternative therapy|0|||
23414686|NCT01274338|65260701|FG000|Overall Study|Other complicating diseases|0|||
23414687|NCT01274338|65260702|FG001|Overall Study|Other complicating diseases|3|||
23414688|NCT01274338|65260703|FG002|Overall Study|Other complicating diseases|1|||
23414689|NCT01274338|65260704|FG003|Overall Study|Other complicating diseases|0|||
23414690|NCT01274338|65260705|FG004|Overall Study|Other complicating diseases|0|||
23414691|NCT01274338|65260706|FG005|Overall Study|Other complicating diseases|0|||
23414692|NCT01274338|65260701|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
23414693|NCT01274338|65260702|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414694|NCT01274338|65260703|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414695|NCT01274338|65260704|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414696|NCT01274338|65260705|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414697|NCT01274338|65260706|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
23414698|NCT01274338|65260701|FG000|Overall Study|Pregnancy|0|||
23414699|NCT01274338|65260702|FG001|Overall Study|Pregnancy|0|||
23414700|NCT01274338|65260703|FG002|Overall Study|Pregnancy|1|||
23414701|NCT01274338|65260704|FG003|Overall Study|Pregnancy|0|||
23414702|NCT01274338|65260705|FG004|Overall Study|Pregnancy|0|||
23414703|NCT01274338|65260706|FG005|Overall Study|Pregnancy|0|||
23414704|NCT01274338|65260701|FG000|Overall Study|Reason not reported|12|||
23414705|NCT01274338|65260702|FG001|Overall Study|Reason not reported|21|||
23414706|NCT01274338|65260703|FG002|Overall Study|Reason not reported|3|||
23414707|NCT01274338|65260704|FG003|Overall Study|Reason not reported|0|||
23414708|NCT01274338|65260705|FG004|Overall Study|Reason not reported|1|||
23414709|NCT01274338|65260706|FG005|Overall Study|Reason not reported|0|||
23414710|NCT03419897|65260709|FG000|Overall Study|Death|180|||
23414711|NCT03419897|65260709|FG000|Overall Study|Lost to Follow-up|1|||
23414712|NCT03419897|65260709|FG000|Overall Study|Withdrawal by Subject|6|||
23414713|NCT03419897|65260709|FG000|Overall Study|Sponsor Decision|61|||
23414714|NCT03419897|65260709|FG000|Overall Study|Physician Decision|1|||
23414715|NCT03640325|65260710|FG000|Overall Study|Withdrawal by Subject|4|||
23414716|NCT03640325|65260711|FG001|Overall Study|Withdrawal by Subject|1|||
23414717|NCT03640325|65260712|FG002|Overall Study|Withdrawal by Subject|0|||
23414718|NCT03640325|65260710|FG000|Overall Study|Lost to Follow-up|4|||
23414719|NCT03640325|65260711|FG001|Overall Study|Lost to Follow-up|5|||
23414720|NCT03640325|65260712|FG002|Overall Study|Lost to Follow-up|21|||
23414721|NCT03640325|65260710|FG000|Overall Study|Death|5|||
23414722|NCT03640325|65260711|FG001|Overall Study|Death|5|||
23414723|NCT03640325|65260712|FG002|Overall Study|Death|0|||
23414724|NCT03493451|65260713|FG000|Overall Study|Death|11|||
23414725|NCT03493451|65260714|FG001|Overall Study|Death|26|||
23414726|NCT03493451|65260715|FG002|Overall Study|Death|3|||
23414727|NCT03493451|65260713|FG000|Overall Study|Lost to Follow-up|1|||
23512232|NCT00105482|65612695|FG001|Overall Study|Adverse Event|1|||
23512233|NCT00105482|65612694|FG000|Overall Study|Lost to Follow-up|26|||
23512234|NCT00105482|65612695|FG001|Overall Study|Lost to Follow-up|17|||
23512235|NCT00105482|65612694|FG000|Overall Study|Withdrawal by Subject|0|||
23512236|NCT00105482|65612695|FG001|Overall Study|Withdrawal by Subject|1|||
23512237|NCT00105482|65612694|FG000|Overall Study|Lost Interest|29|||
23512238|NCT00105482|65612695|FG001|Overall Study|Lost Interest|32|||
23512239|NCT00105482|65612694|FG000|Overall Study|Scheduling Conflict|2|||
23512240|NCT00105482|65612695|FG001|Overall Study|Scheduling Conflict|3|||
23512241|NCT00105482|65612694|FG000|Overall Study|Withdrawn by PI|1|||
23512242|NCT00105482|65612695|FG001|Overall Study|Withdrawn by PI|1|||
23512243|NCT01411228|65612696|FG000|Overall Study|Lost to Follow-up|0|||
23512244|NCT01411228|65612697|FG001|Overall Study|Lost to Follow-up|0|||
23414728|NCT03493451|65260714|FG001|Overall Study|Lost to Follow-up|4|||
23414729|NCT03493451|65260715|FG002|Overall Study|Lost to Follow-up|1|||
23414730|NCT03493451|65260713|FG000|Overall Study|Withdrawal by Subject|1|||
23414731|NCT03493451|65260714|FG001|Overall Study|Withdrawal by Subject|1|||
23414732|NCT03493451|65260715|FG002|Overall Study|Withdrawal by Subject|2|||
23414733|NCT03493451|65260713|FG000|Overall Study|Progressive Disease|1|||
23414734|NCT03493451|65260714|FG001|Overall Study|Progressive Disease|0|||
23414735|NCT03493451|65260715|FG002|Overall Study|Progressive Disease|0|||
23414736|NCT03493451|65260713|FG000|Overall Study|Transferred to long term extension study|8|||
23414737|NCT03493451|65260714|FG001|Overall Study|Transferred to long term extension study|13|||
23414738|NCT03493451|65260715|FG002|Overall Study|Transferred to long term extension study|5|||
23414739|NCT03430843|65260716|FG000|Overall Study|Death|233|||
23414740|NCT03430843|65260717|FG001|Overall Study|Death|233|||
23414741|NCT03430843|65260716|FG000|Overall Study|Sponsor Decision|17|||
23414742|NCT03430843|65260717|FG001|Overall Study|Sponsor Decision|6|||
23414743|NCT03430843|65260716|FG000|Overall Study|Withdrawal by Subject|5|||
23414744|NCT03430843|65260717|FG001|Overall Study|Withdrawal by Subject|14|||
23414745|NCT03430843|65260716|FG000|Overall Study|Lost to Follow-up|1|||
23414746|NCT03430843|65260717|FG001|Overall Study|Lost to Follow-up|3|||
23610939|NCT00889863|65962944|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
23610940|NCT00889863|65962945|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
23610941|NCT00889863|65962944|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
23610942|NCT00889863|65962945|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
23610943|NCT00889863|65962944|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
23610944|NCT00889863|65962945|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
23610945|NCT01912599|65962950|FG000|Overall Study|Withdrawal by Subject|0|||
23610946|NCT01912599|65962951|FG001|Overall Study|Withdrawal by Subject|1|||
23610947|NCT01280721|65962954|FG000|Overall Study|Adverse Event|4|||
23610948|NCT01280721|65962954|FG000|Overall Study|Physician Decision|3|||
23610949|NCT01280721|65962954|FG000|Overall Study|Withdrawal by Subject|6|||
23610950|NCT01280721|65962954|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
23610951|NCT01280721|65962954|FG000|Overall Study|No tolerability for the lowest dose|2|||
23610952|NCT00753896|65962957|FG000|Overall Study|Adverse Event|4|||
23610953|NCT00753896|65962957|FG000|Overall Study|Death|1|||
23610954|NCT00753896|65962957|FG000|Overall Study|Lost to Follow-up|2|||
23610955|NCT00753896|65962957|FG000|Overall Study|Protocol Violation|1|||
23610956|NCT00753896|65962957|FG000|Overall Study|Withdrawal by Subject|4|||
23610957|NCT00753896|65962957|FG000|Overall Study|Entry Criteria Not Met|4|||
23610958|NCT01077284|65962958|FG000|Overall Study|Adverse Event|2|||
23610959|NCT01077284|65962959|FG001|Overall Study|Adverse Event|0|||
23610960|NCT01077284|65962960|FG002|Overall Study|Adverse Event|1|||
23610961|NCT01077284|65962958|FG000|Overall Study|Lost to Follow-up|1|||
23610962|NCT01077284|65962959|FG001|Overall Study|Lost to Follow-up|2|||
23610963|NCT01077284|65962960|FG002|Overall Study|Lost to Follow-up|0|||
23610964|NCT01077284|65962958|FG000|Overall Study|Withdrawal by Subject|2|||
23610965|NCT01077284|65962959|FG001|Overall Study|Withdrawal by Subject|3|||
23610966|NCT01077284|65962960|FG002|Overall Study|Withdrawal by Subject|1|||
23610967|NCT01077284|65962958|FG000|Overall Study|Other|0|||
23610968|NCT01077284|65962959|FG001|Overall Study|Other|0|||
23512245|NCT01411228|65612698|FG002|Overall Study|Lost to Follow-up|1|||
23610969|NCT01077284|65962960|FG002|Overall Study|Other|1|||
23610970|NCT04085614|65962963|FG000|Overall Study|Protocol Violation|9|||
23610971|NCT04085614|65962964|FG001|Overall Study|Protocol Violation|6|||
23610972|NCT02213094|65962971|FG000|Overall Study|Adverse Event|1|||
23610973|NCT02213094|65962972|FG001|Overall Study|Adverse Event|0|||
23610974|NCT02066389|65966674|FG000|Overall Study|Adverse Event|1|||
23610975|NCT02066389|65966675|FG001|Overall Study|Adverse Event|1|||
23610976|NCT02066389|65966676|FG002|Overall Study|Adverse Event|1|||
23610977|NCT02066389|65966677|FG003|Overall Study|Adverse Event|1|||
23610978|NCT02066389|65966678|FG004|Overall Study|Adverse Event|5|||
23512246|NCT01411228|65612696|FG000|Overall Study|Withdrawal by Subject|1|||
23512247|NCT01411228|65612697|FG001|Overall Study|Withdrawal by Subject|0|||
23610979|NCT02066389|65966679|FG005|Overall Study|Adverse Event|1|||
23610980|NCT02066389|65966674|FG000|Overall Study|Withdrawal by Subject|4|||
23610981|NCT02066389|65966675|FG001|Overall Study|Withdrawal by Subject|0|||
23610982|NCT02066389|65966676|FG002|Overall Study|Withdrawal by Subject|5|||
23610983|NCT02066389|65966677|FG003|Overall Study|Withdrawal by Subject|1|||
23610984|NCT02066389|65966678|FG004|Overall Study|Withdrawal by Subject|1|||
23610985|NCT02066389|65966679|FG005|Overall Study|Withdrawal by Subject|2|||
23610986|NCT02066389|65966674|FG000|Overall Study|Lost to Follow-up|0|||
23610987|NCT02066389|65966675|FG001|Overall Study|Lost to Follow-up|0|||
23414795|NCT03941873|65260732|FG000|Overall Study|Death|0|||
23414796|NCT03941873|65260733|FG001|Overall Study|Death|12|||
23414797|NCT03941873|65260734|FG002|Overall Study|Death|2|||
23414798|NCT03941873|65260735|FG003|Overall Study|Death|53|||
23414799|NCT03941873|65260732|FG000|Overall Study|Withdrawal by Subject|1|||
23414800|NCT03941873|65260733|FG001|Overall Study|Withdrawal by Subject|1|||
23414801|NCT03941873|65260734|FG002|Overall Study|Withdrawal by Subject|0|||
23414802|NCT03941873|65260735|FG003|Overall Study|Withdrawal by Subject|5|||
23414803|NCT03941873|65260732|FG000|Overall Study|Lost to Follow-up|1|||
23414804|NCT03941873|65260733|FG001|Overall Study|Lost to Follow-up|2|||
23414805|NCT03941873|65260734|FG002|Overall Study|Lost to Follow-up|0|||
23414806|NCT03941873|65260735|FG003|Overall Study|Lost to Follow-up|0|||
23414807|NCT03941873|65260732|FG000|Overall Study|Sponsor Decision|0|||
23414808|NCT03941873|65260733|FG001|Overall Study|Sponsor Decision|6|||
23414809|NCT03941873|65260734|FG002|Overall Study|Sponsor Decision|0|||
23414810|NCT03941873|65260735|FG003|Overall Study|Sponsor Decision|15|||
23414811|NCT03062280|65260736|FG000|Overall Study|Adverse Event|1|||
23414812|NCT03062280|65260736|FG000|Overall Study|Death|1|||
23414813|NCT03062280|65260736|FG000|Overall Study|Fertility Treatment|2|||
23414814|NCT03062280|65260736|FG000|Overall Study|Physician Decision|2|||
23414815|NCT03062280|65260736|FG000|Overall Study|Pregnancy|5|||
23414816|NCT03062280|65260736|FG000|Overall Study|Withdrawal by Subject|11|||
23414817|NCT04472650|65260737|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
23414818|NCT04472650|65260738|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
23414819|NCT00937937|65260741|FG000|Overall Study|Adverse Event|6|||
23414820|NCT00937937|65260741|FG000|Overall Study|Withdrawal by Subject|2|||
23414821|NCT00937937|65260741|FG000|Overall Study|Progression/relapse|61|||
23414822|NCT00937937|65260741|FG000|Overall Study|Death|1|||
23414823|NCT00937937|65260741|FG000|Overall Study|Other|2|||
23610988|NCT02066389|65966676|FG002|Overall Study|Lost to Follow-up|0|||
23610989|NCT02066389|65966677|FG003|Overall Study|Lost to Follow-up|1|||
23610990|NCT02066389|65966678|FG004|Overall Study|Lost to Follow-up|1|||
23414827|NCT03505788|65260745|FG000|Overall Study|Lost to Follow-up|2|||
23414828|NCT03505788|65260746|FG001|Overall Study|Lost to Follow-up|1|||
23414829|NCT03505788|65260745|FG000|Overall Study|Withdrawal by Subject|1|||
23414830|NCT03505788|65260746|FG001|Overall Study|Withdrawal by Subject|3|||
23414831|NCT03505788|65260745|FG000|Overall Study|Physician Decision|0|||
23414832|NCT03505788|65260746|FG001|Overall Study|Physician Decision|1|||
23512248|NCT01411228|65612698|FG002|Overall Study|Withdrawal by Subject|0|||
23512249|NCT02598076|65612699|FG000|Overall Study|Lost to Follow-up|2|||
23512250|NCT02598076|65612700|FG001|Overall Study|Lost to Follow-up|3|||
23512251|NCT02255981|65612709|FG000|Overall Study|Lost to Follow-up|3|||
23512252|NCT02255981|65612709|FG000|Overall Study|Withdrawal by Subject|1|||
23512253|NCT01599234|65612710|FG000|Overall Study|Adverse Event|9|||
23512254|NCT01599234|65612711|FG001|Overall Study|Adverse Event|5|||
23512255|NCT01599234|65612710|FG000|Overall Study|Withdrawal by Subject|2|||
23512256|NCT01599234|65612711|FG001|Overall Study|Withdrawal by Subject|1|||
23512257|NCT01599234|65612710|FG000|Overall Study|Lost to Follow-up|1|||
23512258|NCT01599234|65612711|FG001|Overall Study|Lost to Follow-up|2|||
23512259|NCT01599234|65612710|FG000|Overall Study|Lack of Efficacy|2|||
23414833|NCT03931382|65260747|FG000|Overall Study|Equipment malfunction|2|||
23414834|NCT03931382|65260748|FG001|Overall Study|Equipment malfunction|0|||
23414835|NCT03931382|65260749|FG002|Overall Study|Equipment malfunction|2|||
23414836|NCT03931382|65260747|FG000|Overall Study|Withdrawal by Subject|0|||
23414837|NCT03931382|65260748|FG001|Overall Study|Withdrawal by Subject|1|||
23414838|NCT03931382|65260749|FG002|Overall Study|Withdrawal by Subject|0|||
23414839|NCT03575065|65260750|FG000|Overall Study|Death|31|||
23414840|NCT03575065|65260751|FG001|Overall Study|Death|12|||
23414841|NCT03575065|65260750|FG000|Overall Study|Sponsor's Decision|28|||
23512260|NCT01599234|65612711|FG001|Overall Study|Lack of Efficacy|4|||
23414842|NCT03575065|65260751|FG001|Overall Study|Sponsor's Decision|13|||
23414843|NCT03575065|65260750|FG000|Overall Study|Withdrawal by Subject|2|||
23414844|NCT03575065|65260751|FG001|Overall Study|Withdrawal by Subject|1|||
23512261|NCT01599234|65612710|FG000|Overall Study|Unable to operate spray|1|||
23512262|NCT01599234|65612711|FG001|Overall Study|Unable to operate spray|0|||
23512263|NCT01599234|65612710|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
23512264|NCT01599234|65612711|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
23414845|NCT03575065|65260750|FG000|Overall Study|Lost to Follow-up|1|||
23414846|NCT03575065|65260751|FG001|Overall Study|Lost to Follow-up|0|||
23610991|NCT02066389|65966679|FG005|Overall Study|Lost to Follow-up|1|||
23414847|NCT03473743|65260754|FG000|Overall Study|Withdrawal by Subject|0|||
23414848|NCT03473743|65260755|FG001|Overall Study|Withdrawal by Subject|0|||
23414849|NCT03473743|65260756|FG002|Overall Study|Withdrawal by Subject|0|||
23414850|NCT03473743|65260757|FG003|Overall Study|Withdrawal by Subject|0|||
23414851|NCT03473743|65260758|FG004|Overall Study|Withdrawal by Subject|0|||
23414852|NCT03473743|65260759|FG005|Overall Study|Withdrawal by Subject|0|||
23414853|NCT03473743|65260760|FG006|Overall Study|Withdrawal by Subject|0|||
23414854|NCT03473743|65260761|FG007|Overall Study|Withdrawal by Subject|3|||
23414855|NCT03473743|65260754|FG000|Overall Study|Other|0|||
23414856|NCT03473743|65260755|FG001|Overall Study|Other|0|||
23414857|NCT03473743|65260756|FG002|Overall Study|Other|0|||
23414858|NCT03473743|65260757|FG003|Overall Study|Other|1|||
23414859|NCT03473743|65260758|FG004|Overall Study|Other|0|||
23414860|NCT03473743|65260759|FG005|Overall Study|Other|0|||
23414861|NCT03473743|65260760|FG006|Overall Study|Other|0|||
23414862|NCT03473743|65260761|FG007|Overall Study|Other|0|||
23414863|NCT03473743|65260754|FG000|Overall Study|Ongoing|0|||
23414864|NCT03473743|65260755|FG001|Overall Study|Ongoing|0|||
23414865|NCT03473743|65260756|FG002|Overall Study|Ongoing|6|||
23414866|NCT03473743|65260757|FG003|Overall Study|Ongoing|8|||
23414867|NCT03473743|65260758|FG004|Overall Study|Ongoing|1|||
23414868|NCT03473743|65260759|FG005|Overall Study|Ongoing|1|||
23414869|NCT03473743|65260760|FG006|Overall Study|Ongoing|22|||
23414870|NCT03473743|65260761|FG007|Overall Study|Ongoing|24|||
23512265|NCT01599234|65612710|FG000|Overall Study|Death|1|||
23512266|NCT01599234|65612711|FG001|Overall Study|Death|0|||
23512267|NCT01599234|65612710|FG000|Overall Study|Patient would not stop driving|1|||
23512268|NCT01599234|65612711|FG001|Overall Study|Patient would not stop driving|0|||
23512269|NCT01599234|65612710|FG000|Overall Study|Contra-indication discovered|0|||
23512270|NCT01599234|65612711|FG001|Overall Study|Contra-indication discovered|1|||
23512271|NCT01599234|65612710|FG000|Overall Study|Pregnancy|0|||
23414871|NCT03473743|65260754|FG000|Overall Study|Randomized but not treated|0|||
23414872|NCT03473743|65260755|FG001|Overall Study|Randomized but not treated|0|||
23414873|NCT03473743|65260756|FG002|Overall Study|Randomized but not treated|0|||
23414874|NCT03473743|65260757|FG003|Overall Study|Randomized but not treated|0|||
23414875|NCT03473743|65260758|FG004|Overall Study|Randomized but not treated|0|||
23414876|NCT03473743|65260759|FG005|Overall Study|Randomized but not treated|0|||
23512272|NCT01599234|65612711|FG001|Overall Study|Pregnancy|1|||
23512273|NCT01905657|65612712|FG000|Overall Study|Adverse Event|23|||
23512274|NCT01905657|65612713|FG001|Overall Study|Adverse Event|17|||
23512275|NCT01905657|65612714|FG002|Overall Study|Adverse Event|18|||
23512276|NCT01905657|65612712|FG000|Overall Study|Clinical Progression|103|||
23512277|NCT01905657|65612713|FG001|Overall Study|Clinical Progression|78|||
23512278|NCT01905657|65612714|FG002|Overall Study|Clinical Progression|59|||
23512279|NCT01905657|65612712|FG000|Overall Study|Death|40|||
23512280|NCT01905657|65612713|FG001|Overall Study|Death|43|||
23512281|NCT01905657|65612714|FG002|Overall Study|Death|47|||
23512282|NCT01905657|65612712|FG000|Overall Study|Excluded Medication|13|||
23512283|NCT01905657|65612713|FG001|Overall Study|Excluded Medication|16|||
23414877|NCT03473743|65260760|FG006|Overall Study|Randomized but not treated|1|||
23414878|NCT03473743|65260761|FG007|Overall Study|Randomized but not treated|1|||
23414879|NCT03994211|65260766|FG000|Core Phase|Adverse Event|0|||
23414880|NCT03994211|65260767|FG001|Core Phase|Adverse Event|1|||
23512284|NCT01905657|65612714|FG002|Overall Study|Excluded Medication|9|||
23512285|NCT01905657|65612712|FG000|Overall Study|Lost to Follow-up|1|||
23414881|NCT03994211|65260768|FG002|Core Phase|Adverse Event|0|||
23414882|NCT03994211|65260766|FG000|Extension Phase|Adverse Event|0|||
23512286|NCT01905657|65612713|FG001|Overall Study|Lost to Follow-up|2|||
23512287|NCT01905657|65612714|FG002|Overall Study|Lost to Follow-up|1|||
23414883|NCT03994211|65260767|FG001|Extension Phase|Adverse Event|0|||
23414884|NCT03994211|65260768|FG002|Extension Phase|Adverse Event|1|||
23414885|NCT03994211|65260766|FG000|Extension Phase|Physician Decision|0|||
23512288|NCT01905657|65612712|FG000|Overall Study|Physician Decision|5|||
23414886|NCT03994211|65260767|FG001|Extension Phase|Physician Decision|0|||
23414887|NCT03994211|65260768|FG002|Extension Phase|Physician Decision|1|||
23414888|NCT03994211|65260766|FG000|Extension Phase|Progressive Disease|0|||
23414889|NCT03994211|65260767|FG001|Extension Phase|Progressive Disease|0|||
23414890|NCT03994211|65260768|FG002|Extension Phase|Progressive Disease|20|||
23414891|NCT03994211|65260766|FG000|Extension Phase|Withdrawal by Subject|0|||
23414892|NCT03994211|65260767|FG001|Extension Phase|Withdrawal by Subject|0|||
23414893|NCT03994211|65260768|FG002|Extension Phase|Withdrawal by Subject|2|||
23610992|NCT02066389|65966674|FG000|Overall Study|Randomized in Error|0|||
23610993|NCT02066389|65966675|FG001|Overall Study|Randomized in Error|0|||
23610994|NCT02066389|65966676|FG002|Overall Study|Randomized in Error|0|||
23610995|NCT02066389|65966677|FG003|Overall Study|Randomized in Error|0|||
23610996|NCT02066389|65966678|FG004|Overall Study|Randomized in Error|0|||
23610997|NCT02066389|65966679|FG005|Overall Study|Randomized in Error|1|||
23610998|NCT00472199|65966683|FG000|Overall Study|Adverse Event|19|||
23610999|NCT00472199|65966684|FG001|Overall Study|Adverse Event|23|||
23611000|NCT00472199|65966683|FG000|Overall Study|Lack of Efficacy|4|||
23611001|NCT00472199|65966684|FG001|Overall Study|Lack of Efficacy|25|||
23611002|NCT00472199|65966683|FG000|Overall Study|Lost to Follow-up|2|||
23611003|NCT00472199|65966684|FG001|Overall Study|Lost to Follow-up|4|||
23611004|NCT00472199|65966683|FG000|Overall Study|Protocol Violation|3|||
23611005|NCT00472199|65966684|FG001|Overall Study|Protocol Violation|2|||
23414908|NCT01272037|65260771|FG000|Overall Study|Death|25|||
23414909|NCT01272037|65260772|FG001|Overall Study|Death|28|||
23414910|NCT01272037|65260771|FG000|Overall Study|Adverse Event|12|||
23414911|NCT01272037|65260772|FG001|Overall Study|Adverse Event|7|||
23414912|NCT01272037|65260771|FG000|Overall Study|Withdrawal by Subject|175|||
23414913|NCT01272037|65260772|FG001|Overall Study|Withdrawal by Subject|93|||
23414914|NCT01272037|65260771|FG000|Overall Study|Disease progression|70|||
23512289|NCT01905657|65612713|FG001|Overall Study|Physician Decision|8|||
23512290|NCT01905657|65612714|FG002|Overall Study|Physician Decision|12|||
23414915|NCT01272037|65260772|FG001|Overall Study|Disease progression|111|||
23512291|NCT01905657|65612712|FG000|Overall Study|Protocol Violation|2|||
23307510|NCT03493386|64870532|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
23307511|NCT03493386|64870533|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23414916|NCT01272037|65260771|FG000|Overall Study|Other reason|42|||
23414917|NCT01272037|65260772|FG001|Overall Study|Other reason|41|||
23414918|NCT01272037|65260771|FG000|Overall Study|Delinquent data|24|||
23414919|NCT01272037|65260772|FG001|Overall Study|Delinquent data|19|||
23414920|NCT01272037|65260771|FG000|Overall Study|Reason under review|33|||
23414921|NCT01272037|65260772|FG001|Overall Study|Reason under review|29|||
23512292|NCT01905657|65612713|FG001|Overall Study|Protocol Violation|1|||
23414922|NCT01272037|65260771|FG000|Overall Study|On treatment|626|||
23414923|NCT01272037|65260772|FG001|Overall Study|On treatment|632|||
23414924|NCT04004221|65260773|FG000|Overall Study|Death|89|||
23414925|NCT04004221|65260773|FG000|Overall Study|Withdrawal by Subject|5|||
23414926|NCT04004221|65260773|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
23414927|NCT04004221|65260773|FG000|Overall Study|Sponsor Decision|9|||
23414928|NCT04004221|65260773|FG000|Overall Study|Participant refused to enter LTE|1|||
23414929|NCT01302834|65260781|FG000|Overall Study|Protocol Violation|17|||
23414930|NCT01302834|65260782|FG001|Overall Study|Protocol Violation|23|||
23414931|NCT01302834|65260781|FG000|Overall Study|HIV positive|1|||
23414932|NCT01302834|65260782|FG001|Overall Study|HIV positive|3|||
23414933|NCT00588770|65260785|FG000|Overall Study|Disease progression|85|||
23414934|NCT00588770|65260786|FG001|Overall Study|Disease progression|68|||
23414935|NCT00588770|65260785|FG000|Overall Study|Adverse Event|29|||
23414936|NCT00588770|65260786|FG001|Overall Study|Adverse Event|58|||
23414937|NCT00588770|65260785|FG000|Overall Study|Death|13|||
23414938|NCT00588770|65260786|FG001|Overall Study|Death|22|||
23414939|NCT00588770|65260785|FG000|Overall Study|Withdrawal by Subject|15|||
23414940|NCT00588770|65260786|FG001|Overall Study|Withdrawal by Subject|25|||
23414941|NCT00588770|65260785|FG000|Overall Study|Alternative therapy|2|||
23414942|NCT00588770|65260786|FG001|Overall Study|Alternative therapy|4|||
23414943|NCT00588770|65260785|FG000|Overall Study|Other complicating disease|3|||
23414944|NCT00588770|65260786|FG001|Overall Study|Other complicating disease|2|||
23414945|NCT00588770|65260785|FG000|Overall Study|Not start protocol therapy|0|||
23414946|NCT00588770|65260786|FG001|Overall Study|Not start protocol therapy|9|||
23414947|NCT00588770|65260785|FG000|Overall Study|Lack of Efficacy|8|||
23414948|NCT00588770|65260786|FG001|Overall Study|Lack of Efficacy|10|||
23414949|NCT00588770|65260785|FG000|Overall Study|Physician discretion|2|||
23414950|NCT00588770|65260786|FG001|Overall Study|Physician discretion|0|||
23414951|NCT00588770|65260785|FG000|Overall Study|Patient non-compliance|2|||
23414952|NCT00588770|65260786|FG001|Overall Study|Patient non-compliance|2|||
23414953|NCT00324805|65260787|FG000|Overall Study|Adverse Event|62|||
23414954|NCT00324805|65260788|FG001|Overall Study|Adverse Event|203|||
23414955|NCT00324805|65260787|FG000|Overall Study|Progression|7|||
23414956|NCT00324805|65260788|FG001|Overall Study|Progression|35|||
23414957|NCT00324805|65260787|FG000|Overall Study|Withdrawal by Subject|51|||
23414958|NCT00324805|65260788|FG001|Overall Study|Withdrawal by Subject|174|||
23414959|NCT00324805|65260787|FG000|Overall Study|Death|6|||
23414960|NCT00324805|65260788|FG001|Overall Study|Death|9|||
23414961|NCT00324805|65260787|FG000|Overall Study|Alternative therapy|4|||
23414962|NCT00324805|65260788|FG001|Overall Study|Alternative therapy|8|||
23414963|NCT00324805|65260787|FG000|Overall Study|Other complicating disease|1|||
23414964|NCT00324805|65260788|FG001|Overall Study|Other complicating disease|9|||
23414965|NCT00324805|65260787|FG000|Overall Study|Other reasons|7|||
23414966|NCT00324805|65260788|FG001|Overall Study|Other reasons|26|||
23414967|NCT00324805|65260787|FG000|Overall Study|Other|0|||
23414968|NCT00324805|65260788|FG001|Overall Study|Other|2|||
23414969|NCT00324805|65260787|FG000|Overall Study|Did not start therapy|12|||
23414970|NCT00324805|65260788|FG001|Overall Study|Did not start therapy|17|||
23414971|NCT00569127|65260789|FG000|Overall Study|Adverse Event|57|||
23414972|NCT00569127|65260790|FG001|Overall Study|Adverse Event|47|||
23414973|NCT00569127|65260789|FG000|Overall Study|Withdrawal by Subject|13|||
23414974|NCT00569127|65260790|FG001|Overall Study|Withdrawal by Subject|27|||
23307512|NCT03493386|64870534|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23414975|NCT00569127|65260789|FG000|Overall Study|Progression|99|||
23414976|NCT00569127|65260790|FG001|Overall Study|Progression|100|||
23414977|NCT00569127|65260789|FG000|Overall Study|Death|4|||
23414978|NCT00569127|65260790|FG001|Overall Study|Death|3|||
23414979|NCT00569127|65260789|FG000|Overall Study|Other|20|||
23414980|NCT00569127|65260790|FG001|Overall Study|Other|19|||
23414981|NCT00569127|65260789|FG000|Overall Study|Lost to Follow-up|0|||
23414982|NCT00569127|65260790|FG001|Overall Study|Lost to Follow-up|3|||
23414983|NCT00569127|65260789|FG000|Overall Study|Not Eligible|14|||
23414984|NCT00569127|65260790|FG001|Overall Study|Not Eligible|11|||
23414985|NCT00569127|65260789|FG000|Overall Study|Still on Treatment|7|||
23414986|NCT00569127|65260790|FG001|Overall Study|Still on Treatment|3|||
23611006|NCT00472199|65966683|FG000|Overall Study|Withdrawal by Subject|6|||
23611007|NCT00472199|65966684|FG001|Overall Study|Withdrawal by Subject|5|||
23611008|NCT00472199|65966683|FG000|Overall Study|personal reason|0|||
23611009|NCT00472199|65966684|FG001|Overall Study|personal reason|1|||
23611010|NCT00472199|65966683|FG000|Overall Study|patient was asymptomatic|1|||
23611011|NCT00472199|65966684|FG001|Overall Study|patient was asymptomatic|0|||
23611012|NCT02268526|65966685|FG000|Overall Study|Adverse Event|0|||
23611013|NCT02268526|65966686|FG001|Overall Study|Adverse Event|2|||
23611014|NCT02268526|65966687|FG002|Overall Study|Adverse Event|1|||
23611015|NCT02268526|65966685|FG000|Overall Study|Death|1|||
23611016|NCT02268526|65966686|FG001|Overall Study|Death|11|||
23611017|NCT02268526|65966687|FG002|Overall Study|Death|0|||
23611018|NCT02268526|65966685|FG000|Overall Study|protocol deviation|0|||
23611019|NCT02268526|65966686|FG001|Overall Study|protocol deviation|1|||
23611020|NCT02268526|65966687|FG002|Overall Study|protocol deviation|0|||
23611021|NCT02268526|65966685|FG000|Overall Study|Physician Decision|0|||
23611022|NCT02268526|65966686|FG001|Overall Study|Physician Decision|0|||
23611023|NCT02268526|65966687|FG002|Overall Study|Physician Decision|1|||
23611024|NCT02268526|65966685|FG000|Overall Study|Subject/guardian decision|0|||
23512293|NCT01905657|65612714|FG002|Overall Study|Protocol Violation|1|||
23611025|NCT02268526|65966686|FG001|Overall Study|Subject/guardian decision|7|||
23611026|NCT02268526|65966687|FG002|Overall Study|Subject/guardian decision|3|||
23611027|NCT00555620|65966688|FG000|Overall Study|Death|0|||
23611028|NCT00555620|65966689|FG001|Overall Study|Death|1|||
23611029|NCT00555620|65966690|FG002|Overall Study|Death|0|||
23611030|NCT00555620|65966691|FG003|Overall Study|Death|0|||
23512294|NCT01905657|65612712|FG000|Overall Study|Screen Failure|0|||
23611031|NCT00555620|65966692|FG004|Overall Study|Death|0|||
23611032|NCT00555620|65966693|FG005|Overall Study|Death|1|||
23611033|NCT00555620|65966688|FG000|Overall Study|Study terminated by sponsor|0|||
23611034|NCT00555620|65966689|FG001|Overall Study|Study terminated by sponsor|0|||
23611035|NCT00555620|65966690|FG002|Overall Study|Study terminated by sponsor|1|||
23611036|NCT00555620|65966691|FG003|Overall Study|Study terminated by sponsor|0|||
23611037|NCT00555620|65966692|FG004|Overall Study|Study terminated by sponsor|0|||
23611038|NCT00555620|65966693|FG005|Overall Study|Study terminated by sponsor|0|||
23611039|NCT00555620|65966688|FG000|Overall Study|Adverse Event|0|||
23611040|NCT00555620|65966689|FG001|Overall Study|Adverse Event|0|||
23611041|NCT00555620|65966690|FG002|Overall Study|Adverse Event|1|||
23611042|NCT00555620|65966691|FG003|Overall Study|Adverse Event|5|||
23611043|NCT00555620|65966692|FG004|Overall Study|Adverse Event|0|||
23611044|NCT00555620|65966693|FG005|Overall Study|Adverse Event|1|||
23611045|NCT00555620|65966688|FG000|Overall Study|Objective progression or relapse|6|||
23611046|NCT00555620|65966689|FG001|Overall Study|Objective progression or relapse|5|||
23611047|NCT00555620|65966690|FG002|Overall Study|Objective progression or relapse|12|||
23611048|NCT00555620|65966691|FG003|Overall Study|Objective progression or relapse|17|||
23611049|NCT00555620|65966692|FG004|Overall Study|Objective progression or relapse|3|||
23611050|NCT00555620|65966693|FG005|Overall Study|Objective progression or relapse|16|||
23611051|NCT00555620|65966688|FG000|Overall Study|Participant refused treatment|0|||
23611052|NCT00555620|65966689|FG001|Overall Study|Participant refused treatment|1|||
23611053|NCT00555620|65966690|FG002|Overall Study|Participant refused treatment|1|||
23611054|NCT00555620|65966691|FG003|Overall Study|Participant refused treatment|0|||
23611055|NCT00555620|65966692|FG004|Overall Study|Participant refused treatment|0|||
23611056|NCT00555620|65966693|FG005|Overall Study|Participant refused treatment|1|||
23611057|NCT00555620|65966688|FG000|Overall Study|Other|0|||
23611058|NCT00555620|65966689|FG001|Overall Study|Other|0|||
23611059|NCT00555620|65966690|FG002|Overall Study|Other|0|||
23611060|NCT00555620|65966691|FG003|Overall Study|Other|1|||
23611061|NCT00555620|65966692|FG004|Overall Study|Other|0|||
23611062|NCT00555620|65966693|FG005|Overall Study|Other|3|||
23611063|NCT01825785|65966698|FG000|Overall Study|Adverse Event|0|||
23611064|NCT01825785|65966699|FG001|Overall Study|Adverse Event|0|||
23611065|NCT01825785|65966700|FG002|Overall Study|Adverse Event|0|||
23611066|NCT01825785|65966701|FG003|Overall Study|Adverse Event|0|||
23611067|NCT01825785|65966702|FG004|Overall Study|Adverse Event|1|||
23611068|NCT01825785|65966703|FG005|Overall Study|Adverse Event|0|||
23611069|NCT01825785|65966704|FG006|Overall Study|Adverse Event|0|||
23611070|NCT01825785|65966698|FG000|Overall Study|Withdrawal by Subject|0|||
23611071|NCT01825785|65966699|FG001|Overall Study|Withdrawal by Subject|0|||
23611072|NCT01825785|65966700|FG002|Overall Study|Withdrawal by Subject|0|||
23611073|NCT01825785|65966701|FG003|Overall Study|Withdrawal by Subject|0|||
23611074|NCT01825785|65966702|FG004|Overall Study|Withdrawal by Subject|1|||
23611075|NCT01825785|65966703|FG005|Overall Study|Withdrawal by Subject|1|||
23611076|NCT01825785|65966704|FG006|Overall Study|Withdrawal by Subject|0|||
23611077|NCT00668746|65966705|FG000|Overall Study|Lost to Follow-up|2|||
23611078|NCT00668746|65966706|FG001|Overall Study|Lost to Follow-up|1|||
23611079|NCT03436797|65966709|FG000|Main Study|Withdrawal by Subject|2|||
23611080|NCT03436797|65966709|FG000|Main Study|Adverse Event|4|||
23611081|NCT03436797|65966709|FG000|Main Study|Lost to Follow-up|1|||
23611082|NCT03436797|65966709|FG000|Main Study|Death|1|||
23611083|NCT03436797|65966709|FG000|Main Study|Non-Specific|2|||
23611084|NCT03436797|65966709|FG000|Extended Dosing|Patient decision|1|||
23611085|NCT03020914|65966710|FG000|Overall Study|Surgery Cancelled|1|||
23611086|NCT03020914|65966711|FG001|Overall Study|Surgery Cancelled|0|||
23611087|NCT01072149|65966713|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611088|NCT01072149|65966714|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611089|NCT01072149|65966715|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23611090|NCT01072149|65966716|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611091|NCT01072149|65966717|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611092|NCT01072149|65966718|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611093|NCT01072149|65966719|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611094|NCT01072149|65966720|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611095|NCT01072149|65966721|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611096|NCT01072149|65966722|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611097|NCT01072149|65966723|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611098|NCT01072149|65966724|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23512295|NCT01905657|65612713|FG001|Overall Study|Screen Failure|1|||
23512296|NCT01905657|65612714|FG002|Overall Study|Screen Failure|0|||
23512297|NCT01905657|65612712|FG000|Overall Study|Withdrawal by Subject|15|||
23512298|NCT01905657|65612713|FG001|Overall Study|Withdrawal by Subject|21|||
23512299|NCT01905657|65612714|FG002|Overall Study|Withdrawal by Subject|53|||
23512300|NCT01905657|65612712|FG000|Overall Study|Sponsor Decision|1|||
23512301|NCT01905657|65612713|FG001|Overall Study|Sponsor Decision|0|||
23512302|NCT01905657|65612714|FG002|Overall Study|Sponsor Decision|0|||
23512303|NCT05035550|65612715|FG000|Overall Study|Withdrawal by Subject|3|||
23512304|NCT05035550|65612716|FG001|Overall Study|Withdrawal by Subject|0|||
23512305|NCT03414424|65612721|FG000|Overall Study|Screened out after consent|0|||
23512306|NCT03414424|65612722|FG001|Overall Study|Screened out after consent|2|||
23512307|NCT03414424|65612721|FG000|Overall Study|Lost to Follow-up|0|||
23512308|NCT03414424|65612722|FG001|Overall Study|Lost to Follow-up|1|||
23611099|NCT01072149|65966725|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611100|NCT01072149|65966726|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611101|NCT01072149|65966727|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611102|NCT01072149|65966728|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611103|NCT01072149|65966729|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611104|NCT01072149|65966730|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23611105|NCT01072149|65966713|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611106|NCT01072149|65966714|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611107|NCT01072149|65966715|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611108|NCT01072149|65966716|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611109|NCT01072149|65966717|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611110|NCT01072149|65966718|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611111|NCT01072149|65966719|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611112|NCT01072149|65966720|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23512309|NCT04501666|65612723|FG000|Overall Study|Physician Decision|0|||
23512310|NCT04501666|65612724|FG001|Overall Study|Physician Decision|1|||
23512311|NCT04501666|65612723|FG000|Overall Study|Adverse Event|12|||
23512312|NCT04501666|65612724|FG001|Overall Study|Adverse Event|4|||
23512313|NCT04501666|65612723|FG000|Overall Study|Subject's request|10|||
23512314|NCT04501666|65612724|FG001|Overall Study|Subject's request|6|||
23512315|NCT04501666|65612723|FG000|Overall Study|Protocol Deviation|2|||
23512316|NCT04501666|65612724|FG001|Overall Study|Protocol Deviation|1|||
23512317|NCT04501666|65612723|FG000|Overall Study|Other-- site permanently closing|0|||
23512318|NCT04501666|65612724|FG001|Overall Study|Other-- site permanently closing|1|||
23512319|NCT02730455|65612725|FG000|Overall Study|Death|5|||
23512320|NCT02730455|65612726|FG001|Overall Study|Death|6|||
23512321|NCT02730455|65612727|FG002|Overall Study|Death|4|||
23512322|NCT02730455|65612725|FG000|Overall Study|Consent withdrawn|2|||
23512323|NCT02730455|65612726|FG001|Overall Study|Consent withdrawn|4|||
23512324|NCT02730455|65612727|FG002|Overall Study|Consent withdrawn|1|||
23512325|NCT02730455|65612725|FG000|Overall Study|Lost to Follow-up|3|||
23512326|NCT02730455|65612726|FG001|Overall Study|Lost to Follow-up|1|||
23512327|NCT02730455|65612727|FG002|Overall Study|Lost to Follow-up|4|||
23512328|NCT02730455|65612725|FG000|Overall Study|Other|1|||
23512329|NCT02730455|65612726|FG001|Overall Study|Other|1|||
23512330|NCT02730455|65612727|FG002|Overall Study|Other|2|||
23512331|NCT02730455|65612725|FG000|Overall Study|Other|2|||
23512332|NCT02730455|65612726|FG001|Overall Study|Other|2|||
23512333|NCT02730455|65612727|FG002|Overall Study|Other|0|||
23512334|NCT03336333|65612728|FG000|Overall Study|Remained on study at time of data cut-off|202|||
23512335|NCT03336333|65612729|FG001|Overall Study|Remained on study at time of data cut-off|219|||
23512336|NCT03336333|65612730|FG002|Overall Study|Remained on study at time of data cut-off|102|||
23512337|NCT03336333|65612728|FG000|Overall Study|Death|14|||
23512338|NCT03336333|65612729|FG001|Overall Study|Death|16|||
23512339|NCT03336333|65612730|FG002|Overall Study|Death|8|||
23512340|NCT03336333|65612728|FG000|Overall Study|Withdrawal by Subject|16|||
23512341|NCT03336333|65612729|FG001|Overall Study|Withdrawal by Subject|5|||
23611113|NCT01072149|65966721|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23512342|NCT03336333|65612730|FG002|Overall Study|Withdrawal by Subject|1|||
23512343|NCT03336333|65612728|FG000|Overall Study|Physician Decision|5|||
23512344|NCT03336333|65612729|FG001|Overall Study|Physician Decision|1|||
23611114|NCT01072149|65966722|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611115|NCT01072149|65966723|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611116|NCT01072149|65966724|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611117|NCT01072149|65966725|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611118|NCT01072149|65966726|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611119|NCT01072149|65966727|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611120|NCT01072149|65966728|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611121|NCT01072149|65966729|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
23611122|NCT01072149|65966730|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
23611123|NCT01072149|65966713|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611124|NCT01072149|65966714|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611125|NCT01072149|65966715|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611126|NCT01072149|65966716|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611127|NCT01072149|65966717|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611128|NCT01072149|65966718|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611129|NCT01072149|65966719|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611130|NCT01072149|65966720|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611131|NCT01072149|65966721|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23415055|NCT04659174|65260803|FG000|Overall Study|Sponsor decision to discontinue study|0|||
23415056|NCT04659174|65260804|FG001|Overall Study|Sponsor decision to discontinue study|2|||
23415057|NCT04659174|65260803|FG000|Overall Study|Lost to Follow-up|9|||
23415058|NCT04659174|65260804|FG001|Overall Study|Lost to Follow-up|11|||
23415059|NCT04659174|65260803|FG000|Overall Study|Adverse Event|8|||
23415060|NCT04659174|65260804|FG001|Overall Study|Adverse Event|5|||
23415061|NCT04659174|65260803|FG000|Overall Study|Withdrawal by Subject|17|||
23415062|NCT04659174|65260804|FG001|Overall Study|Withdrawal by Subject|33|||
23415063|NCT04659174|65260803|FG000|Overall Study|Progressive disease|0|||
23415064|NCT04659174|65260804|FG001|Overall Study|Progressive disease|2|||
23415065|NCT04659174|65260803|FG000|Overall Study|Other reasons|0|||
23512345|NCT03336333|65612730|FG002|Overall Study|Physician Decision|0|||
23512346|NCT03336333|65612728|FG000|Overall Study|Lost to Follow-up|1|||
23512347|NCT03336333|65612729|FG001|Overall Study|Lost to Follow-up|0|||
23512348|NCT03336333|65612730|FG002|Overall Study|Lost to Follow-up|0|||
23512349|NCT00662363|65612731|FG000|Overall Study|Withdrawal by Subject|6|||
23512350|NCT00662363|65612732|FG001|Overall Study|Withdrawal by Subject|5|||
23512351|NCT00662363|65612731|FG000|Overall Study|Adverse Event|0|||
23512352|NCT00662363|65612732|FG001|Overall Study|Adverse Event|3|||
23512353|NCT00662363|65612731|FG000|Overall Study|Discharged early from rehab|4|||
23512354|NCT00662363|65612732|FG001|Overall Study|Discharged early from rehab|1|||
23512355|NCT00662363|65612731|FG000|Overall Study|Protocol Violation|1|||
23512356|NCT00662363|65612732|FG001|Overall Study|Protocol Violation|1|||
23512357|NCT05620563|65612733|FG000|Overall Study|Adverse Event|3|||
23512358|NCT05620563|65612734|FG001|Overall Study|Adverse Event|1|||
23512359|NCT05620563|65612733|FG000|Overall Study|Lost to Follow-up|0|||
23512360|NCT05620563|65612734|FG001|Overall Study|Lost to Follow-up|2|||
23512361|NCT05620563|65612733|FG000|Overall Study|Protocol Deviation|1|||
23512362|NCT05620563|65612734|FG001|Overall Study|Protocol Deviation|2|||
23512363|NCT05620563|65612733|FG000|Overall Study|Withdrawal by Subject|3|||
23512364|NCT05620563|65612734|FG001|Overall Study|Withdrawal by Subject|3|||
23512365|NCT05620563|65612733|FG000|Overall Study|Physician Decision|0|||
23512366|NCT05620563|65612734|FG001|Overall Study|Physician Decision|1|||
23512367|NCT00865124|65612739|FG000|Overall Study|Physician Decision|2|||
23512368|NCT00865124|65612740|FG001|Overall Study|Physician Decision|1|||
23512369|NCT00865124|65612741|FG002|Overall Study|Physician Decision|0|||
23415066|NCT04659174|65260804|FG001|Overall Study|Other reasons|2|||
23415067|NCT04659174|65260803|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
23415068|NCT04659174|65260804|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
23415069|NCT04659174|65260803|FG000|Overall Study|Alcohol or illegal drug use|0|||
23512370|NCT00865124|65612739|FG000|Overall Study|Withdrawn consent|2|||
23512371|NCT00865124|65612740|FG001|Overall Study|Withdrawn consent|0|||
23512372|NCT00865124|65612741|FG002|Overall Study|Withdrawn consent|0|||
23512373|NCT01806545|65612742|FG000|Overall Study|Adverse Event|2|||
23415070|NCT04659174|65260804|FG001|Overall Study|Alcohol or illegal drug use|3|||
23415071|NCT04659174|65260803|FG000|Overall Study|Violation of entry criteria|1|||
23415072|NCT04659174|65260804|FG001|Overall Study|Violation of entry criteria|0|||
23415073|NCT04659174|65260803|FG000|Overall Study|Death|0|||
23415074|NCT04659174|65260804|FG001|Overall Study|Death|1|||
23415075|NCT04238481|65260809|FG000|Overall Study|Miscellaneous|0|||
23512374|NCT01806545|65612743|FG001|Overall Study|Adverse Event|3|||
23512375|NCT01806545|65612742|FG000|Overall Study|Lost to Follow-up|1|||
23512376|NCT01806545|65612743|FG001|Overall Study|Lost to Follow-up|0|||
23512377|NCT01806545|65612742|FG000|Overall Study|Withdrawal by Subject|3|||
23512378|NCT01806545|65612743|FG001|Overall Study|Withdrawal by Subject|2|||
23512379|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23415076|NCT04238481|65260810|FG001|Overall Study|Miscellaneous|1|||
23415077|NCT04238481|65260811|FG002|Overall Study|Miscellaneous|0|||
23415078|NCT04238481|65260812|FG003|Overall Study|Miscellaneous|0|||
23415079|NCT03462719|65260813|FG000|Overall Study|Withdrawal by Subject|4|||
23415080|NCT03462719|65260814|FG001|Overall Study|Withdrawal by Subject|3|||
23415081|NCT03462719|65260813|FG000|Overall Study|Ongoing|87|||
23415082|NCT03462719|65260814|FG001|Overall Study|Ongoing|72|||
23415083|NCT03006848|65260815|FG000|Overall Study|Adverse Event|1|||
23415084|NCT03006848|65260815|FG000|Overall Study|Physician Decision|1|||
23415085|NCT03006848|65260815|FG000|Overall Study|Lack of Efficacy|16|||
23415086|NCT03783442|65260816|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
23415087|NCT03783442|65260817|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
23415088|NCT03783442|65260816|FG000|Overall Study|Death|196|||
23415089|NCT03783442|65260817|FG001|Overall Study|Death|226|||
23415090|NCT03783442|65260816|FG000|Overall Study|Withdrawal by Subject|14|||
23415091|NCT03783442|65260817|FG001|Overall Study|Withdrawal by Subject|17|||
23415092|NCT03783442|65260816|FG000|Overall Study|Lost to Follow-up|2|||
23415093|NCT03783442|65260817|FG001|Overall Study|Lost to Follow-up|3|||
23415094|NCT01932372|65260820|FG000|Overall Study|Not meeting eligibility criteria|33|||
23415095|NCT01932372|65260821|FG001|Overall Study|Not meeting eligibility criteria|179|||
23415096|NCT05145322|65260822|FG000|Overall Study|Lost to Follow-up|4|||
23415097|NCT05145322|65260823|FG001|Overall Study|Lost to Follow-up|5|||
23611132|NCT01072149|65966722|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611133|NCT01072149|65966723|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
23611134|NCT01072149|65966724|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611135|NCT01072149|65966725|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611136|NCT01072149|65966726|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611137|NCT01072149|65966727|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611138|NCT01072149|65966728|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611139|NCT01072149|65966729|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611140|NCT01072149|65966730|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23611141|NCT01072149|65966713|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611142|NCT01072149|65966714|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
23611143|NCT01072149|65966715|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611144|NCT01072149|65966716|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611145|NCT01072149|65966717|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23415112|NCT04382586|65260826|FG000|Overall Study|Death|3|||
23415113|NCT04382586|65260827|FG001|Overall Study|Death|4|||
23415114|NCT04382586|65260826|FG000|Overall Study|Lost to Follow-up|11|||
23415115|NCT04382586|65260827|FG001|Overall Study|Lost to Follow-up|8|||
23415116|NCT04382586|65260826|FG000|Overall Study|Withdrawal by Subject|3|||
23415117|NCT04382586|65260827|FG001|Overall Study|Withdrawal by Subject|1|||
23415118|NCT04382586|65260826|FG000|Overall Study|Physician Decision|0|||
23415119|NCT04382586|65260827|FG001|Overall Study|Physician Decision|3|||
23415120|NCT04532294|65260828|FG000|Overall Study|Withdrawal by Subject|0|||
23415121|NCT04532294|65260829|FG001|Overall Study|Withdrawal by Subject|0|||
23415122|NCT04532294|65260830|FG002|Overall Study|Withdrawal by Subject|1|||
23415123|NCT04532294|65260828|FG000|Overall Study|Participants Not Dosed|0|||
23415124|NCT04532294|65260829|FG001|Overall Study|Participants Not Dosed|0|||
23415125|NCT04532294|65260830|FG002|Overall Study|Participants Not Dosed|2|||
23611146|NCT01072149|65966718|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611147|NCT01072149|65966719|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611148|NCT01072149|65966720|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611149|NCT01072149|65966721|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23415132|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
23415133|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
23415134|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
23415135|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
23307513|NCT01884311|64870537|FG000|Overall Study|Withdrawal by Subject|3|||
23307514|NCT01884311|64870537|FG000|Overall Study|withdrew consent due to AEs|1|||
23415136|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
23415137|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
23415138|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Death|1|||
23415139|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Death|4|||
23415140|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
23415141|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
23415142|NCT00658814|65260844|FG000|Remission Induction Chemotherapy|Not eligible|1|||
23415143|NCT00658814|65260845|FG001|Remission Induction Chemotherapy|Not eligible|2|||
23415144|NCT00658814|65260844|FG000|Consolidation Therapy|Not protocol specified|0|||
23415145|NCT00658814|65260845|FG001|Consolidation Therapy|Not protocol specified|1|||
23415146|NCT00658814|65260844|FG000|Consolidation Therapy|Not eligible|2|||
23415147|NCT00658814|65260845|FG001|Consolidation Therapy|Not eligible|2|||
23415148|NCT00658814|65260844|FG000|Maintenance Therapy|Adverse Event|1|||
23415149|NCT00658814|65260845|FG001|Maintenance Therapy|Adverse Event|1|||
23415150|NCT00658814|65260844|FG000|Maintenance Therapy|Not protocol specified|1|||
23415151|NCT00658814|65260845|FG001|Maintenance Therapy|Not protocol specified|0|||
23415152|NCT00658814|65260844|FG000|Maintenance Therapy|Not eligible|1|||
23415153|NCT00658814|65260845|FG001|Maintenance Therapy|Not eligible|0|||
23415154|NCT00769379|65260846|FG000|Overall Study|No follow up data mapped to Other.|3|||
23415155|NCT00769379|65260847|FG001|Overall Study|No follow up data mapped to Other.|13|||
23415156|NCT02265536|65260848|FG000|Overall Study|Adverse Event|1|||
23415157|NCT02265536|65260849|FG001|Overall Study|Adverse Event|0|||
23415158|NCT02265536|65260850|FG002|Overall Study|Adverse Event|0|||
23415159|NCT02265536|65260851|FG003|Overall Study|Adverse Event|0|||
23415160|NCT02265536|65260852|FG004|Overall Study|Adverse Event|1|||
23415161|NCT02265536|65260853|FG005|Overall Study|Adverse Event|0|||
23415162|NCT02265536|65260848|FG000|Overall Study|Physician Decision|0|||
23415163|NCT02265536|65260849|FG001|Overall Study|Physician Decision|0|||
23415164|NCT02265536|65260850|FG002|Overall Study|Physician Decision|0|||
23415165|NCT02265536|65260851|FG003|Overall Study|Physician Decision|0|||
23415166|NCT02265536|65260852|FG004|Overall Study|Physician Decision|2|||
23415167|NCT02265536|65260853|FG005|Overall Study|Physician Decision|0|||
23415168|NCT02265536|65260848|FG000|Overall Study|Withdrawal by Subject|0|||
23415169|NCT02265536|65260849|FG001|Overall Study|Withdrawal by Subject|3|||
23415170|NCT02265536|65260850|FG002|Overall Study|Withdrawal by Subject|0|||
23415171|NCT02265536|65260851|FG003|Overall Study|Withdrawal by Subject|0|||
23415172|NCT02265536|65260852|FG004|Overall Study|Withdrawal by Subject|0|||
23415173|NCT02265536|65260853|FG005|Overall Study|Withdrawal by Subject|0|||
23415174|NCT03562975|65260863|FG000|Overall Study|Death|1|||
23415175|NCT03562975|65260863|FG000|Overall Study|Lost to Follow-up|1|||
23415176|NCT03562975|65260863|FG000|Overall Study|Withdrawal by Subject|1|||
23415177|NCT02470585|65260864|FG000|Overall Study|Death|224|||
23415178|NCT02470585|65260865|FG001|Overall Study|Death|227|||
23415179|NCT02470585|65260866|FG002|Overall Study|Death|199|||
23415180|NCT02470585|65260864|FG000|Overall Study|Withdrew consent|21|||
23415181|NCT02470585|65260865|FG001|Overall Study|Withdrew consent|22|||
23415182|NCT02470585|65260866|FG002|Overall Study|Withdrew consent|31|||
23415183|NCT02470585|65260864|FG000|Overall Study|Lost to Follow-up|8|||
23415184|NCT02470585|65260865|FG001|Overall Study|Lost to Follow-up|15|||
23415185|NCT02470585|65260866|FG002|Overall Study|Lost to Follow-up|13|||
23415186|NCT02470585|65260864|FG000|Overall Study|Sponsor discontinued study|117|||
23415187|NCT02470585|65260865|FG001|Overall Study|Sponsor discontinued study|110|||
23415188|NCT02470585|65260866|FG002|Overall Study|Sponsor discontinued study|122|||
23415189|NCT02470585|65260864|FG000|Overall Study|Other, not specified|5|||
23415190|NCT02470585|65260865|FG001|Overall Study|Other, not specified|7|||
23415191|NCT02470585|65260866|FG002|Overall Study|Other, not specified|14|||
23415192|NCT02470585|65260864|FG000|Overall Study|Missing due to site non-compliance|0|||
23415193|NCT02470585|65260865|FG001|Overall Study|Missing due to site non-compliance|2|||
23415194|NCT02470585|65260866|FG002|Overall Study|Missing due to site non-compliance|3|||
23415195|NCT01096368|65260876|FG000|Overall Study|Death|0|||
23415196|NCT01096368|65260877|FG001|Overall Study|Death|1|||
23512380|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512381|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512382|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512383|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512384|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
23512385|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
23512386|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512387|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512388|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512389|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512390|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512391|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
23512392|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
23512393|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512394|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512395|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512396|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512397|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512398|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
23512399|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
23512400|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23512401|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23512402|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23512403|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23415197|NCT01096368|65260878|FG002|Overall Study|Death|0|||
23415198|NCT01096368|65260879|FG003|Overall Study|Death|0|||
23415199|NCT01096368|65260880|FG004|Overall Study|Death|0|||
23415200|NCT01096368|65260876|FG000|Overall Study|Physician Decision|0|||
23415201|NCT01096368|65260877|FG001|Overall Study|Physician Decision|13|||
23415202|NCT01096368|65260878|FG002|Overall Study|Physician Decision|2|||
23415203|NCT01096368|65260879|FG003|Overall Study|Physician Decision|4|||
23415204|NCT01096368|65260880|FG004|Overall Study|Physician Decision|6|||
23415205|NCT01096368|65260876|FG000|Overall Study|Withdrawal by Subject|0|||
23415206|NCT01096368|65260877|FG001|Overall Study|Withdrawal by Subject|52|||
23415207|NCT01096368|65260878|FG002|Overall Study|Withdrawal by Subject|0|||
23512404|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23512405|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
23415208|NCT01096368|65260879|FG003|Overall Study|Withdrawal by Subject|10|||
23512406|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
23512407|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
23512408|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
23512409|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
23512410|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
23512411|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
23512412|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
23512413|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
23512414|NCT01059825|65612744|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
23512415|NCT01059825|65612745|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
23512416|NCT01059825|65612746|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
23512417|NCT01059825|65612747|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
23512418|NCT01059825|65612748|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
23512419|NCT01059825|65612749|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
23512420|NCT01059825|65612750|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
23512421|NCT01059825|65612744|FG000|Treatment Period|Lost to Follow-up|2|||
23512422|NCT01059825|65612745|FG001|Treatment Period|Lost to Follow-up|1|||
23512423|NCT01059825|65612746|FG002|Treatment Period|Lost to Follow-up|0|||
23512424|NCT01059825|65612747|FG003|Treatment Period|Lost to Follow-up|1|||
23512425|NCT01059825|65612748|FG004|Treatment Period|Lost to Follow-up|2|||
23512426|NCT01059825|65612749|FG005|Treatment Period|Lost to Follow-up|0|||
23512427|NCT01059825|65612750|FG006|Treatment Period|Lost to Follow-up|0|||
23512428|NCT01059825|65612744|FG000|Treatment Period|Withdrawal by Subject|3|||
23512429|NCT01059825|65612745|FG001|Treatment Period|Withdrawal by Subject|0|||
23512430|NCT01059825|65612746|FG002|Treatment Period|Withdrawal by Subject|1|||
23512431|NCT01059825|65612747|FG003|Treatment Period|Withdrawal by Subject|5|||
23512432|NCT01059825|65612748|FG004|Treatment Period|Withdrawal by Subject|4|||
23512433|NCT01059825|65612749|FG005|Treatment Period|Withdrawal by Subject|1|||
23512434|NCT01059825|65612750|FG006|Treatment Period|Withdrawal by Subject|0|||
23512435|NCT01059825|65612744|FG000|Treatment Period|Other reason not specified|1|||
23512436|NCT01059825|65612745|FG001|Treatment Period|Other reason not specified|2|||
23512437|NCT01059825|65612746|FG002|Treatment Period|Other reason not specified|1|||
23512438|NCT01059825|65612747|FG003|Treatment Period|Other reason not specified|2|||
23512439|NCT01059825|65612748|FG004|Treatment Period|Other reason not specified|0|||
23512440|NCT01059825|65612749|FG005|Treatment Period|Other reason not specified|0|||
23512441|NCT01059825|65612750|FG006|Treatment Period|Other reason not specified|0|||
23512442|NCT01059825|65612744|FG000|Treatment Period|Protocol Violation|0|||
23512443|NCT01059825|65612745|FG001|Treatment Period|Protocol Violation|0|||
23512444|NCT01059825|65612746|FG002|Treatment Period|Protocol Violation|1|||
23512445|NCT01059825|65612747|FG003|Treatment Period|Protocol Violation|1|||
23512446|NCT01059825|65612748|FG004|Treatment Period|Protocol Violation|1|||
23512447|NCT01059825|65612749|FG005|Treatment Period|Protocol Violation|1|||
23512448|NCT01059825|65612750|FG006|Treatment Period|Protocol Violation|0|||
23512449|NCT01059825|65612744|FG000|Treatment Period|Adverse event related to study drug|1|||
23512450|NCT01059825|65612745|FG001|Treatment Period|Adverse event related to study drug|0|||
23512451|NCT01059825|65612746|FG002|Treatment Period|Adverse event related to study drug|1|||
23512452|NCT01059825|65612747|FG003|Treatment Period|Adverse event related to study drug|1|||
23512453|NCT01059825|65612748|FG004|Treatment Period|Adverse event related to study drug|0|||
23512454|NCT01059825|65612749|FG005|Treatment Period|Adverse event related to study drug|0|||
23512455|NCT01059825|65612750|FG006|Treatment Period|Adverse event related to study drug|0|||
23512456|NCT01059825|65612744|FG000|Treatment Period|Insufficient clinical response|3|||
23512457|NCT01059825|65612745|FG001|Treatment Period|Insufficient clinical response|0|||
23512458|NCT01059825|65612746|FG002|Treatment Period|Insufficient clinical response|0|||
23512459|NCT01059825|65612747|FG003|Treatment Period|Insufficient clinical response|0|||
23512460|NCT01059825|65612748|FG004|Treatment Period|Insufficient clinical response|0|||
23512461|NCT01059825|65612749|FG005|Treatment Period|Insufficient clinical response|0|||
23512462|NCT01059825|65612750|FG006|Treatment Period|Insufficient clinical response|0|||
23512463|NCT01059825|65612744|FG000|Treatment Period|Adverse event not related to study drug|0|||
23611150|NCT01072149|65966722|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23415209|NCT01096368|65260880|FG004|Overall Study|Withdrawal by Subject|14|||
23415210|NCT01096368|65260876|FG000|Overall Study|Ineligible|0|||
23415211|NCT01096368|65260877|FG001|Overall Study|Ineligible|3|||
23415212|NCT01096368|65260878|FG002|Overall Study|Ineligible|2|||
23415213|NCT01096368|65260879|FG003|Overall Study|Ineligible|0|||
23415214|NCT01096368|65260880|FG004|Overall Study|Ineligible|25|||
23415215|NCT01096368|65260876|FG000|Overall Study|Did not start treatment|0|||
23415216|NCT01096368|65260877|FG001|Overall Study|Did not start treatment|4|||
23415217|NCT01096368|65260878|FG002|Overall Study|Did not start treatment|4|||
23415218|NCT01096368|65260879|FG003|Overall Study|Did not start treatment|0|||
23415219|NCT01096368|65260880|FG004|Overall Study|Did not start treatment|0|||
23415220|NCT01096368|65260876|FG000|Overall Study|Progressive disease|0|||
23415221|NCT01096368|65260877|FG001|Overall Study|Progressive disease|6|||
23415222|NCT01096368|65260878|FG002|Overall Study|Progressive disease|0|||
23415223|NCT01096368|65260879|FG003|Overall Study|Progressive disease|10|||
23415224|NCT01096368|65260880|FG004|Overall Study|Progressive disease|3|||
23415225|NCT01096368|65260876|FG000|Overall Study|Other|0|||
23415226|NCT01096368|65260877|FG001|Overall Study|Other|0|||
23415227|NCT01096368|65260878|FG002|Overall Study|Other|1|||
23415228|NCT01096368|65260879|FG003|Overall Study|Other|0|||
23415229|NCT01096368|65260880|FG004|Overall Study|Other|0|||
23415230|NCT01096368|65260876|FG000|Overall Study|Treated with institutional review|0|||
23415231|NCT01096368|65260877|FG001|Overall Study|Treated with institutional review|0|||
23415232|NCT01096368|65260878|FG002|Overall Study|Treated with institutional review|0|||
23415233|NCT01096368|65260879|FG003|Overall Study|Treated with institutional review|0|||
23415234|NCT01096368|65260880|FG004|Overall Study|Treated with institutional review|1|||
23415235|NCT00309985|65260881|FG000|Overall Study|Disease progression|12|||
23415236|NCT00309985|65260882|FG001|Overall Study|Disease progression|0|||
23512464|NCT01059825|65612745|FG001|Treatment Period|Adverse event not related to study drug|1|||
23512465|NCT01059825|65612746|FG002|Treatment Period|Adverse event not related to study drug|2|||
23512466|NCT01059825|65612747|FG003|Treatment Period|Adverse event not related to study drug|1|||
23512467|NCT01059825|65612748|FG004|Treatment Period|Adverse event not related to study drug|1|||
23512468|NCT01059825|65612749|FG005|Treatment Period|Adverse event not related to study drug|1|||
23512469|NCT01059825|65612750|FG006|Treatment Period|Adverse event not related to study drug|0|||
23512470|NCT01831544|65612751|FG000|Overall Study|Death|1|||
23512471|NCT01831544|65612751|FG000|Overall Study|Still on original MVAD device|2|||
23512472|NCT03958955|65612752|FG000|Overall Study|Adverse Event|1|||
23512473|NCT03187262|65612753|FG000|Induction|Lack of Efficacy|2|||
23512474|NCT03187262|65612753|FG000|Induction|Progressive Disease|4|||
23512475|NCT03187262|65612753|FG000|Consolidation|Progressive Disease|5|||
23512476|NCT01409564|65612754|FG000|Overall Study|low medication compliance|4|||
23512477|NCT01409564|65612755|FG001|Overall Study|low medication compliance|3|||
23512478|NCT01409564|65612754|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
23512479|NCT01409564|65612755|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
23512480|NCT01508650|65612756|FG000|Overall Study|Lost to Follow-up|0|||
23512481|NCT01508650|65612757|FG001|Overall Study|Lost to Follow-up|3|||
23512482|NCT02769247|65612758|FG000|Overall Study|Withdrawal by Subject|1|||
23512483|NCT02769247|65612759|FG001|Overall Study|Withdrawal by Subject|0|||
23512484|NCT02769247|65612760|FG002|Overall Study|Withdrawal by Subject|0|||
23512485|NCT02769247|65612761|FG003|Overall Study|Withdrawal by Subject|1|||
23512486|NCT02769247|65612758|FG000|Overall Study|Protocol Violation|0|||
23512487|NCT02769247|65612759|FG001|Overall Study|Protocol Violation|0|||
23512488|NCT02769247|65612760|FG002|Overall Study|Protocol Violation|1|||
23512489|NCT02769247|65612761|FG003|Overall Study|Protocol Violation|0|||
23512490|NCT02769247|65612758|FG000|Overall Study|Physician Decision|1|||
23512491|NCT02769247|65612759|FG001|Overall Study|Physician Decision|0|||
23512492|NCT02769247|65612760|FG002|Overall Study|Physician Decision|0|||
23512493|NCT02769247|65612761|FG003|Overall Study|Physician Decision|0|||
23512494|NCT00143403|65612763|FG000|Overall Study|Adverse Event|3|||
23512495|NCT00143403|65612764|FG001|Overall Study|Adverse Event|8|||
23512496|NCT00143403|65612763|FG000|Overall Study|Death|1|||
23512497|NCT00143403|65612764|FG001|Overall Study|Death|0|||
23512498|NCT00143403|65612763|FG000|Overall Study|Withdrawal by Subject|3|||
23512499|NCT00143403|65612764|FG001|Overall Study|Withdrawal by Subject|12|||
23512500|NCT00143403|65612763|FG000|Overall Study|Relapse|15|||
23512501|NCT00143403|65612764|FG001|Overall Study|Relapse|7|||
23512502|NCT00143403|65612763|FG000|Overall Study|Protocol Violation|2|||
23512503|NCT00143403|65612764|FG001|Overall Study|Protocol Violation|2|||
23512504|NCT00143403|65612763|FG000|Overall Study|specified by site|4|||
23512505|NCT00143403|65612764|FG001|Overall Study|specified by site|9|||
23512506|NCT00143403|65612763|FG000|Overall Study|Randomized Not Treated|7|||
23512507|NCT00143403|65612764|FG001|Overall Study|Randomized Not Treated|8|||
23512508|NCT02927080|65612765|FG000|Overall Study|Withdrawal by Subject|0|||
23512509|NCT02927080|65612766|FG001|Overall Study|Withdrawal by Subject|0|||
23512510|NCT02927080|65612767|FG002|Overall Study|Withdrawal by Subject|0|||
23512511|NCT02927080|65612768|FG003|Overall Study|Withdrawal by Subject|0|||
23415237|NCT00309985|65260881|FG000|Overall Study|Adverse Event|30|||
23512512|NCT02927080|65612769|FG004|Overall Study|Withdrawal by Subject|1|||
23512513|NCT02927080|65612770|FG005|Overall Study|Withdrawal by Subject|0|||
23512514|NCT02927080|65612771|FG006|Overall Study|Withdrawal by Subject|1|||
23512515|NCT02927080|65612772|FG007|Overall Study|Withdrawal by Subject|1|||
23512516|NCT02927080|65612773|FG008|Overall Study|Withdrawal by Subject|0|||
23512517|NCT02927080|65612774|FG009|Overall Study|Withdrawal by Subject|2|||
23512518|NCT02927080|65612765|FG000|Overall Study|Willingness to comply with protocol|0|||
23512519|NCT02927080|65612766|FG001|Overall Study|Willingness to comply with protocol|0|||
23512520|NCT02927080|65612767|FG002|Overall Study|Willingness to comply with protocol|0|||
23512521|NCT02927080|65612768|FG003|Overall Study|Willingness to comply with protocol|0|||
23512522|NCT02927080|65612769|FG004|Overall Study|Willingness to comply with protocol|0|||
23512523|NCT02927080|65612770|FG005|Overall Study|Willingness to comply with protocol|0|||
23512524|NCT02927080|65612771|FG006|Overall Study|Willingness to comply with protocol|0|||
23512525|NCT02927080|65612772|FG007|Overall Study|Willingness to comply with protocol|0|||
23512526|NCT02927080|65612773|FG008|Overall Study|Willingness to comply with protocol|0|||
23512527|NCT02927080|65612774|FG009|Overall Study|Willingness to comply with protocol|1|||
23512528|NCT02927080|65612765|FG000|Overall Study|Study terminated by Sponsor|0|||
23512529|NCT02927080|65612766|FG001|Overall Study|Study terminated by Sponsor|0|||
23512530|NCT02927080|65612767|FG002|Overall Study|Study terminated by Sponsor|0|||
23512531|NCT02927080|65612768|FG003|Overall Study|Study terminated by Sponsor|0|||
23512532|NCT02927080|65612769|FG004|Overall Study|Study terminated by Sponsor|0|||
23512533|NCT02927080|65612770|FG005|Overall Study|Study terminated by Sponsor|0|||
23512534|NCT02927080|65612771|FG006|Overall Study|Study terminated by Sponsor|6|||
23512535|NCT02927080|65612772|FG007|Overall Study|Study terminated by Sponsor|7|||
23512536|NCT02927080|65612773|FG008|Overall Study|Study terminated by Sponsor|2|||
23512537|NCT02927080|65612774|FG009|Overall Study|Study terminated by Sponsor|3|||
23512538|NCT02927080|65612765|FG000|Overall Study|Adverse Event|0|||
23415238|NCT00309985|65260882|FG001|Overall Study|Adverse Event|0|||
23415239|NCT00309985|65260881|FG000|Overall Study|Death|2|||
23415240|NCT00309985|65260882|FG001|Overall Study|Death|0|||
23512539|NCT02927080|65612766|FG001|Overall Study|Adverse Event|1|||
23512540|NCT02927080|65612767|FG002|Overall Study|Adverse Event|0|||
23512541|NCT02927080|65612768|FG003|Overall Study|Adverse Event|0|||
23512542|NCT02927080|65612769|FG004|Overall Study|Adverse Event|0|||
23512543|NCT02927080|65612770|FG005|Overall Study|Adverse Event|0|||
23512544|NCT02927080|65612771|FG006|Overall Study|Adverse Event|0|||
23512545|NCT02927080|65612772|FG007|Overall Study|Adverse Event|1|||
23512546|NCT02927080|65612773|FG008|Overall Study|Adverse Event|0|||
23512547|NCT02927080|65612774|FG009|Overall Study|Adverse Event|1|||
23415241|NCT00309985|65260881|FG000|Overall Study|Withdrawal by Subject|5|||
23415242|NCT00309985|65260882|FG001|Overall Study|Withdrawal by Subject|1|||
23415243|NCT00309985|65260881|FG000|Overall Study|Physician Decision|3|||
23415244|NCT00309985|65260882|FG001|Overall Study|Physician Decision|0|||
23415245|NCT00309985|65260881|FG000|Overall Study|Never started treatment|7|||
23415246|NCT00309985|65260882|FG001|Overall Study|Never started treatment|0|||
23415247|NCT00309985|65260881|FG000|Overall Study|Complicating disease|1|||
23415248|NCT00309985|65260882|FG001|Overall Study|Complicating disease|0|||
23415249|NCT00309985|65260881|FG000|Overall Study|Non-compliance|1|||
23415250|NCT00309985|65260882|FG001|Overall Study|Non-compliance|0|||
23415251|NCT00309985|65260881|FG000|Overall Study|Chemotherapy discontinued only|1|||
23415252|NCT00309985|65260882|FG001|Overall Study|Chemotherapy discontinued only|0|||
23415253|NCT04730635|65260886|FG000|Overall Study|Lost to Follow-up|1|||
23415254|NCT04730635|65260887|FG001|Overall Study|Lost to Follow-up|0|||
23415255|NCT04730635|65260886|FG000|Overall Study|Withdrawal by Subject|0|||
23415256|NCT04730635|65260887|FG001|Overall Study|Withdrawal by Subject|1|||
23415257|NCT03070223|65260888|FG000|Overall Study|Lost to Follow-up|34|||
23415258|NCT03070223|65260889|FG001|Overall Study|Lost to Follow-up|27|||
23415259|NCT03070223|65260888|FG000|Overall Study|Withdrawal by Subject|12|||
23415260|NCT03070223|65260889|FG001|Overall Study|Withdrawal by Subject|22|||
23415261|NCT03070223|65260888|FG000|Overall Study|Protocol Violation|0|||
23415262|NCT03070223|65260889|FG001|Overall Study|Protocol Violation|1|||
23415263|NCT02308163|65260890|FG000|Overall Study|Not fulfill eligible criteria|1|||
23415264|NCT02308163|65260891|FG001|Overall Study|Not fulfill eligible criteria|2|||
23415265|NCT02308163|65260892|FG002|Overall Study|Not fulfill eligible criteria|0|||
23415266|NCT02308163|65260893|FG003|Overall Study|Not fulfill eligible criteria|1|||
23415267|NCT02308163|65260894|FG004|Overall Study|Not fulfill eligible criteria|1|||
23415268|NCT02308163|65260890|FG000|Overall Study|Adverse Event|9|||
23415269|NCT02308163|65260891|FG001|Overall Study|Adverse Event|5|||
23415270|NCT02308163|65260892|FG002|Overall Study|Adverse Event|2|||
23415271|NCT02308163|65260893|FG003|Overall Study|Adverse Event|2|||
23415272|NCT02308163|65260894|FG004|Overall Study|Adverse Event|11|||
23415273|NCT02308163|65260890|FG000|Overall Study|Lack of Efficacy|11|||
23415274|NCT02308163|65260891|FG001|Overall Study|Lack of Efficacy|3|||
23415275|NCT02308163|65260892|FG002|Overall Study|Lack of Efficacy|8|||
23415276|NCT02308163|65260893|FG003|Overall Study|Lack of Efficacy|4|||
23415277|NCT02308163|65260894|FG004|Overall Study|Lack of Efficacy|6|||
23512548|NCT02927080|65612765|FG000|Overall Study|Other|0|||
23415278|NCT02308163|65260890|FG000|Overall Study|Withdrawal of consent|2|||
23415279|NCT02308163|65260891|FG001|Overall Study|Withdrawal of consent|3|||
23415280|NCT02308163|65260892|FG002|Overall Study|Withdrawal of consent|0|||
23415281|NCT02308163|65260893|FG003|Overall Study|Withdrawal of consent|2|||
23415282|NCT02308163|65260894|FG004|Overall Study|Withdrawal of consent|6|||
23415283|NCT02308163|65260890|FG000|Overall Study|Protocol Violation|3|||
23415284|NCT02308163|65260891|FG001|Overall Study|Protocol Violation|3|||
23415285|NCT02308163|65260892|FG002|Overall Study|Protocol Violation|3|||
23512549|NCT02927080|65612766|FG001|Overall Study|Other|0|||
23512550|NCT02927080|65612767|FG002|Overall Study|Other|0|||
23512551|NCT02927080|65612768|FG003|Overall Study|Other|0|||
23512552|NCT02927080|65612769|FG004|Overall Study|Other|0|||
23512553|NCT02927080|65612770|FG005|Overall Study|Other|0|||
23512554|NCT02927080|65612771|FG006|Overall Study|Other|1|||
23512555|NCT02927080|65612772|FG007|Overall Study|Other|0|||
23512556|NCT02927080|65612773|FG008|Overall Study|Other|1|||
23512557|NCT02927080|65612774|FG009|Overall Study|Other|0|||
23512558|NCT02671422|65612777|FG000|Overall Study|Lost to Follow-up|1|||
23512559|NCT02671422|65612777|FG000|Overall Study|Adverse Event|68|||
23512560|NCT02671422|65612777|FG000|Overall Study|Lack of Efficacy|1|||
23512561|NCT02671422|65612777|FG000|Overall Study|Lost to Follow-up|4|||
23512562|NCT02671422|65612777|FG000|Overall Study|Withdrawal by Subject|7|||
23512563|NCT02671422|65612777|FG000|Overall Study|Progressive Disease|156|||
23512564|NCT02671422|65612777|FG000|Overall Study|Worsening of Disease|4|||
23512565|NCT02671422|65612777|FG000|Overall Study|Sponsor decision|5|||
23512566|NCT02671422|65612777|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
23512567|NCT02671422|65612777|FG000|Overall Study|Not treated with Vargatef®|3|||
23512568|NCT02671422|65612777|FG000|Overall Study|Other not defined above|3|||
23512569|NCT00580606|65612782|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
23512570|NCT00580606|65612783|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
23512571|NCT00580606|65612782|FG000|Open Label (OL)|Withdrawal by Subject|4|||
23512572|NCT00580606|65612783|FG001|Open Label (OL)|Withdrawal by Subject|6|||
23512573|NCT00580606|65612782|FG000|Open Label (OL)|Dosing Symptoms|0|||
23512574|NCT00580606|65612783|FG001|Open Label (OL)|Dosing Symptoms|1|||
23512575|NCT00580606|65612782|FG000|Open Label (OL)|Lost to Follow-up|0|||
23512576|NCT00580606|65612783|FG001|Open Label (OL)|Lost to Follow-up|1|||
23512577|NCT00580606|65612782|FG000|Open Label (OL)|Pregnancy|0|||
23512578|NCT00580606|65612783|FG001|Open Label (OL)|Pregnancy|1|||
23512579|NCT00580606|65612782|FG000|Open Label (OL)|Non-compliance|2|||
23512580|NCT00580606|65612783|FG001|Open Label (OL)|Non-compliance|0|||
23512581|NCT00580606|65612782|FG000|Open Label (OL)|Physician Decision|1|||
23512582|NCT00580606|65612783|FG001|Open Label (OL)|Physician Decision|1|||
23512583|NCT00580606|65612782|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
23512584|NCT00580606|65612783|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
23512585|NCT02452398|65612784|FG000|Overall Study|Adverse Event|1|||
23512586|NCT02452398|65612784|FG000|Overall Study|Lost to Follow-up|28|||
23512587|NCT02452398|65612784|FG000|Overall Study|Physician Decision|2|||
23512588|NCT02452398|65612784|FG000|Overall Study|Withdrawal by Subject|6|||
23512589|NCT02452398|65612784|FG000|Overall Study|Moved away|4|||
23512590|NCT00793403|65612789|FG000|Overall Study|Other|73|||
23512591|NCT02289079|65612790|FG000|Overall Study|Physician Decision|2|||
23512592|NCT02289079|65612791|FG001|Overall Study|Physician Decision|0|||
23512593|NCT02289079|65612790|FG000|Overall Study|Lost to Follow-up|0|||
23512594|NCT02289079|65612791|FG001|Overall Study|Lost to Follow-up|1|||
23512595|NCT00267046|65612793|FG000|Overall Study|Disease progression|4|||
23512596|NCT00267046|65612794|FG001|Overall Study|Disease progression|2|||
23512597|NCT00267046|65612793|FG000|Overall Study|Chemotoxicity|2|||
23512598|NCT00267046|65612794|FG001|Overall Study|Chemotoxicity|0|||
23512599|NCT00267046|65612793|FG000|Overall Study|Open-label palifermin|2|||
23512600|NCT00267046|65612794|FG001|Overall Study|Open-label palifermin|7|||
23512601|NCT00267046|65612793|FG000|Overall Study|Surgery|3|||
23512602|NCT00267046|65612794|FG001|Overall Study|Surgery|1|||
23512603|NCT00267046|65612793|FG000|Overall Study|Withdrawal by Subject|1|||
23512604|NCT00267046|65612794|FG001|Overall Study|Withdrawal by Subject|0|||
23512605|NCT00267046|65612793|FG000|Overall Study|Radiation|0|||
23512606|NCT00267046|65612794|FG001|Overall Study|Radiation|1|||
23512607|NCT01506479|65612795|FG000|Overall Study|Lost to Follow-up|1|||
23512608|NCT01506479|65612796|FG001|Overall Study|Lost to Follow-up|2|||
23512609|NCT01506479|65612797|FG002|Overall Study|Lost to Follow-up|2|||
23512610|NCT01506479|65612795|FG000|Overall Study|Withdrawal by Subject|1|||
23512611|NCT01506479|65612796|FG001|Overall Study|Withdrawal by Subject|2|||
23512612|NCT01506479|65612797|FG002|Overall Study|Withdrawal by Subject|1|||
23512613|NCT01506479|65612795|FG000|Overall Study|Missing assessment|1|||
23512614|NCT01506479|65612796|FG001|Overall Study|Missing assessment|0|||
23512615|NCT01506479|65612797|FG002|Overall Study|Missing assessment|0|||
23512616|NCT01506479|65612795|FG000|Overall Study|Adverse Event|0|||
23512617|NCT01506479|65612796|FG001|Overall Study|Adverse Event|1|||
23512618|NCT01506479|65612797|FG002|Overall Study|Adverse Event|0|||
23512619|NCT00533845|65612799|FG000|Overall Study|Physician Decision|1|||
23512620|NCT00533845|65612800|FG001|Overall Study|Physician Decision|0|||
23512621|NCT02864953|65612801|FG000|Overall Study|Adverse Event|22|||
23512622|NCT02864953|65612802|FG001|Overall Study|Adverse Event|19|||
23512623|NCT02864953|65612801|FG000|Overall Study|Withdrawal by Subject|1|||
23512624|NCT02864953|65612802|FG001|Overall Study|Withdrawal by Subject|0|||
23512625|NCT02864953|65612801|FG000|Overall Study|Physician Decision|4|||
23512626|NCT02864953|65612802|FG001|Overall Study|Physician Decision|2|||
23512627|NCT02864953|65612801|FG000|Overall Study|Death|3|||
23512628|NCT02864953|65612802|FG001|Overall Study|Death|13|||
23512629|NCT02864953|65612801|FG000|Overall Study|Reason not specified|14|||
23512630|NCT02864953|65612802|FG001|Overall Study|Reason not specified|12|||
23512631|NCT02864953|65612801|FG000|Overall Study|Withdrew Prior to Dosing|9|||
23512632|NCT02864953|65612802|FG001|Overall Study|Withdrew Prior to Dosing|8|||
23512633|NCT01064401|65612803|FG000|Overall Study|Adverse Event|47|||
23512634|NCT01064401|65612804|FG001|Overall Study|Adverse Event|56|||
23512635|NCT01064401|65612803|FG000|Overall Study|Lack of Efficacy|46|||
23512636|NCT01064401|65612804|FG001|Overall Study|Lack of Efficacy|23|||
23512637|NCT01064401|65612803|FG000|Overall Study|Lost to Follow-up|12|||
23512638|NCT01064401|65612804|FG001|Overall Study|Lost to Follow-up|9|||
23512639|NCT01064401|65612803|FG000|Overall Study|Consent Withdrawn|98|||
23512640|NCT01064401|65612804|FG001|Overall Study|Consent Withdrawn|80|||
23512641|NCT01064401|65612803|FG000|Overall Study|Investigator Decision|4|||
23512642|NCT01064401|65612804|FG001|Overall Study|Investigator Decision|6|||
23512643|NCT01064401|65612803|FG000|Overall Study|Death|4|||
23512644|NCT01064401|65612804|FG001|Overall Study|Death|0|||
23512645|NCT01064401|65612803|FG000|Overall Study|Pregnancy|4|||
23512646|NCT01064401|65612804|FG001|Overall Study|Pregnancy|7|||
23415286|NCT02308163|65260893|FG003|Overall Study|Protocol Violation|2|||
23415287|NCT02308163|65260894|FG004|Overall Study|Protocol Violation|5|||
23415288|NCT02308163|65260890|FG000|Overall Study|Lab data met discontinuation criteria|3|||
23415289|NCT02308163|65260891|FG001|Overall Study|Lab data met discontinuation criteria|0|||
23415290|NCT02308163|65260892|FG002|Overall Study|Lab data met discontinuation criteria|0|||
23415291|NCT02308163|65260893|FG003|Overall Study|Lab data met discontinuation criteria|2|||
23512647|NCT01064401|65612803|FG000|Overall Study|Noncompliance|7|||
23512648|NCT01064401|65612804|FG001|Overall Study|Noncompliance|8|||
23512649|NCT01064401|65612803|FG000|Overall Study|Site Closure|4|||
23512650|NCT01064401|65612804|FG001|Overall Study|Site Closure|5|||
23512651|NCT01064401|65612803|FG000|Overall Study|Other|2|||
23512652|NCT01064401|65612804|FG001|Overall Study|Other|1|||
23512653|NCT00362115|65612805|FG000|Overall Study|Adverse Event|0|||
23512654|NCT00362115|65612806|FG001|Overall Study|Adverse Event|1|||
23512655|NCT00362115|65612807|FG002|Overall Study|Adverse Event|1|||
23512656|NCT00362115|65612808|FG003|Overall Study|Adverse Event|1|||
23512657|NCT00362115|65612809|FG004|Overall Study|Adverse Event|2|||
23512658|NCT00362115|65612810|FG005|Overall Study|Adverse Event|2|||
23512659|NCT00362115|65612811|FG006|Overall Study|Adverse Event|1|||
23512660|NCT00362115|65612805|FG000|Overall Study|Protocol Violation|0|||
23512661|NCT00362115|65612806|FG001|Overall Study|Protocol Violation|0|||
23512662|NCT00362115|65612807|FG002|Overall Study|Protocol Violation|0|||
23512663|NCT00362115|65612808|FG003|Overall Study|Protocol Violation|0|||
23512664|NCT00362115|65612809|FG004|Overall Study|Protocol Violation|0|||
23415292|NCT02308163|65260894|FG004|Overall Study|Lab data met discontinuation criteria|0|||
23415293|NCT02308163|65260890|FG000|Overall Study|Miscellaneous|2|||
23415294|NCT02308163|65260891|FG001|Overall Study|Miscellaneous|2|||
23415295|NCT02308163|65260892|FG002|Overall Study|Miscellaneous|1|||
23512665|NCT00362115|65612810|FG005|Overall Study|Protocol Violation|1|||
23415296|NCT02308163|65260893|FG003|Overall Study|Miscellaneous|0|||
23415297|NCT02308163|65260894|FG004|Overall Study|Miscellaneous|5|||
23415298|NCT00516906|65261597|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
23415299|NCT00516906|65261598|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
23415300|NCT03734016|65261599|FG000|Overall Study|Participants Remaining in the Study|260|||
23415301|NCT03734016|65261600|FG001|Overall Study|Participants Remaining in the Study|240|||
23415302|NCT03734016|65261599|FG000|Overall Study|Death|48|||
23415303|NCT03734016|65261600|FG001|Overall Study|Death|60|||
23415304|NCT03734016|65261599|FG000|Overall Study|Withdrawal by Subject|14|||
23415305|NCT03734016|65261600|FG001|Overall Study|Withdrawal by Subject|16|||
23415306|NCT03734016|65261599|FG000|Overall Study|Physician Decision|0|||
23415307|NCT03734016|65261600|FG001|Overall Study|Physician Decision|7|||
23415308|NCT03734016|65261599|FG000|Overall Study|Lost to Follow-up|3|||
23415309|NCT03734016|65261600|FG001|Overall Study|Lost to Follow-up|1|||
23415310|NCT03734016|65261599|FG000|Overall Study|Adverse Event|2|||
23415311|NCT03734016|65261600|FG001|Overall Study|Adverse Event|1|||
23415312|NCT03268954|65261608|FG000|Overall Study|Ongoing|23|||
23415313|NCT03268954|65261609|FG001|Overall Study|Ongoing|31|||
23415314|NCT03268954|65261608|FG000|Overall Study|Adverse Event|53|||
23512666|NCT00362115|65612811|FG006|Overall Study|Protocol Violation|0|||
23512667|NCT00362115|65612805|FG000|Overall Study|Lost to Follow-up|0|||
23512668|NCT00362115|65612806|FG001|Overall Study|Lost to Follow-up|1|||
23512669|NCT00362115|65612807|FG002|Overall Study|Lost to Follow-up|0|||
23415315|NCT03268954|65261609|FG001|Overall Study|Adverse Event|62|||
23415316|NCT03268954|65261608|FG000|Overall Study|Withdrawal by Subject|25|||
23512670|NCT00362115|65612808|FG003|Overall Study|Lost to Follow-up|0|||
23512671|NCT00362115|65612809|FG004|Overall Study|Lost to Follow-up|2|||
23512672|NCT00362115|65612810|FG005|Overall Study|Lost to Follow-up|0|||
23512673|NCT00362115|65612811|FG006|Overall Study|Lost to Follow-up|1|||
23512674|NCT00362115|65612805|FG000|Overall Study|Withdrawal by Subject|1|||
23512675|NCT00362115|65612806|FG001|Overall Study|Withdrawal by Subject|3|||
23512676|NCT00362115|65612807|FG002|Overall Study|Withdrawal by Subject|1|||
23512677|NCT00362115|65612808|FG003|Overall Study|Withdrawal by Subject|0|||
23512678|NCT00362115|65612809|FG004|Overall Study|Withdrawal by Subject|1|||
23512679|NCT00362115|65612810|FG005|Overall Study|Withdrawal by Subject|3|||
23512680|NCT00362115|65612811|FG006|Overall Study|Withdrawal by Subject|4|||
23512681|NCT00362115|65612805|FG000|Overall Study|Lack of Efficacy|1|||
23512682|NCT00362115|65612806|FG001|Overall Study|Lack of Efficacy|0|||
23512683|NCT00362115|65612807|FG002|Overall Study|Lack of Efficacy|5|||
23512684|NCT00362115|65612808|FG003|Overall Study|Lack of Efficacy|2|||
23512685|NCT00362115|65612809|FG004|Overall Study|Lack of Efficacy|2|||
23512686|NCT00362115|65612810|FG005|Overall Study|Lack of Efficacy|0|||
23512687|NCT00362115|65612811|FG006|Overall Study|Lack of Efficacy|3|||
23512688|NCT00362115|65612805|FG000|Overall Study|Physician Decision|0|||
23512689|NCT00362115|65612806|FG001|Overall Study|Physician Decision|0|||
23512690|NCT00362115|65612807|FG002|Overall Study|Physician Decision|0|||
23512691|NCT00362115|65612808|FG003|Overall Study|Physician Decision|0|||
23512692|NCT00362115|65612809|FG004|Overall Study|Physician Decision|0|||
23512693|NCT00362115|65612810|FG005|Overall Study|Physician Decision|0|||
23512694|NCT00362115|65612811|FG006|Overall Study|Physician Decision|3|||
23512695|NCT00362115|65612805|FG000|Overall Study|Other|0|||
23512696|NCT00362115|65612806|FG001|Overall Study|Other|1|||
23512697|NCT00362115|65612807|FG002|Overall Study|Other|0|||
23512698|NCT00362115|65612808|FG003|Overall Study|Other|1|||
23512699|NCT00362115|65612809|FG004|Overall Study|Other|0|||
23512700|NCT00362115|65612810|FG005|Overall Study|Other|1|||
23512701|NCT00362115|65612811|FG006|Overall Study|Other|0|||
23512702|NCT02700815|65612814|FG000|Overall Study|Adverse Event|0|||
23512703|NCT02700815|65612815|FG001|Overall Study|Adverse Event|6|||
23512704|NCT02700815|65612816|FG002|Overall Study|Adverse Event|2|||
23512705|NCT02700815|65612817|FG003|Overall Study|Adverse Event|3|||
23512706|NCT02700815|65612814|FG000|Overall Study|Lack of Efficacy|0|||
23512707|NCT02700815|65612815|FG001|Overall Study|Lack of Efficacy|0|||
23512708|NCT02700815|65612816|FG002|Overall Study|Lack of Efficacy|1|||
23512709|NCT02700815|65612817|FG003|Overall Study|Lack of Efficacy|2|||
23512710|NCT02700815|65612814|FG000|Overall Study|Lost to Follow-up|1|||
23512711|NCT02700815|65612815|FG001|Overall Study|Lost to Follow-up|0|||
23512712|NCT02700815|65612816|FG002|Overall Study|Lost to Follow-up|0|||
23512713|NCT02700815|65612817|FG003|Overall Study|Lost to Follow-up|1|||
23512714|NCT02700815|65612814|FG000|Overall Study|Refusal to continue medication|0|||
23512715|NCT02700815|65612815|FG001|Overall Study|Refusal to continue medication|1|||
23512716|NCT02700815|65612816|FG002|Overall Study|Refusal to continue medication|0|||
23512717|NCT02700815|65612817|FG003|Overall Study|Refusal to continue medication|1|||
23512718|NCT02700815|65612814|FG000|Overall Study|Withdrawal by Subject|0|||
23512719|NCT02700815|65612815|FG001|Overall Study|Withdrawal by Subject|0|||
23512720|NCT02700815|65612816|FG002|Overall Study|Withdrawal by Subject|1|||
23512721|NCT02700815|65612817|FG003|Overall Study|Withdrawal by Subject|0|||
23512722|NCT00742001|65612818|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
23512723|NCT00742001|65612819|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
23512724|NCT00742001|65612820|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
23512725|NCT03655691|65612823|FG000|Overall Study|Adverse Event|0|||
23512726|NCT03655691|65612824|FG001|Overall Study|Adverse Event|0|||
23512727|NCT03655691|65612825|FG002|Overall Study|Adverse Event|1|||
23512728|NCT03655691|65612823|FG000|Overall Study|Lost to Follow-up|1|||
23512729|NCT03655691|65612824|FG001|Overall Study|Lost to Follow-up|1|||
23512730|NCT03655691|65612825|FG002|Overall Study|Lost to Follow-up|2|||
23512731|NCT03655691|65612823|FG000|Overall Study|Protocol Violation|0|||
23512732|NCT03655691|65612824|FG001|Overall Study|Protocol Violation|1|||
23512733|NCT03655691|65612825|FG002|Overall Study|Protocol Violation|0|||
23512734|NCT03655691|65612823|FG000|Overall Study|Withdrawal by Subject|1|||
23512735|NCT03655691|65612824|FG001|Overall Study|Withdrawal by Subject|1|||
23512736|NCT03655691|65612825|FG002|Overall Study|Withdrawal by Subject|0|||
23512737|NCT00558025|65612828|FG000|Overall Study|Adverse Event|1|||
23512738|NCT00558025|65612829|FG001|Overall Study|Adverse Event|1|||
23512739|NCT00558025|65612828|FG000|Overall Study|Withdrawal by Subject|2|||
23512740|NCT00558025|65612829|FG001|Overall Study|Withdrawal by Subject|2|||
23512741|NCT00558025|65612828|FG000|Overall Study|Protocol Violation|1|||
23512742|NCT00558025|65612829|FG001|Overall Study|Protocol Violation|0|||
23512743|NCT02345850|65612830|FG000|Overall Study|Not transplanted|10|||
23512744|NCT02345850|65612831|FG001|Overall Study|Not transplanted|5|||
23512745|NCT02345850|65612832|FG002|Overall Study|Not transplanted|4|||
23512746|NCT02345850|65612830|FG000|Overall Study|Lost to Follow-up|2|||
23611151|NCT01072149|65966723|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23512747|NCT02345850|65612831|FG001|Overall Study|Lost to Follow-up|3|||
23512748|NCT02345850|65612832|FG002|Overall Study|Lost to Follow-up|2|||
23512749|NCT02345850|65612830|FG000|Overall Study|Withdrawal by Subject|1|||
23512750|NCT02345850|65612831|FG001|Overall Study|Withdrawal by Subject|0|||
23512751|NCT02345850|65612832|FG002|Overall Study|Withdrawal by Subject|0|||
23512752|NCT00996216|65612833|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
23512753|NCT00996216|65612833|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
23512754|NCT00996216|65612833|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
23512755|NCT00065507|65612834|FG000|Overall Study|Death|16|||
23512756|NCT00065507|65612835|FG001|Overall Study|Death|17|||
23512757|NCT00065507|65612834|FG000|Overall Study|Adverse Event|4|||
23512758|NCT00065507|65612835|FG001|Overall Study|Adverse Event|3|||
23512759|NCT00065507|65612834|FG000|Overall Study|Lack of Efficacy|0|||
23512760|NCT00065507|65612835|FG001|Overall Study|Lack of Efficacy|6|||
23512761|NCT00065507|65612834|FG000|Overall Study|Poor/Non-compliance|3|||
23512762|NCT00065507|65612835|FG001|Overall Study|Poor/Non-compliance|2|||
23512763|NCT00065507|65612834|FG000|Overall Study|Lost to Follow-up|3|||
23512764|NCT00065507|65612835|FG001|Overall Study|Lost to Follow-up|0|||
23512765|NCT00065507|65612834|FG000|Overall Study|Subject Withdrew Consent|2|||
23512766|NCT00065507|65612835|FG001|Overall Study|Subject Withdrew Consent|1|||
23512767|NCT00065507|65612834|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
23512768|NCT00065507|65612835|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
23512769|NCT04326231|65612837|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
23512770|NCT00429273|65612838|FG000|Overall Study|Lost to Follow-up|1|||
23512771|NCT00429273|65612839|FG001|Overall Study|Lost to Follow-up|2|||
23512772|NCT00429273|65612840|FG002|Overall Study|Lost to Follow-up|2|||
23512773|NCT00429273|65612838|FG000|Overall Study|Physician Decision|6|||
23512774|NCT00429273|65612839|FG001|Overall Study|Physician Decision|5|||
23512775|NCT00429273|65612840|FG002|Overall Study|Physician Decision|5|||
23512776|NCT00429273|65612838|FG000|Overall Study|Adverse Event|1|||
23512777|NCT00429273|65612839|FG001|Overall Study|Adverse Event|1|||
23512778|NCT00429273|65612840|FG002|Overall Study|Adverse Event|2|||
23512779|NCT00518986|65615996|FG000|Overall Study|Adverse Event|12|||
23512780|NCT00518986|65615997|FG001|Overall Study|Adverse Event|7|||
23512781|NCT00518986|65615996|FG000|Overall Study|Lack of Efficacy|0|||
23512782|NCT00518986|65615997|FG001|Overall Study|Lack of Efficacy|2|||
23512783|NCT00518986|65615996|FG000|Overall Study|Lost to Follow-up|3|||
23512784|NCT00518986|65615997|FG001|Overall Study|Lost to Follow-up|2|||
23512785|NCT00518986|65615996|FG000|Overall Study|Physician Decision|0|||
23512786|NCT00518986|65615997|FG001|Overall Study|Physician Decision|3|||
23512787|NCT00518986|65615996|FG000|Overall Study|Protocol Violation|5|||
23512788|NCT00518986|65615997|FG001|Overall Study|Protocol Violation|7|||
23512789|NCT00518986|65615996|FG000|Overall Study|Withdrawal by Subject|4|||
23512790|NCT00518986|65615997|FG001|Overall Study|Withdrawal by Subject|4|||
23512791|NCT00518986|65615996|FG000|Overall Study|Non-Specific|2|||
23512792|NCT00518986|65615997|FG001|Overall Study|Non-Specific|1|||
23512793|NCT00524368|65616003|FG000|Overall Study|Adverse Event|10|||
23512794|NCT00524368|65616004|FG001|Overall Study|Adverse Event|12|||
23512795|NCT00524368|65616003|FG000|Overall Study|Lost to Follow-up|9|||
23512796|NCT00524368|65616004|FG001|Overall Study|Lost to Follow-up|13|||
23512797|NCT00524368|65616003|FG000|Overall Study|Withdrawal by Subject|4|||
23512798|NCT00524368|65616004|FG001|Overall Study|Withdrawal by Subject|5|||
23512799|NCT00524368|65616003|FG000|Overall Study|Non-compliant|8|||
23512800|NCT00524368|65616004|FG001|Overall Study|Non-compliant|9|||
23512801|NCT00524368|65616003|FG000|Overall Study|Reached a Virologic Endpoint|3|||
23512802|NCT00524368|65616004|FG001|Overall Study|Reached a Virologic Endpoint|2|||
23512803|NCT00524368|65616003|FG000|Overall Study|Sponsor's Decision|2|||
23512804|NCT00524368|65616004|FG001|Overall Study|Sponsor's Decision|0|||
23512805|NCT00524368|65616003|FG000|Overall Study|Ineligible to Continue the study|2|||
23512806|NCT00524368|65616004|FG001|Overall Study|Ineligible to Continue the study|5|||
23512807|NCT00524368|65616003|FG000|Overall Study|Other|3|||
23512808|NCT00524368|65616004|FG001|Overall Study|Other|2|||
23512809|NCT03316131|65616005|FG000|Treatment Period 2|Protocol deviation|1|||
23512810|NCT03316131|65616006|FG001|Treatment Period 2|Protocol deviation|0|||
23512811|NCT03158051|65616014|FG000|Overall Study|Lost to Follow-up|41|||
23512812|NCT03158051|65616015|FG001|Overall Study|Lost to Follow-up|47|||
23512813|NCT03158051|65616014|FG000|Overall Study|Physician Decision|6|||
23512814|NCT03158051|65616015|FG001|Overall Study|Physician Decision|7|||
23512815|NCT03158051|65616014|FG000|Overall Study|Withdrawal by Subject|24|||
23512816|NCT03158051|65616015|FG001|Overall Study|Withdrawal by Subject|15|||
23512817|NCT03158051|65616014|FG000|Overall Study|Death|0|||
23512818|NCT03158051|65616015|FG001|Overall Study|Death|1|||
23512819|NCT01702454|65616016|FG000|Overall Study|Consent withdrawal|0|||
23512820|NCT01702454|65616017|FG001|Overall Study|Consent withdrawal|1|||
23512821|NCT01702454|65616016|FG000|Overall Study|Migrated/moved from study area|0|||
23512822|NCT01702454|65616017|FG001|Overall Study|Migrated/moved from study area|1|||
23512823|NCT01702454|65616016|FG000|Overall Study|Lost to Follow-up|3|||
23512824|NCT01702454|65616017|FG001|Overall Study|Lost to Follow-up|6|||
23512825|NCT00513474|65616018|FG000|Overall Study|Death|6|||
23512826|NCT00513474|65616019|FG001|Overall Study|Death|9|||
23512827|NCT00513474|65616018|FG000|Overall Study|Participant Withdrew Consent|1|||
23512828|NCT00513474|65616019|FG001|Overall Study|Participant Withdrew Consent|0|||
23512829|NCT00449540|65616020|FG000|Pretreatment Phase|No migraine experienced|66|||
23512830|NCT00449540|65616021|FG001|Pretreatment Phase|No migraine experienced|0|||
23512831|NCT00449540|65616022|FG002|Pretreatment Phase|No migraine experienced|0|||
23512832|NCT00449540|65616020|FG000|Treatment Phase|did not experience or treat migraine|0|||
23512833|NCT00449540|65616021|FG001|Treatment Phase|did not experience or treat migraine|20|||
23512834|NCT00449540|65616022|FG002|Treatment Phase|did not experience or treat migraine|17|||
23512835|NCT02902965|65616023|FG000|Overall Study|Withdrawal by Subject|10|||
23512836|NCT01574326|65616024|FG000|Overall Study|Randomized but not treated|0|||
23512837|NCT01574326|65616025|FG001|Overall Study|Randomized but not treated|1|||
23512838|NCT01574326|65616024|FG000|Overall Study|Withdrawal by Participant|2|||
23512839|NCT01574326|65616025|FG001|Overall Study|Withdrawal by Participant|4|||
23512840|NCT01574326|65616024|FG000|Overall Study|Physician Decision|5|||
23512841|NCT01574326|65616025|FG001|Overall Study|Physician Decision|3|||
23512842|NCT01574326|65616024|FG000|Overall Study|Adverse Event|1|||
23512843|NCT01574326|65616025|FG001|Overall Study|Adverse Event|3|||
23512844|NCT01574326|65616024|FG000|Overall Study|Other: Mainly kidney transplant|8|||
23512845|NCT01574326|65616025|FG001|Overall Study|Other: Mainly kidney transplant|8|||
23512846|NCT03804879|65616028|FG000|Overall Study|Adverse Event|3|||
23415317|NCT03268954|65261609|FG001|Overall Study|Withdrawal by Subject|16|||
23415318|NCT03268954|65261608|FG000|Overall Study|Progressive Disease|61|||
23415319|NCT03268954|65261609|FG001|Overall Study|Progressive Disease|48|||
23512847|NCT03804879|65616029|FG001|Overall Study|Adverse Event|0|||
23415320|NCT03268954|65261608|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
23415321|NCT03268954|65261609|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
23415322|NCT03268954|65261608|FG000|Overall Study|Reason not Specified|40|||
23415323|NCT03268954|65261609|FG001|Overall Study|Reason not Specified|40|||
23415324|NCT01974206|65261610|FG000|Overall Study|Did Not Take Study Drug|0|||
23415325|NCT01974206|65261611|FG001|Overall Study|Did Not Take Study Drug|1|||
23415326|NCT01974206|65261610|FG000|Overall Study|Physician Decision|1|||
23415327|NCT01974206|65261611|FG001|Overall Study|Physician Decision|0|||
23415328|NCT01974206|65261610|FG000|Overall Study|Withdrawal by Subject|3|||
23415329|NCT01974206|65261611|FG001|Overall Study|Withdrawal by Subject|0|||
23415330|NCT01974206|65261610|FG000|Overall Study|Lost to Follow-up|1|||
23415331|NCT01974206|65261611|FG001|Overall Study|Lost to Follow-up|0|||
23415332|NCT01974206|65261610|FG000|Overall Study|Death|1|||
23415333|NCT01974206|65261611|FG001|Overall Study|Death|0|||
23415334|NCT05111002|65261612|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
23415335|NCT05111002|65261613|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
23415336|NCT05111002|65261612|FG000|Secondary Outcome|Lost to Follow-up|1|||
23415337|NCT05111002|65261613|FG001|Secondary Outcome|Lost to Follow-up|0|||
23415338|NCT03201965|65261616|FG000|Overall Study|Death|5|||
23415339|NCT03201965|65261617|FG001|Overall Study|Death|27|||
23415340|NCT03201965|65261618|FG002|Overall Study|Death|27|||
23415341|NCT03201965|65261616|FG000|Overall Study|Lost to Follow-up|0|||
23415342|NCT03201965|65261617|FG001|Overall Study|Lost to Follow-up|1|||
23415343|NCT03201965|65261618|FG002|Overall Study|Lost to Follow-up|0|||
23415344|NCT03201965|65261616|FG000|Overall Study|Withdrawal by Subject|3|||
23415345|NCT03201965|65261617|FG001|Overall Study|Withdrawal by Subject|13|||
23415346|NCT03201965|65261618|FG002|Overall Study|Withdrawal by Subject|4|||
23415347|NCT03201965|65261616|FG000|Overall Study|Ongoing|20|||
23415348|NCT03201965|65261617|FG001|Overall Study|Ongoing|152|||
23415349|NCT03201965|65261618|FG002|Overall Study|Ongoing|164|||
23415350|NCT03635424|65261619|FG000|Overall Study|Adverse Event|1|||
23415351|NCT03635424|65261619|FG000|Overall Study|Death|1|||
23415352|NCT03635424|65261619|FG000|Overall Study|Device not implanted|1|||
23415353|NCT04644237|65261620|FG000|Overall Study|Death|3|||
23512848|NCT03804879|65616028|FG000|Overall Study|Study Terminated By Sponsor|10|||
23512849|NCT03804879|65616029|FG001|Overall Study|Study Terminated By Sponsor|12|||
23512850|NCT03804879|65616028|FG000|Overall Study|Withdrawal by Subject|3|||
23512851|NCT03804879|65616029|FG001|Overall Study|Withdrawal by Subject|1|||
23512852|NCT00268996|65616030|FG000|Overall Study|Adverse Event|11|||
23415354|NCT04644237|65261621|FG001|Overall Study|Death|2|||
23415355|NCT04644237|65261620|FG000|Overall Study|Adverse Event|15|||
23415356|NCT04644237|65261621|FG001|Overall Study|Adverse Event|12|||
23415357|NCT04644237|65261620|FG000|Overall Study|Progressive Disease|47|||
23415358|NCT04644237|65261621|FG001|Overall Study|Progressive Disease|19|||
23415359|NCT04644237|65261620|FG000|Overall Study|Clinical Progression|4|||
23415360|NCT04644237|65261621|FG001|Overall Study|Clinical Progression|1|||
23415361|NCT04644237|65261620|FG000|Overall Study|Withdrawal by Subject|1|||
23415362|NCT04644237|65261621|FG001|Overall Study|Withdrawal by Subject|2|||
23415363|NCT04644237|65261620|FG000|Overall Study|Physician Decision|3|||
23512853|NCT00268996|65616031|FG001|Overall Study|Adverse Event|7|||
23512854|NCT00268996|65616030|FG000|Overall Study|Lost to Follow-up|3|||
23512855|NCT00268996|65616031|FG001|Overall Study|Lost to Follow-up|1|||
23512856|NCT00268996|65616030|FG000|Overall Study|Withdrawal by Subject|5|||
23512857|NCT00268996|65616031|FG001|Overall Study|Withdrawal by Subject|11|||
23512858|NCT00268996|65616030|FG000|Overall Study|Non-compliance|1|||
23512859|NCT00268996|65616031|FG001|Overall Study|Non-compliance|0|||
23512860|NCT00268996|65616030|FG000|Overall Study|Other|1|||
23512861|NCT00268996|65616031|FG001|Overall Study|Other|1|||
23512862|NCT00512707|65616032|FG000|Overall Study|Lost to Follow-up|5|||
23512863|NCT00512707|65616033|FG001|Overall Study|Lost to Follow-up|11|||
23512864|NCT00512707|65616032|FG000|Overall Study|Developed skin irritation|2|||
23512865|NCT00512707|65616033|FG001|Overall Study|Developed skin irritation|1|||
23512866|NCT00512707|65616032|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
23512867|NCT00512707|65616033|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
23512868|NCT00512707|65616032|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
23512869|NCT00512707|65616033|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
23512870|NCT04517253|65616034|FG000|Overall Study|Adverse Event|1|||
23512871|NCT04517253|65616035|FG001|Overall Study|Adverse Event|0|||
23512872|NCT04517253|65616036|FG002|Overall Study|Adverse Event|0|||
23512873|NCT04517253|65616034|FG000|Overall Study|Death|0|||
23512874|NCT04517253|65616035|FG001|Overall Study|Death|1|||
23512875|NCT04517253|65616036|FG002|Overall Study|Death|0|||
23512876|NCT00799487|65616037|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
23512877|NCT00799487|65616038|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
23512878|NCT00799487|65616039|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
23512879|NCT00799487|65616037|FG000|Dose Adjustment Period|Adverse Event|2|||
23512880|NCT00799487|65616038|FG001|Dose Adjustment Period|Adverse Event|0|||
23512881|NCT00799487|65616039|FG002|Dose Adjustment Period|Adverse Event|0|||
23512882|NCT00799487|65616037|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
23512883|NCT00799487|65616038|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
23512884|NCT00799487|65616039|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
23512885|NCT00799487|65616037|FG000|Dose Adjustment Period|Investigator Discretion|2|||
23512886|NCT00799487|65616038|FG001|Dose Adjustment Period|Investigator Discretion|0|||
23512887|NCT00799487|65616039|FG002|Dose Adjustment Period|Investigator Discretion|0|||
23512888|NCT00799487|65616037|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
23512889|NCT00799487|65616038|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
23512890|NCT00799487|65616039|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
23512891|NCT00799487|65616037|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
23512892|NCT00799487|65616038|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
23512893|NCT00799487|65616039|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
23415364|NCT04644237|65261621|FG001|Overall Study|Physician Decision|0|||
23415365|NCT04644237|65261620|FG000|Overall Study|Other|1|||
23415366|NCT04644237|65261621|FG001|Overall Study|Other|0|||
23415367|NCT04644237|65261620|FG000|Overall Study|Randomized but not Treated|1|||
23415368|NCT04644237|65261621|FG001|Overall Study|Randomized but not Treated|0|||
23415369|NCT02438683|65261625|FG000|Overall Study|Adverse Event|1|||
23415370|NCT02438683|65261626|FG001|Overall Study|Adverse Event|0|||
23415371|NCT02438683|65261627|FG002|Overall Study|Adverse Event|0|||
23415372|NCT02438683|65261628|FG003|Overall Study|Adverse Event|0|||
23415373|NCT02438683|65261629|FG004|Overall Study|Adverse Event|0|||
23415374|NCT02438683|65261630|FG005|Overall Study|Adverse Event|0|||
23611152|NCT01072149|65966724|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611153|NCT01072149|65966725|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611154|NCT01072149|65966726|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611155|NCT01072149|65966727|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611156|NCT01072149|65966728|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611157|NCT01072149|65966729|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23415381|NCT03988621|65261632|FG000|Overall Study|Lost to Follow-up|16|||
23415382|NCT03988621|65261633|FG001|Overall Study|Lost to Follow-up|17|||
23415383|NCT03988621|65261632|FG000|Overall Study|Withdrawal by Subject|14|||
23415384|NCT03988621|65261633|FG001|Overall Study|Withdrawal by Subject|7|||
23415385|NCT03988621|65261632|FG000|Overall Study|Patient Lost to Follow Up|1|||
23415386|NCT03988621|65261633|FG001|Overall Study|Patient Lost to Follow Up|8|||
23415387|NCT03988621|65261632|FG000|Overall Study|Patient death|15|||
23415388|NCT03988621|65261633|FG001|Overall Study|Patient death|12|||
23415389|NCT02257528|65261636|FG000|Overall Study|Never received study treatment|1|||
23415390|NCT02254278|65261639|FG000|Overall Study|Protocol Violation|1|||
23415391|NCT02254278|65261640|FG001|Overall Study|Protocol Violation|1|||
23611158|NCT01072149|65966730|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23611159|NCT01072149|65966713|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23512894|NCT00799487|65616037|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
23512895|NCT00799487|65616038|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
23512896|NCT00799487|65616039|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
23512897|NCT00799487|65616037|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
23611160|NCT01072149|65966714|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611161|NCT01072149|65966715|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
23611162|NCT01072149|65966716|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611163|NCT01072149|65966717|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23512898|NCT00799487|65616038|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
23512899|NCT00799487|65616039|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
23512900|NCT00799487|65616037|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
23512901|NCT00799487|65616038|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
23512902|NCT00799487|65616039|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
23512903|NCT00799487|65616037|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
23512904|NCT00799487|65616038|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
23512905|NCT00799487|65616039|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
23512906|NCT00799487|65616037|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
23512907|NCT00799487|65616038|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
23512908|NCT00799487|65616039|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
23512909|NCT00799487|65616037|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
23512910|NCT00799487|65616038|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
23512911|NCT00799487|65616039|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
23512912|NCT01110707|65616041|FG000|Overall Study|Protocol Violation|0|||
23512913|NCT01110707|65616042|FG001|Overall Study|Protocol Violation|3|||
23512914|NCT01413191|65616046|FG000|Overall Study|Lost to Follow-up|5|||
23512915|NCT01413191|65616046|FG000|Overall Study|Disease Progression|5|||
23512916|NCT01413191|65616046|FG000|Overall Study|Death|1|||
23512917|NCT00759863|65616047|FG000|Overall Study|Death, moved, or lost contact|20|||
23512918|NCT00759863|65616048|FG001|Overall Study|Death, moved, or lost contact|18|||
23512919|NCT01922089|65616049|FG000|Overall Study|Adverse Event|18|||
23512920|NCT01922089|65616050|FG001|Overall Study|Adverse Event|13|||
23512921|NCT01922089|65616049|FG000|Overall Study|Protocol Deviation|10|||
23512922|NCT01922089|65616050|FG001|Overall Study|Protocol Deviation|7|||
23512923|NCT01922089|65616049|FG000|Overall Study|Withdrawal by Subject|3|||
23512924|NCT01922089|65616050|FG001|Overall Study|Withdrawal by Subject|4|||
23512925|NCT01922089|65616049|FG000|Overall Study|administrative problems|4|||
23512926|NCT01922089|65616050|FG001|Overall Study|administrative problems|1|||
23512927|NCT01922089|65616049|FG000|Overall Study|Physician Decision|2|||
23512928|NCT01922089|65616050|FG001|Overall Study|Physician Decision|3|||
23512929|NCT01922089|65616049|FG000|Overall Study|Death|2|||
23512930|NCT01922089|65616050|FG001|Overall Study|Death|1|||
23512931|NCT01922089|65616049|FG000|Overall Study|Lost to Follow-up|0|||
23512932|NCT01922089|65616050|FG001|Overall Study|Lost to Follow-up|1|||
23512933|NCT03042533|65616051|FG000|Overall Study|MD left program|1|||
23512934|NCT03042533|65616052|FG001|Overall Study|MD left program|4|||
23512935|NCT03042533|65616053|FG002|Overall Study|MD left program|1|||
23512936|NCT00642941|65616056|FG000|Overall Study|Physician Decision|3|||
23512937|NCT00642941|65616057|FG001|Overall Study|Physician Decision|1|||
23512938|NCT00642941|65616058|FG002|Overall Study|Physician Decision|0|||
23512939|NCT00642941|65616059|FG003|Overall Study|Physician Decision|0|||
23512940|NCT00642941|65616060|FG004|Overall Study|Physician Decision|0|||
23512941|NCT00642941|65616061|FG005|Overall Study|Physician Decision|0|||
23512942|NCT00642941|65616062|FG006|Overall Study|Physician Decision|1|||
23512943|NCT00642941|65616063|FG007|Overall Study|Physician Decision|0|||
23512944|NCT00642941|65616064|FG008|Overall Study|Physician Decision|0|||
23512945|NCT00642941|65616065|FG009|Overall Study|Physician Decision|1|||
23512946|NCT00642941|65616066|FG010|Overall Study|Physician Decision|0|||
23512947|NCT00642941|65616067|FG011|Overall Study|Physician Decision|1|||
23512948|NCT00642941|65616056|FG000|Overall Study|Death|4|||
23512949|NCT00642941|65616057|FG001|Overall Study|Death|0|||
23512950|NCT00642941|65616058|FG002|Overall Study|Death|1|||
23512951|NCT00642941|65616059|FG003|Overall Study|Death|1|||
23512952|NCT00642941|65616060|FG004|Overall Study|Death|2|||
23512953|NCT00642941|65616061|FG005|Overall Study|Death|1|||
23512954|NCT00642941|65616062|FG006|Overall Study|Death|0|||
23512955|NCT00642941|65616063|FG007|Overall Study|Death|0|||
23512956|NCT00642941|65616064|FG008|Overall Study|Death|0|||
23512957|NCT00642941|65616065|FG009|Overall Study|Death|0|||
23512958|NCT00642941|65616066|FG010|Overall Study|Death|0|||
23512959|NCT00642941|65616067|FG011|Overall Study|Death|1|||
23512960|NCT00642941|65616056|FG000|Overall Study|Study closed by Sponsor|0|||
23307515|NCT01884311|64870537|FG000|Overall Study|Precautionary measure|1|||
23512961|NCT00642941|65616057|FG001|Overall Study|Study closed by Sponsor|1|||
23512962|NCT00642941|65616058|FG002|Overall Study|Study closed by Sponsor|0|||
23512963|NCT00642941|65616059|FG003|Overall Study|Study closed by Sponsor|0|||
23512964|NCT00642941|65616060|FG004|Overall Study|Study closed by Sponsor|0|||
23512965|NCT00642941|65616061|FG005|Overall Study|Study closed by Sponsor|0|||
23512966|NCT00642941|65616062|FG006|Overall Study|Study closed by Sponsor|0|||
23512967|NCT00642941|65616063|FG007|Overall Study|Study closed by Sponsor|0|||
23512968|NCT00642941|65616064|FG008|Overall Study|Study closed by Sponsor|0|||
23307516|NCT03301623|64870538|FG000|Overall Study|Death|3|||
23307517|NCT03301623|64870539|FG001|Overall Study|Death|1|||
23307518|NCT03301623|64870538|FG000|Overall Study|Withdrawal by Subject|11|||
23307519|NCT03301623|64870539|FG001|Overall Study|Withdrawal by Subject|13|||
23512969|NCT00642941|65616065|FG009|Overall Study|Study closed by Sponsor|0|||
23512970|NCT00642941|65616066|FG010|Overall Study|Study closed by Sponsor|0|||
23512971|NCT00642941|65616067|FG011|Overall Study|Study closed by Sponsor|0|||
23512972|NCT00642941|65616056|FG000|Overall Study|Withdrawal by Subject|1|||
23512973|NCT00642941|65616057|FG001|Overall Study|Withdrawal by Subject|0|||
23512974|NCT00642941|65616058|FG002|Overall Study|Withdrawal by Subject|0|||
23512975|NCT00642941|65616059|FG003|Overall Study|Withdrawal by Subject|2|||
23512976|NCT00642941|65616060|FG004|Overall Study|Withdrawal by Subject|0|||
23512977|NCT00642941|65616061|FG005|Overall Study|Withdrawal by Subject|0|||
23512978|NCT00642941|65616062|FG006|Overall Study|Withdrawal by Subject|2|||
23512979|NCT00642941|65616063|FG007|Overall Study|Withdrawal by Subject|0|||
23512980|NCT00642941|65616064|FG008|Overall Study|Withdrawal by Subject|1|||
23512981|NCT00642941|65616065|FG009|Overall Study|Withdrawal by Subject|0|||
23512982|NCT00642941|65616066|FG010|Overall Study|Withdrawal by Subject|0|||
23512983|NCT00642941|65616067|FG011|Overall Study|Withdrawal by Subject|1|||
23512984|NCT00642941|65616056|FG000|Overall Study|Protocol Violation|0|||
23512985|NCT00642941|65616057|FG001|Overall Study|Protocol Violation|0|||
23512986|NCT00642941|65616058|FG002|Overall Study|Protocol Violation|0|||
23512987|NCT00642941|65616059|FG003|Overall Study|Protocol Violation|0|||
23512988|NCT00642941|65616060|FG004|Overall Study|Protocol Violation|0|||
23512989|NCT00642941|65616061|FG005|Overall Study|Protocol Violation|0|||
23512990|NCT00642941|65616062|FG006|Overall Study|Protocol Violation|1|||
23512991|NCT00642941|65616063|FG007|Overall Study|Protocol Violation|0|||
23512992|NCT00642941|65616064|FG008|Overall Study|Protocol Violation|0|||
23512993|NCT00642941|65616065|FG009|Overall Study|Protocol Violation|0|||
23512994|NCT00642941|65616066|FG010|Overall Study|Protocol Violation|0|||
23512995|NCT00642941|65616067|FG011|Overall Study|Protocol Violation|0|||
23512996|NCT00642941|65616056|FG000|Overall Study|Adverse Event|1|||
23512997|NCT00642941|65616057|FG001|Overall Study|Adverse Event|1|||
23512998|NCT00642941|65616058|FG002|Overall Study|Adverse Event|0|||
23512999|NCT00642941|65616059|FG003|Overall Study|Adverse Event|0|||
23513000|NCT00642941|65616060|FG004|Overall Study|Adverse Event|0|||
23513001|NCT00642941|65616061|FG005|Overall Study|Adverse Event|0|||
23513002|NCT00642941|65616062|FG006|Overall Study|Adverse Event|1|||
23513003|NCT00642941|65616063|FG007|Overall Study|Adverse Event|1|||
23513004|NCT00642941|65616064|FG008|Overall Study|Adverse Event|0|||
23513005|NCT00642941|65616065|FG009|Overall Study|Adverse Event|1|||
23513006|NCT00642941|65616066|FG010|Overall Study|Adverse Event|0|||
23513007|NCT00642941|65616067|FG011|Overall Study|Adverse Event|0|||
23513008|NCT00642941|65616056|FG000|Overall Study|Other|1|||
23513009|NCT00642941|65616057|FG001|Overall Study|Other|1|||
23513010|NCT00642941|65616058|FG002|Overall Study|Other|1|||
23513011|NCT00642941|65616059|FG003|Overall Study|Other|1|||
23513012|NCT00642941|65616060|FG004|Overall Study|Other|0|||
23513013|NCT00642941|65616061|FG005|Overall Study|Other|1|||
23513014|NCT00642941|65616062|FG006|Overall Study|Other|0|||
23513015|NCT00642941|65616063|FG007|Overall Study|Other|1|||
23513016|NCT00642941|65616064|FG008|Overall Study|Other|0|||
23513017|NCT00642941|65616065|FG009|Overall Study|Other|0|||
23513018|NCT00642941|65616066|FG010|Overall Study|Other|0|||
23513019|NCT00642941|65616067|FG011|Overall Study|Other|1|||
23513020|NCT00642941|65616056|FG000|Overall Study|Disease progression|60|||
23513021|NCT00642941|65616057|FG001|Overall Study|Disease progression|50|||
23513022|NCT00642941|65616058|FG002|Overall Study|Disease progression|5|||
23513023|NCT00642941|65616059|FG003|Overall Study|Disease progression|36|||
23513024|NCT00642941|65616060|FG004|Overall Study|Disease progression|23|||
23513025|NCT00642941|65616061|FG005|Overall Study|Disease progression|39|||
23513026|NCT00642941|65616062|FG006|Overall Study|Disease progression|18|||
23513027|NCT00642941|65616063|FG007|Overall Study|Disease progression|12|||
23513028|NCT00642941|65616064|FG008|Overall Study|Disease progression|10|||
23513029|NCT00642941|65616065|FG009|Overall Study|Disease progression|7|||
23513030|NCT00642941|65616066|FG010|Overall Study|Disease progression|12|||
23513031|NCT00642941|65616067|FG011|Overall Study|Disease progression|7|||
23513032|NCT00770289|65616071|FG000|Overall Study|Other|6|||
23513033|NCT03021265|65616081|FG000|Overall Study|Adverse Event|29|||
23513034|NCT03021265|65616081|FG000|Overall Study|Lack of Efficacy|3|||
23513035|NCT03021265|65616081|FG000|Overall Study|Improved|17|||
23513036|NCT03021265|65616081|FG000|Overall Study|Lost to Follow-up|67|||
23513037|NCT03021265|65616081|FG000|Overall Study|No reason given|2|||
23415400|NCT03763656|65261654|FG000|Overall Study|Physician Decision|1|||
23415401|NCT03763656|65261654|FG000|Overall Study|Protocol Violation|1|||
23415402|NCT03763656|65261654|FG000|Overall Study|Withdrawal by Subject|7|||
23415403|NCT02701283|65261655|FG000|Overall Study|Death|25|||
23415404|NCT02701283|65261656|FG001|Overall Study|Death|29|||
23415405|NCT02701283|65261657|FG002|Overall Study|Death|19|||
23415406|NCT02701283|65261655|FG000|Overall Study|Lost to Follow-up|3|||
23415407|NCT02701283|65261656|FG001|Overall Study|Lost to Follow-up|8|||
23415408|NCT02701283|65261657|FG002|Overall Study|Lost to Follow-up|1|||
23415409|NCT02701283|65261655|FG000|Overall Study|Withdrawal by Subject|12|||
23415410|NCT02701283|65261656|FG001|Overall Study|Withdrawal by Subject|41|||
23415411|NCT02701283|65261657|FG002|Overall Study|Withdrawal by Subject|1|||
23415412|NCT02701283|65261655|FG000|Overall Study|Missed 2-year visit|22|||
23415413|NCT02701283|65261656|FG001|Overall Study|Missed 2-year visit|27|||
23415414|NCT02701283|65261657|FG002|Overall Study|Missed 2-year visit|0|||
23415415|NCT02701283|65261655|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
23415416|NCT02701283|65261656|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
23415417|NCT02701283|65261657|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
23415418|NCT00211757|65261658|FG000|Overall Study|Withdrawal by Subject|1|||
23415419|NCT00211757|65261659|FG001|Overall Study|Withdrawal by Subject|1|||
23415420|NCT00211757|65261658|FG000|Overall Study|Lack of Efficacy|0|||
23415421|NCT00211757|65261659|FG001|Overall Study|Lack of Efficacy|1|||
23415422|NCT04669262|65262426|FG000|Overall Study|Withdrawal by Subject|0|||
23415423|NCT04669262|65262427|FG001|Overall Study|Withdrawal by Subject|0|||
23415424|NCT04669262|65262428|FG002|Overall Study|Withdrawal by Subject|0|||
23415425|NCT04669262|65262429|FG003|Overall Study|Withdrawal by Subject|1|||
23415426|NCT04669262|65262426|FG000|Overall Study|Randomized but Not Treated|0|||
23415427|NCT04669262|65262427|FG001|Overall Study|Randomized but Not Treated|1|||
23415428|NCT04669262|65262428|FG002|Overall Study|Randomized but Not Treated|0|||
23415429|NCT04669262|65262429|FG003|Overall Study|Randomized but Not Treated|0|||
23415430|NCT05151445|65262430|FG000|Overall Study|Withdrawal by Subject|3|||
23415431|NCT01638013|65262431|FG000|Overall Study|Adverse Event|36|||
23415432|NCT01638013|65262432|FG001|Overall Study|Adverse Event|29|||
23415433|NCT01638013|65262433|FG002|Overall Study|Adverse Event|48|||
23415434|NCT01638013|65262431|FG000|Overall Study|Lack of Efficacy|39|||
23415435|NCT01638013|65262432|FG001|Overall Study|Lack of Efficacy|11|||
23415436|NCT01638013|65262433|FG002|Overall Study|Lack of Efficacy|14|||
23415437|NCT01638013|65262431|FG000|Overall Study|Protocol Violation|10|||
23415438|NCT01638013|65262432|FG001|Overall Study|Protocol Violation|7|||
23415439|NCT01638013|65262433|FG002|Overall Study|Protocol Violation|11|||
23415440|NCT01638013|65262431|FG000|Overall Study|Met discontinuation criteria|4|||
23415441|NCT01638013|65262432|FG001|Overall Study|Met discontinuation criteria|0|||
23415442|NCT01638013|65262433|FG002|Overall Study|Met discontinuation criteria|7|||
23415443|NCT01638013|65262431|FG000|Overall Study|Subject Lost to Follow up|1|||
23415444|NCT01638013|65262432|FG001|Overall Study|Subject Lost to Follow up|0|||
23415445|NCT01638013|65262433|FG002|Overall Study|Subject Lost to Follow up|1|||
23415446|NCT01638013|65262431|FG000|Overall Study|Miscellaneous|25|||
23415447|NCT01638013|65262432|FG001|Overall Study|Miscellaneous|19|||
23415448|NCT01638013|65262433|FG002|Overall Study|Miscellaneous|23|||
23415449|NCT01638013|65262431|FG000|Overall Study|Withdrawal of Consent|16|||
23415450|NCT01638013|65262432|FG001|Overall Study|Withdrawal of Consent|12|||
23415451|NCT01638013|65262433|FG002|Overall Study|Withdrawal of Consent|16|||
23415452|NCT01638013|65262431|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
23415453|NCT01638013|65262432|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
23415454|NCT01638013|65262433|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
23415455|NCT04647253|65262436|FG000|Overall Study|Death ≤ 365 Days|16|||
23415456|NCT04647253|65262437|FG001|Overall Study|Death ≤ 365 Days|7|||
23415457|NCT04647253|65262436|FG000|Overall Study|Physician Decision|0|||
23415458|NCT04647253|65262437|FG001|Overall Study|Physician Decision|1|||
23415459|NCT04647253|65262436|FG000|Overall Study|Withdrawal by Subject|7|||
23415460|NCT04647253|65262437|FG001|Overall Study|Withdrawal by Subject|2|||
23415461|NCT04647253|65262436|FG000|Overall Study|Missed 12-Month Visit|9|||
23415462|NCT04647253|65262437|FG001|Overall Study|Missed 12-Month Visit|7|||
23415463|NCT04647253|65262436|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
23453510|NCT01147666|65403333|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23415464|NCT04647253|65262437|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
23415465|NCT00977574|65262438|FG000|Overall Study|Never Treated|4|||
23415466|NCT00977574|65262439|FG001|Overall Study|Never Treated|2|||
23415467|NCT00977574|65262440|FG002|Overall Study|Never Treated|4|||
23415468|NCT04470908|65262444|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
23415469|NCT03206918|65262445|FG000|Overall Study|Death|11|||
23415470|NCT03206918|65262445|FG000|Overall Study|Withdrawal by Subject|5|||
23415471|NCT03206918|65262445|FG000|Overall Study|Study terminated by sponsor|12|||
23415472|NCT03206918|65262445|FG000|Overall Study|Lost to Follow-up|3|||
23415473|NCT03206918|65262445|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
23611164|NCT01072149|65966718|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611165|NCT01072149|65966719|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611166|NCT01072149|65966720|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611167|NCT01072149|65966721|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611168|NCT01072149|65966722|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611169|NCT01072149|65966723|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611170|NCT01072149|65966724|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611171|NCT01072149|65966725|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611172|NCT01072149|65966726|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611173|NCT01072149|65966727|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611174|NCT01072149|65966728|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611175|NCT01072149|65966729|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611176|NCT01072149|65966730|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23611177|NCT01072149|65966713|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611178|NCT01072149|65966714|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611179|NCT01072149|65966715|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611180|NCT01072149|65966716|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611181|NCT01072149|65966717|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611182|NCT01072149|65966718|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611183|NCT01072149|65966719|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611184|NCT01072149|65966720|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
23415498|NCT02305849|65262448|FG000|Overall Study|Adverse Event|10|||
23415499|NCT02305849|65262449|FG001|Overall Study|Adverse Event|12|||
23415500|NCT02305849|65262450|FG002|Overall Study|Adverse Event|7|||
23415501|NCT02305849|65262451|FG003|Overall Study|Adverse Event|3|||
23415502|NCT02305849|65262448|FG000|Overall Study|Lack of Efficacy|10|||
23415503|NCT02305849|65262449|FG001|Overall Study|Lack of Efficacy|6|||
23415504|NCT02305849|65262450|FG002|Overall Study|Lack of Efficacy|3|||
23415505|NCT02305849|65262451|FG003|Overall Study|Lack of Efficacy|9|||
23415506|NCT02305849|65262448|FG000|Overall Study|Withdrawal by Subject|2|||
23415507|NCT02305849|65262449|FG001|Overall Study|Withdrawal by Subject|2|||
23415508|NCT02305849|65262450|FG002|Overall Study|Withdrawal by Subject|1|||
23415509|NCT02305849|65262451|FG003|Overall Study|Withdrawal by Subject|4|||
23415510|NCT02305849|65262448|FG000|Overall Study|Lost to Follow-up|0|||
23415511|NCT02305849|65262449|FG001|Overall Study|Lost to Follow-up|2|||
23415512|NCT02305849|65262450|FG002|Overall Study|Lost to Follow-up|0|||
23415513|NCT02305849|65262451|FG003|Overall Study|Lost to Follow-up|0|||
23415514|NCT02305849|65262448|FG000|Overall Study|Protocol Violation|3|||
23415515|NCT02305849|65262449|FG001|Overall Study|Protocol Violation|2|||
23415516|NCT02305849|65262450|FG002|Overall Study|Protocol Violation|1|||
23415517|NCT02305849|65262451|FG003|Overall Study|Protocol Violation|1|||
23415518|NCT02305849|65262448|FG000|Overall Study|Lab data met discontinuation criteria|0|||
23415519|NCT02305849|65262449|FG001|Overall Study|Lab data met discontinuation criteria|1|||
23415520|NCT02305849|65262450|FG002|Overall Study|Lab data met discontinuation criteria|2|||
23415521|NCT02305849|65262451|FG003|Overall Study|Lab data met discontinuation criteria|1|||
23415522|NCT02305849|65262448|FG000|Overall Study|Miscellaneous|1|||
23415523|NCT02305849|65262449|FG001|Overall Study|Miscellaneous|2|||
23415524|NCT02305849|65262450|FG002|Overall Study|Miscellaneous|4|||
23415525|NCT02305849|65262451|FG003|Overall Study|Miscellaneous|1|||
23415526|NCT02305849|65262448|FG000|Overall Study|Not fulfill eligibility criteria|1|||
23513038|NCT03021265|65616081|FG000|Overall Study|No visit since the first visit|4|||
23415527|NCT02305849|65262449|FG001|Overall Study|Not fulfill eligibility criteria|1|||
23415528|NCT02305849|65262450|FG002|Overall Study|Not fulfill eligibility criteria|0|||
23415529|NCT02305849|65262451|FG003|Overall Study|Not fulfill eligibility criteria|0|||
23415530|NCT04068519|65262463|FG000|Dose Verification|Death|15|||
23415531|NCT04068519|65262463|FG000|Dose Verification|Withdrawal by Subject|1|||
23415532|NCT04068519|65262463|FG000|Pharmacokinetic Sub-study|Death|35|||
23415533|NCT04068519|65262463|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
23415534|NCT04068519|65262463|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
23415535|NCT04068519|65262463|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
23415536|NCT04068519|65262463|FG000|Indication Expansion|Death|152|||
23513039|NCT01502423|65616082|FG000|Overall Study|Withdrawal by Subject|0|||
23513040|NCT01502423|65616083|FG001|Overall Study|Withdrawal by Subject|1|||
23513041|NCT00842712|65616084|FG000|Safety Run-in Part|Adverse Event|0|||
23513042|NCT00842712|65616085|FG001|Safety Run-in Part|Adverse Event|1|||
23513043|NCT00842712|65616086|FG002|Safety Run-in Part|Adverse Event|0|||
23513044|NCT00842712|65616087|FG003|Safety Run-in Part|Adverse Event|0|||
23513045|NCT00842712|65616088|FG004|Safety Run-in Part|Adverse Event|0|||
23513046|NCT00842712|65616089|FG005|Safety Run-in Part|Adverse Event|0|||
23513047|NCT00842712|65616090|FG006|Safety Run-in Part|Adverse Event|0|||
23513048|NCT00842712|65616084|FG000|Safety Run-in Part|Progressive disease|3|||
23513049|NCT00842712|65616085|FG001|Safety Run-in Part|Progressive disease|1|||
23513050|NCT00842712|65616086|FG002|Safety Run-in Part|Progressive disease|0|||
23513051|NCT00842712|65616087|FG003|Safety Run-in Part|Progressive disease|1|||
23513052|NCT00842712|65616088|FG004|Safety Run-in Part|Progressive disease|0|||
23513053|NCT00842712|65616089|FG005|Safety Run-in Part|Progressive disease|0|||
23513054|NCT00842712|65616090|FG006|Safety Run-in Part|Progressive disease|0|||
23513055|NCT00842712|65616084|FG000|Randomized Part|Randomized but not treated|0|||
23513056|NCT00842712|65616085|FG001|Randomized Part|Randomized but not treated|0|||
23513057|NCT00842712|65616086|FG002|Randomized Part|Randomized but not treated|0|||
23513058|NCT00842712|65616087|FG003|Randomized Part|Randomized but not treated|0|||
23513059|NCT00842712|65616088|FG004|Randomized Part|Randomized but not treated|0|||
23513060|NCT00842712|65616089|FG005|Randomized Part|Randomized but not treated|1|||
23513061|NCT00842712|65616090|FG006|Randomized Part|Randomized but not treated|4|||
23513062|NCT00842712|65616084|FG000|Randomized Part|Ongoing at cut-off date|0|||
23513063|NCT00842712|65616085|FG001|Randomized Part|Ongoing at cut-off date|0|||
23513064|NCT00842712|65616086|FG002|Randomized Part|Ongoing at cut-off date|0|||
23513065|NCT00842712|65616087|FG003|Randomized Part|Ongoing at cut-off date|0|||
23513066|NCT00842712|65616088|FG004|Randomized Part|Ongoing at cut-off date|0|||
23513067|NCT00842712|65616089|FG005|Randomized Part|Ongoing at cut-off date|0|||
23513068|NCT00842712|65616090|FG006|Randomized Part|Ongoing at cut-off date|2|||
23513069|NCT00656474|65616093|FG000|Overall Study|Other Reason|1|||
23513070|NCT00540514|65616094|FG000|Overall Study|Still on treatment|3|||
23513071|NCT00540514|65616095|FG001|Overall Study|Still on treatment|0|||
23513072|NCT00540514|65616094|FG000|Overall Study|Unacceptable Toxicity|61|||
23513073|NCT00540514|65616095|FG001|Overall Study|Unacceptable Toxicity|62|||
23513074|NCT00540514|65616094|FG000|Overall Study|Adverse Event|20|||
23513075|NCT00540514|65616095|FG001|Overall Study|Adverse Event|24|||
23513076|NCT00540514|65616094|FG000|Overall Study|Physician Decision|86|||
23513077|NCT00540514|65616095|FG001|Overall Study|Physician Decision|99|||
23513078|NCT00540514|65616094|FG000|Overall Study|Protocol Deviation|3|||
23513079|NCT00540514|65616095|FG001|Overall Study|Protocol Deviation|4|||
23513080|NCT00540514|65616094|FG000|Overall Study|Lost to Follow-up|1|||
23513081|NCT00540514|65616095|FG001|Overall Study|Lost to Follow-up|1|||
23513082|NCT00540514|65616094|FG000|Overall Study|Withdrawal by Subject|65|||
23513083|NCT00540514|65616095|FG001|Overall Study|Withdrawal by Subject|67|||
23513084|NCT00540514|65616094|FG000|Overall Study|Excluded prior to treatment|7|||
23513085|NCT00540514|65616095|FG001|Overall Study|Excluded prior to treatment|7|||
23513086|NCT00540514|65616094|FG000|Overall Study|Paclitaxel not available|0|||
23513087|NCT00540514|65616095|FG001|Overall Study|Paclitaxel not available|2|||
23513088|NCT00511667|65616096|FG000|Overall Study|Adverse Event|1|||
23513089|NCT00511667|65616097|FG001|Overall Study|Adverse Event|0|||
23513090|NCT00511667|65616096|FG000|Overall Study|Protocol Violation|1|||
23513091|NCT00511667|65616097|FG001|Overall Study|Protocol Violation|1|||
23513092|NCT00511667|65616096|FG000|Overall Study|Withdrawal by Subject|2|||
23513093|NCT00511667|65616097|FG001|Overall Study|Withdrawal by Subject|0|||
23513094|NCT00511667|65616096|FG000|Overall Study|Site terminated|6|||
23513095|NCT00511667|65616097|FG001|Overall Study|Site terminated|1|||
23513096|NCT00511667|65616096|FG000|Overall Study|Other|2|||
23513097|NCT00511667|65616097|FG001|Overall Study|Other|1|||
23513098|NCT00592839|65616098|FG000|Overall Study|Withdrawal by Subject|1|||
23513099|NCT00592839|65616099|FG001|Overall Study|Withdrawal by Subject|1|||
23513100|NCT00592839|65616100|FG002|Overall Study|Withdrawal by Subject|3|||
23513101|NCT00592839|65616098|FG000|Overall Study|Protocol Violation|1|||
23513102|NCT00592839|65616099|FG001|Overall Study|Protocol Violation|1|||
23513103|NCT00592839|65616100|FG002|Overall Study|Protocol Violation|2|||
23513104|NCT00592839|65616098|FG000|Overall Study|Adverse Event|0|||
23513105|NCT00592839|65616099|FG001|Overall Study|Adverse Event|1|||
23513106|NCT00592839|65616100|FG002|Overall Study|Adverse Event|0|||
23513107|NCT00592839|65616098|FG000|Overall Study|Lost to Follow-up|0|||
23513108|NCT00592839|65616099|FG001|Overall Study|Lost to Follow-up|1|||
23513109|NCT00592839|65616100|FG002|Overall Study|Lost to Follow-up|1|||
23513110|NCT01846611|65616102|FG000|Overall Study|Lost to Follow-up|4|||
23513111|NCT01846611|65616103|FG001|Overall Study|Lost to Follow-up|6|||
23513112|NCT01846611|65616102|FG000|Overall Study|Withdrawal by Subject|15|||
23513113|NCT01846611|65616103|FG001|Overall Study|Withdrawal by Subject|19|||
23513114|NCT01846611|65616102|FG000|Overall Study|Other|19|||
23513115|NCT01846611|65616103|FG001|Overall Study|Other|18|||
23513116|NCT01414075|65616104|FG000|Overall Study|Adverse Event|1|||
23513117|NCT01414075|65616105|FG001|Overall Study|Adverse Event|0|||
23513118|NCT01414075|65616106|FG002|Overall Study|Adverse Event|1|||
23513119|NCT01414075|65616107|FG003|Overall Study|Adverse Event|0|||
23513120|NCT01414075|65616104|FG000|Overall Study|Death|1|||
23513121|NCT01414075|65616105|FG001|Overall Study|Death|0|||
23513122|NCT01414075|65616106|FG002|Overall Study|Death|0|||
23513123|NCT01414075|65616107|FG003|Overall Study|Death|1|||
23513124|NCT01414075|65616104|FG000|Overall Study|Withdrawal by Subject|0|||
23513125|NCT01414075|65616105|FG001|Overall Study|Withdrawal by Subject|0|||
23513126|NCT01414075|65616106|FG002|Overall Study|Withdrawal by Subject|0|||
23513127|NCT01414075|65616107|FG003|Overall Study|Withdrawal by Subject|1|||
23513128|NCT01414075|65616104|FG000|Overall Study|Other than specified|1|||
23513129|NCT01414075|65616105|FG001|Overall Study|Other than specified|0|||
23513130|NCT01414075|65616106|FG002|Overall Study|Other than specified|1|||
23513131|NCT01414075|65616107|FG003|Overall Study|Other than specified|0|||
23513132|NCT02392247|65616108|FG000|Overall Study|Withdrawal by Subject|1|||
23513133|NCT02392247|65616108|FG000|Overall Study|Surgery cancelled; no data|1|||
23513134|NCT01499667|65616109|FG000|Overall Study|administrative problems|4|||
23513135|NCT01499667|65616110|FG001|Overall Study|administrative problems|5|||
23513136|NCT01499667|65616111|FG002|Overall Study|administrative problems|5|||
23513137|NCT01499667|65616109|FG000|Overall Study|Protocol Violation|1|||
23513138|NCT01499667|65616110|FG001|Overall Study|Protocol Violation|3|||
23513139|NCT01499667|65616111|FG002|Overall Study|Protocol Violation|2|||
23513140|NCT01499667|65616109|FG000|Overall Study|Adverse Event|0|||
23513141|NCT01499667|65616110|FG001|Overall Study|Adverse Event|2|||
23513142|NCT01499667|65616111|FG002|Overall Study|Adverse Event|2|||
23513143|NCT01499667|65616109|FG000|Overall Study|Withdrawal by Subject|2|||
23513144|NCT01499667|65616110|FG001|Overall Study|Withdrawal by Subject|1|||
23513145|NCT01499667|65616111|FG002|Overall Study|Withdrawal by Subject|1|||
23513146|NCT01499667|65616109|FG000|Overall Study|Lack of Efficacy|2|||
23513147|NCT01499667|65616110|FG001|Overall Study|Lack of Efficacy|0|||
23513148|NCT01499667|65616111|FG002|Overall Study|Lack of Efficacy|0|||
23513149|NCT04007094|65616112|FG000|Overall Study|Lost to Follow-up|1|||
23513150|NCT04007094|65616113|FG001|Overall Study|Lost to Follow-up|1|||
23513151|NCT00728130|65616114|FG000|Overall Study|Withdrawal by Subject|1|||
23513152|NCT00728130|65616114|FG000|Overall Study|Paperwork not completed in time|1|||
23513153|NCT00728130|65616114|FG000|Overall Study|Physician Decision|1|||
23513154|NCT01344161|65616116|FG000|Overall Study|Lost to Follow-up|4|||
23513155|NCT01344161|65616117|FG001|Overall Study|Lost to Follow-up|1|||
23513156|NCT01344161|65616116|FG000|Overall Study|Pregnancy|0|||
23513157|NCT01344161|65616117|FG001|Overall Study|Pregnancy|1|||
23513158|NCT01344161|65616116|FG000|Overall Study|Protocol Violation|1|||
23513159|NCT01344161|65616117|FG001|Overall Study|Protocol Violation|1|||
23513160|NCT03342690|65616120|FG000|Overall Study|Missing Information|9|||
23513161|NCT03342690|65616120|FG000|Overall Study|Protocol Violation|16|||
23513162|NCT01949051|65616123|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
23513163|NCT01949051|65616124|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
23513164|NCT01949051|65616125|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
23513165|NCT01949051|65616126|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
23513166|NCT01949051|65616127|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
23513167|NCT01949051|65616128|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
23513168|NCT01949051|65616123|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
23513169|NCT01949051|65616124|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513170|NCT01949051|65616125|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513171|NCT01949051|65616126|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513172|NCT01949051|65616127|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513173|NCT01949051|65616128|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23513174|NCT01949051|65616123|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513175|NCT01949051|65616124|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513176|NCT01949051|65616125|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513177|NCT01949051|65616126|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513178|NCT01949051|65616127|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
23513179|NCT01949051|65616128|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
23513180|NCT01949051|65616123|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513181|NCT01949051|65616124|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
23513182|NCT01949051|65616125|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513183|NCT01949051|65616126|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513184|NCT01949051|65616127|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513185|NCT01949051|65616128|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
23513186|NCT01949051|65616123|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513187|NCT01949051|65616124|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513188|NCT01949051|65616125|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
23513189|NCT01949051|65616126|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513190|NCT01949051|65616127|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513191|NCT01949051|65616128|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
23513192|NCT01286012|65616133|FG000|Overall Study|Adverse Event|3|||
23513193|NCT01286012|65616134|FG001|Overall Study|Adverse Event|3|||
23513194|NCT01286012|65616133|FG000|Overall Study|Death|2|||
23513195|NCT01286012|65616134|FG001|Overall Study|Death|3|||
23513196|NCT01286012|65616133|FG000|Overall Study|Protocol Violation|1|||
23513197|NCT01286012|65616134|FG001|Overall Study|Protocol Violation|1|||
23513198|NCT01286012|65616133|FG000|Overall Study|Withdrawal by Subject|4|||
23513199|NCT01286012|65616134|FG001|Overall Study|Withdrawal by Subject|4|||
23513200|NCT01286012|65616133|FG000|Overall Study|Physician Decision|2|||
23513201|NCT01286012|65616134|FG001|Overall Study|Physician Decision|0|||
23513202|NCT01286012|65616133|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
23307520|NCT03301623|64870538|FG000|Overall Study|Lost to Follow-up|3|||
23415537|NCT04068519|65262463|FG000|Indication Expansion|Withdrawal by Subject|10|||
23415538|NCT04068519|65262463|FG000|Indication Expansion|Lost to Follow-up|7|||
23611185|NCT01072149|65966721|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611186|NCT01072149|65966722|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611187|NCT01072149|65966723|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611188|NCT01072149|65966724|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611189|NCT01072149|65966725|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611190|NCT01072149|65966726|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
23611191|NCT01072149|65966727|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
23453511|NCT01147666|65403334|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453512|NCT01147666|65403335|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453513|NCT01147666|65403336|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453514|NCT01147666|65403337|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453515|NCT01147666|65403338|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453516|NCT01147666|65403339|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453517|NCT01147666|65403340|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453518|NCT01147666|65403341|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453519|NCT01147666|65403342|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453520|NCT01147666|65403343|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
23453521|NCT01147666|65403344|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
23453522|NCT01147666|65403345|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
23453523|NCT01419769|65403346|FG000|Overall Study|Did not receive the AXIOS stent|3|||
23453524|NCT01419769|65403346|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
23453525|NCT00561652|65403347|FG000|Overall Study|Withdrawal by Subject|0|||
23453526|NCT00561652|65403348|FG001|Overall Study|Withdrawal by Subject|1|||
23453527|NCT03367858|65403352|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
23453528|NCT03367858|65403353|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
23453529|NCT03367858|65403352|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
23453530|NCT03367858|65403353|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
23453531|NCT03367858|65403352|FG000|3 Month Follow Up|Lost to Follow-up|8|||
23453532|NCT03367858|65403353|FG001|3 Month Follow Up|Lost to Follow-up|3|||
23453533|NCT03367858|65403352|FG000|3 Month Follow Up|Moved out of study area|2|||
23453534|NCT03367858|65403353|FG001|3 Month Follow Up|Moved out of study area|6|||
23453535|NCT03367858|65403352|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
23453536|NCT03367858|65403353|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
23453537|NCT03367858|65403352|FG000|3 Month Follow Up|MRI contraindication|2|||
23453538|NCT03367858|65403353|FG001|3 Month Follow Up|MRI contraindication|1|||
23453539|NCT03367858|65403352|FG000|3 Month Follow Up|Incarcerated|0|||
23513203|NCT01286012|65616134|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
23513204|NCT00423150|65616135|FG000|Overall Study|Adverse Event|11|||
23513205|NCT00423150|65616135|FG000|Overall Study|Progression of disease being studied|69|||
23415547|NCT02684058|65265924|FG000|Treatment Period|Progressive disease|4|||
23415548|NCT02684058|65265925|FG001|Treatment Period|Progressive disease|10|||
23415549|NCT02684058|65265926|FG002|Treatment Period|Progressive disease|19|||
23415550|NCT02684058|65265924|FG000|Treatment Period|Adverse Event|3|||
23415551|NCT02684058|65265925|FG001|Treatment Period|Adverse Event|8|||
23415552|NCT02684058|65265926|FG002|Treatment Period|Adverse Event|1|||
23415553|NCT02684058|65265924|FG000|Treatment Period|Physician Decision|5|||
23415554|NCT02684058|65265925|FG001|Treatment Period|Physician Decision|1|||
23415555|NCT02684058|65265926|FG002|Treatment Period|Physician Decision|2|||
23415556|NCT02684058|65265924|FG000|Treatment Period|New therapy for study indication|1|||
23415557|NCT02684058|65265925|FG001|Treatment Period|New therapy for study indication|0|||
23415558|NCT02684058|65265926|FG002|Treatment Period|New therapy for study indication|0|||
23415559|NCT02684058|65265924|FG000|Treatment Period|Protocol deviation|0|||
23415560|NCT02684058|65265925|FG001|Treatment Period|Protocol deviation|1|||
23415561|NCT02684058|65265926|FG002|Treatment Period|Protocol deviation|0|||
23415562|NCT02684058|65265924|FG000|Treatment Period|Subject/guardian decision|4|||
23415563|NCT02684058|65265925|FG001|Treatment Period|Subject/guardian decision|3|||
23415564|NCT02684058|65265926|FG002|Treatment Period|Subject/guardian decision|0|||
23415565|NCT02684058|65265924|FG000|Treatment Period|Death|0|||
23415566|NCT02684058|65265925|FG001|Treatment Period|Death|0|||
23415567|NCT02684058|65265926|FG002|Treatment Period|Death|2|||
23415568|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23415569|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
23415570|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23415571|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
23415572|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
23415573|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
23415574|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23415575|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23415576|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
23415577|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|Death|0|||
23415578|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|Death|0|||
23415579|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|Death|3|||
23415580|NCT02684058|65265924|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
23415581|NCT02684058|65265925|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
23415582|NCT02684058|65265926|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
23415583|NCT02684058|65265924|FG000|Post-treatment Survival Follow-up|Death|0|||
23415584|NCT02684058|65265925|FG001|Post-treatment Survival Follow-up|Death|0|||
23415585|NCT02684058|65265926|FG002|Post-treatment Survival Follow-up|Death|7|||
23415586|NCT02684058|65265924|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
23415587|NCT02684058|65265925|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
23415588|NCT02684058|65265926|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
23415589|NCT02684058|65265924|FG000|Crossover Treatment Period|Progressive disease|0|||
23415590|NCT02684058|65265925|FG001|Crossover Treatment Period|Progressive disease|1|||
23415591|NCT02684058|65265926|FG002|Crossover Treatment Period|Progressive disease|0|||
23415592|NCT02301546|65265927|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
23415593|NCT02301546|65265928|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
23415594|NCT02301546|65265927|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
23415595|NCT02301546|65265928|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
23415596|NCT02301546|65265927|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
23415597|NCT02301546|65265928|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
23415598|NCT02301546|65265927|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
23415599|NCT02301546|65265928|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
23415600|NCT02301546|65265927|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
23415601|NCT02301546|65265928|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
23415602|NCT02301546|65265927|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
23415603|NCT02301546|65265928|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
23415604|NCT02301546|65265927|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
23415605|NCT02301546|65265928|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
23415606|NCT00054327|65265931|FG000|Overall Study|Engraftment failure|1|||
23513206|NCT00423150|65616135|FG000|Overall Study|Withdrawal by Subject|1|||
23513207|NCT00423150|65616135|FG000|Overall Study|Non-compliance with protocol|1|||
23513208|NCT00423150|65616135|FG000|Overall Study|Administrative|4|||
23513209|NCT02998840|65616136|FG000|Overall Study|Lost to Follow-up|1|||
23513210|NCT02998840|65616137|FG001|Overall Study|Lost to Follow-up|1|||
23415607|NCT00054327|65265932|FG001|Overall Study|Engraftment failure|0|||
23415608|NCT00054327|65265933|FG002|Overall Study|Engraftment failure|0|||
23415609|NCT00054327|65265934|FG003|Overall Study|Engraftment failure|0|||
23513211|NCT02998840|65616138|FG002|Overall Study|Lost to Follow-up|2|||
23513212|NCT02998840|65616139|FG003|Overall Study|Lost to Follow-up|3|||
23513213|NCT02998840|65616136|FG000|Overall Study|Withdrawal by Subject|1|||
23513214|NCT02998840|65616137|FG001|Overall Study|Withdrawal by Subject|1|||
23513215|NCT02998840|65616138|FG002|Overall Study|Withdrawal by Subject|0|||
23513216|NCT02998840|65616139|FG003|Overall Study|Withdrawal by Subject|1|||
23513217|NCT02998840|65616136|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
23513218|NCT02998840|65616137|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
23513219|NCT02998840|65616138|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
23513220|NCT02998840|65616139|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
23513221|NCT01218204|65616142|FG000|Part B Washout|Adverse Event|0|||
23513222|NCT01218204|65616143|FG001|Part B Washout|Adverse Event|1|||
23513223|NCT01218204|65616144|FG002|Part B Washout|Adverse Event|0|||
23513224|NCT01218204|65616145|FG003|Part B Washout|Adverse Event|0|||
23513225|NCT01218204|65616142|FG000|Part B Washout|Lost to Follow-up|0|||
23513226|NCT01218204|65616143|FG001|Part B Washout|Lost to Follow-up|2|||
23513227|NCT01218204|65616144|FG002|Part B Washout|Lost to Follow-up|0|||
23513228|NCT01218204|65616145|FG003|Part B Washout|Lost to Follow-up|0|||
23513229|NCT01218204|65616142|FG000|Part B Washout|Physician Decision|0|||
23513230|NCT01218204|65616143|FG001|Part B Washout|Physician Decision|14|||
23513231|NCT01218204|65616144|FG002|Part B Washout|Physician Decision|0|||
23513232|NCT01218204|65616145|FG003|Part B Washout|Physician Decision|0|||
23513233|NCT01218204|65616142|FG000|Part B Washout|Withdrawal by Subject|0|||
23513234|NCT01218204|65616143|FG001|Part B Washout|Withdrawal by Subject|14|||
23513235|NCT01218204|65616144|FG002|Part B Washout|Withdrawal by Subject|0|||
23513236|NCT01218204|65616145|FG003|Part B Washout|Withdrawal by Subject|0|||
23513237|NCT01218204|65616142|FG000|Part B Washout|Reached defined stopping criteria|0|||
23513238|NCT01218204|65616143|FG001|Part B Washout|Reached defined stopping criteria|2|||
23513239|NCT01218204|65616144|FG002|Part B Washout|Reached defined stopping criteria|0|||
23513240|NCT01218204|65616145|FG003|Part B Washout|Reached defined stopping criteria|0|||
23513241|NCT01218204|65616142|FG000|Part B Washout|Did not meet continuation criteria|0|||
23513242|NCT01218204|65616143|FG001|Part B Washout|Did not meet continuation criteria|112|||
23513243|NCT01218204|65616144|FG002|Part B Washout|Did not meet continuation criteria|0|||
23513244|NCT01218204|65616145|FG003|Part B Washout|Did not meet continuation criteria|0|||
23513245|NCT01218204|65616142|FG000|Part B Run-in|Adverse Event|0|||
23513246|NCT01218204|65616143|FG001|Part B Run-in|Adverse Event|0|||
23307521|NCT03301623|64870539|FG001|Overall Study|Lost to Follow-up|1|||
23513247|NCT01218204|65616144|FG002|Part B Run-in|Adverse Event|1|||
23513248|NCT01218204|65616145|FG003|Part B Run-in|Adverse Event|0|||
23513249|NCT01218204|65616142|FG000|Part B Run-in|Protocol Violation|0|||
23513250|NCT01218204|65616143|FG001|Part B Run-in|Protocol Violation|0|||
23513251|NCT01218204|65616144|FG002|Part B Run-in|Protocol Violation|2|||
23513252|NCT01218204|65616145|FG003|Part B Run-in|Protocol Violation|0|||
23513253|NCT01218204|65616142|FG000|Part B Run-in|Withdrawal by Subject|0|||
23513254|NCT01218204|65616143|FG001|Part B Run-in|Withdrawal by Subject|0|||
23513255|NCT01218204|65616144|FG002|Part B Run-in|Withdrawal by Subject|3|||
23513256|NCT01218204|65616145|FG003|Part B Run-in|Withdrawal by Subject|0|||
23513257|NCT01218204|65616142|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
23513258|NCT01218204|65616143|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
23513259|NCT01218204|65616144|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
23513260|NCT01218204|65616145|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
23513261|NCT01218204|65616142|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
23513262|NCT01218204|65616143|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
23513263|NCT01218204|65616144|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
23513264|NCT01218204|65616145|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
23513265|NCT02064894|65616146|FG000|Overall Study|Withdrawal by Subject|43|||
23513266|NCT02064894|65616147|FG001|Overall Study|Withdrawal by Subject|102|||
23513267|NCT02064894|65616148|FG002|Overall Study|Withdrawal by Subject|115|||
23513268|NCT00459108|65616153|FG000|Overall Study|Withdrawal by Subject|5|||
23513269|NCT00459108|65616153|FG000|Overall Study|Adverse Event|3|||
23513270|NCT00459108|65616153|FG000|Overall Study|Death|2|||
23513271|NCT00459108|65616153|FG000|Overall Study|Progression|1|||
23513272|NCT01414114|65616154|FG000|Overall Study|Adverse Event|2|||
23513273|NCT01414114|65616154|FG000|Overall Study|Withdrawal by Subject|1|||
23513274|NCT01414114|65616154|FG000|Overall Study|Other|2|||
23513275|NCT02953314|65616155|FG000|Overall Study|Adverse Event|0|||
23513276|NCT02953314|65616156|FG001|Overall Study|Adverse Event|1|||
23513277|NCT02953314|65616155|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
23513278|NCT02953314|65616156|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
23513279|NCT01338493|65616159|FG000|Enrolled|Withdrawal by Subject|1|||
23513280|NCT01338493|65616159|FG000|Enrolled|Patient not implanted|4|||
23513281|NCT01338493|65616159|FG000|Discharge|Death|1|||
23513282|NCT01338493|65616159|FG000|Discharge|Missed visit|1|||
23513283|NCT01338493|65616159|FG000|6 Months Follow up|Lost to Follow-up|11|||
23513284|NCT01338493|65616159|FG000|6 Months Follow up|Missed visit|8|||
23513285|NCT01338493|65616159|FG000|12 Months Follow up|Lost to Follow-up|9|||
23513286|NCT03641651|65616160|FG000|Overall Study|organizational issues at one study site|1|||
23513287|NCT00894322|65616161|FG000|Overall Study|Withdrawal by Subject|1|||
23513288|NCT00894322|65616162|FG001|Overall Study|Withdrawal by Subject|0|||
23513289|NCT00894322|65616163|FG002|Overall Study|Withdrawal by Subject|0|||
23513290|NCT02485301|65616168|FG000|Overall Study|Serious Adverse Events|2|||
23513291|NCT02485301|65616169|FG001|Overall Study|Serious Adverse Events|1|||
23513292|NCT02485301|65616168|FG000|Overall Study|Protocol Violation|0|||
23513293|NCT02485301|65616169|FG001|Overall Study|Protocol Violation|1|||
23513294|NCT02485301|65616168|FG000|Overall Study|Withdrawal by Subject|6|||
23513295|NCT02485301|65616169|FG001|Overall Study|Withdrawal by Subject|7|||
23513296|NCT02485301|65616168|FG000|Overall Study|Migrated/moved from study area|10|||
23513297|NCT02485301|65616169|FG001|Overall Study|Migrated/moved from study area|19|||
23513298|NCT02485301|65616168|FG000|Overall Study|Lost to Follow-up|17|||
23513299|NCT02485301|65616169|FG001|Overall Study|Lost to Follow-up|17|||
23513300|NCT02485301|65616168|FG000|Overall Study|Other|3|||
23513301|NCT02485301|65616169|FG001|Overall Study|Other|4|||
23513302|NCT00680043|65616170|FG000|Overall Study|Withdrawal by Subject|1|||
23415610|NCT00054327|65265935|FG004|Overall Study|Engraftment failure|0|||
23415611|NCT00054327|65265936|FG005|Overall Study|Engraftment failure|0|||
23415612|NCT00716482|65265940|FG000|Overall Study|Lost to Follow-up|6|||
23415613|NCT00716482|65265940|FG000|Overall Study|Inadequate acquisition or analysis|50|||
23415614|NCT00716482|65265940|FG000|Overall Study|no pathology obtained|10|||
23415615|NCT00716482|65265940|FG000|Overall Study|technical/machine error|28|||
23415616|NCT00716482|65265940|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
23415617|NCT01885208|65265941|FG000|Overall Study|Unclassified|32|||
23415618|NCT01885208|65265942|FG001|Overall Study|Unclassified|38|||
23415619|NCT00487942|65265946|FG000|Overall Study|Adverse Event|1|||
23415620|NCT00487942|65265947|FG001|Overall Study|Adverse Event|1|||
23415621|NCT00487942|65265948|FG002|Overall Study|Adverse Event|1|||
23415622|NCT00487942|65265949|FG003|Overall Study|Adverse Event|1|||
23415623|NCT00487942|65265946|FG000|Overall Study|Lost to Follow-up|1|||
23415624|NCT00487942|65265947|FG001|Overall Study|Lost to Follow-up|0|||
23415625|NCT00487942|65265948|FG002|Overall Study|Lost to Follow-up|0|||
23415626|NCT00487942|65265949|FG003|Overall Study|Lost to Follow-up|1|||
23415627|NCT00487942|65265946|FG000|Overall Study|Protocol Violation|1|||
23415628|NCT00487942|65265947|FG001|Overall Study|Protocol Violation|1|||
23415629|NCT00487942|65265948|FG002|Overall Study|Protocol Violation|0|||
23415630|NCT00487942|65265949|FG003|Overall Study|Protocol Violation|0|||
23415631|NCT00487942|65265946|FG000|Overall Study|Withdrawal by Subject|0|||
23415632|NCT00487942|65265947|FG001|Overall Study|Withdrawal by Subject|1|||
23415633|NCT00487942|65265948|FG002|Overall Study|Withdrawal by Subject|2|||
23415634|NCT00487942|65265949|FG003|Overall Study|Withdrawal by Subject|0|||
23415635|NCT00118846|65265953|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
23415636|NCT00118846|65265954|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
23415637|NCT00118846|65265953|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
23415638|NCT00118846|65265954|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
23415639|NCT00118846|65265953|FG000|Overall Study|Physician Decision|1|||
23415640|NCT00118846|65265954|FG001|Overall Study|Physician Decision|0|||
23415641|NCT00118846|65265953|FG000|Overall Study|Medical condition|2|||
23415642|NCT00118846|65265954|FG001|Overall Study|Medical condition|2|||
23415643|NCT00118846|65265953|FG000|Overall Study|Lost to Follow-up|0|||
23415644|NCT00118846|65265954|FG001|Overall Study|Lost to Follow-up|2|||
23415645|NCT00118846|65265953|FG000|Overall Study|Personal reason|4|||
23415646|NCT00118846|65265954|FG001|Overall Study|Personal reason|5|||
23415647|NCT02120300|65265955|FG000|Overall Study|Enrolled but Never Treated|2|||
23415648|NCT02120300|65265956|FG001|Overall Study|Enrolled but Never Treated|0|||
23513303|NCT00680043|65616171|FG001|Overall Study|Withdrawal by Subject|0|||
23415649|NCT02120300|65265957|FG002|Overall Study|Enrolled but Never Treated|0|||
23415650|NCT02120300|65265958|FG003|Overall Study|Enrolled but Never Treated|0|||
23415651|NCT02120300|65265955|FG000|Overall Study|Lack of Efficacy|0|||
23415652|NCT02120300|65265956|FG001|Overall Study|Lack of Efficacy|0|||
23415653|NCT02120300|65265957|FG002|Overall Study|Lack of Efficacy|0|||
23415654|NCT02120300|65265958|FG003|Overall Study|Lack of Efficacy|1|||
23415655|NCT02120300|65265955|FG000|Overall Study|Lost to Follow-up|1|||
23415656|NCT02120300|65265956|FG001|Overall Study|Lost to Follow-up|0|||
23415657|NCT02120300|65265957|FG002|Overall Study|Lost to Follow-up|0|||
23415658|NCT02120300|65265958|FG003|Overall Study|Lost to Follow-up|0|||
23415659|NCT00405392|65265959|FG000|Overall Study|Adverse Event|15|||
23513304|NCT00680043|65616172|FG002|Overall Study|Withdrawal by Subject|0|||
23513305|NCT00680043|65616170|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
23513306|NCT00680043|65616171|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
23415660|NCT00405392|65265960|FG001|Overall Study|Adverse Event|14|||
23415661|NCT00405392|65265959|FG000|Overall Study|Did not meet Eligibility criteria|7|||
23415662|NCT00405392|65265960|FG001|Overall Study|Did not meet Eligibility criteria|2|||
23415663|NCT00405392|65265959|FG000|Overall Study|Withdrawal by Subject|4|||
23415664|NCT00405392|65265960|FG001|Overall Study|Withdrawal by Subject|3|||
23415665|NCT00405392|65265959|FG000|Overall Study|Lost to Follow-up|1|||
23415666|NCT00405392|65265960|FG001|Overall Study|Lost to Follow-up|2|||
23415667|NCT00405392|65265959|FG000|Overall Study|Data missing|2|||
23415668|NCT00405392|65265960|FG001|Overall Study|Data missing|0|||
23415669|NCT00405392|65265959|FG000|Overall Study|Non-compliance|0|||
23415670|NCT00405392|65265960|FG001|Overall Study|Non-compliance|1|||
23415671|NCT00405392|65265959|FG000|Overall Study|Other|1|||
23415672|NCT00405392|65265960|FG001|Overall Study|Other|5|||
23415673|NCT00623233|65265972|FG000|Overall Study|Adverse Event|10|||
23415674|NCT00623233|65265972|FG000|Overall Study|Physician Decision|10|||
23415675|NCT00623233|65265972|FG000|Overall Study|Lost to Follow-up|1|||
23415676|NCT00623233|65265972|FG000|Overall Study|Withdrawal by Subject|3|||
23415677|NCT00443872|65265975|FG000|Overall Study|Protocol Violation|7|||
23415678|NCT00443872|65265975|FG000|Overall Study|Lost to Follow-up|2|||
23415679|NCT00443872|65265975|FG000|Overall Study|Adverse Event|8|||
23415680|NCT04556591|65265978|FG000|Overall Study|Lost to Follow-up|1|||
23415681|NCT04556591|65265979|FG001|Overall Study|Lost to Follow-up|0|||
23415682|NCT04556591|65265978|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
23415683|NCT04556591|65265979|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
23415684|NCT02791516|65265982|FG000|Overall Study|Withdrawal by Subject|1|||
23415685|NCT02791516|65265983|FG001|Overall Study|Withdrawal by Subject|1|||
23513307|NCT00680043|65616172|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
23513308|NCT00680043|65616170|FG000|Overall Study|Renal Transplant|1|||
23513309|NCT00680043|65616171|FG001|Overall Study|Renal Transplant|0|||
23513310|NCT00680043|65616172|FG002|Overall Study|Renal Transplant|4|||
23513311|NCT00661622|65616173|FG000|Overall Study|Protocol Violation|1|||
23513312|NCT00661622|65616174|FG001|Overall Study|Protocol Violation|0|||
23513313|NCT01288469|65616177|FG000|Overall Study|Adverse Event|4|||
23415686|NCT01133756|65265984|FG000|Overall Study|Adverse Event|1|||
23415687|NCT01133756|65265985|FG001|Overall Study|Adverse Event|2|||
23415688|NCT01133756|65265986|FG002|Overall Study|Adverse Event|1|||
23415689|NCT01133756|65265984|FG000|Overall Study|Investigator Decision|1|||
23415690|NCT01133756|65265985|FG001|Overall Study|Investigator Decision|0|||
23513314|NCT01288469|65616178|FG001|Overall Study|Adverse Event|1|||
23513315|NCT01288469|65616179|FG002|Overall Study|Adverse Event|1|||
23513316|NCT01288469|65616177|FG000|Overall Study|Poor compliance to protocol|0|||
23513317|NCT01288469|65616178|FG001|Overall Study|Poor compliance to protocol|1|||
23513318|NCT01288469|65616179|FG002|Overall Study|Poor compliance to protocol|0|||
23513319|NCT01288469|65616177|FG000|Overall Study|Participant Moved|1|||
23513320|NCT01288469|65616178|FG001|Overall Study|Participant Moved|0|||
23513321|NCT01288469|65616179|FG002|Overall Study|Participant Moved|0|||
23513322|NCT01288469|65616177|FG000|Overall Study|Consent withdrawn by subject|1|||
23513323|NCT01288469|65616178|FG001|Overall Study|Consent withdrawn by subject|1|||
23513324|NCT01288469|65616179|FG002|Overall Study|Consent withdrawn by subject|1|||
23513325|NCT01288469|65616177|FG000|Overall Study|Exclusion criteria finally met|1|||
23513326|NCT01288469|65616178|FG001|Overall Study|Exclusion criteria finally met|0|||
23513327|NCT01288469|65616179|FG002|Overall Study|Exclusion criteria finally met|0|||
23513328|NCT00467259|65616180|FG000|Overall Study|Adverse Event|24|||
23513329|NCT00467259|65616181|FG001|Overall Study|Adverse Event|90|||
23513330|NCT00467259|65616180|FG000|Overall Study|Protocol Violation|1|||
23513331|NCT00467259|65616181|FG001|Overall Study|Protocol Violation|7|||
23513332|NCT00467259|65616180|FG000|Overall Study|Withdrawal by Subject|34|||
23513333|NCT00467259|65616181|FG001|Overall Study|Withdrawal by Subject|108|||
23513334|NCT00467259|65616180|FG000|Overall Study|Physician Decision|0|||
23513335|NCT00467259|65616181|FG001|Overall Study|Physician Decision|2|||
23513336|NCT00467259|65616180|FG000|Overall Study|Lost to Follow-up|14|||
23513337|NCT00467259|65616181|FG001|Overall Study|Lost to Follow-up|34|||
23513338|NCT00467259|65616180|FG000|Overall Study|Site Closed|2|||
23513339|NCT00467259|65616181|FG001|Overall Study|Site Closed|1|||
23513340|NCT01438957|65616182|FG000|Overall Study|Physician Decision|1|||
23513341|NCT01438957|65616183|FG001|Overall Study|Physician Decision|1|||
23513342|NCT01438957|65616184|FG002|Overall Study|Physician Decision|0|||
23513343|NCT01438957|65616185|FG003|Overall Study|Physician Decision|1|||
23513344|NCT01438957|65616186|FG004|Overall Study|Physician Decision|0|||
23513345|NCT02892760|65616187|FG000|Overall Study|Withdrawal by Subject|3|||
23513346|NCT02457910|65616188|FG000|Overall Study|Withdrawal by Subject|0|||
23513347|NCT02457910|65616189|FG001|Overall Study|Withdrawal by Subject|0|||
23513348|NCT02457910|65616190|FG002|Overall Study|Withdrawal by Subject|0|||
23513349|NCT02457910|65616191|FG003|Overall Study|Withdrawal by Subject|0|||
23513350|NCT02457910|65616192|FG004|Overall Study|Withdrawal by Subject|0|||
23513351|NCT02457910|65616193|FG005|Overall Study|Withdrawal by Subject|1|||
23513352|NCT02457910|65616188|FG000|Overall Study|Adverse Event|0|||
23513353|NCT02457910|65616189|FG001|Overall Study|Adverse Event|2|||
23513354|NCT02457910|65616190|FG002|Overall Study|Adverse Event|1|||
23513355|NCT02457910|65616191|FG003|Overall Study|Adverse Event|1|||
23513356|NCT02457910|65616192|FG004|Overall Study|Adverse Event|1|||
23513357|NCT02457910|65616193|FG005|Overall Study|Adverse Event|3|||
23513358|NCT02457910|65616188|FG000|Overall Study|Disease progression|3|||
23513359|NCT02457910|65616189|FG001|Overall Study|Disease progression|3|||
23513360|NCT02457910|65616190|FG002|Overall Study|Disease progression|1|||
23513361|NCT02457910|65616191|FG003|Overall Study|Disease progression|1|||
23513362|NCT02457910|65616192|FG004|Overall Study|Disease progression|4|||
23513363|NCT02457910|65616193|FG005|Overall Study|Disease progression|6|||
23513364|NCT02457910|65616188|FG000|Overall Study|Other complicating illness|0|||
23513365|NCT02457910|65616189|FG001|Overall Study|Other complicating illness|0|||
23513366|NCT02457910|65616190|FG002|Overall Study|Other complicating illness|0|||
23513367|NCT02457910|65616191|FG003|Overall Study|Other complicating illness|0|||
23513368|NCT02457910|65616192|FG004|Overall Study|Other complicating illness|0|||
23513369|NCT02457910|65616193|FG005|Overall Study|Other complicating illness|1|||
23415691|NCT01133756|65265986|FG002|Overall Study|Investigator Decision|0|||
23415692|NCT01133756|65265984|FG000|Overall Study|Withdrawal by Subject|0|||
23415693|NCT01133756|65265985|FG001|Overall Study|Withdrawal by Subject|1|||
23415694|NCT01133756|65265986|FG002|Overall Study|Withdrawal by Subject|0|||
23415695|NCT01133756|65265984|FG000|Overall Study|Progression of Disease|0|||
23415696|NCT01133756|65265985|FG001|Overall Study|Progression of Disease|0|||
23415697|NCT01133756|65265986|FG002|Overall Study|Progression of Disease|1|||
23415698|NCT05243745|65265987|FG000|Overall Study|Withdrawal by Subject|0|||
23415699|NCT05243745|65265988|FG001|Overall Study|Withdrawal by Subject|0|||
23513370|NCT02457910|65616188|FG000|Overall Study|Death|0|||
23513371|NCT02457910|65616189|FG001|Overall Study|Death|0|||
23513372|NCT02457910|65616190|FG002|Overall Study|Death|1|||
23513373|NCT02457910|65616191|FG003|Overall Study|Death|0|||
23513374|NCT02457910|65616192|FG004|Overall Study|Death|0|||
23513375|NCT02457910|65616193|FG005|Overall Study|Death|0|||
23513376|NCT02744391|65616198|FG000|Overall Study|Lost to Follow-up|9|||
23513377|NCT02744391|65616198|FG000|Overall Study|Physician Decision|2|||
23513378|NCT02744391|65616198|FG000|Overall Study|Withdrawal by Subject|3|||
23513379|NCT03051607|65616200|FG000|Overall Study|Adverse Event|66|||
23513380|NCT02415127|65616211|FG000|Overall Study|Adverse Event|1|||
23513381|NCT02415127|65616212|FG001|Overall Study|Adverse Event|0|||
23513382|NCT02626520|65616213|FG000|Overall Study|Physician Decision|1|||
23513383|NCT02626520|65616214|FG001|Overall Study|Physician Decision|1|||
23513384|NCT02626520|65616213|FG000|Overall Study|Adverse Event|0|||
23513385|NCT02626520|65616214|FG001|Overall Study|Adverse Event|4|||
23513386|NCT02626520|65616213|FG000|Overall Study|Lack of Efficacy|0|||
23513387|NCT02626520|65616214|FG001|Overall Study|Lack of Efficacy|2|||
23513388|NCT02626520|65616213|FG000|Overall Study|Did not start protocol therapy|0|||
23513389|NCT02626520|65616214|FG001|Overall Study|Did not start protocol therapy|2|||
23513390|NCT02626520|65616213|FG000|Overall Study|Study terminated|0|||
23513391|NCT02626520|65616214|FG001|Overall Study|Study terminated|1|||
23513392|NCT00498602|65616215|FG000|Overall Study|Death|0|||
23513393|NCT00498602|65616216|FG001|Overall Study|Death|0|||
23513394|NCT00498602|65616217|FG002|Overall Study|Death|0|||
23513395|NCT00498602|65616218|FG003|Overall Study|Death|0|||
23513396|NCT00498602|65616219|FG004|Overall Study|Death|0|||
23513397|NCT00498602|65616220|FG005|Overall Study|Death|1|||
23513398|NCT00498602|65616221|FG006|Overall Study|Death|0|||
23513399|NCT00498602|65616215|FG000|Overall Study|Lack of Efficacy|1|||
23513400|NCT00498602|65616216|FG001|Overall Study|Lack of Efficacy|0|||
23513401|NCT00498602|65616217|FG002|Overall Study|Lack of Efficacy|0|||
23513402|NCT00498602|65616218|FG003|Overall Study|Lack of Efficacy|0|||
23513403|NCT00498602|65616219|FG004|Overall Study|Lack of Efficacy|0|||
23513404|NCT00498602|65616220|FG005|Overall Study|Lack of Efficacy|0|||
23513405|NCT00498602|65616221|FG006|Overall Study|Lack of Efficacy|0|||
23513406|NCT00498602|65616215|FG000|Overall Study|Lost to Follow-up|0|||
23513407|NCT00498602|65616216|FG001|Overall Study|Lost to Follow-up|2|||
23513408|NCT00498602|65616217|FG002|Overall Study|Lost to Follow-up|0|||
23513409|NCT00498602|65616218|FG003|Overall Study|Lost to Follow-up|2|||
23513410|NCT00498602|65616219|FG004|Overall Study|Lost to Follow-up|0|||
23513411|NCT00498602|65616220|FG005|Overall Study|Lost to Follow-up|0|||
23513412|NCT00498602|65616221|FG006|Overall Study|Lost to Follow-up|0|||
23513413|NCT00498602|65616215|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
23513414|NCT00498602|65616216|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23513415|NCT00498602|65616217|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
23513416|NCT00498602|65616218|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
23513417|NCT00498602|65616219|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23513418|NCT00498602|65616220|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
23513419|NCT00498602|65616221|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23513420|NCT00498602|65616215|FG000|Overall Study|AE not related to Study Drug|1|||
23513421|NCT00498602|65616216|FG001|Overall Study|AE not related to Study Drug|3|||
23513422|NCT00498602|65616217|FG002|Overall Study|AE not related to Study Drug|0|||
23513423|NCT00498602|65616218|FG003|Overall Study|AE not related to Study Drug|0|||
23513424|NCT00498602|65616219|FG004|Overall Study|AE not related to Study Drug|2|||
23513425|NCT00498602|65616220|FG005|Overall Study|AE not related to Study Drug|2|||
23513426|NCT00498602|65616221|FG006|Overall Study|AE not related to Study Drug|1|||
23513427|NCT00498602|65616215|FG000|Overall Study|Caregiver Request|2|||
23611192|NCT01072149|65966728|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
23513428|NCT00498602|65616216|FG001|Overall Study|Caregiver Request|2|||
23513429|NCT00498602|65616217|FG002|Overall Study|Caregiver Request|2|||
23513430|NCT00498602|65616218|FG003|Overall Study|Caregiver Request|0|||
23307522|NCT04091659|64870540|FG000|Overall Study|Protocol Violation|3|||
23307523|NCT04091659|64870541|FG001|Overall Study|Protocol Violation|0|||
23307524|NCT04091659|64870540|FG000|Overall Study|Lost to Follow-up|0|||
23307525|NCT04091659|64870541|FG001|Overall Study|Lost to Follow-up|1|||
23307526|NCT01868893|64870542|FG000|Overall Study|Adverse Event|2|||
23307527|NCT01868893|64870542|FG000|Overall Study|Commercial availability of study drug|17|||
23307528|NCT01868893|64870542|FG000|Overall Study|Neutropenia|1|||
23307529|NCT00773734|64870548|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
23307530|NCT00773734|64870549|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
23307531|NCT00773734|64870550|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
23307532|NCT00773734|64870551|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
23307533|NCT00773734|64870552|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
23307534|NCT00773734|64870553|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
23307535|NCT00773734|64870548|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
23307536|NCT00773734|64870549|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
23307537|NCT00773734|64870550|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
23307538|NCT00773734|64870551|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
23307539|NCT00773734|64870552|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
23415700|NCT05243745|65265989|FG002|Overall Study|Withdrawal by Subject|0|||
23415701|NCT05243745|65265990|FG003|Overall Study|Withdrawal by Subject|1|||
23415702|NCT05243745|65265987|FG000|Overall Study|Unable to Attend Visit 6|0|||
23415703|NCT05243745|65265988|FG001|Overall Study|Unable to Attend Visit 6|0|||
23415704|NCT05243745|65265989|FG002|Overall Study|Unable to Attend Visit 6|1|||
23415705|NCT05243745|65265990|FG003|Overall Study|Unable to Attend Visit 6|0|||
23415706|NCT02910401|65265991|FG000|Overall Study|Study closure Study closure|0|||
23415707|NCT02910401|65265992|FG001|Overall Study|Study closure Study closure|0|||
23415708|NCT02910401|65265993|FG002|Overall Study|Study closure Study closure|2|||
23415709|NCT02910401|65265991|FG000|Overall Study|Physician Decision|1|||
23415710|NCT02910401|65265992|FG001|Overall Study|Physician Decision|0|||
23415711|NCT02910401|65265993|FG002|Overall Study|Physician Decision|0|||
23415712|NCT03249909|65265994|FG000|Overall Study|Withdrawal by Subject|3|||
23415713|NCT03249909|65265995|FG001|Overall Study|Withdrawal by Subject|0|||
23415714|NCT03249909|65265996|FG002|Overall Study|Withdrawal by Subject|0|||
23415715|NCT03249909|65265994|FG000|Overall Study|Adverse Event|3|||
23415716|NCT03249909|65265995|FG001|Overall Study|Adverse Event|0|||
23415717|NCT03249909|65265996|FG002|Overall Study|Adverse Event|0|||
23415718|NCT03249909|65265994|FG000|Overall Study|Lost to Follow-up|0|||
23415719|NCT03249909|65265995|FG001|Overall Study|Lost to Follow-up|1|||
23415720|NCT03249909|65265996|FG002|Overall Study|Lost to Follow-up|0|||
23415721|NCT02321319|65265997|FG000|Overall Study|Product discontinued|5|||
23415722|NCT03006458|65265998|FG000|First Intervention|Unsatisfied Vision|0|||
23415723|NCT03006458|65265999|FG001|First Intervention|Unsatisfied Vision|3|||
23415724|NCT03077438|65266000|FG000|Overall Study|Protocol Violation|3|||
23415725|NCT03077438|65266001|FG001|Overall Study|Protocol Violation|5|||
23415726|NCT03077438|65266000|FG000|Overall Study|Withdrawal by Subject|3|||
23415727|NCT03077438|65266001|FG001|Overall Study|Withdrawal by Subject|6|||
23415728|NCT03077438|65266000|FG000|Overall Study|Lost to Follow-up|6|||
23415729|NCT03077438|65266001|FG001|Overall Study|Lost to Follow-up|3|||
23415730|NCT03305081|65266002|FG000|Overall Study|Lost to Follow-up|10|||
23415731|NCT03305081|65266003|FG001|Overall Study|Lost to Follow-up|15|||
23415732|NCT01208961|65266004|FG000|High-Fat Period III|Protocol Violation|1|||
23415733|NCT01208961|65266005|FG001|High-Fat Period III|Protocol Violation|0|||
23415734|NCT01439971|65266010|FG000|Overall Study|Required number in cohort dosed|0|||
23415735|NCT01439971|65266011|FG001|Overall Study|Required number in cohort dosed|1|||
23415736|NCT01439971|65266012|FG002|Overall Study|Required number in cohort dosed|2|||
23415737|NCT01439971|65266013|FG003|Overall Study|Required number in cohort dosed|0|||
23415738|NCT01439971|65266014|FG004|Overall Study|Required number in cohort dosed|1|||
23415739|NCT01942161|65266015|FG000|Overall Study|Adverse Event|1|||
23415740|NCT01942161|65266016|FG001|Overall Study|Adverse Event|2|||
23415741|NCT01942161|65266017|FG002|Overall Study|Adverse Event|5|||
23415742|NCT01942161|65266015|FG000|Overall Study|Physician Decision|3|||
23415743|NCT01942161|65266016|FG001|Overall Study|Physician Decision|1|||
23415744|NCT01942161|65266017|FG002|Overall Study|Physician Decision|0|||
23415745|NCT01942161|65266015|FG000|Overall Study|Protocol Violation|1|||
23415746|NCT01942161|65266016|FG001|Overall Study|Protocol Violation|0|||
23415747|NCT01942161|65266017|FG002|Overall Study|Protocol Violation|0|||
23415748|NCT01942161|65266015|FG000|Overall Study|Withdrawal by Subject|3|||
23415749|NCT01942161|65266016|FG001|Overall Study|Withdrawal by Subject|3|||
23415750|NCT01942161|65266017|FG002|Overall Study|Withdrawal by Subject|1|||
23415751|NCT00271856|65266022|FG000|Overall Study|Withdrawal by Subject|1|||
23415752|NCT00271856|65266023|FG001|Overall Study|Withdrawal by Subject|7|||
23513431|NCT00498602|65616219|FG004|Overall Study|Caregiver Request|1|||
23513432|NCT00498602|65616220|FG005|Overall Study|Caregiver Request|2|||
23513433|NCT00498602|65616221|FG006|Overall Study|Caregiver Request|0|||
23513434|NCT00498602|65616215|FG000|Overall Study|Investigator Request|0|||
23415753|NCT00271856|65266022|FG000|Overall Study|Lost to Follow-up|10|||
23415754|NCT00271856|65266023|FG001|Overall Study|Lost to Follow-up|11|||
23415755|NCT00443053|65266026|FG000|Overall Study|Adverse Event|2|||
23415756|NCT00443053|65266027|FG001|Overall Study|Adverse Event|1|||
23415757|NCT00443053|65266026|FG000|Overall Study|Withdrawal by Subject|9|||
23415758|NCT00443053|65266027|FG001|Overall Study|Withdrawal by Subject|18|||
23415759|NCT00443053|65266026|FG000|Overall Study|Lost to Follow-up|4|||
23415760|NCT00443053|65266027|FG001|Overall Study|Lost to Follow-up|5|||
23415761|NCT00443053|65266026|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
23415762|NCT00443053|65266027|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
23415763|NCT00443053|65266026|FG000|Overall Study|Noncompliance|2|||
23415764|NCT00443053|65266027|FG001|Overall Study|Noncompliance|1|||
23415765|NCT00443053|65266026|FG000|Overall Study|Other|3|||
23415766|NCT00443053|65266027|FG001|Overall Study|Other|4|||
23415767|NCT00443053|65266026|FG000|Overall Study|Physician Decision|0|||
23415768|NCT00443053|65266027|FG001|Overall Study|Physician Decision|4|||
23415769|NCT03219034|65266028|FG000|Overall Study|Lost to Follow-up|9|||
23415770|NCT03219034|65266029|FG001|Overall Study|Lost to Follow-up|13|||
23415771|NCT03219034|65266028|FG000|Overall Study|Additional dental work needed|1|||
23415772|NCT03219034|65266029|FG001|Overall Study|Additional dental work needed|0|||
23415773|NCT03219034|65266028|FG000|Overall Study|UPPP Surgery|1|||
23415774|NCT03219034|65266029|FG001|Overall Study|UPPP Surgery|0|||
23415775|NCT03219034|65266028|FG000|Overall Study|Dental sensitivity|0|||
23415776|NCT03219034|65266029|FG001|Overall Study|Dental sensitivity|1|||
23415777|NCT03219034|65266028|FG000|Overall Study|Death in family|0|||
23415778|NCT03219034|65266029|FG001|Overall Study|Death in family|1|||
23415779|NCT03403361|65266031|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
23415780|NCT01406938|65266037|FG000|Induction Period|Subject/guardian decision|6|||
23415781|NCT01406938|65266038|FG001|Induction Period|Subject/guardian decision|8|||
23415782|NCT01406938|65266039|FG002|Induction Period|Subject/guardian decision|0|||
23415783|NCT01406938|65266040|FG003|Induction Period|Subject/guardian decision|0|||
23415784|NCT01406938|65266041|FG004|Induction Period|Subject/guardian decision|0|||
23415785|NCT01406938|65266042|FG005|Induction Period|Subject/guardian decision|0|||
23415786|NCT01406938|65266037|FG000|Induction Period|Protocol deviation|1|||
23415787|NCT01406938|65266038|FG001|Induction Period|Protocol deviation|0|||
23415788|NCT01406938|65266039|FG002|Induction Period|Protocol deviation|0|||
23415789|NCT01406938|65266040|FG003|Induction Period|Protocol deviation|0|||
23415790|NCT01406938|65266041|FG004|Induction Period|Protocol deviation|0|||
23415791|NCT01406938|65266042|FG005|Induction Period|Protocol deviation|0|||
23415792|NCT01406938|65266037|FG000|Induction Period|Adverse Event|8|||
23415793|NCT01406938|65266038|FG001|Induction Period|Adverse Event|9|||
23415794|NCT01406938|65266039|FG002|Induction Period|Adverse Event|0|||
23415795|NCT01406938|65266040|FG003|Induction Period|Adverse Event|0|||
23415796|NCT01406938|65266041|FG004|Induction Period|Adverse Event|0|||
23415797|NCT01406938|65266042|FG005|Induction Period|Adverse Event|0|||
23415798|NCT01406938|65266037|FG000|Induction Period|Lack of Efficacy|1|||
23415799|NCT01406938|65266038|FG001|Induction Period|Lack of Efficacy|0|||
23415800|NCT01406938|65266039|FG002|Induction Period|Lack of Efficacy|0|||
23415801|NCT01406938|65266040|FG003|Induction Period|Lack of Efficacy|0|||
23415802|NCT01406938|65266041|FG004|Induction Period|Lack of Efficacy|0|||
23415803|NCT01406938|65266042|FG005|Induction Period|Lack of Efficacy|0|||
23415804|NCT01406938|65266037|FG000|Induction Period|Lost to Follow-up|2|||
23415805|NCT01406938|65266038|FG001|Induction Period|Lost to Follow-up|3|||
23513435|NCT00498602|65616216|FG001|Overall Study|Investigator Request|0|||
23513436|NCT00498602|65616217|FG002|Overall Study|Investigator Request|1|||
23513437|NCT00498602|65616218|FG003|Overall Study|Investigator Request|0|||
23513438|NCT00498602|65616219|FG004|Overall Study|Investigator Request|0|||
23415806|NCT01406938|65266039|FG002|Induction Period|Lost to Follow-up|0|||
23415807|NCT01406938|65266040|FG003|Induction Period|Lost to Follow-up|0|||
23415808|NCT01406938|65266041|FG004|Induction Period|Lost to Follow-up|0|||
23415809|NCT01406938|65266042|FG005|Induction Period|Lost to Follow-up|0|||
23415810|NCT01406938|65266037|FG000|Maintenance Period|Adverse Event|0|||
23415811|NCT01406938|65266038|FG001|Maintenance Period|Adverse Event|0|||
23415812|NCT01406938|65266039|FG002|Maintenance Period|Adverse Event|2|||
23415813|NCT01406938|65266040|FG003|Maintenance Period|Adverse Event|8|||
23415814|NCT01406938|65266041|FG004|Maintenance Period|Adverse Event|4|||
23415815|NCT01406938|65266042|FG005|Maintenance Period|Adverse Event|2|||
23415816|NCT01406938|65266037|FG000|Maintenance Period|Death|0|||
23415817|NCT01406938|65266038|FG001|Maintenance Period|Death|0|||
23415818|NCT01406938|65266039|FG002|Maintenance Period|Death|0|||
23415819|NCT01406938|65266040|FG003|Maintenance Period|Death|0|||
23415820|NCT01406938|65266041|FG004|Maintenance Period|Death|1|||
23415821|NCT01406938|65266042|FG005|Maintenance Period|Death|0|||
23415822|NCT01406938|65266037|FG000|Maintenance Period|Subject/guardian decision|0|||
23415823|NCT01406938|65266038|FG001|Maintenance Period|Subject/guardian decision|0|||
23415824|NCT01406938|65266039|FG002|Maintenance Period|Subject/guardian decision|11|||
23415825|NCT01406938|65266040|FG003|Maintenance Period|Subject/guardian decision|7|||
23415826|NCT01406938|65266041|FG004|Maintenance Period|Subject/guardian decision|10|||
23513439|NCT00498602|65616220|FG005|Overall Study|Investigator Request|0|||
23513440|NCT00498602|65616221|FG006|Overall Study|Investigator Request|0|||
23513441|NCT00498602|65616215|FG000|Overall Study|Subject Request|3|||
23513442|NCT00498602|65616216|FG001|Overall Study|Subject Request|0|||
23513443|NCT00498602|65616217|FG002|Overall Study|Subject Request|1|||
23513444|NCT00498602|65616218|FG003|Overall Study|Subject Request|1|||
23513445|NCT00498602|65616219|FG004|Overall Study|Subject Request|1|||
23513446|NCT00498602|65616220|FG005|Overall Study|Subject Request|4|||
23513447|NCT00498602|65616221|FG006|Overall Study|Subject Request|1|||
23513448|NCT00498602|65616215|FG000|Overall Study|Other|2|||
23513449|NCT00498602|65616216|FG001|Overall Study|Other|3|||
23513450|NCT00498602|65616217|FG002|Overall Study|Other|1|||
23513451|NCT00498602|65616218|FG003|Overall Study|Other|0|||
23513452|NCT00498602|65616219|FG004|Overall Study|Other|0|||
23513453|NCT00498602|65616220|FG005|Overall Study|Other|3|||
23513454|NCT00498602|65616221|FG006|Overall Study|Other|0|||
23513455|NCT00619801|65616222|FG000|Overall Study|Lack of Efficacy|0|||
23513456|NCT00619801|65616223|FG001|Overall Study|Lack of Efficacy|1|||
23513457|NCT00619801|65616222|FG000|Overall Study|Withdrawal by Subject|1|||
23513458|NCT00619801|65616223|FG001|Overall Study|Withdrawal by Subject|1|||
23513459|NCT00619801|65616222|FG000|Overall Study|Loss of efficacy|0|||
23513460|NCT00619801|65616223|FG001|Overall Study|Loss of efficacy|1|||
23513461|NCT02961751|65616226|FG000|Overall Study|Lost to Follow-up|11|||
23513462|NCT02961751|65616226|FG000|Overall Study|Physician Decision|2|||
23513463|NCT02961751|65616226|FG000|Overall Study|Not Eligible at Enrollment|1|||
23513464|NCT02961751|65616226|FG000|Overall Study|Protocol Violation|1|||
23513465|NCT01244906|65616227|FG000|Overall Study|Death|2|||
23513466|NCT01244906|65616227|FG000|Overall Study|Progression of disease post treatment|6|||
23513467|NCT02436889|65616243|FG000|Overall Study|No improvement in symptoms|1|||
23513468|NCT02436889|65616244|FG001|Overall Study|No improvement in symptoms|0|||
23513469|NCT02436889|65616243|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
23513470|NCT02436889|65616244|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
23513471|NCT03824912|65616247|FG000|Overall Study|Lost to Follow-up|18|||
23513472|NCT03824912|65616248|FG001|Overall Study|Lost to Follow-up|15|||
23513473|NCT03824912|65616249|FG002|Overall Study|Lost to Follow-up|8|||
23513474|NCT03824912|65616247|FG000|Overall Study|Negative Baseline Culture Result|118|||
23513475|NCT03824912|65616248|FG001|Overall Study|Negative Baseline Culture Result|112|||
23513476|NCT03824912|65616249|FG002|Overall Study|Negative Baseline Culture Result|57|||
23513477|NCT03824912|65616247|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23513478|NCT03824912|65616248|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23513479|NCT03824912|65616249|FG002|Overall Study|Non-Compliance with Study Drug|1|||
23513480|NCT03824912|65616247|FG000|Overall Study|Protocol Violation|1|||
23513481|NCT03824912|65616248|FG001|Overall Study|Protocol Violation|4|||
23513482|NCT03824912|65616249|FG002|Overall Study|Protocol Violation|1|||
23513483|NCT03824912|65616247|FG000|Overall Study|Withdrawal by Subject|3|||
23513484|NCT03824912|65616248|FG001|Overall Study|Withdrawal by Subject|2|||
23513485|NCT03824912|65616249|FG002|Overall Study|Withdrawal by Subject|1|||
23513486|NCT03824912|65616247|FG000|Overall Study|Participation in another study|0|||
23513487|NCT03824912|65616248|FG001|Overall Study|Participation in another study|1|||
23513488|NCT03824912|65616249|FG002|Overall Study|Participation in another study|0|||
23513489|NCT04080297|65616250|FG000|Overall Study|Adverse Event|1|||
23513490|NCT04080297|65616251|FG001|Overall Study|Adverse Event|3|||
23513491|NCT04080297|65616250|FG000|Overall Study|concurrent illness|1|||
23513492|NCT04080297|65616251|FG001|Overall Study|concurrent illness|0|||
23513493|NCT00232817|65616252|FG000|Overall Study|Protocol Violation|2|||
23513494|NCT00232817|65616253|FG001|Overall Study|Protocol Violation|1|||
23513495|NCT00463346|65616254|FG000|Overall Study|Withdrawal by Subject|3|||
23513496|NCT00463346|65616255|FG001|Overall Study|Withdrawal by Subject|3|||
23513497|NCT04053023|65616256|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
23513498|NCT04053023|65616257|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
23513499|NCT02738151|65616258|FG000|Overall Study|Randomized but not treated|4|||
23513500|NCT02738151|65616259|FG001|Overall Study|Randomized but not treated|1|||
23513501|NCT02738151|65616258|FG000|Overall Study|Adverse Event|4|||
23513502|NCT02738151|65616259|FG001|Overall Study|Adverse Event|5|||
23513503|NCT02738151|65616258|FG000|Overall Study|Hypoglycemia|0|||
23513504|NCT02738151|65616259|FG001|Overall Study|Hypoglycemia|1|||
23513505|NCT02738151|65616258|FG000|Overall Study|Poor Compliance to Protocol|4|||
23513506|NCT02738151|65616259|FG001|Overall Study|Poor Compliance to Protocol|3|||
23513507|NCT02738151|65616258|FG000|Overall Study|Other than specified above|11|||
23513508|NCT02738151|65616259|FG001|Overall Study|Other than specified above|21|||
23513509|NCT00788151|65616264|FG000|Overall Study|Other adverse event|0|||
23513510|NCT00788151|65616265|FG001|Overall Study|Other adverse event|2|||
23513511|NCT00788151|65616264|FG000|Overall Study|Protocol Violation|0|||
23513512|NCT00788151|65616265|FG001|Overall Study|Protocol Violation|1|||
23513513|NCT00788151|65616264|FG000|Overall Study|Withdrawal by Subject|13|||
23513514|NCT00788151|65616265|FG001|Overall Study|Withdrawal by Subject|6|||
23513515|NCT00788151|65616264|FG000|Overall Study|Enrolled but not treated|1|||
23513516|NCT00788151|65616265|FG001|Overall Study|Enrolled but not treated|1|||
23513517|NCT01387347|65616266|FG000|Overall Study|Lost to Follow-up|2|||
23513518|NCT01387347|65616267|FG001|Overall Study|Lost to Follow-up|1|||
23513519|NCT00535223|65619470|FG000|Overall Study|Withdrawal by Subject|4|||
23513520|NCT00535223|65619471|FG001|Overall Study|Withdrawal by Subject|1|||
23513521|NCT01751867|65619479|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
23513522|NCT01751867|65619480|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
23513523|NCT01751867|65619479|FG000|Overall Study|Diease Progression|4|||
23513524|NCT01751867|65619480|FG001|Overall Study|Diease Progression|18|||
23513525|NCT01751867|65619479|FG000|Overall Study|Adverse Event|8|||
23513526|NCT01751867|65619480|FG001|Overall Study|Adverse Event|15|||
23513527|NCT01751867|65619479|FG000|Overall Study|Poor Compliance|0|||
23513528|NCT01751867|65619480|FG001|Overall Study|Poor Compliance|5|||
23513529|NCT01751867|65619479|FG000|Overall Study|Withdrawal by Subject|3|||
23513530|NCT01751867|65619480|FG001|Overall Study|Withdrawal by Subject|1|||
23513531|NCT01751867|65619479|FG000|Overall Study|Physician Decision|4|||
23513532|NCT01751867|65619480|FG001|Overall Study|Physician Decision|7|||
23513533|NCT01751867|65619479|FG000|Overall Study|Protocol Violation|0|||
23513534|NCT01751867|65619480|FG001|Overall Study|Protocol Violation|2|||
23513535|NCT01751867|65619479|FG000|Overall Study|Death|0|||
23513536|NCT01751867|65619480|FG001|Overall Study|Death|5|||
23513537|NCT01751867|65619479|FG000|Overall Study|Other|11|||
23513538|NCT01751867|65619480|FG001|Overall Study|Other|37|||
23513539|NCT01751867|65619479|FG000|Overall Study|Randomized but not treated.|2|||
23513540|NCT01751867|65619480|FG001|Overall Study|Randomized but not treated.|1|||
23513541|NCT00396591|65619481|FG000|Overall Study|Disease Progression|13|||
23513542|NCT00396591|65619481|FG000|Overall Study|Adverse Event|2|||
23513543|NCT00396591|65619481|FG000|Overall Study|Participant request|1|||
23513544|NCT00254540|65619482|FG000|Overall Study|Adverse Event|6|||
23513545|NCT00254540|65619483|FG001|Overall Study|Adverse Event|7|||
23513546|NCT00254540|65619482|FG000|Overall Study|Lack of Efficacy|13|||
23513547|NCT00254540|65619483|FG001|Overall Study|Lack of Efficacy|13|||
23513548|NCT00254540|65619482|FG000|Overall Study|Death|0|||
23513549|NCT00254540|65619483|FG001|Overall Study|Death|1|||
23513550|NCT00254540|65619482|FG000|Overall Study|Laboratory Test Abnormality|0|||
23513551|NCT00254540|65619483|FG001|Overall Study|Laboratory Test Abnormality|1|||
23513552|NCT01408914|65619484|FG000|Overall Study|Could not complete tx in protocol period|5|||
23513553|NCT01408914|65619485|FG001|Overall Study|Could not complete tx in protocol period|5|||
23513554|NCT01408914|65619486|FG002|Overall Study|Could not complete tx in protocol period|6|||
23513555|NCT01408914|65619484|FG000|Overall Study|Lost to Follow-up|4|||
23513556|NCT01408914|65619485|FG001|Overall Study|Lost to Follow-up|1|||
23513557|NCT01408914|65619486|FG002|Overall Study|Lost to Follow-up|2|||
23513558|NCT01408914|65619484|FG000|Overall Study|Physician Decision|1|||
23513559|NCT01408914|65619485|FG001|Overall Study|Physician Decision|1|||
23513560|NCT01408914|65619486|FG002|Overall Study|Physician Decision|0|||
23513561|NCT01408914|65619484|FG000|Overall Study|Withdrawal by Subject|1|||
23513562|NCT01408914|65619485|FG001|Overall Study|Withdrawal by Subject|0|||
23513563|NCT01408914|65619486|FG002|Overall Study|Withdrawal by Subject|1|||
23513564|NCT01408914|65619484|FG000|Overall Study|Moved out of study jurisdiction|1|||
23513565|NCT01408914|65619485|FG001|Overall Study|Moved out of study jurisdiction|1|||
23513566|NCT01408914|65619486|FG002|Overall Study|Moved out of study jurisdiction|0|||
23513567|NCT01408914|65619484|FG000|Overall Study|Late exclusion|0|||
23513568|NCT01408914|65619485|FG001|Overall Study|Late exclusion|3|||
23513569|NCT01408914|65619486|FG002|Overall Study|Late exclusion|3|||
23513570|NCT01408914|65619484|FG000|Overall Study|Change in local TB/HIV norms|0|||
23513571|NCT01408914|65619485|FG001|Overall Study|Change in local TB/HIV norms|1|||
23513572|NCT01408914|65619486|FG002|Overall Study|Change in local TB/HIV norms|1|||
23513573|NCT02643082|65619488|FG000|Period 1|Adverse Event|1|||
23513574|NCT02643082|65619489|FG001|Period 1|Adverse Event|0|||
23513575|NCT03635957|65619492|FG000|Run-In Period|Lost to Follow-up|1|||
23513576|NCT03635957|65619492|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
23513577|NCT01892501|65619493|FG000|Overall Study|Protocol Violation|2|||
23513578|NCT01892501|65619493|FG000|Overall Study|Puncture not carried out|9|||
23513579|NCT01892501|65619493|FG000|Overall Study|Radiological monitoring not carried out|5|||
23513580|NCT01892501|65619493|FG000|Overall Study|Non-contributory histological result|12|||
23513581|NCT00469092|65619494|FG000|Overall Study|Adverse Event|5|||
23513582|NCT00469092|65619495|FG001|Overall Study|Adverse Event|4|||
23513583|NCT00469092|65619494|FG000|Overall Study|Lack of Efficacy|1|||
23513584|NCT00469092|65619495|FG001|Overall Study|Lack of Efficacy|0|||
23513585|NCT00469092|65619494|FG000|Overall Study|Lost to Follow-up|1|||
23513586|NCT00469092|65619495|FG001|Overall Study|Lost to Follow-up|2|||
23513587|NCT00469092|65619494|FG000|Overall Study|Protocol Violation|3|||
23513588|NCT00469092|65619495|FG001|Overall Study|Protocol Violation|3|||
23513589|NCT00469092|65619494|FG000|Overall Study|Withdrawal by Subject|4|||
23513590|NCT00469092|65619495|FG001|Overall Study|Withdrawal by Subject|4|||
23513591|NCT00469092|65619494|FG000|Overall Study|Withdrawal Criteria|3|||
23513592|NCT00469092|65619495|FG001|Overall Study|Withdrawal Criteria|4|||
23513593|NCT00469092|65619494|FG000|Overall Study|Incorrectly Randomised|4|||
23513594|NCT00469092|65619495|FG001|Overall Study|Incorrectly Randomised|3|||
23513595|NCT00469092|65619494|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
23513596|NCT00469092|65619495|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
23513597|NCT00469092|65619494|FG000|Overall Study|Use of lipid lowering drug|1|||
23513598|NCT00469092|65619495|FG001|Overall Study|Use of lipid lowering drug|0|||
23513599|NCT00469092|65619494|FG000|Overall Study|Hypoglycaemic Episodes|1|||
23513600|NCT00469092|65619495|FG001|Overall Study|Hypoglycaemic Episodes|1|||
23513601|NCT00469092|65619494|FG000|Overall Study|Abnormal lab value|1|||
23513602|NCT00469092|65619495|FG001|Overall Study|Abnormal lab value|0|||
23513603|NCT00469092|65619494|FG000|Overall Study|Use of Corticosteroid|1|||
23513604|NCT00469092|65619495|FG001|Overall Study|Use of Corticosteroid|0|||
23513605|NCT02728895|65619496|FG000|Overall Study|Other|1|||
23513606|NCT02728895|65619497|FG001|Overall Study|Other|2|||
23513607|NCT02728895|65619496|FG000|Overall Study|Withdrawal by Subject|0|||
23513608|NCT02728895|65619497|FG001|Overall Study|Withdrawal by Subject|3|||
23513609|NCT00003479|65619499|FG000|Overall Study|Not evaluable|3|||
23513610|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
23513611|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
23513612|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
23513613|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
23513614|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
23513615|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
23513616|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
23513617|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
23513618|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
23513619|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
23513620|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
23513621|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
23513622|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
23513623|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
23513624|NCT00293254|65619510|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
23513625|NCT00293254|65619511|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
23513626|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
23513627|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
23513628|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Death|4|||
23513629|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Death|1|||
23513630|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
23513631|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
23513632|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
23513633|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
23513634|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
23513635|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
23513636|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
23513637|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
23513638|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
23513639|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
23513640|NCT00293254|65619510|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
23513641|NCT00293254|65619511|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
23513642|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
23513643|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
23513644|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
23513645|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
23513646|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
23513647|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
23513648|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
23513649|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
23513650|NCT00293254|65619510|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
23513651|NCT00293254|65619511|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
23513652|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
23513653|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
23513654|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
23513655|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
23513656|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
23513657|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
23513658|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
23513659|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
23513660|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
23513661|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
23513662|NCT00293254|65619510|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
23513663|NCT00293254|65619511|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
23513664|NCT00391274|65619512|FG000|Overall Study|Death Due to Study Disease|55|||
23513665|NCT00391274|65619513|FG001|Overall Study|Death Due to Study Disease|45|||
23513666|NCT00391274|65619512|FG000|Overall Study|Lost to Follow-up|0|||
23513667|NCT00391274|65619513|FG001|Overall Study|Lost to Follow-up|3|||
23513668|NCT00391274|65619512|FG000|Overall Study|Physician Decision|4|||
23513669|NCT00391274|65619513|FG001|Overall Study|Physician Decision|2|||
23513670|NCT00391274|65619512|FG000|Overall Study|Withdrawal by Subject|0|||
23513671|NCT00391274|65619513|FG001|Overall Study|Withdrawal by Subject|3|||
23513672|NCT00391274|65619512|FG000|Overall Study|Death Due to Adverse Event|1|||
23513673|NCT00391274|65619513|FG001|Overall Study|Death Due to Adverse Event|3|||
23513674|NCT00391274|65619512|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
23513675|NCT00391274|65619513|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
23513676|NCT00391274|65619512|FG000|Overall Study|Death Not Study Related|0|||
23513677|NCT00391274|65619513|FG001|Overall Study|Death Not Study Related|1|||
23513678|NCT00003492|65619514|FG000|Overall Study|Not evaluable|6|||
23513679|NCT01119131|65619522|FG000|Overall Study|Adverse Event|1|||
23513680|NCT01119131|65619523|FG001|Overall Study|Adverse Event|1|||
23513681|NCT01119131|65619524|FG002|Overall Study|Adverse Event|1|||
23513682|NCT01119131|65619522|FG000|Overall Study|Non-Compliance|1|||
23513683|NCT01119131|65619523|FG001|Overall Study|Non-Compliance|0|||
23513684|NCT01119131|65619524|FG002|Overall Study|Non-Compliance|4|||
23513685|NCT01119131|65619522|FG000|Overall Study|Physician Decision|0|||
23513686|NCT01119131|65619523|FG001|Overall Study|Physician Decision|0|||
23513687|NCT01119131|65619524|FG002|Overall Study|Physician Decision|1|||
23513688|NCT02200445|65619528|FG000|Overall Study|Lack of Efficacy|1|||
23513689|NCT02200445|65619529|FG001|Overall Study|Lack of Efficacy|2|||
23513690|NCT02200445|65619530|FG002|Overall Study|Lack of Efficacy|2|||
23513691|NCT02200445|65619528|FG000|Overall Study|Adverse Event|0|||
23513692|NCT02200445|65619529|FG001|Overall Study|Adverse Event|2|||
23513693|NCT02200445|65619530|FG002|Overall Study|Adverse Event|0|||
23513694|NCT00881712|65619533|FG000|Overall Study|Death|1|||
23513695|NCT00881712|65619534|FG001|Overall Study|Death|0|||
23513696|NCT00881712|65619535|FG002|Overall Study|Death|0|||
23513697|NCT00881712|65619533|FG000|Overall Study|Withdrawal by Subject|1|||
23513698|NCT00881712|65619534|FG001|Overall Study|Withdrawal by Subject|0|||
23513699|NCT00881712|65619535|FG002|Overall Study|Withdrawal by Subject|0|||
23513700|NCT02625259|65619536|FG000|First Intervention (Day 1)|Other|0|||
23513701|NCT02625259|65619537|FG001|First Intervention (Day 1)|Other|0|||
23513702|NCT02625259|65619538|FG002|First Intervention (Day 1)|Other|1|||
23513703|NCT02625259|65619539|FG003|First Intervention (Day 1)|Other|0|||
23513704|NCT02625259|65619540|FG004|First Intervention (Day 1)|Other|0|||
23513705|NCT02625259|65619536|FG000|First Intervention (Day 1)|Adverse Event|2|||
23513706|NCT02625259|65619537|FG001|First Intervention (Day 1)|Adverse Event|1|||
23513707|NCT02625259|65619538|FG002|First Intervention (Day 1)|Adverse Event|0|||
23513708|NCT02625259|65619539|FG003|First Intervention (Day 1)|Adverse Event|0|||
23513709|NCT02625259|65619540|FG004|First Intervention (Day 1)|Adverse Event|0|||
23513710|NCT02625259|65619536|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
23513711|NCT02625259|65619537|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
23513712|NCT02625259|65619538|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23513713|NCT02625259|65619539|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
23513714|NCT02625259|65619540|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
23513715|NCT02288559|65619541|FG000|Overall Study|Adverse Event|1|||
23513716|NCT02288559|65619542|FG001|Overall Study|Adverse Event|1|||
23513717|NCT02288559|65619543|FG002|Overall Study|Adverse Event|5|||
23513718|NCT02288559|65619544|FG003|Overall Study|Adverse Event|0|||
23513719|NCT02288559|65619541|FG000|Overall Study|Death|0|||
23513720|NCT02288559|65619542|FG001|Overall Study|Death|0|||
23513721|NCT02288559|65619543|FG002|Overall Study|Death|1|||
23513722|NCT02288559|65619544|FG003|Overall Study|Death|0|||
23513723|NCT02288559|65619541|FG000|Overall Study|Lost to Follow-up|0|||
23513724|NCT02288559|65619542|FG001|Overall Study|Lost to Follow-up|0|||
23513725|NCT02288559|65619543|FG002|Overall Study|Lost to Follow-up|0|||
23513726|NCT02288559|65619544|FG003|Overall Study|Lost to Follow-up|1|||
23513727|NCT02288559|65619541|FG000|Overall Study|Withdrawal by Subject|0|||
23513728|NCT02288559|65619542|FG001|Overall Study|Withdrawal by Subject|0|||
23513729|NCT02288559|65619543|FG002|Overall Study|Withdrawal by Subject|2|||
23513730|NCT02288559|65619544|FG003|Overall Study|Withdrawal by Subject|1|||
23513731|NCT02288559|65619541|FG000|Overall Study|Reason Not Specified|0|||
23513732|NCT02288559|65619542|FG001|Overall Study|Reason Not Specified|0|||
23513733|NCT02288559|65619543|FG002|Overall Study|Reason Not Specified|3|||
23513734|NCT02288559|65619544|FG003|Overall Study|Reason Not Specified|0|||
23513735|NCT02631850|65619545|FG000|Treatment Period|Lost to Follow-up|0|||
23513736|NCT02631850|65619546|FG001|Treatment Period|Lost to Follow-up|1|||
23513737|NCT02631850|65619547|FG002|Treatment Period|Lost to Follow-up|0|||
23513738|NCT02631850|65619548|FG003|Treatment Period|Lost to Follow-up|0|||
23513739|NCT02631850|65619545|FG000|Treatment Period|Protocol Violation|1|||
23513740|NCT02631850|65619546|FG001|Treatment Period|Protocol Violation|0|||
23513741|NCT02631850|65619547|FG002|Treatment Period|Protocol Violation|0|||
23513742|NCT02631850|65619548|FG003|Treatment Period|Protocol Violation|0|||
23513743|NCT02631850|65619545|FG000|Treatment Period|Withdrawal by Subject|0|||
23513744|NCT02631850|65619546|FG001|Treatment Period|Withdrawal by Subject|5|||
23513745|NCT02631850|65619547|FG002|Treatment Period|Withdrawal by Subject|2|||
23513746|NCT02631850|65619548|FG003|Treatment Period|Withdrawal by Subject|2|||
23513747|NCT02631850|65619545|FG000|Treatment Period|Adverse Event|1|||
23513748|NCT02631850|65619546|FG001|Treatment Period|Adverse Event|0|||
23513749|NCT02631850|65619547|FG002|Treatment Period|Adverse Event|2|||
23513750|NCT02631850|65619548|FG003|Treatment Period|Adverse Event|3|||
23513751|NCT02631850|65619545|FG000|Treatment Period|Family medical issue|1|||
23513752|NCT02631850|65619546|FG001|Treatment Period|Family medical issue|0|||
23513753|NCT02631850|65619547|FG002|Treatment Period|Family medical issue|0|||
23513754|NCT02631850|65619548|FG003|Treatment Period|Family medical issue|0|||
23513755|NCT02631850|65619545|FG000|6 Month Follow up|Lost to Follow-up|5|||
23513756|NCT02631850|65619546|FG001|6 Month Follow up|Lost to Follow-up|8|||
23513757|NCT02631850|65619547|FG002|6 Month Follow up|Lost to Follow-up|3|||
23513758|NCT02631850|65619548|FG003|6 Month Follow up|Lost to Follow-up|5|||
23513759|NCT02631850|65619545|FG000|6 Month Follow up|Withdrawal by Subject|1|||
23513760|NCT02631850|65619546|FG001|6 Month Follow up|Withdrawal by Subject|0|||
23513761|NCT02631850|65619547|FG002|6 Month Follow up|Withdrawal by Subject|0|||
23513762|NCT02631850|65619548|FG003|6 Month Follow up|Withdrawal by Subject|2|||
23513763|NCT02631850|65619545|FG000|6 Month Follow up|Adverse Event|1|||
23513764|NCT02631850|65619546|FG001|6 Month Follow up|Adverse Event|4|||
23513765|NCT02631850|65619547|FG002|6 Month Follow up|Adverse Event|1|||
23513766|NCT02631850|65619548|FG003|6 Month Follow up|Adverse Event|3|||
23513767|NCT02631850|65619545|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
23513768|NCT02631850|65619546|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
23513769|NCT02631850|65619547|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
23513770|NCT02631850|65619548|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
23513771|NCT00249444|65619549|FG000|Overall Study|Lost to Follow-up|2|||
23513772|NCT00249444|65619550|FG001|Overall Study|Lost to Follow-up|2|||
23513773|NCT00249444|65619549|FG000|Overall Study|non-compliant|9|||
23513774|NCT00249444|65619550|FG001|Overall Study|non-compliant|11|||
23513775|NCT00249444|65619549|FG000|Overall Study|Adverse Event|1|||
23513776|NCT00249444|65619550|FG001|Overall Study|Adverse Event|1|||
23513777|NCT00249444|65619549|FG000|Overall Study|life event|0|||
23513778|NCT00249444|65619550|FG001|Overall Study|life event|1|||
23513779|NCT01750242|65619554|FG000|Overall Study|Unreadable Images|3|||
23513780|NCT00531050|65619555|FG000|Part 1: Period 1|Adverse Event|0|||
23513781|NCT00531050|65619556|FG001|Part 1: Period 1|Adverse Event|1|||
23513782|NCT00531050|65619557|FG002|Part 1: Period 1|Adverse Event|0|||
23513783|NCT00531050|65619558|FG003|Part 1: Period 1|Adverse Event|0|||
23513784|NCT00531050|65619559|FG004|Part 1: Period 1|Adverse Event|0|||
23513785|NCT00531050|65619560|FG005|Part 1: Period 1|Adverse Event|0|||
23513786|NCT00531050|65619555|FG000|Part 1: Period 1|Protocol Deviation|0|||
23513787|NCT00531050|65619556|FG001|Part 1: Period 1|Protocol Deviation|0|||
23513788|NCT00531050|65619557|FG002|Part 1: Period 1|Protocol Deviation|0|||
23513789|NCT00531050|65619558|FG003|Part 1: Period 1|Protocol Deviation|1|||
23513790|NCT00531050|65619559|FG004|Part 1: Period 1|Protocol Deviation|0|||
23513791|NCT00531050|65619560|FG005|Part 1: Period 1|Protocol Deviation|0|||
23513792|NCT00531050|65619555|FG000|Part 1: Period 3|Adverse Event|1|||
23513793|NCT00531050|65619556|FG001|Part 1: Period 3|Adverse Event|0|||
23513794|NCT00531050|65619557|FG002|Part 1: Period 3|Adverse Event|0|||
23513795|NCT00531050|65619558|FG003|Part 1: Period 3|Adverse Event|0|||
23513796|NCT00531050|65619559|FG004|Part 1: Period 3|Adverse Event|0|||
23513797|NCT00531050|65619560|FG005|Part 1: Period 3|Adverse Event|0|||
23513798|NCT00531050|65619555|FG000|Part 2: Period 1|Adverse Event|0|||
23513799|NCT00531050|65619556|FG001|Part 2: Period 1|Adverse Event|0|||
23513800|NCT00531050|65619557|FG002|Part 2: Period 1|Adverse Event|0|||
23513801|NCT00531050|65619558|FG003|Part 2: Period 1|Adverse Event|0|||
23513802|NCT00531050|65619559|FG004|Part 2: Period 1|Adverse Event|0|||
23513803|NCT00531050|65619560|FG005|Part 2: Period 1|Adverse Event|1|||
23513804|NCT00531050|65619555|FG000|Part 2: Period 3|Abnormal test procedure|1|||
23513805|NCT00531050|65619556|FG001|Part 2: Period 3|Abnormal test procedure|0|||
23513806|NCT00531050|65619557|FG002|Part 2: Period 3|Abnormal test procedure|0|||
23513807|NCT00531050|65619558|FG003|Part 2: Period 3|Abnormal test procedure|0|||
23513808|NCT00531050|65619559|FG004|Part 2: Period 3|Abnormal test procedure|0|||
23513809|NCT00531050|65619560|FG005|Part 2: Period 3|Abnormal test procedure|1|||
23513810|NCT00909389|65619561|FG000|Overall Study|Adverse Event|6|||
23513811|NCT00909389|65619561|FG000|Overall Study|Death|4|||
23513812|NCT00909389|65619561|FG000|Overall Study|Poor Compliance|16|||
23513813|NCT00909389|65619561|FG000|Overall Study|Lost to Follow-up|4|||
23513814|NCT00909389|65619561|FG000|Overall Study|No Information|103|||
23513815|NCT03303079|65619562|FG000|Overall Study|Adverse Event|0|||
23513816|NCT03303079|65619563|FG001|Overall Study|Adverse Event|1|||
23513817|NCT03303079|65619564|FG002|Overall Study|Adverse Event|3|||
23513818|NCT03303079|65619562|FG000|Overall Study|Protocol Violation|5|||
23513819|NCT03303079|65619563|FG001|Overall Study|Protocol Violation|4|||
23513820|NCT03303079|65619564|FG002|Overall Study|Protocol Violation|7|||
23513821|NCT03303079|65619562|FG000|Overall Study|Withdrawal by Subject|2|||
23513822|NCT03303079|65619563|FG001|Overall Study|Withdrawal by Subject|4|||
23513823|NCT03303079|65619564|FG002|Overall Study|Withdrawal by Subject|2|||
23513824|NCT03303079|65619562|FG000|Overall Study|Other than specified|0|||
23513825|NCT03303079|65619563|FG001|Overall Study|Other than specified|2|||
23513826|NCT03303079|65619564|FG002|Overall Study|Other than specified|0|||
23513827|NCT02733367|65619565|FG000|Overall Study|Withdrawal by Subject|6|||
23513828|NCT00309842|65619566|FG000|Overall Study|Lost to Follow-up|1|||
23513829|NCT04814433|65619567|FG000|Overall Study|Survey not returned|4|||
23513830|NCT04814433|65619568|FG001|Overall Study|Survey not returned|8|||
23513831|NCT04814433|65619569|FG002|Overall Study|Survey not returned|4|||
23513832|NCT04814433|65619570|FG003|Overall Study|Survey not returned|5|||
23513833|NCT03232281|65619573|FG000|Overall Study|Adverse Event|1|||
23513834|NCT03232281|65619574|FG001|Overall Study|Adverse Event|1|||
23513835|NCT03232281|65619573|FG000|Overall Study|Withdrawal by Subject|5|||
23513836|NCT03232281|65619574|FG001|Overall Study|Withdrawal by Subject|4|||
23513837|NCT03232281|65619573|FG000|Overall Study|Protocol Deviation|1|||
23513838|NCT03232281|65619574|FG001|Overall Study|Protocol Deviation|1|||
23513839|NCT01712854|65619575|FG000|Overall Study|Physician Decision|1|||
23513840|NCT02233309|65619576|FG000|Overall Study|Physician Decision|5|||
23513841|NCT01961323|65619578|FG000|Overall Study|Withdrawal by Subject|7|||
23513842|NCT01961323|65619578|FG000|Overall Study|Lost to Follow-up|8|||
23513843|NCT01961323|65619578|FG000|Overall Study|screen failure|34|||
23513844|NCT03480750|65619579|FG000|Overall Study|Withdrawal by Subject|0|||
23513845|NCT03480750|65619580|FG001|Overall Study|Withdrawal by Subject|1|||
23513846|NCT03480750|65619581|FG002|Overall Study|Withdrawal by Subject|0|||
23513847|NCT03480750|65619582|FG003|Overall Study|Withdrawal by Subject|0|||
23513848|NCT03480750|65619583|FG004|Overall Study|Withdrawal by Subject|0|||
23513849|NCT03480750|65619584|FG005|Overall Study|Withdrawal by Subject|0|||
23513850|NCT03480750|65619579|FG000|Overall Study|The interruption in Trientine shippment|0|||
23513851|NCT03480750|65619580|FG001|Overall Study|The interruption in Trientine shippment|0|||
23513852|NCT03480750|65619581|FG002|Overall Study|The interruption in Trientine shippment|0|||
23513853|NCT03480750|65619582|FG003|Overall Study|The interruption in Trientine shippment|0|||
23513854|NCT03480750|65619583|FG004|Overall Study|The interruption in Trientine shippment|0|||
23513855|NCT03480750|65619584|FG005|Overall Study|The interruption in Trientine shippment|1|||
23513856|NCT02554812|65619585|FG000|Overall Study|Adverse Event|2|||
23513857|NCT02554812|65619586|FG001|Overall Study|Adverse Event|5|||
23513858|NCT02554812|65619587|FG002|Overall Study|Adverse Event|3|||
23513859|NCT02554812|65619588|FG003|Overall Study|Adverse Event|0|||
23513860|NCT02554812|65619589|FG004|Overall Study|Adverse Event|5|||
23513861|NCT02554812|65619590|FG005|Overall Study|Adverse Event|0|||
23513862|NCT02554812|65619591|FG006|Overall Study|Adverse Event|1|||
23513863|NCT02554812|65619592|FG007|Overall Study|Adverse Event|6|||
23513864|NCT02554812|65619593|FG008|Overall Study|Adverse Event|2|||
23513865|NCT02554812|65619594|FG009|Overall Study|Adverse Event|2|||
23513866|NCT02554812|65619595|FG010|Overall Study|Adverse Event|1|||
23513867|NCT02554812|65619596|FG011|Overall Study|Adverse Event|2|||
23513868|NCT02554812|65619597|FG012|Overall Study|Adverse Event|0|||
23513869|NCT02554812|65619598|FG013|Overall Study|Adverse Event|3|||
23513870|NCT02554812|65619599|FG014|Overall Study|Adverse Event|2|||
23513871|NCT02554812|65619600|FG015|Overall Study|Adverse Event|1|||
23513872|NCT02554812|65619601|FG016|Overall Study|Adverse Event|0|||
23513873|NCT02554812|65619602|FG017|Overall Study|Adverse Event|1|||
23513874|NCT02554812|65619603|FG018|Overall Study|Adverse Event|0|||
23513875|NCT02554812|65619604|FG019|Overall Study|Adverse Event|0|||
23513876|NCT02554812|65619605|FG020|Overall Study|Adverse Event|0|||
23513877|NCT02554812|65619606|FG021|Overall Study|Adverse Event|2|||
23513878|NCT02554812|65619607|FG022|Overall Study|Adverse Event|1|||
23513879|NCT02554812|65619608|FG023|Overall Study|Adverse Event|1|||
23513880|NCT02554812|65619609|FG024|Overall Study|Adverse Event|1|||
23513881|NCT02554812|65619610|FG025|Overall Study|Adverse Event|2|||
23513882|NCT02554812|65619611|FG026|Overall Study|Adverse Event|1|||
23513883|NCT02554812|65619585|FG000|Overall Study|Death|1|||
23513884|NCT02554812|65619586|FG001|Overall Study|Death|2|||
23513885|NCT02554812|65619587|FG002|Overall Study|Death|2|||
23513886|NCT02554812|65619588|FG003|Overall Study|Death|2|||
23513887|NCT02554812|65619589|FG004|Overall Study|Death|0|||
23513888|NCT02554812|65619590|FG005|Overall Study|Death|1|||
23513889|NCT02554812|65619591|FG006|Overall Study|Death|1|||
23513890|NCT02554812|65619592|FG007|Overall Study|Death|1|||
23513891|NCT02554812|65619593|FG008|Overall Study|Death|0|||
23513892|NCT02554812|65619594|FG009|Overall Study|Death|0|||
23513893|NCT02554812|65619595|FG010|Overall Study|Death|0|||
23513894|NCT02554812|65619596|FG011|Overall Study|Death|0|||
23513895|NCT02554812|65619597|FG012|Overall Study|Death|0|||
23513896|NCT02554812|65619598|FG013|Overall Study|Death|0|||
23513897|NCT02554812|65619599|FG014|Overall Study|Death|1|||
23513898|NCT02554812|65619600|FG015|Overall Study|Death|1|||
23513899|NCT02554812|65619601|FG016|Overall Study|Death|1|||
23513900|NCT02554812|65619602|FG017|Overall Study|Death|0|||
23513901|NCT02554812|65619603|FG018|Overall Study|Death|1|||
23513902|NCT02554812|65619604|FG019|Overall Study|Death|2|||
23513903|NCT02554812|65619605|FG020|Overall Study|Death|0|||
23513904|NCT02554812|65619606|FG021|Overall Study|Death|1|||
23513905|NCT02554812|65619607|FG022|Overall Study|Death|1|||
23513906|NCT02554812|65619608|FG023|Overall Study|Death|0|||
23513907|NCT02554812|65619609|FG024|Overall Study|Death|0|||
23513908|NCT02554812|65619610|FG025|Overall Study|Death|0|||
23513909|NCT02554812|65619611|FG026|Overall Study|Death|0|||
23513910|NCT02554812|65619585|FG000|Overall Study|Lost to Follow-up|0|||
23513911|NCT02554812|65619586|FG001|Overall Study|Lost to Follow-up|1|||
23513912|NCT02554812|65619587|FG002|Overall Study|Lost to Follow-up|0|||
23513913|NCT02554812|65619588|FG003|Overall Study|Lost to Follow-up|0|||
23513914|NCT02554812|65619589|FG004|Overall Study|Lost to Follow-up|0|||
23513915|NCT02554812|65619590|FG005|Overall Study|Lost to Follow-up|0|||
23513916|NCT02554812|65619591|FG006|Overall Study|Lost to Follow-up|0|||
23513917|NCT02554812|65619592|FG007|Overall Study|Lost to Follow-up|0|||
23513918|NCT02554812|65619593|FG008|Overall Study|Lost to Follow-up|0|||
23513919|NCT02554812|65619594|FG009|Overall Study|Lost to Follow-up|0|||
23513920|NCT02554812|65619595|FG010|Overall Study|Lost to Follow-up|0|||
23513921|NCT02554812|65619596|FG011|Overall Study|Lost to Follow-up|0|||
23513922|NCT02554812|65619597|FG012|Overall Study|Lost to Follow-up|0|||
23513923|NCT02554812|65619598|FG013|Overall Study|Lost to Follow-up|0|||
23513924|NCT02554812|65619599|FG014|Overall Study|Lost to Follow-up|0|||
23415827|NCT01406938|65266042|FG005|Maintenance Period|Subject/guardian decision|7|||
23415828|NCT01406938|65266037|FG000|Maintenance Period|Protocol Violation|0|||
23415829|NCT01406938|65266038|FG001|Maintenance Period|Protocol Violation|0|||
23415830|NCT01406938|65266039|FG002|Maintenance Period|Protocol Violation|2|||
23415831|NCT01406938|65266040|FG003|Maintenance Period|Protocol Violation|2|||
23415832|NCT01406938|65266041|FG004|Maintenance Period|Protocol Violation|2|||
23415833|NCT01406938|65266042|FG005|Maintenance Period|Protocol Violation|2|||
23415834|NCT01406938|65266037|FG000|Maintenance Period|Pregnancy|0|||
23415835|NCT01406938|65266038|FG001|Maintenance Period|Pregnancy|0|||
23415836|NCT01406938|65266039|FG002|Maintenance Period|Pregnancy|0|||
23415837|NCT01406938|65266040|FG003|Maintenance Period|Pregnancy|0|||
23415838|NCT01406938|65266041|FG004|Maintenance Period|Pregnancy|1|||
23415839|NCT01406938|65266042|FG005|Maintenance Period|Pregnancy|0|||
23415840|NCT01406938|65266037|FG000|Maintenance Period|Lost to Follow-up|0|||
23415841|NCT01406938|65266038|FG001|Maintenance Period|Lost to Follow-up|0|||
23415842|NCT01406938|65266039|FG002|Maintenance Period|Lost to Follow-up|0|||
23415843|NCT01406938|65266040|FG003|Maintenance Period|Lost to Follow-up|0|||
23415844|NCT01406938|65266041|FG004|Maintenance Period|Lost to Follow-up|4|||
23415845|NCT01406938|65266042|FG005|Maintenance Period|Lost to Follow-up|0|||
23415846|NCT01406938|65266037|FG000|Maintenance Period|Lack of Efficacy|0|||
23415847|NCT01406938|65266038|FG001|Maintenance Period|Lack of Efficacy|0|||
23415848|NCT01406938|65266039|FG002|Maintenance Period|Lack of Efficacy|2|||
23415849|NCT01406938|65266040|FG003|Maintenance Period|Lack of Efficacy|1|||
23415850|NCT01406938|65266041|FG004|Maintenance Period|Lack of Efficacy|3|||
23415851|NCT01406938|65266042|FG005|Maintenance Period|Lack of Efficacy|5|||
23415852|NCT01406938|65266037|FG000|Follow up|Lack of Efficacy|3|||
23415853|NCT01406938|65266038|FG001|Follow up|Lack of Efficacy|2|||
23415854|NCT01406938|65266039|FG002|Follow up|Lack of Efficacy|1|||
23415855|NCT01406938|65266040|FG003|Follow up|Lack of Efficacy|0|||
23415856|NCT01406938|65266041|FG004|Follow up|Lack of Efficacy|0|||
23415857|NCT01406938|65266042|FG005|Follow up|Lack of Efficacy|0|||
23415858|NCT01406938|65266037|FG000|Follow up|Patient/guardian decision|4|||
23415859|NCT01406938|65266038|FG001|Follow up|Patient/guardian decision|2|||
23415860|NCT01406938|65266039|FG002|Follow up|Patient/guardian decision|4|||
23415861|NCT01406938|65266040|FG003|Follow up|Patient/guardian decision|2|||
23415862|NCT01406938|65266041|FG004|Follow up|Patient/guardian decision|4|||
23415863|NCT01406938|65266042|FG005|Follow up|Patient/guardian decision|1|||
23415864|NCT01406938|65266037|FG000|Follow up|Protocol Violation|0|||
23415865|NCT01406938|65266038|FG001|Follow up|Protocol Violation|0|||
23415866|NCT01406938|65266039|FG002|Follow up|Protocol Violation|1|||
23415867|NCT01406938|65266040|FG003|Follow up|Protocol Violation|0|||
23415868|NCT01406938|65266041|FG004|Follow up|Protocol Violation|0|||
23415869|NCT01406938|65266042|FG005|Follow up|Protocol Violation|0|||
23415870|NCT01406938|65266037|FG000|Follow up|Physician Decision|0|||
23415871|NCT01406938|65266038|FG001|Follow up|Physician Decision|0|||
23415872|NCT01406938|65266039|FG002|Follow up|Physician Decision|2|||
23415873|NCT01406938|65266040|FG003|Follow up|Physician Decision|0|||
23415874|NCT01406938|65266041|FG004|Follow up|Physician Decision|3|||
23415875|NCT01406938|65266042|FG005|Follow up|Physician Decision|1|||
23415876|NCT01406938|65266037|FG000|Follow up|Lost to Follow-up|1|||
23415877|NCT01406938|65266038|FG001|Follow up|Lost to Follow-up|1|||
23415878|NCT01406938|65266039|FG002|Follow up|Lost to Follow-up|0|||
23415879|NCT01406938|65266040|FG003|Follow up|Lost to Follow-up|1|||
23415880|NCT01406938|65266041|FG004|Follow up|Lost to Follow-up|2|||
23415881|NCT01406938|65266042|FG005|Follow up|Lost to Follow-up|1|||
23415882|NCT01813058|65266047|FG000|Overall Study|Withdrawal by Subject|5|||
23415883|NCT01813058|65266048|FG001|Overall Study|Withdrawal by Subject|4|||
23415884|NCT01252186|65266050|FG000|Overall Study|Adverse Event|9|||
23415885|NCT01252186|65266051|FG001|Overall Study|Adverse Event|6|||
23415886|NCT01252186|65266052|FG002|Overall Study|Adverse Event|8|||
23415887|NCT01252186|65266050|FG000|Overall Study|Withdrawal by Subject|2|||
23513925|NCT02554812|65619600|FG015|Overall Study|Lost to Follow-up|0|||
23513926|NCT02554812|65619601|FG016|Overall Study|Lost to Follow-up|0|||
23513927|NCT02554812|65619602|FG017|Overall Study|Lost to Follow-up|0|||
23513928|NCT02554812|65619603|FG018|Overall Study|Lost to Follow-up|0|||
23513929|NCT02554812|65619604|FG019|Overall Study|Lost to Follow-up|0|||
23513930|NCT02554812|65619605|FG020|Overall Study|Lost to Follow-up|0|||
23513931|NCT02554812|65619606|FG021|Overall Study|Lost to Follow-up|0|||
23513932|NCT02554812|65619607|FG022|Overall Study|Lost to Follow-up|0|||
23513933|NCT02554812|65619608|FG023|Overall Study|Lost to Follow-up|0|||
23513934|NCT02554812|65619609|FG024|Overall Study|Lost to Follow-up|0|||
23513935|NCT02554812|65619610|FG025|Overall Study|Lost to Follow-up|0|||
23513936|NCT02554812|65619611|FG026|Overall Study|Lost to Follow-up|0|||
23513937|NCT02554812|65619585|FG000|Overall Study|Global deterioration of health status|4|||
23513938|NCT02554812|65619586|FG001|Overall Study|Global deterioration of health status|3|||
23513939|NCT02554812|65619587|FG002|Overall Study|Global deterioration of health status|3|||
23513940|NCT02554812|65619588|FG003|Overall Study|Global deterioration of health status|2|||
23513941|NCT02554812|65619589|FG004|Overall Study|Global deterioration of health status|5|||
23513942|NCT02554812|65619590|FG005|Overall Study|Global deterioration of health status|0|||
23513943|NCT02554812|65619591|FG006|Overall Study|Global deterioration of health status|2|||
23513944|NCT02554812|65619592|FG007|Overall Study|Global deterioration of health status|1|||
23513945|NCT02554812|65619593|FG008|Overall Study|Global deterioration of health status|1|||
23513946|NCT02554812|65619594|FG009|Overall Study|Global deterioration of health status|1|||
23513947|NCT02554812|65619595|FG010|Overall Study|Global deterioration of health status|2|||
23513948|NCT02554812|65619596|FG011|Overall Study|Global deterioration of health status|1|||
23513949|NCT02554812|65619597|FG012|Overall Study|Global deterioration of health status|0|||
23513950|NCT02554812|65619598|FG013|Overall Study|Global deterioration of health status|0|||
23513951|NCT02554812|65619599|FG014|Overall Study|Global deterioration of health status|0|||
23513952|NCT02554812|65619600|FG015|Overall Study|Global deterioration of health status|1|||
23513953|NCT02554812|65619601|FG016|Overall Study|Global deterioration of health status|0|||
23513954|NCT02554812|65619602|FG017|Overall Study|Global deterioration of health status|0|||
23513955|NCT02554812|65619603|FG018|Overall Study|Global deterioration of health status|0|||
23513956|NCT02554812|65619604|FG019|Overall Study|Global deterioration of health status|0|||
23513957|NCT02554812|65619605|FG020|Overall Study|Global deterioration of health status|0|||
23513958|NCT02554812|65619606|FG021|Overall Study|Global deterioration of health status|0|||
23513959|NCT02554812|65619607|FG022|Overall Study|Global deterioration of health status|0|||
23513960|NCT02554812|65619608|FG023|Overall Study|Global deterioration of health status|0|||
23513961|NCT02554812|65619609|FG024|Overall Study|Global deterioration of health status|0|||
23513962|NCT02554812|65619610|FG025|Overall Study|Global deterioration of health status|0|||
23513963|NCT02554812|65619611|FG026|Overall Study|Global deterioration of health status|0|||
23513964|NCT02554812|65619585|FG000|Overall Study|Progressive disease|20|||
23513965|NCT02554812|65619586|FG001|Overall Study|Progressive disease|16|||
23513966|NCT02554812|65619587|FG002|Overall Study|Progressive disease|19|||
23513967|NCT02554812|65619588|FG003|Overall Study|Progressive disease|18|||
23513968|NCT02554812|65619589|FG004|Overall Study|Progressive disease|21|||
23513969|NCT02554812|65619590|FG005|Overall Study|Progressive disease|15|||
23513970|NCT02554812|65619591|FG006|Overall Study|Progressive disease|6|||
23513971|NCT02554812|65619592|FG007|Overall Study|Progressive disease|13|||
23513972|NCT02554812|65619593|FG008|Overall Study|Progressive disease|6|||
23513973|NCT02554812|65619594|FG009|Overall Study|Progressive disease|6|||
23513974|NCT02554812|65619595|FG010|Overall Study|Progressive disease|8|||
23513975|NCT02554812|65619596|FG011|Overall Study|Progressive disease|8|||
23513976|NCT02554812|65619597|FG012|Overall Study|Progressive disease|6|||
23513977|NCT02554812|65619598|FG013|Overall Study|Progressive disease|10|||
23513978|NCT02554812|65619599|FG014|Overall Study|Progressive disease|20|||
23513979|NCT02554812|65619600|FG015|Overall Study|Progressive disease|6|||
23513980|NCT02554812|65619601|FG016|Overall Study|Progressive disease|3|||
23513981|NCT02554812|65619602|FG017|Overall Study|Progressive disease|3|||
23513982|NCT02554812|65619603|FG018|Overall Study|Progressive disease|11|||
23513983|NCT02554812|65619604|FG019|Overall Study|Progressive disease|7|||
23513984|NCT02554812|65619605|FG020|Overall Study|Progressive disease|11|||
23513985|NCT02554812|65619606|FG021|Overall Study|Progressive disease|6|||
23513986|NCT02554812|65619607|FG022|Overall Study|Progressive disease|9|||
23513987|NCT02554812|65619608|FG023|Overall Study|Progressive disease|9|||
23513988|NCT02554812|65619609|FG024|Overall Study|Progressive disease|4|||
23513989|NCT02554812|65619610|FG025|Overall Study|Progressive disease|5|||
23513990|NCT02554812|65619611|FG026|Overall Study|Progressive disease|5|||
23513991|NCT02554812|65619585|FG000|Overall Study|Other|0|||
23513992|NCT02554812|65619586|FG001|Overall Study|Other|0|||
23513993|NCT02554812|65619587|FG002|Overall Study|Other|2|||
23513994|NCT02554812|65619588|FG003|Overall Study|Other|3|||
23513995|NCT02554812|65619589|FG004|Overall Study|Other|2|||
23513996|NCT02554812|65619590|FG005|Overall Study|Other|1|||
23513997|NCT02554812|65619591|FG006|Overall Study|Other|0|||
23513998|NCT02554812|65619592|FG007|Overall Study|Other|0|||
23513999|NCT02554812|65619593|FG008|Overall Study|Other|1|||
23611193|NCT01072149|65966729|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
23514000|NCT02554812|65619594|FG009|Overall Study|Other|1|||
23514001|NCT02554812|65619595|FG010|Overall Study|Other|0|||
23514002|NCT02554812|65619596|FG011|Overall Study|Other|0|||
23514003|NCT02554812|65619597|FG012|Overall Study|Other|1|||
23514004|NCT02554812|65619598|FG013|Overall Study|Other|0|||
23514005|NCT02554812|65619599|FG014|Overall Study|Other|1|||
23514006|NCT02554812|65619600|FG015|Overall Study|Other|0|||
23514007|NCT02554812|65619601|FG016|Overall Study|Other|0|||
23514008|NCT02554812|65619602|FG017|Overall Study|Other|0|||
23514009|NCT02554812|65619603|FG018|Overall Study|Other|0|||
23514010|NCT02554812|65619604|FG019|Overall Study|Other|0|||
23514011|NCT02554812|65619605|FG020|Overall Study|Other|0|||
23514012|NCT02554812|65619606|FG021|Overall Study|Other|2|||
23514013|NCT02554812|65619607|FG022|Overall Study|Other|0|||
23514014|NCT02554812|65619608|FG023|Overall Study|Other|0|||
23514015|NCT02554812|65619609|FG024|Overall Study|Other|0|||
23514016|NCT02554812|65619610|FG025|Overall Study|Other|0|||
23514017|NCT02554812|65619611|FG026|Overall Study|Other|0|||
23514018|NCT02554812|65619585|FG000|Overall Study|Withdrawal by Subject|1|||
23514019|NCT02554812|65619586|FG001|Overall Study|Withdrawal by Subject|0|||
23514020|NCT02554812|65619587|FG002|Overall Study|Withdrawal by Subject|0|||
23514021|NCT02554812|65619588|FG003|Overall Study|Withdrawal by Subject|2|||
23514022|NCT02554812|65619589|FG004|Overall Study|Withdrawal by Subject|2|||
23514023|NCT02554812|65619590|FG005|Overall Study|Withdrawal by Subject|3|||
23514024|NCT02554812|65619591|FG006|Overall Study|Withdrawal by Subject|0|||
23514025|NCT02554812|65619592|FG007|Overall Study|Withdrawal by Subject|0|||
23514026|NCT02554812|65619593|FG008|Overall Study|Withdrawal by Subject|1|||
23514027|NCT02554812|65619594|FG009|Overall Study|Withdrawal by Subject|1|||
23514028|NCT02554812|65619595|FG010|Overall Study|Withdrawal by Subject|0|||
23514029|NCT02554812|65619596|FG011|Overall Study|Withdrawal by Subject|1|||
23514030|NCT02554812|65619597|FG012|Overall Study|Withdrawal by Subject|1|||
23514031|NCT02554812|65619598|FG013|Overall Study|Withdrawal by Subject|1|||
23514032|NCT02554812|65619599|FG014|Overall Study|Withdrawal by Subject|1|||
23514033|NCT02554812|65619600|FG015|Overall Study|Withdrawal by Subject|1|||
23514034|NCT02554812|65619601|FG016|Overall Study|Withdrawal by Subject|3|||
23514035|NCT02554812|65619602|FG017|Overall Study|Withdrawal by Subject|1|||
23514036|NCT02554812|65619603|FG018|Overall Study|Withdrawal by Subject|0|||
23514037|NCT02554812|65619604|FG019|Overall Study|Withdrawal by Subject|2|||
23514038|NCT02554812|65619605|FG020|Overall Study|Withdrawal by Subject|0|||
23514039|NCT02554812|65619606|FG021|Overall Study|Withdrawal by Subject|1|||
23514040|NCT02554812|65619607|FG022|Overall Study|Withdrawal by Subject|0|||
23514041|NCT02554812|65619608|FG023|Overall Study|Withdrawal by Subject|1|||
23514042|NCT02554812|65619609|FG024|Overall Study|Withdrawal by Subject|0|||
23514043|NCT02554812|65619610|FG025|Overall Study|Withdrawal by Subject|0|||
23514044|NCT02554812|65619611|FG026|Overall Study|Withdrawal by Subject|1|||
23514045|NCT02554812|65619585|FG000|Overall Study|Physician Decision|1|||
23514046|NCT02554812|65619586|FG001|Overall Study|Physician Decision|0|||
23514047|NCT02554812|65619587|FG002|Overall Study|Physician Decision|0|||
23307540|NCT00773734|64870553|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
23307541|NCT00773734|64870548|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
23307542|NCT00773734|64870549|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
23307543|NCT00773734|64870550|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
23307544|NCT00773734|64870551|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
23307545|NCT00773734|64870552|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
23307546|NCT00773734|64870553|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
23514048|NCT02554812|65619588|FG003|Overall Study|Physician Decision|1|||
23514049|NCT02554812|65619589|FG004|Overall Study|Physician Decision|0|||
23514050|NCT02554812|65619590|FG005|Overall Study|Physician Decision|1|||
23514051|NCT02554812|65619591|FG006|Overall Study|Physician Decision|0|||
23514052|NCT02554812|65619592|FG007|Overall Study|Physician Decision|0|||
23514053|NCT02554812|65619593|FG008|Overall Study|Physician Decision|0|||
23514054|NCT02554812|65619594|FG009|Overall Study|Physician Decision|0|||
23514055|NCT02554812|65619595|FG010|Overall Study|Physician Decision|1|||
23514056|NCT02554812|65619596|FG011|Overall Study|Physician Decision|0|||
23514057|NCT02554812|65619597|FG012|Overall Study|Physician Decision|0|||
23514058|NCT02554812|65619598|FG013|Overall Study|Physician Decision|0|||
23514059|NCT02554812|65619599|FG014|Overall Study|Physician Decision|0|||
23514060|NCT02554812|65619600|FG015|Overall Study|Physician Decision|0|||
23514061|NCT02554812|65619601|FG016|Overall Study|Physician Decision|1|||
23514062|NCT02554812|65619602|FG017|Overall Study|Physician Decision|1|||
23514063|NCT02554812|65619603|FG018|Overall Study|Physician Decision|0|||
23514064|NCT02554812|65619604|FG019|Overall Study|Physician Decision|1|||
23514065|NCT02554812|65619605|FG020|Overall Study|Physician Decision|1|||
23514066|NCT02554812|65619606|FG021|Overall Study|Physician Decision|0|||
23514067|NCT02554812|65619607|FG022|Overall Study|Physician Decision|1|||
23514068|NCT02554812|65619608|FG023|Overall Study|Physician Decision|0|||
23514069|NCT02554812|65619609|FG024|Overall Study|Physician Decision|0|||
23514070|NCT02554812|65619610|FG025|Overall Study|Physician Decision|0|||
23514071|NCT02554812|65619611|FG026|Overall Study|Physician Decision|0|||
23514072|NCT02554812|65619585|FG000|Overall Study|Study terminated by sponsor|0|||
23514073|NCT02554812|65619586|FG001|Overall Study|Study terminated by sponsor|0|||
23514074|NCT02554812|65619587|FG002|Overall Study|Study terminated by sponsor|0|||
23514075|NCT02554812|65619588|FG003|Overall Study|Study terminated by sponsor|0|||
23514076|NCT02554812|65619589|FG004|Overall Study|Study terminated by sponsor|0|||
23514077|NCT02554812|65619590|FG005|Overall Study|Study terminated by sponsor|0|||
23514078|NCT02554812|65619591|FG006|Overall Study|Study terminated by sponsor|0|||
23514079|NCT02554812|65619592|FG007|Overall Study|Study terminated by sponsor|0|||
23514080|NCT02554812|65619593|FG008|Overall Study|Study terminated by sponsor|0|||
23514081|NCT02554812|65619594|FG009|Overall Study|Study terminated by sponsor|0|||
23514082|NCT02554812|65619595|FG010|Overall Study|Study terminated by sponsor|0|||
23514083|NCT02554812|65619596|FG011|Overall Study|Study terminated by sponsor|0|||
23514084|NCT02554812|65619597|FG012|Overall Study|Study terminated by sponsor|0|||
23514085|NCT02554812|65619598|FG013|Overall Study|Study terminated by sponsor|0|||
23514086|NCT02554812|65619599|FG014|Overall Study|Study terminated by sponsor|0|||
23514087|NCT02554812|65619600|FG015|Overall Study|Study terminated by sponsor|0|||
23514088|NCT02554812|65619601|FG016|Overall Study|Study terminated by sponsor|0|||
23514089|NCT02554812|65619602|FG017|Overall Study|Study terminated by sponsor|0|||
23514090|NCT02554812|65619603|FG018|Overall Study|Study terminated by sponsor|0|||
23514091|NCT02554812|65619604|FG019|Overall Study|Study terminated by sponsor|0|||
23514092|NCT02554812|65619605|FG020|Overall Study|Study terminated by sponsor|0|||
23514093|NCT02554812|65619606|FG021|Overall Study|Study terminated by sponsor|0|||
23514094|NCT02554812|65619607|FG022|Overall Study|Study terminated by sponsor|0|||
23514095|NCT02554812|65619608|FG023|Overall Study|Study terminated by sponsor|0|||
23514096|NCT02554812|65619609|FG024|Overall Study|Study terminated by sponsor|1|||
23514097|NCT02554812|65619610|FG025|Overall Study|Study terminated by sponsor|0|||
23514098|NCT02554812|65619611|FG026|Overall Study|Study terminated by sponsor|0|||
23514099|NCT02554812|65619585|FG000|Overall Study|No longer meets eligibility criteria|0|||
23514100|NCT02554812|65619586|FG001|Overall Study|No longer meets eligibility criteria|1|||
23514101|NCT02554812|65619587|FG002|Overall Study|No longer meets eligibility criteria|0|||
23514102|NCT02554812|65619588|FG003|Overall Study|No longer meets eligibility criteria|0|||
23514103|NCT02554812|65619589|FG004|Overall Study|No longer meets eligibility criteria|0|||
23514104|NCT02554812|65619590|FG005|Overall Study|No longer meets eligibility criteria|0|||
23514105|NCT02554812|65619591|FG006|Overall Study|No longer meets eligibility criteria|0|||
23514106|NCT02554812|65619592|FG007|Overall Study|No longer meets eligibility criteria|0|||
23514107|NCT02554812|65619593|FG008|Overall Study|No longer meets eligibility criteria|0|||
23514108|NCT02554812|65619594|FG009|Overall Study|No longer meets eligibility criteria|0|||
23514109|NCT02554812|65619595|FG010|Overall Study|No longer meets eligibility criteria|0|||
23514110|NCT02554812|65619596|FG011|Overall Study|No longer meets eligibility criteria|0|||
23514111|NCT02554812|65619597|FG012|Overall Study|No longer meets eligibility criteria|0|||
23514112|NCT02554812|65619598|FG013|Overall Study|No longer meets eligibility criteria|0|||
23514113|NCT02554812|65619599|FG014|Overall Study|No longer meets eligibility criteria|0|||
23514114|NCT02554812|65619600|FG015|Overall Study|No longer meets eligibility criteria|0|||
23514115|NCT02554812|65619601|FG016|Overall Study|No longer meets eligibility criteria|0|||
23514116|NCT02554812|65619602|FG017|Overall Study|No longer meets eligibility criteria|0|||
23514117|NCT02554812|65619603|FG018|Overall Study|No longer meets eligibility criteria|0|||
23514118|NCT02554812|65619604|FG019|Overall Study|No longer meets eligibility criteria|0|||
23514119|NCT02554812|65619605|FG020|Overall Study|No longer meets eligibility criteria|0|||
23514120|NCT02554812|65619606|FG021|Overall Study|No longer meets eligibility criteria|0|||
23514121|NCT02554812|65619607|FG022|Overall Study|No longer meets eligibility criteria|0|||
23514122|NCT02554812|65619608|FG023|Overall Study|No longer meets eligibility criteria|0|||
23514123|NCT02554812|65619609|FG024|Overall Study|No longer meets eligibility criteria|0|||
23514124|NCT02554812|65619610|FG025|Overall Study|No longer meets eligibility criteria|0|||
23514125|NCT02554812|65619611|FG026|Overall Study|No longer meets eligibility criteria|0|||
23514126|NCT02673489|65619616|FG000|Treatment Period|Lost to Follow-up|3|||
23514127|NCT02673489|65619617|FG001|Treatment Period|Lost to Follow-up|0|||
23514128|NCT02673489|65619616|FG000|Treatment Period|Participant request to discontinue|1|||
23514129|NCT02673489|65619617|FG001|Treatment Period|Participant request to discontinue|1|||
23514130|NCT02673489|65619616|FG000|Treatment Period|Participant moved to another province|1|||
23514131|NCT02673489|65619617|FG001|Treatment Period|Participant moved to another province|0|||
23514132|NCT02673489|65619616|FG000|Treatment Period|Participant was incarcerated|0|||
23514133|NCT02673489|65619617|FG001|Treatment Period|Participant was incarcerated|1|||
23514134|NCT02673489|65619616|FG000|Treatment Period|Adverse Event|0|||
23514135|NCT02673489|65619617|FG001|Treatment Period|Adverse Event|1|||
23514136|NCT02673489|65619616|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
23514137|NCT02673489|65619617|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
23514138|NCT02673489|65619616|FG000|Follow Up Period|Unable to return for follow-up|0|||
23514139|NCT02673489|65619617|FG001|Follow Up Period|Unable to return for follow-up|1|||
23514140|NCT02738450|65619620|FG000|Overall Study|Withdrawal by Subject|0|||
23514141|NCT02738450|65619621|FG001|Overall Study|Withdrawal by Subject|2|||
23514142|NCT02738450|65619622|FG002|Overall Study|Withdrawal by Subject|0|||
23514143|NCT00412854|65619623|FG000|Overall Study|Withdrawn due to adverse events|1|||
23514144|NCT00412854|65619624|FG001|Overall Study|Withdrawn due to adverse events|5|||
23514145|NCT00412854|65619623|FG000|Overall Study|Withdrawn for other reasons|13|||
23514146|NCT00412854|65619624|FG001|Overall Study|Withdrawn for other reasons|11|||
23514147|NCT00674661|65619626|FG000|Overall Study|Other|5|||
23514148|NCT00674661|65619627|FG001|Overall Study|Other|7|||
23514149|NCT00674661|65619626|FG000|Overall Study|Lost to Follow-up|6|||
23514150|NCT00674661|65619627|FG001|Overall Study|Lost to Follow-up|3|||
23514151|NCT00674661|65619626|FG000|Overall Study|Withdrawal by Subject|0|||
23514152|NCT00674661|65619627|FG001|Overall Study|Withdrawal by Subject|5|||
23514153|NCT00103142|65619630|FG000|Overall Study|Adverse Event|1|||
23514154|NCT00103142|65619631|FG001|Overall Study|Adverse Event|0|||
23514155|NCT00103142|65619630|FG000|Overall Study|Progression of disease|2|||
23514156|NCT00103142|65619631|FG001|Overall Study|Progression of disease|1|||
23514157|NCT03341533|65619634|FG000|Overall Study|Withdrawal by Subject|1|||
23514158|NCT03341533|65619635|FG001|Overall Study|Withdrawal by Subject|1|||
23514159|NCT03341533|65619634|FG000|Overall Study|Not eligible after randomization|2|||
23514160|NCT03341533|65619635|FG001|Overall Study|Not eligible after randomization|1|||
23514161|NCT03263442|65619636|FG000|Inpatient Phase|Death|1|||
23514162|NCT03263442|65619637|FG001|Inpatient Phase|Death|0|||
23514163|NCT03263442|65619636|FG000|Inpatient Phase|Withdrawal by Subject|1|||
23514164|NCT03263442|65619637|FG001|Inpatient Phase|Withdrawal by Subject|0|||
23514165|NCT03263442|65619636|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
23514166|NCT03263442|65619637|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
23514167|NCT03263442|65619636|FG000|1-month Follow-Up|Lost to Follow-up|1|||
23514168|NCT03263442|65619637|FG001|1-month Follow-Up|Lost to Follow-up|0|||
23514169|NCT03263442|65619636|FG000|3-month Follow-Up|Lost to Follow-up|1|||
23514170|NCT03263442|65619637|FG001|3-month Follow-Up|Lost to Follow-up|3|||
23514171|NCT03263442|65619636|FG000|6-month Follow-Up|Lost to Follow-up|2|||
23514172|NCT03263442|65619637|FG001|6-month Follow-Up|Lost to Follow-up|2|||
23514173|NCT01333059|65619644|FG000|Overall Study|Physician Decision|3|||
23514174|NCT01333059|65619645|FG001|Overall Study|Physician Decision|3|||
23514175|NCT01333059|65619644|FG000|Overall Study|Protocol Violation|3|||
23514176|NCT01333059|65619645|FG001|Overall Study|Protocol Violation|0|||
23514177|NCT02188589|65619646|FG000|Overall Study|Withdrawal by Subject|5|||
23514178|NCT00818662|65619647|FG000|Overall Study|Adverse Event|5|||
23514179|NCT00818662|65619648|FG001|Overall Study|Adverse Event|14|||
23514180|NCT00818662|65619649|FG002|Overall Study|Adverse Event|4|||
23514181|NCT00818662|65619650|FG003|Overall Study|Adverse Event|3|||
23514182|NCT00818662|65619647|FG000|Overall Study|Withdrawal by Subject|5|||
23514183|NCT00818662|65619648|FG001|Overall Study|Withdrawal by Subject|4|||
23514184|NCT00818662|65619649|FG002|Overall Study|Withdrawal by Subject|2|||
23514185|NCT00818662|65619650|FG003|Overall Study|Withdrawal by Subject|2|||
23514186|NCT00818662|65619647|FG000|Overall Study|Death|1|||
23514187|NCT00818662|65619648|FG001|Overall Study|Death|3|||
23514188|NCT00818662|65619649|FG002|Overall Study|Death|0|||
23514189|NCT00818662|65619650|FG003|Overall Study|Death|0|||
23514190|NCT00818662|65619647|FG000|Overall Study|Physician Decision|1|||
23514191|NCT00818662|65619648|FG001|Overall Study|Physician Decision|0|||
23514192|NCT00818662|65619649|FG002|Overall Study|Physician Decision|0|||
23514193|NCT00818662|65619650|FG003|Overall Study|Physician Decision|0|||
23514194|NCT00818662|65619647|FG000|Overall Study|Lost to Follow-up|0|||
23514195|NCT00818662|65619648|FG001|Overall Study|Lost to Follow-up|0|||
23514196|NCT00818662|65619649|FG002|Overall Study|Lost to Follow-up|0|||
23514197|NCT00818662|65619650|FG003|Overall Study|Lost to Follow-up|1|||
23514198|NCT00818662|65619647|FG000|Overall Study|Unwilling or Unable to Participate|4|||
23514199|NCT00818662|65619648|FG001|Overall Study|Unwilling or Unable to Participate|6|||
23514200|NCT00818662|65619649|FG002|Overall Study|Unwilling or Unable to Participate|2|||
23514201|NCT00818662|65619650|FG003|Overall Study|Unwilling or Unable to Participate|4|||
23514202|NCT00818662|65619647|FG000|Overall Study|Protocol Violation|1|||
23514203|NCT00818662|65619648|FG001|Overall Study|Protocol Violation|1|||
23514204|NCT00818662|65619649|FG002|Overall Study|Protocol Violation|0|||
23514205|NCT00818662|65619650|FG003|Overall Study|Protocol Violation|0|||
23514206|NCT00818662|65619647|FG000|Overall Study|Requires a Prohibited Medication|1|||
23514207|NCT00818662|65619648|FG001|Overall Study|Requires a Prohibited Medication|0|||
23514208|NCT00818662|65619649|FG002|Overall Study|Requires a Prohibited Medication|0|||
23514209|NCT00818662|65619650|FG003|Overall Study|Requires a Prohibited Medication|0|||
23514210|NCT00818662|65619647|FG000|Overall Study|Safety Risk|1|||
23514211|NCT00818662|65619648|FG001|Overall Study|Safety Risk|1|||
23514212|NCT00818662|65619649|FG002|Overall Study|Safety Risk|0|||
23514213|NCT00818662|65619650|FG003|Overall Study|Safety Risk|1|||
23514214|NCT00818662|65619647|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
23514215|NCT00818662|65619648|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
23514216|NCT00818662|65619649|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
23514217|NCT00818662|65619650|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
23514218|NCT00818662|65619647|FG000|Overall Study|Participant's health declined|0|||
23514219|NCT00818662|65619648|FG001|Overall Study|Participant's health declined|0|||
23514220|NCT00818662|65619649|FG002|Overall Study|Participant's health declined|0|||
23514221|NCT00818662|65619650|FG003|Overall Study|Participant's health declined|1|||
23514222|NCT00818662|65619647|FG000|Overall Study|Caregiver to pursue other treatment|0|||
23514223|NCT00818662|65619648|FG001|Overall Study|Caregiver to pursue other treatment|1|||
23514224|NCT00818662|65619649|FG002|Overall Study|Caregiver to pursue other treatment|0|||
23514225|NCT00818662|65619650|FG003|Overall Study|Caregiver to pursue other treatment|0|||
23514226|NCT00818662|65619647|FG000|Overall Study|Moving out of state|0|||
23514227|NCT00818662|65619648|FG001|Overall Study|Moving out of state|0|||
23514228|NCT00818662|65619649|FG002|Overall Study|Moving out of state|0|||
23514229|NCT00818662|65619650|FG003|Overall Study|Moving out of state|1|||
23514230|NCT00818662|65619647|FG000|Overall Study|Declined move to another study site|1|||
23514231|NCT00818662|65619648|FG001|Overall Study|Declined move to another study site|0|||
23514232|NCT00818662|65619649|FG002|Overall Study|Declined move to another study site|0|||
23514233|NCT00818662|65619650|FG003|Overall Study|Declined move to another study site|0|||
23514234|NCT00818662|65619647|FG000|Overall Study|Change in living situation|0|||
23514235|NCT00818662|65619648|FG001|Overall Study|Change in living situation|0|||
23514236|NCT00818662|65619649|FG002|Overall Study|Change in living situation|0|||
23514237|NCT00818662|65619650|FG003|Overall Study|Change in living situation|1|||
23514238|NCT00818662|65619647|FG000|Overall Study|Study partner decision|0|||
23514239|NCT00818662|65619648|FG001|Overall Study|Study partner decision|0|||
23514240|NCT00818662|65619649|FG002|Overall Study|Study partner decision|0|||
23514241|NCT00818662|65619650|FG003|Overall Study|Study partner decision|1|||
23514242|NCT00818662|65619647|FG000|Overall Study|Admitted to long term nursing care|0|||
23514243|NCT00818662|65619648|FG001|Overall Study|Admitted to long term nursing care|1|||
23514244|NCT00818662|65619649|FG002|Overall Study|Admitted to long term nursing care|0|||
23514245|NCT00818662|65619650|FG003|Overall Study|Admitted to long term nursing care|0|||
23514246|NCT03649711|65619651|FG000|Overall Study|Adverse Event|0|||
23514247|NCT03649711|65619652|FG001|Overall Study|Adverse Event|1|||
23514248|NCT03649711|65619653|FG002|Overall Study|Adverse Event|0|||
23514249|NCT03649711|65619651|FG000|Overall Study|Kidney Transplant|1|||
23514250|NCT03649711|65619652|FG001|Overall Study|Kidney Transplant|0|||
23514251|NCT03649711|65619653|FG002|Overall Study|Kidney Transplant|0|||
23514252|NCT03138889|65619654|FG000|Overall Study|Withdrawal by Subject|5|||
23514253|NCT03138889|65619655|FG001|Overall Study|Withdrawal by Subject|5|||
23514254|NCT03138889|65619656|FG002|Overall Study|Withdrawal by Subject|0|||
23514255|NCT03138889|65619657|FG003|Overall Study|Withdrawal by Subject|2|||
23514256|NCT03138889|65619658|FG004|Overall Study|Withdrawal by Subject|1|||
23514257|NCT03138889|65619659|FG005|Overall Study|Withdrawal by Subject|3|||
23514258|NCT03138889|65619660|FG006|Overall Study|Withdrawal by Subject|0|||
23514259|NCT03138889|65619661|FG007|Overall Study|Withdrawal by Subject|1|||
23514260|NCT00460408|65619662|FG000|Overall Study|Adverse Event|1|||
23514261|NCT00460408|65619663|FG001|Overall Study|Adverse Event|0|||
23514262|NCT00460408|65619664|FG002|Overall Study|Adverse Event|0|||
23514263|NCT00460408|65619665|FG003|Overall Study|Adverse Event|0|||
23514264|NCT00460408|65619662|FG000|Overall Study|Death|7|||
23514265|NCT00460408|65619663|FG001|Overall Study|Death|0|||
23514266|NCT00460408|65619664|FG002|Overall Study|Death|0|||
23514267|NCT00460408|65619665|FG003|Overall Study|Death|0|||
23514268|NCT00460408|65619662|FG000|Overall Study|Lost to Follow-up|11|||
23514269|NCT00460408|65619663|FG001|Overall Study|Lost to Follow-up|0|||
23514270|NCT00460408|65619664|FG002|Overall Study|Lost to Follow-up|1|||
23514271|NCT00460408|65619665|FG003|Overall Study|Lost to Follow-up|0|||
23514272|NCT00460408|65619662|FG000|Overall Study|Withdrawal by Subject|31|||
23514273|NCT00460408|65619663|FG001|Overall Study|Withdrawal by Subject|0|||
23514274|NCT00460408|65619664|FG002|Overall Study|Withdrawal by Subject|0|||
23514275|NCT00460408|65619665|FG003|Overall Study|Withdrawal by Subject|0|||
23514276|NCT00460408|65619662|FG000|Overall Study|Insufficient clinical response|5|||
23514277|NCT00460408|65619663|FG001|Overall Study|Insufficient clinical response|1|||
23514278|NCT00460408|65619664|FG002|Overall Study|Insufficient clinical response|5|||
23514279|NCT00460408|65619665|FG003|Overall Study|Insufficient clinical response|0|||
23514280|NCT00460408|65619662|FG000|Overall Study|Other|12|||
23514281|NCT00460408|65619663|FG001|Overall Study|Other|2|||
23514282|NCT00460408|65619664|FG002|Overall Study|Other|0|||
23514283|NCT00460408|65619665|FG003|Overall Study|Other|0|||
23514284|NCT05286307|65619666|FG000|Overall Study|Incomplete outcome assessments|2|||
23514285|NCT05286307|65619667|FG001|Overall Study|Incomplete outcome assessments|1|||
23514286|NCT05286307|65619666|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
23514287|NCT05286307|65619667|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
23514288|NCT05286307|65619666|FG000|Overall Study|Lost to follow up at 6 months|25|||
23514289|NCT05286307|65619667|FG001|Overall Study|Lost to follow up at 6 months|35|||
23514290|NCT05286307|65619666|FG000|Overall Study|Study medication not available|1|||
23514291|NCT05286307|65619667|FG001|Overall Study|Study medication not available|1|||
23514292|NCT00553150|65619668|FG000|Overall Study|Withdrawal by Subject|0|||
23514293|NCT00553150|65619669|FG001|Overall Study|Withdrawal by Subject|0|||
23514294|NCT00553150|65619670|FG002|Overall Study|Withdrawal by Subject|0|||
23514295|NCT00553150|65619671|FG003|Overall Study|Withdrawal by Subject|2|||
23514296|NCT00553150|65619668|FG000|Overall Study|Protocol Violation|0|||
23514297|NCT00553150|65619669|FG001|Overall Study|Protocol Violation|0|||
23514298|NCT00553150|65619670|FG002|Overall Study|Protocol Violation|0|||
23514299|NCT00553150|65619671|FG003|Overall Study|Protocol Violation|1|||
23514300|NCT00553150|65619668|FG000|Overall Study|Ineligible|0|||
23514301|NCT00553150|65619669|FG001|Overall Study|Ineligible|0|||
23514302|NCT00553150|65619670|FG002|Overall Study|Ineligible|0|||
23514303|NCT00553150|65619671|FG003|Overall Study|Ineligible|1|||
23514304|NCT02514447|65619672|FG000|Overall Study|Withdrawal by Subject|3|||
23307547|NCT00773734|64870548|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
23307548|NCT00773734|64870549|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23453540|NCT03367858|65403353|FG001|3 Month Follow Up|Incarcerated|1|||
23453541|NCT03367858|65403352|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
23453542|NCT03367858|65403353|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
23453543|NCT03367858|65403352|FG000|6 Month Follow Up|Lost to Follow-up|5|||
23453544|NCT03367858|65403353|FG001|6 Month Follow Up|Lost to Follow-up|2|||
23453545|NCT03367858|65403352|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
23453546|NCT03367858|65403353|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
23453547|NCT03367858|65403352|FG000|12 Month Follow Up|Lost to Follow-up|3|||
23453548|NCT03367858|65403353|FG001|12 Month Follow Up|Lost to Follow-up|3|||
23453549|NCT03367858|65403352|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
23453550|NCT03367858|65403353|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
23453551|NCT00740220|65403357|FG000|Overall Study|screen failures (non-COPD patients)|9|||
23453552|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453553|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453554|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453555|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
23453556|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453557|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453558|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453559|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453560|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453561|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
23453562|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
23453563|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
23453564|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453565|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
23453566|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
23453567|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
23514305|NCT02514447|65619673|FG001|Overall Study|Withdrawal by Subject|1|||
23514306|NCT02514447|65619674|FG002|Overall Study|Withdrawal by Subject|1|||
23514307|NCT02514447|65619675|FG003|Overall Study|Withdrawal by Subject|0|||
23514308|NCT02514447|65619676|FG004|Overall Study|Withdrawal by Subject|0|||
23514309|NCT02514447|65619677|FG005|Overall Study|Withdrawal by Subject|0|||
23514310|NCT02514447|65619678|FG006|Overall Study|Withdrawal by Subject|0|||
23514311|NCT02514447|65619679|FG007|Overall Study|Withdrawal by Subject|1|||
23514312|NCT02514447|65619680|FG008|Overall Study|Withdrawal by Subject|1|||
23514313|NCT02514447|65619672|FG000|Overall Study|Death|24|||
23514314|NCT02514447|65619673|FG001|Overall Study|Death|28|||
23514315|NCT02514447|65619674|FG002|Overall Study|Death|29|||
23514316|NCT02514447|65619675|FG003|Overall Study|Death|0|||
23514317|NCT02514447|65619676|FG004|Overall Study|Death|3|||
23514318|NCT02514447|65619677|FG005|Overall Study|Death|4|||
23514319|NCT02514447|65619678|FG006|Overall Study|Death|8|||
23514320|NCT02514447|65619679|FG007|Overall Study|Death|6|||
23514321|NCT02514447|65619680|FG008|Overall Study|Death|5|||
23514322|NCT02514447|65619672|FG000|Overall Study|Lost to Follow-up|1|||
23514323|NCT02514447|65619673|FG001|Overall Study|Lost to Follow-up|0|||
23514324|NCT02514447|65619674|FG002|Overall Study|Lost to Follow-up|0|||
23514325|NCT02514447|65619675|FG003|Overall Study|Lost to Follow-up|0|||
23514326|NCT02514447|65619676|FG004|Overall Study|Lost to Follow-up|0|||
23514327|NCT02514447|65619677|FG005|Overall Study|Lost to Follow-up|0|||
23514328|NCT02514447|65619678|FG006|Overall Study|Lost to Follow-up|0|||
23514329|NCT02514447|65619679|FG007|Overall Study|Lost to Follow-up|0|||
23514330|NCT02514447|65619680|FG008|Overall Study|Lost to Follow-up|1|||
23514331|NCT02514447|65619672|FG000|Overall Study|Sponsor Termination of Study|0|||
23514332|NCT02514447|65619673|FG001|Overall Study|Sponsor Termination of Study|1|||
23514333|NCT02514447|65619674|FG002|Overall Study|Sponsor Termination of Study|1|||
23514334|NCT02514447|65619675|FG003|Overall Study|Sponsor Termination of Study|0|||
23514335|NCT02514447|65619676|FG004|Overall Study|Sponsor Termination of Study|0|||
23514336|NCT02514447|65619677|FG005|Overall Study|Sponsor Termination of Study|0|||
23514337|NCT02514447|65619678|FG006|Overall Study|Sponsor Termination of Study|0|||
23514338|NCT02514447|65619679|FG007|Overall Study|Sponsor Termination of Study|0|||
23514339|NCT02514447|65619680|FG008|Overall Study|Sponsor Termination of Study|0|||
23514340|NCT02514447|65619672|FG000|Overall Study|Study completion per Investigator|1|||
23514341|NCT02514447|65619673|FG001|Overall Study|Study completion per Investigator|0|||
23514342|NCT02514447|65619674|FG002|Overall Study|Study completion per Investigator|1|||
23514343|NCT02514447|65619675|FG003|Overall Study|Study completion per Investigator|2|||
23514344|NCT02514447|65619676|FG004|Overall Study|Study completion per Investigator|0|||
23514345|NCT02514447|65619677|FG005|Overall Study|Study completion per Investigator|0|||
23514346|NCT02514447|65619678|FG006|Overall Study|Study completion per Investigator|0|||
23514347|NCT02514447|65619679|FG007|Overall Study|Study completion per Investigator|0|||
23514348|NCT02514447|65619680|FG008|Overall Study|Study completion per Investigator|1|||
23514349|NCT03065244|65619681|FG000|Overall Study|Lost to Follow-up|1|||
23514350|NCT03065244|65619682|FG001|Overall Study|Lost to Follow-up|1|||
23514351|NCT03065244|65619681|FG000|Overall Study|Diagnosed with a different disease|1|||
23514352|NCT03065244|65619682|FG001|Overall Study|Diagnosed with a different disease|1|||
23514353|NCT03065244|65619681|FG000|Overall Study|Protocol Violation|0|||
23514354|NCT03065244|65619682|FG001|Overall Study|Protocol Violation|1|||
23514355|NCT03065244|65619681|FG000|Overall Study|Withdrawal by Subject|1|||
23514356|NCT03065244|65619682|FG001|Overall Study|Withdrawal by Subject|1|||
23514357|NCT02339740|65619683|FG000|Overall Study|Death|1|||
23514358|NCT02339740|65619684|FG001|Overall Study|Death|0|||
23514359|NCT02339740|65619683|FG000|Overall Study|Physician Decision|0|||
23514360|NCT02339740|65619684|FG001|Overall Study|Physician Decision|2|||
23514361|NCT02339740|65619683|FG000|Overall Study|Withdrawal by Subject|5|||
23514362|NCT02339740|65619684|FG001|Overall Study|Withdrawal by Subject|1|||
23514363|NCT02339740|65619683|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
23514364|NCT02339740|65619684|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
23514365|NCT00224055|65619685|FG000|Overall Study|Adverse Event|9|||
23514366|NCT00224055|65619686|FG001|Overall Study|Adverse Event|3|||
23514367|NCT00224055|65619685|FG000|Overall Study|Lost to Follow-up|1|||
23514368|NCT00224055|65619686|FG001|Overall Study|Lost to Follow-up|2|||
23514369|NCT00224055|65619685|FG000|Overall Study|Protocol Violation|1|||
23514370|NCT00224055|65619686|FG001|Overall Study|Protocol Violation|1|||
23514371|NCT00224055|65619685|FG000|Overall Study|Inclusion Violation|3|||
23514372|NCT00224055|65619686|FG001|Overall Study|Inclusion Violation|6|||
23514373|NCT00224055|65619685|FG000|Overall Study|Withdrawal by Subject|0|||
23514374|NCT00224055|65619686|FG001|Overall Study|Withdrawal by Subject|2|||
23514375|NCT00224055|65619685|FG000|Overall Study|Other|1|||
23514376|NCT00224055|65619686|FG001|Overall Study|Other|0|||
23514377|NCT01770379|65619687|FG000|Overall Study|Technical issues|1|||
23514378|NCT01770379|65619688|FG001|Overall Study|Technical issues|0|||
23514379|NCT01770379|65619689|FG002|Overall Study|Technical issues|0|||
23514380|NCT01770379|65619687|FG000|Overall Study|Withdrawal by Subject|7|||
23514381|NCT01770379|65619688|FG001|Overall Study|Withdrawal by Subject|10|||
23514382|NCT01770379|65619689|FG002|Overall Study|Withdrawal by Subject|7|||
23514383|NCT01770379|65619687|FG000|Overall Study|study terminated by sponsor|22|||
23514384|NCT01770379|65619688|FG001|Overall Study|study terminated by sponsor|23|||
23514385|NCT01770379|65619689|FG002|Overall Study|study terminated by sponsor|22|||
23514386|NCT01770379|65619687|FG000|Overall Study|Protocol Violation|0|||
23514387|NCT01770379|65619688|FG001|Overall Study|Protocol Violation|1|||
23514388|NCT01770379|65619689|FG002|Overall Study|Protocol Violation|1|||
23514389|NCT01770379|65619687|FG000|Overall Study|Physician Decision|0|||
23514390|NCT01770379|65619688|FG001|Overall Study|Physician Decision|1|||
23514391|NCT01770379|65619689|FG002|Overall Study|Physician Decision|2|||
23514392|NCT01770379|65619687|FG000|Overall Study|Lost to Follow-up|0|||
23514393|NCT01770379|65619688|FG001|Overall Study|Lost to Follow-up|0|||
23514394|NCT01770379|65619689|FG002|Overall Study|Lost to Follow-up|2|||
23514395|NCT01770379|65619687|FG000|Overall Study|Lack of Efficacy|8|||
23514396|NCT01770379|65619688|FG001|Overall Study|Lack of Efficacy|6|||
23514397|NCT01770379|65619689|FG002|Overall Study|Lack of Efficacy|6|||
23514398|NCT01770379|65619687|FG000|Overall Study|Adverse Event|1|||
23514399|NCT01770379|65619688|FG001|Overall Study|Adverse Event|3|||
23514400|NCT01770379|65619689|FG002|Overall Study|Adverse Event|2|||
23514401|NCT02062879|65619690|FG000|Overall Study|Withdrawal by Subject|4|||
23514402|NCT02062879|65619691|FG001|Overall Study|Withdrawal by Subject|1|||
23514403|NCT01059786|65619696|FG000|Overall Study|Did not receive 6 cycles.|0|||
23514404|NCT01059786|65619697|FG001|Overall Study|Did not receive 6 cycles.|0|||
23514405|NCT01059786|65619698|FG002|Overall Study|Did not receive 6 cycles.|4|||
23514406|NCT01059786|65619699|FG003|Overall Study|Did not receive 6 cycles.|1|||
23514407|NCT01059786|65619700|FG004|Overall Study|Did not receive 6 cycles.|0|||
23514408|NCT00410046|65619701|FG000|Overall Study|Adverse Event|3|||
23514409|NCT00410046|65619701|FG000|Overall Study|Withdrawal by Subject|1|||
23514410|NCT00410046|65619701|FG000|Overall Study|Lost to Follow-up|1|||
23514411|NCT01408030|65619702|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
23514412|NCT01408030|65619703|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
23514413|NCT01408030|65619704|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
23514414|NCT01408030|65619705|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
23514415|NCT01408030|65619702|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
23514416|NCT01408030|65619703|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
23514417|NCT01408030|65619704|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
23514418|NCT01408030|65619705|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
23514419|NCT01408030|65619702|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
23514420|NCT01408030|65619703|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
23514421|NCT01408030|65619704|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
23514422|NCT01408030|65619705|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
23514423|NCT01408030|65619702|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
23514424|NCT01408030|65619703|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
23514425|NCT01408030|65619704|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
23514426|NCT01408030|65619705|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
23514427|NCT01408030|65619702|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
23514428|NCT01408030|65619703|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
23514429|NCT01408030|65619704|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
23514430|NCT01408030|65619705|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
23514431|NCT01408030|65619702|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
23514432|NCT01408030|65619703|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
23514433|NCT01408030|65619704|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
23514434|NCT01408030|65619705|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
23514435|NCT01408030|65619702|FG000|Observation Phase (Off Drug)|Other|1|||
23514436|NCT01408030|65619703|FG001|Observation Phase (Off Drug)|Other|1|||
23514437|NCT01408030|65619704|FG002|Observation Phase (Off Drug)|Other|1|||
23514438|NCT01408030|65619705|FG003|Observation Phase (Off Drug)|Other|1|||
23514439|NCT04984993|65619706|FG000|Overall Study|Withdrawal by Subject|8|||
23514440|NCT04984993|65619707|FG001|Overall Study|Withdrawal by Subject|2|||
23514441|NCT04984993|65619706|FG000|Overall Study|Lost to Follow-up|2|||
23514442|NCT04984993|65619707|FG001|Overall Study|Lost to Follow-up|2|||
23514443|NCT04984993|65619706|FG000|Overall Study|Both patients moved to another country|4|||
23514444|NCT04984993|65619707|FG001|Overall Study|Both patients moved to another country|0|||
23514445|NCT01867021|65619708|FG000|Overall Study|Adverse Event|0|||
23514446|NCT01867021|65619709|FG001|Overall Study|Adverse Event|1|||
23514447|NCT01867021|65619708|FG000|Overall Study|Not Eligible|0|||
23514448|NCT01867021|65619709|FG001|Overall Study|Not Eligible|1|||
23514449|NCT01867021|65619708|FG000|Overall Study|Death|1|||
23514450|NCT01867021|65619709|FG001|Overall Study|Death|0|||
23514451|NCT01867021|65619708|FG000|Overall Study|Lost to Follow-up|0|||
23514452|NCT01867021|65619709|FG001|Overall Study|Lost to Follow-up|2|||
23514453|NCT01867021|65619708|FG000|Overall Study|Withdrawal by Subject|1|||
23514454|NCT01867021|65619709|FG001|Overall Study|Withdrawal by Subject|6|||
23514455|NCT03089606|65619711|FG000|Overall Study|Progression after Cycle 1|1|||
23514456|NCT04772755|65619712|FG000|Overall Study|Withdrawal by Subject|1|||
23514457|NCT04772755|65619713|FG001|Overall Study|Withdrawal by Subject|0|||
23514458|NCT04772755|65619712|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
23514459|NCT04772755|65619713|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
23514460|NCT02289690|65619718|FG000|Overall Study|Adverse Event Related to Progression|0|||
23514461|NCT02289690|65619719|FG001|Overall Study|Adverse Event Related to Progression|1|||
23514462|NCT02289690|65619720|FG002|Overall Study|Adverse Event Related to Progression|1|||
23514463|NCT02289690|65619721|FG003|Overall Study|Adverse Event Related to Progression|0|||
23514464|NCT02289690|65619722|FG004|Overall Study|Adverse Event Related to Progression|1|||
23514465|NCT02289690|65619723|FG005|Overall Study|Adverse Event Related to Progression|0|||
23514466|NCT02289690|65619724|FG006|Overall Study|Adverse Event Related to Progression|1|||
23514467|NCT02289690|65619725|FG007|Overall Study|Adverse Event Related to Progression|0|||
23514468|NCT02289690|65619726|FG008|Overall Study|Adverse Event Related to Progression|0|||
23514469|NCT02289690|65619727|FG009|Overall Study|Adverse Event Related to Progression|0|||
23514470|NCT02289690|65619718|FG000|Overall Study|Withdrawal by Subject|1|||
23514471|NCT02289690|65619719|FG001|Overall Study|Withdrawal by Subject|0|||
23514472|NCT02289690|65619720|FG002|Overall Study|Withdrawal by Subject|0|||
23514473|NCT02289690|65619721|FG003|Overall Study|Withdrawal by Subject|0|||
23514474|NCT02289690|65619722|FG004|Overall Study|Withdrawal by Subject|1|||
23514475|NCT02289690|65619723|FG005|Overall Study|Withdrawal by Subject|1|||
23514476|NCT02289690|65619724|FG006|Overall Study|Withdrawal by Subject|0|||
23514477|NCT02289690|65619725|FG007|Overall Study|Withdrawal by Subject|0|||
23514478|NCT02289690|65619726|FG008|Overall Study|Withdrawal by Subject|4|||
23514479|NCT02289690|65619727|FG009|Overall Study|Withdrawal by Subject|2|||
23514480|NCT02289690|65619718|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
23514481|NCT02289690|65619719|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
23514482|NCT02289690|65619720|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
23514483|NCT02289690|65619721|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
23514484|NCT02289690|65619722|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
23514485|NCT02289690|65619723|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
23514486|NCT02289690|65619724|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
23514487|NCT02289690|65619725|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
23514488|NCT02289690|65619726|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
23514489|NCT02289690|65619727|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
23514490|NCT02289690|65619718|FG000|Overall Study|Lost to Follow-up|0|||
23514491|NCT02289690|65619719|FG001|Overall Study|Lost to Follow-up|0|||
23514492|NCT02289690|65619720|FG002|Overall Study|Lost to Follow-up|0|||
23514493|NCT02289690|65619721|FG003|Overall Study|Lost to Follow-up|0|||
23514494|NCT02289690|65619722|FG004|Overall Study|Lost to Follow-up|0|||
23514495|NCT02289690|65619723|FG005|Overall Study|Lost to Follow-up|0|||
23514496|NCT02289690|65619724|FG006|Overall Study|Lost to Follow-up|0|||
23514497|NCT02289690|65619725|FG007|Overall Study|Lost to Follow-up|1|||
23514498|NCT02289690|65619726|FG008|Overall Study|Lost to Follow-up|0|||
23514499|NCT02289690|65619727|FG009|Overall Study|Lost to Follow-up|2|||
23514500|NCT02289690|65619718|FG000|Overall Study|Death|0|||
23514501|NCT02289690|65619719|FG001|Overall Study|Death|0|||
23514502|NCT02289690|65619720|FG002|Overall Study|Death|0|||
23514503|NCT02289690|65619721|FG003|Overall Study|Death|0|||
23514504|NCT02289690|65619722|FG004|Overall Study|Death|0|||
23514505|NCT02289690|65619723|FG005|Overall Study|Death|0|||
23514506|NCT02289690|65619724|FG006|Overall Study|Death|0|||
23514507|NCT02289690|65619725|FG007|Overall Study|Death|49|||
23514508|NCT02289690|65619726|FG008|Overall Study|Death|45|||
23514509|NCT02289690|65619727|FG009|Overall Study|Death|41|||
23514510|NCT02289690|65619718|FG000|Overall Study|Sponsor Discontinued Study|0|||
23514511|NCT02289690|65619719|FG001|Overall Study|Sponsor Discontinued Study|0|||
23514512|NCT02289690|65619720|FG002|Overall Study|Sponsor Discontinued Study|0|||
23514513|NCT02289690|65619721|FG003|Overall Study|Sponsor Discontinued Study|0|||
23514514|NCT02289690|65619722|FG004|Overall Study|Sponsor Discontinued Study|0|||
23514515|NCT02289690|65619723|FG005|Overall Study|Sponsor Discontinued Study|0|||
23514516|NCT02289690|65619724|FG006|Overall Study|Sponsor Discontinued Study|0|||
23514517|NCT02289690|65619725|FG007|Overall Study|Sponsor Discontinued Study|9|||
23514518|NCT02289690|65619726|FG008|Overall Study|Sponsor Discontinued Study|7|||
23514519|NCT02289690|65619727|FG009|Overall Study|Sponsor Discontinued Study|15|||
23514520|NCT02289690|65619718|FG000|Overall Study|Other|0|||
23514521|NCT02289690|65619719|FG001|Overall Study|Other|0|||
23514522|NCT02289690|65619720|FG002|Overall Study|Other|0|||
23514523|NCT02289690|65619721|FG003|Overall Study|Other|1|||
23514524|NCT02289690|65619722|FG004|Overall Study|Other|1|||
23514525|NCT02289690|65619723|FG005|Overall Study|Other|0|||
23514526|NCT02289690|65619724|FG006|Overall Study|Other|1|||
23514527|NCT02289690|65619725|FG007|Overall Study|Other|2|||
23514528|NCT02289690|65619726|FG008|Overall Study|Other|3|||
23514529|NCT02289690|65619727|FG009|Overall Study|Other|1|||
23514530|NCT01980992|65619728|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
23514531|NCT01980992|65619729|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
23514532|NCT01980992|65619728|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
23514533|NCT01980992|65619729|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
23514534|NCT01980992|65619728|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
23514535|NCT01980992|65619729|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
23514536|NCT01980992|65619728|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
23514537|NCT01980992|65619729|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
23514538|NCT01980992|65619728|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
23514539|NCT01980992|65619729|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
23514540|NCT01980992|65619728|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
23514541|NCT01980992|65619729|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
23514542|NCT00748033|65619733|FG000|Overall Study|Adverse Event|0|||
23514543|NCT00748033|65619734|FG001|Overall Study|Adverse Event|1|||
23514544|NCT00759954|65619735|FG000|Overall Study|Personal reason|1|||
23514545|NCT00759954|65619736|FG001|Overall Study|Personal reason|0|||
23514546|NCT00759954|65619735|FG000|Overall Study|Adverse Event|1|||
23514547|NCT00759954|65619736|FG001|Overall Study|Adverse Event|2|||
23514548|NCT01525550|65619737|FG000|Overall Study|Lost to Follow-up|8|||
23514549|NCT01525550|65619738|FG001|Overall Study|Lost to Follow-up|2|||
23514550|NCT01525550|65619737|FG000|Overall Study|Death|19|||
23514551|NCT01525550|65619738|FG001|Overall Study|Death|28|||
23514552|NCT01525550|65619737|FG000|Overall Study|Other|0|||
23514553|NCT01525550|65619738|FG001|Overall Study|Other|4|||
23514554|NCT01525550|65619737|FG000|Overall Study|Sponsor's Decision|30|||
23514555|NCT01525550|65619738|FG001|Overall Study|Sponsor's Decision|11|||
23514556|NCT01525550|65619737|FG000|Overall Study|Withdrawal by Subject|4|||
23514557|NCT01525550|65619738|FG001|Overall Study|Withdrawal by Subject|0|||
23514558|NCT00372112|65619739|FG000|Overall Study|Adverse Event|0|||
23514559|NCT00372112|65619740|FG001|Overall Study|Adverse Event|1|||
23514560|NCT00372112|65619741|FG002|Overall Study|Adverse Event|1|||
23514561|NCT00372112|65619742|FG003|Overall Study|Adverse Event|1|||
23514562|NCT00372112|65619739|FG000|Overall Study|Withdrawal by Subject|0|||
23514563|NCT00372112|65619740|FG001|Overall Study|Withdrawal by Subject|0|||
23514564|NCT00372112|65619741|FG002|Overall Study|Withdrawal by Subject|2|||
23514565|NCT00372112|65619742|FG003|Overall Study|Withdrawal by Subject|1|||
23514566|NCT00372112|65619739|FG000|Overall Study|Exacerbation|0|||
23514567|NCT00372112|65619740|FG001|Overall Study|Exacerbation|0|||
23514568|NCT00372112|65619741|FG002|Overall Study|Exacerbation|0|||
23514569|NCT00372112|65619742|FG003|Overall Study|Exacerbation|1|||
23514570|NCT00372112|65619739|FG000|Overall Study|PR >240 at Visit 3|0|||
23514571|NCT00372112|65619740|FG001|Overall Study|PR >240 at Visit 3|0|||
23514572|NCT00372112|65619741|FG002|Overall Study|PR >240 at Visit 3|0|||
23514573|NCT00372112|65619742|FG003|Overall Study|PR >240 at Visit 3|1|||
23514574|NCT00372112|65619739|FG000|Overall Study|Hepatitis B|1|||
23514575|NCT00372112|65619740|FG001|Overall Study|Hepatitis B|0|||
23514576|NCT00372112|65619741|FG002|Overall Study|Hepatitis B|0|||
23514577|NCT00372112|65619742|FG003|Overall Study|Hepatitis B|0|||
23514578|NCT00372112|65619739|FG000|Overall Study|Other-protocol violation|0|||
23514579|NCT00372112|65619740|FG001|Overall Study|Other-protocol violation|0|||
23514580|NCT00372112|65619741|FG002|Overall Study|Other-protocol violation|1|||
23514581|NCT00372112|65619742|FG003|Overall Study|Other-protocol violation|0|||
23514582|NCT00271609|65619747|FG000|Overall Study|Adverse Event|11|||
23514583|NCT00271609|65619748|FG001|Overall Study|Adverse Event|3|||
23514584|NCT00271609|65619747|FG000|Overall Study|Withdrawal by Subject|2|||
23307549|NCT00773734|64870550|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23307550|NCT00773734|64870551|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23514585|NCT00271609|65619748|FG001|Overall Study|Withdrawal by Subject|0|||
23514586|NCT01356966|65619749|FG000|Overall Study|Withdrawal by Subject|1|||
23514587|NCT01356966|65619750|FG001|Overall Study|Withdrawal by Subject|2|||
23514588|NCT01356966|65619749|FG000|Overall Study|Physician Decision|1|||
23514589|NCT01356966|65619750|FG001|Overall Study|Physician Decision|0|||
23514590|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
23514591|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
23514592|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
23514593|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
23415888|NCT01252186|65266051|FG001|Overall Study|Withdrawal by Subject|5|||
23415889|NCT01252186|65266052|FG002|Overall Study|Withdrawal by Subject|2|||
23514594|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
23514595|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
23514596|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
23514597|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
23514598|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
23514599|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
23514600|NCT02528643|65619751|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
23514601|NCT02528643|65619752|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
23514602|NCT02528643|65619751|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
23514603|NCT02528643|65619752|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
23514604|NCT00386776|65619754|FG000|Overall Study|Withdrawal by Subject|8|||
23415890|NCT01252186|65266050|FG000|Overall Study|Physician Decision|0|||
23415891|NCT01252186|65266051|FG001|Overall Study|Physician Decision|0|||
23415892|NCT01252186|65266052|FG002|Overall Study|Physician Decision|1|||
23415893|NCT01252186|65266050|FG000|Overall Study|Non-compliance|0|||
23415894|NCT01252186|65266051|FG001|Overall Study|Non-compliance|3|||
23415895|NCT01252186|65266052|FG002|Overall Study|Non-compliance|4|||
23415896|NCT01252186|65266050|FG000|Overall Study|Protocol Violation|0|||
23415897|NCT01252186|65266051|FG001|Overall Study|Protocol Violation|0|||
23415898|NCT01252186|65266052|FG002|Overall Study|Protocol Violation|1|||
23415899|NCT01252186|65266050|FG000|Overall Study|Pregnancy|2|||
23415900|NCT01252186|65266051|FG001|Overall Study|Pregnancy|2|||
23415901|NCT01252186|65266052|FG002|Overall Study|Pregnancy|0|||
23415902|NCT01252186|65266050|FG000|Overall Study|Sponsor Request|2|||
23415903|NCT01252186|65266051|FG001|Overall Study|Sponsor Request|1|||
23415904|NCT01252186|65266052|FG002|Overall Study|Sponsor Request|0|||
23415905|NCT01252186|65266050|FG000|Overall Study|Lost to Follow-up|10|||
23415906|NCT01252186|65266051|FG001|Overall Study|Lost to Follow-up|10|||
23415907|NCT01252186|65266052|FG002|Overall Study|Lost to Follow-up|11|||
23415908|NCT01252186|65266050|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
23415909|NCT01252186|65266051|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
23415910|NCT01252186|65266052|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
23415911|NCT02680041|65266053|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
23415912|NCT02680041|65266053|FG000|Overall Study|Lost to Follow-up|2|||
23415913|NCT01795495|65266054|FG000|Overall Study|Protocol Violation|1|||
23415914|NCT01795495|65266055|FG001|Overall Study|Protocol Violation|0|||
23415915|NCT01795495|65266056|FG002|Overall Study|Protocol Violation|1|||
23415916|NCT01795495|65266054|FG000|Overall Study|Physician Decision|0|||
23415917|NCT01795495|65266055|FG001|Overall Study|Physician Decision|0|||
23415918|NCT01795495|65266056|FG002|Overall Study|Physician Decision|1|||
23415919|NCT00485758|65266057|FG000|Overall Study|Adverse Event|102|||
23415920|NCT00485758|65266058|FG001|Overall Study|Adverse Event|31|||
23415921|NCT00485758|65266057|FG000|Overall Study|Death|0|||
23415922|NCT00485758|65266058|FG001|Overall Study|Death|1|||
23415923|NCT00485758|65266057|FG000|Overall Study|Lost to Follow-up|5|||
23415924|NCT00485758|65266058|FG001|Overall Study|Lost to Follow-up|1|||
23415925|NCT00485758|65266057|FG000|Overall Study|Physician Decision|3|||
23415926|NCT00485758|65266058|FG001|Overall Study|Physician Decision|3|||
23415927|NCT00485758|65266057|FG000|Overall Study|Protocol Violation|11|||
23415928|NCT00485758|65266058|FG001|Overall Study|Protocol Violation|2|||
23415929|NCT00485758|65266057|FG000|Overall Study|Withdrawal by Subject|32|||
23415930|NCT00485758|65266058|FG001|Overall Study|Withdrawal by Subject|27|||
23415931|NCT00485758|65266057|FG000|Overall Study|Study Terminated by Sponsor|3|||
23415932|NCT00485758|65266058|FG001|Overall Study|Study Terminated by Sponsor|0|||
23415933|NCT02543281|65266059|FG000|Overall Study|Lost to Follow-up|0|||
23415934|NCT02543281|65266060|FG001|Overall Study|Lost to Follow-up|0|||
23415935|NCT02543281|65266061|FG002|Overall Study|Lost to Follow-up|1|||
23415936|NCT00675441|65266069|FG000|Overall Study|Withdrawal by Subject|2|||
23415937|NCT00675441|65266069|FG000|Overall Study|Death|1|||
23415938|NCT00306293|65266080|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
23415939|NCT00306293|65266081|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
23415940|NCT00306293|65266080|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
23415941|NCT00306293|65266081|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
23514605|NCT00137423|65619755|FG000|Overall Study|Adverse Event|7|||
23415942|NCT00306293|65266080|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
23415943|NCT00306293|65266081|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
23415944|NCT00306293|65266080|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
23611194|NCT01072149|65966730|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
23415945|NCT00306293|65266081|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
23415946|NCT00306293|65266080|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
23415947|NCT00306293|65266081|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
23415948|NCT00306293|65266080|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
23415949|NCT00306293|65266081|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
23415950|NCT00306293|65266080|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
23415951|NCT00306293|65266081|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
23415952|NCT00306293|65266080|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
23415953|NCT00306293|65266081|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
23415954|NCT02290691|65266082|FG000|Overall Study|Noncompliance|0|||
23415955|NCT02290691|65266083|FG001|Overall Study|Noncompliance|1|||
23415956|NCT02290691|65266082|FG000|Overall Study|Withdrawal by Subject|1|||
23415957|NCT02290691|65266083|FG001|Overall Study|Withdrawal by Subject|1|||
23415958|NCT02290691|65266082|FG000|Overall Study|Lost to Follow-up|7|||
23415959|NCT02290691|65266083|FG001|Overall Study|Lost to Follow-up|7|||
23415960|NCT01597908|65266084|FG000|Randomized Phase|Death|217|||
23415961|NCT01597908|65266085|FG001|Randomized Phase|Death|238|||
23415962|NCT01597908|65266086|FG002|Randomized Phase|Death|0|||
23415963|NCT01597908|65266084|FG000|Randomized Phase|Sponsor Decision|93|||
23415964|NCT01597908|65266085|FG001|Randomized Phase|Sponsor Decision|39|||
23415965|NCT01597908|65266086|FG002|Randomized Phase|Sponsor Decision|0|||
23415966|NCT01597908|65266084|FG000|Randomized Phase|Lost to Follow-up|9|||
23415967|NCT01597908|65266085|FG001|Randomized Phase|Lost to Follow-up|16|||
23415968|NCT01597908|65266086|FG002|Randomized Phase|Lost to Follow-up|0|||
23415969|NCT01597908|65266084|FG000|Randomized Phase|Physician Decision|6|||
23415970|NCT01597908|65266085|FG001|Randomized Phase|Physician Decision|3|||
23415971|NCT01597908|65266086|FG002|Randomized Phase|Physician Decision|0|||
23415972|NCT01597908|65266084|FG000|Randomized Phase|Withdrawal by Subject|26|||
23415973|NCT01597908|65266085|FG001|Randomized Phase|Withdrawal by Subject|22|||
23415974|NCT01597908|65266086|FG002|Randomized Phase|Withdrawal by Subject|0|||
23415975|NCT01597908|65266084|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
23415976|NCT01597908|65266085|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
23415977|NCT01597908|65266086|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
23415978|NCT01597908|65266084|FG000|Crossover Phase|Death|0|||
23415979|NCT01597908|65266085|FG001|Crossover Phase|Death|0|||
23415980|NCT01597908|65266086|FG002|Crossover Phase|Death|11|||
23415981|NCT01597908|65266084|FG000|Crossover Phase|Withdrawal by Subject|0|||
23415982|NCT01597908|65266085|FG001|Crossover Phase|Withdrawal by Subject|0|||
23415983|NCT01597908|65266086|FG002|Crossover Phase|Withdrawal by Subject|3|||
23415984|NCT01597908|65266084|FG000|Crossover Phase|Sponsor Decision|0|||
23415985|NCT01597908|65266085|FG001|Crossover Phase|Sponsor Decision|0|||
23415986|NCT01597908|65266086|FG002|Crossover Phase|Sponsor Decision|20|||
23415987|NCT01576146|65266089|FG000|Extension Period 1|Adverse Event|2|||
23415988|NCT01576146|65266089|FG000|Extension Period 1|Death|2|||
23415989|NCT01576146|65266089|FG000|Extension Period 1|Physician Decision|2|||
23415990|NCT01576146|65266089|FG000|Extension Period 1|Withdrawal by Subject|1|||
23415991|NCT01576146|65266089|FG000|Extension Period 1|Lost to Follow-up|1|||
23415992|NCT01576146|65266089|FG000|Extension Period 1|Parathyroidectomy|1|||
23415993|NCT01576146|65266089|FG000|Extension Period 1|Renal Transplant|1|||
23415994|NCT01576146|65266089|FG000|Extension Period 2|Sponsor Decision|13|||
23415995|NCT01576146|65266089|FG000|Extension Period 2|Death|1|||
23415996|NCT01576146|65266089|FG000|Extension Period 2|Adverse Event|1|||
23415997|NCT01576146|65266089|FG000|Extension Period 2|Renal Transplant|1|||
23415998|NCT01576146|65266089|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
23415999|NCT04537208|65266090|FG000|Overall Study|Adverse Event|0|||
23416000|NCT04537208|65266091|FG001|Overall Study|Adverse Event|0|||
23416001|NCT04537208|65266092|FG002|Overall Study|Adverse Event|0|||
23416002|NCT04537208|65266093|FG003|Overall Study|Adverse Event|0|||
23416003|NCT04537208|65266094|FG004|Overall Study|Adverse Event|0|||
23416004|NCT04537208|65266095|FG005|Overall Study|Adverse Event|0|||
23416005|NCT04537208|65266096|FG006|Overall Study|Adverse Event|0|||
23416006|NCT04537208|65266097|FG007|Overall Study|Adverse Event|0|||
23416007|NCT04537208|65266098|FG008|Overall Study|Adverse Event|1|||
23514606|NCT00137423|65619756|FG001|Overall Study|Adverse Event|9|||
23514607|NCT00137423|65619755|FG000|Overall Study|consent withdrawn|1|||
23514608|NCT00137423|65619756|FG001|Overall Study|consent withdrawn|1|||
23514609|NCT00137423|65619755|FG000|Overall Study|Lack of Efficacy|31|||
23514610|NCT00137423|65619756|FG001|Overall Study|Lack of Efficacy|33|||
23514611|NCT00137423|65619755|FG000|Overall Study|Death|0|||
23514612|NCT00137423|65619756|FG001|Overall Study|Death|1|||
23514613|NCT00847704|65619757|FG000|Overall Study|Withdrawal by Subject|1|||
23514614|NCT00503009|65619758|FG000|Overall Study|Protocol Violation|1|||
23514615|NCT00503009|65619759|FG001|Overall Study|Protocol Violation|0|||
23514616|NCT00503009|65619760|FG002|Overall Study|Protocol Violation|1|||
23514617|NCT00503009|65619758|FG000|Overall Study|Withdrawal by Subject|0|||
23514618|NCT00503009|65619759|FG001|Overall Study|Withdrawal by Subject|1|||
23514619|NCT00503009|65619760|FG002|Overall Study|Withdrawal by Subject|1|||
23514620|NCT00503009|65619758|FG000|Overall Study|Physician Decision|0|||
23514621|NCT00503009|65619759|FG001|Overall Study|Physician Decision|1|||
23514622|NCT00503009|65619760|FG002|Overall Study|Physician Decision|1|||
23514623|NCT01313767|65619761|FG000|Overall Study|Adverse Event|1|||
23514624|NCT01313767|65619762|FG001|Overall Study|Adverse Event|0|||
23514625|NCT01313767|65619761|FG000|Overall Study|Lost to Follow-up|1|||
23514626|NCT01313767|65619762|FG001|Overall Study|Lost to Follow-up|0|||
23514627|NCT01313767|65619761|FG000|Overall Study|Withdrawal by Subject|2|||
23514628|NCT01313767|65619762|FG001|Overall Study|Withdrawal by Subject|1|||
23514629|NCT01313767|65619761|FG000|Overall Study|Protocol Violation|3|||
23514630|NCT01313767|65619762|FG001|Overall Study|Protocol Violation|1|||
23514631|NCT02140567|65619765|FG000|Overall Study|Problems with recording equipment|6|||
23514632|NCT01084174|65619766|FG000|Overall Study|gastrointestinal symptoms|1|||
23514633|NCT01084174|65619767|FG001|Overall Study|gastrointestinal symptoms|1|||
23514634|NCT01084174|65619766|FG000|Overall Study|Eosinophilic esophagitis|0|||
23514635|NCT01084174|65619767|FG001|Overall Study|Eosinophilic esophagitis|1|||
23514636|NCT01084174|65619766|FG000|Overall Study|Anaphylaxis|0|||
23514637|NCT01084174|65619767|FG001|Overall Study|Anaphylaxis|1|||
23514638|NCT01084174|65619766|FG000|Overall Study|Participant noncompliance|0|||
23514639|NCT01084174|65619767|FG001|Overall Study|Participant noncompliance|1|||
23514640|NCT03518073|65619768|FG000|Overall Study|Adverse Event|2|||
23514641|NCT03518073|65619769|FG001|Overall Study|Adverse Event|4|||
23514642|NCT03518073|65619770|FG002|Overall Study|Adverse Event|2|||
23307551|NCT00773734|64870552|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23307552|NCT00773734|64870553|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
23307553|NCT00773734|64870548|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
23514643|NCT03518073|65619768|FG000|Overall Study|Death|2|||
23514644|NCT03518073|65619769|FG001|Overall Study|Death|1|||
23514645|NCT03518073|65619770|FG002|Overall Study|Death|3|||
23307554|NCT00773734|64870549|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
23514646|NCT03518073|65619768|FG000|Overall Study|Lost to Follow-up|1|||
23514647|NCT03518073|65619769|FG001|Overall Study|Lost to Follow-up|0|||
23514648|NCT03518073|65619770|FG002|Overall Study|Lost to Follow-up|1|||
23514649|NCT03518073|65619768|FG000|Overall Study|Physician Decision|5|||
23514650|NCT03518073|65619769|FG001|Overall Study|Physician Decision|0|||
23514651|NCT03518073|65619770|FG002|Overall Study|Physician Decision|2|||
23514652|NCT03518073|65619768|FG000|Overall Study|Progressive disease|1|||
23514653|NCT03518073|65619769|FG001|Overall Study|Progressive disease|1|||
23514654|NCT03518073|65619770|FG002|Overall Study|Progressive disease|1|||
23514655|NCT03518073|65619768|FG000|Overall Study|Protocol Violation|1|||
23514656|NCT03518073|65619769|FG001|Overall Study|Protocol Violation|0|||
23514657|NCT03518073|65619770|FG002|Overall Study|Protocol Violation|0|||
23514658|NCT03518073|65619768|FG000|Overall Study|Withdrawal by Subject|30|||
23514659|NCT03518073|65619769|FG001|Overall Study|Withdrawal by Subject|34|||
23514660|NCT03518073|65619770|FG002|Overall Study|Withdrawal by Subject|29|||
23514661|NCT03518073|65619768|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
23514662|NCT03518073|65619769|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
23514663|NCT03518073|65619770|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
23514664|NCT03518073|65619768|FG000|Overall Study|Covid-19|1|||
23514665|NCT03518073|65619769|FG001|Overall Study|Covid-19|2|||
23514666|NCT03518073|65619770|FG002|Overall Study|Covid-19|1|||
23514667|NCT01519960|65619771|FG000|Overall Study|Withdrawal from the study|26|||
23514668|NCT01519960|65619772|FG001|Overall Study|Withdrawal from the study|22|||
23514669|NCT01519960|65619773|FG002|Overall Study|Withdrawal from the study|5|||
23514670|NCT02810392|65619774|FG000|Overall Study|Subject too ill to continue|1|||
23514671|NCT02810392|65619775|FG001|Overall Study|Subject too ill to continue|0|||
23514672|NCT02810392|65619774|FG000|Overall Study|COVID 19 research restrictions|0|||
23514673|NCT02810392|65619775|FG001|Overall Study|COVID 19 research restrictions|1|||
23514674|NCT02111850|65619778|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514675|NCT02111850|65619779|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23416008|NCT04537208|65266099|FG009|Overall Study|Adverse Event|0|||
23416009|NCT04537208|65266100|FG010|Overall Study|Adverse Event|0|||
23416010|NCT04537208|65266090|FG000|Overall Study|Protocol deviation|0|||
23416011|NCT04537208|65266091|FG001|Overall Study|Protocol deviation|0|||
23416012|NCT04537208|65266092|FG002|Overall Study|Protocol deviation|2|||
23416013|NCT04537208|65266093|FG003|Overall Study|Protocol deviation|0|||
23416014|NCT04537208|65266094|FG004|Overall Study|Protocol deviation|0|||
23416015|NCT04537208|65266095|FG005|Overall Study|Protocol deviation|2|||
23416016|NCT04537208|65266096|FG006|Overall Study|Protocol deviation|4|||
23416017|NCT04537208|65266097|FG007|Overall Study|Protocol deviation|0|||
23416018|NCT04537208|65266098|FG008|Overall Study|Protocol deviation|1|||
23416019|NCT04537208|65266099|FG009|Overall Study|Protocol deviation|0|||
23416020|NCT04537208|65266100|FG010|Overall Study|Protocol deviation|2|||
23416021|NCT04537208|65266090|FG000|Overall Study|Withdrawal by Subject|4|||
23416022|NCT04537208|65266091|FG001|Overall Study|Withdrawal by Subject|2|||
23416023|NCT04537208|65266092|FG002|Overall Study|Withdrawal by Subject|1|||
23416024|NCT04537208|65266093|FG003|Overall Study|Withdrawal by Subject|3|||
23416025|NCT04537208|65266094|FG004|Overall Study|Withdrawal by Subject|5|||
23416026|NCT04537208|65266095|FG005|Overall Study|Withdrawal by Subject|1|||
23416027|NCT04537208|65266096|FG006|Overall Study|Withdrawal by Subject|6|||
23416028|NCT04537208|65266097|FG007|Overall Study|Withdrawal by Subject|1|||
23416029|NCT04537208|65266098|FG008|Overall Study|Withdrawal by Subject|7|||
23416030|NCT04537208|65266099|FG009|Overall Study|Withdrawal by Subject|2|||
23416031|NCT04537208|65266100|FG010|Overall Study|Withdrawal by Subject|4|||
23416032|NCT04537208|65266090|FG000|Overall Study|Lost to Follow-up|4|||
23416033|NCT04537208|65266091|FG001|Overall Study|Lost to Follow-up|1|||
23416034|NCT04537208|65266092|FG002|Overall Study|Lost to Follow-up|3|||
23416035|NCT04537208|65266093|FG003|Overall Study|Lost to Follow-up|4|||
23416036|NCT04537208|65266094|FG004|Overall Study|Lost to Follow-up|3|||
23416037|NCT04537208|65266095|FG005|Overall Study|Lost to Follow-up|2|||
23416038|NCT04537208|65266096|FG006|Overall Study|Lost to Follow-up|3|||
23416039|NCT04537208|65266097|FG007|Overall Study|Lost to Follow-up|2|||
23416040|NCT04537208|65266098|FG008|Overall Study|Lost to Follow-up|7|||
23416041|NCT04537208|65266099|FG009|Overall Study|Lost to Follow-up|2|||
23416042|NCT04537208|65266100|FG010|Overall Study|Lost to Follow-up|2|||
23416043|NCT01355679|65266107|FG000|Overall Study|benign tumor types found at biopsy|2|||
23416044|NCT02379988|65266108|FG000|Overall Study|Not eligible|1|||
23416045|NCT00791479|65266124|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416046|NCT00791479|65266125|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416047|NCT00791479|65266126|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416048|NCT00791479|65266127|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416049|NCT00791479|65266128|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
23416050|NCT00791479|65266129|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
23416051|NCT00791479|65266124|FG000|Overall Study|Adverse Event|0|||
23416052|NCT00791479|65266125|FG001|Overall Study|Adverse Event|1|||
23416053|NCT00791479|65266126|FG002|Overall Study|Adverse Event|0|||
23416054|NCT00791479|65266127|FG003|Overall Study|Adverse Event|2|||
23416055|NCT00791479|65266128|FG004|Overall Study|Adverse Event|0|||
23416056|NCT00791479|65266129|FG005|Overall Study|Adverse Event|1|||
23416057|NCT00791479|65266124|FG000|Overall Study|Lost to Follow-up|0|||
23416058|NCT00791479|65266125|FG001|Overall Study|Lost to Follow-up|1|||
23416059|NCT00791479|65266126|FG002|Overall Study|Lost to Follow-up|0|||
23416060|NCT00791479|65266127|FG003|Overall Study|Lost to Follow-up|0|||
23416061|NCT00791479|65266128|FG004|Overall Study|Lost to Follow-up|0|||
23416062|NCT00791479|65266129|FG005|Overall Study|Lost to Follow-up|1|||
23416063|NCT00791479|65266124|FG000|Overall Study|Protocol Violation|2|||
23416064|NCT00791479|65266125|FG001|Overall Study|Protocol Violation|1|||
23416065|NCT00791479|65266126|FG002|Overall Study|Protocol Violation|0|||
23416066|NCT00791479|65266127|FG003|Overall Study|Protocol Violation|1|||
23416067|NCT00791479|65266128|FG004|Overall Study|Protocol Violation|0|||
23416068|NCT00791479|65266129|FG005|Overall Study|Protocol Violation|0|||
23416069|NCT00791479|65266124|FG000|Overall Study|Withdrawal by Subject|0|||
23416070|NCT00791479|65266125|FG001|Overall Study|Withdrawal by Subject|0|||
23416071|NCT00791479|65266126|FG002|Overall Study|Withdrawal by Subject|0|||
23416072|NCT00791479|65266127|FG003|Overall Study|Withdrawal by Subject|1|||
23416073|NCT00791479|65266128|FG004|Overall Study|Withdrawal by Subject|0|||
23416074|NCT00791479|65266129|FG005|Overall Study|Withdrawal by Subject|1|||
23416075|NCT02719691|65266130|FG000|Overall Study|Physician Decision|0|||
23416076|NCT02719691|65266131|FG001|Overall Study|Physician Decision|0|||
23416077|NCT02719691|65266132|FG002|Overall Study|Physician Decision|1|||
23416078|NCT02719691|65266133|FG003|Overall Study|Physician Decision|0|||
23416079|NCT02719691|65266134|FG004|Overall Study|Physician Decision|0|||
23416080|NCT02719691|65266135|FG005|Overall Study|Physician Decision|0|||
23514676|NCT02111850|65619780|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514677|NCT02111850|65619781|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514678|NCT02111850|65619782|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
23514679|NCT02111850|65619783|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514680|NCT02111850|65619784|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514681|NCT02111850|65619785|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514682|NCT02111850|65619786|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514683|NCT02111850|65619787|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514684|NCT02111850|65619788|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
23514685|NCT03566823|65619792|FG000|Overall Study|Lack of Efficacy|0|||
23514686|NCT03566823|65619793|FG001|Overall Study|Lack of Efficacy|1|||
23514687|NCT03566823|65619794|FG002|Overall Study|Lack of Efficacy|0|||
23514688|NCT03566823|65619792|FG000|Overall Study|Withdrawal by Subject|1|||
23514689|NCT03566823|65619793|FG001|Overall Study|Withdrawal by Subject|2|||
23514690|NCT03566823|65619794|FG002|Overall Study|Withdrawal by Subject|0|||
23514691|NCT03566823|65619792|FG000|Overall Study|Adverse Event|1|||
23514692|NCT03566823|65619793|FG001|Overall Study|Adverse Event|0|||
23514693|NCT03566823|65619794|FG002|Overall Study|Adverse Event|2|||
23514694|NCT02436356|65624015|FG000|Overall Study|Excluded by MRI Screening|0|||
23514695|NCT02436356|65624016|FG001|Overall Study|Excluded by MRI Screening|0|||
23514696|NCT02436356|65624017|FG002|Overall Study|Excluded by MRI Screening|2|||
23514697|NCT02436356|65624015|FG000|Overall Study|Lost to Follow-up|0|||
23514698|NCT02436356|65624016|FG001|Overall Study|Lost to Follow-up|1|||
23514699|NCT02436356|65624017|FG002|Overall Study|Lost to Follow-up|0|||
23514700|NCT02436356|65624015|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
23514701|NCT02436356|65624016|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
23514702|NCT02436356|65624017|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
23514703|NCT02436356|65624015|FG000|Overall Study|Excluded due to other medical conditions|3|||
23514704|NCT02436356|65624016|FG001|Overall Study|Excluded due to other medical conditions|0|||
23514705|NCT02436356|65624017|FG002|Overall Study|Excluded due to other medical conditions|0|||
23514706|NCT02436356|65624015|FG000|Overall Study|Withdrawal by Subject|1|||
23514707|NCT02436356|65624016|FG001|Overall Study|Withdrawal by Subject|0|||
23514708|NCT02436356|65624017|FG002|Overall Study|Withdrawal by Subject|0|||
23514709|NCT00225251|65624018|FG000|Overall Study|Withdrawal by Subject|1|||
23514710|NCT00225251|65624019|FG001|Overall Study|Withdrawal by Subject|1|||
23514711|NCT02377466|65624020|FG000|Overall Study|Other: Randomized and not treated|0|||
23514712|NCT02377466|65624021|FG001|Overall Study|Other: Randomized and not treated|2|||
23514713|NCT02672423|65624022|FG000|Period 1|Adverse Event|0|||
23514714|NCT02672423|65624023|FG001|Period 1|Adverse Event|0|||
23514715|NCT02672423|65624024|FG002|Period 1|Adverse Event|0|||
23514716|NCT02672423|65624025|FG003|Period 1|Adverse Event|0|||
23514717|NCT02672423|65624026|FG004|Period 1|Adverse Event|1|||
23514718|NCT02672423|65624027|FG005|Period 1|Adverse Event|0|||
23514719|NCT02672423|65624028|FG006|Period 1|Adverse Event|0|||
23514720|NCT02672423|65624029|FG007|Period 1|Adverse Event|0|||
23514721|NCT02672423|65624030|FG008|Period 1|Adverse Event|0|||
23514722|NCT02672423|65624031|FG009|Period 1|Adverse Event|0|||
23514723|NCT02672423|65624022|FG000|Period 2|Withdrawal by Subject|0|||
23514724|NCT02672423|65624023|FG001|Period 2|Withdrawal by Subject|0|||
23514725|NCT02672423|65624024|FG002|Period 2|Withdrawal by Subject|1|||
23514726|NCT02672423|65624025|FG003|Period 2|Withdrawal by Subject|0|||
23514727|NCT02672423|65624026|FG004|Period 2|Withdrawal by Subject|0|||
23514728|NCT02672423|65624027|FG005|Period 2|Withdrawal by Subject|0|||
23514729|NCT02672423|65624028|FG006|Period 2|Withdrawal by Subject|0|||
23514730|NCT02672423|65624029|FG007|Period 2|Withdrawal by Subject|0|||
23514731|NCT02672423|65624030|FG008|Period 2|Withdrawal by Subject|0|||
23514732|NCT02672423|65624031|FG009|Period 2|Withdrawal by Subject|0|||
23514733|NCT02672423|65624022|FG000|Period 3|Withdrawal by Subject|0|||
23514734|NCT02672423|65624023|FG001|Period 3|Withdrawal by Subject|0|||
23514735|NCT02672423|65624024|FG002|Period 3|Withdrawal by Subject|0|||
23514736|NCT02672423|65624025|FG003|Period 3|Withdrawal by Subject|0|||
23514737|NCT02672423|65624026|FG004|Period 3|Withdrawal by Subject|0|||
23514738|NCT02672423|65624027|FG005|Period 3|Withdrawal by Subject|0|||
23514739|NCT02672423|65624028|FG006|Period 3|Withdrawal by Subject|0|||
23514740|NCT02672423|65624029|FG007|Period 3|Withdrawal by Subject|1|||
23514741|NCT02672423|65624030|FG008|Period 3|Withdrawal by Subject|0|||
23514742|NCT02672423|65624031|FG009|Period 3|Withdrawal by Subject|0|||
23514743|NCT02672423|65624022|FG000|Period 3|Physician Decision|0|||
23514744|NCT02672423|65624023|FG001|Period 3|Physician Decision|0|||
23514745|NCT02672423|65624024|FG002|Period 3|Physician Decision|0|||
23514746|NCT02672423|65624025|FG003|Period 3|Physician Decision|0|||
23514747|NCT02672423|65624026|FG004|Period 3|Physician Decision|0|||
23514748|NCT02672423|65624027|FG005|Period 3|Physician Decision|1|||
23514749|NCT02672423|65624028|FG006|Period 3|Physician Decision|0|||
23514750|NCT02672423|65624029|FG007|Period 3|Physician Decision|0|||
23514751|NCT02672423|65624030|FG008|Period 3|Physician Decision|0|||
23514752|NCT02672423|65624031|FG009|Period 3|Physician Decision|0|||
23514753|NCT00255047|65624032|FG000|Overall Study|Serious Adverse Events|2|||
23514754|NCT00255047|65624033|FG001|Overall Study|Serious Adverse Events|1|||
23514755|NCT00255047|65624034|FG002|Overall Study|Serious Adverse Events|2|||
23514756|NCT00255047|65624035|FG003|Overall Study|Serious Adverse Events|1|||
23514757|NCT00255047|65624032|FG000|Overall Study|Adverse Event|0|||
23514758|NCT00255047|65624033|FG001|Overall Study|Adverse Event|3|||
23514759|NCT00255047|65624034|FG002|Overall Study|Adverse Event|2|||
23514760|NCT00255047|65624035|FG003|Overall Study|Adverse Event|1|||
23514761|NCT00255047|65624032|FG000|Overall Study|Protocol Violation|13|||
23514762|NCT00255047|65624033|FG001|Overall Study|Protocol Violation|13|||
23514763|NCT00255047|65624034|FG002|Overall Study|Protocol Violation|16|||
23514764|NCT00255047|65624035|FG003|Overall Study|Protocol Violation|20|||
23514765|NCT00255047|65624032|FG000|Overall Study|Lost to Follow-up|9|||
23514766|NCT00255047|65624033|FG001|Overall Study|Lost to Follow-up|8|||
23514767|NCT00255047|65624034|FG002|Overall Study|Lost to Follow-up|5|||
23514768|NCT00255047|65624035|FG003|Overall Study|Lost to Follow-up|6|||
23514769|NCT00255047|65624032|FG000|Overall Study|Withdrawal by Subject|24|||
23514770|NCT00255047|65624033|FG001|Overall Study|Withdrawal by Subject|23|||
23514771|NCT00255047|65624034|FG002|Overall Study|Withdrawal by Subject|25|||
23514772|NCT00255047|65624035|FG003|Overall Study|Withdrawal by Subject|18|||
23514773|NCT01572909|65624036|FG000|Overall Study|Adverse Event|7|||
23514774|NCT01572909|65624037|FG001|Overall Study|Adverse Event|2|||
23514775|NCT01572909|65624036|FG000|Overall Study|Death|3|||
23514776|NCT01572909|65624037|FG001|Overall Study|Death|1|||
23514777|NCT01572909|65624036|FG000|Overall Study|Lost to Follow-up|8|||
23514778|NCT01572909|65624037|FG001|Overall Study|Lost to Follow-up|7|||
23514779|NCT01572909|65624036|FG000|Overall Study|Physician Decision|1|||
23514780|NCT01572909|65624037|FG001|Overall Study|Physician Decision|1|||
23514781|NCT01572909|65624036|FG000|Overall Study|Technical Issues|1|||
23514782|NCT01572909|65624037|FG001|Overall Study|Technical Issues|0|||
23514783|NCT01572909|65624036|FG000|Overall Study|Withdrawal by Subject|12|||
23514784|NCT01572909|65624037|FG001|Overall Study|Withdrawal by Subject|11|||
23514785|NCT01572909|65624036|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
23514786|NCT01572909|65624037|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
23514787|NCT00503308|65624040|FG000|Overall Study|Protocol Violation|2|||
23514788|NCT00503308|65624041|FG001|Overall Study|Protocol Violation|1|||
23514789|NCT01846507|65624049|FG000|Overall Study|Lost to Follow-up|4|||
23514790|NCT01846507|65624049|FG000|Overall Study|Protocol Violation|1|||
23514791|NCT01846507|65624049|FG000|Overall Study|Missing data|2|||
23514792|NCT03654651|65624050|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23307555|NCT00773734|64870550|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
23514793|NCT03654651|65624051|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
23514794|NCT01705652|65624052|FG000|Overall Study|Adverse Event|1|||
23514795|NCT01705652|65624053|FG001|Overall Study|Adverse Event|0|||
23514796|NCT01705652|65624052|FG000|Overall Study|Withdrawal by Subject|1|||
23514797|NCT01705652|65624053|FG001|Overall Study|Withdrawal by Subject|2|||
23514798|NCT01705652|65624052|FG000|Overall Study|non-compliance|1|||
23514799|NCT01705652|65624053|FG001|Overall Study|non-compliance|1|||
23514800|NCT00588848|65624062|FG000|Overall Study|Physician Decision|0|||
23514801|NCT00588848|65624063|FG001|Overall Study|Physician Decision|3|||
23514802|NCT03036072|65624064|FG000|Overall Study|Death|0|||
23514803|NCT03036072|65624065|FG001|Overall Study|Death|1|||
23514804|NCT03036072|65624064|FG000|Overall Study|Withdrawal by Subject|0|||
23514805|NCT03036072|65624065|FG001|Overall Study|Withdrawal by Subject|1|||
23514806|NCT03036072|65624064|FG000|Overall Study|Physician Decision|0|||
23514807|NCT03036072|65624065|FG001|Overall Study|Physician Decision|1|||
23514808|NCT00975481|65624066|FG000|Second Intervention Period|Adverse Event|2|||
23514809|NCT00975481|65624067|FG001|Second Intervention Period|Adverse Event|1|||
23514810|NCT00975481|65624068|FG002|Second Intervention Period|Adverse Event|0|||
23514811|NCT00975481|65624069|FG003|Second Intervention Period|Adverse Event|0|||
23514812|NCT00975481|65624070|FG004|Second Intervention Period|Adverse Event|0|||
23514813|NCT00975481|65624071|FG005|Second Intervention Period|Adverse Event|0|||
23514814|NCT00975481|65624066|FG000|Second Intervention Period|Withdrawal by Subject|0|||
23514815|NCT00975481|65624067|FG001|Second Intervention Period|Withdrawal by Subject|0|||
23514816|NCT00975481|65624068|FG002|Second Intervention Period|Withdrawal by Subject|1|||
23514817|NCT00975481|65624069|FG003|Second Intervention Period|Withdrawal by Subject|0|||
23514818|NCT00975481|65624070|FG004|Second Intervention Period|Withdrawal by Subject|0|||
23514819|NCT00975481|65624071|FG005|Second Intervention Period|Withdrawal by Subject|0|||
23514820|NCT00975481|65624066|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
23514821|NCT00975481|65624067|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
23514822|NCT00975481|65624068|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
23514823|NCT00975481|65624069|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
23514824|NCT00975481|65624070|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
23514825|NCT00975481|65624071|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
23514826|NCT00975481|65624066|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
23514827|NCT00975481|65624067|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
23514828|NCT00975481|65624068|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
23514829|NCT00975481|65624069|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
23514830|NCT00975481|65624070|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
23514831|NCT00975481|65624071|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
23514832|NCT00927784|65624072|FG000|Overall Study|Death|1|||
23514833|NCT00927784|65624073|FG001|Overall Study|Death|0|||
23514834|NCT00927784|65624072|FG000|Overall Study|Withdrawal by Subject|1|||
23514835|NCT00927784|65624073|FG001|Overall Study|Withdrawal by Subject|0|||
23514836|NCT01484873|65624074|FG000|Overall Study|Withdrawal by Subject|2|||
23514837|NCT03251079|65624075|FG000|Overall Study|Withdrawal by Subject|1|||
23514838|NCT04461015|65624080|FG000|Overall Study|IV access lost during the study|0|||
23514839|NCT04461015|65624081|FG001|Overall Study|IV access lost during the study|1|||
23514840|NCT04461015|65624080|FG000|Overall Study|Withdrawal by Subject|0|||
23514841|NCT04461015|65624081|FG001|Overall Study|Withdrawal by Subject|1|||
23514842|NCT01594125|65624082|FG000|Overall Study|Withdrawal by Subject|1|||
23514843|NCT01594125|65624083|FG001|Overall Study|Withdrawal by Subject|0|||
23514844|NCT01594125|65624084|FG002|Overall Study|Withdrawal by Subject|0|||
23514845|NCT01594125|65624085|FG003|Overall Study|Withdrawal by Subject|1|||
23514846|NCT01594125|65624086|FG004|Overall Study|Withdrawal by Subject|0|||
23514847|NCT01594125|65624082|FG000|Overall Study|Progressive Disease|3|||
23307556|NCT00773734|64870551|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
23514848|NCT01594125|65624083|FG001|Overall Study|Progressive Disease|12|||
23514849|NCT01594125|65624084|FG002|Overall Study|Progressive Disease|3|||
23514850|NCT01594125|65624085|FG003|Overall Study|Progressive Disease|3|||
23514851|NCT01594125|65624086|FG004|Overall Study|Progressive Disease|7|||
23514852|NCT00323115|65624089|FG000|Vaccine Administration|Adverse Event|1|||
23611195|NCT01072149|65966713|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
23611196|NCT01072149|65966714|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
23611197|NCT01072149|65966715|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
23611198|NCT01072149|65966716|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
23611199|NCT01072149|65966717|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
23611200|NCT01072149|65966718|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
23611201|NCT01072149|65966719|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
23611202|NCT01072149|65966720|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
23611203|NCT01072149|65966721|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
23611204|NCT01072149|65966722|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
23611205|NCT01072149|65966723|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
23611206|NCT01072149|65966724|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
23611207|NCT01072149|65966725|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
23611208|NCT01072149|65966726|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
23611209|NCT01072149|65966727|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
23611210|NCT01072149|65966728|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
23611211|NCT01072149|65966729|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
23611212|NCT01072149|65966730|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
23611213|NCT01072149|65966713|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23514853|NCT00323115|65624089|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
23514854|NCT02904512|65624090|FG000|Overall Study|Withdrawal by Subject|1|||
23514855|NCT02904512|65624091|FG001|Overall Study|Withdrawal by Subject|0|||
23514856|NCT02904512|65624090|FG000|Overall Study|Transferred to ICU|1|||
23514857|NCT02904512|65624091|FG001|Overall Study|Transferred to ICU|0|||
23514858|NCT02904512|65624090|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
23514859|NCT02904512|65624091|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
23514860|NCT02484729|65624092|FG000|Overall Study|Failure of IntelliCap Error|0|||
23514861|NCT02484729|65624093|FG001|Overall Study|Failure of IntelliCap Error|0|||
23514862|NCT02484729|65624094|FG002|Overall Study|Failure of IntelliCap Error|0|||
23514863|NCT02484729|65624095|FG003|Overall Study|Failure of IntelliCap Error|0|||
23416081|NCT02719691|65266136|FG006|Overall Study|Physician Decision|0|||
23416082|NCT02719691|65266130|FG000|Overall Study|Withdrawal by Subject|0|||
23416083|NCT02719691|65266131|FG001|Overall Study|Withdrawal by Subject|0|||
23416084|NCT02719691|65266132|FG002|Overall Study|Withdrawal by Subject|0|||
23416085|NCT02719691|65266133|FG003|Overall Study|Withdrawal by Subject|0|||
23416086|NCT02719691|65266134|FG004|Overall Study|Withdrawal by Subject|0|||
23416087|NCT02719691|65266135|FG005|Overall Study|Withdrawal by Subject|1|||
23416088|NCT02719691|65266136|FG006|Overall Study|Withdrawal by Subject|0|||
23416089|NCT02003638|65266137|FG000|Overall Study|Withdrawal by Subject|1|||
23416090|NCT02003638|65266138|FG001|Overall Study|Withdrawal by Subject|0|||
23416091|NCT01132651|65266144|FG000|Overall Study|Lost to Follow-up|1|||
23416092|NCT01132651|65266145|FG001|Overall Study|Lost to Follow-up|1|||
23416093|NCT03655054|65266147|FG000|Overall Study|Lost to Follow-up|1|||
23416094|NCT01923363|65266148|FG000|Overall Study|Protocol Violation|1|||
23416095|NCT02218697|65266149|FG000|Overall Study|Adverse Event|0|||
23416096|NCT02218697|65266150|FG001|Overall Study|Adverse Event|2|||
23416097|NCT02218697|65266149|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
23416098|NCT02218697|65266150|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
23416099|NCT02218697|65266149|FG000|Overall Study|Withdrawal by Subject|2|||
23416100|NCT02218697|65266150|FG001|Overall Study|Withdrawal by Subject|3|||
23416101|NCT00316706|65266151|FG000|Overall Study|Lost to Follow-up|38|||
23416102|NCT00316706|65266152|FG001|Overall Study|Lost to Follow-up|48|||
23416103|NCT00413894|65266153|FG000|Overall Study|Withdrawal by Subject|10|||
23416104|NCT00413894|65266153|FG000|Overall Study|Administrative Reasons|1|||
23416105|NCT00413894|65266153|FG000|Overall Study|Hb <10 grams/deciliter|12|||
23416106|NCT00413894|65266153|FG000|Overall Study|Adverse Event|28|||
23514864|NCT02484729|65624096|FG004|Overall Study|Failure of IntelliCap Error|0|||
23514865|NCT02484729|65624097|FG005|Overall Study|Failure of IntelliCap Error|0|||
23514866|NCT02484729|65624098|FG006|Overall Study|Failure of IntelliCap Error|0|||
23514867|NCT02484729|65624099|FG007|Overall Study|Failure of IntelliCap Error|0|||
23514868|NCT02484729|65624100|FG008|Overall Study|Failure of IntelliCap Error|0|||
23514869|NCT02484729|65624101|FG009|Overall Study|Failure of IntelliCap Error|1|||
23514870|NCT01647282|65624102|FG000|Overall Study|Physician Decision|7|||
23514871|NCT01647282|65624103|FG001|Overall Study|Physician Decision|5|||
23514872|NCT00613938|65624104|FG000|Overall Study|Withdrawal by Subject|2|||
23514873|NCT00613938|65624105|FG001|Overall Study|Withdrawal by Subject|4|||
23514874|NCT00613938|65624106|FG002|Overall Study|Withdrawal by Subject|9|||
23514875|NCT00613938|65624107|FG003|Overall Study|Withdrawal by Subject|9|||
23514876|NCT00613938|65624104|FG000|Overall Study|Adverse Event|1|||
23514877|NCT00613938|65624105|FG001|Overall Study|Adverse Event|4|||
23514878|NCT00613938|65624106|FG002|Overall Study|Adverse Event|8|||
23514879|NCT00613938|65624107|FG003|Overall Study|Adverse Event|5|||
23514880|NCT00613938|65624104|FG000|Overall Study|Lack of Efficacy|16|||
23514881|NCT00613938|65624105|FG001|Overall Study|Lack of Efficacy|18|||
23514882|NCT00613938|65624106|FG002|Overall Study|Lack of Efficacy|5|||
23514883|NCT00613938|65624107|FG003|Overall Study|Lack of Efficacy|9|||
23514884|NCT00613938|65624104|FG000|Overall Study|Other|1|||
23514885|NCT00613938|65624105|FG001|Overall Study|Other|2|||
23514886|NCT00613938|65624106|FG002|Overall Study|Other|1|||
23514887|NCT00613938|65624107|FG003|Overall Study|Other|3|||
23514888|NCT01614067|65624108|FG000|Overall Study|Pregnancy|1|||
23514889|NCT01614067|65624109|FG001|Overall Study|Pregnancy|0|||
23514890|NCT01614067|65624108|FG000|Overall Study|Physician Decision|6|||
23514891|NCT01614067|65624109|FG001|Overall Study|Physician Decision|5|||
23514892|NCT01614067|65624108|FG000|Overall Study|Withdrawal by Subject|0|||
23514893|NCT01614067|65624109|FG001|Overall Study|Withdrawal by Subject|1|||
23514894|NCT01614067|65624108|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
23514895|NCT01614067|65624109|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
23514896|NCT01013701|65624110|FG000|Overall Study|study prematurely terminated|7|||
23514897|NCT03909295|65624111|FG000|Overall Study|Adverse Event|2|||
23514898|NCT03909295|65624111|FG000|Overall Study|Study terminated by sponsor|50|||
23514899|NCT01349803|65624114|FG000|Overall Study|Adverse Event|0|||
23514900|NCT01349803|65624115|FG001|Overall Study|Adverse Event|0|||
23514901|NCT01349803|65624116|FG002|Overall Study|Adverse Event|0|||
23514902|NCT01349803|65624117|FG003|Overall Study|Adverse Event|2|||
23514903|NCT01349803|65624114|FG000|Overall Study|Withdrawal by Subject|1|||
23514904|NCT01349803|65624115|FG001|Overall Study|Withdrawal by Subject|0|||
23514905|NCT01349803|65624116|FG002|Overall Study|Withdrawal by Subject|0|||
23514906|NCT01349803|65624117|FG003|Overall Study|Withdrawal by Subject|0|||
23514907|NCT01349803|65624114|FG000|Overall Study|Protocol-specified criteria|0|||
23514908|NCT01349803|65624115|FG001|Overall Study|Protocol-specified criteria|1|||
23514909|NCT01349803|65624116|FG002|Overall Study|Protocol-specified criteria|3|||
23514910|NCT01349803|65624117|FG003|Overall Study|Protocol-specified criteria|0|||
23514911|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
23514912|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
23514913|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
23514914|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
23514915|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
23514916|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
23514917|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
23514918|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
23514919|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
23514920|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
23514921|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
23514922|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
23514923|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
23514924|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
23514925|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
23514926|NCT00561080|65624118|FG000|Vaccination Period (up to Month 4)|Other|0|||
23514927|NCT00561080|65624119|FG001|Vaccination Period (up to Month 4)|Other|2|||
23514928|NCT00561080|65624120|FG002|Vaccination Period (up to Month 4)|Other|1|||
23514929|NCT00561080|65624118|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
23514930|NCT00561080|65624119|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
23514931|NCT00561080|65624120|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
23514932|NCT00561080|65624118|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
23514933|NCT00561080|65624119|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
23514934|NCT00561080|65624120|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
23514935|NCT00561080|65624118|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
23514936|NCT00561080|65624119|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
23514937|NCT00561080|65624120|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
23514938|NCT00561080|65624118|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
23514939|NCT00561080|65624119|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
23514940|NCT00561080|65624120|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
23514941|NCT02659631|65624121|FG000|Overall Study|Lost to Follow-up|0|||
23514942|NCT02659631|65624122|FG001|Overall Study|Lost to Follow-up|0|||
23514943|NCT02659631|65624123|FG002|Overall Study|Lost to Follow-up|2|||
23514944|NCT02659631|65624124|FG003|Overall Study|Lost to Follow-up|0|||
23514945|NCT02659631|65624125|FG004|Overall Study|Lost to Follow-up|0|||
23514946|NCT02659631|65624126|FG005|Overall Study|Lost to Follow-up|1|||
23514947|NCT02659631|65624127|FG006|Overall Study|Lost to Follow-up|0|||
23514948|NCT02659631|65624128|FG007|Overall Study|Lost to Follow-up|0|||
23514949|NCT02659631|65624129|FG008|Overall Study|Lost to Follow-up|0|||
23514950|NCT02659631|65624130|FG009|Overall Study|Lost to Follow-up|0|||
23514951|NCT02659631|65624121|FG000|Overall Study|Withdrawal prior to treatment|0|||
23514952|NCT02659631|65624122|FG001|Overall Study|Withdrawal prior to treatment|0|||
23514953|NCT02659631|65624123|FG002|Overall Study|Withdrawal prior to treatment|0|||
23514954|NCT02659631|65624124|FG003|Overall Study|Withdrawal prior to treatment|0|||
23514955|NCT02659631|65624125|FG004|Overall Study|Withdrawal prior to treatment|1|||
23514956|NCT02659631|65624126|FG005|Overall Study|Withdrawal prior to treatment|0|||
23514957|NCT02659631|65624127|FG006|Overall Study|Withdrawal prior to treatment|0|||
23514958|NCT02659631|65624128|FG007|Overall Study|Withdrawal prior to treatment|0|||
23514959|NCT02659631|65624129|FG008|Overall Study|Withdrawal prior to treatment|0|||
23514960|NCT02659631|65624130|FG009|Overall Study|Withdrawal prior to treatment|0|||
23514961|NCT02659631|65624121|FG000|Overall Study|Participant refused further follow-up|0|||
23514962|NCT02659631|65624122|FG001|Overall Study|Participant refused further follow-up|0|||
23514963|NCT02659631|65624123|FG002|Overall Study|Participant refused further follow-up|0|||
23514964|NCT02659631|65624124|FG003|Overall Study|Participant refused further follow-up|1|||
23514965|NCT02659631|65624125|FG004|Overall Study|Participant refused further follow-up|0|||
23514966|NCT02659631|65624126|FG005|Overall Study|Participant refused further follow-up|0|||
23514967|NCT02659631|65624127|FG006|Overall Study|Participant refused further follow-up|0|||
23514968|NCT02659631|65624128|FG007|Overall Study|Participant refused further follow-up|0|||
23514969|NCT02659631|65624129|FG008|Overall Study|Participant refused further follow-up|1|||
23514970|NCT02659631|65624130|FG009|Overall Study|Participant refused further follow-up|0|||
23514971|NCT02659631|65624121|FG000|Overall Study|Death (follow-up phase)|1|||
23514972|NCT02659631|65624122|FG001|Overall Study|Death (follow-up phase)|2|||
23514973|NCT02659631|65624123|FG002|Overall Study|Death (follow-up phase)|1|||
23514974|NCT02659631|65624124|FG003|Overall Study|Death (follow-up phase)|1|||
23514975|NCT02659631|65624125|FG004|Overall Study|Death (follow-up phase)|3|||
23514976|NCT02659631|65624126|FG005|Overall Study|Death (follow-up phase)|2|||
23514977|NCT02659631|65624127|FG006|Overall Study|Death (follow-up phase)|0|||
23514978|NCT02659631|65624128|FG007|Overall Study|Death (follow-up phase)|3|||
23514979|NCT02659631|65624129|FG008|Overall Study|Death (follow-up phase)|1|||
23514980|NCT02659631|65624130|FG009|Overall Study|Death (follow-up phase)|0|||
23514981|NCT02659631|65624121|FG000|Overall Study|Death (treatment phase)|0|||
23307557|NCT00773734|64870552|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
23514982|NCT02659631|65624122|FG001|Overall Study|Death (treatment phase)|0|||
23514983|NCT02659631|65624123|FG002|Overall Study|Death (treatment phase)|0|||
23514984|NCT02659631|65624124|FG003|Overall Study|Death (treatment phase)|0|||
23514985|NCT02659631|65624125|FG004|Overall Study|Death (treatment phase)|1|||
23514986|NCT02659631|65624126|FG005|Overall Study|Death (treatment phase)|0|||
23514987|NCT02659631|65624127|FG006|Overall Study|Death (treatment phase)|1|||
23514988|NCT02659631|65624128|FG007|Overall Study|Death (treatment phase)|0|||
23514989|NCT02659631|65624129|FG008|Overall Study|Death (treatment phase)|0|||
23514990|NCT02659631|65624130|FG009|Overall Study|Death (treatment phase)|0|||
23514991|NCT01034462|65624131|FG000|Overall Study|Adverse Event|7|||
23514992|NCT01034462|65624132|FG001|Overall Study|Adverse Event|17|||
23514993|NCT01034462|65624131|FG000|Overall Study|Lack of Efficacy|4|||
23514994|NCT01034462|65624132|FG001|Overall Study|Lack of Efficacy|4|||
23514995|NCT01034462|65624131|FG000|Overall Study|Protocol Violation|10|||
23514996|NCT01034462|65624132|FG001|Overall Study|Protocol Violation|7|||
23514997|NCT01034462|65624131|FG000|Overall Study|Withdrawal by Subject|9|||
23514998|NCT01034462|65624132|FG001|Overall Study|Withdrawal by Subject|8|||
23514999|NCT01034462|65624131|FG000|Overall Study|Lost to Follow-up|14|||
23515000|NCT01034462|65624132|FG001|Overall Study|Lost to Follow-up|16|||
23515001|NCT01034462|65624131|FG000|Overall Study|Other reasons|1|||
23515002|NCT01034462|65624132|FG001|Overall Study|Other reasons|2|||
23515003|NCT01585428|65624135|FG000|Overall Study|Death during treatment|1|||
23515004|NCT01585428|65624136|FG001|Overall Study|Death during treatment|0|||
23515005|NCT01287897|65624139|FG000|Overall Study|Adverse Event|5|||
23515006|NCT01287897|65624140|FG001|Overall Study|Adverse Event|3|||
23515007|NCT01287897|65624141|FG002|Overall Study|Adverse Event|6|||
23515008|NCT01287897|65624142|FG003|Overall Study|Adverse Event|4|||
23515009|NCT01287897|65624139|FG000|Overall Study|Lack of Efficacy|2|||
23515010|NCT01287897|65624140|FG001|Overall Study|Lack of Efficacy|0|||
23515011|NCT01287897|65624141|FG002|Overall Study|Lack of Efficacy|0|||
23515012|NCT01287897|65624142|FG003|Overall Study|Lack of Efficacy|0|||
23515013|NCT01287897|65624139|FG000|Overall Study|Protocol Violation|1|||
23515014|NCT01287897|65624140|FG001|Overall Study|Protocol Violation|1|||
23515015|NCT01287897|65624141|FG002|Overall Study|Protocol Violation|0|||
23515016|NCT01287897|65624142|FG003|Overall Study|Protocol Violation|1|||
23515017|NCT01287897|65624139|FG000|Overall Study|Lost to Follow-up|0|||
23515018|NCT01287897|65624140|FG001|Overall Study|Lost to Follow-up|0|||
23515019|NCT01287897|65624141|FG002|Overall Study|Lost to Follow-up|2|||
23515020|NCT01287897|65624142|FG003|Overall Study|Lost to Follow-up|0|||
23515021|NCT01287897|65624139|FG000|Overall Study|Withdrawal by Subject|1|||
23515022|NCT01287897|65624140|FG001|Overall Study|Withdrawal by Subject|5|||
23515023|NCT01287897|65624141|FG002|Overall Study|Withdrawal by Subject|3|||
23515024|NCT01287897|65624142|FG003|Overall Study|Withdrawal by Subject|2|||
23515025|NCT01287897|65624139|FG000|Overall Study|Not consented properly|0|||
23515026|NCT01287897|65624140|FG001|Overall Study|Not consented properly|1|||
23515027|NCT01287897|65624141|FG002|Overall Study|Not consented properly|0|||
23515028|NCT01287897|65624142|FG003|Overall Study|Not consented properly|0|||
23515029|NCT01287897|65624139|FG000|Overall Study|Not meeting entrance criteria|1|||
23515030|NCT01287897|65624140|FG001|Overall Study|Not meeting entrance criteria|1|||
23515031|NCT01287897|65624141|FG002|Overall Study|Not meeting entrance criteria|0|||
23515032|NCT01287897|65624142|FG003|Overall Study|Not meeting entrance criteria|0|||
23515033|NCT01287897|65624139|FG000|Overall Study|Other|1|||
23515034|NCT01287897|65624140|FG001|Overall Study|Other|0|||
23515035|NCT01287897|65624141|FG002|Overall Study|Other|1|||
23515036|NCT01287897|65624142|FG003|Overall Study|Other|0|||
23515037|NCT00773292|65624145|FG000|Treatment 48 Weeks|Adverse Event|1|||
23515038|NCT00773292|65624145|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
23515039|NCT03261947|65624146|FG000|Overall Study|Death|10|||
23515040|NCT03261947|65624147|FG001|Overall Study|Death|13|||
23515041|NCT03261947|65624148|FG002|Overall Study|Death|17|||
23515042|NCT03261947|65624149|FG003|Overall Study|Death|12|||
23515043|NCT03261947|65624150|FG004|Overall Study|Death|8|||
23515044|NCT03261947|65624146|FG000|Overall Study|Lost to Follow-up|0|||
23515045|NCT03261947|65624147|FG001|Overall Study|Lost to Follow-up|0|||
23515046|NCT03261947|65624148|FG002|Overall Study|Lost to Follow-up|2|||
23515047|NCT03261947|65624149|FG003|Overall Study|Lost to Follow-up|1|||
23515048|NCT03261947|65624150|FG004|Overall Study|Lost to Follow-up|0|||
23515049|NCT03261947|65624146|FG000|Overall Study|Withdrawal by Subject|0|||
23515050|NCT03261947|65624147|FG001|Overall Study|Withdrawal by Subject|0|||
23515051|NCT03261947|65624148|FG002|Overall Study|Withdrawal by Subject|3|||
23515052|NCT03261947|65624149|FG003|Overall Study|Withdrawal by Subject|0|||
23515053|NCT03261947|65624150|FG004|Overall Study|Withdrawal by Subject|1|||
23515054|NCT03261947|65624146|FG000|Overall Study|Site Terminated by Sponsor|0|||
23515055|NCT03261947|65624147|FG001|Overall Study|Site Terminated by Sponsor|0|||
23515056|NCT03261947|65624148|FG002|Overall Study|Site Terminated by Sponsor|4|||
23515057|NCT03261947|65624149|FG003|Overall Study|Site Terminated by Sponsor|7|||
23515058|NCT03261947|65624150|FG004|Overall Study|Site Terminated by Sponsor|5|||
23515059|NCT03261947|65624146|FG000|Overall Study|Reason not Specified|2|||
23515060|NCT03261947|65624147|FG001|Overall Study|Reason not Specified|0|||
23515061|NCT03261947|65624148|FG002|Overall Study|Reason not Specified|4|||
23515062|NCT03261947|65624149|FG003|Overall Study|Reason not Specified|1|||
23515063|NCT03261947|65624150|FG004|Overall Study|Reason not Specified|3|||
23515064|NCT00849381|65624151|FG000|Overall Study|Adverse Event|1|||
23515065|NCT00849381|65624151|FG000|Overall Study|Lost to Follow-up|129|||
23515066|NCT00849381|65624151|FG000|Overall Study|Protocol Violation|5|||
23515067|NCT00849381|65624151|FG000|Overall Study|Withdrawal by Subject|6|||
23515068|NCT00849381|65624151|FG000|Overall Study|Other|4|||
23515069|NCT02564042|65624153|FG000|Overall Study|Adverse Event|4|||
23515070|NCT02564042|65624154|FG001|Overall Study|Adverse Event|4|||
23515071|NCT02564042|65624155|FG002|Overall Study|Adverse Event|3|||
23515072|NCT02564042|65624156|FG003|Overall Study|Adverse Event|0|||
23515073|NCT02564042|65624157|FG004|Overall Study|Adverse Event|0|||
23515074|NCT02564042|65624158|FG005|Overall Study|Adverse Event|1|||
23515075|NCT02564042|65624153|FG000|Overall Study|Lost to Follow-up|1|||
23515076|NCT02564042|65624154|FG001|Overall Study|Lost to Follow-up|1|||
23515077|NCT02564042|65624155|FG002|Overall Study|Lost to Follow-up|1|||
23515078|NCT02564042|65624156|FG003|Overall Study|Lost to Follow-up|0|||
23515079|NCT02564042|65624157|FG004|Overall Study|Lost to Follow-up|1|||
23515080|NCT02564042|65624158|FG005|Overall Study|Lost to Follow-up|1|||
23515081|NCT02564042|65624153|FG000|Overall Study|Physician Decision|1|||
23515082|NCT02564042|65624154|FG001|Overall Study|Physician Decision|0|||
23515083|NCT02564042|65624155|FG002|Overall Study|Physician Decision|0|||
23515084|NCT02564042|65624156|FG003|Overall Study|Physician Decision|1|||
23515085|NCT02564042|65624157|FG004|Overall Study|Physician Decision|0|||
23515086|NCT02564042|65624158|FG005|Overall Study|Physician Decision|0|||
23515087|NCT02564042|65624153|FG000|Overall Study|Withdrawal by Subject|5|||
23515088|NCT02564042|65624154|FG001|Overall Study|Withdrawal by Subject|3|||
23515089|NCT02564042|65624155|FG002|Overall Study|Withdrawal by Subject|2|||
23515090|NCT02564042|65624156|FG003|Overall Study|Withdrawal by Subject|2|||
23515091|NCT02564042|65624157|FG004|Overall Study|Withdrawal by Subject|10|||
23515092|NCT02564042|65624158|FG005|Overall Study|Withdrawal by Subject|12|||
23515093|NCT00708643|65624161|FG000|Overall Study|Adverse Event|0|||
23515094|NCT00708643|65624162|FG001|Overall Study|Adverse Event|1|||
23515095|NCT01741701|65624163|FG000|Overall Study|Adverse Event|5|||
23515096|NCT01741701|65624164|FG001|Overall Study|Adverse Event|1|||
23515097|NCT01741701|65624163|FG000|Overall Study|Withdrawal by Subject|0|||
23515098|NCT01741701|65624164|FG001|Overall Study|Withdrawal by Subject|1|||
23515099|NCT01998633|65624167|FG000|Overall Study|Death|1|||
23515100|NCT00529542|65624168|FG000|Overall Study|Withdrawal by Subject|1|||
23515101|NCT00529542|65624169|FG001|Overall Study|Withdrawal by Subject|0|||
23515102|NCT00529542|65624168|FG000|Overall Study|Lost to Follow-up|0|||
23515103|NCT00529542|65624169|FG001|Overall Study|Lost to Follow-up|1|||
23515104|NCT00356369|65624170|FG000|Active Phase|Withdrawal by Subject|2|||
23515105|NCT00356369|65624171|FG001|Active Phase|Withdrawal by Subject|1|||
23515106|NCT03277105|65624172|FG000|Overall Study|Death|129|||
23515107|NCT03277105|65624173|FG001|Overall Study|Death|124|||
23515108|NCT03277105|65624172|FG000|Overall Study|Lost to Follow-up|2|||
23515109|NCT03277105|65624173|FG001|Overall Study|Lost to Follow-up|4|||
23515110|NCT03277105|65624172|FG000|Overall Study|Withdrawal by Subject|10|||
23515111|NCT03277105|65624173|FG001|Overall Study|Withdrawal by Subject|10|||
23515112|NCT03277105|65624172|FG000|Overall Study|Other|118|||
23515113|NCT03277105|65624173|FG001|Overall Study|Other|125|||
23515114|NCT01500629|65624174|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
23515115|NCT01500629|65624175|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
23515116|NCT03108027|65624176|FG000|Period 1|Subject/Guardian Decision|0|||
23515117|NCT03108027|65624177|FG001|Period 1|Subject/Guardian Decision|0|||
23515118|NCT03108027|65624178|FG002|Period 1|Subject/Guardian Decision|0|||
23515119|NCT03108027|65624179|FG003|Period 1|Subject/Guardian Decision|2|||
23515120|NCT03108027|65624180|FG004|Period 1|Subject/Guardian Decision|0|||
23515121|NCT03108027|65624181|FG005|Period 1|Subject/Guardian Decision|0|||
23515122|NCT03108027|65624176|FG000|Period 3|Adverse Event|0|||
23515123|NCT03108027|65624177|FG001|Period 3|Adverse Event|1|||
23515124|NCT03108027|65624178|FG002|Period 3|Adverse Event|0|||
23515125|NCT03108027|65624179|FG003|Period 3|Adverse Event|0|||
23515126|NCT03108027|65624180|FG004|Period 3|Adverse Event|0|||
23515127|NCT03108027|65624181|FG005|Period 3|Adverse Event|0|||
23515128|NCT00202644|65624182|FG000|Overall Study|Adverse Event|12|||
23515129|NCT00202644|65624183|FG001|Overall Study|Adverse Event|13|||
23515130|NCT00202644|65624182|FG000|Overall Study|Withdrawal by Subject|8|||
23515131|NCT00202644|65624183|FG001|Overall Study|Withdrawal by Subject|6|||
23515132|NCT00202644|65624182|FG000|Overall Study|Lack of Efficacy|6|||
23515133|NCT00202644|65624183|FG001|Overall Study|Lack of Efficacy|6|||
23515134|NCT00202644|65624182|FG000|Overall Study|Lost to Follow-up|0|||
23515135|NCT00202644|65624183|FG001|Overall Study|Lost to Follow-up|1|||
23515136|NCT00202644|65624182|FG000|Overall Study|Other|9|||
23515137|NCT00202644|65624183|FG001|Overall Study|Other|1|||
23515138|NCT01752907|65624192|FG000|Overall Study|Withdrawal by Subject|4|||
23515139|NCT01752907|65624193|FG001|Overall Study|Withdrawal by Subject|10|||
23515140|NCT01752907|65624192|FG000|Overall Study|Lost to Follow-up|2|||
23307558|NCT00773734|64870553|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
23515141|NCT01752907|65624193|FG001|Overall Study|Lost to Follow-up|1|||
23515142|NCT01752907|65624192|FG000|Overall Study|Decision by Sponsor|6|||
23515143|NCT01752907|65624193|FG001|Overall Study|Decision by Sponsor|9|||
23515144|NCT04741074|65624196|FG000|Overall Study|Withdrawal by Subject|1|||
23515145|NCT04741074|65624197|FG001|Overall Study|Withdrawal by Subject|1|||
23515146|NCT04741074|65624196|FG000|Overall Study|Study terminated prematurely|1|||
23515147|NCT04741074|65624197|FG001|Overall Study|Study terminated prematurely|0|||
23515148|NCT04446377|65624198|FG000|Overall Study|Withdrawal by Subject|6|||
23515149|NCT04446377|65624199|FG001|Overall Study|Withdrawal by Subject|1|||
23515150|NCT04446377|65624198|FG000|Overall Study|Physician Decision|1|||
23515151|NCT04446377|65624199|FG001|Overall Study|Physician Decision|1|||
23515152|NCT04446377|65624198|FG000|Overall Study|Lost to Follow-up|0|||
23515153|NCT04446377|65624199|FG001|Overall Study|Lost to Follow-up|2|||
23515154|NCT04446377|65624198|FG000|Overall Study|Not eligible|0|||
23515155|NCT04446377|65624199|FG001|Overall Study|Not eligible|1|||
23515156|NCT01686633|65624201|FG000|Overall Study|Lack of Efficacy|33|||
23515157|NCT01686633|65624202|FG001|Overall Study|Lack of Efficacy|13|||
23515158|NCT01686633|65624203|FG002|Overall Study|Lack of Efficacy|11|||
23515159|NCT01686633|65624201|FG000|Overall Study|Withdrawal by Subject|8|||
23515160|NCT01686633|65624202|FG001|Overall Study|Withdrawal by Subject|8|||
23515161|NCT01686633|65624203|FG002|Overall Study|Withdrawal by Subject|5|||
23515162|NCT01686633|65624201|FG000|Overall Study|Physician Decision|3|||
23515163|NCT01686633|65624202|FG001|Overall Study|Physician Decision|4|||
23515164|NCT01686633|65624203|FG002|Overall Study|Physician Decision|4|||
23515165|NCT01686633|65624201|FG000|Overall Study|Adverse Event|4|||
23515166|NCT01686633|65624202|FG001|Overall Study|Adverse Event|3|||
23515167|NCT01686633|65624203|FG002|Overall Study|Adverse Event|3|||
23515168|NCT01686633|65624201|FG000|Overall Study|Protocol Violation|2|||
23515169|NCT01686633|65624202|FG001|Overall Study|Protocol Violation|3|||
23515170|NCT01686633|65624203|FG002|Overall Study|Protocol Violation|0|||
23515171|NCT01686633|65624201|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
23515172|NCT01686633|65624202|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
23515173|NCT01686633|65624203|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
23515174|NCT01686633|65624201|FG000|Overall Study|Lost to Follow-up|0|||
23515175|NCT01686633|65624202|FG001|Overall Study|Lost to Follow-up|1|||
23515176|NCT01686633|65624203|FG002|Overall Study|Lost to Follow-up|1|||
23515177|NCT02877082|65624204|FG000|Overall Study|Trial was closed early|5|||
23515178|NCT01026792|65624205|FG000|Overall Study|Protocol Violation|1|||
23515179|NCT01529346|65624206|FG000|Overall Study|Lost to Follow-up|2|||
23515180|NCT01529346|65624207|FG001|Overall Study|Lost to Follow-up|0|||
23515181|NCT01529346|65624208|FG002|Overall Study|Lost to Follow-up|1|||
23515182|NCT01529346|65624209|FG003|Overall Study|Lost to Follow-up|0|||
23515183|NCT01529346|65624210|FG004|Overall Study|Lost to Follow-up|0|||
23515184|NCT01529346|65624206|FG000|Overall Study|Other|0|||
23515185|NCT01529346|65624207|FG001|Overall Study|Other|1|||
23515186|NCT01529346|65624208|FG002|Overall Study|Other|1|||
23515187|NCT01529346|65624209|FG003|Overall Study|Other|0|||
23515188|NCT01529346|65624210|FG004|Overall Study|Other|0|||
23515189|NCT00723892|65624211|FG000|Overall Study|Participant not tracked|33|||
23515190|NCT00723892|65624212|FG001|Overall Study|Participant not tracked|35|||
23515191|NCT00723892|65624211|FG000|Overall Study|Virological criterion|24|||
23515192|NCT00723892|65624212|FG001|Overall Study|Virological criterion|9|||
23515193|NCT00723892|65624211|FG000|Overall Study|Withdrawal by Subject|6|||
23515194|NCT00723892|65624212|FG001|Overall Study|Withdrawal by Subject|9|||
23515195|NCT00723892|65624211|FG000|Overall Study|End planned|11|||
23515196|NCT00723892|65624212|FG001|Overall Study|End planned|7|||
23515197|NCT00723892|65624211|FG000|Overall Study|Bad tolerance|5|||
23515198|NCT00723892|65624212|FG001|Overall Study|Bad tolerance|5|||
23515199|NCT00723892|65624211|FG000|Overall Study|Multiple reasons|17|||
23515200|NCT00723892|65624212|FG001|Overall Study|Multiple reasons|12|||
23515201|NCT00723892|65624211|FG000|Overall Study|Other|6|||
23515202|NCT00723892|65624212|FG001|Overall Study|Other|3|||
23515203|NCT00723892|65624211|FG000|Overall Study|Study end|1|||
23515204|NCT00723892|65624212|FG001|Overall Study|Study end|3|||
23515205|NCT00723892|65624211|FG000|Overall Study|Weight loss|1|||
23515206|NCT00723892|65624212|FG001|Overall Study|Weight loss|3|||
23515207|NCT00723892|65624211|FG000|Overall Study|Alcohol abuse|0|||
23515208|NCT00723892|65624212|FG001|Overall Study|Alcohol abuse|1|||
23515209|NCT00723892|65624211|FG000|Overall Study|Intercurrent infection|2|||
23515210|NCT00723892|65624212|FG001|Overall Study|Intercurrent infection|0|||
23515211|NCT00723892|65624211|FG000|Overall Study|Drug addiction|1|||
23515212|NCT00723892|65624212|FG001|Overall Study|Drug addiction|0|||
23515213|NCT01472081|65624214|FG000|Overall Study|Continuing treatment at time of analysis|1|||
23515214|NCT01472081|65624215|FG001|Overall Study|Continuing treatment at time of analysis|4|||
23515215|NCT01472081|65624216|FG002|Overall Study|Continuing treatment at time of analysis|1|||
23515216|NCT01472081|65624217|FG003|Overall Study|Continuing treatment at time of analysis|8|||
23515217|NCT01472081|65624218|FG004|Overall Study|Continuing treatment at time of analysis|9|||
23515218|NCT01472081|65624219|FG005|Overall Study|Continuing treatment at time of analysis|0|||
23515219|NCT01472081|65624214|FG000|Overall Study|Disease Progression|4|||
23515220|NCT01472081|65624215|FG001|Overall Study|Disease Progression|10|||
23515221|NCT01472081|65624216|FG002|Overall Study|Disease Progression|12|||
23515222|NCT01472081|65624217|FG003|Overall Study|Disease Progression|31|||
23515223|NCT01472081|65624218|FG004|Overall Study|Disease Progression|22|||
23515224|NCT01472081|65624219|FG005|Overall Study|Disease Progression|3|||
23515225|NCT01472081|65624214|FG000|Overall Study|Study drug toxicity|2|||
23515226|NCT01472081|65624215|FG001|Overall Study|Study drug toxicity|9|||
23515227|NCT01472081|65624216|FG002|Overall Study|Study drug toxicity|4|||
23515228|NCT01472081|65624217|FG003|Overall Study|Study drug toxicity|6|||
23515229|NCT01472081|65624218|FG004|Overall Study|Study drug toxicity|13|||
23515230|NCT01472081|65624219|FG005|Overall Study|Study drug toxicity|2|||
23515231|NCT01472081|65624214|FG000|Overall Study|Death|0|||
23515232|NCT01472081|65624215|FG001|Overall Study|Death|0|||
23515233|NCT01472081|65624216|FG002|Overall Study|Death|0|||
23515234|NCT01472081|65624217|FG003|Overall Study|Death|0|||
23515235|NCT01472081|65624218|FG004|Overall Study|Death|1|||
23515236|NCT01472081|65624219|FG005|Overall Study|Death|0|||
23515237|NCT01472081|65624214|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
23515238|NCT01472081|65624215|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
23515239|NCT01472081|65624216|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
23515240|NCT01472081|65624217|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
23515241|NCT01472081|65624218|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
23515242|NCT01472081|65624219|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
23515243|NCT01472081|65624214|FG000|Overall Study|Withdrawal by Subject|0|||
23515244|NCT01472081|65624215|FG001|Overall Study|Withdrawal by Subject|0|||
23515245|NCT01472081|65624216|FG002|Overall Study|Withdrawal by Subject|0|||
23515246|NCT01472081|65624217|FG003|Overall Study|Withdrawal by Subject|0|||
23515247|NCT01472081|65624218|FG004|Overall Study|Withdrawal by Subject|0|||
23515248|NCT01472081|65624219|FG005|Overall Study|Withdrawal by Subject|1|||
23515249|NCT01472081|65624214|FG000|Overall Study|Poor/non-compliance|0|||
23515250|NCT01472081|65624215|FG001|Overall Study|Poor/non-compliance|0|||
23515251|NCT01472081|65624216|FG002|Overall Study|Poor/non-compliance|1|||
23515252|NCT01472081|65624217|FG003|Overall Study|Poor/non-compliance|0|||
23515253|NCT01472081|65624218|FG004|Overall Study|Poor/non-compliance|1|||
23515254|NCT01472081|65624219|FG005|Overall Study|Poor/non-compliance|0|||
23515255|NCT01472081|65624214|FG000|Overall Study|No longer meets study criteria|0|||
23515256|NCT01472081|65624215|FG001|Overall Study|No longer meets study criteria|0|||
23515257|NCT01472081|65624216|FG002|Overall Study|No longer meets study criteria|1|||
23515258|NCT01472081|65624217|FG003|Overall Study|No longer meets study criteria|0|||
23515259|NCT01472081|65624218|FG004|Overall Study|No longer meets study criteria|0|||
23515260|NCT01472081|65624219|FG005|Overall Study|No longer meets study criteria|0|||
23515261|NCT01472081|65624214|FG000|Overall Study|Subject request to discontinue treatment|0|||
23515262|NCT01472081|65624215|FG001|Overall Study|Subject request to discontinue treatment|3|||
23515263|NCT01472081|65624216|FG002|Overall Study|Subject request to discontinue treatment|1|||
23515264|NCT01472081|65624217|FG003|Overall Study|Subject request to discontinue treatment|1|||
23515265|NCT01472081|65624218|FG004|Overall Study|Subject request to discontinue treatment|0|||
23515266|NCT01472081|65624219|FG005|Overall Study|Subject request to discontinue treatment|0|||
23515267|NCT03447990|65624228|FG000|Overall Study|Withdrawal by Subject|0|||
23515268|NCT03447990|65624229|FG001|Overall Study|Withdrawal by Subject|0|||
23515269|NCT03447990|65624230|FG002|Overall Study|Withdrawal by Subject|0|||
23515270|NCT03447990|65624231|FG003|Overall Study|Withdrawal by Subject|0|||
23515271|NCT03447990|65624232|FG004|Overall Study|Withdrawal by Subject|0|||
23515272|NCT03447990|65624233|FG005|Overall Study|Withdrawal by Subject|0|||
23515273|NCT03447990|65624234|FG006|Overall Study|Withdrawal by Subject|1|||
23515274|NCT00744627|65624235|FG000|Overall Study|Adverse Event|6|||
23515275|NCT00744627|65624236|FG001|Overall Study|Adverse Event|9|||
23515276|NCT00744627|65624235|FG000|Overall Study|Lack of Efficacy|7|||
23515277|NCT00744627|65624236|FG001|Overall Study|Lack of Efficacy|3|||
23515278|NCT00744627|65624235|FG000|Overall Study|Noncompliance|0|||
23515279|NCT00744627|65624236|FG001|Overall Study|Noncompliance|1|||
23515280|NCT00744627|65624235|FG000|Overall Study|Protocol Deviations|0|||
23515281|NCT00744627|65624236|FG001|Overall Study|Protocol Deviations|2|||
23515282|NCT00744627|65624235|FG000|Overall Study|Voluntary Withdrawal|9|||
23515283|NCT00744627|65624236|FG001|Overall Study|Voluntary Withdrawal|6|||
23515284|NCT00744627|65624235|FG000|Overall Study|Lost to Follow-up|2|||
23515285|NCT00744627|65624236|FG001|Overall Study|Lost to Follow-up|1|||
23515286|NCT00744627|65624235|FG000|Overall Study|Other|1|||
23515287|NCT00744627|65624236|FG001|Overall Study|Other|0|||
23515288|NCT04483011|65624239|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
23515289|NCT04483011|65624240|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
23515290|NCT01103284|65624244|FG000|Overall Study|Death|2|||
23515291|NCT01103284|65624245|FG001|Overall Study|Death|0|||
23515292|NCT01103284|65624244|FG000|Overall Study|Lost to Follow-up|9|||
23515293|NCT01103284|65624245|FG001|Overall Study|Lost to Follow-up|10|||
23515294|NCT01103284|65624244|FG000|Overall Study|Pregnancy|3|||
23515295|NCT01103284|65624245|FG001|Overall Study|Pregnancy|1|||
23515296|NCT01103284|65624244|FG000|Overall Study|Protocol Violation|12|||
23515297|NCT01103284|65624245|FG001|Overall Study|Protocol Violation|5|||
23515298|NCT01103284|65624244|FG000|Overall Study|Adverse Event|0|||
23515299|NCT01103284|65624245|FG001|Overall Study|Adverse Event|5|||
23515300|NCT01103284|65624244|FG000|Overall Study|Withdrawal by Subject|14|||
23515301|NCT01103284|65624245|FG001|Overall Study|Withdrawal by Subject|18|||
23515302|NCT01103284|65624244|FG000|Overall Study|Dermal Hypersensitivity|0|||
23515303|NCT01103284|65624245|FG001|Overall Study|Dermal Hypersensitivity|1|||
23515304|NCT01103284|65624244|FG000|Overall Study|Termination by the Sponsor|0|||
23515305|NCT01103284|65624245|FG001|Overall Study|Termination by the Sponsor|1|||
23515306|NCT01103284|65624244|FG000|Overall Study|Not described|2|||
23515307|NCT01103284|65624245|FG001|Overall Study|Not described|1|||
23515308|NCT01103284|65624244|FG000|Overall Study|Missing CRF entries for study completion|0|||
23515309|NCT01103284|65624245|FG001|Overall Study|Missing CRF entries for study completion|2|||
23515310|NCT02588833|65624246|FG000|Part 1|Withdrawal by Subject|1|||
23515311|NCT02588833|65624247|FG001|Part 1|Withdrawal by Subject|0|||
23515312|NCT02588833|65624246|FG000|Part 2A|Physician Decision|0|||
23515313|NCT02588833|65624247|FG001|Part 2A|Physician Decision|1|||
23515314|NCT02588833|65624246|FG000|Part 2A|Withdrawal by Subject|0|||
23515315|NCT02588833|65624247|FG001|Part 2A|Withdrawal by Subject|1|||
23515316|NCT02588833|65624246|FG000|Part 2B|Adverse Event|0|||
23515317|NCT02588833|65624247|FG001|Part 2B|Adverse Event|1|||
23515318|NCT02588833|65624246|FG000|Part 2C|Adverse Event|0|||
23515319|NCT02588833|65624247|FG001|Part 2C|Adverse Event|1|||
23515320|NCT02588833|65624246|FG000|Part 2C|Withdrawal by Subject|0|||
23515321|NCT02588833|65624247|FG001|Part 2C|Withdrawal by Subject|1|||
23515322|NCT02588833|65624246|FG000|Part 3 (Safety Follow-up)|Other|0|||
23515323|NCT02588833|65624247|FG001|Part 3 (Safety Follow-up)|Other|2|||
23515324|NCT03338855|65624248|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
23515325|NCT03338855|65624249|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
23611214|NCT01072149|65966714|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611215|NCT01072149|65966715|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611216|NCT01072149|65966716|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611217|NCT01072149|65966717|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611218|NCT01072149|65966718|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611219|NCT01072149|65966719|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611220|NCT01072149|65966720|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23515334|NCT02335489|65624285|FG000|Overall Study|Sponsor terminated study|4|||
23515335|NCT02335489|65624285|FG000|Overall Study|Lost to Follow-up|1|||
23515336|NCT02335489|65624285|FG000|Overall Study|Withdrawal by Subject|2|||
23515337|NCT02335489|65624285|FG000|Overall Study|Physician Decision|2|||
23515338|NCT02335489|65624285|FG000|Overall Study|Lack of Efficacy|1|||
23515339|NCT02611778|65624286|FG000|Overall Study|Withdrawal by Subject|2|||
23515340|NCT02611778|65624287|FG001|Overall Study|Withdrawal by Subject|8|||
23515341|NCT02611778|65624286|FG000|Overall Study|Adverse Event|1|||
23515342|NCT02611778|65624287|FG001|Overall Study|Adverse Event|2|||
23515343|NCT02611778|65624286|FG000|Overall Study|Death|2|||
23515344|NCT02611778|65624287|FG001|Overall Study|Death|1|||
23515345|NCT02611778|65624286|FG000|Overall Study|Protocol Violation|1|||
23515346|NCT02611778|65624287|FG001|Overall Study|Protocol Violation|0|||
23515347|NCT02611778|65624286|FG000|Overall Study|Lost to Follow-up|3|||
23515348|NCT02611778|65624287|FG001|Overall Study|Lost to Follow-up|1|||
23515349|NCT02611778|65624286|FG000|Overall Study|Need for alternative treatment|1|||
23515350|NCT02611778|65624287|FG001|Overall Study|Need for alternative treatment|0|||
23515351|NCT02611778|65624286|FG000|Overall Study|Other Reason|2|||
23515352|NCT02611778|65624287|FG001|Overall Study|Other Reason|1|||
23515353|NCT00549302|65624288|FG000|Double-Blind|Death|2|||
23515354|NCT00549302|65624289|FG001|Double-Blind|Death|9|||
23515355|NCT00549302|65624290|FG002|Double-Blind|Death|0|||
23515356|NCT00549302|65624288|FG000|Double-Blind|Adverse Event|3|||
23515357|NCT00549302|65624289|FG001|Double-Blind|Adverse Event|16|||
23515358|NCT00549302|65624290|FG002|Double-Blind|Adverse Event|0|||
23515359|NCT00549302|65624288|FG000|Double-Blind|Withdrawal by Subject|3|||
23515360|NCT00549302|65624289|FG001|Double-Blind|Withdrawal by Subject|8|||
23515361|NCT00549302|65624290|FG002|Double-Blind|Withdrawal by Subject|0|||
23515362|NCT00549302|65624288|FG000|Double-Blind|Investigator Decision|1|||
23515363|NCT00549302|65624289|FG001|Double-Blind|Investigator Decision|5|||
23515364|NCT00549302|65624290|FG002|Double-Blind|Investigator Decision|0|||
23515365|NCT00549302|65624288|FG000|Double-Blind|Sponsor Decision|0|||
23515366|NCT00549302|65624289|FG001|Double-Blind|Sponsor Decision|1|||
23515367|NCT00549302|65624290|FG002|Double-Blind|Sponsor Decision|0|||
23515368|NCT00549302|65624288|FG000|Double-Blind|Lost to Follow-up|1|||
23515369|NCT00549302|65624289|FG001|Double-Blind|Lost to Follow-up|2|||
23515370|NCT00549302|65624290|FG002|Double-Blind|Lost to Follow-up|0|||
23515371|NCT00549302|65624288|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
23515372|NCT00549302|65624289|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
23515373|NCT00549302|65624290|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
23515374|NCT00549302|65624288|FG000|Double-Blind|New condition or starts new therapy|0|||
23515375|NCT00549302|65624289|FG001|Double-Blind|New condition or starts new therapy|2|||
23515376|NCT00549302|65624290|FG002|Double-Blind|New condition or starts new therapy|0|||
23515377|NCT00549302|65624288|FG000|Open-Label|Adverse Event|0|||
23515378|NCT00549302|65624289|FG001|Open-Label|Adverse Event|0|||
23515379|NCT00549302|65624290|FG002|Open-Label|Adverse Event|11|||
23515380|NCT00549302|65624288|FG000|Open-Label|Death|0|||
23515381|NCT00549302|65624289|FG001|Open-Label|Death|0|||
23515382|NCT00549302|65624290|FG002|Open-Label|Death|40|||
23515383|NCT00549302|65624288|FG000|Open-Label|Investigator Decision|0|||
23515384|NCT00549302|65624289|FG001|Open-Label|Investigator Decision|0|||
23515385|NCT00549302|65624290|FG002|Open-Label|Investigator Decision|5|||
23515386|NCT00549302|65624288|FG000|Open-Label|Lost to Follow-up|0|||
23515387|NCT00549302|65624289|FG001|Open-Label|Lost to Follow-up|0|||
23515388|NCT00549302|65624290|FG002|Open-Label|Lost to Follow-up|2|||
23515389|NCT00549302|65624288|FG000|Open-Label|Other|0|||
23515390|NCT00549302|65624289|FG001|Open-Label|Other|0|||
23515391|NCT00549302|65624290|FG002|Open-Label|Other|3|||
23515392|NCT00549302|65624288|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
23515393|NCT00549302|65624289|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
23515394|NCT00549302|65624290|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
23515395|NCT00549302|65624288|FG000|Open-Label|Withdrawal by Subject|0|||
23515396|NCT00549302|65624289|FG001|Open-Label|Withdrawal by Subject|0|||
23515397|NCT00549302|65624290|FG002|Open-Label|Withdrawal by Subject|6|||
23515398|NCT00157950|65624293|FG000|Overall Study|Death|1|||
23515399|NCT00157950|65624294|FG001|Overall Study|Death|0|||
23515400|NCT02169739|65624302|FG000|Overall Study|Lost to Follow-up|0|||
23515401|NCT02169739|65624303|FG001|Overall Study|Lost to Follow-up|4|||
23515402|NCT00492115|65624304|FG000|Overall Study|Withdrawal by Subject|3|||
23515403|NCT00492115|65624305|FG001|Overall Study|Withdrawal by Subject|4|||
23515404|NCT00616655|65624306|FG000|Overall Study|Adverse Event|10|||
23515405|NCT00616655|65624307|FG001|Overall Study|Adverse Event|7|||
23515406|NCT00616655|65624308|FG002|Overall Study|Adverse Event|12|||
23515407|NCT00616655|65624306|FG000|Overall Study|Lack of Efficacy|5|||
23515408|NCT00616655|65624307|FG001|Overall Study|Lack of Efficacy|5|||
23515409|NCT00616655|65624308|FG002|Overall Study|Lack of Efficacy|5|||
23515410|NCT00616655|65624306|FG000|Overall Study|Lost to Follow-up|3|||
23515411|NCT00616655|65624307|FG001|Overall Study|Lost to Follow-up|12|||
23515412|NCT00616655|65624308|FG002|Overall Study|Lost to Follow-up|10|||
23515413|NCT00616655|65624306|FG000|Overall Study|Protocol Violation|2|||
23515414|NCT00616655|65624307|FG001|Overall Study|Protocol Violation|4|||
23515415|NCT00616655|65624308|FG002|Overall Study|Protocol Violation|3|||
23515416|NCT00616655|65624306|FG000|Overall Study|Withdrawal by Subject|9|||
23515417|NCT00616655|65624307|FG001|Overall Study|Withdrawal by Subject|7|||
23515418|NCT00616655|65624308|FG002|Overall Study|Withdrawal by Subject|11|||
23515419|NCT00616655|65624306|FG000|Overall Study|Does not meet in/ex criteria|0|||
23515420|NCT00616655|65624307|FG001|Overall Study|Does not meet in/ex criteria|0|||
23515421|NCT00616655|65624308|FG002|Overall Study|Does not meet in/ex criteria|2|||
23515422|NCT00616655|65624306|FG000|Overall Study|Other|6|||
23515423|NCT00616655|65624307|FG001|Overall Study|Other|6|||
23515424|NCT00616655|65624308|FG002|Overall Study|Other|5|||
23515425|NCT01462084|65624309|FG000|Overall Study|Withdrawal by Subject|1|||
23515426|NCT01462084|65624310|FG001|Overall Study|Withdrawal by Subject|0|||
23515427|NCT01462084|65624309|FG000|Overall Study|Protocol Violation|1|||
23515428|NCT01462084|65624310|FG001|Overall Study|Protocol Violation|1|||
23515429|NCT01881776|65624311|FG000|Overall Study|Lost to Follow-up|1|||
23515430|NCT01881776|65624312|FG001|Overall Study|Lost to Follow-up|2|||
23515431|NCT01881776|65624313|FG002|Overall Study|Lost to Follow-up|1|||
23515432|NCT01881776|65624311|FG000|Overall Study|Protocol Violation|0|||
23515433|NCT01881776|65624312|FG001|Overall Study|Protocol Violation|2|||
23515434|NCT01881776|65624313|FG002|Overall Study|Protocol Violation|1|||
23515435|NCT03070392|65624314|FG000|Overall Study|Not Treated|7|||
23515436|NCT03070392|65624315|FG001|Overall Study|Not Treated|0|||
23515437|NCT03070392|65624316|FG002|Overall Study|Not Treated|3|||
23515438|NCT03070392|65624317|FG003|Overall Study|Not Treated|12|||
23515439|NCT03070392|65624314|FG000|Overall Study|Death|3|||
23515440|NCT03070392|65624315|FG001|Overall Study|Death|0|||
23515441|NCT03070392|65624316|FG002|Overall Study|Death|0|||
23515442|NCT03070392|65624317|FG003|Overall Study|Death|1|||
23515443|NCT03070392|65624314|FG000|Overall Study|Withdrawal by Subject|7|||
23515444|NCT03070392|65624315|FG001|Overall Study|Withdrawal by Subject|0|||
23515445|NCT03070392|65624316|FG002|Overall Study|Withdrawal by Subject|0|||
23515446|NCT03070392|65624317|FG003|Overall Study|Withdrawal by Subject|3|||
23515447|NCT03070392|65624314|FG000|Overall Study|Physician Decision|1|||
23515448|NCT03070392|65624315|FG001|Overall Study|Physician Decision|0|||
23515449|NCT03070392|65624316|FG002|Overall Study|Physician Decision|0|||
23515450|NCT03070392|65624317|FG003|Overall Study|Physician Decision|2|||
23515451|NCT03070392|65624314|FG000|Overall Study|Progressive Disease|154|||
23515452|NCT03070392|65624315|FG001|Overall Study|Progressive Disease|6|||
23515453|NCT03070392|65624316|FG002|Overall Study|Progressive Disease|2|||
23515454|NCT03070392|65624317|FG003|Overall Study|Progressive Disease|70|||
23515455|NCT03070392|65624314|FG000|Overall Study|Adverse Event|6|||
23515456|NCT03070392|65624315|FG001|Overall Study|Adverse Event|1|||
23515457|NCT03070392|65624316|FG002|Overall Study|Adverse Event|1|||
23515458|NCT03070392|65624317|FG003|Overall Study|Adverse Event|3|||
23515459|NCT03070392|65624314|FG000|Overall Study|Alternate anticancer treatment|1|||
23515460|NCT03070392|65624315|FG001|Overall Study|Alternate anticancer treatment|0|||
23515461|NCT03070392|65624316|FG002|Overall Study|Alternate anticancer treatment|0|||
23515462|NCT03070392|65624317|FG003|Overall Study|Alternate anticancer treatment|1|||
23515463|NCT03070392|65624314|FG000|Overall Study|Ongoing|73|||
23515464|NCT03070392|65624315|FG001|Overall Study|Ongoing|0|||
23515465|NCT03070392|65624316|FG002|Overall Study|Ongoing|0|||
23515466|NCT03070392|65624317|FG003|Overall Study|Ongoing|11|||
23515467|NCT01165554|65624319|FG000|Overall Study|Withdrawal by Subject|23|||
23515468|NCT00380978|65624320|FG000|Overall Study|Refused allocated intervention|0|||
23515469|NCT00380978|65624321|FG001|Overall Study|Refused allocated intervention|6|||
23515470|NCT00380978|65624320|FG000|Overall Study|Wrong study envelope|0|||
23515471|NCT00380978|65624321|FG001|Overall Study|Wrong study envelope|2|||
23515472|NCT00380978|65624320|FG000|Overall Study|Allocation prior to analgesia request|1|||
23515473|NCT00380978|65624321|FG001|Overall Study|Allocation prior to analgesia request|2|||
23515474|NCT00380978|65624320|FG000|Overall Study|Parous patient|1|||
23515475|NCT00380978|65624321|FG001|Overall Study|Parous patient|0|||
23515476|NCT00383149|65624322|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
23515477|NCT00383149|65624322|FG000|Overall Study|Death|2|||
23515478|NCT00383149|65624322|FG000|Overall Study|Disease Progression|38|||
23515479|NCT00383149|65624322|FG000|Overall Study|Lost to Follow-up|1|||
23515480|NCT00383149|65624322|FG000|Overall Study|Other|1|||
23515481|NCT00383149|65624322|FG000|Overall Study|Study Drug Toxicity|4|||
23416107|NCT00413894|65266153|FG000|Overall Study|Protocol Violation|11|||
23515482|NCT00383149|65624322|FG000|Overall Study|Request to Discontinue Treatment|4|||
23515483|NCT00383149|65624322|FG000|Overall Study|Participant Withdrew Consent|1|||
23515484|NCT00082355|65624323|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
23515485|NCT00082355|65624323|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
23515486|NCT00082355|65624323|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
23515487|NCT02357901|65624324|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
23515488|NCT02357901|65624325|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
23515489|NCT02357901|65624326|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
23515490|NCT02357901|65624327|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
23515491|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
23515492|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
23515493|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
23515494|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
23515495|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
23515496|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
23515497|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
23515498|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
23515499|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
23515500|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
23515501|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
23515502|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
23515503|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
23515504|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
23515505|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
23515506|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
23515507|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
23515508|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
23515509|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
23515510|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
23515511|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
23515512|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
23515513|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
23515514|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
23515515|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
23515516|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
23515517|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
23515518|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
23515519|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
23515520|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
23515521|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
23515522|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
23515523|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
23515524|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
23515525|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
23515526|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
23515527|NCT02357901|65624324|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
23515528|NCT02357901|65624325|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
23515529|NCT02357901|65624326|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
23515530|NCT02357901|65624327|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
23515531|NCT03630120|65624328|FG000|Overall Study|Disease progression|0|||
23515532|NCT03630120|65624329|FG001|Overall Study|Disease progression|1|||
23515533|NCT03630120|65624330|FG002|Overall Study|Disease progression|1|||
23515534|NCT03630120|65624331|FG003|Overall Study|Disease progression|1|||
23515535|NCT04577118|65624332|FG000|Overall Study|Withdrawal by Subject|4|||
23515536|NCT02153112|65624338|FG000|Overall Study|Adverse Event|0|||
23515537|NCT02153112|65624339|FG001|Overall Study|Adverse Event|0|||
23515538|NCT02153112|65624340|FG002|Overall Study|Adverse Event|1|||
23515539|NCT02153112|65624341|FG003|Overall Study|Adverse Event|0|||
23515540|NCT02153112|65624342|FG004|Overall Study|Adverse Event|0|||
23515541|NCT02153112|65624343|FG005|Overall Study|Adverse Event|0|||
23515542|NCT02153112|65624344|FG006|Overall Study|Adverse Event|0|||
23515543|NCT02153112|65624345|FG007|Overall Study|Adverse Event|0|||
23515544|NCT02153112|65624346|FG008|Overall Study|Adverse Event|0|||
23515545|NCT02153112|65624347|FG009|Overall Study|Adverse Event|0|||
23515546|NCT02153112|65624338|FG000|Overall Study|Lost to Follow-up|1|||
23515547|NCT02153112|65624339|FG001|Overall Study|Lost to Follow-up|1|||
23515548|NCT02153112|65624340|FG002|Overall Study|Lost to Follow-up|0|||
23515549|NCT02153112|65624341|FG003|Overall Study|Lost to Follow-up|0|||
23515550|NCT02153112|65624342|FG004|Overall Study|Lost to Follow-up|2|||
23515551|NCT02153112|65624343|FG005|Overall Study|Lost to Follow-up|1|||
23515552|NCT02153112|65624344|FG006|Overall Study|Lost to Follow-up|1|||
23515553|NCT02153112|65624345|FG007|Overall Study|Lost to Follow-up|0|||
23515554|NCT02153112|65624346|FG008|Overall Study|Lost to Follow-up|1|||
23515555|NCT02153112|65624347|FG009|Overall Study|Lost to Follow-up|1|||
23515556|NCT02153112|65624338|FG000|Overall Study|Withdrawal by Subject|3|||
23515557|NCT02153112|65624339|FG001|Overall Study|Withdrawal by Subject|1|||
23515558|NCT02153112|65624340|FG002|Overall Study|Withdrawal by Subject|2|||
23515559|NCT02153112|65624341|FG003|Overall Study|Withdrawal by Subject|2|||
23515560|NCT02153112|65624342|FG004|Overall Study|Withdrawal by Subject|1|||
23515561|NCT02153112|65624343|FG005|Overall Study|Withdrawal by Subject|1|||
23515562|NCT02153112|65624344|FG006|Overall Study|Withdrawal by Subject|7|||
23515563|NCT02153112|65624345|FG007|Overall Study|Withdrawal by Subject|2|||
23515564|NCT02153112|65624346|FG008|Overall Study|Withdrawal by Subject|13|||
23515565|NCT02153112|65624347|FG009|Overall Study|Withdrawal by Subject|12|||
23515566|NCT02153112|65624338|FG000|Overall Study|Reason not Specified|0|||
23515567|NCT02153112|65624339|FG001|Overall Study|Reason not Specified|0|||
23515568|NCT02153112|65624340|FG002|Overall Study|Reason not Specified|0|||
23515569|NCT02153112|65624341|FG003|Overall Study|Reason not Specified|0|||
23515570|NCT02153112|65624342|FG004|Overall Study|Reason not Specified|0|||
23515571|NCT02153112|65624343|FG005|Overall Study|Reason not Specified|0|||
23515572|NCT02153112|65624344|FG006|Overall Study|Reason not Specified|0|||
23515573|NCT02153112|65624345|FG007|Overall Study|Reason not Specified|0|||
23515574|NCT02153112|65624346|FG008|Overall Study|Reason not Specified|1|||
23515575|NCT02153112|65624347|FG009|Overall Study|Reason not Specified|1|||
23515576|NCT02864251|65624356|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
23515577|NCT02864251|65624357|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
23515578|NCT02864251|65624358|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
23515579|NCT02864251|65624356|FG000|Pre-Treatment|Withdrawal by Participant|0|||
23515580|NCT02864251|65624357|FG001|Pre-Treatment|Withdrawal by Participant|0|||
23515581|NCT02864251|65624358|FG002|Pre-Treatment|Withdrawal by Participant|4|||
23515582|NCT02864251|65624356|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
23515583|NCT02864251|65624357|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
23515584|NCT02864251|65624358|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
23515585|NCT02864251|65624356|FG000|Pre-Treatment|Other Reasons|0|||
23515586|NCT02864251|65624357|FG001|Pre-Treatment|Other Reasons|1|||
23515587|NCT02864251|65624358|FG002|Pre-Treatment|Other Reasons|1|||
23515588|NCT02864251|65624356|FG000|Treatment|Disease Progression|109|||
23515589|NCT02864251|65624357|FG001|Treatment|Disease Progression|52|||
23515590|NCT02864251|65624358|FG002|Treatment|Disease Progression|101|||
23515591|NCT02864251|65624356|FG000|Treatment|Study Drug Toxicity|9|||
23515592|NCT02864251|65624357|FG001|Treatment|Study Drug Toxicity|4|||
23515593|NCT02864251|65624358|FG002|Treatment|Study Drug Toxicity|10|||
23515594|NCT02864251|65624356|FG000|Treatment|Death|0|||
23515595|NCT02864251|65624357|FG001|Treatment|Death|2|||
23515596|NCT02864251|65624358|FG002|Treatment|Death|3|||
23515597|NCT02864251|65624356|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
23515598|NCT02864251|65624357|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
23515599|NCT02864251|65624358|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
23515600|NCT02864251|65624356|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
23515601|NCT02864251|65624357|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
23515602|NCT02864251|65624358|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
23515603|NCT02864251|65624356|FG000|Treatment|Withdrawal by Participant|8|||
23515604|NCT02864251|65624357|FG001|Treatment|Withdrawal by Participant|5|||
23515605|NCT02864251|65624358|FG002|Treatment|Withdrawal by Participant|13|||
23515606|NCT02864251|65624356|FG000|Treatment|Maximum Clinical Benefit|1|||
23515607|NCT02864251|65624357|FG001|Treatment|Maximum Clinical Benefit|0|||
23515608|NCT02864251|65624358|FG002|Treatment|Maximum Clinical Benefit|1|||
23515609|NCT02864251|65624356|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
23515610|NCT02864251|65624357|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
23515611|NCT02864251|65624358|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
23515612|NCT02864251|65624356|FG000|Treatment|Other Reasons|1|||
23515613|NCT02864251|65624357|FG001|Treatment|Other Reasons|1|||
23515614|NCT02864251|65624358|FG002|Treatment|Other Reasons|4|||
23515615|NCT02864251|65624356|FG000|Treatment|Administrative Reason by Sponsor|1|||
23515616|NCT02864251|65624357|FG001|Treatment|Administrative Reason by Sponsor|0|||
23515617|NCT02864251|65624358|FG002|Treatment|Administrative Reason by Sponsor|0|||
23515618|NCT01189812|65624359|FG000|Overall Study|Withdrawal by Subject|2|||
23515619|NCT01189812|65624360|FG001|Overall Study|Withdrawal by Subject|3|||
23515620|NCT01189812|65624359|FG000|Overall Study|Adverse Event|1|||
23515621|NCT01189812|65624360|FG001|Overall Study|Adverse Event|0|||
23515622|NCT01189812|65624359|FG000|Overall Study|Out of Window|4|||
23515623|NCT01189812|65624360|FG001|Overall Study|Out of Window|3|||
23515624|NCT01189812|65624359|FG000|Overall Study|Moved out of State|1|||
23515625|NCT01189812|65624360|FG001|Overall Study|Moved out of State|2|||
23515626|NCT00455429|65624361|FG000|Overall Study|Study Terminated by Sponsor|0|||
23515627|NCT00455429|65624362|FG001|Overall Study|Study Terminated by Sponsor|0|||
23515628|NCT00455429|65624363|FG002|Overall Study|Study Terminated by Sponsor|0|||
23515629|NCT00455429|65624364|FG003|Overall Study|Study Terminated by Sponsor|3|||
23515630|NCT00455429|65624361|FG000|Overall Study|Lost to Follow-up|1|||
23515631|NCT00455429|65624362|FG001|Overall Study|Lost to Follow-up|0|||
23515632|NCT00455429|65624363|FG002|Overall Study|Lost to Follow-up|0|||
23515633|NCT00455429|65624364|FG003|Overall Study|Lost to Follow-up|3|||
23515634|NCT00455429|65624361|FG000|Overall Study|Withdrawal by Subject|0|||
23515635|NCT00455429|65624362|FG001|Overall Study|Withdrawal by Subject|1|||
23515636|NCT00455429|65624363|FG002|Overall Study|Withdrawal by Subject|1|||
23515637|NCT00455429|65624364|FG003|Overall Study|Withdrawal by Subject|0|||
23515638|NCT00455429|65624361|FG000|Overall Study|Lack of Efficacy|0|||
23515639|NCT00455429|65624362|FG001|Overall Study|Lack of Efficacy|1|||
23515640|NCT00455429|65624363|FG002|Overall Study|Lack of Efficacy|0|||
23515641|NCT00455429|65624364|FG003|Overall Study|Lack of Efficacy|1|||
23515642|NCT00455429|65624361|FG000|Overall Study|Adverse Event|0|||
23515643|NCT00455429|65624362|FG001|Overall Study|Adverse Event|1|||
23515644|NCT00455429|65624363|FG002|Overall Study|Adverse Event|0|||
23515645|NCT00455429|65624364|FG003|Overall Study|Adverse Event|3|||
23515646|NCT00455429|65624361|FG000|Overall Study|Randomly assigned but not treated|0|||
23515647|NCT00455429|65624362|FG001|Overall Study|Randomly assigned but not treated|0|||
23515648|NCT00455429|65624363|FG002|Overall Study|Randomly assigned but not treated|0|||
23515649|NCT00455429|65624364|FG003|Overall Study|Randomly assigned but not treated|2|||
23515650|NCT00455429|65624361|FG000|Overall Study|Personal Reason|1|||
23515651|NCT00455429|65624362|FG001|Overall Study|Personal Reason|0|||
23515652|NCT00455429|65624363|FG002|Overall Study|Personal Reason|0|||
23515653|NCT00455429|65624364|FG003|Overall Study|Personal Reason|0|||
23515654|NCT00455429|65624361|FG000|Overall Study|Non-compliance|0|||
23515655|NCT00455429|65624362|FG001|Overall Study|Non-compliance|0|||
23515656|NCT00455429|65624363|FG002|Overall Study|Non-compliance|0|||
23515657|NCT00455429|65624364|FG003|Overall Study|Non-compliance|1|||
23515658|NCT00455429|65624361|FG000|Overall Study|Other|0|||
23515659|NCT00455429|65624362|FG001|Overall Study|Other|2|||
23515660|NCT00455429|65624363|FG002|Overall Study|Other|0|||
23515661|NCT00455429|65624364|FG003|Overall Study|Other|1|||
23515662|NCT01358357|65627783|FG000|Open Label Phase|Adverse Event|0|||
23515663|NCT01358357|65627784|FG001|Open Label Phase|Adverse Event|0|||
23515664|NCT01358357|65627785|FG002|Open Label Phase|Adverse Event|59|||
23515665|NCT01358357|65627783|FG000|Open Label Phase|Lack of Efficacy|0|||
23515666|NCT01358357|65627784|FG001|Open Label Phase|Lack of Efficacy|0|||
23515667|NCT01358357|65627785|FG002|Open Label Phase|Lack of Efficacy|107|||
23515668|NCT01358357|65627783|FG000|Open Label Phase|Lost to Follow-up|0|||
23515669|NCT01358357|65627784|FG001|Open Label Phase|Lost to Follow-up|0|||
23515670|NCT01358357|65627785|FG002|Open Label Phase|Lost to Follow-up|76|||
23515671|NCT01358357|65627783|FG000|Open Label Phase|Protocol Violation|0|||
23515672|NCT01358357|65627784|FG001|Open Label Phase|Protocol Violation|0|||
23515673|NCT01358357|65627785|FG002|Open Label Phase|Protocol Violation|45|||
23515674|NCT01358357|65627783|FG000|Open Label Phase|Withdrawal by Subject|0|||
23515675|NCT01358357|65627784|FG001|Open Label Phase|Withdrawal by Subject|0|||
23515676|NCT01358357|65627785|FG002|Open Label Phase|Withdrawal by Subject|112|||
23515677|NCT01358357|65627783|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
23515678|NCT01358357|65627784|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
23307559|NCT00773734|64870548|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
23307560|NCT00773734|64870549|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
23515679|NCT01358357|65627785|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
23515680|NCT01358357|65627783|FG000|Open Label Phase|Terminated at study completion|0|||
23515681|NCT01358357|65627784|FG001|Open Label Phase|Terminated at study completion|0|||
23515682|NCT01358357|65627785|FG002|Open Label Phase|Terminated at study completion|5|||
23515683|NCT01358357|65627783|FG000|Open Label Phase|Mood episode|0|||
23515684|NCT01358357|65627784|FG001|Open Label Phase|Mood episode|0|||
23515685|NCT01358357|65627785|FG002|Open Label Phase|Mood episode|42|||
23515686|NCT01358357|65627783|FG000|Double-Blind Phase|Adverse Event|8|||
23515687|NCT01358357|65627784|FG001|Double-Blind Phase|Adverse Event|5|||
23515688|NCT01358357|65627785|FG002|Double-Blind Phase|Adverse Event|0|||
23515689|NCT01358357|65627783|FG000|Double-Blind Phase|Lost to Follow-up|5|||
23515690|NCT01358357|65627784|FG001|Double-Blind Phase|Lost to Follow-up|7|||
23515691|NCT01358357|65627785|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23515692|NCT01358357|65627783|FG000|Double-Blind Phase|Protocol Violation|1|||
23515693|NCT01358357|65627784|FG001|Double-Blind Phase|Protocol Violation|11|||
23515694|NCT01358357|65627785|FG002|Double-Blind Phase|Protocol Violation|0|||
23515695|NCT01358357|65627783|FG000|Double-Blind Phase|Protocol Violation|16|||
23515696|NCT01358357|65627784|FG001|Double-Blind Phase|Protocol Violation|12|||
23515697|NCT01358357|65627785|FG002|Double-Blind Phase|Protocol Violation|0|||
23515698|NCT01358357|65627783|FG000|Double-Blind Phase|Terminated at study completion|2|||
23515699|NCT01358357|65627784|FG001|Double-Blind Phase|Terminated at study completion|0|||
23515700|NCT01358357|65627785|FG002|Double-Blind Phase|Terminated at study completion|0|||
23515701|NCT01358357|65627783|FG000|Double-Blind Phase|Recurrence of mood event|48|||
23515702|NCT01358357|65627784|FG001|Double-Blind Phase|Recurrence of mood event|64|||
23515703|NCT01358357|65627785|FG002|Double-Blind Phase|Recurrence of mood event|0|||
23515704|NCT01358357|65627783|FG000|Double-Blind Phase|Administrative|0|||
23515705|NCT01358357|65627784|FG001|Double-Blind Phase|Administrative|1|||
23515706|NCT01358357|65627785|FG002|Double-Blind Phase|Administrative|0|||
23515707|NCT02320149|65627786|FG000|Overall Study|Adverse Event|3|||
23515708|NCT02320149|65627787|FG001|Overall Study|Adverse Event|7|||
23515709|NCT02320149|65627786|FG000|Overall Study|Withdrawal of Consent|28|||
23515710|NCT02320149|65627787|FG001|Overall Study|Withdrawal of Consent|32|||
23515711|NCT02320149|65627786|FG000|Overall Study|Lost to Follow-up|21|||
23515712|NCT02320149|65627787|FG001|Overall Study|Lost to Follow-up|34|||
23515713|NCT02320149|65627786|FG000|Overall Study|Protocol Violation|2|||
23515714|NCT02320149|65627787|FG001|Overall Study|Protocol Violation|1|||
23515715|NCT02320149|65627786|FG000|Overall Study|Noncompliance with Study Treatment|7|||
23515716|NCT02320149|65627787|FG001|Overall Study|Noncompliance with Study Treatment|2|||
23515717|NCT02320149|65627786|FG000|Overall Study|Lack of Efficacy|0|||
23515718|NCT02320149|65627787|FG001|Overall Study|Lack of Efficacy|1|||
23515719|NCT02320149|65627786|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23515720|NCT02320149|65627787|FG001|Overall Study|Other Miscellaneous Reasons|3|||
23515721|NCT01505868|65627788|FG000|Overall Study|Withdrawal by Subject|1|||
23515722|NCT01505868|65627789|FG001|Overall Study|Withdrawal by Subject|0|||
23515723|NCT01505868|65627790|FG002|Overall Study|Withdrawal by Subject|0|||
23515724|NCT01505868|65627791|FG003|Overall Study|Withdrawal by Subject|0|||
23515725|NCT01505868|65627792|FG004|Overall Study|Withdrawal by Subject|0|||
23515726|NCT02278263|65627793|FG000|Overall Study|Protocol Violation|7|||
23515727|NCT02278263|65627794|FG001|Overall Study|Protocol Violation|0|||
23515728|NCT02278263|65627795|FG002|Overall Study|Protocol Violation|9|||
23515729|NCT02882854|65627796|FG000|Overall Study|Lost to Follow-up|1|||
23515730|NCT02882854|65627797|FG001|Overall Study|Lost to Follow-up|2|||
23515731|NCT02882854|65627796|FG000|Overall Study|Physician Decision|0|||
23515732|NCT02882854|65627797|FG001|Overall Study|Physician Decision|1|||
23515733|NCT00732615|65627799|FG000|Overall Study|Withdrawal by Subject|3|||
23515734|NCT00732615|65627800|FG001|Overall Study|Withdrawal by Subject|1|||
23515735|NCT00732615|65627799|FG000|Overall Study|Lost to Follow-up|0|||
23515736|NCT00732615|65627800|FG001|Overall Study|Lost to Follow-up|1|||
23515737|NCT00732615|65627799|FG000|Overall Study|Adverse Event|0|||
23515738|NCT00732615|65627800|FG001|Overall Study|Adverse Event|2|||
23515739|NCT00732615|65627799|FG000|Overall Study|Physician Decision|3|||
23515740|NCT00732615|65627800|FG001|Overall Study|Physician Decision|0|||
23515741|NCT00732615|65627799|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
23515742|NCT00732615|65627800|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
23515743|NCT00010374|65627801|FG000|Overall Study|False positive phrenic nerve test|1|||
23515744|NCT00597766|65627803|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
23515745|NCT00597766|65627804|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
23515746|NCT00597766|65627805|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
23515747|NCT00597766|65627803|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
23515748|NCT00597766|65627804|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
23515749|NCT00597766|65627805|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
23515750|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Adverse Event|82|||
23515751|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Death|6|||
23515752|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
23515753|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
23515754|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
23515755|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
23515756|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
23515757|NCT00195676|65627806|FG000|Period O - Open-label Treatment|Other reasons|68|||
23515758|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
23515759|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
23515760|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
23515761|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
23515762|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
23515763|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
23515764|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
23515765|NCT00195676|65627806|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
23515766|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
23515767|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
23515768|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
23515769|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
23515770|NCT00195676|65627806|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
23515771|NCT02946047|65627807|FG000|Overall Study|Adverse Event|1|||
23515772|NCT02946047|65627808|FG001|Overall Study|Adverse Event|0|||
23515773|NCT02946047|65627809|FG002|Overall Study|Adverse Event|0|||
23515774|NCT02946047|65627810|FG003|Overall Study|Adverse Event|0|||
23515775|NCT03164928|65627812|FG000|Overall Study|Lost to Follow-up|1|||
23515776|NCT03164928|65627813|FG001|Overall Study|Lost to Follow-up|0|||
23515777|NCT00541034|65627814|FG000|Overall Study|Non-Compliance|3|||
23515778|NCT02802592|65627815|FG000|Overall Study|Study terminated due to loss of funding|4|||
23515779|NCT03020407|65627818|FG000|Overall Study|Withdrawal by Subject|2|||
23515780|NCT03020407|65627819|FG001|Overall Study|Withdrawal by Subject|1|||
23515781|NCT03020407|65627818|FG000|Overall Study|Lost to Follow-up|2|||
23515782|NCT03020407|65627819|FG001|Overall Study|Lost to Follow-up|3|||
23515783|NCT03020407|65627818|FG000|Overall Study|Protocol Violation|0|||
23515784|NCT03020407|65627819|FG001|Overall Study|Protocol Violation|1|||
23515785|NCT01853046|65627820|FG000|Overall Study|Withdrawal by Subject|1|||
23515786|NCT01853046|65627821|FG001|Overall Study|Withdrawal by Subject|1|||
23515787|NCT01853046|65627820|FG000|Overall Study|Adverse Event|4|||
23515788|NCT01853046|65627821|FG001|Overall Study|Adverse Event|2|||
23515789|NCT01853046|65627820|FG000|Overall Study|Disease progression|13|||
23515790|NCT01853046|65627821|FG001|Overall Study|Disease progression|3|||
23515791|NCT01946425|65627822|FG000|Overall Study|Protocol Violation|1|||
23515792|NCT01946425|65627823|FG001|Overall Study|Protocol Violation|0|||
23515793|NCT01946425|65627822|FG000|Overall Study|Withdrawal by Subject|1|||
23515794|NCT01946425|65627823|FG001|Overall Study|Withdrawal by Subject|0|||
23515795|NCT05517382|65627824|FG000|Overall Study|Lost to Follow-up|0|||
23515796|NCT05517382|65627825|FG001|Overall Study|Lost to Follow-up|1|||
23515797|NCT03686384|65627826|FG000|Overall Study|Lack of Efficacy|4|||
23515798|NCT03686384|65627827|FG001|Overall Study|Lack of Efficacy|13|||
23515799|NCT03686384|65627826|FG000|Overall Study|Lost to Follow-up|3|||
23515800|NCT03686384|65627827|FG001|Overall Study|Lost to Follow-up|0|||
23515801|NCT03686384|65627826|FG000|Overall Study|Physician Decision|0|||
23515802|NCT03686384|65627827|FG001|Overall Study|Physician Decision|1|||
23515803|NCT03686384|65627826|FG000|Overall Study|Took prohibited medication|0|||
23515804|NCT03686384|65627827|FG001|Overall Study|Took prohibited medication|1|||
23515805|NCT00462761|65627830|FG000|Overall Study|Adverse Event|6|||
23515806|NCT00462761|65627830|FG000|Overall Study|Withdrawal by Subject|9|||
23515807|NCT00462761|65627830|FG000|Overall Study|Physician Decision|5|||
23515808|NCT00462761|65627830|FG000|Overall Study|Disease progression|43|||
23515809|NCT00462761|65627830|FG000|Overall Study|Death|12|||
23515810|NCT00462761|65627830|FG000|Overall Study|Other|1|||
23515811|NCT00708162|65627831|FG000|Randomized Phase|Randomized but Not Treated|7|||
23515812|NCT00708162|65627832|FG001|Randomized Phase|Randomized but Not Treated|5|||
23515813|NCT00708162|65627831|FG000|Randomized Phase|Participant Noncompliance|40|||
23515814|NCT00708162|65627832|FG001|Randomized Phase|Participant Noncompliance|32|||
23515815|NCT00708162|65627831|FG000|Randomized Phase|Lost to Follow-up|34|||
23515816|NCT00708162|65627832|FG001|Randomized Phase|Lost to Follow-up|34|||
23515817|NCT00708162|65627831|FG000|Randomized Phase|Withdrew Consent|31|||
23515818|NCT00708162|65627832|FG001|Randomized Phase|Withdrew Consent|22|||
23515819|NCT00708162|65627831|FG000|Randomized Phase|Lack of Efficacy|14|||
23515820|NCT00708162|65627832|FG001|Randomized Phase|Lack of Efficacy|19|||
23515821|NCT00708162|65627831|FG000|Randomized Phase|Protocol Violation|10|||
23515822|NCT00708162|65627832|FG001|Randomized Phase|Protocol Violation|11|||
23515823|NCT00708162|65627831|FG000|Randomized Phase|Adverse Event|8|||
23515824|NCT00708162|65627832|FG001|Randomized Phase|Adverse Event|12|||
23416108|NCT00413894|65266153|FG000|Overall Study|Other|18|||
23416109|NCT00152477|65266154|FG000|Chemotherapy Period|Adverse Event|9|||
23416110|NCT00152477|65266155|FG001|Chemotherapy Period|Adverse Event|4|||
23416111|NCT00152477|65266156|FG002|Chemotherapy Period|Adverse Event|5|||
23416112|NCT00152477|65266154|FG000|Chemotherapy Period|Death|1|||
23416113|NCT00152477|65266155|FG001|Chemotherapy Period|Death|3|||
23416114|NCT00152477|65266156|FG002|Chemotherapy Period|Death|3|||
23515825|NCT00708162|65627831|FG000|Randomized Phase|Investigator's Discretion|7|||
23515826|NCT00708162|65627832|FG001|Randomized Phase|Investigator's Discretion|10|||
23515827|NCT00708162|65627831|FG000|Randomized Phase|Death|2|||
23515828|NCT00708162|65627832|FG001|Randomized Phase|Death|9|||
23515829|NCT00708162|65627831|FG000|Randomized Phase|Pregnancy|3|||
23515830|NCT00708162|65627832|FG001|Randomized Phase|Pregnancy|0|||
23515831|NCT00708162|65627831|FG000|Open-Label Phase|Lost to Follow-up|10|||
23515832|NCT00708162|65627832|FG001|Open-Label Phase|Lost to Follow-up|8|||
23515833|NCT00708162|65627831|FG000|Open-Label Phase|Withdrew Consent|12|||
23515834|NCT00708162|65627832|FG001|Open-Label Phase|Withdrew Consent|6|||
23515835|NCT00708162|65627831|FG000|Open-Label Phase|Participant Noncompliance|7|||
23515836|NCT00708162|65627832|FG001|Open-Label Phase|Participant Noncompliance|7|||
23515837|NCT00708162|65627831|FG000|Open-Label Phase|Lack of Efficacy|7|||
23515838|NCT00708162|65627832|FG001|Open-Label Phase|Lack of Efficacy|4|||
23515839|NCT00708162|65627831|FG000|Open-Label Phase|Investigator's Discretion|3|||
23515840|NCT00708162|65627832|FG001|Open-Label Phase|Investigator's Discretion|2|||
23515841|NCT00708162|65627831|FG000|Open-Label Phase|Death|3|||
23515842|NCT00708162|65627832|FG001|Open-Label Phase|Death|1|||
23515843|NCT00708162|65627831|FG000|Open-Label Phase|Adverse Event|1|||
23515844|NCT00708162|65627832|FG001|Open-Label Phase|Adverse Event|2|||
23515845|NCT00708162|65627831|FG000|Open-Label Phase|Other|1|||
23515846|NCT00708162|65627832|FG001|Open-Label Phase|Other|0|||
23515847|NCT00227903|65627833|FG000|Overall Study|Withdrawal by Subject|2|||
23515848|NCT00227903|65627834|FG001|Overall Study|Withdrawal by Subject|5|||
23515849|NCT00227903|65627833|FG000|Overall Study|Subject moved out of area|1|||
23515850|NCT00227903|65627834|FG001|Overall Study|Subject moved out of area|2|||
23515851|NCT00227903|65627833|FG000|Overall Study|Lost to Follow-up|1|||
23515852|NCT00227903|65627834|FG001|Overall Study|Lost to Follow-up|3|||
23515853|NCT00227903|65627833|FG000|Overall Study|Miscarriage|1|||
23515854|NCT00227903|65627834|FG001|Overall Study|Miscarriage|0|||
23515855|NCT02118012|65627838|FG000|Overall Study|Adverse Event|0|||
23515856|NCT02118012|65627839|FG001|Overall Study|Adverse Event|1|||
23515857|NCT02118012|65627838|FG000|Overall Study|Physician Decision|0|||
23515858|NCT02118012|65627839|FG001|Overall Study|Physician Decision|1|||
23515859|NCT00156533|65627843|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
23515860|NCT00156533|65627844|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
23515861|NCT00156533|65627845|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
23515862|NCT00156533|65627846|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
23515863|NCT00156533|65627843|FG000|Overall Study|Withdrawal by Subject|1|||
23515864|NCT00156533|65627844|FG001|Overall Study|Withdrawal by Subject|0|||
23515865|NCT00156533|65627845|FG002|Overall Study|Withdrawal by Subject|0|||
23515866|NCT00156533|65627846|FG003|Overall Study|Withdrawal by Subject|1|||
23515867|NCT00156533|65627843|FG000|Overall Study|Failed Screening|1|||
23515868|NCT00156533|65627844|FG001|Overall Study|Failed Screening|0|||
23515869|NCT00156533|65627845|FG002|Overall Study|Failed Screening|1|||
23515870|NCT00156533|65627846|FG003|Overall Study|Failed Screening|1|||
23515871|NCT01166178|65627850|FG000|Overall Study|Withdrawal by Subject|1|||
23515872|NCT01166178|65627851|FG001|Overall Study|Withdrawal by Subject|0|||
23515873|NCT01166178|65627850|FG000|Overall Study|Study was terminated|20|||
23515874|NCT01166178|65627851|FG001|Overall Study|Study was terminated|8|||
23515875|NCT04210310|65627855|FG000|Overall Study|Lost to Follow-up|32|||
23515876|NCT04210310|65627856|FG001|Overall Study|Lost to Follow-up|1|||
23515877|NCT01254227|65627862|FG000|Overall Study|Withdrawal by Subject|6|||
23515878|NCT01254227|65627862|FG000|Overall Study|Lost to Follow-up|6|||
23515879|NCT01254227|65627862|FG000|Overall Study|Adverse Event|5|||
23515880|NCT01254227|65627862|FG000|Overall Study|Abnormal test procedure result|5|||
23515881|NCT01254227|65627862|FG000|Overall Study|Administrative problems|2|||
23515882|NCT01254227|65627862|FG000|Overall Study|Death|1|||
23515883|NCT01254227|65627862|FG000|Overall Study|Protocol deviation|1|||
23515884|NCT00311623|65627865|FG000|Overall Study|Physician Decision|0|||
23515885|NCT00311623|65627866|FG001|Overall Study|Physician Decision|0|||
23515886|NCT00311623|65627867|FG002|Overall Study|Physician Decision|2|||
23515887|NCT00056407|65627868|FG000|Overall Study|Adverse Event|282|||
23515888|NCT00056407|65627869|FG001|Overall Study|Adverse Event|364|||
23515889|NCT00056407|65627868|FG000|Overall Study|Withdrawal by Subject|377|||
23515890|NCT00056407|65627869|FG001|Overall Study|Withdrawal by Subject|361|||
23515891|NCT00056407|65627868|FG000|Overall Study|Lost to Follow-up|123|||
23515892|NCT00056407|65627869|FG001|Overall Study|Lost to Follow-up|113|||
23515893|NCT00056407|65627868|FG000|Overall Study|Protocol Violation|104|||
23515894|NCT00056407|65627869|FG001|Overall Study|Protocol Violation|95|||
23515895|NCT00056407|65627868|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
23515896|NCT00056407|65627869|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
23515897|NCT00056407|65627868|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
23515898|NCT00056407|65627869|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
23515899|NCT00056407|65627868|FG000|Overall Study|Missing|25|||
23515900|NCT00056407|65627869|FG001|Overall Study|Missing|34|||
23515901|NCT01199289|65627870|FG000|Overall Study|Ineligibility determined|2|||
23515902|NCT01199289|65627871|FG001|Overall Study|Ineligibility determined|1|||
23515903|NCT01199289|65627872|FG002|Overall Study|Ineligibility determined|0|||
23515904|NCT01199289|65627873|FG003|Overall Study|Ineligibility determined|0|||
23515905|NCT01199289|65627870|FG000|Overall Study|Protocol Violation|1|||
23515906|NCT01199289|65627871|FG001|Overall Study|Protocol Violation|0|||
23515907|NCT01199289|65627872|FG002|Overall Study|Protocol Violation|0|||
23515908|NCT01199289|65627873|FG003|Overall Study|Protocol Violation|1|||
23515909|NCT01199289|65627870|FG000|Overall Study|Noncompliance|1|||
23515910|NCT01199289|65627871|FG001|Overall Study|Noncompliance|0|||
23515911|NCT01199289|65627872|FG002|Overall Study|Noncompliance|2|||
23515912|NCT01199289|65627873|FG003|Overall Study|Noncompliance|0|||
23515913|NCT01199289|65627870|FG000|Overall Study|Adverse Event|0|||
23515914|NCT01199289|65627871|FG001|Overall Study|Adverse Event|3|||
23515915|NCT01199289|65627872|FG002|Overall Study|Adverse Event|1|||
23515916|NCT01199289|65627873|FG003|Overall Study|Adverse Event|4|||
23515917|NCT01199289|65627870|FG000|Overall Study|Full consent withdrawn|2|||
23515918|NCT01199289|65627871|FG001|Overall Study|Full consent withdrawn|2|||
23515919|NCT01199289|65627872|FG002|Overall Study|Full consent withdrawn|2|||
23515920|NCT01199289|65627873|FG003|Overall Study|Full consent withdrawn|3|||
23515921|NCT01199289|65627870|FG000|Overall Study|Administrative decision|0|||
23515922|NCT01199289|65627871|FG001|Overall Study|Administrative decision|0|||
23515923|NCT01199289|65627872|FG002|Overall Study|Administrative decision|0|||
23515924|NCT01199289|65627873|FG003|Overall Study|Administrative decision|1|||
23515925|NCT01199289|65627870|FG000|Overall Study|Lost to Follow-up|0|||
23515926|NCT01199289|65627871|FG001|Overall Study|Lost to Follow-up|0|||
23515927|NCT01199289|65627872|FG002|Overall Study|Lost to Follow-up|0|||
23515928|NCT01199289|65627873|FG003|Overall Study|Lost to Follow-up|1|||
23515929|NCT01199289|65627870|FG000|Overall Study|Protocol-specified criteria|3|||
23515930|NCT01199289|65627871|FG001|Overall Study|Protocol-specified criteria|0|||
23515931|NCT01199289|65627872|FG002|Overall Study|Protocol-specified criteria|0|||
23515932|NCT01199289|65627873|FG003|Overall Study|Protocol-specified criteria|1|||
23515933|NCT01199289|65627870|FG000|Overall Study|Pregnancy|0|||
23515934|NCT01199289|65627871|FG001|Overall Study|Pregnancy|1|||
23515935|NCT01199289|65627872|FG002|Overall Study|Pregnancy|0|||
23515936|NCT01199289|65627873|FG003|Overall Study|Pregnancy|1|||
23515937|NCT01641692|65627874|FG000|Treatment Period 1|Adverse Event|1|||
23515938|NCT01641692|65627875|FG001|Treatment Period 1|Adverse Event|0|||
23515939|NCT01641692|65627876|FG002|Treatment Period 1|Adverse Event|0|||
23515940|NCT01641692|65627877|FG003|Treatment Period 1|Adverse Event|0|||
23515941|NCT01641692|65627878|FG004|Treatment Period 1|Adverse Event|0|||
23515942|NCT01641692|65627879|FG005|Treatment Period 1|Adverse Event|0|||
23515943|NCT01641692|65627880|FG006|Treatment Period 1|Adverse Event|0|||
23515944|NCT01641692|65627881|FG007|Treatment Period 1|Adverse Event|0|||
23515945|NCT01641692|65627874|FG000|Treatment Period 1|Lack of Efficacy|0|||
23515946|NCT01641692|65627875|FG001|Treatment Period 1|Lack of Efficacy|0|||
23515947|NCT01641692|65627876|FG002|Treatment Period 1|Lack of Efficacy|0|||
23515948|NCT01641692|65627877|FG003|Treatment Period 1|Lack of Efficacy|0|||
23515949|NCT01641692|65627878|FG004|Treatment Period 1|Lack of Efficacy|0|||
23515950|NCT01641692|65627879|FG005|Treatment Period 1|Lack of Efficacy|0|||
23515951|NCT01641692|65627880|FG006|Treatment Period 1|Lack of Efficacy|0|||
23515952|NCT01641692|65627881|FG007|Treatment Period 1|Lack of Efficacy|1|||
23515953|NCT01641692|65627874|FG000|Treatment Period 1|Protocol Violation|1|||
23515954|NCT01641692|65627875|FG001|Treatment Period 1|Protocol Violation|0|||
23515955|NCT01641692|65627876|FG002|Treatment Period 1|Protocol Violation|0|||
23515956|NCT01641692|65627877|FG003|Treatment Period 1|Protocol Violation|0|||
23515957|NCT01641692|65627878|FG004|Treatment Period 1|Protocol Violation|2|||
23515958|NCT01641692|65627879|FG005|Treatment Period 1|Protocol Violation|0|||
23515959|NCT01641692|65627880|FG006|Treatment Period 1|Protocol Violation|0|||
23515960|NCT01641692|65627881|FG007|Treatment Period 1|Protocol Violation|0|||
23515961|NCT01641692|65627874|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515962|NCT01641692|65627875|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515963|NCT01641692|65627876|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515964|NCT01641692|65627877|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515965|NCT01641692|65627878|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
23515966|NCT01641692|65627879|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515967|NCT01641692|65627880|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
23515968|NCT01641692|65627881|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
23515969|NCT01641692|65627874|FG000|Treatment Period 1|Lost to Follow-up|0|||
23515970|NCT01641692|65627875|FG001|Treatment Period 1|Lost to Follow-up|0|||
23515971|NCT01641692|65627876|FG002|Treatment Period 1|Lost to Follow-up|1|||
23515972|NCT01641692|65627877|FG003|Treatment Period 1|Lost to Follow-up|0|||
23515973|NCT01641692|65627878|FG004|Treatment Period 1|Lost to Follow-up|0|||
23515974|NCT01641692|65627879|FG005|Treatment Period 1|Lost to Follow-up|0|||
23515975|NCT01641692|65627880|FG006|Treatment Period 1|Lost to Follow-up|0|||
23515976|NCT01641692|65627881|FG007|Treatment Period 1|Lost to Follow-up|0|||
23515977|NCT01641692|65627874|FG000|Treatment Period 1|Physician Decision|0|||
23515978|NCT01641692|65627875|FG001|Treatment Period 1|Physician Decision|0|||
23515979|NCT01641692|65627876|FG002|Treatment Period 1|Physician Decision|0|||
23515980|NCT01641692|65627877|FG003|Treatment Period 1|Physician Decision|0|||
23515981|NCT01641692|65627878|FG004|Treatment Period 1|Physician Decision|1|||
23515982|NCT01641692|65627879|FG005|Treatment Period 1|Physician Decision|0|||
23515983|NCT01641692|65627880|FG006|Treatment Period 1|Physician Decision|0|||
23515984|NCT01641692|65627881|FG007|Treatment Period 1|Physician Decision|0|||
23515985|NCT01641692|65627874|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23515986|NCT01641692|65627875|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23515987|NCT01641692|65627876|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23515988|NCT01641692|65627877|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23515989|NCT01641692|65627878|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23515990|NCT01641692|65627879|FG005|Treatment Period 1|Withdrawal by Subject|2|||
23515991|NCT01641692|65627880|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23515992|NCT01641692|65627881|FG007|Treatment Period 1|Withdrawal by Subject|1|||
23515993|NCT01641692|65627874|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
23515994|NCT01641692|65627875|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515995|NCT01641692|65627876|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515996|NCT01641692|65627877|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515997|NCT01641692|65627878|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515998|NCT01641692|65627879|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23515999|NCT01641692|65627880|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23516000|NCT01641692|65627881|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
23516001|NCT01641692|65627874|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516002|NCT01641692|65627875|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516003|NCT01641692|65627876|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516004|NCT01641692|65627877|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516005|NCT01641692|65627878|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516006|NCT01641692|65627879|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516007|NCT01641692|65627880|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
23516008|NCT01641692|65627881|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23516009|NCT01641692|65627874|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
23516010|NCT01641692|65627875|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516011|NCT01641692|65627876|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
23516012|NCT01641692|65627877|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
23516013|NCT01641692|65627878|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
23516014|NCT01641692|65627879|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516015|NCT01641692|65627880|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516016|NCT01641692|65627881|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
23516017|NCT01641692|65627874|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23307561|NCT00773734|64870550|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
23516018|NCT01641692|65627875|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23516019|NCT01641692|65627876|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23516020|NCT01641692|65627877|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23516021|NCT01641692|65627878|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23516022|NCT01641692|65627879|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23516023|NCT01641692|65627880|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23516024|NCT01641692|65627881|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23516025|NCT01641692|65627874|FG000|Treatment Period 2|Lack of Efficacy|1|||
23516026|NCT01641692|65627875|FG001|Treatment Period 2|Lack of Efficacy|0|||
23516027|NCT01641692|65627876|FG002|Treatment Period 2|Lack of Efficacy|0|||
23516028|NCT01641692|65627877|FG003|Treatment Period 2|Lack of Efficacy|0|||
23516029|NCT01641692|65627878|FG004|Treatment Period 2|Lack of Efficacy|0|||
23516030|NCT01641692|65627879|FG005|Treatment Period 2|Lack of Efficacy|0|||
23516031|NCT01641692|65627880|FG006|Treatment Period 2|Lack of Efficacy|0|||
23516032|NCT01641692|65627881|FG007|Treatment Period 2|Lack of Efficacy|0|||
23516033|NCT01641692|65627874|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
23516034|NCT01641692|65627875|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516035|NCT01641692|65627876|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516036|NCT01641692|65627877|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516037|NCT01641692|65627878|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516038|NCT01641692|65627879|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516039|NCT01641692|65627880|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516040|NCT01641692|65627881|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23516041|NCT01641692|65627874|FG000|Treatment Period 2|Lost to Follow-up|0|||
23516042|NCT01641692|65627875|FG001|Treatment Period 2|Lost to Follow-up|0|||
23307562|NCT00773734|64870551|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
23307563|NCT00773734|64870552|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
23307564|NCT00773734|64870553|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
23307565|NCT00773734|64870548|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
23307566|NCT00773734|64870549|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
23516043|NCT01641692|65627876|FG002|Treatment Period 2|Lost to Follow-up|0|||
23516044|NCT01641692|65627877|FG003|Treatment Period 2|Lost to Follow-up|0|||
23516045|NCT01641692|65627878|FG004|Treatment Period 2|Lost to Follow-up|0|||
23516046|NCT01641692|65627879|FG005|Treatment Period 2|Lost to Follow-up|1|||
23516047|NCT01641692|65627880|FG006|Treatment Period 2|Lost to Follow-up|0|||
23516048|NCT01641692|65627881|FG007|Treatment Period 2|Lost to Follow-up|0|||
23516049|NCT01641692|65627874|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23516050|NCT01641692|65627875|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23516051|NCT01641692|65627876|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23516052|NCT01641692|65627877|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23516053|NCT01641692|65627878|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23516054|NCT01641692|65627879|FG005|Treatment Period 2|Withdrawal by Subject|1|||
23516055|NCT01641692|65627880|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23516056|NCT01641692|65627881|FG007|Treatment Period 2|Withdrawal by Subject|1|||
23516057|NCT01641692|65627874|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516058|NCT01641692|65627875|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516059|NCT01641692|65627876|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516060|NCT01641692|65627877|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23307567|NCT00773734|64870550|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
23516061|NCT01641692|65627878|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
23516062|NCT01641692|65627879|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516063|NCT01641692|65627880|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
23516064|NCT01641692|65627881|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
23516065|NCT01641692|65627874|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516066|NCT01641692|65627875|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516067|NCT01641692|65627876|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23516068|NCT01641692|65627877|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516069|NCT01641692|65627878|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516070|NCT01641692|65627879|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23516071|NCT01641692|65627880|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23516072|NCT01641692|65627881|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23516073|NCT01641692|65627874|FG000|Treatment Period 3|Adverse Event|0|||
23516074|NCT01641692|65627875|FG001|Treatment Period 3|Adverse Event|0|||
23516075|NCT01641692|65627876|FG002|Treatment Period 3|Adverse Event|0|||
23516076|NCT01641692|65627877|FG003|Treatment Period 3|Adverse Event|0|||
23516077|NCT01641692|65627878|FG004|Treatment Period 3|Adverse Event|0|||
23516078|NCT01641692|65627879|FG005|Treatment Period 3|Adverse Event|0|||
23516079|NCT01641692|65627880|FG006|Treatment Period 3|Adverse Event|1|||
23516080|NCT01641692|65627881|FG007|Treatment Period 3|Adverse Event|0|||
23516081|NCT01641692|65627874|FG000|Treatment Period 3|Protocol Violation|0|||
23516082|NCT01641692|65627875|FG001|Treatment Period 3|Protocol Violation|0|||
23516083|NCT01641692|65627876|FG002|Treatment Period 3|Protocol Violation|1|||
23516084|NCT01641692|65627877|FG003|Treatment Period 3|Protocol Violation|0|||
23516085|NCT01641692|65627878|FG004|Treatment Period 3|Protocol Violation|0|||
23516086|NCT01641692|65627879|FG005|Treatment Period 3|Protocol Violation|0|||
23516087|NCT01641692|65627880|FG006|Treatment Period 3|Protocol Violation|0|||
23516088|NCT01641692|65627881|FG007|Treatment Period 3|Protocol Violation|0|||
23516089|NCT01641692|65627874|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516090|NCT01641692|65627875|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516091|NCT01641692|65627876|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516092|NCT01641692|65627877|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516093|NCT01641692|65627878|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516094|NCT01641692|65627879|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516095|NCT01641692|65627880|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
23516096|NCT01641692|65627881|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23516097|NCT01641692|65627874|FG000|Treatment Period 3|Lost to Follow-up|0|||
23516098|NCT01641692|65627875|FG001|Treatment Period 3|Lost to Follow-up|1|||
23516099|NCT01641692|65627876|FG002|Treatment Period 3|Lost to Follow-up|0|||
23516100|NCT01641692|65627877|FG003|Treatment Period 3|Lost to Follow-up|0|||
23516101|NCT01641692|65627878|FG004|Treatment Period 3|Lost to Follow-up|0|||
23516102|NCT01641692|65627879|FG005|Treatment Period 3|Lost to Follow-up|0|||
23516103|NCT01641692|65627880|FG006|Treatment Period 3|Lost to Follow-up|0|||
23516104|NCT01641692|65627881|FG007|Treatment Period 3|Lost to Follow-up|0|||
23516105|NCT01641692|65627874|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516106|NCT01641692|65627875|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516107|NCT01641692|65627876|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516108|NCT01641692|65627877|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516109|NCT01641692|65627878|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516110|NCT01641692|65627879|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
23516111|NCT01641692|65627880|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516112|NCT01641692|65627881|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
23516113|NCT01641692|65627874|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516114|NCT01641692|65627875|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
23516115|NCT01641692|65627876|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516116|NCT01641692|65627877|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516117|NCT01641692|65627878|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
23516118|NCT01641692|65627879|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516119|NCT01641692|65627880|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
23516120|NCT01641692|65627881|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
23516121|NCT02905331|65627882|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
23516122|NCT02905331|65627883|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
23516123|NCT02905331|65627884|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
23516124|NCT02905331|65627882|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
23516125|NCT02905331|65627883|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
23516126|NCT02905331|65627884|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
23307568|NCT00773734|64870551|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
23516127|NCT02905331|65627882|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
23516128|NCT02905331|65627883|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
23516129|NCT02905331|65627884|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
23516130|NCT02905331|65627882|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
23516131|NCT02905331|65627883|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
23516132|NCT02905331|65627884|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
23307569|NCT00773734|64870552|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
23307570|NCT00773734|64870553|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
23307571|NCT00773734|64870548|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
23307572|NCT00773734|64870549|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
23307573|NCT00773734|64870550|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
23307574|NCT00773734|64870551|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
23307575|NCT00773734|64870552|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
23307576|NCT00773734|64870553|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
23307577|NCT00773734|64870548|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
23307578|NCT00773734|64870549|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
23307579|NCT00773734|64870550|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
23307580|NCT00773734|64870551|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
23307581|NCT00773734|64870552|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
23307582|NCT00773734|64870553|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
23307583|NCT00773734|64870548|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
23307584|NCT00773734|64870549|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
23516133|NCT02905331|65627882|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
23516134|NCT02905331|65627883|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
23516135|NCT02905331|65627884|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
23516136|NCT01359449|65627885|FG000|Overall Study|Lost to Follow-up|1|||
23516137|NCT01359449|65627886|FG001|Overall Study|Lost to Follow-up|0|||
23516138|NCT01359449|65627885|FG000|Overall Study|Protocol Violation|0|||
23516139|NCT01359449|65627886|FG001|Overall Study|Protocol Violation|2|||
23516140|NCT01359449|65627885|FG000|Overall Study|Withdrawal by Subject|3|||
23516141|NCT01359449|65627886|FG001|Overall Study|Withdrawal by Subject|2|||
23516142|NCT03010254|65627887|FG000|Overall Study|Adverse Event|0|||
23516143|NCT03010254|65627888|FG001|Overall Study|Adverse Event|1|||
23516144|NCT03010254|65627887|FG000|Overall Study|Lost to Follow-up|4|||
23516145|NCT03010254|65627888|FG001|Overall Study|Lost to Follow-up|0|||
23516146|NCT03010254|65627887|FG000|Overall Study|Withdrawal by Subject|1|||
23516147|NCT03010254|65627888|FG001|Overall Study|Withdrawal by Subject|1|||
23516148|NCT03010254|65627887|FG000|Overall Study|Other|2|||
23516149|NCT03010254|65627888|FG001|Overall Study|Other|3|||
23516150|NCT02154581|65627902|FG000|Overall Study|Lost to Follow-up|7|||
23516151|NCT02154581|65627903|FG001|Overall Study|Lost to Follow-up|8|||
23516152|NCT01991067|65627911|FG000|Overall Study|Lost to Follow-up|6|||
23516153|NCT01991067|65627912|FG001|Overall Study|Lost to Follow-up|5|||
23516154|NCT02189473|65627916|FG000|Overall Study|Death|22|||
23516155|NCT02189473|65627917|FG001|Overall Study|Death|23|||
23516156|NCT02189473|65627916|FG000|Overall Study|Lost to Follow-up|1|||
23516157|NCT02189473|65627917|FG001|Overall Study|Lost to Follow-up|2|||
23516158|NCT02197806|65627925|FG000|Overall Study|Adverse Event|0|||
23516159|NCT02197806|65627926|FG001|Overall Study|Adverse Event|1|||
23516160|NCT02197806|65627927|FG002|Overall Study|Adverse Event|0|||
23516161|NCT02197806|65627928|FG003|Overall Study|Adverse Event|1|||
23516162|NCT00100815|65627929|FG000|Overall Study|Progression|24|||
23516163|NCT00100815|65627929|FG000|Overall Study|Adverse Event|18|||
23516164|NCT00100815|65627929|FG000|Overall Study|Death|4|||
23516165|NCT00100815|65627929|FG000|Overall Study|Other|3|||
23516166|NCT03519347|65627932|FG000|Interventional Crossover Period 1|Death|0|||
23516167|NCT03519347|65627933|FG001|Interventional Crossover Period 1|Death|0|||
23516168|NCT03519347|65627934|FG002|Interventional Crossover Period 1|Death|0|||
23516169|NCT03519347|65627935|FG003|Interventional Crossover Period 1|Death|1|||
23516170|NCT03312933|65627936|FG000|Overall Study|Protocol Violation|15|||
23516171|NCT03312933|65627936|FG000|Overall Study|Lost to Follow-up|36|||
23516172|NCT03312933|65627936|FG000|Overall Study|Withdrawal by Subject|3|||
23516173|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
23516174|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
23516175|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
23516176|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
23516177|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
23516178|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
23516179|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
23516180|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
23516181|NCT01541969|65627937|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
23516182|NCT01541969|65627938|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
23516183|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
23516184|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
23516185|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
23516186|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
23516187|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
23516188|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
23516189|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
23516190|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
23516191|NCT01541969|65627937|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
23516192|NCT01541969|65627938|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
23516193|NCT02063854|65627939|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
23516194|NCT02063854|65627940|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
23516195|NCT02063854|65627941|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
23516196|NCT02063854|65627942|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
23516197|NCT02063854|65627943|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
23516198|NCT02063854|65627944|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
23516199|NCT02063854|65627945|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
23516200|NCT02063854|65627939|FG000|Overall Study|Major Protocol Deviation|0|||
23516201|NCT02063854|65627940|FG001|Overall Study|Major Protocol Deviation|0|||
23516202|NCT02063854|65627941|FG002|Overall Study|Major Protocol Deviation|3|||
23516203|NCT02063854|65627942|FG003|Overall Study|Major Protocol Deviation|0|||
23516204|NCT02063854|65627943|FG004|Overall Study|Major Protocol Deviation|0|||
23516205|NCT02063854|65627944|FG005|Overall Study|Major Protocol Deviation|0|||
23516206|NCT02063854|65627945|FG006|Overall Study|Major Protocol Deviation|0|||
23516207|NCT02063854|65627939|FG000|Overall Study|Voluntary Withdrawal|2|||
23516208|NCT02063854|65627940|FG001|Overall Study|Voluntary Withdrawal|0|||
23516209|NCT02063854|65627941|FG002|Overall Study|Voluntary Withdrawal|8|||
23516210|NCT02063854|65627942|FG003|Overall Study|Voluntary Withdrawal|1|||
23516211|NCT02063854|65627943|FG004|Overall Study|Voluntary Withdrawal|3|||
23516212|NCT02063854|65627944|FG005|Overall Study|Voluntary Withdrawal|6|||
23516213|NCT02063854|65627945|FG006|Overall Study|Voluntary Withdrawal|1|||
23516214|NCT02063854|65627939|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
23516215|NCT02063854|65627940|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
23516216|NCT02063854|65627941|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
23516217|NCT02063854|65627942|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
23516218|NCT02063854|65627943|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
23516219|NCT02063854|65627944|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
23516220|NCT02063854|65627945|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
23516221|NCT02063854|65627939|FG000|Overall Study|Reason Not Specified|1|||
23516222|NCT02063854|65627940|FG001|Overall Study|Reason Not Specified|0|||
23516223|NCT02063854|65627941|FG002|Overall Study|Reason Not Specified|0|||
23516224|NCT02063854|65627942|FG003|Overall Study|Reason Not Specified|0|||
23516225|NCT02063854|65627943|FG004|Overall Study|Reason Not Specified|0|||
23516226|NCT02063854|65627944|FG005|Overall Study|Reason Not Specified|0|||
23516227|NCT02063854|65627945|FG006|Overall Study|Reason Not Specified|0|||
23516228|NCT02063854|65627939|FG000|Overall Study|Did Not Receive Study Drug|0|||
23516229|NCT02063854|65627940|FG001|Overall Study|Did Not Receive Study Drug|0|||
23516230|NCT02063854|65627941|FG002|Overall Study|Did Not Receive Study Drug|0|||
23516231|NCT02063854|65627942|FG003|Overall Study|Did Not Receive Study Drug|0|||
23516232|NCT02063854|65627943|FG004|Overall Study|Did Not Receive Study Drug|0|||
23516233|NCT02063854|65627944|FG005|Overall Study|Did Not Receive Study Drug|1|||
23516234|NCT02063854|65627945|FG006|Overall Study|Did Not Receive Study Drug|0|||
23516235|NCT03178773|65627946|FG000|Overall Study|Death|0|||
23516236|NCT03178773|65627947|FG001|Overall Study|Death|1|||
23516237|NCT03178773|65627946|FG000|Overall Study|Lost to Follow-up|29|||
23516238|NCT03178773|65627947|FG001|Overall Study|Lost to Follow-up|25|||
23516239|NCT03178773|65627946|FG000|Overall Study|Withdrawal by Subject|10|||
23516240|NCT03178773|65627947|FG001|Overall Study|Withdrawal by Subject|14|||
23516241|NCT00378209|65627948|FG000|Overall Study|Progressive disease|11|||
23516242|NCT00378209|65627948|FG000|Overall Study|Adverse Event|3|||
23516243|NCT00378209|65627948|FG000|Overall Study|Initiation of non-protocol therapy|3|||
23516244|NCT00378209|65627948|FG000|Overall Study|Physician Decision|3|||
23516245|NCT00378209|65627948|FG000|Overall Study|Death|1|||
23516246|NCT00378209|65627948|FG000|Overall Study|Treatment delay|1|||
23516247|NCT02335099|65627949|FG000|Treatment|Withdrawal by Subject|1|||
23516248|NCT02335099|65627950|FG001|Treatment|Withdrawal by Subject|3|||
23516249|NCT02335099|65627949|FG000|Treatment|Lost to Follow-up|2|||
23516250|NCT02335099|65627950|FG001|Treatment|Lost to Follow-up|0|||
23516251|NCT02335099|65627949|FG000|Treatment|Death|1|||
23516252|NCT02335099|65627950|FG001|Treatment|Death|0|||
23516253|NCT02335099|65627949|FG000|Treatment|Adverse Event|1|||
23516254|NCT02335099|65627950|FG001|Treatment|Adverse Event|2|||
23516255|NCT02335099|65627949|FG000|Follow-up|Death|0|||
23516256|NCT02335099|65627950|FG001|Follow-up|Death|1|||
23516257|NCT01404325|65627956|FG000|Overall Study|Lost to Follow-up|1|||
23516258|NCT01404325|65627957|FG001|Overall Study|Lost to Follow-up|0|||
23516259|NCT01404325|65627956|FG000|Overall Study|Death|2|||
23516260|NCT01404325|65627957|FG001|Overall Study|Death|0|||
23516261|NCT01404325|65627956|FG000|Overall Study|Graft loss/Retransplantation|1|||
23516262|NCT01404325|65627957|FG001|Overall Study|Graft loss/Retransplantation|0|||
23516263|NCT01404325|65627956|FG000|Overall Study|non-specified reason|0|||
23516264|NCT01404325|65627957|FG001|Overall Study|non-specified reason|2|||
23516265|NCT01994629|65627958|FG000|Overall Study|Withdrawal by Subject|1|||
23516266|NCT01994629|65627959|FG001|Overall Study|Withdrawal by Subject|0|||
23516267|NCT01994629|65627958|FG000|Overall Study|Lost to Follow-up|0|||
23516268|NCT01994629|65627959|FG001|Overall Study|Lost to Follow-up|3|||
23516269|NCT03204305|65627960|FG000|Overall Study|Lost to Follow-up|6|||
23516270|NCT03204305|65627961|FG001|Overall Study|Lost to Follow-up|4|||
23516271|NCT03204305|65627962|FG002|Overall Study|Lost to Follow-up|0|||
23516272|NCT03204305|65627963|FG003|Overall Study|Lost to Follow-up|0|||
23516273|NCT03204305|65627960|FG000|Overall Study|Physician Decision|1|||
23516274|NCT03204305|65627961|FG001|Overall Study|Physician Decision|0|||
23516275|NCT03204305|65627962|FG002|Overall Study|Physician Decision|0|||
23516276|NCT03204305|65627963|FG003|Overall Study|Physician Decision|0|||
23516277|NCT03204305|65627960|FG000|Overall Study|failure to place arterial line|2|||
23516278|NCT03204305|65627961|FG001|Overall Study|failure to place arterial line|1|||
23516279|NCT03204305|65627962|FG002|Overall Study|failure to place arterial line|0|||
23516280|NCT03204305|65627963|FG003|Overall Study|failure to place arterial line|0|||
23516281|NCT03204305|65627960|FG000|Overall Study|Withdrawal by Subject|2|||
23516282|NCT03204305|65627961|FG001|Overall Study|Withdrawal by Subject|0|||
23516283|NCT03204305|65627962|FG002|Overall Study|Withdrawal by Subject|0|||
23516284|NCT03204305|65627963|FG003|Overall Study|Withdrawal by Subject|0|||
23516285|NCT01558752|65627965|FG000|Overall Study|Physician Decision|2|||
23516286|NCT01558752|65627966|FG001|Overall Study|Physician Decision|0|||
23516287|NCT01980875|65627967|FG000|Overall Study|Withdrew Consent|1|||
23516288|NCT01980875|65627968|FG001|Overall Study|Withdrew Consent|1|||
23516289|NCT01980875|65627969|FG002|Overall Study|Withdrew Consent|1|||
23516290|NCT01980875|65627967|FG000|Overall Study|Study Terminated by Sponsor|7|||
23516291|NCT01980875|65627968|FG001|Overall Study|Study Terminated by Sponsor|24|||
23516292|NCT01980875|65627969|FG002|Overall Study|Study Terminated by Sponsor|22|||
23516293|NCT01980875|65627967|FG000|Overall Study|Lost to Follow-up|0|||
23516294|NCT01980875|65627968|FG001|Overall Study|Lost to Follow-up|0|||
23516295|NCT01980875|65627969|FG002|Overall Study|Lost to Follow-up|1|||
23516296|NCT03325075|65627970|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
23516297|NCT03325075|65627971|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
23516298|NCT03325075|65627972|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
23516299|NCT03325075|65627973|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
23516300|NCT03325075|65627970|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
23516301|NCT03325075|65627971|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
23516302|NCT03325075|65627972|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
23516303|NCT03325075|65627973|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
23516304|NCT03325075|65627970|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
23516305|NCT03325075|65627971|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
23516306|NCT03325075|65627972|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
23307585|NCT00773734|64870550|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
23307586|NCT00773734|64870551|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
23307587|NCT00773734|64870552|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
23307588|NCT00773734|64870553|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
23307589|NCT00773734|64870548|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
23307590|NCT00773734|64870549|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
23307591|NCT00773734|64870550|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
23516307|NCT03325075|65627973|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
23516308|NCT00695396|65627974|FG000|Overall Study|Study Closed Prematurely|5|||
23516309|NCT00695396|65627975|FG001|Overall Study|Study Closed Prematurely|6|||
23516310|NCT00695396|65627976|FG002|Overall Study|Study Closed Prematurely|8|||
23516311|NCT00695396|65627974|FG000|Overall Study|Withdrawal by Subject|2|||
23516312|NCT00695396|65627975|FG001|Overall Study|Withdrawal by Subject|2|||
23516313|NCT00695396|65627976|FG002|Overall Study|Withdrawal by Subject|0|||
23516314|NCT01349790|65627977|FG000|Overall Study|Investigator Judgement|3|||
23307592|NCT00773734|64870551|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
23307593|NCT00773734|64870552|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
23307594|NCT00773734|64870553|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
23307595|NCT00773734|64870548|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
23307596|NCT00773734|64870549|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
23307597|NCT00773734|64870550|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
23307598|NCT00773734|64870551|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
23307599|NCT00773734|64870552|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
23307600|NCT00773734|64870553|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
23307601|NCT00773734|64870548|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
23307602|NCT00773734|64870549|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
23307603|NCT00773734|64870550|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
23307604|NCT00773734|64870551|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
23307605|NCT00773734|64870552|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
23307606|NCT00773734|64870553|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
23307607|NCT00773734|64870548|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
23307608|NCT00773734|64870549|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
23307609|NCT00773734|64870550|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
23307610|NCT00773734|64870551|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
23307611|NCT00773734|64870552|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
23307612|NCT00773734|64870553|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
23307613|NCT00773734|64870548|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
23307614|NCT00773734|64870549|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
23307615|NCT00773734|64870550|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
23307616|NCT00773734|64870551|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
23307617|NCT00773734|64870552|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
23307618|NCT00773734|64870553|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
23307619|NCT00773734|64870548|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
23307620|NCT00773734|64870549|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
23307621|NCT00773734|64870550|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
23307622|NCT00773734|64870551|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
23307623|NCT00773734|64870552|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
23307624|NCT00773734|64870553|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
23307625|NCT00773734|64870548|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
23307626|NCT00773734|64870549|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
23307627|NCT00773734|64870550|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
23307628|NCT00773734|64870551|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
23307629|NCT00773734|64870552|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
23307630|NCT00773734|64870553|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
23307631|NCT00773734|64870548|FG000|Extension: Active Treatment Week 24-52|Other|0|||
23307632|NCT00773734|64870549|FG001|Extension: Active Treatment Week 24-52|Other|0|||
23307633|NCT00773734|64870550|FG002|Extension: Active Treatment Week 24-52|Other|1|||
23307634|NCT00773734|64870551|FG003|Extension: Active Treatment Week 24-52|Other|2|||
23307635|NCT00773734|64870552|FG004|Extension: Active Treatment Week 24-52|Other|0|||
23307636|NCT00773734|64870553|FG005|Extension: Active Treatment Week 24-52|Other|1|||
23307637|NCT00773734|64870548|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23307638|NCT00773734|64870549|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23307639|NCT00773734|64870550|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23307640|NCT00773734|64870551|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
23307641|NCT00773734|64870552|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23307642|NCT00773734|64870553|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
23307643|NCT00773734|64870548|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
23307644|NCT00773734|64870549|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
23307645|NCT00773734|64870550|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
23516315|NCT01349790|65627977|FG000|Overall Study|Death|2|||
23516316|NCT01349790|65627977|FG000|Overall Study|Withdrawal by Patient|2|||
23516317|NCT01349790|65627977|FG000|Overall Study|Adverse Event|1|||
23516318|NCT01349790|65627977|FG000|Overall Study|Lost to Follow-up|1|||
23516319|NCT00006903|65627981|FG000|Overall Study|Still receiving treatment|0|||
23516320|NCT00006903|65627982|FG001|Overall Study|Still receiving treatment|0|||
23516321|NCT00006903|65627983|FG002|Overall Study|Still receiving treatment|1|||
23516322|NCT00006903|65627981|FG000|Overall Study|Refused further treatment|0|||
23516323|NCT00006903|65627982|FG001|Overall Study|Refused further treatment|2|||
23516324|NCT00006903|65627983|FG002|Overall Study|Refused further treatment|1|||
23516325|NCT00006903|65627981|FG000|Overall Study|Adverse Event|0|||
23516326|NCT00006903|65627982|FG001|Overall Study|Adverse Event|0|||
23516327|NCT00006903|65627983|FG002|Overall Study|Adverse Event|1|||
23516328|NCT00006903|65627981|FG000|Overall Study|Death|0|||
23516329|NCT00006903|65627982|FG001|Overall Study|Death|1|||
23516330|NCT00006903|65627983|FG002|Overall Study|Death|0|||
23516331|NCT00006903|65627981|FG000|Overall Study|Patient never treated|0|||
23516332|NCT00006903|65627982|FG001|Overall Study|Patient never treated|0|||
23516333|NCT00006903|65627983|FG002|Overall Study|Patient never treated|1|||
23516334|NCT00006903|65627981|FG000|Overall Study|Ineligible|10|||
23516335|NCT00006903|65627982|FG001|Overall Study|Ineligible|1|||
23516336|NCT00006903|65627983|FG002|Overall Study|Ineligible|2|||
23516337|NCT00276159|65627984|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
23516338|NCT00422591|65627985|FG000|Overall Study|Physician Decision|4|||
23516339|NCT00422591|65627985|FG000|Overall Study|Withdrawal by Subject|2|||
23516340|NCT00665847|65627986|FG000|Overall Study|Adverse Event|8|||
23516341|NCT00665847|65627986|FG000|Overall Study|Withdrawal by Subject|2|||
23516342|NCT00665847|65627986|FG000|Overall Study|Subject non-compliant|8|||
23516343|NCT00665847|65627986|FG000|Overall Study|Subject reached a virologic endpoint|4|||
23516344|NCT00665847|65627986|FG000|Overall Study|Resistance to TMC125|1|||
23516345|NCT00665847|65627986|FG000|Overall Study|Subject ineligible to continue the trial|1|||
23516346|NCT00665847|65627986|FG000|Overall Study|Switch to Commercial Medication|1|||
23516347|NCT01372501|65627987|FG000|Overall Study|Adverse Event|4|||
23516348|NCT01372501|65627987|FG000|Overall Study|Device migration|1|||
23516349|NCT01106898|65627988|FG000|Overall Study|Adverse Event|6|||
23516350|NCT02036502|65627991|FG000|Part 1:Dose Determination/Escalation|Death|3|||
23516351|NCT02036502|65627992|FG001|Part 1:Dose Determination/Escalation|Death|2|||
23516352|NCT02036502|65627993|FG002|Part 1:Dose Determination/Escalation|Death|0|||
23516353|NCT02036502|65627994|FG003|Part 1:Dose Determination/Escalation|Death|0|||
23516354|NCT02036502|65627995|FG004|Part 1:Dose Determination/Escalation|Death|0|||
23516355|NCT02036502|65627996|FG005|Part 1:Dose Determination/Escalation|Death|0|||
23516356|NCT02036502|65627997|FG006|Part 1:Dose Determination/Escalation|Death|0|||
23516357|NCT02036502|65627998|FG007|Part 1:Dose Determination/Escalation|Death|0|||
23516358|NCT02036502|65627991|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
23516359|NCT02036502|65627992|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516360|NCT02036502|65627993|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516361|NCT02036502|65627994|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516362|NCT02036502|65627995|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516363|NCT02036502|65627996|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516364|NCT02036502|65627997|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516365|NCT02036502|65627998|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
23516366|NCT02036502|65627991|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516367|NCT02036502|65627992|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
23516368|NCT02036502|65627993|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516369|NCT02036502|65627994|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516370|NCT02036502|65627995|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516371|NCT02036502|65627996|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516372|NCT02036502|65627997|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516373|NCT02036502|65627998|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
23516374|NCT02036502|65627991|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
23516375|NCT02036502|65627992|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
23516376|NCT02036502|65627993|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
23516377|NCT02036502|65627994|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
23516378|NCT02036502|65627995|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
23516379|NCT02036502|65627996|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
23516380|NCT02036502|65627997|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
23516381|NCT02036502|65627998|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
23516382|NCT02036502|65627991|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516383|NCT02036502|65627992|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516384|NCT02036502|65627993|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
23516385|NCT02036502|65627994|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
23516386|NCT02036502|65627995|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
23516387|NCT02036502|65627996|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516388|NCT02036502|65627997|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516389|NCT02036502|65627998|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
23516390|NCT02036502|65627991|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516391|NCT02036502|65627992|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516392|NCT02036502|65627993|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
23516393|NCT02036502|65627994|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516394|NCT02036502|65627995|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516395|NCT02036502|65627996|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516396|NCT02036502|65627997|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516397|NCT02036502|65627998|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
23516398|NCT02036502|65627991|FG000|Part 2:Dose Confirmation|Death|0|||
23516399|NCT02036502|65627992|FG001|Part 2:Dose Confirmation|Death|0|||
23516400|NCT02036502|65627993|FG002|Part 2:Dose Confirmation|Death|1|||
23516401|NCT02036502|65627994|FG003|Part 2:Dose Confirmation|Death|0|||
23516402|NCT02036502|65627995|FG004|Part 2:Dose Confirmation|Death|0|||
23516403|NCT02036502|65627996|FG005|Part 2:Dose Confirmation|Death|0|||
23516404|NCT02036502|65627997|FG006|Part 2:Dose Confirmation|Death|0|||
23516405|NCT02036502|65627998|FG007|Part 2:Dose Confirmation|Death|0|||
23516406|NCT02036502|65627991|FG000|Part 2:Dose Confirmation|Not treated|0|||
23516407|NCT02036502|65627992|FG001|Part 2:Dose Confirmation|Not treated|0|||
23516408|NCT02036502|65627993|FG002|Part 2:Dose Confirmation|Not treated|0|||
23516409|NCT02036502|65627994|FG003|Part 2:Dose Confirmation|Not treated|1|||
23516410|NCT02036502|65627995|FG004|Part 2:Dose Confirmation|Not treated|0|||
23516411|NCT02036502|65627996|FG005|Part 2:Dose Confirmation|Not treated|0|||
23516412|NCT02036502|65627997|FG006|Part 2:Dose Confirmation|Not treated|0|||
23516413|NCT02036502|65627998|FG007|Part 2:Dose Confirmation|Not treated|0|||
23516414|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Adverse Event|0|||
23516415|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Adverse Event|0|||
23516416|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Adverse Event|0|||
23516417|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Adverse Event|0|||
23516418|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Adverse Event|0|||
23516419|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Adverse Event|4|||
23516420|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Adverse Event|0|||
23516421|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Adverse Event|2|||
23516422|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Death|0|||
23516423|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Death|0|||
23516424|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Death|0|||
23516425|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Death|0|||
23516426|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Death|0|||
23516427|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Death|24|||
23516428|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Death|0|||
23516429|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Death|3|||
23516430|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516431|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516432|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516433|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516434|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516435|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516436|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
23516437|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
23516438|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Physician Decision|0|||
23516439|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Physician Decision|0|||
23516440|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Physician Decision|0|||
23516441|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Physician Decision|0|||
23516442|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Physician Decision|0|||
23516443|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Physician Decision|1|||
23516444|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Physician Decision|0|||
23516445|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Physician Decision|0|||
23516446|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
23516447|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
23516448|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
23516449|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
23516450|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
23516451|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
23516452|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
23516453|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
23516454|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516455|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516456|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516457|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516458|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516459|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
23516460|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
23516461|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
23516462|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516463|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516464|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516465|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516466|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
23516467|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
23516468|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
23516469|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
23516470|NCT02036502|65627991|FG000|Part 3:Dose Expansion|Not Treated|0|||
23516471|NCT02036502|65627992|FG001|Part 3:Dose Expansion|Not Treated|0|||
23516472|NCT02036502|65627993|FG002|Part 3:Dose Expansion|Not Treated|0|||
23516473|NCT02036502|65627994|FG003|Part 3:Dose Expansion|Not Treated|0|||
23516474|NCT02036502|65627995|FG004|Part 3:Dose Expansion|Not Treated|0|||
23516475|NCT02036502|65627996|FG005|Part 3:Dose Expansion|Not Treated|2|||
23516476|NCT02036502|65627997|FG006|Part 3:Dose Expansion|Not Treated|0|||
23516477|NCT02036502|65627998|FG007|Part 3:Dose Expansion|Not Treated|0|||
23516478|NCT01361464|65627999|FG000|Overall Study|Death|1|||
23516479|NCT01361464|65627999|FG000|Overall Study|Withdrawal by Subject|2|||
23516480|NCT02587065|65628001|FG000|Overall Study|Adverse Event|14|||
23516481|NCT02587065|65628001|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
23516482|NCT02587065|65628001|FG000|Overall Study|Non-adherence to the Protocol|3|||
23516483|NCT02587065|65628001|FG000|Overall Study|Discontinuation of Study Medication|2|||
23516484|NCT02587065|65628001|FG000|Overall Study|Reason not Specified|3|||
23516485|NCT01928329|65628002|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
23516486|NCT01928329|65628003|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
23516487|NCT01928329|65628002|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
23516488|NCT01928329|65628003|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
23516489|NCT01928329|65628002|FG000|Overall Study|Adverse Event|5|||
23516490|NCT01928329|65628003|FG001|Overall Study|Adverse Event|3|||
23516491|NCT01928329|65628002|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
23516492|NCT01928329|65628003|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
23516493|NCT01928329|65628002|FG000|Overall Study|Withdrawal by Subject|1|||
23516494|NCT01928329|65628003|FG001|Overall Study|Withdrawal by Subject|5|||
23516495|NCT01928329|65628002|FG000|Overall Study|Physician Decision|1|||
23516496|NCT01928329|65628003|FG001|Overall Study|Physician Decision|1|||
23516497|NCT03340025|65628004|FG000|Overall Study|Lost to Follow-up|2|||
23516498|NCT03340025|65628005|FG001|Overall Study|Lost to Follow-up|2|||
23516499|NCT02746874|65628007|FG000|Overall Study|Withdrawal by Subject|0|||
23516500|NCT02746874|65628008|FG001|Overall Study|Withdrawal by Subject|1|||
23516501|NCT02746874|65628007|FG000|Overall Study|Surgery Date Changed|0|||
23516502|NCT02746874|65628008|FG001|Overall Study|Surgery Date Changed|2|||
23516503|NCT00488345|65628009|FG000|Overall Study|Adverse Event|0|||
23516504|NCT00488345|65628010|FG001|Overall Study|Adverse Event|1|||
23516505|NCT00488345|65628011|FG002|Overall Study|Adverse Event|1|||
23516506|NCT00488345|65628009|FG000|Overall Study|Unable to administer antibiotics at home|0|||
23516507|NCT00488345|65628010|FG001|Overall Study|Unable to administer antibiotics at home|1|||
23516508|NCT00488345|65628011|FG002|Overall Study|Unable to administer antibiotics at home|0|||
23516509|NCT00488345|65628009|FG000|Overall Study|Institutional Review Board review|0|||
23516510|NCT00488345|65628010|FG001|Overall Study|Institutional Review Board review|0|||
23516511|NCT00488345|65628011|FG002|Overall Study|Institutional Review Board review|1|||
23516512|NCT00488345|65628009|FG000|Overall Study|Surgical team recommendation|0|||
23516513|NCT00488345|65628010|FG001|Overall Study|Surgical team recommendation|1|||
23516514|NCT00488345|65628011|FG002|Overall Study|Surgical team recommendation|0|||
23516515|NCT00488345|65628009|FG000|Overall Study|Parent/legal guardian request|0|||
23307646|NCT00773734|64870551|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
23307647|NCT00773734|64870552|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
23307648|NCT00773734|64870553|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
23307649|NCT00773734|64870548|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
23307650|NCT00773734|64870549|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
23307651|NCT00773734|64870550|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
23307652|NCT00773734|64870551|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
23416115|NCT00152477|65266154|FG000|Chemotherapy Period|Lack of Efficacy|4|||
23416116|NCT00152477|65266155|FG001|Chemotherapy Period|Lack of Efficacy|5|||
23416117|NCT00152477|65266156|FG002|Chemotherapy Period|Lack of Efficacy|6|||
23416118|NCT00152477|65266154|FG000|Chemotherapy Period|Lost to Follow-up|1|||
23416119|NCT00152477|65266155|FG001|Chemotherapy Period|Lost to Follow-up|0|||
23416120|NCT00152477|65266156|FG002|Chemotherapy Period|Lost to Follow-up|1|||
23416121|NCT00152477|65266154|FG000|Chemotherapy Period|Protocol Violation|1|||
23416122|NCT00152477|65266155|FG001|Chemotherapy Period|Protocol Violation|1|||
23416123|NCT00152477|65266156|FG002|Chemotherapy Period|Protocol Violation|0|||
23416124|NCT00152477|65266154|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
23416125|NCT00152477|65266155|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
23416126|NCT00152477|65266156|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
23416127|NCT00152477|65266154|FG000|Chemotherapy Period|Progression of Disease|6|||
23516516|NCT00488345|65628010|FG001|Overall Study|Parent/legal guardian request|1|||
23516517|NCT00488345|65628011|FG002|Overall Study|Parent/legal guardian request|1|||
23516518|NCT00810407|65628013|FG000|Overall Study|Protocol Violation|3|||
23516519|NCT00810407|65628013|FG000|Overall Study|No Visit After First Day of Treatment|3|||
23516520|NCT00481195|65628014|FG000|Overall Study|Adverse Event|16|||
23516521|NCT00481195|65628015|FG001|Overall Study|Adverse Event|11|||
23516522|NCT00481195|65628014|FG000|Overall Study|Lack of Efficacy|1|||
23516523|NCT00481195|65628015|FG001|Overall Study|Lack of Efficacy|3|||
23516524|NCT00481195|65628014|FG000|Overall Study|Lost to Follow-up|4|||
23516525|NCT00481195|65628015|FG001|Overall Study|Lost to Follow-up|6|||
23516526|NCT00481195|65628014|FG000|Overall Study|Physician Decision|3|||
23516527|NCT00481195|65628015|FG001|Overall Study|Physician Decision|1|||
23516528|NCT00481195|65628014|FG000|Overall Study|Protocol Violation|10|||
23516529|NCT00481195|65628015|FG001|Overall Study|Protocol Violation|7|||
23516530|NCT00481195|65628014|FG000|Overall Study|Withdrawal by Subject|3|||
23516531|NCT00481195|65628015|FG001|Overall Study|Withdrawal by Subject|9|||
23516532|NCT00481195|65628014|FG000|Overall Study|Miscellaneous|2|||
23516533|NCT00481195|65628015|FG001|Overall Study|Miscellaneous|2|||
23516534|NCT02677922|65628016|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
23516535|NCT02677922|65628017|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
23516536|NCT02677922|65628018|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
23516537|NCT02677922|65628019|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
23516538|NCT02677922|65628020|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
23516539|NCT02677922|65628021|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
23516540|NCT02677922|65628016|FG000|Treatment Period|Adverse Event|0|||
23516541|NCT02677922|65628017|FG001|Treatment Period|Adverse Event|0|||
23516542|NCT02677922|65628018|FG002|Treatment Period|Adverse Event|1|||
23516543|NCT02677922|65628019|FG003|Treatment Period|Adverse Event|3|||
23516544|NCT02677922|65628020|FG004|Treatment Period|Adverse Event|5|||
23516545|NCT02677922|65628021|FG005|Treatment Period|Adverse Event|2|||
23516546|NCT02677922|65628016|FG000|Treatment Period|Progressive Disease|1|||
23516547|NCT02677922|65628017|FG001|Treatment Period|Progressive Disease|1|||
23516548|NCT02677922|65628018|FG002|Treatment Period|Progressive Disease|0|||
23516549|NCT02677922|65628019|FG003|Treatment Period|Progressive Disease|0|||
23516550|NCT02677922|65628020|FG004|Treatment Period|Progressive Disease|8|||
23516551|NCT02677922|65628021|FG005|Treatment Period|Progressive Disease|7|||
23516552|NCT02677922|65628016|FG000|Treatment Period|Lack of Efficacy|0|||
23516553|NCT02677922|65628017|FG001|Treatment Period|Lack of Efficacy|0|||
23516554|NCT02677922|65628018|FG002|Treatment Period|Lack of Efficacy|0|||
23516555|NCT02677922|65628019|FG003|Treatment Period|Lack of Efficacy|1|||
23516556|NCT02677922|65628020|FG004|Treatment Period|Lack of Efficacy|1|||
23516557|NCT02677922|65628021|FG005|Treatment Period|Lack of Efficacy|6|||
23516558|NCT02677922|65628016|FG000|Treatment Period|Withdrawal by Subject|0|||
23516559|NCT02677922|65628017|FG001|Treatment Period|Withdrawal by Subject|0|||
23516560|NCT02677922|65628018|FG002|Treatment Period|Withdrawal by Subject|1|||
23516561|NCT02677922|65628019|FG003|Treatment Period|Withdrawal by Subject|3|||
23516562|NCT02677922|65628020|FG004|Treatment Period|Withdrawal by Subject|5|||
23516563|NCT02677922|65628021|FG005|Treatment Period|Withdrawal by Subject|5|||
23516564|NCT02677922|65628016|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
23516565|NCT02677922|65628017|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
23516566|NCT02677922|65628018|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
23516567|NCT02677922|65628019|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
23516568|NCT02677922|65628020|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
23516569|NCT02677922|65628021|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
23516570|NCT02677922|65628016|FG000|Treatment Period|Disease Relapse|0|||
23516571|NCT02677922|65628017|FG001|Treatment Period|Disease Relapse|0|||
23516572|NCT02677922|65628018|FG002|Treatment Period|Disease Relapse|0|||
23516573|NCT02677922|65628019|FG003|Treatment Period|Disease Relapse|3|||
23516574|NCT02677922|65628020|FG004|Treatment Period|Disease Relapse|6|||
23516575|NCT02677922|65628021|FG005|Treatment Period|Disease Relapse|1|||
23516576|NCT02677922|65628016|FG000|Treatment Period|Allogeneic HSCT|1|||
23516577|NCT02677922|65628017|FG001|Treatment Period|Allogeneic HSCT|0|||
23516578|NCT02677922|65628018|FG002|Treatment Period|Allogeneic HSCT|0|||
23307653|NCT00773734|64870552|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
23307654|NCT00773734|64870553|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
23307655|NCT00773734|64870548|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
23516579|NCT02677922|65628019|FG003|Treatment Period|Allogeneic HSCT|1|||
23516580|NCT02677922|65628020|FG004|Treatment Period|Allogeneic HSCT|4|||
23516581|NCT02677922|65628021|FG005|Treatment Period|Allogeneic HSCT|1|||
23516582|NCT02677922|65628016|FG000|Treatment Period|Other Reasons|0|||
23516583|NCT02677922|65628017|FG001|Treatment Period|Other Reasons|0|||
23516584|NCT02677922|65628018|FG002|Treatment Period|Other Reasons|0|||
23516585|NCT02677922|65628019|FG003|Treatment Period|Other Reasons|1|||
23516586|NCT02677922|65628020|FG004|Treatment Period|Other Reasons|3|||
23516587|NCT02677922|65628021|FG005|Treatment Period|Other Reasons|5|||
23516588|NCT02677922|65628016|FG000|Treatment Period|Death|0|||
23516589|NCT02677922|65628017|FG001|Treatment Period|Death|0|||
23516590|NCT02677922|65628018|FG002|Treatment Period|Death|0|||
23516591|NCT02677922|65628019|FG003|Treatment Period|Death|0|||
23516592|NCT02677922|65628020|FG004|Treatment Period|Death|12|||
23516593|NCT02677922|65628021|FG005|Treatment Period|Death|1|||
23516594|NCT02677922|65628016|FG000|Treatment Period|Non-compliance with Study Drug|0|||
23516595|NCT02677922|65628017|FG001|Treatment Period|Non-compliance with Study Drug|0|||
23516596|NCT02677922|65628018|FG002|Treatment Period|Non-compliance with Study Drug|0|||
23516597|NCT02677922|65628019|FG003|Treatment Period|Non-compliance with Study Drug|0|||
23516598|NCT02677922|65628020|FG004|Treatment Period|Non-compliance with Study Drug|1|||
23516599|NCT02677922|65628021|FG005|Treatment Period|Non-compliance with Study Drug|0|||
23516600|NCT02677922|65628016|FG000|Treatment Period|Physician Decision|0|||
23516601|NCT02677922|65628017|FG001|Treatment Period|Physician Decision|0|||
23516602|NCT02677922|65628018|FG002|Treatment Period|Physician Decision|0|||
23516603|NCT02677922|65628019|FG003|Treatment Period|Physician Decision|0|||
23516604|NCT02677922|65628020|FG004|Treatment Period|Physician Decision|0|||
23516605|NCT02677922|65628021|FG005|Treatment Period|Physician Decision|1|||
23516606|NCT02677922|65628016|FG000|Treatment Period|Symptomatic Deterioration|0|||
23516607|NCT02677922|65628017|FG001|Treatment Period|Symptomatic Deterioration|0|||
23516608|NCT02677922|65628018|FG002|Treatment Period|Symptomatic Deterioration|0|||
23516609|NCT02677922|65628019|FG003|Treatment Period|Symptomatic Deterioration|0|||
23516610|NCT02677922|65628020|FG004|Treatment Period|Symptomatic Deterioration|1|||
23516611|NCT02677922|65628021|FG005|Treatment Period|Symptomatic Deterioration|0|||
23516612|NCT01729754|65628022|FG000|Part 1|Adverse Event|2|||
23516613|NCT01729754|65628023|FG001|Part 1|Adverse Event|0|||
23516614|NCT01729754|65628024|FG002|Part 1|Adverse Event|0|||
23516615|NCT01729754|65628025|FG003|Part 1|Adverse Event|1|||
23516616|NCT01729754|65628026|FG004|Part 1|Adverse Event|0|||
23516617|NCT01729754|65628027|FG005|Part 1|Adverse Event|0|||
23516618|NCT01729754|65628028|FG006|Part 1|Adverse Event|2|||
23516619|NCT01729754|65628029|FG007|Part 1|Adverse Event|0|||
23516620|NCT01729754|65628030|FG008|Part 1|Adverse Event|0|||
23516621|NCT01729754|65628031|FG009|Part 1|Adverse Event|5|||
23516622|NCT01729754|65628022|FG000|Part 1|Lack of Efficacy|1|||
23516623|NCT01729754|65628023|FG001|Part 1|Lack of Efficacy|0|||
23516624|NCT01729754|65628024|FG002|Part 1|Lack of Efficacy|0|||
23516625|NCT01729754|65628025|FG003|Part 1|Lack of Efficacy|0|||
23516626|NCT01729754|65628026|FG004|Part 1|Lack of Efficacy|0|||
23516627|NCT01729754|65628027|FG005|Part 1|Lack of Efficacy|0|||
23516628|NCT01729754|65628028|FG006|Part 1|Lack of Efficacy|2|||
23516629|NCT01729754|65628029|FG007|Part 1|Lack of Efficacy|0|||
23516630|NCT01729754|65628030|FG008|Part 1|Lack of Efficacy|0|||
23516631|NCT01729754|65628031|FG009|Part 1|Lack of Efficacy|0|||
23516632|NCT01729754|65628022|FG000|Part 1|Lost to Follow-up|1|||
23516633|NCT01729754|65628023|FG001|Part 1|Lost to Follow-up|0|||
23516634|NCT01729754|65628024|FG002|Part 1|Lost to Follow-up|0|||
23516635|NCT01729754|65628025|FG003|Part 1|Lost to Follow-up|2|||
23516636|NCT01729754|65628026|FG004|Part 1|Lost to Follow-up|0|||
23516637|NCT01729754|65628027|FG005|Part 1|Lost to Follow-up|0|||
23516638|NCT01729754|65628028|FG006|Part 1|Lost to Follow-up|3|||
23516639|NCT01729754|65628029|FG007|Part 1|Lost to Follow-up|0|||
23516640|NCT01729754|65628030|FG008|Part 1|Lost to Follow-up|0|||
23516641|NCT01729754|65628031|FG009|Part 1|Lost to Follow-up|3|||
23516642|NCT01729754|65628022|FG000|Part 1|Non-compliance with Study Drug|1|||
23516643|NCT01729754|65628023|FG001|Part 1|Non-compliance with Study Drug|0|||
23516644|NCT01729754|65628024|FG002|Part 1|Non-compliance with Study Drug|0|||
23516645|NCT01729754|65628025|FG003|Part 1|Non-compliance with Study Drug|0|||
23516646|NCT01729754|65628026|FG004|Part 1|Non-compliance with Study Drug|0|||
23516647|NCT01729754|65628027|FG005|Part 1|Non-compliance with Study Drug|0|||
23516648|NCT01729754|65628028|FG006|Part 1|Non-compliance with Study Drug|0|||
23516649|NCT01729754|65628029|FG007|Part 1|Non-compliance with Study Drug|0|||
23516650|NCT01729754|65628030|FG008|Part 1|Non-compliance with Study Drug|0|||
23516651|NCT01729754|65628031|FG009|Part 1|Non-compliance with Study Drug|0|||
23516652|NCT01729754|65628022|FG000|Part 1|Physician Decision|0|||
23516653|NCT01729754|65628023|FG001|Part 1|Physician Decision|0|||
23516654|NCT01729754|65628024|FG002|Part 1|Physician Decision|0|||
23516655|NCT01729754|65628025|FG003|Part 1|Physician Decision|0|||
23516656|NCT01729754|65628026|FG004|Part 1|Physician Decision|0|||
23516657|NCT01729754|65628027|FG005|Part 1|Physician Decision|0|||
23516658|NCT01729754|65628028|FG006|Part 1|Physician Decision|0|||
23516659|NCT01729754|65628029|FG007|Part 1|Physician Decision|0|||
23516660|NCT01729754|65628030|FG008|Part 1|Physician Decision|0|||
23516661|NCT01729754|65628031|FG009|Part 1|Physician Decision|4|||
23516662|NCT01729754|65628022|FG000|Part 1|Pregnancy|0|||
23516663|NCT01729754|65628023|FG001|Part 1|Pregnancy|0|||
23516664|NCT01729754|65628024|FG002|Part 1|Pregnancy|0|||
23516665|NCT01729754|65628025|FG003|Part 1|Pregnancy|1|||
23516666|NCT01729754|65628026|FG004|Part 1|Pregnancy|0|||
23516667|NCT01729754|65628027|FG005|Part 1|Pregnancy|0|||
23516668|NCT01729754|65628028|FG006|Part 1|Pregnancy|0|||
23516669|NCT01729754|65628029|FG007|Part 1|Pregnancy|0|||
23516670|NCT01729754|65628030|FG008|Part 1|Pregnancy|0|||
23516671|NCT01729754|65628031|FG009|Part 1|Pregnancy|1|||
23516672|NCT01729754|65628022|FG000|Part 1|Progressive Disease|0|||
23516673|NCT01729754|65628023|FG001|Part 1|Progressive Disease|0|||
23516674|NCT01729754|65628024|FG002|Part 1|Progressive Disease|0|||
23307656|NCT00773734|64870549|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
23416128|NCT00152477|65266155|FG001|Chemotherapy Period|Progression of Disease|8|||
23416129|NCT00152477|65266156|FG002|Chemotherapy Period|Progression of Disease|4|||
23416130|NCT00152477|65266154|FG000|Chemotherapy Period|Investigator decision|0|||
23416131|NCT00152477|65266155|FG001|Chemotherapy Period|Investigator decision|0|||
23416132|NCT00152477|65266156|FG002|Chemotherapy Period|Investigator decision|1|||
23416133|NCT00152477|65266154|FG000|Chemotherapy Period|Patient condition worsened|1|||
23416134|NCT00152477|65266155|FG001|Chemotherapy Period|Patient condition worsened|0|||
23416135|NCT00152477|65266156|FG002|Chemotherapy Period|Patient condition worsened|0|||
23416136|NCT00152477|65266154|FG000|Monotherapy Period|Adverse Event|1|||
23416137|NCT00152477|65266155|FG001|Monotherapy Period|Adverse Event|0|||
23416138|NCT00152477|65266156|FG002|Monotherapy Period|Adverse Event|5|||
23416139|NCT00152477|65266154|FG000|Monotherapy Period|Death|2|||
23416140|NCT00152477|65266155|FG001|Monotherapy Period|Death|0|||
23416141|NCT00152477|65266156|FG002|Monotherapy Period|Death|1|||
23416142|NCT00152477|65266154|FG000|Monotherapy Period|Lack of Efficacy|7|||
23416143|NCT00152477|65266155|FG001|Monotherapy Period|Lack of Efficacy|16|||
23416144|NCT00152477|65266156|FG002|Monotherapy Period|Lack of Efficacy|10|||
23416145|NCT00152477|65266154|FG000|Monotherapy Period|Protocol Violation|0|||
23416146|NCT00152477|65266155|FG001|Monotherapy Period|Protocol Violation|1|||
23416147|NCT00152477|65266156|FG002|Monotherapy Period|Protocol Violation|0|||
23416148|NCT00152477|65266154|FG000|Monotherapy Period|Withdrawal by Subject|0|||
23416149|NCT00152477|65266155|FG001|Monotherapy Period|Withdrawal by Subject|0|||
23416150|NCT00152477|65266156|FG002|Monotherapy Period|Withdrawal by Subject|4|||
23416151|NCT00152477|65266154|FG000|Monotherapy Period|Progression of Disease|5|||
23416152|NCT00152477|65266155|FG001|Monotherapy Period|Progression of Disease|11|||
23416153|NCT00152477|65266156|FG002|Monotherapy Period|Progression of Disease|12|||
23416154|NCT00152477|65266154|FG000|Monotherapy Period|Patient decision|0|||
23416155|NCT00152477|65266155|FG001|Monotherapy Period|Patient decision|1|||
23416156|NCT00152477|65266156|FG002|Monotherapy Period|Patient decision|1|||
23416157|NCT00152477|65266154|FG000|Monotherapy Period|Study personel decision|0|||
23416158|NCT00152477|65266155|FG001|Monotherapy Period|Study personel decision|0|||
23416159|NCT00152477|65266156|FG002|Monotherapy Period|Study personel decision|1|||
23416160|NCT02851797|65266157|FG000|Overall Study|Withdrawal by Subject|4|||
23416161|NCT02851797|65266158|FG001|Overall Study|Withdrawal by Subject|2|||
23416162|NCT02851797|65266157|FG000|Overall Study|Adverse Event|3|||
23416163|NCT02851797|65266158|FG001|Overall Study|Adverse Event|0|||
23416164|NCT00113399|65266161|FG000|Overall Study|Death|1|||
23416165|NCT00113399|65266162|FG001|Overall Study|Death|1|||
23416166|NCT00113399|65266161|FG000|Overall Study|Withdrawal by Subject|1|||
23416167|NCT00113399|65266162|FG001|Overall Study|Withdrawal by Subject|2|||
23416168|NCT00113399|65266161|FG000|Overall Study|Complete Response|0|||
23416169|NCT00113399|65266162|FG001|Overall Study|Complete Response|1|||
23416170|NCT00113399|65266161|FG000|Overall Study|Other|0|||
23416171|NCT00113399|65266162|FG001|Overall Study|Other|1|||
23416172|NCT01893411|65266165|FG000|Overall Study|Protocol Violation|1|||
23416173|NCT01893411|65266166|FG001|Overall Study|Protocol Violation|0|||
23416174|NCT01893411|65266167|FG002|Overall Study|Protocol Violation|0|||
23416175|NCT01893411|65266165|FG000|Overall Study|Physician Decision|1|||
23416176|NCT01893411|65266166|FG001|Overall Study|Physician Decision|1|||
23416177|NCT01893411|65266167|FG002|Overall Study|Physician Decision|2|||
23416178|NCT01893411|65266165|FG000|Overall Study|Lack of Efficacy|2|||
23416179|NCT01893411|65266166|FG001|Overall Study|Lack of Efficacy|1|||
23416180|NCT01893411|65266167|FG002|Overall Study|Lack of Efficacy|0|||
23416181|NCT01893411|65266165|FG000|Overall Study|Other|3|||
23416182|NCT01893411|65266166|FG001|Overall Study|Other|1|||
23416183|NCT01893411|65266167|FG002|Overall Study|Other|3|||
23416184|NCT01893411|65266165|FG000|Overall Study|Adverse Event|1|||
23416185|NCT01893411|65266166|FG001|Overall Study|Adverse Event|0|||
23416186|NCT01893411|65266167|FG002|Overall Study|Adverse Event|0|||
23416187|NCT01893411|65266165|FG000|Overall Study|Withdrawal by Subject|7|||
23416188|NCT01893411|65266166|FG001|Overall Study|Withdrawal by Subject|4|||
23416189|NCT01893411|65266167|FG002|Overall Study|Withdrawal by Subject|3|||
23416190|NCT01893411|65266165|FG000|Overall Study|Lost to Follow-up|2|||
23516675|NCT01729754|65628025|FG003|Part 1|Progressive Disease|0|||
23516676|NCT01729754|65628026|FG004|Part 1|Progressive Disease|0|||
23516677|NCT01729754|65628027|FG005|Part 1|Progressive Disease|0|||
23516678|NCT01729754|65628028|FG006|Part 1|Progressive Disease|0|||
23516679|NCT01729754|65628029|FG007|Part 1|Progressive Disease|0|||
23516680|NCT01729754|65628030|FG008|Part 1|Progressive Disease|0|||
23516681|NCT01729754|65628031|FG009|Part 1|Progressive Disease|1|||
23516682|NCT01729754|65628022|FG000|Part 1|Protocol Violation|2|||
23516683|NCT01729754|65628023|FG001|Part 1|Protocol Violation|0|||
23516684|NCT01729754|65628024|FG002|Part 1|Protocol Violation|0|||
23516685|NCT01729754|65628025|FG003|Part 1|Protocol Violation|1|||
23516686|NCT01729754|65628026|FG004|Part 1|Protocol Violation|0|||
23516687|NCT01729754|65628027|FG005|Part 1|Protocol Violation|0|||
23516688|NCT01729754|65628028|FG006|Part 1|Protocol Violation|1|||
23516689|NCT01729754|65628029|FG007|Part 1|Protocol Violation|0|||
23516690|NCT01729754|65628030|FG008|Part 1|Protocol Violation|0|||
23516691|NCT01729754|65628031|FG009|Part 1|Protocol Violation|0|||
23516692|NCT01729754|65628022|FG000|Part 1|Withdrawal by Subject|5|||
23516693|NCT01729754|65628023|FG001|Part 1|Withdrawal by Subject|0|||
23516694|NCT01729754|65628024|FG002|Part 1|Withdrawal by Subject|0|||
23516695|NCT01729754|65628025|FG003|Part 1|Withdrawal by Subject|7|||
23516696|NCT01729754|65628026|FG004|Part 1|Withdrawal by Subject|0|||
23516697|NCT01729754|65628027|FG005|Part 1|Withdrawal by Subject|0|||
23516698|NCT01729754|65628028|FG006|Part 1|Withdrawal by Subject|5|||
23516699|NCT01729754|65628029|FG007|Part 1|Withdrawal by Subject|0|||
23516700|NCT01729754|65628030|FG008|Part 1|Withdrawal by Subject|0|||
23516701|NCT01729754|65628031|FG009|Part 1|Withdrawal by Subject|6|||
23516702|NCT01729754|65628022|FG000|Part 1|Other Protocol Specified Criteria|2|||
23516703|NCT01729754|65628023|FG001|Part 1|Other Protocol Specified Criteria|0|||
23516704|NCT01729754|65628024|FG002|Part 1|Other Protocol Specified Criteria|0|||
23516705|NCT01729754|65628025|FG003|Part 1|Other Protocol Specified Criteria|0|||
23516706|NCT01729754|65628026|FG004|Part 1|Other Protocol Specified Criteria|0|||
23516707|NCT01729754|65628027|FG005|Part 1|Other Protocol Specified Criteria|0|||
23516708|NCT01729754|65628028|FG006|Part 1|Other Protocol Specified Criteria|1|||
23516709|NCT01729754|65628029|FG007|Part 1|Other Protocol Specified Criteria|0|||
23516710|NCT01729754|65628030|FG008|Part 1|Other Protocol Specified Criteria|0|||
23516711|NCT01729754|65628031|FG009|Part 1|Other Protocol Specified Criteria|4|||
23516712|NCT01729754|65628022|FG000|Part 2|Adverse Event|2|||
23516713|NCT01729754|65628023|FG001|Part 2|Adverse Event|0|||
23516714|NCT01729754|65628024|FG002|Part 2|Adverse Event|0|||
23516715|NCT01729754|65628025|FG003|Part 2|Adverse Event|0|||
23516716|NCT01729754|65628026|FG004|Part 2|Adverse Event|0|||
23516717|NCT01729754|65628027|FG005|Part 2|Adverse Event|0|||
23516718|NCT01729754|65628028|FG006|Part 2|Adverse Event|0|||
23516719|NCT01729754|65628029|FG007|Part 2|Adverse Event|0|||
23516720|NCT01729754|65628030|FG008|Part 2|Adverse Event|1|||
23516721|NCT01729754|65628031|FG009|Part 2|Adverse Event|2|||
23516722|NCT01729754|65628022|FG000|Part 2|Lack of Efficacy|0|||
23516723|NCT01729754|65628023|FG001|Part 2|Lack of Efficacy|0|||
23516724|NCT01729754|65628024|FG002|Part 2|Lack of Efficacy|0|||
23516725|NCT01729754|65628025|FG003|Part 2|Lack of Efficacy|0|||
23516726|NCT01729754|65628026|FG004|Part 2|Lack of Efficacy|0|||
23516727|NCT01729754|65628027|FG005|Part 2|Lack of Efficacy|0|||
23516728|NCT01729754|65628028|FG006|Part 2|Lack of Efficacy|0|||
23516729|NCT01729754|65628029|FG007|Part 2|Lack of Efficacy|0|||
23516730|NCT01729754|65628030|FG008|Part 2|Lack of Efficacy|2|||
23307657|NCT00773734|64870550|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
23307658|NCT00773734|64870551|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
23516731|NCT01729754|65628031|FG009|Part 2|Lack of Efficacy|2|||
23516732|NCT01729754|65628022|FG000|Part 2|Lost to Follow-up|0|||
23516733|NCT01729754|65628023|FG001|Part 2|Lost to Follow-up|0|||
23516734|NCT01729754|65628024|FG002|Part 2|Lost to Follow-up|0|||
23516735|NCT01729754|65628025|FG003|Part 2|Lost to Follow-up|2|||
23516736|NCT01729754|65628026|FG004|Part 2|Lost to Follow-up|0|||
23516737|NCT01729754|65628027|FG005|Part 2|Lost to Follow-up|0|||
23516738|NCT01729754|65628028|FG006|Part 2|Lost to Follow-up|0|||
23516739|NCT01729754|65628029|FG007|Part 2|Lost to Follow-up|1|||
23516740|NCT01729754|65628030|FG008|Part 2|Lost to Follow-up|0|||
23516741|NCT01729754|65628031|FG009|Part 2|Lost to Follow-up|2|||
23516742|NCT01729754|65628022|FG000|Part 2|Non-Compliance with Study Drug|0|||
23516743|NCT01729754|65628023|FG001|Part 2|Non-Compliance with Study Drug|0|||
23516744|NCT01729754|65628024|FG002|Part 2|Non-Compliance with Study Drug|0|||
23516745|NCT01729754|65628025|FG003|Part 2|Non-Compliance with Study Drug|0|||
23516746|NCT01729754|65628026|FG004|Part 2|Non-Compliance with Study Drug|0|||
23516747|NCT01729754|65628027|FG005|Part 2|Non-Compliance with Study Drug|0|||
23516748|NCT01729754|65628028|FG006|Part 2|Non-Compliance with Study Drug|0|||
23516749|NCT01729754|65628029|FG007|Part 2|Non-Compliance with Study Drug|0|||
23516750|NCT01729754|65628030|FG008|Part 2|Non-Compliance with Study Drug|0|||
23516751|NCT01729754|65628031|FG009|Part 2|Non-Compliance with Study Drug|1|||
23516752|NCT01729754|65628022|FG000|Part 2|Pregnancy|0|||
23516753|NCT01729754|65628023|FG001|Part 2|Pregnancy|0|||
23516754|NCT01729754|65628024|FG002|Part 2|Pregnancy|0|||
23516755|NCT01729754|65628025|FG003|Part 2|Pregnancy|1|||
23516756|NCT01729754|65628026|FG004|Part 2|Pregnancy|0|||
23516757|NCT01729754|65628027|FG005|Part 2|Pregnancy|0|||
23516758|NCT01729754|65628028|FG006|Part 2|Pregnancy|0|||
23516759|NCT01729754|65628029|FG007|Part 2|Pregnancy|0|||
23516760|NCT01729754|65628030|FG008|Part 2|Pregnancy|0|||
23516761|NCT01729754|65628031|FG009|Part 2|Pregnancy|1|||
23516762|NCT01729754|65628022|FG000|Part 2|Withdrawal by Subject|3|||
23516763|NCT01729754|65628023|FG001|Part 2|Withdrawal by Subject|0|||
23516764|NCT01729754|65628024|FG002|Part 2|Withdrawal by Subject|0|||
23516765|NCT01729754|65628025|FG003|Part 2|Withdrawal by Subject|2|||
23516766|NCT01729754|65628026|FG004|Part 2|Withdrawal by Subject|0|||
23516767|NCT01729754|65628027|FG005|Part 2|Withdrawal by Subject|0|||
23516768|NCT01729754|65628028|FG006|Part 2|Withdrawal by Subject|0|||
23516769|NCT01729754|65628029|FG007|Part 2|Withdrawal by Subject|1|||
23516770|NCT01729754|65628030|FG008|Part 2|Withdrawal by Subject|1|||
23516771|NCT01729754|65628031|FG009|Part 2|Withdrawal by Subject|4|||
23516772|NCT01729754|65628022|FG000|Part 2|Other Protocol Specified Criteria|1|||
23516773|NCT01729754|65628023|FG001|Part 2|Other Protocol Specified Criteria|0|||
23516774|NCT01729754|65628024|FG002|Part 2|Other Protocol Specified Criteria|0|||
23516775|NCT01729754|65628025|FG003|Part 2|Other Protocol Specified Criteria|0|||
23516776|NCT01729754|65628026|FG004|Part 2|Other Protocol Specified Criteria|0|||
23307659|NCT00773734|64870552|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
23307660|NCT00773734|64870553|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
23307661|NCT00859586|64870555|FG000|Overall Study|Donors|4|||
23307662|NCT00587990|64870558|FG000|Overall Study|Death|0|||
23516777|NCT01729754|65628027|FG005|Part 2|Other Protocol Specified Criteria|0|||
23516778|NCT01729754|65628028|FG006|Part 2|Other Protocol Specified Criteria|0|||
23516779|NCT01729754|65628029|FG007|Part 2|Other Protocol Specified Criteria|1|||
23516780|NCT01729754|65628030|FG008|Part 2|Other Protocol Specified Criteria|0|||
23516781|NCT01729754|65628031|FG009|Part 2|Other Protocol Specified Criteria|0|||
23516782|NCT01729754|65628022|FG000|Part 3|Adverse Event|0|||
23516783|NCT01729754|65628023|FG001|Part 3|Adverse Event|0|||
23516784|NCT01729754|65628024|FG002|Part 3|Adverse Event|1|||
23516785|NCT01729754|65628025|FG003|Part 3|Adverse Event|0|||
23516786|NCT01729754|65628026|FG004|Part 3|Adverse Event|0|||
23516787|NCT01729754|65628027|FG005|Part 3|Adverse Event|5|||
23516788|NCT01729754|65628028|FG006|Part 3|Adverse Event|0|||
23516789|NCT01729754|65628029|FG007|Part 3|Adverse Event|0|||
23516790|NCT01729754|65628030|FG008|Part 3|Adverse Event|0|||
23516791|NCT01729754|65628031|FG009|Part 3|Adverse Event|3|||
23516792|NCT01729754|65628022|FG000|Part 3|Death|0|||
23516793|NCT01729754|65628023|FG001|Part 3|Death|0|||
23516794|NCT01729754|65628024|FG002|Part 3|Death|0|||
23516795|NCT01729754|65628025|FG003|Part 3|Death|0|||
23516796|NCT01729754|65628026|FG004|Part 3|Death|0|||
23516797|NCT01729754|65628027|FG005|Part 3|Death|2|||
23516798|NCT01729754|65628028|FG006|Part 3|Death|0|||
23516799|NCT01729754|65628029|FG007|Part 3|Death|0|||
23516800|NCT01729754|65628030|FG008|Part 3|Death|0|||
23516801|NCT01729754|65628031|FG009|Part 3|Death|0|||
23516802|NCT01729754|65628022|FG000|Part 3|Lack of Efficacy|0|||
23516803|NCT01729754|65628023|FG001|Part 3|Lack of Efficacy|0|||
23516804|NCT01729754|65628024|FG002|Part 3|Lack of Efficacy|0|||
23516805|NCT01729754|65628025|FG003|Part 3|Lack of Efficacy|0|||
23516806|NCT01729754|65628026|FG004|Part 3|Lack of Efficacy|2|||
23516807|NCT01729754|65628027|FG005|Part 3|Lack of Efficacy|0|||
23516808|NCT01729754|65628028|FG006|Part 3|Lack of Efficacy|0|||
23516809|NCT01729754|65628029|FG007|Part 3|Lack of Efficacy|0|||
23516810|NCT01729754|65628030|FG008|Part 3|Lack of Efficacy|0|||
23516811|NCT01729754|65628031|FG009|Part 3|Lack of Efficacy|4|||
23516812|NCT01729754|65628022|FG000|Part 3|Lost to Follow-up|0|||
23307663|NCT00587990|64870559|FG001|Overall Study|Death|0|||
23516813|NCT01729754|65628023|FG001|Part 3|Lost to Follow-up|1|||
23516814|NCT01729754|65628024|FG002|Part 3|Lost to Follow-up|2|||
23516815|NCT01729754|65628025|FG003|Part 3|Lost to Follow-up|0|||
23516816|NCT01729754|65628026|FG004|Part 3|Lost to Follow-up|0|||
23516817|NCT01729754|65628027|FG005|Part 3|Lost to Follow-up|3|||
23516818|NCT01729754|65628028|FG006|Part 3|Lost to Follow-up|0|||
23516819|NCT01729754|65628029|FG007|Part 3|Lost to Follow-up|0|||
23516820|NCT01729754|65628030|FG008|Part 3|Lost to Follow-up|1|||
23516821|NCT01729754|65628031|FG009|Part 3|Lost to Follow-up|0|||
23516822|NCT01729754|65628022|FG000|Part 3|Physician Decision|0|||
23516823|NCT01729754|65628023|FG001|Part 3|Physician Decision|0|||
23516824|NCT01729754|65628024|FG002|Part 3|Physician Decision|1|||
23516825|NCT01729754|65628025|FG003|Part 3|Physician Decision|0|||
23516826|NCT01729754|65628026|FG004|Part 3|Physician Decision|0|||
23516827|NCT01729754|65628027|FG005|Part 3|Physician Decision|0|||
23516828|NCT01729754|65628028|FG006|Part 3|Physician Decision|0|||
23516829|NCT01729754|65628029|FG007|Part 3|Physician Decision|0|||
23516830|NCT01729754|65628030|FG008|Part 3|Physician Decision|0|||
23516831|NCT01729754|65628031|FG009|Part 3|Physician Decision|0|||
23516832|NCT01729754|65628022|FG000|Part 3|Withdrawal by Subject|0|||
23516833|NCT01729754|65628023|FG001|Part 3|Withdrawal by Subject|4|||
23516834|NCT01729754|65628024|FG002|Part 3|Withdrawal by Subject|1|||
23516835|NCT01729754|65628025|FG003|Part 3|Withdrawal by Subject|0|||
23516836|NCT01729754|65628026|FG004|Part 3|Withdrawal by Subject|2|||
23516837|NCT01729754|65628027|FG005|Part 3|Withdrawal by Subject|1|||
23516838|NCT01729754|65628028|FG006|Part 3|Withdrawal by Subject|0|||
23516839|NCT01729754|65628029|FG007|Part 3|Withdrawal by Subject|2|||
23516840|NCT01729754|65628030|FG008|Part 3|Withdrawal by Subject|0|||
23516841|NCT01729754|65628031|FG009|Part 3|Withdrawal by Subject|0|||
23516842|NCT01729754|65628022|FG000|Part 3|Other Protocol Specified Criteria|0|||
23516843|NCT01729754|65628023|FG001|Part 3|Other Protocol Specified Criteria|0|||
23516844|NCT01729754|65628024|FG002|Part 3|Other Protocol Specified Criteria|0|||
23516845|NCT01729754|65628025|FG003|Part 3|Other Protocol Specified Criteria|0|||
23516846|NCT01729754|65628026|FG004|Part 3|Other Protocol Specified Criteria|0|||
23516847|NCT01729754|65628027|FG005|Part 3|Other Protocol Specified Criteria|2|||
23516848|NCT01729754|65628028|FG006|Part 3|Other Protocol Specified Criteria|0|||
23516849|NCT01729754|65628029|FG007|Part 3|Other Protocol Specified Criteria|1|||
23516850|NCT01729754|65628030|FG008|Part 3|Other Protocol Specified Criteria|0|||
23516851|NCT01729754|65628031|FG009|Part 3|Other Protocol Specified Criteria|0|||
23516852|NCT02743806|65628032|FG000|Overall Study|Adverse Event|9|||
23516853|NCT02743806|65628032|FG000|Overall Study|Lost to Follow-up|8|||
23516854|NCT02743806|65628032|FG000|Overall Study|Voluntary Withdrawal|54|||
23516855|NCT02743806|65628032|FG000|Overall Study|Study Termination|65|||
23516856|NCT02743806|65628032|FG000|Overall Study|Pregnancy|6|||
23516857|NCT02743806|65628032|FG000|Overall Study|No Longer Clinically Benefiting|27|||
23516858|NCT02743806|65628032|FG000|Overall Study|Reason Not Specified|12|||
23516859|NCT02736409|65628038|FG000|Overall Study|Withdrawal by Subject|4|||
23516860|NCT02736409|65628039|FG001|Overall Study|Withdrawal by Subject|2|||
23516861|NCT02736409|65628040|FG002|Overall Study|Withdrawal by Subject|17|||
23516862|NCT02736409|65628041|FG003|Overall Study|Withdrawal by Subject|3|||
23516863|NCT02736409|65628038|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23516864|NCT02736409|65628039|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23516865|NCT02736409|65628040|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23516866|NCT02736409|65628041|FG003|Overall Study|Non-Compliance with Study Drug|1|||
23516867|NCT02736409|65628038|FG000|Overall Study|Adverse Event|0|||
23516868|NCT02736409|65628039|FG001|Overall Study|Adverse Event|1|||
23516869|NCT02736409|65628040|FG002|Overall Study|Adverse Event|5|||
23516870|NCT02736409|65628041|FG003|Overall Study|Adverse Event|4|||
23516871|NCT02736409|65628038|FG000|Overall Study|Other|0|||
23516872|NCT02736409|65628039|FG001|Overall Study|Other|0|||
23516873|NCT02736409|65628040|FG002|Overall Study|Other|1|||
23516874|NCT02736409|65628041|FG003|Overall Study|Other|1|||
23516875|NCT02736409|65628038|FG000|Overall Study|Pregnancy|0|||
23516876|NCT02736409|65628039|FG001|Overall Study|Pregnancy|0|||
23516877|NCT02736409|65628040|FG002|Overall Study|Pregnancy|1|||
23516878|NCT02736409|65628041|FG003|Overall Study|Pregnancy|0|||
23516879|NCT02736409|65628038|FG000|Overall Study|Lost to Follow-up|0|||
23516880|NCT02736409|65628039|FG001|Overall Study|Lost to Follow-up|0|||
23516881|NCT02736409|65628040|FG002|Overall Study|Lost to Follow-up|2|||
23516882|NCT02736409|65628041|FG003|Overall Study|Lost to Follow-up|1|||
23516883|NCT02736409|65628038|FG000|Overall Study|Physician Decision|0|||
23516884|NCT02736409|65628039|FG001|Overall Study|Physician Decision|0|||
23516885|NCT02736409|65628040|FG002|Overall Study|Physician Decision|0|||
23516886|NCT02736409|65628041|FG003|Overall Study|Physician Decision|2|||
23516887|NCT01581307|65628042|FG000|Overall Study|Withdrawal by Subject|1|||
23516888|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
23516889|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
23516890|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
23516891|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
23516892|NCT01589445|65628045|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
23516893|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
23516894|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
23516895|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
23516896|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
23516897|NCT01589445|65628045|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
23516898|NCT02150954|65628046|FG000|Overall Study|Protocol Violation|1|||
23516899|NCT02150954|65628047|FG001|Overall Study|Protocol Violation|0|||
23516900|NCT03045081|65628051|FG000|Overall Study|Withdrawal by Subject|6|||
23516901|NCT03045081|65628052|FG001|Overall Study|Withdrawal by Subject|11|||
23516902|NCT00453544|65628054|FG000|Overall Study|Withdrawal by Subject|1|||
23516903|NCT00453544|65628055|FG001|Overall Study|Withdrawal by Subject|0|||
23516904|NCT00453544|65628056|FG002|Overall Study|Withdrawal by Subject|0|||
23516905|NCT00453544|65628057|FG003|Overall Study|Withdrawal by Subject|0|||
23516906|NCT00453544|65628054|FG000|Overall Study|Primary outcome measure not completed|1|||
23516907|NCT00453544|65628055|FG001|Overall Study|Primary outcome measure not completed|1|||
23516908|NCT00453544|65628056|FG002|Overall Study|Primary outcome measure not completed|0|||
23516909|NCT00453544|65628057|FG003|Overall Study|Primary outcome measure not completed|1|||
23516910|NCT00993291|65628058|FG000|Overall Study|Withdrawal by Subject|1|||
23516911|NCT03538158|65628059|FG000|Overall Study|Lost to Follow-up|13|||
23516912|NCT03538158|65628060|FG001|Overall Study|Lost to Follow-up|7|||
23516913|NCT03538158|65628059|FG000|Overall Study|Withdrawal by Subject|2|||
23516914|NCT03538158|65628060|FG001|Overall Study|Withdrawal by Subject|1|||
23516915|NCT03761147|65628061|FG000|Overall Study|Withdrawal by Subject|6|||
23516916|NCT03761147|65628062|FG001|Overall Study|Withdrawal by Subject|1|||
23516917|NCT03761147|65628061|FG000|Overall Study|Adverse Event|1|||
23516918|NCT03761147|65628062|FG001|Overall Study|Adverse Event|3|||
23516919|NCT01485640|65632464|FG000|Overall Study|Adverse Event|10|||
23516920|NCT01485640|65632464|FG000|Overall Study|Lack of Efficacy|2|||
23516921|NCT01485640|65632464|FG000|Overall Study|Protocol Violation|1|||
23516922|NCT01485640|65632464|FG000|Overall Study|Withdrawal by Subject|14|||
23516923|NCT01485640|65632464|FG000|Overall Study|Terminated by Sponsor|95|||
23516924|NCT03315208|65632467|FG000|Overall Study|Lost to Follow-up|11|||
23516925|NCT03315208|65632468|FG001|Overall Study|Lost to Follow-up|6|||
23516926|NCT03315208|65632467|FG000|Overall Study|Withdrawal by Subject|2|||
23516927|NCT03315208|65632468|FG001|Overall Study|Withdrawal by Subject|0|||
23516928|NCT01405963|65632469|FG000|Overall Study|Moved Away|2|||
23516929|NCT01405963|65632470|FG001|Overall Study|Moved Away|0|||
23516930|NCT01405963|65632469|FG000|Overall Study|Adverse Event|0|||
23516931|NCT01405963|65632470|FG001|Overall Study|Adverse Event|1|||
23516932|NCT01405963|65632469|FG000|Overall Study|Lost to Follow-up|0|||
23516933|NCT01405963|65632470|FG001|Overall Study|Lost to Follow-up|1|||
23516934|NCT01111149|65632472|FG000|Overall Study|Protocol Violation|1|||
23516935|NCT01111149|65632473|FG001|Overall Study|Protocol Violation|1|||
23516936|NCT01111149|65632474|FG002|Overall Study|Protocol Violation|2|||
23516937|NCT01111149|65632472|FG000|Overall Study|Withdrawal by Subject|1|||
23516938|NCT01111149|65632473|FG001|Overall Study|Withdrawal by Subject|0|||
23516939|NCT01111149|65632474|FG002|Overall Study|Withdrawal by Subject|2|||
23516940|NCT02699554|65632477|FG000|Overall Study|Lost to Follow-up|9|||
23516941|NCT01826487|65632478|FG000|Overall Study|Adverse Event|1|||
23516942|NCT01826487|65632479|FG001|Overall Study|Adverse Event|1|||
23516943|NCT01826487|65632478|FG000|Overall Study|Lost to Follow-up|1|||
23516944|NCT01826487|65632479|FG001|Overall Study|Lost to Follow-up|0|||
23307664|NCT00587990|64870560|FG002|Overall Study|Death|1|||
23516945|NCT01826487|65632478|FG000|Overall Study|Withdrawal by Subject|1|||
23516946|NCT01826487|65632479|FG001|Overall Study|Withdrawal by Subject|3|||
23516947|NCT01826487|65632478|FG000|Overall Study|Protocol Violation|1|||
23516948|NCT01826487|65632479|FG001|Overall Study|Protocol Violation|1|||
23516949|NCT00537381|65632480|FG000|Overall Study|Adverse Event|13|||
23516950|NCT00537381|65632481|FG001|Overall Study|Adverse Event|9|||
23516951|NCT00537381|65632480|FG000|Overall Study|Death|3|||
23516952|NCT00537381|65632481|FG001|Overall Study|Death|3|||
23516953|NCT00537381|65632480|FG000|Overall Study|Withdrawal by Subject|5|||
23516954|NCT00537381|65632481|FG001|Overall Study|Withdrawal by Subject|14|||
23516955|NCT00537381|65632480|FG000|Overall Study|Physician Decision|7|||
23516956|NCT00537381|65632481|FG001|Overall Study|Physician Decision|6|||
23516957|NCT00537381|65632480|FG000|Overall Study|Disease Progression|9|||
23516958|NCT00537381|65632481|FG001|Overall Study|Disease Progression|18|||
23516959|NCT00537381|65632480|FG000|Overall Study|Sponsor decision|14|||
23516960|NCT00537381|65632481|FG001|Overall Study|Sponsor decision|9|||
23516961|NCT00537381|65632480|FG000|Overall Study|Other|5|||
23516962|NCT00537381|65632481|FG001|Overall Study|Other|3|||
23516963|NCT02221284|65632485|FG000|Overall Study|Case Report Forms Uncollected|56|||
23516964|NCT02221284|65632485|FG000|Overall Study|Protocol Deviation|5|||
23516965|NCT01172847|65632486|FG000|Overall Study|Withdrawal by Subject|3|||
23516966|NCT01475331|65632487|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
23516967|NCT01475331|65632488|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
23516968|NCT01475331|65632487|FG000|Overall Study|excessive main duct communication|1|||
23516969|NCT01475331|65632488|FG001|Overall Study|excessive main duct communication|1|||
23516970|NCT01475331|65632487|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
23516971|NCT01475331|65632488|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
23516972|NCT01475331|65632487|FG000|Overall Study|Sign of malignancy during the procedure|2|||
23516973|NCT01475331|65632488|FG001|Overall Study|Sign of malignancy during the procedure|0|||
23516974|NCT01475331|65632487|FG000|Overall Study|cyst found to be prohibitively small|0|||
23516975|NCT01475331|65632488|FG001|Overall Study|cyst found to be prohibitively small|1|||
23516976|NCT05089682|65632489|FG000|Overall Study|Withdrawal by Subject|2|||
23516977|NCT00322842|65632498|FG000|Overall Study|Withdrawal by Subject|0|||
23516978|NCT00322842|65632499|FG001|Overall Study|Withdrawal by Subject|1|||
23516979|NCT00322842|65632498|FG000|Overall Study|Lost to Follow-up|0|||
23516980|NCT00322842|65632499|FG001|Overall Study|Lost to Follow-up|1|||
23516981|NCT00322842|65632498|FG000|Overall Study|Refused transplant|1|||
23516982|NCT00322842|65632499|FG001|Overall Study|Refused transplant|0|||
23516983|NCT00322842|65632498|FG000|Overall Study|Death|1|||
23516984|NCT00322842|65632499|FG001|Overall Study|Death|0|||
23516985|NCT00450333|65632500|FG000|Overall Study|Study terminated|47|||
23516986|NCT00450333|65632501|FG001|Overall Study|Study terminated|54|||
23516987|NCT00450333|65632502|FG002|Overall Study|Study terminated|16|||
23516988|NCT00450333|65632503|FG003|Overall Study|Study terminated|21|||
23516989|NCT00450333|65632500|FG000|Overall Study|Adverse Event|1|||
23516990|NCT00450333|65632501|FG001|Overall Study|Adverse Event|7|||
23516991|NCT00450333|65632502|FG002|Overall Study|Adverse Event|2|||
23516992|NCT00450333|65632503|FG003|Overall Study|Adverse Event|2|||
23516993|NCT00450333|65632500|FG000|Overall Study|Protocol Violation|1|||
23516994|NCT00450333|65632501|FG001|Overall Study|Protocol Violation|0|||
23516995|NCT00450333|65632502|FG002|Overall Study|Protocol Violation|1|||
23516996|NCT00450333|65632503|FG003|Overall Study|Protocol Violation|0|||
23516997|NCT00450333|65632500|FG000|Overall Study|Withdrawal by Subject|1|||
23516998|NCT00450333|65632501|FG001|Overall Study|Withdrawal by Subject|0|||
23516999|NCT00450333|65632502|FG002|Overall Study|Withdrawal by Subject|3|||
23517000|NCT00450333|65632503|FG003|Overall Study|Withdrawal by Subject|0|||
23517001|NCT00450333|65632500|FG000|Overall Study|Kidney transplant|1|||
23517002|NCT00450333|65632501|FG001|Overall Study|Kidney transplant|0|||
23517003|NCT00450333|65632502|FG002|Overall Study|Kidney transplant|1|||
23517004|NCT00450333|65632503|FG003|Overall Study|Kidney transplant|3|||
23517005|NCT00450333|65632500|FG000|Overall Study|Death|3|||
23517006|NCT00450333|65632501|FG001|Overall Study|Death|2|||
23517007|NCT00450333|65632502|FG002|Overall Study|Death|2|||
23517008|NCT00450333|65632503|FG003|Overall Study|Death|2|||
23517009|NCT01394523|65632504|FG000|Overall Study|Unable to place block|1|||
23517010|NCT01394523|65632505|FG001|Overall Study|Unable to place block|0|||
23517011|NCT01394523|65632506|FG002|Overall Study|Unable to place block|0|||
23517012|NCT03045887|65632507|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
23517013|NCT03045887|65632508|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517014|NCT03045887|65632509|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517015|NCT03045887|65632510|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517016|NCT03045887|65632511|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517017|NCT03045887|65632512|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517018|NCT03045887|65632513|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517019|NCT03045887|65632514|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517020|NCT03045887|65632515|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517021|NCT03045887|65632516|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
23517022|NCT03045887|65632507|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517023|NCT03045887|65632508|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517024|NCT03045887|65632509|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517025|NCT03045887|65632510|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
23517026|NCT03045887|65632511|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517027|NCT03045887|65632512|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517028|NCT03045887|65632513|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517029|NCT03045887|65632514|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517030|NCT03045887|65632515|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517031|NCT03045887|65632516|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
23517032|NCT03045887|65632507|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
23517033|NCT03045887|65632508|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517034|NCT03045887|65632509|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517035|NCT03045887|65632510|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517036|NCT03045887|65632511|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517037|NCT03045887|65632512|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517038|NCT03045887|65632513|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517039|NCT03045887|65632514|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517040|NCT03045887|65632515|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517041|NCT03045887|65632516|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
23517042|NCT03045887|65632507|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517043|NCT03045887|65632508|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517044|NCT03045887|65632509|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
23517045|NCT03045887|65632510|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
23517046|NCT03045887|65632511|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517047|NCT03045887|65632512|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517048|NCT03045887|65632513|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517049|NCT03045887|65632514|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517050|NCT03045887|65632515|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517051|NCT03045887|65632516|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
23517052|NCT03045887|65632507|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517053|NCT03045887|65632508|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517054|NCT03045887|65632509|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517055|NCT03045887|65632510|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
23517056|NCT03045887|65632511|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517057|NCT03045887|65632512|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517058|NCT03045887|65632513|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517059|NCT03045887|65632514|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517060|NCT03045887|65632515|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517061|NCT03045887|65632516|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23517062|NCT01996826|65632517|FG000|Overall Study|Lost to Follow-up|6|||
23517063|NCT01996826|65632518|FG001|Overall Study|Lost to Follow-up|2|||
23517064|NCT01996826|65632517|FG000|Overall Study|Physician Decision|1|||
23517065|NCT01996826|65632518|FG001|Overall Study|Physician Decision|1|||
23517066|NCT01365507|65632519|FG000|Overall Study|Withdrawal Criteria|8|||
23517067|NCT01365507|65632520|FG001|Overall Study|Withdrawal Criteria|5|||
23517068|NCT01365507|65632519|FG000|Overall Study|Unclassified|1|||
23517069|NCT01365507|65632520|FG001|Overall Study|Unclassified|4|||
23517070|NCT01154218|65632521|FG000|Third Intervention Period|Adverse Event|0|||
23517071|NCT01154218|65632522|FG001|Third Intervention Period|Adverse Event|1|||
23517072|NCT01154218|65632523|FG002|Third Intervention Period|Adverse Event|0|||
23517073|NCT01154218|65632524|FG003|Third Intervention Period|Adverse Event|0|||
23517074|NCT01154218|65632521|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23517075|NCT01154218|65632522|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23517076|NCT01154218|65632523|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23517077|NCT01154218|65632524|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
23517078|NCT01154218|65632521|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
23517079|NCT01154218|65632522|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
23517080|NCT01154218|65632523|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
23517081|NCT01154218|65632524|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
23517082|NCT02951156|65632525|FG000|Overall Study|Death|3|||
23517083|NCT02951156|65632526|FG001|Overall Study|Death|8|||
23517084|NCT02951156|65632527|FG002|Overall Study|Death|5|||
23517085|NCT02951156|65632525|FG000|Overall Study|Progressive disease|1|||
23517086|NCT02951156|65632526|FG001|Overall Study|Progressive disease|0|||
23517087|NCT02951156|65632527|FG002|Overall Study|Progressive disease|1|||
23517088|NCT02951156|65632525|FG000|Overall Study|Withdrawal by Subject|0|||
23517089|NCT02951156|65632526|FG001|Overall Study|Withdrawal by Subject|0|||
23517090|NCT02951156|65632527|FG002|Overall Study|Withdrawal by Subject|1|||
23517091|NCT02951156|65632525|FG000|Overall Study|Study terminated by sponsor|0|||
23517092|NCT02951156|65632526|FG001|Overall Study|Study terminated by sponsor|0|||
23517093|NCT02951156|65632527|FG002|Overall Study|Study terminated by sponsor|1|||
23517094|NCT02951156|65632525|FG000|Overall Study|Other|5|||
23517095|NCT02951156|65632526|FG001|Overall Study|Other|1|||
23517096|NCT02951156|65632527|FG002|Overall Study|Other|2|||
23517097|NCT02426892|65632535|FG000|Overall Study|Adverse Event|2|||
23517098|NCT02426892|65632535|FG000|Overall Study|Lack of Efficacy|17|||
23517099|NCT02426892|65632535|FG000|Overall Study|Withdrawal by Subject|1|||
23517100|NCT02921776|65632536|FG000|Overall Study|patient deterioration, fatigue|2|||
23517101|NCT02921776|65632537|FG001|Overall Study|patient deterioration, fatigue|6|||
23517102|NCT02921776|65632538|FG002|Overall Study|patient deterioration, fatigue|0|||
23517103|NCT02921776|65632539|FG003|Overall Study|patient deterioration, fatigue|0|||
23517104|NCT02921776|65632540|FG004|Overall Study|patient deterioration, fatigue|0|||
23517105|NCT02921776|65632541|FG005|Overall Study|patient deterioration, fatigue|0|||
23517106|NCT02921776|65632542|FG006|Overall Study|patient deterioration, fatigue|0|||
23517107|NCT02921776|65632543|FG007|Overall Study|patient deterioration, fatigue|0|||
23517108|NCT02921776|65632536|FG000|Overall Study|Withdrawal by Subject|0|||
23517109|NCT02921776|65632537|FG001|Overall Study|Withdrawal by Subject|2|||
23517110|NCT02921776|65632538|FG002|Overall Study|Withdrawal by Subject|0|||
23517111|NCT02921776|65632539|FG003|Overall Study|Withdrawal by Subject|1|||
23517112|NCT02921776|65632540|FG004|Overall Study|Withdrawal by Subject|1|||
23517113|NCT02921776|65632541|FG005|Overall Study|Withdrawal by Subject|0|||
23517114|NCT02921776|65632542|FG006|Overall Study|Withdrawal by Subject|8|||
23517115|NCT02921776|65632543|FG007|Overall Study|Withdrawal by Subject|1|||
23517116|NCT02921776|65632536|FG000|Overall Study|Death|0|||
23517117|NCT02921776|65632537|FG001|Overall Study|Death|0|||
23517118|NCT02921776|65632538|FG002|Overall Study|Death|0|||
23517119|NCT02921776|65632539|FG003|Overall Study|Death|2|||
23517120|NCT02921776|65632540|FG004|Overall Study|Death|0|||
23517121|NCT02921776|65632541|FG005|Overall Study|Death|0|||
23517122|NCT02921776|65632542|FG006|Overall Study|Death|0|||
23517123|NCT02921776|65632543|FG007|Overall Study|Death|0|||
23517124|NCT02921776|65632536|FG000|Overall Study|extubation or early discharge|0|||
23517125|NCT02921776|65632537|FG001|Overall Study|extubation or early discharge|0|||
23517126|NCT02921776|65632538|FG002|Overall Study|extubation or early discharge|0|||
23517127|NCT02921776|65632539|FG003|Overall Study|extubation or early discharge|5|||
23517128|NCT02921776|65632540|FG004|Overall Study|extubation or early discharge|5|||
23517129|NCT02921776|65632541|FG005|Overall Study|extubation or early discharge|0|||
23517130|NCT02921776|65632542|FG006|Overall Study|extubation or early discharge|0|||
23517131|NCT02921776|65632543|FG007|Overall Study|extubation or early discharge|0|||
23517132|NCT02921776|65632536|FG000|Overall Study|Lost to Follow-up|0|||
23517133|NCT02921776|65632537|FG001|Overall Study|Lost to Follow-up|0|||
23517134|NCT02921776|65632538|FG002|Overall Study|Lost to Follow-up|0|||
23307665|NCT02963441|64870561|FG000|Overall Study|Protocol violation or withdrawn|8|||
23517135|NCT02921776|65632539|FG003|Overall Study|Lost to Follow-up|0|||
23517136|NCT02921776|65632540|FG004|Overall Study|Lost to Follow-up|0|||
23517137|NCT02921776|65632541|FG005|Overall Study|Lost to Follow-up|2|||
23517138|NCT02921776|65632542|FG006|Overall Study|Lost to Follow-up|3|||
23517139|NCT02921776|65632543|FG007|Overall Study|Lost to Follow-up|6|||
23517140|NCT01675128|65632545|FG000|Overall Study|Disease progression on study|1|||
23517141|NCT01675128|65632546|FG001|Overall Study|Disease progression on study|1|||
23517142|NCT01675128|65632547|FG002|Overall Study|Disease progression on study|1|||
23517143|NCT01675128|65632545|FG000|Overall Study|Refused further treatment|1|||
23517144|NCT01675128|65632546|FG001|Overall Study|Refused further treatment|0|||
23517145|NCT01675128|65632547|FG002|Overall Study|Refused further treatment|0|||
23517146|NCT01675128|65632545|FG000|Overall Study|Pulmonary complication; off study|0|||
23517147|NCT01675128|65632546|FG001|Overall Study|Pulmonary complication; off study|1|||
23517148|NCT01675128|65632547|FG002|Overall Study|Pulmonary complication; off study|0|||
23517149|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
23517150|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
23517151|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
23517152|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
23517153|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
23517154|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
23517155|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
23517156|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
23517157|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
23517158|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
23517159|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
23517160|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
23517161|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
23517162|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
23517163|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
23517164|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
23517165|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
23517166|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
23517167|NCT00887354|65632548|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
23517168|NCT00887354|65632549|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
23517169|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
23517170|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
23517171|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
23517172|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
23517173|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
23517174|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
23517175|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
23517176|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
23517177|NCT00887354|65632548|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
23517178|NCT00887354|65632549|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
23517179|NCT02068443|65632550|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23517180|NCT02068443|65632551|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
23517181|NCT02068443|65632552|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
23517182|NCT02068443|65632550|FG000|Overall Study|Voluntary Withdrawal|4|||
23517183|NCT02068443|65632551|FG001|Overall Study|Voluntary Withdrawal|0|||
23517184|NCT02068443|65632552|FG002|Overall Study|Voluntary Withdrawal|1|||
23517185|NCT02068443|65632550|FG000|Overall Study|Lack of Efficacy|2|||
23517186|NCT02068443|65632551|FG001|Overall Study|Lack of Efficacy|1|||
23517187|NCT02068443|65632552|FG002|Overall Study|Lack of Efficacy|0|||
23517188|NCT02068443|65632550|FG000|Overall Study|Other Reason Not Specified|1|||
23517189|NCT02068443|65632551|FG001|Overall Study|Other Reason Not Specified|0|||
23517190|NCT02068443|65632552|FG002|Overall Study|Other Reason Not Specified|0|||
23517191|NCT02069366|65632554|FG000|Overall Study|Lost to Follow-up|0|||
23517192|NCT02069366|65632555|FG001|Overall Study|Lost to Follow-up|0|||
23517193|NCT02069366|65632556|FG002|Overall Study|Lost to Follow-up|1|||
23517194|NCT02069366|65632557|FG003|Overall Study|Lost to Follow-up|0|||
23517195|NCT02069366|65632558|FG004|Overall Study|Lost to Follow-up|0|||
23517196|NCT02069366|65632559|FG005|Overall Study|Lost to Follow-up|2|||
23517197|NCT02069366|65632554|FG000|Overall Study|Protocol Violation|0|||
23517198|NCT02069366|65632555|FG001|Overall Study|Protocol Violation|0|||
23517199|NCT02069366|65632556|FG002|Overall Study|Protocol Violation|1|||
23517200|NCT02069366|65632557|FG003|Overall Study|Protocol Violation|0|||
23517201|NCT02069366|65632558|FG004|Overall Study|Protocol Violation|0|||
23517202|NCT02069366|65632559|FG005|Overall Study|Protocol Violation|0|||
23517203|NCT02069366|65632554|FG000|Overall Study|Withdrawal by Subject|1|||
23517204|NCT02069366|65632555|FG001|Overall Study|Withdrawal by Subject|0|||
23517205|NCT02069366|65632556|FG002|Overall Study|Withdrawal by Subject|1|||
23517206|NCT02069366|65632557|FG003|Overall Study|Withdrawal by Subject|2|||
23517207|NCT02069366|65632558|FG004|Overall Study|Withdrawal by Subject|0|||
23517208|NCT02069366|65632559|FG005|Overall Study|Withdrawal by Subject|0|||
23517209|NCT02120950|65632560|FG000|Overall Study|Adverse Event|5|||
23517210|NCT02120950|65632561|FG001|Overall Study|Adverse Event|4|||
23517211|NCT02120950|65632562|FG002|Overall Study|Adverse Event|3|||
23517212|NCT02120950|65632560|FG000|Overall Study|Death|3|||
23517213|NCT02120950|65632561|FG001|Overall Study|Death|0|||
23517214|NCT02120950|65632562|FG002|Overall Study|Death|1|||
23517215|NCT02120950|65632560|FG000|Overall Study|Withdrawal by Subject|6|||
23517216|NCT02120950|65632561|FG001|Overall Study|Withdrawal by Subject|3|||
23517217|NCT02120950|65632562|FG002|Overall Study|Withdrawal by Subject|2|||
23517218|NCT02120950|65632560|FG000|Overall Study|Protocol Violation|1|||
23517219|NCT02120950|65632561|FG001|Overall Study|Protocol Violation|1|||
23517220|NCT02120950|65632562|FG002|Overall Study|Protocol Violation|7|||
23517221|NCT02120950|65632560|FG000|Overall Study|Other reasons|5|||
23517222|NCT02120950|65632561|FG001|Overall Study|Other reasons|4|||
23517223|NCT02120950|65632562|FG002|Overall Study|Other reasons|1|||
23517224|NCT02120950|65632560|FG000|Overall Study|Lost to Follow-up|0|||
23517225|NCT02120950|65632561|FG001|Overall Study|Lost to Follow-up|2|||
23517226|NCT02120950|65632562|FG002|Overall Study|Lost to Follow-up|1|||
23517227|NCT02617511|65632563|FG000|Overall Study|Withdrawal by Subject|1|||
23517228|NCT02617511|65632564|FG001|Overall Study|Withdrawal by Subject|0|||
23517229|NCT04351087|65632566|FG000|Overall Study|Lost to Follow-up|7|||
23517230|NCT04351087|65632567|FG001|Overall Study|Lost to Follow-up|3|||
23517231|NCT04351087|65632566|FG000|Overall Study|Withdrawal by Subject|3|||
23517232|NCT04351087|65632567|FG001|Overall Study|Withdrawal by Subject|4|||
23517233|NCT04351087|65632566|FG000|Overall Study|Lack of Efficacy|3|||
23517234|NCT04351087|65632567|FG001|Overall Study|Lack of Efficacy|2|||
23517235|NCT00624052|65632570|FG000|Overall Study|Adverse Event|7|||
23517236|NCT00624052|65632571|FG001|Overall Study|Adverse Event|6|||
23517237|NCT00624052|65632572|FG002|Overall Study|Adverse Event|0|||
23517238|NCT00624052|65632573|FG003|Overall Study|Adverse Event|3|||
23517239|NCT00624052|65632570|FG000|Overall Study|Lack of Efficacy|1|||
23517240|NCT00624052|65632571|FG001|Overall Study|Lack of Efficacy|1|||
23517241|NCT00624052|65632572|FG002|Overall Study|Lack of Efficacy|0|||
23517242|NCT00624052|65632573|FG003|Overall Study|Lack of Efficacy|0|||
23517243|NCT00624052|65632570|FG000|Overall Study|Lost to Follow-up|2|||
23517244|NCT00624052|65632571|FG001|Overall Study|Lost to Follow-up|3|||
23517245|NCT00624052|65632572|FG002|Overall Study|Lost to Follow-up|1|||
23517246|NCT00624052|65632573|FG003|Overall Study|Lost to Follow-up|0|||
23517247|NCT00624052|65632570|FG000|Overall Study|Non compliant with the protocol|2|||
23517248|NCT00624052|65632571|FG001|Overall Study|Non compliant with the protocol|1|||
23517249|NCT00624052|65632572|FG002|Overall Study|Non compliant with the protocol|1|||
23517250|NCT00624052|65632573|FG003|Overall Study|Non compliant with the protocol|1|||
23517251|NCT00624052|65632570|FG000|Overall Study|Consent withdrawn|3|||
23517252|NCT00624052|65632571|FG001|Overall Study|Consent withdrawn|1|||
23517253|NCT00624052|65632572|FG002|Overall Study|Consent withdrawn|1|||
23517254|NCT00624052|65632573|FG003|Overall Study|Consent withdrawn|0|||
23517255|NCT00624052|65632570|FG000|Overall Study|Changed job/ran out if meds|0|||
23517256|NCT00624052|65632571|FG001|Overall Study|Changed job/ran out if meds|2|||
23517257|NCT00624052|65632572|FG002|Overall Study|Changed job/ran out if meds|0|||
23517258|NCT00624052|65632573|FG003|Overall Study|Changed job/ran out if meds|0|||
23517259|NCT01782859|65632575|FG000|Overall Study|Protocol Violation|6|||
23517260|NCT01782859|65632576|FG001|Overall Study|Protocol Violation|6|||
23517261|NCT01782859|65632575|FG000|Overall Study|Withdrawal by Subject|0|||
23517262|NCT01782859|65632576|FG001|Overall Study|Withdrawal by Subject|1|||
23517263|NCT00411645|65632578|FG000|Overall Study|Consent Withdrawn|13|||
23517264|NCT00411645|65632579|FG001|Overall Study|Consent Withdrawn|22|||
23517265|NCT00411645|65632578|FG000|Overall Study|Death|56|||
23517266|NCT00411645|65632579|FG001|Overall Study|Death|135|||
23517267|NCT00411645|65632578|FG000|Overall Study|Investigator/Sponsor Decision|10|||
23517268|NCT00411645|65632579|FG001|Overall Study|Investigator/Sponsor Decision|7|||
23517269|NCT00411645|65632578|FG000|Overall Study|Lost to Follow-up|2|||
23517270|NCT00411645|65632579|FG001|Overall Study|Lost to Follow-up|0|||
23517271|NCT02723084|65632580|FG000|Overall Study|Withdrawal by Subject|1|||
23517272|NCT02723084|65632581|FG001|Overall Study|Withdrawal by Subject|1|||
23517273|NCT02723084|65632580|FG000|Overall Study|Lost to Follow-up|3|||
23517274|NCT02723084|65632581|FG001|Overall Study|Lost to Follow-up|0|||
23517275|NCT00560950|65632582|FG000|Overall Study|Lost to Follow-up|1|||
23517276|NCT00560950|65632583|FG001|Overall Study|Lost to Follow-up|0|||
23517277|NCT01428453|65632587|FG000|Overall Study|Adverse Event|2|||
23517278|NCT01428453|65632588|FG001|Overall Study|Adverse Event|7|||
23517279|NCT01428453|65632587|FG000|Overall Study|Protocol Violation|1|||
23517280|NCT01428453|65632588|FG001|Overall Study|Protocol Violation|0|||
23517281|NCT01428453|65632587|FG000|Overall Study|Lost to Follow-up|0|||
23517282|NCT01428453|65632588|FG001|Overall Study|Lost to Follow-up|1|||
23517283|NCT01428453|65632587|FG000|Overall Study|Withdrawal by Subject|3|||
23517284|NCT01428453|65632588|FG001|Overall Study|Withdrawal by Subject|1|||
23416191|NCT01893411|65266166|FG001|Overall Study|Lost to Follow-up|0|||
23517285|NCT02968563|65632589|FG000|Overall Study|Adverse Event|0|||
23517286|NCT02968563|65632590|FG001|Overall Study|Adverse Event|6|||
23517287|NCT02968563|65632589|FG000|Overall Study|Death|1|||
23517288|NCT02968563|65632590|FG001|Overall Study|Death|1|||
23517289|NCT02968563|65632589|FG000|Overall Study|Lost to Follow-up|0|||
23517290|NCT02968563|65632590|FG001|Overall Study|Lost to Follow-up|1|||
23517291|NCT00003901|65632591|FG000|Overall Study|Adverse Event|1|||
23517292|NCT00003901|65632591|FG000|Overall Study|Withdrawal by Subject|1|||
23517293|NCT00003901|65632591|FG000|Overall Study|Ineligible|6|||
23517294|NCT00003901|65632591|FG000|Overall Study|CT Scan not within protocol requirement|2|||
23517295|NCT00003901|65632591|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
23517296|NCT00003901|65632591|FG000|Overall Study|Medical problems|6|||
23517297|NCT01275833|65632592|FG000|Overall Study|Study terminated|1|||
23517298|NCT01275833|65632593|FG001|Overall Study|Study terminated|1|||
23517299|NCT01466348|65632594|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
23517300|NCT01466348|65632595|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
23517301|NCT02551731|65632598|FG000|Overall Study|Withdrawal by Subject|2|||
23517302|NCT02141282|65632599|FG000|Overall Study|Adverse event, not related to progression|8|||
23517303|NCT02141282|65632600|FG001|Overall Study|Adverse event, not related to progression|1|||
23517304|NCT02141282|65632601|FG002|Overall Study|Adverse event, not related to progression|3|||
23517305|NCT02141282|65632602|FG003|Overall Study|Adverse event, not related to progression|1|||
23517306|NCT02141282|65632599|FG000|Overall Study|Adverse event, related to progression|1|||
23517307|NCT02141282|65632600|FG001|Overall Study|Adverse event, related to progression|0|||
23517308|NCT02141282|65632601|FG002|Overall Study|Adverse event, related to progression|2|||
23517309|NCT02141282|65632602|FG003|Overall Study|Adverse event, related to progression|0|||
23517310|NCT02141282|65632599|FG000|Overall Study|COVID-19 infection|1|||
23517311|NCT02141282|65632600|FG001|Overall Study|COVID-19 infection|0|||
23517312|NCT02141282|65632601|FG002|Overall Study|COVID-19 infection|0|||
23517313|NCT02141282|65632602|FG003|Overall Study|COVID-19 infection|0|||
23517314|NCT02141282|65632599|FG000|Overall Study|Lost to Follow-up|0|||
23517315|NCT02141282|65632600|FG001|Overall Study|Lost to Follow-up|0|||
23517316|NCT02141282|65632601|FG002|Overall Study|Lost to Follow-up|4|||
23517317|NCT02141282|65632602|FG003|Overall Study|Lost to Follow-up|2|||
23517318|NCT02141282|65632599|FG000|Overall Study|Other, not specified|14|||
23517319|NCT02141282|65632600|FG001|Overall Study|Other, not specified|11|||
23517320|NCT02141282|65632601|FG002|Overall Study|Other, not specified|23|||
23517321|NCT02141282|65632602|FG003|Overall Study|Other, not specified|9|||
23517322|NCT02141282|65632599|FG000|Overall Study|Progressive disease, Richter's|4|||
23517323|NCT02141282|65632600|FG001|Overall Study|Progressive disease, Richter's|1|||
23517324|NCT02141282|65632601|FG002|Overall Study|Progressive disease, Richter's|1|||
23517325|NCT02141282|65632602|FG003|Overall Study|Progressive disease, Richter's|1|||
23517326|NCT02141282|65632599|FG000|Overall Study|Progressive disease per protocol|12|||
23517327|NCT02141282|65632600|FG001|Overall Study|Progressive disease per protocol|7|||
23517328|NCT02141282|65632601|FG002|Overall Study|Progressive disease per protocol|9|||
23517329|NCT02141282|65632602|FG003|Overall Study|Progressive disease per protocol|2|||
23517330|NCT02141282|65632599|FG000|Overall Study|Stem cell transplant|1|||
23517331|NCT02141282|65632600|FG001|Overall Study|Stem cell transplant|0|||
23517332|NCT02141282|65632601|FG002|Overall Study|Stem cell transplant|1|||
23517333|NCT02141282|65632602|FG003|Overall Study|Stem cell transplant|0|||
23517334|NCT02141282|65632599|FG000|Overall Study|Study terminated by Sponsor|0|||
23517335|NCT02141282|65632600|FG001|Overall Study|Study terminated by Sponsor|1|||
23517336|NCT02141282|65632601|FG002|Overall Study|Study terminated by Sponsor|0|||
23517337|NCT02141282|65632602|FG003|Overall Study|Study terminated by Sponsor|0|||
23517338|NCT02141282|65632599|FG000|Overall Study|Subject non-compliance|0|||
23517339|NCT02141282|65632600|FG001|Overall Study|Subject non-compliance|0|||
23517340|NCT02141282|65632601|FG002|Overall Study|Subject non-compliance|1|||
23517341|NCT02141282|65632602|FG003|Overall Study|Subject non-compliance|0|||
23517342|NCT02141282|65632599|FG000|Overall Study|Withdrew consent|2|||
23517343|NCT02141282|65632600|FG001|Overall Study|Withdrew consent|0|||
23517344|NCT02141282|65632601|FG002|Overall Study|Withdrew consent|4|||
23517345|NCT02141282|65632602|FG003|Overall Study|Withdrew consent|0|||
23517346|NCT01881230|65632603|FG000|Overall Study|Death|2|||
23517347|NCT01881230|65632604|FG001|Overall Study|Death|0|||
23517348|NCT01881230|65632605|FG002|Overall Study|Death|1|||
23517349|NCT01881230|65632603|FG000|Overall Study|Adverse Event|9|||
23517350|NCT01881230|65632604|FG001|Overall Study|Adverse Event|13|||
23517351|NCT01881230|65632605|FG002|Overall Study|Adverse Event|12|||
23517352|NCT01881230|65632603|FG000|Overall Study|Progressive Disease|31|||
23517353|NCT01881230|65632604|FG001|Overall Study|Progressive Disease|35|||
23517354|NCT01881230|65632605|FG002|Overall Study|Progressive Disease|36|||
23517355|NCT01881230|65632603|FG000|Overall Study|Symptomatic Deterioration|3|||
23517356|NCT01881230|65632604|FG001|Overall Study|Symptomatic Deterioration|3|||
23517357|NCT01881230|65632605|FG002|Overall Study|Symptomatic Deterioration|1|||
23517358|NCT01881230|65632603|FG000|Overall Study|Withdrawal by Subject|6|||
23517359|NCT01881230|65632604|FG001|Overall Study|Withdrawal by Subject|4|||
23517360|NCT01881230|65632605|FG002|Overall Study|Withdrawal by Subject|6|||
23517361|NCT01881230|65632603|FG000|Overall Study|Physician Decision|4|||
23517362|NCT01881230|65632604|FG001|Overall Study|Physician Decision|3|||
23517363|NCT01881230|65632605|FG002|Overall Study|Physician Decision|6|||
23517364|NCT01881230|65632603|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23517365|NCT01881230|65632604|FG001|Overall Study|Non-Compliance with Study Drug|2|||
23517366|NCT01881230|65632605|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23517367|NCT01881230|65632603|FG000|Overall Study|Given Commercially Available Drug|0|||
23517368|NCT01881230|65632604|FG001|Overall Study|Given Commercially Available Drug|0|||
23517369|NCT01881230|65632605|FG002|Overall Study|Given Commercially Available Drug|2|||
23517370|NCT01881230|65632603|FG000|Overall Study|Protocol Violation|1|||
23517371|NCT01881230|65632604|FG001|Overall Study|Protocol Violation|1|||
23517372|NCT01881230|65632605|FG002|Overall Study|Protocol Violation|0|||
23517373|NCT01881230|65632603|FG000|Overall Study|Miscellaneous|3|||
23517374|NCT01881230|65632604|FG001|Overall Study|Miscellaneous|3|||
23517375|NCT01881230|65632605|FG002|Overall Study|Miscellaneous|0|||
23517376|NCT01881230|65632603|FG000|Overall Study|Untreated: Other|0|||
23517377|NCT01881230|65632604|FG001|Overall Study|Untreated: Other|0|||
23517378|NCT01881230|65632605|FG002|Overall Study|Untreated: Other|1|||
23517379|NCT01881230|65632603|FG000|Overall Study|Untreated: Death|0|||
23517380|NCT01881230|65632604|FG001|Overall Study|Untreated: Death|0|||
23517381|NCT01881230|65632605|FG002|Overall Study|Untreated: Death|1|||
23517382|NCT01881230|65632603|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
23517383|NCT01881230|65632604|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
23517384|NCT01881230|65632605|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
23517385|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Death|3|||
23517386|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Death|2|||
23517387|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Death|4|||
23517388|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Death|3|||
23517389|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Death|0|||
23517390|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Death|0|||
23517391|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
23517392|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
23517393|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
23517394|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
23307666|NCT02963441|64870561|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
23307667|NCT02963441|64870561|FG000|Overall Study|IDx-DR insufficient quality|33|||
23517395|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
23517396|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
23517397|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
23517398|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23517399|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23517400|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23517401|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23517402|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
23517403|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
23517404|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
23517405|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
23517406|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
23517407|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
23517408|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
23517409|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
23517410|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
23517411|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
23517412|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
23517413|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
23517414|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
23517415|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
23517416|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
23517417|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
23517418|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
23517419|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
23517420|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
23517421|NCT02432846|65632606|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517422|NCT02432846|65632607|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517423|NCT02432846|65632608|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
23517424|NCT02432846|65632609|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517425|NCT02432846|65632610|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517426|NCT02432846|65632611|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
23517427|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
23517428|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
23517429|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
23517430|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
23517431|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
23517432|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
23517433|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
23517434|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
23517435|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
23517436|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
23517437|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
23517438|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
23517439|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517440|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517441|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517442|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517443|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
23517444|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
23517445|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
23517446|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
23517447|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
23517448|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
23517449|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
23517450|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
23517451|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
23517452|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
23517453|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
23517454|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
23517455|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
23517456|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
23517457|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
23517458|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
23517459|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
23517460|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
23517461|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
23307668|NCT02730351|64870562|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
23307669|NCT02730351|64870563|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
23517462|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
23307670|NCT02730351|64870562|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
23416192|NCT01893411|65266167|FG002|Overall Study|Lost to Follow-up|1|||
23517463|NCT02432846|65632606|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517464|NCT02432846|65632607|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517465|NCT02432846|65632608|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517466|NCT02432846|65632609|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517467|NCT02432846|65632610|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
23517468|NCT02432846|65632611|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
23517469|NCT01166763|65632612|FG000|Overall Study|Withdrawal by Subject|3|||
23517470|NCT02393547|65632613|FG000|Overall Study|Adverse Event|2|||
23517471|NCT02393547|65632613|FG000|Overall Study|Withdrawal by Subject|3|||
23517472|NCT02393547|65632613|FG000|Overall Study|Lost to Follow-up|1|||
23517473|NCT02206828|65632614|FG000|Overall Study|Lost to Follow-up|7|||
23517474|NCT04256785|65632615|FG000|Overall Study|Adverse Event|8|||
23517475|NCT04256785|65632616|FG001|Overall Study|Adverse Event|6|||
23517476|NCT04256785|65632615|FG000|Overall Study|Lack of Efficacy|3|||
23517477|NCT04256785|65632616|FG001|Overall Study|Lack of Efficacy|4|||
23517478|NCT04256785|65632615|FG000|Overall Study|Lost to Follow-up|7|||
23517479|NCT04256785|65632616|FG001|Overall Study|Lost to Follow-up|7|||
23517480|NCT04256785|65632615|FG000|Overall Study|Protocol Violation|1|||
23517481|NCT04256785|65632616|FG001|Overall Study|Protocol Violation|0|||
23517482|NCT04256785|65632615|FG000|Overall Study|Withdrawal by Subject|4|||
23517483|NCT04256785|65632616|FG001|Overall Study|Withdrawal by Subject|1|||
23517484|NCT04256785|65632615|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
23517485|NCT04256785|65632616|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
23517486|NCT02276872|65632621|FG000|Overall Study|Adverse Event|1|||
23517487|NCT02276872|65632622|FG001|Overall Study|Adverse Event|0|||
23517488|NCT02276872|65632623|FG002|Overall Study|Adverse Event|0|||
23517489|NCT02039674|65632625|FG000|Overall Study|Adverse Event|0|||
23517490|NCT02039674|65632626|FG001|Overall Study|Adverse Event|0|||
23517491|NCT02039674|65632627|FG002|Overall Study|Adverse Event|0|||
23517492|NCT02039674|65632628|FG003|Overall Study|Adverse Event|1|||
23517493|NCT02039674|65632629|FG004|Overall Study|Adverse Event|0|||
23517494|NCT02039674|65632630|FG005|Overall Study|Adverse Event|0|||
23517495|NCT02039674|65632631|FG006|Overall Study|Adverse Event|0|||
23517496|NCT02039674|65632632|FG007|Overall Study|Adverse Event|0|||
23517497|NCT02039674|65632633|FG008|Overall Study|Adverse Event|2|||
23517498|NCT02039674|65632634|FG009|Overall Study|Adverse Event|1|||
23517499|NCT02039674|65632635|FG010|Overall Study|Adverse Event|0|||
23517500|NCT02039674|65632636|FG011|Overall Study|Adverse Event|2|||
23517501|NCT02039674|65632637|FG012|Overall Study|Adverse Event|3|||
23517502|NCT02039674|65632638|FG013|Overall Study|Adverse Event|1|||
23517503|NCT02039674|65632625|FG000|Overall Study|Death|2|||
23517504|NCT02039674|65632626|FG001|Overall Study|Death|0|||
23517505|NCT02039674|65632627|FG002|Overall Study|Death|2|||
23517506|NCT02039674|65632628|FG003|Overall Study|Death|3|||
23517507|NCT02039674|65632629|FG004|Overall Study|Death|0|||
23517508|NCT02039674|65632630|FG005|Overall Study|Death|0|||
23517509|NCT02039674|65632631|FG006|Overall Study|Death|1|||
23517510|NCT02039674|65632632|FG007|Overall Study|Death|0|||
23517511|NCT02039674|65632633|FG008|Overall Study|Death|2|||
23517512|NCT02039674|65632634|FG009|Overall Study|Death|0|||
23517513|NCT02039674|65632635|FG010|Overall Study|Death|1|||
23517514|NCT02039674|65632636|FG011|Overall Study|Death|3|||
23517515|NCT02039674|65632637|FG012|Overall Study|Death|2|||
23517516|NCT02039674|65632638|FG013|Overall Study|Death|8|||
23517517|NCT02039674|65632625|FG000|Overall Study|Excluded Medication|1|||
23517518|NCT02039674|65632626|FG001|Overall Study|Excluded Medication|1|||
23517519|NCT02039674|65632627|FG002|Overall Study|Excluded Medication|0|||
23517520|NCT02039674|65632628|FG003|Overall Study|Excluded Medication|1|||
23517521|NCT02039674|65632629|FG004|Overall Study|Excluded Medication|0|||
23517522|NCT02039674|65632630|FG005|Overall Study|Excluded Medication|1|||
23517523|NCT02039674|65632631|FG006|Overall Study|Excluded Medication|0|||
23517524|NCT02039674|65632632|FG007|Overall Study|Excluded Medication|0|||
23517525|NCT02039674|65632633|FG008|Overall Study|Excluded Medication|2|||
23517526|NCT02039674|65632634|FG009|Overall Study|Excluded Medication|3|||
23517527|NCT02039674|65632635|FG010|Overall Study|Excluded Medication|5|||
23517528|NCT02039674|65632636|FG011|Overall Study|Excluded Medication|6|||
23517529|NCT02039674|65632637|FG012|Overall Study|Excluded Medication|8|||
23517530|NCT02039674|65632638|FG013|Overall Study|Excluded Medication|3|||
23517531|NCT02039674|65632625|FG000|Overall Study|Lost to Follow-up|0|||
23517532|NCT02039674|65632626|FG001|Overall Study|Lost to Follow-up|0|||
23517533|NCT02039674|65632627|FG002|Overall Study|Lost to Follow-up|0|||
23517534|NCT02039674|65632628|FG003|Overall Study|Lost to Follow-up|0|||
23517535|NCT02039674|65632629|FG004|Overall Study|Lost to Follow-up|1|||
23517536|NCT02039674|65632630|FG005|Overall Study|Lost to Follow-up|1|||
23517537|NCT02039674|65632631|FG006|Overall Study|Lost to Follow-up|0|||
23517538|NCT02039674|65632632|FG007|Overall Study|Lost to Follow-up|0|||
23517539|NCT02039674|65632633|FG008|Overall Study|Lost to Follow-up|0|||
23517540|NCT02039674|65632634|FG009|Overall Study|Lost to Follow-up|0|||
23517541|NCT02039674|65632635|FG010|Overall Study|Lost to Follow-up|0|||
23517542|NCT02039674|65632636|FG011|Overall Study|Lost to Follow-up|2|||
23517543|NCT02039674|65632637|FG012|Overall Study|Lost to Follow-up|2|||
23517544|NCT02039674|65632638|FG013|Overall Study|Lost to Follow-up|1|||
23517545|NCT02039674|65632625|FG000|Overall Study|Physician Decision|0|||
23517546|NCT02039674|65632626|FG001|Overall Study|Physician Decision|0|||
23517547|NCT02039674|65632627|FG002|Overall Study|Physician Decision|0|||
23517548|NCT02039674|65632628|FG003|Overall Study|Physician Decision|0|||
23517549|NCT02039674|65632629|FG004|Overall Study|Physician Decision|0|||
23517550|NCT02039674|65632630|FG005|Overall Study|Physician Decision|0|||
23517551|NCT02039674|65632631|FG006|Overall Study|Physician Decision|0|||
23517552|NCT02039674|65632632|FG007|Overall Study|Physician Decision|0|||
23517553|NCT02039674|65632633|FG008|Overall Study|Physician Decision|0|||
23517554|NCT02039674|65632634|FG009|Overall Study|Physician Decision|0|||
23517555|NCT02039674|65632635|FG010|Overall Study|Physician Decision|0|||
23517556|NCT02039674|65632636|FG011|Overall Study|Physician Decision|1|||
23517557|NCT02039674|65632637|FG012|Overall Study|Physician Decision|1|||
23517558|NCT02039674|65632638|FG013|Overall Study|Physician Decision|0|||
23517559|NCT02039674|65632625|FG000|Overall Study|Progressive Disease|8|||
23517560|NCT02039674|65632626|FG001|Overall Study|Progressive Disease|8|||
23517561|NCT02039674|65632627|FG002|Overall Study|Progressive Disease|6|||
23517562|NCT02039674|65632628|FG003|Overall Study|Progressive Disease|7|||
23517563|NCT02039674|65632629|FG004|Overall Study|Progressive Disease|9|||
23517564|NCT02039674|65632630|FG005|Overall Study|Progressive Disease|10|||
23517565|NCT02039674|65632631|FG006|Overall Study|Progressive Disease|1|||
23517566|NCT02039674|65632632|FG007|Overall Study|Progressive Disease|3|||
23517567|NCT02039674|65632633|FG008|Overall Study|Progressive Disease|6|||
23517568|NCT02039674|65632634|FG009|Overall Study|Progressive Disease|4|||
23517569|NCT02039674|65632635|FG010|Overall Study|Progressive Disease|0|||
23517570|NCT02039674|65632636|FG011|Overall Study|Progressive Disease|34|||
23517571|NCT02039674|65632637|FG012|Overall Study|Progressive Disease|34|||
23517572|NCT02039674|65632638|FG013|Overall Study|Progressive Disease|18|||
23517573|NCT02039674|65632625|FG000|Overall Study|Withdrawal by Subject|1|||
23517574|NCT02039674|65632626|FG001|Overall Study|Withdrawal by Subject|2|||
23517575|NCT02039674|65632627|FG002|Overall Study|Withdrawal by Subject|3|||
23517576|NCT02039674|65632628|FG003|Overall Study|Withdrawal by Subject|0|||
23517577|NCT02039674|65632629|FG004|Overall Study|Withdrawal by Subject|1|||
23517578|NCT02039674|65632630|FG005|Overall Study|Withdrawal by Subject|0|||
23517579|NCT02039674|65632631|FG006|Overall Study|Withdrawal by Subject|0|||
23517580|NCT02039674|65632632|FG007|Overall Study|Withdrawal by Subject|0|||
23517581|NCT02039674|65632633|FG008|Overall Study|Withdrawal by Subject|0|||
23517582|NCT02039674|65632634|FG009|Overall Study|Withdrawal by Subject|1|||
23517583|NCT02039674|65632635|FG010|Overall Study|Withdrawal by Subject|1|||
23517584|NCT02039674|65632636|FG011|Overall Study|Withdrawal by Subject|4|||
23517585|NCT02039674|65632637|FG012|Overall Study|Withdrawal by Subject|6|||
23517586|NCT02039674|65632638|FG013|Overall Study|Withdrawal by Subject|2|||
23517587|NCT02039674|65632625|FG000|Overall Study|Clinical Progression|0|||
23517588|NCT02039674|65632626|FG001|Overall Study|Clinical Progression|0|||
23517589|NCT02039674|65632627|FG002|Overall Study|Clinical Progression|0|||
23307671|NCT02730351|64870563|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
23517590|NCT02039674|65632628|FG003|Overall Study|Clinical Progression|0|||
23517591|NCT02039674|65632629|FG004|Overall Study|Clinical Progression|0|||
23517592|NCT02039674|65632630|FG005|Overall Study|Clinical Progression|0|||
23517593|NCT02039674|65632631|FG006|Overall Study|Clinical Progression|1|||
23517594|NCT02039674|65632632|FG007|Overall Study|Clinical Progression|0|||
23517595|NCT02039674|65632633|FG008|Overall Study|Clinical Progression|0|||
23517596|NCT02039674|65632634|FG009|Overall Study|Clinical Progression|0|||
23307672|NCT02730351|64870562|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
23517597|NCT02039674|65632635|FG010|Overall Study|Clinical Progression|0|||
23517598|NCT02039674|65632636|FG011|Overall Study|Clinical Progression|0|||
23517599|NCT02039674|65632637|FG012|Overall Study|Clinical Progression|1|||
23517600|NCT02039674|65632638|FG013|Overall Study|Clinical Progression|0|||
23517601|NCT02039674|65632625|FG000|Overall Study|Sponsor Decision|1|||
23517602|NCT02039674|65632626|FG001|Overall Study|Sponsor Decision|1|||
23517603|NCT02039674|65632627|FG002|Overall Study|Sponsor Decision|1|||
23517604|NCT02039674|65632628|FG003|Overall Study|Sponsor Decision|1|||
23517605|NCT02039674|65632629|FG004|Overall Study|Sponsor Decision|1|||
23517606|NCT02039674|65632630|FG005|Overall Study|Sponsor Decision|0|||
23517607|NCT02039674|65632631|FG006|Overall Study|Sponsor Decision|0|||
23517608|NCT02039674|65632632|FG007|Overall Study|Sponsor Decision|0|||
23517609|NCT02039674|65632633|FG008|Overall Study|Sponsor Decision|0|||
23517610|NCT02039674|65632634|FG009|Overall Study|Sponsor Decision|3|||
23517611|NCT02039674|65632635|FG010|Overall Study|Sponsor Decision|0|||
23517612|NCT02039674|65632636|FG011|Overall Study|Sponsor Decision|8|||
23517613|NCT02039674|65632637|FG012|Overall Study|Sponsor Decision|5|||
23517614|NCT02039674|65632638|FG013|Overall Study|Sponsor Decision|0|||
23517615|NCT02039674|65632625|FG000|Overall Study|Other|0|||
23517616|NCT02039674|65632626|FG001|Overall Study|Other|0|||
23517617|NCT02039674|65632627|FG002|Overall Study|Other|0|||
23517618|NCT02039674|65632628|FG003|Overall Study|Other|0|||
23517619|NCT02039674|65632629|FG004|Overall Study|Other|0|||
23517620|NCT02039674|65632630|FG005|Overall Study|Other|0|||
23517621|NCT02039674|65632631|FG006|Overall Study|Other|0|||
23517622|NCT02039674|65632632|FG007|Overall Study|Other|0|||
23517623|NCT02039674|65632633|FG008|Overall Study|Other|0|||
23517624|NCT02039674|65632634|FG009|Overall Study|Other|0|||
23517625|NCT02039674|65632635|FG010|Overall Study|Other|0|||
23517626|NCT02039674|65632636|FG011|Overall Study|Other|0|||
23517627|NCT02039674|65632637|FG012|Overall Study|Other|1|||
23517628|NCT02039674|65632638|FG013|Overall Study|Other|0|||
23517629|NCT02081079|65632639|FG000|Overall Study|Lack of Efficacy|3|||
23517630|NCT02081079|65632640|FG001|Overall Study|Lack of Efficacy|2|||
23517631|NCT02081079|65632639|FG000|Overall Study|Lost to Follow-up|1|||
23517632|NCT02081079|65632640|FG001|Overall Study|Lost to Follow-up|0|||
23517633|NCT00680745|65632641|FG000|Overall Study|Withdrawal by Subject|8|||
23517634|NCT00680745|65632642|FG001|Overall Study|Withdrawal by Subject|3|||
23517635|NCT00680745|65632643|FG002|Overall Study|Withdrawal by Subject|2|||
23517636|NCT00680745|65632644|FG003|Overall Study|Withdrawal by Subject|8|||
23517637|NCT00680745|65632641|FG000|Overall Study|Lost to Follow-up|0|||
23517638|NCT00680745|65632642|FG001|Overall Study|Lost to Follow-up|1|||
23517639|NCT00680745|65632643|FG002|Overall Study|Lost to Follow-up|1|||
23517640|NCT00680745|65632644|FG003|Overall Study|Lost to Follow-up|0|||
23517641|NCT00680745|65632641|FG000|Overall Study|Death|1|||
23517642|NCT00680745|65632642|FG001|Overall Study|Death|0|||
23517643|NCT00680745|65632643|FG002|Overall Study|Death|1|||
23517644|NCT00680745|65632644|FG003|Overall Study|Death|0|||
23517645|NCT00680745|65632641|FG000|Overall Study|Adverse Event|5|||
23517646|NCT00680745|65632642|FG001|Overall Study|Adverse Event|3|||
23517647|NCT00680745|65632643|FG002|Overall Study|Adverse Event|3|||
23517648|NCT00680745|65632644|FG003|Overall Study|Adverse Event|3|||
23517649|NCT00680745|65632641|FG000|Overall Study|Poor/Non-compliance|0|||
23517650|NCT00680745|65632642|FG001|Overall Study|Poor/Non-compliance|3|||
23517651|NCT00680745|65632643|FG002|Overall Study|Poor/Non-compliance|0|||
23517652|NCT00680745|65632644|FG003|Overall Study|Poor/Non-compliance|0|||
23517653|NCT00680745|65632641|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
23517654|NCT00680745|65632642|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
23517655|NCT00680745|65632643|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
23517656|NCT00680745|65632644|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
23517657|NCT00680745|65632641|FG000|Overall Study|False Treatment|0|||
23517658|NCT00680745|65632642|FG001|Overall Study|False Treatment|1|||
23517659|NCT00680745|65632643|FG002|Overall Study|False Treatment|3|||
23517660|NCT00680745|65632644|FG003|Overall Study|False Treatment|0|||
23517661|NCT00730912|65632645|FG000|Overall Study|Discontinued|0|||
23517662|NCT00730912|65632646|FG001|Overall Study|Discontinued|0|||
23517663|NCT00730912|65632647|FG002|Overall Study|Discontinued|1|||
23517664|NCT02024867|65632650|FG000|Overall Study|Protocol Violation|3|||
23517665|NCT02024867|65632651|FG001|Overall Study|Protocol Violation|3|||
23517666|NCT02024867|65632650|FG000|Overall Study|Lost to Follow-up|6|||
23517667|NCT02024867|65632651|FG001|Overall Study|Lost to Follow-up|4|||
23517668|NCT01549392|65632652|FG000|Overall Study|Withdrawal by Subject|1|||
23517669|NCT01549392|65632653|FG001|Overall Study|Withdrawal by Subject|0|||
23517670|NCT00664742|65632660|FG000|Overall Study|Withdrawn due to adverse events|3|||
23517671|NCT00664742|65632660|FG000|Overall Study|Withdrawal by Subject|31|||
23517672|NCT00664742|65632660|FG000|Overall Study|Lost to Follow-up|92|||
23517673|NCT02677987|65632661|FG000|Overall Study|Withdrawal by Subject|3|||
23517674|NCT02677987|65632662|FG001|Overall Study|Withdrawal by Subject|0|||
23517675|NCT02677987|65632661|FG000|Overall Study|Lost to Follow-up|1|||
23517676|NCT02677987|65632662|FG001|Overall Study|Lost to Follow-up|0|||
23517677|NCT04200456|65632663|FG000|Overall Study|Physician Decision|0|||
23517678|NCT04200456|65632664|FG001|Overall Study|Physician Decision|1|||
23517679|NCT04200456|65632663|FG000|Overall Study|Withdrawal by Subject|2|||
23517680|NCT04200456|65632664|FG001|Overall Study|Withdrawal by Subject|2|||
23517681|NCT04200456|65632663|FG000|Overall Study|Lack of Efficacy|1|||
23517682|NCT04200456|65632664|FG001|Overall Study|Lack of Efficacy|1|||
23517683|NCT04200456|65632663|FG000|Overall Study|Adverse event, non-fatal|0|||
23517684|NCT04200456|65632664|FG001|Overall Study|Adverse event, non-fatal|1|||
23517685|NCT04200456|65632663|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
23517686|NCT04200456|65632664|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
23517687|NCT03897179|65632674|FG000|Overall Study|Withdrawal by Subject|1|||
23517688|NCT01348347|65632677|FG000|Overall Study|Withdrawal by Subject|1|||
23517689|NCT01348347|65632678|FG001|Overall Study|Withdrawal by Subject|1|||
23517690|NCT01348347|65632679|FG002|Overall Study|Withdrawal by Subject|1|||
23517691|NCT01348347|65632677|FG000|Overall Study|Progressive disease|2|||
23517692|NCT01348347|65632678|FG001|Overall Study|Progressive disease|5|||
23517693|NCT01348347|65632679|FG002|Overall Study|Progressive disease|5|||
23517694|NCT03721276|65632680|FG000|Overall Study|Lost to Follow-up|5|||
23517695|NCT03721276|65632681|FG001|Overall Study|Lost to Follow-up|3|||
23517696|NCT03721276|65632680|FG000|Overall Study|Adverse Event|0|||
23517697|NCT03721276|65632681|FG001|Overall Study|Adverse Event|1|||
23517698|NCT00909779|65632683|FG000|Overall Study|Adverse Event|53|||
23517699|NCT00909779|65632684|FG001|Overall Study|Adverse Event|55|||
23517700|NCT00909779|65632683|FG000|Overall Study|Lack of Efficacy|7|||
23517701|NCT00909779|65632684|FG001|Overall Study|Lack of Efficacy|4|||
23517702|NCT00909779|65632683|FG000|Overall Study|Lost to Follow-up|19|||
23517703|NCT00909779|65632684|FG001|Overall Study|Lost to Follow-up|15|||
23517704|NCT00909779|65632683|FG000|Overall Study|Physician Decision|8|||
23517705|NCT00909779|65632684|FG001|Overall Study|Physician Decision|2|||
23517706|NCT00909779|65632683|FG000|Overall Study|Protocol Violation|2|||
23517707|NCT00909779|65632684|FG001|Overall Study|Protocol Violation|5|||
23517708|NCT00909779|65632683|FG000|Overall Study|Withdrawal by Subject|116|||
23517709|NCT00909779|65632684|FG001|Overall Study|Withdrawal by Subject|80|||
23517710|NCT00909779|65632683|FG000|Overall Study|Site Ceasing Operation|2|||
23517711|NCT00909779|65632684|FG001|Overall Study|Site Ceasing Operation|2|||
23517712|NCT00909779|65632683|FG000|Overall Study|Medical Monitor Decision|1|||
23517713|NCT00909779|65632684|FG001|Overall Study|Medical Monitor Decision|0|||
23517714|NCT00909779|65632683|FG000|Overall Study|Noncompliance|1|||
23517715|NCT00909779|65632684|FG001|Overall Study|Noncompliance|1|||
23517716|NCT00909779|65632683|FG000|Overall Study|Randomized in error|1|||
23517717|NCT00909779|65632684|FG001|Overall Study|Randomized in error|1|||
23517718|NCT02045797|65632685|FG000|Overall Study|Adverse Event|3|||
23517719|NCT02045797|65632686|FG001|Overall Study|Adverse Event|1|||
23517720|NCT02045797|65632687|FG002|Overall Study|Adverse Event|0|||
23517721|NCT02045797|65632685|FG000|Overall Study|Lack of Efficacy|1|||
23517722|NCT02045797|65632686|FG001|Overall Study|Lack of Efficacy|0|||
23517723|NCT02045797|65632687|FG002|Overall Study|Lack of Efficacy|0|||
23517724|NCT02045797|65632685|FG000|Overall Study|Lost to Follow-up|2|||
23517725|NCT02045797|65632686|FG001|Overall Study|Lost to Follow-up|3|||
23517726|NCT02045797|65632687|FG002|Overall Study|Lost to Follow-up|1|||
23517727|NCT02045797|65632685|FG000|Overall Study|Physician Decision|0|||
23517728|NCT02045797|65632686|FG001|Overall Study|Physician Decision|1|||
23517729|NCT02045797|65632687|FG002|Overall Study|Physician Decision|0|||
23517730|NCT02045797|65632685|FG000|Overall Study|Withdrawal by Subject|1|||
23517731|NCT02045797|65632686|FG001|Overall Study|Withdrawal by Subject|2|||
23517732|NCT02045797|65632687|FG002|Overall Study|Withdrawal by Subject|0|||
23517733|NCT01266460|65632697|FG000|Overall Study|Adverse Event|3|||
23517734|NCT01266460|65632697|FG000|Overall Study|Withdrawal by Subject|5|||
23517735|NCT01266460|65632697|FG000|Overall Study|Disease Progression|18|||
23517736|NCT01266460|65632697|FG000|Overall Study|Not otherwise specified|8|||
23517737|NCT02956486|65632698|FG000|Core Phase|Adverse Event|51|||
23517738|NCT02956486|65632699|FG001|Core Phase|Adverse Event|88|||
23517739|NCT02956486|65632700|FG002|Core Phase|Adverse Event|0|||
23517740|NCT02956486|65632698|FG000|Core Phase|Lost to Follow-up|8|||
23517741|NCT02956486|65632699|FG001|Core Phase|Lost to Follow-up|6|||
23517742|NCT02956486|65632700|FG002|Core Phase|Lost to Follow-up|0|||
23517743|NCT02956486|65632698|FG000|Core Phase|Inadequate therapeutic effect|4|||
23517744|NCT02956486|65632699|FG001|Core Phase|Inadequate therapeutic effect|5|||
23517745|NCT02956486|65632700|FG002|Core Phase|Inadequate therapeutic effect|0|||
23517746|NCT02956486|65632698|FG000|Core Phase|Withdrawal by Subject|101|||
23517747|NCT02956486|65632699|FG001|Core Phase|Withdrawal by Subject|104|||
23517748|NCT02956486|65632700|FG002|Core Phase|Withdrawal by Subject|0|||
23517749|NCT02956486|65632698|FG000|Core Phase|Study terminated by sponsor|888|||
23517750|NCT02956486|65632699|FG001|Core Phase|Study terminated by sponsor|848|||
23517751|NCT02956486|65632700|FG002|Core Phase|Study terminated by sponsor|0|||
23517752|NCT02956486|65632698|FG000|Core Phase|Other|27|||
23517753|NCT02956486|65632699|FG001|Core Phase|Other|18|||
23517754|NCT02956486|65632700|FG002|Core Phase|Other|0|||
23517755|NCT02956486|65632698|FG000|Core Phase|Not treated|0|||
23517756|NCT02956486|65632699|FG001|Core Phase|Not treated|3|||
23517757|NCT02956486|65632700|FG002|Core Phase|Not treated|0|||
23517758|NCT02956486|65632698|FG000|Extension Phase|Adverse Event|0|||
23517759|NCT02956486|65632699|FG001|Extension Phase|Adverse Event|0|||
23517760|NCT02956486|65632700|FG002|Extension Phase|Adverse Event|2|||
23517761|NCT02956486|65632698|FG000|Extension Phase|Study terminated by sponsor|0|||
23517762|NCT02956486|65632699|FG001|Extension Phase|Study terminated by sponsor|0|||
23517763|NCT02956486|65632700|FG002|Extension Phase|Study terminated by sponsor|16|||
23517764|NCT02956486|65632698|FG000|Extension Phase|Not Treated|0|||
23517765|NCT02956486|65632699|FG001|Extension Phase|Not Treated|0|||
23416193|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
23416194|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
23416195|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
23416196|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
23416197|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
23416198|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
23416199|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
23416200|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
23416201|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
23416202|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
23416203|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
23416204|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
23205191|NCT00492856|64491285|FG000|Consolidation|Not protocol specified|2|||
23205192|NCT00492856|64491286|FG001|Consolidation|Not protocol specified|0|||
23205193|NCT00492856|64491287|FG002|Consolidation|Not protocol specified|0|||
23205194|NCT00492856|64491288|FG003|Consolidation|Not protocol specified|0|||
23205195|NCT00492856|64491285|FG000|Consolidation|Lost to Follow-up|1|||
23205196|NCT00492856|64491286|FG001|Consolidation|Lost to Follow-up|0|||
23205197|NCT00492856|64491287|FG002|Consolidation|Lost to Follow-up|0|||
23205198|NCT00492856|64491288|FG003|Consolidation|Lost to Follow-up|0|||
23205199|NCT00492856|64491285|FG000|Post-consolidation|Adverse Event|0|||
23205200|NCT00492856|64491286|FG001|Post-consolidation|Adverse Event|4|||
23205201|NCT00492856|64491287|FG002|Post-consolidation|Adverse Event|0|||
23205202|NCT00492856|64491288|FG003|Post-consolidation|Adverse Event|1|||
23205203|NCT00492856|64491285|FG000|Post-consolidation|Withdrawal by Subject|0|||
23205204|NCT00492856|64491286|FG001|Post-consolidation|Withdrawal by Subject|4|||
23205205|NCT00492856|64491287|FG002|Post-consolidation|Withdrawal by Subject|0|||
23205206|NCT00492856|64491288|FG003|Post-consolidation|Withdrawal by Subject|0|||
23205207|NCT00492856|64491285|FG000|Post-consolidation|Death|0|||
23205208|NCT00492856|64491286|FG001|Post-consolidation|Death|1|||
23205209|NCT00492856|64491287|FG002|Post-consolidation|Death|0|||
23205210|NCT00492856|64491288|FG003|Post-consolidation|Death|0|||
23517766|NCT02956486|65632700|FG002|Extension Phase|Not Treated|1|||
23517767|NCT02094261|65632701|FG000|Overall Study|Death|24|||
23517768|NCT02094261|65632701|FG000|Overall Study|Lost to Follow-up|1|||
23517769|NCT02094261|65632701|FG000|Overall Study|Withdrawal by Subject|4|||
23517770|NCT02094261|65632701|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
23517771|NCT00326950|65632703|FG000|Overall Study|Progressive Disease|1|||
23517772|NCT00567892|65632704|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517773|NCT00567892|65632705|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517774|NCT00567892|65632706|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
23517775|NCT00567892|65632707|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
23517776|NCT00567892|65632704|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517777|NCT00567892|65632705|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517778|NCT00567892|65632706|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
23517779|NCT00567892|65632707|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
23517780|NCT02355691|65632710|FG000|Overall Study|Loss of Research Personnel|7|||
23517781|NCT02355691|65632711|FG001|Overall Study|Loss of Research Personnel|9|||
23517782|NCT00589914|65632715|FG000|Overall Study|Adverse Event|19|||
23517783|NCT00589914|65632716|FG001|Overall Study|Adverse Event|10|||
23517784|NCT00589914|65632715|FG000|Overall Study|Death|2|||
23517785|NCT00589914|65632716|FG001|Overall Study|Death|0|||
23517786|NCT00589914|65632715|FG000|Overall Study|Lack of Efficacy|40|||
23517787|NCT00589914|65632716|FG001|Overall Study|Lack of Efficacy|43|||
23517788|NCT00589914|65632715|FG000|Overall Study|Lost to Follow-up|11|||
23517789|NCT00589914|65632716|FG001|Overall Study|Lost to Follow-up|18|||
23517790|NCT00589914|65632715|FG000|Overall Study|Pregnancy|1|||
23517791|NCT00589914|65632716|FG001|Overall Study|Pregnancy|0|||
23517792|NCT00589914|65632715|FG000|Overall Study|Withdrawal by Subject|55|||
23517793|NCT00589914|65632716|FG001|Overall Study|Withdrawal by Subject|49|||
23517794|NCT00589914|65632715|FG000|Overall Study|Other|22|||
23517795|NCT00589914|65632716|FG001|Overall Study|Other|17|||
23517796|NCT03287804|65632717|FG000|Overall Study|Death|1|||
23517797|NCT03287804|65632717|FG000|Overall Study|Physician Decision|2|||
23517798|NCT03287804|65632717|FG000|Overall Study|Progressive disease|8|||
23517799|NCT00518323|65632718|FG000|Overall Study|Lack of Efficacy|14|||
23517800|NCT00518323|65632719|FG001|Overall Study|Lack of Efficacy|2|||
23517801|NCT00518323|65632720|FG002|Overall Study|Lack of Efficacy|4|||
23517802|NCT00518323|65632721|FG003|Overall Study|Lack of Efficacy|20|||
23517803|NCT00518323|65632718|FG000|Overall Study|Withdrawal by Subject|1|||
23517804|NCT00518323|65632719|FG001|Overall Study|Withdrawal by Subject|2|||
23517805|NCT00518323|65632720|FG002|Overall Study|Withdrawal by Subject|4|||
23517806|NCT00518323|65632721|FG003|Overall Study|Withdrawal by Subject|2|||
23517807|NCT00518323|65632718|FG000|Overall Study|Lost to Follow-up|0|||
23517808|NCT00518323|65632719|FG001|Overall Study|Lost to Follow-up|2|||
23517809|NCT00518323|65632720|FG002|Overall Study|Lost to Follow-up|1|||
23517810|NCT00518323|65632721|FG003|Overall Study|Lost to Follow-up|3|||
23517811|NCT00518323|65632718|FG000|Overall Study|Adverse Event|1|||
23517812|NCT00518323|65632719|FG001|Overall Study|Adverse Event|1|||
23517813|NCT00518323|65632720|FG002|Overall Study|Adverse Event|1|||
23517814|NCT00518323|65632721|FG003|Overall Study|Adverse Event|0|||
23517815|NCT00518323|65632718|FG000|Overall Study|Prohibited medication and others|3|||
23517816|NCT00518323|65632719|FG001|Overall Study|Prohibited medication and others|1|||
23517817|NCT00518323|65632720|FG002|Overall Study|Prohibited medication and others|1|||
23517818|NCT00518323|65632721|FG003|Overall Study|Prohibited medication and others|0|||
23517819|NCT02632552|65632722|FG000|Overall Study|Lost to Follow-up|14|||
23517820|NCT02632552|65632723|FG001|Overall Study|Lost to Follow-up|8|||
23517821|NCT02632552|65632722|FG000|Overall Study|Withdrawal by Subject|2|||
23517822|NCT02632552|65632723|FG001|Overall Study|Withdrawal by Subject|0|||
23517823|NCT02632552|65632722|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
23517824|NCT02632552|65632723|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
23517825|NCT01986855|65632724|FG000|Overall Study|Adverse Event|1|||
23517826|NCT01986855|65632725|FG001|Overall Study|Adverse Event|0|||
23517827|NCT01986855|65632726|FG002|Overall Study|Adverse Event|0|||
23517828|NCT01986855|65632724|FG000|Overall Study|Death|3|||
23517829|NCT01986855|65632725|FG001|Overall Study|Death|4|||
23517830|NCT01986855|65632726|FG002|Overall Study|Death|4|||
23517831|NCT01986855|65632724|FG000|Overall Study|Lost to Follow-up|2|||
23205211|NCT00492856|64491285|FG000|Post-consolidation|Not protocol specified|0|||
23517832|NCT01986855|65632725|FG001|Overall Study|Lost to Follow-up|1|||
23517833|NCT01986855|65632726|FG002|Overall Study|Lost to Follow-up|0|||
23517834|NCT01986855|65632724|FG000|Overall Study|Screen Failure|0|||
23517835|NCT01986855|65632725|FG001|Overall Study|Screen Failure|1|||
23517836|NCT01986855|65632726|FG002|Overall Study|Screen Failure|0|||
23517837|NCT01986855|65632724|FG000|Overall Study|Participant Moved|0|||
23517838|NCT01986855|65632725|FG001|Overall Study|Participant Moved|0|||
23517839|NCT01986855|65632726|FG002|Overall Study|Participant Moved|2|||
23517840|NCT01986855|65632724|FG000|Overall Study|Withdrawal by Subject|7|||
23517841|NCT01986855|65632725|FG001|Overall Study|Withdrawal by Subject|8|||
23517842|NCT01986855|65632726|FG002|Overall Study|Withdrawal by Subject|5|||
23517843|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
23517844|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
23517845|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
23517846|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
23517847|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
23517848|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
23517849|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
23517850|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
23517851|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Other|4|||
23517852|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Other|1|||
23517853|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
23517854|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
23517855|NCT00303498|65632727|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
23517856|NCT00303498|65632728|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
23517857|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
23517858|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
23517859|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Death|1|||
23517860|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Death|0|||
23517861|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
23517862|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
23517863|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
23517864|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
23517865|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
23517866|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
23517867|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
23517868|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
23517869|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Other|1|||
23517870|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Other|0|||
23517871|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
23517872|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
23517873|NCT00303498|65632727|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
23517874|NCT00303498|65632728|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
23517875|NCT00483379|65632732|FG000|Treatment Period|Adverse Event|1|||
23517876|NCT00483379|65632733|FG001|Treatment Period|Adverse Event|0|||
23517877|NCT00483379|65632732|FG000|Treatment Period|Withdrawal by Subject|1|||
23517878|NCT00483379|65632733|FG001|Treatment Period|Withdrawal by Subject|0|||
23517879|NCT04964128|65632734|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
23517880|NCT04964128|65632734|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
23517881|NCT03564145|65632735|FG000|Overall Study|Adverse Event|4|||
23517882|NCT03564145|65632735|FG000|Overall Study|Lost to Follow-up|21|||
23517883|NCT03564145|65632735|FG000|Overall Study|Protocol Violation|2|||
23517884|NCT03564145|65632735|FG000|Overall Study|Withdrawal by Subject|48|||
23517885|NCT03564145|65632735|FG000|Overall Study|Study Terminated by Sponsor|146|||
23517886|NCT03564145|65632735|FG000|Overall Study|Physician Decision|1|||
23517887|NCT03564145|65632735|FG000|Overall Study|Other Than Specified|1|||
23517888|NCT03564145|65632735|FG000|Overall Study|Pregnancy|1|||
23517889|NCT02268786|65632749|FG000|Overall Study|No Euploid Embryos available|42|||
23517890|NCT02268786|65632750|FG001|Overall Study|No Euploid Embryos available|0|||
23517891|NCT02268786|65632749|FG000|Overall Study|Withdrawal by Subject|7|||
23517892|NCT02268786|65632750|FG001|Overall Study|Withdrawal by Subject|14|||
23517893|NCT02268786|65632749|FG000|Overall Study|Thaw Failure|6|||
23517894|NCT02268786|65632750|FG001|Overall Study|Thaw Failure|4|||
23517895|NCT02268786|65632749|FG000|Overall Study|Protocol Violation|1|||
23517896|NCT02268786|65632750|FG001|Overall Study|Protocol Violation|0|||
23517897|NCT00405587|65632751|FG000|Overall Study|Death|0|||
23517898|NCT00405587|65632752|FG001|Overall Study|Death|0|||
23517899|NCT00405587|65632753|FG002|Overall Study|Death|0|||
23517900|NCT00405587|65632754|FG003|Overall Study|Death|1|||
23517901|NCT00405587|65632751|FG000|Overall Study|Disease Progression|22|||
23517902|NCT00405587|65632752|FG001|Overall Study|Disease Progression|23|||
23517903|NCT00405587|65632753|FG002|Overall Study|Disease Progression|21|||
23517904|NCT00405587|65632754|FG003|Overall Study|Disease Progression|17|||
23517905|NCT00405587|65632751|FG000|Overall Study|Physician Decision|3|||
23517906|NCT00405587|65632752|FG001|Overall Study|Physician Decision|2|||
23517907|NCT00405587|65632753|FG002|Overall Study|Physician Decision|0|||
23517908|NCT00405587|65632754|FG003|Overall Study|Physician Decision|0|||
23517909|NCT00405587|65632751|FG000|Overall Study|Adverse Event|1|||
23517910|NCT00405587|65632752|FG001|Overall Study|Adverse Event|0|||
23205212|NCT00492856|64491286|FG001|Post-consolidation|Not protocol specified|1|||
23517911|NCT00405587|65632753|FG002|Overall Study|Adverse Event|0|||
23517912|NCT00405587|65632754|FG003|Overall Study|Adverse Event|0|||
23517913|NCT00405587|65632751|FG000|Overall Study|Lost to Follow-up|0|||
23517914|NCT00405587|65632752|FG001|Overall Study|Lost to Follow-up|1|||
23517915|NCT00405587|65632753|FG002|Overall Study|Lost to Follow-up|1|||
23517916|NCT00405587|65632754|FG003|Overall Study|Lost to Follow-up|0|||
23517917|NCT00405587|65632751|FG000|Overall Study|Radiation induced necrosis|0|||
23517918|NCT00405587|65632752|FG001|Overall Study|Radiation induced necrosis|1|||
23517919|NCT00405587|65632753|FG002|Overall Study|Radiation induced necrosis|0|||
23517920|NCT00405587|65632754|FG003|Overall Study|Radiation induced necrosis|0|||
23517921|NCT00405587|65632751|FG000|Overall Study|Withdrawal by Subject|0|||
23517922|NCT00405587|65632752|FG001|Overall Study|Withdrawal by Subject|0|||
23517923|NCT00405587|65632753|FG002|Overall Study|Withdrawal by Subject|0|||
23517924|NCT00405587|65632754|FG003|Overall Study|Withdrawal by Subject|2|||
23517925|NCT00405587|65632751|FG000|Overall Study|Participant not dosed|0|||
23517926|NCT00405587|65632752|FG001|Overall Study|Participant not dosed|1|||
23517927|NCT00405587|65632753|FG002|Overall Study|Participant not dosed|0|||
23517928|NCT00405587|65632754|FG003|Overall Study|Participant not dosed|0|||
23517929|NCT01082965|65632755|FG000|Overall Study|Protocol Violation|0|||
23517930|NCT01082965|65632756|FG001|Overall Study|Protocol Violation|1|||
23517931|NCT01082965|65632755|FG000|Overall Study|Other|1|||
23517932|NCT01082965|65632756|FG001|Overall Study|Other|1|||
23517933|NCT01382446|65632757|FG000|Overall Study|Withdrawal by Subject|0|||
23517934|NCT01382446|65632758|FG001|Overall Study|Withdrawal by Subject|1|||
23517935|NCT01382446|65632757|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
23517936|NCT01382446|65632758|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
23517937|NCT01710033|65632763|FG000|Stage 2|Adverse Event|0|||
23517938|NCT01710033|65632764|FG001|Stage 2|Adverse Event|0|||
23517939|NCT01710033|65632765|FG002|Stage 2|Adverse Event|0|||
23517940|NCT01710033|65632766|FG003|Stage 2|Adverse Event|0|||
23517941|NCT01710033|65632767|FG004|Stage 2|Adverse Event|1|||
23517942|NCT02710045|65632768|FG000|Overall Study|Death|1|||
23517943|NCT02710045|65632769|FG001|Overall Study|Death|2|||
23517944|NCT02710045|65632770|FG002|Overall Study|Death|0|||
23517945|NCT02710045|65632768|FG000|Overall Study|Withdrawal by Subject|6|||
23517946|NCT02710045|65632769|FG001|Overall Study|Withdrawal by Subject|6|||
23517947|NCT02710045|65632770|FG002|Overall Study|Withdrawal by Subject|2|||
23517948|NCT02710045|65632768|FG000|Overall Study|Protocol Violation|1|||
23517949|NCT02710045|65632769|FG001|Overall Study|Protocol Violation|2|||
23517950|NCT02710045|65632770|FG002|Overall Study|Protocol Violation|3|||
23517951|NCT02710045|65632768|FG000|Overall Study|Lost to Follow-up|3|||
23517952|NCT02710045|65632769|FG001|Overall Study|Lost to Follow-up|6|||
23517953|NCT02710045|65632770|FG002|Overall Study|Lost to Follow-up|7|||
23517954|NCT02710045|65632768|FG000|Overall Study|Physician Decision|0|||
23517955|NCT02710045|65632769|FG001|Overall Study|Physician Decision|0|||
23517956|NCT02710045|65632770|FG002|Overall Study|Physician Decision|1|||
23517957|NCT02710045|65632768|FG000|Overall Study|Poor Attendance|0|||
23517958|NCT02710045|65632769|FG001|Overall Study|Poor Attendance|1|||
23517959|NCT02710045|65632770|FG002|Overall Study|Poor Attendance|0|||
23517960|NCT00811473|65632773|FG000|Overall Study|Adverse Event|3|||
23517961|NCT00811473|65632774|FG001|Overall Study|Adverse Event|12|||
23517962|NCT00811473|65632773|FG000|Overall Study|Lost to Follow-up|5|||
23517963|NCT00811473|65632774|FG001|Overall Study|Lost to Follow-up|1|||
23517964|NCT00811473|65632773|FG000|Overall Study|Withdrawal by Subject|2|||
23517965|NCT00811473|65632774|FG001|Overall Study|Withdrawal by Subject|4|||
23517966|NCT00811473|65632773|FG000|Overall Study|Severe non-compliance to protocol|2|||
23517967|NCT00811473|65632774|FG001|Overall Study|Severe non-compliance to protocol|4|||
23517968|NCT00811473|65632773|FG000|Overall Study|Lack of therapeutic response|4|||
23517969|NCT00811473|65632774|FG001|Overall Study|Lack of therapeutic response|1|||
23517970|NCT00811473|65632773|FG000|Overall Study|Condition under investigation worsened|1|||
23517971|NCT00811473|65632774|FG001|Overall Study|Condition under investigation worsened|3|||
23517972|NCT00811473|65632773|FG000|Overall Study|Other 2|4|||
23517973|NCT00811473|65632774|FG001|Overall Study|Other 2|1|||
23517974|NCT00811473|65632773|FG000|Overall Study|Incorrect Enrollment|1|||
23517975|NCT00811473|65632774|FG001|Overall Study|Incorrect Enrollment|0|||
23517976|NCT00811473|65632773|FG000|Overall Study|Safety Reasons|1|||
23517977|NCT00811473|65632774|FG001|Overall Study|Safety Reasons|0|||
23517978|NCT02608268|65632775|FG000|Overall Study|Adverse Event|0|||
23517979|NCT02608268|65632776|FG001|Overall Study|Adverse Event|0|||
23517980|NCT02608268|65632777|FG002|Overall Study|Adverse Event|1|||
23517981|NCT02608268|65632778|FG003|Overall Study|Adverse Event|0|||
23517982|NCT02608268|65632779|FG004|Overall Study|Adverse Event|0|||
23517983|NCT02608268|65632780|FG005|Overall Study|Adverse Event|0|||
23517984|NCT02608268|65632781|FG006|Overall Study|Adverse Event|0|||
23517985|NCT02608268|65632782|FG007|Overall Study|Adverse Event|0|||
23517986|NCT02608268|65632783|FG008|Overall Study|Adverse Event|0|||
23517987|NCT02608268|65632784|FG009|Overall Study|Adverse Event|0|||
23517988|NCT02608268|65632785|FG010|Overall Study|Adverse Event|0|||
23517989|NCT02608268|65632786|FG011|Overall Study|Adverse Event|0|||
23517990|NCT02608268|65632787|FG012|Overall Study|Adverse Event|2|||
23517991|NCT02608268|65632788|FG013|Overall Study|Adverse Event|0|||
23517992|NCT02608268|65632789|FG014|Overall Study|Adverse Event|0|||
23517993|NCT02608268|65632790|FG015|Overall Study|Adverse Event|0|||
23517994|NCT02608268|65632791|FG016|Overall Study|Adverse Event|0|||
23517995|NCT02608268|65632792|FG017|Overall Study|Adverse Event|0|||
23517996|NCT02608268|65632793|FG018|Overall Study|Adverse Event|0|||
23517997|NCT02608268|65632794|FG019|Overall Study|Adverse Event|0|||
23517998|NCT02608268|65632795|FG020|Overall Study|Adverse Event|1|||
23517999|NCT02608268|65632796|FG021|Overall Study|Adverse Event|1|||
23518000|NCT02608268|65632797|FG022|Overall Study|Adverse Event|0|||
23518001|NCT02608268|65632798|FG023|Overall Study|Adverse Event|0|||
23518002|NCT02608268|65632799|FG024|Overall Study|Adverse Event|1|||
23518003|NCT02608268|65632800|FG025|Overall Study|Adverse Event|0|||
23518004|NCT02608268|65632801|FG026|Overall Study|Adverse Event|0|||
23518005|NCT02608268|65632802|FG027|Overall Study|Adverse Event|0|||
23518006|NCT02608268|65632803|FG028|Overall Study|Adverse Event|1|||
23518007|NCT02608268|65632804|FG029|Overall Study|Adverse Event|0|||
23518008|NCT02608268|65632775|FG000|Overall Study|Death|1|||
23518009|NCT02608268|65632776|FG001|Overall Study|Death|0|||
23518010|NCT02608268|65632777|FG002|Overall Study|Death|0|||
23518011|NCT02608268|65632778|FG003|Overall Study|Death|0|||
23518012|NCT02608268|65632779|FG004|Overall Study|Death|0|||
23518013|NCT02608268|65632780|FG005|Overall Study|Death|0|||
23518014|NCT02608268|65632781|FG006|Overall Study|Death|0|||
23518015|NCT02608268|65632782|FG007|Overall Study|Death|0|||
23518016|NCT02608268|65632783|FG008|Overall Study|Death|1|||
23518017|NCT02608268|65632784|FG009|Overall Study|Death|1|||
23518018|NCT02608268|65632785|FG010|Overall Study|Death|0|||
23518019|NCT02608268|65632786|FG011|Overall Study|Death|0|||
23518020|NCT02608268|65632787|FG012|Overall Study|Death|0|||
23518021|NCT02608268|65632788|FG013|Overall Study|Death|0|||
23518022|NCT02608268|65632789|FG014|Overall Study|Death|0|||
23518023|NCT02608268|65632790|FG015|Overall Study|Death|1|||
23518024|NCT02608268|65632791|FG016|Overall Study|Death|0|||
23518025|NCT02608268|65632792|FG017|Overall Study|Death|1|||
23518026|NCT02608268|65632793|FG018|Overall Study|Death|0|||
23518027|NCT02608268|65632794|FG019|Overall Study|Death|1|||
23518028|NCT02608268|65632795|FG020|Overall Study|Death|1|||
23518029|NCT02608268|65632796|FG021|Overall Study|Death|0|||
23518030|NCT02608268|65632797|FG022|Overall Study|Death|0|||
23518031|NCT02608268|65632798|FG023|Overall Study|Death|0|||
23518032|NCT02608268|65632799|FG024|Overall Study|Death|1|||
23518033|NCT02608268|65632800|FG025|Overall Study|Death|2|||
23518034|NCT02608268|65632801|FG026|Overall Study|Death|0|||
23518035|NCT02608268|65632802|FG027|Overall Study|Death|1|||
23518036|NCT02608268|65632803|FG028|Overall Study|Death|4|||
23518037|NCT02608268|65632804|FG029|Overall Study|Death|0|||
23518038|NCT02608268|65632775|FG000|Overall Study|Physician Decision|0|||
23518039|NCT02608268|65632776|FG001|Overall Study|Physician Decision|0|||
23518040|NCT02608268|65632777|FG002|Overall Study|Physician Decision|0|||
23518041|NCT02608268|65632778|FG003|Overall Study|Physician Decision|0|||
23518042|NCT02608268|65632779|FG004|Overall Study|Physician Decision|0|||
23518043|NCT02608268|65632780|FG005|Overall Study|Physician Decision|0|||
23518044|NCT02608268|65632781|FG006|Overall Study|Physician Decision|0|||
23518045|NCT02608268|65632782|FG007|Overall Study|Physician Decision|0|||
23518046|NCT02608268|65632783|FG008|Overall Study|Physician Decision|0|||
23518047|NCT02608268|65632784|FG009|Overall Study|Physician Decision|0|||
23518048|NCT02608268|65632785|FG010|Overall Study|Physician Decision|1|||
23518049|NCT02608268|65632786|FG011|Overall Study|Physician Decision|0|||
23518050|NCT02608268|65632787|FG012|Overall Study|Physician Decision|0|||
23518051|NCT02608268|65632788|FG013|Overall Study|Physician Decision|1|||
23518052|NCT02608268|65632789|FG014|Overall Study|Physician Decision|0|||
23518053|NCT02608268|65632790|FG015|Overall Study|Physician Decision|0|||
23518054|NCT02608268|65632791|FG016|Overall Study|Physician Decision|0|||
23518055|NCT02608268|65632792|FG017|Overall Study|Physician Decision|0|||
23518056|NCT02608268|65632793|FG018|Overall Study|Physician Decision|0|||
23518057|NCT02608268|65632794|FG019|Overall Study|Physician Decision|0|||
23518058|NCT02608268|65632795|FG020|Overall Study|Physician Decision|0|||
23518059|NCT02608268|65632796|FG021|Overall Study|Physician Decision|0|||
23518060|NCT02608268|65632797|FG022|Overall Study|Physician Decision|1|||
23518061|NCT02608268|65632798|FG023|Overall Study|Physician Decision|1|||
23518062|NCT02608268|65632799|FG024|Overall Study|Physician Decision|1|||
23518063|NCT02608268|65632800|FG025|Overall Study|Physician Decision|0|||
23518064|NCT02608268|65632801|FG026|Overall Study|Physician Decision|0|||
23518065|NCT02608268|65632802|FG027|Overall Study|Physician Decision|2|||
23518066|NCT02608268|65632803|FG028|Overall Study|Physician Decision|1|||
23518067|NCT02608268|65632804|FG029|Overall Study|Physician Decision|1|||
23518068|NCT02608268|65632775|FG000|Overall Study|Progressive disease|12|||
23518069|NCT02608268|65632776|FG001|Overall Study|Progressive disease|8|||
23518070|NCT02608268|65632777|FG002|Overall Study|Progressive disease|13|||
23518071|NCT02608268|65632778|FG003|Overall Study|Progressive disease|5|||
23518072|NCT02608268|65632779|FG004|Overall Study|Progressive disease|2|||
23518073|NCT02608268|65632780|FG005|Overall Study|Progressive disease|4|||
23518074|NCT02608268|65632781|FG006|Overall Study|Progressive disease|6|||
23518075|NCT02608268|65632782|FG007|Overall Study|Progressive disease|2|||
23518076|NCT02608268|65632783|FG008|Overall Study|Progressive disease|5|||
23518077|NCT02608268|65632784|FG009|Overall Study|Progressive disease|6|||
23518078|NCT02608268|65632785|FG010|Overall Study|Progressive disease|5|||
23518079|NCT02608268|65632786|FG011|Overall Study|Progressive disease|5|||
23518080|NCT02608268|65632787|FG012|Overall Study|Progressive disease|4|||
23518081|NCT02608268|65632788|FG013|Overall Study|Progressive disease|11|||
23518082|NCT02608268|65632789|FG014|Overall Study|Progressive disease|6|||
23518083|NCT02608268|65632790|FG015|Overall Study|Progressive disease|3|||
23518084|NCT02608268|65632791|FG016|Overall Study|Progressive disease|5|||
23518085|NCT02608268|65632792|FG017|Overall Study|Progressive disease|5|||
23518086|NCT02608268|65632793|FG018|Overall Study|Progressive disease|5|||
23518087|NCT02608268|65632794|FG019|Overall Study|Progressive disease|2|||
23518088|NCT02608268|65632795|FG020|Overall Study|Progressive disease|10|||
23518089|NCT02608268|65632796|FG021|Overall Study|Progressive disease|4|||
23518090|NCT02608268|65632797|FG022|Overall Study|Progressive disease|5|||
23518091|NCT02608268|65632798|FG023|Overall Study|Progressive disease|5|||
23518092|NCT02608268|65632799|FG024|Overall Study|Progressive disease|3|||
23518093|NCT02608268|65632800|FG025|Overall Study|Progressive disease|11|||
23518094|NCT02608268|65632801|FG026|Overall Study|Progressive disease|16|||
23518095|NCT02608268|65632802|FG027|Overall Study|Progressive disease|11|||
23518096|NCT02608268|65632803|FG028|Overall Study|Progressive disease|10|||
23518097|NCT02608268|65632804|FG029|Overall Study|Progressive disease|15|||
23518098|NCT02608268|65632775|FG000|Overall Study|Subject/guardian decision|1|||
23518099|NCT02608268|65632776|FG001|Overall Study|Subject/guardian decision|1|||
23518100|NCT02608268|65632777|FG002|Overall Study|Subject/guardian decision|2|||
23518101|NCT02608268|65632778|FG003|Overall Study|Subject/guardian decision|0|||
23518102|NCT02608268|65632779|FG004|Overall Study|Subject/guardian decision|0|||
23518103|NCT02608268|65632780|FG005|Overall Study|Subject/guardian decision|0|||
23518104|NCT02608268|65632781|FG006|Overall Study|Subject/guardian decision|0|||
23518105|NCT02608268|65632782|FG007|Overall Study|Subject/guardian decision|0|||
23518106|NCT02608268|65632783|FG008|Overall Study|Subject/guardian decision|2|||
23518107|NCT02608268|65632784|FG009|Overall Study|Subject/guardian decision|2|||
23518108|NCT02608268|65632785|FG010|Overall Study|Subject/guardian decision|0|||
23518109|NCT02608268|65632786|FG011|Overall Study|Subject/guardian decision|1|||
23518110|NCT02608268|65632787|FG012|Overall Study|Subject/guardian decision|0|||
23518111|NCT02608268|65632788|FG013|Overall Study|Subject/guardian decision|1|||
23518112|NCT02608268|65632789|FG014|Overall Study|Subject/guardian decision|0|||
23518113|NCT02608268|65632790|FG015|Overall Study|Subject/guardian decision|1|||
23518114|NCT02608268|65632791|FG016|Overall Study|Subject/guardian decision|0|||
23518115|NCT02608268|65632792|FG017|Overall Study|Subject/guardian decision|0|||
23518116|NCT02608268|65632793|FG018|Overall Study|Subject/guardian decision|1|||
23518117|NCT02608268|65632794|FG019|Overall Study|Subject/guardian decision|0|||
23518118|NCT02608268|65632795|FG020|Overall Study|Subject/guardian decision|0|||
23518119|NCT02608268|65632796|FG021|Overall Study|Subject/guardian decision|0|||
23518120|NCT02608268|65632797|FG022|Overall Study|Subject/guardian decision|1|||
23518121|NCT02608268|65632798|FG023|Overall Study|Subject/guardian decision|0|||
23518122|NCT02608268|65632799|FG024|Overall Study|Subject/guardian decision|0|||
23518123|NCT02608268|65632800|FG025|Overall Study|Subject/guardian decision|1|||
23518124|NCT02608268|65632801|FG026|Overall Study|Subject/guardian decision|1|||
23518125|NCT02608268|65632802|FG027|Overall Study|Subject/guardian decision|1|||
23518126|NCT02608268|65632803|FG028|Overall Study|Subject/guardian decision|1|||
23518127|NCT02608268|65632804|FG029|Overall Study|Subject/guardian decision|0|||
23518128|NCT00832585|65632814|FG000|Overall Study|Withdrawal by Subject|1|||
23518129|NCT00832585|65632814|FG000|Overall Study|Lost to Follow-up|1|||
23518130|NCT01894581|65632815|FG000|Overall Study|Withdrawal by Subject|2|||
23518131|NCT01894581|65632816|FG001|Overall Study|Withdrawal by Subject|3|||
23518132|NCT01894581|65632815|FG000|Overall Study|Screen Failure|3|||
23518133|NCT01894581|65632816|FG001|Overall Study|Screen Failure|4|||
23518134|NCT03103919|65632821|FG000|Overall Study|Adverse Event|2|||
23518135|NCT03103919|65632822|FG001|Overall Study|Adverse Event|2|||
23518136|NCT00350636|65632823|FG000|Overall Study|Adverse Event|19|||
23518137|NCT00350636|65632824|FG001|Overall Study|Adverse Event|13|||
23518138|NCT00350636|65632823|FG000|Overall Study|Protocol Violation|1|||
23518139|NCT00350636|65632824|FG001|Overall Study|Protocol Violation|3|||
23518140|NCT00350636|65632823|FG000|Overall Study|Withdrawal by Subject|13|||
23518141|NCT00350636|65632824|FG001|Overall Study|Withdrawal by Subject|17|||
23518142|NCT00350636|65632823|FG000|Overall Study|Lost to Follow-up|9|||
23518143|NCT00350636|65632824|FG001|Overall Study|Lost to Follow-up|8|||
23518144|NCT00350636|65632823|FG000|Overall Study|Physician Decision|0|||
23518145|NCT00350636|65632824|FG001|Overall Study|Physician Decision|2|||
23518146|NCT00350636|65632823|FG000|Overall Study|Other|1|||
23518147|NCT00350636|65632824|FG001|Overall Study|Other|2|||
23611221|NCT01072149|65966721|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23518148|NCT01156311|65632825|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
23518149|NCT01156311|65632826|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
23518150|NCT01156311|65632827|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
23518151|NCT01156311|65632828|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
23518152|NCT01156311|65632825|FG000|2-Month Monotherapy Period|Physician Decision|0|||
23518153|NCT01156311|65632826|FG001|2-Month Monotherapy Period|Physician Decision|1|||
23518154|NCT01156311|65632827|FG002|2-Month Monotherapy Period|Physician Decision|0|||
23518155|NCT01156311|65632828|FG003|2-Month Monotherapy Period|Physician Decision|0|||
23518156|NCT01156311|65632825|FG000|2-Month Monotherapy Period|Other|1|||
23518157|NCT01156311|65632826|FG001|2-Month Monotherapy Period|Other|0|||
23518158|NCT01156311|65632827|FG002|2-Month Monotherapy Period|Other|0|||
23518159|NCT01156311|65632828|FG003|2-Month Monotherapy Period|Other|0|||
23518160|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
23518161|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
23518162|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
23518163|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
23518164|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
23518165|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
23518166|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
23518167|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
23518168|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
23518169|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
23518170|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
23518171|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
23518172|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
23518173|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
23518174|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
23518175|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
23518176|NCT01156311|65632825|FG000|6-month Add-on Therapy Period|Other|0|||
23518177|NCT01156311|65632826|FG001|6-month Add-on Therapy Period|Other|0|||
23518178|NCT01156311|65632827|FG002|6-month Add-on Therapy Period|Other|1|||
23518179|NCT01156311|65632828|FG003|6-month Add-on Therapy Period|Other|2|||
23518180|NCT00413192|65632829|FG000|Overall Study|Disease progression|26|||
23518181|NCT00413192|65632830|FG001|Overall Study|Disease progression|31|||
23518182|NCT00413192|65632831|FG002|Overall Study|Disease progression|16|||
23518183|NCT00413192|65632832|FG003|Overall Study|Disease progression|25|||
23518184|NCT00413192|65632829|FG000|Overall Study|Toxicity|3|||
23518185|NCT00413192|65632830|FG001|Overall Study|Toxicity|2|||
23518186|NCT00413192|65632831|FG002|Overall Study|Toxicity|2|||
23518187|NCT00413192|65632832|FG003|Overall Study|Toxicity|2|||
23518188|NCT00413192|65632829|FG000|Overall Study|Withdrawal by Subject|3|||
23518189|NCT00413192|65632830|FG001|Overall Study|Withdrawal by Subject|5|||
23518190|NCT00413192|65632831|FG002|Overall Study|Withdrawal by Subject|0|||
23518191|NCT00413192|65632832|FG003|Overall Study|Withdrawal by Subject|1|||
23518192|NCT00413192|65632829|FG000|Overall Study|Intercurrent illness|0|||
23518193|NCT00413192|65632830|FG001|Overall Study|Intercurrent illness|0|||
23518194|NCT00413192|65632831|FG002|Overall Study|Intercurrent illness|0|||
23518195|NCT00413192|65632832|FG003|Overall Study|Intercurrent illness|1|||
23518196|NCT00413192|65632829|FG000|Overall Study|Intercurrent death|0|||
23518197|NCT00413192|65632830|FG001|Overall Study|Intercurrent death|1|||
23518198|NCT00413192|65632831|FG002|Overall Study|Intercurrent death|0|||
23518199|NCT00413192|65632832|FG003|Overall Study|Intercurrent death|0|||
23518200|NCT00413192|65632829|FG000|Overall Study|Other|5|||
23518201|NCT00413192|65632830|FG001|Overall Study|Other|1|||
23518202|NCT00413192|65632831|FG002|Overall Study|Other|1|||
23518203|NCT00413192|65632832|FG003|Overall Study|Other|2|||
23518204|NCT00413192|65632829|FG000|Overall Study|Not treated|0|||
23518205|NCT00413192|65632830|FG001|Overall Study|Not treated|0|||
23518206|NCT00413192|65632831|FG002|Overall Study|Not treated|0|||
23518207|NCT00413192|65632832|FG003|Overall Study|Not treated|1|||
23518208|NCT00487747|65632833|FG000|Overall Study|Adverse Event|1|||
23518209|NCT00487747|65632833|FG000|Overall Study|Lost to Follow-up|9|||
23518210|NCT00487747|65632833|FG000|Overall Study|Lack of Efficacy|1|||
23518211|NCT01963403|65632836|FG000|Overall Study|Lost to Follow-up|2|||
23518212|NCT01963403|65632837|FG001|Overall Study|Lost to Follow-up|3|||
23518213|NCT01963403|65632836|FG000|Overall Study|Implant removal|0|||
23518214|NCT01963403|65632837|FG001|Overall Study|Implant removal|1|||
23518215|NCT03605303|65632841|FG000|Period 1|Study Terminated|2|||
23518216|NCT03605303|65632842|FG001|Period 1|Study Terminated|1|||
23518217|NCT00495170|65632843|FG000|Overall Study|Lost to Follow-up|9|||
23518218|NCT00495170|65632843|FG000|Overall Study|Withdrawal by Subject|3|||
23518219|NCT00495170|65632843|FG000|Overall Study|Inappropriate staging|8|||
23518220|NCT02522286|65636109|FG000|Overall Study|Withdrawal by Subject|3|||
23518221|NCT02522286|65636110|FG001|Overall Study|Withdrawal by Subject|0|||
23518222|NCT02522286|65636111|FG002|Overall Study|Withdrawal by Subject|0|||
23518223|NCT02522286|65636112|FG003|Overall Study|Withdrawal by Subject|3|||
23518224|NCT01857934|65636116|FG000|Overall Study|Relapse or progression|2|||
23518225|NCT01857934|65636116|FG000|Overall Study|Unacceptable toxicity|3|||
23518226|NCT01857934|65636116|FG000|Overall Study|Unwillingness or inability to comply|2|||
23518227|NCT01857934|65636116|FG000|Overall Study|Physician Decision|3|||
23518228|NCT00741039|65636117|FG000|Overall Study|Patient non-compliance|2|||
23518229|NCT00741039|65636118|FG001|Overall Study|Patient non-compliance|0|||
23518230|NCT01696994|65636119|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
23518231|NCT01696994|65636120|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
23518232|NCT01696994|65636119|FG000|Overall Study|Died Before Randomization|1|||
23518233|NCT01696994|65636120|FG001|Overall Study|Died Before Randomization|2|||
23518234|NCT01696994|65636119|FG000|Overall Study|Died Before ASU (Control)|73|||
23518235|NCT01696994|65636120|FG001|Overall Study|Died Before ASU (Control)|0|||
23518236|NCT01696994|65636119|FG000|Overall Study|No Ovaries at Baseline|4807|||
23518237|NCT01696994|65636120|FG001|Overall Study|No Ovaries at Baseline|4851|||
23518238|NCT01696994|65636119|FG000|Overall Study|Refused ASU (Control)|311|||
23518239|NCT01696994|65636120|FG001|Overall Study|Refused ASU (Control)|0|||
23518240|NCT01696994|65636119|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
23518241|NCT01696994|65636120|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
23518242|NCT02136576|65636121|FG000|Overall Study|Lost to Follow-up|2|||
23518243|NCT02136576|65636122|FG001|Overall Study|Lost to Follow-up|0|||
23518244|NCT02136576|65636123|FG002|Overall Study|Lost to Follow-up|0|||
23518245|NCT02081690|65636126|FG000|Overall Study|Death|3|||
23518246|NCT02081690|65636126|FG000|Overall Study|Physician Decision|3|||
23518247|NCT02081690|65636126|FG000|Overall Study|Withdrawal by Subject|1|||
23518248|NCT01092182|65636128|FG000|Overall Study|Death|0|||
23518249|NCT01092182|65636129|FG001|Overall Study|Death|5|||
23518250|NCT01092182|65636130|FG002|Overall Study|Death|3|||
23518251|NCT01092182|65636128|FG000|Overall Study|participant safety|1|||
23518252|NCT01092182|65636129|FG001|Overall Study|participant safety|2|||
23518253|NCT01092182|65636130|FG002|Overall Study|participant safety|0|||
23518254|NCT01092182|65636128|FG000|Overall Study|Physician Decision|0|||
23518255|NCT01092182|65636129|FG001|Overall Study|Physician Decision|6|||
23518256|NCT01092182|65636130|FG002|Overall Study|Physician Decision|0|||
23518257|NCT01092182|65636128|FG000|Overall Study|Did not meet criteria|0|||
23518258|NCT01092182|65636129|FG001|Overall Study|Did not meet criteria|0|||
23518259|NCT01092182|65636130|FG002|Overall Study|Did not meet criteria|25|||
23518260|NCT01092182|65636128|FG000|Overall Study|Non-compliance|0|||
23518261|NCT01092182|65636129|FG001|Overall Study|Non-compliance|3|||
23518262|NCT01092182|65636130|FG002|Overall Study|Non-compliance|0|||
23518263|NCT01092182|65636128|FG000|Overall Study|Participant refused follow-up|0|||
23518264|NCT01092182|65636129|FG001|Overall Study|Participant refused follow-up|2|||
23518265|NCT01092182|65636130|FG002|Overall Study|Participant refused follow-up|0|||
23518266|NCT00623727|65636131|FG000|Double Blind (DB)|Adverse Event|1|||
23518267|NCT00623727|65636132|FG001|Double Blind (DB)|Adverse Event|3|||
23518268|NCT00623727|65636131|FG000|Double Blind (DB)|Physician Decision|0|||
23518269|NCT00623727|65636132|FG001|Double Blind (DB)|Physician Decision|1|||
23518270|NCT00623727|65636131|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
23518271|NCT00623727|65636132|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
23518272|NCT00623727|65636131|FG000|Double Blind (DB)|Lack of Efficacy|2|||
23518273|NCT00623727|65636132|FG001|Double Blind (DB)|Lack of Efficacy|2|||
23518274|NCT00623727|65636131|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
23518275|NCT00623727|65636132|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
23518276|NCT00623727|65636131|FG000|Double Blind (DB)|Lost to Follow-up|1|||
23518277|NCT00623727|65636132|FG001|Double Blind (DB)|Lost to Follow-up|1|||
23518278|NCT00623727|65636131|FG000|Double Blind (DB)|Protocol Violation|2|||
23518279|NCT00623727|65636132|FG001|Double Blind (DB)|Protocol Violation|2|||
23518280|NCT00623727|65636131|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
23518281|NCT00623727|65636132|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
23518282|NCT00623727|65636131|FG000|Open Label Follow-up|Study termination|0|||
23518283|NCT00623727|65636132|FG001|Open Label Follow-up|Study termination|6|||
23518284|NCT00623727|65636131|FG000|Open Label Follow-up|Participant convenience|0|||
23518285|NCT00623727|65636132|FG001|Open Label Follow-up|Participant convenience|1|||
23518286|NCT02005250|65636133|FG000|Overall Study|Lost to Follow-up|15|||
23518287|NCT02005250|65636134|FG001|Overall Study|Lost to Follow-up|5|||
23518288|NCT00878709|65636135|FG000|Overall Study|Withdrawal by Subject|197|||
23518289|NCT00878709|65636136|FG001|Overall Study|Withdrawal by Subject|120|||
23518290|NCT00878709|65636135|FG000|Overall Study|Lost to Follow-up|35|||
23518291|NCT00878709|65636136|FG001|Overall Study|Lost to Follow-up|33|||
23518292|NCT00878709|65636135|FG000|Overall Study|Other Reasons|93|||
23518293|NCT00878709|65636136|FG001|Overall Study|Other Reasons|84|||
23518294|NCT00507442|65636139|FG000|Overall Study|Adverse Event|8|||
23518295|NCT00507442|65636140|FG001|Overall Study|Adverse Event|11|||
23518296|NCT00507442|65636141|FG002|Overall Study|Adverse Event|4|||
23518297|NCT00507442|65636142|FG003|Overall Study|Adverse Event|1|||
23518298|NCT00507442|65636139|FG000|Overall Study|Protocol Violation|0|||
23518299|NCT00507442|65636140|FG001|Overall Study|Protocol Violation|1|||
23518300|NCT00507442|65636141|FG002|Overall Study|Protocol Violation|0|||
23518301|NCT00507442|65636142|FG003|Overall Study|Protocol Violation|0|||
23518302|NCT00507442|65636139|FG000|Overall Study|Lost to Follow-up|0|||
23518303|NCT00507442|65636140|FG001|Overall Study|Lost to Follow-up|0|||
23518304|NCT00507442|65636141|FG002|Overall Study|Lost to Follow-up|1|||
23518305|NCT00507442|65636142|FG003|Overall Study|Lost to Follow-up|0|||
23518306|NCT00507442|65636139|FG000|Overall Study|Physician Decision|0|||
23518307|NCT00507442|65636140|FG001|Overall Study|Physician Decision|2|||
23518308|NCT00507442|65636141|FG002|Overall Study|Physician Decision|4|||
23518309|NCT00507442|65636142|FG003|Overall Study|Physician Decision|1|||
23518310|NCT00507442|65636139|FG000|Overall Study|Progressive Disease|2|||
23518311|NCT00507442|65636140|FG001|Overall Study|Progressive Disease|4|||
23518312|NCT00507442|65636141|FG002|Overall Study|Progressive Disease|2|||
23518313|NCT00507442|65636142|FG003|Overall Study|Progressive Disease|0|||
23518314|NCT00507442|65636139|FG000|Overall Study|Withdrawal by Subject|4|||
23518315|NCT00507442|65636140|FG001|Overall Study|Withdrawal by Subject|4|||
23518316|NCT00507442|65636141|FG002|Overall Study|Withdrawal by Subject|2|||
23518317|NCT00507442|65636142|FG003|Overall Study|Withdrawal by Subject|1|||
23518318|NCT00507442|65636139|FG000|Overall Study|Other|2|||
23518319|NCT00507442|65636140|FG001|Overall Study|Other|5|||
23518320|NCT00507442|65636141|FG002|Overall Study|Other|2|||
23518321|NCT00507442|65636142|FG003|Overall Study|Other|2|||
23518322|NCT04007523|65636143|FG000|Overall Study|Withdrawal by Subject|0|||
23518323|NCT04007523|65636144|FG001|Overall Study|Withdrawal by Subject|1|||
23518324|NCT04007523|65636145|FG002|Overall Study|Withdrawal by Subject|1|||
23518325|NCT04007523|65636146|FG003|Overall Study|Withdrawal by Subject|0|||
23518326|NCT04007523|65636143|FG000|Overall Study|ICU Transfer|0|||
23518327|NCT04007523|65636144|FG001|Overall Study|ICU Transfer|1|||
23518328|NCT04007523|65636145|FG002|Overall Study|ICU Transfer|0|||
23518329|NCT04007523|65636146|FG003|Overall Study|ICU Transfer|0|||
23518330|NCT04007523|65636143|FG000|Overall Study|COVID hospital closure|0|||
23518331|NCT04007523|65636144|FG001|Overall Study|COVID hospital closure|0|||
23518332|NCT04007523|65636145|FG002|Overall Study|COVID hospital closure|1|||
23518333|NCT04007523|65636146|FG003|Overall Study|COVID hospital closure|2|||
23518334|NCT04007523|65636143|FG000|Overall Study|Surgery cancelled|0|||
23518335|NCT04007523|65636144|FG001|Overall Study|Surgery cancelled|0|||
23518336|NCT04007523|65636145|FG002|Overall Study|Surgery cancelled|1|||
23518337|NCT04007523|65636146|FG003|Overall Study|Surgery cancelled|1|||
23518338|NCT02092662|65636147|FG000|Overall Study|Lost to Follow-up|13|||
23518339|NCT02092662|65636148|FG001|Overall Study|Lost to Follow-up|0|||
23518340|NCT01046682|65636149|FG000|Overall Study|Adverse Event|2|||
23518341|NCT01046682|65636150|FG001|Overall Study|Adverse Event|0|||
23518342|NCT01062555|65636151|FG000|Phase 1|Death|10|||
23518343|NCT01062555|65636152|FG001|Phase 1|Death|17|||
23518344|NCT01062555|65636153|FG002|Phase 1|Death|0|||
23518345|NCT01062555|65636154|FG003|Phase 1|Death|0|||
23518346|NCT01062555|65636151|FG000|Phase 1|Graft Failure|12|||
23518347|NCT01062555|65636152|FG001|Phase 1|Graft Failure|8|||
23518348|NCT01062555|65636153|FG002|Phase 1|Graft Failure|0|||
23518349|NCT01062555|65636154|FG003|Phase 1|Graft Failure|0|||
23518350|NCT01062555|65636151|FG000|Phase 1|Withdrawal by Subject|1|||
23518351|NCT01062555|65636152|FG001|Phase 1|Withdrawal by Subject|1|||
23518352|NCT01062555|65636153|FG002|Phase 1|Withdrawal by Subject|0|||
23518353|NCT01062555|65636154|FG003|Phase 1|Withdrawal by Subject|0|||
23518354|NCT01062555|65636151|FG000|Phase 2|Death|0|||
23518355|NCT01062555|65636152|FG001|Phase 2|Death|0|||
23518356|NCT01062555|65636153|FG002|Phase 2|Death|8|||
23518357|NCT01062555|65636154|FG003|Phase 2|Death|3|||
23518358|NCT01062555|65636151|FG000|Phase 2|Graft failure|0|||
23518359|NCT01062555|65636152|FG001|Phase 2|Graft failure|0|||
23518360|NCT01062555|65636153|FG002|Phase 2|Graft failure|7|||
23518361|NCT01062555|65636154|FG003|Phase 2|Graft failure|4|||
23518362|NCT01062555|65636151|FG000|Phase 2|Withdrawal by Subject|0|||
23518363|NCT01062555|65636152|FG001|Phase 2|Withdrawal by Subject|0|||
23518364|NCT01062555|65636153|FG002|Phase 2|Withdrawal by Subject|0|||
23518365|NCT01062555|65636154|FG003|Phase 2|Withdrawal by Subject|7|||
23518366|NCT01062555|65636151|FG000|Phase 2|Protocol Violation|0|||
23307673|NCT02730351|64870563|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
23518367|NCT01062555|65636152|FG001|Phase 2|Protocol Violation|0|||
23518368|NCT01062555|65636153|FG002|Phase 2|Protocol Violation|0|||
23518369|NCT01062555|65636154|FG003|Phase 2|Protocol Violation|3|||
23518370|NCT01062555|65636151|FG000|Phase 2|Physician Decision|0|||
23518371|NCT01062555|65636152|FG001|Phase 2|Physician Decision|0|||
23518372|NCT01062555|65636153|FG002|Phase 2|Physician Decision|0|||
23518373|NCT01062555|65636154|FG003|Phase 2|Physician Decision|17|||
23518374|NCT00333866|65636155|FG000|Overall Study|Adverse Event|23|||
23518375|NCT00333866|65636156|FG001|Overall Study|Adverse Event|37|||
23518376|NCT00333866|65636157|FG002|Overall Study|Adverse Event|38|||
23518377|NCT00333866|65636158|FG003|Overall Study|Adverse Event|47|||
23518378|NCT00333866|65636155|FG000|Overall Study|Other|3|||
23518379|NCT00333866|65636156|FG001|Overall Study|Other|2|||
23518380|NCT00333866|65636157|FG002|Overall Study|Other|2|||
23518381|NCT00333866|65636158|FG003|Overall Study|Other|2|||
23518382|NCT00333866|65636155|FG000|Overall Study|Lack of Efficacy|8|||
23518383|NCT00333866|65636156|FG001|Overall Study|Lack of Efficacy|6|||
23518384|NCT00333866|65636157|FG002|Overall Study|Lack of Efficacy|3|||
23518385|NCT00333866|65636158|FG003|Overall Study|Lack of Efficacy|5|||
23518386|NCT00333866|65636155|FG000|Overall Study|Lost to Follow-up|1|||
23518387|NCT00333866|65636156|FG001|Overall Study|Lost to Follow-up|2|||
23518388|NCT00333866|65636157|FG002|Overall Study|Lost to Follow-up|2|||
23518389|NCT00333866|65636158|FG003|Overall Study|Lost to Follow-up|2|||
23518390|NCT00333866|65636155|FG000|Overall Study|Withdrawal by Subject|8|||
23518391|NCT00333866|65636156|FG001|Overall Study|Withdrawal by Subject|14|||
23518392|NCT00333866|65636157|FG002|Overall Study|Withdrawal by Subject|4|||
23518393|NCT00333866|65636158|FG003|Overall Study|Withdrawal by Subject|9|||
23518394|NCT00333866|65636155|FG000|Overall Study|Randomized but not Treated|5|||
23518395|NCT00333866|65636156|FG001|Overall Study|Randomized but not Treated|3|||
23518396|NCT00333866|65636157|FG002|Overall Study|Randomized but not Treated|2|||
23518397|NCT00333866|65636158|FG003|Overall Study|Randomized but not Treated|1|||
23518398|NCT01951157|65636162|FG000|Overall Study|Progressive Disease|12|||
23518399|NCT01951157|65636163|FG001|Overall Study|Progressive Disease|13|||
23518400|NCT01951157|65636164|FG002|Overall Study|Progressive Disease|10|||
23518401|NCT01951157|65636162|FG000|Overall Study|Treatment-unrelated AE|1|||
23518402|NCT01951157|65636163|FG001|Overall Study|Treatment-unrelated AE|0|||
23518403|NCT01951157|65636164|FG002|Overall Study|Treatment-unrelated AE|3|||
23518404|NCT01951157|65636162|FG000|Overall Study|Study Termination|0|||
23518405|NCT01951157|65636163|FG001|Overall Study|Study Termination|0|||
23518406|NCT01951157|65636164|FG002|Overall Study|Study Termination|1|||
23518407|NCT01951157|65636162|FG000|Overall Study|Physician Decision|5|||
23518408|NCT01951157|65636163|FG001|Overall Study|Physician Decision|3|||
23518409|NCT01951157|65636164|FG002|Overall Study|Physician Decision|2|||
23518410|NCT01951157|65636162|FG000|Overall Study|Non-treatmentrelated death|2|||
23518411|NCT01951157|65636163|FG001|Overall Study|Non-treatmentrelated death|2|||
23518412|NCT01951157|65636164|FG002|Overall Study|Non-treatmentrelated death|2|||
23518413|NCT01951157|65636162|FG000|Overall Study|No treated|0|||
23518414|NCT01951157|65636163|FG001|Overall Study|No treated|1|||
23518415|NCT01951157|65636164|FG002|Overall Study|No treated|0|||
23518416|NCT01951157|65636162|FG000|Overall Study|Treatment-related AE|2|||
23518417|NCT01951157|65636163|FG001|Overall Study|Treatment-related AE|0|||
23518418|NCT01951157|65636164|FG002|Overall Study|Treatment-related AE|4|||
23518419|NCT01951157|65636162|FG000|Overall Study|Consent withdrawn by subject|0|||
23518420|NCT01951157|65636163|FG001|Overall Study|Consent withdrawn by subject|1|||
23518421|NCT01951157|65636164|FG002|Overall Study|Consent withdrawn by subject|3|||
23518422|NCT01951157|65636162|FG000|Overall Study|Treatment-related death|0|||
23518423|NCT01951157|65636163|FG001|Overall Study|Treatment-related death|2|||
23518424|NCT01951157|65636164|FG002|Overall Study|Treatment-related death|0|||
23518425|NCT00228917|65636165|FG000|Overall Study|Migrated/moved from study area|0|||
23518426|NCT00228917|65636166|FG001|Overall Study|Migrated/moved from study area|0|||
23518427|NCT00228917|65636167|FG002|Overall Study|Migrated/moved from study area|0|||
23518428|NCT00228917|65636168|FG003|Overall Study|Migrated/moved from study area|0|||
23518429|NCT00228917|65636169|FG004|Overall Study|Migrated/moved from study area|0|||
23518430|NCT00228917|65636170|FG005|Overall Study|Migrated/moved from study area|2|||
23518431|NCT00228917|65636171|FG006|Overall Study|Migrated/moved from study area|0|||
23518432|NCT00228917|65636172|FG007|Overall Study|Migrated/moved from study area|0|||
23518433|NCT02636868|65636174|FG000|Overall Study|Death|0|||
23518434|NCT02636868|65636175|FG001|Overall Study|Death|1|||
23518435|NCT02636868|65636176|FG002|Overall Study|Death|2|||
23518436|NCT03255382|65636177|FG000|Overall Study|Adverse Event|3|||
23518437|NCT03255382|65636178|FG001|Overall Study|Adverse Event|0|||
23518438|NCT03255382|65636177|FG000|Overall Study|Lost to Follow-up|2|||
23518439|NCT03255382|65636178|FG001|Overall Study|Lost to Follow-up|0|||
23518440|NCT03255382|65636177|FG000|Overall Study|Withdrawal by Subject|2|||
23518441|NCT03255382|65636178|FG001|Overall Study|Withdrawal by Subject|0|||
23518442|NCT03255382|65636177|FG000|Overall Study|Other|6|||
23518443|NCT03255382|65636178|FG001|Overall Study|Other|0|||
23518444|NCT04779489|65636179|FG000|Overall Study|Physician Decision|1|||
23518445|NCT00536107|65636180|FG000|Overall Study|Death|5|||
23307674|NCT02730351|64870562|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
23518446|NCT00536107|65636181|FG001|Overall Study|Death|1|||
23518447|NCT00536107|65636180|FG000|Overall Study|Incorrect enrolment|1|||
23518448|NCT00536107|65636181|FG001|Overall Study|Incorrect enrolment|0|||
23518449|NCT00536107|65636180|FG000|Overall Study|Withdrawal by Subject|0|||
23518450|NCT00536107|65636181|FG001|Overall Study|Withdrawal by Subject|1|||
23518451|NCT00536107|65636180|FG000|Overall Study|Study Termination|2|||
23518452|NCT00536107|65636181|FG001|Overall Study|Study Termination|4|||
23518453|NCT03970733|65636190|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
23518454|NCT03970733|65636191|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
23518455|NCT03970733|65636192|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
23518456|NCT03970733|65636193|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
23518457|NCT03970733|65636194|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
23518458|NCT03970733|65636190|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
23518459|NCT03970733|65636191|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
23518460|NCT03970733|65636192|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
23518461|NCT03970733|65636193|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
23518462|NCT03970733|65636194|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
23518463|NCT03970733|65636190|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
23518464|NCT03970733|65636191|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
23518465|NCT03970733|65636192|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
23518466|NCT03970733|65636193|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
23518467|NCT03970733|65636194|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
23518468|NCT03970733|65636190|FG000|Main Study Phase (18 Months)|Other|1|||
23518469|NCT03970733|65636191|FG001|Main Study Phase (18 Months)|Other|1|||
23518470|NCT03970733|65636192|FG002|Main Study Phase (18 Months)|Other|0|||
23518471|NCT03970733|65636193|FG003|Main Study Phase (18 Months)|Other|0|||
23518472|NCT03970733|65636194|FG004|Main Study Phase (18 Months)|Other|0|||
23518473|NCT03970733|65636190|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
23518474|NCT03970733|65636191|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
23518475|NCT03970733|65636192|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
23518476|NCT03970733|65636193|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
23518477|NCT03970733|65636194|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
23518478|NCT00415909|65636197|FG000|Overall Study|Withdrawal by Subject|2|||
23518479|NCT00415909|65636197|FG000|Overall Study|Death|1|||
23518480|NCT00475176|65636210|FG000|Overall Study|Adverse Event|2|||
23518481|NCT00475176|65636210|FG000|Overall Study|Withdrawal by Subject|1|||
23518482|NCT00475176|65636210|FG000|Overall Study|Protocol Violation|1|||
23518483|NCT04568590|65636211|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
23518484|NCT03265249|65636212|FG000|Overall Study|Withdrawal by Subject|0|||
23518485|NCT03265249|65636213|FG001|Overall Study|Withdrawal by Subject|1|||
23518486|NCT00108160|65636214|FG000|Overall Study|Lost to Follow-up|25|||
23518487|NCT00108160|65636215|FG001|Overall Study|Lost to Follow-up|12|||
23518488|NCT00108160|65636214|FG000|Overall Study|Death|1|||
23518489|NCT00108160|65636215|FG001|Overall Study|Death|2|||
23518490|NCT00108160|65636214|FG000|Overall Study|Withdrawal by Subject|4|||
23518491|NCT00108160|65636215|FG001|Overall Study|Withdrawal by Subject|2|||
23518492|NCT00108160|65636214|FG000|Overall Study|Protocol Violation|9|||
23518493|NCT00108160|65636215|FG001|Overall Study|Protocol Violation|5|||
23518494|NCT02794103|65636216|FG000|Overall Study|Loss to follow up due to high sedation|3|||
23518495|NCT02411292|65636217|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
23518496|NCT02411292|65636217|FG000|Overall Study|Death|2|||
23518497|NCT02411292|65636217|FG000|Overall Study|Lost to Follow-up|3|||
23518498|NCT00945009|65636218|FG000|Overall Study|Lack of Efficacy|10|||
23518499|NCT00945009|65636219|FG001|Overall Study|Lack of Efficacy|0|||
23518500|NCT00945009|65636220|FG002|Overall Study|Lack of Efficacy|0|||
23518501|NCT00945009|65636218|FG000|Overall Study|Physician Decision|21|||
23518502|NCT00945009|65636219|FG001|Overall Study|Physician Decision|4|||
23518503|NCT00945009|65636220|FG002|Overall Study|Physician Decision|3|||
23518504|NCT00945009|65636218|FG000|Overall Study|Protocol Violation|6|||
23518505|NCT00945009|65636219|FG001|Overall Study|Protocol Violation|1|||
23518506|NCT00945009|65636220|FG002|Overall Study|Protocol Violation|0|||
23518507|NCT00945009|65636218|FG000|Overall Study|Withdrawal by Subject|1|||
23518508|NCT00945009|65636219|FG001|Overall Study|Withdrawal by Subject|0|||
23518509|NCT00945009|65636220|FG002|Overall Study|Withdrawal by Subject|0|||
23518510|NCT00945009|65636218|FG000|Overall Study|Ineligible|6|||
23518511|NCT00945009|65636219|FG001|Overall Study|Ineligible|1|||
23518512|NCT00945009|65636220|FG002|Overall Study|Ineligible|0|||
23518513|NCT00945009|65636218|FG000|Overall Study|Inevaluable|0|||
23518514|NCT00945009|65636219|FG001|Overall Study|Inevaluable|1|||
23518515|NCT00945009|65636220|FG002|Overall Study|Inevaluable|0|||
23518516|NCT00945009|65636218|FG000|Overall Study|Refusal of further protocol|1|||
23518517|NCT00945009|65636219|FG001|Overall Study|Refusal of further protocol|0|||
23518518|NCT00945009|65636220|FG002|Overall Study|Refusal of further protocol|0|||
23518519|NCT02255500|65636221|FG000|Overall Study|Withdrawal by Subject|1|||
23518520|NCT02255500|65636222|FG001|Overall Study|Withdrawal by Subject|0|||
23518521|NCT00271947|65636223|FG000|Overall Study|Lost to Follow-up|1|||
23518522|NCT00352846|65636224|FG000|Overall Study|Disease progression|0|||
23518523|NCT00352846|65636225|FG001|Overall Study|Disease progression|2|||
23518524|NCT00352846|65636224|FG000|Overall Study|Withdrawal by Subject|3|||
23518525|NCT00352846|65636225|FG001|Overall Study|Withdrawal by Subject|8|||
23518526|NCT00352846|65636224|FG000|Overall Study|Ineligible|3|||
23518527|NCT00352846|65636225|FG001|Overall Study|Ineligible|2|||
23518528|NCT00352846|65636224|FG000|Overall Study|Non-compliance|2|||
23518529|NCT00352846|65636225|FG001|Overall Study|Non-compliance|0|||
23518530|NCT00352846|65636224|FG000|Overall Study|Death|0|||
23518531|NCT00352846|65636225|FG001|Overall Study|Death|1|||
23518532|NCT03311659|65636226|FG000|Overall Study|Protocol Violation|1|||
23518533|NCT00501293|65636227|FG000|Optimization Period|Enrolled in error|1|||
23518534|NCT00501293|65636228|FG001|Optimization Period|Enrolled in error|0|||
23518535|NCT00501293|65636227|FG000|Maintenance Period|Withdrawal by Subject|14|||
23518536|NCT00501293|65636228|FG001|Maintenance Period|Withdrawal by Subject|13|||
23518537|NCT00501293|65636227|FG000|Maintenance Period|Lost to Follow-up|12|||
23518538|NCT00501293|65636228|FG001|Maintenance Period|Lost to Follow-up|7|||
23518539|NCT00501293|65636227|FG000|Maintenance Period|Adverse Event|6|||
23518540|NCT00501293|65636228|FG001|Maintenance Period|Adverse Event|6|||
23518541|NCT00501293|65636227|FG000|Maintenance Period|Protocol Violation|2|||
23518542|NCT00501293|65636228|FG001|Maintenance Period|Protocol Violation|1|||
23518543|NCT00501293|65636227|FG000|Maintenance Period|Lack of Efficacy|4|||
23518544|NCT00501293|65636228|FG001|Maintenance Period|Lack of Efficacy|1|||
23518545|NCT00501293|65636227|FG000|Maintenance Period|Noncompliant with study medication|5|||
23518546|NCT00501293|65636228|FG001|Maintenance Period|Noncompliant with study medication|0|||
23518547|NCT00501293|65636227|FG000|Maintenance Period|Went into rehabilitation|1|||
23518548|NCT00501293|65636228|FG001|Maintenance Period|Went into rehabilitation|0|||
23518549|NCT00501293|65636227|FG000|Maintenance Period|Would not wear patch|1|||
23518550|NCT00501293|65636228|FG001|Maintenance Period|Would not wear patch|0|||
23518551|NCT00501293|65636227|FG000|Maintenance Period|Application site reaction|1|||
23518552|NCT00501293|65636228|FG001|Maintenance Period|Application site reaction|0|||
23518553|NCT00491387|65636230|FG000|Overall Study|study terminated|20|||
23518554|NCT02385084|65636233|FG000|Period 2|Protocol Violation|0|||
23518555|NCT02385084|65636234|FG001|Period 2|Protocol Violation|0|||
23518556|NCT02385084|65636235|FG002|Period 2|Protocol Violation|1|||
23518557|NCT02385084|65636236|FG003|Period 2|Protocol Violation|0|||
23518558|NCT02385084|65636237|FG004|Period 2|Protocol Violation|0|||
23518559|NCT02385084|65636238|FG005|Period 2|Protocol Violation|0|||
23518560|NCT00939809|65636240|FG000|Overall Study|Adverse Event|2|||
23518561|NCT00939809|65636240|FG000|Overall Study|Death|1|||
23518562|NCT01514760|65636242|FG000|Overall Study|Lost to Follow-up|2|||
23518563|NCT03011307|65636245|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
23518564|NCT03011307|65636246|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
23518565|NCT03011307|65636245|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
23518566|NCT03011307|65636246|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
23518567|NCT03011307|65636245|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
23518568|NCT03011307|65636246|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
23518569|NCT02389998|65636251|FG000|Overall Study|car accident|1|||
23518570|NCT02389998|65636252|FG001|Overall Study|car accident|0|||
23518571|NCT00768300|65636253|FG000|Overall Study|Randomized but not treated|1|||
23518572|NCT00768300|65636254|FG001|Overall Study|Randomized but not treated|1|||
23518573|NCT00768300|65636253|FG000|Overall Study|Adverse Event|10|||
23518574|NCT00768300|65636254|FG001|Overall Study|Adverse Event|2|||
23518575|NCT00768300|65636253|FG000|Overall Study|Protocol Violation|6|||
23518576|NCT00768300|65636254|FG001|Overall Study|Protocol Violation|1|||
23518577|NCT00768300|65636253|FG000|Overall Study|Withdrawal by Subject|13|||
23518578|NCT00768300|65636254|FG001|Overall Study|Withdrawal by Subject|7|||
23518579|NCT00768300|65636253|FG000|Overall Study|Physician Decision|2|||
23518580|NCT00768300|65636254|FG001|Overall Study|Physician Decision|3|||
23518581|NCT00768300|65636253|FG000|Overall Study|Study discontinued by Sponsor|271|||
23518582|NCT00768300|65636254|FG001|Overall Study|Study discontinued by Sponsor|140|||
23518583|NCT00768300|65636253|FG000|Overall Study|Death|21|||
23518584|NCT00768300|65636254|FG001|Overall Study|Death|5|||
23518585|NCT00768300|65636253|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
23518586|NCT00768300|65636254|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
23518587|NCT00768300|65636253|FG000|Overall Study|Screen failure following randomization|1|||
23518588|NCT00768300|65636254|FG001|Overall Study|Screen failure following randomization|0|||
23518589|NCT00768300|65636253|FG000|Overall Study|Received lung transplant|1|||
23518590|NCT00768300|65636254|FG001|Overall Study|Received lung transplant|1|||
23518591|NCT00768300|65636253|FG000|Overall Study|Lost to Follow-up|0|||
23518592|NCT00768300|65636254|FG001|Overall Study|Lost to Follow-up|1|||
23518593|NCT00768300|65636253|FG000|Overall Study|Began prohibited concomitant medication|0|||
23518594|NCT00768300|65636254|FG001|Overall Study|Began prohibited concomitant medication|1|||
23518595|NCT00768300|65636253|FG000|Overall Study|Treated but never dosed with Study drug|1|||
23518596|NCT00768300|65636254|FG001|Overall Study|Treated but never dosed with Study drug|0|||
23518597|NCT00768300|65636253|FG000|Overall Study|Missing data|1|||
23518598|NCT00768300|65636254|FG001|Overall Study|Missing data|0|||
23518599|NCT02741700|65636257|FG000|Overall Study|Lost to Follow-up|17|||
23518600|NCT02741700|65636258|FG001|Overall Study|Lost to Follow-up|8|||
23518601|NCT02741700|65636257|FG000|Overall Study|Withdrawal by Subject|2|||
23518602|NCT02741700|65636258|FG001|Overall Study|Withdrawal by Subject|5|||
23518603|NCT02741700|65636257|FG000|Overall Study|Physician Decision|3|||
23518604|NCT02741700|65636258|FG001|Overall Study|Physician Decision|0|||
23518605|NCT02741700|65636257|FG000|Overall Study|Moved out of State|0|||
23518606|NCT02741700|65636258|FG001|Overall Study|Moved out of State|1|||
23518607|NCT02741700|65636257|FG000|Overall Study|Death|4|||
23518608|NCT02741700|65636258|FG001|Overall Study|Death|5|||
23518609|NCT02085785|65636259|FG000|Overall Study|Withdrawal by Subject|2|||
23518610|NCT02085785|65636260|FG001|Overall Study|Withdrawal by Subject|1|||
23518611|NCT02085785|65636259|FG000|Overall Study|Lost to Follow-up|0|||
23518612|NCT02085785|65636260|FG001|Overall Study|Lost to Follow-up|1|||
23518613|NCT04251221|65636265|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
23518614|NCT04251221|65636266|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
23518615|NCT01471379|65636269|FG000|Overall Study|Adverse Event|1|||
23518616|NCT01471379|65636270|FG001|Overall Study|Adverse Event|0|||
23518617|NCT01471379|65636271|FG002|Overall Study|Adverse Event|0|||
23518618|NCT01471379|65636269|FG000|Overall Study|Study terminated|0|||
23518619|NCT01471379|65636270|FG001|Overall Study|Study terminated|1|||
23518620|NCT01471379|65636271|FG002|Overall Study|Study terminated|0|||
23518621|NCT01412021|65636272|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
23518622|NCT01412021|65636272|FG000|Overall Study|Treatment Prior to Approval|3|||
23518623|NCT01412021|65636272|FG000|Overall Study|Transferred to Other Hospital|9|||
23518624|NCT04267133|65636278|FG000|Overall Study|Withdrawal by Subject|1|||
23518625|NCT04267133|65636278|FG000|Overall Study|Adverse Event|4|||
23518626|NCT00853723|65636289|FG000|Overall Study|Adverse Event|3|||
23518627|NCT00853723|65636290|FG001|Overall Study|Adverse Event|4|||
23518628|NCT00853723|65636291|FG002|Overall Study|Adverse Event|1|||
23518629|NCT00853723|65636289|FG000|Overall Study|Withdrawal by Subject|2|||
23518630|NCT00853723|65636290|FG001|Overall Study|Withdrawal by Subject|1|||
23518631|NCT00853723|65636291|FG002|Overall Study|Withdrawal by Subject|0|||
23518632|NCT00853723|65636289|FG000|Overall Study|Protocol Violation|1|||
23518633|NCT00853723|65636290|FG001|Overall Study|Protocol Violation|2|||
23518634|NCT00853723|65636291|FG002|Overall Study|Protocol Violation|1|||
23518635|NCT02447081|65636295|FG000|Overall Study|Death|161|||
23518636|NCT02447081|65636295|FG000|Overall Study|Lost to Follow-up|36|||
23518637|NCT02447081|65636295|FG000|Overall Study|Visit not completed|17|||
23518638|NCT02447081|65636295|FG000|Overall Study|unsuccessful implant procedure|10|||
23518639|NCT01374087|65636297|FG000|Overall Study|Adverse Event|1|||
23518640|NCT01374087|65636298|FG001|Overall Study|Adverse Event|0|||
23518641|NCT01374087|65636297|FG000|Overall Study|Disease progression|2|||
23518642|NCT01374087|65636298|FG001|Overall Study|Disease progression|2|||
23518643|NCT01374087|65636297|FG000|Overall Study|Study discontinued|13|||
23518644|NCT01374087|65636298|FG001|Overall Study|Study discontinued|13|||
23518645|NCT03204981|65636299|FG000|Overall Study|Physician Decision|2|||
23518646|NCT03204981|65636299|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
23518647|NCT02424383|65636300|FG000|Overall Study|Withdrawal by Subject|32|||
23518648|NCT02424383|65636300|FG000|Overall Study|Death|170|||
23518649|NCT02424383|65636300|FG000|Overall Study|Sponsor's decision|3|||
23518650|NCT02424383|65636300|FG000|Overall Study|Investigator's decision|44|||
23518651|NCT02424383|65636300|FG000|Overall Study|Lost to Follow-up|81|||
23518652|NCT02424383|65636300|FG000|Overall Study|Other|7|||
23518653|NCT02424383|65636300|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
23611222|NCT01072149|65966722|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23518654|NCT02542631|65636304|FG000|Overall Study|Adverse Event|1|||
23518655|NCT02542631|65636305|FG001|Overall Study|Adverse Event|1|||
23518656|NCT02542631|65636304|FG000|Overall Study|Sponsor Termination|1|||
23518657|NCT02542631|65636305|FG001|Overall Study|Sponsor Termination|0|||
23518658|NCT02542631|65636304|FG000|Overall Study|Withdrawal by Subject|11|||
23518659|NCT02542631|65636305|FG001|Overall Study|Withdrawal by Subject|16|||
23518660|NCT02542631|65636304|FG000|Overall Study|Protocol Violation|1|||
23518661|NCT02542631|65636305|FG001|Overall Study|Protocol Violation|1|||
23518662|NCT02542631|65636304|FG000|Overall Study|Physician Decision|6|||
23518663|NCT02542631|65636305|FG001|Overall Study|Physician Decision|4|||
23518664|NCT02542631|65636304|FG000|Overall Study|Lost to Follow-up|6|||
23518665|NCT02542631|65636305|FG001|Overall Study|Lost to Follow-up|5|||
23518666|NCT02542631|65636304|FG000|Overall Study|Death|1|||
23518667|NCT02542631|65636305|FG001|Overall Study|Death|2|||
23518668|NCT02542631|65636304|FG000|Overall Study|Other|2|||
23518669|NCT02542631|65636305|FG001|Overall Study|Other|1|||
23518670|NCT02542631|65636304|FG000|Overall Study|Used Prohibited Medication|2|||
23518671|NCT02542631|65636305|FG001|Overall Study|Used Prohibited Medication|1|||
23518672|NCT00772707|65636307|FG000|Overall Study|Withdrawn|3|||
23518673|NCT01603459|65636308|FG000|Overall Study|Adverse Event|5|||
23518674|NCT01603459|65636308|FG000|Overall Study|Withdrawal by Subject|5|||
23518675|NCT01603459|65636308|FG000|Overall Study|Lost to Follow-up|3|||
23518676|NCT01603459|65636308|FG000|Overall Study|Predefined discontinuation criteria|3|||
23518677|NCT01603459|65636308|FG000|Overall Study|Non-compliance|1|||
23518678|NCT01603459|65636308|FG000|Overall Study|Administrative reason|1|||
23518679|NCT00399360|65636312|FG000|Overall Study|Lost to Follow-up|2|||
23518680|NCT00399360|65636313|FG001|Overall Study|Lost to Follow-up|1|||
23518681|NCT00399360|65636314|FG002|Overall Study|Lost to Follow-up|2|||
23518682|NCT00399360|65636315|FG003|Overall Study|Lost to Follow-up|4|||
23518683|NCT00399360|65636312|FG000|Overall Study|Adverse Event|0|||
23518684|NCT00399360|65636313|FG001|Overall Study|Adverse Event|0|||
23518685|NCT00399360|65636314|FG002|Overall Study|Adverse Event|1|||
23518686|NCT00399360|65636315|FG003|Overall Study|Adverse Event|0|||
23518687|NCT00399360|65636312|FG000|Overall Study|Withdrawal by Subject|0|||
23518688|NCT00399360|65636313|FG001|Overall Study|Withdrawal by Subject|2|||
23518689|NCT00399360|65636314|FG002|Overall Study|Withdrawal by Subject|0|||
23518690|NCT00399360|65636315|FG003|Overall Study|Withdrawal by Subject|2|||
23518691|NCT00484939|65636320|FG000|Overall Study|Death|9|||
23518692|NCT00484939|65636321|FG001|Overall Study|Death|13|||
23518693|NCT00484939|65636320|FG000|Overall Study|Adverse Event|22|||
23518694|NCT00484939|65636321|FG001|Overall Study|Adverse Event|12|||
23518695|NCT00484939|65636320|FG000|Overall Study|Patient Withdrew Consent|19|||
23518696|NCT00484939|65636321|FG001|Overall Study|Patient Withdrew Consent|10|||
23518697|NCT00484939|65636320|FG000|Overall Study|Protocol Violation|3|||
23518698|NCT00484939|65636321|FG001|Overall Study|Protocol Violation|3|||
23518699|NCT00484939|65636320|FG000|Overall Study|Lost to Follow-up|0|||
23518700|NCT00484939|65636321|FG001|Overall Study|Lost to Follow-up|3|||
23518701|NCT00484939|65636320|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
23518702|NCT00484939|65636321|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
23518703|NCT00484939|65636320|FG000|Overall Study|Disease progression|67|||
23518704|NCT00484939|65636321|FG001|Overall Study|Disease progression|88|||
23518705|NCT00484939|65636320|FG000|Overall Study|Screen Failure|2|||
23518706|NCT00484939|65636321|FG001|Overall Study|Screen Failure|2|||
23518707|NCT00484939|65636320|FG000|Overall Study|Reason Not Specified|11|||
23518708|NCT00484939|65636321|FG001|Overall Study|Reason Not Specified|6|||
23518709|NCT02532647|65636322|FG000|Overall Study|Did not receive trial medication|1|||
23518710|NCT02532647|65636323|FG001|Overall Study|Did not receive trial medication|0|||
23518711|NCT02532647|65636324|FG002|Overall Study|Did not receive trial medication|1|||
23518712|NCT02875860|65636325|FG000|Overall Study|Withdrawal by Subject|0|||
23518713|NCT02875860|65636326|FG001|Overall Study|Withdrawal by Subject|1|||
23518714|NCT01042236|65636327|FG000|Treatment Period 1|Adverse Event|0|||
23518715|NCT01042236|65636328|FG001|Treatment Period 1|Adverse Event|1|||
23518716|NCT01042236|65636329|FG002|Treatment Period 1|Adverse Event|0|||
23518717|NCT01042236|65636330|FG003|Treatment Period 1|Adverse Event|0|||
23518718|NCT01042236|65636331|FG004|Treatment Period 1|Adverse Event|1|||
23518719|NCT01042236|65636332|FG005|Treatment Period 1|Adverse Event|0|||
23518720|NCT01042236|65636327|FG000|Treatment Period 3|Adverse Event|0|||
23518721|NCT01042236|65636328|FG001|Treatment Period 3|Adverse Event|0|||
23518722|NCT01042236|65636329|FG002|Treatment Period 3|Adverse Event|0|||
23518723|NCT01042236|65636330|FG003|Treatment Period 3|Adverse Event|1|||
23518724|NCT01042236|65636331|FG004|Treatment Period 3|Adverse Event|0|||
23518725|NCT01042236|65636332|FG005|Treatment Period 3|Adverse Event|0|||
23518726|NCT01042236|65636327|FG000|Treatment Period 3|Protocol Violation|0|||
23518727|NCT01042236|65636328|FG001|Treatment Period 3|Protocol Violation|0|||
23518728|NCT01042236|65636329|FG002|Treatment Period 3|Protocol Violation|0|||
23518729|NCT01042236|65636330|FG003|Treatment Period 3|Protocol Violation|1|||
23518730|NCT01042236|65636331|FG004|Treatment Period 3|Protocol Violation|0|||
23518731|NCT01042236|65636332|FG005|Treatment Period 3|Protocol Violation|0|||
23518732|NCT00022633|65636335|FG000|Overall Study|Adverse Event|11|||
23518733|NCT00022633|65636336|FG001|Overall Study|Adverse Event|1|||
23518734|NCT00022633|65636335|FG000|Overall Study|Refusal unrelated to adverse event|1|||
23518735|NCT00022633|65636336|FG001|Overall Study|Refusal unrelated to adverse event|0|||
23518736|NCT00022633|65636335|FG000|Overall Study|Progression/relapse|9|||
23518737|NCT00022633|65636336|FG001|Overall Study|Progression/relapse|2|||
23518738|NCT00022633|65636335|FG000|Overall Study|Death|4|||
23518739|NCT00022633|65636336|FG001|Overall Study|Death|0|||
23518740|NCT00022633|65636335|FG000|Overall Study|Other - not protocol specified|3|||
23518741|NCT00022633|65636336|FG001|Overall Study|Other - not protocol specified|2|||
23518742|NCT00022633|65636335|FG000|Overall Study|Ineligible|4|||
23518743|NCT00022633|65636336|FG001|Overall Study|Ineligible|0|||
23518744|NCT04273217|65636341|FG000|Overall Study|Lost to Follow-up|0|||
23518745|NCT04273217|65636342|FG001|Overall Study|Lost to Follow-up|0|||
23518746|NCT04273217|65636343|FG002|Overall Study|Lost to Follow-up|0|||
23518747|NCT04273217|65636344|FG003|Overall Study|Lost to Follow-up|0|||
23518748|NCT04273217|65636345|FG004|Overall Study|Lost to Follow-up|0|||
23518749|NCT04273217|65636346|FG005|Overall Study|Lost to Follow-up|1|||
23518750|NCT04273217|65636341|FG000|Overall Study|Participant non-compliance|0|||
23518751|NCT04273217|65636342|FG001|Overall Study|Participant non-compliance|0|||
23518752|NCT04273217|65636343|FG002|Overall Study|Participant non-compliance|0|||
23518753|NCT04273217|65636344|FG003|Overall Study|Participant non-compliance|0|||
23518754|NCT04273217|65636345|FG004|Overall Study|Participant non-compliance|1|||
23518755|NCT04273217|65636346|FG005|Overall Study|Participant non-compliance|0|||
23518756|NCT04273217|65636341|FG000|Overall Study|Positive urine drug screen|1|||
23518757|NCT04273217|65636342|FG001|Overall Study|Positive urine drug screen|0|||
23518758|NCT04273217|65636343|FG002|Overall Study|Positive urine drug screen|1|||
23518759|NCT04273217|65636344|FG003|Overall Study|Positive urine drug screen|0|||
23518760|NCT04273217|65636345|FG004|Overall Study|Positive urine drug screen|0|||
23518761|NCT04273217|65636346|FG005|Overall Study|Positive urine drug screen|1|||
23518762|NCT00768144|65636347|FG000|Overall Study|Adverse Event|13|||
23518763|NCT00768144|65636347|FG000|Overall Study|Progressive Disease|21|||
23518764|NCT00768144|65636347|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
23518765|NCT00768144|65636347|FG000|Overall Study|Pt Withdrew Consent|1|||
23518766|NCT00520975|65636350|FG000|Overall Study|Disease progression|31|||
23518767|NCT00520975|65636351|FG001|Overall Study|Disease progression|23|||
23518768|NCT00520975|65636350|FG000|Overall Study|Adverse Event|7|||
23518769|NCT00520975|65636351|FG001|Overall Study|Adverse Event|10|||
23518770|NCT00520975|65636350|FG000|Overall Study|Death|0|||
23518771|NCT00520975|65636351|FG001|Overall Study|Death|2|||
23518772|NCT00520975|65636350|FG000|Overall Study|Withdrawal by Subject|3|||
23518773|NCT00520975|65636351|FG001|Overall Study|Withdrawal by Subject|5|||
23518774|NCT00520975|65636350|FG000|Overall Study|Other therapy|2|||
23518775|NCT00520975|65636351|FG001|Overall Study|Other therapy|4|||
23518776|NCT00520975|65636350|FG000|Overall Study|Other reasons|4|||
23518777|NCT00520975|65636351|FG001|Overall Study|Other reasons|2|||
23518778|NCT00520975|65636350|FG000|Overall Study|Not start protocol therapy|1|||
23518779|NCT00520975|65636351|FG001|Overall Study|Not start protocol therapy|2|||
23518780|NCT00951665|65636363|FG000|Phase 1b|Adverse Event|2|||
23518781|NCT00951665|65636364|FG001|Phase 1b|Adverse Event|1|||
23518782|NCT00951665|65636365|FG002|Phase 1b|Adverse Event|0|||
23518783|NCT00951665|65636366|FG003|Phase 1b|Adverse Event|1|||
23518784|NCT00951665|65636367|FG004|Phase 1b|Adverse Event|0|||
23518785|NCT00951665|65636368|FG005|Phase 1b|Adverse Event|0|||
23518786|NCT00951665|65636363|FG000|Phase 1b|Death|1|||
23518787|NCT00951665|65636364|FG001|Phase 1b|Death|0|||
23518788|NCT00951665|65636365|FG002|Phase 1b|Death|2|||
23518789|NCT00951665|65636366|FG003|Phase 1b|Death|0|||
23518790|NCT00951665|65636367|FG004|Phase 1b|Death|0|||
23518791|NCT00951665|65636368|FG005|Phase 1b|Death|0|||
23518792|NCT00951665|65636363|FG000|Phase 1b|Physician Decision|4|||
23518793|NCT00951665|65636364|FG001|Phase 1b|Physician Decision|0|||
23518794|NCT00951665|65636365|FG002|Phase 1b|Physician Decision|1|||
23518795|NCT00951665|65636366|FG003|Phase 1b|Physician Decision|0|||
23518796|NCT00951665|65636367|FG004|Phase 1b|Physician Decision|0|||
23518797|NCT00951665|65636368|FG005|Phase 1b|Physician Decision|0|||
23518798|NCT00951665|65636363|FG000|Phase 1b|Withdrawal by Subject|0|||
23518799|NCT00951665|65636364|FG001|Phase 1b|Withdrawal by Subject|1|||
23518800|NCT00951665|65636365|FG002|Phase 1b|Withdrawal by Subject|0|||
23518801|NCT00951665|65636366|FG003|Phase 1b|Withdrawal by Subject|0|||
23205213|NCT00492856|64491287|FG002|Post-consolidation|Not protocol specified|0|||
23518802|NCT00951665|65636367|FG004|Phase 1b|Withdrawal by Subject|0|||
23518803|NCT00951665|65636368|FG005|Phase 1b|Withdrawal by Subject|0|||
23518804|NCT00951665|65636363|FG000|Phase 1b|Disease Progression|13|||
23518805|NCT00951665|65636364|FG001|Phase 1b|Disease Progression|2|||
23518806|NCT00951665|65636365|FG002|Phase 1b|Disease Progression|14|||
23518807|NCT00951665|65636366|FG003|Phase 1b|Disease Progression|0|||
23518808|NCT00951665|65636367|FG004|Phase 1b|Disease Progression|0|||
23518809|NCT00951665|65636368|FG005|Phase 1b|Disease Progression|0|||
23518810|NCT00951665|65636363|FG000|Phase 1b|Protocol Violation|2|||
23518811|NCT00951665|65636364|FG001|Phase 1b|Protocol Violation|0|||
23518812|NCT00951665|65636365|FG002|Phase 1b|Protocol Violation|0|||
23518813|NCT00951665|65636366|FG003|Phase 1b|Protocol Violation|0|||
23518814|NCT00951665|65636367|FG004|Phase 1b|Protocol Violation|0|||
23518815|NCT00951665|65636368|FG005|Phase 1b|Protocol Violation|0|||
23518816|NCT00951665|65636363|FG000|Phase 2a|Adverse Event|0|||
23518817|NCT00951665|65636364|FG001|Phase 2a|Adverse Event|0|||
23518818|NCT00951665|65636365|FG002|Phase 2a|Adverse Event|0|||
23518819|NCT00951665|65636366|FG003|Phase 2a|Adverse Event|0|||
23518820|NCT00951665|65636367|FG004|Phase 2a|Adverse Event|2|||
23518821|NCT00951665|65636368|FG005|Phase 2a|Adverse Event|0|||
23518822|NCT00951665|65636363|FG000|Phase 2a|Death|0|||
23518823|NCT00951665|65636364|FG001|Phase 2a|Death|0|||
23518824|NCT00951665|65636365|FG002|Phase 2a|Death|0|||
23518825|NCT00951665|65636366|FG003|Phase 2a|Death|0|||
23518826|NCT00951665|65636367|FG004|Phase 2a|Death|1|||
23518827|NCT00951665|65636368|FG005|Phase 2a|Death|1|||
23518828|NCT00951665|65636363|FG000|Phase 2a|Lost to Follow-up|0|||
23518829|NCT00951665|65636364|FG001|Phase 2a|Lost to Follow-up|0|||
23518830|NCT00951665|65636365|FG002|Phase 2a|Lost to Follow-up|0|||
23518831|NCT00951665|65636366|FG003|Phase 2a|Lost to Follow-up|0|||
23518832|NCT00951665|65636367|FG004|Phase 2a|Lost to Follow-up|1|||
23518833|NCT00951665|65636368|FG005|Phase 2a|Lost to Follow-up|0|||
23518834|NCT00951665|65636363|FG000|Phase 2a|Physician Decision|0|||
23518835|NCT00951665|65636364|FG001|Phase 2a|Physician Decision|0|||
23518836|NCT00951665|65636365|FG002|Phase 2a|Physician Decision|0|||
23518837|NCT00951665|65636366|FG003|Phase 2a|Physician Decision|0|||
23307675|NCT02730351|64870563|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
23307676|NCT02730351|64870562|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
23307677|NCT02730351|64870563|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
23416205|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
23518838|NCT00951665|65636367|FG004|Phase 2a|Physician Decision|0|||
23518839|NCT00951665|65636368|FG005|Phase 2a|Physician Decision|1|||
23518840|NCT00951665|65636363|FG000|Phase 2a|Withdrawal by Subject|0|||
23307678|NCT01083810|64870564|FG000|Overall Study|Lost to Follow-up|23|||
23518841|NCT00951665|65636364|FG001|Phase 2a|Withdrawal by Subject|0|||
23518842|NCT00951665|65636365|FG002|Phase 2a|Withdrawal by Subject|0|||
23518843|NCT00951665|65636366|FG003|Phase 2a|Withdrawal by Subject|0|||
23518844|NCT00951665|65636367|FG004|Phase 2a|Withdrawal by Subject|2|||
23518845|NCT00951665|65636368|FG005|Phase 2a|Withdrawal by Subject|0|||
23518846|NCT00951665|65636363|FG000|Phase 2a|Disease Progression|0|||
23518847|NCT00951665|65636364|FG001|Phase 2a|Disease Progression|0|||
23518848|NCT00951665|65636365|FG002|Phase 2a|Disease Progression|0|||
23518849|NCT00951665|65636366|FG003|Phase 2a|Disease Progression|0|||
23518850|NCT00951665|65636367|FG004|Phase 2a|Disease Progression|6|||
23518851|NCT00951665|65636368|FG005|Phase 2a|Disease Progression|5|||
23518852|NCT00840294|65636369|FG000|Overall Study|Withdrawal by Subject|2|||
23518853|NCT00840294|65636370|FG001|Overall Study|Withdrawal by Subject|1|||
23518854|NCT00840294|65636369|FG000|Overall Study|Protocol Violation|1|||
23518855|NCT00840294|65636370|FG001|Overall Study|Protocol Violation|3|||
23518856|NCT00840294|65636369|FG000|Overall Study|Illness|0|||
23518857|NCT00840294|65636370|FG001|Overall Study|Illness|1|||
23518858|NCT01909479|65636371|FG000|From Baseline to Week 26|Adverse Event|3|||
23518859|NCT01909479|65636372|FG001|From Baseline to Week 26|Adverse Event|2|||
23518860|NCT01909479|65636371|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
23518861|NCT01909479|65636372|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
23205214|NCT00492856|64491288|FG003|Post-consolidation|Not protocol specified|0|||
23518862|NCT01909479|65636371|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
23205215|NCT00492856|64491285|FG000|Post-consolidation|Lost to Follow-up|0|||
23205216|NCT00492856|64491286|FG001|Post-consolidation|Lost to Follow-up|2|||
23205217|NCT00492856|64491287|FG002|Post-consolidation|Lost to Follow-up|0|||
23205218|NCT00492856|64491288|FG003|Post-consolidation|Lost to Follow-up|0|||
23205219|NCT00492856|64491285|FG000|Post-consolidation|Observation Arm|0|||
23205220|NCT00492856|64491286|FG001|Post-consolidation|Observation Arm|0|||
23205221|NCT00492856|64491287|FG002|Post-consolidation|Observation Arm|27|||
23205222|NCT00492856|64491288|FG003|Post-consolidation|Observation Arm|0|||
23205223|NCT04494633|64491290|FG000|Overall Study|Lost to Follow-up|5|||
23205224|NCT04494633|64491291|FG001|Overall Study|Lost to Follow-up|3|||
23205225|NCT04494633|64491290|FG000|Overall Study|Protocol Violation|1|||
23205226|NCT04494633|64491291|FG001|Overall Study|Protocol Violation|1|||
23205227|NCT02922634|64491292|FG000|Overall Study|Withdrawal by Subject|5|||
23205228|NCT02922634|64491292|FG000|Overall Study|Did not have their surgery|5|||
23205229|NCT05216406|64491293|FG000|Overall Study|Lost to Follow-up|8|||
23205230|NCT05216406|64491294|FG001|Overall Study|Lost to Follow-up|9|||
23518863|NCT01909479|65636372|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
23518864|NCT01909479|65636371|FG000|26 - 52 Weeks|Adverse Event|0|||
23518865|NCT01909479|65636372|FG001|26 - 52 Weeks|Adverse Event|1|||
23518866|NCT01909479|65636371|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
23518867|NCT01909479|65636372|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
23518868|NCT01909479|65636371|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
23518869|NCT01909479|65636372|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
23518870|NCT01909479|65636371|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
23518871|NCT01909479|65636372|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
23518872|NCT01909479|65636371|FG000|52 Weeks to End of Study|Adverse Event|2|||
23518873|NCT01909479|65636372|FG001|52 Weeks to End of Study|Adverse Event|1|||
23518874|NCT01909479|65636371|FG000|52 Weeks to End of Study|Death|0|||
23518875|NCT01909479|65636372|FG001|52 Weeks to End of Study|Death|1|||
23518876|NCT01909479|65636371|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
23518877|NCT01909479|65636372|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
23518878|NCT01909479|65636371|FG000|52 Weeks to End of Study|Protocol Violation|1|||
23518879|NCT01909479|65636372|FG001|52 Weeks to End of Study|Protocol Violation|0|||
23518880|NCT01909479|65636371|FG000|52 Weeks to End of Study|Progressive disease|1|||
23518881|NCT01909479|65636372|FG001|52 Weeks to End of Study|Progressive disease|1|||
23518882|NCT01909479|65636371|FG000|52 Weeks to End of Study|Personal reasons|2|||
23518883|NCT01909479|65636372|FG001|52 Weeks to End of Study|Personal reasons|1|||
23518884|NCT01909479|65636371|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
23518885|NCT01909479|65636372|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
23518886|NCT01909479|65636371|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
23518887|NCT01909479|65636372|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
23518888|NCT01909479|65636371|FG000|52 Weeks to End of Study|Lack of contact|1|||
23518889|NCT01909479|65636372|FG001|52 Weeks to End of Study|Lack of contact|0|||
23518890|NCT01909479|65636371|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
23518891|NCT01909479|65636372|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
23518892|NCT01909479|65636371|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
23518893|NCT01909479|65636372|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
23518894|NCT02016482|65636373|FG000|Period A|Adverse Event|3|||
23518895|NCT02016482|65636374|FG001|Period A|Adverse Event|5|||
23518896|NCT02016482|65636373|FG000|Period A|Withdrawal by Subject|3|||
23518897|NCT02016482|65636374|FG001|Period A|Withdrawal by Subject|4|||
23518898|NCT02016482|65636373|FG000|Period A|Lost to Follow-up|3|||
23518899|NCT02016482|65636374|FG001|Period A|Lost to Follow-up|3|||
23518900|NCT02016482|65636373|FG000|Period A|Lack of Efficacy|2|||
23518901|NCT02016482|65636374|FG001|Period A|Lack of Efficacy|1|||
23518902|NCT02016482|65636373|FG000|Period A|Other|3|||
23518903|NCT02016482|65636374|FG001|Period A|Other|0|||
23518904|NCT02016482|65636373|FG000|Period A|Protocol Violation|0|||
23518905|NCT02016482|65636374|FG001|Period A|Protocol Violation|1|||
23518906|NCT02016482|65636373|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
23518907|NCT02016482|65636374|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
23518908|NCT02016482|65636373|FG000|Period B|Withdrawal by Subject|1|||
23518909|NCT02016482|65636374|FG001|Period B|Withdrawal by Subject|1|||
23518910|NCT02016482|65636373|FG000|Period B|Lost to Follow-up|2|||
23518911|NCT02016482|65636374|FG001|Period B|Lost to Follow-up|0|||
23518912|NCT02016482|65636373|FG000|Period B|Lack of Efficacy|6|||
23518913|NCT02016482|65636374|FG001|Period B|Lack of Efficacy|4|||
23518914|NCT02016482|65636373|FG000|Period B|Other|4|||
23518915|NCT02016482|65636374|FG001|Period B|Other|0|||
23518916|NCT02016482|65636373|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
23518917|NCT02016482|65636374|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
23518918|NCT02232425|65636381|FG000|Overall Study|Lost to Follow-up|6|||
23518919|NCT02232425|65636382|FG001|Overall Study|Lost to Follow-up|2|||
23518920|NCT02232425|65636381|FG000|Overall Study|Adverse Event|2|||
23518921|NCT02232425|65636382|FG001|Overall Study|Adverse Event|0|||
23518922|NCT02232425|65636381|FG000|Overall Study|Withdrawal by Subject|5|||
23518923|NCT02232425|65636382|FG001|Overall Study|Withdrawal by Subject|6|||
23518924|NCT02232425|65636381|FG000|Overall Study|Lack of Efficacy|1|||
23518925|NCT02232425|65636382|FG001|Overall Study|Lack of Efficacy|0|||
23518926|NCT00704535|65636383|FG000|Overall Study|Adverse Event|2|||
23518927|NCT00704535|65636383|FG000|Overall Study|Death|2|||
23518928|NCT00704535|65636383|FG000|Overall Study|Lost to Follow-up|8|||
23518929|NCT00704535|65636383|FG000|Overall Study|Protocol Violation|10|||
23518930|NCT00704535|65636383|FG000|Overall Study|Completed status not on Case Report Form|124|||
23518931|NCT01077804|65636388|FG000|Overall Study|Unreachable|102|||
23518932|NCT01077804|65636388|FG000|Overall Study|Refused to continue|79|||
23518933|NCT01077804|65636388|FG000|Overall Study|Other|18|||
23518934|NCT03316885|65636389|FG000|Overall Study|Adverse Event|1|||
23518935|NCT03316885|65636389|FG000|Overall Study|Death|10|||
23518936|NCT03316885|65636389|FG000|Overall Study|Lost to Follow-up|4|||
23518937|NCT03316885|65636389|FG000|Overall Study|Withdrawal by Subject|9|||
23518938|NCT03316885|65636389|FG000|Overall Study|COVID related|8|||
23518939|NCT01782664|65636395|FG000|Overall Study|Adverse Event|2|||
23518940|NCT01782664|65636396|FG001|Overall Study|Adverse Event|2|||
23518941|NCT01782664|65636397|FG002|Overall Study|Adverse Event|2|||
23518942|NCT01782664|65636398|FG003|Overall Study|Adverse Event|2|||
23518943|NCT01782664|65636399|FG004|Overall Study|Adverse Event|0|||
23518944|NCT01782664|65636400|FG005|Overall Study|Adverse Event|0|||
23518945|NCT01782664|65636395|FG000|Overall Study|Lack of Efficacy|2|||
23518946|NCT01782664|65636396|FG001|Overall Study|Lack of Efficacy|0|||
23518947|NCT01782664|65636397|FG002|Overall Study|Lack of Efficacy|2|||
23518948|NCT01782664|65636398|FG003|Overall Study|Lack of Efficacy|2|||
23518949|NCT01782664|65636399|FG004|Overall Study|Lack of Efficacy|0|||
23518950|NCT01782664|65636400|FG005|Overall Study|Lack of Efficacy|0|||
23518951|NCT01782664|65636395|FG000|Overall Study|Protocol Violation|0|||
23518952|NCT01782664|65636396|FG001|Overall Study|Protocol Violation|1|||
23518953|NCT01782664|65636397|FG002|Overall Study|Protocol Violation|0|||
23518954|NCT01782664|65636398|FG003|Overall Study|Protocol Violation|1|||
23518955|NCT01782664|65636399|FG004|Overall Study|Protocol Violation|0|||
23518956|NCT01782664|65636400|FG005|Overall Study|Protocol Violation|0|||
23205231|NCT00751114|64491295|FG000|Overall Study|Adverse Event|2|||
23518957|NCT01782664|65636395|FG000|Overall Study|Withdrawal by Subject|2|||
23518958|NCT01782664|65636396|FG001|Overall Study|Withdrawal by Subject|2|||
23518959|NCT01782664|65636397|FG002|Overall Study|Withdrawal by Subject|0|||
23518960|NCT01782664|65636398|FG003|Overall Study|Withdrawal by Subject|0|||
23518961|NCT01782664|65636399|FG004|Overall Study|Withdrawal by Subject|0|||
23518962|NCT01782664|65636400|FG005|Overall Study|Withdrawal by Subject|0|||
23518963|NCT02406651|65636401|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
23518964|NCT02009046|65636402|FG000|Overall Study|Lost to Follow-up|256|||
23518965|NCT02009046|65636403|FG001|Overall Study|Lost to Follow-up|206|||
23518966|NCT00075582|65636406|FG000|Overall Study|Adverse Event|3|||
23518967|NCT00075582|65636407|FG001|Overall Study|Adverse Event|1|||
23518968|NCT00075582|65636406|FG000|Overall Study|Lack of Efficacy|4|||
23518969|NCT00075582|65636407|FG001|Overall Study|Lack of Efficacy|8|||
23518970|NCT00075582|65636406|FG000|Overall Study|Physician Decision|5|||
23518971|NCT00075582|65636407|FG001|Overall Study|Physician Decision|8|||
23518972|NCT00075582|65636406|FG000|Overall Study|Withdrawal by Subject|2|||
23518973|NCT00075582|65636407|FG001|Overall Study|Withdrawal by Subject|2|||
23518974|NCT00075582|65636406|FG000|Overall Study|Ineligible for study|36|||
23518975|NCT00075582|65636407|FG001|Overall Study|Ineligible for study|16|||
23518976|NCT01990495|65636408|FG000|Overall Study|Physician Decision|5|||
23518977|NCT01990495|65636409|FG001|Overall Study|Physician Decision|4|||
23518978|NCT01955161|65636410|FG000|Overall Study|Withdrawal before treatment|2|||
23518979|NCT01955161|65636411|FG001|Overall Study|Withdrawal before treatment|0|||
23518980|NCT01955161|65636412|FG002|Overall Study|Withdrawal before treatment|1|||
23518981|NCT01955161|65636410|FG000|Overall Study|Adverse Event|10|||
23518982|NCT01955161|65636411|FG001|Overall Study|Adverse Event|14|||
23518983|NCT01955161|65636412|FG002|Overall Study|Adverse Event|15|||
23518984|NCT01955161|65636410|FG000|Overall Study|Death|1|||
23518985|NCT01955161|65636411|FG001|Overall Study|Death|1|||
23518986|NCT01955161|65636412|FG002|Overall Study|Death|3|||
23518987|NCT01955161|65636410|FG000|Overall Study|Withdrawal by Subject|9|||
23518988|NCT01955161|65636411|FG001|Overall Study|Withdrawal by Subject|8|||
23518989|NCT01955161|65636412|FG002|Overall Study|Withdrawal by Subject|12|||
23518990|NCT01955161|65636410|FG000|Overall Study|Protocol Violation|2|||
23518991|NCT01955161|65636411|FG001|Overall Study|Protocol Violation|0|||
23518992|NCT01955161|65636412|FG002|Overall Study|Protocol Violation|0|||
23518993|NCT01955161|65636410|FG000|Overall Study|Other reason: physician decision|0|||
23518994|NCT01955161|65636411|FG001|Overall Study|Other reason: physician decision|1|||
23518995|NCT01955161|65636412|FG002|Overall Study|Other reason: physician decision|1|||
23518996|NCT01955161|65636410|FG000|Overall Study|Other reason: disallowed medication|1|||
23518997|NCT01955161|65636411|FG001|Overall Study|Other reason: disallowed medication|0|||
23518998|NCT01955161|65636412|FG002|Overall Study|Other reason: disallowed medication|1|||
23518999|NCT01955161|65636410|FG000|Overall Study|Other reason: caregiver unavailable|1|||
23519000|NCT01955161|65636411|FG001|Overall Study|Other reason: caregiver unavailable|0|||
23519001|NCT01955161|65636412|FG002|Overall Study|Other reason: caregiver unavailable|0|||
23519002|NCT01955161|65636410|FG000|Overall Study|Other reason: moved to nursing home|0|||
23519003|NCT01955161|65636411|FG001|Overall Study|Other reason: moved to nursing home|1|||
23416206|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
23519004|NCT01955161|65636412|FG002|Overall Study|Other reason: moved to nursing home|0|||
23519005|NCT01955161|65636410|FG000|Overall Study|Other reason: insufficient compliance|0|||
23519006|NCT01955161|65636411|FG001|Overall Study|Other reason: insufficient compliance|0|||
23519007|NCT01955161|65636412|FG002|Overall Study|Other reason: insufficient compliance|1|||
23519008|NCT01955161|65636410|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
23519009|NCT01955161|65636411|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
23519010|NCT01955161|65636412|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
23519011|NCT01955161|65636410|FG000|Overall Study|Other reason: patient's will|0|||
23519012|NCT01955161|65636411|FG001|Overall Study|Other reason: patient's will|0|||
23519013|NCT01955161|65636412|FG002|Overall Study|Other reason: patient's will|1|||
23519014|NCT02574247|65636415|FG000|Overall Study|Withdrawal by Subject|1|||
23519015|NCT02574247|65636416|FG001|Overall Study|Withdrawal by Subject|0|||
23519016|NCT02574247|65636417|FG002|Overall Study|Withdrawal by Subject|0|||
23519017|NCT02574247|65636415|FG000|Overall Study|Did not meet inclusion criteria|4|||
23519018|NCT02574247|65636416|FG001|Overall Study|Did not meet inclusion criteria|3|||
23519019|NCT02574247|65636417|FG002|Overall Study|Did not meet inclusion criteria|5|||
23519020|NCT00281684|65636419|FG000|Overall Study|Lost to Follow-up|0|||
23519021|NCT00281684|65636420|FG001|Overall Study|Lost to Follow-up|0|||
23519022|NCT00281684|65636421|FG002|Overall Study|Lost to Follow-up|1|||
23519023|NCT00281684|65636422|FG003|Overall Study|Lost to Follow-up|0|||
23519024|NCT00281684|65636419|FG000|Overall Study|Withdrawal by Subject|1|||
23519025|NCT00281684|65636420|FG001|Overall Study|Withdrawal by Subject|0|||
23519026|NCT00281684|65636421|FG002|Overall Study|Withdrawal by Subject|0|||
23519027|NCT00281684|65636422|FG003|Overall Study|Withdrawal by Subject|0|||
23519028|NCT04339296|65636423|FG000|Overall Study|Refuse to participate after allocation|1|||
23519029|NCT04339296|65636424|FG001|Overall Study|Refuse to participate after allocation|1|||
23519030|NCT04339296|65636423|FG000|Overall Study|Withdrew after completion of baseline|2|||
23519031|NCT04339296|65636424|FG001|Overall Study|Withdrew after completion of baseline|1|||
23519032|NCT04339296|65636423|FG000|Overall Study|Lost to Follow-up|0|||
23519033|NCT04339296|65636424|FG001|Overall Study|Lost to Follow-up|4|||
23519034|NCT04339296|65636423|FG000|Overall Study|Discontinued intervention|5|||
23519035|NCT04339296|65636424|FG001|Overall Study|Discontinued intervention|3|||
23519036|NCT00930579|65636425|FG000|Overall Study|Withdrawal by Subject|1|||
23519037|NCT00930579|65636425|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
23519038|NCT03839212|65636426|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
23519039|NCT03717480|65636427|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
23519040|NCT02066467|65636428|FG000|Overall Study|Did not undergo implant procedure|24|||
23519041|NCT02066467|65636428|FG000|Overall Study|Attempted to implant withoput success|43|||
23519042|NCT02066467|65636428|FG000|Overall Study|Consent ineligible|1|||
23519043|NCT02066467|65636428|FG000|Overall Study|Death|54|||
23519044|NCT02066467|65636428|FG000|Overall Study|Lost to Follow-up|51|||
23519045|NCT02066467|65636428|FG000|Overall Study|Adverse Event|20|||
23519046|NCT02066467|65636428|FG000|Overall Study|Withdrawal by Subject|16|||
23519047|NCT02066467|65636428|FG000|Overall Study|Physician Decision|2|||
23519048|NCT02066467|65636428|FG000|Overall Study|Not defined|4|||
23519049|NCT00736723|65636429|FG000|Overall Study|Withdrawal by Subject|4|||
23519050|NCT00736723|65636430|FG001|Overall Study|Withdrawal by Subject|3|||
23519051|NCT01132547|65639844|FG000|Overall Study|Withdrawal by Subject|3|||
23519052|NCT01132547|65639845|FG001|Overall Study|Withdrawal by Subject|1|||
23519053|NCT01132547|65639844|FG000|Overall Study|Death|1|||
23519054|NCT01132547|65639845|FG001|Overall Study|Death|0|||
23519055|NCT00613015|65639846|FG000|Overall Study|Lost to Follow-up|0|||
23519056|NCT00613015|65639847|FG001|Overall Study|Lost to Follow-up|1|||
23519057|NCT00613015|65639848|FG002|Overall Study|Lost to Follow-up|3|||
23519058|NCT00613015|65639849|FG003|Overall Study|Lost to Follow-up|3|||
23519059|NCT00613015|65639850|FG004|Overall Study|Lost to Follow-up|2|||
23519060|NCT00613015|65639851|FG005|Overall Study|Lost to Follow-up|3|||
23519061|NCT00811577|65639852|FG000|Overall Study|Lost to Follow-up|7|||
23519062|NCT00811577|65639853|FG001|Overall Study|Lost to Follow-up|1|||
23519063|NCT00811577|65639852|FG000|Overall Study|Withdrawal by Subject|3|||
23519064|NCT00811577|65639853|FG001|Overall Study|Withdrawal by Subject|0|||
23519065|NCT00329407|65639857|FG000|Overall Study|Withdrawal by Subject|1|||
23519066|NCT00335972|65639858|FG000|Overall Study|not given treatments|0|||
23519067|NCT00335972|65639859|FG001|Overall Study|not given treatments|3|||
23519068|NCT01288287|65639860|FG000|Overall Study|Lost to Follow-up|8|||
23519069|NCT01288287|65639860|FG000|Overall Study|Withdrawal by Subject|4|||
23519070|NCT01288287|65639860|FG000|Overall Study|Lack of Efficacy|13|||
23519071|NCT01288287|65639860|FG000|Overall Study|Other Reason|13|||
23519072|NCT01288287|65639860|FG000|Overall Study|Unknown Reason|1|||
23205232|NCT00751114|64491296|FG001|Overall Study|Adverse Event|4|||
23519073|NCT01288287|65639860|FG000|Overall Study|Unknown Status|7|||
23519074|NCT02750592|65639863|FG000|Overall Study|Adverse Event|3|||
23519075|NCT02750592|65639863|FG000|Overall Study|Lack of Efficacy|2|||
23519076|NCT03406858|65639864|FG000|Overall Study|Failure to receive treatment drug.|1|||
23519077|NCT03406858|65639864|FG000|Overall Study|ineligible|1|||
23519078|NCT02489344|65639865|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
23519079|NCT02489344|65639865|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
23519080|NCT02489344|65639865|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
23519081|NCT02489344|65639865|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
23519082|NCT01086540|65639870|FG000|Overall Study|Death|3|||
23519083|NCT01086540|65639871|FG001|Overall Study|Death|1|||
23519084|NCT01086540|65639870|FG000|Overall Study|Physician Decision|2|||
23519085|NCT01086540|65639871|FG001|Overall Study|Physician Decision|1|||
23519086|NCT01086540|65639870|FG000|Overall Study|Addition of new therapy for PAH|1|||
23519087|NCT01086540|65639871|FG001|Overall Study|Addition of new therapy for PAH|0|||
23519088|NCT01528254|65639872|FG000|Overall Study|Administrative problems|96|||
23519089|NCT01528254|65639873|FG001|Overall Study|Administrative problems|94|||
23519090|NCT01528254|65639872|FG000|Overall Study|Adverse Event|28|||
23519091|NCT01528254|65639873|FG001|Overall Study|Adverse Event|44|||
23519092|NCT01528254|65639872|FG000|Overall Study|Lost to Follow-up|17|||
23519093|NCT01528254|65639873|FG001|Overall Study|Lost to Follow-up|24|||
23519094|NCT01528254|65639872|FG000|Overall Study|Death|13|||
23519095|NCT01528254|65639873|FG001|Overall Study|Death|9|||
23519096|NCT01528254|65639872|FG000|Overall Study|Protocol deviation|9|||
23519097|NCT01528254|65639873|FG001|Overall Study|Protocol deviation|19|||
23519098|NCT01528254|65639872|FG000|Overall Study|New therapy for study indication|8|||
23519099|NCT01528254|65639873|FG001|Overall Study|New therapy for study indication|6|||
23519100|NCT01528254|65639872|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
23519101|NCT01528254|65639873|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23519102|NCT01528254|65639872|FG000|Overall Study|Withdrawal by Subject|5|||
23519103|NCT01528254|65639873|FG001|Overall Study|Withdrawal by Subject|4|||
23519104|NCT01528254|65639872|FG000|Overall Study|Abnormal laboratory value(s)|3|||
23519105|NCT01528254|65639873|FG001|Overall Study|Abnormal laboratory value(s)|7|||
23519106|NCT01528254|65639872|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23205233|NCT00751114|64491295|FG000|Overall Study|Protocol Violation|8|||
23519107|NCT01528254|65639873|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23519108|NCT01528254|65639872|FG000|Overall Study|No longer requires study drug|1|||
23519109|NCT01528254|65639873|FG001|Overall Study|No longer requires study drug|1|||
23519110|NCT01614990|65639878|FG000|Overall Study|Protocol Violation|1|||
23519111|NCT01614990|65639879|FG001|Overall Study|Protocol Violation|1|||
23519112|NCT02268812|65639880|FG000|Overall Study|Adverse Event|8|||
23519113|NCT02268812|65639881|FG001|Overall Study|Adverse Event|26|||
23519114|NCT02268812|65639882|FG002|Overall Study|Adverse Event|7|||
23519115|NCT02268812|65639883|FG003|Overall Study|Adverse Event|10|||
23519116|NCT02268812|65639880|FG000|Overall Study|Protocol deviation|0|||
23519117|NCT02268812|65639881|FG001|Overall Study|Protocol deviation|0|||
23519118|NCT02268812|65639882|FG002|Overall Study|Protocol deviation|1|||
23519119|NCT02268812|65639883|FG003|Overall Study|Protocol deviation|0|||
23519120|NCT02268812|65639880|FG000|Overall Study|Withdrawal by Subject|0|||
23519121|NCT02268812|65639881|FG001|Overall Study|Withdrawal by Subject|1|||
23519122|NCT02268812|65639882|FG002|Overall Study|Withdrawal by Subject|0|||
23519123|NCT02268812|65639883|FG003|Overall Study|Withdrawal by Subject|0|||
23519124|NCT02268812|65639880|FG000|Overall Study|Physician Decision|3|||
23519125|NCT02268812|65639881|FG001|Overall Study|Physician Decision|1|||
23519126|NCT02268812|65639882|FG002|Overall Study|Physician Decision|0|||
23519127|NCT02268812|65639883|FG003|Overall Study|Physician Decision|1|||
23519128|NCT02268812|65639880|FG000|Overall Study|Other|5|||
23519129|NCT02268812|65639881|FG001|Overall Study|Other|4|||
23519130|NCT02268812|65639882|FG002|Overall Study|Other|1|||
23519131|NCT02268812|65639883|FG003|Overall Study|Other|3|||
23519132|NCT03774433|65639884|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
23519133|NCT01852942|65639885|FG000|Overall Study|Physician Decision|1|||
23519134|NCT01852942|65639886|FG001|Overall Study|Physician Decision|0|||
23519135|NCT01852942|65639885|FG000|Overall Study|Death|1|||
23519136|NCT01852942|65639886|FG001|Overall Study|Death|1|||
23519137|NCT01852942|65639885|FG000|Overall Study|Withdrawal by Subject|2|||
23519138|NCT01852942|65639886|FG001|Overall Study|Withdrawal by Subject|3|||
23519139|NCT01852942|65639885|FG000|Overall Study|Lost to Follow-up|1|||
23519140|NCT01852942|65639886|FG001|Overall Study|Lost to Follow-up|2|||
23519141|NCT03571581|65639887|FG000|Overall Study|Death|2|||
23519142|NCT03571581|65639887|FG000|Overall Study|Withdrawal by Subject|2|||
23519143|NCT02345811|65639889|FG000|First Intervention|Withdrawal by Subject|1|||
23519144|NCT02345811|65639890|FG001|First Intervention|Withdrawal by Subject|1|||
23519145|NCT02419742|65639893|FG000|Overall Study|Adverse Event|2|||
23519146|NCT02419742|65639894|FG001|Overall Study|Adverse Event|0|||
23519147|NCT02419742|65639893|FG000|Overall Study|Disease Progression|0|||
23519148|NCT02419742|65639894|FG001|Overall Study|Disease Progression|1|||
23519149|NCT02419742|65639893|FG000|Overall Study|Withdrew Consent|2|||
23519150|NCT02419742|65639894|FG001|Overall Study|Withdrew Consent|1|||
23519151|NCT02419742|65639893|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
23519152|NCT02419742|65639894|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
23519153|NCT01288911|65639895|FG000|Double-blind Period|Death|11|||
23519154|NCT01288911|65639896|FG001|Double-blind Period|Death|7|||
23519155|NCT01288911|65639895|FG000|Double-blind Period|Lost to Follow-up|0|||
23519156|NCT01288911|65639896|FG001|Double-blind Period|Lost to Follow-up|2|||
23519157|NCT01288911|65639895|FG000|Double-blind Period|Progressive Disease|75|||
23519158|NCT01288911|65639896|FG001|Double-blind Period|Progressive Disease|103|||
23519159|NCT01288911|65639895|FG000|Double-blind Period|Protocol Violation|1|||
23519160|NCT01288911|65639896|FG001|Double-blind Period|Protocol Violation|0|||
23519161|NCT01288911|65639895|FG000|Double-blind Period|Withdrawal by Subject|25|||
23519162|NCT01288911|65639896|FG001|Double-blind Period|Withdrawal by Subject|26|||
23519163|NCT01288911|65639895|FG000|Double-blind Period|Miscellaneous Reason|29|||
23519164|NCT01288911|65639896|FG001|Double-blind Period|Miscellaneous Reason|42|||
23519165|NCT01288911|65639895|FG000|Double-blind Period|Randomized but never received study drug|1|||
23519166|NCT01288911|65639896|FG001|Double-blind Period|Randomized but never received study drug|2|||
23519167|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Death|0|||
23519168|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Death|1|||
23519169|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
23519170|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
23519171|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
23519172|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
23519173|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
23519174|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
23519175|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
23519176|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
23519177|NCT01288911|65639895|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
23307679|NCT01083810|64870565|FG001|Overall Study|Lost to Follow-up|11|||
23307680|NCT01083810|64870566|FG002|Overall Study|Lost to Follow-up|4|||
23519178|NCT01288911|65639896|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
23519179|NCT02784821|65639897|FG000|Overall Study|Death|0|||
23519180|NCT02784821|65639898|FG001|Overall Study|Death|5|||
23519181|NCT02784821|65639899|FG002|Overall Study|Death|4|||
23519182|NCT02784821|65639900|FG003|Overall Study|Death|5|||
23519183|NCT01173718|65639909|FG000|Overall Study|Death|17|||
23519184|NCT01173718|65639909|FG000|Overall Study|Abandonment of study graft|27|||
23519185|NCT00923559|65639910|FG000|Overall Study|Lost to Follow-up|2|||
23519186|NCT00923559|65639911|FG001|Overall Study|Lost to Follow-up|3|||
23519187|NCT01998737|65639913|FG000|Overall Study|Corrupted database|23|||
23307681|NCT01083810|64870564|FG000|Overall Study|Adverse Event|15|||
23519188|NCT01998737|65639914|FG001|Overall Study|Corrupted database|0|||
23205234|NCT00751114|64491296|FG001|Overall Study|Protocol Violation|9|||
23519189|NCT01644175|65639917|FG000|Overall Study|Randomized But Not Treated|0|||
23519190|NCT01644175|65639918|FG001|Overall Study|Randomized But Not Treated|2|||
23519191|NCT01644175|65639917|FG000|Overall Study|Adverse Event|8|||
23519192|NCT01644175|65639918|FG001|Overall Study|Adverse Event|13|||
23519193|NCT01644175|65639917|FG000|Overall Study|Death|1|||
23519194|NCT01644175|65639918|FG001|Overall Study|Death|2|||
23519195|NCT01644175|65639917|FG000|Overall Study|Poor compliance to protocol|9|||
23519196|NCT01644175|65639918|FG001|Overall Study|Poor compliance to protocol|10|||
23519197|NCT01644175|65639917|FG000|Overall Study|Physician Decision|1|||
23519198|NCT01644175|65639918|FG001|Overall Study|Physician Decision|2|||
23519199|NCT01644175|65639917|FG000|Overall Study|Participant Moved|1|||
23519200|NCT01644175|65639918|FG001|Overall Study|Participant Moved|2|||
23205235|NCT00751114|64491295|FG000|Overall Study|Withdrawal by Subject|9|||
23205236|NCT00751114|64491296|FG001|Overall Study|Withdrawal by Subject|4|||
23205237|NCT00751114|64491295|FG000|Overall Study|Lost to Follow-up|4|||
23205238|NCT00751114|64491296|FG001|Overall Study|Lost to Follow-up|7|||
23205239|NCT00751114|64491295|FG000|Overall Study|Lack of Efficacy|0|||
23205240|NCT00751114|64491296|FG001|Overall Study|Lack of Efficacy|7|||
23205241|NCT00751114|64491295|FG000|Overall Study|Not Treated|13|||
23205242|NCT00751114|64491296|FG001|Overall Study|Not Treated|1|||
23205243|NCT00751114|64491295|FG000|Overall Study|Out of country for 2 months|1|||
23205244|NCT00751114|64491296|FG001|Overall Study|Out of country for 2 months|0|||
23205245|NCT00751114|64491295|FG000|Overall Study|Move to another city|1|||
23205246|NCT00751114|64491296|FG001|Overall Study|Move to another city|0|||
23205247|NCT02106455|64491297|FG000|Overall Study|Case Report Form Uncollected|6|||
23205248|NCT02106455|64491297|FG000|Overall Study|Protocol Deviation|2|||
23205249|NCT02546674|64491300|FG000|Overall Study|Adverse Event|19|||
23205250|NCT02546674|64491300|FG000|Overall Study|Death|1|||
23205251|NCT02546674|64491300|FG000|Overall Study|Lost to Follow-up|1|||
23205252|NCT02546674|64491300|FG000|Overall Study|Physician Decision|13|||
23205253|NCT02546674|64491300|FG000|Overall Study|Pregnancy|1|||
23205254|NCT02546674|64491300|FG000|Overall Study|Progressive Disease|2|||
23205255|NCT02546674|64491300|FG000|Overall Study|Protocol Deviation|2|||
23205256|NCT02546674|64491300|FG000|Overall Study|Subject/Guardian Decision|6|||
23205257|NCT02546674|64491300|FG000|Overall Study|Withdrawal of Informed Consent|3|||
23205258|NCT04348591|64491311|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
23205259|NCT04348591|64491312|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
23205260|NCT04348591|64491311|FG000|Imaging Session (120 Min)|Physician Decision|0|||
23205261|NCT04348591|64491312|FG001|Imaging Session (120 Min)|Physician Decision|1|||
23205262|NCT04348591|64491311|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
23205263|NCT04348591|64491312|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
23205264|NCT02457182|64491316|FG000|Overall Study|Lost to Follow-up|1|||
23205265|NCT02457182|64491317|FG001|Overall Study|Lost to Follow-up|0|||
23205266|NCT02065622|64491318|FG000|Induction Study|Adverse Event|13|||
23205267|NCT02065622|64491319|FG001|Induction Study|Adverse Event|19|||
23205268|NCT02065622|64491320|FG002|Induction Study|Adverse Event|0|||
23205269|NCT02065622|64491321|FG003|Induction Study|Adverse Event|0|||
23205270|NCT02065622|64491322|FG004|Induction Study|Adverse Event|0|||
23416207|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
23205271|NCT02065622|64491318|FG000|Induction Study|Withdrawal by Subject|3|||
23205272|NCT02065622|64491319|FG001|Induction Study|Withdrawal by Subject|5|||
23519201|NCT01644175|65639917|FG000|Overall Study|Consent withdrawn by participant|3|||
23519202|NCT01644175|65639918|FG001|Overall Study|Consent withdrawn by participant|4|||
23519203|NCT01644175|65639917|FG000|Overall Study|Related to Autoinjector Administration|2|||
23519204|NCT01644175|65639918|FG001|Overall Study|Related to Autoinjector Administration|1|||
23519205|NCT01644175|65639917|FG000|Overall Study|Last visit outside protocol visit window|4|||
23519206|NCT01644175|65639918|FG001|Overall Study|Last visit outside protocol visit window|11|||
23519207|NCT01644175|65639917|FG000|Overall Study|Selection criteria finally not met|0|||
23519208|NCT01644175|65639918|FG001|Overall Study|Selection criteria finally not met|1|||
23519209|NCT01644175|65639917|FG000|Overall Study|Site closure|2|||
23519210|NCT01644175|65639918|FG001|Overall Study|Site closure|2|||
23519211|NCT01644175|65639917|FG000|Overall Study|Lost to Follow-up|1|||
23519212|NCT01644175|65639918|FG001|Overall Study|Lost to Follow-up|0|||
23519213|NCT01644175|65639917|FG000|Overall Study|Other than specified above|0|||
23519214|NCT01644175|65639918|FG001|Overall Study|Other than specified above|3|||
23519215|NCT00605813|65639921|FG000|Overall Study|Protocol Violation|25|||
23519216|NCT02446236|65639922|FG000|Overall Study|Screen Failure|1|||
23519217|NCT02446236|65639923|FG001|Overall Study|Screen Failure|0|||
23519218|NCT02446236|65639924|FG002|Overall Study|Screen Failure|1|||
23519219|NCT02446236|65639922|FG000|Overall Study|Actively Receiving Therapy|0|||
23519220|NCT02446236|65639923|FG001|Overall Study|Actively Receiving Therapy|0|||
23519221|NCT02446236|65639924|FG002|Overall Study|Actively Receiving Therapy|1|||
23519222|NCT02064166|65639925|FG000|Overall Study|Adverse Event|1|||
23519223|NCT02064166|65639926|FG001|Overall Study|Adverse Event|0|||
23519224|NCT00453921|65639929|FG000|Overall Study|Withdrawal by Subject|1|||
23519225|NCT00453921|65639930|FG001|Overall Study|Withdrawal by Subject|1|||
23519226|NCT00453921|65639931|FG002|Overall Study|Withdrawal by Subject|1|||
23519227|NCT00453921|65639932|FG003|Overall Study|Withdrawal by Subject|1|||
23519228|NCT00453921|65639929|FG000|Overall Study|Lost to Follow-up|0|||
23519229|NCT00453921|65639930|FG001|Overall Study|Lost to Follow-up|0|||
23519230|NCT00453921|65639931|FG002|Overall Study|Lost to Follow-up|1|||
23519231|NCT00453921|65639932|FG003|Overall Study|Lost to Follow-up|0|||
23519232|NCT03060447|65639933|FG000|Overall Study|Withdrawal by Subject|2|||
23519233|NCT03060447|65639934|FG001|Overall Study|Withdrawal by Subject|0|||
23519234|NCT01838642|65639935|FG000|Overall Study|Died on study|1|||
23519235|NCT03320564|65639936|FG000|Overall Study|Protocol Violation|1|||
23519236|NCT02788981|65639937|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
23519237|NCT02788981|65639938|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
23519238|NCT03220217|65639946|FG000|Overall Study|Withdrawal by Subject|0|||
23519239|NCT03220217|65639947|FG001|Overall Study|Withdrawal by Subject|1|||
23519240|NCT03220217|65639948|FG002|Overall Study|Withdrawal by Subject|0|||
23519241|NCT03220217|65639946|FG000|Overall Study|Subject Missed Procedure|0|||
23519242|NCT03220217|65639947|FG001|Overall Study|Subject Missed Procedure|0|||
23519243|NCT03220217|65639948|FG002|Overall Study|Subject Missed Procedure|1|||
23519244|NCT02068222|65639951|FG000|Overall Study|Lost to Follow-up|1|||
23519245|NCT01912287|65639953|FG000|Overall Study|Ineligible|1|||
23519246|NCT01912287|65639954|FG001|Overall Study|Ineligible|0|||
23519247|NCT01912287|65639955|FG002|Overall Study|Ineligible|1|||
23519248|NCT01912287|65639953|FG000|Overall Study|No-show|0|||
23519249|NCT01912287|65639954|FG001|Overall Study|No-show|0|||
23519250|NCT01912287|65639955|FG002|Overall Study|No-show|1|||
23519251|NCT01912287|65639953|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
23519252|NCT01912287|65639954|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
23519253|NCT01912287|65639955|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
23205273|NCT02065622|64491320|FG002|Induction Study|Withdrawal by Subject|0|||
23519254|NCT01912287|65639953|FG000|Overall Study|Felt treatment no longer needed|0|||
23519255|NCT01912287|65639954|FG001|Overall Study|Felt treatment no longer needed|1|||
23519256|NCT01912287|65639955|FG002|Overall Study|Felt treatment no longer needed|0|||
23519257|NCT01912287|65639953|FG000|Overall Study|Life circumstances|4|||
23519258|NCT01912287|65639954|FG001|Overall Study|Life circumstances|2|||
23519259|NCT01912287|65639955|FG002|Overall Study|Life circumstances|0|||
23519260|NCT01912287|65639953|FG000|Overall Study|Lost Interest|1|||
23519261|NCT01912287|65639954|FG001|Overall Study|Lost Interest|0|||
23519262|NCT01912287|65639955|FG002|Overall Study|Lost Interest|0|||
23519263|NCT01912287|65639953|FG000|Overall Study|Uknown reason - subject drop out|5|||
23519264|NCT01912287|65639954|FG001|Overall Study|Uknown reason - subject drop out|7|||
23519265|NCT01912287|65639955|FG002|Overall Study|Uknown reason - subject drop out|3|||
23519266|NCT01912287|65639953|FG000|Overall Study|Missed Assesment|1|||
23519267|NCT01912287|65639954|FG001|Overall Study|Missed Assesment|1|||
23519268|NCT01912287|65639955|FG002|Overall Study|Missed Assesment|1|||
23519269|NCT01912287|65639953|FG000|Overall Study|Scheduling/change in availability|17|||
23519270|NCT01912287|65639954|FG001|Overall Study|Scheduling/change in availability|10|||
23519271|NCT01912287|65639955|FG002|Overall Study|Scheduling/change in availability|8|||
23519272|NCT01277523|65639969|FG000|Overall Study|Adverse Event|1|||
23519273|NCT01277523|65639970|FG001|Overall Study|Adverse Event|0|||
23519274|NCT01277523|65639971|FG002|Overall Study|Adverse Event|0|||
23519275|NCT01277523|65639969|FG000|Overall Study|Protocol Violation|2|||
23519276|NCT01277523|65639970|FG001|Overall Study|Protocol Violation|0|||
23519277|NCT01277523|65639971|FG002|Overall Study|Protocol Violation|0|||
23519278|NCT01277523|65639969|FG000|Overall Study|Other Reason not Defined|0|||
23519279|NCT01277523|65639970|FG001|Overall Study|Other Reason not Defined|1|||
23519280|NCT01277523|65639971|FG002|Overall Study|Other Reason not Defined|0|||
23519281|NCT03245008|65639976|FG000|Overall Study|Adverse Event|15|||
23519282|NCT03245008|65639977|FG001|Overall Study|Adverse Event|18|||
23519283|NCT03245008|65639978|FG002|Overall Study|Adverse Event|15|||
23519284|NCT03245008|65639979|FG003|Overall Study|Adverse Event|0|||
23519285|NCT03245008|65639980|FG004|Overall Study|Adverse Event|1|||
23519286|NCT03245008|65639976|FG000|Overall Study|Lack of Efficacy|0|||
23519287|NCT03245008|65639977|FG001|Overall Study|Lack of Efficacy|1|||
23519288|NCT03245008|65639978|FG002|Overall Study|Lack of Efficacy|0|||
23519289|NCT03245008|65639979|FG003|Overall Study|Lack of Efficacy|0|||
23519290|NCT03245008|65639980|FG004|Overall Study|Lack of Efficacy|0|||
23519291|NCT03245008|65639976|FG000|Overall Study|Lost to Follow-up|4|||
23519292|NCT03245008|65639977|FG001|Overall Study|Lost to Follow-up|1|||
23519293|NCT03245008|65639978|FG002|Overall Study|Lost to Follow-up|0|||
23519294|NCT03245008|65639979|FG003|Overall Study|Lost to Follow-up|0|||
23519295|NCT03245008|65639980|FG004|Overall Study|Lost to Follow-up|1|||
23519296|NCT03245008|65639976|FG000|Overall Study|Physician Decision|1|||
23519297|NCT03245008|65639977|FG001|Overall Study|Physician Decision|3|||
23519298|NCT03245008|65639978|FG002|Overall Study|Physician Decision|4|||
23519299|NCT03245008|65639979|FG003|Overall Study|Physician Decision|0|||
23519300|NCT03245008|65639980|FG004|Overall Study|Physician Decision|0|||
23519301|NCT03245008|65639976|FG000|Overall Study|Protocol Violation|0|||
23519302|NCT03245008|65639977|FG001|Overall Study|Protocol Violation|1|||
23519303|NCT03245008|65639978|FG002|Overall Study|Protocol Violation|0|||
23519304|NCT03245008|65639979|FG003|Overall Study|Protocol Violation|0|||
23519305|NCT03245008|65639980|FG004|Overall Study|Protocol Violation|0|||
23519306|NCT03245008|65639976|FG000|Overall Study|Withdrawal by Subject|20|||
23519307|NCT03245008|65639977|FG001|Overall Study|Withdrawal by Subject|19|||
23519308|NCT03245008|65639978|FG002|Overall Study|Withdrawal by Subject|11|||
23519309|NCT03245008|65639979|FG003|Overall Study|Withdrawal by Subject|0|||
23519310|NCT03245008|65639980|FG004|Overall Study|Withdrawal by Subject|0|||
23519311|NCT03245008|65639976|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
23519312|NCT03245008|65639977|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
23519313|NCT03245008|65639978|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
23519314|NCT03245008|65639979|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
23519315|NCT03245008|65639980|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
23519316|NCT03245008|65639976|FG000|Overall Study|Failure to meet randomization criteria|0|||
23519317|NCT03245008|65639977|FG001|Overall Study|Failure to meet randomization criteria|1|||
23519318|NCT03245008|65639978|FG002|Overall Study|Failure to meet randomization criteria|0|||
23519319|NCT03245008|65639979|FG003|Overall Study|Failure to meet randomization criteria|1|||
23519320|NCT03245008|65639980|FG004|Overall Study|Failure to meet randomization criteria|0|||
23519321|NCT01265849|65639987|FG000|Overall Study|Randomized//Treatment not initiated|1|||
23519322|NCT01265849|65639988|FG001|Overall Study|Randomized//Treatment not initiated|4|||
23519323|NCT01265849|65639989|FG002|Overall Study|Randomized//Treatment not initiated|0|||
23519324|NCT01265849|65639987|FG000|Overall Study|Physician Decision|1|||
23519325|NCT01265849|65639988|FG001|Overall Study|Physician Decision|2|||
23519326|NCT01265849|65639989|FG002|Overall Study|Physician Decision|0|||
23519327|NCT01265849|65639987|FG000|Overall Study|Lost to Follow-up|18|||
23519328|NCT01265849|65639988|FG001|Overall Study|Lost to Follow-up|15|||
23519329|NCT01265849|65639989|FG002|Overall Study|Lost to Follow-up|5|||
23519330|NCT01265849|65639987|FG000|Overall Study|Not otherwise specified|1|||
23519331|NCT01265849|65639988|FG001|Overall Study|Not otherwise specified|6|||
23519332|NCT01265849|65639989|FG002|Overall Study|Not otherwise specified|1|||
23519333|NCT01265849|65639987|FG000|Overall Study|Withdrawal by Subject|25|||
23519334|NCT01265849|65639988|FG001|Overall Study|Withdrawal by Subject|34|||
23519335|NCT01265849|65639989|FG002|Overall Study|Withdrawal by Subject|13|||
23519336|NCT02747420|65639990|FG000|Overall Study|Lost to Follow-up|4|||
23519337|NCT02747420|65639991|FG001|Overall Study|Lost to Follow-up|2|||
23519338|NCT02747420|65639990|FG000|Overall Study|Withdrawal by Subject|3|||
23519339|NCT02747420|65639991|FG001|Overall Study|Withdrawal by Subject|2|||
23519340|NCT00238121|65640004|FG000|Overall Study|Withdrawal by Subject|1|||
23519341|NCT00238121|65640005|FG001|Overall Study|Withdrawal by Subject|1|||
23519342|NCT00238121|65640004|FG000|Overall Study|Adverse Event|2|||
23519343|NCT00238121|65640005|FG001|Overall Study|Adverse Event|1|||
23519344|NCT00651755|65640006|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
23519345|NCT00651755|65640007|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
23519346|NCT00651755|65640006|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
23519347|NCT00651755|65640007|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
23519348|NCT01132482|65640008|FG000|Overall Study|Adverse Event|1|||
23519349|NCT01132482|65640009|FG001|Overall Study|Adverse Event|0|||
23519350|NCT00500292|65640010|FG000|Overall Study|Adverse Event|3|||
23519351|NCT00500292|65640011|FG001|Overall Study|Adverse Event|6|||
23519352|NCT00500292|65640012|FG002|Overall Study|Adverse Event|4|||
23519353|NCT00500292|65640010|FG000|Overall Study|Condition under investigation worsened|21|||
23519354|NCT00500292|65640011|FG001|Overall Study|Condition under investigation worsened|23|||
23519355|NCT00500292|65640012|FG002|Overall Study|Condition under investigation worsened|19|||
23519356|NCT00500292|65640010|FG000|Overall Study|Withdrawal by Subject|0|||
23519357|NCT00500292|65640011|FG001|Overall Study|Withdrawal by Subject|1|||
23519358|NCT00500292|65640012|FG002|Overall Study|Withdrawal by Subject|0|||
23519359|NCT00500292|65640010|FG000|Overall Study|Other|1|||
23519360|NCT00500292|65640011|FG001|Overall Study|Other|1|||
23519361|NCT00500292|65640012|FG002|Overall Study|Other|4|||
23519362|NCT04117347|65640013|FG000|Overall Study|Adverse Event|0|||
23519363|NCT04117347|65640014|FG001|Overall Study|Adverse Event|0|||
23519364|NCT04117347|65640015|FG002|Overall Study|Adverse Event|1|||
23519365|NCT04117347|65640013|FG000|Overall Study|No time for study|0|||
23519366|NCT04117347|65640014|FG001|Overall Study|No time for study|2|||
23519367|NCT04117347|65640015|FG002|Overall Study|No time for study|0|||
23519368|NCT04117347|65640013|FG000|Overall Study|Family emergency|1|||
23519369|NCT04117347|65640014|FG001|Overall Study|Family emergency|0|||
23519370|NCT04117347|65640015|FG002|Overall Study|Family emergency|0|||
23519371|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
23519372|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
23519373|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
23519374|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
23519375|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
23519376|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
23519377|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
23519378|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
23519379|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
23519380|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
23519381|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
23519382|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
23519383|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
23519384|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
23519385|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
23519386|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
23519387|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
23519388|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
23519389|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
23519390|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
23519391|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
23519392|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
23307682|NCT01083810|64870565|FG001|Overall Study|Adverse Event|11|||
23519393|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
23519394|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
23519395|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
23519396|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
23519397|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
23519398|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
23519399|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
23519400|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
23519401|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
23519402|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
23519403|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
23519404|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
23519405|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
23519406|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
23519407|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
23519408|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
23519409|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
23519410|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
23519411|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
23519412|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
23519413|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
23519414|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
23519415|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
23519416|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
23519417|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
23519418|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
23519419|NCT03720470|65640018|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519420|NCT03720470|65640019|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519421|NCT03720470|65640020|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519422|NCT03720470|65640021|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519423|NCT03720470|65640022|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
23519424|NCT03720470|65640023|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
23519425|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
23205274|NCT02065622|64491321|FG003|Induction Study|Withdrawal by Subject|0|||
23307683|NCT01083810|64870566|FG002|Overall Study|Adverse Event|4|||
23416208|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
23416209|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
23416210|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
23416211|NCT03308968|65266168|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
23519426|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
23519427|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
23519428|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
23519429|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
23519430|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
23519431|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23519432|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23519433|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
23416212|NCT03308968|65266169|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
23416213|NCT03308968|65266170|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
23416214|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
23519434|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23519435|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23307684|NCT01083810|64870564|FG000|Overall Study|Withdrawal by Subject|7|||
23307685|NCT01083810|64870565|FG001|Overall Study|Withdrawal by Subject|2|||
23519436|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
23519437|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
23519438|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
23519439|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
23519440|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
23307686|NCT01083810|64870566|FG002|Overall Study|Withdrawal by Subject|4|||
23416215|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
23416216|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
23416217|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
23416218|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
23416219|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
23416220|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
23519441|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
23519442|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
23519443|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519444|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519445|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519446|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519447|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
23519448|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
23519449|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519450|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519451|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
23519452|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519453|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519454|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
23519455|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
23519456|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
23519457|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
23519458|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
23519459|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
23519460|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
23519461|NCT03720470|65640018|FG000|Treatment Period: Final 4 Weeks|Other|0|||
23519462|NCT03720470|65640019|FG001|Treatment Period: Final 4 Weeks|Other|1|||
23519463|NCT03720470|65640020|FG002|Treatment Period: Final 4 Weeks|Other|0|||
23519464|NCT03720470|65640021|FG003|Treatment Period: Final 4 Weeks|Other|2|||
23519465|NCT03720470|65640022|FG004|Treatment Period: Final 4 Weeks|Other|1|||
23519466|NCT03720470|65640023|FG005|Treatment Period: Final 4 Weeks|Other|0|||
23519467|NCT00857220|65640028|FG000|Overall Study|Adverse Event|35|||
23519468|NCT00857220|65640028|FG000|Overall Study|Death|1|||
23519469|NCT00857220|65640028|FG000|Overall Study|Lack of Efficacy|11|||
23519470|NCT00857220|65640028|FG000|Overall Study|Lost to Follow-up|30|||
23519471|NCT00857220|65640028|FG000|Overall Study|Physician Decision|4|||
23519472|NCT00857220|65640028|FG000|Overall Study|Protocol Violation|16|||
23519473|NCT00857220|65640028|FG000|Overall Study|Withdrawal by Subject|67|||
23519474|NCT00857220|65640028|FG000|Overall Study|Clinical Hold|6|||
23519475|NCT00857220|65640028|FG000|Overall Study|Site Closed|5|||
23519476|NCT00857220|65640028|FG000|Overall Study|Miscellaneous|8|||
23519477|NCT01536379|65640032|FG000|Overall Study|Adverse Event|1|||
23519478|NCT01536379|65640033|FG001|Overall Study|Adverse Event|2|||
23519479|NCT01536379|65640032|FG000|Overall Study|Withdrawal by Subject|1|||
23519480|NCT01536379|65640033|FG001|Overall Study|Withdrawal by Subject|1|||
23519481|NCT02939560|65640034|FG000|Overall Study|Withdrawal by Subject|2|||
23519482|NCT02939560|65640034|FG000|Overall Study|Protocol Violation|1|||
23519483|NCT00149747|65640035|FG000|Overall Study|Death|1|||
23519484|NCT00149747|65640036|FG001|Overall Study|Death|0|||
23519485|NCT00149747|65640035|FG000|Overall Study|Withdrawal by Subject|3|||
23519486|NCT00149747|65640036|FG001|Overall Study|Withdrawal by Subject|3|||
23519487|NCT02580357|65640037|FG000|Overall Study|Lost to Follow-up|2|||
23519488|NCT02580357|65640038|FG001|Overall Study|Lost to Follow-up|0|||
23519489|NCT02580357|65640039|FG002|Overall Study|Lost to Follow-up|0|||
23519490|NCT02580357|65640037|FG000|Overall Study|Protocol Violation|1|||
23519491|NCT02580357|65640038|FG001|Overall Study|Protocol Violation|0|||
23519492|NCT02580357|65640039|FG002|Overall Study|Protocol Violation|0|||
23519493|NCT01474876|65640040|FG000|Overall Study|Adverse Event|11|||
23519494|NCT01474876|65640041|FG001|Overall Study|Adverse Event|5|||
23519495|NCT01474876|65640042|FG002|Overall Study|Adverse Event|0|||
23519496|NCT01474876|65640040|FG000|Overall Study|Serious Adverse Event|2|||
23519497|NCT01474876|65640041|FG001|Overall Study|Serious Adverse Event|3|||
23519498|NCT01474876|65640042|FG002|Overall Study|Serious Adverse Event|0|||
23519499|NCT01474876|65640040|FG000|Overall Study|Lost to Follow-up|5|||
23519500|NCT01474876|65640041|FG001|Overall Study|Lost to Follow-up|4|||
23519501|NCT01474876|65640042|FG002|Overall Study|Lost to Follow-up|0|||
23519502|NCT01474876|65640040|FG000|Overall Study|Investigator's decision|28|||
23519503|NCT01474876|65640041|FG001|Overall Study|Investigator's decision|6|||
23519504|NCT01474876|65640042|FG002|Overall Study|Investigator's decision|0|||
23519505|NCT01474876|65640040|FG000|Overall Study|Patient's request|19|||
23519506|NCT01474876|65640041|FG001|Overall Study|Patient's request|5|||
23519507|NCT01474876|65640042|FG002|Overall Study|Patient's request|0|||
23519508|NCT01474876|65640040|FG000|Overall Study|Investigator's decision and pt request|1|||
23519509|NCT01474876|65640041|FG001|Overall Study|Investigator's decision and pt request|0|||
23519510|NCT01474876|65640042|FG002|Overall Study|Investigator's decision and pt request|0|||
23519511|NCT00227305|65640043|FG000|Overall Study|Adverse Event|40|||
23519512|NCT00227305|65640043|FG000|Overall Study|Withdrawal by Subject|42|||
23519513|NCT00227305|65640043|FG000|Overall Study|Lost to Follow-up|33|||
23519514|NCT00227305|65640043|FG000|Overall Study|Study specific discontinuation|13|||
23519515|NCT00227305|65640043|FG000|Overall Study|MOVED OUT OF AREA|3|||
23519516|NCT00227305|65640043|FG000|Overall Study|Lack of Efficacy|7|||
23519517|NCT00227305|65640043|FG000|Overall Study|Physician Decision|3|||
23519518|NCT00227305|65640043|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
23519519|NCT00227305|65640043|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
23519520|NCT00227305|65640043|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
23519521|NCT05024058|65640044|FG000|Treatment|Study terminated by sponsor|5|||
23519522|NCT05024058|65640045|FG001|Treatment|Study terminated by sponsor|6|||
23519523|NCT05024058|65640046|FG002|Treatment|Study terminated by sponsor|4|||
23519524|NCT05024058|65640047|FG003|Treatment|Study terminated by sponsor|2|||
23519525|NCT05024058|65640048|FG004|Treatment|Study terminated by sponsor|3|||
23519526|NCT05024058|65640049|FG005|Treatment|Study terminated by sponsor|3|||
23519527|NCT05024058|65640050|FG006|Treatment|Study terminated by sponsor|1|||
23519528|NCT05024058|65640051|FG007|Treatment|Study terminated by sponsor|3|||
23519529|NCT05024058|65640052|FG008|Treatment|Study terminated by sponsor|6|||
23519530|NCT05024058|65640053|FG009|Treatment|Study terminated by sponsor|6|||
23519531|NCT05024058|65640044|FG000|Follow-up|Withdrawal by Subject|1|||
23519532|NCT05024058|65640045|FG001|Follow-up|Withdrawal by Subject|0|||
23519533|NCT05024058|65640046|FG002|Follow-up|Withdrawal by Subject|1|||
23519534|NCT05024058|65640047|FG003|Follow-up|Withdrawal by Subject|0|||
23519535|NCT05024058|65640048|FG004|Follow-up|Withdrawal by Subject|0|||
23519536|NCT05024058|65640049|FG005|Follow-up|Withdrawal by Subject|0|||
23519537|NCT05024058|65640050|FG006|Follow-up|Withdrawal by Subject|0|||
23519538|NCT05024058|65640051|FG007|Follow-up|Withdrawal by Subject|1|||
23519539|NCT05024058|65640052|FG008|Follow-up|Withdrawal by Subject|0|||
23519540|NCT05024058|65640053|FG009|Follow-up|Withdrawal by Subject|1|||
23519541|NCT02205333|65640054|FG000|Overall Study|Death|5|||
23519542|NCT02205333|65640055|FG001|Overall Study|Death|6|||
23519543|NCT02205333|65640056|FG002|Overall Study|Death|2|||
23519544|NCT02205333|65640057|FG003|Overall Study|Death|6|||
23519545|NCT02205333|65640058|FG004|Overall Study|Death|5|||
23519546|NCT02205333|65640059|FG005|Overall Study|Death|3|||
23519547|NCT02205333|65640060|FG006|Overall Study|Death|3|||
23519548|NCT02205333|65640061|FG007|Overall Study|Death|2|||
23519549|NCT02205333|65640062|FG008|Overall Study|Death|0|||
23519550|NCT02205333|65640054|FG000|Overall Study|Withdrawal by Subject|1|||
23519551|NCT02205333|65640055|FG001|Overall Study|Withdrawal by Subject|0|||
23519552|NCT02205333|65640056|FG002|Overall Study|Withdrawal by Subject|0|||
23519553|NCT02205333|65640057|FG003|Overall Study|Withdrawal by Subject|1|||
23519554|NCT02205333|65640058|FG004|Overall Study|Withdrawal by Subject|0|||
23519555|NCT02205333|65640059|FG005|Overall Study|Withdrawal by Subject|0|||
23519556|NCT02205333|65640060|FG006|Overall Study|Withdrawal by Subject|2|||
23519557|NCT02205333|65640061|FG007|Overall Study|Withdrawal by Subject|0|||
23519558|NCT02205333|65640062|FG008|Overall Study|Withdrawal by Subject|0|||
23519559|NCT02515045|65640063|FG000|Overall Study|Adverse Event|0|||
23519560|NCT02515045|65640064|FG001|Overall Study|Adverse Event|3|||
23519561|NCT02515045|65640065|FG002|Overall Study|Adverse Event|3|||
23519562|NCT02515045|65640063|FG000|Overall Study|Lost to Follow-up|0|||
23519563|NCT02515045|65640064|FG001|Overall Study|Lost to Follow-up|1|||
23519564|NCT02515045|65640065|FG002|Overall Study|Lost to Follow-up|1|||
23519565|NCT00720057|65640067|FG000|Overall Study|Lost to Follow-up|0|||
23519566|NCT00720057|65640068|FG001|Overall Study|Lost to Follow-up|2|||
23519567|NCT00720057|65640067|FG000|Overall Study|Protocol Violation|1|||
23519568|NCT00720057|65640068|FG001|Overall Study|Protocol Violation|0|||
23519569|NCT00720057|65640067|FG000|Overall Study|Withdrawal by Subject|0|||
23519570|NCT00720057|65640068|FG001|Overall Study|Withdrawal by Subject|1|||
23519571|NCT00949325|65640069|FG000|Overall Study|Adverse Event|0|||
23519572|NCT00949325|65640070|FG001|Overall Study|Adverse Event|2|||
23519573|NCT00949325|65640071|FG002|Overall Study|Adverse Event|0|||
23519574|NCT02018458|65640073|FG000|Overall Study|Death|4|||
23519575|NCT01455012|65640074|FG000|Overall Study|Adverse Event|0|||
23519576|NCT01455012|65640075|FG001|Overall Study|Adverse Event|2|||
23519577|NCT01455012|65640074|FG000|Overall Study|Lack of Efficacy|6|||
23519578|NCT01455012|65640075|FG001|Overall Study|Lack of Efficacy|1|||
23519579|NCT01455012|65640074|FG000|Overall Study|Withdrawal by Subject|3|||
23519580|NCT01455012|65640075|FG001|Overall Study|Withdrawal by Subject|1|||
23519581|NCT01455012|65640074|FG000|Overall Study|Unknown reason|2|||
23519582|NCT01455012|65640075|FG001|Overall Study|Unknown reason|0|||
23519583|NCT03683758|65640076|FG000|Overall Study|Non-study commitment conflict|1|||
23519584|NCT03683758|65640077|FG001|Overall Study|Non-study commitment conflict|3|||
23519585|NCT03683758|65640076|FG000|Overall Study|Illness preventing participation|1|||
23519586|NCT03683758|65640077|FG001|Overall Study|Illness preventing participation|0|||
23519587|NCT03683758|65640076|FG000|Overall Study|Adverse Event|1|||
23519588|NCT03683758|65640077|FG001|Overall Study|Adverse Event|0|||
23519589|NCT03745937|65640079|FG000|Overall Study|Withdrawal by Subject|0|||
23519590|NCT03745937|65640080|FG001|Overall Study|Withdrawal by Subject|0|||
23519591|NCT03745937|65640081|FG002|Overall Study|Withdrawal by Subject|0|||
23519592|NCT03745937|65640082|FG003|Overall Study|Withdrawal by Subject|1|||
23519593|NCT03745937|65640079|FG000|Overall Study|Not-specifed|0|||
23519594|NCT03745937|65640080|FG001|Overall Study|Not-specifed|1|||
23519595|NCT03745937|65640081|FG002|Overall Study|Not-specifed|0|||
23519596|NCT03745937|65640082|FG003|Overall Study|Not-specifed|1|||
23519597|NCT01996709|65640083|FG000|Overall Study|Withdrawal by Subject|1|||
23519598|NCT01996709|65640084|FG001|Overall Study|Withdrawal by Subject|0|||
23519599|NCT01996709|65640083|FG000|Overall Study|Lost to Follow-up|3|||
23519600|NCT01996709|65640084|FG001|Overall Study|Lost to Follow-up|0|||
23519601|NCT01996709|65640083|FG000|Overall Study|Subject Non-Compliant|1|||
23519602|NCT01996709|65640084|FG001|Overall Study|Subject Non-Compliant|0|||
23519603|NCT01996709|65640083|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
23519604|NCT01996709|65640084|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
23519605|NCT04120974|65640085|FG000|Overall Study|Death|1|||
23519606|NCT04120974|65640085|FG000|Overall Study|Physician Decision|1|||
23519607|NCT04120974|65640085|FG000|Overall Study|Lost to Follow-up|6|||
23519608|NCT03082599|65640086|FG000|Overall Study|Lost to Follow-up|1|||
23519609|NCT03082599|65640087|FG001|Overall Study|Lost to Follow-up|0|||
23519610|NCT05045144|65640088|FG000|Overall Study|Lost to Follow-up|3|||
23519611|NCT05045144|65640089|FG001|Overall Study|Lost to Follow-up|2|||
23519612|NCT05045144|65640090|FG002|Overall Study|Lost to Follow-up|3|||
23519613|NCT05045144|65640091|FG003|Overall Study|Lost to Follow-up|5|||
23519614|NCT05045144|65640092|FG004|Overall Study|Lost to Follow-up|13|||
23519615|NCT05045144|65640088|FG000|Overall Study|Withdrawal by Subject|0|||
23519616|NCT05045144|65640089|FG001|Overall Study|Withdrawal by Subject|1|||
23519617|NCT05045144|65640090|FG002|Overall Study|Withdrawal by Subject|0|||
23519618|NCT05045144|65640091|FG003|Overall Study|Withdrawal by Subject|0|||
23519619|NCT05045144|65640092|FG004|Overall Study|Withdrawal by Subject|0|||
23519620|NCT05045144|65640088|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23519621|NCT05045144|65640089|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23519622|NCT05045144|65640090|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23519623|NCT05045144|65640091|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23519624|NCT05045144|65640092|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23519625|NCT02738333|65640093|FG000|Overall Study|Death|1|||
23519626|NCT02738333|65640094|FG001|Overall Study|Death|0|||
23519627|NCT02738333|65640095|FG002|Overall Study|Death|0|||
23519628|NCT02738333|65640093|FG000|Overall Study|Lost to Follow-up|1|||
23519629|NCT02738333|65640094|FG001|Overall Study|Lost to Follow-up|0|||
23519630|NCT02738333|65640095|FG002|Overall Study|Lost to Follow-up|0|||
23519631|NCT00454987|65640096|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
23519632|NCT00454987|65640097|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
23519633|NCT00454987|65640098|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
23519634|NCT00454987|65640096|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
23519635|NCT00454987|65640097|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
23519636|NCT00454987|65640098|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
23519637|NCT00454987|65640096|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
23519638|NCT00454987|65640097|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
23519639|NCT00454987|65640098|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
23519640|NCT02225743|65640099|FG000|Overall Study|Withdrawal by Subject|18|||
23519641|NCT02132767|65640100|FG000|Overall Study|Death|3|||
23519642|NCT02132767|65640101|FG001|Overall Study|Death|2|||
23519643|NCT02132767|65640100|FG000|Overall Study|Withdrawal by Subject|10|||
23519644|NCT02132767|65640101|FG001|Overall Study|Withdrawal by Subject|9|||
23519645|NCT02132767|65640100|FG000|Overall Study|Lost to Follow-up|4|||
23519646|NCT02132767|65640101|FG001|Overall Study|Lost to Follow-up|4|||
23519647|NCT00071760|65640102|FG000|Overall Study|Adverse Event|2|||
23519648|NCT00071760|65640103|FG001|Overall Study|Adverse Event|1|||
23519649|NCT00071760|65640102|FG000|Overall Study|Lost to Follow-up|0|||
23307687|NCT01083810|64870564|FG000|Overall Study|Reason not reported|6|||
23307688|NCT01083810|64870565|FG001|Overall Study|Reason not reported|1|||
23307689|NCT01083810|64870566|FG002|Overall Study|Reason not reported|1|||
23416221|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
23519650|NCT00071760|65640103|FG001|Overall Study|Lost to Follow-up|3|||
23519651|NCT00071760|65640102|FG000|Overall Study|Protocol Violation|1|||
23519652|NCT00071760|65640103|FG001|Overall Study|Protocol Violation|0|||
23519653|NCT00071760|65640102|FG000|Overall Study|Withdrawal by Subject|0|||
23519654|NCT00071760|65640103|FG001|Overall Study|Withdrawal by Subject|1|||
23519655|NCT00071760|65640102|FG000|Overall Study|Insufficient Viral Load Response|1|||
23519656|NCT00071760|65640103|FG001|Overall Study|Insufficient Viral Load Response|1|||
23519657|NCT00071760|65640102|FG000|Overall Study|Lack of availability of RTV|1|||
23519658|NCT00071760|65640103|FG001|Overall Study|Lack of availability of RTV|0|||
23519659|NCT00071760|65640102|FG000|Overall Study|Physician Decision|2|||
23519660|NCT00071760|65640103|FG001|Overall Study|Physician Decision|1|||
23519661|NCT00071760|65640102|FG000|Overall Study|Relocation|0|||
23519662|NCT00071760|65640103|FG001|Overall Study|Relocation|1|||
23519663|NCT03054870|65640113|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
23519664|NCT03054870|65640113|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
23519665|NCT00600938|65640120|FG000|Core Study|Abnormal test procedure result(s)|3|||
23519666|NCT00600938|65640121|FG001|Core Study|Abnormal test procedure result(s)|2|||
23519667|NCT00600938|65640122|FG002|Core Study|Abnormal test procedure result(s)|0|||
23519668|NCT00600938|65640123|FG003|Core Study|Abnormal test procedure result(s)|0|||
23519669|NCT00600938|65640120|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
23519670|NCT00600938|65640121|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
23519671|NCT00600938|65640122|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
23519672|NCT00600938|65640123|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
23519673|NCT00600938|65640120|FG000|Core Study|Patient withdrew consent|7|||
23519674|NCT00600938|65640121|FG001|Core Study|Patient withdrew consent|12|||
23519675|NCT00600938|65640122|FG002|Core Study|Patient withdrew consent|0|||
23519676|NCT00600938|65640123|FG003|Core Study|Patient withdrew consent|0|||
23519677|NCT00600938|65640120|FG000|Core Study|Lost to Follow-up|3|||
23519678|NCT00600938|65640121|FG001|Core Study|Lost to Follow-up|2|||
23519679|NCT00600938|65640122|FG002|Core Study|Lost to Follow-up|0|||
23519680|NCT00600938|65640123|FG003|Core Study|Lost to Follow-up|0|||
23519681|NCT00600938|65640120|FG000|Core Study|Death|1|||
23519682|NCT00600938|65640121|FG001|Core Study|Death|1|||
23519683|NCT00600938|65640122|FG002|Core Study|Death|0|||
23519684|NCT00600938|65640123|FG003|Core Study|Death|0|||
23519685|NCT00600938|65640120|FG000|Core Study|Protocol Violation|1|||
23519686|NCT00600938|65640121|FG001|Core Study|Protocol Violation|2|||
23519687|NCT00600938|65640122|FG002|Core Study|Protocol Violation|0|||
23519688|NCT00600938|65640123|FG003|Core Study|Protocol Violation|0|||
23519689|NCT00600938|65640120|FG000|Extension Study|Adverse Event|1|||
23519690|NCT00600938|65640121|FG001|Extension Study|Adverse Event|0|||
23519691|NCT00600938|65640122|FG002|Extension Study|Adverse Event|2|||
23519692|NCT00600938|65640123|FG003|Extension Study|Adverse Event|0|||
23519693|NCT00600938|65640120|FG000|Extension Study|Abnormal test procedure results|0|||
23519694|NCT00600938|65640121|FG001|Extension Study|Abnormal test procedure results|1|||
23519695|NCT00600938|65640122|FG002|Extension Study|Abnormal test procedure results|1|||
23519696|NCT00600938|65640123|FG003|Extension Study|Abnormal test procedure results|1|||
23519697|NCT00600938|65640120|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
23519698|NCT00600938|65640121|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
23519699|NCT00600938|65640122|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
23519700|NCT00600938|65640123|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
23519701|NCT00600938|65640120|FG000|Extension Study|Withdrawal by Subject|2|||
23519702|NCT00600938|65640121|FG001|Extension Study|Withdrawal by Subject|2|||
23519703|NCT00600938|65640122|FG002|Extension Study|Withdrawal by Subject|3|||
23519704|NCT00600938|65640123|FG003|Extension Study|Withdrawal by Subject|0|||
23519705|NCT00600938|65640120|FG000|Extension Study|Lost to Follow-up|1|||
23519706|NCT00600938|65640121|FG001|Extension Study|Lost to Follow-up|1|||
23519707|NCT00600938|65640122|FG002|Extension Study|Lost to Follow-up|2|||
23519708|NCT00600938|65640123|FG003|Extension Study|Lost to Follow-up|0|||
23519709|NCT00600938|65640120|FG000|Extension Study|Death|1|||
23519710|NCT00600938|65640121|FG001|Extension Study|Death|0|||
23519711|NCT00600938|65640122|FG002|Extension Study|Death|0|||
23519712|NCT00600938|65640123|FG003|Extension Study|Death|0|||
23519713|NCT02250443|65640125|FG000|Overall Study|Administrative problems|7|||
23519714|NCT02250443|65640125|FG000|Overall Study|Adverse Event|3|||
23519715|NCT00265343|65640132|FG000|Overall Study|Adverse Event|10|||
23519716|NCT00265343|65640133|FG001|Overall Study|Adverse Event|7|||
23519717|NCT00265343|65640132|FG000|Overall Study|Withdrawal by Subject|3|||
23519718|NCT00265343|65640133|FG001|Overall Study|Withdrawal by Subject|9|||
23519719|NCT00265343|65640132|FG000|Overall Study|Other|8|||
23519720|NCT00265343|65640133|FG001|Overall Study|Other|3|||
23519721|NCT01030523|65640134|FG000|Initial Study (5 Years)|Death|1|||
23519722|NCT01030523|65640135|FG001|Initial Study (5 Years)|Death|0|||
23519723|NCT01030523|65640134|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
23519724|NCT01030523|65640135|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
23519725|NCT01030523|65640134|FG000|Initial Study (5 Years)|Implant failure|1|||
23519726|NCT01030523|65640135|FG001|Initial Study (5 Years)|Implant failure|0|||
23519727|NCT01030523|65640134|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
23519728|NCT01030523|65640135|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
23519729|NCT01030523|65640134|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
23519730|NCT01030523|65640135|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
23519731|NCT01030523|65640134|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
23519732|NCT01030523|65640135|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
23519733|NCT02420691|65640138|FG000|Overall Study|Adverse Event|3|||
23519734|NCT02420691|65640138|FG000|Overall Study|Withdrawal by Subject|3|||
23519735|NCT04668950|65640139|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
23416222|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
23519736|NCT04668950|65640140|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
23519737|NCT04668950|65640139|FG000|Overall Study|Could not confirm started study medication|15|||
23519738|NCT04668950|65640140|FG001|Overall Study|Could not confirm started study medication|15|||
23519739|NCT04668950|65640139|FG000|Overall Study|Could not confirm baseline status|6|||
23519740|NCT04668950|65640140|FG001|Overall Study|Could not confirm baseline status|2|||
23519741|NCT04668950|65640139|FG000|Overall Study|Drop out and did not start medication|15|||
23519742|NCT04668950|65640140|FG001|Overall Study|Drop out and did not start medication|17|||
23519743|NCT04668950|65640139|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
23519744|NCT04668950|65640140|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
23519745|NCT04668950|65640139|FG000|Overall Study|Other|2|||
23519746|NCT04668950|65640140|FG001|Overall Study|Other|4|||
23519747|NCT00665353|65640151|FG000|Study Step 1|Adverse Event|1|||
23519748|NCT00665353|65640151|FG000|Study Step 1|Withdrawal by Subject|2|||
23519749|NCT00665353|65640151|FG000|Study Step 2|Lost to Follow-up|2|||
23519750|NCT00665353|65640151|FG000|Study Step 2|Lack of Efficacy|12|||
23519751|NCT04824131|65640152|FG000|CAB LA Oral Phase|Adverse Event|1|||
23519752|NCT04824131|65640152|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
23519753|NCT04824131|65640152|FG000|Step 3|Withdrawal by Subject|2|||
23519754|NCT02981342|65643260|FG000|Overall Study|Adverse Event|0|||
23519755|NCT02981342|65643261|FG001|Overall Study|Adverse Event|0|||
23519756|NCT02981342|65643262|FG002|Overall Study|Adverse Event|0|||
23519757|NCT02981342|65643263|FG003|Overall Study|Adverse Event|1|||
23519758|NCT02981342|65643260|FG000|Overall Study|Death|0|||
23519759|NCT02981342|65643261|FG001|Overall Study|Death|9|||
23519760|NCT02981342|65643262|FG002|Overall Study|Death|9|||
23519761|NCT02981342|65643263|FG003|Overall Study|Death|4|||
23519762|NCT02981342|65643260|FG000|Overall Study|Withdrawal by Subject|0|||
23519763|NCT02981342|65643261|FG001|Overall Study|Withdrawal by Subject|0|||
23519764|NCT02981342|65643262|FG002|Overall Study|Withdrawal by Subject|3|||
23519765|NCT02981342|65643263|FG003|Overall Study|Withdrawal by Subject|1|||
23519766|NCT02981342|65643260|FG000|Overall Study|Study closed by sponsor|0|||
23519767|NCT02981342|65643261|FG001|Overall Study|Study closed by sponsor|0|||
23519768|NCT02981342|65643262|FG002|Overall Study|Study closed by sponsor|1|||
23519769|NCT02981342|65643263|FG003|Overall Study|Study closed by sponsor|1|||
23519770|NCT02981342|65643260|FG000|Overall Study|Randomized, Never Treated|0|||
23519771|NCT02981342|65643261|FG001|Overall Study|Randomized, Never Treated|1|||
23519772|NCT02981342|65643262|FG002|Overall Study|Randomized, Never Treated|0|||
23519773|NCT02981342|65643263|FG003|Overall Study|Randomized, Never Treated|7|||
23519774|NCT02981342|65643260|FG000|Overall Study|Lost to Follow-up|0|||
23205275|NCT02065622|64491322|FG004|Induction Study|Withdrawal by Subject|0|||
23205276|NCT02065622|64491318|FG000|Induction Study|Lost to Follow-up|1|||
23205277|NCT02065622|64491319|FG001|Induction Study|Lost to Follow-up|0|||
23205278|NCT02065622|64491320|FG002|Induction Study|Lost to Follow-up|0|||
23205279|NCT02065622|64491321|FG003|Induction Study|Lost to Follow-up|0|||
23205280|NCT02065622|64491322|FG004|Induction Study|Lost to Follow-up|0|||
23519775|NCT02981342|65643261|FG001|Overall Study|Lost to Follow-up|1|||
23519776|NCT02981342|65643262|FG002|Overall Study|Lost to Follow-up|0|||
23519777|NCT02981342|65643263|FG003|Overall Study|Lost to Follow-up|0|||
23519778|NCT01480076|65643264|FG000|Overall Study|Run-in Failure|52|||
23519779|NCT01480076|65643264|FG000|Overall Study|Adverse Event|39|||
23519780|NCT01480076|65643264|FG000|Overall Study|Death|2|||
23519781|NCT01480076|65643264|FG000|Overall Study|Disease Progression|5|||
23519782|NCT01480076|65643264|FG000|Overall Study|Non-compliance With Study Protocol|15|||
23519783|NCT01480076|65643264|FG000|Overall Study|Withdrawal by Subject|105|||
23205281|NCT02065622|64491318|FG000|Induction Study|Lack of Efficacy|22|||
23205282|NCT02065622|64491319|FG001|Induction Study|Lack of Efficacy|27|||
23205283|NCT02065622|64491320|FG002|Induction Study|Lack of Efficacy|0|||
23205284|NCT02065622|64491321|FG003|Induction Study|Lack of Efficacy|0|||
23205285|NCT02065622|64491322|FG004|Induction Study|Lack of Efficacy|0|||
23519784|NCT01480076|65643264|FG000|Overall Study|Lost to Follow-up|7|||
23519785|NCT01480076|65643264|FG000|Overall Study|Investigator Decision|13|||
23519786|NCT01480076|65643264|FG000|Overall Study|Other|52|||
23519787|NCT01413360|65643265|FG000|Overall Study|Lost to Follow-up|2|||
23519788|NCT01413360|65643265|FG000|Overall Study|Adverse Event|1|||
23519789|NCT02590939|65643266|FG000|Overall Study|Withdrawal by Subject|3|||
23519790|NCT02590939|65643267|FG001|Overall Study|Withdrawal by Subject|1|||
23519791|NCT02590939|65643266|FG000|Overall Study|Failed the nociceptive test|2|||
23519792|NCT02590939|65643267|FG001|Overall Study|Failed the nociceptive test|1|||
23519793|NCT01476696|65643268|FG000|Overall Study|Sponsor decision|2|||
23519794|NCT01476696|65643269|FG001|Overall Study|Sponsor decision|1|||
23519795|NCT01476696|65643270|FG002|Overall Study|Sponsor decision|0|||
23519796|NCT01476696|65643268|FG000|Overall Study|Withdrawal by Subject|1|||
23519797|NCT01476696|65643269|FG001|Overall Study|Withdrawal by Subject|0|||
23519798|NCT01476696|65643270|FG002|Overall Study|Withdrawal by Subject|0|||
23519799|NCT01586819|65643277|FG000|Overall Study|Withdrawal by Subject|1|||
23519800|NCT01586819|65643278|FG001|Overall Study|Withdrawal by Subject|0|||
23519801|NCT01068509|65643279|FG000|Overall Study|Death|0|||
23519802|NCT01068509|65643280|FG001|Overall Study|Death|0|||
23519803|NCT01068509|65643281|FG002|Overall Study|Death|1|||
23519804|NCT01068509|65643279|FG000|Overall Study|Disease Progression|5|||
23519805|NCT01068509|65643280|FG001|Overall Study|Disease Progression|20|||
23519806|NCT01068509|65643281|FG002|Overall Study|Disease Progression|18|||
23519807|NCT01068509|65643279|FG000|Overall Study|Lost to Follow-up|1|||
23519808|NCT01068509|65643280|FG001|Overall Study|Lost to Follow-up|0|||
23519809|NCT01068509|65643281|FG002|Overall Study|Lost to Follow-up|0|||
23519810|NCT01068509|65643279|FG000|Overall Study|Withdrew Consent|0|||
23519811|NCT01068509|65643280|FG001|Overall Study|Withdrew Consent|1|||
23519812|NCT01068509|65643281|FG002|Overall Study|Withdrew Consent|2|||
23519813|NCT01068509|65643279|FG000|Overall Study|Reason Not Specified|0|||
23519814|NCT01068509|65643280|FG001|Overall Study|Reason Not Specified|1|||
23519815|NCT01068509|65643281|FG002|Overall Study|Reason Not Specified|0|||
23519816|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|5|||
23519817|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|1|||
23519818|NCT00304356|65643282|FG000|Nitazoxanide|number is 0|1|||
23519819|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|1|||
23519820|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|1|||
23519821|NCT00304356|65643282|FG000|Nitazoxanide|Physician Decision|1|||
23519822|NCT02775344|65643297|FG000|Overall Study|No ovarian cyst identified|3|||
23519823|NCT02775344|65643298|FG001|Overall Study|No ovarian cyst identified|2|||
23519824|NCT05333900|65643299|FG000|Overall Study|Protocol Violation|0|||
23519825|NCT05333900|65643300|FG001|Overall Study|Protocol Violation|1|||
23519826|NCT05333900|65643299|FG000|Overall Study|Withdrawal by Subject|0|||
23519827|NCT05333900|65643300|FG001|Overall Study|Withdrawal by Subject|1|||
23519828|NCT05333900|65643299|FG000|Overall Study|COVID-19 Pandemic|1|||
23519829|NCT05333900|65643300|FG001|Overall Study|COVID-19 Pandemic|1|||
23519830|NCT03886220|65643301|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
23519831|NCT03886220|65643302|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
23519832|NCT03886220|65643301|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
23519833|NCT03886220|65643302|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23519834|NCT03886220|65643301|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
23519835|NCT03886220|65643302|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23519836|NCT01454570|65643307|FG000|Overall Study|Withdrawal by Subject|2|||
23519837|NCT01454570|65643307|FG000|Overall Study|Screen Failure|7|||
23519838|NCT02503332|65643308|FG000|Overall Study|Adverse Event|17|||
23519839|NCT02503332|65643309|FG001|Overall Study|Adverse Event|5|||
23519840|NCT02503332|65643310|FG002|Overall Study|Adverse Event|3|||
23519841|NCT02503332|65643311|FG003|Overall Study|Adverse Event|1|||
23519842|NCT02503332|65643308|FG000|Overall Study|Investigator's Decision|5|||
23519843|NCT02503332|65643309|FG001|Overall Study|Investigator's Decision|1|||
23519844|NCT02503332|65643310|FG002|Overall Study|Investigator's Decision|0|||
23519845|NCT02503332|65643311|FG003|Overall Study|Investigator's Decision|0|||
23519846|NCT02503332|65643308|FG000|Overall Study|Sponsor's Decision|1|||
23519847|NCT02503332|65643309|FG001|Overall Study|Sponsor's Decision|0|||
23519848|NCT02503332|65643310|FG002|Overall Study|Sponsor's Decision|0|||
23519849|NCT02503332|65643311|FG003|Overall Study|Sponsor's Decision|1|||
23519850|NCT02503332|65643308|FG000|Overall Study|Subject Request|6|||
23519851|NCT02503332|65643309|FG001|Overall Study|Subject Request|5|||
23519852|NCT02503332|65643310|FG002|Overall Study|Subject Request|2|||
23519853|NCT02503332|65643311|FG003|Overall Study|Subject Request|1|||
23519854|NCT02503332|65643308|FG000|Overall Study|Death|0|||
23519855|NCT02503332|65643309|FG001|Overall Study|Death|2|||
23519856|NCT02503332|65643310|FG002|Overall Study|Death|2|||
23519857|NCT02503332|65643311|FG003|Overall Study|Death|0|||
23519858|NCT02503332|65643308|FG000|Overall Study|Other|5|||
23519859|NCT02503332|65643309|FG001|Overall Study|Other|6|||
23519860|NCT02503332|65643310|FG002|Overall Study|Other|1|||
23519861|NCT02503332|65643311|FG003|Overall Study|Other|1|||
23519862|NCT01464346|65643312|FG000|Overall Study|Withdrawal by Subject|0|||
23519863|NCT01464346|65643313|FG001|Overall Study|Withdrawal by Subject|0|||
23519864|NCT01464346|65643314|FG002|Overall Study|Withdrawal by Subject|1|||
23519865|NCT02385266|65643315|FG000|Overall Study|Withdrawal by Subject|1|||
23519866|NCT02385266|65643316|FG001|Overall Study|Withdrawal by Subject|3|||
23519867|NCT01708174|65643317|FG000|Treatment Period|Withdrawal by Subject|1|||
23519868|NCT01708174|65643318|FG001|Treatment Period|Withdrawal by Subject|0|||
23519869|NCT01708174|65643319|FG002|Treatment Period|Withdrawal by Subject|0|||
23519870|NCT01708174|65643317|FG000|Treatment Period|Progressive disease|0|||
23519871|NCT01708174|65643318|FG001|Treatment Period|Progressive disease|1|||
23519872|NCT01708174|65643319|FG002|Treatment Period|Progressive disease|0|||
23519873|NCT01708174|65643317|FG000|Treatment Period|Death|0|||
23519874|NCT01708174|65643318|FG001|Treatment Period|Death|0|||
23519875|NCT01708174|65643319|FG002|Treatment Period|Death|1|||
23519876|NCT01708174|65643317|FG000|Treatment Period|Adverse Event|0|||
23519877|NCT01708174|65643318|FG001|Treatment Period|Adverse Event|1|||
23519878|NCT01708174|65643319|FG002|Treatment Period|Adverse Event|0|||
23519879|NCT01528072|65643320|FG000|Overall Study|Withdrawal by Subject|5|||
23519880|NCT01528072|65643320|FG000|Overall Study|Physician Decision|1|||
23519881|NCT01528072|65643320|FG000|Overall Study|Determined not eligible by AEAC|1|||
23519882|NCT01528072|65643320|FG000|Overall Study|Missed Visit|2|||
23519883|NCT01528072|65643320|FG000|Overall Study|Lost to Follow-up|5|||
23519884|NCT01528072|65643320|FG000|Overall Study|Explanted|2|||
23519885|NCT01528072|65643320|FG000|Overall Study|Site Closure|4|||
23519886|NCT01528072|65643320|FG000|Overall Study|Death|2|||
23519887|NCT01528072|65643320|FG000|Overall Study|Early Termination of Study|52|||
23519888|NCT03318315|65643321|FG000|Overall Study|Lost to Follow-up|3|||
23519889|NCT03318315|65643322|FG001|Overall Study|Lost to Follow-up|2|||
23205286|NCT02065622|64491318|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
23307690|NCT01083810|64870564|FG000|Overall Study|Non-compliance|4|||
23519890|NCT03318315|65643323|FG002|Overall Study|Lost to Follow-up|1|||
23519891|NCT03318315|65643321|FG000|Overall Study|Protocol Violation|1|||
23519892|NCT03318315|65643322|FG001|Overall Study|Protocol Violation|1|||
23519893|NCT03318315|65643323|FG002|Overall Study|Protocol Violation|1|||
23519894|NCT03318315|65643321|FG000|Overall Study|Withdrawal by Subject|0|||
23519895|NCT03318315|65643322|FG001|Overall Study|Withdrawal by Subject|0|||
23519896|NCT03318315|65643323|FG002|Overall Study|Withdrawal by Subject|2|||
23519897|NCT02874742|65643324|FG000|Overall Study|Death|0|||
23519898|NCT02874742|65643325|FG001|Overall Study|Death|1|||
23519899|NCT02874742|65643326|FG002|Overall Study|Death|0|||
23519900|NCT02874742|65643324|FG000|Overall Study|Lost to Follow-up|5|||
23519901|NCT02874742|65643325|FG001|Overall Study|Lost to Follow-up|4|||
23519902|NCT02874742|65643326|FG002|Overall Study|Lost to Follow-up|1|||
23519903|NCT02874742|65643324|FG000|Overall Study|Withdrawal by Subject|17|||
23519904|NCT02874742|65643325|FG001|Overall Study|Withdrawal by Subject|8|||
23519905|NCT02874742|65643326|FG002|Overall Study|Withdrawal by Subject|0|||
23519906|NCT02874742|65643324|FG000|Overall Study|Other|4|||
23519907|NCT02874742|65643325|FG001|Overall Study|Other|1|||
23519908|NCT02874742|65643326|FG002|Overall Study|Other|0|||
23519909|NCT02874742|65643324|FG000|Overall Study|Progressive Disease|1|||
23519910|NCT02874742|65643325|FG001|Overall Study|Progressive Disease|0|||
23519911|NCT02874742|65643326|FG002|Overall Study|Progressive Disease|0|||
23519912|NCT02874742|65643324|FG000|Overall Study|Screen Failure|0|||
23519913|NCT02874742|65643325|FG001|Overall Study|Screen Failure|2|||
23519914|NCT02874742|65643326|FG002|Overall Study|Screen Failure|0|||
23519915|NCT03165110|65643327|FG000|Overall Study|Anroid phone software incompatibility|1|||
23519916|NCT02410954|65643328|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
23519917|NCT02410954|65643329|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
23519918|NCT02410954|65643328|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
23519919|NCT02410954|65643329|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
23519920|NCT01085097|65643330|FG000|Overall Study|Adverse Event|0|||
23519921|NCT01085097|65643331|FG001|Overall Study|Adverse Event|0|||
23519922|NCT01085097|65643332|FG002|Overall Study|Adverse Event|2|||
23519923|NCT01085097|65643330|FG000|Overall Study|Treatment failure|2|||
23519924|NCT01085097|65643331|FG001|Overall Study|Treatment failure|0|||
23519925|NCT01085097|65643332|FG002|Overall Study|Treatment failure|0|||
23519926|NCT02053753|65643341|FG000|Overall Study|Withdrawal by Subject|2|||
23519927|NCT02053753|65643342|FG001|Overall Study|Withdrawal by Subject|4|||
23519928|NCT02053753|65643341|FG000|Overall Study|Decision by Sponsor|1|||
23519929|NCT02053753|65643342|FG001|Overall Study|Decision by Sponsor|1|||
23519930|NCT02053753|65643341|FG000|Overall Study|Lost to Follow-up|4|||
23519931|NCT02053753|65643342|FG001|Overall Study|Lost to Follow-up|3|||
23519932|NCT01774786|65643343|FG000|Overall Study|Death|300|||
23519933|NCT01774786|65643344|FG001|Overall Study|Death|319|||
23519934|NCT01774786|65643343|FG000|Overall Study|Lost to Follow-up|6|||
23519935|NCT01774786|65643344|FG001|Overall Study|Lost to Follow-up|7|||
23519936|NCT01774786|65643343|FG000|Overall Study|Withdrawal by Subject|18|||
23519937|NCT01774786|65643344|FG001|Overall Study|Withdrawal by Subject|14|||
23519938|NCT01774786|65643343|FG000|Overall Study|Physician Decision|2|||
23519939|NCT01774786|65643344|FG001|Overall Study|Physician Decision|0|||
23519940|NCT01774786|65643343|FG000|Overall Study|Non-compliance|0|||
23519941|NCT01774786|65643344|FG001|Overall Study|Non-compliance|1|||
23519942|NCT01774786|65643343|FG000|Overall Study|Reason Not Specified|2|||
23519943|NCT01774786|65643344|FG001|Overall Study|Reason Not Specified|5|||
23519944|NCT01859494|65643345|FG000|Overall Study|Adverse Event|1|||
23519945|NCT02275481|65643346|FG000|Overall Study|Death|2|||
23519946|NCT02275481|65643347|FG001|Overall Study|Death|1|||
23519947|NCT02275481|65643346|FG000|Overall Study|Lost to Follow-up|2|||
23519948|NCT02275481|65643347|FG001|Overall Study|Lost to Follow-up|0|||
23519949|NCT02275481|65643346|FG000|Overall Study|Withdrawal by Subject|3|||
23519950|NCT02275481|65643347|FG001|Overall Study|Withdrawal by Subject|0|||
23519951|NCT02275481|65643346|FG000|Overall Study|all other reasons combined|2|||
23519952|NCT02275481|65643347|FG001|Overall Study|all other reasons combined|1|||
23519953|NCT02275481|65643346|FG000|Overall Study|Physician Decision|0|||
23519954|NCT02275481|65643347|FG001|Overall Study|Physician Decision|1|||
23519955|NCT00698581|65643348|FG000|Overall Study|Lack of Efficacy|23|||
23519956|NCT00698581|65643349|FG001|Overall Study|Lack of Efficacy|11|||
23519957|NCT00698581|65643348|FG000|Overall Study|Withdrawal by Subject|6|||
23519958|NCT00698581|65643349|FG001|Overall Study|Withdrawal by Subject|0|||
23519959|NCT00698581|65643348|FG000|Overall Study|Other reason|9|||
23519960|NCT00698581|65643349|FG001|Overall Study|Other reason|1|||
23519961|NCT00698581|65643348|FG000|Overall Study|SAE, non-fatal|1|||
23519962|NCT00698581|65643349|FG001|Overall Study|SAE, non-fatal|0|||
23519963|NCT00698581|65643348|FG000|Overall Study|AE, non-serious non-fatal|4|||
23519964|NCT00698581|65643349|FG001|Overall Study|AE, non-serious non-fatal|0|||
23519965|NCT00698581|65643348|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23519966|NCT00698581|65643349|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23519967|NCT00698581|65643348|FG000|Overall Study|AE of unknown type|1|||
23519968|NCT00698581|65643349|FG001|Overall Study|AE of unknown type|0|||
23519969|NCT01163279|65643350|FG000|Overall Study|Withdrawal by Subject|2|||
23519970|NCT01163279|65643351|FG001|Overall Study|Withdrawal by Subject|0|||
23519971|NCT00192504|65643352|FG000|Overall Study|Lost to Follow-up|1|||
23519972|NCT00192504|65643353|FG001|Overall Study|Lost to Follow-up|0|||
23519973|NCT00192504|65643354|FG002|Overall Study|Lost to Follow-up|0|||
23519974|NCT00192504|65643355|FG003|Overall Study|Lost to Follow-up|0|||
23519975|NCT00192504|65643352|FG000|Overall Study|Dosing window missed|0|||
23519976|NCT00192504|65643353|FG001|Overall Study|Dosing window missed|0|||
23519977|NCT00192504|65643354|FG002|Overall Study|Dosing window missed|1|||
23519978|NCT00192504|65643355|FG003|Overall Study|Dosing window missed|0|||
23519979|NCT02625090|65643356|FG000|Overall Study|Participant wants to be pregnant|2|||
23519980|NCT02625090|65643356|FG000|Overall Study|For the Promoter|1|||
23519981|NCT02625090|65643356|FG000|Overall Study|Sponsor's Decision|9|||
23519982|NCT02625090|65643356|FG000|Overall Study|Somnolence|1|||
23519983|NCT02625090|65643356|FG000|Overall Study|Study terminated by Sponsor|7|||
23519984|NCT02625090|65643356|FG000|Overall Study|Negative Benefit/Risk|1|||
23519985|NCT02625090|65643356|FG000|Overall Study|Protocol Deviation|2|||
23519986|NCT02625090|65643356|FG000|Overall Study|Lack of Efficacy|16|||
23519987|NCT02625090|65643356|FG000|Overall Study|Adverse Event|3|||
23519988|NCT00112502|65643357|FG000|Overall Study|Withdrawal by Subject|0|||
23519989|NCT00112502|65643358|FG001|Overall Study|Withdrawal by Subject|1|||
23519990|NCT00112502|65643359|FG002|Overall Study|Withdrawal by Subject|1|||
23519991|NCT00112502|65643360|FG003|Overall Study|Withdrawal by Subject|4|||
23519992|NCT00112502|65643361|FG004|Overall Study|Withdrawal by Subject|2|||
23519993|NCT00112502|65643362|FG005|Overall Study|Withdrawal by Subject|5|||
23519994|NCT00112502|65643363|FG006|Overall Study|Withdrawal by Subject|3|||
23519995|NCT00112502|65643364|FG007|Overall Study|Withdrawal by Subject|7|||
23519996|NCT04248933|65643365|FG000|Overall Study|Lost to Follow-up|9|||
23519997|NCT04248933|65643365|FG000|Overall Study|Withdrawal by Subject|2|||
23519998|NCT01465022|65643376|FG000|Overall Study|Lost to Follow-up|15|||
23519999|NCT01465022|65643377|FG001|Overall Study|Lost to Follow-up|14|||
23520000|NCT01465022|65643378|FG002|Overall Study|Lost to Follow-up|0|||
23520001|NCT01465022|65643376|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
23520002|NCT01465022|65643377|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
23520003|NCT01465022|65643378|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
23520004|NCT01465022|65643376|FG000|Overall Study|Not Randomized|0|||
23520005|NCT01465022|65643377|FG001|Overall Study|Not Randomized|0|||
23520006|NCT01465022|65643378|FG002|Overall Study|Not Randomized|70|||
23520007|NCT02917031|65643379|FG000|Overall Study|Reason not specified|7|||
23520008|NCT02917031|65643380|FG001|Overall Study|Reason not specified|5|||
23520009|NCT02917031|65643381|FG002|Overall Study|Reason not specified|6|||
23520010|NCT02917031|65643379|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
23520011|NCT02917031|65643380|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
23520012|NCT02917031|65643381|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
23520013|NCT02917031|65643379|FG000|Overall Study|Withdrawal by Subject|3|||
23520014|NCT02917031|65643380|FG001|Overall Study|Withdrawal by Subject|3|||
23520015|NCT02917031|65643381|FG002|Overall Study|Withdrawal by Subject|0|||
23520016|NCT02917031|65643379|FG000|Overall Study|Physician Decision|1|||
23520017|NCT02917031|65643380|FG001|Overall Study|Physician Decision|0|||
23520018|NCT02917031|65643381|FG002|Overall Study|Physician Decision|0|||
23520019|NCT02917031|65643379|FG000|Overall Study|Adverse Event|4|||
23520020|NCT02917031|65643380|FG001|Overall Study|Adverse Event|1|||
23307691|NCT01083810|64870565|FG001|Overall Study|Non-compliance|7|||
23520021|NCT02917031|65643381|FG002|Overall Study|Adverse Event|5|||
23520022|NCT02917031|65643379|FG000|Overall Study|Death|2|||
23520023|NCT02917031|65643380|FG001|Overall Study|Death|3|||
23520024|NCT02917031|65643381|FG002|Overall Study|Death|4|||
23520025|NCT00101907|65643386|FG000|Overall Study|Adverse Event|1|||
23520026|NCT00101907|65643387|FG001|Overall Study|Adverse Event|0|||
23520027|NCT00101907|65643388|FG002|Overall Study|Adverse Event|0|||
23520028|NCT00101907|65643389|FG003|Overall Study|Adverse Event|0|||
23520029|NCT00101907|65643390|FG004|Overall Study|Adverse Event|0|||
23520030|NCT00101907|65643391|FG005|Overall Study|Adverse Event|0|||
23520031|NCT00101907|65643386|FG000|Overall Study|Death|0|||
23520032|NCT00101907|65643387|FG001|Overall Study|Death|1|||
23520033|NCT00101907|65643388|FG002|Overall Study|Death|0|||
23520034|NCT00101907|65643389|FG003|Overall Study|Death|0|||
23520035|NCT00101907|65643390|FG004|Overall Study|Death|3|||
23520036|NCT00101907|65643391|FG005|Overall Study|Death|0|||
23520037|NCT00101907|65643386|FG000|Overall Study|Physician Decision|0|||
23520038|NCT00101907|65643387|FG001|Overall Study|Physician Decision|0|||
23520039|NCT00101907|65643388|FG002|Overall Study|Physician Decision|0|||
23520040|NCT00101907|65643389|FG003|Overall Study|Physician Decision|1|||
23520041|NCT00101907|65643390|FG004|Overall Study|Physician Decision|1|||
23520042|NCT00101907|65643391|FG005|Overall Study|Physician Decision|0|||
23520043|NCT00101907|65643386|FG000|Overall Study|Withdrawal by Subject|1|||
23520044|NCT00101907|65643387|FG001|Overall Study|Withdrawal by Subject|0|||
23520045|NCT00101907|65643388|FG002|Overall Study|Withdrawal by Subject|1|||
23520046|NCT00101907|65643389|FG003|Overall Study|Withdrawal by Subject|0|||
23520047|NCT00101907|65643390|FG004|Overall Study|Withdrawal by Subject|1|||
23520048|NCT00101907|65643391|FG005|Overall Study|Withdrawal by Subject|0|||
23520049|NCT01852812|65643399|FG000|Overall Study|Adverse Event|0|||
23520050|NCT01852812|65643400|FG001|Overall Study|Adverse Event|0|||
23520051|NCT01852812|65643401|FG002|Overall Study|Adverse Event|1|||
23520052|NCT01852812|65643399|FG000|Overall Study|Non-compliance With Study Drug|0|||
23520053|NCT01852812|65643400|FG001|Overall Study|Non-compliance With Study Drug|1|||
23520054|NCT01852812|65643401|FG002|Overall Study|Non-compliance With Study Drug|0|||
23520055|NCT00994240|65643402|FG000|Overall Study|Lost to Follow-up|3|||
23520056|NCT00994240|65643403|FG001|Overall Study|Lost to Follow-up|2|||
23520057|NCT00994240|65643402|FG000|Overall Study|Withdrawal by Subject|1|||
23520058|NCT00994240|65643403|FG001|Overall Study|Withdrawal by Subject|0|||
23520059|NCT00994240|65643402|FG000|Overall Study|study termination|2|||
23520060|NCT00994240|65643403|FG001|Overall Study|study termination|3|||
23520061|NCT00791518|65643404|FG000|Overall Study|Protocol Violation|93|||
23520062|NCT04127786|65643407|FG000|Primary Series|Adverse Event|1|||
23520063|NCT04127786|65643408|FG001|Primary Series|Adverse Event|0|||
23520064|NCT04127786|65643409|FG002|Primary Series|Adverse Event|0|||
23520065|NCT04127786|65643410|FG003|Primary Series|Adverse Event|1|||
23520066|NCT04127786|65643411|FG004|Primary Series|Adverse Event|0|||
23520067|NCT04127786|65643412|FG005|Primary Series|Adverse Event|1|||
23520068|NCT04127786|65643407|FG000|Primary Series|Protocol Violation|5|||
23520069|NCT04127786|65643408|FG001|Primary Series|Protocol Violation|3|||
23520070|NCT04127786|65643409|FG002|Primary Series|Protocol Violation|4|||
23520071|NCT04127786|65643410|FG003|Primary Series|Protocol Violation|3|||
23520072|NCT04127786|65643411|FG004|Primary Series|Protocol Violation|2|||
23520073|NCT04127786|65643412|FG005|Primary Series|Protocol Violation|0|||
23520074|NCT04127786|65643407|FG000|Primary Series|Withdrawal by Subject|0|||
23520075|NCT04127786|65643408|FG001|Primary Series|Withdrawal by Subject|0|||
23520076|NCT04127786|65643409|FG002|Primary Series|Withdrawal by Subject|0|||
23520077|NCT04127786|65643410|FG003|Primary Series|Withdrawal by Subject|1|||
23520078|NCT04127786|65643411|FG004|Primary Series|Withdrawal by Subject|0|||
23520079|NCT04127786|65643412|FG005|Primary Series|Withdrawal by Subject|0|||
23520080|NCT04127786|65643407|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
23520081|NCT04127786|65643408|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
23520082|NCT04127786|65643409|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
23520083|NCT04127786|65643410|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
23520084|NCT04127786|65643411|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
23520085|NCT04127786|65643412|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
23520086|NCT04127786|65643407|FG000|Booster Phase|Withdrawal by Subject|2|||
23520087|NCT04127786|65643408|FG001|Booster Phase|Withdrawal by Subject|0|||
23520088|NCT04127786|65643409|FG002|Booster Phase|Withdrawal by Subject|0|||
23520089|NCT04127786|65643410|FG003|Booster Phase|Withdrawal by Subject|0|||
23520090|NCT04127786|65643411|FG004|Booster Phase|Withdrawal by Subject|0|||
23520091|NCT04127786|65643412|FG005|Booster Phase|Withdrawal by Subject|0|||
23520092|NCT01367158|65643413|FG000|Overall Study|Withdrew consent|0|||
23520093|NCT01367158|65643414|FG001|Overall Study|Withdrew consent|2|||
23520094|NCT01367158|65643415|FG002|Overall Study|Withdrew consent|1|||
23520095|NCT01367158|65643416|FG003|Overall Study|Withdrew consent|0|||
23520096|NCT01367158|65643417|FG004|Overall Study|Withdrew consent|2|||
23205287|NCT02065622|64491319|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
23205288|NCT02065622|64491320|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
23307692|NCT01083810|64870566|FG002|Overall Study|Non-compliance|2|||
23520097|NCT01367158|65643418|FG005|Overall Study|Withdrew consent|0|||
23520098|NCT01367158|65643419|FG006|Overall Study|Withdrew consent|0|||
23520099|NCT01367158|65643420|FG007|Overall Study|Withdrew consent|1|||
23520100|NCT01367158|65643421|FG008|Overall Study|Withdrew consent|0|||
23520101|NCT01367158|65643422|FG009|Overall Study|Withdrew consent|0|||
23520102|NCT01367158|65643423|FG010|Overall Study|Withdrew consent|0|||
23520103|NCT01367158|65643413|FG000|Overall Study|Lost to Follow-up|0|||
23520104|NCT01367158|65643414|FG001|Overall Study|Lost to Follow-up|0|||
23520105|NCT01367158|65643415|FG002|Overall Study|Lost to Follow-up|0|||
23520106|NCT01367158|65643416|FG003|Overall Study|Lost to Follow-up|1|||
23520107|NCT01367158|65643417|FG004|Overall Study|Lost to Follow-up|0|||
23520108|NCT01367158|65643418|FG005|Overall Study|Lost to Follow-up|2|||
23520109|NCT01367158|65643419|FG006|Overall Study|Lost to Follow-up|0|||
23520110|NCT01367158|65643420|FG007|Overall Study|Lost to Follow-up|1|||
23520111|NCT01367158|65643421|FG008|Overall Study|Lost to Follow-up|0|||
23520112|NCT01367158|65643422|FG009|Overall Study|Lost to Follow-up|0|||
23520113|NCT01367158|65643423|FG010|Overall Study|Lost to Follow-up|1|||
23520114|NCT01367158|65643413|FG000|Overall Study|Protocol Violation|0|||
23520115|NCT01367158|65643414|FG001|Overall Study|Protocol Violation|1|||
23520116|NCT01367158|65643415|FG002|Overall Study|Protocol Violation|0|||
23520117|NCT01367158|65643416|FG003|Overall Study|Protocol Violation|0|||
23520118|NCT01367158|65643417|FG004|Overall Study|Protocol Violation|0|||
23520119|NCT01367158|65643418|FG005|Overall Study|Protocol Violation|0|||
23520120|NCT01367158|65643419|FG006|Overall Study|Protocol Violation|0|||
23520121|NCT01367158|65643420|FG007|Overall Study|Protocol Violation|0|||
23520122|NCT01367158|65643421|FG008|Overall Study|Protocol Violation|0|||
23520123|NCT01367158|65643422|FG009|Overall Study|Protocol Violation|0|||
23520124|NCT01367158|65643423|FG010|Overall Study|Protocol Violation|0|||
23520125|NCT01324349|65643424|FG000|Overall Study|Death|1|||
23520126|NCT01324349|65643425|FG001|Overall Study|Death|1|||
23520127|NCT01324349|65643424|FG000|Overall Study|Withdrawal by Subject|0|||
23520128|NCT01324349|65643425|FG001|Overall Study|Withdrawal by Subject|1|||
23520129|NCT00323492|65643426|FG000|Study Phase 1|Adverse Event|2|||
23520130|NCT00323492|65643427|FG001|Study Phase 1|Adverse Event|0|||
23520131|NCT00323492|65643428|FG002|Study Phase 1|Adverse Event|0|||
23520132|NCT00323492|65643426|FG000|Study Phase 2|Adverse Event|1|||
23520133|NCT00323492|65643427|FG001|Study Phase 2|Adverse Event|0|||
23520134|NCT00323492|65643428|FG002|Study Phase 2|Adverse Event|0|||
23520135|NCT00323492|65643426|FG000|Study Phase 2|Physician Decision|1|||
23520136|NCT00323492|65643427|FG001|Study Phase 2|Physician Decision|0|||
23520137|NCT00323492|65643428|FG002|Study Phase 2|Physician Decision|0|||
23520138|NCT00323492|65643426|FG000|Study Phase 2|Lost to Follow-up|1|||
23520139|NCT00323492|65643427|FG001|Study Phase 2|Lost to Follow-up|0|||
23520140|NCT00323492|65643428|FG002|Study Phase 2|Lost to Follow-up|0|||
23520141|NCT00323492|65643426|FG000|Study Phase 2|Withdrawal by Subject|0|||
23520142|NCT00323492|65643427|FG001|Study Phase 2|Withdrawal by Subject|1|||
23520143|NCT00323492|65643428|FG002|Study Phase 2|Withdrawal by Subject|0|||
23520144|NCT00323492|65643426|FG000|Study Phase 2|Noncompliance with study schedule|0|||
23520145|NCT00323492|65643427|FG001|Study Phase 2|Noncompliance with study schedule|0|||
23520146|NCT00323492|65643428|FG002|Study Phase 2|Noncompliance with study schedule|1|||
23520147|NCT00323492|65643426|FG000|Study Phase 2|Protocol Violation|1|||
23520148|NCT00323492|65643427|FG001|Study Phase 2|Protocol Violation|0|||
23520149|NCT00323492|65643428|FG002|Study Phase 2|Protocol Violation|0|||
23520150|NCT04404855|65643429|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
23520151|NCT04404855|65643430|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
23520152|NCT00409617|65643431|FG000|Overall Study|Adverse Event|57|||
23520153|NCT00409617|65643431|FG000|Overall Study|Lack of Efficacy|54|||
23520154|NCT00409617|65643431|FG000|Overall Study|Lost to Follow-up|2|||
23520155|NCT00409617|65643431|FG000|Overall Study|Protocol Violation|24|||
23520156|NCT00409617|65643431|FG000|Overall Study|Withdrawal by Subject|8|||
23520157|NCT00409617|65643431|FG000|Overall Study|Administrative reasons|1|||
23520158|NCT00409617|65643431|FG000|Overall Study|Not described|14|||
23520159|NCT01012622|65643433|FG000|Overall Study|Withdrawal by Subject|6|||
23520160|NCT01012622|65643433|FG000|Overall Study|Lost to Follow-up|5|||
23520161|NCT01012622|65643433|FG000|Overall Study|Adverse Event|7|||
23520162|NCT01012622|65643433|FG000|Overall Study|non-compliance with the drug|9|||
23520163|NCT01012622|65643433|FG000|Overall Study|Other|1|||
23520164|NCT01012622|65643433|FG000|Overall Study|screening failure|1|||
23520165|NCT01012622|65643433|FG000|Overall Study|withdrawal of consent by a parent|2|||
23520166|NCT01179477|65643435|FG000|Overall Study|Death|542|||
23520167|NCT01179477|65643435|FG000|Overall Study|Unsuccessful implant|80|||
23520168|NCT01179477|65643435|FG000|Overall Study|Non-death withdrawal|438|||
23520169|NCT01179477|65643435|FG000|Overall Study|Did not complete final visit|27|||
23520170|NCT01327300|65643442|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
23520171|NCT01327300|65643443|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
23520172|NCT02075658|65643444|FG000|Overall Study|Physician Decision|2|||
23520173|NCT02075658|65643445|FG001|Overall Study|Physician Decision|2|||
23520174|NCT01176266|65643446|FG000|Overall Study|Death|6|||
23520175|NCT01176266|65643446|FG000|Overall Study|Withdrawal by Subject|3|||
23307693|NCT01083810|64870564|FG000|Overall Study|Simplification|4|||
23520176|NCT01150123|65643447|FG000|Overall Study|Withdrawal by Subject|1|||
23520177|NCT01150123|65643448|FG001|Overall Study|Withdrawal by Subject|1|||
23520178|NCT01150123|65643449|FG002|Overall Study|Withdrawal by Subject|2|||
23520179|NCT01150123|65643450|FG003|Overall Study|Withdrawal by Subject|1|||
23520180|NCT01150123|65643451|FG004|Overall Study|Withdrawal by Subject|1|||
23520181|NCT01150123|65643452|FG005|Overall Study|Withdrawal by Subject|1|||
23520182|NCT01150123|65643453|FG006|Overall Study|Withdrawal by Subject|0|||
23520183|NCT01150123|65643454|FG007|Overall Study|Withdrawal by Subject|3|||
23520184|NCT01150123|65643455|FG008|Overall Study|Withdrawal by Subject|2|||
23520185|NCT01150123|65643456|FG009|Overall Study|Withdrawal by Subject|0|||
23520186|NCT01150123|65643457|FG010|Overall Study|Withdrawal by Subject|1|||
23520187|NCT01150123|65643458|FG011|Overall Study|Withdrawal by Subject|0|||
23520188|NCT01150123|65643459|FG012|Overall Study|Withdrawal by Subject|1|||
23520189|NCT01150123|65643460|FG013|Overall Study|Withdrawal by Subject|0|||
23520190|NCT01150123|65643461|FG014|Overall Study|Withdrawal by Subject|0|||
23520191|NCT01150123|65643462|FG015|Overall Study|Withdrawal by Subject|1|||
23520192|NCT01150123|65643463|FG016|Overall Study|Withdrawal by Subject|0|||
23520193|NCT01150123|65643464|FG017|Overall Study|Withdrawal by Subject|1|||
23520194|NCT01150123|65643447|FG000|Overall Study|Lost to Follow-up|2|||
23520195|NCT01150123|65643448|FG001|Overall Study|Lost to Follow-up|1|||
23520196|NCT01150123|65643449|FG002|Overall Study|Lost to Follow-up|2|||
23520197|NCT01150123|65643450|FG003|Overall Study|Lost to Follow-up|2|||
23520198|NCT01150123|65643451|FG004|Overall Study|Lost to Follow-up|2|||
23520199|NCT01150123|65643452|FG005|Overall Study|Lost to Follow-up|5|||
23520200|NCT01150123|65643453|FG006|Overall Study|Lost to Follow-up|0|||
23520201|NCT01150123|65643454|FG007|Overall Study|Lost to Follow-up|0|||
23520202|NCT01150123|65643455|FG008|Overall Study|Lost to Follow-up|3|||
23520203|NCT01150123|65643456|FG009|Overall Study|Lost to Follow-up|1|||
23520204|NCT01150123|65643457|FG010|Overall Study|Lost to Follow-up|1|||
23520205|NCT01150123|65643458|FG011|Overall Study|Lost to Follow-up|1|||
23520206|NCT01150123|65643459|FG012|Overall Study|Lost to Follow-up|2|||
23520207|NCT01150123|65643460|FG013|Overall Study|Lost to Follow-up|0|||
23520208|NCT01150123|65643461|FG014|Overall Study|Lost to Follow-up|0|||
23520209|NCT01150123|65643462|FG015|Overall Study|Lost to Follow-up|0|||
23520210|NCT01150123|65643463|FG016|Overall Study|Lost to Follow-up|0|||
23520211|NCT01150123|65643464|FG017|Overall Study|Lost to Follow-up|0|||
23520212|NCT01527682|65643465|FG000|Overall Study|Protocol Violation|8|||
23520213|NCT04809220|65643466|FG000|Overall Study|Adverse Event|4|||
23520214|NCT04809220|65643467|FG001|Overall Study|Adverse Event|0|||
23520215|NCT04809220|65643466|FG000|Overall Study|Death|1|||
23520216|NCT04809220|65643467|FG001|Overall Study|Death|0|||
23520217|NCT04809220|65643466|FG000|Overall Study|Lost to Follow-up|3|||
23520218|NCT04809220|65643467|FG001|Overall Study|Lost to Follow-up|0|||
23520219|NCT04809220|65643466|FG000|Overall Study|Physician Decision|0|||
23520220|NCT04809220|65643467|FG001|Overall Study|Physician Decision|1|||
23520221|NCT04809220|65643466|FG000|Overall Study|Withdrawal by Subject|9|||
23520222|NCT04809220|65643467|FG001|Overall Study|Withdrawal by Subject|5|||
23520223|NCT04809220|65643466|FG000|Overall Study|Due to long-term overseas business trips|1|||
23520224|NCT04809220|65643467|FG001|Overall Study|Due to long-term overseas business trips|0|||
23520225|NCT01050257|65643468|FG000|Overall Study|Adverse Event|4|||
23520226|NCT01050257|65643469|FG001|Overall Study|Adverse Event|4|||
23520227|NCT01050257|65643470|FG002|Overall Study|Adverse Event|2|||
23520228|NCT01050257|65643468|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
23520229|NCT01050257|65643469|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
23520230|NCT01050257|65643470|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
23520231|NCT01050257|65643468|FG000|Overall Study|Withdrawal by Subject|0|||
23520232|NCT01050257|65643469|FG001|Overall Study|Withdrawal by Subject|3|||
23520233|NCT01050257|65643470|FG002|Overall Study|Withdrawal by Subject|0|||
23520234|NCT01050257|65643468|FG000|Overall Study|No reason specified|0|||
23520235|NCT01050257|65643469|FG001|Overall Study|No reason specified|0|||
23520236|NCT01050257|65643470|FG002|Overall Study|No reason specified|2|||
23520237|NCT01050257|65643468|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
23520238|NCT01050257|65643469|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
23520239|NCT01050257|65643470|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
23520240|NCT01050257|65643468|FG000|Overall Study|Violation criteria|0|||
23520241|NCT01050257|65643469|FG001|Overall Study|Violation criteria|1|||
23520242|NCT01050257|65643470|FG002|Overall Study|Violation criteria|0|||
23520243|NCT01050257|65643468|FG000|Overall Study|Failure to return|0|||
23520244|NCT01050257|65643469|FG001|Overall Study|Failure to return|2|||
23520245|NCT01050257|65643470|FG002|Overall Study|Failure to return|0|||
23520246|NCT01050257|65643468|FG000|Overall Study|Death|0|||
23520247|NCT01050257|65643469|FG001|Overall Study|Death|0|||
23520248|NCT01050257|65643470|FG002|Overall Study|Death|1|||
23520249|NCT02520011|65643471|FG000|Overall Study|Adverse Event|0|||
23520250|NCT02520011|65643472|FG001|Overall Study|Adverse Event|1|||
23520251|NCT02520011|65643473|FG002|Overall Study|Adverse Event|2|||
23307694|NCT01083810|64870565|FG001|Overall Study|Simplification|1|||
23520252|NCT02520011|65643471|FG000|Overall Study|Death|0|||
23520253|NCT02520011|65643472|FG001|Overall Study|Death|8|||
23520254|NCT02520011|65643473|FG002|Overall Study|Death|1|||
23520255|NCT02520011|65643471|FG000|Overall Study|Lack of Efficacy|4|||
23520256|NCT02520011|65643472|FG001|Overall Study|Lack of Efficacy|26|||
23520257|NCT02520011|65643473|FG002|Overall Study|Lack of Efficacy|4|||
23520258|NCT02520011|65643471|FG000|Overall Study|Physician Decision|0|||
23520259|NCT02520011|65643472|FG001|Overall Study|Physician Decision|2|||
23520260|NCT02520011|65643473|FG002|Overall Study|Physician Decision|0|||
23520261|NCT02520011|65643471|FG000|Overall Study|Withdrawal by Subject|1|||
23520262|NCT02520011|65643472|FG001|Overall Study|Withdrawal by Subject|3|||
23520263|NCT02520011|65643473|FG002|Overall Study|Withdrawal by Subject|0|||
23520264|NCT02520011|65643471|FG000|Overall Study|Protocol Deviation|0|||
23520265|NCT02520011|65643472|FG001|Overall Study|Protocol Deviation|1|||
23520266|NCT02520011|65643473|FG002|Overall Study|Protocol Deviation|0|||
23520267|NCT02520011|65643471|FG000|Overall Study|Patient went to hospice|0|||
23520268|NCT02520011|65643472|FG001|Overall Study|Patient went to hospice|1|||
23520269|NCT02520011|65643473|FG002|Overall Study|Patient went to hospice|0|||
23520270|NCT02520011|65643471|FG000|Overall Study|Progressive disease following response|0|||
23520271|NCT02520011|65643472|FG001|Overall Study|Progressive disease following response|4|||
23520272|NCT02520011|65643473|FG002|Overall Study|Progressive disease following response|2|||
23520273|NCT00644969|65643474|FG000|Treatment Phase|Randomized, not treated|1|||
23520274|NCT00644969|65643475|FG001|Treatment Phase|Randomized, not treated|0|||
23520275|NCT00644969|65643474|FG000|Treatment Phase|Adverse Event|3|||
23520276|NCT00644969|65643475|FG001|Treatment Phase|Adverse Event|0|||
23520277|NCT00644969|65643474|FG000|Treatment Phase|Withdrawal by Subject|4|||
23520278|NCT00644969|65643475|FG001|Treatment Phase|Withdrawal by Subject|0|||
23520279|NCT00644969|65643474|FG000|Treatment Phase|Lost to Follow-up|2|||
23520280|NCT00644969|65643475|FG001|Treatment Phase|Lost to Follow-up|2|||
23520281|NCT00644969|65643474|FG000|Treatment Phase|Other|4|||
23520282|NCT00644969|65643475|FG001|Treatment Phase|Other|1|||
23520283|NCT00644969|65643474|FG000|Post Treatment Phase|Death|1|||
23520284|NCT00644969|65643475|FG001|Post Treatment Phase|Death|0|||
23520285|NCT00644969|65643474|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
23520286|NCT00644969|65643475|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
23520287|NCT00644969|65643474|FG000|Post Treatment Phase|Lost to Follow-up|4|||
23520288|NCT00644969|65643475|FG001|Post Treatment Phase|Lost to Follow-up|1|||
23520289|NCT00644969|65643474|FG000|Post Treatment Phase|Other|1|||
23520290|NCT00644969|65643475|FG001|Post Treatment Phase|Other|0|||
23520291|NCT02171260|65643476|FG000|Overall Study|Death|0|||
23520292|NCT02171260|65643477|FG001|Overall Study|Death|0|||
23520293|NCT02171260|65643478|FG002|Overall Study|Death|0|||
23520294|NCT02171260|65643479|FG003|Overall Study|Death|1|||
23520295|NCT02171260|65643476|FG000|Overall Study|Physician Decision|1|||
23520296|NCT02171260|65643477|FG001|Overall Study|Physician Decision|0|||
23520297|NCT02171260|65643478|FG002|Overall Study|Physician Decision|1|||
23520298|NCT02171260|65643479|FG003|Overall Study|Physician Decision|0|||
23520299|NCT02171260|65643476|FG000|Overall Study|Withdrawal by Subject|1|||
23520300|NCT02171260|65643477|FG001|Overall Study|Withdrawal by Subject|0|||
23520301|NCT02171260|65643478|FG002|Overall Study|Withdrawal by Subject|0|||
23520302|NCT02171260|65643479|FG003|Overall Study|Withdrawal by Subject|0|||
23520303|NCT02171260|65643476|FG000|Overall Study|Evidence of progressive disease|4|||
23520304|NCT02171260|65643477|FG001|Overall Study|Evidence of progressive disease|6|||
23520305|NCT02171260|65643478|FG002|Overall Study|Evidence of progressive disease|4|||
23520306|NCT02171260|65643479|FG003|Overall Study|Evidence of progressive disease|4|||
23520307|NCT02762266|65643482|FG000|Overall Study|Physician Decision|2|||
23520308|NCT02762266|65643483|FG001|Overall Study|Physician Decision|0|||
23520309|NCT00460031|65643484|FG000|Overall Study|Adverse Event|5|||
23520310|NCT00460031|65643484|FG000|Overall Study|Withdrawal by Subject|5|||
23520311|NCT00460031|65643484|FG000|Overall Study|Death|1|||
23520312|NCT00256698|65643486|FG000|Overall Study|Withdrawal by Subject|7|||
23520313|NCT00256698|65643487|FG001|Overall Study|Withdrawal by Subject|7|||
23520314|NCT00256698|65643486|FG000|Overall Study|Adverse Event|13|||
23520315|NCT00256698|65643487|FG001|Overall Study|Adverse Event|6|||
23520316|NCT00256698|65643486|FG000|Overall Study|Protocol Violation|6|||
23520317|NCT00256698|65643487|FG001|Overall Study|Protocol Violation|5|||
23520318|NCT00256698|65643486|FG000|Overall Study|Lost to Follow-up|1|||
23520319|NCT00256698|65643487|FG001|Overall Study|Lost to Follow-up|3|||
23520320|NCT00256698|65643486|FG000|Overall Study|disease progression|97|||
23520321|NCT00256698|65643487|FG001|Overall Study|disease progression|105|||
23520322|NCT00256698|65643486|FG000|Overall Study|still ongoing at data cut-off|41|||
23520323|NCT00256698|65643487|FG001|Overall Study|still ongoing at data cut-off|46|||
23205289|NCT02065622|64491321|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
23520324|NCT00256698|65643486|FG000|Overall Study|withdrawn due to osteoporosis|1|||
23520325|NCT00256698|65643487|FG001|Overall Study|withdrawn due to osteoporosis|0|||
23520326|NCT00256698|65643486|FG000|Overall Study|Prematurely Discontinued|1|||
23520327|NCT00256698|65643487|FG001|Overall Study|Prematurely Discontinued|0|||
23520328|NCT01466387|65643488|FG000|Overall Study|Adverse Event|0|||
23520329|NCT01466387|65643489|FG001|Overall Study|Adverse Event|0|||
23520330|NCT01466387|65643490|FG002|Overall Study|Adverse Event|1|||
23520331|NCT01466387|65643491|FG003|Overall Study|Adverse Event|1|||
23520332|NCT01466387|65643492|FG004|Overall Study|Adverse Event|0|||
23520333|NCT01466387|65643493|FG005|Overall Study|Adverse Event|0|||
23520334|NCT01466387|65643488|FG000|Overall Study|Lost to Follow-up|0|||
23520335|NCT01466387|65643489|FG001|Overall Study|Lost to Follow-up|0|||
23520336|NCT01466387|65643490|FG002|Overall Study|Lost to Follow-up|0|||
23520337|NCT01466387|65643491|FG003|Overall Study|Lost to Follow-up|0|||
23520338|NCT01466387|65643492|FG004|Overall Study|Lost to Follow-up|0|||
23520339|NCT01466387|65643493|FG005|Overall Study|Lost to Follow-up|1|||
23520340|NCT01466387|65643488|FG000|Overall Study|Protocol Violation|1|||
23520341|NCT01466387|65643489|FG001|Overall Study|Protocol Violation|0|||
23520342|NCT01466387|65643490|FG002|Overall Study|Protocol Violation|0|||
23520343|NCT01466387|65643491|FG003|Overall Study|Protocol Violation|1|||
23520344|NCT01466387|65643492|FG004|Overall Study|Protocol Violation|0|||
23520345|NCT01466387|65643493|FG005|Overall Study|Protocol Violation|0|||
23520346|NCT01623596|65643494|FG000|Overall Study|Abnormal laboratory values|2|||
23520347|NCT01623596|65643495|FG001|Overall Study|Abnormal laboratory values|0|||
23520348|NCT01623596|65643494|FG000|Overall Study|Administrative problems|9|||
23520349|NCT01623596|65643495|FG001|Overall Study|Administrative problems|13|||
23520350|NCT01623596|65643494|FG000|Overall Study|Adverse Event|20|||
23520351|NCT01623596|65643495|FG001|Overall Study|Adverse Event|29|||
23520352|NCT01623596|65643494|FG000|Overall Study|Death|0|||
23520353|NCT01623596|65643495|FG001|Overall Study|Death|2|||
23520354|NCT01623596|65643494|FG000|Overall Study|Lost to Follow-up|12|||
23520355|NCT01623596|65643495|FG001|Overall Study|Lost to Follow-up|16|||
23520356|NCT01623596|65643494|FG000|Overall Study|Withdrawal by Subject|13|||
23520357|NCT01623596|65643495|FG001|Overall Study|Withdrawal by Subject|31|||
23520358|NCT01623596|65643494|FG000|Overall Study|Patient no longer requires study drug|1|||
23520359|NCT01623596|65643495|FG001|Overall Study|Patient no longer requires study drug|0|||
23520360|NCT01623596|65643494|FG000|Overall Study|Protocol Violation|0|||
23520361|NCT01623596|65643495|FG001|Overall Study|Protocol Violation|6|||
23520362|NCT01623596|65643494|FG000|Overall Study|Lack of Efficacy|5|||
23520363|NCT01623596|65643495|FG001|Overall Study|Lack of Efficacy|3|||
23520364|NCT01316276|65643496|FG000|Overall Study|Death|1|||
23520365|NCT01316276|65643496|FG000|Overall Study|Adverse Event|19|||
23520366|NCT01316276|65643496|FG000|Overall Study|Withdrawal of consent|24|||
23520367|NCT01316276|65643496|FG000|Overall Study|Lost to Follow-up|1|||
23520368|NCT01316276|65643496|FG000|Overall Study|Other|22|||
23520369|NCT01139450|65643499|FG000|Overall Study|Withdrawal by Subject|7|||
23520370|NCT01139450|65643500|FG001|Overall Study|Withdrawal by Subject|10|||
23520371|NCT01139450|65643501|FG002|Overall Study|Withdrawal by Subject|13|||
23520372|NCT01139450|65643499|FG000|Overall Study|Lack of Efficacy|3|||
23520373|NCT01139450|65643500|FG001|Overall Study|Lack of Efficacy|1|||
23520374|NCT01139450|65643501|FG002|Overall Study|Lack of Efficacy|8|||
23520375|NCT01139450|65643499|FG000|Overall Study|Protocol Violation|6|||
23520376|NCT01139450|65643500|FG001|Overall Study|Protocol Violation|5|||
23520377|NCT01139450|65643501|FG002|Overall Study|Protocol Violation|2|||
23520378|NCT01139450|65643499|FG000|Overall Study|Lost to Follow-up|9|||
23520379|NCT01139450|65643500|FG001|Overall Study|Lost to Follow-up|7|||
23520380|NCT01139450|65643501|FG002|Overall Study|Lost to Follow-up|11|||
23520381|NCT01139450|65643499|FG000|Overall Study|Administrative|0|||
23520382|NCT01139450|65643500|FG001|Overall Study|Administrative|0|||
23520383|NCT01139450|65643501|FG002|Overall Study|Administrative|1|||
23520384|NCT01139450|65643499|FG000|Overall Study|Adverse Event|2|||
23520385|NCT01139450|65643500|FG001|Overall Study|Adverse Event|2|||
23520386|NCT01139450|65643501|FG002|Overall Study|Adverse Event|3|||
23520387|NCT01290666|65643503|FG000|Overall Study|Lost to Follow-up|11|||
23520388|NCT01290666|65643503|FG000|Overall Study|Withdrawal by Subject|23|||
23520389|NCT01290666|65643503|FG000|Overall Study|Early Termination of Study|4|||
23520390|NCT03989440|65643504|FG000|Overall Study|COVID-19 travel restrictions|0|||
23520391|NCT03989440|65643505|FG001|Overall Study|COVID-19 travel restrictions|0|||
23520392|NCT03989440|65643506|FG002|Overall Study|COVID-19 travel restrictions|1|||
23520393|NCT03989440|65643507|FG003|Overall Study|COVID-19 travel restrictions|0|||
23520394|NCT03989440|65643508|FG004|Overall Study|COVID-19 travel restrictions|0|||
23520395|NCT03989440|65643509|FG005|Overall Study|COVID-19 travel restrictions|0|||
23520396|NCT03989440|65643504|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
23520397|NCT03989440|65643505|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
23520398|NCT03989440|65643506|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
23520399|NCT03989440|65643507|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
23520400|NCT03989440|65643508|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
23520401|NCT03989440|65643509|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
23416223|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
23520402|NCT02604212|65643510|FG000|Overall Study|Study Terminated by Sponsor|2|||
23520403|NCT02604212|65643511|FG001|Overall Study|Study Terminated by Sponsor|1|||
23520404|NCT02604212|65643512|FG002|Overall Study|Study Terminated by Sponsor|3|||
23520405|NCT02604212|65643513|FG003|Overall Study|Study Terminated by Sponsor|3|||
23520406|NCT02604212|65643510|FG000|Overall Study|Withdrawal by Subject|0|||
23520407|NCT02604212|65643511|FG001|Overall Study|Withdrawal by Subject|0|||
23520408|NCT02604212|65643512|FG002|Overall Study|Withdrawal by Subject|1|||
23520409|NCT02604212|65643513|FG003|Overall Study|Withdrawal by Subject|0|||
23520410|NCT03424265|65643514|FG000|Overall Study|screening failure|1|||
23520411|NCT03424265|65643515|FG001|Overall Study|screening failure|0|||
23520412|NCT03424265|65643514|FG000|Overall Study|Withdrawal by Subject|0|||
23520413|NCT03424265|65643515|FG001|Overall Study|Withdrawal by Subject|2|||
23520414|NCT03025542|65643521|FG000|Overall Study|Adverse Event|0|||
23520415|NCT03025542|65643522|FG001|Overall Study|Adverse Event|2|||
23520416|NCT03025542|65643521|FG000|Overall Study|Lost to Follow-up|1|||
23520417|NCT03025542|65643522|FG001|Overall Study|Lost to Follow-up|0|||
23520418|NCT03025542|65643521|FG000|Overall Study|Withdrawal by Subject|1|||
23520419|NCT03025542|65643522|FG001|Overall Study|Withdrawal by Subject|0|||
23520420|NCT01224639|65643523|FG000|Overall Study|Withdrawal by Subject|0|||
23520421|NCT01224639|65643524|FG001|Overall Study|Withdrawal by Subject|0|||
23520422|NCT01224639|65643525|FG002|Overall Study|Withdrawal by Subject|0|||
23520423|NCT01224639|65643526|FG003|Overall Study|Withdrawal by Subject|0|||
23520424|NCT01224639|65643527|FG004|Overall Study|Withdrawal by Subject|2|||
23520425|NCT01224639|65643528|FG005|Overall Study|Withdrawal by Subject|0|||
23520426|NCT01224639|65643529|FG006|Overall Study|Withdrawal by Subject|1|||
23520427|NCT01224639|65643530|FG007|Overall Study|Withdrawal by Subject|1|||
23520428|NCT01224639|65643523|FG000|Overall Study|Adverse Event|0|||
23520429|NCT01224639|65643524|FG001|Overall Study|Adverse Event|0|||
23520430|NCT01224639|65643525|FG002|Overall Study|Adverse Event|0|||
23520431|NCT01224639|65643526|FG003|Overall Study|Adverse Event|0|||
23520432|NCT01224639|65643527|FG004|Overall Study|Adverse Event|0|||
23520433|NCT01224639|65643528|FG005|Overall Study|Adverse Event|0|||
23520434|NCT01224639|65643529|FG006|Overall Study|Adverse Event|0|||
23520435|NCT01224639|65643530|FG007|Overall Study|Adverse Event|1|||
23520436|NCT00679263|65643536|FG000|Visit 2/Dose 1|Adverse Event|1|||
23520437|NCT00679263|65643537|FG001|Visit 2/Dose 1|Adverse Event|0|||
23520438|NCT00679263|65643538|FG002|Visit 2/Dose 1|Adverse Event|0|||
23520439|NCT00679263|65643536|FG000|Visit 2/Dose 1|subject not compliance|1|||
23520440|NCT00679263|65643537|FG001|Visit 2/Dose 1|subject not compliance|1|||
23520441|NCT00679263|65643538|FG002|Visit 2/Dose 1|subject not compliance|0|||
23520442|NCT01148511|65643542|FG000|Exposed to Study Drug|Protocol Violation|2|||
23520443|NCT01148511|65643543|FG001|Exposed to Study Drug|Protocol Violation|0|||
23520444|NCT01148511|65643544|FG002|Exposed to Study Drug|Protocol Violation|0|||
23520445|NCT01148511|65643542|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
23520446|NCT01148511|65643543|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
23520447|NCT01148511|65643544|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
23520448|NCT01148511|65643542|FG000|Randomized|Adverse Event|0|||
23520449|NCT01148511|65643543|FG001|Randomized|Adverse Event|1|||
23520450|NCT01148511|65643544|FG002|Randomized|Adverse Event|0|||
23520451|NCT01148511|65643542|FG000|Randomized|Protocol Violation|0|||
23520452|NCT01148511|65643543|FG001|Randomized|Protocol Violation|2|||
23520453|NCT01148511|65643544|FG002|Randomized|Protocol Violation|1|||
23520454|NCT01148511|65643542|FG000|Randomized|Lost to Follow-up|0|||
23520455|NCT01148511|65643543|FG001|Randomized|Lost to Follow-up|1|||
23520456|NCT01148511|65643544|FG002|Randomized|Lost to Follow-up|1|||
23520457|NCT01148511|65643542|FG000|Randomized|Consent withdrawal|0|||
23520458|NCT01148511|65643543|FG001|Randomized|Consent withdrawal|5|||
23520459|NCT01148511|65643544|FG002|Randomized|Consent withdrawal|3|||
23520460|NCT01148511|65643542|FG000|Randomized|Other|0|||
23520461|NCT01148511|65643543|FG001|Randomized|Other|1|||
23520462|NCT01148511|65643544|FG002|Randomized|Other|1|||
23520463|NCT02337907|65643545|FG000|Overall Study|Other than listed|1|||
23520464|NCT02337907|65643546|FG001|Overall Study|Other than listed|0|||
23520465|NCT02337907|65643547|FG002|Overall Study|Other than listed|0|||
23520466|NCT02337907|65643548|FG003|Overall Study|Other than listed|1|||
23520467|NCT02337907|65643549|FG004|Overall Study|Other than listed|1|||
23520468|NCT02337907|65643550|FG005|Overall Study|Other than listed|0|||
23520469|NCT02337907|65643545|FG000|Overall Study|Withdrawal by Subject|2|||
23520470|NCT02337907|65643546|FG001|Overall Study|Withdrawal by Subject|3|||
23205290|NCT02065622|64491322|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
23520471|NCT02337907|65643547|FG002|Overall Study|Withdrawal by Subject|0|||
23520472|NCT02337907|65643548|FG003|Overall Study|Withdrawal by Subject|2|||
23520473|NCT02337907|65643549|FG004|Overall Study|Withdrawal by Subject|5|||
23520474|NCT02337907|65643550|FG005|Overall Study|Withdrawal by Subject|0|||
23520475|NCT02337907|65643545|FG000|Overall Study|Lost to Follow-up|0|||
23520476|NCT02337907|65643546|FG001|Overall Study|Lost to Follow-up|0|||
23520477|NCT02337907|65643547|FG002|Overall Study|Lost to Follow-up|0|||
23520478|NCT02337907|65643548|FG003|Overall Study|Lost to Follow-up|0|||
23520479|NCT02337907|65643549|FG004|Overall Study|Lost to Follow-up|0|||
23520480|NCT02337907|65643550|FG005|Overall Study|Lost to Follow-up|1|||
23520481|NCT02337907|65643545|FG000|Overall Study|Adverse Event|1|||
23520482|NCT02337907|65643546|FG001|Overall Study|Adverse Event|1|||
23520483|NCT02337907|65643547|FG002|Overall Study|Adverse Event|1|||
23520484|NCT02337907|65643548|FG003|Overall Study|Adverse Event|1|||
23520485|NCT02337907|65643549|FG004|Overall Study|Adverse Event|4|||
23520486|NCT02337907|65643550|FG005|Overall Study|Adverse Event|0|||
23520487|NCT00171223|65643551|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
23520488|NCT00171223|65643552|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
23520489|NCT00171223|65643553|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
23520490|NCT00171223|65643551|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
23520491|NCT00171223|65643552|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
23520492|NCT00171223|65643553|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
23520493|NCT00171223|65643551|FG000|Overall Study|Abnormal Procedure|1|||
23520494|NCT00171223|65643552|FG001|Overall Study|Abnormal Procedure|0|||
23520495|NCT00171223|65643553|FG002|Overall Study|Abnormal Procedure|0|||
23520496|NCT00171223|65643551|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
23520497|NCT00171223|65643552|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
23520498|NCT00171223|65643553|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
23520499|NCT00171223|65643551|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
23520500|NCT00171223|65643552|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
23520501|NCT00171223|65643553|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
23520502|NCT00171223|65643551|FG000|Overall Study|Protocol Violation|2|||
23520503|NCT00171223|65643552|FG001|Overall Study|Protocol Violation|2|||
23520504|NCT00171223|65643553|FG002|Overall Study|Protocol Violation|3|||
23520505|NCT00171223|65643551|FG000|Overall Study|Participant Withdrew Consent|12|||
23520506|NCT00171223|65643552|FG001|Overall Study|Participant Withdrew Consent|21|||
23520507|NCT00171223|65643553|FG002|Overall Study|Participant Withdrew Consent|15|||
23520508|NCT00171223|65643551|FG000|Overall Study|Lost to Follow-up|5|||
23520509|NCT00171223|65643552|FG001|Overall Study|Lost to Follow-up|2|||
23520510|NCT00171223|65643553|FG002|Overall Study|Lost to Follow-up|3|||
23520511|NCT00171223|65643551|FG000|Overall Study|Administrative Problems|4|||
23520512|NCT00171223|65643552|FG001|Overall Study|Administrative Problems|7|||
23520513|NCT00171223|65643553|FG002|Overall Study|Administrative Problems|6|||
23520514|NCT00171223|65643551|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
23520515|NCT00171223|65643552|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
23520516|NCT00171223|65643553|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
23520517|NCT00171223|65643551|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
23520518|NCT00171223|65643552|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
23520519|NCT00171223|65643553|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
23520520|NCT00914810|65643554|FG000|Overall Study|Withdrawal by Subject|1|||
23520521|NCT00914810|65643555|FG001|Overall Study|Withdrawal by Subject|0|||
23520522|NCT00914810|65643554|FG000|Overall Study|Relocated out of state|1|||
23520523|NCT00914810|65643555|FG001|Overall Study|Relocated out of state|0|||
23520524|NCT00914810|65643554|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
23520525|NCT00914810|65643555|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
23520526|NCT03200899|65643556|FG000|Overall Study|Lost to Follow-up|10|||
23520527|NCT03200899|65643557|FG001|Overall Study|Lost to Follow-up|23|||
23520528|NCT00858442|65643561|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
23520529|NCT00858442|65643562|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
23520530|NCT04865354|65643566|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
23520531|NCT04865354|65643567|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
23520532|NCT04865354|65643566|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
23520533|NCT04865354|65643567|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
23520534|NCT04865354|65643566|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
23520535|NCT04865354|65643567|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
23520536|NCT00982488|65643570|FG000|Overall Study|Administrative reason by sponsor|81|||
23520537|NCT00982488|65643571|FG001|Overall Study|Administrative reason by sponsor|3|||
23520538|NCT00982488|65643572|FG002|Overall Study|Administrative reason by sponsor|11|||
23520539|NCT00982488|65643573|FG003|Overall Study|Administrative reason by sponsor|0|||
23520540|NCT00982488|65643574|FG004|Overall Study|Administrative reason by sponsor|0|||
23520541|NCT00982488|65643570|FG000|Overall Study|Adverse event unrelated to study drug|5|||
23520542|NCT00982488|65643571|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23520543|NCT00982488|65643572|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23416224|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
23520544|NCT00982488|65643573|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23520545|NCT00982488|65643574|FG004|Overall Study|Adverse event unrelated to study drug|0|||
23520546|NCT00982488|65643570|FG000|Overall Study|Death|11|||
23520547|NCT00982488|65643571|FG001|Overall Study|Death|0|||
23520548|NCT00982488|65643572|FG002|Overall Study|Death|2|||
23520549|NCT00982488|65643573|FG003|Overall Study|Death|0|||
23520550|NCT00982488|65643574|FG004|Overall Study|Death|0|||
23520551|NCT00982488|65643570|FG000|Overall Study|Disease progression|30|||
23520552|NCT00982488|65643571|FG001|Overall Study|Disease progression|5|||
23520553|NCT00982488|65643572|FG002|Overall Study|Disease progression|10|||
23520554|NCT00982488|65643573|FG003|Overall Study|Disease progression|1|||
23520555|NCT00982488|65643574|FG004|Overall Study|Disease progression|1|||
23520556|NCT00982488|65643570|FG000|Overall Study|Lost to Follow-up|1|||
23520557|NCT00982488|65643571|FG001|Overall Study|Lost to Follow-up|0|||
23520558|NCT00982488|65643572|FG002|Overall Study|Lost to Follow-up|0|||
23520559|NCT00982488|65643573|FG003|Overall Study|Lost to Follow-up|0|||
23520560|NCT00982488|65643574|FG004|Overall Study|Lost to Follow-up|0|||
23520561|NCT00982488|65643570|FG000|Overall Study|Maximum clinical benefit|1|||
23520562|NCT00982488|65643571|FG001|Overall Study|Maximum clinical benefit|1|||
23520563|NCT00982488|65643572|FG002|Overall Study|Maximum clinical benefit|1|||
23520564|NCT00982488|65643573|FG003|Overall Study|Maximum clinical benefit|0|||
23520565|NCT00982488|65643574|FG004|Overall Study|Maximum clinical benefit|0|||
23520566|NCT00982488|65643570|FG000|Overall Study|Other|15|||
23520567|NCT00982488|65643571|FG001|Overall Study|Other|1|||
23520568|NCT00982488|65643572|FG002|Overall Study|Other|3|||
23520569|NCT00982488|65643573|FG003|Overall Study|Other|1|||
23520570|NCT00982488|65643574|FG004|Overall Study|Other|0|||
23520571|NCT00982488|65643570|FG000|Overall Study|Poor compliance/noncompliance|0|||
23520572|NCT00982488|65643571|FG001|Overall Study|Poor compliance/noncompliance|1|||
23520573|NCT00982488|65643572|FG002|Overall Study|Poor compliance/noncompliance|0|||
23520574|NCT00982488|65643573|FG003|Overall Study|Poor compliance/noncompliance|0|||
23520575|NCT00982488|65643574|FG004|Overall Study|Poor compliance/noncompliance|0|||
23520576|NCT00982488|65643570|FG000|Overall Study|Stem cell transplant|2|||
23520577|NCT00982488|65643571|FG001|Overall Study|Stem cell transplant|0|||
23520578|NCT00982488|65643572|FG002|Overall Study|Stem cell transplant|0|||
23520579|NCT00982488|65643573|FG003|Overall Study|Stem cell transplant|1|||
23520580|NCT00982488|65643574|FG004|Overall Study|Stem cell transplant|0|||
23520581|NCT00982488|65643570|FG000|Overall Study|Study drug toxicity|34|||
23520582|NCT00982488|65643571|FG001|Overall Study|Study drug toxicity|1|||
23520583|NCT00982488|65643572|FG002|Overall Study|Study drug toxicity|6|||
23520584|NCT00982488|65643573|FG003|Overall Study|Study drug toxicity|0|||
23520585|NCT00982488|65643574|FG004|Overall Study|Study drug toxicity|0|||
23520586|NCT00982488|65643570|FG000|Overall Study|Withdrawal by Subject|5|||
23520587|NCT00982488|65643571|FG001|Overall Study|Withdrawal by Subject|1|||
23520588|NCT00982488|65643572|FG002|Overall Study|Withdrawal by Subject|1|||
23520589|NCT00982488|65643573|FG003|Overall Study|Withdrawal by Subject|0|||
23520590|NCT00982488|65643574|FG004|Overall Study|Withdrawal by Subject|0|||
23520591|NCT01522365|65643575|FG000|Overall Study|Withdrawal by Subject|1|||
23520592|NCT01522365|65643576|FG001|Overall Study|Withdrawal by Subject|1|||
23520593|NCT01522365|65643575|FG000|Overall Study|Lost to Follow-up|1|||
23520594|NCT01522365|65643576|FG001|Overall Study|Lost to Follow-up|1|||
23520595|NCT00445965|65643577|FG000|Overall Study|Adverse Event|2|||
23520596|NCT00445965|65643577|FG000|Overall Study|Physician Decision|1|||
23520597|NCT00445965|65643577|FG000|Overall Study|Enrolled but not treated|1|||
23520598|NCT00445965|65643577|FG000|Overall Study|Removed due to progressive disease|29|||
23520599|NCT01988103|65643578|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
23520600|NCT01988103|65643579|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
23520601|NCT01988103|65643580|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
23520602|NCT01988103|65643581|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
23520603|NCT01988103|65643582|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
23520604|NCT01988103|65643578|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
23520605|NCT01988103|65643579|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
23520606|NCT01988103|65643580|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
23520607|NCT01988103|65643581|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
23520608|NCT01988103|65643582|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
23205291|NCT02065622|64491318|FG000|Induction Study|Subject Noncompliance|1|||
23205292|NCT02065622|64491319|FG001|Induction Study|Subject Noncompliance|1|||
23205293|NCT02065622|64491320|FG002|Induction Study|Subject Noncompliance|0|||
23205294|NCT02065622|64491321|FG003|Induction Study|Subject Noncompliance|0|||
23520609|NCT01988103|65643578|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
23520610|NCT01988103|65643579|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
23520611|NCT01988103|65643580|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
23205295|NCT02065622|64491322|FG004|Induction Study|Subject Noncompliance|0|||
23520612|NCT01988103|65643581|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
23520613|NCT01988103|65643582|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
23520614|NCT01988103|65643578|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
23205296|NCT02065622|64491318|FG000|Induction Study|Other, Not Specified|3|||
23520615|NCT01988103|65643579|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
23520616|NCT01988103|65643580|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
23520617|NCT01988103|65643581|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
23520618|NCT01988103|65643582|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
23520619|NCT01988103|65643578|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
23520620|NCT01988103|65643579|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
23520621|NCT01988103|65643580|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
23520622|NCT01988103|65643581|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
23520623|NCT01988103|65643582|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
23520624|NCT01988103|65643578|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
23520625|NCT01988103|65643579|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
23520626|NCT01988103|65643580|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
23520627|NCT01988103|65643581|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
23520628|NCT01988103|65643582|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
23520629|NCT01988103|65643578|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
23520630|NCT01988103|65643579|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
23520631|NCT01988103|65643580|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
23520632|NCT01988103|65643581|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
23520633|NCT01988103|65643582|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
23520634|NCT01523886|65643583|FG000|Overall Study|surgery cancelled|0|||
23520635|NCT01523886|65643584|FG001|Overall Study|surgery cancelled|1|||
23520636|NCT05778786|65643585|FG000|Period 1|COVID-19 Related|3|||
23520637|NCT05778786|65643586|FG001|Period 1|COVID-19 Related|3|||
23520638|NCT05778786|65643585|FG000|Period 1|Withdrew Consent during Study|1|||
23520639|NCT05778786|65643586|FG001|Period 1|Withdrew Consent during Study|0|||
23520640|NCT05778786|65643585|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
23520641|NCT05778786|65643586|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
23520642|NCT05778786|65643585|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
23520643|NCT05778786|65643586|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
23520644|NCT00946712|65643587|FG000|Overall Study|Adverse Event|118|||
23520645|NCT00946712|65643588|FG001|Overall Study|Adverse Event|124|||
23520646|NCT00946712|65643587|FG000|Overall Study|Disease progression|308|||
23520647|NCT00946712|65643588|FG001|Overall Study|Disease progression|404|||
23520648|NCT00946712|65643587|FG000|Overall Study|Death|21|||
23520649|NCT00946712|65643588|FG001|Overall Study|Death|22|||
23520650|NCT00946712|65643587|FG000|Overall Study|No treatment given|25|||
23520651|NCT00946712|65643588|FG001|Overall Study|No treatment given|29|||
23520652|NCT00946712|65643587|FG000|Overall Study|Other reasons|61|||
23520653|NCT00946712|65643588|FG001|Overall Study|Other reasons|73|||
23520654|NCT00946712|65643587|FG000|Overall Study|On Treatment|0|||
23520655|NCT00946712|65643588|FG001|Overall Study|On Treatment|4|||
23520656|NCT00946712|65643587|FG000|Overall Study|Ineligible|14|||
23520657|NCT00946712|65643588|FG001|Overall Study|Ineligible|6|||
23520658|NCT03739112|65643589|FG000|Overall Study|Adverse Event|2|||
23520659|NCT03739112|65643590|FG001|Overall Study|Adverse Event|2|||
23520660|NCT03739112|65643589|FG000|Overall Study|Withdrawal by Subject|38|||
23520661|NCT03739112|65643590|FG001|Overall Study|Withdrawal by Subject|19|||
23520662|NCT03739112|65643589|FG000|Overall Study|Lost to Follow-up|31|||
23520663|NCT03739112|65643590|FG001|Overall Study|Lost to Follow-up|33|||
23520664|NCT03739112|65643589|FG000|Overall Study|Protocol Deviation|12|||
23520665|NCT03739112|65643590|FG001|Overall Study|Protocol Deviation|9|||
23520666|NCT03739112|65643589|FG000|Overall Study|Physician Decision|1|||
23520667|NCT03739112|65643590|FG001|Overall Study|Physician Decision|0|||
23520668|NCT03739112|65643589|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
23520669|NCT03739112|65643590|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
23520670|NCT03739112|65643589|FG000|Overall Study|Site went on hold|65|||
23307695|NCT01083810|64870566|FG002|Overall Study|Simplification|0|||
23520671|NCT03739112|65643590|FG001|Overall Study|Site went on hold|67|||
23520672|NCT03739112|65643589|FG000|Overall Study|Other than specified|8|||
23520673|NCT03739112|65643590|FG001|Overall Study|Other than specified|5|||
23520674|NCT03739112|65643589|FG000|Overall Study|Randomized but not vaccinated|31|||
23520675|NCT03739112|65643590|FG001|Overall Study|Randomized but not vaccinated|25|||
23520676|NCT00673179|65647425|FG000|Overall Study|Toxicity/Complications|3|||
23520677|NCT00673179|65647426|FG001|Overall Study|Toxicity/Complications|0|||
23520678|NCT02486042|65647431|FG000|Overall Study|Physician Decision|1|||
23520679|NCT02486042|65647432|FG001|Overall Study|Physician Decision|7|||
23520680|NCT02486042|65647431|FG000|Overall Study|Hospital transfer|2|||
23520681|NCT02486042|65647432|FG001|Overall Study|Hospital transfer|2|||
23520682|NCT02486042|65647431|FG000|Overall Study|Withdrawal by Subject|0|||
23520683|NCT02486042|65647432|FG001|Overall Study|Withdrawal by Subject|2|||
23520684|NCT00278954|65647438|FG000|Overall Study|Adverse Event|3|||
23520685|NCT00278954|65647438|FG000|Overall Study|Lost to Follow-up|1|||
23520686|NCT00278954|65647438|FG000|Overall Study|Withdrawal by Subject|1|||
23520687|NCT00735878|65647442|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
23520688|NCT00735878|65647443|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
23520689|NCT00735878|65647444|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
23520690|NCT02291055|65647446|FG000|Overall Study|Death|2|||
23520691|NCT02291055|65647447|FG001|Overall Study|Death|2|||
23520692|NCT02291055|65647448|FG002|Overall Study|Death|5|||
23520693|NCT02291055|65647449|FG003|Overall Study|Death|8|||
23520694|NCT02291055|65647450|FG004|Overall Study|Death|12|||
23520695|NCT02291055|65647446|FG000|Overall Study|Lost to Follow-up|0|||
23520696|NCT02291055|65647447|FG001|Overall Study|Lost to Follow-up|0|||
23520697|NCT02291055|65647448|FG002|Overall Study|Lost to Follow-up|0|||
23520698|NCT02291055|65647449|FG003|Overall Study|Lost to Follow-up|1|||
23520699|NCT02291055|65647450|FG004|Overall Study|Lost to Follow-up|2|||
23520700|NCT02291055|65647446|FG000|Overall Study|Withdrawal by Subject|3|||
23520701|NCT02291055|65647447|FG001|Overall Study|Withdrawal by Subject|1|||
23520702|NCT02291055|65647448|FG002|Overall Study|Withdrawal by Subject|1|||
23520703|NCT02291055|65647449|FG003|Overall Study|Withdrawal by Subject|5|||
23520704|NCT02291055|65647450|FG004|Overall Study|Withdrawal by Subject|10|||
23520705|NCT02291055|65647446|FG000|Overall Study|Progressive Disease|0|||
23520706|NCT02291055|65647447|FG001|Overall Study|Progressive Disease|0|||
23520707|NCT02291055|65647448|FG002|Overall Study|Progressive Disease|1|||
23520708|NCT02291055|65647449|FG003|Overall Study|Progressive Disease|4|||
23520709|NCT02291055|65647450|FG004|Overall Study|Progressive Disease|2|||
23520710|NCT02291055|65647446|FG000|Overall Study|Study Terminated by Sponsor|0|||
23520711|NCT02291055|65647447|FG001|Overall Study|Study Terminated by Sponsor|0|||
23520712|NCT02291055|65647448|FG002|Overall Study|Study Terminated by Sponsor|0|||
23520713|NCT02291055|65647449|FG003|Overall Study|Study Terminated by Sponsor|5|||
23520714|NCT02291055|65647450|FG004|Overall Study|Study Terminated by Sponsor|1|||
23520715|NCT02291055|65647446|FG000|Overall Study|Other|0|||
23520716|NCT02291055|65647447|FG001|Overall Study|Other|2|||
23520717|NCT02291055|65647448|FG002|Overall Study|Other|1|||
23520718|NCT02291055|65647449|FG003|Overall Study|Other|4|||
23520719|NCT02291055|65647450|FG004|Overall Study|Other|0|||
23520720|NCT03131440|65647452|FG000|Overall Study|Withdrawal by Subject|1|||
23520721|NCT03131440|65647453|FG001|Overall Study|Withdrawal by Subject|3|||
23520722|NCT03131440|65647454|FG002|Overall Study|Withdrawal by Subject|0|||
23520723|NCT03131440|65647455|FG003|Overall Study|Withdrawal by Subject|0|||
23520724|NCT03131440|65647456|FG004|Overall Study|Withdrawal by Subject|1|||
23520725|NCT03131440|65647457|FG005|Overall Study|Withdrawal by Subject|0|||
23520726|NCT03131440|65647458|FG006|Overall Study|Withdrawal by Subject|0|||
23520727|NCT03131440|65647459|FG007|Overall Study|Withdrawal by Subject|1|||
23520728|NCT03131440|65647460|FG008|Overall Study|Withdrawal by Subject|1|||
23520729|NCT03131440|65647461|FG009|Overall Study|Withdrawal by Subject|1|||
23520730|NCT03131440|65647462|FG010|Overall Study|Withdrawal by Subject|0|||
23520731|NCT03131440|65647463|FG011|Overall Study|Withdrawal by Subject|1|||
23520732|NCT03131440|65647464|FG012|Overall Study|Withdrawal by Subject|1|||
23520733|NCT03131440|65647465|FG013|Overall Study|Withdrawal by Subject|0|||
23520734|NCT03131440|65647466|FG014|Overall Study|Withdrawal by Subject|1|||
23520735|NCT03131440|65647467|FG015|Overall Study|Withdrawal by Subject|0|||
23520736|NCT03131440|65647468|FG016|Overall Study|Withdrawal by Subject|0|||
23520737|NCT03131440|65647469|FG017|Overall Study|Withdrawal by Subject|0|||
23520738|NCT03131440|65647470|FG018|Overall Study|Withdrawal by Subject|1|||
23520739|NCT03131440|65647471|FG019|Overall Study|Withdrawal by Subject|0|||
23520740|NCT03131440|65647472|FG020|Overall Study|Withdrawal by Subject|1|||
23520741|NCT03131440|65647473|FG021|Overall Study|Withdrawal by Subject|1|||
23520742|NCT03131440|65647474|FG022|Overall Study|Withdrawal by Subject|1|||
23520743|NCT03131440|65647475|FG023|Overall Study|Withdrawal by Subject|0|||
23520744|NCT03131440|65647476|FG024|Overall Study|Withdrawal by Subject|0|||
23520745|NCT03131440|65647477|FG025|Overall Study|Withdrawal by Subject|0|||
23520746|NCT03131440|65647478|FG026|Overall Study|Withdrawal by Subject|0|||
23520747|NCT03131440|65647479|FG027|Overall Study|Withdrawal by Subject|0|||
23520748|NCT03131440|65647480|FG028|Overall Study|Withdrawal by Subject|0|||
23520749|NCT03131440|65647481|FG029|Overall Study|Withdrawal by Subject|0|||
23520750|NCT03131440|65647482|FG030|Overall Study|Withdrawal by Subject|1|||
23520751|NCT03131440|65647483|FG031|Overall Study|Withdrawal by Subject|0|||
23520752|NCT03131440|65647452|FG000|Overall Study|Lost to Follow-up|0|||
23520753|NCT03131440|65647453|FG001|Overall Study|Lost to Follow-up|0|||
23520754|NCT03131440|65647454|FG002|Overall Study|Lost to Follow-up|0|||
23520755|NCT03131440|65647455|FG003|Overall Study|Lost to Follow-up|0|||
23520756|NCT03131440|65647456|FG004|Overall Study|Lost to Follow-up|0|||
23520757|NCT03131440|65647457|FG005|Overall Study|Lost to Follow-up|1|||
23520758|NCT03131440|65647458|FG006|Overall Study|Lost to Follow-up|0|||
23520759|NCT03131440|65647459|FG007|Overall Study|Lost to Follow-up|0|||
23520760|NCT03131440|65647460|FG008|Overall Study|Lost to Follow-up|0|||
23520761|NCT03131440|65647461|FG009|Overall Study|Lost to Follow-up|0|||
23520762|NCT03131440|65647462|FG010|Overall Study|Lost to Follow-up|0|||
23520763|NCT03131440|65647463|FG011|Overall Study|Lost to Follow-up|0|||
23520764|NCT03131440|65647464|FG012|Overall Study|Lost to Follow-up|0|||
23520765|NCT03131440|65647465|FG013|Overall Study|Lost to Follow-up|0|||
23520766|NCT03131440|65647466|FG014|Overall Study|Lost to Follow-up|0|||
23520767|NCT03131440|65647467|FG015|Overall Study|Lost to Follow-up|0|||
23520768|NCT03131440|65647468|FG016|Overall Study|Lost to Follow-up|0|||
23520769|NCT03131440|65647469|FG017|Overall Study|Lost to Follow-up|0|||
23520770|NCT03131440|65647470|FG018|Overall Study|Lost to Follow-up|0|||
23520771|NCT03131440|65647471|FG019|Overall Study|Lost to Follow-up|2|||
23520772|NCT03131440|65647472|FG020|Overall Study|Lost to Follow-up|1|||
23520773|NCT03131440|65647473|FG021|Overall Study|Lost to Follow-up|0|||
23520774|NCT03131440|65647474|FG022|Overall Study|Lost to Follow-up|1|||
23520775|NCT03131440|65647475|FG023|Overall Study|Lost to Follow-up|0|||
23520776|NCT03131440|65647476|FG024|Overall Study|Lost to Follow-up|1|||
23520777|NCT03131440|65647477|FG025|Overall Study|Lost to Follow-up|0|||
23520778|NCT03131440|65647478|FG026|Overall Study|Lost to Follow-up|0|||
23520779|NCT03131440|65647479|FG027|Overall Study|Lost to Follow-up|2|||
23520780|NCT03131440|65647480|FG028|Overall Study|Lost to Follow-up|0|||
23520781|NCT03131440|65647481|FG029|Overall Study|Lost to Follow-up|2|||
23307696|NCT01083810|64870564|FG000|Overall Study|Death|2|||
23520782|NCT03131440|65647482|FG030|Overall Study|Lost to Follow-up|0|||
23520783|NCT03131440|65647483|FG031|Overall Study|Lost to Follow-up|0|||
23520784|NCT03131440|65647452|FG000|Overall Study|Death|0|||
23520785|NCT03131440|65647453|FG001|Overall Study|Death|0|||
23520786|NCT03131440|65647454|FG002|Overall Study|Death|0|||
23520787|NCT03131440|65647455|FG003|Overall Study|Death|0|||
23520788|NCT03131440|65647456|FG004|Overall Study|Death|0|||
23520789|NCT03131440|65647457|FG005|Overall Study|Death|0|||
23520790|NCT03131440|65647458|FG006|Overall Study|Death|0|||
23520791|NCT03131440|65647459|FG007|Overall Study|Death|0|||
23520792|NCT03131440|65647460|FG008|Overall Study|Death|0|||
23520793|NCT03131440|65647461|FG009|Overall Study|Death|0|||
23520794|NCT03131440|65647462|FG010|Overall Study|Death|0|||
23520795|NCT03131440|65647463|FG011|Overall Study|Death|0|||
23520796|NCT03131440|65647464|FG012|Overall Study|Death|0|||
23520797|NCT03131440|65647465|FG013|Overall Study|Death|0|||
23205297|NCT02065622|64491319|FG001|Induction Study|Other, Not Specified|2|||
23205298|NCT02065622|64491320|FG002|Induction Study|Other, Not Specified|0|||
23205299|NCT02065622|64491321|FG003|Induction Study|Other, Not Specified|0|||
23520798|NCT03131440|65647466|FG014|Overall Study|Death|0|||
23520799|NCT03131440|65647467|FG015|Overall Study|Death|0|||
23520800|NCT03131440|65647468|FG016|Overall Study|Death|0|||
23520801|NCT03131440|65647469|FG017|Overall Study|Death|0|||
23520802|NCT03131440|65647470|FG018|Overall Study|Death|0|||
23520803|NCT03131440|65647471|FG019|Overall Study|Death|0|||
23520804|NCT03131440|65647472|FG020|Overall Study|Death|0|||
23520805|NCT03131440|65647473|FG021|Overall Study|Death|0|||
23520806|NCT03131440|65647474|FG022|Overall Study|Death|0|||
23520807|NCT03131440|65647475|FG023|Overall Study|Death|0|||
23520808|NCT03131440|65647476|FG024|Overall Study|Death|0|||
23520809|NCT03131440|65647477|FG025|Overall Study|Death|1|||
23520810|NCT03131440|65647478|FG026|Overall Study|Death|0|||
23520811|NCT03131440|65647479|FG027|Overall Study|Death|0|||
23520812|NCT03131440|65647480|FG028|Overall Study|Death|0|||
23520813|NCT03131440|65647481|FG029|Overall Study|Death|0|||
23520814|NCT03131440|65647482|FG030|Overall Study|Death|0|||
23520815|NCT03131440|65647483|FG031|Overall Study|Death|0|||
23520816|NCT00605475|65647490|FG000|Overall Study|Abnormal Laboratory Values|0|||
23520817|NCT00605475|65647491|FG001|Overall Study|Abnormal Laboratory Values|0|||
23520818|NCT00605475|65647492|FG002|Overall Study|Abnormal Laboratory Values|0|||
23520819|NCT00605475|65647493|FG003|Overall Study|Abnormal Laboratory Values|0|||
23520820|NCT00605475|65647494|FG004|Overall Study|Abnormal Laboratory Values|0|||
23520821|NCT00605475|65647495|FG005|Overall Study|Abnormal Laboratory Values|0|||
23520822|NCT00605475|65647496|FG006|Overall Study|Abnormal Laboratory Values|0|||
23520823|NCT00605475|65647497|FG007|Overall Study|Abnormal Laboratory Values|0|||
23520824|NCT00605475|65647498|FG008|Overall Study|Abnormal Laboratory Values|1|||
23520825|NCT00605475|65647499|FG009|Overall Study|Abnormal Laboratory Values|0|||
23520826|NCT00605475|65647490|FG000|Overall Study|Administrative problems|0|||
23520827|NCT00605475|65647491|FG001|Overall Study|Administrative problems|0|||
23520828|NCT00605475|65647492|FG002|Overall Study|Administrative problems|0|||
23520829|NCT00605475|65647493|FG003|Overall Study|Administrative problems|0|||
23520830|NCT00605475|65647494|FG004|Overall Study|Administrative problems|0|||
23520831|NCT00605475|65647495|FG005|Overall Study|Administrative problems|0|||
23520832|NCT00605475|65647496|FG006|Overall Study|Administrative problems|1|||
23205300|NCT02065622|64491322|FG004|Induction Study|Other, Not Specified|0|||
23520833|NCT00605475|65647497|FG007|Overall Study|Administrative problems|0|||
23520834|NCT00605475|65647498|FG008|Overall Study|Administrative problems|0|||
23520835|NCT00605475|65647499|FG009|Overall Study|Administrative problems|0|||
23520836|NCT00605475|65647490|FG000|Overall Study|Lost to Follow-up|0|||
23520837|NCT00605475|65647491|FG001|Overall Study|Lost to Follow-up|0|||
23520838|NCT00605475|65647492|FG002|Overall Study|Lost to Follow-up|0|||
23520839|NCT00605475|65647493|FG003|Overall Study|Lost to Follow-up|0|||
23520840|NCT00605475|65647494|FG004|Overall Study|Lost to Follow-up|0|||
23520841|NCT00605475|65647495|FG005|Overall Study|Lost to Follow-up|0|||
23520842|NCT00605475|65647496|FG006|Overall Study|Lost to Follow-up|0|||
23307697|NCT01083810|64870565|FG001|Overall Study|Death|2|||
23307698|NCT01083810|64870566|FG002|Overall Study|Death|3|||
23307699|NCT01083810|64870564|FG000|Overall Study|Co-morbidities|1|||
23520843|NCT00605475|65647497|FG007|Overall Study|Lost to Follow-up|0|||
23520844|NCT00605475|65647498|FG008|Overall Study|Lost to Follow-up|1|||
23520845|NCT00605475|65647499|FG009|Overall Study|Lost to Follow-up|1|||
23520846|NCT00605475|65647490|FG000|Overall Study|Protocol Violation|0|||
23520847|NCT00605475|65647491|FG001|Overall Study|Protocol Violation|0|||
23520848|NCT00605475|65647492|FG002|Overall Study|Protocol Violation|0|||
23520849|NCT00605475|65647493|FG003|Overall Study|Protocol Violation|0|||
23520850|NCT00605475|65647494|FG004|Overall Study|Protocol Violation|1|||
23520851|NCT00605475|65647495|FG005|Overall Study|Protocol Violation|0|||
23520852|NCT00605475|65647496|FG006|Overall Study|Protocol Violation|0|||
23520853|NCT00605475|65647497|FG007|Overall Study|Protocol Violation|0|||
23520854|NCT00605475|65647498|FG008|Overall Study|Protocol Violation|0|||
23520855|NCT00605475|65647499|FG009|Overall Study|Protocol Violation|0|||
23520856|NCT00605475|65647490|FG000|Overall Study|Withdrawal by Subject|0|||
23520857|NCT00605475|65647491|FG001|Overall Study|Withdrawal by Subject|0|||
23520858|NCT00605475|65647492|FG002|Overall Study|Withdrawal by Subject|0|||
23520859|NCT00605475|65647493|FG003|Overall Study|Withdrawal by Subject|0|||
23520860|NCT00605475|65647494|FG004|Overall Study|Withdrawal by Subject|0|||
23520861|NCT00605475|65647495|FG005|Overall Study|Withdrawal by Subject|2|||
23520862|NCT00605475|65647496|FG006|Overall Study|Withdrawal by Subject|0|||
23520863|NCT00605475|65647497|FG007|Overall Study|Withdrawal by Subject|0|||
23520864|NCT00605475|65647498|FG008|Overall Study|Withdrawal by Subject|0|||
23520865|NCT00605475|65647499|FG009|Overall Study|Withdrawal by Subject|1|||
23520866|NCT00371254|65647501|FG000|Overall Study|Disease progression|13|||
23520867|NCT00371254|65647502|FG001|Overall Study|Disease progression|13|||
23520868|NCT00371254|65647501|FG000|Overall Study|Study drug toxicity|3|||
23520869|NCT00371254|65647502|FG001|Overall Study|Study drug toxicity|5|||
23520870|NCT00371254|65647501|FG000|Overall Study|Subject request|5|||
23520871|NCT00371254|65647502|FG001|Overall Study|Subject request|0|||
23520872|NCT00371254|65647501|FG000|Overall Study|Investigator Decision|2|||
23520873|NCT00371254|65647502|FG001|Overall Study|Investigator Decision|0|||
23520874|NCT00371254|65647501|FG000|Overall Study|Adverse event unrelated to study drug|0|||
23520875|NCT00371254|65647502|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23307700|NCT01083810|64870565|FG001|Overall Study|Co-morbidities|0|||
23520876|NCT00371254|65647501|FG000|Overall Study|Lost to Follow-up|0|||
23520877|NCT00371254|65647502|FG001|Overall Study|Lost to Follow-up|1|||
23520878|NCT00371254|65647501|FG000|Overall Study|Withdrawal by Subject|0|||
23520879|NCT00371254|65647502|FG001|Overall Study|Withdrawal by Subject|1|||
23520880|NCT01894152|65647503|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
23520881|NCT02442778|65647504|FG000|Overall Study|Adverse Event|2|||
23520882|NCT02442778|65647505|FG001|Overall Study|Adverse Event|6|||
23520883|NCT02442778|65647506|FG002|Overall Study|Adverse Event|6|||
23520884|NCT02442778|65647504|FG000|Overall Study|Death|0|||
23520885|NCT02442778|65647505|FG001|Overall Study|Death|2|||
23520886|NCT02442778|65647506|FG002|Overall Study|Death|0|||
23520887|NCT02442778|65647504|FG000|Overall Study|Lack of Efficacy|1|||
23520888|NCT02442778|65647505|FG001|Overall Study|Lack of Efficacy|0|||
23520889|NCT02442778|65647506|FG002|Overall Study|Lack of Efficacy|0|||
23520890|NCT02442778|65647504|FG000|Overall Study|Lost to Follow-up|1|||
23520891|NCT02442778|65647505|FG001|Overall Study|Lost to Follow-up|1|||
23520892|NCT02442778|65647506|FG002|Overall Study|Lost to Follow-up|1|||
23520893|NCT02442778|65647504|FG000|Overall Study|Non-compliance with study drug|2|||
23520894|NCT02442778|65647505|FG001|Overall Study|Non-compliance with study drug|0|||
23520895|NCT02442778|65647506|FG002|Overall Study|Non-compliance with study drug|1|||
23520896|NCT02442778|65647504|FG000|Overall Study|Physician Decision|1|||
23520897|NCT02442778|65647505|FG001|Overall Study|Physician Decision|1|||
23520898|NCT02442778|65647506|FG002|Overall Study|Physician Decision|1|||
23520899|NCT02442778|65647504|FG000|Overall Study|Protocol Deviation|3|||
23520900|NCT02442778|65647505|FG001|Overall Study|Protocol Deviation|0|||
23520901|NCT02442778|65647506|FG002|Overall Study|Protocol Deviation|1|||
23520902|NCT02442778|65647504|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
23520903|NCT02442778|65647505|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
23520904|NCT02442778|65647506|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
23520905|NCT02442778|65647504|FG000|Overall Study|Withdrawal by Subject|4|||
23520906|NCT02442778|65647505|FG001|Overall Study|Withdrawal by Subject|4|||
23520907|NCT02442778|65647506|FG002|Overall Study|Withdrawal by Subject|3|||
23520908|NCT02442778|65647504|FG000|Overall Study|Reason not specified|1|||
23520909|NCT02442778|65647505|FG001|Overall Study|Reason not specified|4|||
23520910|NCT02442778|65647506|FG002|Overall Study|Reason not specified|0|||
23520911|NCT02120794|65647507|FG000|Overall Study|Withdrawal by Subject|43|||
23520912|NCT02120794|65647507|FG000|Overall Study|Adverse Event|10|||
23520913|NCT02120794|65647507|FG000|Overall Study|Physician Decision|4|||
23520914|NCT02120794|65647507|FG000|Overall Study|Due to insurance coverage|1|||
23520915|NCT02369341|65647516|FG000|Overall Study|Migrated/moved from study area|1|||
23520916|NCT02369341|65647517|FG001|Overall Study|Migrated/moved from study area|0|||
23520917|NCT04254978|65647518|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
23520918|NCT04254978|65647518|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
23520919|NCT04254978|65647518|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
23520920|NCT04254978|65647518|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
23520921|NCT04254978|65647518|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
23520922|NCT04254978|65647518|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
23520923|NCT03274986|65647523|FG000|Overall Study|Withdrawal by Subject|0|||
23520924|NCT03274986|65647524|FG001|Overall Study|Withdrawal by Subject|1|||
23520925|NCT03274986|65647523|FG000|Overall Study|Lost to Follow-up|0|||
23520926|NCT03274986|65647524|FG001|Overall Study|Lost to Follow-up|1|||
23520927|NCT03526458|65647525|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
23520928|NCT03526458|65647526|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
23520929|NCT03526458|65647525|FG000|Overall Study|Stone passed, surgery cancelled|2|||
23520930|NCT03526458|65647526|FG001|Overall Study|Stone passed, surgery cancelled|1|||
23520931|NCT03526458|65647525|FG000|Overall Study|Withdrawal by Subject|1|||
23520932|NCT03526458|65647526|FG001|Overall Study|Withdrawal by Subject|0|||
23520933|NCT03526458|65647525|FG000|Overall Study|Physician Decision|2|||
23520934|NCT03526458|65647526|FG001|Overall Study|Physician Decision|1|||
23520935|NCT03526458|65647525|FG000|Overall Study|Lack of equipment|1|||
23520936|NCT03526458|65647526|FG001|Overall Study|Lack of equipment|1|||
23520937|NCT04898673|65647527|FG000|Overall Study|Screenfail|1|||
23520938|NCT04898673|65647528|FG001|Overall Study|Screenfail|0|||
23520939|NCT00733746|65647529|FG000|Overall Study|Ineligible|5|||
23520940|NCT01592344|65647532|FG000|Overall Study|Adverse Event|1|||
23520941|NCT01592344|65647533|FG001|Overall Study|Adverse Event|1|||
23520942|NCT01592344|65647532|FG000|Overall Study|Lack of Efficacy|1|||
23520943|NCT01592344|65647533|FG001|Overall Study|Lack of Efficacy|0|||
23520944|NCT01592344|65647532|FG000|Overall Study|not available at primary outcome visit|2|||
23520945|NCT01592344|65647533|FG001|Overall Study|not available at primary outcome visit|4|||
23520946|NCT05071183|65647538|FG000|Overall Study|Death|1|||
23520947|NCT05071183|65647539|FG001|Overall Study|Death|2|||
23520948|NCT05071183|65647540|FG002|Overall Study|Death|0|||
23520949|NCT05071183|65647538|FG000|Overall Study|Other Reasons|1|||
23520950|NCT05071183|65647539|FG001|Overall Study|Other Reasons|3|||
23520951|NCT05071183|65647540|FG002|Overall Study|Other Reasons|2|||
23520952|NCT01478321|65647543|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
23520953|NCT01478321|65647543|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
23520954|NCT01478321|65647543|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
23520955|NCT01478321|65647543|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
23520956|NCT01478321|65647543|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
23520957|NCT01478321|65647543|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
23520958|NCT01478321|65647543|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
23520959|NCT01478321|65647543|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
23520960|NCT04532099|65647544|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
23520961|NCT04532099|65647545|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
23520962|NCT04532099|65647546|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
23520963|NCT00885755|65647547|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
23520964|NCT00885755|65647548|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
23520965|NCT00885755|65647549|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
23520966|NCT00885755|65647547|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
23520967|NCT00885755|65647548|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
23520968|NCT00885755|65647549|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
23520969|NCT00885755|65647547|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
23520970|NCT00885755|65647548|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
23520971|NCT00885755|65647549|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
23520972|NCT00885755|65647547|FG000|Part I: Trastuzumab+Taxane|Death|0|||
23520973|NCT00885755|65647548|FG001|Part I: Trastuzumab+Taxane|Death|0|||
23520974|NCT00885755|65647549|FG002|Part I: Trastuzumab+Taxane|Death|1|||
23520975|NCT00885755|65647547|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
23520976|NCT00885755|65647548|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
23520977|NCT00885755|65647549|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
23520978|NCT01712256|65647552|FG000|Overall Study|Lost to Follow-up|1|||
23520979|NCT02968979|65647554|FG000|Overall Study|Protocol Violation|7|||
23520980|NCT02968979|65647554|FG000|Overall Study|Withdrawal by Subject|1|||
23520981|NCT01870583|65647557|FG000|Overall Study|Protocol Violation|0|||
23520982|NCT01870583|65647558|FG001|Overall Study|Protocol Violation|5|||
23520983|NCT01870583|65647559|FG002|Overall Study|Protocol Violation|3|||
23520984|NCT01870583|65647557|FG000|Overall Study|Lost to Follow-up|11|||
23520985|NCT01870583|65647558|FG001|Overall Study|Lost to Follow-up|13|||
23520986|NCT01870583|65647559|FG002|Overall Study|Lost to Follow-up|5|||
23520987|NCT01848756|65647564|FG000|Overall Study|Adverse Event|1|||
23520988|NCT01848756|65647564|FG000|Overall Study|Withdrawal by Subject|1|||
23520989|NCT01848756|65647564|FG000|Overall Study|Enrolled in Error|1|||
23520990|NCT00798369|65647565|FG000|Overall Study|Subject withdrew consent|0|||
23520991|NCT00798369|65647566|FG001|Overall Study|Subject withdrew consent|0|||
23520992|NCT00798369|65647567|FG002|Overall Study|Subject withdrew consent|1|||
23520993|NCT00798369|65647568|FG003|Overall Study|Subject withdrew consent|1|||
23520994|NCT00798369|65647569|FG004|Overall Study|Subject withdrew consent|0|||
23520995|NCT00798369|65647570|FG005|Overall Study|Subject withdrew consent|2|||
23520996|NCT00798369|65647565|FG000|Overall Study|Lost to Follow-up|1|||
23520997|NCT00798369|65647566|FG001|Overall Study|Lost to Follow-up|1|||
23520998|NCT00798369|65647567|FG002|Overall Study|Lost to Follow-up|1|||
23520999|NCT00798369|65647568|FG003|Overall Study|Lost to Follow-up|0|||
23521000|NCT00798369|65647569|FG004|Overall Study|Lost to Follow-up|1|||
23521001|NCT00798369|65647570|FG005|Overall Study|Lost to Follow-up|0|||
23521002|NCT00798369|65647565|FG000|Overall Study|Adminstrative problems|0|||
23521003|NCT00798369|65647566|FG001|Overall Study|Adminstrative problems|0|||
23521004|NCT00798369|65647567|FG002|Overall Study|Adminstrative problems|0|||
23521005|NCT00798369|65647568|FG003|Overall Study|Adminstrative problems|0|||
23521006|NCT00798369|65647569|FG004|Overall Study|Adminstrative problems|0|||
23521007|NCT00798369|65647570|FG005|Overall Study|Adminstrative problems|1|||
23521008|NCT01251380|65647571|FG000|Overall Study|Other (Not otherwise specified)|12|||
23521009|NCT01251380|65647571|FG000|Overall Study|Withdrawal by Subject|6|||
23521010|NCT01251380|65647571|FG000|Overall Study|Lack of Efficacy|1|||
23521011|NCT01251380|65647571|FG000|Overall Study|Adverse Event|1|||
23521012|NCT01251380|65647571|FG000|Overall Study|Lost to Follow-up|2|||
23521013|NCT02063737|65647572|FG000|Overall Study|Lost to Follow-up|11|||
23521014|NCT02063737|65647573|FG001|Overall Study|Lost to Follow-up|4|||
23521015|NCT00451321|65647575|FG000|Overall Study|Lost to Follow-up|3|||
23521016|NCT00451321|65647576|FG001|Overall Study|Lost to Follow-up|3|||
23521017|NCT00451321|65647577|FG002|Overall Study|Lost to Follow-up|1|||
23521018|NCT00451321|65647578|FG003|Overall Study|Lost to Follow-up|3|||
23521019|NCT00451321|65647579|FG004|Overall Study|Lost to Follow-up|0|||
23521020|NCT00451321|65647580|FG005|Overall Study|Lost to Follow-up|1|||
23521021|NCT00451321|65647581|FG006|Overall Study|Lost to Follow-up|0|||
23521022|NCT00451321|65647582|FG007|Overall Study|Lost to Follow-up|0|||
23521023|NCT00451321|65647575|FG000|Overall Study|Withdrawal by Subject|3|||
23521024|NCT00451321|65647576|FG001|Overall Study|Withdrawal by Subject|1|||
23521025|NCT00451321|65647577|FG002|Overall Study|Withdrawal by Subject|0|||
23521026|NCT00451321|65647578|FG003|Overall Study|Withdrawal by Subject|4|||
23521027|NCT00451321|65647579|FG004|Overall Study|Withdrawal by Subject|0|||
23521028|NCT00451321|65647580|FG005|Overall Study|Withdrawal by Subject|0|||
23521029|NCT00451321|65647581|FG006|Overall Study|Withdrawal by Subject|0|||
23521030|NCT00451321|65647582|FG007|Overall Study|Withdrawal by Subject|0|||
23521031|NCT00451321|65647575|FG000|Overall Study|Study closed/terminated|1|||
23521032|NCT00451321|65647576|FG001|Overall Study|Study closed/terminated|1|||
23521033|NCT00451321|65647577|FG002|Overall Study|Study closed/terminated|17|||
23521034|NCT00451321|65647578|FG003|Overall Study|Study closed/terminated|5|||
23521035|NCT00451321|65647579|FG004|Overall Study|Study closed/terminated|7|||
23521036|NCT00451321|65647580|FG005|Overall Study|Study closed/terminated|7|||
23521037|NCT00451321|65647581|FG006|Overall Study|Study closed/terminated|5|||
23521038|NCT00451321|65647582|FG007|Overall Study|Study closed/terminated|3|||
23521039|NCT00451321|65647575|FG000|Overall Study|Sponsor decision to amend protocol|0|||
23521040|NCT00451321|65647576|FG001|Overall Study|Sponsor decision to amend protocol|0|||
23521041|NCT00451321|65647577|FG002|Overall Study|Sponsor decision to amend protocol|0|||
23521042|NCT00451321|65647578|FG003|Overall Study|Sponsor decision to amend protocol|0|||
23521043|NCT00451321|65647579|FG004|Overall Study|Sponsor decision to amend protocol|0|||
23521044|NCT00451321|65647580|FG005|Overall Study|Sponsor decision to amend protocol|1|||
23521045|NCT00451321|65647581|FG006|Overall Study|Sponsor decision to amend protocol|1|||
23521046|NCT00451321|65647582|FG007|Overall Study|Sponsor decision to amend protocol|3|||
23521047|NCT03412084|65647585|FG000|Overall Study|Withdrawal by Subject|2|||
23521048|NCT03412084|65647586|FG001|Overall Study|Withdrawal by Subject|0|||
23521049|NCT03412084|65647585|FG000|Overall Study|Participant moved|1|||
23521050|NCT03412084|65647586|FG001|Overall Study|Participant moved|0|||
23521051|NCT03412084|65647585|FG000|Overall Study|Lost to Follow-up|1|||
23521052|NCT03412084|65647586|FG001|Overall Study|Lost to Follow-up|1|||
23521053|NCT00778700|65647587|FG000|Overall Study|Adverse Event|6|||
23521054|NCT00778700|65647588|FG001|Overall Study|Adverse Event|1|||
23521055|NCT00778700|65647589|FG002|Overall Study|Adverse Event|3|||
23521056|NCT00778700|65647590|FG003|Overall Study|Adverse Event|5|||
23521057|NCT00778700|65647587|FG000|Overall Study|Protocol Violation|1|||
23521058|NCT00778700|65647588|FG001|Overall Study|Protocol Violation|1|||
23521059|NCT00778700|65647589|FG002|Overall Study|Protocol Violation|0|||
23521060|NCT00778700|65647590|FG003|Overall Study|Protocol Violation|0|||
23521061|NCT00778700|65647587|FG000|Overall Study|Subject Withdrew Consent|6|||
23521062|NCT00778700|65647588|FG001|Overall Study|Subject Withdrew Consent|4|||
23521063|NCT00778700|65647589|FG002|Overall Study|Subject Withdrew Consent|1|||
23521064|NCT00778700|65647590|FG003|Overall Study|Subject Withdrew Consent|4|||
23521065|NCT00778700|65647587|FG000|Overall Study|Lost to Follow-up|3|||
23521066|NCT00778700|65647588|FG001|Overall Study|Lost to Follow-up|1|||
23521067|NCT00778700|65647589|FG002|Overall Study|Lost to Follow-up|0|||
23521068|NCT00778700|65647590|FG003|Overall Study|Lost to Follow-up|1|||
23521069|NCT00778700|65647587|FG000|Overall Study|Reason not Specified|2|||
23521070|NCT00778700|65647588|FG001|Overall Study|Reason not Specified|0|||
23521071|NCT00778700|65647589|FG002|Overall Study|Reason not Specified|1|||
23521072|NCT00778700|65647590|FG003|Overall Study|Reason not Specified|3|||
23521073|NCT00778700|65647587|FG000|Overall Study|Other|0|||
23521074|NCT00778700|65647588|FG001|Overall Study|Other|0|||
23521075|NCT00778700|65647589|FG002|Overall Study|Other|1|||
23521076|NCT00778700|65647590|FG003|Overall Study|Other|0|||
23521077|NCT01452412|65647591|FG000|Overall Study|Withdrawal by Subject|15|||
23521078|NCT01452412|65647592|FG001|Overall Study|Withdrawal by Subject|11|||
23521079|NCT01452412|65647591|FG000|Overall Study|Adverse Event|4|||
23521080|NCT01452412|65647592|FG001|Overall Study|Adverse Event|3|||
23521081|NCT01452412|65647591|FG000|Overall Study|Lost to Follow-up|5|||
23521082|NCT01452412|65647592|FG001|Overall Study|Lost to Follow-up|3|||
23521083|NCT01452412|65647591|FG000|Overall Study|Death|1|||
23521084|NCT01452412|65647592|FG001|Overall Study|Death|0|||
23521085|NCT01452412|65647591|FG000|Overall Study|Initiated dialysis|1|||
23521086|NCT01452412|65647592|FG001|Overall Study|Initiated dialysis|0|||
23521087|NCT01452412|65647591|FG000|Overall Study|Other|2|||
23521088|NCT01452412|65647592|FG001|Overall Study|Other|0|||
23521089|NCT02466555|65647598|FG000|Overall Study|Lost to Follow-up|2|||
23521090|NCT01822132|65647614|FG000|Overall Study|Lost to Follow-up|4|||
23521091|NCT01822132|65647615|FG001|Overall Study|Lost to Follow-up|2|||
23521092|NCT02579265|65647616|FG000|Overall Study|Weaned off earlier than 28 days|44|||
23521093|NCT02579265|65647617|FG001|Overall Study|Weaned off earlier than 28 days|43|||
23521094|NCT02579265|65647616|FG000|Overall Study|Adverse Event|2|||
23521095|NCT02579265|65647617|FG001|Overall Study|Adverse Event|0|||
23521096|NCT02579265|65647616|FG000|Overall Study|Any other reason not specified|0|||
23521097|NCT02579265|65647617|FG001|Overall Study|Any other reason not specified|2|||
23521098|NCT02579265|65647616|FG000|Overall Study|Withdrawal by Subject|2|||
23521099|NCT02579265|65647617|FG001|Overall Study|Withdrawal by Subject|0|||
23521100|NCT02579265|65647616|FG000|Overall Study|Physician Decision|1|||
23521101|NCT02579265|65647617|FG001|Overall Study|Physician Decision|0|||
23521102|NCT02579265|65647616|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
23521103|NCT02579265|65647617|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
23521104|NCT00218296|65647618|FG000|Overall Study|Lost to Follow-up|9|||
23521105|NCT00218296|65647619|FG001|Overall Study|Lost to Follow-up|7|||
23521106|NCT00218296|65647618|FG000|Overall Study|Withdrawal by Subject|36|||
23521107|NCT00218296|65647619|FG001|Overall Study|Withdrawal by Subject|47|||
23521108|NCT00218296|65647618|FG000|Overall Study|Randomized but did not enter treatment|66|||
23521109|NCT00218296|65647619|FG001|Overall Study|Randomized but did not enter treatment|67|||
23521110|NCT00729183|65647621|FG000|Overall Study|Adverse Event|11|||
23521111|NCT00729183|65647622|FG001|Overall Study|Adverse Event|5|||
23521112|NCT00729183|65647621|FG000|Overall Study|Lack of Efficacy|0|||
23521113|NCT00729183|65647622|FG001|Overall Study|Lack of Efficacy|1|||
23521114|NCT00729183|65647621|FG000|Overall Study|Lost to Follow-up|3|||
23521115|NCT00729183|65647622|FG001|Overall Study|Lost to Follow-up|1|||
23521116|NCT00729183|65647621|FG000|Overall Study|Physician Decision|1|||
23521117|NCT00729183|65647622|FG001|Overall Study|Physician Decision|1|||
23521118|NCT00729183|65647621|FG000|Overall Study|Protocol Violation|1|||
23521119|NCT00729183|65647622|FG001|Overall Study|Protocol Violation|0|||
23521120|NCT00729183|65647621|FG000|Overall Study|Withdrawal by Subject|9|||
23521121|NCT00729183|65647622|FG001|Overall Study|Withdrawal by Subject|7|||
23521122|NCT01921179|65647625|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
23521123|NCT01921179|65647626|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
23521124|NCT01921179|65647625|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
23521125|NCT01921179|65647626|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
23521126|NCT02642432|65647627|FG000|Overall Study|Adverse Event|2|||
23521127|NCT02642432|65647627|FG000|Overall Study|Withdrew Consent|1|||
23521128|NCT02642432|65647627|FG000|Overall Study|Lost to Follow-up|2|||
23521129|NCT02642432|65647627|FG000|Overall Study|Other|3|||
23521130|NCT02347189|65647628|FG000|Overall Study|No implant attempted of study device|9|||
23521131|NCT02347189|65647628|FG000|Overall Study|No primary outcome data available|2|||
23521132|NCT01165138|65647629|FG000|Overall Study|Adverse Event|0|||
23521133|NCT01165138|65647630|FG001|Overall Study|Adverse Event|1|||
23521134|NCT01165138|65647631|FG002|Overall Study|Adverse Event|0|||
23521135|NCT01165138|65647632|FG003|Overall Study|Adverse Event|2|||
23521136|NCT01165138|65647629|FG000|Overall Study|Lack of Efficacy|0|||
23521137|NCT01165138|65647630|FG001|Overall Study|Lack of Efficacy|32|||
23521138|NCT01165138|65647631|FG002|Overall Study|Lack of Efficacy|6|||
23521139|NCT01165138|65647632|FG003|Overall Study|Lack of Efficacy|7|||
23521140|NCT01165138|65647629|FG000|Overall Study|Protocol Violation|0|||
23521141|NCT01165138|65647630|FG001|Overall Study|Protocol Violation|7|||
23521142|NCT01165138|65647631|FG002|Overall Study|Protocol Violation|0|||
23521143|NCT01165138|65647632|FG003|Overall Study|Protocol Violation|2|||
23521144|NCT01165138|65647629|FG000|Overall Study|Lost to Follow-up|0|||
23521145|NCT01165138|65647630|FG001|Overall Study|Lost to Follow-up|0|||
23521146|NCT01165138|65647631|FG002|Overall Study|Lost to Follow-up|1|||
23521147|NCT01165138|65647632|FG003|Overall Study|Lost to Follow-up|2|||
23521148|NCT01165138|65647629|FG000|Overall Study|Physician Decision|0|||
23521149|NCT01165138|65647630|FG001|Overall Study|Physician Decision|6|||
23521150|NCT01165138|65647631|FG002|Overall Study|Physician Decision|7|||
23521151|NCT01165138|65647632|FG003|Overall Study|Physician Decision|6|||
23521152|NCT01165138|65647629|FG000|Overall Study|Withdrawal by Subject|0|||
23521153|NCT01165138|65647630|FG001|Overall Study|Withdrawal by Subject|6|||
23521154|NCT01165138|65647631|FG002|Overall Study|Withdrawal by Subject|6|||
23521155|NCT01165138|65647632|FG003|Overall Study|Withdrawal by Subject|3|||
23521156|NCT03745144|65647639|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
23521157|NCT03745144|65647640|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
23521158|NCT03745144|65647641|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
23521159|NCT03745144|65647639|FG000|Period 1|Other|0|||
23521160|NCT03745144|65647640|FG001|Period 1|Other|0|||
23521161|NCT03745144|65647641|FG002|Period 1|Other|1|||
23521162|NCT01365273|65647649|FG000|Overall Study|Lost to Follow-up|1|||
23521163|NCT01365273|65647650|FG001|Overall Study|Lost to Follow-up|0|||
23521164|NCT01365273|65647649|FG000|Overall Study|Protocol Violation|0|||
23521165|NCT01365273|65647650|FG001|Overall Study|Protocol Violation|1|||
23521166|NCT01365273|65647649|FG000|Overall Study|Physician Decision|1|||
23521167|NCT01365273|65647650|FG001|Overall Study|Physician Decision|0|||
23521168|NCT00464568|65647657|FG000|Overall Study|Adverse Event|2|||
23521169|NCT03329690|65647659|FG000|Overall Study|Progressive disease per RECIST|85|||
23521170|NCT03329690|65647660|FG001|Overall Study|Progressive disease per RECIST|44|||
23521171|NCT03329690|65647661|FG002|Overall Study|Progressive disease per RECIST|6|||
23521172|NCT03329690|65647662|FG003|Overall Study|Progressive disease per RECIST|16|||
23521173|NCT03329690|65647663|FG004|Overall Study|Progressive disease per RECIST|20|||
23521174|NCT03329690|65647659|FG000|Overall Study|Clinical progression|7|||
23521175|NCT03329690|65647660|FG001|Overall Study|Clinical progression|4|||
23521176|NCT03329690|65647661|FG002|Overall Study|Clinical progression|1|||
23521177|NCT03329690|65647662|FG003|Overall Study|Clinical progression|1|||
23521178|NCT03329690|65647663|FG004|Overall Study|Clinical progression|1|||
23521179|NCT03329690|65647659|FG000|Overall Study|Adverse Event|22|||
23521180|NCT03329690|65647660|FG001|Overall Study|Adverse Event|4|||
23521181|NCT03329690|65647661|FG002|Overall Study|Adverse Event|0|||
23521182|NCT03329690|65647662|FG003|Overall Study|Adverse Event|1|||
23521183|NCT03329690|65647663|FG004|Overall Study|Adverse Event|2|||
23521184|NCT03329690|65647659|FG000|Overall Study|Death|2|||
23521185|NCT03329690|65647660|FG001|Overall Study|Death|0|||
23521186|NCT03329690|65647661|FG002|Overall Study|Death|0|||
23521187|NCT03329690|65647662|FG003|Overall Study|Death|1|||
23521188|NCT03329690|65647663|FG004|Overall Study|Death|0|||
23521189|NCT03329690|65647659|FG000|Overall Study|Withdrawal by Subject|2|||
23521190|NCT03329690|65647660|FG001|Overall Study|Withdrawal by Subject|3|||
23521191|NCT03329690|65647661|FG002|Overall Study|Withdrawal by Subject|0|||
23521192|NCT03329690|65647662|FG003|Overall Study|Withdrawal by Subject|1|||
23521193|NCT03329690|65647663|FG004|Overall Study|Withdrawal by Subject|0|||
23521194|NCT03329690|65647659|FG000|Overall Study|Physician Decision|1|||
23521195|NCT03329690|65647660|FG001|Overall Study|Physician Decision|0|||
23521196|NCT03329690|65647661|FG002|Overall Study|Physician Decision|0|||
23521197|NCT03329690|65647662|FG003|Overall Study|Physician Decision|0|||
23521198|NCT03329690|65647663|FG004|Overall Study|Physician Decision|1|||
23521199|NCT03329690|65647659|FG000|Overall Study|Miscellaneous|6|||
23521200|NCT03329690|65647660|FG001|Overall Study|Miscellaneous|0|||
23521201|NCT03329690|65647661|FG002|Overall Study|Miscellaneous|0|||
23521202|NCT03329690|65647662|FG003|Overall Study|Miscellaneous|0|||
23521203|NCT03329690|65647663|FG004|Overall Study|Miscellaneous|0|||
23521204|NCT03329690|65647659|FG000|Overall Study|Did not receive treatment|1|||
23521205|NCT03329690|65647660|FG001|Overall Study|Did not receive treatment|0|||
23521206|NCT03329690|65647661|FG002|Overall Study|Did not receive treatment|0|||
23521207|NCT03329690|65647662|FG003|Overall Study|Did not receive treatment|1|||
23521208|NCT03329690|65647663|FG004|Overall Study|Did not receive treatment|0|||
23521209|NCT02246673|65647664|FG000|Overall Study|Sponsor Decision|1|||
23521210|NCT02246673|65647665|FG001|Overall Study|Sponsor Decision|0|||
23521211|NCT02246673|65647666|FG002|Overall Study|Sponsor Decision|0|||
23521212|NCT02246673|65647667|FG003|Overall Study|Sponsor Decision|0|||
23521213|NCT02246673|65647668|FG004|Overall Study|Sponsor Decision|0|||
23521214|NCT02246673|65647664|FG000|Overall Study|Withdrawal by Subject|0|||
23521215|NCT02246673|65647665|FG001|Overall Study|Withdrawal by Subject|0|||
23521216|NCT02246673|65647666|FG002|Overall Study|Withdrawal by Subject|0|||
23521217|NCT02246673|65647667|FG003|Overall Study|Withdrawal by Subject|0|||
23521218|NCT02246673|65647668|FG004|Overall Study|Withdrawal by Subject|1|||
23521219|NCT02246673|65647664|FG000|Overall Study|Lost to Follow-up|0|||
23521220|NCT02246673|65647665|FG001|Overall Study|Lost to Follow-up|0|||
23521221|NCT02246673|65647666|FG002|Overall Study|Lost to Follow-up|0|||
23521222|NCT02246673|65647667|FG003|Overall Study|Lost to Follow-up|1|||
23521223|NCT02246673|65647668|FG004|Overall Study|Lost to Follow-up|0|||
23521224|NCT02246673|65647664|FG000|Overall Study|Protocol Violation|0|||
23521225|NCT02246673|65647665|FG001|Overall Study|Protocol Violation|0|||
23521226|NCT02246673|65647666|FG002|Overall Study|Protocol Violation|0|||
23521227|NCT02246673|65647667|FG003|Overall Study|Protocol Violation|1|||
23521228|NCT02246673|65647668|FG004|Overall Study|Protocol Violation|0|||
23521229|NCT03034954|65647673|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
23521230|NCT03034954|65647674|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
23521231|NCT00477672|65647677|FG000|Overall Study|Adverse Event|3|||
23521232|NCT00477672|65647678|FG001|Overall Study|Adverse Event|5|||
23521233|NCT00477672|65647679|FG002|Overall Study|Adverse Event|6|||
23521234|NCT00477672|65647677|FG000|Overall Study|Death|0|||
23521235|NCT00477672|65647678|FG001|Overall Study|Death|1|||
23521236|NCT00477672|65647679|FG002|Overall Study|Death|0|||
23521237|NCT00477672|65647677|FG000|Overall Study|Disease progression|0|||
23521238|NCT00477672|65647678|FG001|Overall Study|Disease progression|1|||
23521239|NCT00477672|65647679|FG002|Overall Study|Disease progression|0|||
23521240|NCT00477672|65647677|FG000|Overall Study|Physician Decision|1|||
23521241|NCT00477672|65647678|FG001|Overall Study|Physician Decision|0|||
23521242|NCT00477672|65647679|FG002|Overall Study|Physician Decision|0|||
23521243|NCT00477672|65647677|FG000|Overall Study|Protocol noncompliance|0|||
23521244|NCT00477672|65647678|FG001|Overall Study|Protocol noncompliance|2|||
23521245|NCT00477672|65647679|FG002|Overall Study|Protocol noncompliance|0|||
23521246|NCT00477672|65647677|FG000|Overall Study|Consent withdrawn|2|||
23521247|NCT00477672|65647678|FG001|Overall Study|Consent withdrawn|5|||
23521248|NCT00477672|65647679|FG002|Overall Study|Consent withdrawn|10|||
23521249|NCT00477672|65647677|FG000|Overall Study|Discretion of Sponsor|1|||
23521250|NCT00477672|65647678|FG001|Overall Study|Discretion of Sponsor|2|||
23521251|NCT00477672|65647679|FG002|Overall Study|Discretion of Sponsor|0|||
23521252|NCT02073279|65647682|FG000|Double-blind Period|Adverse Event|1|||
23521253|NCT02073279|65647683|FG001|Double-blind Period|Adverse Event|1|||
23521254|NCT02073279|65647682|FG000|Double-blind Period|Switched to another treatment|1|||
23521255|NCT02073279|65647683|FG001|Double-blind Period|Switched to another treatment|2|||
23521256|NCT02073279|65647682|FG000|Double-blind Period|Protocol Violation|0|||
23521257|NCT02073279|65647683|FG001|Double-blind Period|Protocol Violation|1|||
23521258|NCT02073279|65647682|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
23521259|NCT02073279|65647683|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
23521260|NCT02073279|65647682|FG000|Double-blind Period|Withdrawal by Subject|2|||
23521261|NCT02073279|65647683|FG001|Double-blind Period|Withdrawal by Subject|2|||
23521262|NCT02073279|65647682|FG000|Open-label Extension Period|Adverse Event|1|||
23521263|NCT02073279|65647683|FG001|Open-label Extension Period|Adverse Event|0|||
23521264|NCT02073279|65647682|FG000|Open-label Extension Period|Lack of Efficacy|1|||
23521265|NCT02073279|65647683|FG001|Open-label Extension Period|Lack of Efficacy|0|||
23521266|NCT02073279|65647682|FG000|Open-label Extension Period|Lost to Follow-up|0|||
23521267|NCT02073279|65647683|FG001|Open-label Extension Period|Lost to Follow-up|4|||
23521268|NCT02073279|65647682|FG000|Open-label Extension Period|Switched to another treatment|1|||
23521269|NCT02073279|65647683|FG001|Open-label Extension Period|Switched to another treatment|4|||
23521270|NCT02073279|65647682|FG000|Open-label Extension Period|Protocol Violation|0|||
23521271|NCT02073279|65647683|FG001|Open-label Extension Period|Protocol Violation|1|||
23521272|NCT02073279|65647682|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
23521273|NCT02073279|65647683|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
23521274|NCT02073279|65647682|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
23521275|NCT02073279|65647683|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
23521276|NCT01498458|65647684|FG000|Overall Study|Adverse Event|4|||
23521277|NCT01498458|65647684|FG000|Overall Study|Physician Decision|3|||
23521278|NCT03560531|65647685|FG000|Overall Study|Death|4|||
23521279|NCT03560531|65647686|FG001|Overall Study|Death|1|||
23521280|NCT03560531|65647687|FG002|Overall Study|Death|1|||
23521281|NCT03560531|65647688|FG003|Overall Study|Death|2|||
23521282|NCT03560531|65647689|FG004|Overall Study|Death|6|||
23521283|NCT03560531|65647690|FG005|Overall Study|Death|1|||
23521284|NCT03560531|65647691|FG006|Overall Study|Death|4|||
23521285|NCT03560531|65647692|FG007|Overall Study|Death|8|||
23521286|NCT03560531|65647693|FG008|Overall Study|Death|1|||
23521287|NCT03560531|65647694|FG009|Overall Study|Death|3|||
23521288|NCT03560531|65647695|FG010|Overall Study|Death|2|||
23521289|NCT03560531|65647696|FG011|Overall Study|Death|0|||
23521290|NCT03560531|65647697|FG012|Overall Study|Death|4|||
23521291|NCT03560531|65647698|FG013|Overall Study|Death|1|||
23521292|NCT03560531|65647685|FG000|Overall Study|Lost to Follow-up|1|||
23521293|NCT03560531|65647686|FG001|Overall Study|Lost to Follow-up|1|||
23521294|NCT03560531|65647687|FG002|Overall Study|Lost to Follow-up|0|||
23521295|NCT03560531|65647688|FG003|Overall Study|Lost to Follow-up|0|||
23521296|NCT03560531|65647689|FG004|Overall Study|Lost to Follow-up|0|||
23521297|NCT03560531|65647690|FG005|Overall Study|Lost to Follow-up|0|||
23521298|NCT03560531|65647691|FG006|Overall Study|Lost to Follow-up|1|||
23521299|NCT03560531|65647692|FG007|Overall Study|Lost to Follow-up|0|||
23521300|NCT03560531|65647693|FG008|Overall Study|Lost to Follow-up|0|||
23521301|NCT03560531|65647694|FG009|Overall Study|Lost to Follow-up|0|||
23521302|NCT03560531|65647695|FG010|Overall Study|Lost to Follow-up|0|||
23521303|NCT03560531|65647696|FG011|Overall Study|Lost to Follow-up|0|||
23521304|NCT03560531|65647697|FG012|Overall Study|Lost to Follow-up|0|||
23521305|NCT03560531|65647698|FG013|Overall Study|Lost to Follow-up|0|||
23521306|NCT03560531|65647685|FG000|Overall Study|Withdrawal by Subject|1|||
23521307|NCT03560531|65647686|FG001|Overall Study|Withdrawal by Subject|0|||
23521308|NCT03560531|65647687|FG002|Overall Study|Withdrawal by Subject|0|||
23521309|NCT03560531|65647688|FG003|Overall Study|Withdrawal by Subject|0|||
23521310|NCT03560531|65647689|FG004|Overall Study|Withdrawal by Subject|0|||
23521311|NCT03560531|65647690|FG005|Overall Study|Withdrawal by Subject|0|||
23521312|NCT03560531|65647691|FG006|Overall Study|Withdrawal by Subject|0|||
23521313|NCT03560531|65647692|FG007|Overall Study|Withdrawal by Subject|3|||
23521314|NCT03560531|65647693|FG008|Overall Study|Withdrawal by Subject|2|||
23521315|NCT03560531|65647694|FG009|Overall Study|Withdrawal by Subject|0|||
23521316|NCT03560531|65647695|FG010|Overall Study|Withdrawal by Subject|0|||
23521317|NCT03560531|65647696|FG011|Overall Study|Withdrawal by Subject|0|||
23521318|NCT03560531|65647697|FG012|Overall Study|Withdrawal by Subject|2|||
23521319|NCT03560531|65647698|FG013|Overall Study|Withdrawal by Subject|0|||
23521320|NCT03560531|65647685|FG000|Overall Study|Study end per-protocol|1|||
23521321|NCT03560531|65647686|FG001|Overall Study|Study end per-protocol|1|||
23521322|NCT03560531|65647687|FG002|Overall Study|Study end per-protocol|2|||
23521323|NCT03560531|65647688|FG003|Overall Study|Study end per-protocol|0|||
23521324|NCT03560531|65647689|FG004|Overall Study|Study end per-protocol|1|||
23521325|NCT03560531|65647690|FG005|Overall Study|Study end per-protocol|0|||
23521326|NCT03560531|65647691|FG006|Overall Study|Study end per-protocol|0|||
23521327|NCT03560531|65647692|FG007|Overall Study|Study end per-protocol|0|||
23521328|NCT03560531|65647693|FG008|Overall Study|Study end per-protocol|0|||
23521329|NCT03560531|65647694|FG009|Overall Study|Study end per-protocol|0|||
23521330|NCT03560531|65647695|FG010|Overall Study|Study end per-protocol|0|||
23521331|NCT03560531|65647696|FG011|Overall Study|Study end per-protocol|0|||
23521332|NCT03560531|65647697|FG012|Overall Study|Study end per-protocol|0|||
23521333|NCT03560531|65647698|FG013|Overall Study|Study end per-protocol|0|||
23521334|NCT03560531|65647685|FG000|Overall Study|Early study termination by sponsor|9|||
23521335|NCT03560531|65647686|FG001|Overall Study|Early study termination by sponsor|0|||
23521336|NCT03560531|65647687|FG002|Overall Study|Early study termination by sponsor|0|||
23521337|NCT03560531|65647688|FG003|Overall Study|Early study termination by sponsor|4|||
23521338|NCT03560531|65647689|FG004|Overall Study|Early study termination by sponsor|8|||
23521339|NCT03560531|65647690|FG005|Overall Study|Early study termination by sponsor|2|||
23521340|NCT03560531|65647691|FG006|Overall Study|Early study termination by sponsor|5|||
23521341|NCT03560531|65647692|FG007|Overall Study|Early study termination by sponsor|64|||
23521342|NCT03560531|65647693|FG008|Overall Study|Early study termination by sponsor|7|||
23307701|NCT01083810|64870566|FG002|Overall Study|Co-morbidities|0|||
23307702|NCT01083810|64870564|FG000|Overall Study|Participation in study|1|||
23521343|NCT03560531|65647694|FG009|Overall Study|Early study termination by sponsor|2|||
23521344|NCT03560531|65647695|FG010|Overall Study|Early study termination by sponsor|16|||
23521345|NCT03560531|65647696|FG011|Overall Study|Early study termination by sponsor|2|||
23521346|NCT03560531|65647697|FG012|Overall Study|Early study termination by sponsor|6|||
23307703|NCT01083810|64870565|FG001|Overall Study|Participation in study|0|||
23307704|NCT01083810|64870566|FG002|Overall Study|Participation in study|0|||
23307705|NCT01083810|64870564|FG000|Overall Study|Therapy break|1|||
23307706|NCT01083810|64870565|FG001|Overall Study|Therapy break|2|||
23307707|NCT01083810|64870566|FG002|Overall Study|Therapy break|2|||
23521347|NCT03560531|65647698|FG013|Overall Study|Early study termination by sponsor|2|||
23521348|NCT01816893|65647699|FG000|Washout Period|Withdrawal by Subject|2|||
23521349|NCT01816893|65647700|FG001|Washout Period|Withdrawal by Subject|0|||
23307708|NCT01083810|64870564|FG000|Overall Study|Virologic failure|1|||
23307709|NCT01083810|64870565|FG001|Overall Study|Virologic failure|8|||
23307710|NCT01083810|64870566|FG002|Overall Study|Virologic failure|0|||
23307711|NCT04492020|64870568|FG000|Overall Study|Adverse Event|1|||
23307712|NCT04492020|64870569|FG001|Overall Study|Adverse Event|3|||
23307713|NCT04492020|64870568|FG000|Overall Study|Withdrawal by Subject|4|||
23307714|NCT04492020|64870569|FG001|Overall Study|Withdrawal by Subject|3|||
23307715|NCT04492020|64870568|FG000|Overall Study|Lost to Follow-up|4|||
23307716|NCT04492020|64870569|FG001|Overall Study|Lost to Follow-up|3|||
23307717|NCT04492020|64870568|FG000|Overall Study|Protocol Violation|5|||
23307718|NCT04492020|64870569|FG001|Overall Study|Protocol Violation|2|||
23307719|NCT04492020|64870568|FG000|Overall Study|Lack of Qualifying Event|25|||
23307720|NCT04492020|64870569|FG001|Overall Study|Lack of Qualifying Event|27|||
23307721|NCT04492020|64870568|FG000|Overall Study|Non-compliance with Study Drug|2|||
23521350|NCT00453999|65647701|FG000|Overall Study|Adverse Event|1|||
23521351|NCT00453999|65647702|FG001|Overall Study|Adverse Event|2|||
23521352|NCT00453999|65647703|FG002|Overall Study|Adverse Event|1|||
23521353|NCT00453999|65647701|FG000|Overall Study|Lost to Follow-up|0|||
23521354|NCT00453999|65647702|FG001|Overall Study|Lost to Follow-up|1|||
23521355|NCT00453999|65647703|FG002|Overall Study|Lost to Follow-up|1|||
23521356|NCT00453999|65647701|FG000|Overall Study|Withdrawal by Subject|2|||
23521357|NCT00453999|65647702|FG001|Overall Study|Withdrawal by Subject|1|||
23521358|NCT00453999|65647703|FG002|Overall Study|Withdrawal by Subject|1|||
23521359|NCT00453999|65647701|FG000|Overall Study|Subject Request|2|||
23521360|NCT00453999|65647702|FG001|Overall Study|Subject Request|1|||
23521361|NCT00453999|65647703|FG002|Overall Study|Subject Request|0|||
23521362|NCT03020823|65647704|FG000|Overall Study|Physician Decision|4|||
23521363|NCT03020823|65647704|FG000|Overall Study|Lack of Efficacy|4|||
23521364|NCT03020823|65647704|FG000|Overall Study|Adverse Event|2|||
23521365|NCT01293240|65647707|FG000|Overall Study|Noncompliance|2|||
23521366|NCT00746941|65647712|FG000|Overall Study|Death|2|||
23521367|NCT00746941|65647713|FG001|Overall Study|Death|0|||
23521368|NCT00746941|65647714|FG002|Overall Study|Death|0|||
23521369|NCT00746941|65647715|FG003|Overall Study|Death|6|||
23521370|NCT00746941|65647712|FG000|Overall Study|Physician Decision|0|||
23521371|NCT00746941|65647713|FG001|Overall Study|Physician Decision|0|||
23521372|NCT00746941|65647714|FG002|Overall Study|Physician Decision|2|||
23521373|NCT00746941|65647715|FG003|Overall Study|Physician Decision|0|||
23521374|NCT00746941|65647712|FG000|Overall Study|Withdrawal by Subject|3|||
23521375|NCT00746941|65647713|FG001|Overall Study|Withdrawal by Subject|0|||
23307722|NCT04492020|64870569|FG001|Overall Study|Non-compliance with Study Drug|1|||
23307723|NCT01288053|64870570|FG000|Overall Study|Death|1|||
23307724|NCT02119286|64870573|FG000|Overall Study|Adverse Event|9|||
23307725|NCT02119286|64870574|FG001|Overall Study|Adverse Event|7|||
23307726|NCT02119286|64870575|FG002|Overall Study|Adverse Event|2|||
23307727|NCT02119286|64870573|FG000|Overall Study|Lack of Efficacy|11|||
23307728|NCT02119286|64870574|FG001|Overall Study|Lack of Efficacy|3|||
23307729|NCT02119286|64870575|FG002|Overall Study|Lack of Efficacy|4|||
23205301|NCT02065622|64491318|FG000|Maintenance Study|Adverse Event|0|||
23307730|NCT02119286|64870573|FG000|Overall Study|Lost to Follow-up|2|||
23521376|NCT00746941|65647714|FG002|Overall Study|Withdrawal by Subject|0|||
23521377|NCT00746941|65647715|FG003|Overall Study|Withdrawal by Subject|2|||
23521378|NCT00746941|65647712|FG000|Overall Study|Other, reason not provided|2|||
23521379|NCT00746941|65647713|FG001|Overall Study|Other, reason not provided|4|||
23521380|NCT00746941|65647714|FG002|Overall Study|Other, reason not provided|0|||
23521381|NCT00746941|65647715|FG003|Overall Study|Other, reason not provided|4|||
23521382|NCT00746941|65647712|FG000|Overall Study|Adverse Event|0|||
23521383|NCT00746941|65647713|FG001|Overall Study|Adverse Event|0|||
23521384|NCT00746941|65647714|FG002|Overall Study|Adverse Event|0|||
23521385|NCT00746941|65647715|FG003|Overall Study|Adverse Event|1|||
23521386|NCT04782856|65647716|FG000|Overall Study|Withdrawal by Subject|0|||
23521387|NCT04782856|65647717|FG001|Overall Study|Withdrawal by Subject|1|||
23307731|NCT02119286|64870574|FG001|Overall Study|Lost to Follow-up|0|||
23521388|NCT01359254|65647718|FG000|Overall Study|Death|1|||
23307732|NCT02119286|64870575|FG002|Overall Study|Lost to Follow-up|1|||
23307733|NCT02119286|64870573|FG000|Overall Study|Withdrawal by Subject|4|||
23307734|NCT02119286|64870574|FG001|Overall Study|Withdrawal by Subject|1|||
23307735|NCT02119286|64870575|FG002|Overall Study|Withdrawal by Subject|0|||
23307736|NCT02352779|64870576|FG000|Overall Study|Personal Issues|1|||
23307737|NCT02352779|64870577|FG001|Overall Study|Personal Issues|1|||
23307738|NCT02352779|64870578|FG002|Overall Study|Personal Issues|0|||
23307739|NCT02352779|64870576|FG000|Overall Study|Too Many Forms|2|||
23307740|NCT02352779|64870577|FG001|Overall Study|Too Many Forms|0|||
23307741|NCT02352779|64870578|FG002|Overall Study|Too Many Forms|0|||
23307742|NCT02352779|64870576|FG000|Overall Study|Feeling Overwhelmed|1|||
23307743|NCT02352779|64870577|FG001|Overall Study|Feeling Overwhelmed|0|||
23307744|NCT02352779|64870578|FG002|Overall Study|Feeling Overwhelmed|0|||
23307745|NCT02352779|64870576|FG000|Overall Study|Disliked Intervention|1|||
23307746|NCT02352779|64870577|FG001|Overall Study|Disliked Intervention|0|||
23307747|NCT02352779|64870578|FG002|Overall Study|Disliked Intervention|0|||
23307748|NCT02352779|64870576|FG000|Overall Study|Changed Mind|1|||
23307749|NCT02352779|64870577|FG001|Overall Study|Changed Mind|0|||
23521389|NCT01359254|65647719|FG001|Overall Study|Death|0|||
23521390|NCT03760146|65647722|FG000|Overall Study|Adverse Event|11|||
23521391|NCT03760146|65647723|FG001|Overall Study|Adverse Event|8|||
23307750|NCT02352779|64870578|FG002|Overall Study|Changed Mind|0|||
23307751|NCT02352779|64870576|FG000|Overall Study|Study Related Symptoms|1|||
23307752|NCT02352779|64870577|FG001|Overall Study|Study Related Symptoms|0|||
23307753|NCT02352779|64870578|FG002|Overall Study|Study Related Symptoms|0|||
23307754|NCT02352779|64870576|FG000|Overall Study|Absence of Symptoms|1|||
23307755|NCT02352779|64870577|FG001|Overall Study|Absence of Symptoms|0|||
23521392|NCT03760146|65647724|FG002|Overall Study|Adverse Event|0|||
23521393|NCT03760146|65647725|FG003|Overall Study|Adverse Event|0|||
23521394|NCT03760146|65647726|FG004|Overall Study|Adverse Event|0|||
23521395|NCT03760146|65647727|FG005|Overall Study|Adverse Event|0|||
23521396|NCT03760146|65647722|FG000|Overall Study|Death|1|||
23521397|NCT03760146|65647723|FG001|Overall Study|Death|0|||
23521398|NCT03760146|65647724|FG002|Overall Study|Death|0|||
23521399|NCT03760146|65647725|FG003|Overall Study|Death|0|||
23521400|NCT03760146|65647726|FG004|Overall Study|Death|0|||
23521401|NCT03760146|65647727|FG005|Overall Study|Death|0|||
23521402|NCT03760146|65647722|FG000|Overall Study|Lost to Follow-up|41|||
23521403|NCT03760146|65647723|FG001|Overall Study|Lost to Follow-up|28|||
23521404|NCT03760146|65647724|FG002|Overall Study|Lost to Follow-up|9|||
23307756|NCT02352779|64870578|FG002|Overall Study|Absence of Symptoms|0|||
23307757|NCT02352779|64870576|FG000|Overall Study|Other Medical Reason|0|||
23307758|NCT02352779|64870577|FG001|Overall Study|Other Medical Reason|0|||
23307759|NCT02352779|64870578|FG002|Overall Study|Other Medical Reason|1|||
23307760|NCT02352779|64870576|FG000|Overall Study|No Reason|0|||
23307761|NCT02352779|64870577|FG001|Overall Study|No Reason|0|||
23307762|NCT02352779|64870578|FG002|Overall Study|No Reason|1|||
23416225|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
23416226|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
23416227|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
23416228|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
23416229|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
23416230|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
23416231|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
23416232|NCT03308968|65266168|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
23416233|NCT03308968|65266169|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
23416234|NCT03308968|65266170|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
23416235|NCT01529515|65266172|FG000|TRANSITION PHASE|Adverse Event|16|||
23416236|NCT01529515|65266173|FG001|TRANSITION PHASE|Adverse Event|0|||
23416237|NCT01529515|65266174|FG002|TRANSITION PHASE|Adverse Event|0|||
23416238|NCT01529515|65266175|FG003|TRANSITION PHASE|Adverse Event|0|||
23416239|NCT01529515|65266172|FG000|TRANSITION PHASE|Death|1|||
23416240|NCT01529515|65266173|FG001|TRANSITION PHASE|Death|0|||
23416241|NCT01529515|65266174|FG002|TRANSITION PHASE|Death|0|||
23416242|NCT01529515|65266175|FG003|TRANSITION PHASE|Death|0|||
23521405|NCT03760146|65647725|FG003|Overall Study|Lost to Follow-up|2|||
23521406|NCT03760146|65647726|FG004|Overall Study|Lost to Follow-up|14|||
23521407|NCT03760146|65647727|FG005|Overall Study|Lost to Follow-up|8|||
23521408|NCT03760146|65647722|FG000|Overall Study|No longer met eligibility criteria|3|||
23521409|NCT03760146|65647723|FG001|Overall Study|No longer met eligibility criteria|9|||
23521410|NCT03760146|65647724|FG002|Overall Study|No longer met eligibility criteria|0|||
23521411|NCT03760146|65647725|FG003|Overall Study|No longer met eligibility criteria|0|||
23521412|NCT03760146|65647726|FG004|Overall Study|No longer met eligibility criteria|1|||
23521413|NCT03760146|65647727|FG005|Overall Study|No longer met eligibility criteria|0|||
23521414|NCT03760146|65647722|FG000|Overall Study|Protocol Violation|21|||
23521415|NCT03760146|65647723|FG001|Overall Study|Protocol Violation|13|||
23521416|NCT03760146|65647724|FG002|Overall Study|Protocol Violation|1|||
23307763|NCT00852969|64870581|FG000|Overall Study|Adverse Event|0|||
23307764|NCT00852969|64870582|FG001|Overall Study|Adverse Event|1|||
23307765|NCT00852969|64870581|FG000|Overall Study|Lost to Follow-up|0|||
23307766|NCT00852969|64870582|FG001|Overall Study|Lost to Follow-up|1|||
23307767|NCT01246011|64870587|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
23307768|NCT01246011|64870588|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
23307769|NCT01246011|64870589|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
23307770|NCT01246011|64870587|FG000|Overall Study|Withdrawal by Subject|0|||
23307771|NCT01246011|64870588|FG001|Overall Study|Withdrawal by Subject|0|||
23307772|NCT01246011|64870589|FG002|Overall Study|Withdrawal by Subject|1|||
23307773|NCT03201250|64870593|FG000|Overall Study|screen failures|3|||
23307774|NCT03201250|64870594|FG001|Overall Study|screen failures|0|||
23307775|NCT03201250|64870595|FG002|Overall Study|screen failures|0|||
23307776|NCT00259272|64870596|FG000|Overall Study|Adverse Event|2|||
23307777|NCT00259272|64870597|FG001|Overall Study|Adverse Event|1|||
23307778|NCT00259272|64870598|FG002|Overall Study|Adverse Event|0|||
23521417|NCT03760146|65647725|FG003|Overall Study|Protocol Violation|0|||
23521418|NCT03760146|65647726|FG004|Overall Study|Protocol Violation|1|||
23521419|NCT03760146|65647727|FG005|Overall Study|Protocol Violation|0|||
23521420|NCT03760146|65647722|FG000|Overall Study|Withdrawal by Subject|19|||
23521421|NCT03760146|65647723|FG001|Overall Study|Withdrawal by Subject|20|||
23307779|NCT00259272|64870599|FG003|Overall Study|Adverse Event|3|||
23307780|NCT00259272|64870596|FG000|Overall Study|Lack of Efficacy|5|||
23307781|NCT00259272|64870597|FG001|Overall Study|Lack of Efficacy|1|||
23307782|NCT00259272|64870598|FG002|Overall Study|Lack of Efficacy|2|||
23307783|NCT00259272|64870599|FG003|Overall Study|Lack of Efficacy|6|||
23307784|NCT00259272|64870596|FG000|Overall Study|Physician Decision|1|||
23307785|NCT00259272|64870597|FG001|Overall Study|Physician Decision|2|||
23307786|NCT00259272|64870598|FG002|Overall Study|Physician Decision|1|||
23307787|NCT00259272|64870599|FG003|Overall Study|Physician Decision|3|||
23307788|NCT00259272|64870596|FG000|Overall Study|Protocol Violation|2|||
23307789|NCT00259272|64870597|FG001|Overall Study|Protocol Violation|0|||
23307790|NCT00259272|64870598|FG002|Overall Study|Protocol Violation|0|||
23307791|NCT00259272|64870599|FG003|Overall Study|Protocol Violation|1|||
23307792|NCT00259272|64870596|FG000|Overall Study|Sponsor Decision|0|||
23307793|NCT00259272|64870597|FG001|Overall Study|Sponsor Decision|1|||
23307794|NCT00259272|64870598|FG002|Overall Study|Sponsor Decision|0|||
23307795|NCT00259272|64870599|FG003|Overall Study|Sponsor Decision|0|||
23307796|NCT00259272|64870596|FG000|Overall Study|Withdrawal by Subject|4|||
23307797|NCT00259272|64870597|FG001|Overall Study|Withdrawal by Subject|2|||
23307798|NCT00259272|64870598|FG002|Overall Study|Withdrawal by Subject|2|||
23307799|NCT00259272|64870599|FG003|Overall Study|Withdrawal by Subject|7|||
23307800|NCT00259272|64870596|FG000|Overall Study|Lost to Follow-up|1|||
23307801|NCT00259272|64870597|FG001|Overall Study|Lost to Follow-up|0|||
23307802|NCT00259272|64870598|FG002|Overall Study|Lost to Follow-up|0|||
23307803|NCT00259272|64870599|FG003|Overall Study|Lost to Follow-up|1|||
23307804|NCT01682863|64870600|FG000|Overall Study|Subject/guardian decision|19|||
23307805|NCT01682863|64870601|FG001|Overall Study|Subject/guardian decision|12|||
23307806|NCT01682863|64870602|FG002|Overall Study|Subject/guardian decision|10|||
23307807|NCT01682863|64870600|FG000|Overall Study|Lost to Follow-up|5|||
23307808|NCT01682863|64870601|FG001|Overall Study|Lost to Follow-up|1|||
23307809|NCT01682863|64870602|FG002|Overall Study|Lost to Follow-up|6|||
23307810|NCT01682863|64870600|FG000|Overall Study|Death|1|||
23307811|NCT01682863|64870601|FG001|Overall Study|Death|3|||
23307812|NCT01682863|64870602|FG002|Overall Study|Death|4|||
23307813|NCT01682863|64870600|FG000|Overall Study|Protocol deviation|1|||
23307814|NCT01682863|64870601|FG001|Overall Study|Protocol deviation|0|||
23521422|NCT03760146|65647724|FG002|Overall Study|Withdrawal by Subject|1|||
23521423|NCT03760146|65647725|FG003|Overall Study|Withdrawal by Subject|0|||
23307815|NCT01682863|64870602|FG002|Overall Study|Protocol deviation|1|||
23521424|NCT03760146|65647726|FG004|Overall Study|Withdrawal by Subject|1|||
23307816|NCT01682863|64870600|FG000|Overall Study|Technical problems|1|||
23307817|NCT01682863|64870601|FG001|Overall Study|Technical problems|0|||
23307818|NCT01682863|64870602|FG002|Overall Study|Technical problems|0|||
23307819|NCT01682863|64870600|FG000|Overall Study|Adverse Event|0|||
23521425|NCT03760146|65647727|FG005|Overall Study|Withdrawal by Subject|0|||
23521426|NCT04552587|65647736|FG000|Overall Study|Lost to Follow-up|4|||
23521427|NCT04475588|65647741|FG000|Overall Study|Adverse Event|2|||
23521428|NCT04475588|65647742|FG001|Overall Study|Adverse Event|0|||
23521429|NCT02357147|65647749|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
23521430|NCT02357147|65647750|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
23521431|NCT02357147|65647749|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
23521432|NCT02357147|65647750|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
23521433|NCT02357147|65647749|FG000|Combination Treatment Phase|Investigator Discretion|1|||
23521434|NCT02357147|65647750|FG001|Combination Treatment Phase|Investigator Discretion|1|||
23521435|NCT02357147|65647749|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
23521436|NCT02357147|65647750|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
23521437|NCT02357147|65647749|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
23521438|NCT02357147|65647750|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
23521439|NCT02357147|65647749|FG000|Combination Treatment Phase|Adverse Event|12|||
23521440|NCT02357147|65647750|FG001|Combination Treatment Phase|Adverse Event|4|||
23521441|NCT02357147|65647749|FG000|Combination Treatment Phase|Death|1|||
23307820|NCT01682863|64870601|FG001|Overall Study|Adverse Event|1|||
23307821|NCT01682863|64870602|FG002|Overall Study|Adverse Event|2|||
23307822|NCT01682863|64870600|FG000|Overall Study|Physician Decision|0|||
23307823|NCT01682863|64870601|FG001|Overall Study|Physician Decision|0|||
23307824|NCT01682863|64870602|FG002|Overall Study|Physician Decision|1|||
23307825|NCT04647721|64870603|FG000|Overall Study|Withdrawal by Subject|0|||
23307826|NCT04647721|64870604|FG001|Overall Study|Withdrawal by Subject|2|||
23307827|NCT04647721|64870603|FG000|Overall Study|Lost to Follow-up|2|||
23521442|NCT02357147|65647750|FG001|Combination Treatment Phase|Death|1|||
23521443|NCT02357147|65647749|FG000|Combination Treatment Phase|Sponsor Decision|0|||
23521444|NCT02357147|65647750|FG001|Combination Treatment Phase|Sponsor Decision|12|||
23521445|NCT02357147|65647749|FG000|Combination Treatment Phase|Other|1|||
23521446|NCT02357147|65647750|FG001|Combination Treatment Phase|Other|0|||
23521447|NCT02357147|65647749|FG000|Combination Treatment Phase|Not treated|0|||
23521448|NCT02357147|65647750|FG001|Combination Treatment Phase|Not treated|2|||
23521449|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
23521450|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
23521451|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23307828|NCT04647721|64870604|FG001|Overall Study|Lost to Follow-up|0|||
23307829|NCT01616953|64870605|FG000|Overall Study|Lost to Follow-up|1|||
23521452|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
23521453|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
23521454|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
23521455|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Adverse Event|0|||
23521456|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Adverse Event|3|||
23521457|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
23521458|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
23521459|NCT02357147|65647749|FG000|Maintenance Treatment Phase|Not Treated|1|||
23521460|NCT02357147|65647750|FG001|Maintenance Treatment Phase|Not Treated|0|||
23521461|NCT00004888|65647751|FG000|Overall Study|Adverse Event|5|||
23521462|NCT00004888|65647752|FG001|Overall Study|Adverse Event|10|||
23521463|NCT00004888|65647751|FG000|Overall Study|Withdrawal by Subject|0|||
23521464|NCT00004888|65647752|FG001|Overall Study|Withdrawal by Subject|3|||
23521465|NCT00004888|65647751|FG000|Overall Study|Physician Decision|1|||
23521466|NCT00004888|65647752|FG001|Overall Study|Physician Decision|1|||
23521467|NCT00004888|65647751|FG000|Overall Study|Progressive Disease|4|||
23521468|NCT00004888|65647752|FG001|Overall Study|Progressive Disease|9|||
23521469|NCT00004888|65647751|FG000|Overall Study|Death without progressive disease|0|||
23521470|NCT00004888|65647752|FG001|Overall Study|Death without progressive disease|1|||
23521471|NCT00004888|65647751|FG000|Overall Study|Toxic death|1|||
23521472|NCT00004888|65647752|FG001|Overall Study|Toxic death|0|||
23521473|NCT03608774|65647756|FG000|Overall Study|Lost to Follow-up|5|||
23521474|NCT03608774|65647757|FG001|Overall Study|Lost to Follow-up|5|||
23521475|NCT03608774|65647756|FG000|Overall Study|Withdrawal by Subject|1|||
23521476|NCT03608774|65647757|FG001|Overall Study|Withdrawal by Subject|0|||
23521477|NCT03608774|65647756|FG000|Overall Study|Protocol Violation|1|||
23521478|NCT03608774|65647757|FG001|Overall Study|Protocol Violation|0|||
23521479|NCT03608774|65647756|FG000|Overall Study|Not eligible at enrollment|0|||
23521480|NCT03608774|65647757|FG001|Overall Study|Not eligible at enrollment|1|||
23521481|NCT03608774|65647756|FG000|Overall Study|Health related event|0|||
23521482|NCT03608774|65647757|FG001|Overall Study|Health related event|1|||
23521483|NCT00316199|65647758|FG000|Overall Study|Adverse Event|2|||
23521484|NCT00316199|65647758|FG000|Overall Study|Death|8|||
23521485|NCT00316199|65647758|FG000|Overall Study|Lost to Follow-up|2|||
23521486|NCT02357940|65647761|FG000|Overall Study|Adverse Event|0|||
23521487|NCT02357940|65647762|FG001|Overall Study|Adverse Event|1|||
23521488|NCT02357940|65647761|FG000|Overall Study|Investigator's judgement|0|||
23521489|NCT02357940|65647762|FG001|Overall Study|Investigator's judgement|1|||
23521490|NCT03343483|65647770|FG000|Overall Study|Death|0|||
23521491|NCT03343483|65647771|FG001|Overall Study|Death|3|||
23521492|NCT03343483|65647770|FG000|Overall Study|Lost to Follow-up|9|||
23521493|NCT03343483|65647771|FG001|Overall Study|Lost to Follow-up|13|||
23521494|NCT03343483|65647770|FG000|Overall Study|Withdrawal by Subject|8|||
23521495|NCT03343483|65647771|FG001|Overall Study|Withdrawal by Subject|17|||
23521496|NCT00325754|65647772|FG000|Overall Study|Adverse Event|4|||
23521497|NCT00325754|65647773|FG001|Overall Study|Adverse Event|1|||
23521498|NCT02211131|65647774|FG000|Overall Study|Death|26|||
23521499|NCT02211131|65647775|FG001|Overall Study|Death|16|||
23521500|NCT02211131|65647774|FG000|Overall Study|Lost to Follow-up|4|||
23521501|NCT02211131|65647775|FG001|Overall Study|Lost to Follow-up|3|||
23521502|NCT02211131|65647774|FG000|Overall Study|Decision by Sponsor|1|||
23521503|NCT02211131|65647775|FG001|Overall Study|Decision by Sponsor|1|||
23521504|NCT02211131|65647774|FG000|Overall Study|Withdrawal by Subject|3|||
23521505|NCT02211131|65647775|FG001|Overall Study|Withdrawal by Subject|8|||
23521506|NCT02678676|65647776|FG000|Overall Study|Death|619|||
23521507|NCT02678676|65647777|FG001|Overall Study|Death|649|||
23521508|NCT02678676|65647776|FG000|Overall Study|Withdrawal by Subject|13|||
23521509|NCT02678676|65647777|FG001|Overall Study|Withdrawal by Subject|5|||
23416243|NCT01529515|65266172|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
23416244|NCT01529515|65266173|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
23416245|NCT01529515|65266174|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
23416246|NCT01529515|65266175|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
23416247|NCT01529515|65266172|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
23416248|NCT01529515|65266173|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
23416249|NCT01529515|65266174|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
23416250|NCT01529515|65266175|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
23416251|NCT01529515|65266172|FG000|TRANSITION PHASE|Protocol Violation|4|||
23416252|NCT01529515|65266173|FG001|TRANSITION PHASE|Protocol Violation|0|||
23416253|NCT01529515|65266174|FG002|TRANSITION PHASE|Protocol Violation|0|||
23416254|NCT01529515|65266175|FG003|TRANSITION PHASE|Protocol Violation|0|||
23416255|NCT01529515|65266172|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
23416256|NCT01529515|65266173|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
23416257|NCT01529515|65266174|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
23416258|NCT01529515|65266175|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
23416259|NCT01529515|65266172|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
23416260|NCT01529515|65266173|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
23416261|NCT01529515|65266174|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
23416262|NCT01529515|65266175|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
23416263|NCT01529515|65266172|FG000|TRANSITION PHASE|Other|9|||
23416264|NCT01529515|65266173|FG001|TRANSITION PHASE|Other|0|||
23416265|NCT01529515|65266174|FG002|TRANSITION PHASE|Other|0|||
23416266|NCT01529515|65266175|FG003|TRANSITION PHASE|Other|0|||
23416267|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Adverse Event|0|||
23416268|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Adverse Event|10|||
23416269|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Adverse Event|0|||
23416270|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Adverse Event|0|||
23416271|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
23416272|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
23416273|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
23416274|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
23416275|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
23416276|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
23416277|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
23416278|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
23416279|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
23416280|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
23416281|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
23416282|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
23416283|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
23416284|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
23416285|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
23416286|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
23416287|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
23416288|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
23416289|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
23416290|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
23416291|NCT01529515|65266172|FG000|MAINTENANCE PHASE|Other|0|||
23521510|NCT02678676|65647776|FG000|Overall Study|Lost to Follow-up|171|||
23521511|NCT02678676|65647777|FG001|Overall Study|Lost to Follow-up|151|||
23416292|NCT01529515|65266173|FG001|MAINTENANCE PHASE|Other|10|||
23416293|NCT01529515|65266174|FG002|MAINTENANCE PHASE|Other|0|||
23416294|NCT01529515|65266175|FG003|MAINTENANCE PHASE|Other|0|||
23416295|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
23521512|NCT02678676|65647776|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
23521513|NCT02678676|65647777|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
23521514|NCT02618434|65647778|FG000|Overall Study|Withdrawal by Subject|0|||
23416296|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
23416297|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
23416298|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
23416299|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
23416300|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
23416301|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
23416302|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
23416303|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
23416304|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
23416305|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
23416306|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
23416307|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
23416308|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
23416309|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
23416310|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
23416311|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
23416312|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
23416313|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
23416314|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
23416315|NCT01529515|65266172|FG000|DOUBLE BLIND PHASE|Other|0|||
23416316|NCT01529515|65266173|FG001|DOUBLE BLIND PHASE|Other|0|||
23416317|NCT01529515|65266174|FG002|DOUBLE BLIND PHASE|Other|9|||
23416318|NCT01529515|65266175|FG003|DOUBLE BLIND PHASE|Other|2|||
23416319|NCT01453205|65266182|FG000|Overall Study|Lost to Follow-up|3|||
23416320|NCT01453205|65266183|FG001|Overall Study|Lost to Follow-up|0|||
23416321|NCT01453205|65266184|FG002|Overall Study|Lost to Follow-up|1|||
23416322|NCT01453205|65266182|FG000|Overall Study|Withdrawal by Subject|8|||
23416323|NCT01453205|65266183|FG001|Overall Study|Withdrawal by Subject|3|||
23416324|NCT01453205|65266184|FG002|Overall Study|Withdrawal by Subject|0|||
23416325|NCT01453205|65266182|FG000|Overall Study|Death|24|||
23416326|NCT01453205|65266183|FG001|Overall Study|Death|22|||
23416327|NCT01453205|65266184|FG002|Overall Study|Death|18|||
23416328|NCT01453205|65266182|FG000|Overall Study|Other|45|||
23416329|NCT01453205|65266183|FG001|Overall Study|Other|27|||
23416330|NCT01453205|65266184|FG002|Overall Study|Other|35|||
23416331|NCT00391430|65266185|FG000|Overall Study|Withdrawal by Subject|3|||
23416332|NCT00391430|65266186|FG001|Overall Study|Withdrawal by Subject|0|||
23416333|NCT00391430|65266187|FG002|Overall Study|Withdrawal by Subject|12|||
23416334|NCT01610557|65266194|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
23416335|NCT01610557|65266195|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
23416336|NCT01610557|65266196|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
23416337|NCT01610557|65266197|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
23416338|NCT01610557|65266198|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
23416339|NCT01610557|65266194|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
23416340|NCT01610557|65266195|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
23416341|NCT01610557|65266196|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
23416342|NCT01610557|65266197|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
23416343|NCT01610557|65266198|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
23416344|NCT00245050|65266199|FG000|Overall Study|Adverse Event|3|||
23416345|NCT00245050|65266200|FG001|Overall Study|Adverse Event|2|||
23416346|NCT00730041|65266203|FG000|Overall Study|Lost to Follow-up|0|||
23416347|NCT00730041|65266204|FG001|Overall Study|Lost to Follow-up|2|||
23416348|NCT01126437|65266205|FG000|Overall Study|Not treated|11|||
23416349|NCT01126437|65266206|FG001|Overall Study|Not treated|18|||
23416350|NCT01126437|65266207|FG002|Overall Study|Not treated|19|||
23416351|NCT01126437|65266205|FG000|Overall Study|Sites with data irregularities/fraud|6|||
23416352|NCT01126437|65266206|FG001|Overall Study|Sites with data irregularities/fraud|6|||
23416353|NCT01126437|65266207|FG002|Overall Study|Sites with data irregularities/fraud|7|||
23521515|NCT02618434|65647779|FG001|Overall Study|Withdrawal by Subject|2|||
23521516|NCT02618434|65647780|FG002|Overall Study|Withdrawal by Subject|3|||
23521517|NCT02618434|65647778|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
23521518|NCT02618434|65647779|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
23521519|NCT02618434|65647780|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
23521520|NCT02618434|65647778|FG000|Overall Study|Lost to Follow-up|3|||
23521521|NCT02618434|65647779|FG001|Overall Study|Lost to Follow-up|1|||
23307830|NCT01616953|64870606|FG001|Overall Study|Lost to Follow-up|0|||
23307831|NCT01616953|64870605|FG000|Overall Study|lack of bone and soft tissue|1|||
23307832|NCT01616953|64870606|FG001|Overall Study|lack of bone and soft tissue|0|||
23416354|NCT01126437|65266205|FG000|Overall Study|Adverse Event|602|||
23416355|NCT01126437|65266206|FG001|Overall Study|Adverse Event|606|||
23416356|NCT01126437|65266207|FG002|Overall Study|Adverse Event|635|||
23416357|NCT01126437|65266205|FG000|Overall Study|Lack of Efficacy|65|||
23416358|NCT01126437|65266206|FG001|Overall Study|Lack of Efficacy|60|||
23416359|NCT01126437|65266207|FG002|Overall Study|Lack of Efficacy|59|||
23416360|NCT01126437|65266205|FG000|Overall Study|Protocol Violation|64|||
23416361|NCT01126437|65266206|FG001|Overall Study|Protocol Violation|66|||
23416362|NCT01126437|65266207|FG002|Overall Study|Protocol Violation|41|||
23416363|NCT01126437|65266205|FG000|Overall Study|Lost to Follow-up|52|||
23416364|NCT01126437|65266206|FG001|Overall Study|Lost to Follow-up|63|||
23521522|NCT02618434|65647780|FG002|Overall Study|Lost to Follow-up|3|||
23416365|NCT01126437|65266207|FG002|Overall Study|Lost to Follow-up|55|||
23416366|NCT01126437|65266205|FG000|Overall Study|Withdrawal by Subject|331|||
23416367|NCT01126437|65266206|FG001|Overall Study|Withdrawal by Subject|335|||
23416368|NCT01126437|65266207|FG002|Overall Study|Withdrawal by Subject|319|||
23416369|NCT01126437|65266205|FG000|Overall Study|Other reason not specified|210|||
23416370|NCT01126437|65266206|FG001|Overall Study|Other reason not specified|176|||
23416371|NCT01126437|65266207|FG002|Overall Study|Other reason not specified|178|||
23416372|NCT01694121|65266208|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
23416373|NCT01694121|65266209|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
23416374|NCT03333252|65266216|FG000|Overall Study|Adverse Event|10|||
23416375|NCT03333252|65266217|FG001|Overall Study|Adverse Event|6|||
23416376|NCT03333252|65266218|FG002|Overall Study|Adverse Event|5|||
23416377|NCT03333252|65266219|FG003|Overall Study|Adverse Event|2|||
23416378|NCT03333252|65266216|FG000|Overall Study|Death|1|||
23416379|NCT03333252|65266217|FG001|Overall Study|Death|3|||
23416380|NCT03333252|65266218|FG002|Overall Study|Death|0|||
23416381|NCT03333252|65266219|FG003|Overall Study|Death|0|||
23416382|NCT03333252|65266216|FG000|Overall Study|Lack of Efficacy|8|||
23416383|NCT03333252|65266217|FG001|Overall Study|Lack of Efficacy|4|||
23416384|NCT03333252|65266218|FG002|Overall Study|Lack of Efficacy|0|||
23416385|NCT03333252|65266219|FG003|Overall Study|Lack of Efficacy|7|||
23416386|NCT03333252|65266216|FG000|Overall Study|Lost to Follow-up|0|||
23416387|NCT03333252|65266217|FG001|Overall Study|Lost to Follow-up|5|||
23416388|NCT03333252|65266218|FG002|Overall Study|Lost to Follow-up|9|||
23416389|NCT03333252|65266219|FG003|Overall Study|Lost to Follow-up|3|||
23416390|NCT03333252|65266216|FG000|Overall Study|Withdrawal by Subject|14|||
23416391|NCT03333252|65266217|FG001|Overall Study|Withdrawal by Subject|24|||
23416392|NCT03333252|65266218|FG002|Overall Study|Withdrawal by Subject|11|||
23416393|NCT03333252|65266219|FG003|Overall Study|Withdrawal by Subject|17|||
23416394|NCT00316225|65266220|FG000|Overall Study|Adverse Event|2|||
23416395|NCT00316225|65266220|FG000|Overall Study|Physician Decision|3|||
23416396|NCT00316225|65266220|FG000|Overall Study|Progressive Disease|15|||
23416397|NCT00316225|65266220|FG000|Overall Study|Withdrawal by Subject|3|||
23416398|NCT00316225|65266220|FG000|Overall Study|Death|2|||
23416399|NCT00079391|65266221|FG000|Overall Study|Withdrawal by Subject|1|||
23416400|NCT02998203|65266222|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
23416401|NCT02998203|65266223|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
23416402|NCT02998203|65266222|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
23416403|NCT02998203|65266223|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
23416404|NCT01352221|65266226|FG000|Double-blind Phase|Adverse Event|6|||
23521523|NCT02618434|65647778|FG000|Overall Study|Adverse Event|1|||
23416405|NCT01352221|65266227|FG001|Double-blind Phase|Adverse Event|4|||
23416406|NCT01352221|65266228|FG002|Double-blind Phase|Adverse Event|0|||
23416407|NCT01352221|65266229|FG003|Double-blind Phase|Adverse Event|0|||
23521524|NCT02618434|65647779|FG001|Overall Study|Adverse Event|0|||
23416408|NCT01352221|65266226|FG000|Double-blind Phase|Withdrawal by Subject|3|||
23416409|NCT01352221|65266227|FG001|Double-blind Phase|Withdrawal by Subject|5|||
23416410|NCT01352221|65266228|FG002|Double-blind Phase|Withdrawal by Subject|0|||
23416411|NCT01352221|65266229|FG003|Double-blind Phase|Withdrawal by Subject|0|||
23416412|NCT01352221|65266226|FG000|Double-blind Phase|Lost to Follow-up|0|||
23416413|NCT01352221|65266227|FG001|Double-blind Phase|Lost to Follow-up|1|||
23416414|NCT01352221|65266228|FG002|Double-blind Phase|Lost to Follow-up|0|||
23416415|NCT01352221|65266229|FG003|Double-blind Phase|Lost to Follow-up|0|||
23416416|NCT01352221|65266226|FG000|Double-blind Phase|Protocol Violation|0|||
23416417|NCT01352221|65266227|FG001|Double-blind Phase|Protocol Violation|1|||
23416418|NCT01352221|65266228|FG002|Double-blind Phase|Protocol Violation|0|||
23416419|NCT01352221|65266229|FG003|Double-blind Phase|Protocol Violation|0|||
23416420|NCT01352221|65266226|FG000|Open-label Phase|Physician Decision|0|||
23416421|NCT01352221|65266227|FG001|Open-label Phase|Physician Decision|0|||
23416422|NCT01352221|65266228|FG002|Open-label Phase|Physician Decision|2|||
23416423|NCT01352221|65266229|FG003|Open-label Phase|Physician Decision|1|||
23416424|NCT01352221|65266226|FG000|Open-label Phase|Pregnancy|0|||
23416425|NCT01352221|65266227|FG001|Open-label Phase|Pregnancy|0|||
23416426|NCT01352221|65266228|FG002|Open-label Phase|Pregnancy|1|||
23416427|NCT01352221|65266229|FG003|Open-label Phase|Pregnancy|0|||
23416428|NCT01352221|65266226|FG000|Open-label Phase|Adverse Event|0|||
23416429|NCT01352221|65266227|FG001|Open-label Phase|Adverse Event|0|||
23416430|NCT01352221|65266228|FG002|Open-label Phase|Adverse Event|8|||
23416431|NCT01352221|65266229|FG003|Open-label Phase|Adverse Event|4|||
23416432|NCT01352221|65266226|FG000|Open-label Phase|Withdrawal by Subject|0|||
23416433|NCT01352221|65266227|FG001|Open-label Phase|Withdrawal by Subject|0|||
23416434|NCT01352221|65266228|FG002|Open-label Phase|Withdrawal by Subject|1|||
23416435|NCT01352221|65266229|FG003|Open-label Phase|Withdrawal by Subject|6|||
23416436|NCT01352221|65266226|FG000|Open-label Phase|Worsening of IBD|0|||
23416437|NCT01352221|65266227|FG001|Open-label Phase|Worsening of IBD|0|||
23416438|NCT01352221|65266228|FG002|Open-label Phase|Worsening of IBD|1|||
23416439|NCT01352221|65266229|FG003|Open-label Phase|Worsening of IBD|0|||
23416440|NCT01092780|65266230|FG000|Washout Period 1|Adverse Event|0|||
23416441|NCT01092780|65266231|FG001|Washout Period 1|Adverse Event|1|||
23416442|NCT01092780|65266232|FG002|Washout Period 1|Adverse Event|0|||
23416443|NCT01092780|65266233|FG003|Washout Period 1|Adverse Event|0|||
23416444|NCT01092780|65266230|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
23416445|NCT01092780|65266231|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
23416446|NCT01092780|65266232|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
23416447|NCT01092780|65266233|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
23416448|NCT01092780|65266230|FG000|Washout Period 2|Adverse Event|0|||
23416449|NCT01092780|65266231|FG001|Washout Period 2|Adverse Event|1|||
23416450|NCT01092780|65266232|FG002|Washout Period 2|Adverse Event|1|||
23416451|NCT01092780|65266233|FG003|Washout Period 2|Adverse Event|0|||
23416452|NCT02566785|65266235|FG000|Overall Study|Lost to Follow-up|0|||
23416453|NCT02566785|65266236|FG001|Overall Study|Lost to Follow-up|2|||
23416454|NCT02566785|65266235|FG000|Overall Study|Worsening condition|1|||
23416455|NCT02566785|65266236|FG001|Overall Study|Worsening condition|1|||
23416456|NCT00516893|65266242|FG000|Overall Study|Lost to Follow-up|4|||
23416457|NCT00516893|65266242|FG000|Overall Study|Adverse Event|3|||
23416458|NCT00516893|65266242|FG000|Overall Study|Withdrawal by Subject|2|||
23416459|NCT00516893|65266242|FG000|Overall Study|Noncompliance|2|||
23416460|NCT00516893|65266242|FG000|Overall Study|Death|1|||
23416461|NCT00516893|65266242|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
23416462|NCT00516893|65266242|FG000|Overall Study|Relocated|1|||
23416463|NCT00516893|65266242|FG000|Overall Study|Pregnancy|1|||
23416464|NCT00516893|65266242|FG000|Overall Study|Received Medication From Another Study|1|||
23416465|NCT00920387|65266243|FG000|Stage 1|Adverse Event|1|||
23416466|NCT00920387|65266244|FG001|Stage 1|Adverse Event|0|||
23416467|NCT00920387|65266245|FG002|Stage 1|Adverse Event|0|||
23416468|NCT00327015|65271169|FG000|Overall Study|Lack of Efficacy|18|||
23416469|NCT00327015|65271170|FG001|Overall Study|Lack of Efficacy|18|||
23521525|NCT02618434|65647780|FG002|Overall Study|Adverse Event|12|||
23521526|NCT02618434|65647778|FG000|Overall Study|Physician Decision|0|||
23521527|NCT02618434|65647779|FG001|Overall Study|Physician Decision|1|||
23521528|NCT02618434|65647780|FG002|Overall Study|Physician Decision|0|||
23416470|NCT00327015|65271171|FG002|Overall Study|Lack of Efficacy|35|||
23416471|NCT00327015|65271172|FG003|Overall Study|Lack of Efficacy|29|||
23416472|NCT00327015|65271169|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
23416473|NCT00327015|65271170|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
23416474|NCT00327015|65271171|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
23416475|NCT00327015|65271172|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
23416476|NCT00327015|65271169|FG000|Overall Study|Lost to Follow-up|22|||
23416477|NCT00327015|65271170|FG001|Overall Study|Lost to Follow-up|23|||
23521529|NCT02618434|65647778|FG000|Overall Study|Protocol Violation|0|||
23416478|NCT00327015|65271171|FG002|Overall Study|Lost to Follow-up|29|||
23416479|NCT00327015|65271172|FG003|Overall Study|Lost to Follow-up|22|||
23416480|NCT00327015|65271169|FG000|Overall Study|Adverse Event|14|||
23521530|NCT02618434|65647779|FG001|Overall Study|Protocol Violation|0|||
23416481|NCT00327015|65271170|FG001|Overall Study|Adverse Event|10|||
23416482|NCT00327015|65271171|FG002|Overall Study|Adverse Event|14|||
23416483|NCT00327015|65271172|FG003|Overall Study|Adverse Event|14|||
23416484|NCT00327015|65271169|FG000|Overall Study|Subject no longer meets study criteria|4|||
23416485|NCT00327015|65271170|FG001|Overall Study|Subject no longer meets study criteria|2|||
23416486|NCT00327015|65271171|FG002|Overall Study|Subject no longer meets study criteria|8|||
23416487|NCT00327015|65271172|FG003|Overall Study|Subject no longer meets study criteria|7|||
23521531|NCT02618434|65647780|FG002|Overall Study|Protocol Violation|1|||
23521532|NCT02618434|65647778|FG000|Overall Study|Other, Multiple categories|1|||
23521533|NCT02618434|65647779|FG001|Overall Study|Other, Multiple categories|1|||
23521534|NCT02618434|65647780|FG002|Overall Study|Other, Multiple categories|1|||
23521535|NCT03509675|65650544|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
23521536|NCT03509675|65650545|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
23521537|NCT03509675|65650544|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
23521538|NCT03509675|65650545|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
23521539|NCT03509675|65650544|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
23521540|NCT03509675|65650545|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
23521541|NCT03509675|65650544|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
23521542|NCT03509675|65650545|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
23521543|NCT03299192|65650546|FG000|Overall Study|Fell before classes started|1|||
23521544|NCT03299192|65650547|FG001|Overall Study|Fell before classes started|0|||
23521545|NCT03299192|65650548|FG002|Overall Study|Fell before classes started|0|||
23521546|NCT03299192|65650546|FG000|Overall Study|Other|0|||
23521547|NCT03299192|65650547|FG001|Overall Study|Other|2|||
23521548|NCT03299192|65650548|FG002|Overall Study|Other|1|||
23521549|NCT03873987|65650551|FG000|Overall Study|Adverse Event|1|||
23521550|NCT03873987|65650552|FG001|Overall Study|Adverse Event|0|||
23521551|NCT03873987|65650551|FG000|Overall Study|staff was unable to start a new IV line|1|||
23521552|NCT03873987|65650552|FG001|Overall Study|staff was unable to start a new IV line|0|||
23521553|NCT03873987|65650551|FG000|Overall Study|Lost to Follow-up|0|||
23521554|NCT03873987|65650552|FG001|Overall Study|Lost to Follow-up|1|||
23521555|NCT01113879|65650563|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
23521556|NCT01113879|65650564|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
23521557|NCT01215227|65650565|FG000|Overall Study|Adverse Event|11|||
23521558|NCT01215227|65650566|FG001|Overall Study|Adverse Event|11|||
23521559|NCT01215227|65650567|FG002|Overall Study|Adverse Event|4|||
23521560|NCT01215227|65650568|FG003|Overall Study|Adverse Event|8|||
23521561|NCT01215227|65650569|FG004|Overall Study|Adverse Event|7|||
23521562|NCT01215227|65650570|FG005|Overall Study|Adverse Event|6|||
23416488|NCT00327015|65271169|FG000|Overall Study|Poor/Noncompliance|11|||
23416489|NCT00327015|65271170|FG001|Overall Study|Poor/Noncompliance|8|||
23416490|NCT00327015|65271171|FG002|Overall Study|Poor/Noncompliance|4|||
23416491|NCT00327015|65271172|FG003|Overall Study|Poor/Noncompliance|5|||
23416492|NCT00327015|65271169|FG000|Overall Study|Physician Decision|0|||
23416493|NCT00327015|65271170|FG001|Overall Study|Physician Decision|1|||
23416494|NCT00327015|65271171|FG002|Overall Study|Physician Decision|3|||
23416495|NCT00327015|65271172|FG003|Overall Study|Physician Decision|2|||
23416496|NCT00327015|65271169|FG000|Overall Study|Death|1|||
23416497|NCT00327015|65271170|FG001|Overall Study|Death|2|||
23416498|NCT00327015|65271171|FG002|Overall Study|Death|2|||
23416499|NCT00327015|65271172|FG003|Overall Study|Death|3|||
23416500|NCT00327015|65271169|FG000|Overall Study|Pregnancy|0|||
23416501|NCT00327015|65271170|FG001|Overall Study|Pregnancy|2|||
23416502|NCT00327015|65271171|FG002|Overall Study|Pregnancy|1|||
23416503|NCT00327015|65271172|FG003|Overall Study|Pregnancy|1|||
23416504|NCT00327015|65271169|FG000|Overall Study|Administrative Reason by Sponsor|1|||
23416505|NCT00327015|65271170|FG001|Overall Study|Administrative Reason by Sponsor|2|||
23416506|NCT00327015|65271171|FG002|Overall Study|Administrative Reason by Sponsor|2|||
23416507|NCT00327015|65271172|FG003|Overall Study|Administrative Reason by Sponsor|1|||
23416508|NCT01164891|65271174|FG000|Overall Study|Disease Progression|5|||
23416509|NCT01164891|65271174|FG000|Overall Study|Adverse Event|1|||
23416510|NCT04308239|65271176|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
23416511|NCT04308239|65271177|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
23416512|NCT04308239|65271176|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
23416513|NCT04308239|65271177|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
23416514|NCT04308239|65271176|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
23521563|NCT01215227|65650565|FG000|Overall Study|Treatment Failure|8|||
23521564|NCT01215227|65650566|FG001|Overall Study|Treatment Failure|4|||
23521565|NCT01215227|65650567|FG002|Overall Study|Treatment Failure|1|||
23416515|NCT04308239|65271177|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
23521566|NCT01215227|65650568|FG003|Overall Study|Treatment Failure|5|||
23521567|NCT01215227|65650569|FG004|Overall Study|Treatment Failure|1|||
23521568|NCT01215227|65650570|FG005|Overall Study|Treatment Failure|1|||
23521569|NCT01215227|65650565|FG000|Overall Study|Lost to Follow-up|1|||
23521570|NCT01215227|65650566|FG001|Overall Study|Lost to Follow-up|4|||
23521571|NCT01215227|65650567|FG002|Overall Study|Lost to Follow-up|1|||
23521572|NCT01215227|65650568|FG003|Overall Study|Lost to Follow-up|1|||
23521573|NCT01215227|65650569|FG004|Overall Study|Lost to Follow-up|1|||
23521574|NCT01215227|65650570|FG005|Overall Study|Lost to Follow-up|2|||
23521575|NCT01215227|65650565|FG000|Overall Study|Subject Withdrew Consent|16|||
23521576|NCT01215227|65650566|FG001|Overall Study|Subject Withdrew Consent|20|||
23521577|NCT01215227|65650567|FG002|Overall Study|Subject Withdrew Consent|7|||
23521578|NCT01215227|65650568|FG003|Overall Study|Subject Withdrew Consent|10|||
23521579|NCT01215227|65650569|FG004|Overall Study|Subject Withdrew Consent|11|||
23521580|NCT01215227|65650570|FG005|Overall Study|Subject Withdrew Consent|8|||
23521581|NCT01215227|65650565|FG000|Overall Study|Non-Compliance With Protocol|2|||
23521582|NCT01215227|65650566|FG001|Overall Study|Non-Compliance With Protocol|6|||
23521583|NCT01215227|65650567|FG002|Overall Study|Non-Compliance With Protocol|1|||
23521584|NCT01215227|65650568|FG003|Overall Study|Non-Compliance With Protocol|0|||
23521585|NCT01215227|65650569|FG004|Overall Study|Non-Compliance With Protocol|0|||
23521586|NCT01215227|65650570|FG005|Overall Study|Non-Compliance With Protocol|0|||
23521587|NCT01215227|65650565|FG000|Overall Study|Administrative|83|||
23521588|NCT01215227|65650566|FG001|Overall Study|Administrative|73|||
23521589|NCT01215227|65650567|FG002|Overall Study|Administrative|42|||
23521590|NCT01215227|65650568|FG003|Overall Study|Administrative|24|||
23521591|NCT01215227|65650569|FG004|Overall Study|Administrative|28|||
23521592|NCT01215227|65650570|FG005|Overall Study|Administrative|40|||
23521593|NCT01215227|65650565|FG000|Overall Study|Missing Status|0|||
23521594|NCT01215227|65650566|FG001|Overall Study|Missing Status|1|||
23521595|NCT01215227|65650567|FG002|Overall Study|Missing Status|0|||
23521596|NCT01215227|65650568|FG003|Overall Study|Missing Status|0|||
23521597|NCT01215227|65650569|FG004|Overall Study|Missing Status|0|||
23521598|NCT01215227|65650570|FG005|Overall Study|Missing Status|0|||
23521599|NCT01215227|65650565|FG000|Overall Study|Randomized but not treated|0|||
23521600|NCT01215227|65650566|FG001|Overall Study|Randomized but not treated|0|||
23521601|NCT01215227|65650567|FG002|Overall Study|Randomized but not treated|1|||
23521602|NCT01215227|65650568|FG003|Overall Study|Randomized but not treated|1|||
23521603|NCT01215227|65650569|FG004|Overall Study|Randomized but not treated|0|||
23521604|NCT01215227|65650570|FG005|Overall Study|Randomized but not treated|1|||
23521605|NCT03662542|65650571|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
23521606|NCT03662542|65650572|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521607|NCT03662542|65650573|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521608|NCT03662542|65650574|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521609|NCT03662542|65650575|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521610|NCT03662542|65650576|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521611|NCT03662542|65650577|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521612|NCT03662542|65650578|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521613|NCT03662542|65650579|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
23521614|NCT03662542|65650571|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521615|NCT03662542|65650572|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
23521616|NCT03662542|65650573|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521617|NCT03662542|65650574|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521618|NCT03662542|65650575|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521619|NCT03662542|65650576|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521620|NCT03662542|65650577|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521621|NCT03662542|65650578|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521622|NCT03662542|65650579|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
23521623|NCT03662542|65650571|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
23521624|NCT03662542|65650572|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
23521625|NCT03662542|65650573|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
23521626|NCT03662542|65650574|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
23521627|NCT03662542|65650575|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
23521628|NCT03662542|65650576|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
23307833|NCT04271735|64870616|FG000|Overall Study|Physician Decision|2|||
23307834|NCT04271735|64870617|FG001|Overall Study|Physician Decision|0|||
23521629|NCT03662542|65650577|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
23521630|NCT03662542|65650578|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
23521631|NCT03662542|65650579|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
23205302|NCT02065622|64491319|FG001|Maintenance Study|Adverse Event|0|||
23521632|NCT03662542|65650571|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
23521633|NCT03662542|65650572|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521634|NCT03662542|65650573|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521635|NCT03662542|65650574|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521636|NCT03662542|65650575|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521637|NCT03662542|65650576|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521638|NCT03662542|65650577|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521639|NCT03662542|65650578|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521640|NCT03662542|65650579|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
23521641|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521642|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521643|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521644|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521645|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521646|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
23521647|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521648|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521649|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
23521650|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521651|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521652|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521653|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
23521654|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
23521655|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521656|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521657|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521658|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
23521659|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521660|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521661|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521662|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
23521663|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
23521664|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
23521665|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521666|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521667|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
23521668|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521669|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521670|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521671|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521672|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
23521673|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
23521674|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521675|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23521676|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
23205303|NCT02065622|64491320|FG002|Maintenance Study|Adverse Event|25|||
23521677|NCT03662542|65650571|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521678|NCT03662542|65650572|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521679|NCT03662542|65650573|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521680|NCT03662542|65650574|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521681|NCT03662542|65650575|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521682|NCT03662542|65650576|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
23521683|NCT03662542|65650577|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521684|NCT03662542|65650578|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521685|NCT03662542|65650579|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
23521686|NCT03662542|65650571|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521687|NCT03662542|65650572|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521688|NCT03662542|65650573|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521689|NCT03662542|65650574|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521690|NCT03662542|65650575|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521691|NCT03662542|65650576|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521692|NCT03662542|65650577|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521693|NCT03662542|65650578|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
23521694|NCT03662542|65650579|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
23521695|NCT03662542|65650571|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521696|NCT03662542|65650572|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521697|NCT03662542|65650573|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521698|NCT03662542|65650574|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521699|NCT03662542|65650575|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521700|NCT03662542|65650576|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521701|NCT03662542|65650577|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
23521702|NCT03662542|65650578|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
23521703|NCT03662542|65650579|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
23521704|NCT03662542|65650571|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521705|NCT03662542|65650572|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521706|NCT03662542|65650573|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521707|NCT03662542|65650574|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521708|NCT03662542|65650575|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521709|NCT03662542|65650576|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521710|NCT03662542|65650577|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
23521711|NCT03662542|65650578|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
23521712|NCT03662542|65650579|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
23521713|NCT03662542|65650571|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521714|NCT03662542|65650572|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521715|NCT03662542|65650573|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521716|NCT03662542|65650574|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521717|NCT03662542|65650575|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521718|NCT03662542|65650576|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
23521719|NCT03662542|65650577|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
23521720|NCT03662542|65650578|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
23521721|NCT03662542|65650579|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
23521722|NCT00978068|65650580|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
23521723|NCT00978068|65650581|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
23521724|NCT00978068|65650580|FG000|Overall Study|Death|1|||
23521725|NCT00978068|65650581|FG001|Overall Study|Death|2|||
23521726|NCT00978068|65650580|FG000|Overall Study|Lost to Follow-up|1|||
23521727|NCT00978068|65650581|FG001|Overall Study|Lost to Follow-up|2|||
23521728|NCT00978068|65650580|FG000|Overall Study|Physician Decision|0|||
23521729|NCT00978068|65650581|FG001|Overall Study|Physician Decision|1|||
23521730|NCT00978068|65650580|FG000|Overall Study|Unable to Comply with Study|0|||
23521731|NCT00978068|65650581|FG001|Overall Study|Unable to Comply with Study|2|||
23521732|NCT02159521|65650582|FG000|Overall Study|Enrolled but not treated|3|||
23521733|NCT02159521|65650582|FG000|Overall Study|Withdrawal by Subject|7|||
23521734|NCT02159521|65650582|FG000|Overall Study|Lost to Follow-up|6|||
23521735|NCT02159521|65650582|FG000|Overall Study|Death|1|||
23453568|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453569|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453570|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453571|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
23453572|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
23453573|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
23453574|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
23453575|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
23453576|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
23453577|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
23453578|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
23453579|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
23453580|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
23453581|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
23453582|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
23521736|NCT02159521|65650582|FG000|Overall Study|Other than specified|1|||
23521737|NCT05129488|65650586|FG000|Overall Study|Protocol Violation|3|||
23521738|NCT01559012|65650588|FG000|Overall Study|Withdrawal by Subject|0|||
23521739|NCT01559012|65650589|FG001|Overall Study|Withdrawal by Subject|1|||
23521740|NCT02689258|65650592|FG000|Overall Study|Subject Non-Compliance|0|||
23521741|NCT02689258|65650593|FG001|Overall Study|Subject Non-Compliance|1|||
23521742|NCT02689258|65650594|FG002|Overall Study|Subject Non-Compliance|0|||
23521743|NCT02689258|65650595|FG003|Overall Study|Subject Non-Compliance|0|||
23521744|NCT02689258|65650596|FG004|Overall Study|Subject Non-Compliance|0|||
23521745|NCT02689258|65650597|FG005|Overall Study|Subject Non-Compliance|0|||
23521746|NCT02689258|65650598|FG006|Overall Study|Subject Non-Compliance|0|||
23521747|NCT02689258|65650599|FG007|Overall Study|Subject Non-Compliance|0|||
23521748|NCT02689258|65650600|FG008|Overall Study|Subject Non-Compliance|0|||
23521749|NCT02689258|65650601|FG009|Overall Study|Subject Non-Compliance|0|||
23521750|NCT02689258|65650602|FG010|Overall Study|Subject Non-Compliance|0|||
23521751|NCT02689258|65650603|FG011|Overall Study|Subject Non-Compliance|0|||
23521752|NCT02689258|65650592|FG000|Overall Study|Subject Refusal to Continue|0|||
23521753|NCT02689258|65650593|FG001|Overall Study|Subject Refusal to Continue|1|||
23521754|NCT02689258|65650594|FG002|Overall Study|Subject Refusal to Continue|0|||
23521755|NCT02689258|65650595|FG003|Overall Study|Subject Refusal to Continue|0|||
23521756|NCT02689258|65650596|FG004|Overall Study|Subject Refusal to Continue|0|||
23521757|NCT02689258|65650597|FG005|Overall Study|Subject Refusal to Continue|0|||
23521758|NCT02689258|65650598|FG006|Overall Study|Subject Refusal to Continue|0|||
23521759|NCT02689258|65650599|FG007|Overall Study|Subject Refusal to Continue|0|||
23521760|NCT02689258|65650600|FG008|Overall Study|Subject Refusal to Continue|1|||
23521761|NCT02689258|65650601|FG009|Overall Study|Subject Refusal to Continue|0|||
23521762|NCT02689258|65650602|FG010|Overall Study|Subject Refusal to Continue|0|||
23521763|NCT02689258|65650603|FG011|Overall Study|Subject Refusal to Continue|1|||
23521764|NCT02689258|65650592|FG000|Overall Study|Other|0|||
23521765|NCT02689258|65650593|FG001|Overall Study|Other|2|||
23521766|NCT02689258|65650594|FG002|Overall Study|Other|0|||
23521767|NCT02689258|65650595|FG003|Overall Study|Other|0|||
23521768|NCT02689258|65650596|FG004|Overall Study|Other|1|||
23521769|NCT02689258|65650597|FG005|Overall Study|Other|0|||
23521770|NCT02689258|65650598|FG006|Overall Study|Other|0|||
23521771|NCT02689258|65650599|FG007|Overall Study|Other|0|||
23521772|NCT02689258|65650600|FG008|Overall Study|Other|1|||
23521773|NCT02689258|65650601|FG009|Overall Study|Other|0|||
23521774|NCT02689258|65650602|FG010|Overall Study|Other|0|||
23521775|NCT02689258|65650603|FG011|Overall Study|Other|0|||
23521776|NCT02641379|65650606|FG000|Overall Study|Exclusion criterion during screening|1|||
23521777|NCT02641379|65650607|FG001|Overall Study|Exclusion criterion during screening|0|||
23521778|NCT02641379|65650608|FG002|Overall Study|Exclusion criterion during screening|0|||
23521779|NCT02641379|65650609|FG003|Overall Study|Exclusion criterion during screening|1|||
23521780|NCT02641379|65650610|FG004|Overall Study|Exclusion criterion during screening|2|||
23521781|NCT02641379|65650611|FG005|Overall Study|Exclusion criterion during screening|0|||
23521782|NCT02641379|65650612|FG006|Overall Study|Exclusion criterion during screening|0|||
23521783|NCT02641379|65650613|FG007|Overall Study|Exclusion criterion during screening|0|||
23521784|NCT02641379|65650614|FG008|Overall Study|Exclusion criterion during screening|0|||
23521785|NCT02641379|65650615|FG009|Overall Study|Exclusion criterion during screening|0|||
23521786|NCT02641379|65650616|FG010|Overall Study|Exclusion criterion during screening|0|||
23521787|NCT02641379|65650606|FG000|Overall Study|Withdrawal of informed consent|0|||
23521788|NCT02641379|65650607|FG001|Overall Study|Withdrawal of informed consent|1|||
23521789|NCT02641379|65650608|FG002|Overall Study|Withdrawal of informed consent|0|||
23521790|NCT02641379|65650609|FG003|Overall Study|Withdrawal of informed consent|0|||
23521791|NCT02641379|65650610|FG004|Overall Study|Withdrawal of informed consent|0|||
23521792|NCT02641379|65650611|FG005|Overall Study|Withdrawal of informed consent|0|||
23521793|NCT02641379|65650612|FG006|Overall Study|Withdrawal of informed consent|0|||
23521794|NCT02641379|65650613|FG007|Overall Study|Withdrawal of informed consent|1|||
23521795|NCT02641379|65650614|FG008|Overall Study|Withdrawal of informed consent|0|||
23521796|NCT02641379|65650615|FG009|Overall Study|Withdrawal of informed consent|0|||
23521797|NCT02641379|65650616|FG010|Overall Study|Withdrawal of informed consent|0|||
23521798|NCT02641379|65650606|FG000|Overall Study|Adverse Event|7|||
23521799|NCT02641379|65650607|FG001|Overall Study|Adverse Event|8|||
23521800|NCT02641379|65650608|FG002|Overall Study|Adverse Event|2|||
23521801|NCT02641379|65650609|FG003|Overall Study|Adverse Event|2|||
23521802|NCT02641379|65650610|FG004|Overall Study|Adverse Event|5|||
23521803|NCT02641379|65650611|FG005|Overall Study|Adverse Event|1|||
23521804|NCT02641379|65650612|FG006|Overall Study|Adverse Event|5|||
23521805|NCT02641379|65650613|FG007|Overall Study|Adverse Event|0|||
23521806|NCT02641379|65650614|FG008|Overall Study|Adverse Event|1|||
23521807|NCT02641379|65650615|FG009|Overall Study|Adverse Event|1|||
23521808|NCT02641379|65650616|FG010|Overall Study|Adverse Event|5|||
23521809|NCT02641379|65650606|FG000|Overall Study|Lack of Efficacy|0|||
23521810|NCT02641379|65650607|FG001|Overall Study|Lack of Efficacy|0|||
23521811|NCT02641379|65650608|FG002|Overall Study|Lack of Efficacy|2|||
23521812|NCT02641379|65650609|FG003|Overall Study|Lack of Efficacy|0|||
23521813|NCT02641379|65650610|FG004|Overall Study|Lack of Efficacy|0|||
23521814|NCT02641379|65650611|FG005|Overall Study|Lack of Efficacy|2|||
23205304|NCT02065622|64491321|FG003|Maintenance Study|Adverse Event|22|||
23205305|NCT02065622|64491322|FG004|Maintenance Study|Adverse Event|11|||
23205306|NCT02065622|64491318|FG000|Maintenance Study|Withdrawal by Subject|0|||
23205307|NCT02065622|64491319|FG001|Maintenance Study|Withdrawal by Subject|0|||
23416516|NCT04308239|65271176|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
23521815|NCT02641379|65650612|FG006|Overall Study|Lack of Efficacy|0|||
23521816|NCT02641379|65650613|FG007|Overall Study|Lack of Efficacy|5|||
23521817|NCT02641379|65650614|FG008|Overall Study|Lack of Efficacy|0|||
23521818|NCT02641379|65650615|FG009|Overall Study|Lack of Efficacy|0|||
23205308|NCT02065622|64491320|FG002|Maintenance Study|Withdrawal by Subject|11|||
23205309|NCT02065622|64491321|FG003|Maintenance Study|Withdrawal by Subject|5|||
23205310|NCT02065622|64491322|FG004|Maintenance Study|Withdrawal by Subject|7|||
23205311|NCT02065622|64491318|FG000|Maintenance Study|Lost to Follow-up|0|||
23205312|NCT02065622|64491319|FG001|Maintenance Study|Lost to Follow-up|0|||
23205313|NCT02065622|64491320|FG002|Maintenance Study|Lost to Follow-up|4|||
23205314|NCT02065622|64491321|FG003|Maintenance Study|Lost to Follow-up|1|||
23205315|NCT02065622|64491322|FG004|Maintenance Study|Lost to Follow-up|1|||
23205316|NCT02065622|64491318|FG000|Maintenance Study|Lack of Efficacy|0|||
23205317|NCT02065622|64491319|FG001|Maintenance Study|Lack of Efficacy|0|||
23521819|NCT02641379|65650616|FG010|Overall Study|Lack of Efficacy|0|||
23521820|NCT02641379|65650606|FG000|Overall Study|Participant unable to attend study visit|4|||
23521821|NCT02641379|65650607|FG001|Overall Study|Participant unable to attend study visit|10|||
23521822|NCT02641379|65650608|FG002|Overall Study|Participant unable to attend study visit|1|||
23521823|NCT02641379|65650609|FG003|Overall Study|Participant unable to attend study visit|2|||
23521824|NCT02641379|65650610|FG004|Overall Study|Participant unable to attend study visit|5|||
23521825|NCT02641379|65650611|FG005|Overall Study|Participant unable to attend study visit|1|||
23521826|NCT02641379|65650612|FG006|Overall Study|Participant unable to attend study visit|1|||
23521827|NCT02641379|65650613|FG007|Overall Study|Participant unable to attend study visit|1|||
23521828|NCT02641379|65650614|FG008|Overall Study|Participant unable to attend study visit|0|||
23521829|NCT02641379|65650615|FG009|Overall Study|Participant unable to attend study visit|2|||
23521830|NCT02641379|65650616|FG010|Overall Study|Participant unable to attend study visit|0|||
23521831|NCT02641379|65650606|FG000|Overall Study|Participant's compliance|0|||
23521832|NCT02641379|65650607|FG001|Overall Study|Participant's compliance|1|||
23521833|NCT02641379|65650608|FG002|Overall Study|Participant's compliance|0|||
23521834|NCT02641379|65650609|FG003|Overall Study|Participant's compliance|1|||
23521835|NCT02641379|65650610|FG004|Overall Study|Participant's compliance|0|||
23521836|NCT02641379|65650611|FG005|Overall Study|Participant's compliance|2|||
23521837|NCT02641379|65650612|FG006|Overall Study|Participant's compliance|0|||
23521838|NCT02641379|65650613|FG007|Overall Study|Participant's compliance|0|||
23521839|NCT02641379|65650614|FG008|Overall Study|Participant's compliance|1|||
23521840|NCT02641379|65650615|FG009|Overall Study|Participant's compliance|1|||
23521841|NCT02641379|65650616|FG010|Overall Study|Participant's compliance|1|||
23521842|NCT02641379|65650606|FG000|Overall Study|Participant cannot be reached|4|||
23521843|NCT02641379|65650607|FG001|Overall Study|Participant cannot be reached|4|||
23521844|NCT02641379|65650608|FG002|Overall Study|Participant cannot be reached|0|||
23521845|NCT02641379|65650609|FG003|Overall Study|Participant cannot be reached|8|||
23521846|NCT02641379|65650610|FG004|Overall Study|Participant cannot be reached|2|||
23521847|NCT02641379|65650611|FG005|Overall Study|Participant cannot be reached|1|||
23521848|NCT02641379|65650612|FG006|Overall Study|Participant cannot be reached|0|||
23521849|NCT02641379|65650613|FG007|Overall Study|Participant cannot be reached|1|||
23521850|NCT02641379|65650614|FG008|Overall Study|Participant cannot be reached|0|||
23521851|NCT02641379|65650615|FG009|Overall Study|Participant cannot be reached|2|||
23521852|NCT02641379|65650616|FG010|Overall Study|Participant cannot be reached|1|||
23521853|NCT02641379|65650606|FG000|Overall Study|PCR positive at Week 24|15|||
23521854|NCT02641379|65650607|FG001|Overall Study|PCR positive at Week 24|21|||
23521855|NCT02641379|65650608|FG002|Overall Study|PCR positive at Week 24|62|||
23521856|NCT02641379|65650609|FG003|Overall Study|PCR positive at Week 24|0|||
23521857|NCT02641379|65650610|FG004|Overall Study|PCR positive at Week 24|0|||
23521858|NCT02641379|65650611|FG005|Overall Study|PCR positive at Week 24|6|||
23521859|NCT02641379|65650612|FG006|Overall Study|PCR positive at Week 24|3|||
23521860|NCT02641379|65650613|FG007|Overall Study|PCR positive at Week 24|8|||
23521861|NCT02641379|65650614|FG008|Overall Study|PCR positive at Week 24|0|||
23521862|NCT02641379|65650615|FG009|Overall Study|PCR positive at Week 24|1|||
23521863|NCT02641379|65650616|FG010|Overall Study|PCR positive at Week 24|0|||
23521864|NCT02641379|65650606|FG000|Overall Study|PCR positive at follow up 2|1|||
23521865|NCT02641379|65650607|FG001|Overall Study|PCR positive at follow up 2|0|||
23205318|NCT02065622|64491320|FG002|Maintenance Study|Lack of Efficacy|70|||
23205319|NCT02065622|64491321|FG003|Maintenance Study|Lack of Efficacy|55|||
23205320|NCT02065622|64491322|FG004|Maintenance Study|Lack of Efficacy|19|||
23205321|NCT02065622|64491318|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
23205322|NCT02065622|64491319|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
23205323|NCT02065622|64491320|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
23521866|NCT02641379|65650608|FG002|Overall Study|PCR positive at follow up 2|0|||
23521867|NCT02641379|65650609|FG003|Overall Study|PCR positive at follow up 2|0|||
23521868|NCT02641379|65650610|FG004|Overall Study|PCR positive at follow up 2|0|||
23521869|NCT02641379|65650611|FG005|Overall Study|PCR positive at follow up 2|0|||
23521870|NCT02641379|65650612|FG006|Overall Study|PCR positive at follow up 2|0|||
23521871|NCT02641379|65650613|FG007|Overall Study|PCR positive at follow up 2|0|||
23205324|NCT02065622|64491321|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
23205325|NCT02065622|64491322|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
23205326|NCT02065622|64491318|FG000|Maintenance Study|Subject Non-Compliance|0|||
23205327|NCT02065622|64491319|FG001|Maintenance Study|Subject Non-Compliance|0|||
23205328|NCT02065622|64491320|FG002|Maintenance Study|Subject Non-Compliance|1|||
23521872|NCT02641379|65650614|FG008|Overall Study|PCR positive at follow up 2|0|||
23521873|NCT02641379|65650615|FG009|Overall Study|PCR positive at follow up 2|0|||
23521874|NCT02641379|65650616|FG010|Overall Study|PCR positive at follow up 2|0|||
23521875|NCT02641379|65650606|FG000|Overall Study|Participant showed relapse|1|||
23521876|NCT02641379|65650607|FG001|Overall Study|Participant showed relapse|0|||
23521877|NCT02641379|65650608|FG002|Overall Study|Participant showed relapse|0|||
23521878|NCT02641379|65650609|FG003|Overall Study|Participant showed relapse|0|||
23521879|NCT02641379|65650610|FG004|Overall Study|Participant showed relapse|0|||
23521880|NCT02641379|65650611|FG005|Overall Study|Participant showed relapse|0|||
23521881|NCT02641379|65650612|FG006|Overall Study|Participant showed relapse|1|||
23521882|NCT02641379|65650613|FG007|Overall Study|Participant showed relapse|0|||
23521883|NCT02641379|65650614|FG008|Overall Study|Participant showed relapse|0|||
23521884|NCT02641379|65650615|FG009|Overall Study|Participant showed relapse|0|||
23521885|NCT02641379|65650616|FG010|Overall Study|Participant showed relapse|0|||
23521886|NCT02641379|65650606|FG000|Overall Study|Participant stopped study/treatment|1|||
23521887|NCT02641379|65650607|FG001|Overall Study|Participant stopped study/treatment|3|||
23307835|NCT02563106|64870619|FG000|Overall Study|Withdrawal by Subject|7|||
23307836|NCT02563106|64870620|FG001|Overall Study|Withdrawal by Subject|8|||
23307837|NCT02563106|64870619|FG000|Overall Study|Adverse Event|17|||
23307838|NCT02563106|64870620|FG001|Overall Study|Adverse Event|15|||
23521888|NCT02641379|65650608|FG002|Overall Study|Participant stopped study/treatment|1|||
23521889|NCT02641379|65650609|FG003|Overall Study|Participant stopped study/treatment|0|||
23521890|NCT02641379|65650610|FG004|Overall Study|Participant stopped study/treatment|0|||
23521891|NCT02641379|65650611|FG005|Overall Study|Participant stopped study/treatment|1|||
23521892|NCT02641379|65650612|FG006|Overall Study|Participant stopped study/treatment|2|||
23521893|NCT02641379|65650613|FG007|Overall Study|Participant stopped study/treatment|0|||
23521894|NCT02641379|65650614|FG008|Overall Study|Participant stopped study/treatment|1|||
23521895|NCT02641379|65650615|FG009|Overall Study|Participant stopped study/treatment|0|||
23521896|NCT02641379|65650616|FG010|Overall Study|Participant stopped study/treatment|0|||
23521897|NCT02641379|65650606|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
23521898|NCT02641379|65650607|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
23521899|NCT02641379|65650608|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
23521900|NCT02641379|65650609|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
23521901|NCT02641379|65650610|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
23521902|NCT02641379|65650611|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
23521903|NCT02641379|65650612|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
23521904|NCT02641379|65650613|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
23521905|NCT02641379|65650614|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
23521906|NCT02641379|65650615|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
23521907|NCT02641379|65650616|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
23521908|NCT02641379|65650606|FG000|Overall Study|Financial problems|0|||
23521909|NCT02641379|65650607|FG001|Overall Study|Financial problems|1|||
23521910|NCT02641379|65650608|FG002|Overall Study|Financial problems|0|||
23521911|NCT02641379|65650609|FG003|Overall Study|Financial problems|0|||
23521912|NCT02641379|65650610|FG004|Overall Study|Financial problems|0|||
23521913|NCT02641379|65650611|FG005|Overall Study|Financial problems|0|||
23521914|NCT02641379|65650612|FG006|Overall Study|Financial problems|0|||
23521915|NCT02641379|65650613|FG007|Overall Study|Financial problems|0|||
23521916|NCT02641379|65650614|FG008|Overall Study|Financial problems|0|||
23521917|NCT02641379|65650615|FG009|Overall Study|Financial problems|0|||
23521918|NCT02641379|65650616|FG010|Overall Study|Financial problems|0|||
23521919|NCT02641379|65650606|FG000|Overall Study|PCR positive at Week 68|0|||
23521920|NCT02641379|65650607|FG001|Overall Study|PCR positive at Week 68|1|||
23521921|NCT02641379|65650608|FG002|Overall Study|PCR positive at Week 68|0|||
23521922|NCT02641379|65650609|FG003|Overall Study|PCR positive at Week 68|0|||
23521923|NCT02641379|65650610|FG004|Overall Study|PCR positive at Week 68|0|||
23521924|NCT02641379|65650611|FG005|Overall Study|PCR positive at Week 68|0|||
23521925|NCT02641379|65650612|FG006|Overall Study|PCR positive at Week 68|0|||
23521926|NCT02641379|65650613|FG007|Overall Study|PCR positive at Week 68|0|||
23521927|NCT02641379|65650614|FG008|Overall Study|PCR positive at Week 68|0|||
23521928|NCT02641379|65650615|FG009|Overall Study|PCR positive at Week 68|0|||
23521929|NCT02641379|65650616|FG010|Overall Study|PCR positive at Week 68|0|||
23521930|NCT02641379|65650606|FG000|Overall Study|PCR positive at Week 48|0|||
23521931|NCT02641379|65650607|FG001|Overall Study|PCR positive at Week 48|1|||
23521932|NCT02641379|65650608|FG002|Overall Study|PCR positive at Week 48|0|||
23521933|NCT02641379|65650609|FG003|Overall Study|PCR positive at Week 48|0|||
23521934|NCT02641379|65650610|FG004|Overall Study|PCR positive at Week 48|0|||
23521935|NCT02641379|65650611|FG005|Overall Study|PCR positive at Week 48|0|||
23307839|NCT02563106|64870619|FG000|Overall Study|Protocol Violation|1|||
23307840|NCT02563106|64870620|FG001|Overall Study|Protocol Violation|0|||
23521936|NCT02641379|65650612|FG006|Overall Study|PCR positive at Week 48|0|||
23521937|NCT02641379|65650613|FG007|Overall Study|PCR positive at Week 48|0|||
23521938|NCT02641379|65650614|FG008|Overall Study|PCR positive at Week 48|0|||
23521939|NCT02641379|65650615|FG009|Overall Study|PCR positive at Week 48|0|||
23307841|NCT02563106|64870619|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
23521940|NCT02641379|65650616|FG010|Overall Study|PCR positive at Week 48|0|||
23521941|NCT02641379|65650606|FG000|Overall Study|PCR not performed at Week 12|0|||
23521942|NCT02641379|65650607|FG001|Overall Study|PCR not performed at Week 12|0|||
23521943|NCT02641379|65650608|FG002|Overall Study|PCR not performed at Week 12|1|||
23521944|NCT02641379|65650609|FG003|Overall Study|PCR not performed at Week 12|0|||
23521945|NCT02641379|65650610|FG004|Overall Study|PCR not performed at Week 12|0|||
23521946|NCT02641379|65650611|FG005|Overall Study|PCR not performed at Week 12|0|||
23521947|NCT02641379|65650612|FG006|Overall Study|PCR not performed at Week 12|0|||
23205329|NCT02065622|64491321|FG003|Maintenance Study|Subject Non-Compliance|3|||
23205330|NCT02065622|64491322|FG004|Maintenance Study|Subject Non-Compliance|2|||
23205331|NCT02065622|64491318|FG000|Maintenance Study|Other, Not Specified|0|||
23205332|NCT02065622|64491319|FG001|Maintenance Study|Other, Not Specified|0|||
23205333|NCT02065622|64491320|FG002|Maintenance Study|Other, Not Specified|6|||
23205334|NCT02065622|64491321|FG003|Maintenance Study|Other, Not Specified|14|||
23205335|NCT02065622|64491322|FG004|Maintenance Study|Other, Not Specified|2|||
23205336|NCT02065622|64491318|FG000|Maintenance Study|Unknown Reason|0|||
23205337|NCT02065622|64491319|FG001|Maintenance Study|Unknown Reason|0|||
23205338|NCT02065622|64491320|FG002|Maintenance Study|Unknown Reason|0|||
23205339|NCT02065622|64491321|FG003|Maintenance Study|Unknown Reason|1|||
23205340|NCT02065622|64491322|FG004|Maintenance Study|Unknown Reason|0|||
23205341|NCT00683475|64491323|FG000|Overall Study|Withdrawal by Subject|1|||
23205342|NCT00683475|64491324|FG001|Overall Study|Withdrawal by Subject|0|||
23205343|NCT00683475|64491323|FG000|Overall Study|Never Treated: Adverse Event|2|||
23307842|NCT02563106|64870620|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
23307843|NCT02563106|64870619|FG000|Overall Study|Lost to Follow-up|3|||
23521948|NCT02641379|65650613|FG007|Overall Study|PCR not performed at Week 12|0|||
23521949|NCT02641379|65650614|FG008|Overall Study|PCR not performed at Week 12|0|||
23521950|NCT02641379|65650615|FG009|Overall Study|PCR not performed at Week 12|0|||
23521951|NCT02641379|65650616|FG010|Overall Study|PCR not performed at Week 12|0|||
23521952|NCT02641379|65650606|FG000|Overall Study|No PCR at baseline|0|||
23521953|NCT02641379|65650607|FG001|Overall Study|No PCR at baseline|0|||
23521954|NCT02641379|65650608|FG002|Overall Study|No PCR at baseline|1|||
23521955|NCT02641379|65650609|FG003|Overall Study|No PCR at baseline|0|||
23521956|NCT02641379|65650610|FG004|Overall Study|No PCR at baseline|0|||
23521957|NCT02641379|65650611|FG005|Overall Study|No PCR at baseline|0|||
23521958|NCT02641379|65650612|FG006|Overall Study|No PCR at baseline|0|||
23521959|NCT02641379|65650613|FG007|Overall Study|No PCR at baseline|0|||
23521960|NCT02641379|65650614|FG008|Overall Study|No PCR at baseline|0|||
23521961|NCT02641379|65650615|FG009|Overall Study|No PCR at baseline|0|||
23521962|NCT02641379|65650616|FG010|Overall Study|No PCR at baseline|0|||
23521963|NCT02641379|65650606|FG000|Overall Study|PCR positive at Week 28|0|||
23521964|NCT02641379|65650607|FG001|Overall Study|PCR positive at Week 28|0|||
23521965|NCT02641379|65650608|FG002|Overall Study|PCR positive at Week 28|1|||
23521966|NCT02641379|65650609|FG003|Overall Study|PCR positive at Week 28|0|||
23521967|NCT02641379|65650610|FG004|Overall Study|PCR positive at Week 28|0|||
23521968|NCT02641379|65650611|FG005|Overall Study|PCR positive at Week 28|0|||
23521969|NCT02641379|65650612|FG006|Overall Study|PCR positive at Week 28|0|||
23521970|NCT02641379|65650613|FG007|Overall Study|PCR positive at Week 28|0|||
23521971|NCT02641379|65650614|FG008|Overall Study|PCR positive at Week 28|0|||
23521972|NCT02641379|65650615|FG009|Overall Study|PCR positive at Week 28|0|||
23521973|NCT02641379|65650616|FG010|Overall Study|PCR positive at Week 28|0|||
23521974|NCT02641379|65650606|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
23521975|NCT02641379|65650607|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
23521976|NCT02641379|65650608|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
23521977|NCT02641379|65650609|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
23521978|NCT02641379|65650610|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
23521979|NCT02641379|65650611|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
23521980|NCT02641379|65650612|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
23521981|NCT02641379|65650613|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
23521982|NCT02641379|65650614|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
23521983|NCT02641379|65650615|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
23205344|NCT00683475|64491324|FG001|Overall Study|Never Treated: Adverse Event|3|||
23521984|NCT02641379|65650616|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
23205345|NCT00683475|64491323|FG000|Overall Study|Never Treated: Progressive Disease|1|||
23521985|NCT02641379|65650606|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
23521986|NCT02641379|65650607|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
23521987|NCT02641379|65650608|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
23521988|NCT02641379|65650609|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
23521989|NCT02641379|65650610|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
23521990|NCT02641379|65650611|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
23521991|NCT02641379|65650612|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
23521992|NCT02641379|65650613|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
23521993|NCT02641379|65650614|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
23521994|NCT02641379|65650615|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
23521995|NCT02641379|65650616|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
23521996|NCT02641379|65650606|FG000|Overall Study|Baseline viral load unavailable|0|||
23521997|NCT02641379|65650607|FG001|Overall Study|Baseline viral load unavailable|0|||
23521998|NCT02641379|65650608|FG002|Overall Study|Baseline viral load unavailable|0|||
23521999|NCT02641379|65650609|FG003|Overall Study|Baseline viral load unavailable|1|||
23522000|NCT02641379|65650610|FG004|Overall Study|Baseline viral load unavailable|0|||
23522001|NCT02641379|65650611|FG005|Overall Study|Baseline viral load unavailable|0|||
23522002|NCT02641379|65650612|FG006|Overall Study|Baseline viral load unavailable|0|||
23522003|NCT02641379|65650613|FG007|Overall Study|Baseline viral load unavailable|0|||
23522004|NCT02641379|65650614|FG008|Overall Study|Baseline viral load unavailable|0|||
23522005|NCT02641379|65650615|FG009|Overall Study|Baseline viral load unavailable|0|||
23522006|NCT02641379|65650616|FG010|Overall Study|Baseline viral load unavailable|0|||
23522007|NCT02641379|65650606|FG000|Overall Study|Blood could not be drawn|0|||
23522008|NCT02641379|65650607|FG001|Overall Study|Blood could not be drawn|0|||
23522009|NCT02641379|65650608|FG002|Overall Study|Blood could not be drawn|0|||
23522010|NCT02641379|65650609|FG003|Overall Study|Blood could not be drawn|0|||
23522011|NCT02641379|65650610|FG004|Overall Study|Blood could not be drawn|1|||
23522012|NCT02641379|65650611|FG005|Overall Study|Blood could not be drawn|0|||
23522013|NCT02641379|65650612|FG006|Overall Study|Blood could not be drawn|0|||
23522014|NCT02641379|65650613|FG007|Overall Study|Blood could not be drawn|0|||
23522015|NCT02641379|65650614|FG008|Overall Study|Blood could not be drawn|0|||
23522016|NCT02641379|65650615|FG009|Overall Study|Blood could not be drawn|0|||
23522017|NCT02641379|65650616|FG010|Overall Study|Blood could not be drawn|0|||
23522018|NCT02641379|65650606|FG000|Overall Study|Protocol Violation|0|||
23522019|NCT02641379|65650607|FG001|Overall Study|Protocol Violation|0|||
23522020|NCT02641379|65650608|FG002|Overall Study|Protocol Violation|0|||
23522021|NCT02641379|65650609|FG003|Overall Study|Protocol Violation|0|||
23522022|NCT02641379|65650610|FG004|Overall Study|Protocol Violation|2|||
23522023|NCT02641379|65650611|FG005|Overall Study|Protocol Violation|0|||
23522024|NCT02641379|65650612|FG006|Overall Study|Protocol Violation|0|||
23522025|NCT02641379|65650613|FG007|Overall Study|Protocol Violation|0|||
23522026|NCT02641379|65650614|FG008|Overall Study|Protocol Violation|1|||
23522027|NCT02641379|65650615|FG009|Overall Study|Protocol Violation|0|||
23522028|NCT02641379|65650616|FG010|Overall Study|Protocol Violation|0|||
23522029|NCT02641379|65650606|FG000|Overall Study|Participation in sili rescue study|0|||
23522030|NCT02641379|65650607|FG001|Overall Study|Participation in sili rescue study|0|||
23522031|NCT02641379|65650608|FG002|Overall Study|Participation in sili rescue study|0|||
23522032|NCT02641379|65650609|FG003|Overall Study|Participation in sili rescue study|0|||
23522033|NCT02641379|65650610|FG004|Overall Study|Participation in sili rescue study|0|||
23522034|NCT02641379|65650611|FG005|Overall Study|Participation in sili rescue study|1|||
23522035|NCT02641379|65650612|FG006|Overall Study|Participation in sili rescue study|0|||
23522036|NCT02641379|65650613|FG007|Overall Study|Participation in sili rescue study|0|||
23522037|NCT02641379|65650614|FG008|Overall Study|Participation in sili rescue study|0|||
23522038|NCT02641379|65650615|FG009|Overall Study|Participation in sili rescue study|0|||
23522039|NCT02641379|65650616|FG010|Overall Study|Participation in sili rescue study|0|||
23522040|NCT02641379|65650606|FG000|Overall Study|Lost to Follow-up|0|||
23522041|NCT02641379|65650607|FG001|Overall Study|Lost to Follow-up|0|||
23522042|NCT02641379|65650608|FG002|Overall Study|Lost to Follow-up|0|||
23522043|NCT02641379|65650609|FG003|Overall Study|Lost to Follow-up|0|||
23522044|NCT02641379|65650610|FG004|Overall Study|Lost to Follow-up|0|||
23522045|NCT02641379|65650611|FG005|Overall Study|Lost to Follow-up|0|||
23522046|NCT02641379|65650612|FG006|Overall Study|Lost to Follow-up|0|||
23522047|NCT02641379|65650613|FG007|Overall Study|Lost to Follow-up|0|||
23522048|NCT02641379|65650614|FG008|Overall Study|Lost to Follow-up|1|||
23522049|NCT02641379|65650615|FG009|Overall Study|Lost to Follow-up|0|||
23522050|NCT02641379|65650616|FG010|Overall Study|Lost to Follow-up|0|||
23522051|NCT02641379|65650606|FG000|Overall Study|Source data not found|0|||
23522052|NCT02641379|65650607|FG001|Overall Study|Source data not found|0|||
23522053|NCT02641379|65650608|FG002|Overall Study|Source data not found|0|||
23522054|NCT02641379|65650609|FG003|Overall Study|Source data not found|0|||
23522055|NCT02641379|65650610|FG004|Overall Study|Source data not found|0|||
23522056|NCT02641379|65650611|FG005|Overall Study|Source data not found|1|||
23522057|NCT02641379|65650612|FG006|Overall Study|Source data not found|0|||
23522058|NCT02641379|65650613|FG007|Overall Study|Source data not found|0|||
23522059|NCT02641379|65650614|FG008|Overall Study|Source data not found|0|||
23205346|NCT00683475|64491324|FG001|Overall Study|Never Treated: Progressive Disease|0|||
23205347|NCT03076190|64491325|FG000|Overall Study|Lost to Follow-up|9|||
23205348|NCT03076190|64491326|FG001|Overall Study|Lost to Follow-up|34|||
23205349|NCT03076190|64491325|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
23522060|NCT02641379|65650615|FG009|Overall Study|Source data not found|0|||
23522061|NCT02641379|65650616|FG010|Overall Study|Source data not found|0|||
23522062|NCT02641379|65650606|FG000|Overall Study|Participant showed weight reduction|0|||
23522063|NCT02641379|65650607|FG001|Overall Study|Participant showed weight reduction|0|||
23522064|NCT02641379|65650608|FG002|Overall Study|Participant showed weight reduction|0|||
23522065|NCT02641379|65650609|FG003|Overall Study|Participant showed weight reduction|0|||
23522066|NCT02641379|65650610|FG004|Overall Study|Participant showed weight reduction|0|||
23522067|NCT02641379|65650611|FG005|Overall Study|Participant showed weight reduction|0|||
23522068|NCT02641379|65650612|FG006|Overall Study|Participant showed weight reduction|0|||
23522069|NCT02641379|65650613|FG007|Overall Study|Participant showed weight reduction|1|||
23522070|NCT02641379|65650614|FG008|Overall Study|Participant showed weight reduction|0|||
23522071|NCT02641379|65650615|FG009|Overall Study|Participant showed weight reduction|0|||
23522072|NCT02641379|65650616|FG010|Overall Study|Participant showed weight reduction|0|||
23522073|NCT02641379|65650606|FG000|Overall Study|Non-response Week 12|0|||
23522074|NCT02641379|65650607|FG001|Overall Study|Non-response Week 12|0|||
23522075|NCT02641379|65650608|FG002|Overall Study|Non-response Week 12|0|||
23522076|NCT02641379|65650609|FG003|Overall Study|Non-response Week 12|0|||
23522077|NCT02641379|65650610|FG004|Overall Study|Non-response Week 12|0|||
23522078|NCT02641379|65650611|FG005|Overall Study|Non-response Week 12|0|||
23522079|NCT02641379|65650612|FG006|Overall Study|Non-response Week 12|0|||
23522080|NCT02641379|65650613|FG007|Overall Study|Non-response Week 12|1|||
23522081|NCT02641379|65650614|FG008|Overall Study|Non-response Week 12|0|||
23522082|NCT02641379|65650615|FG009|Overall Study|Non-response Week 12|0|||
23522083|NCT02641379|65650616|FG010|Overall Study|Non-response Week 12|0|||
23522084|NCT02641379|65650606|FG000|Overall Study|No 2 Log drop at Week 12|0|||
23522085|NCT02641379|65650607|FG001|Overall Study|No 2 Log drop at Week 12|0|||
23522086|NCT02641379|65650608|FG002|Overall Study|No 2 Log drop at Week 12|0|||
23522087|NCT02641379|65650609|FG003|Overall Study|No 2 Log drop at Week 12|0|||
23522088|NCT02641379|65650610|FG004|Overall Study|No 2 Log drop at Week 12|0|||
23522089|NCT02641379|65650611|FG005|Overall Study|No 2 Log drop at Week 12|0|||
23522090|NCT02641379|65650612|FG006|Overall Study|No 2 Log drop at Week 12|0|||
23522091|NCT02641379|65650613|FG007|Overall Study|No 2 Log drop at Week 12|0|||
23522092|NCT02641379|65650614|FG008|Overall Study|No 2 Log drop at Week 12|0|||
23522093|NCT02641379|65650615|FG009|Overall Study|No 2 Log drop at Week 12|0|||
23522094|NCT02641379|65650616|FG010|Overall Study|No 2 Log drop at Week 12|1|||
23522095|NCT02641379|65650606|FG000|Overall Study|Negative PCR result|0|||
23522096|NCT02641379|65650607|FG001|Overall Study|Negative PCR result|0|||
23522097|NCT02641379|65650608|FG002|Overall Study|Negative PCR result|0|||
23522098|NCT02641379|65650609|FG003|Overall Study|Negative PCR result|0|||
23522099|NCT02641379|65650610|FG004|Overall Study|Negative PCR result|0|||
23522100|NCT02641379|65650611|FG005|Overall Study|Negative PCR result|0|||
23522101|NCT02641379|65650612|FG006|Overall Study|Negative PCR result|0|||
23522102|NCT02641379|65650613|FG007|Overall Study|Negative PCR result|0|||
23522103|NCT02641379|65650614|FG008|Overall Study|Negative PCR result|0|||
23522104|NCT02641379|65650615|FG009|Overall Study|Negative PCR result|1|||
23522105|NCT02641379|65650616|FG010|Overall Study|Negative PCR result|0|||
23522106|NCT02641379|65650606|FG000|Overall Study|Participant's PCR high|0|||
23522107|NCT02641379|65650607|FG001|Overall Study|Participant's PCR high|0|||
23522108|NCT02641379|65650608|FG002|Overall Study|Participant's PCR high|0|||
23522109|NCT02641379|65650609|FG003|Overall Study|Participant's PCR high|0|||
23522110|NCT02641379|65650610|FG004|Overall Study|Participant's PCR high|0|||
23522111|NCT02641379|65650611|FG005|Overall Study|Participant's PCR high|0|||
23611223|NCT01072149|65966723|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23205350|NCT03076190|64491326|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
23205351|NCT04876599|64491329|FG000|Overall Study|Missed|2|||
23205352|NCT04876599|64491330|FG001|Overall Study|Missed|0|||
23205353|NCT04876599|64491329|FG000|Overall Study|Declined|2|||
23205354|NCT04876599|64491330|FG001|Overall Study|Declined|3|||
23205355|NCT01533935|64491331|FG000|Overall Study|Adverse Event|5|||
23522112|NCT02641379|65650612|FG006|Overall Study|Participant's PCR high|0|||
23522113|NCT02641379|65650613|FG007|Overall Study|Participant's PCR high|1|||
23522114|NCT02641379|65650614|FG008|Overall Study|Participant's PCR high|0|||
23522115|NCT02641379|65650615|FG009|Overall Study|Participant's PCR high|0|||
23522116|NCT02641379|65650616|FG010|Overall Study|Participant's PCR high|0|||
23522117|NCT02641379|65650606|FG000|Overall Study|Participant treated after Week 24|0|||
23522118|NCT02641379|65650607|FG001|Overall Study|Participant treated after Week 24|0|||
23522119|NCT02641379|65650608|FG002|Overall Study|Participant treated after Week 24|0|||
23522120|NCT02641379|65650609|FG003|Overall Study|Participant treated after Week 24|0|||
23522121|NCT02641379|65650610|FG004|Overall Study|Participant treated after Week 24|0|||
23522122|NCT02641379|65650611|FG005|Overall Study|Participant treated after Week 24|0|||
23205356|NCT01533935|64491332|FG001|Overall Study|Adverse Event|7|||
23205357|NCT01533935|64491333|FG002|Overall Study|Adverse Event|1|||
23205358|NCT01533935|64491334|FG003|Overall Study|Adverse Event|5|||
23205359|NCT01533935|64491335|FG004|Overall Study|Adverse Event|3|||
23205360|NCT01533935|64491331|FG000|Overall Study|Protocol Violation|0|||
23205361|NCT01533935|64491332|FG001|Overall Study|Protocol Violation|2|||
23205362|NCT01533935|64491333|FG002|Overall Study|Protocol Violation|0|||
23205363|NCT01533935|64491334|FG003|Overall Study|Protocol Violation|0|||
23205364|NCT01533935|64491335|FG004|Overall Study|Protocol Violation|0|||
23205365|NCT01533935|64491331|FG000|Overall Study|Lost to Follow-up|0|||
23205366|NCT01533935|64491332|FG001|Overall Study|Lost to Follow-up|0|||
23307844|NCT02563106|64870620|FG001|Overall Study|Lost to Follow-up|2|||
23522123|NCT02641379|65650612|FG006|Overall Study|Participant treated after Week 24|0|||
23522124|NCT02641379|65650613|FG007|Overall Study|Participant treated after Week 24|0|||
23522125|NCT02641379|65650614|FG008|Overall Study|Participant treated after Week 24|1|||
23522126|NCT02641379|65650615|FG009|Overall Study|Participant treated after Week 24|0|||
23522127|NCT02641379|65650616|FG010|Overall Study|Participant treated after Week 24|0|||
23522128|NCT02641379|65650606|FG000|Overall Study|Missing PCR result at Week 8|0|||
23522129|NCT02641379|65650607|FG001|Overall Study|Missing PCR result at Week 8|0|||
23522130|NCT02641379|65650608|FG002|Overall Study|Missing PCR result at Week 8|0|||
23522131|NCT02641379|65650609|FG003|Overall Study|Missing PCR result at Week 8|0|||
23522132|NCT02641379|65650610|FG004|Overall Study|Missing PCR result at Week 8|0|||
23522133|NCT02641379|65650611|FG005|Overall Study|Missing PCR result at Week 8|0|||
23522134|NCT02641379|65650612|FG006|Overall Study|Missing PCR result at Week 8|0|||
23522135|NCT02641379|65650613|FG007|Overall Study|Missing PCR result at Week 8|0|||
23522136|NCT02641379|65650614|FG008|Overall Study|Missing PCR result at Week 8|0|||
23522137|NCT02641379|65650615|FG009|Overall Study|Missing PCR result at Week 8|1|||
23522138|NCT02641379|65650616|FG010|Overall Study|Missing PCR result at Week 8|0|||
23522139|NCT02641379|65650606|FG000|Overall Study|PCR positive|0|||
23522140|NCT02641379|65650607|FG001|Overall Study|PCR positive|0|||
23522141|NCT02641379|65650608|FG002|Overall Study|PCR positive|0|||
23522142|NCT02641379|65650609|FG003|Overall Study|PCR positive|0|||
23522143|NCT02641379|65650610|FG004|Overall Study|PCR positive|0|||
23522144|NCT02641379|65650611|FG005|Overall Study|PCR positive|0|||
23522145|NCT02641379|65650612|FG006|Overall Study|PCR positive|1|||
23522146|NCT02641379|65650613|FG007|Overall Study|PCR positive|0|||
23522147|NCT02641379|65650614|FG008|Overall Study|PCR positive|0|||
23522148|NCT02641379|65650615|FG009|Overall Study|PCR positive|0|||
23522149|NCT02641379|65650616|FG010|Overall Study|PCR positive|0|||
23522150|NCT02436759|65650617|FG000|Overall Study|Adverse Event|3|||
23522151|NCT02436759|65650618|FG001|Overall Study|Adverse Event|0|||
23522152|NCT02436759|65650617|FG000|Overall Study|Protocol Violation|1|||
23205367|NCT01533935|64491333|FG002|Overall Study|Lost to Follow-up|1|||
23205368|NCT01533935|64491334|FG003|Overall Study|Lost to Follow-up|0|||
23205369|NCT01533935|64491335|FG004|Overall Study|Lost to Follow-up|0|||
23205370|NCT01533935|64491331|FG000|Overall Study|Withdrawal by Subject|0|||
23522153|NCT02436759|65650618|FG001|Overall Study|Protocol Violation|0|||
23522154|NCT02436759|65650617|FG000|Overall Study|Withdrawal by Subject|0|||
23522155|NCT02436759|65650618|FG001|Overall Study|Withdrawal by Subject|1|||
23522156|NCT02281552|65650623|FG000|Overall Study|Medication error|1|||
23522157|NCT02281552|65650624|FG001|Overall Study|Medication error|0|||
23522158|NCT02281552|65650623|FG000|Overall Study|Insufficient clinical response|0|||
23522159|NCT02281552|65650624|FG001|Overall Study|Insufficient clinical response|1|||
23522160|NCT02281552|65650623|FG000|Overall Study|Adverse Event|3|||
23522161|NCT02281552|65650624|FG001|Overall Study|Adverse Event|9|||
23522162|NCT00573755|65650629|FG000|Overall Study|Still receiving treatment|1|||
23522163|NCT00573755|65650630|FG001|Overall Study|Still receiving treatment|0|||
23522164|NCT00480779|65650636|FG000|Overall Study|Other|2|||
23522165|NCT00480779|65650637|FG001|Overall Study|Other|0|||
23522166|NCT00480779|65650636|FG000|Overall Study|Job and Health-related|0|||
23522167|NCT00480779|65650637|FG001|Overall Study|Job and Health-related|3|||
23522168|NCT01859507|65650638|FG000|Overall Study|left the country|4|||
23522169|NCT02519712|65650639|FG000|Overall Study|Disease Relapse|1|||
23522170|NCT02519712|65650639|FG000|Overall Study|Disease Progression|1|||
23522171|NCT02519712|65650639|FG000|Overall Study|Accruals are donors|2|||
23522172|NCT00896337|65650640|FG000|Overall Study|Death|7|||
23522173|NCT00896337|65650640|FG000|Overall Study|Withdrawal by Subject|7|||
23522174|NCT00896337|65650640|FG000|Overall Study|Lost to Follow-up|11|||
23522175|NCT02276612|65650643|FG000|Overall Study|Death|1|||
23522176|NCT02276612|65650644|FG001|Overall Study|Death|0|||
23522177|NCT02276612|65650643|FG000|Overall Study|Pregnancy|1|||
23522178|NCT02276612|65650644|FG001|Overall Study|Pregnancy|0|||
23522179|NCT02276612|65650643|FG000|Overall Study|Withdrew Consent|1|||
23522180|NCT02276612|65650644|FG001|Overall Study|Withdrew Consent|0|||
23522181|NCT02276612|65650643|FG000|Overall Study|Lost to Follow-up|1|||
23522182|NCT02276612|65650644|FG001|Overall Study|Lost to Follow-up|0|||
23522183|NCT00026793|65650646|FG000|Overall Study|Death on study due to underlying disease|4|||
23522184|NCT00026793|65650646|FG000|Overall Study|Physician Decision|2|||
23522185|NCT00026793|65650646|FG000|Overall Study|Off study|2|||
23522186|NCT04356963|65650647|FG000|First Session|Withdrawal by Subject|1|||
23522187|NCT04356963|65650647|FG000|Second Session|Withdrawal by Subject|3|||
23522188|NCT04356963|65650647|FG000|Second Session|Lost to Follow-up|1|||
23522189|NCT04356963|65650647|FG000|Third Session|Lost to Follow-up|6|||
23522190|NCT04356963|65650647|FG000|Third Session|Withdrawal by Subject|1|||
23522191|NCT03724812|65650650|FG000|Overall Study|Missed Visit|1|||
23522192|NCT03724812|65650650|FG000|Overall Study|Death|2|||
23522193|NCT03724812|65650650|FG000|Overall Study|Withdrawal by Subject|1|||
23522194|NCT01574612|65650651|FG000|Overall Study|Adverse Event|3|||
23522195|NCT01574612|65650651|FG000|Overall Study|non compliant with drug|2|||
23522196|NCT01574612|65650651|FG000|Overall Study|Withdrawal by Subject|1|||
23522197|NCT01574612|65650651|FG000|Overall Study|Lost to Follow-up|2|||
23522198|NCT02295995|65650654|FG000|Overall Study|Lost to Follow-up|5|||
23522199|NCT02295995|65650655|FG001|Overall Study|Lost to Follow-up|1|||
23307845|NCT02563106|64870619|FG000|Overall Study|Physician Decision|3|||
23307846|NCT02563106|64870620|FG001|Overall Study|Physician Decision|1|||
23307847|NCT02563106|64870619|FG000|Overall Study|Other reason - not specified|2|||
23522200|NCT03999892|65650659|FG000|Overall Study|Lost to Follow-up|1|||
23522201|NCT03642717|65650660|FG000|Overall Study|Lost to Follow-up|2|||
23522202|NCT03642717|65650660|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
23522203|NCT03642717|65650660|FG000|Overall Study|Taken study drug prior to contract date|3|||
23522204|NCT01289847|65650663|FG000|Overall Study|Patient could not comply with visits|1|||
23522205|NCT04059146|65650664|FG000|Overall Study|Withdrawal by Subject|0|||
23522206|NCT04059146|65650665|FG001|Overall Study|Withdrawal by Subject|1|||
23522207|NCT01526889|65650667|FG000|Treatment Period|Adverse Event|2|||
23522208|NCT01526889|65650668|FG001|Treatment Period|Adverse Event|0|||
23522209|NCT01526889|65650667|FG000|Treatment Extension Period|Administrative problems|1|||
23522210|NCT01526889|65650668|FG001|Treatment Extension Period|Administrative problems|0|||
23522211|NCT01549964|65650669|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
23522212|NCT01549964|65650670|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
23522213|NCT01549964|65650671|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
23522214|NCT01549964|65650672|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
23522215|NCT01549964|65650669|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
23522216|NCT01549964|65650670|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
23522217|NCT01549964|65650671|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
23522218|NCT01549964|65650672|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
23522219|NCT01549964|65650669|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
23522220|NCT01549964|65650670|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
23522221|NCT01549964|65650671|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
23522222|NCT01549964|65650672|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
23522223|NCT01549964|65650669|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
23522224|NCT01549964|65650670|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
23522225|NCT01549964|65650671|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
23522226|NCT01549964|65650672|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
23522227|NCT01549964|65650669|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
23307848|NCT02563106|64870620|FG001|Overall Study|Other reason - not specified|1|||
23307849|NCT00506129|64870621|FG000|Overall Study|Disease Progression/Relapse|15|||
23307850|NCT00506129|64870621|FG000|Overall Study|Death|7|||
23307851|NCT03327792|64873890|FG000|Overall Study|Adverse Event|4|||
23307852|NCT03327792|64873891|FG001|Overall Study|Adverse Event|0|||
23307853|NCT03327792|64873890|FG000|Overall Study|Family/Personal issues|3|||
23307854|NCT03327792|64873891|FG001|Overall Study|Family/Personal issues|2|||
23522228|NCT01549964|65650670|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
23522229|NCT01549964|65650671|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
23522230|NCT01549964|65650672|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
23522231|NCT01549964|65650669|FG000|24-Week Treatment Period|Other|1|||
23522232|NCT01549964|65650670|FG001|24-Week Treatment Period|Other|0|||
23307855|NCT03327792|64873890|FG000|Overall Study|Lost to Follow-up|0|||
23307856|NCT03327792|64873891|FG001|Overall Study|Lost to Follow-up|1|||
23522233|NCT01549964|65650671|FG002|24-Week Treatment Period|Other|1|||
23307857|NCT00128830|64873892|FG000|Overall Study|Adverse Event|10|||
23522234|NCT01549964|65650672|FG003|24-Week Treatment Period|Other|0|||
23307858|NCT00128830|64873892|FG000|Overall Study|Withdrawal by Subject|14|||
23307859|NCT00128830|64873892|FG000|Overall Study|Lost to Follow-up|4|||
23522235|NCT01549964|65650669|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
23307860|NCT00128830|64873892|FG000|Overall Study|Reached a virologic endpoint|29|||
23307861|NCT00128830|64873892|FG000|Overall Study|Non-compliant|4|||
23307862|NCT00128830|64873892|FG000|Overall Study|Discontinued or ineligible for study|2|||
23307863|NCT00128830|64873892|FG000|Overall Study|Other|9|||
23307864|NCT00936897|64873893|FG000|Overall Study|Withdrawal by Subject|9|||
23522236|NCT01549964|65650670|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
23522237|NCT01549964|65650671|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
23522238|NCT01549964|65650672|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
23522239|NCT01549964|65650669|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
23522240|NCT01549964|65650670|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
23522241|NCT01549964|65650671|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
23522242|NCT01549964|65650672|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
23522243|NCT01549964|65650669|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
23522244|NCT01549964|65650670|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
23522245|NCT01549964|65650671|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
23522246|NCT01549964|65650672|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
23522247|NCT01549964|65650669|FG000|80-Week Extension Period|Pregnancy|0|||
23522248|NCT01549964|65650670|FG001|80-Week Extension Period|Pregnancy|0|||
23522249|NCT01549964|65650671|FG002|80-Week Extension Period|Pregnancy|1|||
23522250|NCT01549964|65650672|FG003|80-Week Extension Period|Pregnancy|0|||
23307865|NCT00936897|64873894|FG001|Overall Study|Withdrawal by Subject|19|||
23522251|NCT01549964|65650669|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
23522252|NCT01549964|65650670|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
23307866|NCT00936897|64873893|FG000|Overall Study|Adverse Event|4|||
23307867|NCT00936897|64873894|FG001|Overall Study|Adverse Event|13|||
23307868|NCT00936897|64873893|FG000|Overall Study|Other|3|||
23307869|NCT00936897|64873894|FG001|Overall Study|Other|9|||
23307870|NCT00936897|64873893|FG000|Overall Study|Lost to Follow-up|1|||
23522253|NCT01549964|65650671|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
23522254|NCT01549964|65650672|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
23522255|NCT01549964|65650669|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
23522256|NCT01549964|65650670|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
23522257|NCT01549964|65650671|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
23522258|NCT01549964|65650672|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
23522259|NCT01549964|65650669|FG000|80-Week Extension Period|Lost to Follow-up|1|||
23522260|NCT01549964|65650670|FG001|80-Week Extension Period|Lost to Follow-up|0|||
23522261|NCT01549964|65650671|FG002|80-Week Extension Period|Lost to Follow-up|2|||
23522262|NCT01549964|65650672|FG003|80-Week Extension Period|Lost to Follow-up|1|||
23522263|NCT01549964|65650669|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
23522264|NCT01549964|65650670|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
23522265|NCT01549964|65650671|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
23522266|NCT01549964|65650672|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
23522267|NCT01520363|65650675|FG000|Overall Study|Withdrawal by Subject|2|||
23522268|NCT01520363|65650676|FG001|Overall Study|Withdrawal by Subject|0|||
23522269|NCT02028988|65650680|FG000|Overall Study|Withdrawal by Subject|2|||
23522270|NCT00549562|65650698|FG000|Overall Study|Adverse Event|1|||
23522271|NCT00549562|65650698|FG000|Overall Study|Lack of Efficacy|1|||
23522272|NCT00235872|65650699|FG000|Overall Study|Adverse Event|34|||
23522273|NCT00235872|65650699|FG000|Overall Study|Death|1|||
23522274|NCT00235872|65650699|FG000|Overall Study|Lost to Follow-up|1|||
23522275|NCT00235872|65650699|FG000|Overall Study|Withdrawal by Subject|50|||
23522276|NCT00235872|65650699|FG000|Overall Study|Administrative reason|61|||
23522277|NCT02726074|65650700|FG000|Overall Study|Withdrawal by Subject|4|||
23522278|NCT02726074|65650700|FG000|Overall Study|Adverse Event|14|||
23522279|NCT02726074|65650700|FG000|Overall Study|Protocol Violation|3|||
23522280|NCT02726074|65650700|FG000|Overall Study|Lost to Follow-up|2|||
23522281|NCT02726074|65650700|FG000|Overall Study|Others|3|||
23522282|NCT01120756|65650701|FG000|Overall Study|Withdrawal by Subject|1|||
23522283|NCT01120756|65650702|FG001|Overall Study|Withdrawal by Subject|1|||
23522284|NCT04649164|65650703|FG000|Overall Study|Withdrawal by Subject|1|||
23522285|NCT04649164|65650704|FG001|Overall Study|Withdrawal by Subject|1|||
23522286|NCT04649164|65650705|FG002|Overall Study|Withdrawal by Subject|2|||
23522287|NCT04649164|65650703|FG000|Overall Study|Participant's care recipient expired|0|||
23522288|NCT04649164|65650704|FG001|Overall Study|Participant's care recipient expired|0|||
23522289|NCT04649164|65650705|FG002|Overall Study|Participant's care recipient expired|2|||
23522290|NCT01319877|65650706|FG000|Overall Study|Lost to Follow-up|100|||
23522291|NCT01319877|65650707|FG001|Overall Study|Lost to Follow-up|37|||
23522292|NCT01319877|65650706|FG000|Overall Study|Physician Decision|2|||
23522293|NCT01319877|65650707|FG001|Overall Study|Physician Decision|0|||
23522294|NCT01319877|65650706|FG000|Overall Study|Disease Progression|2|||
23522295|NCT01319877|65650707|FG001|Overall Study|Disease Progression|2|||
23522296|NCT01319877|65650706|FG000|Overall Study|Withdrawal by Subject|0|||
23522297|NCT01319877|65650707|FG001|Overall Study|Withdrawal by Subject|1|||
23522298|NCT01319877|65650706|FG000|Overall Study|Reason Not Specified|4|||
23522299|NCT01319877|65650707|FG001|Overall Study|Reason Not Specified|5|||
23522300|NCT03979638|65650709|FG000|Period 1|Physician Decision|1|||
23522301|NCT03979638|65650710|FG001|Period 1|Physician Decision|1|||
23522302|NCT03979638|65650709|FG000|Period 1|Withdrawal by Subject|4|||
23522303|NCT03979638|65650710|FG001|Period 1|Withdrawal by Subject|3|||
23522304|NCT03979638|65650709|FG000|Period 1|Study terminated by Sponsor|1|||
23522305|NCT03979638|65650710|FG001|Period 1|Study terminated by Sponsor|3|||
23522306|NCT03979638|65650709|FG000|Period 1|Protocol Violation|1|||
23522307|NCT03979638|65650710|FG001|Period 1|Protocol Violation|0|||
23522308|NCT03979638|65650709|FG000|Period 2|Study terminated by Sponsor|1|||
23522309|NCT03979638|65650710|FG001|Period 2|Study terminated by Sponsor|1|||
23522310|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
23522311|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
23522312|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
23522313|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
23522314|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
23522315|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
23307871|NCT00936897|64873894|FG001|Overall Study|Lost to Follow-up|10|||
23307872|NCT00936897|64873893|FG000|Overall Study|Administrative Decision|1|||
23522316|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
23522317|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23522318|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23522319|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23522320|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
23522321|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
23522322|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
23522323|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
23522324|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
23522325|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
23522326|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
23522327|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
23522328|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
23522329|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
23522330|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
23522331|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
23522332|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
23522333|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
23522334|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
23522335|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
23522336|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
23522337|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
23522338|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
23522339|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
23522340|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
23522341|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
23522342|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
23522343|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
23522344|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
23522345|NCT03373383|65650713|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
23522346|NCT03373383|65650714|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
23522347|NCT03373383|65650715|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
23522348|NCT03373383|65650716|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
23522349|NCT03373383|65650717|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
23522350|NCT03373383|65650713|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
23522351|NCT03373383|65650714|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
23522352|NCT03373383|65650715|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
23522353|NCT03373383|65650716|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
23522354|NCT03373383|65650717|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
23522355|NCT05620576|65650719|FG000|Overall Study|Adverse Event|1|||
23522356|NCT05620576|65650720|FG001|Overall Study|Adverse Event|1|||
23522357|NCT05620576|65650719|FG000|Overall Study|Lost to Follow-up|3|||
23522358|NCT05620576|65650720|FG001|Overall Study|Lost to Follow-up|1|||
23522359|NCT05620576|65650719|FG000|Overall Study|Physician Decision|0|||
23522360|NCT05620576|65650720|FG001|Overall Study|Physician Decision|1|||
23522361|NCT05620576|65650719|FG000|Overall Study|Protocol Deviation|1|||
23522362|NCT05620576|65650720|FG001|Overall Study|Protocol Deviation|1|||
23522363|NCT05620576|65650719|FG000|Overall Study|Withdrawal by Subject|2|||
23522364|NCT05620576|65650720|FG001|Overall Study|Withdrawal by Subject|3|||
23522365|NCT02910167|65650740|FG000|Overall Study|Adverse Event|1|||
23522366|NCT02910167|65650740|FG000|Overall Study|Lost to Follow-up|18|||
23522367|NCT04327999|65650741|FG000|Overall Study|Protocol Violation|1|||
23522368|NCT02013167|65650742|FG000|Overall Study|Withdrawal by Subject|15|||
23522369|NCT02013167|65650743|FG001|Overall Study|Withdrawal by Subject|14|||
23522370|NCT02013167|65650742|FG000|Overall Study|Sponsor Decision|1|||
23522371|NCT02013167|65650743|FG001|Overall Study|Sponsor Decision|3|||
23522372|NCT02013167|65650742|FG000|Overall Study|Lost to Follow-up|0|||
23522373|NCT02013167|65650743|FG001|Overall Study|Lost to Follow-up|1|||
23522374|NCT02013167|65650742|FG000|Overall Study|Death|85|||
23522375|NCT02013167|65650743|FG001|Overall Study|Death|160|||
23522376|NCT01498952|65650754|FG000|Overall Study|Death|2|||
23522377|NCT01498952|65650755|FG001|Overall Study|Death|2|||
23522378|NCT01498952|65650756|FG002|Overall Study|Death|0|||
23522379|NCT01498952|65650757|FG003|Overall Study|Death|0|||
23522380|NCT01498952|65650758|FG004|Overall Study|Death|0|||
23522381|NCT03025828|65650759|FG000|Overall Study|Lost to Follow-up|1|||
23522382|NCT01498640|65650760|FG000|Overall Study|Lost to Follow-up|1|||
23522383|NCT01498640|65650760|FG000|Overall Study|Death|1|||
23522384|NCT01498640|65650760|FG000|Overall Study|Other|3|||
23416517|NCT04308239|65271177|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
23416518|NCT00580034|65271178|FG000|Overall Study|Toxicity|10|||
23416519|NCT00580034|65271179|FG001|Overall Study|Toxicity|0|||
23416520|NCT01961297|65271189|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
23416521|NCT01961297|65271190|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
23416522|NCT00338286|65271195|FG000|Overall Study|Withdrawal by Subject|50|||
23416523|NCT00338286|65271196|FG001|Overall Study|Withdrawal by Subject|54|||
23416524|NCT00338286|65271195|FG000|Overall Study|Lost to Follow-up|80|||
23416525|NCT00338286|65271196|FG001|Overall Study|Lost to Follow-up|66|||
23416526|NCT00338286|65271195|FG000|Overall Study|Other|103|||
23416527|NCT00338286|65271196|FG001|Overall Study|Other|93|||
23416528|NCT00185380|65271202|FG000|Overall Study|Adverse Event|41|||
23416529|NCT00185380|65271203|FG001|Overall Study|Adverse Event|43|||
23416530|NCT00185380|65271204|FG002|Overall Study|Adverse Event|48|||
23416531|NCT00185380|65271202|FG000|Overall Study|Lost to Follow-up|0|||
23416532|NCT00185380|65271203|FG001|Overall Study|Lost to Follow-up|4|||
23522385|NCT04656132|65650761|FG000|Overall Study|Lost to Follow-up|4|||
23522386|NCT04656132|65650761|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
23522387|NCT00244712|65650763|FG000|Overall Study|Adverse Event|20|||
23522388|NCT00244712|65650764|FG001|Overall Study|Adverse Event|21|||
23522389|NCT00244712|65650763|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
23522390|NCT00244712|65650764|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
23522391|NCT00244712|65650763|FG000|Overall Study|Lack of Compliance|10|||
23522392|NCT00244712|65650764|FG001|Overall Study|Lack of Compliance|11|||
23522393|NCT00244712|65650763|FG000|Overall Study|Lost to Follow-up|45|||
23522394|NCT00244712|65650764|FG001|Overall Study|Lost to Follow-up|52|||
23522395|NCT00244712|65650763|FG000|Overall Study|Withdrawal by Subject|13|||
23522396|NCT00244712|65650764|FG001|Overall Study|Withdrawal by Subject|23|||
23416533|NCT00185380|65271204|FG002|Overall Study|Lost to Follow-up|3|||
23416534|NCT00185380|65271202|FG000|Overall Study|Pregnancy|1|||
23416535|NCT00185380|65271203|FG001|Overall Study|Pregnancy|4|||
23416536|NCT00185380|65271204|FG002|Overall Study|Pregnancy|0|||
23416537|NCT00185380|65271202|FG000|Overall Study|Protocol Violation|2|||
23416538|NCT00185380|65271203|FG001|Overall Study|Protocol Violation|2|||
23522397|NCT00244712|65650763|FG000|Overall Study|Protocol Violation, disease progression|13|||
23522398|NCT00244712|65650764|FG001|Overall Study|Protocol Violation, disease progression|11|||
23522399|NCT00278109|65650770|FG000|Overall Study|Adverse Event|3|||
23522400|NCT00278109|65650770|FG000|Overall Study|social circumstances|1|||
23522401|NCT02867709|65650771|FG000|Treatment Period|Adverse Event|1|||
23522402|NCT02867709|65650772|FG001|Treatment Period|Adverse Event|1|||
23522403|NCT02867709|65650773|FG002|Treatment Period|Adverse Event|2|||
23522404|NCT02867709|65650771|FG000|Treatment Period|Withdrawal of Consent|7|||
23522405|NCT02867709|65650772|FG001|Treatment Period|Withdrawal of Consent|9|||
23522406|NCT02867709|65650773|FG002|Treatment Period|Withdrawal of Consent|8|||
23522407|NCT02867709|65650771|FG000|Treatment Period|Lost to Follow-up|17|||
23522408|NCT02867709|65650772|FG001|Treatment Period|Lost to Follow-up|20|||
23522409|NCT02867709|65650773|FG002|Treatment Period|Lost to Follow-up|20|||
23522410|NCT02867709|65650771|FG000|Treatment Period|Lack of Qualifying Event|42|||
23522411|NCT02867709|65650772|FG001|Treatment Period|Lack of Qualifying Event|55|||
23522412|NCT02867709|65650773|FG002|Treatment Period|Lack of Qualifying Event|42|||
23522413|NCT02867709|65650771|FG000|Treatment Period|Protocol Violation|3|||
23522414|NCT02867709|65650772|FG001|Treatment Period|Protocol Violation|2|||
23522415|NCT02867709|65650773|FG002|Treatment Period|Protocol Violation|3|||
23522416|NCT02867709|65650771|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
23522417|NCT02867709|65650772|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
23522418|NCT02867709|65650773|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
23522419|NCT02867709|65650771|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
23522420|NCT02867709|65650772|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
23522421|NCT02867709|65650773|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
23522422|NCT02867709|65650771|FG000|Safety Follow-up Period|Pregnancy|0|||
23522423|NCT02867709|65650772|FG001|Safety Follow-up Period|Pregnancy|1|||
23522424|NCT02867709|65650773|FG002|Safety Follow-up Period|Pregnancy|0|||
23522425|NCT02867709|65650771|FG000|Safety Follow-up Period|Protocol Violation|0|||
23522426|NCT02867709|65650772|FG001|Safety Follow-up Period|Protocol Violation|1|||
23522427|NCT02867709|65650773|FG002|Safety Follow-up Period|Protocol Violation|1|||
23522428|NCT00851799|65650774|FG000|Overall Study|Death|1|||
23416539|NCT00185380|65271204|FG002|Overall Study|Protocol Violation|1|||
23416540|NCT00185380|65271202|FG000|Overall Study|Withdrawal by Subject|1|||
23416541|NCT00185380|65271203|FG001|Overall Study|Withdrawal by Subject|2|||
23416542|NCT00185380|65271204|FG002|Overall Study|Withdrawal by Subject|0|||
23416543|NCT00185380|65271202|FG000|Overall Study|Failed insertion|1|||
23522429|NCT00851799|65650775|FG001|Overall Study|Death|0|||
23522430|NCT00851799|65650776|FG002|Overall Study|Death|1|||
23522431|NCT00851799|65650774|FG000|Overall Study|Lost to Follow-up|5|||
23522432|NCT00851799|65650775|FG001|Overall Study|Lost to Follow-up|3|||
23416544|NCT00185380|65271203|FG001|Overall Study|Failed insertion|1|||
23416545|NCT00185380|65271204|FG002|Overall Study|Failed insertion|2|||
23416546|NCT00185380|65271202|FG000|Overall Study|Planned pregnancy|9|||
23416547|NCT00185380|65271203|FG001|Overall Study|Planned pregnancy|12|||
23416548|NCT00185380|65271204|FG002|Overall Study|Planned pregnancy|12|||
23416549|NCT00185380|65271202|FG000|Overall Study|No need for contraception|3|||
23416550|NCT00185380|65271203|FG001|Overall Study|No need for contraception|3|||
23416551|NCT00185380|65271204|FG002|Overall Study|No need for contraception|3|||
23416552|NCT00185380|65271202|FG000|Overall Study|Could not attend visits|2|||
23416553|NCT00185380|65271203|FG001|Overall Study|Could not attend visits|0|||
23416554|NCT00185380|65271204|FG002|Overall Study|Could not attend visits|4|||
23416555|NCT00185380|65271202|FG000|Overall Study|personal reason|6|||
23416556|NCT00185380|65271203|FG001|Overall Study|personal reason|1|||
23416557|NCT00185380|65271204|FG002|Overall Study|personal reason|1|||
23416558|NCT01524224|65271205|FG000|Overall Study|Progressive Disease|1|||
23416559|NCT01524224|65271206|FG001|Overall Study|Progressive Disease|0|||
23416560|NCT01524224|65271207|FG002|Overall Study|Progressive Disease|2|||
23416561|NCT01524224|65271208|FG003|Overall Study|Progressive Disease|1|||
23416562|NCT01524224|65271209|FG004|Overall Study|Progressive Disease|2|||
23416563|NCT01524224|65271210|FG005|Overall Study|Progressive Disease|1|||
23416564|NCT01524224|65271211|FG006|Overall Study|Progressive Disease|1|||
23416565|NCT01524224|65271212|FG007|Overall Study|Progressive Disease|5|||
23416566|NCT01524224|65271205|FG000|Overall Study|Withdrawal by Subject|2|||
23416567|NCT01524224|65271206|FG001|Overall Study|Withdrawal by Subject|0|||
23416568|NCT01524224|65271207|FG002|Overall Study|Withdrawal by Subject|0|||
23416569|NCT01524224|65271208|FG003|Overall Study|Withdrawal by Subject|0|||
23416570|NCT01524224|65271209|FG004|Overall Study|Withdrawal by Subject|0|||
23416571|NCT01524224|65271210|FG005|Overall Study|Withdrawal by Subject|0|||
23416572|NCT01524224|65271211|FG006|Overall Study|Withdrawal by Subject|2|||
23416573|NCT01524224|65271212|FG007|Overall Study|Withdrawal by Subject|0|||
23416574|NCT01524224|65271205|FG000|Overall Study|Adverse Event|0|||
23416575|NCT01524224|65271206|FG001|Overall Study|Adverse Event|1|||
23416576|NCT01524224|65271207|FG002|Overall Study|Adverse Event|0|||
23416577|NCT01524224|65271208|FG003|Overall Study|Adverse Event|0|||
23416578|NCT01524224|65271209|FG004|Overall Study|Adverse Event|0|||
23416579|NCT01524224|65271210|FG005|Overall Study|Adverse Event|1|||
23416580|NCT01524224|65271211|FG006|Overall Study|Adverse Event|0|||
23416581|NCT01524224|65271212|FG007|Overall Study|Adverse Event|0|||
23416582|NCT01524224|65271205|FG000|Overall Study|Physician Decision|0|||
23416583|NCT01524224|65271206|FG001|Overall Study|Physician Decision|0|||
23416584|NCT01524224|65271207|FG002|Overall Study|Physician Decision|0|||
23416585|NCT01524224|65271208|FG003|Overall Study|Physician Decision|1|||
23416586|NCT01524224|65271209|FG004|Overall Study|Physician Decision|1|||
23416587|NCT01524224|65271210|FG005|Overall Study|Physician Decision|0|||
23416588|NCT01524224|65271211|FG006|Overall Study|Physician Decision|0|||
23416589|NCT01524224|65271212|FG007|Overall Study|Physician Decision|1|||
23416590|NCT01524224|65271205|FG000|Overall Study|Sponsor Decision|0|||
23416591|NCT01524224|65271206|FG001|Overall Study|Sponsor Decision|0|||
23416592|NCT01524224|65271207|FG002|Overall Study|Sponsor Decision|0|||
23416593|NCT01524224|65271208|FG003|Overall Study|Sponsor Decision|0|||
23416594|NCT01524224|65271209|FG004|Overall Study|Sponsor Decision|1|||
23416595|NCT01524224|65271210|FG005|Overall Study|Sponsor Decision|0|||
23416596|NCT01524224|65271211|FG006|Overall Study|Sponsor Decision|0|||
23416597|NCT01524224|65271212|FG007|Overall Study|Sponsor Decision|0|||
23522433|NCT00851799|65650776|FG002|Overall Study|Lost to Follow-up|10|||
23416598|NCT04776720|65271213|FG000|Overall Study|COVID Related|4|||
23416599|NCT04776720|65271214|FG001|Overall Study|COVID Related|2|||
23416600|NCT04776720|65271213|FG000|Overall Study|Adverse Event|2|||
23416601|NCT04776720|65271214|FG001|Overall Study|Adverse Event|0|||
23416602|NCT04776720|65271213|FG000|Overall Study|Serious Adverse Event|0|||
23416603|NCT04776720|65271214|FG001|Overall Study|Serious Adverse Event|1|||
23416604|NCT04776720|65271213|FG000|Overall Study|Too Busy|3|||
23416605|NCT04776720|65271214|FG001|Overall Study|Too Busy|1|||
23416606|NCT04776720|65271213|FG000|Overall Study|Lost to Follow-up|1|||
23416607|NCT04776720|65271214|FG001|Overall Study|Lost to Follow-up|2|||
23416608|NCT04776720|65271213|FG000|Overall Study|Family|2|||
23416609|NCT04776720|65271214|FG001|Overall Study|Family|2|||
23522434|NCT00851799|65650774|FG000|Overall Study|Not able to get to clinic|8|||
23522435|NCT00851799|65650775|FG001|Overall Study|Not able to get to clinic|5|||
23416610|NCT04776720|65271213|FG000|Overall Study|No remote technology access|0|||
23416611|NCT04776720|65271214|FG001|Overall Study|No remote technology access|1|||
23416612|NCT04776720|65271213|FG000|Overall Study|Withdrawal by Subject|1|||
23416613|NCT04776720|65271214|FG001|Overall Study|Withdrawal by Subject|0|||
23416614|NCT04776720|65271213|FG000|Overall Study|Cannot tolerate intervention|1|||
23416615|NCT04776720|65271214|FG001|Overall Study|Cannot tolerate intervention|0|||
23416616|NCT04776720|65271213|FG000|Overall Study|Incomplete outcome data|6|||
23416617|NCT04776720|65271214|FG001|Overall Study|Incomplete outcome data|1|||
23522436|NCT00851799|65650776|FG002|Overall Study|Not able to get to clinic|9|||
23522437|NCT00851799|65650774|FG000|Overall Study|Not willing to adhere to requirements|1|||
23416618|NCT01468233|65271218|FG000|Treatment Period 1|Adverse Event|5|||
23416619|NCT01468233|65271219|FG001|Treatment Period 1|Adverse Event|3|||
23416620|NCT01468233|65271220|FG002|Treatment Period 1|Adverse Event|0|||
23416621|NCT01468233|65271221|FG003|Treatment Period 1|Adverse Event|0|||
23416622|NCT01468233|65271222|FG004|Treatment Period 1|Adverse Event|0|||
23416623|NCT01468233|65271223|FG005|Treatment Period 1|Adverse Event|0|||
23416624|NCT01468233|65271218|FG000|Treatment Period 1|Withdrawal by Subject|3|||
23416625|NCT01468233|65271219|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23416626|NCT01468233|65271220|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23416627|NCT01468233|65271221|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23416628|NCT01468233|65271222|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23416629|NCT01468233|65271223|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23416630|NCT01468233|65271218|FG000|Treatment Period 1|Lost to Follow-up|3|||
23416631|NCT01468233|65271219|FG001|Treatment Period 1|Lost to Follow-up|0|||
23416632|NCT01468233|65271220|FG002|Treatment Period 1|Lost to Follow-up|0|||
23416633|NCT01468233|65271221|FG003|Treatment Period 1|Lost to Follow-up|0|||
23416634|NCT01468233|65271222|FG004|Treatment Period 1|Lost to Follow-up|0|||
23416635|NCT01468233|65271223|FG005|Treatment Period 1|Lost to Follow-up|0|||
23416636|NCT01468233|65271218|FG000|Treatment Period 1|Other|1|||
23416637|NCT01468233|65271219|FG001|Treatment Period 1|Other|1|||
23416638|NCT01468233|65271220|FG002|Treatment Period 1|Other|0|||
23416639|NCT01468233|65271221|FG003|Treatment Period 1|Other|0|||
23416640|NCT01468233|65271222|FG004|Treatment Period 1|Other|0|||
23416641|NCT01468233|65271223|FG005|Treatment Period 1|Other|0|||
23416642|NCT01468233|65271218|FG000|Treatment Period 2|Adverse Event|0|||
23416643|NCT01468233|65271219|FG001|Treatment Period 2|Adverse Event|0|||
23416644|NCT01468233|65271220|FG002|Treatment Period 2|Adverse Event|3|||
23416645|NCT01468233|65271221|FG003|Treatment Period 2|Adverse Event|0|||
23416646|NCT01468233|65271222|FG004|Treatment Period 2|Adverse Event|2|||
23416647|NCT01468233|65271223|FG005|Treatment Period 2|Adverse Event|1|||
23416648|NCT01468233|65271218|FG000|Treatment Period 2|Lack of Efficacy|0|||
23416649|NCT01468233|65271219|FG001|Treatment Period 2|Lack of Efficacy|0|||
23522438|NCT00851799|65650775|FG001|Overall Study|Not willing to adhere to requirements|2|||
23522439|NCT00851799|65650776|FG002|Overall Study|Not willing to adhere to requirements|2|||
23522440|NCT00851799|65650774|FG000|Overall Study|Withdrew consent prior study completion|1|||
23522441|NCT00851799|65650775|FG001|Overall Study|Withdrew consent prior study completion|2|||
23522442|NCT00851799|65650776|FG002|Overall Study|Withdrew consent prior study completion|1|||
23416650|NCT01468233|65271220|FG002|Treatment Period 2|Lack of Efficacy|9|||
23416651|NCT01468233|65271221|FG003|Treatment Period 2|Lack of Efficacy|2|||
23416652|NCT01468233|65271222|FG004|Treatment Period 2|Lack of Efficacy|0|||
23522443|NCT00851799|65650774|FG000|Overall Study|Severe Debilitation|0|||
23522444|NCT00851799|65650775|FG001|Overall Study|Severe Debilitation|1|||
23416653|NCT01468233|65271223|FG005|Treatment Period 2|Lack of Efficacy|1|||
23416654|NCT01468233|65271218|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23416655|NCT01468233|65271219|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23416656|NCT01468233|65271220|FG002|Treatment Period 2|Withdrawal by Subject|9|||
23416657|NCT01468233|65271221|FG003|Treatment Period 2|Withdrawal by Subject|1|||
23522445|NCT00851799|65650776|FG002|Overall Study|Severe Debilitation|0|||
23522446|NCT00851799|65650774|FG000|Overall Study|Completed protocol due to pregnancy|0|||
23522447|NCT00851799|65650775|FG001|Overall Study|Completed protocol due to pregnancy|0|||
23522448|NCT00851799|65650776|FG002|Overall Study|Completed protocol due to pregnancy|1|||
23522449|NCT00908960|65650777|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
23522450|NCT00908960|65650778|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
23522451|NCT00908960|65650779|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
23522452|NCT02319031|65650780|FG000|Treatment Period|Death|1|||
23522453|NCT02319031|65650781|FG001|Treatment Period|Death|0|||
23522454|NCT00174915|65650782|FG000|Overall Study|Lost to Follow-up|19|||
23522455|NCT00174915|65650783|FG001|Overall Study|Lost to Follow-up|17|||
23522456|NCT00174915|65650784|FG002|Overall Study|Lost to Follow-up|9|||
23522457|NCT00174915|65650785|FG003|Overall Study|Lost to Follow-up|17|||
23522458|NCT00174915|65650786|FG004|Overall Study|Lost to Follow-up|10|||
23522459|NCT00174915|65650782|FG000|Overall Study|Adverse Event|18|||
23522460|NCT00174915|65650783|FG001|Overall Study|Adverse Event|16|||
23522461|NCT00174915|65650784|FG002|Overall Study|Adverse Event|11|||
23522462|NCT00174915|65650785|FG003|Overall Study|Adverse Event|18|||
23522463|NCT00174915|65650786|FG004|Overall Study|Adverse Event|5|||
23522464|NCT00174915|65650782|FG000|Overall Study|Personal Reason(s)|16|||
23522465|NCT00174915|65650783|FG001|Overall Study|Personal Reason(s)|16|||
23522466|NCT00174915|65650784|FG002|Overall Study|Personal Reason(s)|9|||
23522467|NCT00174915|65650785|FG003|Overall Study|Personal Reason(s)|9|||
23522468|NCT00174915|65650786|FG004|Overall Study|Personal Reason(s)|9|||
23522469|NCT00174915|65650782|FG000|Overall Study|Other|15|||
23522470|NCT00174915|65650783|FG001|Overall Study|Other|8|||
23522471|NCT00174915|65650784|FG002|Overall Study|Other|6|||
23522472|NCT00174915|65650785|FG003|Overall Study|Other|5|||
23522473|NCT00174915|65650786|FG004|Overall Study|Other|3|||
23522474|NCT00174915|65650782|FG000|Overall Study|Gout Flare|13|||
23522475|NCT00174915|65650783|FG001|Overall Study|Gout Flare|6|||
23522476|NCT00174915|65650784|FG002|Overall Study|Gout Flare|8|||
23522477|NCT00174915|65650785|FG003|Overall Study|Gout Flare|1|||
23522478|NCT00174915|65650786|FG004|Overall Study|Gout Flare|0|||
23522479|NCT00174915|65650782|FG000|Overall Study|Protocol Violation|6|||
23522480|NCT00174915|65650783|FG001|Overall Study|Protocol Violation|3|||
23522481|NCT00174915|65650784|FG002|Overall Study|Protocol Violation|3|||
23522482|NCT00174915|65650785|FG003|Overall Study|Protocol Violation|6|||
23522483|NCT00174915|65650786|FG004|Overall Study|Protocol Violation|3|||
23522484|NCT00174915|65650782|FG000|Overall Study|Therapeutic Failure|6|||
23522485|NCT00174915|65650783|FG001|Overall Study|Therapeutic Failure|3|||
23522486|NCT00174915|65650784|FG002|Overall Study|Therapeutic Failure|2|||
23522487|NCT00174915|65650785|FG003|Overall Study|Therapeutic Failure|1|||
23522488|NCT00174915|65650786|FG004|Overall Study|Therapeutic Failure|3|||
23522489|NCT04608500|65650787|FG000|Overall Study|Adverse Event|2|||
23522490|NCT04608500|65650788|FG001|Overall Study|Adverse Event|0|||
23522491|NCT04608500|65650787|FG000|Overall Study|Lost to Follow-up|15|||
23416658|NCT01468233|65271222|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23522492|NCT04608500|65650788|FG001|Overall Study|Lost to Follow-up|9|||
23522493|NCT04608500|65650787|FG000|Overall Study|Participant request|11|||
23522494|NCT04608500|65650788|FG001|Overall Study|Participant request|7|||
23522495|NCT04608500|65650787|FG000|Overall Study|Protocol Violation|1|||
23522496|NCT04608500|65650788|FG001|Overall Study|Protocol Violation|0|||
23522497|NCT04608500|65650787|FG000|Overall Study|Other|6|||
23522498|NCT04608500|65650788|FG001|Overall Study|Other|2|||
23522499|NCT01023581|65650789|FG000|Overall Study|Adverse Event|4|||
23522500|NCT01023581|65650790|FG001|Overall Study|Adverse Event|4|||
23522501|NCT01023581|65650791|FG002|Overall Study|Adverse Event|7|||
23522502|NCT01023581|65650792|FG003|Overall Study|Adverse Event|3|||
23522503|NCT01023581|65650793|FG004|Overall Study|Adverse Event|2|||
23522504|NCT01023581|65650794|FG005|Overall Study|Adverse Event|5|||
23522505|NCT01023581|65650795|FG006|Overall Study|Adverse Event|11|||
23522506|NCT01023581|65650789|FG000|Overall Study|Major protocol deviation|2|||
23522507|NCT01023581|65650790|FG001|Overall Study|Major protocol deviation|0|||
23522508|NCT01023581|65650791|FG002|Overall Study|Major protocol deviation|3|||
23522509|NCT01023581|65650792|FG003|Overall Study|Major protocol deviation|0|||
23522510|NCT01023581|65650793|FG004|Overall Study|Major protocol deviation|0|||
23522511|NCT01023581|65650794|FG005|Overall Study|Major protocol deviation|0|||
23522512|NCT01023581|65650795|FG006|Overall Study|Major protocol deviation|0|||
23522513|NCT01023581|65650789|FG000|Overall Study|Lost to Follow-up|4|||
23522514|NCT01023581|65650790|FG001|Overall Study|Lost to Follow-up|8|||
23522515|NCT01023581|65650791|FG002|Overall Study|Lost to Follow-up|7|||
23522516|NCT01023581|65650792|FG003|Overall Study|Lost to Follow-up|2|||
23522517|NCT01023581|65650793|FG004|Overall Study|Lost to Follow-up|5|||
23522518|NCT01023581|65650794|FG005|Overall Study|Lost to Follow-up|2|||
23522519|NCT01023581|65650795|FG006|Overall Study|Lost to Follow-up|2|||
23522520|NCT01023581|65650789|FG000|Overall Study|Withdrawal by Subject|13|||
23522521|NCT01023581|65650790|FG001|Overall Study|Withdrawal by Subject|8|||
23522522|NCT01023581|65650791|FG002|Overall Study|Withdrawal by Subject|16|||
23522523|NCT01023581|65650792|FG003|Overall Study|Withdrawal by Subject|10|||
23522524|NCT01023581|65650793|FG004|Overall Study|Withdrawal by Subject|6|||
23522525|NCT01023581|65650794|FG005|Overall Study|Withdrawal by Subject|8|||
23522526|NCT01023581|65650795|FG006|Overall Study|Withdrawal by Subject|5|||
23522527|NCT01023581|65650789|FG000|Overall Study|Pregnancy|0|||
23522528|NCT01023581|65650790|FG001|Overall Study|Pregnancy|0|||
23522529|NCT01023581|65650791|FG002|Overall Study|Pregnancy|0|||
23522530|NCT01023581|65650792|FG003|Overall Study|Pregnancy|2|||
23522531|NCT01023581|65650793|FG004|Overall Study|Pregnancy|0|||
23522532|NCT01023581|65650794|FG005|Overall Study|Pregnancy|1|||
23522533|NCT01023581|65650795|FG006|Overall Study|Pregnancy|0|||
23522534|NCT01023581|65650789|FG000|Overall Study|Lack of Efficacy|9|||
23522535|NCT01023581|65650790|FG001|Overall Study|Lack of Efficacy|3|||
23522536|NCT01023581|65650791|FG002|Overall Study|Lack of Efficacy|6|||
23522537|NCT01023581|65650792|FG003|Overall Study|Lack of Efficacy|2|||
23522538|NCT01023581|65650793|FG004|Overall Study|Lack of Efficacy|1|||
23522539|NCT01023581|65650794|FG005|Overall Study|Lack of Efficacy|2|||
23522540|NCT01023581|65650795|FG006|Overall Study|Lack of Efficacy|1|||
23522541|NCT01023581|65650789|FG000|Overall Study|Physician Decision|2|||
23522542|NCT01023581|65650790|FG001|Overall Study|Physician Decision|0|||
23522543|NCT01023581|65650791|FG002|Overall Study|Physician Decision|2|||
23522544|NCT01023581|65650792|FG003|Overall Study|Physician Decision|1|||
23522545|NCT01023581|65650793|FG004|Overall Study|Physician Decision|1|||
23522546|NCT01023581|65650794|FG005|Overall Study|Physician Decision|1|||
23522547|NCT01023581|65650795|FG006|Overall Study|Physician Decision|1|||
23522548|NCT01023581|65650789|FG000|Overall Study|Other|1|||
23522549|NCT01023581|65650790|FG001|Overall Study|Other|0|||
23522550|NCT01023581|65650791|FG002|Overall Study|Other|1|||
23522551|NCT01023581|65650792|FG003|Overall Study|Other|0|||
23522552|NCT01023581|65650793|FG004|Overall Study|Other|1|||
23522553|NCT01023581|65650794|FG005|Overall Study|Other|0|||
23522554|NCT01023581|65650795|FG006|Overall Study|Other|0|||
23522555|NCT00291668|65650796|FG000|Overall Study|Lack of Efficacy|1|||
23522556|NCT00291668|65650797|FG001|Overall Study|Lack of Efficacy|0|||
23522557|NCT00291668|65650798|FG002|Overall Study|Lack of Efficacy|0|||
23522558|NCT00291668|65650796|FG000|Overall Study|SAE, non-fatal|1|||
23522559|NCT00291668|65650797|FG001|Overall Study|SAE, non-fatal|1|||
23522560|NCT00291668|65650798|FG002|Overall Study|SAE, non-fatal|1|||
23522561|NCT00291668|65650796|FG000|Overall Study|AE, non-serious non-fatal|1|||
23522562|NCT00291668|65650797|FG001|Overall Study|AE, non-serious non-fatal|0|||
23522563|NCT00291668|65650798|FG002|Overall Study|AE, non-serious non-fatal|0|||
23416659|NCT01468233|65271223|FG005|Treatment Period 2|Withdrawal by Subject|1|||
23416660|NCT01468233|65271218|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
23416661|NCT01468233|65271219|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
23416662|NCT01468233|65271220|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
23416663|NCT01468233|65271221|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
23416664|NCT01468233|65271222|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
23416665|NCT01468233|65271223|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
23416666|NCT01468233|65271218|FG000|Treatment Period 2|Lost to Follow-up|0|||
23416667|NCT01468233|65271219|FG001|Treatment Period 2|Lost to Follow-up|0|||
23416668|NCT01468233|65271220|FG002|Treatment Period 2|Lost to Follow-up|3|||
23416669|NCT01468233|65271221|FG003|Treatment Period 2|Lost to Follow-up|0|||
23416670|NCT01468233|65271222|FG004|Treatment Period 2|Lost to Follow-up|2|||
23416671|NCT01468233|65271223|FG005|Treatment Period 2|Lost to Follow-up|0|||
23416672|NCT01468233|65271218|FG000|Treatment Period 2|Other|0|||
23416673|NCT01468233|65271219|FG001|Treatment Period 2|Other|0|||
23416674|NCT01468233|65271220|FG002|Treatment Period 2|Other|3|||
23416675|NCT01468233|65271221|FG003|Treatment Period 2|Other|0|||
23416676|NCT01468233|65271222|FG004|Treatment Period 2|Other|1|||
23416677|NCT01468233|65271223|FG005|Treatment Period 2|Other|0|||
23416678|NCT00939029|65271232|FG000|Overall Study|Withdrawal by Subject|3|||
23416679|NCT00939029|65271233|FG001|Overall Study|Withdrawal by Subject|7|||
23416680|NCT00939029|65271232|FG000|Overall Study|Lost to Follow-up|3|||
23416681|NCT00939029|65271233|FG001|Overall Study|Lost to Follow-up|4|||
23416682|NCT00939029|65271232|FG000|Overall Study|Adverse Event|0|||
23416683|NCT00939029|65271233|FG001|Overall Study|Adverse Event|1|||
23416684|NCT02550288|65271244|FG000|Overall Study|Adverse Event|0|||
23416685|NCT02550288|65271245|FG001|Overall Study|Adverse Event|1|||
23416686|NCT02550288|65271246|FG002|Overall Study|Adverse Event|0|||
23416687|NCT02550288|65271247|FG003|Overall Study|Adverse Event|0|||
23416688|NCT02550288|65271248|FG004|Overall Study|Adverse Event|0|||
23416689|NCT02550288|65271244|FG000|Overall Study|Physician Decision|0|||
23416690|NCT02550288|65271245|FG001|Overall Study|Physician Decision|0|||
23416691|NCT02550288|65271246|FG002|Overall Study|Physician Decision|0|||
23416692|NCT02550288|65271247|FG003|Overall Study|Physician Decision|1|||
23522564|NCT00291668|65650796|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23522565|NCT00291668|65650797|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23522566|NCT00291668|65650798|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23522567|NCT03168464|65650799|FG000|Overall Study|Death|9|||
23522568|NCT03168464|65650799|FG000|Overall Study|Progression of disease|6|||
23522569|NCT04105998|65650800|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
23522570|NCT04105998|65650801|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
23522571|NCT05402995|65650802|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
23522572|NCT05402995|65650803|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
23416693|NCT02550288|65271248|FG004|Overall Study|Physician Decision|0|||
23416694|NCT02550288|65271244|FG000|Overall Study|Protocol Violation|2|||
23416695|NCT02550288|65271245|FG001|Overall Study|Protocol Violation|2|||
23416696|NCT02550288|65271246|FG002|Overall Study|Protocol Violation|1|||
23416697|NCT02550288|65271247|FG003|Overall Study|Protocol Violation|0|||
23416698|NCT02550288|65271248|FG004|Overall Study|Protocol Violation|3|||
23522573|NCT05402995|65650804|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
23522574|NCT05402995|65650805|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
23522575|NCT01124643|65650807|FG000|Overall Study|Death|1|||
23522576|NCT01531387|65650809|FG000|Overall Study|Early termination of study|11|||
23522577|NCT01531387|65650810|FG001|Overall Study|Early termination of study|11|||
23522578|NCT05179421|65650811|FG000|First Infusion Day|Adverse Event|1|||
23522579|NCT05179421|65650812|FG001|First Infusion Day|Adverse Event|0|||
23522580|NCT02865915|65650813|FG000|Overall Study|Pregnancy|1|||
23522581|NCT02865915|65650814|FG001|Overall Study|Pregnancy|0|||
23522582|NCT02865915|65650813|FG000|Overall Study|Withdrawal by Subject|1|||
23522583|NCT02865915|65650814|FG001|Overall Study|Withdrawal by Subject|1|||
23522584|NCT02865915|65650813|FG000|Overall Study|Adverse Event|0|||
23522585|NCT02865915|65650814|FG001|Overall Study|Adverse Event|4|||
23522586|NCT02865915|65650813|FG000|Overall Study|Lost to Follow-up|0|||
23522587|NCT02865915|65650814|FG001|Overall Study|Lost to Follow-up|1|||
23522588|NCT02865915|65650813|FG000|Overall Study|Protocol Violation|0|||
23522589|NCT02865915|65650814|FG001|Overall Study|Protocol Violation|1|||
23522590|NCT02865915|65650813|FG000|Overall Study|Study terminated by sponsor|23|||
23522591|NCT02865915|65650814|FG001|Overall Study|Study terminated by sponsor|18|||
23522592|NCT02865915|65650813|FG000|Overall Study|Dosing group discontinued|0|||
23522593|NCT02865915|65650814|FG001|Overall Study|Dosing group discontinued|5|||
23522594|NCT04307446|65650815|FG000|Overall Study|Lost to Follow-up|2|||
23522595|NCT04307446|65650816|FG001|Overall Study|Lost to Follow-up|0|||
23522596|NCT02226003|65650817|FG000|Overall Study|Lost to Follow-up|2|||
23522597|NCT02226003|65650818|FG001|Overall Study|Lost to Follow-up|1|||
23522598|NCT02226003|65650819|FG002|Overall Study|Lost to Follow-up|3|||
23522599|NCT02226003|65650817|FG000|Overall Study|Withdrawal by Subject|0|||
23522600|NCT02226003|65650818|FG001|Overall Study|Withdrawal by Subject|0|||
23522601|NCT02226003|65650819|FG002|Overall Study|Withdrawal by Subject|3|||
23522602|NCT00451035|65650820|FG000|Overall Study|Disease progression|11|||
23522603|NCT00451035|65650820|FG000|Overall Study|Death|3|||
23522604|NCT00451035|65650820|FG000|Overall Study|New anti-neoplastic therapy|3|||
23522605|NCT01524627|65650821|FG000|Overall Study|Physician Decision|0|||
23522606|NCT01524627|65650822|FG001|Overall Study|Physician Decision|1|||
23522607|NCT01524627|65650821|FG000|Overall Study|Lost to Follow-up|1|||
23522608|NCT01524627|65650822|FG001|Overall Study|Lost to Follow-up|1|||
23522609|NCT04211337|65650823|FG000|Overall Study|On Treatment|175|||
23522610|NCT04211337|65650824|FG001|Overall Study|On Treatment|40|||
23522611|NCT04211337|65650823|FG000|Overall Study|Withdrawal by Subject|0|||
23522612|NCT04211337|65650824|FG001|Overall Study|Withdrawal by Subject|2|||
23522613|NCT01350128|65650825|FG000|Overall Study|Withdrawal by Subject|3|||
23522614|NCT01350128|65650825|FG000|Overall Study|Protocol discontinuation criteria|8|||
23522615|NCT01350128|65650825|FG000|Overall Study|Physician Decision|1|||
23522616|NCT01350128|65650825|FG000|Overall Study|Lost to Follow-up|2|||
23522617|NCT02253810|65650826|FG000|Overall Study|Withdrawal by Subject|2|||
23522618|NCT02253810|65650827|FG001|Overall Study|Withdrawal by Subject|1|||
23522619|NCT02253810|65650826|FG000|Overall Study|Unknown concomitant procedure|3|||
23522620|NCT02253810|65650827|FG001|Overall Study|Unknown concomitant procedure|2|||
23522621|NCT01400516|65650829|FG000|Primary Trial|Withdrawal by Subject|0|||
23522622|NCT01400516|65650830|FG001|Primary Trial|Withdrawal by Subject|2|||
23522623|NCT02174848|65650832|FG000|Overall Study|Adverse Event|2|||
23522624|NCT02174848|65650833|FG001|Overall Study|Adverse Event|1|||
23522625|NCT02174848|65650832|FG000|Overall Study|Withdrawal by Subject|3|||
23522626|NCT02174848|65650833|FG001|Overall Study|Withdrawal by Subject|3|||
23522627|NCT02174848|65650832|FG000|Overall Study|Lost to Follow-up|0|||
23522628|NCT02174848|65650833|FG001|Overall Study|Lost to Follow-up|1|||
23522629|NCT02174848|65650832|FG000|Overall Study|Worsening of disease|1|||
23522630|NCT02174848|65650833|FG001|Overall Study|Worsening of disease|1|||
23522631|NCT02174848|65650832|FG000|Overall Study|Unable to comply with study requirements|1|||
23522632|NCT02174848|65650833|FG001|Overall Study|Unable to comply with study requirements|0|||
23522633|NCT01765153|65650834|FG000|Training Phase 1|Format of intervention differed|1|||
23522634|NCT01765153|65650835|FG001|Training Phase 1|Format of intervention differed|0|||
23522635|NCT01765153|65650834|FG000|Training Phase 1|Poor participation in intervention|0|||
23522636|NCT01765153|65650835|FG001|Training Phase 1|Poor participation in intervention|1|||
23522637|NCT01765153|65650834|FG000|Rest Phase 1|Withdrawal by Subject|0|||
23522638|NCT01765153|65650835|FG001|Rest Phase 1|Withdrawal by Subject|1|||
23205371|NCT01533935|64491332|FG001|Overall Study|Withdrawal by Subject|4|||
23205372|NCT01533935|64491333|FG002|Overall Study|Withdrawal by Subject|5|||
23205373|NCT01533935|64491334|FG003|Overall Study|Withdrawal by Subject|2|||
23307873|NCT00936897|64873894|FG001|Overall Study|Administrative Decision|2|||
23522639|NCT01765153|65650834|FG000|Training Phase 2|Withdrawal by Subject|0|||
23522640|NCT01765153|65650835|FG001|Training Phase 2|Withdrawal by Subject|1|||
23522641|NCT01765153|65650834|FG000|Rest Phase 2|Lost to Follow-up|2|||
23522642|NCT01765153|65650835|FG001|Rest Phase 2|Lost to Follow-up|1|||
23522643|NCT03144674|65650844|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
23522644|NCT03144674|65650845|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
23522645|NCT03144674|65650846|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
23307874|NCT00936897|64873893|FG000|Overall Study|Protocol Violation|1|||
23307875|NCT00936897|64873894|FG001|Overall Study|Protocol Violation|1|||
23307876|NCT00936897|64873893|FG000|Overall Study|Ineligibility Determined|0|||
23307877|NCT00936897|64873894|FG001|Overall Study|Ineligibility Determined|3|||
23307878|NCT00936897|64873893|FG000|Overall Study|Noncompliance|0|||
23307879|NCT00936897|64873894|FG001|Overall Study|Noncompliance|2|||
23307880|NCT00936897|64873893|FG000|Overall Study|Death|0|||
23307881|NCT00936897|64873894|FG001|Overall Study|Death|1|||
23307882|NCT04844762|64873900|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307883|NCT04844762|64873901|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23416699|NCT02550288|65271244|FG000|Overall Study|Participant moved|0|||
23522646|NCT03144674|65650847|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
23522647|NCT03144674|65650844|FG000|Overall Study|Death|3|||
23522648|NCT03144674|65650845|FG001|Overall Study|Death|1|||
23205374|NCT01533935|64491335|FG004|Overall Study|Withdrawal by Subject|4|||
23205375|NCT01533935|64491331|FG000|Overall Study|Other reason not defined above|1|||
23205376|NCT01533935|64491332|FG001|Overall Study|Other reason not defined above|0|||
23205377|NCT01533935|64491333|FG002|Overall Study|Other reason not defined above|1|||
23205378|NCT01533935|64491334|FG003|Overall Study|Other reason not defined above|0|||
23205379|NCT01533935|64491335|FG004|Overall Study|Other reason not defined above|1|||
23205380|NCT02662985|64494651|FG000|Treatment Period 1|Adverse Event|0|||
23205381|NCT02662985|64494652|FG001|Treatment Period 1|Adverse Event|2|||
23205382|NCT02662985|64494651|FG000|Treatment Period 1|Protocol Violation|0|||
23205383|NCT02662985|64494652|FG001|Treatment Period 1|Protocol Violation|1|||
23205384|NCT02662985|64494651|FG000|Treatment Period 1|Physician Decision|1|||
23205385|NCT02662985|64494652|FG001|Treatment Period 1|Physician Decision|0|||
23205386|NCT02662985|64494651|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23205387|NCT02662985|64494652|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23205388|NCT02662985|64494651|FG000|Treatment Period 2|Lack of Efficacy|0|||
23205389|NCT02662985|64494652|FG001|Treatment Period 2|Lack of Efficacy|1|||
23205390|NCT02662985|64494651|FG000|Treatment Period 2|Lost to Follow-up|1|||
23307884|NCT04844762|64873902|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
23307885|NCT04844762|64873903|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23205391|NCT02662985|64494652|FG001|Treatment Period 2|Lost to Follow-up|0|||
23307886|NCT04844762|64873904|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307887|NCT04844762|64873905|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307888|NCT04844762|64873900|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
23307889|NCT04844762|64873901|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
23522649|NCT03144674|65650846|FG002|Overall Study|Death|1|||
23522650|NCT03144674|65650847|FG003|Overall Study|Death|10|||
23522651|NCT03144674|65650844|FG000|Overall Study|Lost to Follow-up|0|||
23522652|NCT03144674|65650845|FG001|Overall Study|Lost to Follow-up|1|||
23522653|NCT03144674|65650846|FG002|Overall Study|Lost to Follow-up|1|||
23522654|NCT03144674|65650847|FG003|Overall Study|Lost to Follow-up|1|||
23522655|NCT03144674|65650844|FG000|Overall Study|Withdrawal by Participant|0|||
23522656|NCT03144674|65650845|FG001|Overall Study|Withdrawal by Participant|0|||
23522657|NCT03144674|65650846|FG002|Overall Study|Withdrawal by Participant|0|||
23522658|NCT03144674|65650847|FG003|Overall Study|Withdrawal by Participant|3|||
23522659|NCT03144674|65650844|FG000|Overall Study|Reason not Specified|0|||
23522660|NCT03144674|65650845|FG001|Overall Study|Reason not Specified|0|||
23522661|NCT03144674|65650846|FG002|Overall Study|Reason not Specified|2|||
23522662|NCT03144674|65650847|FG003|Overall Study|Reason not Specified|4|||
23522663|NCT00902564|65650848|FG000|Overall Study|Withdrawal by Subject|2|||
23522664|NCT00697515|65650849|FG000|Dose Optimization Period|Adverse Event|4|||
23522665|NCT00697515|65650850|FG001|Dose Optimization Period|Adverse Event|0|||
23522666|NCT00697515|65650849|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
23522667|NCT00697515|65650850|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
23522668|NCT00697515|65650849|FG000|Dose Optimization Period|Lost to Follow-up|2|||
23522669|NCT00697515|65650850|FG001|Dose Optimization Period|Lost to Follow-up|0|||
23522670|NCT00697515|65650849|FG000|Dose Optimization Period|sponsor request|2|||
23522671|NCT00697515|65650850|FG001|Dose Optimization Period|sponsor request|0|||
23522672|NCT00697515|65650849|FG000|Dose Optimization Period|called to active duty|1|||
23522673|NCT00697515|65650850|FG001|Dose Optimization Period|called to active duty|0|||
23522674|NCT00697515|65650849|FG000|Dose Optimization Period|elevated QTc|1|||
23522675|NCT00697515|65650850|FG001|Dose Optimization Period|elevated QTc|0|||
23522676|NCT00697515|65650849|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
23522677|NCT00697515|65650850|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
23522678|NCT00697515|65650849|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
23205392|NCT02662985|64494651|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
23522679|NCT00697515|65650850|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
23522680|NCT00697515|65650849|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
23522681|NCT00697515|65650850|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
23522682|NCT00697515|65650849|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
23522683|NCT00697515|65650850|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
23522684|NCT02113956|65650851|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
23522685|NCT02113956|65650852|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
23522686|NCT02113956|65650851|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
23522687|NCT02113956|65650852|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
23522688|NCT02113956|65650851|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
23522689|NCT02113956|65650852|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
23522690|NCT01334866|65653886|FG000|Overall Study|Withdrawal by Subject|10|||
23522691|NCT01334866|65653886|FG000|Overall Study|Lost to Follow-up|3|||
23205393|NCT02662985|64494652|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
23205394|NCT02662985|64494651|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
23205395|NCT02662985|64494652|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
23205396|NCT02662985|64494651|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
23205397|NCT02662985|64494652|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
23205398|NCT02662985|64494651|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
23205399|NCT02662985|64494652|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
23205400|NCT02662985|64494651|FG000|Treatment Period 3 (Extension Period)|Death|0|||
23205401|NCT02662985|64494652|FG001|Treatment Period 3 (Extension Period)|Death|1|||
23205402|NCT01021852|64494655|FG000|Treatment Period 1|Adverse Event|3|||
23205403|NCT01021852|64494656|FG001|Treatment Period 1|Adverse Event|1|||
23205404|NCT01021852|64494657|FG002|Treatment Period 1|Adverse Event|1|||
23205405|NCT01021852|64494658|FG003|Treatment Period 1|Adverse Event|0|||
23205406|NCT01021852|64494659|FG004|Treatment Period 1|Adverse Event|2|||
23205407|NCT01021852|64494660|FG005|Treatment Period 1|Adverse Event|2|||
23522692|NCT01334866|65653886|FG000|Overall Study|Physician Decision|3|||
23307890|NCT04844762|64873902|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
23522693|NCT01334866|65653886|FG000|Overall Study|medically necessary prior to procedure|2|||
23522694|NCT01334866|65653886|FG000|Overall Study|medically necessary post-procedure|1|||
23522695|NCT01736696|65653889|FG000|Overall Study|Withdrawal by Subject|0|||
23522696|NCT01736696|65653890|FG001|Overall Study|Withdrawal by Subject|0|||
23522697|NCT01736696|65653891|FG002|Overall Study|Withdrawal by Subject|1|||
23522698|NCT01736696|65653892|FG003|Overall Study|Withdrawal by Subject|0|||
23522699|NCT01736696|65653893|FG004|Overall Study|Withdrawal by Subject|0|||
23522700|NCT01736696|65653894|FG005|Overall Study|Withdrawal by Subject|0|||
23522701|NCT01736696|65653895|FG006|Overall Study|Withdrawal by Subject|0|||
23522702|NCT02596854|65653896|FG000|Overall Study|Withdrawn|8|||
23522703|NCT01104636|65653898|FG000|Overall Study|Lack of Efficacy|43|||
23522704|NCT01104636|65653898|FG000|Overall Study|Lost to Follow-up|24|||
23205408|NCT01021852|64494661|FG006|Treatment Period 1|Adverse Event|0|||
23522705|NCT01104636|65653898|FG000|Overall Study|Withdrawal by Subject|4|||
23522706|NCT01104636|65653898|FG000|Overall Study|Other|43|||
23205409|NCT01021852|64494662|FG007|Treatment Period 1|Adverse Event|0|||
23205410|NCT01021852|64494655|FG000|Treatment Period 1|Pregnancy|0|||
23205411|NCT01021852|64494656|FG001|Treatment Period 1|Pregnancy|0|||
23205412|NCT01021852|64494657|FG002|Treatment Period 1|Pregnancy|1|||
23205413|NCT01021852|64494658|FG003|Treatment Period 1|Pregnancy|0|||
23205414|NCT01021852|64494659|FG004|Treatment Period 1|Pregnancy|0|||
23205415|NCT01021852|64494660|FG005|Treatment Period 1|Pregnancy|0|||
23205416|NCT01021852|64494661|FG006|Treatment Period 1|Pregnancy|0|||
23205417|NCT01021852|64494662|FG007|Treatment Period 1|Pregnancy|0|||
23205418|NCT01021852|64494655|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23205419|NCT01021852|64494656|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23205420|NCT01021852|64494657|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23205421|NCT01021852|64494658|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23205422|NCT01021852|64494659|FG004|Treatment Period 1|Withdrawal by Subject|1|||
23205423|NCT01021852|64494660|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23205424|NCT01021852|64494661|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23205425|NCT01021852|64494662|FG007|Treatment Period 1|Withdrawal by Subject|1|||
23205426|NCT01021852|64494655|FG000|Treatment Period 1|Not Treated|0|||
23205427|NCT01021852|64494656|FG001|Treatment Period 1|Not Treated|0|||
23205428|NCT01021852|64494657|FG002|Treatment Period 1|Not Treated|0|||
23205429|NCT01021852|64494658|FG003|Treatment Period 1|Not Treated|2|||
23205430|NCT01021852|64494659|FG004|Treatment Period 1|Not Treated|0|||
23416700|NCT02550288|65271245|FG001|Overall Study|Participant moved|0|||
23416701|NCT02550288|65271246|FG002|Overall Study|Participant moved|0|||
23416702|NCT02550288|65271247|FG003|Overall Study|Participant moved|1|||
23522707|NCT01104636|65653898|FG000|Overall Study|Study terminated by sponsor|1|||
23205431|NCT01021852|64494660|FG005|Treatment Period 1|Not Treated|0|||
23205432|NCT01021852|64494661|FG006|Treatment Period 1|Not Treated|0|||
23205433|NCT01021852|64494662|FG007|Treatment Period 1|Not Treated|0|||
23416703|NCT02550288|65271248|FG004|Overall Study|Participant moved|0|||
23522708|NCT01104636|65653898|FG000|Overall Study|Pregnancy|2|||
23522709|NCT01104636|65653898|FG000|Overall Study|Adverse Event|40|||
23416704|NCT02550288|65271244|FG000|Overall Study|Withdrawal by Subject|0|||
23416705|NCT02550288|65271245|FG001|Overall Study|Withdrawal by Subject|0|||
23416706|NCT02550288|65271246|FG002|Overall Study|Withdrawal by Subject|0|||
23416707|NCT02550288|65271247|FG003|Overall Study|Withdrawal by Subject|1|||
23416708|NCT02550288|65271248|FG004|Overall Study|Withdrawal by Subject|0|||
23416709|NCT00290771|65271249|FG000|Overall Study|Disease progression|95|||
23416710|NCT00290771|65271250|FG001|Overall Study|Disease progression|73|||
23416711|NCT00290771|65271249|FG000|Overall Study|Death|11|||
23416712|NCT00290771|65271250|FG001|Overall Study|Death|10|||
23416713|NCT00290771|65271249|FG000|Overall Study|Adverse Event|12|||
23416714|NCT00290771|65271250|FG001|Overall Study|Adverse Event|6|||
23416715|NCT00290771|65271249|FG000|Overall Study|Withdrawal by Subject|5|||
23416716|NCT00290771|65271250|FG001|Overall Study|Withdrawal by Subject|6|||
23416717|NCT00290771|65271249|FG000|Overall Study|Administrative problems|2|||
23416718|NCT00290771|65271250|FG001|Overall Study|Administrative problems|1|||
23416719|NCT00290771|65271249|FG000|Overall Study|Protocol Violation|2|||
23416720|NCT00290771|65271250|FG001|Overall Study|Protocol Violation|0|||
23416721|NCT00290771|65271249|FG000|Overall Study|Lost to Follow-up|0|||
23522710|NCT01104636|65653898|FG000|Overall Study|Ongoing|21|||
23522711|NCT00302458|65653899|FG000|Overall Study|Lost to Follow-up|1|||
23522712|NCT00302458|65653899|FG000|Overall Study|Ineligible after screening|1|||
23522713|NCT00302458|65653899|FG000|Overall Study|Withdrawal by Subject|1|||
23522714|NCT01727141|65653923|FG000|Overall Study|Physician Decision|0|||
23522715|NCT01727141|65653924|FG001|Overall Study|Physician Decision|1|||
23522716|NCT01727141|65653925|FG002|Overall Study|Physician Decision|0|||
23522717|NCT01727141|65653926|FG003|Overall Study|Physician Decision|2|||
23522718|NCT01727141|65653923|FG000|Overall Study|Lost to Follow-up|0|||
23522719|NCT01727141|65653924|FG001|Overall Study|Lost to Follow-up|2|||
23522720|NCT01727141|65653925|FG002|Overall Study|Lost to Follow-up|0|||
23522721|NCT01727141|65653926|FG003|Overall Study|Lost to Follow-up|0|||
23522722|NCT01727141|65653923|FG000|Overall Study|Death|0|||
23522723|NCT01727141|65653924|FG001|Overall Study|Death|1|||
23522724|NCT01727141|65653925|FG002|Overall Study|Death|1|||
23522725|NCT01727141|65653926|FG003|Overall Study|Death|1|||
23522726|NCT01727141|65653923|FG000|Overall Study|Protocol deviation|1|||
23522727|NCT01727141|65653924|FG001|Overall Study|Protocol deviation|1|||
23522728|NCT01727141|65653925|FG002|Overall Study|Protocol deviation|0|||
23522729|NCT01727141|65653926|FG003|Overall Study|Protocol deviation|1|||
23522730|NCT01727141|65653923|FG000|Overall Study|Withdrawal by Subject|4|||
23522731|NCT01727141|65653924|FG001|Overall Study|Withdrawal by Subject|4|||
23416722|NCT00290771|65271250|FG001|Overall Study|Lost to Follow-up|1|||
23522732|NCT01727141|65653925|FG002|Overall Study|Withdrawal by Subject|2|||
23416723|NCT01895543|65271251|FG000|Overall Study|Withdrawal by Subject|43|||
23416724|NCT01895543|65271251|FG000|Overall Study|Lost to Follow-up|25|||
23416725|NCT01895543|65271251|FG000|Overall Study|Adverse Event|28|||
23416726|NCT01895543|65271251|FG000|Overall Study|Subject's substantial non-compliance|6|||
23416727|NCT01895543|65271251|FG000|Overall Study|Protocol Violation|1|||
23522733|NCT01727141|65653926|FG003|Overall Study|Withdrawal by Subject|11|||
23522734|NCT01462357|65653934|FG000|Overall Study|Death|0|||
23522735|NCT01462357|65653935|FG001|Overall Study|Death|0|||
23522736|NCT01462357|65653936|FG002|Overall Study|Death|1|||
23522737|NCT01462357|65653934|FG000|Overall Study|Withdrawal by Subject|3|||
23522738|NCT01462357|65653935|FG001|Overall Study|Withdrawal by Subject|11|||
23522739|NCT01462357|65653936|FG002|Overall Study|Withdrawal by Subject|3|||
23522740|NCT01462357|65653934|FG000|Overall Study|Migrated/moved from study area|2|||
23522741|NCT01462357|65653935|FG001|Overall Study|Migrated/moved from study area|3|||
23522742|NCT01462357|65653936|FG002|Overall Study|Migrated/moved from study area|1|||
23522743|NCT01462357|65653934|FG000|Overall Study|Lost to Follow-up|3|||
23522744|NCT01462357|65653935|FG001|Overall Study|Lost to Follow-up|5|||
23522745|NCT01462357|65653936|FG002|Overall Study|Lost to Follow-up|7|||
23522746|NCT01398956|65653944|FG000|Overall Study|Withdrawal by Subject|4|||
23522747|NCT01398956|65653944|FG000|Overall Study|AE, non-serious non-fatal|4|||
23522748|NCT01398956|65653944|FG000|Overall Study|Withdrawal Criteria No.3|1|||
23522749|NCT01398956|65653944|FG000|Overall Study|Subject moved a long distance|1|||
23522750|NCT00706641|65653948|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
23522751|NCT00706641|65653948|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
23522752|NCT00706641|65653948|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
23522753|NCT01851720|65653949|FG000|Overall Study|Lost to Follow-up|0|||
23522754|NCT01851720|65653950|FG001|Overall Study|Lost to Follow-up|1|||
23522755|NCT04248816|65653952|FG000|Overall Study|Ineligible post-randomization|7|||
23522756|NCT04248816|65653953|FG001|Overall Study|Ineligible post-randomization|21|||
23522757|NCT04248816|65653954|FG002|Overall Study|Ineligible post-randomization|25|||
23522758|NCT02141997|65653958|FG000|Overall Study|Adverse Event|0|||
23522759|NCT02141997|65653959|FG001|Overall Study|Adverse Event|2|||
23522760|NCT02141997|65653960|FG002|Overall Study|Adverse Event|0|||
23522761|NCT02141997|65653961|FG003|Overall Study|Adverse Event|1|||
23522762|NCT02141997|65653958|FG000|Overall Study|Participant noncompliance|1|||
23416728|NCT01895543|65271251|FG000|Overall Study|Physician Decision|2|||
23416729|NCT01895543|65271251|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
23416730|NCT02789345|65271258|FG000|Overall Study|Adverse Event|0|||
23416731|NCT02789345|65271259|FG001|Overall Study|Adverse Event|0|||
23416732|NCT02789345|65271260|FG002|Overall Study|Adverse Event|1|||
23416733|NCT02789345|65271258|FG000|Overall Study|Death|0|||
23416734|NCT02789345|65271259|FG001|Overall Study|Death|0|||
23416735|NCT02789345|65271260|FG002|Overall Study|Death|1|||
23416736|NCT02789345|65271258|FG000|Overall Study|Physician Decision|2|||
23416737|NCT02789345|65271259|FG001|Overall Study|Physician Decision|0|||
23416738|NCT02789345|65271260|FG002|Overall Study|Physician Decision|1|||
23416739|NCT02789345|65271258|FG000|Overall Study|Progressive Disease|1|||
23416740|NCT02789345|65271259|FG001|Overall Study|Progressive Disease|3|||
23416741|NCT02789345|65271260|FG002|Overall Study|Progressive Disease|14|||
23416742|NCT00441142|65271261|FG000|Overall Study|Adverse Event|2|||
23416743|NCT00441142|65271262|FG001|Overall Study|Adverse Event|3|||
23416744|NCT00441142|65271263|FG002|Overall Study|Adverse Event|3|||
23416745|NCT00441142|65271264|FG003|Overall Study|Adverse Event|22|||
23416746|NCT00441142|65271261|FG000|Overall Study|Lack of Efficacy|3|||
23416747|NCT00441142|65271262|FG001|Overall Study|Lack of Efficacy|3|||
23416748|NCT00441142|65271263|FG002|Overall Study|Lack of Efficacy|17|||
23416749|NCT00441142|65271264|FG003|Overall Study|Lack of Efficacy|32|||
23416750|NCT00441142|65271261|FG000|Overall Study|Withdrawal by Subject|0|||
23416751|NCT00441142|65271262|FG001|Overall Study|Withdrawal by Subject|0|||
23416752|NCT00441142|65271263|FG002|Overall Study|Withdrawal by Subject|2|||
23416753|NCT00441142|65271264|FG003|Overall Study|Withdrawal by Subject|10|||
23416754|NCT00441142|65271261|FG000|Overall Study|Patient still receiving active study tx|1|||
23416755|NCT00441142|65271262|FG001|Overall Study|Patient still receiving active study tx|0|||
23416756|NCT00441142|65271263|FG002|Overall Study|Patient still receiving active study tx|0|||
23416757|NCT00441142|65271264|FG003|Overall Study|Patient still receiving active study tx|2|||
23416758|NCT00441142|65271261|FG000|Overall Study|Physician Decision|0|||
23416759|NCT00441142|65271262|FG001|Overall Study|Physician Decision|1|||
23416760|NCT00441142|65271263|FG002|Overall Study|Physician Decision|0|||
23416761|NCT00441142|65271264|FG003|Overall Study|Physician Decision|1|||
23522763|NCT02141997|65653959|FG001|Overall Study|Participant noncompliance|0|||
23522764|NCT02141997|65653960|FG002|Overall Study|Participant noncompliance|0|||
23522765|NCT02141997|65653961|FG003|Overall Study|Participant noncompliance|0|||
23522766|NCT02141997|65653958|FG000|Overall Study|Withdrew consent|1|||
23416762|NCT00441142|65271261|FG000|Overall Study|Death|0|||
23416763|NCT00441142|65271262|FG001|Overall Study|Death|0|||
23416764|NCT00441142|65271263|FG002|Overall Study|Death|0|||
23416765|NCT00441142|65271264|FG003|Overall Study|Death|1|||
23416766|NCT01190475|65271265|FG000|Overall Study|Withdrawal by Subject|0|||
23416767|NCT01190475|65271266|FG001|Overall Study|Withdrawal by Subject|0|||
23416768|NCT01190475|65271267|FG002|Overall Study|Withdrawal by Subject|1|||
23416769|NCT03928418|65271268|FG000|Overall Study|Lost to Follow-up|5|||
23416770|NCT03928418|65271269|FG001|Overall Study|Lost to Follow-up|3|||
23522767|NCT02141997|65653959|FG001|Overall Study|Withdrew consent|0|||
23522768|NCT02141997|65653960|FG002|Overall Study|Withdrew consent|3|||
23522769|NCT02141997|65653961|FG003|Overall Study|Withdrew consent|0|||
23522770|NCT02141997|65653958|FG000|Overall Study|Other|1|||
23522771|NCT02141997|65653959|FG001|Overall Study|Other|4|||
23522772|NCT02141997|65653960|FG002|Overall Study|Other|0|||
23522773|NCT02141997|65653961|FG003|Overall Study|Other|0|||
23522774|NCT02622828|65653964|FG000|Overall Study|participant withdrew|3|||
23522775|NCT01817725|65653967|FG000|Overall Study|Withdrawal by Subject|1|||
23522776|NCT01324388|65653968|FG000|Part 1 of Study|Adverse Event|2|||
23522777|NCT01324388|65653969|FG001|Part 1 of Study|Adverse Event|0|||
23522778|NCT01324388|65653970|FG002|Part 1 of Study|Adverse Event|0|||
23522779|NCT01324388|65653971|FG003|Part 1 of Study|Adverse Event|0|||
23522780|NCT01324388|65653968|FG000|Part 1 of Study|Protocol Violation|1|||
23522781|NCT01324388|65653969|FG001|Part 1 of Study|Protocol Violation|2|||
23522782|NCT01324388|65653970|FG002|Part 1 of Study|Protocol Violation|0|||
23522783|NCT01324388|65653971|FG003|Part 1 of Study|Protocol Violation|0|||
23522784|NCT01324388|65653968|FG000|Part 1 of Study|Physician Decision|1|||
23522785|NCT01324388|65653969|FG001|Part 1 of Study|Physician Decision|0|||
23522786|NCT01324388|65653970|FG002|Part 1 of Study|Physician Decision|0|||
23522787|NCT01324388|65653971|FG003|Part 1 of Study|Physician Decision|0|||
23522788|NCT01324388|65653968|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
23522789|NCT01324388|65653969|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
23522790|NCT01324388|65653970|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
23522791|NCT01324388|65653971|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
23522792|NCT01324388|65653968|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
23522793|NCT01324388|65653969|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
23522794|NCT01324388|65653970|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
23522795|NCT01324388|65653971|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
23522796|NCT00048542|65653972|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23522797|NCT00048542|65653973|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
23522798|NCT00048542|65653974|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23522799|NCT00048542|65653975|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23522800|NCT00048542|65653976|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23522801|NCT00048542|65653977|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
23522802|NCT00048542|65653978|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
23522803|NCT00048542|65653979|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
23522804|NCT00048542|65653972|FG000|Double-Blind Phase|Protocol Violation|0|||
23522805|NCT00048542|65653973|FG001|Double-Blind Phase|Protocol Violation|0|||
23522806|NCT00048542|65653974|FG002|Double-Blind Phase|Protocol Violation|1|||
23522807|NCT00048542|65653975|FG003|Double-Blind Phase|Protocol Violation|0|||
23522808|NCT00048542|65653976|FG004|Double-Blind Phase|Protocol Violation|0|||
23522809|NCT00048542|65653977|FG005|Double-Blind Phase|Protocol Violation|0|||
23522810|NCT00048542|65653978|FG006|Double-Blind Phase|Protocol Violation|0|||
23205434|NCT01021852|64494655|FG000|Washout Period-Placebo|Adverse Event|0|||
23205435|NCT01021852|64494656|FG001|Washout Period-Placebo|Adverse Event|0|||
23205436|NCT01021852|64494657|FG002|Washout Period-Placebo|Adverse Event|0|||
23205437|NCT01021852|64494658|FG003|Washout Period-Placebo|Adverse Event|1|||
23205438|NCT01021852|64494659|FG004|Washout Period-Placebo|Adverse Event|0|||
23205439|NCT01021852|64494660|FG005|Washout Period-Placebo|Adverse Event|1|||
23205440|NCT01021852|64494661|FG006|Washout Period-Placebo|Adverse Event|0|||
23205441|NCT01021852|64494662|FG007|Washout Period-Placebo|Adverse Event|0|||
23205442|NCT01021852|64494655|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
23205443|NCT01021852|64494656|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
23205444|NCT01021852|64494657|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
23205445|NCT01021852|64494658|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
23205446|NCT01021852|64494659|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
23205447|NCT01021852|64494660|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
23205448|NCT01021852|64494661|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
23205449|NCT01021852|64494662|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
23205450|NCT01021852|64494655|FG000|Washout Period-Placebo|Protocol Violation|0|||
23205451|NCT01021852|64494656|FG001|Washout Period-Placebo|Protocol Violation|0|||
23205452|NCT01021852|64494657|FG002|Washout Period-Placebo|Protocol Violation|0|||
23205453|NCT01021852|64494658|FG003|Washout Period-Placebo|Protocol Violation|0|||
23205454|NCT01021852|64494659|FG004|Washout Period-Placebo|Protocol Violation|0|||
23205455|NCT01021852|64494660|FG005|Washout Period-Placebo|Protocol Violation|0|||
23522811|NCT00048542|65653979|FG007|Double-Blind Phase|Protocol Violation|0|||
23522812|NCT00048542|65653972|FG000|Double-Blind Phase|Sponsor request or decision|2|||
23205456|NCT01021852|64494661|FG006|Washout Period-Placebo|Protocol Violation|1|||
23205457|NCT01021852|64494662|FG007|Washout Period-Placebo|Protocol Violation|0|||
23416771|NCT03928418|65271270|FG002|Overall Study|Lost to Follow-up|5|||
23522813|NCT00048542|65653973|FG001|Double-Blind Phase|Sponsor request or decision|0|||
23522814|NCT00048542|65653974|FG002|Double-Blind Phase|Sponsor request or decision|0|||
23522815|NCT00048542|65653975|FG003|Double-Blind Phase|Sponsor request or decision|0|||
23205458|NCT01021852|64494655|FG000|Washout Period-No Drug|Adverse Event|1|||
23205459|NCT01021852|64494656|FG001|Washout Period-No Drug|Adverse Event|0|||
23205460|NCT01021852|64494657|FG002|Washout Period-No Drug|Adverse Event|0|||
23416772|NCT03928418|65271268|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
23416773|NCT03928418|65271269|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
23416774|NCT03928418|65271270|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
23416775|NCT00218634|65271271|FG000|Overall Study|Lost to Follow-up|8|||
23416776|NCT00218634|65271272|FG001|Overall Study|Lost to Follow-up|15|||
23416777|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
23416778|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
23416779|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
23416780|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
23416781|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
23416782|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
23522816|NCT00048542|65653976|FG004|Double-Blind Phase|Sponsor request or decision|0|||
23522817|NCT00048542|65653977|FG005|Double-Blind Phase|Sponsor request or decision|0|||
23522818|NCT00048542|65653978|FG006|Double-Blind Phase|Sponsor request or decision|0|||
23522819|NCT00048542|65653979|FG007|Double-Blind Phase|Sponsor request or decision|0|||
23416783|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
23416784|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
23416785|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
23522820|NCT00048542|65653972|FG000|Double-Blind Phase|Randomized in error|1|||
23522821|NCT00048542|65653973|FG001|Double-Blind Phase|Randomized in error|0|||
23522822|NCT00048542|65653974|FG002|Double-Blind Phase|Randomized in error|0|||
23522823|NCT00048542|65653975|FG003|Double-Blind Phase|Randomized in error|0|||
23522824|NCT00048542|65653976|FG004|Double-Blind Phase|Randomized in error|0|||
23522825|NCT00048542|65653977|FG005|Double-Blind Phase|Randomized in error|0|||
23522826|NCT00048542|65653978|FG006|Double-Blind Phase|Randomized in error|0|||
23522827|NCT00048542|65653979|FG007|Double-Blind Phase|Randomized in error|0|||
23522828|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522829|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522830|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522831|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522832|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
23522833|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
23522834|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522835|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
23522836|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522837|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522838|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522839|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522840|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522841|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
23522842|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522843|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
23522844|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522845|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522846|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522847|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522848|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
23522849|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
23522850|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23522851|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
23416786|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
23416787|NCT01639339|65271275|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
23522852|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
23522853|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
23522854|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
23522855|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
23522856|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
23522857|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
23522858|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
23522859|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
23522860|NCT00048542|65653972|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522861|NCT00048542|65653973|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522862|NCT00048542|65653974|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522863|NCT00048542|65653975|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522864|NCT00048542|65653976|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
23522865|NCT00048542|65653977|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
23522866|NCT00048542|65653978|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522867|NCT00048542|65653979|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
23522868|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522869|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522870|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522871|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522872|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522873|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
23522874|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
23522875|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
23522876|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522877|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522878|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522879|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522880|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522881|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
23522882|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
23522883|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
23522884|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522885|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522886|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522887|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522888|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522889|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
23522890|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
23522891|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
23522892|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522893|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522894|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522895|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522896|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522897|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
23522898|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
23522899|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
23522900|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522901|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522902|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522903|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522904|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522905|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
23522906|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
23522907|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
23522908|NCT00048542|65653972|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23205461|NCT01021852|64494658|FG003|Washout Period-No Drug|Adverse Event|0|||
23205462|NCT01021852|64494659|FG004|Washout Period-No Drug|Adverse Event|0|||
23522909|NCT00048542|65653973|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522910|NCT00048542|65653974|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522911|NCT00048542|65653975|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522912|NCT00048542|65653976|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522913|NCT00048542|65653977|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
23522914|NCT00048542|65653978|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
23522915|NCT00048542|65653979|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
23522916|NCT02098109|65653980|FG000|Overall Study|Protocol Violation|3|||
23522917|NCT02098109|65653981|FG001|Overall Study|Protocol Violation|0|||
23522918|NCT01505608|65653982|FG000|Phase I|Lack of Efficacy|0|||
23522919|NCT01505608|65653983|FG001|Phase I|Lack of Efficacy|4|||
23522920|NCT01505608|65653982|FG000|Phase I|Adverse Event|0|||
23522921|NCT01505608|65653983|FG001|Phase I|Adverse Event|1|||
23522922|NCT01505608|65653982|FG000|Phase I|Withdrawal by Subject|0|||
23522923|NCT01505608|65653983|FG001|Phase I|Withdrawal by Subject|1|||
23522924|NCT01505608|65653982|FG000|Phase II|Lack of Efficacy|2|||
23522925|NCT01505608|65653983|FG001|Phase II|Lack of Efficacy|1|||
23522926|NCT01505608|65653982|FG000|Phase II|Protocol Violation|0|||
23522927|NCT01505608|65653983|FG001|Phase II|Protocol Violation|1|||
23522928|NCT00314366|65653984|FG000|Overall Study|not treated due to patient medical condi|1|||
23522929|NCT00314366|65653985|FG001|Overall Study|not treated due to patient medical condi|0|||
23522930|NCT00542919|65653986|FG000|Overall Study|Adverse Event|1|||
23522931|NCT00542919|65653987|FG001|Overall Study|Adverse Event|5|||
23522932|NCT00542919|65653988|FG002|Overall Study|Adverse Event|1|||
23522933|NCT00542919|65653986|FG000|Overall Study|Withdrawal by Subject|1|||
23522934|NCT00542919|65653987|FG001|Overall Study|Withdrawal by Subject|0|||
23522935|NCT00542919|65653988|FG002|Overall Study|Withdrawal by Subject|3|||
23522936|NCT00542919|65653986|FG000|Overall Study|Physician Decision|2|||
23522937|NCT00542919|65653987|FG001|Overall Study|Physician Decision|2|||
23522938|NCT00542919|65653988|FG002|Overall Study|Physician Decision|1|||
23522939|NCT00542919|65653986|FG000|Overall Study|Sponsor Decision|1|||
23522940|NCT00542919|65653987|FG001|Overall Study|Sponsor Decision|0|||
23522941|NCT00542919|65653988|FG002|Overall Study|Sponsor Decision|0|||
23522942|NCT00542919|65653986|FG000|Overall Study|Lost to Follow-up|2|||
23522943|NCT00542919|65653987|FG001|Overall Study|Lost to Follow-up|0|||
23522944|NCT00542919|65653988|FG002|Overall Study|Lost to Follow-up|1|||
23522945|NCT02046148|65653993|FG000|Overall Study|Lost to Follow-up|1|||
23522946|NCT02046148|65653994|FG001|Overall Study|Lost to Follow-up|1|||
23522947|NCT02046148|65653993|FG000|Overall Study|Withdrawal by Subject|0|||
23205463|NCT01021852|64494660|FG005|Washout Period-No Drug|Adverse Event|1|||
23205464|NCT01021852|64494661|FG006|Washout Period-No Drug|Adverse Event|0|||
23522948|NCT02046148|65653994|FG001|Overall Study|Withdrawal by Subject|2|||
23522949|NCT01928862|65653996|FG000|Overall Study|Lost to Follow-up|1|||
23522950|NCT01928862|65653997|FG001|Overall Study|Lost to Follow-up|0|||
23522951|NCT01928862|65653998|FG002|Overall Study|Lost to Follow-up|0|||
23522952|NCT01928862|65653999|FG003|Overall Study|Lost to Follow-up|0|||
23522953|NCT01928862|65654000|FG004|Overall Study|Lost to Follow-up|1|||
23522954|NCT04753164|65654001|FG000|Overall Study|Adverse Event|0|||
23522955|NCT04753164|65654002|FG001|Overall Study|Adverse Event|2|||
23522956|NCT04753164|65654001|FG000|Overall Study|Withdrawal by Subject|9|||
23522957|NCT04753164|65654002|FG001|Overall Study|Withdrawal by Subject|7|||
23205465|NCT01021852|64494662|FG007|Washout Period-No Drug|Adverse Event|0|||
23205466|NCT01021852|64494655|FG000|Treatment Period 2|Adverse Event|0|||
23522958|NCT04753164|65654001|FG000|Overall Study|Lost to Follow-up|6|||
23522959|NCT04753164|65654002|FG001|Overall Study|Lost to Follow-up|6|||
23522960|NCT04753164|65654001|FG000|Overall Study|Other|12|||
23522961|NCT04753164|65654002|FG001|Overall Study|Other|5|||
23522962|NCT04014075|65654005|FG000|Overall Study|Progressive Disease|48|||
23522963|NCT04014075|65654005|FG000|Overall Study|Adverse Event|11|||
23522964|NCT04014075|65654005|FG000|Overall Study|Clinical Progression|4|||
23522965|NCT04014075|65654005|FG000|Overall Study|Death|2|||
23522966|NCT04014075|65654005|FG000|Overall Study|Withdrawal by Subject|2|||
23522967|NCT04014075|65654005|FG000|Overall Study|Miscellaneous|1|||
23522968|NCT04014075|65654005|FG000|Overall Study|Physician Decision|1|||
23522969|NCT01660412|65654006|FG000|Overall Study|Protocol Violation|0|||
23522970|NCT01660412|65654007|FG001|Overall Study|Protocol Violation|3|||
23522971|NCT00588822|65654009|FG000|Overall Study|progression of disease|8|||
23522972|NCT03465878|65654010|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
23522973|NCT03465878|65654011|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
23522974|NCT03465878|65654012|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
23522975|NCT03465878|65654013|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
23522976|NCT03465878|65654010|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
23522977|NCT03465878|65654011|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
23522978|NCT03465878|65654012|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
23522979|NCT03465878|65654013|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
23522980|NCT03465878|65654010|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
23522981|NCT03465878|65654011|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
23522982|NCT03465878|65654012|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
23522983|NCT03465878|65654013|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
23522984|NCT03388138|65654014|FG000|Overall Study|Protocol Violation|1|||
23522985|NCT03388138|65654015|FG001|Overall Study|Protocol Violation|0|||
23522986|NCT01187043|65654017|FG000|Overall Study|Adverse Event|0|||
23522987|NCT01187043|65654018|FG001|Overall Study|Adverse Event|0|||
23522988|NCT01187043|65654019|FG002|Overall Study|Adverse Event|0|||
23522989|NCT01187043|65654020|FG003|Overall Study|Adverse Event|0|||
23522990|NCT01187043|65654021|FG004|Overall Study|Adverse Event|1|||
23522991|NCT01187043|65654017|FG000|Overall Study|Unable to make scheduled visits|1|||
23522992|NCT01187043|65654018|FG001|Overall Study|Unable to make scheduled visits|0|||
23522993|NCT01187043|65654019|FG002|Overall Study|Unable to make scheduled visits|4|||
23522994|NCT01187043|65654020|FG003|Overall Study|Unable to make scheduled visits|0|||
23522995|NCT01187043|65654021|FG004|Overall Study|Unable to make scheduled visits|1|||
23522996|NCT00634088|65654022|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
23522997|NCT00634088|65654023|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
23522998|NCT00634088|65654024|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
23522999|NCT00634088|65654025|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
23523000|NCT00634088|65654022|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
23523001|NCT00634088|65654023|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
23523002|NCT00634088|65654024|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
23523003|NCT00634088|65654025|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
23523004|NCT00634088|65654022|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
23523005|NCT00634088|65654023|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
23523006|NCT00634088|65654024|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
23523007|NCT00634088|65654025|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
23523008|NCT00634088|65654022|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
23523009|NCT00634088|65654023|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
23523010|NCT00634088|65654024|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
23523011|NCT00634088|65654025|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
23523012|NCT00634088|65654022|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
23523013|NCT00634088|65654023|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
23523014|NCT00634088|65654024|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
23523015|NCT00634088|65654025|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
23523016|NCT00634088|65654022|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
23523017|NCT00634088|65654023|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
23523018|NCT00634088|65654024|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
23523019|NCT00634088|65654025|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
23523020|NCT00445328|65654026|FG000|Overall Study|Death|0|||
23523021|NCT00445328|65654027|FG001|Overall Study|Death|1|||
23523022|NCT00445328|65654026|FG000|Overall Study|Adverse Event|0|||
23523023|NCT00445328|65654027|FG001|Overall Study|Adverse Event|3|||
23523024|NCT00445328|65654026|FG000|Overall Study|Other|0|||
23523025|NCT00445328|65654027|FG001|Overall Study|Other|2|||
23523026|NCT00445328|65654026|FG000|Overall Study|Withdrawal by Subject|2|||
23523027|NCT00445328|65654027|FG001|Overall Study|Withdrawal by Subject|0|||
23523028|NCT00445328|65654026|FG000|Overall Study|Protocol Violation|1|||
23523029|NCT00445328|65654027|FG001|Overall Study|Protocol Violation|0|||
23523030|NCT02586493|65654029|FG000|Overall Study|Adverse Event|4|||
23523031|NCT02586493|65654029|FG000|Overall Study|Protocol Violation|6|||
23523032|NCT02586493|65654029|FG000|Overall Study|Lost to Follow-up|1|||
23523033|NCT02586493|65654029|FG000|Overall Study|Withdrawal by Subject|1|||
23523034|NCT00312494|65654035|FG000|Overall Study|Randomized; not treated with study drug|9|||
23523035|NCT00312494|65654036|FG001|Overall Study|Randomized; not treated with study drug|10|||
23523036|NCT00312494|65654037|FG002|Overall Study|Randomized; not treated with study drug|5|||
23523037|NCT00312494|65654035|FG000|Overall Study|Adverse Event|33|||
23523038|NCT00312494|65654036|FG001|Overall Study|Adverse Event|15|||
23523039|NCT00312494|65654037|FG002|Overall Study|Adverse Event|11|||
23523040|NCT00312494|65654035|FG000|Overall Study|Lack of Efficacy|4|||
23523041|NCT00312494|65654036|FG001|Overall Study|Lack of Efficacy|6|||
23523042|NCT00312494|65654037|FG002|Overall Study|Lack of Efficacy|8|||
23523043|NCT00312494|65654035|FG000|Overall Study|Laboratory abnormality|1|||
23523044|NCT00312494|65654036|FG001|Overall Study|Laboratory abnormality|0|||
23523045|NCT00312494|65654037|FG002|Overall Study|Laboratory abnormality|0|||
23523046|NCT00312494|65654035|FG000|Overall Study|Lost to Follow-up|8|||
23523047|NCT00312494|65654036|FG001|Overall Study|Lost to Follow-up|8|||
23523048|NCT00312494|65654037|FG002|Overall Study|Lost to Follow-up|8|||
23523049|NCT00312494|65654035|FG000|Overall Study|Withdrawal by Subject|6|||
23523050|NCT00312494|65654036|FG001|Overall Study|Withdrawal by Subject|9|||
23523051|NCT00312494|65654037|FG002|Overall Study|Withdrawal by Subject|10|||
23523052|NCT00312494|65654035|FG000|Overall Study|Other|10|||
23523053|NCT00312494|65654036|FG001|Overall Study|Other|10|||
23523054|NCT00312494|65654037|FG002|Overall Study|Other|1|||
23523055|NCT00006478|65654038|FG000|Overall Study|Vaccine could not be produced|1|||
23523056|NCT00006478|65654038|FG000|Overall Study|Physician Decision|6|||
23523057|NCT00006489|65654047|FG000|Overall Study|Adverse Event|3|||
23523058|NCT00006489|65654048|FG001|Overall Study|Adverse Event|2|||
23523059|NCT00006489|65654049|FG002|Overall Study|Adverse Event|4|||
23523060|NCT00006489|65654050|FG003|Overall Study|Adverse Event|3|||
23523061|NCT00006489|65654047|FG000|Overall Study|Withdrawal by Subject|10|||
23523062|NCT00006489|65654048|FG001|Overall Study|Withdrawal by Subject|9|||
23523063|NCT00006489|65654049|FG002|Overall Study|Withdrawal by Subject|9|||
23523064|NCT00006489|65654050|FG003|Overall Study|Withdrawal by Subject|6|||
23523065|NCT00006489|65654047|FG000|Overall Study|Scheduling Conflict|0|||
23523066|NCT00006489|65654048|FG001|Overall Study|Scheduling Conflict|3|||
23523067|NCT00006489|65654049|FG002|Overall Study|Scheduling Conflict|2|||
23523068|NCT00006489|65654050|FG003|Overall Study|Scheduling Conflict|1|||
23523069|NCT00006489|65654047|FG000|Overall Study|Death|0|||
23523070|NCT00006489|65654048|FG001|Overall Study|Death|0|||
23523071|NCT00006489|65654049|FG002|Overall Study|Death|0|||
23523072|NCT00006489|65654050|FG003|Overall Study|Death|1|||
23523073|NCT00854581|65654053|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
23523074|NCT00854581|65654053|FG000|Induction (Up to Day 21)|Death|1|||
23523075|NCT00854581|65654053|FG000|Induction (Up to Day 21)|Physician Decision|1|||
23523076|NCT00854581|65654053|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
23523077|NCT01652664|65654054|FG000|Overall Study|Treatment Failure|5|||
23523078|NCT01652664|65654055|FG001|Overall Study|Treatment Failure|1|||
23523079|NCT01652664|65654054|FG000|Overall Study|Inadequate IOP control|1|||
23523080|NCT01652664|65654055|FG001|Overall Study|Inadequate IOP control|0|||
23523081|NCT01063595|65654056|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
23523082|NCT01063595|65654057|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
23523083|NCT01063595|65654056|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
23523084|NCT01063595|65654057|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
23523085|NCT01063595|65654056|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
23523086|NCT01063595|65654057|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
23523087|NCT01063595|65654056|FG000|First Intervention|Adverse Event|1|||
23523088|NCT01063595|65654057|FG001|First Intervention|Adverse Event|4|||
23523089|NCT01063595|65654056|FG000|First Intervention|Withdrawal by Subject|1|||
23523090|NCT01063595|65654057|FG001|First Intervention|Withdrawal by Subject|0|||
23523091|NCT01063595|65654056|FG000|First Intervention|Reason not Specified|0|||
23523092|NCT01063595|65654057|FG001|First Intervention|Reason not Specified|1|||
23523093|NCT02082210|65654060|FG000|Overall Study|Death|0|||
23416788|NCT01639339|65271276|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
23523094|NCT02082210|65654061|FG001|Overall Study|Death|0|||
23523095|NCT02082210|65654062|FG002|Overall Study|Death|1|||
23523096|NCT02082210|65654063|FG003|Overall Study|Death|1|||
23523097|NCT02082210|65654064|FG004|Overall Study|Death|1|||
23523098|NCT02082210|65654065|FG005|Overall Study|Death|0|||
23523099|NCT02082210|65654060|FG000|Overall Study|Withdrawal by Subject|0|||
23523100|NCT02082210|65654061|FG001|Overall Study|Withdrawal by Subject|0|||
23523101|NCT02082210|65654062|FG002|Overall Study|Withdrawal by Subject|0|||
23523102|NCT02082210|65654063|FG003|Overall Study|Withdrawal by Subject|1|||
23523103|NCT02082210|65654064|FG004|Overall Study|Withdrawal by Subject|2|||
23523104|NCT02082210|65654065|FG005|Overall Study|Withdrawal by Subject|2|||
23523105|NCT02082210|65654060|FG000|Overall Study|Clinical Progression|0|||
23523106|NCT02082210|65654061|FG001|Overall Study|Clinical Progression|0|||
23523107|NCT02082210|65654062|FG002|Overall Study|Clinical Progression|0|||
23523108|NCT02082210|65654063|FG003|Overall Study|Clinical Progression|1|||
23523109|NCT02082210|65654064|FG004|Overall Study|Clinical Progression|0|||
23523110|NCT02082210|65654065|FG005|Overall Study|Clinical Progression|0|||
23523111|NCT02082210|65654060|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
23523112|NCT02082210|65654061|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
23523113|NCT02082210|65654062|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
23523114|NCT02082210|65654063|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
23523115|NCT02082210|65654064|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
23523116|NCT02082210|65654065|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
23523117|NCT02082210|65654060|FG000|Overall Study|Physician Decision|0|||
23523118|NCT02082210|65654061|FG001|Overall Study|Physician Decision|0|||
23523119|NCT02082210|65654062|FG002|Overall Study|Physician Decision|1|||
23523120|NCT02082210|65654063|FG003|Overall Study|Physician Decision|1|||
23523121|NCT02082210|65654064|FG004|Overall Study|Physician Decision|0|||
23523122|NCT02082210|65654065|FG005|Overall Study|Physician Decision|0|||
23523123|NCT00788827|65654066|FG000|Overall Study|Lack of Efficacy|2|||
23523124|NCT00694369|65654068|FG000|Overall Study|Adverse Event|0|||
23523125|NCT00694369|65654069|FG001|Overall Study|Adverse Event|1|||
23523126|NCT00694369|65654070|FG002|Overall Study|Adverse Event|0|||
23523127|NCT00694369|65654071|FG003|Overall Study|Adverse Event|1|||
23523128|NCT00694369|65654072|FG004|Overall Study|Adverse Event|3|||
23523129|NCT00694369|65654068|FG000|Overall Study|Lost to Follow-up|0|||
23523130|NCT00694369|65654069|FG001|Overall Study|Lost to Follow-up|0|||
23523131|NCT00694369|65654070|FG002|Overall Study|Lost to Follow-up|1|||
23523132|NCT00694369|65654071|FG003|Overall Study|Lost to Follow-up|1|||
23523133|NCT00694369|65654072|FG004|Overall Study|Lost to Follow-up|0|||
23523134|NCT00694369|65654068|FG000|Overall Study|Physician Decision|0|||
23523135|NCT00694369|65654069|FG001|Overall Study|Physician Decision|0|||
23523136|NCT00694369|65654070|FG002|Overall Study|Physician Decision|0|||
23523137|NCT00694369|65654071|FG003|Overall Study|Physician Decision|0|||
23523138|NCT00694369|65654072|FG004|Overall Study|Physician Decision|1|||
23523139|NCT00694369|65654068|FG000|Overall Study|Protocol Violation|0|||
23523140|NCT00694369|65654069|FG001|Overall Study|Protocol Violation|1|||
23523141|NCT00694369|65654070|FG002|Overall Study|Protocol Violation|0|||
23523142|NCT00694369|65654071|FG003|Overall Study|Protocol Violation|0|||
23523143|NCT00694369|65654072|FG004|Overall Study|Protocol Violation|0|||
23523144|NCT00694369|65654068|FG000|Overall Study|Withdrawal by Subject|1|||
23523145|NCT00694369|65654069|FG001|Overall Study|Withdrawal by Subject|1|||
23523146|NCT00694369|65654070|FG002|Overall Study|Withdrawal by Subject|1|||
23523147|NCT00694369|65654071|FG003|Overall Study|Withdrawal by Subject|1|||
23523148|NCT00694369|65654072|FG004|Overall Study|Withdrawal by Subject|2|||
23523149|NCT01177540|65654073|FG000|Overall Study|Adverse Event|1|||
23523150|NCT01177540|65654074|FG001|Overall Study|Adverse Event|0|||
23523151|NCT02612428|65654075|FG000|VTL-308|Death|14|||
23523152|NCT02612428|65654076|FG001|VTL-308|Death|16|||
23523153|NCT02612428|65654075|FG000|VTL-308|Withdrawal by Subject|0|||
23523154|NCT02612428|65654076|FG001|VTL-308|Withdrawal by Subject|1|||
23523155|NCT02612428|65654075|FG000|VTL-308E|Death|9|||
23523156|NCT02612428|65654076|FG001|VTL-308E|Death|7|||
23523157|NCT02612428|65654075|FG000|VTL-308E|Lost to Follow-up|2|||
23523158|NCT02612428|65654076|FG001|VTL-308E|Lost to Follow-up|0|||
23523159|NCT00751348|65654077|FG000|Overall Study|Withdrawal by Subject|5|||
23523160|NCT00751348|65654078|FG001|Overall Study|Withdrawal by Subject|2|||
23523161|NCT00751348|65654077|FG000|Overall Study|Migration from study area|1|||
23523162|NCT00751348|65654078|FG001|Overall Study|Migration from study area|0|||
23523163|NCT00314574|65654079|FG000|Overall Study|Death|3|||
23523164|NCT00314574|65654080|FG001|Overall Study|Death|0|||
23523165|NCT00314574|65654079|FG000|Overall Study|Adverse Event|11|||
23523166|NCT00314574|65654080|FG001|Overall Study|Adverse Event|16|||
23523167|NCT00314574|65654079|FG000|Overall Study|Lost to Follow-up|19|||
23523168|NCT00314574|65654080|FG001|Overall Study|Lost to Follow-up|25|||
23523169|NCT00314574|65654079|FG000|Overall Study|Withdrawal by Subject|33|||
23523170|NCT00314574|65654080|FG001|Overall Study|Withdrawal by Subject|22|||
23523171|NCT00314574|65654079|FG000|Overall Study|Physician Decision|22|||
23523172|NCT00314574|65654080|FG001|Overall Study|Physician Decision|15|||
23205467|NCT01021852|64494656|FG001|Treatment Period 2|Adverse Event|1|||
23523173|NCT00314574|65654079|FG000|Overall Study|Pregnancy|6|||
23523174|NCT00314574|65654080|FG001|Overall Study|Pregnancy|4|||
23523175|NCT00314574|65654079|FG000|Overall Study|Data unknown at database lock|0|||
23523176|NCT00314574|65654080|FG001|Overall Study|Data unknown at database lock|1|||
23523177|NCT03323658|65654083|FG000|Overall Study|Adverse Event|0|||
23523178|NCT03323658|65654084|FG001|Overall Study|Adverse Event|1|||
23523179|NCT03323658|65654085|FG002|Overall Study|Adverse Event|0|||
23523180|NCT03792672|65654086|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
23523181|NCT03792672|65654087|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
23523182|NCT03792672|65654088|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
23523183|NCT03792672|65654089|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
23523184|NCT03792672|65654090|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
23205468|NCT01021852|64494657|FG002|Treatment Period 2|Adverse Event|0|||
23523185|NCT03792672|65654091|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
23523186|NCT03792672|65654086|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
23523187|NCT03792672|65654087|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
23523188|NCT03792672|65654088|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
23523189|NCT03792672|65654089|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
23523190|NCT03792672|65654090|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
23523191|NCT03792672|65654091|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
23523192|NCT03792672|65654086|FG000|Treatment Period 4 (2 Days)|Other|1|||
23523193|NCT03792672|65654087|FG001|Treatment Period 4 (2 Days)|Other|0|||
23523194|NCT03792672|65654088|FG002|Treatment Period 4 (2 Days)|Other|0|||
23523195|NCT03792672|65654089|FG003|Treatment Period 4 (2 Days)|Other|0|||
23523196|NCT03792672|65654090|FG004|Treatment Period 4 (2 Days)|Other|0|||
23523197|NCT03792672|65654091|FG005|Treatment Period 4 (2 Days)|Other|0|||
23523198|NCT00066066|65654095|FG000|Overall Study|Lost to Follow-up|6|||
23523199|NCT00066066|65654096|FG001|Overall Study|Lost to Follow-up|4|||
23523200|NCT00066066|65654097|FG002|Overall Study|Lost to Follow-up|7|||
23523201|NCT00066066|65654098|FG003|Overall Study|Lost to Follow-up|4|||
23523202|NCT00066066|65654099|FG004|Overall Study|Lost to Follow-up|3|||
23523203|NCT00066066|65654100|FG005|Overall Study|Lost to Follow-up|5|||
23523204|NCT03257631|65654101|FG000|Overall Study|Death|1|||
23523205|NCT03257631|65654102|FG001|Overall Study|Death|0|||
23523206|NCT03257631|65654103|FG002|Overall Study|Death|1|||
23523207|NCT03257631|65654104|FG003|Overall Study|Death|1|||
23523208|NCT03257631|65654101|FG000|Overall Study|Progressive Disease|10|||
23523209|NCT03257631|65654102|FG001|Overall Study|Progressive Disease|9|||
23523210|NCT03257631|65654103|FG002|Overall Study|Progressive Disease|17|||
23523211|NCT03257631|65654104|FG003|Overall Study|Progressive Disease|8|||
23523212|NCT03257631|65654101|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23523213|NCT03257631|65654102|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23523214|NCT03257631|65654103|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
23523215|NCT03257631|65654104|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
23523216|NCT03257631|65654101|FG000|Overall Study|Adverse Event|0|||
23523217|NCT03257631|65654102|FG001|Overall Study|Adverse Event|0|||
23523218|NCT03257631|65654103|FG002|Overall Study|Adverse Event|2|||
23523219|NCT03257631|65654104|FG003|Overall Study|Adverse Event|0|||
23523220|NCT00718328|65654105|FG000|Overall Study|Lost to Follow-up|1|||
23523221|NCT00718328|65654106|FG001|Overall Study|Lost to Follow-up|0|||
23523222|NCT01869192|65654109|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
23523223|NCT01869192|65654110|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
23523224|NCT01869192|65654109|FG000|Postoperative Chemotherapy|Physician Decision|0|||
23523225|NCT01869192|65654110|FG001|Postoperative Chemotherapy|Physician Decision|2|||
23523226|NCT02290821|65654113|FG000|Overall Study|Withdrawal by Subject|1|||
23523227|NCT02290821|65654114|FG001|Overall Study|Withdrawal by Subject|1|||
23523228|NCT02290821|65654113|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
23205469|NCT01021852|64494658|FG003|Treatment Period 2|Adverse Event|0|||
23523229|NCT02290821|65654114|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
23523230|NCT02290821|65654113|FG000|Overall Study|Lost to Follow-up|3|||
23523231|NCT02290821|65654114|FG001|Overall Study|Lost to Follow-up|2|||
23523232|NCT01752855|65654116|FG000|Overall Study|Adverse Event|1|||
23523233|NCT01752855|65654117|FG001|Overall Study|Adverse Event|0|||
23523234|NCT01752855|65654116|FG000|Overall Study|Withdrew Consent|0|||
23523235|NCT01752855|65654117|FG001|Overall Study|Withdrew Consent|2|||
23523236|NCT01752855|65654116|FG000|Overall Study|Lack of Efficacy|0|||
23523237|NCT01752855|65654117|FG001|Overall Study|Lack of Efficacy|2|||
23523238|NCT02780804|65654118|FG000|Overall Study|Death|1|||
23523239|NCT02780804|65654119|FG001|Overall Study|Death|0|||
23523240|NCT02780804|65654120|FG002|Overall Study|Death|0|||
23523241|NCT02780804|65654118|FG000|Overall Study|Lack of Efficacy|5|||
23523242|NCT02780804|65654119|FG001|Overall Study|Lack of Efficacy|8|||
23523243|NCT02780804|65654120|FG002|Overall Study|Lack of Efficacy|4|||
23523244|NCT02780804|65654118|FG000|Overall Study|Physician Decision|0|||
23523245|NCT02780804|65654119|FG001|Overall Study|Physician Decision|0|||
23523246|NCT02780804|65654120|FG002|Overall Study|Physician Decision|2|||
23523247|NCT02780804|65654118|FG000|Overall Study|Withdrawal by Subject|0|||
23523248|NCT02780804|65654119|FG001|Overall Study|Withdrawal by Subject|1|||
23523249|NCT02780804|65654120|FG002|Overall Study|Withdrawal by Subject|0|||
23523250|NCT00603746|65654121|FG000|Overall Study|Adverse Event|2|||
23523251|NCT00603746|65654122|FG001|Overall Study|Adverse Event|3|||
23523252|NCT00603746|65654123|FG002|Overall Study|Adverse Event|0|||
23205470|NCT01021852|64494659|FG004|Treatment Period 2|Adverse Event|1|||
23205471|NCT01021852|64494660|FG005|Treatment Period 2|Adverse Event|0|||
23205472|NCT01021852|64494661|FG006|Treatment Period 2|Adverse Event|1|||
23205473|NCT01021852|64494662|FG007|Treatment Period 2|Adverse Event|0|||
23205474|NCT01021852|64494655|FG000|Treatment Period 2|Lack of Efficacy|0|||
23205475|NCT01021852|64494656|FG001|Treatment Period 2|Lack of Efficacy|0|||
23205476|NCT01021852|64494657|FG002|Treatment Period 2|Lack of Efficacy|0|||
23205477|NCT01021852|64494658|FG003|Treatment Period 2|Lack of Efficacy|0|||
23205478|NCT01021852|64494659|FG004|Treatment Period 2|Lack of Efficacy|0|||
23205479|NCT01021852|64494660|FG005|Treatment Period 2|Lack of Efficacy|1|||
23205480|NCT01021852|64494661|FG006|Treatment Period 2|Lack of Efficacy|0|||
23205481|NCT01021852|64494662|FG007|Treatment Period 2|Lack of Efficacy|0|||
23205482|NCT01021852|64494655|FG000|Treatment Period 2|Physician Decision|0|||
23205483|NCT01021852|64494656|FG001|Treatment Period 2|Physician Decision|0|||
23205484|NCT01021852|64494657|FG002|Treatment Period 2|Physician Decision|1|||
23205485|NCT01021852|64494658|FG003|Treatment Period 2|Physician Decision|0|||
23205486|NCT01021852|64494659|FG004|Treatment Period 2|Physician Decision|0|||
23205487|NCT01021852|64494660|FG005|Treatment Period 2|Physician Decision|0|||
23205488|NCT01021852|64494661|FG006|Treatment Period 2|Physician Decision|0|||
23205489|NCT01021852|64494662|FG007|Treatment Period 2|Physician Decision|0|||
23205490|NCT01021852|64494655|FG000|Treatment Period 2|Protocol Violation|0|||
23205491|NCT01021852|64494656|FG001|Treatment Period 2|Protocol Violation|0|||
23205492|NCT01021852|64494657|FG002|Treatment Period 2|Protocol Violation|0|||
23205493|NCT01021852|64494658|FG003|Treatment Period 2|Protocol Violation|0|||
23205494|NCT01021852|64494659|FG004|Treatment Period 2|Protocol Violation|1|||
23205495|NCT01021852|64494660|FG005|Treatment Period 2|Protocol Violation|0|||
23205496|NCT01021852|64494661|FG006|Treatment Period 2|Protocol Violation|1|||
23205497|NCT01021852|64494662|FG007|Treatment Period 2|Protocol Violation|0|||
23205498|NCT01021852|64494655|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23205499|NCT01021852|64494656|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23205500|NCT01021852|64494657|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23205501|NCT01021852|64494658|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23205502|NCT01021852|64494659|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23205503|NCT01021852|64494660|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23205504|NCT01021852|64494661|FG006|Treatment Period 2|Withdrawal by Subject|1|||
23205505|NCT01021852|64494662|FG007|Treatment Period 2|Withdrawal by Subject|2|||
23205506|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
23523253|NCT00603746|65654124|FG003|Overall Study|Adverse Event|1|||
23523254|NCT00603746|65654125|FG004|Overall Study|Adverse Event|0|||
23523255|NCT00603746|65654126|FG005|Overall Study|Adverse Event|4|||
23523256|NCT00603746|65654121|FG000|Overall Study|Lack of Efficacy|34|||
23523257|NCT00603746|65654122|FG001|Overall Study|Lack of Efficacy|11|||
23523258|NCT00603746|65654123|FG002|Overall Study|Lack of Efficacy|6|||
23523259|NCT00603746|65654124|FG003|Overall Study|Lack of Efficacy|11|||
23523260|NCT00603746|65654125|FG004|Overall Study|Lack of Efficacy|12|||
23523261|NCT00603746|65654126|FG005|Overall Study|Lack of Efficacy|8|||
23523262|NCT00603746|65654121|FG000|Overall Study|Protocol Violation|0|||
23523263|NCT00603746|65654122|FG001|Overall Study|Protocol Violation|3|||
23523264|NCT00603746|65654123|FG002|Overall Study|Protocol Violation|1|||
23523265|NCT00603746|65654124|FG003|Overall Study|Protocol Violation|0|||
23523266|NCT00603746|65654125|FG004|Overall Study|Protocol Violation|1|||
23523267|NCT00603746|65654126|FG005|Overall Study|Protocol Violation|0|||
23523268|NCT00603746|65654121|FG000|Overall Study|Lost to Follow-up|0|||
23523269|NCT00603746|65654122|FG001|Overall Study|Lost to Follow-up|1|||
23523270|NCT00603746|65654123|FG002|Overall Study|Lost to Follow-up|1|||
23523271|NCT00603746|65654124|FG003|Overall Study|Lost to Follow-up|0|||
23523272|NCT00603746|65654125|FG004|Overall Study|Lost to Follow-up|0|||
23523273|NCT00603746|65654126|FG005|Overall Study|Lost to Follow-up|0|||
23523274|NCT00603746|65654121|FG000|Overall Study|Physician Decision|1|||
23523275|NCT00603746|65654122|FG001|Overall Study|Physician Decision|0|||
23523276|NCT00603746|65654123|FG002|Overall Study|Physician Decision|0|||
23523277|NCT00603746|65654124|FG003|Overall Study|Physician Decision|0|||
23523278|NCT00603746|65654125|FG004|Overall Study|Physician Decision|1|||
23523279|NCT00603746|65654126|FG005|Overall Study|Physician Decision|0|||
23523280|NCT00603746|65654121|FG000|Overall Study|Withdrawal by Subject|1|||
23523281|NCT00603746|65654122|FG001|Overall Study|Withdrawal by Subject|0|||
23523282|NCT00603746|65654123|FG002|Overall Study|Withdrawal by Subject|0|||
23523283|NCT00603746|65654124|FG003|Overall Study|Withdrawal by Subject|1|||
23523284|NCT00603746|65654125|FG004|Overall Study|Withdrawal by Subject|3|||
23523285|NCT00603746|65654126|FG005|Overall Study|Withdrawal by Subject|1|||
23523286|NCT02818777|65654128|FG000|Overall Study|Adverse Event|3|||
23523287|NCT02086110|65654133|FG000|Overall Study|Withdrawal by Subject|1|||
23523288|NCT02086110|65654134|FG001|Overall Study|Withdrawal by Subject|1|||
23523289|NCT00702403|65654135|FG000|From Consent to Engraftment|Progressive leukemia|6|||
23523290|NCT00702403|65654135|FG000|From Consent to Engraftment|Critically ill|2|||
23523291|NCT00702403|65654135|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
23523292|NCT00702403|65654135|FG000|From Consent to Engraftment|Myocardial infarction|1|||
23523293|NCT00702403|65654135|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
23523294|NCT00702403|65654135|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
23523295|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
23523296|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
23523297|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Non-compliance|2|||
23523298|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
23523299|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
23523300|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Suicide|1|||
23523301|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
23523302|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
23523303|NCT00702403|65654135|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
23523304|NCT04056195|65654138|FG000|Overall Study|Adverse Event|1|||
23523305|NCT04056195|65654139|FG001|Overall Study|Adverse Event|0|||
23523306|NCT04056195|65654140|FG002|Overall Study|Adverse Event|0|||
23523307|NCT04056195|65654138|FG000|Overall Study|Withdrawal by Subject|0|||
23523308|NCT04056195|65654139|FG001|Overall Study|Withdrawal by Subject|1|||
23523309|NCT04056195|65654140|FG002|Overall Study|Withdrawal by Subject|1|||
23523310|NCT04056195|65654138|FG000|Overall Study|Physician Decision|1|||
23523311|NCT04056195|65654139|FG001|Overall Study|Physician Decision|1|||
23523312|NCT04056195|65654140|FG002|Overall Study|Physician Decision|1|||
23523313|NCT01217060|65654141|FG000|Overall Study|Withdrawal by Subject|1|||
23523314|NCT00666757|65654142|FG000|Overall Study|Lost to Follow-up|39|||
23523315|NCT00666757|65654143|FG001|Overall Study|Lost to Follow-up|35|||
23523316|NCT00666757|65654142|FG000|Overall Study|Protocol Violation|23|||
23523317|NCT00666757|65654143|FG001|Overall Study|Protocol Violation|24|||
23523318|NCT00666757|65654142|FG000|Overall Study|Adverse Event|22|||
23523319|NCT00666757|65654143|FG001|Overall Study|Adverse Event|12|||
23523320|NCT00666757|65654142|FG000|Overall Study|Withdrawal by Subject|13|||
23523321|NCT00666757|65654143|FG001|Overall Study|Withdrawal by Subject|17|||
23523322|NCT00666757|65654142|FG000|Overall Study|Lack of Efficacy|3|||
23523323|NCT00666757|65654143|FG001|Overall Study|Lack of Efficacy|6|||
23523324|NCT00666757|65654142|FG000|Overall Study|Physician Decision|0|||
23523325|NCT00666757|65654143|FG001|Overall Study|Physician Decision|2|||
23523326|NCT00666757|65654142|FG000|Overall Study|Sponsor decision|0|||
23523327|NCT00666757|65654143|FG001|Overall Study|Sponsor decision|1|||
23523328|NCT00663052|65654144|FG000|Overall Study|Adverse Event|6|||
23523329|NCT00663052|65654145|FG001|Overall Study|Adverse Event|3|||
23523330|NCT00663052|65654144|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
23523331|NCT00663052|65654145|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23523332|NCT00663052|65654144|FG000|Overall Study|Protocol Violation|1|||
23205507|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
23205508|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
23205509|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
23307891|NCT04844762|64873903|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
23205510|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
23205511|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
23205512|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
23523333|NCT00663052|65654145|FG001|Overall Study|Protocol Violation|0|||
23523334|NCT00663052|65654144|FG000|Overall Study|Withdrawal by Subject|2|||
23523335|NCT00663052|65654145|FG001|Overall Study|Withdrawal by Subject|5|||
23523336|NCT00663052|65654144|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
23523337|NCT00663052|65654145|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
23523338|NCT00663052|65654144|FG000|Overall Study|Other|0|||
23523339|NCT00663052|65654145|FG001|Overall Study|Other|1|||
23523340|NCT03093428|65654156|FG000|Overall Study|Not eligible for treatment|2|||
23523341|NCT03093428|65654157|FG001|Overall Study|Not eligible for treatment|1|||
23523342|NCT03093428|65654156|FG000|Overall Study|Progression|14|||
23523343|NCT03093428|65654157|FG001|Overall Study|Progression|4|||
23523344|NCT03093428|65654156|FG000|Overall Study|Death|1|||
23523345|NCT03093428|65654157|FG001|Overall Study|Death|0|||
23523346|NCT03093428|65654156|FG000|Overall Study|Adverse Event|1|||
23523347|NCT03093428|65654157|FG001|Overall Study|Adverse Event|0|||
23523348|NCT03093428|65654156|FG000|Overall Study|Withdrawal by Subject|1|||
23523349|NCT03093428|65654157|FG001|Overall Study|Withdrawal by Subject|1|||
23523350|NCT04151290|65654158|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
23523351|NCT01945489|65654161|FG000|Cycle 1|Adverse Event|2|||
23523352|NCT01945489|65654162|FG001|Cycle 1|Adverse Event|0|||
23523353|NCT01945489|65654161|FG000|Cycle 1|Lost to Follow-up|4|||
23523354|NCT01945489|65654162|FG001|Cycle 1|Lost to Follow-up|0|||
23523355|NCT01945489|65654161|FG000|Cycle 1|Personal Reasons|4|||
23523356|NCT01945489|65654162|FG001|Cycle 1|Personal Reasons|2|||
23523357|NCT01945489|65654161|FG000|Cycle 1|Protocol Violation|0|||
23523358|NCT01945489|65654162|FG001|Cycle 1|Protocol Violation|1|||
23523359|NCT01945489|65654161|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
23523360|NCT01945489|65654162|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
23523361|NCT01945489|65654161|FG000|Cycle 2|Adverse Event|1|||
23523362|NCT01945489|65654162|FG001|Cycle 2|Adverse Event|0|||
23523363|NCT01945489|65654161|FG000|Cycle 2|Lost to Follow-up|0|||
23523364|NCT01945489|65654162|FG001|Cycle 2|Lost to Follow-up|1|||
23523365|NCT00696137|65654163|FG000|Overall Study|Withdrawal by Subject|2|||
23523366|NCT00642668|65654164|FG000|Overall Study|Lost to Follow-up|1|||
23523367|NCT00642668|65654164|FG000|Overall Study|Adverse Event|2|||
23523368|NCT00642668|65654164|FG000|Overall Study|Death|2|||
23523369|NCT00642668|65654164|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23523370|NCT00642668|65654164|FG000|Overall Study|Failure to Return|1|||
23523371|NCT00642668|65654164|FG000|Overall Study|Dialysis Initiation|5|||
23523372|NCT00642668|65654164|FG000|Overall Study|Blood Transfusion|2|||
23523373|NCT01200797|65654168|FG000|Overall Study|symptomatic deterioration|2|||
23523374|NCT01200797|65654168|FG000|Overall Study|Adverse Event|4|||
23523375|NCT01200797|65654168|FG000|Overall Study|Disease Progression|13|||
23523376|NCT01675882|65654169|FG000|Overall Study|Adverse Event|0|||
23523377|NCT01675882|65654170|FG001|Overall Study|Adverse Event|2|||
23523378|NCT01675882|65654171|FG002|Overall Study|Adverse Event|1|||
23523379|NCT01675882|65654172|FG003|Overall Study|Adverse Event|0|||
23523380|NCT01675882|65654169|FG000|Overall Study|Participant unwilling to continue|2|||
23523381|NCT01675882|65654170|FG001|Overall Study|Participant unwilling to continue|4|||
23523382|NCT01675882|65654171|FG002|Overall Study|Participant unwilling to continue|2|||
23523383|NCT01675882|65654172|FG003|Overall Study|Participant unwilling to continue|1|||
23523384|NCT01675882|65654169|FG000|Overall Study|Lost to Follow-up|0|||
23523385|NCT01675882|65654170|FG001|Overall Study|Lost to Follow-up|1|||
23523386|NCT01675882|65654171|FG002|Overall Study|Lost to Follow-up|0|||
23523387|NCT01675882|65654172|FG003|Overall Study|Lost to Follow-up|0|||
23523388|NCT01675882|65654169|FG000|Overall Study|Non-compliance|0|||
23523389|NCT01675882|65654170|FG001|Overall Study|Non-compliance|0|||
23523390|NCT01675882|65654171|FG002|Overall Study|Non-compliance|0|||
23523391|NCT01675882|65654172|FG003|Overall Study|Non-compliance|1|||
23523392|NCT04327986|65654173|FG000|Overall Study|Physician Decision|2|||
23523393|NCT04327986|65654174|FG001|Overall Study|Physician Decision|0|||
23523394|NCT04327986|65654175|FG002|Overall Study|Physician Decision|0|||
23523395|NCT04327986|65654173|FG000|Overall Study|Death|1|||
23523396|NCT04327986|65654174|FG001|Overall Study|Death|0|||
23523397|NCT04327986|65654175|FG002|Overall Study|Death|0|||
23523398|NCT01380184|65654179|FG000|Part 1 (19 Days)|Adverse Event|1|||
23523399|NCT01380184|65654179|FG000|Part 2|Adverse Event|5|||
23523400|NCT01380184|65654179|FG000|Part 2|Disease Progression|8|||
23523401|NCT01380184|65654179|FG000|Part 2|Lost to Follow-up|1|||
23523402|NCT03818516|65654180|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
23523403|NCT04098458|65657600|FG000|Overall Study|Death|1|||
23523404|NCT04098458|65657600|FG000|Overall Study|did not meet study inclusion criteria|3|||
23523405|NCT00558103|65657601|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
23523406|NCT00558103|65657602|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
23523407|NCT00558103|65657603|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
23523408|NCT00558103|65657604|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
23523409|NCT00558103|65657605|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
23523410|NCT00558103|65657606|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
23523411|NCT00558103|65657601|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
23307892|NCT04844762|64873904|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
23307893|NCT04844762|64873905|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
23307894|NCT04844762|64873900|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307895|NCT04844762|64873901|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307896|NCT04844762|64873902|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23523412|NCT00558103|65657602|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
23523413|NCT00558103|65657603|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
23523414|NCT00558103|65657604|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
23523415|NCT00558103|65657605|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
23523416|NCT00558103|65657606|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
23205513|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
23205514|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
23205515|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
23205516|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
23205517|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
23205518|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
23205519|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
23205520|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
23205521|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
23205522|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Missing|3|||
23205523|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Missing|1|||
23205524|NCT00838916|64494663|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
23205525|NCT00838916|64494664|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
23205526|NCT00838916|64494663|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
23205527|NCT00838916|64494664|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
23205528|NCT00838916|64494663|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
23205529|NCT00838916|64494664|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
23205530|NCT00838916|64494663|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
23205531|NCT00838916|64494664|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
23205532|NCT00838916|64494663|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
23205533|NCT00838916|64494664|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
23205534|NCT00838916|64494663|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
23205535|NCT00838916|64494664|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
23205536|NCT00838916|64494663|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
23205537|NCT00838916|64494664|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
23205538|NCT00838916|64494663|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
23205539|NCT00838916|64494664|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
23205540|NCT00838916|64494663|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
23205541|NCT00838916|64494664|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
23205542|NCT00838916|64494663|FG000|Follow-up Period (8 Weeks)|Missing|3|||
23205543|NCT00838916|64494664|FG001|Follow-up Period (8 Weeks)|Missing|0|||
23205544|NCT00632541|64494674|FG000|Overall Study|Adverse Event|7|||
23205545|NCT00495495|64494675|FG000|Overall Study|Protocol Violation|99|||
23205546|NCT00008138|64494676|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
23205547|NCT00008138|64494676|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
23205548|NCT00008138|64494676|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
23205549|NCT00008138|64494676|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
23205550|NCT00008138|64494676|FG000|Interval Debulking|Withdrawal by Subject|2|||
23205551|NCT00008138|64494676|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
23205552|NCT00008138|64494676|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
23205553|NCT00008138|64494676|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
23205554|NCT00434512|64494677|FG000|Overall Study|Migrated/moved from study area|0|||
23205555|NCT00434512|64494678|FG001|Overall Study|Migrated/moved from study area|0|||
23205556|NCT00434512|64494679|FG002|Overall Study|Migrated/moved from study area|0|||
23205557|NCT00434512|64494680|FG003|Overall Study|Migrated/moved from study area|1|||
23205558|NCT00434512|64494681|FG004|Overall Study|Migrated/moved from study area|1|||
23205559|NCT00434512|64494682|FG005|Overall Study|Migrated/moved from study area|1|||
23205560|NCT00434512|64494677|FG000|Overall Study|Other|0|||
23205561|NCT00434512|64494678|FG001|Overall Study|Other|1|||
23205562|NCT00434512|64494679|FG002|Overall Study|Other|0|||
23205563|NCT00434512|64494680|FG003|Overall Study|Other|0|||
23205564|NCT00434512|64494681|FG004|Overall Study|Other|0|||
23307897|NCT04844762|64873903|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
23307898|NCT04844762|64873904|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307899|NCT04844762|64873905|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23307900|NCT04844762|64873900|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307901|NCT04844762|64873901|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307902|NCT04844762|64873902|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
23307903|NCT04844762|64873903|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
23307904|NCT04844762|64873904|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
23307905|NCT04844762|64873905|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307906|NCT04844762|64873900|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
23307907|NCT04844762|64873901|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
23307908|NCT04844762|64873902|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23307909|NCT04844762|64873903|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23307910|NCT04844762|64873904|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23307911|NCT04844762|64873905|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23307912|NCT04844762|64873900|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23523417|NCT00558103|65657601|FG000|Randomized Treatment Phase|Disease Progression|1|||
23523418|NCT00558103|65657602|FG001|Randomized Treatment Phase|Disease Progression|0|||
23523419|NCT00558103|65657603|FG002|Randomized Treatment Phase|Disease Progression|1|||
23523420|NCT00558103|65657604|FG003|Randomized Treatment Phase|Disease Progression|0|||
23523421|NCT00558103|65657605|FG004|Randomized Treatment Phase|Disease Progression|0|||
23523422|NCT00558103|65657606|FG005|Randomized Treatment Phase|Disease Progression|0|||
23523423|NCT00558103|65657601|FG000|Randomized Treatment Phase|Adverse Event|0|||
23523424|NCT00558103|65657602|FG001|Randomized Treatment Phase|Adverse Event|0|||
23523425|NCT00558103|65657603|FG002|Randomized Treatment Phase|Adverse Event|0|||
23523426|NCT00558103|65657604|FG003|Randomized Treatment Phase|Adverse Event|1|||
23523427|NCT00558103|65657605|FG004|Randomized Treatment Phase|Adverse Event|1|||
23523428|NCT00558103|65657606|FG005|Randomized Treatment Phase|Adverse Event|0|||
23523429|NCT00558103|65657601|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
23523430|NCT00558103|65657602|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
23523431|NCT00558103|65657603|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
23523432|NCT00558103|65657604|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
23523433|NCT00558103|65657605|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
23523434|NCT00558103|65657606|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
23523435|NCT00558103|65657601|FG000|Monotherapy Extension Phase|Disease Progression|0|||
23523436|NCT00558103|65657602|FG001|Monotherapy Extension Phase|Disease Progression|0|||
23523437|NCT00558103|65657603|FG002|Monotherapy Extension Phase|Disease Progression|0|||
23523438|NCT00558103|65657604|FG003|Monotherapy Extension Phase|Disease Progression|0|||
23205565|NCT00434512|64494682|FG005|Overall Study|Other|0|||
23205566|NCT01885078|64494683|FG000|Treatment Period|Adverse Event|52|||
23205567|NCT01885078|64494684|FG001|Treatment Period|Adverse Event|136|||
23205568|NCT01885078|64494685|FG002|Treatment Period|Adverse Event|30|||
23205569|NCT01885078|64494686|FG003|Treatment Period|Adverse Event|73|||
23205570|NCT01885078|64494687|FG004|Treatment Period|Adverse Event|17|||
23205571|NCT01885078|64494688|FG005|Treatment Period|Adverse Event|72|||
23205572|NCT01885078|64494689|FG006|Treatment Period|Adverse Event|24|||
23205573|NCT01885078|64494690|FG007|Treatment Period|Adverse Event|5|||
23205574|NCT01885078|64494691|FG008|Treatment Period|Adverse Event|0|||
23205575|NCT01885078|64494692|FG009|Treatment Period|Adverse Event|0|||
23205576|NCT01885078|64494683|FG000|Treatment Period|Death|13|||
23205577|NCT01885078|64494684|FG001|Treatment Period|Death|33|||
23205578|NCT01885078|64494685|FG002|Treatment Period|Death|5|||
23205579|NCT01885078|64494686|FG003|Treatment Period|Death|9|||
23205580|NCT01885078|64494687|FG004|Treatment Period|Death|2|||
23205581|NCT01885078|64494688|FG005|Treatment Period|Death|10|||
23205582|NCT01885078|64494689|FG006|Treatment Period|Death|3|||
23205583|NCT01885078|64494690|FG007|Treatment Period|Death|2|||
23205584|NCT01885078|64494691|FG008|Treatment Period|Death|0|||
23205585|NCT01885078|64494692|FG009|Treatment Period|Death|0|||
23205586|NCT01885078|64494683|FG000|Treatment Period|Lack of Efficacy|12|||
23205587|NCT01885078|64494684|FG001|Treatment Period|Lack of Efficacy|33|||
23205588|NCT01885078|64494685|FG002|Treatment Period|Lack of Efficacy|10|||
23205589|NCT01885078|64494686|FG003|Treatment Period|Lack of Efficacy|23|||
23205590|NCT01885078|64494687|FG004|Treatment Period|Lack of Efficacy|24|||
23205591|NCT01885078|64494688|FG005|Treatment Period|Lack of Efficacy|58|||
23205592|NCT01885078|64494689|FG006|Treatment Period|Lack of Efficacy|9|||
23205593|NCT01885078|64494690|FG007|Treatment Period|Lack of Efficacy|5|||
23205594|NCT01885078|64494691|FG008|Treatment Period|Lack of Efficacy|0|||
23205595|NCT01885078|64494692|FG009|Treatment Period|Lack of Efficacy|0|||
23205596|NCT01885078|64494683|FG000|Treatment Period|Lost to Follow-up|16|||
23205597|NCT01885078|64494684|FG001|Treatment Period|Lost to Follow-up|19|||
23205598|NCT01885078|64494685|FG002|Treatment Period|Lost to Follow-up|7|||
23205599|NCT01885078|64494686|FG003|Treatment Period|Lost to Follow-up|9|||
23307913|NCT04844762|64873901|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23523439|NCT00558103|65657605|FG004|Monotherapy Extension Phase|Disease Progression|0|||
23523440|NCT00558103|65657606|FG005|Monotherapy Extension Phase|Disease Progression|8|||
23523441|NCT02734810|65657607|FG000|Overall Study|Adverse Event|1|||
23523442|NCT02734810|65657608|FG001|Overall Study|Adverse Event|0|||
23523443|NCT02734810|65657607|FG000|Overall Study|Lack of Efficacy|1|||
23523444|NCT02734810|65657608|FG001|Overall Study|Lack of Efficacy|0|||
23523445|NCT02346136|65657611|FG000|Overall Study|Withdrawal by Subject|7|||
23523446|NCT02346136|65657612|FG001|Overall Study|Withdrawal by Subject|5|||
23523447|NCT02346136|65657611|FG000|Overall Study|Death|1|||
23523448|NCT02346136|65657612|FG001|Overall Study|Death|0|||
23523449|NCT02346136|65657611|FG000|Overall Study|Study termination|14|||
23523450|NCT02346136|65657612|FG001|Overall Study|Study termination|18|||
23523451|NCT00486265|65657613|FG000|Overall Study|Adverse Event|1|||
23523452|NCT00486265|65657613|FG000|Overall Study|Lack of Efficacy|8|||
23523453|NCT02449239|65657614|FG000|Induction Phase|Lack of Efficacy|64|||
23523454|NCT02449239|65657614|FG000|Induction Phase|Adverse Event|1|||
23523455|NCT02449239|65657614|FG000|Induction Phase|Lost to Follow-up|1|||
23523456|NCT02449239|65657614|FG000|Induction Phase|Protocol Violation|1|||
23523457|NCT02449239|65657614|FG000|Induction Phase|Physician Decision|1|||
23523458|NCT02449239|65657614|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
23523459|NCT02449239|65657614|FG000|Induction Phase|Withdrawal by Subject|1|||
23523460|NCT02449239|65657614|FG000|Maintenance Month 3|Lack of Efficacy|14|||
23523461|NCT02449239|65657614|FG000|Maintenance Month 6|Lack of Efficacy|10|||
23523462|NCT02449239|65657614|FG000|Maintenance Month 6|Adverse Event|2|||
23523463|NCT02449239|65657614|FG000|Maintenance Month 6|Physician Decision|1|||
23523464|NCT02449239|65657614|FG000|Maintenance Month 9|Lack of Efficacy|2|||
23523465|NCT02449239|65657614|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
23523466|NCT02449239|65657614|FG000|Maintenance Month 12|Lack of Efficacy|5|||
23523467|NCT02449239|65657614|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
23523468|NCT02449239|65657614|FG000|Maintenance Month 12|Subject moved from area|1|||
23523469|NCT02449239|65657614|FG000|Maintenance Month 15|Lack of Efficacy|1|||
23523470|NCT02449239|65657614|FG000|Maintenance Month 21|Lack of Efficacy|1|||
23523471|NCT02449239|65657614|FG000|Maintenance Month 21|Sponsor decision|1|||
23523472|NCT03925727|65657624|FG000|Overall Study|Adverse Event|4|||
23523473|NCT03925727|65657625|FG001|Overall Study|Adverse Event|0|||
23523474|NCT03925727|65657626|FG002|Overall Study|Adverse Event|3|||
23523475|NCT03925727|65657624|FG000|Overall Study|Protocol Violation|1|||
23523476|NCT03925727|65657625|FG001|Overall Study|Protocol Violation|2|||
23523477|NCT03925727|65657626|FG002|Overall Study|Protocol Violation|2|||
23523478|NCT03925727|65657624|FG000|Overall Study|Withdrawal by Subject|3|||
23523479|NCT03925727|65657625|FG001|Overall Study|Withdrawal by Subject|2|||
23523480|NCT03925727|65657626|FG002|Overall Study|Withdrawal by Subject|4|||
23523481|NCT03925727|65657624|FG000|Overall Study|Administrative Reasons|3|||
23523482|NCT03925727|65657625|FG001|Overall Study|Administrative Reasons|1|||
23523483|NCT03925727|65657626|FG002|Overall Study|Administrative Reasons|2|||
23523484|NCT03925727|65657624|FG000|Overall Study|Randomized in error or Disqualified|8|||
23523485|NCT03925727|65657625|FG001|Overall Study|Randomized in error or Disqualified|1|||
23523486|NCT03925727|65657626|FG002|Overall Study|Randomized in error or Disqualified|7|||
23523487|NCT01070316|65657627|FG000|Extension Phase|Lack of Efficacy|3|||
23523488|NCT01070316|65657627|FG000|Extension Phase|Withdrawal by Subject|1|||
23523489|NCT01063764|65657636|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
23523490|NCT01063764|65657636|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
23523491|NCT01063764|65657636|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
23523492|NCT01063764|65657636|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
23523493|NCT01063764|65657636|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
23523494|NCT01063764|65657636|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
23523495|NCT01063764|65657636|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
23523496|NCT00097721|65657637|FG000|Overall Study|Adverse Event|8|||
23523497|NCT00097721|65657638|FG001|Overall Study|Adverse Event|1|||
23523498|NCT00097721|65657637|FG000|Overall Study|Withdrawal by Subject|6|||
23523499|NCT00097721|65657638|FG001|Overall Study|Withdrawal by Subject|1|||
23523500|NCT00097721|65657637|FG000|Overall Study|Progressive Disease|55|||
23523501|NCT00097721|65657638|FG001|Overall Study|Progressive Disease|27|||
23523502|NCT00097721|65657637|FG000|Overall Study|Physician Decision|1|||
23523503|NCT00097721|65657638|FG001|Overall Study|Physician Decision|3|||
23523504|NCT00097721|65657637|FG000|Overall Study|Reason not given|1|||
23523505|NCT00097721|65657638|FG001|Overall Study|Reason not given|1|||
23523506|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
23205600|NCT01885078|64494687|FG004|Treatment Period|Lost to Follow-up|2|||
23523507|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
23523508|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
23523509|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
23523510|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
23523511|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
23523512|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
23307914|NCT04844762|64873902|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307915|NCT04844762|64873903|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307916|NCT04844762|64873904|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307917|NCT04844762|64873905|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307918|NCT04844762|64873900|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307919|NCT04844762|64873901|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307920|NCT04844762|64873902|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23205601|NCT01885078|64494688|FG005|Treatment Period|Lost to Follow-up|8|||
23307921|NCT04844762|64873903|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307922|NCT04844762|64873904|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
23307923|NCT04844762|64873905|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
23307924|NCT04844762|64873900|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
23307925|NCT04844762|64873901|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23307926|NCT04844762|64873902|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23307927|NCT04844762|64873903|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23307928|NCT04844762|64873904|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23307929|NCT04844762|64873905|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
23307930|NCT04844762|64873900|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23307931|NCT04844762|64873901|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307932|NCT04844762|64873902|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307933|NCT04844762|64873903|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307934|NCT04844762|64873904|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
23307935|NCT04844762|64873905|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
23307936|NCT04844762|64873900|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23307937|NCT04844762|64873901|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
23307938|NCT04844762|64873902|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23307939|NCT04844762|64873903|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23307940|NCT04844762|64873904|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23307941|NCT04844762|64873905|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
23307942|NCT04844762|64873900|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23307943|NCT04844762|64873901|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23307944|NCT04844762|64873902|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23307945|NCT04844762|64873903|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
23307946|NCT04844762|64873904|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23205602|NCT01885078|64494689|FG006|Treatment Period|Lost to Follow-up|2|||
23205603|NCT01885078|64494690|FG007|Treatment Period|Lost to Follow-up|0|||
23205604|NCT01885078|64494691|FG008|Treatment Period|Lost to Follow-up|0|||
23205605|NCT01885078|64494692|FG009|Treatment Period|Lost to Follow-up|0|||
23205606|NCT01885078|64494683|FG000|Treatment Period|Physician Decision|19|||
23205607|NCT01885078|64494684|FG001|Treatment Period|Physician Decision|21|||
23205608|NCT01885078|64494685|FG002|Treatment Period|Physician Decision|5|||
23205609|NCT01885078|64494686|FG003|Treatment Period|Physician Decision|12|||
23205610|NCT01885078|64494687|FG004|Treatment Period|Physician Decision|9|||
23307947|NCT04844762|64873905|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
23307948|NCT04729309|64873906|FG000|Period 1|Subject unable to return for Period 2|3|||
23307949|NCT04729309|64873907|FG001|Period 1|Subject unable to return for Period 2|0|||
23307950|NCT04729309|64873906|FG000|Period 1|Lost to Follow-up|1|||
23307951|NCT04729309|64873907|FG001|Period 1|Lost to Follow-up|0|||
23307952|NCT02628743|64873911|FG000|Overall Study|Other|3|||
23307953|NCT02628743|64873911|FG000|Overall Study|Withdrawal by Subject|50|||
23307954|NCT02628743|64873911|FG000|Overall Study|Study Terminated by Sponsor|76|||
23307955|NCT02628743|64873911|FG000|Overall Study|Physician Decision|2|||
23307956|NCT02143583|64873912|FG000|Overall Study|Withdrawal by Subject|1|||
23307957|NCT02143583|64873913|FG001|Overall Study|Withdrawal by Subject|0|||
23307958|NCT02143583|64873914|FG002|Overall Study|Withdrawal by Subject|1|||
23307959|NCT02143583|64873912|FG000|Overall Study|husband illness|0|||
23307960|NCT02143583|64873913|FG001|Overall Study|husband illness|0|||
23307961|NCT02143583|64873914|FG002|Overall Study|husband illness|1|||
23307962|NCT01206101|64873915|FG000|Overall Study|Adverse Event|1|||
23307963|NCT01206101|64873916|FG001|Overall Study|Adverse Event|0|||
23307964|NCT01206101|64873915|FG000|Overall Study|Physician Decision|0|||
23307965|NCT01206101|64873916|FG001|Overall Study|Physician Decision|1|||
23307966|NCT01206101|64873915|FG000|Overall Study|Unclassified|1|||
23307967|NCT01206101|64873916|FG001|Overall Study|Unclassified|0|||
23307968|NCT00140426|64873919|FG000|Overall Study|Withdrawal by Subject|0|||
23307969|NCT00140426|64873920|FG001|Overall Study|Withdrawal by Subject|3|||
23307970|NCT02488330|64873923|FG000|Overall Study|Adverse Event|1|||
23307971|NCT02488330|64873923|FG000|Overall Study|Physician Decision|2|||
23307972|NCT02488330|64873923|FG000|Overall Study|Death|2|||
23307973|NCT02488330|64873923|FG000|Overall Study|Disease Progression|3|||
23307974|NCT02488330|64873923|FG000|Overall Study|Study Termination by Sponsor|4|||
23307975|NCT00090363|64873924|FG000|Overall Study|Lost to Follow-up|1|||
23307976|NCT00090363|64873925|FG001|Overall Study|Lost to Follow-up|2|||
23307977|NCT00090363|64873926|FG002|Overall Study|Lost to Follow-up|1|||
23307978|NCT00090363|64873924|FG000|Overall Study|Withdrawal by Subject|7|||
23307979|NCT00090363|64873925|FG001|Overall Study|Withdrawal by Subject|7|||
23307980|NCT00090363|64873926|FG002|Overall Study|Withdrawal by Subject|6|||
23307981|NCT00090363|64873924|FG000|Overall Study|Study-specific discontinuation criteria|75|||
23307982|NCT00090363|64873925|FG001|Overall Study|Study-specific discontinuation criteria|74|||
23307983|NCT00090363|64873926|FG002|Overall Study|Study-specific discontinuation criteria|62|||
23307984|NCT00090363|64873924|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23307985|NCT00090363|64873925|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23307986|NCT00090363|64873926|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23307987|NCT00090363|64873924|FG000|Overall Study|Consent expired|7|||
23307988|NCT00090363|64873925|FG001|Overall Study|Consent expired|10|||
23307989|NCT00090363|64873926|FG002|Overall Study|Consent expired|9|||
23307990|NCT00090363|64873924|FG000|Overall Study|Reasons not specified|2|||
23307991|NCT00090363|64873925|FG001|Overall Study|Reasons not specified|1|||
23307992|NCT00090363|64873926|FG002|Overall Study|Reasons not specified|1|||
23307993|NCT00090363|64873924|FG000|Overall Study|Continuing on study off treatment|14|||
23307994|NCT00090363|64873925|FG001|Overall Study|Continuing on study off treatment|13|||
23307995|NCT00090363|64873926|FG002|Overall Study|Continuing on study off treatment|16|||
23307996|NCT02910063|64873927|FG000|Phase 2|Withdrawal by Subject|3|||
23307997|NCT02910063|64873928|FG001|Phase 2|Withdrawal by Subject|0|||
23307998|NCT02910063|64873929|FG002|Phase 2|Withdrawal by Subject|0|||
23307999|NCT02910063|64873927|FG000|Phase 2|Lost to Follow-up|1|||
23308000|NCT02910063|64873928|FG001|Phase 2|Lost to Follow-up|0|||
23308001|NCT02910063|64873929|FG002|Phase 2|Lost to Follow-up|0|||
23308002|NCT02910063|64873927|FG000|Phase 2|Death|24|||
23308003|NCT02910063|64873928|FG001|Phase 2|Death|0|||
23308004|NCT02910063|64873929|FG002|Phase 2|Death|0|||
23308005|NCT03861481|64873930|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
23308006|NCT03861481|64873931|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
23308007|NCT03861481|64873930|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
23308008|NCT03861481|64873931|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
23308009|NCT03861481|64873930|FG000|Overall Study|Relapse|1|||
23308010|NCT03861481|64873931|FG001|Overall Study|Relapse|0|||
23308011|NCT03861481|64873930|FG000|Overall Study|Withdrawal by Subject|0|||
23308012|NCT03861481|64873931|FG001|Overall Study|Withdrawal by Subject|1|||
23308013|NCT03861481|64873930|FG000|Overall Study|Lack of Efficacy|4|||
23308014|NCT03861481|64873931|FG001|Overall Study|Lack of Efficacy|5|||
23308015|NCT02836496|64873934|FG000|Overall Study|Adverse Event|2|||
23308016|NCT02836496|64873935|FG001|Overall Study|Adverse Event|1|||
23308017|NCT02836496|64873934|FG000|Overall Study|Withdrawal by Subject|0|||
23308018|NCT02836496|64873935|FG001|Overall Study|Withdrawal by Subject|1|||
23308019|NCT00927394|64873936|FG000|Overall Study|Adverse Event|14|||
23308020|NCT00927394|64873937|FG001|Overall Study|Adverse Event|9|||
23308021|NCT00927394|64873936|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
23308022|NCT00927394|64873937|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
23308023|NCT00927394|64873936|FG000|Overall Study|Withdrawal by Subject|20|||
23308024|NCT00927394|64873937|FG001|Overall Study|Withdrawal by Subject|24|||
23308025|NCT00927394|64873936|FG000|Overall Study|Lost to Follow-up|8|||
23308026|NCT00927394|64873937|FG001|Overall Study|Lost to Follow-up|14|||
23308027|NCT00927394|64873936|FG000|Overall Study|Administrative Problem|1|||
23308028|NCT00927394|64873937|FG001|Overall Study|Administrative Problem|0|||
23308029|NCT00927394|64873936|FG000|Overall Study|Death|1|||
23308030|NCT00927394|64873937|FG001|Overall Study|Death|1|||
23308031|NCT00927394|64873936|FG000|Overall Study|Protocol deviation|16|||
23308032|NCT00927394|64873937|FG001|Overall Study|Protocol deviation|13|||
23308033|NCT00927394|64873936|FG000|Overall Study|Randomized in error|0|||
23523513|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
23523514|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
23523515|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
23523516|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
23523517|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
23523518|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
23523519|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
23523520|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
23523521|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
23523522|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
23523523|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
23523524|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
23308034|NCT00927394|64873937|FG001|Overall Study|Randomized in error|1|||
23308035|NCT01523457|64873938|FG000|Overall Study|Withdrawal by Subject|7|||
23523525|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
23308036|NCT01523457|64873939|FG001|Overall Study|Withdrawal by Subject|2|||
23308037|NCT01372774|64873942|FG000|Overall Study|Withdrawal prior to treatment|4|||
23308038|NCT01372774|64873943|FG001|Overall Study|Withdrawal prior to treatment|5|||
23308039|NCT01197755|64873944|FG000|Overall Study|Adverse Event|8|||
23308040|NCT01197755|64873945|FG001|Overall Study|Adverse Event|10|||
23308041|NCT01197755|64873946|FG002|Overall Study|Adverse Event|10|||
23308042|NCT01197755|64873944|FG000|Overall Study|Study-specific discontinuation criteria|2|||
23308043|NCT01197755|64873945|FG001|Overall Study|Study-specific discontinuation criteria|1|||
23308044|NCT01197755|64873946|FG002|Overall Study|Study-specific discontinuation criteria|0|||
23308045|NCT01197755|64873944|FG000|Overall Study|Entered the long-term extension study|18|||
23308046|NCT01197755|64873945|FG001|Overall Study|Entered the long-term extension study|21|||
23308047|NCT01197755|64873946|FG002|Overall Study|Entered the long-term extension study|35|||
23308048|NCT01197755|64873944|FG000|Overall Study|Lack of therapeutic response|0|||
23308049|NCT01197755|64873945|FG001|Overall Study|Lack of therapeutic response|7|||
23308050|NCT01197755|64873946|FG002|Overall Study|Lack of therapeutic response|4|||
23308051|NCT01197755|64873944|FG000|Overall Study|Severe non-compliance to the protocol|2|||
23308052|NCT01197755|64873945|FG001|Overall Study|Severe non-compliance to the protocol|1|||
23308053|NCT01197755|64873946|FG002|Overall Study|Severe non-compliance to the protocol|2|||
23308054|NCT01197755|64873944|FG000|Overall Study|Withdrawal by Subject|1|||
23308055|NCT01197755|64873945|FG001|Overall Study|Withdrawal by Subject|0|||
23308056|NCT01197755|64873946|FG002|Overall Study|Withdrawal by Subject|0|||
23308057|NCT01197755|64873944|FG000|Overall Study|Lost to Follow-up|0|||
23308058|NCT01197755|64873945|FG001|Overall Study|Lost to Follow-up|0|||
23308059|NCT01197755|64873946|FG002|Overall Study|Lost to Follow-up|1|||
23308060|NCT01197755|64873944|FG000|Overall Study|eg, change in circumstances|7|||
23308061|NCT01197755|64873945|FG001|Overall Study|eg, change in circumstances|3|||
23308062|NCT01197755|64873946|FG002|Overall Study|eg, change in circumstances|2|||
23308063|NCT03768726|64873947|FG000|Treatment Phase|Adverse Event|2|||
23308064|NCT03768726|64873948|FG001|Treatment Phase|Adverse Event|2|||
23308065|NCT03768726|64873947|FG000|Treatment Phase|Lost to Follow-up|1|||
23308066|NCT03768726|64873948|FG001|Treatment Phase|Lost to Follow-up|0|||
23308067|NCT03768726|64873947|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
23308068|NCT03768726|64873948|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
23308069|NCT03768726|64873947|FG000|Treatment Phase|Withdrawal by Subject|3|||
23308070|NCT03768726|64873948|FG001|Treatment Phase|Withdrawal by Subject|1|||
23308071|NCT03768726|64873947|FG000|Follow-Up|Adverse Event|2|||
23308072|NCT03768726|64873948|FG001|Follow-Up|Adverse Event|2|||
23308073|NCT03768726|64873947|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
23308074|NCT03768726|64873948|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
23523526|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
23523527|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
23523528|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
23523529|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
23523530|NCT00277212|65657641|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
23523531|NCT00277212|65657642|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
23523532|NCT00277212|65657643|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
23523533|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
23523534|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
23523535|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
23523536|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
23523537|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
23523538|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
23523539|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
23523540|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
23523541|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
23523542|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
23523543|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
23523544|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
23523545|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
23523546|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
23523547|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
23523548|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
23523549|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
23523550|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
23523551|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
23523552|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
23523553|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
23523554|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
23523555|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
23523556|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
23523557|NCT00277212|65657641|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
23523558|NCT00277212|65657642|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
23523559|NCT00277212|65657643|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
23523560|NCT00127712|65657653|FG000|Overall Study|Adverse Event|3|||
23523561|NCT00127712|65657654|FG001|Overall Study|Adverse Event|0|||
23523562|NCT00127712|65657653|FG000|Overall Study|Lack of GI access to continue|2|||
23523563|NCT00127712|65657654|FG001|Overall Study|Lack of GI access to continue|0|||
23523564|NCT01354496|65657656|FG000|Period 1|Adverse Event|0|||
23523565|NCT01354496|65657657|FG001|Period 1|Adverse Event|0|||
23523566|NCT01354496|65657658|FG002|Period 1|Adverse Event|1|||
23523567|NCT01354496|65657659|FG003|Period 1|Adverse Event|0|||
23523568|NCT01354496|65657660|FG004|Period 1|Adverse Event|0|||
23523569|NCT01354496|65657661|FG005|Period 1|Adverse Event|0|||
23523570|NCT01354496|65657656|FG000|Period 1|Physician Decision|0|||
23523571|NCT01354496|65657657|FG001|Period 1|Physician Decision|0|||
23523572|NCT01354496|65657658|FG002|Period 1|Physician Decision|1|||
23523573|NCT01354496|65657659|FG003|Period 1|Physician Decision|0|||
23523574|NCT01354496|65657660|FG004|Period 1|Physician Decision|0|||
23523575|NCT01354496|65657661|FG005|Period 1|Physician Decision|0|||
23523576|NCT01354496|65657656|FG000|Period 2|Adverse Event|0|||
23523577|NCT01354496|65657657|FG001|Period 2|Adverse Event|0|||
23523578|NCT01354496|65657658|FG002|Period 2|Adverse Event|0|||
23523579|NCT01354496|65657659|FG003|Period 2|Adverse Event|1|||
23523580|NCT01354496|65657660|FG004|Period 2|Adverse Event|0|||
23523581|NCT01354496|65657661|FG005|Period 2|Adverse Event|0|||
23523582|NCT01354496|65657656|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
23523583|NCT01354496|65657657|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
23523584|NCT01354496|65657658|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
23523585|NCT01354496|65657659|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
23523586|NCT01354496|65657660|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
23523587|NCT01354496|65657661|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
23523588|NCT01116232|65657665|FG000|Overall Study|Progressive diease|4|||
23523589|NCT00378703|65657673|FG000|Overall Study|Disease progression|59|||
23523590|NCT00378703|65657674|FG001|Overall Study|Disease progression|43|||
23523591|NCT00378703|65657675|FG002|Overall Study|Disease progression|48|||
23523592|NCT00378703|65657676|FG003|Overall Study|Disease progression|49|||
23523593|NCT00378703|65657673|FG000|Overall Study|Adverse Event|11|||
23523594|NCT00378703|65657674|FG001|Overall Study|Adverse Event|17|||
23523595|NCT00378703|65657675|FG002|Overall Study|Adverse Event|20|||
23523596|NCT00378703|65657676|FG003|Overall Study|Adverse Event|18|||
23523597|NCT00378703|65657673|FG000|Overall Study|Death|2|||
23523598|NCT00378703|65657674|FG001|Overall Study|Death|2|||
23523599|NCT00378703|65657675|FG002|Overall Study|Death|4|||
23523600|NCT00378703|65657676|FG003|Overall Study|Death|3|||
23523601|NCT00378703|65657673|FG000|Overall Study|Withdrawal by Subject|4|||
23523602|NCT00378703|65657674|FG001|Overall Study|Withdrawal by Subject|8|||
23523603|NCT00378703|65657675|FG002|Overall Study|Withdrawal by Subject|5|||
23523604|NCT00378703|65657676|FG003|Overall Study|Withdrawal by Subject|7|||
23523605|NCT00378703|65657673|FG000|Overall Study|Physician Decision|1|||
23523606|NCT00378703|65657674|FG001|Overall Study|Physician Decision|4|||
23523607|NCT00378703|65657675|FG002|Overall Study|Physician Decision|1|||
23523608|NCT00378703|65657676|FG003|Overall Study|Physician Decision|0|||
23523609|NCT00378703|65657673|FG000|Overall Study|Alternative therapy|4|||
23523610|NCT00378703|65657674|FG001|Overall Study|Alternative therapy|2|||
23523611|NCT00378703|65657675|FG002|Overall Study|Alternative therapy|0|||
23523612|NCT00378703|65657676|FG003|Overall Study|Alternative therapy|0|||
23523613|NCT00378703|65657673|FG000|Overall Study|Other complicated disease|0|||
23523614|NCT00378703|65657674|FG001|Overall Study|Other complicated disease|2|||
23523615|NCT00378703|65657675|FG002|Overall Study|Other complicated disease|2|||
23523616|NCT00378703|65657676|FG003|Overall Study|Other complicated disease|0|||
23523617|NCT00378703|65657673|FG000|Overall Study|Symptomatic deterioration|0|||
23523618|NCT00378703|65657674|FG001|Overall Study|Symptomatic deterioration|1|||
23523619|NCT00378703|65657675|FG002|Overall Study|Symptomatic deterioration|0|||
23523620|NCT00378703|65657676|FG003|Overall Study|Symptomatic deterioration|2|||
23523621|NCT00378703|65657673|FG000|Overall Study|Surgery|1|||
23523622|NCT00378703|65657674|FG001|Overall Study|Surgery|0|||
23523623|NCT00378703|65657675|FG002|Overall Study|Surgery|0|||
23523624|NCT00378703|65657676|FG003|Overall Study|Surgery|1|||
23523625|NCT00378703|65657673|FG000|Overall Study|Joint decision of physician and patient|1|||
23523626|NCT00378703|65657674|FG001|Overall Study|Joint decision of physician and patient|0|||
23523627|NCT00378703|65657675|FG002|Overall Study|Joint decision of physician and patient|0|||
23523628|NCT00378703|65657676|FG003|Overall Study|Joint decision of physician and patient|0|||
23523629|NCT00378703|65657673|FG000|Overall Study|Adverse events and progressive disease|0|||
23523630|NCT00378703|65657674|FG001|Overall Study|Adverse events and progressive disease|0|||
23523631|NCT00378703|65657675|FG002|Overall Study|Adverse events and progressive disease|0|||
23523632|NCT00378703|65657676|FG003|Overall Study|Adverse events and progressive disease|1|||
23523633|NCT00378703|65657673|FG000|Overall Study|Relocation|0|||
23523634|NCT00378703|65657674|FG001|Overall Study|Relocation|0|||
23523635|NCT00378703|65657675|FG002|Overall Study|Relocation|1|||
23523636|NCT00378703|65657676|FG003|Overall Study|Relocation|0|||
23523637|NCT00378703|65657673|FG000|Overall Study|Ineligible|4|||
23523638|NCT00378703|65657674|FG001|Overall Study|Ineligible|7|||
23523639|NCT00378703|65657675|FG002|Overall Study|Ineligible|7|||
23523640|NCT00378703|65657676|FG003|Overall Study|Ineligible|7|||
23523641|NCT00378703|65657673|FG000|Overall Study|Never started treatment|1|||
23523642|NCT00378703|65657674|FG001|Overall Study|Never started treatment|4|||
23523643|NCT00378703|65657675|FG002|Overall Study|Never started treatment|0|||
23523644|NCT00378703|65657676|FG003|Overall Study|Never started treatment|0|||
23523645|NCT00378703|65657673|FG000|Overall Study|Other|1|||
23523646|NCT00378703|65657674|FG001|Overall Study|Other|1|||
23523647|NCT00378703|65657675|FG002|Overall Study|Other|2|||
23523648|NCT00378703|65657676|FG003|Overall Study|Other|3|||
23523649|NCT02016625|65657678|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
23523650|NCT02016625|65657679|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
23523651|NCT02016625|65657678|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
23523652|NCT02016625|65657679|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
23523653|NCT02016625|65657678|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
23523654|NCT02016625|65657679|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
23523655|NCT00655564|65657692|FG000|Overall Study|Adverse Event|1|||
23523656|NCT00655564|65657692|FG000|Overall Study|Lost to Follow-up|1|||
23523657|NCT00655564|65657692|FG000|Overall Study|Desired Alternate Therapy|1|||
23523658|NCT00129129|65657693|FG000|Primary Phase|Adverse Event|2|||
23523659|NCT00129129|65657694|FG001|Primary Phase|Adverse Event|1|||
23523660|NCT00129129|65657695|FG002|Primary Phase|Adverse Event|0|||
23523661|NCT00129129|65657696|FG003|Primary Phase|Adverse Event|0|||
23523662|NCT00129129|65657697|FG004|Primary Phase|Adverse Event|0|||
23523663|NCT00129129|65657693|FG000|Primary Phase|Withdrawal by Subject|12|||
23523664|NCT00129129|65657694|FG001|Primary Phase|Withdrawal by Subject|10|||
23523665|NCT00129129|65657695|FG002|Primary Phase|Withdrawal by Subject|0|||
23523666|NCT00129129|65657696|FG003|Primary Phase|Withdrawal by Subject|0|||
23523667|NCT00129129|65657697|FG004|Primary Phase|Withdrawal by Subject|0|||
23523668|NCT00129129|65657693|FG000|Primary Phase|Migration from study area|1|||
23523669|NCT00129129|65657694|FG001|Primary Phase|Migration from study area|3|||
23523670|NCT00129129|65657695|FG002|Primary Phase|Migration from study area|0|||
23416789|NCT01639339|65271275|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
23416790|NCT01639339|65271276|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
23416791|NCT01639339|65271275|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
23416792|NCT01639339|65271276|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
23416793|NCT01639339|65271275|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
23416794|NCT01639339|65271276|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
23416795|NCT01639339|65271275|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
23416796|NCT01639339|65271276|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
23416797|NCT00813865|65271277|FG000|Overall Study|Failure to Respond|3|||
23416798|NCT00813865|65271277|FG000|Overall Study|Lost to Follow-up|3|||
23416799|NCT00813865|65271277|FG000|Overall Study|Withdrawal by Subject|1|||
23523671|NCT00129129|65657696|FG003|Primary Phase|Migration from study area|0|||
23523672|NCT00129129|65657697|FG004|Primary Phase|Migration from study area|0|||
23523673|NCT00129129|65657693|FG000|Primary Phase|Lost to Follow-up|8|||
23523674|NCT00129129|65657694|FG001|Primary Phase|Lost to Follow-up|6|||
23523675|NCT00129129|65657695|FG002|Primary Phase|Lost to Follow-up|0|||
23523676|NCT00129129|65657696|FG003|Primary Phase|Lost to Follow-up|0|||
23523677|NCT00129129|65657697|FG004|Primary Phase|Lost to Follow-up|0|||
23416800|NCT00855933|65271278|FG000|Overall Study|Withdrawal by Subject|0|||
23416801|NCT00855933|65271279|FG001|Overall Study|Withdrawal by Subject|1|||
23416802|NCT00920218|65271282|FG000|Overall Study|Serious Adverse Event|2|||
23416803|NCT00920218|65271283|FG001|Overall Study|Serious Adverse Event|0|||
23416804|NCT00920218|65271284|FG002|Overall Study|Serious Adverse Event|2|||
23416805|NCT00920218|65271285|FG003|Overall Study|Serious Adverse Event|1|||
23416806|NCT00920218|65271282|FG000|Overall Study|Withdrawal by Subject|0|||
23416807|NCT00920218|65271283|FG001|Overall Study|Withdrawal by Subject|3|||
23416808|NCT00920218|65271284|FG002|Overall Study|Withdrawal by Subject|2|||
23416809|NCT00920218|65271285|FG003|Overall Study|Withdrawal by Subject|0|||
23416810|NCT00920218|65271282|FG000|Overall Study|Migrated/moved from study area|0|||
23416811|NCT00920218|65271283|FG001|Overall Study|Migrated/moved from study area|0|||
23416812|NCT00920218|65271284|FG002|Overall Study|Migrated/moved from study area|1|||
23416813|NCT00920218|65271285|FG003|Overall Study|Migrated/moved from study area|0|||
23416814|NCT00920218|65271282|FG000|Overall Study|Lost to Follow-up|0|||
23416815|NCT00920218|65271283|FG001|Overall Study|Lost to Follow-up|1|||
23416816|NCT00920218|65271284|FG002|Overall Study|Lost to Follow-up|0|||
23416817|NCT00920218|65271285|FG003|Overall Study|Lost to Follow-up|3|||
23416818|NCT00920218|65271282|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
23416819|NCT00920218|65271283|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
23416820|NCT00920218|65271284|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
23416821|NCT00920218|65271285|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
23416822|NCT00920218|65271282|FG000|Overall Study|Other|0|||
23416823|NCT00920218|65271283|FG001|Overall Study|Other|0|||
23416824|NCT00920218|65271284|FG002|Overall Study|Other|1|||
23416825|NCT00920218|65271285|FG003|Overall Study|Other|0|||
23416826|NCT03213938|65271288|FG000|Overall Study|Lost to Follow-up|4|||
23416827|NCT03213938|65271289|FG001|Overall Study|Lost to Follow-up|3|||
23416828|NCT03213938|65271288|FG000|Overall Study|Lack of Efficacy|1|||
23416829|NCT03213938|65271289|FG001|Overall Study|Lack of Efficacy|0|||
23416830|NCT03213938|65271288|FG000|Overall Study|Decline to participate|5|||
23416831|NCT03213938|65271289|FG001|Overall Study|Decline to participate|4|||
23416832|NCT03213938|65271288|FG000|Overall Study|Without reason|4|||
23416833|NCT03213938|65271289|FG001|Overall Study|Without reason|5|||
23416834|NCT00853242|65271290|FG000|Overall Study|Adverse Event|0|||
23416835|NCT00853242|65271291|FG001|Overall Study|Adverse Event|1|||
23416836|NCT00853242|65271292|FG002|Overall Study|Adverse Event|1|||
23416837|NCT00853242|65271293|FG003|Overall Study|Adverse Event|0|||
23416838|NCT00853242|65271294|FG004|Overall Study|Adverse Event|3|||
23416839|NCT00853242|65271295|FG005|Overall Study|Adverse Event|1|||
23523678|NCT00129129|65657693|FG000|Primary Phase|Other|2|||
23523679|NCT00129129|65657694|FG001|Primary Phase|Other|5|||
23523680|NCT00129129|65657695|FG002|Primary Phase|Other|0|||
23523681|NCT00129129|65657696|FG003|Primary Phase|Other|0|||
23523682|NCT00129129|65657697|FG004|Primary Phase|Other|0|||
23416840|NCT00853242|65271296|FG006|Overall Study|Adverse Event|1|||
23416841|NCT00853242|65271290|FG000|Overall Study|Noncompliant|0|||
23416842|NCT00853242|65271291|FG001|Overall Study|Noncompliant|0|||
23416843|NCT00853242|65271292|FG002|Overall Study|Noncompliant|0|||
23416844|NCT00853242|65271293|FG003|Overall Study|Noncompliant|0|||
23416845|NCT00853242|65271294|FG004|Overall Study|Noncompliant|1|||
23416846|NCT00853242|65271295|FG005|Overall Study|Noncompliant|0|||
23416847|NCT00853242|65271296|FG006|Overall Study|Noncompliant|0|||
23416848|NCT00853242|65271290|FG000|Overall Study|Withdrawal by Subject|1|||
23416849|NCT00853242|65271291|FG001|Overall Study|Withdrawal by Subject|2|||
23523683|NCT00129129|65657693|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
23523684|NCT00129129|65657694|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
23523685|NCT00129129|65657695|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
23523686|NCT00129129|65657696|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
23523687|NCT00129129|65657697|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
23523688|NCT00129129|65657693|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
23523689|NCT00129129|65657694|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
23523690|NCT00129129|65657695|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
23523691|NCT00129129|65657696|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
23523692|NCT00129129|65657697|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
23523693|NCT00129129|65657693|FG000|Fourth Dose Phase|Migration from study area|0|||
23523694|NCT00129129|65657694|FG001|Fourth Dose Phase|Migration from study area|0|||
23523695|NCT00129129|65657695|FG002|Fourth Dose Phase|Migration from study area|0|||
23523696|NCT00129129|65657696|FG003|Fourth Dose Phase|Migration from study area|0|||
23523697|NCT00129129|65657697|FG004|Fourth Dose Phase|Migration from study area|2|||
23523698|NCT00129129|65657693|FG000|Fourth Dose Phase|Other|0|||
23523699|NCT00129129|65657694|FG001|Fourth Dose Phase|Other|0|||
23523700|NCT00129129|65657695|FG002|Fourth Dose Phase|Other|0|||
23523701|NCT00129129|65657696|FG003|Fourth Dose Phase|Other|1|||
23523702|NCT00129129|65657697|FG004|Fourth Dose Phase|Other|1|||
23523703|NCT00129129|65657693|FG000|Fourth Dose Phase|Protocol Violation|0|||
23523704|NCT00129129|65657694|FG001|Fourth Dose Phase|Protocol Violation|0|||
23523705|NCT00129129|65657695|FG002|Fourth Dose Phase|Protocol Violation|0|||
23523706|NCT00129129|65657696|FG003|Fourth Dose Phase|Protocol Violation|1|||
23523707|NCT00129129|65657697|FG004|Fourth Dose Phase|Protocol Violation|0|||
23523708|NCT00805935|65657705|FG000|Overall Study|Stimulation Failure|1|||
23523709|NCT00805935|65657706|FG001|Overall Study|Stimulation Failure|5|||
23523710|NCT00805935|65657707|FG002|Overall Study|Stimulation Failure|2|||
23523711|NCT00805935|65657708|FG003|Overall Study|Stimulation Failure|2|||
23523712|NCT00805935|65657705|FG000|Overall Study|Cycle cancelled|0|||
23523713|NCT00805935|65657706|FG001|Overall Study|Cycle cancelled|0|||
23523714|NCT00805935|65657707|FG002|Overall Study|Cycle cancelled|2|||
23523715|NCT00805935|65657708|FG003|Overall Study|Cycle cancelled|0|||
23523716|NCT00805935|65657705|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
23523717|NCT00805935|65657706|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
23523718|NCT00805935|65657707|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
23523719|NCT00805935|65657708|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
23523720|NCT00805935|65657705|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
23523721|NCT00805935|65657706|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
23523722|NCT00805935|65657707|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
23523723|NCT00805935|65657708|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
23523724|NCT00805935|65657705|FG000|Overall Study|Lost to Follow-up|1|||
23523725|NCT00805935|65657706|FG001|Overall Study|Lost to Follow-up|0|||
23523726|NCT00805935|65657707|FG002|Overall Study|Lost to Follow-up|0|||
23523727|NCT00805935|65657708|FG003|Overall Study|Lost to Follow-up|0|||
23523728|NCT00805935|65657705|FG000|Overall Study|No positive serum pregnancy|8|||
23523729|NCT00805935|65657706|FG001|Overall Study|No positive serum pregnancy|7|||
23523730|NCT00805935|65657707|FG002|Overall Study|No positive serum pregnancy|6|||
23523731|NCT00805935|65657708|FG003|Overall Study|No positive serum pregnancy|5|||
23523732|NCT00805935|65657705|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23523733|NCT00805935|65657706|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23523734|NCT00805935|65657707|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23523735|NCT00805935|65657708|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
23523736|NCT00805935|65657705|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
23523737|NCT00805935|65657706|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
23523738|NCT00805935|65657707|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
23523739|NCT00805935|65657708|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
23523740|NCT00805935|65657705|FG000|Overall Study|Biochemical pregnancy|0|||
23523741|NCT00805935|65657706|FG001|Overall Study|Biochemical pregnancy|1|||
23523742|NCT00805935|65657707|FG002|Overall Study|Biochemical pregnancy|0|||
23523743|NCT00805935|65657708|FG003|Overall Study|Biochemical pregnancy|0|||
23523744|NCT00805935|65657705|FG000|Overall Study|Chemical pregnancy|0|||
23523745|NCT00805935|65657706|FG001|Overall Study|Chemical pregnancy|5|||
23523746|NCT00805935|65657707|FG002|Overall Study|Chemical pregnancy|3|||
23523747|NCT00805935|65657708|FG003|Overall Study|Chemical pregnancy|2|||
23205611|NCT01885078|64494688|FG005|Treatment Period|Physician Decision|24|||
23205612|NCT01885078|64494689|FG006|Treatment Period|Physician Decision|4|||
23523748|NCT00805935|65657705|FG000|Overall Study|Ectopic pregnancy|0|||
23523749|NCT00805935|65657706|FG001|Overall Study|Ectopic pregnancy|0|||
23523750|NCT00805935|65657707|FG002|Overall Study|Ectopic pregnancy|1|||
23523751|NCT00805935|65657708|FG003|Overall Study|Ectopic pregnancy|0|||
23523752|NCT00805935|65657705|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
23523753|NCT00805935|65657706|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
23523754|NCT00805935|65657707|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
23523755|NCT00805935|65657708|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
23523756|NCT00136084|65657709|FG000|Overall Study|Death|12|||
23205613|NCT01885078|64494690|FG007|Treatment Period|Physician Decision|3|||
23523757|NCT00136084|65657710|FG001|Overall Study|Death|5|||
23523758|NCT00136084|65657709|FG000|Overall Study|Unacceptable toxicity|8|||
23523759|NCT00136084|65657710|FG001|Overall Study|Unacceptable toxicity|11|||
23523760|NCT00136084|65657709|FG000|Overall Study|Relapse|20|||
23523761|NCT00136084|65657710|FG001|Overall Study|Relapse|23|||
23523762|NCT00136084|65657709|FG000|Overall Study|Lost to Follow-up|2|||
23523763|NCT00136084|65657710|FG001|Overall Study|Lost to Follow-up|0|||
23523764|NCT00136084|65657709|FG000|Overall Study|No Response|1|||
23523765|NCT00136084|65657710|FG001|Overall Study|No Response|2|||
23523766|NCT00136084|65657709|FG000|Overall Study|Withdrawal by Subject|5|||
23523767|NCT00136084|65657710|FG001|Overall Study|Withdrawal by Subject|1|||
23523768|NCT00973479|65657711|FG000|Overall Study|Lost to Follow-up|0|||
23523769|NCT00973479|65657712|FG001|Overall Study|Lost to Follow-up|3|||
23523770|NCT00973479|65657711|FG000|Overall Study|Death|2|||
23523771|NCT00973479|65657712|FG001|Overall Study|Death|2|||
23523772|NCT00973479|65657711|FG000|Overall Study|Withdrawal by Subject|15|||
23523773|NCT00973479|65657712|FG001|Overall Study|Withdrawal by Subject|16|||
23523774|NCT00973479|65657711|FG000|Overall Study|Lack of Efficacy|5|||
23523775|NCT00973479|65657712|FG001|Overall Study|Lack of Efficacy|7|||
23523776|NCT00973479|65657711|FG000|Overall Study|Adverse Event|12|||
23523777|NCT00973479|65657712|FG001|Overall Study|Adverse Event|32|||
23523778|NCT00973479|65657711|FG000|Overall Study|Protocol Violation|2|||
23523779|NCT00973479|65657712|FG001|Overall Study|Protocol Violation|2|||
23523780|NCT00973479|65657711|FG000|Overall Study|Other|1|||
23523781|NCT00973479|65657712|FG001|Overall Study|Other|7|||
23523782|NCT04200248|65657713|FG000|Overall Study|Personal reasons|0|||
23523783|NCT04200248|65657714|FG001|Overall Study|Personal reasons|0|||
23523784|NCT04200248|65657715|FG002|Overall Study|Personal reasons|1|||
23523785|NCT04200248|65657713|FG000|Overall Study|Discontinued prior to treatment|3|||
23523786|NCT04200248|65657714|FG001|Overall Study|Discontinued prior to treatment|3|||
23523787|NCT04200248|65657715|FG002|Overall Study|Discontinued prior to treatment|2|||
23523788|NCT03080961|65657716|FG000|Overall Study|Withdrawal by Subject|3|||
23523789|NCT01957462|65657720|FG000|Test Period 1|Withdrawal by Subject|1|||
23523790|NCT01957462|65657721|FG001|Test Period 1|Withdrawal by Subject|0|||
23523791|NCT01957462|65657720|FG000|Test Period 1|Adverse Event|1|||
23523792|NCT01957462|65657721|FG001|Test Period 1|Adverse Event|0|||
23523793|NCT01904604|65657722|FG000|Overall Study|Withdrew before receiving dosing|0|||
23523794|NCT01904604|65657723|FG001|Overall Study|Withdrew before receiving dosing|1|||
23523795|NCT01904604|65657724|FG002|Overall Study|Withdrew before receiving dosing|0|||
23523796|NCT01904604|65657722|FG000|Overall Study|Non-compliance|1|||
23523797|NCT01904604|65657723|FG001|Overall Study|Non-compliance|0|||
23523798|NCT01904604|65657724|FG002|Overall Study|Non-compliance|0|||
23523799|NCT01904604|65657722|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
23523800|NCT01904604|65657723|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
23523801|NCT01904604|65657724|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
23523802|NCT01904604|65657722|FG000|Overall Study|Patch site reactions|1|||
23523803|NCT01904604|65657723|FG001|Overall Study|Patch site reactions|1|||
23523804|NCT01904604|65657724|FG002|Overall Study|Patch site reactions|0|||
23523805|NCT01904604|65657722|FG000|Overall Study|Increased syncope|0|||
23523806|NCT01904604|65657723|FG001|Overall Study|Increased syncope|1|||
23523807|NCT01904604|65657724|FG002|Overall Study|Increased syncope|0|||
23523808|NCT01904604|65657722|FG000|Overall Study|Unrelated illness|0|||
23523809|NCT01904604|65657723|FG001|Overall Study|Unrelated illness|1|||
23523810|NCT01904604|65657724|FG002|Overall Study|Unrelated illness|0|||
23523811|NCT01904604|65657722|FG000|Overall Study|Passed Week 52 OFC|1|||
23523812|NCT01904604|65657723|FG001|Overall Study|Passed Week 52 OFC|0|||
23523813|NCT01904604|65657724|FG002|Overall Study|Passed Week 52 OFC|0|||
23523814|NCT01904604|65657722|FG000|Overall Study|Withdrawal by Subject|1|||
23523815|NCT01904604|65657723|FG001|Overall Study|Withdrawal by Subject|2|||
23523816|NCT01904604|65657724|FG002|Overall Study|Withdrawal by Subject|0|||
23523817|NCT01904604|65657722|FG000|Overall Study|Participant Relocated|1|||
23523818|NCT01904604|65657723|FG001|Overall Study|Participant Relocated|1|||
23523819|NCT01904604|65657724|FG002|Overall Study|Participant Relocated|1|||
23523820|NCT01904604|65657722|FG000|Overall Study|Lost to Follow-up|0|||
23523821|NCT01904604|65657723|FG001|Overall Study|Lost to Follow-up|0|||
23523822|NCT01904604|65657724|FG002|Overall Study|Lost to Follow-up|1|||
23523823|NCT02680639|65657725|FG000|Screening Period|Screen Failure|7|||
23523824|NCT02680639|65657726|FG001|Screening Period|Screen Failure|0|||
23523825|NCT02680639|65657727|FG002|Screening Period|Screen Failure|0|||
23523826|NCT01418209|65657728|FG000|Overall Study|Withdrawal by Subject|1|||
23523827|NCT01418209|65657729|FG001|Overall Study|Withdrawal by Subject|0|||
23523828|NCT01418209|65657730|FG002|Overall Study|Withdrawal by Subject|1|||
23523829|NCT01418209|65657728|FG000|Overall Study|Did not provide hot flash diary data|1|||
23523830|NCT01418209|65657729|FG001|Overall Study|Did not provide hot flash diary data|3|||
23523831|NCT01418209|65657730|FG002|Overall Study|Did not provide hot flash diary data|3|||
23523832|NCT00747435|65657733|FG000|Overall Study|Lost to Follow-up|2|||
23523833|NCT00747435|65657733|FG000|Overall Study|Withdrawal by Subject|3|||
23523834|NCT00747435|65657733|FG000|Overall Study|Still undergoing follow up|1|||
23523835|NCT00449956|65657735|FG000|Overall Study|Adverse Event|7|||
23523836|NCT00449956|65657736|FG001|Overall Study|Adverse Event|1|||
23523837|NCT00449956|65657737|FG002|Overall Study|Adverse Event|6|||
23523838|NCT00449956|65657735|FG000|Overall Study|Lack of Efficacy|0|||
23523839|NCT00449956|65657736|FG001|Overall Study|Lack of Efficacy|0|||
23523840|NCT00449956|65657737|FG002|Overall Study|Lack of Efficacy|1|||
23523841|NCT00449956|65657735|FG000|Overall Study|Protocol Violation|1|||
23523842|NCT00449956|65657736|FG001|Overall Study|Protocol Violation|1|||
23523843|NCT00449956|65657737|FG002|Overall Study|Protocol Violation|1|||
23523844|NCT00449956|65657735|FG000|Overall Study|Withdrawal by Subject|0|||
23523845|NCT00449956|65657736|FG001|Overall Study|Withdrawal by Subject|1|||
23523846|NCT00449956|65657737|FG002|Overall Study|Withdrawal by Subject|0|||
23523847|NCT00449956|65657735|FG000|Overall Study|Physician Decision|2|||
23523848|NCT00449956|65657736|FG001|Overall Study|Physician Decision|1|||
23523849|NCT00449956|65657737|FG002|Overall Study|Physician Decision|1|||
23523850|NCT03239470|65657738|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
23523851|NCT03239470|65657739|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
23523852|NCT02308735|65657742|FG000|Overall Study|Physician Decision|2|||
23523853|NCT02308735|65657743|FG001|Overall Study|Physician Decision|0|||
23523854|NCT02308735|65657744|FG002|Overall Study|Physician Decision|0|||
23523855|NCT02308735|65657745|FG003|Overall Study|Physician Decision|2|||
23523856|NCT01393405|65657746|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
23523857|NCT01393405|65657747|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
23523858|NCT01393405|65657748|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
23523859|NCT01393405|65657746|FG000|Induction Period (week1-16)|Adverse Event|16|||
23523860|NCT01393405|65657747|FG001|Induction Period (week1-16)|Adverse Event|0|||
23523861|NCT01393405|65657748|FG002|Induction Period (week1-16)|Adverse Event|0|||
23523862|NCT01393405|65657746|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
23523863|NCT01393405|65657747|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
23523864|NCT01393405|65657748|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
23523865|NCT01393405|65657746|FG000|Maintenance Period Week|Lack of Efficacy|0|||
23523866|NCT01393405|65657747|FG001|Maintenance Period Week|Lack of Efficacy|22|||
23523867|NCT01393405|65657748|FG002|Maintenance Period Week|Lack of Efficacy|22|||
23523868|NCT01393405|65657746|FG000|Maintenance Period Week|Adverse Event|0|||
23523869|NCT01393405|65657747|FG001|Maintenance Period Week|Adverse Event|5|||
23523870|NCT01393405|65657748|FG002|Maintenance Period Week|Adverse Event|2|||
23523871|NCT01393405|65657746|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
23523872|NCT01393405|65657747|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
23523873|NCT01393405|65657748|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
23523874|NCT01393405|65657746|FG000|Maintenance Period Week|Lost to Follow-up|0|||
23523875|NCT01393405|65657747|FG001|Maintenance Period Week|Lost to Follow-up|1|||
23523876|NCT01393405|65657748|FG002|Maintenance Period Week|Lost to Follow-up|0|||
23523877|NCT01723163|65657749|FG000|Treatment Phase|Withdrawal by Subject|14|||
23523878|NCT01723163|65657750|FG001|Treatment Phase|Withdrawal by Subject|6|||
23523879|NCT01723163|65657749|FG000|Treatment Phase|Withdrawal by PI|5|||
23523880|NCT01723163|65657750|FG001|Treatment Phase|Withdrawal by PI|1|||
23523881|NCT01723163|65657749|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
23523882|NCT01723163|65657750|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
23523883|NCT01723163|65657749|FG000|3-Month Follow-up|Unable to Contact|12|||
23523884|NCT01723163|65657750|FG001|3-Month Follow-up|Unable to Contact|19|||
23523885|NCT01723163|65657749|FG000|6-Month Follow-up|Death|1|||
23523886|NCT01723163|65657750|FG001|6-Month Follow-up|Death|0|||
23523887|NCT01723163|65657749|FG000|6-Month Follow-up|Unable to Contact|17|||
23523888|NCT01723163|65657750|FG001|6-Month Follow-up|Unable to Contact|15|||
23523889|NCT01723163|65657749|FG000|12-Month Follow-up|Death|1|||
23523890|NCT01723163|65657750|FG001|12-Month Follow-up|Death|0|||
23523891|NCT01723163|65657749|FG000|12-Month Follow-up|Unable to Contact|23|||
23523892|NCT01723163|65657750|FG001|12-Month Follow-up|Unable to Contact|28|||
23523893|NCT01554618|65657756|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
23523894|NCT01554618|65657757|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
23523895|NCT01554618|65657756|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
23523896|NCT01554618|65657757|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
23523897|NCT01554618|65657756|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
23523898|NCT01554618|65657757|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
23523899|NCT01554618|65657756|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
23523900|NCT01554618|65657757|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
23523901|NCT01554618|65657756|FG000|Open-Label Extension Period|Physician Decision|0|||
23523902|NCT01554618|65657757|FG001|Open-Label Extension Period|Physician Decision|1|||
23523903|NCT01554618|65657756|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
23523904|NCT01554618|65657757|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
23523905|NCT02286193|65657758|FG000|Overall Study|Referred: CRS unable to make contact|62|||
23523906|NCT02286193|65657758|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
23523907|NCT02286193|65657758|FG000|Overall Study|Referred: Declined service|38|||
23523908|NCT02439320|65657759|FG000|Overall Study|Adverse Event|0|||
23523909|NCT02439320|65657760|FG001|Overall Study|Adverse Event|2|||
23523910|NCT02439320|65657761|FG002|Overall Study|Adverse Event|0|||
23523911|NCT02439320|65657759|FG000|Overall Study|Lost to Follow-up|37|||
23523912|NCT02439320|65657760|FG001|Overall Study|Lost to Follow-up|34|||
23523913|NCT02439320|65657761|FG002|Overall Study|Lost to Follow-up|42|||
23523914|NCT02439320|65657759|FG000|Overall Study|Death|0|||
23523915|NCT02439320|65657760|FG001|Overall Study|Death|1|||
23523916|NCT02439320|65657761|FG002|Overall Study|Death|0|||
23523917|NCT02439320|65657759|FG000|Overall Study|Noncompliance with Protocol|10|||
23523918|NCT02439320|65657760|FG001|Overall Study|Noncompliance with Protocol|11|||
23523919|NCT02439320|65657761|FG002|Overall Study|Noncompliance with Protocol|7|||
23523920|NCT02439320|65657759|FG000|Overall Study|Pregnancy|0|||
23523921|NCT02439320|65657760|FG001|Overall Study|Pregnancy|1|||
23523922|NCT02439320|65657761|FG002|Overall Study|Pregnancy|1|||
23523923|NCT02439320|65657759|FG000|Overall Study|Withdrawal by Subject|12|||
23523924|NCT02439320|65657760|FG001|Overall Study|Withdrawal by Subject|16|||
23523925|NCT02439320|65657761|FG002|Overall Study|Withdrawal by Subject|14|||
23523926|NCT02439320|65657759|FG000|Overall Study|Physician Decision|2|||
23523927|NCT02439320|65657760|FG001|Overall Study|Physician Decision|1|||
23523928|NCT02439320|65657761|FG002|Overall Study|Physician Decision|0|||
23523929|NCT02439320|65657759|FG000|Overall Study|Sponsor Request|0|||
23523930|NCT02439320|65657760|FG001|Overall Study|Sponsor Request|2|||
23523931|NCT02439320|65657761|FG002|Overall Study|Sponsor Request|1|||
23523932|NCT02439320|65657759|FG000|Overall Study|Randomization Failure|35|||
23523933|NCT02439320|65657760|FG001|Overall Study|Randomization Failure|46|||
23523934|NCT02439320|65657761|FG002|Overall Study|Randomization Failure|34|||
23523935|NCT01649375|65657762|FG000|Up to Week 16|Adverse Event|2|||
23523936|NCT01649375|65657763|FG001|Up to Week 16|Adverse Event|5|||
23523937|NCT01649375|65657764|FG002|Up to Week 16|Adverse Event|4|||
23523938|NCT01649375|65657765|FG003|Up to Week 16|Adverse Event|0|||
23523939|NCT01649375|65657766|FG004|Up to Week 16|Adverse Event|0|||
23523940|NCT01649375|65657762|FG000|Up to Week 16|Lack of Efficacy|0|||
23523941|NCT01649375|65657763|FG001|Up to Week 16|Lack of Efficacy|0|||
23523942|NCT01649375|65657764|FG002|Up to Week 16|Lack of Efficacy|1|||
23523943|NCT01649375|65657765|FG003|Up to Week 16|Lack of Efficacy|0|||
23523944|NCT01649375|65657766|FG004|Up to Week 16|Lack of Efficacy|0|||
23523945|NCT01649375|65657762|FG000|Up to Week 16|Physician Decision|0|||
23523946|NCT01649375|65657763|FG001|Up to Week 16|Physician Decision|0|||
23523947|NCT01649375|65657764|FG002|Up to Week 16|Physician Decision|1|||
23523948|NCT01649375|65657765|FG003|Up to Week 16|Physician Decision|0|||
23523949|NCT01649375|65657766|FG004|Up to Week 16|Physician Decision|0|||
23523950|NCT01649375|65657762|FG000|Up to Week 16|Withdrawal by Subject|2|||
23523951|NCT01649375|65657763|FG001|Up to Week 16|Withdrawal by Subject|1|||
23523952|NCT01649375|65657764|FG002|Up to Week 16|Withdrawal by Subject|2|||
23523953|NCT01649375|65657765|FG003|Up to Week 16|Withdrawal by Subject|0|||
23523954|NCT01649375|65657766|FG004|Up to Week 16|Withdrawal by Subject|0|||
23523955|NCT01649375|65657762|FG000|Up to Week 16|Death|1|||
23523956|NCT01649375|65657763|FG001|Up to Week 16|Death|0|||
23523957|NCT01649375|65657764|FG002|Up to Week 16|Death|0|||
23205614|NCT01885078|64494691|FG008|Treatment Period|Physician Decision|0|||
23205615|NCT01885078|64494692|FG009|Treatment Period|Physician Decision|0|||
23205616|NCT01885078|64494683|FG000|Treatment Period|Protocol Violation|3|||
23205617|NCT01885078|64494684|FG001|Treatment Period|Protocol Violation|5|||
23523958|NCT01649375|65657765|FG003|Up to Week 16|Death|0|||
23523959|NCT01649375|65657766|FG004|Up to Week 16|Death|0|||
23523960|NCT01649375|65657762|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
23523961|NCT01649375|65657763|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
23205618|NCT01885078|64494685|FG002|Treatment Period|Protocol Violation|0|||
23308075|NCT03768726|64873947|FG000|Follow-Up|Withdrawal by Subject|2|||
23523962|NCT01649375|65657764|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
23523963|NCT01649375|65657765|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
23523964|NCT01649375|65657766|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
23523965|NCT01649375|65657762|FG000|Week 16 up to Week 260|Non-compliance|0|||
23523966|NCT01649375|65657763|FG001|Week 16 up to Week 260|Non-compliance|1|||
23523967|NCT01649375|65657764|FG002|Week 16 up to Week 260|Non-compliance|0|||
23523968|NCT01649375|65657765|FG003|Week 16 up to Week 260|Non-compliance|1|||
23205619|NCT01885078|64494686|FG003|Treatment Period|Protocol Violation|3|||
23205620|NCT01885078|64494687|FG004|Treatment Period|Protocol Violation|1|||
23205621|NCT01885078|64494688|FG005|Treatment Period|Protocol Violation|6|||
23205622|NCT01885078|64494689|FG006|Treatment Period|Protocol Violation|0|||
23205623|NCT01885078|64494690|FG007|Treatment Period|Protocol Violation|0|||
23205624|NCT01885078|64494691|FG008|Treatment Period|Protocol Violation|0|||
23205625|NCT01885078|64494692|FG009|Treatment Period|Protocol Violation|0|||
23205626|NCT01885078|64494683|FG000|Treatment Period|Sponsor Decision|245|||
23205627|NCT01885078|64494684|FG001|Treatment Period|Sponsor Decision|648|||
23205628|NCT01885078|64494685|FG002|Treatment Period|Sponsor Decision|49|||
23205629|NCT01885078|64494686|FG003|Treatment Period|Sponsor Decision|90|||
23205630|NCT01885078|64494687|FG004|Treatment Period|Sponsor Decision|20|||
23523969|NCT01649375|65657766|FG004|Week 16 up to Week 260|Non-compliance|0|||
23523970|NCT01649375|65657762|FG000|Week 16 up to Week 260|Physician Decision|0|||
23523971|NCT01649375|65657763|FG001|Week 16 up to Week 260|Physician Decision|2|||
23523972|NCT01649375|65657764|FG002|Week 16 up to Week 260|Physician Decision|0|||
23523973|NCT01649375|65657765|FG003|Week 16 up to Week 260|Physician Decision|0|||
23523974|NCT01649375|65657766|FG004|Week 16 up to Week 260|Physician Decision|0|||
23523975|NCT01649375|65657762|FG000|Week 16 up to Week 260|Technical issues|0|||
23523976|NCT01649375|65657763|FG001|Week 16 up to Week 260|Technical issues|1|||
23523977|NCT01649375|65657764|FG002|Week 16 up to Week 260|Technical issues|0|||
23523978|NCT01649375|65657765|FG003|Week 16 up to Week 260|Technical issues|1|||
23523979|NCT01649375|65657766|FG004|Week 16 up to Week 260|Technical issues|0|||
23523980|NCT01649375|65657762|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
23523981|NCT01649375|65657763|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
23523982|NCT01649375|65657764|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
23523983|NCT01649375|65657765|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
23523984|NCT01649375|65657766|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
23523985|NCT01649375|65657762|FG000|Week 16 up to Week 260|Death|1|||
23523986|NCT01649375|65657763|FG001|Week 16 up to Week 260|Death|1|||
23523987|NCT01649375|65657764|FG002|Week 16 up to Week 260|Death|0|||
23523988|NCT01649375|65657765|FG003|Week 16 up to Week 260|Death|0|||
23523989|NCT01649375|65657766|FG004|Week 16 up to Week 260|Death|0|||
23523990|NCT01649375|65657762|FG000|Week 16 up to Week 260|Adverse Event|5|||
23523991|NCT01649375|65657763|FG001|Week 16 up to Week 260|Adverse Event|2|||
23523992|NCT01649375|65657764|FG002|Week 16 up to Week 260|Adverse Event|0|||
23523993|NCT01649375|65657765|FG003|Week 16 up to Week 260|Adverse Event|3|||
23523994|NCT01649375|65657766|FG004|Week 16 up to Week 260|Adverse Event|2|||
23523995|NCT00922766|65657767|FG000|Overall Study|Death|3|||
23523996|NCT00922766|65657767|FG000|Overall Study|Withdrawal by Subject|2|||
23523997|NCT00922766|65657767|FG000|Overall Study|Other|1|||
23523998|NCT00922766|65657767|FG000|Overall Study|Adverse Event|1|||
23523999|NCT00076011|65657768|FG000|Overall Study|Death|1|||
23524000|NCT00076011|65657768|FG000|Overall Study|Adverse Event|10|||
23524001|NCT00076011|65657768|FG000|Overall Study|Lack of Efficacy|25|||
23524002|NCT00076011|65657768|FG000|Overall Study|Withdrawal by Subject|1|||
23524003|NCT00076011|65657768|FG000|Overall Study|Study terminated by sponsor|3|||
23524004|NCT00076011|65657768|FG000|Overall Study|Other|11|||
23524005|NCT00076011|65657768|FG000|Overall Study|Ongoing|1|||
23524006|NCT00806546|65657769|FG000|Overall Study|Enrolled, not treated|35|||
23524007|NCT00806546|65657769|FG000|Overall Study|Lost to Follow-up|32|||
23205631|NCT01885078|64494688|FG005|Treatment Period|Sponsor Decision|38|||
23205632|NCT01885078|64494689|FG006|Treatment Period|Sponsor Decision|162|||
23205633|NCT01885078|64494690|FG007|Treatment Period|Sponsor Decision|3|||
23205634|NCT01885078|64494691|FG008|Treatment Period|Sponsor Decision|0|||
23205635|NCT01885078|64494692|FG009|Treatment Period|Sponsor Decision|0|||
23205636|NCT01885078|64494683|FG000|Treatment Period|Withdrawal by Subject|72|||
23205637|NCT01885078|64494684|FG001|Treatment Period|Withdrawal by Subject|132|||
23205638|NCT01885078|64494685|FG002|Treatment Period|Withdrawal by Subject|25|||
23205639|NCT01885078|64494686|FG003|Treatment Period|Withdrawal by Subject|63|||
23205640|NCT01885078|64494687|FG004|Treatment Period|Withdrawal by Subject|15|||
23205641|NCT01885078|64494688|FG005|Treatment Period|Withdrawal by Subject|34|||
23205642|NCT01885078|64494689|FG006|Treatment Period|Withdrawal by Subject|17|||
23205643|NCT01885078|64494690|FG007|Treatment Period|Withdrawal by Subject|10|||
23205644|NCT01885078|64494691|FG008|Treatment Period|Withdrawal by Subject|0|||
23205645|NCT01885078|64494692|FG009|Treatment Period|Withdrawal by Subject|0|||
23524008|NCT00806546|65657769|FG000|Overall Study|Adverse Event|74|||
23524009|NCT00806546|65657769|FG000|Overall Study|Withdrawal by Subject|75|||
23524010|NCT00806546|65657769|FG000|Overall Study|Protocol Violation|49|||
23524011|NCT00806546|65657769|FG000|Overall Study|Various|42|||
23524012|NCT02972632|65657774|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
23524013|NCT02972632|65657774|FG000|Overall Study|Lost to Follow-up|4|||
23524014|NCT02972632|65657774|FG000|Overall Study|Voluntary Withdrawal|10|||
23524015|NCT03385239|65657777|FG000|Overall Study|Voluntary Withdrawal|2|||
23524016|NCT03385239|65657778|FG001|Overall Study|Voluntary Withdrawal|3|||
23205646|NCT01885078|64494683|FG000|Treatment Period|Other|0|||
23205647|NCT01885078|64494684|FG001|Treatment Period|Other|0|||
23205648|NCT01885078|64494685|FG002|Treatment Period|Other|0|||
23205649|NCT01885078|64494686|FG003|Treatment Period|Other|1|||
23205650|NCT01885078|64494687|FG004|Treatment Period|Other|0|||
23205651|NCT01885078|64494688|FG005|Treatment Period|Other|0|||
23205652|NCT01885078|64494689|FG006|Treatment Period|Other|0|||
23205653|NCT01885078|64494690|FG007|Treatment Period|Other|0|||
23205654|NCT01885078|64494691|FG008|Treatment Period|Other|0|||
23205655|NCT01885078|64494692|FG009|Treatment Period|Other|0|||
23205656|NCT01885078|64494683|FG000|Step-down Period|Sponsor Decision|0|||
23205657|NCT01885078|64494684|FG001|Step-down Period|Sponsor Decision|0|||
23205658|NCT01885078|64494685|FG002|Step-down Period|Sponsor Decision|0|||
23205659|NCT01885078|64494686|FG003|Step-down Period|Sponsor Decision|0|||
23205660|NCT01885078|64494687|FG004|Step-down Period|Sponsor Decision|0|||
23205661|NCT01885078|64494688|FG005|Step-down Period|Sponsor Decision|0|||
23205662|NCT01885078|64494689|FG006|Step-down Period|Sponsor Decision|0|||
23205663|NCT01885078|64494690|FG007|Step-down Period|Sponsor Decision|0|||
23205664|NCT01885078|64494691|FG008|Step-down Period|Sponsor Decision|1|||
23205665|NCT01885078|64494692|FG009|Step-down Period|Sponsor Decision|1|||
23205666|NCT01885078|64494683|FG000|Step-down Period|Adverse Event|0|||
23205667|NCT01885078|64494684|FG001|Step-down Period|Adverse Event|0|||
23205668|NCT01885078|64494685|FG002|Step-down Period|Adverse Event|0|||
23205669|NCT01885078|64494686|FG003|Step-down Period|Adverse Event|0|||
23205670|NCT01885078|64494687|FG004|Step-down Period|Adverse Event|0|||
23205671|NCT01885078|64494688|FG005|Step-down Period|Adverse Event|0|||
23205672|NCT01885078|64494689|FG006|Step-down Period|Adverse Event|0|||
23524017|NCT03385239|65657779|FG002|Overall Study|Voluntary Withdrawal|2|||
23524018|NCT03385239|65657780|FG003|Overall Study|Voluntary Withdrawal|3|||
23205673|NCT01885078|64494690|FG007|Step-down Period|Adverse Event|0|||
23205674|NCT01885078|64494691|FG008|Step-down Period|Adverse Event|29|||
23205675|NCT01885078|64494692|FG009|Step-down Period|Adverse Event|38|||
23205676|NCT01885078|64494683|FG000|Step-down Period|Withdrawal by Subject|0|||
23205677|NCT01885078|64494684|FG001|Step-down Period|Withdrawal by Subject|0|||
23205678|NCT01885078|64494685|FG002|Step-down Period|Withdrawal by Subject|0|||
23205679|NCT01885078|64494686|FG003|Step-down Period|Withdrawal by Subject|0|||
23205680|NCT01885078|64494687|FG004|Step-down Period|Withdrawal by Subject|0|||
23205681|NCT01885078|64494688|FG005|Step-down Period|Withdrawal by Subject|0|||
23205682|NCT01885078|64494689|FG006|Step-down Period|Withdrawal by Subject|0|||
23205683|NCT01885078|64494690|FG007|Step-down Period|Withdrawal by Subject|0|||
23205684|NCT01885078|64494691|FG008|Step-down Period|Withdrawal by Subject|25|||
23205685|NCT01885078|64494692|FG009|Step-down Period|Withdrawal by Subject|15|||
23205686|NCT01885078|64494683|FG000|Step-down Period|Physician Decision|0|||
23205687|NCT01885078|64494684|FG001|Step-down Period|Physician Decision|0|||
23205688|NCT01885078|64494685|FG002|Step-down Period|Physician Decision|0|||
23205689|NCT01885078|64494686|FG003|Step-down Period|Physician Decision|0|||
23205690|NCT01885078|64494687|FG004|Step-down Period|Physician Decision|0|||
23205691|NCT01885078|64494688|FG005|Step-down Period|Physician Decision|0|||
23205692|NCT01885078|64494689|FG006|Step-down Period|Physician Decision|0|||
23205693|NCT01885078|64494690|FG007|Step-down Period|Physician Decision|0|||
23205694|NCT01885078|64494691|FG008|Step-down Period|Physician Decision|7|||
23205695|NCT01885078|64494692|FG009|Step-down Period|Physician Decision|2|||
23205696|NCT01885078|64494683|FG000|Step-down Period|Death|0|||
23205697|NCT01885078|64494684|FG001|Step-down Period|Death|0|||
23416850|NCT00853242|65271292|FG002|Overall Study|Withdrawal by Subject|0|||
23416851|NCT00853242|65271293|FG003|Overall Study|Withdrawal by Subject|4|||
23416852|NCT00853242|65271294|FG004|Overall Study|Withdrawal by Subject|0|||
23416853|NCT00853242|65271295|FG005|Overall Study|Withdrawal by Subject|0|||
23416854|NCT00853242|65271296|FG006|Overall Study|Withdrawal by Subject|2|||
23416855|NCT00853242|65271290|FG000|Overall Study|Other|2|||
23416856|NCT00853242|65271291|FG001|Overall Study|Other|0|||
23416857|NCT00853242|65271292|FG002|Overall Study|Other|2|||
23416858|NCT00853242|65271293|FG003|Overall Study|Other|0|||
23524019|NCT03385239|65657781|FG004|Overall Study|Voluntary Withdrawal|0|||
23524020|NCT03385239|65657777|FG000|Overall Study|Adverse Event|0|||
23205698|NCT01885078|64494685|FG002|Step-down Period|Death|0|||
23205699|NCT01885078|64494686|FG003|Step-down Period|Death|0|||
23205700|NCT01885078|64494687|FG004|Step-down Period|Death|0|||
23205701|NCT01885078|64494688|FG005|Step-down Period|Death|0|||
23205702|NCT01885078|64494689|FG006|Step-down Period|Death|0|||
23205703|NCT01885078|64494690|FG007|Step-down Period|Death|0|||
23205704|NCT01885078|64494691|FG008|Step-down Period|Death|4|||
23205705|NCT01885078|64494692|FG009|Step-down Period|Death|3|||
23308076|NCT03768726|64873948|FG001|Follow-Up|Withdrawal by Subject|0|||
23524021|NCT03385239|65657778|FG001|Overall Study|Adverse Event|0|||
23524022|NCT03385239|65657779|FG002|Overall Study|Adverse Event|1|||
23205706|NCT01885078|64494683|FG000|Step-down Period|Lost to Follow-up|0|||
23205707|NCT01885078|64494684|FG001|Step-down Period|Lost to Follow-up|0|||
23205708|NCT01885078|64494685|FG002|Step-down Period|Lost to Follow-up|0|||
23308077|NCT03768726|64873947|FG000|Follow-Up|Other|1|||
23308078|NCT03768726|64873948|FG001|Follow-Up|Other|0|||
23524023|NCT03385239|65657780|FG003|Overall Study|Adverse Event|0|||
23308079|NCT00210249|64873957|FG000|Overall Study|Lost to Follow-up|5|||
23308080|NCT00210249|64873957|FG000|Overall Study|Protocol Violation|11|||
23308081|NCT00171301|64873962|FG000|Overall Study|Death|1|||
23308082|NCT00171301|64873963|FG001|Overall Study|Death|2|||
23308083|NCT00171301|64873962|FG000|Overall Study|Adverse Event|1|||
23308084|NCT00171301|64873963|FG001|Overall Study|Adverse Event|2|||
23308085|NCT00171301|64873962|FG000|Overall Study|Lost to Follow-up|6|||
23308086|NCT00171301|64873963|FG001|Overall Study|Lost to Follow-up|2|||
23308087|NCT00171301|64873962|FG000|Overall Study|Protocol Violation|0|||
23308088|NCT00171301|64873963|FG001|Overall Study|Protocol Violation|2|||
23308089|NCT00171301|64873962|FG000|Overall Study|Withdrawal by Subject|0|||
23308090|NCT00171301|64873963|FG001|Overall Study|Withdrawal by Subject|1|||
23308091|NCT01986010|64873970|FG000|Overall Study|Adverse Event|0|||
23308092|NCT01986010|64873971|FG001|Overall Study|Adverse Event|1|||
23308093|NCT01986010|64873972|FG002|Overall Study|Adverse Event|0|||
23308094|NCT01986010|64873973|FG003|Overall Study|Adverse Event|0|||
23308095|NCT01986010|64873974|FG004|Overall Study|Adverse Event|0|||
23308096|NCT01986010|64873975|FG005|Overall Study|Adverse Event|0|||
23308097|NCT01986010|64873976|FG006|Overall Study|Adverse Event|0|||
23308098|NCT01986010|64873977|FG007|Overall Study|Adverse Event|0|||
23308099|NCT01986010|64873978|FG008|Overall Study|Adverse Event|0|||
23308100|NCT01986010|64873979|FG009|Overall Study|Adverse Event|0|||
23308101|NCT01986010|64873980|FG010|Overall Study|Adverse Event|0|||
23308102|NCT01986010|64873981|FG011|Overall Study|Adverse Event|0|||
23308103|NCT01986010|64873982|FG012|Overall Study|Adverse Event|0|||
23308104|NCT01986010|64873983|FG013|Overall Study|Adverse Event|0|||
23308105|NCT01986010|64873984|FG014|Overall Study|Adverse Event|0|||
23308106|NCT01986010|64873985|FG015|Overall Study|Adverse Event|1|||
23308107|NCT01986010|64873986|FG016|Overall Study|Adverse Event|0|||
23308108|NCT01986010|64873970|FG000|Overall Study|Lost to Follow-up|2|||
23308109|NCT01986010|64873971|FG001|Overall Study|Lost to Follow-up|1|||
23308110|NCT01986010|64873972|FG002|Overall Study|Lost to Follow-up|2|||
23308111|NCT01986010|64873973|FG003|Overall Study|Lost to Follow-up|2|||
23308112|NCT01986010|64873974|FG004|Overall Study|Lost to Follow-up|2|||
23308113|NCT01986010|64873975|FG005|Overall Study|Lost to Follow-up|2|||
23308114|NCT01986010|64873976|FG006|Overall Study|Lost to Follow-up|0|||
23308115|NCT01986010|64873977|FG007|Overall Study|Lost to Follow-up|0|||
23524024|NCT03385239|65657781|FG004|Overall Study|Adverse Event|0|||
23524025|NCT03385239|65657777|FG000|Overall Study|Other|0|||
23524026|NCT03385239|65657778|FG001|Overall Study|Other|0|||
23524027|NCT03385239|65657779|FG002|Overall Study|Other|0|||
23524028|NCT03385239|65657780|FG003|Overall Study|Other|1|||
23524029|NCT03385239|65657781|FG004|Overall Study|Other|0|||
23524030|NCT02535741|65657784|FG000|Overall Study|Adverse Event|3|||
23524031|NCT02535741|65657784|FG000|Overall Study|Withdrawal by Subject|9|||
23524032|NCT02535741|65657784|FG000|Overall Study|Lost to Follow-up|10|||
23524033|NCT02535741|65657784|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
23308116|NCT01986010|64873978|FG008|Overall Study|Lost to Follow-up|4|||
23308117|NCT01986010|64873979|FG009|Overall Study|Lost to Follow-up|2|||
23524034|NCT02535741|65657784|FG000|Overall Study|Missing data|6|||
23308118|NCT01986010|64873980|FG010|Overall Study|Lost to Follow-up|0|||
23308119|NCT01986010|64873981|FG011|Overall Study|Lost to Follow-up|1|||
23308120|NCT01986010|64873982|FG012|Overall Study|Lost to Follow-up|1|||
23308121|NCT01986010|64873983|FG013|Overall Study|Lost to Follow-up|1|||
23308122|NCT01986010|64873984|FG014|Overall Study|Lost to Follow-up|2|||
23308123|NCT01986010|64873985|FG015|Overall Study|Lost to Follow-up|0|||
23524035|NCT00531232|65657785|FG000|Overall Study|Investigator decision|0|||
23308124|NCT01986010|64873986|FG016|Overall Study|Lost to Follow-up|0|||
23308125|NCT01986010|64873970|FG000|Overall Study|Physician Decision|0|||
23308126|NCT01986010|64873971|FG001|Overall Study|Physician Decision|0|||
23308127|NCT01986010|64873972|FG002|Overall Study|Physician Decision|0|||
23308128|NCT01986010|64873973|FG003|Overall Study|Physician Decision|0|||
23308129|NCT01986010|64873974|FG004|Overall Study|Physician Decision|0|||
23308130|NCT01986010|64873975|FG005|Overall Study|Physician Decision|0|||
23308131|NCT01986010|64873976|FG006|Overall Study|Physician Decision|0|||
23308132|NCT01986010|64873977|FG007|Overall Study|Physician Decision|0|||
23308133|NCT01986010|64873978|FG008|Overall Study|Physician Decision|0|||
23308134|NCT01986010|64873979|FG009|Overall Study|Physician Decision|0|||
23308135|NCT01986010|64873980|FG010|Overall Study|Physician Decision|0|||
23308136|NCT01986010|64873981|FG011|Overall Study|Physician Decision|0|||
23308137|NCT01986010|64873982|FG012|Overall Study|Physician Decision|0|||
23308138|NCT01986010|64873983|FG013|Overall Study|Physician Decision|0|||
23308139|NCT01986010|64873984|FG014|Overall Study|Physician Decision|1|||
23308140|NCT01986010|64873985|FG015|Overall Study|Physician Decision|0|||
23308141|NCT01986010|64873986|FG016|Overall Study|Physician Decision|0|||
23308142|NCT01986010|64873970|FG000|Overall Study|Withdrawal by Subject|2|||
23308143|NCT01986010|64873971|FG001|Overall Study|Withdrawal by Subject|2|||
23308144|NCT01986010|64873972|FG002|Overall Study|Withdrawal by Subject|3|||
23308145|NCT01986010|64873973|FG003|Overall Study|Withdrawal by Subject|0|||
23308146|NCT01986010|64873974|FG004|Overall Study|Withdrawal by Subject|2|||
23308147|NCT01986010|64873975|FG005|Overall Study|Withdrawal by Subject|4|||
23308148|NCT01986010|64873976|FG006|Overall Study|Withdrawal by Subject|0|||
23308149|NCT01986010|64873977|FG007|Overall Study|Withdrawal by Subject|0|||
23308150|NCT01986010|64873978|FG008|Overall Study|Withdrawal by Subject|0|||
23308151|NCT01986010|64873979|FG009|Overall Study|Withdrawal by Subject|0|||
23308152|NCT01986010|64873980|FG010|Overall Study|Withdrawal by Subject|0|||
23308153|NCT01986010|64873981|FG011|Overall Study|Withdrawal by Subject|2|||
23308154|NCT01986010|64873982|FG012|Overall Study|Withdrawal by Subject|0|||
23308155|NCT01986010|64873983|FG013|Overall Study|Withdrawal by Subject|1|||
23308156|NCT01986010|64873984|FG014|Overall Study|Withdrawal by Subject|2|||
23308157|NCT01986010|64873985|FG015|Overall Study|Withdrawal by Subject|0|||
23308158|NCT01986010|64873986|FG016|Overall Study|Withdrawal by Subject|0|||
23308159|NCT01986010|64873970|FG000|Overall Study|Status Not Recorded|2|||
23308160|NCT01986010|64873971|FG001|Overall Study|Status Not Recorded|4|||
23308161|NCT01986010|64873972|FG002|Overall Study|Status Not Recorded|2|||
23308162|NCT01986010|64873973|FG003|Overall Study|Status Not Recorded|0|||
23308163|NCT01986010|64873974|FG004|Overall Study|Status Not Recorded|1|||
23308164|NCT01986010|64873975|FG005|Overall Study|Status Not Recorded|2|||
23308165|NCT01986010|64873976|FG006|Overall Study|Status Not Recorded|0|||
23308166|NCT01986010|64873977|FG007|Overall Study|Status Not Recorded|0|||
23308167|NCT01986010|64873978|FG008|Overall Study|Status Not Recorded|2|||
23308168|NCT01986010|64873979|FG009|Overall Study|Status Not Recorded|1|||
23308169|NCT01986010|64873980|FG010|Overall Study|Status Not Recorded|7|||
23308170|NCT01986010|64873981|FG011|Overall Study|Status Not Recorded|7|||
23308171|NCT01986010|64873982|FG012|Overall Study|Status Not Recorded|9|||
23308172|NCT01986010|64873983|FG013|Overall Study|Status Not Recorded|9|||
23308173|NCT01986010|64873984|FG014|Overall Study|Status Not Recorded|5|||
23308174|NCT01986010|64873985|FG015|Overall Study|Status Not Recorded|10|||
23308175|NCT01986010|64873986|FG016|Overall Study|Status Not Recorded|4|||
23308176|NCT00758680|64873989|FG000|Overall Study|Adverse Event|0|||
23308177|NCT00758680|64873990|FG001|Overall Study|Adverse Event|0|||
23308178|NCT00758680|64873991|FG002|Overall Study|Adverse Event|0|||
23308179|NCT00758680|64873992|FG003|Overall Study|Adverse Event|0|||
23308180|NCT00758680|64873993|FG004|Overall Study|Adverse Event|0|||
23308181|NCT00758680|64873994|FG005|Overall Study|Adverse Event|0|||
23308182|NCT00758680|64873995|FG006|Overall Study|Adverse Event|0|||
23308183|NCT00758680|64873996|FG007|Overall Study|Adverse Event|1|||
23308184|NCT00758680|64873997|FG008|Overall Study|Adverse Event|0|||
23308185|NCT00758680|64873998|FG009|Overall Study|Adverse Event|1|||
23308186|NCT00758680|64873989|FG000|Overall Study|Laboratory Adverse Event|0|||
23308187|NCT00758680|64873990|FG001|Overall Study|Laboratory Adverse Event|0|||
23308188|NCT00758680|64873991|FG002|Overall Study|Laboratory Adverse Event|0|||
23308189|NCT00758680|64873992|FG003|Overall Study|Laboratory Adverse Event|0|||
23308190|NCT00758680|64873993|FG004|Overall Study|Laboratory Adverse Event|0|||
23308191|NCT00758680|64873994|FG005|Overall Study|Laboratory Adverse Event|0|||
23308192|NCT00758680|64873995|FG006|Overall Study|Laboratory Adverse Event|0|||
23308193|NCT00758680|64873996|FG007|Overall Study|Laboratory Adverse Event|0|||
23308194|NCT00758680|64873997|FG008|Overall Study|Laboratory Adverse Event|1|||
23308195|NCT00758680|64873998|FG009|Overall Study|Laboratory Adverse Event|0|||
23308196|NCT00758680|64873989|FG000|Overall Study|Withdrawal by Subject|0|||
23308197|NCT00758680|64873990|FG001|Overall Study|Withdrawal by Subject|0|||
23308198|NCT00758680|64873991|FG002|Overall Study|Withdrawal by Subject|0|||
23308199|NCT00758680|64873992|FG003|Overall Study|Withdrawal by Subject|0|||
23308200|NCT00758680|64873993|FG004|Overall Study|Withdrawal by Subject|0|||
23308201|NCT00758680|64873994|FG005|Overall Study|Withdrawal by Subject|0|||
23416859|NCT00853242|65271294|FG004|Overall Study|Other|0|||
23308202|NCT00758680|64873995|FG006|Overall Study|Withdrawal by Subject|1|||
23308203|NCT00758680|64873996|FG007|Overall Study|Withdrawal by Subject|0|||
23308204|NCT00758680|64873997|FG008|Overall Study|Withdrawal by Subject|1|||
23524036|NCT00531232|65657786|FG001|Overall Study|Investigator decision|0|||
23524037|NCT00531232|65657787|FG002|Overall Study|Investigator decision|4|||
23524038|NCT00531232|65657785|FG000|Overall Study|Participants refused further treatment|0|||
23205709|NCT01885078|64494686|FG003|Step-down Period|Lost to Follow-up|0|||
23205710|NCT01885078|64494687|FG004|Step-down Period|Lost to Follow-up|0|||
23205711|NCT01885078|64494688|FG005|Step-down Period|Lost to Follow-up|0|||
23205712|NCT01885078|64494689|FG006|Step-down Period|Lost to Follow-up|0|||
23205713|NCT01885078|64494690|FG007|Step-down Period|Lost to Follow-up|0|||
23205714|NCT01885078|64494691|FG008|Step-down Period|Lost to Follow-up|1|||
23205715|NCT01885078|64494692|FG009|Step-down Period|Lost to Follow-up|1|||
23205716|NCT01885078|64494683|FG000|Step-down Period|Lack of Efficacy|0|||
23205717|NCT01885078|64494684|FG001|Step-down Period|Lack of Efficacy|0|||
23205718|NCT01885078|64494685|FG002|Step-down Period|Lack of Efficacy|0|||
23205719|NCT01885078|64494686|FG003|Step-down Period|Lack of Efficacy|0|||
23205720|NCT01885078|64494687|FG004|Step-down Period|Lack of Efficacy|0|||
23205721|NCT01885078|64494688|FG005|Step-down Period|Lack of Efficacy|0|||
23205722|NCT01885078|64494689|FG006|Step-down Period|Lack of Efficacy|0|||
23205723|NCT01885078|64494690|FG007|Step-down Period|Lack of Efficacy|0|||
23205724|NCT01885078|64494691|FG008|Step-down Period|Lack of Efficacy|1|||
23205725|NCT01885078|64494692|FG009|Step-down Period|Lack of Efficacy|0|||
23205726|NCT01885078|64494683|FG000|Step-down Period|Protocol Violation|0|||
23205727|NCT01885078|64494684|FG001|Step-down Period|Protocol Violation|0|||
23205728|NCT01885078|64494685|FG002|Step-down Period|Protocol Violation|0|||
23205729|NCT01885078|64494686|FG003|Step-down Period|Protocol Violation|0|||
23205730|NCT01885078|64494687|FG004|Step-down Period|Protocol Violation|0|||
23205731|NCT01885078|64494688|FG005|Step-down Period|Protocol Violation|0|||
23205732|NCT01885078|64494689|FG006|Step-down Period|Protocol Violation|0|||
23205733|NCT01885078|64494690|FG007|Step-down Period|Protocol Violation|0|||
23205734|NCT01885078|64494691|FG008|Step-down Period|Protocol Violation|1|||
23205735|NCT01885078|64494692|FG009|Step-down Period|Protocol Violation|1|||
23205736|NCT00976950|64494693|FG000|Overall Study|Adverse Event|3|||
23205737|NCT00976950|64494693|FG000|Overall Study|Events with no relationship to Aptivus|3|||
23205738|NCT00501046|64494696|FG000|Overall Study|Adverse Event|21|||
23205739|NCT00501046|64494697|FG001|Overall Study|Adverse Event|25|||
23205740|NCT00501046|64494696|FG000|Overall Study|Death|23|||
23205741|NCT00501046|64494697|FG001|Overall Study|Death|30|||
23205742|NCT00501046|64494696|FG000|Overall Study|Lost to Follow-up|14|||
23205743|NCT00501046|64494697|FG001|Overall Study|Lost to Follow-up|13|||
23205744|NCT00501046|64494696|FG000|Overall Study|Physician Decision|7|||
23205745|NCT00501046|64494697|FG001|Overall Study|Physician Decision|2|||
23205746|NCT00501046|64494696|FG000|Overall Study|Pregnancy|0|||
23205747|NCT00501046|64494697|FG001|Overall Study|Pregnancy|3|||
23205748|NCT00501046|64494696|FG000|Overall Study|Protocol Violation|2|||
23205749|NCT00501046|64494697|FG001|Overall Study|Protocol Violation|1|||
23205750|NCT00501046|64494696|FG000|Overall Study|Withdrawal by Subject|84|||
23205751|NCT00501046|64494697|FG001|Overall Study|Withdrawal by Subject|83|||
23205752|NCT00501046|64494696|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
23205753|NCT00501046|64494697|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
23205754|NCT04169061|64494700|FG000|Overall Study|Adverse Event|2|||
23205755|NCT04169061|64494700|FG000|Overall Study|Death|1|||
23205756|NCT04169061|64494700|FG000|Overall Study|Withdrawal by Subject|1|||
23205757|NCT04169061|64494700|FG000|Overall Study|Protocol Violation|1|||
23205758|NCT00575094|64494701|FG000|Overall Study|Adverse Event|2|||
23205759|NCT00575094|64494701|FG000|Overall Study|Withdrawal by Subject|1|||
23205760|NCT02841787|64494702|FG000|Overall Study|Lost to Follow-up|1|||
23205761|NCT02841787|64494703|FG001|Overall Study|Lost to Follow-up|0|||
23205762|NCT02841787|64494704|FG002|Overall Study|Lost to Follow-up|0|||
23205763|NCT02841787|64494702|FG000|Overall Study|Symptoms dropped below threshold|1|||
23205764|NCT02841787|64494703|FG001|Overall Study|Symptoms dropped below threshold|0|||
23205765|NCT02841787|64494704|FG002|Overall Study|Symptoms dropped below threshold|0|||
23205766|NCT02841787|64494702|FG000|Overall Study|Withdrawal by Subject|1|||
23205767|NCT02841787|64494703|FG001|Overall Study|Withdrawal by Subject|4|||
23205768|NCT02841787|64494704|FG002|Overall Study|Withdrawal by Subject|0|||
23205769|NCT04397718|64494706|FG000|Overall Study|Death|7|||
23205770|NCT04397718|64494707|FG001|Overall Study|Death|11|||
23205771|NCT04397718|64494706|FG000|Overall Study|Lost to Follow-up|0|||
23308205|NCT00758680|64873998|FG009|Overall Study|Withdrawal by Subject|0|||
23308206|NCT02455050|64874006|FG000|Treatment Period 1|Lost to Follow-up|1|||
23308207|NCT02455050|64874007|FG001|Treatment Period 1|Lost to Follow-up|1|||
23308208|NCT02455050|64874008|FG002|Treatment Period 1|Lost to Follow-up|1|||
23308209|NCT02455050|64874009|FG003|Treatment Period 1|Lost to Follow-up|2|||
23308210|NCT02455050|64874006|FG000|Treatment Period 2|Lost to Follow-up|1|||
23308211|NCT02455050|64874007|FG001|Treatment Period 2|Lost to Follow-up|0|||
23308212|NCT02455050|64874008|FG002|Treatment Period 2|Lost to Follow-up|2|||
23308213|NCT02455050|64874009|FG003|Treatment Period 2|Lost to Follow-up|1|||
23308214|NCT02677714|64874014|FG000|Overall Study|Withdrawal by Subject|2|||
23308215|NCT02677714|64874015|FG001|Overall Study|Withdrawal by Subject|0|||
23308216|NCT03283319|64874016|FG000|Overall Study|Lost to Follow-up|5|||
23308217|NCT03283319|64874017|FG001|Overall Study|Lost to Follow-up|4|||
23308218|NCT03283319|64874018|FG002|Overall Study|Lost to Follow-up|5|||
23308219|NCT03283319|64874019|FG003|Overall Study|Lost to Follow-up|5|||
23308220|NCT03283319|64874020|FG004|Overall Study|Lost to Follow-up|4|||
23308221|NCT03283319|64874021|FG005|Overall Study|Lost to Follow-up|3|||
23308222|NCT03283319|64874016|FG000|Overall Study|Withdrawal by Subject|2|||
23308223|NCT03283319|64874017|FG001|Overall Study|Withdrawal by Subject|2|||
23308224|NCT03283319|64874018|FG002|Overall Study|Withdrawal by Subject|2|||
23308225|NCT03283319|64874019|FG003|Overall Study|Withdrawal by Subject|1|||
23308226|NCT03283319|64874020|FG004|Overall Study|Withdrawal by Subject|0|||
23308227|NCT03283319|64874021|FG005|Overall Study|Withdrawal by Subject|1|||
23308228|NCT03283319|64874016|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
23308229|NCT03283319|64874017|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
23308230|NCT03283319|64874018|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
23308231|NCT03283319|64874019|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
23308232|NCT03283319|64874020|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
23308233|NCT03283319|64874021|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
23308234|NCT00721630|64874023|FG000|Overall Study|Participant found to be ineligible|1|||
23308235|NCT00469144|64874025|FG000|Overall Study|Death|0|||
23308236|NCT00469144|64874026|FG001|Overall Study|Death|1|||
23308237|NCT00469144|64874025|FG000|Overall Study|No Response|5|||
23308238|NCT00469144|64874026|FG001|Overall Study|No Response|5|||
23308239|NCT00469144|64874025|FG000|Overall Study|Progressive Disease|1|||
23308240|NCT00469144|64874026|FG001|Overall Study|Progressive Disease|0|||
23308241|NCT00470067|64874027|FG000|Overall Study|Death|1|||
23308242|NCT00470067|64874027|FG000|Overall Study|Disease Progression|6|||
23308243|NCT01437943|64874028|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
23308244|NCT01437943|64874029|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
23308245|NCT01437943|64874028|FG000|Overall Study|Subject expressed pregnancy plans|1|||
23308246|NCT01437943|64874029|FG001|Overall Study|Subject expressed pregnancy plans|0|||
23308247|NCT01437943|64874028|FG000|Overall Study|Adverse Event|2|||
23308248|NCT01437943|64874029|FG001|Overall Study|Adverse Event|0|||
23308249|NCT03375203|64874034|FG000|Overall Study|Protocol Violation|0|||
23308250|NCT03375203|64874035|FG001|Overall Study|Protocol Violation|0|||
23308251|NCT03375203|64874036|FG002|Overall Study|Protocol Violation|1|||
23308252|NCT03375203|64874037|FG003|Overall Study|Protocol Violation|0|||
23416860|NCT00853242|65271295|FG005|Overall Study|Other|1|||
23416861|NCT00853242|65271296|FG006|Overall Study|Other|2|||
23416862|NCT00606034|65271301|FG000|Overall Study|incarceration|1|||
23416863|NCT00765037|65271308|FG000|Overall Study|Lost to Follow-up|5|||
23416864|NCT00765037|65271308|FG000|Overall Study|Adverse Event|1|||
23416865|NCT00873041|65271315|FG000|Core Study|Adverse Event|2|||
23416866|NCT00873041|65271316|FG001|Core Study|Adverse Event|3|||
23416867|NCT00873041|65271317|FG002|Core Study|Adverse Event|1|||
23416868|NCT00873041|65271315|FG000|Core Study|Withdrawal by Subject|1|||
23416869|NCT00873041|65271316|FG001|Core Study|Withdrawal by Subject|2|||
23416870|NCT00873041|65271317|FG002|Core Study|Withdrawal by Subject|2|||
23416871|NCT00873041|65271315|FG000|Core Study|Lost to Follow-up|3|||
23524039|NCT00531232|65657786|FG001|Overall Study|Participants refused further treatment|1|||
23524040|NCT00531232|65657787|FG002|Overall Study|Participants refused further treatment|2|||
23524041|NCT00531232|65657785|FG000|Overall Study|Adverse events (AEs)|1|||
23308253|NCT03375203|64874038|FG004|Overall Study|Protocol Violation|0|||
23308254|NCT03375203|64874034|FG000|Overall Study|Adverse Event|2|||
23308255|NCT03375203|64874035|FG001|Overall Study|Adverse Event|3|||
23308256|NCT03375203|64874036|FG002|Overall Study|Adverse Event|0|||
23308257|NCT03375203|64874037|FG003|Overall Study|Adverse Event|2|||
23308258|NCT03375203|64874038|FG004|Overall Study|Adverse Event|2|||
23308259|NCT03375203|64874034|FG000|Overall Study|Withdrawal by Subject|3|||
23308260|NCT03375203|64874035|FG001|Overall Study|Withdrawal by Subject|0|||
23308261|NCT03375203|64874036|FG002|Overall Study|Withdrawal by Subject|1|||
23308262|NCT03375203|64874037|FG003|Overall Study|Withdrawal by Subject|0|||
23308263|NCT03375203|64874038|FG004|Overall Study|Withdrawal by Subject|2|||
23308264|NCT03375203|64874034|FG000|Overall Study|Non-compliance with study drug|1|||
23308265|NCT03375203|64874035|FG001|Overall Study|Non-compliance with study drug|0|||
23308266|NCT03375203|64874036|FG002|Overall Study|Non-compliance with study drug|0|||
23308267|NCT03375203|64874037|FG003|Overall Study|Non-compliance with study drug|0|||
23308268|NCT03375203|64874038|FG004|Overall Study|Non-compliance with study drug|0|||
23308269|NCT03375203|64874034|FG000|Overall Study|Randomized, not treated.|0|||
23308270|NCT03375203|64874035|FG001|Overall Study|Randomized, not treated.|1|||
23308271|NCT03375203|64874036|FG002|Overall Study|Randomized, not treated.|0|||
23308272|NCT03375203|64874037|FG003|Overall Study|Randomized, not treated.|0|||
23308273|NCT03375203|64874038|FG004|Overall Study|Randomized, not treated.|0|||
23308274|NCT02130882|64874041|FG000|Overall Study|Withdrawal by Subject|0|||
23308275|NCT02130882|64874042|FG001|Overall Study|Withdrawal by Subject|1|||
23308276|NCT00132028|64874043|FG000|Overall Study|Adverse Event|7|||
23308277|NCT00132028|64874043|FG000|Overall Study|Death|2|||
23308278|NCT00132028|64874043|FG000|Overall Study|Lack of Efficacy|11|||
23308279|NCT00132028|64874043|FG000|Overall Study|Withdrawal by Subject|2|||
23308280|NCT00132028|64874043|FG000|Overall Study|not eligible|2|||
23308281|NCT00132028|64874043|FG000|Overall Study|Physician Decision|3|||
23308282|NCT00369655|64874044|FG000|Overall Study|Refusal of further treatment|2|||
23308283|NCT01770392|64874047|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
23308284|NCT00003875|64874048|FG000|Overall Study|Screen Failed|1|||
23308285|NCT02447744|64874049|FG000|Overall Study|Withdrawal by Subject|3|||
23308286|NCT02447744|64874050|FG001|Overall Study|Withdrawal by Subject|1|||
23308287|NCT02447744|64874049|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
23308288|NCT02447744|64874050|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
23308289|NCT03837743|64874051|FG000|Overall Study|Adverse Event|1|||
23308290|NCT03837743|64874051|FG000|Overall Study|Withdrawal by Subject|2|||
23308291|NCT01908816|64874052|FG000|Overall Study|Subject's no longer requires study drug|0|||
23308292|NCT01908816|64874053|FG001|Overall Study|Subject's no longer requires study drug|0|||
23416872|NCT00873041|65271316|FG001|Core Study|Lost to Follow-up|1|||
23416873|NCT00873041|65271317|FG002|Core Study|Lost to Follow-up|0|||
23416874|NCT00873041|65271315|FG000|Core Study|Abnormal laboratory value|0|||
23308293|NCT01908816|64874054|FG002|Overall Study|Subject's no longer requires study drug|0|||
23308294|NCT01908816|64874055|FG003|Overall Study|Subject's no longer requires study drug|1|||
23308295|NCT01908816|64874052|FG000|Overall Study|Protocol deviation|1|||
23308296|NCT01908816|64874053|FG001|Overall Study|Protocol deviation|2|||
23416875|NCT00873041|65271316|FG001|Core Study|Abnormal laboratory value|0|||
23416876|NCT00873041|65271317|FG002|Core Study|Abnormal laboratory value|1|||
23416877|NCT00873041|65271315|FG000|Core Study|Protocol deviation|1|||
23416878|NCT00873041|65271316|FG001|Core Study|Protocol deviation|0|||
23524042|NCT00531232|65657786|FG001|Overall Study|Adverse events (AEs)|2|||
23524043|NCT00531232|65657787|FG002|Overall Study|Adverse events (AEs)|2|||
23416879|NCT00873041|65271317|FG002|Core Study|Protocol deviation|1|||
23524044|NCT00531232|65657785|FG000|Overall Study|Treatment failure|1|||
23524045|NCT00531232|65657786|FG001|Overall Study|Treatment failure|3|||
23524046|NCT00531232|65657787|FG002|Overall Study|Treatment failure|7|||
23524047|NCT00531232|65657785|FG000|Overall Study|Disease recurrence|0|||
23524048|NCT00531232|65657786|FG001|Overall Study|Disease recurrence|0|||
23524049|NCT00531232|65657787|FG002|Overall Study|Disease recurrence|1|||
23524050|NCT00531232|65657785|FG000|Overall Study|Deceased|2|||
23524051|NCT00531232|65657786|FG001|Overall Study|Deceased|2|||
23524052|NCT00531232|65657787|FG002|Overall Study|Deceased|2|||
23205772|NCT04397718|64494707|FG001|Overall Study|Lost to Follow-up|4|||
23205773|NCT02669862|64494710|FG000|Overall Study|Lost to Follow-up|0|||
23205774|NCT02669862|64494711|FG001|Overall Study|Lost to Follow-up|2|||
23205775|NCT02669862|64494712|FG002|Overall Study|Lost to Follow-up|1|||
23205776|NCT02669862|64494710|FG000|Overall Study|Withdrawal by Subject|2|||
23205777|NCT02669862|64494711|FG001|Overall Study|Withdrawal by Subject|2|||
23205778|NCT02669862|64494712|FG002|Overall Study|Withdrawal by Subject|3|||
23205779|NCT02669862|64494710|FG000|Overall Study|moved|0|||
23205780|NCT02669862|64494711|FG001|Overall Study|moved|1|||
23205781|NCT02669862|64494712|FG002|Overall Study|moved|0|||
23205782|NCT02669862|64494710|FG000|Overall Study|Protocol Violation|0|||
23205783|NCT02669862|64494711|FG001|Overall Study|Protocol Violation|0|||
23205784|NCT02669862|64494712|FG002|Overall Study|Protocol Violation|1|||
23205785|NCT02796391|64494713|FG000|Overall Study|Lost to Follow-up|2|||
23205786|NCT02796391|64494714|FG001|Overall Study|Lost to Follow-up|2|||
23205787|NCT02796391|64494715|FG002|Overall Study|Lost to Follow-up|13|||
23205788|NCT02796391|64494716|FG003|Overall Study|Lost to Follow-up|8|||
23205789|NCT02796391|64494717|FG004|Overall Study|Lost to Follow-up|14|||
23205790|NCT02796391|64494718|FG005|Overall Study|Lost to Follow-up|13|||
23205791|NCT02796391|64494713|FG000|Overall Study|COVID|0|||
23205792|NCT02796391|64494714|FG001|Overall Study|COVID|0|||
23205793|NCT02796391|64494715|FG002|Overall Study|COVID|5|||
23205794|NCT02796391|64494716|FG003|Overall Study|COVID|5|||
23205795|NCT02796391|64494717|FG004|Overall Study|COVID|2|||
23205796|NCT02796391|64494718|FG005|Overall Study|COVID|4|||
23205797|NCT02796391|64494713|FG000|Overall Study|Participant did not like study cigarettes|0|||
23205798|NCT02796391|64494714|FG001|Overall Study|Participant did not like study cigarettes|0|||
23205799|NCT02796391|64494715|FG002|Overall Study|Participant did not like study cigarettes|3|||
23205800|NCT02796391|64494716|FG003|Overall Study|Participant did not like study cigarettes|0|||
23205801|NCT02796391|64494717|FG004|Overall Study|Participant did not like study cigarettes|0|||
23205802|NCT02796391|64494718|FG005|Overall Study|Participant did not like study cigarettes|0|||
23308297|NCT01908816|64874054|FG002|Overall Study|Protocol deviation|1|||
23308298|NCT01908816|64874055|FG003|Overall Study|Protocol deviation|1|||
23308299|NCT01908816|64874052|FG000|Overall Study|Withdrawal by Subject|0|||
23308300|NCT01908816|64874053|FG001|Overall Study|Withdrawal by Subject|4|||
23308301|NCT01908816|64874054|FG002|Overall Study|Withdrawal by Subject|2|||
23524053|NCT00531232|65657785|FG000|Overall Study|Withdrawal by Subject|0|||
23524054|NCT00531232|65657786|FG001|Overall Study|Withdrawal by Subject|1|||
23524055|NCT00531232|65657787|FG002|Overall Study|Withdrawal by Subject|2|||
23524056|NCT00531232|65657785|FG000|Overall Study|Other|0|||
23524057|NCT00531232|65657786|FG001|Overall Study|Other|0|||
23524058|NCT00531232|65657787|FG002|Overall Study|Other|5|||
23524059|NCT01527292|65657791|FG000|Overall Study|Physician Decision|0|||
23524060|NCT01527292|65657792|FG001|Overall Study|Physician Decision|3|||
23524061|NCT03254134|65657793|FG000|Overall Study|Not eligible patients|599|||
23524062|NCT03254134|65657794|FG001|Overall Study|Not eligible patients|3630|||
23524063|NCT00606892|65657795|FG000|First Intervention|Protocol Violation|1|||
23524064|NCT00606892|65657796|FG001|First Intervention|Protocol Violation|4|||
23524065|NCT00748215|65657798|FG000|Overall Study|Withdrawal by Subject|7|||
23524066|NCT00748215|65657799|FG001|Overall Study|Withdrawal by Subject|7|||
23524067|NCT00748215|65657798|FG000|Overall Study|Treatment change|2|||
23524068|NCT00748215|65657799|FG001|Overall Study|Treatment change|1|||
23524069|NCT00748215|65657798|FG000|Overall Study|Change in patient condition|0|||
23524070|NCT00748215|65657799|FG001|Overall Study|Change in patient condition|3|||
23524071|NCT00748215|65657798|FG000|Overall Study|Non-compliant|0|||
23524072|NCT00748215|65657799|FG001|Overall Study|Non-compliant|2|||
23524073|NCT00748215|65657798|FG000|Overall Study|Adverse Event|0|||
23524074|NCT00748215|65657799|FG001|Overall Study|Adverse Event|5|||
23524075|NCT01446965|65657811|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
23524076|NCT01446965|65657812|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
23524077|NCT01446965|65657811|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
23524078|NCT01446965|65657812|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
23524079|NCT03690388|65657813|FG000|Overall Study|Adverse Event|8|||
23524080|NCT03690388|65657814|FG001|Overall Study|Adverse Event|1|||
23524081|NCT03690388|65657813|FG000|Overall Study|Radiographic Progression|14|||
23524082|NCT03690388|65657814|FG001|Overall Study|Radiographic Progression|29|||
23524083|NCT03690388|65657813|FG000|Overall Study|Clinical deterioration|10|||
23205803|NCT02796391|64494713|FG000|Overall Study|Withdrawal by Subject|1|||
23205804|NCT02796391|64494714|FG001|Overall Study|Withdrawal by Subject|1|||
23205805|NCT02796391|64494715|FG002|Overall Study|Withdrawal by Subject|4|||
23205806|NCT02796391|64494716|FG003|Overall Study|Withdrawal by Subject|3|||
23308302|NCT01908816|64874055|FG003|Overall Study|Withdrawal by Subject|2|||
23524084|NCT03690388|65657814|FG001|Overall Study|Clinical deterioration|6|||
23524085|NCT03690388|65657813|FG000|Overall Study|Withdrawal by Subject|2|||
23205807|NCT02796391|64494717|FG004|Overall Study|Withdrawal by Subject|4|||
23524086|NCT03690388|65657814|FG001|Overall Study|Withdrawal by Subject|0|||
23524087|NCT03690388|65657813|FG000|Overall Study|Lack of Efficacy|1|||
23524088|NCT03690388|65657814|FG001|Overall Study|Lack of Efficacy|0|||
23524089|NCT03690388|65657813|FG000|Overall Study|Lost to Follow-up|1|||
23524090|NCT03690388|65657814|FG001|Overall Study|Lost to Follow-up|0|||
23524091|NCT01417481|65657815|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
23524092|NCT01417481|65657816|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23524093|NCT02871739|65657817|FG000|Overall Study|Lost to Follow-up|3|||
23524094|NCT02871739|65657818|FG001|Overall Study|Lost to Follow-up|2|||
23524095|NCT02871739|65657819|FG002|Overall Study|Lost to Follow-up|0|||
23524096|NCT02871739|65657820|FG003|Overall Study|Lost to Follow-up|2|||
23524097|NCT01132495|65657821|FG000|Overall Study|Various reasons|40|||
23205808|NCT02796391|64494718|FG005|Overall Study|Withdrawal by Subject|3|||
23524098|NCT01132495|65657822|FG001|Overall Study|Various reasons|38|||
23524099|NCT01132495|65657823|FG002|Overall Study|Various reasons|20|||
23524100|NCT01132495|65657824|FG003|Overall Study|Various reasons|12|||
23524101|NCT03595878|65657826|FG000|Overall Study|Death|2|||
23524102|NCT03595878|65657827|FG001|Overall Study|Death|1|||
23524103|NCT03595878|65657828|FG002|Overall Study|Death|0|||
23524104|NCT03595878|65657826|FG000|Overall Study|Disease progression|2|||
23524105|NCT03595878|65657827|FG001|Overall Study|Disease progression|1|||
23524106|NCT03595878|65657828|FG002|Overall Study|Disease progression|2|||
23308303|NCT01908816|64874052|FG000|Overall Study|Lost to Follow-up|3|||
23308304|NCT01908816|64874053|FG001|Overall Study|Lost to Follow-up|5|||
23308305|NCT01908816|64874054|FG002|Overall Study|Lost to Follow-up|4|||
23308306|NCT01908816|64874055|FG003|Overall Study|Lost to Follow-up|2|||
23308307|NCT01908816|64874052|FG000|Overall Study|Death|1|||
23308308|NCT01908816|64874053|FG001|Overall Study|Death|0|||
23308309|NCT01908816|64874054|FG002|Overall Study|Death|7|||
23308310|NCT01908816|64874055|FG003|Overall Study|Death|1|||
23308311|NCT01908816|64874052|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23308312|NCT01908816|64874053|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
23308313|NCT01908816|64874054|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
23308314|NCT01908816|64874055|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23308315|NCT01908816|64874052|FG000|Overall Study|Early termination|87|||
23308316|NCT01908816|64874053|FG001|Overall Study|Early termination|60|||
23308317|NCT01908816|64874054|FG002|Overall Study|Early termination|43|||
23308318|NCT01908816|64874055|FG003|Overall Study|Early termination|28|||
23308319|NCT03222583|64874065|FG000|Overall Study|Withdrawal by Subject|3|||
23308320|NCT03222583|64874066|FG001|Overall Study|Withdrawal by Subject|3|||
23308321|NCT03222583|64874065|FG000|Overall Study|Lost to Follow-up|1|||
23308322|NCT03222583|64874066|FG001|Overall Study|Lost to Follow-up|0|||
23308323|NCT03222583|64874065|FG000|Overall Study|Other|1|||
23308324|NCT03222583|64874066|FG001|Overall Study|Other|3|||
23308325|NCT02246439|64874067|FG000|Overall Study|Adverse Event|3|||
23308326|NCT02246439|64874068|FG001|Overall Study|Adverse Event|0|||
23308327|NCT02246439|64874067|FG000|Overall Study|Lost to Follow-up|7|||
23308328|NCT02246439|64874068|FG001|Overall Study|Lost to Follow-up|5|||
23308329|NCT02246439|64874067|FG000|Overall Study|Protocol Violation|0|||
23308330|NCT02246439|64874068|FG001|Overall Study|Protocol Violation|2|||
23308331|NCT02246439|64874067|FG000|Overall Study|Physician Decision|0|||
23308332|NCT02246439|64874068|FG001|Overall Study|Physician Decision|1|||
23308333|NCT02246439|64874067|FG000|Overall Study|Unkonwn|1|||
23308334|NCT02246439|64874068|FG001|Overall Study|Unkonwn|3|||
23308335|NCT02246439|64874067|FG000|Overall Study|Withdrawal by Subject|1|||
23308336|NCT02246439|64874068|FG001|Overall Study|Withdrawal by Subject|0|||
23308337|NCT03393806|64874069|FG000|Overall Study|Physician Decision|1|||
23308338|NCT03393806|64874070|FG001|Overall Study|Physician Decision|0|||
23308339|NCT01671332|64874071|FG000|Overall Study|Withdrawal by Subject|1|||
23308340|NCT01671332|64874072|FG001|Overall Study|Withdrawal by Subject|1|||
23524107|NCT00813358|65657829|FG000|Overall Study|Death|32|||
23524108|NCT00813358|65657829|FG000|Overall Study|Lost to Follow-up|12|||
23524109|NCT00813358|65657829|FG000|Overall Study|other endpoints|5|||
23524110|NCT00813358|65657829|FG000|Overall Study|Withdrawal by Subject|20|||
23524111|NCT00407563|65657832|FG000|Overall Study|Patient continues on treatment|1|||
23524112|NCT00590954|65657836|FG000|Overall Study|Inevaluable|2|||
23524113|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
23308341|NCT04280705|64874073|FG000|Overall Study|Enrolled but not treated|4|||
23308342|NCT04280705|64874074|FG001|Overall Study|Enrolled but not treated|10|||
23308343|NCT04280705|64874073|FG000|Overall Study|Physician Decision|1|||
23308344|NCT04280705|64874074|FG001|Overall Study|Physician Decision|0|||
23308345|NCT04280705|64874073|FG000|Overall Study|Withdrawal by Subject|7|||
23308346|NCT04280705|64874074|FG001|Overall Study|Withdrawal by Subject|9|||
23308347|NCT04280705|64874073|FG000|Overall Study|Adverse Event|0|||
23308348|NCT04280705|64874074|FG001|Overall Study|Adverse Event|4|||
23308349|NCT04280705|64874073|FG000|Overall Study|Transferred to another hospital|1|||
23524114|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
23524115|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
23524116|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
23524117|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
23524118|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
23524119|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
23205809|NCT02796391|64494713|FG000|Overall Study|Adverse Event|0|||
23205810|NCT02796391|64494714|FG001|Overall Study|Adverse Event|0|||
23205811|NCT02796391|64494715|FG002|Overall Study|Adverse Event|0|||
23205812|NCT02796391|64494716|FG003|Overall Study|Adverse Event|1|||
23205813|NCT02796391|64494717|FG004|Overall Study|Adverse Event|0|||
23205814|NCT02796391|64494718|FG005|Overall Study|Adverse Event|0|||
23205815|NCT02796391|64494713|FG000|Overall Study|Protocol Violation|0|||
23205816|NCT02796391|64494714|FG001|Overall Study|Protocol Violation|0|||
23205817|NCT02796391|64494715|FG002|Overall Study|Protocol Violation|0|||
23205818|NCT02796391|64494716|FG003|Overall Study|Protocol Violation|1|||
23205819|NCT02796391|64494717|FG004|Overall Study|Protocol Violation|0|||
23205820|NCT02796391|64494718|FG005|Overall Study|Protocol Violation|0|||
23205821|NCT01982773|64494719|FG000|Overall Study|Withdrawal by Subject|1|||
23205822|NCT01982773|64494720|FG001|Overall Study|Withdrawal by Subject|3|||
23205823|NCT01982773|64494719|FG000|Overall Study|Lost to Follow-up|7|||
23205824|NCT01982773|64494720|FG001|Overall Study|Lost to Follow-up|1|||
23205825|NCT01575197|64494721|FG000|Overall Study|Migration out of study area|1|||
23205826|NCT01575197|64494722|FG001|Overall Study|Migration out of study area|5|||
23205827|NCT01575197|64494723|FG002|Overall Study|Migration out of study area|4|||
23205828|NCT01575197|64494721|FG000|Overall Study|SAE|0|||
23205829|NCT01575197|64494722|FG001|Overall Study|SAE|1|||
23205830|NCT01575197|64494723|FG002|Overall Study|SAE|0|||
23205831|NCT01575197|64494721|FG000|Overall Study|Lost to Follow-up|0|||
23205832|NCT01575197|64494722|FG001|Overall Study|Lost to Follow-up|1|||
23205833|NCT01575197|64494723|FG002|Overall Study|Lost to Follow-up|0|||
23205834|NCT01575197|64494721|FG000|Overall Study|Withdrawal by Subject|0|||
23205835|NCT01575197|64494722|FG001|Overall Study|Withdrawal by Subject|1|||
23205836|NCT01575197|64494723|FG002|Overall Study|Withdrawal by Subject|1|||
23205837|NCT01575197|64494721|FG000|Overall Study|Protocol Violation|2|||
23205838|NCT01575197|64494722|FG001|Overall Study|Protocol Violation|1|||
23205839|NCT01575197|64494723|FG002|Overall Study|Protocol Violation|1|||
23205840|NCT01069523|64494728|FG000|Overall Study|Withdrawal by Subject|4|||
23205841|NCT01069523|64494729|FG001|Overall Study|Withdrawal by Subject|7|||
23205842|NCT00786032|64494730|FG000|Overall Study|Death|4|||
23205843|NCT00786032|64494730|FG000|Overall Study|Withdrawal by Subject|14|||
23205844|NCT00786032|64494730|FG000|Overall Study|Did not complete in the timeframe|6|||
23205845|NCT01702363|64494734|FG000|Overall Study|Adverse Event|14|||
23205846|NCT01702363|64494734|FG000|Overall Study|Lack of Efficacy|4|||
23205847|NCT01702363|64494734|FG000|Overall Study|Withdrawal by Subject|2|||
23524120|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
23524121|NCT00380393|65657837|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
23524122|NCT00380393|65657838|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
23524123|NCT00380393|65657837|FG000|Month 14|Withdrawal by Subject|9|||
23308350|NCT04280705|64874074|FG001|Overall Study|Transferred to another hospital|1|||
23416880|NCT00873041|65271315|FG000|Extension Study|Adverse Event|1|||
23416881|NCT00873041|65271316|FG001|Extension Study|Adverse Event|0|||
23416882|NCT00873041|65271317|FG002|Extension Study|Adverse Event|1|||
23416883|NCT00873041|65271315|FG000|Extension Study|Administrative reasons|0|||
23416884|NCT00873041|65271316|FG001|Extension Study|Administrative reasons|0|||
23416885|NCT00873041|65271317|FG002|Extension Study|Administrative reasons|1|||
23416886|NCT04731298|65271328|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
23416887|NCT04731298|65271329|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
23416888|NCT02141633|65271335|FG000|Overall Study|Physician Decision|1|||
23416889|NCT02141633|65271336|FG001|Overall Study|Physician Decision|0|||
23416890|NCT00882583|65271338|FG000|Overall Study|Physician Decision|1|||
23416891|NCT00882583|65271339|FG001|Overall Study|Physician Decision|0|||
23416892|NCT00882583|65271338|FG000|Overall Study|Adverse Event|0|||
23416893|NCT00882583|65271339|FG001|Overall Study|Adverse Event|1|||
23416894|NCT03632993|65271340|FG000|Overall Study|Withdrawal by Subject|1|||
23416895|NCT03632993|65271341|FG001|Overall Study|Withdrawal by Subject|0|||
23416896|NCT03632993|65271342|FG002|Overall Study|Withdrawal by Subject|0|||
23416897|NCT03632993|65271343|FG003|Overall Study|Withdrawal by Subject|0|||
23416898|NCT03632993|65271344|FG004|Overall Study|Withdrawal by Subject|0|||
23416899|NCT03632993|65271345|FG005|Overall Study|Withdrawal by Subject|0|||
23416900|NCT03632993|65271346|FG006|Overall Study|Withdrawal by Subject|0|||
23416901|NCT03632993|65271347|FG007|Overall Study|Withdrawal by Subject|0|||
23416902|NCT03632993|65271348|FG008|Overall Study|Withdrawal by Subject|0|||
23416903|NCT03632993|65271349|FG009|Overall Study|Withdrawal by Subject|1|||
23524124|NCT00380393|65657838|FG001|Month 14|Withdrawal by Subject|7|||
23524125|NCT00380393|65657837|FG000|Month 14|Death|1|||
23524126|NCT00380393|65657838|FG001|Month 14|Death|0|||
23524127|NCT00380393|65657837|FG000|Month 14|Lost to Follow-up|0|||
23524128|NCT00380393|65657838|FG001|Month 14|Lost to Follow-up|1|||
23524129|NCT00380393|65657837|FG000|Month 14|Migrated/moved from study area|39|||
23524130|NCT00380393|65657838|FG001|Month 14|Migrated/moved from study area|42|||
23524131|NCT00380393|65657837|FG000|Month 14|Protocol Violation|2|||
23524132|NCT00380393|65657838|FG001|Month 14|Protocol Violation|0|||
23524133|NCT00380393|65657837|FG000|Month 14|Others|6|||
23524134|NCT00380393|65657838|FG001|Month 14|Others|6|||
23524135|NCT01488097|65657839|FG000|Overall Study|Lost to Follow-up|1|||
23524136|NCT01652716|65657842|FG000|Overall Study|Loss of glucose control|1|||
23524137|NCT01652716|65657843|FG001|Overall Study|Loss of glucose control|0|||
23524138|NCT01652716|65657842|FG000|Overall Study|Administrative|0|||
23524139|NCT01652716|65657843|FG001|Overall Study|Administrative|2|||
23524140|NCT01652716|65657842|FG000|Overall Study|Investigator decision|1|||
23524141|NCT01652716|65657843|FG001|Overall Study|Investigator decision|4|||
23524142|NCT01652716|65657842|FG000|Overall Study|Lost to Follow-up|12|||
23524143|NCT01652716|65657843|FG001|Overall Study|Lost to Follow-up|11|||
23524144|NCT01652716|65657842|FG000|Overall Study|Protocol Violation|2|||
23524145|NCT01652716|65657843|FG001|Overall Study|Protocol Violation|1|||
23524146|NCT01652716|65657842|FG000|Overall Study|Adverse Event|7|||
23308351|NCT03511326|64874078|FG000|Overall Study|Withdrawal by Subject|1|||
23416904|NCT03632993|65271340|FG000|Overall Study|Protocol Non-compliance|0|||
23416905|NCT03632993|65271341|FG001|Overall Study|Protocol Non-compliance|1|||
23416906|NCT03632993|65271342|FG002|Overall Study|Protocol Non-compliance|0|||
23416907|NCT03632993|65271343|FG003|Overall Study|Protocol Non-compliance|0|||
23416908|NCT03632993|65271344|FG004|Overall Study|Protocol Non-compliance|0|||
23416909|NCT03632993|65271345|FG005|Overall Study|Protocol Non-compliance|0|||
23416910|NCT03632993|65271346|FG006|Overall Study|Protocol Non-compliance|0|||
23524147|NCT01652716|65657843|FG001|Overall Study|Adverse Event|10|||
23524148|NCT01652716|65657842|FG000|Overall Study|Withdrawal by Subject|33|||
23524149|NCT01652716|65657843|FG001|Overall Study|Withdrawal by Subject|18|||
23524150|NCT02945410|65657844|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524151|NCT02945410|65657845|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
23524152|NCT02945410|65657846|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524153|NCT02945410|65657847|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524154|NCT02945410|65657848|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524155|NCT02945410|65657849|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23524156|NCT02945410|65657844|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
23524157|NCT02945410|65657845|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
23524158|NCT02945410|65657846|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
23524159|NCT02945410|65657847|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
23524160|NCT02945410|65657848|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
23524161|NCT02945410|65657849|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
23524162|NCT02945410|65657844|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
23524163|NCT02945410|65657845|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
23524164|NCT02945410|65657846|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
23524165|NCT02945410|65657847|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
23524166|NCT02945410|65657848|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
23524167|NCT02945410|65657849|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
23524168|NCT02584504|65657850|FG000|Double-blind Treatment|Participant withdrew consent|0|||
23524169|NCT02584504|65657851|FG001|Double-blind Treatment|Participant withdrew consent|0|||
23524170|NCT02584504|65657852|FG002|Double-blind Treatment|Participant withdrew consent|1|||
23524171|NCT02584504|65657850|FG000|Double-blind Treatment|Adverse Event|0|||
23524172|NCT02584504|65657851|FG001|Double-blind Treatment|Adverse Event|1|||
23524173|NCT02584504|65657852|FG002|Double-blind Treatment|Adverse Event|0|||
23524174|NCT02584504|65657850|FG000|Double-blind Treatment|Family Matter|0|||
23524175|NCT02584504|65657851|FG001|Double-blind Treatment|Family Matter|1|||
23524176|NCT02584504|65657852|FG002|Double-blind Treatment|Family Matter|0|||
23524177|NCT02584504|65657850|FG000|Open-label Treatment|Participant withdrew consent|0|||
23524178|NCT02584504|65657851|FG001|Open-label Treatment|Participant withdrew consent|0|||
23524179|NCT02584504|65657852|FG002|Open-label Treatment|Participant withdrew consent|4|||
23524180|NCT02584504|65657850|FG000|Open-label Treatment|Adverse Event|2|||
23524181|NCT02584504|65657851|FG001|Open-label Treatment|Adverse Event|2|||
23524182|NCT02584504|65657852|FG002|Open-label Treatment|Adverse Event|3|||
23524183|NCT02584504|65657850|FG000|Open-label Treatment|Physician Decision|0|||
23524184|NCT02584504|65657851|FG001|Open-label Treatment|Physician Decision|1|||
23524185|NCT02584504|65657852|FG002|Open-label Treatment|Physician Decision|0|||
23524186|NCT02584504|65657850|FG000|Open-label Treatment|Entered but not treated|0|||
23524187|NCT02584504|65657851|FG001|Open-label Treatment|Entered but not treated|1|||
23524188|NCT02584504|65657852|FG002|Open-label Treatment|Entered but not treated|1|||
23524189|NCT00962104|65657858|FG000|Overall Study|Adverse Event|10|||
23524190|NCT00962104|65657859|FG001|Overall Study|Adverse Event|3|||
23524191|NCT00962104|65657858|FG000|Overall Study|Entry Criteria Not Met|1|||
23524192|NCT00962104|65657859|FG001|Overall Study|Entry Criteria Not Met|2|||
23524193|NCT00962104|65657858|FG000|Overall Study|Lack of Efficacy|0|||
23524194|NCT00962104|65657859|FG001|Overall Study|Lack of Efficacy|1|||
23524195|NCT00962104|65657858|FG000|Overall Study|Lost to Follow-up|10|||
23524196|NCT00962104|65657859|FG001|Overall Study|Lost to Follow-up|4|||
23524197|NCT00962104|65657858|FG000|Overall Study|Physician Decision|1|||
23524198|NCT00962104|65657859|FG001|Overall Study|Physician Decision|0|||
23524199|NCT00962104|65657858|FG000|Overall Study|Protocol Violation|6|||
23524200|NCT00962104|65657859|FG001|Overall Study|Protocol Violation|8|||
23524201|NCT00962104|65657858|FG000|Overall Study|Sponsor Decision|0|||
23524202|NCT00962104|65657859|FG001|Overall Study|Sponsor Decision|1|||
23524203|NCT00962104|65657858|FG000|Overall Study|Withdrawal by Subject|10|||
23524204|NCT00962104|65657859|FG001|Overall Study|Withdrawal by Subject|6|||
23524205|NCT00962104|65657858|FG000|Overall Study|Other|2|||
23524206|NCT00962104|65657859|FG001|Overall Study|Other|0|||
23524207|NCT02558790|65657862|FG000|Overall Study|Lost to Follow-up|2|||
23524208|NCT02558790|65657862|FG000|Overall Study|Physician Decision|1|||
23524209|NCT02558790|65657862|FG000|Overall Study|Withdrawal by Subject|1|||
23524210|NCT02558790|65657862|FG000|Overall Study|Screen Fail|3|||
23524211|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
23205858|NCT00808249|64494741|FG000|Overall Study|Adverse Event|4|||
23205859|NCT00808249|64494742|FG001|Overall Study|Adverse Event|7|||
23416911|NCT03632993|65271347|FG007|Overall Study|Protocol Non-compliance|0|||
23416912|NCT03632993|65271348|FG008|Overall Study|Protocol Non-compliance|0|||
23416913|NCT03632993|65271349|FG009|Overall Study|Protocol Non-compliance|0|||
23416914|NCT03632993|65271340|FG000|Overall Study|Lost to Follow-up|0|||
23416915|NCT03632993|65271341|FG001|Overall Study|Lost to Follow-up|0|||
23416916|NCT03632993|65271342|FG002|Overall Study|Lost to Follow-up|0|||
23416917|NCT03632993|65271343|FG003|Overall Study|Lost to Follow-up|0|||
23416918|NCT03632993|65271344|FG004|Overall Study|Lost to Follow-up|0|||
23416919|NCT03632993|65271345|FG005|Overall Study|Lost to Follow-up|1|||
23416920|NCT03632993|65271346|FG006|Overall Study|Lost to Follow-up|0|||
23416921|NCT03632993|65271347|FG007|Overall Study|Lost to Follow-up|1|||
23416922|NCT03632993|65271348|FG008|Overall Study|Lost to Follow-up|0|||
23416923|NCT03632993|65271349|FG009|Overall Study|Lost to Follow-up|0|||
23416924|NCT03632993|65271340|FG000|Overall Study|Adverse Event|0|||
23416925|NCT03632993|65271341|FG001|Overall Study|Adverse Event|0|||
23416926|NCT03632993|65271342|FG002|Overall Study|Adverse Event|0|||
23416927|NCT03632993|65271343|FG003|Overall Study|Adverse Event|0|||
23416928|NCT03632993|65271344|FG004|Overall Study|Adverse Event|0|||
23416929|NCT03632993|65271345|FG005|Overall Study|Adverse Event|1|||
23416930|NCT03632993|65271346|FG006|Overall Study|Adverse Event|0|||
23416931|NCT03632993|65271347|FG007|Overall Study|Adverse Event|1|||
23416932|NCT03632993|65271348|FG008|Overall Study|Adverse Event|0|||
23416933|NCT03632993|65271349|FG009|Overall Study|Adverse Event|0|||
23416934|NCT04026009|65271350|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23416935|NCT04026009|65271351|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23416936|NCT04026009|65271352|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23416937|NCT04026009|65271353|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23416938|NCT04026009|65271354|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
23416939|NCT04026009|65271350|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
23416940|NCT04026009|65271351|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
23416941|NCT04026009|65271352|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
23416942|NCT04026009|65271353|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
23416943|NCT04026009|65271354|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
23416944|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
23416945|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
23416946|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
23416947|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
23416948|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
23416949|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
23416950|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
23416951|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
23416952|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
23416953|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
23416954|NCT00510718|65271364|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
23416955|NCT00510718|65271365|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
23416956|NCT00962741|65271366|FG000|Overall Study|Failed to return|3|||
23416957|NCT00962741|65271366|FG000|Overall Study|Lost to Follow-up|2|||
23416958|NCT00962741|65271366|FG000|Overall Study|Withdrawal by Subject|1|||
23416959|NCT00962741|65271366|FG000|Overall Study|Lack of Efficacy|1|||
23416960|NCT00962741|65271366|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
23416961|NCT01443364|65271370|FG000|Overall Study|Lack of Efficacy|14|||
23416962|NCT01443364|65271370|FG000|Overall Study|Lost to Follow-up|3|||
23416963|NCT01443364|65271370|FG000|Overall Study|Withdrawal by Subject|5|||
23416964|NCT01443364|65271370|FG000|Overall Study|Other Reason|4|||
23416965|NCT01443364|65271370|FG000|Overall Study|SAE, non-fatal|6|||
23416966|NCT01443364|65271370|FG000|Overall Study|AE, non-serious non-fatal|8|||
23308352|NCT00574912|64874080|FG000|Overall Study|Could not place IV lines.|3|||
23308353|NCT00574912|64874080|FG000|Overall Study|scheduling conflicts|3|||
23308354|NCT00574912|64874080|FG000|Overall Study|Physician Decision|2|||
23416967|NCT01443364|65271370|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23416968|NCT01066104|65271371|FG000|Overall Study|Adverse Event|1|||
23416969|NCT01066104|65271372|FG001|Overall Study|Adverse Event|1|||
23524212|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
23205860|NCT00808249|64494743|FG002|Overall Study|Adverse Event|10|||
23205861|NCT00808249|64494744|FG003|Overall Study|Adverse Event|6|||
23205862|NCT00808249|64494741|FG000|Overall Study|Lost to Follow-up|2|||
23205863|NCT00808249|64494742|FG001|Overall Study|Lost to Follow-up|3|||
23524213|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
23524214|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
23524215|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
23524216|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
23524217|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
23524218|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
23524219|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
23524220|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
23416970|NCT01066104|65271371|FG000|Overall Study|Protocol Violation|1|||
23416971|NCT01066104|65271372|FG001|Overall Study|Protocol Violation|0|||
23416972|NCT01667224|65271373|FG000|Overall Study|Withdrawal by Subject|3|||
23416973|NCT01667224|65271374|FG001|Overall Study|Withdrawal by Subject|1|||
23416974|NCT01667224|65271373|FG000|Overall Study|Protocol Violation|1|||
23416975|NCT01667224|65271374|FG001|Overall Study|Protocol Violation|1|||
23416976|NCT02778555|65271375|FG000|Overall Study|Withdrawal by Subject|55|||
23416977|NCT02778555|65271376|FG001|Overall Study|Withdrawal by Subject|32|||
23416978|NCT02778555|65271377|FG002|Overall Study|Withdrawal by Subject|107|||
23416979|NCT00666588|65271378|FG000|Overall Study|ineligible|2|||
23416980|NCT00666588|65271379|FG001|Overall Study|ineligible|0|||
23416981|NCT00666588|65271380|FG002|Overall Study|ineligible|0|||
23416982|NCT00666588|65271381|FG003|Overall Study|ineligible|2|||
23416983|NCT00666588|65271378|FG000|Overall Study|inevaluable|2|||
23416984|NCT00666588|65271379|FG001|Overall Study|inevaluable|0|||
23416985|NCT00666588|65271380|FG002|Overall Study|inevaluable|0|||
23416986|NCT00666588|65271381|FG003|Overall Study|inevaluable|0|||
23416987|NCT00733291|65271382|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
23416988|NCT00733291|65271383|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
23416989|NCT00733291|65271384|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
23416990|NCT00733291|65271385|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
23416991|NCT01986231|65271389|FG000|Overall Study|Adverse Event|1|||
23416992|NCT01818258|65271390|FG000|Overall Study|Death|3|||
23416993|NCT01818258|65271391|FG001|Overall Study|Death|0|||
23416994|NCT01818258|65271390|FG000|Overall Study|Withdrawal by Subject|0|||
23416995|NCT01818258|65271391|FG001|Overall Study|Withdrawal by Subject|1|||
23416996|NCT01818258|65271390|FG000|Overall Study|Lost to Follow-up|0|||
23416997|NCT01818258|65271391|FG001|Overall Study|Lost to Follow-up|1|||
23416998|NCT01818258|65271390|FG000|Overall Study|Unable to Travel to Clinic|0|||
23416999|NCT01818258|65271391|FG001|Overall Study|Unable to Travel to Clinic|1|||
23417000|NCT00960011|65271395|FG000|Overall Study|Death|5|||
23417001|NCT00960011|65271396|FG001|Overall Study|Death|0|||
23417002|NCT00960011|65271395|FG000|Overall Study|Lost to Follow-up|6|||
23417003|NCT00960011|65271396|FG001|Overall Study|Lost to Follow-up|2|||
23417004|NCT00431444|65271407|FG000|Overall Study|Protocol Violation|1|||
23417005|NCT00431444|65271408|FG001|Overall Study|Protocol Violation|4|||
23417006|NCT00431444|65271407|FG000|Overall Study|Adverse Event|2|||
23417007|NCT00431444|65271408|FG001|Overall Study|Adverse Event|1|||
23417008|NCT00431444|65271407|FG000|Overall Study|Withdrawal by Subject|1|||
23417009|NCT00431444|65271408|FG001|Overall Study|Withdrawal by Subject|1|||
23417010|NCT00431444|65271407|FG000|Overall Study|Lost to Follow-up|1|||
23417011|NCT00431444|65271408|FG001|Overall Study|Lost to Follow-up|0|||
23417012|NCT00431444|65271407|FG000|Overall Study|Administrative Problems|0|||
23417013|NCT00431444|65271408|FG001|Overall Study|Administrative Problems|1|||
23417014|NCT04848220|65271409|FG000|Overall Study|Unable to proceed to study procedure|0|||
23524221|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
23524222|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
23524223|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
23524224|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
23524225|NCT03434041|65657863|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
23524226|NCT03434041|65657864|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
23524227|NCT03434041|65657863|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
23524228|NCT03434041|65657864|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
23524229|NCT03434041|65657863|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
23524230|NCT03434041|65657864|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
23524231|NCT03434041|65657863|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
23524232|NCT03434041|65657864|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
23524233|NCT00313612|65657865|FG000|Overall Study|Patient never received treatment|0|||
23524234|NCT00313612|65657866|FG001|Overall Study|Patient never received treatment|1|||
23524235|NCT01203072|65657869|FG000|Overall Study|Adverse Event|5|||
23524236|NCT01203072|65657870|FG001|Overall Study|Adverse Event|3|||
23524237|NCT01203072|65657871|FG002|Overall Study|Adverse Event|2|||
23524238|NCT01203072|65657872|FG003|Overall Study|Adverse Event|4|||
23524239|NCT01203072|65657873|FG004|Overall Study|Adverse Event|2|||
23524240|NCT01203072|65657869|FG000|Overall Study|Lack of Efficacy|1|||
23524241|NCT01203072|65657870|FG001|Overall Study|Lack of Efficacy|0|||
23524242|NCT01203072|65657871|FG002|Overall Study|Lack of Efficacy|0|||
23524243|NCT01203072|65657872|FG003|Overall Study|Lack of Efficacy|0|||
23524244|NCT01203072|65657873|FG004|Overall Study|Lack of Efficacy|0|||
23524245|NCT01203072|65657869|FG000|Overall Study|Lost to Follow-up|0|||
23524246|NCT01203072|65657870|FG001|Overall Study|Lost to Follow-up|1|||
23524247|NCT01203072|65657871|FG002|Overall Study|Lost to Follow-up|0|||
23524248|NCT01203072|65657872|FG003|Overall Study|Lost to Follow-up|0|||
23524249|NCT01203072|65657873|FG004|Overall Study|Lost to Follow-up|0|||
23524250|NCT01203072|65657869|FG000|Overall Study|Protocol Violation|2|||
23524251|NCT01203072|65657870|FG001|Overall Study|Protocol Violation|0|||
23524252|NCT01203072|65657871|FG002|Overall Study|Protocol Violation|0|||
23524253|NCT01203072|65657872|FG003|Overall Study|Protocol Violation|0|||
23524254|NCT01203072|65657873|FG004|Overall Study|Protocol Violation|1|||
23524255|NCT01203072|65657869|FG000|Overall Study|Withdrawal by Subject|2|||
23524256|NCT01203072|65657870|FG001|Overall Study|Withdrawal by Subject|2|||
23524257|NCT01203072|65657871|FG002|Overall Study|Withdrawal by Subject|1|||
23524258|NCT01203072|65657872|FG003|Overall Study|Withdrawal by Subject|2|||
23524259|NCT01203072|65657873|FG004|Overall Study|Withdrawal by Subject|3|||
23524260|NCT01072201|65657874|FG000|Overall Study|Lost to Follow-up|0|||
23524261|NCT01072201|65657875|FG001|Overall Study|Lost to Follow-up|1|||
23524262|NCT00439556|65657890|FG000|Overall Study|Patient was taken off study for non-comp|0|||
23524263|NCT00439556|65657891|FG001|Overall Study|Patient was taken off study for non-comp|1|||
23524264|NCT00439556|65657892|FG002|Overall Study|Patient was taken off study for non-comp|0|||
23417015|NCT04848220|65271410|FG001|Overall Study|Unable to proceed to study procedure|1|||
23417016|NCT04848220|65271411|FG002|Overall Study|Unable to proceed to study procedure|0|||
23417017|NCT04848220|65271409|FG000|Overall Study|Fractional flow not significant|0|||
23417018|NCT04848220|65271410|FG001|Overall Study|Fractional flow not significant|1|||
23417019|NCT04848220|65271411|FG002|Overall Study|Fractional flow not significant|0|||
23417020|NCT02545517|65271412|FG000|Overall Study|Death|2|||
23417021|NCT02545517|65271413|FG001|Overall Study|Death|2|||
23417022|NCT02545517|65271414|FG002|Overall Study|Death|1|||
23417023|NCT02545517|65271412|FG000|Overall Study|Lost to Follow-up|14|||
23417024|NCT02545517|65271413|FG001|Overall Study|Lost to Follow-up|13|||
23417025|NCT02545517|65271414|FG002|Overall Study|Lost to Follow-up|17|||
23417026|NCT02545517|65271412|FG000|Overall Study|Protocol Violation|0|||
23417027|NCT02545517|65271413|FG001|Overall Study|Protocol Violation|1|||
23417028|NCT02545517|65271414|FG002|Overall Study|Protocol Violation|1|||
23417029|NCT02545517|65271412|FG000|Overall Study|Withdrawal by Subject|5|||
23417030|NCT02545517|65271413|FG001|Overall Study|Withdrawal by Subject|8|||
23417031|NCT02545517|65271414|FG002|Overall Study|Withdrawal by Subject|9|||
23417032|NCT02545517|65271412|FG000|Overall Study|Administrative reason|5|||
23417033|NCT02545517|65271413|FG001|Overall Study|Administrative reason|6|||
23417034|NCT02545517|65271414|FG002|Overall Study|Administrative reason|10|||
23524265|NCT00449644|65657896|FG000|Overall Study|Adverse Event|0|||
23417035|NCT02545517|65271412|FG000|Overall Study|Other|2|||
23417036|NCT02545517|65271413|FG001|Overall Study|Other|4|||
23417037|NCT02545517|65271414|FG002|Overall Study|Other|3|||
23524266|NCT00449644|65657897|FG001|Overall Study|Adverse Event|0|||
23524267|NCT00449644|65657898|FG002|Overall Study|Adverse Event|3|||
23524268|NCT00449644|65657899|FG003|Overall Study|Adverse Event|5|||
23524269|NCT00449644|65657896|FG000|Overall Study|Death|1|||
23524270|NCT00449644|65657897|FG001|Overall Study|Death|0|||
23524271|NCT00449644|65657898|FG002|Overall Study|Death|6|||
23524272|NCT00449644|65657899|FG003|Overall Study|Death|1|||
23524273|NCT00449644|65657896|FG000|Overall Study|Lost to Follow-up|1|||
23524274|NCT00449644|65657897|FG001|Overall Study|Lost to Follow-up|1|||
23524275|NCT00449644|65657898|FG002|Overall Study|Lost to Follow-up|5|||
23524276|NCT00449644|65657899|FG003|Overall Study|Lost to Follow-up|3|||
23524277|NCT00449644|65657896|FG000|Overall Study|Pregnancy|0|||
23524278|NCT00449644|65657897|FG001|Overall Study|Pregnancy|0|||
23524279|NCT00449644|65657898|FG002|Overall Study|Pregnancy|3|||
23524280|NCT00449644|65657899|FG003|Overall Study|Pregnancy|2|||
23524281|NCT00449644|65657896|FG000|Overall Study|Protocol Violation|4|||
23524282|NCT00449644|65657897|FG001|Overall Study|Protocol Violation|4|||
23524283|NCT00449644|65657898|FG002|Overall Study|Protocol Violation|3|||
23524284|NCT00449644|65657899|FG003|Overall Study|Protocol Violation|7|||
23524285|NCT00449644|65657896|FG000|Overall Study|Withdrawal by Subject|3|||
23524286|NCT00449644|65657897|FG001|Overall Study|Withdrawal by Subject|4|||
23524287|NCT00449644|65657898|FG002|Overall Study|Withdrawal by Subject|6|||
23524288|NCT00449644|65657899|FG003|Overall Study|Withdrawal by Subject|7|||
23524289|NCT00449644|65657896|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
23524290|NCT00449644|65657897|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
23524291|NCT00449644|65657898|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
23524292|NCT00449644|65657899|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
23524293|NCT00449644|65657896|FG000|Overall Study|Other|1|||
23524294|NCT00449644|65657897|FG001|Overall Study|Other|4|||
23524295|NCT00449644|65657898|FG002|Overall Study|Other|1|||
23524296|NCT00449644|65657899|FG003|Overall Study|Other|0|||
23524297|NCT00449644|65657896|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
23524298|NCT00449644|65657897|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
23524299|NCT00449644|65657898|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
23524300|NCT00449644|65657899|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
23524301|NCT04536727|65657900|FG000|Overall Study|Lost to Follow-up|1|||
23524302|NCT04536727|65657901|FG001|Overall Study|Lost to Follow-up|1|||
23524303|NCT04536727|65657900|FG000|Overall Study|Death|0|||
23524304|NCT04536727|65657901|FG001|Overall Study|Death|1|||
23524305|NCT02731729|65657902|FG000|Overall Study|Death|2|||
23524306|NCT02731729|65657903|FG001|Overall Study|Death|2|||
23524307|NCT02731729|65657902|FG000|Overall Study|Study terminated by Sponsor|6|||
23524308|NCT02731729|65657903|FG001|Overall Study|Study terminated by Sponsor|6|||
23524309|NCT02731729|65657902|FG000|Overall Study|Withdrawal by Subject|1|||
23524310|NCT02731729|65657903|FG001|Overall Study|Withdrawal by Subject|0|||
23524311|NCT01342510|65657904|FG000|Overall Study|Protocol Violation|12|||
23524312|NCT01342510|65657905|FG001|Overall Study|Protocol Violation|6|||
23524313|NCT01342510|65657906|FG002|Overall Study|Protocol Violation|13|||
23524314|NCT01342510|65657907|FG003|Overall Study|Protocol Violation|11|||
23524315|NCT02196324|65657910|FG000|Overall Study|Withdrawal by Subject|8|||
23524316|NCT02196324|65657911|FG001|Overall Study|Withdrawal by Subject|4|||
23524317|NCT02196324|65657910|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
23524318|NCT02196324|65657911|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
23524319|NCT02196324|65657910|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
23524320|NCT02196324|65657911|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
23524321|NCT02196324|65657910|FG000|Overall Study|Other|1|||
23524322|NCT02196324|65657911|FG001|Overall Study|Other|0|||
23524323|NCT00116831|65657912|FG000|Overall Study|Adverse Event|14|||
23524324|NCT00116831|65657913|FG001|Overall Study|Adverse Event|16|||
23524325|NCT00116831|65657912|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
23524326|NCT00116831|65657913|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
23524327|NCT00116831|65657912|FG000|Overall Study|Lost to Follow-up|8|||
23524328|NCT00116831|65657913|FG001|Overall Study|Lost to Follow-up|6|||
23524329|NCT00116831|65657912|FG000|Overall Study|Protocol Violation|3|||
23524330|NCT00116831|65657913|FG001|Overall Study|Protocol Violation|6|||
23524331|NCT00116831|65657912|FG000|Overall Study|Hypoglycaemic events|1|||
23524332|NCT00116831|65657913|FG001|Overall Study|Hypoglycaemic events|0|||
23524333|NCT00116831|65657912|FG000|Overall Study|Low haemoglobin on screening|1|||
23524334|NCT00116831|65657913|FG001|Overall Study|Low haemoglobin on screening|0|||
23524335|NCT00116831|65657912|FG000|Overall Study|Withdrawn investigational product|1|||
23524336|NCT00116831|65657913|FG001|Overall Study|Withdrawn investigational product|0|||
23524337|NCT00116831|65657912|FG000|Overall Study|Withdrawal by Subject|32|||
23524338|NCT00116831|65657913|FG001|Overall Study|Withdrawal by Subject|32|||
23524339|NCT00116831|65657912|FG000|Overall Study|Insufficient therapeutic effect|0|||
23524340|NCT00116831|65657913|FG001|Overall Study|Insufficient therapeutic effect|1|||
23524341|NCT00116831|65657912|FG000|Overall Study|Missing data for participant|1|||
23524342|NCT00116831|65657913|FG001|Overall Study|Missing data for participant|0|||
23524343|NCT01275066|65657914|FG000|Overall Study|Withdrawal by Subject|0|||
23524344|NCT01275066|65657915|FG001|Overall Study|Withdrawal by Subject|0|||
23524345|NCT01275066|65657916|FG002|Overall Study|Withdrawal by Subject|1|||
23524346|NCT01275066|65657914|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
23524347|NCT01275066|65657915|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
23524348|NCT01275066|65657916|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
23524349|NCT03711162|65657917|FG000|Overall Study|Adverse Event|5|||
23524350|NCT03711162|65657918|FG001|Overall Study|Adverse Event|2|||
23524351|NCT03711162|65657919|FG002|Overall Study|Adverse Event|4|||
23524352|NCT03711162|65657917|FG000|Overall Study|Death|11|||
23524353|NCT03711162|65657918|FG001|Overall Study|Death|7|||
23524354|NCT03711162|65657919|FG002|Overall Study|Death|8|||
23524355|NCT03711162|65657917|FG000|Overall Study|Lost to Follow-up|1|||
23524356|NCT03711162|65657918|FG001|Overall Study|Lost to Follow-up|0|||
23524357|NCT03711162|65657919|FG002|Overall Study|Lost to Follow-up|1|||
23524358|NCT03711162|65657917|FG000|Overall Study|Study Terminated by Sponsor|139|||
23524359|NCT03711162|65657918|FG001|Overall Study|Study Terminated by Sponsor|152|||
23524360|NCT03711162|65657919|FG002|Overall Study|Study Terminated by Sponsor|146|||
23524361|NCT03711162|65657917|FG000|Overall Study|Withdrawal by Subject|17|||
23524362|NCT03711162|65657918|FG001|Overall Study|Withdrawal by Subject|10|||
23524363|NCT03711162|65657919|FG002|Overall Study|Withdrawal by Subject|10|||
23524364|NCT03711162|65657917|FG000|Overall Study|Miscellaneous|1|||
23524365|NCT03711162|65657918|FG001|Overall Study|Miscellaneous|2|||
23524366|NCT03711162|65657919|FG002|Overall Study|Miscellaneous|2|||
23524367|NCT03711162|65657917|FG000|Overall Study|Not Treated|1|||
23524368|NCT03711162|65657918|FG001|Overall Study|Not Treated|0|||
23524369|NCT03711162|65657919|FG002|Overall Study|Not Treated|1|||
23524370|NCT03711162|65657917|FG000|Overall Study|Physician Decision|0|||
23524371|NCT03711162|65657918|FG001|Overall Study|Physician Decision|2|||
23524372|NCT03711162|65657919|FG002|Overall Study|Physician Decision|0|||
23524373|NCT03711162|65657917|FG000|Overall Study|Lack of Efficacy|0|||
23524374|NCT03711162|65657918|FG001|Overall Study|Lack of Efficacy|0|||
23524375|NCT03711162|65657919|FG002|Overall Study|Lack of Efficacy|2|||
23524376|NCT03711162|65657917|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
23524377|NCT03711162|65657918|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
23524378|NCT03711162|65657919|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
23524379|NCT03240133|65657920|FG000|Overall Study|Withdrawal by Subject|0|||
23524380|NCT03240133|65657921|FG001|Overall Study|Withdrawal by Subject|1|||
23524381|NCT03240133|65657922|FG002|Overall Study|Withdrawal by Subject|0|||
23524382|NCT03240133|65657920|FG000|Overall Study|Adverse Event|1|||
23524383|NCT03240133|65657921|FG001|Overall Study|Adverse Event|1|||
23524384|NCT03240133|65657922|FG002|Overall Study|Adverse Event|0|||
23524385|NCT03240133|65657920|FG000|Overall Study|Rash|1|||
23524386|NCT03240133|65657921|FG001|Overall Study|Rash|0|||
23524387|NCT03240133|65657922|FG002|Overall Study|Rash|0|||
23524388|NCT03240133|65657920|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
23524389|NCT03240133|65657921|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
23524390|NCT03240133|65657922|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
23524391|NCT03240133|65657920|FG000|Overall Study|Intercurrent illness.|0|||
23205864|NCT00808249|64494743|FG002|Overall Study|Lost to Follow-up|3|||
23205865|NCT00808249|64494744|FG003|Overall Study|Lost to Follow-up|5|||
23205866|NCT00808249|64494741|FG000|Overall Study|Withdrawal by Subject|4|||
23205867|NCT00808249|64494742|FG001|Overall Study|Withdrawal by Subject|0|||
23205868|NCT00808249|64494743|FG002|Overall Study|Withdrawal by Subject|2|||
23205869|NCT00808249|64494744|FG003|Overall Study|Withdrawal by Subject|4|||
23205870|NCT00808249|64494741|FG000|Overall Study|Protocol Violation|3|||
23205871|NCT00808249|64494742|FG001|Overall Study|Protocol Violation|3|||
23524392|NCT03240133|65657921|FG001|Overall Study|Intercurrent illness.|1|||
23524393|NCT03240133|65657922|FG002|Overall Study|Intercurrent illness.|0|||
23524394|NCT03240133|65657920|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
23524395|NCT03240133|65657921|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
23524396|NCT03240133|65657922|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
23524397|NCT02321462|65657925|FG000|Overall Study|Withdrawal by Subject|5|||
23524398|NCT02321462|65657926|FG001|Overall Study|Withdrawal by Subject|2|||
23524399|NCT02321462|65657925|FG000|Overall Study|Subject withdrawn before any treatment|1|||
23524400|NCT02321462|65657926|FG001|Overall Study|Subject withdrawn before any treatment|1|||
23524401|NCT00856908|65657927|FG000|Overall Study|Lost to Follow-up|1|||
23524402|NCT00856908|65657928|FG001|Overall Study|Lost to Follow-up|0|||
23205872|NCT00808249|64494743|FG002|Overall Study|Protocol Violation|3|||
23205873|NCT00808249|64494744|FG003|Overall Study|Protocol Violation|0|||
23524403|NCT02603432|65657930|FG000|Overall Study|Adverse Event|1|||
23524404|NCT02603432|65657931|FG001|Overall Study|Adverse Event|0|||
23524405|NCT02603432|65657930|FG000|Overall Study|Death|221|||
23205874|NCT00808249|64494741|FG000|Overall Study|Lack of Efficacy|1|||
23308355|NCT01212588|64874081|FG000|Overall Study|Physician Decision|0|||
23205875|NCT00808249|64494742|FG001|Overall Study|Lack of Efficacy|1|||
23524406|NCT02603432|65657931|FG001|Overall Study|Death|242|||
23524407|NCT02603432|65657930|FG000|Overall Study|Lost to Follow-up|3|||
23524408|NCT02603432|65657931|FG001|Overall Study|Lost to Follow-up|9|||
23524409|NCT02603432|65657930|FG000|Overall Study|Progressive Disease|7|||
23524410|NCT02603432|65657931|FG001|Overall Study|Progressive Disease|5|||
23524411|NCT02603432|65657930|FG000|Overall Study|Withdrawal by Subject|12|||
23524412|NCT02603432|65657931|FG001|Overall Study|Withdrawal by Subject|18|||
23524413|NCT02603432|65657930|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
23524414|NCT02603432|65657931|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23524415|NCT02603432|65657930|FG000|Overall Study|Study terminated by sponsor|74|||
23524416|NCT02603432|65657931|FG001|Overall Study|Study terminated by sponsor|75|||
23524417|NCT02603432|65657930|FG000|Overall Study|Other|13|||
23524418|NCT02603432|65657931|FG001|Overall Study|Other|0|||
23524419|NCT04220411|65657932|FG000|Overall Study|Adverse Event|0|||
23524420|NCT04220411|65657933|FG001|Overall Study|Adverse Event|0|||
23524421|NCT04220411|65657934|FG002|Overall Study|Adverse Event|0|||
23524422|NCT04220411|65657935|FG003|Overall Study|Adverse Event|1|||
23524423|NCT02563028|65657936|FG000|Overall Study|Lack of equipment|1|||
23524424|NCT02563028|65657936|FG000|Overall Study|Unable to elicit VEP post induction|1|||
23524425|NCT01339390|65657937|FG000|Overall Study|Death|32|||
23524426|NCT01339390|65657938|FG001|Overall Study|Death|29|||
23524427|NCT01339390|65657937|FG000|Overall Study|Lost to Follow-up|125|||
23524428|NCT01339390|65657938|FG001|Overall Study|Lost to Follow-up|127|||
23524429|NCT02529137|65657941|FG000|Overall Study|Discontinuation for different reasons|8|||
23524430|NCT00907374|65657949|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
23524431|NCT00907374|65657950|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
23524432|NCT02488681|65657955|FG000|Overall Study|Implant unsuccessful|7|||
23308356|NCT01212588|64874082|FG001|Overall Study|Physician Decision|1|||
23308357|NCT01212588|64874081|FG000|Overall Study|Protocol Violation|1|||
23308358|NCT01212588|64874082|FG001|Overall Study|Protocol Violation|1|||
23308359|NCT00117325|64874083|FG000|Overall Study|Adverse Event|3|||
23308360|NCT00117325|64874084|FG001|Overall Study|Adverse Event|3|||
23524433|NCT01706003|65657964|FG000|Overall Study|Withdrawal by Subject|2|||
23524434|NCT01706003|65657965|FG001|Overall Study|Withdrawal by Subject|0|||
23524435|NCT01706003|65657964|FG000|Overall Study|Not scheduled|3|||
23524436|NCT01706003|65657965|FG001|Overall Study|Not scheduled|0|||
23524437|NCT01706003|65657964|FG000|Overall Study|Lost to Follow-up|6|||
23524438|NCT01706003|65657965|FG001|Overall Study|Lost to Follow-up|4|||
23524439|NCT03338062|65657966|FG000|Overall Study|Alternative Therapy|1|||
23524440|NCT03338062|65657967|FG001|Overall Study|Alternative Therapy|0|||
23524441|NCT04033159|65657968|FG000|Washout Period|Physician Decision|0|||
23524442|NCT04033159|65657969|FG001|Washout Period|Physician Decision|1|||
23524443|NCT04033159|65657970|FG002|Washout Period|Physician Decision|0|||
23524444|NCT04033159|65657968|FG000|Washout Period|Study terminated by Sponsor|0|||
23524445|NCT04033159|65657969|FG001|Washout Period|Study terminated by Sponsor|7|||
23524446|NCT04033159|65657970|FG002|Washout Period|Study terminated by Sponsor|0|||
23524447|NCT04033159|65657968|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
23524448|NCT04033159|65657969|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
23524449|NCT04033159|65657970|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
23524450|NCT03336216|65657971|FG000|Randomization|Not reported|2|||
23524451|NCT03336216|65657972|FG001|Randomization|Not reported|0|||
23524452|NCT03336216|65657973|FG002|Randomization|Not reported|1|||
23524453|NCT03336216|65657974|FG003|Randomization|Not reported|0|||
23524454|NCT03336216|65657971|FG000|Randomization|Other reasons|1|||
23524455|NCT03336216|65657972|FG001|Randomization|Other reasons|1|||
23524456|NCT03336216|65657973|FG002|Randomization|Other reasons|1|||
23524457|NCT03336216|65657974|FG003|Randomization|Other reasons|0|||
23524458|NCT03336216|65657971|FG000|Randomization|Participant no longer meets study criteria|0|||
23524459|NCT03336216|65657972|FG001|Randomization|Participant no longer meets study criteria|2|||
23205876|NCT00808249|64494743|FG002|Overall Study|Lack of Efficacy|0|||
23308361|NCT00117325|64874083|FG000|Overall Study|Lost to Follow-up|1|||
23308362|NCT00117325|64874084|FG001|Overall Study|Lost to Follow-up|1|||
23308363|NCT00117325|64874083|FG000|Overall Study|Protocol Violation|2|||
23308364|NCT00117325|64874084|FG001|Overall Study|Protocol Violation|3|||
23308365|NCT00117325|64874083|FG000|Overall Study|Withdrawal by Subject|3|||
23308366|NCT00117325|64874084|FG001|Overall Study|Withdrawal by Subject|2|||
23308367|NCT00117325|64874083|FG000|Overall Study|Lack of Efficacy|1|||
23308368|NCT00117325|64874084|FG001|Overall Study|Lack of Efficacy|0|||
23524460|NCT03336216|65657973|FG002|Randomization|Participant no longer meets study criteria|4|||
23308369|NCT00117325|64874083|FG000|Overall Study|Use of prohibited medicine|1|||
23524461|NCT03336216|65657974|FG003|Randomization|Participant no longer meets study criteria|1|||
23524462|NCT03336216|65657971|FG000|Randomization|Lost to Follow-up|1|||
23524463|NCT03336216|65657972|FG001|Randomization|Lost to Follow-up|0|||
23524464|NCT03336216|65657973|FG002|Randomization|Lost to Follow-up|0|||
23524465|NCT03336216|65657974|FG003|Randomization|Lost to Follow-up|0|||
23524466|NCT03336216|65657971|FG000|Randomization|Participant withdrew consent|9|||
23524467|NCT03336216|65657972|FG001|Randomization|Participant withdrew consent|1|||
23524468|NCT03336216|65657973|FG002|Randomization|Participant withdrew consent|0|||
23308370|NCT00117325|64874084|FG001|Overall Study|Use of prohibited medicine|2|||
23308371|NCT00117325|64874083|FG000|Overall Study|Early termination|1|||
23308372|NCT00117325|64874084|FG001|Overall Study|Early termination|1|||
23308373|NCT00117325|64874083|FG000|Overall Study|Admisnitrative|1|||
23308374|NCT00117325|64874084|FG001|Overall Study|Admisnitrative|0|||
23308375|NCT01195103|64874085|FG000|Overall Study|Withdrawal by Subject|1|||
23308376|NCT01195103|64874086|FG001|Overall Study|Withdrawal by Subject|0|||
23308377|NCT01195103|64874087|FG002|Overall Study|Withdrawal by Subject|0|||
23308378|NCT00780910|64874090|FG000|Overall Study|Adverse Event|2|||
23308379|NCT00655876|64874095|FG000|Overall Study|Protocol Violation|9|||
23308380|NCT00655876|64874096|FG001|Overall Study|Protocol Violation|7|||
23308381|NCT00394524|64874098|FG000|Overall Study|Protocol Violation|2|||
23308382|NCT00394524|64874099|FG001|Overall Study|Protocol Violation|3|||
23308383|NCT00394524|64874098|FG000|Overall Study|Death|1|||
23308384|NCT00394524|64874099|FG001|Overall Study|Death|0|||
23308385|NCT00394524|64874098|FG000|Overall Study|Withdrawal by Subject|0|||
23308386|NCT00394524|64874099|FG001|Overall Study|Withdrawal by Subject|1|||
23308387|NCT02140411|64874100|FG000|Overall Study|Adverse Event|1|||
23308388|NCT03822832|64874106|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
23308389|NCT03822832|64874107|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
23308390|NCT03822832|64874106|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
23308391|NCT03822832|64874107|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
23308392|NCT03822832|64874106|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
23308393|NCT03822832|64874107|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
23308394|NCT03822832|64874106|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
23308395|NCT03822832|64874107|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
23308396|NCT03822832|64874106|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
23308397|NCT03822832|64874107|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
23308398|NCT03822832|64874106|FG000|Re-allocation|Not re-allocated to open label period|2|||
23308399|NCT03822832|64874107|FG001|Re-allocation|Not re-allocated to open label period|6|||
23308400|NCT03822832|64874106|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
23308401|NCT03822832|64874107|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
23308402|NCT03822832|64874106|FG000|Period 2 - Open Label Period|Adverse Event|0|||
23308403|NCT03822832|64874107|FG001|Period 2 - Open Label Period|Adverse Event|3|||
23308404|NCT04431726|64874108|FG000|Overall Study|Ongoing in the Study|55|||
23308405|NCT00893737|64874111|FG000|Overall Study|Adverse Event|4|||
23308406|NCT00893737|64874111|FG000|Overall Study|Withdrawal by Subject|2|||
23308407|NCT00893737|64874111|FG000|Overall Study|Lost to Follow-up|6|||
23308408|NCT00369317|64874112|FG000|Overall Study|Adverse Event|3|||
23308409|NCT00369317|64874112|FG000|Overall Study|Death|1|||
23308410|NCT00369317|64874112|FG000|Overall Study|Lack of Efficacy|5|||
23308411|NCT00369317|64874112|FG000|Overall Study|Physician Decision|2|||
23308412|NCT00369317|64874112|FG000|Overall Study|Withdrawal by Subject|8|||
23308413|NCT00369317|64874112|FG000|Overall Study|Ineligible|1|||
23308414|NCT01359969|64874115|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
23308415|NCT04268316|64874117|FG000|Overall Study|Withdrawal by Subject|2|||
23308416|NCT04268316|64874118|FG001|Overall Study|Withdrawal by Subject|1|||
23308417|NCT04268316|64874119|FG002|Overall Study|Withdrawal by Subject|0|||
23308418|NCT01154816|64874120|FG000|Overall Study|Withdrawal by Subject|1|||
23308419|NCT01154816|64874121|FG001|Overall Study|Withdrawal by Subject|0|||
23205877|NCT00808249|64494744|FG003|Overall Study|Lack of Efficacy|0|||
23308420|NCT01154816|64874122|FG002|Overall Study|Withdrawal by Subject|0|||
23308421|NCT01154816|64874123|FG003|Overall Study|Withdrawal by Subject|1|||
23308422|NCT01154816|64874124|FG004|Overall Study|Withdrawal by Subject|0|||
23308423|NCT01154816|64874125|FG005|Overall Study|Withdrawal by Subject|0|||
23308424|NCT01154816|64874126|FG006|Overall Study|Withdrawal by Subject|0|||
23308425|NCT01154816|64874127|FG007|Overall Study|Withdrawal by Subject|0|||
23308426|NCT01154816|64874128|FG008|Overall Study|Withdrawal by Subject|1|||
23308427|NCT01154816|64874129|FG009|Overall Study|Withdrawal by Subject|3|||
23417038|NCT01814878|65271415|FG000|Overall Study|Adverse Event|16|||
23308428|NCT01154816|64874130|FG010|Overall Study|Withdrawal by Subject|0|||
23524469|NCT03336216|65657974|FG003|Randomization|Participant withdrew consent|0|||
23524470|NCT03336216|65657971|FG000|Randomization|Adverse Event|1|||
23524471|NCT03336216|65657972|FG001|Randomization|Adverse Event|1|||
23524472|NCT03336216|65657973|FG002|Randomization|Adverse Event|0|||
23524473|NCT03336216|65657974|FG003|Randomization|Adverse Event|0|||
23524474|NCT03336216|65657971|FG000|Treatment|Adverse Event|2|||
23524475|NCT03336216|65657972|FG001|Treatment|Adverse Event|3|||
23524476|NCT03336216|65657973|FG002|Treatment|Adverse Event|4|||
23524477|NCT03336216|65657974|FG003|Treatment|Adverse Event|4|||
23524478|NCT03336216|65657971|FG000|Treatment|Participant request to discontinue treatment|2|||
23524479|NCT03336216|65657972|FG001|Treatment|Participant request to discontinue treatment|1|||
23524480|NCT03336216|65657973|FG002|Treatment|Participant request to discontinue treatment|2|||
23524481|NCT03336216|65657974|FG003|Treatment|Participant request to discontinue treatment|2|||
23524482|NCT03336216|65657971|FG000|Treatment|Participant withdrew consent|7|||
23524483|NCT03336216|65657972|FG001|Treatment|Participant withdrew consent|2|||
23524484|NCT03336216|65657973|FG002|Treatment|Participant withdrew consent|3|||
23524485|NCT03336216|65657974|FG003|Treatment|Participant withdrew consent|2|||
23524486|NCT03336216|65657971|FG000|Treatment|Death|2|||
23524487|NCT03336216|65657972|FG001|Treatment|Death|3|||
23524488|NCT03336216|65657973|FG002|Treatment|Death|3|||
23524489|NCT03336216|65657974|FG003|Treatment|Death|4|||
23308429|NCT01154816|64874131|FG011|Overall Study|Withdrawal by Subject|0|||
23308430|NCT01154816|64874120|FG000|Overall Study|Progressive Disease|13|||
23308431|NCT01154816|64874121|FG001|Overall Study|Progressive Disease|8|||
23308432|NCT01154816|64874122|FG002|Overall Study|Progressive Disease|9|||
23308433|NCT01154816|64874123|FG003|Overall Study|Progressive Disease|9|||
23308434|NCT01154816|64874124|FG004|Overall Study|Progressive Disease|8|||
23308435|NCT01154816|64874125|FG005|Overall Study|Progressive Disease|8|||
23308436|NCT01154816|64874126|FG006|Overall Study|Progressive Disease|5|||
23308437|NCT01154816|64874127|FG007|Overall Study|Progressive Disease|6|||
23308438|NCT01154816|64874128|FG008|Overall Study|Progressive Disease|8|||
23308439|NCT01154816|64874129|FG009|Overall Study|Progressive Disease|6|||
23308440|NCT01154816|64874130|FG010|Overall Study|Progressive Disease|10|||
23308441|NCT01154816|64874131|FG011|Overall Study|Progressive Disease|3|||
23308442|NCT01154816|64874120|FG000|Overall Study|Physician Decision|1|||
23308443|NCT01154816|64874121|FG001|Overall Study|Physician Decision|0|||
23308444|NCT01154816|64874122|FG002|Overall Study|Physician Decision|1|||
23308445|NCT01154816|64874123|FG003|Overall Study|Physician Decision|0|||
23308446|NCT01154816|64874124|FG004|Overall Study|Physician Decision|2|||
23308447|NCT01154816|64874125|FG005|Overall Study|Physician Decision|0|||
23308448|NCT01154816|64874126|FG006|Overall Study|Physician Decision|0|||
23308449|NCT01154816|64874127|FG007|Overall Study|Physician Decision|0|||
23308450|NCT01154816|64874128|FG008|Overall Study|Physician Decision|0|||
23308451|NCT01154816|64874129|FG009|Overall Study|Physician Decision|1|||
23524490|NCT03336216|65657971|FG000|Treatment|Participant no longer meets study criteria|0|||
23524491|NCT03336216|65657972|FG001|Treatment|Participant no longer meets study criteria|1|||
23524492|NCT03336216|65657973|FG002|Treatment|Participant no longer meets study criteria|0|||
23524493|NCT03336216|65657974|FG003|Treatment|Participant no longer meets study criteria|0|||
23308452|NCT01154816|64874130|FG010|Overall Study|Physician Decision|1|||
23308453|NCT01154816|64874131|FG011|Overall Study|Physician Decision|1|||
23308454|NCT01154816|64874120|FG000|Overall Study|Adverse Event|5|||
23308455|NCT01154816|64874121|FG001|Overall Study|Adverse Event|2|||
23308456|NCT01154816|64874122|FG002|Overall Study|Adverse Event|0|||
23308457|NCT01154816|64874123|FG003|Overall Study|Adverse Event|0|||
23308458|NCT01154816|64874124|FG004|Overall Study|Adverse Event|0|||
23524494|NCT03336216|65657971|FG000|Treatment|Other reasons|2|||
23524495|NCT03336216|65657972|FG001|Treatment|Other reasons|0|||
23524496|NCT03336216|65657973|FG002|Treatment|Other reasons|0|||
23524497|NCT03336216|65657974|FG003|Treatment|Other reasons|3|||
23524498|NCT03336216|65657971|FG000|Treatment|Disease progression|23|||
23524499|NCT03336216|65657972|FG001|Treatment|Disease progression|34|||
23524500|NCT03336216|65657973|FG002|Treatment|Disease progression|33|||
23524501|NCT03336216|65657974|FG003|Treatment|Disease progression|26|||
23524502|NCT03336216|65657971|FG000|Treatment|Study drug toxicity|0|||
23524503|NCT03336216|65657972|FG001|Treatment|Study drug toxicity|3|||
23524504|NCT03336216|65657973|FG002|Treatment|Study drug toxicity|2|||
23524505|NCT03336216|65657974|FG003|Treatment|Study drug toxicity|0|||
23524506|NCT03336216|65657971|FG000|Treatment|Adverse Event unrelated to study drug|1|||
23524507|NCT03336216|65657972|FG001|Treatment|Adverse Event unrelated to study drug|1|||
23308459|NCT01154816|64874125|FG005|Overall Study|Adverse Event|0|||
23308460|NCT01154816|64874126|FG006|Overall Study|Adverse Event|1|||
23308461|NCT01154816|64874127|FG007|Overall Study|Adverse Event|1|||
23308462|NCT01154816|64874128|FG008|Overall Study|Adverse Event|0|||
23308463|NCT01154816|64874129|FG009|Overall Study|Adverse Event|0|||
23308464|NCT01154816|64874130|FG010|Overall Study|Adverse Event|0|||
23308465|NCT01154816|64874131|FG011|Overall Study|Adverse Event|0|||
23308466|NCT00988442|64874132|FG000|Overall Study|Death|1|||
23308467|NCT00988442|64874133|FG001|Overall Study|Death|2|||
23308468|NCT00988442|64874132|FG000|Overall Study|Lost to Follow-up|0|||
23308469|NCT00988442|64874133|FG001|Overall Study|Lost to Follow-up|1|||
23308470|NCT00988442|64874132|FG000|Overall Study|Early Study Closure|29|||
23308471|NCT00988442|64874133|FG001|Overall Study|Early Study Closure|25|||
23308472|NCT01070771|64874134|FG000|Overall Study|Adverse Event|2|||
23308473|NCT01070771|64874134|FG000|Overall Study|Protocol Violation|1|||
23308474|NCT00724048|64874137|FG000|Overall Study|Adverse Event|1|||
23308475|NCT00724048|64874138|FG001|Overall Study|Adverse Event|1|||
23308476|NCT00724048|64874139|FG002|Overall Study|Adverse Event|1|||
23308477|NCT00724048|64874140|FG003|Overall Study|Adverse Event|0|||
23308478|NCT00724048|64874137|FG000|Overall Study|Lost to Follow-up|0|||
23308479|NCT00724048|64874138|FG001|Overall Study|Lost to Follow-up|1|||
23308480|NCT00724048|64874139|FG002|Overall Study|Lost to Follow-up|0|||
23308481|NCT00724048|64874140|FG003|Overall Study|Lost to Follow-up|0|||
23308482|NCT00724048|64874137|FG000|Overall Study|Withdrawal by Subject|1|||
23308483|NCT00724048|64874138|FG001|Overall Study|Withdrawal by Subject|2|||
23308484|NCT00724048|64874139|FG002|Overall Study|Withdrawal by Subject|1|||
23308485|NCT00724048|64874140|FG003|Overall Study|Withdrawal by Subject|2|||
23308486|NCT00724048|64874137|FG000|Overall Study|Investigator decision|0|||
23308487|NCT00724048|64874138|FG001|Overall Study|Investigator decision|0|||
23308488|NCT00724048|64874139|FG002|Overall Study|Investigator decision|1|||
23308489|NCT00724048|64874140|FG003|Overall Study|Investigator decision|0|||
23308490|NCT00724048|64874137|FG000|Overall Study|Did not tolerate study drug|0|||
23308491|NCT00724048|64874138|FG001|Overall Study|Did not tolerate study drug|0|||
23308492|NCT00724048|64874139|FG002|Overall Study|Did not tolerate study drug|0|||
23308493|NCT00724048|64874140|FG003|Overall Study|Did not tolerate study drug|1|||
23308494|NCT00724048|64874137|FG000|Overall Study|Other than specified|1|||
23308495|NCT00724048|64874138|FG001|Overall Study|Other than specified|1|||
23308496|NCT00724048|64874139|FG002|Overall Study|Other than specified|0|||
23308497|NCT00724048|64874140|FG003|Overall Study|Other than specified|0|||
23308498|NCT04620135|64874146|FG000|Study Completion|Adverse Event|2|||
23308499|NCT04620135|64874147|FG001|Study Completion|Adverse Event|3|||
23308500|NCT04620135|64874146|FG000|Study Completion|Withdrawal by Subject|2|||
23308501|NCT04620135|64874147|FG001|Study Completion|Withdrawal by Subject|0|||
23308502|NCT03310411|64874148|FG000|Period 1|Adverse Event|0|||
23308503|NCT03310411|64874149|FG001|Period 1|Adverse Event|0|||
23308504|NCT03310411|64874150|FG002|Period 1|Adverse Event|0|||
23524508|NCT03336216|65657973|FG002|Treatment|Adverse Event unrelated to study drug|1|||
23308505|NCT03310411|64874151|FG003|Period 1|Adverse Event|1|||
23308506|NCT02492880|64874152|FG000|Overall Study|Lost to Follow-up|1|||
23308507|NCT02492880|64874152|FG000|Overall Study|Protocol Violation|1|||
23308508|NCT00191113|64874154|FG000|Core Study|Withdrawal by Subject|25|||
23308509|NCT00191113|64874155|FG001|Core Study|Withdrawal by Subject|9|||
23308510|NCT00191113|64874154|FG000|Core Study|Protocol Violation|6|||
23308511|NCT00191113|64874155|FG001|Core Study|Protocol Violation|2|||
23308512|NCT00191113|64874154|FG000|Core Study|Lost to Follow-up|3|||
23524509|NCT03336216|65657974|FG003|Treatment|Adverse Event unrelated to study drug|0|||
23205878|NCT00808249|64494741|FG000|Overall Study|study specific discontinuation criteria|1|||
23205879|NCT00808249|64494742|FG001|Overall Study|study specific discontinuation criteria|0|||
23205880|NCT00808249|64494743|FG002|Overall Study|study specific discontinuation criteria|1|||
23205881|NCT00808249|64494744|FG003|Overall Study|study specific discontinuation criteria|0|||
23205882|NCT00808249|64494741|FG000|Overall Study|All other reasons|2|||
23205883|NCT00808249|64494742|FG001|Overall Study|All other reasons|1|||
23205884|NCT00808249|64494743|FG002|Overall Study|All other reasons|3|||
23205885|NCT00808249|64494744|FG003|Overall Study|All other reasons|1|||
23205886|NCT02045212|64494748|FG000|Overall Study|Adverse Event|0|||
23205887|NCT02045212|64494749|FG001|Overall Study|Adverse Event|1|||
23205888|NCT02045212|64494748|FG000|Overall Study|Withdrawal by Subject|1|||
23417039|NCT01814878|65271416|FG001|Overall Study|Adverse Event|5|||
23417040|NCT01814878|65271415|FG000|Overall Study|Withdrawal by Subject|20|||
23417041|NCT01814878|65271416|FG001|Overall Study|Withdrawal by Subject|16|||
23417042|NCT01814878|65271415|FG000|Overall Study|Protocol Violation|5|||
23205889|NCT02045212|64494749|FG001|Overall Study|Withdrawal by Subject|0|||
23205890|NCT02045212|64494748|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
23308513|NCT00191113|64874155|FG001|Core Study|Lost to Follow-up|0|||
23417043|NCT01814878|65271416|FG001|Overall Study|Protocol Violation|5|||
23524510|NCT03336216|65657971|FG000|Treatment|Disease Recurrence|1|||
23524511|NCT03336216|65657972|FG001|Treatment|Disease Recurrence|0|||
23205891|NCT02045212|64494749|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
23205892|NCT03151148|64494750|FG000|Overall Study|Lost to Follow-up|1|||
23308514|NCT00191113|64874154|FG000|Core Study|Adverse Event|0|||
23308515|NCT00191113|64874155|FG001|Core Study|Adverse Event|2|||
23308516|NCT00191113|64874154|FG000|Core Study|Lack of Efficacy|0|||
23308517|NCT00191113|64874155|FG001|Core Study|Lack of Efficacy|2|||
23417044|NCT01814878|65271415|FG000|Overall Study|Physician Decision|3|||
23205893|NCT03151148|64494751|FG001|Overall Study|Lost to Follow-up|0|||
23205894|NCT03151148|64494750|FG000|Overall Study|Withdrawal by Subject|1|||
23308518|NCT00191113|64874154|FG000|Core Study|Death|1|||
23308519|NCT00191113|64874155|FG001|Core Study|Death|0|||
23417045|NCT01814878|65271416|FG001|Overall Study|Physician Decision|1|||
23524512|NCT03336216|65657973|FG002|Treatment|Disease Recurrence|0|||
23524513|NCT03336216|65657974|FG003|Treatment|Disease Recurrence|0|||
23524514|NCT00903617|65657975|FG000|Overall Study|Adverse Event|0|||
23524515|NCT00903617|65657976|FG001|Overall Study|Adverse Event|1|||
23524516|NCT00903617|65657977|FG002|Overall Study|Adverse Event|1|||
23524517|NCT00903617|65657978|FG003|Overall Study|Adverse Event|0|||
23524518|NCT00903617|65657975|FG000|Overall Study|Protocol-defined stopping criteria|0|||
23524519|NCT00903617|65657976|FG001|Overall Study|Protocol-defined stopping criteria|2|||
23524520|NCT00903617|65657977|FG002|Overall Study|Protocol-defined stopping criteria|0|||
23524521|NCT00903617|65657978|FG003|Overall Study|Protocol-defined stopping criteria|0|||
23524522|NCT00903617|65657975|FG000|Overall Study|Lost to Follow-up|2|||
23524523|NCT00903617|65657976|FG001|Overall Study|Lost to Follow-up|0|||
23524524|NCT00903617|65657977|FG002|Overall Study|Lost to Follow-up|1|||
23524525|NCT00903617|65657978|FG003|Overall Study|Lost to Follow-up|1|||
23524526|NCT00903617|65657975|FG000|Overall Study|Withdrawal by Subject|1|||
23524527|NCT00903617|65657976|FG001|Overall Study|Withdrawal by Subject|2|||
23524528|NCT00903617|65657977|FG002|Overall Study|Withdrawal by Subject|3|||
23524529|NCT00903617|65657978|FG003|Overall Study|Withdrawal by Subject|0|||
23524530|NCT00969553|65657979|FG000|Overall Study|Progressive disease (PD)|2|||
23524531|NCT00969553|65657980|FG001|Overall Study|Progressive disease (PD)|2|||
23524532|NCT00969553|65657981|FG002|Overall Study|Progressive disease (PD)|6|||
23524533|NCT00969553|65657982|FG003|Overall Study|Progressive disease (PD)|9|||
23524534|NCT00969553|65657983|FG004|Overall Study|Progressive disease (PD)|2|||
23524535|NCT00969553|65657984|FG005|Overall Study|Progressive disease (PD)|4|||
23524536|NCT00969553|65657985|FG006|Overall Study|Progressive disease (PD)|2|||
23524537|NCT00969553|65657986|FG007|Overall Study|Progressive disease (PD)|12|||
23524538|NCT00969553|65657987|FG008|Overall Study|Progressive disease (PD)|3|||
23524539|NCT00969553|65657979|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524540|NCT00969553|65657980|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524541|NCT00969553|65657981|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524542|NCT00969553|65657982|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524543|NCT00969553|65657983|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
23524544|NCT00969553|65657984|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524545|NCT00969553|65657985|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524546|NCT00969553|65657986|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524547|NCT00969553|65657987|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
23524548|NCT00969553|65657979|FG000|Overall Study|Other Adverse Event|0|||
23524549|NCT00969553|65657980|FG001|Overall Study|Other Adverse Event|0|||
23524550|NCT00969553|65657981|FG002|Overall Study|Other Adverse Event|0|||
23524551|NCT00969553|65657982|FG003|Overall Study|Other Adverse Event|1|||
23524552|NCT00969553|65657983|FG004|Overall Study|Other Adverse Event|0|||
23524553|NCT00969553|65657984|FG005|Overall Study|Other Adverse Event|0|||
23524554|NCT00969553|65657985|FG006|Overall Study|Other Adverse Event|1|||
23524555|NCT00969553|65657986|FG007|Overall Study|Other Adverse Event|0|||
23524556|NCT00969553|65657987|FG008|Overall Study|Other Adverse Event|0|||
23524557|NCT00969553|65657979|FG000|Overall Study|Refused cont. medication|1|||
23524558|NCT00969553|65657980|FG001|Overall Study|Refused cont. medication|1|||
23524559|NCT00969553|65657981|FG002|Overall Study|Refused cont. medication|0|||
23524560|NCT00969553|65657982|FG003|Overall Study|Refused cont. medication|2|||
23524561|NCT00969553|65657983|FG004|Overall Study|Refused cont. medication|0|||
23524562|NCT00969553|65657984|FG005|Overall Study|Refused cont. medication|0|||
23524563|NCT00969553|65657985|FG006|Overall Study|Refused cont. medication|0|||
23524564|NCT00969553|65657986|FG007|Overall Study|Refused cont. medication|1|||
23524565|NCT00969553|65657987|FG008|Overall Study|Refused cont. medication|0|||
23524566|NCT00969553|65657979|FG000|Overall Study|Not specified above|0|||
23524567|NCT00969553|65657980|FG001|Overall Study|Not specified above|0|||
23524568|NCT00969553|65657981|FG002|Overall Study|Not specified above|0|||
23524569|NCT00969553|65657982|FG003|Overall Study|Not specified above|4|||
23524570|NCT00969553|65657983|FG004|Overall Study|Not specified above|0|||
23524571|NCT00969553|65657984|FG005|Overall Study|Not specified above|0|||
23524572|NCT00969553|65657985|FG006|Overall Study|Not specified above|1|||
23524573|NCT00969553|65657986|FG007|Overall Study|Not specified above|1|||
23524574|NCT00969553|65657987|FG008|Overall Study|Not specified above|0|||
23524575|NCT02515942|65657988|FG000|Overall Study|Adverse Event|5|||
23524576|NCT02515942|65657989|FG001|Overall Study|Adverse Event|0|||
23524577|NCT02515942|65657990|FG002|Overall Study|Adverse Event|0|||
23524578|NCT02515942|65657988|FG000|Overall Study|Death|0|||
23524579|NCT02515942|65657989|FG001|Overall Study|Death|0|||
23524580|NCT02515942|65657990|FG002|Overall Study|Death|1|||
23524581|NCT02515942|65657988|FG000|Overall Study|Lack of Efficacy|0|||
23524582|NCT02515942|65657989|FG001|Overall Study|Lack of Efficacy|0|||
23524583|NCT02515942|65657990|FG002|Overall Study|Lack of Efficacy|1|||
23524584|NCT02515942|65657988|FG000|Overall Study|Lost to Follow-up|2|||
23524585|NCT02515942|65657989|FG001|Overall Study|Lost to Follow-up|0|||
23524586|NCT02515942|65657990|FG002|Overall Study|Lost to Follow-up|0|||
23524587|NCT02515942|65657988|FG000|Overall Study|Withdrawal by Subject|0|||
23524588|NCT02515942|65657989|FG001|Overall Study|Withdrawal by Subject|3|||
23524589|NCT02515942|65657990|FG002|Overall Study|Withdrawal by Subject|2|||
23524590|NCT03551210|65657991|FG000|Overall Study|Adverse Event|5|||
23524591|NCT03551210|65657992|FG001|Overall Study|Adverse Event|6|||
23524592|NCT03551210|65657991|FG000|Overall Study|Withdrawal by Subject|1|||
23524593|NCT03551210|65657992|FG001|Overall Study|Withdrawal by Subject|7|||
23524594|NCT03551210|65657991|FG000|Overall Study|Needed in other antibiotic treatment|2|||
23524595|NCT03551210|65657992|FG001|Overall Study|Needed in other antibiotic treatment|5|||
23524596|NCT03551210|65657991|FG000|Overall Study|Lost to Follow-up|1|||
23524597|NCT03551210|65657992|FG001|Overall Study|Lost to Follow-up|1|||
23524598|NCT03551210|65657991|FG000|Overall Study|Absence of visit 4 and 5|1|||
23524599|NCT03551210|65657992|FG001|Overall Study|Absence of visit 4 and 5|0|||
23524600|NCT03551210|65657991|FG000|Overall Study|No drug for dispensing|0|||
23524601|NCT03551210|65657992|FG001|Overall Study|No drug for dispensing|1|||
23524602|NCT03913091|65661553|FG000|Overall Study|Lost to Follow-up|18|||
23524603|NCT03913091|65661554|FG001|Overall Study|Lost to Follow-up|11|||
23524604|NCT03913091|65661553|FG000|Overall Study|Required additional meds/surgery|1|||
23524605|NCT03913091|65661554|FG001|Overall Study|Required additional meds/surgery|2|||
23524606|NCT03913091|65661553|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
23524607|NCT03913091|65661554|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
23524608|NCT01158222|65661555|FG000|Overall Study|Not eligible for intermediate phase|17|||
23524609|NCT02350309|65661556|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524610|NCT02350309|65661557|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524611|NCT02350309|65661558|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
23524612|NCT02350309|65661559|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524613|NCT02350309|65661560|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524614|NCT02350309|65661561|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
23524615|NCT02350309|65661556|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524616|NCT02350309|65661557|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524617|NCT02350309|65661558|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524618|NCT02350309|65661559|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524619|NCT02350309|65661560|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
23524620|NCT02350309|65661561|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
23524621|NCT01364428|65661562|FG000|Overall Study|Adverse Event|1|||
23524622|NCT01364428|65661563|FG001|Overall Study|Adverse Event|2|||
23524623|NCT01364428|65661562|FG000|Overall Study|Protocol Violation|2|||
23308520|NCT02011386|64874156|FG000|Overall Study|Non-compliance|2|||
23308521|NCT02011386|64874156|FG000|Overall Study|Lack of Efficacy|3|||
23308522|NCT01189487|64874157|FG000|Overall Study|Lack of Efficacy|2|||
23308523|NCT01189487|64874157|FG000|Overall Study|Adverse Event|1|||
23308524|NCT03400943|64874163|FG000|Treatment Period 1|Adverse Event|0|||
23524624|NCT01364428|65661563|FG001|Overall Study|Protocol Violation|0|||
23524625|NCT01364428|65661562|FG000|Overall Study|Withdrawal Criteria|14|||
23308525|NCT03400943|64874164|FG001|Treatment Period 1|Adverse Event|0|||
23417046|NCT01814878|65271415|FG000|Overall Study|Screening failure (drop-out)|0|||
23524626|NCT01364428|65661563|FG001|Overall Study|Withdrawal Criteria|10|||
23524627|NCT01364428|65661562|FG000|Overall Study|Other|3|||
23524628|NCT01364428|65661563|FG001|Overall Study|Other|3|||
23524629|NCT00508742|65661564|FG000|Period 1: Infant Series|Adverse Event|5|||
23524630|NCT00508742|65661565|FG001|Period 1: Infant Series|Adverse Event|4|||
23524631|NCT00508742|65661564|FG000|Period 1: Infant Series|Protocol Violation|1|||
23524632|NCT00508742|65661565|FG001|Period 1: Infant Series|Protocol Violation|0|||
23524633|NCT00508742|65661564|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
23524634|NCT00508742|65661565|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
23524635|NCT00508742|65661564|FG000|Period 1: Infant Series|Physician Decision|1|||
23524636|NCT00508742|65661565|FG001|Period 1: Infant Series|Physician Decision|0|||
23524637|NCT00508742|65661564|FG000|Period 1: Infant Series|Other|4|||
23524638|NCT00508742|65661565|FG001|Period 1: Infant Series|Other|1|||
23524639|NCT00508742|65661564|FG000|Period 2: After Infant Series|Adverse Event|2|||
23524640|NCT00508742|65661565|FG001|Period 2: After Infant Series|Adverse Event|6|||
23524641|NCT00508742|65661564|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
23524642|NCT00508742|65661565|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
23524643|NCT00508742|65661564|FG000|Period 2: After Infant Series|Protocol Violation|1|||
23524644|NCT00508742|65661565|FG001|Period 2: After Infant Series|Protocol Violation|0|||
23524645|NCT00508742|65661564|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
23524646|NCT00508742|65661565|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
23524647|NCT00508742|65661564|FG000|Period 2: After Infant Series|Failed to Return|1|||
23524648|NCT00508742|65661565|FG001|Period 2: After Infant Series|Failed to Return|0|||
23524649|NCT00508742|65661564|FG000|Period 2: After Infant Series|Other|2|||
23524650|NCT00508742|65661565|FG001|Period 2: After Infant Series|Other|1|||
23524651|NCT00508742|65661564|FG000|Period 3: Toddler Dose|Adverse Event|1|||
23524652|NCT00508742|65661565|FG001|Period 3: Toddler Dose|Adverse Event|0|||
23524653|NCT00508742|65661564|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
23524654|NCT00508742|65661565|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
23524655|NCT00508742|65661564|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
23524656|NCT00508742|65661565|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
23524657|NCT00508742|65661564|FG000|Period 3: Toddler Dose|Other|5|||
23524658|NCT00508742|65661565|FG001|Period 3: Toddler Dose|Other|4|||
23524659|NCT01236755|65661568|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
23524660|NCT01236755|65661568|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
23524661|NCT01236755|65661568|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
23524662|NCT01236755|65661568|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
23524663|NCT01971346|65661569|FG000|Overall Study|Protocol Violation|3|||
23524664|NCT01971346|65661569|FG000|Overall Study|Lost to Follow-up|2|||
23524665|NCT01971346|65661569|FG000|Overall Study|Withdrawal by Subject|2|||
23524666|NCT01971346|65661569|FG000|Overall Study|Physician Decision|1|||
23524667|NCT03925324|65661570|FG000|Overall Study|Death|1|||
23524668|NCT03925324|65661571|FG001|Overall Study|Death|1|||
23524669|NCT01399593|65661574|FG000|Overall Study|Physician Decision|1|||
23524670|NCT01399593|65661575|FG001|Overall Study|Physician Decision|0|||
23524671|NCT01399593|65661574|FG000|Overall Study|Adverse Event|1|||
23524672|NCT01399593|65661575|FG001|Overall Study|Adverse Event|0|||
23524673|NCT01399593|65661574|FG000|Overall Study|Death|1|||
23524674|NCT01399593|65661575|FG001|Overall Study|Death|1|||
23524675|NCT01399593|65661574|FG000|Overall Study|Transplantectomy|0|||
23524676|NCT01399593|65661575|FG001|Overall Study|Transplantectomy|1|||
23524677|NCT00205712|65661576|FG000|Overall Study|Lost to Follow-up|0|||
23524678|NCT00205712|65661577|FG001|Overall Study|Lost to Follow-up|1|||
23524679|NCT01190254|65661580|FG000|Overall Study|Adverse Event|3|||
23524680|NCT01190254|65661581|FG001|Overall Study|Adverse Event|6|||
23524681|NCT01190254|65661582|FG002|Overall Study|Adverse Event|8|||
23524682|NCT01190254|65661580|FG000|Overall Study|Lack of Efficacy|7|||
23524683|NCT01190254|65661581|FG001|Overall Study|Lack of Efficacy|4|||
23524684|NCT01190254|65661582|FG002|Overall Study|Lack of Efficacy|5|||
23524685|NCT01190254|65661580|FG000|Overall Study|Lost to Follow-up|4|||
23524686|NCT01190254|65661581|FG001|Overall Study|Lost to Follow-up|2|||
23524687|NCT01190254|65661582|FG002|Overall Study|Lost to Follow-up|0|||
23524688|NCT01190254|65661580|FG000|Overall Study|Withdrawal by Subject|4|||
23524689|NCT01190254|65661581|FG001|Overall Study|Withdrawal by Subject|5|||
23524690|NCT01190254|65661582|FG002|Overall Study|Withdrawal by Subject|7|||
23524691|NCT01190254|65661580|FG000|Overall Study|Protocol Violation|2|||
23524692|NCT01190254|65661581|FG001|Overall Study|Protocol Violation|0|||
23524693|NCT01190254|65661582|FG002|Overall Study|Protocol Violation|2|||
23524694|NCT01190254|65661580|FG000|Overall Study|Did not meet protocol eligibility|1|||
23524695|NCT01190254|65661581|FG001|Overall Study|Did not meet protocol eligibility|0|||
23524696|NCT01190254|65661582|FG002|Overall Study|Did not meet protocol eligibility|0|||
23524697|NCT00838201|65661586|FG000|Overall Study|Investigator decision, or other reasons|2|||
23524698|NCT00838201|65661587|FG001|Overall Study|Investigator decision, or other reasons|3|||
23524699|NCT00838201|65661586|FG000|Overall Study|Noncompliance|0|||
23524700|NCT00838201|65661587|FG001|Overall Study|Noncompliance|1|||
23524701|NCT00838201|65661586|FG000|Overall Study|Administrative decision|1|||
23524702|NCT00838201|65661587|FG001|Overall Study|Administrative decision|2|||
23417047|NCT01814878|65271416|FG001|Overall Study|Screening failure (drop-out)|3|||
23417048|NCT01814878|65271415|FG000|Overall Study|Other|2|||
23524703|NCT00838201|65661586|FG000|Overall Study|Disease progression|3|||
23524704|NCT00838201|65661587|FG001|Overall Study|Disease progression|3|||
23524705|NCT00838201|65661586|FG000|Overall Study|Consent withdrawn|16|||
23524706|NCT00838201|65661587|FG001|Overall Study|Consent withdrawn|19|||
23524707|NCT00838201|65661586|FG000|Overall Study|Lost to Follow-up|4|||
23524708|NCT00838201|65661587|FG001|Overall Study|Lost to Follow-up|3|||
23524709|NCT00838201|65661586|FG000|Overall Study|Adverse Event|5|||
23524710|NCT00838201|65661587|FG001|Overall Study|Adverse Event|9|||
23205895|NCT03151148|64494751|FG001|Overall Study|Withdrawal by Subject|0|||
23205896|NCT03259490|64494752|FG000|Period 1|Withdrawal by Subject|0|||
23205897|NCT03259490|64494753|FG001|Period 1|Withdrawal by Subject|1|||
23205898|NCT03259490|64494752|FG000|Period 2|Protocol Violation|1|||
23205899|NCT03259490|64494753|FG001|Period 2|Protocol Violation|0|||
23524711|NCT00838201|65661586|FG000|Overall Study|Death|11|||
23524712|NCT00838201|65661587|FG001|Overall Study|Death|13|||
23524713|NCT00842348|65661590|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
23524714|NCT00842348|65661591|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
23524715|NCT00842348|65661590|FG000|Study 729|Disease progression/death|19|||
23524716|NCT00842348|65661591|FG001|Study 729|Disease progression/death|30|||
23524717|NCT00842348|65661590|FG000|Study 729|Adverse Event|1|||
23524718|NCT00842348|65661591|FG001|Study 729|Adverse Event|1|||
23524719|NCT00842348|65661590|FG000|Study 729|Protocol Violation|1|||
23524720|NCT00842348|65661591|FG001|Study 729|Protocol Violation|1|||
23524721|NCT00842348|65661590|FG000|Study 729|Withdrawal by Subject|2|||
23524722|NCT00842348|65661591|FG001|Study 729|Withdrawal by Subject|4|||
23524723|NCT00842348|65661590|FG000|Study 729|Due to Sponsor stopping the study|1|||
23524724|NCT00842348|65661591|FG001|Study 729|Due to Sponsor stopping the study|1|||
23524725|NCT00842348|65661590|FG000|Study 729|Due to non-availability of IP|0|||
23205900|NCT00296725|64494756|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
23205901|NCT00296725|64494756|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
23205902|NCT00296725|64494756|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
23524726|NCT00842348|65661591|FG001|Study 729|Due to non-availability of IP|1|||
23524727|NCT00842348|65661590|FG000|Study 729|Sponsor's decision|1|||
23524728|NCT00842348|65661591|FG001|Study 729|Sponsor's decision|0|||
23524729|NCT00842348|65661590|FG000|Study 729|Surgical resection|1|||
23524730|NCT00842348|65661591|FG001|Study 729|Surgical resection|0|||
23524731|NCT04244786|65661592|FG000|Overall Study|Adverse Event|0|||
23417049|NCT01814878|65271416|FG001|Overall Study|Other|0|||
23205903|NCT00448916|64494759|FG000|Overall Study|Adverse Event|2|||
23205904|NCT00448916|64494760|FG001|Overall Study|Adverse Event|2|||
23205905|NCT00448916|64494761|FG002|Overall Study|Adverse Event|3|||
23205906|NCT00448916|64494762|FG003|Overall Study|Adverse Event|2|||
23205907|NCT00448916|64494759|FG000|Overall Study|Lack of Efficacy|1|||
23205908|NCT00448916|64494760|FG001|Overall Study|Lack of Efficacy|0|||
23205909|NCT00448916|64494761|FG002|Overall Study|Lack of Efficacy|2|||
23205910|NCT00448916|64494762|FG003|Overall Study|Lack of Efficacy|1|||
23205911|NCT00448916|64494759|FG000|Overall Study|Withdrawal by Subject|3|||
23205912|NCT00448916|64494760|FG001|Overall Study|Withdrawal by Subject|3|||
23205913|NCT00448916|64494761|FG002|Overall Study|Withdrawal by Subject|1|||
23205914|NCT00448916|64494762|FG003|Overall Study|Withdrawal by Subject|1|||
23205915|NCT00448916|64494759|FG000|Overall Study|Other|1|||
23205916|NCT00448916|64494760|FG001|Overall Study|Other|0|||
23205917|NCT00448916|64494761|FG002|Overall Study|Other|0|||
23205918|NCT00448916|64494762|FG003|Overall Study|Other|0|||
23205919|NCT00448916|64494759|FG000|Overall Study|Lost to Follow-up|0|||
23205920|NCT00448916|64494760|FG001|Overall Study|Lost to Follow-up|1|||
23205921|NCT00448916|64494761|FG002|Overall Study|Lost to Follow-up|0|||
23205922|NCT00448916|64494762|FG003|Overall Study|Lost to Follow-up|1|||
23205923|NCT00448916|64494759|FG000|Overall Study|Protocol Violation|0|||
23205924|NCT00448916|64494760|FG001|Overall Study|Protocol Violation|0|||
23205925|NCT00448916|64494761|FG002|Overall Study|Protocol Violation|0|||
23205926|NCT00448916|64494762|FG003|Overall Study|Protocol Violation|1|||
23205927|NCT00980343|64494763|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
23205928|NCT00980343|64494764|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
23308526|NCT03400943|64874165|FG002|Treatment Period 1|Adverse Event|0|||
23308527|NCT03400943|64874166|FG003|Treatment Period 1|Adverse Event|1|||
23308528|NCT03400943|64874163|FG000|Treatment Period 1|Lost to Follow-up|1|||
23308529|NCT03400943|64874164|FG001|Treatment Period 1|Lost to Follow-up|0|||
23308530|NCT03400943|64874165|FG002|Treatment Period 1|Lost to Follow-up|0|||
23308531|NCT03400943|64874166|FG003|Treatment Period 1|Lost to Follow-up|0|||
23308532|NCT03400943|64874163|FG000|Treatment Period 1|Protocol Violation|0|||
23524732|NCT04244786|65661593|FG001|Overall Study|Adverse Event|0|||
23205929|NCT01056341|64494765|FG000|Overall Study|Treatment Intolerance|0|||
23205930|NCT01056341|64494766|FG001|Overall Study|Treatment Intolerance|2|||
23205931|NCT01056341|64494767|FG002|Overall Study|Treatment Intolerance|0|||
23205932|NCT01056341|64494768|FG003|Overall Study|Treatment Intolerance|2|||
23205933|NCT01056341|64494769|FG004|Overall Study|Treatment Intolerance|0|||
23205934|NCT01056341|64494765|FG000|Overall Study|Lack of Efficacy|32|||
23524733|NCT04244786|65661594|FG002|Overall Study|Adverse Event|2|||
23205935|NCT01056341|64494766|FG001|Overall Study|Lack of Efficacy|30|||
23308533|NCT03400943|64874164|FG001|Treatment Period 1|Protocol Violation|1|||
23417050|NCT00778375|65271425|FG000|Overall Study|Ineligible|3|||
23308534|NCT03400943|64874165|FG002|Treatment Period 1|Protocol Violation|1|||
23308535|NCT03400943|64874166|FG003|Treatment Period 1|Protocol Violation|0|||
23308536|NCT03400943|64874163|FG000|Treatment Period 1|Study terminated by sponsor|2|||
23308537|NCT03400943|64874164|FG001|Treatment Period 1|Study terminated by sponsor|0|||
23308538|NCT03400943|64874165|FG002|Treatment Period 1|Study terminated by sponsor|0|||
23308539|NCT03400943|64874166|FG003|Treatment Period 1|Study terminated by sponsor|1|||
23308540|NCT03400943|64874163|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23524734|NCT04244786|65661592|FG000|Overall Study|Withdrawal by Subject|0|||
23205936|NCT01056341|64494767|FG002|Overall Study|Lack of Efficacy|7|||
23205937|NCT01056341|64494768|FG003|Overall Study|Lack of Efficacy|25|||
23205938|NCT01056341|64494769|FG004|Overall Study|Lack of Efficacy|9|||
23205939|NCT01056341|64494765|FG000|Overall Study|Other reasons|4|||
23205940|NCT01056341|64494766|FG001|Overall Study|Other reasons|4|||
23205941|NCT01056341|64494767|FG002|Overall Study|Other reasons|8|||
23205942|NCT01056341|64494768|FG003|Overall Study|Other reasons|9|||
23205943|NCT01056341|64494769|FG004|Overall Study|Other reasons|5|||
23205944|NCT00059215|64494772|FG000|Overall Study|Adverse Event|5|||
23205945|NCT00059215|64494773|FG001|Overall Study|Adverse Event|5|||
23205946|NCT00059215|64494774|FG002|Overall Study|Adverse Event|9|||
23524735|NCT04244786|65661593|FG001|Overall Study|Withdrawal by Subject|0|||
23524736|NCT04244786|65661594|FG002|Overall Study|Withdrawal by Subject|5|||
23524737|NCT00419562|65661595|FG000|Overall Study|Lost to Follow-up|12|||
23205947|NCT00059215|64494775|FG003|Overall Study|Adverse Event|9|||
23205948|NCT00059215|64494772|FG000|Overall Study|Death|0|||
23205949|NCT00059215|64494773|FG001|Overall Study|Death|0|||
23308541|NCT03400943|64874164|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23205950|NCT00059215|64494774|FG002|Overall Study|Death|3|||
23205951|NCT00059215|64494775|FG003|Overall Study|Death|0|||
23205952|NCT00059215|64494772|FG000|Overall Study|Lost to Follow-up|1|||
23205953|NCT00059215|64494773|FG001|Overall Study|Lost to Follow-up|2|||
23205954|NCT00059215|64494774|FG002|Overall Study|Lost to Follow-up|0|||
23205955|NCT00059215|64494775|FG003|Overall Study|Lost to Follow-up|0|||
23205956|NCT00059215|64494772|FG000|Overall Study|Withdrawal by Subject|4|||
23205957|NCT00059215|64494773|FG001|Overall Study|Withdrawal by Subject|4|||
23205958|NCT00059215|64494774|FG002|Overall Study|Withdrawal by Subject|1|||
23205959|NCT00059215|64494775|FG003|Overall Study|Withdrawal by Subject|3|||
23205960|NCT00059215|64494772|FG000|Overall Study|Protocol Violation|1|||
23524738|NCT00419562|65661596|FG001|Overall Study|Lost to Follow-up|13|||
23417051|NCT00098748|65271426|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
23417052|NCT00098748|65271427|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
23417053|NCT00098748|65271428|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
23417054|NCT00098748|65271426|FG000|Received Study Treatment|Death|2|||
23417055|NCT00098748|65271427|FG001|Received Study Treatment|Death|1|||
23417056|NCT00098748|65271428|FG002|Received Study Treatment|Death|2|||
23417057|NCT00098748|65271426|FG000|Received Study Treatment|Adverse Event|1|||
23417058|NCT00098748|65271427|FG001|Received Study Treatment|Adverse Event|2|||
23417059|NCT00098748|65271428|FG002|Received Study Treatment|Adverse Event|5|||
23417060|NCT00098748|65271426|FG000|Received Study Treatment|Lack of Efficacy|40|||
23417061|NCT00098748|65271427|FG001|Received Study Treatment|Lack of Efficacy|27|||
23417062|NCT00098748|65271428|FG002|Received Study Treatment|Lack of Efficacy|27|||
23417063|NCT00098748|65271426|FG000|Received Study Treatment|Other|2|||
23417064|NCT00098748|65271427|FG001|Received Study Treatment|Other|2|||
23417065|NCT00098748|65271428|FG002|Received Study Treatment|Other|6|||
23417066|NCT00098748|65271426|FG000|Received Study Treatment|Subject defaulted|3|||
23417067|NCT00098748|65271427|FG001|Received Study Treatment|Subject defaulted|4|||
23417068|NCT00098748|65271428|FG002|Received Study Treatment|Subject defaulted|4|||
23417069|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
23417070|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
23417071|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
23417072|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
23417073|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
23417074|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
23417075|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
23417076|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
23417077|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
23417078|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
23417079|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
23417080|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
23417081|NCT00098748|65271426|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
23417082|NCT00098748|65271427|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
23417083|NCT00098748|65271428|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
23417084|NCT01519791|65271429|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
23524739|NCT00419562|65661595|FG000|Overall Study|Withdrawal by Subject|20|||
23524740|NCT00419562|65661596|FG001|Overall Study|Withdrawal by Subject|18|||
23524741|NCT00419562|65661595|FG000|Overall Study|Participant Institutionalized|1|||
23524742|NCT00419562|65661596|FG001|Overall Study|Participant Institutionalized|0|||
23524743|NCT01557400|65661597|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
23524744|NCT01557400|65661597|FG000|Overall Study|Adverse Event|3|||
23417085|NCT01519791|65271430|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
23417086|NCT01519791|65271429|FG000|Overall Study|Protocol Violation|6|||
23417087|NCT01519791|65271430|FG001|Overall Study|Protocol Violation|19|||
23417088|NCT01519791|65271429|FG000|Overall Study|Other Reason|87|||
23417089|NCT01519791|65271430|FG001|Overall Study|Other Reason|222|||
23417090|NCT01519791|65271429|FG000|Overall Study|subjects randomized in error|2|||
23417091|NCT01519791|65271430|FG001|Overall Study|subjects randomized in error|0|||
23524745|NCT01557400|65661597|FG000|Overall Study|Lost to Follow-up|5|||
23205961|NCT00059215|64494773|FG001|Overall Study|Protocol Violation|0|||
23417092|NCT01519791|65271429|FG000|Overall Study|Lack of Efficacy|16|||
23417093|NCT01519791|65271430|FG001|Overall Study|Lack of Efficacy|20|||
23417094|NCT01519791|65271429|FG000|Overall Study|SAE, non-fatal|6|||
23417095|NCT01519791|65271430|FG001|Overall Study|SAE, non-fatal|22|||
23417096|NCT01519791|65271429|FG000|Overall Study|AE, serious fatal|0|||
23417097|NCT01519791|65271430|FG001|Overall Study|AE, serious fatal|1|||
23417098|NCT01519791|65271429|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
23417099|NCT01519791|65271430|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
23417100|NCT01519791|65271429|FG000|Overall Study|AE, non-serious non-fatal|12|||
23417101|NCT01519791|65271430|FG001|Overall Study|AE, non-serious non-fatal|31|||
23417102|NCT01519791|65271429|FG000|Overall Study|Withdrawal by Subject|15|||
23417103|NCT01519791|65271430|FG001|Overall Study|Withdrawal by Subject|37|||
23417104|NCT01519791|65271429|FG000|Overall Study|Lost to Follow-up|6|||
23417105|NCT01519791|65271430|FG001|Overall Study|Lost to Follow-up|14|||
23417106|NCT04115748|65271438|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
23417107|NCT04115748|65271439|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
23417108|NCT04115748|65271440|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
23417109|NCT04115748|65271441|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
23417110|NCT04115748|65271442|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417111|NCT04115748|65271443|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417112|NCT04115748|65271444|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417113|NCT04115748|65271445|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417114|NCT04115748|65271446|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417115|NCT04115748|65271447|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
23417116|NCT04115748|65271438|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417117|NCT04115748|65271439|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417118|NCT04115748|65271440|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417119|NCT04115748|65271441|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
23417120|NCT04115748|65271442|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417121|NCT04115748|65271443|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417122|NCT04115748|65271444|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417123|NCT04115748|65271445|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417124|NCT04115748|65271446|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417125|NCT04115748|65271447|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
23417126|NCT04115748|65271438|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
23417127|NCT04115748|65271439|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
23417128|NCT04115748|65271440|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
23417129|NCT04115748|65271441|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
23417130|NCT04115748|65271442|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
23417131|NCT04115748|65271443|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
23417132|NCT04115748|65271444|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
23417133|NCT04115748|65271445|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
23417134|NCT04115748|65271446|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
23417135|NCT04115748|65271447|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
23417136|NCT04115748|65271438|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417137|NCT04115748|65271439|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417138|NCT04115748|65271440|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417139|NCT04115748|65271441|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417140|NCT04115748|65271442|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417141|NCT04115748|65271443|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417142|NCT04115748|65271444|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417143|NCT04115748|65271445|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417144|NCT04115748|65271446|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
23417145|NCT04115748|65271447|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
23417146|NCT01106651|65271452|FG000|Overall Study|Adverse Event|17|||
23417147|NCT01106651|65271453|FG001|Overall Study|Adverse Event|9|||
23417148|NCT01106651|65271454|FG002|Overall Study|Adverse Event|23|||
23417149|NCT01106651|65271452|FG000|Overall Study|Lost to Follow-up|8|||
23417150|NCT01106651|65271453|FG001|Overall Study|Lost to Follow-up|2|||
23417151|NCT01106651|65271454|FG002|Overall Study|Lost to Follow-up|6|||
23417152|NCT01106651|65271452|FG000|Overall Study|Physician Decision|4|||
23417153|NCT01106651|65271453|FG001|Overall Study|Physician Decision|3|||
23417154|NCT01106651|65271454|FG002|Overall Study|Physician Decision|1|||
23417155|NCT01106651|65271452|FG000|Overall Study|Protocol Violation|1|||
23417156|NCT01106651|65271453|FG001|Overall Study|Protocol Violation|2|||
23417157|NCT01106651|65271454|FG002|Overall Study|Protocol Violation|1|||
23417158|NCT01106651|65271452|FG000|Overall Study|Withdrawal by Subject|14|||
23417159|NCT01106651|65271453|FG001|Overall Study|Withdrawal by Subject|7|||
23417160|NCT01106651|65271454|FG002|Overall Study|Withdrawal by Subject|4|||
23417161|NCT01106651|65271452|FG000|Overall Study|Noncompliance with study drug|1|||
23417162|NCT01106651|65271453|FG001|Overall Study|Noncompliance with study drug|0|||
23417163|NCT01106651|65271454|FG002|Overall Study|Noncompliance with study drug|2|||
23417164|NCT01106651|65271452|FG000|Overall Study|Other|34|||
23205962|NCT00059215|64494774|FG002|Overall Study|Protocol Violation|1|||
23205963|NCT00059215|64494775|FG003|Overall Study|Protocol Violation|0|||
23205964|NCT00059215|64494772|FG000|Overall Study|Protocol entry criteria not met|1|||
23205965|NCT00059215|64494773|FG001|Overall Study|Protocol entry criteria not met|1|||
23205966|NCT00059215|64494774|FG002|Overall Study|Protocol entry criteria not met|0|||
23205967|NCT00059215|64494775|FG003|Overall Study|Protocol entry criteria not met|2|||
23205968|NCT00059215|64494772|FG000|Overall Study|Physician Decision|1|||
23205969|NCT00059215|64494773|FG001|Overall Study|Physician Decision|2|||
23205970|NCT00059215|64494774|FG002|Overall Study|Physician Decision|1|||
23205971|NCT00059215|64494775|FG003|Overall Study|Physician Decision|1|||
23205972|NCT04465396|64494776|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
23205973|NCT04465396|64494777|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
23205974|NCT04465396|64494778|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
23205975|NCT04465396|64494779|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
23205976|NCT00701727|64494780|FG000|First Treatment Period|Adverse Event|0|||
23205977|NCT00701727|64494781|FG001|First Treatment Period|Adverse Event|0|||
23205978|NCT00701727|64494780|FG000|First Treatment Period|Withdrawal by Subject|1|||
23205979|NCT00701727|64494781|FG001|First Treatment Period|Withdrawal by Subject|0|||
23205980|NCT00701727|64494780|FG000|First Treatment Period|sponsor decision|0|||
23205981|NCT00701727|64494781|FG001|First Treatment Period|sponsor decision|1|||
23205982|NCT00701727|64494780|FG000|First Treatment Period|Lost to Follow-up|0|||
23205983|NCT00701727|64494781|FG001|First Treatment Period|Lost to Follow-up|1|||
23205984|NCT00701727|64494780|FG000|Second Treatment Period|Withdrawal by Subject|2|||
23205985|NCT00701727|64494781|FG001|Second Treatment Period|Withdrawal by Subject|0|||
23205986|NCT00423085|64494782|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
23205987|NCT00423085|64494783|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
23205988|NCT00423085|64494784|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
23205989|NCT00423085|64494785|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
23205990|NCT00423085|64494782|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
23205991|NCT00423085|64494783|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
23417165|NCT01106651|65271453|FG001|Overall Study|Other|31|||
23417166|NCT01106651|65271454|FG002|Overall Study|Other|21|||
23417167|NCT01106651|65271452|FG000|Overall Study|Death|0|||
23417168|NCT01106651|65271453|FG001|Overall Study|Death|3|||
23417169|NCT01106651|65271454|FG002|Overall Study|Death|0|||
23417170|NCT04187144|65271455|FG000|Overall Study|Lost to Follow-up|12|||
23417171|NCT04187144|65271456|FG001|Overall Study|Lost to Follow-up|11|||
23205992|NCT00423085|64494784|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
23205993|NCT00423085|64494785|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23205994|NCT00423085|64494782|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
23205995|NCT00423085|64494783|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
23205996|NCT00423085|64494784|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
23205997|NCT00423085|64494785|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
23205998|NCT00423085|64494782|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
23205999|NCT00423085|64494783|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
23206000|NCT00423085|64494784|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
23206001|NCT00423085|64494785|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
23206002|NCT00423085|64494782|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
23206003|NCT00423085|64494783|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
23206004|NCT00423085|64494784|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
23308542|NCT03400943|64874165|FG002|Treatment Period 1|Withdrawal by Subject|3|||
23308543|NCT03400943|64874166|FG003|Treatment Period 1|Withdrawal by Subject|1|||
23417172|NCT04187144|65271455|FG000|Overall Study|Withdrawal by Subject|20|||
23417173|NCT04187144|65271456|FG001|Overall Study|Withdrawal by Subject|18|||
23524746|NCT01557400|65661597|FG000|Overall Study|Withdrawal by Subject|9|||
23524747|NCT02027844|65661598|FG000|Overall Study|Withdrawal by Subject|3|||
23524748|NCT02027844|65661599|FG001|Overall Study|Withdrawal by Subject|2|||
23524749|NCT02027844|65661600|FG002|Overall Study|Withdrawal by Subject|1|||
23524750|NCT02027844|65661598|FG000|Overall Study|Lost to Follow-up|0|||
23524751|NCT02027844|65661599|FG001|Overall Study|Lost to Follow-up|2|||
23524752|NCT02027844|65661600|FG002|Overall Study|Lost to Follow-up|1|||
23524753|NCT02027844|65661598|FG000|Overall Study|Protocol Violation|0|||
23524754|NCT02027844|65661599|FG001|Overall Study|Protocol Violation|2|||
23524755|NCT02027844|65661600|FG002|Overall Study|Protocol Violation|0|||
23524756|NCT02027844|65661598|FG000|Overall Study|Incomlete data|2|||
23524757|NCT02027844|65661599|FG001|Overall Study|Incomlete data|0|||
23524758|NCT02027844|65661600|FG002|Overall Study|Incomlete data|0|||
23524759|NCT02658890|65661603|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524760|NCT02658890|65661604|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524761|NCT02658890|65661605|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524762|NCT02658890|65661606|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524763|NCT02658890|65661607|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524764|NCT02658890|65661608|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524765|NCT02658890|65661609|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524766|NCT02658890|65661610|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524767|NCT02658890|65661611|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23524768|NCT02658890|65661612|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524769|NCT02658890|65661613|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524770|NCT02658890|65661614|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524771|NCT02658890|65661615|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524772|NCT02658890|65661616|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524773|NCT02658890|65661617|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524774|NCT02658890|65661618|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524775|NCT02658890|65661619|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524776|NCT02658890|65661620|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524777|NCT02658890|65661621|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524778|NCT02658890|65661622|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524779|NCT02658890|65661623|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524780|NCT02658890|65661624|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524781|NCT02658890|65661625|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524782|NCT02658890|65661626|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23308544|NCT03400943|64874163|FG000|Treatment Period 1|Other|2|||
23417174|NCT04187144|65271455|FG000|Overall Study|Adverse Event|19|||
23417175|NCT04187144|65271456|FG001|Overall Study|Adverse Event|4|||
23417176|NCT04187144|65271455|FG000|Overall Study|Physician Decision|5|||
23417177|NCT04187144|65271456|FG001|Overall Study|Physician Decision|3|||
23417178|NCT04187144|65271455|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
23417179|NCT04187144|65271456|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
23417180|NCT04187144|65271455|FG000|Overall Study|Protocol Deviation|1|||
23417181|NCT04187144|65271456|FG001|Overall Study|Protocol Deviation|4|||
23417182|NCT00281099|65271457|FG000|Overall Study|Death|46|||
23524783|NCT02658890|65661627|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524784|NCT02658890|65661628|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524785|NCT02658890|65661629|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23524786|NCT02658890|65661603|FG000|Treatment Phase|Adverse Event|0|||
23524787|NCT02658890|65661604|FG001|Treatment Phase|Adverse Event|1|||
23524788|NCT02658890|65661605|FG002|Treatment Phase|Adverse Event|2|||
23524789|NCT02658890|65661606|FG003|Treatment Phase|Adverse Event|2|||
23524790|NCT02658890|65661607|FG004|Treatment Phase|Adverse Event|1|||
23524791|NCT02658890|65661608|FG005|Treatment Phase|Adverse Event|0|||
23524792|NCT02658890|65661609|FG006|Treatment Phase|Adverse Event|0|||
23524793|NCT02658890|65661610|FG007|Treatment Phase|Adverse Event|2|||
23524794|NCT02658890|65661611|FG008|Treatment Phase|Adverse Event|1|||
23524795|NCT02658890|65661612|FG009|Treatment Phase|Adverse Event|2|||
23524796|NCT02658890|65661613|FG010|Treatment Phase|Adverse Event|3|||
23524797|NCT02658890|65661614|FG011|Treatment Phase|Adverse Event|0|||
23524798|NCT02658890|65661615|FG012|Treatment Phase|Adverse Event|1|||
23524799|NCT02658890|65661616|FG013|Treatment Phase|Adverse Event|4|||
23524800|NCT02658890|65661617|FG014|Treatment Phase|Adverse Event|0|||
23524801|NCT02658890|65661618|FG015|Treatment Phase|Adverse Event|0|||
23524802|NCT02658890|65661619|FG016|Treatment Phase|Adverse Event|0|||
23524803|NCT02658890|65661620|FG017|Treatment Phase|Adverse Event|0|||
23524804|NCT02658890|65661621|FG018|Treatment Phase|Adverse Event|5|||
23524805|NCT02658890|65661622|FG019|Treatment Phase|Adverse Event|1|||
23524806|NCT02658890|65661623|FG020|Treatment Phase|Adverse Event|3|||
23524807|NCT02658890|65661624|FG021|Treatment Phase|Adverse Event|0|||
23524808|NCT02658890|65661625|FG022|Treatment Phase|Adverse Event|5|||
23524809|NCT02658890|65661626|FG023|Treatment Phase|Adverse Event|0|||
23524810|NCT02658890|65661627|FG024|Treatment Phase|Adverse Event|0|||
23524811|NCT02658890|65661628|FG025|Treatment Phase|Adverse Event|2|||
23524812|NCT02658890|65661629|FG026|Treatment Phase|Adverse Event|1|||
23524813|NCT02658890|65661603|FG000|Treatment Phase|Death|0|||
23524814|NCT02658890|65661604|FG001|Treatment Phase|Death|0|||
23524815|NCT02658890|65661605|FG002|Treatment Phase|Death|0|||
23524816|NCT02658890|65661606|FG003|Treatment Phase|Death|0|||
23524817|NCT02658890|65661607|FG004|Treatment Phase|Death|0|||
23524818|NCT02658890|65661608|FG005|Treatment Phase|Death|0|||
23524819|NCT02658890|65661609|FG006|Treatment Phase|Death|0|||
23524820|NCT02658890|65661610|FG007|Treatment Phase|Death|0|||
23524821|NCT02658890|65661611|FG008|Treatment Phase|Death|0|||
23524822|NCT02658890|65661612|FG009|Treatment Phase|Death|0|||
23524823|NCT02658890|65661613|FG010|Treatment Phase|Death|0|||
23524824|NCT02658890|65661614|FG011|Treatment Phase|Death|0|||
23524825|NCT02658890|65661615|FG012|Treatment Phase|Death|0|||
23524826|NCT02658890|65661616|FG013|Treatment Phase|Death|0|||
23524827|NCT02658890|65661617|FG014|Treatment Phase|Death|0|||
23524828|NCT02658890|65661618|FG015|Treatment Phase|Death|0|||
23524829|NCT02658890|65661619|FG016|Treatment Phase|Death|0|||
23524830|NCT02658890|65661620|FG017|Treatment Phase|Death|0|||
23524831|NCT02658890|65661621|FG018|Treatment Phase|Death|1|||
23524832|NCT02658890|65661622|FG019|Treatment Phase|Death|0|||
23524833|NCT02658890|65661623|FG020|Treatment Phase|Death|0|||
23524834|NCT02658890|65661624|FG021|Treatment Phase|Death|0|||
23524835|NCT02658890|65661625|FG022|Treatment Phase|Death|0|||
23524836|NCT02658890|65661626|FG023|Treatment Phase|Death|0|||
23524837|NCT02658890|65661627|FG024|Treatment Phase|Death|0|||
23524838|NCT02658890|65661628|FG025|Treatment Phase|Death|0|||
23524839|NCT02658890|65661629|FG026|Treatment Phase|Death|0|||
23524840|NCT02658890|65661603|FG000|Treatment Phase|Lost to Follow-up|0|||
23524841|NCT02658890|65661604|FG001|Treatment Phase|Lost to Follow-up|0|||
23524842|NCT02658890|65661605|FG002|Treatment Phase|Lost to Follow-up|0|||
23524843|NCT02658890|65661606|FG003|Treatment Phase|Lost to Follow-up|0|||
23524844|NCT02658890|65661607|FG004|Treatment Phase|Lost to Follow-up|0|||
23524845|NCT02658890|65661608|FG005|Treatment Phase|Lost to Follow-up|0|||
23524846|NCT02658890|65661609|FG006|Treatment Phase|Lost to Follow-up|1|||
23524847|NCT02658890|65661610|FG007|Treatment Phase|Lost to Follow-up|0|||
23524848|NCT02658890|65661611|FG008|Treatment Phase|Lost to Follow-up|0|||
23524849|NCT02658890|65661612|FG009|Treatment Phase|Lost to Follow-up|0|||
23524850|NCT02658890|65661613|FG010|Treatment Phase|Lost to Follow-up|0|||
23524851|NCT02658890|65661614|FG011|Treatment Phase|Lost to Follow-up|0|||
23524852|NCT02658890|65661615|FG012|Treatment Phase|Lost to Follow-up|0|||
23524853|NCT02658890|65661616|FG013|Treatment Phase|Lost to Follow-up|0|||
23524854|NCT02658890|65661617|FG014|Treatment Phase|Lost to Follow-up|0|||
23524855|NCT02658890|65661618|FG015|Treatment Phase|Lost to Follow-up|0|||
23524856|NCT02658890|65661619|FG016|Treatment Phase|Lost to Follow-up|0|||
23524857|NCT02658890|65661620|FG017|Treatment Phase|Lost to Follow-up|0|||
23524858|NCT02658890|65661621|FG018|Treatment Phase|Lost to Follow-up|0|||
23524859|NCT02658890|65661622|FG019|Treatment Phase|Lost to Follow-up|0|||
23524860|NCT02658890|65661623|FG020|Treatment Phase|Lost to Follow-up|0|||
23524861|NCT02658890|65661624|FG021|Treatment Phase|Lost to Follow-up|0|||
23524862|NCT02658890|65661625|FG022|Treatment Phase|Lost to Follow-up|0|||
23524863|NCT02658890|65661626|FG023|Treatment Phase|Lost to Follow-up|0|||
23524864|NCT02658890|65661627|FG024|Treatment Phase|Lost to Follow-up|0|||
23524865|NCT02658890|65661628|FG025|Treatment Phase|Lost to Follow-up|0|||
23524866|NCT02658890|65661629|FG026|Treatment Phase|Lost to Follow-up|0|||
23524867|NCT02658890|65661603|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
23524868|NCT02658890|65661604|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
23206005|NCT00423085|64494785|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
23206006|NCT00423085|64494782|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
23206007|NCT00423085|64494783|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
23206008|NCT00423085|64494784|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
23206009|NCT00423085|64494785|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
23308545|NCT03400943|64874164|FG001|Treatment Period 1|Other|1|||
23308546|NCT03400943|64874165|FG002|Treatment Period 1|Other|2|||
23524869|NCT02658890|65661605|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
23524870|NCT02658890|65661606|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
23524871|NCT02658890|65661607|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
23524872|NCT02658890|65661608|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
23524873|NCT02658890|65661609|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
23524874|NCT02658890|65661610|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
23524875|NCT02658890|65661611|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
23524876|NCT02658890|65661612|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
23524877|NCT02658890|65661613|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
23524878|NCT02658890|65661614|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
23524879|NCT02658890|65661615|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
23524880|NCT02658890|65661616|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
23524881|NCT02658890|65661617|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
23524882|NCT02658890|65661618|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
23524883|NCT02658890|65661619|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
23524884|NCT02658890|65661620|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
23524885|NCT02658890|65661621|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
23524886|NCT02658890|65661622|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
23524887|NCT02658890|65661623|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
23524888|NCT02658890|65661624|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
23524889|NCT02658890|65661625|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
23524890|NCT02658890|65661626|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
23524891|NCT02658890|65661627|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
23524892|NCT02658890|65661628|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
23524893|NCT02658890|65661629|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
23524894|NCT02658890|65661603|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
23524895|NCT02658890|65661604|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
23524896|NCT02658890|65661605|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
23524897|NCT02658890|65661606|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
23524898|NCT02658890|65661607|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
23524899|NCT02658890|65661608|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
23524900|NCT02658890|65661609|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
23524901|NCT02658890|65661610|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
23524902|NCT02658890|65661611|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
23524903|NCT02658890|65661612|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
23524904|NCT02658890|65661613|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
23524905|NCT02658890|65661614|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
23524906|NCT02658890|65661615|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
23524907|NCT02658890|65661616|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
23524908|NCT02658890|65661617|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
23524909|NCT02658890|65661618|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
23524910|NCT02658890|65661619|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
23524911|NCT02658890|65661620|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
23524912|NCT02658890|65661621|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
23524913|NCT02658890|65661622|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
23524914|NCT02658890|65661623|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
23524915|NCT02658890|65661624|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
23524916|NCT02658890|65661625|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
23524917|NCT02658890|65661626|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
23524918|NCT02658890|65661627|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
23524919|NCT02658890|65661628|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
23524920|NCT02658890|65661629|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
23524921|NCT02658890|65661603|FG000|Treatment Phase|Other Reasons|0|||
23524922|NCT02658890|65661604|FG001|Treatment Phase|Other Reasons|0|||
23524923|NCT02658890|65661605|FG002|Treatment Phase|Other Reasons|0|||
23524924|NCT02658890|65661606|FG003|Treatment Phase|Other Reasons|0|||
23524925|NCT02658890|65661607|FG004|Treatment Phase|Other Reasons|0|||
23524926|NCT02658890|65661608|FG005|Treatment Phase|Other Reasons|0|||
23524927|NCT02658890|65661609|FG006|Treatment Phase|Other Reasons|1|||
23524928|NCT02658890|65661610|FG007|Treatment Phase|Other Reasons|0|||
23524929|NCT02658890|65661611|FG008|Treatment Phase|Other Reasons|1|||
23524930|NCT02658890|65661612|FG009|Treatment Phase|Other Reasons|0|||
23524931|NCT02658890|65661613|FG010|Treatment Phase|Other Reasons|0|||
23524932|NCT02658890|65661614|FG011|Treatment Phase|Other Reasons|0|||
23524933|NCT02658890|65661615|FG012|Treatment Phase|Other Reasons|0|||
23524934|NCT02658890|65661616|FG013|Treatment Phase|Other Reasons|2|||
23524935|NCT02658890|65661617|FG014|Treatment Phase|Other Reasons|0|||
23524936|NCT02658890|65661618|FG015|Treatment Phase|Other Reasons|0|||
23524937|NCT02658890|65661619|FG016|Treatment Phase|Other Reasons|0|||
23524938|NCT02658890|65661620|FG017|Treatment Phase|Other Reasons|0|||
23524939|NCT02658890|65661621|FG018|Treatment Phase|Other Reasons|1|||
23524940|NCT02658890|65661622|FG019|Treatment Phase|Other Reasons|0|||
23524941|NCT02658890|65661623|FG020|Treatment Phase|Other Reasons|0|||
23524942|NCT02658890|65661624|FG021|Treatment Phase|Other Reasons|0|||
23524943|NCT02658890|65661625|FG022|Treatment Phase|Other Reasons|0|||
23524944|NCT02658890|65661626|FG023|Treatment Phase|Other Reasons|0|||
23524945|NCT02658890|65661627|FG024|Treatment Phase|Other Reasons|1|||
23524946|NCT02658890|65661628|FG025|Treatment Phase|Other Reasons|0|||
23524947|NCT02658890|65661629|FG026|Treatment Phase|Other Reasons|1|||
23524948|NCT02658890|65661603|FG000|Treatment Phase|Progressive Disease|6|||
23524949|NCT02658890|65661604|FG001|Treatment Phase|Progressive Disease|7|||
23524950|NCT02658890|65661605|FG002|Treatment Phase|Progressive Disease|6|||
23524951|NCT02658890|65661606|FG003|Treatment Phase|Progressive Disease|12|||
23524952|NCT02658890|65661607|FG004|Treatment Phase|Progressive Disease|6|||
23524953|NCT02658890|65661608|FG005|Treatment Phase|Progressive Disease|18|||
23524954|NCT02658890|65661609|FG006|Treatment Phase|Progressive Disease|12|||
23524955|NCT02658890|65661610|FG007|Treatment Phase|Progressive Disease|19|||
23524956|NCT02658890|65661611|FG008|Treatment Phase|Progressive Disease|26|||
23524957|NCT02658890|65661612|FG009|Treatment Phase|Progressive Disease|8|||
23524958|NCT02658890|65661613|FG010|Treatment Phase|Progressive Disease|7|||
23524959|NCT02658890|65661614|FG011|Treatment Phase|Progressive Disease|9|||
23524960|NCT02658890|65661615|FG012|Treatment Phase|Progressive Disease|8|||
23524961|NCT02658890|65661616|FG013|Treatment Phase|Progressive Disease|29|||
23524962|NCT02658890|65661617|FG014|Treatment Phase|Progressive Disease|6|||
23524963|NCT02658890|65661618|FG015|Treatment Phase|Progressive Disease|2|||
23524964|NCT02658890|65661619|FG016|Treatment Phase|Progressive Disease|32|||
23524965|NCT02658890|65661620|FG017|Treatment Phase|Progressive Disease|14|||
23524966|NCT02658890|65661621|FG018|Treatment Phase|Progressive Disease|40|||
23524967|NCT02658890|65661622|FG019|Treatment Phase|Progressive Disease|32|||
23524968|NCT02658890|65661623|FG020|Treatment Phase|Progressive Disease|19|||
23524969|NCT02658890|65661624|FG021|Treatment Phase|Progressive Disease|30|||
23524970|NCT02658890|65661625|FG022|Treatment Phase|Progressive Disease|15|||
23524971|NCT02658890|65661626|FG023|Treatment Phase|Progressive Disease|0|||
23524972|NCT02658890|65661627|FG024|Treatment Phase|Progressive Disease|0|||
23524973|NCT02658890|65661628|FG025|Treatment Phase|Progressive Disease|14|||
23524974|NCT02658890|65661629|FG026|Treatment Phase|Progressive Disease|11|||
23524975|NCT02658890|65661603|FG000|Treatment Phase|Study Drug Toxicity|0|||
23524976|NCT02658890|65661604|FG001|Treatment Phase|Study Drug Toxicity|0|||
23524977|NCT02658890|65661605|FG002|Treatment Phase|Study Drug Toxicity|2|||
23524978|NCT02658890|65661606|FG003|Treatment Phase|Study Drug Toxicity|0|||
23524979|NCT02658890|65661607|FG004|Treatment Phase|Study Drug Toxicity|0|||
23524980|NCT02658890|65661608|FG005|Treatment Phase|Study Drug Toxicity|0|||
23524981|NCT02658890|65661609|FG006|Treatment Phase|Study Drug Toxicity|0|||
23524982|NCT02658890|65661610|FG007|Treatment Phase|Study Drug Toxicity|0|||
23524983|NCT02658890|65661611|FG008|Treatment Phase|Study Drug Toxicity|3|||
23524984|NCT02658890|65661612|FG009|Treatment Phase|Study Drug Toxicity|0|||
23524985|NCT02658890|65661613|FG010|Treatment Phase|Study Drug Toxicity|1|||
23524986|NCT02658890|65661614|FG011|Treatment Phase|Study Drug Toxicity|1|||
23524987|NCT02658890|65661615|FG012|Treatment Phase|Study Drug Toxicity|2|||
23524988|NCT02658890|65661616|FG013|Treatment Phase|Study Drug Toxicity|9|||
23524989|NCT02658890|65661617|FG014|Treatment Phase|Study Drug Toxicity|0|||
23524990|NCT02658890|65661618|FG015|Treatment Phase|Study Drug Toxicity|1|||
23524991|NCT02658890|65661619|FG016|Treatment Phase|Study Drug Toxicity|1|||
23524992|NCT02658890|65661620|FG017|Treatment Phase|Study Drug Toxicity|0|||
23524993|NCT02658890|65661621|FG018|Treatment Phase|Study Drug Toxicity|8|||
23524994|NCT02658890|65661622|FG019|Treatment Phase|Study Drug Toxicity|3|||
23524995|NCT02658890|65661623|FG020|Treatment Phase|Study Drug Toxicity|2|||
23524996|NCT02658890|65661624|FG021|Treatment Phase|Study Drug Toxicity|0|||
23524997|NCT02658890|65661625|FG022|Treatment Phase|Study Drug Toxicity|8|||
23524998|NCT02658890|65661626|FG023|Treatment Phase|Study Drug Toxicity|0|||
23524999|NCT02658890|65661627|FG024|Treatment Phase|Study Drug Toxicity|0|||
23525000|NCT02658890|65661628|FG025|Treatment Phase|Study Drug Toxicity|2|||
23525001|NCT02658890|65661629|FG026|Treatment Phase|Study Drug Toxicity|0|||
23525002|NCT02658890|65661603|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525003|NCT02658890|65661604|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525004|NCT02658890|65661605|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525005|NCT02658890|65661606|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23525006|NCT02658890|65661607|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525007|NCT02658890|65661608|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525008|NCT02658890|65661609|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525009|NCT02658890|65661610|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525010|NCT02658890|65661611|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525011|NCT02658890|65661612|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23525012|NCT02658890|65661613|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525013|NCT02658890|65661614|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525014|NCT02658890|65661615|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525015|NCT02658890|65661616|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525016|NCT02658890|65661617|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525017|NCT02658890|65661618|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525018|NCT02658890|65661619|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525019|NCT02658890|65661620|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525020|NCT02658890|65661621|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23525021|NCT02658890|65661622|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525022|NCT02658890|65661623|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525023|NCT02658890|65661624|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525024|NCT02658890|65661625|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
23525025|NCT02658890|65661626|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525026|NCT02658890|65661627|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525027|NCT02658890|65661628|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525028|NCT02658890|65661629|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
23525029|NCT02658890|65661603|FG000|Treatment Phase|Withdrawal by Subject|0|||
23525030|NCT02658890|65661604|FG001|Treatment Phase|Withdrawal by Subject|1|||
23525031|NCT02658890|65661605|FG002|Treatment Phase|Withdrawal by Subject|0|||
23525032|NCT02658890|65661606|FG003|Treatment Phase|Withdrawal by Subject|0|||
23308547|NCT03400943|64874166|FG003|Treatment Period 1|Other|2|||
23525033|NCT02658890|65661607|FG004|Treatment Phase|Withdrawal by Subject|0|||
23525034|NCT02658890|65661608|FG005|Treatment Phase|Withdrawal by Subject|0|||
23525035|NCT02658890|65661609|FG006|Treatment Phase|Withdrawal by Subject|1|||
23525036|NCT02658890|65661610|FG007|Treatment Phase|Withdrawal by Subject|0|||
23525037|NCT02658890|65661611|FG008|Treatment Phase|Withdrawal by Subject|0|||
23525038|NCT02658890|65661612|FG009|Treatment Phase|Withdrawal by Subject|1|||
23525039|NCT02658890|65661613|FG010|Treatment Phase|Withdrawal by Subject|0|||
23206010|NCT00423085|64494782|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
23206011|NCT00423085|64494783|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
23206012|NCT00423085|64494784|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
23206013|NCT00423085|64494785|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
23206014|NCT00423085|64494782|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
23206015|NCT00423085|64494783|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
23206016|NCT00423085|64494784|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
23206017|NCT00423085|64494785|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
23206018|NCT00423085|64494782|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
23206019|NCT00423085|64494783|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
23206020|NCT00423085|64494784|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
23206021|NCT00423085|64494785|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
23206022|NCT00423085|64494782|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
23206023|NCT00423085|64494783|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
23206024|NCT00423085|64494784|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
23206025|NCT00423085|64494785|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
23206026|NCT00423085|64494782|FG000|52-Week Open-Label Extension Phase|Death|0|||
23206027|NCT00423085|64494783|FG001|52-Week Open-Label Extension Phase|Death|0|||
23206028|NCT00423085|64494784|FG002|52-Week Open-Label Extension Phase|Death|0|||
23206029|NCT00423085|64494785|FG003|52-Week Open-Label Extension Phase|Death|2|||
23206030|NCT01000727|64494790|FG000|Overall Study|Lost to Follow-up|41|||
23206031|NCT01000727|64494791|FG001|Overall Study|Lost to Follow-up|43|||
23206032|NCT01000727|64494790|FG000|Overall Study|Withdrawal by Subject|111|||
23206033|NCT01000727|64494791|FG001|Overall Study|Withdrawal by Subject|109|||
23206034|NCT01000727|64494790|FG000|Overall Study|Study closed/terminated|23|||
23206035|NCT01000727|64494791|FG001|Overall Study|Study closed/terminated|24|||
23206036|NCT00262080|64494794|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
23206037|NCT00262080|64494795|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23206038|NCT00262080|64494796|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
23206039|NCT00262080|64494794|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
23206040|NCT00262080|64494795|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
23206041|NCT00262080|64494796|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
23525040|NCT02658890|65661614|FG011|Treatment Phase|Withdrawal by Subject|0|||
23525041|NCT02658890|65661615|FG012|Treatment Phase|Withdrawal by Subject|1|||
23525042|NCT02658890|65661616|FG013|Treatment Phase|Withdrawal by Subject|3|||
23525043|NCT02658890|65661617|FG014|Treatment Phase|Withdrawal by Subject|0|||
23206042|NCT00262080|64494794|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
23206043|NCT00262080|64494795|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
23206044|NCT00262080|64494796|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
23206045|NCT00262080|64494794|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
23206046|NCT00262080|64494795|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
23206047|NCT00262080|64494796|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
23206048|NCT00262080|64494794|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
23206049|NCT00262080|64494795|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
23206050|NCT00262080|64494796|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
23206051|NCT00262080|64494794|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
23206052|NCT00262080|64494795|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
23206053|NCT00262080|64494796|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
23206054|NCT04507867|64494797|FG000|Overall Study|Death|7|||
23206055|NCT04507867|64494798|FG001|Overall Study|Death|1|||
23206056|NCT00352755|64494799|FG000|Overall Study|Physician Decision|1|||
23206057|NCT00352755|64494799|FG000|Overall Study|Adverse Event|1|||
23206058|NCT00171314|64494800|FG000|Overall Study|Adverse Event|44|||
23206059|NCT00171314|64494801|FG001|Overall Study|Adverse Event|41|||
23206060|NCT00171314|64494800|FG000|Overall Study|Lack of Efficacy|19|||
23206061|NCT00171314|64494801|FG001|Overall Study|Lack of Efficacy|14|||
23206062|NCT00171314|64494800|FG000|Overall Study|Withdrawal by Subject|9|||
23206063|NCT00171314|64494801|FG001|Overall Study|Withdrawal by Subject|6|||
23206064|NCT00171314|64494800|FG000|Overall Study|Abnormal Test Procedure Results|9|||
23206065|NCT00171314|64494801|FG001|Overall Study|Abnormal Test Procedure Results|3|||
23206066|NCT00171314|64494800|FG000|Overall Study|Protocol Violation|3|||
23206067|NCT00171314|64494801|FG001|Overall Study|Protocol Violation|7|||
23206068|NCT00171314|64494800|FG000|Overall Study|Administrative Problems|4|||
23206069|NCT00171314|64494801|FG001|Overall Study|Administrative Problems|3|||
23206070|NCT00171314|64494800|FG000|Overall Study|Lost to Follow-up|1|||
23417183|NCT00281099|65271458|FG001|Overall Study|Death|57|||
23525044|NCT02658890|65661618|FG015|Treatment Phase|Withdrawal by Subject|0|||
23525045|NCT02658890|65661619|FG016|Treatment Phase|Withdrawal by Subject|1|||
23206071|NCT00171314|64494801|FG001|Overall Study|Lost to Follow-up|3|||
23206072|NCT00171314|64494800|FG000|Overall Study|Death|2|||
23206073|NCT00171314|64494801|FG001|Overall Study|Death|1|||
23417184|NCT00281099|65271457|FG000|Overall Study|Lost to Follow-up|10|||
23206074|NCT00356863|64494802|FG000|Overall Study|Death|16|||
23206075|NCT00356863|64494803|FG001|Overall Study|Death|32|||
23206076|NCT00356863|64494802|FG000|Overall Study|Lost to Follow-up|76|||
23206077|NCT00356863|64494803|FG001|Overall Study|Lost to Follow-up|43|||
23206078|NCT02345252|64494804|FG000|Double-Blind Phase|Adverse Event|2|||
23206079|NCT02345252|64494805|FG001|Double-Blind Phase|Adverse Event|3|||
23525046|NCT02658890|65661620|FG017|Treatment Phase|Withdrawal by Subject|0|||
23525047|NCT02658890|65661621|FG018|Treatment Phase|Withdrawal by Subject|4|||
23525048|NCT02658890|65661622|FG019|Treatment Phase|Withdrawal by Subject|3|||
23525049|NCT02658890|65661623|FG020|Treatment Phase|Withdrawal by Subject|0|||
23525050|NCT02658890|65661624|FG021|Treatment Phase|Withdrawal by Subject|4|||
23525051|NCT02658890|65661625|FG022|Treatment Phase|Withdrawal by Subject|1|||
23525052|NCT02658890|65661626|FG023|Treatment Phase|Withdrawal by Subject|1|||
23525053|NCT02658890|65661627|FG024|Treatment Phase|Withdrawal by Subject|0|||
23525054|NCT02658890|65661628|FG025|Treatment Phase|Withdrawal by Subject|0|||
23525055|NCT02658890|65661629|FG026|Treatment Phase|Withdrawal by Subject|0|||
23525056|NCT02268409|65661630|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
23525057|NCT02268409|65661630|FG000|Overall Study|Death|1|||
23525058|NCT02268409|65661630|FG000|Overall Study|Lost to Follow-up|1|||
23525059|NCT02268409|65661630|FG000|Overall Study|Protocol Violation|3|||
23525060|NCT02268409|65661630|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
23525061|NCT02268409|65661630|FG000|Overall Study|Withdrawal by Subject|5|||
23525062|NCT01071512|65661631|FG000|Overall Study|Adverse Event|1|||
23525063|NCT01071512|65661631|FG000|Overall Study|Development of antibodies to drug|2|||
23525064|NCT01071512|65661631|FG000|Overall Study|positive anti-JC virus antibody test|2|||
23525065|NCT01124604|65661632|FG000|Overall Study|Adverse Event|10|||
23206080|NCT02345252|64494804|FG000|Double-Blind Phase|Death|1|||
23206081|NCT02345252|64494805|FG001|Double-Blind Phase|Death|2|||
23206082|NCT02345252|64494804|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23206083|NCT02345252|64494805|FG001|Double-Blind Phase|Lack of Efficacy|0|||
23206084|NCT02345252|64494804|FG000|Double-Blind Phase|Investigator's Discretion|4|||
23525066|NCT01124604|65661633|FG001|Overall Study|Adverse Event|1|||
23525067|NCT01124604|65661632|FG000|Overall Study|Lack of Efficacy|1|||
23525068|NCT01124604|65661633|FG001|Overall Study|Lack of Efficacy|0|||
23525069|NCT01124604|65661632|FG000|Overall Study|Withdrawal by Subject|4|||
23525070|NCT01124604|65661633|FG001|Overall Study|Withdrawal by Subject|0|||
23525071|NCT01124604|65661632|FG000|Overall Study|Disease Progression|0|||
23525072|NCT01124604|65661633|FG001|Overall Study|Disease Progression|1|||
23525073|NCT01537783|65661638|FG000|Overall Study|Lost to Follow-up|11|||
23525074|NCT01537783|65661639|FG001|Overall Study|Lost to Follow-up|2|||
23525075|NCT00850395|65661640|FG000|Overall Study|Death|1|||
23525076|NCT00850395|65661640|FG000|Overall Study|Adverse Event|1|||
23525077|NCT00850395|65661640|FG000|Overall Study|Insufficient clinical response|3|||
23525078|NCT00850395|65661640|FG000|Overall Study|Other|5|||
23525079|NCT01940120|65661642|FG000|Overall Study|Death|40|||
23525080|NCT01940120|65661642|FG000|Overall Study|Withdrawal by Subject|8|||
23525081|NCT00613509|65661643|FG000|Cycle 1|Adverse Event|2|||
23525082|NCT00613509|65661644|FG001|Cycle 1|Adverse Event|1|||
23525083|NCT00613509|65661643|FG000|Cycle 1|Disease Progression|2|||
23525084|NCT00613509|65661644|FG001|Cycle 1|Disease Progression|6|||
23206085|NCT02345252|64494805|FG001|Double-Blind Phase|Investigator's Discretion|6|||
23525085|NCT00613509|65661643|FG000|Cycle 1|Unacceptable Toxicity|1|||
23206086|NCT02345252|64494804|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
23206087|NCT02345252|64494805|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
23525086|NCT00613509|65661644|FG001|Cycle 1|Unacceptable Toxicity|0|||
23525087|NCT00613509|65661643|FG000|Cycle 1|Other administrative reason|0|||
23525088|NCT00613509|65661644|FG001|Cycle 1|Other administrative reason|1|||
23525089|NCT00394212|65661645|FG000|Overall Study|Lost to Follow-up|3|||
23206088|NCT02345252|64494804|FG000|Double-Blind Phase|Protocol Violation|2|||
23206089|NCT02345252|64494805|FG001|Double-Blind Phase|Protocol Violation|1|||
23206090|NCT02345252|64494804|FG000|Double-Blind Phase|Withdrew Consent|21|||
23417185|NCT00281099|65271458|FG001|Overall Study|Lost to Follow-up|19|||
23525090|NCT00394212|65661646|FG001|Overall Study|Lost to Follow-up|0|||
23525091|NCT00394212|65661645|FG000|Overall Study|Withdrawal by Subject|4|||
23525092|NCT00394212|65661646|FG001|Overall Study|Withdrawal by Subject|1|||
23525093|NCT00058825|65661647|FG000|Overall Study|Relapse|9|||
23525094|NCT00058825|65661647|FG000|Overall Study|Progressive Disease|5|||
23525095|NCT00058825|65661647|FG000|Overall Study|Graft Failure|5|||
23525096|NCT00058825|65661647|FG000|Overall Study|Death|3|||
23525097|NCT00615056|65661648|FG000|Overall Study|Death|31|||
23525098|NCT00615056|65661649|FG001|Overall Study|Death|31|||
23525099|NCT00615056|65661650|FG002|Overall Study|Death|21|||
23525100|NCT00615056|65661651|FG003|Overall Study|Death|23|||
23525101|NCT00615056|65661648|FG000|Overall Study|Lost to Follow-up|1|||
23525102|NCT00615056|65661649|FG001|Overall Study|Lost to Follow-up|2|||
23525103|NCT00615056|65661650|FG002|Overall Study|Lost to Follow-up|4|||
23308548|NCT03400943|64874163|FG000|Post-treatment Period 1|Adverse Event|2|||
23308549|NCT03400943|64874164|FG001|Post-treatment Period 1|Adverse Event|0|||
23525104|NCT00615056|65661651|FG003|Overall Study|Lost to Follow-up|5|||
23417186|NCT00281099|65271457|FG000|Overall Study|Withdrawal by Subject|65|||
23525105|NCT00615056|65661648|FG000|Overall Study|Other|13|||
23525106|NCT00615056|65661649|FG001|Overall Study|Other|15|||
23525107|NCT00615056|65661650|FG002|Overall Study|Other|10|||
23525108|NCT00615056|65661651|FG003|Overall Study|Other|7|||
23525109|NCT00615056|65661648|FG000|Overall Study|Objective progression or relapse|0|||
23525110|NCT00615056|65661649|FG001|Overall Study|Objective progression or relapse|2|||
23525111|NCT00615056|65661650|FG002|Overall Study|Objective progression or relapse|0|||
23525112|NCT00615056|65661651|FG003|Overall Study|Objective progression or relapse|0|||
23525113|NCT00615056|65661648|FG000|Overall Study|Withdrawal by Subject|0|||
23525114|NCT00615056|65661649|FG001|Overall Study|Withdrawal by Subject|1|||
23525115|NCT00615056|65661650|FG002|Overall Study|Withdrawal by Subject|1|||
23525116|NCT00615056|65661651|FG003|Overall Study|Withdrawal by Subject|0|||
23525117|NCT00615056|65661648|FG000|Overall Study|Discontinued by Sponsor|1|||
23525118|NCT00615056|65661649|FG001|Overall Study|Discontinued by Sponsor|0|||
23525119|NCT00615056|65661650|FG002|Overall Study|Discontinued by Sponsor|0|||
23525120|NCT00615056|65661651|FG003|Overall Study|Discontinued by Sponsor|0|||
23525121|NCT00615056|65661648|FG000|Overall Study|Randomized but not treated|3|||
23525122|NCT00615056|65661649|FG001|Overall Study|Randomized but not treated|0|||
23525123|NCT00615056|65661650|FG002|Overall Study|Randomized but not treated|0|||
23525124|NCT00615056|65661651|FG003|Overall Study|Randomized but not treated|0|||
23525125|NCT02155738|65661652|FG000|Overall Study|Missing critical information|1|||
23525126|NCT02155738|65661653|FG001|Overall Study|Missing critical information|0|||
23525127|NCT02155738|65661654|FG002|Overall Study|Missing critical information|0|||
23525128|NCT02155738|65661655|FG003|Overall Study|Missing critical information|1|||
23525129|NCT03149237|65661656|FG000|Overall Study|Withdrawal by Subject|4|||
23417187|NCT00281099|65271458|FG001|Overall Study|Withdrawal by Subject|70|||
23417188|NCT00281099|65271457|FG000|Overall Study|Physician Decision|79|||
23417189|NCT00281099|65271458|FG001|Overall Study|Physician Decision|72|||
23417190|NCT00281099|65271457|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
23417191|NCT00281099|65271458|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
23417192|NCT00957944|65271460|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
23417193|NCT00957944|65271461|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
23417194|NCT03276026|65271466|FG000|Overall Study|Protocol Violation|1|||
23417195|NCT03276026|65271467|FG001|Overall Study|Protocol Violation|0|||
23417196|NCT02449889|65271468|FG000|Overall Study|Adverse Event|1|||
23417197|NCT02449889|65271469|FG001|Overall Study|Adverse Event|2|||
23417198|NCT02449889|65271470|FG002|Overall Study|Adverse Event|0|||
23417199|NCT02449889|65271468|FG000|Overall Study|Protocol Violation|0|||
23417200|NCT02449889|65271469|FG001|Overall Study|Protocol Violation|4|||
23417201|NCT02449889|65271470|FG002|Overall Study|Protocol Violation|1|||
23417202|NCT00347438|65271471|FG000|Overall Study|Withdrawal by Subject|1|||
23417203|NCT00347438|65271471|FG000|Overall Study|Physician Decision|1|||
23417204|NCT00176488|65271472|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
23417205|NCT01005316|65271473|FG000|Overall Study|Adverse Event|0|||
23417206|NCT01005316|65271474|FG001|Overall Study|Adverse Event|0|||
23417207|NCT01005316|65271475|FG002|Overall Study|Adverse Event|0|||
23417208|NCT01005316|65271476|FG003|Overall Study|Adverse Event|1|||
23417209|NCT01005316|65271473|FG000|Overall Study|Death|20|||
23417210|NCT01005316|65271474|FG001|Overall Study|Death|5|||
23417211|NCT01005316|65271475|FG002|Overall Study|Death|1|||
23417212|NCT01005316|65271476|FG003|Overall Study|Death|15|||
23417213|NCT01005316|65271473|FG000|Overall Study|Study Termination|5|||
23417214|NCT01005316|65271474|FG001|Overall Study|Study Termination|63|||
23417215|NCT01005316|65271475|FG002|Overall Study|Study Termination|9|||
23417216|NCT01005316|65271476|FG003|Overall Study|Study Termination|85|||
23417217|NCT01005316|65271473|FG000|Overall Study|Lost to Follow-up|1|||
23417218|NCT01005316|65271474|FG001|Overall Study|Lost to Follow-up|3|||
23417219|NCT01005316|65271475|FG002|Overall Study|Lost to Follow-up|0|||
23417220|NCT01005316|65271476|FG003|Overall Study|Lost to Follow-up|2|||
23417221|NCT01005316|65271473|FG000|Overall Study|Physician Decision|6|||
23417222|NCT01005316|65271474|FG001|Overall Study|Physician Decision|0|||
23417223|NCT01005316|65271475|FG002|Overall Study|Physician Decision|0|||
23417224|NCT01005316|65271476|FG003|Overall Study|Physician Decision|0|||
23417225|NCT01005316|65271473|FG000|Overall Study|Sponsor Decision|6|||
23417226|NCT01005316|65271474|FG001|Overall Study|Sponsor Decision|3|||
23417227|NCT01005316|65271475|FG002|Overall Study|Sponsor Decision|0|||
23417228|NCT01005316|65271476|FG003|Overall Study|Sponsor Decision|0|||
23417229|NCT01005316|65271473|FG000|Overall Study|Withdrawal by Subject|1|||
23417230|NCT01005316|65271474|FG001|Overall Study|Withdrawal by Subject|1|||
23417231|NCT01005316|65271475|FG002|Overall Study|Withdrawal by Subject|0|||
23417232|NCT01005316|65271476|FG003|Overall Study|Withdrawal by Subject|2|||
23417233|NCT01005316|65271473|FG000|Overall Study|Consented to Another Study|2|||
23417234|NCT01005316|65271474|FG001|Overall Study|Consented to Another Study|0|||
23417235|NCT01005316|65271475|FG002|Overall Study|Consented to Another Study|0|||
23417236|NCT01005316|65271476|FG003|Overall Study|Consented to Another Study|0|||
23417237|NCT01005316|65271473|FG000|Overall Study|Delisted|8|||
23417238|NCT01005316|65271474|FG001|Overall Study|Delisted|0|||
23417239|NCT01005316|65271475|FG002|Overall Study|Delisted|0|||
23417240|NCT01005316|65271476|FG003|Overall Study|Delisted|0|||
23417241|NCT01005316|65271473|FG000|Overall Study|Transferred Care|1|||
23417242|NCT01005316|65271474|FG001|Overall Study|Transferred Care|0|||
23417243|NCT01005316|65271475|FG002|Overall Study|Transferred Care|1|||
23417244|NCT01005316|65271476|FG003|Overall Study|Transferred Care|3|||
23417245|NCT01005316|65271473|FG000|Overall Study|Retransplanted|0|||
23417246|NCT01005316|65271474|FG001|Overall Study|Retransplanted|1|||
23417247|NCT01005316|65271475|FG002|Overall Study|Retransplanted|0|||
23417248|NCT01005316|65271476|FG003|Overall Study|Retransplanted|0|||
23417249|NCT00336284|65271477|FG000|Overall Study|Death|52|||
23417250|NCT00336284|65271478|FG001|Overall Study|Death|26|||
23417251|NCT00336284|65271477|FG000|Overall Study|Lost to Follow-up|82|||
23417252|NCT00336284|65271478|FG001|Overall Study|Lost to Follow-up|61|||
23417253|NCT00336284|65271477|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
23417254|NCT00336284|65271478|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
23417255|NCT00578877|65271479|FG000|Overall Study|Lost to Follow-up|8|||
23417256|NCT00578877|65271480|FG001|Overall Study|Lost to Follow-up|10|||
23417257|NCT00578877|65271479|FG000|Overall Study|early discontinue|61|||
23417258|NCT00578877|65271480|FG001|Overall Study|early discontinue|101|||
23417259|NCT00578877|65271479|FG000|Overall Study|did not provide follow-up data|12|||
23417260|NCT00578877|65271480|FG001|Overall Study|did not provide follow-up data|17|||
23417261|NCT01610713|65271483|FG000|Overall Study|Adverse Event|3|||
23417262|NCT01610713|65271484|FG001|Overall Study|Adverse Event|0|||
23417263|NCT01610713|65271483|FG000|Overall Study|Lack of Efficacy|1|||
23417264|NCT01610713|65271484|FG001|Overall Study|Lack of Efficacy|0|||
23417265|NCT01610713|65271483|FG000|Overall Study|low mood and poor motivation|1|||
23417266|NCT01610713|65271484|FG001|Overall Study|low mood and poor motivation|0|||
23417267|NCT01610713|65271483|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
23417268|NCT01610713|65271484|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
23417269|NCT01610713|65271483|FG000|Overall Study|Lost to Follow-up|0|||
23417270|NCT01610713|65271484|FG001|Overall Study|Lost to Follow-up|1|||
23417271|NCT00616018|65271485|FG000|Overall Study|Protocol Violation|3|||
23417272|NCT03199053|65271492|FG000|ST Period|Withdrawal by Subject|2|||
23417273|NCT03199053|65271493|FG001|ST Period|Withdrawal by Subject|4|||
23417274|NCT03199053|65271494|FG002|ST Period|Withdrawal by Subject|6|||
23417275|NCT03199053|65271492|FG000|ST Period|Withdrawal by parent/guardian|1|||
23417276|NCT03199053|65271493|FG001|ST Period|Withdrawal by parent/guardian|1|||
23417277|NCT03199053|65271494|FG002|ST Period|Withdrawal by parent/guardian|1|||
23417278|NCT03199053|65271492|FG000|ST Period|Lost to Follow-up|2|||
23417279|NCT03199053|65271493|FG001|ST Period|Lost to Follow-up|0|||
23417280|NCT03199053|65271494|FG002|ST Period|Lost to Follow-up|1|||
23417281|NCT03199053|65271492|FG000|LT Period|Withdrawal by Subject|1|||
23417282|NCT03199053|65271493|FG001|LT Period|Withdrawal by Subject|3|||
23417283|NCT03199053|65271494|FG002|LT Period|Withdrawal by Subject|3|||
23417284|NCT03199053|65271492|FG000|LT Period|Withdrawal by parent/guardian|0|||
23417285|NCT03199053|65271493|FG001|LT Period|Withdrawal by parent/guardian|0|||
23417286|NCT03199053|65271494|FG002|LT Period|Withdrawal by parent/guardian|1|||
23417287|NCT03199053|65271492|FG000|LT Period|Lost to Follow-up|0|||
23417288|NCT03199053|65271493|FG001|LT Period|Lost to Follow-up|1|||
23417289|NCT03199053|65271494|FG002|LT Period|Lost to Follow-up|1|||
23417290|NCT03199053|65271492|FG000|LT Period|Miscellaneous|0|||
23417291|NCT03199053|65271493|FG001|LT Period|Miscellaneous|0|||
23417292|NCT03199053|65271494|FG002|LT Period|Miscellaneous|2|||
23417293|NCT03199053|65271492|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
23417294|NCT03199053|65271493|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
23417295|NCT03199053|65271494|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
23417296|NCT03199053|65271492|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
23417297|NCT03199053|65271493|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
23417298|NCT03199053|65271494|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
23417299|NCT03199053|65271492|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
23417300|NCT03199053|65271493|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
23417301|NCT03199053|65271494|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
23417302|NCT03199053|65271492|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
23417303|NCT03199053|65271493|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
23417304|NCT03199053|65271494|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
23417305|NCT00654745|65271495|FG000|Overall Study|Adverse Event|12|||
23417306|NCT00654745|65271495|FG000|Overall Study|Lost to Follow-up|7|||
23417307|NCT00654745|65271495|FG000|Overall Study|Protocol Violation|11|||
23417308|NCT00654745|65271495|FG000|Overall Study|Withdrawal by Subject|10|||
23525130|NCT03149237|65661657|FG001|Overall Study|Withdrawal by Subject|5|||
23417309|NCT00654745|65271495|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
23417310|NCT00396136|65271496|FG000|Overall Study|Death|43|||
23417311|NCT00396136|65271496|FG000|Overall Study|Withdrawal by Subject|59|||
23417312|NCT00396136|65271496|FG000|Overall Study|Lost to Follow-up|15|||
23417313|NCT00396136|65271496|FG000|Overall Study|Study device explanted|8|||
23417314|NCT01127607|65274264|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
23417315|NCT01127607|65274265|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
23417316|NCT01127607|65274264|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
23417317|NCT01127607|65274265|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
23417318|NCT01425359|65274266|FG000|Overall Study|Randomized but Not Treated|2|||
23417319|NCT01425359|65274267|FG001|Overall Study|Randomized but Not Treated|3|||
23206091|NCT02345252|64494805|FG001|Double-Blind Phase|Withdrew Consent|23|||
23206092|NCT02345252|64494804|FG000|Double-Blind Phase|Lost to Follow-up|8|||
23206093|NCT02345252|64494805|FG001|Double-Blind Phase|Lost to Follow-up|10|||
23206094|NCT02345252|64494804|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
23417320|NCT01425359|65274266|FG000|Overall Study|Adverse Event|9|||
23417321|NCT01425359|65274267|FG001|Overall Study|Adverse Event|8|||
23417322|NCT01425359|65274266|FG000|Overall Study|Revascularization|0|||
23417323|NCT01425359|65274267|FG001|Overall Study|Revascularization|1|||
23417324|NCT01425359|65274266|FG000|Overall Study|Death|0|||
23417325|NCT01425359|65274267|FG001|Overall Study|Death|1|||
23417326|NCT01425359|65274266|FG000|Overall Study|Unsatisfactory Response|1|||
23417327|NCT01425359|65274267|FG001|Overall Study|Unsatisfactory Response|0|||
23417328|NCT01425359|65274266|FG000|Overall Study|Protocol Violation|1|||
23417329|NCT01425359|65274267|FG001|Overall Study|Protocol Violation|2|||
23417330|NCT01425359|65274266|FG000|Overall Study|Subject Withdrew Consent|1|||
23417331|NCT01425359|65274267|FG001|Overall Study|Subject Withdrew Consent|2|||
23417332|NCT01425359|65274266|FG000|Overall Study|Investigator's Discretion|2|||
23417333|NCT01425359|65274267|FG001|Overall Study|Investigator's Discretion|0|||
23417334|NCT01425359|65274266|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
23417335|NCT01425359|65274267|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
23417336|NCT05935878|65274276|FG000|Overall Study|Death|1|||
23417337|NCT05935878|65274277|FG001|Overall Study|Death|2|||
23417338|NCT05935878|65274276|FG000|Overall Study|Withdrawal by Subject|5|||
23417339|NCT05935878|65274277|FG001|Overall Study|Withdrawal by Subject|5|||
23417340|NCT05935878|65274276|FG000|Overall Study|Revision of implant|1|||
23417341|NCT05935878|65274277|FG001|Overall Study|Revision of implant|1|||
23417342|NCT05935878|65274276|FG000|Overall Study|Mobile bearing dislocation|0|||
23417343|NCT05935878|65274277|FG001|Overall Study|Mobile bearing dislocation|1|||
23417344|NCT02839720|65274278|FG000|Overall Study|Adverse Event|2|||
23417345|NCT02839720|65274278|FG000|Overall Study|Non-compliance|2|||
23417346|NCT02839720|65274278|FG000|Overall Study|Intercurrent Illness|1|||
23417347|NCT02839720|65274278|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
23417348|NCT05289271|65274282|FG000|Overall Study|Mistakenly allocated, untreated|1|||
23417349|NCT05289271|65274283|FG001|Overall Study|Mistakenly allocated, untreated|0|||
23417350|NCT03654040|65274285|FG000|Overall Study|Death|1|||
23417351|NCT03654040|65274286|FG001|Overall Study|Death|0|||
23417352|NCT03654040|65274285|FG000|Overall Study|Withdrawal by Subject|1|||
23417353|NCT03654040|65274286|FG001|Overall Study|Withdrawal by Subject|0|||
23206095|NCT02345252|64494805|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
23417354|NCT03654040|65274285|FG000|Overall Study|Study terminated by sponsor|8|||
23417355|NCT03654040|65274286|FG001|Overall Study|Study terminated by sponsor|2|||
23206096|NCT01963208|64494806|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
23417356|NCT03654040|65274285|FG000|Overall Study|Failure to initiate study therapy|2|||
23417357|NCT03654040|65274286|FG001|Overall Study|Failure to initiate study therapy|0|||
23417358|NCT03654040|65274285|FG000|Overall Study|Transplanted at another center|2|||
23417359|NCT03654040|65274286|FG001|Overall Study|Transplanted at another center|0|||
23417360|NCT03654040|65274285|FG000|Overall Study|Failure to meet eligibility criteria|14|||
23417361|NCT03654040|65274286|FG001|Overall Study|Failure to meet eligibility criteria|2|||
23417362|NCT03654040|65274285|FG000|Overall Study|No longer transplant candidate|1|||
23417363|NCT03654040|65274286|FG001|Overall Study|No longer transplant candidate|0|||
23417364|NCT03654040|65274285|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
23417365|NCT03654040|65274286|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
23417366|NCT03654040|65274285|FG000|Overall Study|Recipient ineligible|0|||
23417367|NCT03654040|65274286|FG001|Overall Study|Recipient ineligible|2|||
23417368|NCT03654040|65274285|FG000|Overall Study|Received deceased liver|0|||
23417369|NCT03654040|65274286|FG001|Overall Study|Received deceased liver|1|||
23417370|NCT01939002|65274291|FG000|Overall Study|Adverse Event|13|||
23417371|NCT01939002|65274292|FG001|Overall Study|Adverse Event|13|||
23417372|NCT01939002|65274291|FG000|Overall Study|Withdrawal by Subject|5|||
23417373|NCT01939002|65274292|FG001|Overall Study|Withdrawal by Subject|3|||
23417374|NCT01939002|65274291|FG000|Overall Study|Other|1|||
23417375|NCT01939002|65274292|FG001|Overall Study|Other|2|||
23417376|NCT00227344|65274293|FG000|Overall Study|study terminated early|12|||
23417377|NCT00227344|65274294|FG001|Overall Study|study terminated early|5|||
23417378|NCT04123093|65274297|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
23417379|NCT04123093|65274298|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
23417380|NCT04123093|65274297|FG000|Phase 2|Physician Decision|0|||
23525131|NCT02114879|65661658|FG000|Overall Study|Withdrawal by Subject|9|||
23525132|NCT02114879|65661659|FG001|Overall Study|Withdrawal by Subject|5|||
23525133|NCT02114879|65661658|FG000|Overall Study|Death|6|||
23525134|NCT02114879|65661659|FG001|Overall Study|Death|11|||
23525135|NCT02114879|65661658|FG000|Overall Study|Lost to Follow-up|4|||
23525136|NCT02114879|65661659|FG001|Overall Study|Lost to Follow-up|6|||
23525137|NCT02114879|65661658|FG000|Overall Study|Physician Decision|0|||
23525138|NCT02114879|65661659|FG001|Overall Study|Physician Decision|2|||
23525139|NCT01982253|65661662|FG000|Overall Study|Withdrawal by Subject|1|||
23525140|NCT01982253|65661663|FG001|Overall Study|Withdrawal by Subject|0|||
23525141|NCT01982253|65661664|FG002|Overall Study|Withdrawal by Subject|0|||
23525142|NCT01982253|65661662|FG000|Overall Study|Study terminated by sponsor|1|||
23525143|NCT01982253|65661663|FG001|Overall Study|Study terminated by sponsor|4|||
23525144|NCT01982253|65661664|FG002|Overall Study|Study terminated by sponsor|4|||
23525145|NCT04238728|65661665|FG000|Overall Study|Withdrawal by Subject|1|||
23525146|NCT04238728|65661665|FG000|Overall Study|Lost to Follow-up|2|||
23525147|NCT00344773|65661666|FG000|Overall Study|Adverse Event|2|||
23525148|NCT00344773|65661666|FG000|Overall Study|Objective Disease Progression|16|||
23525149|NCT00344773|65661666|FG000|Overall Study|Withdrawal by Subject|1|||
23525150|NCT00344773|65661666|FG000|Overall Study|Not Eligible for the study|2|||
23525151|NCT00913744|65661669|FG000|Overall Study|Adverse Event|2|||
23525152|NCT00913744|65661670|FG001|Overall Study|Adverse Event|0|||
23525153|NCT00913744|65661669|FG000|Overall Study|Withdrawal by Subject|2|||
23525154|NCT00913744|65661670|FG001|Overall Study|Withdrawal by Subject|1|||
23525155|NCT00913744|65661669|FG000|Overall Study|Death|1|||
23525156|NCT00913744|65661670|FG001|Overall Study|Death|0|||
23525157|NCT00082433|65661678|FG000|Overall Study|Adverse Event|12|||
23525158|NCT00082433|65661679|FG001|Overall Study|Adverse Event|17|||
23525159|NCT00082433|65661678|FG000|Overall Study|Death|8|||
23525160|NCT00082433|65661679|FG001|Overall Study|Death|18|||
23525161|NCT00082433|65661678|FG000|Overall Study|Disease Progression/Relapse|270|||
23525162|NCT00082433|65661679|FG001|Overall Study|Disease Progression/Relapse|388|||
23525163|NCT00082433|65661678|FG000|Overall Study|Physician Decision|50|||
23525164|NCT00082433|65661679|FG001|Overall Study|Physician Decision|61|||
23525165|NCT00082433|65661678|FG000|Overall Study|Lost to Follow-up|1|||
23525166|NCT00082433|65661679|FG001|Overall Study|Lost to Follow-up|2|||
23525167|NCT00082433|65661678|FG000|Overall Study|Study Drug Toxicity|179|||
23525168|NCT00082433|65661679|FG001|Overall Study|Study Drug Toxicity|66|||
23417381|NCT04123093|65274298|FG001|Phase 2|Physician Decision|1|||
23417382|NCT04123093|65274297|FG000|Phase 2|Withdrawal by Subject|0|||
23417383|NCT04123093|65274298|FG001|Phase 2|Withdrawal by Subject|1|||
23525169|NCT00082433|65661678|FG000|Overall Study|Withdrawal by Subject|55|||
23525170|NCT00082433|65661679|FG001|Overall Study|Withdrawal by Subject|30|||
23525171|NCT00082433|65661678|FG000|Overall Study|Still On Treatment|2|||
23525172|NCT00082433|65661679|FG001|Overall Study|Still On Treatment|1|||
23525173|NCT00082433|65661678|FG000|Overall Study|Not Treated|12|||
23525174|NCT00082433|65661679|FG001|Overall Study|Not Treated|11|||
23525175|NCT00082433|65661678|FG000|Overall Study|Ineligible|2|||
23525176|NCT00082433|65661679|FG001|Overall Study|Ineligible|1|||
23525177|NCT00082433|65661678|FG000|Overall Study|Noncompliance|2|||
23525178|NCT00082433|65661679|FG001|Overall Study|Noncompliance|1|||
23525179|NCT00082433|65661678|FG000|Overall Study|New primary cancer|1|||
23525180|NCT00082433|65661679|FG001|Overall Study|New primary cancer|0|||
23525181|NCT00082433|65661678|FG000|Overall Study|Impending surgery|0|||
23525182|NCT00082433|65661679|FG001|Overall Study|Impending surgery|1|||
23525183|NCT03161483|65661685|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
23525184|NCT03161483|65661686|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
23525185|NCT03161483|65661687|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
23525186|NCT03161483|65661688|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
23525187|NCT03161483|65661685|FG000|Treatment Period|Death|1|||
23525188|NCT03161483|65661686|FG001|Treatment Period|Death|0|||
23525189|NCT03161483|65661687|FG002|Treatment Period|Death|0|||
23525190|NCT03161483|65661688|FG003|Treatment Period|Death|0|||
23525191|NCT03161483|65661685|FG000|Treatment Period|Adverse Event|5|||
23525192|NCT03161483|65661686|FG001|Treatment Period|Adverse Event|2|||
23525193|NCT03161483|65661687|FG002|Treatment Period|Adverse Event|1|||
23525194|NCT03161483|65661688|FG003|Treatment Period|Adverse Event|11|||
23525195|NCT03161483|65661685|FG000|Treatment Period|Pregnancy|1|||
23525196|NCT03161483|65661686|FG001|Treatment Period|Pregnancy|0|||
23525197|NCT03161483|65661687|FG002|Treatment Period|Pregnancy|0|||
23525198|NCT03161483|65661688|FG003|Treatment Period|Pregnancy|0|||
23525199|NCT03161483|65661685|FG000|Treatment Period|Lack of Efficacy|0|||
23525200|NCT03161483|65661686|FG001|Treatment Period|Lack of Efficacy|0|||
23525201|NCT03161483|65661687|FG002|Treatment Period|Lack of Efficacy|0|||
23525202|NCT03161483|65661688|FG003|Treatment Period|Lack of Efficacy|1|||
23525203|NCT03161483|65661685|FG000|Treatment Period|Withdrawal by Subject|2|||
23525204|NCT03161483|65661686|FG001|Treatment Period|Withdrawal by Subject|5|||
23525205|NCT03161483|65661687|FG002|Treatment Period|Withdrawal by Subject|2|||
23525206|NCT03161483|65661688|FG003|Treatment Period|Withdrawal by Subject|6|||
23525207|NCT03161483|65661685|FG000|Treatment Period|Lost to Follow-up|0|||
23525208|NCT03161483|65661686|FG001|Treatment Period|Lost to Follow-up|0|||
23525209|NCT03161483|65661687|FG002|Treatment Period|Lost to Follow-up|0|||
23525210|NCT03161483|65661688|FG003|Treatment Period|Lost to Follow-up|1|||
23525211|NCT03161483|65661685|FG000|Treatment Period|Protocol Violation|0|||
23525212|NCT03161483|65661686|FG001|Treatment Period|Protocol Violation|0|||
23525213|NCT03161483|65661687|FG002|Treatment Period|Protocol Violation|0|||
23525214|NCT03161483|65661688|FG003|Treatment Period|Protocol Violation|1|||
23525215|NCT03161483|65661685|FG000|Treatment Period|Other reasons|1|||
23525216|NCT03161483|65661686|FG001|Treatment Period|Other reasons|1|||
23525217|NCT03161483|65661687|FG002|Treatment Period|Other reasons|0|||
23525218|NCT03161483|65661688|FG003|Treatment Period|Other reasons|0|||
23525219|NCT03238911|65661689|FG000|Overall Study|Withdrawal by Subject|1|||
23525220|NCT03238911|65661690|FG001|Overall Study|Withdrawal by Subject|2|||
23525221|NCT03238911|65661689|FG000|Overall Study|Lost to Follow-up|2|||
23525222|NCT03238911|65661690|FG001|Overall Study|Lost to Follow-up|1|||
23525223|NCT01428193|65661692|FG000|Overall Study|Physician Decision|1|||
23525224|NCT01428193|65661692|FG000|Overall Study|Elevated screening liver enzymes|1|||
23525225|NCT04145895|65661693|FG000|Overall Study|Physician Decision|2|||
23525226|NCT04145895|65661694|FG001|Overall Study|Physician Decision|0|||
23525227|NCT04145895|65661693|FG000|Overall Study|Withdrawal by Subject|0|||
23525228|NCT04145895|65661694|FG001|Overall Study|Withdrawal by Subject|2|||
23525229|NCT02659020|65661696|FG000|Overall Study|Adverse Event|0|||
23525230|NCT02659020|65661697|FG001|Overall Study|Adverse Event|0|||
23525231|NCT02659020|65661698|FG002|Overall Study|Adverse Event|0|||
23525232|NCT02659020|65661699|FG003|Overall Study|Adverse Event|2|||
23525233|NCT02659020|65661700|FG004|Overall Study|Adverse Event|0|||
23525234|NCT02659020|65661701|FG005|Overall Study|Adverse Event|0|||
23525235|NCT02659020|65661702|FG006|Overall Study|Adverse Event|2|||
23525236|NCT02659020|65661696|FG000|Overall Study|Lost to Follow-up|1|||
23525237|NCT02659020|65661697|FG001|Overall Study|Lost to Follow-up|2|||
23525238|NCT02659020|65661698|FG002|Overall Study|Lost to Follow-up|1|||
23525239|NCT02659020|65661699|FG003|Overall Study|Lost to Follow-up|6|||
23525240|NCT02659020|65661700|FG004|Overall Study|Lost to Follow-up|1|||
23525241|NCT02659020|65661701|FG005|Overall Study|Lost to Follow-up|5|||
23525242|NCT02659020|65661702|FG006|Overall Study|Lost to Follow-up|0|||
23525243|NCT02659020|65661696|FG000|Overall Study|Physician Decision|0|||
23525244|NCT02659020|65661697|FG001|Overall Study|Physician Decision|0|||
23525245|NCT02659020|65661698|FG002|Overall Study|Physician Decision|0|||
23525246|NCT02659020|65661699|FG003|Overall Study|Physician Decision|1|||
23525247|NCT02659020|65661700|FG004|Overall Study|Physician Decision|1|||
23525248|NCT02659020|65661701|FG005|Overall Study|Physician Decision|0|||
23525249|NCT02659020|65661702|FG006|Overall Study|Physician Decision|1|||
23525250|NCT02659020|65661696|FG000|Overall Study|Withdrawal by Subject|2|||
23525251|NCT02659020|65661697|FG001|Overall Study|Withdrawal by Subject|1|||
23525252|NCT02659020|65661698|FG002|Overall Study|Withdrawal by Subject|0|||
23525253|NCT02659020|65661699|FG003|Overall Study|Withdrawal by Subject|3|||
23525254|NCT02659020|65661700|FG004|Overall Study|Withdrawal by Subject|3|||
23525255|NCT02659020|65661701|FG005|Overall Study|Withdrawal by Subject|6|||
23525256|NCT02659020|65661702|FG006|Overall Study|Withdrawal by Subject|3|||
23525257|NCT02659020|65661696|FG000|Overall Study|Progressive Disease|0|||
23525258|NCT02659020|65661697|FG001|Overall Study|Progressive Disease|0|||
23525259|NCT02659020|65661698|FG002|Overall Study|Progressive Disease|0|||
23525260|NCT02659020|65661699|FG003|Overall Study|Progressive Disease|4|||
23525261|NCT02659020|65661700|FG004|Overall Study|Progressive Disease|1|||
23525262|NCT02659020|65661701|FG005|Overall Study|Progressive Disease|0|||
23525263|NCT02659020|65661702|FG006|Overall Study|Progressive Disease|2|||
23525264|NCT01859715|65661719|FG000|Overall Study|No 2nd VAS|16|||
23525265|NCT01859715|65661720|FG001|Overall Study|No 2nd VAS|8|||
23525266|NCT01859715|65661721|FG002|Overall Study|No 2nd VAS|23|||
23525267|NCT00006916|65661722|FG000|Overall Study|Device not inserted|4|||
23525268|NCT00006916|65661722|FG000|Overall Study|Complication of device insertion|1|||
23525269|NCT00358527|65661723|FG000|Overall Study|Adverse Event|4|||
23525270|NCT00358527|65661724|FG001|Overall Study|Adverse Event|0|||
23525271|NCT00358527|65661723|FG000|Overall Study|Withdrawal by Subject|1|||
23525272|NCT00358527|65661724|FG001|Overall Study|Withdrawal by Subject|1|||
23525273|NCT00358527|65661723|FG000|Overall Study|Non-compliance with protocol|6|||
23525274|NCT00358527|65661724|FG001|Overall Study|Non-compliance with protocol|1|||
23525275|NCT00358527|65661723|FG000|Overall Study|Administrative|2|||
23525276|NCT00358527|65661724|FG001|Overall Study|Administrative|1|||
23525277|NCT02739269|65661729|FG000|Overall Study|Protocol Violation|5|||
23525278|NCT02739269|65661730|FG001|Overall Study|Protocol Violation|0|||
23525279|NCT02739269|65661729|FG000|Overall Study|Cycle cancellation|2|||
23525280|NCT02739269|65661730|FG001|Overall Study|Cycle cancellation|2|||
23525281|NCT02739269|65661729|FG000|Overall Study|Withdrawal by Subject|0|||
23525282|NCT02739269|65661730|FG001|Overall Study|Withdrawal by Subject|2|||
23525283|NCT00974571|65661731|FG000|Overall Study|Adverse Event|31|||
23525284|NCT00974571|65661732|FG001|Overall Study|Adverse Event|4|||
23525285|NCT00974571|65661733|FG002|Overall Study|Adverse Event|27|||
23525286|NCT00974571|65661731|FG000|Overall Study|Lack of Efficacy|3|||
23525287|NCT00974571|65661732|FG001|Overall Study|Lack of Efficacy|2|||
23525288|NCT00974571|65661733|FG002|Overall Study|Lack of Efficacy|9|||
23525289|NCT00974571|65661731|FG000|Overall Study|Lost to Follow-up|2|||
23525290|NCT00974571|65661732|FG001|Overall Study|Lost to Follow-up|1|||
23525291|NCT00974571|65661733|FG002|Overall Study|Lost to Follow-up|2|||
23525292|NCT00974571|65661731|FG000|Overall Study|Protocol Violation|13|||
23525293|NCT00974571|65661732|FG001|Overall Study|Protocol Violation|4|||
23206097|NCT01963208|64494807|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
23308550|NCT03400943|64874165|FG002|Post-treatment Period 1|Adverse Event|0|||
23308551|NCT03400943|64874166|FG003|Post-treatment Period 1|Adverse Event|0|||
23308552|NCT03400943|64874163|FG000|Post-treatment Period 1|Protocol Violation|1|||
23308553|NCT03400943|64874164|FG001|Post-treatment Period 1|Protocol Violation|0|||
23308554|NCT03400943|64874165|FG002|Post-treatment Period 1|Protocol Violation|0|||
23308555|NCT03400943|64874166|FG003|Post-treatment Period 1|Protocol Violation|0|||
23308556|NCT03400943|64874163|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
23308557|NCT03400943|64874164|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
23308558|NCT03400943|64874165|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
23308559|NCT03400943|64874166|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
23308560|NCT03400943|64874163|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
23308561|NCT03400943|64874164|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
23308562|NCT03400943|64874165|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
23308563|NCT03400943|64874166|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
23206098|NCT01963208|64494808|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
23308564|NCT03400943|64874163|FG000|Post-treatment Period 1|Other|2|||
23308565|NCT03400943|64874164|FG001|Post-treatment Period 1|Other|0|||
23308566|NCT03400943|64874165|FG002|Post-treatment Period 1|Other|4|||
23308567|NCT03400943|64874166|FG003|Post-treatment Period 1|Other|5|||
23308568|NCT03400943|64874163|FG000|Treatment Period 2|Study terminated by sponsor|0|||
23308569|NCT03400943|64874164|FG001|Treatment Period 2|Study terminated by sponsor|1|||
23308570|NCT03400943|64874165|FG002|Treatment Period 2|Study terminated by sponsor|0|||
23308571|NCT03400943|64874166|FG003|Treatment Period 2|Study terminated by sponsor|0|||
23525294|NCT00974571|65661733|FG002|Overall Study|Protocol Violation|18|||
23525295|NCT00974571|65661731|FG000|Overall Study|Withdrawal by Subject|14|||
23525296|NCT00974571|65661732|FG001|Overall Study|Withdrawal by Subject|5|||
23308572|NCT03400943|64874163|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23308573|NCT03400943|64874164|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23308574|NCT03400943|64874165|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23308575|NCT03400943|64874166|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23308576|NCT03400943|64874163|FG000|Treatment Period 2|Other|1|||
23308577|NCT03400943|64874164|FG001|Treatment Period 2|Other|6|||
23525297|NCT00974571|65661733|FG002|Overall Study|Withdrawal by Subject|16|||
23525298|NCT00974571|65661731|FG000|Overall Study|Patient Moved|1|||
23525299|NCT00974571|65661732|FG001|Overall Study|Patient Moved|0|||
23525300|NCT00974571|65661733|FG002|Overall Study|Patient Moved|1|||
23308578|NCT03400943|64874165|FG002|Treatment Period 2|Other|0|||
23525301|NCT00974571|65661731|FG000|Overall Study|Other|4|||
23525302|NCT00974571|65661732|FG001|Overall Study|Other|0|||
23525303|NCT00974571|65661733|FG002|Overall Study|Other|10|||
23525304|NCT04019041|65661737|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
23525305|NCT04019041|65661738|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
23525306|NCT04019041|65661739|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
23525307|NCT04019041|65661740|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23525308|NCT04019041|65661741|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23525309|NCT04019041|65661742|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23525310|NCT04019041|65661737|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525311|NCT04019041|65661738|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525312|NCT04019041|65661739|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
23525313|NCT04019041|65661740|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525314|NCT04019041|65661741|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525315|NCT04019041|65661742|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
23525316|NCT04019041|65661737|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
23525317|NCT04019041|65661738|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
23525318|NCT04019041|65661739|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
23525319|NCT04019041|65661740|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23525320|NCT04019041|65661741|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23525321|NCT04019041|65661742|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23525322|NCT04019041|65661737|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23525323|NCT04019041|65661738|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23525324|NCT04019041|65661739|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
23525325|NCT04019041|65661740|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23525326|NCT04019041|65661741|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23308579|NCT03400943|64874166|FG003|Treatment Period 2|Other|0|||
23308580|NCT03400943|64874163|FG000|Follow-up Period|Withdrawal by Subject|1|||
23308581|NCT03400943|64874164|FG001|Follow-up Period|Withdrawal by Subject|0|||
23308582|NCT03400943|64874165|FG002|Follow-up Period|Withdrawal by Subject|0|||
23308583|NCT03400943|64874166|FG003|Follow-up Period|Withdrawal by Subject|0|||
23308584|NCT03858634|64874167|FG000|Overall Study|Withdrawal by Subject|1|||
23308585|NCT03858634|64874168|FG001|Overall Study|Withdrawal by Subject|0|||
23308586|NCT03858634|64874167|FG000|Overall Study|Adverse Event|1|||
23308587|NCT03858634|64874168|FG001|Overall Study|Adverse Event|0|||
23525327|NCT04019041|65661742|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
23525328|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23525329|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23206099|NCT01963208|64494809|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
23206100|NCT01963208|64494810|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
23525330|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23308588|NCT03858634|64874167|FG000|Overall Study|Lost to Follow-up|0|||
23308589|NCT03858634|64874168|FG001|Overall Study|Lost to Follow-up|1|||
23308590|NCT03858634|64874167|FG000|Overall Study|Other, Not Specified|1|||
23308591|NCT03858634|64874168|FG001|Overall Study|Other, Not Specified|1|||
23308592|NCT02524730|64874169|FG000|Overall Study|Lost to Follow-up|5|||
23308593|NCT02524730|64874169|FG000|Overall Study|Withdrawal by Subject|18|||
23417384|NCT01774097|65274301|FG000|Overall Study|Withdrawal by Subject|1|||
23417385|NCT01774097|65274302|FG001|Overall Study|Withdrawal by Subject|1|||
23417386|NCT01774097|65274301|FG000|Overall Study|Adverse Event|1|||
23417387|NCT01774097|65274302|FG001|Overall Study|Adverse Event|1|||
23417388|NCT01535599|65274306|FG000|Overall Study|Adverse Event|6|||
23417389|NCT01535599|65274307|FG001|Overall Study|Adverse Event|15|||
23417390|NCT01535599|65274306|FG000|Overall Study|Lost to Follow-up|3|||
23417391|NCT01535599|65274307|FG001|Overall Study|Lost to Follow-up|4|||
23417392|NCT01535599|65274306|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
23417393|NCT01535599|65274307|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
23417394|NCT01535599|65274306|FG000|Overall Study|Treatment Failure|33|||
23417395|NCT01535599|65274307|FG001|Overall Study|Treatment Failure|66|||
23417396|NCT01535599|65274306|FG000|Overall Study|BL Culture + for Group A Strep|0|||
23417397|NCT01535599|65274307|FG001|Overall Study|BL Culture + for Group A Strep|1|||
23417398|NCT01535599|65274306|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
23417399|NCT01535599|65274307|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
23417400|NCT01535599|65274306|FG000|Overall Study|Randomized in Error|2|||
23417401|NCT01535599|65274307|FG001|Overall Study|Randomized in Error|4|||
23417402|NCT01535599|65274306|FG000|Overall Study|Did not use product|1|||
23417403|NCT01535599|65274307|FG001|Overall Study|Did not use product|0|||
23417404|NCT01535599|65274306|FG000|Overall Study|Other|1|||
23417405|NCT01535599|65274307|FG001|Overall Study|Other|0|||
23417406|NCT01535599|65274306|FG000|Overall Study|Stopped medication|0|||
23417407|NCT01535599|65274307|FG001|Overall Study|Stopped medication|1|||
23417408|NCT01535599|65274306|FG000|Overall Study|Noncompliance|0|||
23417409|NCT01535599|65274307|FG001|Overall Study|Noncompliance|1|||
23525331|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
23525332|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
23525333|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
23525334|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23525335|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23525336|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23525337|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
23417410|NCT01257568|65274308|FG000|Overall Study|Lost to Follow-up|2|||
23417411|NCT01257568|65274308|FG000|Overall Study|Withdrawal by Subject|6|||
23417412|NCT01257568|65274308|FG000|Overall Study|Terminated|1|||
23417413|NCT01257568|65274308|FG000|Overall Study|Component Revision|24|||
23417414|NCT03350256|65274313|FG000|Overall Study|Inclusion/exclusion violation|4|||
23417415|NCT03350256|65274313|FG000|Overall Study|Recommended for other therapies|2|||
23417416|NCT03350256|65274313|FG000|Overall Study|Protocol Violation|3|||
23417417|NCT03350256|65274313|FG000|Overall Study|Non compliance|2|||
23417418|NCT03350256|65274313|FG000|Overall Study|Denial by insurance|1|||
23417419|NCT03350256|65274313|FG000|Overall Study|Adverse Event|2|||
23525338|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23417420|NCT03350256|65274313|FG000|Overall Study|Trial failure|12|||
23417421|NCT03350256|65274313|FG000|Overall Study|Did not proceed to permanent implant|3|||
23308594|NCT02524730|64874169|FG000|Overall Study|Death|10|||
23417422|NCT03350256|65274313|FG000|Overall Study|Withdrawal by Subject|3|||
23417423|NCT03350256|65274313|FG000|Overall Study|Subject moving out of state|1|||
23417424|NCT03350256|65274313|FG000|Overall Study|Lost to Follow-up|1|||
23417425|NCT03350256|65274313|FG000|Overall Study|Lack of Efficacy|2|||
23417426|NCT03070171|65274314|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
23417427|NCT03070171|65274315|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
23417428|NCT03070171|65274314|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
23417429|NCT03070171|65274315|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
23417430|NCT02019108|65274316|FG000|Overall Study|Lost to Follow-up|5|||
23417431|NCT02019108|65274317|FG001|Overall Study|Lost to Follow-up|7|||
23417432|NCT02461290|65274318|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
23417433|NCT02461290|65274318|FG000|Overall Study|Lost to Follow-up|3|||
23417434|NCT02447250|65274319|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
23417435|NCT02447250|65274319|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
23417436|NCT02447250|65274319|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
23417437|NCT02152371|65274320|FG000|Overall Study|Adverse Event|6|||
23417438|NCT02152371|65274321|FG001|Overall Study|Adverse Event|2|||
23417439|NCT02152371|65274320|FG000|Overall Study|Withdrawal by Subject|3|||
23417440|NCT02152371|65274321|FG001|Overall Study|Withdrawal by Subject|7|||
23417441|NCT02152371|65274320|FG000|Overall Study|Protocol Violation|2|||
23417442|NCT02152371|65274321|FG001|Overall Study|Protocol Violation|3|||
23417443|NCT02152371|65274320|FG000|Overall Study|Lost to Follow-up|1|||
23417444|NCT02152371|65274321|FG001|Overall Study|Lost to Follow-up|0|||
23417445|NCT02152371|65274320|FG000|Overall Study|Lack of Efficacy|0|||
23417446|NCT02152371|65274321|FG001|Overall Study|Lack of Efficacy|1|||
23417447|NCT02152371|65274320|FG000|Overall Study|Physician Decision|0|||
23417448|NCT02152371|65274321|FG001|Overall Study|Physician Decision|2|||
23417449|NCT02152371|65274320|FG000|Overall Study|Reason Not Given|0|||
23417450|NCT02152371|65274321|FG001|Overall Study|Reason Not Given|1|||
23417451|NCT00066222|65274322|FG000|Overall Study|No protocol treatment received|1|||
23417452|NCT02524275|65274323|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
23417453|NCT03037476|65274327|FG000|Overall Study|Lost to Follow-up|63|||
23417454|NCT03037476|65274328|FG001|Overall Study|Lost to Follow-up|46|||
23417455|NCT01369641|65274330|FG000|Overall Study|Withdrawal by Subject|1|||
23417456|NCT03650803|65274338|FG000|Overall Study|Lost to Follow-up|6|||
23417457|NCT01944098|65274339|FG000|Overall Study|Physician Decision|1|||
23417458|NCT01944098|65274340|FG001|Overall Study|Physician Decision|0|||
23417459|NCT02256384|65274341|FG000|Overall Study|Withdrawal by Subject|12|||
23417460|NCT02256384|65274341|FG000|Overall Study|Equipment not capturing data|2|||
23417461|NCT01482169|65274342|FG000|Overall Study|Physician Decision|2|||
23417462|NCT01331837|65274345|FG000|Overall Study|Death|30|||
23417463|NCT01331837|65274346|FG001|Overall Study|Death|34|||
23417464|NCT01331837|65274345|FG000|Overall Study|Lost to Follow-up|3|||
23417465|NCT01331837|65274346|FG001|Overall Study|Lost to Follow-up|1|||
23417466|NCT01331837|65274345|FG000|Overall Study|Info not recorded|10|||
23417467|NCT01331837|65274346|FG001|Overall Study|Info not recorded|16|||
23417468|NCT01331837|65274345|FG000|Overall Study|Withdrawal by Subject|13|||
23417469|NCT01331837|65274346|FG001|Overall Study|Withdrawal by Subject|16|||
23417470|NCT01659996|65274347|FG000|Overall Study|Protocol Violation|3|||
23417471|NCT01659996|65274348|FG001|Overall Study|Protocol Violation|3|||
23417472|NCT01659996|65274349|FG002|Overall Study|Protocol Violation|3|||
23417473|NCT01659996|65274347|FG000|Overall Study|Lost to Follow-up|1|||
23417474|NCT01659996|65274348|FG001|Overall Study|Lost to Follow-up|3|||
23417475|NCT01659996|65274349|FG002|Overall Study|Lost to Follow-up|2|||
23417476|NCT01659996|65274347|FG000|Overall Study|Adverse Event|0|||
23417477|NCT01659996|65274348|FG001|Overall Study|Adverse Event|0|||
23417478|NCT01659996|65274349|FG002|Overall Study|Adverse Event|1|||
23417479|NCT01659996|65274347|FG000|Overall Study|Withdrawal by Subject|4|||
23417480|NCT01659996|65274348|FG001|Overall Study|Withdrawal by Subject|1|||
23417481|NCT01659996|65274349|FG002|Overall Study|Withdrawal by Subject|5|||
23417482|NCT01801436|65274357|FG000|Overall Study|Withdrawal by Subject|3|||
23417483|NCT01801436|65274357|FG000|Overall Study|Adverse Event|2|||
23417484|NCT01801436|65274357|FG000|Overall Study|Progressive disease|4|||
23417485|NCT01545934|65274358|FG000|Overall Study|Withdrawal by Subject|4|||
23417486|NCT01545934|65274359|FG001|Overall Study|Withdrawal by Subject|3|||
23417487|NCT01545934|65274358|FG000|Overall Study|Lost to Follow-up|1|||
23417488|NCT01545934|65274359|FG001|Overall Study|Lost to Follow-up|0|||
23417489|NCT00433966|65274362|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
23417490|NCT00433966|65274363|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
23417491|NCT00433966|65274364|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
23417492|NCT00433966|65274365|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
23417493|NCT00433966|65274362|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
23417494|NCT00433966|65274363|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
23417495|NCT00433966|65274364|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
23417496|NCT00433966|65274365|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
23417497|NCT00433966|65274362|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
23417498|NCT00433966|65274363|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
23417499|NCT00433966|65274364|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
23417500|NCT00433966|65274365|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
23417501|NCT00433966|65274362|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
23417502|NCT00433966|65274363|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
23417503|NCT00433966|65274364|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
23417504|NCT00433966|65274365|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
23417505|NCT00433966|65274362|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
23417506|NCT00433966|65274363|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
23417507|NCT00433966|65274364|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
23417508|NCT00433966|65274365|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
23417509|NCT01920568|65274366|FG000|Overall Study|Adverse Event|27|||
23417510|NCT01920568|65274367|FG001|Overall Study|Adverse Event|8|||
23417511|NCT01920568|65274366|FG000|Overall Study|Protocol Violation|5|||
23417512|NCT01920568|65274367|FG001|Overall Study|Protocol Violation|3|||
23417513|NCT01920568|65274366|FG000|Overall Study|Lost to Follow-up|2|||
23417514|NCT01920568|65274367|FG001|Overall Study|Lost to Follow-up|2|||
23417515|NCT01920568|65274366|FG000|Overall Study|Physician Decision|13|||
23417516|NCT01920568|65274367|FG001|Overall Study|Physician Decision|4|||
23417517|NCT01920568|65274366|FG000|Overall Study|Withdrawal by Subject|79|||
23417518|NCT01920568|65274367|FG001|Overall Study|Withdrawal by Subject|55|||
23417519|NCT01920568|65274366|FG000|Overall Study|Death due to disease progression|25|||
23417520|NCT01920568|65274367|FG001|Overall Study|Death due to disease progression|12|||
23417521|NCT02324205|65274368|FG000|Overall Study|Withdrawal by Subject|37|||
23417522|NCT04098367|65274369|FG000|Overall Study|Adverse Event|0|||
23417523|NCT04098367|65274370|FG001|Overall Study|Adverse Event|0|||
23417524|NCT04098367|65274371|FG002|Overall Study|Adverse Event|1|||
23417525|NCT04098367|65274369|FG000|Overall Study|Lost to Follow-up|1|||
23417526|NCT04098367|65274370|FG001|Overall Study|Lost to Follow-up|5|||
23417527|NCT04098367|65274371|FG002|Overall Study|Lost to Follow-up|2|||
23417528|NCT04098367|65274369|FG000|Overall Study|Withdrawal by Subject|0|||
23417529|NCT04098367|65274370|FG001|Overall Study|Withdrawal by Subject|0|||
23417530|NCT04098367|65274371|FG002|Overall Study|Withdrawal by Subject|1|||
23417531|NCT04098367|65274369|FG000|Overall Study|Sick . Could not attend visit|1|||
23417532|NCT04098367|65274370|FG001|Overall Study|Sick . Could not attend visit|0|||
23417533|NCT04098367|65274371|FG002|Overall Study|Sick . Could not attend visit|0|||
23417534|NCT00951080|65274374|FG000|Overall Study|Adverse Event|3|||
23417535|NCT00951080|65274375|FG001|Overall Study|Adverse Event|3|||
23417536|NCT00951080|65274374|FG000|Overall Study|Lost to Follow-up|0|||
23417537|NCT00951080|65274375|FG001|Overall Study|Lost to Follow-up|1|||
23417538|NCT00951080|65274374|FG000|Overall Study|Physician Decision|4|||
23417539|NCT00951080|65274375|FG001|Overall Study|Physician Decision|1|||
23417540|NCT00951080|65274374|FG000|Overall Study|Other|19|||
23417541|NCT00951080|65274375|FG001|Overall Study|Other|22|||
23417542|NCT02135029|65274376|FG000|Overall Study|Adverse Event|2|||
23417543|NCT02135029|65274377|FG001|Overall Study|Adverse Event|2|||
23417544|NCT02135029|65274378|FG002|Overall Study|Adverse Event|2|||
23525339|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
23525340|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525341|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525342|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525343|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525344|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
23525345|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
23525346|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23525347|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23525348|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23525349|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
23525350|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
23525351|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
23525352|NCT04019041|65661737|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23525353|NCT04019041|65661738|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23525354|NCT04019041|65661739|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23525355|NCT04019041|65661740|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23525356|NCT04019041|65661741|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
23525357|NCT04019041|65661742|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
23525358|NCT01494610|65661747|FG000|Period 1|Withdrawal by Subject|1|||
23417545|NCT02135029|65274376|FG000|Overall Study|Lost to Follow-up|0|||
23417546|NCT02135029|65274377|FG001|Overall Study|Lost to Follow-up|1|||
23417547|NCT02135029|65274378|FG002|Overall Study|Lost to Follow-up|0|||
23417548|NCT02135029|65274376|FG000|Overall Study|Withdrawal by Subject|2|||
23417549|NCT02135029|65274377|FG001|Overall Study|Withdrawal by Subject|0|||
23417550|NCT02135029|65274378|FG002|Overall Study|Withdrawal by Subject|1|||
23417551|NCT02135029|65274376|FG000|Overall Study|Other|0|||
23417552|NCT02135029|65274377|FG001|Overall Study|Other|1|||
23525359|NCT01494610|65661748|FG001|Period 1|Withdrawal by Subject|1|||
23417553|NCT02135029|65274378|FG002|Overall Study|Other|0|||
23417554|NCT02135029|65274376|FG000|Overall Study|Death|0|||
23525360|NCT01494610|65661747|FG000|Period 3|Adverse Event|1|||
23525361|NCT01494610|65661748|FG001|Period 3|Adverse Event|0|||
23525362|NCT01494610|65661747|FG000|Period 3|Withdrawal by Subject|1|||
23525363|NCT01494610|65661748|FG001|Period 3|Withdrawal by Subject|0|||
23525364|NCT01494610|65661747|FG000|Period 4|Protocol Violation|1|||
23525365|NCT01494610|65661748|FG001|Period 4|Protocol Violation|0|||
23525366|NCT02404350|65661749|FG000|Overall Study|Adverse Event|2|||
23525367|NCT02404350|65661750|FG001|Overall Study|Adverse Event|2|||
23525368|NCT02404350|65661751|FG002|Overall Study|Adverse Event|3|||
23525369|NCT02404350|65661752|FG003|Overall Study|Adverse Event|9|||
23525370|NCT02404350|65661749|FG000|Overall Study|Lack of Efficacy|3|||
23525371|NCT02404350|65661750|FG001|Overall Study|Lack of Efficacy|1|||
23525372|NCT02404350|65661751|FG002|Overall Study|Lack of Efficacy|0|||
23525373|NCT02404350|65661752|FG003|Overall Study|Lack of Efficacy|3|||
23525374|NCT02404350|65661749|FG000|Overall Study|Lost to Follow-up|2|||
23525375|NCT02404350|65661750|FG001|Overall Study|Lost to Follow-up|0|||
23525376|NCT02404350|65661751|FG002|Overall Study|Lost to Follow-up|0|||
23525377|NCT02404350|65661752|FG003|Overall Study|Lost to Follow-up|1|||
23525378|NCT02404350|65661749|FG000|Overall Study|Physician Decision|1|||
23525379|NCT02404350|65661750|FG001|Overall Study|Physician Decision|0|||
23525380|NCT02404350|65661751|FG002|Overall Study|Physician Decision|0|||
23417555|NCT02135029|65274377|FG001|Overall Study|Death|1|||
23417556|NCT02135029|65274378|FG002|Overall Study|Death|0|||
23417557|NCT00522418|65274379|FG000|Overall Study|Local IRB Consent Violation|5|||
23417558|NCT00522418|65274380|FG001|Overall Study|Local IRB Consent Violation|5|||
23417559|NCT00522418|65274379|FG000|Overall Study|Early Study Termination|46|||
23417560|NCT00522418|65274380|FG001|Overall Study|Early Study Termination|47|||
23417561|NCT00522418|65274379|FG000|Overall Study|Noncompliance|2|||
23525381|NCT02404350|65661752|FG003|Overall Study|Physician Decision|2|||
23525382|NCT02404350|65661749|FG000|Overall Study|Pregnancy|0|||
23525383|NCT02404350|65661750|FG001|Overall Study|Pregnancy|0|||
23525384|NCT02404350|65661751|FG002|Overall Study|Pregnancy|0|||
23525385|NCT02404350|65661752|FG003|Overall Study|Pregnancy|1|||
23525386|NCT02404350|65661749|FG000|Overall Study|Withdrawal by Subject|7|||
23525387|NCT02404350|65661750|FG001|Overall Study|Withdrawal by Subject|3|||
23525388|NCT02404350|65661751|FG002|Overall Study|Withdrawal by Subject|3|||
23525389|NCT02404350|65661752|FG003|Overall Study|Withdrawal by Subject|19|||
23525390|NCT02404350|65661749|FG000|Overall Study|Due to Non-compliance with treatment|0|||
23525391|NCT02404350|65661750|FG001|Overall Study|Due to Non-compliance with treatment|0|||
23525392|NCT02404350|65661751|FG002|Overall Study|Due to Non-compliance with treatment|0|||
23525393|NCT02404350|65661752|FG003|Overall Study|Due to Non-compliance with treatment|1|||
23525394|NCT02404350|65661749|FG000|Overall Study|Due to Technical problems|0|||
23525395|NCT02404350|65661750|FG001|Overall Study|Due to Technical problems|0|||
23525396|NCT02404350|65661751|FG002|Overall Study|Due to Technical problems|0|||
23525397|NCT02404350|65661752|FG003|Overall Study|Due to Technical problems|1|||
23417562|NCT00522418|65274380|FG001|Overall Study|Noncompliance|2|||
23417563|NCT00522418|65274379|FG000|Overall Study|Reason Not Specified|3|||
23417564|NCT00522418|65274380|FG001|Overall Study|Reason Not Specified|1|||
23525398|NCT04371380|65661755|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
23417565|NCT00522418|65274379|FG000|Overall Study|Consent Withdraw|1|||
23417566|NCT00522418|65274380|FG001|Overall Study|Consent Withdraw|2|||
23417567|NCT00522418|65274379|FG000|Overall Study|Lack of Efficacy|0|||
23417568|NCT00522418|65274380|FG001|Overall Study|Lack of Efficacy|1|||
23525399|NCT04371380|65661756|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
23525400|NCT04371380|65661757|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
23525401|NCT02375672|65661769|FG000|Overall Study|remain on follow up|20|||
23417569|NCT00624585|65274382|FG000|Overall Study|Death|3|||
23525402|NCT02457325|65661770|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
23525403|NCT02457325|65661771|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
23525404|NCT00588445|65661772|FG000|Overall Study|Protocol Violation|1|||
23525405|NCT00588445|65661772|FG000|Overall Study|Withdrawal by Subject|3|||
23525406|NCT00588445|65661772|FG000|Overall Study|Disease Progression|1|||
23525407|NCT00588445|65661772|FG000|Overall Study|Not Treated|10|||
23525408|NCT02789176|65661773|FG000|Overall Study|Death|0|||
23525409|NCT02789176|65661774|FG001|Overall Study|Death|0|||
23525410|NCT02789176|65661775|FG002|Overall Study|Death|3|||
23525411|NCT02789176|65661776|FG003|Overall Study|Death|0|||
23525412|NCT02789176|65661773|FG000|Overall Study|Withdrawal by Subject|0|||
23308595|NCT02524730|64874169|FG000|Overall Study|Adverse Event|8|||
23308596|NCT02524730|64874169|FG000|Overall Study|Protocol Violation|1|||
23308597|NCT02524730|64874169|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
23308598|NCT00265395|64874174|FG000|Overall Study|Adverse Event|3|||
23308599|NCT00265395|64874175|FG001|Overall Study|Adverse Event|6|||
23308600|NCT00265395|64874174|FG000|Overall Study|Lost to Follow-up|2|||
23308601|NCT00265395|64874175|FG001|Overall Study|Lost to Follow-up|1|||
23417570|NCT00624585|65274382|FG000|Overall Study|Disease Progression|6|||
23206101|NCT01963208|64494811|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
23308602|NCT00265395|64874174|FG000|Overall Study|Withdrawal by Subject|1|||
23417571|NCT00624585|65274382|FG000|Overall Study|Adverse Event|3|||
23417572|NCT01703208|65274393|FG000|Overall Study|Death|61|||
23417573|NCT01703208|65274394|FG001|Overall Study|Death|48|||
23417574|NCT01703208|65274393|FG000|Overall Study|Lack of Efficacy|1|||
23417575|NCT01703208|65274394|FG001|Overall Study|Lack of Efficacy|2|||
23417576|NCT01703208|65274393|FG000|Overall Study|Lost to Follow-up|68|||
23417577|NCT01703208|65274394|FG001|Overall Study|Lost to Follow-up|62|||
23417578|NCT01703208|65274393|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23417579|NCT01703208|65274394|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23417580|NCT01703208|65274393|FG000|Overall Study|Excluded Medication|1|||
23417581|NCT01703208|65274394|FG001|Overall Study|Excluded Medication|2|||
23417582|NCT01703208|65274393|FG000|Overall Study|Site Discontinued Study Participation|23|||
23417583|NCT01703208|65274394|FG001|Overall Study|Site Discontinued Study Participation|27|||
23417584|NCT01703208|65274393|FG000|Overall Study|Physician Decision|11|||
23417585|NCT01703208|65274394|FG001|Overall Study|Physician Decision|13|||
23417586|NCT01703208|65274393|FG000|Overall Study|Progressive disease|2|||
23417587|NCT01703208|65274394|FG001|Overall Study|Progressive disease|2|||
23417588|NCT01703208|65274393|FG000|Overall Study|Protocol Violation|1|||
23417589|NCT01703208|65274394|FG001|Overall Study|Protocol Violation|1|||
23417590|NCT01703208|65274393|FG000|Overall Study|Study Terminated by Sponsor|1710|||
23417591|NCT01703208|65274394|FG001|Overall Study|Study Terminated by Sponsor|1716|||
23417592|NCT01703208|65274393|FG000|Overall Study|Withdrawal by Subject|205|||
23417593|NCT01703208|65274394|FG001|Overall Study|Withdrawal by Subject|209|||
23417594|NCT01703208|65274393|FG000|Overall Study|Adverse Event|14|||
23417595|NCT01703208|65274394|FG001|Overall Study|Adverse Event|19|||
23417596|NCT01703208|65274393|FG000|Overall Study|Technical Problems|0|||
23417597|NCT01703208|65274394|FG001|Overall Study|Technical Problems|1|||
23417598|NCT01703208|65274393|FG000|Overall Study|Protocol Deviation|2|||
23417599|NCT01703208|65274394|FG001|Overall Study|Protocol Deviation|0|||
23417600|NCT01685801|65274395|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
23417601|NCT01685801|65274396|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
23417602|NCT01685801|65274397|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
23417603|NCT01685801|65274398|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
23417604|NCT01685801|65274395|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
23417605|NCT01685801|65274396|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
23417606|NCT01685801|65274397|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
23417607|NCT01685801|65274398|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
23417608|NCT00734604|65274399|FG000|Overall Study|Adverse Event|0|||
23417609|NCT00734604|65274400|FG001|Overall Study|Adverse Event|2|||
23417610|NCT00734604|65274401|FG002|Overall Study|Adverse Event|0|||
23417611|NCT00734604|65274402|FG003|Overall Study|Adverse Event|2|||
23417612|NCT00734604|65274403|FG004|Overall Study|Adverse Event|1|||
23417613|NCT00734604|65274404|FG005|Overall Study|Adverse Event|1|||
23525413|NCT02789176|65661774|FG001|Overall Study|Withdrawal by Subject|0|||
23525414|NCT02789176|65661775|FG002|Overall Study|Withdrawal by Subject|1|||
23308603|NCT00265395|64874175|FG001|Overall Study|Withdrawal by Subject|6|||
23417614|NCT00734604|65274399|FG000|Overall Study|Serious Adverse Event|1|||
23417615|NCT00734604|65274400|FG001|Overall Study|Serious Adverse Event|0|||
23417616|NCT00734604|65274401|FG002|Overall Study|Serious Adverse Event|1|||
23417617|NCT00734604|65274402|FG003|Overall Study|Serious Adverse Event|2|||
23417618|NCT00734604|65274403|FG004|Overall Study|Serious Adverse Event|0|||
23417619|NCT00734604|65274404|FG005|Overall Study|Serious Adverse Event|1|||
23417620|NCT00734604|65274399|FG000|Overall Study|Lost to Follow-up|1|||
23417621|NCT00734604|65274400|FG001|Overall Study|Lost to Follow-up|2|||
23417622|NCT00734604|65274401|FG002|Overall Study|Lost to Follow-up|2|||
23525415|NCT02789176|65661776|FG003|Overall Study|Withdrawal by Subject|0|||
23308604|NCT00265395|64874174|FG000|Overall Study|Protocol Violation|2|||
23308605|NCT00265395|64874175|FG001|Overall Study|Protocol Violation|2|||
23308606|NCT00265395|64874174|FG000|Overall Study|Lack of Efficacy|0|||
23308607|NCT00265395|64874175|FG001|Overall Study|Lack of Efficacy|1|||
23308608|NCT00265395|64874174|FG000|Overall Study|Administrative|0|||
23308609|NCT00265395|64874175|FG001|Overall Study|Administrative|1|||
23308610|NCT00923273|64874177|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
23308611|NCT00923273|64874178|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
23308612|NCT00923273|64874179|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
23417623|NCT00734604|65274402|FG003|Overall Study|Lost to Follow-up|4|||
23417624|NCT00734604|65274403|FG004|Overall Study|Lost to Follow-up|2|||
23417625|NCT00734604|65274404|FG005|Overall Study|Lost to Follow-up|3|||
23417626|NCT00734604|65274399|FG000|Overall Study|Physician Decision|0|||
23417627|NCT00734604|65274400|FG001|Overall Study|Physician Decision|1|||
23417628|NCT00734604|65274401|FG002|Overall Study|Physician Decision|1|||
23417629|NCT00734604|65274402|FG003|Overall Study|Physician Decision|0|||
23417630|NCT00734604|65274403|FG004|Overall Study|Physician Decision|0|||
23417631|NCT00734604|65274404|FG005|Overall Study|Physician Decision|0|||
23417632|NCT00734604|65274399|FG000|Overall Study|Protocol Violation|0|||
23417633|NCT00734604|65274400|FG001|Overall Study|Protocol Violation|2|||
23417634|NCT00734604|65274401|FG002|Overall Study|Protocol Violation|0|||
23417635|NCT00734604|65274402|FG003|Overall Study|Protocol Violation|0|||
23525416|NCT02789176|65661773|FG000|Overall Study|Lost to Follow-up|8|||
23525417|NCT02789176|65661774|FG001|Overall Study|Lost to Follow-up|2|||
23525418|NCT02789176|65661775|FG002|Overall Study|Lost to Follow-up|6|||
23525419|NCT02789176|65661776|FG003|Overall Study|Lost to Follow-up|1|||
23525420|NCT03616912|65661777|FG000|Overall Study|Adverse Event|17|||
23525421|NCT03616912|65661778|FG001|Overall Study|Adverse Event|21|||
23525422|NCT03616912|65661779|FG002|Overall Study|Adverse Event|9|||
23525423|NCT03616912|65661780|FG003|Overall Study|Adverse Event|0|||
23525424|NCT03616912|65661781|FG004|Overall Study|Adverse Event|0|||
23525425|NCT03616912|65661782|FG005|Overall Study|Adverse Event|0|||
23525426|NCT03616912|65661777|FG000|Overall Study|Death|1|||
23525427|NCT03616912|65661778|FG001|Overall Study|Death|1|||
23525428|NCT03616912|65661779|FG002|Overall Study|Death|0|||
23525429|NCT03616912|65661780|FG003|Overall Study|Death|0|||
23525430|NCT03616912|65661781|FG004|Overall Study|Death|0|||
23525431|NCT03616912|65661782|FG005|Overall Study|Death|0|||
23525432|NCT03616912|65661777|FG000|Overall Study|Lack of Efficacy|13|||
23525433|NCT03616912|65661778|FG001|Overall Study|Lack of Efficacy|6|||
23525434|NCT03616912|65661779|FG002|Overall Study|Lack of Efficacy|8|||
23525435|NCT03616912|65661780|FG003|Overall Study|Lack of Efficacy|4|||
23525436|NCT03616912|65661781|FG004|Overall Study|Lack of Efficacy|5|||
23525437|NCT03616912|65661782|FG005|Overall Study|Lack of Efficacy|1|||
23525438|NCT03616912|65661777|FG000|Overall Study|Lost to Follow-up|1|||
23525439|NCT03616912|65661778|FG001|Overall Study|Lost to Follow-up|2|||
23525440|NCT03616912|65661779|FG002|Overall Study|Lost to Follow-up|3|||
23525441|NCT03616912|65661780|FG003|Overall Study|Lost to Follow-up|0|||
23525442|NCT03616912|65661781|FG004|Overall Study|Lost to Follow-up|0|||
23525443|NCT03616912|65661782|FG005|Overall Study|Lost to Follow-up|0|||
23525444|NCT03616912|65661777|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
23525445|NCT03616912|65661778|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
23525446|NCT03616912|65661779|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
23525447|NCT03616912|65661780|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
23525448|NCT03616912|65661781|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
23525449|NCT03616912|65661782|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
23525450|NCT03616912|65661777|FG000|Overall Study|Withdrawal by Subject|12|||
23525451|NCT03616912|65661778|FG001|Overall Study|Withdrawal by Subject|12|||
23525452|NCT03616912|65661779|FG002|Overall Study|Withdrawal by Subject|15|||
23525453|NCT03616912|65661780|FG003|Overall Study|Withdrawal by Subject|2|||
23525454|NCT03616912|65661781|FG004|Overall Study|Withdrawal by Subject|0|||
23525455|NCT03616912|65661782|FG005|Overall Study|Withdrawal by Subject|2|||
23525456|NCT03616912|65661777|FG000|Overall Study|Study Terminated by Sponsor|0|||
23525457|NCT03616912|65661778|FG001|Overall Study|Study Terminated by Sponsor|0|||
23525458|NCT03616912|65661779|FG002|Overall Study|Study Terminated by Sponsor|0|||
23308613|NCT00923273|64874180|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
23308614|NCT00923273|64874181|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
23417636|NCT00734604|65274403|FG004|Overall Study|Protocol Violation|1|||
23417637|NCT00734604|65274404|FG005|Overall Study|Protocol Violation|0|||
23417638|NCT00734604|65274399|FG000|Overall Study|Sponsor Decision|1|||
23417639|NCT00734604|65274400|FG001|Overall Study|Sponsor Decision|2|||
23417640|NCT00734604|65274401|FG002|Overall Study|Sponsor Decision|1|||
23417641|NCT00734604|65274402|FG003|Overall Study|Sponsor Decision|0|||
23525459|NCT03616912|65661780|FG003|Overall Study|Study Terminated by Sponsor|10|||
23525460|NCT03616912|65661781|FG004|Overall Study|Study Terminated by Sponsor|9|||
23525461|NCT03616912|65661782|FG005|Overall Study|Study Terminated by Sponsor|11|||
23525462|NCT03616912|65661777|FG000|Overall Study|Protocol Deviation|1|||
23525463|NCT03616912|65661778|FG001|Overall Study|Protocol Deviation|1|||
23525464|NCT03616912|65661779|FG002|Overall Study|Protocol Deviation|0|||
23525465|NCT03616912|65661780|FG003|Overall Study|Protocol Deviation|0|||
23525466|NCT03616912|65661781|FG004|Overall Study|Protocol Deviation|0|||
23525467|NCT03616912|65661782|FG005|Overall Study|Protocol Deviation|0|||
23525468|NCT03616912|65661777|FG000|Overall Study|Pregnancy|1|||
23525469|NCT03616912|65661778|FG001|Overall Study|Pregnancy|0|||
23525470|NCT03616912|65661779|FG002|Overall Study|Pregnancy|4|||
23525471|NCT03616912|65661780|FG003|Overall Study|Pregnancy|0|||
23525472|NCT03616912|65661781|FG004|Overall Study|Pregnancy|0|||
23525473|NCT03616912|65661782|FG005|Overall Study|Pregnancy|0|||
23525474|NCT03616912|65661777|FG000|Overall Study|Protocol Violation|1|||
23525475|NCT03616912|65661778|FG001|Overall Study|Protocol Violation|0|||
23525476|NCT03616912|65661779|FG002|Overall Study|Protocol Violation|2|||
23525477|NCT03616912|65661780|FG003|Overall Study|Protocol Violation|0|||
23525478|NCT03616912|65661781|FG004|Overall Study|Protocol Violation|0|||
23525479|NCT03616912|65661782|FG005|Overall Study|Protocol Violation|0|||
23525480|NCT03616912|65661777|FG000|Overall Study|Physician Decision|2|||
23525481|NCT03616912|65661778|FG001|Overall Study|Physician Decision|0|||
23525482|NCT03616912|65661779|FG002|Overall Study|Physician Decision|0|||
23525483|NCT03616912|65661780|FG003|Overall Study|Physician Decision|0|||
23525484|NCT03616912|65661781|FG004|Overall Study|Physician Decision|1|||
23525485|NCT03616912|65661782|FG005|Overall Study|Physician Decision|0|||
23525486|NCT03616912|65661777|FG000|Overall Study|Randomized But Never Treated|0|||
23525487|NCT03616912|65661778|FG001|Overall Study|Randomized But Never Treated|2|||
23525488|NCT03616912|65661779|FG002|Overall Study|Randomized But Never Treated|0|||
23525489|NCT03616912|65661780|FG003|Overall Study|Randomized But Never Treated|0|||
23525490|NCT03616912|65661781|FG004|Overall Study|Randomized But Never Treated|0|||
23525491|NCT03616912|65661782|FG005|Overall Study|Randomized But Never Treated|0|||
23525492|NCT00578175|65661783|FG000|Overall Study|Adverse Event|0|||
23525493|NCT00578175|65661784|FG001|Overall Study|Adverse Event|1|||
23525494|NCT00578175|65661785|FG002|Overall Study|Adverse Event|1|||
23525495|NCT00578175|65661783|FG000|Overall Study|Other reasons|70|||
23525496|NCT00578175|65661784|FG001|Overall Study|Other reasons|42|||
23525497|NCT00578175|65661785|FG002|Overall Study|Other reasons|23|||
23525498|NCT00749463|65661789|FG000|Overall Study|Adverse Event|0|||
23206102|NCT01963208|64494806|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
23206103|NCT01963208|64494807|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
23308615|NCT00923273|64874177|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
23525499|NCT00749463|65661790|FG001|Overall Study|Adverse Event|4|||
23525500|NCT00749463|65661791|FG002|Overall Study|Adverse Event|1|||
23525501|NCT00749463|65661789|FG000|Overall Study|Withdrawal by Subject|1|||
23525502|NCT00749463|65661790|FG001|Overall Study|Withdrawal by Subject|0|||
23525503|NCT00749463|65661791|FG002|Overall Study|Withdrawal by Subject|0|||
23525504|NCT00207142|65661792|FG000|Induction Phase|Adverse Event|9|||
23525505|NCT00207142|65661793|FG001|Induction Phase|Adverse Event|0|||
23525506|NCT00207142|65661794|FG002|Induction Phase|Adverse Event|0|||
23525507|NCT00207142|65661795|FG003|Induction Phase|Adverse Event|0|||
23525508|NCT00207142|65661792|FG000|Induction Phase|Death|1|||
23525509|NCT00207142|65661793|FG001|Induction Phase|Death|0|||
23525510|NCT00207142|65661794|FG002|Induction Phase|Death|0|||
23525511|NCT00207142|65661795|FG003|Induction Phase|Death|0|||
23525512|NCT00207142|65661792|FG000|Induction Phase|Lack of Efficacy|1|||
23525513|NCT00207142|65661793|FG001|Induction Phase|Lack of Efficacy|0|||
23525514|NCT00207142|65661794|FG002|Induction Phase|Lack of Efficacy|0|||
23525515|NCT00207142|65661795|FG003|Induction Phase|Lack of Efficacy|0|||
23525516|NCT00207142|65661792|FG000|Induction Phase|Lost to Follow-up|5|||
23525517|NCT00207142|65661793|FG001|Induction Phase|Lost to Follow-up|0|||
23525518|NCT00207142|65661794|FG002|Induction Phase|Lost to Follow-up|0|||
23525519|NCT00207142|65661795|FG003|Induction Phase|Lost to Follow-up|0|||
23525520|NCT00207142|65661792|FG000|Induction Phase|Physician Decision|2|||
23525521|NCT00207142|65661793|FG001|Induction Phase|Physician Decision|0|||
23525522|NCT00207142|65661794|FG002|Induction Phase|Physician Decision|0|||
23525523|NCT00207142|65661795|FG003|Induction Phase|Physician Decision|0|||
23525524|NCT00207142|65661792|FG000|Induction Phase|Poor/noncompliance|2|||
23525525|NCT00207142|65661793|FG001|Induction Phase|Poor/noncompliance|0|||
23525526|NCT00207142|65661794|FG002|Induction Phase|Poor/noncompliance|0|||
23525527|NCT00207142|65661795|FG003|Induction Phase|Poor/noncompliance|0|||
23525528|NCT00207142|65661792|FG000|Induction Phase|Pregnancy|1|||
23525529|NCT00207142|65661793|FG001|Induction Phase|Pregnancy|0|||
23525530|NCT00207142|65661794|FG002|Induction Phase|Pregnancy|0|||
23525531|NCT00207142|65661795|FG003|Induction Phase|Pregnancy|0|||
23525532|NCT00207142|65661792|FG000|Induction Phase|Subject no longer meets study criteria|3|||
23525533|NCT00207142|65661793|FG001|Induction Phase|Subject no longer meets study criteria|0|||
23525534|NCT00207142|65661794|FG002|Induction Phase|Subject no longer meets study criteria|0|||
23525535|NCT00207142|65661795|FG003|Induction Phase|Subject no longer meets study criteria|0|||
23525536|NCT00207142|65661792|FG000|Induction Phase|Withdrawal by Subject|4|||
23525537|NCT00207142|65661793|FG001|Induction Phase|Withdrawal by Subject|0|||
23525538|NCT00207142|65661794|FG002|Induction Phase|Withdrawal by Subject|0|||
23525539|NCT00207142|65661795|FG003|Induction Phase|Withdrawal by Subject|0|||
23525540|NCT00207142|65661792|FG000|Induction Phase|Incarceration|1|||
23525541|NCT00207142|65661793|FG001|Induction Phase|Incarceration|0|||
23525542|NCT00207142|65661794|FG002|Induction Phase|Incarceration|0|||
23525543|NCT00207142|65661795|FG003|Induction Phase|Incarceration|0|||
23525544|NCT00207142|65661792|FG000|Induction Phase|Missing lab data|1|||
23525545|NCT00207142|65661793|FG001|Induction Phase|Missing lab data|0|||
23525546|NCT00207142|65661794|FG002|Induction Phase|Missing lab data|0|||
23525547|NCT00207142|65661795|FG003|Induction Phase|Missing lab data|0|||
23525548|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
23525549|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
23525550|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
23525551|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
23525552|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
23525553|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
23525554|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
23525555|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
23525556|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
23525557|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
23525558|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
23206104|NCT01963208|64494808|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
23206105|NCT01963208|64494809|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
23206106|NCT01963208|64494810|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
23206107|NCT01963208|64494811|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
23206108|NCT01963208|64494806|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23206109|NCT01963208|64494807|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23308616|NCT00923273|64874178|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
23308617|NCT00923273|64874179|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
23308618|NCT00923273|64874180|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
23308619|NCT00923273|64874181|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
23308620|NCT02085135|64874182|FG000|Overall Study|Adverse Event|4|||
23308621|NCT02085135|64874183|FG001|Overall Study|Adverse Event|7|||
23308622|NCT02085135|64874182|FG000|Overall Study|Lost to Follow-up|2|||
23308623|NCT02085135|64874183|FG001|Overall Study|Lost to Follow-up|2|||
23308624|NCT02085135|64874182|FG000|Overall Study|Withdrawal by Subject|3|||
23308625|NCT02085135|64874183|FG001|Overall Study|Withdrawal by Subject|0|||
23206110|NCT01963208|64494808|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
23206111|NCT01963208|64494809|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23206112|NCT01963208|64494810|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23206113|NCT01963208|64494811|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
23308626|NCT02085135|64874182|FG000|Overall Study|Lack of Efficacy|2|||
23308627|NCT02085135|64874183|FG001|Overall Study|Lack of Efficacy|0|||
23308628|NCT00950963|64874184|FG000|Overall Study|Lost to Follow-up|29|||
23308629|NCT00950963|64874185|FG001|Overall Study|Lost to Follow-up|24|||
23308630|NCT00896480|64874186|FG000|Overall Study|Disease progression/recurrence|21|||
23308631|NCT00144781|64874187|FG000|Overall Study|Adverse Event|0|||
23308632|NCT00144781|64874188|FG001|Overall Study|Adverse Event|1|||
23308633|NCT00144781|64874189|FG002|Overall Study|Adverse Event|0|||
23308634|NCT00144781|64874190|FG003|Overall Study|Adverse Event|0|||
23308635|NCT00144781|64874187|FG000|Overall Study|Non-compliant|0|||
23206114|NCT01963208|64494806|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
23308636|NCT00144781|64874188|FG001|Overall Study|Non-compliant|1|||
23417642|NCT00734604|65274403|FG004|Overall Study|Sponsor Decision|2|||
23417643|NCT00734604|65274404|FG005|Overall Study|Sponsor Decision|0|||
23417644|NCT00734604|65274399|FG000|Overall Study|Withdrawal by Subject|0|||
23525559|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
23525560|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
23525561|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
23525562|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
23206115|NCT01963208|64494807|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
23417645|NCT00734604|65274400|FG001|Overall Study|Withdrawal by Subject|2|||
23417646|NCT00734604|65274401|FG002|Overall Study|Withdrawal by Subject|0|||
23417647|NCT00734604|65274402|FG003|Overall Study|Withdrawal by Subject|1|||
23417648|NCT00734604|65274403|FG004|Overall Study|Withdrawal by Subject|2|||
23417649|NCT00734604|65274404|FG005|Overall Study|Withdrawal by Subject|1|||
23417650|NCT00734604|65274399|FG000|Overall Study|Lack of Efficacy|0|||
23417651|NCT00734604|65274400|FG001|Overall Study|Lack of Efficacy|1|||
23525563|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
23525564|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
23417652|NCT00734604|65274401|FG002|Overall Study|Lack of Efficacy|1|||
23525565|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
23525566|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
23525567|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
23525568|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
23525569|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
23525570|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
23525571|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
23525572|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
23525573|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
23206116|NCT01963208|64494808|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
23206117|NCT01963208|64494809|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
23206118|NCT01963208|64494810|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
23417653|NCT00734604|65274402|FG003|Overall Study|Lack of Efficacy|0|||
23417654|NCT00734604|65274403|FG004|Overall Study|Lack of Efficacy|0|||
23417655|NCT00734604|65274404|FG005|Overall Study|Lack of Efficacy|0|||
23417656|NCT05286658|65274405|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
23417657|NCT05286658|65274405|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
23417658|NCT02923830|65274406|FG000|Overall Study|Physician Decision|13|||
23417659|NCT02923830|65274407|FG001|Overall Study|Physician Decision|15|||
23417660|NCT03654404|65274408|FG000|Overall Study|Death|1|||
23417661|NCT03654404|65274408|FG000|Overall Study|Lost to Follow-up|2|||
23417662|NCT03654404|65274408|FG000|Overall Study|Withdrawal by Subject|5|||
23417663|NCT02516098|65274409|FG000|Period 1|Protocol Violation|1|||
23417664|NCT02516098|65274410|FG001|Period 1|Protocol Violation|0|||
23417665|NCT02516098|65274409|FG000|Washout After Period 1|Adverse Event|0|||
23417666|NCT02516098|65274410|FG001|Washout After Period 1|Adverse Event|1|||
23417667|NCT02516098|65274409|FG000|Period 2|Withdrawal by Subject|0|||
23417668|NCT02516098|65274410|FG001|Period 2|Withdrawal by Subject|1|||
23525574|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
23206119|NCT01963208|64494811|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
23206120|NCT01963208|64494806|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
23206121|NCT01963208|64494807|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
23206122|NCT01963208|64494808|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
23206123|NCT01963208|64494809|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
23206124|NCT01963208|64494810|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
23206125|NCT01963208|64494811|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
23206126|NCT01963208|64494806|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23206127|NCT01963208|64494807|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23206128|NCT01963208|64494808|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23206129|NCT01963208|64494809|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
23206130|NCT01963208|64494810|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23206131|NCT01963208|64494811|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
23206132|NCT01963208|64494806|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23206133|NCT01963208|64494807|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23206134|NCT01963208|64494808|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23206135|NCT01963208|64494809|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
23417669|NCT00721578|65274411|FG000|Overall Study|Death|1|||
23417670|NCT00721578|65274412|FG001|Overall Study|Death|1|||
23525575|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
23525576|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Death|0|||
23206136|NCT01963208|64494810|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23417671|NCT00721578|65274411|FG000|Overall Study|Withdrawal by Subject|1|||
23525577|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Death|0|||
23525578|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Death|0|||
23525579|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Death|1|||
23525580|NCT00207142|65661792|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
23525581|NCT00207142|65661793|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
23525582|NCT00207142|65661794|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
23525583|NCT00207142|65661795|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
23525584|NCT04372602|65661810|FG000|Overall Study|Withdrawal by Subject|1|||
23525585|NCT04372602|65661811|FG001|Overall Study|Withdrawal by Subject|1|||
23525586|NCT04372602|65661810|FG000|Overall Study|Adverse Event|0|||
23525587|NCT04372602|65661811|FG001|Overall Study|Adverse Event|1|||
23525588|NCT04372602|65661810|FG000|Overall Study|Transitioned to comfort care|0|||
23525589|NCT04372602|65661811|FG001|Overall Study|Transitioned to comfort care|1|||
23525590|NCT03569371|65661812|FG000|Overall Study|Lack of Efficacy|1|||
23525591|NCT03569371|65661812|FG000|Overall Study|Lost to Follow-up|1|||
23525592|NCT03569371|65661812|FG000|Overall Study|Adverse Event|1|||
23525593|NCT03907683|65661813|FG000|Overall Study|Pregnancy|1|||
23525594|NCT03907683|65661813|FG000|Overall Study|Withdrawal by Subject|1|||
23417672|NCT00721578|65274412|FG001|Overall Study|Withdrawal by Subject|1|||
23417673|NCT00022763|65274413|FG000|Overall Study|Adverse Event|1|||
23417674|NCT00022763|65274414|FG001|Overall Study|Adverse Event|2|||
23417675|NCT00022763|65274413|FG000|Overall Study|Injection Site Reactions|0|||
23417676|NCT00022763|65274414|FG001|Overall Study|Injection Site Reactions|2|||
23417677|NCT00022763|65274413|FG000|Overall Study|Death|0|||
23417678|NCT00022763|65274414|FG001|Overall Study|Death|1|||
23417679|NCT00022763|65274413|FG000|Overall Study|Lost to Follow-up|0|||
23417680|NCT00022763|65274414|FG001|Overall Study|Lost to Follow-up|3|||
23417681|NCT00022763|65274413|FG000|Overall Study|Withdrawal by Subject|4|||
23417682|NCT00022763|65274414|FG001|Overall Study|Withdrawal by Subject|7|||
23417683|NCT00022763|65274413|FG000|Overall Study|Insufficient Therapy|1|||
23417684|NCT00022763|65274414|FG001|Overall Study|Insufficient Therapy|0|||
23417685|NCT00022763|65274413|FG000|Overall Study|Admin|3|||
23417686|NCT00022763|65274414|FG001|Overall Study|Admin|2|||
23417687|NCT00244933|65274418|FG000|Overall Study|Not response evaluable|2|||
23525595|NCT01418937|65661816|FG000|Overall Study|Lost to Follow-up|5|||
23525596|NCT01418937|65661816|FG000|Overall Study|Protocol Violation|1|||
23525597|NCT01418937|65661816|FG000|Overall Study|Pregnancy|1|||
23525598|NCT01418937|65661816|FG000|Overall Study|Withdrawal by Subject|1|||
23206137|NCT01963208|64494811|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
23417688|NCT02570152|65274419|FG000|Overall Study|Protocol Violation|2|||
23417689|NCT02570152|65274419|FG000|Overall Study|Migrated/moved from study area|13|||
23417690|NCT02954406|65274420|FG000|Overall Study|Adverse Event|0|||
23417691|NCT02954406|65274421|FG001|Overall Study|Adverse Event|1|||
23525599|NCT02244580|65661817|FG000|Overall Study|No cancer tissues available|241|||
23525600|NCT02476968|65661818|FG000|Overall Study|Other|0|||
23525601|NCT02476968|65661819|FG001|Overall Study|Other|2|||
23525602|NCT02476968|65661820|FG002|Overall Study|Other|0|||
23525603|NCT02476968|65661818|FG000|Overall Study|Lost to Follow-up|10|||
23525604|NCT02476968|65661819|FG001|Overall Study|Lost to Follow-up|0|||
23525605|NCT02476968|65661820|FG002|Overall Study|Lost to Follow-up|1|||
23525606|NCT02476968|65661818|FG000|Overall Study|Death|48|||
23525607|NCT02476968|65661819|FG001|Overall Study|Death|8|||
23525608|NCT02476968|65661820|FG002|Overall Study|Death|1|||
23525609|NCT02476968|65661818|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23525610|NCT02476968|65661819|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23525611|NCT02476968|65661820|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23525612|NCT02476968|65661818|FG000|Overall Study|Patient decision|37|||
23525613|NCT02476968|65661819|FG001|Overall Study|Patient decision|8|||
23525614|NCT02476968|65661820|FG002|Overall Study|Patient decision|0|||
23525615|NCT00414388|65661821|FG000|Overall Study|Adverse Event|1|||
23525616|NCT00245765|65661822|FG000|Overall Study|Adverse Event|1|||
23525617|NCT00245765|65661823|FG001|Overall Study|Adverse Event|1|||
23525618|NCT00245765|65661824|FG002|Overall Study|Adverse Event|0|||
23525619|NCT00245765|65661822|FG000|Overall Study|Lack of Efficacy|14|||
23525620|NCT00245765|65661823|FG001|Overall Study|Lack of Efficacy|7|||
23525621|NCT00245765|65661824|FG002|Overall Study|Lack of Efficacy|0|||
23525622|NCT00245765|65661822|FG000|Overall Study|Lost to Follow-up|1|||
23525623|NCT00245765|65661823|FG001|Overall Study|Lost to Follow-up|2|||
23525624|NCT00245765|65661824|FG002|Overall Study|Lost to Follow-up|0|||
23525625|NCT00245765|65661822|FG000|Overall Study|Withdrawal by Subject|1|||
23525626|NCT00245765|65661823|FG001|Overall Study|Withdrawal by Subject|0|||
23525627|NCT00245765|65661824|FG002|Overall Study|Withdrawal by Subject|3|||
23525628|NCT00245765|65661822|FG000|Overall Study|Other reason|2|||
23525629|NCT00245765|65661823|FG001|Overall Study|Other reason|0|||
23525630|NCT00245765|65661824|FG002|Overall Study|Other reason|1|||
23525631|NCT00245765|65661822|FG000|Overall Study|Other|13|||
23525632|NCT00245765|65661823|FG001|Overall Study|Other|4|||
23525633|NCT00245765|65661824|FG002|Overall Study|Other|4|||
23525634|NCT00692770|65661828|FG000|Overall Study|Protocol Violation|2|||
23525635|NCT00692770|65661829|FG001|Overall Study|Protocol Violation|7|||
23525636|NCT00692770|65661828|FG000|Overall Study|Withdrawal by Subject|97|||
23525637|NCT00692770|65661829|FG001|Overall Study|Withdrawal by Subject|36|||
23525638|NCT00692770|65661828|FG000|Overall Study|Adverse Event|136|||
23525639|NCT00692770|65661829|FG001|Overall Study|Adverse Event|41|||
23525640|NCT00692770|65661828|FG000|Overall Study|Death|10|||
23525641|NCT00692770|65661829|FG001|Overall Study|Death|5|||
23525642|NCT00692770|65661828|FG000|Overall Study|Lost to Follow-up|7|||
23206138|NCT01963208|64494806|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
23206139|NCT01963208|64494807|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
23206140|NCT01963208|64494808|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
23206141|NCT01963208|64494809|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
23206142|NCT01963208|64494810|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
23206143|NCT01963208|64494811|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
23206144|NCT01963208|64494806|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
23206145|NCT01963208|64494807|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
23206146|NCT01963208|64494808|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
23206147|NCT01963208|64494809|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
23206148|NCT01963208|64494810|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
23206149|NCT01963208|64494811|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
23206150|NCT01963208|64494806|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23206151|NCT01963208|64494807|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23206152|NCT01963208|64494808|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23206153|NCT01963208|64494809|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23206154|NCT01963208|64494810|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
23206155|NCT01963208|64494811|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
23206156|NCT01963208|64494806|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23206157|NCT01963208|64494807|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23206158|NCT01963208|64494808|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23206159|NCT01963208|64494809|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23417692|NCT02954406|65274422|FG002|Overall Study|Adverse Event|0|||
23417693|NCT02954406|65274423|FG003|Overall Study|Adverse Event|0|||
23417694|NCT02954406|65274424|FG004|Overall Study|Adverse Event|1|||
23417695|NCT02954406|65274425|FG005|Overall Study|Adverse Event|0|||
23417696|NCT02954406|65274426|FG006|Overall Study|Adverse Event|0|||
23417697|NCT02954406|65274427|FG007|Overall Study|Adverse Event|0|||
23417698|NCT02954406|65274428|FG008|Overall Study|Adverse Event|1|||
23417699|NCT02954406|65274429|FG009|Overall Study|Adverse Event|1|||
23417700|NCT02954406|65274430|FG010|Overall Study|Adverse Event|0|||
23417701|NCT02954406|65274420|FG000|Overall Study|Progressive Disease|3|||
23417702|NCT02954406|65274421|FG001|Overall Study|Progressive Disease|4|||
23417703|NCT02954406|65274422|FG002|Overall Study|Progressive Disease|3|||
23417704|NCT02954406|65274423|FG003|Overall Study|Progressive Disease|4|||
23417705|NCT02954406|65274424|FG004|Overall Study|Progressive Disease|3|||
23417706|NCT02954406|65274425|FG005|Overall Study|Progressive Disease|3|||
23417707|NCT02954406|65274426|FG006|Overall Study|Progressive Disease|2|||
23417708|NCT02954406|65274427|FG007|Overall Study|Progressive Disease|2|||
23417709|NCT02954406|65274428|FG008|Overall Study|Progressive Disease|1|||
23417710|NCT02954406|65274429|FG009|Overall Study|Progressive Disease|1|||
23417711|NCT02954406|65274430|FG010|Overall Study|Progressive Disease|0|||
23417712|NCT02954406|65274420|FG000|Overall Study|Symptomatic Deterioration|0|||
23417713|NCT02954406|65274421|FG001|Overall Study|Symptomatic Deterioration|1|||
23417714|NCT02954406|65274422|FG002|Overall Study|Symptomatic Deterioration|0|||
23417715|NCT02954406|65274423|FG003|Overall Study|Symptomatic Deterioration|0|||
23417716|NCT02954406|65274424|FG004|Overall Study|Symptomatic Deterioration|0|||
23417717|NCT02954406|65274425|FG005|Overall Study|Symptomatic Deterioration|0|||
23417718|NCT02954406|65274426|FG006|Overall Study|Symptomatic Deterioration|0|||
23417719|NCT02954406|65274427|FG007|Overall Study|Symptomatic Deterioration|0|||
23417720|NCT02954406|65274428|FG008|Overall Study|Symptomatic Deterioration|0|||
23417721|NCT02954406|65274429|FG009|Overall Study|Symptomatic Deterioration|0|||
23417722|NCT02954406|65274430|FG010|Overall Study|Symptomatic Deterioration|0|||
23525643|NCT00692770|65661829|FG001|Overall Study|Lost to Follow-up|3|||
23417723|NCT02954406|65274420|FG000|Overall Study|Death|0|||
23417724|NCT02954406|65274421|FG001|Overall Study|Death|0|||
23417725|NCT02954406|65274422|FG002|Overall Study|Death|0|||
23525644|NCT00692770|65661828|FG000|Overall Study|Non-compliant with study medication|11|||
23206160|NCT01963208|64494810|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
23206161|NCT01963208|64494811|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
23206162|NCT01963208|64494806|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
23417726|NCT02954406|65274423|FG003|Overall Study|Death|0|||
23525645|NCT00692770|65661829|FG001|Overall Study|Non-compliant with study medication|5|||
23525646|NCT00692770|65661828|FG000|Overall Study|Progression by clinical judgment|2|||
23525647|NCT00692770|65661829|FG001|Overall Study|Progression by clinical judgment|3|||
23525648|NCT00692770|65661828|FG000|Overall Study|Physician decision not protocol driven|10|||
23525649|NCT00692770|65661829|FG001|Overall Study|Physician decision not protocol driven|14|||
23525650|NCT00692770|65661828|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
23525651|NCT00692770|65661829|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
23525652|NCT00692770|65661828|FG000|Overall Study|Protocol driven decision point|3|||
23525653|NCT00692770|65661829|FG001|Overall Study|Protocol driven decision point|7|||
23525654|NCT00692770|65661828|FG000|Overall Study|Completed all planned assessments|79|||
23525655|NCT00692770|65661829|FG001|Overall Study|Completed all planned assessments|101|||
23525656|NCT00692770|65661828|FG000|Overall Study|Radiological and clinical progression|8|||
23525657|NCT00692770|65661829|FG001|Overall Study|Radiological and clinical progression|8|||
23525658|NCT00692770|65661828|FG000|Overall Study|Clinical endpoint reached|16|||
23525659|NCT00692770|65661829|FG001|Overall Study|Clinical endpoint reached|43|||
23525660|NCT00692770|65661828|FG000|Overall Study|Study terminated by sponsor|2|||
23525661|NCT00692770|65661829|FG001|Overall Study|Study terminated by sponsor|2|||
23525662|NCT00692770|65661828|FG000|Overall Study|Randomized but not treated|3|||
23525663|NCT00692770|65661829|FG001|Overall Study|Randomized but not treated|4|||
23525664|NCT02129803|65661834|FG000|Overall Study|Protocol Violation|4|||
23525665|NCT02129803|65661835|FG001|Overall Study|Protocol Violation|0|||
23525666|NCT02129803|65661834|FG000|Overall Study|Physician Decision|0|||
23525667|NCT02129803|65661835|FG001|Overall Study|Physician Decision|1|||
23525668|NCT02129803|65661834|FG000|Overall Study|Difficulty sleeping|1|||
23525669|NCT02129803|65661835|FG001|Overall Study|Difficulty sleeping|0|||
23525670|NCT02129803|65661834|FG000|Overall Study|Morning headache|0|||
23525671|NCT02129803|65661835|FG001|Overall Study|Morning headache|1|||
23525672|NCT02129803|65661834|FG000|Overall Study|Withdrawal by Subject|1|||
23525673|NCT02129803|65661835|FG001|Overall Study|Withdrawal by Subject|1|||
23525674|NCT02167256|65661843|FG000|Overall Study|Adverse Event|13|||
23525675|NCT02167256|65661844|FG001|Overall Study|Adverse Event|6|||
23525676|NCT02167256|65661843|FG000|Overall Study|Withdrawal by Subject|4|||
23525677|NCT02167256|65661844|FG001|Overall Study|Withdrawal by Subject|4|||
23525678|NCT02167256|65661843|FG000|Overall Study|non-compliance|3|||
23525679|NCT02167256|65661844|FG001|Overall Study|non-compliance|0|||
23525680|NCT02167256|65661843|FG000|Overall Study|Study partner unable to participate|1|||
23525681|NCT02167256|65661844|FG001|Overall Study|Study partner unable to participate|0|||
23525682|NCT02540954|65661845|FG000|Overall Study|Physician Decision|3|||
23525683|NCT02540954|65661846|FG001|Overall Study|Physician Decision|1|||
23525684|NCT02540954|65661845|FG000|Overall Study|Withdrawal by Subject|6|||
23308637|NCT00144781|64874189|FG002|Overall Study|Non-compliant|0|||
23308638|NCT00144781|64874190|FG003|Overall Study|Non-compliant|0|||
23308639|NCT01502410|64874191|FG000|Overall Study|Adverse Event|1|||
23308640|NCT01502410|64874192|FG001|Overall Study|Adverse Event|2|||
23308641|NCT01502410|64874193|FG002|Overall Study|Adverse Event|0|||
23525685|NCT02540954|65661846|FG001|Overall Study|Withdrawal by Subject|5|||
23525686|NCT02540954|65661845|FG000|Overall Study|Lost to Follow-up|1|||
23525687|NCT02540954|65661846|FG001|Overall Study|Lost to Follow-up|1|||
23525688|NCT02540954|65661845|FG000|Overall Study|Adverse Event|4|||
23525689|NCT02540954|65661846|FG001|Overall Study|Adverse Event|2|||
23525690|NCT02540954|65661845|FG000|Overall Study|Death|0|||
23525691|NCT02540954|65661846|FG001|Overall Study|Death|3|||
23525692|NCT02540954|65661845|FG000|Overall Study|Treatment failure|1|||
23525693|NCT02540954|65661846|FG001|Overall Study|Treatment failure|0|||
23525694|NCT02540954|65661845|FG000|Overall Study|Other reason|4|||
23525695|NCT02540954|65661846|FG001|Overall Study|Other reason|2|||
23525696|NCT00743652|65661849|FG000|Overall Study|Parent/Legal Guardian Request|3|||
23525697|NCT00743652|65661850|FG001|Overall Study|Parent/Legal Guardian Request|2|||
23525698|NCT00743652|65661851|FG002|Overall Study|Parent/Legal Guardian Request|2|||
23525699|NCT00743652|65661852|FG003|Overall Study|Parent/Legal Guardian Request|2|||
23525700|NCT00743652|65661853|FG004|Overall Study|Parent/Legal Guardian Request|0|||
23525701|NCT00743652|65661849|FG000|Overall Study|Adverse Event|3|||
23525702|NCT00743652|65661850|FG001|Overall Study|Adverse Event|0|||
23525703|NCT00743652|65661851|FG002|Overall Study|Adverse Event|0|||
23525704|NCT00743652|65661852|FG003|Overall Study|Adverse Event|0|||
23525705|NCT00743652|65661853|FG004|Overall Study|Adverse Event|0|||
23525706|NCT00743652|65661849|FG000|Overall Study|Death|2|||
23525707|NCT00743652|65661850|FG001|Overall Study|Death|0|||
23525708|NCT00743652|65661851|FG002|Overall Study|Death|0|||
23525709|NCT00743652|65661852|FG003|Overall Study|Death|0|||
23525710|NCT00743652|65661853|FG004|Overall Study|Death|0|||
23525711|NCT00743652|65661849|FG000|Overall Study|Investigator Request|0|||
23525712|NCT00743652|65661850|FG001|Overall Study|Investigator Request|0|||
23525713|NCT00743652|65661851|FG002|Overall Study|Investigator Request|0|||
23525714|NCT00743652|65661852|FG003|Overall Study|Investigator Request|2|||
23525715|NCT00743652|65661853|FG004|Overall Study|Investigator Request|0|||
23525716|NCT00743652|65661849|FG000|Overall Study|Other|1|||
23525717|NCT00743652|65661850|FG001|Overall Study|Other|1|||
23525718|NCT00743652|65661851|FG002|Overall Study|Other|0|||
23525719|NCT00743652|65661852|FG003|Overall Study|Other|0|||
23525720|NCT00743652|65661853|FG004|Overall Study|Other|0|||
23525721|NCT00743652|65661849|FG000|Overall Study|Lost to Follow-up|1|||
23525722|NCT00743652|65661850|FG001|Overall Study|Lost to Follow-up|0|||
23525723|NCT00743652|65661851|FG002|Overall Study|Lost to Follow-up|0|||
23525724|NCT00743652|65661852|FG003|Overall Study|Lost to Follow-up|0|||
23525725|NCT00743652|65661853|FG004|Overall Study|Lost to Follow-up|0|||
23525726|NCT01231581|65661855|FG000|Overall Study|Lost to Follow-up|2|||
23525727|NCT01231581|65661856|FG001|Overall Study|Lost to Follow-up|2|||
23525728|NCT01231581|65661855|FG000|Overall Study|Withdrawal by Subject|6|||
23525729|NCT01231581|65661856|FG001|Overall Study|Withdrawal by Subject|9|||
23525730|NCT01231581|65661855|FG000|Overall Study|Study Closed/Terminated|6|||
23525731|NCT01231581|65661856|FG001|Overall Study|Study Closed/Terminated|5|||
23525732|NCT01231581|65661855|FG000|Overall Study|Death|65|||
23525733|NCT01231581|65661856|FG001|Overall Study|Death|64|||
23525734|NCT01231581|65661855|FG000|Overall Study|Ongoing|1|||
23525735|NCT01231581|65661856|FG001|Overall Study|Ongoing|0|||
23525736|NCT04907032|65661857|FG000|Overall Study|Withdrawal by Subject|7|||
23525737|NCT04907032|65661858|FG001|Overall Study|Withdrawal by Subject|1|||
23525738|NCT02702401|65661859|FG000|Overall Study|Death|242|||
23525739|NCT02702401|65661860|FG001|Overall Study|Death|125|||
23525740|NCT02702401|65661859|FG000|Overall Study|Withdrawal by Subject|15|||
23525741|NCT02702401|65661860|FG001|Overall Study|Withdrawal by Subject|5|||
23525742|NCT02702401|65661859|FG000|Overall Study|Sponsor Decision|19|||
23525743|NCT02702401|65661860|FG001|Overall Study|Sponsor Decision|3|||
23525744|NCT02702401|65661859|FG000|Overall Study|Physician Decision|1|||
23525745|NCT02702401|65661860|FG001|Overall Study|Physician Decision|2|||
23308642|NCT01502410|64874194|FG003|Overall Study|Adverse Event|0|||
23308643|NCT01502410|64874191|FG000|Overall Study|Lack of Efficacy|7|||
23525746|NCT02702401|65661859|FG000|Overall Study|Lost to Follow-up|1|||
23525747|NCT02702401|65661860|FG001|Overall Study|Lost to Follow-up|0|||
23525748|NCT01009099|65661861|FG000|Overall Study|Lost to Follow-up|1|||
23525749|NCT01009099|65661862|FG001|Overall Study|Lost to Follow-up|0|||
23525750|NCT01009099|65661861|FG000|Overall Study|Physician Decision|3|||
23525751|NCT01009099|65661862|FG001|Overall Study|Physician Decision|2|||
23525752|NCT01009099|65661861|FG000|Overall Study|Withdrawal by Subject|1|||
23525753|NCT01009099|65661862|FG001|Overall Study|Withdrawal by Subject|1|||
23525754|NCT01009099|65661861|FG000|Overall Study|Death|0|||
23525755|NCT01009099|65661862|FG001|Overall Study|Death|1|||
23525756|NCT00489853|65661863|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
23525757|NCT00489853|65661864|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
23525758|NCT00489853|65661865|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
23525759|NCT00489853|65661863|FG000|Wash-out Period 1|Adverse Event|0|||
23525760|NCT00489853|65661864|FG001|Wash-out Period 1|Adverse Event|1|||
23525761|NCT00489853|65661865|FG002|Wash-out Period 1|Adverse Event|1|||
23525762|NCT00489853|65661863|FG000|Wash-out Period 1|Protocol Violation|0|||
23525763|NCT00489853|65661864|FG001|Wash-out Period 1|Protocol Violation|1|||
23525764|NCT00489853|65661865|FG002|Wash-out Period 1|Protocol Violation|1|||
23525765|NCT00489853|65661863|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
23525766|NCT00489853|65661864|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
23525767|NCT00489853|65661865|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
23525768|NCT00489853|65661863|FG000|Wash-out Period 2|Adverse Event|1|||
23525769|NCT00489853|65661864|FG001|Wash-out Period 2|Adverse Event|1|||
23525770|NCT00489853|65661865|FG002|Wash-out Period 2|Adverse Event|0|||
23525771|NCT00489853|65661863|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
23525772|NCT00489853|65661864|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
23525773|NCT00489853|65661865|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
23525774|NCT00489853|65661863|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
23525775|NCT00489853|65661864|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
23525776|NCT00489853|65661865|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
23525777|NCT01933048|65661871|FG000|Overall Study|Lost to Follow-up|15|||
23525778|NCT01933048|65661872|FG001|Overall Study|Lost to Follow-up|18|||
23525779|NCT01933048|65661871|FG000|Overall Study|personal reasons|1|||
23525780|NCT01933048|65661872|FG001|Overall Study|personal reasons|1|||
23525781|NCT01933048|65661871|FG000|Overall Study|Protocol Violation|7|||
23525782|NCT01933048|65661872|FG001|Overall Study|Protocol Violation|8|||
23525783|NCT01933048|65661871|FG000|Overall Study|Physician Decision|1|||
23525784|NCT01933048|65661872|FG001|Overall Study|Physician Decision|0|||
23525785|NCT01933048|65661871|FG000|Overall Study|unknown reasons|1|||
23525786|NCT01933048|65661872|FG001|Overall Study|unknown reasons|1|||
23308644|NCT01502410|64874192|FG001|Overall Study|Lack of Efficacy|7|||
23308645|NCT01502410|64874193|FG002|Overall Study|Lack of Efficacy|0|||
23308646|NCT01502410|64874194|FG003|Overall Study|Lack of Efficacy|0|||
23308647|NCT01502410|64874191|FG000|Overall Study|Physician Decision|0|||
23308648|NCT01502410|64874192|FG001|Overall Study|Physician Decision|1|||
23308649|NCT01502410|64874193|FG002|Overall Study|Physician Decision|0|||
23308650|NCT01502410|64874194|FG003|Overall Study|Physician Decision|0|||
23308651|NCT01502410|64874191|FG000|Overall Study|Withdrawal by Subject|2|||
23308652|NCT01502410|64874192|FG001|Overall Study|Withdrawal by Subject|0|||
23308653|NCT01502410|64874193|FG002|Overall Study|Withdrawal by Subject|0|||
23308654|NCT01502410|64874194|FG003|Overall Study|Withdrawal by Subject|0|||
23308655|NCT03283761|64874197|FG000|Study Treatment|Patient Non-Compliance|1|||
23525787|NCT00983580|65661873|FG000|Overall Study|Cancel Prior to treatment|1|||
23525788|NCT00983580|65661874|FG001|Overall Study|Cancel Prior to treatment|3|||
23525789|NCT00983580|65661873|FG000|Overall Study|Protocol Violation|1|||
23525790|NCT00983580|65661874|FG001|Overall Study|Protocol Violation|1|||
23525791|NCT00983580|65661873|FG000|Overall Study|Ineligible|3|||
23525792|NCT00983580|65661874|FG001|Overall Study|Ineligible|0|||
23525793|NCT03026257|65661875|FG000|Overall Study|Adverse Event|3|||
23206163|NCT01963208|64494807|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
23206164|NCT01963208|64494808|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
23206165|NCT01963208|64494809|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
23206166|NCT01963208|64494810|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
23206167|NCT01963208|64494811|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
23206168|NCT01963208|64494806|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
23206169|NCT01963208|64494807|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
23206170|NCT01963208|64494808|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
23206171|NCT01963208|64494809|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
23206172|NCT01963208|64494810|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
23206173|NCT01963208|64494811|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
23308656|NCT03283761|64874197|FG000|Study Treatment|Alternative Cancer Therapy|7|||
23308657|NCT03283761|64874197|FG000|Study Treatment|Disease progression|21|||
23308658|NCT03283761|64874197|FG000|Study Treatment|Adverse Event|3|||
23525794|NCT03026257|65661876|FG001|Overall Study|Adverse Event|0|||
23525795|NCT03026257|65661877|FG002|Overall Study|Adverse Event|0|||
23525796|NCT03026257|65661878|FG003|Overall Study|Adverse Event|0|||
23525797|NCT03026257|65661879|FG004|Overall Study|Adverse Event|0|||
23308659|NCT03283761|64874197|FG000|Study Treatment|Withdrawal by Subject|4|||
23525798|NCT03026257|65661880|FG005|Overall Study|Adverse Event|0|||
23525799|NCT03026257|65661875|FG000|Overall Study|Lost to Follow-up|1|||
23308660|NCT03283761|64874197|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
23525800|NCT03026257|65661876|FG001|Overall Study|Lost to Follow-up|0|||
23525801|NCT03026257|65661877|FG002|Overall Study|Lost to Follow-up|0|||
23525802|NCT03026257|65661878|FG003|Overall Study|Lost to Follow-up|0|||
23525803|NCT03026257|65661879|FG004|Overall Study|Lost to Follow-up|0|||
23525804|NCT03026257|65661880|FG005|Overall Study|Lost to Follow-up|0|||
23525805|NCT03026257|65661875|FG000|Overall Study|Protocol Violation|1|||
23525806|NCT03026257|65661876|FG001|Overall Study|Protocol Violation|0|||
23525807|NCT03026257|65661877|FG002|Overall Study|Protocol Violation|0|||
23525808|NCT03026257|65661878|FG003|Overall Study|Protocol Violation|1|||
23525809|NCT03026257|65661879|FG004|Overall Study|Protocol Violation|1|||
23525810|NCT03026257|65661880|FG005|Overall Study|Protocol Violation|0|||
23525811|NCT03026257|65661875|FG000|Overall Study|Withdrawal by Subject|1|||
23525812|NCT03026257|65661876|FG001|Overall Study|Withdrawal by Subject|1|||
23525813|NCT03026257|65661877|FG002|Overall Study|Withdrawal by Subject|0|||
23308661|NCT03283761|64874197|FG000|Study Treatment|Symptomatic Deterioration|1|||
23308662|NCT03283761|64874197|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
23308663|NCT03283761|64874197|FG000|Follow up|Lost to Follow-up|1|||
23308664|NCT03283761|64874197|FG000|Follow up|Symptomatic Deterioration|1|||
23308665|NCT03283761|64874197|FG000|Follow up|Death|29|||
23308666|NCT03283761|64874197|FG000|Follow up|study terminated|4|||
23308667|NCT03283761|64874197|FG000|Follow up|Primary Investigator Withdrawal|1|||
23417727|NCT02954406|65274424|FG004|Overall Study|Death|1|||
23417728|NCT02954406|65274425|FG005|Overall Study|Death|0|||
23417729|NCT02954406|65274426|FG006|Overall Study|Death|0|||
23417730|NCT02954406|65274427|FG007|Overall Study|Death|0|||
23417731|NCT02954406|65274428|FG008|Overall Study|Death|1|||
23417732|NCT02954406|65274429|FG009|Overall Study|Death|1|||
23417733|NCT02954406|65274430|FG010|Overall Study|Death|0|||
23417734|NCT02954406|65274420|FG000|Overall Study|Reason Not Specified|0|||
23417735|NCT02954406|65274421|FG001|Overall Study|Reason Not Specified|0|||
23417736|NCT02954406|65274422|FG002|Overall Study|Reason Not Specified|3|||
23417737|NCT02954406|65274423|FG003|Overall Study|Reason Not Specified|2|||
23417738|NCT02954406|65274424|FG004|Overall Study|Reason Not Specified|2|||
23417739|NCT02954406|65274425|FG005|Overall Study|Reason Not Specified|0|||
23417740|NCT02954406|65274426|FG006|Overall Study|Reason Not Specified|1|||
23417741|NCT02954406|65274427|FG007|Overall Study|Reason Not Specified|0|||
23525814|NCT03026257|65661878|FG003|Overall Study|Withdrawal by Subject|0|||
23525815|NCT03026257|65661879|FG004|Overall Study|Withdrawal by Subject|0|||
23525816|NCT03026257|65661880|FG005|Overall Study|Withdrawal by Subject|0|||
23525817|NCT04365699|65661881|FG000|Overall Study|Death|2|||
23525818|NCT04365699|65661882|FG001|Overall Study|Death|5|||
23525819|NCT04365699|65661883|FG002|Overall Study|Death|15|||
23525820|NCT01640366|65661884|FG000|Overall Study|Withdrawal by Subject|1|||
23525821|NCT01640366|65661884|FG000|Overall Study|Protocol Violation|16|||
23525822|NCT01640366|65661884|FG000|Overall Study|Lost to Follow-up|5|||
23525823|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23525824|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
23525825|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
23525826|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
23525827|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
23525828|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
23525829|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
23525830|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
23525831|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
23525832|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23525833|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
23525834|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23525835|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
23525836|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
23525837|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
23525838|NCT01257204|65665299|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
23525839|NCT01257204|65665300|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
23417742|NCT02954406|65274428|FG008|Overall Study|Reason Not Specified|1|||
23417743|NCT02954406|65274429|FG009|Overall Study|Reason Not Specified|0|||
23525840|NCT01257204|65665301|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
23525841|NCT01257204|65665299|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
23525842|NCT01257204|65665300|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
23525843|NCT01257204|65665301|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
23417744|NCT02954406|65274430|FG010|Overall Study|Reason Not Specified|0|||
23308668|NCT03283761|64874197|FG000|Follow up|Switched to alternative therapy|1|||
23308669|NCT03283761|64874197|FG000|Follow up|Subject is now in Hospice|1|||
23525844|NCT01257204|65665299|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
23525845|NCT01257204|65665300|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
23525846|NCT01257204|65665301|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
23525847|NCT01257204|65665299|FG000|Follow-up Period (up to Week 48)|Other|0|||
23525848|NCT01257204|65665300|FG001|Follow-up Period (up to Week 48)|Other|0|||
23525849|NCT01257204|65665301|FG002|Follow-up Period (up to Week 48)|Other|5|||
23525850|NCT01465464|65665304|FG000|Overall Study|Adverse Event|96|||
23525851|NCT01465464|65665305|FG001|Overall Study|Adverse Event|49|||
23525852|NCT01465464|65665304|FG000|Overall Study|Lack of Efficacy|139|||
23525853|NCT01465464|65665305|FG001|Overall Study|Lack of Efficacy|190|||
23525854|NCT01465464|65665304|FG000|Overall Study|Physician Decision|13|||
23525855|NCT01465464|65665305|FG001|Overall Study|Physician Decision|5|||
23525856|NCT01465464|65665304|FG000|Overall Study|Protocol Violation|1|||
23525857|NCT01465464|65665305|FG001|Overall Study|Protocol Violation|1|||
23525858|NCT01465464|65665304|FG000|Overall Study|Withdrawal by Subject|46|||
23525859|NCT01465464|65665305|FG001|Overall Study|Withdrawal by Subject|30|||
23525860|NCT01465464|65665304|FG000|Overall Study|Other|9|||
23525861|NCT01465464|65665305|FG001|Overall Study|Other|3|||
23525862|NCT01465464|65665304|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
23525863|NCT01465464|65665305|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
23525864|NCT00357370|65665306|FG000|Cohort 2|Lack of Efficacy|0|||
23525865|NCT00357370|65665307|FG001|Cohort 2|Lack of Efficacy|2|||
23525866|NCT00357370|65665308|FG002|Cohort 2|Lack of Efficacy|1|||
23525867|NCT00357370|65665306|FG000|Cohort 2|Adverse Event|1|||
23525868|NCT00357370|65665307|FG001|Cohort 2|Adverse Event|1|||
23525869|NCT00357370|65665308|FG002|Cohort 2|Adverse Event|1|||
23525870|NCT00357370|65665306|FG000|Cohort 2|Lost to Follow-up|0|||
23525871|NCT00357370|65665307|FG001|Cohort 2|Lost to Follow-up|1|||
23525872|NCT00357370|65665308|FG002|Cohort 2|Lost to Follow-up|0|||
23525873|NCT00357370|65665306|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
23525874|NCT00357370|65665307|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
23525875|NCT00357370|65665308|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
23525876|NCT00357370|65665306|FG000|Cohort 2|Withdrawal by Subject|0|||
23525877|NCT00357370|65665307|FG001|Cohort 2|Withdrawal by Subject|2|||
23525878|NCT00357370|65665308|FG002|Cohort 2|Withdrawal by Subject|0|||
23525879|NCT00677807|65665309|FG000|Overall Study|Adverse Event|4|||
23525880|NCT00677807|65665310|FG001|Overall Study|Adverse Event|1|||
23525881|NCT00677807|65665311|FG002|Overall Study|Adverse Event|6|||
23525882|NCT00677807|65665309|FG000|Overall Study|Lack of Efficacy|0|||
23525883|NCT00677807|65665310|FG001|Overall Study|Lack of Efficacy|0|||
23525884|NCT00677807|65665311|FG002|Overall Study|Lack of Efficacy|2|||
23525885|NCT00677807|65665309|FG000|Overall Study|Participant no longer needs study drug|0|||
23525886|NCT00677807|65665310|FG001|Overall Study|Participant no longer needs study drug|0|||
23525887|NCT00677807|65665311|FG002|Overall Study|Participant no longer needs study drug|1|||
23525888|NCT00677807|65665309|FG000|Overall Study|Withdrawal by Subject|10|||
23525889|NCT00677807|65665310|FG001|Overall Study|Withdrawal by Subject|3|||
23525890|NCT00677807|65665311|FG002|Overall Study|Withdrawal by Subject|6|||
23525891|NCT00677807|65665309|FG000|Overall Study|Lost to Follow-up|2|||
23525892|NCT00677807|65665310|FG001|Overall Study|Lost to Follow-up|2|||
23525893|NCT00677807|65665311|FG002|Overall Study|Lost to Follow-up|2|||
23525894|NCT00677807|65665309|FG000|Overall Study|Administrative problems|1|||
23525895|NCT00677807|65665310|FG001|Overall Study|Administrative problems|1|||
23525896|NCT00677807|65665311|FG002|Overall Study|Administrative problems|2|||
23525897|NCT00677807|65665309|FG000|Overall Study|Death|0|||
23525898|NCT00677807|65665310|FG001|Overall Study|Death|1|||
23525899|NCT00677807|65665311|FG002|Overall Study|Death|1|||
23525900|NCT00677807|65665309|FG000|Overall Study|Protocol Deviation|1|||
23525901|NCT00677807|65665310|FG001|Overall Study|Protocol Deviation|3|||
23525902|NCT00677807|65665311|FG002|Overall Study|Protocol Deviation|0|||
23525903|NCT00794196|65665318|FG000|Overall Study|Lost to Follow-up|5|||
23417745|NCT00557310|65274431|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
23525904|NCT00794196|65665319|FG001|Overall Study|Lost to Follow-up|23|||
23525905|NCT02188485|65665323|FG000|Overall Study|Withdrawal by Subject|2|||
23525906|NCT02188485|65665324|FG001|Overall Study|Withdrawal by Subject|1|||
23525907|NCT02188485|65665323|FG000|Overall Study|PI withdrew, lack of capacity|0|||
23175807|NCT00560755|64386565|FG000|Overall Study|Withdrawal by Subject|26|||
23525908|NCT02188485|65665324|FG001|Overall Study|PI withdrew, lack of capacity|2|||
23525909|NCT03044197|65665327|FG000|Overall Study|Withdrawal by Subject|3|||
23525910|NCT03044197|65665328|FG001|Overall Study|Withdrawal by Subject|1|||
23525911|NCT00405548|65665330|FG000|Overall Study|Cognitive Memory problems on study day|1|||
23525912|NCT00405548|65665331|FG001|Overall Study|Cognitive Memory problems on study day|0|||
23308670|NCT00077857|64874198|FG000|Overall Study|Adverse Event|30|||
23308671|NCT00077857|64874199|FG001|Overall Study|Adverse Event|32|||
23308672|NCT00077857|64874198|FG000|Overall Study|Death|7|||
23308673|NCT00077857|64874199|FG001|Overall Study|Death|3|||
23308674|NCT00077857|64874198|FG000|Overall Study|Insufficient therapeutic response|112|||
23308675|NCT00077857|64874199|FG001|Overall Study|Insufficient therapeutic response|128|||
23308676|NCT00077857|64874198|FG000|Overall Study|Violation of selection criteria at entry|3|||
23308677|NCT00077857|64874199|FG001|Overall Study|Violation of selection criteria at entry|1|||
23308678|NCT00077857|64874198|FG000|Overall Study|Other protocol violation|0|||
23308679|NCT00077857|64874199|FG001|Overall Study|Other protocol violation|1|||
23308680|NCT00077857|64874198|FG000|Overall Study|Refused treatment|29|||
23308681|NCT00077857|64874199|FG001|Overall Study|Refused treatment|21|||
23308682|NCT00077857|64874198|FG000|Overall Study|Failure to return|5|||
23308683|NCT00077857|64874199|FG001|Overall Study|Failure to return|5|||
23308684|NCT00077857|64874198|FG000|Overall Study|Other|15|||
23308685|NCT00077857|64874199|FG001|Overall Study|Other|13|||
23308686|NCT01329549|64877691|FG000|Overall Study|Withdrawal by Subject|1|||
23308687|NCT01329549|64877691|FG000|Overall Study|Adverse Event|1|||
23525913|NCT00405548|65665330|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
23525914|NCT00405548|65665331|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
23525915|NCT00405548|65665330|FG000|Overall Study|Unable to self-administer shots|1|||
23525916|NCT00405548|65665331|FG001|Overall Study|Unable to self-administer shots|0|||
23525917|NCT00405548|65665330|FG000|Overall Study|Venous access failed during study day|1|||
23525918|NCT00405548|65665331|FG001|Overall Study|Venous access failed during study day|0|||
23525919|NCT00405548|65665330|FG000|Overall Study|Withdrawal by Subject|1|||
23525920|NCT00405548|65665331|FG001|Overall Study|Withdrawal by Subject|0|||
23525921|NCT01344369|65665340|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
23525922|NCT01344369|65665341|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
23525923|NCT01344369|65665340|FG000|Washout of 28 Days|Physician Decision|0|||
23525924|NCT01344369|65665341|FG001|Washout of 28 Days|Physician Decision|1|||
23525925|NCT01344369|65665340|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
23525926|NCT01344369|65665341|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
23308688|NCT01104792|64877696|FG000|Overall Study|Adverse Event|77|||
23308689|NCT01104792|64877696|FG000|Overall Study|Insufficient Therapeutic Response|22|||
23308690|NCT01104792|64877696|FG000|Overall Study|Protocol Violation|45|||
23417746|NCT00557310|65274431|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
23417747|NCT00557310|65274431|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
23525927|NCT01709695|65665342|FG000|Overall Study|Withdrawal by Subject|1|||
23525928|NCT01709695|65665343|FG001|Overall Study|Withdrawal by Subject|1|||
23525929|NCT04847674|65665344|FG000|Overall Study|Withdrawal by Subject|0|||
23525930|NCT04847674|65665345|FG001|Overall Study|Withdrawal by Subject|1|||
23525931|NCT04847674|65665346|FG002|Overall Study|Withdrawal by Subject|0|||
23525932|NCT04847674|65665344|FG000|Overall Study|Lost to Follow-up|0|||
23525933|NCT04847674|65665345|FG001|Overall Study|Lost to Follow-up|0|||
23525934|NCT04847674|65665346|FG002|Overall Study|Lost to Follow-up|2|||
23525935|NCT04847674|65665344|FG000|Overall Study|Other than specified|21|||
23525936|NCT04847674|65665345|FG001|Overall Study|Other than specified|20|||
23525937|NCT04847674|65665346|FG002|Overall Study|Other than specified|20|||
23525938|NCT03299842|65665353|FG000|Overall Study|Caregiver withdrew consent|2|||
23525939|NCT03299842|65665353|FG000|Overall Study|Child would not keep the watch on|3|||
23525940|NCT01572038|65665355|FG000|Overall Study|Death|648|||
23525941|NCT01572038|65665355|FG000|Overall Study|Withdrawal by Subject|204|||
23525942|NCT01572038|65665355|FG000|Overall Study|Lost to Follow-up|81|||
23525943|NCT01572038|65665355|FG000|Overall Study|Physician Decision|20|||
23525944|NCT01572038|65665355|FG000|Overall Study|Patient Decision|14|||
23525945|NCT01572038|65665355|FG000|Overall Study|Progressive Disease|8|||
23525946|NCT01572038|65665355|FG000|Overall Study|Site Closed Before Completing Form|6|||
23525947|NCT01572038|65665355|FG000|Overall Study|Enrolled into Another Trial|3|||
23525948|NCT01572038|65665355|FG000|Overall Study|Participated in Another Trial|3|||
23308691|NCT01104792|64877696|FG000|Overall Study|Withdrawal of Consent|179|||
23308692|NCT01104792|64877696|FG000|Overall Study|Lost to Follow-up|43|||
23308693|NCT01104792|64877696|FG000|Overall Study|Reasons Not Specified|27|||
23308694|NCT01104792|64877696|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
23308695|NCT01383135|64877697|FG000|Overall Study|Not Scanned / Imaged|1|||
23308696|NCT01383135|64877698|FG001|Overall Study|Not Scanned / Imaged|0|||
23308697|NCT01383135|64877699|FG002|Overall Study|Not Scanned / Imaged|1|||
23308698|NCT01383135|64877700|FG003|Overall Study|Not Scanned / Imaged|0|||
23308699|NCT03323437|64877701|FG000|Overall Study|Withdrawal by Subject|0|||
23308700|NCT03323437|64877702|FG001|Overall Study|Withdrawal by Subject|4|||
23308701|NCT03825341|64877705|FG000|Overall Study|Withdrawal by Subject|0|||
23308702|NCT03825341|64877706|FG001|Overall Study|Withdrawal by Subject|1|||
23308703|NCT03753763|64877707|FG000|Overall Study|Adverse Event|2|||
23308704|NCT03753763|64877708|FG001|Overall Study|Adverse Event|0|||
23308705|NCT03753763|64877707|FG000|Overall Study|Withdrawal by Subject|3|||
23308706|NCT03753763|64877708|FG001|Overall Study|Withdrawal by Subject|1|||
23308707|NCT03753763|64877707|FG000|Overall Study|clinical deterioration|1|||
23308708|NCT03753763|64877708|FG001|Overall Study|clinical deterioration|0|||
23308709|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
23308710|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
23308711|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
23308712|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
23308713|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
23308714|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
23308715|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
23308716|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
23308717|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
23308718|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
23308719|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Death|1|||
23308720|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Death|0|||
23308721|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Death|0|||
23308722|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Death|0|||
23308723|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Death|0|||
23308724|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
23308725|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
23308726|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
23308727|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
23308728|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
23308729|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
23206174|NCT01963208|64494806|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
23206175|NCT01963208|64494807|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
23206176|NCT01963208|64494808|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
23206177|NCT01963208|64494809|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
23206178|NCT01963208|64494810|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
23206179|NCT01963208|64494811|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
23206180|NCT00511342|64494812|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
23206181|NCT00511342|64494813|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
23308730|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
23308731|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
23308732|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
23308733|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
23417748|NCT00557310|65274431|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
23417749|NCT00557310|65274431|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
23417750|NCT00557310|65274431|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
23417751|NCT00157196|65274434|FG000|Overall Study|Ongoing at data cut-off|9|||
23417752|NCT02439450|65274435|FG000|Overall Study|Adverse Event|4|||
23417753|NCT02439450|65274436|FG001|Overall Study|Adverse Event|1|||
23417754|NCT02439450|65274437|FG002|Overall Study|Adverse Event|0|||
23525949|NCT01572038|65665355|FG000|Overall Study|Termination by Sponsor|2|||
23525950|NCT01572038|65665355|FG000|Overall Study|Patient Deterioration|1|||
23308734|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
23308735|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
23308736|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
23308737|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
23308738|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
23308739|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
23308740|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
23308741|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
23308742|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
23308743|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23308744|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
23308745|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23206182|NCT00511342|64494812|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
23308746|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23417755|NCT02439450|65274438|FG003|Overall Study|Adverse Event|0|||
23417756|NCT02439450|65274435|FG000|Overall Study|Withdrawal by Subject|1|||
23417757|NCT02439450|65274436|FG001|Overall Study|Withdrawal by Subject|2|||
23417758|NCT02439450|65274437|FG002|Overall Study|Withdrawal by Subject|0|||
23417759|NCT02439450|65274438|FG003|Overall Study|Withdrawal by Subject|0|||
23417760|NCT02439450|65274435|FG000|Overall Study|Death|3|||
23417761|NCT02439450|65274436|FG001|Overall Study|Death|0|||
23417762|NCT02439450|65274437|FG002|Overall Study|Death|0|||
23417763|NCT02439450|65274438|FG003|Overall Study|Death|1|||
23417764|NCT02439450|65274435|FG000|Overall Study|Progressive Disease|18|||
23417765|NCT02439450|65274436|FG001|Overall Study|Progressive Disease|41|||
23417766|NCT02439450|65274437|FG002|Overall Study|Progressive Disease|2|||
23417767|NCT02439450|65274438|FG003|Overall Study|Progressive Disease|3|||
23417768|NCT03842969|65274439|FG000|Overall Study|Participant declined follow-up visit|0|||
23417769|NCT03842969|65274440|FG001|Overall Study|Participant declined follow-up visit|1|||
23417770|NCT03842969|65274441|FG002|Overall Study|Participant declined follow-up visit|0|||
23417771|NCT03842969|65274439|FG000|Overall Study|Sponsor's decision|12|||
23417772|NCT03842969|65274440|FG001|Overall Study|Sponsor's decision|99|||
23417773|NCT03842969|65274441|FG002|Overall Study|Sponsor's decision|61|||
23417774|NCT03842969|65274439|FG000|Overall Study|Pregnancy|0|||
23417775|NCT03842969|65274440|FG001|Overall Study|Pregnancy|0|||
23417776|NCT03842969|65274441|FG002|Overall Study|Pregnancy|1|||
23417777|NCT03842969|65274439|FG000|Overall Study|Death|1|||
23417778|NCT03842969|65274440|FG001|Overall Study|Death|0|||
23417779|NCT03842969|65274441|FG002|Overall Study|Death|1|||
23417780|NCT03842969|65274439|FG000|Overall Study|Withdrawal by Subject|3|||
23417781|NCT03842969|65274440|FG001|Overall Study|Withdrawal by Subject|30|||
23417782|NCT03842969|65274441|FG002|Overall Study|Withdrawal by Subject|18|||
23417783|NCT03842969|65274439|FG000|Overall Study|Protocol Violation|1|||
23417784|NCT03842969|65274440|FG001|Overall Study|Protocol Violation|1|||
23417785|NCT03842969|65274441|FG002|Overall Study|Protocol Violation|0|||
23417786|NCT03842969|65274439|FG000|Overall Study|Physician Decision|0|||
23417787|NCT03842969|65274440|FG001|Overall Study|Physician Decision|3|||
23417788|NCT03842969|65274441|FG002|Overall Study|Physician Decision|0|||
23417789|NCT03842969|65274439|FG000|Overall Study|Lost to Follow-up|0|||
23417790|NCT03842969|65274440|FG001|Overall Study|Lost to Follow-up|2|||
23417791|NCT03842969|65274441|FG002|Overall Study|Lost to Follow-up|0|||
23417792|NCT03842969|65274439|FG000|Overall Study|Adverse Event|0|||
23417793|NCT03842969|65274440|FG001|Overall Study|Adverse Event|2|||
23417794|NCT03842969|65274441|FG002|Overall Study|Adverse Event|0|||
23417795|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
23417796|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
23417797|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
23417798|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
23417799|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
23417800|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
23417801|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
23417802|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
23417803|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
23417804|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
23417805|NCT00737568|65274443|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
23417806|NCT00737568|65274444|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
23417807|NCT00737568|65274443|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
23417808|NCT00737568|65274444|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
23417809|NCT00737568|65274443|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
23417810|NCT00737568|65274444|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
23417811|NCT00737568|65274443|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
23417812|NCT00737568|65274444|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
23525951|NCT01572038|65665355|FG000|Overall Study|Sponsor Decision|1|||
23525952|NCT00637195|65665356|FG000|Overall Study|Lost to Follow-up|1|||
23206183|NCT00511342|64494813|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
23206184|NCT00511342|64494812|FG000|Overall Study|Pregnancy|0|||
23417813|NCT00875485|65274445|FG000|Challenge Dose Epoch|Pregnancy|1|||
23417814|NCT00875485|65274446|FG001|Challenge Dose Epoch|Pregnancy|0|||
23417815|NCT00368836|65274449|FG000|Phase II|Screen Failure|1|||
23417816|NCT00368836|65274449|FG000|Phase II|Withdrawal by Subject|1|||
23417817|NCT00368836|65274449|FG000|Phase II|unable to collect blood and/or breath|17|||
23417818|NCT00368836|65274449|FG000|Phase II|Protocol Violation|2|||
23417819|NCT01779856|65274450|FG000|Overall Study|Withdrawal by Subject|15|||
23417820|NCT01779856|65274450|FG000|Overall Study|Death|3|||
23206185|NCT00511342|64494813|FG001|Overall Study|Pregnancy|1|||
23308747|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23417821|NCT01779856|65274450|FG000|Overall Study|Physician Decision|1|||
23417822|NCT01779856|65274450|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
23525953|NCT00637195|65665357|FG001|Overall Study|Lost to Follow-up|0|||
23417823|NCT01779856|65274450|FG000|Overall Study|Delays in scheduling implant|1|||
23417824|NCT01779856|65274450|FG000|Overall Study|Subject ineligible for Implant|2|||
23417825|NCT03905265|65274457|FG000|Overall Study|Withdrawal by Subject|1|||
23417826|NCT03905265|65274458|FG001|Overall Study|Withdrawal by Subject|1|||
23417827|NCT03905265|65274459|FG002|Overall Study|Withdrawal by Subject|0|||
23417828|NCT03905265|65274460|FG003|Overall Study|Withdrawal by Subject|0|||
23417829|NCT01265563|65274461|FG000|Overall Study|Withdrawal by Subject|0|||
23417830|NCT01265563|65274462|FG001|Overall Study|Withdrawal by Subject|1|||
23417831|NCT01265563|65274463|FG002|Overall Study|Withdrawal by Subject|1|||
23417832|NCT01265563|65274464|FG003|Overall Study|Withdrawal by Subject|0|||
23417833|NCT01265563|65274465|FG004|Overall Study|Withdrawal by Subject|2|||
23417834|NCT00695955|65274466|FG000|Cohort 1|Adverse Event|26|||
23417835|NCT00695955|65274466|FG000|Cohort 1|Protocol Violation|2|||
23417836|NCT00695955|65274466|FG000|Cohort 1|Lost to Follow-up|30|||
23417837|NCT00695955|65274466|FG000|Cohort 1|Withdrawal by Subject|25|||
23417838|NCT00695955|65274466|FG000|Cohort 1|Lack of Efficacy|3|||
23417839|NCT00695955|65274466|FG000|Cohort 1|Other|16|||
23417840|NCT00695955|65274466|FG000|Cohort 2|Adverse Event|24|||
23417841|NCT00695955|65274466|FG000|Cohort 2|Protocol Violation|5|||
23417842|NCT00695955|65274466|FG000|Cohort 2|Lost to Follow-up|38|||
23417843|NCT00695955|65274466|FG000|Cohort 2|Withdrawal by Subject|28|||
23417844|NCT00695955|65274466|FG000|Cohort 2|Lack of Efficacy|4|||
23417845|NCT00695955|65274466|FG000|Cohort 2|Other|5|||
23417846|NCT00984165|65274469|FG000|Overall Study|Death on study|2|||
23417847|NCT00984165|65274470|FG001|Overall Study|Death on study|0|||
23417848|NCT00984165|65274471|FG002|Overall Study|Death on study|0|||
23417849|NCT00984165|65274472|FG003|Overall Study|Death on study|0|||
23417850|NCT00984165|65274469|FG000|Overall Study|Disease progression on study|5|||
23417851|NCT00984165|65274470|FG001|Overall Study|Disease progression on study|1|||
23525954|NCT00637195|65665356|FG000|Overall Study|Other|2|||
23525955|NCT00637195|65665357|FG001|Overall Study|Other|0|||
23525956|NCT00637195|65665356|FG000|Overall Study|Withdrawal by Subject|0|||
23525957|NCT00637195|65665357|FG001|Overall Study|Withdrawal by Subject|1|||
23525958|NCT03554291|65665359|FG000|Overall Study|Death|2|||
23525959|NCT03554291|65665360|FG001|Overall Study|Death|1|||
23525960|NCT03554291|65665359|FG000|Overall Study|Lost to Follow-up|1|||
23525961|NCT03554291|65665360|FG001|Overall Study|Lost to Follow-up|0|||
23308748|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23308749|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Other|4|||
23308750|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Other|4|||
23525962|NCT03554291|65665359|FG000|Overall Study|Withdrawal by Subject|1|||
23525963|NCT03554291|65665360|FG001|Overall Study|Withdrawal by Subject|0|||
23525964|NCT03554291|65665359|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
23525965|NCT03554291|65665360|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
23525966|NCT05091307|65665362|FG000|Overall Study|Death|0|||
23525967|NCT05091307|65665363|FG001|Overall Study|Death|0|||
23525968|NCT05091307|65665364|FG002|Overall Study|Death|1|||
23417852|NCT00984165|65274471|FG002|Overall Study|Disease progression on study|0|||
23417853|NCT00984165|65274472|FG003|Overall Study|Disease progression on study|0|||
23417854|NCT00984165|65274469|FG000|Overall Study|Death of recipient|0|||
23417855|NCT00984165|65274470|FG001|Overall Study|Death of recipient|0|||
23417856|NCT00984165|65274471|FG002|Overall Study|Death of recipient|0|||
23417857|NCT00984165|65274472|FG003|Overall Study|Death of recipient|1|||
23417858|NCT00984165|65274469|FG000|Overall Study|New protocol|0|||
23417859|NCT00984165|65274470|FG001|Overall Study|New protocol|0|||
23417860|NCT00984165|65274471|FG002|Overall Study|New protocol|0|||
23417861|NCT00984165|65274472|FG003|Overall Study|New protocol|1|||
23417862|NCT00984165|65274469|FG000|Overall Study|P+/donor pair removed from protocol|0|||
23206186|NCT00511342|64494812|FG000|Overall Study|Pregnancy wish|0|||
23417863|NCT00984165|65274470|FG001|Overall Study|P+/donor pair removed from protocol|0|||
23417864|NCT00984165|65274471|FG002|Overall Study|P+/donor pair removed from protocol|0|||
23417865|NCT00984165|65274472|FG003|Overall Study|P+/donor pair removed from protocol|1|||
23417866|NCT00984165|65274469|FG000|Overall Study|removed with a pair recipient|0|||
23417867|NCT00984165|65274470|FG001|Overall Study|removed with a pair recipient|0|||
23417868|NCT00984165|65274471|FG002|Overall Study|removed with a pair recipient|0|||
23417869|NCT00984165|65274472|FG003|Overall Study|removed with a pair recipient|1|||
23417870|NCT02499900|65274473|FG000|Core Study Period|Other|1|||
23525969|NCT05091307|65665365|FG003|Overall Study|Death|0|||
23525970|NCT05091307|65665362|FG000|Overall Study|Lost to Follow-up|33|||
23417871|NCT02499900|65274474|FG001|Core Study Period|Other|4|||
23525971|NCT05091307|65665363|FG001|Overall Study|Lost to Follow-up|33|||
23525972|NCT05091307|65665364|FG002|Overall Study|Lost to Follow-up|2|||
23308751|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Other|3|||
23417872|NCT02499900|65274473|FG000|Core Study Period|Lost to Follow-up|1|||
23525973|NCT05091307|65665365|FG003|Overall Study|Lost to Follow-up|0|||
23525974|NCT05091307|65665362|FG000|Overall Study|Physician Decision|1|||
23417873|NCT02499900|65274474|FG001|Core Study Period|Lost to Follow-up|2|||
23417874|NCT02499900|65274473|FG000|Core Study Period|Per sponsor request|0|||
23525975|NCT05091307|65665363|FG001|Overall Study|Physician Decision|0|||
23525976|NCT05091307|65665364|FG002|Overall Study|Physician Decision|0|||
23525977|NCT05091307|65665365|FG003|Overall Study|Physician Decision|0|||
23525978|NCT05091307|65665362|FG000|Overall Study|Protocol Violation|1|||
23525979|NCT05091307|65665363|FG001|Overall Study|Protocol Violation|0|||
23525980|NCT05091307|65665364|FG002|Overall Study|Protocol Violation|0|||
23525981|NCT05091307|65665365|FG003|Overall Study|Protocol Violation|0|||
23525982|NCT05091307|65665362|FG000|Overall Study|Withdrawal by Subject|16|||
23525983|NCT05091307|65665363|FG001|Overall Study|Withdrawal by Subject|16|||
23525984|NCT05091307|65665364|FG002|Overall Study|Withdrawal by Subject|0|||
23525985|NCT05091307|65665365|FG003|Overall Study|Withdrawal by Subject|1|||
23525986|NCT05091307|65665362|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
23525987|NCT05091307|65665363|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
23525988|NCT05091307|65665364|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
23525989|NCT05091307|65665365|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
23525990|NCT05091307|65665362|FG000|Overall Study|Initiated Prohibited Medication|1|||
23525991|NCT05091307|65665363|FG001|Overall Study|Initiated Prohibited Medication|0|||
23525992|NCT05091307|65665364|FG002|Overall Study|Initiated Prohibited Medication|0|||
23525993|NCT05091307|65665365|FG003|Overall Study|Initiated Prohibited Medication|0|||
23525994|NCT05091307|65665362|FG000|Overall Study|Other|4|||
23525995|NCT05091307|65665363|FG001|Overall Study|Other|4|||
23525996|NCT05091307|65665364|FG002|Overall Study|Other|0|||
23525997|NCT05091307|65665365|FG003|Overall Study|Other|0|||
23525998|NCT05091307|65665362|FG000|Overall Study|Randomized but not vaccinated|0|||
23525999|NCT05091307|65665363|FG001|Overall Study|Randomized but not vaccinated|2|||
23526000|NCT05091307|65665364|FG002|Overall Study|Randomized but not vaccinated|0|||
23526001|NCT05091307|65665365|FG003|Overall Study|Randomized but not vaccinated|0|||
23526002|NCT00323414|65665368|FG000|Overall Study|Withdrawal by Subject|0|||
23526003|NCT00323414|65665369|FG001|Overall Study|Withdrawal by Subject|1|||
23526004|NCT01907828|65665370|FG000|Overall Study|Exclusion criteria not met|0|||
23526005|NCT01907828|65665371|FG001|Overall Study|Exclusion criteria not met|1|||
23526006|NCT01907828|65665370|FG000|Overall Study|Withdrawal by Subject|3|||
23526007|NCT01907828|65665371|FG001|Overall Study|Withdrawal by Subject|4|||
23526008|NCT01907828|65665370|FG000|Overall Study|Lost to Follow-up|3|||
23526009|NCT01907828|65665371|FG001|Overall Study|Lost to Follow-up|0|||
23526010|NCT01907828|65665370|FG000|Overall Study|Participant refused 24-month follow-up|1|||
23526011|NCT01907828|65665371|FG001|Overall Study|Participant refused 24-month follow-up|0|||
23526012|NCT01907828|65665370|FG000|Overall Study|Participant met exclusion criteria|0|||
23526013|NCT01907828|65665371|FG001|Overall Study|Participant met exclusion criteria|1|||
23526014|NCT02272413|65665374|FG000|Randomized Through Treatment Start|Not treated|3|||
23526015|NCT02272413|65665375|FG001|Randomized Through Treatment Start|Not treated|5|||
23526016|NCT02272413|65665374|FG000|Pre-switch Period|Adverse Event|38|||
23526017|NCT02272413|65665375|FG001|Pre-switch Period|Adverse Event|37|||
23526018|NCT02272413|65665374|FG000|Pre-switch Period|Death|26|||
23526019|NCT02272413|65665375|FG001|Pre-switch Period|Death|26|||
23526020|NCT02272413|65665374|FG000|Pre-switch Period|Withdrawal by Subject|27|||
23526021|NCT02272413|65665375|FG001|Pre-switch Period|Withdrawal by Subject|15|||
23526022|NCT02272413|65665374|FG000|Pre-switch Period|Physician Decision|6|||
23526023|NCT02272413|65665375|FG001|Pre-switch Period|Physician Decision|18|||
23526024|NCT02272413|65665374|FG000|Pre-switch Period|Progressive disease|185|||
23526025|NCT02272413|65665375|FG001|Pre-switch Period|Progressive disease|173|||
23526026|NCT02272413|65665374|FG000|Pre-switch Period|Lost to Follow-up|0|||
23526027|NCT02272413|65665375|FG001|Pre-switch Period|Lost to Follow-up|2|||
23526028|NCT02272413|65665374|FG000|Pre-switch Period|Protocol Violation|1|||
23526029|NCT02272413|65665375|FG001|Pre-switch Period|Protocol Violation|0|||
23526030|NCT02272413|65665374|FG000|Pre-switch Period|Other than listed|10|||
23526031|NCT02272413|65665375|FG001|Pre-switch Period|Other than listed|11|||
23526032|NCT02272413|65665374|FG000|Post-switch Period|Adverse Event|4|||
23526033|NCT02272413|65665375|FG001|Post-switch Period|Adverse Event|4|||
23526034|NCT02272413|65665374|FG000|Post-switch Period|Death|3|||
23526035|NCT02272413|65665375|FG001|Post-switch Period|Death|2|||
23526036|NCT02272413|65665374|FG000|Post-switch Period|Withdrawal by Subject|1|||
23611224|NCT01072149|65966724|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611225|NCT01072149|65966725|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611226|NCT01072149|65966726|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23308752|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Other|1|||
23308753|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Other|0|||
23526037|NCT02272413|65665375|FG001|Post-switch Period|Withdrawal by Subject|2|||
23526038|NCT02272413|65665374|FG000|Post-switch Period|Physician Decision|1|||
23526039|NCT02272413|65665375|FG001|Post-switch Period|Physician Decision|1|||
23526040|NCT02272413|65665374|FG000|Post-switch Period|Progressive disease|21|||
23526041|NCT02272413|65665375|FG001|Post-switch Period|Progressive disease|21|||
23526042|NCT02272413|65665374|FG000|Post-switch Period|Study terminated by sponsor|8|||
23526043|NCT02272413|65665375|FG001|Post-switch Period|Study terminated by sponsor|11|||
23526044|NCT02272413|65665374|FG000|Post-switch Period|Other than listed|4|||
23526045|NCT02272413|65665375|FG001|Post-switch Period|Other than listed|5|||
23526046|NCT01856790|65665378|FG000|Closed Loop Control|Withdrawal by Subject|2|||
23526047|NCT01856790|65665378|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
23526048|NCT02347527|65665381|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
23526049|NCT02347527|65665382|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
23526050|NCT02347527|65665383|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
23526051|NCT02347527|65665384|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
23526052|NCT02347527|65665381|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
23526053|NCT02347527|65665382|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
23526054|NCT02347527|65665383|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
23526055|NCT02347527|65665384|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
23526056|NCT02347527|65665381|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
23526057|NCT02347527|65665382|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
23526058|NCT02347527|65665383|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
23526059|NCT02347527|65665384|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
23526060|NCT02347527|65665381|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
23526061|NCT02347527|65665382|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
23526062|NCT02347527|65665383|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
23526063|NCT02347527|65665384|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
23526064|NCT02347527|65665381|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
23526065|NCT02347527|65665382|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
23526066|NCT02347527|65665383|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
23526067|NCT02347527|65665384|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
23526068|NCT01192152|65665385|FG000|Period 1|left prematurely (while on treatment B)|0|||
23526069|NCT01192152|65665386|FG001|Period 1|left prematurely (while on treatment B)|1|||
23526070|NCT01192152|65665385|FG000|Period 3|family emergency|1|||
23526071|NCT01192152|65665386|FG001|Period 3|family emergency|0|||
23526072|NCT00660348|65665387|FG000|Overall Study|Withdrawal by Subject|1|||
23526073|NCT00660348|65665388|FG001|Overall Study|Withdrawal by Subject|0|||
23526074|NCT00717769|65665390|FG000|Overall Study|Adverse Event|9|||
23526075|NCT00717769|65665391|FG001|Overall Study|Adverse Event|6|||
23526076|NCT00717769|65665392|FG002|Overall Study|Adverse Event|1|||
23526077|NCT00717769|65665390|FG000|Overall Study|Lack of compliance|0|||
23526078|NCT00717769|65665391|FG001|Overall Study|Lack of compliance|2|||
23526079|NCT00717769|65665392|FG002|Overall Study|Lack of compliance|0|||
23526080|NCT00717769|65665390|FG000|Overall Study|Lost to Follow-up|3|||
23526081|NCT00717769|65665391|FG001|Overall Study|Lost to Follow-up|4|||
23526082|NCT00717769|65665392|FG002|Overall Study|Lost to Follow-up|0|||
23526083|NCT00717769|65665390|FG000|Overall Study|Lack of Efficacy|1|||
23526084|NCT00717769|65665391|FG001|Overall Study|Lack of Efficacy|2|||
23526085|NCT00717769|65665392|FG002|Overall Study|Lack of Efficacy|0|||
23526086|NCT00717769|65665390|FG000|Overall Study|Protocol Violation|0|||
23526087|NCT00717769|65665391|FG001|Overall Study|Protocol Violation|2|||
23526088|NCT00717769|65665392|FG002|Overall Study|Protocol Violation|0|||
23526089|NCT00717769|65665390|FG000|Overall Study|Sponsor decision|1|||
23526090|NCT00717769|65665391|FG001|Overall Study|Sponsor decision|0|||
23526091|NCT00717769|65665392|FG002|Overall Study|Sponsor decision|10|||
23526092|NCT00717769|65665390|FG000|Overall Study|Withdrew consent|2|||
23526093|NCT00717769|65665391|FG001|Overall Study|Withdrew consent|2|||
23526094|NCT00717769|65665392|FG002|Overall Study|Withdrew consent|0|||
23526095|NCT01449526|65665393|FG000|Overall Study|Lost to Follow-up|1|||
23526096|NCT01449526|65665394|FG001|Overall Study|Lost to Follow-up|2|||
23526097|NCT01449526|65665393|FG000|Overall Study|Withdrawal by Subject|1|||
23526098|NCT01449526|65665394|FG001|Overall Study|Withdrawal by Subject|1|||
23526099|NCT01449526|65665393|FG000|Overall Study|Symptoms/complaints|0|||
23526100|NCT01449526|65665394|FG001|Overall Study|Symptoms/complaints|1|||
23526101|NCT01449526|65665393|FG000|Overall Study|Lack of Motivation|0|||
23526102|NCT01449526|65665394|FG001|Overall Study|Lack of Motivation|1|||
23526103|NCT01449526|65665393|FG000|Overall Study|Cannot maintain visits|0|||
23526104|NCT01449526|65665394|FG001|Overall Study|Cannot maintain visits|1|||
23526105|NCT03216850|65665405|FG000|Overall Study|Pre-analytical error|6|||
23206187|NCT00511342|64494813|FG001|Overall Study|Pregnancy wish|1|||
23206188|NCT00511342|64494812|FG000|Overall Study|Lost to Follow-up|1|||
23206189|NCT00511342|64494813|FG001|Overall Study|Lost to Follow-up|5|||
23206190|NCT00511342|64494812|FG000|Overall Study|Other Reason|2|||
23526106|NCT03400033|65665406|FG000|Overall Study|Withdrawal by Subject|1|||
23526107|NCT03400033|65665407|FG001|Overall Study|Withdrawal by Subject|2|||
23526108|NCT01434290|65665408|FG000|Overall Study|Protocol Violation|6|||
23526109|NCT01434290|65665409|FG001|Overall Study|Protocol Violation|3|||
23526110|NCT01434290|65665408|FG000|Overall Study|No protocol treatment|2|||
23526111|NCT01434290|65665409|FG001|Overall Study|No protocol treatment|4|||
23206191|NCT00511342|64494813|FG001|Overall Study|Other Reason|2|||
23206192|NCT03649321|64494814|FG000|Overall Study|Withdrawal by Subject|1|||
23526112|NCT00964392|65665410|FG000|Overall Study|Withdrawal by Subject|4|||
23526113|NCT00964392|65665411|FG001|Overall Study|Withdrawal by Subject|6|||
23526114|NCT00964392|65665410|FG000|Overall Study|Lost to Follow-up|4|||
23526115|NCT00964392|65665411|FG001|Overall Study|Lost to Follow-up|10|||
23526116|NCT00964392|65665410|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
23526117|NCT00964392|65665411|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
23526118|NCT00964392|65665410|FG000|Overall Study|Not completed|44|||
23526119|NCT00964392|65665411|FG001|Overall Study|Not completed|168|||
23526120|NCT05074433|65665420|FG000|Overall Study|Adverse Event|0|||
23526121|NCT05074433|65665421|FG001|Overall Study|Adverse Event|2|||
23526122|NCT05074433|65665422|FG002|Overall Study|Adverse Event|0|||
23526123|NCT05074433|65665423|FG003|Overall Study|Adverse Event|1|||
23526124|NCT05074433|65665420|FG000|Overall Study|Sponsor Request|0|||
23526125|NCT05074433|65665421|FG001|Overall Study|Sponsor Request|1|||
23526126|NCT05074433|65665422|FG002|Overall Study|Sponsor Request|1|||
23526127|NCT05074433|65665423|FG003|Overall Study|Sponsor Request|0|||
23526128|NCT05074433|65665420|FG000|Overall Study|Death|1|||
23526129|NCT05074433|65665421|FG001|Overall Study|Death|0|||
23526130|NCT05074433|65665422|FG002|Overall Study|Death|0|||
23526131|NCT05074433|65665423|FG003|Overall Study|Death|0|||
23526132|NCT05074433|65665420|FG000|Overall Study|Lost to Follow-up|0|||
23526133|NCT05074433|65665421|FG001|Overall Study|Lost to Follow-up|0|||
23526134|NCT05074433|65665422|FG002|Overall Study|Lost to Follow-up|2|||
23526135|NCT05074433|65665423|FG003|Overall Study|Lost to Follow-up|0|||
23526136|NCT05074433|65665420|FG000|Overall Study|Subject Decision|8|||
23526137|NCT05074433|65665421|FG001|Overall Study|Subject Decision|6|||
23526138|NCT05074433|65665422|FG002|Overall Study|Subject Decision|4|||
23526139|NCT05074433|65665423|FG003|Overall Study|Subject Decision|5|||
23526140|NCT00594464|65665424|FG000|Overall Study|Withdrawal by Subject|1|||
23526141|NCT00594464|65665424|FG000|Overall Study|Delay in operation|2|||
23526142|NCT01723228|65665425|FG000|Overall Study|Adverse Event|2|||
23526143|NCT01723228|65665426|FG001|Overall Study|Adverse Event|6|||
23526144|NCT01723228|65665425|FG000|Overall Study|Withdrawal by Subject|2|||
23526145|NCT01723228|65665426|FG001|Overall Study|Withdrawal by Subject|1|||
23526146|NCT01723228|65665425|FG000|Overall Study|Protocol Violation|0|||
23526147|NCT01723228|65665426|FG001|Overall Study|Protocol Violation|2|||
23526148|NCT01723228|65665425|FG000|Overall Study|Lost to Follow-up|2|||
23526149|NCT01723228|65665426|FG001|Overall Study|Lost to Follow-up|1|||
23526150|NCT01723228|65665425|FG000|Overall Study|Other|2|||
23526151|NCT01723228|65665426|FG001|Overall Study|Other|1|||
23526152|NCT00578942|65665427|FG000|Overall Study|Lost to Follow-up|1|||
23526153|NCT02126969|65665432|FG000|Overall Study|Withdrawal by Subject|1|||
23526154|NCT02126969|65665433|FG001|Overall Study|Withdrawal by Subject|2|||
23526155|NCT00735371|65665434|FG000|Overall Study|Adverse Event|3|||
23526156|NCT00735371|65665435|FG001|Overall Study|Adverse Event|3|||
23526157|NCT00735371|65665436|FG002|Overall Study|Adverse Event|4|||
23526158|NCT00735371|65665437|FG003|Overall Study|Adverse Event|1|||
23526159|NCT00735371|65665434|FG000|Overall Study|Protocol Violation|2|||
23526160|NCT00735371|65665435|FG001|Overall Study|Protocol Violation|2|||
23526161|NCT00735371|65665436|FG002|Overall Study|Protocol Violation|0|||
23526162|NCT00735371|65665437|FG003|Overall Study|Protocol Violation|3|||
23526163|NCT00735371|65665434|FG000|Overall Study|Withdrawal by Subject|0|||
23526164|NCT00735371|65665435|FG001|Overall Study|Withdrawal by Subject|2|||
23526165|NCT00735371|65665436|FG002|Overall Study|Withdrawal by Subject|2|||
23526166|NCT00735371|65665437|FG003|Overall Study|Withdrawal by Subject|0|||
23526167|NCT00735371|65665434|FG000|Overall Study|Lost to Follow-up|1|||
23526168|NCT00735371|65665435|FG001|Overall Study|Lost to Follow-up|1|||
23526169|NCT00735371|65665436|FG002|Overall Study|Lost to Follow-up|3|||
23526170|NCT00735371|65665437|FG003|Overall Study|Lost to Follow-up|1|||
23526171|NCT00735371|65665434|FG000|Overall Study|Lack of Efficacy|4|||
23526172|NCT00735371|65665435|FG001|Overall Study|Lack of Efficacy|2|||
23526173|NCT00735371|65665436|FG002|Overall Study|Lack of Efficacy|0|||
23526174|NCT00735371|65665437|FG003|Overall Study|Lack of Efficacy|4|||
23526175|NCT00735371|65665434|FG000|Overall Study|Sponsor Decision|3|||
23526176|NCT00735371|65665435|FG001|Overall Study|Sponsor Decision|1|||
23526177|NCT00735371|65665436|FG002|Overall Study|Sponsor Decision|0|||
23526178|NCT00735371|65665437|FG003|Overall Study|Sponsor Decision|1|||
23526179|NCT00735371|65665434|FG000|Overall Study|Protocol Violation|0|||
23526180|NCT00735371|65665435|FG001|Overall Study|Protocol Violation|1|||
23526181|NCT00735371|65665436|FG002|Overall Study|Protocol Violation|2|||
23526182|NCT00735371|65665437|FG003|Overall Study|Protocol Violation|0|||
23526183|NCT00735371|65665434|FG000|Overall Study|Prior Vyvanse Exposure|1|||
23526184|NCT00735371|65665435|FG001|Overall Study|Prior Vyvanse Exposure|1|||
23526185|NCT00735371|65665436|FG002|Overall Study|Prior Vyvanse Exposure|0|||
23526186|NCT00735371|65665437|FG003|Overall Study|Prior Vyvanse Exposure|0|||
23526187|NCT00735371|65665434|FG000|Overall Study|Exclusion criteria|1|||
23526188|NCT00735371|65665435|FG001|Overall Study|Exclusion criteria|0|||
23526189|NCT00735371|65665436|FG002|Overall Study|Exclusion criteria|0|||
23526190|NCT00735371|65665437|FG003|Overall Study|Exclusion criteria|0|||
23611227|NCT01072149|65966727|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611228|NCT01072149|65966728|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
23611229|NCT01072149|65966729|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611230|NCT01072149|65966730|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
23611231|NCT01072149|65966713|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
23526191|NCT02214121|65665438|FG000|Part A|Patient decision|2|||
23526192|NCT02214121|65665439|FG001|Part A|Patient decision|0|||
23526193|NCT02214121|65665440|FG002|Part A|Patient decision|0|||
23526194|NCT02214121|65665438|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
23526195|NCT02214121|65665439|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
23526196|NCT02214121|65665440|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
23526197|NCT02214121|65665438|FG000|Part A|Other|1|||
23611232|NCT01072149|65966714|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
23611233|NCT01072149|65966715|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
23611234|NCT01072149|65966716|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
23611235|NCT01072149|65966717|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
23611236|NCT01072149|65966718|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
23611237|NCT01072149|65966719|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
23611238|NCT01072149|65966720|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
23611239|NCT01072149|65966721|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
23611240|NCT01072149|65966722|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
23611241|NCT01072149|65966723|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
23611242|NCT01072149|65966724|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
23611243|NCT01072149|65966725|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
23611244|NCT01072149|65966726|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
23611245|NCT01072149|65966727|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
23611246|NCT01072149|65966728|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
23526198|NCT02214121|65665439|FG001|Part A|Other|0|||
23526199|NCT02214121|65665440|FG002|Part A|Other|0|||
23526200|NCT02214121|65665438|FG000|Part B|Patient decision|0|||
23526201|NCT02214121|65665439|FG001|Part B|Patient decision|1|||
23526202|NCT02214121|65665440|FG002|Part B|Patient decision|0|||
23526203|NCT02214121|65665438|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
23526204|NCT02214121|65665439|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
23526205|NCT02214121|65665440|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
23526206|NCT02214121|65665438|FG000|Part B|Lost to Follow-up|0|||
23526207|NCT02214121|65665439|FG001|Part B|Lost to Follow-up|0|||
23526208|NCT02214121|65665440|FG002|Part B|Lost to Follow-up|1|||
23526209|NCT01371656|65665451|FG000|Overall Study|Death|7|||
23526210|NCT01371656|65665452|FG001|Overall Study|Death|4|||
23526211|NCT01371656|65665451|FG000|Overall Study|Physician Decision|46|||
23526212|NCT01371656|65665452|FG001|Overall Study|Physician Decision|7|||
23611247|NCT01072149|65966729|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
23611248|NCT01072149|65966730|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
23611249|NCT01072149|65966713|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611250|NCT01072149|65966714|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611251|NCT01072149|65966715|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611252|NCT01072149|65966716|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611253|NCT01072149|65966717|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611254|NCT01072149|65966718|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611255|NCT01072149|65966719|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611256|NCT01072149|65966720|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611257|NCT01072149|65966721|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611258|NCT01072149|65966722|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611259|NCT01072149|65966723|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611260|NCT01072149|65966724|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611261|NCT01072149|65966725|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
23611262|NCT01072149|65966726|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611263|NCT01072149|65966727|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611264|NCT01072149|65966728|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611265|NCT01072149|65966729|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611266|NCT01072149|65966730|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
23611267|NCT01072149|65966713|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23526213|NCT01371656|65665451|FG000|Overall Study|Withdrawal by Subject|7|||
23526214|NCT01371656|65665452|FG001|Overall Study|Withdrawal by Subject|0|||
23526215|NCT01371656|65665451|FG000|Overall Study|Ineligible|4|||
23526216|NCT01371656|65665452|FG001|Overall Study|Ineligible|3|||
23611268|NCT01072149|65966714|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611269|NCT01072149|65966715|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
23526217|NCT04091646|65665453|FG000|Overall Study|Adverse Event|2|||
23611270|NCT01072149|65966716|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23526218|NCT04091646|65665454|FG001|Overall Study|Adverse Event|1|||
23526219|NCT04091646|65665453|FG000|Overall Study|Lost to Follow-up|6|||
23611271|NCT01072149|65966717|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611272|NCT01072149|65966718|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611273|NCT01072149|65966719|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611274|NCT01072149|65966720|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611275|NCT01072149|65966721|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611276|NCT01072149|65966722|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611277|NCT01072149|65966723|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611278|NCT01072149|65966724|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611279|NCT01072149|65966725|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611280|NCT01072149|65966726|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
23611281|NCT01072149|65966727|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611282|NCT01072149|65966728|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611283|NCT01072149|65966729|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611284|NCT01072149|65966730|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
23611285|NCT04050722|65966731|FG000|Overall Study|Withdrawal by Subject|1|||
23611286|NCT04050722|65966732|FG001|Overall Study|Withdrawal by Subject|0|||
23611287|NCT00304278|65966733|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
23611288|NCT00304278|65966733|FG000|Overall Study|PT had medical condition preventing TX|1|||
23611289|NCT00476957|65966734|FG000|Overall Study|Lost to Follow-up|176|||
23611290|NCT00476957|65966735|FG001|Overall Study|Lost to Follow-up|193|||
23611291|NCT01131325|65966740|FG000|Overall Study|Adverse Event|1|||
23611292|NCT01131325|65966740|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
23611293|NCT00621842|65966745|FG000|Overall Study|Adverse Event|6|||
23611294|NCT00621842|65966745|FG000|Overall Study|Withdrawal by Subject|7|||
23611295|NCT00621842|65966745|FG000|Overall Study|Protocol Violation|4|||
23611296|NCT00621842|65966745|FG000|Overall Study|Lack of Efficacy|2|||
23611297|NCT03493282|65966747|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
23611298|NCT03493282|65966748|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
23611299|NCT03493282|65966749|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
23611300|NCT03493282|65966747|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
23611301|NCT03493282|65966748|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
23611302|NCT03493282|65966749|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
23526220|NCT04091646|65665454|FG001|Overall Study|Lost to Follow-up|2|||
23526221|NCT04091646|65665453|FG000|Overall Study|Protocol Violation|0|||
23611303|NCT00440037|65966753|FG000|Overall Study|Withdrawal by Subject|6|||
23308754|NCT01081834|64877709|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
23526222|NCT04091646|65665454|FG001|Overall Study|Protocol Violation|1|||
23526223|NCT04091646|65665453|FG000|Overall Study|Withdrawal by Subject|4|||
23526224|NCT04091646|65665454|FG001|Overall Study|Withdrawal by Subject|1|||
23526225|NCT04091646|65665453|FG000|Overall Study|Participant Incarcerated|1|||
23526226|NCT04091646|65665454|FG001|Overall Study|Participant Incarcerated|0|||
23526227|NCT02382016|65665462|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
23526228|NCT02382016|65665463|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
23526229|NCT02382016|65665462|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
23526230|NCT02382016|65665463|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
23526231|NCT02382016|65665462|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
23526232|NCT02382016|65665463|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
23526233|NCT02382016|65665462|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
23526234|NCT02382016|65665463|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
23526235|NCT02382016|65665462|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
23526236|NCT02382016|65665463|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
23526237|NCT02382016|65665462|FG000|Open-label (OL) Treatment Period|Death|4|||
23526238|NCT02382016|65665463|FG001|Open-label (OL) Treatment Period|Death|0|||
23526239|NCT02382016|65665462|FG000|OL Extension Period|Physician Decision|3|||
23526240|NCT02382016|65665463|FG001|OL Extension Period|Physician Decision|0|||
23526241|NCT02382016|65665462|FG000|OL Extension Period|Death|2|||
23526242|NCT02382016|65665463|FG001|OL Extension Period|Death|0|||
23526243|NCT02382016|65665462|FG000|OL Extension Period|Withdrawal by Subject|1|||
23526244|NCT02382016|65665463|FG001|OL Extension Period|Withdrawal by Subject|0|||
23526245|NCT02703636|65665467|FG000|Overall Study|Adverse Event|14|||
23526246|NCT02703636|65665467|FG000|Overall Study|Study stopped by sponsor|1|||
23526247|NCT02703636|65665467|FG000|Overall Study|Withdrawal by Subject|1|||
23526248|NCT00283439|65665472|FG000|Overall Study|Adverse Event|0|||
23526249|NCT00283439|65665473|FG001|Overall Study|Adverse Event|0|||
23526250|NCT00283439|65665474|FG002|Overall Study|Adverse Event|0|||
23611304|NCT00440037|65966753|FG000|Overall Study|Administrative decision|3|||
23611305|NCT02205476|65966759|FG000|Overall Study|Study termination by Sponsor|7|||
23611306|NCT02205476|65966760|FG001|Overall Study|Study termination by Sponsor|3|||
23526251|NCT00283439|65665475|FG003|Overall Study|Adverse Event|1|||
23526252|NCT00283439|65665472|FG000|Overall Study|Death|0|||
23611307|NCT00308113|65966766|FG000|Overall Study|Protocol closure|0|||
23611308|NCT00308113|65966767|FG001|Overall Study|Protocol closure|0|||
23526253|NCT00283439|65665473|FG001|Overall Study|Death|0|||
23526254|NCT00283439|65665474|FG002|Overall Study|Death|1|||
23526255|NCT00283439|65665475|FG003|Overall Study|Death|0|||
23526256|NCT00283439|65665472|FG000|Overall Study|Disease progression|0|||
23526257|NCT00283439|65665473|FG001|Overall Study|Disease progression|1|||
23526258|NCT00283439|65665474|FG002|Overall Study|Disease progression|0|||
23526259|NCT00283439|65665475|FG003|Overall Study|Disease progression|0|||
23526260|NCT00283439|65665472|FG000|Overall Study|Requirement for alternative therapy|1|||
23526261|NCT00283439|65665473|FG001|Overall Study|Requirement for alternative therapy|2|||
23526262|NCT00283439|65665474|FG002|Overall Study|Requirement for alternative therapy|5|||
23526263|NCT00283439|65665475|FG003|Overall Study|Requirement for alternative therapy|2|||
23526264|NCT00283439|65665472|FG000|Overall Study|Stem cell transplant|6|||
23526265|NCT00283439|65665473|FG001|Overall Study|Stem cell transplant|6|||
23526266|NCT00283439|65665474|FG002|Overall Study|Stem cell transplant|4|||
23526267|NCT00283439|65665475|FG003|Overall Study|Stem cell transplant|3|||
23526268|NCT00283439|65665472|FG000|Overall Study|Treatment discontinued|0|||
23526269|NCT00283439|65665473|FG001|Overall Study|Treatment discontinued|2|||
23526270|NCT00283439|65665474|FG002|Overall Study|Treatment discontinued|1|||
23526271|NCT00283439|65665475|FG003|Overall Study|Treatment discontinued|3|||
23526272|NCT00283439|65665472|FG000|Overall Study|Other|1|||
23526273|NCT00283439|65665473|FG001|Overall Study|Other|0|||
23526274|NCT00283439|65665474|FG002|Overall Study|Other|0|||
23526275|NCT00283439|65665475|FG003|Overall Study|Other|0|||
23526276|NCT00829296|65665476|FG000|Overall Study|Adverse Event|5|||
23526277|NCT00829296|65665477|FG001|Overall Study|Adverse Event|4|||
23526278|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
23526279|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
23526280|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
23526281|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
23526282|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
23526283|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
23526284|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
23526285|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
23526286|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
23526287|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
23526288|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
23526289|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
23526290|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
23611309|NCT00308113|65966768|FG002|Overall Study|Protocol closure|0|||
23611310|NCT00308113|65966769|FG003|Overall Study|Protocol closure|1|||
23611311|NCT01812707|65966772|FG000|Overall Study|Adverse Event|0|||
23611312|NCT01812707|65966773|FG001|Overall Study|Adverse Event|0|||
23611313|NCT01812707|65966774|FG002|Overall Study|Adverse Event|0|||
23611314|NCT01812707|65966775|FG003|Overall Study|Adverse Event|2|||
23611315|NCT01812707|65966772|FG000|Overall Study|Poor compliance to protocol|1|||
23611316|NCT01812707|65966773|FG001|Overall Study|Poor compliance to protocol|0|||
23611317|NCT01812707|65966774|FG002|Overall Study|Poor compliance to protocol|0|||
23611318|NCT01812707|65966775|FG003|Overall Study|Poor compliance to protocol|0|||
23611319|NCT01812707|65966772|FG000|Overall Study|Consent withdrawn by participant|1|||
23611320|NCT01812707|65966773|FG001|Overall Study|Consent withdrawn by participant|0|||
23611321|NCT01812707|65966774|FG002|Overall Study|Consent withdrawn by participant|0|||
23611322|NCT01812707|65966775|FG003|Overall Study|Consent withdrawn by participant|0|||
23611323|NCT00607789|65966776|FG000|Overall Study|Adverse Event|3|||
23611324|NCT00607789|65966777|FG001|Overall Study|Adverse Event|0|||
23611325|NCT00607789|65966776|FG000|Overall Study|Lack of Efficacy|0|||
23611326|NCT00607789|65966777|FG001|Overall Study|Lack of Efficacy|1|||
23611327|NCT00607789|65966776|FG000|Overall Study|Inadequate adherence|3|||
23611328|NCT00607789|65966777|FG001|Overall Study|Inadequate adherence|0|||
23611329|NCT00607789|65966776|FG000|Overall Study|Lost to Follow-up|0|||
23611330|NCT00607789|65966777|FG001|Overall Study|Lost to Follow-up|5|||
23611331|NCT00607789|65966776|FG000|Overall Study|Withdrawal by Subject|1|||
23611332|NCT00607789|65966777|FG001|Overall Study|Withdrawal by Subject|0|||
23611333|NCT01280656|65966779|FG000|Overall Study|Adverse Event|1|||
23206193|NCT03649321|64494815|FG001|Overall Study|Withdrawal by Subject|0|||
23611334|NCT01280656|65966780|FG001|Overall Study|Adverse Event|14|||
23206194|NCT03649321|64494814|FG000|Overall Study|Death|1|||
23206195|NCT03649321|64494815|FG001|Overall Study|Death|0|||
23526291|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
23526292|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
23526293|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
23526294|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
23526295|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
23526296|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Death|0|||
23526297|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Death|0|||
23611335|NCT01280656|65966781|FG002|Overall Study|Adverse Event|13|||
23611336|NCT01280656|65966779|FG000|Overall Study|Lack of Efficacy|1|||
23611337|NCT01280656|65966780|FG001|Overall Study|Lack of Efficacy|22|||
23611338|NCT01280656|65966781|FG002|Overall Study|Lack of Efficacy|38|||
23526298|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Death|1|||
23526299|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Death|0|||
23526300|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Death|0|||
23526301|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Death|0|||
23526302|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Death|0|||
23526303|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Death|0|||
23526304|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Death|0|||
23526305|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
23526306|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
23526307|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
23526308|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526309|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526310|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526311|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526312|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526313|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
23526314|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
23526315|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
23526316|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
23526317|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526318|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526319|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526320|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526321|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526322|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
23526323|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
23526324|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
23526325|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
23526326|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
23526327|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
23526328|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
23526329|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
23526330|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
23526331|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
23526332|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
23526333|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
23526334|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
23526335|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
23526336|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
23526337|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
23526338|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
23526339|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
23526340|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
23526341|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
23526342|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
23526343|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
23526344|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526345|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526346|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526347|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526348|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526349|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
23526350|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526351|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
23526352|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526353|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526354|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526355|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526356|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526357|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526358|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
23526359|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
23526360|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
23526361|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
23611339|NCT01280656|65966779|FG000|Overall Study|Treatment shortening (RGT)|0|||
23611340|NCT01280656|65966780|FG001|Overall Study|Treatment shortening (RGT)|4|||
23206196|NCT00377611|64494816|FG000|Overall Study|Adverse Event|2|||
23526362|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
23526363|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
23526364|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
23526365|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
23526366|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
23526367|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
23526368|NCT00404352|65665478|FG000|Double Blind (up to 24 Month)|Other|0|||
23526369|NCT00404352|65665479|FG001|Double Blind (up to 24 Month)|Other|1|||
23526370|NCT00404352|65665480|FG002|Double Blind (up to 24 Month)|Other|0|||
23526371|NCT00404352|65665481|FG003|Double Blind (up to 24 Month)|Other|0|||
23526372|NCT00404352|65665482|FG004|Double Blind (up to 24 Month)|Other|0|||
23526373|NCT00404352|65665483|FG005|Double Blind (up to 24 Month)|Other|0|||
23526374|NCT00404352|65665484|FG006|Double Blind (up to 24 Month)|Other|0|||
23526375|NCT00404352|65665485|FG007|Double Blind (up to 24 Month)|Other|0|||
23526376|NCT00404352|65665486|FG008|Double Blind (up to 24 Month)|Other|0|||
23526377|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
23526378|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
23526379|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
23526380|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
23526381|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
23526382|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
23526383|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
23526384|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
23526385|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
23526386|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
23526387|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
23526388|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
23526389|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
23526390|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
23526391|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
23526392|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
23526393|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
23526394|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
23526395|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526396|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526397|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526398|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526399|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
23526400|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526401|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526402|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526403|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
23526404|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526405|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526406|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526407|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526408|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526409|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
23526410|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526411|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526412|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
23526413|NCT00404352|65665478|FG000|Open Label (up to 24 Month)|Disease progression|0|||
23526414|NCT00404352|65665479|FG001|Open Label (up to 24 Month)|Disease progression|0|||
23526415|NCT00404352|65665480|FG002|Open Label (up to 24 Month)|Disease progression|0|||
23526416|NCT00404352|65665481|FG003|Open Label (up to 24 Month)|Disease progression|1|||
23526417|NCT00404352|65665482|FG004|Open Label (up to 24 Month)|Disease progression|0|||
23526418|NCT00404352|65665483|FG005|Open Label (up to 24 Month)|Disease progression|0|||
23526419|NCT00404352|65665484|FG006|Open Label (up to 24 Month)|Disease progression|0|||
23526420|NCT00404352|65665485|FG007|Open Label (up to 24 Month)|Disease progression|0|||
23526421|NCT00404352|65665486|FG008|Open Label (up to 24 Month)|Disease progression|0|||
23526422|NCT00404352|65665478|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526423|NCT00404352|65665479|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526424|NCT00404352|65665480|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526425|NCT00404352|65665481|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526426|NCT00404352|65665482|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23308755|NCT01081834|64877710|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
23526427|NCT00404352|65665483|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526428|NCT00404352|65665484|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
23526429|NCT00404352|65665485|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
23526430|NCT00404352|65665486|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
23526431|NCT00404352|65665478|FG000|Open Label Extension (up to 36 Months)|Other|0|||
23526432|NCT00404352|65665479|FG001|Open Label Extension (up to 36 Months)|Other|0|||
23526433|NCT00404352|65665480|FG002|Open Label Extension (up to 36 Months)|Other|0|||
23526434|NCT00404352|65665481|FG003|Open Label Extension (up to 36 Months)|Other|0|||
23526435|NCT00404352|65665482|FG004|Open Label Extension (up to 36 Months)|Other|0|||
23526436|NCT00404352|65665483|FG005|Open Label Extension (up to 36 Months)|Other|0|||
23526437|NCT00404352|65665484|FG006|Open Label Extension (up to 36 Months)|Other|0|||
23526438|NCT00404352|65665485|FG007|Open Label Extension (up to 36 Months)|Other|0|||
23526439|NCT00404352|65665486|FG008|Open Label Extension (up to 36 Months)|Other|2|||
23526440|NCT01252290|65665491|FG000|Overall Study|Withdrawal by Subject|1|||
23526441|NCT02385799|65665502|FG000|Overall Study|Lost to Follow-up|1|||
23526442|NCT02385799|65665503|FG001|Overall Study|Lost to Follow-up|2|||
23526443|NCT02385799|65665502|FG000|Overall Study|Adverse Event|4|||
23526444|NCT02385799|65665503|FG001|Overall Study|Adverse Event|2|||
23526445|NCT02385799|65665502|FG000|Overall Study|Withdrawal by Subject|0|||
23526446|NCT02385799|65665503|FG001|Overall Study|Withdrawal by Subject|4|||
23526447|NCT01482767|65665505|FG000|Overall Study|Death|1|||
23526448|NCT01482767|65665506|FG001|Overall Study|Death|1|||
23526449|NCT01482767|65665505|FG000|Overall Study|Withdrawal by Subject|7|||
23526450|NCT01482767|65665506|FG001|Overall Study|Withdrawal by Subject|5|||
23526451|NCT01482767|65665505|FG000|Overall Study|Lost to Follow-up|12|||
23526452|NCT01482767|65665506|FG001|Overall Study|Lost to Follow-up|6|||
23526453|NCT01482767|65665505|FG000|Overall Study|Adverse Event|0|||
23526454|NCT01482767|65665506|FG001|Overall Study|Adverse Event|3|||
23526455|NCT01482767|65665505|FG000|Overall Study|Site closure|22|||
23526456|NCT01482767|65665506|FG001|Overall Study|Site closure|14|||
23526457|NCT01482767|65665505|FG000|Overall Study|Non-adherence to study requirements|4|||
23526458|NCT01482767|65665506|FG001|Overall Study|Non-adherence to study requirements|7|||
23526459|NCT01482767|65665505|FG000|Overall Study|Alternate HCV treatment|7|||
23526460|NCT01482767|65665506|FG001|Overall Study|Alternate HCV treatment|8|||
23526461|NCT01482767|65665505|FG000|Overall Study|Ineligible|0|||
23526462|NCT01482767|65665506|FG001|Overall Study|Ineligible|5|||
23526463|NCT01482767|65665505|FG000|Overall Study|Nurse error|1|||
23526464|NCT01482767|65665506|FG001|Overall Study|Nurse error|0|||
23526465|NCT03829046|65665507|FG000|Overall Study|Withdrawal by Subject|1|||
23526466|NCT03829046|65665508|FG001|Overall Study|Withdrawal by Subject|0|||
23526467|NCT00348556|65665509|FG000|Overall Study|Adverse Event|1|||
23526468|NCT01720069|65665510|FG000|Overall Study|Could not use e-diary correctly|0|||
23526469|NCT01720069|65665511|FG001|Overall Study|Could not use e-diary correctly|1|||
23526470|NCT01720069|65665512|FG002|Overall Study|Could not use e-diary correctly|1|||
23526471|NCT01720069|65665510|FG000|Overall Study|Randomised without baseline values|0|||
23526472|NCT01720069|65665511|FG001|Overall Study|Randomised without baseline values|0|||
23526473|NCT01720069|65665512|FG002|Overall Study|Randomised without baseline values|1|||
23526474|NCT01720069|65665510|FG000|Overall Study|Adverse Event|0|||
23526475|NCT01720069|65665511|FG001|Overall Study|Adverse Event|0|||
23526476|NCT01720069|65665512|FG002|Overall Study|Adverse Event|1|||
23526477|NCT01720069|65665510|FG000|Overall Study|Lack of Efficacy|0|||
23526478|NCT01720069|65665511|FG001|Overall Study|Lack of Efficacy|4|||
23526479|NCT01720069|65665512|FG002|Overall Study|Lack of Efficacy|0|||
23526480|NCT01720069|65665510|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
23526481|NCT01720069|65665511|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
23526482|NCT01720069|65665512|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
23526483|NCT01720069|65665510|FG000|Overall Study|Withdrawal by Subject|0|||
23526484|NCT01720069|65665511|FG001|Overall Study|Withdrawal by Subject|2|||
23526485|NCT01720069|65665512|FG002|Overall Study|Withdrawal by Subject|1|||
23526486|NCT01720069|65665510|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
23526487|NCT01720069|65665511|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
23526488|NCT01720069|65665512|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
23526489|NCT01720069|65665510|FG000|Overall Study|Non-compliance on using e-diary|0|||
23526490|NCT01720069|65665511|FG001|Overall Study|Non-compliance on using e-diary|0|||
23526491|NCT01720069|65665512|FG002|Overall Study|Non-compliance on using e-diary|1|||
23526492|NCT01720069|65665510|FG000|Overall Study|Lost to Follow-up|0|||
23526493|NCT01720069|65665511|FG001|Overall Study|Lost to Follow-up|0|||
23526494|NCT01720069|65665512|FG002|Overall Study|Lost to Follow-up|1|||
23526495|NCT02239536|65665513|FG000|Overall Study|Non-neoplastic polyp|23|||
23526496|NCT02239536|65665514|FG001|Overall Study|Non-neoplastic polyp|17|||
23526497|NCT00116558|65665515|FG000|Overall Study|Death|11|||
23526498|NCT00116558|65665516|FG001|Overall Study|Death|5|||
23526499|NCT00116558|65665517|FG002|Overall Study|Death|3|||
23526500|NCT00116558|65665515|FG000|Overall Study|Withdrawal by Subject|17|||
23526501|NCT00116558|65665516|FG001|Overall Study|Withdrawal by Subject|3|||
23526502|NCT00116558|65665517|FG002|Overall Study|Withdrawal by Subject|12|||
23526503|NCT00116558|65665515|FG000|Overall Study|disease progression|3|||
23526504|NCT00116558|65665516|FG001|Overall Study|disease progression|7|||
23526505|NCT00116558|65665517|FG002|Overall Study|disease progression|18|||
23526506|NCT03090100|65665520|FG000|Overall Study|Adverse Event|9|||
23526507|NCT03090100|65665521|FG001|Overall Study|Adverse Event|11|||
23417875|NCT02499900|65274474|FG001|Core Study Period|Per sponsor request|1|||
23417876|NCT02499900|65274473|FG000|Core Study Period|Pregnancy|1|||
23417877|NCT02499900|65274474|FG001|Core Study Period|Pregnancy|0|||
23417878|NCT02499900|65274473|FG000|Core Study Period|Protocol Violation|3|||
23417879|NCT02499900|65274474|FG001|Core Study Period|Protocol Violation|0|||
23417880|NCT02499900|65274473|FG000|Core Study Period|Withdrawal by Subject|11|||
23417881|NCT02499900|65274474|FG001|Core Study Period|Withdrawal by Subject|10|||
23417882|NCT02499900|65274473|FG000|Core Study Period|Adverse Event|18|||
23417883|NCT02499900|65274474|FG001|Core Study Period|Adverse Event|14|||
23417884|NCT02499900|65274473|FG000|Core Study Period|Death|0|||
23417885|NCT02499900|65274474|FG001|Core Study Period|Death|1|||
23417886|NCT02499900|65274473|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
23417887|NCT02499900|65274474|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
23417888|NCT02499900|65274473|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
23417889|NCT02499900|65274474|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
23417890|NCT02499900|65274473|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
23417891|NCT02499900|65274474|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
23417892|NCT02499900|65274473|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
23417893|NCT02499900|65274474|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
23417894|NCT02499900|65274473|FG000|Extension Study Period|Adverse Event|2|||
23417895|NCT02499900|65274474|FG001|Extension Study Period|Adverse Event|4|||
23417896|NCT02499900|65274473|FG000|Extension Study Period|Withdrawal by Subject|5|||
23417897|NCT02499900|65274474|FG001|Extension Study Period|Withdrawal by Subject|2|||
23417898|NCT02499900|65274473|FG000|Extension Study Period|Physician Decision|2|||
23417899|NCT02499900|65274474|FG001|Extension Study Period|Physician Decision|5|||
23417900|NCT02499900|65274473|FG000|Extension Study Period|Pregnancy|1|||
23417901|NCT02499900|65274474|FG001|Extension Study Period|Pregnancy|2|||
23417902|NCT02499900|65274473|FG000|Extension Study Period|Lost to Follow-up|2|||
23417903|NCT02499900|65274474|FG001|Extension Study Period|Lost to Follow-up|5|||
23417904|NCT02499900|65274473|FG000|Extension Study Period|Other|0|||
23417905|NCT02499900|65274474|FG001|Extension Study Period|Other|2|||
23417906|NCT01271712|65274475|FG000|Double Blind Treatment|Death|2|||
23417907|NCT01271712|65274476|FG001|Double Blind Treatment|Death|0|||
23417908|NCT01271712|65274475|FG000|Double Blind Treatment|Lack of Efficacy|1|||
23417909|NCT01271712|65274476|FG001|Double Blind Treatment|Lack of Efficacy|0|||
23417910|NCT01271712|65274475|FG000|Double Blind Treatment|Adverse Event|9|||
23417911|NCT01271712|65274476|FG001|Double Blind Treatment|Adverse Event|4|||
23417912|NCT01271712|65274475|FG000|Double Blind Treatment|Progressive disease|23|||
23417913|NCT01271712|65274476|FG001|Double Blind Treatment|Progressive disease|3|||
23417914|NCT01271712|65274475|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
23417915|NCT01271712|65274476|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
23417916|NCT01271712|65274475|FG000|Double Blind Treatment|Non compliance with study drug|2|||
23417917|NCT01271712|65274476|FG001|Double Blind Treatment|Non compliance with study drug|0|||
23417918|NCT01271712|65274475|FG000|Double Blind Treatment|receive no study drug|1|||
23417919|NCT01271712|65274476|FG001|Double Blind Treatment|receive no study drug|0|||
23417920|NCT01271712|65274475|FG000|Open Label Treatment|Death|6|||
23417921|NCT01271712|65274476|FG001|Open Label Treatment|Death|5|||
23417922|NCT01271712|65274475|FG000|Open Label Treatment|Withdrawal by Subject|6|||
23417923|NCT01271712|65274476|FG001|Open Label Treatment|Withdrawal by Subject|11|||
23417924|NCT01271712|65274475|FG000|Open Label Treatment|Physician Decision|2|||
23417925|NCT01271712|65274476|FG001|Open Label Treatment|Physician Decision|0|||
23417926|NCT01271712|65274475|FG000|Open Label Treatment|Adverse Event|14|||
23417927|NCT01271712|65274476|FG001|Open Label Treatment|Adverse Event|8|||
23417928|NCT01271712|65274475|FG000|Open Label Treatment|Progressive disease|59|||
23417929|NCT01271712|65274476|FG001|Open Label Treatment|Progressive disease|32|||
23417930|NCT01271712|65274475|FG000|Open Label Treatment|transferred to rollover study|1|||
23417931|NCT01271712|65274476|FG001|Open Label Treatment|transferred to rollover study|0|||
23417932|NCT01271712|65274475|FG000|Open Label Treatment|Non-compliance with study drug|1|||
23417933|NCT01271712|65274476|FG001|Open Label Treatment|Non-compliance with study drug|0|||
23417934|NCT01271712|65274475|FG000|Open Label Treatment|Protocol Violation|0|||
23417935|NCT01271712|65274476|FG001|Open Label Treatment|Protocol Violation|1|||
23417936|NCT01271712|65274475|FG000|Open Label Treatment|Switching to other therapy|2|||
23417937|NCT01271712|65274476|FG001|Open Label Treatment|Switching to other therapy|1|||
23417938|NCT01271712|65274475|FG000|Safety Follow-up|Death|11|||
23417939|NCT01271712|65274476|FG001|Safety Follow-up|Death|7|||
23417940|NCT01271712|65274475|FG000|Safety Follow-up|Withdrawal by Subject|4|||
23417941|NCT01271712|65274476|FG001|Safety Follow-up|Withdrawal by Subject|2|||
23417942|NCT01271712|65274475|FG000|Safety Follow-up|Protocol Violation|1|||
23417943|NCT01271712|65274476|FG001|Safety Follow-up|Protocol Violation|1|||
23417944|NCT01271712|65274475|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
23417945|NCT01271712|65274476|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
23417946|NCT01271712|65274475|FG000|Safety Follow-up|No follow-up|1|||
23417947|NCT01271712|65274476|FG001|Safety Follow-up|No follow-up|1|||
23611341|NCT01280656|65966781|FG002|Overall Study|Treatment shortening (RGT)|5|||
23611342|NCT01280656|65966779|FG000|Overall Study|Other|1|||
23611343|NCT01280656|65966780|FG001|Overall Study|Other|7|||
23611344|NCT01280656|65966781|FG002|Overall Study|Other|7|||
23611345|NCT00871494|65966784|FG000|Overall Study|Protocol Violation|5|||
23611346|NCT00871494|65966784|FG000|Overall Study|Lack of Efficacy|4|||
23611347|NCT00871494|65966784|FG000|Overall Study|Adverse Event|4|||
23611348|NCT00871494|65966784|FG000|Overall Study|Lost to Follow-up|1|||
23611349|NCT01695993|65966787|FG000|Overall Study|Lost to Follow-up|2|||
23611350|NCT01695993|65966788|FG001|Overall Study|Lost to Follow-up|1|||
23611351|NCT01695993|65966789|FG002|Overall Study|Lost to Follow-up|3|||
23611352|NCT01695993|65966787|FG000|Overall Study|Withdrawal by Subject|2|||
23611353|NCT01695993|65966788|FG001|Overall Study|Withdrawal by Subject|2|||
23611354|NCT01695993|65966789|FG002|Overall Study|Withdrawal by Subject|2|||
23611355|NCT01695993|65966787|FG000|Overall Study|To ill to continue|1|||
23611356|NCT01695993|65966788|FG001|Overall Study|To ill to continue|2|||
23611357|NCT01695993|65966789|FG002|Overall Study|To ill to continue|0|||
23611358|NCT01695993|65966787|FG000|Overall Study|Changed Medical Facility|0|||
23611359|NCT01695993|65966788|FG001|Overall Study|Changed Medical Facility|0|||
23611360|NCT01695993|65966789|FG002|Overall Study|Changed Medical Facility|1|||
23611361|NCT00794573|65966794|FG000|Overall Study|Death|3|||
23611362|NCT00794573|65966795|FG001|Overall Study|Death|0|||
23611363|NCT00794573|65966794|FG000|Overall Study|Withdrawal by Subject|9|||
23611364|NCT00794573|65966795|FG001|Overall Study|Withdrawal by Subject|12|||
23611365|NCT00794573|65966794|FG000|Overall Study|Lost to Follow-up|26|||
23611366|NCT00794573|65966795|FG001|Overall Study|Lost to Follow-up|33|||
23611367|NCT00422162|65966797|FG000|Overall Study|Adverse Event|11|||
23611368|NCT00422162|65966798|FG001|Overall Study|Adverse Event|9|||
23611369|NCT00422162|65966797|FG000|Overall Study|Lack of Efficacy|4|||
23611370|NCT00422162|65966798|FG001|Overall Study|Lack of Efficacy|10|||
23611371|NCT00422162|65966797|FG000|Overall Study|Withdrawal by Subject|7|||
23611372|NCT00422162|65966798|FG001|Overall Study|Withdrawal by Subject|6|||
23611373|NCT00422162|65966797|FG000|Overall Study|Lost to Follow-up|1|||
23611374|NCT00422162|65966798|FG001|Overall Study|Lost to Follow-up|2|||
23611375|NCT00422162|65966797|FG000|Overall Study|Non-Compliant with Protocol|1|||
23611376|NCT00422162|65966798|FG001|Overall Study|Non-Compliant with Protocol|1|||
23611377|NCT00422162|65966797|FG000|Overall Study|Other|0|||
23611378|NCT00422162|65966798|FG001|Overall Study|Other|1|||
23526508|NCT03090100|65665520|FG000|Overall Study|Pregnancy|1|||
23526509|NCT03090100|65665521|FG001|Overall Study|Pregnancy|1|||
23526510|NCT03090100|65665520|FG000|Overall Study|Lack of Efficacy|2|||
23526511|NCT03090100|65665521|FG001|Overall Study|Lack of Efficacy|7|||
23526512|NCT03090100|65665520|FG000|Overall Study|Lost to Follow-up|2|||
23526513|NCT03090100|65665521|FG001|Overall Study|Lost to Follow-up|2|||
23526514|NCT03090100|65665520|FG000|Overall Study|Withdrawal by Subject|7|||
23526515|NCT03090100|65665521|FG001|Overall Study|Withdrawal by Subject|19|||
23526516|NCT03090100|65665520|FG000|Overall Study|Protocol Violation|2|||
23526517|NCT03090100|65665521|FG001|Overall Study|Protocol Violation|6|||
23526518|NCT03090100|65665520|FG000|Overall Study|Non-compliance|2|||
23526519|NCT03090100|65665521|FG001|Overall Study|Non-compliance|0|||
23526520|NCT03090100|65665520|FG000|Overall Study|Other|2|||
23526521|NCT03090100|65665521|FG001|Overall Study|Other|2|||
23526522|NCT01886833|65665522|FG000|Overall Study|IgA not available from both periods|204|||
23526523|NCT04144166|65665523|FG000|Overall Study|Discharged before study start|1|||
23526524|NCT04144166|65665523|FG000|Overall Study|Pregnancy|1|||
23526525|NCT04144166|65665523|FG000|Overall Study|Nail polish could not be removed from finger|1|||
23526526|NCT01806896|65665529|FG000|Overall Study|Adverse Event|2|||
23526527|NCT01806896|65665530|FG001|Overall Study|Adverse Event|0|||
23526528|NCT01806896|65665529|FG000|Overall Study|Other|1|||
23526529|NCT01806896|65665530|FG001|Overall Study|Other|0|||
23526530|NCT04193176|65665531|FG000|Overall Study|Withdrawal by Subject|6|||
23526531|NCT04193176|65665532|FG001|Overall Study|Withdrawal by Subject|10|||
23526532|NCT03848845|65665533|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
23526533|NCT03848845|65665534|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
23526534|NCT03848845|65665535|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
23526535|NCT03848845|65665536|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
23526536|NCT03848845|65665533|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
23526537|NCT03848845|65665534|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
23611379|NCT00422162|65966797|FG000|Overall Study|Didn't Receive Treatment|0|||
23611380|NCT00422162|65966798|FG001|Overall Study|Didn't Receive Treatment|1|||
23611381|NCT02465866|65966799|FG000|Period 3|Withdrawal by Subject|0|||
23611382|NCT02465866|65966800|FG001|Period 3|Withdrawal by Subject|1|||
23611383|NCT02465866|65966801|FG002|Period 3|Withdrawal by Subject|0|||
23611384|NCT02465866|65966802|FG003|Period 3|Withdrawal by Subject|0|||
23526538|NCT03848845|65665535|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
23526539|NCT03848845|65665536|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
23611385|NCT00087516|65966808|FG000|Overall Study|Adverse Event|10|||
23611386|NCT00087516|65966809|FG001|Overall Study|Adverse Event|10|||
23308756|NCT01081834|64877711|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23308757|NCT01081834|64877712|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23308758|NCT01081834|64877713|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23308759|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23308760|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23308761|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23308762|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23526540|NCT03848845|65665533|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
23526541|NCT03848845|65665534|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
23308763|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23308764|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Death|1|||
23308765|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Death|0|||
23308766|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Death|0|||
23308767|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Death|0|||
23308768|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Death|0|||
23308769|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
23308770|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
23308771|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23308772|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23308773|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23308774|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23308775|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23308776|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23308777|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23417948|NCT01271712|65274475|FG000|Safety Follow-up|Progressive disease|1|||
23417949|NCT01271712|65274476|FG001|Safety Follow-up|Progressive disease|0|||
23417950|NCT01271712|65274475|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
23417951|NCT01271712|65274476|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
23417952|NCT01044745|65274477|FG000|Overall Study|Ineiligible|2|||
23417953|NCT01089413|65274480|FG000|Overall Study|Lost to Follow-up|1|||
23417954|NCT01089413|65274480|FG000|Overall Study|Progressive Disease|93|||
23417955|NCT01089413|65274480|FG000|Overall Study|Participant Withdrew Consent|1|||
23417956|NCT01089413|65274480|FG000|Overall Study|Unacceptable Toxicity|12|||
23417957|NCT01089413|65274480|FG000|Overall Study|Death|10|||
23417958|NCT01089413|65274480|FG000|Overall Study|Metastasectomy|13|||
23417959|NCT01089413|65274480|FG000|Overall Study|Other|71|||
23417960|NCT03255967|65274481|FG000|Overall Study|Adverse Event|26|||
23417961|NCT03255967|65274482|FG001|Overall Study|Adverse Event|30|||
23417962|NCT03255967|65274481|FG000|Overall Study|Withdrawal by Subject|6|||
23526542|NCT03848845|65665535|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
23526543|NCT03848845|65665536|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
23526544|NCT03848845|65665533|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
23526545|NCT03848845|65665534|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
23526546|NCT03848845|65665535|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
23526547|NCT03848845|65665536|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
23526548|NCT02506816|65665543|FG000|Overall Study|Adverse Event|3|||
23526549|NCT03013543|65665544|FG000|Overall Study|Withdrawal by Subject|0|||
23526550|NCT03013543|65665545|FG001|Overall Study|Withdrawal by Subject|2|||
23526551|NCT03013543|65665546|FG002|Overall Study|Withdrawal by Subject|0|||
23526552|NCT03013543|65665547|FG003|Overall Study|Withdrawal by Subject|5|||
23526553|NCT03013543|65665548|FG004|Overall Study|Withdrawal by Subject|6|||
23526554|NCT03013543|65665549|FG005|Overall Study|Withdrawal by Subject|2|||
23526555|NCT03013543|65665550|FG006|Overall Study|Withdrawal by Subject|3|||
23308778|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23308779|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23308780|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
23308781|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23417963|NCT03255967|65274482|FG001|Overall Study|Withdrawal by Subject|6|||
23417964|NCT03255967|65274481|FG000|Overall Study|Schedule conflict|6|||
23417965|NCT03255967|65274482|FG001|Overall Study|Schedule conflict|4|||
23417966|NCT03255967|65274481|FG000|Overall Study|POA did not sign consent form|2|||
23417967|NCT03255967|65274482|FG001|Overall Study|POA did not sign consent form|0|||
23526556|NCT03013543|65665551|FG007|Overall Study|Withdrawal by Subject|1|||
23417968|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Death|5|||
23417969|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Death|0|||
23417970|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Death|0|||
23526557|NCT03013543|65665552|FG008|Overall Study|Withdrawal by Subject|0|||
23526558|NCT03013543|65665553|FG009|Overall Study|Withdrawal by Subject|4|||
23526559|NCT03013543|65665544|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23526560|NCT03013543|65665545|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
23526561|NCT03013543|65665546|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
23417971|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
23417972|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
23417973|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
23417974|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
23417975|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
23417976|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
23417977|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
23417978|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
23417979|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
23417980|NCT01357161|65274487|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
23526562|NCT03013543|65665547|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
23526563|NCT03013543|65665548|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
23526564|NCT03013543|65665549|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
23526565|NCT03013543|65665550|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
23526566|NCT03013543|65665551|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
23526567|NCT03013543|65665552|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
23526568|NCT03013543|65665553|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
23526569|NCT03013543|65665544|FG000|Overall Study|Other|0|||
23526570|NCT03013543|65665545|FG001|Overall Study|Other|0|||
23526571|NCT03013543|65665546|FG002|Overall Study|Other|2|||
23611387|NCT00087516|65966810|FG002|Overall Study|Adverse Event|3|||
23611388|NCT00087516|65966811|FG003|Overall Study|Adverse Event|6|||
23611389|NCT00087516|65966808|FG000|Overall Study|Lack of Efficacy|82|||
23611390|NCT00087516|65966809|FG001|Overall Study|Lack of Efficacy|80|||
23611391|NCT00087516|65966810|FG002|Overall Study|Lack of Efficacy|39|||
23611392|NCT00087516|65966811|FG003|Overall Study|Lack of Efficacy|29|||
23611393|NCT00087516|65966808|FG000|Overall Study|Lost to Follow-up|8|||
23611394|NCT00087516|65966809|FG001|Overall Study|Lost to Follow-up|6|||
23611395|NCT00087516|65966810|FG002|Overall Study|Lost to Follow-up|5|||
23526572|NCT03013543|65665547|FG003|Overall Study|Other|0|||
23526573|NCT03013543|65665548|FG004|Overall Study|Other|2|||
23526574|NCT03013543|65665549|FG005|Overall Study|Other|0|||
23611396|NCT00087516|65966811|FG003|Overall Study|Lost to Follow-up|5|||
23611397|NCT00087516|65966808|FG000|Overall Study|Protocol Violation|4|||
23611398|NCT00087516|65966809|FG001|Overall Study|Protocol Violation|8|||
23611399|NCT00087516|65966810|FG002|Overall Study|Protocol Violation|3|||
23611400|NCT00087516|65966811|FG003|Overall Study|Protocol Violation|6|||
23611401|NCT00087516|65966808|FG000|Overall Study|Withdrawal by Subject|16|||
23611402|NCT00087516|65966809|FG001|Overall Study|Withdrawal by Subject|27|||
23611403|NCT00087516|65966810|FG002|Overall Study|Withdrawal by Subject|11|||
23611404|NCT00087516|65966811|FG003|Overall Study|Withdrawal by Subject|12|||
23611405|NCT00087516|65966808|FG000|Overall Study|Site terminated|0|||
23611406|NCT00087516|65966809|FG001|Overall Study|Site terminated|2|||
23611407|NCT00087516|65966810|FG002|Overall Study|Site terminated|1|||
23611408|NCT00087516|65966811|FG003|Overall Study|Site terminated|0|||
23611409|NCT00087516|65966808|FG000|Overall Study|Protocol specified discontinuation|35|||
23611410|NCT00087516|65966809|FG001|Overall Study|Protocol specified discontinuation|33|||
23206197|NCT00377611|64494817|FG001|Overall Study|Adverse Event|9|||
23526575|NCT03013543|65665550|FG006|Overall Study|Other|0|||
23526576|NCT03013543|65665551|FG007|Overall Study|Other|0|||
23526577|NCT03013543|65665552|FG008|Overall Study|Other|1|||
23526578|NCT03013543|65665553|FG009|Overall Study|Other|0|||
23611411|NCT00087516|65966810|FG002|Overall Study|Protocol specified discontinuation|33|||
23611412|NCT00087516|65966811|FG003|Overall Study|Protocol specified discontinuation|26|||
23611413|NCT00087516|65966808|FG000|Overall Study|Patient moved|3|||
23611414|NCT00087516|65966809|FG001|Overall Study|Patient moved|2|||
23417981|NCT01357161|65274488|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
23417982|NCT01357161|65274489|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
23417983|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
23417984|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
23526579|NCT03013543|65665544|FG000|Overall Study|Adverse Event|0|||
23417985|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
23417986|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
23417987|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
23417988|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
23417989|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
23417990|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
23417991|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
23417992|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
23417993|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
23417994|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
23417995|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
23417996|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
23417997|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
23417998|NCT01357161|65274487|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
23417999|NCT01357161|65274488|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
23418000|NCT01357161|65274489|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
23418001|NCT02576535|65274492|FG000|Overall Study|Withdrawal by Subject|2|||
23418002|NCT00322452|65274493|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23418003|NCT00322452|65274494|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23418004|NCT00322452|65274493|FG000|Overall Study|Lost to Follow-up|5|||
23418005|NCT00322452|65274494|FG001|Overall Study|Lost to Follow-up|2|||
23418006|NCT00322452|65274493|FG000|Overall Study|Withdrawal by Subject|19|||
23418007|NCT00322452|65274494|FG001|Overall Study|Withdrawal by Subject|46|||
23526580|NCT03013543|65665545|FG001|Overall Study|Adverse Event|0|||
23526581|NCT03013543|65665546|FG002|Overall Study|Adverse Event|0|||
23526582|NCT03013543|65665547|FG003|Overall Study|Adverse Event|3|||
23526583|NCT03013543|65665548|FG004|Overall Study|Adverse Event|2|||
23526584|NCT03013543|65665549|FG005|Overall Study|Adverse Event|1|||
23526585|NCT03013543|65665550|FG006|Overall Study|Adverse Event|3|||
23526586|NCT03013543|65665551|FG007|Overall Study|Adverse Event|8|||
23526587|NCT03013543|65665552|FG008|Overall Study|Adverse Event|0|||
23526588|NCT03013543|65665553|FG009|Overall Study|Adverse Event|2|||
23526589|NCT03013543|65665544|FG000|Overall Study|Death|0|||
23526590|NCT03013543|65665545|FG001|Overall Study|Death|0|||
23526591|NCT03013543|65665546|FG002|Overall Study|Death|0|||
23526592|NCT03013543|65665547|FG003|Overall Study|Death|1|||
23526593|NCT03013543|65665548|FG004|Overall Study|Death|0|||
23526594|NCT03013543|65665549|FG005|Overall Study|Death|0|||
23526595|NCT03013543|65665550|FG006|Overall Study|Death|0|||
23526596|NCT03013543|65665551|FG007|Overall Study|Death|0|||
23526597|NCT03013543|65665552|FG008|Overall Study|Death|0|||
23526598|NCT03013543|65665553|FG009|Overall Study|Death|0|||
23526599|NCT03013543|65665544|FG000|Overall Study|Lack of Efficacy|0|||
23526600|NCT03013543|65665545|FG001|Overall Study|Lack of Efficacy|0|||
23526601|NCT03013543|65665546|FG002|Overall Study|Lack of Efficacy|0|||
23526602|NCT03013543|65665547|FG003|Overall Study|Lack of Efficacy|1|||
23526603|NCT03013543|65665548|FG004|Overall Study|Lack of Efficacy|0|||
23526604|NCT03013543|65665549|FG005|Overall Study|Lack of Efficacy|0|||
23526605|NCT03013543|65665550|FG006|Overall Study|Lack of Efficacy|0|||
23526606|NCT03013543|65665551|FG007|Overall Study|Lack of Efficacy|0|||
23526607|NCT03013543|65665552|FG008|Overall Study|Lack of Efficacy|0|||
23526608|NCT03013543|65665553|FG009|Overall Study|Lack of Efficacy|0|||
23526609|NCT03013543|65665544|FG000|Overall Study|Lost to Follow-up|0|||
23526610|NCT03013543|65665545|FG001|Overall Study|Lost to Follow-up|0|||
23526611|NCT03013543|65665546|FG002|Overall Study|Lost to Follow-up|0|||
23526612|NCT03013543|65665547|FG003|Overall Study|Lost to Follow-up|1|||
23526613|NCT03013543|65665548|FG004|Overall Study|Lost to Follow-up|0|||
23526614|NCT03013543|65665549|FG005|Overall Study|Lost to Follow-up|0|||
23526615|NCT03013543|65665550|FG006|Overall Study|Lost to Follow-up|1|||
23526616|NCT03013543|65665551|FG007|Overall Study|Lost to Follow-up|0|||
23526617|NCT03013543|65665552|FG008|Overall Study|Lost to Follow-up|0|||
23526618|NCT03013543|65665553|FG009|Overall Study|Lost to Follow-up|2|||
23526619|NCT03013543|65665544|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23526620|NCT03013543|65665545|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23526621|NCT03013543|65665546|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23526622|NCT03013543|65665547|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23526623|NCT03013543|65665548|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23526624|NCT03013543|65665549|FG005|Overall Study|Non-Compliance With Study Drug|0|||
23526625|NCT03013543|65665550|FG006|Overall Study|Non-Compliance With Study Drug|0|||
23526626|NCT03013543|65665551|FG007|Overall Study|Non-Compliance With Study Drug|0|||
23418008|NCT00322452|65274493|FG000|Overall Study|Death|223|||
23418009|NCT00322452|65274494|FG001|Overall Study|Death|227|||
23418010|NCT02199314|65274495|FG000|Overall Study|Withdrawal by Subject|6|||
23526627|NCT03013543|65665552|FG008|Overall Study|Non-Compliance With Study Drug|1|||
23526628|NCT03013543|65665553|FG009|Overall Study|Non-Compliance With Study Drug|0|||
23526629|NCT03013543|65665544|FG000|Overall Study|Physician Decision|0|||
23526630|NCT03013543|65665545|FG001|Overall Study|Physician Decision|0|||
23526631|NCT03013543|65665546|FG002|Overall Study|Physician Decision|0|||
23526632|NCT03013543|65665547|FG003|Overall Study|Physician Decision|0|||
23526633|NCT03013543|65665548|FG004|Overall Study|Physician Decision|1|||
23526634|NCT03013543|65665549|FG005|Overall Study|Physician Decision|0|||
23526635|NCT03013543|65665550|FG006|Overall Study|Physician Decision|0|||
23526636|NCT03013543|65665551|FG007|Overall Study|Physician Decision|0|||
23526637|NCT03013543|65665552|FG008|Overall Study|Physician Decision|0|||
23526638|NCT03013543|65665553|FG009|Overall Study|Physician Decision|0|||
23526639|NCT03013543|65665544|FG000|Overall Study|Protocol Violation|0|||
23526640|NCT03013543|65665545|FG001|Overall Study|Protocol Violation|0|||
23526641|NCT03013543|65665546|FG002|Overall Study|Protocol Violation|0|||
23526642|NCT03013543|65665547|FG003|Overall Study|Protocol Violation|0|||
23526643|NCT03013543|65665548|FG004|Overall Study|Protocol Violation|0|||
23526644|NCT03013543|65665549|FG005|Overall Study|Protocol Violation|0|||
23526645|NCT03013543|65665550|FG006|Overall Study|Protocol Violation|0|||
23526646|NCT03013543|65665551|FG007|Overall Study|Protocol Violation|0|||
23526647|NCT03013543|65665552|FG008|Overall Study|Protocol Violation|0|||
23526648|NCT03013543|65665553|FG009|Overall Study|Protocol Violation|1|||
23526649|NCT00582933|65665554|FG000|Overall Study|Physician Decision|3|||
23526650|NCT00397982|65665560|FG000|Overall Study|Withdrawal by Subject|1|||
23526651|NCT00397982|65665560|FG000|Overall Study|Adverse Event|1|||
23526652|NCT00397982|65665560|FG000|Overall Study|noncompliance|1|||
23526653|NCT00397982|65665560|FG000|Overall Study|Unrelated health issues|1|||
23526654|NCT01541826|65665561|FG000|Overall Study|Lost to Follow-up|2|||
23526655|NCT01541826|65665562|FG001|Overall Study|Lost to Follow-up|3|||
23526656|NCT01541826|65665563|FG002|Overall Study|Lost to Follow-up|0|||
23526657|NCT01541826|65665561|FG000|Overall Study|Withdrawal by Subject|2|||
23526658|NCT01541826|65665562|FG001|Overall Study|Withdrawal by Subject|0|||
23526659|NCT01541826|65665563|FG002|Overall Study|Withdrawal by Subject|0|||
23526660|NCT00297037|65665564|FG000|Overall Study|Withdrawal by Subject|2|||
23526661|NCT00297037|65665565|FG001|Overall Study|Withdrawal by Subject|0|||
23526662|NCT01921829|65665580|FG000|Overall Study|Withdrawal by Subject|0|||
23526663|NCT01921829|65665581|FG001|Overall Study|Withdrawal by Subject|1|||
23526664|NCT00697346|65665588|FG000|Overall Study|Adverse Event|4|||
23526665|NCT00697346|65665589|FG001|Overall Study|Adverse Event|5|||
23526666|NCT00697346|65665590|FG002|Overall Study|Adverse Event|0|||
23526667|NCT00697346|65665588|FG000|Overall Study|Progressive Disease|19|||
23526668|NCT00697346|65665589|FG001|Overall Study|Progressive Disease|18|||
23526669|NCT00697346|65665590|FG002|Overall Study|Progressive Disease|0|||
23526670|NCT00697346|65665588|FG000|Overall Study|Symptomatic Deterioration|0|||
23526671|NCT00697346|65665589|FG001|Overall Study|Symptomatic Deterioration|1|||
23526672|NCT00697346|65665590|FG002|Overall Study|Symptomatic Deterioration|0|||
23526673|NCT00697346|65665588|FG000|Overall Study|Withdrawal by Subject|2|||
23526674|NCT00697346|65665589|FG001|Overall Study|Withdrawal by Subject|2|||
23526675|NCT00697346|65665590|FG002|Overall Study|Withdrawal by Subject|0|||
23526676|NCT00697346|65665588|FG000|Overall Study|Reason not Specified|3|||
23526677|NCT00697346|65665589|FG001|Overall Study|Reason not Specified|0|||
23526678|NCT00697346|65665590|FG002|Overall Study|Reason not Specified|1|||
23526679|NCT00836875|65665592|FG000|Overall Study|Death|3|||
23526680|NCT00836875|65665593|FG001|Overall Study|Death|2|||
23526681|NCT00836875|65665592|FG000|Overall Study|Withdrawal by Subject|0|||
23526682|NCT00836875|65665593|FG001|Overall Study|Withdrawal by Subject|1|||
23526683|NCT04116710|65665594|FG000|Overall Study|Death|4|||
23526684|NCT04116710|65665595|FG001|Overall Study|Death|6|||
23526685|NCT04116710|65665596|FG002|Overall Study|Death|3|||
23526686|NCT04116710|65665597|FG003|Overall Study|Death|1|||
23526687|NCT04116710|65665594|FG000|Overall Study|Withdrawal by Subject|0|||
23526688|NCT04116710|65665595|FG001|Overall Study|Withdrawal by Subject|0|||
23526689|NCT04116710|65665596|FG002|Overall Study|Withdrawal by Subject|0|||
23526690|NCT04116710|65665597|FG003|Overall Study|Withdrawal by Subject|1|||
23611415|NCT00087516|65966810|FG002|Overall Study|Patient moved|1|||
23611416|NCT00087516|65966811|FG003|Overall Study|Patient moved|0|||
23526691|NCT00547703|65665598|FG000|Overall Study|Lost to Follow-up|1|||
23611417|NCT00087516|65966808|FG000|Overall Study|Patient was non-compliant|3|||
23611418|NCT00087516|65966809|FG001|Overall Study|Patient was non-compliant|1|||
23526692|NCT00547703|65665599|FG001|Overall Study|Lost to Follow-up|0|||
23526693|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
23526694|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
23526695|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
23526696|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
23526697|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
23526698|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
23526699|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
23526700|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
23526701|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
23611419|NCT00087516|65966810|FG002|Overall Study|Patient was non-compliant|0|||
23611420|NCT00087516|65966811|FG003|Overall Study|Patient was non-compliant|0|||
23611421|NCT00087516|65966808|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
23611422|NCT00087516|65966809|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
23611423|NCT00087516|65966810|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
23611424|NCT00087516|65966811|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
23526702|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
23526703|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
23526704|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
23526705|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
23526706|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
23526707|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
23526708|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Death|5|||
23526709|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Death|0|||
23526710|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Death|2|||
23526711|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Death|0|||
23526712|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Death|4|||
23526713|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
23526714|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
23526715|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
23526716|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
23526717|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
23526718|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
23526719|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
23526720|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
23526721|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
23526722|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
23526723|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
23526724|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
23526725|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
23526726|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
23526727|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
23526728|NCT01604343|65665602|FG000|Prior to W52 Administration(Through W52)|Other|15|||
23526729|NCT01604343|65665603|FG001|Prior to W52 Administration(Through W52)|Other|0|||
23526730|NCT01604343|65665604|FG002|Prior to W52 Administration(Through W52)|Other|10|||
23526731|NCT01604343|65665605|FG003|Prior to W52 Administration(Through W52)|Other|0|||
23526732|NCT01604343|65665606|FG004|Prior to W52 Administration(Through W52)|Other|6|||
23526733|NCT01604343|65665602|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
23526734|NCT01604343|65665603|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
23526735|NCT01604343|65665604|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
23526736|NCT01604343|65665605|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
23526737|NCT01604343|65665606|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
23526738|NCT01604343|65665602|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
23526739|NCT01604343|65665603|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
23526740|NCT01604343|65665604|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
23526741|NCT01604343|65665605|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
23526742|NCT01604343|65665606|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
23526743|NCT01604343|65665602|FG000|Week 52 to Week 104|Adverse Event|0|||
23526744|NCT01604343|65665603|FG001|Week 52 to Week 104|Adverse Event|12|||
23526745|NCT01604343|65665604|FG002|Week 52 to Week 104|Adverse Event|26|||
23526746|NCT01604343|65665605|FG003|Week 52 to Week 104|Adverse Event|21|||
23526747|NCT01604343|65665606|FG004|Week 52 to Week 104|Adverse Event|27|||
23526748|NCT01604343|65665602|FG000|Week 52 to Week 104|Death|0|||
23526749|NCT01604343|65665603|FG001|Week 52 to Week 104|Death|4|||
23526750|NCT01604343|65665604|FG002|Week 52 to Week 104|Death|2|||
23526751|NCT01604343|65665605|FG003|Week 52 to Week 104|Death|5|||
23526752|NCT01604343|65665606|FG004|Week 52 to Week 104|Death|0|||
23526753|NCT01604343|65665602|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
23526754|NCT01604343|65665603|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
23526755|NCT01604343|65665604|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
23526756|NCT01604343|65665605|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
23526757|NCT01604343|65665606|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
23526758|NCT01604343|65665602|FG000|Week 52 to Week 104|Physician Decision|0|||
23611425|NCT00087516|65966808|FG000|Overall Study|Other|0|||
23611426|NCT00087516|65966809|FG001|Overall Study|Other|0|||
23526759|NCT01604343|65665603|FG001|Week 52 to Week 104|Physician Decision|1|||
23526760|NCT01604343|65665604|FG002|Week 52 to Week 104|Physician Decision|0|||
23526761|NCT01604343|65665605|FG003|Week 52 to Week 104|Physician Decision|0|||
23526762|NCT01604343|65665606|FG004|Week 52 to Week 104|Physician Decision|2|||
23526763|NCT01604343|65665602|FG000|Week 52 to Week 104|Pregnancy|0|||
23526764|NCT01604343|65665603|FG001|Week 52 to Week 104|Pregnancy|0|||
23526765|NCT01604343|65665604|FG002|Week 52 to Week 104|Pregnancy|1|||
23611427|NCT00087516|65966810|FG002|Overall Study|Other|1|||
23611428|NCT00087516|65966811|FG003|Overall Study|Other|0|||
23611429|NCT01587703|65966812|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
23611430|NCT01587703|65966813|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611431|NCT01587703|65966814|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611432|NCT01587703|65966815|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23526766|NCT01604343|65665605|FG003|Week 52 to Week 104|Pregnancy|2|||
23526767|NCT01604343|65665606|FG004|Week 52 to Week 104|Pregnancy|1|||
23526768|NCT01604343|65665602|FG000|Week 52 to Week 104|Other|0|||
23526769|NCT01604343|65665603|FG001|Week 52 to Week 104|Other|11|||
23526770|NCT01604343|65665604|FG002|Week 52 to Week 104|Other|11|||
23526771|NCT01604343|65665605|FG003|Week 52 to Week 104|Other|6|||
23526772|NCT01604343|65665606|FG004|Week 52 to Week 104|Other|3|||
23526773|NCT01604343|65665602|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
23526774|NCT01604343|65665603|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
23526775|NCT01604343|65665604|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
23611433|NCT01587703|65966816|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611434|NCT01587703|65966817|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611435|NCT01587703|65966818|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611436|NCT01587703|65966819|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611437|NCT01587703|65966820|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611438|NCT01587703|65966821|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611439|NCT01587703|65966822|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611440|NCT01587703|65966823|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611441|NCT01587703|65966824|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611442|NCT01587703|65966825|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611443|NCT01587703|65966826|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611444|NCT01587703|65966827|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611445|NCT01587703|65966828|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611446|NCT01587703|65966829|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611447|NCT01587703|65966830|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
23611448|NCT01587703|65966812|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611449|NCT01587703|65966813|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611450|NCT01587703|65966814|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611451|NCT01587703|65966815|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611452|NCT01587703|65966816|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611453|NCT01587703|65966817|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
23611454|NCT01587703|65966818|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611455|NCT01587703|65966819|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
23611456|NCT01587703|65966820|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611457|NCT01587703|65966821|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611458|NCT01587703|65966822|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611459|NCT01587703|65966823|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611460|NCT01587703|65966824|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611461|NCT01587703|65966825|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611462|NCT01587703|65966826|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23526776|NCT01604343|65665605|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
23526777|NCT01604343|65665606|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
23526778|NCT01604343|65665602|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
23526779|NCT01604343|65665603|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
23526780|NCT01604343|65665604|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
23526781|NCT01604343|65665605|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
23526782|NCT01604343|65665606|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
23526783|NCT01604343|65665602|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
23526784|NCT01604343|65665603|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
23526785|NCT01604343|65665604|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
23526786|NCT01604343|65665605|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
23526787|NCT01604343|65665606|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
23526788|NCT03277261|65665607|FG000|Overall Study|Adverse Event|17|||
23526789|NCT03277261|65665608|FG001|Overall Study|Adverse Event|1|||
23526790|NCT03277261|65665607|FG000|Overall Study|Participant Withdrawal of Consent|6|||
23526791|NCT03277261|65665608|FG001|Overall Study|Participant Withdrawal of Consent|15|||
23526792|NCT03277261|65665607|FG000|Overall Study|Investigator / Sponsor Decision|4|||
23526793|NCT03277261|65665608|FG001|Overall Study|Investigator / Sponsor Decision|2|||
23526794|NCT03277261|65665607|FG000|Overall Study|Pregnancy|2|||
23526795|NCT03277261|65665608|FG001|Overall Study|Pregnancy|0|||
23526796|NCT03277261|65665607|FG000|Overall Study|Lost to Follow-up|2|||
23526797|NCT03277261|65665608|FG001|Overall Study|Lost to Follow-up|2|||
23526798|NCT03277261|65665607|FG000|Overall Study|Lack of Efficacy|2|||
23611463|NCT01587703|65966827|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23526799|NCT03277261|65665608|FG001|Overall Study|Lack of Efficacy|2|||
23526800|NCT03277261|65665607|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
23526801|NCT03277261|65665608|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
23526802|NCT02501096|65665609|FG000|Overall Study|Lost to Follow-up|0|||
23526803|NCT02501096|65665610|FG001|Overall Study|Lost to Follow-up|0|||
23526804|NCT02501096|65665611|FG002|Overall Study|Lost to Follow-up|0|||
23611464|NCT01587703|65966828|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611465|NCT01587703|65966829|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611466|NCT01587703|65966830|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
23611467|NCT01587703|65966812|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611468|NCT01587703|65966813|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611469|NCT01587703|65966814|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611470|NCT01587703|65966815|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611471|NCT01587703|65966816|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611472|NCT01587703|65966817|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611473|NCT01587703|65966818|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
23611474|NCT01587703|65966819|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611475|NCT01587703|65966820|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611476|NCT01587703|65966821|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611477|NCT01587703|65966822|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611478|NCT01587703|65966823|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611479|NCT01587703|65966824|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611480|NCT01587703|65966825|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611481|NCT01587703|65966826|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611482|NCT01587703|65966827|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611483|NCT01587703|65966828|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611484|NCT01587703|65966829|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611485|NCT01587703|65966830|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
23611486|NCT01587703|65966812|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
23611487|NCT01587703|65966813|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
23611488|NCT01587703|65966814|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
23611489|NCT01587703|65966815|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
23611490|NCT01587703|65966816|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
23611491|NCT01587703|65966817|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
23611492|NCT01587703|65966818|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
23611493|NCT01587703|65966819|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
23611494|NCT01587703|65966820|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611495|NCT01587703|65966821|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611496|NCT01587703|65966822|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611497|NCT01587703|65966823|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611498|NCT01587703|65966824|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23206198|NCT00377611|64494816|FG000|Overall Study|Protocol Violation|2|||
23206199|NCT00377611|64494817|FG001|Overall Study|Protocol Violation|0|||
23206200|NCT00377611|64494816|FG000|Overall Study|Withdrawal by Subject|0|||
23526805|NCT02501096|65665612|FG003|Overall Study|Lost to Follow-up|0|||
23526806|NCT02501096|65665613|FG004|Overall Study|Lost to Follow-up|1|||
23526807|NCT02501096|65665614|FG005|Overall Study|Lost to Follow-up|1|||
23611499|NCT01587703|65966825|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611500|NCT01587703|65966826|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611501|NCT01587703|65966827|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611502|NCT01587703|65966828|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611503|NCT01587703|65966829|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611504|NCT01587703|65966830|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
23611505|NCT01587703|65966812|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23526808|NCT02501096|65665615|FG006|Overall Study|Lost to Follow-up|3|||
23526809|NCT02501096|65665616|FG007|Overall Study|Lost to Follow-up|0|||
23526810|NCT02501096|65665617|FG008|Overall Study|Lost to Follow-up|0|||
23526811|NCT02501096|65665609|FG000|Overall Study|Withdrawal by Subject|1|||
23526812|NCT02501096|65665610|FG001|Overall Study|Withdrawal by Subject|0|||
23611506|NCT01587703|65966813|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23206201|NCT00377611|64494817|FG001|Overall Study|Withdrawal by Subject|5|||
23308782|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23526813|NCT02501096|65665611|FG002|Overall Study|Withdrawal by Subject|7|||
23611507|NCT01587703|65966814|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611508|NCT01587703|65966815|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611509|NCT01587703|65966816|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611510|NCT01587703|65966817|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611511|NCT01587703|65966818|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611512|NCT01587703|65966819|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611513|NCT01587703|65966820|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
23611514|NCT01587703|65966821|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
23611515|NCT01587703|65966822|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
23611516|NCT01587703|65966823|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611517|NCT01587703|65966824|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611518|NCT01587703|65966825|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611519|NCT01587703|65966826|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611520|NCT01587703|65966827|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611521|NCT01587703|65966828|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611522|NCT01587703|65966829|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611523|NCT01587703|65966830|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
23611524|NCT01587703|65966812|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611525|NCT01587703|65966813|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611526|NCT01587703|65966814|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611527|NCT01587703|65966815|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611528|NCT01587703|65966816|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611529|NCT01587703|65966817|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611530|NCT01587703|65966818|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611531|NCT01587703|65966819|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611532|NCT01587703|65966820|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
23611533|NCT01587703|65966821|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611534|NCT01587703|65966822|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
23611535|NCT01587703|65966823|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611536|NCT01587703|65966824|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611537|NCT01587703|65966825|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611538|NCT01587703|65966826|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611539|NCT01587703|65966827|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611540|NCT01587703|65966828|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611541|NCT01587703|65966829|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611542|NCT01587703|65966830|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
23611543|NCT01587703|65966812|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611544|NCT01587703|65966813|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611545|NCT01587703|65966814|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611546|NCT01587703|65966815|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611547|NCT01587703|65966816|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611548|NCT01587703|65966817|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611549|NCT01587703|65966818|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611550|NCT01587703|65966819|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23418011|NCT02199314|65274495|FG000|Overall Study|Physician Decision|10|||
23418012|NCT00633074|65274496|FG000|Overall Study|Adverse Event|1|||
23611551|NCT01587703|65966820|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611552|NCT01587703|65966821|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
23611553|NCT01587703|65966822|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
23611554|NCT01587703|65966823|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611555|NCT01587703|65966824|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611556|NCT01587703|65966825|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611557|NCT01587703|65966826|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611558|NCT01587703|65966827|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611559|NCT01587703|65966828|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611560|NCT01587703|65966829|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611561|NCT01587703|65966830|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
23611562|NCT01587703|65966812|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611563|NCT01587703|65966813|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23206202|NCT00377611|64494816|FG000|Overall Study|Lost to Follow-up|18|||
23418013|NCT00633074|65274497|FG001|Overall Study|Adverse Event|0|||
23418014|NCT00328562|65274498|FG000|Overall Study|Disease progression|1|||
23611564|NCT01587703|65966814|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23418015|NCT03327220|65274499|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
23418016|NCT03327220|65274500|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
23526814|NCT02501096|65665612|FG003|Overall Study|Withdrawal by Subject|13|||
23526815|NCT02501096|65665613|FG004|Overall Study|Withdrawal by Subject|2|||
23526816|NCT02501096|65665614|FG005|Overall Study|Withdrawal by Subject|2|||
23526817|NCT02501096|65665615|FG006|Overall Study|Withdrawal by Subject|2|||
23526818|NCT02501096|65665616|FG007|Overall Study|Withdrawal by Subject|3|||
23526819|NCT02501096|65665617|FG008|Overall Study|Withdrawal by Subject|0|||
23526820|NCT02501096|65665609|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
23526821|NCT02501096|65665610|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
23526822|NCT02501096|65665611|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
23526823|NCT02501096|65665612|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
23526824|NCT02501096|65665613|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
23526825|NCT02501096|65665614|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
23611565|NCT01587703|65966815|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23526826|NCT02501096|65665615|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
23526827|NCT02501096|65665616|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
23526828|NCT02501096|65665617|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
23526829|NCT02501096|65665609|FG000|Overall Study|Death|1|||
23526830|NCT02501096|65665610|FG001|Overall Study|Death|1|||
23526831|NCT02501096|65665611|FG002|Overall Study|Death|88|||
23526832|NCT02501096|65665612|FG003|Overall Study|Death|74|||
23526833|NCT02501096|65665613|FG004|Overall Study|Death|15|||
23526834|NCT02501096|65665614|FG005|Overall Study|Death|16|||
23526835|NCT02501096|65665615|FG006|Overall Study|Death|15|||
23526836|NCT02501096|65665616|FG007|Overall Study|Death|16|||
23526837|NCT02501096|65665617|FG008|Overall Study|Death|1|||
23526838|NCT03181542|65665618|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
23526839|NCT03181542|65665619|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
23526840|NCT04292730|65665620|FG000|Overall Study|Lost to Follow-up|8|||
23526841|NCT04292730|65665621|FG001|Overall Study|Lost to Follow-up|12|||
23526842|NCT04292730|65665622|FG002|Overall Study|Lost to Follow-up|12|||
23526843|NCT04292730|65665623|FG003|Overall Study|Lost to Follow-up|48|||
23526844|NCT04292730|65665620|FG000|Overall Study|Death|2|||
23526845|NCT04292730|65665621|FG001|Overall Study|Death|2|||
23526846|NCT04292730|65665622|FG002|Overall Study|Death|4|||
23526847|NCT04292730|65665623|FG003|Overall Study|Death|12|||
23526848|NCT04292730|65665620|FG000|Overall Study|Withdrew Consent|2|||
23526849|NCT04292730|65665621|FG001|Overall Study|Withdrew Consent|2|||
23526850|NCT04292730|65665622|FG002|Overall Study|Withdrew Consent|5|||
23526851|NCT04292730|65665623|FG003|Overall Study|Withdrew Consent|6|||
23526852|NCT04292730|65665620|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23526853|NCT04292730|65665621|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23526854|NCT04292730|65665622|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23526855|NCT04292730|65665623|FG003|Overall Study|Non-Compliance with Study Drug|0|||
23526856|NCT04292730|65665620|FG000|Overall Study|Protocol Violation|0|||
23526857|NCT04292730|65665621|FG001|Overall Study|Protocol Violation|0|||
23526858|NCT04292730|65665622|FG002|Overall Study|Protocol Violation|1|||
23526859|NCT04292730|65665623|FG003|Overall Study|Protocol Violation|0|||
23526860|NCT04292730|65665620|FG000|Overall Study|Randomized but not Treated|8|||
23526861|NCT04292730|65665621|FG001|Overall Study|Randomized but not Treated|4|||
23526862|NCT04292730|65665622|FG002|Overall Study|Randomized but not Treated|0|||
23526863|NCT04292730|65665623|FG003|Overall Study|Randomized but not Treated|14|||
23526864|NCT04889625|65665627|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
23526865|NCT04889625|65665628|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
23526866|NCT04889625|65665627|FG000|Period 1|Subject out of window|0|||
23526867|NCT04889625|65665628|FG001|Period 1|Subject out of window|1|||
23526868|NCT04889625|65665627|FG000|Period 1|Wrong add power dispensed|0|||
23526869|NCT04889625|65665628|FG001|Period 1|Wrong add power dispensed|1|||
23526870|NCT04889625|65665627|FG000|Period 1|Discontinued due to fitting guide error|1|||
23611566|NCT01587703|65966816|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611567|NCT01587703|65966817|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23526871|NCT04889625|65665628|FG001|Period 1|Discontinued due to fitting guide error|1|||
23526872|NCT04889625|65665627|FG000|Period 2|Test article no longer available|1|||
23526873|NCT04889625|65665628|FG001|Period 2|Test article no longer available|0|||
23526874|NCT04889625|65665627|FG000|Period 2|Incorrect lens dispensed|1|||
23526875|NCT04889625|65665628|FG001|Period 2|Incorrect lens dispensed|0|||
23526876|NCT04889625|65665627|FG000|Period 2|Wrong add power dispensed|0|||
23526877|NCT04889625|65665628|FG001|Period 2|Wrong add power dispensed|1|||
23526878|NCT01574703|65665631|FG000|Overall Study|Adverse Event|0|||
23526879|NCT01574703|65665632|FG001|Overall Study|Adverse Event|2|||
23526880|NCT01574703|65665633|FG002|Overall Study|Adverse Event|1|||
23526881|NCT01574703|65665634|FG003|Overall Study|Adverse Event|1|||
23526882|NCT01574703|65665631|FG000|Overall Study|Protocol Violation|0|||
23526883|NCT01574703|65665632|FG001|Overall Study|Protocol Violation|0|||
23526884|NCT01574703|65665633|FG002|Overall Study|Protocol Violation|0|||
23611568|NCT01587703|65966818|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611569|NCT01587703|65966819|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611570|NCT01587703|65966820|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
23611571|NCT01587703|65966821|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23526885|NCT01574703|65665634|FG003|Overall Study|Protocol Violation|1|||
23526886|NCT01574703|65665631|FG000|Overall Study|Unspecified Reason|27|||
23526887|NCT01574703|65665632|FG001|Overall Study|Unspecified Reason|15|||
23526888|NCT01574703|65665633|FG002|Overall Study|Unspecified Reason|20|||
23526889|NCT01574703|65665634|FG003|Overall Study|Unspecified Reason|16|||
23526890|NCT01574703|65665631|FG000|Overall Study|Withdrawal by Subject|53|||
23526891|NCT01574703|65665632|FG001|Overall Study|Withdrawal by Subject|52|||
23526892|NCT01574703|65665633|FG002|Overall Study|Withdrawal by Subject|36|||
23526893|NCT01574703|65665634|FG003|Overall Study|Withdrawal by Subject|61|||
23526894|NCT01574703|65665631|FG000|Overall Study|Met Withdrawal Criteria|0|||
23526895|NCT01574703|65665632|FG001|Overall Study|Met Withdrawal Criteria|1|||
23526896|NCT01574703|65665633|FG002|Overall Study|Met Withdrawal Criteria|1|||
23526897|NCT01574703|65665634|FG003|Overall Study|Met Withdrawal Criteria|0|||
23526898|NCT01574703|65665631|FG000|Overall Study|Lost to Follow-up|43|||
23526899|NCT01574703|65665632|FG001|Overall Study|Lost to Follow-up|41|||
23526900|NCT01574703|65665633|FG002|Overall Study|Lost to Follow-up|46|||
23526901|NCT01574703|65665634|FG003|Overall Study|Lost to Follow-up|35|||
23526902|NCT01574703|65665631|FG000|Overall Study|Death|2|||
23526903|NCT01574703|65665632|FG001|Overall Study|Death|1|||
23526904|NCT01574703|65665633|FG002|Overall Study|Death|1|||
23526905|NCT01574703|65665634|FG003|Overall Study|Death|0|||
23582126|NCT02028884|65862334|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
23582127|NCT02028884|65862335|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
23582128|NCT02028884|65862333|FG000|Double-blind Period|Withdrawal by Subject|2|||
23582129|NCT02028884|65862334|FG001|Double-blind Period|Withdrawal by Subject|0|||
23582130|NCT02028884|65862335|FG002|Double-blind Period|Withdrawal by Subject|0|||
23582131|NCT02028884|65862333|FG000|Open-label Extension Period|Adverse Event|3|||
23582132|NCT02028884|65862334|FG001|Open-label Extension Period|Adverse Event|1|||
23582133|NCT02028884|65862335|FG002|Open-label Extension Period|Adverse Event|0|||
23582134|NCT02028884|65862333|FG000|Open-label Extension Period|Lack of Efficacy|3|||
23582135|NCT02028884|65862334|FG001|Open-label Extension Period|Lack of Efficacy|0|||
23582136|NCT02028884|65862335|FG002|Open-label Extension Period|Lack of Efficacy|0|||
23582137|NCT02028884|65862333|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
23582138|NCT02028884|65862334|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
23582139|NCT02028884|65862335|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
23582140|NCT02028884|65862333|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
23582141|NCT02028884|65862334|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
23582142|NCT02028884|65862335|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
23582143|NCT02028884|65862333|FG000|Open-label Extension Period|Switched to another treatment option|3|||
23582144|NCT02028884|65862334|FG001|Open-label Extension Period|Switched to another treatment option|0|||
23582145|NCT02028884|65862335|FG002|Open-label Extension Period|Switched to another treatment option|0|||
23582146|NCT01155869|65862336|FG000|Overall Study|Lost to Follow-up|3|||
23582147|NCT01155869|65862337|FG001|Overall Study|Lost to Follow-up|1|||
23582148|NCT01168401|65862340|FG000|Overall Study|Lost to Follow-up|1|||
23582149|NCT01168401|65862341|FG001|Overall Study|Lost to Follow-up|1|||
23582150|NCT01168401|65862342|FG002|Overall Study|Lost to Follow-up|2|||
23582151|NCT01168401|65862343|FG003|Overall Study|Lost to Follow-up|1|||
23582152|NCT01168401|65862344|FG004|Overall Study|Lost to Follow-up|0|||
23582153|NCT01168401|65862345|FG005|Overall Study|Lost to Follow-up|0|||
23582154|NCT01168401|65862346|FG006|Overall Study|Lost to Follow-up|0|||
23582155|NCT01168401|65862347|FG007|Overall Study|Lost to Follow-up|0|||
23582156|NCT01168401|65862348|FG008|Overall Study|Lost to Follow-up|0|||
23582157|NCT01168401|65862349|FG009|Overall Study|Lost to Follow-up|0|||
23582158|NCT01168401|65862350|FG010|Overall Study|Lost to Follow-up|0|||
23582159|NCT01168401|65862340|FG000|Overall Study|Withdrawal by Subject|0|||
23582160|NCT01168401|65862341|FG001|Overall Study|Withdrawal by Subject|0|||
23582161|NCT01168401|65862342|FG002|Overall Study|Withdrawal by Subject|0|||
23611572|NCT01587703|65966822|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23582162|NCT01168401|65862343|FG003|Overall Study|Withdrawal by Subject|1|||
23582163|NCT01168401|65862344|FG004|Overall Study|Withdrawal by Subject|0|||
23582164|NCT01168401|65862345|FG005|Overall Study|Withdrawal by Subject|0|||
23582165|NCT01168401|65862346|FG006|Overall Study|Withdrawal by Subject|0|||
23582166|NCT01168401|65862347|FG007|Overall Study|Withdrawal by Subject|0|||
23582167|NCT01168401|65862348|FG008|Overall Study|Withdrawal by Subject|0|||
23582168|NCT01168401|65862349|FG009|Overall Study|Withdrawal by Subject|0|||
23582169|NCT01168401|65862350|FG010|Overall Study|Withdrawal by Subject|0|||
23582170|NCT02223793|65862351|FG000|Overall Study|Lost to Follow-up|10|||
23582171|NCT02223793|65862352|FG001|Overall Study|Lost to Follow-up|1|||
23582172|NCT02223793|65862353|FG002|Overall Study|Lost to Follow-up|2|||
23582173|NCT02223793|65862351|FG000|Overall Study|Withdrawal by Subject|3|||
23611573|NCT01587703|65966823|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611574|NCT01587703|65966824|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611575|NCT01587703|65966825|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611576|NCT01587703|65966826|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611577|NCT01587703|65966827|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611578|NCT01587703|65966828|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611579|NCT01587703|65966829|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611580|NCT01587703|65966830|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
23611581|NCT01587703|65966812|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611582|NCT01587703|65966813|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611583|NCT01587703|65966814|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611584|NCT01587703|65966815|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611585|NCT01587703|65966816|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611586|NCT01587703|65966817|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611587|NCT01587703|65966818|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611588|NCT01587703|65966819|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611589|NCT01587703|65966820|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611590|NCT01587703|65966821|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611591|NCT01587703|65966822|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611592|NCT01587703|65966823|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611593|NCT01587703|65966824|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611594|NCT01587703|65966825|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611595|NCT01587703|65966826|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611596|NCT01587703|65966827|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611597|NCT01587703|65966828|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23611598|NCT01587703|65966829|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
23308783|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23308784|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23308785|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23308786|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23308787|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23308788|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23308789|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
23308790|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
23308791|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
23308792|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
23308793|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
23308794|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Other|4|||
23308795|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Other|5|||
23308796|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Other|4|||
23308797|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Other|0|||
23308798|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Other|0|||
23308799|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
23308800|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
23308801|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
23308802|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
23308803|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
23308804|NCT01081834|64877709|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23526906|NCT01302392|65669173|FG000|Overall Study|Lost to Follow-up|1|||
23526907|NCT01302392|65669174|FG001|Overall Study|Lost to Follow-up|0|||
23526908|NCT01302392|65669173|FG000|Overall Study|Withdrawal by Subject|6|||
23526909|NCT01302392|65669174|FG001|Overall Study|Withdrawal by Subject|1|||
23526910|NCT00579826|65669175|FG000|Overall Study|Withdrawal by Subject|5|||
23526911|NCT00579826|65669176|FG001|Overall Study|Withdrawal by Subject|3|||
23526912|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526913|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
23526914|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
23526915|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
23526916|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526917|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526918|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23308805|NCT01081834|64877710|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
23308806|NCT01081834|64877711|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23308807|NCT01081834|64877712|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23308808|NCT01081834|64877713|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23308809|NCT01934335|64877714|FG000|Overall Study|Withdrawal by Subject|1|||
23308810|NCT01934335|64877715|FG001|Overall Study|Withdrawal by Subject|1|||
23308811|NCT00510289|64877716|FG000|Overall Study|Withdrawal by Subject|7|||
23308812|NCT00510289|64877716|FG000|Overall Study|Refused bone marrow biopsy|2|||
23308813|NCT00510289|64877716|FG000|Overall Study|Lost to Follow-up|1|||
23308814|NCT00510289|64877716|FG000|Overall Study|Progressed prior to starting drug|2|||
23308815|NCT04740814|64877717|FG000|Overall Study|Adverse Event|3|||
23308816|NCT04740814|64877717|FG000|Overall Study|Protocol Violation|2|||
23308817|NCT04740814|64877717|FG000|Overall Study|Lost to Follow-up|2|||
23308818|NCT04740814|64877717|FG000|Overall Study|Withdrawal by Subject|3|||
23308819|NCT00593736|64877723|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
23308820|NCT00593736|64877724|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
23308821|NCT00593736|64877725|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
23308822|NCT00593736|64877726|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
23308823|NCT00593736|64877723|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
23308824|NCT00593736|64877724|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
23308825|NCT00593736|64877725|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
23308826|NCT00593736|64877726|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
23308827|NCT00593736|64877723|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
23308828|NCT00593736|64877724|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
23308829|NCT00593736|64877725|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
23308830|NCT00593736|64877726|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
23308831|NCT00593736|64877723|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
23308832|NCT00593736|64877724|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
23308833|NCT00593736|64877725|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
23308834|NCT00593736|64877726|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
23308835|NCT00593736|64877723|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
23308836|NCT00593736|64877724|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
23526919|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23308837|NCT00593736|64877725|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
23308838|NCT00593736|64877726|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
23418017|NCT03327220|65274499|FG000|Overall Study|Investigator Decision|2|||
23418018|NCT03327220|65274500|FG001|Overall Study|Investigator Decision|0|||
23526920|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526921|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23206203|NCT00377611|64494817|FG001|Overall Study|Lost to Follow-up|16|||
23206204|NCT00377611|64494816|FG000|Overall Study|Other|0|||
23206205|NCT00377611|64494817|FG001|Overall Study|Other|3|||
23206206|NCT00353496|64494818|FG000|Overall Study|Adverse Event|1|||
23206207|NCT00353496|64494819|FG001|Overall Study|Adverse Event|0|||
23206208|NCT00353496|64494818|FG000|Overall Study|Protocol Violation|2|||
23206209|NCT00353496|64494819|FG001|Overall Study|Protocol Violation|2|||
23206210|NCT00353496|64494818|FG000|Overall Study|Withdrawal by Subject|3|||
23206211|NCT00353496|64494819|FG001|Overall Study|Withdrawal by Subject|4|||
23206212|NCT00353496|64494818|FG000|Overall Study|Physician Decision|6|||
23206213|NCT00353496|64494819|FG001|Overall Study|Physician Decision|9|||
23206214|NCT00353496|64494818|FG000|Overall Study|Not otherwise specified|4|||
23206215|NCT00353496|64494819|FG001|Overall Study|Not otherwise specified|2|||
23206216|NCT02815293|64494820|FG000|Overall Study|Study termination by sponsor|10|||
23206217|NCT02815293|64494821|FG001|Overall Study|Study termination by sponsor|7|||
23206218|NCT02815293|64494822|FG002|Overall Study|Study termination by sponsor|0|||
23206219|NCT02815293|64494820|FG000|Overall Study|Participants not randomized|0|||
23206220|NCT02815293|64494821|FG001|Overall Study|Participants not randomized|0|||
23206221|NCT02815293|64494822|FG002|Overall Study|Participants not randomized|18|||
23206222|NCT02815293|64494820|FG000|Overall Study|Adverse Event|0|||
23206223|NCT02815293|64494821|FG001|Overall Study|Adverse Event|1|||
23206224|NCT02815293|64494822|FG002|Overall Study|Adverse Event|0|||
23206225|NCT04587453|64494823|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
23206226|NCT04587453|64494824|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
23206227|NCT00948818|64494831|FG000|Overall Study|Adverse Event|10|||
23206228|NCT00948818|64494832|FG001|Overall Study|Adverse Event|32|||
23206229|NCT00948818|64494831|FG000|Overall Study|Protocol Violation|9|||
23206230|NCT00948818|64494832|FG001|Overall Study|Protocol Violation|10|||
23206231|NCT00948818|64494831|FG000|Overall Study|Withdrawal by Subject|25|||
23206232|NCT00948818|64494832|FG001|Overall Study|Withdrawal by Subject|25|||
23206233|NCT00948818|64494831|FG000|Overall Study|Lost to Follow-up|10|||
23206234|NCT00948818|64494832|FG001|Overall Study|Lost to Follow-up|17|||
23206235|NCT00948818|64494831|FG000|Overall Study|Lack of Efficacy|4|||
23206236|NCT00948818|64494832|FG001|Overall Study|Lack of Efficacy|5|||
23206237|NCT00948818|64494831|FG000|Overall Study|Other Reason|4|||
23206238|NCT00948818|64494832|FG001|Overall Study|Other Reason|5|||
23206239|NCT02927873|64494833|FG000|Overall Study|Lost to Follow-up|0|||
23206240|NCT02927873|64494834|FG001|Overall Study|Lost to Follow-up|1|||
23206241|NCT02927873|64494835|FG002|Overall Study|Lost to Follow-up|0|||
23206242|NCT02927873|64494836|FG003|Overall Study|Lost to Follow-up|0|||
23206243|NCT02927873|64494837|FG004|Overall Study|Lost to Follow-up|0|||
23206244|NCT02927873|64494838|FG005|Overall Study|Lost to Follow-up|0|||
23206245|NCT02927873|64494833|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23206246|NCT02927873|64494834|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
23206247|NCT02927873|64494835|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23206248|NCT02927873|64494836|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23206249|NCT02927873|64494837|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23206250|NCT02927873|64494838|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23206251|NCT02927873|64494833|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23206252|NCT02927873|64494834|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23206253|NCT02927873|64494835|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23206254|NCT02927873|64494836|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23206255|NCT02927873|64494837|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23206256|NCT02927873|64494838|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23206257|NCT02927873|64494833|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23206258|NCT02927873|64494834|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
23206259|NCT02927873|64494835|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23206260|NCT02927873|64494836|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23206261|NCT02927873|64494837|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23206262|NCT02927873|64494838|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
23206263|NCT02927873|64494833|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
23206264|NCT02927873|64494834|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23206265|NCT02927873|64494835|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23206266|NCT02927873|64494836|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23206267|NCT02927873|64494837|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23418019|NCT03327220|65274499|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
23418020|NCT03327220|65274500|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
23418021|NCT03327220|65274499|FG000|Overall Study|Fungal infection|1|||
23418022|NCT03327220|65274500|FG001|Overall Study|Fungal infection|0|||
23418023|NCT03327220|65274499|FG000|Overall Study|Discharged to Rehabilitation|0|||
23418024|NCT03327220|65274500|FG001|Overall Study|Discharged to Rehabilitation|1|||
23418025|NCT03327220|65274499|FG000|Overall Study|Missing|1|||
23418026|NCT03327220|65274500|FG001|Overall Study|Missing|0|||
23418027|NCT04437511|65274507|FG000|Overall Study|Adverse Event|50|||
23418028|NCT04437511|65274508|FG001|Overall Study|Adverse Event|21|||
23418029|NCT04437511|65274507|FG000|Overall Study|Death|15|||
23418030|NCT04437511|65274508|FG001|Overall Study|Death|10|||
23418031|NCT04437511|65274507|FG000|Overall Study|Lost to Follow-up|11|||
23418032|NCT04437511|65274508|FG001|Overall Study|Lost to Follow-up|11|||
23418033|NCT04437511|65274507|FG000|Overall Study|Physician Decision|19|||
23418034|NCT04437511|65274508|FG001|Overall Study|Physician Decision|10|||
23418035|NCT04437511|65274507|FG000|Overall Study|Progressive Disease|4|||
23418036|NCT04437511|65274508|FG001|Overall Study|Progressive Disease|7|||
23418037|NCT04437511|65274507|FG000|Overall Study|Withdrawal by Subject|111|||
23418038|NCT04437511|65274508|FG001|Overall Study|Withdrawal by Subject|94|||
23418039|NCT04437511|65274507|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
23418040|NCT04437511|65274508|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
23418041|NCT04437511|65274507|FG000|Overall Study|Continuing Study|7|||
23418042|NCT04437511|65274508|FG001|Overall Study|Continuing Study|5|||
23418043|NCT01960998|65274509|FG000|Overall Study|Lost to Follow-up|3|||
23418044|NCT01960998|65274510|FG001|Overall Study|Lost to Follow-up|7|||
23418045|NCT01960998|65274509|FG000|Overall Study|Death|0|||
23418046|NCT01960998|65274510|FG001|Overall Study|Death|1|||
23418047|NCT01960998|65274509|FG000|Overall Study|Withdrawal by Subject|8|||
23418048|NCT01960998|65274510|FG001|Overall Study|Withdrawal by Subject|2|||
23418049|NCT01960998|65274509|FG000|Overall Study|lost computer access|0|||
23418050|NCT01960998|65274510|FG001|Overall Study|lost computer access|1|||
23418051|NCT04493333|65274511|FG000|Overall Study|Withdrawal by Subject|1|||
23418052|NCT04493333|65274512|FG001|Overall Study|Withdrawal by Subject|1|||
23418053|NCT04493333|65274511|FG000|Overall Study|Ineligible|0|||
23418054|NCT04493333|65274512|FG001|Overall Study|Ineligible|1|||
23418055|NCT04493333|65274511|FG000|Overall Study|Noncompliance|2|||
23418056|NCT04493333|65274512|FG001|Overall Study|Noncompliance|1|||
23418057|NCT02534935|65274514|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
23418058|NCT02534935|65274515|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
23418059|NCT02534935|65274516|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
23418060|NCT02534935|65274514|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
23418061|NCT02534935|65274515|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
23418062|NCT02534935|65274516|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
23418063|NCT02534935|65274514|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
23418064|NCT02534935|65274515|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
23418065|NCT02534935|65274516|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
23418066|NCT02534935|65274514|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
23418067|NCT02534935|65274515|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
23418068|NCT02534935|65274516|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
23418069|NCT02534935|65274514|FG000|Stage 1: 24 Months|Adverse Event|0|||
23418070|NCT02534935|65274515|FG001|Stage 1: 24 Months|Adverse Event|2|||
23418071|NCT02534935|65274516|FG002|Stage 1: 24 Months|Adverse Event|0|||
23418072|NCT02534935|65274514|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
23418073|NCT02534935|65274515|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
23418074|NCT02534935|65274516|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
23418075|NCT02534935|65274514|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
23418076|NCT02534935|65274515|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
23418077|NCT02534935|65274516|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
23418078|NCT00564902|65274517|FG000|Overall Study|Withdrawal by Subject|0|||
23418079|NCT00564902|65274518|FG001|Overall Study|Withdrawal by Subject|3|||
23418080|NCT00564902|65274519|FG002|Overall Study|Withdrawal by Subject|4|||
23418081|NCT00564902|65274517|FG000|Overall Study|Death|1|||
23418082|NCT00564902|65274518|FG001|Overall Study|Death|1|||
23418083|NCT00564902|65274519|FG002|Overall Study|Death|0|||
23418084|NCT03576066|65277140|FG000|Overall Study|Noncompliance with study drug|0|||
23526922|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23611599|NCT01587703|65966830|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
23611600|NCT01587703|65966812|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23526923|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23308839|NCT00593736|64877723|FG000|Screening Period and Placebo Run-in|Various|0|||
23308840|NCT00593736|64877724|FG001|Screening Period and Placebo Run-in|Various|0|||
23418085|NCT03576066|65277141|FG001|Overall Study|Noncompliance with study drug|1|||
23418086|NCT00978380|65277142|FG000|Overall Study|Protocol Violation|2|||
23418087|NCT00978380|65277142|FG000|Overall Study|Withdrawal criteria|9|||
23418088|NCT00978380|65277142|FG000|Overall Study|Unclassified|8|||
23418089|NCT02359045|65277145|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
23418090|NCT02359045|65277146|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23418091|NCT02359045|65277145|FG000|Overall Study|Lost to Follow-up|1|||
23418092|NCT02359045|65277146|FG001|Overall Study|Lost to Follow-up|1|||
23418093|NCT02359045|65277145|FG000|Overall Study|Adverse Event|0|||
23418094|NCT02359045|65277146|FG001|Overall Study|Adverse Event|1|||
23418095|NCT03344549|65277149|FG000|Overall Study|Withdrawal by Subject|3|||
23418096|NCT03344549|65277150|FG001|Overall Study|Withdrawal by Subject|2|||
23418097|NCT03344549|65277149|FG000|Overall Study|Dialysis|2|||
23418098|NCT03344549|65277150|FG001|Overall Study|Dialysis|0|||
23418099|NCT03344549|65277149|FG000|Overall Study|Cancer|1|||
23418100|NCT03344549|65277150|FG001|Overall Study|Cancer|0|||
23418101|NCT03344549|65277149|FG000|Overall Study|Lack of electronic device|1|||
23418102|NCT03344549|65277150|FG001|Overall Study|Lack of electronic device|0|||
23418103|NCT03344549|65277149|FG000|Overall Study|Transportation difficulty|0|||
23418104|NCT03344549|65277150|FG001|Overall Study|Transportation difficulty|13|||
23418105|NCT00090233|65277151|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
23418106|NCT00090233|65277152|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
23418107|NCT00090233|65277151|FG000|Overall Study|Adverse Event|214|||
23418108|NCT00090233|65277152|FG001|Overall Study|Adverse Event|198|||
23418109|NCT00090233|65277151|FG000|Overall Study|Lost to Follow-up|68|||
23418110|NCT00090233|65277152|FG001|Overall Study|Lost to Follow-up|95|||
23418111|NCT00090233|65277151|FG000|Overall Study|Protocol Violation|960|||
23418112|NCT00090233|65277152|FG001|Overall Study|Protocol Violation|1022|||
23418113|NCT00090233|65277151|FG000|Overall Study|Withdrawal by Subject|182|||
23418114|NCT00090233|65277152|FG001|Overall Study|Withdrawal by Subject|211|||
23418115|NCT00090233|65277151|FG000|Overall Study|Moved|203|||
23418116|NCT00090233|65277152|FG001|Overall Study|Moved|189|||
23418117|NCT00090233|65277151|FG000|Overall Study|Other|1211|||
23418118|NCT00090233|65277152|FG001|Overall Study|Other|1160|||
23418119|NCT00090233|65277151|FG000|Overall Study|Data not available at data cut-off point|1552|||
23418120|NCT00090233|65277152|FG001|Overall Study|Data not available at data cut-off point|1563|||
23418121|NCT02759107|65277160|FG000|Overall Study|Adverse Event|0|||
23418122|NCT02759107|65277161|FG001|Overall Study|Adverse Event|0|||
23418123|NCT02759107|65277162|FG002|Overall Study|Adverse Event|0|||
23418124|NCT02759107|65277163|FG003|Overall Study|Adverse Event|0|||
23418125|NCT02759107|65277164|FG004|Overall Study|Adverse Event|0|||
23418126|NCT02759107|65277165|FG005|Overall Study|Adverse Event|0|||
23418127|NCT02759107|65277166|FG006|Overall Study|Adverse Event|0|||
23418128|NCT02759107|65277167|FG007|Overall Study|Adverse Event|0|||
23418129|NCT02759107|65277168|FG008|Overall Study|Adverse Event|0|||
23418130|NCT02759107|65277169|FG009|Overall Study|Adverse Event|0|||
23418131|NCT02759107|65277170|FG010|Overall Study|Adverse Event|0|||
23418132|NCT02759107|65277171|FG011|Overall Study|Adverse Event|0|||
23418133|NCT02759107|65277172|FG012|Overall Study|Adverse Event|2|||
23418134|NCT02759107|65277173|FG013|Overall Study|Adverse Event|0|||
23418135|NCT02759107|65277174|FG014|Overall Study|Adverse Event|0|||
23418136|NCT02759107|65277175|FG015|Overall Study|Adverse Event|1|||
23418137|NCT02759107|65277176|FG016|Overall Study|Adverse Event|0|||
23418138|NCT02759107|65277177|FG017|Overall Study|Adverse Event|2|||
23418139|NCT02759107|65277160|FG000|Overall Study|Scheduling Conflict|0|||
23418140|NCT02759107|65277161|FG001|Overall Study|Scheduling Conflict|0|||
23418141|NCT02759107|65277162|FG002|Overall Study|Scheduling Conflict|0|||
23418142|NCT02759107|65277163|FG003|Overall Study|Scheduling Conflict|0|||
23418143|NCT02759107|65277164|FG004|Overall Study|Scheduling Conflict|0|||
23418144|NCT02759107|65277165|FG005|Overall Study|Scheduling Conflict|0|||
23418145|NCT02759107|65277166|FG006|Overall Study|Scheduling Conflict|0|||
23418146|NCT02759107|65277167|FG007|Overall Study|Scheduling Conflict|0|||
23418147|NCT02759107|65277168|FG008|Overall Study|Scheduling Conflict|0|||
23418148|NCT02759107|65277169|FG009|Overall Study|Scheduling Conflict|1|||
23418149|NCT02759107|65277170|FG010|Overall Study|Scheduling Conflict|0|||
23418150|NCT02759107|65277171|FG011|Overall Study|Scheduling Conflict|0|||
23418151|NCT02759107|65277172|FG012|Overall Study|Scheduling Conflict|0|||
23418152|NCT02759107|65277173|FG013|Overall Study|Scheduling Conflict|0|||
23418153|NCT02759107|65277174|FG014|Overall Study|Scheduling Conflict|0|||
23418154|NCT02759107|65277175|FG015|Overall Study|Scheduling Conflict|0|||
23418155|NCT02759107|65277176|FG016|Overall Study|Scheduling Conflict|0|||
23418156|NCT02759107|65277177|FG017|Overall Study|Scheduling Conflict|0|||
23418157|NCT00772369|65277184|FG000|Overall Study|Did not return record release form|1|||
23418158|NCT04795167|65277190|FG000|Overall Study|Death|1|||
23418159|NCT04795167|65277191|FG001|Overall Study|Death|18|||
23418160|NCT04795167|65277192|FG002|Overall Study|Death|1|||
23418161|NCT04795167|65277190|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
23526924|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23418162|NCT04795167|65277191|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
23418163|NCT04795167|65277192|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
23418164|NCT00759356|65277194|FG000|Overall Study|Adverse Event|0|||
23418165|NCT00759356|65277195|FG001|Overall Study|Adverse Event|1|||
23418166|NCT00759356|65277194|FG000|Overall Study|Withdrawal by Subject|0|||
23418167|NCT00759356|65277195|FG001|Overall Study|Withdrawal by Subject|2|||
23418168|NCT00759356|65277194|FG000|Overall Study|Subject was unable to return|1|||
23418169|NCT00759356|65277195|FG001|Overall Study|Subject was unable to return|0|||
23418170|NCT01257230|65277198|FG000|Overall Study|Not Treated|0|||
23418171|NCT01257230|65277199|FG001|Overall Study|Not Treated|0|||
23418172|NCT01257230|65277200|FG002|Overall Study|Not Treated|1|||
23418173|NCT01257230|65277198|FG000|Overall Study|Adverse Event|2|||
23526925|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526926|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526927|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526928|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526929|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526930|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526931|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526932|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526933|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526934|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526935|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
23526936|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23611601|NCT01587703|65966813|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611602|NCT01587703|65966814|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611603|NCT01587703|65966815|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611604|NCT01587703|65966816|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611605|NCT01587703|65966817|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611606|NCT01587703|65966818|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23526937|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
23526938|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526939|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23611607|NCT01587703|65966819|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611608|NCT01587703|65966820|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611609|NCT01587703|65966821|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611610|NCT01587703|65966822|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611611|NCT01587703|65966823|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611612|NCT01587703|65966824|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611613|NCT01587703|65966825|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611614|NCT01587703|65966826|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611615|NCT01587703|65966827|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611616|NCT01587703|65966828|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
23611617|NCT01587703|65966829|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
23611618|NCT01587703|65966830|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
23611619|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611620|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611621|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611622|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611623|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611624|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611625|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611626|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611627|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611628|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611629|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611630|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611631|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611632|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611633|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611634|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
23611635|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611636|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23611637|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
23418174|NCT01257230|65277199|FG001|Overall Study|Adverse Event|0|||
23526940|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526941|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526942|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526943|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526944|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23418175|NCT01257230|65277200|FG002|Overall Study|Adverse Event|0|||
23611638|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611639|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611640|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611641|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611642|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611643|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611644|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611645|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611646|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611647|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611648|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611649|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
23611650|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611651|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611652|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
23611653|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611654|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611655|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611656|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
23611657|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611658|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611659|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611660|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611661|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611662|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611663|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611664|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611665|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611666|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611667|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611668|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
23611669|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
23611670|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
23611671|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
23611672|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
23611673|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
23611674|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611675|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
23611676|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611677|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611678|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611679|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611680|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611681|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
23206268|NCT02927873|64494838|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
23206269|NCT02927873|64494833|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
23206270|NCT02927873|64494834|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23206271|NCT02927873|64494835|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23206272|NCT02927873|64494836|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23206273|NCT02927873|64494837|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23206274|NCT02927873|64494838|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
23611682|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611683|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611684|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611685|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611686|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611687|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
23611688|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
23611689|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
23611690|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
23611691|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
23206275|NCT01658579|64494841|FG000|Treatment Period A|Other|0|||
23611692|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
23611693|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611694|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
23611695|NCT01587703|65966812|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23206276|NCT01658579|64494842|FG001|Treatment Period A|Other|0|||
23206277|NCT01658579|64494843|FG002|Treatment Period A|Other|1|||
23611696|NCT01587703|65966813|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611697|NCT01587703|65966814|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611698|NCT01587703|65966815|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611699|NCT01587703|65966816|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611700|NCT01587703|65966817|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611701|NCT01587703|65966818|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611702|NCT01587703|65966819|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611703|NCT01587703|65966820|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611704|NCT01587703|65966821|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611705|NCT01587703|65966822|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611706|NCT01587703|65966823|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
23611707|NCT01587703|65966824|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611708|NCT01587703|65966825|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611709|NCT01587703|65966826|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611710|NCT01587703|65966827|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611711|NCT01587703|65966828|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611712|NCT01587703|65966829|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611713|NCT01587703|65966830|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
23611714|NCT02316171|65966831|FG000|Overall Study|difficulties with urinary catheter|1|||
23611715|NCT02316171|65966832|FG001|Overall Study|difficulties with urinary catheter|0|||
23611716|NCT02316171|65966833|FG002|Overall Study|difficulties with urinary catheter|0|||
23611717|NCT02316171|65966834|FG003|Overall Study|difficulties with urinary catheter|0|||
23611718|NCT05287178|65966835|FG000|Overall Study|Lost to Follow-up|2|||
23611719|NCT02389894|65966836|FG000|Overall Study|Death|4|||
23611720|NCT02389894|65966837|FG001|Overall Study|Death|5|||
23611721|NCT02389894|65966838|FG002|Overall Study|Death|3|||
23611722|NCT02389894|65966836|FG000|Overall Study|Withdrawal by Subject|2|||
23611723|NCT02389894|65966837|FG001|Overall Study|Withdrawal by Subject|4|||
23611724|NCT02389894|65966838|FG002|Overall Study|Withdrawal by Subject|5|||
23611725|NCT02389894|65966836|FG000|Overall Study|Lost to Follow-up|2|||
23611726|NCT02389894|65966837|FG001|Overall Study|Lost to Follow-up|1|||
23611727|NCT02389894|65966838|FG002|Overall Study|Lost to Follow-up|1|||
23611728|NCT03686176|65966840|FG000|Overall Study|Procedure cancelled|1|||
23611729|NCT03686176|65966841|FG001|Overall Study|Procedure cancelled|0|||
23611730|NCT03686176|65966842|FG002|Overall Study|Procedure cancelled|0|||
23308841|NCT00593736|64877725|FG002|Screening Period and Placebo Run-in|Various|0|||
23526945|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526946|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526947|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526948|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526949|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526950|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526951|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23611731|NCT03686176|65966840|FG000|Overall Study|VR Malfunction|1|||
23611732|NCT03686176|65966841|FG001|Overall Study|VR Malfunction|0|||
23611733|NCT03686176|65966842|FG002|Overall Study|VR Malfunction|0|||
23611734|NCT00670449|65966843|FG000|Overall Study|Adverse Event|6|||
23611735|NCT00670449|65966844|FG001|Overall Study|Adverse Event|2|||
23611736|NCT00670449|65966845|FG002|Overall Study|Adverse Event|8|||
23611737|NCT00670449|65966846|FG003|Overall Study|Adverse Event|5|||
23611738|NCT00670449|65966843|FG000|Overall Study|Protocol Deviation|1|||
23611739|NCT00670449|65966844|FG001|Overall Study|Protocol Deviation|2|||
23611740|NCT00670449|65966845|FG002|Overall Study|Protocol Deviation|0|||
23611741|NCT00670449|65966846|FG003|Overall Study|Protocol Deviation|1|||
23611742|NCT00670449|65966843|FG000|Overall Study|Administrative Problems|0|||
23418176|NCT01257230|65277198|FG000|Overall Study|Lack of Efficacy|0|||
23418177|NCT01257230|65277199|FG001|Overall Study|Lack of Efficacy|1|||
23418178|NCT01257230|65277200|FG002|Overall Study|Lack of Efficacy|0|||
23418179|NCT01257230|65277198|FG000|Overall Study|Protocol Violation|3|||
23418180|NCT01257230|65277199|FG001|Overall Study|Protocol Violation|0|||
23418181|NCT01257230|65277200|FG002|Overall Study|Protocol Violation|1|||
23418182|NCT01257230|65277198|FG000|Overall Study|Withdrawal by Subject|0|||
23418183|NCT01257230|65277199|FG001|Overall Study|Withdrawal by Subject|4|||
23418184|NCT01257230|65277200|FG002|Overall Study|Withdrawal by Subject|1|||
23418185|NCT01257230|65277198|FG000|Overall Study|Other reason not defined above|1|||
23418186|NCT01257230|65277199|FG001|Overall Study|Other reason not defined above|5|||
23418187|NCT01257230|65277200|FG002|Overall Study|Other reason not defined above|3|||
23418188|NCT00459875|65277201|FG000|Overall Study|Ineligible participant|1|||
23418189|NCT00459875|65277201|FG000|Overall Study|Adverse Event|2|||
23418190|NCT02589665|65277202|FG000|Induction Period|Did not receive drug|0|||
23418191|NCT02589665|65277203|FG001|Induction Period|Did not receive drug|0|||
23418192|NCT02589665|65277204|FG002|Induction Period|Did not receive drug|0|||
23418193|NCT02589665|65277205|FG003|Induction Period|Did not receive drug|1|||
23526952|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23611743|NCT00670449|65966844|FG001|Overall Study|Administrative Problems|2|||
23611744|NCT00670449|65966845|FG002|Overall Study|Administrative Problems|0|||
23611745|NCT00670449|65966846|FG003|Overall Study|Administrative Problems|1|||
23611746|NCT00670449|65966843|FG000|Overall Study|Subject Withdrew Consent|0|||
23418194|NCT02589665|65277206|FG004|Induction Period|Did not receive drug|0|||
23418195|NCT02589665|65277207|FG005|Induction Period|Did not receive drug|0|||
23418196|NCT02589665|65277208|FG006|Induction Period|Did not receive drug|0|||
23418197|NCT02589665|65277209|FG007|Induction Period|Did not receive drug|0|||
23175808|NCT00560755|64386565|FG000|Overall Study|Lost to Follow-up|9|||
23418198|NCT02589665|65277210|FG008|Induction Period|Did not receive drug|0|||
23526953|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526954|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526955|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526956|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526957|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526958|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526959|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
23526960|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526961|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
23526962|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526963|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526964|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526965|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526966|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526967|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526968|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526969|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526970|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526971|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526972|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526973|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526974|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526975|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526976|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526977|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526978|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526979|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526980|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526981|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526982|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526983|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
23526984|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
23526985|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
23526986|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
23526987|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
23526988|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526989|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526990|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526991|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526992|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526993|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526994|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526995|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526996|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526997|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526998|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23526999|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527000|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527001|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527002|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527003|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527004|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527005|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527006|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527007|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
23527008|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
23527009|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
23527010|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
23527011|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
23527012|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527013|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527014|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527015|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527016|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527017|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527018|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527019|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527020|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527021|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527022|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527023|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527024|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23308842|NCT00593736|64877726|FG003|Screening Period and Placebo Run-in|Various|25|||
23308843|NCT00593736|64877723|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
23308844|NCT00593736|64877724|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
23308845|NCT00593736|64877725|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
23308846|NCT00593736|64877726|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
23527025|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527026|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527027|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527028|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527029|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527030|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527031|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
23527032|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527033|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
23527034|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527035|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
23527036|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527037|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527038|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527039|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527040|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527041|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527042|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527043|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527044|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527045|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527046|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527047|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527048|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527049|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527050|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527051|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527052|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527053|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527054|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527055|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
23527056|NCT02346240|65669183|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527057|NCT02346240|65669184|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527058|NCT02346240|65669185|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
23527059|NCT02346240|65669186|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527060|NCT02346240|65669187|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527061|NCT02346240|65669188|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527062|NCT02346240|65669189|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527063|NCT02346240|65669190|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527064|NCT02346240|65669191|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527065|NCT02346240|65669192|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527066|NCT02346240|65669193|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527067|NCT02346240|65669194|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527068|NCT02346240|65669195|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527069|NCT02346240|65669196|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527070|NCT02346240|65669197|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527071|NCT02346240|65669198|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527072|NCT02346240|65669199|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527073|NCT02346240|65669200|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527074|NCT02346240|65669201|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23308847|NCT00593736|64877723|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
23527075|NCT02346240|65669202|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527076|NCT02346240|65669203|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527077|NCT02346240|65669204|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527078|NCT02346240|65669205|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527079|NCT02346240|65669206|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
23527080|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527081|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527082|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527083|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527084|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527085|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527086|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527087|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23527088|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
23527089|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527090|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527091|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527092|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527093|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23527094|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
23527095|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23527096|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
23527097|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527098|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527099|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527100|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527101|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527102|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527103|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23527104|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527105|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527106|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527107|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23206278|NCT01658579|64494844|FG003|Treatment Period A|Other|1|||
23206279|NCT01658579|64494841|FG000|Treatment Period A|Adverse Event|1|||
23206280|NCT01658579|64494842|FG001|Treatment Period A|Adverse Event|0|||
23527108|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527109|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23206281|NCT01658579|64494843|FG002|Treatment Period A|Adverse Event|0|||
23206282|NCT01658579|64494844|FG003|Treatment Period A|Adverse Event|0|||
23206283|NCT01658579|64494841|FG000|Treatment Period B|Other|0|||
23527110|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527111|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527112|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527113|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527114|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527115|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527116|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527117|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
23527118|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527119|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
23527120|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527121|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527122|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527123|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527124|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527125|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527126|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527127|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23527128|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527129|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527130|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527131|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527132|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527133|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527134|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527135|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527136|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527137|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527138|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527139|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527140|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527141|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527142|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
23527143|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527144|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527145|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527146|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527147|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527148|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527149|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527150|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527151|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23527152|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527153|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527154|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527155|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527156|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527157|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527158|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527159|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527160|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527161|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527162|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527163|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
23527164|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23611747|NCT00670449|65966844|FG001|Overall Study|Subject Withdrew Consent|2|||
23611748|NCT00670449|65966845|FG002|Overall Study|Subject Withdrew Consent|0|||
23611749|NCT00670449|65966846|FG003|Overall Study|Subject Withdrew Consent|1|||
23206284|NCT01658579|64494842|FG001|Treatment Period B|Other|0|||
23206285|NCT01658579|64494843|FG002|Treatment Period B|Other|0|||
23206286|NCT01658579|64494844|FG003|Treatment Period B|Other|1|||
23206287|NCT02559713|64494849|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
23206288|NCT00579501|64494851|FG000|Overall Study|Death|1|||
23527165|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
23611750|NCT00670449|65966843|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
23206289|NCT00579501|64494851|FG000|Overall Study|End of neoadjuvant therapy|25|||
23611751|NCT00670449|65966844|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23611752|NCT00670449|65966845|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
23611753|NCT00670449|65966846|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23611754|NCT00670449|65966843|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
23611755|NCT00670449|65966844|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
23611756|NCT00670449|65966845|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
23611757|NCT00670449|65966846|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
23611758|NCT00379210|65966847|FG000|Overall Study|Withdrawal by Subject|10|||
23611759|NCT00379210|65966848|FG001|Overall Study|Withdrawal by Subject|7|||
23527166|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
23527167|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
23527168|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23527169|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527170|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527171|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527172|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527173|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527174|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527175|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23527176|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527177|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527178|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527179|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527180|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527181|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527182|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527183|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527184|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527185|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527186|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527187|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527188|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527189|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
23527190|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
23527191|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
23527192|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
23527193|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527194|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527195|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527196|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527197|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527198|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527199|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23527200|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527201|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527202|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527203|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527204|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527205|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527206|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
23527207|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527208|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527209|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527210|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527211|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527212|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527213|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527214|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527215|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527216|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527217|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23611760|NCT01375777|65966850|FG000|Overall Study|Withdrawal by Subject|0|||
23611761|NCT01375777|65966851|FG001|Overall Study|Withdrawal by Subject|2|||
23527218|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527219|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527220|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527221|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527222|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527223|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
23527224|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527225|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527226|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527227|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527228|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527229|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527230|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527231|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527232|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
23527233|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527234|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23206290|NCT00579501|64494851|FG000|Overall Study|toxicity|1|||
23527235|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
23527236|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527237|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
23527238|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
23527239|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527240|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527241|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527242|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527243|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527244|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527245|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527246|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527247|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
23527248|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527249|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527250|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527251|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527252|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527253|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527254|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527255|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527256|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527257|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
23527258|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527259|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527260|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23611762|NCT01375777|65966852|FG002|Overall Study|Withdrawal by Subject|1|||
23611763|NCT01375777|65966853|FG003|Overall Study|Withdrawal by Subject|0|||
23611764|NCT01375777|65966854|FG004|Overall Study|Withdrawal by Subject|1|||
23611765|NCT01375777|65966855|FG005|Overall Study|Withdrawal by Subject|1|||
23611766|NCT01375777|65966856|FG006|Overall Study|Withdrawal by Subject|1|||
23611767|NCT01375777|65966857|FG007|Overall Study|Withdrawal by Subject|2|||
23611768|NCT01375777|65966858|FG008|Overall Study|Withdrawal by Subject|1|||
23611769|NCT01375777|65966850|FG000|Overall Study|Lost to Follow-up|1|||
23611770|NCT01375777|65966851|FG001|Overall Study|Lost to Follow-up|0|||
23611771|NCT01375777|65966852|FG002|Overall Study|Lost to Follow-up|0|||
23611772|NCT01375777|65966853|FG003|Overall Study|Lost to Follow-up|0|||
23611773|NCT01375777|65966854|FG004|Overall Study|Lost to Follow-up|0|||
23611774|NCT01375777|65966855|FG005|Overall Study|Lost to Follow-up|0|||
23611775|NCT01375777|65966856|FG006|Overall Study|Lost to Follow-up|1|||
23611776|NCT01375777|65966857|FG007|Overall Study|Lost to Follow-up|0|||
23611777|NCT01375777|65966858|FG008|Overall Study|Lost to Follow-up|0|||
23611778|NCT01375777|65966850|FG000|Overall Study|Other|1|||
23611779|NCT01375777|65966851|FG001|Overall Study|Other|1|||
23611780|NCT01375777|65966852|FG002|Overall Study|Other|0|||
23611781|NCT01375777|65966853|FG003|Overall Study|Other|0|||
23611782|NCT01375777|65966854|FG004|Overall Study|Other|0|||
23611783|NCT01375777|65966855|FG005|Overall Study|Other|0|||
23611784|NCT01375777|65966856|FG006|Overall Study|Other|0|||
23611785|NCT01375777|65966857|FG007|Overall Study|Other|0|||
23611786|NCT01375777|65966858|FG008|Overall Study|Other|1|||
23611787|NCT04783389|65966859|FG000|Overall Study|Withdrawal by Subject|2|||
23611788|NCT04783389|65966860|FG001|Overall Study|Withdrawal by Subject|0|||
23611789|NCT04783389|65966861|FG002|Overall Study|Withdrawal by Subject|0|||
23611790|NCT04783389|65966859|FG000|Overall Study|Termination of Study by Sponsor|10|||
23611791|NCT04783389|65966860|FG001|Overall Study|Termination of Study by Sponsor|12|||
23611792|NCT04783389|65966861|FG002|Overall Study|Termination of Study by Sponsor|14|||
23611793|NCT00274287|65966867|FG000|Overall Study|Withdrawal by Subject|1|||
23527261|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527262|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527263|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527264|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527265|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527266|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527267|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527268|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527269|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527270|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527271|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
23527272|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527273|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527274|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527275|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527276|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527277|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527278|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527279|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527280|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527281|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527282|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
23527283|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527284|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527285|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23611794|NCT00274287|65966867|FG000|Overall Study|subject non-compliance|1|||
23611795|NCT03694210|65966876|FG000|Overall Study|Death|1|||
23611796|NCT03694210|65966876|FG000|Overall Study|Screen Failure|7|||
23611797|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
23611798|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
23611799|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
23611800|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
23611801|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
23611802|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
23611803|NCT03557307|65966877|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
23611804|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
23611805|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Death|3|||
23611806|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
23611807|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
23611808|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
23611809|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
23611810|NCT03557307|65966877|FG000|Period 2: Maintenance Phase|other|3|||
23611811|NCT04421456|65966878|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
23611812|NCT04421456|65966879|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
23611813|NCT04421456|65966880|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
23611814|NCT04421456|65966878|FG000|Randomized Treatment Period|Adverse Event|0|||
23611815|NCT04421456|65966879|FG001|Randomized Treatment Period|Adverse Event|1|||
23611816|NCT04421456|65966880|FG002|Randomized Treatment Period|Adverse Event|0|||
23611817|NCT04421456|65966878|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
23611818|NCT04421456|65966879|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
23611819|NCT04421456|65966880|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
23611820|NCT04421456|65966878|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
23611821|NCT04421456|65966879|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
23611822|NCT04421456|65966880|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
23611823|NCT04421456|65966878|FG000|Randomized Treatment Period|Participant non-compliance|1|||
23611824|NCT04421456|65966879|FG001|Randomized Treatment Period|Participant non-compliance|1|||
23611825|NCT04421456|65966880|FG002|Randomized Treatment Period|Participant non-compliance|2|||
23611826|NCT04421456|65966878|FG000|Randomized Treatment Period|Other|0|||
23611827|NCT04421456|65966879|FG001|Randomized Treatment Period|Other|1|||
23611828|NCT04421456|65966880|FG002|Randomized Treatment Period|Other|3|||
23527286|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527287|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527288|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527289|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527290|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527291|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527292|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527293|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527294|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527295|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
23527296|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527297|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527298|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527299|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527300|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527301|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527302|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527303|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527304|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527305|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527306|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527307|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527308|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527309|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527310|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
23527311|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527312|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527313|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527314|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527315|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527316|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527317|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527318|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527319|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
23527320|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527321|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527322|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23611829|NCT04271254|65966881|FG000|Overall Study|Withdrawal by Subject|3|||
23611830|NCT01123356|65966882|FG000|Overall Study|Adverse Event|2|||
23527323|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527324|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527325|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527326|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527327|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527328|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527329|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527330|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527331|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527332|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527333|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527334|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
23527335|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527336|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527337|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527338|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527339|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527340|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527341|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527342|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527343|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
23527344|NCT02346240|65669183|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527345|NCT02346240|65669184|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527346|NCT02346240|65669185|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527347|NCT02346240|65669186|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527348|NCT02346240|65669187|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527349|NCT02346240|65669188|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527350|NCT02346240|65669189|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527351|NCT02346240|65669190|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527352|NCT02346240|65669191|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527353|NCT02346240|65669192|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527354|NCT02346240|65669193|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527355|NCT02346240|65669194|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527356|NCT02346240|65669195|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527357|NCT02346240|65669196|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527358|NCT02346240|65669197|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
23527359|NCT02346240|65669198|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527360|NCT02346240|65669199|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527361|NCT02346240|65669200|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527362|NCT02346240|65669201|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527363|NCT02346240|65669202|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527364|NCT02346240|65669203|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527365|NCT02346240|65669204|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527366|NCT02346240|65669205|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527367|NCT02346240|65669206|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
23527368|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527369|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527370|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527371|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527372|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527373|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527374|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527375|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527376|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527377|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527378|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527379|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23418199|NCT02589665|65277211|FG009|Induction Period|Did not receive drug|0|||
23418200|NCT02589665|65277202|FG000|Induction Period|Adverse Event|3|||
23418201|NCT02589665|65277203|FG001|Induction Period|Adverse Event|0|||
23611831|NCT01123356|65966882|FG000|Overall Study|Lack of Efficacy|4|||
23611832|NCT01123356|65966882|FG000|Overall Study|Withdrawal by Subject|1|||
23611833|NCT04474691|65966883|FG000|Overall Study|Withdrawal by Subject|9|||
23611834|NCT02291861|65966886|FG000|Overall Study|Adverse Event|2|||
23611835|NCT02291861|65966887|FG001|Overall Study|Adverse Event|4|||
23611836|NCT02291861|65966888|FG002|Overall Study|Adverse Event|1|||
23611837|NCT02291861|65966889|FG003|Overall Study|Adverse Event|2|||
23611838|NCT02291861|65966886|FG000|Overall Study|Death|0|||
23611839|NCT02291861|65966887|FG001|Overall Study|Death|0|||
23611840|NCT02291861|65966888|FG002|Overall Study|Death|1|||
23611841|NCT02291861|65966889|FG003|Overall Study|Death|1|||
23611842|NCT02291861|65966886|FG000|Overall Study|Protocol Violation|1|||
23611843|NCT02291861|65966887|FG001|Overall Study|Protocol Violation|0|||
23611844|NCT02291861|65966888|FG002|Overall Study|Protocol Violation|0|||
23611845|NCT02291861|65966889|FG003|Overall Study|Protocol Violation|1|||
23611846|NCT02291861|65966886|FG000|Overall Study|Withdrawal by Subject|1|||
23611847|NCT02291861|65966887|FG001|Overall Study|Withdrawal by Subject|2|||
23611848|NCT02291861|65966888|FG002|Overall Study|Withdrawal by Subject|1|||
23611849|NCT02291861|65966889|FG003|Overall Study|Withdrawal by Subject|4|||
23611850|NCT02291861|65966886|FG000|Overall Study|Noncompliance|1|||
23611851|NCT02291861|65966887|FG001|Overall Study|Noncompliance|1|||
23611852|NCT02291861|65966888|FG002|Overall Study|Noncompliance|2|||
23611853|NCT02291861|65966889|FG003|Overall Study|Noncompliance|1|||
23611854|NCT02291861|65966886|FG000|Overall Study|Lost to Follow-up|2|||
23611855|NCT02291861|65966887|FG001|Overall Study|Lost to Follow-up|1|||
23611856|NCT02291861|65966888|FG002|Overall Study|Lost to Follow-up|4|||
23611857|NCT02291861|65966889|FG003|Overall Study|Lost to Follow-up|0|||
23611858|NCT02291861|65966886|FG000|Overall Study|Other|0|||
23611859|NCT02291861|65966887|FG001|Overall Study|Other|0|||
23611860|NCT02291861|65966888|FG002|Overall Study|Other|0|||
23611861|NCT02291861|65966889|FG003|Overall Study|Other|1|||
23611862|NCT02942771|65966892|FG000|Overall Study|Adverse Event|1|||
23611863|NCT02942771|65966893|FG001|Overall Study|Adverse Event|0|||
23611864|NCT02942771|65966894|FG002|Overall Study|Adverse Event|0|||
23611865|NCT02942771|65966895|FG003|Overall Study|Adverse Event|0|||
23611866|NCT02942771|65966896|FG004|Overall Study|Adverse Event|2|||
23611867|NCT02942771|65966892|FG000|Overall Study|Lost to Follow-up|1|||
23611868|NCT02942771|65966893|FG001|Overall Study|Lost to Follow-up|0|||
23611869|NCT02942771|65966894|FG002|Overall Study|Lost to Follow-up|0|||
23611870|NCT02942771|65966895|FG003|Overall Study|Lost to Follow-up|0|||
23611871|NCT02942771|65966896|FG004|Overall Study|Lost to Follow-up|0|||
23206291|NCT00579501|64494851|FG000|Overall Study|Secondary lesion|1|||
23206292|NCT00579501|64494851|FG000|Overall Study|Radiation therapy before surgery|1|||
23206293|NCT04570657|64494852|FG000|Overall Study|Adverse Event|0|||
23206294|NCT04570657|64494853|FG001|Overall Study|Adverse Event|0|||
23611872|NCT02942771|65966892|FG000|Overall Study|Withdrawal by Subject|1|||
23611873|NCT02942771|65966893|FG001|Overall Study|Withdrawal by Subject|0|||
23611874|NCT02942771|65966894|FG002|Overall Study|Withdrawal by Subject|0|||
23611875|NCT02942771|65966895|FG003|Overall Study|Withdrawal by Subject|0|||
23611876|NCT02942771|65966896|FG004|Overall Study|Withdrawal by Subject|2|||
23206295|NCT04570657|64494854|FG002|Overall Study|Adverse Event|1|||
23206296|NCT04570657|64494852|FG000|Overall Study|Lost to Follow-up|0|||
23206297|NCT04570657|64494853|FG001|Overall Study|Lost to Follow-up|0|||
23611877|NCT00848198|65966897|FG000|Overall Study|Incomplete Case Report Forms|15|||
23611878|NCT00472082|65966899|FG000|Overall Study|Study prematurely terminated|5|||
23611879|NCT03672188|65966900|FG000|Overall Study|Withdrawal by Subject|0|||
23611880|NCT03672188|65966901|FG001|Overall Study|Withdrawal by Subject|0|||
23611881|NCT03672188|65966902|FG002|Overall Study|Withdrawal by Subject|0|||
23611882|NCT03672188|65966903|FG003|Overall Study|Withdrawal by Subject|3|||
23611883|NCT03672188|65966904|FG004|Overall Study|Withdrawal by Subject|0|||
23611884|NCT03672188|65966905|FG005|Overall Study|Withdrawal by Subject|0|||
23611885|NCT03672188|65966906|FG006|Overall Study|Withdrawal by Subject|0|||
23527380|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527381|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527382|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527383|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527384|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
23527385|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
23527386|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
23527387|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
23527388|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
23527389|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
23527390|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
23527391|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
23527392|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527393|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527394|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527395|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527396|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527397|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527398|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527399|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527400|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527401|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527402|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527403|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527404|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527405|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527406|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527407|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527408|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527409|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527410|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
23527411|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
23527412|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527413|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
23527414|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527415|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
23527416|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527417|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527418|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527419|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527420|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527421|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527422|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527423|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527424|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527425|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527426|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527427|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23611886|NCT03672188|65966907|FG007|Overall Study|Withdrawal by Subject|0|||
23611887|NCT03672188|65966908|FG008|Overall Study|Withdrawal by Subject|0|||
23611888|NCT03672188|65966909|FG009|Overall Study|Withdrawal by Subject|0|||
23175809|NCT00560755|64386565|FG000|Overall Study|Adverse Event|8|||
23611889|NCT03672188|65966910|FG010|Overall Study|Withdrawal by Subject|0|||
23611890|NCT03672188|65966911|FG011|Overall Study|Withdrawal by Subject|0|||
23611891|NCT03672188|65966912|FG012|Overall Study|Withdrawal by Subject|0|||
23527428|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527429|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527430|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527431|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527432|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23611892|NCT03672188|65966913|FG013|Overall Study|Withdrawal by Subject|0|||
23611893|NCT03672188|65966914|FG014|Overall Study|Withdrawal by Subject|0|||
23611894|NCT03672188|65966900|FG000|Overall Study|Death|0|||
23611895|NCT03672188|65966901|FG001|Overall Study|Death|0|||
23611896|NCT03672188|65966902|FG002|Overall Study|Death|0|||
23611897|NCT03672188|65966903|FG003|Overall Study|Death|0|||
23611898|NCT03672188|65966904|FG004|Overall Study|Death|0|||
23611899|NCT03672188|65966905|FG005|Overall Study|Death|0|||
23611900|NCT03672188|65966906|FG006|Overall Study|Death|0|||
23611901|NCT03672188|65966907|FG007|Overall Study|Death|0|||
23611902|NCT03672188|65966908|FG008|Overall Study|Death|0|||
23611903|NCT03672188|65966909|FG009|Overall Study|Death|0|||
23611904|NCT03672188|65966910|FG010|Overall Study|Death|0|||
23611905|NCT03672188|65966911|FG011|Overall Study|Death|0|||
23611906|NCT03672188|65966912|FG012|Overall Study|Death|1|||
23611907|NCT03672188|65966913|FG013|Overall Study|Death|0|||
23527433|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23611908|NCT03672188|65966914|FG014|Overall Study|Death|0|||
23611909|NCT03672188|65966900|FG000|Overall Study|Lost to Follow-up|0|||
23611910|NCT03672188|65966901|FG001|Overall Study|Lost to Follow-up|0|||
23611911|NCT03672188|65966902|FG002|Overall Study|Lost to Follow-up|1|||
23611912|NCT03672188|65966903|FG003|Overall Study|Lost to Follow-up|0|||
23611913|NCT03672188|65966904|FG004|Overall Study|Lost to Follow-up|0|||
23611914|NCT03672188|65966905|FG005|Overall Study|Lost to Follow-up|0|||
23611915|NCT03672188|65966906|FG006|Overall Study|Lost to Follow-up|0|||
23611916|NCT03672188|65966907|FG007|Overall Study|Lost to Follow-up|0|||
23611917|NCT03672188|65966908|FG008|Overall Study|Lost to Follow-up|0|||
23611918|NCT03672188|65966909|FG009|Overall Study|Lost to Follow-up|0|||
23611919|NCT03672188|65966910|FG010|Overall Study|Lost to Follow-up|0|||
23611920|NCT03672188|65966911|FG011|Overall Study|Lost to Follow-up|0|||
23611921|NCT03672188|65966912|FG012|Overall Study|Lost to Follow-up|0|||
23527434|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23527435|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527436|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527437|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23527438|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527439|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23527440|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527441|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527442|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527443|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527444|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527445|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527446|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527447|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527448|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527449|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527450|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527451|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527452|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527453|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527454|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527455|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527456|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23611922|NCT03672188|65966913|FG013|Overall Study|Lost to Follow-up|0|||
23611923|NCT03672188|65966914|FG014|Overall Study|Lost to Follow-up|0|||
23206298|NCT04570657|64494854|FG002|Overall Study|Lost to Follow-up|1|||
23308848|NCT00593736|64877724|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
23611924|NCT01807234|65966919|FG000|Overall Study|Lost to Follow-up|2|||
23611925|NCT01807234|65966920|FG001|Overall Study|Lost to Follow-up|5|||
23611926|NCT01807234|65966921|FG002|Overall Study|Lost to Follow-up|1|||
23611927|NCT01807234|65966922|FG003|Overall Study|Lost to Follow-up|1|||
23611928|NCT01807234|65966923|FG004|Overall Study|Lost to Follow-up|1|||
23611929|NCT01807234|65966924|FG005|Overall Study|Lost to Follow-up|2|||
23308849|NCT00593736|64877725|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
23418202|NCT02589665|65277204|FG002|Induction Period|Adverse Event|2|||
23418203|NCT02589665|65277205|FG003|Induction Period|Adverse Event|2|||
23418204|NCT02589665|65277206|FG004|Induction Period|Adverse Event|0|||
23527457|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527458|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527459|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527460|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23418205|NCT02589665|65277207|FG005|Induction Period|Adverse Event|0|||
23418206|NCT02589665|65277208|FG006|Induction Period|Adverse Event|0|||
23418207|NCT02589665|65277209|FG007|Induction Period|Adverse Event|0|||
23418208|NCT02589665|65277210|FG008|Induction Period|Adverse Event|0|||
23418209|NCT02589665|65277211|FG009|Induction Period|Adverse Event|0|||
23418210|NCT02589665|65277202|FG000|Induction Period|Withdrawal by Subject|0|||
23418211|NCT02589665|65277203|FG001|Induction Period|Withdrawal by Subject|1|||
23418212|NCT02589665|65277204|FG002|Induction Period|Withdrawal by Subject|0|||
23418213|NCT02589665|65277205|FG003|Induction Period|Withdrawal by Subject|1|||
23418214|NCT02589665|65277206|FG004|Induction Period|Withdrawal by Subject|0|||
23418215|NCT02589665|65277207|FG005|Induction Period|Withdrawal by Subject|0|||
23418216|NCT02589665|65277208|FG006|Induction Period|Withdrawal by Subject|0|||
23418217|NCT02589665|65277209|FG007|Induction Period|Withdrawal by Subject|0|||
23418218|NCT02589665|65277210|FG008|Induction Period|Withdrawal by Subject|0|||
23418219|NCT02589665|65277211|FG009|Induction Period|Withdrawal by Subject|0|||
23418220|NCT02589665|65277202|FG000|Induction Period|Protocol Violation|0|||
23418221|NCT02589665|65277203|FG001|Induction Period|Protocol Violation|1|||
23418222|NCT02589665|65277204|FG002|Induction Period|Protocol Violation|0|||
23418223|NCT02589665|65277205|FG003|Induction Period|Protocol Violation|0|||
23418224|NCT02589665|65277206|FG004|Induction Period|Protocol Violation|0|||
23418225|NCT02589665|65277207|FG005|Induction Period|Protocol Violation|0|||
23418226|NCT02589665|65277208|FG006|Induction Period|Protocol Violation|0|||
23418227|NCT02589665|65277209|FG007|Induction Period|Protocol Violation|0|||
23418228|NCT02589665|65277210|FG008|Induction Period|Protocol Violation|0|||
23418229|NCT02589665|65277211|FG009|Induction Period|Protocol Violation|0|||
23418230|NCT02589665|65277202|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418231|NCT02589665|65277203|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418232|NCT02589665|65277204|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418233|NCT02589665|65277205|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418234|NCT02589665|65277206|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
23418235|NCT02589665|65277207|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
23527461|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
23527462|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527463|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
23527464|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527465|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527466|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527467|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527468|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527469|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23418236|NCT02589665|65277208|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
23418237|NCT02589665|65277209|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418238|NCT02589665|65277210|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418239|NCT02589665|65277211|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418240|NCT02589665|65277202|FG000|Maintenance Period|Withdrawal by Subject|0|||
23418241|NCT02589665|65277203|FG001|Maintenance Period|Withdrawal by Subject|0|||
23418242|NCT02589665|65277204|FG002|Maintenance Period|Withdrawal by Subject|0|||
23418243|NCT02589665|65277205|FG003|Maintenance Period|Withdrawal by Subject|0|||
23418244|NCT02589665|65277206|FG004|Maintenance Period|Withdrawal by Subject|4|||
23527470|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23418245|NCT02589665|65277207|FG005|Maintenance Period|Withdrawal by Subject|2|||
23418246|NCT02589665|65277208|FG006|Maintenance Period|Withdrawal by Subject|4|||
23418247|NCT02589665|65277209|FG007|Maintenance Period|Withdrawal by Subject|0|||
23418248|NCT02589665|65277210|FG008|Maintenance Period|Withdrawal by Subject|0|||
23418249|NCT02589665|65277211|FG009|Maintenance Period|Withdrawal by Subject|0|||
23418250|NCT02589665|65277202|FG000|Maintenance Period|Lack of Efficacy|0|||
23418251|NCT02589665|65277203|FG001|Maintenance Period|Lack of Efficacy|0|||
23527471|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527472|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527473|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527474|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527475|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527476|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527477|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527478|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527479|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527480|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527481|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
23527482|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
23527483|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
23527484|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23527485|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
23527486|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
23527487|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
23527488|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527489|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527490|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527491|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527492|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527493|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527494|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527495|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527496|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527497|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527498|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527499|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527500|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527501|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527502|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527503|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527504|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527505|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527506|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
23527507|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
23527508|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23527509|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
23527510|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
23527511|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
23527512|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527513|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527514|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527515|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527516|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527517|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527518|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527519|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527520|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527521|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527522|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527523|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23418252|NCT02589665|65277204|FG002|Maintenance Period|Lack of Efficacy|0|||
23611930|NCT01807234|65966919|FG000|Overall Study|Withdrawal by Subject|3|||
23527524|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527525|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527526|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527527|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527528|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527529|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527530|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
23527531|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527532|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
23527533|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
23527534|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
23611931|NCT01807234|65966920|FG001|Overall Study|Withdrawal by Subject|1|||
23611932|NCT01807234|65966921|FG002|Overall Study|Withdrawal by Subject|1|||
23611933|NCT01807234|65966922|FG003|Overall Study|Withdrawal by Subject|1|||
23611934|NCT01807234|65966923|FG004|Overall Study|Withdrawal by Subject|2|||
23611935|NCT01807234|65966924|FG005|Overall Study|Withdrawal by Subject|1|||
23611936|NCT01807234|65966919|FG000|Overall Study|Lack of Efficacy|0|||
23611937|NCT01807234|65966920|FG001|Overall Study|Lack of Efficacy|0|||
23611938|NCT01807234|65966921|FG002|Overall Study|Lack of Efficacy|0|||
23611939|NCT01807234|65966922|FG003|Overall Study|Lack of Efficacy|0|||
23611940|NCT01807234|65966923|FG004|Overall Study|Lack of Efficacy|1|||
23611941|NCT01807234|65966924|FG005|Overall Study|Lack of Efficacy|1|||
23611942|NCT05203822|65966925|FG000|Overall Study|Adverse Event|1|||
23611943|NCT05203822|65966925|FG000|Overall Study|Withdrawal by Subject|1|||
23611944|NCT03976102|65966926|FG000|Overall Study|Withdrawal by Subject|4|||
23611945|NCT03976102|65966927|FG001|Overall Study|Withdrawal by Subject|4|||
23611946|NCT03976102|65966926|FG000|Overall Study|Adverse Event|2|||
23611947|NCT03976102|65966927|FG001|Overall Study|Adverse Event|4|||
23611948|NCT03976102|65966926|FG000|Overall Study|Not related to Covid-19|9|||
23611949|NCT03976102|65966927|FG001|Overall Study|Not related to Covid-19|13|||
23611950|NCT03976102|65966926|FG000|Overall Study|Lost to Follow-up|0|||
23611951|NCT03976102|65966927|FG001|Overall Study|Lost to Follow-up|2|||
23611952|NCT03976102|65966926|FG000|Overall Study|Death|3|||
23611953|NCT03976102|65966927|FG001|Overall Study|Death|2|||
23611954|NCT03976102|65966926|FG000|Overall Study|Physician Decision|1|||
23611955|NCT03976102|65966927|FG001|Overall Study|Physician Decision|1|||
23611956|NCT01075815|65966928|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
23611957|NCT01075815|65966929|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
23611958|NCT01075815|65966928|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
23611959|NCT01075815|65966929|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
23611960|NCT01075815|65966928|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
23611961|NCT01075815|65966929|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
23206299|NCT04570657|64494852|FG000|Overall Study|Physician Decision|0|||
23206300|NCT04570657|64494853|FG001|Overall Study|Physician Decision|1|||
23206301|NCT04570657|64494854|FG002|Overall Study|Physician Decision|0|||
23206302|NCT04570657|64494852|FG000|Overall Study|Withdrawal by Subject|1|||
23206303|NCT04570657|64494853|FG001|Overall Study|Withdrawal by Subject|2|||
23206304|NCT04570657|64494854|FG002|Overall Study|Withdrawal by Subject|2|||
23206305|NCT02622724|64494855|FG000|Overall Study|Death|51|||
23527535|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
23527536|NCT02346240|65669183|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527537|NCT02346240|65669184|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527538|NCT02346240|65669185|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527539|NCT02346240|65669186|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527540|NCT02346240|65669187|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527541|NCT02346240|65669188|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527542|NCT02346240|65669189|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527543|NCT02346240|65669190|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527544|NCT02346240|65669191|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527545|NCT02346240|65669192|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23611962|NCT01714947|65966930|FG000|Part B|Progressive Disease|3|||
23611963|NCT03394508|65966933|FG000|Overall Study|Protocol Violation|0|||
23611964|NCT03394508|65966934|FG001|Overall Study|Protocol Violation|3|||
23611965|NCT03394508|65966933|FG000|Overall Study|Lost to Follow-up|1|||
23206306|NCT02622724|64494856|FG001|Overall Study|Death|53|||
23206307|NCT02622724|64494855|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
23611966|NCT03394508|65966934|FG001|Overall Study|Lost to Follow-up|0|||
23611967|NCT00203502|65966938|FG000|Overall Study|Death|1|||
23611968|NCT00942188|65966939|FG000|Overall Study|Adverse Event|0|||
23611969|NCT00942188|65966940|FG001|Overall Study|Adverse Event|3|||
23611970|NCT00942188|65966941|FG002|Overall Study|Adverse Event|2|||
23527546|NCT02346240|65669193|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527547|NCT02346240|65669194|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23611971|NCT00942188|65966942|FG003|Overall Study|Adverse Event|0|||
23611972|NCT00942188|65966939|FG000|Overall Study|Lack of Efficacy|0|||
23611973|NCT00942188|65966940|FG001|Overall Study|Lack of Efficacy|0|||
23527548|NCT02346240|65669195|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527549|NCT02346240|65669196|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527550|NCT02346240|65669197|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527551|NCT02346240|65669198|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527552|NCT02346240|65669199|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527553|NCT02346240|65669200|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527554|NCT02346240|65669201|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
23527555|NCT02346240|65669202|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527556|NCT02346240|65669203|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527557|NCT02346240|65669204|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527558|NCT02346240|65669205|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527559|NCT02346240|65669206|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
23527560|NCT02777125|65669207|FG000|Overall Study|Consent form violation|14|||
23527561|NCT02777125|65669208|FG001|Overall Study|Consent form violation|12|||
23611974|NCT00942188|65966941|FG002|Overall Study|Lack of Efficacy|0|||
23611975|NCT00942188|65966942|FG003|Overall Study|Lack of Efficacy|1|||
23611976|NCT00942188|65966939|FG000|Overall Study|Protocol Violation|1|||
23611977|NCT00942188|65966940|FG001|Overall Study|Protocol Violation|1|||
23527562|NCT02777125|65669207|FG000|Overall Study|Assent form violation|21|||
23527563|NCT02777125|65669208|FG001|Overall Study|Assent form violation|23|||
23527564|NCT02777125|65669207|FG000|Overall Study|Protocol Violation|8|||
23527565|NCT02777125|65669208|FG001|Overall Study|Protocol Violation|12|||
23527566|NCT04999111|65669209|FG000|Overall Study|Lost to Follow-up|21|||
23527567|NCT04999111|65669210|FG001|Overall Study|Lost to Follow-up|16|||
23527568|NCT04999111|65669211|FG002|Overall Study|Lost to Follow-up|2|||
23527569|NCT04999111|65669212|FG003|Overall Study|Lost to Follow-up|26|||
23527570|NCT04999111|65669213|FG004|Overall Study|Lost to Follow-up|30|||
23527571|NCT04999111|65669214|FG005|Overall Study|Lost to Follow-up|6|||
23527572|NCT04999111|65669209|FG000|Overall Study|Physician Decision|1|||
23527573|NCT04999111|65669210|FG001|Overall Study|Physician Decision|3|||
23527574|NCT04999111|65669211|FG002|Overall Study|Physician Decision|0|||
23527575|NCT04999111|65669212|FG003|Overall Study|Physician Decision|1|||
23527576|NCT04999111|65669213|FG004|Overall Study|Physician Decision|2|||
23527577|NCT04999111|65669214|FG005|Overall Study|Physician Decision|0|||
23527578|NCT04999111|65669209|FG000|Overall Study|Withdrawal by Subject|23|||
23527579|NCT04999111|65669210|FG001|Overall Study|Withdrawal by Subject|29|||
23527580|NCT04999111|65669211|FG002|Overall Study|Withdrawal by Subject|15|||
23527581|NCT04999111|65669212|FG003|Overall Study|Withdrawal by Subject|30|||
23527582|NCT04999111|65669213|FG004|Overall Study|Withdrawal by Subject|35|||
23527583|NCT04999111|65669214|FG005|Overall Study|Withdrawal by Subject|10|||
23308850|NCT00593736|64877726|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
23308851|NCT00593736|64877723|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
23527584|NCT04999111|65669209|FG000|Overall Study|Other|6|||
23527585|NCT04999111|65669210|FG001|Overall Study|Other|6|||
23527586|NCT04999111|65669211|FG002|Overall Study|Other|3|||
23527587|NCT04999111|65669212|FG003|Overall Study|Other|8|||
23527588|NCT04999111|65669213|FG004|Overall Study|Other|8|||
23527589|NCT04999111|65669214|FG005|Overall Study|Other|5|||
23527590|NCT04999111|65669209|FG000|Overall Study|Non-compliance with study schedule|1|||
23527591|NCT04999111|65669210|FG001|Overall Study|Non-compliance with study schedule|0|||
23527592|NCT04999111|65669211|FG002|Overall Study|Non-compliance with study schedule|0|||
23527593|NCT04999111|65669212|FG003|Overall Study|Non-compliance with study schedule|1|||
23527594|NCT04999111|65669213|FG004|Overall Study|Non-compliance with study schedule|1|||
23527595|NCT04999111|65669214|FG005|Overall Study|Non-compliance with study schedule|1|||
23527596|NCT04999111|65669209|FG000|Overall Study|Randomized but not vaccinated|1|||
23527597|NCT04999111|65669210|FG001|Overall Study|Randomized but not vaccinated|2|||
23527598|NCT04999111|65669211|FG002|Overall Study|Randomized but not vaccinated|0|||
23527599|NCT04999111|65669212|FG003|Overall Study|Randomized but not vaccinated|3|||
23527600|NCT04999111|65669213|FG004|Overall Study|Randomized but not vaccinated|3|||
23527601|NCT04999111|65669214|FG005|Overall Study|Randomized but not vaccinated|0|||
23527602|NCT04999111|65669209|FG000|Overall Study|Adverse Event|1|||
23527603|NCT04999111|65669210|FG001|Overall Study|Adverse Event|1|||
23527604|NCT04999111|65669211|FG002|Overall Study|Adverse Event|0|||
23527605|NCT04999111|65669212|FG003|Overall Study|Adverse Event|0|||
23527606|NCT04999111|65669213|FG004|Overall Study|Adverse Event|0|||
23527607|NCT04999111|65669214|FG005|Overall Study|Adverse Event|0|||
23527608|NCT04999111|65669209|FG000|Overall Study|Initiated prohibited medication|0|||
23527609|NCT04999111|65669210|FG001|Overall Study|Initiated prohibited medication|0|||
23527610|NCT04999111|65669211|FG002|Overall Study|Initiated prohibited medication|0|||
23527611|NCT04999111|65669212|FG003|Overall Study|Initiated prohibited medication|0|||
23527612|NCT04999111|65669213|FG004|Overall Study|Initiated prohibited medication|1|||
23527613|NCT04999111|65669214|FG005|Overall Study|Initiated prohibited medication|0|||
23527614|NCT03027466|65669217|FG000|Overall Study|Opting out of the app|1869|||
23527615|NCT03027466|65669218|FG001|Overall Study|Opting out of the app|1819|||
23527616|NCT03027466|65669219|FG002|Overall Study|Opting out of the app|1743|||
23527617|NCT03027466|65669220|FG003|Overall Study|Opting out of the app|1821|||
23527618|NCT00145509|65669222|FG000|Overall Study|Adverse Event|10|||
23527619|NCT00145509|65669223|FG001|Overall Study|Adverse Event|3|||
23527620|NCT00145509|65669222|FG000|Overall Study|Lack of Efficacy|3|||
23527621|NCT00145509|65669223|FG001|Overall Study|Lack of Efficacy|1|||
23527622|NCT00145509|65669222|FG000|Overall Study|Lost to Follow-up|5|||
23527623|NCT00145509|65669223|FG001|Overall Study|Lost to Follow-up|9|||
23418253|NCT02589665|65277205|FG003|Maintenance Period|Lack of Efficacy|0|||
23418254|NCT02589665|65277206|FG004|Maintenance Period|Lack of Efficacy|2|||
23418255|NCT02589665|65277207|FG005|Maintenance Period|Lack of Efficacy|1|||
23418256|NCT02589665|65277208|FG006|Maintenance Period|Lack of Efficacy|0|||
23418257|NCT02589665|65277209|FG007|Maintenance Period|Lack of Efficacy|0|||
23418258|NCT02589665|65277210|FG008|Maintenance Period|Lack of Efficacy|0|||
23418259|NCT02589665|65277211|FG009|Maintenance Period|Lack of Efficacy|0|||
23418260|NCT02589665|65277202|FG000|Maintenance Period|Adverse Event|0|||
23418261|NCT02589665|65277203|FG001|Maintenance Period|Adverse Event|0|||
23418262|NCT02589665|65277204|FG002|Maintenance Period|Adverse Event|0|||
23418263|NCT02589665|65277205|FG003|Maintenance Period|Adverse Event|0|||
23418264|NCT02589665|65277206|FG004|Maintenance Period|Adverse Event|0|||
23418265|NCT02589665|65277207|FG005|Maintenance Period|Adverse Event|0|||
23418266|NCT02589665|65277208|FG006|Maintenance Period|Adverse Event|2|||
23418267|NCT02589665|65277209|FG007|Maintenance Period|Adverse Event|0|||
23418268|NCT02589665|65277210|FG008|Maintenance Period|Adverse Event|0|||
23418269|NCT02589665|65277211|FG009|Maintenance Period|Adverse Event|0|||
23418270|NCT02589665|65277202|FG000|Maintenance Period|Lost to Follow-up|0|||
23418271|NCT02589665|65277203|FG001|Maintenance Period|Lost to Follow-up|0|||
23418272|NCT02589665|65277204|FG002|Maintenance Period|Lost to Follow-up|0|||
23418273|NCT02589665|65277205|FG003|Maintenance Period|Lost to Follow-up|0|||
23418274|NCT02589665|65277206|FG004|Maintenance Period|Lost to Follow-up|0|||
23418275|NCT02589665|65277207|FG005|Maintenance Period|Lost to Follow-up|1|||
23418276|NCT02589665|65277208|FG006|Maintenance Period|Lost to Follow-up|0|||
23418277|NCT02589665|65277209|FG007|Maintenance Period|Lost to Follow-up|0|||
23418278|NCT02589665|65277210|FG008|Maintenance Period|Lost to Follow-up|0|||
23418279|NCT02589665|65277211|FG009|Maintenance Period|Lost to Follow-up|0|||
23418280|NCT02589665|65277202|FG000|Maintenance Period|Physician Decision|0|||
23418281|NCT02589665|65277203|FG001|Maintenance Period|Physician Decision|0|||
23418282|NCT02589665|65277204|FG002|Maintenance Period|Physician Decision|0|||
23418283|NCT02589665|65277205|FG003|Maintenance Period|Physician Decision|0|||
23418284|NCT02589665|65277206|FG004|Maintenance Period|Physician Decision|0|||
23418285|NCT02589665|65277207|FG005|Maintenance Period|Physician Decision|1|||
23418286|NCT02589665|65277208|FG006|Maintenance Period|Physician Decision|0|||
23418287|NCT02589665|65277209|FG007|Maintenance Period|Physician Decision|0|||
23418288|NCT02589665|65277210|FG008|Maintenance Period|Physician Decision|0|||
23418289|NCT02589665|65277211|FG009|Maintenance Period|Physician Decision|0|||
23418290|NCT02589665|65277202|FG000|Maintenance Period|Reason Not Collected|0|||
23418291|NCT02589665|65277203|FG001|Maintenance Period|Reason Not Collected|0|||
23418292|NCT02589665|65277204|FG002|Maintenance Period|Reason Not Collected|0|||
23418293|NCT02589665|65277205|FG003|Maintenance Period|Reason Not Collected|0|||
23418294|NCT02589665|65277206|FG004|Maintenance Period|Reason Not Collected|0|||
23418295|NCT02589665|65277207|FG005|Maintenance Period|Reason Not Collected|1|||
23418296|NCT02589665|65277208|FG006|Maintenance Period|Reason Not Collected|1|||
23418297|NCT02589665|65277209|FG007|Maintenance Period|Reason Not Collected|0|||
23418298|NCT02589665|65277210|FG008|Maintenance Period|Reason Not Collected|0|||
23418299|NCT02589665|65277211|FG009|Maintenance Period|Reason Not Collected|0|||
23418300|NCT02589665|65277202|FG000|Induction Extension Period|Adverse Event|0|||
23418301|NCT02589665|65277203|FG001|Induction Extension Period|Adverse Event|0|||
23418302|NCT02589665|65277204|FG002|Induction Extension Period|Adverse Event|0|||
23418303|NCT02589665|65277205|FG003|Induction Extension Period|Adverse Event|0|||
23418304|NCT02589665|65277206|FG004|Induction Extension Period|Adverse Event|0|||
23418305|NCT02589665|65277207|FG005|Induction Extension Period|Adverse Event|0|||
23418306|NCT02589665|65277208|FG006|Induction Extension Period|Adverse Event|0|||
23418307|NCT02589665|65277209|FG007|Induction Extension Period|Adverse Event|0|||
23418308|NCT02589665|65277210|FG008|Induction Extension Period|Adverse Event|4|||
23418309|NCT02589665|65277211|FG009|Induction Extension Period|Adverse Event|0|||
23418310|NCT02589665|65277202|FG000|Induction Extension Period|Lack of Efficacy|0|||
23418311|NCT02589665|65277203|FG001|Induction Extension Period|Lack of Efficacy|0|||
23418312|NCT02589665|65277204|FG002|Induction Extension Period|Lack of Efficacy|0|||
23418313|NCT02589665|65277205|FG003|Induction Extension Period|Lack of Efficacy|0|||
23418314|NCT02589665|65277206|FG004|Induction Extension Period|Lack of Efficacy|0|||
23418315|NCT02589665|65277207|FG005|Induction Extension Period|Lack of Efficacy|0|||
23418316|NCT02589665|65277208|FG006|Induction Extension Period|Lack of Efficacy|0|||
23418317|NCT02589665|65277209|FG007|Induction Extension Period|Lack of Efficacy|0|||
23418318|NCT02589665|65277210|FG008|Induction Extension Period|Lack of Efficacy|3|||
23418319|NCT02589665|65277211|FG009|Induction Extension Period|Lack of Efficacy|0|||
23418320|NCT02589665|65277202|FG000|Induction Extension Period|Withdrawal by Subject|0|||
23418321|NCT02589665|65277203|FG001|Induction Extension Period|Withdrawal by Subject|0|||
23418322|NCT02589665|65277204|FG002|Induction Extension Period|Withdrawal by Subject|0|||
23418323|NCT02589665|65277205|FG003|Induction Extension Period|Withdrawal by Subject|0|||
23418324|NCT02589665|65277206|FG004|Induction Extension Period|Withdrawal by Subject|0|||
23418325|NCT02589665|65277207|FG005|Induction Extension Period|Withdrawal by Subject|0|||
23418326|NCT02589665|65277208|FG006|Induction Extension Period|Withdrawal by Subject|0|||
23527624|NCT00145509|65669222|FG000|Overall Study|Withdrew Consent|2|||
23527625|NCT00145509|65669223|FG001|Overall Study|Withdrew Consent|7|||
23527626|NCT00145509|65669222|FG000|Overall Study|Reason not provided|2|||
23527627|NCT00145509|65669223|FG001|Overall Study|Reason not provided|1|||
23527628|NCT02296112|65669226|FG000|Overall Study|Disease progression|7|||
23527629|NCT02296112|65669226|FG000|Overall Study|Toxicity|1|||
23527630|NCT02296112|65669226|FG000|Overall Study|Began an alternate therapy|1|||
23527631|NCT01454934|65669227|FG000|Overall Study|Clinical progression|28|||
23527632|NCT01454934|65669228|FG001|Overall Study|Clinical progression|25|||
23527633|NCT01454934|65669227|FG000|Overall Study|Other|6|||
23527634|NCT01454934|65669228|FG001|Overall Study|Other|17|||
23527635|NCT01454934|65669227|FG000|Overall Study|Adverse Event|28|||
23527636|NCT01454934|65669228|FG001|Overall Study|Adverse Event|24|||
23527637|NCT01454934|65669227|FG000|Overall Study|Withdrawn consent|2|||
23527638|NCT01454934|65669228|FG001|Overall Study|Withdrawn consent|5|||
23527639|NCT01454934|65669227|FG000|Overall Study|Withdrawal by Subject|11|||
23527640|NCT01454934|65669228|FG001|Overall Study|Withdrawal by Subject|15|||
23527641|NCT01454934|65669227|FG000|Overall Study|Disease progression|194|||
23527642|NCT01454934|65669228|FG001|Overall Study|Disease progression|181|||
23527643|NCT01454934|65669227|FG000|Overall Study|Lost to Follow-up|0|||
23527644|NCT01454934|65669228|FG001|Overall Study|Lost to Follow-up|1|||
23527645|NCT01454934|65669227|FG000|Overall Study|Not treated|1|||
23527646|NCT01454934|65669228|FG001|Overall Study|Not treated|2|||
23527647|NCT00989833|65669230|FG000|Overall Study|Lost to Follow-up|0|||
23527648|NCT00989833|65669231|FG001|Overall Study|Lost to Follow-up|1|||
23527649|NCT00989833|65669232|FG002|Overall Study|Lost to Follow-up|0|||
23527650|NCT00989833|65669230|FG000|Overall Study|Protocol Violation|1|||
23527651|NCT00989833|65669231|FG001|Overall Study|Protocol Violation|2|||
23527652|NCT00989833|65669232|FG002|Overall Study|Protocol Violation|1|||
23527653|NCT00989833|65669230|FG000|Overall Study|Withdrawal by Subject|0|||
23611978|NCT00942188|65966941|FG002|Overall Study|Protocol Violation|0|||
23611979|NCT00942188|65966942|FG003|Overall Study|Protocol Violation|0|||
23611980|NCT00942188|65966939|FG000|Overall Study|Lost to Follow-up|2|||
23611981|NCT00942188|65966940|FG001|Overall Study|Lost to Follow-up|1|||
23611982|NCT00942188|65966941|FG002|Overall Study|Lost to Follow-up|2|||
23611983|NCT00942188|65966942|FG003|Overall Study|Lost to Follow-up|0|||
23611984|NCT00942188|65966939|FG000|Overall Study|Withdrawal by Subject|1|||
23527654|NCT00989833|65669231|FG001|Overall Study|Withdrawal by Subject|0|||
23527655|NCT00989833|65669232|FG002|Overall Study|Withdrawal by Subject|1|||
23611985|NCT00942188|65966940|FG001|Overall Study|Withdrawal by Subject|3|||
23206308|NCT02622724|64494856|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
23206309|NCT02622724|64494855|FG000|Overall Study|Early termination of study|38|||
23206310|NCT02622724|64494856|FG001|Overall Study|Early termination of study|43|||
23206311|NCT03136367|64494859|FG000|T1 Consultation|discontinued mistakenly included|2|||
23206312|NCT03136367|64494860|FG001|T1 Consultation|discontinued mistakenly included|6|||
23206313|NCT03136367|64494861|FG002|T1 Consultation|discontinued mistakenly included|1|||
23206314|NCT03136367|64494859|FG000|T1 Consultation|Discontinued other|0|||
23206315|NCT03136367|64494860|FG001|T1 Consultation|Discontinued other|1|||
23527656|NCT00989833|65669230|FG000|Overall Study|Incorrectly randomized|1|||
23527657|NCT00989833|65669231|FG001|Overall Study|Incorrectly randomized|0|||
23527658|NCT00989833|65669232|FG002|Overall Study|Incorrectly randomized|0|||
23527659|NCT01147653|65669233|FG000|Year 2|Withdrawal by Subject|2|||
23611986|NCT00942188|65966941|FG002|Overall Study|Withdrawal by Subject|4|||
23611987|NCT00942188|65966942|FG003|Overall Study|Withdrawal by Subject|2|||
23527660|NCT01147653|65669234|FG001|Year 2|Withdrawal by Subject|3|||
23527661|NCT02418468|65669235|FG000|Overall Study|Adverse Event|1|||
23527662|NCT02418468|65669236|FG001|Overall Study|Adverse Event|0|||
23611988|NCT00942188|65966939|FG000|Overall Study|Physician Decision|0|||
23308852|NCT00593736|64877724|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
23308853|NCT00593736|64877725|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
23308854|NCT00593736|64877726|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
23308855|NCT00593736|64877723|FG000|Treatment Period and Placebo Run-out|Various|1|||
23308856|NCT00593736|64877724|FG001|Treatment Period and Placebo Run-out|Various|1|||
23308857|NCT00593736|64877725|FG002|Treatment Period and Placebo Run-out|Various|1|||
23308858|NCT00593736|64877726|FG003|Treatment Period and Placebo Run-out|Various|0|||
23308859|NCT00565617|64877728|FG000|Overall Study|Withdrawal by Subject|1|||
23308860|NCT02679235|64877737|FG000|Overall Study|Withdrawal by Subject|3|||
23308861|NCT02679235|64877737|FG000|Overall Study|Adverse Event|1|||
23308862|NCT00849186|64877738|FG000|Overall Study|Adverse Event|2|||
23308863|NCT00849186|64877738|FG000|Overall Study|Withdrawal by Subject|1|||
23308864|NCT00849186|64877738|FG000|Overall Study|not treated|6|||
23308865|NCT00849186|64877738|FG000|Overall Study|Other|1|||
23308866|NCT02517463|64877748|FG000|Overall Study|Lost to Follow-up|5|||
23308867|NCT02517463|64877749|FG001|Overall Study|Lost to Follow-up|2|||
23308868|NCT01032018|64877750|FG000|Overall Study|Lost to Follow-up|6|||
23308869|NCT01032018|64877751|FG001|Overall Study|Lost to Follow-up|5|||
23308870|NCT01032018|64877750|FG000|Overall Study|Death|0|||
23308871|NCT01032018|64877751|FG001|Overall Study|Death|1|||
23308872|NCT01001988|64877752|FG000|Overall Study|Protocol Violation|84|||
23308873|NCT01001988|64877752|FG000|Overall Study|Withdrawal by Subject|18|||
23308874|NCT01001988|64877752|FG000|Overall Study|Lost to Follow-up|15|||
23308875|NCT01248013|64877756|FG000|Overall Study|Withdrawal by Subject|14|||
23308876|NCT02712333|64877757|FG000|First Period|Withdrawal by Subject|3|||
23308877|NCT02712333|64877758|FG001|First Period|Withdrawal by Subject|2|||
23527663|NCT02418468|65669235|FG000|Overall Study|Withdrawal of informed consent|1|||
23527664|NCT02418468|65669236|FG001|Overall Study|Withdrawal of informed consent|1|||
23527665|NCT01466270|65669237|FG000|Overall Study|Withdrawal by Subject|4|||
23527666|NCT01466270|65669238|FG001|Overall Study|Withdrawal by Subject|1|||
23527667|NCT01466270|65669237|FG000|Overall Study|Physician Decision|1|||
23527668|NCT01466270|65669238|FG001|Overall Study|Physician Decision|0|||
23527669|NCT01466270|65669237|FG000|Overall Study|Lost to Follow-up|1|||
23527670|NCT01466270|65669238|FG001|Overall Study|Lost to Follow-up|3|||
23527671|NCT01466270|65669237|FG000|Overall Study|Progression|1|||
23527672|NCT01466270|65669238|FG001|Overall Study|Progression|0|||
23527673|NCT01466270|65669237|FG000|Overall Study|Toxicity|4|||
23527674|NCT01466270|65669238|FG001|Overall Study|Toxicity|1|||
23527675|NCT01466270|65669237|FG000|Overall Study|Multiple|1|||
23527676|NCT01466270|65669238|FG001|Overall Study|Multiple|1|||
23527677|NCT02474199|65669239|FG000|Overall Study|Lost to Follow-up|1|||
23527678|NCT02474199|65669240|FG001|Overall Study|Lost to Follow-up|0|||
23527679|NCT02474199|65669241|FG002|Overall Study|Lost to Follow-up|0|||
23527680|NCT02474199|65669242|FG003|Overall Study|Lost to Follow-up|0|||
23527681|NCT02474199|65669239|FG000|Overall Study|Withdrawal by Subject|1|||
23527682|NCT02474199|65669240|FG001|Overall Study|Withdrawal by Subject|2|||
23527683|NCT02474199|65669241|FG002|Overall Study|Withdrawal by Subject|0|||
23527684|NCT02474199|65669242|FG003|Overall Study|Withdrawal by Subject|1|||
23527685|NCT02474199|65669239|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
23527686|NCT02474199|65669240|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
23527687|NCT02474199|65669241|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
23527688|NCT02474199|65669242|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
23527689|NCT02474199|65669239|FG000|Overall Study|Did not meet eligibility criteria|0|||
23527690|NCT02474199|65669240|FG001|Overall Study|Did not meet eligibility criteria|0|||
23527691|NCT02474199|65669241|FG002|Overall Study|Did not meet eligibility criteria|2|||
23527692|NCT02474199|65669242|FG003|Overall Study|Did not meet eligibility criteria|2|||
23527693|NCT00997503|65669243|FG000|Overall Study|Death|53|||
23527694|NCT00997503|65669243|FG000|Overall Study|Withdrawal by Subject|76|||
23527695|NCT00997503|65669243|FG000|Overall Study|Lost to Follow-up|33|||
23527696|NCT00997503|65669243|FG000|Overall Study|Adverse Event|3|||
23527697|NCT00997503|65669243|FG000|Overall Study|Physician Decision|10|||
23527698|NCT00997503|65669243|FG000|Overall Study|Missed 12-month follow-up|85|||
23527699|NCT00997503|65669243|FG000|Overall Study|Other reason|13|||
23527700|NCT00326612|65669244|FG000|Overall Study|They did not have a seizure requiring tx|129|||
23527701|NCT00326612|65669245|FG001|Overall Study|They did not have a seizure requiring tx|137|||
23527702|NCT00838565|65669246|FG000|Overall Study|Withdrawal by Subject|0|||
23527703|NCT00838565|65669247|FG001|Overall Study|Withdrawal by Subject|0|||
23527704|NCT00838565|65669248|FG002|Overall Study|Withdrawal by Subject|1|||
23527705|NCT00838565|65669249|FG003|Overall Study|Withdrawal by Subject|0|||
23611989|NCT00942188|65966940|FG001|Overall Study|Physician Decision|0|||
23308878|NCT01955083|64877759|FG000|Overall Study|Lost to Follow-up|1|||
23308879|NCT01955083|64877760|FG001|Overall Study|Lost to Follow-up|1|||
23527706|NCT00838565|65669250|FG004|Overall Study|Withdrawal by Subject|0|||
23308880|NCT00620555|64877761|FG000|Overall Study|Adverse Event|4|||
23308881|NCT00620555|64877761|FG000|Overall Study|Protocol Violation|2|||
23308882|NCT00620555|64877761|FG000|Overall Study|Lack of Efficacy|12|||
23611990|NCT00942188|65966941|FG002|Overall Study|Physician Decision|1|||
23611991|NCT00942188|65966942|FG003|Overall Study|Physician Decision|0|||
23611992|NCT00942188|65966939|FG000|Overall Study|Sponsor Decision|0|||
23611993|NCT00942188|65966940|FG001|Overall Study|Sponsor Decision|2|||
23611994|NCT00942188|65966941|FG002|Overall Study|Sponsor Decision|0|||
23611995|NCT00942188|65966942|FG003|Overall Study|Sponsor Decision|1|||
23611996|NCT01544309|65966943|FG000|Overall Study|Withdrawal by Subject|12|||
23611997|NCT01544309|65966944|FG001|Overall Study|Withdrawal by Subject|7|||
23611998|NCT01544309|65966943|FG000|Overall Study|Protocol Violation|2|||
23611999|NCT01544309|65966944|FG001|Overall Study|Protocol Violation|1|||
23612000|NCT01544309|65966943|FG000|Overall Study|Physician Decision|4|||
23612001|NCT01544309|65966944|FG001|Overall Study|Physician Decision|1|||
23612002|NCT01544309|65966943|FG000|Overall Study|Not performed pre-dose examination|1|||
23612003|NCT01544309|65966944|FG001|Overall Study|Not performed pre-dose examination|2|||
23612004|NCT01544309|65966943|FG000|Overall Study|Administered prohibit prior medication|1|||
23612005|NCT01544309|65966944|FG001|Overall Study|Administered prohibit prior medication|0|||
23612006|NCT04175392|65966945|FG000|Overall Study|Withdrawal by Subject|3|||
23612007|NCT04175392|65966946|FG001|Overall Study|Withdrawal by Subject|2|||
23612008|NCT03640754|65966947|FG000|Overall Study|Withdrawal by Subject|1|||
23612009|NCT03640754|65966948|FG001|Overall Study|Withdrawal by Subject|0|||
23612010|NCT03640754|65966947|FG000|Overall Study|Lost to Follow-up|0|||
23612011|NCT03640754|65966948|FG001|Overall Study|Lost to Follow-up|1|||
23612012|NCT03740919|65966949|FG000|Lead-in Period|Lost to Follow-up|1|||
23612013|NCT03740919|65966950|FG001|Lead-in Period|Lost to Follow-up|0|||
23612014|NCT03740919|65966951|FG002|Lead-in Period|Lost to Follow-up|0|||
23612015|NCT03740919|65966952|FG003|Lead-in Period|Lost to Follow-up|0|||
23612016|NCT03740919|65966949|FG000|Lead-in Period|Physician Decision|2|||
23612017|NCT03740919|65966950|FG001|Lead-in Period|Physician Decision|0|||
23612018|NCT03740919|65966951|FG002|Lead-in Period|Physician Decision|0|||
23418327|NCT02589665|65277209|FG007|Induction Extension Period|Withdrawal by Subject|2|||
23418328|NCT02589665|65277210|FG008|Induction Extension Period|Withdrawal by Subject|3|||
23418329|NCT02589665|65277211|FG009|Induction Extension Period|Withdrawal by Subject|0|||
23418330|NCT02589665|65277202|FG000|Induction Extension Period|Physician Decision|0|||
23418331|NCT02589665|65277203|FG001|Induction Extension Period|Physician Decision|0|||
23418332|NCT02589665|65277204|FG002|Induction Extension Period|Physician Decision|0|||
23418333|NCT02589665|65277205|FG003|Induction Extension Period|Physician Decision|0|||
23418334|NCT02589665|65277206|FG004|Induction Extension Period|Physician Decision|0|||
23418335|NCT02589665|65277207|FG005|Induction Extension Period|Physician Decision|0|||
23418336|NCT02589665|65277208|FG006|Induction Extension Period|Physician Decision|0|||
23418337|NCT02589665|65277209|FG007|Induction Extension Period|Physician Decision|0|||
23418338|NCT02589665|65277210|FG008|Induction Extension Period|Physician Decision|1|||
23418339|NCT02589665|65277211|FG009|Induction Extension Period|Physician Decision|0|||
23418340|NCT02589665|65277202|FG000|Induction Extension Period|Reason Not Collected|0|||
23418341|NCT02589665|65277203|FG001|Induction Extension Period|Reason Not Collected|0|||
23418342|NCT02589665|65277204|FG002|Induction Extension Period|Reason Not Collected|0|||
23418343|NCT02589665|65277205|FG003|Induction Extension Period|Reason Not Collected|0|||
23418344|NCT02589665|65277206|FG004|Induction Extension Period|Reason Not Collected|0|||
23418345|NCT02589665|65277207|FG005|Induction Extension Period|Reason Not Collected|0|||
23418346|NCT02589665|65277208|FG006|Induction Extension Period|Reason Not Collected|0|||
23418347|NCT02589665|65277209|FG007|Induction Extension Period|Reason Not Collected|0|||
23418348|NCT02589665|65277210|FG008|Induction Extension Period|Reason Not Collected|1|||
23418349|NCT02589665|65277211|FG009|Induction Extension Period|Reason Not Collected|0|||
23527707|NCT00838565|65669251|FG005|Overall Study|Withdrawal by Subject|2|||
23527708|NCT00838565|65669246|FG000|Overall Study|Other|0|||
23527709|NCT00838565|65669247|FG001|Overall Study|Other|2|||
23527710|NCT00838565|65669248|FG002|Overall Study|Other|0|||
23527711|NCT00838565|65669249|FG003|Overall Study|Other|0|||
23527712|NCT00838565|65669250|FG004|Overall Study|Other|0|||
23527713|NCT00838565|65669251|FG005|Overall Study|Other|0|||
23527714|NCT00838565|65669246|FG000|Overall Study|Randomized but not Treated|0|||
23527715|NCT00838565|65669247|FG001|Overall Study|Randomized but not Treated|1|||
23527716|NCT00838565|65669248|FG002|Overall Study|Randomized but not Treated|0|||
23527717|NCT00838565|65669249|FG003|Overall Study|Randomized but not Treated|0|||
23527718|NCT00838565|65669250|FG004|Overall Study|Randomized but not Treated|0|||
23527719|NCT00838565|65669251|FG005|Overall Study|Randomized but not Treated|0|||
23527720|NCT01856543|65669252|FG000|Overall Study|Treatment discontinued|6|||
23612019|NCT03740919|65966952|FG003|Lead-in Period|Physician Decision|0|||
23612020|NCT03740919|65966949|FG000|Lead-in Period|Protocol Violation|1|||
23612021|NCT03740919|65966950|FG001|Lead-in Period|Protocol Violation|0|||
23612022|NCT03740919|65966951|FG002|Lead-in Period|Protocol Violation|0|||
23612023|NCT03740919|65966952|FG003|Lead-in Period|Protocol Violation|0|||
23612024|NCT03740919|65966949|FG000|Lead-in Period|Withdrawal by Subject|10|||
23612025|NCT03740919|65966950|FG001|Lead-in Period|Withdrawal by Subject|0|||
23612026|NCT03740919|65966951|FG002|Lead-in Period|Withdrawal by Subject|0|||
23418350|NCT02589665|65277202|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418351|NCT02589665|65277203|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418352|NCT02589665|65277204|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418353|NCT02589665|65277205|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418354|NCT02589665|65277206|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418355|NCT02589665|65277207|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418356|NCT02589665|65277208|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418357|NCT02589665|65277209|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418358|NCT02589665|65277210|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
23418359|NCT02589665|65277211|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
23418360|NCT02589665|65277202|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
23418361|NCT02589665|65277203|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
23418362|NCT02589665|65277204|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
23418363|NCT02589665|65277205|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
23418364|NCT02589665|65277206|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
23418365|NCT02589665|65277207|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
23418366|NCT02589665|65277208|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
23418367|NCT02589665|65277209|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
23418368|NCT02589665|65277210|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
23418369|NCT02589665|65277211|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
23418370|NCT02589665|65277202|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
23418371|NCT02589665|65277203|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
23418372|NCT02589665|65277204|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
23418373|NCT02589665|65277205|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
23418374|NCT02589665|65277206|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
23418375|NCT02589665|65277207|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
23418376|NCT02589665|65277208|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
23418377|NCT02589665|65277209|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
23418378|NCT02589665|65277210|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
23418379|NCT02589665|65277211|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
23418380|NCT02589665|65277202|FG000|Maintenance Extension Period|Adverse Event|0|||
23418381|NCT02589665|65277203|FG001|Maintenance Extension Period|Adverse Event|0|||
23418382|NCT02589665|65277204|FG002|Maintenance Extension Period|Adverse Event|0|||
23418383|NCT02589665|65277205|FG003|Maintenance Extension Period|Adverse Event|0|||
23418384|NCT02589665|65277206|FG004|Maintenance Extension Period|Adverse Event|0|||
23527721|NCT01856543|65669253|FG001|Overall Study|Treatment discontinued|3|||
23527722|NCT01856543|65669252|FG000|Overall Study|Withdrawn before start|7|||
23527723|NCT01856543|65669253|FG001|Overall Study|Withdrawn before start|3|||
23527724|NCT03029624|65669255|FG000|Overall Study|Adverse Event|1|||
23527725|NCT03029624|65669255|FG000|Overall Study|Withdrawal by Subject|1|||
23527726|NCT03029624|65669255|FG000|Overall Study|Lack of Efficacy|1|||
23527727|NCT03029624|65669255|FG000|Overall Study|MRI need|2|||
23527728|NCT04334460|65669257|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
23206316|NCT03136367|64494861|FG002|T1 Consultation|Discontinued other|0|||
23206317|NCT03136367|64494859|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
23206318|NCT03136367|64494860|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
23527729|NCT04334460|65669258|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
23527730|NCT04334460|65669257|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
23206319|NCT03136367|64494861|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
23418385|NCT02589665|65277207|FG005|Maintenance Extension Period|Adverse Event|0|||
23527731|NCT04334460|65669258|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
23527732|NCT01393743|65669259|FG000|Core Study|Adverse Event|5|||
23527733|NCT01393743|65669260|FG001|Core Study|Adverse Event|9|||
23527734|NCT01393743|65669261|FG002|Core Study|Adverse Event|0|||
23527735|NCT01393743|65669259|FG000|Core Study|Lost to Follow-up|1|||
23527736|NCT01393743|65669260|FG001|Core Study|Lost to Follow-up|1|||
23527737|NCT01393743|65669261|FG002|Core Study|Lost to Follow-up|0|||
23527738|NCT01393743|65669259|FG000|Core Study|Participant's Choice|2|||
23527739|NCT01393743|65669260|FG001|Core Study|Participant's Choice|3|||
23418386|NCT02589665|65277208|FG006|Maintenance Extension Period|Adverse Event|0|||
23418387|NCT02589665|65277209|FG007|Maintenance Extension Period|Adverse Event|0|||
23418388|NCT02589665|65277210|FG008|Maintenance Extension Period|Adverse Event|0|||
23418389|NCT02589665|65277211|FG009|Maintenance Extension Period|Adverse Event|2|||
23418390|NCT02589665|65277202|FG000|Maintenance Extension Period|Non-responder|0|||
23418391|NCT02589665|65277203|FG001|Maintenance Extension Period|Non-responder|0|||
23527740|NCT01393743|65669261|FG002|Core Study|Participant's Choice|0|||
23527741|NCT01393743|65669259|FG000|Core Study|Inadequate therapeutic effect|2|||
23527742|NCT01393743|65669260|FG001|Core Study|Inadequate therapeutic effect|0|||
23527743|NCT01393743|65669261|FG002|Core Study|Inadequate therapeutic effect|0|||
23527744|NCT01393743|65669259|FG000|Extension Phase|Adverse Event|0|||
23527745|NCT01393743|65669260|FG001|Extension Phase|Adverse Event|0|||
23527746|NCT01393743|65669261|FG002|Extension Phase|Adverse Event|12|||
23527747|NCT01393743|65669259|FG000|Extension Phase|Lost to Follow-up|0|||
23527748|NCT01393743|65669260|FG001|Extension Phase|Lost to Follow-up|0|||
23527749|NCT01393743|65669261|FG002|Extension Phase|Lost to Follow-up|2|||
23527750|NCT01393743|65669259|FG000|Extension Phase|Participant choice|0|||
23527751|NCT01393743|65669260|FG001|Extension Phase|Participant choice|0|||
23527752|NCT01393743|65669261|FG002|Extension Phase|Participant choice|16|||
23527753|NCT01393743|65669259|FG000|Extension Phase|Inadequate therapeutic effect|0|||
23527754|NCT01393743|65669260|FG001|Extension Phase|Inadequate therapeutic effect|0|||
23527755|NCT01393743|65669261|FG002|Extension Phase|Inadequate therapeutic effect|7|||
23418392|NCT02589665|65277204|FG002|Maintenance Extension Period|Non-responder|0|||
23418393|NCT02589665|65277205|FG003|Maintenance Extension Period|Non-responder|0|||
23418394|NCT02589665|65277206|FG004|Maintenance Extension Period|Non-responder|0|||
23418395|NCT02589665|65277207|FG005|Maintenance Extension Period|Non-responder|0|||
23418396|NCT02589665|65277208|FG006|Maintenance Extension Period|Non-responder|0|||
23418397|NCT02589665|65277209|FG007|Maintenance Extension Period|Non-responder|0|||
23418398|NCT02589665|65277210|FG008|Maintenance Extension Period|Non-responder|0|||
23418399|NCT02589665|65277211|FG009|Maintenance Extension Period|Non-responder|1|||
23418400|NCT01110330|65277212|FG000|Overall Study|Adverse Event|0|||
23418401|NCT01110330|65277213|FG001|Overall Study|Adverse Event|4|||
23418402|NCT01110330|65277214|FG002|Overall Study|Adverse Event|3|||
23418403|NCT01110330|65277212|FG000|Overall Study|Lack of Efficacy|3|||
23418404|NCT01110330|65277213|FG001|Overall Study|Lack of Efficacy|1|||
23418405|NCT01110330|65277214|FG002|Overall Study|Lack of Efficacy|1|||
23418406|NCT01110330|65277212|FG000|Overall Study|Lost to Follow-up|9|||
23418407|NCT01110330|65277213|FG001|Overall Study|Lost to Follow-up|10|||
23527756|NCT01393743|65669259|FG000|Extension Phase|Withdrawal by Subject|0|||
23527757|NCT01393743|65669260|FG001|Extension Phase|Withdrawal by Subject|0|||
23527758|NCT01393743|65669261|FG002|Extension Phase|Withdrawal by Subject|8|||
23418408|NCT01110330|65277214|FG002|Overall Study|Lost to Follow-up|15|||
23418409|NCT01110330|65277212|FG000|Overall Study|Physician Decision|0|||
23527759|NCT01393743|65669259|FG000|Extension Phase|Pregnancy|0|||
23527760|NCT01393743|65669260|FG001|Extension Phase|Pregnancy|0|||
23527761|NCT01393743|65669261|FG002|Extension Phase|Pregnancy|1|||
23418410|NCT01110330|65277213|FG001|Overall Study|Physician Decision|1|||
23418411|NCT01110330|65277214|FG002|Overall Study|Physician Decision|0|||
23527762|NCT01393743|65669259|FG000|Extension Phase|Other|0|||
23418412|NCT01110330|65277212|FG000|Overall Study|Protocol Violation|2|||
23418413|NCT01110330|65277213|FG001|Overall Study|Protocol Violation|0|||
23418414|NCT01110330|65277214|FG002|Overall Study|Protocol Violation|4|||
23527763|NCT01393743|65669260|FG001|Extension Phase|Other|0|||
23527764|NCT01393743|65669261|FG002|Extension Phase|Other|14|||
23527765|NCT02920983|65669264|FG000|Dispense 1|Unacceptable Lens Fit|0|||
23527766|NCT02920983|65669265|FG001|Dispense 1|Unacceptable Lens Fit|0|||
23418415|NCT01110330|65277212|FG000|Overall Study|Withdrawal by Subject|0|||
23418416|NCT01110330|65277213|FG001|Overall Study|Withdrawal by Subject|6|||
23418417|NCT01110330|65277214|FG002|Overall Study|Withdrawal by Subject|2|||
23418418|NCT01110330|65277212|FG000|Overall Study|Other|1|||
23418419|NCT01110330|65277213|FG001|Overall Study|Other|1|||
23418420|NCT01110330|65277214|FG002|Overall Study|Other|1|||
23418421|NCT04049266|65277215|FG000|Overall Study|Adverse Event|16|||
23418422|NCT04049266|65277216|FG001|Overall Study|Adverse Event|9|||
23418423|NCT04049266|65277215|FG000|Overall Study|Non-compliance with study drug|0|||
23418424|NCT04049266|65277216|FG001|Overall Study|Non-compliance with study drug|3|||
23418425|NCT04049266|65277215|FG000|Overall Study|Withdrawal by Subject|6|||
23418426|NCT04049266|65277216|FG001|Overall Study|Withdrawal by Subject|10|||
23418427|NCT04049266|65277215|FG000|Overall Study|Lost to Follow-up|2|||
23418428|NCT04049266|65277216|FG001|Overall Study|Lost to Follow-up|2|||
23418429|NCT04049266|65277215|FG000|Overall Study|Progressive disease|11|||
23418430|NCT04049266|65277216|FG001|Overall Study|Progressive disease|2|||
23527767|NCT02920983|65669266|FG002|Dispense 1|Unacceptable Lens Fit|0|||
23527768|NCT02920983|65669267|FG003|Dispense 1|Unacceptable Lens Fit|0|||
23418431|NCT04049266|65277215|FG000|Overall Study|Physician Decision|1|||
23418432|NCT04049266|65277216|FG001|Overall Study|Physician Decision|0|||
23418433|NCT04049266|65277215|FG000|Overall Study|Patient moved out of state|1|||
23418434|NCT04049266|65277216|FG001|Overall Study|Patient moved out of state|0|||
23206320|NCT03136367|64494859|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
23206321|NCT03136367|64494860|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
23206322|NCT03136367|64494861|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
23206323|NCT03136367|64494859|FG000|T2 Post-consultation|Discontinued other|0|||
23206324|NCT03136367|64494860|FG001|T2 Post-consultation|Discontinued other|2|||
23206325|NCT03136367|64494861|FG002|T2 Post-consultation|Discontinued other|6|||
23206326|NCT03136367|64494859|FG000|T2 Post-consultation|Discontinued transferred care|0|||
23206327|NCT03136367|64494860|FG001|T2 Post-consultation|Discontinued transferred care|0|||
23418435|NCT04085458|65277217|FG000|Overall Study|Other|1|||
23418436|NCT04085458|65277217|FG000|Overall Study|Withdrawal by Subject|2|||
23418437|NCT04085458|65277217|FG000|Overall Study|Adverse Event|2|||
23418438|NCT02141399|65277222|FG000|Overall Study|Adverse Event|158|||
23418439|NCT02141399|65277222|FG000|Overall Study|Lack of Efficacy|62|||
23418440|NCT02141399|65277222|FG000|Overall Study|Lost to Follow-up|151|||
23418441|NCT02141399|65277222|FG000|Overall Study|Non-compliance with study drug|18|||
23418442|NCT02141399|65277222|FG000|Overall Study|Other|45|||
23418443|NCT02141399|65277222|FG000|Overall Study|Physician Decision|17|||
23418444|NCT02141399|65277222|FG000|Overall Study|Pregnancy|3|||
23527769|NCT02920983|65669268|FG004|Dispense 1|Unacceptable Lens Fit|1|||
23527770|NCT02920983|65669269|FG005|Dispense 1|Unacceptable Lens Fit|0|||
23527771|NCT02920983|65669264|FG000|Dispense 2|Unscceptable lens fit|1|||
23527772|NCT02920983|65669265|FG001|Dispense 2|Unscceptable lens fit|0|||
23527773|NCT02920983|65669266|FG002|Dispense 2|Unscceptable lens fit|0|||
23527774|NCT02920983|65669267|FG003|Dispense 2|Unscceptable lens fit|0|||
23527775|NCT02920983|65669268|FG004|Dispense 2|Unscceptable lens fit|1|||
23527776|NCT02920983|65669269|FG005|Dispense 2|Unscceptable lens fit|0|||
23527777|NCT02920983|65669264|FG000|Dispense 3|Unacceptable Lens Fit|1|||
23527778|NCT02920983|65669265|FG001|Dispense 3|Unacceptable Lens Fit|1|||
23527779|NCT02920983|65669266|FG002|Dispense 3|Unacceptable Lens Fit|0|||
23527780|NCT02920983|65669267|FG003|Dispense 3|Unacceptable Lens Fit|0|||
23527781|NCT02920983|65669268|FG004|Dispense 3|Unacceptable Lens Fit|1|||
23527782|NCT02920983|65669269|FG005|Dispense 3|Unacceptable Lens Fit|0|||
23527783|NCT01256593|65669270|FG000|Overall Study|Protocol Violation|26|||
23527784|NCT01256593|65669270|FG000|Overall Study|No Drug Administration Information|2|||
23527785|NCT01256593|65669270|FG000|Overall Study|No Visit After Treatment|186|||
23527786|NCT00855309|65669273|FG000|Overall Study|patient never recieved drug|1|||
23527787|NCT00855309|65669274|FG001|Overall Study|patient never recieved drug|0|||
23527788|NCT02932904|65669282|FG000|Overall Study|Reason not Specified|1|||
23527789|NCT02932904|65669283|FG001|Overall Study|Reason not Specified|0|||
23527790|NCT02932904|65669284|FG002|Overall Study|Reason not Specified|2|||
23527791|NCT02932904|65669285|FG003|Overall Study|Reason not Specified|2|||
23527792|NCT02932904|65669282|FG000|Overall Study|Noncompliance with Study Drug|2|||
23527793|NCT02932904|65669283|FG001|Overall Study|Noncompliance with Study Drug|3|||
23527794|NCT02932904|65669284|FG002|Overall Study|Noncompliance with Study Drug|3|||
23527795|NCT02932904|65669285|FG003|Overall Study|Noncompliance with Study Drug|4|||
23527796|NCT02932904|65669282|FG000|Overall Study|Pregnancy|0|||
23527797|NCT02932904|65669283|FG001|Overall Study|Pregnancy|1|||
23527798|NCT02932904|65669284|FG002|Overall Study|Pregnancy|1|||
23206328|NCT03136367|64494861|FG002|T2 Post-consultation|Discontinued transferred care|3|||
23527799|NCT02932904|65669285|FG003|Overall Study|Pregnancy|0|||
23527800|NCT02932904|65669282|FG000|Overall Study|Study Termination|0|||
23527801|NCT02932904|65669283|FG001|Overall Study|Study Termination|1|||
23527802|NCT02932904|65669284|FG002|Overall Study|Study Termination|0|||
23527803|NCT02932904|65669285|FG003|Overall Study|Study Termination|0|||
23206329|NCT03136367|64494859|FG000|T2 Post-consultation|Discontinued lost contact|0|||
23418445|NCT02141399|65277222|FG000|Overall Study|Protocol Violation|38|||
23418446|NCT02141399|65277222|FG000|Overall Study|Withdrawal by Subject|238|||
23527804|NCT02932904|65669282|FG000|Overall Study|Voluntary Withdrawal|2|||
23527805|NCT02932904|65669283|FG001|Overall Study|Voluntary Withdrawal|1|||
23527806|NCT02932904|65669284|FG002|Overall Study|Voluntary Withdrawal|4|||
23527807|NCT02932904|65669285|FG003|Overall Study|Voluntary Withdrawal|2|||
23527808|NCT02932904|65669282|FG000|Overall Study|Lost to Follow-up|5|||
23527809|NCT02932904|65669283|FG001|Overall Study|Lost to Follow-up|3|||
23527810|NCT02932904|65669284|FG002|Overall Study|Lost to Follow-up|6|||
23527811|NCT02932904|65669285|FG003|Overall Study|Lost to Follow-up|0|||
23527812|NCT02932904|65669282|FG000|Overall Study|Significant Protocol Deviation|2|||
23527813|NCT02932904|65669283|FG001|Overall Study|Significant Protocol Deviation|3|||
23527814|NCT02932904|65669284|FG002|Overall Study|Significant Protocol Deviation|6|||
23527815|NCT02932904|65669285|FG003|Overall Study|Significant Protocol Deviation|1|||
23527816|NCT02932904|65669282|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
23527817|NCT02932904|65669283|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
23527818|NCT02932904|65669284|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
23527819|NCT02932904|65669285|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
23527820|NCT02932904|65669282|FG000|Overall Study|Randomized But Not Treated|1|||
23527821|NCT02932904|65669283|FG001|Overall Study|Randomized But Not Treated|1|||
23527822|NCT02932904|65669284|FG002|Overall Study|Randomized But Not Treated|0|||
23527823|NCT02932904|65669285|FG003|Overall Study|Randomized But Not Treated|2|||
23527824|NCT01600586|65669286|FG000|Overall Study|Physician Decision|3|||
23527825|NCT01600586|65669287|FG001|Overall Study|Physician Decision|3|||
23527826|NCT00360334|65669289|FG000|Overall Study|Adverse Event|7|||
23527827|NCT00360334|65669290|FG001|Overall Study|Adverse Event|4|||
23527828|NCT00360334|65669289|FG000|Overall Study|Protocol Violation|1|||
23527829|NCT00360334|65669290|FG001|Overall Study|Protocol Violation|1|||
23527830|NCT00360334|65669289|FG000|Overall Study|Physician Decision|2|||
23527831|NCT00360334|65669290|FG001|Overall Study|Physician Decision|3|||
23527832|NCT00360334|65669289|FG000|Overall Study|Lack of Efficacy|0|||
23527833|NCT00360334|65669290|FG001|Overall Study|Lack of Efficacy|1|||
23527834|NCT00360334|65669289|FG000|Overall Study|Entry criterion not met|1|||
23527835|NCT00360334|65669290|FG001|Overall Study|Entry criterion not met|2|||
23527836|NCT00360334|65669289|FG000|Overall Study|Subject decision|8|||
23527837|NCT00360334|65669290|FG001|Overall Study|Subject decision|2|||
23527838|NCT01524770|65669291|FG000|First Intervention|Withdrawal by Subject|1|||
23527839|NCT01524770|65669292|FG001|First Intervention|Withdrawal by Subject|0|||
23527840|NCT01524770|65669291|FG000|First Intervention|Adverse Event|1|||
23527841|NCT01524770|65669292|FG001|First Intervention|Adverse Event|1|||
23527842|NCT01524770|65669291|FG000|First Intervention|Protocol Violation|1|||
23527843|NCT01524770|65669292|FG001|First Intervention|Protocol Violation|0|||
23527844|NCT00670228|65669295|FG000|Overall Study|Adverse Event|1|||
23527845|NCT00670228|65669296|FG001|Overall Study|Adverse Event|0|||
23527846|NCT00670228|65669295|FG000|Overall Study|Death or MACE|0|||
23527847|NCT00670228|65669296|FG001|Overall Study|Death or MACE|1|||
23527848|NCT00670228|65669295|FG000|Overall Study|Not treated|2|||
23527849|NCT00670228|65669296|FG001|Overall Study|Not treated|2|||
23527850|NCT00670228|65669295|FG000|Overall Study|Not meeting the selection criteria|2|||
23527851|NCT00670228|65669296|FG001|Overall Study|Not meeting the selection criteria|0|||
23527852|NCT02849548|65669297|FG000|Overall Study|Lost to Follow-up|1|||
23527853|NCT02849548|65669298|FG001|Overall Study|Lost to Follow-up|2|||
23527854|NCT02849548|65669297|FG000|Overall Study|Protocol Violation|1|||
23527855|NCT02849548|65669298|FG001|Overall Study|Protocol Violation|0|||
23527856|NCT00779675|65669299|FG000|Treatment Period|Adverse Event|87|||
23527857|NCT00779675|65669299|FG000|Treatment Period|Treatment Failure|80|||
23206330|NCT03136367|64494860|FG001|T2 Post-consultation|Discontinued lost contact|1|||
23206331|NCT03136367|64494861|FG002|T2 Post-consultation|Discontinued lost contact|0|||
23527858|NCT00779675|65669299|FG000|Treatment Period|Transferred to Another Study|38|||
23527859|NCT00779675|65669299|FG000|Treatment Period|Lost to Follow-up|23|||
23527860|NCT00779675|65669299|FG000|Treatment Period|Withdrawal by Subject|46|||
23527861|NCT00779675|65669299|FG000|Treatment Period|Protocol Violation|54|||
23527862|NCT00779675|65669299|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
23527863|NCT00779675|65669299|FG000|Treatment Period|Administrative|3|||
23527864|NCT00779675|65669299|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
23527865|NCT00779675|65669299|FG000|Extended Treatment Period|Protocol Violation|13|||
23527866|NCT00779675|65669299|FG000|Extended Treatment Period|Adverse Event|6|||
23612027|NCT03740919|65966952|FG003|Lead-in Period|Withdrawal by Subject|0|||
23612028|NCT03740919|65966949|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
23612029|NCT03740919|65966950|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
23612030|NCT03740919|65966951|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
23612031|NCT03740919|65966952|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
23612032|NCT03740919|65966949|FG000|Lead-in Period|Study Task Too Burdensome|1|||
23612033|NCT03740919|65966950|FG001|Lead-in Period|Study Task Too Burdensome|0|||
23612034|NCT03740919|65966951|FG002|Lead-in Period|Study Task Too Burdensome|0|||
23612035|NCT03740919|65966952|FG003|Lead-in Period|Study Task Too Burdensome|0|||
23612036|NCT03740919|65966949|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
23612037|NCT03740919|65966950|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
23612038|NCT03740919|65966951|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
23612039|NCT03740919|65966952|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
23612040|NCT03740919|65966949|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
23612041|NCT03740919|65966950|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
23612042|NCT03740919|65966951|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
23612043|NCT03740919|65966952|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
23612044|NCT03740919|65966949|FG000|Treatment Period|Adverse Event|0|||
23612045|NCT03740919|65966950|FG001|Treatment Period|Adverse Event|0|||
23612046|NCT03740919|65966951|FG002|Treatment Period|Adverse Event|2|||
23612047|NCT03740919|65966952|FG003|Treatment Period|Adverse Event|0|||
23612048|NCT03740919|65966949|FG000|Treatment Period|Protocol Violation|0|||
23612049|NCT03740919|65966950|FG001|Treatment Period|Protocol Violation|1|||
23612050|NCT03740919|65966951|FG002|Treatment Period|Protocol Violation|0|||
23612051|NCT03740919|65966952|FG003|Treatment Period|Protocol Violation|0|||
23612052|NCT03740919|65966949|FG000|Treatment Period|Withdrawal by Subject|0|||
23612053|NCT03740919|65966950|FG001|Treatment Period|Withdrawal by Subject|7|||
23612054|NCT03740919|65966951|FG002|Treatment Period|Withdrawal by Subject|6|||
23612055|NCT03740919|65966952|FG003|Treatment Period|Withdrawal by Subject|2|||
23612056|NCT03740919|65966949|FG000|Treatment Period|Terminated by Sponsor|0|||
23612057|NCT03740919|65966950|FG001|Treatment Period|Terminated by Sponsor|1|||
23612058|NCT03740919|65966951|FG002|Treatment Period|Terminated by Sponsor|0|||
23612059|NCT03740919|65966952|FG003|Treatment Period|Terminated by Sponsor|0|||
23612060|NCT03740919|65966949|FG000|Treatment Period|Issue with Insulin Pump|0|||
23612061|NCT03740919|65966950|FG001|Treatment Period|Issue with Insulin Pump|1|||
23612062|NCT03740919|65966951|FG002|Treatment Period|Issue with Insulin Pump|0|||
23612063|NCT03740919|65966952|FG003|Treatment Period|Issue with Insulin Pump|0|||
23612064|NCT03740919|65966949|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
23612065|NCT03740919|65966950|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
23527867|NCT00779675|65669299|FG000|Extended Treatment Period|Treatment Failure|11|||
23527868|NCT00779675|65669299|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
23527869|NCT00779675|65669299|FG000|Extended Treatment Period|Lost to Follow-up|6|||
23527870|NCT02547129|65669300|FG000|Overall Study|Difficulty with ongoing infection|1|||
23612066|NCT03740919|65966951|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
23612067|NCT03740919|65966952|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
23612068|NCT03740919|65966949|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
23612069|NCT03740919|65966950|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
23612070|NCT03740919|65966951|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
23612071|NCT03740919|65966952|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
23206332|NCT03136367|64494859|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
23206333|NCT03136367|64494860|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
23206334|NCT03136367|64494861|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
23527871|NCT02547129|65669301|FG001|Overall Study|Difficulty with ongoing infection|0|||
23527872|NCT02052739|65669302|FG000|Overall Study|Withdrew due to Adverse Event|3|||
23527873|NCT02052739|65669303|FG001|Overall Study|Withdrew due to Adverse Event|0|||
23612072|NCT03740919|65966949|FG000|Treatment Period|Not Completing Diary|0|||
23612073|NCT03740919|65966950|FG001|Treatment Period|Not Completing Diary|0|||
23612074|NCT03740919|65966951|FG002|Treatment Period|Not Completing Diary|1|||
23612075|NCT03740919|65966952|FG003|Treatment Period|Not Completing Diary|0|||
23612076|NCT03740919|65966949|FG000|Treatment Period|Insulin Painful to Participant|0|||
23206335|NCT03136367|64494859|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
23206336|NCT03136367|64494860|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
23206337|NCT03136367|64494861|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
23206338|NCT03136367|64494859|FG000|T3 1 Week After Surgery|other discontinued|2|||
23206339|NCT03136367|64494860|FG001|T3 1 Week After Surgery|other discontinued|4|||
23206340|NCT03136367|64494861|FG002|T3 1 Week After Surgery|other discontinued|3|||
23527874|NCT02052739|65669302|FG000|Overall Study|Participant Died|2|||
23527875|NCT02052739|65669303|FG001|Overall Study|Participant Died|1|||
23527876|NCT04187196|65669304|FG000|Overall Study|Screen Failure|2|||
23527877|NCT04187196|65669305|FG001|Overall Study|Screen Failure|0|||
23527878|NCT00805766|65669306|FG000|Screening Period|Adverse Event|1|||
23527879|NCT00805766|65669306|FG000|Screening Period|Lack of Efficacy|2|||
23527880|NCT00805766|65669306|FG000|Screening Period|Pregnancy|1|||
23527881|NCT00805766|65669306|FG000|Screening Period|Responder|2|||
23527882|NCT00805766|65669306|FG000|Increased Dose Period|Adverse Event|4|||
23527883|NCT00805766|65669306|FG000|Increased Dose Period|Lack of Efficacy|7|||
23527884|NCT00805766|65669306|FG000|Increased Dose Period|Pregnancy|1|||
23527885|NCT00805766|65669306|FG000|Increased Dose Period|Withdrawal by Subject|1|||
23527886|NCT03102918|65669308|FG000|Overall Study|Protocol Violation|1|||
23527887|NCT03102918|65669309|FG001|Overall Study|Protocol Violation|0|||
23206341|NCT03136367|64494859|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
23527888|NCT00159588|65669310|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
23527889|NCT00159588|65669311|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
23527890|NCT00159588|65669312|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
23527891|NCT01888497|65669313|FG000|Washout Period 1|Withdrawal by Subject|0|||
23206342|NCT03136367|64494860|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
23206343|NCT03136367|64494861|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
23206344|NCT03136367|64494859|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
23206345|NCT03136367|64494860|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
23206346|NCT03136367|64494861|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
23206347|NCT03136367|64494859|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
23206348|NCT03136367|64494860|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
23206349|NCT03136367|64494861|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
23527892|NCT01888497|65669314|FG001|Washout Period 1|Withdrawal by Subject|0|||
23612077|NCT03740919|65966950|FG001|Treatment Period|Insulin Painful to Participant|0|||
23612078|NCT03740919|65966951|FG002|Treatment Period|Insulin Painful to Participant|1|||
23612079|NCT03740919|65966952|FG003|Treatment Period|Insulin Painful to Participant|0|||
23612080|NCT00609245|65966954|FG000|Overall Study|Adverse Event|1|||
23612081|NCT03696342|65966955|FG000|Overall Study|Lost to Follow-up|1|||
23612082|NCT03696342|65966956|FG001|Overall Study|Lost to Follow-up|0|||
23612083|NCT01021683|65966957|FG000|Overall Study|Lack of Efficacy|12|||
23612084|NCT01021683|65966957|FG000|Overall Study|Recovery of neutrophil count|51|||
23612085|NCT01021683|65966957|FG000|Overall Study|Other|8|||
23612086|NCT02014402|65966958|FG000|Overall Study|Adverse Event|1|||
23612087|NCT02014402|65966959|FG001|Overall Study|Adverse Event|0|||
23612088|NCT02014402|65966960|FG002|Overall Study|Adverse Event|0|||
23612089|NCT02014402|65966961|FG003|Overall Study|Adverse Event|0|||
23612090|NCT02014402|65966958|FG000|Overall Study|Withdrawal by Subject|1|||
23612091|NCT02014402|65966959|FG001|Overall Study|Withdrawal by Subject|2|||
23612092|NCT02014402|65966960|FG002|Overall Study|Withdrawal by Subject|2|||
23612093|NCT02014402|65966961|FG003|Overall Study|Withdrawal by Subject|1|||
23612094|NCT02014402|65966958|FG000|Overall Study|Subject did not have transportation|0|||
23612095|NCT02014402|65966959|FG001|Overall Study|Subject did not have transportation|1|||
23612096|NCT02014402|65966960|FG002|Overall Study|Subject did not have transportation|0|||
23612097|NCT02014402|65966961|FG003|Overall Study|Subject did not have transportation|0|||
23612098|NCT02014402|65966958|FG000|Overall Study|Lost to Follow-up|0|||
23612099|NCT02014402|65966959|FG001|Overall Study|Lost to Follow-up|0|||
23612100|NCT02014402|65966960|FG002|Overall Study|Lost to Follow-up|1|||
23612101|NCT02014402|65966961|FG003|Overall Study|Lost to Follow-up|2|||
23612102|NCT02097056|65966962|FG000|Overall Study|Protocol Violation|2|||
23612103|NCT02097056|65966962|FG000|Overall Study|Withdrawal by Subject|15|||
23612104|NCT02097056|65966962|FG000|Overall Study|Lost to Follow-up|2|||
23612105|NCT02097056|65966962|FG000|Overall Study|Adverse Event|37|||
23206350|NCT03136367|64494859|FG000|T4 12 Weeks After Surgery|Death|0|||
23206351|NCT03136367|64494860|FG001|T4 12 Weeks After Surgery|Death|1|||
23527893|NCT01888497|65669315|FG002|Washout Period 1|Withdrawal by Subject|1|||
23527894|NCT01888497|65669316|FG003|Washout Period 1|Withdrawal by Subject|1|||
23527895|NCT01888497|65669313|FG000|Washout Period 2|Adverse Event|0|||
23527896|NCT01888497|65669314|FG001|Washout Period 2|Adverse Event|0|||
23527897|NCT01888497|65669315|FG002|Washout Period 2|Adverse Event|0|||
23612106|NCT02097056|65966962|FG000|Overall Study|Other|2|||
23612107|NCT03906240|65966966|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
23612108|NCT03906240|65966967|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
23612109|NCT03906240|65966966|FG000|Overall Study|Lost to Follow-up|1|||
23612110|NCT03906240|65966967|FG001|Overall Study|Lost to Follow-up|0|||
23612111|NCT03906240|65966966|FG000|Overall Study|Withdrawal by Subject|0|||
23612112|NCT03906240|65966967|FG001|Overall Study|Withdrawal by Subject|1|||
23612113|NCT01922102|65966968|FG000|Overall Study|Withdrawal by Subject|7|||
23612114|NCT01922102|65966969|FG001|Overall Study|Withdrawal by Subject|3|||
23612115|NCT01922102|65966970|FG002|Overall Study|Withdrawal by Subject|7|||
23612116|NCT01922102|65966968|FG000|Overall Study|Physician Decision|0|||
23612117|NCT01922102|65966969|FG001|Overall Study|Physician Decision|2|||
23612118|NCT01922102|65966970|FG002|Overall Study|Physician Decision|1|||
23612119|NCT01922102|65966968|FG000|Overall Study|Adverse Event|1|||
23612120|NCT01922102|65966969|FG001|Overall Study|Adverse Event|2|||
23612121|NCT01922102|65966970|FG002|Overall Study|Adverse Event|0|||
23612122|NCT01922102|65966968|FG000|Overall Study|Lost to Follow-up|1|||
23612123|NCT01922102|65966969|FG001|Overall Study|Lost to Follow-up|0|||
23612124|NCT01922102|65966970|FG002|Overall Study|Lost to Follow-up|0|||
23612125|NCT01922102|65966968|FG000|Overall Study|Administrative problems|0|||
23612126|NCT01922102|65966969|FG001|Overall Study|Administrative problems|2|||
23612127|NCT01922102|65966970|FG002|Overall Study|Administrative problems|0|||
23612128|NCT00409006|65966971|FG000|Overall Study|Death|15|||
23612129|NCT00409006|65966972|FG001|Overall Study|Death|6|||
23612130|NCT00409006|65966971|FG000|Overall Study|Lost to Follow-up|1|||
23612131|NCT00409006|65966972|FG001|Overall Study|Lost to Follow-up|2|||
23612132|NCT00409006|65966971|FG000|Overall Study|Withdrawal by Subject|3|||
23612133|NCT00409006|65966972|FG001|Overall Study|Withdrawal by Subject|2|||
23612134|NCT00409006|65966971|FG000|Overall Study|Physician Decision|1|||
23612135|NCT00409006|65966972|FG001|Overall Study|Physician Decision|2|||
23612136|NCT04908800|65966976|FG000|Overall Study|Adverse Event|0|||
23612137|NCT04908800|65966977|FG001|Overall Study|Adverse Event|0|||
23612138|NCT04908800|65966978|FG002|Overall Study|Adverse Event|0|||
23612139|NCT04908800|65966979|FG003|Overall Study|Adverse Event|0|||
23612140|NCT04908800|65966980|FG004|Overall Study|Adverse Event|0|||
23612141|NCT04908800|65966981|FG005|Overall Study|Adverse Event|0|||
23612142|NCT04908800|65966982|FG006|Overall Study|Adverse Event|0|||
23612143|NCT04908800|65966983|FG007|Overall Study|Adverse Event|0|||
23612144|NCT04908800|65966984|FG008|Overall Study|Adverse Event|0|||
23612145|NCT04908800|65966985|FG009|Overall Study|Adverse Event|0|||
23612146|NCT04908800|65966986|FG010|Overall Study|Adverse Event|1|||
23612147|NCT04908800|65966987|FG011|Overall Study|Adverse Event|0|||
23612148|NCT04908800|65966988|FG012|Overall Study|Adverse Event|0|||
23612149|NCT01804140|65966997|FG000|Overall Study|No sampling or biopsy procedures done|114|||
23612150|NCT01180400|65966998|FG000|Overall Study|Withdrawal by Subject|5|||
23612151|NCT01180400|65966999|FG001|Overall Study|Withdrawal by Subject|6|||
23612152|NCT01180400|65966998|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23612153|NCT01180400|65966999|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
23612154|NCT01180400|65966998|FG000|Overall Study|Adverse Event|12|||
23612155|NCT01180400|65966999|FG001|Overall Study|Adverse Event|10|||
23612156|NCT01180400|65966998|FG000|Overall Study|Severe non-compliance to protocol|1|||
23612157|NCT01180400|65966999|FG001|Overall Study|Severe non-compliance to protocol|2|||
23612158|NCT01180400|65966998|FG000|Overall Study|Condition under investigation worsened|2|||
23612159|NCT01180400|65966999|FG001|Overall Study|Condition under investigation worsened|1|||
23612160|NCT01180400|65966998|FG000|Overall Study|Lack of Efficacy|2|||
23612161|NCT01180400|65966999|FG001|Overall Study|Lack of Efficacy|0|||
23612162|NCT01180400|65966998|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23612163|NCT01180400|65966999|FG001|Overall Study|Study-specific withdrawal criteria|2|||
23612164|NCT01180400|65966998|FG000|Overall Study|Lost to Follow-up|2|||
23612165|NCT01180400|65966999|FG001|Overall Study|Lost to Follow-up|3|||
23612166|NCT01180400|65966998|FG000|Overall Study|Other|0|||
23612167|NCT01180400|65966999|FG001|Overall Study|Other|1|||
23612168|NCT01322347|65967000|FG000|Overall Study|Adverse Event|7|||
23612169|NCT01322347|65967001|FG001|Overall Study|Adverse Event|2|||
23612170|NCT01322347|65967000|FG000|Overall Study|Death|5|||
23612171|NCT01322347|65967001|FG001|Overall Study|Death|3|||
23612172|NCT01322347|65967000|FG000|Overall Study|Physician Decision|2|||
23612173|NCT01322347|65967001|FG001|Overall Study|Physician Decision|1|||
23612174|NCT01322347|65967000|FG000|Overall Study|Protocol Violation|5|||
23612175|NCT01322347|65967001|FG001|Overall Study|Protocol Violation|2|||
23527898|NCT01888497|65669316|FG003|Washout Period 2|Adverse Event|1|||
23527899|NCT01888497|65669313|FG000|Washout Period 2|Withdrawal by Subject|0|||
23527900|NCT01888497|65669314|FG001|Washout Period 2|Withdrawal by Subject|0|||
23527901|NCT01888497|65669315|FG002|Washout Period 2|Withdrawal by Subject|0|||
23527902|NCT01888497|65669316|FG003|Washout Period 2|Withdrawal by Subject|1|||
23527903|NCT00994448|65669317|FG000|Overall Study|Adverse Event|1|||
23527904|NCT00994448|65669318|FG001|Overall Study|Adverse Event|0|||
23527905|NCT00994448|65669317|FG000|Overall Study|Lost to Follow-up|5|||
23527906|NCT00994448|65669318|FG001|Overall Study|Lost to Follow-up|1|||
23527907|NCT00994448|65669317|FG000|Overall Study|Withdrawal by Subject|1|||
23527908|NCT00994448|65669318|FG001|Overall Study|Withdrawal by Subject|1|||
23527909|NCT00994448|65669317|FG000|Overall Study|Physician Decision|1|||
23527910|NCT00994448|65669318|FG001|Overall Study|Physician Decision|0|||
23206352|NCT03136367|64494861|FG002|T4 12 Weeks After Surgery|Death|3|||
23206353|NCT03136367|64494859|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
23206354|NCT03136367|64494860|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
23527911|NCT03851016|65669326|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23527912|NCT03851016|65669327|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
23527913|NCT01440322|65669334|FG000|Overall Study|Discomfort|2|||
23527914|NCT01440322|65669335|FG001|Overall Study|Discomfort|0|||
23527915|NCT01440322|65669334|FG000|Overall Study|Biomicroscopy|1|||
23527916|NCT01440322|65669335|FG001|Overall Study|Biomicroscopy|0|||
23527917|NCT01440322|65669334|FG000|Overall Study|Symptoms and Problems|1|||
23527918|NCT01440322|65669335|FG001|Overall Study|Symptoms and Problems|0|||
23527919|NCT01440322|65669334|FG000|Overall Study|Unacceptable Subjective Vision|1|||
23527920|NCT01440322|65669335|FG001|Overall Study|Unacceptable Subjective Vision|0|||
23527921|NCT01440322|65669334|FG000|Overall Study|Other Product Related|1|||
23527922|NCT01440322|65669335|FG001|Overall Study|Other Product Related|0|||
23527923|NCT01440322|65669334|FG000|Overall Study|Unrelated Medical Problem|0|||
23527924|NCT01440322|65669335|FG001|Overall Study|Unrelated Medical Problem|1|||
23527925|NCT01440322|65669334|FG000|Overall Study|Other Non-Product Related|1|||
23527926|NCT01440322|65669335|FG001|Overall Study|Other Non-Product Related|0|||
23527927|NCT02433834|65669336|FG000|Overall Study|Protocol-specified criteria|7|||
23527928|NCT02433834|65669336|FG000|Overall Study|Protocol Violation|3|||
23527929|NCT02433834|65669336|FG000|Overall Study|Lost to Follow-up|6|||
23527930|NCT02433834|65669336|FG000|Overall Study|Withdrawal by Subject|14|||
23527931|NCT02433834|65669336|FG000|Overall Study|Adverse Event|6|||
23527932|NCT02433834|65669336|FG000|Overall Study|Physician Decision|1|||
23527933|NCT01849588|65669337|FG000|Overall Study|Lack of Efficacy|3|||
23527934|NCT00539838|65669338|FG000|Overall Study|Fail to return|2|||
23527935|NCT00539838|65669339|FG001|Overall Study|Fail to return|0|||
23527936|NCT00539838|65669340|FG002|Overall Study|Fail to return|0|||
23612176|NCT01322347|65967000|FG000|Overall Study|Withdrawal by Subject|1|||
23527937|NCT00539838|65669338|FG000|Overall Study|Withdrawal by Subject|0|||
23206355|NCT03136367|64494861|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
23206356|NCT03136367|64494859|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
23206357|NCT03136367|64494860|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
23206358|NCT03136367|64494861|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
23206359|NCT03136367|64494859|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
23206360|NCT03136367|64494860|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
23206361|NCT03136367|64494861|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
23206362|NCT03136367|64494859|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
23206363|NCT03136367|64494860|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
23206364|NCT03136367|64494861|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
23206365|NCT03136367|64494859|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
23206366|NCT03136367|64494860|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
23527938|NCT00539838|65669339|FG001|Overall Study|Withdrawal by Subject|4|||
23527939|NCT00539838|65669340|FG002|Overall Study|Withdrawal by Subject|0|||
23527940|NCT00539838|65669338|FG000|Overall Study|Death|0|||
23527941|NCT00539838|65669339|FG001|Overall Study|Death|2|||
23527942|NCT00539838|65669340|FG002|Overall Study|Death|0|||
23527943|NCT00539838|65669338|FG000|Overall Study|Did not cooperate|1|||
23612177|NCT01322347|65967001|FG001|Overall Study|Withdrawal by Subject|4|||
23612178|NCT01322347|65967000|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
23612179|NCT01322347|65967001|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
23612180|NCT01322347|65967000|FG000|Overall Study|blood transfusion|5|||
23612181|NCT01322347|65967001|FG001|Overall Study|blood transfusion|5|||
23612182|NCT01322347|65967000|FG000|Overall Study|sponsor decision|1|||
23527944|NCT00539838|65669339|FG001|Overall Study|Did not cooperate|0|||
23527945|NCT00539838|65669340|FG002|Overall Study|Did not cooperate|1|||
23527946|NCT00539838|65669338|FG000|Overall Study|Administrative|4|||
23612183|NCT01322347|65967001|FG001|Overall Study|sponsor decision|3|||
23612184|NCT01322347|65967000|FG000|Overall Study|ineligible|6|||
23612185|NCT01322347|65967001|FG001|Overall Study|ineligible|3|||
23612186|NCT01322347|65967000|FG000|Overall Study|kidney transplant|3|||
23612187|NCT01322347|65967001|FG001|Overall Study|kidney transplant|1|||
23612188|NCT01322347|65967000|FG000|Overall Study|study drug withheld > 12 wks|0|||
23612189|NCT01322347|65967001|FG001|Overall Study|study drug withheld > 12 wks|1|||
23612190|NCT01322347|65967000|FG000|Overall Study|moved/changed dialysis|2|||
23612191|NCT01322347|65967001|FG001|Overall Study|moved/changed dialysis|4|||
23612192|NCT00476151|65967004|FG000|Overall Study|Adverse Event|0|||
23612193|NCT00476151|65967005|FG001|Overall Study|Adverse Event|2|||
23612194|NCT00476151|65967004|FG000|Overall Study|Protocol Violation|1|||
23612195|NCT00476151|65967005|FG001|Overall Study|Protocol Violation|3|||
23612196|NCT00476151|65967004|FG000|Overall Study|Withdrawal by Subject|2|||
23612197|NCT00476151|65967005|FG001|Overall Study|Withdrawal by Subject|0|||
23612198|NCT00476151|65967004|FG000|Overall Study|Physician Decision|0|||
23612199|NCT00476151|65967005|FG001|Overall Study|Physician Decision|2|||
23612200|NCT00748098|65967006|FG000|First Treatment Intervention Period|Adverse Event|1|||
23612201|NCT00748098|65967007|FG001|First Treatment Intervention Period|Adverse Event|1|||
23612202|NCT00748098|65967006|FG000|First Treatment Intervention Period|Protocol Violation|1|||
23612203|NCT00748098|65967007|FG001|First Treatment Intervention Period|Protocol Violation|0|||
23612204|NCT00748098|65967006|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
23612205|NCT00748098|65967007|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
23612206|NCT00748098|65967006|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
23612207|NCT00748098|65967007|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
23612208|NCT00748098|65967006|FG000|First Taper Period|Protocol Violation|1|||
23612209|NCT00748098|65967007|FG001|First Taper Period|Protocol Violation|0|||
23206367|NCT03136367|64494861|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
23527947|NCT00539838|65669339|FG001|Overall Study|Administrative|0|||
23527948|NCT00539838|65669340|FG002|Overall Study|Administrative|8|||
23527949|NCT00086580|65669341|FG000|Treatment Period|Disease progression|9|||
23612210|NCT00748098|65967006|FG000|First Taper Period|Withdrawal by Subject|2|||
23527950|NCT00086580|65669342|FG001|Treatment Period|Disease progression|8|||
23527951|NCT00086580|65669341|FG000|Treatment Period|Unable to comply with protocol|3|||
23612211|NCT00748098|65967007|FG001|First Taper Period|Withdrawal by Subject|0|||
23612212|NCT00748098|65967006|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
23527952|NCT00086580|65669342|FG001|Treatment Period|Unable to comply with protocol|1|||
23527953|NCT00086580|65669341|FG000|Treatment Period|Withdrawal by Subject|7|||
23527954|NCT00086580|65669342|FG001|Treatment Period|Withdrawal by Subject|8|||
23527955|NCT00086580|65669341|FG000|Treatment Period|Physician Decision|13|||
23527956|NCT00086580|65669342|FG001|Treatment Period|Physician Decision|7|||
23527957|NCT00086580|65669341|FG000|Treatment Period|AE - not treatment related|7|||
23527958|NCT00086580|65669342|FG001|Treatment Period|AE - not treatment related|7|||
23527959|NCT00086580|65669341|FG000|Treatment Period|Toxicity - treatment related|15|||
23527960|NCT00086580|65669342|FG001|Treatment Period|Toxicity - treatment related|15|||
23527961|NCT00086580|65669341|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
23527962|NCT00086580|65669342|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
23612213|NCT00748098|65967007|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
23612214|NCT00748098|65967006|FG000|1-Week Washout Period|Adverse Event|0|||
23612215|NCT00748098|65967007|FG001|1-Week Washout Period|Adverse Event|1|||
23612216|NCT00748098|65967006|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
23612217|NCT00748098|65967007|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
23612218|NCT00748098|65967006|FG000|Second Treatment Intervention Period|Adverse Event|4|||
23612219|NCT00748098|65967007|FG001|Second Treatment Intervention Period|Adverse Event|1|||
23612220|NCT00748098|65967006|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
23612221|NCT00748098|65967007|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
23612222|NCT00748098|65967006|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
23612223|NCT00748098|65967007|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
23612224|NCT01199302|65967008|FG000|Overall Study|Adverse Event|1|||
23612225|NCT01199302|65967009|FG001|Overall Study|Adverse Event|1|||
23612226|NCT01199302|65967010|FG002|Overall Study|Adverse Event|2|||
23612227|NCT01199302|65967011|FG003|Overall Study|Adverse Event|0|||
23612228|NCT01199302|65967008|FG000|Overall Study|Withdrawal by Subject|2|||
23612229|NCT01199302|65967009|FG001|Overall Study|Withdrawal by Subject|2|||
23612230|NCT01199302|65967010|FG002|Overall Study|Withdrawal by Subject|3|||
23612231|NCT01199302|65967011|FG003|Overall Study|Withdrawal by Subject|0|||
23612232|NCT01199302|65967008|FG000|Overall Study|Disease Progression|3|||
23612233|NCT01199302|65967009|FG001|Overall Study|Disease Progression|4|||
23612234|NCT01199302|65967010|FG002|Overall Study|Disease Progression|4|||
23612235|NCT01199302|65967011|FG003|Overall Study|Disease Progression|2|||
23612236|NCT01199302|65967008|FG000|Overall Study|Study Termination|13|||
23612237|NCT01199302|65967009|FG001|Overall Study|Study Termination|8|||
23612238|NCT01199302|65967010|FG002|Overall Study|Study Termination|11|||
23612239|NCT01199302|65967011|FG003|Overall Study|Study Termination|9|||
23612240|NCT01199302|65967008|FG000|Overall Study|Lost to Follow-up|0|||
23206368|NCT03136367|64494859|FG000|T5 1 Year After Surgery|Death|0|||
23206369|NCT03136367|64494860|FG001|T5 1 Year After Surgery|Death|0|||
23206370|NCT03136367|64494861|FG002|T5 1 Year After Surgery|Death|1|||
23206371|NCT03136367|64494859|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
23206372|NCT03136367|64494860|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
23206373|NCT03136367|64494861|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
23206374|NCT03136367|64494859|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
23206375|NCT03136367|64494860|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
23206376|NCT03136367|64494861|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
23206377|NCT03136367|64494859|FG000|T5 1 Year After Surgery|study ended before due|31|||
23206378|NCT03136367|64494860|FG001|T5 1 Year After Surgery|study ended before due|103|||
23527963|NCT00086580|65669341|FG000|Treatment Period|Death|5|||
23527964|NCT00086580|65669342|FG001|Treatment Period|Death|7|||
23527965|NCT00086580|65669341|FG000|Treatment Period|Other|5|||
23527966|NCT00086580|65669342|FG001|Treatment Period|Other|3|||
23527967|NCT00086580|65669341|FG000|Follow-up Period|Disease progression|72|||
23612241|NCT01199302|65967009|FG001|Overall Study|Lost to Follow-up|1|||
23612242|NCT01199302|65967010|FG002|Overall Study|Lost to Follow-up|0|||
23612243|NCT01199302|65967011|FG003|Overall Study|Lost to Follow-up|0|||
23527968|NCT00086580|65669342|FG001|Follow-up Period|Disease progression|99|||
23308883|NCT00620555|64877761|FG000|Overall Study|Withdrawal by Subject|1|||
23308884|NCT00620555|64877761|FG000|Overall Study|Choice of other treatment|1|||
23308885|NCT00620555|64877761|FG000|Overall Study|Visit failure against planned|1|||
23308886|NCT04392583|64877762|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
23308887|NCT02994940|64877763|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
23308888|NCT02994940|64877764|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
23308889|NCT02994940|64877763|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
23308890|NCT02994940|64877764|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
23308891|NCT02994940|64877763|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
23308892|NCT02994940|64877764|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
23308893|NCT02325518|64877766|FG000|Overall Study|Adverse Event|4|||
23308894|NCT02325518|64877767|FG001|Overall Study|Adverse Event|1|||
23308895|NCT02325518|64877766|FG000|Overall Study|Physician Decision|0|||
23308896|NCT02325518|64877767|FG001|Overall Study|Physician Decision|1|||
23308897|NCT02325518|64877766|FG000|Overall Study|Withdrawal by Subject|0|||
23308898|NCT02325518|64877767|FG001|Overall Study|Withdrawal by Subject|1|||
23308899|NCT03190330|64877769|FG000|Overall Study|Adverse Event|2|||
23308900|NCT03190330|64877769|FG000|Overall Study|Death|10|||
23308901|NCT03190330|64877769|FG000|Overall Study|Lost to Follow-up|1|||
23308902|NCT03190330|64877769|FG000|Overall Study|Withdrawal by Subject|6|||
23308903|NCT03190330|64877769|FG000|Overall Study|Progressive Disease|1|||
23308904|NCT00777036|64877773|FG000|On Treatment|Reason Not Specified|4|||
23308905|NCT00777036|64877774|FG001|On Treatment|Reason Not Specified|7|||
23308906|NCT00777036|64877775|FG002|On Treatment|Reason Not Specified|12|||
23527969|NCT00086580|65669341|FG000|Follow-up Period|Unable to comply with protocol|5|||
23527970|NCT00086580|65669342|FG001|Follow-up Period|Unable to comply with protocol|0|||
23527971|NCT00086580|65669341|FG000|Follow-up Period|Withdrawal by Subject|6|||
23308907|NCT00777036|64877773|FG000|On Treatment|Failure to Meet Study Criteria|0|||
23527972|NCT00086580|65669342|FG001|Follow-up Period|Withdrawal by Subject|6|||
23527973|NCT00086580|65669341|FG000|Follow-up Period|Physician Decision|0|||
23527974|NCT00086580|65669342|FG001|Follow-up Period|Physician Decision|1|||
23527975|NCT00086580|65669341|FG000|Follow-up Period|AE - not related|1|||
23527976|NCT00086580|65669342|FG001|Follow-up Period|AE - not related|0|||
23527977|NCT00086580|65669341|FG000|Follow-up Period|Death|13|||
23527978|NCT00086580|65669342|FG001|Follow-up Period|Death|7|||
23527979|NCT00086580|65669341|FG000|Follow-up Period|Other|7|||
23527980|NCT00086580|65669342|FG001|Follow-up Period|Other|6|||
23527981|NCT00086580|65669341|FG000|Observation Period|Unable to comply with protocol|1|||
23527982|NCT00086580|65669342|FG001|Observation Period|Unable to comply with protocol|1|||
23527983|NCT00086580|65669341|FG000|Observation Period|Withdrawal by Subject|4|||
23527984|NCT00086580|65669342|FG001|Observation Period|Withdrawal by Subject|2|||
23527985|NCT00086580|65669341|FG000|Observation Period|Death|33|||
23527986|NCT00086580|65669342|FG001|Observation Period|Death|55|||
23527987|NCT00086580|65669341|FG000|Observation Period|Other|8|||
23527988|NCT00086580|65669342|FG001|Observation Period|Other|7|||
23308908|NCT00777036|64877774|FG001|On Treatment|Failure to Meet Study Criteria|1|||
23308909|NCT00777036|64877775|FG002|On Treatment|Failure to Meet Study Criteria|0|||
23308910|NCT00777036|64877773|FG000|On Treatment|Non-compliance with Study Drug|1|||
23308911|NCT00777036|64877774|FG001|On Treatment|Non-compliance with Study Drug|0|||
23308912|NCT00777036|64877775|FG002|On Treatment|Non-compliance with Study Drug|0|||
23308913|NCT00777036|64877773|FG000|On Treatment|Maximum Clinical Benefit|2|||
23308914|NCT00777036|64877774|FG001|On Treatment|Maximum Clinical Benefit|0|||
23308915|NCT00777036|64877775|FG002|On Treatment|Maximum Clinical Benefit|1|||
23308916|NCT00777036|64877773|FG000|On Treatment|Withdrawal by Subject|3|||
23308917|NCT00777036|64877774|FG001|On Treatment|Withdrawal by Subject|2|||
23308918|NCT00777036|64877775|FG002|On Treatment|Withdrawal by Subject|3|||
23308919|NCT00777036|64877773|FG000|On Treatment|Death|0|||
23308920|NCT00777036|64877774|FG001|On Treatment|Death|2|||
23308921|NCT00777036|64877775|FG002|On Treatment|Death|0|||
23308922|NCT00777036|64877773|FG000|On Treatment|Study Drug Toxicity|0|||
23308923|NCT00777036|64877774|FG001|On Treatment|Study Drug Toxicity|0|||
23308924|NCT00777036|64877775|FG002|On Treatment|Study Drug Toxicity|1|||
23308925|NCT00777036|64877773|FG000|On Treatment|Progressive Disease|5|||
23308926|NCT00777036|64877774|FG001|On Treatment|Progressive Disease|4|||
23308927|NCT00777036|64877775|FG002|On Treatment|Progressive Disease|6|||
23308928|NCT00777036|64877773|FG000|Follow-Up|Lost to Follow-up|1|||
23308929|NCT00777036|64877774|FG001|Follow-Up|Lost to Follow-up|0|||
23308930|NCT00777036|64877775|FG002|Follow-Up|Lost to Follow-up|0|||
23308931|NCT00777036|64877773|FG000|Follow-Up|Reason Not Specified|2|||
23308932|NCT00777036|64877774|FG001|Follow-Up|Reason Not Specified|0|||
23308933|NCT00777036|64877775|FG002|Follow-Up|Reason Not Specified|0|||
23308934|NCT00777036|64877773|FG000|Follow-Up|Withdrawal by Subject|1|||
23308935|NCT00777036|64877774|FG001|Follow-Up|Withdrawal by Subject|0|||
23308936|NCT00777036|64877775|FG002|Follow-Up|Withdrawal by Subject|4|||
23308937|NCT00777036|64877773|FG000|Follow-Up|Death|1|||
23308938|NCT00777036|64877774|FG001|Follow-Up|Death|8|||
23308939|NCT00777036|64877775|FG002|Follow-Up|Death|0|||
23308940|NCT01292226|64877780|FG000|Overall Study|Adverse Event|5|||
23308941|NCT01292226|64877780|FG000|Overall Study|Death|1|||
23308942|NCT01292226|64877780|FG000|Overall Study|Graft loss|1|||
23308943|NCT01292226|64877780|FG000|Overall Study|Protocol Violation|3|||
23308944|NCT01292226|64877780|FG000|Overall Study|Withdrawal by Subject|1|||
23308945|NCT01292226|64877780|FG000|Overall Study|Other|2|||
23308946|NCT04594707|64877781|FG000|Overall Study|Adverse Event|0|||
23308947|NCT04594707|64877782|FG001|Overall Study|Adverse Event|0|||
23308948|NCT04594707|64877783|FG002|Overall Study|Adverse Event|1|||
23308949|NCT04594707|64877781|FG000|Overall Study|Death|0|||
23308950|NCT04594707|64877782|FG001|Overall Study|Death|2|||
23308951|NCT04594707|64877783|FG002|Overall Study|Death|2|||
23308952|NCT04594707|64877781|FG000|Overall Study|Lung Transplant|0|||
23308953|NCT04594707|64877782|FG001|Overall Study|Lung Transplant|0|||
23527989|NCT00430092|65669346|FG000|Overall Study|Adverse Event|0|||
23527990|NCT00430092|65669347|FG001|Overall Study|Adverse Event|0|||
23527991|NCT00430092|65669348|FG002|Overall Study|Adverse Event|1|||
23527992|NCT00430092|65669346|FG000|Overall Study|Lack of Efficacy|5|||
23527993|NCT00430092|65669347|FG001|Overall Study|Lack of Efficacy|2|||
23527994|NCT00430092|65669348|FG002|Overall Study|Lack of Efficacy|54|||
23308954|NCT04594707|64877783|FG002|Overall Study|Lung Transplant|1|||
23308955|NCT04594707|64877781|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
23308956|NCT04594707|64877782|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
23308957|NCT04594707|64877783|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
23308958|NCT04594707|64877781|FG000|Overall Study|Study Terminated By Sponsor|19|||
23308959|NCT04594707|64877782|FG001|Overall Study|Study Terminated By Sponsor|47|||
23527995|NCT00430092|65669346|FG000|Overall Study|Lost to Follow-up|1|||
23527996|NCT00430092|65669347|FG001|Overall Study|Lost to Follow-up|0|||
23527997|NCT00430092|65669348|FG002|Overall Study|Lost to Follow-up|0|||
23527998|NCT00430092|65669346|FG000|Overall Study|Protocol Violation|0|||
23308960|NCT04594707|64877783|FG002|Overall Study|Study Terminated By Sponsor|41|||
23308961|NCT04594707|64877781|FG000|Overall Study|Withdrawal by Subject|1|||
23308962|NCT04594707|64877782|FG001|Overall Study|Withdrawal by Subject|0|||
23418447|NCT02141399|65277222|FG000|Overall Study|Failure to meet eligibility criteria|14|||
23418448|NCT01205061|65277223|FG000|Overall Study|Adverse Event|4|||
23418449|NCT01205061|65277223|FG000|Overall Study|Withdrawal by Subject|11|||
23418450|NCT01205061|65277223|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
23418451|NCT01205061|65277223|FG000|Overall Study|Lost to Follow-up|9|||
23418452|NCT01205061|65277223|FG000|Overall Study|Other|1|||
23418453|NCT02013206|65277224|FG000|Overall Study|Progressive disease (PD)|14|||
23418454|NCT02013206|65277225|FG001|Overall Study|Progressive disease (PD)|17|||
23418455|NCT02013206|65277224|FG000|Overall Study|Symptomatic deterioration|3|||
23418456|NCT02013206|65277225|FG001|Overall Study|Symptomatic deterioration|1|||
23418457|NCT02013206|65277224|FG000|Overall Study|Adverse Event|1|||
23418458|NCT02013206|65277225|FG001|Overall Study|Adverse Event|0|||
23527999|NCT00430092|65669347|FG001|Overall Study|Protocol Violation|1|||
23528000|NCT00430092|65669348|FG002|Overall Study|Protocol Violation|1|||
23528001|NCT00430092|65669346|FG000|Overall Study|Withdrawal by Subject|0|||
23528002|NCT00430092|65669347|FG001|Overall Study|Withdrawal by Subject|1|||
23528003|NCT00430092|65669348|FG002|Overall Study|Withdrawal by Subject|1|||
23528004|NCT01541930|65669349|FG000|Overall Study|Withdrawal by Subject|1|||
23528005|NCT00529386|65669350|FG000|Overall Study|Lost to Follow-up|1|||
23528006|NCT03670810|65669351|FG000|Main Study|Adverse Event|37|||
23528007|NCT03670810|65669352|FG001|Main Study|Adverse Event|38|||
23528008|NCT03670810|65669353|FG002|Main Study|Adverse Event|3|||
23528009|NCT03670810|65669354|FG003|Main Study|Adverse Event|4|||
23528010|NCT03670810|65669355|FG004|Main Study|Adverse Event|4|||
23528011|NCT03670810|65669356|FG005|Main Study|Adverse Event|5|||
23528012|NCT03670810|65669357|FG006|Main Study|Adverse Event|0|||
23528013|NCT03670810|65669358|FG007|Main Study|Adverse Event|0|||
23528014|NCT03670810|65669359|FG008|Main Study|Adverse Event|0|||
23528015|NCT03670810|65669351|FG000|Main Study|Lack of Efficacy|8|||
23528016|NCT03670810|65669352|FG001|Main Study|Lack of Efficacy|9|||
23528017|NCT03670810|65669353|FG002|Main Study|Lack of Efficacy|3|||
23528018|NCT03670810|65669354|FG003|Main Study|Lack of Efficacy|4|||
23528019|NCT03670810|65669355|FG004|Main Study|Lack of Efficacy|0|||
23528020|NCT03670810|65669356|FG005|Main Study|Lack of Efficacy|0|||
23528021|NCT03670810|65669357|FG006|Main Study|Lack of Efficacy|0|||
23528022|NCT03670810|65669358|FG007|Main Study|Lack of Efficacy|0|||
23528023|NCT03670810|65669359|FG008|Main Study|Lack of Efficacy|0|||
23528024|NCT03670810|65669351|FG000|Main Study|Lost to Follow-up|9|||
23528025|NCT03670810|65669352|FG001|Main Study|Lost to Follow-up|7|||
23528026|NCT03670810|65669353|FG002|Main Study|Lost to Follow-up|4|||
23528027|NCT03670810|65669354|FG003|Main Study|Lost to Follow-up|6|||
23528028|NCT03670810|65669355|FG004|Main Study|Lost to Follow-up|1|||
23528029|NCT03670810|65669356|FG005|Main Study|Lost to Follow-up|0|||
23528030|NCT03670810|65669357|FG006|Main Study|Lost to Follow-up|0|||
23528031|NCT03670810|65669358|FG007|Main Study|Lost to Follow-up|0|||
23528032|NCT03670810|65669359|FG008|Main Study|Lost to Follow-up|0|||
23528033|NCT03670810|65669351|FG000|Main Study|Non-compliance with Study Drug|0|||
23528034|NCT03670810|65669352|FG001|Main Study|Non-compliance with Study Drug|2|||
23528035|NCT03670810|65669353|FG002|Main Study|Non-compliance with Study Drug|3|||
23528036|NCT03670810|65669354|FG003|Main Study|Non-compliance with Study Drug|0|||
23528037|NCT03670810|65669355|FG004|Main Study|Non-compliance with Study Drug|0|||
23528038|NCT03670810|65669356|FG005|Main Study|Non-compliance with Study Drug|0|||
23528039|NCT03670810|65669357|FG006|Main Study|Non-compliance with Study Drug|0|||
23418459|NCT02013206|65277224|FG000|Overall Study|Patient refusal|2|||
23418460|NCT02013206|65277225|FG001|Overall Study|Patient refusal|0|||
23528040|NCT03670810|65669358|FG007|Main Study|Non-compliance with Study Drug|1|||
23528041|NCT03670810|65669359|FG008|Main Study|Non-compliance with Study Drug|0|||
23528042|NCT03670810|65669351|FG000|Main Study|Physician Decision|3|||
23528043|NCT03670810|65669352|FG001|Main Study|Physician Decision|0|||
23528044|NCT03670810|65669353|FG002|Main Study|Physician Decision|1|||
23528045|NCT03670810|65669354|FG003|Main Study|Physician Decision|0|||
23528046|NCT03670810|65669355|FG004|Main Study|Physician Decision|0|||
23528047|NCT03670810|65669356|FG005|Main Study|Physician Decision|0|||
23528048|NCT03670810|65669357|FG006|Main Study|Physician Decision|1|||
23528049|NCT03670810|65669358|FG007|Main Study|Physician Decision|1|||
23528050|NCT03670810|65669359|FG008|Main Study|Physician Decision|0|||
23528051|NCT03670810|65669351|FG000|Main Study|Pregnancy|1|||
23528052|NCT03670810|65669352|FG001|Main Study|Pregnancy|2|||
23528053|NCT03670810|65669353|FG002|Main Study|Pregnancy|0|||
23528054|NCT03670810|65669354|FG003|Main Study|Pregnancy|0|||
23418461|NCT02013206|65277224|FG000|Overall Study|Patient non-compliance|1|||
23528055|NCT03670810|65669355|FG004|Main Study|Pregnancy|0|||
23528056|NCT03670810|65669356|FG005|Main Study|Pregnancy|0|||
23528057|NCT03670810|65669357|FG006|Main Study|Pregnancy|0|||
23528058|NCT03670810|65669358|FG007|Main Study|Pregnancy|0|||
23528059|NCT03670810|65669359|FG008|Main Study|Pregnancy|0|||
23528060|NCT03670810|65669351|FG000|Main Study|Protocol Deviation|2|||
23528061|NCT03670810|65669352|FG001|Main Study|Protocol Deviation|12|||
23418462|NCT02013206|65277225|FG001|Overall Study|Patient non-compliance|0|||
23418463|NCT02013206|65277224|FG000|Overall Study|Death|1|||
23418464|NCT02013206|65277225|FG001|Overall Study|Death|2|||
23418465|NCT02013206|65277224|FG000|Overall Study|Other reasons off treatment|5|||
23418466|NCT02013206|65277225|FG001|Overall Study|Other reasons off treatment|2|||
23418467|NCT02438384|65277226|FG000|Overall Study|Lost to Follow-up|8|||
23418468|NCT02438384|65277227|FG001|Overall Study|Lost to Follow-up|6|||
23418469|NCT02438384|65277228|FG002|Overall Study|Lost to Follow-up|4|||
23418470|NCT03781323|65277243|FG000|Overall Study|Withdrawal by Subject|1|||
23418471|NCT01082874|65277244|FG000|Overall Study|Lost to Follow-up|10|||
23418472|NCT01082874|65277245|FG001|Overall Study|Lost to Follow-up|10|||
23418473|NCT01082874|65277246|FG002|Overall Study|Lost to Follow-up|6|||
23418474|NCT01082874|65277247|FG003|Overall Study|Lost to Follow-up|10|||
23418475|NCT01082874|65277244|FG000|Overall Study|Withdrawal by Subject|1|||
23418476|NCT01082874|65277245|FG001|Overall Study|Withdrawal by Subject|2|||
23418477|NCT01082874|65277246|FG002|Overall Study|Withdrawal by Subject|5|||
23418478|NCT01082874|65277247|FG003|Overall Study|Withdrawal by Subject|3|||
23418479|NCT01988662|65277250|FG000|Overall Study|Subject/guardian decision|1|||
23418480|NCT01988662|65277251|FG001|Overall Study|Subject/guardian decision|1|||
23418481|NCT01988662|65277250|FG000|Overall Study|Adverse Event|3|||
23418482|NCT01988662|65277251|FG001|Overall Study|Adverse Event|1|||
23418483|NCT01229254|65277252|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
23418484|NCT01229254|65277253|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
23418485|NCT01229254|65277254|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
23418486|NCT01229254|65277252|FG000|Overall Study|Adverse Event|4|||
23418487|NCT01229254|65277253|FG001|Overall Study|Adverse Event|5|||
23418488|NCT01229254|65277254|FG002|Overall Study|Adverse Event|3|||
23418489|NCT01229254|65277252|FG000|Overall Study|Lost to Follow-up|3|||
23418490|NCT01229254|65277253|FG001|Overall Study|Lost to Follow-up|0|||
23418491|NCT01229254|65277254|FG002|Overall Study|Lost to Follow-up|1|||
23418492|NCT01229254|65277252|FG000|Overall Study|Physician Decision|0|||
23418493|NCT01229254|65277253|FG001|Overall Study|Physician Decision|3|||
23418494|NCT01229254|65277254|FG002|Overall Study|Physician Decision|0|||
23418495|NCT01229254|65277252|FG000|Overall Study|Protocol Violation|4|||
23418496|NCT01229254|65277253|FG001|Overall Study|Protocol Violation|6|||
23418497|NCT01229254|65277254|FG002|Overall Study|Protocol Violation|5|||
23418498|NCT01229254|65277252|FG000|Overall Study|Withdrawal by Subject|1|||
23418499|NCT01229254|65277253|FG001|Overall Study|Withdrawal by Subject|0|||
23418500|NCT01229254|65277254|FG002|Overall Study|Withdrawal by Subject|1|||
23418501|NCT01229254|65277252|FG000|Overall Study|Non-compliance with Study Drug|0|||
23418502|NCT01229254|65277253|FG001|Overall Study|Non-compliance with Study Drug|1|||
23418503|NCT01229254|65277254|FG002|Overall Study|Non-compliance with Study Drug|1|||
23418504|NCT02487654|65277255|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
23418505|NCT02487654|65277256|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
23418506|NCT02487654|65277255|FG000|Overall Study|Withdrawal by Subject|3|||
23418507|NCT02487654|65277256|FG001|Overall Study|Withdrawal by Subject|7|||
23418508|NCT01035463|65277257|FG000|Overall Study|Adverse Event|0|||
23418509|NCT01035463|65277258|FG001|Overall Study|Adverse Event|0|||
23418510|NCT01035463|65277259|FG002|Overall Study|Adverse Event|4|||
23418511|NCT01035463|65277260|FG003|Overall Study|Adverse Event|1|||
23418512|NCT01035463|65277261|FG004|Overall Study|Adverse Event|5|||
23418513|NCT01035463|65277262|FG005|Overall Study|Adverse Event|7|||
23418514|NCT01035463|65277257|FG000|Overall Study|Withdrawal by Subject|0|||
23418515|NCT01035463|65277258|FG001|Overall Study|Withdrawal by Subject|2|||
23418516|NCT01035463|65277259|FG002|Overall Study|Withdrawal by Subject|1|||
23418517|NCT01035463|65277260|FG003|Overall Study|Withdrawal by Subject|0|||
23418518|NCT01035463|65277261|FG004|Overall Study|Withdrawal by Subject|1|||
23418519|NCT01035463|65277262|FG005|Overall Study|Withdrawal by Subject|4|||
23418520|NCT01035463|65277257|FG000|Overall Study|Disease progression|0|||
23418521|NCT01035463|65277258|FG001|Overall Study|Disease progression|0|||
23418522|NCT01035463|65277259|FG002|Overall Study|Disease progression|0|||
23418523|NCT01035463|65277260|FG003|Overall Study|Disease progression|0|||
23418524|NCT01035463|65277261|FG004|Overall Study|Disease progression|0|||
23418525|NCT01035463|65277262|FG005|Overall Study|Disease progression|3|||
23418526|NCT01035463|65277257|FG000|Overall Study|Other Malignancy|0|||
23418527|NCT01035463|65277258|FG001|Overall Study|Other Malignancy|0|||
23418528|NCT01035463|65277259|FG002|Overall Study|Other Malignancy|0|||
23418529|NCT01035463|65277260|FG003|Overall Study|Other Malignancy|0|||
23418530|NCT01035463|65277261|FG004|Overall Study|Other Malignancy|0|||
23418531|NCT01035463|65277262|FG005|Overall Study|Other Malignancy|2|||
23418532|NCT01035463|65277257|FG000|Overall Study|Other|0|||
23418533|NCT01035463|65277258|FG001|Overall Study|Other|0|||
23418534|NCT01035463|65277259|FG002|Overall Study|Other|0|||
23418535|NCT01035463|65277260|FG003|Overall Study|Other|1|||
23418536|NCT01035463|65277261|FG004|Overall Study|Other|0|||
23418537|NCT01035463|65277262|FG005|Overall Study|Other|2|||
23418538|NCT02585830|65277264|FG000|Overall Study|Withdrawal by Subject|3|||
23418539|NCT05312632|65277265|FG000|Overall Study|Adverse Event|12|||
23528062|NCT03670810|65669353|FG002|Main Study|Protocol Deviation|8|||
23528063|NCT03670810|65669354|FG003|Main Study|Protocol Deviation|4|||
23528064|NCT03670810|65669355|FG004|Main Study|Protocol Deviation|0|||
23528065|NCT03670810|65669356|FG005|Main Study|Protocol Deviation|0|||
23528066|NCT03670810|65669357|FG006|Main Study|Protocol Deviation|0|||
23528067|NCT03670810|65669358|FG007|Main Study|Protocol Deviation|0|||
23528068|NCT03670810|65669359|FG008|Main Study|Protocol Deviation|0|||
23528069|NCT03670810|65669351|FG000|Main Study|Withdrawal by Subject|21|||
23528070|NCT03670810|65669352|FG001|Main Study|Withdrawal by Subject|21|||
23528071|NCT03670810|65669353|FG002|Main Study|Withdrawal by Subject|8|||
23528072|NCT03670810|65669354|FG003|Main Study|Withdrawal by Subject|9|||
23528073|NCT03670810|65669355|FG004|Main Study|Withdrawal by Subject|5|||
23528074|NCT03670810|65669356|FG005|Main Study|Withdrawal by Subject|2|||
23528075|NCT03670810|65669357|FG006|Main Study|Withdrawal by Subject|1|||
23528076|NCT03670810|65669358|FG007|Main Study|Withdrawal by Subject|1|||
23528077|NCT03670810|65669359|FG008|Main Study|Withdrawal by Subject|0|||
23528078|NCT03670810|65669351|FG000|Main Study|Participant did not want to take the three other treatments|1|||
23528079|NCT03670810|65669352|FG001|Main Study|Participant did not want to take the three other treatments|0|||
23528080|NCT03670810|65669353|FG002|Main Study|Participant did not want to take the three other treatments|0|||
23528081|NCT03670810|65669354|FG003|Main Study|Participant did not want to take the three other treatments|0|||
23528082|NCT03670810|65669355|FG004|Main Study|Participant did not want to take the three other treatments|0|||
23528083|NCT03670810|65669356|FG005|Main Study|Participant did not want to take the three other treatments|0|||
23528084|NCT03670810|65669357|FG006|Main Study|Participant did not want to take the three other treatments|0|||
23528085|NCT03670810|65669358|FG007|Main Study|Participant did not want to take the three other treatments|0|||
23528086|NCT03670810|65669359|FG008|Main Study|Participant did not want to take the three other treatments|0|||
23528087|NCT03670810|65669351|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528088|NCT03670810|65669352|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
23528089|NCT03670810|65669353|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528090|NCT03670810|65669354|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528091|NCT03670810|65669355|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528092|NCT03670810|65669356|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528093|NCT03670810|65669357|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528094|NCT03670810|65669358|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528095|NCT03670810|65669359|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
23528096|NCT03670810|65669351|FG000|Main Study|Travel and Coronavirus issues|0|||
23528097|NCT03670810|65669352|FG001|Main Study|Travel and Coronavirus issues|0|||
23528098|NCT03670810|65669353|FG002|Main Study|Travel and Coronavirus issues|0|||
23528099|NCT03670810|65669354|FG003|Main Study|Travel and Coronavirus issues|1|||
23528100|NCT03670810|65669355|FG004|Main Study|Travel and Coronavirus issues|0|||
23528101|NCT03670810|65669356|FG005|Main Study|Travel and Coronavirus issues|0|||
23528102|NCT03670810|65669357|FG006|Main Study|Travel and Coronavirus issues|0|||
23528103|NCT03670810|65669358|FG007|Main Study|Travel and Coronavirus issues|0|||
23528104|NCT03670810|65669359|FG008|Main Study|Travel and Coronavirus issues|0|||
23528105|NCT03670810|65669351|FG000|Open Label Extension|Protocol Deviation|0|||
23528106|NCT03670810|65669352|FG001|Open Label Extension|Protocol Deviation|0|||
23528107|NCT03670810|65669353|FG002|Open Label Extension|Protocol Deviation|0|||
23528108|NCT03670810|65669354|FG003|Open Label Extension|Protocol Deviation|0|||
23528109|NCT03670810|65669355|FG004|Open Label Extension|Protocol Deviation|0|||
23528110|NCT03670810|65669356|FG005|Open Label Extension|Protocol Deviation|0|||
23528111|NCT03670810|65669357|FG006|Open Label Extension|Protocol Deviation|0|||
23528112|NCT03670810|65669358|FG007|Open Label Extension|Protocol Deviation|0|||
23528113|NCT03670810|65669359|FG008|Open Label Extension|Protocol Deviation|5|||
23528114|NCT03670810|65669351|FG000|Open Label Extension|Death|0|||
23528115|NCT03670810|65669352|FG001|Open Label Extension|Death|0|||
23528116|NCT03670810|65669353|FG002|Open Label Extension|Death|0|||
23528117|NCT03670810|65669354|FG003|Open Label Extension|Death|0|||
23528118|NCT03670810|65669355|FG004|Open Label Extension|Death|0|||
23528119|NCT03670810|65669356|FG005|Open Label Extension|Death|0|||
23528120|NCT03670810|65669357|FG006|Open Label Extension|Death|0|||
23528121|NCT03670810|65669358|FG007|Open Label Extension|Death|0|||
23528122|NCT03670810|65669359|FG008|Open Label Extension|Death|1|||
23528123|NCT03670810|65669351|FG000|Open Label Extension|COVID-19|0|||
23528124|NCT03670810|65669352|FG001|Open Label Extension|COVID-19|0|||
23528125|NCT03670810|65669353|FG002|Open Label Extension|COVID-19|0|||
23528126|NCT03670810|65669354|FG003|Open Label Extension|COVID-19|0|||
23528127|NCT03670810|65669355|FG004|Open Label Extension|COVID-19|0|||
23528128|NCT03670810|65669356|FG005|Open Label Extension|COVID-19|0|||
23528129|NCT03670810|65669357|FG006|Open Label Extension|COVID-19|0|||
23528130|NCT03670810|65669358|FG007|Open Label Extension|COVID-19|0|||
23528131|NCT03670810|65669359|FG008|Open Label Extension|COVID-19|1|||
23528132|NCT03670810|65669351|FG000|Open Label Extension|Lack of Efficacy|0|||
23528133|NCT03670810|65669352|FG001|Open Label Extension|Lack of Efficacy|0|||
23418540|NCT05312632|65277265|FG000|Overall Study|Withdrawal by Subject|10|||
23418541|NCT05312632|65277265|FG000|Overall Study|Lack of Efficacy|4|||
23418542|NCT05312632|65277265|FG000|Overall Study|Non-compliance with study procedures|9|||
23418543|NCT05312632|65277265|FG000|Overall Study|Other|4|||
23418544|NCT02901054|65277266|FG000|Overall Study|Physician Decision|1|||
23418545|NCT02901054|65277266|FG000|Overall Study|Withdrawal by Subject|3|||
23418546|NCT00294645|65277267|FG000|Overall Study|Death|10|||
23418547|NCT00294645|65277268|FG001|Overall Study|Death|18|||
23418548|NCT00294645|65277267|FG000|Overall Study|Lost to Follow-up|1|||
23418549|NCT00294645|65277268|FG001|Overall Study|Lost to Follow-up|10|||
23418550|NCT00294645|65277267|FG000|Overall Study|Withdrawal by Subject|18|||
23418551|NCT00294645|65277268|FG001|Overall Study|Withdrawal by Subject|34|||
23418552|NCT00294645|65277267|FG000|Overall Study|Physician Decision|15|||
23418553|NCT00294645|65277268|FG001|Overall Study|Physician Decision|20|||
23418554|NCT00294645|65277267|FG000|Overall Study|Other|4|||
23418555|NCT00294645|65277268|FG001|Overall Study|Other|10|||
23418556|NCT00541866|65277269|FG000|Overall Study|Adverse Event|3|||
23418557|NCT00541866|65277270|FG001|Overall Study|Adverse Event|0|||
23418558|NCT00541866|65277271|FG002|Overall Study|Adverse Event|0|||
23418559|NCT00541866|65277272|FG003|Overall Study|Adverse Event|0|||
23418560|NCT00541866|65277273|FG004|Overall Study|Adverse Event|0|||
23418561|NCT00541866|65277269|FG000|Overall Study|Death|1|||
23418562|NCT00541866|65277270|FG001|Overall Study|Death|0|||
23418563|NCT00541866|65277271|FG002|Overall Study|Death|0|||
23418564|NCT00541866|65277272|FG003|Overall Study|Death|0|||
23418565|NCT00541866|65277273|FG004|Overall Study|Death|0|||
23418566|NCT00541866|65277269|FG000|Overall Study|Lack of Efficacy|19|||
23418567|NCT00541866|65277270|FG001|Overall Study|Lack of Efficacy|15|||
23418568|NCT00541866|65277271|FG002|Overall Study|Lack of Efficacy|10|||
23206379|NCT03136367|64494861|FG002|T5 1 Year After Surgery|study ended before due|110|||
23206380|NCT03136367|64494859|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
23206381|NCT03136367|64494860|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
23206382|NCT03136367|64494861|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
23206383|NCT04387136|64494862|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
23206384|NCT04387136|64494863|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
23206385|NCT01111539|64494864|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
23206386|NCT01111539|64494865|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23206387|NCT01111539|64494866|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23206388|NCT01111539|64494867|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23206389|NCT01111539|64494868|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23206390|NCT01111539|64494864|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
23206391|NCT01111539|64494865|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23206392|NCT01111539|64494866|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23206393|NCT01111539|64494867|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23206394|NCT01111539|64494868|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23206395|NCT01111539|64494864|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
23206396|NCT01111539|64494865|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23206397|NCT01111539|64494866|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23206398|NCT01111539|64494867|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23206399|NCT01111539|64494868|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23206400|NCT01111539|64494864|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
23206401|NCT01111539|64494865|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
23206402|NCT01111539|64494866|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
23206403|NCT01111539|64494867|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
23206404|NCT01111539|64494868|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
23206405|NCT01111539|64494864|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
23206406|NCT01111539|64494865|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
23206407|NCT01111539|64494866|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
23206408|NCT01111539|64494867|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
23206409|NCT01111539|64494868|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
23206410|NCT01111539|64494864|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
23418569|NCT00541866|65277272|FG003|Overall Study|Lack of Efficacy|12|||
23418570|NCT00541866|65277273|FG004|Overall Study|Lack of Efficacy|14|||
23418571|NCT00541866|65277269|FG000|Overall Study|Not Reported or Other|11|||
23206411|NCT01111539|64494865|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23418572|NCT00541866|65277270|FG001|Overall Study|Not Reported or Other|3|||
23418573|NCT00541866|65277271|FG002|Overall Study|Not Reported or Other|3|||
23418574|NCT00541866|65277272|FG003|Overall Study|Not Reported or Other|3|||
23418575|NCT00541866|65277273|FG004|Overall Study|Not Reported or Other|1|||
23418576|NCT00541866|65277269|FG000|Overall Study|Physician Decision|0|||
23418577|NCT00541866|65277270|FG001|Overall Study|Physician Decision|0|||
23418578|NCT00541866|65277271|FG002|Overall Study|Physician Decision|2|||
23418579|NCT00541866|65277272|FG003|Overall Study|Physician Decision|1|||
23418580|NCT00541866|65277273|FG004|Overall Study|Physician Decision|0|||
23206412|NCT01111539|64494866|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23206413|NCT01111539|64494867|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23206414|NCT01111539|64494868|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23206415|NCT01111539|64494864|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
23206416|NCT01111539|64494865|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
23206417|NCT01111539|64494866|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
23206418|NCT01111539|64494867|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
23206419|NCT01111539|64494868|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
23206420|NCT01111539|64494864|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23206421|NCT01111539|64494865|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23206422|NCT01111539|64494866|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
23206423|NCT01111539|64494867|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23206424|NCT01111539|64494868|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
23206425|NCT01111539|64494864|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23206426|NCT01111539|64494865|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23206427|NCT01111539|64494866|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
23206428|NCT01111539|64494867|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23206429|NCT01111539|64494868|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
23206430|NCT01111539|64494864|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
23418581|NCT01126268|65277275|FG000|Overall Study|Adverse Event|1|||
23418582|NCT04195438|65277276|FG000|Overall Study|Withdrawal by Subject|1|||
23418583|NCT00313313|65277278|FG000|Overall Study|Lack of Efficacy|14|||
23418584|NCT00313313|65277279|FG001|Overall Study|Lack of Efficacy|9|||
23418585|NCT00313313|65277280|FG002|Overall Study|Lack of Efficacy|20|||
23418586|NCT00313313|65277278|FG000|Overall Study|Withdrawal of consent by subject|18|||
23418587|NCT00313313|65277279|FG001|Overall Study|Withdrawal of consent by subject|17|||
23418588|NCT00313313|65277280|FG002|Overall Study|Withdrawal of consent by subject|31|||
23418589|NCT00313313|65277278|FG000|Overall Study|Lost to Follow-up|10|||
23418590|NCT00313313|65277279|FG001|Overall Study|Lost to Follow-up|7|||
23418591|NCT00313313|65277280|FG002|Overall Study|Lost to Follow-up|9|||
23418592|NCT00313313|65277278|FG000|Overall Study|Adverse Event|15|||
23418593|NCT00313313|65277279|FG001|Overall Study|Adverse Event|16|||
23418594|NCT00313313|65277280|FG002|Overall Study|Adverse Event|12|||
23418595|NCT00313313|65277278|FG000|Overall Study|Physician Decision|2|||
23418596|NCT00313313|65277279|FG001|Overall Study|Physician Decision|6|||
23418597|NCT00313313|65277280|FG002|Overall Study|Physician Decision|4|||
23418598|NCT00313313|65277278|FG000|Overall Study|Poor/Noncompliance|3|||
23418599|NCT00313313|65277279|FG001|Overall Study|Poor/Noncompliance|6|||
23418600|NCT00313313|65277280|FG002|Overall Study|Poor/Noncompliance|2|||
23418601|NCT00313313|65277278|FG000|Overall Study|Pregnancy|1|||
23418602|NCT00313313|65277279|FG001|Overall Study|Pregnancy|2|||
23418603|NCT00313313|65277280|FG002|Overall Study|Pregnancy|0|||
23418604|NCT00313313|65277278|FG000|Overall Study|Death|0|||
23418605|NCT00313313|65277279|FG001|Overall Study|Death|0|||
23418606|NCT00313313|65277280|FG002|Overall Study|Death|2|||
23418607|NCT00313313|65277278|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
23418608|NCT00313313|65277279|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
23418609|NCT00313313|65277280|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
23418610|NCT01471028|65277281|FG000|VTI-208|Adverse Event|39|||
23528134|NCT03670810|65669353|FG002|Open Label Extension|Lack of Efficacy|0|||
23528135|NCT03670810|65669354|FG003|Open Label Extension|Lack of Efficacy|0|||
23528136|NCT03670810|65669355|FG004|Open Label Extension|Lack of Efficacy|0|||
23528137|NCT03670810|65669356|FG005|Open Label Extension|Lack of Efficacy|0|||
23528138|NCT03670810|65669357|FG006|Open Label Extension|Lack of Efficacy|0|||
23528139|NCT03670810|65669358|FG007|Open Label Extension|Lack of Efficacy|0|||
23528140|NCT03670810|65669359|FG008|Open Label Extension|Lack of Efficacy|39|||
23528141|NCT03670810|65669351|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
23418611|NCT01471028|65277282|FG001|VTI-208|Adverse Event|41|||
23418612|NCT01471028|65277281|FG000|VTI-208|Withdrawal by Subject|0|||
23418613|NCT01471028|65277282|FG001|VTI-208|Withdrawal by Subject|2|||
23418614|NCT01471028|65277281|FG000|VTI-208|Lost to Follow-up|1|||
23418615|NCT01471028|65277282|FG001|VTI-208|Lost to Follow-up|1|||
23418616|NCT01471028|65277281|FG000|VTI-208E|Death|7|||
23528142|NCT03670810|65669352|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
23528143|NCT03670810|65669353|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
23528144|NCT03670810|65669354|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
23528145|NCT03670810|65669355|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
23528146|NCT03670810|65669356|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
23528147|NCT03670810|65669357|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
23528148|NCT03670810|65669358|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
23528149|NCT03670810|65669359|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
23528150|NCT03670810|65669351|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528151|NCT03670810|65669352|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528152|NCT03670810|65669353|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528153|NCT03670810|65669354|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528154|NCT03670810|65669355|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528155|NCT03670810|65669356|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528156|NCT03670810|65669357|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528157|NCT03670810|65669358|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
23528158|NCT03670810|65669359|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
23528159|NCT03670810|65669351|FG000|Open Label Extension|Withdrawal by Subject|0|||
23528160|NCT03670810|65669352|FG001|Open Label Extension|Withdrawal by Subject|0|||
23528161|NCT03670810|65669353|FG002|Open Label Extension|Withdrawal by Subject|0|||
23528162|NCT03670810|65669354|FG003|Open Label Extension|Withdrawal by Subject|0|||
23528163|NCT03670810|65669355|FG004|Open Label Extension|Withdrawal by Subject|0|||
23528164|NCT03670810|65669356|FG005|Open Label Extension|Withdrawal by Subject|0|||
23528165|NCT03670810|65669357|FG006|Open Label Extension|Withdrawal by Subject|0|||
23528166|NCT03670810|65669358|FG007|Open Label Extension|Withdrawal by Subject|0|||
23528167|NCT03670810|65669359|FG008|Open Label Extension|Withdrawal by Subject|46|||
23528168|NCT03670810|65669351|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528169|NCT03670810|65669352|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23206431|NCT01111539|64494865|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
23528170|NCT03670810|65669353|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528171|NCT03670810|65669354|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23418617|NCT01471028|65277282|FG001|VTI-208E|Death|10|||
23418618|NCT01471028|65277281|FG000|VTI-208E|Withdrawal by Subject|1|||
23418619|NCT01471028|65277282|FG001|VTI-208E|Withdrawal by Subject|0|||
23418620|NCT01471028|65277281|FG000|VTI-208E|Lost to Follow-up|0|||
23418621|NCT01471028|65277282|FG001|VTI-208E|Lost to Follow-up|2|||
23528172|NCT03670810|65669355|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528173|NCT03670810|65669356|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528174|NCT03670810|65669357|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528175|NCT03670810|65669358|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
23528176|NCT03670810|65669359|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
23528177|NCT03670810|65669351|FG000|Open Label Extension|Physician Decision|0|||
23528178|NCT03670810|65669352|FG001|Open Label Extension|Physician Decision|0|||
23612244|NCT01199302|65967008|FG000|Overall Study|Other|1|||
23612245|NCT01199302|65967009|FG001|Overall Study|Other|0|||
23612246|NCT01199302|65967010|FG002|Overall Study|Other|0|||
23612247|NCT01199302|65967011|FG003|Overall Study|Other|0|||
23612248|NCT03839355|65967012|FG000|Overall Study|Withdrawal by Subject|1|||
23612249|NCT03839355|65967013|FG001|Overall Study|Withdrawal by Subject|0|||
23612250|NCT03861078|65969573|FG000|Overall Study|COVID-19 shut down|4|||
23612251|NCT03861078|65969573|FG000|Overall Study|Lost to Follow-up|1|||
23612252|NCT03861078|65969573|FG000|Overall Study|Protocol Violation|2|||
23612253|NCT03861078|65969573|FG000|Overall Study|lack of venous access|1|||
23612254|NCT00312845|65969574|FG000|Overall Study|Adverse Event|19|||
23612255|NCT00312845|65969575|FG001|Overall Study|Adverse Event|5|||
23612256|NCT00312845|65969574|FG000|Overall Study|Death|2|||
23612257|NCT00312845|65969575|FG001|Overall Study|Death|2|||
23612258|NCT00312845|65969574|FG000|Overall Study|Withdrawal by Subject|14|||
23612259|NCT00312845|65969575|FG001|Overall Study|Withdrawal by Subject|6|||
23612260|NCT00312845|65969574|FG000|Overall Study|Disease Progression|56|||
23612261|NCT00312845|65969575|FG001|Overall Study|Disease Progression|77|||
23612262|NCT00312845|65969574|FG000|Overall Study|Lost to Follow-up|2|||
23612263|NCT00312845|65969575|FG001|Overall Study|Lost to Follow-up|0|||
23612264|NCT00312845|65969574|FG000|Overall Study|Other|6|||
23612265|NCT00312845|65969575|FG001|Overall Study|Other|5|||
23612266|NCT02473913|65969576|FG000|Overall Study|Lost to Follow-up|3|||
23612267|NCT02473913|65969577|FG001|Overall Study|Lost to Follow-up|3|||
23612268|NCT01919489|65969579|FG000|Overall Study|Rejected the need of injections|4|||
23612269|NCT01919489|65969580|FG001|Overall Study|Rejected the need of injections|7|||
23612270|NCT01919489|65969579|FG000|Overall Study|Adverse Event|10|||
23612271|NCT01919489|65969580|FG001|Overall Study|Adverse Event|0|||
23612272|NCT01919489|65969579|FG000|Overall Study|Hospital readmission|2|||
23612273|NCT01919489|65969580|FG001|Overall Study|Hospital readmission|9|||
23612274|NCT01919489|65969579|FG000|Overall Study|Death|2|||
23612275|NCT01919489|65969580|FG001|Overall Study|Death|1|||
23612276|NCT01919489|65969579|FG000|Overall Study|Lost to Follow-up|38|||
23612277|NCT01919489|65969580|FG001|Overall Study|Lost to Follow-up|27|||
23612278|NCT02722278|65969581|FG000|Overall Study|Withdrawal by Subject|5|||
23612279|NCT02722278|65969582|FG001|Overall Study|Withdrawal by Subject|3|||
23528179|NCT03670810|65669353|FG002|Open Label Extension|Physician Decision|0|||
23528180|NCT03670810|65669354|FG003|Open Label Extension|Physician Decision|0|||
23612280|NCT02722278|65969581|FG000|Overall Study|Adverse Event|4|||
23528181|NCT03670810|65669355|FG004|Open Label Extension|Physician Decision|0|||
23528182|NCT03670810|65669356|FG005|Open Label Extension|Physician Decision|0|||
23528183|NCT03670810|65669357|FG006|Open Label Extension|Physician Decision|0|||
23612281|NCT02722278|65969582|FG001|Overall Study|Adverse Event|1|||
23612282|NCT02722278|65969581|FG000|Overall Study|Lost to Follow-up|2|||
23528184|NCT03670810|65669358|FG007|Open Label Extension|Physician Decision|0|||
23528185|NCT03670810|65669359|FG008|Open Label Extension|Physician Decision|2|||
23528186|NCT03670810|65669351|FG000|Open Label Extension|Non-compliance with study drug|0|||
23528187|NCT03670810|65669352|FG001|Open Label Extension|Non-compliance with study drug|0|||
23528188|NCT03670810|65669353|FG002|Open Label Extension|Non-compliance with study drug|0|||
23528189|NCT03670810|65669354|FG003|Open Label Extension|Non-compliance with study drug|0|||
23528190|NCT03670810|65669355|FG004|Open Label Extension|Non-compliance with study drug|0|||
23612283|NCT02722278|65969582|FG001|Overall Study|Lost to Follow-up|0|||
23528191|NCT03670810|65669356|FG005|Open Label Extension|Non-compliance with study drug|0|||
23528192|NCT03670810|65669357|FG006|Open Label Extension|Non-compliance with study drug|0|||
23528193|NCT03670810|65669358|FG007|Open Label Extension|Non-compliance with study drug|0|||
23612284|NCT02722278|65969581|FG000|Overall Study|Protocol Violation|1|||
23612285|NCT02722278|65969582|FG001|Overall Study|Protocol Violation|0|||
23612286|NCT02722278|65969581|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
23612287|NCT02722278|65969582|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
23612288|NCT02722278|65969581|FG000|Overall Study|Subject declined after tx assignment|0|||
23612289|NCT02722278|65969582|FG001|Overall Study|Subject declined after tx assignment|1|||
23206432|NCT01111539|64494866|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
23206433|NCT01111539|64494867|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
23206434|NCT01111539|64494868|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
23236637|NCT00280059|64608259|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
23308963|NCT04594707|64877783|FG002|Overall Study|Withdrawal by Subject|2|||
23308964|NCT01517373|64877786|FG000|Run-in Period|Death|1|||
23308965|NCT01517373|64877787|FG001|Run-in Period|Death|0|||
23528194|NCT03670810|65669359|FG008|Open Label Extension|Non-compliance with study drug|5|||
23528195|NCT03670810|65669351|FG000|Open Label Extension|Pregnancy|0|||
23528196|NCT03670810|65669352|FG001|Open Label Extension|Pregnancy|0|||
23528197|NCT03670810|65669353|FG002|Open Label Extension|Pregnancy|0|||
23528198|NCT03670810|65669354|FG003|Open Label Extension|Pregnancy|0|||
23528199|NCT03670810|65669355|FG004|Open Label Extension|Pregnancy|0|||
23528200|NCT03670810|65669356|FG005|Open Label Extension|Pregnancy|0|||
23528201|NCT03670810|65669357|FG006|Open Label Extension|Pregnancy|0|||
23528202|NCT03670810|65669358|FG007|Open Label Extension|Pregnancy|0|||
23528203|NCT03670810|65669359|FG008|Open Label Extension|Pregnancy|3|||
23528204|NCT03670810|65669351|FG000|Open Label Extension|Adverse Event|0|||
23528205|NCT03670810|65669352|FG001|Open Label Extension|Adverse Event|0|||
23528206|NCT03670810|65669353|FG002|Open Label Extension|Adverse Event|0|||
23528207|NCT03670810|65669354|FG003|Open Label Extension|Adverse Event|0|||
23528208|NCT03670810|65669355|FG004|Open Label Extension|Adverse Event|0|||
23528209|NCT03670810|65669356|FG005|Open Label Extension|Adverse Event|0|||
23528210|NCT03670810|65669357|FG006|Open Label Extension|Adverse Event|0|||
23528211|NCT03670810|65669358|FG007|Open Label Extension|Adverse Event|0|||
23308966|NCT01517373|64877788|FG002|Run-in Period|Death|0|||
23308967|NCT01517373|64877789|FG003|Run-in Period|Death|0|||
23308968|NCT01517373|64877790|FG004|Run-in Period|Death|0|||
23308969|NCT01517373|64877791|FG005|Run-in Period|Death|0|||
23308970|NCT01517373|64877786|FG000|Run-in Period|Adverse Event|5|||
23308971|NCT01517373|64877787|FG001|Run-in Period|Adverse Event|0|||
23308972|NCT01517373|64877788|FG002|Run-in Period|Adverse Event|0|||
23528212|NCT03670810|65669359|FG008|Open Label Extension|Adverse Event|24|||
23528213|NCT03670810|65669351|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
23528214|NCT03670810|65669352|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
23528215|NCT03670810|65669353|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
23528216|NCT03670810|65669354|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
23528217|NCT03670810|65669355|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
23528218|NCT03670810|65669356|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
23528219|NCT03670810|65669357|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
23528220|NCT03670810|65669358|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
23528221|NCT03670810|65669359|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
23528222|NCT03670810|65669351|FG000|Open Label Extension|Lost to Follow-up|0|||
23528223|NCT03670810|65669352|FG001|Open Label Extension|Lost to Follow-up|0|||
23528224|NCT03670810|65669353|FG002|Open Label Extension|Lost to Follow-up|0|||
23528225|NCT03670810|65669354|FG003|Open Label Extension|Lost to Follow-up|0|||
23528226|NCT03670810|65669355|FG004|Open Label Extension|Lost to Follow-up|0|||
23528227|NCT03670810|65669356|FG005|Open Label Extension|Lost to Follow-up|0|||
23528228|NCT03670810|65669357|FG006|Open Label Extension|Lost to Follow-up|0|||
23528229|NCT03670810|65669358|FG007|Open Label Extension|Lost to Follow-up|0|||
23528230|NCT03670810|65669359|FG008|Open Label Extension|Lost to Follow-up|23|||
23528231|NCT02356783|65669360|FG000|Overall Study|Lost to Follow-up|1|||
23528232|NCT02356783|65669361|FG001|Overall Study|Lost to Follow-up|3|||
23528233|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
23528234|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
23528235|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
23528236|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
23528237|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
23582174|NCT02223793|65862352|FG001|Overall Study|Withdrawal by Subject|2|||
23308973|NCT01517373|64877789|FG003|Run-in Period|Adverse Event|0|||
23308974|NCT01517373|64877790|FG004|Run-in Period|Adverse Event|0|||
23528238|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
23528239|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
23528240|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
23528241|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
23206435|NCT01111539|64494864|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
23206436|NCT01111539|64494865|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
23206437|NCT01111539|64494866|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
23206438|NCT01111539|64494867|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
23206439|NCT01111539|64494868|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
23308975|NCT01517373|64877791|FG005|Run-in Period|Adverse Event|0|||
23528242|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
23528243|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
23528244|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
23528245|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
23528246|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
23528247|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
23528248|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
23528249|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
23528250|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
23528251|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
23528252|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
23528253|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
23528254|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
23528255|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
23528256|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
23528257|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
23528258|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
23528259|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
23528260|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
23528261|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
23528262|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
23528263|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
23528264|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
23528265|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
23528266|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
23528267|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
23528268|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
23528269|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
23528270|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
23528271|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
23528272|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
23528273|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
23528274|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
23528275|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
23528276|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
23528277|NCT01218516|65669362|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
23528278|NCT01218516|65669363|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
23528279|NCT01218516|65669364|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
23528280|NCT01218516|65669365|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
23528281|NCT03881696|65669367|FG000|Overall Study|Adverse Event|2|||
23528282|NCT03881696|65669368|FG001|Overall Study|Adverse Event|0|||
23528283|NCT03881696|65669367|FG000|Overall Study|Withdrawal by Subject|2|||
23528284|NCT03881696|65669368|FG001|Overall Study|Withdrawal by Subject|0|||
23528285|NCT03881696|65669367|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
23528286|NCT03881696|65669368|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
23528287|NCT03881696|65669367|FG000|Overall Study|Failure to meet continuation criteria|1|||
23528288|NCT03881696|65669368|FG001|Overall Study|Failure to meet continuation criteria|0|||
23528289|NCT03139916|65669369|FG000|Overall Study|Withdrawal by Subject|2|||
23528290|NCT03139916|65669369|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
23528291|NCT02552316|65669370|FG000|Overall Study|Withdrawal by Subject|1|||
23528292|NCT02552316|65669370|FG000|Overall Study|Withdrawal due to non-compliance|1|||
23528293|NCT03548584|65669375|FG000|Overall Study|Lost to Follow-up|0|||
23612290|NCT02722278|65969581|FG000|Overall Study|Site closure not study related|0|||
23612291|NCT02722278|65969582|FG001|Overall Study|Site closure not study related|1|||
23612292|NCT00755716|65969585|FG000|Overall Study|Adverse Event|1|||
23612293|NCT00755716|65969586|FG001|Overall Study|Adverse Event|4|||
23612294|NCT00755716|65969587|FG002|Overall Study|Adverse Event|1|||
23612295|NCT00755716|65969585|FG000|Overall Study|Lack of Efficacy|2|||
23612296|NCT00755716|65969586|FG001|Overall Study|Lack of Efficacy|0|||
23612297|NCT00755716|65969587|FG002|Overall Study|Lack of Efficacy|0|||
23612298|NCT00755716|65969585|FG000|Overall Study|Lost to Follow-up|5|||
23612299|NCT00755716|65969586|FG001|Overall Study|Lost to Follow-up|3|||
23612300|NCT00755716|65969587|FG002|Overall Study|Lost to Follow-up|1|||
23612301|NCT00755716|65969585|FG000|Overall Study|work schedule issues|0|||
23612302|NCT00755716|65969586|FG001|Overall Study|work schedule issues|1|||
23612303|NCT00755716|65969587|FG002|Overall Study|work schedule issues|1|||
23612304|NCT00451906|65969588|FG000|Overall Study|Adverse Event|515|||
23612305|NCT00451906|65969588|FG000|Overall Study|Lost to Follow-up|31|||
23612306|NCT00451906|65969588|FG000|Overall Study|Withdrawal by Subject|111|||
23612307|NCT00451906|65969588|FG000|Overall Study|Protocol Violation|21|||
23612308|NCT00451906|65969588|FG000|Overall Study|Progressive disease|1328|||
23612309|NCT00451906|65969588|FG000|Overall Study|Termination of the study|108|||
23612310|NCT00451906|65969588|FG000|Overall Study|Other Reasons|121|||
23612311|NCT00451906|65969588|FG000|Overall Study|Did not complete final visit|4|||
23612312|NCT01061775|65969589|FG000|Overall Study|Physician Decision|2|||
23612313|NCT01061775|65969589|FG000|Overall Study|Lost to Follow-up|1|||
23175810|NCT00560755|64386565|FG000|Overall Study|Physician Decision|2|||
23528294|NCT03548584|65669376|FG001|Overall Study|Lost to Follow-up|0|||
23528295|NCT03548584|65669377|FG002|Overall Study|Lost to Follow-up|1|||
23528296|NCT03548584|65669375|FG000|Overall Study|Adverse Event|1|||
23528297|NCT03548584|65669376|FG001|Overall Study|Adverse Event|11|||
23528298|NCT03548584|65669377|FG002|Overall Study|Adverse Event|5|||
23528299|NCT03548584|65669375|FG000|Overall Study|Site Terminated by Sponsor|1|||
23528300|NCT03548584|65669376|FG001|Overall Study|Site Terminated by Sponsor|3|||
23528301|NCT03548584|65669377|FG002|Overall Study|Site Terminated by Sponsor|2|||
23528302|NCT03548584|65669375|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
23528303|NCT03548584|65669376|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
23528304|NCT03548584|65669377|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
23528305|NCT03548584|65669375|FG000|Overall Study|Lack of Efficacy|0|||
23528306|NCT03548584|65669376|FG001|Overall Study|Lack of Efficacy|1|||
23528307|NCT03548584|65669377|FG002|Overall Study|Lack of Efficacy|0|||
23528308|NCT03548584|65669375|FG000|Overall Study|Non-compliance with Study Drug|0|||
23528309|NCT03548584|65669376|FG001|Overall Study|Non-compliance with Study Drug|1|||
23528310|NCT03548584|65669377|FG002|Overall Study|Non-compliance with Study Drug|0|||
23528311|NCT03548584|65669375|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
23528312|NCT03548584|65669376|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
23528313|NCT03548584|65669377|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
23528314|NCT00353366|65669378|FG000|Overall Study|Adverse Event|8|||
23528315|NCT00353366|65669378|FG000|Overall Study|Protocol Violation|12|||
23528316|NCT00353366|65669378|FG000|Overall Study|Withdrawal by Subject|12|||
23528317|NCT00353366|65669378|FG000|Overall Study|Lost to Follow-up|92|||
23528318|NCT00353366|65669378|FG000|Overall Study|Other|19|||
23528319|NCT00101101|65669386|FG000|Overall Study|never received vaccine|20|||
23528320|NCT03350503|65669387|FG000|Overall Study|Adverse Event|5|||
23528321|NCT03350503|65669387|FG000|Overall Study|Withdrawal by Subject|5|||
23528322|NCT03350503|65669387|FG000|Overall Study|Continuation impossible due to move|4|||
23528323|NCT03350503|65669387|FG000|Overall Study|Physician Decision|3|||
23528324|NCT01454726|65669390|FG000|Overall Study|Withdrawal by Subject|0|||
23528325|NCT01454726|65669391|FG001|Overall Study|Withdrawal by Subject|1|||
23528326|NCT02821962|65669392|FG000|Overall Study|Lost to Follow-up|2|||
23528327|NCT02821962|65669393|FG001|Overall Study|Lost to Follow-up|0|||
23528328|NCT00094653|65669394|FG000|Overall Study|Death|306|||
23528329|NCT00094653|65669395|FG001|Overall Study|Death|100|||
23528330|NCT00094653|65669396|FG002|Overall Study|Death|119|||
23528331|NCT00094653|65669394|FG000|Overall Study|Subject Withdrew Consent|10|||
23528332|NCT00094653|65669395|FG001|Overall Study|Subject Withdrew Consent|2|||
23528333|NCT00094653|65669396|FG002|Overall Study|Subject Withdrew Consent|3|||
23528334|NCT00094653|65669394|FG000|Overall Study|Other|2|||
23528335|NCT00094653|65669395|FG001|Overall Study|Other|2|||
23528336|NCT00094653|65669396|FG002|Overall Study|Other|2|||
23528337|NCT00094653|65669394|FG000|Overall Study|Lost to Follow-up|3|||
23528338|NCT00094653|65669395|FG001|Overall Study|Lost to Follow-up|2|||
23528339|NCT00094653|65669396|FG002|Overall Study|Lost to Follow-up|1|||
23528340|NCT00094653|65669394|FG000|Overall Study|Protocol Violation|0|||
23612314|NCT02632747|65969592|FG000|Wash-out Period|Adverse Event|1|||
23528341|NCT00094653|65669395|FG001|Overall Study|Protocol Violation|0|||
23528342|NCT00094653|65669396|FG002|Overall Study|Protocol Violation|1|||
23612315|NCT02632747|65969593|FG001|Wash-out Period|Adverse Event|0|||
23612316|NCT01393964|65969597|FG000|Overall Study|Disease Progression|4|||
23528343|NCT00192075|65669397|FG000|Overall Study|Disease Progression|23|||
23528344|NCT00192075|65669398|FG001|Overall Study|Disease Progression|6|||
23528345|NCT00192075|65669397|FG000|Overall Study|Adverse Event|1|||
23528346|NCT00192075|65669398|FG001|Overall Study|Adverse Event|3|||
23528347|NCT00192075|65669397|FG000|Overall Study|Death|0|||
23528348|NCT00192075|65669398|FG001|Overall Study|Death|1|||
23528349|NCT00192075|65669397|FG000|Overall Study|Lack of Efficacy|0|||
23308976|NCT01517373|64877786|FG000|Run-in Period|Did not meet eligibility criteria|34|||
23308977|NCT01517373|64877787|FG001|Run-in Period|Did not meet eligibility criteria|0|||
23308978|NCT01517373|64877788|FG002|Run-in Period|Did not meet eligibility criteria|0|||
23308979|NCT01517373|64877789|FG003|Run-in Period|Did not meet eligibility criteria|0|||
23308980|NCT01517373|64877790|FG004|Run-in Period|Did not meet eligibility criteria|0|||
23308981|NCT01517373|64877791|FG005|Run-in Period|Did not meet eligibility criteria|0|||
23418622|NCT00191724|65277287|FG000|Overall Study|Adverse Event|0|||
23418623|NCT00191724|65277288|FG001|Overall Study|Adverse Event|0|||
23418624|NCT00191724|65277289|FG002|Overall Study|Adverse Event|1|||
23528350|NCT00192075|65669398|FG001|Overall Study|Lack of Efficacy|0|||
23528351|NCT00192075|65669397|FG000|Overall Study|Physician Decision|3|||
23528352|NCT00192075|65669398|FG001|Overall Study|Physician Decision|0|||
23528353|NCT00192075|65669397|FG000|Overall Study|Withdrawal by Subject|5|||
23528354|NCT00192075|65669398|FG001|Overall Study|Withdrawal by Subject|5|||
23528355|NCT00192075|65669397|FG000|Overall Study|Patient Non-Compliance|0|||
23528356|NCT00192075|65669398|FG001|Overall Study|Patient Non-Compliance|1|||
23528357|NCT00192075|65669397|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
23528358|NCT00192075|65669398|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
23528359|NCT00192075|65669397|FG000|Overall Study|Other|5|||
23528360|NCT00192075|65669398|FG001|Overall Study|Other|2|||
23528361|NCT02223767|65669399|FG000|Overall Study|Withdrawal by Subject|4|||
23528362|NCT02223767|65669400|FG001|Overall Study|Withdrawal by Subject|4|||
23528363|NCT00235989|65669405|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528364|NCT00235989|65669406|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528365|NCT00235989|65669407|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528366|NCT00235989|65669408|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528367|NCT00235989|65669409|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
23528368|NCT00235989|65669410|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
23528369|NCT00235989|65669405|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
23528370|NCT00235989|65669406|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
23528371|NCT00235989|65669407|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
23528372|NCT00235989|65669408|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
23528373|NCT00235989|65669409|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
23418625|NCT00191724|65277290|FG003|Overall Study|Adverse Event|0|||
23418626|NCT00191724|65277291|FG004|Overall Study|Adverse Event|0|||
23418627|NCT00191724|65277287|FG000|Overall Study|Lost to Follow-up|1|||
23418628|NCT00191724|65277288|FG001|Overall Study|Lost to Follow-up|1|||
23418629|NCT00191724|65277289|FG002|Overall Study|Lost to Follow-up|0|||
23418630|NCT00191724|65277290|FG003|Overall Study|Lost to Follow-up|2|||
23418631|NCT00191724|65277291|FG004|Overall Study|Lost to Follow-up|3|||
23418632|NCT00191724|65277287|FG000|Overall Study|Withdrawal by Subject|0|||
23418633|NCT00191724|65277288|FG001|Overall Study|Withdrawal by Subject|0|||
23418634|NCT00191724|65277289|FG002|Overall Study|Withdrawal by Subject|0|||
23418635|NCT00191724|65277290|FG003|Overall Study|Withdrawal by Subject|1|||
23418636|NCT00191724|65277291|FG004|Overall Study|Withdrawal by Subject|0|||
23418637|NCT03215758|65277294|FG000|Overall Study|Technical Problems|1|||
23418638|NCT03215758|65277295|FG001|Overall Study|Technical Problems|0|||
23418639|NCT03215758|65277294|FG000|Overall Study|Protocol deviation|0|||
23418640|NCT03215758|65277295|FG001|Overall Study|Protocol deviation|1|||
23528374|NCT00235989|65669410|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
23528375|NCT00235989|65669405|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
23528376|NCT00235989|65669406|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
23528377|NCT00235989|65669407|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
23528378|NCT00235989|65669408|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
23528379|NCT00235989|65669409|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
23528380|NCT00235989|65669410|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
23528381|NCT00235989|65669405|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
23418641|NCT03215758|65277294|FG000|Overall Study|Physician Decision|0|||
23418642|NCT03215758|65277295|FG001|Overall Study|Physician Decision|1|||
23308982|NCT01517373|64877786|FG000|Run-in Period|Lost to Follow-up|1|||
23308983|NCT01517373|64877787|FG001|Run-in Period|Lost to Follow-up|0|||
23308984|NCT01517373|64877788|FG002|Run-in Period|Lost to Follow-up|0|||
23308985|NCT01517373|64877789|FG003|Run-in Period|Lost to Follow-up|0|||
23308986|NCT01517373|64877790|FG004|Run-in Period|Lost to Follow-up|0|||
23308987|NCT01517373|64877791|FG005|Run-in Period|Lost to Follow-up|0|||
23308988|NCT01517373|64877786|FG000|Run-in Period|Withdrawal by Subject|12|||
23308989|NCT01517373|64877787|FG001|Run-in Period|Withdrawal by Subject|0|||
23308990|NCT01517373|64877788|FG002|Run-in Period|Withdrawal by Subject|0|||
23308991|NCT01517373|64877789|FG003|Run-in Period|Withdrawal by Subject|0|||
23308992|NCT01517373|64877790|FG004|Run-in Period|Withdrawal by Subject|0|||
23308993|NCT01517373|64877791|FG005|Run-in Period|Withdrawal by Subject|0|||
23308994|NCT01517373|64877786|FG000|Run-in Period|Sponsor Decision|3|||
23308995|NCT01517373|64877787|FG001|Run-in Period|Sponsor Decision|0|||
23308996|NCT01517373|64877788|FG002|Run-in Period|Sponsor Decision|0|||
23308997|NCT01517373|64877789|FG003|Run-in Period|Sponsor Decision|0|||
23308998|NCT01517373|64877790|FG004|Run-in Period|Sponsor Decision|0|||
23308999|NCT01517373|64877791|FG005|Run-in Period|Sponsor Decision|0|||
23309000|NCT01517373|64877786|FG000|Run-in Period|Other|1|||
23309001|NCT01517373|64877787|FG001|Run-in Period|Other|0|||
23309002|NCT01517373|64877788|FG002|Run-in Period|Other|0|||
23309003|NCT01517373|64877789|FG003|Run-in Period|Other|0|||
23418643|NCT03215758|65277294|FG000|Overall Study|Death|0|||
23309004|NCT01517373|64877790|FG004|Run-in Period|Other|0|||
23309005|NCT01517373|64877791|FG005|Run-in Period|Other|0|||
23309006|NCT01517373|64877786|FG000|Treatment Period|Adverse Event|0|||
23309007|NCT01517373|64877787|FG001|Treatment Period|Adverse Event|0|||
23612317|NCT01393964|65969598|FG001|Overall Study|Disease Progression|3|||
23309008|NCT01517373|64877788|FG002|Treatment Period|Adverse Event|0|||
23309009|NCT01517373|64877789|FG003|Treatment Period|Adverse Event|0|||
23418644|NCT03215758|65277295|FG001|Overall Study|Death|1|||
23418645|NCT03215758|65277294|FG000|Overall Study|Adverse Event|1|||
23418646|NCT03215758|65277295|FG001|Overall Study|Adverse Event|2|||
23418647|NCT03215758|65277294|FG000|Overall Study|Subject/Guardian Decision|3|||
23418648|NCT03215758|65277295|FG001|Overall Study|Subject/Guardian Decision|3|||
23418649|NCT02095873|65277296|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
23418650|NCT02095873|65277297|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
23418651|NCT02095873|65277296|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
23418652|NCT02095873|65277297|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
23418653|NCT02095873|65277296|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
23418654|NCT02095873|65277297|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
23418655|NCT00713349|65277298|FG000|Overall Study|Protocol Violation|1|||
23418656|NCT00724854|65277300|FG000|Overall Study|Lack of Efficacy|187|||
23418657|NCT00724854|65277301|FG001|Overall Study|Lack of Efficacy|13|||
23418658|NCT00724854|65277300|FG000|Overall Study|Lost to Follow-up|87|||
23418659|NCT00724854|65277301|FG001|Overall Study|Lost to Follow-up|10|||
23418660|NCT00724854|65277300|FG000|Overall Study|Adverse Event|62|||
23418661|NCT00724854|65277301|FG001|Overall Study|Adverse Event|4|||
23418662|NCT00724854|65277300|FG000|Overall Study|Other|42|||
23418663|NCT00724854|65277301|FG001|Overall Study|Other|3|||
23418664|NCT00724854|65277300|FG000|Overall Study|Death|11|||
23418665|NCT00724854|65277301|FG001|Overall Study|Death|0|||
23418666|NCT00724854|65277300|FG000|Overall Study|Change of treatment|7|||
23418667|NCT00724854|65277301|FG001|Overall Study|Change of treatment|0|||
23418668|NCT00724854|65277300|FG000|Overall Study|Withdrawal by Subject|5|||
23418669|NCT00724854|65277301|FG001|Overall Study|Withdrawal by Subject|0|||
23418670|NCT00724854|65277300|FG000|Overall Study|Adverse event + lack of efficacy|2|||
23418671|NCT00724854|65277301|FG001|Overall Study|Adverse event + lack of efficacy|1|||
23418672|NCT01560637|65277302|FG000|Overall Study|Adverse Event|63|||
23418673|NCT01560637|65277302|FG000|Overall Study|Death|69|||
23418674|NCT01560637|65277302|FG000|Overall Study|Lost to Follow-up|8|||
23418675|NCT01560637|65277302|FG000|Overall Study|Protocol Violation|8|||
23418676|NCT01560637|65277302|FG000|Overall Study|Withdrawal by Subject|24|||
23418677|NCT01560637|65277302|FG000|Overall Study|Progressive Disease|20|||
23418678|NCT01560637|65277302|FG000|Overall Study|Other Reason Not Specified|6|||
23418679|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
23418680|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
23418681|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
23418682|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
23418683|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
23418684|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
23418685|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
23418686|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
23418687|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
23418688|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
23418689|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
23418690|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
23418691|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
23418692|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
23418693|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
23418694|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
23418695|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
23418696|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418697|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418698|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418699|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418700|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418701|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418702|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418703|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418704|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418705|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418706|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418707|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418708|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23418709|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
23418710|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
23206440|NCT01111539|64494864|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
23206441|NCT01111539|64494865|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
23206442|NCT01111539|64494866|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
23206443|NCT01111539|64494867|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
23206444|NCT01111539|64494868|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
23418711|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
23418712|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
23418713|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
23418714|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
23418715|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
23418716|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
23418717|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
23418718|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
23528382|NCT00235989|65669406|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
23418719|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
23418720|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
23418721|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
23528383|NCT00235989|65669407|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
23418722|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
23418723|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
23418724|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
23528384|NCT00235989|65669408|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
23528385|NCT00235989|65669409|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
23528386|NCT00235989|65669410|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
23528387|NCT00235989|65669405|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
23528388|NCT00235989|65669406|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
23528389|NCT00235989|65669407|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
23528390|NCT00235989|65669408|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
23528391|NCT00235989|65669409|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
23528392|NCT00235989|65669410|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
23418725|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
23418726|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
23612318|NCT01393964|65969599|FG002|Overall Study|Disease Progression|5|||
23612319|NCT01393964|65969597|FG000|Overall Study|Study drug toxicity|1|||
23612320|NCT01393964|65969598|FG001|Overall Study|Study drug toxicity|0|||
23612321|NCT01393964|65969599|FG002|Overall Study|Study drug toxicity|0|||
23612322|NCT01393964|65969597|FG000|Overall Study|Withdrawal by Subject|0|||
23612323|NCT01393964|65969598|FG001|Overall Study|Withdrawal by Subject|0|||
23612324|NCT01393964|65969599|FG002|Overall Study|Withdrawal by Subject|1|||
23612325|NCT01393964|65969597|FG000|Overall Study|Adverse event unrelated to study drug|0|||
23612326|NCT01393964|65969598|FG001|Overall Study|Adverse event unrelated to study drug|3|||
23612327|NCT01393964|65969599|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23612328|NCT01393964|65969597|FG000|Overall Study|Subject request stop study treatment|0|||
23612329|NCT01393964|65969598|FG001|Overall Study|Subject request stop study treatment|1|||
23612330|NCT01393964|65969599|FG002|Overall Study|Subject request stop study treatment|0|||
23612331|NCT01393964|65969597|FG000|Overall Study|Subject decided to move to transplant|1|||
23612332|NCT01393964|65969598|FG001|Overall Study|Subject decided to move to transplant|0|||
23309010|NCT01517373|64877790|FG004|Treatment Period|Adverse Event|0|||
23528393|NCT04587193|65669411|FG000|Overall Study|Screen failure after consent|3|||
23528394|NCT04587193|65669412|FG001|Overall Study|Screen failure after consent|0|||
23528395|NCT04587193|65669411|FG000|Overall Study|Device broke during study|3|||
23528396|NCT04587193|65669412|FG001|Overall Study|Device broke during study|2|||
23528397|NCT01344447|65669413|FG000|Overall Study|Adverse Event|1|||
23528398|NCT01344447|65669413|FG000|Overall Study|Protocol Violation|1|||
23528399|NCT01344447|65669413|FG000|Overall Study|Withdrawal by Subject|1|||
23528400|NCT01344447|65669413|FG000|Overall Study|The contrast was not seen|1|||
23528401|NCT01344447|65669413|FG000|Overall Study|Physician Decision|1|||
23528402|NCT01344447|65669413|FG000|Overall Study|MRA unsuccessful|1|||
23528403|NCT01344447|65669413|FG000|Overall Study|Bolus tracking failed|1|||
23528404|NCT01344447|65669413|FG000|Overall Study|Error of power injector|1|||
23528405|NCT00096044|65669414|FG000|Overall Study|Withdrawal by Subject|9|||
23528406|NCT00096044|65669414|FG000|Overall Study|Adverse Event|21|||
23528407|NCT00096044|65669414|FG000|Overall Study|Disease Progression|4|||
23528408|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
23528409|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
23528410|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Graft loss|1|||
23528411|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Graft loss|2|||
23528412|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Death|5|||
23528413|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Death|3|||
23528414|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
23528415|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
23528416|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
23528417|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
23528418|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
23528419|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
23528420|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
23528421|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
23528422|NCT00378014|65669415|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
23528423|NCT00378014|65669416|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
23528424|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
23528425|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
23528426|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Death|1|||
23528427|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Death|2|||
23528428|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
23528429|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
23528430|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
23528431|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
23528432|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
23528433|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
23528434|NCT00378014|65669415|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
23528435|NCT00378014|65669416|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
23528436|NCT00799617|65669417|FG000|Main Testosterone Trial|Randomized in error|1|||
23528437|NCT00799617|65669418|FG001|Main Testosterone Trial|Randomized in error|1|||
23528438|NCT00799617|65669417|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
23528439|NCT00799617|65669418|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
23528440|NCT00799617|65669417|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
23528441|NCT00799617|65669418|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
23528442|NCT00799617|65669417|FG000|Sexual Funtion Trial|No Baseline Data|4|||
23528443|NCT00799617|65669418|FG001|Sexual Funtion Trial|No Baseline Data|7|||
23528444|NCT00799617|65669417|FG000|Physical Function Trial|Lost to Follow-up|6|||
23612333|NCT01393964|65969599|FG002|Overall Study|Subject decided to move to transplant|0|||
23612334|NCT01393964|65969597|FG000|Overall Study|Subject switched to commercial supply|1|||
23612335|NCT01393964|65969598|FG001|Overall Study|Subject switched to commercial supply|0|||
23612336|NCT01393964|65969599|FG002|Overall Study|Subject switched to commercial supply|2|||
23612337|NCT01393964|65969597|FG000|Overall Study|Subject plateaued in terms of effect|1|||
23612338|NCT01393964|65969598|FG001|Overall Study|Subject plateaued in terms of effect|0|||
23612339|NCT01393964|65969599|FG002|Overall Study|Subject plateaued in terms of effect|0|||
23612340|NCT01393964|65969597|FG000|Overall Study|Investigator removed subject from study|0|||
23612341|NCT01393964|65969598|FG001|Overall Study|Investigator removed subject from study|1|||
23612342|NCT01393964|65969599|FG002|Overall Study|Investigator removed subject from study|0|||
23612343|NCT01393964|65969597|FG000|Overall Study|Subject converted to roll-over study|0|||
23612344|NCT01393964|65969598|FG001|Overall Study|Subject converted to roll-over study|1|||
23612345|NCT01393964|65969599|FG002|Overall Study|Subject converted to roll-over study|0|||
23612346|NCT01393964|65969597|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
23612347|NCT01393964|65969598|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
23612348|NCT01393964|65969599|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
23612349|NCT00538629|65969600|FG000|Overall Study|At subject's request|1|||
23612350|NCT00538629|65969600|FG000|Overall Study|Adverse Event|2|||
23612351|NCT00538629|65969600|FG000|Overall Study|Lack of Efficacy|12|||
23612352|NCT00538629|65969600|FG000|Overall Study|Lost to Follow-up|6|||
23612353|NCT00538629|65969600|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
23612354|NCT02522299|65969606|FG000|Overall Study|Adverse Event|2|||
23612355|NCT02522299|65969607|FG001|Overall Study|Adverse Event|0|||
23612356|NCT02522299|65969606|FG000|Overall Study|Physician Decision|0|||
23612357|NCT02522299|65969607|FG001|Overall Study|Physician Decision|1|||
23612358|NCT02522299|65969606|FG000|Overall Study|Withdrawal by Subject|2|||
23612359|NCT02522299|65969607|FG001|Overall Study|Withdrawal by Subject|0|||
23612360|NCT02069379|65969608|FG000|Baseline Measurements|Lost to Follow-up|1|||
23612361|NCT02069379|65969609|FG001|Baseline Measurements|Lost to Follow-up|0|||
23612362|NCT02069379|65969610|FG002|Baseline Measurements|Lost to Follow-up|0|||
23612363|NCT02069379|65969611|FG003|Baseline Measurements|Lost to Follow-up|0|||
23612364|NCT02069379|65969608|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
23612365|NCT02069379|65969609|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
23612366|NCT02069379|65969610|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
23612367|NCT02069379|65969611|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
23612368|NCT02069379|65969608|FG000|First Treatment Arm|Lost to Follow-up|0|||
23612369|NCT02069379|65969609|FG001|First Treatment Arm|Lost to Follow-up|1|||
23612370|NCT02069379|65969610|FG002|First Treatment Arm|Lost to Follow-up|1|||
23528445|NCT00799617|65669418|FG001|Physical Function Trial|Lost to Follow-up|11|||
23528446|NCT00799617|65669417|FG000|Vitality Trial|Lost to Follow-up|7|||
23528447|NCT00799617|65669418|FG001|Vitality Trial|Lost to Follow-up|22|||
23528448|NCT00799617|65669417|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
23528449|NCT00799617|65669418|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
23528450|NCT00799617|65669417|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
23528451|NCT00799617|65669418|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
23528452|NCT00799617|65669417|FG000|Bone Trial|Month 12 scan not available|6|||
23528453|NCT00799617|65669418|FG001|Bone Trial|Month 12 scan not available|16|||
23528454|NCT00799617|65669417|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
23528455|NCT00799617|65669418|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
23528456|NCT00799617|65669417|FG000|Anemia Trial|Withdrawal by Subject|3|||
23528457|NCT00799617|65669418|FG001|Anemia Trial|Withdrawal by Subject|3|||
23528458|NCT01073865|65669423|FG000|Overall Study|Reasons other than below|19|||
23528459|NCT01073865|65669424|FG001|Overall Study|Reasons other than below|31|||
23528460|NCT01073865|65669423|FG000|Overall Study|Lost to Follow-up|1|||
23528461|NCT01073865|65669424|FG001|Overall Study|Lost to Follow-up|1|||
23528462|NCT01073865|65669423|FG000|Overall Study|Death|3|||
23528463|NCT01073865|65669424|FG001|Overall Study|Death|2|||
23528464|NCT01073865|65669423|FG000|Overall Study|Withdrawal by Subject|5|||
23528465|NCT01073865|65669424|FG001|Overall Study|Withdrawal by Subject|5|||
23528466|NCT02342704|65669425|FG000|Overall Study|Physician Decision|0|||
23528467|NCT02342704|65669426|FG001|Overall Study|Physician Decision|3|||
23528468|NCT02342704|65669425|FG000|Overall Study|Sponsor Termination|49|||
23528469|NCT02342704|65669426|FG001|Overall Study|Sponsor Termination|43|||
23528470|NCT02342704|65669425|FG000|Overall Study|Other|0|||
23528471|NCT02342704|65669426|FG001|Overall Study|Other|1|||
23528472|NCT02342704|65669425|FG000|Overall Study|Withdrawal by Subject|1|||
23528473|NCT02342704|65669426|FG001|Overall Study|Withdrawal by Subject|0|||
23528474|NCT02342704|65669425|FG000|Overall Study|Lost to Follow-up|2|||
23528475|NCT02342704|65669426|FG001|Overall Study|Lost to Follow-up|1|||
23612371|NCT02069379|65969611|FG003|First Treatment Arm|Lost to Follow-up|0|||
23612372|NCT02069379|65969608|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
23528476|NCT02342704|65669425|FG000|Overall Study|Adverse Event|1|||
23528477|NCT02342704|65669426|FG001|Overall Study|Adverse Event|3|||
23528478|NCT03568942|65669427|FG000|Overall Study|Family emergency|1|||
23528479|NCT03568942|65669427|FG000|Overall Study|Lost to Follow-up|1|||
23528480|NCT01466192|65669428|FG000|Overall Study|Physician Decision|1|||
23528481|NCT01466192|65669428|FG000|Overall Study|Withdrawal by Subject|3|||
23528482|NCT01944059|65669429|FG000|Overall Study|Lost to Follow-up|1|||
23528483|NCT01944059|65669429|FG000|Overall Study|Physician Decision|3|||
23528484|NCT01944059|65669429|FG000|Overall Study|Withdrawal by Subject|1|||
23528485|NCT01944059|65669429|FG000|Overall Study|Adverse Event|2|||
23528486|NCT02256891|65669430|FG000|Overall Study|Death|0|||
23528487|NCT02256891|65669431|FG001|Overall Study|Death|2|||
23528488|NCT02256891|65669430|FG000|Overall Study|Lost to Follow-up|0|||
23528489|NCT02256891|65669431|FG001|Overall Study|Lost to Follow-up|3|||
23528490|NCT02256891|65669430|FG000|Overall Study|Physician Decision|7|||
23528491|NCT02256891|65669431|FG001|Overall Study|Physician Decision|3|||
23528492|NCT02256891|65669430|FG000|Overall Study|Screen Fail|5|||
23528493|NCT02256891|65669431|FG001|Overall Study|Screen Fail|4|||
23528494|NCT02256891|65669430|FG000|Overall Study|Equipment Malfunction|0|||
23528495|NCT02256891|65669431|FG001|Overall Study|Equipment Malfunction|1|||
23528496|NCT00701129|65669432|FG000|Overall Study|Death|2|||
23528497|NCT03467425|65669433|FG000|Overall Study|Adverse Event|9|||
23528498|NCT03467425|65669434|FG001|Overall Study|Adverse Event|9|||
23528499|NCT03467425|65669433|FG000|Overall Study|Lack of Efficacy|3|||
23309011|NCT01517373|64877791|FG005|Treatment Period|Adverse Event|2|||
23309012|NCT01517373|64877786|FG000|Treatment Period|Lost to Follow-up|0|||
23309013|NCT01517373|64877787|FG001|Treatment Period|Lost to Follow-up|0|||
23309014|NCT01517373|64877788|FG002|Treatment Period|Lost to Follow-up|1|||
23309015|NCT01517373|64877789|FG003|Treatment Period|Lost to Follow-up|1|||
23309016|NCT01517373|64877790|FG004|Treatment Period|Lost to Follow-up|0|||
23309017|NCT01517373|64877791|FG005|Treatment Period|Lost to Follow-up|0|||
23309018|NCT01517373|64877786|FG000|Treatment Period|Withdrawal by Subject|0|||
23309019|NCT01517373|64877787|FG001|Treatment Period|Withdrawal by Subject|3|||
23309020|NCT01517373|64877788|FG002|Treatment Period|Withdrawal by Subject|2|||
23309021|NCT01517373|64877789|FG003|Treatment Period|Withdrawal by Subject|2|||
23309022|NCT01517373|64877790|FG004|Treatment Period|Withdrawal by Subject|2|||
23309023|NCT01517373|64877791|FG005|Treatment Period|Withdrawal by Subject|3|||
23309024|NCT01517373|64877786|FG000|Treatment Period|Other|0|||
23309025|NCT01517373|64877787|FG001|Treatment Period|Other|0|||
23309026|NCT01517373|64877788|FG002|Treatment Period|Other|0|||
23309027|NCT01517373|64877789|FG003|Treatment Period|Other|0|||
23309028|NCT01517373|64877790|FG004|Treatment Period|Other|1|||
23528500|NCT03467425|65669434|FG001|Overall Study|Lack of Efficacy|1|||
23528501|NCT03467425|65669433|FG000|Overall Study|Protocol Violation|0|||
23309029|NCT01517373|64877791|FG005|Treatment Period|Other|0|||
23309030|NCT01517373|64877786|FG000|Treatment Period|Protocol Violation|0|||
23309031|NCT01517373|64877787|FG001|Treatment Period|Protocol Violation|0|||
23528502|NCT03467425|65669434|FG001|Overall Study|Protocol Violation|1|||
23528503|NCT03467425|65669433|FG000|Overall Study|Lost to Follow-up|18|||
23528504|NCT03467425|65669434|FG001|Overall Study|Lost to Follow-up|25|||
23528505|NCT03467425|65669433|FG000|Overall Study|Physician Decision|2|||
23528506|NCT03467425|65669434|FG001|Overall Study|Physician Decision|1|||
23528507|NCT03467425|65669433|FG000|Overall Study|Withdrawal by Subject|15|||
23309032|NCT01517373|64877788|FG002|Treatment Period|Protocol Violation|0|||
23309033|NCT01517373|64877789|FG003|Treatment Period|Protocol Violation|0|||
23309034|NCT01517373|64877790|FG004|Treatment Period|Protocol Violation|1|||
23309035|NCT01517373|64877791|FG005|Treatment Period|Protocol Violation|0|||
23309036|NCT01517373|64877786|FG000|Treatment Period|Lack of Efficacy|0|||
23309037|NCT01517373|64877787|FG001|Treatment Period|Lack of Efficacy|1|||
23309038|NCT01517373|64877788|FG002|Treatment Period|Lack of Efficacy|1|||
23309039|NCT01517373|64877789|FG003|Treatment Period|Lack of Efficacy|3|||
23309040|NCT01517373|64877790|FG004|Treatment Period|Lack of Efficacy|2|||
23309041|NCT01517373|64877791|FG005|Treatment Period|Lack of Efficacy|0|||
23309042|NCT01517373|64877786|FG000|Treatment Period|Medication error without AEs|0|||
23309043|NCT01517373|64877787|FG001|Treatment Period|Medication error without AEs|0|||
23309044|NCT01517373|64877788|FG002|Treatment Period|Medication error without AEs|2|||
23309045|NCT01517373|64877789|FG003|Treatment Period|Medication error without AEs|1|||
23309046|NCT01517373|64877790|FG004|Treatment Period|Medication error without AEs|0|||
23309047|NCT01517373|64877791|FG005|Treatment Period|Medication error without AEs|2|||
23309048|NCT04933968|64877793|FG000|Overall Study|Adverse Event|0|||
23309049|NCT04933968|64877794|FG001|Overall Study|Adverse Event|0|||
23309050|NCT04933968|64877795|FG002|Overall Study|Adverse Event|1|||
23309051|NCT04933968|64877796|FG003|Overall Study|Adverse Event|1|||
23309052|NCT04933968|64877797|FG004|Overall Study|Adverse Event|0|||
23309053|NCT04933968|64877798|FG005|Overall Study|Adverse Event|0|||
23309054|NCT04933968|64877793|FG000|Overall Study|Lost to Follow-up|1|||
23309055|NCT04933968|64877794|FG001|Overall Study|Lost to Follow-up|0|||
23309056|NCT04933968|64877795|FG002|Overall Study|Lost to Follow-up|1|||
23309057|NCT04933968|64877796|FG003|Overall Study|Lost to Follow-up|0|||
23309058|NCT04933968|64877797|FG004|Overall Study|Lost to Follow-up|0|||
23309059|NCT04933968|64877798|FG005|Overall Study|Lost to Follow-up|0|||
23309060|NCT04933968|64877793|FG000|Overall Study|Randomized not treated|1|||
23309061|NCT04933968|64877794|FG001|Overall Study|Randomized not treated|0|||
23309062|NCT04933968|64877795|FG002|Overall Study|Randomized not treated|0|||
23309063|NCT04933968|64877796|FG003|Overall Study|Randomized not treated|0|||
23309064|NCT04933968|64877797|FG004|Overall Study|Randomized not treated|0|||
23309065|NCT04933968|64877798|FG005|Overall Study|Randomized not treated|0|||
23309066|NCT04933968|64877793|FG000|Overall Study|Sponsor terminated study|0|||
23309067|NCT04933968|64877794|FG001|Overall Study|Sponsor terminated study|0|||
23309068|NCT04933968|64877795|FG002|Overall Study|Sponsor terminated study|0|||
23309069|NCT04933968|64877796|FG003|Overall Study|Sponsor terminated study|1|||
23309070|NCT04933968|64877797|FG004|Overall Study|Sponsor terminated study|2|||
23309071|NCT04933968|64877798|FG005|Overall Study|Sponsor terminated study|0|||
23309072|NCT04933968|64877793|FG000|Overall Study|Other|0|||
23309073|NCT04933968|64877794|FG001|Overall Study|Other|0|||
23528508|NCT03467425|65669434|FG001|Overall Study|Withdrawal by Subject|17|||
23528509|NCT01387607|65669435|FG000|Overall Study|Adverse Event|23|||
23528510|NCT01387607|65669436|FG001|Overall Study|Adverse Event|11|||
23528511|NCT01387607|65669435|FG000|Overall Study|Lack of Efficacy|8|||
23528512|NCT01387607|65669436|FG001|Overall Study|Lack of Efficacy|6|||
23528513|NCT01387607|65669435|FG000|Overall Study|Lost to Follow-up|2|||
23528514|NCT01387607|65669436|FG001|Overall Study|Lost to Follow-up|1|||
23528515|NCT01387607|65669435|FG000|Overall Study|No longer meets eligibility criteria|0|||
23528516|NCT01387607|65669436|FG001|Overall Study|No longer meets eligibility criteria|1|||
23528517|NCT01387607|65669435|FG000|Overall Study|Protocol Violation|1|||
23528518|NCT01387607|65669436|FG001|Overall Study|Protocol Violation|5|||
23528519|NCT01387607|65669435|FG000|Overall Study|Withdrawal by Subject|13|||
23528520|NCT01387607|65669436|FG001|Overall Study|Withdrawal by Subject|14|||
23528521|NCT01387607|65669435|FG000|Overall Study|Other|1|||
23528522|NCT01387607|65669436|FG001|Overall Study|Other|1|||
23528523|NCT01387607|65669435|FG000|Overall Study|Randomized, not treated|3|||
23528524|NCT01387607|65669436|FG001|Overall Study|Randomized, not treated|6|||
23528525|NCT00715793|65669437|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
23528526|NCT00715793|65669438|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
23528527|NCT00715793|65669437|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
23528528|NCT00715793|65669438|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
23528529|NCT00308711|65669439|FG000|Overall Study|Withdrawal by Subject|1|||
23528530|NCT00308711|65669440|FG001|Overall Study|Withdrawal by Subject|0|||
23528531|NCT00308711|65669441|FG002|Overall Study|Withdrawal by Subject|1|||
23528532|NCT00308711|65669439|FG000|Overall Study|Protocol Violation|0|||
23528533|NCT00308711|65669440|FG001|Overall Study|Protocol Violation|1|||
23528534|NCT00308711|65669441|FG002|Overall Study|Protocol Violation|1|||
23528535|NCT00308711|65669439|FG000|Overall Study|Lost to Follow-up|0|||
23309074|NCT04933968|64877795|FG002|Overall Study|Other|0|||
23528536|NCT00308711|65669440|FG001|Overall Study|Lost to Follow-up|1|||
23528537|NCT00308711|65669441|FG002|Overall Study|Lost to Follow-up|0|||
23528538|NCT00308711|65669439|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
23528539|NCT00308711|65669440|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
23528540|NCT00308711|65669441|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
23528541|NCT00308711|65669439|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
23612373|NCT02069379|65969609|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
23612374|NCT02069379|65969610|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
23612375|NCT02069379|65969611|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
23612376|NCT02069379|65969608|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
23612377|NCT02069379|65969609|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
23612378|NCT02069379|65969610|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
23612379|NCT02069379|65969611|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
23612380|NCT02069379|65969608|FG000|Second Treatment Arm|Lost to Follow-up|0|||
23612381|NCT02069379|65969609|FG001|Second Treatment Arm|Lost to Follow-up|0|||
23612382|NCT02069379|65969610|FG002|Second Treatment Arm|Lost to Follow-up|1|||
23612383|NCT02069379|65969611|FG003|Second Treatment Arm|Lost to Follow-up|0|||
23612384|NCT03409276|65969612|FG000|Overall Study|Withdrawal by Subject|0|||
23612385|NCT03409276|65969613|FG001|Overall Study|Withdrawal by Subject|0|||
23612386|NCT03409276|65969614|FG002|Overall Study|Withdrawal by Subject|0|||
23612387|NCT03409276|65969615|FG003|Overall Study|Withdrawal by Subject|0|||
23612388|NCT03409276|65969616|FG004|Overall Study|Withdrawal by Subject|1|||
23612389|NCT03409276|65969612|FG000|Overall Study|Lost to Follow-up|0|||
23612390|NCT03409276|65969613|FG001|Overall Study|Lost to Follow-up|0|||
23612391|NCT03409276|65969614|FG002|Overall Study|Lost to Follow-up|0|||
23612392|NCT03409276|65969615|FG003|Overall Study|Lost to Follow-up|2|||
23612393|NCT03409276|65969616|FG004|Overall Study|Lost to Follow-up|2|||
23528542|NCT00308711|65669440|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
23528543|NCT00308711|65669441|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
23528544|NCT00025883|65669442|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
23528545|NCT00025883|65669442|FG000|Overall Study|no baseline data|1|||
23528546|NCT00025883|65669442|FG000|Overall Study|Death|1|||
23528547|NCT00025883|65669442|FG000|Overall Study|Adverse Event|1|||
23528548|NCT00025883|65669442|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
23528549|NCT00600756|65669445|FG000|Analysis After 6 Months|Adverse Event|43|||
23528550|NCT00600756|65669446|FG001|Analysis After 6 Months|Adverse Event|33|||
23612394|NCT01277302|65969622|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
23612395|NCT01277302|65969623|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
23612396|NCT01277302|65969624|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
23612397|NCT01277302|65969622|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
23612398|NCT01277302|65969623|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
23612399|NCT01277302|65969624|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
23612400|NCT01277302|65969622|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
23612401|NCT01277302|65969623|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
23612402|NCT01277302|65969624|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
23612403|NCT01277302|65969622|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
23612404|NCT01277302|65969623|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
23612405|NCT01277302|65969624|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
23612406|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
23612407|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
23612408|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
23528551|NCT00600756|65669445|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
23528552|NCT00600756|65669446|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
23528553|NCT00600756|65669445|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
23528554|NCT00600756|65669446|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
23528555|NCT00600756|65669445|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
23528556|NCT00600756|65669446|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
23612409|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
23612410|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
23612411|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
23612412|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
23612413|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
23528557|NCT00600756|65669445|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
23528558|NCT00600756|65669446|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
23612414|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
23528559|NCT00600756|65669445|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
23528560|NCT00600756|65669446|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
23528561|NCT00600756|65669445|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
23528562|NCT00600756|65669446|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
23528563|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
23528564|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
23528565|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
23528566|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
23528567|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
23528568|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
23528569|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
23528570|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
23528571|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
23528572|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
23528573|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
23528574|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
23528575|NCT00600756|65669445|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
23528576|NCT00600756|65669446|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
23528577|NCT01559311|65669447|FG000|Overall Study|Protocol Violation|0|||
23528578|NCT01559311|65669448|FG001|Overall Study|Protocol Violation|0|||
23528579|NCT01559311|65669449|FG002|Overall Study|Protocol Violation|2|||
23528580|NCT01559311|65669447|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
23528581|NCT01559311|65669448|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
23528582|NCT01559311|65669449|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
23528583|NCT01559311|65669447|FG000|Overall Study|Withdrawal by Subject|2|||
23528584|NCT01559311|65669448|FG001|Overall Study|Withdrawal by Subject|1|||
23528585|NCT01559311|65669449|FG002|Overall Study|Withdrawal by Subject|0|||
23528586|NCT01559311|65669447|FG000|Overall Study|Death|0|||
23528587|NCT01559311|65669448|FG001|Overall Study|Death|2|||
23528588|NCT01559311|65669449|FG002|Overall Study|Death|3|||
23528589|NCT01559311|65669447|FG000|Overall Study|Lost to Follow-up|0|||
23528590|NCT01559311|65669448|FG001|Overall Study|Lost to Follow-up|3|||
23528591|NCT01559311|65669449|FG002|Overall Study|Lost to Follow-up|2|||
23528592|NCT01559311|65669447|FG000|Overall Study|Adverse Event|0|||
23528593|NCT01559311|65669448|FG001|Overall Study|Adverse Event|0|||
23528594|NCT01559311|65669449|FG002|Overall Study|Adverse Event|1|||
23528595|NCT01247090|65669450|FG000|Overall Study|Physician Decision|1|||
23528596|NCT01247090|65669451|FG001|Overall Study|Physician Decision|0|||
23528597|NCT01247090|65669452|FG002|Overall Study|Physician Decision|0|||
23528598|NCT01247090|65669450|FG000|Overall Study|Withdrawal by Subject|0|||
23528599|NCT01247090|65669451|FG001|Overall Study|Withdrawal by Subject|1|||
23528600|NCT01247090|65669452|FG002|Overall Study|Withdrawal by Subject|0|||
23528601|NCT02448875|65669453|FG000|Overall Study|Adverse Event|2|||
23528602|NCT02448875|65669454|FG001|Overall Study|Adverse Event|1|||
23528603|NCT02448875|65669455|FG002|Overall Study|Adverse Event|0|||
23528604|NCT02448875|65669453|FG000|Overall Study|Lost to Follow-up|1|||
23528605|NCT02448875|65669454|FG001|Overall Study|Lost to Follow-up|0|||
23528606|NCT02448875|65669455|FG002|Overall Study|Lost to Follow-up|0|||
23528607|NCT02448875|65669453|FG000|Overall Study|Investigator Decision|3|||
23528608|NCT02448875|65669454|FG001|Overall Study|Investigator Decision|0|||
23528609|NCT02448875|65669455|FG002|Overall Study|Investigator Decision|1|||
23528610|NCT02448875|65669453|FG000|Overall Study|Withdrawal by Subject|1|||
23528611|NCT02448875|65669454|FG001|Overall Study|Withdrawal by Subject|0|||
23528612|NCT02448875|65669455|FG002|Overall Study|Withdrawal by Subject|0|||
23528613|NCT00958776|65669456|FG000|Overall Study|Adverse Event|0|||
23528614|NCT00958776|65669457|FG001|Overall Study|Adverse Event|1|||
23528615|NCT00958776|65669456|FG000|Overall Study|Physician Decision|1|||
23528616|NCT00958776|65669457|FG001|Overall Study|Physician Decision|0|||
23528617|NCT00958776|65669456|FG000|Overall Study|Lost to Follow-up|2|||
23528618|NCT00958776|65669457|FG001|Overall Study|Lost to Follow-up|6|||
23528619|NCT00958776|65669456|FG000|Overall Study|Withdrawal by Subject|7|||
23528620|NCT00958776|65669457|FG001|Overall Study|Withdrawal by Subject|16|||
23528621|NCT00958776|65669456|FG000|Overall Study|Protocol Violation|1|||
23528622|NCT00958776|65669457|FG001|Overall Study|Protocol Violation|1|||
23528623|NCT00958776|65669456|FG000|Overall Study|Death|2|||
23528624|NCT00958776|65669457|FG001|Overall Study|Death|1|||
23528625|NCT00958776|65669456|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
23528626|NCT00958776|65669457|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
23528627|NCT00958776|65669456|FG000|Overall Study|Missing|1|||
23528628|NCT00958776|65669457|FG001|Overall Study|Missing|1|||
23528629|NCT00262067|65669459|FG000|Overall Study|Death|190|||
23528630|NCT00262067|65669460|FG001|Overall Study|Death|89|||
23528631|NCT00262067|65669461|FG002|Overall Study|Death|186|||
23528632|NCT00262067|65669462|FG003|Overall Study|Death|99|||
23528633|NCT00262067|65669459|FG000|Overall Study|Lost to Follow-up|5|||
23528634|NCT00262067|65669460|FG001|Overall Study|Lost to Follow-up|4|||
23528635|NCT00262067|65669461|FG002|Overall Study|Lost to Follow-up|7|||
23528636|NCT00262067|65669462|FG003|Overall Study|Lost to Follow-up|5|||
23528637|NCT00262067|65669459|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
23528638|NCT00262067|65669460|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
23528639|NCT00262067|65669461|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
23528640|NCT00262067|65669462|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
23206445|NCT01111539|64494864|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
23528641|NCT00262067|65669459|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
23528642|NCT00262067|65669460|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
23528643|NCT00262067|65669461|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
23528644|NCT00262067|65669462|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
23528645|NCT01828034|65669465|FG000|Overall Study|Withdrawal by Subject|0|||
23528646|NCT01828034|65669466|FG001|Overall Study|Withdrawal by Subject|0|||
23528647|NCT01828034|65669467|FG002|Overall Study|Withdrawal by Subject|0|||
23528648|NCT01828034|65669468|FG003|Overall Study|Withdrawal by Subject|1|||
23528649|NCT00500370|65669469|FG000|Overall Study|Adverse Event|9|||
23528650|NCT00500370|65669470|FG001|Overall Study|Adverse Event|3|||
23528651|NCT00500370|65669469|FG000|Overall Study|Lost to Follow-up|10|||
23528652|NCT00500370|65669470|FG001|Overall Study|Lost to Follow-up|10|||
23528653|NCT00500370|65669469|FG000|Overall Study|Protocol Violation|2|||
23528654|NCT00500370|65669470|FG001|Overall Study|Protocol Violation|4|||
23528655|NCT00500370|65669469|FG000|Overall Study|Sponsor Decision|2|||
23528656|NCT00500370|65669470|FG001|Overall Study|Sponsor Decision|0|||
23528657|NCT00500370|65669469|FG000|Overall Study|Subject Decision|10|||
23528658|NCT00500370|65669470|FG001|Overall Study|Subject Decision|17|||
23528659|NCT02410811|65669473|FG000|Overall Study|Withdrawal by Subject|0|||
23528660|NCT02410811|65669474|FG001|Overall Study|Withdrawal by Subject|0|||
23528661|NCT02410811|65669475|FG002|Overall Study|Withdrawal by Subject|1|||
23528662|NCT02410811|65669476|FG003|Overall Study|Withdrawal by Subject|0|||
23528663|NCT01440946|65669477|FG000|Overall Study|Lost to Follow-up|1|||
23528664|NCT01440946|65669478|FG001|Overall Study|Lost to Follow-up|1|||
23528665|NCT01440946|65669477|FG000|Overall Study|Physician Decision|1|||
23528666|NCT01440946|65669478|FG001|Overall Study|Physician Decision|0|||
23528667|NCT02553421|65669487|FG000|Overall Study|Lost to Follow-up|21|||
23528668|NCT02553421|65669488|FG001|Overall Study|Lost to Follow-up|1|||
23528669|NCT02553421|65669487|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
23528670|NCT02553421|65669488|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
23528671|NCT02553421|65669487|FG000|Overall Study|Improper Device Placement|3|||
23528672|NCT02553421|65669488|FG001|Overall Study|Improper Device Placement|0|||
23528673|NCT00337103|65669489|FG000|Overall Study|Progressive Disease|414|||
23528674|NCT00337103|65669490|FG001|Overall Study|Progressive Disease|410|||
23528675|NCT00337103|65669489|FG000|Overall Study|Adverse Event|45|||
23528676|NCT00337103|65669490|FG001|Overall Study|Adverse Event|59|||
23528677|NCT00337103|65669489|FG000|Overall Study|Subject Choice|34|||
23528678|NCT00337103|65669490|FG001|Overall Study|Subject Choice|27|||
23528679|NCT00337103|65669489|FG000|Overall Study|Clinical Progression|27|||
23528680|NCT00337103|65669490|FG001|Overall Study|Clinical Progression|24|||
23528681|NCT00337103|65669489|FG000|Overall Study|Physician Decision|15|||
23528682|NCT00337103|65669490|FG001|Overall Study|Physician Decision|14|||
23528683|NCT00337103|65669489|FG000|Overall Study|Withdrawal by Subject|8|||
23528684|NCT00337103|65669490|FG001|Overall Study|Withdrawal by Subject|5|||
23528685|NCT00337103|65669489|FG000|Overall Study|Other|5|||
23528686|NCT00337103|65669490|FG001|Overall Study|Other|6|||
23528687|NCT00337103|65669489|FG000|Overall Study|Entry Criteria Not Met|4|||
23528688|NCT00337103|65669490|FG001|Overall Study|Entry Criteria Not Met|1|||
23528689|NCT00337103|65669489|FG000|Overall Study|Lost to Follow-up|1|||
23528690|NCT00337103|65669490|FG001|Overall Study|Lost to Follow-up|2|||
23528691|NCT00337103|65669489|FG000|Overall Study|Death|1|||
23528692|NCT00337103|65669490|FG001|Overall Study|Death|0|||
23528693|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
23528694|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
23528695|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
23528696|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
23528697|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
23528698|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
23528699|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
23206446|NCT01111539|64494865|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
23206447|NCT01111539|64494866|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
23206448|NCT01111539|64494867|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
23206449|NCT01111539|64494868|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
23206450|NCT01111539|64494864|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23206451|NCT01111539|64494865|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23206452|NCT01111539|64494866|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23206453|NCT01111539|64494867|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23206454|NCT01111539|64494868|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
23206455|NCT02142894|64494871|FG000|Overall Study|Protocol Violation|8|||
23206456|NCT01093755|64494872|FG000|Overall Study|Withdrawal by Subject|3|||
23206457|NCT01093755|64494873|FG001|Overall Study|Withdrawal by Subject|4|||
23206458|NCT04105244|64494875|FG000|Overall Study|Withdrawal by Subject|10|||
23206459|NCT04105244|64494876|FG001|Overall Study|Withdrawal by Subject|12|||
23206460|NCT04105244|64494875|FG000|Overall Study|Lost to Follow-up|20|||
23206461|NCT04105244|64494876|FG001|Overall Study|Lost to Follow-up|15|||
23206462|NCT04105244|64494875|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
23206463|NCT04105244|64494876|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
23206464|NCT04105244|64494875|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
23206465|NCT04105244|64494876|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
23528700|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
23528701|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
23528702|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
23528703|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
23528704|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
23528705|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
23528706|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
23528707|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
23528708|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
23528709|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
23528710|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
23528711|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
23528712|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
23528713|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
23528714|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
23528715|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
23528716|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
23528717|NCT04542070|65669491|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
23528718|NCT04542070|65669492|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
23528719|NCT04542070|65669493|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
23528720|NCT04542070|65669494|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
23528721|NCT04542070|65669491|FG000|Maintenance + Extension Period|Adverse Event|10|||
23528722|NCT04542070|65669492|FG001|Maintenance + Extension Period|Adverse Event|2|||
23528723|NCT04542070|65669493|FG002|Maintenance + Extension Period|Adverse Event|0|||
23528724|NCT04542070|65669494|FG003|Maintenance + Extension Period|Adverse Event|0|||
23528725|NCT04542070|65669491|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
23528726|NCT04542070|65669492|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
23528727|NCT04542070|65669493|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
23528728|NCT04542070|65669494|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
23528729|NCT04542070|65669491|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
23528730|NCT04542070|65669492|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
23528731|NCT04542070|65669493|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
23528732|NCT04542070|65669494|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
23528733|NCT04542070|65669491|FG000|Maintenance + Extension Period|Physician Decision|1|||
23528734|NCT04542070|65669492|FG001|Maintenance + Extension Period|Physician Decision|1|||
23528735|NCT04542070|65669493|FG002|Maintenance + Extension Period|Physician Decision|0|||
23528736|NCT04542070|65669494|FG003|Maintenance + Extension Period|Physician Decision|0|||
23528737|NCT04542070|65669491|FG000|Maintenance + Extension Period|Protocol Violation|2|||
23528738|NCT04542070|65669492|FG001|Maintenance + Extension Period|Protocol Violation|5|||
23528739|NCT04542070|65669493|FG002|Maintenance + Extension Period|Protocol Violation|0|||
23528740|NCT04542070|65669494|FG003|Maintenance + Extension Period|Protocol Violation|0|||
23528741|NCT04542070|65669491|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
23528742|NCT04542070|65669492|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
23528743|NCT04542070|65669493|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
23528744|NCT04542070|65669494|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
23528745|NCT04542070|65669491|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
23418727|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
23418728|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
23418729|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
23418730|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
23418731|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
23418732|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
23418733|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
23528746|NCT04542070|65669492|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
23528747|NCT04542070|65669493|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
23206466|NCT01067508|64494877|FG000|Overall Study|Physician Decision|0|||
23206467|NCT01067508|64494878|FG001|Overall Study|Physician Decision|1|||
23418734|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
23418735|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
23528748|NCT04542070|65669494|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
23528749|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
23528750|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
23528751|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
23528752|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
23528753|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
23528754|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
23528755|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
23206468|NCT01067508|64494877|FG000|Overall Study|Withdrawal by Subject|0|||
23206469|NCT01067508|64494878|FG001|Overall Study|Withdrawal by Subject|1|||
23206470|NCT01875367|64494879|FG000|Overall Study|Not complete at least 2 questionaries|4|||
23206471|NCT01875367|64494880|FG001|Overall Study|Not complete at least 2 questionaries|2|||
23206472|NCT01875367|64494879|FG000|Overall Study|Not receive study treatment|1|||
23206473|NCT01875367|64494880|FG001|Overall Study|Not receive study treatment|0|||
23206474|NCT01357915|64494881|FG000|Overall Study|Lost to Follow-up|3|||
23206475|NCT01357915|64494882|FG001|Overall Study|Lost to Follow-up|0|||
23206476|NCT01104558|64494885|FG000|Overall Study|Protocol Violation|6|||
23206477|NCT01104558|64494885|FG000|Overall Study|Missing of primary efficacy assessment|10|||
23206478|NCT01104558|64494885|FG000|Overall Study|Missing of genetic analysis results|1|||
23206479|NCT01072539|64494887|FG000|Overall Study|Treated prior to the Site Initiation|1|||
23206480|NCT01072539|64494887|FG000|Overall Study|Protocol Violation|2|||
23206481|NCT03137121|64494890|FG000|Overall Study|Withdrawal by Subject|0|||
23206482|NCT03137121|64494891|FG001|Overall Study|Withdrawal by Subject|1|||
23206483|NCT00165841|64494892|FG000|Overall Study|Adverse Event|2|||
23206484|NCT00165841|64494893|FG001|Overall Study|Adverse Event|3|||
23206485|NCT00165841|64494892|FG000|Overall Study|Lack of Efficacy|6|||
23206486|NCT00165841|64494893|FG001|Overall Study|Lack of Efficacy|33|||
23206487|NCT00165841|64494892|FG000|Overall Study|Lost to Follow-up|4|||
23206488|NCT00165841|64494893|FG001|Overall Study|Lost to Follow-up|4|||
23206489|NCT00165841|64494892|FG000|Overall Study|Withdrawal by Subject|7|||
23206490|NCT00165841|64494893|FG001|Overall Study|Withdrawal by Subject|8|||
23206491|NCT00165841|64494892|FG000|Overall Study|Physician Decision|1|||
23206492|NCT00165841|64494893|FG001|Overall Study|Physician Decision|0|||
23206493|NCT00165841|64494892|FG000|Overall Study|Protocol Violation|6|||
23206494|NCT00165841|64494893|FG001|Overall Study|Protocol Violation|8|||
23206495|NCT00165841|64494892|FG000|Overall Study|Other|3|||
23206496|NCT00165841|64494893|FG001|Overall Study|Other|5|||
23206497|NCT00165841|64494892|FG000|Overall Study|Medication Noncompliance|1|||
23206498|NCT00165841|64494893|FG001|Overall Study|Medication Noncompliance|1|||
23206499|NCT01626352|64494894|FG000|Overall Study|Disease Progression|3|||
23206500|NCT01626352|64494894|FG000|Overall Study|Intercurrent Illness|2|||
23206501|NCT01626352|64494894|FG000|Overall Study|Death|2|||
23206502|NCT01626352|64494894|FG000|Overall Study|Withdrawal by Subject|1|||
23206503|NCT01626352|64494894|FG000|Overall Study|Non-Compliance|1|||
23309075|NCT04933968|64877796|FG003|Overall Study|Other|1|||
23528756|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
23528757|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
23528758|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
23528759|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
23528760|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
23528761|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
23528762|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
23528763|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
23528764|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
23528765|NCT04542070|65669491|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
23528766|NCT04542070|65669492|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
23528767|NCT04542070|65669493|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
23528768|NCT04542070|65669494|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
23528769|NCT00218543|65669497|FG000|Overall Study|Lost to Follow-up|8|||
23418736|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
23418737|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
23418738|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
23418739|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
23418740|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
23418741|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
23418742|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
23418743|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418744|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418745|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418746|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418747|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418748|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418749|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418750|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418751|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418752|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418753|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23418754|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
23418755|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
23418756|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
23418757|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
23418758|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418759|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418760|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418761|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418762|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418763|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418764|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418765|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418766|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418767|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418768|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
23418769|NCT03831191|65277303|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418770|NCT03831191|65277304|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418771|NCT03831191|65277305|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
23528770|NCT00218543|65669497|FG000|Overall Study|relocated|1|||
23528771|NCT00218543|65669497|FG000|Overall Study|Withdrawal by Subject|1|||
23528772|NCT00218543|65669497|FG000|Overall Study|Physician Decision|3|||
23528773|NCT00218543|65669497|FG000|Overall Study|Adverse Event|2|||
23528774|NCT00427635|65669502|FG000|Treatment Phase|Withdrawal by Subject|1|||
23528775|NCT00427635|65669503|FG001|Treatment Phase|Withdrawal by Subject|0|||
23528776|NCT00427635|65669502|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
23528777|NCT00427635|65669503|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
23528778|NCT01755416|65669504|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
23528779|NCT01755416|65669505|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
23528780|NCT01589822|65669509|FG000|Overall Study|Withdrawal by Subject|1|||
23528781|NCT01589822|65669510|FG001|Overall Study|Withdrawal by Subject|2|||
23418772|NCT03831191|65277306|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
23528782|NCT01589822|65669511|FG002|Overall Study|Withdrawal by Subject|0|||
23528783|NCT01589822|65669509|FG000|Overall Study|Death|1|||
23528784|NCT01589822|65669510|FG001|Overall Study|Death|0|||
23528785|NCT01589822|65669511|FG002|Overall Study|Death|0|||
23528786|NCT01589822|65669509|FG000|Overall Study|Missed 90 day visit|2|||
23528787|NCT01589822|65669510|FG001|Overall Study|Missed 90 day visit|1|||
23418773|NCT03831191|65277307|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418774|NCT03831191|65277308|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418775|NCT03831191|65277309|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418776|NCT03831191|65277310|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418777|NCT03831191|65277311|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418778|NCT03831191|65277312|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
23528788|NCT01589822|65669511|FG002|Overall Study|Missed 90 day visit|1|||
23418779|NCT03831191|65277313|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418780|NCT03831191|65277314|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418781|NCT03831191|65277315|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418782|NCT03831191|65277316|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
23528789|NCT00581776|65669512|FG000|Overall Study|Disease progression or no response|3|||
23528790|NCT01632891|65669513|FG000|Overall Study|Lost to Follow-up|0|||
23528791|NCT01632891|65669514|FG001|Overall Study|Lost to Follow-up|1|||
23528792|NCT01632891|65669513|FG000|Overall Study|Withdrawal by Subject|1|||
23528793|NCT01632891|65669514|FG001|Overall Study|Withdrawal by Subject|0|||
23528794|NCT00376168|65669515|FG000|Overall Study|Adverse Event|1|||
23418783|NCT03831191|65277317|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
23418784|NCT03831191|65277303|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
23418785|NCT03831191|65277304|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
23418786|NCT03831191|65277305|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
23418787|NCT03831191|65277306|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
23418788|NCT03831191|65277307|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
23418789|NCT03831191|65277308|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
23418790|NCT03831191|65277309|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
23418791|NCT03831191|65277310|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
23418792|NCT03831191|65277311|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
23418793|NCT03831191|65277312|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
23418794|NCT03831191|65277313|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
23418795|NCT03831191|65277314|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
23418796|NCT03831191|65277315|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
23418797|NCT03831191|65277316|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
23418798|NCT03831191|65277317|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
23418799|NCT03831191|65277303|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418800|NCT03831191|65277304|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418801|NCT03831191|65277305|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418802|NCT03831191|65277306|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418803|NCT03831191|65277307|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418804|NCT03831191|65277308|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418805|NCT03831191|65277309|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418806|NCT03831191|65277310|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418807|NCT03831191|65277311|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418808|NCT03831191|65277312|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418809|NCT03831191|65277313|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418810|NCT03831191|65277314|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418811|NCT03831191|65277315|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418812|NCT03831191|65277316|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23418813|NCT03831191|65277317|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
23418814|NCT03831191|65277303|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418815|NCT03831191|65277304|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418816|NCT03831191|65277305|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418817|NCT03831191|65277306|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418818|NCT03831191|65277307|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23528795|NCT00376168|65669516|FG001|Overall Study|Adverse Event|1|||
23528796|NCT00376168|65669515|FG000|Overall Study|Pregnancy|1|||
23309076|NCT04933968|64877797|FG004|Overall Study|Other|0|||
23418819|NCT03831191|65277308|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418820|NCT03831191|65277309|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418821|NCT03831191|65277310|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418822|NCT03831191|65277311|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418823|NCT03831191|65277312|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418824|NCT03831191|65277313|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418825|NCT03831191|65277314|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418826|NCT03831191|65277315|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23418827|NCT03831191|65277316|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23528797|NCT00376168|65669516|FG001|Overall Study|Pregnancy|0|||
23528798|NCT02075320|65669517|FG000|Overall Study|Withdrawal by Subject|2|||
23528799|NCT00684424|65669521|FG000|Overall Study|Adverse Event|1|||
23528800|NCT00684424|65669521|FG000|Overall Study|Lost to Follow-up|2|||
23528801|NCT00684424|65669521|FG000|Overall Study|Other|2|||
23528802|NCT02774681|65669524|FG000|Treatment on Study|Progressive Disease|7|||
23528803|NCT02774681|65669524|FG000|Follow-Up for 3 Years|Death|11|||
23528804|NCT02774681|65669524|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
23528805|NCT01120210|65669525|FG000|MAIN INFUSION|Adverse Event|1|||
23528806|NCT01120210|65669526|FG001|MAIN INFUSION|Adverse Event|0|||
23528807|NCT01120210|65669525|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
23528808|NCT01120210|65669526|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
23418828|NCT03831191|65277317|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
23418829|NCT04225676|65277318|FG000|Overall Study|Physician Decision|1|||
23418830|NCT04225676|65277318|FG000|Overall Study|Lack of Efficacy|1|||
23418831|NCT04225676|65277318|FG000|Overall Study|Study terminated by sponsor|3|||
23418832|NCT00349921|65277320|FG000|First Spinal Injection|Physician Decision|1|||
23418833|NCT00349921|65277321|FG001|First Spinal Injection|Physician Decision|0|||
23418834|NCT00349921|65277322|FG002|First Spinal Injection|Physician Decision|0|||
23418835|NCT00349921|65277323|FG003|First Spinal Injection|Physician Decision|0|||
23418836|NCT00349921|65277320|FG000|First Spinal Injection|Adverse Event|0|||
23418837|NCT00349921|65277321|FG001|First Spinal Injection|Adverse Event|0|||
23418838|NCT00349921|65277322|FG002|First Spinal Injection|Adverse Event|1|||
23418839|NCT00349921|65277323|FG003|First Spinal Injection|Adverse Event|0|||
23418840|NCT00473668|65277324|FG000|Overall Study|Withdrawal by Subject|0|||
23418841|NCT00473668|65277325|FG001|Overall Study|Withdrawal by Subject|2|||
23418842|NCT00473668|65277326|FG002|Overall Study|Withdrawal by Subject|0|||
23418843|NCT00473668|65277324|FG000|Overall Study|Migrated/moved from study area|3|||
23418844|NCT00473668|65277325|FG001|Overall Study|Migrated/moved from study area|2|||
23418845|NCT00473668|65277326|FG002|Overall Study|Migrated/moved from study area|0|||
23418846|NCT00473668|65277324|FG000|Overall Study|Lost to Follow-up|0|||
23418847|NCT00473668|65277325|FG001|Overall Study|Lost to Follow-up|4|||
23418848|NCT00473668|65277326|FG002|Overall Study|Lost to Follow-up|6|||
23418849|NCT00473668|65277324|FG000|Overall Study|Other|2|||
23418850|NCT00473668|65277325|FG001|Overall Study|Other|3|||
23418851|NCT00473668|65277326|FG002|Overall Study|Other|4|||
23418852|NCT01534260|65277333|FG000|Overall Study|Adverse Event|1|||
23418853|NCT01534260|65277334|FG001|Overall Study|Adverse Event|8|||
23418854|NCT01534260|65277333|FG000|Overall Study|Death|2|||
23418855|NCT01534260|65277334|FG001|Overall Study|Death|0|||
23418856|NCT01534260|65277333|FG000|Overall Study|Lack of Efficacy|1|||
23418857|NCT01534260|65277334|FG001|Overall Study|Lack of Efficacy|1|||
23418858|NCT01534260|65277333|FG000|Overall Study|Withdrawal by Subject|1|||
23418859|NCT01534260|65277334|FG001|Overall Study|Withdrawal by Subject|3|||
23418860|NCT01534260|65277333|FG000|Overall Study|Disease Progression|8|||
23418861|NCT01534260|65277334|FG001|Overall Study|Disease Progression|6|||
23418862|NCT01534260|65277333|FG000|Overall Study|Physician Decision|3|||
23418863|NCT01534260|65277334|FG001|Overall Study|Physician Decision|1|||
23418864|NCT01534260|65277333|FG000|Overall Study|No treatment, per protocol|0|||
23528809|NCT04568122|65672702|FG000|Overall Study|Lost to Follow-up|48|||
23528810|NCT04568122|65672703|FG001|Overall Study|Lost to Follow-up|44|||
23528811|NCT04568122|65672704|FG002|Overall Study|Lost to Follow-up|4|||
23528812|NCT04568122|65672705|FG003|Overall Study|Lost to Follow-up|0|||
23528813|NCT04568122|65672706|FG004|Overall Study|Lost to Follow-up|0|||
23528814|NCT04206293|65672707|FG000|Overall Study|Consent withdrawal|1|||
23528815|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
23528816|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
23528817|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
23528818|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
23528819|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
23528820|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
23418865|NCT01534260|65277334|FG001|Overall Study|No treatment, per protocol|1|||
23418866|NCT01451931|65277337|FG000|Overall Study|Lost to Follow-up|17|||
23418867|NCT01451931|65277338|FG001|Overall Study|Lost to Follow-up|36|||
23418868|NCT01451931|65277339|FG002|Overall Study|Lost to Follow-up|21|||
23418869|NCT01451931|65277337|FG000|Overall Study|Withdrawal by Subject|16|||
23418870|NCT01451931|65277338|FG001|Overall Study|Withdrawal by Subject|22|||
23418871|NCT01451931|65277339|FG002|Overall Study|Withdrawal by Subject|22|||
23418872|NCT05791565|65277341|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
23418873|NCT05791565|65277342|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
23418874|NCT04686084|65277343|FG000|Overall Study|Lost to Follow-up|1|||
23528821|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
23528822|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
23528823|NCT04033003|65672721|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
23528824|NCT04033003|65672722|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
23528825|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
23528826|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
23528827|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
23528828|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
23528829|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
23528830|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
23528831|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
23528832|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
23528833|NCT04033003|65672721|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
23528834|NCT04033003|65672722|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
23528835|NCT04033003|65672721|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
23528836|NCT04033003|65672722|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
23528837|NCT04033003|65672721|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
23528838|NCT04033003|65672722|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
23528839|NCT04033003|65672721|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
23528840|NCT04033003|65672722|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
23528841|NCT02399085|65672724|FG000|Overall Study|Adverse Event|16|||
23528842|NCT02399085|65672724|FG000|Overall Study|Death|2|||
23528843|NCT02399085|65672724|FG000|Overall Study|Withdrawal by Subject|8|||
23612415|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
23612416|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
23612417|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
23612418|NCT01277302|65969622|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
23612419|NCT01277302|65969623|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
23612420|NCT01277302|65969624|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
23612421|NCT01975701|65969625|FG000|Overall Study|Lost to Follow-up|1|||
23612422|NCT01975701|65969625|FG000|Overall Study|Death|23|||
23612423|NCT01975701|65969625|FG000|Overall Study|Physician Decision|1|||
23612424|NCT03209492|65969626|FG000|Overall Study|Case Report Forms Uncollected|5|||
23528844|NCT02399085|65672724|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
23528845|NCT02399085|65672724|FG000|Overall Study|Physician Decision|5|||
23528846|NCT03450707|65672727|FG000|Overall Study|Outside enrollment window|4|||
23528847|NCT03450707|65672728|FG001|Overall Study|Outside enrollment window|1|||
23528848|NCT03450707|65672727|FG000|Overall Study|Death|1|||
23528849|NCT03450707|65672728|FG001|Overall Study|Death|0|||
23528850|NCT03450707|65672727|FG000|Overall Study|Indication for thiamine|1|||
23528851|NCT03450707|65672728|FG001|Overall Study|Indication for thiamine|1|||
23528852|NCT03450707|65672727|FG000|Overall Study|Evidence of traumatic brain injury|1|||
23528853|NCT03450707|65672728|FG001|Overall Study|Evidence of traumatic brain injury|0|||
23612425|NCT01090076|65969627|FG000|Overall Study|Death|1|||
23612426|NCT01090076|65969628|FG001|Overall Study|Death|1|||
23612427|NCT01090076|65969627|FG000|Overall Study|Withdrawal by Subject|0|||
23612428|NCT01090076|65969628|FG001|Overall Study|Withdrawal by Subject|1|||
23612429|NCT05265247|65969629|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
23528854|NCT03450707|65672727|FG000|Overall Study|Following commands|0|||
23528855|NCT03450707|65672728|FG001|Overall Study|Following commands|3|||
23528856|NCT03450707|65672727|FG000|Overall Study|Lactate < 3.5|0|||
23612430|NCT05265247|65969630|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
23206504|NCT01626352|64494894|FG000|Overall Study|Never Treated|1|||
23206505|NCT00302718|64494897|FG000|Overall Study|Participant left the hospital|1|||
23206506|NCT00302718|64494898|FG001|Overall Study|Participant left the hospital|0|||
23206507|NCT00302718|64494899|FG002|Overall Study|Participant left the hospital|0|||
23528857|NCT03450707|65672728|FG001|Overall Study|Lactate < 3.5|2|||
23528858|NCT03450707|65672727|FG000|Overall Study|Rearrest with ECMO|0|||
23528859|NCT03450707|65672728|FG001|Overall Study|Rearrest with ECMO|1|||
23528860|NCT03450707|65672727|FG000|Overall Study|Indication for thiamine + head CT results|0|||
23528861|NCT03450707|65672728|FG001|Overall Study|Indication for thiamine + head CT results|1|||
23528862|NCT03450707|65672727|FG000|Overall Study|Family/patient goals of care|0|||
23528863|NCT03450707|65672728|FG001|Overall Study|Family/patient goals of care|1|||
23528864|NCT02603809|65672729|FG000|Overall Study|Withdrawal by Subject|4|||
23528865|NCT02603809|65672730|FG001|Overall Study|Withdrawal by Subject|1|||
23528866|NCT02603809|65672731|FG002|Overall Study|Withdrawal by Subject|2|||
23528867|NCT02603809|65672732|FG003|Overall Study|Withdrawal by Subject|3|||
23528868|NCT02603809|65672733|FG004|Overall Study|Withdrawal by Subject|3|||
23528869|NCT02603809|65672734|FG005|Overall Study|Withdrawal by Subject|4|||
23528870|NCT02603809|65672729|FG000|Overall Study|Lost to Follow-up|2|||
23528871|NCT02603809|65672730|FG001|Overall Study|Lost to Follow-up|3|||
23528872|NCT02603809|65672731|FG002|Overall Study|Lost to Follow-up|1|||
23528873|NCT02603809|65672732|FG003|Overall Study|Lost to Follow-up|4|||
23528874|NCT02603809|65672733|FG004|Overall Study|Lost to Follow-up|2|||
23528875|NCT02603809|65672734|FG005|Overall Study|Lost to Follow-up|2|||
23528876|NCT02603809|65672729|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
23528877|NCT02603809|65672730|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
23528878|NCT02603809|65672731|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
23528879|NCT02603809|65672732|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
23528880|NCT02603809|65672733|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
23528881|NCT02603809|65672734|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
23528882|NCT02603809|65672729|FG000|Overall Study|Physician Decision|0|||
23528883|NCT02603809|65672730|FG001|Overall Study|Physician Decision|0|||
23528884|NCT02603809|65672731|FG002|Overall Study|Physician Decision|0|||
23528885|NCT02603809|65672732|FG003|Overall Study|Physician Decision|1|||
23528886|NCT02603809|65672733|FG004|Overall Study|Physician Decision|2|||
23528887|NCT02603809|65672734|FG005|Overall Study|Physician Decision|1|||
23528888|NCT02603809|65672729|FG000|Overall Study|Adverse Event|3|||
23528889|NCT02603809|65672730|FG001|Overall Study|Adverse Event|0|||
23528890|NCT02603809|65672731|FG002|Overall Study|Adverse Event|2|||
23528891|NCT02603809|65672732|FG003|Overall Study|Adverse Event|2|||
23528892|NCT02603809|65672733|FG004|Overall Study|Adverse Event|1|||
23528893|NCT02603809|65672734|FG005|Overall Study|Adverse Event|1|||
23528894|NCT02603809|65672729|FG000|Overall Study|Lack of Efficacy|0|||
23528895|NCT02603809|65672730|FG001|Overall Study|Lack of Efficacy|1|||
23528896|NCT02603809|65672731|FG002|Overall Study|Lack of Efficacy|0|||
23528897|NCT02603809|65672732|FG003|Overall Study|Lack of Efficacy|0|||
23528898|NCT02603809|65672733|FG004|Overall Study|Lack of Efficacy|0|||
23528899|NCT02603809|65672734|FG005|Overall Study|Lack of Efficacy|1|||
23528900|NCT02357576|65672738|FG000|Treatment Period|Withdrawal by Subject|0|||
23528901|NCT02357576|65672739|FG001|Treatment Period|Withdrawal by Subject|1|||
23528902|NCT02357576|65672738|FG000|Treatment Period|Physician Decision|0|||
23528903|NCT02357576|65672739|FG001|Treatment Period|Physician Decision|1|||
23206508|NCT00302718|64494900|FG003|Overall Study|Participant left the hospital|1|||
23206509|NCT00302718|64494897|FG000|Overall Study|Withdrawal by Subject|0|||
23528904|NCT02357576|65672738|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
23528905|NCT02357576|65672739|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
23528906|NCT02357576|65672738|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
23528907|NCT02357576|65672739|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
23528908|NCT02357576|65672738|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
23528909|NCT02357576|65672739|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
23528910|NCT02357576|65672738|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
23528911|NCT02357576|65672739|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
23528912|NCT02722928|65672740|FG000|Overall Study|Standard CT was not as required per prot|5|||
23528913|NCT02722928|65672741|FG001|Overall Study|Standard CT was not as required per prot|13|||
23528914|NCT02722928|65672740|FG000|Overall Study|Required Intraoperative MRI|5|||
23528915|NCT02722928|65672741|FG001|Overall Study|Required Intraoperative MRI|7|||
23528916|NCT00502697|65672742|FG000|Overall Study|Withdrawal by Subject|3|||
23528917|NCT00502697|65672743|FG001|Overall Study|Withdrawal by Subject|1|||
23528918|NCT00502697|65672742|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
23528919|NCT00502697|65672743|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
23528920|NCT00502697|65672742|FG000|Overall Study|found not to meet eligibility criteria|3|||
23528921|NCT00502697|65672743|FG001|Overall Study|found not to meet eligibility criteria|4|||
23528922|NCT00502697|65672742|FG000|Overall Study|did not meet assignment criteria|4|||
23528923|NCT00502697|65672743|FG001|Overall Study|did not meet assignment criteria|2|||
23528924|NCT02203591|65672744|FG000|Overall Study|Did not meet treatment day baseline|147|||
23528925|NCT02203591|65672745|FG001|Overall Study|Did not meet treatment day baseline|141|||
23528926|NCT02203591|65672746|FG002|Overall Study|Did not meet treatment day baseline|150|||
23528927|NCT02203591|65672747|FG003|Overall Study|Did not meet treatment day baseline|45|||
23528928|NCT02203591|65672748|FG004|Overall Study|Did not meet treatment day baseline|33|||
23528929|NCT02203591|65672749|FG005|Overall Study|Did not meet treatment day baseline|35|||
23528930|NCT02203591|65672750|FG006|Overall Study|Did not meet treatment day baseline|29|||
23528931|NCT02203591|65672751|FG007|Overall Study|Did not meet treatment day baseline|12|||
23528932|NCT02203591|65672744|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
23528933|NCT02203591|65672745|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
23528934|NCT02203591|65672746|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
23528935|NCT02203591|65672747|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
23528936|NCT02203591|65672748|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
23528937|NCT02203591|65672749|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
23528938|NCT02203591|65672750|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
23528939|NCT02203591|65672751|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
23528940|NCT00596011|65672752|FG000|Overall Study|Withdrawal by Subject|2|||
23528941|NCT00596011|65672753|FG001|Overall Study|Withdrawal by Subject|3|||
23528942|NCT00596011|65672752|FG000|Overall Study|Adverse Event|11|||
23528943|NCT00596011|65672753|FG001|Overall Study|Adverse Event|7|||
23528944|NCT02624284|65672755|FG000|Overall Study|Withdrawal by Subject|3|||
23528945|NCT02624284|65672756|FG001|Overall Study|Withdrawal by Subject|6|||
23528946|NCT02624284|65672757|FG002|Overall Study|Withdrawal by Subject|3|||
23528947|NCT02624284|65672755|FG000|Overall Study|Protocol Violation|9|||
23528948|NCT02624284|65672756|FG001|Overall Study|Protocol Violation|10|||
23528949|NCT02624284|65672757|FG002|Overall Study|Protocol Violation|7|||
23528950|NCT02624284|65672755|FG000|Overall Study|Revealed exclusionary condition|2|||
23528951|NCT02624284|65672756|FG001|Overall Study|Revealed exclusionary condition|2|||
23528952|NCT02624284|65672757|FG002|Overall Study|Revealed exclusionary condition|0|||
23528953|NCT02624284|65672755|FG000|Overall Study|Adverse Event|0|||
23528954|NCT02624284|65672756|FG001|Overall Study|Adverse Event|0|||
23528955|NCT02624284|65672757|FG002|Overall Study|Adverse Event|1|||
23528956|NCT01481116|65672758|FG000|Overall Study|Adverse Event|26|||
23528957|NCT01481116|65672759|FG001|Overall Study|Adverse Event|26|||
23528958|NCT01481116|65672760|FG002|Overall Study|Adverse Event|42|||
23528959|NCT01481116|65672758|FG000|Overall Study|Major Protocol Deviation|3|||
23528960|NCT01481116|65672759|FG001|Overall Study|Major Protocol Deviation|7|||
23528961|NCT01481116|65672760|FG002|Overall Study|Major Protocol Deviation|1|||
23528962|NCT01481116|65672758|FG000|Overall Study|Lost to Follow-up|8|||
23528963|NCT01481116|65672759|FG001|Overall Study|Lost to Follow-up|12|||
23528964|NCT01481116|65672760|FG002|Overall Study|Lost to Follow-up|11|||
23528965|NCT01481116|65672758|FG000|Overall Study|Withdrawal by Subject|37|||
23528966|NCT01481116|65672759|FG001|Overall Study|Withdrawal by Subject|33|||
23528967|NCT01481116|65672760|FG002|Overall Study|Withdrawal by Subject|37|||
23528968|NCT01481116|65672758|FG000|Overall Study|Study Termination|730|||
23528969|NCT01481116|65672759|FG001|Overall Study|Study Termination|729|||
23528970|NCT01481116|65672760|FG002|Overall Study|Study Termination|713|||
23528971|NCT01481116|65672758|FG000|Overall Study|Pregnancy|0|||
23528972|NCT01481116|65672759|FG001|Overall Study|Pregnancy|0|||
23528973|NCT01481116|65672760|FG002|Overall Study|Pregnancy|1|||
23528974|NCT01481116|65672758|FG000|Overall Study|Lack of Efficacy|3|||
23528975|NCT01481116|65672759|FG001|Overall Study|Lack of Efficacy|3|||
23528976|NCT01481116|65672760|FG002|Overall Study|Lack of Efficacy|1|||
23528977|NCT01481116|65672758|FG000|Overall Study|Contraindications|1|||
23528978|NCT01481116|65672759|FG001|Overall Study|Contraindications|1|||
23528979|NCT01481116|65672760|FG002|Overall Study|Contraindications|0|||
23528980|NCT01481116|65672758|FG000|Overall Study|Other|1|||
23528981|NCT01481116|65672759|FG001|Overall Study|Other|1|||
23528982|NCT01481116|65672760|FG002|Overall Study|Other|0|||
23528983|NCT01481116|65672758|FG000|Overall Study|Participant Started Taking Glipizide|1|||
23528984|NCT01481116|65672759|FG001|Overall Study|Participant Started Taking Glipizide|0|||
23528985|NCT01481116|65672760|FG002|Overall Study|Participant Started Taking Glipizide|0|||
23528986|NCT01481116|65672758|FG000|Overall Study|Participant Moved Out of Area|2|||
23528987|NCT01481116|65672759|FG001|Overall Study|Participant Moved Out of Area|0|||
23528988|NCT01481116|65672760|FG002|Overall Study|Participant Moved Out of Area|1|||
23528989|NCT01481116|65672758|FG000|Overall Study|Participant Moved Out of Country|1|||
23528990|NCT01481116|65672759|FG001|Overall Study|Participant Moved Out of Country|0|||
23528991|NCT01481116|65672760|FG002|Overall Study|Participant Moved Out of Country|1|||
23528992|NCT01481116|65672758|FG000|Overall Study|Investigator Decision|3|||
23528993|NCT01481116|65672759|FG001|Overall Study|Investigator Decision|2|||
23528994|NCT01481116|65672760|FG002|Overall Study|Investigator Decision|1|||
23528995|NCT01481116|65672758|FG000|Overall Study|Sponsor Decision|0|||
23528996|NCT01481116|65672759|FG001|Overall Study|Sponsor Decision|1|||
23528997|NCT01481116|65672760|FG002|Overall Study|Sponsor Decision|3|||
23528998|NCT01481116|65672758|FG000|Overall Study|Non-Compliant With Study Drug|0|||
23528999|NCT01481116|65672759|FG001|Overall Study|Non-Compliant With Study Drug|1|||
23529000|NCT01481116|65672760|FG002|Overall Study|Non-Compliant With Study Drug|1|||
23529001|NCT01481116|65672758|FG000|Overall Study|Investigator's Discretion|2|||
23529002|NCT01481116|65672759|FG001|Overall Study|Investigator's Discretion|0|||
23529003|NCT01481116|65672760|FG002|Overall Study|Investigator's Discretion|0|||
23529004|NCT01481116|65672758|FG000|Overall Study|Death|2|||
23529005|NCT01481116|65672759|FG001|Overall Study|Death|1|||
23529006|NCT01481116|65672760|FG002|Overall Study|Death|0|||
23529007|NCT01481116|65672758|FG000|Overall Study|Hypoglycemic Event|4|||
23529008|NCT01481116|65672759|FG001|Overall Study|Hypoglycemic Event|0|||
23529009|NCT01481116|65672760|FG002|Overall Study|Hypoglycemic Event|0|||
23529010|NCT02751983|65672761|FG000|Treatment|Stopped ACT, but Remained in study|2|||
23529011|NCT02751983|65672762|FG001|Treatment|Stopped ACT, but Remained in study|0|||
23529012|NCT02751983|65672761|FG000|Treatment|Discharged prior to beginning ACT|2|||
23529013|NCT02751983|65672762|FG001|Treatment|Discharged prior to beginning ACT|0|||
23529014|NCT02751983|65672761|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
23529015|NCT02751983|65672762|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
23529016|NCT02751983|65672761|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
23529017|NCT02751983|65672762|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
23529018|NCT02751983|65672761|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
23529019|NCT02751983|65672762|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
23529020|NCT04765358|65672763|FG000|Overall Study|Withdrawal by Subject|1|||
23529021|NCT00586469|65672770|FG000|Overall Study|Adverse Event|0|||
23529022|NCT00586469|65672771|FG001|Overall Study|Adverse Event|1|||
23529023|NCT00057746|65672774|FG000|Overall Study|Withdrawal by Subject|0|||
23529024|NCT00057746|65672775|FG001|Overall Study|Withdrawal by Subject|0|||
23529025|NCT00057746|65672776|FG002|Overall Study|Withdrawal by Subject|1|||
23529026|NCT02510794|65672779|FG000|Overall Study|Adverse Event|0|||
23529027|NCT02510794|65672780|FG001|Overall Study|Adverse Event|1|||
23529028|NCT02510794|65672781|FG002|Overall Study|Adverse Event|0|||
23529029|NCT02510794|65672782|FG003|Overall Study|Adverse Event|0|||
23206510|NCT00302718|64494898|FG001|Overall Study|Withdrawal by Subject|1|||
23418875|NCT02743949|65277344|FG000|Overall Study|Adverse Event|0|||
23529030|NCT02510794|65672779|FG000|Overall Study|Death|1|||
23529031|NCT02510794|65672780|FG001|Overall Study|Death|2|||
23529032|NCT02510794|65672781|FG002|Overall Study|Death|1|||
23206511|NCT00302718|64494899|FG002|Overall Study|Withdrawal by Subject|0|||
23206512|NCT00302718|64494900|FG003|Overall Study|Withdrawal by Subject|0|||
23206513|NCT00302718|64494897|FG000|Overall Study|Participant left primary care setting|0|||
23206514|NCT00302718|64494898|FG001|Overall Study|Participant left primary care setting|0|||
23206515|NCT00302718|64494899|FG002|Overall Study|Participant left primary care setting|2|||
23206516|NCT00302718|64494900|FG003|Overall Study|Participant left primary care setting|1|||
23529033|NCT02510794|65672782|FG003|Overall Study|Death|1|||
23529034|NCT02510794|65672779|FG000|Overall Study|Lack of Efficacy|3|||
23529035|NCT02510794|65672780|FG001|Overall Study|Lack of Efficacy|1|||
23529036|NCT02510794|65672781|FG002|Overall Study|Lack of Efficacy|1|||
23529037|NCT02510794|65672782|FG003|Overall Study|Lack of Efficacy|0|||
23529038|NCT02510794|65672779|FG000|Overall Study|Participant moved out of the area|0|||
23529039|NCT02510794|65672780|FG001|Overall Study|Participant moved out of the area|0|||
23529040|NCT02510794|65672781|FG002|Overall Study|Participant moved out of the area|0|||
23529041|NCT02510794|65672782|FG003|Overall Study|Participant moved out of the area|1|||
23529042|NCT02510794|65672779|FG000|Overall Study|Physician Decision|3|||
23529043|NCT02510794|65672780|FG001|Overall Study|Physician Decision|0|||
23529044|NCT02510794|65672781|FG002|Overall Study|Physician Decision|0|||
23529045|NCT02510794|65672782|FG003|Overall Study|Physician Decision|0|||
23529046|NCT02510794|65672779|FG000|Overall Study|Protocol Violation|0|||
23529047|NCT02510794|65672780|FG001|Overall Study|Protocol Violation|0|||
23529048|NCT02510794|65672781|FG002|Overall Study|Protocol Violation|1|||
23529049|NCT02510794|65672782|FG003|Overall Study|Protocol Violation|0|||
23529050|NCT02510794|65672779|FG000|Overall Study|Withdrawal by Subject|1|||
23529051|NCT02510794|65672780|FG001|Overall Study|Withdrawal by Subject|2|||
23529052|NCT02510794|65672781|FG002|Overall Study|Withdrawal by Subject|4|||
23529053|NCT02510794|65672782|FG003|Overall Study|Withdrawal by Subject|3|||
23529054|NCT03643562|65672783|FG000|Overall Study|Adverse Event|1|||
23529055|NCT03643562|65672784|FG001|Overall Study|Adverse Event|0|||
23529056|NCT03643562|65672783|FG000|Overall Study|Lack of Efficacy|0|||
23529057|NCT03643562|65672784|FG001|Overall Study|Lack of Efficacy|1|||
23529058|NCT03643562|65672783|FG000|Overall Study|Physician Decision|0|||
23529059|NCT03643562|65672784|FG001|Overall Study|Physician Decision|1|||
23529060|NCT03643562|65672783|FG000|Overall Study|Study Terminated by Sponsor|2|||
23529061|NCT03643562|65672784|FG001|Overall Study|Study Terminated by Sponsor|10|||
23529062|NCT03643562|65672783|FG000|Overall Study|Withdrawal by Subject|2|||
23529063|NCT03643562|65672784|FG001|Overall Study|Withdrawal by Subject|2|||
23529064|NCT03643562|65672783|FG000|Overall Study|Other than specified|3|||
23529065|NCT03643562|65672784|FG001|Overall Study|Other than specified|2|||
23529066|NCT01469065|65672787|FG000|Overall Study|Lack of Efficacy|0|||
23529067|NCT01469065|65672788|FG001|Overall Study|Lack of Efficacy|0|||
23529068|NCT01469065|65672789|FG002|Overall Study|Lack of Efficacy|0|||
23529069|NCT01469065|65672790|FG003|Overall Study|Lack of Efficacy|0|||
23529070|NCT01469065|65672791|FG004|Overall Study|Lack of Efficacy|1|||
23529071|NCT01469065|65672787|FG000|Overall Study|Other|0|||
23529072|NCT01469065|65672788|FG001|Overall Study|Other|1|||
23529073|NCT01469065|65672789|FG002|Overall Study|Other|0|||
23529074|NCT01469065|65672790|FG003|Overall Study|Other|0|||
23529075|NCT01469065|65672791|FG004|Overall Study|Other|0|||
23529076|NCT03491150|65672795|FG000|Overall Study|Adverse Event|1|||
23529077|NCT03491150|65672796|FG001|Overall Study|Adverse Event|0|||
23529078|NCT03491150|65672795|FG000|Overall Study|Study Terminated by Sponsor|74|||
23529079|NCT03491150|65672796|FG001|Overall Study|Study Terminated by Sponsor|70|||
23529080|NCT03491150|65672795|FG000|Overall Study|Other|0|||
23529081|NCT03491150|65672796|FG001|Overall Study|Other|1|||
23529082|NCT03491150|65672795|FG000|Overall Study|Withdrawal by Subject|1|||
23529083|NCT03491150|65672796|FG001|Overall Study|Withdrawal by Subject|2|||
23529084|NCT00595582|65672797|FG000|Overall Study|Pilot study that PI terminated|2|||
23529085|NCT00595582|65672797|FG000|Overall Study|Lost to Follow-up|1|||
23529086|NCT00595582|65672797|FG000|Overall Study|Adverse Event|2|||
23529087|NCT00595582|65672797|FG000|Overall Study|Physician Decision|5|||
23529088|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
23529089|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
23529090|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
23529091|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
23529092|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
23529093|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
23529094|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
23529095|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
23529096|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
23529097|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
23529098|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
23529099|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
23529100|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
23529101|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
23529102|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
23529103|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
23529104|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
23529105|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
23529106|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
23529107|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
23529108|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Other|3|||
23529109|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Other|0|||
23529110|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Other|2|||
23529111|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Other|2|||
23529112|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Other|7|||
23529113|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529114|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529115|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529116|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
23529117|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529118|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529119|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529120|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529121|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529122|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
23529123|NCT00213148|65672798|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
23529124|NCT00213148|65672799|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
23529125|NCT00213148|65672800|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
23529126|NCT00213148|65672801|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
23529127|NCT00213148|65672802|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
23529128|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
23529129|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
23529130|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
23529131|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
23529132|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
23529133|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
23529134|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
23529135|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
23529136|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
23529137|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
23529138|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Other|2|||
23529139|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Other|1|||
23529140|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Other|2|||
23529141|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Other|8|||
23529142|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Other|7|||
23529143|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529144|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
23529145|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529146|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529147|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
23529148|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
23529149|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529150|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529151|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529152|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
23529153|NCT00213148|65672798|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
23529154|NCT00213148|65672799|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
23529155|NCT00213148|65672800|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
23529156|NCT00213148|65672801|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
23529157|NCT00213148|65672802|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
23529158|NCT00213148|65672798|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
23529159|NCT00213148|65672799|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
23529160|NCT00213148|65672800|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
23529161|NCT00213148|65672801|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
23529162|NCT00213148|65672802|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
23529163|NCT00213148|65672798|FG000|Cycle 3 (1 Month)|Other|0|||
23529164|NCT00213148|65672799|FG001|Cycle 3 (1 Month)|Other|0|||
23529165|NCT00213148|65672800|FG002|Cycle 3 (1 Month)|Other|1|||
23529166|NCT00213148|65672801|FG003|Cycle 3 (1 Month)|Other|1|||
23529167|NCT00213148|65672802|FG004|Cycle 3 (1 Month)|Other|0|||
23529168|NCT04476030|65672803|FG000|Overall Study|Withdrawal by Subject|20|||
23529169|NCT04476030|65672804|FG001|Overall Study|Withdrawal by Subject|16|||
23529170|NCT04476030|65672803|FG000|Overall Study|Adverse Event|10|||
23529171|NCT04476030|65672804|FG001|Overall Study|Adverse Event|11|||
23529172|NCT04476030|65672803|FG000|Overall Study|Lost to Follow-up|7|||
23529173|NCT04476030|65672804|FG001|Overall Study|Lost to Follow-up|4|||
23529174|NCT04476030|65672803|FG000|Overall Study|Physician Decision|1|||
23529175|NCT04476030|65672804|FG001|Overall Study|Physician Decision|1|||
23529176|NCT04476030|65672803|FG000|Overall Study|Protocol Deviation|2|||
23529177|NCT04476030|65672804|FG001|Overall Study|Protocol Deviation|0|||
23529178|NCT04476030|65672803|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
23529179|NCT04476030|65672804|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
23529180|NCT04476030|65672803|FG000|Overall Study|Randomized but not Dosed|2|||
23529181|NCT04476030|65672804|FG001|Overall Study|Randomized but not Dosed|8|||
23529182|NCT01467076|65672805|FG000|Overall Study|Lost to Follow-up|1|||
23529183|NCT01467076|65672806|FG001|Overall Study|Lost to Follow-up|0|||
23529184|NCT01467076|65672807|FG002|Overall Study|Lost to Follow-up|0|||
23529185|NCT00111228|65672808|FG000|Overall Study|Withdrawal by Subject|5|||
23529186|NCT00111228|65672809|FG001|Overall Study|Withdrawal by Subject|1|||
23529187|NCT00111228|65672810|FG002|Overall Study|Withdrawal by Subject|0|||
23529188|NCT01565291|65672811|FG000|Overall Study|Withdrawal by Subject|1|||
23529189|NCT01565291|65672812|FG001|Overall Study|Withdrawal by Subject|0|||
23529190|NCT00423891|65672813|FG000|Enrolled|Withdrawal by Subject|0|||
23529191|NCT00423891|65672814|FG001|Enrolled|Withdrawal by Subject|0|||
23529192|NCT00423891|65672815|FG002|Enrolled|Withdrawal by Subject|1|||
23529193|NCT00423891|65672813|FG000|Enrolled|Lost to Follow-up|0|||
23529194|NCT00423891|65672814|FG001|Enrolled|Lost to Follow-up|0|||
23529195|NCT00423891|65672815|FG002|Enrolled|Lost to Follow-up|1|||
23529196|NCT00423891|65672813|FG000|Enrolled|No longer met criteria|11|||
23529197|NCT00423891|65672814|FG001|Enrolled|No longer met criteria|2|||
23529198|NCT00423891|65672815|FG002|Enrolled|No longer met criteria|1|||
23529199|NCT00423891|65672813|FG000|Treatment|Withdrawal by Subject|1|||
23529200|NCT00423891|65672814|FG001|Treatment|Withdrawal by Subject|0|||
23529201|NCT00423891|65672815|FG002|Treatment|Withdrawal by Subject|0|||
23529202|NCT00423891|65672813|FG000|Treatment|Lost to Follow-up|1|||
23529203|NCT00423891|65672814|FG001|Treatment|Lost to Follow-up|0|||
23529204|NCT00423891|65672815|FG002|Treatment|Lost to Follow-up|0|||
23529205|NCT00423891|65672813|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
23529206|NCT00423891|65672814|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
23529207|NCT00423891|65672815|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
23529208|NCT00423891|65672813|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
23529209|NCT00423891|65672814|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
23529210|NCT00423891|65672815|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
23529211|NCT04074317|65672816|FG000|Third Period|Withdrawal by Subject|0|||
23529212|NCT04074317|65672817|FG001|Third Period|Withdrawal by Subject|0|||
23529213|NCT04074317|65672818|FG002|Third Period|Withdrawal by Subject|0|||
23529214|NCT04074317|65672819|FG003|Third Period|Withdrawal by Subject|1|||
23529215|NCT04074317|65672820|FG004|Third Period|Withdrawal by Subject|0|||
23529216|NCT04074317|65672821|FG005|Third Period|Withdrawal by Subject|0|||
23529217|NCT01077960|65672822|FG000|Overall Study|Adverse Event|6|||
23529218|NCT01077960|65672822|FG000|Overall Study|Protocol Violation|3|||
23529219|NCT01077960|65672822|FG000|Overall Study|Lost to Follow-up|5|||
23529220|NCT01077960|65672822|FG000|Overall Study|Subject decision|1|||
23529221|NCT01077960|65672822|FG000|Overall Study|Reason unspecified|1|||
23529222|NCT02118428|65672823|FG000|Overall Study|Physician Decision|0|||
23529223|NCT02118428|65672824|FG001|Overall Study|Physician Decision|1|||
23529224|NCT02118428|65672825|FG002|Overall Study|Physician Decision|0|||
23529225|NCT02118428|65672823|FG000|Overall Study|Withdrawal by Subject|2|||
23529226|NCT02118428|65672824|FG001|Overall Study|Withdrawal by Subject|2|||
23529227|NCT02118428|65672825|FG002|Overall Study|Withdrawal by Subject|0|||
23529228|NCT02118428|65672823|FG000|Overall Study|Death|7|||
23529229|NCT02118428|65672824|FG001|Overall Study|Death|5|||
23529230|NCT02118428|65672825|FG002|Overall Study|Death|0|||
23529231|NCT02118428|65672823|FG000|Overall Study|Lost to Follow-up|3|||
23418876|NCT02743949|65277345|FG001|Overall Study|Adverse Event|0|||
23529232|NCT02118428|65672824|FG001|Overall Study|Lost to Follow-up|1|||
23529233|NCT02118428|65672825|FG002|Overall Study|Lost to Follow-up|0|||
23529234|NCT02118428|65672823|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
23529235|NCT02118428|65672824|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
23418877|NCT02743949|65277346|FG002|Overall Study|Adverse Event|2|||
23529236|NCT02118428|65672825|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
23529237|NCT00354172|65672826|FG000|Overall Study|Did not receive transplant|1|||
23529238|NCT00403273|65672827|FG000|Overall Study|Lost to Follow-up|3|||
23529239|NCT00403273|65672828|FG001|Overall Study|Lost to Follow-up|2|||
23529240|NCT00403273|65672827|FG000|Overall Study|Physician Decision|0|||
23529241|NCT00403273|65672828|FG001|Overall Study|Physician Decision|1|||
23529242|NCT00403273|65672827|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
23529243|NCT00403273|65672828|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
23529244|NCT01574352|65672831|FG000|Overall Study|Withdrawal by Subject|6|||
23529245|NCT01574352|65672832|FG001|Overall Study|Withdrawal by Subject|13|||
23206517|NCT03970395|64494901|FG000|Overall Study|Withdrawal by Subject|3|||
23206518|NCT03970395|64494902|FG001|Overall Study|Withdrawal by Subject|4|||
23206519|NCT03970395|64494901|FG000|Overall Study|Lost to Follow-up|4|||
23206520|NCT03970395|64494902|FG001|Overall Study|Lost to Follow-up|8|||
23206521|NCT01606761|64494903|FG000|Prior to Week 24|Lost to Follow-up|0|||
23206522|NCT01606761|64494904|FG001|Prior to Week 24|Lost to Follow-up|3|||
23206523|NCT01606761|64494905|FG002|Prior to Week 24|Lost to Follow-up|2|||
23206524|NCT01606761|64494906|FG003|Prior to Week 24|Lost to Follow-up|0|||
23206525|NCT01606761|64494907|FG004|Prior to Week 24|Lost to Follow-up|0|||
23206526|NCT01606761|64494903|FG000|Prior to Week 24|Withdrawal by Subject|12|||
23206527|NCT01606761|64494904|FG001|Prior to Week 24|Withdrawal by Subject|10|||
23206528|NCT01606761|64494905|FG002|Prior to Week 24|Withdrawal by Subject|9|||
23206529|NCT01606761|64494906|FG003|Prior to Week 24|Withdrawal by Subject|0|||
23206530|NCT01606761|64494907|FG004|Prior to Week 24|Withdrawal by Subject|0|||
23206531|NCT01606761|64494903|FG000|Prior to Week 24|Adverse Event|11|||
23206532|NCT01606761|64494904|FG001|Prior to Week 24|Adverse Event|18|||
23206533|NCT01606761|64494905|FG002|Prior to Week 24|Adverse Event|22|||
23206534|NCT01606761|64494906|FG003|Prior to Week 24|Adverse Event|0|||
23206535|NCT01606761|64494907|FG004|Prior to Week 24|Adverse Event|0|||
23206536|NCT01606761|64494903|FG000|Prior to Week 24|Lack of Efficacy|15|||
23206537|NCT01606761|64494904|FG001|Prior to Week 24|Lack of Efficacy|14|||
23206538|NCT01606761|64494905|FG002|Prior to Week 24|Lack of Efficacy|8|||
23206539|NCT01606761|64494906|FG003|Prior to Week 24|Lack of Efficacy|0|||
23206540|NCT01606761|64494907|FG004|Prior to Week 24|Lack of Efficacy|0|||
23206541|NCT01606761|64494903|FG000|Prior to Week 24|Physician Decision|0|||
23206542|NCT01606761|64494904|FG001|Prior to Week 24|Physician Decision|3|||
23206543|NCT01606761|64494905|FG002|Prior to Week 24|Physician Decision|1|||
23206544|NCT01606761|64494906|FG003|Prior to Week 24|Physician Decision|0|||
23206545|NCT01606761|64494907|FG004|Prior to Week 24|Physician Decision|0|||
23206546|NCT01606761|64494903|FG000|Prior to Week 24|Other|4|||
23206547|NCT01606761|64494904|FG001|Prior to Week 24|Other|7|||
23206548|NCT01606761|64494905|FG002|Prior to Week 24|Other|5|||
23206549|NCT01606761|64494906|FG003|Prior to Week 24|Other|0|||
23206550|NCT01606761|64494907|FG004|Prior to Week 24|Other|0|||
23206551|NCT01606761|64494903|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
23206552|NCT01606761|64494904|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
23206553|NCT01606761|64494905|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
23206554|NCT01606761|64494906|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
23206555|NCT01606761|64494907|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
23206556|NCT01606761|64494903|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
23206557|NCT01606761|64494904|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
23206558|NCT01606761|64494905|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
23206559|NCT01606761|64494906|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
23206560|NCT01606761|64494907|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
23206561|NCT01606761|64494903|FG000|Week 24 to Week 52|Adverse Event|0|||
23206562|NCT01606761|64494904|FG001|Week 24 to Week 52|Adverse Event|11|||
23206563|NCT01606761|64494905|FG002|Week 24 to Week 52|Adverse Event|14|||
23206564|NCT01606761|64494906|FG003|Week 24 to Week 52|Adverse Event|3|||
23206565|NCT01606761|64494907|FG004|Week 24 to Week 52|Adverse Event|15|||
23206566|NCT01606761|64494903|FG000|Week 24 to Week 52|Death|0|||
23206567|NCT01606761|64494904|FG001|Week 24 to Week 52|Death|0|||
23206568|NCT01606761|64494905|FG002|Week 24 to Week 52|Death|2|||
23206569|NCT01606761|64494906|FG003|Week 24 to Week 52|Death|1|||
23206570|NCT01606761|64494907|FG004|Week 24 to Week 52|Death|0|||
23206571|NCT01606761|64494903|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
23206572|NCT01606761|64494904|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
23206573|NCT01606761|64494905|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
23206574|NCT01606761|64494906|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
23206575|NCT01606761|64494907|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
23206576|NCT01606761|64494903|FG000|Week 24 to Week 52|Physician Decision|0|||
23206577|NCT01606761|64494904|FG001|Week 24 to Week 52|Physician Decision|1|||
23206578|NCT01606761|64494905|FG002|Week 24 to Week 52|Physician Decision|1|||
23206579|NCT01606761|64494906|FG003|Week 24 to Week 52|Physician Decision|0|||
23206580|NCT01606761|64494907|FG004|Week 24 to Week 52|Physician Decision|0|||
23206581|NCT01606761|64494903|FG000|Week 24 to Week 52|Other|0|||
23206582|NCT01606761|64494904|FG001|Week 24 to Week 52|Other|1|||
23206583|NCT01606761|64494905|FG002|Week 24 to Week 52|Other|5|||
23206584|NCT01606761|64494906|FG003|Week 24 to Week 52|Other|2|||
23206585|NCT01606761|64494907|FG004|Week 24 to Week 52|Other|2|||
23206586|NCT01606761|64494903|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
23206587|NCT01606761|64494904|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
23206588|NCT01606761|64494905|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
23206589|NCT01606761|64494906|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
23206590|NCT01606761|64494907|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
23206591|NCT01606761|64494903|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
23206592|NCT01606761|64494904|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
23309077|NCT04933968|64877798|FG005|Overall Study|Other|0|||
23529246|NCT01574352|65672831|FG000|Overall Study|Injury in non-camp related sport|1|||
23529247|NCT01574352|65672832|FG001|Overall Study|Injury in non-camp related sport|0|||
23529248|NCT00720941|65672835|FG000|Overall Study|Death|334|||
23529249|NCT00720941|65672836|FG001|Overall Study|Death|335|||
23529250|NCT00720941|65672835|FG000|Overall Study|Protocol Violation|0|||
23529251|NCT00720941|65672836|FG001|Overall Study|Protocol Violation|2|||
23529252|NCT00720941|65672835|FG000|Overall Study|Lost to Follow-up|17|||
23529253|NCT00720941|65672836|FG001|Overall Study|Lost to Follow-up|15|||
23529254|NCT00720941|65672835|FG000|Overall Study|Physician Decision|1|||
23529255|NCT00720941|65672836|FG001|Overall Study|Physician Decision|5|||
23529256|NCT00720941|65672835|FG000|Overall Study|Withdrawal by Subject|27|||
23529257|NCT00720941|65672836|FG001|Overall Study|Withdrawal by Subject|35|||
23529258|NCT00720941|65672835|FG000|Overall Study|Ongoing|34|||
23529259|NCT00720941|65672836|FG001|Overall Study|Ongoing|23|||
23529260|NCT00834912|65672841|FG000|Treatment Period 1|Adverse Event|0|||
23529261|NCT00834912|65672842|FG001|Treatment Period 1|Adverse Event|1|||
23529262|NCT00834912|65672843|FG002|Treatment Period 1|Adverse Event|0|||
23529263|NCT00834912|65672844|FG003|Treatment Period 1|Adverse Event|1|||
23529264|NCT00834912|65672845|FG004|Treatment Period 1|Adverse Event|0|||
23529265|NCT00834912|65672846|FG005|Treatment Period 1|Adverse Event|0|||
23529266|NCT00834912|65672841|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23529267|NCT00834912|65672842|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23529268|NCT00834912|65672843|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23529269|NCT00834912|65672844|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23529270|NCT00834912|65672845|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23529271|NCT00834912|65672846|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23529272|NCT04382911|65672847|FG000|Overall Study|unable to be imaged prior to surgery|2|||
23529273|NCT02023151|65672848|FG000|Overall Study|Lost to Follow-up|4|||
23529274|NCT00910715|65672851|FG000|Overall Study|Lost to Follow-up|22|||
23529275|NCT00910715|65672852|FG001|Overall Study|Lost to Follow-up|26|||
23529276|NCT00910715|65672853|FG002|Overall Study|Lost to Follow-up|0|||
23529277|NCT01207778|65672854|FG000|Overall Study|Lost to Follow-up|0|||
23529278|NCT01207778|65672855|FG001|Overall Study|Lost to Follow-up|3|||
23529279|NCT01207778|65672856|FG002|Overall Study|Lost to Follow-up|3|||
23529280|NCT02042924|65672857|FG000|Overall Study|Early Death|1|||
23529281|NCT01864291|65672858|FG000|Overall Study|need for revision surgery|2|||
23529282|NCT02404311|65672861|FG000|Part A: Month 0-18|Death|2|||
23529283|NCT02404311|65672862|FG001|Part A: Month 0-18|Death|0|||
23529284|NCT02404311|65672863|FG002|Part A: Month 0-18|Death|0|||
23529285|NCT02404311|65672864|FG003|Part A: Month 0-18|Death|0|||
23529286|NCT02404311|65672865|FG004|Part A: Month 0-18|Death|0|||
23529287|NCT02404311|65672861|FG000|Part A: Month 0-18|Physician Decision|1|||
23529288|NCT02404311|65672862|FG001|Part A: Month 0-18|Physician Decision|0|||
23529289|NCT02404311|65672863|FG002|Part A: Month 0-18|Physician Decision|0|||
23529290|NCT02404311|65672864|FG003|Part A: Month 0-18|Physician Decision|0|||
23529291|NCT02404311|65672865|FG004|Part A: Month 0-18|Physician Decision|0|||
23529292|NCT02404311|65672861|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
23529293|NCT02404311|65672862|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
23529294|NCT02404311|65672863|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
23529295|NCT02404311|65672864|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
23529296|NCT02404311|65672865|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
23529297|NCT02404311|65672861|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
23529298|NCT02404311|65672862|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
23529299|NCT02404311|65672863|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
23529300|NCT02404311|65672864|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
23529301|NCT02404311|65672865|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
23529302|NCT02404311|65672861|FG000|Part A: Month 0-18|HIV Infection|6|||
23529303|NCT02404311|65672862|FG001|Part A: Month 0-18|HIV Infection|2|||
23529304|NCT02404311|65672863|FG002|Part A: Month 0-18|HIV Infection|0|||
23529305|NCT02404311|65672864|FG003|Part A: Month 0-18|HIV Infection|0|||
23529306|NCT02404311|65672865|FG004|Part A: Month 0-18|HIV Infection|0|||
23529307|NCT02404311|65672861|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
23529308|NCT02404311|65672862|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
23529309|NCT02404311|65672863|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
23529310|NCT02404311|65672864|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
23529311|NCT02404311|65672865|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
23529312|NCT01552772|65672866|FG000|Overall Study|Lost to Follow-up|2|||
23529313|NCT01552772|65672866|FG000|Overall Study|Adverse Event|1|||
23529314|NCT01552772|65672866|FG000|Overall Study|Protocol Deviation|1|||
23529315|NCT02318693|65672867|FG000|Overall Study|Protocol Violation|0|||
23529316|NCT02318693|65672868|FG001|Overall Study|Protocol Violation|1|||
23529317|NCT00259857|65672869|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
23529318|NCT00259857|65672870|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
23529319|NCT00259857|65672869|FG000|24 Months Treatment|Lost to Follow-up|0|||
23529320|NCT00259857|65672870|FG001|24 Months Treatment|Lost to Follow-up|3|||
23529321|NCT00577122|65672871|FG000|Overall Study|Adverse Event|0|||
23529322|NCT00577122|65672872|FG001|Overall Study|Adverse Event|2|||
23529323|NCT00577122|65672871|FG000|Overall Study|Progression, relapse during active trt|6|||
23529324|NCT00577122|65672872|FG001|Overall Study|Progression, relapse during active trt|8|||
23529325|NCT00577122|65672871|FG000|Overall Study|Prog, refract disease during active trt|8|||
23529326|NCT00577122|65672872|FG001|Overall Study|Prog, refract disease during active trt|5|||
23529327|NCT00577122|65672871|FG000|Overall Study|Alternative Therapy|0|||
23529328|NCT00577122|65672872|FG001|Overall Study|Alternative Therapy|1|||
23529329|NCT01176292|65672873|FG000|Overall Study|Lost to Follow-up|2|||
23529330|NCT01176292|65672874|FG001|Overall Study|Lost to Follow-up|4|||
23529331|NCT01176292|65672873|FG000|Overall Study|Adverse Event|1|||
23529332|NCT01176292|65672874|FG001|Overall Study|Adverse Event|1|||
23529333|NCT01176292|65672873|FG000|Overall Study|Physician Decision|0|||
23529334|NCT01176292|65672874|FG001|Overall Study|Physician Decision|2|||
23529335|NCT01176292|65672873|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
23529336|NCT01176292|65672874|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
23529337|NCT00004412|65672875|FG000|Randomized Period|Moved to Crossover Period|3|||
23529338|NCT00004412|65672876|FG001|Randomized Period|Moved to Crossover Period|0|||
23529339|NCT00004412|65672877|FG002|Randomized Period|Moved to Crossover Period|0|||
23529340|NCT00436748|65672878|FG000|Overall Study|Ineligibility Determined|1|||
23529341|NCT00436748|65672879|FG001|Overall Study|Ineligibility Determined|1|||
23529342|NCT00436748|65672878|FG000|Overall Study|Adverse Event|0|||
23529343|NCT00436748|65672879|FG001|Overall Study|Adverse Event|2|||
23529344|NCT00436748|65672878|FG000|Overall Study|Consent Withdrawn|1|||
23529345|NCT00436748|65672879|FG001|Overall Study|Consent Withdrawn|4|||
23529346|NCT00436748|65672878|FG000|Overall Study|Administrative Decision|1|||
23529347|NCT00436748|65672879|FG001|Overall Study|Administrative Decision|0|||
23529348|NCT00436748|65672878|FG000|Overall Study|Lost to Follow-up|0|||
23529349|NCT00436748|65672879|FG001|Overall Study|Lost to Follow-up|1|||
23529350|NCT00436748|65672878|FG000|Overall Study|Protocol-specified Criteria|5|||
23529351|NCT00436748|65672879|FG001|Overall Study|Protocol-specified Criteria|4|||
23529352|NCT00436748|65672878|FG000|Overall Study|Other|3|||
23529353|NCT00436748|65672879|FG001|Overall Study|Other|0|||
23529354|NCT01577758|65672882|FG000|Dose Escalation Phase|Adverse Event|0|||
23529355|NCT01577758|65672883|FG001|Dose Escalation Phase|Adverse Event|0|||
23529356|NCT01577758|65672884|FG002|Dose Escalation Phase|Adverse Event|0|||
23529357|NCT01577758|65672885|FG003|Dose Escalation Phase|Adverse Event|0|||
23529358|NCT01577758|65672886|FG004|Dose Escalation Phase|Adverse Event|0|||
23529359|NCT01577758|65672887|FG005|Dose Escalation Phase|Adverse Event|2|||
23529360|NCT01577758|65672888|FG006|Dose Escalation Phase|Adverse Event|1|||
23529361|NCT01577758|65672889|FG007|Dose Escalation Phase|Adverse Event|0|||
23529362|NCT01577758|65672882|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529363|NCT01577758|65672883|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529364|NCT01577758|65672884|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
23529365|NCT01577758|65672885|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529366|NCT01577758|65672886|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
23529367|NCT01577758|65672887|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
23529368|NCT01577758|65672888|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529369|NCT01577758|65672889|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
23529370|NCT01577758|65672882|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23529371|NCT01577758|65672883|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23529372|NCT01577758|65672884|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23529373|NCT01577758|65672885|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23529374|NCT01577758|65672886|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
23529375|NCT01577758|65672887|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
23529376|NCT01577758|65672888|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
23309078|NCT04933968|64877793|FG000|Overall Study|Missing|1|||
23309079|NCT04933968|64877794|FG001|Overall Study|Missing|3|||
23309080|NCT04933968|64877795|FG002|Overall Study|Missing|2|||
23309081|NCT04933968|64877796|FG003|Overall Study|Missing|1|||
23309082|NCT04933968|64877797|FG004|Overall Study|Missing|1|||
23309083|NCT04933968|64877798|FG005|Overall Study|Missing|0|||
23309084|NCT01593696|64877801|FG000|Dose Escalation|Progressive Disease|2|||
23309085|NCT01593696|64877802|FG001|Dose Escalation|Progressive Disease|0|||
23309086|NCT01593696|64877803|FG002|Dose Escalation|Progressive Disease|0|||
23309087|NCT01593696|64877804|FG003|Dose Escalation|Progressive Disease|0|||
23529377|NCT01577758|65672889|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
23529378|NCT01577758|65672882|FG000|Dose Escalation Phase|Progression Disease|2|||
23529379|NCT01577758|65672883|FG001|Dose Escalation Phase|Progression Disease|2|||
23529380|NCT01577758|65672884|FG002|Dose Escalation Phase|Progression Disease|1|||
23529381|NCT01577758|65672885|FG003|Dose Escalation Phase|Progression Disease|2|||
23529382|NCT01577758|65672886|FG004|Dose Escalation Phase|Progression Disease|5|||
23529383|NCT01577758|65672887|FG005|Dose Escalation Phase|Progression Disease|0|||
23529384|NCT01577758|65672888|FG006|Dose Escalation Phase|Progression Disease|0|||
23529385|NCT01577758|65672889|FG007|Dose Escalation Phase|Progression Disease|0|||
23529386|NCT01577758|65672882|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529387|NCT01577758|65672883|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23309088|NCT01593696|64877801|FG000|Dose Expansion|Fungal infection|0|||
23309089|NCT01593696|64877802|FG001|Dose Expansion|Fungal infection|0|||
23309090|NCT01593696|64877803|FG002|Dose Expansion|Fungal infection|1|||
23309091|NCT01593696|64877804|FG003|Dose Expansion|Fungal infection|0|||
23309092|NCT02132637|64877806|FG000|Study Period 1|Withdrawal by Subject|0|||
23309093|NCT02132637|64877807|FG001|Study Period 1|Withdrawal by Subject|4|||
23309094|NCT02132637|64877806|FG000|Study Period 1|Physician Decision|1|||
23309095|NCT02132637|64877807|FG001|Study Period 1|Physician Decision|0|||
23309096|NCT02132637|64877806|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
23309097|NCT02132637|64877807|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
23309098|NCT02132637|64877806|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
23309099|NCT02132637|64877807|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
23309100|NCT02006693|64877808|FG000|Overall Study|No Reason Specified|6|||
23309101|NCT02006693|64877809|FG001|Overall Study|No Reason Specified|8|||
23309102|NCT02006693|64877808|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
23309103|NCT02006693|64877809|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
23309104|NCT02006693|64877808|FG000|Overall Study|XEN Implant Explantation|0|||
23309105|NCT02006693|64877809|FG001|Overall Study|XEN Implant Explantation|1|||
23309106|NCT02006693|64877808|FG000|Overall Study|Death|2|||
23309107|NCT02006693|64877809|FG001|Overall Study|Death|2|||
23309108|NCT02006693|64877808|FG000|Overall Study|Lost to Follow-up|4|||
23309109|NCT02006693|64877809|FG001|Overall Study|Lost to Follow-up|1|||
23309110|NCT02006693|64877808|FG000|Overall Study|Patient Decision|4|||
23309111|NCT02006693|64877809|FG001|Overall Study|Patient Decision|0|||
23309112|NCT01147107|64877820|FG000|Overall Study|Lack of Efficacy|5|||
23309113|NCT01147107|64877821|FG001|Overall Study|Lack of Efficacy|0|||
23309114|NCT01147107|64877820|FG000|Overall Study|Withdrawal by Subject|1|||
23309115|NCT01147107|64877821|FG001|Overall Study|Withdrawal by Subject|1|||
23309116|NCT03981419|64877824|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
23309117|NCT03981419|64877825|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
23309118|NCT02458287|64877827|FG000|Overall Study|Adverse Event|0|||
23309119|NCT02458287|64877828|FG001|Overall Study|Adverse Event|0|||
23309120|NCT02458287|64877829|FG002|Overall Study|Adverse Event|0|||
23309121|NCT02458287|64877830|FG003|Overall Study|Adverse Event|1|||
23309122|NCT02458287|64877827|FG000|Overall Study|Lost to Follow-up|0|||
23309123|NCT02458287|64877828|FG001|Overall Study|Lost to Follow-up|1|||
23309124|NCT02458287|64877829|FG002|Overall Study|Lost to Follow-up|1|||
23309125|NCT02458287|64877830|FG003|Overall Study|Lost to Follow-up|0|||
23309126|NCT02458287|64877827|FG000|Overall Study|Protocol Violation|0|||
23309127|NCT02458287|64877828|FG001|Overall Study|Protocol Violation|1|||
23309128|NCT02458287|64877829|FG002|Overall Study|Protocol Violation|0|||
23309129|NCT02458287|64877830|FG003|Overall Study|Protocol Violation|0|||
23309130|NCT02458287|64877827|FG000|Overall Study|Withdrawal by Subject|0|||
23309131|NCT02458287|64877828|FG001|Overall Study|Withdrawal by Subject|2|||
23309132|NCT02458287|64877829|FG002|Overall Study|Withdrawal by Subject|2|||
23309133|NCT02458287|64877830|FG003|Overall Study|Withdrawal by Subject|1|||
23309134|NCT02458287|64877827|FG000|Overall Study|Relocated Out of State|0|||
23309135|NCT02458287|64877828|FG001|Overall Study|Relocated Out of State|0|||
23309136|NCT02458287|64877829|FG002|Overall Study|Relocated Out of State|0|||
23309137|NCT02458287|64877830|FG003|Overall Study|Relocated Out of State|1|||
23309138|NCT02377427|64877831|FG000|Part A (Up to Week 20)|Physician Decision|1|||
23309139|NCT02377427|64877832|FG001|Part A (Up to Week 20)|Physician Decision|0|||
23309140|NCT02377427|64877833|FG002|Part A (Up to Week 20)|Physician Decision|0|||
23309141|NCT02377427|64877834|FG003|Part A (Up to Week 20)|Physician Decision|0|||
23309142|NCT02377427|64877835|FG004|Part A (Up to Week 20)|Physician Decision|0|||
23309143|NCT02377427|64877831|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
23309144|NCT02377427|64877832|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
23309145|NCT02377427|64877833|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
23309146|NCT02377427|64877834|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
23309147|NCT02377427|64877835|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
23309148|NCT02377427|64877831|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
23309149|NCT02377427|64877832|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
23309150|NCT02377427|64877833|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
23309151|NCT02377427|64877834|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
23309152|NCT02377427|64877835|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
23529388|NCT01577758|65672884|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23309153|NCT02377427|64877831|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
23309154|NCT02377427|64877832|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
23309155|NCT02377427|64877833|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
23309156|NCT02377427|64877834|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
23309157|NCT02377427|64877835|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
23309158|NCT01857271|64877836|FG000|Overall Study|Lost to Follow-up|1|||
23309159|NCT00638027|64877837|FG000|Overall Study|Adverse Event|0|||
23309160|NCT00638027|64877838|FG001|Overall Study|Adverse Event|2|||
23309161|NCT01199471|64877839|FG000|Overall Study|Protocol Violation|4|||
23309162|NCT01199471|64877839|FG000|Overall Study|Withdrawal by Subject|1|||
23309163|NCT01199471|64877839|FG000|Overall Study|Physician Decision|1|||
23309164|NCT00213135|64877840|FG000|Overall Study|Adverse Event|9|||
23309165|NCT00213135|64877841|FG001|Overall Study|Adverse Event|5|||
23309166|NCT00213135|64877842|FG002|Overall Study|Adverse Event|5|||
23309167|NCT00213135|64877840|FG000|Overall Study|Lost to Follow-up|11|||
23309168|NCT00213135|64877841|FG001|Overall Study|Lost to Follow-up|8|||
23309169|NCT00213135|64877842|FG002|Overall Study|Lost to Follow-up|4|||
23309170|NCT00213135|64877840|FG000|Overall Study|Protocol Violation|4|||
23309171|NCT00213135|64877841|FG001|Overall Study|Protocol Violation|4|||
23309172|NCT00213135|64877842|FG002|Overall Study|Protocol Violation|10|||
23309173|NCT00213135|64877840|FG000|Overall Study|Death|1|||
23309174|NCT00213135|64877841|FG001|Overall Study|Death|1|||
23309175|NCT00213135|64877842|FG002|Overall Study|Death|2|||
23309176|NCT00213135|64877840|FG000|Overall Study|Disease progression|4|||
23309177|NCT00213135|64877841|FG001|Overall Study|Disease progression|5|||
23309178|NCT00213135|64877842|FG002|Overall Study|Disease progression|21|||
23309179|NCT00213135|64877840|FG000|Overall Study|Other|21|||
23309180|NCT00213135|64877841|FG001|Overall Study|Other|12|||
23309181|NCT00213135|64877842|FG002|Overall Study|Other|15|||
23309182|NCT03786718|64877854|FG000|Overall Study|Lost to Follow-up|3|||
23309183|NCT03786718|64877854|FG000|Overall Study|Withdrawal by Subject|1|||
23309184|NCT03786718|64877854|FG000|Overall Study|Did not use the intervention|2|||
23309185|NCT03786718|64877854|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
23309186|NCT02992418|64877855|FG000|Overall Study|Withdrawal by Subject|11|||
23309187|NCT02992418|64877856|FG001|Overall Study|Withdrawal by Subject|12|||
23309188|NCT02992418|64877855|FG000|Overall Study|Non-compliance with the protocol|308|||
23309189|NCT02992418|64877856|FG001|Overall Study|Non-compliance with the protocol|308|||
23309190|NCT02992418|64877855|FG000|Overall Study|Lost to Follow-up|27|||
23309191|NCT02992418|64877856|FG001|Overall Study|Lost to Follow-up|22|||
23309192|NCT00678886|64877857|FG000|Overall Study|Withdrawal by Subject|0|||
23309193|NCT00678886|64877858|FG001|Overall Study|Withdrawal by Subject|0|||
23309194|NCT00678886|64877859|FG002|Overall Study|Withdrawal by Subject|4|||
23309195|NCT00678886|64877860|FG003|Overall Study|Withdrawal by Subject|6|||
23309196|NCT00678886|64877857|FG000|Overall Study|Physician Decision|0|||
23309197|NCT00678886|64877858|FG001|Overall Study|Physician Decision|0|||
23309198|NCT00678886|64877859|FG002|Overall Study|Physician Decision|1|||
23309199|NCT00678886|64877860|FG003|Overall Study|Physician Decision|1|||
23309200|NCT00678886|64877857|FG000|Overall Study|Lost to Follow-up|0|||
23309201|NCT00678886|64877858|FG001|Overall Study|Lost to Follow-up|0|||
23309202|NCT00678886|64877859|FG002|Overall Study|Lost to Follow-up|3|||
23309203|NCT00678886|64877860|FG003|Overall Study|Lost to Follow-up|2|||
23309204|NCT00678886|64877857|FG000|Overall Study|Other|0|||
23309205|NCT00678886|64877858|FG001|Overall Study|Other|0|||
23309206|NCT00678886|64877859|FG002|Overall Study|Other|1|||
23309207|NCT00678886|64877860|FG003|Overall Study|Other|0|||
23309208|NCT02040779|64877861|FG000|Overall Study|Adverse Event|1|||
23309209|NCT02040779|64877862|FG001|Overall Study|Adverse Event|0|||
23529389|NCT01577758|65672885|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529390|NCT01577758|65672886|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529391|NCT01577758|65672887|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529392|NCT01577758|65672888|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
23529393|NCT01577758|65672889|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
23529394|NCT01577758|65672882|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529395|NCT01577758|65672883|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529396|NCT01577758|65672884|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529397|NCT01577758|65672885|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529398|NCT01577758|65672886|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
23309210|NCT02040779|64877863|FG002|Overall Study|Adverse Event|0|||
23309211|NCT02040779|64877861|FG000|Overall Study|Withdrawal by Subject|4|||
23309212|NCT02040779|64877862|FG001|Overall Study|Withdrawal by Subject|1|||
23309213|NCT02040779|64877863|FG002|Overall Study|Withdrawal by Subject|3|||
23309214|NCT02040779|64877861|FG000|Overall Study|Non-compliance|0|||
23309215|NCT02040779|64877862|FG001|Overall Study|Non-compliance|1|||
23309216|NCT02040779|64877863|FG002|Overall Study|Non-compliance|0|||
23309217|NCT02040779|64877861|FG000|Overall Study|Protocol Violation|2|||
23309218|NCT02040779|64877862|FG001|Overall Study|Protocol Violation|1|||
23309219|NCT02040779|64877863|FG002|Overall Study|Protocol Violation|0|||
23309220|NCT02040779|64877861|FG000|Overall Study|Lost to Follow-up|1|||
23309221|NCT02040779|64877862|FG001|Overall Study|Lost to Follow-up|2|||
23309222|NCT02040779|64877863|FG002|Overall Study|Lost to Follow-up|1|||
23309223|NCT02040779|64877861|FG000|Overall Study|Lack of Efficacy|4|||
23309224|NCT02040779|64877862|FG001|Overall Study|Lack of Efficacy|2|||
23309225|NCT02040779|64877863|FG002|Overall Study|Lack of Efficacy|0|||
23309226|NCT04283500|64877864|FG000|Overall Study|Lost to Follow-up|8|||
23529399|NCT01577758|65672887|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529400|NCT01577758|65672888|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
23529401|NCT01577758|65672889|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
23529402|NCT01577758|65672882|FG000|mCRC Expansion Phase|Progression Disease|0|||
23529403|NCT01577758|65672883|FG001|mCRC Expansion Phase|Progression Disease|0|||
23529404|NCT01577758|65672884|FG002|mCRC Expansion Phase|Progression Disease|0|||
23529405|NCT01577758|65672885|FG003|mCRC Expansion Phase|Progression Disease|0|||
23529406|NCT01577758|65672886|FG004|mCRC Expansion Phase|Progression Disease|0|||
23529407|NCT01577758|65672887|FG005|mCRC Expansion Phase|Progression Disease|0|||
23529408|NCT01577758|65672888|FG006|mCRC Expansion Phase|Progression Disease|0|||
23529409|NCT01577758|65672889|FG007|mCRC Expansion Phase|Progression Disease|19|||
23529410|NCT01785602|65672890|FG000|Overall Study|Withdrawal by Subject|2|||
23529411|NCT01785602|65672891|FG001|Overall Study|Withdrawal by Subject|0|||
23529412|NCT01785602|65672890|FG000|Overall Study|Lost to Follow-up|1|||
23529413|NCT01785602|65672891|FG001|Overall Study|Lost to Follow-up|1|||
23529414|NCT01785602|65672890|FG000|Overall Study|Adverse Event|3|||
23529415|NCT01785602|65672891|FG001|Overall Study|Adverse Event|5|||
23529416|NCT01785602|65672890|FG000|Overall Study|Administrative problems|7|||
23529417|NCT01785602|65672891|FG001|Overall Study|Administrative problems|3|||
23529418|NCT02434770|65672892|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
23206593|NCT01606761|64494905|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
23206594|NCT01606761|64494906|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
23206595|NCT01606761|64494907|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
23206596|NCT01606761|64494903|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
23206597|NCT01606761|64494904|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
23206598|NCT01606761|64494905|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
23206599|NCT01606761|64494906|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
23206600|NCT01606761|64494907|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
23206601|NCT01606761|64494903|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
23206602|NCT01606761|64494904|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
23206603|NCT01606761|64494905|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
23206604|NCT01606761|64494906|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
23206605|NCT01606761|64494907|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
23206606|NCT02985450|64494908|FG000|Overall Study|Lost to Follow-up|7|||
23206607|NCT02605447|64494911|FG000|Overall Study|Death|66|||
23206608|NCT02605447|64494911|FG000|Overall Study|Physician Decision|1|||
23206609|NCT02605447|64494911|FG000|Overall Study|Lost to Follow-up|24|||
23206610|NCT02605447|64494911|FG000|Overall Study|Withdrawal by Subject|10|||
23206611|NCT02605447|64494911|FG000|Overall Study|Not disclosed|1|||
23206612|NCT00645567|64494912|FG000|Overall Study|Adverse Event|1|||
23206613|NCT05674344|64494913|FG000|Overall Study|Screen Fail|21|||
23206614|NCT05674344|64494913|FG000|Overall Study|Incomplete study procedures|3|||
23206615|NCT01651052|64494914|FG000|Overall Study|Death|21|||
23206616|NCT01651052|64494914|FG000|Overall Study|Explant|1|||
23206617|NCT01651052|64494914|FG000|Overall Study|Withdrawal by Subject|1|||
23206618|NCT01651052|64494914|FG000|Overall Study|Lost to Follow-up|3|||
23418878|NCT02743949|65277344|FG000|Overall Study|Significant Protocol Deviation|2|||
23418879|NCT02743949|65277345|FG001|Overall Study|Significant Protocol Deviation|0|||
23206619|NCT02939937|64494915|FG000|Overall Study|Adverse Event|5|||
23206620|NCT02939937|64494916|FG001|Overall Study|Adverse Event|0|||
23206621|NCT02939937|64494915|FG000|Overall Study|Lost to Follow-up|1|||
23206622|NCT02939937|64494916|FG001|Overall Study|Lost to Follow-up|3|||
23206623|NCT01051986|64494917|FG000|Overall Study|Death|1|||
23206624|NCT01051986|64494918|FG001|Overall Study|Death|0|||
23206625|NCT01051986|64494917|FG000|Overall Study|Withdrawal by Subject|2|||
23206626|NCT01051986|64494918|FG001|Overall Study|Withdrawal by Subject|1|||
23206627|NCT01051986|64494917|FG000|Overall Study|Protocol Violation|2|||
23418880|NCT02743949|65277346|FG002|Overall Study|Significant Protocol Deviation|1|||
23418881|NCT02743949|65277344|FG000|Overall Study|Voluntary Withdrawal|2|||
23418882|NCT02743949|65277345|FG001|Overall Study|Voluntary Withdrawal|1|||
23418883|NCT02743949|65277346|FG002|Overall Study|Voluntary Withdrawal|0|||
23418884|NCT02109432|65277347|FG000|Overall Study|Withdrawal by Subject|1|||
23418885|NCT04027049|65277348|FG000|Overall Study|Withdrawn by family|1|||
23529419|NCT02434770|65672893|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
23529420|NCT02434770|65672894|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
23206628|NCT01051986|64494918|FG001|Overall Study|Protocol Violation|3|||
23206629|NCT00471445|64494920|FG000|Overall Study|Withdrawal by Subject|1|||
23206630|NCT00471445|64494921|FG001|Overall Study|Withdrawal by Subject|1|||
23206631|NCT00471445|64494920|FG000|Overall Study|Ineligible|1|||
23206632|NCT00471445|64494921|FG001|Overall Study|Ineligible|0|||
23206633|NCT00471445|64494920|FG000|Overall Study|Protocol Violation|0|||
23340852|NCT01936181|64992873|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
23529421|NCT02434770|65672892|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
23529422|NCT02434770|65672893|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
23206634|NCT00471445|64494921|FG001|Overall Study|Protocol Violation|1|||
23206635|NCT01561560|64494922|FG000|First Two Weeks of Wear|Time/job conflict|0|||
23418886|NCT04027049|65277349|FG001|Overall Study|Withdrawn by family|0|||
23418887|NCT04027049|65277348|FG000|Overall Study|Participant safety|1|||
23418888|NCT04027049|65277349|FG001|Overall Study|Participant safety|0|||
23418889|NCT03645421|65277350|FG000|Overall Study|Adverse Event|0|||
23418890|NCT03645421|65277351|FG001|Overall Study|Adverse Event|0|||
23418891|NCT03645421|65277352|FG002|Overall Study|Adverse Event|4|||
23418892|NCT03645421|65277353|FG003|Overall Study|Adverse Event|1|||
23418893|NCT03645421|65277350|FG000|Overall Study|Withdrawal by patient|0|||
23418894|NCT03645421|65277351|FG001|Overall Study|Withdrawal by patient|0|||
23206636|NCT01561560|64494923|FG001|First Two Weeks of Wear|Time/job conflict|1|||
23418895|NCT03645421|65277352|FG002|Overall Study|Withdrawal by patient|0|||
23206637|NCT01561560|64494922|FG000|First Two Weeks of Wear|Adverse Event|0|||
23418896|NCT03645421|65277353|FG003|Overall Study|Withdrawal by patient|3|||
23418897|NCT03645421|65277350|FG000|Overall Study|Study specific withdrawal criteria|0|||
23418898|NCT03645421|65277351|FG001|Overall Study|Study specific withdrawal criteria|0|||
23418899|NCT03645421|65277352|FG002|Overall Study|Study specific withdrawal criteria|1|||
23418900|NCT03645421|65277353|FG003|Overall Study|Study specific withdrawal criteria|0|||
23418901|NCT01631747|65277357|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
23418902|NCT01631747|65277358|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
23418903|NCT01631747|65277357|FG000|Live Birth|Pregnancy Termination|1|||
23418904|NCT01631747|65277358|FG001|Live Birth|Pregnancy Termination|0|||
23418905|NCT01631747|65277357|FG000|Live Birth|MIscarriage|2|||
23418906|NCT01631747|65277358|FG001|Live Birth|MIscarriage|0|||
23418907|NCT01631747|65277357|FG000|Live Birth|Stillbirth|1|||
23418908|NCT01631747|65277358|FG001|Live Birth|Stillbirth|1|||
23418909|NCT01631747|65277357|FG000|One Year Infant Outcomes|Patient Refused|13|||
23418910|NCT01631747|65277358|FG001|One Year Infant Outcomes|Patient Refused|9|||
23529423|NCT02434770|65672894|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
23529424|NCT02434770|65672892|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
23529425|NCT02434770|65672893|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
23206638|NCT01561560|64494923|FG001|First Two Weeks of Wear|Adverse Event|1|||
23418911|NCT03727646|65277361|FG000|Overall Study|Adverse Event|1|||
23418912|NCT03727646|65277362|FG001|Overall Study|Adverse Event|0|||
23418913|NCT02513485|65277377|FG000|Overall Study|Adverse Event|1|||
23418914|NCT02513485|65277378|FG001|Overall Study|Adverse Event|0|||
23418915|NCT02379221|65277379|FG000|Overall Study|Lost to Follow-up|1|||
23418916|NCT01296711|65277382|FG000|Overall Study|Adverse Event|3|||
23418917|NCT01296711|65277383|FG001|Overall Study|Adverse Event|1|||
23418918|NCT01296711|65277384|FG002|Overall Study|Adverse Event|4|||
23418919|NCT01296711|65277385|FG003|Overall Study|Adverse Event|3|||
23418920|NCT01296711|65277386|FG004|Overall Study|Adverse Event|1|||
23418921|NCT01296711|65277387|FG005|Overall Study|Adverse Event|6|||
23418922|NCT01296711|65277388|FG006|Overall Study|Adverse Event|11|||
23418923|NCT01296711|65277389|FG007|Overall Study|Adverse Event|3|||
23418924|NCT01296711|65277382|FG000|Overall Study|Lack of Efficacy|1|||
23418925|NCT01296711|65277383|FG001|Overall Study|Lack of Efficacy|4|||
23418926|NCT01296711|65277384|FG002|Overall Study|Lack of Efficacy|1|||
23418927|NCT01296711|65277385|FG003|Overall Study|Lack of Efficacy|1|||
23418928|NCT01296711|65277386|FG004|Overall Study|Lack of Efficacy|1|||
23418929|NCT01296711|65277387|FG005|Overall Study|Lack of Efficacy|0|||
23206639|NCT01561560|64494922|FG000|Second Two Weeks of Wear|Adverse Event|0|||
23418930|NCT01296711|65277388|FG006|Overall Study|Lack of Efficacy|2|||
23418931|NCT01296711|65277389|FG007|Overall Study|Lack of Efficacy|3|||
23418932|NCT01296711|65277382|FG000|Overall Study|Lost to Follow-up|0|||
23418933|NCT01296711|65277383|FG001|Overall Study|Lost to Follow-up|0|||
23418934|NCT01296711|65277384|FG002|Overall Study|Lost to Follow-up|1|||
23418935|NCT01296711|65277385|FG003|Overall Study|Lost to Follow-up|1|||
23418936|NCT01296711|65277386|FG004|Overall Study|Lost to Follow-up|2|||
23418937|NCT01296711|65277387|FG005|Overall Study|Lost to Follow-up|0|||
23418938|NCT01296711|65277388|FG006|Overall Study|Lost to Follow-up|4|||
23418939|NCT01296711|65277389|FG007|Overall Study|Lost to Follow-up|2|||
23418940|NCT01296711|65277382|FG000|Overall Study|Protocol Violation|0|||
23418941|NCT01296711|65277383|FG001|Overall Study|Protocol Violation|0|||
23418942|NCT01296711|65277384|FG002|Overall Study|Protocol Violation|0|||
23418943|NCT01296711|65277385|FG003|Overall Study|Protocol Violation|1|||
23418944|NCT01296711|65277386|FG004|Overall Study|Protocol Violation|1|||
23418945|NCT01296711|65277387|FG005|Overall Study|Protocol Violation|0|||
23418946|NCT01296711|65277388|FG006|Overall Study|Protocol Violation|0|||
23418947|NCT01296711|65277389|FG007|Overall Study|Protocol Violation|0|||
23418948|NCT01296711|65277382|FG000|Overall Study|Withdrawal by Subject|4|||
23418949|NCT01296711|65277383|FG001|Overall Study|Withdrawal by Subject|2|||
23418950|NCT01296711|65277384|FG002|Overall Study|Withdrawal by Subject|2|||
23418951|NCT01296711|65277385|FG003|Overall Study|Withdrawal by Subject|1|||
23418952|NCT01296711|65277386|FG004|Overall Study|Withdrawal by Subject|1|||
23418953|NCT01296711|65277387|FG005|Overall Study|Withdrawal by Subject|1|||
23418954|NCT01296711|65277388|FG006|Overall Study|Withdrawal by Subject|2|||
23418955|NCT01296711|65277389|FG007|Overall Study|Withdrawal by Subject|1|||
23418956|NCT01296711|65277382|FG000|Overall Study|Study termination|8|||
23418957|NCT01296711|65277383|FG001|Overall Study|Study termination|1|||
23418958|NCT01296711|65277384|FG002|Overall Study|Study termination|5|||
23418959|NCT01296711|65277385|FG003|Overall Study|Study termination|4|||
23418960|NCT01296711|65277386|FG004|Overall Study|Study termination|4|||
23418961|NCT01296711|65277387|FG005|Overall Study|Study termination|4|||
23418962|NCT01296711|65277388|FG006|Overall Study|Study termination|8|||
23418963|NCT01296711|65277389|FG007|Overall Study|Study termination|10|||
23418964|NCT01296711|65277382|FG000|Overall Study|Continued elevated liver enzymes|0|||
23418965|NCT01296711|65277383|FG001|Overall Study|Continued elevated liver enzymes|0|||
23418966|NCT01296711|65277384|FG002|Overall Study|Continued elevated liver enzymes|0|||
23418967|NCT01296711|65277385|FG003|Overall Study|Continued elevated liver enzymes|1|||
23418968|NCT01296711|65277386|FG004|Overall Study|Continued elevated liver enzymes|0|||
23418969|NCT01296711|65277387|FG005|Overall Study|Continued elevated liver enzymes|0|||
23418970|NCT01296711|65277388|FG006|Overall Study|Continued elevated liver enzymes|0|||
23418971|NCT01296711|65277389|FG007|Overall Study|Continued elevated liver enzymes|0|||
23418972|NCT01296711|65277382|FG000|Overall Study|Methotrexate discontinued|0|||
23418973|NCT01296711|65277383|FG001|Overall Study|Methotrexate discontinued|0|||
23418974|NCT01296711|65277384|FG002|Overall Study|Methotrexate discontinued|0|||
23418975|NCT01296711|65277385|FG003|Overall Study|Methotrexate discontinued|1|||
23418976|NCT01296711|65277386|FG004|Overall Study|Methotrexate discontinued|0|||
23418977|NCT01296711|65277387|FG005|Overall Study|Methotrexate discontinued|0|||
23418978|NCT01296711|65277388|FG006|Overall Study|Methotrexate discontinued|0|||
23418979|NCT01296711|65277389|FG007|Overall Study|Methotrexate discontinued|0|||
23418980|NCT01296711|65277382|FG000|Overall Study|Investigator discretion|0|||
23418981|NCT01296711|65277383|FG001|Overall Study|Investigator discretion|0|||
23418982|NCT01296711|65277384|FG002|Overall Study|Investigator discretion|0|||
23418983|NCT01296711|65277385|FG003|Overall Study|Investigator discretion|0|||
23418984|NCT01296711|65277386|FG004|Overall Study|Investigator discretion|0|||
23418985|NCT01296711|65277387|FG005|Overall Study|Investigator discretion|0|||
23418986|NCT01296711|65277388|FG006|Overall Study|Investigator discretion|1|||
23418987|NCT01296711|65277389|FG007|Overall Study|Investigator discretion|0|||
23418988|NCT01296711|65277382|FG000|Overall Study|Other|0|||
23418989|NCT01296711|65277383|FG001|Overall Study|Other|0|||
23418990|NCT01296711|65277384|FG002|Overall Study|Other|0|||
23418991|NCT01296711|65277385|FG003|Overall Study|Other|0|||
23418992|NCT01296711|65277386|FG004|Overall Study|Other|0|||
23418993|NCT01296711|65277387|FG005|Overall Study|Other|0|||
23418994|NCT01296711|65277388|FG006|Overall Study|Other|1|||
23418995|NCT01296711|65277389|FG007|Overall Study|Other|0|||
23418996|NCT01296711|65277382|FG000|Overall Study|Required restricted steroid injections|0|||
23418997|NCT01296711|65277383|FG001|Overall Study|Required restricted steroid injections|0|||
23418998|NCT01296711|65277384|FG002|Overall Study|Required restricted steroid injections|0|||
23418999|NCT01296711|65277385|FG003|Overall Study|Required restricted steroid injections|0|||
23419000|NCT01296711|65277386|FG004|Overall Study|Required restricted steroid injections|0|||
23419001|NCT01296711|65277387|FG005|Overall Study|Required restricted steroid injections|0|||
23419002|NCT01296711|65277388|FG006|Overall Study|Required restricted steroid injections|1|||
23529426|NCT02434770|65672894|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
23529427|NCT02434770|65672892|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
23419003|NCT01296711|65277389|FG007|Overall Study|Required restricted steroid injections|0|||
23419004|NCT01296711|65277382|FG000|Overall Study|Ongoing missed appointments|0|||
23419005|NCT01296711|65277383|FG001|Overall Study|Ongoing missed appointments|0|||
23419006|NCT01296711|65277384|FG002|Overall Study|Ongoing missed appointments|0|||
23419007|NCT01296711|65277385|FG003|Overall Study|Ongoing missed appointments|0|||
23419008|NCT01296711|65277386|FG004|Overall Study|Ongoing missed appointments|0|||
23419009|NCT01296711|65277387|FG005|Overall Study|Ongoing missed appointments|0|||
23419010|NCT01296711|65277388|FG006|Overall Study|Ongoing missed appointments|1|||
23419011|NCT01296711|65277389|FG007|Overall Study|Ongoing missed appointments|0|||
23419012|NCT01296711|65277382|FG000|Overall Study|Failure to comply with visits|0|||
23419013|NCT01296711|65277383|FG001|Overall Study|Failure to comply with visits|0|||
23419014|NCT01296711|65277384|FG002|Overall Study|Failure to comply with visits|0|||
23419015|NCT01296711|65277385|FG003|Overall Study|Failure to comply with visits|0|||
23419016|NCT01296711|65277386|FG004|Overall Study|Failure to comply with visits|0|||
23419017|NCT01296711|65277387|FG005|Overall Study|Failure to comply with visits|0|||
23419018|NCT01296711|65277388|FG006|Overall Study|Failure to comply with visits|0|||
23419019|NCT01296711|65277389|FG007|Overall Study|Failure to comply with visits|1|||
23419020|NCT01296711|65277382|FG000|Overall Study|Patient decision due to transport|0|||
23419021|NCT01296711|65277383|FG001|Overall Study|Patient decision due to transport|0|||
23419022|NCT01296711|65277384|FG002|Overall Study|Patient decision due to transport|0|||
23419023|NCT01296711|65277385|FG003|Overall Study|Patient decision due to transport|0|||
23419024|NCT01296711|65277386|FG004|Overall Study|Patient decision due to transport|0|||
23419025|NCT01296711|65277387|FG005|Overall Study|Patient decision due to transport|0|||
23419026|NCT01296711|65277388|FG006|Overall Study|Patient decision due to transport|0|||
23419027|NCT01296711|65277389|FG007|Overall Study|Patient decision due to transport|1|||
23419028|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Death|1|||
23419029|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Death|1|||
23419030|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Death|0|||
23419031|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Death|0|||
23419032|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Death|1|||
23419033|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Death|0|||
23419034|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Death|0|||
23419035|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Death|0|||
23419036|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Death|0|||
23419037|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Death|0|||
23419038|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
23419039|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
23419040|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
23419041|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419042|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
23419043|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419044|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419045|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419046|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419047|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
23419048|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419049|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23206640|NCT01561560|64494923|FG001|Second Two Weeks of Wear|Adverse Event|1|||
23206641|NCT00772382|64494924|FG000|Overall Study|Adverse Event|19|||
23206642|NCT00772382|64494924|FG000|Overall Study|Death|6|||
23206643|NCT00772382|64494924|FG000|Overall Study|Lack of Efficacy|4|||
23206644|NCT00772382|64494924|FG000|Overall Study|Physician Decision|5|||
23206645|NCT00772382|64494924|FG000|Overall Study|Protocol Violation|1|||
23206646|NCT00772382|64494924|FG000|Overall Study|Withdrawal by Subject|10|||
23206647|NCT00772382|64494924|FG000|Overall Study|Other Reasons|10|||
23206648|NCT04402008|64494927|FG000|Overall Study|Adverse Event|0|||
23206649|NCT04402008|64494928|FG001|Overall Study|Adverse Event|0|||
23206650|NCT04402008|64494929|FG002|Overall Study|Adverse Event|0|||
23206651|NCT04402008|64494930|FG003|Overall Study|Adverse Event|1|||
23206652|NCT04402008|64494931|FG004|Overall Study|Adverse Event|0|||
23529428|NCT02434770|65672893|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
23529429|NCT02434770|65672894|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
23529430|NCT02434770|65672892|FG000|Week 1 to Week 18|Death|1|||
23529431|NCT02434770|65672893|FG001|Week 1 to Week 18|Death|0|||
23529432|NCT02434770|65672894|FG002|Week 1 to Week 18|Death|0|||
23529433|NCT02434770|65672892|FG000|Week 18 to Week|Lost to Follow-up|2|||
23529434|NCT02434770|65672893|FG001|Week 18 to Week|Lost to Follow-up|2|||
23529435|NCT02434770|65672894|FG002|Week 18 to Week|Lost to Follow-up|1|||
23206653|NCT04402008|64494932|FG005|Overall Study|Adverse Event|0|||
23206654|NCT04402008|64494933|FG006|Overall Study|Adverse Event|0|||
23529436|NCT02434770|65672892|FG000|Week 18 to Week|Withdrawal by Subject|0|||
23529437|NCT02434770|65672893|FG001|Week 18 to Week|Withdrawal by Subject|0|||
23529438|NCT02434770|65672894|FG002|Week 18 to Week|Withdrawal by Subject|2|||
23340853|NCT01936181|64992870|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
23419050|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419051|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419052|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
23419053|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419054|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419055|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419056|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23419057|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
23529439|NCT02434770|65672892|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
23529440|NCT02434770|65672893|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
23529441|NCT02434770|65672894|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
23529442|NCT00670800|65672895|FG000|Overall Study|2 controls were insulin resistant|0|||
23529443|NCT00670800|65672896|FG001|Overall Study|2 controls were insulin resistant|2|||
23529444|NCT01802775|65672901|FG000|Overall Study|Death|0|||
23529445|NCT01802775|65672902|FG001|Overall Study|Death|3|||
23529446|NCT01802775|65672901|FG000|Overall Study|Reason not provided|0|||
23529447|NCT01802775|65672902|FG001|Overall Study|Reason not provided|1|||
23529448|NCT01802775|65672901|FG000|Overall Study|Physician Decision|1|||
23529449|NCT01802775|65672902|FG001|Overall Study|Physician Decision|0|||
23529450|NCT01802775|65672901|FG000|Overall Study|Adverse Event|1|||
23529451|NCT01802775|65672902|FG001|Overall Study|Adverse Event|1|||
23529452|NCT01802775|65672901|FG000|Overall Study|Withdrawal by Subject|3|||
23529453|NCT01802775|65672902|FG001|Overall Study|Withdrawal by Subject|5|||
23529454|NCT01802775|65672901|FG000|Overall Study|Lost to Follow-up|1|||
23529455|NCT01802775|65672902|FG001|Overall Study|Lost to Follow-up|2|||
23419058|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
23419059|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419060|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419061|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419062|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419063|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419064|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23529456|NCT01762943|65672903|FG000|Overall Study|Physician Decision|1|||
23529457|NCT01762943|65672904|FG001|Overall Study|Physician Decision|1|||
23529458|NCT01762943|65672903|FG000|Overall Study|Protocol Violation|1|||
23529459|NCT01762943|65672904|FG001|Overall Study|Protocol Violation|0|||
23419065|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23529460|NCT01762943|65672903|FG000|Overall Study|Withdrawal by Subject|2|||
23529461|NCT01762943|65672904|FG001|Overall Study|Withdrawal by Subject|1|||
23529462|NCT01434823|65672907|FG000|Overall Study|Incomplete data in medical record|4|||
23529463|NCT01434823|65672908|FG001|Overall Study|Incomplete data in medical record|7|||
23529464|NCT01916304|65672909|FG000|Overall Study|Screening failure|17|||
23529465|NCT01420081|65672910|FG000|Overall Study|Death|1|||
23529466|NCT01420081|65672911|FG001|Overall Study|Death|0|||
23529467|NCT01420081|65672912|FG002|Overall Study|Death|8|||
23529468|NCT01420081|65672913|FG003|Overall Study|Death|0|||
23529469|NCT01420081|65672914|FG004|Overall Study|Death|7|||
23529470|NCT01420081|65672915|FG005|Overall Study|Death|12|||
23529471|NCT01420081|65672916|FG006|Overall Study|Death|0|||
23529472|NCT01420081|65672917|FG007|Overall Study|Death|1|||
23529473|NCT01420081|65672918|FG008|Overall Study|Death|1|||
23529474|NCT01420081|65672910|FG000|Overall Study|Lost to Follow-up|0|||
23529475|NCT01420081|65672911|FG001|Overall Study|Lost to Follow-up|0|||
23529476|NCT01420081|65672912|FG002|Overall Study|Lost to Follow-up|0|||
23529477|NCT01420081|65672913|FG003|Overall Study|Lost to Follow-up|0|||
23529478|NCT01420081|65672914|FG004|Overall Study|Lost to Follow-up|1|||
23419066|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419067|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
23419068|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
23419069|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419070|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419071|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
23419072|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
23419073|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419074|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419075|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419076|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419077|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
23419078|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
23419079|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419080|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419081|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
23419082|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419083|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419084|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419085|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419086|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419087|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
23419088|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
23419089|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
23419090|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
23419091|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
23419092|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
23419093|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419094|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419095|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419096|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419097|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
23419098|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
23419099|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
23529479|NCT01420081|65672915|FG005|Overall Study|Lost to Follow-up|1|||
23529480|NCT01420081|65672916|FG006|Overall Study|Lost to Follow-up|0|||
23529481|NCT01420081|65672917|FG007|Overall Study|Lost to Follow-up|0|||
23529482|NCT01420081|65672918|FG008|Overall Study|Lost to Follow-up|0|||
23529483|NCT01420081|65672910|FG000|Overall Study|Study Terminated by Sponsor|2|||
23419100|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
23529484|NCT01420081|65672911|FG001|Overall Study|Study Terminated by Sponsor|1|||
23206655|NCT04402008|64494927|FG000|Overall Study|Disease Progression|3|||
23206656|NCT04402008|64494928|FG001|Overall Study|Disease Progression|2|||
23529485|NCT01420081|65672912|FG002|Overall Study|Study Terminated by Sponsor|1|||
23529486|NCT01420081|65672913|FG003|Overall Study|Study Terminated by Sponsor|3|||
23529487|NCT01420081|65672914|FG004|Overall Study|Study Terminated by Sponsor|11|||
23529488|NCT01420081|65672915|FG005|Overall Study|Study Terminated by Sponsor|7|||
23529489|NCT01420081|65672916|FG006|Overall Study|Study Terminated by Sponsor|3|||
23529490|NCT01420081|65672917|FG007|Overall Study|Study Terminated by Sponsor|2|||
23529491|NCT01420081|65672918|FG008|Overall Study|Study Terminated by Sponsor|2|||
23529492|NCT01420081|65672910|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
23529493|NCT01420081|65672911|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
23529494|NCT01420081|65672912|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
23529495|NCT01420081|65672913|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
23206657|NCT04402008|64494929|FG002|Overall Study|Disease Progression|3|||
23453583|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
23529496|NCT01420081|65672914|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
23529497|NCT01420081|65672915|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
23206658|NCT04402008|64494930|FG003|Overall Study|Disease Progression|3|||
23206659|NCT04402008|64494931|FG004|Overall Study|Disease Progression|4|||
23529498|NCT01420081|65672916|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
23529499|NCT01420081|65672917|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
23529500|NCT01420081|65672918|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
23529501|NCT01420081|65672910|FG000|Overall Study|Other Reasons|0|||
23529502|NCT01420081|65672911|FG001|Overall Study|Other Reasons|0|||
23529503|NCT01420081|65672912|FG002|Overall Study|Other Reasons|1|||
23529504|NCT01420081|65672913|FG003|Overall Study|Other Reasons|0|||
23529505|NCT01420081|65672914|FG004|Overall Study|Other Reasons|0|||
23529506|NCT01420081|65672915|FG005|Overall Study|Other Reasons|0|||
23529507|NCT01420081|65672916|FG006|Overall Study|Other Reasons|0|||
23529508|NCT01420081|65672917|FG007|Overall Study|Other Reasons|0|||
23529509|NCT01420081|65672918|FG008|Overall Study|Other Reasons|0|||
23529510|NCT02586012|65672919|FG000|Overall Study|Withdrawal by Subject|1|||
23529511|NCT02586012|65672920|FG001|Overall Study|Withdrawal by Subject|1|||
23529512|NCT02586012|65672921|FG002|Overall Study|Withdrawal by Subject|0|||
23529513|NCT02586012|65672922|FG003|Overall Study|Withdrawal by Subject|1|||
23529514|NCT02586012|65672923|FG004|Overall Study|Withdrawal by Subject|0|||
23529515|NCT02586012|65672924|FG005|Overall Study|Withdrawal by Subject|2|||
23529516|NCT02586012|65672919|FG000|Overall Study|Protocol Violation|0|||
23529517|NCT02586012|65672920|FG001|Overall Study|Protocol Violation|0|||
23529518|NCT02586012|65672921|FG002|Overall Study|Protocol Violation|0|||
23529519|NCT02586012|65672922|FG003|Overall Study|Protocol Violation|0|||
23529520|NCT02586012|65672923|FG004|Overall Study|Protocol Violation|0|||
23529521|NCT02586012|65672924|FG005|Overall Study|Protocol Violation|1|||
23529522|NCT02586012|65672919|FG000|Overall Study|study terminated|0|||
23529523|NCT02586012|65672920|FG001|Overall Study|study terminated|2|||
23529524|NCT02586012|65672921|FG002|Overall Study|study terminated|1|||
23529525|NCT02586012|65672922|FG003|Overall Study|study terminated|1|||
23529526|NCT02586012|65672923|FG004|Overall Study|study terminated|1|||
23419101|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23529527|NCT02586012|65672924|FG005|Overall Study|study terminated|0|||
23529528|NCT02365636|65672925|FG000|Overall Study|Adverse Event|3|||
23529529|NCT02365636|65672926|FG001|Overall Study|Adverse Event|3|||
23529530|NCT02365636|65672927|FG002|Overall Study|Adverse Event|2|||
23529531|NCT02365636|65672925|FG000|Overall Study|Protocol Violation|1|||
23612431|NCT05265247|65969629|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
23612432|NCT05265247|65969630|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
23612433|NCT05265247|65969629|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
23612434|NCT05265247|65969630|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
23612435|NCT01654289|65969631|FG000|Overall Study|Withdrawal by Subject|10|||
23309227|NCT04283500|64877864|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
23309228|NCT00090610|64877865|FG000|Overall Study|Withdrawal by Subject|1|||
23309229|NCT00090610|64877866|FG001|Overall Study|Withdrawal by Subject|1|||
23612436|NCT01654289|65969632|FG001|Overall Study|Withdrawal by Subject|8|||
23612437|NCT01654289|65969633|FG002|Overall Study|Withdrawal by Subject|5|||
23612438|NCT01654289|65969631|FG000|Overall Study|Withdrew from intervention only|17|||
23612439|NCT01654289|65969632|FG001|Overall Study|Withdrew from intervention only|20|||
23612440|NCT01654289|65969633|FG002|Overall Study|Withdrew from intervention only|0|||
23309230|NCT00858143|64877867|FG000|Overall Study|Adverse Event|16|||
23612441|NCT02379078|65969634|FG000|Overall Study|Lost to Follow-up|33|||
23612442|NCT02379078|65969635|FG001|Overall Study|Lost to Follow-up|30|||
23419102|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
23419103|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419104|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419105|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419106|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419107|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419108|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
23419109|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419110|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419111|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
23419112|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
23419113|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419114|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419115|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419116|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23419117|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
23453584|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
23206660|NCT04402008|64494932|FG005|Overall Study|Disease Progression|3|||
23206661|NCT04402008|64494933|FG006|Overall Study|Disease Progression|10|||
23206662|NCT04402008|64494927|FG000|Overall Study|Withdrawal by Subject|0|||
23206663|NCT04402008|64494928|FG001|Overall Study|Withdrawal by Subject|1|||
23206664|NCT04402008|64494929|FG002|Overall Study|Withdrawal by Subject|0|||
23206665|NCT04402008|64494930|FG003|Overall Study|Withdrawal by Subject|0|||
23206666|NCT04402008|64494931|FG004|Overall Study|Withdrawal by Subject|1|||
23206667|NCT04402008|64494932|FG005|Overall Study|Withdrawal by Subject|0|||
23206668|NCT04402008|64494933|FG006|Overall Study|Withdrawal by Subject|0|||
23206669|NCT04402008|64494927|FG000|Overall Study|Sponsor Decision|0|||
23206670|NCT04402008|64494928|FG001|Overall Study|Sponsor Decision|0|||
23206671|NCT04402008|64494929|FG002|Overall Study|Sponsor Decision|0|||
23206672|NCT04402008|64494930|FG003|Overall Study|Sponsor Decision|0|||
23206673|NCT04402008|64494931|FG004|Overall Study|Sponsor Decision|0|||
23206674|NCT04402008|64494932|FG005|Overall Study|Sponsor Decision|0|||
23206675|NCT04402008|64494933|FG006|Overall Study|Sponsor Decision|3|||
23206676|NCT04402008|64494927|FG000|Overall Study|Death|0|||
23206677|NCT04402008|64494928|FG001|Overall Study|Death|0|||
23206678|NCT04402008|64494929|FG002|Overall Study|Death|0|||
23206679|NCT04402008|64494930|FG003|Overall Study|Death|0|||
23206680|NCT04402008|64494931|FG004|Overall Study|Death|1|||
23206681|NCT04402008|64494932|FG005|Overall Study|Death|0|||
23206682|NCT04402008|64494933|FG006|Overall Study|Death|2|||
23206683|NCT04402008|64494927|FG000|Overall Study|Other|0|||
23206684|NCT04402008|64494928|FG001|Overall Study|Other|0|||
23309231|NCT00858143|64877867|FG000|Overall Study|Lack of Efficacy|4|||
23309232|NCT00858143|64877867|FG000|Overall Study|Death|7|||
23206685|NCT04402008|64494929|FG002|Overall Study|Other|0|||
23206686|NCT04402008|64494930|FG003|Overall Study|Other|0|||
23309233|NCT00858143|64877867|FG000|Overall Study|Other|23|||
23206687|NCT04402008|64494931|FG004|Overall Study|Other|0|||
23419118|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419119|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419120|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419121|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419122|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419123|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419124|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419125|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419126|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419127|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419128|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419129|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419130|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
23419131|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419132|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
23419133|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419134|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419135|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419136|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419137|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419138|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
23419139|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
23419140|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
23419141|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
23206688|NCT04402008|64494932|FG005|Overall Study|Other|0|||
23529532|NCT02365636|65672926|FG001|Overall Study|Protocol Violation|4|||
23612443|NCT02379078|65969634|FG000|Overall Study|Withdrawal by Subject|6|||
23206689|NCT04402008|64494933|FG006|Overall Study|Other|5|||
23206690|NCT01999946|64494934|FG000|Overall Study|Participant not released from jail|2|||
23206691|NCT01999946|64494935|FG001|Overall Study|Participant not released from jail|2|||
23419142|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
23419143|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419144|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419145|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419146|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419147|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
23419148|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419149|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419150|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419151|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
23419152|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
23419153|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23206692|NCT01999946|64494936|FG002|Overall Study|Participant not released from jail|0|||
23206693|NCT01999946|64494934|FG000|Overall Study|Not included in primary outcome analysis|0|||
23206694|NCT01999946|64494935|FG001|Overall Study|Not included in primary outcome analysis|0|||
23206695|NCT01999946|64494936|FG002|Overall Study|Not included in primary outcome analysis|79|||
23419154|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419155|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419156|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419157|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23529533|NCT02365636|65672927|FG002|Overall Study|Protocol Violation|0|||
23529534|NCT02365636|65672925|FG000|Overall Study|Lost to Follow-up|0|||
23612444|NCT02379078|65969635|FG001|Overall Study|Withdrawal by Subject|5|||
23612445|NCT02542293|65969636|FG000|Overall Study|Death|367|||
23612446|NCT02542293|65969637|FG001|Overall Study|Death|377|||
23612447|NCT02542293|65969636|FG000|Overall Study|Withdrawal by Subject|8|||
23612448|NCT02542293|65969637|FG001|Overall Study|Withdrawal by Subject|19|||
23612449|NCT03529942|65969638|FG000|Overall Study|Withdrawal by Subject|13|||
23612450|NCT03529942|65969638|FG000|Overall Study|Physician Decision|1|||
23612451|NCT03529942|65969638|FG000|Overall Study|Lost to Follow-up|7|||
23612452|NCT03529942|65969638|FG000|Overall Study|Needle inserted but no drug administered|1|||
23612453|NCT03529942|65969638|FG000|Overall Study|Personal reasons|1|||
23612454|NCT00278395|65969639|FG000|Overall Study|Adverse Event|2|||
23612455|NCT00278395|65969639|FG000|Overall Study|Nonevaluable|1|||
23612456|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612457|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612458|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612459|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
23612460|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612461|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
23612462|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
23612463|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
23612464|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
23612465|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
23612466|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
23612467|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
23612468|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23612469|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23612470|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
23206696|NCT00310388|64494937|FG000|Primary Reporting Phase|Adverse Event|101|||
23206697|NCT00310388|64494938|FG001|Primary Reporting Phase|Adverse Event|0|||
23206698|NCT00310388|64494937|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
23612471|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23612472|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23612473|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
23419158|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419159|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419160|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419161|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419162|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419163|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419164|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419165|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419166|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419167|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419168|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
23419169|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23529535|NCT02365636|65672926|FG001|Overall Study|Lost to Follow-up|0|||
23529536|NCT02365636|65672927|FG002|Overall Study|Lost to Follow-up|1|||
23529537|NCT02365636|65672925|FG000|Overall Study|Other|2|||
23529538|NCT02365636|65672926|FG001|Overall Study|Other|0|||
23529539|NCT02365636|65672927|FG002|Overall Study|Other|0|||
23529540|NCT00279708|65672928|FG000|Overall Study|Withdrawal by Subject|2|||
23529541|NCT00279708|65672929|FG001|Overall Study|Withdrawal by Subject|3|||
23529542|NCT00279708|65672928|FG000|Overall Study|Adverse Event|1|||
23529543|NCT00279708|65672929|FG001|Overall Study|Adverse Event|1|||
23529544|NCT00261716|65672932|FG000|Overall Study|Withdrawal by Subject|6|||
23529545|NCT00261716|65672933|FG001|Overall Study|Withdrawal by Subject|8|||
23529546|NCT00261716|65672932|FG000|Overall Study|Lost to Follow-up|0|||
23529547|NCT00261716|65672933|FG001|Overall Study|Lost to Follow-up|2|||
23529548|NCT02554656|65672937|FG000|Overall Study|Protocol Violation|3|||
23529549|NCT02643251|65672938|FG000|Overall Study|Adverse Event|3|||
23529550|NCT02643251|65672939|FG001|Overall Study|Adverse Event|1|||
23529551|NCT02643251|65672938|FG000|Overall Study|Withdrawal by Subject|2|||
23529552|NCT02643251|65672939|FG001|Overall Study|Withdrawal by Subject|0|||
23529553|NCT02643251|65672938|FG000|Overall Study|Lost to Follow-up|4|||
23529554|NCT02643251|65672939|FG001|Overall Study|Lost to Follow-up|1|||
23529555|NCT02643251|65672938|FG000|Overall Study|Protocol Violation|1|||
23529556|NCT02643251|65672939|FG001|Overall Study|Protocol Violation|0|||
23529557|NCT02643251|65672938|FG000|Overall Study|PI Decision to terminate patient|1|||
23529558|NCT02643251|65672939|FG001|Overall Study|PI Decision to terminate patient|0|||
23529559|NCT01485861|65672940|FG000|Phase Ib|Death|1|||
23529560|NCT01485861|65672941|FG001|Phase Ib|Death|0|||
23529561|NCT01485861|65672942|FG002|Phase Ib|Death|0|||
23529562|NCT01485861|65672943|FG003|Phase Ib|Death|0|||
23529563|NCT01485861|65672944|FG004|Phase Ib|Death|0|||
23529564|NCT01485861|65672945|FG005|Phase Ib|Death|0|||
23529565|NCT01485861|65672940|FG000|Phase Ib|Physician Decision|1|||
23529566|NCT01485861|65672941|FG001|Phase Ib|Physician Decision|1|||
23529567|NCT01485861|65672942|FG002|Phase Ib|Physician Decision|0|||
23529568|NCT01485861|65672943|FG003|Phase Ib|Physician Decision|0|||
23529569|NCT01485861|65672944|FG004|Phase Ib|Physician Decision|0|||
23529570|NCT01485861|65672945|FG005|Phase Ib|Physician Decision|0|||
23529571|NCT01485861|65672940|FG000|Phase Ib|Adverse Event|0|||
23529572|NCT01485861|65672941|FG001|Phase Ib|Adverse Event|4|||
23529573|NCT01485861|65672942|FG002|Phase Ib|Adverse Event|0|||
23529574|NCT01485861|65672943|FG003|Phase Ib|Adverse Event|0|||
23529575|NCT01485861|65672944|FG004|Phase Ib|Adverse Event|0|||
23529576|NCT01485861|65672945|FG005|Phase Ib|Adverse Event|0|||
23529577|NCT01485861|65672940|FG000|Phase Ib|Progression of disease|5|||
23529578|NCT01485861|65672941|FG001|Phase Ib|Progression of disease|0|||
23529579|NCT01485861|65672942|FG002|Phase Ib|Progression of disease|0|||
23529580|NCT01485861|65672943|FG003|Phase Ib|Progression of disease|0|||
23529581|NCT01485861|65672944|FG004|Phase Ib|Progression of disease|0|||
23529582|NCT01485861|65672945|FG005|Phase Ib|Progression of disease|0|||
23529583|NCT01485861|65672940|FG000|Phase Ib|Other|3|||
23529584|NCT01485861|65672941|FG001|Phase Ib|Other|0|||
23529585|NCT01485861|65672942|FG002|Phase Ib|Other|0|||
23529586|NCT01485861|65672943|FG003|Phase Ib|Other|0|||
23529587|NCT01485861|65672944|FG004|Phase Ib|Other|0|||
23529588|NCT01485861|65672945|FG005|Phase Ib|Other|0|||
23529589|NCT01485861|65672940|FG000|Phase Ib|Withdrawal by Subject|4|||
23529590|NCT01485861|65672941|FG001|Phase Ib|Withdrawal by Subject|1|||
23529591|NCT01485861|65672942|FG002|Phase Ib|Withdrawal by Subject|0|||
23529592|NCT01485861|65672943|FG003|Phase Ib|Withdrawal by Subject|0|||
23529593|NCT01485861|65672944|FG004|Phase Ib|Withdrawal by Subject|0|||
23529594|NCT01485861|65672945|FG005|Phase Ib|Withdrawal by Subject|0|||
23419170|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419171|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419172|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
23419173|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419174|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419175|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419176|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419177|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
23419178|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419179|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419180|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419181|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419182|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
23419183|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419184|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419185|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419186|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23206699|NCT00310388|64494938|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
23206700|NCT00310388|64494937|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
23206701|NCT00310388|64494938|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
23206702|NCT00310388|64494937|FG000|Primary Reporting Phase|Protocol Violation|10|||
23206703|NCT00310388|64494938|FG001|Primary Reporting Phase|Protocol Violation|0|||
23206704|NCT00310388|64494937|FG000|Primary Reporting Phase|Pregnancy|3|||
23206705|NCT00310388|64494938|FG001|Primary Reporting Phase|Pregnancy|0|||
23206706|NCT00310388|64494937|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
23206707|NCT00310388|64494938|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
23206708|NCT00310388|64494937|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
23206709|NCT00310388|64494938|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
23206710|NCT00310388|64494937|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
23206711|NCT00310388|64494938|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
23206712|NCT00310388|64494937|FG000|Primary Reporting Phase|Physician Decision|2|||
23206713|NCT00310388|64494938|FG001|Primary Reporting Phase|Physician Decision|0|||
23206714|NCT00310388|64494937|FG000|Primary Reporting Phase|Request of the sponsor|19|||
23206715|NCT00310388|64494938|FG001|Primary Reporting Phase|Request of the sponsor|0|||
23206716|NCT00310388|64494937|FG000|Primary Reporting Phase|Failed to return|8|||
23206717|NCT00310388|64494938|FG001|Primary Reporting Phase|Failed to return|0|||
23206718|NCT00310388|64494937|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
23206719|NCT00310388|64494938|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
23206720|NCT00310388|64494937|FG000|Primary Reporting Phase|Participant request|2|||
23529595|NCT01485861|65672940|FG000|Phase II|Death|0|||
23529596|NCT01485861|65672941|FG001|Phase II|Death|0|||
23529597|NCT01485861|65672942|FG002|Phase II|Death|67|||
23529598|NCT01485861|65672943|FG003|Phase II|Death|71|||
23529599|NCT01485861|65672944|FG004|Phase II|Death|68|||
23529600|NCT01485861|65672945|FG005|Phase II|Death|0|||
23529601|NCT01485861|65672940|FG000|Phase II|Progression of Disease|0|||
23529602|NCT01485861|65672941|FG001|Phase II|Progression of Disease|0|||
23529603|NCT01485861|65672942|FG002|Phase II|Progression of Disease|1|||
23529604|NCT01485861|65672943|FG003|Phase II|Progression of Disease|0|||
23529605|NCT01485861|65672944|FG004|Phase II|Progression of Disease|0|||
23529606|NCT01485861|65672945|FG005|Phase II|Progression of Disease|0|||
23529607|NCT01485861|65672940|FG000|Phase II|Other|0|||
23529608|NCT01485861|65672941|FG001|Phase II|Other|0|||
23529609|NCT01485861|65672942|FG002|Phase II|Other|0|||
23529610|NCT01485861|65672943|FG003|Phase II|Other|1|||
23529611|NCT01485861|65672944|FG004|Phase II|Other|0|||
23529612|NCT01485861|65672945|FG005|Phase II|Other|0|||
23529613|NCT01485861|65672940|FG000|Phase II|Withdrawal by Subject|0|||
23529614|NCT01485861|65672941|FG001|Phase II|Withdrawal by Subject|0|||
23529615|NCT01485861|65672942|FG002|Phase II|Withdrawal by Subject|6|||
23529616|NCT01485861|65672943|FG003|Phase II|Withdrawal by Subject|3|||
23529617|NCT01485861|65672944|FG004|Phase II|Withdrawal by Subject|4|||
23529618|NCT01485861|65672945|FG005|Phase II|Withdrawal by Subject|0|||
23529619|NCT01485861|65672940|FG000|Phase II|Lost to Follow-up|0|||
23529620|NCT01485861|65672941|FG001|Phase II|Lost to Follow-up|0|||
23529621|NCT01485861|65672942|FG002|Phase II|Lost to Follow-up|2|||
23529622|NCT01485861|65672943|FG003|Phase II|Lost to Follow-up|3|||
23529623|NCT01485861|65672944|FG004|Phase II|Lost to Follow-up|5|||
23529624|NCT01485861|65672945|FG005|Phase II|Lost to Follow-up|0|||
23529625|NCT01485861|65672940|FG000|Phase II|Study Ended|0|||
23529626|NCT01485861|65672941|FG001|Phase II|Study Ended|0|||
23529627|NCT01485861|65672942|FG002|Phase II|Study Ended|7|||
23529628|NCT01485861|65672943|FG003|Phase II|Study Ended|8|||
23529629|NCT01485861|65672944|FG004|Phase II|Study Ended|6|||
23612474|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
23612475|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
23612476|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
23612477|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
23612478|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
23612479|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
23612480|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
23612481|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
23612482|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
23612483|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
23612484|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
23612485|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
23612486|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
23612487|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
23612488|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
23612489|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
23612490|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
23206721|NCT00310388|64494938|FG001|Primary Reporting Phase|Participant request|0|||
23206722|NCT00310388|64494937|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
23206723|NCT00310388|64494938|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
23529630|NCT01485861|65672945|FG005|Phase II|Study Ended|0|||
23529631|NCT01485861|65672940|FG000|Safety Phase|Death|0|||
23529632|NCT01485861|65672941|FG001|Safety Phase|Death|0|||
23529633|NCT01485861|65672942|FG002|Safety Phase|Death|0|||
23529634|NCT01485861|65672943|FG003|Safety Phase|Death|0|||
23529635|NCT01485861|65672944|FG004|Safety Phase|Death|0|||
23529636|NCT01485861|65672945|FG005|Safety Phase|Death|2|||
23529637|NCT01485861|65672940|FG000|Safety Phase|Adverse Event|0|||
23529638|NCT01485861|65672941|FG001|Safety Phase|Adverse Event|0|||
23529639|NCT01485861|65672942|FG002|Safety Phase|Adverse Event|0|||
23529640|NCT01485861|65672943|FG003|Safety Phase|Adverse Event|0|||
23529641|NCT01485861|65672944|FG004|Safety Phase|Adverse Event|0|||
23529642|NCT01485861|65672945|FG005|Safety Phase|Adverse Event|1|||
23529643|NCT01485861|65672940|FG000|Safety Phase|Other|0|||
23529644|NCT01485861|65672941|FG001|Safety Phase|Other|0|||
23529645|NCT01485861|65672942|FG002|Safety Phase|Other|0|||
23529646|NCT01485861|65672943|FG003|Safety Phase|Other|0|||
23529647|NCT01485861|65672944|FG004|Safety Phase|Other|0|||
23529648|NCT01485861|65672945|FG005|Safety Phase|Other|5|||
23529649|NCT01485861|65672940|FG000|Safety Phase|Progression of Disease|0|||
23529650|NCT01485861|65672941|FG001|Safety Phase|Progression of Disease|0|||
23529651|NCT01485861|65672942|FG002|Safety Phase|Progression of Disease|0|||
23529652|NCT01485861|65672943|FG003|Safety Phase|Progression of Disease|0|||
23529653|NCT01485861|65672944|FG004|Safety Phase|Progression of Disease|0|||
23529654|NCT01485861|65672945|FG005|Safety Phase|Progression of Disease|9|||
23529655|NCT01485861|65672940|FG000|Safety Phase|Withdrawal by Subject|0|||
23529656|NCT01485861|65672941|FG001|Safety Phase|Withdrawal by Subject|0|||
23612491|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
23612492|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
23612493|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
23612494|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
23612495|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
23612496|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
23529657|NCT01485861|65672942|FG002|Safety Phase|Withdrawal by Subject|0|||
23529658|NCT01485861|65672943|FG003|Safety Phase|Withdrawal by Subject|0|||
23529659|NCT01485861|65672944|FG004|Safety Phase|Withdrawal by Subject|0|||
23529660|NCT01485861|65672945|FG005|Safety Phase|Withdrawal by Subject|6|||
23529661|NCT01485861|65672940|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
23529662|NCT01485861|65672941|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
23529663|NCT01485861|65672942|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
23612497|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
23529664|NCT01485861|65672943|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
23612498|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
23612499|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
23612500|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
23612501|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
23612502|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
23612503|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
23612504|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
23612505|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
23612506|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
23612507|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
23612508|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
23612509|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
23612510|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
23612511|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
23612512|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
23612513|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
23612514|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
23612515|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
23612516|NCT03395197|65969640|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
23612517|NCT03395197|65969641|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
23612518|NCT03395197|65969642|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
23612519|NCT03395197|65969643|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
23612520|NCT03395197|65969644|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
23612521|NCT03395197|65969645|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
23612522|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Death|0|||
23612523|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Death|0|||
23309234|NCT02885181|64877874|FG000|Overall Study|Investigator's Discretion|0|||
23309235|NCT02885181|64877875|FG001|Overall Study|Investigator's Discretion|1|||
23529665|NCT01485861|65672944|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
23529666|NCT01485861|65672945|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
23529667|NCT00678691|65672947|FG000|Overall Study|Adverse Event|6|||
23529668|NCT00678691|65672948|FG001|Overall Study|Adverse Event|4|||
23529669|NCT02107703|65672949|FG000|Overall Study|Withdrawal by Subject|46|||
23529670|NCT02107703|65672950|FG001|Overall Study|Withdrawal by Subject|21|||
23529671|NCT02107703|65672949|FG000|Overall Study|Lost to Follow-up|20|||
23529672|NCT02107703|65672950|FG001|Overall Study|Lost to Follow-up|9|||
23529673|NCT02107703|65672949|FG000|Overall Study|On study treatment/follow up|48|||
23529674|NCT02107703|65672950|FG001|Overall Study|On study treatment/follow up|5|||
23529675|NCT03878134|65672951|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
23529676|NCT01800903|65672952|FG000|Second Test Period|unable to catheterise|1|||
23529677|NCT01800903|65672953|FG001|Second Test Period|unable to catheterise|0|||
23529678|NCT01800903|65672954|FG002|Second Test Period|unable to catheterise|0|||
23529679|NCT01800903|65672955|FG003|Second Test Period|unable to catheterise|0|||
23529680|NCT01800903|65672956|FG004|Second Test Period|unable to catheterise|0|||
23529681|NCT01800903|65672957|FG005|Second Test Period|unable to catheterise|0|||
23529682|NCT00749775|65672964|FG000|Overall Study|Protocol Violation|24|||
23529683|NCT00749775|65672964|FG000|Overall Study|Lost to Follow-up|36|||
23529684|NCT00749775|65672964|FG000|Overall Study|No visit after first day of treatment|44|||
23529685|NCT00749775|65672964|FG000|Overall Study|No drug administration|3|||
23529686|NCT02059148|65672975|FG000|Treatment 1|Protocol Violation|0|||
23529687|NCT02059148|65672976|FG001|Treatment 1|Protocol Violation|0|||
23529688|NCT02059148|65672977|FG002|Treatment 1|Protocol Violation|0|||
23529689|NCT02059148|65672978|FG003|Treatment 1|Protocol Violation|0|||
23529690|NCT02059148|65672979|FG004|Treatment 1|Protocol Violation|0|||
23529691|NCT02059148|65672980|FG005|Treatment 1|Protocol Violation|1|||
23529692|NCT02181556|65672981|FG000|Overall Study|Withdrawal by Subject|1|||
23529693|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
23529694|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
23529695|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
23529696|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
23529697|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
23529698|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
23529699|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
23529700|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
23529701|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
23529702|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
23309236|NCT02885181|64877876|FG002|Overall Study|Investigator's Discretion|0|||
23309237|NCT02885181|64877877|FG003|Overall Study|Investigator's Discretion|1|||
23309238|NCT02885181|64877874|FG000|Overall Study|Adverse Event|0|||
23309239|NCT02885181|64877875|FG001|Overall Study|Adverse Event|0|||
23309240|NCT02885181|64877876|FG002|Overall Study|Adverse Event|0|||
23309241|NCT02885181|64877877|FG003|Overall Study|Adverse Event|1|||
23309242|NCT02885181|64877874|FG000|Overall Study|Withdrawal by Subject|0|||
23309243|NCT02885181|64877875|FG001|Overall Study|Withdrawal by Subject|0|||
23529703|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
23529704|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
23309244|NCT02885181|64877876|FG002|Overall Study|Withdrawal by Subject|0|||
23309245|NCT02885181|64877877|FG003|Overall Study|Withdrawal by Subject|1|||
23309246|NCT01330459|64877885|FG000|Overall Study|Physician Decision|0|||
23309247|NCT01330459|64877886|FG001|Overall Study|Physician Decision|2|||
23309248|NCT04495283|64877887|FG000|Overall Study|Physician Decision|0|||
23309249|NCT04495283|64877888|FG001|Overall Study|Physician Decision|0|||
23309250|NCT04495283|64877889|FG002|Overall Study|Physician Decision|1|||
23529705|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
23529706|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
23309251|NCT04495283|64877887|FG000|Overall Study|Withdrawal by Subject|0|||
23309252|NCT04495283|64877888|FG001|Overall Study|Withdrawal by Subject|1|||
23309253|NCT04495283|64877889|FG002|Overall Study|Withdrawal by Subject|1|||
23309254|NCT04495283|64877887|FG000|Overall Study|Other|1|||
23309255|NCT04495283|64877888|FG001|Overall Study|Other|0|||
23206724|NCT00310388|64494937|FG000|Primary Reporting Phase|Discontinuation of study|1|||
23206725|NCT00310388|64494938|FG001|Primary Reporting Phase|Discontinuation of study|0|||
23309256|NCT04495283|64877889|FG002|Overall Study|Other|1|||
23309257|NCT00976911|64877898|FG000|Overall Study|Withdrawal by Subject|4|||
23309258|NCT00976911|64877899|FG001|Overall Study|Withdrawal by Subject|6|||
23309259|NCT00976911|64877898|FG000|Overall Study|Death|138|||
23309260|NCT00976911|64877899|FG001|Overall Study|Death|126|||
23309261|NCT00976911|64877898|FG000|Overall Study|Adverse Event|0|||
23309262|NCT00976911|64877899|FG001|Overall Study|Adverse Event|1|||
23309263|NCT00976911|64877898|FG000|Overall Study|Protocol Violation|2|||
23309264|NCT00976911|64877899|FG001|Overall Study|Protocol Violation|0|||
23309265|NCT00976911|64877898|FG000|Overall Study|Other|8|||
23309266|NCT00976911|64877899|FG001|Overall Study|Other|9|||
23309267|NCT00976911|64877898|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
23309268|NCT00976911|64877899|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
23309269|NCT02011113|64877900|FG000|Overall Study|Adverse Event|4|||
23309270|NCT02011113|64877900|FG000|Overall Study|Disease Progression (DP)|16|||
23309271|NCT02011113|64877900|FG000|Overall Study|Death|1|||
23309272|NCT02011113|64877900|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
23309273|NCT02011113|64877900|FG000|Overall Study|Investigator's judgement- DP|3|||
23206726|NCT00310388|64494937|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
23206727|NCT00310388|64494938|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
23206728|NCT00310388|64494937|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
23206729|NCT00310388|64494938|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
23206730|NCT00310388|64494937|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
23206731|NCT00310388|64494938|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
23206732|NCT00310388|64494937|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
23206733|NCT00310388|64494938|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
23206734|NCT00310388|64494937|FG000|Primary Reporting Phase|Participant passed away|1|||
23206735|NCT00310388|64494938|FG001|Primary Reporting Phase|Participant passed away|0|||
23206736|NCT00310388|64494937|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
23206737|NCT00310388|64494938|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
23206738|NCT00310388|64494937|FG000|Primary Reporting Phase|Missing|1|||
23206739|NCT00310388|64494938|FG001|Primary Reporting Phase|Missing|0|||
23206740|NCT00310388|64494937|FG000|Primary Reporting Phase|Other|1|||
23206741|NCT00310388|64494938|FG001|Primary Reporting Phase|Other|0|||
23206742|NCT00310388|64494937|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
23206743|NCT00310388|64494938|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
23206744|NCT00310388|64494937|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
23206745|NCT00310388|64494938|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
23206746|NCT00310388|64494937|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
23206747|NCT00310388|64494938|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
23206748|NCT00310388|64494937|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
23206749|NCT00310388|64494938|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
23206750|NCT04321252|64494942|FG000|Overall Study|Withdrawal by Subject|0|||
23206751|NCT04321252|64494943|FG001|Overall Study|Withdrawal by Subject|0|||
23206752|NCT04321252|64494944|FG002|Overall Study|Withdrawal by Subject|0|||
23206753|NCT04321252|64494945|FG003|Overall Study|Withdrawal by Subject|0|||
23206754|NCT04321252|64494946|FG004|Overall Study|Withdrawal by Subject|0|||
23206755|NCT04321252|64494947|FG005|Overall Study|Withdrawal by Subject|1|||
23206756|NCT04321252|64494948|FG006|Overall Study|Withdrawal by Subject|0|||
23206757|NCT04321252|64494949|FG007|Overall Study|Withdrawal by Subject|0|||
23206758|NCT04321252|64494950|FG008|Overall Study|Withdrawal by Subject|0|||
23206759|NCT01996904|64494951|FG000|Overall Study|Lost to Follow-up|38|||
23206760|NCT01996904|64494952|FG001|Overall Study|Lost to Follow-up|27|||
23206761|NCT02504268|64498075|FG000|Overall Study|Adverse Event|18|||
23206762|NCT02504268|64498076|FG001|Overall Study|Adverse Event|8|||
23206763|NCT02504268|64498077|FG002|Overall Study|Adverse Event|14|||
23206764|NCT02504268|64498078|FG003|Overall Study|Adverse Event|0|||
23206765|NCT02504268|64498079|FG004|Overall Study|Adverse Event|0|||
23206766|NCT02504268|64498080|FG005|Overall Study|Adverse Event|0|||
23206767|NCT02504268|64498081|FG006|Overall Study|Adverse Event|0|||
23206768|NCT02504268|64498082|FG007|Overall Study|Adverse Event|0|||
23206769|NCT02504268|64498083|FG008|Overall Study|Adverse Event|0|||
23206770|NCT02504268|64498075|FG000|Overall Study|Withdrawal of Consent|11|||
23309274|NCT02011113|64877900|FG000|Overall Study|Study terminated by sponsor|11|||
23309275|NCT00289536|64877909|FG000|Period 3|Lost to Follow-up|0|||
23206771|NCT02504268|64498076|FG001|Overall Study|Withdrawal of Consent|10|||
23206772|NCT02504268|64498077|FG002|Overall Study|Withdrawal of Consent|3|||
23309276|NCT00289536|64877910|FG001|Period 3|Lost to Follow-up|0|||
23309277|NCT00289536|64877911|FG002|Period 3|Lost to Follow-up|1|||
23529707|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
23309278|NCT02952898|64877914|FG000|Overall Study|Withdrawal by Subject|10|||
23309279|NCT02952898|64877915|FG001|Overall Study|Withdrawal by Subject|8|||
23309280|NCT02952898|64877916|FG002|Overall Study|Withdrawal by Subject|8|||
23309281|NCT02952898|64877914|FG000|Overall Study|Adverse Event|8|||
23309282|NCT02952898|64877915|FG001|Overall Study|Adverse Event|8|||
23309283|NCT02952898|64877916|FG002|Overall Study|Adverse Event|3|||
23309284|NCT02952898|64877914|FG000|Overall Study|Lost to Follow-up|3|||
23309285|NCT02952898|64877915|FG001|Overall Study|Lost to Follow-up|2|||
23309286|NCT02952898|64877916|FG002|Overall Study|Lost to Follow-up|2|||
23309287|NCT02952898|64877914|FG000|Overall Study|Non-compliance with study drug|1|||
23309288|NCT02952898|64877915|FG001|Overall Study|Non-compliance with study drug|1|||
23309289|NCT02952898|64877916|FG002|Overall Study|Non-compliance with study drug|2|||
23309290|NCT03262038|64877917|FG000|Overall Study|Withdrawal by Subject|0|||
23309291|NCT03262038|64877918|FG001|Overall Study|Withdrawal by Subject|1|||
23309292|NCT02283294|64877924|FG000|Overall Study|Lost to Follow-up|1|||
23309293|NCT02283294|64877925|FG001|Overall Study|Lost to Follow-up|1|||
23309294|NCT02283294|64877924|FG000|Overall Study|Withdrawal by Subject|1|||
23309295|NCT02283294|64877925|FG001|Overall Study|Withdrawal by Subject|6|||
23309296|NCT02283294|64877924|FG000|Overall Study|Protocol Violation|1|||
23453585|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
23529708|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
23529709|NCT02047110|65672982|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
23529710|NCT02047110|65672983|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
23529711|NCT02047110|65672984|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
23529712|NCT02047110|65672985|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
23529713|NCT02047110|65672982|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
23529714|NCT02047110|65672983|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
23529715|NCT02047110|65672984|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
23529716|NCT02047110|65672985|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
23529717|NCT02047110|65672982|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
23529718|NCT02047110|65672983|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
23612524|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Death|0|||
23206773|NCT02504268|64498078|FG003|Overall Study|Withdrawal of Consent|0|||
23206774|NCT02504268|64498079|FG004|Overall Study|Withdrawal of Consent|0|||
23206775|NCT02504268|64498080|FG005|Overall Study|Withdrawal of Consent|0|||
23206776|NCT02504268|64498081|FG006|Overall Study|Withdrawal of Consent|0|||
23206777|NCT02504268|64498082|FG007|Overall Study|Withdrawal of Consent|0|||
23206778|NCT02504268|64498083|FG008|Overall Study|Withdrawal of Consent|0|||
23206779|NCT02504268|64498075|FG000|Overall Study|Pregnancy|2|||
23206780|NCT02504268|64498076|FG001|Overall Study|Pregnancy|0|||
23206781|NCT02504268|64498077|FG002|Overall Study|Pregnancy|0|||
23206782|NCT02504268|64498078|FG003|Overall Study|Pregnancy|0|||
23206783|NCT02504268|64498079|FG004|Overall Study|Pregnancy|0|||
23206784|NCT02504268|64498080|FG005|Overall Study|Pregnancy|0|||
23206785|NCT02504268|64498081|FG006|Overall Study|Pregnancy|0|||
23206786|NCT02504268|64498082|FG007|Overall Study|Pregnancy|0|||
23206787|NCT02504268|64498083|FG008|Overall Study|Pregnancy|0|||
23206788|NCT02504268|64498075|FG000|Overall Study|Lost to Follow-up|3|||
23206789|NCT02504268|64498076|FG001|Overall Study|Lost to Follow-up|6|||
23206790|NCT02504268|64498077|FG002|Overall Study|Lost to Follow-up|4|||
23206791|NCT02504268|64498078|FG003|Overall Study|Lost to Follow-up|0|||
23206792|NCT02504268|64498079|FG004|Overall Study|Lost to Follow-up|0|||
23206793|NCT02504268|64498080|FG005|Overall Study|Lost to Follow-up|0|||
23206794|NCT02504268|64498081|FG006|Overall Study|Lost to Follow-up|0|||
23206795|NCT02504268|64498082|FG007|Overall Study|Lost to Follow-up|0|||
23206796|NCT02504268|64498083|FG008|Overall Study|Lost to Follow-up|0|||
23206797|NCT02504268|64498075|FG000|Overall Study|Death|1|||
23206798|NCT02504268|64498076|FG001|Overall Study|Death|1|||
23206799|NCT02504268|64498077|FG002|Overall Study|Death|0|||
23206800|NCT02504268|64498078|FG003|Overall Study|Death|0|||
23206801|NCT02504268|64498079|FG004|Overall Study|Death|0|||
23206802|NCT02504268|64498080|FG005|Overall Study|Death|0|||
23206803|NCT02504268|64498081|FG006|Overall Study|Death|0|||
23206804|NCT02504268|64498082|FG007|Overall Study|Death|0|||
23206805|NCT02504268|64498083|FG008|Overall Study|Death|0|||
23529719|NCT02047110|65672984|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
23206806|NCT02504268|64498075|FG000|Overall Study|Subject Request to Discontinue|11|||
23206807|NCT02504268|64498076|FG001|Overall Study|Subject Request to Discontinue|3|||
23206808|NCT02504268|64498077|FG002|Overall Study|Subject Request to Discontinue|6|||
23206809|NCT02504268|64498078|FG003|Overall Study|Subject Request to Discontinue|0|||
23206810|NCT02504268|64498079|FG004|Overall Study|Subject Request to Discontinue|0|||
23206811|NCT02504268|64498080|FG005|Overall Study|Subject Request to Discontinue|0|||
23206812|NCT02504268|64498081|FG006|Overall Study|Subject Request to Discontinue|0|||
23206813|NCT02504268|64498082|FG007|Overall Study|Subject Request to Discontinue|0|||
23206814|NCT02504268|64498083|FG008|Overall Study|Subject Request to Discontinue|0|||
23206815|NCT02504268|64498075|FG000|Overall Study|No Longer Meets Study Criteria|2|||
23309297|NCT02283294|64877925|FG001|Overall Study|Protocol Violation|0|||
23309298|NCT02283294|64877924|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
23309299|NCT02283294|64877925|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
23309300|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
23612525|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Death|0|||
23612526|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Death|1|||
23612527|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Death|4|||
23612528|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
23612529|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
23612530|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
23612531|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
23612532|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
23612533|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
23206816|NCT02504268|64498076|FG001|Overall Study|No Longer Meets Study Criteria|3|||
23612534|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612535|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612536|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612537|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612538|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
23612539|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
23612540|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
23612541|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
23612542|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
23612543|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
23612544|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
23612545|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
23612546|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
23612547|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
23612548|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
23612549|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
23612550|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
23612551|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
23612552|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
23612553|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
23612554|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
23612555|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
23612556|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
23612557|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
23612558|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
23612559|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
23612560|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
23612561|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
23612562|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
23206817|NCT02504268|64498077|FG002|Overall Study|No Longer Meets Study Criteria|0|||
23419187|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419188|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419189|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
23419190|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419191|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419192|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
23419193|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419194|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419195|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419196|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419197|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
23419198|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
23419199|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419200|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419201|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419202|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
23419203|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419204|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419205|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419206|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419207|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
23419208|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
23419209|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419210|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
23419211|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419212|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
23419213|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419214|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419215|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419216|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419217|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
23419218|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Other|5|||
23419219|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Other|1|||
23419220|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Other|0|||
23419221|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Other|3|||
23309301|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
23309302|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
23309303|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
23309304|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
23309305|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
23309306|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
23419222|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Other|0|||
23419223|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Other|0|||
23419224|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Other|0|||
23419225|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Other|0|||
23419226|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Other|0|||
23419227|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Other|0|||
23419228|NCT03352557|65277390|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419229|NCT03352557|65277391|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419230|NCT03352557|65277392|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419231|NCT03352557|65277393|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419232|NCT03352557|65277394|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
23419233|NCT03352557|65277395|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419234|NCT03352557|65277396|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419235|NCT03352557|65277397|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419236|NCT03352557|65277398|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419237|NCT03352557|65277399|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
23419238|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Death|0|||
23419239|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Death|0|||
23419240|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Death|0|||
23419241|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Death|0|||
23419242|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Death|0|||
23419243|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Death|1|||
23419244|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Death|0|||
23419245|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Death|1|||
23419246|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Death|1|||
23419247|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Death|1|||
23419248|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419249|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23612563|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
23419250|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419251|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419252|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23529720|NCT02047110|65672985|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
23529721|NCT02047110|65672982|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
23529722|NCT02047110|65672983|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
23529723|NCT02047110|65672984|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
23529724|NCT02047110|65672985|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
23529725|NCT02047110|65672982|FG000|Escape Treatment Period|Adverse Event|1|||
23529726|NCT02047110|65672983|FG001|Escape Treatment Period|Adverse Event|2|||
23529727|NCT02047110|65672984|FG002|Escape Treatment Period|Adverse Event|2|||
23529728|NCT02047110|65672985|FG003|Escape Treatment Period|Adverse Event|0|||
23529729|NCT02047110|65672982|FG000|Escape Treatment Period|Other than specified|1|||
23529730|NCT02047110|65672983|FG001|Escape Treatment Period|Other than specified|2|||
23529731|NCT02047110|65672984|FG002|Escape Treatment Period|Other than specified|0|||
23529732|NCT02047110|65672985|FG003|Escape Treatment Period|Other than specified|1|||
23529733|NCT02047110|65672982|FG000|OLE Treatment Period|Other than specified|0|||
23529734|NCT02047110|65672983|FG001|OLE Treatment Period|Other than specified|0|||
23529735|NCT02047110|65672984|FG002|OLE Treatment Period|Other than specified|1|||
23529736|NCT02047110|65672985|FG003|OLE Treatment Period|Other than specified|0|||
23529737|NCT00463060|65672986|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
23529738|NCT00463060|65672986|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
23529739|NCT02852265|65672987|FG000|3-month Follow-up|Lost to Follow-up|1|||
23529740|NCT02852265|65672988|FG001|3-month Follow-up|Lost to Follow-up|1|||
23529741|NCT00302003|65672989|FG000|Overall Study|Lack of Efficacy|62|||
23206818|NCT02504268|64498078|FG003|Overall Study|No Longer Meets Study Criteria|0|||
23206819|NCT02504268|64498079|FG004|Overall Study|No Longer Meets Study Criteria|0|||
23206820|NCT02504268|64498080|FG005|Overall Study|No Longer Meets Study Criteria|0|||
23206821|NCT02504268|64498081|FG006|Overall Study|No Longer Meets Study Criteria|0|||
23206822|NCT02504268|64498082|FG007|Overall Study|No Longer Meets Study Criteria|0|||
23419253|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
23419254|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419255|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419256|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23419257|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
23529742|NCT00302003|65672989|FG000|Overall Study|Lost to Follow-up|1|||
23529743|NCT00302003|65672989|FG000|Overall Study|Physician Decision|2|||
23529744|NCT00302003|65672989|FG000|Overall Study|Withdrawal by Subject|5|||
23206823|NCT02504268|64498083|FG008|Overall Study|No Longer Meets Study Criteria|0|||
23206824|NCT02504268|64498075|FG000|Overall Study|Lack of Efficacy|11|||
23206825|NCT02504268|64498076|FG001|Overall Study|Lack of Efficacy|35|||
23206826|NCT02504268|64498077|FG002|Overall Study|Lack of Efficacy|9|||
23206827|NCT02504268|64498078|FG003|Overall Study|Lack of Efficacy|0|||
23206828|NCT02504268|64498079|FG004|Overall Study|Lack of Efficacy|0|||
23309307|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
23529745|NCT00302003|65672989|FG000|Overall Study|Ineligible|9|||
23529746|NCT00302003|65672989|FG000|Overall Study|Protocol Violation|1|||
23529747|NCT01069289|65672990|FG000|Overall Study|Withdrawal by Subject|15|||
23529748|NCT01069289|65672991|FG001|Overall Study|Withdrawal by Subject|26|||
23529749|NCT01069289|65672990|FG000|Overall Study|Adverse Event|21|||
23529750|NCT01069289|65672991|FG001|Overall Study|Adverse Event|28|||
23529751|NCT01069289|65672990|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23529752|NCT01069289|65672991|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23529753|NCT01069289|65672990|FG000|Overall Study|Severe non-compliance to protocol|3|||
23529754|NCT01069289|65672991|FG001|Overall Study|Severe non-compliance to protocol|2|||
23529755|NCT01069289|65672990|FG000|Overall Study|Due to deteriorating health condition|1|||
23529756|NCT01069289|65672991|FG001|Overall Study|Due to deteriorating health condition|0|||
23529757|NCT01782313|65672992|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
23529758|NCT01782313|65672992|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
23529759|NCT01782313|65672992|FG000|Treated Cycle 3|Progressive Disease|21|||
23529760|NCT01782313|65672992|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
23529761|NCT01782313|65672992|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
23529762|NCT01782313|65672992|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
23529763|NCT01782313|65672992|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
23529764|NCT01782313|65672992|FG000|Survival Follow up|Lost to Follow-up|1|||
23419258|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419259|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419260|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419261|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419262|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419263|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419264|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419265|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419266|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
23529765|NCT01140477|65672993|FG000|Overall Study|Lost to Follow-up|4|||
23529766|NCT01140477|65672994|FG001|Overall Study|Lost to Follow-up|0|||
23529767|NCT01140477|65672993|FG000|Overall Study|Withdrawal by Subject|1|||
23529768|NCT01140477|65672994|FG001|Overall Study|Withdrawal by Subject|4|||
23529769|NCT01140477|65672993|FG000|Overall Study|Surgical complication preventing implant|2|||
23529770|NCT01140477|65672994|FG001|Overall Study|Surgical complication preventing implant|0|||
23529771|NCT01140477|65672993|FG000|Overall Study|Death|1|||
23529772|NCT01140477|65672994|FG001|Overall Study|Death|1|||
23529773|NCT01140477|65672993|FG000|Overall Study|Subject explanted|0|||
23529774|NCT01140477|65672994|FG001|Overall Study|Subject explanted|1|||
23529775|NCT00480636|65673005|FG000|Overall Study|Death|12|||
23529776|NCT00480636|65673005|FG000|Overall Study|Lost to Follow-up|4|||
23529777|NCT00480636|65673005|FG000|Overall Study|Other|2|||
23529778|NCT00480636|65673005|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
23529779|NCT00110812|65673010|FG000|Main Study|Death|0|||
23529780|NCT00110812|65673011|FG001|Main Study|Death|0|||
23529781|NCT00110812|65673012|FG002|Main Study|Death|2|||
23529782|NCT00110812|65673010|FG000|Main Study|Withdrawal by Subject|0|||
23529783|NCT00110812|65673011|FG001|Main Study|Withdrawal by Subject|0|||
23529784|NCT00110812|65673012|FG002|Main Study|Withdrawal by Subject|1|||
23529785|NCT00110812|65673010|FG000|Main Study|Lost to Follow-up|8|||
23529786|NCT00110812|65673011|FG001|Main Study|Lost to Follow-up|11|||
23529787|NCT00110812|65673012|FG002|Main Study|Lost to Follow-up|10|||
23529788|NCT00110812|65673010|FG000|Extended Follow-up|Death|1|||
23529789|NCT00110812|65673011|FG001|Extended Follow-up|Death|0|||
23529790|NCT00110812|65673012|FG002|Extended Follow-up|Death|3|||
23529791|NCT00110812|65673010|FG000|Extended Follow-up|Withdrawal by Subject|0|||
23529792|NCT00110812|65673011|FG001|Extended Follow-up|Withdrawal by Subject|1|||
23529793|NCT00110812|65673012|FG002|Extended Follow-up|Withdrawal by Subject|0|||
23529794|NCT00110812|65673010|FG000|Extended Follow-up|Lost to Follow-up|1|||
23529795|NCT00110812|65673011|FG001|Extended Follow-up|Lost to Follow-up|3|||
23529796|NCT00110812|65673012|FG002|Extended Follow-up|Lost to Follow-up|1|||
23529797|NCT01239368|65673013|FG000|Overall Study|Principal investigator discretion|1|||
23529798|NCT01239368|65673014|FG001|Overall Study|Principal investigator discretion|0|||
23529799|NCT01239368|65673015|FG002|Overall Study|Principal investigator discretion|0|||
23529800|NCT01239368|65673016|FG003|Overall Study|Principal investigator discretion|0|||
23529801|NCT01239368|65673017|FG004|Overall Study|Principal investigator discretion|1|||
23529802|NCT01239368|65673018|FG005|Overall Study|Principal investigator discretion|2|||
23529803|NCT01239368|65673019|FG006|Overall Study|Principal investigator discretion|0|||
23529804|NCT01239368|65673020|FG007|Overall Study|Principal investigator discretion|0|||
23529805|NCT01239368|65673021|FG008|Overall Study|Principal investigator discretion|0|||
23529806|NCT01239368|65673022|FG009|Overall Study|Principal investigator discretion|1|||
23612564|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Other|0|||
23612565|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Other|0|||
23612566|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Other|0|||
23612567|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Other|0|||
23612568|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Other|3|||
23612569|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Other|3|||
23612570|NCT03395197|65969640|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
23612571|NCT03395197|65969641|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
23612572|NCT03395197|65969642|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
23612573|NCT03395197|65969643|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
23612574|NCT03395197|65969644|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
23612575|NCT03395197|65969645|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
23612576|NCT04839289|65969646|FG000|Overall Study|Withdrawal by Subject|1|||
23612577|NCT04839289|65969647|FG001|Overall Study|Withdrawal by Subject|0|||
23612578|NCT01774929|65969648|FG000|Overall Study|Adverse Event|3|||
23612579|NCT04879823|65969651|FG000|Overall Study|Physician Decision|3|||
23612580|NCT04879823|65969652|FG001|Overall Study|Physician Decision|1|||
23612581|NCT04879823|65969651|FG000|Overall Study|Protocol Violation|2|||
23612582|NCT04879823|65969652|FG001|Overall Study|Protocol Violation|3|||
23612583|NCT04879823|65969651|FG000|Overall Study|Lost to Follow-up|43|||
23612584|NCT04879823|65969652|FG001|Overall Study|Lost to Follow-up|35|||
23612585|NCT02879448|65969653|FG000|Overall Study|No implant attempt|17|||
23612586|NCT02879448|65969654|FG001|Overall Study|No implant attempt|28|||
23612587|NCT02879448|65969653|FG000|Overall Study|Withdrawal by Subject|20|||
23612588|NCT02879448|65969654|FG001|Overall Study|Withdrawal by Subject|46|||
23612589|NCT02879448|65969653|FG000|Overall Study|Death|63|||
23612590|NCT02879448|65969654|FG001|Overall Study|Death|85|||
23612591|NCT02879448|65969653|FG000|Overall Study|Lost to Follow-up|3|||
23612592|NCT02879448|65969654|FG001|Overall Study|Lost to Follow-up|4|||
23612593|NCT02879448|65969653|FG000|Overall Study|Missing visit|34|||
23612594|NCT02879448|65969654|FG001|Overall Study|Missing visit|39|||
23612595|NCT02879448|65969653|FG000|Overall Study|Pending evaluation|1|||
23612596|NCT02879448|65969654|FG001|Overall Study|Pending evaluation|0|||
23612597|NCT03481725|65969655|FG000|Overall Study|Withdrawal by Subject|1|||
23612598|NCT03481725|65969656|FG001|Overall Study|Withdrawal by Subject|0|||
23612599|NCT04620733|65969657|FG000|Overall Study|Adverse Event|4|||
23612600|NCT04620733|65969658|FG001|Overall Study|Adverse Event|3|||
23612601|NCT04620733|65969657|FG000|Overall Study|Withdrawal by Subject|2|||
23612602|NCT04620733|65969658|FG001|Overall Study|Withdrawal by Subject|5|||
23612603|NCT04620733|65969657|FG000|Overall Study|Lost to Follow-up|1|||
23612604|NCT04620733|65969658|FG001|Overall Study|Lost to Follow-up|1|||
23612605|NCT04620733|65969657|FG000|Overall Study|Protocol Deviation|1|||
23612606|NCT04620733|65969658|FG001|Overall Study|Protocol Deviation|1|||
23612607|NCT04620733|65969657|FG000|Overall Study|Reason Not Specified|0|||
23612608|NCT04620733|65969658|FG001|Overall Study|Reason Not Specified|1|||
23612609|NCT02105688|65969660|FG000|Part A: Double-Blind|Adverse Event|1|||
23612610|NCT02105688|65969661|FG001|Part A: Double-Blind|Adverse Event|0|||
23612611|NCT02105688|65969660|FG000|Part A: Double-Blind|Death|0|||
23612612|NCT02105688|65969661|FG001|Part A: Double-Blind|Death|1|||
23529807|NCT01239368|65673013|FG000|Overall Study|Disease progression on study|1|||
23529808|NCT01239368|65673014|FG001|Overall Study|Disease progression on study|1|||
23529809|NCT01239368|65673015|FG002|Overall Study|Disease progression on study|1|||
23529810|NCT01239368|65673016|FG003|Overall Study|Disease progression on study|1|||
23529811|NCT01239368|65673017|FG004|Overall Study|Disease progression on study|4|||
23529812|NCT01239368|65673018|FG005|Overall Study|Disease progression on study|2|||
23529813|NCT01239368|65673019|FG006|Overall Study|Disease progression on study|5|||
23529814|NCT01239368|65673020|FG007|Overall Study|Disease progression on study|0|||
23529815|NCT01239368|65673021|FG008|Overall Study|Disease progression on study|0|||
23529816|NCT01239368|65673022|FG009|Overall Study|Disease progression on study|2|||
23529817|NCT01239368|65673013|FG000|Overall Study|Refused further treatment|0|||
23529818|NCT01239368|65673014|FG001|Overall Study|Refused further treatment|0|||
23529819|NCT01239368|65673015|FG002|Overall Study|Refused further treatment|0|||
23529820|NCT01239368|65673016|FG003|Overall Study|Refused further treatment|0|||
23529821|NCT01239368|65673017|FG004|Overall Study|Refused further treatment|0|||
23529822|NCT01239368|65673018|FG005|Overall Study|Refused further treatment|0|||
23529823|NCT01239368|65673019|FG006|Overall Study|Refused further treatment|0|||
23612613|NCT02105688|65969660|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
23612614|NCT02105688|65969661|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
23612615|NCT02105688|65969660|FG000|Part A: Double-Blind|Physician Decision|0|||
23612616|NCT02105688|65969661|FG001|Part A: Double-Blind|Physician Decision|1|||
23612617|NCT02105688|65969660|FG000|Part A: Double-Blind|Status Unknown|0|||
23612618|NCT02105688|65969661|FG001|Part A: Double-Blind|Status Unknown|2|||
23529824|NCT01239368|65673020|FG007|Overall Study|Refused further treatment|0|||
23529825|NCT01239368|65673021|FG008|Overall Study|Refused further treatment|0|||
23529826|NCT01239368|65673022|FG009|Overall Study|Refused further treatment|1|||
23529827|NCT01239368|65673013|FG000|Overall Study|Death|0|||
23529828|NCT01239368|65673014|FG001|Overall Study|Death|0|||
23529829|NCT01239368|65673015|FG002|Overall Study|Death|0|||
23529830|NCT01239368|65673016|FG003|Overall Study|Death|0|||
23529831|NCT01239368|65673017|FG004|Overall Study|Death|0|||
23529832|NCT01239368|65673018|FG005|Overall Study|Death|0|||
23529833|NCT01239368|65673019|FG006|Overall Study|Death|1|||
23529834|NCT01239368|65673020|FG007|Overall Study|Death|0|||
23529835|NCT01239368|65673021|FG008|Overall Study|Death|0|||
23529836|NCT01239368|65673022|FG009|Overall Study|Death|0|||
23529837|NCT01232296|65673030|FG000|Overall Study|Adverse Event|24|||
23529838|NCT01232296|65673031|FG001|Overall Study|Adverse Event|12|||
23529839|NCT01232296|65673030|FG000|Overall Study|Physician Decision|1|||
23529840|NCT01232296|65673031|FG001|Overall Study|Physician Decision|1|||
23529841|NCT01232296|65673030|FG000|Overall Study|Progressive disease|43|||
23529842|NCT01232296|65673031|FG001|Overall Study|Progressive disease|61|||
23529843|NCT01232296|65673030|FG000|Overall Study|Study terminated by sponsor|0|||
23529844|NCT01232296|65673031|FG001|Overall Study|Study terminated by sponsor|1|||
23529845|NCT01232296|65673030|FG000|Overall Study|Technical problems|3|||
23529846|NCT01232296|65673031|FG001|Overall Study|Technical problems|0|||
23529847|NCT01232296|65673030|FG000|Overall Study|Subject/guardian decision|10|||
23529848|NCT01232296|65673031|FG001|Overall Study|Subject/guardian decision|2|||
23529849|NCT01232296|65673030|FG000|Overall Study|Death|1|||
23529850|NCT01232296|65673031|FG001|Overall Study|Death|6|||
23529851|NCT02412631|65673032|FG000|Overall Study|Adverse Event|1|||
23529852|NCT02412631|65673033|FG001|Overall Study|Adverse Event|2|||
23529853|NCT02412631|65673032|FG000|Overall Study|Lost to Follow-up|5|||
23529854|NCT02412631|65673033|FG001|Overall Study|Lost to Follow-up|9|||
23529855|NCT02412631|65673032|FG000|Overall Study|Withdrawal by Subject|9|||
23529856|NCT02412631|65673033|FG001|Overall Study|Withdrawal by Subject|3|||
23529857|NCT02412631|65673032|FG000|Overall Study|Early stop by FDA|5|||
23529858|NCT02412631|65673033|FG001|Overall Study|Early stop by FDA|2|||
23529859|NCT02412631|65673032|FG000|Overall Study|Unspecified reason|6|||
23529860|NCT02412631|65673033|FG001|Overall Study|Unspecified reason|8|||
23529861|NCT01502644|65673034|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
23529862|NCT01502644|65673035|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
23529863|NCT01502644|65673036|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
23529864|NCT01502644|65673037|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
23529865|NCT01502644|65673034|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
23529866|NCT01502644|65673035|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
23529867|NCT01502644|65673036|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
23529868|NCT01502644|65673037|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
23529869|NCT01502644|65673034|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
23529870|NCT01502644|65673035|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
23529871|NCT01502644|65673036|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
23529872|NCT01502644|65673037|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
23529873|NCT01502644|65673034|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
23529874|NCT01502644|65673035|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
23529875|NCT01502644|65673036|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
23529876|NCT01502644|65673037|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
23529877|NCT01502644|65673034|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
23529878|NCT01502644|65673035|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
23529879|NCT01502644|65673036|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
23529880|NCT01502644|65673037|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
23529881|NCT01433263|65673041|FG000|Overall Study|Adverse Event|3|||
23529882|NCT01433263|65673042|FG001|Overall Study|Adverse Event|1|||
23529883|NCT01433263|65673041|FG000|Overall Study|Death|5|||
23529884|NCT01433263|65673042|FG001|Overall Study|Death|3|||
23529885|NCT01433263|65673041|FG000|Overall Study|Lost to Follow-up|0|||
23529886|NCT01433263|65673042|FG001|Overall Study|Lost to Follow-up|1|||
23529887|NCT01433263|65673041|FG000|Overall Study|Protocol Deviation|1|||
23529888|NCT01433263|65673042|FG001|Overall Study|Protocol Deviation|0|||
23529889|NCT01433263|65673041|FG000|Overall Study|Withdrawal by Subject|10|||
23529890|NCT01433263|65673042|FG001|Overall Study|Withdrawal by Subject|7|||
23529891|NCT01848990|65673043|FG000|Overall Study|Adverse Event|6|||
23529892|NCT01848990|65673044|FG001|Overall Study|Adverse Event|2|||
23529893|NCT01848990|65673045|FG002|Overall Study|Adverse Event|0|||
23529894|NCT01848990|65673043|FG000|Overall Study|Lost to Follow-up|6|||
23529895|NCT01848990|65673044|FG001|Overall Study|Lost to Follow-up|2|||
23529896|NCT01848990|65673045|FG002|Overall Study|Lost to Follow-up|2|||
23529897|NCT01848990|65673043|FG000|Overall Study|Protocol Violation|1|||
23529898|NCT01848990|65673044|FG001|Overall Study|Protocol Violation|1|||
23529899|NCT01848990|65673045|FG002|Overall Study|Protocol Violation|0|||
23529900|NCT01848990|65673043|FG000|Overall Study|Withdrawal by Subject|29|||
23529901|NCT01848990|65673044|FG001|Overall Study|Withdrawal by Subject|10|||
23529902|NCT01848990|65673045|FG002|Overall Study|Withdrawal by Subject|11|||
23529903|NCT01848990|65673043|FG000|Overall Study|Physician Decision|1|||
23529904|NCT01848990|65673044|FG001|Overall Study|Physician Decision|1|||
23529905|NCT01848990|65673045|FG002|Overall Study|Physician Decision|0|||
23529906|NCT01848990|65673043|FG000|Overall Study|Non Compliance|1|||
23529907|NCT01848990|65673044|FG001|Overall Study|Non Compliance|0|||
23529908|NCT01848990|65673045|FG002|Overall Study|Non Compliance|0|||
23529909|NCT01848990|65673043|FG000|Overall Study|Death|1|||
23529910|NCT01848990|65673044|FG001|Overall Study|Death|0|||
23529911|NCT01848990|65673045|FG002|Overall Study|Death|1|||
23206829|NCT02504268|64498080|FG005|Overall Study|Lack of Efficacy|0|||
23529912|NCT01848990|65673043|FG000|Overall Study|Other|1|||
23529913|NCT01848990|65673044|FG001|Overall Study|Other|4|||
23529914|NCT01848990|65673045|FG002|Overall Study|Other|2|||
23529915|NCT01533246|65673051|FG000|Overall Study|Adverse Event|1|||
23529916|NCT01533246|65673051|FG000|Overall Study|Withdrawal by Subject|1|||
23529917|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Adverse Event|2|||
23529918|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Adverse Event|3|||
23529919|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Adverse Event|4|||
23529920|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Adverse Event|4|||
23529921|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
23529922|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
23529923|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
23529924|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
23529925|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
23529926|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
23529927|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
23529928|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
23529929|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
23529930|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
23529931|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
23529932|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
23529933|NCT00071812|65676003|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
23529934|NCT00071812|65676004|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
23529935|NCT00071812|65676005|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
23529936|NCT00071812|65676006|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
23529937|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
23529938|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
23529939|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
23529940|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
23529941|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23529942|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23529943|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23529944|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
23529945|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23529946|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23529947|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23529948|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
23529949|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23529950|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23529951|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23529952|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
23529953|NCT00071812|65676003|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23529954|NCT00071812|65676004|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23529955|NCT00071812|65676005|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
23529956|NCT00071812|65676006|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
23529957|NCT01712984|65676007|FG000|Overall Study|Adverse Event|0|||
23529958|NCT01712984|65676008|FG001|Overall Study|Adverse Event|0|||
23529959|NCT01712984|65676009|FG002|Overall Study|Adverse Event|1|||
23529960|NCT01712984|65676007|FG000|Overall Study|Protocol Violation|2|||
23529961|NCT01712984|65676008|FG001|Overall Study|Protocol Violation|0|||
23529962|NCT01712984|65676009|FG002|Overall Study|Protocol Violation|1|||
23612619|NCT02105688|65969660|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
23206830|NCT02504268|64498081|FG006|Overall Study|Lack of Efficacy|0|||
23529963|NCT01712984|65676007|FG000|Overall Study|Lost to Follow-up|8|||
23529964|NCT01712984|65676008|FG001|Overall Study|Lost to Follow-up|10|||
23529965|NCT01712984|65676009|FG002|Overall Study|Lost to Follow-up|1|||
23529966|NCT01712984|65676007|FG000|Overall Study|Withdrawal by Subject|6|||
23529967|NCT01712984|65676008|FG001|Overall Study|Withdrawal by Subject|6|||
23612620|NCT02105688|65969661|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
23529968|NCT01712984|65676009|FG002|Overall Study|Withdrawal by Subject|7|||
23529969|NCT01438541|65676010|FG000|Overall Study|Physician Decision|1|||
23529970|NCT01438541|65676010|FG000|Overall Study|Withdrawal by Subject|1|||
23529971|NCT01438541|65676010|FG000|Overall Study|discharge from the hospital|5|||
23529972|NCT02517905|65676011|FG000|Overall Study|Lost to Follow-up|4|||
23529973|NCT02517905|65676012|FG001|Overall Study|Lost to Follow-up|0|||
23529974|NCT02517905|65676011|FG000|Overall Study|Withdrawal by Subject|4|||
23529975|NCT02517905|65676012|FG001|Overall Study|Withdrawal by Subject|0|||
23529976|NCT02517905|65676011|FG000|Overall Study|Screen failure|2|||
23529977|NCT02517905|65676012|FG001|Overall Study|Screen failure|2|||
23529978|NCT02487394|65676015|FG000|Phase 1|Withdrawal by Subject|0|||
23529979|NCT02487394|65676016|FG001|Phase 1|Withdrawal by Subject|1|||
23529980|NCT00393939|65676019|FG000|Overall Study|Protocol Violation|1|||
23529981|NCT00393939|65676020|FG001|Overall Study|Protocol Violation|1|||
23529982|NCT00393939|65676019|FG000|Overall Study|Lost to Follow-up|2|||
23529983|NCT00393939|65676020|FG001|Overall Study|Lost to Follow-up|4|||
23529984|NCT00393939|65676019|FG000|Overall Study|Death|10|||
23529985|NCT00393939|65676020|FG001|Overall Study|Death|4|||
23529986|NCT00393939|65676019|FG000|Overall Study|Sponsor|5|||
23529987|NCT00393939|65676020|FG001|Overall Study|Sponsor|13|||
23529988|NCT00393939|65676019|FG000|Overall Study|Objective progression or relapse|239|||
23529989|NCT00393939|65676020|FG001|Overall Study|Objective progression or relapse|223|||
23529990|NCT00393939|65676019|FG000|Overall Study|Withdrawal by Subject|2|||
23529991|NCT00393939|65676020|FG001|Overall Study|Withdrawal by Subject|7|||
23529992|NCT00393939|65676019|FG000|Overall Study|Other|37|||
23529993|NCT00393939|65676020|FG001|Overall Study|Other|45|||
23529994|NCT05044234|65676021|FG000|Overall Study|Lost to Follow-up|2|||
23529995|NCT05044234|65676022|FG001|Overall Study|Lost to Follow-up|1|||
23529996|NCT05044234|65676023|FG002|Overall Study|Lost to Follow-up|1|||
23529997|NCT05044234|65676024|FG003|Overall Study|Lost to Follow-up|2|||
23529998|NCT05044234|65676021|FG000|Overall Study|Withdrawal by Subject|6|||
23529999|NCT05044234|65676022|FG001|Overall Study|Withdrawal by Subject|4|||
23530000|NCT05044234|65676023|FG002|Overall Study|Withdrawal by Subject|5|||
23530001|NCT05044234|65676024|FG003|Overall Study|Withdrawal by Subject|8|||
23530002|NCT05044234|65676021|FG000|Overall Study|Study terminated by Sponsor|21|||
23530003|NCT05044234|65676022|FG001|Overall Study|Study terminated by Sponsor|21|||
23530004|NCT05044234|65676023|FG002|Overall Study|Study terminated by Sponsor|20|||
23530005|NCT05044234|65676024|FG003|Overall Study|Study terminated by Sponsor|14|||
23530006|NCT05044234|65676021|FG000|Overall Study|Other, not specified|0|||
23530007|NCT05044234|65676022|FG001|Overall Study|Other, not specified|0|||
23530008|NCT05044234|65676023|FG002|Overall Study|Other, not specified|1|||
23530009|NCT05044234|65676024|FG003|Overall Study|Other, not specified|2|||
23612621|NCT02105688|65969660|FG000|Part B: Observational Follow-up|Death|2|||
23612622|NCT02105688|65969661|FG001|Part B: Observational Follow-up|Death|1|||
23612623|NCT02105688|65969660|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
23612624|NCT02105688|65969661|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
23612625|NCT02105688|65969660|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
23612626|NCT02105688|65969661|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
23612627|NCT02105688|65969660|FG000|Part B: Observational Follow-up|Physician Decision|3|||
23612628|NCT02105688|65969661|FG001|Part B: Observational Follow-up|Physician Decision|1|||
23612629|NCT01234675|65969662|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
23612630|NCT01234675|65969663|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
23612631|NCT01234675|65969662|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23612632|NCT01234675|65969663|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
23612633|NCT01332318|65969664|FG000|Overall Study|Adverse Event|0|||
23612634|NCT01332318|65969665|FG001|Overall Study|Adverse Event|3|||
23612635|NCT01332318|65969666|FG002|Overall Study|Adverse Event|0|||
23530010|NCT05044234|65676021|FG000|Overall Study|Delayed data entry|0|||
23530011|NCT05044234|65676022|FG001|Overall Study|Delayed data entry|0|||
23530012|NCT05044234|65676023|FG002|Overall Study|Delayed data entry|0|||
23530013|NCT05044234|65676024|FG003|Overall Study|Delayed data entry|1|||
23530014|NCT00004031|65676025|FG000|Overall Study|Adverse Event|5|||
23530015|NCT00004031|65676026|FG001|Overall Study|Adverse Event|0|||
23530016|NCT00004031|65676025|FG000|Overall Study|Refusal unrelated to adverse events|2|||
23530017|NCT00004031|65676026|FG001|Overall Study|Refusal unrelated to adverse events|11|||
23530018|NCT00004031|65676025|FG000|Overall Study|Progression/relapse|9|||
23530019|NCT00004031|65676026|FG001|Overall Study|Progression/relapse|4|||
23530020|NCT00004031|65676025|FG000|Overall Study|Death|3|||
23530021|NCT00004031|65676026|FG001|Overall Study|Death|1|||
23530022|NCT00004031|65676025|FG000|Overall Study|Other- not protocol specified|3|||
23530023|NCT00004031|65676026|FG001|Overall Study|Other- not protocol specified|3|||
23612636|NCT01332318|65969667|FG003|Overall Study|Adverse Event|0|||
23612637|NCT01332318|65969664|FG000|Overall Study|Withdrawal by Subject|1|||
23612638|NCT01332318|65969665|FG001|Overall Study|Withdrawal by Subject|1|||
23530024|NCT00004031|65676025|FG000|Overall Study|Reason under review|3|||
23530025|NCT00004031|65676026|FG001|Overall Study|Reason under review|2|||
23419267|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
23419268|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23419269|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23530026|NCT03277846|65676028|FG000|Overall Study|Inpatient stay too brief|12|||
23530027|NCT03277846|65676029|FG001|Overall Study|Inpatient stay too brief|11|||
23530028|NCT01603875|65676038|FG000|Overall Study|Preexisting rabies antibody|3|||
23530029|NCT01603875|65676039|FG001|Overall Study|Preexisting rabies antibody|4|||
23530030|NCT01603875|65676040|FG002|Overall Study|Preexisting rabies antibody|3|||
23530031|NCT01603875|65676038|FG000|Overall Study|Lost to Follow-up|4|||
23530032|NCT01603875|65676039|FG001|Overall Study|Lost to Follow-up|3|||
23530033|NCT01603875|65676040|FG002|Overall Study|Lost to Follow-up|6|||
23530034|NCT01603875|65676038|FG000|Overall Study|Protocol Violation|0|||
23530035|NCT01603875|65676039|FG001|Overall Study|Protocol Violation|1|||
23530036|NCT01603875|65676040|FG002|Overall Study|Protocol Violation|0|||
23530037|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
23530038|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
23530039|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
23530040|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
23530041|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
23530042|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
23530043|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
23530044|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
23419270|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23419271|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23419272|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
23419273|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
23419274|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
23419275|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
23419276|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
23419277|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
23419278|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419279|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419280|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419281|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419282|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23530045|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
23530046|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
23530047|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
23530048|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
23530049|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
23530050|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
23530051|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
23530052|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
23530053|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
23530054|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
23530055|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
23530056|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
23530057|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
23530058|NCT00934544|65676049|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
23530059|NCT00934544|65676050|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
23530060|NCT00934544|65676051|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
23530061|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
23530062|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
23530063|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
23530064|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
23530065|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
23530066|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
23612639|NCT01332318|65969666|FG002|Overall Study|Withdrawal by Subject|0|||
23612640|NCT01332318|65969667|FG003|Overall Study|Withdrawal by Subject|1|||
23612641|NCT01332318|65969664|FG000|Overall Study|Protocol Violation|1|||
23612642|NCT01332318|65969665|FG001|Overall Study|Protocol Violation|0|||
23612643|NCT01332318|65969666|FG002|Overall Study|Protocol Violation|1|||
23530067|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
23530068|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
23530069|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
23530070|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
23530071|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
23530072|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
23530073|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
23530074|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
23530075|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
23530076|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
23530077|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
23530078|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
23309308|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
23309309|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
23309310|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
23309311|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
23309312|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
23309313|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
23309314|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
23309315|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
23309316|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
23309317|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
23309318|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
23309319|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
23309320|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
23309321|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
23530079|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
23530080|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
23612644|NCT01332318|65969667|FG003|Overall Study|Protocol Violation|1|||
23612645|NCT03449979|65969668|FG000|Overall Study|Technical difficulty|0|||
23612646|NCT03449979|65969669|FG001|Overall Study|Technical difficulty|0|||
23612647|NCT03449979|65969670|FG002|Overall Study|Technical difficulty|0|||
23612648|NCT03449979|65969671|FG003|Overall Study|Technical difficulty|1|||
23612649|NCT02854436|65969676|FG000|Overall Study|Adverse Event|1|||
23612650|NCT02854436|65969676|FG000|Overall Study|Death|208|||
23612651|NCT02854436|65969676|FG000|Overall Study|Lost to Follow-up|5|||
23612652|NCT02854436|65969676|FG000|Overall Study|Withdrawal by Subject|24|||
23612653|NCT02854436|65969676|FG000|Overall Study|Other|45|||
23612654|NCT02854436|65969676|FG000|Overall Study|Physician Decision|6|||
23612655|NCT00080119|65969677|FG000|Overall Study|Discontinued because of study closure|0|||
23612656|NCT00080119|65969678|FG001|Overall Study|Discontinued because of study closure|0|||
23612657|NCT00080119|65969679|FG002|Overall Study|Discontinued because of study closure|130|||
23612658|NCT00080119|65969680|FG003|Overall Study|Discontinued because of study closure|141|||
23612659|NCT00080119|65969677|FG000|Overall Study|Unable to get to clinic|24|||
23612660|NCT00080119|65969678|FG001|Overall Study|Unable to get to clinic|24|||
23612661|NCT00080119|65969679|FG002|Overall Study|Unable to get to clinic|7|||
23612662|NCT00080119|65969680|FG003|Overall Study|Unable to get to clinic|1|||
23612663|NCT00080119|65969677|FG000|Overall Study|Consent withdrawn|13|||
23612664|NCT00080119|65969678|FG001|Overall Study|Consent withdrawn|17|||
23612665|NCT00080119|65969679|FG002|Overall Study|Consent withdrawn|4|||
23612666|NCT00080119|65969680|FG003|Overall Study|Consent withdrawn|6|||
23612667|NCT00080119|65969677|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
23612668|NCT00080119|65969678|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
23612669|NCT00080119|65969679|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
23612670|NCT00080119|65969680|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
23612671|NCT00080119|65969677|FG000|Overall Study|Lost to Follow-up|16|||
23612672|NCT00080119|65969678|FG001|Overall Study|Lost to Follow-up|19|||
23612673|NCT00080119|65969679|FG002|Overall Study|Lost to Follow-up|19|||
23612674|NCT00080119|65969680|FG003|Overall Study|Lost to Follow-up|14|||
23612675|NCT02092285|65969684|FG000|Induction Phase|Adverse Event|7|||
23612676|NCT02092285|65969684|FG000|Induction Phase|Physician Decision|4|||
23612677|NCT02092285|65969684|FG000|Induction Phase|Pregnancy|1|||
23612678|NCT02092285|65969684|FG000|Induction Phase|Relapse/Recurrence|7|||
23612679|NCT02092285|65969684|FG000|Induction Phase|Withdrawal by Subject|2|||
23612680|NCT02092285|65969684|FG000|Induction Phase|Lack of Efficacy|14|||
23612681|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
23612682|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
23612683|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
23206831|NCT02504268|64498082|FG007|Overall Study|Lack of Efficacy|0|||
23309322|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
23309323|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
23309324|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
23309325|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
23309326|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
23309327|NCT02552212|64877926|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
23309328|NCT02552212|64877927|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
23309329|NCT02552212|64877928|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
23309330|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
23309331|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
23309332|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
23309333|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
23309334|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
23309335|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
23309336|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
23206832|NCT02504268|64498083|FG008|Overall Study|Lack of Efficacy|0|||
23206833|NCT02504268|64498075|FG000|Overall Study|Poor/Non-Compliance|3|||
23206834|NCT02504268|64498076|FG001|Overall Study|Poor/Non-Compliance|2|||
23206835|NCT02504268|64498077|FG002|Overall Study|Poor/Non-Compliance|3|||
23206836|NCT02504268|64498078|FG003|Overall Study|Poor/Non-Compliance|0|||
23206837|NCT02504268|64498079|FG004|Overall Study|Poor/Non-Compliance|0|||
23206838|NCT02504268|64498080|FG005|Overall Study|Poor/Non-Compliance|0|||
23206839|NCT02504268|64498081|FG006|Overall Study|Poor/Non-Compliance|0|||
23206840|NCT02504268|64498082|FG007|Overall Study|Poor/Non-Compliance|0|||
23206841|NCT02504268|64498083|FG008|Overall Study|Poor/Non-Compliance|0|||
23206842|NCT02504268|64498075|FG000|Overall Study|Not Disclosed|1|||
23206843|NCT02504268|64498076|FG001|Overall Study|Not Disclosed|0|||
23206844|NCT02504268|64498077|FG002|Overall Study|Not Disclosed|2|||
23206845|NCT02504268|64498078|FG003|Overall Study|Not Disclosed|0|||
23206846|NCT02504268|64498079|FG004|Overall Study|Not Disclosed|0|||
23206847|NCT02504268|64498080|FG005|Overall Study|Not Disclosed|0|||
23206848|NCT02504268|64498081|FG006|Overall Study|Not Disclosed|0|||
23206849|NCT02504268|64498082|FG007|Overall Study|Not Disclosed|0|||
23206850|NCT02504268|64498083|FG008|Overall Study|Not Disclosed|0|||
23206851|NCT04533815|64498084|FG000|Overall Study|Adverse Event|2|||
23206852|NCT04533815|64498084|FG000|Overall Study|Site withdrew|5|||
23206853|NCT02062463|64498085|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
23206854|NCT02062463|64498086|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
23206855|NCT02062463|64498087|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
23206856|NCT02062463|64498088|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
23206857|NCT02062463|64498085|FG000|Stage 2|Adverse Event|0|||
23206858|NCT02062463|64498086|FG001|Stage 2|Adverse Event|0|||
23206859|NCT02062463|64498087|FG002|Stage 2|Adverse Event|12|||
23206860|NCT02062463|64498088|FG003|Stage 2|Adverse Event|20|||
23206861|NCT02062463|64498085|FG000|Stage 2|Lack of Efficacy|0|||
23206862|NCT02062463|64498086|FG001|Stage 2|Lack of Efficacy|0|||
23206863|NCT02062463|64498087|FG002|Stage 2|Lack of Efficacy|3|||
23309337|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
23309338|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
23309339|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
23206864|NCT02062463|64498088|FG003|Stage 2|Lack of Efficacy|4|||
23206865|NCT02062463|64498085|FG000|Stage 2|Lost to Follow-up|0|||
23206866|NCT02062463|64498086|FG001|Stage 2|Lost to Follow-up|0|||
23206867|NCT02062463|64498087|FG002|Stage 2|Lost to Follow-up|20|||
23206868|NCT02062463|64498088|FG003|Stage 2|Lost to Follow-up|20|||
23206869|NCT02062463|64498085|FG000|Stage 2|Non-Compliance|0|||
23206870|NCT02062463|64498086|FG001|Stage 2|Non-Compliance|0|||
23309340|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
23309341|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
23309342|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
23309343|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
23309344|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
23309345|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
23309346|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
23206871|NCT02062463|64498087|FG002|Stage 2|Non-Compliance|0|||
23206872|NCT02062463|64498088|FG003|Stage 2|Non-Compliance|1|||
23206873|NCT02062463|64498085|FG000|Stage 2|Other than specified|0|||
23206874|NCT02062463|64498086|FG001|Stage 2|Other than specified|0|||
23206875|NCT02062463|64498087|FG002|Stage 2|Other than specified|3|||
23206876|NCT02062463|64498088|FG003|Stage 2|Other than specified|1|||
23206877|NCT02062463|64498085|FG000|Stage 2|Withdrawal by Subject|0|||
23206878|NCT02062463|64498086|FG001|Stage 2|Withdrawal by Subject|0|||
23206879|NCT02062463|64498087|FG002|Stage 2|Withdrawal by Subject|15|||
23206880|NCT02062463|64498088|FG003|Stage 2|Withdrawal by Subject|10|||
23206881|NCT00650091|64498094|FG000|Amended Study Design|Withdrawal by Subject|12|||
23206882|NCT00650091|64498095|FG001|Amended Study Design|Withdrawal by Subject|11|||
23206883|NCT00650091|64498096|FG002|Amended Study Design|Withdrawal by Subject|0|||
23206884|NCT00650091|64498094|FG000|Amended Study Design|Physician Decision|5|||
23206885|NCT00650091|64498095|FG001|Amended Study Design|Physician Decision|0|||
23206886|NCT00650091|64498096|FG002|Amended Study Design|Physician Decision|0|||
23206887|NCT00650091|64498094|FG000|Amended Study Design|Adverse Event|1|||
23206888|NCT00650091|64498095|FG001|Amended Study Design|Adverse Event|4|||
23206889|NCT00650091|64498096|FG002|Amended Study Design|Adverse Event|0|||
23206890|NCT00650091|64498094|FG000|Amended Study Design|Lung transplantation|4|||
23206891|NCT00650091|64498095|FG001|Amended Study Design|Lung transplantation|2|||
23206892|NCT00650091|64498096|FG002|Amended Study Design|Lung transplantation|0|||
23206893|NCT00650091|64498094|FG000|Amended Study Design|Other|1|||
23206894|NCT00650091|64498095|FG001|Amended Study Design|Other|3|||
23206895|NCT00650091|64498096|FG002|Amended Study Design|Other|0|||
23206896|NCT02163993|64498097|FG000|Treatment Period|Adverse Event|0|||
23206897|NCT02163993|64498098|FG001|Treatment Period|Adverse Event|1|||
23206898|NCT02163993|64498099|FG002|Treatment Period|Adverse Event|0|||
23206899|NCT02163993|64498100|FG003|Treatment Period|Adverse Event|0|||
23206900|NCT02163993|64498101|FG004|Treatment Period|Adverse Event|1|||
23206901|NCT02163993|64498097|FG000|Treatment Period|Lost to Follow-up|2|||
23206902|NCT02163993|64498098|FG001|Treatment Period|Lost to Follow-up|3|||
23206903|NCT02163993|64498099|FG002|Treatment Period|Lost to Follow-up|1|||
23206904|NCT02163993|64498100|FG003|Treatment Period|Lost to Follow-up|3|||
23206905|NCT02163993|64498101|FG004|Treatment Period|Lost to Follow-up|1|||
23206906|NCT02163993|64498097|FG000|Treatment Period|Physician Decision|1|||
23206907|NCT02163993|64498098|FG001|Treatment Period|Physician Decision|0|||
23206908|NCT02163993|64498099|FG002|Treatment Period|Physician Decision|0|||
23206909|NCT02163993|64498100|FG003|Treatment Period|Physician Decision|0|||
23206910|NCT02163993|64498101|FG004|Treatment Period|Physician Decision|0|||
23206911|NCT02163993|64498097|FG000|Treatment Period|Protocol Violation|2|||
23206912|NCT02163993|64498098|FG001|Treatment Period|Protocol Violation|1|||
23206913|NCT02163993|64498099|FG002|Treatment Period|Protocol Violation|0|||
23206914|NCT02163993|64498100|FG003|Treatment Period|Protocol Violation|1|||
23206915|NCT02163993|64498101|FG004|Treatment Period|Protocol Violation|2|||
23206916|NCT02163993|64498097|FG000|Treatment Period|Withdrawal by Subject|6|||
23206917|NCT02163993|64498098|FG001|Treatment Period|Withdrawal by Subject|4|||
23206918|NCT02163993|64498099|FG002|Treatment Period|Withdrawal by Subject|1|||
23206919|NCT02163993|64498100|FG003|Treatment Period|Withdrawal by Subject|4|||
23206920|NCT02163993|64498101|FG004|Treatment Period|Withdrawal by Subject|1|||
23206921|NCT02163993|64498097|FG000|Treatment Period|Not treated|1|||
23206922|NCT02163993|64498098|FG001|Treatment Period|Not treated|0|||
23206923|NCT02163993|64498099|FG002|Treatment Period|Not treated|0|||
23206924|NCT02163993|64498100|FG003|Treatment Period|Not treated|1|||
23206925|NCT02163993|64498101|FG004|Treatment Period|Not treated|2|||
23206926|NCT02163993|64498097|FG000|Post-treatment Period|Adverse Event|0|||
23206927|NCT02163993|64498098|FG001|Post-treatment Period|Adverse Event|0|||
23206928|NCT02163993|64498099|FG002|Post-treatment Period|Adverse Event|1|||
23206929|NCT02163993|64498100|FG003|Post-treatment Period|Adverse Event|0|||
23206930|NCT02163993|64498101|FG004|Post-treatment Period|Adverse Event|0|||
23206931|NCT02163993|64498097|FG000|Post-treatment Period|Lost to Follow-up|2|||
23206932|NCT02163993|64498098|FG001|Post-treatment Period|Lost to Follow-up|2|||
23206933|NCT02163993|64498099|FG002|Post-treatment Period|Lost to Follow-up|3|||
23206934|NCT02163993|64498100|FG003|Post-treatment Period|Lost to Follow-up|1|||
23206935|NCT02163993|64498101|FG004|Post-treatment Period|Lost to Follow-up|0|||
23206936|NCT02163993|64498097|FG000|Post-treatment Period|Protocol Violation|0|||
23206937|NCT02163993|64498098|FG001|Post-treatment Period|Protocol Violation|0|||
23206938|NCT02163993|64498099|FG002|Post-treatment Period|Protocol Violation|0|||
23309347|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
23309348|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
23309349|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
23309350|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
23309351|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
23309352|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
23309353|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
23309354|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
23309355|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
23309356|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
23309357|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
23309358|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
23309359|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
23309360|NCT02552212|64877926|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
23309361|NCT02552212|64877927|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
23309362|NCT02552212|64877928|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
23309363|NCT02968849|64877934|FG000|Overall Study|Death|8|||
23309364|NCT02968849|64877935|FG001|Overall Study|Death|10|||
23309365|NCT02968849|64877934|FG000|Overall Study|Lost to Follow-up|31|||
23309366|NCT02968849|64877935|FG001|Overall Study|Lost to Follow-up|29|||
23309367|NCT02968849|64877934|FG000|Overall Study|Withdrawal by Subject|73|||
23309368|NCT02968849|64877935|FG001|Overall Study|Withdrawal by Subject|64|||
23309369|NCT02968849|64877934|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
23309370|NCT02968849|64877935|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
23309371|NCT02968849|64877934|FG000|Overall Study|Physician Decision|6|||
23309372|NCT02968849|64877935|FG001|Overall Study|Physician Decision|9|||
23309373|NCT02968849|64877934|FG000|Overall Study|Other|16|||
23309374|NCT02968849|64877935|FG001|Overall Study|Other|10|||
23309375|NCT04713553|64877936|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
23309376|NCT04713553|64877937|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
23309377|NCT04713553|64877938|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
23309378|NCT04713553|64877939|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
23309379|NCT04713553|64877940|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
23309380|NCT04713553|64877941|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
23309381|NCT04713553|64877942|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
23309382|NCT04713553|64877936|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23309383|NCT04713553|64877937|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23530081|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
23530082|NCT00934544|65676049|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
23530083|NCT00934544|65676050|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
23530084|NCT00934544|65676051|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
23530085|NCT02884089|65676055|FG000|Period 1|Dosing error|2|||
23530086|NCT02884089|65676056|FG001|Period 1|Dosing error|2|||
23530087|NCT02884089|65676057|FG002|Period 1|Dosing error|0|||
23530088|NCT02884089|65676058|FG003|Period 1|Dosing error|0|||
23530089|NCT02884089|65676055|FG000|Washout Period 1|Lost to Follow-up|0|||
23530090|NCT02884089|65676056|FG001|Washout Period 1|Lost to Follow-up|1|||
23530091|NCT02884089|65676057|FG002|Washout Period 1|Lost to Follow-up|0|||
23530092|NCT02884089|65676058|FG003|Washout Period 1|Lost to Follow-up|1|||
23530093|NCT02884089|65676055|FG000|Washout Period 1|Withdrawal by Subject|0|||
23530094|NCT02884089|65676056|FG001|Washout Period 1|Withdrawal by Subject|1|||
23530095|NCT02884089|65676057|FG002|Washout Period 1|Withdrawal by Subject|0|||
23530096|NCT02884089|65676058|FG003|Washout Period 1|Withdrawal by Subject|0|||
23530097|NCT02884089|65676055|FG000|Period 2|Adverse Event|1|||
23530098|NCT02884089|65676056|FG001|Period 2|Adverse Event|0|||
23530099|NCT02884089|65676057|FG002|Period 2|Adverse Event|0|||
23530100|NCT02884089|65676058|FG003|Period 2|Adverse Event|0|||
23530101|NCT02884089|65676055|FG000|Period 3|Withdrawal by Subject|0|||
23530102|NCT02884089|65676056|FG001|Period 3|Withdrawal by Subject|0|||
23530103|NCT02884089|65676057|FG002|Period 3|Withdrawal by Subject|1|||
23530104|NCT02884089|65676058|FG003|Period 3|Withdrawal by Subject|0|||
23530105|NCT02884089|65676055|FG000|Washout Period 3|Withdrawal by Subject|0|||
23530106|NCT02884089|65676056|FG001|Washout Period 3|Withdrawal by Subject|0|||
23612684|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
23612685|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
23612686|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
23612687|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
23612688|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
23612689|NCT02092285|65969684|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
23612690|NCT00561678|65969686|FG000|Overall Study|Withdrawal by Subject|4|||
23309384|NCT04713553|64877938|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23309385|NCT04713553|64877939|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
23612691|NCT00561678|65969687|FG001|Overall Study|Withdrawal by Subject|3|||
23612692|NCT00561678|65969686|FG000|Overall Study|surgery cancelled|1|||
23612693|NCT00561678|65969687|FG001|Overall Study|surgery cancelled|1|||
23612694|NCT00561678|65969686|FG000|Overall Study|surgery rescheduled to different site|2|||
23612695|NCT00561678|65969687|FG001|Overall Study|surgery rescheduled to different site|2|||
23612696|NCT00561678|65969686|FG000|Overall Study|anesthesia provider refusal|1|||
23612697|NCT00561678|65969687|FG001|Overall Study|anesthesia provider refusal|0|||
23612698|NCT00587171|65969688|FG000|Overall Study|Lost to Follow-up|1|||
23612699|NCT00587171|65969689|FG001|Overall Study|Lost to Follow-up|1|||
23612700|NCT01525875|65969690|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
23612701|NCT01525875|65969691|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
23612702|NCT01525875|65969690|FG000|Open-label Period|Lost to Follow-up|0|||
23612703|NCT01525875|65969691|FG001|Open-label Period|Lost to Follow-up|2|||
23612704|NCT03023878|65969692|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
23612705|NCT03023878|65969692|FG000|Pre-Study Run-In Period|Death|1|||
23612706|NCT03023878|65969692|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
23612707|NCT03023878|65969692|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
23612708|NCT03023878|65969692|FG000|Treatment Period|Disease Progression|1|||
23612709|NCT03023878|65969692|FG000|Treatment Period|Withdrawal by Subject|1|||
23612710|NCT03023878|65969692|FG000|Treatment Period|Adverse Event|1|||
23309386|NCT04713553|64877940|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23530107|NCT02884089|65676057|FG002|Washout Period 3|Withdrawal by Subject|1|||
23612711|NCT03023878|65969692|FG000|Long Term Follow-Up Period|Death|2|||
23612712|NCT03214198|65969693|FG000|Overall Study|Case Report Forms Uncollected|18|||
23612713|NCT03214198|65969693|FG000|Overall Study|Protocol Deviation|18|||
23612714|NCT00700999|65969694|FG000|Overall Study|Lost to Follow-up|7|||
23612715|NCT00700999|65969695|FG001|Overall Study|Lost to Follow-up|7|||
23309387|NCT04713553|64877941|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23530108|NCT02884089|65676058|FG003|Washout Period 3|Withdrawal by Subject|0|||
23530109|NCT02884089|65676055|FG000|Washout Period 3|Lost to Follow-up|0|||
23530110|NCT02884089|65676056|FG001|Washout Period 3|Lost to Follow-up|0|||
23530111|NCT02884089|65676057|FG002|Washout Period 3|Lost to Follow-up|0|||
23530112|NCT02884089|65676058|FG003|Washout Period 3|Lost to Follow-up|1|||
23530113|NCT02884089|65676055|FG000|Period 4|Withdrawal by Subject|0|||
23206939|NCT02163993|64498100|FG003|Post-treatment Period|Protocol Violation|0|||
23206940|NCT02163993|64498101|FG004|Post-treatment Period|Protocol Violation|1|||
23419283|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
23419284|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
23419285|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
23419286|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
23419287|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
23419288|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419289|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419290|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419291|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419292|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419293|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419294|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419295|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419296|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
23419297|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
23419298|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419299|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419300|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419301|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419302|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419303|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
23419304|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
23419305|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
23419306|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
23419307|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
23419308|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419309|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419310|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419311|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419312|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419313|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419314|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419315|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
23419316|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
23419317|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
23419318|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419319|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419320|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419321|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419322|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419323|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419324|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419325|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
23419326|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419327|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
23419328|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419329|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419330|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419331|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419332|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23530114|NCT02884089|65676056|FG001|Period 4|Withdrawal by Subject|1|||
23419333|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23530115|NCT02884089|65676057|FG002|Period 4|Withdrawal by Subject|0|||
23530116|NCT02884089|65676058|FG003|Period 4|Withdrawal by Subject|0|||
23530117|NCT02884089|65676055|FG000|Period 4|Lost to Follow-up|1|||
23530118|NCT02884089|65676056|FG001|Period 4|Lost to Follow-up|0|||
23419334|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419335|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
23419336|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419337|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
23419338|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23530119|NCT02884089|65676057|FG002|Period 4|Lost to Follow-up|0|||
23530120|NCT02884089|65676058|FG003|Period 4|Lost to Follow-up|0|||
23530121|NCT02884089|65676055|FG000|Follow-up Visit|Withdrawal by Subject|1|||
23530122|NCT02884089|65676056|FG001|Follow-up Visit|Withdrawal by Subject|0|||
23530123|NCT02884089|65676057|FG002|Follow-up Visit|Withdrawal by Subject|0|||
23530124|NCT02884089|65676058|FG003|Follow-up Visit|Withdrawal by Subject|1|||
23530125|NCT03921411|65676071|FG000|Overall Study|Withdrawal by Subject|1|||
23530126|NCT03921411|65676071|FG000|Overall Study|Protocol Deviation|2|||
23530127|NCT03921411|65676071|FG000|Overall Study|Enrolled, but never treated|2|||
23530128|NCT01227512|65676072|FG000|Overall Study|Physician Decision|6|||
23530129|NCT01227512|65676073|FG001|Overall Study|Physician Decision|6|||
23530130|NCT01227512|65676072|FG000|Overall Study|Adverse Event|4|||
23530131|NCT01227512|65676073|FG001|Overall Study|Adverse Event|3|||
23530132|NCT01227512|65676072|FG000|Overall Study|Withdrawal by Subject|3|||
23530133|NCT01227512|65676073|FG001|Overall Study|Withdrawal by Subject|0|||
23530134|NCT01227512|65676072|FG000|Overall Study|Participant met withdrawal criteria|0|||
23530135|NCT01227512|65676073|FG001|Overall Study|Participant met withdrawal criteria|1|||
23530136|NCT03325166|65676074|FG000|Overall Study|Adverse Event|1|||
23530137|NCT00699972|65676077|FG000|Overall Study|Adverse Event|7|||
23530138|NCT00699972|65676078|FG001|Overall Study|Adverse Event|9|||
23530139|NCT00699972|65676079|FG002|Overall Study|Adverse Event|24|||
23453586|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
23453587|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
23453588|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
23453589|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
23453590|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
23453591|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
23453592|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
23453593|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453594|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
23453595|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453596|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
23453597|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453598|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453599|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453600|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453601|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
23453602|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
23530140|NCT00699972|65676077|FG000|Overall Study|Lost to Follow-up|0|||
23530141|NCT00699972|65676078|FG001|Overall Study|Lost to Follow-up|2|||
23530142|NCT00699972|65676079|FG002|Overall Study|Lost to Follow-up|0|||
23530143|NCT00699972|65676077|FG000|Overall Study|Withdrawal by Subject|3|||
23530144|NCT00699972|65676078|FG001|Overall Study|Withdrawal by Subject|7|||
23530145|NCT00699972|65676079|FG002|Overall Study|Withdrawal by Subject|4|||
23530146|NCT00699972|65676077|FG000|Overall Study|Lack of Efficacy|2|||
23530147|NCT00699972|65676078|FG001|Overall Study|Lack of Efficacy|0|||
23530148|NCT00699972|65676079|FG002|Overall Study|Lack of Efficacy|2|||
23530149|NCT00699972|65676077|FG000|Overall Study|Administrative/Other|3|||
23530150|NCT00699972|65676078|FG001|Overall Study|Administrative/Other|1|||
23612716|NCT00700999|65969694|FG000|Overall Study|Excluded - did not meet study criteria|0|||
23612717|NCT00700999|65969695|FG001|Overall Study|Excluded - did not meet study criteria|1|||
23612718|NCT00700999|65969694|FG000|Overall Study|Withdrawal by Subject|8|||
23612719|NCT00700999|65969695|FG001|Overall Study|Withdrawal by Subject|1|||
23612720|NCT00784277|65969696|FG000|IR Treatment|Adverse Event|4|||
23612721|NCT00784277|65969697|FG001|IR Treatment|Adverse Event|8|||
23612722|NCT00784277|65969698|FG002|IR Treatment|Adverse Event|19|||
23612723|NCT00784277|65969699|FG003|IR Treatment|Adverse Event|35|||
23612724|NCT00784277|65969700|FG004|IR Treatment|Adverse Event|0|||
23612725|NCT00784277|65969701|FG005|IR Treatment|Adverse Event|0|||
23612726|NCT00784277|65969702|FG006|IR Treatment|Adverse Event|0|||
23612727|NCT00784277|65969696|FG000|IR Treatment|Lack of Efficacy|4|||
23612728|NCT00784277|65969697|FG001|IR Treatment|Lack of Efficacy|4|||
23612729|NCT00784277|65969698|FG002|IR Treatment|Lack of Efficacy|1|||
23612730|NCT00784277|65969699|FG003|IR Treatment|Lack of Efficacy|0|||
23612731|NCT00784277|65969700|FG004|IR Treatment|Lack of Efficacy|0|||
23612732|NCT00784277|65969701|FG005|IR Treatment|Lack of Efficacy|0|||
23612733|NCT00784277|65969702|FG006|IR Treatment|Lack of Efficacy|0|||
23612734|NCT00784277|65969696|FG000|IR Treatment|Lost to Follow-up|1|||
23206941|NCT02163993|64498097|FG000|Post-treatment Period|Withdrawal by Subject|2|||
23530151|NCT00699972|65676079|FG002|Overall Study|Administrative/Other|4|||
23530152|NCT00699972|65676077|FG000|Overall Study|Randomized, Not Treated|1|||
23530153|NCT00699972|65676078|FG001|Overall Study|Randomized, Not Treated|0|||
23530154|NCT00699972|65676079|FG002|Overall Study|Randomized, Not Treated|1|||
23612735|NCT00784277|65969697|FG001|IR Treatment|Lost to Follow-up|0|||
23206942|NCT02163993|64498098|FG001|Post-treatment Period|Withdrawal by Subject|4|||
23530155|NCT00640510|65676080|FG000|Overall Study|Lack of Efficacy|0|||
23612736|NCT00784277|65969698|FG002|IR Treatment|Lost to Follow-up|1|||
23612737|NCT00784277|65969699|FG003|IR Treatment|Lost to Follow-up|0|||
23612738|NCT00784277|65969700|FG004|IR Treatment|Lost to Follow-up|0|||
23612739|NCT00784277|65969701|FG005|IR Treatment|Lost to Follow-up|0|||
23612740|NCT00784277|65969702|FG006|IR Treatment|Lost to Follow-up|0|||
23612741|NCT00784277|65969696|FG000|IR Treatment|Withdrawal by Subject|5|||
23612742|NCT00784277|65969697|FG001|IR Treatment|Withdrawal by Subject|1|||
23612743|NCT00784277|65969698|FG002|IR Treatment|Withdrawal by Subject|4|||
23612744|NCT00784277|65969699|FG003|IR Treatment|Withdrawal by Subject|6|||
23612745|NCT00784277|65969700|FG004|IR Treatment|Withdrawal by Subject|0|||
23612746|NCT00784277|65969701|FG005|IR Treatment|Withdrawal by Subject|0|||
23612747|NCT00784277|65969702|FG006|IR Treatment|Withdrawal by Subject|0|||
23612748|NCT00784277|65969696|FG000|IR Treatment|Resolution Of Pain|0|||
23612749|NCT00784277|65969697|FG001|IR Treatment|Resolution Of Pain|1|||
23612750|NCT00784277|65969698|FG002|IR Treatment|Resolution Of Pain|0|||
23612751|NCT00784277|65969699|FG003|IR Treatment|Resolution Of Pain|0|||
23612752|NCT00784277|65969700|FG004|IR Treatment|Resolution Of Pain|0|||
23612753|NCT00784277|65969701|FG005|IR Treatment|Resolution Of Pain|0|||
23612754|NCT00784277|65969702|FG006|IR Treatment|Resolution Of Pain|0|||
23612755|NCT00784277|65969696|FG000|IR Treatment|Other|2|||
23612756|NCT00784277|65969697|FG001|IR Treatment|Other|3|||
23612757|NCT00784277|65969698|FG002|IR Treatment|Other|3|||
23206943|NCT02163993|64498099|FG002|Post-treatment Period|Withdrawal by Subject|0|||
23206944|NCT02163993|64498100|FG003|Post-treatment Period|Withdrawal by Subject|1|||
23612758|NCT00784277|65969699|FG003|IR Treatment|Other|2|||
23612759|NCT00784277|65969700|FG004|IR Treatment|Other|0|||
23612760|NCT00784277|65969701|FG005|IR Treatment|Other|0|||
23612761|NCT00784277|65969702|FG006|IR Treatment|Other|0|||
23612762|NCT00784277|65969696|FG000|ER Treatment|Adverse Event|0|||
23530156|NCT00640510|65676081|FG001|Overall Study|Lack of Efficacy|1|||
23530157|NCT00640510|65676080|FG000|Overall Study|Protocol Violation|1|||
23530158|NCT00640510|65676081|FG001|Overall Study|Protocol Violation|0|||
23530159|NCT00640510|65676080|FG000|Overall Study|Physician Decision|0|||
23530160|NCT00640510|65676081|FG001|Overall Study|Physician Decision|1|||
23530161|NCT00298831|65676082|FG000|Overall Study|Adverse Event|1|||
23530162|NCT00298831|65676082|FG000|Overall Study|Lost to Follow-up|3|||
23530163|NCT00298831|65676082|FG000|Overall Study|Withdrawal by Subject|1|||
23530164|NCT00298831|65676082|FG000|Overall Study|Participants did not receive treatment|27|||
23530165|NCT00689481|65676083|FG000|Overall Study|Adverse Event|7|||
23206945|NCT02163993|64498101|FG004|Post-treatment Period|Withdrawal by Subject|2|||
23206946|NCT04831515|64498102|FG000|First Intervention|Adverse Event|0|||
23206947|NCT04831515|64498103|FG001|First Intervention|Adverse Event|1|||
23206948|NCT00315705|64498106|FG000|Phase 1|Refused further treatment|1|||
23419339|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23530166|NCT00689481|65676084|FG001|Overall Study|Adverse Event|1|||
23530167|NCT00689481|65676083|FG000|Overall Study|Lost to Follow-up|4|||
23530168|NCT00689481|65676084|FG001|Overall Study|Lost to Follow-up|3|||
23530169|NCT00689481|65676083|FG000|Overall Study|Lack of Efficacy|4|||
23530170|NCT00689481|65676084|FG001|Overall Study|Lack of Efficacy|3|||
23530171|NCT00689481|65676083|FG000|Overall Study|Non-compliance with study treatment|1|||
23530172|NCT00689481|65676084|FG001|Overall Study|Non-compliance with study treatment|1|||
23530173|NCT00689481|65676083|FG000|Overall Study|Withdrawal by Subject|8|||
23612763|NCT00784277|65969697|FG001|ER Treatment|Adverse Event|0|||
23612764|NCT00784277|65969698|FG002|ER Treatment|Adverse Event|0|||
23612765|NCT00784277|65969699|FG003|ER Treatment|Adverse Event|0|||
23612766|NCT00784277|65969700|FG004|ER Treatment|Adverse Event|1|||
23612767|NCT00784277|65969701|FG005|ER Treatment|Adverse Event|7|||
23612768|NCT00784277|65969702|FG006|ER Treatment|Adverse Event|7|||
23612769|NCT00784277|65969696|FG000|ER Treatment|Lack of Efficacy|0|||
23612770|NCT00784277|65969697|FG001|ER Treatment|Lack of Efficacy|0|||
23612771|NCT00784277|65969698|FG002|ER Treatment|Lack of Efficacy|0|||
23612772|NCT00784277|65969699|FG003|ER Treatment|Lack of Efficacy|0|||
23612773|NCT00784277|65969700|FG004|ER Treatment|Lack of Efficacy|3|||
23612774|NCT00784277|65969701|FG005|ER Treatment|Lack of Efficacy|4|||
23612775|NCT00784277|65969702|FG006|ER Treatment|Lack of Efficacy|0|||
23612776|NCT00784277|65969696|FG000|ER Treatment|Lost to Follow-up|0|||
23612777|NCT00784277|65969697|FG001|ER Treatment|Lost to Follow-up|0|||
23612778|NCT00784277|65969698|FG002|ER Treatment|Lost to Follow-up|0|||
23612779|NCT00784277|65969699|FG003|ER Treatment|Lost to Follow-up|0|||
23612780|NCT00784277|65969700|FG004|ER Treatment|Lost to Follow-up|0|||
23612781|NCT00784277|65969701|FG005|ER Treatment|Lost to Follow-up|2|||
23612782|NCT00784277|65969702|FG006|ER Treatment|Lost to Follow-up|0|||
23530174|NCT00689481|65676084|FG001|Overall Study|Withdrawal by Subject|4|||
23530175|NCT00689481|65676083|FG000|Overall Study|Excluded medication started during study|0|||
23530176|NCT00689481|65676084|FG001|Overall Study|Excluded medication started during study|1|||
23530177|NCT00689481|65676083|FG000|Overall Study|Subject early term, left on vacation|0|||
23530178|NCT00689481|65676084|FG001|Overall Study|Subject early term, left on vacation|1|||
23530179|NCT00515827|65676085|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
23530180|NCT00515827|65676086|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
23530181|NCT00515827|65676085|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
23530182|NCT00515827|65676086|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
23530183|NCT02043015|65676087|FG000|Overall Study|Lost to Follow-up|4|||
23530184|NCT02043015|65676087|FG000|Overall Study|Withdrawal by Subject|4|||
23530185|NCT02043015|65676087|FG000|Overall Study|Removed once target enrollment reached|15|||
23530186|NCT02043015|65676087|FG000|Overall Study|Participant moved away from study city|4|||
23530187|NCT02043015|65676087|FG000|Overall Study|Incarceration|1|||
23530188|NCT03742141|65676088|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
23530189|NCT02806726|65676089|FG000|Overall Study|Lost to Follow-up|1|||
23530190|NCT03191903|65676090|FG000|Overall Study|Withdrawal by Subject|6|||
23530191|NCT03191903|65676091|FG001|Overall Study|Withdrawal by Subject|5|||
23530192|NCT03191903|65676092|FG002|Overall Study|Withdrawal by Subject|4|||
23530193|NCT03191903|65676090|FG000|Overall Study|Adverse Event|1|||
23530194|NCT03191903|65676091|FG001|Overall Study|Adverse Event|0|||
23530195|NCT03191903|65676092|FG002|Overall Study|Adverse Event|0|||
23530196|NCT00418691|65676094|FG000|Overall Study|Lost to Follow-up|1|||
23530197|NCT00418691|65676095|FG001|Overall Study|Lost to Follow-up|2|||
23530198|NCT00418691|65676096|FG002|Overall Study|Lost to Follow-up|3|||
23530199|NCT00418691|65676094|FG000|Overall Study|Started new medication voiding entry|0|||
23530200|NCT00418691|65676095|FG001|Overall Study|Started new medication voiding entry|0|||
23530201|NCT00418691|65676096|FG002|Overall Study|Started new medication voiding entry|1|||
23530202|NCT00418691|65676094|FG000|Overall Study|Progressive Disease|1|||
23530203|NCT00418691|65676095|FG001|Overall Study|Progressive Disease|0|||
23530204|NCT00418691|65676096|FG002|Overall Study|Progressive Disease|1|||
23530205|NCT01777997|65676097|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
23530206|NCT01777997|65676097|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
23530207|NCT01777997|65676097|FG000|Weeks 48 to 72/96 on ART|Death|1|||
23530208|NCT01777997|65676097|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
23530209|NCT02948842|65676101|FG000|Overall Study|Withdrawal by Subject|4|||
23530210|NCT00519649|65676102|FG000|Overall Study|Withdrawal by Subject|1|||
23530211|NCT01205165|65676105|FG000|Overall Study|Lost to Follow-up|2|||
23530212|NCT01633944|65676106|FG000|Open-label Titration Phase|Adverse Event|109|||
23530213|NCT01633944|65676107|FG001|Open-label Titration Phase|Adverse Event|0|||
23530214|NCT01633944|65676108|FG002|Open-label Titration Phase|Adverse Event|0|||
23530215|NCT01633944|65676106|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
23530216|NCT01633944|65676107|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
23530217|NCT01633944|65676108|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
23530218|NCT01633944|65676106|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
23530219|NCT01633944|65676107|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
23530220|NCT01633944|65676108|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
23530221|NCT01633944|65676106|FG000|Open-label Titration Phase|Protocol Violation|24|||
23530222|NCT01633944|65676107|FG001|Open-label Titration Phase|Protocol Violation|0|||
23530223|NCT01633944|65676108|FG002|Open-label Titration Phase|Protocol Violation|0|||
23530224|NCT01633944|65676106|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
23309388|NCT04713553|64877942|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
23419340|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23530225|NCT01633944|65676107|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
23530226|NCT01633944|65676108|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
23530227|NCT01633944|65676106|FG000|Open-label Titration Phase|Other|68|||
23530228|NCT01633944|65676107|FG001|Open-label Titration Phase|Other|0|||
23530229|NCT01633944|65676108|FG002|Open-label Titration Phase|Other|0|||
23530230|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23530231|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Adverse Event|13|||
23530232|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Adverse Event|7|||
23530233|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
23530234|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
23530235|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
23530236|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23530237|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
23530238|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
23530239|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
23530240|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
23530241|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
23530242|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23530243|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
23530244|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
23530245|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
23530246|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
23530247|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
23530248|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
23530249|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
23530250|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
23530251|NCT01633944|65676106|FG000|Double-blind Treatment Phase|Other|0|||
23530252|NCT01633944|65676107|FG001|Double-blind Treatment Phase|Other|7|||
23530253|NCT01633944|65676108|FG002|Double-blind Treatment Phase|Other|0|||
23530254|NCT00774995|65676109|FG000|Overall Study|Protocol Violation|0|||
23530255|NCT00774995|65676110|FG001|Overall Study|Protocol Violation|0|||
23530256|NCT00774995|65676111|FG002|Overall Study|Protocol Violation|1|||
23530257|NCT00774995|65676112|FG003|Overall Study|Protocol Violation|0|||
23530258|NCT00953329|65676113|FG000|Overall Study|Lack of Efficacy|1|||
23530259|NCT02908529|65676114|FG000|Overall Study|Lost to Follow-up|0|||
23530260|NCT02908529|65676115|FG001|Overall Study|Lost to Follow-up|2|||
23530261|NCT01337297|65676119|FG000|Overall Study|They entered to single anodal tDCS|4|||
23530262|NCT01337297|65676120|FG001|Overall Study|They entered to single anodal tDCS|3|||
23530263|NCT01337297|65676119|FG000|Overall Study|Lost to Follow-up|1|||
23206949|NCT00315705|64498106|FG000|Phase 1|Failure to achieve response|8|||
23206950|NCT00315705|64498106|FG000|Phase 1|Disease relapse|4|||
23206951|NCT00315705|64498106|FG000|Phase 1|Scheduled for transplant|9|||
23206952|NCT00315705|64498106|FG000|Phase 1|Death|3|||
23206953|NCT00315705|64498106|FG000|Phase 2|Physician Decision|4|||
23206954|NCT00315705|64498106|FG000|Phase 2|Adverse Event|1|||
23206955|NCT00315705|64498106|FG000|Phase 2|Failure to achieve response|3|||
23206956|NCT00315705|64498106|FG000|Phase 2|Disease relapse|1|||
23206957|NCT00315705|64498106|FG000|Phase 2|Scheduled for transplant|8|||
23206958|NCT00315705|64498106|FG000|Phase 2|Other|1|||
23206959|NCT00315705|64498106|FG000|Phase 2|Death|7|||
23206960|NCT03583372|64498107|FG000|Overall Study|Withdrawal by Subject|6|||
23206961|NCT03583372|64498108|FG001|Overall Study|Withdrawal by Subject|11|||
23206962|NCT03583372|64498109|FG002|Overall Study|Withdrawal by Subject|7|||
23206963|NCT03583372|64498110|FG003|Overall Study|Withdrawal by Subject|8|||
23206964|NCT03583372|64498107|FG000|Overall Study|Lost to Follow-up|4|||
23206965|NCT03583372|64498108|FG001|Overall Study|Lost to Follow-up|6|||
23206966|NCT03583372|64498109|FG002|Overall Study|Lost to Follow-up|3|||
23206967|NCT03583372|64498110|FG003|Overall Study|Lost to Follow-up|2|||
23206968|NCT03583372|64498107|FG000|Overall Study|Adverse Event|1|||
23206969|NCT03583372|64498108|FG001|Overall Study|Adverse Event|3|||
23206970|NCT03583372|64498109|FG002|Overall Study|Adverse Event|4|||
23206971|NCT03583372|64498110|FG003|Overall Study|Adverse Event|4|||
23206972|NCT03583372|64498107|FG000|Overall Study|Physician Decision|0|||
23206973|NCT03583372|64498108|FG001|Overall Study|Physician Decision|1|||
23206974|NCT03583372|64498109|FG002|Overall Study|Physician Decision|1|||
23206975|NCT03583372|64498110|FG003|Overall Study|Physician Decision|1|||
23206976|NCT03583372|64498107|FG000|Overall Study|Lack of Efficacy|0|||
23206977|NCT03583372|64498108|FG001|Overall Study|Lack of Efficacy|1|||
23530264|NCT01337297|65676120|FG001|Overall Study|Lost to Follow-up|3|||
23530265|NCT02316717|65676129|FG000|Overall Study|Adverse Event|2|||
23530266|NCT02316717|65676130|FG001|Overall Study|Adverse Event|2|||
23530267|NCT02316717|65676131|FG002|Overall Study|Adverse Event|0|||
23530268|NCT02316717|65676129|FG000|Overall Study|Lost to Follow-up|1|||
23530269|NCT02316717|65676130|FG001|Overall Study|Lost to Follow-up|2|||
23530270|NCT02316717|65676131|FG002|Overall Study|Lost to Follow-up|1|||
23530271|NCT02316717|65676129|FG000|Overall Study|Non compliance|3|||
23530272|NCT02316717|65676130|FG001|Overall Study|Non compliance|1|||
23530273|NCT02316717|65676131|FG002|Overall Study|Non compliance|0|||
23530274|NCT02316717|65676129|FG000|Overall Study|Protocol Violation|2|||
23206978|NCT03583372|64498109|FG002|Overall Study|Lack of Efficacy|0|||
23206979|NCT03583372|64498110|FG003|Overall Study|Lack of Efficacy|1|||
23206980|NCT03583372|64498107|FG000|Overall Study|Death|1|||
23206981|NCT03583372|64498108|FG001|Overall Study|Death|0|||
23206982|NCT03583372|64498109|FG002|Overall Study|Death|0|||
23206983|NCT03583372|64498110|FG003|Overall Study|Death|0|||
23206984|NCT03583372|64498107|FG000|Overall Study|Protocol Violation|0|||
23206985|NCT03583372|64498108|FG001|Overall Study|Protocol Violation|1|||
23206986|NCT03583372|64498109|FG002|Overall Study|Protocol Violation|0|||
23206987|NCT03583372|64498110|FG003|Overall Study|Protocol Violation|0|||
23206988|NCT03583372|64498107|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
23206989|NCT03583372|64498108|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
23206990|NCT03583372|64498109|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
23206991|NCT03583372|64498110|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
23206992|NCT03583372|64498107|FG000|Overall Study|Did Not Receive Study Drug|0|||
23206993|NCT03583372|64498108|FG001|Overall Study|Did Not Receive Study Drug|1|||
23206994|NCT03583372|64498109|FG002|Overall Study|Did Not Receive Study Drug|0|||
23206995|NCT03583372|64498110|FG003|Overall Study|Did Not Receive Study Drug|0|||
23206996|NCT03583372|64498107|FG000|Overall Study|Captured as Other in the Database|1|||
23206997|NCT03583372|64498108|FG001|Overall Study|Captured as Other in the Database|2|||
23206998|NCT03583372|64498109|FG002|Overall Study|Captured as Other in the Database|4|||
23206999|NCT03583372|64498110|FG003|Overall Study|Captured as Other in the Database|1|||
23207000|NCT00946881|64498112|FG000|First Treatment|Withdrawal by Subject|1|||
23207001|NCT00946881|64498112|FG000|First Treatment|Patient relocated to another state|1|||
23207002|NCT00946881|64498112|FG000|Retreatment|Withdrawal by Subject|1|||
23207003|NCT01714817|64498114|FG000|Year 1 Period|Lack of Efficacy|11|||
23207004|NCT01714817|64498115|FG001|Year 1 Period|Lack of Efficacy|9|||
23207005|NCT01714817|64498114|FG000|Year 1 Period|Adverse Event|20|||
23207006|NCT01714817|64498115|FG001|Year 1 Period|Adverse Event|17|||
23207007|NCT01714817|64498114|FG000|Year 1 Period|Withdrawal by Subject|6|||
23207008|NCT01714817|64498115|FG001|Year 1 Period|Withdrawal by Subject|7|||
23207009|NCT01714817|64498114|FG000|Year 1 Period|Death|1|||
23207010|NCT01714817|64498115|FG001|Year 1 Period|Death|1|||
23207011|NCT01714817|64498114|FG000|Year 1 Period|Lost to Follow-up|0|||
23207012|NCT01714817|64498115|FG001|Year 1 Period|Lost to Follow-up|2|||
23207013|NCT01714817|64498114|FG000|Year 1 Period|Poor / non-compliance|0|||
23207014|NCT01714817|64498115|FG001|Year 1 Period|Poor / non-compliance|1|||
23207015|NCT01714817|64498114|FG000|Year 1 Period|Pregnancy|2|||
23207016|NCT01714817|64498115|FG001|Year 1 Period|Pregnancy|0|||
23207017|NCT01714817|64498114|FG000|Year 1 Period|Participant no longer meets criteria|6|||
23207018|NCT01714817|64498115|FG001|Year 1 Period|Participant no longer meets criteria|2|||
23207019|NCT01714817|64498114|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
23207020|NCT01714817|64498115|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
23207021|NCT01714817|64498114|FG000|Year 1 Period|Change in Concomitant Medication|0|||
23207022|NCT01714817|64498115|FG001|Year 1 Period|Change in Concomitant Medication|1|||
23207023|NCT01714817|64498114|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
23530275|NCT02316717|65676130|FG001|Overall Study|Protocol Violation|0|||
23530276|NCT02316717|65676131|FG002|Overall Study|Protocol Violation|0|||
23530277|NCT02316717|65676129|FG000|Overall Study|Withdrawal by Subject|2|||
23530278|NCT02316717|65676130|FG001|Overall Study|Withdrawal by Subject|1|||
23530279|NCT02316717|65676131|FG002|Overall Study|Withdrawal by Subject|1|||
23530280|NCT02316717|65676129|FG000|Overall Study|Death|0|||
23530281|NCT02316717|65676130|FG001|Overall Study|Death|0|||
23530282|NCT02316717|65676131|FG002|Overall Study|Death|1|||
23530283|NCT02316717|65676129|FG000|Overall Study|Physician Decision|0|||
23530284|NCT02316717|65676130|FG001|Overall Study|Physician Decision|1|||
23530285|NCT02316717|65676131|FG002|Overall Study|Physician Decision|0|||
23530286|NCT02316717|65676129|FG000|Overall Study|TBC|1|||
23530287|NCT02316717|65676130|FG001|Overall Study|TBC|0|||
23530288|NCT02316717|65676131|FG002|Overall Study|TBC|0|||
23530289|NCT02797262|65676132|FG000|Overall Study|Withdrawal by Subject|5|||
23207024|NCT01714817|64498115|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
23207025|NCT01714817|64498114|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
23207026|NCT01714817|64498115|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
23207027|NCT01714817|64498114|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
23309389|NCT04713553|64877936|FG000|Primary Study (2 Months)|Other|1|||
23530290|NCT02797262|65676133|FG001|Overall Study|Withdrawal by Subject|1|||
23530291|NCT02797262|65676132|FG000|Overall Study|Lost to Follow-up|10|||
23530292|NCT02797262|65676133|FG001|Overall Study|Lost to Follow-up|7|||
23207028|NCT01714817|64498115|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
23207029|NCT01714817|64498114|FG000|Year 2 Period|Lack of Efficacy|4|||
23207030|NCT01714817|64498115|FG001|Year 2 Period|Lack of Efficacy|12|||
23207031|NCT01714817|64498114|FG000|Year 2 Period|Adverse Event|7|||
23207032|NCT01714817|64498115|FG001|Year 2 Period|Adverse Event|6|||
23207033|NCT01714817|64498114|FG000|Year 2 Period|Participant request to stop treatment|4|||
23207034|NCT01714817|64498115|FG001|Year 2 Period|Participant request to stop treatment|4|||
23207035|NCT01714817|64498114|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
23207036|NCT01714817|64498115|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
23530293|NCT02797262|65676132|FG000|Overall Study|Death|1|||
23530294|NCT02797262|65676133|FG001|Overall Study|Death|2|||
23530295|NCT02797262|65676132|FG000|Overall Study|Adverse Event|1|||
23530296|NCT02797262|65676133|FG001|Overall Study|Adverse Event|0|||
23530297|NCT02797262|65676132|FG000|Overall Study|COVID-19|2|||
23530298|NCT02797262|65676133|FG001|Overall Study|COVID-19|1|||
23530299|NCT02797262|65676132|FG000|Overall Study|Out-of-country|1|||
23530300|NCT02797262|65676133|FG001|Overall Study|Out-of-country|0|||
23530301|NCT00931307|65676134|FG000|Overall Study|Lack of Efficacy|12|||
23530302|NCT00931307|65676134|FG000|Overall Study|Biomicroscopy|1|||
23530303|NCT02177266|65676142|FG000|Overall Study|Adverse Event|0|||
23530304|NCT02177266|65676143|FG001|Overall Study|Adverse Event|1|||
23530305|NCT02177266|65676142|FG000|Overall Study|Withdrawal by Subject|1|||
23530306|NCT02177266|65676143|FG001|Overall Study|Withdrawal by Subject|0|||
23530307|NCT01914666|65676146|FG000|Treatment Period|Lack of Efficacy|0|||
23530308|NCT01914666|65676147|FG001|Treatment Period|Lack of Efficacy|0|||
23530309|NCT01914666|65676148|FG002|Treatment Period|Lack of Efficacy|2|||
23530310|NCT01914666|65676146|FG000|Treatment Period|Adverse Event|10|||
23530311|NCT01914666|65676147|FG001|Treatment Period|Adverse Event|4|||
23530312|NCT01914666|65676148|FG002|Treatment Period|Adverse Event|2|||
23530313|NCT01914666|65676146|FG000|Treatment Period|Withdrawal by Subject|3|||
23530314|NCT01914666|65676147|FG001|Treatment Period|Withdrawal by Subject|2|||
23530315|NCT01914666|65676148|FG002|Treatment Period|Withdrawal by Subject|2|||
23530316|NCT01914666|65676146|FG000|Treatment Period|Physician Decision|0|||
23530317|NCT01914666|65676147|FG001|Treatment Period|Physician Decision|0|||
23530318|NCT01914666|65676148|FG002|Treatment Period|Physician Decision|2|||
23530319|NCT03773757|65676149|FG000|Overall Study|Withdrawal by Subject|2|||
23530320|NCT03773757|65676150|FG001|Overall Study|Withdrawal by Subject|4|||
23530321|NCT00727714|65676151|FG000|Overall Study|Lost to Follow-up|2|||
23530322|NCT03228680|65676154|FG000|Overall Study|Adverse Event|13|||
23530323|NCT03228680|65676155|FG001|Overall Study|Adverse Event|18|||
23530324|NCT03228680|65676154|FG000|Overall Study|Randomization failure|0|||
23530325|NCT03228680|65676155|FG001|Overall Study|Randomization failure|1|||
23530326|NCT03228680|65676154|FG000|Overall Study|Withdrawal by Subject|1|||
23530327|NCT03228680|65676155|FG001|Overall Study|Withdrawal by Subject|0|||
23530328|NCT03228680|65676154|FG000|Overall Study|Other|9|||
23530329|NCT03228680|65676155|FG001|Overall Study|Other|16|||
23530330|NCT01430585|65676156|FG000|Overall Study|Death|1|||
23530331|NCT01430585|65676156|FG000|Overall Study|Objective Progression or Relapse|3|||
23530332|NCT01430585|65676156|FG000|Overall Study|Study Terminated by Sponsor|3|||
23530333|NCT01430585|65676156|FG000|Overall Study|Other|7|||
23530334|NCT03571516|65676172|FG000|Overall Study|Severe diarrhea|1|||
23530335|NCT03571516|65676173|FG001|Overall Study|Severe diarrhea|0|||
23530336|NCT03571516|65676172|FG000|Overall Study|Withdrawal by Subject|0|||
23530337|NCT03571516|65676173|FG001|Overall Study|Withdrawal by Subject|1|||
23530338|NCT01988571|65676179|FG000|Overall Study|Death|3|||
23530339|NCT01988571|65676180|FG001|Overall Study|Death|1|||
23530340|NCT01988571|65676179|FG000|Overall Study|Physician Decision|2|||
23530341|NCT01988571|65676180|FG001|Overall Study|Physician Decision|1|||
23530342|NCT01988571|65676179|FG000|Overall Study|Lost to Follow-up|3|||
23530343|NCT01988571|65676180|FG001|Overall Study|Lost to Follow-up|0|||
23530344|NCT01988571|65676179|FG000|Overall Study|Withdrawal by Subject|31|||
23530345|NCT01988571|65676180|FG001|Overall Study|Withdrawal by Subject|33|||
23530346|NCT02708680|65676181|FG000|Overall Study|Withdrawal by Subject|4|||
23530347|NCT02708680|65676182|FG001|Overall Study|Withdrawal by Subject|12|||
23530348|NCT02708680|65676183|FG002|Overall Study|Withdrawal by Subject|12|||
23530349|NCT02708680|65676181|FG000|Overall Study|Death|4|||
23309390|NCT04713553|64877937|FG001|Primary Study (2 Months)|Other|2|||
23530350|NCT02708680|65676182|FG001|Overall Study|Death|19|||
23530351|NCT02708680|65676183|FG002|Overall Study|Death|21|||
23530352|NCT02708680|65676181|FG000|Overall Study|Lost to Follow-up|0|||
23530353|NCT02708680|65676182|FG001|Overall Study|Lost to Follow-up|3|||
23530354|NCT02708680|65676183|FG002|Overall Study|Lost to Follow-up|3|||
23530355|NCT02708680|65676181|FG000|Overall Study|Study Terminated By Sponsor|0|||
23530356|NCT02708680|65676182|FG001|Overall Study|Study Terminated By Sponsor|5|||
23530357|NCT02708680|65676183|FG002|Overall Study|Study Terminated By Sponsor|4|||
23530358|NCT02708680|65676181|FG000|Overall Study|Other than Specified|0|||
23530359|NCT02708680|65676182|FG001|Overall Study|Other than Specified|0|||
23530360|NCT02708680|65676183|FG002|Overall Study|Other than Specified|1|||
23530361|NCT02708680|65676181|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
23612783|NCT00784277|65969696|FG000|ER Treatment|Withdrawal by Subject|0|||
23612784|NCT00784277|65969697|FG001|ER Treatment|Withdrawal by Subject|0|||
23612785|NCT00784277|65969698|FG002|ER Treatment|Withdrawal by Subject|0|||
23612786|NCT00784277|65969699|FG003|ER Treatment|Withdrawal by Subject|0|||
23612787|NCT00784277|65969700|FG004|ER Treatment|Withdrawal by Subject|2|||
23612788|NCT00784277|65969701|FG005|ER Treatment|Withdrawal by Subject|5|||
23612789|NCT00784277|65969702|FG006|ER Treatment|Withdrawal by Subject|3|||
23612790|NCT00784277|65969696|FG000|ER Treatment|Study Medication Non-Compliant|0|||
23612791|NCT00784277|65969697|FG001|ER Treatment|Study Medication Non-Compliant|0|||
23612792|NCT00784277|65969698|FG002|ER Treatment|Study Medication Non-Compliant|0|||
23612793|NCT00784277|65969699|FG003|ER Treatment|Study Medication Non-Compliant|0|||
23612794|NCT00784277|65969700|FG004|ER Treatment|Study Medication Non-Compliant|2|||
23612795|NCT00784277|65969701|FG005|ER Treatment|Study Medication Non-Compliant|3|||
23612796|NCT00784277|65969702|FG006|ER Treatment|Study Medication Non-Compliant|3|||
23612797|NCT00784277|65969696|FG000|ER Treatment|Other|0|||
23530362|NCT02708680|65676182|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
23530363|NCT02708680|65676183|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
23530364|NCT01956110|65676184|FG000|Overall Study|Protocol Violation|25|||
23530365|NCT01956110|65676185|FG001|Overall Study|Protocol Violation|11|||
23530366|NCT01956110|65676184|FG000|Overall Study|Adverse Event|9|||
23612798|NCT00784277|65969697|FG001|ER Treatment|Other|0|||
23612799|NCT00784277|65969698|FG002|ER Treatment|Other|0|||
23612800|NCT00784277|65969699|FG003|ER Treatment|Other|0|||
23612801|NCT00784277|65969700|FG004|ER Treatment|Other|1|||
23612802|NCT00784277|65969701|FG005|ER Treatment|Other|3|||
23612803|NCT00784277|65969702|FG006|ER Treatment|Other|2|||
23612804|NCT03873714|65969703|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
23612805|NCT02097420|65969706|FG000|Overall Study|Death|6|||
23612806|NCT02097420|65969706|FG000|Overall Study|Valve explanted|13|||
23612807|NCT02097420|65969706|FG000|Overall Study|Other Reason|1|||
23612808|NCT01864200|65969713|FG000|Overall Study|Lost to Follow-up|1|||
23612809|NCT01864200|65969714|FG001|Overall Study|Lost to Follow-up|3|||
23530367|NCT01956110|65676185|FG001|Overall Study|Adverse Event|10|||
23530368|NCT01956110|65676184|FG000|Overall Study|Personal reasons|1|||
23530369|NCT01956110|65676185|FG001|Overall Study|Personal reasons|1|||
23530370|NCT00785486|65676187|FG000|Midazolam Alone|Withdrawal by Subject|1|||
23530371|NCT02932891|65676188|FG000|Overall Study|Lost to Follow-up|2|||
23530372|NCT02932891|65676188|FG000|Overall Study|HPA Suppress|2|||
23530373|NCT01539226|65676189|FG000|Overall Study|Withdrawal by Subject|24|||
23530374|NCT01539226|65676190|FG001|Overall Study|Withdrawal by Subject|54|||
23530375|NCT01539226|65676189|FG000|Overall Study|Lost to Follow-up|20|||
23530376|NCT01539226|65676190|FG001|Overall Study|Lost to Follow-up|54|||
23530377|NCT01539226|65676189|FG000|Overall Study|Death|1|||
23530378|NCT01539226|65676190|FG001|Overall Study|Death|2|||
23530379|NCT01539226|65676189|FG000|Overall Study|Adverse Event|2|||
23530380|NCT01539226|65676190|FG001|Overall Study|Adverse Event|0|||
23530381|NCT01539226|65676189|FG000|Overall Study|Pregnancy|13|||
23530382|NCT01539226|65676190|FG001|Overall Study|Pregnancy|29|||
23530383|NCT01539226|65676189|FG000|Overall Study|inappropriate enrollment|0|||
23530384|NCT01539226|65676190|FG001|Overall Study|inappropriate enrollment|1|||
23530385|NCT01539226|65676189|FG000|Overall Study|Multiple Reasons|3|||
23530386|NCT01539226|65676190|FG001|Overall Study|Multiple Reasons|1|||
23530387|NCT01539226|65676189|FG000|Overall Study|not HIV seroconversion-related|93|||
23530388|NCT01539226|65676190|FG001|Overall Study|not HIV seroconversion-related|176|||
23530389|NCT01539226|65676189|FG000|Overall Study|HIV seroconversion-related|55|||
23530390|NCT01539226|65676190|FG001|Overall Study|HIV seroconversion-related|80|||
23530391|NCT01539226|65676189|FG000|Overall Study|Non-compliance|6|||
23530392|NCT01539226|65676190|FG001|Overall Study|Non-compliance|8|||
23530393|NCT01143090|65676196|FG000|Overall Study|Lack of Efficacy|2|||
23530394|NCT01143090|65676196|FG000|Overall Study|Adverse Event|17|||
23530395|NCT01143090|65676196|FG000|Overall Study|Lost to Follow-up|9|||
23530396|NCT01143090|65676196|FG000|Overall Study|Protocol Violation|2|||
23612810|NCT01864200|65969713|FG000|Overall Study|Protocol Violation|1|||
23612811|NCT01864200|65969714|FG001|Overall Study|Protocol Violation|0|||
23612812|NCT01064856|65969722|FG000|Double-blind (DB) Period|Adverse Event|1|||
23612813|NCT01064856|65969723|FG001|Double-blind (DB) Period|Adverse Event|0|||
23530397|NCT01143090|65676196|FG000|Overall Study|Withdrawal by Subject|18|||
23530398|NCT01143090|65676196|FG000|Overall Study|Non-compliance with study drug|1|||
23530399|NCT01143090|65676196|FG000|Overall Study|Failure to meet eligibility criteria|1|||
23530400|NCT01143090|65676196|FG000|Overall Study|Administrative|1|||
23530401|NCT03192150|65676199|FG000|Overall Study|Adverse Event|14|||
23530402|NCT03192150|65676200|FG001|Overall Study|Adverse Event|12|||
23530403|NCT03192150|65676199|FG000|Overall Study|Lack of Efficacy|23|||
23530404|NCT03192150|65676200|FG001|Overall Study|Lack of Efficacy|30|||
23612814|NCT01064856|65969724|FG002|Double-blind (DB) Period|Adverse Event|0|||
23612815|NCT01064856|65969725|FG003|Double-blind (DB) Period|Adverse Event|0|||
23612816|NCT01064856|65969722|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
23612817|NCT01064856|65969723|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
23612818|NCT01064856|65969724|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
23530405|NCT03192150|65676199|FG000|Overall Study|Lost to Follow-up|1|||
23612819|NCT01064856|65969725|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
23612820|NCT01064856|65969722|FG000|Open-label (OL) Period|Adverse Event|0|||
23309391|NCT04713553|64877938|FG002|Primary Study (2 Months)|Other|0|||
23309392|NCT04713553|64877939|FG003|Primary Study (2 Months)|Other|0|||
23309393|NCT04713553|64877940|FG004|Primary Study (2 Months)|Other|1|||
23309394|NCT04713553|64877941|FG005|Primary Study (2 Months)|Other|0|||
23309395|NCT04713553|64877942|FG006|Primary Study (2 Months)|Other|0|||
23309396|NCT04713553|64877936|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
23530406|NCT03192150|65676200|FG001|Overall Study|Lost to Follow-up|1|||
23612821|NCT01064856|65969723|FG001|Open-label (OL) Period|Adverse Event|0|||
23612822|NCT01064856|65969724|FG002|Open-label (OL) Period|Adverse Event|12|||
23612823|NCT01064856|65969725|FG003|Open-label (OL) Period|Adverse Event|6|||
23612824|NCT01064856|65969722|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
23612825|NCT01064856|65969723|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
23612826|NCT01064856|65969724|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
23612827|NCT01064856|65969725|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
23612828|NCT01064856|65969722|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
23612829|NCT01064856|65969723|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
23612830|NCT01064856|65969724|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
23612831|NCT01064856|65969725|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
23612832|NCT01064856|65969722|FG000|Open-label (OL) Period|Other|0|||
23612833|NCT01064856|65969723|FG001|Open-label (OL) Period|Other|0|||
23612834|NCT01064856|65969724|FG002|Open-label (OL) Period|Other|7|||
23612835|NCT01064856|65969725|FG003|Open-label (OL) Period|Other|7|||
23612836|NCT03034772|65969726|FG000|Overall Study|Adverse Event|0|||
23612837|NCT03034772|65969727|FG001|Overall Study|Adverse Event|1|||
23612838|NCT03034772|65969726|FG000|Overall Study|Withdrawal by Subject|0|||
23612839|NCT03034772|65969727|FG001|Overall Study|Withdrawal by Subject|1|||
23612840|NCT01320683|65969728|FG000|Overall Study|Positive antibody response|1|||
23612841|NCT01863368|65969732|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
23612842|NCT01863368|65969733|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
23612843|NCT01863368|65969732|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
23612844|NCT01863368|65969733|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
23612845|NCT01863368|65969732|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
23530407|NCT03192150|65676199|FG000|Overall Study|Withdrawal by Subject|4|||
23530408|NCT03192150|65676200|FG001|Overall Study|Withdrawal by Subject|2|||
23530409|NCT03192150|65676199|FG000|Overall Study|Protocol Violation|5|||
23530410|NCT03192150|65676200|FG001|Overall Study|Protocol Violation|2|||
23530411|NCT03192150|65676199|FG000|Overall Study|Surgery Canceled|6|||
23530412|NCT03192150|65676200|FG001|Overall Study|Surgery Canceled|2|||
23530413|NCT03192150|65676199|FG000|Overall Study|Other-Various Administrative Reasons|2|||
23530414|NCT03192150|65676200|FG001|Overall Study|Other-Various Administrative Reasons|5|||
23530415|NCT04152447|65676213|FG000|Overall Study|Lost to Follow-up|1|||
23530416|NCT04152447|65676214|FG001|Overall Study|Lost to Follow-up|0|||
23530417|NCT04152447|65676213|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
23530418|NCT04152447|65676214|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
23530419|NCT04152447|65676213|FG000|Overall Study|Withdrawal by Subject|0|||
23530420|NCT04152447|65676214|FG001|Overall Study|Withdrawal by Subject|1|||
23530421|NCT04152447|65676213|FG000|Overall Study|Found ineligible after enrolling|1|||
23530422|NCT04152447|65676214|FG001|Overall Study|Found ineligible after enrolling|1|||
23530423|NCT04152447|65676213|FG000|Overall Study|Did not receive VR headset in time.|0|||
23530424|NCT04152447|65676214|FG001|Overall Study|Did not receive VR headset in time.|2|||
23612846|NCT01863368|65969733|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
23612847|NCT01863368|65969732|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
23612848|NCT01863368|65969733|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
23612849|NCT01863368|65969732|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
23612850|NCT01863368|65969733|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
23612851|NCT01863368|65969732|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
23612852|NCT01863368|65969733|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
23612853|NCT01721759|65969734|FG000|Treatment Period|Disease Progression|85|||
23612854|NCT01721759|65969734|FG000|Treatment Period|Study drug toxicity|14|||
23309397|NCT04713553|64877937|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
23612855|NCT01721759|65969734|FG000|Treatment Period|Death|1|||
23612856|NCT01721759|65969734|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
23612857|NCT01721759|65969734|FG000|Treatment Period|Participant request to withdraw|3|||
23309398|NCT04713553|64877938|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
23309399|NCT04713553|64877939|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
23530425|NCT04380857|65676215|FG000|Overall Study|Lost to Follow-up|3|||
23530426|NCT04380857|65676216|FG001|Overall Study|Lost to Follow-up|3|||
23530427|NCT00183872|65676220|FG000|Overall Study|Death|3|||
23612858|NCT01721759|65969734|FG000|Treatment Period|Other Reasons|3|||
23612859|NCT01721759|65969734|FG000|End of Study Period|Participant Withdrew Consent|5|||
23612860|NCT01721759|65969734|FG000|End of Study Period|Death|101|||
23612861|NCT01721759|65969734|FG000|End of Study Period|Lost to Follow-up|1|||
23612862|NCT01721759|65969734|FG000|End of Study Period|Other Reasons|10|||
23612863|NCT03341312|65969735|FG000|Period 1|Withdrawal by Subject|0|||
23612864|NCT03341312|65969736|FG001|Period 1|Withdrawal by Subject|1|||
23612865|NCT03341312|65969737|FG002|Period 1|Withdrawal by Subject|0|||
23612866|NCT03341312|65969738|FG003|Period 1|Withdrawal by Subject|0|||
23612867|NCT02516202|65969739|FG000|Overall Study|Withdrawal by Subject|1|||
23612868|NCT02516202|65969740|FG001|Overall Study|Withdrawal by Subject|0|||
23612869|NCT02516202|65969741|FG002|Overall Study|Withdrawal by Subject|1|||
23612870|NCT02516202|65969739|FG000|Overall Study|Lost to Follow-up|1|||
23612871|NCT02516202|65969740|FG001|Overall Study|Lost to Follow-up|1|||
23612872|NCT02516202|65969741|FG002|Overall Study|Lost to Follow-up|1|||
23612873|NCT02516202|65969739|FG000|Overall Study|Stopped Follow-up|0|||
23612874|NCT02516202|65969740|FG001|Overall Study|Stopped Follow-up|0|||
23612875|NCT02516202|65969741|FG002|Overall Study|Stopped Follow-up|1|||
23612876|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
23207037|NCT01714817|64498114|FG000|Year 2 Period|Participant withdrew consent|1|||
23207038|NCT01714817|64498115|FG001|Year 2 Period|Participant withdrew consent|5|||
23207039|NCT01714817|64498114|FG000|Year 2 Period|Participant no longer meets criteria|1|||
23207040|NCT01714817|64498115|FG001|Year 2 Period|Participant no longer meets criteria|4|||
23207041|NCT01714817|64498114|FG000|Year 2 Period|Lost to Follow-up|2|||
23207042|NCT01714817|64498115|FG001|Year 2 Period|Lost to Follow-up|0|||
23207043|NCT01714817|64498114|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
23207044|NCT01714817|64498115|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
23530428|NCT00183872|65676220|FG000|Overall Study|Adverse Event|9|||
23530429|NCT00183872|65676220|FG000|Overall Study|Withdrawal by Subject|2|||
23530430|NCT00183872|65676220|FG000|Overall Study|Drug delayed more than 28 days|2|||
23530431|NCT01400841|65676221|FG000|Initial Study Phase (6 Months)|Death|1|||
23207045|NCT01714817|64498114|FG000|Year 2 Period|Pregnancy|1|||
23207046|NCT01714817|64498115|FG001|Year 2 Period|Pregnancy|1|||
23207047|NCT01714817|64498114|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
23530432|NCT01400841|65676221|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
23530433|NCT00706966|65676222|FG000|Overall Study|Adverse Event|1|||
23530434|NCT00705575|65676225|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23530435|NCT00705575|65676226|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23530436|NCT00705575|65676225|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23612877|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
23612878|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
23612879|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
23612880|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
23612881|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
23612882|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
23612883|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
23612884|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
23612885|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
23612886|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
23612887|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
23612888|NCT01345253|65969742|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
23530437|NCT00705575|65676226|FG001|Overall Study|Abnormal test procedure result(s)|12|||
23530438|NCT00705575|65676225|FG000|Overall Study|Adverse Event|11|||
23612889|NCT01345253|65969743|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
23207048|NCT01714817|64498115|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
23207049|NCT01714817|64498114|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
23207050|NCT01714817|64498115|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
23530439|NCT00705575|65676226|FG001|Overall Study|Adverse Event|15|||
23612890|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
23530440|NCT00705575|65676225|FG000|Overall Study|Lost to Follow-up|3|||
23612891|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
23612892|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
23419341|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419342|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419343|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419344|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23530441|NCT00705575|65676226|FG001|Overall Study|Lost to Follow-up|4|||
23530442|NCT00705575|65676225|FG000|Overall Study|Protocol Violation|2|||
23530443|NCT00705575|65676226|FG001|Overall Study|Protocol Violation|2|||
23530444|NCT00705575|65676225|FG000|Overall Study|Withdrawal by Subject|5|||
23530445|NCT00705575|65676226|FG001|Overall Study|Withdrawal by Subject|10|||
23530446|NCT01687166|65676234|FG000|Overall Study|Attempt subject|2|||
23530447|NCT01687166|65676235|FG001|Overall Study|Attempt subject|3|||
23530448|NCT01687166|65676236|FG002|Overall Study|Attempt subject|2|||
23530449|NCT01687166|65676237|FG003|Overall Study|Attempt subject|0|||
23530450|NCT01687166|65676234|FG000|Overall Study|Did not meet eligibility criteria|4|||
23530451|NCT01687166|65676235|FG001|Overall Study|Did not meet eligibility criteria|6|||
23530452|NCT01687166|65676236|FG002|Overall Study|Did not meet eligibility criteria|1|||
23530453|NCT01687166|65676237|FG003|Overall Study|Did not meet eligibility criteria|1|||
23530454|NCT01687166|65676234|FG000|Overall Study|Adverse Event|2|||
23530455|NCT01687166|65676235|FG001|Overall Study|Adverse Event|1|||
23530456|NCT01687166|65676236|FG002|Overall Study|Adverse Event|0|||
23530457|NCT01687166|65676237|FG003|Overall Study|Adverse Event|0|||
23530458|NCT01687166|65676234|FG000|Overall Study|Physician Decision|3|||
23530459|NCT01687166|65676235|FG001|Overall Study|Physician Decision|2|||
23530460|NCT01687166|65676236|FG002|Overall Study|Physician Decision|1|||
23530461|NCT01687166|65676237|FG003|Overall Study|Physician Decision|0|||
23530462|NCT01687166|65676234|FG000|Overall Study|Withdrawal by Subject|11|||
23530463|NCT01687166|65676235|FG001|Overall Study|Withdrawal by Subject|4|||
23530464|NCT01687166|65676236|FG002|Overall Study|Withdrawal by Subject|3|||
23530465|NCT01687166|65676237|FG003|Overall Study|Withdrawal by Subject|0|||
23612893|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
23612894|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
23612895|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
23612896|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
23612897|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
23612898|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
23530466|NCT01687166|65676234|FG000|Overall Study|Lost to Follow-up|2|||
23530467|NCT01687166|65676235|FG001|Overall Study|Lost to Follow-up|5|||
23530468|NCT01687166|65676236|FG002|Overall Study|Lost to Follow-up|1|||
23530469|NCT01687166|65676237|FG003|Overall Study|Lost to Follow-up|0|||
23530470|NCT01687166|65676234|FG000|Overall Study|Equipment/Device Availability|0|||
23530471|NCT01687166|65676235|FG001|Overall Study|Equipment/Device Availability|1|||
23530472|NCT01687166|65676236|FG002|Overall Study|Equipment/Device Availability|0|||
23530473|NCT01687166|65676237|FG003|Overall Study|Equipment/Device Availability|0|||
23612899|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
23612900|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
23612901|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
23612902|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
23612903|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
23530474|NCT01687166|65676234|FG000|Overall Study|Death|1|||
23530475|NCT01687166|65676235|FG001|Overall Study|Death|1|||
23530476|NCT01687166|65676236|FG002|Overall Study|Death|0|||
23530477|NCT01687166|65676237|FG003|Overall Study|Death|0|||
23530478|NCT01687166|65676234|FG000|Overall Study|Protocol Violation|1|||
23530479|NCT01687166|65676235|FG001|Overall Study|Protocol Violation|1|||
23419345|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
23419346|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
23309400|NCT04713553|64877940|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
23309401|NCT04713553|64877941|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
23309402|NCT04713553|64877942|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
23309403|NCT04713553|64877936|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
23309404|NCT04713553|64877937|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
23309405|NCT04713553|64877938|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
23309406|NCT04713553|64877939|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
23309407|NCT04713553|64877940|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
23309408|NCT04713553|64877941|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
23309409|NCT04713553|64877942|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
23309410|NCT02365558|64877943|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
23309411|NCT02365558|64877944|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
23309412|NCT02365558|64877943|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
23309413|NCT02365558|64877944|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
23309414|NCT01664130|64877945|FG000|Overall Study|competing secondary disease|2|||
23309415|NCT01275430|64877946|FG000|Overall Study|Adverse Event|1|||
23309416|NCT01275430|64877946|FG000|Overall Study|No Contrast Injection|6|||
23309417|NCT01275430|64877946|FG000|Overall Study|Device Malfunction|1|||
23309418|NCT01275430|64877946|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
23419347|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
23419348|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23309419|NCT01214915|64877950|FG000|Overall Study|Adverse Event|8|||
23309420|NCT01214915|64877950|FG000|Overall Study|Lack of Efficacy|3|||
23309421|NCT00867503|64877951|FG000|Overall Study|Withdrawal by Subject|1|||
23309422|NCT01646138|64877955|FG000|Overall Study|Lost to Follow-up|0|||
23309423|NCT01646138|64877956|FG001|Overall Study|Lost to Follow-up|0|||
23309424|NCT01646138|64877957|FG002|Overall Study|Lost to Follow-up|0|||
23309425|NCT01646138|64877958|FG003|Overall Study|Lost to Follow-up|0|||
23309426|NCT01646138|64877959|FG004|Overall Study|Lost to Follow-up|2|||
23309427|NCT04669691|64877960|FG000|Overall Study|Death|0|||
23309428|NCT04669691|64877961|FG001|Overall Study|Death|1|||
23309429|NCT04669691|64877962|FG002|Overall Study|Death|0|||
23309430|NCT04669691|64877963|FG003|Overall Study|Death|0|||
23309431|NCT04669691|64877964|FG004|Overall Study|Death|0|||
23309432|NCT04669691|64877965|FG005|Overall Study|Death|0|||
23309433|NCT02087189|64877966|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
23309434|NCT04645966|64877967|FG000|Vaccination Phase|Adverse Event|1|||
23309435|NCT04645966|64877968|FG001|Vaccination Phase|Adverse Event|0|||
23309436|NCT04645966|64877969|FG002|Vaccination Phase|Adverse Event|0|||
23309437|NCT04645966|64877970|FG003|Vaccination Phase|Adverse Event|0|||
23309438|NCT04645966|64877971|FG004|Vaccination Phase|Adverse Event|0|||
23309439|NCT04645966|64877972|FG005|Vaccination Phase|Adverse Event|0|||
23309440|NCT04645966|64877973|FG006|Vaccination Phase|Adverse Event|1|||
23309441|NCT04645966|64877974|FG007|Vaccination Phase|Adverse Event|0|||
23309442|NCT04645966|64877975|FG008|Vaccination Phase|Adverse Event|0|||
23309443|NCT04645966|64877967|FG000|Vaccination Phase|Death|0|||
23309444|NCT04645966|64877968|FG001|Vaccination Phase|Death|0|||
23309445|NCT04645966|64877969|FG002|Vaccination Phase|Death|0|||
23309446|NCT04645966|64877970|FG003|Vaccination Phase|Death|0|||
23309447|NCT04645966|64877971|FG004|Vaccination Phase|Death|0|||
23309448|NCT04645966|64877972|FG005|Vaccination Phase|Death|1|||
23309449|NCT04645966|64877973|FG006|Vaccination Phase|Death|0|||
23309450|NCT04645966|64877974|FG007|Vaccination Phase|Death|0|||
23309451|NCT04645966|64877975|FG008|Vaccination Phase|Death|0|||
23309452|NCT04645966|64877967|FG000|Vaccination Phase|Protocol Violation|0|||
23309453|NCT04645966|64877968|FG001|Vaccination Phase|Protocol Violation|0|||
23309454|NCT04645966|64877969|FG002|Vaccination Phase|Protocol Violation|0|||
23309455|NCT04645966|64877970|FG003|Vaccination Phase|Protocol Violation|0|||
23309456|NCT04645966|64877971|FG004|Vaccination Phase|Protocol Violation|1|||
23309457|NCT04645966|64877972|FG005|Vaccination Phase|Protocol Violation|0|||
23309458|NCT04645966|64877973|FG006|Vaccination Phase|Protocol Violation|0|||
23309459|NCT04645966|64877974|FG007|Vaccination Phase|Protocol Violation|0|||
23309460|NCT04645966|64877975|FG008|Vaccination Phase|Protocol Violation|0|||
23309461|NCT04645966|64877967|FG000|Vaccination Phase|Study terminated by sponsor|0|||
23309462|NCT04645966|64877968|FG001|Vaccination Phase|Study terminated by sponsor|0|||
23309463|NCT04645966|64877969|FG002|Vaccination Phase|Study terminated by sponsor|14|||
23309464|NCT04645966|64877970|FG003|Vaccination Phase|Study terminated by sponsor|15|||
23309465|NCT04645966|64877971|FG004|Vaccination Phase|Study terminated by sponsor|47|||
23309466|NCT04645966|64877972|FG005|Vaccination Phase|Study terminated by sponsor|43|||
23309467|NCT04645966|64877973|FG006|Vaccination Phase|Study terminated by sponsor|29|||
23309468|NCT04645966|64877974|FG007|Vaccination Phase|Study terminated by sponsor|29|||
23309469|NCT04645966|64877975|FG008|Vaccination Phase|Study terminated by sponsor|12|||
23309470|NCT04645966|64877967|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
23309471|NCT04645966|64877968|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
23309472|NCT04645966|64877969|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
23309473|NCT04645966|64877970|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
23309474|NCT04645966|64877971|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
23309475|NCT04645966|64877972|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
23309476|NCT04645966|64877973|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
23309477|NCT04645966|64877974|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
23309478|NCT04645966|64877975|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
23309479|NCT04645966|64877967|FG000|Vaccination Phase|Other|0|||
23309480|NCT04645966|64877968|FG001|Vaccination Phase|Other|0|||
23309481|NCT04645966|64877969|FG002|Vaccination Phase|Other|0|||
23309482|NCT04645966|64877970|FG003|Vaccination Phase|Other|0|||
23309483|NCT04645966|64877971|FG004|Vaccination Phase|Other|0|||
23309484|NCT04645966|64877972|FG005|Vaccination Phase|Other|2|||
23309485|NCT04645966|64877973|FG006|Vaccination Phase|Other|0|||
23309486|NCT04645966|64877974|FG007|Vaccination Phase|Other|0|||
23309487|NCT04645966|64877975|FG008|Vaccination Phase|Other|0|||
23309488|NCT04645966|64877967|FG000|Vaccination Phase|Lost to Follow-up|0|||
23309489|NCT04645966|64877968|FG001|Vaccination Phase|Lost to Follow-up|0|||
23309490|NCT04645966|64877969|FG002|Vaccination Phase|Lost to Follow-up|0|||
23207051|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
23207052|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
23207053|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
23207054|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
23207055|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
23207056|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
23207057|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
23207058|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
23207059|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
23207060|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
23207061|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
23309491|NCT04645966|64877970|FG003|Vaccination Phase|Lost to Follow-up|0|||
23419349|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419350|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23530480|NCT01687166|65676236|FG002|Overall Study|Protocol Violation|1|||
23530481|NCT01687166|65676237|FG003|Overall Study|Protocol Violation|0|||
23530482|NCT01687166|65676234|FG000|Overall Study|Subject moved out of state|0|||
23419351|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23530483|NCT01687166|65676235|FG001|Overall Study|Subject moved out of state|1|||
23530484|NCT01687166|65676236|FG002|Overall Study|Subject moved out of state|0|||
23530485|NCT01687166|65676237|FG003|Overall Study|Subject moved out of state|0|||
23530486|NCT01687166|65676234|FG000|Overall Study|Patient unable to be compliant|1|||
23419352|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419353|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
23419354|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419355|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419356|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
23419357|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
23419358|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419359|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419360|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419361|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419362|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419363|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23530487|NCT01687166|65676235|FG001|Overall Study|Patient unable to be compliant|0|||
23530488|NCT01687166|65676236|FG002|Overall Study|Patient unable to be compliant|0|||
23530489|NCT01687166|65676237|FG003|Overall Study|Patient unable to be compliant|0|||
23530490|NCT01687166|65676234|FG000|Overall Study|Physician choice to use different device|1|||
23530491|NCT01687166|65676235|FG001|Overall Study|Physician choice to use different device|2|||
23530492|NCT01687166|65676236|FG002|Overall Study|Physician choice to use different device|4|||
23530493|NCT01687166|65676237|FG003|Overall Study|Physician choice to use different device|0|||
23530494|NCT01687166|65676234|FG000|Overall Study|Insurance|0|||
23530495|NCT01687166|65676235|FG001|Overall Study|Insurance|0|||
23530496|NCT01687166|65676236|FG002|Overall Study|Insurance|1|||
23530497|NCT01687166|65676237|FG003|Overall Study|Insurance|1|||
23530498|NCT03144180|65676238|FG000|Overall Study|STAT Delivery|1|||
23530499|NCT03144180|65676239|FG001|Overall Study|STAT Delivery|1|||
23309492|NCT04645966|64877971|FG004|Vaccination Phase|Lost to Follow-up|0|||
23309493|NCT04645966|64877972|FG005|Vaccination Phase|Lost to Follow-up|0|||
23309494|NCT04645966|64877973|FG006|Vaccination Phase|Lost to Follow-up|0|||
23309495|NCT04645966|64877974|FG007|Vaccination Phase|Lost to Follow-up|1|||
23309496|NCT04645966|64877975|FG008|Vaccination Phase|Lost to Follow-up|0|||
23309497|NCT04645966|64877967|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
23309498|NCT04645966|64877968|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
23309499|NCT04645966|64877969|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
23309500|NCT04645966|64877970|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
23309501|NCT04645966|64877971|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
23309502|NCT04645966|64877972|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
23309503|NCT04645966|64877973|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
23309504|NCT04645966|64877974|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
23309505|NCT04645966|64877975|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
23309506|NCT04645966|64877967|FG000|Follow-up Phase|Lost to Follow-up|0|||
23309507|NCT04645966|64877968|FG001|Follow-up Phase|Lost to Follow-up|0|||
23309508|NCT04645966|64877969|FG002|Follow-up Phase|Lost to Follow-up|0|||
23309509|NCT04645966|64877970|FG003|Follow-up Phase|Lost to Follow-up|0|||
23309510|NCT04645966|64877971|FG004|Follow-up Phase|Lost to Follow-up|0|||
23309511|NCT04645966|64877972|FG005|Follow-up Phase|Lost to Follow-up|0|||
23309512|NCT04645966|64877973|FG006|Follow-up Phase|Lost to Follow-up|0|||
23309513|NCT04645966|64877974|FG007|Follow-up Phase|Lost to Follow-up|1|||
23309514|NCT04645966|64877975|FG008|Follow-up Phase|Lost to Follow-up|0|||
23309515|NCT00478426|64877976|FG000|Overall Study|Withdrawal by Subject|1|||
23309516|NCT03084367|64877977|FG000|Overall Study|Lost to Follow-up|32|||
23309517|NCT03084367|64877977|FG000|Overall Study|Withdrawal by Subject|4|||
23309518|NCT03084367|64877977|FG000|Overall Study|Other|1|||
23309519|NCT02549027|64877980|FG000|Washout After Period 4|Withdrawal by Subject|0|||
23309520|NCT02549027|64877981|FG001|Washout After Period 4|Withdrawal by Subject|1|||
23309521|NCT02549027|64877982|FG002|Washout After Period 4|Withdrawal by Subject|1|||
23309522|NCT02549027|64877983|FG003|Washout After Period 4|Withdrawal by Subject|1|||
23309523|NCT02549027|64877984|FG004|Washout After Period 4|Withdrawal by Subject|0|||
23309524|NCT02549027|64877985|FG005|Washout After Period 4|Withdrawal by Subject|0|||
23309525|NCT02549027|64877980|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23309526|NCT02549027|64877981|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23309527|NCT02549027|64877982|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23309528|NCT02549027|64877983|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23309529|NCT02549027|64877984|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
23309530|NCT02549027|64877985|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
23309531|NCT00619112|64877986|FG000|Overall Study|Adverse Event|1|||
23309532|NCT00619112|64877987|FG001|Overall Study|Adverse Event|2|||
23309533|NCT02116608|64877988|FG000|Overall Study|Lost to Follow-up|0|||
23309534|NCT02116608|64877989|FG001|Overall Study|Lost to Follow-up|0|||
23309535|NCT02116608|64877990|FG002|Overall Study|Lost to Follow-up|1|||
23309536|NCT02116608|64877988|FG000|Overall Study|Physician Decision|0|||
23309537|NCT02116608|64877989|FG001|Overall Study|Physician Decision|1|||
23309538|NCT02116608|64877990|FG002|Overall Study|Physician Decision|0|||
23309539|NCT02116608|64877988|FG000|Overall Study|Death|0|||
23309540|NCT02116608|64877989|FG001|Overall Study|Death|1|||
23309541|NCT02116608|64877990|FG002|Overall Study|Death|0|||
23309542|NCT02185053|64877991|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
23309543|NCT02185053|64877992|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
23309544|NCT02185053|64877993|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
23309545|NCT02185053|64877991|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
23309546|NCT02185053|64877992|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
23309547|NCT02185053|64877993|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
23530500|NCT03144180|65676238|FG000|Overall Study|Provider forgot to fill out forms|1|||
23530501|NCT03144180|65676239|FG001|Overall Study|Provider forgot to fill out forms|3|||
23530502|NCT03144180|65676238|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
23530503|NCT03144180|65676239|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
23530504|NCT03144180|65676238|FG000|Overall Study|Scrub tech removed tube cap|0|||
23612904|NCT01345253|65969742|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
23309548|NCT02185053|64877991|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
23309549|NCT02185053|64877992|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
23309550|NCT02185053|64877993|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
23309551|NCT02185053|64877991|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
23309552|NCT02185053|64877992|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
23309553|NCT02185053|64877993|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
23309554|NCT02185053|64877991|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
23309555|NCT02185053|64877992|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
23309556|NCT02185053|64877993|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
23309557|NCT02185053|64877991|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
23309558|NCT02185053|64877992|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
23309559|NCT02185053|64877993|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
23309560|NCT02185053|64877991|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
23309561|NCT02185053|64877992|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
23309562|NCT02185053|64877993|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
23309563|NCT02185053|64877991|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
23309564|NCT02185053|64877992|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
23309565|NCT02185053|64877993|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
23309566|NCT03560986|64878000|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
23309567|NCT03560986|64878001|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
23309568|NCT03560986|64878000|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
23309569|NCT03560986|64878001|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
23309570|NCT03560986|64878000|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
23309571|NCT03560986|64878001|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
23309572|NCT03560986|64878000|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
23309573|NCT03560986|64878001|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
23309574|NCT03560986|64878000|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
23309575|NCT03560986|64878001|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
23309576|NCT03560986|64878000|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
23309577|NCT03560986|64878001|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
23309578|NCT03560986|64878000|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
23309579|NCT03560986|64878001|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
23309580|NCT00658021|64878012|FG000|28-Week Treatment Period|Adverse Event|3|||
23309581|NCT00658021|64878013|FG001|28-Week Treatment Period|Adverse Event|1|||
23309582|NCT00658021|64878014|FG002|28-Week Treatment Period|Adverse Event|0|||
23309583|NCT00658021|64878012|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
23309584|NCT00658021|64878013|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
23309585|NCT00658021|64878014|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
23309586|NCT00658021|64878012|FG000|28-Week Treatment Period|Protocol Violation|0|||
23309587|NCT00658021|64878013|FG001|28-Week Treatment Period|Protocol Violation|2|||
23309588|NCT00658021|64878014|FG002|28-Week Treatment Period|Protocol Violation|1|||
23309589|NCT00658021|64878012|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
23309590|NCT00658021|64878013|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
23309591|NCT00658021|64878014|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
23309592|NCT00658021|64878012|FG000|28-Week Treatment Period|Physician Decision|1|||
23309593|NCT00658021|64878013|FG001|28-Week Treatment Period|Physician Decision|2|||
23309594|NCT00658021|64878014|FG002|28-Week Treatment Period|Physician Decision|1|||
23309595|NCT00658021|64878012|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
23309596|NCT00658021|64878013|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
23309597|NCT00658021|64878014|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
23309598|NCT00658021|64878012|FG000|28-Week Treatment Period|Loss of glucose control|1|||
23309599|NCT00658021|64878013|FG001|28-Week Treatment Period|Loss of glucose control|1|||
23309600|NCT00658021|64878014|FG002|28-Week Treatment Period|Loss of glucose control|10|||
23419364|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419365|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419366|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
23419367|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
23530505|NCT03144180|65676239|FG001|Overall Study|Scrub tech removed tube cap|1|||
23530506|NCT04960228|65676240|FG000|Overall Study|Withdrawal by Subject|216|||
23419368|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419369|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419370|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419371|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419372|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419373|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419374|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419375|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
23419376|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
23419377|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
23419378|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419379|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419380|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419381|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419382|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419383|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419384|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23530507|NCT04960228|65676241|FG001|Overall Study|Withdrawal by Subject|35|||
23530508|NCT04960228|65676240|FG000|Overall Study|Failed attention check|69|||
23530509|NCT04960228|65676241|FG001|Overall Study|Failed attention check|148|||
23530510|NCT04960228|65676240|FG000|Overall Study|Flagged for response quality by Dynata|3|||
23530511|NCT04960228|65676241|FG001|Overall Study|Flagged for response quality by Dynata|3|||
23530512|NCT01282424|65676246|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
23530513|NCT01282424|65676246|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
23530514|NCT01282424|65676246|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
23530515|NCT01282424|65676246|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
23530516|NCT01282424|65676246|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
23530517|NCT01282424|65676246|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
23530518|NCT01282424|65676246|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
23530519|NCT01282424|65676246|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
23530520|NCT01866709|65676252|FG000|Overall Study|Adverse Event|1|||
23530521|NCT01866709|65676253|FG001|Overall Study|Adverse Event|0|||
23530522|NCT00782210|65676254|FG000|Overall Study|Adverse Event|21|||
23530523|NCT00782210|65676255|FG001|Overall Study|Adverse Event|17|||
23530524|NCT00782210|65676256|FG002|Overall Study|Adverse Event|16|||
23530525|NCT00782210|65676254|FG000|Overall Study|Lost to Follow-up|2|||
23530526|NCT00782210|65676255|FG001|Overall Study|Lost to Follow-up|1|||
23530527|NCT00782210|65676256|FG002|Overall Study|Lost to Follow-up|2|||
23530528|NCT00782210|65676254|FG000|Overall Study|Withdrawal by Subject|11|||
23612905|NCT01345253|65969743|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
23612906|NCT02164578|65969744|FG000|Treatment Period|Withdrawal by Subject|3|||
23612907|NCT02164578|65969745|FG001|Treatment Period|Withdrawal by Subject|3|||
23612908|NCT02164578|65969744|FG000|Treatment Period|Adverse Event|13|||
23612909|NCT02164578|65969745|FG001|Treatment Period|Adverse Event|6|||
23612910|NCT02164578|65969744|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
23419385|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
23530529|NCT00782210|65676255|FG001|Overall Study|Withdrawal by Subject|8|||
23530530|NCT00782210|65676256|FG002|Overall Study|Withdrawal by Subject|11|||
23530531|NCT00782210|65676254|FG000|Overall Study|Non compliance with protocol|0|||
23530532|NCT00782210|65676255|FG001|Overall Study|Non compliance with protocol|3|||
23530533|NCT00782210|65676256|FG002|Overall Study|Non compliance with protocol|2|||
23530534|NCT00782210|65676254|FG000|Overall Study|Lack of Efficacy|13|||
23530535|NCT00782210|65676255|FG001|Overall Study|Lack of Efficacy|4|||
23530536|NCT00782210|65676256|FG002|Overall Study|Lack of Efficacy|1|||
23530537|NCT00782210|65676254|FG000|Overall Study|Other reason not described above|3|||
23530538|NCT00782210|65676255|FG001|Overall Study|Other reason not described above|2|||
23530539|NCT00782210|65676256|FG002|Overall Study|Other reason not described above|3|||
23530540|NCT01109316|65676257|FG000|Study Period 1|Adverse Event|0|||
23530541|NCT01109316|65676258|FG001|Study Period 1|Adverse Event|0|||
23530542|NCT01109316|65676259|FG002|Study Period 1|Adverse Event|1|||
23530543|NCT01109316|65676260|FG003|Study Period 1|Adverse Event|0|||
23530544|NCT01109316|65676261|FG004|Study Period 1|Adverse Event|0|||
23530545|NCT01109316|65676262|FG005|Study Period 1|Adverse Event|0|||
23530546|NCT01109316|65676257|FG000|Study Period 1|Lost to Follow-up|0|||
23612911|NCT02164578|65969745|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
23530547|NCT01109316|65676258|FG001|Study Period 1|Lost to Follow-up|0|||
23530548|NCT01109316|65676259|FG002|Study Period 1|Lost to Follow-up|1|||
23530549|NCT01109316|65676260|FG003|Study Period 1|Lost to Follow-up|1|||
23530550|NCT01109316|65676261|FG004|Study Period 1|Lost to Follow-up|0|||
23612912|NCT02164578|65969744|FG000|Treatment Period|Protocol Violation|0|||
23530551|NCT01109316|65676262|FG005|Study Period 1|Lost to Follow-up|0|||
23612913|NCT02164578|65969745|FG001|Treatment Period|Protocol Violation|2|||
23612914|NCT02164578|65969744|FG000|Extension Period|Withdrawal by Subject|2|||
23530552|NCT01109316|65676257|FG000|Study Period 1|Withdrawal by Subject|0|||
23530553|NCT01109316|65676258|FG001|Study Period 1|Withdrawal by Subject|0|||
23530554|NCT01109316|65676259|FG002|Study Period 1|Withdrawal by Subject|1|||
23530555|NCT01109316|65676260|FG003|Study Period 1|Withdrawal by Subject|0|||
23530556|NCT01109316|65676261|FG004|Study Period 1|Withdrawal by Subject|2|||
23530557|NCT01109316|65676262|FG005|Study Period 1|Withdrawal by Subject|0|||
23530558|NCT01109316|65676257|FG000|Study Period 1|Sponsor Decision|0|||
23530559|NCT01109316|65676258|FG001|Study Period 1|Sponsor Decision|0|||
23530560|NCT01109316|65676259|FG002|Study Period 1|Sponsor Decision|0|||
23530561|NCT01109316|65676260|FG003|Study Period 1|Sponsor Decision|0|||
23530562|NCT01109316|65676261|FG004|Study Period 1|Sponsor Decision|0|||
23530563|NCT01109316|65676262|FG005|Study Period 1|Sponsor Decision|2|||
23530564|NCT01109316|65676257|FG000|Study Period 2|Entry Criteria Not Met|0|||
23530565|NCT01109316|65676258|FG001|Study Period 2|Entry Criteria Not Met|1|||
23530566|NCT01109316|65676259|FG002|Study Period 2|Entry Criteria Not Met|0|||
23530567|NCT01109316|65676260|FG003|Study Period 2|Entry Criteria Not Met|0|||
23530568|NCT01109316|65676261|FG004|Study Period 2|Entry Criteria Not Met|0|||
23530569|NCT01109316|65676262|FG005|Study Period 2|Entry Criteria Not Met|0|||
23530570|NCT01109316|65676257|FG000|Study Period 2|Physician Decision|0|||
23530571|NCT01109316|65676258|FG001|Study Period 2|Physician Decision|0|||
23530572|NCT01109316|65676259|FG002|Study Period 2|Physician Decision|0|||
23530573|NCT01109316|65676260|FG003|Study Period 2|Physician Decision|1|||
23530574|NCT01109316|65676261|FG004|Study Period 2|Physician Decision|0|||
23530575|NCT01109316|65676262|FG005|Study Period 2|Physician Decision|0|||
23530576|NCT01109316|65676257|FG000|Study Period 2|Protocol Violation|1|||
23530577|NCT01109316|65676258|FG001|Study Period 2|Protocol Violation|0|||
23530578|NCT01109316|65676259|FG002|Study Period 2|Protocol Violation|0|||
23530579|NCT01109316|65676260|FG003|Study Period 2|Protocol Violation|0|||
23530580|NCT01109316|65676261|FG004|Study Period 2|Protocol Violation|0|||
23530581|NCT01109316|65676262|FG005|Study Period 2|Protocol Violation|0|||
23530582|NCT01109316|65676257|FG000|Study Period 2|Withdrawal by Subject|0|||
23530583|NCT01109316|65676258|FG001|Study Period 2|Withdrawal by Subject|0|||
23530584|NCT01109316|65676259|FG002|Study Period 2|Withdrawal by Subject|1|||
23530585|NCT01109316|65676260|FG003|Study Period 2|Withdrawal by Subject|0|||
23530586|NCT01109316|65676261|FG004|Study Period 2|Withdrawal by Subject|0|||
23530587|NCT01109316|65676262|FG005|Study Period 2|Withdrawal by Subject|1|||
23530588|NCT01109316|65676257|FG000|Study Period 3|Lost to Follow-up|0|||
23530589|NCT01109316|65676258|FG001|Study Period 3|Lost to Follow-up|0|||
23530590|NCT01109316|65676259|FG002|Study Period 3|Lost to Follow-up|0|||
23530591|NCT01109316|65676260|FG003|Study Period 3|Lost to Follow-up|0|||
23530592|NCT01109316|65676261|FG004|Study Period 3|Lost to Follow-up|1|||
23530593|NCT01109316|65676262|FG005|Study Period 3|Lost to Follow-up|0|||
23530594|NCT01109316|65676257|FG000|Study Period 3|Withdrawal by Subject|1|||
23530595|NCT01109316|65676258|FG001|Study Period 3|Withdrawal by Subject|0|||
23530596|NCT01109316|65676259|FG002|Study Period 3|Withdrawal by Subject|0|||
23530597|NCT01109316|65676260|FG003|Study Period 3|Withdrawal by Subject|0|||
23530598|NCT01109316|65676261|FG004|Study Period 3|Withdrawal by Subject|1|||
23530599|NCT01109316|65676262|FG005|Study Period 3|Withdrawal by Subject|0|||
23530600|NCT01020019|65676266|FG000|Overall Study|Lost to Follow-up|21|||
23530601|NCT01020019|65676267|FG001|Overall Study|Lost to Follow-up|18|||
23530602|NCT01020019|65676266|FG000|Overall Study|Adverse Event|1|||
23530603|NCT01020019|65676267|FG001|Overall Study|Adverse Event|5|||
23530604|NCT01020019|65676266|FG000|Overall Study|not interested in treatment|4|||
23530605|NCT01020019|65676267|FG001|Overall Study|not interested in treatment|4|||
23530606|NCT01020019|65676266|FG000|Overall Study|moving|0|||
23530607|NCT01020019|65676267|FG001|Overall Study|moving|2|||
23530608|NCT01639040|65676271|FG000|Overall Study|Adverse Event|1|||
23530609|NCT01639040|65676272|FG001|Overall Study|Adverse Event|0|||
23530610|NCT03019627|65676273|FG000|Overall Study|Adverse Event|8|||
23530611|NCT03019627|65676274|FG001|Overall Study|Adverse Event|0|||
23530612|NCT03019627|65676273|FG000|Overall Study|Unrelated to adverse event|1|||
23530613|NCT03019627|65676274|FG001|Overall Study|Unrelated to adverse event|3|||
23530614|NCT03019627|65676273|FG000|Overall Study|Lost to Follow-up|2|||
23530615|NCT03019627|65676274|FG001|Overall Study|Lost to Follow-up|1|||
23530616|NCT03019627|65676273|FG000|Overall Study|not compliance|2|||
23530617|NCT03019627|65676274|FG001|Overall Study|not compliance|2|||
23530618|NCT03019627|65676273|FG000|Overall Study|Other|2|||
23530619|NCT03019627|65676274|FG001|Overall Study|Other|2|||
23530620|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
23530621|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
23530622|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
23530623|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
23530624|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
23530625|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
23530626|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
23530627|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
23530628|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
23530629|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
23530630|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
23530631|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
23530632|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
23530633|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
23530634|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
23530635|NCT00280566|65676277|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
23530636|NCT00280566|65676278|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
23530637|NCT00280566|65676279|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
23530638|NCT00280566|65676277|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
23530639|NCT00280566|65676278|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
23530640|NCT00280566|65676279|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
23530641|NCT00280566|65676277|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
23530642|NCT00280566|65676278|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
23530643|NCT00280566|65676279|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
23530644|NCT00280566|65676277|FG000|Period 2 Double Blind|Adverse Event|0|||
23530645|NCT00280566|65676278|FG001|Period 2 Double Blind|Adverse Event|11|||
23530646|NCT00280566|65676279|FG002|Period 2 Double Blind|Adverse Event|15|||
23530647|NCT00280566|65676277|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
23530648|NCT00280566|65676278|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
23530649|NCT00280566|65676279|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
23530650|NCT00280566|65676277|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
23530651|NCT00280566|65676278|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
23530652|NCT00280566|65676279|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
23530653|NCT00280566|65676277|FG000|Period 2 Double Blind|miscellaneous|0|||
23530654|NCT00280566|65676278|FG001|Period 2 Double Blind|miscellaneous|10|||
23530655|NCT00280566|65676279|FG002|Period 2 Double Blind|miscellaneous|5|||
23612915|NCT02164578|65969745|FG001|Extension Period|Withdrawal by Subject|0|||
23612916|NCT02164578|65969744|FG000|Extension Period|Adverse Event|4|||
23530656|NCT02940691|65676280|FG000|Overall Study|Lost to Follow-up|5|||
23530657|NCT02940691|65676280|FG000|Overall Study|Incarceration|1|||
23530658|NCT00622635|65676287|FG000|Treatment Period 1|Adverse Event|0|||
23530659|NCT00622635|65676288|FG001|Treatment Period 1|Adverse Event|0|||
23530660|NCT00622635|65676289|FG002|Treatment Period 1|Adverse Event|1|||
23530661|NCT00622635|65676290|FG003|Treatment Period 1|Adverse Event|0|||
23530662|NCT00622635|65676291|FG004|Treatment Period 1|Adverse Event|0|||
23530663|NCT00622635|65676292|FG005|Treatment Period 1|Adverse Event|0|||
23530664|NCT00622635|65676287|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23530665|NCT00622635|65676288|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23530666|NCT00622635|65676289|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23530667|NCT00622635|65676290|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23612917|NCT02164578|65969745|FG001|Extension Period|Adverse Event|0|||
23419386|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
23419387|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
23419388|NCT03352557|65277390|FG000|LTE Period: Week 80 to Week 173|Other|0|||
23419389|NCT03352557|65277391|FG001|LTE Period: Week 80 to Week 173|Other|0|||
23419390|NCT03352557|65277392|FG002|LTE Period: Week 80 to Week 173|Other|0|||
23419391|NCT03352557|65277393|FG003|LTE Period: Week 80 to Week 173|Other|0|||
23419392|NCT03352557|65277394|FG004|LTE Period: Week 80 to Week 173|Other|0|||
23419393|NCT03352557|65277395|FG005|LTE Period: Week 80 to Week 173|Other|0|||
23419394|NCT03352557|65277396|FG006|LTE Period: Week 80 to Week 173|Other|0|||
23419395|NCT03352557|65277397|FG007|LTE Period: Week 80 to Week 173|Other|1|||
23419396|NCT03352557|65277398|FG008|LTE Period: Week 80 to Week 173|Other|0|||
23419397|NCT03352557|65277399|FG009|LTE Period: Week 80 to Week 173|Other|0|||
23419398|NCT00503776|65277400|FG000|Overall Study|Withdrawal by Subject|1|||
23419399|NCT00503776|65277401|FG001|Overall Study|Withdrawal by Subject|0|||
23419400|NCT00503776|65277402|FG002|Overall Study|Withdrawal by Subject|1|||
23419401|NCT00503776|65277403|FG003|Overall Study|Withdrawal by Subject|1|||
23419402|NCT00503776|65277400|FG000|Overall Study|Physician Decision|0|||
23419403|NCT00503776|65277401|FG001|Overall Study|Physician Decision|0|||
23530668|NCT00622635|65676291|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23207062|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
23419404|NCT00503776|65277402|FG002|Overall Study|Physician Decision|1|||
23419405|NCT00503776|65277403|FG003|Overall Study|Physician Decision|1|||
23207063|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23419406|NCT01200407|65277414|FG000|Overall Study|Lost to Follow-up|56|||
23612918|NCT02164578|65969744|FG000|Extension Period|Expiry of study medication|1|||
23612919|NCT02164578|65969745|FG001|Extension Period|Expiry of study medication|0|||
23612920|NCT02164578|65969744|FG000|Extension Period|Protocol Violation|0|||
23612921|NCT02164578|65969745|FG001|Extension Period|Protocol Violation|1|||
23612922|NCT01018992|65969746|FG000|Overall Study|Adverse Event|8|||
23612923|NCT01018992|65969747|FG001|Overall Study|Adverse Event|3|||
23612924|NCT01018992|65969746|FG000|Overall Study|Withdrawal by Subject|3|||
23612925|NCT01018992|65969747|FG001|Overall Study|Withdrawal by Subject|8|||
23612926|NCT01018992|65969746|FG000|Overall Study|Protocol Violation|0|||
23530669|NCT00622635|65676292|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23530670|NCT00622635|65676287|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530671|NCT00622635|65676288|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530672|NCT00622635|65676289|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530673|NCT00622635|65676290|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530674|NCT00622635|65676291|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
23530675|NCT00622635|65676292|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
23530676|NCT00622635|65676287|FG000|Treatment Period 2|Adverse Event|1|||
23612927|NCT01018992|65969747|FG001|Overall Study|Protocol Violation|4|||
23612928|NCT01018992|65969746|FG000|Overall Study|Lost to Follow-up|5|||
23612929|NCT01018992|65969747|FG001|Overall Study|Lost to Follow-up|1|||
23530677|NCT00622635|65676288|FG001|Treatment Period 2|Adverse Event|0|||
23530678|NCT00622635|65676289|FG002|Treatment Period 2|Adverse Event|0|||
23530679|NCT00622635|65676290|FG003|Treatment Period 2|Adverse Event|0|||
23530680|NCT00622635|65676291|FG004|Treatment Period 2|Adverse Event|0|||
23530681|NCT00622635|65676292|FG005|Treatment Period 2|Adverse Event|0|||
23530682|NCT00622635|65676287|FG000|Treatment Period 3|Adverse Event|0|||
23530683|NCT00622635|65676288|FG001|Treatment Period 3|Adverse Event|0|||
23530684|NCT00622635|65676289|FG002|Treatment Period 3|Adverse Event|0|||
23530685|NCT00622635|65676290|FG003|Treatment Period 3|Adverse Event|2|||
23530686|NCT00622635|65676291|FG004|Treatment Period 3|Adverse Event|0|||
23530687|NCT00622635|65676292|FG005|Treatment Period 3|Adverse Event|0|||
23530688|NCT00622635|65676287|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23530689|NCT00622635|65676288|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23530690|NCT00622635|65676289|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23530691|NCT00622635|65676290|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23530692|NCT00622635|65676291|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23530693|NCT00622635|65676292|FG005|Treatment Period 3|Withdrawal by Subject|0|||
23530694|NCT01183975|65676293|FG000|Overall Study|Lost to Follow-up|73|||
23530695|NCT03149328|65676296|FG000|Overall Study|Withdrawal by Subject|30|||
23530696|NCT03149328|65676297|FG001|Overall Study|Withdrawal by Subject|26|||
23530697|NCT03149328|65676296|FG000|Overall Study|Changed Dialysis Modality|18|||
23530698|NCT03149328|65676297|FG001|Overall Study|Changed Dialysis Modality|1|||
23530699|NCT03149328|65676296|FG000|Overall Study|Transplant|9|||
23530700|NCT03149328|65676297|FG001|Overall Study|Transplant|1|||
23530701|NCT03149328|65676296|FG000|Overall Study|Lost to Follow-up|25|||
23530702|NCT03149328|65676297|FG001|Overall Study|Lost to Follow-up|16|||
23530703|NCT03149328|65676296|FG000|Overall Study|Left Study Site|1|||
23530704|NCT03149328|65676297|FG001|Overall Study|Left Study Site|2|||
23530705|NCT03149328|65676296|FG000|Overall Study|Language Barrier|1|||
23530706|NCT03149328|65676297|FG001|Overall Study|Language Barrier|0|||
23530707|NCT00437034|65676298|FG000|Overall Study|Adverse Event|1|||
23530708|NCT00437034|65676298|FG000|Overall Study|Disease progression during treatment|5|||
23530709|NCT03591575|65676299|FG000|Overall Study|Adverse Event|2|||
23530710|NCT03591575|65676300|FG001|Overall Study|Adverse Event|0|||
23530711|NCT03591575|65676299|FG000|Overall Study|Withdrawal by Subject|4|||
23530712|NCT03591575|65676300|FG001|Overall Study|Withdrawal by Subject|1|||
23309601|NCT00658021|64878012|FG000|28-Week Treatment Period|Other|2|||
23309602|NCT00658021|64878013|FG001|28-Week Treatment Period|Other|3|||
23419407|NCT01200407|65277414|FG000|Overall Study|Adverse Event|3|||
23530713|NCT01660711|65679904|FG000|Overall Study|Adverse Event|7|||
23530714|NCT01660711|65679904|FG000|Overall Study|Withdrawal by Subject|1|||
23530715|NCT01585766|65679905|FG000|Overall Study|Withdrawal by Subject|0|||
23530716|NCT01585766|65679906|FG001|Overall Study|Withdrawal by Subject|1|||
23530717|NCT01585766|65679907|FG002|Overall Study|Withdrawal by Subject|1|||
23530718|NCT01585766|65679908|FG003|Overall Study|Withdrawal by Subject|0|||
23530719|NCT01585766|65679909|FG004|Overall Study|Withdrawal by Subject|0|||
23530720|NCT01585766|65679910|FG005|Overall Study|Withdrawal by Subject|0|||
23612930|NCT02305797|65969748|FG000|Overall Study|Adverse Event|11|||
23309603|NCT00658021|64878014|FG002|28-Week Treatment Period|Other|1|||
23530721|NCT01585766|65679905|FG000|Overall Study|Death|0|||
23530722|NCT01585766|65679906|FG001|Overall Study|Death|1|||
23530723|NCT01585766|65679907|FG002|Overall Study|Death|0|||
23207064|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
23612931|NCT02305797|65969749|FG001|Overall Study|Adverse Event|2|||
23612932|NCT02305797|65969748|FG000|Overall Study|Withdrawal by Subject|9|||
23612933|NCT02305797|65969749|FG001|Overall Study|Withdrawal by Subject|10|||
23612934|NCT02305797|65969748|FG000|Overall Study|Lack of Efficacy|6|||
23207065|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
23530724|NCT01585766|65679908|FG003|Overall Study|Death|0|||
23530725|NCT01585766|65679909|FG004|Overall Study|Death|0|||
23530726|NCT01585766|65679910|FG005|Overall Study|Death|0|||
23530727|NCT01585766|65679905|FG000|Overall Study|Physician Decision|0|||
23530728|NCT01585766|65679906|FG001|Overall Study|Physician Decision|0|||
23530729|NCT01585766|65679907|FG002|Overall Study|Physician Decision|1|||
23530730|NCT01585766|65679908|FG003|Overall Study|Physician Decision|0|||
23530731|NCT01585766|65679909|FG004|Overall Study|Physician Decision|0|||
23530732|NCT01585766|65679910|FG005|Overall Study|Physician Decision|0|||
23530733|NCT00978731|65679911|FG000|Overall Study|Death|4|||
23530734|NCT00978731|65679912|FG001|Overall Study|Death|1|||
23530735|NCT00978731|65679913|FG002|Overall Study|Death|1|||
23530736|NCT00978731|65679914|FG003|Overall Study|Death|0|||
23530737|NCT00978731|65679911|FG000|Overall Study|Lost to Follow-up|0|||
23530738|NCT00978731|65679912|FG001|Overall Study|Lost to Follow-up|0|||
23530739|NCT00978731|65679913|FG002|Overall Study|Lost to Follow-up|0|||
23530740|NCT00978731|65679914|FG003|Overall Study|Lost to Follow-up|1|||
23612935|NCT02305797|65969749|FG001|Overall Study|Lack of Efficacy|0|||
23207066|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
23207067|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
23207068|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
23207069|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
23207070|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
23207071|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
23207072|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
23207073|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
23207074|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
23207075|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
23207076|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
23207077|NCT01714817|64498114|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
23207078|NCT01714817|64498115|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
23207079|NCT00960934|64498118|FG000|Overall Study|Adverse Event|2|||
23207080|NCT00960934|64498119|FG001|Overall Study|Adverse Event|3|||
23207081|NCT00960934|64498120|FG002|Overall Study|Adverse Event|3|||
23207082|NCT00960934|64498121|FG003|Overall Study|Adverse Event|2|||
23207083|NCT00960934|64498122|FG004|Overall Study|Adverse Event|4|||
23207084|NCT00960934|64498123|FG005|Overall Study|Adverse Event|3|||
23207085|NCT00960934|64498118|FG000|Overall Study|Lack of Efficacy|1|||
23207086|NCT00960934|64498119|FG001|Overall Study|Lack of Efficacy|0|||
23207087|NCT00960934|64498120|FG002|Overall Study|Lack of Efficacy|0|||
23207088|NCT00960934|64498121|FG003|Overall Study|Lack of Efficacy|0|||
23207089|NCT00960934|64498122|FG004|Overall Study|Lack of Efficacy|0|||
23207090|NCT00960934|64498123|FG005|Overall Study|Lack of Efficacy|0|||
23207091|NCT00960934|64498118|FG000|Overall Study|Lost to Follow-up|0|||
23207092|NCT00960934|64498119|FG001|Overall Study|Lost to Follow-up|1|||
23207093|NCT00960934|64498120|FG002|Overall Study|Lost to Follow-up|0|||
23207094|NCT00960934|64498121|FG003|Overall Study|Lost to Follow-up|0|||
23207095|NCT00960934|64498122|FG004|Overall Study|Lost to Follow-up|0|||
23530741|NCT00978731|65679911|FG000|Overall Study|Adverse Event|5|||
23530742|NCT00978731|65679912|FG001|Overall Study|Adverse Event|2|||
23612936|NCT02305797|65969748|FG000|Overall Study|Lost to Follow-up|5|||
23530743|NCT00978731|65679913|FG002|Overall Study|Adverse Event|0|||
23207096|NCT00960934|64498123|FG005|Overall Study|Lost to Follow-up|0|||
23530744|NCT00978731|65679914|FG003|Overall Study|Adverse Event|0|||
23530745|NCT00978731|65679911|FG000|Overall Study|Participant's request|1|||
23530746|NCT00978731|65679912|FG001|Overall Study|Participant's request|0|||
23530747|NCT00978731|65679913|FG002|Overall Study|Participant's request|0|||
23612937|NCT02305797|65969749|FG001|Overall Study|Lost to Follow-up|11|||
23207097|NCT00960934|64498118|FG000|Overall Study|Other|2|||
23207098|NCT00960934|64498119|FG001|Overall Study|Other|1|||
23207099|NCT00960934|64498120|FG002|Overall Study|Other|5|||
23207100|NCT00960934|64498121|FG003|Overall Study|Other|4|||
23207101|NCT00960934|64498122|FG004|Overall Study|Other|2|||
23207102|NCT00960934|64498123|FG005|Overall Study|Other|2|||
23207103|NCT00960934|64498118|FG000|Overall Study|Physician Decision|0|||
23207104|NCT00960934|64498119|FG001|Overall Study|Physician Decision|1|||
23612938|NCT02305797|65969748|FG000|Overall Study|Pregnancy|0|||
23612939|NCT02305797|65969749|FG001|Overall Study|Pregnancy|2|||
23612940|NCT02305797|65969748|FG000|Overall Study|Noncompliance|14|||
23612941|NCT02305797|65969749|FG001|Overall Study|Noncompliance|12|||
23612942|NCT02305797|65969748|FG000|Overall Study|Reason not collected|0|||
23612943|NCT02305797|65969749|FG001|Overall Study|Reason not collected|1|||
23612944|NCT00331799|65969750|FG000|Overall Study|Withdrawal by Subject|2|||
23612945|NCT00331799|65969750|FG000|Overall Study|Sedation|1|||
23612946|NCT00910871|65969751|FG000|Overall Study|Adverse Event|5|||
23612947|NCT00910871|65969751|FG000|Overall Study|Death|12|||
23612948|NCT00910871|65969751|FG000|Overall Study|Lost to Follow-up|8|||
23612949|NCT00910871|65969751|FG000|Overall Study|Protocol Violation|11|||
23612950|NCT00910871|65969751|FG000|Overall Study|Withdrawal by Subject|12|||
23612951|NCT00910871|65969751|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
23612952|NCT00910871|65969751|FG000|Overall Study|Undefined|1|||
23612953|NCT03651271|65969752|FG000|Overall Study|Death|4|||
23612954|NCT03651271|65969753|FG001|Overall Study|Death|37|||
23612955|NCT03651271|65969754|FG002|Overall Study|Death|0|||
23612956|NCT03651271|65969755|FG003|Overall Study|Death|2|||
23612957|NCT03651271|65969756|FG004|Overall Study|Death|6|||
23612958|NCT03651271|65969752|FG000|Overall Study|Lost to Follow-up|1|||
23612959|NCT03651271|65969753|FG001|Overall Study|Lost to Follow-up|5|||
23612960|NCT03651271|65969754|FG002|Overall Study|Lost to Follow-up|0|||
23612961|NCT03651271|65969755|FG003|Overall Study|Lost to Follow-up|1|||
23612962|NCT03651271|65969756|FG004|Overall Study|Lost to Follow-up|0|||
23612963|NCT03651271|65969752|FG000|Overall Study|Physician Decision|0|||
23612964|NCT03651271|65969753|FG001|Overall Study|Physician Decision|2|||
23612965|NCT03651271|65969754|FG002|Overall Study|Physician Decision|0|||
23612966|NCT03651271|65969755|FG003|Overall Study|Physician Decision|0|||
23207105|NCT00960934|64498120|FG002|Overall Study|Physician Decision|0|||
23207106|NCT00960934|64498121|FG003|Overall Study|Physician Decision|0|||
23207107|NCT00960934|64498122|FG004|Overall Study|Physician Decision|0|||
23207108|NCT00960934|64498123|FG005|Overall Study|Physician Decision|0|||
23207109|NCT00960934|64498118|FG000|Overall Study|Progressive Disease|1|||
23207110|NCT00960934|64498119|FG001|Overall Study|Progressive Disease|1|||
23207111|NCT00960934|64498120|FG002|Overall Study|Progressive Disease|0|||
23207112|NCT00960934|64498121|FG003|Overall Study|Progressive Disease|0|||
23207113|NCT00960934|64498122|FG004|Overall Study|Progressive Disease|1|||
23207114|NCT00960934|64498123|FG005|Overall Study|Progressive Disease|1|||
23207115|NCT00960934|64498118|FG000|Overall Study|Protocol Violation|3|||
23207116|NCT00960934|64498119|FG001|Overall Study|Protocol Violation|4|||
23207117|NCT00960934|64498120|FG002|Overall Study|Protocol Violation|0|||
23207118|NCT00960934|64498121|FG003|Overall Study|Protocol Violation|3|||
23207119|NCT00960934|64498122|FG004|Overall Study|Protocol Violation|3|||
23207120|NCT00960934|64498123|FG005|Overall Study|Protocol Violation|2|||
23207121|NCT00960934|64498118|FG000|Overall Study|Withdrawal by Subject|5|||
23207122|NCT00960934|64498119|FG001|Overall Study|Withdrawal by Subject|6|||
23207123|NCT00960934|64498120|FG002|Overall Study|Withdrawal by Subject|4|||
23207124|NCT00960934|64498121|FG003|Overall Study|Withdrawal by Subject|5|||
23207125|NCT00960934|64498122|FG004|Overall Study|Withdrawal by Subject|5|||
23207126|NCT00960934|64498123|FG005|Overall Study|Withdrawal by Subject|7|||
23207127|NCT00960934|64498118|FG000|Overall Study|Study Terminated by Sponsor|50|||
23207128|NCT00960934|64498119|FG001|Overall Study|Study Terminated by Sponsor|46|||
23207129|NCT00960934|64498120|FG002|Overall Study|Study Terminated by Sponsor|52|||
23612967|NCT03651271|65969756|FG004|Overall Study|Physician Decision|0|||
23207130|NCT00960934|64498121|FG003|Overall Study|Study Terminated by Sponsor|50|||
23207131|NCT00960934|64498122|FG004|Overall Study|Study Terminated by Sponsor|49|||
23207132|NCT00960934|64498123|FG005|Overall Study|Study Terminated by Sponsor|49|||
23207133|NCT01536119|64498125|FG000|Overall Study|Lost to Follow-up|17|||
23207134|NCT01536119|64498126|FG001|Overall Study|Lost to Follow-up|14|||
23207135|NCT01195363|64498129|FG000|Overall Study|Lost to Follow-up|7|||
23207136|NCT01195363|64498130|FG001|Overall Study|Lost to Follow-up|4|||
23207137|NCT01195363|64498129|FG000|Overall Study|Adverse Event|3|||
23612968|NCT03651271|65969752|FG000|Overall Study|Withdrawal by Subject|1|||
23612969|NCT03651271|65969753|FG001|Overall Study|Withdrawal by Subject|15|||
23207138|NCT01195363|64498130|FG001|Overall Study|Adverse Event|1|||
23207139|NCT01195363|64498129|FG000|Overall Study|Lack of Efficacy|0|||
23207140|NCT01195363|64498130|FG001|Overall Study|Lack of Efficacy|4|||
23207141|NCT01195363|64498129|FG000|Overall Study|incarceration|1|||
23207142|NCT01195363|64498130|FG001|Overall Study|incarceration|0|||
23612970|NCT03651271|65969754|FG002|Overall Study|Withdrawal by Subject|0|||
23612971|NCT03651271|65969755|FG003|Overall Study|Withdrawal by Subject|0|||
23612972|NCT03651271|65969756|FG004|Overall Study|Withdrawal by Subject|1|||
23207143|NCT01094730|64498134|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
23207144|NCT01094730|64498135|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
23207145|NCT01094730|64498134|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
23207146|NCT01094730|64498135|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
23207147|NCT01094730|64498134|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
23207148|NCT01094730|64498135|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
23207149|NCT01094730|64498134|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
23207150|NCT01094730|64498135|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
23207151|NCT01094730|64498134|FG000|Period 2 (14 Days)|Protocol Violation|2|||
23207152|NCT01094730|64498135|FG001|Period 2 (14 Days)|Protocol Violation|0|||
23207153|NCT01094730|64498134|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
23207154|NCT01094730|64498135|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
23207155|NCT01094730|64498134|FG000|Period 2 (14 Days)|Adverse Event|0|||
23207156|NCT01094730|64498135|FG001|Period 2 (14 Days)|Adverse Event|1|||
23207157|NCT01094730|64498134|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
23207158|NCT01094730|64498135|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
23207159|NCT01397448|64498136|FG000|Overall Study|Adverse Event|4|||
23207160|NCT01397448|64498137|FG001|Overall Study|Adverse Event|4|||
23207161|NCT01397448|64498138|FG002|Overall Study|Adverse Event|6|||
23207162|NCT01397448|64498136|FG000|Overall Study|Withdrawal by Subject|4|||
23207163|NCT01397448|64498137|FG001|Overall Study|Withdrawal by Subject|4|||
23207164|NCT01397448|64498138|FG002|Overall Study|Withdrawal by Subject|3|||
23207165|NCT01397448|64498136|FG000|Overall Study|Lack of Efficacy|2|||
23207166|NCT01397448|64498137|FG001|Overall Study|Lack of Efficacy|0|||
23207167|NCT01397448|64498138|FG002|Overall Study|Lack of Efficacy|5|||
23207168|NCT01397448|64498136|FG000|Overall Study|Other|8|||
23207169|NCT01397448|64498137|FG001|Overall Study|Other|7|||
23207170|NCT01397448|64498138|FG002|Overall Study|Other|4|||
23207171|NCT01188564|64498139|FG000|Double-blind Phase|randomized not treated|1|||
23612973|NCT03651271|65969752|FG000|Overall Study|Patient medically unable to continue|0|||
23612974|NCT03651271|65969753|FG001|Overall Study|Patient medically unable to continue|0|||
23612975|NCT03651271|65969754|FG002|Overall Study|Patient medically unable to continue|0|||
23612976|NCT03651271|65969755|FG003|Overall Study|Patient medically unable to continue|1|||
23612977|NCT03651271|65969756|FG004|Overall Study|Patient medically unable to continue|0|||
23612978|NCT00841321|65969758|FG000|Overall Study|Lost to Follow-up|1|||
23612979|NCT00841321|65969759|FG001|Overall Study|Lost to Follow-up|1|||
23612980|NCT00841321|65969758|FG000|Overall Study|Adverse Event|0|||
23612981|NCT00841321|65969759|FG001|Overall Study|Adverse Event|2|||
23612982|NCT01799993|65969760|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
23612983|NCT01799993|65969761|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
23612984|NCT01799993|65969760|FG000|Overall Study|Death|61|||
23612985|NCT01799993|65969761|FG001|Overall Study|Death|45|||
23612986|NCT01799993|65969760|FG000|Overall Study|Withdrawal by Subject|23|||
23612987|NCT01799993|65969761|FG001|Overall Study|Withdrawal by Subject|24|||
23207172|NCT01188564|64498140|FG001|Double-blind Phase|randomized not treated|0|||
23207173|NCT01608724|64498141|FG000|Overall Study|Withdrawal by Subject|131|||
23207174|NCT01608724|64498141|FG000|Overall Study|Lost to Follow-up|41|||
23207175|NCT01608724|64498141|FG000|Overall Study|Study-specific discontinuation criteria|32|||
23207176|NCT01608724|64498141|FG000|Overall Study|Adverse Event|29|||
23207177|NCT01608724|64498141|FG000|Overall Study|Protocol Violation|6|||
23612988|NCT01799993|65969760|FG000|Overall Study|Lost to Follow-up|5|||
23612989|NCT01799993|65969761|FG001|Overall Study|Lost to Follow-up|8|||
23207178|NCT01608724|64498141|FG000|Overall Study|bood sugar too high, etc.|3|||
23207179|NCT01608724|64498141|FG000|Overall Study|Safety reasons|1|||
23207180|NCT00764478|64498145|FG000|Overall Study|Adverse Event|1|||
23207181|NCT00764478|64498146|FG001|Overall Study|Adverse Event|1|||
23207182|NCT00764478|64498147|FG002|Overall Study|Adverse Event|1|||
23612990|NCT01799993|65969760|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
23612991|NCT01799993|65969761|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
23612992|NCT01799993|65969760|FG000|Overall Study|Protocol driven decision point|0|||
23612993|NCT01799993|65969761|FG001|Overall Study|Protocol driven decision point|3|||
23612994|NCT01799993|65969760|FG000|Overall Study|Protocol Violation|1|||
23612995|NCT01799993|65969761|FG001|Overall Study|Protocol Violation|1|||
23612996|NCT01799993|65969760|FG000|Overall Study|Deterioration of general conditions|2|||
23612997|NCT01799993|65969761|FG001|Overall Study|Deterioration of general conditions|0|||
23612998|NCT01799993|65969760|FG000|Overall Study|Screen failure|0|||
23612999|NCT01799993|65969761|FG001|Overall Study|Screen failure|1|||
23613000|NCT01799993|65969760|FG000|Overall Study|Adverse Event|1|||
23613001|NCT01799993|65969761|FG001|Overall Study|Adverse Event|0|||
23613002|NCT01799993|65969760|FG000|Overall Study|Lack of Efficacy|1|||
23613003|NCT01799993|65969761|FG001|Overall Study|Lack of Efficacy|0|||
23613004|NCT01799993|65969760|FG000|Overall Study|Recovery|0|||
23613005|NCT01799993|65969761|FG001|Overall Study|Recovery|1|||
23613006|NCT01799993|65969760|FG000|Overall Study|Logistical difficulties|1|||
23613007|NCT01799993|65969761|FG001|Overall Study|Logistical difficulties|0|||
23613008|NCT01799993|65969760|FG000|Overall Study|Protocol deviation|1|||
23613009|NCT01799993|65969761|FG001|Overall Study|Protocol deviation|0|||
23613010|NCT01799993|65969760|FG000|Overall Study|Non-compliance with medical device|1|||
23613011|NCT01799993|65969761|FG001|Overall Study|Non-compliance with medical device|0|||
23613012|NCT01799993|65969760|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23613013|NCT01799993|65969761|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23613014|NCT01799993|65969760|FG000|Overall Study|Other|1|||
23613015|NCT01799993|65969761|FG001|Overall Study|Other|0|||
23207183|NCT00764478|64498145|FG000|Overall Study|Withdrawal by Subject|7|||
23207184|NCT00764478|64498146|FG001|Overall Study|Withdrawal by Subject|12|||
23207185|NCT00764478|64498147|FG002|Overall Study|Withdrawal by Subject|1|||
23207186|NCT00764478|64498145|FG000|Overall Study|Lost to Follow-up|7|||
23207187|NCT00764478|64498146|FG001|Overall Study|Lost to Follow-up|8|||
23207188|NCT00764478|64498147|FG002|Overall Study|Lost to Follow-up|5|||
23530748|NCT00978731|65679914|FG003|Overall Study|Participant's request|0|||
23530749|NCT00978731|65679911|FG000|Overall Study|Administrative reason|3|||
23530750|NCT00978731|65679912|FG001|Overall Study|Administrative reason|3|||
23530751|NCT00978731|65679913|FG002|Overall Study|Administrative reason|1|||
23530752|NCT00978731|65679914|FG003|Overall Study|Administrative reason|0|||
23530753|NCT00978731|65679911|FG000|Overall Study|Deterioration without progression|0|||
23530754|NCT00978731|65679912|FG001|Overall Study|Deterioration without progression|1|||
23530755|NCT00978731|65679913|FG002|Overall Study|Deterioration without progression|0|||
23613016|NCT01799993|65969760|FG000|Overall Study|Subject didn't return for follow-up|0|||
23613017|NCT01799993|65969761|FG001|Overall Study|Subject didn't return for follow-up|1|||
23207189|NCT00764478|64498145|FG000|Overall Study|Protocol Violation|0|||
23207190|NCT00764478|64498146|FG001|Overall Study|Protocol Violation|1|||
23613018|NCT01074229|65969762|FG000|Overall Study|Lost to Follow-up|1|||
23207191|NCT00764478|64498147|FG002|Overall Study|Protocol Violation|1|||
23207192|NCT00238303|64498152|FG000|Overall Study|Withdrawal by Subject|11|||
23613019|NCT01074229|65969763|FG001|Overall Study|Lost to Follow-up|0|||
23613020|NCT01074229|65969764|FG002|Overall Study|Lost to Follow-up|0|||
23613021|NCT01074229|65969762|FG000|Overall Study|Change to open surgical procedure|1|||
23613022|NCT01074229|65969763|FG001|Overall Study|Change to open surgical procedure|3|||
23530756|NCT00978731|65679914|FG003|Overall Study|Deterioration without progression|0|||
23530757|NCT00978731|65679911|FG000|Overall Study|Disease progression/relapse|5|||
23530758|NCT00978731|65679912|FG001|Overall Study|Disease progression/relapse|4|||
23530759|NCT00978731|65679913|FG002|Overall Study|Disease progression/relapse|2|||
23530760|NCT00978731|65679914|FG003|Overall Study|Disease progression/relapse|2|||
23530761|NCT00978731|65679911|FG000|Overall Study|Study closure|3|||
23530762|NCT00978731|65679912|FG001|Overall Study|Study closure|4|||
23530763|NCT00978731|65679913|FG002|Overall Study|Study closure|1|||
23530764|NCT00978731|65679914|FG003|Overall Study|Study closure|1|||
23530765|NCT00978731|65679911|FG000|Overall Study|No response|1|||
23530766|NCT00978731|65679912|FG001|Overall Study|No response|0|||
23530767|NCT00978731|65679913|FG002|Overall Study|No response|0|||
23530768|NCT00978731|65679914|FG003|Overall Study|No response|0|||
23530769|NCT02759120|65679915|FG000|Overall Study|Death|34|||
23530770|NCT02759120|65679916|FG001|Overall Study|Death|36|||
23530771|NCT02759120|65679915|FG000|Overall Study|Lost to Follow-up|4|||
23530772|NCT02759120|65679916|FG001|Overall Study|Lost to Follow-up|7|||
23530773|NCT02759120|65679915|FG000|Overall Study|Physician Decision|3|||
23530774|NCT02759120|65679916|FG001|Overall Study|Physician Decision|0|||
23530775|NCT02759120|65679915|FG000|Overall Study|Withdrawal by Subject|28|||
23530776|NCT02759120|65679916|FG001|Overall Study|Withdrawal by Subject|15|||
23530777|NCT02759120|65679915|FG000|Overall Study|Moved out of area|3|||
23530778|NCT02759120|65679916|FG001|Overall Study|Moved out of area|4|||
23530779|NCT02759120|65679915|FG000|Overall Study|Lung transplant|3|||
23530780|NCT02759120|65679916|FG001|Overall Study|Lung transplant|5|||
23530781|NCT02759120|65679915|FG000|Overall Study|Other reason not completed|10|||
23530782|NCT02759120|65679916|FG001|Overall Study|Other reason not completed|12|||
23530783|NCT00578565|65679917|FG000|Overall Study|Adverse Event|3|||
23530784|NCT01610791|65679918|FG000|Overall Study|Lost to Follow-up|7|||
23530785|NCT01610791|65679918|FG000|Overall Study|Adverse Event|6|||
23530786|NCT01610791|65679918|FG000|Overall Study|Physician Decision|1|||
23530787|NCT01610791|65679918|FG000|Overall Study|Adverse event and Investigator decision|1|||
23530788|NCT01610791|65679918|FG000|Overall Study|Death|1|||
23530789|NCT01610791|65679918|FG000|Overall Study|Not determined|5|||
23530790|NCT01987427|65679919|FG000|Overall Study|Adverse Event|4|||
23530791|NCT01987427|65679920|FG001|Overall Study|Adverse Event|2|||
23530792|NCT01987427|65679921|FG002|Overall Study|Adverse Event|8|||
23530793|NCT01987427|65679919|FG000|Overall Study|Lost to Follow-up|6|||
23530794|NCT01987427|65679920|FG001|Overall Study|Lost to Follow-up|6|||
23530795|NCT01987427|65679921|FG002|Overall Study|Lost to Follow-up|9|||
23530796|NCT01987427|65679919|FG000|Overall Study|Withdrawal by Subject|2|||
23207193|NCT00238303|64498153|FG001|Overall Study|Withdrawal by Subject|1|||
23207194|NCT00238303|64498154|FG002|Overall Study|Withdrawal by Subject|2|||
23207195|NCT00238303|64498152|FG000|Overall Study|Death|1|||
23207196|NCT00238303|64498153|FG001|Overall Study|Death|0|||
23207197|NCT00238303|64498154|FG002|Overall Study|Death|1|||
23207198|NCT00238303|64498152|FG000|Overall Study|Other Medical Problems|2|||
23207199|NCT00238303|64498153|FG001|Overall Study|Other Medical Problems|0|||
23207200|NCT00238303|64498154|FG002|Overall Study|Other Medical Problems|2|||
23207201|NCT00238303|64498152|FG000|Overall Study|Poor tolerance of study treatment|1|||
23207202|NCT00238303|64498153|FG001|Overall Study|Poor tolerance of study treatment|0|||
23207203|NCT00238303|64498154|FG002|Overall Study|Poor tolerance of study treatment|1|||
23207204|NCT00238303|64498152|FG000|Overall Study|Adverse Event|0|||
23207205|NCT00238303|64498153|FG001|Overall Study|Adverse Event|1|||
23309604|NCT00658021|64878012|FG000|28-Week Treatment Period|Did not receive treatment|2|||
23309605|NCT00658021|64878013|FG001|28-Week Treatment Period|Did not receive treatment|0|||
23309606|NCT00658021|64878014|FG002|28-Week Treatment Period|Did not receive treatment|0|||
23309607|NCT00658021|64878012|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
23309608|NCT00658021|64878013|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
23309609|NCT00658021|64878014|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
23530797|NCT01987427|65679920|FG001|Overall Study|Withdrawal by Subject|1|||
23613023|NCT01074229|65969764|FG002|Overall Study|Change to open surgical procedure|4|||
23613024|NCT01358175|65969765|FG000|Overall Study|Death|1|||
23530798|NCT01987427|65679921|FG002|Overall Study|Withdrawal by Subject|3|||
23530799|NCT01987427|65679919|FG000|Overall Study|Lack of Efficacy|1|||
23530800|NCT01987427|65679920|FG001|Overall Study|Lack of Efficacy|0|||
23530801|NCT01987427|65679921|FG002|Overall Study|Lack of Efficacy|0|||
23530802|NCT01987427|65679919|FG000|Overall Study|Other|1|||
23530803|NCT01987427|65679920|FG001|Overall Study|Other|1|||
23530804|NCT01987427|65679921|FG002|Overall Study|Other|0|||
23530805|NCT04251533|65679924|FG000|Overall Study|Progressive disease|33|||
23530806|NCT04251533|65679925|FG001|Overall Study|Progressive disease|29|||
23530807|NCT04251533|65679926|FG002|Overall Study|Progressive disease|22|||
23530808|NCT04251533|65679924|FG000|Overall Study|Death|5|||
23530809|NCT04251533|65679925|FG001|Overall Study|Death|1|||
23530810|NCT04251533|65679926|FG002|Overall Study|Death|3|||
23530811|NCT04251533|65679924|FG000|Overall Study|Physician Decision|3|||
23530812|NCT04251533|65679925|FG001|Overall Study|Physician Decision|2|||
23530813|NCT04251533|65679926|FG002|Overall Study|Physician Decision|4|||
23530814|NCT04251533|65679924|FG000|Overall Study|Participant decision|1|||
23530815|NCT04251533|65679925|FG001|Overall Study|Participant decision|3|||
23530816|NCT04251533|65679926|FG002|Overall Study|Participant decision|1|||
23530817|NCT04251533|65679924|FG000|Overall Study|Adverse Event|2|||
23530818|NCT04251533|65679925|FG001|Overall Study|Adverse Event|1|||
23530819|NCT04251533|65679926|FG002|Overall Study|Adverse Event|1|||
23530820|NCT00333229|65679931|FG000|Overall Study|Lack of Efficacy|0|||
23530821|NCT00333229|65679932|FG001|Overall Study|Lack of Efficacy|1|||
23530822|NCT01701258|65679935|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
23530823|NCT01701258|65679936|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
23530824|NCT01701258|65679937|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
23530825|NCT01701258|65679938|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
23530826|NCT01701258|65679939|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
23530827|NCT01701258|65679940|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
23207206|NCT00238303|64498154|FG002|Overall Study|Adverse Event|3|||
23613025|NCT01358175|65969766|FG001|Overall Study|Death|0|||
23419408|NCT01200407|65277414|FG000|Overall Study|Withdrawal by Subject|4|||
23530828|NCT01701258|65679941|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
23530829|NCT01701258|65679942|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
23530830|NCT01701258|65679943|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
23530831|NCT01701258|65679944|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
23530832|NCT01701258|65679945|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
23530833|NCT01701258|65679946|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
23530834|NCT01701258|65679947|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
23530835|NCT01701258|65679935|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
23309610|NCT00658021|64878012|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
23419409|NCT01200407|65277414|FG000|Overall Study|Other|19|||
23419410|NCT01239381|65277415|FG000|Overall Study|Protocol Violation|1|||
23419411|NCT01239381|65277415|FG000|Overall Study|Withdrawal by Subject|1|||
23419412|NCT01340625|65277416|FG000|First Intervention|Adverse Event|1|||
23419413|NCT01340625|65277417|FG001|First Intervention|Adverse Event|0|||
23419414|NCT01340625|65277416|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
23613026|NCT01358175|65969767|FG002|Overall Study|Death|1|||
23613027|NCT01358175|65969765|FG000|Overall Study|Withdrawal by Subject|9|||
23419415|NCT01340625|65277417|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
23419416|NCT02080481|65277418|FG000|Overall Study|Never received a block.|1|||
23207207|NCT01797965|64498155|FG000|Overall Study|Adverse Event|104|||
23207208|NCT01797965|64498156|FG001|Overall Study|Adverse Event|129|||
23207209|NCT01797965|64498157|FG002|Overall Study|Adverse Event|4|||
23207210|NCT01797965|64498158|FG003|Overall Study|Adverse Event|21|||
23207211|NCT01797965|64498155|FG000|Overall Study|Lost to Follow-up|9|||
23207212|NCT01797965|64498156|FG001|Overall Study|Lost to Follow-up|8|||
23207213|NCT01797965|64498157|FG002|Overall Study|Lost to Follow-up|1|||
23207214|NCT01797965|64498158|FG003|Overall Study|Lost to Follow-up|2|||
23207215|NCT01797965|64498155|FG000|Overall Study|Consent withdrawn|130|||
23207216|NCT01797965|64498156|FG001|Overall Study|Consent withdrawn|117|||
23207217|NCT01797965|64498157|FG002|Overall Study|Consent withdrawn|3|||
23207218|NCT01797965|64498158|FG003|Overall Study|Consent withdrawn|35|||
23207219|NCT01797965|64498155|FG000|Overall Study|Investigator decision|21|||
23207220|NCT01797965|64498156|FG001|Overall Study|Investigator decision|15|||
23207221|NCT01797965|64498157|FG002|Overall Study|Investigator decision|0|||
23207222|NCT01797965|64498158|FG003|Overall Study|Investigator decision|0|||
23207223|NCT01797965|64498155|FG000|Overall Study|Death|2|||
23207224|NCT01797965|64498156|FG001|Overall Study|Death|4|||
23207225|NCT01797965|64498157|FG002|Overall Study|Death|0|||
23207226|NCT01797965|64498158|FG003|Overall Study|Death|0|||
23207227|NCT01797965|64498155|FG000|Overall Study|Disease progression, defined by protocol|3|||
23207228|NCT01797965|64498156|FG001|Overall Study|Disease progression, defined by protocol|1|||
23207229|NCT01797965|64498157|FG002|Overall Study|Disease progression, defined by protocol|0|||
23207230|NCT01797965|64498158|FG003|Overall Study|Disease progression, defined by protocol|0|||
23309611|NCT00658021|64878013|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
23309612|NCT00658021|64878014|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
23309613|NCT01119508|64878015|FG000|Overall Study|Adverse Event|56|||
23309614|NCT01119508|64878015|FG000|Overall Study|Withdrawal by Subject|2|||
23309615|NCT01119508|64878015|FG000|Overall Study|Died before tumor response evaluation|1|||
23309616|NCT01524679|64878016|FG000|Overall Study|Lost to Follow-up|1|||
23309617|NCT01524679|64878017|FG001|Overall Study|Lost to Follow-up|4|||
23207231|NCT01797965|64498155|FG000|Overall Study|Reason Not Specified|280|||
23207232|NCT01797965|64498156|FG001|Overall Study|Reason Not Specified|295|||
23207233|NCT01797965|64498157|FG002|Overall Study|Reason Not Specified|0|||
23309618|NCT01524679|64878016|FG000|Overall Study|Withdrawal by Subject|4|||
23309619|NCT01524679|64878017|FG001|Overall Study|Withdrawal by Subject|4|||
23309620|NCT01524679|64878016|FG000|Overall Study|Adverse Event|9|||
23309621|NCT01524679|64878017|FG001|Overall Study|Adverse Event|0|||
23309622|NCT01524679|64878016|FG000|Overall Study|Protocol Violation|1|||
23309623|NCT01524679|64878017|FG001|Overall Study|Protocol Violation|0|||
23309624|NCT01524679|64878016|FG000|Overall Study|Lack of Efficacy|2|||
23309625|NCT01524679|64878017|FG001|Overall Study|Lack of Efficacy|0|||
23309626|NCT01524679|64878016|FG000|Overall Study|e.g.wish for children, relocation|6|||
23309627|NCT01524679|64878017|FG001|Overall Study|e.g.wish for children, relocation|1|||
23309628|NCT03052127|64878018|FG000|Overall Study|Withdrawal by Subject|0|||
23309629|NCT03052127|64878019|FG001|Overall Study|Withdrawal by Subject|0|||
23309630|NCT03052127|64878020|FG002|Overall Study|Withdrawal by Subject|0|||
23309631|NCT03052127|64878021|FG003|Overall Study|Withdrawal by Subject|0|||
23309632|NCT03052127|64878022|FG004|Overall Study|Withdrawal by Subject|0|||
23309633|NCT03052127|64878023|FG005|Overall Study|Withdrawal by Subject|0|||
23419417|NCT02080481|65277419|FG001|Overall Study|Never received a block.|0|||
23207234|NCT01797965|64498158|FG003|Overall Study|Reason Not Specified|15|||
23207235|NCT02397694|64498159|FG000|Double-Blinded Phase|Adverse Event|1|||
23207236|NCT02397694|64498160|FG001|Double-Blinded Phase|Adverse Event|0|||
23207237|NCT02397694|64498159|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
23207238|NCT02397694|64498160|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
23207239|NCT02397694|64498159|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
23309634|NCT03052127|64878024|FG006|Overall Study|Withdrawal by Subject|0|||
23309635|NCT03052127|64878025|FG007|Overall Study|Withdrawal by Subject|1|||
23309636|NCT03052127|64878026|FG008|Overall Study|Withdrawal by Subject|1|||
23530836|NCT01701258|65679936|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
23207240|NCT02397694|64498160|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
23207241|NCT02397694|64498159|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
23207242|NCT02397694|64498160|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
23207243|NCT02397694|64498159|FG000|Open Label Extension Phase|Protocol Violation|1|||
23207244|NCT02397694|64498160|FG001|Open Label Extension Phase|Protocol Violation|0|||
23207245|NCT02397694|64498159|FG000|Open Label Extension Phase|Withdrew Consent|3|||
23207246|NCT02397694|64498160|FG001|Open Label Extension Phase|Withdrew Consent|1|||
23207247|NCT02397694|64498159|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
23207248|NCT02397694|64498160|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
23207249|NCT02349789|64498161|FG000|Overall Study|Withdrawal by Subject|2|||
23207250|NCT00082758|64498162|FG000|Overall Study|Adverse Event|0|||
23207251|NCT00082758|64498163|FG001|Overall Study|Adverse Event|2|||
23207252|NCT00082758|64498164|FG002|Overall Study|Adverse Event|0|||
23207253|NCT00082758|64498162|FG000|Overall Study|Lack of Efficacy|12|||
23207254|NCT00082758|64498163|FG001|Overall Study|Lack of Efficacy|13|||
23207255|NCT00082758|64498164|FG002|Overall Study|Lack of Efficacy|0|||
23207256|NCT00082758|64498162|FG000|Overall Study|Physician Decision|0|||
23207257|NCT00082758|64498163|FG001|Overall Study|Physician Decision|1|||
23207258|NCT00082758|64498164|FG002|Overall Study|Physician Decision|0|||
23207259|NCT00082758|64498162|FG000|Overall Study|Withdrawal by Subject|3|||
23207260|NCT00082758|64498163|FG001|Overall Study|Withdrawal by Subject|0|||
23207261|NCT00082758|64498164|FG002|Overall Study|Withdrawal by Subject|0|||
23207262|NCT00082758|64498162|FG000|Overall Study|Protocol Violation|0|||
23207263|NCT00082758|64498163|FG001|Overall Study|Protocol Violation|1|||
23207264|NCT00082758|64498164|FG002|Overall Study|Protocol Violation|0|||
23207265|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
23207266|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
23207267|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
23207268|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
23207269|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Death|8|||
23207270|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Death|3|||
23207271|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
23207272|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
23207273|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
23207274|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
23207275|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
23207276|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
23207277|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
23207278|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
23207279|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
23207280|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
23207281|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
23207282|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
23207283|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
23207284|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
23207285|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
23207286|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
23207287|NCT00494871|64498165|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
23207288|NCT00494871|64498166|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
23207289|NCT00494871|64498165|FG000|Follow-up (FU) Period|Adverse Event|1|||
23207290|NCT00494871|64498166|FG001|Follow-up (FU) Period|Adverse Event|1|||
23207291|NCT00494871|64498165|FG000|Follow-up (FU) Period|Death|13|||
23207292|NCT00494871|64498166|FG001|Follow-up (FU) Period|Death|12|||
23207293|NCT00494871|64498165|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
23207294|NCT00494871|64498166|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
23207295|NCT00494871|64498165|FG000|Follow-up (FU) Period|Physician Decision|0|||
23207296|NCT00494871|64498166|FG001|Follow-up (FU) Period|Physician Decision|1|||
23207297|NCT00494871|64498165|FG000|Follow-up (FU) Period|Protocol Violation|1|||
23207298|NCT00494871|64498166|FG001|Follow-up (FU) Period|Protocol Violation|0|||
23530837|NCT01701258|65679937|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
23309637|NCT03052127|64878027|FG009|Overall Study|Withdrawal by Subject|1|||
23309638|NCT03052127|64878028|FG010|Overall Study|Withdrawal by Subject|0|||
23309639|NCT03052127|64878029|FG011|Overall Study|Withdrawal by Subject|0|||
23309640|NCT03052127|64878018|FG000|Overall Study|Discontinuation by Sponsor|0|||
23309641|NCT03052127|64878019|FG001|Overall Study|Discontinuation by Sponsor|0|||
23309642|NCT03052127|64878020|FG002|Overall Study|Discontinuation by Sponsor|0|||
23309643|NCT03052127|64878021|FG003|Overall Study|Discontinuation by Sponsor|0|||
23309644|NCT03052127|64878022|FG004|Overall Study|Discontinuation by Sponsor|0|||
23309645|NCT03052127|64878023|FG005|Overall Study|Discontinuation by Sponsor|0|||
23309646|NCT03052127|64878024|FG006|Overall Study|Discontinuation by Sponsor|0|||
23309647|NCT03052127|64878025|FG007|Overall Study|Discontinuation by Sponsor|0|||
23309648|NCT03052127|64878026|FG008|Overall Study|Discontinuation by Sponsor|4|||
23309649|NCT03052127|64878027|FG009|Overall Study|Discontinuation by Sponsor|2|||
23309650|NCT03052127|64878028|FG010|Overall Study|Discontinuation by Sponsor|5|||
23309651|NCT03052127|64878029|FG011|Overall Study|Discontinuation by Sponsor|13|||
23309652|NCT03052127|64878018|FG000|Overall Study|Inability to comply with trial requirements|0|||
23309653|NCT03052127|64878019|FG001|Overall Study|Inability to comply with trial requirements|0|||
23309654|NCT03052127|64878020|FG002|Overall Study|Inability to comply with trial requirements|1|||
23309655|NCT03052127|64878021|FG003|Overall Study|Inability to comply with trial requirements|0|||
23309656|NCT03052127|64878022|FG004|Overall Study|Inability to comply with trial requirements|0|||
23309657|NCT03052127|64878023|FG005|Overall Study|Inability to comply with trial requirements|0|||
23309658|NCT03052127|64878024|FG006|Overall Study|Inability to comply with trial requirements|0|||
23309659|NCT03052127|64878025|FG007|Overall Study|Inability to comply with trial requirements|0|||
23309660|NCT03052127|64878026|FG008|Overall Study|Inability to comply with trial requirements|0|||
23309661|NCT03052127|64878027|FG009|Overall Study|Inability to comply with trial requirements|0|||
23309662|NCT03052127|64878028|FG010|Overall Study|Inability to comply with trial requirements|0|||
23309663|NCT03052127|64878029|FG011|Overall Study|Inability to comply with trial requirements|0|||
23309664|NCT03052127|64878018|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
23309665|NCT03052127|64878019|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23309666|NCT03052127|64878020|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23309667|NCT03052127|64878021|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23309668|NCT03052127|64878022|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
23309669|NCT03052127|64878023|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
23309670|NCT03052127|64878024|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
23613028|NCT01358175|65969766|FG001|Overall Study|Withdrawal by Subject|5|||
23309671|NCT03052127|64878025|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23309672|NCT03052127|64878026|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23309673|NCT03052127|64878027|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23613029|NCT01358175|65969767|FG002|Overall Study|Withdrawal by Subject|10|||
23613030|NCT01358175|65969765|FG000|Overall Study|Technical issues|0|||
23613031|NCT01358175|65969766|FG001|Overall Study|Technical issues|1|||
23207299|NCT00494871|64498165|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
23207300|NCT00494871|64498166|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
23207301|NCT00494871|64498165|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
23207302|NCT00494871|64498166|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
23207303|NCT02358369|64498167|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
23207304|NCT02358369|64498168|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
23207305|NCT02358369|64498169|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
23207306|NCT02358369|64498170|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
23207307|NCT02358369|64498171|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
23207308|NCT02358369|64498167|FG000|Treatment Period A/B|Adverse Event|0|||
23207309|NCT02358369|64498168|FG001|Treatment Period A/B|Adverse Event|0|||
23207310|NCT02358369|64498169|FG002|Treatment Period A/B|Adverse Event|1|||
23207311|NCT02358369|64498170|FG003|Treatment Period A/B|Adverse Event|2|||
23207312|NCT02358369|64498171|FG004|Treatment Period A/B|Adverse Event|0|||
23207313|NCT02358369|64498167|FG000|Treatment Period A/B|Death|0|||
23207314|NCT02358369|64498168|FG001|Treatment Period A/B|Death|0|||
23207315|NCT02358369|64498169|FG002|Treatment Period A/B|Death|1|||
23207316|NCT02358369|64498170|FG003|Treatment Period A/B|Death|0|||
23207317|NCT02358369|64498171|FG004|Treatment Period A/B|Death|0|||
23207318|NCT02358369|64498167|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
23207319|NCT02358369|64498168|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
23207320|NCT02358369|64498169|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
23207321|NCT02358369|64498170|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
23207322|NCT02358369|64498171|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
23207323|NCT02358369|64498167|FG000|Treatment Period C|Adverse Event|0|||
23207324|NCT02358369|64498168|FG001|Treatment Period C|Adverse Event|0|||
23207325|NCT02358369|64498169|FG002|Treatment Period C|Adverse Event|0|||
23207326|NCT02358369|64498170|FG003|Treatment Period C|Adverse Event|0|||
23207327|NCT02358369|64498171|FG004|Treatment Period C|Adverse Event|7|||
23207328|NCT02723591|64498172|FG000|Overall Study|Adverse Event|48|||
23207329|NCT02723591|64498173|FG001|Overall Study|Adverse Event|40|||
23207330|NCT02723591|64498172|FG000|Overall Study|Death|2|||
23207331|NCT02723591|64498173|FG001|Overall Study|Death|2|||
23207332|NCT02723591|64498172|FG000|Overall Study|Lack of Efficacy|4|||
23207333|NCT02723591|64498173|FG001|Overall Study|Lack of Efficacy|3|||
23207334|NCT02723591|64498172|FG000|Overall Study|Lost to Follow-up|1|||
23207335|NCT02723591|64498173|FG001|Overall Study|Lost to Follow-up|7|||
23207336|NCT02723591|64498172|FG000|Overall Study|Protocol Violation|20|||
23207337|NCT02723591|64498173|FG001|Overall Study|Protocol Violation|23|||
23207338|NCT02723591|64498172|FG000|Overall Study|Withdrawal by Subject|4|||
23207339|NCT02723591|64498173|FG001|Overall Study|Withdrawal by Subject|8|||
23207340|NCT02723591|64498172|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
23207341|NCT02723591|64498173|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
23207342|NCT02723591|64498172|FG000|Overall Study|Miscellaneous|5|||
23530838|NCT01701258|65679938|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
23207343|NCT02723591|64498173|FG001|Overall Study|Miscellaneous|6|||
23207344|NCT01397552|64498181|FG000|Overall Study|Adverse Event|1|||
23207345|NCT01397552|64498182|FG001|Overall Study|Adverse Event|0|||
23207346|NCT01397552|64498181|FG000|Overall Study|Withdrawal by Subject|2|||
23530839|NCT01701258|65679939|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
23530840|NCT01701258|65679940|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
23207347|NCT01397552|64498182|FG001|Overall Study|Withdrawal by Subject|1|||
23207348|NCT01795898|64498183|FG000|Overall Study|Adverse Event|27|||
23207349|NCT01795898|64498183|FG000|Overall Study|Lost to Follow-up|20|||
23207350|NCT01795898|64498183|FG000|Overall Study|Withdrawal of consent|6|||
23530841|NCT01701258|65679941|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
23530842|NCT01701258|65679942|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
23530843|NCT01701258|65679943|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
23530844|NCT01701258|65679944|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
23207351|NCT01795898|64498183|FG000|Overall Study|Diagnosed with metastasis|1|||
23207352|NCT01795898|64498183|FG000|Overall Study|No pain|1|||
23207353|NCT01795898|64498183|FG000|Overall Study|Death|1|||
23207354|NCT01795898|64498183|FG000|Overall Study|Withdrew consent & had adverse events|3|||
23207355|NCT01795898|64498183|FG000|Overall Study|Physician Decision|1|||
23207356|NCT01361919|64498184|FG000|Overall Study|technical issues|10|||
23207357|NCT01361919|64498185|FG001|Overall Study|technical issues|12|||
23207358|NCT01361919|64498186|FG002|Overall Study|technical issues|10|||
23207359|NCT01969799|64498192|FG000|Overall Study|Adverse Event|0|||
23207360|NCT01969799|64498193|FG001|Overall Study|Adverse Event|1|||
23207361|NCT01969799|64498192|FG000|Overall Study|Death|16|||
23207362|NCT01969799|64498193|FG001|Overall Study|Death|11|||
23207363|NCT01969799|64498192|FG000|Overall Study|Lost to Follow-up|0|||
23207364|NCT01969799|64498193|FG001|Overall Study|Lost to Follow-up|2|||
23207365|NCT01969799|64498192|FG000|Overall Study|Physician Decision|1|||
23207366|NCT01969799|64498193|FG001|Overall Study|Physician Decision|0|||
23613032|NCT01358175|65969767|FG002|Overall Study|Technical issues|0|||
23207367|NCT00710034|64498194|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
23207368|NCT00710034|64498195|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
23207369|NCT00710034|64498194|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
23207370|NCT00710034|64498195|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
23207371|NCT00710034|64498194|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
23207372|NCT00710034|64498195|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
23207373|NCT00710034|64498194|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
23207374|NCT00710034|64498195|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
23207375|NCT00710034|64498194|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
23207376|NCT00710034|64498195|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
23207377|NCT00710034|64498194|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
23207378|NCT00710034|64498195|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
23530845|NCT01701258|65679945|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
23530846|NCT01701258|65679946|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
23613033|NCT01358175|65969765|FG000|Overall Study|Pregnancy|0|||
23613034|NCT01358175|65969766|FG001|Overall Study|Pregnancy|1|||
23207379|NCT00710034|64498194|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
23419418|NCT03194568|65280244|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
23419419|NCT00072293|65280245|FG000|Overall Study|Lost to Follow-up|1|||
23419420|NCT00072293|65280246|FG001|Overall Study|Lost to Follow-up|1|||
23419421|NCT00072293|65280245|FG000|Overall Study|Withdrawal by Subject|0|||
23419422|NCT00072293|65280246|FG001|Overall Study|Withdrawal by Subject|1|||
23419423|NCT04417218|65280249|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
23419424|NCT04417218|65280250|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
23419425|NCT03136497|65280251|FG000|Overall Study|Screen Failure|1|||
23419426|NCT03136497|65280252|FG001|Overall Study|Screen Failure|0|||
23419427|NCT03136497|65280253|FG002|Overall Study|Screen Failure|0|||
23419428|NCT02867813|65280256|FG000|Overall Study|Withdrawal by Subject|57|||
23419429|NCT02867813|65280257|FG001|Overall Study|Withdrawal by Subject|56|||
23419430|NCT02867813|65280256|FG000|Overall Study|Decision by Sponsor|7|||
23419431|NCT02867813|65280257|FG001|Overall Study|Decision by Sponsor|7|||
23207380|NCT00710034|64498195|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
23530847|NCT01701258|65679947|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
23530848|NCT01701258|65679935|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
23530849|NCT01701258|65679936|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
23530850|NCT01701258|65679937|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
23530851|NCT01701258|65679938|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
23530852|NCT01701258|65679939|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
23530853|NCT01701258|65679940|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
23530854|NCT01701258|65679941|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
23530855|NCT01701258|65679942|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
23530856|NCT01701258|65679943|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
23530857|NCT01701258|65679944|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
23530858|NCT01701258|65679945|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
23530859|NCT01701258|65679946|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
23530860|NCT01701258|65679947|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
23530861|NCT01701258|65679935|FG000|Assessment and Scheduling|Investigator Terminated|2|||
23530862|NCT01701258|65679936|FG001|Assessment and Scheduling|Investigator Terminated|0|||
23530863|NCT01701258|65679937|FG002|Assessment and Scheduling|Investigator Terminated|0|||
23530864|NCT01701258|65679938|FG003|Assessment and Scheduling|Investigator Terminated|0|||
23530865|NCT01701258|65679939|FG004|Assessment and Scheduling|Investigator Terminated|0|||
23530866|NCT01701258|65679940|FG005|Assessment and Scheduling|Investigator Terminated|0|||
23530867|NCT01701258|65679941|FG006|Assessment and Scheduling|Investigator Terminated|0|||
23530868|NCT01701258|65679942|FG007|Assessment and Scheduling|Investigator Terminated|0|||
23530869|NCT01701258|65679943|FG008|Assessment and Scheduling|Investigator Terminated|0|||
23530870|NCT01701258|65679944|FG009|Assessment and Scheduling|Investigator Terminated|0|||
23530871|NCT01701258|65679945|FG010|Assessment and Scheduling|Investigator Terminated|0|||
23530872|NCT01701258|65679946|FG011|Assessment and Scheduling|Investigator Terminated|0|||
23530873|NCT01701258|65679947|FG012|Assessment and Scheduling|Investigator Terminated|0|||
23530874|NCT02310672|65679948|FG000|Overall Study|Death|1|||
23530875|NCT02310672|65679948|FG000|Overall Study|Lost to Follow-up|1|||
23530876|NCT02310672|65679948|FG000|Overall Study|Withdrawal by Subject|1|||
23530877|NCT02310672|65679948|FG000|Overall Study|Sponsor's decision|12|||
23530878|NCT00293384|65679949|FG000|Overall Study|Non-compliance|2|||
23530879|NCT00293384|65679949|FG000|Overall Study|Missed dosage/study drug|1|||
23530880|NCT00293384|65679949|FG000|Overall Study|Ineligible|2|||
23530881|NCT01516879|65679952|FG000|Overall Study|Withdrawal by Subject|9|||
23530882|NCT01516879|65679953|FG001|Overall Study|Withdrawal by Subject|11|||
23530883|NCT01516879|65679952|FG000|Overall Study|Death|0|||
23530884|NCT01516879|65679953|FG001|Overall Study|Death|2|||
23530885|NCT01516879|65679952|FG000|Overall Study|Lost to Follow-up|2|||
23530886|NCT01516879|65679953|FG001|Overall Study|Lost to Follow-up|11|||
23530887|NCT01516879|65679952|FG000|Overall Study|Other|5|||
23530888|NCT01516879|65679953|FG001|Overall Study|Other|10|||
23530889|NCT04399161|65679954|FG000|Overall Study|Withdrawal by Subject|1|||
23530890|NCT04399161|65679955|FG001|Overall Study|Withdrawal by Subject|0|||
23530891|NCT04399161|65679956|FG002|Overall Study|Withdrawal by Subject|2|||
23530892|NCT04399161|65679954|FG000|Overall Study|Protocol Violation|1|||
23530893|NCT04399161|65679955|FG001|Overall Study|Protocol Violation|2|||
23530894|NCT04399161|65679956|FG002|Overall Study|Protocol Violation|0|||
23530895|NCT00678561|65679957|FG000|Overall Study|Adverse Event|0|||
23530896|NCT00678561|65679958|FG001|Overall Study|Adverse Event|1|||
23530897|NCT00678561|65679959|FG002|Overall Study|Adverse Event|1|||
23530898|NCT00678561|65679960|FG003|Overall Study|Adverse Event|0|||
23530899|NCT00678561|65679961|FG004|Overall Study|Adverse Event|1|||
23530900|NCT00678561|65679962|FG005|Overall Study|Adverse Event|0|||
23530901|NCT00678561|65679963|FG006|Overall Study|Adverse Event|0|||
23530902|NCT00678561|65679964|FG007|Overall Study|Adverse Event|0|||
23530903|NCT00678561|65679957|FG000|Overall Study|Protocol Violation|0|||
23419432|NCT02867813|65280256|FG000|Overall Study|Lost to Follow-up|91|||
23419433|NCT02867813|65280257|FG001|Overall Study|Lost to Follow-up|78|||
23419434|NCT02867813|65280256|FG000|Overall Study|Missing|2|||
23613035|NCT01358175|65969767|FG002|Overall Study|Pregnancy|0|||
23613036|NCT01358175|65969765|FG000|Overall Study|Physician Decision|1|||
23613037|NCT01358175|65969766|FG001|Overall Study|Physician Decision|0|||
23613038|NCT01358175|65969767|FG002|Overall Study|Physician Decision|0|||
23613039|NCT01358175|65969765|FG000|Overall Study|Non Compliance with Study Treatment|0|||
23613040|NCT01358175|65969766|FG001|Overall Study|Non Compliance with Study Treatment|1|||
23613041|NCT01358175|65969767|FG002|Overall Study|Non Compliance with Study Treatment|1|||
23613042|NCT01358175|65969765|FG000|Overall Study|Lost to Follow-up|1|||
23613043|NCT01358175|65969766|FG001|Overall Study|Lost to Follow-up|1|||
23613044|NCT01358175|65969767|FG002|Overall Study|Lost to Follow-up|3|||
23613045|NCT01358175|65969765|FG000|Overall Study|Lack of Efficacy|3|||
23613046|NCT01358175|65969766|FG001|Overall Study|Lack of Efficacy|8|||
23613047|NCT01358175|65969767|FG002|Overall Study|Lack of Efficacy|6|||
23613048|NCT01358175|65969765|FG000|Overall Study|Adverse Event|6|||
23613049|NCT01358175|65969766|FG001|Overall Study|Adverse Event|11|||
23613050|NCT01358175|65969767|FG002|Overall Study|Adverse Event|11|||
23613051|NCT00248794|65969768|FG000|Overall Study|Lost to Follow-up|6|||
23613052|NCT00248794|65969769|FG001|Overall Study|Lost to Follow-up|8|||
23613053|NCT00248794|65969770|FG002|Overall Study|Lost to Follow-up|3|||
23613054|NCT01767376|65969771|FG000|Overall Study|Lost to Follow-up|3|||
23613055|NCT01767376|65969772|FG001|Overall Study|Lost to Follow-up|2|||
23530904|NCT00678561|65679958|FG001|Overall Study|Protocol Violation|0|||
23530905|NCT00678561|65679959|FG002|Overall Study|Protocol Violation|0|||
23530906|NCT00678561|65679960|FG003|Overall Study|Protocol Violation|0|||
23530907|NCT00678561|65679961|FG004|Overall Study|Protocol Violation|1|||
23530908|NCT00678561|65679962|FG005|Overall Study|Protocol Violation|1|||
23530909|NCT00678561|65679963|FG006|Overall Study|Protocol Violation|0|||
23530910|NCT00678561|65679964|FG007|Overall Study|Protocol Violation|0|||
23530911|NCT00678561|65679957|FG000|Overall Study|Withdrawal by Subject|0|||
23530912|NCT00678561|65679958|FG001|Overall Study|Withdrawal by Subject|0|||
23530913|NCT00678561|65679959|FG002|Overall Study|Withdrawal by Subject|0|||
23530914|NCT00678561|65679960|FG003|Overall Study|Withdrawal by Subject|0|||
23530915|NCT00678561|65679961|FG004|Overall Study|Withdrawal by Subject|0|||
23530916|NCT00678561|65679962|FG005|Overall Study|Withdrawal by Subject|0|||
23613056|NCT01767376|65969773|FG002|Overall Study|Lost to Follow-up|0|||
23613057|NCT01767376|65969771|FG000|Overall Study|Withdrawal by Subject|1|||
23419435|NCT02867813|65280257|FG001|Overall Study|Missing|1|||
23613058|NCT01767376|65969772|FG001|Overall Study|Withdrawal by Subject|1|||
23613059|NCT01767376|65969773|FG002|Overall Study|Withdrawal by Subject|0|||
23613060|NCT03018288|65969781|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
23207381|NCT00710034|64498194|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
23207382|NCT00710034|64498195|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
23419436|NCT02867813|65280256|FG000|Overall Study|Death|294|||
23419437|NCT02867813|65280257|FG001|Overall Study|Death|268|||
23419438|NCT01007435|65280260|FG000|Overall Study|Adverse Event|16|||
23419439|NCT01007435|65280261|FG001|Overall Study|Adverse Event|25|||
23419440|NCT01007435|65280262|FG002|Overall Study|Adverse Event|47|||
23419441|NCT01007435|65280263|FG003|Overall Study|Adverse Event|31|||
23419442|NCT01007435|65280260|FG000|Overall Study|Death|2|||
23419443|NCT01007435|65280261|FG001|Overall Study|Death|4|||
23419444|NCT01007435|65280262|FG002|Overall Study|Death|2|||
23419445|NCT01007435|65280263|FG003|Overall Study|Death|1|||
23419446|NCT01007435|65280260|FG000|Overall Study|Insufficient Therapeutic Response|21|||
23419447|NCT01007435|65280261|FG001|Overall Study|Insufficient Therapeutic Response|7|||
23419448|NCT01007435|65280262|FG002|Overall Study|Insufficient Therapeutic Response|2|||
23419449|NCT01007435|65280263|FG003|Overall Study|Insufficient Therapeutic Response|9|||
23419450|NCT01007435|65280260|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
23419451|NCT01007435|65280261|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
23419452|NCT01007435|65280262|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
23419453|NCT01007435|65280263|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
23419454|NCT01007435|65280260|FG000|Overall Study|Other Protocol Violation|2|||
23419455|NCT01007435|65280261|FG001|Overall Study|Other Protocol Violation|0|||
23419456|NCT01007435|65280262|FG002|Overall Study|Other Protocol Violation|1|||
23419457|NCT01007435|65280263|FG003|Overall Study|Other Protocol Violation|0|||
23613061|NCT03018288|65969782|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
23613062|NCT03018288|65969783|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
23613063|NCT03018288|65969784|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
23613064|NCT03018288|65969781|FG000|Overall Study|Participant withdrew consent.|0|||
23613065|NCT03018288|65969782|FG001|Overall Study|Participant withdrew consent.|0|||
23419458|NCT01007435|65280260|FG000|Overall Study|Refused Treatment|13|||
23419459|NCT01007435|65280261|FG001|Overall Study|Refused Treatment|13|||
23419460|NCT01007435|65280262|FG002|Overall Study|Refused Treatment|5|||
23419461|NCT01007435|65280263|FG003|Overall Study|Refused Treatment|8|||
23530917|NCT00678561|65679963|FG006|Overall Study|Withdrawal by Subject|0|||
23530918|NCT00678561|65679964|FG007|Overall Study|Withdrawal by Subject|1|||
23530919|NCT00424372|65679965|FG000|Overall Study|Death|1|||
23530920|NCT00424372|65679965|FG000|Overall Study|Adverse Event|18|||
23530921|NCT00424372|65679965|FG000|Overall Study|Lack of Efficacy|6|||
23530922|NCT00424372|65679965|FG000|Overall Study|Withdrawal by Subject|4|||
23530923|NCT00424372|65679965|FG000|Overall Study|Protocol Violation|1|||
23530924|NCT00424372|65679965|FG000|Overall Study|Health deterioration|1|||
23530925|NCT01857063|65679966|FG000|Period 1 (7 Days)|Adverse Event|0|||
23530926|NCT01857063|65679967|FG001|Period 1 (7 Days)|Adverse Event|1|||
23530927|NCT01857063|65679966|FG000|Period 1 (7 Days)|Physician Decision|1|||
23530928|NCT01857063|65679967|FG001|Period 1 (7 Days)|Physician Decision|0|||
23530929|NCT01857063|65679966|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
23530930|NCT01857063|65679967|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
23530931|NCT01857063|65679966|FG000|Period 2 (7 Days)|Adverse Event|2|||
23530932|NCT01857063|65679967|FG001|Period 2 (7 Days)|Adverse Event|1|||
23530933|NCT01857063|65679966|FG000|Period 2 (7 Days)|Physician Decision|1|||
23530934|NCT01857063|65679967|FG001|Period 2 (7 Days)|Physician Decision|1|||
23530935|NCT01857063|65679966|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
23530936|NCT01857063|65679967|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
23530937|NCT04280783|65679968|FG000|Overall Study|Family issues unrelated to the study.|1|||
23530938|NCT04280783|65679969|FG001|Overall Study|Family issues unrelated to the study.|0|||
23530939|NCT04280783|65679968|FG000|Overall Study|Withdrawal by Subject|0|||
23530940|NCT04280783|65679969|FG001|Overall Study|Withdrawal by Subject|1|||
23530941|NCT04208412|65679970|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
23530942|NCT04208412|65679971|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
23530943|NCT04208412|65679970|FG000|Overall Study|Withdrawal by Subject|1|||
23530944|NCT04208412|65679971|FG001|Overall Study|Withdrawal by Subject|0|||
23530945|NCT04208412|65679970|FG000|Overall Study|Lost to Follow-up|0|||
23530946|NCT04208412|65679971|FG001|Overall Study|Lost to Follow-up|1|||
23530947|NCT01470469|65679974|FG000|Overall Study|Withdrawal by Subject|4|||
23530948|NCT01470469|65679975|FG001|Overall Study|Withdrawal by Subject|6|||
23530949|NCT01470469|65679974|FG000|Overall Study|Lack of Efficacy|1|||
23530950|NCT01470469|65679975|FG001|Overall Study|Lack of Efficacy|7|||
23530951|NCT01470469|65679974|FG000|Overall Study|Adverse Event|0|||
23530952|NCT01470469|65679975|FG001|Overall Study|Adverse Event|7|||
23530953|NCT01470469|65679974|FG000|Overall Study|Lost to Follow-up|2|||
23530954|NCT01470469|65679975|FG001|Overall Study|Lost to Follow-up|2|||
23530955|NCT01470469|65679974|FG000|Overall Study|Protocol Violation|1|||
23530956|NCT01470469|65679975|FG001|Overall Study|Protocol Violation|1|||
23530957|NCT01470469|65679974|FG000|Overall Study|Other|2|||
23530958|NCT01470469|65679975|FG001|Overall Study|Other|1|||
23530959|NCT02469610|65679976|FG000|Overall Study|Death|1|||
23530960|NCT02469610|65679977|FG001|Overall Study|Death|0|||
23530961|NCT02469610|65679976|FG000|Overall Study|Lost to Follow-up|1|||
23530962|NCT02469610|65679977|FG001|Overall Study|Lost to Follow-up|0|||
23530963|NCT02469610|65679976|FG000|Overall Study|exclusion criteria|2|||
23530964|NCT02469610|65679977|FG001|Overall Study|exclusion criteria|1|||
23530965|NCT00724451|65679980|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
23530966|NCT00724451|65679980|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
23530967|NCT00724451|65679980|FG000|Overall Study|Not Eligible for Treatment|431|||
23530968|NCT00724451|65679980|FG000|Overall Study|Participant Refused Treatment|89|||
23530969|NCT00724451|65679980|FG000|Overall Study|Never Started Treatment|89|||
23530970|NCT00724451|65679980|FG000|Overall Study|Unknown; No Data Sources Available|9|||
23530971|NCT00724451|65679980|FG000|Overall Study|Physician Decision|116|||
23530972|NCT00724451|65679980|FG000|Overall Study|Withdrawal by Subject|45|||
23530973|NCT00724451|65679980|FG000|Overall Study|Investigator + Participant Decision|13|||
23530974|NCT04258839|65679986|FG000|Overall Study|Adverse Event|2|||
23530975|NCT04258839|65679987|FG001|Overall Study|Adverse Event|4|||
23530976|NCT04258839|65679986|FG000|Overall Study|Lack of Efficacy|0|||
23530977|NCT04258839|65679987|FG001|Overall Study|Lack of Efficacy|2|||
23530978|NCT04258839|65679986|FG000|Overall Study|Lost to Follow-up|2|||
23530979|NCT04258839|65679987|FG001|Overall Study|Lost to Follow-up|0|||
23530980|NCT04258839|65679986|FG000|Overall Study|Withdrawal by Subject|1|||
23530981|NCT04258839|65679987|FG001|Overall Study|Withdrawal by Subject|2|||
23530982|NCT04258839|65679986|FG000|Overall Study|Withdrawal by Caregiver|5|||
23530983|NCT04258839|65679987|FG001|Overall Study|Withdrawal by Caregiver|6|||
23530984|NCT04258839|65679986|FG000|Overall Study|Reason not Specified|0|||
23530985|NCT04258839|65679987|FG001|Overall Study|Reason not Specified|1|||
23530986|NCT00654628|65679988|FG000|6-week Active Treatment Period|Adverse Event|9|||
23530987|NCT00654628|65679988|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
23530988|NCT00654628|65679988|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
23530989|NCT00654628|65679988|FG000|6-week Active Treatment Period|Out of window period|1|||
23530990|NCT00654628|65679988|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
23530991|NCT00654628|65679988|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
23530992|NCT01632800|65679989|FG000|Overall Study|Subject did not fit in apparatus|1|||
23530993|NCT02907359|65679991|FG000|Overall Study|Death|234|||
23530994|NCT02907359|65679992|FG001|Overall Study|Death|117|||
23530995|NCT02907359|65679991|FG000|Overall Study|Withdrawal by Subject|6|||
23530996|NCT02907359|65679992|FG001|Overall Study|Withdrawal by Subject|11|||
23613066|NCT03018288|65969783|FG002|Overall Study|Participant withdrew consent.|1|||
23613067|NCT03018288|65969784|FG003|Overall Study|Participant withdrew consent.|0|||
23613068|NCT03018288|65969781|FG000|Overall Study|Switched to alternative treatment.|0|||
23613069|NCT03018288|65969782|FG001|Overall Study|Switched to alternative treatment.|0|||
23613070|NCT03018288|65969783|FG002|Overall Study|Switched to alternative treatment.|1|||
23613071|NCT03018288|65969784|FG003|Overall Study|Switched to alternative treatment.|0|||
23613072|NCT03018288|65969781|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
23613073|NCT03018288|65969782|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
23613074|NCT03018288|65969783|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
23613075|NCT03018288|65969784|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
23613076|NCT03018288|65969781|FG000|Overall Study|Screen failures|0|||
23530997|NCT02907359|65679991|FG000|Overall Study|Lost to Follow-up|1|||
23530998|NCT02907359|65679992|FG001|Overall Study|Lost to Follow-up|0|||
23530999|NCT00179647|65679993|FG000|Overall Study|Adverse Event|294|||
23531000|NCT00179647|65679993|FG000|Overall Study|Lack of Efficacy|478|||
23531001|NCT00179647|65679993|FG000|Overall Study|Withdrawal by Subject|83|||
23531002|NCT00179647|65679993|FG000|Overall Study|Lost to Follow-up|4|||
23531003|NCT00179647|65679993|FG000|Overall Study|Death|94|||
23531004|NCT00179647|65679993|FG000|Overall Study|Other|960|||
23531005|NCT04013191|65679996|FG000|Overall Study|Adverse Event|1|||
23531006|NCT04013191|65679997|FG001|Overall Study|Adverse Event|0|||
23531007|NCT01641367|65679998|FG000|Cohorts|Death|18|||
23531008|NCT01641367|65679999|FG001|Cohorts|Death|1|||
23531009|NCT01641367|65680000|FG002|Cohorts|Death|2|||
23531010|NCT01641367|65680001|FG003|Cohorts|Death|0|||
23531011|NCT01641367|65680002|FG004|Cohorts|Death|1|||
23613077|NCT03018288|65969782|FG001|Overall Study|Screen failures|0|||
23613078|NCT03018288|65969783|FG002|Overall Study|Screen failures|0|||
23613079|NCT03018288|65969784|FG003|Overall Study|Screen failures|51|||
23613080|NCT03018288|65969781|FG000|Overall Study|Chose treatment outside of UNC|0|||
23613081|NCT03018288|65969782|FG001|Overall Study|Chose treatment outside of UNC|0|||
23613082|NCT03018288|65969783|FG002|Overall Study|Chose treatment outside of UNC|0|||
23613083|NCT03018288|65969784|FG003|Overall Study|Chose treatment outside of UNC|1|||
23613084|NCT03018288|65969781|FG000|Overall Study|Unable to comply with protocol requirements|1|||
23613085|NCT03018288|65969782|FG001|Overall Study|Unable to comply with protocol requirements|1|||
23613086|NCT03018288|65969783|FG002|Overall Study|Unable to comply with protocol requirements|0|||
23613087|NCT03018288|65969784|FG003|Overall Study|Unable to comply with protocol requirements|1|||
23613088|NCT03018288|65969781|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
23613089|NCT03018288|65969782|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
23613090|NCT03018288|65969783|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
23613091|NCT03018288|65969784|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
23613092|NCT03018288|65969781|FG000|Overall Study|Physician Decision|0|||
23613093|NCT03018288|65969782|FG001|Overall Study|Physician Decision|0|||
23613094|NCT03018288|65969783|FG002|Overall Study|Physician Decision|0|||
23613095|NCT03018288|65969784|FG003|Overall Study|Physician Decision|1|||
23613096|NCT00914732|65969787|FG000|Overall Study|Lost to Follow-up|6|||
23613097|NCT00914732|65969788|FG001|Overall Study|Lost to Follow-up|7|||
23613098|NCT00914732|65969789|FG002|Overall Study|Lost to Follow-up|9|||
23613099|NCT00914732|65969787|FG000|Overall Study|Withdrawal by Subject|3|||
23613100|NCT00914732|65969788|FG001|Overall Study|Withdrawal by Subject|0|||
23613101|NCT00914732|65969789|FG002|Overall Study|Withdrawal by Subject|2|||
23613102|NCT00914732|65969787|FG000|Overall Study|Adverse Event|1|||
23613103|NCT00914732|65969788|FG001|Overall Study|Adverse Event|0|||
23613104|NCT00914732|65969789|FG002|Overall Study|Adverse Event|0|||
23613105|NCT00443820|65969790|FG000|Overall Study|Adverse Event|1|||
23613106|NCT00443820|65969791|FG001|Overall Study|Adverse Event|1|||
23613107|NCT00443820|65969792|FG002|Overall Study|Adverse Event|0|||
23613108|NCT00443820|65969793|FG003|Overall Study|Adverse Event|0|||
23613109|NCT00443820|65969790|FG000|Overall Study|Lack of Efficacy|3|||
23613110|NCT00443820|65969791|FG001|Overall Study|Lack of Efficacy|2|||
23613111|NCT00443820|65969792|FG002|Overall Study|Lack of Efficacy|1|||
23613112|NCT00443820|65969793|FG003|Overall Study|Lack of Efficacy|1|||
23531012|NCT01641367|65680003|FG005|Cohorts|Death|1|||
23531013|NCT01641367|65680004|FG006|Cohorts|Death|0|||
23531014|NCT01641367|65680005|FG007|Cohorts|Death|0|||
23613113|NCT00443820|65969790|FG000|Overall Study|Protocol Violation|2|||
23613114|NCT00443820|65969791|FG001|Overall Study|Protocol Violation|1|||
23613115|NCT00443820|65969792|FG002|Overall Study|Protocol Violation|2|||
23531015|NCT01641367|65679998|FG000|Cohorts|Lost to Follow-up|16|||
23613116|NCT00443820|65969793|FG003|Overall Study|Protocol Violation|1|||
23613117|NCT00443820|65969790|FG000|Overall Study|Withdrawal by Subject|6|||
23419462|NCT01007435|65280260|FG000|Overall Study|Failure to Return|5|||
23531016|NCT01641367|65679999|FG001|Cohorts|Lost to Follow-up|0|||
23531017|NCT01641367|65680000|FG002|Cohorts|Lost to Follow-up|2|||
23531018|NCT01641367|65680001|FG003|Cohorts|Lost to Follow-up|0|||
23613118|NCT00443820|65969791|FG001|Overall Study|Withdrawal by Subject|7|||
23613119|NCT00443820|65969792|FG002|Overall Study|Withdrawal by Subject|8|||
23613120|NCT00443820|65969793|FG003|Overall Study|Withdrawal by Subject|9|||
23613121|NCT00443820|65969790|FG000|Overall Study|Lost to Follow-up|9|||
23613122|NCT00443820|65969791|FG001|Overall Study|Lost to Follow-up|8|||
23613123|NCT00443820|65969792|FG002|Overall Study|Lost to Follow-up|6|||
23613124|NCT00443820|65969793|FG003|Overall Study|Lost to Follow-up|5|||
23613125|NCT00443820|65969790|FG000|Overall Study|Administrative problems|0|||
23613126|NCT00443820|65969791|FG001|Overall Study|Administrative problems|0|||
23613127|NCT00443820|65969792|FG002|Overall Study|Administrative problems|0|||
23613128|NCT00443820|65969793|FG003|Overall Study|Administrative problems|1|||
23613129|NCT00443820|65969790|FG000|Overall Study|Death|0|||
23613130|NCT00443820|65969791|FG001|Overall Study|Death|0|||
23613131|NCT00443820|65969792|FG002|Overall Study|Death|1|||
23613132|NCT00443820|65969793|FG003|Overall Study|Death|0|||
23613133|NCT03219216|65969796|FG000|Overall Study|Lost to Follow-up|0|||
23613134|NCT03219216|65969797|FG001|Overall Study|Lost to Follow-up|1|||
23613135|NCT02577315|65969798|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23613136|NCT02577315|65969799|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
23613137|NCT00988429|65969800|FG000|Overall Study|Adverse Event|9|||
23613138|NCT00988429|65969801|FG001|Overall Study|Adverse Event|21|||
23613139|NCT00988429|65969802|FG002|Overall Study|Adverse Event|45|||
23613140|NCT00988429|65969800|FG000|Overall Study|Lack of Efficacy|0|||
23613141|NCT00988429|65969801|FG001|Overall Study|Lack of Efficacy|0|||
23613142|NCT00988429|65969802|FG002|Overall Study|Lack of Efficacy|1|||
23613143|NCT00988429|65969800|FG000|Overall Study|Non-Compliance with Study Drug|5|||
23613144|NCT00988429|65969801|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23613145|NCT00988429|65969802|FG002|Overall Study|Non-Compliance with Study Drug|3|||
23613146|NCT00988429|65969800|FG000|Overall Study|Physician Decision|1|||
23613147|NCT00988429|65969801|FG001|Overall Study|Physician Decision|0|||
23613148|NCT00988429|65969802|FG002|Overall Study|Physician Decision|3|||
23613149|NCT00988429|65969800|FG000|Overall Study|Pregnancy|2|||
23613150|NCT00988429|65969801|FG001|Overall Study|Pregnancy|1|||
23613151|NCT00988429|65969802|FG002|Overall Study|Pregnancy|0|||
23613152|NCT00988429|65969800|FG000|Overall Study|Protocol Violation|4|||
23613153|NCT00988429|65969801|FG001|Overall Study|Protocol Violation|3|||
23613154|NCT00988429|65969802|FG002|Overall Study|Protocol Violation|3|||
23613155|NCT00988429|65969800|FG000|Overall Study|Withdrawal by Subject|7|||
23613156|NCT00988429|65969801|FG001|Overall Study|Withdrawal by Subject|7|||
23613157|NCT00988429|65969802|FG002|Overall Study|Withdrawal by Subject|12|||
23613158|NCT00988429|65969800|FG000|Overall Study|Administrative Reasons|1|||
23613159|NCT00988429|65969801|FG001|Overall Study|Administrative Reasons|2|||
23613160|NCT00988429|65969802|FG002|Overall Study|Administrative Reasons|1|||
23613161|NCT00988429|65969800|FG000|Overall Study|other reasons|8|||
23613162|NCT00988429|65969801|FG001|Overall Study|other reasons|8|||
23613163|NCT00988429|65969802|FG002|Overall Study|other reasons|1|||
23613164|NCT01524887|65969803|FG000|Overall Study|Withdrawal by Subject|6|||
23613165|NCT01524887|65969804|FG001|Overall Study|Withdrawal by Subject|2|||
23613166|NCT01524887|65969805|FG002|Overall Study|Withdrawal by Subject|3|||
23613167|NCT01524887|65969803|FG000|Overall Study|Adverse Event|5|||
23613168|NCT01524887|65969804|FG001|Overall Study|Adverse Event|1|||
23613169|NCT01524887|65969805|FG002|Overall Study|Adverse Event|1|||
23613170|NCT01524887|65969803|FG000|Overall Study|Protocol Violation|0|||
23613171|NCT01524887|65969804|FG001|Overall Study|Protocol Violation|0|||
23613172|NCT01524887|65969805|FG002|Overall Study|Protocol Violation|1|||
23613173|NCT01524887|65969803|FG000|Overall Study|Study termination|73|||
23613174|NCT01524887|65969804|FG001|Overall Study|Study termination|87|||
23613175|NCT01524887|65969805|FG002|Overall Study|Study termination|79|||
23613176|NCT01524887|65969803|FG000|Overall Study|Withdrawal by Caregiver|0|||
23613177|NCT01524887|65969804|FG001|Overall Study|Withdrawal by Caregiver|0|||
23613178|NCT01524887|65969805|FG002|Overall Study|Withdrawal by Caregiver|2|||
23613179|NCT01524887|65969803|FG000|Overall Study|Use of prohibited medication|1|||
23613180|NCT01524887|65969804|FG001|Overall Study|Use of prohibited medication|0|||
23613181|NCT01524887|65969805|FG002|Overall Study|Use of prohibited medication|0|||
23613182|NCT01876823|65969806|FG000|Overall Study|Withdrawal by Subject|5|||
23613183|NCT01876823|65969806|FG000|Overall Study|Physician Decision|2|||
23613184|NCT01876823|65969806|FG000|Overall Study|Patients moved|2|||
23613185|NCT00447499|65969809|FG000|Overall Study|Adverse Event|1|||
23613186|NCT00447499|65969809|FG000|Overall Study|Patient Decision|4|||
23613187|NCT00447499|65969809|FG000|Overall Study|Sponsor Decision|1|||
23613188|NCT00447499|65969809|FG000|Overall Study|Physician Decision|1|||
23613189|NCT02489799|65969810|FG000|Overall Study|Lost to Follow-up|4|||
23613190|NCT02489799|65969811|FG001|Overall Study|Lost to Follow-up|1|||
23613191|NCT02489799|65969810|FG000|Overall Study|Failure to Maintain Eligibility|4|||
23613192|NCT02489799|65969811|FG001|Overall Study|Failure to Maintain Eligibility|6|||
23613193|NCT02489799|65969810|FG000|Overall Study|Withdrawal by Subject|1|||
23613194|NCT02489799|65969811|FG001|Overall Study|Withdrawal by Subject|1|||
23613195|NCT02489799|65969810|FG000|Overall Study|Death|0|||
23613196|NCT02489799|65969811|FG001|Overall Study|Death|1|||
23309674|NCT03052127|64878028|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23309675|NCT03052127|64878029|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
23309676|NCT03397771|64878042|FG000|Overall Study|2 erroneously randomized, never treated|3|||
23309677|NCT03397771|64878043|FG001|Overall Study|2 erroneously randomized, never treated|1|||
23309678|NCT03397771|64878042|FG000|Overall Study|Withdrawal by Subject|1|||
23309679|NCT03397771|64878043|FG001|Overall Study|Withdrawal by Subject|3|||
23309680|NCT03397771|64878042|FG000|Overall Study|Protocol Violation|2|||
23309681|NCT03397771|64878043|FG001|Overall Study|Protocol Violation|2|||
23309682|NCT03397771|64878042|FG000|Overall Study|Adverse Event|2|||
23309683|NCT03397771|64878043|FG001|Overall Study|Adverse Event|1|||
23309684|NCT04159935|64878046|FG000|Overall Study|Study terminated due to COVID-19|1|||
23309685|NCT04159935|64878047|FG001|Overall Study|Study terminated due to COVID-19|3|||
23309686|NCT03421730|64878048|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309687|NCT03421730|64878049|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
23309688|NCT03421730|64878050|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309689|NCT03421730|64878051|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309690|NCT03421730|64878052|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309691|NCT03421730|64878053|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309692|NCT03421730|64878054|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309693|NCT03421730|64878055|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309694|NCT03421730|64878056|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309695|NCT03421730|64878057|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309696|NCT03421730|64878058|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309697|NCT03421730|64878059|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
23309698|NCT03421730|64878048|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23309699|NCT03421730|64878049|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23309700|NCT03421730|64878050|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23309701|NCT03421730|64878051|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23309702|NCT03421730|64878052|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
23309703|NCT03421730|64878053|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23309704|NCT03421730|64878054|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23419463|NCT01007435|65280261|FG001|Overall Study|Failure to Return|4|||
23419464|NCT01007435|65280262|FG002|Overall Study|Failure to Return|3|||
23419465|NCT01007435|65280263|FG003|Overall Study|Failure to Return|6|||
23419466|NCT01007435|65280260|FG000|Overall Study|Reason not Specified|1|||
23419467|NCT01007435|65280261|FG001|Overall Study|Reason not Specified|1|||
23419468|NCT01007435|65280262|FG002|Overall Study|Reason not Specified|2|||
23419469|NCT01007435|65280263|FG003|Overall Study|Reason not Specified|1|||
23419470|NCT00549900|65280264|FG000|Overall Study|Adverse Event|1|||
23419471|NCT01421303|65280265|FG000|Overall Study|Lost to Follow-up|13|||
23419472|NCT01421303|65280265|FG000|Overall Study|Non compliance with study procedure|1|||
23419473|NCT01421303|65280265|FG000|Overall Study|Other|7|||
23419474|NCT01421303|65280265|FG000|Overall Study|Withdrawal by Subject|1|||
23419475|NCT03457142|65280266|FG000|Overall Study|Death|1|||
23419476|NCT02403817|65280267|FG000|Overall Study|Withdrawal by Subject|5|||
23419477|NCT02403817|65280268|FG001|Overall Study|Withdrawal by Subject|0|||
23419478|NCT01579565|65280269|FG000|Randomized|Adverse Event|1|||
23419479|NCT01579565|65280270|FG001|Randomized|Adverse Event|3|||
23419480|NCT01579565|65280269|FG000|Randomized|Withdrawal by Subject|3|||
23419481|NCT01579565|65280270|FG001|Randomized|Withdrawal by Subject|0|||
23419482|NCT01579565|65280269|FG000|Randomized|inadequate preoperative pupil dilation|0|||
23419483|NCT01579565|65280270|FG001|Randomized|inadequate preoperative pupil dilation|1|||
23419484|NCT01579565|65280269|FG000|Randomized|prohibited preoperative eating|1|||
23419485|NCT01579565|65280270|FG001|Randomized|prohibited preoperative eating|0|||
23419486|NCT01579565|65280269|FG000|Randomized|prohibited preoperative medication|0|||
23419487|NCT01579565|65280270|FG001|Randomized|prohibited preoperative medication|1|||
23419488|NCT01579565|65280269|FG000|Treated|Physician Decision|0|||
23419489|NCT01579565|65280270|FG001|Treated|Physician Decision|1|||
23419490|NCT01579565|65280269|FG000|Treated|Lost to Follow-up|2|||
23419491|NCT01579565|65280270|FG001|Treated|Lost to Follow-up|1|||
23419492|NCT01579565|65280269|FG000|Treated|declined to return for final visit|0|||
23419493|NCT01579565|65280270|FG001|Treated|declined to return for final visit|1|||
23419494|NCT00778258|65280271|FG000|Overall Study|Adverse Event|1|||
23419495|NCT00778258|65280272|FG001|Overall Study|Adverse Event|0|||
23419496|NCT00778258|65280273|FG002|Overall Study|Adverse Event|0|||
23419497|NCT00778258|65280274|FG003|Overall Study|Adverse Event|0|||
23419498|NCT00778258|65280275|FG004|Overall Study|Adverse Event|0|||
23419499|NCT00778258|65280276|FG005|Overall Study|Adverse Event|1|||
23419500|NCT00778258|65280277|FG006|Overall Study|Adverse Event|0|||
23419501|NCT00778258|65280278|FG007|Overall Study|Adverse Event|0|||
23419502|NCT00778258|65280279|FG008|Overall Study|Adverse Event|0|||
23419503|NCT00778258|65280271|FG000|Overall Study|Lost to Follow-up|0|||
23419504|NCT00778258|65280272|FG001|Overall Study|Lost to Follow-up|0|||
23419505|NCT00778258|65280273|FG002|Overall Study|Lost to Follow-up|2|||
23419506|NCT00778258|65280274|FG003|Overall Study|Lost to Follow-up|0|||
23419507|NCT00778258|65280275|FG004|Overall Study|Lost to Follow-up|0|||
23419508|NCT00778258|65280276|FG005|Overall Study|Lost to Follow-up|3|||
23419509|NCT00778258|65280277|FG006|Overall Study|Lost to Follow-up|2|||
23419510|NCT00778258|65280278|FG007|Overall Study|Lost to Follow-up|2|||
23419511|NCT00778258|65280279|FG008|Overall Study|Lost to Follow-up|0|||
23419512|NCT00778258|65280271|FG000|Overall Study|Withdrawal by Subject|6|||
23419513|NCT00778258|65280272|FG001|Overall Study|Withdrawal by Subject|2|||
23419514|NCT00778258|65280273|FG002|Overall Study|Withdrawal by Subject|8|||
23419515|NCT00778258|65280274|FG003|Overall Study|Withdrawal by Subject|2|||
23419516|NCT00778258|65280275|FG004|Overall Study|Withdrawal by Subject|0|||
23419517|NCT00778258|65280276|FG005|Overall Study|Withdrawal by Subject|6|||
23419518|NCT00778258|65280277|FG006|Overall Study|Withdrawal by Subject|12|||
23419519|NCT00778258|65280278|FG007|Overall Study|Withdrawal by Subject|12|||
23419520|NCT00778258|65280279|FG008|Overall Study|Withdrawal by Subject|4|||
23419521|NCT00778258|65280271|FG000|Overall Study|New Contraindication|0|||
23419522|NCT00778258|65280272|FG001|Overall Study|New Contraindication|0|||
23419523|NCT00778258|65280273|FG002|Overall Study|New Contraindication|0|||
23419524|NCT00778258|65280274|FG003|Overall Study|New Contraindication|0|||
23419525|NCT00778258|65280275|FG004|Overall Study|New Contraindication|0|||
23419526|NCT00778258|65280276|FG005|Overall Study|New Contraindication|0|||
23419527|NCT00778258|65280277|FG006|Overall Study|New Contraindication|0|||
23419528|NCT00778258|65280278|FG007|Overall Study|New Contraindication|1|||
23419529|NCT00778258|65280279|FG008|Overall Study|New Contraindication|0|||
23419530|NCT00778258|65280271|FG000|Overall Study|Non-compliance|0|||
23419531|NCT00778258|65280272|FG001|Overall Study|Non-compliance|0|||
23419532|NCT00778258|65280273|FG002|Overall Study|Non-compliance|0|||
23419533|NCT00778258|65280274|FG003|Overall Study|Non-compliance|1|||
23531019|NCT01641367|65680002|FG004|Cohorts|Lost to Follow-up|2|||
23531020|NCT01641367|65680003|FG005|Cohorts|Lost to Follow-up|0|||
23419534|NCT00778258|65280275|FG004|Overall Study|Non-compliance|0|||
23419535|NCT00778258|65280276|FG005|Overall Study|Non-compliance|0|||
23419536|NCT00778258|65280277|FG006|Overall Study|Non-compliance|0|||
23419537|NCT00778258|65280278|FG007|Overall Study|Non-compliance|0|||
23419538|NCT00778258|65280279|FG008|Overall Study|Non-compliance|0|||
23531021|NCT01641367|65680004|FG006|Cohorts|Lost to Follow-up|0|||
23419539|NCT00778258|65280271|FG000|Overall Study|Other|0|||
23419540|NCT00778258|65280272|FG001|Overall Study|Other|0|||
23419541|NCT00778258|65280273|FG002|Overall Study|Other|0|||
23419542|NCT00778258|65280274|FG003|Overall Study|Other|0|||
23419543|NCT00778258|65280275|FG004|Overall Study|Other|0|||
23419544|NCT00778258|65280276|FG005|Overall Study|Other|0|||
23419545|NCT00778258|65280277|FG006|Overall Study|Other|1|||
23419546|NCT00778258|65280278|FG007|Overall Study|Other|0|||
23531022|NCT01641367|65680005|FG007|Cohorts|Lost to Follow-up|0|||
23531023|NCT01641367|65679998|FG000|Randomized Adherence Intervention|Death|0|||
23531024|NCT01641367|65679999|FG001|Randomized Adherence Intervention|Death|0|||
23531025|NCT01641367|65680000|FG002|Randomized Adherence Intervention|Death|0|||
23531026|NCT01641367|65680001|FG003|Randomized Adherence Intervention|Death|0|||
23531027|NCT01641367|65680002|FG004|Randomized Adherence Intervention|Death|0|||
23531028|NCT01641367|65680003|FG005|Randomized Adherence Intervention|Death|0|||
23531029|NCT01641367|65680004|FG006|Randomized Adherence Intervention|Death|11|||
23531030|NCT01641367|65680005|FG007|Randomized Adherence Intervention|Death|12|||
23531031|NCT01641367|65679998|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531032|NCT01641367|65679999|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531033|NCT01641367|65680000|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531034|NCT01641367|65680001|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531035|NCT01641367|65680002|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531036|NCT01641367|65680003|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
23531037|NCT01641367|65680004|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
23531038|NCT01641367|65680005|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
23531039|NCT02696096|65680006|FG000|Overall Study|ruled out at screening|1|||
23531040|NCT02696096|65680006|FG000|Overall Study|did not attend second fMRI|1|||
23531041|NCT01986829|65680007|FG000|Overall Study|Death|1|||
23531042|NCT03364049|65680008|FG000|Overall Study|Death|6|||
23419547|NCT00778258|65280279|FG008|Overall Study|Other|0|||
23419548|NCT00096226|65280282|FG000|Overall Study|Ineligible|2|||
23419549|NCT00096226|65280282|FG000|Overall Study|Protocol treatment not started|1|||
23419550|NCT03172325|65280285|FG000|Overall Study|Adverse Event|2|||
23419551|NCT03172325|65280286|FG001|Overall Study|Adverse Event|3|||
23419552|NCT03172325|65280285|FG000|Overall Study|Positive PPD|1|||
23419553|NCT03172325|65280286|FG001|Overall Study|Positive PPD|0|||
23419554|NCT03172325|65280285|FG000|Overall Study|Poor Compliance|1|||
23419555|NCT03172325|65280286|FG001|Overall Study|Poor Compliance|1|||
23419556|NCT02557100|65280290|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
23419557|NCT02557100|65280291|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
23419558|NCT02557100|65280292|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
23419559|NCT02557100|65280290|FG000|Single Blind Treatment Period|Death|0|||
23419560|NCT02557100|65280291|FG001|Single Blind Treatment Period|Death|1|||
23419561|NCT02557100|65280292|FG002|Single Blind Treatment Period|Death|0|||
23419562|NCT02557100|65280290|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
23419563|NCT02557100|65280291|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
23419564|NCT02557100|65280292|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
23419565|NCT02557100|65280290|FG000|Single Blind Treatment Period|Adverse Event|0|||
23419566|NCT02557100|65280291|FG001|Single Blind Treatment Period|Adverse Event|1|||
23419567|NCT02557100|65280292|FG002|Single Blind Treatment Period|Adverse Event|0|||
23419568|NCT02557100|65280290|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
23419569|NCT02557100|65280291|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
23419570|NCT02557100|65280292|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
23419571|NCT02557100|65280290|FG000|Cumulative Abatacept Period|Other Reasons|0|||
23419572|NCT02557100|65280291|FG001|Cumulative Abatacept Period|Other Reasons|0|||
23419573|NCT02557100|65280292|FG002|Cumulative Abatacept Period|Other Reasons|1|||
23419574|NCT02557100|65280290|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
23419575|NCT02557100|65280291|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
23419576|NCT02557100|65280292|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
23419577|NCT02557100|65280290|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
23419578|NCT02557100|65280291|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
23419579|NCT02557100|65280292|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
23419580|NCT00923975|65280295|FG000|Overall Study|Did not meet inclusion criteria|1|||
23419581|NCT03319953|65280296|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
23531043|NCT03364049|65680009|FG001|Overall Study|Death|4|||
23419582|NCT03319953|65280297|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
23419583|NCT03319953|65280298|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
23531044|NCT03364049|65680010|FG002|Overall Study|Death|5|||
23531045|NCT03364049|65680011|FG003|Overall Study|Death|14|||
23582175|NCT02223793|65862353|FG002|Overall Study|Withdrawal by Subject|3|||
23419584|NCT03319953|65280299|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
23419585|NCT03319953|65280296|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
23419586|NCT03319953|65280297|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
23419587|NCT03319953|65280298|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
23419588|NCT03319953|65280299|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
23419589|NCT00519376|65280302|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419590|NCT00519376|65280303|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419591|NCT00519376|65280304|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419592|NCT00519376|65280305|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419593|NCT00519376|65280306|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419594|NCT00519376|65280307|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419595|NCT00519376|65280308|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419596|NCT00519376|65280309|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419597|NCT00519376|65280310|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419598|NCT00519376|65280311|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419599|NCT00519376|65280312|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419600|NCT00519376|65280313|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419601|NCT00519376|65280314|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
23419602|NCT00519376|65280315|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419603|NCT00519376|65280316|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419604|NCT00519376|65280317|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
23419605|NCT00519376|65280302|FG000|Treatment Period 4|Lost to Follow-up|0|||
23419606|NCT00519376|65280303|FG001|Treatment Period 4|Lost to Follow-up|0|||
23419607|NCT00519376|65280304|FG002|Treatment Period 4|Lost to Follow-up|1|||
23419608|NCT00519376|65280305|FG003|Treatment Period 4|Lost to Follow-up|0|||
23419609|NCT00519376|65280306|FG004|Treatment Period 4|Lost to Follow-up|0|||
23419610|NCT00519376|65280307|FG005|Treatment Period 4|Lost to Follow-up|0|||
23419611|NCT00519376|65280308|FG006|Treatment Period 4|Lost to Follow-up|0|||
23419612|NCT00519376|65280309|FG007|Treatment Period 4|Lost to Follow-up|0|||
23419613|NCT00519376|65280310|FG008|Treatment Period 4|Lost to Follow-up|0|||
23419614|NCT00519376|65280311|FG009|Treatment Period 4|Lost to Follow-up|0|||
23419615|NCT00519376|65280312|FG010|Treatment Period 4|Lost to Follow-up|0|||
23419616|NCT00519376|65280313|FG011|Treatment Period 4|Lost to Follow-up|0|||
23419617|NCT00519376|65280314|FG012|Treatment Period 4|Lost to Follow-up|0|||
23419618|NCT00519376|65280315|FG013|Treatment Period 4|Lost to Follow-up|0|||
23419619|NCT00519376|65280316|FG014|Treatment Period 4|Lost to Follow-up|0|||
23419620|NCT00519376|65280317|FG015|Treatment Period 4|Lost to Follow-up|0|||
23419621|NCT03315793|65280318|FG000|Overall Study|Adverse Event|4|||
23419622|NCT03315793|65280319|FG001|Overall Study|Adverse Event|2|||
23419623|NCT03315793|65280318|FG000|Overall Study|Protocol Deviation|1|||
23419624|NCT03315793|65280319|FG001|Overall Study|Protocol Deviation|0|||
23419625|NCT03315793|65280318|FG000|Overall Study|Difficult for regular visit|0|||
23419626|NCT03315793|65280319|FG001|Overall Study|Difficult for regular visit|1|||
23419627|NCT00064259|65280324|FG000|Overall Study|Adverse Event|1|||
23419628|NCT00064259|65280325|FG001|Overall Study|Adverse Event|0|||
23419629|NCT00064259|65280326|FG002|Overall Study|Adverse Event|0|||
23419630|NCT00064259|65280327|FG003|Overall Study|Adverse Event|1|||
23419631|NCT01118520|65280334|FG000|Overall Study|AAA repair|9|||
23419632|NCT01118520|65280335|FG001|Overall Study|AAA repair|7|||
23419633|NCT01118520|65280336|FG002|Overall Study|AAA repair|9|||
23419634|NCT01118520|65280334|FG000|Overall Study|Adverse Event|3|||
23419635|NCT01118520|65280335|FG001|Overall Study|Adverse Event|3|||
23419636|NCT01118520|65280336|FG002|Overall Study|Adverse Event|3|||
23419637|NCT01118520|65280334|FG000|Overall Study|Withdrawal by Subject|8|||
23419638|NCT01118520|65280335|FG001|Overall Study|Withdrawal by Subject|13|||
23419639|NCT01118520|65280336|FG002|Overall Study|Withdrawal by Subject|8|||
23419640|NCT00676520|65280339|FG000|Overall Study|Withdrawal by Subject|163|||
23419641|NCT00676520|65280339|FG000|Overall Study|Lost to Follow-up|162|||
23419642|NCT00676520|65280339|FG000|Overall Study|Death|159|||
23419643|NCT00676520|65280339|FG000|Overall Study|Physician Decision|20|||
23419644|NCT00676520|65280339|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
23419645|NCT00676520|65280339|FG000|Overall Study|Other Reason|18|||
23419646|NCT01566149|65280340|FG000|Overall Study|Adverse Event|0|||
23419647|NCT01566149|65280341|FG001|Overall Study|Adverse Event|1|||
23419648|NCT01566149|65280340|FG000|Overall Study|Non-compliance with study medication|2|||
23419649|NCT01566149|65280341|FG001|Overall Study|Non-compliance with study medication|0|||
23207383|NCT00710034|64498194|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
23419650|NCT01566149|65280340|FG000|Overall Study|Protocol Violation|0|||
23419651|NCT01566149|65280341|FG001|Overall Study|Protocol Violation|1|||
23419652|NCT01566149|65280340|FG000|Overall Study|Withdrawal by Subject|1|||
23419653|NCT01566149|65280341|FG001|Overall Study|Withdrawal by Subject|0|||
23419654|NCT02099344|65280344|FG000|Overall Study|Physician Decision|1|||
23419655|NCT02099344|65280345|FG001|Overall Study|Physician Decision|0|||
23419656|NCT01159171|65280346|FG000|Overall Study|Adverse Event|11|||
23419657|NCT01159171|65280346|FG000|Overall Study|Progression of Disease|28|||
23419658|NCT01159171|65280346|FG000|Overall Study|Protocol Violation|1|||
23419659|NCT01159171|65280346|FG000|Overall Study|Need for Surgery|5|||
23419660|NCT01159171|65280346|FG000|Overall Study|Medical Decision|4|||
23419661|NCT01159171|65280346|FG000|Overall Study|Death|1|||
23419662|NCT01691885|65280349|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
23419663|NCT01691885|65280350|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
23419664|NCT01691885|65280349|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
23419665|NCT01691885|65280350|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
23419666|NCT01166373|65280353|FG000|Overall Study|Lost to Follow-up|3|||
23419667|NCT01166373|65280354|FG001|Overall Study|Lost to Follow-up|2|||
23419668|NCT01166373|65280355|FG002|Overall Study|Lost to Follow-up|2|||
23419669|NCT01166373|65280356|FG003|Overall Study|Lost to Follow-up|2|||
23419670|NCT01166373|65280353|FG000|Overall Study|Withdrawal by Subject|1|||
23419671|NCT01166373|65280354|FG001|Overall Study|Withdrawal by Subject|2|||
23419672|NCT01166373|65280355|FG002|Overall Study|Withdrawal by Subject|2|||
23419673|NCT01166373|65280356|FG003|Overall Study|Withdrawal by Subject|3|||
23419674|NCT01166373|65280353|FG000|Overall Study|Physician Decision|1|||
23419675|NCT01166373|65280354|FG001|Overall Study|Physician Decision|0|||
23419676|NCT01166373|65280355|FG002|Overall Study|Physician Decision|0|||
23419677|NCT01166373|65280356|FG003|Overall Study|Physician Decision|0|||
23419678|NCT00559845|65280357|FG000|Overall Study|Withdrew Consent|1|||
23419679|NCT00559845|65280357|FG000|Overall Study|Disease Progression|1|||
23419680|NCT00559845|65280357|FG000|Overall Study|Adverse Event|3|||
23419681|NCT00559845|65280357|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
23419682|NCT00559845|65280357|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
23419683|NCT04065074|65280358|FG000|Overall Study|Adverse Event|1|||
23419684|NCT04065074|65280358|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
23419685|NCT00090142|65280362|FG000|Treatment Period I|Lost to Follow-up|1|||
23419686|NCT00090142|65280363|FG001|Treatment Period I|Lost to Follow-up|2|||
23419687|NCT00090142|65280362|FG000|Treatment Period I|Protocol Violation|2|||
23419688|NCT00090142|65280363|FG001|Treatment Period I|Protocol Violation|0|||
23419689|NCT00090142|65280362|FG000|Treatment Period I|Withdrawal by Subject|2|||
23419690|NCT00090142|65280363|FG001|Treatment Period I|Withdrawal by Subject|0|||
23419691|NCT00090142|65280362|FG000|Treatment Period I|Other|0|||
23419692|NCT00090142|65280363|FG001|Treatment Period I|Other|1|||
23419693|NCT00090142|65280362|FG000|Treatment Period II|Other|1|||
23419694|NCT00090142|65280363|FG001|Treatment Period II|Other|0|||
23419695|NCT04600076|65280372|FG000|Overall Study|Lost to Follow-up|3|||
23419696|NCT00948857|65280373|FG000|Overall Study|Lost to Follow-up|1|||
23419697|NCT00948857|65280374|FG001|Overall Study|Lost to Follow-up|0|||
23419698|NCT00790647|65280376|FG000|Overall Study|Adverse Event|1|||
23419699|NCT03116828|65280377|FG000|Overall Study|Adverse Event|1|||
23419700|NCT03116828|65280378|FG001|Overall Study|Adverse Event|10|||
23419701|NCT03116828|65280377|FG000|Overall Study|Withdrawal by Subject|4|||
23419702|NCT03116828|65280378|FG001|Overall Study|Withdrawal by Subject|8|||
23419703|NCT03116828|65280377|FG000|Overall Study|OTHER|3|||
23419704|NCT03116828|65280378|FG001|Overall Study|OTHER|3|||
23419705|NCT01177553|65280381|FG000|Overall Study|babies not yet 6 months of age|1|||
23419706|NCT01177553|65280382|FG001|Overall Study|babies not yet 6 months of age|0|||
23419707|NCT01734395|65280383|FG000|Overall Study|Other|65|||
23419708|NCT01734395|65280383|FG000|Overall Study|Lost to Follow-up|287|||
23419709|NCT01734395|65280383|FG000|Overall Study|Lack of Efficacy|5|||
23419710|NCT01734395|65280383|FG000|Overall Study|Adverse Event|40|||
23419711|NCT01734395|65280383|FG000|Overall Study|Withdrawal by Subject|10|||
23419712|NCT01734395|65280383|FG000|Overall Study|Missing the reasons for not completed|3|||
23419713|NCT02247011|65280386|FG000|Overall Study|Poor quality of radiological results|125|||
23419714|NCT02509052|65280387|FG000|Overall Study|Non compliance|0|||
23419715|NCT02509052|65280388|FG001|Overall Study|Non compliance|0|||
23419716|NCT02509052|65280389|FG002|Overall Study|Non compliance|1|||
23419717|NCT02039219|65280390|FG000|Treatment|Withdrawal by Subject|1|||
23419718|NCT02039219|65280391|FG001|Treatment|Withdrawal by Subject|0|||
23419719|NCT02039219|65280390|FG000|Treatment|Adverse Event|0|||
23419720|NCT02039219|65280391|FG001|Treatment|Adverse Event|1|||
23419721|NCT02039219|65280390|FG000|Treatment|Physician Decision|1|||
23419722|NCT02039219|65280391|FG001|Treatment|Physician Decision|0|||
23419723|NCT02039219|65280390|FG000|Treatment|Lost to Follow-up|0|||
23613197|NCT02959866|65969812|FG000|Overall Study|Withdrawal by Subject|1|||
23419724|NCT02039219|65280391|FG001|Treatment|Lost to Follow-up|1|||
23419725|NCT02039219|65280390|FG000|Treatment|Protocol Violation|1|||
23419726|NCT02039219|65280391|FG001|Treatment|Protocol Violation|0|||
23419727|NCT02039219|65280390|FG000|Treatment|Death|1|||
23419728|NCT02039219|65280391|FG001|Treatment|Death|0|||
23419729|NCT02039219|65280390|FG000|Follow up|Adverse Event|0|||
23419730|NCT02039219|65280391|FG001|Follow up|Adverse Event|1|||
23419731|NCT00570037|65280392|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
23419732|NCT00570037|65280393|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
23419733|NCT00737711|65280394|FG000|Overall Study|Adverse Event|2|||
23419734|NCT00737711|65280394|FG000|Overall Study|Death|8|||
23419735|NCT00737711|65280394|FG000|Overall Study|Failure to return|4|||
23419736|NCT00737711|65280394|FG000|Overall Study|Protocol Violation|1|||
23419737|NCT00737711|65280394|FG000|Overall Study|Withdrawal by Subject|5|||
23419738|NCT00737711|65280394|FG000|Overall Study|Blood transfusion|6|||
23419739|NCT00737711|65280394|FG000|Overall Study|Other|5|||
23419740|NCT00404755|65280395|FG000|Phase I (Bupropion)|Adverse Event|3|||
23419741|NCT00404755|65280395|FG000|Phase I (Bupropion)|Other|1|||
23419742|NCT00404755|65280395|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
23419743|NCT03359785|65280399|FG000|Overall Study|Protocol Violation|0|||
23419744|NCT03359785|65280400|FG001|Overall Study|Protocol Violation|1|||
23419745|NCT03359785|65280401|FG002|Overall Study|Protocol Violation|0|||
23419746|NCT03359785|65280402|FG003|Overall Study|Protocol Violation|0|||
23419747|NCT03359785|65280399|FG000|Overall Study|Early study termination due to study pause|0|||
23419748|NCT03359785|65280400|FG001|Overall Study|Early study termination due to study pause|0|||
23419749|NCT03359785|65280401|FG002|Overall Study|Early study termination due to study pause|2|||
23419750|NCT03359785|65280402|FG003|Overall Study|Early study termination due to study pause|0|||
23419751|NCT03359785|65280399|FG000|Overall Study|Withdrawal by Subject|2|||
23419752|NCT03359785|65280400|FG001|Overall Study|Withdrawal by Subject|2|||
23419753|NCT03359785|65280401|FG002|Overall Study|Withdrawal by Subject|0|||
23419754|NCT03359785|65280402|FG003|Overall Study|Withdrawal by Subject|0|||
23207384|NCT00710034|64498195|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
23419755|NCT03555981|65280405|FG000|Overall Study|Lost to Follow-up|0|||
23419756|NCT03555981|65280406|FG001|Overall Study|Lost to Follow-up|2|||
23419757|NCT01626118|65280407|FG000|Overall Study|Lack of Efficacy|1|||
23419758|NCT01626118|65280408|FG001|Overall Study|Lack of Efficacy|0|||
23419759|NCT01626118|65280409|FG002|Overall Study|Lack of Efficacy|1|||
23419760|NCT01626118|65280410|FG003|Overall Study|Lack of Efficacy|3|||
23419761|NCT01626118|65280407|FG000|Overall Study|Lost to Follow-up|1|||
23419762|NCT01626118|65280408|FG001|Overall Study|Lost to Follow-up|0|||
23419763|NCT01626118|65280409|FG002|Overall Study|Lost to Follow-up|0|||
23419764|NCT01626118|65280410|FG003|Overall Study|Lost to Follow-up|0|||
23419765|NCT01626118|65280407|FG000|Overall Study|Adverse Event|0|||
23419766|NCT01626118|65280408|FG001|Overall Study|Adverse Event|1|||
23419767|NCT01626118|65280409|FG002|Overall Study|Adverse Event|1|||
23419768|NCT01626118|65280410|FG003|Overall Study|Adverse Event|0|||
23419769|NCT01626118|65280407|FG000|Overall Study|Investigator Decision|0|||
23419770|NCT01626118|65280408|FG001|Overall Study|Investigator Decision|1|||
23531046|NCT03364049|65680008|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
23582176|NCT02223793|65862351|FG000|Overall Study|Moved/studycenter unable to participate|4|||
23207385|NCT00710034|64498194|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
23207386|NCT00710034|64498195|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
23207387|NCT00710034|64498194|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
23419771|NCT01626118|65280409|FG002|Overall Study|Investigator Decision|0|||
23419772|NCT01626118|65280410|FG003|Overall Study|Investigator Decision|0|||
23419773|NCT00394251|65280412|FG000|Overall Study|Adverse Event|7|||
23419774|NCT00394251|65280413|FG001|Overall Study|Adverse Event|5|||
23419775|NCT00394251|65280412|FG000|Overall Study|Unacceptable Toxicity|20|||
23419776|NCT00394251|65280413|FG001|Overall Study|Unacceptable Toxicity|18|||
23419777|NCT00394251|65280412|FG000|Overall Study|Physician Decision|1|||
23419778|NCT00394251|65280413|FG001|Overall Study|Physician Decision|1|||
23419779|NCT00394251|65280412|FG000|Overall Study|Protocol Violation|0|||
23419780|NCT00394251|65280413|FG001|Overall Study|Protocol Violation|1|||
23419781|NCT00394251|65280412|FG000|Overall Study|Withdrawal by Subject|7|||
23419782|NCT00394251|65280413|FG001|Overall Study|Withdrawal by Subject|11|||
23419783|NCT00394251|65280412|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
23419784|NCT00394251|65280413|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
23419785|NCT00283803|65280422|FG000|Overall Study|Physician Decision|9|||
23419786|NCT00283803|65280422|FG000|Overall Study|Withdrawal by Subject|4|||
23419787|NCT05260073|65280423|FG000|Overall Study|Physician Decision|1|||
23419788|NCT05260073|65280423|FG000|Overall Study|Withdrawal by Subject|6|||
23419789|NCT05260073|65280423|FG000|Overall Study|Lost to Follow-up|14|||
23419790|NCT03299881|65280428|FG000|Overall Study|Study Termination|17|||
23419791|NCT03299881|65280429|FG001|Overall Study|Study Termination|13|||
23419792|NCT01345591|65280430|FG000|Overall Study|Lost to Follow-up|1|||
23419793|NCT01921218|65280437|FG000|Overall Study|Death|2|||
23419794|NCT01921218|65280438|FG001|Overall Study|Death|1|||
23419795|NCT01921218|65280437|FG000|Overall Study|Withdrawal by Subject|0|||
23419796|NCT01921218|65280438|FG001|Overall Study|Withdrawal by Subject|2|||
23419797|NCT01921218|65280437|FG000|Overall Study|Kidney transplant|1|||
23419798|NCT01921218|65280438|FG001|Overall Study|Kidney transplant|1|||
23419799|NCT04173260|65280439|FG000|Overall Study|Early termination|4|||
23419800|NCT03596047|65280442|FG000|Overall Study|Withdrawal by Subject|7|||
23419801|NCT03596047|65280443|FG001|Overall Study|Withdrawal by Subject|4|||
23419802|NCT03596047|65280442|FG000|Overall Study|Lost to Follow-up|0|||
23419803|NCT03596047|65280443|FG001|Overall Study|Lost to Follow-up|2|||
23419804|NCT03389555|65280444|FG000|Overall Study|Protocol Violation|1|||
23419805|NCT03389555|65280445|FG001|Overall Study|Protocol Violation|3|||
23419806|NCT03389555|65280444|FG000|Overall Study|Death|1|||
23419807|NCT03389555|65280445|FG001|Overall Study|Death|0|||
23531047|NCT03364049|65680009|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
23531048|NCT03364049|65680010|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
23531049|NCT03364049|65680011|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
23531050|NCT03364049|65680008|FG000|Overall Study|Withdrawal by Subject|0|||
23531051|NCT03364049|65680009|FG001|Overall Study|Withdrawal by Subject|1|||
23531052|NCT03364049|65680010|FG002|Overall Study|Withdrawal by Subject|1|||
23531053|NCT03364049|65680011|FG003|Overall Study|Withdrawal by Subject|1|||
23531054|NCT00813124|65680012|FG000|Overall Study|Death|2|||
23531055|NCT00813124|65680012|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
23531056|NCT00813124|65680012|FG000|Overall Study|Withdrawal by Subject|1|||
23531057|NCT00414661|65680017|FG000|Overall Study|Death|2|||
23531058|NCT00414661|65680018|FG001|Overall Study|Death|5|||
23531059|NCT00414661|65680019|FG002|Overall Study|Death|0|||
23531060|NCT00414661|65680020|FG003|Overall Study|Death|0|||
23531061|NCT00414661|65680017|FG000|Overall Study|Lost to Follow-up|1|||
23531062|NCT00414661|65680018|FG001|Overall Study|Lost to Follow-up|4|||
23531063|NCT00414661|65680019|FG002|Overall Study|Lost to Follow-up|0|||
23531064|NCT00414661|65680020|FG003|Overall Study|Lost to Follow-up|1|||
23531065|NCT00414661|65680017|FG000|Overall Study|Withdrawal by Subject|5|||
23531066|NCT00414661|65680018|FG001|Overall Study|Withdrawal by Subject|2|||
23531067|NCT00414661|65680019|FG002|Overall Study|Withdrawal by Subject|2|||
23531068|NCT00414661|65680020|FG003|Overall Study|Withdrawal by Subject|2|||
23531069|NCT00414661|65680017|FG000|Overall Study|Other|6|||
23531070|NCT00414661|65680018|FG001|Overall Study|Other|3|||
23531071|NCT00414661|65680019|FG002|Overall Study|Other|0|||
23531072|NCT00414661|65680020|FG003|Overall Study|Other|0|||
23531073|NCT00482391|65680021|FG000|Overall Study|Withdrawal by Subject|1|||
23531074|NCT00482391|65680021|FG000|Overall Study|Adverse Event|1|||
23531075|NCT00482391|65680021|FG000|Overall Study|Death|1|||
23531076|NCT00700011|65680022|FG000|Overall Study|Death|0|||
23531077|NCT00700011|65680023|FG001|Overall Study|Death|1|||
23531078|NCT05009251|65680026|FG000|Overall Study|Protocol Violation|100|||
23531079|NCT05009251|65680027|FG001|Overall Study|Protocol Violation|105|||
23531080|NCT05009251|65680028|FG002|Overall Study|Protocol Violation|119|||
23531081|NCT05009251|65680029|FG003|Overall Study|Protocol Violation|120|||
23531082|NCT05009251|65680030|FG004|Overall Study|Protocol Violation|119|||
23531083|NCT05009251|65680026|FG000|Overall Study|Death|25|||
23531084|NCT05009251|65680027|FG001|Overall Study|Death|22|||
23531085|NCT05009251|65680028|FG002|Overall Study|Death|24|||
23531086|NCT05009251|65680029|FG003|Overall Study|Death|19|||
23531087|NCT05009251|65680030|FG004|Overall Study|Death|15|||
23531088|NCT03354429|65680048|FG000|Overall Study|Withdrawal by Subject|8|||
23531089|NCT03354429|65680049|FG001|Overall Study|Withdrawal by Subject|7|||
23531090|NCT03354429|65680048|FG000|Overall Study|Lost to Follow-up|1|||
23531091|NCT03354429|65680049|FG001|Overall Study|Lost to Follow-up|0|||
23531092|NCT02579616|65680050|FG000|Overall Study|Participants did not receive treatment|3|||
23531093|NCT00499603|65680053|FG000|Overall Study|Adverse Event|0|||
23613198|NCT01655498|65969813|FG000|Overall Study|Unrelated health issue|2|||
23613199|NCT01655498|65969813|FG000|Overall Study|Protocol Violation|2|||
23531094|NCT00499603|65680054|FG001|Overall Study|Adverse Event|1|||
23531095|NCT01786629|65680055|FG000|Overall Study|Lack of Efficacy|0|||
23613200|NCT01655498|65969813|FG000|Overall Study|Withdrawal by Subject|1|||
23613201|NCT00839306|65969821|FG000|Overall Study|Adverse Event|3|||
23531096|NCT01786629|65680056|FG001|Overall Study|Lack of Efficacy|4|||
23531097|NCT01786629|65680055|FG000|Overall Study|Adverse Event|0|||
23531098|NCT01786629|65680056|FG001|Overall Study|Adverse Event|1|||
23531099|NCT00451282|65680057|FG000|Overall Study|Lost to Follow-up|6|||
23531100|NCT00451282|65680058|FG001|Overall Study|Lost to Follow-up|5|||
23531101|NCT00952341|65680059|FG000|Cycle 1|Adverse Event|4|||
23531102|NCT00952341|65680060|FG001|Cycle 1|Adverse Event|1|||
23531103|NCT00952341|65680059|FG000|Cycle 1|Withdrawal by Subject|3|||
23613202|NCT00839306|65969822|FG001|Overall Study|Adverse Event|5|||
23613203|NCT00839306|65969821|FG000|Overall Study|Lost to Follow-up|6|||
23613204|NCT00839306|65969822|FG001|Overall Study|Lost to Follow-up|9|||
23613205|NCT00839306|65969821|FG000|Overall Study|Withdrawal by Subject|5|||
23613206|NCT00839306|65969822|FG001|Overall Study|Withdrawal by Subject|7|||
23613207|NCT00839306|65969821|FG000|Overall Study|Lack of Efficacy|5|||
23613208|NCT00839306|65969822|FG001|Overall Study|Lack of Efficacy|4|||
23613209|NCT00839306|65969821|FG000|Overall Study|Other|6|||
23613210|NCT00839306|65969822|FG001|Overall Study|Other|18|||
23613211|NCT01636258|65969823|FG000|Overall Study|Lost to Follow-up|1|||
23531104|NCT00952341|65680060|FG001|Cycle 1|Withdrawal by Subject|8|||
23531105|NCT00952341|65680059|FG000|Cycle 1|Protocol Violation|2|||
23531106|NCT00952341|65680060|FG001|Cycle 1|Protocol Violation|1|||
23531107|NCT00952341|65680059|FG000|Cycle 1|Lost to Follow-up|11|||
23531108|NCT00952341|65680060|FG001|Cycle 1|Lost to Follow-up|2|||
23531109|NCT00952341|65680059|FG000|Cycle 1|Physician Decision|0|||
23531110|NCT00952341|65680060|FG001|Cycle 1|Physician Decision|1|||
23531111|NCT00952341|65680059|FG000|Cycle 2|Withdrawal by Subject|1|||
23531112|NCT00952341|65680060|FG001|Cycle 2|Withdrawal by Subject|1|||
23531113|NCT00952341|65680059|FG000|Cycle 2|Protocol Violation|1|||
23531114|NCT00952341|65680060|FG001|Cycle 2|Protocol Violation|0|||
23531115|NCT00952341|65680059|FG000|Cycle 2|Lost to Follow-up|6|||
23531116|NCT00952341|65680060|FG001|Cycle 2|Lost to Follow-up|9|||
23531117|NCT00952341|65680059|FG000|Cycle 2|Physician Decision|1|||
23531118|NCT00952341|65680060|FG001|Cycle 2|Physician Decision|1|||
23531119|NCT00952341|65680059|FG000|Cycle 2|Progressive Disease|0|||
23531120|NCT00952341|65680060|FG001|Cycle 2|Progressive Disease|1|||
23531121|NCT04055116|65680061|FG000|First Intervention|Physician Decision|2|||
23613212|NCT01636258|65969824|FG001|Overall Study|Lost to Follow-up|0|||
23613213|NCT01786551|65969825|FG000|Overall Study|Participant withdrew consent|2|||
23613214|NCT05072795|65969826|FG000|Overall Study|Lost to Follow-up|5|||
23613215|NCT01350102|65969827|FG000|Overall Study|Adverse Event|0|||
23613216|NCT01350102|65969828|FG001|Overall Study|Adverse Event|0|||
23613217|NCT01350102|65969829|FG002|Overall Study|Adverse Event|1|||
23613218|NCT01350102|65969830|FG003|Overall Study|Adverse Event|0|||
23613219|NCT03386344|65969831|FG000|Overall Study|Adverse Event|6|||
23613220|NCT03386344|65969832|FG001|Overall Study|Adverse Event|3|||
23613221|NCT03386344|65969833|FG002|Overall Study|Adverse Event|1|||
23613222|NCT03386344|65969831|FG000|Overall Study|Poor Compliance to Protocol|0|||
23613223|NCT03386344|65969832|FG001|Overall Study|Poor Compliance to Protocol|1|||
23613224|NCT03386344|65969833|FG002|Overall Study|Poor Compliance to Protocol|0|||
23613225|NCT03386344|65969831|FG000|Overall Study|Study Terminated by Sponsor|101|||
23613226|NCT03386344|65969832|FG001|Overall Study|Study Terminated by Sponsor|102|||
23613227|NCT03386344|65969833|FG002|Overall Study|Study Terminated by Sponsor|106|||
23613228|NCT03386344|65969831|FG000|Overall Study|Lost to Follow-up|3|||
23613229|NCT03386344|65969832|FG001|Overall Study|Lost to Follow-up|2|||
23613230|NCT03386344|65969833|FG002|Overall Study|Lost to Follow-up|1|||
23613231|NCT03386344|65969831|FG000|Overall Study|At the Participant's own Request|7|||
23613232|NCT03386344|65969832|FG001|Overall Study|At the Participant's own Request|7|||
23613233|NCT03386344|65969833|FG002|Overall Study|At the Participant's own Request|8|||
23613234|NCT03386344|65969831|FG000|Overall Study|Reason not Specified|0|||
23613235|NCT03386344|65969832|FG001|Overall Study|Reason not Specified|1|||
23613236|NCT03386344|65969833|FG002|Overall Study|Reason not Specified|0|||
23613237|NCT04361617|65969834|FG000|Overall Study|Withdrawal by Subject|0|||
23613238|NCT04361617|65969835|FG001|Overall Study|Withdrawal by Subject|1|||
23613239|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
23419808|NCT03245736|65280446|FG000|Overall Study|Adverse Event|1|||
23419809|NCT03245736|65280446|FG000|Overall Study|Progressive Disease|4|||
23419810|NCT02685748|65280447|FG000|Overall Study|Withdrawal by Subject|3|||
23419811|NCT02685748|65280448|FG001|Overall Study|Withdrawal by Subject|2|||
23419812|NCT00252694|65280449|FG000|Overall Study|Withdrawal by Subject|83|||
23419813|NCT00252694|65280450|FG001|Overall Study|Withdrawal by Subject|91|||
23419814|NCT00252694|65280449|FG000|Overall Study|Death|36|||
23419815|NCT00252694|65280450|FG001|Overall Study|Death|34|||
23419816|NCT00252694|65280449|FG000|Overall Study|Mostly Lost to Follow Up|8|||
23419817|NCT00252694|65280450|FG001|Overall Study|Mostly Lost to Follow Up|13|||
23419818|NCT00252694|65280449|FG000|Overall Study|Patient Moving|17|||
23419819|NCT00252694|65280450|FG001|Overall Study|Patient Moving|16|||
23531122|NCT04055116|65680062|FG001|First Intervention|Physician Decision|7|||
23531123|NCT02953821|65680063|FG000|Overall Study|Adverse Event|0|||
23531124|NCT02953821|65680064|FG001|Overall Study|Adverse Event|4|||
23531125|NCT02953821|65680063|FG000|Overall Study|Death|1|||
23613240|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
23613241|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
23613242|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
23613243|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
23613244|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
23531126|NCT02953821|65680064|FG001|Overall Study|Death|0|||
23531127|NCT02953821|65680063|FG000|Overall Study|Progressive Disease|5|||
23613245|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
23613246|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Death|0|||
23613247|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Death|1|||
23613248|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Death|0|||
23613249|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Death|0|||
23613250|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Death|0|||
23613251|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Death|0|||
23613252|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Death|0|||
23613253|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
23613254|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613255|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613256|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613257|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613258|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613259|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
23613260|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613261|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
23613262|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613263|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613264|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613265|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613266|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
23613267|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Other|1|||
23613268|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Other|0|||
23613269|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Other|0|||
23207388|NCT00710034|64498195|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
23207389|NCT03004469|64498196|FG000|Overall Study|Adverse Event|6|||
23309705|NCT03421730|64878055|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23309706|NCT03421730|64878056|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23531128|NCT02953821|65680064|FG001|Overall Study|Progressive Disease|1|||
23531129|NCT02953821|65680063|FG000|Overall Study|Lost to Follow-up|2|||
23531130|NCT02953821|65680064|FG001|Overall Study|Lost to Follow-up|0|||
23531131|NCT02953821|65680063|FG000|Overall Study|Physician Decision|1|||
23531132|NCT02953821|65680064|FG001|Overall Study|Physician Decision|1|||
23531133|NCT02953821|65680063|FG000|Overall Study|Withdrawal by Subject|3|||
23531134|NCT02953821|65680064|FG001|Overall Study|Withdrawal by Subject|3|||
23531135|NCT02953821|65680063|FG000|Overall Study|Change of address|0|||
23531136|NCT02953821|65680064|FG001|Overall Study|Change of address|1|||
23531137|NCT02953821|65680063|FG000|Overall Study|Lack of Efficacy|1|||
23531138|NCT02953821|65680064|FG001|Overall Study|Lack of Efficacy|0|||
23531139|NCT02953821|65680063|FG000|Overall Study|Out of state for indeterminate time|0|||
23531140|NCT02953821|65680064|FG001|Overall Study|Out of state for indeterminate time|1|||
23531141|NCT02953821|65680063|FG000|Overall Study|No improvement|0|||
23531142|NCT02953821|65680064|FG001|Overall Study|No improvement|1|||
23531143|NCT02953821|65680063|FG000|Overall Study|Refused follow-up visit|2|||
23531144|NCT02953821|65680064|FG001|Overall Study|Refused follow-up visit|1|||
23531145|NCT03795922|65680069|FG000|Overall Study|Adverse Event|2|||
23531146|NCT03795922|65680070|FG001|Overall Study|Adverse Event|1|||
23309707|NCT03421730|64878057|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23309708|NCT03421730|64878058|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23309709|NCT03421730|64878059|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
23309710|NCT02397408|64878060|FG000|Overall Study|Physician Decision|4|||
23309711|NCT02397408|64878060|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
23309712|NCT00792935|64881209|FG000|Overall Study|Adverse Event|2|||
23309713|NCT00792935|64881210|FG001|Overall Study|Adverse Event|1|||
23309714|NCT00792935|64881209|FG000|Overall Study|Lost to Follow-up|0|||
23309715|NCT00792935|64881210|FG001|Overall Study|Lost to Follow-up|1|||
23309716|NCT00792935|64881209|FG000|Overall Study|Protocol Violation|2|||
23309717|NCT00792935|64881210|FG001|Overall Study|Protocol Violation|0|||
23309718|NCT00792935|64881209|FG000|Overall Study|Withdrawal by Subject|0|||
23309719|NCT00792935|64881210|FG001|Overall Study|Withdrawal by Subject|1|||
23309720|NCT02853370|64881211|FG000|Overall Study|Physician Decision|1|||
23309721|NCT02853370|64881211|FG000|Overall Study|Lack of Efficacy|2|||
23309722|NCT02853370|64881211|FG000|Overall Study|Death|1|||
23309723|NCT02853370|64881211|FG000|Overall Study|Adverse Event|4|||
23309724|NCT02853370|64881211|FG000|Overall Study|Withdrawal by Subject|3|||
23309725|NCT04305587|64881212|FG000|Overall Study|Withdrawal by Subject|0|||
23531147|NCT03795922|65680069|FG000|Overall Study|Withdrawal by Subject|5|||
23531148|NCT03795922|65680070|FG001|Overall Study|Withdrawal by Subject|13|||
23613270|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Other|0|||
23613271|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Other|0|||
23531149|NCT03795922|65680069|FG000|Overall Study|Lost to Follow-up|2|||
23309726|NCT04305587|64881213|FG001|Overall Study|Withdrawal by Subject|0|||
23309727|NCT04305587|64881214|FG002|Overall Study|Withdrawal by Subject|0|||
23309728|NCT04305587|64881215|FG003|Overall Study|Withdrawal by Subject|1|||
23309729|NCT04305587|64881216|FG004|Overall Study|Withdrawal by Subject|0|||
23309730|NCT04305587|64881217|FG005|Overall Study|Withdrawal by Subject|0|||
23309731|NCT04305587|64881218|FG006|Overall Study|Withdrawal by Subject|0|||
23309732|NCT04305587|64881219|FG007|Overall Study|Withdrawal by Subject|0|||
23309733|NCT04305587|64881220|FG008|Overall Study|Withdrawal by Subject|0|||
23309734|NCT03371459|64881221|FG000|Washout|Lost to Follow-up|0|||
23309735|NCT03371459|64881222|FG001|Washout|Lost to Follow-up|1|||
23309736|NCT03559400|64881227|FG000|Overall Study|Lost to Follow-up|9|||
23309737|NCT03559400|64881228|FG001|Overall Study|Lost to Follow-up|7|||
23309738|NCT03559400|64881227|FG000|Overall Study|Death|0|||
23309739|NCT03559400|64881228|FG001|Overall Study|Death|2|||
23309740|NCT01898650|64881229|FG000|Overall Study|the subject would not lie still for imaging|1|||
23309741|NCT04715932|64881230|FG000|Overall Study|Lost to Follow-up|1|||
23309742|NCT04715932|64881231|FG001|Overall Study|Lost to Follow-up|0|||
23309743|NCT02932306|64881232|FG000|Overall Study|Withdrawal by Subject|16|||
23309744|NCT02932306|64881233|FG001|Overall Study|Withdrawal by Subject|25|||
23309745|NCT02932306|64881232|FG000|Overall Study|Adverse Event|3|||
23309746|NCT02932306|64881233|FG001|Overall Study|Adverse Event|0|||
23309747|NCT02932306|64881232|FG000|Overall Study|Pregnancy|2|||
23309748|NCT02932306|64881233|FG001|Overall Study|Pregnancy|0|||
23309749|NCT02932306|64881232|FG000|Overall Study|Protocol Violation|1|||
23309750|NCT02932306|64881233|FG001|Overall Study|Protocol Violation|1|||
23309751|NCT02932306|64881232|FG000|Overall Study|Noncompliance with Study Drug|1|||
23309752|NCT02932306|64881233|FG001|Overall Study|Noncompliance with Study Drug|1|||
23309753|NCT02932306|64881232|FG000|Overall Study|Lost to Follow-up|36|||
23309754|NCT02932306|64881233|FG001|Overall Study|Lost to Follow-up|40|||
23309755|NCT02932306|64881232|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
23309756|NCT02932306|64881233|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
23309757|NCT02932306|64881232|FG000|Overall Study|Lack of Efficacy|0|||
23309758|NCT02932306|64881233|FG001|Overall Study|Lack of Efficacy|2|||
23309759|NCT02932306|64881232|FG000|Overall Study|Worsening condition|2|||
23309760|NCT02932306|64881233|FG001|Overall Study|Worsening condition|0|||
23309761|NCT02932306|64881232|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
23309762|NCT02932306|64881233|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
23309763|NCT00252239|64881236|FG000|Overall Study|Withdrawal by Subject|1|||
23309764|NCT00252239|64881237|FG001|Overall Study|Withdrawal by Subject|0|||
23309765|NCT00252239|64881238|FG002|Overall Study|Withdrawal by Subject|0|||
23309766|NCT00252239|64881239|FG003|Overall Study|Withdrawal by Subject|1|||
23309767|NCT00252239|64881236|FG000|Overall Study|Lost to Follow-up|0|||
23309768|NCT00252239|64881237|FG001|Overall Study|Lost to Follow-up|0|||
23309769|NCT00252239|64881238|FG002|Overall Study|Lost to Follow-up|2|||
23309770|NCT00252239|64881239|FG003|Overall Study|Lost to Follow-up|0|||
23309771|NCT00174954|64881240|FG000|Overall Study|Adverse Event|2|||
23309772|NCT00174954|64881240|FG000|Overall Study|No tophi found in MRI|1|||
23309773|NCT00174954|64881240|FG000|Overall Study|Physician Decision|1|||
23309774|NCT01087489|64881241|FG000|Overall Study|enrolled in another VA study|0|||
23309775|NCT01087489|64881242|FG001|Overall Study|enrolled in another VA study|1|||
23309776|NCT01087489|64881241|FG000|Overall Study|Death|0|||
23309777|NCT01087489|64881242|FG001|Overall Study|Death|1|||
23309778|NCT01087489|64881241|FG000|Overall Study|unable to survey by telephone|0|||
23309779|NCT01087489|64881242|FG001|Overall Study|unable to survey by telephone|1|||
23309780|NCT01320150|64881243|FG000|Overall Study|Protocol Violation|15|||
23613272|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Other|0|||
23613273|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Other|0|||
23309781|NCT01320150|64881243|FG000|Overall Study|Withdrawal by Subject|5|||
23309782|NCT01320150|64881243|FG000|Overall Study|Death|2|||
23309783|NCT01320150|64881243|FG000|Overall Study|Lost to Follow-up|44|||
23309784|NCT00509795|64881245|FG000|Overall Study|Adverse Event|4|||
23309785|NCT00509795|64881246|FG001|Overall Study|Adverse Event|3|||
23309786|NCT00509795|64881247|FG002|Overall Study|Adverse Event|5|||
23309787|NCT00509795|64881248|FG003|Overall Study|Adverse Event|4|||
23613274|NCT04585815|65973054|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
23613275|NCT04585815|65973055|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
23309788|NCT00509795|64881245|FG000|Overall Study|Death|3|||
23309789|NCT00509795|64881246|FG001|Overall Study|Death|1|||
23309790|NCT00509795|64881247|FG002|Overall Study|Death|2|||
23309791|NCT00509795|64881248|FG003|Overall Study|Death|7|||
23309792|NCT00509795|64881245|FG000|Overall Study|Lack of Efficacy|0|||
23309793|NCT00509795|64881246|FG001|Overall Study|Lack of Efficacy|0|||
23309794|NCT00509795|64881247|FG002|Overall Study|Lack of Efficacy|2|||
23309795|NCT00509795|64881248|FG003|Overall Study|Lack of Efficacy|2|||
23309796|NCT00509795|64881245|FG000|Overall Study|Lost to Follow-up|1|||
23309797|NCT00509795|64881246|FG001|Overall Study|Lost to Follow-up|2|||
23309798|NCT00509795|64881247|FG002|Overall Study|Lost to Follow-up|4|||
23309799|NCT00509795|64881248|FG003|Overall Study|Lost to Follow-up|4|||
23309800|NCT00509795|64881245|FG000|Overall Study|OTHER|1|||
23309801|NCT00509795|64881246|FG001|Overall Study|OTHER|0|||
23309802|NCT00509795|64881247|FG002|Overall Study|OTHER|4|||
23309803|NCT00509795|64881248|FG003|Overall Study|OTHER|1|||
23309804|NCT00509795|64881245|FG000|Overall Study|Protocol Violation|3|||
23309805|NCT00509795|64881246|FG001|Overall Study|Protocol Violation|0|||
23309806|NCT00509795|64881247|FG002|Overall Study|Protocol Violation|3|||
23309807|NCT00509795|64881248|FG003|Overall Study|Protocol Violation|1|||
23309808|NCT00509795|64881245|FG000|Overall Study|Withdrawal by Subject|10|||
23309809|NCT00509795|64881246|FG001|Overall Study|Withdrawal by Subject|5|||
23309810|NCT00509795|64881247|FG002|Overall Study|Withdrawal by Subject|7|||
23309811|NCT00509795|64881248|FG003|Overall Study|Withdrawal by Subject|8|||
23309812|NCT01783548|64881249|FG000|Overall Study|Adverse Event|8|||
23309813|NCT01783548|64881250|FG001|Overall Study|Adverse Event|4|||
23309814|NCT01783548|64881249|FG000|Overall Study|Withdrawal by Subject|11|||
23309815|NCT01783548|64881250|FG001|Overall Study|Withdrawal by Subject|8|||
23309816|NCT01783548|64881249|FG000|Overall Study|Non-compliance|4|||
23309817|NCT01783548|64881250|FG001|Overall Study|Non-compliance|0|||
23309818|NCT01783548|64881249|FG000|Overall Study|Protocol Violation|2|||
23309819|NCT01783548|64881250|FG001|Overall Study|Protocol Violation|2|||
23309820|NCT01783548|64881249|FG000|Overall Study|Lost to Follow-up|8|||
23309821|NCT01783548|64881250|FG001|Overall Study|Lost to Follow-up|3|||
23309822|NCT01783548|64881249|FG000|Overall Study|Lack of Efficacy|1|||
23309823|NCT01783548|64881250|FG001|Overall Study|Lack of Efficacy|1|||
23309824|NCT00509366|64881251|FG000|Overall Study|Not Treated (Screen Failure)|1|||
23309825|NCT00509366|64881252|FG001|Overall Study|Not Treated (Screen Failure)|1|||
23309826|NCT00509366|64881253|FG002|Overall Study|Not Treated (Screen Failure)|1|||
23309827|NCT00509366|64881254|FG003|Overall Study|Not Treated (Screen Failure)|0|||
23309828|NCT00509366|64881255|FG004|Overall Study|Not Treated (Screen Failure)|0|||
23309829|NCT02293863|64881262|FG000|Overall Study|Death|4|||
23309830|NCT02293863|64881263|FG001|Overall Study|Death|6|||
23309831|NCT02293863|64881264|FG002|Overall Study|Death|4|||
23309832|NCT02293863|64881262|FG000|Overall Study|Lost to Follow-up|2|||
23309833|NCT02293863|64881263|FG001|Overall Study|Lost to Follow-up|2|||
23309834|NCT02293863|64881264|FG002|Overall Study|Lost to Follow-up|2|||
23309835|NCT02293863|64881262|FG000|Overall Study|Withdrawal by Subject|3|||
23309836|NCT02293863|64881263|FG001|Overall Study|Withdrawal by Subject|3|||
23309837|NCT02293863|64881264|FG002|Overall Study|Withdrawal by Subject|1|||
23309838|NCT02293863|64881262|FG000|Overall Study|Reason Not Specified|0|||
23309839|NCT02293863|64881263|FG001|Overall Study|Reason Not Specified|2|||
23309840|NCT02293863|64881264|FG002|Overall Study|Reason Not Specified|2|||
23309841|NCT01243775|64881265|FG000|Overall Study|Withdrawal by Subject|2|||
23309842|NCT01823835|64881268|FG000|Overall Study|Adverse Event|0|||
23309843|NCT01823835|64881269|FG001|Overall Study|Adverse Event|0|||
23531150|NCT03795922|65680070|FG001|Overall Study|Lost to Follow-up|3|||
23531151|NCT03795922|65680069|FG000|Overall Study|Pregnancy|0|||
23531152|NCT03795922|65680070|FG001|Overall Study|Pregnancy|1|||
23531153|NCT03795922|65680069|FG000|Overall Study|Physician Decision|1|||
23309844|NCT01823835|64881270|FG002|Overall Study|Adverse Event|0|||
23309845|NCT01823835|64881271|FG003|Overall Study|Adverse Event|0|||
23309846|NCT01823835|64881272|FG004|Overall Study|Adverse Event|1|||
23309847|NCT01823835|64881273|FG005|Overall Study|Adverse Event|0|||
23309848|NCT01823835|64881274|FG006|Overall Study|Adverse Event|1|||
23309849|NCT01823835|64881275|FG007|Overall Study|Adverse Event|0|||
23309850|NCT01823835|64881276|FG008|Overall Study|Adverse Event|0|||
23309851|NCT01823835|64881277|FG009|Overall Study|Adverse Event|0|||
23309852|NCT01823835|64881278|FG010|Overall Study|Adverse Event|1|||
23531154|NCT03795922|65680070|FG001|Overall Study|Physician Decision|2|||
23207390|NCT03004469|64498197|FG001|Overall Study|Adverse Event|4|||
23309853|NCT01823835|64881279|FG011|Overall Study|Adverse Event|2|||
23207391|NCT03004469|64498198|FG002|Overall Study|Adverse Event|6|||
23207392|NCT03004469|64498196|FG000|Overall Study|Lack of Efficacy|1|||
23419820|NCT01751906|65280451|FG000|Overall Study|Lost to Follow-up|151|||
23419821|NCT01751906|65280452|FG001|Overall Study|Lost to Follow-up|68|||
23419822|NCT01751906|65280451|FG000|Overall Study|Withdrawal by Subject|22|||
23419823|NCT01751906|65280452|FG001|Overall Study|Withdrawal by Subject|18|||
23419824|NCT01751906|65280451|FG000|Overall Study|Physician Decision|5|||
23419825|NCT01751906|65280452|FG001|Overall Study|Physician Decision|2|||
23419826|NCT01751906|65280451|FG000|Overall Study|Death|84|||
23419827|NCT01751906|65280452|FG001|Overall Study|Death|43|||
23419828|NCT01751906|65280451|FG000|Overall Study|Denied on premises for follow-up by law|1|||
23419829|NCT01751906|65280452|FG001|Overall Study|Denied on premises for follow-up by law|0|||
23419830|NCT01892436|65280453|FG000|Overall Study|Withdrawal by Subject|8|||
23419831|NCT01892436|65280454|FG001|Overall Study|Withdrawal by Subject|15|||
23419832|NCT01892436|65280455|FG002|Overall Study|Withdrawal by Subject|4|||
23419833|NCT01892436|65280456|FG003|Overall Study|Withdrawal by Subject|4|||
23419834|NCT01892436|65280453|FG000|Overall Study|Death|1|||
23419835|NCT01892436|65280454|FG001|Overall Study|Death|1|||
23419836|NCT01892436|65280455|FG002|Overall Study|Death|0|||
23419837|NCT01892436|65280456|FG003|Overall Study|Death|0|||
23419838|NCT01892436|65280453|FG000|Overall Study|Physician Decision|2|||
23419839|NCT01892436|65280454|FG001|Overall Study|Physician Decision|1|||
23419840|NCT01892436|65280455|FG002|Overall Study|Physician Decision|0|||
23419841|NCT01892436|65280456|FG003|Overall Study|Physician Decision|1|||
23419842|NCT01892436|65280453|FG000|Overall Study|Pregnancy|0|||
23419843|NCT01892436|65280454|FG001|Overall Study|Pregnancy|2|||
23419844|NCT01892436|65280455|FG002|Overall Study|Pregnancy|1|||
23419845|NCT01892436|65280456|FG003|Overall Study|Pregnancy|0|||
23419846|NCT01892436|65280453|FG000|Overall Study|Technical problems|2|||
23419847|NCT01892436|65280454|FG001|Overall Study|Technical problems|1|||
23419848|NCT01892436|65280455|FG002|Overall Study|Technical problems|1|||
23419849|NCT01892436|65280456|FG003|Overall Study|Technical problems|1|||
23419850|NCT01892436|65280453|FG000|Overall Study|Lack of Efficacy|1|||
23419851|NCT01892436|65280454|FG001|Overall Study|Lack of Efficacy|2|||
23419852|NCT01892436|65280455|FG002|Overall Study|Lack of Efficacy|2|||
23419853|NCT01892436|65280456|FG003|Overall Study|Lack of Efficacy|2|||
23419854|NCT01892436|65280453|FG000|Overall Study|Lost to Follow-up|1|||
23419855|NCT01892436|65280454|FG001|Overall Study|Lost to Follow-up|1|||
23419856|NCT01892436|65280455|FG002|Overall Study|Lost to Follow-up|1|||
23419857|NCT01892436|65280456|FG003|Overall Study|Lost to Follow-up|3|||
23419858|NCT01892436|65280453|FG000|Overall Study|non-compliance with treatment|1|||
23419859|NCT01892436|65280454|FG001|Overall Study|non-compliance with treatment|0|||
23419860|NCT01892436|65280455|FG002|Overall Study|non-compliance with treatment|0|||
23419861|NCT01892436|65280456|FG003|Overall Study|non-compliance with treatment|0|||
23419862|NCT01892436|65280453|FG000|Overall Study|Adverse Event|7|||
23419863|NCT01892436|65280454|FG001|Overall Study|Adverse Event|6|||
23419864|NCT01892436|65280455|FG002|Overall Study|Adverse Event|2|||
23419865|NCT01892436|65280456|FG003|Overall Study|Adverse Event|3|||
23419866|NCT01330628|65280457|FG000|Overall Study|Death|2|||
23419867|NCT01330628|65280458|FG001|Overall Study|Death|3|||
23419868|NCT01330628|65280457|FG000|Overall Study|Lost to Follow-up|5|||
23419869|NCT01330628|65280458|FG001|Overall Study|Lost to Follow-up|6|||
23419870|NCT01330628|65280457|FG000|Overall Study|Adverse Event|44|||
23419871|NCT01330628|65280458|FG001|Overall Study|Adverse Event|25|||
23419872|NCT01330628|65280457|FG000|Overall Study|Withdrawn|18|||
23419873|NCT01330628|65280458|FG001|Overall Study|Withdrawn|6|||
23419874|NCT01330628|65280457|FG000|Overall Study|Didn't receive study treatment|1|||
23419875|NCT01330628|65280458|FG001|Overall Study|Didn't receive study treatment|0|||
23419876|NCT03362502|65280459|FG000|Overall Study|Death|0|||
23419877|NCT03362502|65280460|FG001|Overall Study|Death|0|||
23419878|NCT03362502|65280461|FG002|Overall Study|Death|1|||
23419879|NCT04649359|65280462|FG000|Overall Study|Withdrawal by Subject|7|||
23419880|NCT04649359|65280463|FG001|Overall Study|Withdrawal by Subject|7|||
23419881|NCT04649359|65280462|FG000|Overall Study|Death|41|||
23207393|NCT03004469|64498197|FG001|Overall Study|Lack of Efficacy|0|||
23419882|NCT04649359|65280463|FG001|Overall Study|Death|26|||
23419883|NCT04649359|65280462|FG000|Overall Study|Ongoing in the study|75|||
23419884|NCT04649359|65280463|FG001|Overall Study|Ongoing in the study|31|||
23419885|NCT01972308|65280464|FG000|Overall Study|Withdrawal by Subject|0|||
23419886|NCT01972308|65280465|FG001|Overall Study|Withdrawal by Subject|1|||
23419887|NCT01972308|65280464|FG000|Overall Study|Lost to Follow-up|4|||
23419888|NCT01972308|65280465|FG001|Overall Study|Lost to Follow-up|6|||
23419889|NCT01972308|65280464|FG000|Overall Study|Death|4|||
23419890|NCT01972308|65280465|FG001|Overall Study|Death|1|||
23419891|NCT00365105|65280466|FG000|Overall Study|Protocol Violation|5|||
23419892|NCT00365105|65280467|FG001|Overall Study|Protocol Violation|8|||
23419893|NCT01549886|65280471|FG000|Overall Study|Sponsor's decision|2|||
23419894|NCT01549886|65280472|FG001|Overall Study|Sponsor's decision|3|||
23419895|NCT00688324|65280473|FG000|Overall Study|Withdrawal by Subject|2|||
23419896|NCT00688324|65280473|FG000|Overall Study|Physician Decision|5|||
23419897|NCT00688324|65280473|FG000|Overall Study|Lost to Follow-up|1|||
23419898|NCT00420004|65280482|FG000|Overall Study|Adverse Event|4|||
23419899|NCT00420004|65280483|FG001|Overall Study|Adverse Event|1|||
23419900|NCT00420004|65280484|FG002|Overall Study|Adverse Event|1|||
23419901|NCT00420004|65280482|FG000|Overall Study|Lack of Efficacy|5|||
23419902|NCT00420004|65280483|FG001|Overall Study|Lack of Efficacy|4|||
23419903|NCT00420004|65280484|FG002|Overall Study|Lack of Efficacy|1|||
23419904|NCT00420004|65280482|FG000|Overall Study|Lost to Follow-up|31|||
23419905|NCT00420004|65280483|FG001|Overall Study|Lost to Follow-up|12|||
23419906|NCT00420004|65280484|FG002|Overall Study|Lost to Follow-up|10|||
23419907|NCT00420004|65280482|FG000|Overall Study|Entry Criteria Not Met|0|||
23419908|NCT00420004|65280483|FG001|Overall Study|Entry Criteria Not Met|1|||
23419909|NCT00420004|65280484|FG002|Overall Study|Entry Criteria Not Met|0|||
23419910|NCT00420004|65280482|FG000|Overall Study|Physician Decision|14|||
23419911|NCT00420004|65280483|FG001|Overall Study|Physician Decision|4|||
23419912|NCT00420004|65280484|FG002|Overall Study|Physician Decision|2|||
23419913|NCT00420004|65280482|FG000|Overall Study|Protocol Violation|5|||
23419914|NCT00420004|65280483|FG001|Overall Study|Protocol Violation|4|||
23419915|NCT00420004|65280484|FG002|Overall Study|Protocol Violation|3|||
23419916|NCT00420004|65280482|FG000|Overall Study|Withdrawal by Subject|67|||
23419917|NCT00420004|65280483|FG001|Overall Study|Withdrawal by Subject|42|||
23419918|NCT00420004|65280484|FG002|Overall Study|Withdrawal by Subject|14|||
23419919|NCT00420004|65280482|FG000|Overall Study|Sponsor Decision|3|||
23419920|NCT00420004|65280483|FG001|Overall Study|Sponsor Decision|3|||
23419921|NCT00420004|65280484|FG002|Overall Study|Sponsor Decision|1|||
23419922|NCT02752958|65280485|FG000|Overall Study|Adverse Event|3|||
23419923|NCT02752958|65280485|FG000|Overall Study|Lost to Follow-up|1|||
23419924|NCT02752958|65280485|FG000|Overall Study|Protocol Violation|1|||
23419925|NCT02752958|65280485|FG000|Overall Study|Withdrawal by Subject|2|||
23419926|NCT02752958|65280485|FG000|Overall Study|Other (Reason not specified)|2|||
23419927|NCT01380535|65280488|FG000|Overall Study|Adverse Event|3|||
23419928|NCT01380535|65280489|FG001|Overall Study|Adverse Event|3|||
23419929|NCT01380535|65280488|FG000|Overall Study|Death|3|||
23419930|NCT01380535|65280489|FG001|Overall Study|Death|0|||
23419931|NCT01380535|65280488|FG000|Overall Study|Study site closed|0|||
23419932|NCT01380535|65280489|FG001|Overall Study|Study site closed|5|||
23419933|NCT01380535|65280488|FG000|Overall Study|Withdrawal by Subject|1|||
23419934|NCT01380535|65280489|FG001|Overall Study|Withdrawal by Subject|2|||
23419935|NCT01380535|65280488|FG000|Overall Study|Protocol Violation|0|||
23419936|NCT01380535|65280489|FG001|Overall Study|Protocol Violation|2|||
23419937|NCT01380535|65280488|FG000|Overall Study|Lack of Efficacy|0|||
23419938|NCT01380535|65280489|FG001|Overall Study|Lack of Efficacy|3|||
23419939|NCT01032291|65280490|FG000|Safety Lead-in|Adverse Event|1|||
23419940|NCT01032291|65280491|FG001|Safety Lead-in|Adverse Event|0|||
23419941|NCT01032291|65280492|FG002|Safety Lead-in|Adverse Event|0|||
23419942|NCT01032291|65280490|FG000|Safety Lead-in|Death|1|||
23419943|NCT01032291|65280491|FG001|Safety Lead-in|Death|0|||
23419944|NCT01032291|65280492|FG002|Safety Lead-in|Death|0|||
23419945|NCT01032291|65280490|FG000|Proof of Concept|Adverse Event|0|||
23419946|NCT01032291|65280491|FG001|Proof of Concept|Adverse Event|5|||
23419947|NCT01032291|65280492|FG002|Proof of Concept|Adverse Event|1|||
23419948|NCT01032291|65280490|FG000|Proof of Concept|Death|0|||
23419949|NCT01032291|65280491|FG001|Proof of Concept|Death|1|||
23419950|NCT01032291|65280492|FG002|Proof of Concept|Death|2|||
23419951|NCT01032291|65280490|FG000|Proof of Concept|Lack of Efficacy|0|||
23419952|NCT01032291|65280491|FG001|Proof of Concept|Lack of Efficacy|1|||
23419953|NCT01032291|65280492|FG002|Proof of Concept|Lack of Efficacy|0|||
23419954|NCT01032291|65280490|FG000|Proof of Concept|Never Received Study Drug|0|||
23419955|NCT01032291|65280491|FG001|Proof of Concept|Never Received Study Drug|1|||
23419956|NCT01032291|65280492|FG002|Proof of Concept|Never Received Study Drug|0|||
23419957|NCT02442310|65280497|FG000|Overall Study|Adverse Event|2|||
23419958|NCT02442310|65280497|FG000|Overall Study|Withdrawal by Subject|1|||
23419959|NCT03054350|65280499|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
23419960|NCT03054350|65280500|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
23419961|NCT03054350|65280501|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
23419962|NCT03054350|65280502|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
23419963|NCT03054350|65280503|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
23419964|NCT03054350|65280504|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
23419965|NCT03054350|65280499|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419966|NCT03054350|65280500|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419967|NCT03054350|65280501|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
23419968|NCT03054350|65280502|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419969|NCT03054350|65280503|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419970|NCT03054350|65280504|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
23419971|NCT03054350|65280499|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
23419972|NCT03054350|65280500|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
23419973|NCT03054350|65280501|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
23419974|NCT03054350|65280502|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
23419975|NCT03054350|65280503|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
23531155|NCT03795922|65680069|FG000|Overall Study|Protocol Violation|0|||
23613276|NCT04585815|65973056|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23613277|NCT04585815|65973057|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23613278|NCT04585815|65973058|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23613279|NCT04585815|65973059|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23613280|NCT04585815|65973060|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
23613281|NCT04585815|65973054|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613282|NCT04585815|65973055|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
23613283|NCT04585815|65973056|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613284|NCT04585815|65973057|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613285|NCT04585815|65973058|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613286|NCT04585815|65973059|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613287|NCT04585815|65973060|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
23613288|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
23613289|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
23613290|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
23613291|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
23613292|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
23613293|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
23613294|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
23613295|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Death|0|||
23613296|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Death|0|||
23613297|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Death|0|||
23613298|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Death|1|||
23613299|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Death|0|||
23613300|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Death|0|||
23613301|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Death|0|||
23613302|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613303|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613304|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613305|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
23613306|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613307|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
23613308|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
23613309|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613310|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613311|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613312|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
23613313|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613314|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613315|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
23613316|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613317|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613318|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613319|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613320|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613321|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
23613322|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
23613323|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
23613324|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
23613325|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
23613326|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
23613327|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
23309854|NCT01823835|64881280|FG012|Overall Study|Adverse Event|0|||
23309855|NCT01823835|64881281|FG013|Overall Study|Adverse Event|0|||
23309856|NCT01823835|64881282|FG014|Overall Study|Adverse Event|0|||
23309857|NCT01823835|64881268|FG000|Overall Study|Physician Decision|0|||
23613328|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
23613329|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
23207394|NCT03004469|64498198|FG002|Overall Study|Lack of Efficacy|1|||
23207395|NCT03004469|64498196|FG000|Overall Study|Lost to Follow-up|23|||
23207396|NCT03004469|64498197|FG001|Overall Study|Lost to Follow-up|14|||
23207397|NCT03004469|64498198|FG002|Overall Study|Lost to Follow-up|6|||
23207398|NCT03004469|64498196|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23207399|NCT03004469|64498197|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23207400|NCT03004469|64498198|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23207401|NCT03004469|64498196|FG000|Overall Study|Protocol Violation|0|||
23207402|NCT03004469|64498197|FG001|Overall Study|Protocol Violation|0|||
23207403|NCT03004469|64498198|FG002|Overall Study|Protocol Violation|1|||
23207404|NCT03004469|64498196|FG000|Overall Study|Withdrawal by Subject|29|||
23531156|NCT03795922|65680070|FG001|Overall Study|Protocol Violation|1|||
23531157|NCT03795922|65680069|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
23531158|NCT03795922|65680070|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
23531159|NCT03337724|65680074|FG000|Overall Study|Reason not Specified|12|||
23531160|NCT03337724|65680075|FG001|Overall Study|Reason not Specified|21|||
23531161|NCT03337724|65680076|FG002|Overall Study|Reason not Specified|9|||
23531162|NCT03337724|65680077|FG003|Overall Study|Reason not Specified|9|||
23531163|NCT03337724|65680078|FG004|Overall Study|Reason not Specified|29|||
23531164|NCT03337724|65680074|FG000|Overall Study|Withdrawal by Subject|13|||
23531165|NCT03337724|65680075|FG001|Overall Study|Withdrawal by Subject|15|||
23531166|NCT03337724|65680076|FG002|Overall Study|Withdrawal by Subject|4|||
23531167|NCT03337724|65680077|FG003|Overall Study|Withdrawal by Subject|15|||
23531168|NCT03337724|65680078|FG004|Overall Study|Withdrawal by Subject|6|||
23531169|NCT03337724|65680074|FG000|Overall Study|Protocol Deviation|0|||
23531170|NCT03337724|65680075|FG001|Overall Study|Protocol Deviation|1|||
23531171|NCT03337724|65680076|FG002|Overall Study|Protocol Deviation|1|||
23531172|NCT03337724|65680077|FG003|Overall Study|Protocol Deviation|1|||
23531173|NCT03337724|65680078|FG004|Overall Study|Protocol Deviation|0|||
23531174|NCT03337724|65680074|FG000|Overall Study|Adverse Event|1|||
23531175|NCT03337724|65680075|FG001|Overall Study|Adverse Event|1|||
23531176|NCT03337724|65680076|FG002|Overall Study|Adverse Event|0|||
23531177|NCT03337724|65680077|FG003|Overall Study|Adverse Event|1|||
23531178|NCT03337724|65680078|FG004|Overall Study|Adverse Event|0|||
23531179|NCT03337724|65680074|FG000|Overall Study|Death|40|||
23531180|NCT03337724|65680075|FG001|Overall Study|Death|89|||
23531181|NCT03337724|65680076|FG002|Overall Study|Death|43|||
23207405|NCT03004469|64498197|FG001|Overall Study|Withdrawal by Subject|27|||
23207406|NCT03004469|64498198|FG002|Overall Study|Withdrawal by Subject|10|||
23207407|NCT03004469|64498196|FG000|Overall Study|Other unspecified reason|0|||
23531182|NCT03337724|65680077|FG003|Overall Study|Death|76|||
23531183|NCT03337724|65680078|FG004|Overall Study|Death|50|||
23531184|NCT03337724|65680074|FG000|Overall Study|Lost to Follow-up|5|||
23531185|NCT03337724|65680075|FG001|Overall Study|Lost to Follow-up|5|||
23613330|NCT04585815|65973054|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
23613331|NCT04585815|65973055|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
23613332|NCT04585815|65973056|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
23531186|NCT03337724|65680076|FG002|Overall Study|Lost to Follow-up|4|||
23531187|NCT03337724|65680077|FG003|Overall Study|Lost to Follow-up|7|||
23531188|NCT03337724|65680078|FG004|Overall Study|Lost to Follow-up|4|||
23531189|NCT03337724|65680074|FG000|Overall Study|Physician Decision|16|||
23531190|NCT03337724|65680075|FG001|Overall Study|Physician Decision|34|||
23531191|NCT03337724|65680076|FG002|Overall Study|Physician Decision|14|||
23531192|NCT03337724|65680077|FG003|Overall Study|Physician Decision|34|||
23531193|NCT03337724|65680078|FG004|Overall Study|Physician Decision|13|||
23531194|NCT03337724|65680074|FG000|Overall Study|Progressive Disease|0|||
23531195|NCT03337724|65680075|FG001|Overall Study|Progressive Disease|2|||
23531196|NCT03337724|65680076|FG002|Overall Study|Progressive Disease|1|||
23531197|NCT03337724|65680077|FG003|Overall Study|Progressive Disease|2|||
23531198|NCT03337724|65680078|FG004|Overall Study|Progressive Disease|0|||
23531199|NCT03337724|65680074|FG000|Overall Study|Symptomatic Deterioration|0|||
23531200|NCT03337724|65680075|FG001|Overall Study|Symptomatic Deterioration|0|||
23531201|NCT03337724|65680076|FG002|Overall Study|Symptomatic Deterioration|0|||
23613333|NCT04585815|65973057|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
23613334|NCT04585815|65973058|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
23613335|NCT04585815|65973059|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
23613336|NCT04585815|65973060|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
23613337|NCT04585815|65973054|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
23613338|NCT04585815|65973055|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
23613339|NCT04585815|65973056|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
23613340|NCT04585815|65973057|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
23613341|NCT04585815|65973058|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
23613342|NCT04585815|65973059|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
23613343|NCT04585815|65973060|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
23613344|NCT04585815|65973054|FG000|Sub-study B- Follow-up Phase|Death|0|||
23613345|NCT04585815|65973055|FG001|Sub-study B- Follow-up Phase|Death|0|||
23613346|NCT04585815|65973056|FG002|Sub-study B- Follow-up Phase|Death|1|||
23613347|NCT04585815|65973057|FG003|Sub-study B- Follow-up Phase|Death|3|||
23613348|NCT04585815|65973058|FG004|Sub-study B- Follow-up Phase|Death|0|||
23613349|NCT04585815|65973059|FG005|Sub-study B- Follow-up Phase|Death|0|||
23613350|NCT04585815|65973060|FG006|Sub-study B- Follow-up Phase|Death|1|||
23613351|NCT00730925|65973063|FG000|Overall Study|Progressive Disease|21|||
23613352|NCT00730925|65973063|FG000|Overall Study|Dose reducing Event|2|||
23613353|NCT00730925|65973063|FG000|Overall Study|Other Averse Event|7|||
23613354|NCT00730925|65973063|FG000|Overall Study|Protocol Violation|1|||
23613355|NCT00730925|65973063|FG000|Overall Study|Withdrawal by Subject|1|||
23613356|NCT00730925|65973063|FG000|Overall Study|Switch to combination therapy|8|||
23613357|NCT00730925|65973063|FG000|Overall Study|Other|1|||
23613358|NCT00402298|65973064|FG000|Overall Study|Withdrawal by Subject|1|||
23613359|NCT00402298|65973065|FG001|Overall Study|Withdrawal by Subject|0|||
23613360|NCT02339506|65973066|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
23613361|NCT02339506|65973067|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
23613362|NCT02339506|65973066|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
23613363|NCT02339506|65973067|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
23531202|NCT03337724|65680077|FG003|Overall Study|Symptomatic Deterioration|1|||
23531203|NCT03337724|65680078|FG004|Overall Study|Symptomatic Deterioration|0|||
23531204|NCT04497987|65680079|FG000|Overall Study|Adverse Event|1|||
23531205|NCT04497987|65680080|FG001|Overall Study|Adverse Event|0|||
23613364|NCT00170950|65973068|FG000|Overall Study|Death|236|||
23613365|NCT00170950|65973069|FG001|Overall Study|Death|274|||
23613366|NCT00170950|65973068|FG000|Overall Study|Withdrawal by Subject|496|||
23613367|NCT00170950|65973069|FG001|Overall Study|Withdrawal by Subject|498|||
23613368|NCT00170950|65973068|FG000|Overall Study|Lost to Follow-up|134|||
23613369|NCT00170950|65973069|FG001|Overall Study|Lost to Follow-up|115|||
23531206|NCT04497987|65680079|FG000|Overall Study|Death|21|||
23531207|NCT04497987|65680080|FG001|Overall Study|Death|13|||
23531208|NCT04497987|65680079|FG000|Overall Study|Lost to Follow-up|19|||
23531209|NCT04497987|65680080|FG001|Overall Study|Lost to Follow-up|17|||
23531210|NCT04497987|65680079|FG000|Overall Study|Other - as reported by the investigator|22|||
23531211|NCT04497987|65680080|FG001|Overall Study|Other - as reported by the investigator|16|||
23531212|NCT04497987|65680079|FG000|Overall Study|Physician Decision|1|||
23531213|NCT04497987|65680080|FG001|Overall Study|Physician Decision|0|||
23531214|NCT04497987|65680079|FG000|Overall Study|Withdrawal by Subject|35|||
23531215|NCT04497987|65680080|FG001|Overall Study|Withdrawal by Subject|21|||
23531216|NCT00770120|65680085|FG000|Overall Study|Progression|31|||
23531217|NCT00770120|65680085|FG000|Overall Study|Adverse Event|11|||
23531218|NCT00770120|65680085|FG000|Overall Study|Not Protocol Specified|11|||
23531219|NCT00770120|65680085|FG000|Overall Study|Death|3|||
23531220|NCT00770120|65680085|FG000|Overall Study|Withdrawal by Subject|2|||
23531221|NCT00770120|65680085|FG000|Overall Study|Ineligible|1|||
23531222|NCT00770120|65680085|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
23531223|NCT00770120|65680085|FG000|Overall Study|Reason under Review|1|||
23531224|NCT04382612|65680098|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
23531225|NCT00006184|65680099|FG000|Overall Study|Death|1|||
23531226|NCT00006184|65680100|FG001|Overall Study|Death|0|||
23531227|NCT02644967|65680101|FG000|Overall Study|Death|26|||
23531228|NCT02644967|65680101|FG000|Overall Study|Physician Decision|1|||
23531229|NCT02644967|65680101|FG000|Overall Study|Withdrawal by Subject|2|||
23531230|NCT02644967|65680101|FG000|Overall Study|Protocol Violation|1|||
23531231|NCT02644967|65680101|FG000|Overall Study|Progressive Disease|1|||
23531232|NCT02644967|65680101|FG000|Overall Study|Study Terminated by Sponsor|4|||
23531233|NCT00080223|65680106|FG000|Overall Study|Adverse Event|23|||
23531234|NCT00080223|65680106|FG000|Overall Study|Death|21|||
23531235|NCT00080223|65680106|FG000|Overall Study|Withdrawal by Subject|13|||
23531236|NCT00080223|65680106|FG000|Overall Study|Lung Transplantation|9|||
23531237|NCT00080223|65680106|FG000|Overall Study|Non-compliance With Study Treatment|7|||
23531238|NCT00080223|65680106|FG000|Overall Study|Participant unwilling to continue|2|||
23531239|NCT00080223|65680106|FG000|Overall Study|Physician Decision|1|||
23531240|NCT02127307|65680109|FG000|Overall Study|Protocol Violation|36|||
23531241|NCT02127307|65680109|FG000|Overall Study|Lost to Follow-up|2|||
23531242|NCT02127307|65680109|FG000|Overall Study|Death|101|||
23531243|NCT02127307|65680109|FG000|Overall Study|Other than specified above|169|||
23531244|NCT00691210|65680112|FG000|Overall Study|Progression of Disease|0|||
23531245|NCT00691210|65680113|FG001|Overall Study|Progression of Disease|0|||
23531246|NCT00691210|65680114|FG002|Overall Study|Progression of Disease|0|||
23531247|NCT00691210|65680115|FG003|Overall Study|Progression of Disease|2|||
23531248|NCT00691210|65680116|FG004|Overall Study|Progression of Disease|0|||
23531249|NCT00691210|65680117|FG005|Overall Study|Progression of Disease|0|||
23531250|NCT00691210|65680118|FG006|Overall Study|Progression of Disease|0|||
23531251|NCT00691210|65680119|FG007|Overall Study|Progression of Disease|0|||
23531252|NCT00691210|65680112|FG000|Overall Study|Lack of Efficacy|0|||
23531253|NCT00691210|65680113|FG001|Overall Study|Lack of Efficacy|0|||
23531254|NCT00691210|65680114|FG002|Overall Study|Lack of Efficacy|0|||
23531255|NCT00691210|65680115|FG003|Overall Study|Lack of Efficacy|1|||
23531256|NCT00691210|65680116|FG004|Overall Study|Lack of Efficacy|0|||
23531257|NCT00691210|65680117|FG005|Overall Study|Lack of Efficacy|1|||
23531258|NCT00691210|65680118|FG006|Overall Study|Lack of Efficacy|0|||
23531259|NCT00691210|65680119|FG007|Overall Study|Lack of Efficacy|0|||
23531260|NCT00797667|65680121|FG000|Overall Study|Lack of Efficacy|0|||
23531261|NCT00797667|65680122|FG001|Overall Study|Lack of Efficacy|1|||
23531262|NCT00797667|65680123|FG002|Overall Study|Lack of Efficacy|0|||
23531263|NCT00797667|65680121|FG000|Overall Study|Lost to Follow-up|8|||
23613370|NCT00170950|65973068|FG000|Overall Study|Missing|2|||
23613371|NCT00170950|65973069|FG001|Overall Study|Missing|1|||
23613372|NCT00170950|65973068|FG000|Overall Study|Termination Data Not Recorded|17|||
23613373|NCT00170950|65973069|FG001|Overall Study|Termination Data Not Recorded|22|||
23531264|NCT00797667|65680122|FG001|Overall Study|Lost to Follow-up|12|||
23613374|NCT02446912|65973070|FG000|Overall Study|Adverse Event|3|||
23613375|NCT02446912|65973071|FG001|Overall Study|Adverse Event|13|||
23531265|NCT00797667|65680123|FG002|Overall Study|Lost to Follow-up|2|||
23531266|NCT00797667|65680121|FG000|Overall Study|Physician Decision|3|||
23531267|NCT00797667|65680122|FG001|Overall Study|Physician Decision|1|||
23531268|NCT00797667|65680123|FG002|Overall Study|Physician Decision|0|||
23531269|NCT00797667|65680121|FG000|Overall Study|Pregnancy|2|||
23531270|NCT00797667|65680122|FG001|Overall Study|Pregnancy|0|||
23531271|NCT00797667|65680123|FG002|Overall Study|Pregnancy|0|||
23531272|NCT00797667|65680121|FG000|Overall Study|Protocol Violation|2|||
23309858|NCT01823835|64881269|FG001|Overall Study|Physician Decision|0|||
23531273|NCT00797667|65680122|FG001|Overall Study|Protocol Violation|7|||
23531274|NCT00797667|65680123|FG002|Overall Study|Protocol Violation|0|||
23531275|NCT00797667|65680121|FG000|Overall Study|Study Terminated by Sponsor|217|||
23531276|NCT00797667|65680122|FG001|Overall Study|Study Terminated by Sponsor|216|||
23531277|NCT00797667|65680123|FG002|Overall Study|Study Terminated by Sponsor|115|||
23531278|NCT00797667|65680121|FG000|Overall Study|Withdrawal by Subject|9|||
23531279|NCT00797667|65680122|FG001|Overall Study|Withdrawal by Subject|14|||
23531280|NCT00797667|65680123|FG002|Overall Study|Withdrawal by Subject|2|||
23531281|NCT00797667|65680121|FG000|Overall Study|Adverse Event|19|||
23531282|NCT00797667|65680122|FG001|Overall Study|Adverse Event|8|||
23531283|NCT00797667|65680123|FG002|Overall Study|Adverse Event|8|||
23531284|NCT04545515|65680124|FG000|Overall Study|Adverse Event|1|||
23531285|NCT04545515|65680124|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
23531286|NCT04545515|65680124|FG000|Overall Study|Commercial drug is available for participant|7|||
23309859|NCT01823835|64881270|FG002|Overall Study|Physician Decision|0|||
23531287|NCT02212730|65680127|FG000|Overall Study|Tumor not of the required cell histology|1|||
23531288|NCT02212730|65680128|FG001|Overall Study|Tumor not of the required cell histology|0|||
23531289|NCT02212730|65680127|FG000|Overall Study|Withdrawal by Subject|1|||
23531290|NCT02212730|65680128|FG001|Overall Study|Withdrawal by Subject|0|||
23531291|NCT02212730|65680127|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
23309860|NCT01823835|64881271|FG003|Overall Study|Physician Decision|0|||
23309861|NCT01823835|64881272|FG004|Overall Study|Physician Decision|0|||
23531292|NCT02212730|65680128|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
23531293|NCT04709575|65680129|FG000|Overall Study|Withdrawal by Subject|6|||
23531294|NCT04709575|65680130|FG001|Overall Study|Withdrawal by Subject|2|||
23531295|NCT04709575|65680129|FG000|Overall Study|Lost to Follow-up|2|||
23531296|NCT04709575|65680130|FG001|Overall Study|Lost to Follow-up|2|||
23531297|NCT04709575|65680129|FG000|Overall Study|Adverse Event|1|||
23531298|NCT04709575|65680130|FG001|Overall Study|Adverse Event|0|||
23531299|NCT04709575|65680129|FG000|Overall Study|Protocol Violation|1|||
23531300|NCT04709575|65680130|FG001|Overall Study|Protocol Violation|1|||
23531301|NCT04879745|65680131|FG000|Overall Study|Lost to Follow-up|4|||
23531302|NCT04879745|65680132|FG001|Overall Study|Lost to Follow-up|1|||
23531303|NCT01957475|65680133|FG000|Test Period 1|Withdrawal by Subject|1|||
23531304|NCT01957475|65680134|FG001|Test Period 1|Withdrawal by Subject|0|||
23531305|NCT01957475|65680133|FG000|Test Period 1|Other|1|||
23531306|NCT01957475|65680134|FG001|Test Period 1|Other|0|||
23531307|NCT01957475|65680133|FG000|Test Period 1|Lack of Efficacy|0|||
23531308|NCT01957475|65680134|FG001|Test Period 1|Lack of Efficacy|1|||
23531309|NCT01957475|65680133|FG000|Test Period 2|Adverse Event|1|||
23531310|NCT01957475|65680134|FG001|Test Period 2|Adverse Event|0|||
23531311|NCT02148003|65680135|FG000|Overall Study|Failed inclusion criteria|1|||
23531312|NCT02148003|65680136|FG001|Overall Study|Failed inclusion criteria|0|||
23531313|NCT02148003|65680135|FG000|Overall Study|Met exclusion criteria|0|||
23531314|NCT02148003|65680136|FG001|Overall Study|Met exclusion criteria|1|||
23531315|NCT02148003|65680135|FG000|Overall Study|Withdrawal by Subject|0|||
23613376|NCT02446912|65973072|FG002|Overall Study|Adverse Event|5|||
23613377|NCT02446912|65973070|FG000|Overall Study|Condition under investigation worsened|0|||
23613378|NCT02446912|65973071|FG001|Overall Study|Condition under investigation worsened|1|||
23613379|NCT02446912|65973072|FG002|Overall Study|Condition under investigation worsened|1|||
23207408|NCT03004469|64498197|FG001|Overall Study|Other unspecified reason|4|||
23531316|NCT02148003|65680136|FG001|Overall Study|Withdrawal by Subject|1|||
23613380|NCT02446912|65973070|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23613381|NCT02446912|65973071|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23207409|NCT03004469|64498198|FG002|Overall Study|Other unspecified reason|1|||
23207410|NCT05086289|64498199|FG000|Overall Study|Adverse Event|4|||
23531317|NCT00355238|65680137|FG000|Overall Study|Adverse event unrelated to study drug|2|||
23531318|NCT00355238|65680138|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23531319|NCT00355238|65680139|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23531320|NCT00355238|65680140|FG003|Overall Study|Adverse event unrelated to study drug|1|||
23207411|NCT05086289|64498200|FG001|Overall Study|Adverse Event|2|||
23531321|NCT00355238|65680137|FG000|Overall Study|Death|1|||
23531322|NCT00355238|65680138|FG001|Overall Study|Death|0|||
23207412|NCT05086289|64498199|FG000|Overall Study|Lost to Follow-up|2|||
23207413|NCT05086289|64498200|FG001|Overall Study|Lost to Follow-up|0|||
23531323|NCT00355238|65680139|FG002|Overall Study|Death|0|||
23531324|NCT00355238|65680140|FG003|Overall Study|Death|0|||
23531325|NCT00355238|65680137|FG000|Overall Study|Disease progression|37|||
23531326|NCT00355238|65680138|FG001|Overall Study|Disease progression|36|||
23531327|NCT00355238|65680139|FG002|Overall Study|Disease progression|16|||
23531328|NCT00355238|65680140|FG003|Overall Study|Disease progression|11|||
23207414|NCT05086289|64498199|FG000|Overall Study|Non-compliance with study drug|2|||
23207415|NCT05086289|64498200|FG001|Overall Study|Non-compliance with study drug|1|||
23207416|NCT05086289|64498199|FG000|Overall Study|Physician Decision|2|||
23207417|NCT05086289|64498200|FG001|Overall Study|Physician Decision|0|||
23207418|NCT05086289|64498199|FG000|Overall Study|Withdrawal by Subject|5|||
23207419|NCT05086289|64498200|FG001|Overall Study|Withdrawal by Subject|2|||
23207420|NCT01025817|64498205|FG000|Completed Study Medication|Adverse Event|66|||
23207421|NCT01025817|64498206|FG001|Completed Study Medication|Adverse Event|39|||
23207422|NCT01025817|64498205|FG000|Completed Study Medication|Protocol Deviation|9|||
23207423|NCT01025817|64498206|FG001|Completed Study Medication|Protocol Deviation|8|||
23207424|NCT01025817|64498205|FG000|Completed Study Medication|Withdrawal by Subject|8|||
23207425|NCT01025817|64498206|FG001|Completed Study Medication|Withdrawal by Subject|9|||
23207426|NCT01025817|64498205|FG000|Completed Study Medication|Administrative problems|7|||
23207427|NCT01025817|64498206|FG001|Completed Study Medication|Administrative problems|5|||
23207428|NCT01025817|64498205|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
23207429|NCT01025817|64498206|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
23207430|NCT01025817|64498205|FG000|Completed Study Medication|Abnormal test procedure|4|||
23207431|NCT01025817|64498206|FG001|Completed Study Medication|Abnormal test procedure|0|||
23207432|NCT01025817|64498205|FG000|Completed Study Medication|Graft loss|2|||
23207433|NCT01025817|64498206|FG001|Completed Study Medication|Graft loss|5|||
23207434|NCT01025817|64498205|FG000|Completed Study Medication|Death|2|||
23207435|NCT01025817|64498206|FG001|Completed Study Medication|Death|2|||
23207436|NCT01025817|64498205|FG000|Completed Study Medication|Abnormal lab values|0|||
23207437|NCT01025817|64498206|FG001|Completed Study Medication|Abnormal lab values|2|||
23207438|NCT01025817|64498205|FG000|Completed Study Medication|Subject no longer required study drug|0|||
23207439|NCT01025817|64498206|FG001|Completed Study Medication|Subject no longer required study drug|1|||
23207440|NCT01025817|64498205|FG000|Completed Study Medication|Lost to Follow-up|0|||
23207441|NCT01025817|64498206|FG001|Completed Study Medication|Lost to Follow-up|1|||
23207442|NCT01025817|64498205|FG000|Completed Study|Withdrawal by Subject|8|||
23207443|NCT01025817|64498206|FG001|Completed Study|Withdrawal by Subject|16|||
23207444|NCT01025817|64498205|FG000|Completed Study|Death|6|||
23207445|NCT01025817|64498206|FG001|Completed Study|Death|5|||
23207446|NCT01025817|64498205|FG000|Completed Study|Missing|2|||
23531329|NCT00355238|65680137|FG000|Overall Study|Study drug toxicity|11|||
23531330|NCT00355238|65680138|FG001|Overall Study|Study drug toxicity|7|||
23531331|NCT00355238|65680139|FG002|Overall Study|Study drug toxicity|5|||
23531332|NCT00355238|65680140|FG003|Overall Study|Study drug toxicity|2|||
23531333|NCT00355238|65680137|FG000|Overall Study|Participant withdrew consent|3|||
23531334|NCT00355238|65680138|FG001|Overall Study|Participant withdrew consent|1|||
23531335|NCT00355238|65680139|FG002|Overall Study|Participant withdrew consent|0|||
23531336|NCT00355238|65680140|FG003|Overall Study|Participant withdrew consent|0|||
23531337|NCT00355238|65680137|FG000|Overall Study|Participant request to discontinue study treatment|1|||
23531338|NCT00355238|65680138|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23531339|NCT00355238|65680139|FG002|Overall Study|Participant request to discontinue study treatment|1|||
23531340|NCT00355238|65680140|FG003|Overall Study|Participant request to discontinue study treatment|0|||
23531341|NCT02755831|65680151|FG000|Overall Study|Lost to Follow-up|3|||
23207447|NCT01025817|64498206|FG001|Completed Study|Missing|0|||
23207448|NCT01025817|64498205|FG000|Completed Study|Lost to Follow-up|0|||
23207449|NCT01025817|64498206|FG001|Completed Study|Lost to Follow-up|1|||
23207450|NCT03580382|64498207|FG000|Overall Study|Early Termination of Study|0|||
23207451|NCT03580382|64498208|FG001|Overall Study|Early Termination of Study|3|||
23309862|NCT01823835|64881273|FG005|Overall Study|Physician Decision|0|||
23531342|NCT02755831|65680152|FG001|Overall Study|Lost to Follow-up|3|||
23531343|NCT03912233|65680153|FG000|Overall Study|Adverse Event|1|||
23531344|NCT03912233|65680154|FG001|Overall Study|Adverse Event|0|||
23531345|NCT03912233|65680155|FG002|Overall Study|Adverse Event|0|||
23531346|NCT03912233|65680156|FG003|Overall Study|Adverse Event|0|||
23531347|NCT03912233|65680157|FG004|Overall Study|Adverse Event|0|||
23531348|NCT03912233|65680158|FG005|Overall Study|Adverse Event|0|||
23531349|NCT03912233|65680153|FG000|Overall Study|Physician Decision|1|||
23531350|NCT03912233|65680154|FG001|Overall Study|Physician Decision|0|||
23531351|NCT03912233|65680155|FG002|Overall Study|Physician Decision|0|||
23531352|NCT03912233|65680156|FG003|Overall Study|Physician Decision|0|||
23531353|NCT03912233|65680157|FG004|Overall Study|Physician Decision|0|||
23531354|NCT03912233|65680158|FG005|Overall Study|Physician Decision|0|||
23531355|NCT03912233|65680153|FG000|Overall Study|Other|0|||
23531356|NCT03912233|65680154|FG001|Overall Study|Other|0|||
23531357|NCT03912233|65680155|FG002|Overall Study|Other|0|||
23531358|NCT03912233|65680156|FG003|Overall Study|Other|0|||
23531359|NCT03912233|65680157|FG004|Overall Study|Other|7|||
23531360|NCT03912233|65680158|FG005|Overall Study|Other|12|||
23531361|NCT03246958|65680159|FG000|Overall Study|Withdrawal by Subject|0|||
23531362|NCT03246958|65680160|FG001|Overall Study|Withdrawal by Subject|1|||
23531363|NCT03246958|65680161|FG002|Overall Study|Withdrawal by Subject|0|||
23531364|NCT03246958|65680162|FG003|Overall Study|Withdrawal by Subject|0|||
23531365|NCT03246958|65680163|FG004|Overall Study|Withdrawal by Subject|0|||
23531366|NCT03246958|65680164|FG005|Overall Study|Withdrawal by Subject|1|||
23531367|NCT03246958|65680165|FG006|Overall Study|Withdrawal by Subject|0|||
23531368|NCT03246958|65680159|FG000|Overall Study|Progression|13|||
23531369|NCT03246958|65680160|FG001|Overall Study|Progression|9|||
23531370|NCT03246958|65680161|FG002|Overall Study|Progression|3|||
23531371|NCT03246958|65680162|FG003|Overall Study|Progression|2|||
23531372|NCT03246958|65680163|FG004|Overall Study|Progression|1|||
23531373|NCT03246958|65680164|FG005|Overall Study|Progression|2|||
23531374|NCT03246958|65680165|FG006|Overall Study|Progression|1|||
23531375|NCT03246958|65680159|FG000|Overall Study|Adverse Event|2|||
23531376|NCT03246958|65680160|FG001|Overall Study|Adverse Event|2|||
23531377|NCT03246958|65680161|FG002|Overall Study|Adverse Event|0|||
23531378|NCT03246958|65680162|FG003|Overall Study|Adverse Event|1|||
23531379|NCT03246958|65680163|FG004|Overall Study|Adverse Event|1|||
23531380|NCT03246958|65680164|FG005|Overall Study|Adverse Event|0|||
23531381|NCT03246958|65680165|FG006|Overall Study|Adverse Event|2|||
23531382|NCT03246958|65680159|FG000|Overall Study|Death|0|||
23531383|NCT03246958|65680160|FG001|Overall Study|Death|1|||
23531384|NCT03246958|65680161|FG002|Overall Study|Death|0|||
23531385|NCT03246958|65680162|FG003|Overall Study|Death|0|||
23531386|NCT03246958|65680163|FG004|Overall Study|Death|0|||
23531387|NCT03246958|65680164|FG005|Overall Study|Death|0|||
23531388|NCT03246958|65680165|FG006|Overall Study|Death|0|||
23309863|NCT01823835|64881274|FG006|Overall Study|Physician Decision|0|||
23531389|NCT03246958|65680159|FG000|Overall Study|Physician Decision|0|||
23531390|NCT03246958|65680160|FG001|Overall Study|Physician Decision|0|||
23531391|NCT03246958|65680161|FG002|Overall Study|Physician Decision|0|||
23531392|NCT03246958|65680162|FG003|Overall Study|Physician Decision|1|||
23531393|NCT03246958|65680163|FG004|Overall Study|Physician Decision|0|||
23531394|NCT03246958|65680164|FG005|Overall Study|Physician Decision|0|||
23531395|NCT03246958|65680165|FG006|Overall Study|Physician Decision|0|||
23531396|NCT03246958|65680159|FG000|Overall Study|Never start treatment|1|||
23531397|NCT03246958|65680160|FG001|Overall Study|Never start treatment|0|||
23531398|NCT03246958|65680161|FG002|Overall Study|Never start treatment|0|||
23531399|NCT03246958|65680162|FG003|Overall Study|Never start treatment|0|||
23531400|NCT03246958|65680163|FG004|Overall Study|Never start treatment|0|||
23531401|NCT03246958|65680164|FG005|Overall Study|Never start treatment|0|||
23531402|NCT03246958|65680165|FG006|Overall Study|Never start treatment|0|||
23531403|NCT03246958|65680159|FG000|Overall Study|Over enrollment|0|||
23309864|NCT01823835|64881275|FG007|Overall Study|Physician Decision|0|||
23309865|NCT01823835|64881276|FG008|Overall Study|Physician Decision|0|||
23309866|NCT01823835|64881277|FG009|Overall Study|Physician Decision|0|||
23309867|NCT01823835|64881278|FG010|Overall Study|Physician Decision|0|||
23309868|NCT01823835|64881279|FG011|Overall Study|Physician Decision|2|||
23531404|NCT03246958|65680160|FG001|Overall Study|Over enrollment|2|||
23309869|NCT01823835|64881280|FG012|Overall Study|Physician Decision|0|||
23531405|NCT03246958|65680161|FG002|Overall Study|Over enrollment|0|||
23531406|NCT03246958|65680162|FG003|Overall Study|Over enrollment|0|||
23419976|NCT03054350|65280504|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
23419977|NCT03054350|65280499|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419978|NCT03054350|65280500|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419979|NCT03054350|65280501|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
23419980|NCT03054350|65280502|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419981|NCT03054350|65280503|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419982|NCT03054350|65280504|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
23419983|NCT03746600|65280505|FG000|Overall Study|Withdrawal by Subject|3|||
23419984|NCT03746600|65280506|FG001|Overall Study|Withdrawal by Subject|3|||
23419985|NCT03746600|65280505|FG000|Overall Study|dismissed from study|1|||
23419986|NCT03746600|65280506|FG001|Overall Study|dismissed from study|0|||
23207452|NCT00254293|64498209|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23207453|NCT00254293|64498210|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
23207454|NCT00254293|64498211|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23207455|NCT00254293|64498212|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
23207456|NCT00254293|64498213|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23207457|NCT00254293|64498214|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23207458|NCT00254293|64498215|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
23207459|NCT00254293|64498209|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23207460|NCT00254293|64498210|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23207461|NCT00254293|64498211|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
23207462|NCT00254293|64498212|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23207463|NCT00254293|64498213|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23207464|NCT00254293|64498214|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23207465|NCT00254293|64498215|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
23207466|NCT00254293|64498209|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23207467|NCT00254293|64498210|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23207468|NCT00254293|64498211|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
23207469|NCT00254293|64498212|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23207470|NCT00254293|64498213|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23207471|NCT00254293|64498214|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23207472|NCT00254293|64498215|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
23207473|NCT00254293|64498209|FG000|LTE Open Label Variable SC Dosing|Death|0|||
23207474|NCT00254293|64498210|FG001|LTE Open Label Variable SC Dosing|Death|0|||
23207475|NCT00254293|64498211|FG002|LTE Open Label Variable SC Dosing|Death|1|||
23207476|NCT00254293|64498212|FG003|LTE Open Label Variable SC Dosing|Death|0|||
23207477|NCT00254293|64498213|FG004|LTE Open Label Variable SC Dosing|Death|0|||
23207478|NCT00254293|64498214|FG005|LTE Open Label Variable SC Dosing|Death|0|||
23207479|NCT00254293|64498215|FG006|LTE Open Label Variable SC Dosing|Death|0|||
23207480|NCT00254293|64498209|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
23207481|NCT00254293|64498210|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
23207482|NCT00254293|64498211|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
23207483|NCT00254293|64498212|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
23207484|NCT00254293|64498213|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
23207485|NCT00254293|64498214|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
23207486|NCT00254293|64498215|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
23207487|NCT00254293|64498209|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
23207488|NCT00254293|64498210|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
23207489|NCT00254293|64498211|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
23207490|NCT00254293|64498212|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
23207491|NCT00254293|64498213|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
23207492|NCT00254293|64498214|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
23207493|NCT00254293|64498215|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
23207494|NCT00254293|64498209|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23531407|NCT03246958|65680163|FG004|Overall Study|Over enrollment|0|||
23207495|NCT00254293|64498210|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23207496|NCT00254293|64498211|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
23419987|NCT03746600|65280505|FG000|Overall Study|Lost to Follow-up|1|||
23419988|NCT03746600|65280506|FG001|Overall Study|Lost to Follow-up|0|||
23419989|NCT01846663|65280511|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
23419990|NCT01846663|65280512|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
23419991|NCT01846663|65280511|FG000|Overall Study|Withdrawal by Subject|1|||
23419992|NCT01846663|65280512|FG001|Overall Study|Withdrawal by Subject|0|||
23419993|NCT01846663|65280511|FG000|Overall Study|Adverse Event|1|||
23419994|NCT01846663|65280512|FG001|Overall Study|Adverse Event|2|||
23419995|NCT04239222|65280513|FG000|Baseline|Withdrawal by Subject|0|||
23419996|NCT04239222|65280514|FG001|Baseline|Withdrawal by Subject|0|||
23419997|NCT04239222|65280515|FG002|Baseline|Withdrawal by Subject|1|||
23419998|NCT04239222|65280516|FG003|Baseline|Withdrawal by Subject|1|||
23419999|NCT04239222|65280513|FG000|First Foot Assignment|Withdrawal by Subject|0|||
23420000|NCT04239222|65280514|FG001|First Foot Assignment|Withdrawal by Subject|0|||
23420001|NCT04239222|65280515|FG002|First Foot Assignment|Withdrawal by Subject|1|||
23420002|NCT04239222|65280516|FG003|First Foot Assignment|Withdrawal by Subject|0|||
23420003|NCT04239222|65280513|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
23420004|NCT04239222|65280514|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
23420005|NCT04239222|65280515|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
23420006|NCT04239222|65280516|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
23420007|NCT03960580|65280520|FG000|Overall Study|Adverse Event|2|||
23420008|NCT03960580|65280521|FG001|Overall Study|Adverse Event|1|||
23420009|NCT03960580|65280522|FG002|Overall Study|Adverse Event|1|||
23420010|NCT03960580|65280520|FG000|Overall Study|Lost to Follow-up|1|||
23531408|NCT03246958|65680164|FG005|Overall Study|Over enrollment|0|||
23531409|NCT03246958|65680165|FG006|Overall Study|Over enrollment|0|||
23207497|NCT00254293|64498212|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23420011|NCT03960580|65280521|FG001|Overall Study|Lost to Follow-up|0|||
23420012|NCT03960580|65280522|FG002|Overall Study|Lost to Follow-up|0|||
23420013|NCT03960580|65280520|FG000|Overall Study|Lack of Efficacy|2|||
23420014|NCT03960580|65280521|FG001|Overall Study|Lack of Efficacy|1|||
23420015|NCT03960580|65280522|FG002|Overall Study|Lack of Efficacy|0|||
23420016|NCT03960580|65280520|FG000|Overall Study|Protocol Violation|0|||
23420017|NCT03960580|65280521|FG001|Overall Study|Protocol Violation|0|||
23420018|NCT03960580|65280522|FG002|Overall Study|Protocol Violation|1|||
23420019|NCT03960580|65280520|FG000|Overall Study|Withdrawal by Subject|1|||
23420020|NCT03960580|65280521|FG001|Overall Study|Withdrawal by Subject|1|||
23420021|NCT03960580|65280522|FG002|Overall Study|Withdrawal by Subject|1|||
23420022|NCT03960580|65280520|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
23420023|NCT03960580|65280521|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
23420024|NCT03960580|65280522|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
23420025|NCT05426031|65280524|FG000|Overall Study|Circulatory Arrest|3|||
23420026|NCT05426031|65280525|FG001|Overall Study|Circulatory Arrest|2|||
23420027|NCT04621240|65280526|FG000|Overall Study|Withdrawal by Subject|36|||
23420028|NCT00543803|65280527|FG000|Overall Study|Adverse Event|14|||
23420029|NCT00543803|65280527|FG000|Overall Study|Lack of Efficacy|22|||
23420030|NCT00543803|65280527|FG000|Overall Study|Lost to Follow-up|20|||
23420031|NCT00543803|65280527|FG000|Overall Study|Other|86|||
23420032|NCT00132691|65280528|FG000|Overall Study|Lost to Follow-up|5|||
23420033|NCT00132691|65280529|FG001|Overall Study|Lost to Follow-up|8|||
23420034|NCT00132691|65280528|FG000|Overall Study|Missed 2-year visit|4|||
23420035|NCT00132691|65280529|FG001|Overall Study|Missed 2-year visit|4|||
23420036|NCT00132691|65280528|FG000|Overall Study|Death|2|||
23420037|NCT00132691|65280529|FG001|Overall Study|Death|0|||
23207498|NCT00254293|64498213|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23207499|NCT00254293|64498214|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23207500|NCT00254293|64498215|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
23207501|NCT00254293|64498209|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23207502|NCT00254293|64498210|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23207503|NCT00254293|64498211|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
23207504|NCT00254293|64498212|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23207505|NCT00254293|64498213|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23207506|NCT00254293|64498214|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23207507|NCT00254293|64498215|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
23207508|NCT00254293|64498209|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23309870|NCT01823835|64881281|FG013|Overall Study|Physician Decision|0|||
23531410|NCT01797536|65680168|FG000|Overall Study|Adverse Event|0|||
23531411|NCT01797536|65680169|FG001|Overall Study|Adverse Event|1|||
23531412|NCT01797536|65680170|FG002|Overall Study|Adverse Event|0|||
23309871|NCT01823835|64881282|FG014|Overall Study|Physician Decision|0|||
23420038|NCT01973387|65280530|FG000|Overall Study|Adverse Event|14|||
23531413|NCT01797536|65680171|FG003|Overall Study|Adverse Event|0|||
23420039|NCT01973387|65280531|FG001|Overall Study|Adverse Event|4|||
23420040|NCT01973387|65280530|FG000|Overall Study|Withdrawal by Subject|7|||
23531414|NCT00546715|65680178|FG000|Overall Study|Withdrawal by Subject|0|||
23309872|NCT01823835|64881268|FG000|Overall Study|Progressive Disease|3|||
23531415|NCT00546715|65680179|FG001|Overall Study|Withdrawal by Subject|1|||
23420041|NCT01973387|65280531|FG001|Overall Study|Withdrawal by Subject|4|||
23420042|NCT01973387|65280530|FG000|Overall Study|Study terminated by sponsor|63|||
23420043|NCT01973387|65280531|FG001|Overall Study|Study terminated by sponsor|0|||
23420044|NCT01973387|65280530|FG000|Overall Study|Progressive disease or relapse|16|||
23420045|NCT01973387|65280531|FG001|Overall Study|Progressive disease or relapse|5|||
23420046|NCT01973387|65280530|FG000|Overall Study|Death|4|||
23420047|NCT01973387|65280531|FG001|Overall Study|Death|3|||
23420048|NCT01973387|65280530|FG000|Overall Study|Randomized, not treated|2|||
23420049|NCT01973387|65280531|FG001|Overall Study|Randomized, not treated|2|||
23420050|NCT00642174|65283734|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
23420051|NCT00642174|65283735|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
23420052|NCT01498575|65283738|FG000|Overall Sample|Withdrawal by Subject|60|||
23420053|NCT01498575|65283739|FG001|Overall Sample|Withdrawal by Subject|14|||
23420054|NCT01498575|65283738|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
23420055|NCT01498575|65283739|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
23420056|NCT01498575|65283738|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
23420057|NCT01498575|65283739|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
23420058|NCT01466660|65283742|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
23420059|NCT01466660|65283743|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
23420060|NCT01466660|65283742|FG000|Overall Study|Worsening of underlying cancer disease|5|||
23420061|NCT01466660|65283743|FG001|Overall Study|Worsening of underlying cancer disease|2|||
23420062|NCT01466660|65283742|FG000|Overall Study|Other adverse event|19|||
23420063|NCT01466660|65283743|FG001|Overall Study|Other adverse event|18|||
23420064|NCT01466660|65283742|FG000|Overall Study|Protocol Violation|2|||
23420065|NCT01466660|65283743|FG001|Overall Study|Protocol Violation|1|||
23420066|NCT01466660|65283742|FG000|Overall Study|Refused continuation of trial medication|4|||
23420067|NCT01466660|65283743|FG001|Overall Study|Refused continuation of trial medication|3|||
23420068|NCT01466660|65283742|FG000|Overall Study|Other reason not defined above|10|||
23420069|NCT01466660|65283743|FG001|Overall Study|Other reason not defined above|8|||
23420070|NCT03100539|65283744|FG000|Overall Study|Lost to Follow-up|60|||
23420071|NCT03100539|65283745|FG001|Overall Study|Lost to Follow-up|54|||
23420072|NCT03100539|65283746|FG002|Overall Study|Lost to Follow-up|17|||
23420073|NCT03100539|65283744|FG000|Overall Study|Uncollected|8|||
23420074|NCT03100539|65283745|FG001|Overall Study|Uncollected|8|||
23420075|NCT03100539|65283746|FG002|Overall Study|Uncollected|0|||
23420076|NCT03100539|65283744|FG000|Overall Study|Ally Health|0|||
23420077|NCT03100539|65283745|FG001|Overall Study|Ally Health|0|||
23420078|NCT03100539|65283746|FG002|Overall Study|Ally Health|3|||
23420079|NCT03100539|65283744|FG000|Overall Study|Disinterest|0|||
23420080|NCT03100539|65283745|FG001|Overall Study|Disinterest|0|||
23420081|NCT03100539|65283746|FG002|Overall Study|Disinterest|22|||
23420082|NCT03100539|65283744|FG000|Overall Study|Veteran Health|0|||
23420083|NCT03100539|65283745|FG001|Overall Study|Veteran Health|0|||
23420084|NCT03100539|65283746|FG002|Overall Study|Veteran Health|8|||
23420085|NCT03100539|65283744|FG000|Overall Study|Moved|0|||
23420086|NCT03100539|65283745|FG001|Overall Study|Moved|0|||
23420087|NCT03100539|65283746|FG002|Overall Study|Moved|1|||
23420088|NCT03100539|65283744|FG000|Overall Study|Scheduling Conflicts|0|||
23420089|NCT03100539|65283745|FG001|Overall Study|Scheduling Conflicts|0|||
23420090|NCT03100539|65283746|FG002|Overall Study|Scheduling Conflicts|12|||
23420091|NCT03816176|65283747|FG000|Overall Study|Miscellaneous|5|||
23420092|NCT03816176|65283747|FG000|Overall Study|Lack of Efficacy|4|||
23420093|NCT03816176|65283747|FG000|Overall Study|Adverse Event|3|||
23420094|NCT03730961|65283748|FG000|Overall Study|Adverse Event|0|||
23420095|NCT03730961|65283749|FG001|Overall Study|Adverse Event|1|||
23420096|NCT00075725|65283755|FG000|Overall Study|Adverse Event|6|||
23420097|NCT00075725|65283756|FG001|Overall Study|Adverse Event|6|||
23420098|NCT00075725|65283757|FG002|Overall Study|Adverse Event|20|||
23420099|NCT00075725|65283758|FG003|Overall Study|Adverse Event|8|||
23420100|NCT00075725|65283759|FG004|Overall Study|Adverse Event|4|||
23420101|NCT00075725|65283760|FG005|Overall Study|Adverse Event|38|||
23420102|NCT00075725|65283761|FG006|Overall Study|Adverse Event|3|||
23420103|NCT00075725|65283762|FG007|Overall Study|Adverse Event|51|||
23420104|NCT00075725|65283763|FG008|Overall Study|Adverse Event|15|||
23420105|NCT00075725|65283764|FG009|Overall Study|Adverse Event|4|||
23420106|NCT00075725|65283765|FG010|Overall Study|Adverse Event|2|||
23420107|NCT00075725|65283766|FG011|Overall Study|Adverse Event|2|||
23420108|NCT00075725|65283755|FG000|Overall Study|Death|3|||
23420109|NCT00075725|65283756|FG001|Overall Study|Death|5|||
23420110|NCT00075725|65283757|FG002|Overall Study|Death|10|||
23420111|NCT00075725|65283758|FG003|Overall Study|Death|2|||
23420112|NCT00075725|65283759|FG004|Overall Study|Death|3|||
23420113|NCT00075725|65283760|FG005|Overall Study|Death|25|||
23420114|NCT00075725|65283761|FG006|Overall Study|Death|4|||
23420115|NCT00075725|65283762|FG007|Overall Study|Death|22|||
23420116|NCT00075725|65283763|FG008|Overall Study|Death|14|||
23420117|NCT00075725|65283764|FG009|Overall Study|Death|4|||
23420118|NCT00075725|65283765|FG010|Overall Study|Death|3|||
23420119|NCT00075725|65283766|FG011|Overall Study|Death|0|||
23420120|NCT00075725|65283755|FG000|Overall Study|Lost to Follow-up|1|||
23420121|NCT00075725|65283756|FG001|Overall Study|Lost to Follow-up|1|||
23420122|NCT00075725|65283757|FG002|Overall Study|Lost to Follow-up|4|||
23420123|NCT00075725|65283758|FG003|Overall Study|Lost to Follow-up|1|||
23420124|NCT00075725|65283759|FG004|Overall Study|Lost to Follow-up|0|||
23420125|NCT00075725|65283760|FG005|Overall Study|Lost to Follow-up|13|||
23531416|NCT00546715|65680180|FG002|Overall Study|Withdrawal by Subject|0|||
23531417|NCT00546715|65680181|FG003|Overall Study|Withdrawal by Subject|0|||
23613382|NCT02446912|65973072|FG002|Overall Study|Study-specific withdrawal criteria|0|||
23613383|NCT02446912|65973070|FG000|Overall Study|Lack of Efficacy|1|||
23531418|NCT02287896|65680184|FG000|Second Injection Visit|Withdrawal by Subject|0|||
23531419|NCT02287896|65680185|FG001|Second Injection Visit|Withdrawal by Subject|1|||
23531420|NCT01631474|65680186|FG000|Overall Study|Lost to Follow-up|8|||
23531421|NCT01631474|65680187|FG001|Overall Study|Lost to Follow-up|5|||
23531422|NCT01631474|65680188|FG002|Overall Study|Lost to Follow-up|7|||
23531423|NCT01631474|65680189|FG003|Overall Study|Lost to Follow-up|5|||
23531424|NCT01631474|65680190|FG004|Overall Study|Lost to Follow-up|5|||
23531425|NCT01631474|65680186|FG000|Overall Study|Withdrawal by Subject|4|||
23531426|NCT01631474|65680187|FG001|Overall Study|Withdrawal by Subject|4|||
23531427|NCT01631474|65680188|FG002|Overall Study|Withdrawal by Subject|2|||
23531428|NCT01631474|65680189|FG003|Overall Study|Withdrawal by Subject|6|||
23531429|NCT01631474|65680190|FG004|Overall Study|Withdrawal by Subject|5|||
23531430|NCT01631474|65680186|FG000|Overall Study|Lack of Efficacy|2|||
23531431|NCT01631474|65680187|FG001|Overall Study|Lack of Efficacy|2|||
23531432|NCT01631474|65680188|FG002|Overall Study|Lack of Efficacy|0|||
23531433|NCT01631474|65680189|FG003|Overall Study|Lack of Efficacy|0|||
23531434|NCT01631474|65680190|FG004|Overall Study|Lack of Efficacy|2|||
23531435|NCT01631474|65680186|FG000|Overall Study|Noncompliance with Study Drug|0|||
23531436|NCT01631474|65680187|FG001|Overall Study|Noncompliance with Study Drug|0|||
23531437|NCT01631474|65680188|FG002|Overall Study|Noncompliance with Study Drug|0|||
23531438|NCT01631474|65680189|FG003|Overall Study|Noncompliance with Study Drug|0|||
23531439|NCT01631474|65680190|FG004|Overall Study|Noncompliance with Study Drug|1|||
23531440|NCT01631474|65680186|FG000|Overall Study|Adverse Event|0|||
23613384|NCT02446912|65973071|FG001|Overall Study|Lack of Efficacy|4|||
23613385|NCT02446912|65973072|FG002|Overall Study|Lack of Efficacy|7|||
23613386|NCT02446912|65973070|FG000|Overall Study|Lost to Follow-up|0|||
23613387|NCT02446912|65973071|FG001|Overall Study|Lost to Follow-up|0|||
23613388|NCT02446912|65973072|FG002|Overall Study|Lost to Follow-up|2|||
23613389|NCT02446912|65973070|FG000|Overall Study|Severe non-compliance to protocol|1|||
23613390|NCT02446912|65973071|FG001|Overall Study|Severe non-compliance to protocol|0|||
23613391|NCT02446912|65973072|FG002|Overall Study|Severe non-compliance to protocol|1|||
23613392|NCT02446912|65973070|FG000|Overall Study|Withdrawal by Subject|10|||
23613393|NCT02446912|65973071|FG001|Overall Study|Withdrawal by Subject|15|||
23613394|NCT02446912|65973072|FG002|Overall Study|Withdrawal by Subject|15|||
23613395|NCT02446912|65973070|FG000|Overall Study|Miscellaneous|2|||
23531441|NCT01631474|65680187|FG001|Overall Study|Adverse Event|1|||
23531442|NCT01631474|65680188|FG002|Overall Study|Adverse Event|0|||
23531443|NCT01631474|65680189|FG003|Overall Study|Adverse Event|0|||
23613396|NCT02446912|65973071|FG001|Overall Study|Miscellaneous|2|||
23613397|NCT02446912|65973072|FG002|Overall Study|Miscellaneous|4|||
23613398|NCT03614923|65973073|FG000|Overall Study|Withdrawal by Subject|2|||
23613399|NCT03614923|65973074|FG001|Overall Study|Withdrawal by Subject|1|||
23613400|NCT03614923|65973075|FG002|Overall Study|Withdrawal by Subject|1|||
23613401|NCT03614923|65973073|FG000|Overall Study|Adverse Event|0|||
23613402|NCT03614923|65973074|FG001|Overall Study|Adverse Event|2|||
23613403|NCT03614923|65973075|FG002|Overall Study|Adverse Event|1|||
23613404|NCT03614923|65973073|FG000|Overall Study|Lost to Follow-up|1|||
23613405|NCT03614923|65973074|FG001|Overall Study|Lost to Follow-up|0|||
23613406|NCT03614923|65973075|FG002|Overall Study|Lost to Follow-up|1|||
23613407|NCT03614923|65973073|FG000|Overall Study|Lack of Efficacy|2|||
23613408|NCT03614923|65973074|FG001|Overall Study|Lack of Efficacy|0|||
23613409|NCT03614923|65973075|FG002|Overall Study|Lack of Efficacy|1|||
23531444|NCT01631474|65680190|FG004|Overall Study|Adverse Event|0|||
23613410|NCT03614923|65973073|FG000|Overall Study|Non-compliance|0|||
23613411|NCT03614923|65973074|FG001|Overall Study|Non-compliance|1|||
23613412|NCT03614923|65973075|FG002|Overall Study|Non-compliance|0|||
23613413|NCT03614923|65973073|FG000|Overall Study|Other|0|||
23420126|NCT00075725|65283761|FG006|Overall Study|Lost to Follow-up|2|||
23613414|NCT03614923|65973074|FG001|Overall Study|Other|1|||
23613415|NCT03614923|65973075|FG002|Overall Study|Other|1|||
23531445|NCT03235024|65680191|FG000|Overall Study|Adverse Event|2|||
23531446|NCT03235024|65680192|FG001|Overall Study|Adverse Event|2|||
23531447|NCT03235024|65680191|FG000|Overall Study|Death|1|||
23531448|NCT03235024|65680192|FG001|Overall Study|Death|0|||
23531449|NCT03235024|65680191|FG000|Overall Study|Lost to Follow-up|2|||
23531450|NCT03235024|65680192|FG001|Overall Study|Lost to Follow-up|5|||
23613416|NCT02592434|65973079|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
23613417|NCT02592434|65973080|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
23613418|NCT02592434|65973081|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
23613419|NCT02592434|65973079|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
23613420|NCT02592434|65973080|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
23613421|NCT02592434|65973081|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
23613422|NCT02592434|65973079|FG000|Open-Label Phase (18 Weeks)|Other|3|||
23613423|NCT02592434|65973080|FG001|Open-Label Phase (18 Weeks)|Other|0|||
23613424|NCT02592434|65973081|FG002|Open-Label Phase (18 Weeks)|Other|0|||
23613425|NCT02592434|65973079|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
23613426|NCT02592434|65973080|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
23613427|NCT02592434|65973081|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
23613428|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
23613429|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
23613430|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
23613431|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
23613432|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
23613433|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
23613434|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Other|0|||
23613435|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Other|1|||
23613436|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Other|0|||
23613437|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
23613438|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
23613439|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
23613440|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
23613441|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
23613442|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
23613443|NCT02592434|65973079|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
23613444|NCT02592434|65973080|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
23613445|NCT02592434|65973081|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
23613446|NCT03169530|65973082|FG000|Overall Study|Study ended by NIH|15|||
23613447|NCT03169530|65973083|FG001|Overall Study|Study ended by NIH|17|||
23613448|NCT03997409|65973084|FG000|Overall Study|Protocol Violation|1|||
23613449|NCT03997409|65973085|FG001|Overall Study|Protocol Violation|1|||
23613450|NCT03997409|65973086|FG002|Overall Study|Protocol Violation|0|||
23613451|NCT03997409|65973084|FG000|Overall Study|Withdrawal by Subject|3|||
23613452|NCT03997409|65973085|FG001|Overall Study|Withdrawal by Subject|0|||
23613453|NCT03997409|65973086|FG002|Overall Study|Withdrawal by Subject|0|||
23613454|NCT03997409|65973084|FG000|Overall Study|Lost to Follow-up|0|||
23613455|NCT03997409|65973085|FG001|Overall Study|Lost to Follow-up|0|||
23613456|NCT03997409|65973086|FG002|Overall Study|Lost to Follow-up|1|||
23613457|NCT01304940|65973087|FG000|Overall Study|not meet symptom severity requirement|3|||
23613458|NCT01304940|65973088|FG001|Overall Study|not meet symptom severity requirement|0|||
23613459|NCT02812706|65973089|FG000|Phase 1|Adverse Event|0|||
23613460|NCT02812706|65973090|FG001|Phase 1|Adverse Event|2|||
23613461|NCT02812706|65973091|FG002|Phase 1|Adverse Event|0|||
23613462|NCT02812706|65973089|FG000|Phase 1|Progressive disease|3|||
23613463|NCT02812706|65973090|FG001|Phase 1|Progressive disease|3|||
23613464|NCT02812706|65973091|FG002|Phase 1|Progressive disease|0|||
23613465|NCT02812706|65973089|FG000|Phase 2|Adverse Event|0|||
23613466|NCT02812706|65973090|FG001|Phase 2|Adverse Event|0|||
23613467|NCT02812706|65973091|FG002|Phase 2|Adverse Event|2|||
23613468|NCT02812706|65973089|FG000|Phase 2|Progressive disease|0|||
23613469|NCT02812706|65973090|FG001|Phase 2|Progressive disease|0|||
23613470|NCT02812706|65973091|FG002|Phase 2|Progressive disease|22|||
23613471|NCT02812706|65973089|FG000|Phase 2|Other-Unspecified|0|||
23613472|NCT02812706|65973090|FG001|Phase 2|Other-Unspecified|0|||
23613473|NCT02812706|65973091|FG002|Phase 2|Other-Unspecified|4|||
23613474|NCT04380688|65973095|FG000|Overall Study|Death|2|||
23613475|NCT04380688|65973096|FG001|Overall Study|Death|2|||
23613476|NCT04380688|65973095|FG000|Overall Study|Lost to Follow-up|2|||
23613477|NCT04380688|65973096|FG001|Overall Study|Lost to Follow-up|4|||
23613478|NCT04380688|65973095|FG000|Overall Study|Withdrawal by Subject|3|||
23613479|NCT04380688|65973096|FG001|Overall Study|Withdrawal by Subject|3|||
23613480|NCT01877720|65973097|FG000|Overall Study|Adverse Event|1|||
23613481|NCT01877720|65973098|FG001|Overall Study|Adverse Event|0|||
23613482|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
23613483|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
23613484|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
23613485|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
23613486|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
23613487|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
23613488|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
23613489|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
23613490|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
23613491|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
23613492|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
23613493|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
23613494|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613495|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
23613496|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613497|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613498|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613499|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
23613500|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613501|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
23613502|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613503|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613504|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613505|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
23613506|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613507|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613508|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
23613509|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613510|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613511|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
23613512|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
23613513|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
23613514|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
23613515|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
23613516|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
23613517|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
23613518|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
23613519|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
23613520|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
23613521|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
23309873|NCT01823835|64881269|FG001|Overall Study|Progressive Disease|4|||
23309874|NCT01823835|64881270|FG002|Overall Study|Progressive Disease|3|||
23309875|NCT01823835|64881271|FG003|Overall Study|Progressive Disease|6|||
23309876|NCT01823835|64881272|FG004|Overall Study|Progressive Disease|4|||
23531451|NCT03235024|65680191|FG000|Overall Study|Protocol Violation|1|||
23531452|NCT03235024|65680192|FG001|Overall Study|Protocol Violation|0|||
23531453|NCT03235024|65680191|FG000|Overall Study|Withdrawal by Subject|0|||
23531454|NCT03235024|65680192|FG001|Overall Study|Withdrawal by Subject|3|||
23531455|NCT01256710|65680198|FG000|Overall Study|Death|449|||
23531456|NCT01256710|65680198|FG000|Overall Study|System Explant|67|||
23531457|NCT01256710|65680198|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
23531458|NCT01256710|65680198|FG000|Overall Study|Lost to Follow-up|67|||
23531459|NCT01256710|65680198|FG000|Overall Study|Withdrawal by Subject|29|||
23531460|NCT01256710|65680198|FG000|Overall Study|Physician Decision|9|||
23531461|NCT01256710|65680198|FG000|Overall Study|Subject Noncompliance|2|||
23531462|NCT01256710|65680198|FG000|Overall Study|Study Terminated by Sponsor|273|||
23531463|NCT01451424|65680199|FG000|Overall Study|Withdrawal by Subject|1|||
23531464|NCT01451424|65680200|FG001|Overall Study|Withdrawal by Subject|1|||
23531465|NCT01451424|65680201|FG002|Overall Study|Withdrawal by Subject|0|||
23531466|NCT01451424|65680202|FG003|Overall Study|Withdrawal by Subject|2|||
23531467|NCT01451424|65680199|FG000|Overall Study|Lost to Follow-up|0|||
23531468|NCT01451424|65680200|FG001|Overall Study|Lost to Follow-up|1|||
23531469|NCT01451424|65680201|FG002|Overall Study|Lost to Follow-up|0|||
23531470|NCT01451424|65680202|FG003|Overall Study|Lost to Follow-up|1|||
23531471|NCT01451424|65680199|FG000|Overall Study|Physician Decision|0|||
23531472|NCT01451424|65680200|FG001|Overall Study|Physician Decision|0|||
23531473|NCT01451424|65680201|FG002|Overall Study|Physician Decision|1|||
23531474|NCT01451424|65680202|FG003|Overall Study|Physician Decision|1|||
23531475|NCT01451424|65680199|FG000|Overall Study|Adverse Event|0|||
23531476|NCT01451424|65680200|FG001|Overall Study|Adverse Event|0|||
23531477|NCT01451424|65680201|FG002|Overall Study|Adverse Event|0|||
23531478|NCT01451424|65680202|FG003|Overall Study|Adverse Event|1|||
23613522|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
23613523|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
23531479|NCT03945981|65680211|FG000|Overall Study|Lost to Follow-up|12|||
23531480|NCT03945981|65680211|FG000|Overall Study|Physician Decision|4|||
23531481|NCT03945981|65680211|FG000|Overall Study|Withdrawal by Subject|6|||
23531482|NCT03945981|65680211|FG000|Overall Study|Protocol Violation|1|||
23531483|NCT00574405|65680212|FG000|Overall Study|Withdrawal by Subject|3|||
23531484|NCT00574405|65680213|FG001|Overall Study|Withdrawal by Subject|2|||
23309877|NCT01823835|64881273|FG005|Overall Study|Progressive Disease|6|||
23531485|NCT00240071|65680214|FG000|Overall Study|Withdrawal by Subject|3|||
23531486|NCT02460224|65680215|FG000|Overall Study|Adverse Event|0|||
23531487|NCT02460224|65680216|FG001|Overall Study|Adverse Event|0|||
23531488|NCT02460224|65680217|FG002|Overall Study|Adverse Event|0|||
23531489|NCT02460224|65680218|FG003|Overall Study|Adverse Event|0|||
23531490|NCT02460224|65680219|FG004|Overall Study|Adverse Event|0|||
23309878|NCT01823835|64881274|FG006|Overall Study|Progressive Disease|5|||
23531491|NCT02460224|65680220|FG005|Overall Study|Adverse Event|0|||
23531492|NCT02460224|65680221|FG006|Overall Study|Adverse Event|1|||
23531493|NCT02460224|65680222|FG007|Overall Study|Adverse Event|0|||
23531494|NCT02460224|65680223|FG008|Overall Study|Adverse Event|0|||
23531495|NCT02460224|65680224|FG009|Overall Study|Adverse Event|0|||
23531496|NCT02460224|65680225|FG010|Overall Study|Adverse Event|0|||
23531497|NCT02460224|65680226|FG011|Overall Study|Adverse Event|0|||
23531498|NCT02460224|65680227|FG012|Overall Study|Adverse Event|1|||
23531499|NCT02460224|65680228|FG013|Overall Study|Adverse Event|0|||
23531500|NCT02460224|65680229|FG014|Overall Study|Adverse Event|0|||
23531501|NCT02460224|65680230|FG015|Overall Study|Adverse Event|0|||
23531502|NCT02460224|65680231|FG016|Overall Study|Adverse Event|1|||
23531503|NCT02460224|65680232|FG017|Overall Study|Adverse Event|0|||
23531504|NCT02460224|65680233|FG018|Overall Study|Adverse Event|1|||
23531505|NCT02460224|65680234|FG019|Overall Study|Adverse Event|0|||
23613524|NCT03524092|65973099|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
23613525|NCT03524092|65973100|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
23613526|NCT03524092|65973101|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
23613527|NCT03524092|65973102|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
23613528|NCT03524092|65973103|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
23613529|NCT03524092|65973104|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
23613530|NCT03524092|65973099|FG000|Loss of Response Rescue Period|Adverse Event|0|||
23613531|NCT03524092|65973100|FG001|Loss of Response Rescue Period|Adverse Event|0|||
23613532|NCT03524092|65973101|FG002|Loss of Response Rescue Period|Adverse Event|0|||
23613533|NCT03524092|65973102|FG003|Loss of Response Rescue Period|Adverse Event|2|||
23613534|NCT03524092|65973103|FG004|Loss of Response Rescue Period|Adverse Event|0|||
23613535|NCT03524092|65973104|FG005|Loss of Response Rescue Period|Adverse Event|0|||
23613536|NCT03524092|65973099|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
23613537|NCT03524092|65973100|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
23613538|NCT03524092|65973101|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
23613539|NCT03524092|65973102|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
23613540|NCT03524092|65973103|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
23531506|NCT02460224|65680235|FG020|Overall Study|Adverse Event|1|||
23531507|NCT02460224|65680236|FG021|Overall Study|Adverse Event|1|||
23531508|NCT02460224|65680237|FG022|Overall Study|Adverse Event|1|||
23531509|NCT02460224|65680238|FG023|Overall Study|Adverse Event|0|||
23531510|NCT02460224|65680239|FG024|Overall Study|Adverse Event|0|||
23531511|NCT02460224|65680240|FG025|Overall Study|Adverse Event|0|||
23531512|NCT02460224|65680241|FG026|Overall Study|Adverse Event|11|||
23613541|NCT03524092|65973104|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
23531513|NCT02460224|65680242|FG027|Overall Study|Adverse Event|1|||
23207509|NCT00254293|64498210|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23613542|NCT03524092|65973099|FG000|Loss of Response Rescue Period|Pregnancy|0|||
23613543|NCT03524092|65973100|FG001|Loss of Response Rescue Period|Pregnancy|0|||
23613544|NCT03524092|65973101|FG002|Loss of Response Rescue Period|Pregnancy|0|||
23613545|NCT03524092|65973102|FG003|Loss of Response Rescue Period|Pregnancy|1|||
23613546|NCT03524092|65973103|FG004|Loss of Response Rescue Period|Pregnancy|0|||
23613547|NCT03524092|65973104|FG005|Loss of Response Rescue Period|Pregnancy|0|||
23613548|NCT03524092|65973099|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613549|NCT03524092|65973100|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613550|NCT03524092|65973101|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613551|NCT03524092|65973102|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
23613552|NCT03524092|65973103|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613553|NCT03524092|65973104|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
23613554|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23613555|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23613556|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23613557|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23207510|NCT00254293|64498211|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
23207511|NCT00254293|64498212|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23207512|NCT00254293|64498213|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23531514|NCT02460224|65680243|FG028|Overall Study|Adverse Event|6|||
23531515|NCT02460224|65680215|FG000|Overall Study|Death|0|||
23531516|NCT02460224|65680216|FG001|Overall Study|Death|0|||
23531517|NCT02460224|65680217|FG002|Overall Study|Death|0|||
23531518|NCT02460224|65680218|FG003|Overall Study|Death|0|||
23531519|NCT02460224|65680219|FG004|Overall Study|Death|0|||
23531520|NCT02460224|65680220|FG005|Overall Study|Death|2|||
23531521|NCT02460224|65680221|FG006|Overall Study|Death|1|||
23531522|NCT02460224|65680222|FG007|Overall Study|Death|0|||
23531523|NCT02460224|65680223|FG008|Overall Study|Death|0|||
23531524|NCT02460224|65680224|FG009|Overall Study|Death|1|||
23531525|NCT02460224|65680225|FG010|Overall Study|Death|0|||
23531526|NCT02460224|65680226|FG011|Overall Study|Death|0|||
23531527|NCT02460224|65680227|FG012|Overall Study|Death|0|||
23531528|NCT02460224|65680228|FG013|Overall Study|Death|1|||
23613558|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
23613559|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
23613560|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613561|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613562|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613563|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613564|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
23613565|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
23613566|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613567|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613568|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613569|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613570|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
23613571|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
23613572|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23613573|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23613574|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23613575|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23207513|NCT00254293|64498214|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23613576|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
23613577|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
23613578|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23613579|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23613580|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23613581|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23309879|NCT01823835|64881275|FG007|Overall Study|Progressive Disease|3|||
23531529|NCT02460224|65680229|FG014|Overall Study|Death|0|||
23309880|NCT01823835|64881276|FG008|Overall Study|Progressive Disease|3|||
23309881|NCT01823835|64881277|FG009|Overall Study|Progressive Disease|18|||
23531530|NCT02460224|65680230|FG015|Overall Study|Death|0|||
23531531|NCT02460224|65680231|FG016|Overall Study|Death|2|||
23531532|NCT02460224|65680232|FG017|Overall Study|Death|1|||
23531533|NCT02460224|65680233|FG018|Overall Study|Death|0|||
23613582|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
23613583|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
23613584|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613585|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613586|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613587|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613588|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
23613589|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
23613590|NCT03524092|65973099|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613591|NCT03524092|65973100|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613592|NCT03524092|65973101|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613593|NCT03524092|65973102|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613594|NCT03524092|65973103|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
23613595|NCT03524092|65973104|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
23613596|NCT03524092|65973099|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613597|NCT03524092|65973100|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613598|NCT03524092|65973101|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613599|NCT03524092|65973102|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613600|NCT03524092|65973103|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
23613601|NCT03524092|65973104|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
23613602|NCT03524092|65973099|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613603|NCT03524092|65973100|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613604|NCT03524092|65973101|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613605|NCT03524092|65973102|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613606|NCT03524092|65973103|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
23613607|NCT03524092|65973104|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
23613608|NCT03524092|65973099|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613609|NCT03524092|65973100|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613610|NCT03524092|65973101|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613611|NCT03524092|65973102|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613612|NCT03524092|65973103|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
23613613|NCT03524092|65973104|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
23613614|NCT03524092|65973099|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613615|NCT03524092|65973100|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613616|NCT03524092|65973101|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613617|NCT03524092|65973102|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613618|NCT03524092|65973103|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
23613619|NCT03524092|65973104|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
23613620|NCT01770509|65973105|FG000|Overall Study|Injury|0|||
23613621|NCT01770509|65973106|FG001|Overall Study|Injury|1|||
23613622|NCT01770509|65973105|FG000|Overall Study|Lost to Follow-up|1|||
23613623|NCT01770509|65973106|FG001|Overall Study|Lost to Follow-up|2|||
23613624|NCT00108355|65973107|FG000|Overall Study|Peritonitis at index paracentesis|1|||
23531534|NCT02460224|65680234|FG019|Overall Study|Death|2|||
23531535|NCT02460224|65680235|FG020|Overall Study|Death|0|||
23531536|NCT02460224|65680236|FG021|Overall Study|Death|0|||
23531537|NCT02460224|65680237|FG022|Overall Study|Death|0|||
23531538|NCT02460224|65680238|FG023|Overall Study|Death|0|||
23531539|NCT02460224|65680239|FG024|Overall Study|Death|1|||
23531540|NCT02460224|65680240|FG025|Overall Study|Death|1|||
23531541|NCT02460224|65680241|FG026|Overall Study|Death|5|||
23531542|NCT02460224|65680242|FG027|Overall Study|Death|0|||
23613625|NCT00108355|65973108|FG001|Overall Study|Peritonitis at index paracentesis|1|||
23613626|NCT00108355|65973107|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
23613627|NCT00108355|65973108|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
23613628|NCT01540474|65973114|FG000|Vaccination Period|Lost to Follow-up|0|||
23309882|NCT01823835|64881278|FG010|Overall Study|Progressive Disease|8|||
23309883|NCT01823835|64881279|FG011|Overall Study|Progressive Disease|46|||
23309884|NCT01823835|64881280|FG012|Overall Study|Progressive Disease|18|||
23309885|NCT01823835|64881281|FG013|Overall Study|Progressive Disease|4|||
23309886|NCT01823835|64881282|FG014|Overall Study|Progressive Disease|6|||
23309887|NCT01823835|64881268|FG000|Overall Study|Study Termination|0|||
23531543|NCT02460224|65680243|FG028|Overall Study|Death|1|||
23531544|NCT02460224|65680215|FG000|Overall Study|Lost to Follow-up|0|||
23531545|NCT02460224|65680216|FG001|Overall Study|Lost to Follow-up|0|||
23613629|NCT01540474|65973115|FG001|Vaccination Period|Lost to Follow-up|1|||
23531546|NCT02460224|65680217|FG002|Overall Study|Lost to Follow-up|0|||
23531547|NCT02460224|65680218|FG003|Overall Study|Lost to Follow-up|0|||
23531548|NCT02460224|65680219|FG004|Overall Study|Lost to Follow-up|0|||
23531549|NCT02460224|65680220|FG005|Overall Study|Lost to Follow-up|0|||
23531550|NCT02460224|65680221|FG006|Overall Study|Lost to Follow-up|0|||
23531551|NCT02460224|65680222|FG007|Overall Study|Lost to Follow-up|0|||
23531552|NCT02460224|65680223|FG008|Overall Study|Lost to Follow-up|0|||
23531553|NCT02460224|65680224|FG009|Overall Study|Lost to Follow-up|0|||
23531554|NCT02460224|65680225|FG010|Overall Study|Lost to Follow-up|0|||
23531555|NCT02460224|65680226|FG011|Overall Study|Lost to Follow-up|0|||
23531556|NCT02460224|65680227|FG012|Overall Study|Lost to Follow-up|0|||
23531557|NCT02460224|65680228|FG013|Overall Study|Lost to Follow-up|0|||
23531558|NCT02460224|65680229|FG014|Overall Study|Lost to Follow-up|0|||
23531559|NCT02460224|65680230|FG015|Overall Study|Lost to Follow-up|0|||
23531560|NCT02460224|65680231|FG016|Overall Study|Lost to Follow-up|0|||
23531561|NCT02460224|65680232|FG017|Overall Study|Lost to Follow-up|0|||
23531562|NCT02460224|65680233|FG018|Overall Study|Lost to Follow-up|0|||
23531563|NCT02460224|65680234|FG019|Overall Study|Lost to Follow-up|0|||
23531564|NCT02460224|65680235|FG020|Overall Study|Lost to Follow-up|0|||
23531565|NCT02460224|65680236|FG021|Overall Study|Lost to Follow-up|0|||
23531566|NCT02460224|65680237|FG022|Overall Study|Lost to Follow-up|1|||
23531567|NCT02460224|65680238|FG023|Overall Study|Lost to Follow-up|0|||
23531568|NCT02460224|65680239|FG024|Overall Study|Lost to Follow-up|0|||
23531569|NCT02460224|65680240|FG025|Overall Study|Lost to Follow-up|0|||
23531570|NCT02460224|65680241|FG026|Overall Study|Lost to Follow-up|0|||
23531571|NCT02460224|65680242|FG027|Overall Study|Lost to Follow-up|0|||
23531572|NCT02460224|65680243|FG028|Overall Study|Lost to Follow-up|0|||
23531573|NCT02460224|65680215|FG000|Overall Study|Physician Decision|0|||
23531574|NCT02460224|65680216|FG001|Overall Study|Physician Decision|1|||
23531575|NCT02460224|65680217|FG002|Overall Study|Physician Decision|0|||
23531576|NCT02460224|65680218|FG003|Overall Study|Physician Decision|0|||
23531577|NCT02460224|65680219|FG004|Overall Study|Physician Decision|1|||
23531578|NCT02460224|65680220|FG005|Overall Study|Physician Decision|0|||
23531579|NCT02460224|65680221|FG006|Overall Study|Physician Decision|0|||
23531580|NCT02460224|65680222|FG007|Overall Study|Physician Decision|1|||
23531581|NCT02460224|65680223|FG008|Overall Study|Physician Decision|0|||
23531582|NCT02460224|65680224|FG009|Overall Study|Physician Decision|0|||
23531583|NCT02460224|65680225|FG010|Overall Study|Physician Decision|0|||
23531584|NCT02460224|65680226|FG011|Overall Study|Physician Decision|1|||
23531585|NCT02460224|65680227|FG012|Overall Study|Physician Decision|0|||
23531586|NCT02460224|65680228|FG013|Overall Study|Physician Decision|1|||
23531587|NCT02460224|65680229|FG014|Overall Study|Physician Decision|0|||
23531588|NCT02460224|65680230|FG015|Overall Study|Physician Decision|0|||
23531589|NCT02460224|65680231|FG016|Overall Study|Physician Decision|2|||
23531590|NCT02460224|65680232|FG017|Overall Study|Physician Decision|1|||
23531591|NCT02460224|65680233|FG018|Overall Study|Physician Decision|1|||
23531592|NCT02460224|65680234|FG019|Overall Study|Physician Decision|2|||
23531593|NCT02460224|65680235|FG020|Overall Study|Physician Decision|1|||
23531594|NCT02460224|65680236|FG021|Overall Study|Physician Decision|1|||
23531595|NCT02460224|65680237|FG022|Overall Study|Physician Decision|0|||
23531596|NCT02460224|65680238|FG023|Overall Study|Physician Decision|0|||
23531597|NCT02460224|65680239|FG024|Overall Study|Physician Decision|1|||
23531598|NCT02460224|65680240|FG025|Overall Study|Physician Decision|0|||
23531599|NCT02460224|65680241|FG026|Overall Study|Physician Decision|14|||
23531600|NCT02460224|65680242|FG027|Overall Study|Physician Decision|1|||
23531601|NCT02460224|65680243|FG028|Overall Study|Physician Decision|6|||
23531602|NCT02460224|65680215|FG000|Overall Study|Progressive disease|15|||
23531603|NCT02460224|65680216|FG001|Overall Study|Progressive disease|11|||
23531604|NCT02460224|65680217|FG002|Overall Study|Progressive disease|5|||
23531605|NCT02460224|65680218|FG003|Overall Study|Progressive disease|6|||
23531606|NCT02460224|65680219|FG004|Overall Study|Progressive disease|3|||
23531607|NCT02460224|65680220|FG005|Overall Study|Progressive disease|26|||
23531608|NCT02460224|65680221|FG006|Overall Study|Progressive disease|28|||
23531609|NCT02460224|65680222|FG007|Overall Study|Progressive disease|4|||
23531610|NCT02460224|65680223|FG008|Overall Study|Progressive disease|5|||
23531611|NCT02460224|65680224|FG009|Overall Study|Progressive disease|9|||
23531612|NCT02460224|65680225|FG010|Overall Study|Progressive disease|5|||
23531613|NCT02460224|65680226|FG011|Overall Study|Progressive disease|4|||
23531614|NCT02460224|65680227|FG012|Overall Study|Progressive disease|5|||
23531615|NCT02460224|65680228|FG013|Overall Study|Progressive disease|4|||
23531616|NCT02460224|65680229|FG014|Overall Study|Progressive disease|5|||
23531617|NCT02460224|65680230|FG015|Overall Study|Progressive disease|5|||
23531618|NCT02460224|65680231|FG016|Overall Study|Progressive disease|15|||
23531619|NCT02460224|65680232|FG017|Overall Study|Progressive disease|3|||
23531620|NCT02460224|65680233|FG018|Overall Study|Progressive disease|8|||
23531621|NCT02460224|65680234|FG019|Overall Study|Progressive disease|3|||
23613630|NCT01540474|65973116|FG002|Vaccination Period|Lost to Follow-up|0|||
23531622|NCT02460224|65680235|FG020|Overall Study|Progressive disease|4|||
23531623|NCT02460224|65680236|FG021|Overall Study|Progressive disease|9|||
23531624|NCT02460224|65680237|FG022|Overall Study|Progressive disease|4|||
23531625|NCT02460224|65680238|FG023|Overall Study|Progressive disease|11|||
23531626|NCT02460224|65680239|FG024|Overall Study|Progressive disease|4|||
23531627|NCT02460224|65680240|FG025|Overall Study|Progressive disease|5|||
23207514|NCT00254293|64498215|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
23207515|NCT00254293|64498209|FG000|LTE Open Label Variable SC Dosing|Other|0|||
23207516|NCT00254293|64498210|FG001|LTE Open Label Variable SC Dosing|Other|0|||
23531628|NCT02460224|65680241|FG026|Overall Study|Progressive disease|85|||
23531629|NCT02460224|65680242|FG027|Overall Study|Progressive disease|17|||
23531630|NCT02460224|65680243|FG028|Overall Study|Progressive disease|77|||
23531631|NCT02460224|65680215|FG000|Overall Study|Subject/guardian decision|2|||
23531632|NCT02460224|65680216|FG001|Overall Study|Subject/guardian decision|0|||
23531633|NCT02460224|65680217|FG002|Overall Study|Subject/guardian decision|1|||
23531634|NCT02460224|65680218|FG003|Overall Study|Subject/guardian decision|0|||
23531635|NCT02460224|65680219|FG004|Overall Study|Subject/guardian decision|2|||
23531636|NCT02460224|65680220|FG005|Overall Study|Subject/guardian decision|2|||
23531637|NCT02460224|65680221|FG006|Overall Study|Subject/guardian decision|0|||
23531638|NCT02460224|65680222|FG007|Overall Study|Subject/guardian decision|0|||
23531639|NCT02460224|65680223|FG008|Overall Study|Subject/guardian decision|1|||
23531640|NCT02460224|65680224|FG009|Overall Study|Subject/guardian decision|1|||
23531641|NCT02460224|65680225|FG010|Overall Study|Subject/guardian decision|0|||
23531642|NCT02460224|65680226|FG011|Overall Study|Subject/guardian decision|1|||
23531643|NCT02460224|65680227|FG012|Overall Study|Subject/guardian decision|0|||
23531644|NCT02460224|65680228|FG013|Overall Study|Subject/guardian decision|0|||
23531645|NCT02460224|65680229|FG014|Overall Study|Subject/guardian decision|0|||
23531646|NCT02460224|65680230|FG015|Overall Study|Subject/guardian decision|1|||
23531647|NCT02460224|65680231|FG016|Overall Study|Subject/guardian decision|0|||
23531648|NCT02460224|65680232|FG017|Overall Study|Subject/guardian decision|1|||
23531649|NCT02460224|65680233|FG018|Overall Study|Subject/guardian decision|2|||
23531650|NCT02460224|65680234|FG019|Overall Study|Subject/guardian decision|0|||
23531651|NCT02460224|65680235|FG020|Overall Study|Subject/guardian decision|0|||
23531652|NCT02460224|65680236|FG021|Overall Study|Subject/guardian decision|1|||
23531653|NCT02460224|65680237|FG022|Overall Study|Subject/guardian decision|0|||
23531654|NCT02460224|65680238|FG023|Overall Study|Subject/guardian decision|0|||
23531655|NCT02460224|65680239|FG024|Overall Study|Subject/guardian decision|0|||
23531656|NCT02460224|65680240|FG025|Overall Study|Subject/guardian decision|0|||
23531657|NCT02460224|65680241|FG026|Overall Study|Subject/guardian decision|6|||
23531658|NCT02460224|65680242|FG027|Overall Study|Subject/guardian decision|2|||
23531659|NCT02460224|65680243|FG028|Overall Study|Subject/guardian decision|3|||
23531660|NCT01800916|65680244|FG000|Test Period 1 (1 Week)|Convex product user|0|||
23531661|NCT01800916|65680245|FG001|Test Period 1 (1 Week)|Convex product user|0|||
23531662|NCT01800916|65680246|FG002|Test Period 1 (1 Week)|Convex product user|0|||
23531663|NCT01800916|65680247|FG003|Test Period 1 (1 Week)|Convex product user|1|||
23531664|NCT01800916|65680248|FG004|Test Period 1 (1 Week)|Convex product user|0|||
23531665|NCT01800916|65680249|FG005|Test Period 1 (1 Week)|Convex product user|0|||
23531666|NCT01800916|65680250|FG006|Test Period 1 (1 Week)|Convex product user|0|||
23531667|NCT01800916|65680251|FG007|Test Period 1 (1 Week)|Convex product user|0|||
23531668|NCT01800916|65680252|FG008|Test Period 1 (1 Week)|Convex product user|0|||
23531669|NCT01800916|65680244|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
23531670|NCT01800916|65680245|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
23531671|NCT01800916|65680246|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
23531672|NCT01800916|65680247|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
23531673|NCT01800916|65680248|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
23531674|NCT01800916|65680249|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
23531675|NCT01800916|65680250|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
23531676|NCT01800916|65680251|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
23531677|NCT01800916|65680252|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
23531678|NCT04171414|65680253|FG000|Overall Study|Death|1|||
23531679|NCT04171414|65680253|FG000|Overall Study|Withdrawal by Subject|1|||
23531680|NCT01158924|65680256|FG000|Overall Study|Withdrawal by Subject|1|||
23531681|NCT01158924|65680257|FG001|Overall Study|Withdrawal by Subject|2|||
23531682|NCT01158924|65680256|FG000|Overall Study|Lost to Follow-up|0|||
23531683|NCT01158924|65680257|FG001|Overall Study|Lost to Follow-up|1|||
23207517|NCT00254293|64498211|FG002|LTE Open Label Variable SC Dosing|Other|2|||
23207518|NCT00254293|64498212|FG003|LTE Open Label Variable SC Dosing|Other|0|||
23207519|NCT00254293|64498213|FG004|LTE Open Label Variable SC Dosing|Other|0|||
23207520|NCT00254293|64498214|FG005|LTE Open Label Variable SC Dosing|Other|0|||
23207521|NCT00254293|64498215|FG006|LTE Open Label Variable SC Dosing|Other|0|||
23207522|NCT00254293|64498209|FG000|LTE Open Label Fixed Dosing|Death|0|||
23207523|NCT00254293|64498210|FG001|LTE Open Label Fixed Dosing|Death|0|||
23207524|NCT00254293|64498211|FG002|LTE Open Label Fixed Dosing|Death|0|||
23207525|NCT00254293|64498212|FG003|LTE Open Label Fixed Dosing|Death|0|||
23207526|NCT00254293|64498213|FG004|LTE Open Label Fixed Dosing|Death|0|||
23531684|NCT01898793|65680265|FG000|Overall Study|Death|2|||
23531685|NCT01898793|65680266|FG001|Overall Study|Death|1|||
23531686|NCT01898793|65680267|FG002|Overall Study|Death|4|||
23531687|NCT01898793|65680268|FG003|Overall Study|Death|0|||
23309888|NCT01823835|64881269|FG001|Overall Study|Study Termination|0|||
23309889|NCT01823835|64881270|FG002|Overall Study|Study Termination|0|||
23309890|NCT01823835|64881271|FG003|Overall Study|Study Termination|0|||
23309891|NCT01823835|64881272|FG004|Overall Study|Study Termination|1|||
23309892|NCT01823835|64881273|FG005|Overall Study|Study Termination|0|||
23309893|NCT01823835|64881274|FG006|Overall Study|Study Termination|0|||
23309894|NCT01823835|64881275|FG007|Overall Study|Study Termination|0|||
23309895|NCT01823835|64881276|FG008|Overall Study|Study Termination|0|||
23309896|NCT01823835|64881277|FG009|Overall Study|Study Termination|0|||
23309897|NCT01823835|64881278|FG010|Overall Study|Study Termination|0|||
23309898|NCT01823835|64881279|FG011|Overall Study|Study Termination|1|||
23309899|NCT01823835|64881280|FG012|Overall Study|Study Termination|0|||
23309900|NCT01823835|64881281|FG013|Overall Study|Study Termination|0|||
23309901|NCT01823835|64881282|FG014|Overall Study|Study Termination|0|||
23309902|NCT01823835|64881268|FG000|Overall Study|Withdrawal by Subject|0|||
23309903|NCT01823835|64881269|FG001|Overall Study|Withdrawal by Subject|0|||
23309904|NCT01823835|64881270|FG002|Overall Study|Withdrawal by Subject|1|||
23309905|NCT01823835|64881271|FG003|Overall Study|Withdrawal by Subject|0|||
23309906|NCT01823835|64881272|FG004|Overall Study|Withdrawal by Subject|0|||
23309907|NCT01823835|64881273|FG005|Overall Study|Withdrawal by Subject|0|||
23309908|NCT01823835|64881274|FG006|Overall Study|Withdrawal by Subject|0|||
23309909|NCT01823835|64881275|FG007|Overall Study|Withdrawal by Subject|0|||
23309910|NCT01823835|64881276|FG008|Overall Study|Withdrawal by Subject|0|||
23309911|NCT01823835|64881277|FG009|Overall Study|Withdrawal by Subject|1|||
23420127|NCT00075725|65283762|FG007|Overall Study|Lost to Follow-up|4|||
23420128|NCT00075725|65283763|FG008|Overall Study|Lost to Follow-up|1|||
23420129|NCT00075725|65283764|FG009|Overall Study|Lost to Follow-up|0|||
23420130|NCT00075725|65283765|FG010|Overall Study|Lost to Follow-up|0|||
23420131|NCT00075725|65283766|FG011|Overall Study|Lost to Follow-up|0|||
23420132|NCT00075725|65283755|FG000|Overall Study|Physician Decision|2|||
23420133|NCT00075725|65283756|FG001|Overall Study|Physician Decision|6|||
23420134|NCT00075725|65283757|FG002|Overall Study|Physician Decision|5|||
23420135|NCT00075725|65283758|FG003|Overall Study|Physician Decision|8|||
23420136|NCT00075725|65283759|FG004|Overall Study|Physician Decision|4|||
23309912|NCT01823835|64881278|FG010|Overall Study|Withdrawal by Subject|1|||
23309913|NCT01823835|64881279|FG011|Overall Study|Withdrawal by Subject|2|||
23309914|NCT01823835|64881280|FG012|Overall Study|Withdrawal by Subject|1|||
23309915|NCT01823835|64881281|FG013|Overall Study|Withdrawal by Subject|0|||
23309916|NCT01823835|64881282|FG014|Overall Study|Withdrawal by Subject|0|||
23309917|NCT02031458|64881284|FG000|May 8, 2015 to January 11, 2019|Death|89|||
23309918|NCT02031458|64881285|FG001|May 8, 2015 to January 11, 2019|Death|193|||
23309919|NCT02031458|64881286|FG002|May 8, 2015 to January 11, 2019|Death|198|||
23309920|NCT02031458|64881284|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
23309921|NCT02031458|64881285|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
23309922|NCT02031458|64881286|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
23309923|NCT02031458|64881284|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
23309924|NCT02031458|64881285|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
23309925|NCT02031458|64881286|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
23309926|NCT02031458|64881284|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
23420137|NCT00075725|65283760|FG005|Overall Study|Physician Decision|19|||
23613631|NCT01540474|65973117|FG003|Vaccination Period|Lost to Follow-up|0|||
23613632|NCT02206607|65973118|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
23613633|NCT02206607|65973119|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
23613634|NCT02206607|65973120|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
23613635|NCT02206607|65973121|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
23613636|NCT02206607|65973122|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
23613637|NCT02206607|65973118|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
23613638|NCT02206607|65973119|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
23613639|NCT02206607|65973120|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
23613640|NCT02206607|65973121|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
23613641|NCT02206607|65973122|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
23613642|NCT03960437|65973123|FG000|Overall Study|Removed by PI|4|||
23613643|NCT03960437|65973123|FG000|Overall Study|Lost to Follow-up|2|||
23613644|NCT03960437|65973123|FG000|Overall Study|Withdrawal by Subject|1|||
23613645|NCT03960437|65973123|FG000|Overall Study|Death|2|||
23613646|NCT05431543|65973132|FG000|Overall Study|Medical History|1|||
23613647|NCT05431543|65973133|FG001|Overall Study|Medical History|0|||
23613648|NCT05431543|65973134|FG002|Overall Study|Medical History|0|||
23613649|NCT04049578|65973157|FG000|Overall Study|Physician Decision|1|||
23613650|NCT04676763|65973158|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
23613651|NCT04676763|65973159|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
23613652|NCT04676763|65973160|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
23613653|NCT04676763|65973158|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
23613654|NCT04676763|65973159|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
23613655|NCT04676763|65973160|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
23613656|NCT04676763|65973158|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
23309927|NCT02031458|64881285|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
23309928|NCT02031458|64881286|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
23309929|NCT02031458|64881284|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
23309930|NCT02031458|64881285|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
23309931|NCT02031458|64881286|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
23309932|NCT02031458|64881284|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
23309933|NCT02031458|64881285|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
23309934|NCT02031458|64881286|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
23309935|NCT02031458|64881284|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
23309936|NCT02031458|64881285|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
23309937|NCT02031458|64881286|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
23309938|NCT02031458|64881284|FG000|Baseline to May 8, 2015|Death|36|||
23309939|NCT02031458|64881285|FG001|Baseline to May 8, 2015|Death|87|||
23309940|NCT02031458|64881286|FG002|Baseline to May 8, 2015|Death|100|||
23309941|NCT02031458|64881284|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
23309942|NCT02031458|64881285|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
23309943|NCT02031458|64881286|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
23309944|NCT02031458|64881284|FG000|Baseline to May 8, 2015|Physician Decision|0|||
23309945|NCT02031458|64881285|FG001|Baseline to May 8, 2015|Physician Decision|1|||
23309946|NCT02031458|64881286|FG002|Baseline to May 8, 2015|Physician Decision|0|||
23309947|NCT02031458|64881284|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
23309948|NCT02031458|64881285|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
23309949|NCT02031458|64881286|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
23309950|NCT02031458|64881284|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
23309951|NCT02031458|64881285|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
23309952|NCT02031458|64881286|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
23309953|NCT02031458|64881284|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
23309954|NCT02031458|64881285|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
23309955|NCT02031458|64881286|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
23309956|NCT02031458|64881284|FG000|Baseline to May 8, 2015|On Treatment|43|||
23309957|NCT02031458|64881285|FG001|Baseline to May 8, 2015|On Treatment|81|||
23309958|NCT02031458|64881286|FG002|Baseline to May 8, 2015|On Treatment|73|||
23309959|NCT02031458|64881284|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
23309960|NCT02031458|64881285|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
23309961|NCT02031458|64881286|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
23613657|NCT04676763|65973159|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
23207527|NCT00254293|64498214|FG005|LTE Open Label Fixed Dosing|Death|0|||
23207528|NCT00254293|64498215|FG006|LTE Open Label Fixed Dosing|Death|3|||
23207529|NCT00254293|64498209|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
23207530|NCT00254293|64498210|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
23207531|NCT00254293|64498211|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
23207532|NCT00254293|64498212|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
23207533|NCT00254293|64498213|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
23207534|NCT00254293|64498214|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
23207535|NCT00254293|64498215|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
23207536|NCT00254293|64498209|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23207537|NCT00254293|64498210|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23309962|NCT00681590|64881290|FG000|Overall Study|Withdrawal by Subject|2|||
23309963|NCT00681590|64881291|FG001|Overall Study|Withdrawal by Subject|12|||
23309964|NCT03146962|64881294|FG000|Overall Study|Lost to Follow-up|1|||
23309965|NCT03146962|64881295|FG001|Overall Study|Lost to Follow-up|1|||
23309966|NCT03146962|64881296|FG002|Overall Study|Lost to Follow-up|0|||
23309967|NCT03146962|64881297|FG003|Overall Study|Lost to Follow-up|0|||
23309968|NCT03146962|64881298|FG004|Overall Study|Lost to Follow-up|0|||
23309969|NCT03146962|64881299|FG005|Overall Study|Lost to Follow-up|0|||
23531688|NCT01898793|65680269|FG004|Overall Study|Death|0|||
23531689|NCT01898793|65680270|FG005|Overall Study|Death|0|||
23613658|NCT04676763|65973160|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
23613659|NCT01365546|65973163|FG000|Overall Study|Withdrawal by Subject|1|||
23613660|NCT01365546|65973163|FG000|Overall Study|Screen failure|9|||
23613661|NCT01365546|65973163|FG000|Overall Study|Study termination|1|||
23613662|NCT01148017|65973164|FG000|Overall Study|Withdrawal by Subject|31|||
23613663|NCT01148017|65973165|FG001|Overall Study|Withdrawal by Subject|14|||
23613664|NCT01148017|65973166|FG002|Overall Study|Withdrawal by Subject|0|||
23613665|NCT01148017|65973167|FG003|Overall Study|Withdrawal by Subject|0|||
23613666|NCT01148017|65973164|FG000|Overall Study|Lost to Follow-up|23|||
23613667|NCT01148017|65973165|FG001|Overall Study|Lost to Follow-up|10|||
23613668|NCT01148017|65973166|FG002|Overall Study|Lost to Follow-up|0|||
23613669|NCT01148017|65973167|FG003|Overall Study|Lost to Follow-up|0|||
23613670|NCT01148017|65973164|FG000|Overall Study|Inappropriate enrollment|1|||
23613671|NCT01148017|65973165|FG001|Overall Study|Inappropriate enrollment|0|||
23613672|NCT01148017|65973166|FG002|Overall Study|Inappropriate enrollment|0|||
23613673|NCT01148017|65973167|FG003|Overall Study|Inappropriate enrollment|0|||
23309970|NCT03146962|64881300|FG006|Overall Study|Lost to Follow-up|0|||
23309971|NCT03146962|64881301|FG007|Overall Study|Lost to Follow-up|0|||
23309972|NCT03146962|64881302|FG008|Overall Study|Lost to Follow-up|0|||
23309973|NCT03146962|64881303|FG009|Overall Study|Lost to Follow-up|0|||
23309974|NCT03146962|64881294|FG000|Overall Study|Adverse Event|0|||
23309975|NCT03146962|64881295|FG001|Overall Study|Adverse Event|3|||
23309976|NCT03146962|64881296|FG002|Overall Study|Adverse Event|0|||
23309977|NCT03146962|64881297|FG003|Overall Study|Adverse Event|0|||
23309978|NCT03146962|64881298|FG004|Overall Study|Adverse Event|0|||
23420138|NCT00075725|65283761|FG006|Overall Study|Physician Decision|3|||
23420139|NCT00075725|65283762|FG007|Overall Study|Physician Decision|17|||
23420140|NCT00075725|65283763|FG008|Overall Study|Physician Decision|5|||
23420141|NCT00075725|65283764|FG009|Overall Study|Physician Decision|0|||
23420142|NCT00075725|65283765|FG010|Overall Study|Physician Decision|1|||
23420143|NCT00075725|65283766|FG011|Overall Study|Physician Decision|0|||
23420144|NCT00075725|65283755|FG000|Overall Study|Pregnancy|0|||
23420145|NCT00075725|65283756|FG001|Overall Study|Pregnancy|0|||
23420146|NCT00075725|65283757|FG002|Overall Study|Pregnancy|0|||
23420147|NCT00075725|65283758|FG003|Overall Study|Pregnancy|0|||
23420148|NCT00075725|65283759|FG004|Overall Study|Pregnancy|0|||
23420149|NCT00075725|65283760|FG005|Overall Study|Pregnancy|1|||
23420150|NCT00075725|65283761|FG006|Overall Study|Pregnancy|0|||
23420151|NCT00075725|65283762|FG007|Overall Study|Pregnancy|1|||
23420152|NCT00075725|65283763|FG008|Overall Study|Pregnancy|0|||
23420153|NCT00075725|65283764|FG009|Overall Study|Pregnancy|0|||
23420154|NCT00075725|65283765|FG010|Overall Study|Pregnancy|0|||
23420155|NCT00075725|65283766|FG011|Overall Study|Pregnancy|0|||
23420156|NCT00075725|65283755|FG000|Overall Study|Protocol Violation|1|||
23420157|NCT00075725|65283756|FG001|Overall Study|Protocol Violation|1|||
23420158|NCT00075725|65283757|FG002|Overall Study|Protocol Violation|0|||
23420159|NCT00075725|65283758|FG003|Overall Study|Protocol Violation|3|||
23420160|NCT00075725|65283759|FG004|Overall Study|Protocol Violation|3|||
23420161|NCT00075725|65283760|FG005|Overall Study|Protocol Violation|2|||
23420162|NCT00075725|65283761|FG006|Overall Study|Protocol Violation|1|||
23420163|NCT00075725|65283762|FG007|Overall Study|Protocol Violation|2|||
23420164|NCT00075725|65283763|FG008|Overall Study|Protocol Violation|3|||
23420165|NCT00075725|65283764|FG009|Overall Study|Protocol Violation|0|||
23420166|NCT00075725|65283765|FG010|Overall Study|Protocol Violation|0|||
23420167|NCT00075725|65283766|FG011|Overall Study|Protocol Violation|1|||
23613674|NCT01148017|65973164|FG000|Overall Study|Administrative reason|22|||
23613675|NCT01148017|65973165|FG001|Overall Study|Administrative reason|9|||
23613676|NCT01148017|65973166|FG002|Overall Study|Administrative reason|0|||
23613677|NCT01148017|65973167|FG003|Overall Study|Administrative reason|0|||
23613678|NCT01148017|65973164|FG000|Overall Study|Unable to classify|3|||
23613679|NCT01148017|65973165|FG001|Overall Study|Unable to classify|1|||
23613680|NCT01148017|65973166|FG002|Overall Study|Unable to classify|0|||
23613681|NCT01148017|65973167|FG003|Overall Study|Unable to classify|0|||
23613682|NCT01469819|65973171|FG000|Overall Study|Withdrawal by Subject|1|||
23613683|NCT01469819|65973171|FG000|Overall Study|Did not meet inclusionary criteria|2|||
23613684|NCT01469819|65973171|FG000|Overall Study|Could not swallow SmartPill|2|||
23613685|NCT01469819|65973171|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
23613686|NCT01446042|65973172|FG000|Overall Study|Withdrawal by Subject|12|||
23613687|NCT01446042|65973173|FG001|Overall Study|Withdrawal by Subject|2|||
23613688|NCT01446042|65973174|FG002|Overall Study|Withdrawal by Subject|4|||
23613689|NCT01446042|65973172|FG000|Overall Study|Adverse Event|1|||
23613690|NCT01446042|65973173|FG001|Overall Study|Adverse Event|0|||
23613691|NCT01446042|65973174|FG002|Overall Study|Adverse Event|4|||
23613692|NCT01446042|65973172|FG000|Overall Study|Lost to Follow-up|5|||
23613693|NCT01446042|65973173|FG001|Overall Study|Lost to Follow-up|0|||
23613694|NCT01446042|65973174|FG002|Overall Study|Lost to Follow-up|0|||
23613695|NCT01446042|65973172|FG000|Overall Study|Other reasons|2|||
23613696|NCT01446042|65973173|FG001|Overall Study|Other reasons|1|||
23613697|NCT01446042|65973174|FG002|Overall Study|Other reasons|1|||
23613698|NCT00376259|65973176|FG000|Overall Study|Sponsor request - study termination|21|||
23613699|NCT00376259|65973177|FG001|Overall Study|Sponsor request - study termination|21|||
23309979|NCT03146962|64881299|FG005|Overall Study|Adverse Event|0|||
23420168|NCT00075725|65283755|FG000|Overall Study|Withdrawal by Subject|12|||
23420169|NCT00075725|65283756|FG001|Overall Study|Withdrawal by Subject|3|||
23420170|NCT00075725|65283757|FG002|Overall Study|Withdrawal by Subject|6|||
23420171|NCT00075725|65283758|FG003|Overall Study|Withdrawal by Subject|10|||
23613700|NCT00376259|65973176|FG000|Overall Study|Patient request|1|||
23420172|NCT00075725|65283759|FG004|Overall Study|Withdrawal by Subject|6|||
23420173|NCT00075725|65283760|FG005|Overall Study|Withdrawal by Subject|27|||
23420174|NCT00075725|65283761|FG006|Overall Study|Withdrawal by Subject|7|||
23420175|NCT00075725|65283762|FG007|Overall Study|Withdrawal by Subject|31|||
23420176|NCT00075725|65283763|FG008|Overall Study|Withdrawal by Subject|10|||
23420177|NCT00075725|65283764|FG009|Overall Study|Withdrawal by Subject|2|||
23420178|NCT00075725|65283765|FG010|Overall Study|Withdrawal by Subject|0|||
23420179|NCT00075725|65283766|FG011|Overall Study|Withdrawal by Subject|0|||
23420180|NCT00075725|65283755|FG000|Overall Study|Disease Progression, all other reasons|17|||
23420181|NCT00075725|65283756|FG001|Overall Study|Disease Progression, all other reasons|5|||
23420182|NCT00075725|65283757|FG002|Overall Study|Disease Progression, all other reasons|33|||
23420183|NCT00075725|65283758|FG003|Overall Study|Disease Progression, all other reasons|6|||
23420184|NCT00075725|65283759|FG004|Overall Study|Disease Progression, all other reasons|21|||
23420185|NCT00075725|65283760|FG005|Overall Study|Disease Progression, all other reasons|59|||
23420186|NCT00075725|65283761|FG006|Overall Study|Disease Progression, all other reasons|20|||
23420187|NCT00075725|65283762|FG007|Overall Study|Disease Progression, all other reasons|46|||
23420188|NCT00075725|65283763|FG008|Overall Study|Disease Progression, all other reasons|21|||
23420189|NCT00075725|65283764|FG009|Overall Study|Disease Progression, all other reasons|4|||
23420190|NCT00075725|65283765|FG010|Overall Study|Disease Progression, all other reasons|0|||
23420191|NCT00075725|65283766|FG011|Overall Study|Disease Progression, all other reasons|5|||
23420192|NCT00075725|65283755|FG000|Overall Study|Patient off treatment|0|||
23420193|NCT00075725|65283756|FG001|Overall Study|Patient off treatment|0|||
23420194|NCT00075725|65283757|FG002|Overall Study|Patient off treatment|1|||
23420195|NCT00075725|65283758|FG003|Overall Study|Patient off treatment|2|||
23420196|NCT00075725|65283759|FG004|Overall Study|Patient off treatment|1|||
23420197|NCT00075725|65283760|FG005|Overall Study|Patient off treatment|0|||
23420198|NCT00075725|65283761|FG006|Overall Study|Patient off treatment|0|||
23420199|NCT00075725|65283762|FG007|Overall Study|Patient off treatment|2|||
23420200|NCT00075725|65283763|FG008|Overall Study|Patient off treatment|1|||
23420201|NCT00075725|65283764|FG009|Overall Study|Patient off treatment|0|||
23420202|NCT00075725|65283765|FG010|Overall Study|Patient off treatment|0|||
23420203|NCT00075725|65283766|FG011|Overall Study|Patient off treatment|0|||
23420204|NCT00075725|65283755|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
23420205|NCT00075725|65283756|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
23420206|NCT00075725|65283757|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
23420207|NCT00075725|65283758|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
23420208|NCT00075725|65283759|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
23420209|NCT00075725|65283760|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
23420210|NCT00075725|65283761|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
23420211|NCT00075725|65283762|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
23420212|NCT00075725|65283763|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
23420213|NCT00075725|65283764|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
23420214|NCT00075725|65283765|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
23420215|NCT00075725|65283766|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
23420216|NCT00075725|65283755|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
23420217|NCT00075725|65283756|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
23420218|NCT00075725|65283757|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
23420219|NCT00075725|65283758|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
23420220|NCT00075725|65283759|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
23420221|NCT00075725|65283760|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
23420222|NCT00075725|65283761|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
23420223|NCT00075725|65283762|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
23420224|NCT00075725|65283763|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
23420225|NCT00075725|65283764|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
23531690|NCT01898793|65680271|FG006|Overall Study|Death|0|||
23531691|NCT05091528|65680276|FG000|Overall Study|Study Termination by Sponsor|0|||
23531692|NCT05091528|65680277|FG001|Overall Study|Study Termination by Sponsor|1|||
23531693|NCT05091528|65680278|FG002|Overall Study|Study Termination by Sponsor|0|||
23531694|NCT05091528|65680279|FG003|Overall Study|Study Termination by Sponsor|1|||
23531695|NCT02388997|65680280|FG000|Overall Study|Adverse Event|1|||
23531696|NCT02388997|65680281|FG001|Overall Study|Adverse Event|2|||
23531697|NCT02388997|65680280|FG000|Overall Study|Withdrawal by Subject|2|||
23420226|NCT00075725|65283765|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
23420227|NCT00075725|65283766|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
23420228|NCT00075725|65283755|FG000|Overall Study|Pt non compliant with therapy|2|||
23420229|NCT00075725|65283756|FG001|Overall Study|Pt non compliant with therapy|1|||
23420230|NCT00075725|65283757|FG002|Overall Study|Pt non compliant with therapy|1|||
23420231|NCT00075725|65283758|FG003|Overall Study|Pt non compliant with therapy|0|||
23420232|NCT00075725|65283759|FG004|Overall Study|Pt non compliant with therapy|2|||
23531698|NCT02388997|65680281|FG001|Overall Study|Withdrawal by Subject|1|||
23613701|NCT00376259|65973177|FG001|Overall Study|Patient request|0|||
23613702|NCT04617847|65973178|FG000|Overall Study|Withdrawal by Subject|1|||
23613703|NCT04617847|65973179|FG001|Overall Study|Withdrawal by Subject|0|||
23613704|NCT04617847|65973178|FG000|Overall Study|Adverse Event|0|||
23613705|NCT04617847|65973179|FG001|Overall Study|Adverse Event|2|||
23613706|NCT04617847|65973178|FG000|Overall Study|Death|0|||
23613707|NCT04617847|65973179|FG001|Overall Study|Death|1|||
23613708|NCT04617847|65973178|FG000|Overall Study|Termination of Study by Sponsor|2|||
23613709|NCT04617847|65973179|FG001|Overall Study|Termination of Study by Sponsor|21|||
23613710|NCT04468633|65973180|FG000|Overall Study|Withdrawal by Subject|4|||
23613711|NCT04468633|65973181|FG001|Overall Study|Withdrawal by Subject|0|||
23613712|NCT00139659|65973183|FG000|Overall Study|Adverse Event|12|||
23613713|NCT00139659|65973184|FG001|Overall Study|Adverse Event|1|||
23613714|NCT00139659|65973183|FG000|Overall Study|Lack of Efficacy|1|||
23613715|NCT00139659|65973184|FG001|Overall Study|Lack of Efficacy|1|||
23613716|NCT00139659|65973183|FG000|Overall Study|Lost to Follow-up|7|||
23613717|NCT00139659|65973184|FG001|Overall Study|Lost to Follow-up|3|||
23613718|NCT00139659|65973183|FG000|Overall Study|Reason not Specified|6|||
23613719|NCT00139659|65973184|FG001|Overall Study|Reason not Specified|3|||
23207538|NCT00254293|64498211|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23309980|NCT03146962|64881300|FG006|Overall Study|Adverse Event|0|||
23613720|NCT00139659|65973183|FG000|Overall Study|Withdrawal by Subject|14|||
23613721|NCT00139659|65973184|FG001|Overall Study|Withdrawal by Subject|10|||
23613722|NCT03512288|65973185|FG000|Overall Study|Adverse Event|1|||
23613723|NCT03512288|65973186|FG001|Overall Study|Adverse Event|0|||
23613724|NCT03512288|65973185|FG000|Overall Study|Lost to Follow-up|12|||
23309981|NCT03146962|64881301|FG007|Overall Study|Adverse Event|1|||
23309982|NCT03146962|64881302|FG008|Overall Study|Adverse Event|0|||
23613725|NCT03512288|65973186|FG001|Overall Study|Lost to Follow-up|15|||
23613726|NCT03512288|65973185|FG000|Overall Study|Physician Decision|0|||
23613727|NCT03512288|65973186|FG001|Overall Study|Physician Decision|2|||
23613728|NCT03512288|65973185|FG000|Overall Study|Protocol Violation|6|||
23613729|NCT03512288|65973186|FG001|Overall Study|Protocol Violation|4|||
23309983|NCT03146962|64881303|FG009|Overall Study|Adverse Event|0|||
23420233|NCT00075725|65283760|FG005|Overall Study|Pt non compliant with therapy|14|||
23613730|NCT03512288|65973185|FG000|Overall Study|Medication error without associated adverse event|1|||
23613731|NCT03512288|65973186|FG001|Overall Study|Medication error without associated adverse event|0|||
23613732|NCT03512288|65973185|FG000|Overall Study|No longer met eligibility criteria|5|||
23613733|NCT03512288|65973186|FG001|Overall Study|No longer met eligibility criteria|2|||
23613734|NCT03512288|65973185|FG000|Overall Study|Withdrawal by parent/guardian|14|||
23613735|NCT03512288|65973186|FG001|Overall Study|Withdrawal by parent/guardian|18|||
23420234|NCT00075725|65283761|FG006|Overall Study|Pt non compliant with therapy|2|||
23420235|NCT00075725|65283762|FG007|Overall Study|Pt non compliant with therapy|5|||
23420236|NCT00075725|65283763|FG008|Overall Study|Pt non compliant with therapy|3|||
23531699|NCT02388997|65680280|FG000|Overall Study|Lung function exclusion criteria|0|||
23531700|NCT02388997|65680281|FG001|Overall Study|Lung function exclusion criteria|2|||
23531701|NCT02388997|65680280|FG000|Overall Study|Tested positive for virus during run-in|0|||
23531702|NCT02388997|65680281|FG001|Overall Study|Tested positive for virus during run-in|1|||
23531703|NCT00325234|65680282|FG000|Overall Study|Adverse Event|10|||
23531704|NCT00325234|65680283|FG001|Overall Study|Adverse Event|7|||
23531705|NCT00325234|65680282|FG000|Overall Study|Death due to Study Disease|1|||
23531706|NCT00325234|65680283|FG001|Overall Study|Death due to Study Disease|0|||
23531707|NCT00325234|65680282|FG000|Overall Study|Entry Criteria Not Met|1|||
23531708|NCT00325234|65680283|FG001|Overall Study|Entry Criteria Not Met|2|||
23531709|NCT00325234|65680282|FG000|Overall Study|Subject Decision|6|||
23531710|NCT00325234|65680283|FG001|Overall Study|Subject Decision|8|||
23531711|NCT00325234|65680282|FG000|Overall Study|Physician Decision|17|||
23531712|NCT00325234|65680283|FG001|Overall Study|Physician Decision|12|||
23531713|NCT00325234|65680282|FG000|Overall Study|Progressive Disease|34|||
23531714|NCT00325234|65680283|FG001|Overall Study|Progressive Disease|37|||
23531715|NCT03240575|65680284|FG000|Overall Study|Adverse Event|0|||
23531716|NCT03240575|65680285|FG001|Overall Study|Adverse Event|2|||
23613736|NCT03512288|65973185|FG000|Overall Study|Other|1|||
23207539|NCT00254293|64498212|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23531717|NCT03240575|65680286|FG002|Overall Study|Adverse Event|0|||
23207540|NCT00254293|64498213|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23420237|NCT00075725|65283764|FG009|Overall Study|Pt non compliant with therapy|0|||
23531718|NCT03240575|65680287|FG003|Overall Study|Adverse Event|1|||
23531719|NCT03240575|65680284|FG000|Overall Study|Withdrawal by Subject|2|||
23613737|NCT03512288|65973186|FG001|Overall Study|Other|1|||
23613738|NCT03512288|65973185|FG000|Overall Study|Randomized but not treated|1|||
23309984|NCT03146962|64881294|FG000|Overall Study|Withdrawal by Subject|0|||
23309985|NCT03146962|64881295|FG001|Overall Study|Withdrawal by Subject|0|||
23309986|NCT03146962|64881296|FG002|Overall Study|Withdrawal by Subject|0|||
23531720|NCT03240575|65680285|FG001|Overall Study|Withdrawal by Subject|11|||
23531721|NCT03240575|65680286|FG002|Overall Study|Withdrawal by Subject|0|||
23531722|NCT03240575|65680287|FG003|Overall Study|Withdrawal by Subject|1|||
23531723|NCT03240575|65680284|FG000|Overall Study|Other|0|||
23531724|NCT03240575|65680285|FG001|Overall Study|Other|1|||
23309987|NCT03146962|64881297|FG003|Overall Study|Withdrawal by Subject|0|||
23531725|NCT03240575|65680286|FG002|Overall Study|Other|0|||
23531726|NCT03240575|65680287|FG003|Overall Study|Other|0|||
23531727|NCT00548808|65680288|FG000|Overall Study|Lost to Follow-up|9|||
23531728|NCT00548808|65680289|FG001|Overall Study|Lost to Follow-up|3|||
23531729|NCT00548808|65680288|FG000|Overall Study|Protocol Violation|8|||
23531730|NCT00548808|65680289|FG001|Overall Study|Protocol Violation|8|||
23309988|NCT03146962|64881298|FG004|Overall Study|Withdrawal by Subject|1|||
23309989|NCT03146962|64881299|FG005|Overall Study|Withdrawal by Subject|0|||
23309990|NCT03146962|64881300|FG006|Overall Study|Withdrawal by Subject|0|||
23531731|NCT00548808|65680288|FG000|Overall Study|Withdrawal by Subject|8|||
23531732|NCT00548808|65680289|FG001|Overall Study|Withdrawal by Subject|4|||
23309991|NCT03146962|64881301|FG007|Overall Study|Withdrawal by Subject|0|||
23309992|NCT03146962|64881302|FG008|Overall Study|Withdrawal by Subject|0|||
23531733|NCT00548808|65680288|FG000|Overall Study|Physician Decision|6|||
23531734|NCT00548808|65680289|FG001|Overall Study|Physician Decision|3|||
23531735|NCT00548808|65680288|FG000|Overall Study|Adverse Event|4|||
23531736|NCT00548808|65680289|FG001|Overall Study|Adverse Event|5|||
23531737|NCT00548808|65680288|FG000|Overall Study|Death|2|||
23531738|NCT00548808|65680289|FG001|Overall Study|Death|0|||
23531739|NCT00548808|65680288|FG000|Overall Study|Entry Criteria Not Met|2|||
23531740|NCT00548808|65680289|FG001|Overall Study|Entry Criteria Not Met|2|||
23531741|NCT00548808|65680288|FG000|Overall Study|Lack of Efficacy|2|||
23531742|NCT00548808|65680289|FG001|Overall Study|Lack of Efficacy|0|||
23531743|NCT00548808|65680288|FG000|Overall Study|Sponsor Decision|1|||
23531744|NCT00548808|65680289|FG001|Overall Study|Sponsor Decision|1|||
23531745|NCT00646204|65680290|FG000|Overall Study|Adverse Event|3|||
23531746|NCT00646204|65680291|FG001|Overall Study|Adverse Event|0|||
23531747|NCT00646204|65680290|FG000|Overall Study|Withdrawal by Subject|1|||
23531748|NCT00646204|65680291|FG001|Overall Study|Withdrawal by Subject|0|||
23531749|NCT02178475|65680292|FG000|Overall Study|Withdrawal by Subject|7|||
23531750|NCT02178475|65680292|FG000|Overall Study|Lost to Follow-up|10|||
23531751|NCT02178475|65680292|FG000|Overall Study|Death|13|||
23531752|NCT02178475|65680292|FG000|Overall Study|Protocol-specified Criteria|99|||
23531753|NCT01448850|65680295|FG000|Overall Study|Death|3|||
23531754|NCT01448850|65680296|FG001|Overall Study|Death|6|||
23531755|NCT01448850|65680295|FG000|Overall Study|Withdrawal by Subject|13|||
23531756|NCT01448850|65680296|FG001|Overall Study|Withdrawal by Subject|21|||
23531757|NCT01448850|65680295|FG000|Overall Study|Lost to Follow-up|3|||
23531758|NCT01448850|65680296|FG001|Overall Study|Lost to Follow-up|1|||
23531759|NCT01448850|65680295|FG000|Overall Study|Other|15|||
23531760|NCT01448850|65680296|FG001|Overall Study|Other|12|||
23531761|NCT02778204|65683085|FG000|Overall Study|Adverse Event|1|||
23531762|NCT02778204|65683086|FG001|Overall Study|Adverse Event|0|||
23420238|NCT00075725|65283765|FG010|Overall Study|Pt non compliant with therapy|0|||
23531763|NCT02778204|65683087|FG002|Overall Study|Adverse Event|0|||
23531764|NCT02778204|65683088|FG003|Overall Study|Adverse Event|0|||
23531765|NCT02778204|65683085|FG000|Overall Study|Withdrawal by Subject|0|||
23531766|NCT02778204|65683086|FG001|Overall Study|Withdrawal by Subject|0|||
23531767|NCT02778204|65683087|FG002|Overall Study|Withdrawal by Subject|1|||
23531768|NCT02778204|65683088|FG003|Overall Study|Withdrawal by Subject|2|||
23531769|NCT02778204|65683085|FG000|Overall Study|Lost to Follow-up|1|||
23531770|NCT02778204|65683086|FG001|Overall Study|Lost to Follow-up|0|||
23531771|NCT02778204|65683087|FG002|Overall Study|Lost to Follow-up|2|||
23531772|NCT02778204|65683088|FG003|Overall Study|Lost to Follow-up|1|||
23531773|NCT02778204|65683085|FG000|Overall Study|Protocol Violation|0|||
23531774|NCT02778204|65683086|FG001|Overall Study|Protocol Violation|0|||
23531775|NCT02778204|65683087|FG002|Overall Study|Protocol Violation|1|||
23531776|NCT02778204|65683088|FG003|Overall Study|Protocol Violation|0|||
23531777|NCT02778204|65683085|FG000|Overall Study|Eligibility Violation|0|||
23531778|NCT02778204|65683086|FG001|Overall Study|Eligibility Violation|0|||
23531779|NCT02778204|65683087|FG002|Overall Study|Eligibility Violation|0|||
23531780|NCT02778204|65683088|FG003|Overall Study|Eligibility Violation|1|||
23531781|NCT02262728|65683091|FG000|Follow-up Phase (3 Years)|Death|0|||
23531782|NCT02262728|65683092|FG001|Follow-up Phase (3 Years)|Death|1|||
23531783|NCT02262728|65683091|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
23531784|NCT02262728|65683092|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
23531785|NCT02262728|65683091|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
23531786|NCT02262728|65683092|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
23531787|NCT02460198|65683093|FG000|Overall Study|Adverse Event|1|||
23531788|NCT02460198|65683094|FG001|Overall Study|Adverse Event|3|||
23531789|NCT02460198|65683093|FG000|Overall Study|Death|36|||
23531790|NCT02460198|65683094|FG001|Overall Study|Death|28|||
23531791|NCT02460198|65683093|FG000|Overall Study|Lost to Follow-up|1|||
23531792|NCT02460198|65683094|FG001|Overall Study|Lost to Follow-up|1|||
23531793|NCT02460198|65683093|FG000|Overall Study|Transferred to Extension Study|15|||
23531794|NCT02460198|65683094|FG001|Overall Study|Transferred to Extension Study|15|||
23531795|NCT02460198|65683093|FG000|Overall Study|Withdrawal by Subject|2|||
23531796|NCT02460198|65683094|FG001|Overall Study|Withdrawal by Subject|4|||
23531797|NCT02460198|65683093|FG000|Overall Study|Site Terminated By Sponsor|0|||
23613739|NCT03512288|65973186|FG001|Overall Study|Randomized but not treated|1|||
23613740|NCT01648699|65973191|FG000|Overall Study|Death|1|||
23613741|NCT01648699|65973191|FG000|Overall Study|Lost to Follow-up|2|||
23613742|NCT01648699|65973191|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
23613743|NCT01753323|65973196|FG000|Overall Study|Lack of Efficacy|0|||
23613744|NCT01753323|65973197|FG001|Overall Study|Lack of Efficacy|0|||
23613745|NCT01753323|65973198|FG002|Overall Study|Lack of Efficacy|8|||
23613746|NCT01753323|65973196|FG000|Overall Study|Protocol deviation|1|||
23613747|NCT01753323|65973197|FG001|Overall Study|Protocol deviation|0|||
23613748|NCT01753323|65973198|FG002|Overall Study|Protocol deviation|0|||
23613749|NCT01753323|65973196|FG000|Overall Study|Adverse Event|0|||
23207541|NCT00254293|64498214|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
23207542|NCT00254293|64498215|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
23420239|NCT00075725|65283766|FG011|Overall Study|Pt non compliant with therapy|0|||
23207543|NCT00254293|64498209|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23207544|NCT00254293|64498210|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23207545|NCT00254293|64498211|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23207546|NCT00254293|64498212|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23207547|NCT00254293|64498213|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23207548|NCT00254293|64498214|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
23207549|NCT00254293|64498215|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
23207550|NCT00254293|64498209|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23207551|NCT00254293|64498210|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23207552|NCT00254293|64498211|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23207553|NCT00254293|64498212|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23531798|NCT02460198|65683094|FG001|Overall Study|Site Terminated By Sponsor|1|||
23420240|NCT00075725|65283755|FG000|Overall Study|Pt age out of range for treatment|0|||
23531799|NCT02460198|65683093|FG000|Overall Study|Did Not Continue on Extension Study|6|||
23531800|NCT02460198|65683094|FG001|Overall Study|Did Not Continue on Extension Study|11|||
23531801|NCT03135522|65683098|FG000|Overall Study|Adverse Event|1|||
23613750|NCT01753323|65973197|FG001|Overall Study|Adverse Event|0|||
23613751|NCT01753323|65973198|FG002|Overall Study|Adverse Event|1|||
23531802|NCT03135522|65683099|FG001|Overall Study|Adverse Event|0|||
23531803|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Adverse Event|9|||
23613752|NCT02023099|65973201|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
23309993|NCT03146962|64881303|FG009|Overall Study|Withdrawal by Subject|0|||
23309994|NCT03146962|64881294|FG000|Overall Study|Death|0|||
23309995|NCT03146962|64881295|FG001|Overall Study|Death|1|||
23309996|NCT03146962|64881296|FG002|Overall Study|Death|0|||
23309997|NCT03146962|64881297|FG003|Overall Study|Death|0|||
23309998|NCT03146962|64881298|FG004|Overall Study|Death|0|||
23309999|NCT03146962|64881299|FG005|Overall Study|Death|0|||
23310000|NCT03146962|64881300|FG006|Overall Study|Death|0|||
23310001|NCT03146962|64881301|FG007|Overall Study|Death|0|||
23310002|NCT03146962|64881302|FG008|Overall Study|Death|0|||
23310003|NCT03146962|64881303|FG009|Overall Study|Death|0|||
23310004|NCT03146962|64881294|FG000|Overall Study|COVID Precautions|1|||
23310005|NCT03146962|64881295|FG001|Overall Study|COVID Precautions|0|||
23310006|NCT03146962|64881296|FG002|Overall Study|COVID Precautions|0|||
23310007|NCT03146962|64881297|FG003|Overall Study|COVID Precautions|0|||
23310008|NCT03146962|64881298|FG004|Overall Study|COVID Precautions|0|||
23310009|NCT03146962|64881299|FG005|Overall Study|COVID Precautions|0|||
23310010|NCT03146962|64881300|FG006|Overall Study|COVID Precautions|0|||
23310011|NCT03146962|64881301|FG007|Overall Study|COVID Precautions|0|||
23310012|NCT03146962|64881302|FG008|Overall Study|COVID Precautions|0|||
23310013|NCT03146962|64881303|FG009|Overall Study|COVID Precautions|0|||
23310014|NCT03146962|64881294|FG000|Overall Study|Physician Decision|0|||
23310015|NCT03146962|64881295|FG001|Overall Study|Physician Decision|0|||
23310016|NCT03146962|64881296|FG002|Overall Study|Physician Decision|0|||
23310017|NCT03146962|64881297|FG003|Overall Study|Physician Decision|0|||
23310018|NCT03146962|64881298|FG004|Overall Study|Physician Decision|0|||
23310019|NCT03146962|64881299|FG005|Overall Study|Physician Decision|0|||
23310020|NCT03146962|64881300|FG006|Overall Study|Physician Decision|0|||
23310021|NCT03146962|64881301|FG007|Overall Study|Physician Decision|0|||
23310022|NCT03146962|64881302|FG008|Overall Study|Physician Decision|0|||
23310023|NCT03146962|64881303|FG009|Overall Study|Physician Decision|1|||
23310024|NCT03146962|64881294|FG000|Overall Study|Started New Treatment|0|||
23310025|NCT03146962|64881295|FG001|Overall Study|Started New Treatment|1|||
23310026|NCT03146962|64881296|FG002|Overall Study|Started New Treatment|0|||
23310027|NCT03146962|64881297|FG003|Overall Study|Started New Treatment|0|||
23310028|NCT03146962|64881298|FG004|Overall Study|Started New Treatment|0|||
23310029|NCT03146962|64881299|FG005|Overall Study|Started New Treatment|0|||
23310030|NCT03146962|64881300|FG006|Overall Study|Started New Treatment|0|||
23310031|NCT03146962|64881301|FG007|Overall Study|Started New Treatment|0|||
23310032|NCT03146962|64881302|FG008|Overall Study|Started New Treatment|0|||
23310033|NCT03146962|64881303|FG009|Overall Study|Started New Treatment|0|||
23310034|NCT03709823|64881304|FG000|Overall Study|Adverse Event|0|||
23310035|NCT03709823|64881305|FG001|Overall Study|Adverse Event|0|||
23310036|NCT03709823|64881306|FG002|Overall Study|Adverse Event|1|||
23310037|NCT03709823|64881307|FG003|Overall Study|Adverse Event|0|||
23310038|NCT03709823|64881308|FG004|Overall Study|Adverse Event|0|||
23310039|NCT03709823|64881309|FG005|Overall Study|Adverse Event|0|||
23310040|NCT03709823|64881304|FG000|Overall Study|Lost to Follow-up|2|||
23613753|NCT02023099|65973202|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
23613754|NCT02023099|65973203|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
23207554|NCT00254293|64498213|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23207555|NCT00254293|64498214|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
23207556|NCT00254293|64498215|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
23207557|NCT00254293|64498209|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23207558|NCT00254293|64498210|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23207559|NCT00254293|64498211|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23207560|NCT00254293|64498212|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23207561|NCT00254293|64498213|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23207562|NCT00254293|64498214|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
23207563|NCT00254293|64498215|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
23207564|NCT00254293|64498209|FG000|LTE Open Label Fixed Dosing|Other|0|||
23207565|NCT00254293|64498210|FG001|LTE Open Label Fixed Dosing|Other|0|||
23207566|NCT00254293|64498211|FG002|LTE Open Label Fixed Dosing|Other|0|||
23207567|NCT00254293|64498212|FG003|LTE Open Label Fixed Dosing|Other|0|||
23207568|NCT00254293|64498213|FG004|LTE Open Label Fixed Dosing|Other|0|||
23207569|NCT00254293|64498214|FG005|LTE Open Label Fixed Dosing|Other|0|||
23207570|NCT00254293|64498215|FG006|LTE Open Label Fixed Dosing|Other|1|||
23207571|NCT01253044|64498216|FG000|Overall Study|Lost to Follow-up|38|||
23207572|NCT01253044|64498217|FG001|Overall Study|Lost to Follow-up|29|||
23207573|NCT00288860|64498218|FG000|Overall Study|Did not complete intake|4|||
23207574|NCT00288860|64498219|FG001|Overall Study|Did not complete intake|8|||
23207575|NCT00288860|64498218|FG000|Overall Study|Death|4|||
23207576|NCT00288860|64498219|FG001|Overall Study|Death|3|||
23207577|NCT00288860|64498218|FG000|Overall Study|Withdrawal by Subject|20|||
23207578|NCT00288860|64498219|FG001|Overall Study|Withdrawal by Subject|15|||
23207579|NCT00288860|64498218|FG000|Overall Study|Lost to Follow-up|74|||
23207580|NCT00288860|64498219|FG001|Overall Study|Lost to Follow-up|71|||
23207581|NCT01935336|64498221|FG000|Overall Study|Adverse Event|1|||
23207582|NCT01935336|64498222|FG001|Overall Study|Adverse Event|0|||
23207583|NCT01935336|64498223|FG002|Overall Study|Adverse Event|0|||
23613755|NCT02023099|65973201|FG000|Overall Study|Withdrawn Consent|3|||
23613756|NCT02023099|65973202|FG001|Overall Study|Withdrawn Consent|0|||
23613757|NCT02023099|65973203|FG002|Overall Study|Withdrawn Consent|1|||
23613758|NCT02023099|65973201|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
23613759|NCT02023099|65973202|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
23613760|NCT02023099|65973203|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
23613761|NCT02188784|65973204|FG000|Overall Study|Death|3|||
23613762|NCT02188784|65973205|FG001|Overall Study|Death|1|||
23613763|NCT02188784|65973204|FG000|Overall Study|Lost to Follow-up|1|||
23207584|NCT01935336|64498224|FG003|Overall Study|Adverse Event|0|||
23310041|NCT03709823|64881305|FG001|Overall Study|Lost to Follow-up|2|||
23613764|NCT02188784|65973205|FG001|Overall Study|Lost to Follow-up|0|||
23207585|NCT01935336|64498221|FG000|Overall Study|Progressive disease|5|||
23207586|NCT01935336|64498222|FG001|Overall Study|Progressive disease|3|||
23207587|NCT01935336|64498223|FG002|Overall Study|Progressive disease|47|||
23207588|NCT01935336|64498224|FG003|Overall Study|Progressive disease|66|||
23207589|NCT01019486|64498225|FG000|Overall Study|Withdrawal by Subject|1|||
23207590|NCT01019486|64498226|FG001|Overall Study|Withdrawal by Subject|1|||
23310042|NCT03709823|64881306|FG002|Overall Study|Lost to Follow-up|2|||
23613765|NCT02188784|65973204|FG000|Overall Study|Withdrawal by Subject|3|||
23613766|NCT02188784|65973205|FG001|Overall Study|Withdrawal by Subject|9|||
23207591|NCT01019486|64498227|FG002|Overall Study|Withdrawal by Subject|1|||
23207592|NCT03225716|64498233|FG000|Overall Study|Withdrawal by Subject|2|||
23207593|NCT03225716|64498234|FG001|Overall Study|Withdrawal by Subject|2|||
23207594|NCT03225716|64498235|FG002|Overall Study|Withdrawal by Subject|0|||
23420241|NCT00075725|65283756|FG001|Overall Study|Pt age out of range for treatment|1|||
23207595|NCT03225716|64498233|FG000|Overall Study|Lack of Efficacy|1|||
23420242|NCT00075725|65283757|FG002|Overall Study|Pt age out of range for treatment|0|||
23420243|NCT00075725|65283758|FG003|Overall Study|Pt age out of range for treatment|0|||
23420244|NCT00075725|65283759|FG004|Overall Study|Pt age out of range for treatment|0|||
23420245|NCT00075725|65283760|FG005|Overall Study|Pt age out of range for treatment|1|||
23420246|NCT00075725|65283761|FG006|Overall Study|Pt age out of range for treatment|0|||
23420247|NCT00075725|65283762|FG007|Overall Study|Pt age out of range for treatment|1|||
23420248|NCT00075725|65283763|FG008|Overall Study|Pt age out of range for treatment|0|||
23420249|NCT00075725|65283764|FG009|Overall Study|Pt age out of range for treatment|0|||
23420250|NCT00075725|65283765|FG010|Overall Study|Pt age out of range for treatment|0|||
23420251|NCT00075725|65283766|FG011|Overall Study|Pt age out of range for treatment|0|||
23420252|NCT00075725|65283755|FG000|Overall Study|Insurance issues|0|||
23420253|NCT00075725|65283756|FG001|Overall Study|Insurance issues|1|||
23420254|NCT00075725|65283757|FG002|Overall Study|Insurance issues|0|||
23420255|NCT00075725|65283758|FG003|Overall Study|Insurance issues|1|||
23420256|NCT00075725|65283759|FG004|Overall Study|Insurance issues|1|||
23420257|NCT00075725|65283760|FG005|Overall Study|Insurance issues|1|||
23420258|NCT00075725|65283761|FG006|Overall Study|Insurance issues|0|||
23420259|NCT00075725|65283762|FG007|Overall Study|Insurance issues|1|||
23207596|NCT03225716|64498234|FG001|Overall Study|Lack of Efficacy|0|||
23207597|NCT03225716|64498235|FG002|Overall Study|Lack of Efficacy|0|||
23207598|NCT03225716|64498233|FG000|Overall Study|Adverse Event|2|||
23207599|NCT03225716|64498234|FG001|Overall Study|Adverse Event|0|||
23207600|NCT03225716|64498235|FG002|Overall Study|Adverse Event|1|||
23207601|NCT03225716|64498233|FG000|Overall Study|Study early termination by Sponsor|0|||
23207602|NCT03225716|64498234|FG001|Overall Study|Study early termination by Sponsor|0|||
23207603|NCT03225716|64498235|FG002|Overall Study|Study early termination by Sponsor|2|||
23207604|NCT00305253|64498236|FG000|Overall Study|Withdrawal by Subject|0|||
23207605|NCT00305253|64498237|FG001|Overall Study|Withdrawal by Subject|1|||
23207606|NCT04311177|64498240|FG000|Overall Study|Adverse Event|3|||
23207607|NCT04311177|64498241|FG001|Overall Study|Adverse Event|1|||
23207608|NCT04311177|64498240|FG000|Overall Study|Physician Decision|4|||
23420260|NCT00075725|65283763|FG008|Overall Study|Insurance issues|0|||
23531804|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Adverse Event|2|||
23531805|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
23207609|NCT04311177|64498241|FG001|Overall Study|Physician Decision|3|||
23420261|NCT00075725|65283764|FG009|Overall Study|Insurance issues|0|||
23420262|NCT00075725|65283765|FG010|Overall Study|Insurance issues|0|||
23420263|NCT00075725|65283766|FG011|Overall Study|Insurance issues|0|||
23420264|NCT00075725|65283755|FG000|Overall Study|MRD positive after extended ind|0|||
23420265|NCT00075725|65283756|FG001|Overall Study|MRD positive after extended ind|1|||
23207610|NCT04311177|64498240|FG000|Overall Study|Withdrawal by Subject|1|||
23207611|NCT04311177|64498241|FG001|Overall Study|Withdrawal by Subject|0|||
23207612|NCT02695524|64498246|FG000|Overall Study|Lost to Follow-up|3|||
23207613|NCT02695524|64498247|FG001|Overall Study|Lost to Follow-up|2|||
23207614|NCT02695524|64498246|FG000|Overall Study|Death|0|||
23613767|NCT02188784|65973204|FG000|Overall Study|Physician Decision|2|||
23420266|NCT00075725|65283757|FG002|Overall Study|MRD positive after extended ind|1|||
23420267|NCT00075725|65283758|FG003|Overall Study|MRD positive after extended ind|0|||
23420268|NCT00075725|65283759|FG004|Overall Study|MRD positive after extended ind|1|||
23420269|NCT00075725|65283760|FG005|Overall Study|MRD positive after extended ind|2|||
23420270|NCT00075725|65283761|FG006|Overall Study|MRD positive after extended ind|0|||
23420271|NCT00075725|65283762|FG007|Overall Study|MRD positive after extended ind|1|||
23420272|NCT00075725|65283763|FG008|Overall Study|MRD positive after extended ind|0|||
23420273|NCT00075725|65283764|FG009|Overall Study|MRD positive after extended ind|0|||
23420274|NCT00075725|65283765|FG010|Overall Study|MRD positive after extended ind|0|||
23420275|NCT00075725|65283766|FG011|Overall Study|MRD positive after extended ind|0|||
23420276|NCT00075725|65283755|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
23420277|NCT00075725|65283756|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
23420278|NCT00075725|65283757|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
23420279|NCT00075725|65283758|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
23420280|NCT00075725|65283759|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
23420281|NCT00075725|65283760|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
23420282|NCT00075725|65283761|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
23420283|NCT00075725|65283762|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
23420284|NCT00075725|65283763|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
23420285|NCT00075725|65283764|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
23420286|NCT00075725|65283765|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
23420287|NCT00075725|65283766|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
23420288|NCT00075725|65283755|FG000|Overall Study|Inevaluable|1|||
23420289|NCT00075725|65283756|FG001|Overall Study|Inevaluable|1|||
23420290|NCT00075725|65283757|FG002|Overall Study|Inevaluable|4|||
23207615|NCT02695524|64498247|FG001|Overall Study|Death|1|||
23310043|NCT03709823|64881307|FG003|Overall Study|Lost to Follow-up|1|||
23420291|NCT00075725|65283758|FG003|Overall Study|Inevaluable|2|||
23420292|NCT00075725|65283759|FG004|Overall Study|Inevaluable|2|||
23420293|NCT00075725|65283760|FG005|Overall Study|Inevaluable|9|||
23420294|NCT00075725|65283761|FG006|Overall Study|Inevaluable|1|||
23420295|NCT00075725|65283762|FG007|Overall Study|Inevaluable|11|||
23420296|NCT00075725|65283763|FG008|Overall Study|Inevaluable|2|||
23420297|NCT00075725|65283764|FG009|Overall Study|Inevaluable|0|||
23420298|NCT00075725|65283765|FG010|Overall Study|Inevaluable|1|||
23420299|NCT00075725|65283766|FG011|Overall Study|Inevaluable|0|||
23420300|NCT00075725|65283755|FG000|Overall Study|Other|4|||
23613768|NCT02188784|65973205|FG001|Overall Study|Physician Decision|3|||
23613769|NCT05274906|65973207|FG000|Overall Study|Withdrawal by Subject|2|||
23613770|NCT05274906|65973208|FG001|Overall Study|Withdrawal by Subject|1|||
23613771|NCT03761849|65973209|FG000|Overall Study|transferred to OpenLabelExtension|35|||
23613772|NCT03761849|65973210|FG001|Overall Study|transferred to OpenLabelExtension|34|||
23613773|NCT03761849|65973211|FG002|Overall Study|transferred to OpenLabelExtension|36|||
23613774|NCT03761849|65973212|FG003|Overall Study|transferred to OpenLabelExtension|0|||
23613775|NCT03761849|65973213|FG004|Overall Study|transferred to OpenLabelExtension|0|||
23613776|NCT03761849|65973214|FG005|Overall Study|transferred to OpenLabelExtension|0|||
23613777|NCT03761849|65973209|FG000|Overall Study|Adverse Event|1|||
23613778|NCT03761849|65973210|FG001|Overall Study|Adverse Event|0|||
23613779|NCT03761849|65973211|FG002|Overall Study|Adverse Event|0|||
23613780|NCT03761849|65973212|FG003|Overall Study|Adverse Event|0|||
23613781|NCT03761849|65973213|FG004|Overall Study|Adverse Event|2|||
23613782|NCT03761849|65973214|FG005|Overall Study|Adverse Event|3|||
23613783|NCT03761849|65973209|FG000|Overall Study|Withdrawal by Subject|0|||
23613784|NCT03761849|65973210|FG001|Overall Study|Withdrawal by Subject|0|||
23613785|NCT03761849|65973211|FG002|Overall Study|Withdrawal by Subject|0|||
23613786|NCT03761849|65973212|FG003|Overall Study|Withdrawal by Subject|41|||
23613787|NCT03761849|65973213|FG004|Overall Study|Withdrawal by Subject|43|||
23613788|NCT03761849|65973214|FG005|Overall Study|Withdrawal by Subject|35|||
23613789|NCT03761849|65973209|FG000|Overall Study|Lost to Follow-up|0|||
23613790|NCT03761849|65973210|FG001|Overall Study|Lost to Follow-up|1|||
23613791|NCT03761849|65973211|FG002|Overall Study|Lost to Follow-up|0|||
23613792|NCT03761849|65973212|FG003|Overall Study|Lost to Follow-up|2|||
23613793|NCT03761849|65973213|FG004|Overall Study|Lost to Follow-up|4|||
23613794|NCT03761849|65973214|FG005|Overall Study|Lost to Follow-up|5|||
23420301|NCT00075725|65283756|FG001|Overall Study|Other|2|||
23207616|NCT00448760|64498248|FG000|Overall Study|Death|3|||
23310044|NCT03709823|64881308|FG004|Overall Study|Lost to Follow-up|1|||
23420302|NCT00075725|65283757|FG002|Overall Study|Other|1|||
23420303|NCT00075725|65283758|FG003|Overall Study|Other|1|||
23420304|NCT00075725|65283759|FG004|Overall Study|Other|1|||
23420305|NCT00075725|65283760|FG005|Overall Study|Other|4|||
23613795|NCT03761849|65973209|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
23613796|NCT03761849|65973210|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
23420306|NCT00075725|65283761|FG006|Overall Study|Other|2|||
23420307|NCT00075725|65283762|FG007|Overall Study|Other|9|||
23420308|NCT00075725|65283763|FG008|Overall Study|Other|2|||
23420309|NCT00075725|65283764|FG009|Overall Study|Other|1|||
23420310|NCT00075725|65283765|FG010|Overall Study|Other|0|||
23420311|NCT00075725|65283766|FG011|Overall Study|Other|3|||
23420312|NCT00075725|65283755|FG000|Overall Study|Pt trying to find a BM donor|0|||
23420313|NCT00075725|65283756|FG001|Overall Study|Pt trying to find a BM donor|1|||
23420314|NCT00075725|65283757|FG002|Overall Study|Pt trying to find a BM donor|0|||
23207617|NCT02953782|64498249|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
23207618|NCT02953782|64498250|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
23420315|NCT00075725|65283758|FG003|Overall Study|Pt trying to find a BM donor|0|||
23420316|NCT00075725|65283759|FG004|Overall Study|Pt trying to find a BM donor|0|||
23420317|NCT00075725|65283760|FG005|Overall Study|Pt trying to find a BM donor|0|||
23420318|NCT00075725|65283761|FG006|Overall Study|Pt trying to find a BM donor|0|||
23420319|NCT00075725|65283762|FG007|Overall Study|Pt trying to find a BM donor|0|||
23420320|NCT00075725|65283763|FG008|Overall Study|Pt trying to find a BM donor|0|||
23420321|NCT00075725|65283764|FG009|Overall Study|Pt trying to find a BM donor|0|||
23420322|NCT00075725|65283765|FG010|Overall Study|Pt trying to find a BM donor|0|||
23420323|NCT00075725|65283766|FG011|Overall Study|Pt trying to find a BM donor|0|||
23420324|NCT00075725|65283755|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
23420325|NCT00075725|65283756|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
23420326|NCT00075725|65283757|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
23420327|NCT00075725|65283758|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
23420328|NCT00075725|65283759|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
23420329|NCT00075725|65283760|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
23420330|NCT00075725|65283761|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
23420331|NCT00075725|65283762|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
23420332|NCT00075725|65283763|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
23420333|NCT00075725|65283764|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
23207619|NCT02953782|64498251|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
23207620|NCT02953782|64498252|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
23207621|NCT02953782|64498253|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
23420334|NCT00075725|65283765|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
23420335|NCT00075725|65283766|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
23420336|NCT00075725|65283755|FG000|Overall Study|Unsuccessful institutional transfer|0|||
23420337|NCT00075725|65283756|FG001|Overall Study|Unsuccessful institutional transfer|0|||
23420338|NCT00075725|65283757|FG002|Overall Study|Unsuccessful institutional transfer|2|||
23207622|NCT02953782|64498254|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
23207623|NCT02953782|64498255|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
23207624|NCT02953782|64498256|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
23420339|NCT00075725|65283758|FG003|Overall Study|Unsuccessful institutional transfer|0|||
23420340|NCT00075725|65283759|FG004|Overall Study|Unsuccessful institutional transfer|0|||
23420341|NCT00075725|65283760|FG005|Overall Study|Unsuccessful institutional transfer|0|||
23420342|NCT00075725|65283761|FG006|Overall Study|Unsuccessful institutional transfer|0|||
23207625|NCT02953782|64498249|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
23207626|NCT02953782|64498250|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23207627|NCT02953782|64498251|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
23420343|NCT00075725|65283762|FG007|Overall Study|Unsuccessful institutional transfer|0|||
23420344|NCT00075725|65283763|FG008|Overall Study|Unsuccessful institutional transfer|0|||
23420345|NCT00075725|65283764|FG009|Overall Study|Unsuccessful institutional transfer|1|||
23420346|NCT00075725|65283765|FG010|Overall Study|Unsuccessful institutional transfer|0|||
23420347|NCT00075725|65283766|FG011|Overall Study|Unsuccessful institutional transfer|0|||
23420348|NCT00075725|65283755|FG000|Overall Study|specimen(s) not submitted|0|||
23420349|NCT00075725|65283756|FG001|Overall Study|specimen(s) not submitted|0|||
23420350|NCT00075725|65283757|FG002|Overall Study|specimen(s) not submitted|2|||
23420351|NCT00075725|65283758|FG003|Overall Study|specimen(s) not submitted|0|||
23420352|NCT00075725|65283759|FG004|Overall Study|specimen(s) not submitted|0|||
23420353|NCT00075725|65283760|FG005|Overall Study|specimen(s) not submitted|0|||
23420354|NCT00075725|65283761|FG006|Overall Study|specimen(s) not submitted|0|||
23420355|NCT00075725|65283762|FG007|Overall Study|specimen(s) not submitted|0|||
23420356|NCT00075725|65283763|FG008|Overall Study|specimen(s) not submitted|0|||
23420357|NCT00075725|65283764|FG009|Overall Study|specimen(s) not submitted|0|||
23420358|NCT00075725|65283765|FG010|Overall Study|specimen(s) not submitted|0|||
23420359|NCT00075725|65283766|FG011|Overall Study|specimen(s) not submitted|0|||
23420360|NCT00075725|65283755|FG000|Overall Study|Pt went to transplant|0|||
23207628|NCT02953782|64498252|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23207629|NCT02953782|64498253|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
23207630|NCT02953782|64498254|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23207631|NCT02953782|64498255|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23207632|NCT02953782|64498256|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
23207633|NCT02953782|64498249|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23207634|NCT02953782|64498250|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
23207635|NCT02953782|64498251|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23207636|NCT02953782|64498252|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
23207637|NCT02953782|64498253|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
23207638|NCT02953782|64498254|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23207639|NCT02953782|64498255|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23207640|NCT02953782|64498256|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
23207641|NCT02953782|64498249|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23207642|NCT02953782|64498250|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23207643|NCT02953782|64498251|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
23207644|NCT02953782|64498252|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
23207645|NCT02953782|64498253|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23207646|NCT02953782|64498254|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23207647|NCT02953782|64498255|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23207648|NCT02953782|64498256|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
23207649|NCT02953782|64498249|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23420361|NCT00075725|65283756|FG001|Overall Study|Pt went to transplant|0|||
23420362|NCT00075725|65283757|FG002|Overall Study|Pt went to transplant|0|||
23420363|NCT00075725|65283758|FG003|Overall Study|Pt went to transplant|1|||
23420364|NCT00075725|65283759|FG004|Overall Study|Pt went to transplant|0|||
23531806|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
23531807|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
23531808|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
23531809|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Physician Decision|1|||
23310045|NCT03709823|64881309|FG005|Overall Study|Lost to Follow-up|0|||
23310046|NCT03709823|64881304|FG000|Overall Study|Withdrawal by Subject|1|||
23310047|NCT03709823|64881305|FG001|Overall Study|Withdrawal by Subject|3|||
23310048|NCT03709823|64881306|FG002|Overall Study|Withdrawal by Subject|0|||
23310049|NCT03709823|64881307|FG003|Overall Study|Withdrawal by Subject|0|||
23310050|NCT03709823|64881308|FG004|Overall Study|Withdrawal by Subject|0|||
23310051|NCT03709823|64881309|FG005|Overall Study|Withdrawal by Subject|0|||
23310052|NCT03709823|64881304|FG000|Overall Study|Other, Not Specified|0|||
23310053|NCT03709823|64881305|FG001|Overall Study|Other, Not Specified|0|||
23531810|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Physician Decision|1|||
23531811|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Pregnancy|2|||
23531812|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Pregnancy|0|||
23531813|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
23531814|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
23531815|NCT02896127|65683100|FG000|COMPLETED WEEK 52|Technical problems|1|||
23531816|NCT02896127|65683101|FG001|COMPLETED WEEK 52|Technical problems|0|||
23613797|NCT03761849|65973211|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
23613798|NCT03761849|65973212|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
23613799|NCT03761849|65973213|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
23613800|NCT03761849|65973214|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
23613801|NCT03761849|65973209|FG000|Overall Study|Physician Decision|0|||
23613802|NCT03761849|65973210|FG001|Overall Study|Physician Decision|0|||
23613803|NCT03761849|65973211|FG002|Overall Study|Physician Decision|0|||
23613804|NCT03761849|65973212|FG003|Overall Study|Physician Decision|1|||
23613805|NCT03761849|65973213|FG004|Overall Study|Physician Decision|4|||
23613806|NCT03761849|65973214|FG005|Overall Study|Physician Decision|4|||
23613807|NCT03761849|65973209|FG000|Overall Study|Death|0|||
23310054|NCT03709823|64881306|FG002|Overall Study|Other, Not Specified|0|||
23310055|NCT03709823|64881307|FG003|Overall Study|Other, Not Specified|1|||
23310056|NCT03709823|64881308|FG004|Overall Study|Other, Not Specified|0|||
23531817|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
23531818|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
23531819|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
23531820|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
23531821|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
23531822|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
23531823|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
23531824|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
23531825|NCT02896127|65683100|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
23531826|NCT02896127|65683101|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
23531827|NCT03394391|65683102|FG000|Overall Study|Lost to Follow-up|1|||
23531828|NCT03394391|65683103|FG001|Overall Study|Lost to Follow-up|2|||
23531829|NCT04439240|65683104|FG000|Overall Study|Ineligible|2|||
23531830|NCT04439240|65683104|FG000|Overall Study|Never started treatment|2|||
23531831|NCT04439240|65683104|FG000|Overall Study|Adverse Event|12|||
23531832|NCT04439240|65683104|FG000|Overall Study|Death|2|||
23531833|NCT04439240|65683104|FG000|Overall Study|Disease progression|25|||
23531834|NCT04439240|65683104|FG000|Overall Study|Other diseases|2|||
23531835|NCT04439240|65683104|FG000|Overall Study|Withdrawal by Subject|3|||
23531836|NCT04439240|65683104|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
23531837|NCT04439240|65683104|FG000|Overall Study|Symptomatic decline|1|||
23531838|NCT04439240|65683104|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
23531839|NCT04439240|65683104|FG000|Overall Study|Clinical progression|1|||
23531840|NCT00503685|65683105|FG000|Overall Study|Adverse Event|0|||
23310057|NCT03709823|64881309|FG005|Overall Study|Other, Not Specified|0|||
23310058|NCT00940316|64881314|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
23310059|NCT00940316|64881315|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
23310060|NCT00940316|64881316|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
23310061|NCT00940316|64881314|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
23310062|NCT00940316|64881315|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
23310063|NCT00940316|64881316|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
23310064|NCT00940316|64881314|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
23310065|NCT00940316|64881315|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
23310066|NCT00940316|64881316|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
23310067|NCT00940316|64881314|FG000|Treated After Cycle 5|Adverse Event|0|||
23310068|NCT00940316|64881315|FG001|Treated After Cycle 5|Adverse Event|0|||
23310069|NCT00940316|64881316|FG002|Treated After Cycle 5|Adverse Event|1|||
23310070|NCT00940316|64881314|FG000|Treated After Cycle 5|Progressive disease|0|||
23310071|NCT00940316|64881315|FG001|Treated After Cycle 5|Progressive disease|1|||
23310072|NCT00940316|64881316|FG002|Treated After Cycle 5|Progressive disease|0|||
23310073|NCT03489109|64881319|FG000|Overall Study|Lost to Follow-up|1|||
23310074|NCT03489109|64881320|FG001|Overall Study|Lost to Follow-up|2|||
23310075|NCT03151811|64881321|FG000|Overall Study|Randomized But Not Treated|18|||
23310076|NCT03151811|64881322|FG001|Overall Study|Randomized But Not Treated|3|||
23310077|NCT03151811|64881321|FG000|Overall Study|Progressive Disease|130|||
23310078|NCT03151811|64881322|FG001|Overall Study|Progressive Disease|170|||
23310079|NCT03151811|64881321|FG000|Overall Study|Adverse Event|49|||
23310080|NCT03151811|64881322|FG001|Overall Study|Adverse Event|40|||
23310081|NCT03151811|64881321|FG000|Overall Study|Lack of Efficacy|6|||
23310082|NCT03151811|64881322|FG001|Overall Study|Lack of Efficacy|8|||
23310083|NCT03151811|64881321|FG000|Overall Study|Physician Decision|21|||
23310084|NCT03151811|64881322|FG001|Overall Study|Physician Decision|9|||
23310085|NCT03151811|64881321|FG000|Overall Study|Withdrawal by Subject|17|||
23531841|NCT00503685|65683106|FG001|Overall Study|Adverse Event|0|||
23531842|NCT00503685|65683107|FG002|Overall Study|Adverse Event|2|||
23531843|NCT00503685|65683105|FG000|Overall Study|Withdrawal by Subject|0|||
23531844|NCT00503685|65683106|FG001|Overall Study|Withdrawal by Subject|1|||
23531845|NCT00503685|65683107|FG002|Overall Study|Withdrawal by Subject|0|||
23531846|NCT00503685|65683105|FG000|Overall Study|Protocol Violation|0|||
23613808|NCT03761849|65973210|FG001|Overall Study|Death|0|||
23613809|NCT03761849|65973211|FG002|Overall Study|Death|0|||
23613810|NCT03761849|65973212|FG003|Overall Study|Death|1|||
23613811|NCT03761849|65973213|FG004|Overall Study|Death|1|||
23613812|NCT03761849|65973214|FG005|Overall Study|Death|3|||
23613813|NCT03761849|65973209|FG000|Overall Study|Protocol Violation|0|||
23613814|NCT03761849|65973210|FG001|Overall Study|Protocol Violation|0|||
23613815|NCT03761849|65973211|FG002|Overall Study|Protocol Violation|0|||
23613816|NCT03761849|65973212|FG003|Overall Study|Protocol Violation|2|||
23613817|NCT03761849|65973213|FG004|Overall Study|Protocol Violation|2|||
23613818|NCT03761849|65973214|FG005|Overall Study|Protocol Violation|1|||
23613819|NCT03761849|65973209|FG000|Overall Study|Participant could not come to site|0|||
23613820|NCT03761849|65973210|FG001|Overall Study|Participant could not come to site|0|||
23613821|NCT03761849|65973211|FG002|Overall Study|Participant could not come to site|0|||
23613822|NCT03761849|65973212|FG003|Overall Study|Participant could not come to site|0|||
23613823|NCT03761849|65973213|FG004|Overall Study|Participant could not come to site|1|||
23613824|NCT03761849|65973214|FG005|Overall Study|Participant could not come to site|0|||
23613825|NCT03761849|65973209|FG000|Overall Study|SF- safety Finding|0|||
23613826|NCT03761849|65973210|FG001|Overall Study|SF- safety Finding|0|||
23613827|NCT03761849|65973211|FG002|Overall Study|SF- safety Finding|0|||
23613828|NCT03761849|65973212|FG003|Overall Study|SF- safety Finding|0|||
23613829|NCT03761849|65973213|FG004|Overall Study|SF- safety Finding|0|||
23613830|NCT03761849|65973214|FG005|Overall Study|SF- safety Finding|1|||
23310086|NCT03151811|64881322|FG001|Overall Study|Withdrawal by Subject|7|||
23310087|NCT03151811|64881321|FG000|Overall Study|Lost to Follow-up|0|||
23310088|NCT03151811|64881322|FG001|Overall Study|Lost to Follow-up|1|||
23531847|NCT00503685|65683106|FG001|Overall Study|Protocol Violation|1|||
23531848|NCT00503685|65683107|FG002|Overall Study|Protocol Violation|0|||
23531849|NCT00503685|65683105|FG000|Overall Study|Eligibility Criteria Not Met|0|||
23531850|NCT00503685|65683106|FG001|Overall Study|Eligibility Criteria Not Met|1|||
23531851|NCT00503685|65683107|FG002|Overall Study|Eligibility Criteria Not Met|0|||
23531852|NCT04524403|65683109|FG000|Overall Study|Withdrawal by Subject|10|||
23531853|NCT04524403|65683110|FG001|Overall Study|Withdrawal by Subject|3|||
23531854|NCT04524403|65683111|FG002|Overall Study|Withdrawal by Subject|8|||
23613831|NCT03761849|65973209|FG000|Overall Study|Patient did not attend visit|0|||
23613832|NCT03761849|65973210|FG001|Overall Study|Patient did not attend visit|0|||
23531855|NCT04524403|65683109|FG000|Overall Study|Lost to Follow-up|3|||
23613833|NCT03761849|65973211|FG002|Overall Study|Patient did not attend visit|0|||
23613834|NCT03761849|65973212|FG003|Overall Study|Patient did not attend visit|0|||
23613835|NCT03761849|65973213|FG004|Overall Study|Patient did not attend visit|0|||
23613836|NCT03761849|65973214|FG005|Overall Study|Patient did not attend visit|1|||
23613837|NCT01113541|65973215|FG000|Overall Study|Withdrawal by Subject|1|||
23613838|NCT01113541|65973215|FG000|Overall Study|Protocol Violation|1|||
23613839|NCT01113541|65973215|FG000|Overall Study|Study Terminated by Sponsor|7|||
23613840|NCT01113541|65973215|FG000|Overall Study|Adverse Event|4|||
23613841|NCT03050372|65973216|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
23613842|NCT03050372|65973217|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
23613843|NCT03050372|65973216|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
23613844|NCT03050372|65973217|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
23613845|NCT04295499|65973218|FG000|Overall Study|moving out of state|1|||
23613846|NCT04295499|65973219|FG001|Overall Study|moving out of state|0|||
23613847|NCT04295499|65973218|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
23613848|NCT04295499|65973219|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
23613849|NCT02005484|65973220|FG000|Overall Study|Death|1|||
23613850|NCT02005484|65973220|FG000|Overall Study|Disease progression|1|||
23613851|NCT02005484|65973220|FG000|Overall Study|Changed to a Different Study|1|||
23613852|NCT02005484|65973220|FG000|Overall Study|Sponsor decision|1|||
23613853|NCT00525915|65973221|FG000|Overall Study|Non-Compliance|0|||
23613854|NCT00525915|65973222|FG001|Overall Study|Non-Compliance|1|||
23613855|NCT00525915|65973221|FG000|Overall Study|Disease Progression|5|||
23613856|NCT00525915|65973222|FG001|Overall Study|Disease Progression|6|||
23207650|NCT02953782|64498250|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23207651|NCT02953782|64498251|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23207652|NCT02953782|64498252|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23207653|NCT02953782|64498253|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
23613857|NCT00525915|65973221|FG000|Overall Study|Withdrawal by Subject|1|||
23613858|NCT00525915|65973222|FG001|Overall Study|Withdrawal by Subject|0|||
23613859|NCT00525915|65973221|FG000|Overall Study|Refused Surgery|1|||
23613860|NCT00525915|65973222|FG001|Overall Study|Refused Surgery|2|||
23613861|NCT00525915|65973221|FG000|Overall Study|Unrelated illness|1|||
23613862|NCT00525915|65973222|FG001|Overall Study|Unrelated illness|0|||
23613863|NCT00762502|65973231|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
23613864|NCT00762502|65973232|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
23613865|NCT00762502|65973233|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
23613866|NCT00762502|65973231|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
23613867|NCT00762502|65973232|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
23613868|NCT00762502|65973233|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
23613869|NCT00762502|65973231|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
23613870|NCT00762502|65973232|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
23613871|NCT00762502|65973233|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
23613872|NCT02525744|65973236|FG000|Period 1|Physician Decision|0|||
23613873|NCT02525744|65973237|FG001|Period 1|Physician Decision|0|||
23613874|NCT02525744|65973238|FG002|Period 1|Physician Decision|1|||
23613875|NCT02525744|65973239|FG003|Period 1|Physician Decision|0|||
23613876|NCT02525744|65973236|FG000|Period 3|Adverse Event|0|||
23613877|NCT02525744|65973237|FG001|Period 3|Adverse Event|1|||
23613878|NCT02525744|65973238|FG002|Period 3|Adverse Event|0|||
23613879|NCT02525744|65973239|FG003|Period 3|Adverse Event|0|||
23613880|NCT02525744|65973236|FG000|Period 4|Withdrawal by Subject|1|||
23613881|NCT02525744|65973237|FG001|Period 4|Withdrawal by Subject|0|||
23613882|NCT02525744|65973238|FG002|Period 4|Withdrawal by Subject|0|||
23613883|NCT02525744|65973239|FG003|Period 4|Withdrawal by Subject|0|||
23613884|NCT02525744|65973236|FG000|Period 5|Physician Decision|1|||
23613885|NCT02525744|65973237|FG001|Period 5|Physician Decision|0|||
23613886|NCT02525744|65973238|FG002|Period 5|Physician Decision|0|||
23613887|NCT02525744|65973239|FG003|Period 5|Physician Decision|0|||
23613888|NCT03613454|65973240|FG000|Overall Study|Protocol Violation|1|||
23613889|NCT03613454|65973241|FG001|Overall Study|Protocol Violation|0|||
23613890|NCT03613454|65973240|FG000|Overall Study|Protocol Violation|0|||
23613891|NCT03613454|65973241|FG001|Overall Study|Protocol Violation|1|||
23613892|NCT01066897|65973246|FG000|Overall Study|Withdrawal by Subject|1|||
23613893|NCT01066897|65973247|FG001|Overall Study|Withdrawal by Subject|0|||
23613894|NCT01066897|65973246|FG000|Overall Study|stopped study after developing the flu.|1|||
23613895|NCT01066897|65973247|FG001|Overall Study|stopped study after developing the flu.|0|||
23613896|NCT00580047|65973249|FG000|Overall Study|Lost to Follow-up|1|||
23613897|NCT00580047|65973250|FG001|Overall Study|Lost to Follow-up|1|||
23613898|NCT00580047|65973251|FG002|Overall Study|Lost to Follow-up|0|||
23613899|NCT00580047|65973249|FG000|Overall Study|Withdrawal by Subject|1|||
23613900|NCT00580047|65973250|FG001|Overall Study|Withdrawal by Subject|1|||
23613901|NCT00580047|65973251|FG002|Overall Study|Withdrawal by Subject|2|||
23613902|NCT00580047|65973249|FG000|Overall Study|Withdrawal by Subject|1|||
23613903|NCT00580047|65973250|FG001|Overall Study|Withdrawal by Subject|0|||
23613904|NCT00580047|65973251|FG002|Overall Study|Withdrawal by Subject|0|||
23613905|NCT02543294|65973252|FG000|Overall Study|Lost to Follow-up|3|||
23613906|NCT02543294|65973252|FG000|Overall Study|Physician Decision|2|||
23613907|NCT02543294|65973252|FG000|Overall Study|Withdrawal by Subject|7|||
23613908|NCT02820298|65973254|FG000|Overall Study|Withdrawal by Subject|0|||
23613909|NCT02820298|65973255|FG001|Overall Study|Withdrawal by Subject|1|||
23613910|NCT02820298|65973254|FG000|Overall Study|Physician Decision|1|||
23613911|NCT02820298|65973255|FG001|Overall Study|Physician Decision|0|||
23613912|NCT02820298|65973254|FG000|Overall Study|Protocol Violation|0|||
23613913|NCT02820298|65973255|FG001|Overall Study|Protocol Violation|1|||
23613914|NCT00296504|65973256|FG000|Interim Analysis|Withdrawal by Subject|8|||
23613915|NCT00296504|65973257|FG001|Interim Analysis|Withdrawal by Subject|0|||
23613916|NCT00296504|65973258|FG002|Interim Analysis|Withdrawal by Subject|12|||
23613917|NCT00296504|65973259|FG003|Interim Analysis|Withdrawal by Subject|0|||
23613918|NCT00296504|65973260|FG004|Interim Analysis|Withdrawal by Subject|5|||
23613919|NCT00296504|65973261|FG005|Interim Analysis|Withdrawal by Subject|5|||
23613920|NCT00296504|65973262|FG006|Interim Analysis|Withdrawal by Subject|9|||
23613921|NCT00296504|65973263|FG007|Interim Analysis|Withdrawal by Subject|3|||
23613922|NCT00296504|65973264|FG008|Interim Analysis|Withdrawal by Subject|0|||
23613923|NCT00296504|65973256|FG000|Interim Analysis|Lost to Follow-up|13|||
23613924|NCT00296504|65973257|FG001|Interim Analysis|Lost to Follow-up|3|||
23613925|NCT00296504|65973258|FG002|Interim Analysis|Lost to Follow-up|26|||
23613926|NCT00296504|65973259|FG003|Interim Analysis|Lost to Follow-up|8|||
23613927|NCT00296504|65973260|FG004|Interim Analysis|Lost to Follow-up|14|||
23613928|NCT00296504|65973261|FG005|Interim Analysis|Lost to Follow-up|4|||
23613929|NCT00296504|65973262|FG006|Interim Analysis|Lost to Follow-up|11|||
23613930|NCT00296504|65973263|FG007|Interim Analysis|Lost to Follow-up|4|||
23613931|NCT00296504|65973264|FG008|Interim Analysis|Lost to Follow-up|0|||
23613932|NCT00296504|65973256|FG000|Interim Analysis|Clinical Progression|1|||
23613933|NCT00296504|65973257|FG001|Interim Analysis|Clinical Progression|0|||
23613934|NCT00296504|65973258|FG002|Interim Analysis|Clinical Progression|1|||
23613935|NCT00296504|65973259|FG003|Interim Analysis|Clinical Progression|1|||
23613936|NCT00296504|65973260|FG004|Interim Analysis|Clinical Progression|0|||
23613937|NCT00296504|65973261|FG005|Interim Analysis|Clinical Progression|2|||
23613938|NCT00296504|65973262|FG006|Interim Analysis|Clinical Progression|1|||
23613939|NCT00296504|65973263|FG007|Interim Analysis|Clinical Progression|2|||
23613940|NCT00296504|65973264|FG008|Interim Analysis|Clinical Progression|0|||
23613941|NCT00296504|65973256|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
23613942|NCT00296504|65973257|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
23613943|NCT00296504|65973258|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
23531856|NCT04524403|65683110|FG001|Overall Study|Lost to Follow-up|4|||
23531857|NCT04524403|65683111|FG002|Overall Study|Lost to Follow-up|3|||
23531858|NCT04524403|65683109|FG000|Overall Study|Adverse Event|3|||
23531859|NCT04524403|65683110|FG001|Overall Study|Adverse Event|1|||
23531860|NCT04524403|65683111|FG002|Overall Study|Adverse Event|4|||
23531861|NCT04524403|65683109|FG000|Overall Study|Non-compliant with study drug|1|||
23531862|NCT04524403|65683110|FG001|Overall Study|Non-compliant with study drug|2|||
23531863|NCT04524403|65683111|FG002|Overall Study|Non-compliant with study drug|3|||
23531864|NCT04524403|65683109|FG000|Overall Study|Moved|0|||
23531865|NCT04524403|65683110|FG001|Overall Study|Moved|1|||
23531866|NCT04524403|65683111|FG002|Overall Study|Moved|0|||
23531867|NCT02472756|65683112|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
23531868|NCT02472756|65683112|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
23531869|NCT02472756|65683112|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
23531870|NCT02472756|65683112|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
23531871|NCT02472756|65683112|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
23531872|NCT03120013|65683115|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23531873|NCT03120013|65683116|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23531874|NCT00528528|65683134|FG000|Overall Study|Lost to Follow-up|0|||
23531875|NCT00528528|65683135|FG001|Overall Study|Lost to Follow-up|0|||
23531876|NCT00528528|65683136|FG002|Overall Study|Lost to Follow-up|1|||
23531877|NCT00528528|65683137|FG003|Overall Study|Lost to Follow-up|1|||
23531878|NCT00528528|65683134|FG000|Overall Study|Ineligible to continue the trial|0|||
23531879|NCT00528528|65683135|FG001|Overall Study|Ineligible to continue the trial|0|||
23531880|NCT00528528|65683136|FG002|Overall Study|Ineligible to continue the trial|0|||
23531881|NCT00528528|65683137|FG003|Overall Study|Ineligible to continue the trial|1|||
23531882|NCT00528528|65683134|FG000|Overall Study|Other|0|||
23613944|NCT00296504|65973259|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
23613945|NCT00296504|65973260|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
23613946|NCT00296504|65973261|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
23613947|NCT00296504|65973262|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
23613948|NCT00296504|65973263|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
23613949|NCT00296504|65973264|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
23531883|NCT00528528|65683135|FG001|Overall Study|Other|1|||
23531884|NCT00528528|65683136|FG002|Overall Study|Other|0|||
23531885|NCT00528528|65683137|FG003|Overall Study|Other|0|||
23531886|NCT00528528|65683134|FG000|Overall Study|Withdrawal by Subject|3|||
23531887|NCT00528528|65683135|FG001|Overall Study|Withdrawal by Subject|2|||
23531888|NCT00528528|65683136|FG002|Overall Study|Withdrawal by Subject|1|||
23531889|NCT00528528|65683137|FG003|Overall Study|Withdrawal by Subject|1|||
23531890|NCT00528528|65683134|FG000|Overall Study|Ongoing participant|0|||
23531891|NCT00528528|65683135|FG001|Overall Study|Ongoing participant|0|||
23531892|NCT00528528|65683136|FG002|Overall Study|Ongoing participant|1|||
23531893|NCT00528528|65683137|FG003|Overall Study|Ongoing participant|0|||
23531894|NCT00775437|65683140|FG000|Overall Study|Loss of efficacy|2|||
23531895|NCT00775437|65683140|FG000|Overall Study|Withdrawal by Subject|3|||
23531896|NCT00775437|65683140|FG000|Overall Study|Lost to Follow-up|1|||
23531897|NCT01000051|65683141|FG000|Overall Study|Withdrawal by Subject|1|||
23531898|NCT01000051|65683142|FG001|Overall Study|Withdrawal by Subject|1|||
23531899|NCT01000051|65683141|FG000|Overall Study|Disease Progression|1|||
23531900|NCT01000051|65683142|FG001|Overall Study|Disease Progression|0|||
23531901|NCT01000051|65683141|FG000|Overall Study|Serious noncompliance|1|||
23531902|NCT01000051|65683142|FG001|Overall Study|Serious noncompliance|0|||
23531903|NCT03852316|65683143|FG000|Overall Study|Protocol Violation|1|||
23531904|NCT03852316|65683143|FG000|Overall Study|Withdrawal by Subject|2|||
23531905|NCT03852316|65683143|FG000|Overall Study|Enrolled but Device not Utilized|1|||
23531906|NCT00079274|65683144|FG000|Overall Study|Withdrawal by Subject|111|||
23531907|NCT00079274|65683145|FG001|Overall Study|Withdrawal by Subject|10|||
23531908|NCT00079274|65683146|FG002|Overall Study|Withdrawal by Subject|12|||
23531909|NCT00079274|65683147|FG003|Overall Study|Withdrawal by Subject|163|||
23531910|NCT00079274|65683148|FG004|Overall Study|Withdrawal by Subject|7|||
23531911|NCT00079274|65683149|FG005|Overall Study|Withdrawal by Subject|8|||
23531912|NCT00079274|65683150|FG006|Overall Study|Withdrawal by Subject|0|||
23531913|NCT00079274|65683144|FG000|Overall Study|Adverse Event|130|||
23531914|NCT00079274|65683145|FG001|Overall Study|Adverse Event|8|||
23531915|NCT00079274|65683146|FG002|Overall Study|Adverse Event|8|||
23531916|NCT00079274|65683147|FG003|Overall Study|Adverse Event|184|||
23531917|NCT00079274|65683148|FG004|Overall Study|Adverse Event|7|||
23531918|NCT00079274|65683149|FG005|Overall Study|Adverse Event|8|||
23531919|NCT00079274|65683150|FG006|Overall Study|Adverse Event|0|||
23531920|NCT00079274|65683144|FG000|Overall Study|Recurrence|21|||
23531921|NCT00079274|65683145|FG001|Overall Study|Recurrence|0|||
23531922|NCT00079274|65683146|FG002|Overall Study|Recurrence|1|||
23531923|NCT00079274|65683147|FG003|Overall Study|Recurrence|15|||
23531924|NCT00079274|65683148|FG004|Overall Study|Recurrence|0|||
23531925|NCT00079274|65683149|FG005|Overall Study|Recurrence|2|||
23531926|NCT00079274|65683150|FG006|Overall Study|Recurrence|0|||
23531927|NCT00079274|65683144|FG000|Overall Study|Alternate Treatment|6|||
23531928|NCT00079274|65683145|FG001|Overall Study|Alternate Treatment|1|||
23531929|NCT00079274|65683146|FG002|Overall Study|Alternate Treatment|0|||
23531930|NCT00079274|65683147|FG003|Overall Study|Alternate Treatment|3|||
23531931|NCT00079274|65683148|FG004|Overall Study|Alternate Treatment|0|||
23531932|NCT00079274|65683149|FG005|Overall Study|Alternate Treatment|0|||
23531933|NCT00079274|65683150|FG006|Overall Study|Alternate Treatment|0|||
23531934|NCT00079274|65683144|FG000|Overall Study|Other Medical Problems|6|||
23531935|NCT00079274|65683145|FG001|Overall Study|Other Medical Problems|1|||
23531936|NCT00079274|65683146|FG002|Overall Study|Other Medical Problems|0|||
23531937|NCT00079274|65683147|FG003|Overall Study|Other Medical Problems|7|||
23531938|NCT00079274|65683148|FG004|Overall Study|Other Medical Problems|0|||
23531939|NCT00079274|65683149|FG005|Overall Study|Other Medical Problems|0|||
23531940|NCT00079274|65683150|FG006|Overall Study|Other Medical Problems|0|||
23531941|NCT00079274|65683144|FG000|Overall Study|Death|4|||
23531942|NCT00079274|65683145|FG001|Overall Study|Death|0|||
23310089|NCT03151811|64881321|FG000|Overall Study|Study Terminated by Sponsor|5|||
23310090|NCT03151811|64881322|FG001|Overall Study|Study Terminated by Sponsor|11|||
23310091|NCT00928707|64881323|FG000|Overall Study|Protocol Violation|1|||
23531943|NCT00079274|65683146|FG002|Overall Study|Death|1|||
23531944|NCT00079274|65683147|FG003|Overall Study|Death|15|||
23531945|NCT00079274|65683148|FG004|Overall Study|Death|0|||
23531946|NCT00079274|65683149|FG005|Overall Study|Death|0|||
23531947|NCT00079274|65683150|FG006|Overall Study|Death|0|||
23531948|NCT00079274|65683144|FG000|Overall Study|Cytogenetic resistance|0|||
23531949|NCT00079274|65683145|FG001|Overall Study|Cytogenetic resistance|0|||
23531950|NCT00079274|65683146|FG002|Overall Study|Cytogenetic resistance|0|||
23531951|NCT00079274|65683147|FG003|Overall Study|Cytogenetic resistance|2|||
23531952|NCT00079274|65683148|FG004|Overall Study|Cytogenetic resistance|0|||
23531953|NCT00079274|65683149|FG005|Overall Study|Cytogenetic resistance|0|||
23531954|NCT00079274|65683150|FG006|Overall Study|Cytogenetic resistance|0|||
23531955|NCT00079274|65683144|FG000|Overall Study|Other|43|||
23531956|NCT00079274|65683145|FG001|Overall Study|Other|7|||
23531957|NCT00079274|65683146|FG002|Overall Study|Other|5|||
23531958|NCT00079274|65683147|FG003|Overall Study|Other|55|||
23531959|NCT00079274|65683148|FG004|Overall Study|Other|1|||
23531960|NCT00079274|65683149|FG005|Overall Study|Other|2|||
23531961|NCT00079274|65683150|FG006|Overall Study|Other|0|||
23531962|NCT02919670|65683152|FG000|Overall Study|Only 17 participants met compliance|43|||
23531963|NCT02919670|65683153|FG001|Overall Study|Only 17 participants met compliance|39|||
23531964|NCT02489981|65683158|FG000|Overall Study|Adverse Event|21|||
23531965|NCT02489981|65683158|FG000|Overall Study|Insufficient effectiveness|16|||
23531966|NCT02489981|65683158|FG000|Overall Study|Improved|31|||
23531967|NCT02489981|65683158|FG000|Overall Study|Lost to Follow-up|31|||
23531968|NCT02489981|65683158|FG000|Overall Study|Other than listed|28|||
23531969|NCT02141516|65683159|FG000|Overall Study|Adverse Event|0|||
23531970|NCT02141516|65683160|FG001|Overall Study|Adverse Event|1|||
23531971|NCT02141516|65683161|FG002|Overall Study|Adverse Event|0|||
23531972|NCT02141516|65683159|FG000|Overall Study|Lost to Follow-up|0|||
23531973|NCT02141516|65683160|FG001|Overall Study|Lost to Follow-up|1|||
23531974|NCT02141516|65683161|FG002|Overall Study|Lost to Follow-up|0|||
23531975|NCT02141516|65683159|FG000|Overall Study|Other|0|||
23531976|NCT02141516|65683160|FG001|Overall Study|Other|3|||
23531977|NCT02141516|65683161|FG002|Overall Study|Other|0|||
23531978|NCT02556710|65683163|FG000|Overall Study|Surgical treatment|3|||
23531979|NCT02556710|65683164|FG001|Overall Study|Surgical treatment|0|||
23531980|NCT02556710|65683163|FG000|Overall Study|Required proscribed pain medication|2|||
23531981|NCT02556710|65683164|FG001|Overall Study|Required proscribed pain medication|1|||
23531982|NCT02556710|65683163|FG000|Overall Study|Lack of Efficacy|1|||
23531983|NCT02556710|65683164|FG001|Overall Study|Lack of Efficacy|0|||
23531984|NCT02556710|65683163|FG000|Overall Study|Worsening osteoarthritis|1|||
23531985|NCT02556710|65683164|FG001|Overall Study|Worsening osteoarthritis|0|||
23531986|NCT02556710|65683163|FG000|Overall Study|Moved out of state|1|||
23531987|NCT02556710|65683164|FG001|Overall Study|Moved out of state|0|||
23531988|NCT02556710|65683163|FG000|Overall Study|Missing reason|3|||
23531989|NCT02556710|65683164|FG001|Overall Study|Missing reason|1|||
23531990|NCT02556710|65683163|FG000|Overall Study|Pain as lack of efficacy|0|||
23531991|NCT02556710|65683164|FG001|Overall Study|Pain as lack of efficacy|4|||
23531992|NCT02376166|65683166|FG000|Overall Study|Adverse Event|1|||
23531993|NCT02376166|65683166|FG000|Overall Study|Discontinued metformin early|2|||
23531994|NCT02442830|65683171|FG000|Overall Study|Technical Failure|0|||
23531995|NCT02442830|65683172|FG001|Overall Study|Technical Failure|1|||
23531996|NCT01700179|65683175|FG000|Overall Study|Physician Decision|2|||
23531997|NCT02388737|65683176|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
23531998|NCT02388737|65683177|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
23531999|NCT02388737|65683178|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
23532000|NCT02388737|65683176|FG000|Overall Study|Major Protocol Deviation|18|||
23532001|NCT02388737|65683177|FG001|Overall Study|Major Protocol Deviation|25|||
23532002|NCT02388737|65683178|FG002|Overall Study|Major Protocol Deviation|22|||
23532003|NCT02388737|65683176|FG000|Overall Study|Lost to Follow-up|5|||
23532004|NCT02388737|65683177|FG001|Overall Study|Lost to Follow-up|1|||
23532005|NCT02388737|65683178|FG002|Overall Study|Lost to Follow-up|4|||
23532006|NCT02388737|65683176|FG000|Overall Study|Voluntary Withdrawal|10|||
23532007|NCT02388737|65683177|FG001|Overall Study|Voluntary Withdrawal|18|||
23532008|NCT02388737|65683178|FG002|Overall Study|Voluntary Withdrawal|17|||
23532009|NCT02388737|65683176|FG000|Overall Study|Lack of Efficacy|3|||
23532010|NCT02388737|65683177|FG001|Overall Study|Lack of Efficacy|0|||
23532011|NCT02388737|65683178|FG002|Overall Study|Lack of Efficacy|3|||
23532012|NCT02388737|65683176|FG000|Overall Study|Reason Not Specified|5|||
23532013|NCT02388737|65683177|FG001|Overall Study|Reason Not Specified|5|||
23532014|NCT02388737|65683178|FG002|Overall Study|Reason Not Specified|4|||
23532015|NCT03417141|65683179|FG000|Overall Study|Withdrawal by Subject|1|||
23532016|NCT03417141|65683179|FG000|Overall Study|Protocol Violation|3|||
23532017|NCT00458484|65683180|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
23613950|NCT00296504|65973256|FG000|Interim Analysis|Adverse Event|0|||
23613951|NCT00296504|65973257|FG001|Interim Analysis|Adverse Event|0|||
23613952|NCT00296504|65973258|FG002|Interim Analysis|Adverse Event|13|||
23613953|NCT00296504|65973259|FG003|Interim Analysis|Adverse Event|4|||
23613954|NCT00296504|65973260|FG004|Interim Analysis|Adverse Event|6|||
23613955|NCT00296504|65973261|FG005|Interim Analysis|Adverse Event|3|||
23613956|NCT00296504|65973262|FG006|Interim Analysis|Adverse Event|4|||
23613957|NCT00296504|65973263|FG007|Interim Analysis|Adverse Event|5|||
23310092|NCT00928707|64881324|FG001|Overall Study|Protocol Violation|0|||
23310093|NCT02933255|64881326|FG000|Overall Study|Discontinued due to study closure.|1|||
23310094|NCT02933255|64881327|FG001|Overall Study|Discontinued due to study closure.|0|||
23310095|NCT01161407|64881330|FG000|Overall Study|Protocol Violation|3|||
23310096|NCT01161407|64881331|FG001|Overall Study|Protocol Violation|1|||
23310097|NCT00351533|64881337|FG000|Overall Study|Extubated before first BAL|1|||
23532018|NCT00458484|65683181|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
23532019|NCT00458484|65683182|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
23532020|NCT00458484|65683183|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
23532021|NCT00458484|65683184|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
23532022|NCT00458484|65683185|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
23532023|NCT00458484|65683186|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
23532024|NCT03306264|65683187|FG000|Overall Study|Death|33|||
23532025|NCT03306264|65683188|FG001|Overall Study|Death|25|||
23532026|NCT03306264|65683189|FG002|Overall Study|Death|34|||
23532027|NCT03306264|65683190|FG003|Overall Study|Death|34|||
23532028|NCT03306264|65683187|FG000|Overall Study|Complete Consent Withdrawal|4|||
23532029|NCT03306264|65683188|FG001|Overall Study|Complete Consent Withdrawal|4|||
23532030|NCT03306264|65683189|FG002|Overall Study|Complete Consent Withdrawal|1|||
23532031|NCT03306264|65683190|FG003|Overall Study|Complete Consent Withdrawal|8|||
23532032|NCT03306264|65683187|FG000|Overall Study|Lost to Follow-up|1|||
23532033|NCT03306264|65683188|FG001|Overall Study|Lost to Follow-up|0|||
23532034|NCT03306264|65683189|FG002|Overall Study|Lost to Follow-up|1|||
23532035|NCT03306264|65683190|FG003|Overall Study|Lost to Follow-up|0|||
23532036|NCT03306264|65683187|FG000|Overall Study|Rollover to ASTX727-06|10|||
23532037|NCT03306264|65683188|FG001|Overall Study|Rollover to ASTX727-06|18|||
23532038|NCT03306264|65683189|FG002|Overall Study|Rollover to ASTX727-06|4|||
23532039|NCT03306264|65683190|FG003|Overall Study|Rollover to ASTX727-06|2|||
23532040|NCT03306264|65683187|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
23532041|NCT03306264|65683188|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
23532042|NCT03306264|65683189|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
23532043|NCT03306264|65683190|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
23532044|NCT02985736|65683191|FG000|Overall Study|Lost to Follow-up|3|||
23532045|NCT00667342|65683193|FG000|Overall Study|Protocol Violation|1|||
23532046|NCT00667342|65683194|FG001|Overall Study|Protocol Violation|0|||
23532047|NCT00667342|65683195|FG002|Overall Study|Protocol Violation|0|||
23532048|NCT00667342|65683193|FG000|Overall Study|Withdrawal by Subject|1|||
23532049|NCT00667342|65683194|FG001|Overall Study|Withdrawal by Subject|0|||
23532050|NCT00667342|65683195|FG002|Overall Study|Withdrawal by Subject|0|||
23532051|NCT00667342|65683193|FG000|Overall Study|Physician Decision|3|||
23532052|NCT00667342|65683194|FG001|Overall Study|Physician Decision|0|||
23532053|NCT00667342|65683195|FG002|Overall Study|Physician Decision|0|||
23532054|NCT00667342|65683193|FG000|Overall Study|Relapse or tumor progression|9|||
23532055|NCT00667342|65683194|FG001|Overall Study|Relapse or tumor progression|0|||
23532056|NCT00667342|65683195|FG002|Overall Study|Relapse or tumor progression|7|||
23532057|NCT00667342|65683193|FG000|Overall Study|Adverse Event|0|||
23532058|NCT00667342|65683194|FG001|Overall Study|Adverse Event|0|||
23532059|NCT00667342|65683195|FG002|Overall Study|Adverse Event|1|||
23532060|NCT00667342|65683193|FG000|Overall Study|Ineligible|0|||
23532061|NCT00667342|65683194|FG001|Overall Study|Ineligible|0|||
23532062|NCT00667342|65683195|FG002|Overall Study|Ineligible|1|||
23532063|NCT00550836|65683197|FG000|Overall Study|Withdrawal by Subject|3|||
23532064|NCT00550836|65683198|FG001|Overall Study|Withdrawal by Subject|9|||
23532065|NCT01545817|65683199|FG000|Pazopanib|Disease progression|51|||
23532066|NCT01545817|65683200|FG001|Pazopanib|Disease progression|0|||
23532067|NCT01545817|65683199|FG000|Pazopanib|Adverse Event|19|||
23532068|NCT01545817|65683200|FG001|Pazopanib|Adverse Event|0|||
23532069|NCT01545817|65683199|FG000|Pazopanib|Other reason|4|||
23532070|NCT01545817|65683200|FG001|Pazopanib|Other reason|0|||
23532071|NCT01545817|65683199|FG000|Everolimus|Other reason|0|||
23532072|NCT01545817|65683200|FG001|Everolimus|Other reason|7|||
23532073|NCT01545817|65683199|FG000|Everolimus|Disease progression|0|||
23532074|NCT01545817|65683200|FG001|Everolimus|Disease progression|25|||
23532075|NCT01545817|65683199|FG000|Everolimus|Adverse Event|0|||
23532076|NCT01545817|65683200|FG001|Everolimus|Adverse Event|6|||
23532077|NCT03252522|65683201|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
23310098|NCT00351533|64881338|FG001|Overall Study|Extubated before first BAL|0|||
23310099|NCT00351533|64881337|FG000|Overall Study|Lost to Follow-up|1|||
23532078|NCT03252522|65683202|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
23207654|NCT02953782|64498254|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
23207655|NCT02953782|64498255|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
23207656|NCT02953782|64498256|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
23207657|NCT02953782|64498249|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23207658|NCT02953782|64498250|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23207659|NCT02953782|64498251|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23207660|NCT02953782|64498252|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23207661|NCT02953782|64498253|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
23207662|NCT02953782|64498254|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
23310100|NCT00351533|64881338|FG001|Overall Study|Lost to Follow-up|3|||
23310101|NCT00351533|64881337|FG000|Overall Study|Physician Decision|0|||
23310102|NCT00351533|64881338|FG001|Overall Study|Physician Decision|1|||
23310103|NCT00351533|64881337|FG000|Overall Study|Withdrawal by Subject|0|||
23310104|NCT00351533|64881338|FG001|Overall Study|Withdrawal by Subject|1|||
23310105|NCT02521376|64881342|FG000|Overall Study|Enrolled, But Not Treated|1|||
23310106|NCT02521376|64881343|FG001|Overall Study|Enrolled, But Not Treated|0|||
23310107|NCT02521376|64881344|FG002|Overall Study|Enrolled, But Not Treated|0|||
23310108|NCT02521376|64881345|FG003|Overall Study|Enrolled, But Not Treated|0|||
23310109|NCT00969540|64881346|FG000|Overall Study|Lost to Follow-up|1|||
23310110|NCT00969540|64881347|FG001|Overall Study|Lost to Follow-up|1|||
23310111|NCT04007991|64881348|FG000|Overall Study|Withdrawal by Subject|1|||
23310112|NCT04007991|64881349|FG001|Overall Study|Withdrawal by Subject|1|||
23310113|NCT04007991|64881348|FG000|Overall Study|Physician Decision|1|||
23310114|NCT04007991|64881349|FG001|Overall Study|Physician Decision|1|||
23310115|NCT04007991|64881348|FG000|Overall Study|Non-compliance with Study Drug|0|||
23310116|NCT04007991|64881349|FG001|Overall Study|Non-compliance with Study Drug|1|||
23310117|NCT04007991|64881348|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
23310118|NCT04007991|64881349|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
23310119|NCT04007991|64881348|FG000|Overall Study|Adverse event, non-fatal|5|||
23310120|NCT04007991|64881349|FG001|Overall Study|Adverse event, non-fatal|0|||
23310121|NCT04007991|64881348|FG000|Overall Study|Lost to Follow-up|2|||
23310122|NCT04007991|64881349|FG001|Overall Study|Lost to Follow-up|1|||
23310123|NCT00699283|64881351|FG000|Overall Study|Lack of Efficacy|15|||
23310124|NCT00699283|64881352|FG001|Overall Study|Lack of Efficacy|5|||
23420365|NCT00075725|65283760|FG005|Overall Study|Pt went to transplant|1|||
23420366|NCT00075725|65283761|FG006|Overall Study|Pt went to transplant|0|||
23420367|NCT00075725|65283762|FG007|Overall Study|Pt went to transplant|0|||
23420368|NCT00075725|65283763|FG008|Overall Study|Pt went to transplant|0|||
23207663|NCT02953782|64498255|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
23207664|NCT02953782|64498256|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
23207665|NCT02953782|64498249|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23310125|NCT00699283|64881351|FG000|Overall Study|Lost to Follow-up|2|||
23310126|NCT00699283|64881352|FG001|Overall Study|Lost to Follow-up|0|||
23310127|NCT00699283|64881351|FG000|Overall Study|Withdrawal by Subject|1|||
23310128|NCT00699283|64881352|FG001|Overall Study|Withdrawal by Subject|0|||
23310129|NCT00699283|64881351|FG000|Overall Study|Other Reason|5|||
23420369|NCT00075725|65283764|FG009|Overall Study|Pt went to transplant|0|||
23420370|NCT00075725|65283765|FG010|Overall Study|Pt went to transplant|0|||
23420371|NCT00075725|65283766|FG011|Overall Study|Pt went to transplant|0|||
23420372|NCT00075725|65283755|FG000|Overall Study|Pt received additional steroids|0|||
23310130|NCT00699283|64881352|FG001|Overall Study|Other Reason|1|||
23310131|NCT00699283|64881351|FG000|Overall Study|SAE, non-fatal|1|||
23310132|NCT00699283|64881352|FG001|Overall Study|SAE, non-fatal|1|||
23310133|NCT00699283|64881351|FG000|Overall Study|AE, non-serious non-fatal|8|||
23310134|NCT00699283|64881352|FG001|Overall Study|AE, non-serious non-fatal|1|||
23310135|NCT00699283|64881351|FG000|Overall Study|AE of unknown type|1|||
23310136|NCT00699283|64881352|FG001|Overall Study|AE of unknown type|0|||
23310137|NCT03186781|64881353|FG000|Overall Study|Lost to Follow-up|0|||
23310138|NCT03186781|64881354|FG001|Overall Study|Lost to Follow-up|0|||
23310139|NCT03186781|64881355|FG002|Overall Study|Lost to Follow-up|1|||
23310140|NCT03186781|64881356|FG003|Overall Study|Lost to Follow-up|0|||
23310141|NCT03186781|64881357|FG004|Overall Study|Lost to Follow-up|1|||
23310142|NCT03186781|64881358|FG005|Overall Study|Lost to Follow-up|0|||
23310143|NCT03186781|64881353|FG000|Overall Study|Moved from Area|0|||
23310144|NCT03186781|64881354|FG001|Overall Study|Moved from Area|0|||
23310145|NCT03186781|64881355|FG002|Overall Study|Moved from Area|0|||
23310146|NCT03186781|64881356|FG003|Overall Study|Moved from Area|0|||
23310147|NCT03186781|64881357|FG004|Overall Study|Moved from Area|1|||
23310148|NCT03186781|64881358|FG005|Overall Study|Moved from Area|0|||
23310149|NCT03186781|64881353|FG000|Overall Study|Withdrawal by Subject|0|||
23310150|NCT03186781|64881354|FG001|Overall Study|Withdrawal by Subject|0|||
23310151|NCT03186781|64881355|FG002|Overall Study|Withdrawal by Subject|0|||
23310152|NCT03186781|64881356|FG003|Overall Study|Withdrawal by Subject|0|||
23310153|NCT03186781|64881357|FG004|Overall Study|Withdrawal by Subject|1|||
23310154|NCT03186781|64881358|FG005|Overall Study|Withdrawal by Subject|0|||
23310155|NCT00537303|64881361|FG000|Overall Study|Adverse Event|1|||
23310156|NCT00537303|64881362|FG001|Overall Study|Adverse Event|4|||
23310157|NCT00537303|64881361|FG000|Overall Study|Lack of Efficacy|6|||
23310158|NCT00537303|64881362|FG001|Overall Study|Lack of Efficacy|7|||
23310159|NCT00537303|64881361|FG000|Overall Study|Protocol Violation|8|||
23310160|NCT00537303|64881362|FG001|Overall Study|Protocol Violation|4|||
23310161|NCT00537303|64881361|FG000|Overall Study|Withdrawal criteria|3|||
23310162|NCT00537303|64881362|FG001|Overall Study|Withdrawal criteria|3|||
23310163|NCT00537303|64881361|FG000|Overall Study|Unclassified|8|||
23310164|NCT00537303|64881362|FG001|Overall Study|Unclassified|7|||
23310165|NCT02092467|64881366|FG000|Overall Study|Death|49|||
23310166|NCT02092467|64881367|FG001|Overall Study|Death|66|||
23310167|NCT02092467|64881368|FG002|Overall Study|Death|38|||
23310168|NCT02092467|64881366|FG000|Overall Study|Lost to Follow-up|38|||
23310169|NCT02092467|64881367|FG001|Overall Study|Lost to Follow-up|35|||
23310170|NCT02092467|64881368|FG002|Overall Study|Lost to Follow-up|40|||
23310171|NCT02092467|64881366|FG000|Overall Study|Global Deterioration of Health Status|1|||
23310172|NCT02092467|64881367|FG001|Overall Study|Global Deterioration of Health Status|0|||
23310173|NCT02092467|64881368|FG002|Overall Study|Global Deterioration of Health Status|0|||
23310174|NCT02092467|64881366|FG000|Overall Study|Other|32|||
23310175|NCT02092467|64881367|FG001|Overall Study|Other|30|||
23310176|NCT02092467|64881368|FG002|Overall Study|Other|24|||
23310177|NCT02092467|64881366|FG000|Overall Study|Withdrawal by Subject|282|||
23310178|NCT02092467|64881367|FG001|Overall Study|Withdrawal by Subject|327|||
23310179|NCT02092467|64881368|FG002|Overall Study|Withdrawal by Subject|289|||
23310180|NCT02092467|64881366|FG000|Overall Study|Randomized but not treated|2|||
23310181|NCT02092467|64881367|FG001|Overall Study|Randomized but not treated|1|||
23310182|NCT02092467|64881368|FG002|Overall Study|Randomized but not treated|7|||
23310183|NCT00642278|64881369|FG000|Overall Study|Adverse Event|2|||
23310184|NCT00642278|64881370|FG001|Overall Study|Adverse Event|1|||
23310185|NCT00642278|64881371|FG002|Overall Study|Adverse Event|3|||
23310186|NCT00642278|64881372|FG003|Overall Study|Adverse Event|1|||
23310187|NCT00642278|64881373|FG004|Overall Study|Adverse Event|2|||
23310188|NCT00642278|64881374|FG005|Overall Study|Adverse Event|2|||
23310189|NCT00642278|64881375|FG006|Overall Study|Adverse Event|0|||
23310190|NCT00642278|64881369|FG000|Overall Study|Lack of Efficacy|0|||
23310191|NCT00642278|64881370|FG001|Overall Study|Lack of Efficacy|1|||
23310192|NCT00642278|64881371|FG002|Overall Study|Lack of Efficacy|0|||
23532079|NCT03252522|65683203|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
23207666|NCT02953782|64498250|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23310193|NCT00642278|64881372|FG003|Overall Study|Lack of Efficacy|0|||
23310194|NCT00642278|64881373|FG004|Overall Study|Lack of Efficacy|0|||
23310195|NCT00642278|64881374|FG005|Overall Study|Lack of Efficacy|0|||
23310196|NCT00642278|64881375|FG006|Overall Study|Lack of Efficacy|0|||
23310197|NCT00642278|64881369|FG000|Overall Study|Lost to Follow-up|5|||
23310198|NCT00642278|64881370|FG001|Overall Study|Lost to Follow-up|1|||
23310199|NCT00642278|64881371|FG002|Overall Study|Lost to Follow-up|0|||
23310200|NCT00642278|64881372|FG003|Overall Study|Lost to Follow-up|1|||
23310201|NCT00642278|64881373|FG004|Overall Study|Lost to Follow-up|0|||
23310202|NCT00642278|64881374|FG005|Overall Study|Lost to Follow-up|1|||
23310203|NCT00642278|64881375|FG006|Overall Study|Lost to Follow-up|1|||
23310204|NCT00642278|64881369|FG000|Overall Study|Physician Decision|0|||
23310205|NCT00642278|64881370|FG001|Overall Study|Physician Decision|0|||
23310206|NCT00642278|64881371|FG002|Overall Study|Physician Decision|0|||
23310207|NCT00642278|64881372|FG003|Overall Study|Physician Decision|1|||
23310208|NCT00642278|64881373|FG004|Overall Study|Physician Decision|0|||
23310209|NCT00642278|64881374|FG005|Overall Study|Physician Decision|0|||
23310210|NCT00642278|64881375|FG006|Overall Study|Physician Decision|0|||
23310211|NCT00642278|64881369|FG000|Overall Study|Protocol Violation|0|||
23310212|NCT00642278|64881370|FG001|Overall Study|Protocol Violation|0|||
23310213|NCT00642278|64881371|FG002|Overall Study|Protocol Violation|1|||
23310214|NCT00642278|64881372|FG003|Overall Study|Protocol Violation|1|||
23310215|NCT00642278|64881373|FG004|Overall Study|Protocol Violation|0|||
23207667|NCT02953782|64498251|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23207668|NCT02953782|64498252|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23207669|NCT02953782|64498253|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
23207670|NCT02953782|64498254|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
23207671|NCT02953782|64498255|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
23207672|NCT02953782|64498256|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
23310216|NCT00642278|64881374|FG005|Overall Study|Protocol Violation|1|||
23310217|NCT00642278|64881375|FG006|Overall Study|Protocol Violation|2|||
23310218|NCT00642278|64881369|FG000|Overall Study|Withdrawal by Subject|1|||
23310219|NCT00642278|64881370|FG001|Overall Study|Withdrawal by Subject|1|||
23310220|NCT00642278|64881371|FG002|Overall Study|Withdrawal by Subject|1|||
23310221|NCT00642278|64881372|FG003|Overall Study|Withdrawal by Subject|3|||
23310222|NCT00642278|64881373|FG004|Overall Study|Withdrawal by Subject|6|||
23207673|NCT02953782|64498249|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23207674|NCT02953782|64498250|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23207675|NCT02953782|64498251|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23207676|NCT02953782|64498252|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23207677|NCT02953782|64498253|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23207678|NCT02953782|64498254|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23207679|NCT02953782|64498255|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
23207680|NCT02953782|64498256|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
23207681|NCT00789958|64498261|FG000|Overall Study|Adverse Event|3|||
23207682|NCT00789958|64498261|FG000|Overall Study|Withdrawal by Subject|4|||
23207683|NCT00789958|64498261|FG000|Overall Study|Progression|3|||
23207684|NCT00789958|64498261|FG000|Overall Study|not protocol specified|1|||
23207685|NCT00789958|64498261|FG000|Overall Study|Not eligible/not analyzable|26|||
23207686|NCT01429792|64498262|FG000|Overall Study|Other Reasons|67|||
23207687|NCT01429792|64498262|FG000|Overall Study|Unknown Disposition|94|||
23207688|NCT01429792|64498262|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
23207689|NCT01429792|64498262|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
23207690|NCT01429792|64498262|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
23207691|NCT01429792|64498262|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
23207692|NCT01429792|64498262|FG000|Overall Study|Withdrawal by Subject|70|||
23207693|NCT01429792|64498262|FG000|Overall Study|Lost to Follow-up|88|||
23207694|NCT02112916|64498263|FG000|Overall Study|Adverse Event|6|||
23207695|NCT02112916|64498264|FG001|Overall Study|Adverse Event|9|||
23207696|NCT02112916|64498265|FG002|Overall Study|Adverse Event|3|||
23207697|NCT02112916|64498266|FG003|Overall Study|Adverse Event|2|||
23207698|NCT02112916|64498263|FG000|Overall Study|Death|9|||
23207699|NCT02112916|64498264|FG001|Overall Study|Death|9|||
23207700|NCT02112916|64498265|FG002|Overall Study|Death|3|||
23207701|NCT02112916|64498266|FG003|Overall Study|Death|4|||
23207702|NCT02112916|64498263|FG000|Overall Study|Lost to Follow-up|1|||
23207703|NCT02112916|64498264|FG001|Overall Study|Lost to Follow-up|0|||
23207704|NCT02112916|64498265|FG002|Overall Study|Lost to Follow-up|0|||
23207705|NCT02112916|64498266|FG003|Overall Study|Lost to Follow-up|0|||
23207706|NCT02112916|64498263|FG000|Overall Study|Physician Decision|94|||
23207707|NCT02112916|64498264|FG001|Overall Study|Physician Decision|72|||
23207708|NCT02112916|64498265|FG002|Overall Study|Physician Decision|24|||
23207709|NCT02112916|64498266|FG003|Overall Study|Physician Decision|15|||
23207710|NCT02112916|64498263|FG000|Overall Study|Withdrawal by Subject|5|||
23207711|NCT02112916|64498264|FG001|Overall Study|Withdrawal by Subject|3|||
23207712|NCT02112916|64498265|FG002|Overall Study|Withdrawal by Subject|1|||
23207713|NCT02112916|64498266|FG003|Overall Study|Withdrawal by Subject|1|||
23310223|NCT00642278|64881374|FG005|Overall Study|Withdrawal by Subject|2|||
23310224|NCT00642278|64881375|FG006|Overall Study|Withdrawal by Subject|2|||
23310225|NCT00642278|64881369|FG000|Overall Study|Noncompliance with study drug regimen|0|||
23310226|NCT00642278|64881370|FG001|Overall Study|Noncompliance with study drug regimen|0|||
23310227|NCT00642278|64881371|FG002|Overall Study|Noncompliance with study drug regimen|0|||
23310228|NCT00642278|64881372|FG003|Overall Study|Noncompliance with study drug regimen|1|||
23310229|NCT00642278|64881373|FG004|Overall Study|Noncompliance with study drug regimen|0|||
23310230|NCT00642278|64881374|FG005|Overall Study|Noncompliance with study drug regimen|0|||
23310231|NCT00642278|64881375|FG006|Overall Study|Noncompliance with study drug regimen|0|||
23310232|NCT00642278|64881369|FG000|Overall Study|Other|2|||
23310233|NCT00642278|64881370|FG001|Overall Study|Other|1|||
23310234|NCT00642278|64881371|FG002|Overall Study|Other|0|||
23310235|NCT00642278|64881372|FG003|Overall Study|Other|1|||
23310236|NCT00642278|64881373|FG004|Overall Study|Other|0|||
23310237|NCT00642278|64881374|FG005|Overall Study|Other|1|||
23310238|NCT00642278|64881375|FG006|Overall Study|Other|0|||
23310239|NCT01687478|64881376|FG000|Overall Study|Adverse Event|3|||
23310240|NCT01687478|64881377|FG001|Overall Study|Adverse Event|10|||
23310241|NCT01687478|64881376|FG000|Overall Study|Lost to Follow-up|1|||
23310242|NCT01687478|64881377|FG001|Overall Study|Lost to Follow-up|3|||
23310243|NCT01687478|64881376|FG000|Overall Study|Protocol Violation|0|||
23310244|NCT01687478|64881377|FG001|Overall Study|Protocol Violation|2|||
23310245|NCT01687478|64881376|FG000|Overall Study|Withdrawal by Subject|21|||
23310246|NCT01687478|64881377|FG001|Overall Study|Withdrawal by Subject|19|||
23310247|NCT01687478|64881376|FG000|Overall Study|Physician Decision|1|||
23310248|NCT01687478|64881377|FG001|Overall Study|Physician Decision|3|||
23310249|NCT01687478|64881376|FG000|Overall Study|Entry Criteria Not Met|6|||
23310250|NCT01687478|64881377|FG001|Overall Study|Entry Criteria Not Met|2|||
23310251|NCT02728843|64881381|FG000|Overall Study|Adverse Event|0|||
23310252|NCT02728843|64881382|FG001|Overall Study|Adverse Event|2|||
23310253|NCT02728843|64881383|FG002|Overall Study|Adverse Event|3|||
23310254|NCT02728843|64881384|FG003|Overall Study|Adverse Event|1|||
23310255|NCT02728843|64881385|FG004|Overall Study|Adverse Event|2|||
23310256|NCT02728843|64881381|FG000|Overall Study|Lack of Efficacy|0|||
23310257|NCT02728843|64881382|FG001|Overall Study|Lack of Efficacy|1|||
23310258|NCT02728843|64881383|FG002|Overall Study|Lack of Efficacy|1|||
23310259|NCT02728843|64881384|FG003|Overall Study|Lack of Efficacy|0|||
23310260|NCT02728843|64881385|FG004|Overall Study|Lack of Efficacy|0|||
23310261|NCT02728843|64881381|FG000|Overall Study|Protocol Violation|2|||
23310262|NCT02728843|64881382|FG001|Overall Study|Protocol Violation|0|||
23310263|NCT02728843|64881383|FG002|Overall Study|Protocol Violation|4|||
23310264|NCT02728843|64881384|FG003|Overall Study|Protocol Violation|2|||
23310265|NCT02728843|64881385|FG004|Overall Study|Protocol Violation|2|||
23310266|NCT02728843|64881381|FG000|Overall Study|Withdrawal by Subject|1|||
23310267|NCT02728843|64881382|FG001|Overall Study|Withdrawal by Subject|0|||
23310268|NCT02728843|64881383|FG002|Overall Study|Withdrawal by Subject|0|||
23310269|NCT02728843|64881384|FG003|Overall Study|Withdrawal by Subject|1|||
23310270|NCT02728843|64881385|FG004|Overall Study|Withdrawal by Subject|0|||
23310271|NCT02728843|64881381|FG000|Overall Study|Use of rescue medication|0|||
23310272|NCT02728843|64881382|FG001|Overall Study|Use of rescue medication|2|||
23310273|NCT02728843|64881383|FG002|Overall Study|Use of rescue medication|0|||
23310274|NCT02728843|64881384|FG003|Overall Study|Use of rescue medication|2|||
23310275|NCT02728843|64881385|FG004|Overall Study|Use of rescue medication|1|||
23310276|NCT00922272|64881388|FG000|Open-label Phase|Adverse Event|5|||
23310277|NCT00922272|64881389|FG001|Open-label Phase|Adverse Event|0|||
23310278|NCT00922272|64881388|FG000|Open-label Phase|Protocol Violation|1|||
23310279|NCT00922272|64881389|FG001|Open-label Phase|Protocol Violation|0|||
23310280|NCT00922272|64881388|FG000|Open-label Phase|Withdrawal by Subject|11|||
23310281|NCT00922272|64881389|FG001|Open-label Phase|Withdrawal by Subject|0|||
23310282|NCT00922272|64881388|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
23310283|NCT00922272|64881389|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
23310284|NCT00922272|64881388|FG000|Open-label Phase|Withdrawal criteria met|5|||
23310285|NCT00922272|64881389|FG001|Open-label Phase|Withdrawal criteria met|0|||
23310286|NCT00922272|64881388|FG000|Double-blind Phase|Adverse Event|1|||
23310287|NCT00922272|64881389|FG001|Double-blind Phase|Adverse Event|1|||
23310288|NCT00922272|64881388|FG000|Double-blind Phase|Withdrawal by Subject|1|||
23310289|NCT00922272|64881389|FG001|Double-blind Phase|Withdrawal by Subject|1|||
23310290|NCT00922272|64881388|FG000|Double-blind Phase|Lost to Follow-up|2|||
23310291|NCT00922272|64881389|FG001|Double-blind Phase|Lost to Follow-up|1|||
23310292|NCT00922272|64881388|FG000|Double-blind Phase|Withdrawal criteria met|1|||
23310293|NCT00922272|64881389|FG001|Double-blind Phase|Withdrawal criteria met|1|||
23310294|NCT00922272|64881388|FG000|Double-blind Phase|Noncompliance|1|||
23310295|NCT00922272|64881389|FG001|Double-blind Phase|Noncompliance|1|||
23310296|NCT00922272|64881388|FG000|Double-blind Phase|Positive urine drug screen|1|||
23310297|NCT00922272|64881389|FG001|Double-blind Phase|Positive urine drug screen|1|||
23310298|NCT01377987|64881392|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
23310299|NCT01377987|64881393|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
23310300|NCT01140503|64881394|FG000|Overall Study|Withdrawal by Subject|1|||
23420373|NCT00075725|65283756|FG001|Overall Study|Pt received additional steroids|0|||
23420374|NCT00075725|65283757|FG002|Overall Study|Pt received additional steroids|0|||
23420375|NCT00075725|65283758|FG003|Overall Study|Pt received additional steroids|1|||
23420376|NCT00075725|65283759|FG004|Overall Study|Pt received additional steroids|0|||
23420377|NCT00075725|65283760|FG005|Overall Study|Pt received additional steroids|0|||
23420378|NCT00075725|65283761|FG006|Overall Study|Pt received additional steroids|0|||
23420379|NCT00075725|65283762|FG007|Overall Study|Pt received additional steroids|0|||
23420380|NCT00075725|65283763|FG008|Overall Study|Pt received additional steroids|0|||
23420381|NCT00075725|65283764|FG009|Overall Study|Pt received additional steroids|0|||
23420382|NCT00075725|65283765|FG010|Overall Study|Pt received additional steroids|0|||
23420383|NCT00075725|65283766|FG011|Overall Study|Pt received additional steroids|0|||
23420384|NCT00075725|65283755|FG000|Overall Study|Pt relocated|0|||
23420385|NCT00075725|65283756|FG001|Overall Study|Pt relocated|0|||
23420386|NCT00075725|65283757|FG002|Overall Study|Pt relocated|0|||
23420387|NCT00075725|65283758|FG003|Overall Study|Pt relocated|2|||
23420388|NCT00075725|65283759|FG004|Overall Study|Pt relocated|0|||
23420389|NCT00075725|65283760|FG005|Overall Study|Pt relocated|1|||
23420390|NCT00075725|65283761|FG006|Overall Study|Pt relocated|1|||
23420391|NCT00075725|65283762|FG007|Overall Study|Pt relocated|2|||
23420392|NCT00075725|65283763|FG008|Overall Study|Pt relocated|1|||
23420393|NCT00075725|65283764|FG009|Overall Study|Pt relocated|0|||
23420394|NCT00075725|65283765|FG010|Overall Study|Pt relocated|0|||
23420395|NCT00075725|65283766|FG011|Overall Study|Pt relocated|0|||
23420396|NCT00075725|65283755|FG000|Overall Study|Institution Terminated|0|||
23420397|NCT00075725|65283756|FG001|Overall Study|Institution Terminated|0|||
23420398|NCT00075725|65283757|FG002|Overall Study|Institution Terminated|0|||
23420399|NCT00075725|65283758|FG003|Overall Study|Institution Terminated|0|||
23420400|NCT00075725|65283759|FG004|Overall Study|Institution Terminated|1|||
23420401|NCT00075725|65283760|FG005|Overall Study|Institution Terminated|0|||
23420402|NCT00075725|65283761|FG006|Overall Study|Institution Terminated|0|||
23420403|NCT00075725|65283762|FG007|Overall Study|Institution Terminated|3|||
23420404|NCT00075725|65283763|FG008|Overall Study|Institution Terminated|0|||
23420405|NCT00075725|65283764|FG009|Overall Study|Institution Terminated|0|||
23420406|NCT00075725|65283765|FG010|Overall Study|Institution Terminated|0|||
23420407|NCT00075725|65283766|FG011|Overall Study|Institution Terminated|0|||
23420408|NCT00075725|65283755|FG000|Overall Study|Study Closure|1|||
23420409|NCT00075725|65283756|FG001|Overall Study|Study Closure|0|||
23420410|NCT00075725|65283757|FG002|Overall Study|Study Closure|0|||
23420411|NCT00075725|65283758|FG003|Overall Study|Study Closure|0|||
23420412|NCT00075725|65283759|FG004|Overall Study|Study Closure|1|||
23420413|NCT00075725|65283760|FG005|Overall Study|Study Closure|3|||
23420414|NCT00075725|65283761|FG006|Overall Study|Study Closure|0|||
23420415|NCT00075725|65283762|FG007|Overall Study|Study Closure|1|||
23420416|NCT00075725|65283763|FG008|Overall Study|Study Closure|0|||
23420417|NCT00075725|65283764|FG009|Overall Study|Study Closure|0|||
23420418|NCT00075725|65283765|FG010|Overall Study|Study Closure|0|||
23420419|NCT00075725|65283766|FG011|Overall Study|Study Closure|0|||
23420420|NCT00075725|65283755|FG000|Overall Study|Other complications|0|||
23420421|NCT00075725|65283756|FG001|Overall Study|Other complications|0|||
23420422|NCT00075725|65283757|FG002|Overall Study|Other complications|0|||
23420423|NCT00075725|65283758|FG003|Overall Study|Other complications|0|||
23420424|NCT00075725|65283759|FG004|Overall Study|Other complications|0|||
23310301|NCT02564211|64881397|FG000|Overall Study|Adverse Event|4|||
23420425|NCT00075725|65283760|FG005|Overall Study|Other complications|1|||
23420426|NCT00075725|65283761|FG006|Overall Study|Other complications|0|||
23420427|NCT00075725|65283762|FG007|Overall Study|Other complications|0|||
23420428|NCT00075725|65283763|FG008|Overall Study|Other complications|0|||
23420429|NCT00075725|65283764|FG009|Overall Study|Other complications|0|||
23420430|NCT00075725|65283765|FG010|Overall Study|Other complications|0|||
23420431|NCT00075725|65283766|FG011|Overall Study|Other complications|0|||
23420432|NCT00075725|65283755|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
23420433|NCT00075725|65283756|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
23420434|NCT00075725|65283757|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
23532080|NCT03252522|65683201|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
23532081|NCT03252522|65683202|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
23420435|NCT00075725|65283758|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
23420436|NCT00075725|65283759|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
23420437|NCT00075725|65283760|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
23420438|NCT00075725|65283761|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
23420439|NCT00075725|65283762|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
23420440|NCT00075725|65283763|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
23420441|NCT00075725|65283764|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
23420442|NCT00075725|65283765|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
23420443|NCT00075725|65283766|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
23420444|NCT00075725|65283755|FG000|Overall Study|Pt incarcerated|0|||
23420445|NCT00075725|65283756|FG001|Overall Study|Pt incarcerated|0|||
23420446|NCT00075725|65283757|FG002|Overall Study|Pt incarcerated|0|||
23420447|NCT00075725|65283758|FG003|Overall Study|Pt incarcerated|0|||
23420448|NCT00075725|65283759|FG004|Overall Study|Pt incarcerated|0|||
23420449|NCT00075725|65283760|FG005|Overall Study|Pt incarcerated|0|||
23420450|NCT00075725|65283761|FG006|Overall Study|Pt incarcerated|0|||
23420451|NCT00075725|65283762|FG007|Overall Study|Pt incarcerated|1|||
23420452|NCT00075725|65283763|FG008|Overall Study|Pt incarcerated|0|||
23420453|NCT00075725|65283764|FG009|Overall Study|Pt incarcerated|0|||
23420454|NCT00075725|65283765|FG010|Overall Study|Pt incarcerated|0|||
23420455|NCT00075725|65283766|FG011|Overall Study|Pt incarcerated|0|||
23420456|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
23420457|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
23420458|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
23420459|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
23420460|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
23420461|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
23420462|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
23420463|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420464|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420465|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420466|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
23420467|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
23420468|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420469|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420470|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420471|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420472|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420473|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
23420474|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
23420475|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420476|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
23420477|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420478|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420479|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
23420480|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
23420481|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420482|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420483|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23613958|NCT00296504|65973264|FG008|Interim Analysis|Adverse Event|0|||
23613959|NCT00296504|65973256|FG000|Interim Analysis|Protocol Violation|0|||
23613960|NCT00296504|65973257|FG001|Interim Analysis|Protocol Violation|0|||
23207714|NCT02112916|64498263|FG000|Overall Study|Ineligible|4|||
23420484|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420485|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420486|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420487|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420488|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420489|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420490|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420491|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
23420492|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420493|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420494|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
23420495|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420496|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420497|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420498|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420499|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420500|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420501|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420502|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420503|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420504|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420505|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420506|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420507|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420508|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420509|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
23420510|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420511|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420512|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
23420513|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420514|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420515|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420516|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420517|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420518|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420519|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420520|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420521|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420522|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23532082|NCT03252522|65683203|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
23532083|NCT03252522|65683201|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
23532084|NCT03252522|65683202|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
23532085|NCT03252522|65683203|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
23532086|NCT03252522|65683201|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
23532087|NCT03252522|65683202|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
23532088|NCT03252522|65683203|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
23532089|NCT03252522|65683201|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
23532090|NCT03252522|65683202|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
23532091|NCT03252522|65683203|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
23532092|NCT03252522|65683201|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
23532093|NCT03252522|65683202|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
23532094|NCT03252522|65683203|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
23532095|NCT03252522|65683201|FG000|Phase 2: Open Label|Adverse Event|0|||
23532096|NCT03252522|65683202|FG001|Phase 2: Open Label|Adverse Event|0|||
23532097|NCT03252522|65683203|FG002|Phase 2: Open Label|Adverse Event|2|||
23420523|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420524|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420525|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420526|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420527|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
23420528|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420529|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420530|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420531|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420532|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420533|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420534|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420535|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420536|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420537|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420538|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
23420539|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420540|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420541|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420542|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420543|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420544|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420545|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
23420546|NCT03447314|65283767|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420547|NCT03447314|65283768|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420548|NCT03447314|65283769|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420549|NCT03447314|65283770|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
23420550|NCT03447314|65283771|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420551|NCT03447314|65283772|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
23420552|NCT03447314|65283773|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420553|NCT03447314|65283774|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420554|NCT03447314|65283775|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420555|NCT03447314|65283776|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420556|NCT03447314|65283777|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420557|NCT03447314|65283778|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420558|NCT03447314|65283779|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420559|NCT03447314|65283780|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420560|NCT03447314|65283781|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420561|NCT03447314|65283782|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420562|NCT03447314|65283783|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420563|NCT03447314|65283784|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
23420564|NCT01271010|65283785|FG000|Overall Study|Reason not specified|11|||
23420565|NCT01271010|65283785|FG000|Overall Study|Start of new CLL therapy|1|||
23420566|NCT01271010|65283785|FG000|Overall Study|Protocol Violation|1|||
23420567|NCT01271010|65283785|FG000|Overall Study|Death|2|||
23420568|NCT01271010|65283785|FG000|Overall Study|Progression and relapse of disease|1|||
23420569|NCT01271010|65283785|FG000|Overall Study|Withdrawal by Subject|18|||
23420570|NCT01271010|65283785|FG000|Overall Study|Disease progression|27|||
23420571|NCT02927925|65283786|FG000|Overall Study|Death|16|||
23420572|NCT02927925|65283786|FG000|Overall Study|Physician Decision|1|||
23420573|NCT02927925|65283786|FG000|Overall Study|Withdrawal by Subject|11|||
23420574|NCT02927925|65283786|FG000|Overall Study|Other|3|||
23420575|NCT02927925|65283786|FG000|Overall Study|Disease progression at clinical cutoff|1|||
23420576|NCT03703817|65283787|FG000|Overall Study|Not meeting eligibility criteria|7|||
23207715|NCT02112916|64498264|FG001|Overall Study|Ineligible|8|||
23207716|NCT02112916|64498265|FG002|Overall Study|Ineligible|3|||
23420577|NCT03703817|65283788|FG001|Overall Study|Not meeting eligibility criteria|4|||
23420578|NCT00585221|65283789|FG000|Overall Study|Protocol Violation|8|||
23420579|NCT04376684|65283790|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
23420580|NCT04376684|65283791|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
23420581|NCT04376684|65283792|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
23420582|NCT04376684|65283793|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
23420583|NCT04376684|65283790|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
23420584|NCT04376684|65283791|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
23420585|NCT04376684|65283792|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
23420586|NCT04376684|65283793|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
23420587|NCT04376684|65283790|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
23207717|NCT02112916|64498266|FG003|Overall Study|Ineligible|8|||
23207718|NCT02112916|64498263|FG000|Overall Study|Inevaluable|6|||
23207719|NCT02112916|64498264|FG001|Overall Study|Inevaluable|4|||
23207720|NCT02112916|64498265|FG002|Overall Study|Inevaluable|5|||
23207721|NCT02112916|64498266|FG003|Overall Study|Inevaluable|5|||
23207722|NCT02112916|64498263|FG000|Overall Study|Refusal of further protocol therapy|19|||
23207723|NCT02112916|64498264|FG001|Overall Study|Refusal of further protocol therapy|16|||
23207724|NCT02112916|64498265|FG002|Overall Study|Refusal of further protocol therapy|1|||
23207725|NCT02112916|64498266|FG003|Overall Study|Refusal of further protocol therapy|7|||
23207726|NCT02112916|64498263|FG000|Overall Study|Development of SMN|1|||
23207727|NCT02112916|64498264|FG001|Overall Study|Development of SMN|0|||
23207728|NCT02112916|64498265|FG002|Overall Study|Development of SMN|0|||
23207729|NCT02112916|64498266|FG003|Overall Study|Development of SMN|1|||
23207730|NCT02112916|64498263|FG000|Overall Study|Relapse/Progression|10|||
23207731|NCT02112916|64498264|FG001|Overall Study|Relapse/Progression|18|||
23207732|NCT02112916|64498265|FG002|Overall Study|Relapse/Progression|15|||
23207733|NCT02112916|64498266|FG003|Overall Study|Relapse/Progression|2|||
23207734|NCT02112916|64498263|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
23420588|NCT04376684|65283791|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
23420589|NCT04376684|65283792|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
23420590|NCT04376684|65283793|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
23420591|NCT04376684|65283790|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
23420592|NCT04376684|65283791|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
23420593|NCT04376684|65283792|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
23420594|NCT04376684|65283793|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
23420595|NCT04376684|65283790|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
23420596|NCT04376684|65283791|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
23420597|NCT04376684|65283792|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
23420598|NCT04376684|65283793|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
23420599|NCT04376684|65283790|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
23532098|NCT03252522|65683201|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
23532099|NCT03252522|65683202|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
23532100|NCT03252522|65683203|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
23532101|NCT00927927|65683206|FG000|Overall Study|Withdrawal by Subject|0|||
23532102|NCT00927927|65683207|FG001|Overall Study|Withdrawal by Subject|0|||
23532103|NCT00927927|65683208|FG002|Overall Study|Withdrawal by Subject|0|||
23532104|NCT00927927|65683209|FG003|Overall Study|Withdrawal by Subject|0|||
23532105|NCT00927927|65683210|FG004|Overall Study|Withdrawal by Subject|0|||
23532106|NCT00927927|65683211|FG005|Overall Study|Withdrawal by Subject|0|||
23532107|NCT00927927|65683212|FG006|Overall Study|Withdrawal by Subject|0|||
23207735|NCT02112916|64498264|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
23207736|NCT02112916|64498265|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
23207737|NCT02112916|64498266|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
23532108|NCT00927927|65683213|FG007|Overall Study|Withdrawal by Subject|2|||
23532109|NCT00927927|65683214|FG008|Overall Study|Withdrawal by Subject|0|||
23532110|NCT00927927|65683215|FG009|Overall Study|Withdrawal by Subject|0|||
23613961|NCT00296504|65973258|FG002|Interim Analysis|Protocol Violation|2|||
23613962|NCT00296504|65973259|FG003|Interim Analysis|Protocol Violation|0|||
23613963|NCT00296504|65973260|FG004|Interim Analysis|Protocol Violation|1|||
23613964|NCT00296504|65973261|FG005|Interim Analysis|Protocol Violation|0|||
23613965|NCT00296504|65973262|FG006|Interim Analysis|Protocol Violation|0|||
23613966|NCT00296504|65973263|FG007|Interim Analysis|Protocol Violation|1|||
23613967|NCT00296504|65973264|FG008|Interim Analysis|Protocol Violation|0|||
23613968|NCT00296504|65973256|FG000|Interim Analysis|Insufficient CD4 Response|0|||
23613969|NCT00296504|65973257|FG001|Interim Analysis|Insufficient CD4 Response|0|||
23613970|NCT00296504|65973258|FG002|Interim Analysis|Insufficient CD4 Response|0|||
23613971|NCT00296504|65973259|FG003|Interim Analysis|Insufficient CD4 Response|0|||
23613972|NCT00296504|65973260|FG004|Interim Analysis|Insufficient CD4 Response|1|||
23613973|NCT00296504|65973261|FG005|Interim Analysis|Insufficient CD4 Response|1|||
23613974|NCT00296504|65973262|FG006|Interim Analysis|Insufficient CD4 Response|0|||
23613975|NCT00296504|65973263|FG007|Interim Analysis|Insufficient CD4 Response|0|||
23613976|NCT00296504|65973264|FG008|Interim Analysis|Insufficient CD4 Response|0|||
23613977|NCT00296504|65973256|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
23613978|NCT00296504|65973257|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
23613979|NCT00296504|65973258|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
23613980|NCT00296504|65973259|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
23613981|NCT00296504|65973260|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
23613982|NCT00296504|65973261|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
23613983|NCT00296504|65973262|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
23613984|NCT00296504|65973263|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
23613985|NCT00296504|65973264|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
23613986|NCT00296504|65973256|FG000|Interim Analysis|Pregnancy|4|||
23613987|NCT00296504|65973257|FG001|Interim Analysis|Pregnancy|1|||
23613988|NCT00296504|65973258|FG002|Interim Analysis|Pregnancy|4|||
23613989|NCT00296504|65973259|FG003|Interim Analysis|Pregnancy|2|||
23613990|NCT00296504|65973260|FG004|Interim Analysis|Pregnancy|0|||
23613991|NCT00296504|65973261|FG005|Interim Analysis|Pregnancy|1|||
23613992|NCT00296504|65973262|FG006|Interim Analysis|Pregnancy|1|||
23613993|NCT00296504|65973263|FG007|Interim Analysis|Pregnancy|1|||
23613994|NCT00296504|65973264|FG008|Interim Analysis|Pregnancy|0|||
23613995|NCT00296504|65973256|FG000|Interim Analysis|Death|1|||
23613996|NCT00296504|65973257|FG001|Interim Analysis|Death|0|||
23613997|NCT00296504|65973258|FG002|Interim Analysis|Death|3|||
23613998|NCT00296504|65973259|FG003|Interim Analysis|Death|0|||
23613999|NCT00296504|65973260|FG004|Interim Analysis|Death|0|||
23207738|NCT02112916|64498263|FG000|Overall Study|Still on Therapy|44|||
23207739|NCT02112916|64498264|FG001|Overall Study|Still on Therapy|47|||
23207740|NCT02112916|64498265|FG002|Overall Study|Still on Therapy|3|||
23207741|NCT02112916|64498266|FG003|Overall Study|Still on Therapy|2|||
23207742|NCT02112916|64498263|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
23420600|NCT04376684|65283791|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
23420601|NCT04376684|65283792|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
23420602|NCT04376684|65283793|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
23420603|NCT04376684|65283790|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
23420604|NCT04376684|65283791|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
23420605|NCT04376684|65283792|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
23420606|NCT04376684|65283793|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
23420607|NCT00350870|65283803|FG000|Overall Study|Withdrawal by Subject|21|||
23420608|NCT00350870|65283804|FG001|Overall Study|Withdrawal by Subject|17|||
23420609|NCT00350870|65283805|FG002|Overall Study|Withdrawal by Subject|15|||
23420610|NCT00350870|65283806|FG003|Overall Study|Withdrawal by Subject|14|||
23420611|NCT00350870|65283803|FG000|Overall Study|Physician Decision|1|||
23420612|NCT00350870|65283804|FG001|Overall Study|Physician Decision|0|||
23420613|NCT00350870|65283805|FG002|Overall Study|Physician Decision|1|||
23420614|NCT00350870|65283806|FG003|Overall Study|Physician Decision|1|||
23420615|NCT02242435|65283807|FG000|Overall Study|Lost to Follow-up|3|||
23420616|NCT02242435|65283808|FG001|Overall Study|Lost to Follow-up|4|||
23614000|NCT00296504|65973261|FG005|Interim Analysis|Death|0|||
23614001|NCT00296504|65973262|FG006|Interim Analysis|Death|0|||
23614002|NCT00296504|65973263|FG007|Interim Analysis|Death|0|||
23614003|NCT00296504|65973264|FG008|Interim Analysis|Death|0|||
23614004|NCT00296504|65973256|FG000|Interim Analysis|Participant Non-compliant|0|||
23614005|NCT00296504|65973257|FG001|Interim Analysis|Participant Non-compliant|1|||
23420617|NCT02242435|65283807|FG000|Overall Study|Adverse Event|3|||
23420618|NCT02242435|65283808|FG001|Overall Study|Adverse Event|2|||
23420619|NCT02242435|65283807|FG000|Overall Study|Withdrawal by Subject|13|||
23614006|NCT00296504|65973258|FG002|Interim Analysis|Participant Non-compliant|2|||
23614007|NCT00296504|65973259|FG003|Interim Analysis|Participant Non-compliant|1|||
23420620|NCT02242435|65283808|FG001|Overall Study|Withdrawal by Subject|8|||
23420621|NCT02242435|65283807|FG000|Overall Study|Death|0|||
23420622|NCT02242435|65283808|FG001|Overall Study|Death|1|||
23420623|NCT02242435|65283807|FG000|Overall Study|Protocol Violation|1|||
23420624|NCT02242435|65283808|FG001|Overall Study|Protocol Violation|0|||
23420625|NCT02242435|65283807|FG000|Overall Study|Physician Decision|0|||
23532111|NCT00927927|65683216|FG010|Overall Study|Withdrawal by Subject|0|||
23532112|NCT00927927|65683217|FG011|Overall Study|Withdrawal by Subject|2|||
23532113|NCT00927927|65683218|FG012|Overall Study|Withdrawal by Subject|0|||
23532114|NCT00927927|65683219|FG013|Overall Study|Withdrawal by Subject|0|||
23532115|NCT00927927|65683220|FG014|Overall Study|Withdrawal by Subject|0|||
23532116|NCT02331446|65683221|FG000|Overall Study|Lost to Follow-up|2|||
23532117|NCT02331446|65683222|FG001|Overall Study|Lost to Follow-up|1|||
23532118|NCT02331446|65683223|FG002|Overall Study|Lost to Follow-up|0|||
23532119|NCT02331446|65683224|FG003|Overall Study|Lost to Follow-up|1|||
23532120|NCT02331446|65683221|FG000|Overall Study|Personal Problem|2|||
23532121|NCT02331446|65683222|FG001|Overall Study|Personal Problem|0|||
23532122|NCT02331446|65683223|FG002|Overall Study|Personal Problem|0|||
23532123|NCT02331446|65683224|FG003|Overall Study|Personal Problem|0|||
23532124|NCT02331446|65683221|FG000|Overall Study|Disease|0|||
23532125|NCT02331446|65683222|FG001|Overall Study|Disease|2|||
23532126|NCT02331446|65683223|FG002|Overall Study|Disease|2|||
23532127|NCT02331446|65683224|FG003|Overall Study|Disease|1|||
23532128|NCT02331446|65683221|FG000|Overall Study|Physician Decision|0|||
23420626|NCT02242435|65283808|FG001|Overall Study|Physician Decision|1|||
23532129|NCT02331446|65683222|FG001|Overall Study|Physician Decision|1|||
23532130|NCT02331446|65683223|FG002|Overall Study|Physician Decision|0|||
23420627|NCT05807464|65283809|FG000|Overall Study|Adverse Event|1|||
23532131|NCT02331446|65683224|FG003|Overall Study|Physician Decision|1|||
23420628|NCT03466099|65283815|FG000|Overall Study|Adverse Event|1|||
23420629|NCT03466099|65283816|FG001|Overall Study|Adverse Event|1|||
23420630|NCT03466099|65283817|FG002|Overall Study|Adverse Event|1|||
23420631|NCT03466099|65283815|FG000|Overall Study|Withdrawal by Subject|2|||
23420632|NCT03466099|65283816|FG001|Overall Study|Withdrawal by Subject|3|||
23420633|NCT03466099|65283817|FG002|Overall Study|Withdrawal by Subject|1|||
23420634|NCT03466099|65283815|FG000|Overall Study|Use of rescue medication|8|||
23420635|NCT03466099|65283816|FG001|Overall Study|Use of rescue medication|9|||
23420636|NCT03466099|65283817|FG002|Overall Study|Use of rescue medication|13|||
23420637|NCT03466099|65283815|FG000|Overall Study|Rescued without meeting criteria|4|||
23420638|NCT03466099|65283816|FG001|Overall Study|Rescued without meeting criteria|1|||
23420639|NCT03466099|65283817|FG002|Overall Study|Rescued without meeting criteria|1|||
23420640|NCT03466099|65283815|FG000|Overall Study|Subject compliance|2|||
23420641|NCT03466099|65283816|FG001|Overall Study|Subject compliance|0|||
23420642|NCT03466099|65283817|FG002|Overall Study|Subject compliance|0|||
23420643|NCT03466099|65283815|FG000|Overall Study|Worsening disease|0|||
23420644|NCT03466099|65283816|FG001|Overall Study|Worsening disease|0|||
23420645|NCT03466099|65283817|FG002|Overall Study|Worsening disease|1|||
23420646|NCT03260894|65283818|FG000|Overall Study|Death|6|||
23420647|NCT03260894|65283819|FG001|Overall Study|Death|8|||
23420648|NCT03260894|65283818|FG000|Overall Study|Withdrawal by Subject|4|||
23420649|NCT03260894|65283819|FG001|Overall Study|Withdrawal by Subject|11|||
23420650|NCT03260894|65283818|FG000|Overall Study|On-going at clinical cut off date|36|||
23420651|NCT03260894|65283819|FG001|Overall Study|On-going at clinical cut off date|31|||
23420652|NCT01774253|65283827|FG000|Overall Study|Lack of Efficacy|4|||
23420653|NCT01774253|65283827|FG000|Overall Study|Physician Decision|2|||
23420654|NCT01774253|65283827|FG000|Overall Study|Withdrawal by Subject|2|||
23420655|NCT01774253|65283827|FG000|Overall Study|Death|1|||
23420656|NCT05593913|65283828|FG000|Overall Study|Insufficient image quality|39|||
23420657|NCT03764631|65283835|FG000|Overall Study|Personal Reasons|3|||
23420658|NCT03764631|65283836|FG001|Overall Study|Personal Reasons|2|||
23420659|NCT03764631|65283835|FG000|Overall Study|Switching Therapy|3|||
23420660|NCT03764631|65283836|FG001|Overall Study|Switching Therapy|3|||
23420661|NCT03764631|65283835|FG000|Overall Study|Adverse Event|0|||
23420662|NCT03764631|65283836|FG001|Overall Study|Adverse Event|1|||
23420663|NCT03764631|65283835|FG000|Overall Study|Lost to Follow-up|33|||
23420664|NCT03764631|65283836|FG001|Overall Study|Lost to Follow-up|41|||
23420665|NCT03764631|65283835|FG000|Overall Study|No data as study site was closed|2|||
23420666|NCT03764631|65283836|FG001|Overall Study|No data as study site was closed|6|||
23420667|NCT00027378|65283847|FG000|Overall Study|Physician Decision|0|||
23420668|NCT00027378|65283848|FG001|Overall Study|Physician Decision|3|||
23420669|NCT05599451|65283856|FG000|Overall Study|Not randomized|11|||
23420670|NCT05599451|65283857|FG001|Overall Study|Not randomized|0|||
23420671|NCT05599451|65283858|FG002|Overall Study|Not randomized|0|||
23420672|NCT05599451|65283859|FG003|Overall Study|Not randomized|0|||
23420673|NCT05599451|65283860|FG004|Overall Study|Not randomized|0|||
23420674|NCT05599451|65283856|FG000|Overall Study|Physician Decision|0|||
23420675|NCT05599451|65283857|FG001|Overall Study|Physician Decision|0|||
23420676|NCT05599451|65283858|FG002|Overall Study|Physician Decision|0|||
23420677|NCT05599451|65283859|FG003|Overall Study|Physician Decision|1|||
23420678|NCT05599451|65283860|FG004|Overall Study|Physician Decision|0|||
23420679|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Adverse Event|76|||
23420680|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Adverse Event|0|||
23420681|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Adverse Event|0|||
23420682|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Death|3|||
23420683|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Death|0|||
23420684|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Death|0|||
23420685|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
23420686|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
23420687|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
23420688|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Physician Decision|9|||
23420689|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Physician Decision|0|||
23420690|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Physician Decision|0|||
23420691|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
23420692|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
23420693|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
23420694|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Disease progression|45|||
23420695|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Disease progression|0|||
23420696|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Disease progression|0|||
23420697|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
23420698|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
23420699|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
23420700|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
23420701|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
23420702|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
23420703|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
23420704|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
23420705|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
23420706|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
23420707|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
23420708|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
23420709|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
23420710|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
23420711|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
23420712|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
23420713|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
23420714|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
23420715|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
23420716|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
23420717|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
23420718|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
23420719|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
23420720|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
23420721|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
23420722|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
23420723|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
23420724|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Promotor request|1|||
23420725|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Promotor request|0|||
23420726|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Promotor request|0|||
23420727|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
23420728|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
23420729|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
23532132|NCT02331446|65683221|FG000|Overall Study|Lost before baseline analysis|0|||
23532133|NCT02331446|65683222|FG001|Overall Study|Lost before baseline analysis|1|||
23532134|NCT02331446|65683223|FG002|Overall Study|Lost before baseline analysis|1|||
23532135|NCT02331446|65683224|FG003|Overall Study|Lost before baseline analysis|0|||
23532136|NCT01096784|65683225|FG000|Overall Study|Withdrawal by Subject|2|||
23532137|NCT01096784|65683226|FG001|Overall Study|Withdrawal by Subject|1|||
23532138|NCT01096784|65683225|FG000|Overall Study|Adverse Event|11|||
23532139|NCT01096784|65683226|FG001|Overall Study|Adverse Event|9|||
23532140|NCT01096784|65683225|FG000|Overall Study|Protocol Deviation|2|||
23532141|NCT01096784|65683226|FG001|Overall Study|Protocol Deviation|2|||
23532142|NCT01096784|65683225|FG000|Overall Study|Administrative Decision|0|||
23532143|NCT01096784|65683226|FG001|Overall Study|Administrative Decision|1|||
23420730|NCT01461928|65283861|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
23420731|NCT01461928|65283862|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
23532144|NCT01096784|65683225|FG000|Overall Study|Other Unspecified|0|||
23532145|NCT01096784|65683226|FG001|Overall Study|Other Unspecified|1|||
23532146|NCT02488629|65683229|FG000|Overall Study|Lack of Efficacy|3|||
23532147|NCT02488629|65683230|FG001|Overall Study|Lack of Efficacy|1|||
23532148|NCT02488629|65683231|FG002|Overall Study|Lack of Efficacy|0|||
23207743|NCT02112916|64498264|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
23207744|NCT02112916|64498265|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
23207745|NCT02112916|64498266|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
23207746|NCT02112916|64498263|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
23207747|NCT02112916|64498264|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
23207748|NCT02112916|64498265|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
23207749|NCT02112916|64498266|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
23207750|NCT01588353|64498267|FG000|Step2|Withdrawal by Subject|0|||
23207751|NCT01588353|64498268|FG001|Step2|Withdrawal by Subject|1|||
23207752|NCT01588353|64498269|FG002|Step2|Withdrawal by Subject|0|||
23207753|NCT01588353|64498267|FG000|Step3|Adverse Event|0|||
23207754|NCT01588353|64498268|FG001|Step3|Adverse Event|0|||
23207755|NCT01588353|64498269|FG002|Step3|Adverse Event|2|||
23207756|NCT03288493|64498270|FG000|Overall Study|Withdrawal by Subject|4|||
23207757|NCT03288493|64498271|FG001|Overall Study|Withdrawal by Subject|0|||
23532149|NCT02488629|65683232|FG003|Overall Study|Lack of Efficacy|0|||
23532150|NCT02488629|65683229|FG000|Overall Study|Withdrawal by Subject|0|||
23532151|NCT02488629|65683230|FG001|Overall Study|Withdrawal by Subject|1|||
23532152|NCT02488629|65683231|FG002|Overall Study|Withdrawal by Subject|0|||
23532153|NCT02488629|65683232|FG003|Overall Study|Withdrawal by Subject|0|||
23532154|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
23532155|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
23532156|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
23207758|NCT03288493|64498272|FG002|Overall Study|Withdrawal by Subject|0|||
23207759|NCT03288493|64498273|FG003|Overall Study|Withdrawal by Subject|0|||
23532157|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Death|1|||
23532158|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
23532159|NCT02840877|65683235|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
23207760|NCT03288493|64498274|FG004|Overall Study|Withdrawal by Subject|0|||
23207761|NCT03288493|64498275|FG005|Overall Study|Withdrawal by Subject|2|||
23207762|NCT03288493|64498276|FG006|Overall Study|Withdrawal by Subject|0|||
23207763|NCT03288493|64498270|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
23236638|NCT00280059|64608260|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
23532160|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
23532161|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Treatment failure|1|||
23532162|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
23532163|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
23207764|NCT03288493|64498271|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
23207765|NCT03288493|64498272|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
23207766|NCT03288493|64498273|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
23207767|NCT03288493|64498274|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
23207768|NCT03288493|64498275|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
23207769|NCT03288493|64498276|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
23532164|NCT02840877|65683235|FG000|12 Weeks to 6 Months|Death|1|||
23532165|NCT02840877|65683235|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
23532166|NCT02840877|65683235|FG000|6 Months to 18 Months|Treatment failure|7|||
23532167|NCT02840877|65683235|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
23532168|NCT02840877|65683235|FG000|6 Months to 18 Months|Moved/transferred out|6|||
23532169|NCT02840877|65683235|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
23532170|NCT02840877|65683235|FG000|6 Months to 18 Months|Death|4|||
23532171|NCT02840877|65683235|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
23532172|NCT02840877|65683235|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
23532173|NCT02840877|65683235|FG000|6 Months to 18 Months|Still in study.|14|||
23532174|NCT04177108|65683236|FG000|Overall Study|Withdrawal by Subject|4|||
23532175|NCT04177108|65683237|FG001|Overall Study|Withdrawal by Subject|8|||
23532176|NCT04177108|65683238|FG002|Overall Study|Withdrawal by Subject|9|||
23532177|NCT04177108|65683239|FG003|Overall Study|Withdrawal by Subject|11|||
23532178|NCT04177108|65683240|FG004|Overall Study|Withdrawal by Subject|13|||
23532179|NCT04177108|65683236|FG000|Overall Study|Physician Decision|23|||
23532180|NCT04177108|65683237|FG001|Overall Study|Physician Decision|15|||
23532181|NCT04177108|65683238|FG002|Overall Study|Physician Decision|18|||
23532182|NCT04177108|65683239|FG003|Overall Study|Physician Decision|29|||
23532183|NCT04177108|65683240|FG004|Overall Study|Physician Decision|23|||
23532184|NCT04177108|65683236|FG000|Overall Study|Reason Not Specified|0|||
23532185|NCT04177108|65683237|FG001|Overall Study|Reason Not Specified|1|||
23532186|NCT04177108|65683238|FG002|Overall Study|Reason Not Specified|0|||
23532187|NCT04177108|65683239|FG003|Overall Study|Reason Not Specified|0|||
23532188|NCT04177108|65683240|FG004|Overall Study|Reason Not Specified|2|||
23532189|NCT04177108|65683236|FG000|Overall Study|Lost to Follow-up|0|||
23532190|NCT04177108|65683237|FG001|Overall Study|Lost to Follow-up|0|||
23532191|NCT04177108|65683238|FG002|Overall Study|Lost to Follow-up|1|||
23532192|NCT04177108|65683239|FG003|Overall Study|Lost to Follow-up|1|||
23532193|NCT04177108|65683240|FG004|Overall Study|Lost to Follow-up|1|||
23532194|NCT04177108|65683236|FG000|Overall Study|Death|16|||
23532195|NCT04177108|65683237|FG001|Overall Study|Death|19|||
23532196|NCT04177108|65683238|FG002|Overall Study|Death|13|||
23532197|NCT04177108|65683239|FG003|Overall Study|Death|17|||
23532198|NCT04177108|65683240|FG004|Overall Study|Death|18|||
23532199|NCT02896400|65683243|FG000|1 Month Follow-up|Lost to Follow-up|7|||
23532200|NCT02896400|65683244|FG001|1 Month Follow-up|Lost to Follow-up|7|||
23532201|NCT02896400|65683245|FG002|1 Month Follow-up|Lost to Follow-up|5|||
23532202|NCT02896400|65683246|FG003|1 Month Follow-up|Lost to Follow-up|8|||
23614008|NCT00296504|65973260|FG004|Interim Analysis|Participant Non-compliant|1|||
23614009|NCT00296504|65973261|FG005|Interim Analysis|Participant Non-compliant|3|||
23614010|NCT00296504|65973262|FG006|Interim Analysis|Participant Non-compliant|6|||
23614011|NCT00296504|65973263|FG007|Interim Analysis|Participant Non-compliant|2|||
23614012|NCT00296504|65973264|FG008|Interim Analysis|Participant Non-compliant|0|||
23614013|NCT00296504|65973256|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614014|NCT00296504|65973257|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614015|NCT00296504|65973258|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
23614016|NCT00296504|65973259|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614017|NCT00296504|65973260|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614018|NCT00296504|65973261|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
23614019|NCT00296504|65973262|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23532203|NCT02896400|65683247|FG004|1 Month Follow-up|Lost to Follow-up|9|||
23532204|NCT02896400|65683248|FG005|1 Month Follow-up|Lost to Follow-up|6|||
23532205|NCT02896400|65683249|FG006|1 Month Follow-up|Lost to Follow-up|5|||
23532206|NCT02896400|65683250|FG007|1 Month Follow-up|Lost to Follow-up|6|||
23532207|NCT02896400|65683251|FG008|1 Month Follow-up|Lost to Follow-up|4|||
23532208|NCT02896400|65683252|FG009|1 Month Follow-up|Lost to Follow-up|7|||
23532209|NCT02896400|65683253|FG010|1 Month Follow-up|Lost to Follow-up|5|||
23614020|NCT00296504|65973263|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614021|NCT00296504|65973264|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
23614022|NCT00296504|65973256|FG000|Interim Analysis|To Simplify Treatment|0|||
23614023|NCT00296504|65973257|FG001|Interim Analysis|To Simplify Treatment|0|||
23614024|NCT00296504|65973258|FG002|Interim Analysis|To Simplify Treatment|1|||
23614025|NCT00296504|65973259|FG003|Interim Analysis|To Simplify Treatment|0|||
23614026|NCT00296504|65973260|FG004|Interim Analysis|To Simplify Treatment|0|||
23614027|NCT00296504|65973261|FG005|Interim Analysis|To Simplify Treatment|0|||
23614028|NCT00296504|65973262|FG006|Interim Analysis|To Simplify Treatment|2|||
23614029|NCT00296504|65973263|FG007|Interim Analysis|To Simplify Treatment|0|||
23614030|NCT00296504|65973264|FG008|Interim Analysis|To Simplify Treatment|0|||
23207770|NCT03288493|64498270|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
23207771|NCT03288493|64498271|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
23207772|NCT03288493|64498272|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
23207773|NCT03288493|64498273|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
23207774|NCT03288493|64498274|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
23207775|NCT03288493|64498275|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
23207776|NCT03288493|64498276|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
23207777|NCT03288493|64498270|FG000|Overall Study|Death|2|||
23207778|NCT03288493|64498271|FG001|Overall Study|Death|0|||
23207779|NCT03288493|64498272|FG002|Overall Study|Death|0|||
23207780|NCT03288493|64498273|FG003|Overall Study|Death|0|||
23207781|NCT03288493|64498274|FG004|Overall Study|Death|0|||
23207782|NCT03288493|64498275|FG005|Overall Study|Death|0|||
23207783|NCT03288493|64498276|FG006|Overall Study|Death|0|||
23207784|NCT03288493|64498270|FG000|Overall Study|other reason not listed above|2|||
23207785|NCT03288493|64498271|FG001|Overall Study|other reason not listed above|0|||
23207786|NCT03288493|64498272|FG002|Overall Study|other reason not listed above|0|||
23207787|NCT03288493|64498273|FG003|Overall Study|other reason not listed above|0|||
23207788|NCT03288493|64498274|FG004|Overall Study|other reason not listed above|0|||
23207789|NCT03288493|64498275|FG005|Overall Study|other reason not listed above|0|||
23207790|NCT03288493|64498276|FG006|Overall Study|other reason not listed above|0|||
23207791|NCT03806179|64498278|FG000|Overall Study|Progressive disease|0|||
23207792|NCT03806179|64498279|FG001|Overall Study|Progressive disease|2|||
23207793|NCT01980706|64498280|FG000|Overall Study|Withdrawal by Subject|9|||
23207794|NCT01980706|64498281|FG001|Overall Study|Withdrawal by Subject|6|||
23420732|NCT01461928|65283863|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
23532210|NCT02896400|65683254|FG011|1 Month Follow-up|Lost to Follow-up|5|||
23532211|NCT02896400|65683255|FG012|1 Month Follow-up|Lost to Follow-up|3|||
23532212|NCT02896400|65683256|FG013|1 Month Follow-up|Lost to Follow-up|4|||
23532213|NCT02896400|65683257|FG014|1 Month Follow-up|Lost to Follow-up|1|||
23532214|NCT02896400|65683258|FG015|1 Month Follow-up|Lost to Follow-up|2|||
23532215|NCT02896400|65683243|FG000|1 Month Follow-up|Death|0|||
23532216|NCT02896400|65683244|FG001|1 Month Follow-up|Death|0|||
23532217|NCT02896400|65683245|FG002|1 Month Follow-up|Death|0|||
23532218|NCT02896400|65683246|FG003|1 Month Follow-up|Death|0|||
23532219|NCT02896400|65683247|FG004|1 Month Follow-up|Death|0|||
23532220|NCT02896400|65683248|FG005|1 Month Follow-up|Death|0|||
23532221|NCT02896400|65683249|FG006|1 Month Follow-up|Death|0|||
23532222|NCT02896400|65683250|FG007|1 Month Follow-up|Death|0|||
23532223|NCT02896400|65683251|FG008|1 Month Follow-up|Death|0|||
23532224|NCT02896400|65683252|FG009|1 Month Follow-up|Death|0|||
23532225|NCT02896400|65683253|FG010|1 Month Follow-up|Death|0|||
23532226|NCT02896400|65683254|FG011|1 Month Follow-up|Death|0|||
23532227|NCT02896400|65683255|FG012|1 Month Follow-up|Death|0|||
23532228|NCT02896400|65683256|FG013|1 Month Follow-up|Death|0|||
23532229|NCT02896400|65683257|FG014|1 Month Follow-up|Death|0|||
23614031|NCT00296504|65973256|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614032|NCT00296504|65973257|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
23207795|NCT01980706|64498282|FG002|Overall Study|Withdrawal by Subject|2|||
23532230|NCT02896400|65683258|FG015|1 Month Follow-up|Death|1|||
23532231|NCT02896400|65683243|FG000|3 Month Follow-up|Lost to Follow-up|6|||
23532232|NCT02896400|65683244|FG001|3 Month Follow-up|Lost to Follow-up|3|||
23532233|NCT02896400|65683245|FG002|3 Month Follow-up|Lost to Follow-up|6|||
23532234|NCT02896400|65683246|FG003|3 Month Follow-up|Lost to Follow-up|11|||
23532235|NCT02896400|65683247|FG004|3 Month Follow-up|Lost to Follow-up|12|||
23532236|NCT02896400|65683248|FG005|3 Month Follow-up|Lost to Follow-up|6|||
23614033|NCT00296504|65973258|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
23614034|NCT00296504|65973259|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614035|NCT00296504|65973260|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614036|NCT00296504|65973261|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614037|NCT00296504|65973262|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
23207796|NCT01980706|64498280|FG000|Overall Study|Adverse Event|1|||
23207797|NCT01980706|64498281|FG001|Overall Study|Adverse Event|2|||
23207798|NCT01980706|64498282|FG002|Overall Study|Adverse Event|5|||
23207799|NCT01980706|64498280|FG000|Overall Study|Lost to Follow-up|3|||
23207800|NCT01980706|64498281|FG001|Overall Study|Lost to Follow-up|4|||
23614038|NCT00296504|65973263|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614039|NCT00296504|65973264|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
23614040|NCT00296504|65973256|FG000|Interim Analysis|Participant Moved|1|||
23614041|NCT00296504|65973257|FG001|Interim Analysis|Participant Moved|0|||
23614042|NCT00296504|65973258|FG002|Interim Analysis|Participant Moved|1|||
23614043|NCT00296504|65973259|FG003|Interim Analysis|Participant Moved|0|||
23614044|NCT00296504|65973260|FG004|Interim Analysis|Participant Moved|0|||
23614045|NCT00296504|65973261|FG005|Interim Analysis|Participant Moved|1|||
23614046|NCT00296504|65973262|FG006|Interim Analysis|Participant Moved|1|||
23614047|NCT00296504|65973263|FG007|Interim Analysis|Participant Moved|0|||
23614048|NCT00296504|65973264|FG008|Interim Analysis|Participant Moved|0|||
23614049|NCT00296504|65973256|FG000|Interim Analysis|Participant Was Incarcerated|2|||
23614050|NCT00296504|65973257|FG001|Interim Analysis|Participant Was Incarcerated|0|||
23614051|NCT00296504|65973258|FG002|Interim Analysis|Participant Was Incarcerated|1|||
23614052|NCT00296504|65973259|FG003|Interim Analysis|Participant Was Incarcerated|0|||
23614053|NCT00296504|65973260|FG004|Interim Analysis|Participant Was Incarcerated|0|||
23614054|NCT00296504|65973261|FG005|Interim Analysis|Participant Was Incarcerated|0|||
23614055|NCT00296504|65973262|FG006|Interim Analysis|Participant Was Incarcerated|0|||
23614056|NCT00296504|65973263|FG007|Interim Analysis|Participant Was Incarcerated|0|||
23614057|NCT00296504|65973264|FG008|Interim Analysis|Participant Was Incarcerated|0|||
23614058|NCT00296504|65973256|FG000|Interim Analysis|Resistance to FPV|0|||
23614059|NCT00296504|65973257|FG001|Interim Analysis|Resistance to FPV|0|||
23614060|NCT00296504|65973258|FG002|Interim Analysis|Resistance to FPV|1|||
23614061|NCT00296504|65973259|FG003|Interim Analysis|Resistance to FPV|0|||
23614062|NCT00296504|65973260|FG004|Interim Analysis|Resistance to FPV|0|||
23614063|NCT00296504|65973261|FG005|Interim Analysis|Resistance to FPV|0|||
23614064|NCT00296504|65973262|FG006|Interim Analysis|Resistance to FPV|0|||
23614065|NCT00296504|65973263|FG007|Interim Analysis|Resistance to FPV|0|||
23614066|NCT00296504|65973264|FG008|Interim Analysis|Resistance to FPV|0|||
23614067|NCT00296504|65973256|FG000|Interim Analysis|Physician Decision|0|||
23614068|NCT00296504|65973257|FG001|Interim Analysis|Physician Decision|0|||
23614069|NCT00296504|65973258|FG002|Interim Analysis|Physician Decision|1|||
23614070|NCT00296504|65973259|FG003|Interim Analysis|Physician Decision|0|||
23614071|NCT00296504|65973260|FG004|Interim Analysis|Physician Decision|0|||
23614072|NCT00296504|65973261|FG005|Interim Analysis|Physician Decision|0|||
23614073|NCT00296504|65973262|FG006|Interim Analysis|Physician Decision|0|||
23207801|NCT01980706|64498282|FG002|Overall Study|Lost to Follow-up|3|||
23207802|NCT01980706|64498280|FG000|Overall Study|miscellaneous|4|||
23614074|NCT00296504|65973263|FG007|Interim Analysis|Physician Decision|0|||
23614075|NCT00296504|65973264|FG008|Interim Analysis|Physician Decision|0|||
23614076|NCT00296504|65973256|FG000|Interim Analysis|Principle Investigator Discretion|2|||
23614077|NCT00296504|65973257|FG001|Interim Analysis|Principle Investigator Discretion|0|||
23614078|NCT00296504|65973258|FG002|Interim Analysis|Principle Investigator Discretion|1|||
23207803|NCT01980706|64498281|FG001|Overall Study|miscellaneous|5|||
23207804|NCT01980706|64498282|FG002|Overall Study|miscellaneous|3|||
23532237|NCT02896400|65683249|FG006|3 Month Follow-up|Lost to Follow-up|4|||
23532238|NCT02896400|65683250|FG007|3 Month Follow-up|Lost to Follow-up|3|||
23532239|NCT02896400|65683251|FG008|3 Month Follow-up|Lost to Follow-up|6|||
23532240|NCT02896400|65683252|FG009|3 Month Follow-up|Lost to Follow-up|5|||
23207805|NCT02431468|64498283|FG000|Overall Study|Adverse Event|2|||
23207806|NCT02431468|64498284|FG001|Overall Study|Adverse Event|4|||
23207807|NCT02431468|64498285|FG002|Overall Study|Adverse Event|5|||
23207808|NCT02431468|64498283|FG000|Overall Study|Withdrawal by Subject|4|||
23207809|NCT02431468|64498284|FG001|Overall Study|Withdrawal by Subject|12|||
23207810|NCT02431468|64498285|FG002|Overall Study|Withdrawal by Subject|2|||
23207811|NCT02431468|64498283|FG000|Overall Study|noncompliance, investigator termination,|2|||
23207812|NCT02431468|64498284|FG001|Overall Study|noncompliance, investigator termination,|2|||
23207813|NCT02431468|64498285|FG002|Overall Study|noncompliance, investigator termination,|2|||
23207814|NCT00383721|64498286|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
23420733|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Death|3|||
23420734|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Death|0|||
23420735|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Death|0|||
23420736|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
23420737|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
23420738|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
23420739|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
23420740|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
23420741|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
23420742|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Diseases progression|91|||
23532241|NCT02896400|65683253|FG010|3 Month Follow-up|Lost to Follow-up|6|||
23532242|NCT02896400|65683254|FG011|3 Month Follow-up|Lost to Follow-up|6|||
23532243|NCT02896400|65683255|FG012|3 Month Follow-up|Lost to Follow-up|3|||
23532244|NCT02896400|65683256|FG013|3 Month Follow-up|Lost to Follow-up|5|||
23532245|NCT02896400|65683257|FG014|3 Month Follow-up|Lost to Follow-up|3|||
23532246|NCT02896400|65683258|FG015|3 Month Follow-up|Lost to Follow-up|2|||
23532247|NCT02896400|65683243|FG000|3 Month Follow-up|Death|0|||
23532248|NCT02896400|65683244|FG001|3 Month Follow-up|Death|0|||
23420743|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Diseases progression|0|||
23532249|NCT02896400|65683245|FG002|3 Month Follow-up|Death|0|||
23532250|NCT02896400|65683246|FG003|3 Month Follow-up|Death|0|||
23532251|NCT02896400|65683247|FG004|3 Month Follow-up|Death|0|||
23532252|NCT02896400|65683248|FG005|3 Month Follow-up|Death|0|||
23532253|NCT02896400|65683249|FG006|3 Month Follow-up|Death|0|||
23532254|NCT02896400|65683250|FG007|3 Month Follow-up|Death|0|||
23532255|NCT02896400|65683251|FG008|3 Month Follow-up|Death|0|||
23532256|NCT02896400|65683252|FG009|3 Month Follow-up|Death|0|||
23532257|NCT02896400|65683253|FG010|3 Month Follow-up|Death|0|||
23532258|NCT02896400|65683254|FG011|3 Month Follow-up|Death|0|||
23532259|NCT02896400|65683255|FG012|3 Month Follow-up|Death|0|||
23532260|NCT02896400|65683256|FG013|3 Month Follow-up|Death|1|||
23532261|NCT02896400|65683257|FG014|3 Month Follow-up|Death|1|||
23532262|NCT02896400|65683258|FG015|3 Month Follow-up|Death|0|||
23420744|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Diseases progression|0|||
23420745|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Adverse Event|70|||
23420746|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Adverse Event|0|||
23532263|NCT02896400|65683243|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532264|NCT02896400|65683244|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23532265|NCT02896400|65683245|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532266|NCT02896400|65683246|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532267|NCT02896400|65683247|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23532268|NCT02896400|65683248|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532269|NCT02896400|65683249|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
23532270|NCT02896400|65683250|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
23532271|NCT02896400|65683251|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532272|NCT02896400|65683252|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532273|NCT02896400|65683253|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23532274|NCT02896400|65683254|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23207815|NCT00383721|64498287|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
23420747|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Adverse Event|0|||
23532275|NCT02896400|65683255|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532276|NCT02896400|65683256|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
23532277|NCT02896400|65683257|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
23532278|NCT02896400|65683258|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
23532279|NCT02896400|65683243|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
23532280|NCT02896400|65683244|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
23532281|NCT02896400|65683245|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
23532282|NCT02896400|65683246|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
23420748|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Physician Decision|9|||
23420749|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Physician Decision|0|||
23420750|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Physician Decision|0|||
23420751|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
23420752|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
23310302|NCT01735955|64881398|FG000|Overall Study|Administrative problems|1|||
23310303|NCT01735955|64881398|FG000|Overall Study|Patient/guardian decision|1|||
23310304|NCT01735955|64881398|FG000|Overall Study|Patient withdrew consent|2|||
23310305|NCT01735955|64881398|FG000|Overall Study|Physician Decision|4|||
23310306|NCT01735955|64881398|FG000|Overall Study|Disease progression|24|||
23310307|NCT01735955|64881398|FG000|Overall Study|Adverse Event|5|||
23310308|NCT04555720|64881402|FG000|Overall Study|Lost to Follow-up|2|||
23310309|NCT04555720|64881403|FG001|Overall Study|Lost to Follow-up|0|||
23420753|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
23420754|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
23420755|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
23420756|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
23420757|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
23420758|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
23420759|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
23420760|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Not compliant|1|||
23420761|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Not compliant|0|||
23420762|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Not compliant|0|||
23420763|NCT01461928|65283861|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
23420764|NCT01461928|65283862|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
23420765|NCT01461928|65283863|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
23420766|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Adverse Event|0|||
23420767|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Adverse Event|2|||
23420768|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Adverse Event|0|||
23420769|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Death|0|||
23420770|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Death|10|||
23420771|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Death|8|||
23420772|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Physician Decision|0|||
23420773|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Physician Decision|0|||
23420774|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Physician Decision|4|||
23420775|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
23420776|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
23420777|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
23420778|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Moved to another town|0|||
23420779|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Moved to another town|1|||
23420780|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Moved to another town|0|||
23420781|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Disease progression|0|||
23420782|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Disease progression|0|||
23310310|NCT04555720|64881404|FG002|Overall Study|Lost to Follow-up|0|||
23310311|NCT04555720|64881405|FG003|Overall Study|Lost to Follow-up|0|||
23420783|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Disease progression|3|||
23420784|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
23310312|NCT04555720|64881402|FG000|Overall Study|Withdrawal by Subject|4|||
23420785|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
23420786|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
23420787|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
23420788|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
23420789|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
23420790|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
23420791|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
23420792|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
23420793|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
23420794|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
23420795|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
23420796|NCT01461928|65283861|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
23532283|NCT02896400|65683247|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
23532284|NCT02896400|65683248|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
23532285|NCT02896400|65683249|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
23532286|NCT02896400|65683250|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
23532287|NCT02896400|65683251|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
23532288|NCT02896400|65683252|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
23532289|NCT02896400|65683253|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
23420797|NCT01461928|65283862|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
23420798|NCT01461928|65283863|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
23420799|NCT05032690|65283865|FG000|Period 1|Adverse Event|0|||
23420800|NCT05032690|65283866|FG001|Period 1|Adverse Event|1|||
23420801|NCT05032690|65283867|FG002|Period 1|Adverse Event|0|||
23420802|NCT05032690|65283868|FG003|Period 1|Adverse Event|0|||
23420803|NCT05032690|65283865|FG000|Period 1|Withdrawal by Subject|1|||
23420804|NCT05032690|65283866|FG001|Period 1|Withdrawal by Subject|0|||
23420805|NCT05032690|65283867|FG002|Period 1|Withdrawal by Subject|0|||
23420806|NCT05032690|65283868|FG003|Period 1|Withdrawal by Subject|0|||
23420807|NCT05032690|65283865|FG000|Period 1|No longer meets eligibility criteria|0|||
23420808|NCT05032690|65283866|FG001|Period 1|No longer meets eligibility criteria|1|||
23420809|NCT05032690|65283867|FG002|Period 1|No longer meets eligibility criteria|0|||
23420810|NCT05032690|65283868|FG003|Period 1|No longer meets eligibility criteria|0|||
23420811|NCT05032690|65283865|FG000|Period 2|Adverse Event|1|||
23420812|NCT05032690|65283866|FG001|Period 2|Adverse Event|0|||
23420813|NCT05032690|65283867|FG002|Period 2|Adverse Event|0|||
23420814|NCT05032690|65283868|FG003|Period 2|Adverse Event|0|||
23420815|NCT05032690|65283865|FG000|Period 2|Withdrawal by Subject|0|||
23420816|NCT05032690|65283866|FG001|Period 2|Withdrawal by Subject|1|||
23420817|NCT05032690|65283867|FG002|Period 2|Withdrawal by Subject|0|||
23420818|NCT05032690|65283868|FG003|Period 2|Withdrawal by Subject|0|||
23420819|NCT05032690|65283865|FG000|Period 2|No longer meets eligibility criteria|0|||
23420820|NCT05032690|65283866|FG001|Period 2|No longer meets eligibility criteria|1|||
23420821|NCT05032690|65283867|FG002|Period 2|No longer meets eligibility criteria|0|||
23420822|NCT05032690|65283868|FG003|Period 2|No longer meets eligibility criteria|0|||
23420823|NCT05032690|65283865|FG000|Period 3|Adverse Event|0|||
23420824|NCT05032690|65283866|FG001|Period 3|Adverse Event|1|||
23420825|NCT05032690|65283867|FG002|Period 3|Adverse Event|0|||
23420826|NCT05032690|65283868|FG003|Period 3|Adverse Event|0|||
23420827|NCT01574157|65283874|FG000|Overall Study|Withdrawal by Subject|4|||
23420828|NCT01574157|65283875|FG001|Overall Study|Withdrawal by Subject|5|||
23420829|NCT01574157|65283874|FG000|Overall Study|Lost to Follow-up|0|||
23420830|NCT01574157|65283875|FG001|Overall Study|Lost to Follow-up|3|||
23420831|NCT04043234|65283878|FG000|Overall Study|Lost to Follow-up|1|||
23420832|NCT04043234|65283878|FG000|Overall Study|Withdrawal by Subject|1|||
23420833|NCT01289353|65283890|FG000|Overall Study|Lost to Follow-up|2|||
23420834|NCT00712725|65283895|FG000|Overall Study|Adverse Event|1|||
23420835|NCT00712725|65283896|FG001|Overall Study|Adverse Event|0|||
23420836|NCT00712725|65283897|FG002|Overall Study|Adverse Event|0|||
23420837|NCT00712725|65283898|FG003|Overall Study|Adverse Event|1|||
23420838|NCT00712725|65283899|FG004|Overall Study|Adverse Event|0|||
23420839|NCT00712725|65283900|FG005|Overall Study|Adverse Event|0|||
23420840|NCT00712725|65283901|FG006|Overall Study|Adverse Event|0|||
23420841|NCT00712725|65283902|FG007|Overall Study|Adverse Event|0|||
23420842|NCT00712725|65283895|FG000|Overall Study|Lost to Follow-up|3|||
23420843|NCT00712725|65283896|FG001|Overall Study|Lost to Follow-up|2|||
23420844|NCT00712725|65283897|FG002|Overall Study|Lost to Follow-up|1|||
23420845|NCT00712725|65283898|FG003|Overall Study|Lost to Follow-up|1|||
23420846|NCT00712725|65283899|FG004|Overall Study|Lost to Follow-up|2|||
23420847|NCT00712725|65283900|FG005|Overall Study|Lost to Follow-up|2|||
23420848|NCT00712725|65283901|FG006|Overall Study|Lost to Follow-up|3|||
23420849|NCT00712725|65283902|FG007|Overall Study|Lost to Follow-up|1|||
23420850|NCT00712725|65283895|FG000|Overall Study|Physician Decision|2|||
23420851|NCT00712725|65283896|FG001|Overall Study|Physician Decision|0|||
23420852|NCT00712725|65283897|FG002|Overall Study|Physician Decision|0|||
23420853|NCT00712725|65283898|FG003|Overall Study|Physician Decision|0|||
23420854|NCT00712725|65283899|FG004|Overall Study|Physician Decision|1|||
23420855|NCT00712725|65283900|FG005|Overall Study|Physician Decision|0|||
23420856|NCT00712725|65283901|FG006|Overall Study|Physician Decision|2|||
23420857|NCT00712725|65283902|FG007|Overall Study|Physician Decision|0|||
23420858|NCT00712725|65283895|FG000|Overall Study|Pregnancy|0|||
23420859|NCT00712725|65283896|FG001|Overall Study|Pregnancy|1|||
23420860|NCT00712725|65283897|FG002|Overall Study|Pregnancy|0|||
23420861|NCT00712725|65283898|FG003|Overall Study|Pregnancy|0|||
23420862|NCT00712725|65283899|FG004|Overall Study|Pregnancy|1|||
23420863|NCT00712725|65283900|FG005|Overall Study|Pregnancy|0|||
23420864|NCT00712725|65283901|FG006|Overall Study|Pregnancy|2|||
23420865|NCT00712725|65283902|FG007|Overall Study|Pregnancy|0|||
23420866|NCT00712725|65283895|FG000|Overall Study|Protocol Violation|2|||
23420867|NCT00712725|65283896|FG001|Overall Study|Protocol Violation|0|||
23420868|NCT00712725|65283897|FG002|Overall Study|Protocol Violation|1|||
23420869|NCT00712725|65283898|FG003|Overall Study|Protocol Violation|3|||
23420870|NCT00712725|65283899|FG004|Overall Study|Protocol Violation|2|||
23420871|NCT00712725|65283900|FG005|Overall Study|Protocol Violation|0|||
23420872|NCT00712725|65283901|FG006|Overall Study|Protocol Violation|1|||
23420873|NCT00712725|65283902|FG007|Overall Study|Protocol Violation|1|||
23420874|NCT00712725|65283895|FG000|Overall Study|Withdrawal by Subject|2|||
23420875|NCT00712725|65283896|FG001|Overall Study|Withdrawal by Subject|1|||
23420876|NCT00712725|65283897|FG002|Overall Study|Withdrawal by Subject|1|||
23420877|NCT00712725|65283898|FG003|Overall Study|Withdrawal by Subject|2|||
23420878|NCT00712725|65283899|FG004|Overall Study|Withdrawal by Subject|1|||
23420879|NCT00712725|65283900|FG005|Overall Study|Withdrawal by Subject|1|||
23420880|NCT00712725|65283901|FG006|Overall Study|Withdrawal by Subject|1|||
23420881|NCT00712725|65283902|FG007|Overall Study|Withdrawal by Subject|2|||
23420882|NCT00712725|65283895|FG000|Overall Study|Lack of Qualifying Event|16|||
23420883|NCT00712725|65283896|FG001|Overall Study|Lack of Qualifying Event|2|||
23420884|NCT00712725|65283897|FG002|Overall Study|Lack of Qualifying Event|6|||
23420885|NCT00712725|65283898|FG003|Overall Study|Lack of Qualifying Event|8|||
23420886|NCT00712725|65283899|FG004|Overall Study|Lack of Qualifying Event|11|||
23420887|NCT00712725|65283900|FG005|Overall Study|Lack of Qualifying Event|13|||
23420888|NCT00712725|65283901|FG006|Overall Study|Lack of Qualifying Event|11|||
23420889|NCT00712725|65283902|FG007|Overall Study|Lack of Qualifying Event|6|||
23420890|NCT00712725|65283895|FG000|Overall Study|Protocol Specified Criteria|3|||
23420891|NCT00712725|65283896|FG001|Overall Study|Protocol Specified Criteria|0|||
23420892|NCT00712725|65283897|FG002|Overall Study|Protocol Specified Criteria|1|||
23420893|NCT00712725|65283898|FG003|Overall Study|Protocol Specified Criteria|2|||
23420894|NCT00712725|65283899|FG004|Overall Study|Protocol Specified Criteria|1|||
23420895|NCT00712725|65283900|FG005|Overall Study|Protocol Specified Criteria|0|||
23420896|NCT00712725|65283901|FG006|Overall Study|Protocol Specified Criteria|2|||
23420897|NCT00712725|65283902|FG007|Overall Study|Protocol Specified Criteria|1|||
23420898|NCT04752566|65283903|FG000|Overall Study|Protocol Violation|0|||
23420899|NCT04752566|65283904|FG001|Overall Study|Protocol Violation|1|||
23420900|NCT04752566|65283903|FG000|Overall Study|Death|1|||
23420901|NCT04752566|65283904|FG001|Overall Study|Death|0|||
23420902|NCT04752566|65283903|FG000|Overall Study|Adverse Event|1|||
23420903|NCT04752566|65283904|FG001|Overall Study|Adverse Event|0|||
23420904|NCT04752566|65283903|FG000|Overall Study|Withdrawal by Subject|2|||
23420905|NCT04752566|65283904|FG001|Overall Study|Withdrawal by Subject|0|||
23420906|NCT04752566|65283903|FG000|Overall Study|Physician Decision|1|||
23420907|NCT04752566|65283904|FG001|Overall Study|Physician Decision|1|||
23420908|NCT01865812|65283905|FG000|Primary Treatment Phase|Adverse Event|2|||
23420909|NCT01865812|65283906|FG001|Primary Treatment Phase|Adverse Event|0|||
23420910|NCT01865812|65283905|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
23420911|NCT01865812|65283906|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
23420912|NCT01865812|65283905|FG000|Long-term Safety Extension Phase|Pruritus|0|||
23420913|NCT01865812|65283906|FG001|Long-term Safety Extension Phase|Pruritus|3|||
23420914|NCT01865812|65283905|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
23420915|NCT01865812|65283906|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
23420916|NCT01865812|65283905|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
23420917|NCT01865812|65283906|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
23420918|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
23420919|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
23420920|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Death|0|||
23420921|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Death|0|||
23420922|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
23420923|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
23420924|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
23420925|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
23420926|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
23420927|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
23420928|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
23420929|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
23420930|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
23420931|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
23420932|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
23420933|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
23420934|NCT00433160|65283909|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
23420935|NCT00433160|65283910|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
23420936|NCT00433160|65283909|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
23420937|NCT00433160|65283910|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
23420938|NCT00433160|65283909|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
23420939|NCT00433160|65283910|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
23420940|NCT00433160|65283909|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
23420941|NCT00433160|65283910|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
23420942|NCT00433160|65283909|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
23420943|NCT00433160|65283910|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
23420944|NCT00433160|65283909|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
23420945|NCT00433160|65283910|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
23420946|NCT00433160|65283909|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
23420947|NCT00433160|65283910|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
23420948|NCT00433160|65283909|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
23420949|NCT00433160|65283910|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
23420950|NCT01327053|65283913|FG000|Overall Study|Adverse Event|23|||
23420951|NCT01327053|65283914|FG001|Overall Study|Adverse Event|57|||
23420952|NCT01327053|65283913|FG000|Overall Study|Patient/guardian decision|11|||
23420953|NCT01327053|65283914|FG001|Overall Study|Patient/guardian decision|35|||
23420954|NCT01327053|65283913|FG000|Overall Study|Physician Decision|10|||
23420955|NCT01327053|65283914|FG001|Overall Study|Physician Decision|14|||
23420956|NCT01327053|65283913|FG000|Overall Study|Death|1|||
23420957|NCT01327053|65283914|FG001|Overall Study|Death|5|||
23420958|NCT01327053|65283913|FG000|Overall Study|Lost to Follow-up|2|||
23420959|NCT01327053|65283914|FG001|Overall Study|Lost to Follow-up|4|||
23420960|NCT01327053|65283913|FG000|Overall Study|Non-compliance with study treatment|0|||
23420961|NCT01327053|65283914|FG001|Overall Study|Non-compliance with study treatment|5|||
23420962|NCT01327053|65283913|FG000|Overall Study|Study terminated by Sponsor|1|||
23420963|NCT01327053|65283914|FG001|Overall Study|Study terminated by Sponsor|3|||
23420964|NCT01327053|65283913|FG000|Overall Study|Progressive disease|31|||
23420965|NCT01327053|65283914|FG001|Overall Study|Progressive disease|26|||
23420966|NCT01327053|65283913|FG000|Overall Study|Protocol Violation|0|||
23420967|NCT01327053|65283914|FG001|Overall Study|Protocol Violation|1|||
23420968|NCT01327053|65283913|FG000|Overall Study|Untreated|0|||
23420969|NCT01327053|65283914|FG001|Overall Study|Untreated|1|||
23420970|NCT00842153|65283915|FG000|Overall Study|Adverse Event|0|||
23420971|NCT00842153|65283916|FG001|Overall Study|Adverse Event|1|||
23420972|NCT00842153|65283915|FG000|Overall Study|Lost to Follow-up|1|||
23420973|NCT00842153|65283916|FG001|Overall Study|Lost to Follow-up|2|||
23420974|NCT04484649|65283919|FG000|Overall Study|Lost to Follow-up|2|||
23420975|NCT04484649|65283920|FG001|Overall Study|Lost to Follow-up|1|||
23420976|NCT04484649|65283919|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
23420977|NCT04484649|65283920|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
23420978|NCT03195660|65283923|FG000|Overall Study|The study was terminated|2|||
23420979|NCT03425006|65283924|FG000|Overall Study|Withdrawal by Subject|1|||
23420980|NCT03425006|65283924|FG000|Overall Study|Physician Decision|1|||
23420981|NCT03425006|65283924|FG000|Overall Study|Death|1|||
23420982|NCT00837265|65283925|FG000|Pilot Phase|Withdrawal by Subject|0|||
23420983|NCT00837265|65283926|FG001|Pilot Phase|Withdrawal by Subject|2|||
23420984|NCT00837265|65283927|FG002|Pilot Phase|Withdrawal by Subject|3|||
23420985|NCT00837265|65283928|FG003|Pilot Phase|Withdrawal by Subject|2|||
23420986|NCT00837265|65283929|FG004|Pilot Phase|Withdrawal by Subject|0|||
23420987|NCT00837265|65283930|FG005|Pilot Phase|Withdrawal by Subject|0|||
23420988|NCT00837265|65283931|FG006|Pilot Phase|Withdrawal by Subject|0|||
23420989|NCT00837265|65283925|FG000|Pilot Phase|Decision of the investigator|2|||
23420990|NCT00837265|65283926|FG001|Pilot Phase|Decision of the investigator|1|||
23420991|NCT00837265|65283927|FG002|Pilot Phase|Decision of the investigator|0|||
23420992|NCT00837265|65283928|FG003|Pilot Phase|Decision of the investigator|0|||
23420993|NCT00837265|65283929|FG004|Pilot Phase|Decision of the investigator|0|||
23420994|NCT00837265|65283930|FG005|Pilot Phase|Decision of the investigator|0|||
23420995|NCT00837265|65283931|FG006|Pilot Phase|Decision of the investigator|0|||
23420996|NCT00837265|65283925|FG000|Pilot Phase|Adverse Event|1|||
23420997|NCT00837265|65283926|FG001|Pilot Phase|Adverse Event|0|||
23420998|NCT00837265|65283927|FG002|Pilot Phase|Adverse Event|0|||
23420999|NCT00837265|65283928|FG003|Pilot Phase|Adverse Event|0|||
23421000|NCT00837265|65283929|FG004|Pilot Phase|Adverse Event|0|||
23421001|NCT00837265|65283930|FG005|Pilot Phase|Adverse Event|0|||
23421002|NCT00837265|65283931|FG006|Pilot Phase|Adverse Event|0|||
23421003|NCT00837265|65283925|FG000|Pilot Phase|Disease progression|0|||
23421004|NCT00837265|65283926|FG001|Pilot Phase|Disease progression|0|||
23421005|NCT00837265|65283927|FG002|Pilot Phase|Disease progression|0|||
23421006|NCT00837265|65283928|FG003|Pilot Phase|Disease progression|1|||
23421007|NCT00837265|65283929|FG004|Pilot Phase|Disease progression|0|||
23421008|NCT00837265|65283930|FG005|Pilot Phase|Disease progression|0|||
23421009|NCT00837265|65283931|FG006|Pilot Phase|Disease progression|0|||
23421010|NCT00837265|65283925|FG000|Pilot Phase|Participant left the city|0|||
23421011|NCT00837265|65283926|FG001|Pilot Phase|Participant left the city|0|||
23421012|NCT00837265|65283927|FG002|Pilot Phase|Participant left the city|0|||
23421013|NCT00837265|65283928|FG003|Pilot Phase|Participant left the city|1|||
23421014|NCT00837265|65283929|FG004|Pilot Phase|Participant left the city|0|||
23421015|NCT00837265|65283930|FG005|Pilot Phase|Participant left the city|0|||
23421016|NCT00837265|65283931|FG006|Pilot Phase|Participant left the city|0|||
23421017|NCT00837265|65283925|FG000|Main Phase|Withdrawal by Subject|0|||
23421018|NCT00837265|65283926|FG001|Main Phase|Withdrawal by Subject|0|||
23421019|NCT00837265|65283927|FG002|Main Phase|Withdrawal by Subject|0|||
23421020|NCT00837265|65283928|FG003|Main Phase|Withdrawal by Subject|0|||
23421021|NCT00837265|65283929|FG004|Main Phase|Withdrawal by Subject|4|||
23421022|NCT00837265|65283930|FG005|Main Phase|Withdrawal by Subject|2|||
23421023|NCT00837265|65283931|FG006|Main Phase|Withdrawal by Subject|1|||
23421024|NCT00837265|65283925|FG000|Main Phase|Decision of the investigator|0|||
23421025|NCT00837265|65283926|FG001|Main Phase|Decision of the investigator|0|||
23421026|NCT00837265|65283927|FG002|Main Phase|Decision of the investigator|0|||
23421027|NCT00837265|65283928|FG003|Main Phase|Decision of the investigator|0|||
23421028|NCT00837265|65283929|FG004|Main Phase|Decision of the investigator|0|||
23421029|NCT00837265|65283930|FG005|Main Phase|Decision of the investigator|2|||
23421030|NCT00837265|65283931|FG006|Main Phase|Decision of the investigator|1|||
23421031|NCT00837265|65283925|FG000|Main Phase|Adverse Event|0|||
23421032|NCT00837265|65283926|FG001|Main Phase|Adverse Event|0|||
23421033|NCT00837265|65283927|FG002|Main Phase|Adverse Event|0|||
23421034|NCT00837265|65283928|FG003|Main Phase|Adverse Event|0|||
23421035|NCT00837265|65283929|FG004|Main Phase|Adverse Event|0|||
23421036|NCT00837265|65283930|FG005|Main Phase|Adverse Event|1|||
23421037|NCT00837265|65283931|FG006|Main Phase|Adverse Event|0|||
23421038|NCT00837265|65283925|FG000|Main Phase|Death|0|||
23421039|NCT00837265|65283926|FG001|Main Phase|Death|0|||
23421040|NCT00837265|65283927|FG002|Main Phase|Death|0|||
23421041|NCT00837265|65283928|FG003|Main Phase|Death|0|||
23421042|NCT00837265|65283929|FG004|Main Phase|Death|2|||
23421043|NCT00837265|65283930|FG005|Main Phase|Death|0|||
23421044|NCT00837265|65283931|FG006|Main Phase|Death|1|||
23421045|NCT00837265|65283925|FG000|Main Phase|Lost to Follow-up|0|||
23421046|NCT00837265|65283926|FG001|Main Phase|Lost to Follow-up|0|||
23421047|NCT00837265|65283927|FG002|Main Phase|Lost to Follow-up|0|||
23421048|NCT00837265|65283928|FG003|Main Phase|Lost to Follow-up|0|||
23421049|NCT00837265|65283929|FG004|Main Phase|Lost to Follow-up|1|||
23421050|NCT00837265|65283930|FG005|Main Phase|Lost to Follow-up|0|||
23421051|NCT00837265|65283931|FG006|Main Phase|Lost to Follow-up|0|||
23421052|NCT00837265|65283925|FG000|Main Phase|Principal investigator resignation|0|||
23421053|NCT00837265|65283926|FG001|Main Phase|Principal investigator resignation|0|||
23421054|NCT00837265|65283927|FG002|Main Phase|Principal investigator resignation|0|||
23421055|NCT00837265|65283928|FG003|Main Phase|Principal investigator resignation|0|||
23614079|NCT00296504|65973259|FG003|Interim Analysis|Principle Investigator Discretion|1|||
23310313|NCT04555720|64881403|FG001|Overall Study|Withdrawal by Subject|6|||
23421056|NCT00837265|65283929|FG004|Main Phase|Principal investigator resignation|2|||
23421057|NCT00837265|65283930|FG005|Main Phase|Principal investigator resignation|0|||
23421058|NCT00837265|65283931|FG006|Main Phase|Principal investigator resignation|0|||
23421059|NCT00837265|65283925|FG000|Main Phase|Participant's personal reason|0|||
23421060|NCT00837265|65283926|FG001|Main Phase|Participant's personal reason|0|||
23421061|NCT00837265|65283927|FG002|Main Phase|Participant's personal reason|0|||
23421062|NCT00837265|65283928|FG003|Main Phase|Participant's personal reason|0|||
23310314|NCT04555720|64881404|FG002|Overall Study|Withdrawal by Subject|0|||
23310315|NCT04555720|64881405|FG003|Overall Study|Withdrawal by Subject|0|||
23421063|NCT00837265|65283929|FG004|Main Phase|Participant's personal reason|1|||
23421064|NCT00837265|65283930|FG005|Main Phase|Participant's personal reason|0|||
23421065|NCT00837265|65283931|FG006|Main Phase|Participant's personal reason|0|||
23421066|NCT00385944|65283932|FG000|1st Maintenance Dose Period|Physician Decision|1|||
23421067|NCT00385944|65283933|FG001|1st Maintenance Dose Period|Physician Decision|0|||
23421068|NCT00385944|65283934|FG002|1st Maintenance Dose Period|Physician Decision|0|||
23421069|NCT00385944|65283932|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
23421070|NCT00385944|65283933|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
23421071|NCT00385944|65283934|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
23421072|NCT00385944|65283932|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
23421073|NCT00385944|65283933|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
23421074|NCT00385944|65283934|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
23421075|NCT00385944|65283932|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
23421076|NCT00385944|65283933|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
23421077|NCT00385944|65283934|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
23421078|NCT02358031|65283935|FG000|Overall Study|Death|253|||
23421079|NCT02358031|65283936|FG001|Overall Study|Death|237|||
23421080|NCT02358031|65283937|FG002|Overall Study|Death|266|||
23421081|NCT02358031|65283935|FG000|Overall Study|Lost to Follow-up|1|||
23421082|NCT02358031|65283936|FG001|Overall Study|Lost to Follow-up|1|||
23421083|NCT02358031|65283937|FG002|Overall Study|Lost to Follow-up|0|||
23421084|NCT02358031|65283935|FG000|Overall Study|Withdrawal by Subject|19|||
23421085|NCT02358031|65283936|FG001|Overall Study|Withdrawal by Subject|14|||
23421086|NCT02358031|65283937|FG002|Overall Study|Withdrawal by Subject|18|||
23421087|NCT02358031|65283935|FG000|Overall Study|Sponsor Decision|26|||
23421088|NCT02358031|65283936|FG001|Overall Study|Sponsor Decision|28|||
23421089|NCT02358031|65283937|FG002|Overall Study|Sponsor Decision|16|||
23421090|NCT02750345|65283938|FG000|Intervention 1|Adverse Event|0|||
23421091|NCT02750345|65283939|FG001|Intervention 1|Adverse Event|0|||
23421092|NCT02750345|65283940|FG002|Intervention 1|Adverse Event|0|||
23421093|NCT02750345|65283941|FG003|Intervention 1|Adverse Event|0|||
23421094|NCT02750345|65283942|FG004|Intervention 1|Adverse Event|1|||
23421095|NCT02750345|65283943|FG005|Intervention 1|Adverse Event|0|||
23421096|NCT00812006|65283946|FG000|Overall Study|Lost to Follow-up|0|||
23421097|NCT00812006|65283947|FG001|Overall Study|Lost to Follow-up|0|||
23421098|NCT00812006|65283948|FG002|Overall Study|Lost to Follow-up|2|||
23421099|NCT00812006|65283946|FG000|Overall Study|Physician Decision|0|||
23421100|NCT00812006|65283947|FG001|Overall Study|Physician Decision|0|||
23421101|NCT00812006|65283948|FG002|Overall Study|Physician Decision|1|||
23421102|NCT00812006|65283946|FG000|Overall Study|Withdrawal by Subject|2|||
23421103|NCT00812006|65283947|FG001|Overall Study|Withdrawal by Subject|1|||
23421104|NCT00812006|65283948|FG002|Overall Study|Withdrawal by Subject|1|||
23421105|NCT00812006|65283946|FG000|Overall Study|Lack of Qualifying Event|4|||
23421106|NCT00812006|65283947|FG001|Overall Study|Lack of Qualifying Event|2|||
23421107|NCT00812006|65283948|FG002|Overall Study|Lack of Qualifying Event|2|||
23421108|NCT01062841|65283949|FG000|Overall Study|Indwelling Device Removed|41|||
23421109|NCT01062841|65283950|FG001|Overall Study|Indwelling Device Removed|48|||
23421110|NCT01062841|65283949|FG000|Overall Study|Death|3|||
23421111|NCT01062841|65283950|FG001|Overall Study|Death|5|||
23421112|NCT01062841|65283949|FG000|Overall Study|Withdrawal by Subject|2|||
23421113|NCT01062841|65283950|FG001|Overall Study|Withdrawal by Subject|0|||
23421114|NCT01062841|65283949|FG000|Overall Study|Withdrawal by Study|3|||
23421115|NCT01062841|65283950|FG001|Overall Study|Withdrawal by Study|0|||
23421116|NCT02300558|65283951|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
23421117|NCT02300558|65283951|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
23421118|NCT02300558|65283951|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
23421119|NCT02300558|65283951|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
23421120|NCT01457014|65283952|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
23421121|NCT01457014|65283953|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
23421122|NCT01457014|65283954|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
23421123|NCT01457014|65283955|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
23421124|NCT01457014|65283952|FG000|First Night|Withdrawal by Subject|3|||
23421125|NCT01457014|65283953|FG001|First Night|Withdrawal by Subject|0|||
23421126|NCT01457014|65283954|FG002|First Night|Withdrawal by Subject|0|||
23421127|NCT01457014|65283955|FG003|First Night|Withdrawal by Subject|0|||
23421128|NCT01145352|65283956|FG000|Overall Study|Found to have been registered twice|6|||
23421129|NCT01145352|65283956|FG000|Overall Study|Treated before marketing approval|4|||
23421130|NCT01145352|65283956|FG000|Overall Study|Syringe formulation was used|1|||
23421131|NCT02509039|65283957|FG000|Overall Study|Adverse Event|0|||
23421132|NCT02509039|65283958|FG001|Overall Study|Adverse Event|1|||
23421133|NCT02509039|65283959|FG002|Overall Study|Adverse Event|1|||
23421134|NCT02509039|65283960|FG003|Overall Study|Adverse Event|1|||
23421135|NCT02509039|65283957|FG000|Overall Study|Withdrawal by Subject|0|||
23421136|NCT02509039|65283958|FG001|Overall Study|Withdrawal by Subject|0|||
23421137|NCT02509039|65283959|FG002|Overall Study|Withdrawal by Subject|1|||
23421138|NCT02509039|65283960|FG003|Overall Study|Withdrawal by Subject|0|||
23421139|NCT02509039|65283957|FG000|Overall Study|Progressive disease|2|||
23421140|NCT02509039|65283958|FG001|Overall Study|Progressive disease|2|||
23421141|NCT02509039|65283959|FG002|Overall Study|Progressive disease|1|||
23421142|NCT02509039|65283960|FG003|Overall Study|Progressive disease|5|||
23421143|NCT02509039|65283957|FG000|Overall Study|Study terminated by Sponsor|1|||
23421144|NCT02509039|65283958|FG001|Overall Study|Study terminated by Sponsor|0|||
23421145|NCT02509039|65283959|FG002|Overall Study|Study terminated by Sponsor|0|||
23421146|NCT02509039|65283960|FG003|Overall Study|Study terminated by Sponsor|0|||
23421147|NCT00503581|65283961|FG000|Overall Study|Study closed|3|||
23532290|NCT02896400|65683254|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
23614080|NCT00296504|65973260|FG004|Interim Analysis|Principle Investigator Discretion|0|||
23614081|NCT00296504|65973261|FG005|Interim Analysis|Principle Investigator Discretion|0|||
23614082|NCT00296504|65973262|FG006|Interim Analysis|Principle Investigator Discretion|0|||
23614083|NCT00296504|65973263|FG007|Interim Analysis|Principle Investigator Discretion|0|||
23614084|NCT00296504|65973264|FG008|Interim Analysis|Principle Investigator Discretion|0|||
23614085|NCT00296504|65973256|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
23614086|NCT00296504|65973257|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
23614087|NCT00296504|65973258|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
23614088|NCT00296504|65973259|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
23614089|NCT00296504|65973260|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
23614090|NCT00296504|65973261|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
23532291|NCT02896400|65683255|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
23532292|NCT02896400|65683256|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
23532293|NCT02896400|65683257|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
23532294|NCT02896400|65683258|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
23532295|NCT05204134|65683263|FG000|Overall Study|Withdrawal by Subject|3|||
23532296|NCT05204134|65683263|FG000|Overall Study|Physician Decision|1|||
23532297|NCT02673775|65683264|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
23532298|NCT02673775|65683265|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
23532299|NCT02673775|65683264|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
23532300|NCT02673775|65683265|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
23532301|NCT02673775|65683264|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
23532302|NCT02673775|65683265|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
23532303|NCT02673775|65683264|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
23532304|NCT02673775|65683265|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
23532305|NCT01852292|65683266|FG000|Overall Study|Untreated - did not receive study drug|3|||
23532306|NCT01852292|65683267|FG001|Overall Study|Untreated - did not receive study drug|1|||
23532307|NCT01852292|65683266|FG000|Overall Study|Death|9|||
23532308|NCT01852292|65683267|FG001|Overall Study|Death|8|||
23532309|NCT01852292|65683266|FG000|Overall Study|Patient/guardian decision|8|||
23532310|NCT01852292|65683267|FG001|Overall Study|Patient/guardian decision|4|||
23532311|NCT01852292|65683266|FG000|Overall Study|Adverse Event|8|||
23532312|NCT01852292|65683267|FG001|Overall Study|Adverse Event|11|||
23532313|NCT01852292|65683266|FG000|Overall Study|Physician Decision|6|||
23532314|NCT01852292|65683267|FG001|Overall Study|Physician Decision|2|||
23532315|NCT01852292|65683266|FG000|Overall Study|Protocol Violation|2|||
23532316|NCT01852292|65683267|FG001|Overall Study|Protocol Violation|0|||
23532317|NCT01852292|65683266|FG000|Overall Study|Non-compliance with study treatment|1|||
23532318|NCT01852292|65683267|FG001|Overall Study|Non-compliance with study treatment|0|||
23532319|NCT01852292|65683266|FG000|Overall Study|Study terminated by Sponsor|0|||
23532320|NCT01852292|65683267|FG001|Overall Study|Study terminated by Sponsor|1|||
23532321|NCT01852292|65683266|FG000|Overall Study|Progressive disease|42|||
23532322|NCT01852292|65683267|FG001|Overall Study|Progressive disease|52|||
23532323|NCT03592641|65683268|FG000|Overall Study|Withdrawal by Subject|1|||
23532324|NCT00512096|65683272|FG000|Overall Study|Adverse Event|2|||
23532325|NCT00512096|65683272|FG000|Overall Study|Withdrawal by Subject|2|||
23532326|NCT00512096|65683272|FG000|Overall Study|Lack of Efficacy|3|||
23614091|NCT00296504|65973262|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
23532327|NCT04300296|65683273|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
23532328|NCT04300296|65683274|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532329|NCT04300296|65683275|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532330|NCT04300296|65683276|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532331|NCT04300296|65683277|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532332|NCT04300296|65683278|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
23532333|NCT04300296|65683273|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532334|NCT04300296|65683274|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532335|NCT04300296|65683275|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532336|NCT04300296|65683276|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532337|NCT04300296|65683277|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
23532338|NCT04300296|65683278|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
23532339|NCT04300296|65683273|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
23532340|NCT04300296|65683274|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
23532341|NCT04300296|65683275|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
23532342|NCT04300296|65683276|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
23532343|NCT04300296|65683277|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
23532344|NCT04300296|65683278|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
23532345|NCT04300296|65683273|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
23532346|NCT04300296|65683274|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
23532347|NCT04300296|65683275|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
23532348|NCT04300296|65683276|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
23532349|NCT04300296|65683277|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
23532350|NCT04300296|65683278|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
23532351|NCT04300296|65683273|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
23532352|NCT04300296|65683274|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
23532353|NCT04300296|65683275|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
23532354|NCT04300296|65683276|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
23532355|NCT04300296|65683277|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
23532356|NCT04300296|65683278|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
23532357|NCT04300296|65683273|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532358|NCT04300296|65683274|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
23532359|NCT04300296|65683275|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532360|NCT04300296|65683276|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532361|NCT04300296|65683277|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532362|NCT04300296|65683278|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
23532363|NCT04300296|65683273|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
23532364|NCT04300296|65683274|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
23532365|NCT04300296|65683275|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
23532366|NCT04300296|65683276|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
23532367|NCT04300296|65683277|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
23532368|NCT04300296|65683278|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
23532369|NCT01632579|65683279|FG000|Washout Period|Adverse Event|1|||
23532370|NCT01632579|65683280|FG001|Washout Period|Adverse Event|0|||
23532371|NCT01632579|65683281|FG002|Washout Period|Adverse Event|0|||
23532372|NCT01632579|65683282|FG003|Washout Period|Adverse Event|0|||
23532373|NCT01632579|65683283|FG004|Washout Period|Adverse Event|0|||
23532374|NCT01632579|65683284|FG005|Washout Period|Adverse Event|0|||
23532375|NCT01632579|65683285|FG006|Washout Period|Adverse Event|0|||
23532376|NCT01632579|65683286|FG007|Washout Period|Adverse Event|0|||
23532377|NCT01632579|65683287|FG008|Washout Period|Adverse Event|0|||
23532378|NCT01632579|65683279|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
23532379|NCT01632579|65683280|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
23532380|NCT01632579|65683281|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
23532381|NCT01632579|65683282|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
23532382|NCT01632579|65683283|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
23532383|NCT01632579|65683284|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
23532384|NCT01632579|65683285|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
23532385|NCT01632579|65683286|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
23532386|NCT01632579|65683287|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
23532387|NCT00654381|65683288|FG000|1st Stage|Adverse Event|3|||
23614092|NCT00296504|65973263|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
23207816|NCT00383721|64498288|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
23532388|NCT00654381|65683289|FG001|1st Stage|Adverse Event|3|||
23532389|NCT00654381|65683290|FG002|1st Stage|Adverse Event|3|||
23532390|NCT00654381|65683291|FG003|1st Stage|Adverse Event|3|||
23532391|NCT00654381|65683292|FG004|1st Stage|Adverse Event|2|||
23532392|NCT00654381|65683293|FG005|1st Stage|Adverse Event|1|||
23532393|NCT00654381|65683288|FG000|1st Stage|Withdrawal by Subject|0|||
23532394|NCT00654381|65683289|FG001|1st Stage|Withdrawal by Subject|0|||
23532395|NCT00654381|65683290|FG002|1st Stage|Withdrawal by Subject|0|||
23532396|NCT00654381|65683291|FG003|1st Stage|Withdrawal by Subject|1|||
23532397|NCT00654381|65683292|FG004|1st Stage|Withdrawal by Subject|0|||
23532398|NCT00654381|65683293|FG005|1st Stage|Withdrawal by Subject|1|||
23532399|NCT00654381|65683288|FG000|1st Stage|Investigator's decision|0|||
23532400|NCT00654381|65683289|FG001|1st Stage|Investigator's decision|0|||
23532401|NCT00654381|65683290|FG002|1st Stage|Investigator's decision|0|||
23532402|NCT00654381|65683291|FG003|1st Stage|Investigator's decision|1|||
23532403|NCT00654381|65683292|FG004|1st Stage|Investigator's decision|0|||
23532404|NCT00654381|65683293|FG005|1st Stage|Investigator's decision|0|||
23532405|NCT00654381|65683288|FG000|2nd Stage|Adverse Event|2|||
23532406|NCT00654381|65683289|FG001|2nd Stage|Adverse Event|0|||
23532407|NCT00654381|65683290|FG002|2nd Stage|Adverse Event|2|||
23532408|NCT00654381|65683291|FG003|2nd Stage|Adverse Event|3|||
23532409|NCT00654381|65683292|FG004|2nd Stage|Adverse Event|7|||
23532410|NCT00654381|65683293|FG005|2nd Stage|Adverse Event|2|||
23532411|NCT00654381|65683288|FG000|2nd Stage|Withdrawal by Subject|0|||
23532412|NCT00654381|65683289|FG001|2nd Stage|Withdrawal by Subject|0|||
23532413|NCT00654381|65683290|FG002|2nd Stage|Withdrawal by Subject|0|||
23532414|NCT00654381|65683291|FG003|2nd Stage|Withdrawal by Subject|0|||
23532415|NCT00654381|65683292|FG004|2nd Stage|Withdrawal by Subject|1|||
23532416|NCT00654381|65683293|FG005|2nd Stage|Withdrawal by Subject|1|||
23532417|NCT00654381|65683288|FG000|2nd Stage|Investigator's decision|0|||
23532418|NCT00654381|65683289|FG001|2nd Stage|Investigator's decision|0|||
23532419|NCT00654381|65683290|FG002|2nd Stage|Investigator's decision|1|||
23532420|NCT00654381|65683291|FG003|2nd Stage|Investigator's decision|1|||
23532421|NCT00654381|65683292|FG004|2nd Stage|Investigator's decision|0|||
23532422|NCT00654381|65683293|FG005|2nd Stage|Investigator's decision|0|||
23532423|NCT00654381|65683288|FG000|Extension Stage|Adverse Event|1|||
23532424|NCT00654381|65683289|FG001|Extension Stage|Adverse Event|2|||
23532425|NCT00654381|65683290|FG002|Extension Stage|Adverse Event|9|||
23532426|NCT00654381|65683291|FG003|Extension Stage|Adverse Event|7|||
23532427|NCT00654381|65683292|FG004|Extension Stage|Adverse Event|1|||
23532428|NCT00654381|65683293|FG005|Extension Stage|Adverse Event|1|||
23532429|NCT00654381|65683288|FG000|Extension Stage|Protocol Violation|0|||
23532430|NCT00654381|65683289|FG001|Extension Stage|Protocol Violation|0|||
23532431|NCT00654381|65683290|FG002|Extension Stage|Protocol Violation|0|||
23532432|NCT00654381|65683291|FG003|Extension Stage|Protocol Violation|1|||
23532433|NCT00654381|65683292|FG004|Extension Stage|Protocol Violation|0|||
23532434|NCT00654381|65683293|FG005|Extension Stage|Protocol Violation|0|||
23532435|NCT00654381|65683288|FG000|Extension Stage|Lack of Efficacy|0|||
23532436|NCT00654381|65683289|FG001|Extension Stage|Lack of Efficacy|0|||
23532437|NCT00654381|65683290|FG002|Extension Stage|Lack of Efficacy|1|||
23532438|NCT00654381|65683291|FG003|Extension Stage|Lack of Efficacy|0|||
23532439|NCT00654381|65683292|FG004|Extension Stage|Lack of Efficacy|0|||
23532440|NCT00654381|65683293|FG005|Extension Stage|Lack of Efficacy|0|||
23532441|NCT00654381|65683288|FG000|Extension Stage|Withdrawal by Subject|0|||
23532442|NCT00654381|65683289|FG001|Extension Stage|Withdrawal by Subject|0|||
23614093|NCT00296504|65973264|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
23236639|NCT01220024|64608261|FG000|Overall Study|Lost to Follow-up|1|||
23532443|NCT00654381|65683290|FG002|Extension Stage|Withdrawal by Subject|1|||
23532444|NCT00654381|65683291|FG003|Extension Stage|Withdrawal by Subject|1|||
23532445|NCT00654381|65683292|FG004|Extension Stage|Withdrawal by Subject|1|||
23532446|NCT00654381|65683293|FG005|Extension Stage|Withdrawal by Subject|1|||
23532447|NCT00654381|65683288|FG000|Extension Stage|Closure of the trial site|0|||
23532448|NCT00654381|65683289|FG001|Extension Stage|Closure of the trial site|0|||
23532449|NCT00654381|65683290|FG002|Extension Stage|Closure of the trial site|0|||
23532450|NCT00654381|65683291|FG003|Extension Stage|Closure of the trial site|0|||
23614094|NCT00296504|65973256|FG000|Interim Analysis|Non-adherence|2|||
23614095|NCT00296504|65973257|FG001|Interim Analysis|Non-adherence|0|||
23614096|NCT00296504|65973258|FG002|Interim Analysis|Non-adherence|0|||
23614097|NCT00296504|65973259|FG003|Interim Analysis|Non-adherence|0|||
23614098|NCT00296504|65973260|FG004|Interim Analysis|Non-adherence|1|||
23614099|NCT00296504|65973261|FG005|Interim Analysis|Non-adherence|0|||
23614100|NCT00296504|65973262|FG006|Interim Analysis|Non-adherence|0|||
23614101|NCT00296504|65973263|FG007|Interim Analysis|Non-adherence|1|||
23614102|NCT00296504|65973264|FG008|Interim Analysis|Non-adherence|0|||
23614103|NCT00296504|65973256|FG000|Interim Analysis|Site Closing|1|||
23614104|NCT00296504|65973257|FG001|Interim Analysis|Site Closing|0|||
23614105|NCT00296504|65973258|FG002|Interim Analysis|Site Closing|0|||
23614106|NCT00296504|65973259|FG003|Interim Analysis|Site Closing|0|||
23614107|NCT00296504|65973260|FG004|Interim Analysis|Site Closing|0|||
23614108|NCT00296504|65973261|FG005|Interim Analysis|Site Closing|1|||
23614109|NCT00296504|65973262|FG006|Interim Analysis|Site Closing|2|||
23614110|NCT00296504|65973263|FG007|Interim Analysis|Site Closing|0|||
23207817|NCT00383721|64498289|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
23207818|NCT00383721|64498290|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
23207819|NCT00383721|64498286|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
23207820|NCT00383721|64498287|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
23207821|NCT00383721|64498288|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
23207822|NCT00383721|64498289|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
23207823|NCT00383721|64498290|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
23421148|NCT00503581|65283962|FG001|Overall Study|Study closed|4|||
23421149|NCT00503581|65283963|FG002|Overall Study|Study closed|2|||
23614111|NCT00296504|65973264|FG008|Interim Analysis|Site Closing|0|||
23614112|NCT00296504|65973256|FG000|Interim Analysis|Lack of Personnel at Site|1|||
23614113|NCT00296504|65973257|FG001|Interim Analysis|Lack of Personnel at Site|0|||
23614114|NCT00296504|65973258|FG002|Interim Analysis|Lack of Personnel at Site|0|||
23614115|NCT00296504|65973259|FG003|Interim Analysis|Lack of Personnel at Site|0|||
23614116|NCT00296504|65973260|FG004|Interim Analysis|Lack of Personnel at Site|0|||
23614117|NCT00296504|65973261|FG005|Interim Analysis|Lack of Personnel at Site|0|||
23614118|NCT00296504|65973262|FG006|Interim Analysis|Lack of Personnel at Site|0|||
23614119|NCT00296504|65973263|FG007|Interim Analysis|Lack of Personnel at Site|0|||
23614120|NCT00296504|65973264|FG008|Interim Analysis|Lack of Personnel at Site|0|||
23614121|NCT00296504|65973256|FG000|Interim Analysis|Missed Schedule Date|1|||
23614122|NCT00296504|65973257|FG001|Interim Analysis|Missed Schedule Date|0|||
23614123|NCT00296504|65973258|FG002|Interim Analysis|Missed Schedule Date|0|||
23614124|NCT00296504|65973259|FG003|Interim Analysis|Missed Schedule Date|0|||
23614125|NCT00296504|65973260|FG004|Interim Analysis|Missed Schedule Date|0|||
23614126|NCT00296504|65973261|FG005|Interim Analysis|Missed Schedule Date|0|||
23614127|NCT00296504|65973262|FG006|Interim Analysis|Missed Schedule Date|0|||
23614128|NCT00296504|65973263|FG007|Interim Analysis|Missed Schedule Date|0|||
23614129|NCT00296504|65973264|FG008|Interim Analysis|Missed Schedule Date|0|||
23614130|NCT00296504|65973256|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
23614131|NCT00296504|65973257|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
23614132|NCT00296504|65973258|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
23614133|NCT00296504|65973259|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
23614134|NCT00296504|65973260|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
23614135|NCT00296504|65973261|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
23614136|NCT00296504|65973262|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
23614137|NCT00296504|65973263|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
23614138|NCT00296504|65973264|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
23614139|NCT00296504|65973256|FG000|Interim Analysis|Participant Stopped|0|||
23614140|NCT00296504|65973257|FG001|Interim Analysis|Participant Stopped|0|||
23614141|NCT00296504|65973258|FG002|Interim Analysis|Participant Stopped|0|||
23614142|NCT00296504|65973259|FG003|Interim Analysis|Participant Stopped|0|||
23614143|NCT00296504|65973260|FG004|Interim Analysis|Participant Stopped|1|||
23614144|NCT00296504|65973261|FG005|Interim Analysis|Participant Stopped|0|||
23207824|NCT00383721|64498286|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
23614145|NCT00296504|65973262|FG006|Interim Analysis|Participant Stopped|0|||
23614146|NCT00296504|65973263|FG007|Interim Analysis|Participant Stopped|0|||
23614147|NCT00296504|65973264|FG008|Interim Analysis|Participant Stopped|0|||
23614148|NCT00296504|65973256|FG000|Interim Analysis|Physician and Participant Decision|0|||
23614149|NCT00296504|65973257|FG001|Interim Analysis|Physician and Participant Decision|0|||
23614150|NCT00296504|65973258|FG002|Interim Analysis|Physician and Participant Decision|0|||
23614151|NCT00296504|65973259|FG003|Interim Analysis|Physician and Participant Decision|0|||
23614152|NCT00296504|65973260|FG004|Interim Analysis|Physician and Participant Decision|0|||
23614153|NCT00296504|65973261|FG005|Interim Analysis|Physician and Participant Decision|1|||
23614154|NCT00296504|65973262|FG006|Interim Analysis|Physician and Participant Decision|0|||
23614155|NCT00296504|65973263|FG007|Interim Analysis|Physician and Participant Decision|0|||
23207825|NCT00383721|64498287|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
23614156|NCT00296504|65973264|FG008|Interim Analysis|Physician and Participant Decision|0|||
23614157|NCT00296504|65973256|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
23614158|NCT00296504|65973257|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
23532451|NCT00654381|65683292|FG004|Extension Stage|Closure of the trial site|1|||
23532452|NCT00654381|65683293|FG005|Extension Stage|Closure of the trial site|1|||
23532453|NCT03096782|65683294|FG000|Overall Study|Death|1|||
23532454|NCT03096782|65683294|FG000|Overall Study|Participant Relapsed|1|||
23532455|NCT00414050|65683295|FG000|Overall Study|Adverse Event|1|||
23532456|NCT00414050|65683296|FG001|Overall Study|Adverse Event|1|||
23532457|NCT00414050|65683297|FG002|Overall Study|Adverse Event|1|||
23532458|NCT00414050|65683298|FG003|Overall Study|Adverse Event|1|||
23532459|NCT00414050|65683295|FG000|Overall Study|Lost to Follow-up|2|||
23532460|NCT00414050|65683296|FG001|Overall Study|Lost to Follow-up|2|||
23532461|NCT00414050|65683297|FG002|Overall Study|Lost to Follow-up|1|||
23532462|NCT00414050|65683298|FG003|Overall Study|Lost to Follow-up|1|||
23532463|NCT00414050|65683295|FG000|Overall Study|Withdrawal by Subject|5|||
23532464|NCT00414050|65683296|FG001|Overall Study|Withdrawal by Subject|3|||
23532465|NCT00414050|65683297|FG002|Overall Study|Withdrawal by Subject|2|||
23532466|NCT00414050|65683298|FG003|Overall Study|Withdrawal by Subject|4|||
23532467|NCT00414050|65683295|FG000|Overall Study|Subject discontinued for other reason|1|||
23532468|NCT00414050|65683296|FG001|Overall Study|Subject discontinued for other reason|2|||
23532469|NCT00414050|65683297|FG002|Overall Study|Subject discontinued for other reason|2|||
23532470|NCT00414050|65683298|FG003|Overall Study|Subject discontinued for other reason|1|||
23532471|NCT00414050|65683295|FG000|Overall Study|Subject Moved|0|||
23532472|NCT00414050|65683296|FG001|Overall Study|Subject Moved|0|||
23532473|NCT00414050|65683297|FG002|Overall Study|Subject Moved|0|||
23532474|NCT00414050|65683298|FG003|Overall Study|Subject Moved|1|||
23532475|NCT03256552|65683301|FG000|Overall Study|Protocol Violation|1|||
23532476|NCT03256552|65683301|FG000|Overall Study|Physician Decision|1|||
23532477|NCT03256552|65683301|FG000|Overall Study|Adverse Event|1|||
23532478|NCT03256552|65683301|FG000|Overall Study|Withdrawal by Subject|2|||
23532479|NCT04537806|65683312|FG000|Overall Study|Randomized but not treated|1|||
23532480|NCT04537806|65683313|FG001|Overall Study|Randomized but not treated|0|||
23532481|NCT04537806|65683312|FG000|Overall Study|Adverse Event|1|||
23532482|NCT04537806|65683313|FG001|Overall Study|Adverse Event|1|||
23532483|NCT00587587|65683314|FG000|Overall Study|Lost to Follow-up|6|||
23532484|NCT00587587|65683315|FG001|Overall Study|Lost to Follow-up|1|||
23614159|NCT00296504|65973258|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
23614160|NCT00296504|65973259|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
23614161|NCT00296504|65973260|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
23614162|NCT00296504|65973261|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
23614163|NCT00296504|65973262|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
23310316|NCT04497948|64881406|FG000|Overall Study|Death|2|||
23421150|NCT01646645|65283964|FG000|Overall Study|No Treated|1|||
23532485|NCT00413413|65683319|FG000|Single-Blind|Adverse Event|0|||
23532486|NCT00413413|65683320|FG001|Single-Blind|Adverse Event|9|||
23532487|NCT00413413|65683321|FG002|Single-Blind|Adverse Event|0|||
23532488|NCT00413413|65683319|FG000|Single-Blind|Lack of Efficacy|0|||
23532489|NCT00413413|65683320|FG001|Single-Blind|Lack of Efficacy|5|||
23532490|NCT00413413|65683321|FG002|Single-Blind|Lack of Efficacy|0|||
23532491|NCT00413413|65683319|FG000|Single-Blind|Subject no longer requires study drug|0|||
23532492|NCT00413413|65683320|FG001|Single-Blind|Subject no longer requires study drug|151|||
23532493|NCT00413413|65683321|FG002|Single-Blind|Subject no longer requires study drug|0|||
23532494|NCT00413413|65683319|FG000|Single-Blind|Protocol Violation|0|||
23532495|NCT00413413|65683320|FG001|Single-Blind|Protocol Violation|16|||
23532496|NCT00413413|65683321|FG002|Single-Blind|Protocol Violation|0|||
23532497|NCT00413413|65683319|FG000|Single-Blind|Withdrawal by Subject|0|||
23532498|NCT00413413|65683320|FG001|Single-Blind|Withdrawal by Subject|27|||
23421151|NCT01646645|65283964|FG000|Overall Study|Inevaluable Donor|29|||
23532499|NCT00413413|65683321|FG002|Single-Blind|Withdrawal by Subject|0|||
23532500|NCT00413413|65683319|FG000|Single-Blind|Lost to Follow-up|0|||
23532501|NCT00413413|65683320|FG001|Single-Blind|Lost to Follow-up|8|||
23532502|NCT00413413|65683321|FG002|Single-Blind|Lost to Follow-up|0|||
23532503|NCT00413413|65683319|FG000|Double-Blind|Adverse Event|6|||
23532504|NCT00413413|65683320|FG001|Double-Blind|Adverse Event|0|||
23532505|NCT00413413|65683321|FG002|Double-Blind|Adverse Event|5|||
23532506|NCT00413413|65683319|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
23532507|NCT00413413|65683320|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
23532508|NCT00413413|65683321|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
23532509|NCT00413413|65683319|FG000|Double-Blind|Protocol deviation|1|||
23532510|NCT00413413|65683320|FG001|Double-Blind|Protocol deviation|2|||
23532511|NCT00413413|65683321|FG002|Double-Blind|Protocol deviation|1|||
23532512|NCT00413413|65683319|FG000|Double-Blind|Subject withdrew consent|4|||
23532513|NCT00413413|65683320|FG001|Double-Blind|Subject withdrew consent|6|||
23532514|NCT00413413|65683321|FG002|Double-Blind|Subject withdrew consent|9|||
23532515|NCT00413413|65683319|FG000|Double-Blind|Lost to Follow-up|3|||
23532516|NCT00413413|65683320|FG001|Double-Blind|Lost to Follow-up|4|||
23532517|NCT00413413|65683321|FG002|Double-Blind|Lost to Follow-up|2|||
23207826|NCT00383721|64498288|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
23207827|NCT00383721|64498289|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
23207828|NCT00383721|64498290|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
23207829|NCT00383721|64498286|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
23207830|NCT00383721|64498287|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
23207831|NCT00383721|64498288|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
23207832|NCT00383721|64498289|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
23207833|NCT00383721|64498290|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
23207834|NCT00383721|64498286|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
23207835|NCT00383721|64498287|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
23207836|NCT00383721|64498288|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
23207837|NCT00383721|64498289|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
23207838|NCT00383721|64498290|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
23207839|NCT00383721|64498286|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
23207840|NCT00383721|64498287|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
23207841|NCT00383721|64498288|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
23207842|NCT00383721|64498289|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
23207843|NCT00383721|64498290|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
23207844|NCT00383721|64498286|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
23207845|NCT00383721|64498287|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
23207846|NCT00383721|64498288|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
23207847|NCT00383721|64498289|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
23207848|NCT00383721|64498290|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
23310317|NCT01724489|64881410|FG000|Overall Study|Adverse Event|8|||
23532518|NCT00773097|65683322|FG000|Overall Study|Withdrawal by Subject|1|||
23614164|NCT00296504|65973263|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
23207849|NCT00383721|64498286|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
23207850|NCT00383721|64498287|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
23207851|NCT00383721|64498288|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
23207852|NCT00383721|64498289|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
23207853|NCT00383721|64498290|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
23207854|NCT00383721|64498286|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
23207855|NCT00383721|64498287|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
23207856|NCT00383721|64498288|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
23207857|NCT00383721|64498289|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
23207858|NCT00383721|64498290|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
23207859|NCT00383721|64498286|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
23207860|NCT00383721|64498287|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
23207861|NCT00383721|64498288|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
23207862|NCT00383721|64498289|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
23207863|NCT00383721|64498290|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
23207864|NCT00383721|64498286|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
23207865|NCT00383721|64498287|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
23207866|NCT00383721|64498288|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
23207867|NCT00383721|64498289|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23207868|NCT00383721|64498290|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
23207869|NCT00383721|64498286|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
23207870|NCT00383721|64498287|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
23207871|NCT00383721|64498288|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
23207872|NCT00383721|64498289|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
23207873|NCT00383721|64498290|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
23207874|NCT00383721|64498286|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
23207875|NCT00383721|64498287|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
23207876|NCT00383721|64498288|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
23207877|NCT00383721|64498289|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
23207878|NCT00383721|64498290|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
23207879|NCT00383721|64498286|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23207880|NCT00383721|64498287|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23207881|NCT00383721|64498288|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23207882|NCT00383721|64498289|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23207883|NCT00383721|64498290|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
23207884|NCT00383721|64498286|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
23207885|NCT00383721|64498287|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23207886|NCT00383721|64498288|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23207887|NCT00383721|64498289|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
23207888|NCT00383721|64498290|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
23207889|NCT00383721|64498286|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23532519|NCT00773097|65683322|FG000|Overall Study|Physician Decision|6|||
23532520|NCT01465802|65683323|FG000|Overall Study|Study terminated by sponsor|1|||
23532521|NCT01465802|65683324|FG001|Overall Study|Study terminated by sponsor|0|||
23532522|NCT01465802|65683325|FG002|Overall Study|Study terminated by sponsor|0|||
23532523|NCT01465802|65683326|FG003|Overall Study|Study terminated by sponsor|1|||
23532524|NCT01465802|65683327|FG004|Overall Study|Study terminated by sponsor|7|||
23532525|NCT01465802|65683323|FG000|Overall Study|Withdrawal by Subject|7|||
23532526|NCT01465802|65683324|FG001|Overall Study|Withdrawal by Subject|7|||
23532527|NCT01465802|65683325|FG002|Overall Study|Withdrawal by Subject|0|||
23532528|NCT01465802|65683326|FG003|Overall Study|Withdrawal by Subject|8|||
23532529|NCT01465802|65683327|FG004|Overall Study|Withdrawal by Subject|1|||
23207890|NCT00383721|64498287|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23207891|NCT00383721|64498288|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23532530|NCT01465802|65683323|FG000|Overall Study|Lost to Follow-up|1|||
23532531|NCT01465802|65683324|FG001|Overall Study|Lost to Follow-up|1|||
23532532|NCT01465802|65683325|FG002|Overall Study|Lost to Follow-up|0|||
23532533|NCT01465802|65683326|FG003|Overall Study|Lost to Follow-up|0|||
23532534|NCT01465802|65683327|FG004|Overall Study|Lost to Follow-up|0|||
23532535|NCT01465802|65683323|FG000|Overall Study|Reason not specified|9|||
23532536|NCT01465802|65683324|FG001|Overall Study|Reason not specified|4|||
23532537|NCT01465802|65683325|FG002|Overall Study|Reason not specified|0|||
23532538|NCT01465802|65683326|FG003|Overall Study|Reason not specified|10|||
23532539|NCT01465802|65683327|FG004|Overall Study|Reason not specified|2|||
23532540|NCT01465802|65683323|FG000|Overall Study|Death|15|||
23532541|NCT01465802|65683324|FG001|Overall Study|Death|12|||
23532542|NCT01465802|65683325|FG002|Overall Study|Death|0|||
23532543|NCT01465802|65683326|FG003|Overall Study|Death|10|||
23532544|NCT01465802|65683327|FG004|Overall Study|Death|2|||
23532545|NCT02477020|65683328|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
23532546|NCT02477020|65683329|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
23532547|NCT02477020|65683328|FG000|Overall Study|Voluntary Withdrawal|7|||
23532548|NCT02477020|65683329|FG001|Overall Study|Voluntary Withdrawal|16|||
23532549|NCT02477020|65683328|FG000|Overall Study|Reason not Specified|3|||
23532550|NCT02477020|65683329|FG001|Overall Study|Reason not Specified|1|||
23532551|NCT02477020|65683328|FG000|Overall Study|Lack of Efficacy|14|||
23421152|NCT03224507|65283965|FG000|Overall Study|Death|3|||
23532552|NCT02477020|65683329|FG001|Overall Study|Lack of Efficacy|5|||
23532553|NCT04115358|65683330|FG000|Overall Study|exfoliation|0|||
23532554|NCT04115358|65683331|FG001|Overall Study|exfoliation|0|||
23532555|NCT04115358|65683332|FG002|Overall Study|exfoliation|1|||
23532556|NCT00326911|65683336|FG000|Overall Study|Hospitalization prior to treatment|0|||
23532557|NCT00326911|65683337|FG001|Overall Study|Hospitalization prior to treatment|1|||
23532558|NCT00326911|65683336|FG000|Overall Study|Physician decision prior to treatment|1|||
23532559|NCT00326911|65683337|FG001|Overall Study|Physician decision prior to treatment|0|||
23532560|NCT00326911|65683336|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
23532561|NCT00326911|65683337|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
23532562|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
23532563|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532564|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532565|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532566|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532567|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532568|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23532569|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
23532570|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532571|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532572|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532573|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532574|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532575|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23532576|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
23532577|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532578|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532579|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532580|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532581|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532582|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23532583|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
23532584|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532585|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532586|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532587|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532588|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23310318|NCT01724489|64881411|FG001|Overall Study|Adverse Event|3|||
23310319|NCT01724489|64881410|FG000|Overall Study|Surgery, medication|1|||
23310320|NCT01724489|64881411|FG001|Overall Study|Surgery, medication|1|||
23310321|NCT01724489|64881410|FG000|Overall Study|Lost to Follow-up|1|||
23310322|NCT01724489|64881411|FG001|Overall Study|Lost to Follow-up|2|||
23310323|NCT01724489|64881410|FG000|Overall Study|Withdrawal by Subject|6|||
23310324|NCT01724489|64881411|FG001|Overall Study|Withdrawal by Subject|6|||
23310325|NCT04502212|64881416|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
23310326|NCT04502212|64881416|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
23310327|NCT01004003|64881417|FG000|Overall Study|Progressive disease|2|||
23614165|NCT00296504|65973264|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
23614166|NCT00296504|65973256|FG000|Interim Analysis|Study Ended|0|||
23614167|NCT00296504|65973257|FG001|Interim Analysis|Study Ended|0|||
23614168|NCT00296504|65973258|FG002|Interim Analysis|Study Ended|0|||
23614169|NCT00296504|65973259|FG003|Interim Analysis|Study Ended|0|||
23614170|NCT00296504|65973260|FG004|Interim Analysis|Study Ended|0|||
23614171|NCT00296504|65973261|FG005|Interim Analysis|Study Ended|0|||
23614172|NCT00296504|65973262|FG006|Interim Analysis|Study Ended|1|||
23614173|NCT00296504|65973263|FG007|Interim Analysis|Study Ended|0|||
23614174|NCT00296504|65973264|FG008|Interim Analysis|Study Ended|0|||
23614175|NCT00296504|65973256|FG000|Interim Analysis|Participant Needed Interferon|0|||
23614176|NCT00296504|65973257|FG001|Interim Analysis|Participant Needed Interferon|0|||
23614177|NCT00296504|65973258|FG002|Interim Analysis|Participant Needed Interferon|0|||
23614178|NCT00296504|65973259|FG003|Interim Analysis|Participant Needed Interferon|0|||
23614179|NCT00296504|65973260|FG004|Interim Analysis|Participant Needed Interferon|0|||
23614180|NCT00296504|65973261|FG005|Interim Analysis|Participant Needed Interferon|0|||
23614181|NCT00296504|65973262|FG006|Interim Analysis|Participant Needed Interferon|0|||
23614182|NCT00296504|65973263|FG007|Interim Analysis|Participant Needed Interferon|1|||
23310328|NCT01004003|64881418|FG001|Overall Study|Progressive disease|1|||
23310329|NCT01004003|64881419|FG002|Overall Study|Progressive disease|1|||
23310330|NCT01004003|64881420|FG003|Overall Study|Progressive disease|0|||
23310331|NCT01004003|64881421|FG004|Overall Study|Progressive disease|2|||
23310332|NCT01004003|64881422|FG005|Overall Study|Progressive disease|1|||
23310333|NCT01004003|64881423|FG006|Overall Study|Progressive disease|1|||
23310334|NCT01004003|64881424|FG007|Overall Study|Progressive disease|39|||
23310335|NCT01004003|64881425|FG008|Overall Study|Progressive disease|22|||
23310336|NCT01004003|64881417|FG000|Overall Study|Adverse Event|4|||
23310337|NCT01004003|64881418|FG001|Overall Study|Adverse Event|2|||
23310338|NCT01004003|64881419|FG002|Overall Study|Adverse Event|3|||
23310339|NCT01004003|64881420|FG003|Overall Study|Adverse Event|3|||
23310340|NCT01004003|64881421|FG004|Overall Study|Adverse Event|2|||
23310341|NCT01004003|64881422|FG005|Overall Study|Adverse Event|2|||
23310342|NCT01004003|64881423|FG006|Overall Study|Adverse Event|7|||
23310343|NCT01004003|64881424|FG007|Overall Study|Adverse Event|21|||
23310344|NCT01004003|64881425|FG008|Overall Study|Adverse Event|6|||
23310345|NCT01004003|64881417|FG000|Overall Study|Refused to continue taking trial med.|0|||
23310346|NCT01004003|64881418|FG001|Overall Study|Refused to continue taking trial med.|0|||
23310347|NCT01004003|64881419|FG002|Overall Study|Refused to continue taking trial med.|0|||
23310348|NCT01004003|64881420|FG003|Overall Study|Refused to continue taking trial med.|0|||
23614183|NCT00296504|65973264|FG008|Interim Analysis|Participant Needed Interferon|0|||
23614184|NCT00296504|65973256|FG000|Interim Analysis|Ongoing|32|||
23614185|NCT00296504|65973257|FG001|Interim Analysis|Ongoing|12|||
23614186|NCT00296504|65973258|FG002|Interim Analysis|Ongoing|16|||
23207892|NCT00383721|64498289|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23207893|NCT00383721|64498290|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23207894|NCT00383721|64498286|FG000|26-Week Treatment Safety Extension|Administrative|1|||
23207895|NCT00383721|64498287|FG001|26-Week Treatment Safety Extension|Administrative|2|||
23207896|NCT00383721|64498288|FG002|26-Week Treatment Safety Extension|Administrative|3|||
23207897|NCT00383721|64498289|FG003|26-Week Treatment Safety Extension|Administrative|1|||
23207898|NCT00383721|64498290|FG004|26-Week Treatment Safety Extension|Administrative|0|||
23207899|NCT04550221|64498291|FG000|Overall Study|Lost to Follow-up|0|||
23207900|NCT04550221|64498292|FG001|Overall Study|Lost to Follow-up|4|||
23207901|NCT04550221|64498291|FG000|Overall Study|Withdrawn|3|||
23207902|NCT04550221|64498292|FG001|Overall Study|Withdrawn|0|||
23207903|NCT04550221|64498291|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
23207904|NCT04550221|64498292|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
23207905|NCT01098461|64498293|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
23207906|NCT01098461|64498294|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
23207907|NCT01098461|64498295|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
23207908|NCT01098461|64498296|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
23207909|NCT01098461|64498293|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
23207910|NCT01098461|64498294|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
23207911|NCT01098461|64498295|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
23207912|NCT01098461|64498296|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
23207913|NCT01098461|64498293|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
23207914|NCT01098461|64498294|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
23207915|NCT01098461|64498295|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
23207916|NCT01098461|64498296|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
23207917|NCT01098461|64498293|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
23207918|NCT01098461|64498294|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
23207919|NCT01098461|64498295|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
23207920|NCT01098461|64498296|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
23207921|NCT01098461|64498293|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
23207922|NCT01098461|64498294|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
23207923|NCT01098461|64498295|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
23207924|NCT01098461|64498296|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
23207925|NCT01098461|64498293|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
23614187|NCT00296504|65973259|FG003|Interim Analysis|Ongoing|22|||
23614188|NCT00296504|65973260|FG004|Interim Analysis|Ongoing|0|||
23614189|NCT00296504|65973261|FG005|Interim Analysis|Ongoing|0|||
23614190|NCT00296504|65973262|FG006|Interim Analysis|Ongoing|30|||
23614191|NCT00296504|65973263|FG007|Interim Analysis|Ongoing|1|||
23614192|NCT00296504|65973264|FG008|Interim Analysis|Ongoing|0|||
23310349|NCT01004003|64881421|FG004|Overall Study|Refused to continue taking trial med.|0|||
23310350|NCT01004003|64881422|FG005|Overall Study|Refused to continue taking trial med.|0|||
23310351|NCT01004003|64881423|FG006|Overall Study|Refused to continue taking trial med.|0|||
23310352|NCT01004003|64881424|FG007|Overall Study|Refused to continue taking trial med.|0|||
23310353|NCT01004003|64881425|FG008|Overall Study|Refused to continue taking trial med.|2|||
23310354|NCT01004003|64881417|FG000|Overall Study|Other|0|||
23310355|NCT01004003|64881418|FG001|Overall Study|Other|0|||
23310356|NCT01004003|64881419|FG002|Overall Study|Other|0|||
23310357|NCT01004003|64881420|FG003|Overall Study|Other|0|||
23310358|NCT01004003|64881421|FG004|Overall Study|Other|0|||
23310359|NCT01004003|64881422|FG005|Overall Study|Other|1|||
23310360|NCT01004003|64881423|FG006|Overall Study|Other|0|||
23310361|NCT01004003|64881424|FG007|Overall Study|Other|0|||
23310362|NCT01004003|64881425|FG008|Overall Study|Other|0|||
23310363|NCT00049530|64881426|FG000|Overall Study|Lack of Efficacy|25|||
23310364|NCT00049530|64881426|FG000|Overall Study|Adverse Event|2|||
23310365|NCT00049530|64881426|FG000|Overall Study|Death|1|||
23310366|NCT00049530|64881426|FG000|Overall Study|symptomatic deterioration|1|||
23310367|NCT00049530|64881426|FG000|Overall Study|ineligible|3|||
23310368|NCT03866902|64881430|FG000|Overall Study|Lost to Follow-up|98|||
23310369|NCT03866902|64881431|FG001|Overall Study|Lost to Follow-up|82|||
23310370|NCT03866902|64881430|FG000|Overall Study|Pregnancy|18|||
23310371|NCT03866902|64881431|FG001|Overall Study|Pregnancy|24|||
23310372|NCT00851318|64881432|FG000|Overall Study|Withdrawal by Subject|7|||
23310373|NCT00851318|64881433|FG001|Overall Study|Withdrawal by Subject|1|||
23310374|NCT00851318|64881434|FG002|Overall Study|Withdrawal by Subject|5|||
23310375|NCT00851318|64881435|FG003|Overall Study|Withdrawal by Subject|3|||
23310376|NCT00851318|64881432|FG000|Overall Study|Adverse Event|13|||
23310377|NCT00851318|64881433|FG001|Overall Study|Adverse Event|2|||
23310378|NCT00851318|64881434|FG002|Overall Study|Adverse Event|9|||
23310379|NCT00851318|64881435|FG003|Overall Study|Adverse Event|12|||
23310380|NCT00851318|64881432|FG000|Overall Study|Pregnancy|0|||
23310381|NCT00851318|64881433|FG001|Overall Study|Pregnancy|0|||
23310382|NCT00851318|64881434|FG002|Overall Study|Pregnancy|1|||
23310383|NCT00851318|64881435|FG003|Overall Study|Pregnancy|1|||
23310384|NCT00851318|64881432|FG000|Overall Study|Lack of Efficacy|8|||
23310385|NCT00851318|64881433|FG001|Overall Study|Lack of Efficacy|2|||
23310386|NCT00851318|64881434|FG002|Overall Study|Lack of Efficacy|4|||
23310387|NCT00851318|64881435|FG003|Overall Study|Lack of Efficacy|2|||
23310388|NCT00851318|64881432|FG000|Overall Study|Non-compliance with Study Procedures|2|||
23310389|NCT00851318|64881433|FG001|Overall Study|Non-compliance with Study Procedures|0|||
23310390|NCT00851318|64881434|FG002|Overall Study|Non-compliance with Study Procedures|1|||
23310391|NCT00851318|64881435|FG003|Overall Study|Non-compliance with Study Procedures|0|||
23310392|NCT00851318|64881432|FG000|Overall Study|Physician Decision|0|||
23310393|NCT00851318|64881433|FG001|Overall Study|Physician Decision|0|||
23310394|NCT00851318|64881434|FG002|Overall Study|Physician Decision|1|||
23310395|NCT00851318|64881435|FG003|Overall Study|Physician Decision|1|||
23310396|NCT02752906|64881436|FG000|Overall Study|Protocol Violation|2|||
23310397|NCT02752906|64881437|FG001|Overall Study|Protocol Violation|1|||
23310398|NCT02752906|64881436|FG000|Overall Study|Withdrawal by Subject|2|||
23310399|NCT02752906|64881437|FG001|Overall Study|Withdrawal by Subject|2|||
23310400|NCT02752906|64881436|FG000|Overall Study|Lost to Follow-up|3|||
23310401|NCT02752906|64881437|FG001|Overall Study|Lost to Follow-up|2|||
23421153|NCT03224507|65283966|FG001|Overall Study|Death|0|||
23421154|NCT03224507|65283965|FG000|Overall Study|Lack of Efficacy|6|||
23421155|NCT03224507|65283966|FG001|Overall Study|Lack of Efficacy|0|||
23421156|NCT03224507|65283965|FG000|Overall Study|Withdrawal by Subject|6|||
23421157|NCT03224507|65283966|FG001|Overall Study|Withdrawal by Subject|0|||
23207926|NCT01098461|64498294|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
23310402|NCT00609518|64881438|FG000|Overall Study|Death from Study Disease|32|||
23310403|NCT00609518|64881439|FG001|Overall Study|Death from Study Disease|32|||
23421158|NCT04240457|65283967|FG000|Overall Study|Lost to Follow-up|5|||
23421159|NCT04240457|65283968|FG001|Overall Study|Lost to Follow-up|1|||
23421160|NCT05275010|65283969|FG000|Overall Study|Reason Not Specified|4|||
23532589|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23532590|NCT01479621|65683340|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
23532591|NCT01479621|65683341|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532592|NCT01479621|65683342|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532593|NCT01479621|65683343|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532594|NCT01479621|65683344|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532595|NCT01479621|65683345|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532596|NCT01479621|65683346|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23532597|NCT01479621|65683340|FG000|Treatment Period|Adverse Event|0|||
23310404|NCT00609518|64881438|FG000|Overall Study|Withdrawal by Subject|5|||
23532598|NCT01479621|65683341|FG001|Treatment Period|Adverse Event|0|||
23310405|NCT00609518|64881439|FG001|Overall Study|Withdrawal by Subject|3|||
23310406|NCT00609518|64881438|FG000|Overall Study|Lost to Follow-up|3|||
23310407|NCT00609518|64881439|FG001|Overall Study|Lost to Follow-up|0|||
23532599|NCT01479621|65683342|FG002|Treatment Period|Adverse Event|0|||
23532600|NCT01479621|65683343|FG003|Treatment Period|Adverse Event|0|||
23532601|NCT01479621|65683344|FG004|Treatment Period|Adverse Event|1|||
23614193|NCT00296504|65973256|FG000|Final Analysis|Withdrawal by Subject|0|||
23614194|NCT00296504|65973257|FG001|Final Analysis|Withdrawal by Subject|0|||
23532602|NCT01479621|65683345|FG005|Treatment Period|Adverse Event|2|||
23614195|NCT00296504|65973258|FG002|Final Analysis|Withdrawal by Subject|0|||
23421161|NCT05275010|65283970|FG001|Overall Study|Reason Not Specified|1|||
23421162|NCT05275010|65283969|FG000|Overall Study|Withdrawal by Subject|1|||
23421163|NCT05275010|65283970|FG001|Overall Study|Withdrawal by Subject|0|||
23421164|NCT05275010|65283969|FG000|Overall Study|Lost to Follow-up|0|||
23421165|NCT05275010|65283970|FG001|Overall Study|Lost to Follow-up|1|||
23421166|NCT00782171|65283971|FG000|Overall Study|Lost to Follow-up|2|||
23421167|NCT00782171|65283972|FG001|Overall Study|Lost to Follow-up|2|||
23421168|NCT00782171|65283971|FG000|Overall Study|Withdrawal by Subject|2|||
23421169|NCT00782171|65283972|FG001|Overall Study|Withdrawal by Subject|1|||
23421170|NCT00782171|65283971|FG000|Overall Study|complications|3|||
23421171|NCT00782171|65283972|FG001|Overall Study|complications|1|||
23421172|NCT00782171|65283971|FG000|Overall Study|others|7|||
23421173|NCT00782171|65283972|FG001|Overall Study|others|9|||
23421174|NCT00782171|65283971|FG000|Overall Study|not eligible|8|||
23421175|NCT00782171|65283972|FG001|Overall Study|not eligible|6|||
23421176|NCT04096820|65283973|FG000|Overall Study|Did not return for intervention|2|||
23421177|NCT04096820|65283973|FG000|Overall Study|Death|1|||
23421178|NCT00884039|65283975|FG000|Overall Study|Withdrawal by Subject|0|||
23421179|NCT00884039|65283976|FG001|Overall Study|Withdrawal by Subject|1|||
23421180|NCT00884039|65283975|FG000|Overall Study|Lack of Efficacy|2|||
23421181|NCT00884039|65283976|FG001|Overall Study|Lack of Efficacy|0|||
23421182|NCT00096174|65283977|FG000|Overall Study|Lack of Efficacy|9|||
23421183|NCT00096174|65283977|FG000|Overall Study|Adverse Event|15|||
23421184|NCT00096174|65283977|FG000|Overall Study|Death|6|||
23421185|NCT00096174|65283977|FG000|Overall Study|Withdrawal by Subject|15|||
23421186|NCT00096174|65283977|FG000|Overall Study|Not started protocol therapy|3|||
23421187|NCT00096174|65283977|FG000|Overall Study|Ineligible|6|||
23421188|NCT00096174|65283977|FG000|Overall Study|other reason|8|||
23421189|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
23421190|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
23421191|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
23421192|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
23421193|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
23421194|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
23421195|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
23421196|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
23421197|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
23421198|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
23421199|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
23421200|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
23421201|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
23421202|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
23421203|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
23421204|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
23532603|NCT01479621|65683346|FG006|Treatment Period|Adverse Event|2|||
23421205|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
23421206|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
23532604|NCT01479621|65683340|FG000|Treatment Period|Withdrawal by Subject|0|||
23532605|NCT01479621|65683341|FG001|Treatment Period|Withdrawal by Subject|4|||
23421207|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
23532606|NCT01479621|65683342|FG002|Treatment Period|Withdrawal by Subject|2|||
23532607|NCT01479621|65683343|FG003|Treatment Period|Withdrawal by Subject|2|||
23532608|NCT01479621|65683344|FG004|Treatment Period|Withdrawal by Subject|5|||
23532609|NCT01479621|65683345|FG005|Treatment Period|Withdrawal by Subject|5|||
23532610|NCT01479621|65683346|FG006|Treatment Period|Withdrawal by Subject|1|||
23532611|NCT01479621|65683340|FG000|Treatment Period|Physician Decision|0|||
23532612|NCT01479621|65683341|FG001|Treatment Period|Physician Decision|0|||
23532613|NCT01479621|65683342|FG002|Treatment Period|Physician Decision|0|||
23532614|NCT01479621|65683343|FG003|Treatment Period|Physician Decision|0|||
23532615|NCT01479621|65683344|FG004|Treatment Period|Physician Decision|1|||
23532616|NCT01479621|65683345|FG005|Treatment Period|Physician Decision|1|||
23614196|NCT00296504|65973259|FG003|Final Analysis|Withdrawal by Subject|0|||
23532617|NCT01479621|65683346|FG006|Treatment Period|Physician Decision|0|||
23532618|NCT01479621|65683340|FG000|Treatment Period|Non-compliance to study drug|0|||
23532619|NCT01479621|65683341|FG001|Treatment Period|Non-compliance to study drug|1|||
23532620|NCT01479621|65683342|FG002|Treatment Period|Non-compliance to study drug|0|||
23532621|NCT01479621|65683343|FG003|Treatment Period|Non-compliance to study drug|0|||
23532622|NCT01479621|65683344|FG004|Treatment Period|Non-compliance to study drug|0|||
23532623|NCT01479621|65683345|FG005|Treatment Period|Non-compliance to study drug|0|||
23532624|NCT01479621|65683346|FG006|Treatment Period|Non-compliance to study drug|1|||
23532625|NCT01479621|65683340|FG000|Treatment Period|Protocol Violation|0|||
23532626|NCT01479621|65683341|FG001|Treatment Period|Protocol Violation|9|||
23532627|NCT01479621|65683342|FG002|Treatment Period|Protocol Violation|6|||
23532628|NCT01479621|65683343|FG003|Treatment Period|Protocol Violation|5|||
23532629|NCT01479621|65683344|FG004|Treatment Period|Protocol Violation|2|||
23532630|NCT01479621|65683345|FG005|Treatment Period|Protocol Violation|10|||
23532631|NCT01479621|65683346|FG006|Treatment Period|Protocol Violation|6|||
23532632|NCT01479621|65683340|FG000|Treatment Period|Pregnancy|0|||
23532633|NCT01479621|65683341|FG001|Treatment Period|Pregnancy|0|||
23532634|NCT01479621|65683342|FG002|Treatment Period|Pregnancy|2|||
23532635|NCT01479621|65683343|FG003|Treatment Period|Pregnancy|0|||
23532636|NCT01479621|65683344|FG004|Treatment Period|Pregnancy|0|||
23532637|NCT01479621|65683345|FG005|Treatment Period|Pregnancy|0|||
23532638|NCT01479621|65683346|FG006|Treatment Period|Pregnancy|0|||
23532639|NCT01479621|65683340|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
23532640|NCT01479621|65683341|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
23421208|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
23421209|NCT03222973|65283984|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
23421210|NCT03222973|65283985|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
23421211|NCT03222973|65283986|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
23421212|NCT03222973|65283987|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
23421213|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
23614197|NCT00296504|65973260|FG004|Final Analysis|Withdrawal by Subject|0|||
23421214|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
23421215|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
23421216|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
23532641|NCT01479621|65683342|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
23532642|NCT01479621|65683343|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
23532643|NCT01479621|65683344|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
23532644|NCT01479621|65683345|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
23532645|NCT01479621|65683346|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
23532646|NCT01479621|65683340|FG000|Treatment Period|Lost to Follow-up|0|||
23532647|NCT01479621|65683341|FG001|Treatment Period|Lost to Follow-up|0|||
23532648|NCT01479621|65683342|FG002|Treatment Period|Lost to Follow-up|1|||
23532649|NCT01479621|65683343|FG003|Treatment Period|Lost to Follow-up|0|||
23532650|NCT01479621|65683344|FG004|Treatment Period|Lost to Follow-up|2|||
23532651|NCT01479621|65683345|FG005|Treatment Period|Lost to Follow-up|2|||
23532652|NCT01479621|65683346|FG006|Treatment Period|Lost to Follow-up|1|||
23532653|NCT01479621|65683340|FG000|Treatment Period|Met stopping criteria|0|||
23532654|NCT01479621|65683341|FG001|Treatment Period|Met stopping criteria|8|||
23532655|NCT01479621|65683342|FG002|Treatment Period|Met stopping criteria|7|||
23532656|NCT01479621|65683343|FG003|Treatment Period|Met stopping criteria|4|||
23532657|NCT01479621|65683344|FG004|Treatment Period|Met stopping criteria|9|||
23532658|NCT01479621|65683345|FG005|Treatment Period|Met stopping criteria|20|||
23532659|NCT01479621|65683346|FG006|Treatment Period|Met stopping criteria|6|||
23532660|NCT03265119|65683349|FG000|Overall Study|Adverse Event|2|||
23532661|NCT03265119|65683350|FG001|Overall Study|Adverse Event|1|||
23532662|NCT03265119|65683349|FG000|Overall Study|Lack of Efficacy|3|||
23614198|NCT00296504|65973261|FG005|Final Analysis|Withdrawal by Subject|0|||
23421217|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
23421218|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
23421219|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
23421220|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
23421221|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
23421222|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
23421223|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
23421224|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
23421225|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
23421226|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
23421227|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
23421228|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
23421229|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
23421230|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
23421231|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
23421232|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
23421233|NCT03222973|65283984|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
23532663|NCT03265119|65683350|FG001|Overall Study|Lack of Efficacy|0|||
23532664|NCT03265119|65683349|FG000|Overall Study|Protocol Violation|1|||
23532665|NCT03265119|65683350|FG001|Overall Study|Protocol Violation|2|||
23532666|NCT03265119|65683349|FG000|Overall Study|Withdrawal by Subject|2|||
23532667|NCT03265119|65683350|FG001|Overall Study|Withdrawal by Subject|4|||
23614199|NCT00296504|65973262|FG006|Final Analysis|Withdrawal by Subject|0|||
23614200|NCT00296504|65973263|FG007|Final Analysis|Withdrawal by Subject|0|||
23614201|NCT00296504|65973264|FG008|Final Analysis|Withdrawal by Subject|1|||
23614202|NCT00296504|65973256|FG000|Final Analysis|Lost to Follow-up|0|||
23614203|NCT00296504|65973257|FG001|Final Analysis|Lost to Follow-up|0|||
23614204|NCT00296504|65973258|FG002|Final Analysis|Lost to Follow-up|0|||
23614205|NCT00296504|65973259|FG003|Final Analysis|Lost to Follow-up|0|||
23614206|NCT00296504|65973260|FG004|Final Analysis|Lost to Follow-up|0|||
23614207|NCT00296504|65973261|FG005|Final Analysis|Lost to Follow-up|0|||
23614208|NCT00296504|65973262|FG006|Final Analysis|Lost to Follow-up|0|||
23614209|NCT00296504|65973263|FG007|Final Analysis|Lost to Follow-up|0|||
23614210|NCT00296504|65973264|FG008|Final Analysis|Lost to Follow-up|5|||
23614211|NCT00296504|65973256|FG000|Final Analysis|Insufficient Viral Load Response|0|||
23614212|NCT00296504|65973257|FG001|Final Analysis|Insufficient Viral Load Response|0|||
23614213|NCT00296504|65973258|FG002|Final Analysis|Insufficient Viral Load Response|0|||
23207927|NCT01098461|64498295|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
23207928|NCT01098461|64498296|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
23207929|NCT01098461|64498293|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
23207930|NCT01098461|64498294|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
23207931|NCT01098461|64498295|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
23207932|NCT01098461|64498296|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
23207933|NCT02657551|64498298|FG000|Overall Study|Adverse Event|2|||
23207934|NCT02657551|64498298|FG000|Overall Study|Withdrawal by Subject|1|||
23207935|NCT02657551|64498298|FG000|Overall Study|Non-Compliance|1|||
23207936|NCT02657551|64498298|FG000|Overall Study|Progression / Relapse|4|||
23207937|NCT00446446|64498299|FG000|Overall Study|Death|10|||
23207938|NCT00446446|64498299|FG000|Overall Study|Withdrawal by Subject|6|||
23207939|NCT00446446|64498299|FG000|Overall Study|Other|4|||
23207940|NCT00446446|64498299|FG000|Overall Study|Disease Progession|2|||
23207941|NCT00446446|64498299|FG000|Overall Study|Adverse Event|1|||
23207942|NCT00446446|64498299|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
23207943|NCT01324622|64498302|FG000|Overall Study|Lost to Follow-up|7|||
23207944|NCT01324622|64498303|FG001|Overall Study|Lost to Follow-up|7|||
23207945|NCT01324622|64498302|FG000|Overall Study|Death|1|||
23207946|NCT01324622|64498303|FG001|Overall Study|Death|0|||
23207947|NCT01324622|64498302|FG000|Overall Study|Lack of Efficacy|1|||
23207948|NCT01324622|64498303|FG001|Overall Study|Lack of Efficacy|0|||
23207949|NCT01953328|64498304|FG000|Overall Study|Withdrawal by Subject|0|||
23207950|NCT01953328|64498305|FG001|Overall Study|Withdrawal by Subject|0|||
23207951|NCT01953328|64498306|FG002|Overall Study|Withdrawal by Subject|0|||
23207952|NCT01953328|64498307|FG003|Overall Study|Withdrawal by Subject|0|||
23532668|NCT03265119|65683349|FG000|Overall Study|Lost to Follow-up|1|||
23532669|NCT03265119|65683350|FG001|Overall Study|Lost to Follow-up|0|||
23532670|NCT03265119|65683349|FG000|Overall Study|Lack of Compliance|1|||
23532671|NCT03265119|65683350|FG001|Overall Study|Lack of Compliance|0|||
23532672|NCT02130765|65683351|FG000|Overall Study|Did not receive treatment|4|||
23532673|NCT02130765|65683352|FG001|Overall Study|Did not receive treatment|0|||
23532674|NCT02130765|65683353|FG002|Overall Study|Did not receive treatment|0|||
23532675|NCT02130765|65683354|FG003|Overall Study|Did not receive treatment|0|||
23532676|NCT01234467|65683355|FG000|Overall Study|Adverse Event|3|||
23614214|NCT00296504|65973259|FG003|Final Analysis|Insufficient Viral Load Response|0|||
23614215|NCT00296504|65973260|FG004|Final Analysis|Insufficient Viral Load Response|0|||
23614216|NCT00296504|65973261|FG005|Final Analysis|Insufficient Viral Load Response|0|||
23614217|NCT00296504|65973262|FG006|Final Analysis|Insufficient Viral Load Response|0|||
23207953|NCT01953328|64498308|FG004|Overall Study|Withdrawal by Subject|1|||
23207954|NCT01953328|64498309|FG005|Overall Study|Withdrawal by Subject|0|||
23532677|NCT01234467|65683355|FG000|Overall Study|Death|2|||
23532678|NCT01234467|65683355|FG000|Overall Study|Withdrawal by Subject|2|||
23532679|NCT01234467|65683355|FG000|Overall Study|Disease Progression|2|||
23532680|NCT01234467|65683355|FG000|Overall Study|Clinical deterioration|1|||
23532681|NCT01234467|65683355|FG000|Overall Study|Physician Decision|1|||
23532682|NCT01234467|65683355|FG000|Overall Study|Other complicating disease (stroke)|1|||
23207955|NCT01953328|64498310|FG006|Overall Study|Withdrawal by Subject|0|||
23207956|NCT01953328|64498311|FG007|Overall Study|Withdrawal by Subject|0|||
23207957|NCT01953328|64498304|FG000|Overall Study|Lost to Follow-up|0|||
23207958|NCT01953328|64498305|FG001|Overall Study|Lost to Follow-up|0|||
23207959|NCT01953328|64498306|FG002|Overall Study|Lost to Follow-up|0|||
23532683|NCT00767676|65683358|FG000|Overall Study|Investigator error|54|||
23532684|NCT04122443|65683359|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
23532685|NCT04122443|65683360|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
23614218|NCT00296504|65973263|FG007|Final Analysis|Insufficient Viral Load Response|0|||
23614219|NCT00296504|65973264|FG008|Final Analysis|Insufficient Viral Load Response|6|||
23614220|NCT00296504|65973256|FG000|Final Analysis|Adverse Event|0|||
23532686|NCT04122443|65683361|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
23532687|NCT04122443|65683359|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
23532688|NCT04122443|65683360|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
23532689|NCT04122443|65683361|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
23532690|NCT00826267|65683362|FG000|Overall Study|Other Adverse Event|1|||
23532691|NCT00826267|65683363|FG001|Overall Study|Other Adverse Event|0|||
23532692|NCT00826267|65683364|FG002|Overall Study|Other Adverse Event|0|||
23532693|NCT02871375|65683365|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
23532694|NCT02871375|65683366|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
23532695|NCT01714310|65683367|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
23532696|NCT01714310|65683368|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
23532697|NCT01714310|65683369|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
23532698|NCT01714310|65683367|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
23532699|NCT01714310|65683368|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
23532700|NCT01714310|65683369|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
23532701|NCT01714310|65683367|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
23532702|NCT01714310|65683368|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
23532703|NCT01714310|65683369|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
23532704|NCT01714310|65683367|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
23532705|NCT01714310|65683368|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
23532706|NCT01714310|65683369|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
23532707|NCT02880371|65683372|FG000|Phase 1b|Lost to Follow-up|1|||
23421234|NCT03222973|65283985|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
23421235|NCT03222973|65283986|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
23421236|NCT03222973|65283987|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
23421237|NCT00489424|65283990|FG000|Overall Study|Adverse Event|3|||
23421238|NCT00489424|65283991|FG001|Overall Study|Adverse Event|3|||
23421239|NCT00489424|65283992|FG002|Overall Study|Adverse Event|4|||
23421240|NCT00489424|65283990|FG000|Overall Study|Lack of Efficacy|1|||
23421241|NCT00489424|65283991|FG001|Overall Study|Lack of Efficacy|0|||
23421242|NCT00489424|65283992|FG002|Overall Study|Lack of Efficacy|0|||
23421243|NCT00489424|65283990|FG000|Overall Study|Administrative problems|0|||
23421244|NCT00489424|65283991|FG001|Overall Study|Administrative problems|2|||
23421245|NCT00489424|65283992|FG002|Overall Study|Administrative problems|1|||
23421246|NCT02310230|65283993|FG000|Overall Study|Physician Decision|1|||
23421247|NCT02310230|65283994|FG001|Overall Study|Physician Decision|3|||
23421248|NCT02310230|65283993|FG000|Overall Study|monitor baseline taken after induction|2|||
23421249|NCT02310230|65283994|FG001|Overall Study|monitor baseline taken after induction|7|||
23421250|NCT02310230|65283993|FG000|Overall Study|Poor signal quality|5|||
23421251|NCT02310230|65283994|FG001|Overall Study|Poor signal quality|8|||
23421252|NCT02310230|65283993|FG000|Overall Study|Case cancelled|1|||
23421253|NCT02310230|65283994|FG001|Overall Study|Case cancelled|0|||
23421254|NCT02220855|65283995|FG000|Overall Study|Adverse Event|8|||
23421255|NCT02220855|65283995|FG000|Overall Study|Disease Progression|5|||
23421256|NCT02220855|65283995|FG000|Overall Study|Withdrawal by Subject|1|||
23421257|NCT01468207|65283996|FG000|Treatment Period 1|Adverse Event|1|||
23421258|NCT01468207|65283997|FG001|Treatment Period 1|Adverse Event|0|||
23421259|NCT01468207|65283998|FG002|Treatment Period 1|Adverse Event|0|||
23421260|NCT01468207|65283999|FG003|Treatment Period 1|Adverse Event|0|||
23421261|NCT01468207|65284000|FG004|Treatment Period 1|Adverse Event|0|||
23421262|NCT01468207|65284001|FG005|Treatment Period 1|Adverse Event|0|||
23421263|NCT01468207|65283996|FG000|Treatment Period 1|Protocol Violation|1|||
23421264|NCT01468207|65283997|FG001|Treatment Period 1|Protocol Violation|1|||
23421265|NCT01468207|65283998|FG002|Treatment Period 1|Protocol Violation|0|||
23421266|NCT01468207|65283999|FG003|Treatment Period 1|Protocol Violation|0|||
23421267|NCT01468207|65284000|FG004|Treatment Period 1|Protocol Violation|0|||
23421268|NCT01468207|65284001|FG005|Treatment Period 1|Protocol Violation|0|||
23421269|NCT01468207|65283996|FG000|Treatment Period 1|Withdrawal by Subject|5|||
23421270|NCT01468207|65283997|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23421271|NCT01468207|65283998|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23421272|NCT01468207|65283999|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23421273|NCT01468207|65284000|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23421274|NCT01468207|65284001|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23421275|NCT01468207|65283996|FG000|Treatment Period 1|Lost to Follow-up|2|||
23532708|NCT02880371|65683373|FG001|Phase 1b|Lost to Follow-up|0|||
23532709|NCT02880371|65683374|FG002|Phase 1b|Lost to Follow-up|0|||
23421276|NCT01468207|65283997|FG001|Treatment Period 1|Lost to Follow-up|1|||
23421277|NCT01468207|65283998|FG002|Treatment Period 1|Lost to Follow-up|0|||
23421278|NCT01468207|65283999|FG003|Treatment Period 1|Lost to Follow-up|0|||
23421279|NCT01468207|65284000|FG004|Treatment Period 1|Lost to Follow-up|0|||
23421280|NCT01468207|65284001|FG005|Treatment Period 1|Lost to Follow-up|0|||
23421281|NCT01468207|65283996|FG000|Treatment Period 1|Other|0|||
23421282|NCT01468207|65283997|FG001|Treatment Period 1|Other|2|||
23421283|NCT01468207|65283998|FG002|Treatment Period 1|Other|0|||
23614221|NCT00296504|65973257|FG001|Final Analysis|Adverse Event|0|||
23614222|NCT00296504|65973258|FG002|Final Analysis|Adverse Event|0|||
23614223|NCT00296504|65973259|FG003|Final Analysis|Adverse Event|0|||
23614224|NCT00296504|65973260|FG004|Final Analysis|Adverse Event|0|||
23614225|NCT00296504|65973261|FG005|Final Analysis|Adverse Event|0|||
23614226|NCT00296504|65973262|FG006|Final Analysis|Adverse Event|0|||
23532710|NCT02880371|65683375|FG003|Phase 1b|Lost to Follow-up|0|||
23532711|NCT02880371|65683376|FG004|Phase 1b|Lost to Follow-up|0|||
23532712|NCT02880371|65683377|FG005|Phase 1b|Lost to Follow-up|0|||
23532713|NCT02880371|65683378|FG006|Phase 1b|Lost to Follow-up|0|||
23532714|NCT02880371|65683379|FG007|Phase 1b|Lost to Follow-up|0|||
23532715|NCT02880371|65683372|FG000|Phase 1b|Participants terminated by Sponsor|1|||
23532716|NCT02880371|65683373|FG001|Phase 1b|Participants terminated by Sponsor|0|||
23532717|NCT02880371|65683374|FG002|Phase 1b|Participants terminated by Sponsor|0|||
23532718|NCT02880371|65683375|FG003|Phase 1b|Participants terminated by Sponsor|0|||
23532719|NCT02880371|65683376|FG004|Phase 1b|Participants terminated by Sponsor|0|||
23532720|NCT02880371|65683377|FG005|Phase 1b|Participants terminated by Sponsor|0|||
23532721|NCT02880371|65683378|FG006|Phase 1b|Participants terminated by Sponsor|0|||
23532722|NCT02880371|65683379|FG007|Phase 1b|Participants terminated by Sponsor|0|||
23532723|NCT02880371|65683372|FG000|Phase 1b|Withdrawal by Subject|0|||
23532724|NCT02880371|65683373|FG001|Phase 1b|Withdrawal by Subject|0|||
23532725|NCT02880371|65683374|FG002|Phase 1b|Withdrawal by Subject|1|||
23532726|NCT02880371|65683375|FG003|Phase 1b|Withdrawal by Subject|0|||
23532727|NCT02880371|65683376|FG004|Phase 1b|Withdrawal by Subject|0|||
23532728|NCT02880371|65683377|FG005|Phase 1b|Withdrawal by Subject|0|||
23532729|NCT02880371|65683378|FG006|Phase 1b|Withdrawal by Subject|0|||
23532730|NCT02880371|65683379|FG007|Phase 1b|Withdrawal by Subject|0|||
23532731|NCT02880371|65683372|FG000|Phase 1b|Death|4|||
23532732|NCT02880371|65683373|FG001|Phase 1b|Death|6|||
23532733|NCT02880371|65683374|FG002|Phase 1b|Death|5|||
23614227|NCT00296504|65973263|FG007|Final Analysis|Adverse Event|0|||
23207960|NCT01953328|64498307|FG003|Overall Study|Lost to Follow-up|0|||
23207961|NCT01953328|64498308|FG004|Overall Study|Lost to Follow-up|1|||
23207962|NCT01953328|64498309|FG005|Overall Study|Lost to Follow-up|0|||
23207963|NCT01953328|64498310|FG006|Overall Study|Lost to Follow-up|0|||
23207964|NCT01953328|64498311|FG007|Overall Study|Lost to Follow-up|0|||
23532734|NCT02880371|65683375|FG003|Phase 1b|Death|1|||
23532735|NCT02880371|65683376|FG004|Phase 1b|Death|0|||
23532736|NCT02880371|65683377|FG005|Phase 1b|Death|0|||
23532737|NCT02880371|65683378|FG006|Phase 1b|Death|0|||
23532738|NCT02880371|65683379|FG007|Phase 1b|Death|0|||
23532739|NCT02880371|65683372|FG000|Phase 1b|Enrolled but not Treated|0|||
23532740|NCT02880371|65683373|FG001|Phase 1b|Enrolled but not Treated|1|||
23532741|NCT02880371|65683374|FG002|Phase 1b|Enrolled but not Treated|0|||
23532742|NCT02880371|65683375|FG003|Phase 1b|Enrolled but not Treated|0|||
23207965|NCT02681055|64498318|FG000|Weeks 5-12|Adverse Event|1|||
23207966|NCT00748553|64498319|FG000|Overall Study|Adverse Event|0|||
23207967|NCT00748553|64498320|FG001|Overall Study|Adverse Event|1|||
23532743|NCT02880371|65683376|FG004|Phase 1b|Enrolled but not Treated|0|||
23532744|NCT02880371|65683377|FG005|Phase 1b|Enrolled but not Treated|0|||
23532745|NCT02880371|65683378|FG006|Phase 1b|Enrolled but not Treated|0|||
23614228|NCT00296504|65973264|FG008|Final Analysis|Adverse Event|2|||
23614229|NCT00296504|65973256|FG000|Final Analysis|Pregnancy|0|||
23207968|NCT00748553|64498319|FG000|Overall Study|disease progression|2|||
23207969|NCT00748553|64498320|FG001|Overall Study|disease progression|0|||
23207970|NCT00748553|64498319|FG000|Overall Study|noncompliance|1|||
23207971|NCT00748553|64498320|FG001|Overall Study|noncompliance|0|||
23207972|NCT00992784|64498321|FG000|Overall Study|Adverse Event|2|||
23207973|NCT00992784|64498322|FG001|Overall Study|Adverse Event|1|||
23207974|NCT00992784|64498323|FG002|Overall Study|Adverse Event|0|||
23207975|NCT00992784|64498321|FG000|Overall Study|Withdrawal by Subject|1|||
23207976|NCT00992784|64498322|FG001|Overall Study|Withdrawal by Subject|1|||
23207977|NCT00992784|64498323|FG002|Overall Study|Withdrawal by Subject|1|||
23207978|NCT01348425|64498331|FG000|Overall Study|Imaging was not taken.|1|||
23421284|NCT01468207|65283999|FG003|Treatment Period 1|Other|0|||
23532746|NCT02880371|65683379|FG007|Phase 1b|Enrolled but not Treated|0|||
23207979|NCT01348425|64498332|FG001|Overall Study|Imaging was not taken.|1|||
23207980|NCT05554471|64498335|FG000|Overall Study|Physician Decision|2|||
23207981|NCT05554471|64498336|FG001|Overall Study|Physician Decision|1|||
23532747|NCT02880371|65683372|FG000|Phase 2|Enrolled but not Treated|0|||
23532748|NCT02880371|65683373|FG001|Phase 2|Enrolled but not Treated|0|||
23532749|NCT02880371|65683374|FG002|Phase 2|Enrolled but not Treated|0|||
23532750|NCT02880371|65683375|FG003|Phase 2|Enrolled but not Treated|0|||
23532751|NCT02880371|65683376|FG004|Phase 2|Enrolled but not Treated|0|||
23532752|NCT02880371|65683377|FG005|Phase 2|Enrolled but not Treated|1|||
23532753|NCT02880371|65683378|FG006|Phase 2|Enrolled but not Treated|1|||
23614230|NCT00296504|65973257|FG001|Final Analysis|Pregnancy|0|||
23614231|NCT00296504|65973258|FG002|Final Analysis|Pregnancy|0|||
23207982|NCT05554471|64498335|FG000|Overall Study|Lost to Follow-up|2|||
23421285|NCT01468207|65284000|FG004|Treatment Period 1|Other|0|||
23614232|NCT00296504|65973259|FG003|Final Analysis|Pregnancy|0|||
23207983|NCT05554471|64498336|FG001|Overall Study|Lost to Follow-up|1|||
23532754|NCT02880371|65683379|FG007|Phase 2|Enrolled but not Treated|0|||
23532755|NCT02880371|65683372|FG000|Phase 2|Other|0|||
23532756|NCT02880371|65683373|FG001|Phase 2|Other|0|||
23532757|NCT02880371|65683374|FG002|Phase 2|Other|0|||
23532758|NCT02880371|65683375|FG003|Phase 2|Other|0|||
23532759|NCT02880371|65683376|FG004|Phase 2|Other|0|||
23532760|NCT02880371|65683377|FG005|Phase 2|Other|1|||
23532761|NCT02880371|65683378|FG006|Phase 2|Other|2|||
23532762|NCT02880371|65683379|FG007|Phase 2|Other|1|||
23532763|NCT02880371|65683372|FG000|Phase 2|Participants terminated by Sponsor|0|||
23532764|NCT02880371|65683373|FG001|Phase 2|Participants terminated by Sponsor|0|||
23532765|NCT02880371|65683374|FG002|Phase 2|Participants terminated by Sponsor|0|||
23532766|NCT02880371|65683375|FG003|Phase 2|Participants terminated by Sponsor|0|||
23532767|NCT02880371|65683376|FG004|Phase 2|Participants terminated by Sponsor|1|||
23532768|NCT02880371|65683377|FG005|Phase 2|Participants terminated by Sponsor|6|||
23532769|NCT02880371|65683378|FG006|Phase 2|Participants terminated by Sponsor|1|||
23532770|NCT02880371|65683379|FG007|Phase 2|Participants terminated by Sponsor|5|||
23532771|NCT02880371|65683372|FG000|Phase 2|Death|0|||
23532772|NCT02880371|65683373|FG001|Phase 2|Death|0|||
23532773|NCT02880371|65683374|FG002|Phase 2|Death|0|||
23532774|NCT02880371|65683375|FG003|Phase 2|Death|0|||
23532775|NCT02880371|65683376|FG004|Phase 2|Death|1|||
23532776|NCT02880371|65683377|FG005|Phase 2|Death|10|||
23532777|NCT02880371|65683378|FG006|Phase 2|Death|20|||
23532778|NCT02880371|65683379|FG007|Phase 2|Death|5|||
23532779|NCT02880371|65683372|FG000|Phase 2|Lost to Follow-up|0|||
23532780|NCT02880371|65683373|FG001|Phase 2|Lost to Follow-up|0|||
23532781|NCT02880371|65683374|FG002|Phase 2|Lost to Follow-up|0|||
23532782|NCT02880371|65683375|FG003|Phase 2|Lost to Follow-up|0|||
23532783|NCT02880371|65683376|FG004|Phase 2|Lost to Follow-up|0|||
23532784|NCT02880371|65683377|FG005|Phase 2|Lost to Follow-up|0|||
23532785|NCT02880371|65683378|FG006|Phase 2|Lost to Follow-up|3|||
23532786|NCT02880371|65683379|FG007|Phase 2|Lost to Follow-up|0|||
23532787|NCT02880371|65683372|FG000|Phase 2|Withdrawal by Subject|0|||
23532788|NCT02880371|65683373|FG001|Phase 2|Withdrawal by Subject|0|||
23532789|NCT02880371|65683374|FG002|Phase 2|Withdrawal by Subject|0|||
23532790|NCT02880371|65683375|FG003|Phase 2|Withdrawal by Subject|0|||
23532791|NCT02880371|65683376|FG004|Phase 2|Withdrawal by Subject|0|||
23532792|NCT02880371|65683377|FG005|Phase 2|Withdrawal by Subject|1|||
23532793|NCT02880371|65683378|FG006|Phase 2|Withdrawal by Subject|1|||
23532794|NCT02880371|65683379|FG007|Phase 2|Withdrawal by Subject|0|||
23532795|NCT02880371|65683372|FG000|Phase 2|End of Study page not completed by error|0|||
23532796|NCT02880371|65683373|FG001|Phase 2|End of Study page not completed by error|0|||
23614233|NCT00296504|65973260|FG004|Final Analysis|Pregnancy|0|||
23614234|NCT00296504|65973261|FG005|Final Analysis|Pregnancy|0|||
23614235|NCT00296504|65973262|FG006|Final Analysis|Pregnancy|0|||
23614236|NCT00296504|65973263|FG007|Final Analysis|Pregnancy|0|||
23614237|NCT00296504|65973264|FG008|Final Analysis|Pregnancy|4|||
23614238|NCT00296504|65973256|FG000|Final Analysis|Tuberculosis|0|||
23614239|NCT00296504|65973257|FG001|Final Analysis|Tuberculosis|0|||
23207984|NCT05554471|64498335|FG000|Overall Study|Death|0|||
23207985|NCT05554471|64498336|FG001|Overall Study|Death|1|||
23614240|NCT00296504|65973258|FG002|Final Analysis|Tuberculosis|0|||
23614241|NCT00296504|65973259|FG003|Final Analysis|Tuberculosis|0|||
23614242|NCT00296504|65973260|FG004|Final Analysis|Tuberculosis|0|||
23614243|NCT00296504|65973261|FG005|Final Analysis|Tuberculosis|0|||
23614244|NCT00296504|65973262|FG006|Final Analysis|Tuberculosis|0|||
23614245|NCT00296504|65973263|FG007|Final Analysis|Tuberculosis|0|||
23614246|NCT00296504|65973264|FG008|Final Analysis|Tuberculosis|1|||
23614247|NCT00296504|65973256|FG000|Final Analysis|Participant Moved to Another Country|0|||
23614248|NCT00296504|65973257|FG001|Final Analysis|Participant Moved to Another Country|0|||
23614249|NCT00296504|65973258|FG002|Final Analysis|Participant Moved to Another Country|0|||
23614250|NCT00296504|65973259|FG003|Final Analysis|Participant Moved to Another Country|0|||
23614251|NCT00296504|65973260|FG004|Final Analysis|Participant Moved to Another Country|0|||
23614252|NCT00296504|65973261|FG005|Final Analysis|Participant Moved to Another Country|0|||
23207986|NCT01114373|64498337|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
23532797|NCT02880371|65683374|FG002|Phase 2|End of Study page not completed by error|0|||
23532798|NCT02880371|65683375|FG003|Phase 2|End of Study page not completed by error|0|||
23532799|NCT02880371|65683376|FG004|Phase 2|End of Study page not completed by error|0|||
23614253|NCT00296504|65973262|FG006|Final Analysis|Participant Moved to Another Country|0|||
23614254|NCT00296504|65973263|FG007|Final Analysis|Participant Moved to Another Country|0|||
23614255|NCT00296504|65973264|FG008|Final Analysis|Participant Moved to Another Country|1|||
23614256|NCT00296504|65973256|FG000|Final Analysis|Poor Adherence|0|||
23614257|NCT00296504|65973257|FG001|Final Analysis|Poor Adherence|0|||
23207987|NCT01114373|64498338|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
23532800|NCT02880371|65683377|FG005|Phase 2|End of Study page not completed by error|1|||
23532801|NCT02880371|65683378|FG006|Phase 2|End of Study page not completed by error|0|||
23532802|NCT02880371|65683379|FG007|Phase 2|End of Study page not completed by error|0|||
23532803|NCT00850200|65683382|FG000|Overall Study|Physician Decision|2|||
23532804|NCT00850200|65683382|FG000|Overall Study|Did not recieve treatment|2|||
23532805|NCT00850200|65683382|FG000|Overall Study|Withdrawal by Subject|1|||
23532806|NCT02143843|65683385|FG000|Overall Study|Adverse Event|8|||
23532807|NCT02143843|65683385|FG000|Overall Study|Lack of Efficacy|2|||
23532808|NCT02143843|65683385|FG000|Overall Study|Withdrawal by Subject|2|||
23532809|NCT00714259|65683386|FG000|Overall Study|Death|2|||
23532810|NCT00853658|65686408|FG000|Overall Study|Death|713|||
23532811|NCT00853658|65686409|FG001|Overall Study|Death|768|||
23532812|NCT00853658|65686410|FG002|Overall Study|Death|753|||
23532813|NCT00853658|65686408|FG000|Overall Study|Lost to Follow-up|11|||
23532814|NCT00853658|65686409|FG001|Overall Study|Lost to Follow-up|6|||
23532815|NCT00853658|65686410|FG002|Overall Study|Lost to Follow-up|11|||
23532816|NCT00853658|65686408|FG000|Overall Study|H.A. Request|26|||
23532817|NCT00853658|65686409|FG001|Overall Study|H.A. Request|23|||
23532818|NCT00853658|65686410|FG002|Overall Study|H.A. Request|19|||
23532819|NCT00853658|65686408|FG000|Overall Study|IRB request|0|||
23532820|NCT00853658|65686409|FG001|Overall Study|IRB request|0|||
23532821|NCT00853658|65686410|FG002|Overall Study|IRB request|2|||
23532822|NCT00853658|65686408|FG000|Overall Study|Vital Status known (alive) at study end|2|||
23532823|NCT00853658|65686409|FG001|Overall Study|Vital Status known (alive) at study end|3|||
23532824|NCT00853658|65686410|FG002|Overall Study|Vital Status known (alive) at study end|3|||
23532825|NCT00853658|65686408|FG000|Overall Study|Vital Status unknown at study end|1|||
23532826|NCT00853658|65686409|FG001|Overall Study|Vital Status unknown at study end|1|||
23532827|NCT00853658|65686410|FG002|Overall Study|Vital Status unknown at study end|0|||
23532828|NCT00853658|65686408|FG000|Overall Study|Vital Status at study end N/A|8|||
23532829|NCT00853658|65686409|FG001|Overall Study|Vital Status at study end N/A|10|||
23532830|NCT00853658|65686410|FG002|Overall Study|Vital Status at study end N/A|10|||
23532831|NCT00853658|65686408|FG000|Overall Study|Patient's request|21|||
23532832|NCT00853658|65686409|FG001|Overall Study|Patient's request|17|||
23532833|NCT00853658|65686410|FG002|Overall Study|Patient's request|11|||
23532834|NCT00853658|65686408|FG000|Overall Study|Missing study completion information|5|||
23532835|NCT00853658|65686409|FG001|Overall Study|Missing study completion information|4|||
23532836|NCT00853658|65686410|FG002|Overall Study|Missing study completion information|6|||
23532837|NCT00941733|65686411|FG000|Overall Study|Death|24|||
23532838|NCT00941733|65686412|FG001|Overall Study|Death|10|||
23532839|NCT00941733|65686411|FG000|Overall Study|Withdrawal by Subject|14|||
23532840|NCT00941733|65686412|FG001|Overall Study|Withdrawal by Subject|6|||
23532841|NCT00941733|65686411|FG000|Overall Study|Adverse Event|20|||
23532842|NCT00941733|65686412|FG001|Overall Study|Adverse Event|4|||
23532843|NCT00941733|65686411|FG000|Overall Study|Lost to Follow-up|1|||
23532844|NCT00941733|65686412|FG001|Overall Study|Lost to Follow-up|2|||
23532845|NCT00941733|65686411|FG000|Overall Study|Protocol Violation|15|||
23532846|NCT00941733|65686412|FG001|Overall Study|Protocol Violation|6|||
23532847|NCT01375049|65686416|FG000|Overall Study|Adverse Event|2|||
23532848|NCT01375049|65686416|FG000|Overall Study|Lost to Follow-up|1|||
23532849|NCT01375049|65686416|FG000|Overall Study|Withdrawal by Subject|2|||
23532850|NCT01375049|65686416|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
23532851|NCT01126541|65686417|FG000|Overall Study|Adverse Event|0|||
23532852|NCT01126541|65686418|FG001|Overall Study|Adverse Event|2|||
23532853|NCT01126541|65686419|FG002|Overall Study|Adverse Event|4|||
23532854|NCT01126541|65686417|FG000|Overall Study|Death|0|||
23532855|NCT01126541|65686418|FG001|Overall Study|Death|1|||
23532856|NCT01126541|65686419|FG002|Overall Study|Death|0|||
23532857|NCT01126541|65686417|FG000|Overall Study|Lack of Efficacy|6|||
23532858|NCT01126541|65686418|FG001|Overall Study|Lack of Efficacy|1|||
23532859|NCT01126541|65686419|FG002|Overall Study|Lack of Efficacy|11|||
23532860|NCT01126541|65686417|FG000|Overall Study|Lost to Follow-up|1|||
23207988|NCT01114373|64498337|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
23207989|NCT01114373|64498338|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
23532861|NCT01126541|65686418|FG001|Overall Study|Lost to Follow-up|2|||
23532862|NCT01126541|65686419|FG002|Overall Study|Lost to Follow-up|2|||
23532863|NCT01126541|65686417|FG000|Overall Study|Withdrawal by Subject|2|||
23207990|NCT01114373|64498337|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
23532864|NCT01126541|65686418|FG001|Overall Study|Withdrawal by Subject|5|||
23532865|NCT01126541|65686419|FG002|Overall Study|Withdrawal by Subject|6|||
23532866|NCT01126541|65686417|FG000|Overall Study|Protocol Violation|0|||
23532867|NCT01126541|65686418|FG001|Overall Study|Protocol Violation|0|||
23532868|NCT01126541|65686419|FG002|Overall Study|Protocol Violation|1|||
23532869|NCT01126541|65686417|FG000|Overall Study|Administrative reason or other|1|||
23207991|NCT01114373|64498338|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
23207992|NCT01114373|64498337|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
23532870|NCT01126541|65686418|FG001|Overall Study|Administrative reason or other|1|||
23532871|NCT01126541|65686419|FG002|Overall Study|Administrative reason or other|2|||
23532872|NCT01410110|65686420|FG000|Overall Study|Withdrawal by Subject|4|||
23532873|NCT01410110|65686421|FG001|Overall Study|Withdrawal by Subject|2|||
23532874|NCT00679341|65686424|FG000|Overall Study|Disease progression|42|||
23532875|NCT00679341|65686425|FG001|Overall Study|Disease progression|36|||
23532876|NCT00679341|65686424|FG000|Overall Study|Adverse Event|5|||
23532877|NCT00679341|65686425|FG001|Overall Study|Adverse Event|6|||
23532878|NCT00679341|65686424|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
23532879|NCT00679341|65686425|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
23532880|NCT00679341|65686424|FG000|Overall Study|Death|1|||
23532881|NCT00679341|65686425|FG001|Overall Study|Death|1|||
23532882|NCT00679341|65686424|FG000|Overall Study|Other|1|||
23532883|NCT00679341|65686425|FG001|Overall Study|Other|0|||
23532884|NCT00679341|65686424|FG000|Overall Study|Physician Decision|1|||
23532885|NCT00679341|65686425|FG001|Overall Study|Physician Decision|0|||
23532886|NCT00679341|65686424|FG000|Overall Study|Not treated|0|||
23532887|NCT00679341|65686425|FG001|Overall Study|Not treated|2|||
23532888|NCT00679341|65686424|FG000|Overall Study|Physician/patient decision to withdraw|0|||
23532889|NCT00679341|65686425|FG001|Overall Study|Physician/patient decision to withdraw|6|||
23532890|NCT02103478|65686426|FG000|Overall Study|Adverse Event|0|||
23532891|NCT02103478|65686427|FG001|Overall Study|Adverse Event|0|||
23532892|NCT02103478|65686428|FG002|Overall Study|Adverse Event|1|||
23532893|NCT02103478|65686429|FG003|Overall Study|Adverse Event|1|||
23532894|NCT02103478|65686430|FG004|Overall Study|Adverse Event|2|||
23532895|NCT02103478|65686431|FG005|Overall Study|Adverse Event|1|||
23532896|NCT02103478|65686432|FG006|Overall Study|Adverse Event|0|||
23532897|NCT02103478|65686433|FG007|Overall Study|Adverse Event|0|||
23532898|NCT02103478|65686434|FG008|Overall Study|Adverse Event|0|||
23532899|NCT02103478|65686426|FG000|Overall Study|Death|2|||
23532900|NCT02103478|65686427|FG001|Overall Study|Death|2|||
23532901|NCT02103478|65686428|FG002|Overall Study|Death|1|||
23532902|NCT02103478|65686429|FG003|Overall Study|Death|1|||
23532903|NCT02103478|65686430|FG004|Overall Study|Death|5|||
23532904|NCT02103478|65686431|FG005|Overall Study|Death|15|||
23532905|NCT02103478|65686432|FG006|Overall Study|Death|14|||
23532906|NCT02103478|65686433|FG007|Overall Study|Death|10|||
23532907|NCT02103478|65686434|FG008|Overall Study|Death|11|||
23532908|NCT02103478|65686426|FG000|Overall Study|Progressive Disease|2|||
23532909|NCT02103478|65686427|FG001|Overall Study|Progressive Disease|1|||
23532910|NCT02103478|65686428|FG002|Overall Study|Progressive Disease|2|||
23532911|NCT02103478|65686429|FG003|Overall Study|Progressive Disease|0|||
23532912|NCT02103478|65686430|FG004|Overall Study|Progressive Disease|9|||
23532913|NCT02103478|65686431|FG005|Overall Study|Progressive Disease|1|||
23532914|NCT02103478|65686432|FG006|Overall Study|Progressive Disease|2|||
23532915|NCT02103478|65686433|FG007|Overall Study|Progressive Disease|0|||
23532916|NCT02103478|65686434|FG008|Overall Study|Progressive Disease|1|||
23532917|NCT02103478|65686426|FG000|Overall Study|Withdrawal by Subject|2|||
23532918|NCT02103478|65686427|FG001|Overall Study|Withdrawal by Subject|0|||
23532919|NCT02103478|65686428|FG002|Overall Study|Withdrawal by Subject|0|||
23532920|NCT02103478|65686429|FG003|Overall Study|Withdrawal by Subject|4|||
23532921|NCT02103478|65686430|FG004|Overall Study|Withdrawal by Subject|0|||
23532922|NCT02103478|65686431|FG005|Overall Study|Withdrawal by Subject|0|||
23532923|NCT02103478|65686432|FG006|Overall Study|Withdrawal by Subject|1|||
23532924|NCT02103478|65686433|FG007|Overall Study|Withdrawal by Subject|1|||
23532925|NCT02103478|65686434|FG008|Overall Study|Withdrawal by Subject|0|||
23532926|NCT02103478|65686426|FG000|Overall Study|Lost to Follow-up|0|||
23532927|NCT02103478|65686427|FG001|Overall Study|Lost to Follow-up|0|||
23532928|NCT02103478|65686428|FG002|Overall Study|Lost to Follow-up|0|||
23532929|NCT02103478|65686429|FG003|Overall Study|Lost to Follow-up|0|||
23532930|NCT02103478|65686430|FG004|Overall Study|Lost to Follow-up|0|||
23532931|NCT02103478|65686431|FG005|Overall Study|Lost to Follow-up|0|||
23532932|NCT02103478|65686432|FG006|Overall Study|Lost to Follow-up|0|||
23532933|NCT02103478|65686433|FG007|Overall Study|Lost to Follow-up|1|||
23532934|NCT02103478|65686434|FG008|Overall Study|Lost to Follow-up|0|||
23532935|NCT02103478|65686426|FG000|Overall Study|Other|1|||
23532936|NCT02103478|65686427|FG001|Overall Study|Other|3|||
23532937|NCT02103478|65686428|FG002|Overall Study|Other|2|||
23532938|NCT02103478|65686429|FG003|Overall Study|Other|0|||
23532939|NCT02103478|65686430|FG004|Overall Study|Other|3|||
23532940|NCT02103478|65686431|FG005|Overall Study|Other|8|||
23532941|NCT02103478|65686432|FG006|Overall Study|Other|8|||
23532942|NCT02103478|65686433|FG007|Overall Study|Other|4|||
23532943|NCT02103478|65686434|FG008|Overall Study|Other|2|||
23532944|NCT02583256|65686437|FG000|Overall Study|Withdrawal by Subject|0|||
23532945|NCT02583256|65686438|FG001|Overall Study|Withdrawal by Subject|1|||
23532946|NCT02583256|65686439|FG002|Overall Study|Withdrawal by Subject|1|||
23532947|NCT02583256|65686440|FG003|Overall Study|Withdrawal by Subject|0|||
23532948|NCT02583256|65686437|FG000|Overall Study|Lost to Follow-up|1|||
23532949|NCT02583256|65686438|FG001|Overall Study|Lost to Follow-up|1|||
23532950|NCT02583256|65686439|FG002|Overall Study|Lost to Follow-up|0|||
23532951|NCT02583256|65686440|FG003|Overall Study|Lost to Follow-up|1|||
23532952|NCT02583256|65686437|FG000|Overall Study|Administrative/Other|2|||
23532953|NCT02583256|65686438|FG001|Overall Study|Administrative/Other|0|||
23532954|NCT02583256|65686439|FG002|Overall Study|Administrative/Other|1|||
23532955|NCT02583256|65686440|FG003|Overall Study|Administrative/Other|2|||
23532956|NCT00440271|65686441|FG000|Overall Study|Protocol Violation|1|||
23532957|NCT00440271|65686442|FG001|Overall Study|Protocol Violation|1|||
23532958|NCT00440271|65686441|FG000|Overall Study|Adverse Event|0|||
23532959|NCT00440271|65686442|FG001|Overall Study|Adverse Event|1|||
23532960|NCT00440271|65686441|FG000|Overall Study|Lost to Follow-up|1|||
23532961|NCT00440271|65686442|FG001|Overall Study|Lost to Follow-up|0|||
23532962|NCT00440271|65686441|FG000|Overall Study|Withdrawal by Subject|0|||
23532963|NCT00440271|65686442|FG001|Overall Study|Withdrawal by Subject|2|||
23532964|NCT00440271|65686441|FG000|Overall Study|Lack of Efficacy|0|||
23532965|NCT00440271|65686442|FG001|Overall Study|Lack of Efficacy|1|||
23532966|NCT00440271|65686441|FG000|Overall Study|Due to closure of trial|8|||
23532967|NCT00440271|65686442|FG001|Overall Study|Due to closure of trial|10|||
23532968|NCT00440271|65686441|FG000|Overall Study|Other|2|||
23532969|NCT00440271|65686442|FG001|Overall Study|Other|0|||
23532970|NCT00833924|65686444|FG000|Overall Study|Death|21|||
23532971|NCT00833924|65686444|FG000|Overall Study|Conversion|2|||
23532972|NCT00833924|65686444|FG000|Overall Study|Lost to Follow-up|2|||
23532973|NCT00833924|65686444|FG000|Overall Study|Withdrawal by Subject|13|||
23532974|NCT00833924|65686444|FG000|Overall Study|In study follow-up|71|||
23532975|NCT02247349|65686445|FG000|Overall Study|Disease Progression|7|||
23532976|NCT02247349|65686446|FG001|Overall Study|Disease Progression|4|||
23532977|NCT02247349|65686447|FG002|Overall Study|Disease Progression|26|||
23532978|NCT02247349|65686448|FG003|Overall Study|Disease Progression|31|||
23532979|NCT02247349|65686449|FG004|Overall Study|Disease Progression|16|||
23532980|NCT02247349|65686450|FG005|Overall Study|Disease Progression|6|||
23532981|NCT02247349|65686445|FG000|Overall Study|Study drug toxicity|0|||
23532982|NCT02247349|65686446|FG001|Overall Study|Study drug toxicity|1|||
23532983|NCT02247349|65686447|FG002|Overall Study|Study drug toxicity|1|||
23532984|NCT02247349|65686448|FG003|Overall Study|Study drug toxicity|1|||
23532985|NCT02247349|65686449|FG004|Overall Study|Study drug toxicity|2|||
23532986|NCT02247349|65686450|FG005|Overall Study|Study drug toxicity|2|||
23532987|NCT02247349|65686445|FG000|Overall Study|Death|0|||
23532988|NCT02247349|65686446|FG001|Overall Study|Death|0|||
23532989|NCT02247349|65686447|FG002|Overall Study|Death|0|||
23532990|NCT02247349|65686448|FG003|Overall Study|Death|1|||
23532991|NCT02247349|65686449|FG004|Overall Study|Death|0|||
23532992|NCT02247349|65686450|FG005|Overall Study|Death|0|||
23532993|NCT02247349|65686445|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
23532994|NCT02247349|65686446|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
23532995|NCT02247349|65686447|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
23532996|NCT02247349|65686448|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
23532997|NCT02247349|65686449|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
23532998|NCT02247349|65686450|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
23532999|NCT02247349|65686445|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23533000|NCT02247349|65686446|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23533001|NCT02247349|65686447|FG002|Overall Study|Participant request to discontinue study treatment|1|||
23533002|NCT02247349|65686448|FG003|Overall Study|Participant request to discontinue study treatment|2|||
23533003|NCT02247349|65686449|FG004|Overall Study|Participant request to discontinue study treatment|1|||
23533004|NCT02247349|65686450|FG005|Overall Study|Participant request to discontinue study treatment|0|||
23533005|NCT02247349|65686445|FG000|Overall Study|Withdrawal by Subject|0|||
23533006|NCT02247349|65686446|FG001|Overall Study|Withdrawal by Subject|1|||
23533007|NCT02247349|65686447|FG002|Overall Study|Withdrawal by Subject|0|||
23533008|NCT02247349|65686448|FG003|Overall Study|Withdrawal by Subject|0|||
23533009|NCT02247349|65686449|FG004|Overall Study|Withdrawal by Subject|0|||
23533010|NCT02247349|65686450|FG005|Overall Study|Withdrawal by Subject|0|||
23533011|NCT02247349|65686445|FG000|Overall Study|Administrative reason by sponsor|0|||
23533012|NCT02247349|65686446|FG001|Overall Study|Administrative reason by sponsor|0|||
23533013|NCT02247349|65686447|FG002|Overall Study|Administrative reason by sponsor|0|||
23533014|NCT02247349|65686448|FG003|Overall Study|Administrative reason by sponsor|0|||
23533015|NCT02247349|65686449|FG004|Overall Study|Administrative reason by sponsor|1|||
23533016|NCT02247349|65686450|FG005|Overall Study|Administrative reason by sponsor|0|||
23533017|NCT02247349|65686445|FG000|Overall Study|Other reasons|0|||
23533018|NCT02247349|65686446|FG001|Overall Study|Other reasons|0|||
23533019|NCT02247349|65686447|FG002|Overall Study|Other reasons|1|||
23533020|NCT02247349|65686448|FG003|Overall Study|Other reasons|0|||
23533021|NCT02247349|65686449|FG004|Overall Study|Other reasons|0|||
23533022|NCT02247349|65686450|FG005|Overall Study|Other reasons|0|||
23533023|NCT03304379|65686457|FG000|Overall Study|Protocol Violation|8|||
23207993|NCT01114373|64498338|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
23207994|NCT00438399|64498340|FG000|Overall Study|Lost to Follow-up|2|||
23207995|NCT00438399|64498341|FG001|Overall Study|Lost to Follow-up|2|||
23533024|NCT03304379|65686458|FG001|Overall Study|Protocol Violation|10|||
23533025|NCT03304379|65686459|FG002|Overall Study|Protocol Violation|5|||
23533026|NCT03304379|65686460|FG003|Overall Study|Protocol Violation|0|||
23533027|NCT03304379|65686461|FG004|Overall Study|Protocol Violation|2|||
23533028|NCT03304379|65686457|FG000|Overall Study|Adverse Event|4|||
23533029|NCT03304379|65686458|FG001|Overall Study|Adverse Event|20|||
23533030|NCT03304379|65686459|FG002|Overall Study|Adverse Event|17|||
23533031|NCT03304379|65686460|FG003|Overall Study|Adverse Event|1|||
23533032|NCT03304379|65686461|FG004|Overall Study|Adverse Event|0|||
23533033|NCT03304379|65686457|FG000|Overall Study|Lack of Efficacy|17|||
23533034|NCT03304379|65686458|FG001|Overall Study|Lack of Efficacy|16|||
23533035|NCT03304379|65686459|FG002|Overall Study|Lack of Efficacy|20|||
23533036|NCT03304379|65686460|FG003|Overall Study|Lack of Efficacy|0|||
23533037|NCT03304379|65686461|FG004|Overall Study|Lack of Efficacy|0|||
23533038|NCT03304379|65686457|FG000|Overall Study|Physician Decision|6|||
23533039|NCT03304379|65686458|FG001|Overall Study|Physician Decision|10|||
23533040|NCT03304379|65686459|FG002|Overall Study|Physician Decision|6|||
23533041|NCT03304379|65686460|FG003|Overall Study|Physician Decision|9|||
23533042|NCT03304379|65686461|FG004|Overall Study|Physician Decision|10|||
23533043|NCT03304379|65686457|FG000|Overall Study|Withdrawal by Subject|26|||
23533044|NCT03304379|65686458|FG001|Overall Study|Withdrawal by Subject|58|||
23533045|NCT03304379|65686459|FG002|Overall Study|Withdrawal by Subject|66|||
23533046|NCT03304379|65686460|FG003|Overall Study|Withdrawal by Subject|3|||
23533047|NCT03304379|65686461|FG004|Overall Study|Withdrawal by Subject|5|||
23533048|NCT03304379|65686457|FG000|Overall Study|Lost to Follow-up|8|||
23533049|NCT03304379|65686458|FG001|Overall Study|Lost to Follow-up|24|||
23533050|NCT03304379|65686459|FG002|Overall Study|Lost to Follow-up|35|||
23533051|NCT03304379|65686460|FG003|Overall Study|Lost to Follow-up|4|||
23533052|NCT03304379|65686461|FG004|Overall Study|Lost to Follow-up|0|||
23533053|NCT03304379|65686457|FG000|Overall Study|Death|1|||
23533054|NCT03304379|65686458|FG001|Overall Study|Death|2|||
23533055|NCT03304379|65686459|FG002|Overall Study|Death|0|||
23533056|NCT03304379|65686460|FG003|Overall Study|Death|0|||
23533057|NCT03304379|65686461|FG004|Overall Study|Death|0|||
23533058|NCT03304379|65686457|FG000|Overall Study|Other|0|||
23533059|NCT03304379|65686458|FG001|Overall Study|Other|1|||
23533060|NCT03304379|65686459|FG002|Overall Study|Other|0|||
23533061|NCT03304379|65686460|FG003|Overall Study|Other|0|||
23533062|NCT03304379|65686461|FG004|Overall Study|Other|0|||
23533063|NCT00938431|65686470|FG000|Overall Study|Adverse Event|5|||
23533064|NCT00938431|65686471|FG001|Overall Study|Adverse Event|8|||
23533065|NCT00938431|65686472|FG002|Overall Study|Adverse Event|6|||
23533066|NCT00938431|65686470|FG000|Overall Study|Lack of Efficacy|0|||
23533067|NCT00938431|65686471|FG001|Overall Study|Lack of Efficacy|1|||
23533068|NCT00938431|65686472|FG002|Overall Study|Lack of Efficacy|0|||
23533069|NCT00938431|65686470|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
23533070|NCT00938431|65686471|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
23533071|NCT00938431|65686472|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
23533072|NCT00938431|65686470|FG000|Overall Study|Dosing compliance issue|0|||
23533073|NCT00938431|65686471|FG001|Overall Study|Dosing compliance issue|0|||
23533074|NCT00938431|65686472|FG002|Overall Study|Dosing compliance issue|1|||
23533075|NCT00938431|65686470|FG000|Overall Study|Reached maximum dose early|0|||
23533076|NCT00938431|65686471|FG001|Overall Study|Reached maximum dose early|0|||
23533077|NCT00938431|65686472|FG002|Overall Study|Reached maximum dose early|1|||
23533078|NCT03146650|65686479|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
23533079|NCT03146650|65686479|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
23533080|NCT03146650|65686479|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
23533081|NCT03146650|65686479|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
23533082|NCT03146650|65686479|FG000|2 Year Follow-up|Death|11|||
23533083|NCT03146650|65686479|FG000|2 Year Follow-up|Still in follow-up|7|||
23533084|NCT03146650|65686479|FG000|2 Year Follow-up|Lost to Follow-up|1|||
23533085|NCT00958880|65686488|FG000|Overall Study|Lost to Follow-up|2|||
23533086|NCT00958880|65686489|FG001|Overall Study|Lost to Follow-up|2|||
23533087|NCT02520531|65686492|FG000|Overall Study|Revision of study device components|2|||
23207996|NCT00438399|64498342|FG002|Overall Study|Lost to Follow-up|1|||
23207997|NCT00438399|64498343|FG003|Overall Study|Lost to Follow-up|1|||
23207998|NCT00438399|64498344|FG004|Overall Study|Lost to Follow-up|1|||
23533088|NCT02520531|65686493|FG001|Overall Study|Revision of study device components|2|||
23533089|NCT02520531|65686492|FG000|Overall Study|Death|1|||
23533090|NCT02520531|65686493|FG001|Overall Study|Death|2|||
23533091|NCT02520531|65686492|FG000|Overall Study|Lost to Follow-up|1|||
23533092|NCT02520531|65686493|FG001|Overall Study|Lost to Follow-up|1|||
23533093|NCT02520531|65686492|FG000|Overall Study|Meet exclusion criterion|0|||
23533094|NCT02520531|65686493|FG001|Overall Study|Meet exclusion criterion|1|||
23533095|NCT02520531|65686492|FG000|Overall Study|Withdrawal by Subject|1|||
23533096|NCT02520531|65686493|FG001|Overall Study|Withdrawal by Subject|0|||
23533097|NCT02520531|65686492|FG000|Overall Study|Not study device|1|||
23207999|NCT00438399|64498345|FG005|Overall Study|Lost to Follow-up|1|||
23533098|NCT02520531|65686493|FG001|Overall Study|Not study device|0|||
23533099|NCT01709318|65686496|FG000|Overall Study|Adverse Event|3|||
23533100|NCT01709318|65686497|FG001|Overall Study|Adverse Event|4|||
23533101|NCT01709318|65686498|FG002|Overall Study|Adverse Event|2|||
23533102|NCT01709318|65686499|FG003|Overall Study|Adverse Event|2|||
23533103|NCT01709318|65686500|FG004|Overall Study|Adverse Event|0|||
23533104|NCT01709318|65686501|FG005|Overall Study|Adverse Event|1|||
23533105|NCT01709318|65686502|FG006|Overall Study|Adverse Event|2|||
23533106|NCT01709318|65686496|FG000|Overall Study|Lost to Follow-up|2|||
23533107|NCT01709318|65686497|FG001|Overall Study|Lost to Follow-up|0|||
23533108|NCT01709318|65686498|FG002|Overall Study|Lost to Follow-up|0|||
23533109|NCT01709318|65686499|FG003|Overall Study|Lost to Follow-up|0|||
23533110|NCT01709318|65686500|FG004|Overall Study|Lost to Follow-up|1|||
23533111|NCT01709318|65686501|FG005|Overall Study|Lost to Follow-up|1|||
23533112|NCT01709318|65686502|FG006|Overall Study|Lost to Follow-up|1|||
23533113|NCT01709318|65686496|FG000|Overall Study|Non-compliance with Study Drug|0|||
23533114|NCT01709318|65686497|FG001|Overall Study|Non-compliance with Study Drug|2|||
23533115|NCT01709318|65686498|FG002|Overall Study|Non-compliance with Study Drug|1|||
23533116|NCT01709318|65686499|FG003|Overall Study|Non-compliance with Study Drug|1|||
23533117|NCT01709318|65686500|FG004|Overall Study|Non-compliance with Study Drug|0|||
23533118|NCT01709318|65686501|FG005|Overall Study|Non-compliance with Study Drug|0|||
23533119|NCT01709318|65686502|FG006|Overall Study|Non-compliance with Study Drug|2|||
23533120|NCT01709318|65686496|FG000|Overall Study|Physician Decision|0|||
23533121|NCT01709318|65686497|FG001|Overall Study|Physician Decision|0|||
23533122|NCT01709318|65686498|FG002|Overall Study|Physician Decision|0|||
23533123|NCT01709318|65686499|FG003|Overall Study|Physician Decision|0|||
23533124|NCT01709318|65686500|FG004|Overall Study|Physician Decision|0|||
23533125|NCT01709318|65686501|FG005|Overall Study|Physician Decision|0|||
23533126|NCT01709318|65686502|FG006|Overall Study|Physician Decision|1|||
23533127|NCT01709318|65686496|FG000|Overall Study|Pregnancy|0|||
23533128|NCT01709318|65686497|FG001|Overall Study|Pregnancy|0|||
23533129|NCT01709318|65686498|FG002|Overall Study|Pregnancy|0|||
23533130|NCT01709318|65686499|FG003|Overall Study|Pregnancy|0|||
23533131|NCT01709318|65686500|FG004|Overall Study|Pregnancy|1|||
23533132|NCT01709318|65686501|FG005|Overall Study|Pregnancy|0|||
23533133|NCT01709318|65686502|FG006|Overall Study|Pregnancy|0|||
23533134|NCT01709318|65686496|FG000|Overall Study|Protocol Violation|0|||
23533135|NCT01709318|65686497|FG001|Overall Study|Protocol Violation|0|||
23533136|NCT01709318|65686498|FG002|Overall Study|Protocol Violation|0|||
23533137|NCT01709318|65686499|FG003|Overall Study|Protocol Violation|0|||
23533138|NCT01709318|65686500|FG004|Overall Study|Protocol Violation|2|||
23533139|NCT01709318|65686501|FG005|Overall Study|Protocol Violation|0|||
23533140|NCT01709318|65686502|FG006|Overall Study|Protocol Violation|1|||
23533141|NCT01709318|65686496|FG000|Overall Study|Technical Problems|1|||
23533142|NCT01709318|65686497|FG001|Overall Study|Technical Problems|0|||
23533143|NCT01709318|65686498|FG002|Overall Study|Technical Problems|0|||
23533144|NCT01709318|65686499|FG003|Overall Study|Technical Problems|0|||
23533145|NCT01709318|65686500|FG004|Overall Study|Technical Problems|0|||
23533146|NCT01709318|65686501|FG005|Overall Study|Technical Problems|0|||
23533147|NCT01709318|65686502|FG006|Overall Study|Technical Problems|0|||
23533148|NCT01709318|65686496|FG000|Overall Study|Withdrawal by Subject|3|||
23533149|NCT01709318|65686497|FG001|Overall Study|Withdrawal by Subject|0|||
23533150|NCT01709318|65686498|FG002|Overall Study|Withdrawal by Subject|3|||
23533151|NCT01709318|65686499|FG003|Overall Study|Withdrawal by Subject|3|||
23533152|NCT01709318|65686500|FG004|Overall Study|Withdrawal by Subject|0|||
23533153|NCT01709318|65686501|FG005|Overall Study|Withdrawal by Subject|2|||
23533154|NCT01709318|65686502|FG006|Overall Study|Withdrawal by Subject|4|||
23533155|NCT01709318|65686496|FG000|Overall Study|Other Protocol Specified Criteria|0|||
23533156|NCT01709318|65686497|FG001|Overall Study|Other Protocol Specified Criteria|1|||
23533157|NCT01709318|65686498|FG002|Overall Study|Other Protocol Specified Criteria|0|||
23533158|NCT01709318|65686499|FG003|Overall Study|Other Protocol Specified Criteria|0|||
23533159|NCT01709318|65686500|FG004|Overall Study|Other Protocol Specified Criteria|0|||
23533160|NCT01709318|65686501|FG005|Overall Study|Other Protocol Specified Criteria|0|||
23533161|NCT01709318|65686502|FG006|Overall Study|Other Protocol Specified Criteria|0|||
23533162|NCT04532112|65686503|FG000|Overall Study|Adverse Event|3|||
23533163|NCT04532112|65686504|FG001|Overall Study|Adverse Event|0|||
23533164|NCT01114516|65686505|FG000|Overall Study|Lost to Follow-up|2|||
23533165|NCT01114516|65686506|FG001|Overall Study|Lost to Follow-up|1|||
23533166|NCT00559962|65686509|FG000|Overall Study|Adverse Event|1|||
23533167|NCT00559962|65686510|FG001|Overall Study|Adverse Event|7|||
23533168|NCT00559962|65686511|FG002|Overall Study|Adverse Event|8|||
23533169|NCT00559962|65686512|FG003|Overall Study|Adverse Event|5|||
23533170|NCT00559962|65686513|FG004|Overall Study|Adverse Event|11|||
23533171|NCT00559962|65686514|FG005|Overall Study|Adverse Event|4|||
23208000|NCT00438399|64498340|FG000|Overall Study|Adverse Event|0|||
23533172|NCT00559962|65686515|FG006|Overall Study|Adverse Event|4|||
23533173|NCT00559962|65686516|FG007|Overall Study|Adverse Event|2|||
23533174|NCT00559962|65686509|FG000|Overall Study|Lost to Follow-up|0|||
23533175|NCT00559962|65686510|FG001|Overall Study|Lost to Follow-up|1|||
23533176|NCT00559962|65686511|FG002|Overall Study|Lost to Follow-up|0|||
23533177|NCT00559962|65686512|FG003|Overall Study|Lost to Follow-up|0|||
23533178|NCT00559962|65686513|FG004|Overall Study|Lost to Follow-up|0|||
23533179|NCT00559962|65686514|FG005|Overall Study|Lost to Follow-up|0|||
23533180|NCT00559962|65686515|FG006|Overall Study|Lost to Follow-up|0|||
23533181|NCT00559962|65686516|FG007|Overall Study|Lost to Follow-up|0|||
23533182|NCT00559962|65686509|FG000|Overall Study|Withdrawal by Subject|1|||
23533183|NCT00559962|65686510|FG001|Overall Study|Withdrawal by Subject|1|||
23614258|NCT00296504|65973258|FG002|Final Analysis|Poor Adherence|0|||
23614259|NCT00296504|65973259|FG003|Final Analysis|Poor Adherence|0|||
23614260|NCT00296504|65973260|FG004|Final Analysis|Poor Adherence|0|||
23614261|NCT00296504|65973261|FG005|Final Analysis|Poor Adherence|0|||
23614262|NCT00296504|65973262|FG006|Final Analysis|Poor Adherence|0|||
23614263|NCT00296504|65973263|FG007|Final Analysis|Poor Adherence|0|||
23614264|NCT00296504|65973264|FG008|Final Analysis|Poor Adherence|1|||
23614265|NCT02374476|65973271|FG000|VT Induced Ablation|Screening Failures|36|||
23614266|NCT02374476|65973272|FG001|VT Induced Ablation|Screening Failures|0|||
23614267|NCT02374476|65973273|FG002|VT Induced Ablation|Screening Failures|0|||
23614268|NCT02374476|65973271|FG000|Arm Assignment|Withdrawal by Subject|0|||
23614269|NCT02374476|65973272|FG001|Arm Assignment|Withdrawal by Subject|0|||
23614270|NCT02374476|65973273|FG002|Arm Assignment|Withdrawal by Subject|1|||
23614271|NCT00316589|65973278|FG000|Overall Study|Withdrawal by Subject|0|||
23614272|NCT00316589|65973279|FG001|Overall Study|Withdrawal by Subject|5|||
23614273|NCT00316589|65973280|FG002|Overall Study|Withdrawal by Subject|0|||
23614274|NCT00316589|65973281|FG003|Overall Study|Withdrawal by Subject|1|||
23614275|NCT00316589|65973278|FG000|Overall Study|Subject unwilling/unable to comply|0|||
23614276|NCT00316589|65973279|FG001|Overall Study|Subject unwilling/unable to comply|6|||
23614277|NCT00316589|65973280|FG002|Overall Study|Subject unwilling/unable to comply|0|||
23614278|NCT00316589|65973281|FG003|Overall Study|Subject unwilling/unable to comply|2|||
23614279|NCT00316589|65973278|FG000|Overall Study|Adverse Event|1|||
23614280|NCT00316589|65973279|FG001|Overall Study|Adverse Event|0|||
23614281|NCT00316589|65973280|FG002|Overall Study|Adverse Event|0|||
23614282|NCT00316589|65973281|FG003|Overall Study|Adverse Event|1|||
23614283|NCT00316589|65973278|FG000|Overall Study|Physician Decision|0|||
23614284|NCT00316589|65973279|FG001|Overall Study|Physician Decision|1|||
23614285|NCT00316589|65973280|FG002|Overall Study|Physician Decision|0|||
23614286|NCT00316589|65973281|FG003|Overall Study|Physician Decision|0|||
23614287|NCT00316589|65973278|FG000|Overall Study|Other reason|0|||
23614288|NCT00316589|65973279|FG001|Overall Study|Other reason|12|||
23614289|NCT00316589|65973280|FG002|Overall Study|Other reason|1|||
23614290|NCT00316589|65973281|FG003|Overall Study|Other reason|1|||
23614291|NCT02798861|65973284|FG000|Overall Study|Lost to Follow-up|22|||
23614292|NCT02798861|65973284|FG000|Overall Study|Withdrawal by Subject|1|||
23614293|NCT00938041|65973288|FG000|Overall Study|Lost to Follow-up|6|||
23614294|NCT00938041|65973288|FG000|Overall Study|Received Alternative Therapy|1|||
23614295|NCT00938041|65973288|FG000|Overall Study|Progressive Disease|5|||
23614296|NCT00938041|65973288|FG000|Overall Study|Death|12|||
23614297|NCT00938041|65973288|FG000|Overall Study|Adrenal Insufficiency|3|||
23614298|NCT01078571|65973289|FG000|Overall Study|Adverse Event|36|||
23614299|NCT01078571|65973289|FG000|Overall Study|Lack of effectiveness|36|||
23614300|NCT01078571|65973289|FG000|Overall Study|Reason not reported|21|||
23614301|NCT01078571|65973289|FG000|Overall Study|Withdrawal by Subject|12|||
23614302|NCT01078571|65973289|FG000|Overall Study|Lost to Follow-up|8|||
23614303|NCT01078571|65973289|FG000|Overall Study|Protocol Violation|2|||
23614304|NCT01133678|65973290|FG000|Overall Study|Death|1|||
23614305|NCT01133678|65973291|FG001|Overall Study|Death|1|||
23614306|NCT01270347|65973292|FG000|Core Phase|Adverse Event|1|||
23614307|NCT01270347|65973293|FG001|Core Phase|Adverse Event|6|||
23614308|NCT01270347|65973292|FG000|Core Phase|Withdrawal by Subject|1|||
23614309|NCT01270347|65973293|FG001|Core Phase|Withdrawal by Subject|2|||
23614310|NCT01270347|65973292|FG000|Core Phase|Lost to Follow-up|0|||
23614311|NCT01270347|65973293|FG001|Core Phase|Lost to Follow-up|1|||
23614312|NCT01270347|65973292|FG000|Core Phase|Miscellaneous|8|||
23614313|NCT01270347|65973293|FG001|Core Phase|Miscellaneous|14|||
23614314|NCT01270347|65973292|FG000|Extension Phase|Adverse Event|1|||
23614315|NCT01270347|65973293|FG001|Extension Phase|Adverse Event|3|||
23614316|NCT01270347|65973292|FG000|Extension Phase|Withdrawal by Subject|3|||
23614317|NCT01270347|65973293|FG001|Extension Phase|Withdrawal by Subject|4|||
23614318|NCT01270347|65973292|FG000|Extension Phase|Miscellaneous|2|||
23614319|NCT01270347|65973293|FG001|Extension Phase|Miscellaneous|2|||
23614320|NCT01038128|65973294|FG000|Overall Study|Lack of Efficacy|1|||
23614321|NCT01038128|65973294|FG000|Overall Study|Lost to Follow-up|1|||
23614322|NCT01038128|65973294|FG000|Overall Study|Withdrawal by Subject|2|||
23614323|NCT00821093|65973298|FG000|Overall Study|Adverse Event|20|||
23614324|NCT00821093|65973299|FG001|Overall Study|Adverse Event|12|||
23614325|NCT00821093|65973298|FG000|Overall Study|Withdrawal by Subject|9|||
23614326|NCT00821093|65973299|FG001|Overall Study|Withdrawal by Subject|13|||
23614327|NCT00821093|65973298|FG000|Overall Study|Lost to Follow-up|9|||
23614328|NCT00821093|65973299|FG001|Overall Study|Lost to Follow-up|3|||
23614329|NCT00821093|65973298|FG000|Overall Study|Protocol deviation|3|||
23614330|NCT00821093|65973299|FG001|Overall Study|Protocol deviation|6|||
23614331|NCT00821093|65973298|FG000|Overall Study|Abnormal laboratory value(s)|2|||
23614332|NCT00821093|65973299|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23614333|NCT00821093|65973298|FG000|Overall Study|Lack of Efficacy|2|||
23614334|NCT00821093|65973299|FG001|Overall Study|Lack of Efficacy|2|||
23614335|NCT00821093|65973298|FG000|Overall Study|Death|2|||
23614336|NCT00821093|65973299|FG001|Overall Study|Death|1|||
23533184|NCT00559962|65686511|FG002|Overall Study|Withdrawal by Subject|2|||
23533185|NCT00559962|65686512|FG003|Overall Study|Withdrawal by Subject|0|||
23533186|NCT00559962|65686513|FG004|Overall Study|Withdrawal by Subject|3|||
23533187|NCT00559962|65686514|FG005|Overall Study|Withdrawal by Subject|1|||
23533188|NCT00559962|65686515|FG006|Overall Study|Withdrawal by Subject|0|||
23533189|NCT00559962|65686516|FG007|Overall Study|Withdrawal by Subject|2|||
23533190|NCT00559962|65686509|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
23533191|NCT00559962|65686510|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
23533192|NCT00559962|65686511|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
23533193|NCT00559962|65686512|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
23533194|NCT00559962|65686513|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
23533195|NCT00559962|65686514|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
23533196|NCT00559962|65686515|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
23533197|NCT00559962|65686516|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
23533198|NCT00720876|65686519|FG000|Overall Study|found to be ineligible after starting tx|2|||
23533199|NCT00718042|65686520|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533200|NCT00718042|65686521|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533201|NCT00718042|65686522|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533202|NCT00718042|65686523|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533203|NCT00718042|65686524|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
23533204|NCT00718042|65686525|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
23533205|NCT00718042|65686520|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
23533206|NCT00718042|65686521|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
23533207|NCT00718042|65686522|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
23533208|NCT00718042|65686523|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
23533209|NCT00718042|65686524|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
23533210|NCT00718042|65686525|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
23533211|NCT00718042|65686520|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
23533212|NCT00718042|65686521|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
23533213|NCT00718042|65686522|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
23533214|NCT00718042|65686523|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
23533215|NCT00718042|65686524|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
23533216|NCT00718042|65686525|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
23533217|NCT00718042|65686520|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533218|NCT00718042|65686521|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
23533219|NCT00718042|65686522|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533220|NCT00718042|65686523|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533221|NCT00718042|65686524|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533222|NCT00718042|65686525|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
23533223|NCT00718042|65686520|FG000|Donor Follow-up|Lost to Follow-up|13|||
23533224|NCT00718042|65686521|FG001|Donor Follow-up|Lost to Follow-up|0|||
23533225|NCT00718042|65686522|FG002|Donor Follow-up|Lost to Follow-up|0|||
23533226|NCT00718042|65686523|FG003|Donor Follow-up|Lost to Follow-up|0|||
23533227|NCT00718042|65686524|FG004|Donor Follow-up|Lost to Follow-up|19|||
23533228|NCT00718042|65686525|FG005|Donor Follow-up|Lost to Follow-up|0|||
23533229|NCT01933932|65686530|FG000|Overall Study|Death|173|||
23533230|NCT01933932|65686531|FG001|Overall Study|Death|163|||
23533231|NCT01933932|65686530|FG000|Overall Study|Withdrawal by Subject|11|||
23533232|NCT01933932|65686531|FG001|Overall Study|Withdrawal by Subject|14|||
23533233|NCT01933932|65686530|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23533234|NCT01933932|65686531|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23533235|NCT00589108|65686536|FG000|Overall Study|Lost to Follow-up|1|||
23533236|NCT00589108|65686537|FG001|Overall Study|Lost to Follow-up|1|||
23533237|NCT00589108|65686538|FG002|Overall Study|Lost to Follow-up|1|||
23533238|NCT00589108|65686536|FG000|Overall Study|Death|3|||
23533239|NCT00589108|65686537|FG001|Overall Study|Death|3|||
23533240|NCT00589108|65686538|FG002|Overall Study|Death|4|||
23533241|NCT01461096|65686539|FG000|Overall Study|Death|3|||
23533242|NCT01461096|65686540|FG001|Overall Study|Death|6|||
23533243|NCT01461096|65686539|FG000|Overall Study|Severe debilitation, unable to continue|1|||
23533244|NCT01461096|65686540|FG001|Overall Study|Severe debilitation, unable to continue|1|||
23533245|NCT01461096|65686539|FG000|Overall Study|Subj not able to get to clinic|15|||
23533246|NCT01461096|65686540|FG001|Overall Study|Subj not able to get to clinic|13|||
23533247|NCT01461096|65686539|FG000|Overall Study|Site is closing|27|||
23533248|NCT01461096|65686540|FG001|Overall Study|Site is closing|30|||
23533249|NCT01461096|65686539|FG000|Overall Study|Withdrawal by Subject|5|||
23533250|NCT01461096|65686540|FG001|Overall Study|Withdrawal by Subject|3|||
23533251|NCT01461096|65686539|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
23533252|NCT01461096|65686540|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
23533253|NCT01461096|65686539|FG000|Overall Study|Lost to Follow-up|8|||
23533254|NCT01461096|65686540|FG001|Overall Study|Lost to Follow-up|4|||
23533255|NCT00098839|65686544|FG000|Overall Study|Adverse Event|5|||
23533256|NCT00098839|65686545|FG001|Overall Study|Adverse Event|2|||
23533257|NCT00098839|65686544|FG000|Overall Study|Death|1|||
23533258|NCT00098839|65686545|FG001|Overall Study|Death|2|||
23533259|NCT00098839|65686544|FG000|Overall Study|Physician Decision|4|||
23533260|NCT00098839|65686545|FG001|Overall Study|Physician Decision|14|||
23533261|NCT00098839|65686544|FG000|Overall Study|Withdrawal by Subject|1|||
23533262|NCT00098839|65686545|FG001|Overall Study|Withdrawal by Subject|0|||
23533263|NCT00098839|65686544|FG000|Overall Study|Refusal of further protocol therapy|3|||
23533264|NCT00098839|65686545|FG001|Overall Study|Refusal of further protocol therapy|1|||
23533265|NCT00098839|65686544|FG000|Overall Study|Relapse|6|||
23533266|NCT00098839|65686545|FG001|Overall Study|Relapse|3|||
23533267|NCT00098839|65686544|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
23533268|NCT00098839|65686545|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
23533269|NCT00098839|65686544|FG000|Overall Study|Ineligible|2|||
23533270|NCT00098839|65686545|FG001|Overall Study|Ineligible|0|||
23533271|NCT03511560|65686546|FG000|Overall Study|Death|0|||
23533272|NCT03511560|65686547|FG001|Overall Study|Death|1|||
23533273|NCT03511560|65686546|FG000|Overall Study|Adverse Event|0|||
23533274|NCT03511560|65686547|FG001|Overall Study|Adverse Event|2|||
23533275|NCT03511560|65686546|FG000|Overall Study|Transplant cancelled|0|||
23533276|NCT03511560|65686547|FG001|Overall Study|Transplant cancelled|1|||
23533277|NCT03511560|65686546|FG000|Overall Study|Patient switched to another drug|1|||
23533278|NCT03511560|65686547|FG001|Overall Study|Patient switched to another drug|0|||
23533279|NCT00436280|65686548|FG000|Period 1: Induction|Adverse Event|8|||
23533280|NCT00436280|65686548|FG000|Period 1: Induction|Progressive Disease|12|||
23533281|NCT00436280|65686548|FG000|Period 1: Induction|Stable Disease|6|||
23533282|NCT00436280|65686548|FG000|Period 1: Induction|Withdrawal by Subject|1|||
23533283|NCT00436280|65686548|FG000|Period 1: Induction|Death|1|||
23533284|NCT00436280|65686548|FG000|Period 2: Consolidation|Adverse Event|1|||
23533285|NCT00436280|65686548|FG000|Period 2: Consolidation|Progressive Disease|10|||
23533286|NCT00436280|65686548|FG000|Period 2: Consolidation|Stable Disease|1|||
23533287|NCT00436280|65686548|FG000|Period 2: Consolidation|Physician Decision|2|||
23533288|NCT00436280|65686548|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
23533289|NCT00436280|65686548|FG000|Period 2: Consolidation|Death|1|||
23533290|NCT00436280|65686548|FG000|Period 3: Maintenance|Adverse Event|6|||
23533291|NCT00436280|65686548|FG000|Period 3: Maintenance|Progressive Disease|12|||
23533292|NCT00727194|65686550|FG000|Screening Period|Low QMG scores|0|||
23533293|NCT00727194|65686551|FG001|Screening Period|Low QMG scores|0|||
23533294|NCT00727194|65686552|FG002|Screening Period|Low QMG scores|6|||
23533295|NCT00727194|65686550|FG000|Screening Period|Lacked AChR antibodies|0|||
23533296|NCT00727194|65686551|FG001|Screening Period|Lacked AChR antibodies|0|||
23533297|NCT00727194|65686552|FG002|Screening Period|Lacked AChR antibodies|5|||
23533298|NCT00727194|65686550|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
23533299|NCT00727194|65686551|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
23533300|NCT00727194|65686552|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
23533301|NCT00727194|65686550|FG000|Screening Period|Severe infections|0|||
23533302|NCT00727194|65686551|FG001|Screening Period|Severe infections|0|||
23533303|NCT00727194|65686552|FG002|Screening Period|Severe infections|2|||
23533304|NCT00727194|65686550|FG000|Screening Period|History of thymoma|0|||
23533305|NCT00727194|65686551|FG001|Screening Period|History of thymoma|0|||
23533306|NCT00727194|65686552|FG002|Screening Period|History of thymoma|1|||
23533307|NCT00727194|65686550|FG000|Treatment Period 2|Lack of Efficacy|0|||
23533308|NCT00727194|65686551|FG001|Treatment Period 2|Lack of Efficacy|1|||
23533309|NCT00727194|65686552|FG002|Treatment Period 2|Lack of Efficacy|0|||
23533310|NCT03085927|65686553|FG000|Overall Study|Withdrawal by Subject|1|||
23533311|NCT03085927|65686554|FG001|Overall Study|Withdrawal by Subject|4|||
23533312|NCT03085927|65686553|FG000|Overall Study|Lost to Follow-up|3|||
23533313|NCT03085927|65686554|FG001|Overall Study|Lost to Follow-up|1|||
23533314|NCT03085927|65686553|FG000|Overall Study|Death|1|||
23533315|NCT03085927|65686554|FG001|Overall Study|Death|0|||
23533316|NCT03085927|65686553|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
23533317|NCT03085927|65686554|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
23533318|NCT03085927|65686553|FG000|Overall Study|Dyad Became Ineligible|0|||
23533319|NCT03085927|65686554|FG001|Overall Study|Dyad Became Ineligible|1|||
23533320|NCT02711800|65686565|FG000|Overall Study|Lost to Follow-up|1|||
23533321|NCT02711800|65686565|FG000|Overall Study|Withdrawal by Subject|1|||
23533322|NCT01978184|65686566|FG000|Overall Study|Progressive disease|5|||
23533323|NCT01978184|65686567|FG001|Overall Study|Progressive disease|5|||
23533324|NCT01978184|65686566|FG000|Overall Study|Other than PDA|2|||
23533325|NCT01978184|65686567|FG001|Overall Study|Other than PDA|2|||
23533326|NCT01978184|65686566|FG000|Overall Study|Physician Decision|0|||
23533327|NCT01978184|65686567|FG001|Overall Study|Physician Decision|3|||
23533328|NCT01978184|65686566|FG000|Overall Study|Noncompliance|1|||
23614337|NCT00821093|65973298|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23614338|NCT00821093|65973299|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23614339|NCT00821093|65973298|FG000|Overall Study|Administrative problems|1|||
23614340|NCT00821093|65973299|FG001|Overall Study|Administrative problems|2|||
23614341|NCT03320941|65973300|FG000|Overall Study|subject/guardian decision|0|||
23614342|NCT03320941|65973301|FG001|Overall Study|subject/guardian decision|0|||
23614343|NCT03320941|65973302|FG002|Overall Study|subject/guardian decision|0|||
23614344|NCT03320941|65973303|FG003|Overall Study|subject/guardian decision|1|||
23614345|NCT03320941|65973304|FG004|Overall Study|subject/guardian decision|0|||
23614346|NCT00417989|65973309|FG000|Overall Study|Withdrawal by Subject|13|||
23614347|NCT00417989|65973310|FG001|Overall Study|Withdrawal by Subject|13|||
23614348|NCT00417989|65973309|FG000|Overall Study|Lost to Follow-up|1|||
23614349|NCT00417989|65973310|FG001|Overall Study|Lost to Follow-up|6|||
23614350|NCT00417989|65973309|FG000|Overall Study|Protocol Violation|1|||
23614351|NCT00417989|65973310|FG001|Overall Study|Protocol Violation|0|||
23614352|NCT00417989|65973309|FG000|Overall Study|Death|0|||
23614353|NCT00417989|65973310|FG001|Overall Study|Death|1|||
23614354|NCT00417989|65973309|FG000|Overall Study|Physician Decision|5|||
23614355|NCT00417989|65973310|FG001|Overall Study|Physician Decision|2|||
23614356|NCT04267393|65973313|FG000|Randomization|Adverse Event|1|||
23614357|NCT04267393|65973314|FG001|Randomization|Adverse Event|0|||
23614358|NCT04267393|65973315|FG002|Randomization|Adverse Event|0|||
23614359|NCT04267393|65973313|FG000|Randomization|Administrative Reasons by Sponsor|0|||
23614360|NCT04267393|65973314|FG001|Randomization|Administrative Reasons by Sponsor|1|||
23614361|NCT04267393|65973315|FG002|Randomization|Administrative Reasons by Sponsor|0|||
23614362|NCT04267393|65973313|FG000|Treatment Period|Adverse Event|0|||
23614363|NCT04267393|65973314|FG001|Treatment Period|Adverse Event|2|||
23614364|NCT04267393|65973315|FG002|Treatment Period|Adverse Event|3|||
23614365|NCT04267393|65973313|FG000|Treatment Period|Participant Withdrew Consent|0|||
23614366|NCT04267393|65973314|FG001|Treatment Period|Participant Withdrew Consent|0|||
23614367|NCT04267393|65973315|FG002|Treatment Period|Participant Withdrew Consent|1|||
23614368|NCT04267393|65973313|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
23614369|NCT04267393|65973314|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
23614370|NCT04267393|65973315|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
23614371|NCT00857311|65973317|FG000|Overall Study|Lost to Follow-up|1|||
23614372|NCT00857311|65973318|FG001|Overall Study|Lost to Follow-up|0|||
23614373|NCT00857311|65973319|FG002|Overall Study|Lost to Follow-up|0|||
23614374|NCT00857311|65973320|FG003|Overall Study|Lost to Follow-up|0|||
23614375|NCT01989156|65973321|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
23614376|NCT01989156|65973322|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
23614377|NCT01989156|65973323|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
23614378|NCT01989156|65973321|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
23614379|NCT01989156|65973322|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
23614380|NCT01989156|65973323|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
23614381|NCT01989156|65973321|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
23614382|NCT01989156|65973322|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
23614383|NCT01989156|65973323|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
23614384|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
23614385|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
23614386|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
23533329|NCT01978184|65686567|FG001|Overall Study|Noncompliance|2|||
23533330|NCT01978184|65686566|FG000|Overall Study|Death|1|||
23533331|NCT01978184|65686567|FG001|Overall Study|Death|0|||
23533332|NCT01978184|65686566|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
23614387|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
23614388|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
23614389|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
23533333|NCT01978184|65686567|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
23614390|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
23614391|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
23614392|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
23614393|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
23614394|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
23614395|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
23614396|NCT01989156|65973321|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
23614397|NCT01989156|65973322|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
23614398|NCT01989156|65973323|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
23614399|NCT01294358|65973324|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
23614400|NCT01294358|65973325|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
23614401|NCT01294358|65973326|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
23614402|NCT01294358|65973327|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
23614403|NCT01294358|65973328|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
23614404|NCT01294358|65973324|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
23614405|NCT01294358|65973325|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
23614406|NCT01294358|65973326|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
23614407|NCT01294358|65973327|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
23614408|NCT01294358|65973328|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
23614409|NCT01294358|65973324|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
23614410|NCT01294358|65973325|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
23614411|NCT01294358|65973326|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
23614412|NCT01294358|65973327|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
23614413|NCT01294358|65973328|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
23614414|NCT01294358|65973324|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
23614415|NCT01294358|65973325|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
23614416|NCT01294358|65973326|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
23614417|NCT01294358|65973327|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
23614418|NCT01294358|65973328|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
23614419|NCT00191984|65973333|FG000|Overall Study|Disease Progression|21|||
23614420|NCT00191984|65973333|FG000|Overall Study|Adverse Event|4|||
23614421|NCT00191984|65973333|FG000|Overall Study|Death|2|||
23614422|NCT00191984|65973333|FG000|Overall Study|Entry Criteria Exclusion|1|||
23614423|NCT00191984|65973333|FG000|Overall Study|Withdrawal by Subject|7|||
23614424|NCT00191984|65973333|FG000|Overall Study|Physician Decision|4|||
23614425|NCT00005908|65973334|FG000|Overall Study|Withdrawal by Subject|1|||
23614426|NCT00005908|65973335|FG001|Overall Study|Withdrawal by Subject|0|||
23614427|NCT02152995|65973336|FG000|Overall Study|Withdrawal by Subject|1|||
23614428|NCT02152995|65973337|FG001|Overall Study|Withdrawal by Subject|0|||
23614429|NCT01631825|65973338|FG000|Overall Study|Adverse Event|42|||
23533334|NCT00723606|65686568|FG000|Overall Study|Adverse Event|2|||
23533335|NCT00723606|65686569|FG001|Overall Study|Adverse Event|5|||
23208001|NCT00438399|64498341|FG001|Overall Study|Adverse Event|0|||
23208002|NCT00438399|64498342|FG002|Overall Study|Adverse Event|1|||
23208003|NCT00438399|64498343|FG003|Overall Study|Adverse Event|1|||
23208004|NCT00438399|64498344|FG004|Overall Study|Adverse Event|0|||
23208005|NCT00438399|64498345|FG005|Overall Study|Adverse Event|1|||
23208006|NCT00438399|64498340|FG000|Overall Study|Withdrawal by Subject|5|||
23208007|NCT00438399|64498341|FG001|Overall Study|Withdrawal by Subject|6|||
23208008|NCT00438399|64498342|FG002|Overall Study|Withdrawal by Subject|3|||
23208009|NCT00438399|64498343|FG003|Overall Study|Withdrawal by Subject|2|||
23208010|NCT00438399|64498344|FG004|Overall Study|Withdrawal by Subject|2|||
23208011|NCT00438399|64498345|FG005|Overall Study|Withdrawal by Subject|2|||
23208012|NCT00438399|64498340|FG000|Overall Study|Protocol Violation|0|||
23208013|NCT00438399|64498341|FG001|Overall Study|Protocol Violation|0|||
23208014|NCT00438399|64498342|FG002|Overall Study|Protocol Violation|1|||
23421286|NCT01468207|65284001|FG005|Treatment Period 1|Other|0|||
23421287|NCT01468207|65283996|FG000|Treatment Period 2|Adverse Event|0|||
23421288|NCT01468207|65283997|FG001|Treatment Period 2|Adverse Event|0|||
23421289|NCT01468207|65283998|FG002|Treatment Period 2|Adverse Event|6|||
23421290|NCT01468207|65283999|FG003|Treatment Period 2|Adverse Event|1|||
23421291|NCT01468207|65284000|FG004|Treatment Period 2|Adverse Event|2|||
23421292|NCT01468207|65284001|FG005|Treatment Period 2|Adverse Event|1|||
23421293|NCT01468207|65283996|FG000|Treatment Period 2|Lack of Efficacy|0|||
23421294|NCT01468207|65283997|FG001|Treatment Period 2|Lack of Efficacy|0|||
23421295|NCT01468207|65283998|FG002|Treatment Period 2|Lack of Efficacy|1|||
23421296|NCT01468207|65283999|FG003|Treatment Period 2|Lack of Efficacy|1|||
23421297|NCT01468207|65284000|FG004|Treatment Period 2|Lack of Efficacy|0|||
23421298|NCT01468207|65284001|FG005|Treatment Period 2|Lack of Efficacy|2|||
23421299|NCT01468207|65283996|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23421300|NCT01468207|65283997|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23421301|NCT01468207|65283998|FG002|Treatment Period 2|Withdrawal by Subject|5|||
23421302|NCT01468207|65283999|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23421303|NCT01468207|65284000|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23421304|NCT01468207|65284001|FG005|Treatment Period 2|Withdrawal by Subject|2|||
23421305|NCT01468207|65283996|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
23421306|NCT01468207|65283997|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
23421307|NCT01468207|65283998|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
23421308|NCT01468207|65283999|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
23421309|NCT01468207|65284000|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
23421310|NCT01468207|65284001|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
23421311|NCT01468207|65283996|FG000|Treatment Period 2|Lost to Follow-up|0|||
23208015|NCT00438399|64498343|FG003|Overall Study|Protocol Violation|0|||
23208016|NCT00438399|64498344|FG004|Overall Study|Protocol Violation|0|||
23208017|NCT00438399|64498345|FG005|Overall Study|Protocol Violation|1|||
23208018|NCT00438399|64498340|FG000|Overall Study|Subje stopped study|0|||
23208019|NCT00438399|64498341|FG001|Overall Study|Subje stopped study|0|||
23421312|NCT01468207|65283997|FG001|Treatment Period 2|Lost to Follow-up|0|||
23421313|NCT01468207|65283998|FG002|Treatment Period 2|Lost to Follow-up|5|||
23421314|NCT01468207|65283999|FG003|Treatment Period 2|Lost to Follow-up|1|||
23421315|NCT01468207|65284000|FG004|Treatment Period 2|Lost to Follow-up|0|||
23421316|NCT01468207|65284001|FG005|Treatment Period 2|Lost to Follow-up|0|||
23421317|NCT01468207|65283996|FG000|Treatment Period 2|Other|0|||
23421318|NCT01468207|65283997|FG001|Treatment Period 2|Other|0|||
23421319|NCT01468207|65283998|FG002|Treatment Period 2|Other|5|||
23421320|NCT01468207|65283999|FG003|Treatment Period 2|Other|1|||
23421321|NCT01468207|65284000|FG004|Treatment Period 2|Other|1|||
23421322|NCT01468207|65284001|FG005|Treatment Period 2|Other|2|||
23421323|NCT01804582|65284007|FG000|Overall Study|Lost to Follow-up|47|||
23421324|NCT01804582|65284008|FG001|Overall Study|Lost to Follow-up|56|||
23421325|NCT01804582|65284007|FG000|Overall Study|Physician Decision|2|||
23421326|NCT01804582|65284008|FG001|Overall Study|Physician Decision|0|||
23421327|NCT02185014|65284011|FG000|Overall Study|Adverse Event|18|||
23421328|NCT02185014|65284011|FG000|Overall Study|Withdrew Consent|8|||
23421329|NCT02185014|65284011|FG000|Overall Study|Lost to Follow-up|4|||
23421330|NCT02185014|65284011|FG000|Overall Study|Lack of Efficacy|14|||
23421331|NCT02185014|65284011|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
23421332|NCT02185014|65284011|FG000|Overall Study|Subject Noncompliance|1|||
23533336|NCT00723606|65686568|FG000|Overall Study|Other|2|||
23533337|NCT00723606|65686569|FG001|Overall Study|Other|0|||
23533338|NCT00723606|65686568|FG000|Overall Study|Withdrawal by Subject|0|||
23533339|NCT00723606|65686569|FG001|Overall Study|Withdrawal by Subject|2|||
23533340|NCT03614793|65686570|FG000|Overall Study|Lost to Follow-up|1|||
23533341|NCT03614793|65686571|FG001|Overall Study|Lost to Follow-up|2|||
23533342|NCT03614793|65686570|FG000|Overall Study|Lack of Efficacy|0|||
23533343|NCT03614793|65686571|FG001|Overall Study|Lack of Efficacy|5|||
23533344|NCT03614793|65686570|FG000|Overall Study|Withdrawal by Subject|0|||
23533345|NCT03614793|65686571|FG001|Overall Study|Withdrawal by Subject|1|||
23533346|NCT03614793|65686570|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
23533347|NCT03614793|65686571|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
23533348|NCT02649972|65686572|FG000|Overall Study|Not treated|1|||
23533349|NCT04360824|65686575|FG000|Overall Study|Withdrawal by Subject|2|||
23533350|NCT04360824|65686576|FG001|Overall Study|Withdrawal by Subject|1|||
23533351|NCT04360824|65686575|FG000|Overall Study|Did not receive assigned treatment|1|||
23533352|NCT04360824|65686576|FG001|Overall Study|Did not receive assigned treatment|3|||
23533353|NCT03351049|65686577|FG000|Overall Study|Withdrawal|26|||
23533354|NCT03351049|65686578|FG001|Overall Study|Withdrawal|22|||
23533355|NCT02504866|65686579|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
23533356|NCT02504866|65686580|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
23533357|NCT02504866|65686581|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
23533358|NCT02465528|65686582|FG000|Overall Study|Progressive disease|0|||
23533359|NCT02465528|65686583|FG001|Overall Study|Progressive disease|2|||
23533360|NCT02465528|65686584|FG002|Overall Study|Progressive disease|9|||
23533361|NCT02465528|65686585|FG003|Overall Study|Progressive disease|4|||
23533362|NCT02465528|65686582|FG000|Overall Study|Study terminated by sponsor|1|||
23533363|NCT02465528|65686583|FG001|Overall Study|Study terminated by sponsor|2|||
23533364|NCT02465528|65686584|FG002|Overall Study|Study terminated by sponsor|0|||
23533365|NCT02465528|65686585|FG003|Overall Study|Study terminated by sponsor|0|||
23533366|NCT02465528|65686582|FG000|Overall Study|Withdrawal by Subject|0|||
23533367|NCT02465528|65686583|FG001|Overall Study|Withdrawal by Subject|0|||
23614430|NCT01631825|65973338|FG000|Overall Study|Lack of Efficacy|7|||
23614431|NCT01631825|65973338|FG000|Overall Study|Withdrawal by Subject|9|||
23614432|NCT01631825|65973338|FG000|Overall Study|Protocol Violation|4|||
23614433|NCT01631825|65973338|FG000|Overall Study|Discontinuation criteria|1|||
23614434|NCT01631825|65973338|FG000|Overall Study|Physician Decision|2|||
23614435|NCT00215943|65973339|FG000|Overall Study|Disease Progression|3|||
23614436|NCT00215943|65973340|FG001|Overall Study|Disease Progression|5|||
23614437|NCT00215943|65973339|FG000|Overall Study|Alternate therapy|0|||
23614438|NCT00215943|65973340|FG001|Overall Study|Alternate therapy|1|||
23614439|NCT00215943|65973339|FG000|Overall Study|Adverse Event|3|||
23421333|NCT02185014|65284011|FG000|Overall Study|Other|4|||
23533368|NCT02465528|65686584|FG002|Overall Study|Withdrawal by Subject|2|||
23533369|NCT02465528|65686585|FG003|Overall Study|Withdrawal by Subject|0|||
23533370|NCT02465528|65686582|FG000|Overall Study|Adverse Event|0|||
23533371|NCT02465528|65686583|FG001|Overall Study|Adverse Event|0|||
23533372|NCT02465528|65686584|FG002|Overall Study|Adverse Event|0|||
23533373|NCT02465528|65686585|FG003|Overall Study|Adverse Event|1|||
23533374|NCT02465528|65686582|FG000|Overall Study|Physician Decision|0|||
23614440|NCT00215943|65973340|FG001|Overall Study|Adverse Event|6|||
23614441|NCT00215943|65973339|FG000|Overall Study|Other disease|0|||
23421334|NCT02118766|65284012|FG000|Overall Study|Adverse Event|7|||
23421335|NCT02118766|65284013|FG001|Overall Study|Adverse Event|2|||
23421336|NCT02118766|65284012|FG000|Overall Study|Withdrawal by Subject|3|||
23533375|NCT02465528|65686583|FG001|Overall Study|Physician Decision|0|||
23533376|NCT02465528|65686584|FG002|Overall Study|Physician Decision|1|||
23533377|NCT02465528|65686585|FG003|Overall Study|Physician Decision|0|||
23533378|NCT03194646|65686590|FG000|Overall Study|Adverse Event|24|||
23533379|NCT03194646|65686591|FG001|Overall Study|Adverse Event|25|||
23533380|NCT03194646|65686592|FG002|Overall Study|Adverse Event|14|||
23533381|NCT03194646|65686593|FG003|Overall Study|Adverse Event|17|||
23533382|NCT03194646|65686590|FG000|Overall Study|Lack of Efficacy|4|||
23533383|NCT03194646|65686591|FG001|Overall Study|Lack of Efficacy|2|||
23533384|NCT03194646|65686592|FG002|Overall Study|Lack of Efficacy|2|||
23533385|NCT03194646|65686593|FG003|Overall Study|Lack of Efficacy|12|||
23533386|NCT03194646|65686590|FG000|Overall Study|Lost to Follow-up|30|||
23533387|NCT03194646|65686591|FG001|Overall Study|Lost to Follow-up|22|||
23533388|NCT03194646|65686592|FG002|Overall Study|Lost to Follow-up|12|||
23533389|NCT03194646|65686593|FG003|Overall Study|Lost to Follow-up|35|||
23533390|NCT03194646|65686590|FG000|Overall Study|Non-compliance with study drug|4|||
23533391|NCT03194646|65686591|FG001|Overall Study|Non-compliance with study drug|0|||
23533392|NCT03194646|65686592|FG002|Overall Study|Non-compliance with study drug|1|||
23533393|NCT03194646|65686593|FG003|Overall Study|Non-compliance with study drug|1|||
23533394|NCT03194646|65686590|FG000|Overall Study|Other|89|||
23533395|NCT03194646|65686591|FG001|Overall Study|Other|68|||
23533396|NCT03194646|65686592|FG002|Overall Study|Other|34|||
23533397|NCT03194646|65686593|FG003|Overall Study|Other|31|||
23533398|NCT03194646|65686590|FG000|Overall Study|Physician Decision|7|||
23533399|NCT03194646|65686591|FG001|Overall Study|Physician Decision|9|||
23533400|NCT03194646|65686592|FG002|Overall Study|Physician Decision|5|||
23533401|NCT03194646|65686593|FG003|Overall Study|Physician Decision|4|||
23533402|NCT03194646|65686590|FG000|Overall Study|Pregnancy|4|||
23533403|NCT03194646|65686591|FG001|Overall Study|Pregnancy|5|||
23533404|NCT03194646|65686592|FG002|Overall Study|Pregnancy|1|||
23533405|NCT03194646|65686593|FG003|Overall Study|Pregnancy|2|||
23533406|NCT03194646|65686590|FG000|Overall Study|Protocol Violation|4|||
23533407|NCT03194646|65686591|FG001|Overall Study|Protocol Violation|2|||
23533408|NCT03194646|65686592|FG002|Overall Study|Protocol Violation|1|||
23533409|NCT03194646|65686593|FG003|Overall Study|Protocol Violation|1|||
23533410|NCT03194646|65686590|FG000|Overall Study|Site terminated by sponsor|0|||
23533411|NCT03194646|65686591|FG001|Overall Study|Site terminated by sponsor|0|||
23533412|NCT03194646|65686592|FG002|Overall Study|Site terminated by sponsor|2|||
23533413|NCT03194646|65686593|FG003|Overall Study|Site terminated by sponsor|0|||
23533414|NCT03194646|65686590|FG000|Overall Study|Study terminated by sponsor|62|||
23614442|NCT00215943|65973340|FG001|Overall Study|Other disease|1|||
23614443|NCT00215943|65973339|FG000|Overall Study|Other complications|3|||
23614444|NCT00215943|65973340|FG001|Overall Study|Other complications|1|||
23614445|NCT00267956|65973341|FG000|Controlled Period|Adverse Event|4|||
23614446|NCT00267956|65973342|FG001|Controlled Period|Adverse Event|1|||
23533415|NCT03194646|65686591|FG001|Overall Study|Study terminated by sponsor|61|||
23533416|NCT03194646|65686592|FG002|Overall Study|Study terminated by sponsor|30|||
23533417|NCT03194646|65686593|FG003|Overall Study|Study terminated by sponsor|34|||
23614447|NCT00267956|65973343|FG002|Controlled Period|Adverse Event|0|||
23614448|NCT00267956|65973344|FG003|Controlled Period|Adverse Event|0|||
23614449|NCT00267956|65973341|FG000|Controlled Period|Lack of Efficacy|4|||
23614450|NCT00267956|65973342|FG001|Controlled Period|Lack of Efficacy|2|||
23614451|NCT00267956|65973343|FG002|Controlled Period|Lack of Efficacy|0|||
23614452|NCT00267956|65973344|FG003|Controlled Period|Lack of Efficacy|0|||
23614453|NCT00267956|65973341|FG000|Controlled Period|Lost to Follow-up|2|||
23614454|NCT00267956|65973342|FG001|Controlled Period|Lost to Follow-up|0|||
23614455|NCT00267956|65973343|FG002|Controlled Period|Lost to Follow-up|0|||
23614456|NCT00267956|65973344|FG003|Controlled Period|Lost to Follow-up|0|||
23614457|NCT00267956|65973341|FG000|Controlled Period|Withdrew consent|3|||
23614458|NCT00267956|65973342|FG001|Controlled Period|Withdrew consent|1|||
23614459|NCT00267956|65973343|FG002|Controlled Period|Withdrew consent|0|||
23614460|NCT00267956|65973344|FG003|Controlled Period|Withdrew consent|0|||
23614461|NCT00267956|65973341|FG000|After Controlled Period|Adverse Event|0|||
23533418|NCT03194646|65686590|FG000|Overall Study|Withdrawal by Subject|75|||
23533419|NCT03194646|65686591|FG001|Overall Study|Withdrawal by Subject|74|||
23533420|NCT03194646|65686592|FG002|Overall Study|Withdrawal by Subject|36|||
23533421|NCT03194646|65686593|FG003|Overall Study|Withdrawal by Subject|131|||
23533422|NCT03194646|65686590|FG000|Overall Study|Missing|1|||
23614462|NCT00267956|65973342|FG001|After Controlled Period|Adverse Event|0|||
23614463|NCT00267956|65973343|FG002|After Controlled Period|Adverse Event|2|||
23614464|NCT00267956|65973344|FG003|After Controlled Period|Adverse Event|1|||
23614465|NCT00267956|65973341|FG000|After Controlled Period|Lack of Efficacy|0|||
23533423|NCT03194646|65686591|FG001|Overall Study|Missing|0|||
23533424|NCT03194646|65686592|FG002|Overall Study|Missing|1|||
23533425|NCT03194646|65686593|FG003|Overall Study|Missing|12|||
23533426|NCT01976845|65686595|FG000|Overall Study|Physician Decision|8|||
23533427|NCT01976845|65686596|FG001|Overall Study|Physician Decision|8|||
23533428|NCT01976845|65686597|FG002|Overall Study|Physician Decision|3|||
23614466|NCT00267956|65973342|FG001|After Controlled Period|Lack of Efficacy|0|||
23614467|NCT00267956|65973343|FG002|After Controlled Period|Lack of Efficacy|1|||
23614468|NCT00267956|65973344|FG003|After Controlled Period|Lack of Efficacy|1|||
23614469|NCT00267956|65973341|FG000|After Controlled Period|Lost to Follow-up|0|||
23614470|NCT00267956|65973342|FG001|After Controlled Period|Lost to Follow-up|0|||
23614471|NCT00267956|65973343|FG002|After Controlled Period|Lost to Follow-up|1|||
23614472|NCT00267956|65973344|FG003|After Controlled Period|Lost to Follow-up|0|||
23614473|NCT00267956|65973341|FG000|After Controlled Period|Withdrew consent|0|||
23614474|NCT00267956|65973342|FG001|After Controlled Period|Withdrew consent|0|||
23614475|NCT00267956|65973343|FG002|After Controlled Period|Withdrew consent|1|||
23614476|NCT00267956|65973344|FG003|After Controlled Period|Withdrew consent|0|||
23614477|NCT01263223|65973349|FG000|Period 2|Withdrawal by Subject|0|||
23614478|NCT01263223|65973350|FG001|Period 2|Withdrawal by Subject|1|||
23614479|NCT01263223|65973349|FG000|7-day Follow-up|Withdrawal by Subject|0|||
23614480|NCT01263223|65973350|FG001|7-day Follow-up|Withdrawal by Subject|1|||
23614481|NCT01263223|65973349|FG000|7-day Follow-up|Lost to Follow-up|1|||
23614482|NCT01263223|65973350|FG001|7-day Follow-up|Lost to Follow-up|0|||
23614483|NCT03444155|65973351|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
23614484|NCT03444155|65973352|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
23614485|NCT04543942|65973360|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
23614486|NCT04543942|65973361|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
23614487|NCT04543942|65973360|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
23614488|NCT04543942|65973361|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
23614489|NCT00276016|65973362|FG000|Intervention 1|Withdrawal by Subject|0|||
23614490|NCT00276016|65973363|FG001|Intervention 1|Withdrawal by Subject|1|||
23614491|NCT00276016|65973364|FG002|Intervention 1|Withdrawal by Subject|0|||
23614492|NCT00276016|65973365|FG003|Intervention 1|Withdrawal by Subject|0|||
23614493|NCT00276016|65973366|FG004|Intervention 1|Withdrawal by Subject|0|||
23614494|NCT00276016|65973367|FG005|Intervention 1|Withdrawal by Subject|0|||
23614495|NCT01283971|65973369|FG000|Overall Study|Adverse Event|3|||
23614496|NCT01283971|65973370|FG001|Overall Study|Adverse Event|5|||
23614497|NCT01283971|65973369|FG000|Overall Study|Insufficient therapeutic responses|3|||
23614498|NCT01283971|65973370|FG001|Overall Study|Insufficient therapeutic responses|3|||
23614499|NCT01283971|65973369|FG000|Overall Study|Protocol Violation|5|||
23614500|NCT01283971|65973370|FG001|Overall Study|Protocol Violation|1|||
23614501|NCT01283971|65973369|FG000|Overall Study|Refused treatment|3|||
23614502|NCT01283971|65973370|FG001|Overall Study|Refused treatment|1|||
23614503|NCT01283971|65973369|FG000|Overall Study|Failure to return|0|||
23614504|NCT01283971|65973370|FG001|Overall Study|Failure to return|1|||
23614505|NCT01283971|65973369|FG000|Overall Study|Administrative reasons|1|||
23614506|NCT01283971|65973370|FG001|Overall Study|Administrative reasons|1|||
23614507|NCT03441789|65973371|FG000|Overall Study|Withdrawal by Subject|1|||
23614508|NCT03441789|65973372|FG001|Overall Study|Withdrawal by Subject|1|||
23614509|NCT03441789|65973371|FG000|Overall Study|Adverse Event|0|||
23614510|NCT03441789|65973372|FG001|Overall Study|Adverse Event|1|||
23614511|NCT03441789|65973371|FG000|Overall Study|Protocol Violation|0|||
23614512|NCT03441789|65973372|FG001|Overall Study|Protocol Violation|1|||
23614513|NCT03441789|65973371|FG000|Overall Study|Lost to Follow-up|0|||
23614514|NCT03441789|65973372|FG001|Overall Study|Lost to Follow-up|1|||
23533429|NCT01706250|65686603|FG000|Overall Study|Lost to Follow-up|2|||
23533430|NCT02052466|65686616|FG000|Overall Study|Withdrawal by Subject|1|||
23533431|NCT02052466|65686616|FG000|Overall Study|Acromial fracture|1|||
23533432|NCT03746522|65686617|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
23533433|NCT03746522|65686618|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
23533434|NCT03746522|65686619|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
23533435|NCT03746522|65686617|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
23533436|NCT03746522|65686618|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
23533437|NCT03746522|65686619|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
23533438|NCT03746522|65686617|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
23533439|NCT03746522|65686618|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
23533440|NCT03746522|65686619|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
23533441|NCT03746522|65686617|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
23533442|NCT03746522|65686618|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
23614515|NCT01622088|65973377|FG000|Overall Study|Adverse Event|20|||
23614516|NCT01622088|65973377|FG000|Overall Study|Lost to Follow-up|1|||
23614517|NCT01622088|65973377|FG000|Overall Study|Withdrawal by Subject|20|||
23614518|NCT01622088|65973377|FG000|Overall Study|Investigator Decision|1|||
23614519|NCT01622088|65973377|FG000|Overall Study|Death|53|||
23614520|NCT01622088|65973377|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
23614521|NCT02849509|65973388|FG000|Overall Study|Worsening of disease under study|1|||
23614522|NCT02849509|65973389|FG001|Overall Study|Worsening of disease under study|1|||
23614523|NCT02849509|65973390|FG002|Overall Study|Worsening of disease under study|1|||
23533443|NCT03746522|65686619|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
23614524|NCT02849509|65973388|FG000|Overall Study|Worsening of other pre-existing disease|0|||
23208020|NCT00438399|64498342|FG002|Overall Study|Subje stopped study|1|||
23208021|NCT00438399|64498343|FG003|Overall Study|Subje stopped study|0|||
23208022|NCT00438399|64498344|FG004|Overall Study|Subje stopped study|0|||
23208023|NCT00438399|64498345|FG005|Overall Study|Subje stopped study|0|||
23208024|NCT00438399|64498340|FG000|Overall Study|Pregnancy|0|||
23208025|NCT00438399|64498341|FG001|Overall Study|Pregnancy|0|||
23208026|NCT00438399|64498342|FG002|Overall Study|Pregnancy|0|||
23208027|NCT00438399|64498343|FG003|Overall Study|Pregnancy|0|||
23208028|NCT00438399|64498344|FG004|Overall Study|Pregnancy|0|||
23208029|NCT00438399|64498345|FG005|Overall Study|Pregnancy|1|||
23208030|NCT00438399|64498340|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
23208031|NCT00438399|64498341|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
23208032|NCT00438399|64498342|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
23208033|NCT00438399|64498343|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
23208034|NCT00438399|64498344|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
23208035|NCT00438399|64498345|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
23533444|NCT03746522|65686617|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
23533445|NCT03746522|65686618|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
23533446|NCT03746522|65686619|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
23533447|NCT00456092|65686620|FG000|Extension Phase|Grade 2 or Greater AE|2|||
23614525|NCT02849509|65973389|FG001|Overall Study|Worsening of other pre-existing disease|1|||
23614526|NCT02849509|65973390|FG002|Overall Study|Worsening of other pre-existing disease|2|||
23614527|NCT02849509|65973388|FG000|Overall Study|Other adverse event|36|||
23614528|NCT02849509|65973389|FG001|Overall Study|Other adverse event|41|||
23614529|NCT02849509|65973390|FG002|Overall Study|Other adverse event|8|||
23614530|NCT02849509|65973388|FG000|Overall Study|Withdrawal by Subject|6|||
23614531|NCT02849509|65973389|FG001|Overall Study|Withdrawal by Subject|17|||
23614532|NCT02849509|65973390|FG002|Overall Study|Withdrawal by Subject|12|||
23614533|NCT02849509|65973388|FG000|Overall Study|Lost to Follow-up|27|||
23614534|NCT02849509|65973389|FG001|Overall Study|Lost to Follow-up|67|||
23614535|NCT02849509|65973390|FG002|Overall Study|Lost to Follow-up|36|||
23614536|NCT02849509|65973388|FG000|Overall Study|Other, reason not specified|14|||
23614537|NCT02849509|65973389|FG001|Overall Study|Other, reason not specified|29|||
23614538|NCT02849509|65973390|FG002|Overall Study|Other, reason not specified|25|||
23614539|NCT02849509|65973388|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
23614540|NCT02849509|65973389|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
23614541|NCT02849509|65973390|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
23614542|NCT01848483|65973391|FG000|Overall Study|Death|2|||
23533448|NCT00456092|65686621|FG001|Extension Phase|Grade 2 or Greater AE|2|||
23533449|NCT00456092|65686622|FG002|Extension Phase|Grade 2 or Greater AE|0|||
23533450|NCT00456092|65686623|FG003|Extension Phase|Grade 2 or Greater AE|0|||
23533451|NCT00456092|65686624|FG004|Extension Phase|Grade 2 or Greater AE|2|||
23533452|NCT00456092|65686620|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
23533453|NCT00456092|65686621|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
23533454|NCT00456092|65686622|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
23533455|NCT00456092|65686623|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
23533456|NCT00456092|65686624|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
23533457|NCT00456092|65686620|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
23533458|NCT00456092|65686621|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
23533459|NCT00456092|65686622|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
23533460|NCT00456092|65686623|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
23533461|NCT00456092|65686624|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
23533462|NCT00456092|65686620|FG000|Extension Phase|Withdrew Consent|2|||
23533463|NCT00456092|65686621|FG001|Extension Phase|Withdrew Consent|0|||
23533464|NCT00456092|65686622|FG002|Extension Phase|Withdrew Consent|0|||
23533465|NCT00456092|65686623|FG003|Extension Phase|Withdrew Consent|0|||
23533466|NCT00456092|65686624|FG004|Extension Phase|Withdrew Consent|0|||
23533467|NCT00456092|65686620|FG000|Extension Phase|Lost to Follow-up|1|||
23533468|NCT00456092|65686621|FG001|Extension Phase|Lost to Follow-up|1|||
23614543|NCT01848483|65973392|FG001|Overall Study|Death|1|||
23614544|NCT01848483|65973391|FG000|Overall Study|Lost to Follow-up|6|||
23614545|NCT01848483|65973392|FG001|Overall Study|Lost to Follow-up|8|||
23614546|NCT01848483|65973391|FG000|Overall Study|Withdrawal by Subject|1|||
23614547|NCT01848483|65973392|FG001|Overall Study|Withdrawal by Subject|0|||
23208036|NCT03074149|64498349|FG000|Overall Study|Reason unknown|22|||
23208037|NCT03074149|64498350|FG001|Overall Study|Reason unknown|35|||
23208038|NCT03074149|64498349|FG000|Overall Study|Death|10|||
23208039|NCT03074149|64498350|FG001|Overall Study|Death|45|||
23533469|NCT00456092|65686622|FG002|Extension Phase|Lost to Follow-up|0|||
23614548|NCT01848483|65973391|FG000|Overall Study|Incarceration|2|||
23614549|NCT01848483|65973392|FG001|Overall Study|Incarceration|2|||
23208040|NCT01934894|64498355|FG000|Overall Study|Adverse Event|1|||
23533470|NCT00456092|65686623|FG003|Extension Phase|Lost to Follow-up|0|||
23533471|NCT00456092|65686624|FG004|Extension Phase|Lost to Follow-up|1|||
23614550|NCT01348763|65973393|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
23614551|NCT01348763|65973393|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
23614552|NCT00547300|65973395|FG000|Overall Study|Study was Administratively Terminated|25|||
23614553|NCT00547300|65973396|FG001|Overall Study|Study was Administratively Terminated|24|||
23614554|NCT00547300|65973395|FG000|Overall Study|Did not Meet Entry Criteria|0|||
23614555|NCT00547300|65973396|FG001|Overall Study|Did not Meet Entry Criteria|2|||
23614556|NCT04203199|65973397|FG000|First Intervention Period|Lost to Follow-up|0|||
23614557|NCT04203199|65973398|FG001|First Intervention Period|Lost to Follow-up|1|||
23614558|NCT04203199|65973397|FG000|Second Intervention Period|Medication change|1|||
23614559|NCT04203199|65973398|FG001|Second Intervention Period|Medication change|0|||
23614560|NCT01014013|65973399|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
23614561|NCT01014013|65973400|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
23614562|NCT01014013|65973399|FG000|Overall Study|Clinical adverse experience|4|||
23614563|NCT01014013|65973400|FG001|Overall Study|Clinical adverse experience|2|||
23614564|NCT01014013|65973399|FG000|Overall Study|Laboratory adverse experience|1|||
23614565|NCT01014013|65973400|FG001|Overall Study|Laboratory adverse experience|1|||
23614566|NCT01014013|65973399|FG000|Overall Study|Protocol Violation|1|||
23614567|NCT01014013|65973400|FG001|Overall Study|Protocol Violation|3|||
23614568|NCT01014013|65973399|FG000|Overall Study|Withdrawal by Subject|7|||
23614569|NCT01014013|65973400|FG001|Overall Study|Withdrawal by Subject|4|||
23614570|NCT01014013|65973399|FG000|Overall Study|Clinical/microbiologic failure|1|||
23614571|NCT01014013|65973400|FG001|Overall Study|Clinical/microbiologic failure|2|||
23614572|NCT01014013|65973399|FG000|Overall Study|Pathogen culture = no growth|26|||
23614573|NCT01014013|65973400|FG001|Overall Study|Pathogen culture = no growth|34|||
23614574|NCT01014013|65973399|FG000|Overall Study|Negative urine culture|2|||
23614575|NCT01014013|65973400|FG001|Overall Study|Negative urine culture|0|||
23614576|NCT01014013|65973399|FG000|Overall Study|Pathogen resistant|7|||
23614577|NCT01014013|65973400|FG001|Overall Study|Pathogen resistant|4|||
23614578|NCT01014013|65973399|FG000|Overall Study|Physician Decision|0|||
23614579|NCT01014013|65973400|FG001|Overall Study|Physician Decision|1|||
23614580|NCT01014013|65973399|FG000|Overall Study|Another antibiotic therapy required|0|||
23614581|NCT01014013|65973400|FG001|Overall Study|Another antibiotic therapy required|1|||
23614582|NCT01014013|65973399|FG000|Overall Study|Appendectomy|1|||
23614583|NCT01014013|65973400|FG001|Overall Study|Appendectomy|0|||
23614584|NCT01014013|65973399|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
23614585|NCT01014013|65973400|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
23614586|NCT00676663|65973401|FG000|Overall Study|Death|43|||
23614587|NCT00676663|65973402|FG001|Overall Study|Death|27|||
23614588|NCT00676663|65973401|FG000|Overall Study|Withdrew Consent|1|||
23614589|NCT00676663|65973402|FG001|Overall Study|Withdrew Consent|8|||
23614590|NCT00676663|65973401|FG000|Overall Study|Lost to Follow-up|1|||
23614591|NCT00676663|65973402|FG001|Overall Study|Lost to Follow-up|3|||
23614592|NCT00714688|65973403|FG000|Overall Study|Lack of Efficacy|14|||
23614593|NCT00714688|65973404|FG001|Overall Study|Lack of Efficacy|1|||
23614594|NCT00714688|65973405|FG002|Overall Study|Lack of Efficacy|4|||
23614595|NCT00714688|65973403|FG000|Overall Study|Withdrawal by Subject|4|||
23614596|NCT00714688|65973404|FG001|Overall Study|Withdrawal by Subject|3|||
23614597|NCT00714688|65973405|FG002|Overall Study|Withdrawal by Subject|3|||
23614598|NCT00714688|65973403|FG000|Overall Study|Lost to Follow-up|5|||
23614599|NCT00714688|65973404|FG001|Overall Study|Lost to Follow-up|2|||
23614600|NCT00714688|65973405|FG002|Overall Study|Lost to Follow-up|0|||
23614601|NCT00714688|65973403|FG000|Overall Study|Adverse Event|2|||
23614602|NCT00714688|65973404|FG001|Overall Study|Adverse Event|15|||
23614603|NCT00714688|65973405|FG002|Overall Study|Adverse Event|19|||
23614604|NCT00714688|65973403|FG000|Overall Study|Subject Non-compliant|3|||
23614605|NCT00714688|65973404|FG001|Overall Study|Subject Non-compliant|5|||
23614606|NCT00714688|65973405|FG002|Overall Study|Subject Non-compliant|5|||
23614607|NCT00714688|65973403|FG000|Overall Study|Ineligible to Continue the Study|0|||
23614608|NCT00714688|65973404|FG001|Overall Study|Ineligible to Continue the Study|1|||
23614609|NCT00714688|65973405|FG002|Overall Study|Ineligible to Continue the Study|1|||
23614610|NCT00714688|65973403|FG000|Overall Study|Sponsor's Decision|0|||
23614611|NCT00714688|65973404|FG001|Overall Study|Sponsor's Decision|2|||
23614612|NCT00714688|65973405|FG002|Overall Study|Sponsor's Decision|0|||
23614613|NCT00714688|65973403|FG000|Overall Study|Other|1|||
23208041|NCT01934894|64498356|FG001|Overall Study|Adverse Event|2|||
23614614|NCT00714688|65973404|FG001|Overall Study|Other|6|||
23614615|NCT00714688|65973405|FG002|Overall Study|Other|5|||
23614616|NCT01755598|65973411|FG000|Overall Study|Other|109|||
23310408|NCT00609518|64881438|FG000|Overall Study|Physician Decision|1|||
23310409|NCT00609518|64881439|FG001|Overall Study|Physician Decision|3|||
23614617|NCT01755598|65973412|FG001|Overall Study|Other|109|||
23614618|NCT01755598|65973411|FG000|Overall Study|Lost to Follow-up|32|||
23614619|NCT01755598|65973412|FG001|Overall Study|Lost to Follow-up|43|||
23614620|NCT01755598|65973411|FG000|Overall Study|Migrated/moved from study area|76|||
23614621|NCT01755598|65973412|FG001|Overall Study|Migrated/moved from study area|65|||
23310410|NCT00609518|64881438|FG000|Overall Study|Death from Adverse Event|2|||
23614622|NCT01755598|65973411|FG000|Overall Study|Withdrawal by Subject|22|||
23614623|NCT01755598|65973412|FG001|Overall Study|Withdrawal by Subject|31|||
23614624|NCT01755598|65973411|FG000|Overall Study|Protocol Violation|7|||
23614625|NCT01755598|65973412|FG001|Overall Study|Protocol Violation|7|||
23614626|NCT01755598|65973411|FG000|Overall Study|Adverse Event|19|||
23614627|NCT01755598|65973412|FG001|Overall Study|Adverse Event|28|||
23614628|NCT03530345|65976241|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
23614629|NCT03530345|65976242|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
23614630|NCT03530345|65976241|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
23614631|NCT03530345|65976242|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
23614632|NCT03530345|65976241|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
23614633|NCT03530345|65976242|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
23614634|NCT03530345|65976241|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
23614635|NCT03530345|65976242|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
23614636|NCT01586910|65976243|FG000|Overall Study|Death|4|||
23614637|NCT01586910|65976244|FG001|Overall Study|Death|4|||
23614638|NCT01586910|65976243|FG000|Overall Study|Withdrawal by Subject|6|||
23614639|NCT01586910|65976244|FG001|Overall Study|Withdrawal by Subject|43|||
23614640|NCT01586910|65976243|FG000|Overall Study|Physician withdrew Subject|5|||
23614641|NCT01586910|65976244|FG001|Overall Study|Physician withdrew Subject|24|||
23614642|NCT03751280|65976245|FG000|Overall Study|Adverse Event|0|||
23614643|NCT03751280|65976246|FG001|Overall Study|Adverse Event|1|||
23614644|NCT03751280|65976245|FG000|Overall Study|Lost to Follow-up|3|||
23614645|NCT03751280|65976246|FG001|Overall Study|Lost to Follow-up|5|||
23614646|NCT03751280|65976245|FG000|Overall Study|Physician Decision|0|||
23614647|NCT03751280|65976246|FG001|Overall Study|Physician Decision|2|||
23614648|NCT03751280|65976245|FG000|Overall Study|Protocol Violation|0|||
23614649|NCT03751280|65976246|FG001|Overall Study|Protocol Violation|2|||
23614650|NCT03751280|65976245|FG000|Overall Study|Withdrawal by Subject|5|||
23614651|NCT03751280|65976246|FG001|Overall Study|Withdrawal by Subject|2|||
23614652|NCT03802513|65976247|FG000|Overall Study|Lost to Follow-up|1|||
23614653|NCT03332589|65976248|FG000|Overall Study|Lack of Efficacy|2|||
23614654|NCT03332589|65976249|FG001|Overall Study|Lack of Efficacy|0|||
23614655|NCT03332589|65976250|FG002|Overall Study|Lack of Efficacy|0|||
23614656|NCT03332589|65976248|FG000|Overall Study|Adverse Event|1|||
23533472|NCT00456092|65686620|FG000|Extension Phase|Other|2|||
23533473|NCT00456092|65686621|FG001|Extension Phase|Other|0|||
23533474|NCT00456092|65686622|FG002|Extension Phase|Other|0|||
23533475|NCT00456092|65686623|FG003|Extension Phase|Other|1|||
23533476|NCT00456092|65686624|FG004|Extension Phase|Other|1|||
23533477|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
23614657|NCT03332589|65976249|FG001|Overall Study|Adverse Event|0|||
23533478|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
23533479|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
23533480|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
23533481|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
23533482|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
23614658|NCT03332589|65976250|FG002|Overall Study|Adverse Event|0|||
23208042|NCT01934894|64498355|FG000|Overall Study|Death|2|||
23533483|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
23533484|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
23614659|NCT03332589|65976248|FG000|Overall Study|Death|1|||
23614660|NCT03332589|65976249|FG001|Overall Study|Death|0|||
23614661|NCT03332589|65976250|FG002|Overall Study|Death|0|||
23614662|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
23614663|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
23533485|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
23208043|NCT01934894|64498356|FG001|Overall Study|Death|0|||
23533486|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
23310411|NCT00609518|64881439|FG001|Overall Study|Death from Adverse Event|2|||
23310412|NCT02099682|64881440|FG000|Overall Study|Data Not Available|51|||
23310413|NCT02099682|64881440|FG000|Overall Study|Lost to Follow-up|31|||
23310414|NCT02099682|64881440|FG000|Overall Study|Other|29|||
23310415|NCT01683838|64881447|FG000|Overall Study|Adverse Event|12|||
23310416|NCT01683838|64881448|FG001|Overall Study|Adverse Event|2|||
23310417|NCT01683838|64881447|FG000|Overall Study|Protocol Violation|3|||
23310418|NCT01683838|64881448|FG001|Overall Study|Protocol Violation|1|||
23310419|NCT01683838|64881447|FG000|Overall Study|Withdrawal by Subject|6|||
23310420|NCT01683838|64881448|FG001|Overall Study|Withdrawal by Subject|5|||
23421337|NCT02118766|65284013|FG001|Overall Study|Withdrawal by Subject|6|||
23421338|NCT02118766|65284012|FG000|Overall Study|Lost to Follow-up|5|||
23421339|NCT02118766|65284013|FG001|Overall Study|Lost to Follow-up|4|||
23310421|NCT01683838|64881447|FG000|Overall Study|Lost to Follow-up|1|||
23310422|NCT01683838|64881448|FG001|Overall Study|Lost to Follow-up|1|||
23310423|NCT01683838|64881447|FG000|Overall Study|Other|4|||
23421340|NCT02118766|65284012|FG000|Overall Study|Withdrawal by parent/guardian|12|||
23421341|NCT02118766|65284013|FG001|Overall Study|Withdrawal by parent/guardian|18|||
23421342|NCT02118766|65284012|FG000|Overall Study|Other|3|||
23421343|NCT02118766|65284013|FG001|Overall Study|Other|1|||
23421344|NCT02182440|65284014|FG000|Overall Study|Adverse Event|0|||
23421345|NCT02182440|65284015|FG001|Overall Study|Adverse Event|1|||
23421346|NCT02182440|65284016|FG002|Overall Study|Adverse Event|0|||
23421347|NCT02182440|65284017|FG003|Overall Study|Adverse Event|0|||
23236640|NCT01220024|64608262|FG001|Overall Study|Lost to Follow-up|1|||
23236641|NCT03159455|64608263|FG000|Overall Study|Adverse Event|0|||
23236642|NCT03159455|64608264|FG001|Overall Study|Adverse Event|0|||
23236643|NCT03159455|64608265|FG002|Overall Study|Adverse Event|0|||
23236644|NCT03159455|64608266|FG003|Overall Study|Adverse Event|0|||
23236645|NCT03159455|64608267|FG004|Overall Study|Adverse Event|0|||
23236646|NCT03159455|64608268|FG005|Overall Study|Adverse Event|1|||
23236647|NCT01249404|64608272|FG000|Overall Study|Study treatment not received|0|||
23236648|NCT01249404|64608273|FG001|Overall Study|Study treatment not received|1|||
23236649|NCT01249404|64608274|FG002|Overall Study|Study treatment not received|2|||
23236650|NCT01249404|64608272|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
23421348|NCT02182440|65284014|FG000|Overall Study|Death|31|||
23421349|NCT02182440|65284015|FG001|Overall Study|Death|8|||
23421350|NCT02182440|65284016|FG002|Overall Study|Death|5|||
23533487|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
23533488|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
23533489|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
23421351|NCT02182440|65284017|FG003|Overall Study|Death|16|||
23421352|NCT02182440|65284014|FG000|Overall Study|Protocol Violation|0|||
23421353|NCT02182440|65284015|FG001|Overall Study|Protocol Violation|1|||
23421354|NCT02182440|65284016|FG002|Overall Study|Protocol Violation|0|||
23421355|NCT02182440|65284017|FG003|Overall Study|Protocol Violation|0|||
23421356|NCT02182440|65284014|FG000|Overall Study|Physician Decision|1|||
23421357|NCT02182440|65284015|FG001|Overall Study|Physician Decision|0|||
23421358|NCT02182440|65284016|FG002|Overall Study|Physician Decision|0|||
23421359|NCT02182440|65284017|FG003|Overall Study|Physician Decision|0|||
23421360|NCT02182440|65284014|FG000|Overall Study|Withdrawal by Subject|1|||
23421361|NCT02182440|65284015|FG001|Overall Study|Withdrawal by Subject|1|||
23421362|NCT02182440|65284016|FG002|Overall Study|Withdrawal by Subject|3|||
23421363|NCT02182440|65284017|FG003|Overall Study|Withdrawal by Subject|4|||
23208044|NCT01934894|64498355|FG000|Overall Study|Withdrawal by Subject|0|||
23208045|NCT01934894|64498356|FG001|Overall Study|Withdrawal by Subject|1|||
23208046|NCT01934894|64498355|FG000|Overall Study|Progressive Disease|3|||
23208047|NCT01934894|64498356|FG001|Overall Study|Progressive Disease|2|||
23208048|NCT02232087|64498357|FG000|Overall Study|Withdrawal by Subject|2|||
23208049|NCT02232087|64498358|FG001|Overall Study|Withdrawal by Subject|0|||
23208050|NCT02232087|64498359|FG002|Overall Study|Withdrawal by Subject|0|||
23421364|NCT02182440|65284014|FG000|Overall Study|different, e.g adm other hospital|12|||
23421365|NCT02182440|65284015|FG001|Overall Study|different, e.g adm other hospital|3|||
23421366|NCT02182440|65284016|FG002|Overall Study|different, e.g adm other hospital|3|||
23421367|NCT02182440|65284017|FG003|Overall Study|different, e.g adm other hospital|10|||
23421368|NCT00907803|65284018|FG000|Overall Study|Withdrawal of consent - long commute|1|||
23421369|NCT00907803|65284019|FG001|Overall Study|Withdrawal of consent - long commute|0|||
23421370|NCT00907803|65284020|FG002|Overall Study|Withdrawal of consent - long commute|0|||
23421371|NCT00907803|65284018|FG000|Overall Study|Adverse Event|2|||
23533490|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
23533491|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
23533492|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
23533493|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
23533494|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
23533495|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
23533496|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
23533497|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
23533498|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
23533499|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
23533500|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
23533501|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
23533502|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
23533503|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
23533504|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
23533505|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
23533506|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
23533507|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
23533508|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
23533509|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
23533510|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
23533511|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
23533512|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23533513|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
23533514|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
23533515|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23533516|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23533517|NCT00456092|65686620|FG000|Treatment Phase (12 Weeks)|Other|1|||
23533518|NCT00456092|65686621|FG001|Treatment Phase (12 Weeks)|Other|0|||
23533519|NCT00456092|65686622|FG002|Treatment Phase (12 Weeks)|Other|1|||
23533520|NCT00456092|65686623|FG003|Treatment Phase (12 Weeks)|Other|0|||
23533521|NCT00456092|65686624|FG004|Treatment Phase (12 Weeks)|Other|0|||
23533522|NCT01863446|65686625|FG000|Overall Study|Withdrawal by Subject|1|||
23533523|NCT01863446|65686626|FG001|Overall Study|Withdrawal by Subject|0|||
23533524|NCT01863446|65686627|FG002|Overall Study|Withdrawal by Subject|1|||
23533525|NCT01863446|65686628|FG003|Overall Study|Withdrawal by Subject|2|||
23533526|NCT01863446|65686625|FG000|Overall Study|Physician Decision|0|||
23310424|NCT01683838|64881448|FG001|Overall Study|Other|3|||
23421372|NCT00907803|65284019|FG001|Overall Study|Adverse Event|0|||
23421373|NCT00907803|65284020|FG002|Overall Study|Adverse Event|0|||
23421374|NCT00907803|65284018|FG000|Overall Study|Withdrawal by Subject|0|||
23421375|NCT00907803|65284019|FG001|Overall Study|Withdrawal by Subject|1|||
23421376|NCT00907803|65284020|FG002|Overall Study|Withdrawal by Subject|0|||
23421377|NCT00907803|65284018|FG000|Overall Study|Lost to Follow-up|0|||
23421378|NCT00907803|65284019|FG001|Overall Study|Lost to Follow-up|1|||
23421379|NCT00907803|65284020|FG002|Overall Study|Lost to Follow-up|0|||
23421380|NCT00907803|65284018|FG000|Overall Study|Protocol Violation|0|||
23421381|NCT00907803|65284019|FG001|Overall Study|Protocol Violation|1|||
23421382|NCT00907803|65284020|FG002|Overall Study|Protocol Violation|0|||
23421383|NCT03280303|65284027|FG000|Overall Study|Death|505|||
23421384|NCT03280303|65284027|FG000|Overall Study|Study terminated by sponsor|383|||
23421385|NCT03280303|65284027|FG000|Overall Study|Other|148|||
23533527|NCT01863446|65686626|FG001|Overall Study|Physician Decision|0|||
23533528|NCT01863446|65686627|FG002|Overall Study|Physician Decision|1|||
23533529|NCT01863446|65686628|FG003|Overall Study|Physician Decision|0|||
23421386|NCT03280303|65284027|FG000|Overall Study|No longer willing to participate in study|101|||
23421387|NCT03280303|65284027|FG000|Overall Study|Lost to follow up|39|||
23421388|NCT03280303|65284027|FG000|Overall Study|Adverse Event|20|||
23533530|NCT00779766|65686629|FG000|Month 24|Serious Adverse Event|2|||
23533531|NCT00779766|65686630|FG001|Month 24|Serious Adverse Event|3|||
23421389|NCT00457821|65288150|FG000|Part 2|Withdrawal by Subject|0|||
23421390|NCT00457821|65288151|FG001|Part 2|Withdrawal by Subject|0|||
23421391|NCT00457821|65288152|FG002|Part 2|Withdrawal by Subject|0|||
23421392|NCT00457821|65288153|FG003|Part 2|Withdrawal by Subject|0|||
23421393|NCT00457821|65288154|FG004|Part 2|Withdrawal by Subject|0|||
23421394|NCT00457821|65288155|FG005|Part 2|Withdrawal by Subject|0|||
23421395|NCT00457821|65288156|FG006|Part 2|Withdrawal by Subject|0|||
23421396|NCT00457821|65288157|FG007|Part 2|Withdrawal by Subject|1|||
23421397|NCT00496483|65288159|FG000|Overall Study|Not dosed|9|||
23421398|NCT00496483|65288159|FG000|Overall Study|Adverse Event|2|||
23421399|NCT00496483|65288159|FG000|Overall Study|Lack of Efficacy|1|||
23421400|NCT02578680|65288160|FG000|Overall Study|Death|329|||
23421401|NCT02578680|65288161|FG001|Overall Study|Death|181|||
23421402|NCT02578680|65288160|FG000|Overall Study|Lost to Follow-up|3|||
23421403|NCT02578680|65288161|FG001|Overall Study|Lost to Follow-up|1|||
23421404|NCT02578680|65288160|FG000|Overall Study|Physician Decision|0|||
23421405|NCT02578680|65288161|FG001|Overall Study|Physician Decision|1|||
23421406|NCT02578680|65288160|FG000|Overall Study|Protocol Violation|1|||
23421407|NCT02578680|65288161|FG001|Overall Study|Protocol Violation|1|||
23421408|NCT02578680|65288160|FG000|Overall Study|Sponsor Decision|64|||
23421409|NCT02578680|65288161|FG001|Overall Study|Sponsor Decision|13|||
23421410|NCT02578680|65288160|FG000|Overall Study|Withdrawal by Subject|13|||
23421411|NCT02578680|65288161|FG001|Overall Study|Withdrawal by Subject|9|||
23421412|NCT02370537|65288162|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
23421413|NCT02370537|65288163|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
23421414|NCT02370537|65288164|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
23421415|NCT02370537|65288162|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
23421416|NCT02370537|65288163|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
23421417|NCT02370537|65288164|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
23421418|NCT02370537|65288162|FG000|Part B|Not randomised to receive treatment|1|||
23421419|NCT02370537|65288163|FG001|Part B|Not randomised to receive treatment|2|||
23421420|NCT02370537|65288164|FG002|Part B|Not randomised to receive treatment|259|||
23421421|NCT02370537|65288162|FG000|Part B|Withdrawal by Subject|0|||
23421422|NCT02370537|65288163|FG001|Part B|Withdrawal by Subject|1|||
23421423|NCT02370537|65288164|FG002|Part B|Withdrawal by Subject|0|||
23421424|NCT04508751|65288165|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
23421425|NCT04508751|65288166|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
23421426|NCT04508751|65288167|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
23421427|NCT04677660|65288168|FG000|Overall Study|Lost to Follow-up|0|||
23421428|NCT04677660|65288169|FG001|Overall Study|Lost to Follow-up|2|||
23421429|NCT04677660|65288168|FG000|Overall Study|Withdrawal by Subject|0|||
23421430|NCT04677660|65288169|FG001|Overall Study|Withdrawal by Subject|1|||
23421431|NCT04677660|65288168|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
23421432|NCT04677660|65288169|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
23421433|NCT01146652|65288173|FG000|Overall Study|Adverse Event|506|||
23421434|NCT01146652|65288174|FG001|Overall Study|Adverse Event|15|||
23421435|NCT01146652|65288173|FG000|Overall Study|Lack of Efficacy|91|||
23421436|NCT01146652|65288174|FG001|Overall Study|Lack of Efficacy|7|||
23421437|NCT01146652|65288173|FG000|Overall Study|Poor compliance to protocol|38|||
23421438|NCT01146652|65288174|FG001|Overall Study|Poor compliance to protocol|1|||
23533532|NCT00779766|65686629|FG000|Month 24|Adverse Event|3|||
23533533|NCT00779766|65686630|FG001|Month 24|Adverse Event|3|||
23533534|NCT00779766|65686629|FG000|Month 24|Protocol Violation|3|||
23533535|NCT00779766|65686630|FG001|Month 24|Protocol Violation|1|||
23421439|NCT01146652|65288173|FG000|Overall Study|Other unspecified reasons|314|||
23421440|NCT01146652|65288174|FG001|Overall Study|Other unspecified reasons|22|||
23421441|NCT01146652|65288173|FG000|Overall Study|Enrolled but not treated|2|||
23421442|NCT01146652|65288174|FG001|Overall Study|Enrolled but not treated|0|||
23421443|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
23421444|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
23421445|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
23421446|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
23421447|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
23421448|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
23421449|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
23421450|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
23533536|NCT00779766|65686629|FG000|Month 24|Withdrawal by Subject|159|||
23533537|NCT00779766|65686630|FG001|Month 24|Withdrawal by Subject|127|||
23533538|NCT00779766|65686629|FG000|Month 24|Migrated/moved from study area|138|||
23533539|NCT00779766|65686630|FG001|Month 24|Migrated/moved from study area|162|||
23533540|NCT00779766|65686629|FG000|Month 24|Lost to Follow-up|9|||
23533541|NCT00779766|65686630|FG001|Month 24|Lost to Follow-up|9|||
23533542|NCT00779766|65686629|FG000|Month 24|Other|18|||
23533543|NCT00779766|65686630|FG001|Month 24|Other|27|||
23533544|NCT00779766|65686629|FG000|Month 48|Withdrawal by Subject|68|||
23421451|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
23421452|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
23421453|NCT03549871|65288175|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
23421454|NCT03549871|65288176|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
23421455|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
23421456|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
23421457|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
23421458|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
23421459|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
23421460|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
23421461|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
23421462|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
23533545|NCT00779766|65686630|FG001|Month 48|Withdrawal by Subject|63|||
23533546|NCT00779766|65686629|FG000|Month 48|Migrated/moved from study area|76|||
23533547|NCT00779766|65686630|FG001|Month 48|Migrated/moved from study area|75|||
23533548|NCT00779766|65686629|FG000|Month 48|Lost to Follow-up|29|||
23533549|NCT00779766|65686630|FG001|Month 48|Lost to Follow-up|30|||
23533550|NCT00779766|65686629|FG000|Month 48|Other|1|||
23533551|NCT00779766|65686630|FG001|Month 48|Other|0|||
23421463|NCT03549871|65288175|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
23421464|NCT03549871|65288176|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
23421465|NCT00006164|65288182|FG000|Overall Study|Withdrew or lost to follow-up|70|||
23421466|NCT00006164|65288183|FG001|Overall Study|Withdrew or lost to follow-up|81|||
23421467|NCT00171925|65288184|FG000|Overall Study|Adverse Event|10|||
23421468|NCT00171925|65288185|FG001|Overall Study|Adverse Event|6|||
23421469|NCT00171925|65288184|FG000|Overall Study|Protocol Violation|1|||
23421470|NCT00171925|65288185|FG001|Overall Study|Protocol Violation|1|||
23421471|NCT00171925|65288184|FG000|Overall Study|Withdrawal by Subject|6|||
23421472|NCT00171925|65288185|FG001|Overall Study|Withdrawal by Subject|9|||
23421473|NCT00171925|65288184|FG000|Overall Study|Lost to Follow-up|2|||
23421474|NCT00171925|65288185|FG001|Overall Study|Lost to Follow-up|2|||
23421475|NCT00171925|65288184|FG000|Overall Study|Administrative problems|10|||
23421476|NCT00171925|65288185|FG001|Overall Study|Administrative problems|11|||
23421477|NCT00171925|65288184|FG000|Overall Study|Death|1|||
23421478|NCT00171925|65288185|FG001|Overall Study|Death|2|||
23421479|NCT02186652|65288186|FG000|Overall Study|Lost to Follow-up|2|||
23421480|NCT02186652|65288187|FG001|Overall Study|Lost to Follow-up|0|||
23421481|NCT01170065|65288188|FG000|Overall Study|Adverse Event|17|||
23421482|NCT01170065|65288189|FG001|Overall Study|Adverse Event|50|||
23421483|NCT01170065|65288190|FG002|Overall Study|Adverse Event|10|||
23421484|NCT01170065|65288188|FG000|Overall Study|Lost to Follow-up|1|||
23421485|NCT01170065|65288189|FG001|Overall Study|Lost to Follow-up|4|||
23421486|NCT01170065|65288190|FG002|Overall Study|Lost to Follow-up|1|||
23421487|NCT01170065|65288188|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
23421488|NCT01170065|65288189|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
23421489|NCT01170065|65288190|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
23421490|NCT01170065|65288188|FG000|Overall Study|Reason other than specified|3|||
23421491|NCT01170065|65288189|FG001|Overall Study|Reason other than specified|8|||
23421492|NCT01170065|65288190|FG002|Overall Study|Reason other than specified|3|||
23421493|NCT01170065|65288188|FG000|Overall Study|Ongoing after planned observation time|5|||
23421494|NCT01170065|65288189|FG001|Overall Study|Ongoing after planned observation time|26|||
23421495|NCT01170065|65288190|FG002|Overall Study|Ongoing after planned observation time|10|||
23421496|NCT00896363|65288191|FG000|Overall Study|Adverse Event|3|||
23421497|NCT00896363|65288192|FG001|Overall Study|Adverse Event|4|||
23421498|NCT00896363|65288193|FG002|Overall Study|Adverse Event|2|||
23421499|NCT00896363|65288191|FG000|Overall Study|Lack of Efficacy|0|||
23421500|NCT00896363|65288192|FG001|Overall Study|Lack of Efficacy|2|||
23421501|NCT00896363|65288193|FG002|Overall Study|Lack of Efficacy|1|||
23421502|NCT00896363|65288191|FG000|Overall Study|Withdrawal by Subject|3|||
23421503|NCT00896363|65288192|FG001|Overall Study|Withdrawal by Subject|5|||
23421504|NCT00896363|65288193|FG002|Overall Study|Withdrawal by Subject|5|||
23421505|NCT02780856|65288196|FG000|Overall Study|Lost to Follow-up|1|||
23421506|NCT01080768|65288197|FG000|Overall Study|Protocol Deviation|2|||
23421507|NCT01080768|65288198|FG001|Overall Study|Protocol Deviation|1|||
23421508|NCT03483038|65288200|FG000|Overall Study|Subjects still in follow-up|18|||
23421509|NCT00969761|65288203|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
23421510|NCT00969761|65288204|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421511|NCT00969761|65288205|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421512|NCT00969761|65288206|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
23421513|NCT00969761|65288207|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421514|NCT00969761|65288208|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421515|NCT00969761|65288209|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421516|NCT00969761|65288210|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421517|NCT00969761|65288211|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
23533552|NCT00779766|65686629|FG000|Month 72|Withdrawal by Subject|55|||
23421518|NCT00969761|65288212|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
23421519|NCT00969761|65288213|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421520|NCT00969761|65288214|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
23421521|NCT00969761|65288203|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421522|NCT00969761|65288204|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421523|NCT00969761|65288205|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
23421524|NCT00969761|65288206|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23533553|NCT00779766|65686630|FG001|Month 72|Withdrawal by Subject|71|||
23533554|NCT00779766|65686629|FG000|Month 72|Migrated/moved from study area|124|||
23421525|NCT00969761|65288207|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421526|NCT00969761|65288208|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421527|NCT00969761|65288209|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421528|NCT00969761|65288210|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421529|NCT00969761|65288211|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421530|NCT00969761|65288212|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421531|NCT00969761|65288213|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421532|NCT00969761|65288214|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
23421533|NCT00969761|65288203|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421534|NCT00969761|65288204|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421535|NCT00969761|65288205|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
23421536|NCT00969761|65288206|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421537|NCT00969761|65288207|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23533555|NCT00779766|65686630|FG001|Month 72|Migrated/moved from study area|109|||
23533556|NCT00779766|65686629|FG000|Month 72|Lost to Follow-up|6|||
23533557|NCT00779766|65686630|FG001|Month 72|Lost to Follow-up|8|||
23533558|NCT00779766|65686629|FG000|Month 72|Other|0|||
23533559|NCT00779766|65686630|FG001|Month 72|Other|1|||
23533560|NCT04068181|65686647|FG000|Overall Study|Withdrawal by Subject|2|||
23533561|NCT04068181|65686648|FG001|Overall Study|Withdrawal by Subject|0|||
23533562|NCT04068181|65686649|FG002|Overall Study|Withdrawal by Subject|0|||
23533563|NCT04068181|65686650|FG003|Overall Study|Withdrawal by Subject|0|||
23533564|NCT04068181|65686647|FG000|Overall Study|Lost to Follow-up|1|||
23533565|NCT04068181|65686648|FG001|Overall Study|Lost to Follow-up|0|||
23533566|NCT04068181|65686649|FG002|Overall Study|Lost to Follow-up|0|||
23310425|NCT02903030|64881449|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23533567|NCT04068181|65686650|FG003|Overall Study|Lost to Follow-up|0|||
23533568|NCT04068181|65686647|FG000|Overall Study|Death|8|||
23614664|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
23614665|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
23614666|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Death|0|||
23614667|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Death|0|||
23614668|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Death|1|||
23614669|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Death|0|||
23614670|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
23421538|NCT00969761|65288208|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23614671|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
23533569|NCT04068181|65686648|FG001|Overall Study|Death|8|||
23614672|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
23614673|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
23614674|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
23614675|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
23614676|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
23614677|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
23614678|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
23614679|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
23614680|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
23614681|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
23614682|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
23614683|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
23614684|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
23614685|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
23614686|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
23614687|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
23614688|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
23614689|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
23614690|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Other|2|||
23614691|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Other|0|||
23614692|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Other|0|||
23614693|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Other|0|||
23614694|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
23614695|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
23614696|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
23614697|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
23614698|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
23614699|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
23614700|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
23614701|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
23614702|NCT03845517|65976261|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
23614703|NCT03845517|65976262|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
23533570|NCT04068181|65686649|FG002|Overall Study|Death|4|||
23533571|NCT04068181|65686650|FG003|Overall Study|Death|2|||
23533572|NCT04068181|65686647|FG000|Overall Study|Continuing Study|16|||
23533573|NCT04068181|65686648|FG001|Overall Study|Continuing Study|7|||
23533574|NCT04068181|65686649|FG002|Overall Study|Continuing Study|11|||
23533575|NCT04068181|65686650|FG003|Overall Study|Continuing Study|13|||
23533576|NCT02707640|65686653|FG000|Overall Study|Adverse Event|4|||
23533577|NCT02707640|65686654|FG001|Overall Study|Adverse Event|2|||
23533578|NCT02707640|65686653|FG000|Overall Study|Death|1|||
23533579|NCT02707640|65686654|FG001|Overall Study|Death|2|||
23614704|NCT03845517|65976263|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
23614705|NCT03845517|65976264|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
23614706|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
23533580|NCT02707640|65686653|FG000|Overall Study|Physician Decision|2|||
23533581|NCT02707640|65686654|FG001|Overall Study|Physician Decision|0|||
23533582|NCT02707640|65686653|FG000|Overall Study|Withdrawal by Subject|0|||
23614707|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
23533583|NCT02707640|65686654|FG001|Overall Study|Withdrawal by Subject|1|||
23533584|NCT02707640|65686653|FG000|Overall Study|Participant's Personal Decision|1|||
23533585|NCT02707640|65686654|FG001|Overall Study|Participant's Personal Decision|2|||
23533586|NCT02707640|65686653|FG000|Overall Study|Sponsor Discretion|1|||
23533587|NCT02707640|65686654|FG001|Overall Study|Sponsor Discretion|0|||
23533588|NCT02039427|65686655|FG000|Overall Study|Duration of surgery > 3h|1|||
23533589|NCT02039427|65686656|FG001|Overall Study|Duration of surgery > 3h|1|||
23533590|NCT02039427|65686657|FG002|Overall Study|Duration of surgery > 3h|0|||
23533591|NCT02039427|65686658|FG003|Overall Study|Duration of surgery > 3h|0|||
23533592|NCT02039427|65686655|FG000|Overall Study|Withdrawal on concent|0|||
23614708|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
23614709|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
23614710|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Death|0|||
23614711|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Death|0|||
23614712|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Death|1|||
23614713|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Death|1|||
23614714|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
23614715|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
23614716|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
23614717|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
23614718|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
23614719|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
23614720|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
23614721|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
23614722|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
23421539|NCT00969761|65288209|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421540|NCT00969761|65288210|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23533593|NCT02039427|65686656|FG001|Overall Study|Withdrawal on concent|0|||
23614723|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
23533594|NCT02039427|65686657|FG002|Overall Study|Withdrawal on concent|0|||
23533595|NCT02039427|65686658|FG003|Overall Study|Withdrawal on concent|1|||
23533596|NCT02039427|65686655|FG000|Overall Study|Cancellation of surgery|0|||
23310426|NCT02903030|64881450|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
23310427|NCT01085201|64881451|FG000|Overall Study|Scheduling conflict|1|||
23310428|NCT01085201|64881452|FG001|Overall Study|Scheduling conflict|0|||
23310429|NCT01085201|64881453|FG002|Overall Study|Scheduling conflict|1|||
23310430|NCT01085201|64881454|FG003|Overall Study|Scheduling conflict|0|||
23310431|NCT01085201|64881455|FG004|Overall Study|Scheduling conflict|0|||
23310432|NCT01085201|64881451|FG000|Overall Study|Unknown- no study drug|2|||
23310433|NCT01085201|64881452|FG001|Overall Study|Unknown- no study drug|0|||
23310434|NCT01085201|64881453|FG002|Overall Study|Unknown- no study drug|0|||
23310435|NCT01085201|64881454|FG003|Overall Study|Unknown- no study drug|0|||
23310436|NCT01085201|64881455|FG004|Overall Study|Unknown- no study drug|0|||
23310437|NCT01085201|64881451|FG000|Overall Study|Fond ineligible after consent|0|||
23310438|NCT01085201|64881452|FG001|Overall Study|Fond ineligible after consent|1|||
23310439|NCT01085201|64881453|FG002|Overall Study|Fond ineligible after consent|1|||
23310440|NCT01085201|64881454|FG003|Overall Study|Fond ineligible after consent|0|||
23310441|NCT01085201|64881455|FG004|Overall Study|Fond ineligible after consent|0|||
23310442|NCT04709835|64881457|FG000|Overall Study|Withdrawal by Subject|0|||
23310443|NCT04709835|64881458|FG001|Overall Study|Withdrawal by Subject|1|||
23310444|NCT04709835|64881459|FG002|Overall Study|Withdrawal by Subject|0|||
23310445|NCT01221363|64881462|FG000|Overall Study|Pregnancy|1|||
23310446|NCT01221363|64881463|FG001|Overall Study|Pregnancy|0|||
23310447|NCT01221363|64881462|FG000|Overall Study|Withdrawal by Subject|11|||
23310448|NCT01221363|64881463|FG001|Overall Study|Withdrawal by Subject|5|||
23310449|NCT03477903|64881466|FG000|Overall Study|Study Terminated by Sponsor|1|||
23310450|NCT02113189|64881471|FG000|Overall Study|Lost to follow up|2|||
23310451|NCT02113189|64881472|FG001|Overall Study|Lost to follow up|1|||
23310452|NCT02113189|64881473|FG002|Overall Study|Lost to follow up|3|||
23310453|NCT00307437|64881474|FG000|Controlled Period|Adverse Event|7|||
23310454|NCT00307437|64881475|FG001|Controlled Period|Adverse Event|2|||
23310455|NCT00307437|64881476|FG002|Controlled Period|Adverse Event|5|||
23310456|NCT00307437|64881477|FG003|Controlled Period|Adverse Event|0|||
23310457|NCT00307437|64881478|FG004|Controlled Period|Adverse Event|0|||
23310458|NCT00307437|64881479|FG005|Controlled Period|Adverse Event|0|||
23310459|NCT00307437|64881480|FG006|Controlled Period|Adverse Event|0|||
23310460|NCT00307437|64881474|FG000|Controlled Period|Death|0|||
23310461|NCT00307437|64881475|FG001|Controlled Period|Death|0|||
23310462|NCT00307437|64881476|FG002|Controlled Period|Death|1|||
23310463|NCT00307437|64881477|FG003|Controlled Period|Death|0|||
23310464|NCT00307437|64881478|FG004|Controlled Period|Death|0|||
23310465|NCT00307437|64881479|FG005|Controlled Period|Death|0|||
23310466|NCT00307437|64881480|FG006|Controlled Period|Death|0|||
23310467|NCT00307437|64881474|FG000|Controlled Period|Lack of Efficacy|2|||
23310468|NCT00307437|64881475|FG001|Controlled Period|Lack of Efficacy|0|||
23310469|NCT00307437|64881476|FG002|Controlled Period|Lack of Efficacy|0|||
23310470|NCT00307437|64881477|FG003|Controlled Period|Lack of Efficacy|0|||
23310471|NCT00307437|64881478|FG004|Controlled Period|Lack of Efficacy|0|||
23310472|NCT00307437|64881479|FG005|Controlled Period|Lack of Efficacy|0|||
23310473|NCT00307437|64881480|FG006|Controlled Period|Lack of Efficacy|0|||
23310474|NCT00307437|64881474|FG000|Controlled Period|Lost to Follow-up|2|||
23310475|NCT00307437|64881475|FG001|Controlled Period|Lost to Follow-up|3|||
23310476|NCT00307437|64881476|FG002|Controlled Period|Lost to Follow-up|0|||
23310477|NCT00307437|64881477|FG003|Controlled Period|Lost to Follow-up|0|||
23310478|NCT00307437|64881478|FG004|Controlled Period|Lost to Follow-up|0|||
23310479|NCT00307437|64881479|FG005|Controlled Period|Lost to Follow-up|0|||
23310480|NCT00307437|64881480|FG006|Controlled Period|Lost to Follow-up|0|||
23310481|NCT00307437|64881474|FG000|Controlled Period|Other|5|||
23310482|NCT00307437|64881475|FG001|Controlled Period|Other|1|||
23310483|NCT00307437|64881476|FG002|Controlled Period|Other|3|||
23310484|NCT00307437|64881477|FG003|Controlled Period|Other|0|||
23310485|NCT00307437|64881478|FG004|Controlled Period|Other|0|||
23310486|NCT00307437|64881479|FG005|Controlled Period|Other|0|||
23310487|NCT00307437|64881480|FG006|Controlled Period|Other|0|||
23310488|NCT00307437|64881474|FG000|After Controlled Period|Adverse Event|0|||
23310489|NCT00307437|64881475|FG001|After Controlled Period|Adverse Event|0|||
23310490|NCT00307437|64881476|FG002|After Controlled Period|Adverse Event|0|||
23310491|NCT00307437|64881477|FG003|After Controlled Period|Adverse Event|18|||
23310492|NCT00307437|64881478|FG004|After Controlled Period|Adverse Event|16|||
23310493|NCT00307437|64881479|FG005|After Controlled Period|Adverse Event|31|||
23310494|NCT00307437|64881480|FG006|After Controlled Period|Adverse Event|40|||
23310495|NCT00307437|64881474|FG000|After Controlled Period|Death|0|||
23310496|NCT00307437|64881475|FG001|After Controlled Period|Death|0|||
23310497|NCT00307437|64881476|FG002|After Controlled Period|Death|0|||
23310498|NCT00307437|64881477|FG003|After Controlled Period|Death|3|||
23310499|NCT00307437|64881478|FG004|After Controlled Period|Death|1|||
23533597|NCT02039427|65686656|FG001|Overall Study|Cancellation of surgery|0|||
23533598|NCT02039427|65686657|FG002|Overall Study|Cancellation of surgery|1|||
23533599|NCT02039427|65686658|FG003|Overall Study|Cancellation of surgery|0|||
23533600|NCT02039427|65686655|FG000|Overall Study|Loss of follow - up|1|||
23533601|NCT02039427|65686656|FG001|Overall Study|Loss of follow - up|0|||
23533602|NCT02039427|65686657|FG002|Overall Study|Loss of follow - up|2|||
23614724|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
23614725|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
23614726|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Other|1|||
23614727|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Other|0|||
23310500|NCT00307437|64881479|FG005|After Controlled Period|Death|1|||
23310501|NCT00307437|64881480|FG006|After Controlled Period|Death|3|||
23310502|NCT00307437|64881474|FG000|After Controlled Period|Lack of Efficacy|0|||
23310503|NCT00307437|64881475|FG001|After Controlled Period|Lack of Efficacy|0|||
23310504|NCT00307437|64881476|FG002|After Controlled Period|Lack of Efficacy|0|||
23310505|NCT00307437|64881477|FG003|After Controlled Period|Lack of Efficacy|15|||
23310506|NCT00307437|64881478|FG004|After Controlled Period|Lack of Efficacy|17|||
23310507|NCT00307437|64881479|FG005|After Controlled Period|Lack of Efficacy|37|||
23310508|NCT00307437|64881480|FG006|After Controlled Period|Lack of Efficacy|24|||
23310509|NCT00307437|64881474|FG000|After Controlled Period|Lost to Follow-up|0|||
23310510|NCT00307437|64881475|FG001|After Controlled Period|Lost to Follow-up|0|||
23310511|NCT00307437|64881476|FG002|After Controlled Period|Lost to Follow-up|0|||
23310512|NCT00307437|64881477|FG003|After Controlled Period|Lost to Follow-up|7|||
23310513|NCT00307437|64881478|FG004|After Controlled Period|Lost to Follow-up|12|||
23310514|NCT00307437|64881479|FG005|After Controlled Period|Lost to Follow-up|13|||
23310515|NCT00307437|64881480|FG006|After Controlled Period|Lost to Follow-up|18|||
23310516|NCT00307437|64881474|FG000|After Controlled Period|Other|0|||
23310517|NCT00307437|64881475|FG001|After Controlled Period|Other|0|||
23310518|NCT00307437|64881476|FG002|After Controlled Period|Other|0|||
23614728|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Other|1|||
23614729|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Other|0|||
23614730|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
23614731|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
23614732|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
23614733|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
23614734|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
23614735|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
23614736|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
23614737|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
23614738|NCT03845517|65976261|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
23614739|NCT03845517|65976262|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
23614740|NCT03845517|65976263|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
23310519|NCT00307437|64881477|FG003|After Controlled Period|Other|15|||
23533603|NCT02039427|65686658|FG003|Overall Study|Loss of follow - up|4|||
23533604|NCT02039427|65686655|FG000|Overall Study|Steroid Use|1|||
23533605|NCT02039427|65686656|FG001|Overall Study|Steroid Use|0|||
23533606|NCT02039427|65686657|FG002|Overall Study|Steroid Use|0|||
23533607|NCT02039427|65686658|FG003|Overall Study|Steroid Use|0|||
23533608|NCT00382733|65686659|FG000|Overall Study|Withdrawal by Subject|0|||
23533609|NCT00382733|65686660|FG001|Overall Study|Withdrawal by Subject|1|||
23533610|NCT00382733|65686661|FG002|Overall Study|Withdrawal by Subject|0|||
23614741|NCT03845517|65976264|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
23614742|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
23208051|NCT02232087|64498360|FG003|Overall Study|Withdrawal by Subject|0|||
23208052|NCT02232087|64498361|FG004|Overall Study|Withdrawal by Subject|0|||
23208053|NCT02232087|64498362|FG005|Overall Study|Withdrawal by Subject|1|||
23208054|NCT02232087|64498357|FG000|Overall Study|poor inhalation technique|0|||
23208055|NCT02232087|64498358|FG001|Overall Study|poor inhalation technique|1|||
23208056|NCT02232087|64498359|FG002|Overall Study|poor inhalation technique|0|||
23208057|NCT02232087|64498360|FG003|Overall Study|poor inhalation technique|0|||
23208058|NCT02232087|64498361|FG004|Overall Study|poor inhalation technique|0|||
23208059|NCT02232087|64498362|FG005|Overall Study|poor inhalation technique|2|||
23208060|NCT02232087|64498357|FG000|Overall Study|protocol stop criteria|0|||
23208061|NCT02232087|64498358|FG001|Overall Study|protocol stop criteria|1|||
23208062|NCT02232087|64498359|FG002|Overall Study|protocol stop criteria|0|||
23208063|NCT02232087|64498360|FG003|Overall Study|protocol stop criteria|1|||
23208064|NCT02232087|64498361|FG004|Overall Study|protocol stop criteria|0|||
23208065|NCT02232087|64498362|FG005|Overall Study|protocol stop criteria|0|||
23208066|NCT02232087|64498357|FG000|Overall Study|Adverse Event|0|||
23208067|NCT02232087|64498358|FG001|Overall Study|Adverse Event|0|||
23208068|NCT02232087|64498359|FG002|Overall Study|Adverse Event|0|||
23208069|NCT02232087|64498360|FG003|Overall Study|Adverse Event|0|||
23208070|NCT02232087|64498361|FG004|Overall Study|Adverse Event|1|||
23208071|NCT02232087|64498362|FG005|Overall Study|Adverse Event|0|||
23208072|NCT03497429|64498363|FG000|Overall Study|Progressive disease|3|||
23208073|NCT03497429|64498364|FG001|Overall Study|Progressive disease|4|||
23208074|NCT03497429|64498363|FG000|Overall Study|Adverse Event|0|||
23208075|NCT03497429|64498364|FG001|Overall Study|Adverse Event|2|||
23208076|NCT01911845|64498366|FG000|Overall Study|Adverse Event|2|||
23208077|NCT01911845|64498366|FG000|Overall Study|Lost to Follow-up|1|||
23208078|NCT01911845|64498366|FG000|Overall Study|Other (not specified)|3|||
23208079|NCT02237157|64498367|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
23208080|NCT02237157|64498368|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
23208081|NCT02237157|64498369|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
23208082|NCT02237157|64498370|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
23208083|NCT02237157|64498367|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
23208084|NCT02237157|64498368|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
23208085|NCT02237157|64498369|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
23208086|NCT02237157|64498370|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
23208087|NCT01778127|64498375|FG000|Overall Study|Lost to Follow-up|5|||
23208088|NCT01778127|64498376|FG001|Overall Study|Lost to Follow-up|1|||
23208089|NCT01778127|64498377|FG002|Overall Study|Lost to Follow-up|2|||
23208090|NCT01778127|64498375|FG000|Overall Study|Withdrawal by Subject|3|||
23208091|NCT01778127|64498376|FG001|Overall Study|Withdrawal by Subject|1|||
23208092|NCT01778127|64498377|FG002|Overall Study|Withdrawal by Subject|4|||
23208093|NCT00393913|64498378|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
23208094|NCT00393913|64498378|FG000|Initial Assessment|Withdrawal by Subject|16|||
23208095|NCT00393913|64498378|FG000|CPAP|Withdrawal by Subject|3|||
23208096|NCT00393913|64498378|FG000|CPAP|Physician Decision|1|||
23208097|NCT00393913|64498378|FG000|CPAP|TEchnical problem with CPAP|3|||
23208098|NCT01401465|64498379|FG000|Treatment Period 1|Adverse Event|4|||
23208099|NCT01401465|64498380|FG001|Treatment Period 1|Adverse Event|1|||
23208100|NCT01401465|64498379|FG000|Treatment Period 1|Pregnancy|0|||
23208101|NCT01401465|64498380|FG001|Treatment Period 1|Pregnancy|1|||
23208102|NCT01401465|64498379|FG000|Treatment Period 1|Protocol Violation|5|||
23310520|NCT00307437|64881478|FG004|After Controlled Period|Other|9|||
23310521|NCT00307437|64881479|FG005|After Controlled Period|Other|40|||
23310522|NCT00307437|64881480|FG006|After Controlled Period|Other|28|||
23310523|NCT03665441|64881483|FG000|Overall Study|survival follow up ongoing|23|||
23310524|NCT03665441|64881484|FG001|Overall Study|survival follow up ongoing|0|||
23310525|NCT03665441|64881483|FG000|Overall Study|Patients ongoing on treatment|9|||
23310526|NCT03665441|64881484|FG001|Overall Study|Patients ongoing on treatment|6|||
23310527|NCT03665441|64881483|FG000|Overall Study|Randomized but not treated|7|||
23310528|NCT03665441|64881484|FG001|Overall Study|Randomized but not treated|11|||
23310529|NCT01341782|64881524|FG000|Overall Study|Adverse Event|1|||
23310530|NCT01341782|64881525|FG001|Overall Study|Adverse Event|1|||
23310531|NCT01341782|64881524|FG000|Overall Study|Withdrawal by Subject|6|||
23310532|NCT01341782|64881525|FG001|Overall Study|Withdrawal by Subject|5|||
23310533|NCT01341782|64881524|FG000|Overall Study|Missed 3 consecutive doses|0|||
23310534|NCT01341782|64881525|FG001|Overall Study|Missed 3 consecutive doses|4|||
23310535|NCT01341782|64881524|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
23310536|NCT01341782|64881525|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
23310537|NCT01341782|64881524|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
23310538|NCT01341782|64881525|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
23310539|NCT01341782|64881524|FG000|Overall Study|Other|5|||
23310540|NCT01341782|64881525|FG001|Overall Study|Other|0|||
23310541|NCT01438996|64881528|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
23310542|NCT01438996|64881529|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
23421541|NCT00969761|65288211|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421542|NCT00969761|65288212|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421543|NCT00969761|65288213|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421544|NCT00969761|65288214|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
23421545|NCT00969761|65288203|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421546|NCT00969761|65288204|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421547|NCT00969761|65288205|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421548|NCT00969761|65288206|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421549|NCT00969761|65288207|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421550|NCT00969761|65288208|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421551|NCT00969761|65288209|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421552|NCT00969761|65288210|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421553|NCT00969761|65288211|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
23421554|NCT00969761|65288212|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421555|NCT00969761|65288213|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421556|NCT00969761|65288214|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
23421557|NCT00969761|65288203|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
23421558|NCT00969761|65288204|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421559|NCT00969761|65288205|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
23421560|NCT00969761|65288206|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421561|NCT00969761|65288207|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
23421562|NCT00969761|65288208|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421563|NCT00969761|65288209|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421564|NCT00969761|65288210|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
23421565|NCT00969761|65288211|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
23421566|NCT00969761|65288212|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
23421567|NCT00969761|65288213|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421568|NCT00969761|65288214|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
23421569|NCT00969761|65288203|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421570|NCT00969761|65288204|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421571|NCT00969761|65288205|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421572|NCT00969761|65288206|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
23421573|NCT00969761|65288207|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
23421574|NCT00969761|65288208|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421575|NCT00969761|65288209|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421576|NCT00969761|65288210|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23310543|NCT01438996|64881530|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
23310544|NCT02036775|64881531|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23310545|NCT02036775|64881532|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23310546|NCT02036775|64881533|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23421577|NCT00969761|65288211|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
23421578|NCT00969761|65288212|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421579|NCT00969761|65288213|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421580|NCT00969761|65288214|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
23421581|NCT03158012|65288215|FG000|Overall Study|Withdrawal by Subject|0|||
23421582|NCT03158012|65288216|FG001|Overall Study|Withdrawal by Subject|1|||
23421583|NCT02785458|65288217|FG000|1 Month|Withdrawal by Subject|2|||
23421584|NCT02785458|65288218|FG001|1 Month|Withdrawal by Subject|1|||
23421585|NCT02785458|65288217|FG000|1 Month|Lost to Follow-up|38|||
23421586|NCT02785458|65288218|FG001|1 Month|Lost to Follow-up|31|||
23421587|NCT02785458|65288217|FG000|1 Month|Deemed Ineligible|1|||
23421588|NCT02785458|65288218|FG001|1 Month|Deemed Ineligible|0|||
23421589|NCT02785458|65288217|FG000|1 Month|Completed Evaluation by Baseline|42|||
23421590|NCT02785458|65288218|FG001|1 Month|Completed Evaluation by Baseline|39|||
23421591|NCT02785458|65288217|FG000|1 Month|Partial Interview|0|||
23421592|NCT02785458|65288218|FG001|1 Month|Partial Interview|4|||
23421593|NCT02785458|65288217|FG000|3 Months|Withdrawal by Subject|3|||
23421594|NCT02785458|65288218|FG001|3 Months|Withdrawal by Subject|1|||
23421595|NCT02785458|65288217|FG000|3 Months|Lost to Follow-up|25|||
23421596|NCT02785458|65288218|FG001|3 Months|Lost to Follow-up|21|||
23421597|NCT02785458|65288217|FG000|3 Months|Completed Evaluation at 1 Month|100|||
23421598|NCT02785458|65288218|FG001|3 Months|Completed Evaluation at 1 Month|89|||
23421599|NCT05463952|65288222|FG000|Treatment|Progressive disease|4|||
23421600|NCT05463952|65288222|FG000|Treatment|Ongoing|2|||
23421601|NCT00744978|65288223|FG000|Period 1|Lost to Follow-up|1|||
23421602|NCT00744978|65288224|FG001|Period 1|Lost to Follow-up|0|||
23421603|NCT00744978|65288223|FG000|Period 1|Withdrawal by Subject|0|||
23208103|NCT01401465|64498380|FG001|Treatment Period 1|Protocol Violation|0|||
23421604|NCT00744978|65288224|FG001|Period 1|Withdrawal by Subject|2|||
23421605|NCT00744978|65288223|FG000|Period 1|Other|0|||
23421606|NCT00744978|65288224|FG001|Period 1|Other|2|||
23421607|NCT00744978|65288223|FG000|Period 1|Adverse Event|4|||
23421608|NCT00744978|65288224|FG001|Period 1|Adverse Event|0|||
23421609|NCT00744978|65288223|FG000|Period 1|Randomized but not Treated|1|||
23421610|NCT00744978|65288224|FG001|Period 1|Randomized but not Treated|1|||
23421611|NCT00744978|65288223|FG000|Period 2|Adverse Event|0|||
23421612|NCT00744978|65288224|FG001|Period 2|Adverse Event|1|||
23421613|NCT01904149|65288225|FG000|Overall Study|Adverse Event|3|||
23421614|NCT01904149|65288226|FG001|Overall Study|Adverse Event|4|||
23421615|NCT01904149|65288227|FG002|Overall Study|Adverse Event|0|||
23421616|NCT01904149|65288228|FG003|Overall Study|Adverse Event|1|||
23421617|NCT01904149|65288229|FG004|Overall Study|Adverse Event|1|||
23421618|NCT01904149|65288230|FG005|Overall Study|Adverse Event|2|||
23421619|NCT01904149|65288225|FG000|Overall Study|Lack of Efficacy|0|||
23421620|NCT01904149|65288226|FG001|Overall Study|Lack of Efficacy|3|||
23421621|NCT01904149|65288227|FG002|Overall Study|Lack of Efficacy|1|||
23421622|NCT01904149|65288228|FG003|Overall Study|Lack of Efficacy|3|||
23421623|NCT01904149|65288229|FG004|Overall Study|Lack of Efficacy|3|||
23421624|NCT01904149|65288230|FG005|Overall Study|Lack of Efficacy|1|||
23421625|NCT01904149|65288225|FG000|Overall Study|Withdrawal by Subject|1|||
23421626|NCT01904149|65288226|FG001|Overall Study|Withdrawal by Subject|3|||
23421627|NCT01904149|65288227|FG002|Overall Study|Withdrawal by Subject|1|||
23421628|NCT01904149|65288228|FG003|Overall Study|Withdrawal by Subject|0|||
23421629|NCT01904149|65288229|FG004|Overall Study|Withdrawal by Subject|1|||
23421630|NCT01904149|65288230|FG005|Overall Study|Withdrawal by Subject|0|||
23421631|NCT01904149|65288225|FG000|Overall Study|Protocol Violation|0|||
23421632|NCT01904149|65288226|FG001|Overall Study|Protocol Violation|1|||
23421633|NCT01904149|65288227|FG002|Overall Study|Protocol Violation|0|||
23421634|NCT01904149|65288228|FG003|Overall Study|Protocol Violation|0|||
23421635|NCT01904149|65288229|FG004|Overall Study|Protocol Violation|0|||
23421636|NCT01904149|65288230|FG005|Overall Study|Protocol Violation|0|||
23421637|NCT01904149|65288225|FG000|Overall Study|non compliance with study drug|1|||
23421638|NCT01904149|65288226|FG001|Overall Study|non compliance with study drug|0|||
23421639|NCT01904149|65288227|FG002|Overall Study|non compliance with study drug|0|||
23421640|NCT01904149|65288228|FG003|Overall Study|non compliance with study drug|0|||
23421641|NCT01904149|65288229|FG004|Overall Study|non compliance with study drug|0|||
23421642|NCT01904149|65288230|FG005|Overall Study|non compliance with study drug|0|||
23421643|NCT01824823|65288232|FG000|Overall Study|Lack of Efficacy|1|||
23421644|NCT01824823|65288233|FG001|Overall Study|Lack of Efficacy|1|||
23421645|NCT01824823|65288232|FG000|Overall Study|Off-treatment reason not submitted|1|||
23533611|NCT00382733|65686662|FG003|Overall Study|Withdrawal by Subject|0|||
23533612|NCT00382733|65686663|FG004|Overall Study|Withdrawal by Subject|0|||
23533613|NCT01328002|65686664|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
23421646|NCT01824823|65288233|FG001|Overall Study|Off-treatment reason not submitted|0|||
23421647|NCT01133405|65288234|FG000|Period 1|Withdrawal by Subject|0|||
23421648|NCT01133405|65288235|FG001|Period 1|Withdrawal by Subject|1|||
23421649|NCT01133405|65288236|FG002|Period 1|Withdrawal by Subject|0|||
23421650|NCT01133405|65288237|FG003|Period 1|Withdrawal by Subject|1|||
23421651|NCT01133405|65288238|FG004|Period 1|Withdrawal by Subject|0|||
23421652|NCT01133405|65288239|FG005|Period 1|Withdrawal by Subject|1|||
23421653|NCT01133405|65288240|FG006|Period 1|Withdrawal by Subject|0|||
23421654|NCT01133405|65288241|FG007|Period 1|Withdrawal by Subject|0|||
23421655|NCT01133405|65288242|FG008|Period 1|Withdrawal by Subject|0|||
23421656|NCT01133405|65288243|FG009|Period 1|Withdrawal by Subject|0|||
23421657|NCT01133405|65288234|FG000|Period 1|Physician Decision|0|||
23421658|NCT01133405|65288235|FG001|Period 1|Physician Decision|0|||
23421659|NCT01133405|65288236|FG002|Period 1|Physician Decision|0|||
23421660|NCT01133405|65288237|FG003|Period 1|Physician Decision|1|||
23421661|NCT01133405|65288238|FG004|Period 1|Physician Decision|0|||
23421662|NCT01133405|65288239|FG005|Period 1|Physician Decision|0|||
23614743|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23421663|NCT01133405|65288240|FG006|Period 1|Physician Decision|0|||
23421664|NCT01133405|65288241|FG007|Period 1|Physician Decision|0|||
23421665|NCT01133405|65288242|FG008|Period 1|Physician Decision|0|||
23421666|NCT01133405|65288243|FG009|Period 1|Physician Decision|0|||
23421667|NCT01133405|65288234|FG000|Period 1|Discontinued after randomization|1|||
23421668|NCT01133405|65288235|FG001|Period 1|Discontinued after randomization|0|||
23421669|NCT01133405|65288236|FG002|Period 1|Discontinued after randomization|0|||
23421670|NCT01133405|65288237|FG003|Period 1|Discontinued after randomization|0|||
23421671|NCT01133405|65288238|FG004|Period 1|Discontinued after randomization|0|||
23421672|NCT01133405|65288239|FG005|Period 1|Discontinued after randomization|0|||
23421673|NCT01133405|65288240|FG006|Period 1|Discontinued after randomization|1|||
23421674|NCT01133405|65288241|FG007|Period 1|Discontinued after randomization|0|||
23421675|NCT01133405|65288242|FG008|Period 1|Discontinued after randomization|0|||
23421676|NCT01133405|65288243|FG009|Period 1|Discontinued after randomization|0|||
23421677|NCT01133405|65288234|FG000|Period 1|Received drug only in period 2|0|||
23421678|NCT01133405|65288235|FG001|Period 1|Received drug only in period 2|1|||
23421679|NCT01133405|65288236|FG002|Period 1|Received drug only in period 2|0|||
23421680|NCT01133405|65288237|FG003|Period 1|Received drug only in period 2|2|||
23421681|NCT01133405|65288238|FG004|Period 1|Received drug only in period 2|0|||
23614744|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23421682|NCT01133405|65288239|FG005|Period 1|Received drug only in period 2|1|||
23421683|NCT01133405|65288240|FG006|Period 1|Received drug only in period 2|0|||
23421684|NCT01133405|65288241|FG007|Period 1|Received drug only in period 2|0|||
23614745|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614746|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614747|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614748|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614749|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614750|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614751|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
23614752|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614753|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614754|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614755|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614756|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614757|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
23614758|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614759|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614760|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614761|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23614762|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
23614763|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614764|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614765|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614766|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614767|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614768|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614769|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614770|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614771|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23614772|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23421685|NCT01133405|65288242|FG008|Period 1|Received drug only in period 2|0|||
23421686|NCT01133405|65288243|FG009|Period 1|Received drug only in period 2|0|||
23421687|NCT01133405|65288234|FG000|Period 1|Received drug only in period 3|0|||
23421688|NCT01133405|65288235|FG001|Period 1|Received drug only in period 3|1|||
23421689|NCT01133405|65288236|FG002|Period 1|Received drug only in period 3|1|||
23421690|NCT01133405|65288237|FG003|Period 1|Received drug only in period 3|0|||
23421691|NCT01133405|65288238|FG004|Period 1|Received drug only in period 3|0|||
23614773|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23614774|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614775|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614776|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614777|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614778|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23421692|NCT01133405|65288239|FG005|Period 1|Received drug only in period 3|0|||
23614779|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614780|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23614781|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23614782|NCT01697592|65976265|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23614783|NCT01697592|65976266|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
23614784|NCT01697592|65976267|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
23421693|NCT01133405|65288240|FG006|Period 1|Received drug only in period 3|0|||
23421694|NCT01133405|65288241|FG007|Period 1|Received drug only in period 3|0|||
23421695|NCT01133405|65288242|FG008|Period 1|Received drug only in period 3|0|||
23421696|NCT01133405|65288243|FG009|Period 1|Received drug only in period 3|0|||
23421697|NCT01133405|65288234|FG000|Period 2|Adverse Event|0|||
23421698|NCT01133405|65288235|FG001|Period 2|Adverse Event|0|||
23421699|NCT01133405|65288236|FG002|Period 2|Adverse Event|1|||
23421700|NCT01133405|65288237|FG003|Period 2|Adverse Event|0|||
23421701|NCT01133405|65288238|FG004|Period 2|Adverse Event|0|||
23421702|NCT01133405|65288239|FG005|Period 2|Adverse Event|0|||
23421703|NCT01133405|65288240|FG006|Period 2|Adverse Event|0|||
23421704|NCT01133405|65288241|FG007|Period 2|Adverse Event|0|||
23421705|NCT01133405|65288242|FG008|Period 2|Adverse Event|0|||
23421706|NCT01133405|65288243|FG009|Period 2|Adverse Event|0|||
23421707|NCT01133405|65288234|FG000|Period 2|Withdrawal by Subject|0|||
23421708|NCT01133405|65288235|FG001|Period 2|Withdrawal by Subject|0|||
23421709|NCT01133405|65288236|FG002|Period 2|Withdrawal by Subject|0|||
23421710|NCT01133405|65288237|FG003|Period 2|Withdrawal by Subject|1|||
23421711|NCT01133405|65288238|FG004|Period 2|Withdrawal by Subject|0|||
23421712|NCT01133405|65288239|FG005|Period 2|Withdrawal by Subject|1|||
23421713|NCT01133405|65288240|FG006|Period 2|Withdrawal by Subject|0|||
23421714|NCT01133405|65288241|FG007|Period 2|Withdrawal by Subject|0|||
23421715|NCT01133405|65288242|FG008|Period 2|Withdrawal by Subject|0|||
23421716|NCT01133405|65288243|FG009|Period 2|Withdrawal by Subject|0|||
23421717|NCT01133405|65288234|FG000|Period 2|Entry Criteria Not Met|0|||
23421718|NCT01133405|65288235|FG001|Period 2|Entry Criteria Not Met|1|||
23421719|NCT01133405|65288236|FG002|Period 2|Entry Criteria Not Met|0|||
23421720|NCT01133405|65288237|FG003|Period 2|Entry Criteria Not Met|0|||
23421721|NCT01133405|65288238|FG004|Period 2|Entry Criteria Not Met|0|||
23421722|NCT01133405|65288239|FG005|Period 2|Entry Criteria Not Met|0|||
23421723|NCT01133405|65288240|FG006|Period 2|Entry Criteria Not Met|0|||
23421724|NCT01133405|65288241|FG007|Period 2|Entry Criteria Not Met|0|||
23421725|NCT01133405|65288242|FG008|Period 2|Entry Criteria Not Met|0|||
23421726|NCT01133405|65288243|FG009|Period 2|Entry Criteria Not Met|0|||
23421727|NCT01133405|65288234|FG000|Period 2|Physician Decision|0|||
23421728|NCT01133405|65288235|FG001|Period 2|Physician Decision|0|||
23421729|NCT01133405|65288236|FG002|Period 2|Physician Decision|0|||
23421730|NCT01133405|65288237|FG003|Period 2|Physician Decision|0|||
23421731|NCT01133405|65288238|FG004|Period 2|Physician Decision|0|||
23421732|NCT01133405|65288239|FG005|Period 2|Physician Decision|1|||
23421733|NCT01133405|65288240|FG006|Period 2|Physician Decision|0|||
23421734|NCT01133405|65288241|FG007|Period 2|Physician Decision|0|||
23421735|NCT01133405|65288242|FG008|Period 2|Physician Decision|0|||
23421736|NCT01133405|65288243|FG009|Period 2|Physician Decision|0|||
23421737|NCT01874275|65288250|FG000|Overall Study|Lost to Follow-up|1|||
23421738|NCT01874275|65288251|FG001|Overall Study|Lost to Follow-up|0|||
23421739|NCT01238835|65288252|FG000|Overall Study|Death|124|||
23421740|NCT01238835|65288252|FG000|Overall Study|Withdrawal by Subject|9|||
23421741|NCT01238835|65288252|FG000|Overall Study|Lost to Follow-up|1|||
23421742|NCT01238835|65288252|FG000|Overall Study|Site early discontinuation|2|||
23421743|NCT03028480|65288258|FG000|Overall Study|No revisit after the first prescription date|2|||
23421744|NCT03028480|65288258|FG000|Overall Study|Did not use the drug|1|||
23421745|NCT03028480|65288258|FG000|Overall Study|Violation of the enrollment deadline|10|||
23421746|NCT03028480|65288258|FG000|Overall Study|Case report forms were not collected|21|||
23421747|NCT02649218|65288259|FG000|Overall Study|Adverse Event|8|||
23421748|NCT02649218|65288259|FG000|Overall Study|Lack of Efficacy|8|||
23421749|NCT02649218|65288259|FG000|Overall Study|Pregnancy|3|||
23421750|NCT02649218|65288259|FG000|Overall Study|Protocol Violation|3|||
23421751|NCT02649218|65288259|FG000|Overall Study|Physician Decision|1|||
23421752|NCT02649218|65288259|FG000|Overall Study|Withdrawal by Subject|2|||
23614785|NCT01697592|65976268|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
23421753|NCT00937404|65288268|FG000|Overall Study|Protocol Violation|1|||
23614786|NCT01697592|65976269|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23421754|NCT00937404|65288268|FG000|Overall Study|Withdrawal by Subject|1|||
23614787|NCT01697592|65976270|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23421755|NCT00068250|65288269|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
23421756|NCT00068250|65288270|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
23421757|NCT00068250|65288271|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
23421758|NCT00068250|65288272|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
23421759|NCT03640052|65288273|FG000|Overall Study|Lost to Follow-up|0|||
23421760|NCT03640052|65288274|FG001|Overall Study|Lost to Follow-up|1|||
23421761|NCT03640052|65288275|FG002|Overall Study|Lost to Follow-up|0|||
23421762|NCT03640052|65288276|FG003|Overall Study|Lost to Follow-up|0|||
23421763|NCT03640052|65288277|FG004|Overall Study|Lost to Follow-up|0|||
23421764|NCT00596154|65288278|FG000|Overall Study|Not Evaluable|2|||
23421765|NCT03298984|65288279|FG000|Overall Study|Physician Decision|1|||
23421766|NCT03298984|65288280|FG001|Overall Study|Physician Decision|0|||
23421767|NCT03298984|65288281|FG002|Overall Study|Physician Decision|0|||
23421768|NCT03298984|65288282|FG003|Overall Study|Physician Decision|6|||
23421769|NCT03298984|65288279|FG000|Overall Study|Lack of Efficacy|0|||
23421770|NCT03298984|65288280|FG001|Overall Study|Lack of Efficacy|1|||
23421771|NCT03298984|65288281|FG002|Overall Study|Lack of Efficacy|1|||
23421772|NCT03298984|65288282|FG003|Overall Study|Lack of Efficacy|4|||
23421773|NCT03298984|65288279|FG000|Overall Study|Relapsed disease (following remission)|0|||
23421774|NCT03298984|65288280|FG001|Overall Study|Relapsed disease (following remission)|0|||
23421775|NCT03298984|65288281|FG002|Overall Study|Relapsed disease (following remission)|1|||
23421776|NCT03298984|65288282|FG003|Overall Study|Relapsed disease (following remission)|1|||
23421777|NCT03298984|65288279|FG000|Overall Study|Adverse Event|0|||
23421778|NCT03298984|65288280|FG001|Overall Study|Adverse Event|0|||
23421779|NCT03298984|65288281|FG002|Overall Study|Adverse Event|0|||
23421780|NCT03298984|65288282|FG003|Overall Study|Adverse Event|1|||
23421781|NCT03298984|65288279|FG000|Overall Study|Death|0|||
23421782|NCT03298984|65288280|FG001|Overall Study|Death|0|||
23421783|NCT03298984|65288281|FG002|Overall Study|Death|0|||
23421784|NCT03298984|65288282|FG003|Overall Study|Death|2|||
23421785|NCT03298984|65288279|FG000|Overall Study|Insurance Company Decision|0|||
23421786|NCT03298984|65288280|FG001|Overall Study|Insurance Company Decision|0|||
23421787|NCT03298984|65288281|FG002|Overall Study|Insurance Company Decision|0|||
23421788|NCT03298984|65288282|FG003|Overall Study|Insurance Company Decision|1|||
23421789|NCT04941807|65288283|FG000|Overall Study|Lost to Follow-up|1|||
23421790|NCT04941807|65288284|FG001|Overall Study|Lost to Follow-up|1|||
23421791|NCT02596958|65288297|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
23421792|NCT02596958|65288297|FG000|Overall Study|Cancer Progression|441|||
23421793|NCT02596958|65288297|FG000|Overall Study|Death From Cancer|112|||
23421794|NCT02596958|65288297|FG000|Overall Study|Death From Other Cause|33|||
23421795|NCT02596958|65288297|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
23421796|NCT02596958|65288297|FG000|Overall Study|Administrative Reasons/Other|231|||
23421797|NCT02596958|65288297|FG000|Overall Study|Lost to Follow-up|33|||
23421798|NCT02596958|65288297|FG000|Overall Study|Missing|32|||
23421799|NCT02596958|65288297|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
23421800|NCT03920293|65288300|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
23421801|NCT03920293|65288301|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
23208104|NCT01401465|64498379|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23208105|NCT01401465|64498380|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23208106|NCT01401465|64498379|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
23208107|NCT01401465|64498380|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
23208108|NCT01401465|64498379|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
23208109|NCT01401465|64498380|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
23208110|NCT01401465|64498379|FG000|Treatment Period 1|Scheduling Difficulties|1|||
23533614|NCT01328002|65686665|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
23533615|NCT01328002|65686664|FG000|Open-Label Period|Adverse Event|8|||
23533616|NCT01328002|65686665|FG001|Open-Label Period|Adverse Event|0|||
23208111|NCT01401465|64498380|FG001|Treatment Period 1|Scheduling Difficulties|1|||
23208112|NCT01401465|64498379|FG000|Treatment Period 2|Lost to Follow-up|0|||
23208113|NCT01401465|64498380|FG001|Treatment Period 2|Lost to Follow-up|1|||
23208114|NCT01401465|64498379|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23208115|NCT01401465|64498380|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23208116|NCT03337139|64498382|FG000|Phase I|Withdrawal by Subject|10|||
23208117|NCT03337139|64498383|FG001|Phase I|Withdrawal by Subject|0|||
23421802|NCT03920293|65288300|FG000|Randomized-Controlled Period|Physician Decision|1|||
23533617|NCT01328002|65686664|FG000|Open-Label Period|Lack of Efficacy|3|||
23533618|NCT01328002|65686665|FG001|Open-Label Period|Lack of Efficacy|0|||
23533619|NCT01328002|65686664|FG000|Open-Label Period|Protocol Violation|2|||
23533620|NCT01328002|65686665|FG001|Open-Label Period|Protocol Violation|0|||
23533621|NCT01328002|65686664|FG000|Open-Label Period|Withdrawal by Subject|9|||
23533622|NCT01328002|65686665|FG001|Open-Label Period|Withdrawal by Subject|0|||
23533623|NCT01328002|65686664|FG000|Open-Label Period|Lost to Follow-up|6|||
23533624|NCT01328002|65686665|FG001|Open-Label Period|Lost to Follow-up|0|||
23533625|NCT01328002|65686664|FG000|Open-Label Period|Other Reason|2|||
23533626|NCT01328002|65686665|FG001|Open-Label Period|Other Reason|0|||
23533627|NCT01328002|65686664|FG000|Double-Blind Period|Adverse Event|1|||
23533628|NCT01328002|65686665|FG001|Double-Blind Period|Adverse Event|0|||
23533629|NCT01328002|65686664|FG000|Double-Blind Period|Lack of Efficacy|1|||
23533630|NCT01328002|65686665|FG001|Double-Blind Period|Lack of Efficacy|0|||
23533631|NCT02652624|65686668|FG000|Randomized Phase|Pregnancy|3|||
23533632|NCT02652624|65686669|FG001|Randomized Phase|Pregnancy|1|||
23533633|NCT02652624|65686668|FG000|Randomized Phase|Investigator's Discretion|0|||
23533634|NCT02652624|65686669|FG001|Randomized Phase|Investigator's Discretion|2|||
23533635|NCT02652624|65686668|FG000|Randomized Phase|Death|0|||
23533636|NCT02652624|65686669|FG001|Randomized Phase|Death|1|||
23533637|NCT02652624|65686668|FG000|Randomized Phase|Lost to Follow-up|0|||
23533638|NCT02652624|65686669|FG001|Randomized Phase|Lost to Follow-up|1|||
23533639|NCT02652624|65686668|FG000|Extension Phase|Lost to Follow-up|3|||
23533640|NCT02652624|65686669|FG001|Extension Phase|Lost to Follow-up|1|||
23533641|NCT02652624|65686668|FG000|Extension Phase|Pregnancy|1|||
23533642|NCT02652624|65686669|FG001|Extension Phase|Pregnancy|1|||
23533643|NCT02652624|65686668|FG000|Extension Phase|Adverse Event|0|||
23533644|NCT02652624|65686669|FG001|Extension Phase|Adverse Event|1|||
23533645|NCT02652624|65686668|FG000|Extension Phase|Withdrew Consent|0|||
23533646|NCT02652624|65686669|FG001|Extension Phase|Withdrew Consent|1|||
23533647|NCT01067352|65686670|FG000|Overall Study|Withdrawal by Subject|1|||
23533648|NCT01067352|65686671|FG001|Overall Study|Withdrawal by Subject|2|||
23533649|NCT01067352|65686672|FG002|Overall Study|Withdrawal by Subject|1|||
23533650|NCT01067352|65686670|FG000|Overall Study|Physician Decision|0|||
23533651|NCT01067352|65686671|FG001|Overall Study|Physician Decision|1|||
23533652|NCT01067352|65686672|FG002|Overall Study|Physician Decision|0|||
23421803|NCT03920293|65288301|FG001|Randomized-Controlled Period|Physician Decision|2|||
23533653|NCT00298896|65686673|FG000|Overall Study|Death|3|||
23533654|NCT00298896|65686673|FG000|Overall Study|Physician Decision|2|||
23533655|NCT00298896|65686673|FG000|Overall Study|Intercurrent Illness|1|||
23533656|NCT00298896|65686673|FG000|Overall Study|Disease Progression|41|||
23533657|NCT00298896|65686673|FG000|Overall Study|Withdrawal by Subject|2|||
23533658|NCT00298896|65686673|FG000|Overall Study|Assigned to treatment in error|1|||
23208118|NCT02864940|64498384|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
23533659|NCT00281840|65686674|FG000|Overall Study|Adverse Event|12|||
23533660|NCT00281840|65686674|FG000|Overall Study|Physician Decision|6|||
23533661|NCT00281840|65686674|FG000|Overall Study|Withdrawal by Subject|3|||
23533662|NCT00281840|65686674|FG000|Overall Study|Disease Progression|2|||
23533663|NCT00281840|65686674|FG000|Overall Study|exceed maximum delay in treatment|1|||
23533664|NCT00281840|65686674|FG000|Overall Study|Complicating Disease|1|||
23533665|NCT03075644|65686675|FG000|Overall Study|Withdrawal by Subject|1|||
23533666|NCT03075644|65686676|FG001|Overall Study|Withdrawal by Subject|1|||
23533667|NCT01209624|65686681|FG000|Overall Study|Death|2|||
23533668|NCT01209624|65686681|FG000|Overall Study|Adverse Event|13|||
23533669|NCT01209624|65686681|FG000|Overall Study|Lack of Efficacy|17|||
23533670|NCT01209624|65686681|FG000|Overall Study|Lost to Follow-up|290|||
23533671|NCT01209624|65686681|FG000|Overall Study|Other|4|||
23533672|NCT00179413|65686682|FG000|Overall Study|Adverse Event|38|||
23533673|NCT00179413|65686683|FG001|Overall Study|Adverse Event|20|||
23533674|NCT00179413|65686682|FG000|Overall Study|Withdrawal by Subject|87|||
23533675|NCT00179413|65686683|FG001|Overall Study|Withdrawal by Subject|95|||
23533676|NCT02082522|65686686|FG000|Overall Study|Sponsor termination|5|||
23533677|NCT02082522|65686687|FG001|Overall Study|Sponsor termination|3|||
23533678|NCT02082522|65686686|FG000|Overall Study|Withdrawal by Subject|2|||
23533679|NCT02082522|65686687|FG001|Overall Study|Withdrawal by Subject|4|||
23533680|NCT02082522|65686686|FG000|Overall Study|Death|1|||
23533681|NCT02082522|65686687|FG001|Overall Study|Death|0|||
23533682|NCT02082522|65686686|FG000|Overall Study|Lost to Follow-up|1|||
23533683|NCT02082522|65686687|FG001|Overall Study|Lost to Follow-up|0|||
23533684|NCT02082522|65686686|FG000|Overall Study|Physician Decision|3|||
23533685|NCT02082522|65686687|FG001|Overall Study|Physician Decision|1|||
23533686|NCT02082522|65686686|FG000|Overall Study|Disease progression|2|||
23533687|NCT02082522|65686687|FG001|Overall Study|Disease progression|2|||
23533688|NCT02082522|65686686|FG000|Overall Study|Chemotherapy change|1|||
23208119|NCT02864940|64498385|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
23208120|NCT02492997|64498386|FG000|Overall Study|Withdrawal by Subject|1|||
23208121|NCT02492997|64498387|FG001|Overall Study|Withdrawal by Subject|0|||
23208122|NCT02492997|64498386|FG000|Overall Study|Gained Weight|1|||
23208123|NCT02492997|64498387|FG001|Overall Study|Gained Weight|0|||
23208124|NCT02492997|64498386|FG000|Overall Study|Lost to Follow-up|0|||
23208125|NCT02492997|64498387|FG001|Overall Study|Lost to Follow-up|1|||
23208126|NCT02862548|64500852|FG000|Randomized Phase (Up to Week 48)|Death|0|||
23208127|NCT02862548|64500853|FG001|Randomized Phase (Up to Week 48)|Death|1|||
23614788|NCT01697592|65976271|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
23614789|NCT01697592|65976272|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23614790|NCT01697592|65976273|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23614791|NCT01697592|65976274|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
23614792|NCT01697592|65976265|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
23614793|NCT01697592|65976266|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23208128|NCT02862548|64500852|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
23310547|NCT02036775|64881534|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23310548|NCT02036775|64881535|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
23310549|NCT02036775|64881536|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
23533689|NCT02082522|65686687|FG001|Overall Study|Chemotherapy change|3|||
23533690|NCT01306617|65686688|FG000|Overall Study|Adverse Event|1|||
23533691|NCT01306617|65686689|FG001|Overall Study|Adverse Event|0|||
23533692|NCT01306617|65686690|FG002|Overall Study|Adverse Event|0|||
23533693|NCT01306617|65686688|FG000|Overall Study|Virologic Failure|0|||
23533694|NCT01306617|65686689|FG001|Overall Study|Virologic Failure|0|||
23533695|NCT01306617|65686690|FG002|Overall Study|Virologic Failure|5|||
23533696|NCT01306617|65686688|FG000|Overall Study|Non-compliance|0|||
23533697|NCT01306617|65686689|FG001|Overall Study|Non-compliance|1|||
23533698|NCT01306617|65686690|FG002|Overall Study|Non-compliance|0|||
23533699|NCT03049813|65686691|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
23533700|NCT03049813|65686692|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
23533701|NCT03049813|65686693|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
23533702|NCT03049813|65686694|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
23533703|NCT03049813|65686691|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
23533704|NCT03049813|65686692|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
23533705|NCT03049813|65686693|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
23533706|NCT03049813|65686694|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
23533707|NCT03049813|65686691|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
23533708|NCT03049813|65686692|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
23533709|NCT03049813|65686693|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
23533710|NCT03049813|65686694|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
23533711|NCT03049813|65686691|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
23533712|NCT03049813|65686692|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
23533713|NCT03049813|65686693|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
23533714|NCT03049813|65686694|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
23614794|NCT01697592|65976267|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23208129|NCT02862548|64500853|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
23533715|NCT01340976|65686695|FG000|Overall Study|Physician Decision|2|||
23533716|NCT01340976|65686696|FG001|Overall Study|Physician Decision|0|||
23533717|NCT01340976|65686697|FG002|Overall Study|Physician Decision|1|||
23533718|NCT01340976|65686698|FG003|Overall Study|Physician Decision|1|||
23533719|NCT01340976|65686699|FG004|Overall Study|Physician Decision|1|||
23533720|NCT01340976|65686700|FG005|Overall Study|Physician Decision|0|||
23533721|NCT01340976|65686695|FG000|Overall Study|Death|0|||
23533722|NCT01340976|65686696|FG001|Overall Study|Death|1|||
23533723|NCT01340976|65686697|FG002|Overall Study|Death|0|||
23533724|NCT01340976|65686698|FG003|Overall Study|Death|0|||
23533725|NCT01340976|65686699|FG004|Overall Study|Death|0|||
23533726|NCT01340976|65686700|FG005|Overall Study|Death|0|||
23533727|NCT01340976|65686695|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
23533728|NCT01340976|65686696|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533729|NCT01340976|65686697|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533730|NCT01340976|65686698|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533731|NCT01340976|65686699|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533732|NCT01340976|65686700|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
23533733|NCT01340976|65686695|FG000|Overall Study|Withdrawal by Subject|0|||
23533734|NCT01340976|65686696|FG001|Overall Study|Withdrawal by Subject|0|||
23533735|NCT01340976|65686697|FG002|Overall Study|Withdrawal by Subject|0|||
23533736|NCT01340976|65686698|FG003|Overall Study|Withdrawal by Subject|1|||
23533737|NCT01340976|65686699|FG004|Overall Study|Withdrawal by Subject|1|||
23533738|NCT01340976|65686700|FG005|Overall Study|Withdrawal by Subject|0|||
23533739|NCT01340976|65686695|FG000|Overall Study|Other anemia treatment|1|||
23533740|NCT01340976|65686696|FG001|Overall Study|Other anemia treatment|0|||
23533741|NCT01340976|65686697|FG002|Overall Study|Other anemia treatment|2|||
23533742|NCT01340976|65686698|FG003|Overall Study|Other anemia treatment|1|||
23533743|NCT01340976|65686699|FG004|Overall Study|Other anemia treatment|0|||
23533744|NCT01340976|65686700|FG005|Overall Study|Other anemia treatment|1|||
23533745|NCT01340976|65686695|FG000|Overall Study|Adverse Event|0|||
23533746|NCT01340976|65686696|FG001|Overall Study|Adverse Event|1|||
23533747|NCT01340976|65686697|FG002|Overall Study|Adverse Event|0|||
23533748|NCT01340976|65686698|FG003|Overall Study|Adverse Event|0|||
23533749|NCT01340976|65686699|FG004|Overall Study|Adverse Event|0|||
23533750|NCT01340976|65686700|FG005|Overall Study|Adverse Event|0|||
23533751|NCT01282216|65686701|FG000|Overall Study|Graft failure|0|||
23533752|NCT01282216|65686702|FG001|Overall Study|Graft failure|0|||
23533753|NCT01282216|65686703|FG002|Overall Study|Graft failure|3|||
23533754|NCT01282216|65686704|FG003|Overall Study|Graft failure|2|||
23533755|NCT01282216|65686701|FG000|Overall Study|Physician Decision|0|||
23533756|NCT01282216|65686702|FG001|Overall Study|Physician Decision|0|||
23533757|NCT01282216|65686703|FG002|Overall Study|Physician Decision|11|||
23533758|NCT01282216|65686704|FG003|Overall Study|Physician Decision|0|||
23533759|NCT01282216|65686701|FG000|Overall Study|Relapse|0|||
23533760|NCT01282216|65686702|FG001|Overall Study|Relapse|0|||
23533761|NCT01282216|65686703|FG002|Overall Study|Relapse|17|||
23533762|NCT01282216|65686704|FG003|Overall Study|Relapse|6|||
23533763|NCT01282216|65686701|FG000|Overall Study|Death|0|||
23533764|NCT01282216|65686702|FG001|Overall Study|Death|0|||
23533765|NCT01282216|65686703|FG002|Overall Study|Death|2|||
23533766|NCT01282216|65686704|FG003|Overall Study|Death|0|||
23533767|NCT01707004|65686705|FG000|Overall Study|Physician Decision|3|||
23533768|NCT02550652|65686708|FG000|Overall Study|Death|1|||
23533769|NCT02550652|65686709|FG001|Overall Study|Death|4|||
23533770|NCT02550652|65686708|FG000|Overall Study|Lack of Efficacy|1|||
23533771|NCT02550652|65686709|FG001|Overall Study|Lack of Efficacy|0|||
23533772|NCT02550652|65686708|FG000|Overall Study|Withdrawal by Subject|4|||
23533773|NCT02550652|65686709|FG001|Overall Study|Withdrawal by Subject|7|||
23533774|NCT02550652|65686708|FG000|Overall Study|Post Trial Access|1|||
23533775|NCT02550652|65686709|FG001|Overall Study|Post Trial Access|0|||
23533776|NCT02550652|65686708|FG000|Overall Study|Lost to Follow-up|1|||
23533777|NCT02550652|65686709|FG001|Overall Study|Lost to Follow-up|3|||
23533778|NCT02550652|65686708|FG000|Overall Study|Physician Decision|0|||
23533779|NCT02550652|65686709|FG001|Overall Study|Physician Decision|2|||
23533780|NCT02550652|65686708|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
23533781|NCT02550652|65686709|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
23533782|NCT00048724|65686710|FG000|Overall Study|Adverse Event|53|||
23533783|NCT00048724|65686711|FG001|Overall Study|Adverse Event|12|||
23533784|NCT00048724|65686710|FG000|Overall Study|Withdrawal by Subject|34|||
23533785|NCT00048724|65686711|FG001|Overall Study|Withdrawal by Subject|54|||
23533786|NCT00048724|65686710|FG000|Overall Study|Lost to Follow-up|5|||
23533787|NCT00048724|65686711|FG001|Overall Study|Lost to Follow-up|5|||
23533788|NCT00048724|65686710|FG000|Overall Study|Protocol-defined Clinical Event|17|||
23533789|NCT00048724|65686711|FG001|Overall Study|Protocol-defined Clinical Event|32|||
23533790|NCT00048724|65686710|FG000|Overall Study|Noncompliance With Protocol|4|||
23533791|NCT00048724|65686711|FG001|Overall Study|Noncompliance With Protocol|12|||
23533792|NCT00048724|65686710|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
23614795|NCT01697592|65976268|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
23614796|NCT01697592|65976269|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614797|NCT01697592|65976270|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614798|NCT01697592|65976271|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614799|NCT01697592|65976272|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614800|NCT01697592|65976273|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614801|NCT01697592|65976274|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
23614802|NCT01697592|65976265|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
23614803|NCT01697592|65976266|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614804|NCT01697592|65976267|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614805|NCT01697592|65976268|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614806|NCT01697592|65976269|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614807|NCT01697592|65976270|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
23614808|NCT01697592|65976271|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614809|NCT01697592|65976272|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
23614810|NCT01697592|65976273|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614811|NCT01697592|65976274|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
23614812|NCT01697592|65976265|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
23614813|NCT01697592|65976266|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
23614814|NCT01697592|65976267|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
23614815|NCT01697592|65976268|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
23614816|NCT01697592|65976269|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
23614817|NCT01697592|65976270|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
23614818|NCT01697592|65976271|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
23614819|NCT01697592|65976272|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
23614820|NCT01697592|65976273|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
23614821|NCT01697592|65976274|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
23614822|NCT00930644|65976277|FG000|Overall Study|Withdrawal by Subject|4|||
23614823|NCT00930644|65976277|FG000|Overall Study|Physician Decision|2|||
23614824|NCT00930644|65976277|FG000|Overall Study|Death|1|||
23614825|NCT00930644|65976277|FG000|Overall Study|Adverse Event|16|||
23614826|NCT00449033|65976278|FG000|Treatment Period|Adverse Event|117|||
23614827|NCT00449033|65976279|FG001|Treatment Period|Adverse Event|83|||
23614828|NCT00449033|65976278|FG000|Treatment Period|Death|21|||
23614829|NCT00449033|65976279|FG001|Treatment Period|Death|12|||
23614830|NCT00449033|65976278|FG000|Treatment Period|Lost to Follow-up|0|||
23614831|NCT00449033|65976279|FG001|Treatment Period|Lost to Follow-up|2|||
23614832|NCT00449033|65976278|FG000|Treatment Period|Physician Decision|4|||
23614833|NCT00449033|65976279|FG001|Treatment Period|Physician Decision|5|||
23614834|NCT00449033|65976278|FG000|Treatment Period|Protocol Violation|8|||
23614835|NCT00449033|65976279|FG001|Treatment Period|Protocol Violation|7|||
23614836|NCT00449033|65976278|FG000|Treatment Period|Disease Progression|231|||
23614837|NCT00449033|65976279|FG001|Treatment Period|Disease Progression|288|||
23614838|NCT00449033|65976278|FG000|Treatment Period|Consent Withdrawn|36|||
23614839|NCT00449033|65976279|FG001|Treatment Period|Consent Withdrawn|20|||
23614840|NCT00449033|65976278|FG000|Treatment Period|Amended Protocol Criteria|22|||
23614841|NCT00449033|65976279|FG001|Treatment Period|Amended Protocol Criteria|18|||
23614842|NCT00449033|65976278|FG000|Treatment Period|Non-compliance|7|||
23614843|NCT00449033|65976279|FG001|Treatment Period|Non-compliance|8|||
23614844|NCT00449033|65976278|FG000|Treatment Period|Second Malignancy|0|||
23614845|NCT00449033|65976279|FG001|Treatment Period|Second Malignancy|1|||
23614846|NCT00449033|65976278|FG000|Treatment Period|Reason Missing|0|||
23614847|NCT00449033|65976279|FG001|Treatment Period|Reason Missing|4|||
23614848|NCT00449033|65976278|FG000|Treatment Period|Treatment Ongoing|6|||
23614849|NCT00449033|65976279|FG001|Treatment Period|Treatment Ongoing|4|||
23614850|NCT00449033|65976278|FG000|Follow-up Period|Death|299|||
23614851|NCT00449033|65976279|FG001|Follow-up Period|Death|311|||
23614852|NCT00449033|65976278|FG000|Follow-up Period|Lost to Follow-up|6|||
23614853|NCT00449033|65976279|FG001|Follow-up Period|Lost to Follow-up|10|||
23614854|NCT00449033|65976278|FG000|Follow-up Period|Reason Missing|120|||
23614855|NCT00449033|65976279|FG001|Follow-up Period|Reason Missing|113|||
23614856|NCT00788671|65976280|FG000|Overall Study|Death|2|||
23614857|NCT00788671|65976280|FG000|Overall Study|Unable to biopsy|1|||
23208130|NCT02862548|64500852|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
23614858|NCT00788671|65976280|FG000|Overall Study|Withdrawal by Subject|4|||
23614859|NCT00788671|65976280|FG000|Overall Study|IUD expulsed|1|||
23614860|NCT00788671|65976280|FG000|Overall Study|Lost to follow up|2|||
23614861|NCT01951105|65976281|FG000|Overall Study|Adverse Event|0|||
23614862|NCT01951105|65976282|FG001|Overall Study|Adverse Event|5|||
23614863|NCT01951105|65976283|FG002|Overall Study|Adverse Event|0|||
23614864|NCT01951105|65976281|FG000|Overall Study|Lost to Follow-up|0|||
23614865|NCT01951105|65976282|FG001|Overall Study|Lost to Follow-up|1|||
23614866|NCT01951105|65976283|FG002|Overall Study|Lost to Follow-up|0|||
23614867|NCT01951105|65976281|FG000|Overall Study|Protocol Violation|1|||
23614868|NCT01951105|65976282|FG001|Overall Study|Protocol Violation|1|||
23310550|NCT04590040|64881537|FG000|Treatment Period|Lost to Follow-up|2|||
23310551|NCT04590040|64881538|FG001|Treatment Period|Lost to Follow-up|5|||
23310552|NCT04590040|64881539|FG002|Treatment Period|Lost to Follow-up|0|||
23310553|NCT04590040|64881537|FG000|Treatment Period|Physician Decision|0|||
23310554|NCT04590040|64881538|FG001|Treatment Period|Physician Decision|0|||
23310555|NCT04590040|64881539|FG002|Treatment Period|Physician Decision|2|||
23310556|NCT01468818|64881540|FG000|Overall Study|Death during treatment|2|||
23310557|NCT02049450|64881541|FG000|Overall Study|Adverse Event|2|||
23310558|NCT02049450|64881541|FG000|Overall Study|Withdrawal by Subject|1|||
23310559|NCT02049450|64881541|FG000|Overall Study|Patients/guardian decision|1|||
23310560|NCT00205803|64881543|FG000|Infant Series|Lost to Follow-up|10|||
23310561|NCT00205803|64881544|FG001|Infant Series|Lost to Follow-up|4|||
23310562|NCT00205803|64881543|FG000|Infant Series|Withdrawal by Subject|2|||
23310563|NCT00205803|64881544|FG001|Infant Series|Withdrawal by Subject|5|||
23310564|NCT00205803|64881543|FG000|Infant Series|Physician Decision|3|||
23310565|NCT00205803|64881544|FG001|Infant Series|Physician Decision|1|||
23310566|NCT00205803|64881543|FG000|Infant Series|Protocol Violation|1|||
23533793|NCT00048724|65686711|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
23533794|NCT00048724|65686710|FG000|Overall Study|Administrative|1|||
23310567|NCT00205803|64881544|FG001|Infant Series|Protocol Violation|0|||
23310568|NCT00205803|64881543|FG000|Infant Series|Lost Kaiser coverage|0|||
23310569|NCT00205803|64881544|FG001|Infant Series|Lost Kaiser coverage|1|||
23310570|NCT00205803|64881543|FG000|Infant Series|Non-compliant|1|||
23310571|NCT00205803|64881544|FG001|Infant Series|Non-compliant|0|||
23310572|NCT00205803|64881543|FG000|Infant Series|Sponsor request|1|||
23310573|NCT00205803|64881544|FG001|Infant Series|Sponsor request|0|||
23310574|NCT00205803|64881543|FG000|After Infant Series|Adverse Event|1|||
23533795|NCT00048724|65686711|FG001|Overall Study|Administrative|1|||
23533796|NCT00773175|65686712|FG000|Overall Study|Adverse Event|2|||
23533797|NCT00773175|65686713|FG001|Overall Study|Adverse Event|0|||
23533798|NCT00773175|65686712|FG000|Overall Study|Consent Withdrawn|0|||
23533799|NCT00773175|65686713|FG001|Overall Study|Consent Withdrawn|2|||
23582177|NCT02223793|65862352|FG001|Overall Study|Moved/studycenter unable to participate|6|||
23582178|NCT02223793|65862353|FG002|Overall Study|Moved/studycenter unable to participate|8|||
23582179|NCT02219490|65862354|FG000|Overall Study|Adverse Event|24|||
23310575|NCT00205803|64881544|FG001|After Infant Series|Adverse Event|1|||
23310576|NCT00205803|64881543|FG000|After Infant Series|Protocol Violation|1|||
23310577|NCT00205803|64881544|FG001|After Infant Series|Protocol Violation|1|||
23310578|NCT00205803|64881543|FG000|After Infant Series|Lost to Follow-up|2|||
23421804|NCT03920293|65288300|FG000|Randomized-Controlled Period|Adverse Event|0|||
23421805|NCT03920293|65288301|FG001|Randomized-Controlled Period|Adverse Event|2|||
23421806|NCT03920293|65288300|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
23421807|NCT03920293|65288301|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
23421808|NCT03920293|65288300|FG000|Randomized-Controlled Period|Death|2|||
23421809|NCT03920293|65288301|FG001|Randomized-Controlled Period|Death|0|||
23421810|NCT03920293|65288300|FG000|Randomized-Controlled Period|Protocol Violation|1|||
23421811|NCT03920293|65288301|FG001|Randomized-Controlled Period|Protocol Violation|0|||
23421812|NCT03920293|65288300|FG000|Randomized-Controlled Period|Noncompliance|1|||
23421813|NCT03920293|65288301|FG001|Randomized-Controlled Period|Noncompliance|0|||
23421814|NCT03920293|65288300|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
23421815|NCT03920293|65288301|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
23421816|NCT03920293|65288300|FG000|Open- Label Extension Period|Death|3|||
23421817|NCT03920293|65288301|FG001|Open- Label Extension Period|Death|3|||
23421818|NCT03920293|65288300|FG000|Open- Label Extension Period|Physician Decision|5|||
23421819|NCT03920293|65288301|FG001|Open- Label Extension Period|Physician Decision|3|||
23421820|NCT03920293|65288300|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
23421821|NCT03920293|65288301|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
23421822|NCT02374814|65288302|FG000|Overall Study|Lost to Follow-up|1|||
23421823|NCT02374814|65288303|FG001|Overall Study|Lost to Follow-up|1|||
23421824|NCT02374814|65288304|FG002|Overall Study|Lost to Follow-up|0|||
23421825|NCT02374814|65288305|FG003|Overall Study|Lost to Follow-up|1|||
23421826|NCT02374814|65288306|FG004|Overall Study|Lost to Follow-up|0|||
23421827|NCT02374814|65288307|FG005|Overall Study|Lost to Follow-up|0|||
23421828|NCT02374814|65288302|FG000|Overall Study|Withdrawal by Subject|0|||
23582180|NCT02219490|65862354|FG000|Overall Study|Withdrew consent|96|||
23310579|NCT00205803|64881544|FG001|After Infant Series|Lost to Follow-up|1|||
23310580|NCT00205803|64881543|FG000|After Infant Series|Physician Decision|3|||
23582181|NCT02219490|65862354|FG000|Overall Study|Lost to Follow-up|126|||
23582182|NCT02219490|65862354|FG000|Overall Study|COVID-19 infection|2|||
23614869|NCT01951105|65976283|FG002|Overall Study|Protocol Violation|1|||
23310581|NCT00205803|64881544|FG001|After Infant Series|Physician Decision|2|||
23310582|NCT00205803|64881543|FG000|After Infant Series|Withdrawal by Subject|1|||
23310583|NCT00205803|64881544|FG001|After Infant Series|Withdrawal by Subject|4|||
23310584|NCT00205803|64881543|FG000|After Infant Series|Other|10|||
23310585|NCT00205803|64881544|FG001|After Infant Series|Other|4|||
23421829|NCT02374814|65288303|FG001|Overall Study|Withdrawal by Subject|0|||
23421830|NCT02374814|65288304|FG002|Overall Study|Withdrawal by Subject|1|||
23421831|NCT02374814|65288305|FG003|Overall Study|Withdrawal by Subject|1|||
23421832|NCT02374814|65288306|FG004|Overall Study|Withdrawal by Subject|0|||
23421833|NCT02374814|65288307|FG005|Overall Study|Withdrawal by Subject|0|||
23421834|NCT05659719|65288308|FG000|Overall Study|At sponsor's request|0|||
23421835|NCT05659719|65288309|FG001|Overall Study|At sponsor's request|0|||
23421836|NCT05659719|65288310|FG002|Overall Study|At sponsor's request|0|||
23421837|NCT05659719|65288311|FG003|Overall Study|At sponsor's request|95|||
23421838|NCT05659719|65288308|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
23421839|NCT05659719|65288309|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
23421840|NCT05659719|65288310|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
23421841|NCT05659719|65288311|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
23421842|NCT05659719|65288308|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
23421843|NCT05659719|65288309|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
23421844|NCT05659719|65288310|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
23421845|NCT05659719|65288311|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
23421846|NCT05659719|65288308|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
23421847|NCT05659719|65288309|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
23421848|NCT05659719|65288310|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
23421849|NCT05659719|65288311|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
23421850|NCT05659719|65288308|FG000|Overall Study|Lost to Follow-up|0|||
23421851|NCT05659719|65288309|FG001|Overall Study|Lost to Follow-up|0|||
23421852|NCT05659719|65288310|FG002|Overall Study|Lost to Follow-up|0|||
23421853|NCT05659719|65288311|FG003|Overall Study|Lost to Follow-up|2|||
23421854|NCT05659719|65288308|FG000|Overall Study|Moved to another observational study|0|||
23421855|NCT05659719|65288309|FG001|Overall Study|Moved to another observational study|0|||
23421856|NCT05659719|65288310|FG002|Overall Study|Moved to another observational study|0|||
23421857|NCT05659719|65288311|FG003|Overall Study|Moved to another observational study|1|||
23421858|NCT05659719|65288308|FG000|Overall Study|The child was enrolled in an interventional study|0|||
23421859|NCT05659719|65288309|FG001|Overall Study|The child was enrolled in an interventional study|0|||
23421860|NCT05659719|65288310|FG002|Overall Study|The child was enrolled in an interventional study|0|||
23421861|NCT05659719|65288311|FG003|Overall Study|The child was enrolled in an interventional study|55|||
23421862|NCT05659719|65288308|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
23421863|NCT05659719|65288309|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
23421864|NCT05659719|65288310|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
23421865|NCT05659719|65288311|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
23421866|NCT05659719|65288308|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
23421867|NCT05659719|65288309|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
23421868|NCT05659719|65288310|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
23421869|NCT05659719|65288311|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
23421870|NCT00470093|65288312|FG000|Overall Study|Adverse Event|2|||
23421871|NCT05438602|65288315|FG000|Treatment (15 Days)|Adverse Event|2|||
23421872|NCT05438602|65288316|FG001|Treatment (15 Days)|Adverse Event|1|||
23421873|NCT05438602|65288317|FG002|Treatment (15 Days)|Adverse Event|3|||
23421874|NCT05438602|65288315|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
23421875|NCT05438602|65288316|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
23533800|NCT03769116|65689242|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
23533801|NCT03769116|65689243|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
23533802|NCT03769116|65689242|FG000|Part 3 - Open Label|Physician Decision|1|||
23533803|NCT03769116|65689243|FG001|Part 3 - Open Label|Physician Decision|0|||
23533804|NCT03769116|65689242|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
23533805|NCT03769116|65689243|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
23533806|NCT03514485|65689248|FG000|Overall Study|Lost to Follow-up|5|||
23533807|NCT03514485|65689249|FG001|Overall Study|Lost to Follow-up|3|||
23533808|NCT03514485|65689250|FG002|Overall Study|Lost to Follow-up|2|||
23533809|NCT03514485|65689251|FG003|Overall Study|Lost to Follow-up|0|||
23533810|NCT03514485|65689252|FG004|Overall Study|Lost to Follow-up|1|||
23533811|NCT03514485|65689253|FG005|Overall Study|Lost to Follow-up|4|||
23533812|NCT03514485|65689248|FG000|Overall Study|Withdrawal by Subject|0|||
23533813|NCT03514485|65689249|FG001|Overall Study|Withdrawal by Subject|1|||
23533814|NCT03514485|65689250|FG002|Overall Study|Withdrawal by Subject|3|||
23310586|NCT00205803|64881543|FG000|Toddler Dose|Lost to Follow-up|2|||
23421876|NCT05438602|65288317|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
23421877|NCT05438602|65288315|FG000|Treatment (15 Days)|Other|0|||
23421878|NCT05438602|65288316|FG001|Treatment (15 Days)|Other|0|||
23421879|NCT05438602|65288317|FG002|Treatment (15 Days)|Other|1|||
23421880|NCT05438602|65288315|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
23421881|NCT05438602|65288316|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
23421882|NCT05438602|65288317|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
23421883|NCT05438602|65288315|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
23421884|NCT05438602|65288316|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
23421885|NCT05438602|65288317|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
23421886|NCT05438602|65288315|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
23421887|NCT05438602|65288316|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
23421888|NCT05438602|65288317|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
23421889|NCT05438602|65288315|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
23421890|NCT05438602|65288316|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
23421891|NCT05438602|65288317|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
23421892|NCT05438602|65288315|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
23421893|NCT05438602|65288316|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
23421894|NCT05438602|65288317|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
23421895|NCT05438602|65288315|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
23421896|NCT05438602|65288316|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
23421897|NCT05438602|65288317|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
23421898|NCT05438602|65288315|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
23421899|NCT05438602|65288316|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
23421900|NCT05438602|65288317|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
23421901|NCT00996281|65288328|FG000|Overall Study|Adverse Event|75|||
23421902|NCT00996281|65288329|FG001|Overall Study|Adverse Event|37|||
23421903|NCT00996281|65288328|FG000|Overall Study|Major Protocol Deviation|6|||
23421904|NCT00996281|65288329|FG001|Overall Study|Major Protocol Deviation|7|||
23421905|NCT00996281|65288328|FG000|Overall Study|Lost to Follow-up|14|||
23421906|NCT00996281|65288329|FG001|Overall Study|Lost to Follow-up|16|||
23421907|NCT00996281|65288328|FG000|Overall Study|Withdrawal by Subject|31|||
23421908|NCT00996281|65288329|FG001|Overall Study|Withdrawal by Subject|20|||
23533815|NCT03514485|65689251|FG003|Overall Study|Withdrawal by Subject|1|||
23533816|NCT03514485|65689252|FG004|Overall Study|Withdrawal by Subject|2|||
23533817|NCT03514485|65689253|FG005|Overall Study|Withdrawal by Subject|1|||
23533818|NCT04310397|65689258|FG000|Overall Study|Lack of Efficacy|3|||
23533819|NCT04310397|65689258|FG000|Overall Study|Withdrawal by Subject|1|||
23421909|NCT00996281|65288328|FG000|Overall Study|Lack of Efficacy|0|||
23310587|NCT00205803|64881544|FG001|Toddler Dose|Lost to Follow-up|3|||
23421910|NCT00996281|65288329|FG001|Overall Study|Lack of Efficacy|2|||
23421911|NCT00996281|65288328|FG000|Overall Study|Other|5|||
23421912|NCT00996281|65288329|FG001|Overall Study|Other|7|||
23421913|NCT00835640|65288330|FG000|Second Intervention|Protocol Violation|1|||
23421914|NCT00835640|65288331|FG001|Second Intervention|Protocol Violation|0|||
23421915|NCT00223808|65288335|FG000|Overall Study|<5 hrs therapy before discharge|3|||
23421916|NCT00223808|65288336|FG001|Overall Study|<5 hrs therapy before discharge|5|||
23421917|NCT00223808|65288337|FG002|Overall Study|<5 hrs therapy before discharge|5|||
23421918|NCT02999477|65288338|FG000|Overall Study|found ineligible after first dose|0|||
23421919|NCT02999477|65288339|FG001|Overall Study|found ineligible after first dose|1|||
23421920|NCT02999477|65288338|FG000|Overall Study|Withdrawal by Subject|1|||
23421921|NCT02999477|65288339|FG001|Overall Study|Withdrawal by Subject|1|||
23421922|NCT00515294|65288342|FG000|Overall Study|Lost to Follow-up|3|||
23421923|NCT00515294|65288343|FG001|Overall Study|Lost to Follow-up|2|||
23421924|NCT00515294|65288344|FG002|Overall Study|Lost to Follow-up|3|||
23421925|NCT00515294|65288345|FG003|Overall Study|Lost to Follow-up|1|||
23421926|NCT00515294|65288342|FG000|Overall Study|Driver simulator problems|1|||
23421927|NCT00515294|65288343|FG001|Overall Study|Driver simulator problems|1|||
23421928|NCT00515294|65288344|FG002|Overall Study|Driver simulator problems|1|||
23421929|NCT00515294|65288345|FG003|Overall Study|Driver simulator problems|3|||
23533820|NCT03362190|65689259|FG000|Overall Study|Adverse Event|0|||
23533821|NCT03362190|65689260|FG001|Overall Study|Adverse Event|0|||
23533822|NCT03362190|65689261|FG002|Overall Study|Adverse Event|0|||
23533823|NCT03362190|65689262|FG003|Overall Study|Adverse Event|1|||
23533824|NCT03362190|65689259|FG000|Overall Study|Withdrawal by Subject|0|||
23533825|NCT03362190|65689260|FG001|Overall Study|Withdrawal by Subject|0|||
23533826|NCT03362190|65689261|FG002|Overall Study|Withdrawal by Subject|0|||
23310588|NCT00326963|64881545|FG000|Overall Study|Adverse Event|2|||
23310589|NCT00326963|64881545|FG000|Overall Study|Injection site reaction|1|||
23533827|NCT03362190|65689262|FG003|Overall Study|Withdrawal by Subject|1|||
23421930|NCT00515294|65288342|FG000|Overall Study|Caffeine amount inaccurate|5|||
23421931|NCT00515294|65288343|FG001|Overall Study|Caffeine amount inaccurate|0|||
23533828|NCT04101526|65689263|FG000|Overall Study|Did not complete all sleep diary entries|0|||
23310590|NCT00326963|64881545|FG000|Overall Study|Death|1|||
23421932|NCT00515294|65288344|FG002|Overall Study|Caffeine amount inaccurate|7|||
23421933|NCT00515294|65288345|FG003|Overall Study|Caffeine amount inaccurate|0|||
23421934|NCT03176472|65288346|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
23421935|NCT03176472|65288347|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
23421936|NCT03176472|65288346|FG000|Double Blind Treatment Period|Adverse Event|0|||
23421937|NCT03176472|65288347|FG001|Double Blind Treatment Period|Adverse Event|5|||
23421938|NCT03176472|65288346|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
23421939|NCT03176472|65288347|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23421940|NCT03176472|65288346|FG000|Double Blind Treatment Period|Physician Decision|0|||
23421941|NCT03176472|65288347|FG001|Double Blind Treatment Period|Physician Decision|1|||
23421942|NCT03176472|65288346|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23421943|NCT03176472|65288347|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23421944|NCT03176472|65288346|FG000|Double Blind Treatment Period|Not Provided|1|||
23421945|NCT03176472|65288347|FG001|Double Blind Treatment Period|Not Provided|0|||
23421946|NCT03176472|65288346|FG000|Open Label Extension|Withdrawal by Subject|3|||
23421947|NCT03176472|65288347|FG001|Open Label Extension|Withdrawal by Subject|4|||
23421948|NCT03176472|65288346|FG000|Open Label Extension|Adverse Event|2|||
23421949|NCT03176472|65288347|FG001|Open Label Extension|Adverse Event|4|||
23421950|NCT03176472|65288346|FG000|Open Label Extension|Lost to Follow-up|1|||
23421951|NCT03176472|65288347|FG001|Open Label Extension|Lost to Follow-up|2|||
23421952|NCT03176472|65288346|FG000|Open Label Extension|Protocol Violation|0|||
23421953|NCT03176472|65288347|FG001|Open Label Extension|Protocol Violation|1|||
23421954|NCT03176472|65288346|FG000|Open Label Extension|Not Provided|2|||
23421955|NCT03176472|65288347|FG001|Open Label Extension|Not Provided|1|||
23421956|NCT04753658|65288349|FG000|Overall Study|Progressive disease|7|||
23421957|NCT04753658|65288349|FG000|Overall Study|Other|7|||
23421958|NCT04753658|65288349|FG000|Overall Study|Adverse Event|1|||
23421959|NCT01328535|65288350|FG000|Overall Study|Ineligible|1|||
23421960|NCT00613925|65288351|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
23421961|NCT00613925|65288352|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
23421962|NCT02088073|65288355|FG000|Acute Phase|Withdrawal by Subject|5|||
23421963|NCT02088073|65288356|FG001|Acute Phase|Withdrawal by Subject|0|||
23421964|NCT02088073|65288357|FG002|Acute Phase|Withdrawal by Subject|0|||
23421965|NCT02088073|65288358|FG003|Acute Phase|Withdrawal by Subject|0|||
23421966|NCT02088073|65288359|FG004|Acute Phase|Withdrawal by Subject|0|||
23421967|NCT02088073|65288355|FG000|Acute Phase|Hyperkalemia|2|||
23421968|NCT02088073|65288356|FG001|Acute Phase|Hyperkalemia|0|||
23421969|NCT02088073|65288357|FG002|Acute Phase|Hyperkalemia|0|||
23421970|NCT02088073|65288358|FG003|Acute Phase|Hyperkalemia|0|||
23421971|NCT02088073|65288359|FG004|Acute Phase|Hyperkalemia|0|||
23421972|NCT02088073|65288355|FG000|Maintanance Phase|Withdrawal by Subject|0|||
23421973|NCT02088073|65288356|FG001|Maintanance Phase|Withdrawal by Subject|2|||
23421974|NCT02088073|65288357|FG002|Maintanance Phase|Withdrawal by Subject|0|||
23421975|NCT02088073|65288358|FG003|Maintanance Phase|Withdrawal by Subject|0|||
23421976|NCT02088073|65288359|FG004|Maintanance Phase|Withdrawal by Subject|0|||
23421977|NCT02088073|65288355|FG000|Maintanance Phase|Adverse Event|0|||
23421978|NCT02088073|65288356|FG001|Maintanance Phase|Adverse Event|0|||
23421979|NCT02088073|65288357|FG002|Maintanance Phase|Adverse Event|3|||
23421980|NCT02088073|65288358|FG003|Maintanance Phase|Adverse Event|0|||
23421981|NCT02088073|65288359|FG004|Maintanance Phase|Adverse Event|1|||
23421982|NCT02088073|65288355|FG000|Maintanance Phase|Physician Decision|0|||
23421983|NCT02088073|65288356|FG001|Maintanance Phase|Physician Decision|0|||
23421984|NCT02088073|65288357|FG002|Maintanance Phase|Physician Decision|0|||
23421985|NCT02088073|65288358|FG003|Maintanance Phase|Physician Decision|0|||
23421986|NCT02088073|65288359|FG004|Maintanance Phase|Physician Decision|1|||
23421987|NCT02088073|65288355|FG000|Maintanance Phase|Sponsor's decision|0|||
23421988|NCT02088073|65288356|FG001|Maintanance Phase|Sponsor's decision|2|||
23421989|NCT02088073|65288357|FG002|Maintanance Phase|Sponsor's decision|0|||
23421990|NCT02088073|65288358|FG003|Maintanance Phase|Sponsor's decision|2|||
23421991|NCT02088073|65288359|FG004|Maintanance Phase|Sponsor's decision|1|||
23421992|NCT02088073|65288355|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
23421993|NCT02088073|65288356|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
23310591|NCT00326963|64881545|FG000|Overall Study|Failure to return|10|||
23310592|NCT00326963|64881545|FG000|Overall Study|Withdrawal by Subject|10|||
23421994|NCT02088073|65288357|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
23421995|NCT02088073|65288358|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
23421996|NCT02088073|65288359|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
23421997|NCT02088073|65288355|FG000|Maintanance Phase|Miscellaneous|0|||
23421998|NCT02088073|65288356|FG001|Maintanance Phase|Miscellaneous|2|||
23421999|NCT02088073|65288357|FG002|Maintanance Phase|Miscellaneous|1|||
23422000|NCT02088073|65288358|FG003|Maintanance Phase|Miscellaneous|2|||
23422001|NCT02088073|65288359|FG004|Maintanance Phase|Miscellaneous|1|||
23422002|NCT02088073|65288355|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
23422003|NCT02088073|65288356|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
23533829|NCT04101526|65689264|FG001|Overall Study|Did not complete all sleep diary entries|1|||
23422004|NCT02088073|65288357|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
23310593|NCT00326963|64881545|FG000|Overall Study|Refused treatment / did not cooperate|5|||
23310594|NCT00326963|64881545|FG000|Overall Study|Violation of selection criteria at entry|2|||
23310595|NCT00326963|64881545|FG000|Overall Study|Other protocol violation|1|||
23310596|NCT00326963|64881545|FG000|Overall Study|Administrative / other|1|||
23310597|NCT01635218|64881546|FG000|Overall Study|Lost to Follow-up|3|||
23422005|NCT02088073|65288358|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
23422006|NCT02088073|65288359|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
23422007|NCT02088073|65288355|FG000|Maintanance Phase|Subject compliance|0|||
23422008|NCT02088073|65288356|FG001|Maintanance Phase|Subject compliance|1|||
23422009|NCT02088073|65288357|FG002|Maintanance Phase|Subject compliance|0|||
23422010|NCT02088073|65288358|FG003|Maintanance Phase|Subject compliance|0|||
23422011|NCT02088073|65288359|FG004|Maintanance Phase|Subject compliance|0|||
23422012|NCT02701777|65288361|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
23422013|NCT02701777|65288362|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
23422014|NCT02701777|65288363|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
23422015|NCT02701777|65288364|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
23422016|NCT02701777|65288361|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
23422017|NCT02701777|65288362|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
23422018|NCT02701777|65288363|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
23422019|NCT02701777|65288364|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
23422020|NCT03894969|65288365|FG000|Overall Study|Adverse Event|0|||
23310598|NCT01635218|64881547|FG001|Overall Study|Lost to Follow-up|7|||
23310599|NCT01635218|64881548|FG002|Overall Study|Lost to Follow-up|6|||
23310600|NCT04581369|64881549|FG000|Overall Study|Death|7|||
23310601|NCT04581369|64881550|FG001|Overall Study|Death|6|||
23310602|NCT04581369|64881551|FG002|Overall Study|Death|0|||
23310603|NCT04581369|64881549|FG000|Overall Study|Lost to Follow-up|7|||
23310604|NCT04581369|64881550|FG001|Overall Study|Lost to Follow-up|3|||
23310605|NCT04581369|64881551|FG002|Overall Study|Lost to Follow-up|0|||
23422021|NCT03894969|65288366|FG001|Overall Study|Adverse Event|2|||
23422022|NCT03894969|65288367|FG002|Overall Study|Adverse Event|0|||
23422023|NCT03894969|65288368|FG003|Overall Study|Adverse Event|1|||
23422024|NCT03894969|65288369|FG004|Overall Study|Adverse Event|2|||
23422025|NCT03894969|65288365|FG000|Overall Study|Lost to Follow-up|3|||
23422026|NCT03894969|65288366|FG001|Overall Study|Lost to Follow-up|1|||
23422027|NCT03894969|65288367|FG002|Overall Study|Lost to Follow-up|1|||
23422028|NCT03894969|65288368|FG003|Overall Study|Lost to Follow-up|0|||
23422029|NCT03894969|65288369|FG004|Overall Study|Lost to Follow-up|0|||
23422030|NCT03894969|65288365|FG000|Overall Study|Withdrawal by Subject|2|||
23422031|NCT03894969|65288366|FG001|Overall Study|Withdrawal by Subject|1|||
23422032|NCT03894969|65288367|FG002|Overall Study|Withdrawal by Subject|3|||
23422033|NCT03894969|65288368|FG003|Overall Study|Withdrawal by Subject|4|||
23533830|NCT02944578|65689265|FG000|Overall Study|Physician Decision|1|||
23533831|NCT02944578|65689266|FG001|Overall Study|Physician Decision|0|||
23533832|NCT04871711|65689267|FG000|Overall Study|Withdrawal by Subject|11|||
23533833|NCT04871711|65689268|FG001|Overall Study|Withdrawal by Subject|5|||
23533834|NCT04871711|65689267|FG000|Overall Study|Lack of Efficacy|5|||
23533835|NCT04871711|65689268|FG001|Overall Study|Lack of Efficacy|7|||
23533836|NCT04871711|65689267|FG000|Overall Study|Adverse Event|2|||
23533837|NCT04871711|65689268|FG001|Overall Study|Adverse Event|6|||
23533838|NCT04871711|65689267|FG000|Overall Study|Various reasons|2|||
23533839|NCT04871711|65689268|FG001|Overall Study|Various reasons|1|||
23533840|NCT04871711|65689267|FG000|Overall Study|Lost to Follow-up|0|||
23533841|NCT04871711|65689268|FG001|Overall Study|Lost to Follow-up|2|||
23533842|NCT00680901|65689276|FG000|Overall Study|Lost to Follow-up|8|||
23533843|NCT00680901|65689277|FG001|Overall Study|Lost to Follow-up|8|||
23533844|NCT00680901|65689276|FG000|Overall Study|Withdrawal by Subject|4|||
23533845|NCT00680901|65689277|FG001|Overall Study|Withdrawal by Subject|13|||
23310606|NCT04581369|64881549|FG000|Overall Study|liver transplant|2|||
23533846|NCT00680901|65689276|FG000|Overall Study|Physician Decision|0|||
23310607|NCT04581369|64881550|FG001|Overall Study|liver transplant|2|||
23310608|NCT04581369|64881551|FG002|Overall Study|liver transplant|0|||
23310609|NCT04581369|64881549|FG000|Overall Study|transitioned to hospice care|0|||
23310610|NCT04581369|64881550|FG001|Overall Study|transitioned to hospice care|5|||
23310611|NCT04581369|64881551|FG002|Overall Study|transitioned to hospice care|0|||
23310612|NCT00985712|64881552|FG000|Overall Study|Adverse Event|0|||
23310613|NCT00985712|64881553|FG001|Overall Study|Adverse Event|1|||
23310614|NCT00985712|64881552|FG000|Overall Study|Lost to Follow-up|2|||
23310615|NCT00985712|64881553|FG001|Overall Study|Lost to Follow-up|2|||
23310616|NCT00985712|64881552|FG000|Overall Study|Protocol Violation|0|||
23310617|NCT00985712|64881553|FG001|Overall Study|Protocol Violation|1|||
23310618|NCT00985712|64881552|FG000|Overall Study|Withdrawal by Subject|4|||
23310619|NCT00985712|64881553|FG001|Overall Study|Withdrawal by Subject|1|||
23310620|NCT00985712|64881552|FG000|Overall Study|Sponsor decision|0|||
23310621|NCT00985712|64881553|FG001|Overall Study|Sponsor decision|2|||
23310622|NCT00416884|64881554|FG000|Overall Study|Study terminated due to low accrual|1|||
23310623|NCT03200912|64881555|FG000|Overall Study|Adverse Event|3|||
23310624|NCT03200912|64881556|FG001|Overall Study|Adverse Event|0|||
23310625|NCT03200912|64881557|FG002|Overall Study|Adverse Event|0|||
23310626|NCT03200912|64881555|FG000|Overall Study|Withdrawal by Subject|1|||
23310627|NCT03200912|64881556|FG001|Overall Study|Withdrawal by Subject|2|||
23310628|NCT03200912|64881557|FG002|Overall Study|Withdrawal by Subject|4|||
23310629|NCT03200912|64881555|FG000|Overall Study|Non-compliance with study drug|0|||
23310630|NCT03200912|64881556|FG001|Overall Study|Non-compliance with study drug|1|||
23310631|NCT03200912|64881557|FG002|Overall Study|Non-compliance with study drug|0|||
23310632|NCT01844856|64881558|FG000|Overall Study|Lost to Follow-up|15|||
23422034|NCT03894969|65288369|FG004|Overall Study|Withdrawal by Subject|8|||
23422035|NCT03894969|65288365|FG000|Overall Study|Other|0|||
23422036|NCT03894969|65288366|FG001|Overall Study|Other|0|||
23422037|NCT03894969|65288367|FG002|Overall Study|Other|0|||
23422038|NCT03894969|65288368|FG003|Overall Study|Other|0|||
23422039|NCT03894969|65288369|FG004|Overall Study|Other|3|||
23422040|NCT03894969|65288365|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
23422041|NCT03894969|65288366|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
23422042|NCT03894969|65288367|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
23422043|NCT03894969|65288368|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
23422044|NCT03894969|65288369|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
23422045|NCT03894969|65288365|FG000|Overall Study|Solicited Adverse Event|0|||
23422046|NCT03894969|65288366|FG001|Overall Study|Solicited Adverse Event|1|||
23422047|NCT03894969|65288367|FG002|Overall Study|Solicited Adverse Event|0|||
23422048|NCT03894969|65288368|FG003|Overall Study|Solicited Adverse Event|0|||
23422049|NCT03894969|65288369|FG004|Overall Study|Solicited Adverse Event|0|||
23422050|NCT02240368|65288374|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
23422051|NCT02240368|65288375|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
23422052|NCT02240368|65288376|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
23422053|NCT02240368|65288374|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
23422054|NCT02240368|65288375|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
23422055|NCT02240368|65288376|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
23422056|NCT02298179|65288377|FG000|Overall Study|Lost to Follow-up|0|||
23422057|NCT02298179|65288378|FG001|Overall Study|Lost to Follow-up|0|||
23422058|NCT02298179|65288379|FG002|Overall Study|Lost to Follow-up|1|||
23422059|NCT02298179|65288380|FG003|Overall Study|Lost to Follow-up|0|||
23422060|NCT02298179|65288381|FG004|Overall Study|Lost to Follow-up|0|||
23422061|NCT02298179|65288382|FG005|Overall Study|Lost to Follow-up|0|||
23422062|NCT02298179|65288383|FG006|Overall Study|Lost to Follow-up|0|||
23422063|NCT02298179|65288384|FG007|Overall Study|Lost to Follow-up|1|||
23422064|NCT02298179|65288385|FG008|Overall Study|Lost to Follow-up|0|||
23422065|NCT02298179|65288386|FG009|Overall Study|Lost to Follow-up|0|||
23422066|NCT02298179|65288387|FG010|Overall Study|Lost to Follow-up|0|||
23422067|NCT02298179|65288388|FG011|Overall Study|Lost to Follow-up|0|||
23422068|NCT02403635|65288400|FG000|Overall Study|Not eligible|9|||
23422069|NCT03895086|65288406|FG000|Overall Study|Early termination study|1|||
23422070|NCT03895086|65288407|FG001|Overall Study|Early termination study|0|||
23422071|NCT04606199|65288408|FG000|Overall Study|Withdrawal by Subject|2|||
23422072|NCT01323270|65288411|FG000|Overall Study|Withdrawal by Subject|19|||
23422073|NCT01323270|65288412|FG001|Overall Study|Withdrawal by Subject|10|||
23422074|NCT01323270|65288411|FG000|Overall Study|Protocol Violation|9|||
23310633|NCT01844856|64881559|FG001|Overall Study|Lost to Follow-up|3|||
23422075|NCT01323270|65288412|FG001|Overall Study|Protocol Violation|7|||
23422076|NCT01323270|65288411|FG000|Overall Study|Lost to Follow-up|4|||
23422077|NCT01323270|65288412|FG001|Overall Study|Lost to Follow-up|6|||
23422078|NCT01323270|65288411|FG000|Overall Study|Adverse Event|8|||
23422079|NCT01323270|65288412|FG001|Overall Study|Adverse Event|0|||
23310634|NCT01844856|64881558|FG000|Overall Study|Adverse Event|3|||
23310635|NCT01844856|64881559|FG001|Overall Study|Adverse Event|6|||
23310636|NCT01844856|64881558|FG000|Overall Study|Withdrawal by Subject|3|||
23310637|NCT01844856|64881559|FG001|Overall Study|Withdrawal by Subject|2|||
23310638|NCT01844856|64881558|FG000|Overall Study|Noncompliance|2|||
23310639|NCT01844856|64881559|FG001|Overall Study|Noncompliance|3|||
23310640|NCT01844856|64881558|FG000|Overall Study|Enterococcus Resistant|0|||
23310641|NCT01844856|64881559|FG001|Overall Study|Enterococcus Resistant|1|||
23310642|NCT01844856|64881558|FG000|Overall Study|Inadvertently Not Scheduled|1|||
23310643|NCT01844856|64881559|FG001|Overall Study|Inadvertently Not Scheduled|0|||
23310644|NCT01844856|64881558|FG000|Overall Study|Randomized but was a Screen Failure|0|||
23310645|NCT01844856|64881559|FG001|Overall Study|Randomized but was a Screen Failure|1|||
23310646|NCT00987389|64881560|FG000|Overall Study|Ineligible|0|||
23310647|NCT00987389|64881561|FG001|Overall Study|Ineligible|3|||
23310648|NCT00987389|64881562|FG002|Overall Study|Ineligible|0|||
23310649|NCT00987389|64881563|FG003|Overall Study|Ineligible|0|||
23310650|NCT00987389|64881560|FG000|Overall Study|Lost to Follow-up|4|||
23310651|NCT00987389|64881561|FG001|Overall Study|Lost to Follow-up|1|||
23310652|NCT00987389|64881562|FG002|Overall Study|Lost to Follow-up|3|||
23310653|NCT00987389|64881563|FG003|Overall Study|Lost to Follow-up|1|||
23310654|NCT00987389|64881560|FG000|Overall Study|Withdrawal by Subject|4|||
23310655|NCT00987389|64881561|FG001|Overall Study|Withdrawal by Subject|3|||
23310656|NCT00987389|64881562|FG002|Overall Study|Withdrawal by Subject|2|||
23310657|NCT00987389|64881563|FG003|Overall Study|Withdrawal by Subject|1|||
23310658|NCT00987389|64881560|FG000|Overall Study|Withdrawn from Treatment|0|||
23310659|NCT00987389|64881561|FG001|Overall Study|Withdrawn from Treatment|1|||
23310660|NCT00987389|64881562|FG002|Overall Study|Withdrawn from Treatment|0|||
23310661|NCT00987389|64881563|FG003|Overall Study|Withdrawn from Treatment|0|||
23310662|NCT00987389|64881560|FG000|Overall Study|Multiple different reasons|1|||
23310663|NCT00987389|64881561|FG001|Overall Study|Multiple different reasons|0|||
23310664|NCT00987389|64881562|FG002|Overall Study|Multiple different reasons|3|||
23310665|NCT00987389|64881563|FG003|Overall Study|Multiple different reasons|1|||
23310666|NCT00912912|64881564|FG000|Overall Study|Withdrawal by Subject|1|||
23310667|NCT00912912|64881564|FG000|Overall Study|Disease Progression|3|||
23310668|NCT00554606|64881567|FG000|Overall Study|Adverse Event|3|||
23310669|NCT00554606|64881567|FG000|Overall Study|Abnormal laboratory values|1|||
23310670|NCT00554606|64881567|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
23310671|NCT00554606|64881567|FG000|Overall Study|Subject withdrew consent|2|||
23310672|NCT00554606|64881567|FG000|Overall Study|Lost to Follow-up|2|||
23310673|NCT00554606|64881567|FG000|Overall Study|Administrative problems|60|||
23310674|NCT00554606|64881567|FG000|Overall Study|Death|1|||
23310675|NCT00554606|64881567|FG000|Overall Study|Protocol deviation|2|||
23310676|NCT05819203|64881568|FG000|Overall Study|Protocol Violation|1|||
23310677|NCT05819203|64881569|FG001|Overall Study|Protocol Violation|2|||
23310678|NCT05819203|64881568|FG000|Overall Study|Withdrawal by Subject|1|||
23310679|NCT05819203|64881569|FG001|Overall Study|Withdrawal by Subject|0|||
23310680|NCT01400919|64881584|FG000|Overall Study|Withdrawal by Subject|4|||
23310681|NCT01400919|64881584|FG000|Overall Study|Lost to Follow-up|2|||
23310682|NCT01400919|64881584|FG000|Overall Study|Missed visit|2|||
23310683|NCT03210714|64886332|FG000|Overall Study|Adverse Event|6|||
23310684|NCT03210714|64886332|FG000|Overall Study|Physician Decision|1|||
23310685|NCT03210714|64886332|FG000|Overall Study|Progressive disease|11|||
23310686|NCT03210714|64886332|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
23310687|NCT03968978|64886335|FG000|Overall Study|Adverse Event|1|||
23310688|NCT03968978|64886336|FG001|Overall Study|Adverse Event|0|||
23310689|NCT00206323|64886337|FG000|Overall Study|Lack of Efficacy|4|||
23310690|NCT00206323|64886338|FG001|Overall Study|Lack of Efficacy|1|||
23310691|NCT00206323|64886337|FG000|Overall Study|Adverse Event|1|||
23310692|NCT00206323|64886338|FG001|Overall Study|Adverse Event|1|||
23422080|NCT01323270|65288411|FG000|Overall Study|Other|0|||
23422081|NCT01323270|65288412|FG001|Overall Study|Other|3|||
23422082|NCT01323270|65288411|FG000|Overall Study|Physician Decision|0|||
23422083|NCT01323270|65288412|FG001|Overall Study|Physician Decision|2|||
23422084|NCT01323270|65288411|FG000|Overall Study|Not eligible|1|||
23422085|NCT01323270|65288412|FG001|Overall Study|Not eligible|1|||
23422086|NCT01323270|65288411|FG000|Overall Study|Death|1|||
23422087|NCT01323270|65288412|FG001|Overall Study|Death|0|||
23422088|NCT01323270|65288411|FG000|Overall Study|Randomized, but not vaccinated|1|||
23422089|NCT01323270|65288412|FG001|Overall Study|Randomized, but not vaccinated|0|||
23422090|NCT03762616|65288413|FG000|Overall Study|Protocol Violation|2|||
23422091|NCT00246025|65288414|FG000|Overall Study|Adverse Event|7|||
23422092|NCT00246025|65288415|FG001|Overall Study|Adverse Event|9|||
23422093|NCT00246025|65288416|FG002|Overall Study|Adverse Event|9|||
23422094|NCT00246025|65288417|FG003|Overall Study|Adverse Event|10|||
23422095|NCT00246025|65288414|FG000|Overall Study|Withdrawal by Subject|3|||
23422096|NCT00246025|65288415|FG001|Overall Study|Withdrawal by Subject|0|||
23422097|NCT00246025|65288416|FG002|Overall Study|Withdrawal by Subject|1|||
23422098|NCT00246025|65288417|FG003|Overall Study|Withdrawal by Subject|2|||
23422099|NCT00246025|65288414|FG000|Overall Study|unsuitable medical history was found|0|||
23422100|NCT00246025|65288415|FG001|Overall Study|unsuitable medical history was found|0|||
23422101|NCT00246025|65288416|FG002|Overall Study|unsuitable medical history was found|0|||
23422102|NCT00246025|65288417|FG003|Overall Study|unsuitable medical history was found|1|||
23422103|NCT02754141|65288418|FG000|Overall Study|Disease progression|11|||
23422104|NCT02754141|65288419|FG001|Overall Study|Disease progression|7|||
23422105|NCT02754141|65288420|FG002|Overall Study|Disease progression|8|||
23422106|NCT02754141|65288421|FG003|Overall Study|Disease progression|5|||
23422107|NCT02754141|65288422|FG004|Overall Study|Disease progression|7|||
23422108|NCT02754141|65288423|FG005|Overall Study|Disease progression|7|||
23422109|NCT02754141|65288424|FG006|Overall Study|Disease progression|7|||
23422110|NCT02754141|65288425|FG007|Overall Study|Disease progression|6|||
23422111|NCT02754141|65288426|FG008|Overall Study|Disease progression|11|||
23422112|NCT02754141|65288427|FG009|Overall Study|Disease progression|16|||
23422113|NCT02754141|65288428|FG010|Overall Study|Disease progression|18|||
23422114|NCT02754141|65288429|FG011|Overall Study|Disease progression|13|||
23422115|NCT02754141|65288430|FG012|Overall Study|Disease progression|10|||
23422116|NCT02754141|65288431|FG013|Overall Study|Disease progression|12|||
23422117|NCT02754141|65288432|FG014|Overall Study|Disease progression|12|||
23422118|NCT02754141|65288433|FG015|Overall Study|Disease progression|14|||
23422119|NCT02754141|65288434|FG016|Overall Study|Disease progression|0|||
23422120|NCT02754141|65288435|FG017|Overall Study|Disease progression|1|||
23422121|NCT02754141|65288418|FG000|Overall Study|Study drug toxicity|1|||
23422122|NCT02754141|65288419|FG001|Overall Study|Study drug toxicity|1|||
23422123|NCT02754141|65288420|FG002|Overall Study|Study drug toxicity|0|||
23422124|NCT02754141|65288421|FG003|Overall Study|Study drug toxicity|0|||
23422125|NCT02754141|65288422|FG004|Overall Study|Study drug toxicity|0|||
23422126|NCT02754141|65288423|FG005|Overall Study|Study drug toxicity|0|||
23422127|NCT02754141|65288424|FG006|Overall Study|Study drug toxicity|0|||
23422128|NCT02754141|65288425|FG007|Overall Study|Study drug toxicity|0|||
23422129|NCT02754141|65288426|FG008|Overall Study|Study drug toxicity|0|||
23422130|NCT02754141|65288427|FG009|Overall Study|Study drug toxicity|0|||
23422131|NCT02754141|65288428|FG010|Overall Study|Study drug toxicity|2|||
23422132|NCT02754141|65288429|FG011|Overall Study|Study drug toxicity|1|||
23422133|NCT02754141|65288430|FG012|Overall Study|Study drug toxicity|1|||
23422134|NCT02754141|65288431|FG013|Overall Study|Study drug toxicity|0|||
23422135|NCT02754141|65288432|FG014|Overall Study|Study drug toxicity|0|||
23422136|NCT02754141|65288433|FG015|Overall Study|Study drug toxicity|0|||
23422137|NCT02754141|65288434|FG016|Overall Study|Study drug toxicity|0|||
23422138|NCT02754141|65288435|FG017|Overall Study|Study drug toxicity|0|||
23422139|NCT02754141|65288418|FG000|Overall Study|AE unrelated to study drug|1|||
23422140|NCT02754141|65288419|FG001|Overall Study|AE unrelated to study drug|1|||
23422141|NCT02754141|65288420|FG002|Overall Study|AE unrelated to study drug|0|||
23422142|NCT02754141|65288421|FG003|Overall Study|AE unrelated to study drug|1|||
23422143|NCT02754141|65288422|FG004|Overall Study|AE unrelated to study drug|3|||
23422144|NCT02754141|65288423|FG005|Overall Study|AE unrelated to study drug|2|||
23422145|NCT02754141|65288424|FG006|Overall Study|AE unrelated to study drug|1|||
23422146|NCT02754141|65288425|FG007|Overall Study|AE unrelated to study drug|0|||
23422147|NCT02754141|65288426|FG008|Overall Study|AE unrelated to study drug|0|||
23422148|NCT02754141|65288427|FG009|Overall Study|AE unrelated to study drug|0|||
23422149|NCT02754141|65288428|FG010|Overall Study|AE unrelated to study drug|0|||
23422150|NCT02754141|65288429|FG011|Overall Study|AE unrelated to study drug|0|||
23422151|NCT02754141|65288430|FG012|Overall Study|AE unrelated to study drug|0|||
23422152|NCT02754141|65288431|FG013|Overall Study|AE unrelated to study drug|0|||
23422153|NCT02754141|65288432|FG014|Overall Study|AE unrelated to study drug|0|||
23422154|NCT02754141|65288433|FG015|Overall Study|AE unrelated to study drug|0|||
23422155|NCT02754141|65288434|FG016|Overall Study|AE unrelated to study drug|0|||
23422156|NCT02754141|65288435|FG017|Overall Study|AE unrelated to study drug|0|||
23422157|NCT02754141|65288418|FG000|Overall Study|Request to discontinue|0|||
23422158|NCT02754141|65288419|FG001|Overall Study|Request to discontinue|0|||
23422159|NCT02754141|65288420|FG002|Overall Study|Request to discontinue|0|||
23422160|NCT02754141|65288421|FG003|Overall Study|Request to discontinue|0|||
23422161|NCT02754141|65288422|FG004|Overall Study|Request to discontinue|0|||
23422162|NCT02754141|65288423|FG005|Overall Study|Request to discontinue|0|||
23422163|NCT02754141|65288424|FG006|Overall Study|Request to discontinue|0|||
23422164|NCT02754141|65288425|FG007|Overall Study|Request to discontinue|0|||
23422165|NCT02754141|65288426|FG008|Overall Study|Request to discontinue|1|||
23422166|NCT02754141|65288427|FG009|Overall Study|Request to discontinue|0|||
23422167|NCT02754141|65288428|FG010|Overall Study|Request to discontinue|0|||
23422168|NCT02754141|65288429|FG011|Overall Study|Request to discontinue|0|||
23422169|NCT02754141|65288430|FG012|Overall Study|Request to discontinue|0|||
23422170|NCT02754141|65288431|FG013|Overall Study|Request to discontinue|1|||
23422171|NCT02754141|65288432|FG014|Overall Study|Request to discontinue|1|||
23422172|NCT02754141|65288433|FG015|Overall Study|Request to discontinue|0|||
23422173|NCT02754141|65288434|FG016|Overall Study|Request to discontinue|0|||
23422174|NCT02754141|65288435|FG017|Overall Study|Request to discontinue|0|||
23422175|NCT02754141|65288418|FG000|Overall Study|Withdrew consent|0|||
23422176|NCT02754141|65288419|FG001|Overall Study|Withdrew consent|0|||
23422177|NCT02754141|65288420|FG002|Overall Study|Withdrew consent|0|||
23422178|NCT02754141|65288421|FG003|Overall Study|Withdrew consent|0|||
23422179|NCT02754141|65288422|FG004|Overall Study|Withdrew consent|0|||
23422180|NCT02754141|65288423|FG005|Overall Study|Withdrew consent|0|||
23422181|NCT02754141|65288424|FG006|Overall Study|Withdrew consent|0|||
23422182|NCT02754141|65288425|FG007|Overall Study|Withdrew consent|0|||
23422183|NCT02754141|65288426|FG008|Overall Study|Withdrew consent|0|||
23422184|NCT02754141|65288427|FG009|Overall Study|Withdrew consent|1|||
23422185|NCT02754141|65288428|FG010|Overall Study|Withdrew consent|0|||
23422186|NCT02754141|65288429|FG011|Overall Study|Withdrew consent|0|||
23422187|NCT02754141|65288430|FG012|Overall Study|Withdrew consent|0|||
23422188|NCT02754141|65288431|FG013|Overall Study|Withdrew consent|0|||
23422189|NCT02754141|65288432|FG014|Overall Study|Withdrew consent|0|||
23422190|NCT02754141|65288433|FG015|Overall Study|Withdrew consent|0|||
23422191|NCT02754141|65288434|FG016|Overall Study|Withdrew consent|0|||
23422192|NCT02754141|65288435|FG017|Overall Study|Withdrew consent|0|||
23422193|NCT02754141|65288418|FG000|Overall Study|Maximum clinical benefit|0|||
23533847|NCT00680901|65689277|FG001|Overall Study|Physician Decision|1|||
23533848|NCT00680901|65689276|FG000|Overall Study|Ongoing: On Study Treatment|16|||
23533849|NCT00680901|65689277|FG001|Overall Study|Ongoing: On Study Treatment|13|||
23533850|NCT00680901|65689276|FG000|Overall Study|Ongoing: In Follow Up|45|||
23533851|NCT00680901|65689277|FG001|Overall Study|Ongoing: In Follow Up|41|||
23533852|NCT01023659|65689279|FG000|Overall Study|Lost to Follow-up|73|||
23533853|NCT01023659|65689280|FG001|Overall Study|Lost to Follow-up|228|||
23533854|NCT01023659|65689281|FG002|Overall Study|Lost to Follow-up|99|||
23533855|NCT00501540|65689283|FG000|Overall Study|Death|5|||
23533856|NCT01175382|65689284|FG000|Overall Study|Lost to Follow-up|4|||
23533857|NCT01175382|65689285|FG001|Overall Study|Lost to Follow-up|3|||
23533858|NCT01175382|65689286|FG002|Overall Study|Lost to Follow-up|1|||
23533859|NCT01175382|65689284|FG000|Overall Study|Physician Decision|0|||
23533860|NCT01175382|65689285|FG001|Overall Study|Physician Decision|1|||
23533861|NCT01175382|65689286|FG002|Overall Study|Physician Decision|0|||
23533862|NCT01175382|65689284|FG000|Overall Study|Withdrawal by Subject|0|||
23533863|NCT01175382|65689285|FG001|Overall Study|Withdrawal by Subject|0|||
23533864|NCT01175382|65689286|FG002|Overall Study|Withdrawal by Subject|1|||
23533865|NCT01175382|65689284|FG000|Overall Study|No longer having problem|1|||
23533866|NCT01175382|65689285|FG001|Overall Study|No longer having problem|0|||
23533867|NCT01175382|65689286|FG002|Overall Study|No longer having problem|1|||
23533868|NCT01175382|65689284|FG000|Overall Study|Unable/unwilling to attend visits|3|||
23533869|NCT01175382|65689285|FG001|Overall Study|Unable/unwilling to attend visits|1|||
23533870|NCT01175382|65689286|FG002|Overall Study|Unable/unwilling to attend visits|2|||
23533871|NCT01175382|65689284|FG000|Overall Study|Unwilling to follow protocol|0|||
23533872|NCT01175382|65689285|FG001|Overall Study|Unwilling to follow protocol|1|||
23533873|NCT01175382|65689286|FG002|Overall Study|Unwilling to follow protocol|0|||
23533874|NCT01175382|65689284|FG000|Overall Study|Unable to tolerate study meds|0|||
23533875|NCT01175382|65689285|FG001|Overall Study|Unable to tolerate study meds|1|||
23422194|NCT02754141|65288419|FG001|Overall Study|Maximum clinical benefit|0|||
23422195|NCT02754141|65288420|FG002|Overall Study|Maximum clinical benefit|0|||
23422196|NCT02754141|65288421|FG003|Overall Study|Maximum clinical benefit|1|||
23422197|NCT02754141|65288422|FG004|Overall Study|Maximum clinical benefit|0|||
23422198|NCT02754141|65288423|FG005|Overall Study|Maximum clinical benefit|0|||
23422199|NCT02754141|65288424|FG006|Overall Study|Maximum clinical benefit|0|||
23533876|NCT01175382|65689286|FG002|Overall Study|Unable to tolerate study meds|1|||
23533877|NCT01824303|65689287|FG000|Randomized Study|Withdrawal by Subject|1|||
23533878|NCT01824303|65689288|FG001|Randomized Study|Withdrawal by Subject|1|||
23533879|NCT01824303|65689287|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
23533880|NCT01824303|65689288|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
23310693|NCT00206323|64886337|FG000|Overall Study|Lost to Follow-up|1|||
23310694|NCT00206323|64886338|FG001|Overall Study|Lost to Follow-up|1|||
23310695|NCT04485039|64886339|FG000|TPOXX Only|Adverse Event|2|||
23310696|NCT04485039|64886339|FG000|TPOXX Only|Physician Decision|1|||
23310697|NCT04485039|64886339|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
23310698|NCT04485039|64886339|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
23310699|NCT00839254|64886342|FG000|Overall Study|Protocol Violation|0|||
23310700|NCT00839254|64886343|FG001|Overall Study|Protocol Violation|1|||
23310701|NCT00839254|64886344|FG002|Overall Study|Protocol Violation|1|||
23310702|NCT00839254|64886345|FG003|Overall Study|Protocol Violation|1|||
23310703|NCT00839254|64886346|FG004|Overall Study|Protocol Violation|0|||
23310704|NCT00839254|64886347|FG005|Overall Study|Protocol Violation|0|||
23310705|NCT00839254|64886348|FG006|Overall Study|Protocol Violation|1|||
23310706|NCT00839254|64886349|FG007|Overall Study|Protocol Violation|2|||
23310707|NCT00839254|64886342|FG000|Overall Study|Physician Decision|0|||
23310708|NCT00839254|64886343|FG001|Overall Study|Physician Decision|1|||
23310709|NCT00839254|64886344|FG002|Overall Study|Physician Decision|0|||
23310710|NCT00839254|64886345|FG003|Overall Study|Physician Decision|0|||
23310711|NCT00839254|64886346|FG004|Overall Study|Physician Decision|0|||
23310712|NCT00839254|64886347|FG005|Overall Study|Physician Decision|0|||
23310713|NCT00839254|64886348|FG006|Overall Study|Physician Decision|0|||
23310714|NCT00839254|64886349|FG007|Overall Study|Physician Decision|1|||
23533881|NCT05338502|65689291|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
23533882|NCT05338502|65689292|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
23533883|NCT05338502|65689293|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
23208131|NCT02862548|64500853|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
23208132|NCT02862548|64500852|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
23208133|NCT02862548|64500853|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
23208134|NCT00929734|64500867|FG000|Overall Study|Lost to Follow-up|2|||
23208135|NCT00929734|64500868|FG001|Overall Study|Lost to Follow-up|1|||
23533884|NCT05338502|65689291|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
23533885|NCT05338502|65689292|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
23533886|NCT05338502|65689293|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
23533887|NCT01034397|65689294|FG000|Overall Study|Lack of compliance|0|||
23533888|NCT01034397|65689295|FG001|Overall Study|Lack of compliance|1|||
23533889|NCT01034397|65689294|FG000|Overall Study|Lack of Efficacy|3|||
23533890|NCT01034397|65689295|FG001|Overall Study|Lack of Efficacy|0|||
23533891|NCT01034397|65689294|FG000|Overall Study|Adverse Event|4|||
23533892|NCT01034397|65689295|FG001|Overall Study|Adverse Event|0|||
23533893|NCT01034397|65689294|FG000|Overall Study|Other|0|||
23533894|NCT01034397|65689295|FG001|Overall Study|Other|1|||
23533895|NCT01600040|65689296|FG000|Overall Study|Withdrawal by Subject|1|||
23533896|NCT00575588|65689299|FG000|Overall Study|Adverse Event|11|||
23208136|NCT00929734|64500867|FG000|Overall Study|Withdrawal by Subject|0|||
23208137|NCT00929734|64500868|FG001|Overall Study|Withdrawal by Subject|2|||
23533897|NCT00575588|65689300|FG001|Overall Study|Adverse Event|13|||
23533898|NCT00575588|65689299|FG000|Overall Study|Withdrawal by Subject|27|||
23533899|NCT00575588|65689300|FG001|Overall Study|Withdrawal by Subject|31|||
23533900|NCT00575588|65689299|FG000|Overall Study|Lost to Follow-up|1|||
23533901|NCT00575588|65689300|FG001|Overall Study|Lost to Follow-up|3|||
23533902|NCT00575588|65689299|FG000|Overall Study|Death|4|||
23310715|NCT00839254|64886342|FG000|Overall Study|Wrong treatment number allocation|0|||
23310716|NCT00839254|64886343|FG001|Overall Study|Wrong treatment number allocation|1|||
23310717|NCT00839254|64886344|FG002|Overall Study|Wrong treatment number allocation|0|||
23310718|NCT00839254|64886345|FG003|Overall Study|Wrong treatment number allocation|0|||
23310719|NCT00839254|64886346|FG004|Overall Study|Wrong treatment number allocation|0|||
23310720|NCT00839254|64886347|FG005|Overall Study|Wrong treatment number allocation|1|||
23310721|NCT00839254|64886348|FG006|Overall Study|Wrong treatment number allocation|0|||
23310722|NCT00839254|64886349|FG007|Overall Study|Wrong treatment number allocation|0|||
23310723|NCT00839254|64886342|FG000|Overall Study|Adverse Event|12|||
23208138|NCT01441115|64500875|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
23208139|NCT02670330|64500879|FG000|Overall Study|Protocol Deviation|1|||
23208140|NCT02670330|64500880|FG001|Overall Study|Protocol Deviation|0|||
23310724|NCT00839254|64886343|FG001|Overall Study|Adverse Event|6|||
23310725|NCT00839254|64886344|FG002|Overall Study|Adverse Event|3|||
23310726|NCT00839254|64886345|FG003|Overall Study|Adverse Event|5|||
23310727|NCT00839254|64886346|FG004|Overall Study|Adverse Event|2|||
23208141|NCT02670330|64500879|FG000|Overall Study|Study Terminated By Sponsor|36|||
23208142|NCT02670330|64500880|FG001|Overall Study|Study Terminated By Sponsor|43|||
23310728|NCT00839254|64886347|FG005|Overall Study|Adverse Event|1|||
23310729|NCT00839254|64886348|FG006|Overall Study|Adverse Event|0|||
23310730|NCT00839254|64886349|FG007|Overall Study|Adverse Event|1|||
23533903|NCT00575588|65689300|FG001|Overall Study|Death|2|||
23533904|NCT00575588|65689299|FG000|Overall Study|Incorrect enrollment|8|||
23533905|NCT00575588|65689300|FG001|Overall Study|Incorrect enrollment|4|||
23533906|NCT00575588|65689299|FG000|Overall Study|Study specific discontinuation criteria|203|||
23533907|NCT00575588|65689300|FG001|Overall Study|Study specific discontinuation criteria|218|||
23310731|NCT00839254|64886342|FG000|Overall Study|Withdrawal by Subject|87|||
23310732|NCT00839254|64886343|FG001|Overall Study|Withdrawal by Subject|53|||
23310733|NCT00839254|64886344|FG002|Overall Study|Withdrawal by Subject|54|||
23310734|NCT00839254|64886345|FG003|Overall Study|Withdrawal by Subject|32|||
23310735|NCT00839254|64886346|FG004|Overall Study|Withdrawal by Subject|27|||
23310736|NCT00839254|64886347|FG005|Overall Study|Withdrawal by Subject|15|||
23310737|NCT00839254|64886348|FG006|Overall Study|Withdrawal by Subject|22|||
23310738|NCT00839254|64886349|FG007|Overall Study|Withdrawal by Subject|9|||
23310739|NCT00839254|64886342|FG000|Overall Study|Wrong group allocation|0|||
23310740|NCT00839254|64886343|FG001|Overall Study|Wrong group allocation|0|||
23310741|NCT00839254|64886344|FG002|Overall Study|Wrong group allocation|0|||
23310742|NCT00839254|64886345|FG003|Overall Study|Wrong group allocation|0|||
23310743|NCT00839254|64886346|FG004|Overall Study|Wrong group allocation|0|||
23310744|NCT00839254|64886347|FG005|Overall Study|Wrong group allocation|0|||
23310745|NCT00839254|64886348|FG006|Overall Study|Wrong group allocation|1|||
23310746|NCT00839254|64886349|FG007|Overall Study|Wrong group allocation|0|||
23310747|NCT00839254|64886342|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
23310748|NCT00839254|64886343|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
23310749|NCT00839254|64886344|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
23310750|NCT00839254|64886345|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
23310751|NCT00839254|64886346|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
23310752|NCT00839254|64886347|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
23310753|NCT00839254|64886348|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
23310754|NCT00839254|64886349|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
23310755|NCT00839254|64886342|FG000|Overall Study|Withdrawn due to non-compliance|2|||
23310756|NCT00839254|64886343|FG001|Overall Study|Withdrawn due to non-compliance|0|||
23310757|NCT00839254|64886344|FG002|Overall Study|Withdrawn due to non-compliance|0|||
23310758|NCT00839254|64886345|FG003|Overall Study|Withdrawn due to non-compliance|0|||
23310759|NCT00839254|64886346|FG004|Overall Study|Withdrawn due to non-compliance|0|||
23310760|NCT00839254|64886347|FG005|Overall Study|Withdrawn due to non-compliance|0|||
23310761|NCT00839254|64886348|FG006|Overall Study|Withdrawn due to non-compliance|0|||
23310762|NCT00839254|64886349|FG007|Overall Study|Withdrawn due to non-compliance|0|||
23310763|NCT00839254|64886342|FG000|Overall Study|Lost to Follow-up|51|||
23310764|NCT00839254|64886343|FG001|Overall Study|Lost to Follow-up|30|||
23310765|NCT00839254|64886344|FG002|Overall Study|Lost to Follow-up|32|||
23310766|NCT00839254|64886345|FG003|Overall Study|Lost to Follow-up|24|||
23310767|NCT00839254|64886346|FG004|Overall Study|Lost to Follow-up|8|||
23310768|NCT00839254|64886347|FG005|Overall Study|Lost to Follow-up|8|||
23310769|NCT00839254|64886348|FG006|Overall Study|Lost to Follow-up|4|||
23310770|NCT00839254|64886349|FG007|Overall Study|Lost to Follow-up|2|||
23310771|NCT02186834|64886350|FG000|Dose Escalation|Death|0|||
23422200|NCT02754141|65288425|FG007|Overall Study|Maximum clinical benefit|0|||
23533908|NCT00575588|65689299|FG000|Overall Study|Severe non-compliance to protocol|5|||
23533909|NCT00575588|65689300|FG001|Overall Study|Severe non-compliance to protocol|7|||
23533910|NCT00575588|65689299|FG000|Overall Study|Safety reasons|2|||
23310772|NCT02186834|64886351|FG001|Dose Escalation|Death|0|||
23310773|NCT02186834|64886352|FG002|Dose Escalation|Death|0|||
23310774|NCT02186834|64886353|FG003|Dose Escalation|Death|1|||
23310775|NCT02186834|64886354|FG004|Dose Escalation|Death|0|||
23310776|NCT02186834|64886355|FG005|Dose Escalation|Death|0|||
23310777|NCT02186834|64886350|FG000|Treatment at RP2D|Died prior to treatment|0|||
23310778|NCT02186834|64886351|FG001|Treatment at RP2D|Died prior to treatment|0|||
23422201|NCT02754141|65288426|FG008|Overall Study|Maximum clinical benefit|0|||
23422202|NCT02754141|65288427|FG009|Overall Study|Maximum clinical benefit|0|||
23422203|NCT02754141|65288428|FG010|Overall Study|Maximum clinical benefit|0|||
23422204|NCT02754141|65288429|FG011|Overall Study|Maximum clinical benefit|0|||
23422205|NCT02754141|65288430|FG012|Overall Study|Maximum clinical benefit|0|||
23422206|NCT02754141|65288431|FG013|Overall Study|Maximum clinical benefit|0|||
23422207|NCT02754141|65288432|FG014|Overall Study|Maximum clinical benefit|0|||
23422208|NCT02754141|65288433|FG015|Overall Study|Maximum clinical benefit|0|||
23422209|NCT02754141|65288434|FG016|Overall Study|Maximum clinical benefit|0|||
23422210|NCT02754141|65288435|FG017|Overall Study|Maximum clinical benefit|0|||
23422211|NCT02754141|65288418|FG000|Overall Study|No longer meets study criteria|0|||
23422212|NCT02754141|65288419|FG001|Overall Study|No longer meets study criteria|0|||
23422213|NCT02754141|65288420|FG002|Overall Study|No longer meets study criteria|0|||
23422214|NCT02754141|65288421|FG003|Overall Study|No longer meets study criteria|1|||
23422215|NCT02754141|65288422|FG004|Overall Study|No longer meets study criteria|0|||
23422216|NCT02754141|65288423|FG005|Overall Study|No longer meets study criteria|0|||
23422217|NCT02754141|65288424|FG006|Overall Study|No longer meets study criteria|0|||
23422218|NCT02754141|65288425|FG007|Overall Study|No longer meets study criteria|0|||
23422219|NCT02754141|65288426|FG008|Overall Study|No longer meets study criteria|0|||
23422220|NCT02754141|65288427|FG009|Overall Study|No longer meets study criteria|0|||
23422221|NCT02754141|65288428|FG010|Overall Study|No longer meets study criteria|0|||
23422222|NCT02754141|65288429|FG011|Overall Study|No longer meets study criteria|0|||
23533911|NCT00575588|65689300|FG001|Overall Study|Safety reasons|1|||
23533912|NCT00575588|65689299|FG000|Overall Study|Elevated triglyceride|1|||
23533913|NCT00575588|65689300|FG001|Overall Study|Elevated triglyceride|0|||
23533914|NCT00575588|65689299|FG000|Overall Study|Patient moved|1|||
23533915|NCT00575588|65689300|FG001|Overall Study|Patient moved|3|||
23533916|NCT00575588|65689299|FG000|Overall Study|Impossible to determine HbA1c|0|||
23533917|NCT00575588|65689300|FG001|Overall Study|Impossible to determine HbA1c|1|||
23533918|NCT02387957|65689301|FG000|Overall Study|The study was discontinued|21|||
23533919|NCT02387957|65689302|FG001|Overall Study|The study was discontinued|21|||
23533920|NCT02387957|65689303|FG002|Overall Study|The study was discontinued|20|||
23533921|NCT04304001|65689305|FG000|Overall Study|Lost to Follow-up|13|||
23533922|NCT04304001|65689306|FG001|Overall Study|Lost to Follow-up|9|||
23533923|NCT04776148|65689307|FG000|Overall Study|Death|172|||
23533924|NCT04776148|65689308|FG001|Overall Study|Death|188|||
23533925|NCT04776148|65689307|FG000|Overall Study|Lost to Follow-up|0|||
23533926|NCT04776148|65689308|FG001|Overall Study|Lost to Follow-up|1|||
23533927|NCT04776148|65689307|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23533928|NCT04776148|65689308|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23533929|NCT04776148|65689307|FG000|Overall Study|Withdrawal by Subject|2|||
23533930|NCT04776148|65689308|FG001|Overall Study|Withdrawal by Subject|4|||
23533931|NCT04776148|65689307|FG000|Overall Study|Ongoing in Study|67|||
23533932|NCT04776148|65689308|FG001|Overall Study|Ongoing in Study|45|||
23533933|NCT03064126|65689309|FG000|Overall Study|Death|40|||
23533934|NCT03064126|65689310|FG001|Overall Study|Death|16|||
23533935|NCT03064126|65689311|FG002|Overall Study|Death|4|||
23533936|NCT03064126|65689312|FG003|Overall Study|Death|2|||
23533937|NCT03064126|65689309|FG000|Overall Study|Withdrawal by Subject|17|||
23533938|NCT03064126|65689310|FG001|Overall Study|Withdrawal by Subject|9|||
23533939|NCT03064126|65689311|FG002|Overall Study|Withdrawal by Subject|0|||
23533940|NCT03064126|65689312|FG003|Overall Study|Withdrawal by Subject|2|||
23533941|NCT03064126|65689309|FG000|Overall Study|Lost to Follow-up|7|||
23533942|NCT03064126|65689310|FG001|Overall Study|Lost to Follow-up|3|||
23310779|NCT02186834|64886352|FG002|Treatment at RP2D|Died prior to treatment|0|||
23310780|NCT02186834|64886353|FG003|Treatment at RP2D|Died prior to treatment|0|||
23310781|NCT02186834|64886354|FG004|Treatment at RP2D|Died prior to treatment|0|||
23310782|NCT02186834|64886355|FG005|Treatment at RP2D|Died prior to treatment|1|||
23310783|NCT00729248|64886362|FG000|Overall Study|Physician Decision|2|||
23310784|NCT04123561|64886363|FG000|Overall Study|Lost to Follow-up|20|||
23310785|NCT04123561|64886364|FG001|Overall Study|Lost to Follow-up|12|||
23310786|NCT04123561|64886365|FG002|Overall Study|Lost to Follow-up|5|||
23310787|NCT04123561|64886363|FG000|Overall Study|Withdrawal by Subject|9|||
23310788|NCT04123561|64886364|FG001|Overall Study|Withdrawal by Subject|7|||
23310789|NCT04123561|64886365|FG002|Overall Study|Withdrawal by Subject|9|||
23310790|NCT04123561|64886363|FG000|Overall Study|Lack of Efficacy|7|||
23310791|NCT04123561|64886364|FG001|Overall Study|Lack of Efficacy|8|||
23310792|NCT04123561|64886365|FG002|Overall Study|Lack of Efficacy|6|||
23310793|NCT04123561|64886363|FG000|Overall Study|Adverse Event|5|||
23310794|NCT04123561|64886364|FG001|Overall Study|Adverse Event|2|||
23310795|NCT04123561|64886365|FG002|Overall Study|Adverse Event|3|||
23310796|NCT04123561|64886363|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
23310797|NCT04123561|64886364|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
23533943|NCT03064126|65689311|FG002|Overall Study|Lost to Follow-up|0|||
23533944|NCT03064126|65689312|FG003|Overall Study|Lost to Follow-up|0|||
23533945|NCT03064126|65689309|FG000|Overall Study|Adverse Event|2|||
23533946|NCT03064126|65689310|FG001|Overall Study|Adverse Event|0|||
23533947|NCT03064126|65689311|FG002|Overall Study|Adverse Event|0|||
23533948|NCT03064126|65689312|FG003|Overall Study|Adverse Event|0|||
23533949|NCT03064126|65689309|FG000|Overall Study|Physician Decision|3|||
23533950|NCT03064126|65689310|FG001|Overall Study|Physician Decision|0|||
23310798|NCT04123561|64886365|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
23310799|NCT04123561|64886363|FG000|Overall Study|Death|0|||
23310800|NCT04123561|64886364|FG001|Overall Study|Death|0|||
23310801|NCT04123561|64886365|FG002|Overall Study|Death|1|||
23310802|NCT04123561|64886363|FG000|Overall Study|Protocol Violation|0|||
23310803|NCT04123561|64886364|FG001|Overall Study|Protocol Violation|1|||
23310804|NCT04123561|64886365|FG002|Overall Study|Protocol Violation|0|||
23310805|NCT02466685|64886366|FG000|Overall Study|Adverse Event|5|||
23310806|NCT02466685|64886367|FG001|Overall Study|Adverse Event|2|||
23310807|NCT02466685|64886366|FG000|Overall Study|Lost to Follow-up|1|||
23310808|NCT02466685|64886367|FG001|Overall Study|Lost to Follow-up|1|||
23310809|NCT02466685|64886366|FG000|Overall Study|Withdrawal by Subject|1|||
23310810|NCT02466685|64886367|FG001|Overall Study|Withdrawal by Subject|0|||
23310811|NCT02466685|64886366|FG000|Overall Study|Physician Decision|1|||
23310812|NCT02466685|64886367|FG001|Overall Study|Physician Decision|1|||
23614870|NCT01951105|65976281|FG000|Overall Study|Withdrawal by Subject|0|||
23614871|NCT01951105|65976282|FG001|Overall Study|Withdrawal by Subject|3|||
23614872|NCT01951105|65976283|FG002|Overall Study|Withdrawal by Subject|1|||
23614873|NCT02762500|65976285|FG000|Overall Study|Lack of Efficacy|1|||
23614874|NCT02762500|65976286|FG001|Overall Study|Lack of Efficacy|0|||
23614875|NCT02762500|65976285|FG000|Overall Study|Withdrawal by Subject|1|||
23614876|NCT02762500|65976286|FG001|Overall Study|Withdrawal by Subject|1|||
23614877|NCT02762500|65976285|FG000|Overall Study|Adverse Event|0|||
23614878|NCT02762500|65976286|FG001|Overall Study|Adverse Event|2|||
23614879|NCT03647709|65976287|FG000|Overall Study|Lost to Follow-up|5|||
23614880|NCT03647709|65976287|FG000|Overall Study|Physician Decision|6|||
23614881|NCT03647709|65976287|FG000|Overall Study|Withdrawal by Subject|3|||
23614882|NCT02246647|65976288|FG000|Overall Study|Withdrawal by Subject|1|||
23614883|NCT02246647|65976289|FG001|Overall Study|Withdrawal by Subject|1|||
23614884|NCT02121808|65976292|FG000|Overall Study|Technical problem|3|||
23614885|NCT04736602|65976293|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
23614886|NCT04736602|65976293|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
23614887|NCT01124916|65976294|FG000|Overall Study|Lost to Follow-up|3|||
23614888|NCT01124916|65976295|FG001|Overall Study|Lost to Follow-up|2|||
23614889|NCT04385849|65976296|FG000|Overall Study|Lost to Follow-up|1|||
23310813|NCT02714426|64886369|FG000|Overall Study|Withdrawal by Subject|2|||
23310814|NCT02714426|64886370|FG001|Overall Study|Withdrawal by Subject|2|||
23310815|NCT00168818|64886376|FG000|Overall Study|Adverse Event|23|||
23310816|NCT00168818|64886377|FG001|Overall Study|Adverse Event|29|||
23310817|NCT00168818|64886378|FG002|Overall Study|Adverse Event|31|||
23310818|NCT00168818|64886376|FG000|Overall Study|Protocol Violation|16|||
23310819|NCT00168818|64886377|FG001|Overall Study|Protocol Violation|11|||
23310820|NCT00168818|64886378|FG002|Overall Study|Protocol Violation|11|||
23310821|NCT00168818|64886376|FG000|Overall Study|Lost to Follow-up|13|||
23614890|NCT04385849|65976297|FG001|Overall Study|Lost to Follow-up|0|||
23614891|NCT02101554|65976298|FG000|Overall Study|Protocol Violation|0|||
23614892|NCT02101554|65976299|FG001|Overall Study|Protocol Violation|1|||
23614893|NCT02101554|65976300|FG002|Overall Study|Protocol Violation|0|||
23614894|NCT02101554|65976298|FG000|Overall Study|Insufficient Clinical Response|0|||
23614895|NCT02101554|65976299|FG001|Overall Study|Insufficient Clinical Response|2|||
23614896|NCT02101554|65976300|FG002|Overall Study|Insufficient Clinical Response|0|||
23614897|NCT02101554|65976298|FG000|Overall Study|Adverse Event|2|||
23614898|NCT02101554|65976299|FG001|Overall Study|Adverse Event|1|||
23614899|NCT02101554|65976300|FG002|Overall Study|Adverse Event|1|||
23614900|NCT02101554|65976298|FG000|Overall Study|Lost to Follow-up|0|||
23614901|NCT02101554|65976299|FG001|Overall Study|Lost to Follow-up|1|||
23614902|NCT02101554|65976300|FG002|Overall Study|Lost to Follow-up|0|||
23310822|NCT00168818|64886377|FG001|Overall Study|Lost to Follow-up|4|||
23310823|NCT00168818|64886378|FG002|Overall Study|Lost to Follow-up|15|||
23310824|NCT00168818|64886376|FG000|Overall Study|Withdrawal by Subject|43|||
23310825|NCT00168818|64886377|FG001|Overall Study|Withdrawal by Subject|41|||
23310826|NCT00168818|64886378|FG002|Overall Study|Withdrawal by Subject|37|||
23310827|NCT00168818|64886376|FG000|Overall Study|Other|22|||
23310828|NCT00168818|64886377|FG001|Overall Study|Other|24|||
23310829|NCT00168818|64886378|FG002|Overall Study|Other|30|||
23310830|NCT00168818|64886376|FG000|Treatment|Adverse Event|77|||
23310831|NCT00168818|64886377|FG001|Treatment|Adverse Event|89|||
23310832|NCT00168818|64886378|FG002|Treatment|Adverse Event|68|||
23310833|NCT00168818|64886376|FG000|Treatment|Protocol Violation|8|||
23310834|NCT00168818|64886377|FG001|Treatment|Protocol Violation|11|||
23310835|NCT00168818|64886378|FG002|Treatment|Protocol Violation|11|||
23310836|NCT00168818|64886376|FG000|Treatment|Lost to Follow-up|0|||
23614903|NCT02101554|65976298|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
23614904|NCT02101554|65976299|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
23310837|NCT00168818|64886377|FG001|Treatment|Lost to Follow-up|2|||
23310838|NCT00168818|64886378|FG002|Treatment|Lost to Follow-up|1|||
23614905|NCT02101554|65976300|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
23310839|NCT00168818|64886376|FG000|Treatment|Withdrawal by Subject|25|||
23310840|NCT00168818|64886377|FG001|Treatment|Withdrawal by Subject|20|||
23310841|NCT00168818|64886378|FG002|Treatment|Withdrawal by Subject|22|||
23310842|NCT00168818|64886376|FG000|Treatment|Other|23|||
23310843|NCT00168818|64886377|FG001|Treatment|Other|29|||
23310844|NCT00168818|64886378|FG002|Treatment|Other|31|||
23310845|NCT01283035|64886379|FG000|Overall Study|Subject later found ineligible|1|||
23310846|NCT04628793|64886380|FG000|Overall Study|Study terminated by sponsor|0|||
23310847|NCT04628793|64886381|FG001|Overall Study|Study terminated by sponsor|0|||
23310848|NCT04628793|64886382|FG002|Overall Study|Study terminated by sponsor|8|||
23310849|NCT04628793|64886380|FG000|Overall Study|Withdrawal by Subject|2|||
23310850|NCT04628793|64886381|FG001|Overall Study|Withdrawal by Subject|3|||
23310851|NCT04628793|64886382|FG002|Overall Study|Withdrawal by Subject|0|||
23310852|NCT04628793|64886380|FG000|Overall Study|Lost to Follow-up|0|||
23310853|NCT04628793|64886381|FG001|Overall Study|Lost to Follow-up|1|||
23310854|NCT04628793|64886382|FG002|Overall Study|Lost to Follow-up|0|||
23310855|NCT01959295|64886383|FG000|Overall Study|Adverse Event|2|||
23310856|NCT01959295|64886384|FG001|Overall Study|Adverse Event|0|||
23310857|NCT01959295|64886383|FG000|Overall Study|Lost to Follow-up|0|||
23310858|NCT01959295|64886384|FG001|Overall Study|Lost to Follow-up|2|||
23533951|NCT03064126|65689311|FG002|Overall Study|Physician Decision|0|||
23533952|NCT03064126|65689312|FG003|Overall Study|Physician Decision|0|||
23614906|NCT01816165|65976302|FG000|Overall Study|Adverse Event|1|||
23614907|NCT01816165|65976303|FG001|Overall Study|Adverse Event|0|||
23614908|NCT01816165|65976304|FG002|Overall Study|Adverse Event|0|||
23614909|NCT01816165|65976305|FG003|Overall Study|Adverse Event|0|||
23614910|NCT04088500|65976311|FG000|Overall Study|Reason unknown|1|||
23614911|NCT04088500|65976311|FG000|Overall Study|Participant withdrew consent|1|||
23614912|NCT04088500|65976311|FG000|Overall Study|Disease progression|3|||
23614913|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
23614914|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
23614915|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
23614916|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Other|1|||
23614917|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Other|0|||
23614918|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Other|0|||
23614919|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Physician Decision|3|||
23614920|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Physician Decision|0|||
23614921|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Physician Decision|0|||
23614922|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
23614923|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
23614924|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
23614925|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
23614926|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
23614927|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
23614928|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Adverse Event|18|||
23614929|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Adverse Event|0|||
23614930|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Adverse Event|0|||
23614931|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
23533953|NCT03064126|65689309|FG000|Overall Study|Other reason for early termination|3|||
23533954|NCT03064126|65689310|FG001|Overall Study|Other reason for early termination|2|||
23533955|NCT03064126|65689311|FG002|Overall Study|Other reason for early termination|0|||
23533956|NCT03064126|65689312|FG003|Overall Study|Other reason for early termination|0|||
23533957|NCT03064126|65689309|FG000|Overall Study|Missed Visit|3|||
23533958|NCT03064126|65689310|FG001|Overall Study|Missed Visit|1|||
23533959|NCT03064126|65689311|FG002|Overall Study|Missed Visit|0|||
23533960|NCT03064126|65689312|FG003|Overall Study|Missed Visit|0|||
23533961|NCT05481125|65689313|FG000|Overall Study|Adverse Event|1|||
23533962|NCT05481125|65689314|FG001|Overall Study|Adverse Event|0|||
23533963|NCT05481125|65689313|FG000|Overall Study|Lost to Follow-up|0|||
23533964|NCT05481125|65689314|FG001|Overall Study|Lost to Follow-up|1|||
23533965|NCT05481125|65689313|FG000|Overall Study|Withdrawal by Subject|0|||
23533966|NCT05481125|65689314|FG001|Overall Study|Withdrawal by Subject|1|||
23614932|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
23614933|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
23614934|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
23614935|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
23614936|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
23614937|NCT03030599|65976312|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
23614938|NCT03030599|65976313|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
23614939|NCT03030599|65976314|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
23310859|NCT01959295|64886383|FG000|Overall Study|Physician Decision|2|||
23310860|NCT01959295|64886384|FG001|Overall Study|Physician Decision|3|||
23310861|NCT01959295|64886383|FG000|Overall Study|Protocol Violation|16|||
23533967|NCT03586999|65689315|FG000|Overall Study|Lack of Efficacy|2|||
23533968|NCT04096560|65689316|FG000|Overall Study|Reason not Specified|1|||
23533969|NCT04096560|65689317|FG001|Overall Study|Reason not Specified|0|||
23208143|NCT02670330|64500879|FG000|Overall Study|Adverse Event|1|||
23208144|NCT02670330|64500880|FG001|Overall Study|Adverse Event|3|||
23208145|NCT02670330|64500879|FG000|Overall Study|Withdrawal by Subject|34|||
23208146|NCT02670330|64500880|FG001|Overall Study|Withdrawal by Subject|29|||
23208147|NCT02670330|64500879|FG000|Overall Study|Lost to Follow-up|3|||
23208148|NCT02670330|64500880|FG001|Overall Study|Lost to Follow-up|2|||
23208149|NCT01511107|64500881|FG000|Overall Study|Ineligible|3|||
23208150|NCT01511107|64500882|FG001|Overall Study|Ineligible|2|||
23208151|NCT01511107|64500881|FG000|Overall Study|Lost to Follow-up|10|||
23208152|NCT01511107|64500882|FG001|Overall Study|Lost to Follow-up|19|||
23208153|NCT01511107|64500881|FG000|Overall Study|Withdrawal by Subject|9|||
23208154|NCT01511107|64500882|FG001|Overall Study|Withdrawal by Subject|20|||
23208155|NCT01124448|64500883|FG000|Overall Study|Lost to Follow-up|0|||
23208156|NCT01124448|64500884|FG001|Overall Study|Lost to Follow-up|3|||
23208157|NCT01124448|64500883|FG000|Overall Study|Protocol Violation|2|||
23310862|NCT01959295|64886384|FG001|Overall Study|Protocol Violation|5|||
23310863|NCT01959295|64886383|FG000|Overall Study|Withdrawal by Subject|3|||
23310864|NCT01959295|64886384|FG001|Overall Study|Withdrawal by Subject|1|||
23422223|NCT02754141|65288430|FG012|Overall Study|No longer meets study criteria|0|||
23422224|NCT02754141|65288431|FG013|Overall Study|No longer meets study criteria|0|||
23422225|NCT02754141|65288432|FG014|Overall Study|No longer meets study criteria|0|||
23422226|NCT02754141|65288433|FG015|Overall Study|No longer meets study criteria|0|||
23422227|NCT02754141|65288434|FG016|Overall Study|No longer meets study criteria|0|||
23422228|NCT02754141|65288435|FG017|Overall Study|No longer meets study criteria|0|||
23422229|NCT02754141|65288418|FG000|Overall Study|Other reasons|0|||
23422230|NCT02754141|65288419|FG001|Overall Study|Other reasons|0|||
23422231|NCT02754141|65288420|FG002|Overall Study|Other reasons|0|||
23422232|NCT02754141|65288421|FG003|Overall Study|Other reasons|0|||
23422233|NCT02754141|65288422|FG004|Overall Study|Other reasons|0|||
23422234|NCT02754141|65288423|FG005|Overall Study|Other reasons|0|||
23422235|NCT02754141|65288424|FG006|Overall Study|Other reasons|0|||
23422236|NCT02754141|65288425|FG007|Overall Study|Other reasons|1|||
23422237|NCT02754141|65288426|FG008|Overall Study|Other reasons|0|||
23422238|NCT02754141|65288427|FG009|Overall Study|Other reasons|0|||
23422239|NCT02754141|65288428|FG010|Overall Study|Other reasons|0|||
23422240|NCT02754141|65288429|FG011|Overall Study|Other reasons|0|||
23422241|NCT02754141|65288430|FG012|Overall Study|Other reasons|2|||
23422242|NCT02754141|65288431|FG013|Overall Study|Other reasons|0|||
23422243|NCT02754141|65288432|FG014|Overall Study|Other reasons|0|||
23422244|NCT02754141|65288433|FG015|Overall Study|Other reasons|0|||
23422245|NCT02754141|65288434|FG016|Overall Study|Other reasons|0|||
23422246|NCT02754141|65288435|FG017|Overall Study|Other reasons|0|||
23422247|NCT02754141|65288418|FG000|Overall Study|Completed treatment as per protocol|0|||
23422248|NCT02754141|65288419|FG001|Overall Study|Completed treatment as per protocol|1|||
23422249|NCT02754141|65288420|FG002|Overall Study|Completed treatment as per protocol|0|||
23422250|NCT02754141|65288421|FG003|Overall Study|Completed treatment as per protocol|0|||
23422251|NCT02754141|65288422|FG004|Overall Study|Completed treatment as per protocol|0|||
23422252|NCT02754141|65288423|FG005|Overall Study|Completed treatment as per protocol|0|||
23422253|NCT02754141|65288424|FG006|Overall Study|Completed treatment as per protocol|0|||
23422254|NCT02754141|65288425|FG007|Overall Study|Completed treatment as per protocol|0|||
23422255|NCT02754141|65288426|FG008|Overall Study|Completed treatment as per protocol|0|||
23422256|NCT02754141|65288427|FG009|Overall Study|Completed treatment as per protocol|0|||
23310865|NCT01959295|64886383|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
23310866|NCT01959295|64886384|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
23310867|NCT02283983|64886385|FG000|Overall Study|Inclusion criteria not met|0|||
23310868|NCT02283983|64886386|FG001|Overall Study|Inclusion criteria not met|1|||
23310869|NCT02283983|64886385|FG000|Overall Study|Withdrawal by Subject|4|||
23310870|NCT02283983|64886386|FG001|Overall Study|Withdrawal by Subject|2|||
23310871|NCT02283983|64886385|FG000|Overall Study|Protocol Violation|0|||
23310872|NCT02283983|64886386|FG001|Overall Study|Protocol Violation|4|||
23310873|NCT02283983|64886385|FG000|Overall Study|Physician Decision|2|||
23310874|NCT02283983|64886386|FG001|Overall Study|Physician Decision|4|||
23310875|NCT02283983|64886385|FG000|Overall Study|Death|1|||
23310876|NCT02283983|64886386|FG001|Overall Study|Death|0|||
23310877|NCT02283983|64886385|FG000|Overall Study|Adverse Event|1|||
23310878|NCT02283983|64886386|FG001|Overall Study|Adverse Event|0|||
23310879|NCT02283983|64886385|FG000|Overall Study|Lost to Follow-up|9|||
23310880|NCT02283983|64886386|FG001|Overall Study|Lost to Follow-up|8|||
23310881|NCT02283983|64886385|FG000|Overall Study|Relapse|1|||
23208158|NCT01124448|64500884|FG001|Overall Study|Protocol Violation|0|||
23310882|NCT02283983|64886386|FG001|Overall Study|Relapse|0|||
23310883|NCT03853148|64886389|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
23422257|NCT02754141|65288428|FG010|Overall Study|Completed treatment as per protocol|0|||
23422258|NCT02754141|65288429|FG011|Overall Study|Completed treatment as per protocol|0|||
23422259|NCT02754141|65288430|FG012|Overall Study|Completed treatment as per protocol|1|||
23208159|NCT02156492|64500887|FG000|Period 1|No Reason Given|0|||
23208160|NCT02156492|64500888|FG001|Period 1|No Reason Given|1|||
23208161|NCT02156492|64500889|FG002|Period 1|No Reason Given|0|||
23208162|NCT02156492|64500887|FG000|Period 3|Adverse Event|0|||
23208163|NCT02156492|64500888|FG001|Period 3|Adverse Event|1|||
23208164|NCT02156492|64500889|FG002|Period 3|Adverse Event|0|||
23208165|NCT02159469|64500891|FG000|Overall Study|Missing Completion status|1|||
23208166|NCT02159469|64500891|FG000|Overall Study|Adverse Event|5|||
23208167|NCT02159469|64500891|FG000|Overall Study|Non-compliance|2|||
23208168|NCT02159469|64500891|FG000|Overall Study|Withdrawal by Subject|9|||
23208169|NCT02159469|64500891|FG000|Overall Study|Lost to Follow-up|1|||
23208170|NCT02159469|64500891|FG000|Overall Study|Sponsor's request|2|||
23208171|NCT02159469|64500891|FG000|Overall Study|Met Stopping Criteria|3|||
23208172|NCT02159469|64500891|FG000|Overall Study|Other|1|||
23208173|NCT02159469|64500891|FG000|Overall Study|Multiple|29|||
23208174|NCT03589885|64500892|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
23208175|NCT03589885|64500893|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
23208176|NCT03589885|64500894|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
23208177|NCT03589885|64500895|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
23208178|NCT03589885|64500896|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
23208179|NCT03589885|64500892|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
23208180|NCT03589885|64500893|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
23208181|NCT03589885|64500894|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
23208182|NCT03589885|64500895|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
23208183|NCT03589885|64500896|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
23208184|NCT03589885|64500892|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
23208185|NCT03589885|64500893|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
23208186|NCT03589885|64500894|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
23208187|NCT03589885|64500895|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
23208188|NCT03589885|64500896|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
23208189|NCT03589885|64500892|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
23208190|NCT03589885|64500893|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
23208191|NCT03589885|64500894|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
23208192|NCT03589885|64500895|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
23208193|NCT03589885|64500896|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
23208194|NCT03589885|64500892|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
23208195|NCT03589885|64500893|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
23208196|NCT03589885|64500894|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
23422260|NCT02754141|65288431|FG013|Overall Study|Completed treatment as per protocol|0|||
23208197|NCT03589885|64500895|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
23422261|NCT02754141|65288432|FG014|Overall Study|Completed treatment as per protocol|0|||
23208198|NCT03589885|64500896|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
23208199|NCT03589885|64500892|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
23208200|NCT03589885|64500893|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
23208201|NCT03589885|64500894|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
23208202|NCT03589885|64500895|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
23208203|NCT03589885|64500896|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
23208204|NCT03589885|64500892|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
23208205|NCT03589885|64500893|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
23208206|NCT03589885|64500894|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
23208207|NCT03589885|64500895|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
23208208|NCT03589885|64500896|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
23208209|NCT03589885|64500892|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
23208210|NCT03589885|64500893|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
23208211|NCT03589885|64500894|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
23208212|NCT03589885|64500895|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
23208213|NCT03589885|64500896|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
23208214|NCT00423735|64500899|FG000|Overall Study|Ineligible / No protocol treatment|8|||
23208215|NCT00423735|64500900|FG001|Overall Study|Ineligible / No protocol treatment|6|||
23208216|NCT00423735|64500901|FG002|Overall Study|Ineligible / No protocol treatment|0|||
23208217|NCT02432040|64500902|FG000|Overall Study|Lack of Efficacy|3|||
23208218|NCT02432040|64500903|FG001|Overall Study|Lack of Efficacy|0|||
23208219|NCT02432040|64500902|FG000|Overall Study|Lost to Follow-up|4|||
23208220|NCT02432040|64500903|FG001|Overall Study|Lost to Follow-up|5|||
23208221|NCT02432040|64500902|FG000|Overall Study|Physician Decision|1|||
23208222|NCT02432040|64500903|FG001|Overall Study|Physician Decision|1|||
23208223|NCT00870818|64500904|FG000|Overall Study|Lost to Follow-up|3|||
23208224|NCT00870818|64500905|FG001|Overall Study|Lost to Follow-up|2|||
23208225|NCT00870818|64500906|FG002|Overall Study|Lost to Follow-up|1|||
23208226|NCT00870818|64500907|FG003|Overall Study|Lost to Follow-up|0|||
23208227|NCT00870818|64500908|FG004|Overall Study|Lost to Follow-up|0|||
23208228|NCT00870818|64500904|FG000|Overall Study|Withdrawal by Subject|0|||
23208229|NCT00870818|64500905|FG001|Overall Study|Withdrawal by Subject|0|||
23208230|NCT00870818|64500906|FG002|Overall Study|Withdrawal by Subject|1|||
23208231|NCT00870818|64500907|FG003|Overall Study|Withdrawal by Subject|2|||
23208232|NCT00870818|64500908|FG004|Overall Study|Withdrawal by Subject|0|||
23208233|NCT00870818|64500904|FG000|Overall Study|Terminated by sponsor|29|||
23208234|NCT00870818|64500905|FG001|Overall Study|Terminated by sponsor|70|||
23208235|NCT00870818|64500906|FG002|Overall Study|Terminated by sponsor|36|||
23208236|NCT00870818|64500907|FG003|Overall Study|Terminated by sponsor|36|||
23208237|NCT00870818|64500908|FG004|Overall Study|Terminated by sponsor|38|||
23208238|NCT00870818|64500904|FG000|Overall Study|Other|0|||
23208239|NCT00870818|64500905|FG001|Overall Study|Other|1|||
23208240|NCT00870818|64500906|FG002|Overall Study|Other|0|||
23208241|NCT00870818|64500907|FG003|Overall Study|Other|0|||
23208242|NCT00870818|64500908|FG004|Overall Study|Other|0|||
23422262|NCT02754141|65288433|FG015|Overall Study|Completed treatment as per protocol|0|||
23422263|NCT02754141|65288434|FG016|Overall Study|Completed treatment as per protocol|0|||
23533970|NCT04096560|65689318|FG002|Overall Study|Reason not Specified|0|||
23533971|NCT04096560|65689319|FG003|Overall Study|Reason not Specified|0|||
23533972|NCT04096560|65689320|FG004|Overall Study|Reason not Specified|1|||
23533973|NCT04096560|65689321|FG005|Overall Study|Reason not Specified|1|||
23533974|NCT04096560|65689322|FG006|Overall Study|Reason not Specified|1|||
23533975|NCT04096560|65689323|FG007|Overall Study|Reason not Specified|0|||
23533976|NCT04096560|65689316|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533977|NCT04096560|65689317|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533978|NCT04096560|65689318|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533979|NCT04096560|65689319|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533980|NCT04096560|65689320|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533981|NCT04096560|65689321|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
23533982|NCT04096560|65689322|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
23533983|NCT04096560|65689323|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
23533984|NCT04096560|65689316|FG000|Overall Study|Study Terminated by Sponsor|0|||
23208243|NCT00788697|64500909|FG000|Overall Study|No study drug administered|12|||
23208244|NCT00788697|64500909|FG000|Overall Study|Training Patients|74|||
23208245|NCT00788697|64500909|FG000|Overall Study|no truth standard procedure available|5|||
23208246|NCT00788697|64500909|FG000|Overall Study|Technically inadequate truth standard|1|||
23208247|NCT00788697|64500909|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
23208248|NCT02721251|64500910|FG000|Overall Study|Withdrawal by Subject|8|||
23208249|NCT02721251|64500911|FG001|Overall Study|Withdrawal by Subject|7|||
23208250|NCT02721251|64500912|FG002|Overall Study|Withdrawal by Subject|9|||
23208251|NCT02721251|64500910|FG000|Overall Study|poor adherence|2|||
23533985|NCT04096560|65689317|FG001|Overall Study|Study Terminated by Sponsor|0|||
23533986|NCT04096560|65689318|FG002|Overall Study|Study Terminated by Sponsor|0|||
23533987|NCT04096560|65689319|FG003|Overall Study|Study Terminated by Sponsor|5|||
23533988|NCT04096560|65689320|FG004|Overall Study|Study Terminated by Sponsor|6|||
23533989|NCT04096560|65689321|FG005|Overall Study|Study Terminated by Sponsor|4|||
23533990|NCT04096560|65689322|FG006|Overall Study|Study Terminated by Sponsor|6|||
23533991|NCT04096560|65689323|FG007|Overall Study|Study Terminated by Sponsor|1|||
23533992|NCT04096560|65689316|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533993|NCT04096560|65689317|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533994|NCT04096560|65689318|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533995|NCT04096560|65689319|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533996|NCT04096560|65689320|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533997|NCT04096560|65689321|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533998|NCT04096560|65689322|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
23533999|NCT04096560|65689323|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
23534000|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
23534001|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
23534002|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
23534003|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
23534004|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
23534005|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
23534006|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
23534007|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
23534008|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
23534009|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
23534010|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
23534011|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
23534012|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
23534013|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
23534014|NCT02464969|65689324|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
23534015|NCT02464969|65689325|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
23534016|NCT02464969|65689324|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
23534017|NCT02464969|65689325|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
23534018|NCT02464969|65689324|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
23534019|NCT02464969|65689325|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
23534020|NCT02464969|65689324|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
23534021|NCT02464969|65689325|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
23534022|NCT01385176|65689328|FG000|Randomization Phase|Death|1|||
23534023|NCT01385176|65689329|FG001|Randomization Phase|Death|2|||
23534024|NCT01385176|65689328|FG000|6-18 Month All VNS Active|Death|1|||
23534025|NCT01385176|65689329|FG001|6-18 Month All VNS Active|Death|2|||
23534026|NCT01385176|65689328|FG000|6-18 Month All VNS Active|Physician Decision|0|||
23534027|NCT01385176|65689329|FG001|6-18 Month All VNS Active|Physician Decision|1|||
23534028|NCT01385176|65689328|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
23534029|NCT01385176|65689329|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
23534030|NCT01385176|65689328|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
23534031|NCT01385176|65689329|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
23534032|NCT02208362|65689332|FG000|Overall Study|Participant did not complete treatment|0|||
23534033|NCT02208362|65689333|FG001|Overall Study|Participant did not complete treatment|1|||
23534034|NCT02208362|65689334|FG002|Overall Study|Participant did not complete treatment|0|||
23534035|NCT02208362|65689335|FG003|Overall Study|Participant did not complete treatment|0|||
23534036|NCT02208362|65689336|FG004|Overall Study|Participant did not complete treatment|0|||
23534037|NCT02208362|65689337|FG005|Overall Study|Participant did not complete treatment|0|||
23534038|NCT02208362|65689338|FG006|Overall Study|Participant did not complete treatment|1|||
23534039|NCT02208362|65689339|FG007|Overall Study|Participant did not complete treatment|1|||
23534040|NCT02208362|65689340|FG008|Overall Study|Participant did not complete treatment|2|||
23208252|NCT02721251|64500911|FG001|Overall Study|poor adherence|2|||
23208253|NCT02721251|64500912|FG002|Overall Study|poor adherence|2|||
23208254|NCT01767519|64500915|FG000|Overall Study|Other Reasons|4|||
23208255|NCT01767519|64500916|FG001|Overall Study|Other Reasons|4|||
23534041|NCT02208362|65689341|FG009|Overall Study|Participant did not complete treatment|0|||
23534042|NCT02208362|65689342|FG010|Overall Study|Participant did not complete treatment|1|||
23534043|NCT02208362|65689343|FG011|Overall Study|Participant did not complete treatment|0|||
23534044|NCT02208362|65689332|FG000|Overall Study|Participant received disallowed treatment|0|||
23534045|NCT02208362|65689333|FG001|Overall Study|Participant received disallowed treatment|0|||
23534046|NCT02208362|65689334|FG002|Overall Study|Participant received disallowed treatment|0|||
23534047|NCT02208362|65689335|FG003|Overall Study|Participant received disallowed treatment|0|||
23614940|NCT03030599|65976312|FG000|Stable Dose|Protocol deviation|3|||
23208256|NCT01767519|64500917|FG002|Overall Study|Other Reasons|2|||
23614941|NCT03030599|65976313|FG001|Stable Dose|Protocol deviation|0|||
23614942|NCT03030599|65976314|FG002|Stable Dose|Protocol deviation|0|||
23614943|NCT03030599|65976312|FG000|Stable Dose|Adverse Event|1|||
23614944|NCT03030599|65976313|FG001|Stable Dose|Adverse Event|0|||
23614945|NCT03030599|65976314|FG002|Stable Dose|Adverse Event|0|||
23614946|NCT03030599|65976312|FG000|Stable Dose|Lost to Follow-up|1|||
23614947|NCT03030599|65976313|FG001|Stable Dose|Lost to Follow-up|0|||
23614948|NCT03030599|65976314|FG002|Stable Dose|Lost to Follow-up|0|||
23614949|NCT03030599|65976312|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
23614950|NCT03030599|65976313|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
23614951|NCT03030599|65976314|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
23614952|NCT03030599|65976312|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
23614953|NCT03030599|65976313|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
23614954|NCT03030599|65976314|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
23614955|NCT03030599|65976312|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
23614956|NCT03030599|65976313|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
23614957|NCT03030599|65976314|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
23614958|NCT03030599|65976312|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
23310884|NCT03853148|64886390|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
23340854|NCT01936181|64992871|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
23208257|NCT01767519|64500915|FG000|Overall Study|Protocol Violation|0|||
23208258|NCT01767519|64500916|FG001|Overall Study|Protocol Violation|3|||
23208259|NCT01767519|64500917|FG002|Overall Study|Protocol Violation|0|||
23208260|NCT01767519|64500915|FG000|Overall Study|Personal Reasons|1|||
23208261|NCT01767519|64500916|FG001|Overall Study|Personal Reasons|0|||
23208262|NCT01767519|64500917|FG002|Overall Study|Personal Reasons|0|||
23208263|NCT01767519|64500915|FG000|Overall Study|Lost to Follow-up|3|||
23208264|NCT01767519|64500916|FG001|Overall Study|Lost to Follow-up|1|||
23208265|NCT01767519|64500917|FG002|Overall Study|Lost to Follow-up|2|||
23208266|NCT01767519|64500915|FG000|Overall Study|Lack of Efficacy|1|||
23208267|NCT01767519|64500916|FG001|Overall Study|Lack of Efficacy|0|||
23208268|NCT01767519|64500917|FG002|Overall Study|Lack of Efficacy|0|||
23208269|NCT01767519|64500915|FG000|Overall Study|Adverse Event|5|||
23208270|NCT01767519|64500916|FG001|Overall Study|Adverse Event|5|||
23208271|NCT01767519|64500917|FG002|Overall Study|Adverse Event|1|||
23208272|NCT01107405|64500918|FG000|Overall Study|Adverse Event|1|||
23208273|NCT01107405|64500919|FG001|Overall Study|Adverse Event|1|||
23208274|NCT01107405|64500920|FG002|Overall Study|Adverse Event|0|||
23208275|NCT01107405|64500921|FG003|Overall Study|Adverse Event|0|||
23208276|NCT01107405|64500922|FG004|Overall Study|Adverse Event|2|||
23208277|NCT01107405|64500918|FG000|Overall Study|Withdrawal by Subject|1|||
23208278|NCT01107405|64500919|FG001|Overall Study|Withdrawal by Subject|0|||
23208279|NCT01107405|64500920|FG002|Overall Study|Withdrawal by Subject|1|||
23208280|NCT01107405|64500921|FG003|Overall Study|Withdrawal by Subject|2|||
23208281|NCT01107405|64500922|FG004|Overall Study|Withdrawal by Subject|1|||
23208282|NCT01107405|64500918|FG000|Overall Study|Protocol Violation|0|||
23208283|NCT01107405|64500919|FG001|Overall Study|Protocol Violation|0|||
23208284|NCT01107405|64500920|FG002|Overall Study|Protocol Violation|1|||
23208285|NCT01107405|64500921|FG003|Overall Study|Protocol Violation|1|||
23208286|NCT01107405|64500922|FG004|Overall Study|Protocol Violation|0|||
23208287|NCT01755195|64500924|FG000|Overall Study|Participant noncompliance|2|||
23208288|NCT01755195|64500924|FG000|Overall Study|Switched to alternative treatment|4|||
23208289|NCT01755195|64500924|FG000|Overall Study|Withdrawal by Subject|1|||
23208290|NCT01755195|64500924|FG000|Overall Study|Participant refused to start treatment|1|||
23614959|NCT03030599|65976313|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
23208291|NCT01755195|64500924|FG000|Overall Study|Participant has been consented for another trial|1|||
23208292|NCT01755195|64500924|FG000|Overall Study|Refused further treatment|3|||
23208293|NCT01755195|64500924|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
23208294|NCT01623531|64500930|FG000|Overall Study|Death|1|||
23208295|NCT01623531|64500931|FG001|Overall Study|Death|0|||
23208296|NCT01623531|64500930|FG000|Overall Study|Protocol Violation|2|||
23208297|NCT01623531|64500931|FG001|Overall Study|Protocol Violation|1|||
23208298|NCT01623531|64500930|FG000|Overall Study|Missing data at primary outcome time poi|1|||
23208299|NCT01623531|64500931|FG001|Overall Study|Missing data at primary outcome time poi|1|||
23208300|NCT00738374|64500932|FG000|Induction Treatment Phase|Adverse Event|14|||
23208301|NCT00738374|64500933|FG001|Induction Treatment Phase|Adverse Event|0|||
23208302|NCT00738374|64500934|FG002|Induction Treatment Phase|Adverse Event|0|||
23208303|NCT00738374|64500935|FG003|Induction Treatment Phase|Adverse Event|0|||
23208304|NCT00738374|64500932|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
23208305|NCT00738374|64500933|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
23208306|NCT00738374|64500934|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
23208307|NCT00738374|64500935|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
23208308|NCT00738374|64500932|FG000|Induction Treatment Phase|Physician Decision|2|||
23208309|NCT00738374|64500933|FG001|Induction Treatment Phase|Physician Decision|0|||
23208310|NCT00738374|64500934|FG002|Induction Treatment Phase|Physician Decision|0|||
23208311|NCT00738374|64500935|FG003|Induction Treatment Phase|Physician Decision|0|||
23208312|NCT00738374|64500932|FG000|Induction Treatment Phase|Protocol Violation|2|||
23208313|NCT00738374|64500933|FG001|Induction Treatment Phase|Protocol Violation|0|||
23208314|NCT00738374|64500934|FG002|Induction Treatment Phase|Protocol Violation|0|||
23208315|NCT00738374|64500935|FG003|Induction Treatment Phase|Protocol Violation|0|||
23208316|NCT00738374|64500932|FG000|Induction Treatment Phase|Non-compliance|1|||
23208317|NCT00738374|64500933|FG001|Induction Treatment Phase|Non-compliance|0|||
23208318|NCT00738374|64500934|FG002|Induction Treatment Phase|Non-compliance|0|||
23208319|NCT00738374|64500935|FG003|Induction Treatment Phase|Non-compliance|0|||
23208320|NCT00738374|64500932|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
23208321|NCT00738374|64500933|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
23208322|NCT00738374|64500934|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
23208323|NCT00738374|64500935|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
23208324|NCT00738374|64500932|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
23208325|NCT00738374|64500933|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
23208326|NCT00738374|64500934|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
23208327|NCT00738374|64500935|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
23534048|NCT02208362|65689336|FG004|Overall Study|Participant received disallowed treatment|0|||
23534049|NCT02208362|65689337|FG005|Overall Study|Participant received disallowed treatment|0|||
23534050|NCT02208362|65689338|FG006|Overall Study|Participant received disallowed treatment|0|||
23534051|NCT02208362|65689339|FG007|Overall Study|Participant received disallowed treatment|0|||
23534052|NCT02208362|65689340|FG008|Overall Study|Participant received disallowed treatment|1|||
23534053|NCT02208362|65689341|FG009|Overall Study|Participant received disallowed treatment|0|||
23534054|NCT02208362|65689342|FG010|Overall Study|Participant received disallowed treatment|0|||
23534055|NCT02208362|65689343|FG011|Overall Study|Participant received disallowed treatment|0|||
23534056|NCT05653427|65689344|FG000|Overall Study|Study Terminated by Sponsor|13|||
23534057|NCT04435366|65689345|FG000|Year 1 (12 Months)|Adverse Event|3|||
23534058|NCT04435366|65689346|FG001|Year 1 (12 Months)|Adverse Event|0|||
23534059|NCT04435366|65689347|FG002|Year 1 (12 Months)|Adverse Event|2|||
23534060|NCT04435366|65689345|FG000|Year 1 (12 Months)|Death|2|||
23534061|NCT04435366|65689346|FG001|Year 1 (12 Months)|Death|0|||
23534062|NCT04435366|65689347|FG002|Year 1 (12 Months)|Death|1|||
23534063|NCT04435366|65689345|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
23534064|NCT04435366|65689346|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
23534065|NCT04435366|65689347|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
23534066|NCT04435366|65689345|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
23534067|NCT04435366|65689346|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
23534068|NCT04435366|65689347|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
23534069|NCT04435366|65689345|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
23534070|NCT04435366|65689346|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
23534071|NCT04435366|65689347|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
23534072|NCT04435366|65689345|FG000|Year 1 (12 Months)|Not treated|0|||
23534073|NCT04435366|65689346|FG001|Year 1 (12 Months)|Not treated|0|||
23534074|NCT04435366|65689347|FG002|Year 1 (12 Months)|Not treated|1|||
23534075|NCT04435366|65689345|FG000|Year 2 (12 Months)|Death|1|||
23534076|NCT04435366|65689346|FG001|Year 2 (12 Months)|Death|4|||
23534077|NCT04435366|65689347|FG002|Year 2 (12 Months)|Death|6|||
23534078|NCT04435366|65689345|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
23534079|NCT04435366|65689346|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
23534080|NCT04435366|65689347|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
23534081|NCT04435366|65689345|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
23534082|NCT04435366|65689346|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
23534083|NCT04435366|65689347|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
23534084|NCT04435366|65689345|FG000|Year 2 (12 Months)|Adverse Event|2|||
23534085|NCT04435366|65689346|FG001|Year 2 (12 Months)|Adverse Event|1|||
23534086|NCT04435366|65689347|FG002|Year 2 (12 Months)|Adverse Event|6|||
23208328|NCT00738374|64500932|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
23208329|NCT00738374|64500933|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
23208330|NCT00738374|64500934|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
23208331|NCT00738374|64500935|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
23534087|NCT01944839|65689354|FG000|Overall Study|Physician Decision|2|||
23534088|NCT01944839|65689355|FG001|Overall Study|Physician Decision|2|||
23534089|NCT01944839|65689354|FG000|Overall Study|Protocol Violation|0|||
23534090|NCT01944839|65689355|FG001|Overall Study|Protocol Violation|1|||
23534091|NCT01944839|65689354|FG000|Overall Study|Adverse Event|10|||
23534092|NCT01944839|65689355|FG001|Overall Study|Adverse Event|5|||
23534093|NCT01944839|65689354|FG000|Overall Study|Withdrawal by Subject|9|||
23534094|NCT01944839|65689355|FG001|Overall Study|Withdrawal by Subject|17|||
23534095|NCT01944839|65689354|FG000|Overall Study|Lost to Follow-up|1|||
23534096|NCT01944839|65689355|FG001|Overall Study|Lost to Follow-up|0|||
23534097|NCT01944839|65689354|FG000|Overall Study|Subject non-compliance|0|||
23534098|NCT01944839|65689355|FG001|Overall Study|Subject non-compliance|3|||
23534099|NCT02980341|65689356|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
23534100|NCT02980341|65689357|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
23534101|NCT02980341|65689358|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
23534102|NCT02980341|65689359|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
23534103|NCT02980341|65689360|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
23534104|NCT02980341|65689361|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23534105|NCT02980341|65689362|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23534106|NCT02980341|65689363|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23310885|NCT03853148|64886391|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
23310886|NCT03853148|64886392|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
23534107|NCT02980341|65689364|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23534108|NCT02980341|65689365|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23534109|NCT02980341|65689366|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
23534110|NCT02980341|65689356|FG000|Dose Escalation|Clinical progression|0|||
23534111|NCT02980341|65689357|FG001|Dose Escalation|Clinical progression|0|||
23534112|NCT02980341|65689358|FG002|Dose Escalation|Clinical progression|2|||
23534113|NCT02980341|65689359|FG003|Dose Escalation|Clinical progression|1|||
23534114|NCT02980341|65689360|FG004|Dose Escalation|Clinical progression|0|||
23534115|NCT02980341|65689361|FG005|Dose Escalation|Clinical progression|0|||
23534116|NCT02980341|65689362|FG006|Dose Escalation|Clinical progression|0|||
23534117|NCT02980341|65689363|FG007|Dose Escalation|Clinical progression|0|||
23534118|NCT02980341|65689364|FG008|Dose Escalation|Clinical progression|0|||
23534119|NCT02980341|65689365|FG009|Dose Escalation|Clinical progression|0|||
23534120|NCT02980341|65689366|FG010|Dose Escalation|Clinical progression|0|||
23534121|NCT02980341|65689356|FG000|Dose Escalation|Adverse Event|0|||
23534122|NCT02980341|65689357|FG001|Dose Escalation|Adverse Event|0|||
23534123|NCT02980341|65689358|FG002|Dose Escalation|Adverse Event|1|||
23534124|NCT02980341|65689359|FG003|Dose Escalation|Adverse Event|2|||
23534125|NCT02980341|65689360|FG004|Dose Escalation|Adverse Event|2|||
23534126|NCT02980341|65689361|FG005|Dose Escalation|Adverse Event|0|||
23534127|NCT02980341|65689362|FG006|Dose Escalation|Adverse Event|0|||
23534128|NCT02980341|65689363|FG007|Dose Escalation|Adverse Event|0|||
23534129|NCT02980341|65689364|FG008|Dose Escalation|Adverse Event|0|||
23534130|NCT02980341|65689365|FG009|Dose Escalation|Adverse Event|0|||
23534131|NCT02980341|65689366|FG010|Dose Escalation|Adverse Event|0|||
23534132|NCT02980341|65689356|FG000|Dose Escalation|Withdrawal by Subject|0|||
23534133|NCT02980341|65689357|FG001|Dose Escalation|Withdrawal by Subject|0|||
23534134|NCT02980341|65689358|FG002|Dose Escalation|Withdrawal by Subject|1|||
23534135|NCT02980341|65689359|FG003|Dose Escalation|Withdrawal by Subject|0|||
23208332|NCT00738374|64500932|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
23208333|NCT00738374|64500933|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
23208334|NCT00738374|64500934|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
23208335|NCT00738374|64500935|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
23208336|NCT00738374|64500932|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
23208337|NCT00738374|64500933|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
23534136|NCT02980341|65689360|FG004|Dose Escalation|Withdrawal by Subject|0|||
23534137|NCT02980341|65689361|FG005|Dose Escalation|Withdrawal by Subject|0|||
23534138|NCT02980341|65689362|FG006|Dose Escalation|Withdrawal by Subject|0|||
23534139|NCT02980341|65689363|FG007|Dose Escalation|Withdrawal by Subject|0|||
23534140|NCT02980341|65689364|FG008|Dose Escalation|Withdrawal by Subject|0|||
23534141|NCT02980341|65689365|FG009|Dose Escalation|Withdrawal by Subject|0|||
23534142|NCT02980341|65689366|FG010|Dose Escalation|Withdrawal by Subject|0|||
23534143|NCT02980341|65689356|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534144|NCT02980341|65689357|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534145|NCT02980341|65689358|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534146|NCT02980341|65689359|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
23208338|NCT00738374|64500934|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
23208339|NCT00738374|64500935|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
23534147|NCT02980341|65689360|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534148|NCT02980341|65689361|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534149|NCT02980341|65689362|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534150|NCT02980341|65689363|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534151|NCT02980341|65689364|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534152|NCT02980341|65689365|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534153|NCT02980341|65689366|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
23534154|NCT02980341|65689356|FG000|Dose Escalation|Due to investigator's decision|0|||
23534155|NCT02980341|65689357|FG001|Dose Escalation|Due to investigator's decision|0|||
23534156|NCT02980341|65689358|FG002|Dose Escalation|Due to investigator's decision|0|||
23534157|NCT02980341|65689359|FG003|Dose Escalation|Due to investigator's decision|0|||
23208340|NCT00738374|64500932|FG000|Maintenance Treatment/Observation Phase|Other|0|||
23534158|NCT02980341|65689360|FG004|Dose Escalation|Due to investigator's decision|1|||
23534159|NCT02980341|65689361|FG005|Dose Escalation|Due to investigator's decision|0|||
23534160|NCT02980341|65689362|FG006|Dose Escalation|Due to investigator's decision|0|||
23534161|NCT02980341|65689363|FG007|Dose Escalation|Due to investigator's decision|0|||
23534162|NCT02980341|65689364|FG008|Dose Escalation|Due to investigator's decision|0|||
23534163|NCT02980341|65689365|FG009|Dose Escalation|Due to investigator's decision|0|||
23534164|NCT02980341|65689366|FG010|Dose Escalation|Due to investigator's decision|0|||
23534165|NCT02980341|65689356|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
23534166|NCT02980341|65689357|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
23534167|NCT02980341|65689358|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
23534168|NCT02980341|65689359|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
23534169|NCT02980341|65689360|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
23534170|NCT02980341|65689361|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
23534171|NCT02980341|65689362|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
23534172|NCT02980341|65689363|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
23534173|NCT02980341|65689364|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
23534174|NCT02980341|65689365|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
23534175|NCT02980341|65689366|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
23534176|NCT02980341|65689356|FG000|Dose Finding|Adverse Event|0|||
23534177|NCT02980341|65689357|FG001|Dose Finding|Adverse Event|0|||
23534178|NCT02980341|65689358|FG002|Dose Finding|Adverse Event|0|||
23534179|NCT02980341|65689359|FG003|Dose Finding|Adverse Event|0|||
23534180|NCT02980341|65689360|FG004|Dose Finding|Adverse Event|0|||
23534181|NCT02980341|65689361|FG005|Dose Finding|Adverse Event|3|||
23534182|NCT02980341|65689362|FG006|Dose Finding|Adverse Event|0|||
23534183|NCT02980341|65689363|FG007|Dose Finding|Adverse Event|0|||
23534184|NCT02980341|65689364|FG008|Dose Finding|Adverse Event|0|||
23534185|NCT02980341|65689365|FG009|Dose Finding|Adverse Event|0|||
23534186|NCT02980341|65689366|FG010|Dose Finding|Adverse Event|0|||
23534187|NCT02980341|65689356|FG000|Dose Finding|Withdrawal by Subject|0|||
23534188|NCT02980341|65689357|FG001|Dose Finding|Withdrawal by Subject|0|||
23534189|NCT02980341|65689358|FG002|Dose Finding|Withdrawal by Subject|0|||
23534190|NCT02980341|65689359|FG003|Dose Finding|Withdrawal by Subject|0|||
23534191|NCT02980341|65689360|FG004|Dose Finding|Withdrawal by Subject|0|||
23208341|NCT00738374|64500933|FG001|Maintenance Treatment/Observation Phase|Other|1|||
23208342|NCT00738374|64500934|FG002|Maintenance Treatment/Observation Phase|Other|0|||
23208343|NCT00738374|64500935|FG003|Maintenance Treatment/Observation Phase|Other|0|||
23208344|NCT01030458|64500936|FG000|Overall Study|Lost to Follow-up|9|||
23208345|NCT01030458|64500937|FG001|Overall Study|Lost to Follow-up|10|||
23208346|NCT01030458|64500936|FG000|Overall Study|Withdrawal by Subject|2|||
23208347|NCT01030458|64500937|FG001|Overall Study|Withdrawal by Subject|3|||
23208348|NCT01030458|64500936|FG000|Overall Study|Logistical reasons|9|||
23208349|NCT01030458|64500937|FG001|Overall Study|Logistical reasons|5|||
23208350|NCT01030458|64500936|FG000|Overall Study|Moved or changed job|6|||
23208351|NCT01030458|64500937|FG001|Overall Study|Moved or changed job|13|||
23208352|NCT01030458|64500936|FG000|Overall Study|Side effect of medication|1|||
23208353|NCT01030458|64500937|FG001|Overall Study|Side effect of medication|1|||
23208354|NCT02326467|64500938|FG000|Overall Study|Withdrawal by Subject|1|||
23208355|NCT01021813|64500941|FG000|DB Treatment Phase|Adverse Event|60|||
23208356|NCT01021813|64500942|FG001|DB Treatment Phase|Adverse Event|22|||
23208357|NCT01021813|64500943|FG002|DB Treatment Phase|Adverse Event|0|||
23208358|NCT01021813|64500944|FG003|DB Treatment Phase|Adverse Event|0|||
23208359|NCT01021813|64500945|FG004|DB Treatment Phase|Adverse Event|0|||
23208360|NCT01021813|64500941|FG000|DB Treatment Phase|Lack of Efficacy|44|||
23208361|NCT01021813|64500942|FG001|DB Treatment Phase|Lack of Efficacy|28|||
23208362|NCT01021813|64500943|FG002|DB Treatment Phase|Lack of Efficacy|0|||
23208363|NCT01021813|64500944|FG003|DB Treatment Phase|Lack of Efficacy|0|||
23208364|NCT01021813|64500945|FG004|DB Treatment Phase|Lack of Efficacy|0|||
23208365|NCT01021813|64500941|FG000|DB Treatment Phase|Lost to Follow-up|14|||
23208366|NCT01021813|64500942|FG001|DB Treatment Phase|Lost to Follow-up|12|||
23208367|NCT01021813|64500943|FG002|DB Treatment Phase|Lost to Follow-up|0|||
23208368|NCT01021813|64500944|FG003|DB Treatment Phase|Lost to Follow-up|0|||
23208369|NCT01021813|64500945|FG004|DB Treatment Phase|Lost to Follow-up|0|||
23208370|NCT01021813|64500941|FG000|DB Treatment Phase|Physician Decision|17|||
23208371|NCT01021813|64500942|FG001|DB Treatment Phase|Physician Decision|8|||
23208372|NCT01021813|64500943|FG002|DB Treatment Phase|Physician Decision|0|||
23208373|NCT01021813|64500944|FG003|DB Treatment Phase|Physician Decision|0|||
23208374|NCT01021813|64500945|FG004|DB Treatment Phase|Physician Decision|0|||
23208375|NCT01021813|64500941|FG000|DB Treatment Phase|Pregnancy|1|||
23208376|NCT01021813|64500942|FG001|DB Treatment Phase|Pregnancy|0|||
23208377|NCT01021813|64500943|FG002|DB Treatment Phase|Pregnancy|0|||
23208378|NCT01021813|64500944|FG003|DB Treatment Phase|Pregnancy|0|||
23208379|NCT01021813|64500945|FG004|DB Treatment Phase|Pregnancy|0|||
23310887|NCT02740699|64886398|FG000|Overall Study|Lost to Follow-up|5|||
23310888|NCT02740699|64886398|FG000|Overall Study|Withdrawal by Subject|14|||
23310889|NCT02740699|64886398|FG000|Overall Study|Physician Decision|5|||
23208380|NCT01021813|64500941|FG000|DB Treatment Phase|Protocol Violation|4|||
23208381|NCT01021813|64500942|FG001|DB Treatment Phase|Protocol Violation|3|||
23208382|NCT01021813|64500943|FG002|DB Treatment Phase|Protocol Violation|0|||
23310890|NCT02437903|64886401|FG000|Overall Study|Adverse Event|1|||
23422264|NCT02754141|65288435|FG017|Overall Study|Completed treatment as per protocol|0|||
23534192|NCT02980341|65689361|FG005|Dose Finding|Withdrawal by Subject|1|||
23534193|NCT02980341|65689362|FG006|Dose Finding|Withdrawal by Subject|1|||
23534194|NCT02980341|65689363|FG007|Dose Finding|Withdrawal by Subject|0|||
23208383|NCT01021813|64500944|FG003|DB Treatment Phase|Protocol Violation|0|||
23208384|NCT01021813|64500945|FG004|DB Treatment Phase|Protocol Violation|0|||
23208385|NCT01021813|64500941|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
23310891|NCT02437903|64886401|FG000|Overall Study|Withdrawal by Subject|1|||
23534195|NCT02980341|65689364|FG008|Dose Finding|Withdrawal by Subject|0|||
23534196|NCT02980341|65689365|FG009|Dose Finding|Withdrawal by Subject|0|||
23208386|NCT01021813|64500942|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
23208387|NCT01021813|64500943|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
23208388|NCT01021813|64500944|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
23208389|NCT01021813|64500945|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
23208390|NCT01021813|64500941|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
23208391|NCT01021813|64500942|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
23208392|NCT01021813|64500943|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
23208393|NCT01021813|64500944|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
23208394|NCT01021813|64500945|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
23208395|NCT01021813|64500941|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
23208396|NCT01021813|64500942|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
23208397|NCT01021813|64500943|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
23208398|NCT01021813|64500944|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
23208399|NCT01021813|64500945|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
23208400|NCT01021813|64500941|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
23208401|NCT01021813|64500942|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
23208402|NCT01021813|64500943|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
23208403|NCT01021813|64500944|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
23208404|NCT01021813|64500945|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
23208405|NCT01021813|64500941|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
23208406|NCT01021813|64500942|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
23208407|NCT01021813|64500943|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
23208408|NCT01021813|64500944|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
23208409|NCT01021813|64500945|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
23208410|NCT01021813|64500941|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
23208411|NCT01021813|64500942|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
23310892|NCT02437903|64886401|FG000|Overall Study|Lost to Follow-up|3|||
23310893|NCT00603837|64886402|FG000|Overall Study|Physician Decision|3|||
23534197|NCT02980341|65689366|FG010|Dose Finding|Withdrawal by Subject|0|||
23534198|NCT02980341|65689356|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23534199|NCT02980341|65689357|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23534200|NCT02980341|65689358|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23534201|NCT02980341|65689359|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23534202|NCT02980341|65689360|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23534203|NCT02980341|65689361|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23534204|NCT02980341|65689362|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
23534205|NCT02980341|65689363|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
23534206|NCT02980341|65689364|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
23534207|NCT02980341|65689365|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
23534208|NCT02980341|65689366|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
23534209|NCT02980341|65689356|FG000|Dose Expansion|Clinical progression|0|||
23534210|NCT02980341|65689357|FG001|Dose Expansion|Clinical progression|0|||
23534211|NCT02980341|65689358|FG002|Dose Expansion|Clinical progression|0|||
23534212|NCT02980341|65689359|FG003|Dose Expansion|Clinical progression|0|||
23534213|NCT02980341|65689360|FG004|Dose Expansion|Clinical progression|0|||
23534214|NCT02980341|65689361|FG005|Dose Expansion|Clinical progression|0|||
23534215|NCT02980341|65689362|FG006|Dose Expansion|Clinical progression|0|||
23534216|NCT02980341|65689363|FG007|Dose Expansion|Clinical progression|4|||
23534217|NCT02980341|65689364|FG008|Dose Expansion|Clinical progression|3|||
23534218|NCT02980341|65689365|FG009|Dose Expansion|Clinical progression|1|||
23534219|NCT02980341|65689366|FG010|Dose Expansion|Clinical progression|4|||
23534220|NCT02980341|65689356|FG000|Dose Expansion|Adverse Event|0|||
23534221|NCT02980341|65689357|FG001|Dose Expansion|Adverse Event|0|||
23534222|NCT02980341|65689358|FG002|Dose Expansion|Adverse Event|0|||
23534223|NCT02980341|65689359|FG003|Dose Expansion|Adverse Event|0|||
23534224|NCT02980341|65689360|FG004|Dose Expansion|Adverse Event|0|||
23534225|NCT02980341|65689361|FG005|Dose Expansion|Adverse Event|0|||
23534226|NCT02980341|65689362|FG006|Dose Expansion|Adverse Event|0|||
23534227|NCT02980341|65689363|FG007|Dose Expansion|Adverse Event|3|||
23534228|NCT02980341|65689364|FG008|Dose Expansion|Adverse Event|0|||
23208412|NCT01021813|64500943|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
23208413|NCT01021813|64500944|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
23422265|NCT02754141|65288418|FG000|Overall Study|Not completing monotherapy|0|||
23534229|NCT02980341|65689365|FG009|Dose Expansion|Adverse Event|1|||
23534230|NCT02980341|65689366|FG010|Dose Expansion|Adverse Event|3|||
23534231|NCT02980341|65689356|FG000|Dose Expansion|Death|0|||
23534232|NCT02980341|65689357|FG001|Dose Expansion|Death|0|||
23534233|NCT02980341|65689358|FG002|Dose Expansion|Death|0|||
23534234|NCT02980341|65689359|FG003|Dose Expansion|Death|0|||
23534235|NCT02980341|65689360|FG004|Dose Expansion|Death|0|||
23534236|NCT02980341|65689361|FG005|Dose Expansion|Death|0|||
23534237|NCT02980341|65689362|FG006|Dose Expansion|Death|0|||
23534238|NCT02980341|65689363|FG007|Dose Expansion|Death|0|||
23534239|NCT02980341|65689364|FG008|Dose Expansion|Death|2|||
23534240|NCT02980341|65689365|FG009|Dose Expansion|Death|1|||
23534241|NCT02980341|65689366|FG010|Dose Expansion|Death|0|||
23310894|NCT00603837|64886403|FG001|Overall Study|Physician Decision|0|||
23310895|NCT01220297|64886412|FG000|Overall Study|Death|2|||
23422266|NCT02754141|65288419|FG001|Overall Study|Not completing monotherapy|0|||
23422267|NCT02754141|65288420|FG002|Overall Study|Not completing monotherapy|0|||
23422268|NCT02754141|65288421|FG003|Overall Study|Not completing monotherapy|0|||
23422269|NCT02754141|65288422|FG004|Overall Study|Not completing monotherapy|0|||
23422270|NCT02754141|65288423|FG005|Overall Study|Not completing monotherapy|0|||
23422271|NCT02754141|65288424|FG006|Overall Study|Not completing monotherapy|0|||
23422272|NCT02754141|65288425|FG007|Overall Study|Not completing monotherapy|0|||
23422273|NCT02754141|65288426|FG008|Overall Study|Not completing monotherapy|0|||
23422274|NCT02754141|65288427|FG009|Overall Study|Not completing monotherapy|0|||
23422275|NCT02754141|65288428|FG010|Overall Study|Not completing monotherapy|0|||
23422276|NCT02754141|65288429|FG011|Overall Study|Not completing monotherapy|0|||
23422277|NCT02754141|65288430|FG012|Overall Study|Not completing monotherapy|0|||
23534242|NCT02980341|65689356|FG000|Dose Expansion|Withdrawal by Subject|0|||
23534243|NCT02980341|65689357|FG001|Dose Expansion|Withdrawal by Subject|0|||
23534244|NCT02980341|65689358|FG002|Dose Expansion|Withdrawal by Subject|0|||
23534245|NCT02980341|65689359|FG003|Dose Expansion|Withdrawal by Subject|0|||
23534246|NCT02980341|65689360|FG004|Dose Expansion|Withdrawal by Subject|0|||
23534247|NCT02980341|65689361|FG005|Dose Expansion|Withdrawal by Subject|0|||
23534248|NCT02980341|65689362|FG006|Dose Expansion|Withdrawal by Subject|0|||
23534249|NCT02980341|65689363|FG007|Dose Expansion|Withdrawal by Subject|2|||
23534250|NCT02980341|65689364|FG008|Dose Expansion|Withdrawal by Subject|0|||
23534251|NCT02980341|65689365|FG009|Dose Expansion|Withdrawal by Subject|1|||
23534252|NCT02980341|65689366|FG010|Dose Expansion|Withdrawal by Subject|0|||
23534253|NCT02980341|65689356|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534254|NCT02980341|65689357|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534255|NCT02980341|65689358|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534256|NCT02980341|65689359|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534257|NCT02980341|65689360|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534258|NCT02980341|65689361|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534259|NCT02980341|65689362|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534260|NCT02980341|65689363|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
23534261|NCT02980341|65689364|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534262|NCT02980341|65689365|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534263|NCT02980341|65689366|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
23534264|NCT02980341|65689356|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23534265|NCT02980341|65689357|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23534266|NCT02980341|65689358|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23534267|NCT02980341|65689359|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23534268|NCT02980341|65689360|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23534269|NCT02980341|65689361|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23534270|NCT02980341|65689362|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23534271|NCT02980341|65689363|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23534272|NCT02980341|65689364|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
23534273|NCT02980341|65689365|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23534274|NCT02980341|65689366|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
23310896|NCT01220297|64886412|FG000|Overall Study|Lost to Follow-up|1|||
23310897|NCT00886288|64886416|FG000|Overall Study|no respect of the 12 weeks period|657|||
23310898|NCT00886288|64886417|FG001|Overall Study|no respect of the 12 weeks period|227|||
23310899|NCT00886288|64886416|FG000|Overall Study|Lost to Follow-up|86|||
23310900|NCT00886288|64886417|FG001|Overall Study|Lost to Follow-up|0|||
23310901|NCT04241315|64886418|FG000|Overall Study|Withdrawal by Subject|0|||
23310902|NCT04241315|64886419|FG001|Overall Study|Withdrawal by Subject|1|||
23310903|NCT04428333|64886431|FG000|Overall Study|Physician Decision|5|||
23310904|NCT04428333|64886432|FG001|Overall Study|Physician Decision|6|||
23422278|NCT02754141|65288431|FG013|Overall Study|Not completing monotherapy|1|||
23422279|NCT02754141|65288432|FG014|Overall Study|Not completing monotherapy|0|||
23422280|NCT02754141|65288433|FG015|Overall Study|Not completing monotherapy|0|||
23422281|NCT02754141|65288434|FG016|Overall Study|Not completing monotherapy|0|||
23534275|NCT02980341|65689356|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23310905|NCT04428333|64886431|FG000|Overall Study|Withdrawal by Subject|1|||
23310906|NCT04428333|64886432|FG001|Overall Study|Withdrawal by Subject|3|||
23310907|NCT04428333|64886431|FG000|Overall Study|Study Terminated By Sponsor|14|||
23310908|NCT04428333|64886432|FG001|Overall Study|Study Terminated By Sponsor|16|||
23310909|NCT01716715|64886433|FG000|Overall Study|Never Treated|2|||
23310910|NCT01716715|64886434|FG001|Overall Study|Never Treated|4|||
23310911|NCT00827632|64886435|FG000|Overall Study|Lost to Follow-up|8|||
23310912|NCT00827632|64886436|FG001|Overall Study|Lost to Follow-up|12|||
23614960|NCT03030599|65976314|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
23614961|NCT03030599|65976312|FG000|Open-label Extension|Adverse Event|3|||
23614962|NCT03030599|65976313|FG001|Open-label Extension|Adverse Event|0|||
23614963|NCT03030599|65976314|FG002|Open-label Extension|Adverse Event|0|||
23614964|NCT03030599|65976312|FG000|Open-label Extension|Lost to Follow-up|2|||
23614965|NCT03030599|65976313|FG001|Open-label Extension|Lost to Follow-up|0|||
23614966|NCT03030599|65976314|FG002|Open-label Extension|Lost to Follow-up|0|||
23614967|NCT03030599|65976312|FG000|Open-label Extension|Lack of Efficacy|1|||
23614968|NCT03030599|65976313|FG001|Open-label Extension|Lack of Efficacy|0|||
23614969|NCT03030599|65976314|FG002|Open-label Extension|Lack of Efficacy|0|||
23614970|NCT03030599|65976312|FG000|Open-label Extension|Other Reason|1|||
23614971|NCT03030599|65976313|FG001|Open-label Extension|Other Reason|0|||
23614972|NCT03030599|65976314|FG002|Open-label Extension|Other Reason|0|||
23614973|NCT00070707|65976315|FG000|Overall Study|Adverse Event|1|||
23614974|NCT00070707|65976316|FG001|Overall Study|Adverse Event|2|||
23614975|NCT00070707|65976315|FG000|Overall Study|Lack of Efficacy|4|||
23614976|NCT00070707|65976316|FG001|Overall Study|Lack of Efficacy|1|||
23614977|NCT00070707|65976315|FG000|Overall Study|Protocol Violation|8|||
23614978|NCT00070707|65976316|FG001|Overall Study|Protocol Violation|4|||
23614979|NCT00070707|65976315|FG000|Overall Study|Unrelated to Study Medication|1|||
23614980|NCT00070707|65976316|FG001|Overall Study|Unrelated to Study Medication|0|||
23614981|NCT01182285|65976317|FG000|First Intervention Week 1-10|Disease progression|1|||
23614982|NCT01182285|65976318|FG001|First Intervention Week 1-10|Disease progression|0|||
23614983|NCT01182285|65976319|FG002|First Intervention Week 1-10|Disease progression|0|||
23614984|NCT01182285|65976317|FG000|First Intervention Week 1-10|Adverse Event|1|||
23614985|NCT01182285|65976318|FG001|First Intervention Week 1-10|Adverse Event|0|||
23614986|NCT01182285|65976319|FG002|First Intervention Week 1-10|Adverse Event|0|||
23614987|NCT01182285|65976317|FG000|First Intervention Week 1-10|Non-compliance|1|||
23614988|NCT01182285|65976318|FG001|First Intervention Week 1-10|Non-compliance|0|||
23614989|NCT01182285|65976319|FG002|First Intervention Week 1-10|Non-compliance|0|||
23614990|NCT01182285|65976317|FG000|Third Intervention Week 11-52|Disease Progression|0|||
23614991|NCT01182285|65976318|FG001|Third Intervention Week 11-52|Disease Progression|0|||
23614992|NCT01182285|65976319|FG002|Third Intervention Week 11-52|Disease Progression|6|||
23614993|NCT01182285|65976317|FG000|Third Intervention Week 11-52|Other|0|||
23614994|NCT01182285|65976318|FG001|Third Intervention Week 11-52|Other|0|||
23310913|NCT00827632|64886435|FG000|Overall Study|Early withdrawal|14|||
23310914|NCT00827632|64886436|FG001|Overall Study|Early withdrawal|11|||
23310915|NCT01822275|64886437|FG000|Overall Study|Withdrawal by Subject|3|||
23310916|NCT01822275|64886437|FG000|Overall Study|Adverse Event|3|||
23310917|NCT01822275|64886437|FG000|Overall Study|Progression|14|||
23310918|NCT01822275|64886437|FG000|Overall Study|Physician Decision|2|||
23310919|NCT01775189|64886438|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23310920|NCT01775189|64886439|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
23310921|NCT01775189|64886440|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23310922|NCT01775189|64886441|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23310923|NCT01775189|64886442|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23310924|NCT01775189|64886443|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23310925|NCT01775189|64886444|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23310926|NCT01775189|64886438|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23310927|NCT01775189|64886439|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
23310928|NCT01775189|64886440|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23310929|NCT01775189|64886441|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23310930|NCT01775189|64886442|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23310931|NCT01775189|64886443|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23310932|NCT01775189|64886444|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23310933|NCT01775189|64886438|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23310934|NCT01775189|64886439|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
23310935|NCT01775189|64886440|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
23310936|NCT01775189|64886441|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23310937|NCT01775189|64886442|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23310938|NCT01775189|64886443|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23310939|NCT01775189|64886444|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
23310940|NCT01775189|64886438|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23310941|NCT01775189|64886439|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23614995|NCT01182285|65976319|FG002|Third Intervention Week 11-52|Other|2|||
23614996|NCT01544153|65976320|FG000|Overall Study|Under 18|0|||
23614997|NCT01544153|65976321|FG001|Overall Study|Under 18|1|||
23614998|NCT01544153|65976322|FG002|Overall Study|Under 18|0|||
23614999|NCT01544153|65976323|FG003|Overall Study|Under 18|0|||
23615000|NCT01544153|65976320|FG000|Overall Study|Non-smoker|0|||
23615001|NCT01544153|65976321|FG001|Overall Study|Non-smoker|0|||
23615002|NCT01544153|65976322|FG002|Overall Study|Non-smoker|1|||
23615003|NCT01544153|65976323|FG003|Overall Study|Non-smoker|0|||
23615004|NCT02176018|65976326|FG000|Overall Study|Adverse Event|0|||
23534276|NCT02980341|65689357|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23534277|NCT02980341|65689358|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23534278|NCT02980341|65689359|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23534279|NCT02980341|65689360|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23534280|NCT02980341|65689361|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23534281|NCT02980341|65689362|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23534282|NCT02980341|65689363|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23534283|NCT02980341|65689364|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
23534284|NCT02980341|65689365|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23534285|NCT02980341|65689366|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
23615005|NCT02176018|65976327|FG001|Overall Study|Adverse Event|2|||
23615006|NCT02176018|65976326|FG000|Overall Study|Lost to Follow-up|3|||
23615007|NCT02176018|65976327|FG001|Overall Study|Lost to Follow-up|1|||
23615008|NCT02176018|65976326|FG000|Overall Study|Protocol Violation|1|||
23615009|NCT02176018|65976327|FG001|Overall Study|Protocol Violation|1|||
23615010|NCT02176018|65976326|FG000|Overall Study|Withdrawal by Subject|1|||
23615011|NCT02176018|65976327|FG001|Overall Study|Withdrawal by Subject|2|||
23615012|NCT02282917|65976328|FG000|Overall Study|Withdrawal by Subject|1|||
23615013|NCT02282917|65976328|FG000|Overall Study|Screen Failure/Not Eligible|1|||
23615014|NCT01268488|65976329|FG000|Overall Study|Adverse Event|3|||
23615015|NCT01268488|65976329|FG000|Overall Study|Physician Decision|2|||
23615016|NCT02499835|65976331|FG000|Overall Study|Withdrawal by Subject|1|||
23615017|NCT02499835|65976332|FG001|Overall Study|Withdrawal by Subject|0|||
23615018|NCT02499835|65976333|FG002|Overall Study|Withdrawal by Subject|0|||
23615019|NCT02499835|65976334|FG003|Overall Study|Withdrawal by Subject|1|||
23615020|NCT02499835|65976331|FG000|Overall Study|Physician Decision|0|||
23615021|NCT02499835|65976332|FG001|Overall Study|Physician Decision|3|||
23615022|NCT02499835|65976333|FG002|Overall Study|Physician Decision|18|||
23615023|NCT02499835|65976334|FG003|Overall Study|Physician Decision|7|||
23615024|NCT02499835|65976331|FG000|Overall Study|Adverse Event|0|||
23615025|NCT02499835|65976332|FG001|Overall Study|Adverse Event|0|||
23615026|NCT02499835|65976333|FG002|Overall Study|Adverse Event|0|||
23615027|NCT02499835|65976334|FG003|Overall Study|Adverse Event|1|||
23615028|NCT02499835|65976331|FG000|Overall Study|Disease progression|2|||
23615029|NCT02499835|65976332|FG001|Overall Study|Disease progression|1|||
23615030|NCT02499835|65976333|FG002|Overall Study|Disease progression|0|||
23615031|NCT02499835|65976334|FG003|Overall Study|Disease progression|7|||
23615032|NCT01745380|65976335|FG000|Overall Study|Lost to Follow-up|1|||
23615033|NCT01745380|65976336|FG001|Overall Study|Lost to Follow-up|0|||
23615034|NCT01745380|65976335|FG000|Overall Study|Lack of Efficacy|0|||
23615035|NCT01745380|65976336|FG001|Overall Study|Lack of Efficacy|1|||
23615036|NCT04288778|65976337|FG000|Overall Study|Withdrawal by Subject|2|||
23615037|NCT04288778|65976337|FG000|Overall Study|Adverse Event|5|||
23615038|NCT04288778|65976337|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23615039|NCT04288778|65976337|FG000|Overall Study|Other|1|||
23615040|NCT04288778|65976337|FG000|Overall Study|Started but not treated|2|||
23615041|NCT03356145|65976339|FG000|Overall Study|Withdrawal by Subject|2|||
23615042|NCT03356145|65976340|FG001|Overall Study|Withdrawal by Subject|1|||
23615043|NCT03356145|65976339|FG000|Overall Study|Did not meet inclusion criteria|1|||
23615044|NCT03356145|65976340|FG001|Overall Study|Did not meet inclusion criteria|0|||
23310942|NCT01775189|64886440|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23615045|NCT03120949|65976341|FG000|Overall Study|randomized in error|1|||
23615046|NCT03120949|65976342|FG001|Overall Study|randomized in error|0|||
23615047|NCT03120949|65976341|FG000|Overall Study|Death|13|||
23615048|NCT03120949|65976342|FG001|Overall Study|Death|13|||
23615049|NCT03120949|65976341|FG000|Overall Study|Lost to Follow-up|23|||
23615050|NCT03120949|65976342|FG001|Overall Study|Lost to Follow-up|13|||
23615051|NCT03120949|65976341|FG000|Overall Study|Withdrawal by Subject|139|||
23310943|NCT01775189|64886441|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23310944|NCT01775189|64886442|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23615052|NCT03120949|65976342|FG001|Overall Study|Withdrawal by Subject|124|||
23615053|NCT03120949|65976341|FG000|Overall Study|Covid-19|43|||
23615054|NCT03120949|65976342|FG001|Overall Study|Covid-19|34|||
23310945|NCT01775189|64886443|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
23310946|NCT01775189|64886444|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
23310947|NCT01775189|64886438|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23310948|NCT01775189|64886439|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23310949|NCT01775189|64886440|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23310950|NCT01775189|64886441|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
23310951|NCT01775189|64886442|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23310952|NCT01775189|64886443|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23310953|NCT01775189|64886444|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
23534286|NCT02980341|65689356|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23534287|NCT02980341|65689357|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23534288|NCT02980341|65689358|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23534289|NCT02980341|65689359|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23534290|NCT02980341|65689360|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23208414|NCT01021813|64500945|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
23208415|NCT00593840|64500946|FG000|Overall Study|Withdrawal by Subject|1|||
23310954|NCT01775189|64886438|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23310955|NCT01775189|64886439|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23310956|NCT01775189|64886440|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23310957|NCT01775189|64886441|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
23310958|NCT01775189|64886442|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23310959|NCT01775189|64886443|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
23310960|NCT01775189|64886444|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
23310961|NCT00824616|64886446|FG000|Overall Study|Adverse Event|2|||
23310962|NCT00824616|64886447|FG001|Overall Study|Adverse Event|1|||
23310963|NCT00824616|64886446|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
23310964|NCT00824616|64886447|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
23310965|NCT00824616|64886446|FG000|Overall Study|Hyperglycemia|1|||
23310966|NCT00824616|64886447|FG001|Overall Study|Hyperglycemia|1|||
23310967|NCT00824616|64886446|FG000|Overall Study|Lack of Efficacy|2|||
23310968|NCT00824616|64886447|FG001|Overall Study|Lack of Efficacy|1|||
23310969|NCT00824616|64886446|FG000|Overall Study|Lost to Follow-up|0|||
23310970|NCT00824616|64886447|FG001|Overall Study|Lost to Follow-up|1|||
23310971|NCT00824616|64886446|FG000|Overall Study|Withdrawal by Subject|1|||
23310972|NCT00824616|64886447|FG001|Overall Study|Withdrawal by Subject|1|||
23208416|NCT00424528|64500947|FG000|Overall Study|Adverse Event|2|||
23208417|NCT00424528|64500948|FG001|Overall Study|Adverse Event|1|||
23208418|NCT00424528|64500949|FG002|Overall Study|Adverse Event|2|||
23208419|NCT00424528|64500947|FG000|Overall Study|Protocol Violation|1|||
23208420|NCT00424528|64500948|FG001|Overall Study|Protocol Violation|1|||
23208421|NCT00424528|64500949|FG002|Overall Study|Protocol Violation|0|||
23208422|NCT00424528|64500947|FG000|Overall Study|Lost to Follow-up|0|||
23208423|NCT00424528|64500948|FG001|Overall Study|Lost to Follow-up|1|||
23534291|NCT02980341|65689361|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23534292|NCT02980341|65689362|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23534293|NCT02980341|65689363|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23534294|NCT02980341|65689364|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23534295|NCT02980341|65689365|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
23534296|NCT02980341|65689366|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
23534297|NCT03946670|65689367|FG000|Overall Study|Progressive Disease|26|||
23534298|NCT03946670|65689368|FG001|Overall Study|Progressive Disease|23|||
23534299|NCT03946670|65689367|FG000|Overall Study|Adverse Event|7|||
23534300|NCT03946670|65689368|FG001|Overall Study|Adverse Event|9|||
23534301|NCT03946670|65689367|FG000|Overall Study|Death|5|||
23534302|NCT03946670|65689368|FG001|Overall Study|Death|6|||
23534303|NCT03946670|65689367|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
23534304|NCT03946670|65689368|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
23310973|NCT01136967|64886448|FG000|Overall Study|Adverse Event|9|||
23310974|NCT01136967|64886449|FG001|Overall Study|Adverse Event|12|||
23310975|NCT01136967|64886448|FG000|Overall Study|Participant Choice|8|||
23310976|NCT01136967|64886449|FG001|Overall Study|Participant Choice|3|||
23208424|NCT00424528|64500949|FG002|Overall Study|Lost to Follow-up|0|||
23208425|NCT00424528|64500947|FG000|Overall Study|noncompliance with study requirements|2|||
23208426|NCT00424528|64500948|FG001|Overall Study|noncompliance with study requirements|1|||
23310977|NCT01136967|64886448|FG000|Overall Study|Lost to Follow-up|0|||
23310978|NCT01136967|64886449|FG001|Overall Study|Lost to Follow-up|1|||
23534305|NCT03946670|65689367|FG000|Overall Study|Subject Decision|4|||
23534306|NCT03946670|65689368|FG001|Overall Study|Subject Decision|4|||
23208427|NCT00424528|64500949|FG002|Overall Study|noncompliance with study requirements|2|||
23208428|NCT01844830|64500950|FG000|Overall Study|Withdrawal by Subject|1|||
23208429|NCT01844830|64500951|FG001|Overall Study|Withdrawal by Subject|0|||
23534307|NCT03946670|65689367|FG000|Overall Study|Physician Decision|3|||
23534308|NCT03946670|65689368|FG001|Overall Study|Physician Decision|3|||
23534309|NCT03946670|65689367|FG000|Overall Study|New Therapy for Study Indication|1|||
23534310|NCT03946670|65689368|FG001|Overall Study|New Therapy for Study Indication|0|||
23534311|NCT03946670|65689367|FG000|Overall Study|Not treated|1|||
23534312|NCT03946670|65689368|FG001|Overall Study|Not treated|1|||
23534313|NCT03833427|65689369|FG000|Overall Study|Death|4|||
23534314|NCT03833427|65689370|FG001|Overall Study|Death|2|||
23534315|NCT03833427|65689371|FG002|Overall Study|Death|9|||
23534316|NCT03833427|65689372|FG003|Overall Study|Death|11|||
23534317|NCT03833427|65689373|FG004|Overall Study|Death|0|||
23534318|NCT03833427|65689374|FG005|Overall Study|Death|0|||
23534319|NCT03833427|65689375|FG006|Overall Study|Death|0|||
23534320|NCT03833427|65689369|FG000|Overall Study|Withdrawal by Subject|0|||
23534321|NCT03833427|65689370|FG001|Overall Study|Withdrawal by Subject|1|||
23534322|NCT03833427|65689371|FG002|Overall Study|Withdrawal by Subject|1|||
23534323|NCT03833427|65689372|FG003|Overall Study|Withdrawal by Subject|0|||
23534324|NCT03833427|65689373|FG004|Overall Study|Withdrawal by Subject|0|||
23534325|NCT03833427|65689374|FG005|Overall Study|Withdrawal by Subject|0|||
23534326|NCT03833427|65689375|FG006|Overall Study|Withdrawal by Subject|0|||
23534327|NCT03833427|65689369|FG000|Overall Study|Sponsor Decision|0|||
23534328|NCT03833427|65689370|FG001|Overall Study|Sponsor Decision|0|||
23534329|NCT03833427|65689371|FG002|Overall Study|Sponsor Decision|1|||
23534330|NCT03833427|65689372|FG003|Overall Study|Sponsor Decision|3|||
23534331|NCT03833427|65689373|FG004|Overall Study|Sponsor Decision|0|||
23534332|NCT03833427|65689374|FG005|Overall Study|Sponsor Decision|0|||
23534333|NCT03833427|65689375|FG006|Overall Study|Sponsor Decision|0|||
23534334|NCT02048813|65689376|FG000|Overall Study|Still on treatment|279|||
23534335|NCT02048813|65689377|FG001|Overall Study|Still on treatment|0|||
23534336|NCT02048813|65689376|FG000|Overall Study|Adverse Event|40|||
23534337|NCT02048813|65689377|FG001|Overall Study|Adverse Event|38|||
23534338|NCT02048813|65689376|FG000|Overall Study|Disease progression|13|||
23534339|NCT02048813|65689377|FG001|Overall Study|Disease progression|3|||
23534340|NCT02048813|65689376|FG000|Overall Study|Withdrawal by Subject|7|||
23534341|NCT02048813|65689377|FG001|Overall Study|Withdrawal by Subject|8|||
23534342|NCT02048813|65689376|FG000|Overall Study|Death|2|||
23534343|NCT02048813|65689377|FG001|Overall Study|Death|1|||
23534344|NCT02048813|65689376|FG000|Overall Study|Complication|2|||
23534345|NCT02048813|65689377|FG001|Overall Study|Complication|2|||
23534346|NCT02048813|65689376|FG000|Overall Study|Non-protocol therapy|0|||
23534347|NCT02048813|65689377|FG001|Overall Study|Non-protocol therapy|1|||
23534348|NCT02048813|65689376|FG000|Overall Study|Second primary cancer|2|||
23534349|NCT02048813|65689377|FG001|Overall Study|Second primary cancer|0|||
23534350|NCT02048813|65689376|FG000|Overall Study|Insurance|2|||
23534351|NCT02048813|65689377|FG001|Overall Study|Insurance|0|||
23534352|NCT02048813|65689376|FG000|Overall Study|Wound infection/healing|2|||
23534353|NCT02048813|65689377|FG001|Overall Study|Wound infection/healing|0|||
23534354|NCT02048813|65689376|FG000|Overall Study|Missed appointment|3|||
23534355|NCT02048813|65689377|FG001|Overall Study|Missed appointment|0|||
23534356|NCT02048813|65689376|FG000|Overall Study|Never started treatment|2|||
23534357|NCT02048813|65689377|FG001|Overall Study|Never started treatment|17|||
23534358|NCT03296696|65689378|FG000|Overall Study|Started Other Antitumor Therapy|1|||
23534359|NCT03296696|65689379|FG001|Overall Study|Started Other Antitumor Therapy|2|||
23534360|NCT03296696|65689380|FG002|Overall Study|Started Other Antitumor Therapy|1|||
23534361|NCT03296696|65689381|FG003|Overall Study|Started Other Antitumor Therapy|2|||
23534362|NCT03296696|65689382|FG004|Overall Study|Started Other Antitumor Therapy|1|||
23534363|NCT03296696|65689383|FG005|Overall Study|Started Other Antitumor Therapy|1|||
23534364|NCT03296696|65689384|FG006|Overall Study|Started Other Antitumor Therapy|2|||
23534365|NCT03296696|65689385|FG007|Overall Study|Started Other Antitumor Therapy|3|||
23534366|NCT03296696|65689386|FG008|Overall Study|Started Other Antitumor Therapy|1|||
23534367|NCT03296696|65689387|FG009|Overall Study|Started Other Antitumor Therapy|0|||
23534368|NCT03296696|65689378|FG000|Overall Study|Death|0|||
23534369|NCT03296696|65689379|FG001|Overall Study|Death|1|||
23534370|NCT03296696|65689380|FG002|Overall Study|Death|1|||
23534371|NCT03296696|65689381|FG003|Overall Study|Death|2|||
23534372|NCT03296696|65689382|FG004|Overall Study|Death|2|||
23534373|NCT03296696|65689383|FG005|Overall Study|Death|3|||
23534374|NCT03296696|65689384|FG006|Overall Study|Death|1|||
23534375|NCT03296696|65689385|FG007|Overall Study|Death|2|||
23534376|NCT03296696|65689386|FG008|Overall Study|Death|0|||
23534377|NCT03296696|65689387|FG009|Overall Study|Death|0|||
23534378|NCT03296696|65689378|FG000|Overall Study|Withdrawal by Subject|0|||
23534379|NCT03296696|65689379|FG001|Overall Study|Withdrawal by Subject|0|||
23534380|NCT03296696|65689380|FG002|Overall Study|Withdrawal by Subject|1|||
23534381|NCT03296696|65689381|FG003|Overall Study|Withdrawal by Subject|0|||
23534382|NCT03296696|65689382|FG004|Overall Study|Withdrawal by Subject|1|||
23615055|NCT03120949|65976341|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
23615056|NCT03120949|65976342|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
23615057|NCT03120949|65976341|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
23615058|NCT03120949|65976342|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
23615059|NCT03120949|65976341|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
23615060|NCT03120949|65976342|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
23615061|NCT03120949|65976341|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
23615062|NCT03120949|65976342|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
23615063|NCT03120949|65976341|FG000|Overall Study|Site was closed|2|||
23615064|NCT03120949|65976342|FG001|Overall Study|Site was closed|3|||
23615065|NCT03120949|65976341|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
23615066|NCT03120949|65976342|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
23615067|NCT03120949|65976341|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
23615068|NCT03120949|65976342|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
23615069|NCT03120949|65976341|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
23615070|NCT03120949|65976342|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
23615071|NCT03120949|65976341|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
23615072|NCT03120949|65976342|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
23615073|NCT03120949|65976341|FG000|Overall Study|Other: Adverse Event|0|||
23615074|NCT03120949|65976342|FG001|Overall Study|Other: Adverse Event|1|||
23615075|NCT03120949|65976341|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
23208430|NCT04410198|64500952|FG000|Overall Study|Death|10|||
23208431|NCT04410198|64500952|FG000|Overall Study|Withdrawal by Subject|7|||
23208432|NCT04410198|64500952|FG000|Overall Study|Transferred/Relocation|4|||
23534383|NCT03296696|65689383|FG005|Overall Study|Withdrawal by Subject|0|||
23534384|NCT03296696|65689384|FG006|Overall Study|Withdrawal by Subject|0|||
23534385|NCT03296696|65689385|FG007|Overall Study|Withdrawal by Subject|0|||
23534386|NCT03296696|65689386|FG008|Overall Study|Withdrawal by Subject|0|||
23534387|NCT03296696|65689387|FG009|Overall Study|Withdrawal by Subject|1|||
23534388|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
23534389|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
23534390|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
23534391|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
23534392|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
23534393|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
23534394|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
23534395|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534396|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
23534397|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23615076|NCT03120949|65976342|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
23615077|NCT03120949|65976341|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
23615078|NCT03120949|65976342|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
23615079|NCT03120949|65976341|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
23615080|NCT03120949|65976342|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
23615081|NCT03120949|65976341|FG000|Overall Study|Personal Reasons|0|||
23615082|NCT03120949|65976342|FG001|Overall Study|Personal Reasons|1|||
23615083|NCT03120949|65976341|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
23615084|NCT03120949|65976342|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
23615085|NCT03120949|65976341|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
23615086|NCT03120949|65976342|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
23615087|NCT03120949|65976341|FG000|Overall Study|Compliance With Medication|0|||
23615088|NCT03120949|65976342|FG001|Overall Study|Compliance With Medication|1|||
23615089|NCT03120949|65976341|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
23208433|NCT04410198|64500952|FG000|Overall Study|Kidney Transplant|9|||
23208434|NCT04410198|64500952|FG000|Overall Study|Adverse Event|4|||
23208435|NCT04410198|64500952|FG000|Overall Study|Physician Decision|2|||
23208436|NCT04410198|64500952|FG000|Overall Study|Other than specified|1|||
23208437|NCT04092816|64500955|FG000|Overall Study|Lost to Follow-up|1|||
23534398|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534399|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534400|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534401|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
23534402|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534403|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
23534404|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
23534405|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534406|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534407|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534408|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
23534409|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
23534410|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534411|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534412|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534413|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534414|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534415|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
23534416|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534417|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
23534418|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534419|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534420|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534421|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534422|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
23534423|NCT02962895|65689388|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534424|NCT02962895|65689389|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534425|NCT02962895|65689390|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534426|NCT02962895|65689391|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
23534427|NCT02962895|65689392|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534428|NCT02962895|65689393|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534429|NCT02962895|65689394|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
23534430|NCT02962895|65689388|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534431|NCT02962895|65689389|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534432|NCT02962895|65689390|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534433|NCT02962895|65689391|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534434|NCT02962895|65689392|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534435|NCT02962895|65689393|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
23534436|NCT02962895|65689394|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
23534437|NCT02962895|65689388|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534438|NCT02962895|65689389|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534439|NCT02962895|65689390|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534440|NCT02962895|65689391|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534441|NCT02962895|65689392|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
23534442|NCT02962895|65689393|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
23534443|NCT02962895|65689394|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
23534444|NCT02962895|65689388|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534445|NCT02962895|65689389|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534446|NCT02962895|65689390|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534447|NCT02962895|65689391|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534448|NCT02962895|65689392|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534449|NCT02962895|65689393|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
23534450|NCT02962895|65689394|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
23534451|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534452|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
23534453|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534454|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534455|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534456|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23208438|NCT04092816|64500956|FG001|Overall Study|Lost to Follow-up|2|||
23310979|NCT01136967|64886448|FG000|Overall Study|Withdrawal by Subject|1|||
23310980|NCT01136967|64886449|FG001|Overall Study|Withdrawal by Subject|2|||
23534457|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
23534458|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534459|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534460|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534461|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534462|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
23534463|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534464|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
23534465|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534466|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534467|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534468|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534469|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
23534470|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23534471|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
23615090|NCT03120949|65976342|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
23615091|NCT03120949|65976341|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
23615092|NCT03120949|65976342|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
23615093|NCT03120949|65976341|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
23615094|NCT03120949|65976342|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
23615095|NCT01679613|65976343|FG000|Overall Study|other than stated above|0|||
23615096|NCT01679613|65976344|FG001|Overall Study|other than stated above|1|||
23615097|NCT01679613|65976345|FG002|Overall Study|other than stated above|2|||
23615098|NCT01679613|65976346|FG003|Overall Study|other than stated above|2|||
23615099|NCT04564027|65976347|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
23615100|NCT04564027|65976348|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
23615101|NCT04564027|65976349|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
23615102|NCT04564027|65976350|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
23615103|NCT01808144|65976353|FG000|Overall Study|Death|1|||
23615104|NCT01808144|65976354|FG001|Overall Study|Death|0|||
23615105|NCT01808144|65976353|FG000|Overall Study|Withdrawal by Subject|16|||
23615106|NCT01808144|65976354|FG001|Overall Study|Withdrawal by Subject|23|||
23615107|NCT01808144|65976353|FG000|Overall Study|Lost to Follow-up|6|||
23615108|NCT01808144|65976354|FG001|Overall Study|Lost to Follow-up|3|||
23615109|NCT01808144|65976353|FG000|Overall Study|Protocol Violation|6|||
23615110|NCT01808144|65976354|FG001|Overall Study|Protocol Violation|6|||
23615111|NCT01808144|65976353|FG000|Overall Study|Gout flare|0|||
23615112|NCT01808144|65976354|FG001|Overall Study|Gout flare|1|||
23615113|NCT01808144|65976353|FG000|Overall Study|Adverse Event|11|||
23615114|NCT01808144|65976354|FG001|Overall Study|Adverse Event|15|||
23615115|NCT00006436|65976355|FG000|Overall Study|Refused further treatment|2|||
23615116|NCT00006436|65976355|FG000|Overall Study|Declined to participate (before treatment started)|1|||
23615117|NCT01536795|65976356|FG000|Overall Study|Lost to Follow-up|0|||
23615118|NCT01536795|65976357|FG001|Overall Study|Lost to Follow-up|2|||
23615119|NCT01536795|65976356|FG000|Overall Study|Lack of Efficacy|1|||
23310981|NCT01136967|64886448|FG000|Overall Study|Clinical Progression|3|||
23310982|NCT01136967|64886449|FG001|Overall Study|Clinical Progression|5|||
23310983|NCT01136967|64886448|FG000|Overall Study|Radiation|1|||
23310984|NCT01136967|64886449|FG001|Overall Study|Radiation|0|||
23310985|NCT01136967|64886448|FG000|Overall Study|Non-compliance|1|||
23615120|NCT01536795|65976357|FG001|Overall Study|Lack of Efficacy|0|||
23615121|NCT00527514|65976358|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
23615122|NCT00527514|65976358|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
23310986|NCT01136967|64886449|FG001|Overall Study|Non-compliance|0|||
23422282|NCT02754141|65288435|FG017|Overall Study|Not completing monotherapy|0|||
23422283|NCT02526524|65288436|FG000|Overall Study|Withdrawal by Subject|3|||
23534472|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
23534473|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
23534474|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
23534475|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
23534476|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
23534477|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
23534478|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
23534479|NCT02962895|65689388|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
23615123|NCT00527514|65976358|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
23615124|NCT00527514|65976358|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
23615125|NCT00527514|65976358|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
23615126|NCT00527514|65976358|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
23615127|NCT00527514|65976358|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
23615128|NCT00265096|65976359|FG000|Overall Study|Adverse Event|14|||
23615129|NCT00265096|65976360|FG001|Overall Study|Adverse Event|18|||
23615130|NCT00265096|65976361|FG002|Overall Study|Adverse Event|18|||
23534480|NCT02962895|65689389|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
23534481|NCT02962895|65689390|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
23534482|NCT02962895|65689391|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
23534483|NCT02962895|65689392|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
23534484|NCT02962895|65689393|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
23534485|NCT02962895|65689394|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
23534486|NCT04456699|65689395|FG000|Overall Study|Death|48|||
23534487|NCT04456699|65689396|FG001|Overall Study|Death|50|||
23534488|NCT04456699|65689397|FG002|Overall Study|Death|52|||
23534489|NCT04456699|65689395|FG000|Overall Study|Physician Decision|0|||
23534490|NCT04456699|65689396|FG001|Overall Study|Physician Decision|0|||
23534491|NCT04456699|65689397|FG002|Overall Study|Physician Decision|2|||
23615131|NCT00265096|65976359|FG000|Overall Study|Lost to Follow-up|2|||
23615132|NCT00265096|65976360|FG001|Overall Study|Lost to Follow-up|5|||
23208439|NCT01996748|64500958|FG000|Overall Study|Personal reason|1|||
23208440|NCT01996748|64500959|FG001|Overall Study|Personal reason|0|||
23310987|NCT01136967|64886448|FG000|Overall Study|Investigator's Choice|1|||
23310988|NCT01136967|64886449|FG001|Overall Study|Investigator's Choice|1|||
23310989|NCT01136967|64886448|FG000|Overall Study|Increase in Lesion Size|0|||
23310990|NCT01136967|64886449|FG001|Overall Study|Increase in Lesion Size|2|||
23310991|NCT01136967|64886448|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
23310992|NCT01136967|64886449|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
23310993|NCT01006135|64886450|FG000|Overall Study|Adverse Event|22|||
23310994|NCT01006135|64886450|FG000|Overall Study|Protocol Violation|14|||
23208441|NCT01996748|64500958|FG000|Overall Study|Physician Decision|2|||
23208442|NCT01996748|64500959|FG001|Overall Study|Physician Decision|0|||
23208443|NCT01996748|64500958|FG000|Overall Study|Adverse Event|1|||
23208444|NCT01996748|64500959|FG001|Overall Study|Adverse Event|4|||
23208445|NCT01996748|64500958|FG000|Overall Study|Withdrawal by Subject|0|||
23208446|NCT01996748|64500959|FG001|Overall Study|Withdrawal by Subject|1|||
23208447|NCT01996748|64500958|FG000|Overall Study|Lost to Follow-up|4|||
23208448|NCT01996748|64500959|FG001|Overall Study|Lost to Follow-up|1|||
23208449|NCT01694420|64500962|FG000|Overall Study|Lost to Follow-up|3|||
23208450|NCT03115476|64500966|FG000|LP0084-1369|Death|1|||
23208451|NCT03115476|64500967|FG001|LP0084-1369|Death|0|||
23208452|NCT03115476|64500968|FG002|LP0084-1369|Death|2|||
23208453|NCT03115476|64500966|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
23208454|NCT03115476|64500967|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
23208455|NCT03115476|64500968|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
23208456|NCT05294211|64500972|FG000|Overall Study|Withdrawal by Subject|3|||
23208457|NCT05294211|64500972|FG000|Overall Study|Physician Decision|2|||
23208458|NCT05294211|64500972|FG000|Overall Study|Progressed to active labor|1|||
23208459|NCT05294211|64500972|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
23208460|NCT05294211|64500972|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
23208461|NCT00343291|64500973|FG000|Overall Study|Adverse Event|13|||
23208462|NCT00343291|64500974|FG001|Overall Study|Adverse Event|13|||
23208463|NCT00343291|64500973|FG000|Overall Study|Death|3|||
23208464|NCT00343291|64500974|FG001|Overall Study|Death|2|||
23208465|NCT00343291|64500973|FG000|Overall Study|Progressive disease|33|||
23208466|NCT00343291|64500974|FG001|Overall Study|Progressive disease|34|||
23208467|NCT00343291|64500973|FG000|Overall Study|Withdrawal by Subject|0|||
23208468|NCT00343291|64500974|FG001|Overall Study|Withdrawal by Subject|2|||
23208469|NCT00343291|64500973|FG000|Overall Study|Other|8|||
23208470|NCT00343291|64500974|FG001|Overall Study|Other|5|||
23208471|NCT00192036|64500975|FG000|Overall Study|Protocol Violation|3|||
23208472|NCT00192036|64500975|FG000|Overall Study|Adverse Event|6|||
23208473|NCT00192036|64500975|FG000|Overall Study|Patient/Physician Perception|1|||
23208474|NCT00192036|64500975|FG000|Overall Study|Objective Tumor Progression|4|||
23208475|NCT00192036|64500975|FG000|Overall Study|Clinical Disease Progression|1|||
23208476|NCT00192036|64500975|FG000|Overall Study|Death|1|||
23208477|NCT00192036|64500975|FG000|Overall Study|Unknown or Not Specified|5|||
23310995|NCT01006135|64886450|FG000|Overall Study|Lost to Follow-up|32|||
23310996|NCT01006135|64886450|FG000|Overall Study|Other|72|||
23208478|NCT03493685|64500976|FG000|Overall Study|Death|4|||
23208479|NCT03493685|64500977|FG001|Overall Study|Death|3|||
23208480|NCT03493685|64500976|FG000|Overall Study|Lost to Follow-up|3|||
23310997|NCT00492024|64886453|FG000|Treatment|Adverse Event|3|||
23310998|NCT00492024|64886454|FG001|Treatment|Adverse Event|1|||
23310999|NCT00492024|64886453|FG000|Treatment|Lack of Efficacy|21|||
23534492|NCT04456699|65689395|FG000|Overall Study|Sponsor Decision|55|||
23615133|NCT00265096|65976361|FG002|Overall Study|Lost to Follow-up|3|||
23615134|NCT00265096|65976359|FG000|Overall Study|Death|0|||
23208481|NCT03493685|64500977|FG001|Overall Study|Lost to Follow-up|2|||
23311000|NCT00492024|64886454|FG001|Treatment|Lack of Efficacy|20|||
23534493|NCT04456699|65689396|FG001|Overall Study|Sponsor Decision|61|||
23311001|NCT00492024|64886453|FG000|Treatment|Lost to Follow-up|3|||
23311002|NCT00492024|64886454|FG001|Treatment|Lost to Follow-up|1|||
23311003|NCT00492024|64886453|FG000|Treatment|Withdrawal by Subject|2|||
23311004|NCT00492024|64886454|FG001|Treatment|Withdrawal by Subject|0|||
23311005|NCT00492024|64886453|FG000|Follow up|Lack of Efficacy|0|||
23311006|NCT00492024|64886454|FG001|Follow up|Lack of Efficacy|1|||
23311007|NCT00492024|64886453|FG000|Follow up|Lost to Follow-up|1|||
23208482|NCT03493685|64500976|FG000|Overall Study|Physician Decision|2|||
23208483|NCT03493685|64500977|FG001|Overall Study|Physician Decision|0|||
23208484|NCT03493685|64500976|FG000|Overall Study|Withdrawal by Subject|7|||
23208485|NCT03493685|64500977|FG001|Overall Study|Withdrawal by Subject|11|||
23208486|NCT00064350|64500984|FG000|Induction Treatment|Disease Progression|5|||
23208487|NCT00064350|64500985|FG001|Induction Treatment|Disease Progression|1|||
23208488|NCT00064350|64500986|FG002|Induction Treatment|Disease Progression|110|||
23208489|NCT00064350|64500984|FG000|Induction Treatment|Adverse Event|0|||
23208490|NCT00064350|64500985|FG001|Induction Treatment|Adverse Event|2|||
23208491|NCT00064350|64500986|FG002|Induction Treatment|Adverse Event|49|||
23208492|NCT00064350|64500984|FG000|Induction Treatment|Death|0|||
23208493|NCT00064350|64500985|FG001|Induction Treatment|Death|0|||
23208494|NCT00064350|64500986|FG002|Induction Treatment|Death|9|||
23208495|NCT00064350|64500984|FG000|Induction Treatment|Withdrawal by Subject|0|||
23208496|NCT00064350|64500985|FG001|Induction Treatment|Withdrawal by Subject|0|||
23208497|NCT00064350|64500986|FG002|Induction Treatment|Withdrawal by Subject|21|||
23208498|NCT00064350|64500984|FG000|Induction Treatment|Ineligible or never started treatment|3|||
23208499|NCT00064350|64500985|FG001|Induction Treatment|Ineligible or never started treatment|6|||
23208500|NCT00064350|64500986|FG002|Induction Treatment|Ineligible or never started treatment|34|||
23208501|NCT00064350|64500984|FG000|Induction Treatment|Other|0|||
23208502|NCT00064350|64500985|FG001|Induction Treatment|Other|0|||
23208503|NCT00064350|64500986|FG002|Induction Treatment|Other|13|||
23208504|NCT00064350|64500984|FG000|Randomization|Adverse Event|8|||
23208505|NCT00064350|64500985|FG001|Randomization|Adverse Event|3|||
23208506|NCT00064350|64500986|FG002|Randomization|Adverse Event|0|||
23208507|NCT00064350|64500984|FG000|Randomization|Death|3|||
23208508|NCT00064350|64500985|FG001|Randomization|Death|0|||
23208509|NCT00064350|64500986|FG002|Randomization|Death|0|||
23208510|NCT00064350|64500984|FG000|Randomization|Withdrawal by Subject|1|||
23208511|NCT00064350|64500985|FG001|Randomization|Withdrawal by Subject|0|||
23208512|NCT00064350|64500986|FG002|Randomization|Withdrawal by Subject|0|||
23208513|NCT00064350|64500984|FG000|Randomization|Ineligible or never started treatment|9|||
23208514|NCT00064350|64500985|FG001|Randomization|Ineligible or never started treatment|15|||
23208515|NCT00064350|64500986|FG002|Randomization|Ineligible or never started treatment|0|||
23208516|NCT00064350|64500984|FG000|Randomization|Other|5|||
23208517|NCT00064350|64500985|FG001|Randomization|Other|0|||
23208518|NCT00064350|64500986|FG002|Randomization|Other|0|||
23208519|NCT00064350|64500984|FG000|Cross-Over|Adverse Event|0|||
23208520|NCT00064350|64500985|FG001|Cross-Over|Adverse Event|1|||
23208521|NCT00064350|64500986|FG002|Cross-Over|Adverse Event|0|||
23208522|NCT00064350|64500984|FG000|Cross-Over|Death|1|||
23208523|NCT00064350|64500985|FG001|Cross-Over|Death|3|||
23208524|NCT00064350|64500986|FG002|Cross-Over|Death|0|||
23208525|NCT00064350|64500984|FG000|Cross-Over|Withdrawal by Subject|2|||
23208526|NCT00064350|64500985|FG001|Cross-Over|Withdrawal by Subject|2|||
23208527|NCT00064350|64500986|FG002|Cross-Over|Withdrawal by Subject|0|||
23208528|NCT00064350|64500984|FG000|Cross-Over|Ineligible or never started treatment|3|||
23208529|NCT00064350|64500985|FG001|Cross-Over|Ineligible or never started treatment|6|||
23208530|NCT00064350|64500986|FG002|Cross-Over|Ineligible or never started treatment|0|||
23208531|NCT00064350|64500984|FG000|Cross-Over|Other|0|||
23311008|NCT00492024|64886454|FG001|Follow up|Lost to Follow-up|1|||
23311009|NCT01739348|64886455|FG000|Part I (Base Study)|Adverse Event|41|||
23208532|NCT00064350|64500985|FG001|Cross-Over|Other|2|||
23208533|NCT00064350|64500986|FG002|Cross-Over|Other|0|||
23208534|NCT00622869|64500987|FG000|Overall Study|Subject Withdrew Consent|13|||
23208535|NCT00622869|64500988|FG001|Overall Study|Subject Withdrew Consent|17|||
23208536|NCT00622869|64500989|FG002|Overall Study|Subject Withdrew Consent|11|||
23208537|NCT00622869|64500987|FG000|Overall Study|Administrative Problems|11|||
23208538|NCT00622869|64500988|FG001|Overall Study|Administrative Problems|17|||
23208539|NCT00622869|64500989|FG002|Overall Study|Administrative Problems|13|||
23208540|NCT00622869|64500987|FG000|Overall Study|Death|12|||
23208541|NCT00622869|64500988|FG001|Overall Study|Death|15|||
23311010|NCT01739348|64886456|FG001|Part I (Base Study)|Adverse Event|52|||
23208542|NCT00622869|64500989|FG002|Overall Study|Death|10|||
23208543|NCT00622869|64500987|FG000|Overall Study|Lost to Follow-up|2|||
23208544|NCT00622869|64500988|FG001|Overall Study|Lost to Follow-up|4|||
23208545|NCT00622869|64500989|FG002|Overall Study|Lost to Follow-up|2|||
23208546|NCT00622869|64500987|FG000|Overall Study|Graft Loss|5|||
23208547|NCT00622869|64500988|FG001|Overall Study|Graft Loss|3|||
23208548|NCT00622869|64500989|FG002|Overall Study|Graft Loss|2|||
23208549|NCT00622869|64500987|FG000|Overall Study|Missing|0|||
23208550|NCT00622869|64500988|FG001|Overall Study|Missing|1|||
23208551|NCT00622869|64500989|FG002|Overall Study|Missing|1|||
23208552|NCT00623467|64500990|FG000|Overall Study|Lost to Follow-up|1|||
23208553|NCT00623467|64500990|FG000|Overall Study|Protocol Violation|4|||
23208554|NCT00623467|64500990|FG000|Overall Study|Withdrawal by Subject|2|||
23208555|NCT00789191|64500991|FG000|Overall Study|Adverse Event|2|||
23208556|NCT00789191|64500992|FG001|Overall Study|Adverse Event|4|||
23208557|NCT00789191|64500991|FG000|Overall Study|Lack of Efficacy|0|||
23208558|NCT00789191|64500992|FG001|Overall Study|Lack of Efficacy|5|||
23208559|NCT00789191|64500991|FG000|Overall Study|Protocol Violation|5|||
23208560|NCT00789191|64500992|FG001|Overall Study|Protocol Violation|3|||
23208561|NCT00789191|64500991|FG000|Overall Study|Withdrawal Criteria|2|||
23208562|NCT00789191|64500992|FG001|Overall Study|Withdrawal Criteria|4|||
23208563|NCT00789191|64500991|FG000|Overall Study|Unclassified|5|||
23208564|NCT00789191|64500992|FG001|Overall Study|Unclassified|3|||
23208565|NCT00589979|64500993|FG000|Run-In Period|Adverse Event|5|||
23208566|NCT00589979|64500994|FG001|Run-In Period|Adverse Event|0|||
23208567|NCT00589979|64500995|FG002|Run-In Period|Adverse Event|0|||
23208568|NCT00589979|64500993|FG000|Run-In Period|Protocol Violation|3|||
23208569|NCT00589979|64500994|FG001|Run-In Period|Protocol Violation|0|||
23208570|NCT00589979|64500995|FG002|Run-In Period|Protocol Violation|0|||
23208571|NCT00589979|64500993|FG000|Run-In Period|Did not qualify for randomization|54|||
23208572|NCT00589979|64500994|FG001|Run-In Period|Did not qualify for randomization|0|||
23208573|NCT00589979|64500995|FG002|Run-In Period|Did not qualify for randomization|0|||
23208574|NCT00589979|64500993|FG000|Run-In Period|Withdrawal by Subject|10|||
23208575|NCT00589979|64500994|FG001|Run-In Period|Withdrawal by Subject|0|||
23208576|NCT00589979|64500995|FG002|Run-In Period|Withdrawal by Subject|0|||
23208577|NCT00589979|64500993|FG000|Run-In Period|Informed Consent Withdrawn|4|||
23208578|NCT00589979|64500994|FG001|Run-In Period|Informed Consent Withdrawn|0|||
23208579|NCT00589979|64500995|FG002|Run-In Period|Informed Consent Withdrawn|0|||
23208580|NCT00589979|64500993|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
23208581|NCT00589979|64500994|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
23208582|NCT00589979|64500995|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
23208583|NCT00589979|64500993|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
23208584|NCT00589979|64500994|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
23208585|NCT00589979|64500995|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
23208586|NCT00589979|64500993|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
23208587|NCT00589979|64500994|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
23208588|NCT00589979|64500995|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
23208589|NCT00589979|64500993|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
23208590|NCT00589979|64500994|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
23208591|NCT00589979|64500995|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
23208592|NCT00589979|64500993|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
23208593|NCT00589979|64500994|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
23208594|NCT00589979|64500995|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
23208595|NCT00589979|64500993|FG000|Double-Blind Treatment Period 2|Other|0|||
23208596|NCT00589979|64500994|FG001|Double-Blind Treatment Period 2|Other|0|||
23208597|NCT00589979|64500995|FG002|Double-Blind Treatment Period 2|Other|1|||
23208598|NCT00589979|64500993|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
23208599|NCT00589979|64500994|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
23311011|NCT01739348|64886457|FG002|Part I (Base Study)|Adverse Event|8|||
23311012|NCT01739348|64886458|FG003|Part I (Base Study)|Adverse Event|33|||
23311013|NCT01739348|64886455|FG000|Part I (Base Study)|Death|10|||
23311014|NCT01739348|64886456|FG001|Part I (Base Study)|Death|7|||
23311015|NCT01739348|64886457|FG002|Part I (Base Study)|Death|2|||
23311016|NCT01739348|64886458|FG003|Part I (Base Study)|Death|8|||
23311017|NCT01739348|64886455|FG000|Part I (Base Study)|Lack of Efficacy|3|||
23422284|NCT02526524|65288437|FG001|Overall Study|Withdrawal by Subject|3|||
23422285|NCT02526524|65288438|FG002|Overall Study|Withdrawal by Subject|6|||
23422286|NCT02526524|65288439|FG003|Overall Study|Withdrawal by Subject|1|||
23422287|NCT02526524|65288440|FG004|Overall Study|Withdrawal by Subject|9|||
23422288|NCT02526524|65288441|FG005|Overall Study|Withdrawal by Subject|5|||
23422289|NCT02526524|65288436|FG000|Overall Study|Adverse Event|3|||
23422290|NCT02526524|65288437|FG001|Overall Study|Adverse Event|2|||
23422291|NCT02526524|65288438|FG002|Overall Study|Adverse Event|4|||
23422292|NCT02526524|65288439|FG003|Overall Study|Adverse Event|2|||
23422293|NCT02526524|65288440|FG004|Overall Study|Adverse Event|6|||
23422294|NCT02526524|65288441|FG005|Overall Study|Adverse Event|8|||
23422295|NCT02526524|65288436|FG000|Overall Study|Lost to Follow-up|2|||
23422296|NCT02526524|65288437|FG001|Overall Study|Lost to Follow-up|3|||
23422297|NCT02526524|65288438|FG002|Overall Study|Lost to Follow-up|8|||
23422298|NCT02526524|65288439|FG003|Overall Study|Lost to Follow-up|1|||
23422299|NCT02526524|65288440|FG004|Overall Study|Lost to Follow-up|2|||
23422300|NCT02526524|65288441|FG005|Overall Study|Lost to Follow-up|5|||
23422301|NCT02526524|65288436|FG000|Overall Study|Protocol Violation|3|||
23422302|NCT02526524|65288437|FG001|Overall Study|Protocol Violation|1|||
23422303|NCT02526524|65288438|FG002|Overall Study|Protocol Violation|5|||
23422304|NCT02526524|65288439|FG003|Overall Study|Protocol Violation|3|||
23422305|NCT02526524|65288440|FG004|Overall Study|Protocol Violation|4|||
23422306|NCT02526524|65288441|FG005|Overall Study|Protocol Violation|3|||
23422307|NCT02526524|65288436|FG000|Overall Study|Loss of Glucose Control|0|||
23422308|NCT02526524|65288437|FG001|Overall Study|Loss of Glucose Control|0|||
23422309|NCT02526524|65288438|FG002|Overall Study|Loss of Glucose Control|3|||
23311018|NCT01739348|64886456|FG001|Part I (Base Study)|Lack of Efficacy|8|||
23311019|NCT01739348|64886457|FG002|Part I (Base Study)|Lack of Efficacy|0|||
23311020|NCT01739348|64886458|FG003|Part I (Base Study)|Lack of Efficacy|7|||
23311021|NCT01739348|64886455|FG000|Part I (Base Study)|Lost to Follow-up|4|||
23422310|NCT02526524|65288439|FG003|Overall Study|Loss of Glucose Control|0|||
23422311|NCT02526524|65288440|FG004|Overall Study|Loss of Glucose Control|2|||
23422312|NCT02526524|65288441|FG005|Overall Study|Loss of Glucose Control|0|||
23422313|NCT02526524|65288436|FG000|Overall Study|Physician Decision|0|||
23422314|NCT02526524|65288437|FG001|Overall Study|Physician Decision|0|||
23422315|NCT02526524|65288438|FG002|Overall Study|Physician Decision|0|||
23422316|NCT02526524|65288439|FG003|Overall Study|Physician Decision|0|||
23422317|NCT02526524|65288440|FG004|Overall Study|Physician Decision|1|||
23422318|NCT02526524|65288441|FG005|Overall Study|Physician Decision|0|||
23422319|NCT02526524|65288436|FG000|Overall Study|Sponsor Decision|1|||
23422320|NCT02526524|65288437|FG001|Overall Study|Sponsor Decision|0|||
23422321|NCT02526524|65288438|FG002|Overall Study|Sponsor Decision|0|||
23422322|NCT02526524|65288439|FG003|Overall Study|Sponsor Decision|0|||
23311022|NCT01739348|64886456|FG001|Part I (Base Study)|Lost to Follow-up|2|||
23311023|NCT01739348|64886457|FG002|Part I (Base Study)|Lost to Follow-up|4|||
23311024|NCT01739348|64886458|FG003|Part I (Base Study)|Lost to Follow-up|4|||
23311025|NCT01739348|64886455|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
23311026|NCT01739348|64886456|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
23311027|NCT01739348|64886457|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
23422323|NCT02526524|65288440|FG004|Overall Study|Sponsor Decision|0|||
23311028|NCT01739348|64886458|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
23422324|NCT02526524|65288441|FG005|Overall Study|Sponsor Decision|0|||
23422325|NCT01598753|65288442|FG000|Overall Study|Adverse Event|1|||
23422326|NCT01598753|65288443|FG001|Overall Study|Adverse Event|9|||
23422327|NCT01598753|65288444|FG002|Overall Study|Adverse Event|1|||
23311029|NCT01739348|64886455|FG000|Part I (Base Study)|Physician Decision|10|||
23311030|NCT01739348|64886456|FG001|Part I (Base Study)|Physician Decision|7|||
23422328|NCT01598753|65288445|FG003|Overall Study|Adverse Event|7|||
23422329|NCT01598753|65288442|FG000|Overall Study|Lost to Follow-up|4|||
23422330|NCT01598753|65288443|FG001|Overall Study|Lost to Follow-up|3|||
23422331|NCT01598753|65288444|FG002|Overall Study|Lost to Follow-up|7|||
23422332|NCT01598753|65288445|FG003|Overall Study|Lost to Follow-up|5|||
23422333|NCT01598753|65288442|FG000|Overall Study|Physician Decision|0|||
23311031|NCT01739348|64886457|FG002|Part I (Base Study)|Physician Decision|1|||
23311032|NCT01739348|64886458|FG003|Part I (Base Study)|Physician Decision|4|||
23311033|NCT01739348|64886455|FG000|Part I (Base Study)|Protocol Violation|2|||
23311034|NCT01739348|64886456|FG001|Part I (Base Study)|Protocol Violation|0|||
23311035|NCT01739348|64886457|FG002|Part I (Base Study)|Protocol Violation|1|||
23311036|NCT01739348|64886458|FG003|Part I (Base Study)|Protocol Violation|2|||
23311037|NCT01739348|64886455|FG000|Part I (Base Study)|Screen Failure|2|||
23311038|NCT01739348|64886456|FG001|Part I (Base Study)|Screen Failure|0|||
23311039|NCT01739348|64886457|FG002|Part I (Base Study)|Screen Failure|0|||
23311040|NCT01739348|64886458|FG003|Part I (Base Study)|Screen Failure|0|||
23311041|NCT01739348|64886455|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
23422334|NCT01598753|65288443|FG001|Overall Study|Physician Decision|1|||
23422335|NCT01598753|65288444|FG002|Overall Study|Physician Decision|0|||
23422336|NCT01598753|65288445|FG003|Overall Study|Physician Decision|2|||
23422337|NCT01598753|65288442|FG000|Overall Study|Withdrawal by Subject|7|||
23422338|NCT01598753|65288443|FG001|Overall Study|Withdrawal by Subject|2|||
23422339|NCT01598753|65288444|FG002|Overall Study|Withdrawal by Subject|0|||
23422340|NCT01598753|65288445|FG003|Overall Study|Withdrawal by Subject|1|||
23422341|NCT01349322|65288454|FG000|Overall Study|Protocol Violation|45|||
23422342|NCT01349322|65288455|FG001|Overall Study|Protocol Violation|47|||
23422343|NCT00322023|65288456|FG000|Overall Study|various|0|||
23422344|NCT00322023|65288457|FG001|Overall Study|various|2|||
23422345|NCT00322023|65288458|FG002|Overall Study|various|6|||
23422346|NCT03334851|65288459|FG000|Overall Study|Other|0|||
23422347|NCT03334851|65288460|FG001|Overall Study|Other|0|||
23422348|NCT03334851|65288461|FG002|Overall Study|Other|0|||
23422349|NCT03334851|65288462|FG003|Overall Study|Other|0|||
23311042|NCT01739348|64886456|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
23311043|NCT01739348|64886457|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
23311044|NCT01739348|64886458|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
23311045|NCT01739348|64886455|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
23422350|NCT03334851|65288463|FG004|Overall Study|Other|0|||
23422351|NCT03334851|65288464|FG005|Overall Study|Other|0|||
23422352|NCT03334851|65288465|FG006|Overall Study|Other|0|||
23422353|NCT03334851|65288466|FG007|Overall Study|Other|1|||
23615135|NCT00265096|65976360|FG001|Overall Study|Death|1|||
23615136|NCT00265096|65976361|FG002|Overall Study|Death|2|||
23208600|NCT00589979|64500995|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
23208601|NCT00589979|64500993|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
23208602|NCT00589979|64500994|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
23208603|NCT00589979|64500995|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
23208604|NCT00574119|64500996|FG000|Overall Study|Adverse Event|1|||
23208605|NCT00574119|64500996|FG000|Overall Study|Protocol Violation|1|||
23208606|NCT00574119|64500996|FG000|Overall Study|Withdrawal by Subject|1|||
23208607|NCT00574119|64500996|FG000|Overall Study|Physician Decision|1|||
23422354|NCT03334851|65288467|FG008|Overall Study|Other|0|||
23422355|NCT03334851|65288468|FG009|Overall Study|Other|0|||
23422356|NCT03334851|65288469|FG010|Overall Study|Other|0|||
23422357|NCT03334851|65288470|FG011|Overall Study|Other|0|||
23422358|NCT03334851|65288471|FG012|Overall Study|Other|0|||
23422359|NCT03334851|65288459|FG000|Overall Study|Adverse Event|0|||
23422360|NCT03334851|65288460|FG001|Overall Study|Adverse Event|0|||
23422361|NCT03334851|65288461|FG002|Overall Study|Adverse Event|0|||
23422362|NCT03334851|65288462|FG003|Overall Study|Adverse Event|0|||
23422363|NCT03334851|65288463|FG004|Overall Study|Adverse Event|0|||
23422364|NCT03334851|65288464|FG005|Overall Study|Adverse Event|0|||
23422365|NCT03334851|65288465|FG006|Overall Study|Adverse Event|0|||
23422366|NCT03334851|65288466|FG007|Overall Study|Adverse Event|1|||
23422367|NCT03334851|65288467|FG008|Overall Study|Adverse Event|0|||
23615137|NCT00265096|65976359|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
23208608|NCT01518244|64500998|FG000|Overall Study|Adverse Event|3|||
23208609|NCT00798655|64501005|FG000|Overall Study|Did not receive at least one dose of pan|2|||
23208610|NCT00012012|64501006|FG000|Overall Study|Protocol Violation|1|||
23311046|NCT01739348|64886456|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
23311047|NCT01739348|64886457|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
23311048|NCT01739348|64886458|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
23422368|NCT03334851|65288468|FG009|Overall Study|Adverse Event|0|||
23422369|NCT03334851|65288469|FG010|Overall Study|Adverse Event|0|||
23422370|NCT03334851|65288470|FG011|Overall Study|Adverse Event|0|||
23422371|NCT03334851|65288471|FG012|Overall Study|Adverse Event|0|||
23422372|NCT03334851|65288459|FG000|Overall Study|Withdrawal by Subject|0|||
23422373|NCT03334851|65288460|FG001|Overall Study|Withdrawal by Subject|0|||
23422374|NCT03334851|65288461|FG002|Overall Study|Withdrawal by Subject|0|||
23422375|NCT03334851|65288462|FG003|Overall Study|Withdrawal by Subject|0|||
23422376|NCT03334851|65288463|FG004|Overall Study|Withdrawal by Subject|0|||
23422377|NCT03334851|65288464|FG005|Overall Study|Withdrawal by Subject|0|||
23615138|NCT00265096|65976360|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23422378|NCT03334851|65288465|FG006|Overall Study|Withdrawal by Subject|0|||
23422379|NCT03334851|65288466|FG007|Overall Study|Withdrawal by Subject|0|||
23422380|NCT03334851|65288467|FG008|Overall Study|Withdrawal by Subject|0|||
23422381|NCT03334851|65288468|FG009|Overall Study|Withdrawal by Subject|0|||
23422382|NCT03334851|65288469|FG010|Overall Study|Withdrawal by Subject|1|||
23422383|NCT03334851|65288470|FG011|Overall Study|Withdrawal by Subject|0|||
23422384|NCT03334851|65288471|FG012|Overall Study|Withdrawal by Subject|1|||
23422385|NCT03334851|65288459|FG000|Overall Study|Lost to Follow-up|0|||
23422386|NCT03334851|65288460|FG001|Overall Study|Lost to Follow-up|0|||
23422387|NCT03334851|65288461|FG002|Overall Study|Lost to Follow-up|0|||
23422388|NCT03334851|65288462|FG003|Overall Study|Lost to Follow-up|0|||
23422389|NCT03334851|65288463|FG004|Overall Study|Lost to Follow-up|0|||
23422390|NCT03334851|65288464|FG005|Overall Study|Lost to Follow-up|0|||
23422391|NCT03334851|65288465|FG006|Overall Study|Lost to Follow-up|0|||
23422392|NCT03334851|65288466|FG007|Overall Study|Lost to Follow-up|0|||
23422393|NCT03334851|65288467|FG008|Overall Study|Lost to Follow-up|0|||
23422394|NCT03334851|65288468|FG009|Overall Study|Lost to Follow-up|0|||
23422395|NCT03334851|65288469|FG010|Overall Study|Lost to Follow-up|2|||
23422396|NCT03334851|65288470|FG011|Overall Study|Lost to Follow-up|1|||
23422397|NCT03334851|65288471|FG012|Overall Study|Lost to Follow-up|0|||
23422398|NCT03500172|65288472|FG000|Period 1: Baseline Randomization|Death|0|||
23422399|NCT03500172|65288473|FG001|Period 1: Baseline Randomization|Death|0|||
23422400|NCT03500172|65288474|FG002|Period 1: Baseline Randomization|Death|0|||
23422401|NCT03500172|65288475|FG003|Period 1: Baseline Randomization|Death|0|||
23422402|NCT03500172|65288476|FG004|Period 1: Baseline Randomization|Death|0|||
23422403|NCT03500172|65288477|FG005|Period 1: Baseline Randomization|Death|0|||
23422404|NCT03500172|65288478|FG006|Period 1: Baseline Randomization|Death|0|||
23422405|NCT03500172|65288479|FG007|Period 1: Baseline Randomization|Death|0|||
23422406|NCT03500172|65288480|FG008|Period 1: Baseline Randomization|Death|0|||
23422407|NCT03500172|65288481|FG009|Period 1: Baseline Randomization|Death|2|||
23422408|NCT03500172|65288482|FG010|Period 1: Baseline Randomization|Death|0|||
23422409|NCT03500172|65288472|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
23422410|NCT03500172|65288473|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
23422411|NCT03500172|65288474|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
23422412|NCT03500172|65288475|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
23422413|NCT03500172|65288476|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
23422414|NCT03500172|65288477|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
23422415|NCT03500172|65288478|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
23422416|NCT03500172|65288479|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
23422417|NCT03500172|65288480|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
23422418|NCT03500172|65288481|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
23208611|NCT00012012|64501007|FG001|Overall Study|Protocol Violation|1|||
23208612|NCT00012012|64501006|FG000|Overall Study|Withdrawal by Subject|0|||
23208613|NCT00012012|64501007|FG001|Overall Study|Withdrawal by Subject|2|||
23208614|NCT00878215|64501008|FG000|Overall Study|Determined to be ineligible|0|||
23208615|NCT00878215|64501009|FG001|Overall Study|Determined to be ineligible|10|||
23208616|NCT00878215|64501010|FG002|Overall Study|Determined to be ineligible|0|||
23208617|NCT00878215|64501011|FG003|Overall Study|Determined to be ineligible|0|||
23208618|NCT00111917|64501012|FG000|Overall Study|Withdrawal by Subject|1|||
23208619|NCT00111917|64501013|FG001|Overall Study|Withdrawal by Subject|1|||
23422419|NCT03500172|65288482|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
23422420|NCT03500172|65288472|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
23422421|NCT03500172|65288473|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
23422422|NCT03500172|65288474|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
23422423|NCT03500172|65288475|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
23422424|NCT03500172|65288476|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
23534494|NCT04456699|65689397|FG002|Overall Study|Sponsor Decision|50|||
23534495|NCT04456699|65689395|FG000|Overall Study|Withdrawal by Subject|8|||
23534496|NCT04456699|65689396|FG001|Overall Study|Withdrawal by Subject|4|||
23534497|NCT04456699|65689397|FG002|Overall Study|Withdrawal by Subject|5|||
23534498|NCT03199469|65689400|FG000|Overall Study|Randomized, not treated|0|||
23534499|NCT03199469|65689401|FG001|Overall Study|Randomized, not treated|3|||
23208620|NCT00819585|64501018|FG000|Core Study|Adverse Event|2|||
23208621|NCT00819585|64501019|FG001|Core Study|Adverse Event|1|||
23422425|NCT03500172|65288477|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
23422426|NCT03500172|65288478|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
23422427|NCT03500172|65288479|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
23422428|NCT03500172|65288480|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
23422429|NCT03500172|65288481|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
23422430|NCT03500172|65288482|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
23534500|NCT03199469|65689400|FG000|Overall Study|Withdrawal by Subject|1|||
23208622|NCT00819585|64501020|FG002|Core Study|Adverse Event|1|||
23208623|NCT00819585|64501021|FG003|Core Study|Adverse Event|4|||
23422431|NCT03500172|65288472|FG000|Period 2: Re-Randomization|Death|0|||
23422432|NCT03500172|65288473|FG001|Period 2: Re-Randomization|Death|0|||
23422433|NCT03500172|65288474|FG002|Period 2: Re-Randomization|Death|0|||
23422434|NCT03500172|65288475|FG003|Period 2: Re-Randomization|Death|4|||
23422435|NCT03500172|65288476|FG004|Period 2: Re-Randomization|Death|2|||
23422436|NCT03500172|65288477|FG005|Period 2: Re-Randomization|Death|0|||
23422437|NCT03500172|65288478|FG006|Period 2: Re-Randomization|Death|5|||
23422438|NCT03500172|65288479|FG007|Period 2: Re-Randomization|Death|2|||
23422439|NCT03500172|65288480|FG008|Period 2: Re-Randomization|Death|0|||
23422440|NCT03500172|65288481|FG009|Period 2: Re-Randomization|Death|0|||
23422441|NCT03500172|65288482|FG010|Period 2: Re-Randomization|Death|0|||
23422442|NCT01474772|65288490|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
23422443|NCT01474772|65288491|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
23422444|NCT01474772|65288490|FG000|Period 1|AE not Related to Study Drug|1|||
23422445|NCT01474772|65288491|FG001|Period 1|AE not Related to Study Drug|0|||
23422446|NCT01474772|65288490|FG000|Period 1|Withdrawal by Subject|3|||
23422447|NCT01474772|65288491|FG001|Period 1|Withdrawal by Subject|1|||
23422448|NCT01474772|65288490|FG000|Period 1|Lost to Follow-up|1|||
23422449|NCT01474772|65288491|FG001|Period 1|Lost to Follow-up|0|||
23422450|NCT01474772|65288490|FG000|Period 1|Reason not Specified|1|||
23422451|NCT01474772|65288491|FG001|Period 1|Reason not Specified|1|||
23422452|NCT01474772|65288490|FG000|Washout|AE not Related to Study Drug|2|||
23422453|NCT01474772|65288491|FG001|Washout|AE not Related to Study Drug|0|||
23422454|NCT01474772|65288490|FG000|Washout|Withdrawal by Subject|1|||
23422455|NCT01474772|65288491|FG001|Washout|Withdrawal by Subject|0|||
23422456|NCT01474772|65288490|FG000|Washout|Lost to Follow-up|0|||
23422457|NCT01474772|65288491|FG001|Washout|Lost to Follow-up|1|||
23422458|NCT01474772|65288490|FG000|Washout|Reason not Specified|0|||
23422459|NCT01474772|65288491|FG001|Washout|Reason not Specified|1|||
23422460|NCT01474772|65288490|FG000|Period 2|Death|0|||
23422461|NCT01474772|65288491|FG001|Period 2|Death|1|||
23422462|NCT01474772|65288490|FG000|Period 2|AE Related to Study Drug|0|||
23422463|NCT01474772|65288491|FG001|Period 2|AE Related to Study Drug|1|||
23422464|NCT01474772|65288490|FG000|Period 2|AE not Related to Study Drug|4|||
23422465|NCT01474772|65288491|FG001|Period 2|AE not Related to Study Drug|1|||
23422466|NCT01474772|65288490|FG000|Period 2|Lack of Efficacy|1|||
23422467|NCT01474772|65288491|FG001|Period 2|Lack of Efficacy|0|||
23422468|NCT01474772|65288490|FG000|Period 2|Withdrawal by Subject|3|||
23422469|NCT01474772|65288491|FG001|Period 2|Withdrawal by Subject|4|||
23422470|NCT01474772|65288490|FG000|Period 2|Lost to Follow-up|1|||
23422471|NCT01474772|65288491|FG001|Period 2|Lost to Follow-up|1|||
23422472|NCT01474772|65288490|FG000|Period 2|Reason not Specified|0|||
23422473|NCT01474772|65288491|FG001|Period 2|Reason not Specified|2|||
23422474|NCT01474772|65288490|FG000|Follow-up|AE not Related to Study Drug|0|||
23422475|NCT01474772|65288491|FG001|Follow-up|AE not Related to Study Drug|1|||
23422476|NCT01510145|65288492|FG000|Overall Study|Adverse Event|6|||
23422477|NCT01510145|65288492|FG000|Overall Study|Lost to Follow-up|5|||
23422478|NCT01510145|65288492|FG000|Overall Study|Withdrawal by Subject|6|||
23422479|NCT01510145|65288492|FG000|Overall Study|Relative reported subject withdrew|1|||
23422480|NCT00683917|65288493|FG000|Overall Study|Study prematurely terminated|10|||
23422481|NCT04126564|65288496|FG000|Overall Study|Withdrawal by Subject|0|||
23422482|NCT04126564|65288497|FG001|Overall Study|Withdrawal by Subject|2|||
23422483|NCT04126564|65288496|FG000|Overall Study|Lost to Follow-up|0|||
23422484|NCT04126564|65288497|FG001|Overall Study|Lost to Follow-up|1|||
23422485|NCT03784846|65288506|FG000|Pre-COVID Study|Lost to Follow-up|3|||
23422486|NCT03784846|65288507|FG001|Pre-COVID Study|Lost to Follow-up|3|||
23422487|NCT03784846|65288508|FG002|Pre-COVID Study|Lost to Follow-up|2|||
23422488|NCT03784846|65288506|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
23422489|NCT03784846|65288507|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
23422490|NCT03784846|65288508|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
23534501|NCT03199469|65689401|FG001|Overall Study|Withdrawal by Subject|0|||
23208624|NCT00819585|64501022|FG004|Core Study|Adverse Event|1|||
23208625|NCT00819585|64501023|FG005|Core Study|Adverse Event|0|||
23208626|NCT00819585|64501024|FG006|Core Study|Adverse Event|2|||
23208627|NCT00819585|64501025|FG007|Core Study|Adverse Event|0|||
23208628|NCT00819585|64501026|FG008|Core Study|Adverse Event|0|||
23208629|NCT00819585|64501027|FG009|Core Study|Adverse Event|0|||
23208630|NCT00819585|64501028|FG010|Core Study|Adverse Event|0|||
23208631|NCT00819585|64501018|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
23311049|NCT01739348|64886455|FG000|Part I (Base Study)|Participant Moved|4|||
23422491|NCT03784846|65288506|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
23422492|NCT03784846|65288507|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
23422493|NCT03784846|65288508|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
23422494|NCT03784846|65288506|FG000|Post-COVID Study|Lost to Follow-up|3|||
23422495|NCT03784846|65288507|FG001|Post-COVID Study|Lost to Follow-up|5|||
23422496|NCT03784846|65288508|FG002|Post-COVID Study|Lost to Follow-up|1|||
23422497|NCT03784846|65288506|FG000|Post-COVID Study|Withdrawal by Subject|1|||
23422498|NCT03784846|65288507|FG001|Post-COVID Study|Withdrawal by Subject|2|||
23422499|NCT03784846|65288508|FG002|Post-COVID Study|Withdrawal by Subject|0|||
23422500|NCT03831880|65288509|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
23534502|NCT03199469|65689400|FG000|Overall Study|Death|1|||
23534503|NCT03199469|65689401|FG001|Overall Study|Death|3|||
23534504|NCT03199469|65689400|FG000|Overall Study|Ongoing|5|||
23208632|NCT00819585|64501019|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
23534505|NCT03199469|65689401|FG001|Overall Study|Ongoing|14|||
23534506|NCT02993146|65689402|FG000|Overall Study|Withdrawal by Subject|0|||
23534507|NCT02993146|65689403|FG001|Overall Study|Withdrawal by Subject|0|||
23534508|NCT02993146|65689404|FG002|Overall Study|Withdrawal by Subject|1|||
23534509|NCT02993146|65689405|FG003|Overall Study|Withdrawal by Subject|1|||
23534510|NCT05413369|65689406|FG000|Overall Study|Adverse Event|1|||
23534511|NCT05413369|65689407|FG001|Overall Study|Adverse Event|1|||
23534512|NCT05413369|65689406|FG000|Overall Study|Withdrawal by Subject|13|||
23534513|NCT05413369|65689407|FG001|Overall Study|Withdrawal by Subject|4|||
23534514|NCT05413369|65689406|FG000|Overall Study|Non-compliance with study schedule|2|||
23534515|NCT05413369|65689407|FG001|Overall Study|Non-compliance with study schedule|1|||
23534516|NCT05413369|65689406|FG000|Overall Study|Other|1|||
23534517|NCT05413369|65689407|FG001|Overall Study|Other|1|||
23534518|NCT02684006|65689408|FG000|Overall Study|Ongoing|31|||
23534519|NCT02684006|65689409|FG001|Overall Study|Ongoing|10|||
23534520|NCT02684006|65689408|FG000|Overall Study|Other|7|||
23534521|NCT02684006|65689409|FG001|Overall Study|Other|6|||
23534522|NCT02684006|65689408|FG000|Overall Study|Protocol Violation|2|||
23208633|NCT00819585|64501020|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
23208634|NCT00819585|64501021|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
23208635|NCT00819585|64501022|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
23208636|NCT00819585|64501023|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
23208637|NCT00819585|64501024|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
23615139|NCT00265096|65976361|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
23615140|NCT00265096|65976359|FG000|Overall Study|Other|11|||
23615141|NCT00265096|65976360|FG001|Overall Study|Other|19|||
23615142|NCT00265096|65976361|FG002|Overall Study|Other|10|||
23615143|NCT00665392|65976364|FG000|Overall Study|not treated|1|||
23615144|NCT00647699|65976366|FG000|Overall Study|Lost to Follow-up|5|||
23615145|NCT00647699|65976367|FG001|Overall Study|Lost to Follow-up|4|||
23615146|NCT00647699|65976366|FG000|Overall Study|Withdrawal by Subject|3|||
23615147|NCT00647699|65976367|FG001|Overall Study|Withdrawal by Subject|8|||
23615148|NCT03899259|65976368|FG000|Overall Study|Adverse Event|5|||
23615149|NCT03899259|65976369|FG001|Overall Study|Adverse Event|4|||
23615150|NCT03899259|65976370|FG002|Overall Study|Adverse Event|6|||
23615151|NCT03899259|65976368|FG000|Overall Study|Lack of Efficacy|5|||
23615152|NCT03899259|65976369|FG001|Overall Study|Lack of Efficacy|0|||
23615153|NCT03899259|65976370|FG002|Overall Study|Lack of Efficacy|2|||
23615154|NCT03899259|65976368|FG000|Overall Study|Pregnancy|3|||
23615155|NCT03899259|65976369|FG001|Overall Study|Pregnancy|0|||
23615156|NCT03899259|65976370|FG002|Overall Study|Pregnancy|1|||
23615157|NCT03899259|65976368|FG000|Overall Study|Physician Decision|0|||
23615158|NCT03899259|65976369|FG001|Overall Study|Physician Decision|1|||
23615159|NCT03899259|65976370|FG002|Overall Study|Physician Decision|0|||
23615160|NCT03899259|65976368|FG000|Overall Study|Protocol Deviation|1|||
23615161|NCT03899259|65976369|FG001|Overall Study|Protocol Deviation|1|||
23615162|NCT03899259|65976370|FG002|Overall Study|Protocol Deviation|1|||
23615163|NCT03899259|65976368|FG000|Overall Study|Withdrawal by Subject|8|||
23615164|NCT03899259|65976369|FG001|Overall Study|Withdrawal by Subject|10|||
23615165|NCT03899259|65976370|FG002|Overall Study|Withdrawal by Subject|12|||
23615166|NCT03899259|65976368|FG000|Overall Study|Lost to Follow-up|5|||
23615167|NCT03899259|65976369|FG001|Overall Study|Lost to Follow-up|6|||
23615168|NCT03899259|65976370|FG002|Overall Study|Lost to Follow-up|2|||
23615169|NCT03899259|65976368|FG000|Overall Study|Lack of Adherence|1|||
23615170|NCT03899259|65976369|FG001|Overall Study|Lack of Adherence|0|||
23615171|NCT03899259|65976370|FG002|Overall Study|Lack of Adherence|0|||
23615172|NCT03899259|65976368|FG000|Overall Study|Screen Failure|1|||
23615173|NCT03899259|65976369|FG001|Overall Study|Screen Failure|0|||
23615174|NCT03899259|65976370|FG002|Overall Study|Screen Failure|0|||
23311050|NCT01739348|64886456|FG001|Part I (Base Study)|Participant Moved|3|||
23534523|NCT02684006|65689409|FG001|Overall Study|Protocol Violation|1|||
23534524|NCT02684006|65689408|FG000|Overall Study|Non-compliance with study drug|1|||
23615175|NCT03899259|65976368|FG000|Overall Study|Ongoing Study Participation|127|||
23615176|NCT03899259|65976369|FG001|Overall Study|Ongoing Study Participation|134|||
23615177|NCT03899259|65976370|FG002|Overall Study|Ongoing Study Participation|210|||
23615178|NCT04748445|65976377|FG000|Overall Study|No longer met eligibility criteria|12|||
23208638|NCT00819585|64501025|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
23534525|NCT02684006|65689409|FG001|Overall Study|Non-compliance with study drug|1|||
23534526|NCT02684006|65689408|FG000|Overall Study|No longer meets eligibility criteria|6|||
23534527|NCT02684006|65689409|FG001|Overall Study|No longer meets eligibility criteria|2|||
23534528|NCT02684006|65689408|FG000|Overall Study|Lost to Follow-up|0|||
23534529|NCT02684006|65689409|FG001|Overall Study|Lost to Follow-up|1|||
23615179|NCT04748445|65976377|FG000|Overall Study|Other|36|||
23615180|NCT04748445|65976377|FG000|Overall Study|Withdrawal by Subject|553|||
23615181|NCT04748445|65976377|FG000|Overall Study|Lost to Follow-up|30|||
23534530|NCT02684006|65689408|FG000|Overall Study|Death|24|||
23534531|NCT02684006|65689409|FG001|Overall Study|Death|22|||
23534532|NCT02684006|65689408|FG000|Overall Study|Global deterioration of health status|18|||
23534533|NCT02684006|65689409|FG001|Overall Study|Global deterioration of health status|20|||
23534534|NCT02684006|65689408|FG000|Overall Study|Physician Decision|14|||
23534535|NCT02684006|65689409|FG001|Overall Study|Physician Decision|9|||
23534536|NCT02684006|65689408|FG000|Overall Study|Adverse Event|74|||
23534537|NCT02684006|65689409|FG001|Overall Study|Adverse Event|65|||
23534538|NCT02684006|65689408|FG000|Overall Study|Withdrawal by Subject|29|||
23534539|NCT02684006|65689409|FG001|Overall Study|Withdrawal by Subject|41|||
23534540|NCT02684006|65689408|FG000|Overall Study|Progressive disease|236|||
23534541|NCT02684006|65689409|FG001|Overall Study|Progressive disease|266|||
23534542|NCT00937547|65689410|FG000|Overall Study|misdiagnosis|1|||
23534543|NCT00937547|65689411|FG001|Overall Study|misdiagnosis|6|||
23534544|NCT00937547|65689412|FG002|Overall Study|misdiagnosis|7|||
23534545|NCT05061446|65689421|FG000|Overall Study|Adverse Event|2|||
23534546|NCT05061446|65689422|FG001|Overall Study|Adverse Event|0|||
23534547|NCT05061446|65689423|FG002|Overall Study|Adverse Event|0|||
23534548|NCT05061446|65689421|FG000|Overall Study|Participant no longer available due to personal reason|0|||
23534549|NCT05061446|65689422|FG001|Overall Study|Participant no longer available due to personal reason|1|||
23534550|NCT05061446|65689423|FG002|Overall Study|Participant no longer available due to personal reason|0|||
23534551|NCT03975647|65689424|FG000|Overall Study|Death|71|||
23534552|NCT03975647|65689425|FG001|Overall Study|Death|63|||
23534553|NCT03975647|65689424|FG000|Overall Study|Lost to Follow-up|2|||
23534554|NCT03975647|65689425|FG001|Overall Study|Lost to Follow-up|2|||
23534555|NCT03975647|65689424|FG000|Overall Study|Subject withdrawal of consent|7|||
23534556|NCT03975647|65689425|FG001|Overall Study|Subject withdrawal of consent|11|||
23534557|NCT04111497|65689426|FG000|Overall Study|relapse of primary disease|1|||
23534558|NCT04111497|65689426|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
23534559|NCT04964544|65689427|FG000|Overall Study|Screen failure or other uncategorised|10|||
23534560|NCT04964544|65689427|FG000|Overall Study|Physician Decision|4|||
23534561|NCT04964544|65689427|FG000|Overall Study|Lost to Follow-up|9|||
23534562|NCT04964544|65689427|FG000|Overall Study|Withdrawal by Subject|18|||
23534563|NCT04964544|65689427|FG000|Overall Study|Death|1|||
23534564|NCT03880578|65689428|FG000|Overall Study|Withdrawal by Subject|0|||
23534565|NCT03880578|65689429|FG001|Overall Study|Withdrawal by Subject|3|||
23534566|NCT03880578|65689430|FG002|Overall Study|Withdrawal by Subject|1|||
23534567|NCT03880578|65689428|FG000|Overall Study|Death|0|||
23534568|NCT03880578|65689429|FG001|Overall Study|Death|1|||
23534569|NCT03880578|65689430|FG002|Overall Study|Death|0|||
23534570|NCT04537715|65689431|FG000|Overall Study|Death|3|||
23534571|NCT04537715|65689432|FG001|Overall Study|Death|1|||
23534572|NCT04537715|65689431|FG000|Overall Study|Withdrawal by Subject|3|||
23534573|NCT04537715|65689432|FG001|Overall Study|Withdrawal by Subject|1|||
23534574|NCT04537715|65689431|FG000|Overall Study|Other|4|||
23534575|NCT04537715|65689432|FG001|Overall Study|Other|3|||
23534576|NCT04537715|65689431|FG000|Overall Study|Progressive disease|1|||
23534577|NCT04537715|65689432|FG001|Overall Study|Progressive disease|0|||
23534578|NCT04429555|65689433|FG000|Overall Study|Death|0|||
23534579|NCT04429555|65689434|FG001|Overall Study|Death|2|||
23534580|NCT04429555|65689433|FG000|Overall Study|Other|2|||
23534581|NCT04429555|65689434|FG001|Overall Study|Other|0|||
23534582|NCT01886872|65689435|FG000|Overall Study|Ineligible|7|||
23534583|NCT01886872|65689436|FG001|Overall Study|Ineligible|4|||
23534584|NCT01886872|65689437|FG002|Overall Study|Ineligible|12|||
23534585|NCT03056690|65689438|FG000|Overall Study|Adverse Event|3|||
23534586|NCT03056690|65689439|FG001|Overall Study|Adverse Event|2|||
23534587|NCT03056690|65689438|FG000|Overall Study|Lack of Efficacy|1|||
23615182|NCT00002540|65976378|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
23615183|NCT00002540|65976379|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
23615184|NCT00002540|65976378|FG000|Overall Study|Died Before Randomization|2|||
23615185|NCT00002540|65976379|FG001|Overall Study|Died Before Randomization|6|||
23534588|NCT03056690|65689439|FG001|Overall Study|Lack of Efficacy|2|||
23534589|NCT03056690|65689438|FG000|Overall Study|Lost to Follow-up|3|||
23534590|NCT03056690|65689439|FG001|Overall Study|Lost to Follow-up|2|||
23615186|NCT00002540|65976378|FG000|Overall Study|Died Before ASU (Control)|202|||
23534591|NCT03056690|65689438|FG000|Overall Study|Protocol Violation|2|||
23534592|NCT03056690|65689439|FG001|Overall Study|Protocol Violation|2|||
23534593|NCT03056690|65689438|FG000|Overall Study|Withdrawal by Subject|3|||
23534594|NCT03056690|65689439|FG001|Overall Study|Withdrawal by Subject|6|||
23534595|NCT03056690|65689438|FG000|Overall Study|Non-compliance with Study Drug|1|||
23534596|NCT03056690|65689439|FG001|Overall Study|Non-compliance with Study Drug|0|||
23615187|NCT00002540|65976379|FG001|Overall Study|Died Before ASU (Control)|0|||
23534597|NCT03056690|65689438|FG000|Overall Study|Miscellaneous|1|||
23534598|NCT03056690|65689439|FG001|Overall Study|Miscellaneous|2|||
23534599|NCT03837899|65689448|FG000|Overall Study|Death|6|||
23534600|NCT03837899|65689449|FG001|Overall Study|Death|8|||
23534601|NCT03837899|65689450|FG002|Overall Study|Death|3|||
23311051|NCT01739348|64886457|FG002|Part I (Base Study)|Participant Moved|1|||
23311052|NCT01739348|64886458|FG003|Part I (Base Study)|Participant Moved|7|||
23311053|NCT01739348|64886455|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
23311054|NCT01739348|64886456|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
23311055|NCT01739348|64886457|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
23311056|NCT01739348|64886458|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
23311057|NCT01739348|64886455|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
23311058|NCT01739348|64886456|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
23311059|NCT01739348|64886457|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
23311060|NCT01739348|64886458|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
23311061|NCT01739348|64886455|FG000|Part II (Extension Study)|Adverse Event|10|||
23311062|NCT01739348|64886456|FG001|Part II (Extension Study)|Adverse Event|11|||
23534602|NCT03837899|65689451|FG003|Overall Study|Death|7|||
23534603|NCT03837899|65689452|FG004|Overall Study|Death|8|||
23534604|NCT03837899|65689453|FG005|Overall Study|Death|7|||
23534605|NCT03837899|65689448|FG000|Overall Study|Moved to post-trial access program|0|||
23534606|NCT03837899|65689449|FG001|Overall Study|Moved to post-trial access program|1|||
23534607|NCT03837899|65689450|FG002|Overall Study|Moved to post-trial access program|0|||
23534608|NCT03837899|65689451|FG003|Overall Study|Moved to post-trial access program|0|||
23534609|NCT03837899|65689452|FG004|Overall Study|Moved to post-trial access program|0|||
23534610|NCT03837899|65689453|FG005|Overall Study|Moved to post-trial access program|0|||
23534611|NCT03837899|65689448|FG000|Overall Study|Other|0|||
23534612|NCT03837899|65689449|FG001|Overall Study|Other|0|||
23534613|NCT03837899|65689450|FG002|Overall Study|Other|0|||
23534614|NCT03837899|65689451|FG003|Overall Study|Other|0|||
23534615|NCT03837899|65689452|FG004|Overall Study|Other|0|||
23534616|NCT03837899|65689453|FG005|Overall Study|Other|2|||
23534617|NCT03837899|65689448|FG000|Overall Study|Lost to Follow-up|0|||
23534618|NCT03837899|65689449|FG001|Overall Study|Lost to Follow-up|1|||
23534619|NCT03837899|65689450|FG002|Overall Study|Lost to Follow-up|0|||
23534620|NCT03837899|65689451|FG003|Overall Study|Lost to Follow-up|0|||
23534621|NCT03837899|65689452|FG004|Overall Study|Lost to Follow-up|0|||
23534622|NCT03837899|65689453|FG005|Overall Study|Lost to Follow-up|0|||
23534623|NCT03837899|65689448|FG000|Overall Study|Withdrawal by Subject|0|||
23534624|NCT03837899|65689449|FG001|Overall Study|Withdrawal by Subject|0|||
23534625|NCT03837899|65689450|FG002|Overall Study|Withdrawal by Subject|0|||
23534626|NCT03837899|65689451|FG003|Overall Study|Withdrawal by Subject|1|||
23534627|NCT03837899|65689452|FG004|Overall Study|Withdrawal by Subject|0|||
23534628|NCT03837899|65689453|FG005|Overall Study|Withdrawal by Subject|0|||
23534629|NCT03837899|65689448|FG000|Overall Study|Study specific discontinuation criteria|0|||
23534630|NCT03837899|65689449|FG001|Overall Study|Study specific discontinuation criteria|1|||
23534631|NCT03837899|65689450|FG002|Overall Study|Study specific discontinuation criteria|0|||
23534632|NCT03837899|65689451|FG003|Overall Study|Study specific discontinuation criteria|0|||
23534633|NCT03837899|65689452|FG004|Overall Study|Study specific discontinuation criteria|3|||
23534634|NCT03837899|65689453|FG005|Overall Study|Study specific discontinuation criteria|1|||
23534635|NCT01856192|65689454|FG000|Overall Study|Adverse Event|12|||
23534636|NCT01856192|65689455|FG001|Overall Study|Adverse Event|4|||
23534637|NCT01856192|65689454|FG000|Overall Study|Alternative therapy|0|||
23615188|NCT00002540|65976378|FG000|Overall Study|Refused ASU (Control)|597|||
23534638|NCT01856192|65689455|FG001|Overall Study|Alternative therapy|3|||
23534639|NCT01856192|65689454|FG000|Overall Study|Death|3|||
23534640|NCT01856192|65689455|FG001|Overall Study|Death|5|||
23534641|NCT01856192|65689454|FG000|Overall Study|Lack of Efficacy|0|||
23534642|NCT01856192|65689455|FG001|Overall Study|Lack of Efficacy|5|||
23534643|NCT01856192|65689454|FG000|Overall Study|Withdrawal by Subject|1|||
23534644|NCT01856192|65689455|FG001|Overall Study|Withdrawal by Subject|1|||
23534645|NCT01856192|65689454|FG000|Overall Study|Other diseases|1|||
23534646|NCT01856192|65689455|FG001|Overall Study|Other diseases|0|||
23534647|NCT01856192|65689454|FG000|Overall Study|Never started treatment|7|||
23534648|NCT01856192|65689455|FG001|Overall Study|Never started treatment|5|||
23534649|NCT01856192|65689454|FG000|Overall Study|Path ineligible|20|||
23208639|NCT00819585|64501026|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
23208640|NCT00819585|64501027|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
23208641|NCT00819585|64501028|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
23208642|NCT00819585|64501018|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
23208643|NCT00819585|64501019|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
23208644|NCT00819585|64501020|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
23208645|NCT00819585|64501021|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
23208646|NCT00819585|64501022|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
23311063|NCT01739348|64886457|FG002|Part II (Extension Study)|Adverse Event|7|||
23311064|NCT01739348|64886458|FG003|Part II (Extension Study)|Adverse Event|26|||
23534650|NCT01856192|65689455|FG001|Overall Study|Path ineligible|34|||
23534651|NCT01856192|65689454|FG000|Overall Study|Non-path ineligible|2|||
23534652|NCT01856192|65689455|FG001|Overall Study|Non-path ineligible|2|||
23534653|NCT01856192|65689454|FG000|Overall Study|Physician Decision|1|||
23534654|NCT01856192|65689455|FG001|Overall Study|Physician Decision|1|||
23534655|NCT01856192|65689454|FG000|Overall Study|Suspicion of progressive disease|1|||
23534656|NCT01856192|65689455|FG001|Overall Study|Suspicion of progressive disease|0|||
23534657|NCT01856192|65689454|FG000|Overall Study|Non-compliance|1|||
23534658|NCT01856192|65689455|FG001|Overall Study|Non-compliance|0|||
23534659|NCT02003209|65689456|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
23534660|NCT02003209|65689457|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
23534661|NCT03433456|65689458|FG000|Overall Study|Death|1|||
23534662|NCT03433456|65689459|FG001|Overall Study|Death|1|||
23534663|NCT03433456|65689458|FG000|Overall Study|Lost to Follow-up|14|||
23534664|NCT03433456|65689459|FG001|Overall Study|Lost to Follow-up|11|||
23534665|NCT03433456|65689458|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
23534666|NCT03433456|65689459|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
23534667|NCT04432831|65689462|FG000|Overall Study|Withdrawal by Subject|24|||
23534668|NCT04432831|65689463|FG001|Overall Study|Withdrawal by Subject|28|||
23534669|NCT04432831|65689464|FG002|Overall Study|Withdrawal by Subject|21|||
23208647|NCT00819585|64501023|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
23311065|NCT01739348|64886455|FG000|Part II (Extension Study)|Death|3|||
23311066|NCT01739348|64886456|FG001|Part II (Extension Study)|Death|3|||
23311067|NCT01739348|64886457|FG002|Part II (Extension Study)|Death|2|||
23311068|NCT01739348|64886458|FG003|Part II (Extension Study)|Death|6|||
23311069|NCT01739348|64886455|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
23311070|NCT01739348|64886456|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
23311071|NCT01739348|64886457|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
23311072|NCT01739348|64886458|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
23311073|NCT01739348|64886455|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
23311074|NCT01739348|64886456|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
23311075|NCT01739348|64886457|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
23311076|NCT01739348|64886458|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
23311077|NCT01739348|64886455|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
23311078|NCT01739348|64886456|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
23311079|NCT01739348|64886457|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
23311080|NCT01739348|64886458|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
23311081|NCT01739348|64886455|FG000|Part II (Extension Study)|Physician Decision|7|||
23311082|NCT01739348|64886456|FG001|Part II (Extension Study)|Physician Decision|11|||
23311083|NCT01739348|64886457|FG002|Part II (Extension Study)|Physician Decision|6|||
23311084|NCT01739348|64886458|FG003|Part II (Extension Study)|Physician Decision|12|||
23311085|NCT01739348|64886455|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
23311086|NCT01739348|64886456|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
23311087|NCT01739348|64886457|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
23311088|NCT01739348|64886458|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
23422501|NCT03831880|65288510|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
23534670|NCT04432831|65689462|FG000|Overall Study|Death|23|||
23534671|NCT04432831|65689463|FG001|Overall Study|Death|23|||
23534672|NCT04432831|65689464|FG002|Overall Study|Death|17|||
23534673|NCT04432831|65689462|FG000|Overall Study|Lost to Follow-up|15|||
23534674|NCT04432831|65689463|FG001|Overall Study|Lost to Follow-up|15|||
23534675|NCT04432831|65689464|FG002|Overall Study|Lost to Follow-up|12|||
23534676|NCT04432831|65689462|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
23534677|NCT04432831|65689463|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
23534678|NCT04432831|65689464|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
23534679|NCT04432831|65689462|FG000|Overall Study|Reason Not Specified|7|||
23534680|NCT04432831|65689463|FG001|Overall Study|Reason Not Specified|11|||
23534681|NCT04432831|65689464|FG002|Overall Study|Reason Not Specified|9|||
23534682|NCT04432831|65689462|FG000|Overall Study|Adverse Event|7|||
23534683|NCT04432831|65689463|FG001|Overall Study|Adverse Event|7|||
23534684|NCT04432831|65689464|FG002|Overall Study|Adverse Event|7|||
23534685|NCT04432831|65689462|FG000|Overall Study|Physician Decision|1|||
23534686|NCT04432831|65689463|FG001|Overall Study|Physician Decision|3|||
23534687|NCT04432831|65689464|FG002|Overall Study|Physician Decision|6|||
23534688|NCT04432831|65689462|FG000|Overall Study|Protocol Violation|1|||
23534689|NCT04432831|65689463|FG001|Overall Study|Protocol Violation|0|||
23534690|NCT04432831|65689464|FG002|Overall Study|Protocol Violation|2|||
23534691|NCT04432831|65689462|FG000|Overall Study|Pregnancy|0|||
23534692|NCT04432831|65689463|FG001|Overall Study|Pregnancy|1|||
23534693|NCT04432831|65689464|FG002|Overall Study|Pregnancy|0|||
23534694|NCT04432831|65689462|FG000|Overall Study|Lack of Efficacy|0|||
23534695|NCT04432831|65689463|FG001|Overall Study|Lack of Efficacy|0|||
23534696|NCT04432831|65689464|FG002|Overall Study|Lack of Efficacy|2|||
23534697|NCT03005327|65689465|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
23534698|NCT03005327|65689466|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
23534699|NCT03005327|65689467|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
23534700|NCT03005327|65689468|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
23534701|NCT03005327|65689465|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23534702|NCT03005327|65689466|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23534703|NCT03005327|65689467|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23534704|NCT03005327|65689468|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23534705|NCT04346615|65690464|FG000|Overall Study|Lost to Follow-up|0|||
23534706|NCT04346615|65690465|FG001|Overall Study|Lost to Follow-up|2|||
23534707|NCT04346615|65690464|FG000|Overall Study|Withdrawal by Subject|1|||
23534708|NCT04346615|65690465|FG001|Overall Study|Withdrawal by Subject|0|||
23534709|NCT04346615|65690464|FG000|Overall Study|Death|5|||
23534710|NCT04346615|65690465|FG001|Overall Study|Death|1|||
23534711|NCT04346615|65690464|FG000|Overall Study|Other|0|||
23534712|NCT04346615|65690465|FG001|Overall Study|Other|2|||
23534713|NCT04346615|65690464|FG000|Overall Study|Randomized not treated|1|||
23534714|NCT04346615|65690465|FG001|Overall Study|Randomized not treated|0|||
23534715|NCT01818336|65690466|FG000|Overall Study|Declined retest visit|0|||
23534716|NCT01818336|65690467|FG001|Overall Study|Declined retest visit|11|||
23534717|NCT01818336|65690466|FG000|Overall Study|Lost to Follow-up|0|||
23534718|NCT01818336|65690467|FG001|Overall Study|Lost to Follow-up|1|||
23534719|NCT03455855|65690470|FG000|Overall Study|Lost to Follow-up|4|||
23534720|NCT03455855|65690471|FG001|Overall Study|Lost to Follow-up|2|||
23534721|NCT03190915|65690472|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
23534722|NCT03190915|65690472|FG000|Overall Study|Progressive Disease|3|||
23534723|NCT04267562|65690473|FG000|Assessed for Eligibility|Screen Failure|64|||
23534724|NCT04267562|65690473|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
23534725|NCT04267562|65690473|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
23534726|NCT04267562|65690473|FG000|Assessed for Eligibility|Site closure|6|||
23534727|NCT04267562|65690473|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
23534728|NCT04267562|65690473|FG000|Assessed for Eligibility|Physician Decision|1|||
23534729|NCT04267562|65690473|FG000|Month 24|Elective hysterectomy|1|||
23534730|NCT04267562|65690473|FG000|Month 24|Lost to Follow-up|1|||
23534731|NCT04267562|65690473|FG000|Month 36|Elective hysterectomy|2|||
23534732|NCT04267562|65690473|FG000|Month 36|Lost to Follow-up|3|||
23534733|NCT02453594|65690474|FG000|Overall Study|Protocol Violation|0|||
23534734|NCT02453594|65690475|FG001|Overall Study|Protocol Violation|0|||
23534735|NCT02453594|65690476|FG002|Overall Study|Protocol Violation|1|||
23534736|NCT02453594|65690474|FG000|Overall Study|Cohort Was Closed|17|||
23534737|NCT02453594|65690475|FG001|Overall Study|Cohort Was Closed|21|||
23534738|NCT02453594|65690476|FG002|Overall Study|Cohort Was Closed|14|||
23534739|NCT02453594|65690474|FG000|Overall Study|Death|20|||
23534740|NCT02453594|65690475|FG001|Overall Study|Death|24|||
23534741|NCT02453594|65690476|FG002|Overall Study|Death|16|||
23534742|NCT02453594|65690474|FG000|Overall Study|Lost to Follow-up|6|||
23534743|NCT02453594|65690475|FG001|Overall Study|Lost to Follow-up|14|||
23534744|NCT02453594|65690476|FG002|Overall Study|Lost to Follow-up|2|||
23534745|NCT02453594|65690474|FG000|Overall Study|Physician Decision|2|||
23534746|NCT02453594|65690475|FG001|Overall Study|Physician Decision|4|||
23534747|NCT02453594|65690476|FG002|Overall Study|Physician Decision|0|||
23534748|NCT02453594|65690474|FG000|Overall Study|Site Terminated by Sponsor|1|||
23534749|NCT02453594|65690475|FG001|Overall Study|Site Terminated by Sponsor|0|||
23534750|NCT02453594|65690476|FG002|Overall Study|Site Terminated by Sponsor|1|||
23534751|NCT02453594|65690474|FG000|Overall Study|Transitioned to Extension Study|16|||
23534752|NCT02453594|65690475|FG001|Overall Study|Transitioned to Extension Study|9|||
23615189|NCT00002540|65976379|FG001|Overall Study|Refused ASU (Control)|0|||
23615190|NCT00002540|65976378|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
23615191|NCT00002540|65976379|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
23615192|NCT02507297|65976380|FG000|Overall Study|Withdrawal by Subject|1|||
23615193|NCT02507297|65976381|FG001|Overall Study|Withdrawal by Subject|0|||
23615194|NCT02507297|65976380|FG000|Overall Study|Lost to Follow-up|0|||
23534753|NCT02453594|65690476|FG002|Overall Study|Transitioned to Extension Study|16|||
23534754|NCT02453594|65690474|FG000|Overall Study|Withdrawal by Subject|7|||
23534755|NCT02453594|65690475|FG001|Overall Study|Withdrawal by Subject|9|||
23534756|NCT02453594|65690476|FG002|Overall Study|Withdrawal by Subject|11|||
23534757|NCT03854370|65690477|FG000|Overall Study|samples not collected|1|||
23534758|NCT03854370|65690478|FG001|Overall Study|samples not collected|1|||
23534759|NCT03854370|65690479|FG002|Overall Study|samples not collected|1|||
23534760|NCT03854370|65690480|FG003|Overall Study|samples not collected|1|||
23534761|NCT03986944|65690481|FG000|Overall Study|Adverse Event|1|||
23534762|NCT03986944|65690482|FG001|Overall Study|Adverse Event|2|||
23534763|NCT03986944|65690483|FG002|Overall Study|Adverse Event|3|||
23534764|NCT03986944|65690481|FG000|Overall Study|Protocol Violation|0|||
23534765|NCT03986944|65690482|FG001|Overall Study|Protocol Violation|1|||
23534766|NCT03986944|65690483|FG002|Overall Study|Protocol Violation|1|||
23534767|NCT03986944|65690481|FG000|Overall Study|Withdrawal by Subject|3|||
23534768|NCT03986944|65690482|FG001|Overall Study|Withdrawal by Subject|5|||
23534769|NCT03986944|65690483|FG002|Overall Study|Withdrawal by Subject|5|||
23534770|NCT03986944|65690481|FG000|Overall Study|Study termination|10|||
23534771|NCT03986944|65690482|FG001|Overall Study|Study termination|10|||
23534772|NCT03986944|65690483|FG002|Overall Study|Study termination|10|||
23534773|NCT03986944|65690481|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
23534774|NCT03986944|65690482|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
23534775|NCT03986944|65690483|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
23534776|NCT03986944|65690481|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
23534777|NCT03986944|65690482|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
23534778|NCT03986944|65690483|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
23534779|NCT02844816|65690484|FG000|Overall Study|No protocol treatment received|5|||
23534780|NCT02844816|65690485|FG001|Overall Study|No protocol treatment received|1|||
23534781|NCT02844816|65690484|FG000|Overall Study|Ineligible|22|||
23534782|NCT02844816|65690485|FG001|Overall Study|Ineligible|15|||
23534783|NCT02844816|65690484|FG000|Overall Study|Participant refusal|5|||
23534784|NCT02844816|65690485|FG001|Overall Study|Participant refusal|5|||
23534785|NCT02844816|65690484|FG000|Overall Study|Adverse Event|5|||
23534786|NCT02844816|65690485|FG001|Overall Study|Adverse Event|4|||
23534787|NCT02844816|65690484|FG000|Overall Study|Death|0|||
23534788|NCT02844816|65690485|FG001|Overall Study|Death|1|||
23534789|NCT02844816|65690484|FG000|Overall Study|Disease progression/recurrence|50|||
23534790|NCT02844816|65690485|FG001|Overall Study|Disease progression/recurrence|24|||
23534791|NCT02844816|65690484|FG000|Overall Study|Physician Decision|1|||
23534792|NCT02844816|65690485|FG001|Overall Study|Physician Decision|1|||
23534793|NCT04983901|65690486|FG000|Overall Study|Death|1|||
23534794|NCT04983901|65690487|FG001|Overall Study|Death|4|||
23534795|NCT04983901|65690486|FG000|Overall Study|Lost to Follow-up|3|||
23534796|NCT04983901|65690487|FG001|Overall Study|Lost to Follow-up|0|||
23534797|NCT04983901|65690486|FG000|Overall Study|Protocol Violation|1|||
23534798|NCT04983901|65690487|FG001|Overall Study|Protocol Violation|0|||
23534799|NCT04983901|65690486|FG000|Overall Study|Withdrawal by Subject|1|||
23534800|NCT04983901|65690487|FG001|Overall Study|Withdrawal by Subject|2|||
23534801|NCT03169881|65690488|FG000|Overall Study|Incomplete Follow-up|10|||
23534802|NCT03169881|65690489|FG001|Overall Study|Incomplete Follow-up|15|||
23534803|NCT03169881|65690488|FG000|Overall Study|Lost to Follow-up|18|||
23534804|NCT03169881|65690489|FG001|Overall Study|Lost to Follow-up|20|||
23534805|NCT03169881|65690488|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
23534806|NCT03169881|65690489|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
23534807|NCT04085523|65690492|FG000|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534808|NCT04085523|65690493|FG001|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534809|NCT04085523|65690494|FG002|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534810|NCT04085523|65690495|FG003|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534811|NCT04085523|65690496|FG004|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
23534812|NCT04085523|65690497|FG005|Open-Label Period (Weeks 52 to 156)|Study Ongoing|57|||
23534813|NCT04815031|65690498|FG000|Overall Study|No adverse event information (missing information)|33|||
23534814|NCT03218826|65690499|FG000|Overall Study|Non-compliance with protocol|1|||
23534815|NCT03218826|65690500|FG001|Overall Study|Non-compliance with protocol|0|||
23534816|NCT03218826|65690501|FG002|Overall Study|Non-compliance with protocol|2|||
23534817|NCT03218826|65690502|FG003|Overall Study|Non-compliance with protocol|1|||
23534818|NCT03218826|65690503|FG004|Overall Study|Non-compliance with protocol|1|||
23615195|NCT02507297|65976381|FG001|Overall Study|Lost to Follow-up|1|||
23615196|NCT02963922|65976382|FG000|Overall Study|Adverse Event|15|||
23615197|NCT02963922|65976383|FG001|Overall Study|Adverse Event|6|||
23615198|NCT02963922|65976382|FG000|Overall Study|Protocol deviation|6|||
23615199|NCT02963922|65976383|FG001|Overall Study|Protocol deviation|6|||
23615200|NCT02963922|65976382|FG000|Overall Study|Lack of Efficacy|1|||
23615201|NCT02963922|65976383|FG001|Overall Study|Lack of Efficacy|1|||
23615202|NCT02963922|65976382|FG000|Overall Study|Lost to Follow-up|2|||
23615203|NCT02963922|65976383|FG001|Overall Study|Lost to Follow-up|3|||
23615204|NCT02963922|65976382|FG000|Overall Study|Other|8|||
23615205|NCT02963922|65976383|FG001|Overall Study|Other|14|||
23615206|NCT01780584|65976384|FG000|Overall Study|Death|1|||
23615207|NCT01780584|65976385|FG001|Overall Study|Death|0|||
23615208|NCT01780584|65976386|FG002|Overall Study|Death|1|||
23615209|NCT01780584|65976384|FG000|Overall Study|Adverse Event|0|||
23615210|NCT01780584|65976385|FG001|Overall Study|Adverse Event|1|||
23615211|NCT01780584|65976386|FG002|Overall Study|Adverse Event|0|||
23615212|NCT01780584|65976384|FG000|Overall Study|Protocol Violation|0|||
23615213|NCT01780584|65976385|FG001|Overall Study|Protocol Violation|0|||
23615214|NCT01780584|65976386|FG002|Overall Study|Protocol Violation|1|||
23615215|NCT01196741|65976387|FG000|Overall Study|Disease progression|34|||
23615216|NCT01196741|65976388|FG001|Overall Study|Disease progression|14|||
23615217|NCT01196741|65976387|FG000|Overall Study|Adverse Event|10|||
23311089|NCT01739348|64886455|FG000|Part II (Extension Study)|Participant Moved|3|||
23311090|NCT01739348|64886456|FG001|Part II (Extension Study)|Participant Moved|3|||
23311091|NCT01739348|64886457|FG002|Part II (Extension Study)|Participant Moved|0|||
23311092|NCT01739348|64886458|FG003|Part II (Extension Study)|Participant Moved|3|||
23311093|NCT01739348|64886455|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
23311094|NCT01739348|64886456|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
23311095|NCT01739348|64886457|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
23311096|NCT01739348|64886458|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
23311097|NCT01739348|64886455|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
23615218|NCT01196741|65976388|FG001|Overall Study|Adverse Event|6|||
23615219|NCT01196741|65976387|FG000|Overall Study|Serious Adverse Event|3|||
23615220|NCT01196741|65976388|FG001|Overall Study|Serious Adverse Event|1|||
23615221|NCT01196741|65976387|FG000|Overall Study|Dose limiting Adverse Event|2|||
23615222|NCT01196741|65976388|FG001|Overall Study|Dose limiting Adverse Event|1|||
23615223|NCT01196741|65976387|FG000|Overall Study|Withdrawal by Subject|3|||
23615224|NCT01196741|65976388|FG001|Overall Study|Withdrawal by Subject|0|||
23615225|NCT01196741|65976387|FG000|Overall Study|Other reason|3|||
23615226|NCT01196741|65976388|FG001|Overall Study|Other reason|3|||
23615227|NCT01196741|65976387|FG000|Overall Study|Other|3|||
23615228|NCT01196741|65976388|FG001|Overall Study|Other|2|||
23615229|NCT01196741|65976387|FG000|Overall Study|Protocol Violation|2|||
23615230|NCT01196741|65976388|FG001|Overall Study|Protocol Violation|1|||
23615231|NCT01023022|65976392|FG000|Overall Study|Death|5|||
23615232|NCT01023022|65976392|FG000|Overall Study|Lost to Follow-up|7|||
23615233|NCT01023022|65976392|FG000|Overall Study|due to technical issues|2|||
23615234|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
23615235|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
23615236|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
23615237|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
23615238|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
23615239|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
23615240|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
23615241|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
23208648|NCT00819585|64501024|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
23208649|NCT00819585|64501025|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
23208650|NCT00819585|64501026|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
23615242|NCT05066230|65976399|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
23615243|NCT05066230|65976400|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
23615244|NCT05066230|65976399|FG000|After Week 48|Adverse Event|1|||
23615245|NCT05066230|65976400|FG001|After Week 48|Adverse Event|0|||
23615246|NCT05066230|65976399|FG000|After Week 48|Non-compliance with study schedule|1|||
23615247|NCT05066230|65976400|FG001|After Week 48|Non-compliance with study schedule|0|||
23615248|NCT05066230|65976399|FG000|After Week 48|Withdrawal by Subject|0|||
23615249|NCT05066230|65976400|FG001|After Week 48|Withdrawal by Subject|1|||
23615250|NCT05066230|65976399|FG000|After Week 48|Lost to Follow-up|3|||
23615251|NCT05066230|65976400|FG001|After Week 48|Lost to Follow-up|3|||
23208651|NCT00819585|64501027|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
23615252|NCT05066230|65976399|FG000|After Week 48|Sponsor Request|115|||
23615253|NCT05066230|65976400|FG001|After Week 48|Sponsor Request|111|||
23615254|NCT00050167|65976405|FG000|Overall Study|not eligible not invasive|1|||
23615255|NCT00050167|65976406|FG001|Overall Study|not eligible not invasive|1|||
23615256|NCT04435522|65976407|FG000|Overall Study|Withdrawal by Subject|2|||
23615257|NCT02267746|65976408|FG000|Overall Study|Adverse Event|0|||
23311098|NCT01739348|64886456|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
23311099|NCT01739348|64886457|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
23311100|NCT01739348|64886458|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
23311101|NCT01398514|64886459|FG000|Overall Study|Adverse Event|1|||
23311102|NCT01398514|64886460|FG001|Overall Study|Adverse Event|0|||
23311103|NCT01398514|64886459|FG000|Overall Study|Non-compliance with study procedures|2|||
23311104|NCT01398514|64886460|FG001|Overall Study|Non-compliance with study procedures|0|||
23311105|NCT01398514|64886459|FG000|Overall Study|Physiologic non-responsiveness|1|||
23311106|NCT01398514|64886460|FG001|Overall Study|Physiologic non-responsiveness|3|||
23311107|NCT01398514|64886459|FG000|Overall Study|Failure to show a conditioned response|4|||
23311108|NCT01398514|64886460|FG001|Overall Study|Failure to show a conditioned response|3|||
23311109|NCT00631657|64886461|FG000|6-Month Treatment Period|Adverse Event|47|||
23615258|NCT02267746|65976409|FG001|Overall Study|Adverse Event|2|||
23615259|NCT02267746|65976410|FG002|Overall Study|Adverse Event|1|||
23615260|NCT02267746|65976408|FG000|Overall Study|Protocol Violation|8|||
23615261|NCT02267746|65976409|FG001|Overall Study|Protocol Violation|7|||
23615262|NCT02267746|65976410|FG002|Overall Study|Protocol Violation|3|||
23615263|NCT02267746|65976408|FG000|Overall Study|Lack of Efficacy|11|||
23311110|NCT00631657|64886462|FG001|6-Month Treatment Period|Adverse Event|0|||
23311111|NCT00631657|64886463|FG002|6-Month Treatment Period|Adverse Event|7|||
23534819|NCT00983814|65690522|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
23534820|NCT00983814|65690523|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
23311112|NCT00631657|64886461|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
23311113|NCT00631657|64886462|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
23311114|NCT00631657|64886463|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
23534821|NCT00983814|65690524|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
23311115|NCT00631657|64886461|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
23311116|NCT00631657|64886462|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
23311117|NCT00631657|64886463|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
23311118|NCT00631657|64886461|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
23311119|NCT00631657|64886462|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
23422502|NCT03831880|65288509|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
23422503|NCT03831880|65288510|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
23422504|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
23422505|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
23422506|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
23422507|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
23422508|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
23422509|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
23422510|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
23422511|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
23422512|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
23422513|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
23422514|NCT01352741|65288514|FG000|Open-label Tapentadol Titration Period|Other|4|||
23422515|NCT01352741|65288515|FG001|Open-label Tapentadol Titration Period|Other|0|||
23422516|NCT01352741|65288514|FG000|Double-blind Comparative Period|Protocol Violation|2|||
23422517|NCT01352741|65288515|FG001|Double-blind Comparative Period|Protocol Violation|0|||
23422518|NCT01352741|65288514|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
23422519|NCT01352741|65288515|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
23534822|NCT00983814|65690522|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
23534823|NCT00983814|65690523|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
23534824|NCT00983814|65690524|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
23534825|NCT00983814|65690522|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
23534826|NCT00983814|65690523|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
23534827|NCT00983814|65690524|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
23534828|NCT00983814|65690522|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
23534829|NCT00983814|65690523|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
23534830|NCT00983814|65690524|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
23534831|NCT00983814|65690522|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
23534832|NCT00983814|65690523|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
23534833|NCT00983814|65690524|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
23534834|NCT01110239|65690525|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
23534835|NCT01110239|65690526|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
23534836|NCT01110239|65690527|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
23615264|NCT02267746|65976409|FG001|Overall Study|Lack of Efficacy|11|||
23208652|NCT00819585|64501028|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
23208653|NCT00819585|64501018|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
23311120|NCT00631657|64886463|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
23534837|NCT01110239|65690528|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
23615265|NCT02267746|65976410|FG002|Overall Study|Lack of Efficacy|15|||
23615266|NCT02267746|65976408|FG000|Overall Study|Protocol Violation|1|||
23422520|NCT01352741|65288514|FG000|Double-blind Comparative Period|Adverse Event|16|||
23422521|NCT01352741|65288515|FG001|Double-blind Comparative Period|Adverse Event|17|||
23422522|NCT01352741|65288514|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
23422523|NCT01352741|65288515|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
23422524|NCT01352741|65288514|FG000|Double-blind Comparative Period|Death|0|||
23422525|NCT01352741|65288515|FG001|Double-blind Comparative Period|Death|1|||
23422526|NCT01352741|65288514|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
23422527|NCT01352741|65288515|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
23422528|NCT01352741|65288514|FG000|Double-blind Comparative Period|Other|1|||
23422529|NCT01352741|65288515|FG001|Double-blind Comparative Period|Other|2|||
23422530|NCT01352741|65288514|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
23422531|NCT01352741|65288515|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
23422532|NCT01352741|65288514|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
23422533|NCT01352741|65288515|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
23422534|NCT01352741|65288514|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
23422535|NCT01352741|65288515|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
23422536|NCT01352741|65288514|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
23422537|NCT01352741|65288515|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
23422538|NCT01713283|65288525|FG000|Overall Study|Lack of Efficacy|10|||
23422539|NCT01713283|65288526|FG001|Overall Study|Lack of Efficacy|2|||
23422540|NCT01713283|65288525|FG000|Overall Study|Lost to Follow-up|1|||
23422541|NCT01713283|65288526|FG001|Overall Study|Lost to Follow-up|1|||
23422542|NCT04422561|65288527|FG000|Overall Study|Lost to Follow-up|25|||
23534838|NCT01110239|65690525|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
23534839|NCT01110239|65690526|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
23534840|NCT01110239|65690527|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
23534841|NCT01110239|65690528|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
23534842|NCT01940900|65690531|FG000|Overall Study|Physician Decision|4|||
23534843|NCT01940900|65690532|FG001|Overall Study|Physician Decision|0|||
23534844|NCT01940900|65690531|FG000|Overall Study|Adverse Event|10|||
23208654|NCT00819585|64501019|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
23208655|NCT00819585|64501020|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
23208656|NCT00819585|64501021|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
23208657|NCT00819585|64501022|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
23208658|NCT00819585|64501023|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
23208659|NCT00819585|64501024|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
23208660|NCT00819585|64501025|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
23208661|NCT00819585|64501026|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
23422543|NCT04422561|65288528|FG001|Overall Study|Lost to Follow-up|11|||
23534845|NCT01940900|65690532|FG001|Overall Study|Adverse Event|15|||
23534846|NCT01940900|65690531|FG000|Overall Study|Withdrawal by Subject|11|||
23534847|NCT01940900|65690532|FG001|Overall Study|Withdrawal by Subject|15|||
23534848|NCT01940900|65690531|FG000|Overall Study|Lost to Follow-up|1|||
23534849|NCT01940900|65690532|FG001|Overall Study|Lost to Follow-up|0|||
23534850|NCT01940900|65690531|FG000|Overall Study|Sponsor Decision|1|||
23534851|NCT01940900|65690532|FG001|Overall Study|Sponsor Decision|0|||
23534852|NCT01940900|65690531|FG000|Overall Study|subject non-compliance|1|||
23534853|NCT01940900|65690532|FG001|Overall Study|subject non-compliance|1|||
23534854|NCT01940900|65690531|FG000|Overall Study|other|1|||
23534855|NCT01940900|65690532|FG001|Overall Study|other|0|||
23534856|NCT03484819|65690543|FG000|Overall Study|Death|2|||
23615267|NCT02267746|65976409|FG001|Overall Study|Protocol Violation|2|||
23208662|NCT00819585|64501027|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
23208663|NCT00819585|64501028|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
23422544|NCT00129701|65288532|FG000|Overall Study|Withdrawal by Subject|33|||
23422545|NCT01069861|65288533|FG000|Overall Study|Death|1|||
23534857|NCT03484819|65690543|FG000|Overall Study|Adverse Event|2|||
23534858|NCT03484819|65690543|FG000|Overall Study|Physician Decision|1|||
23534859|NCT03484819|65690543|FG000|Overall Study|Withdrawal by Subject|2|||
23534860|NCT03484819|65690543|FG000|Overall Study|Disease Progression|4|||
23534861|NCT03484819|65690543|FG000|Overall Study|Complicating Condition|1|||
23422546|NCT01069861|65288533|FG000|Overall Study|Adverse Event|1|||
23422547|NCT01069861|65288533|FG000|Overall Study|Did not meet entrance criteria|1|||
23422548|NCT00149994|65288534|FG000|Overall Study|Administrative problems:|1|||
23422549|NCT00149994|65288535|FG001|Overall Study|Administrative problems:|0|||
23422550|NCT00149994|65288534|FG000|Overall Study|Protocol Violation|0|||
23422551|NCT00149994|65288535|FG001|Overall Study|Protocol Violation|1|||
23422552|NCT01994863|65288538|FG000|Period 1|Adverse Event|4|||
23422553|NCT01994863|65288539|FG001|Period 1|Adverse Event|0|||
23422554|NCT01994863|65288538|FG000|Period 1|Withdrawal by Subject|1|||
23422555|NCT01994863|65288539|FG001|Period 1|Withdrawal by Subject|0|||
23422556|NCT01994863|65288538|FG000|Period 1|Trial stopped by sponsor|1|||
23422557|NCT01994863|65288539|FG001|Period 1|Trial stopped by sponsor|3|||
23422558|NCT01994863|65288538|FG000|Period 1|Lack of Efficacy|1|||
23422559|NCT01994863|65288539|FG001|Period 1|Lack of Efficacy|0|||
23422560|NCT01994863|65288538|FG000|Period 2|Adverse Event|0|||
23422561|NCT01994863|65288539|FG001|Period 2|Adverse Event|1|||
23422562|NCT01994863|65288538|FG000|Period 2|Lack of Efficacy|0|||
23422563|NCT01994863|65288539|FG001|Period 2|Lack of Efficacy|2|||
23422564|NCT01994863|65288538|FG000|Period 2|Withdrawal by Subject|1|||
23422565|NCT01994863|65288539|FG001|Period 2|Withdrawal by Subject|1|||
23422566|NCT01396265|65288542|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
23422567|NCT04979897|65288547|FG000|Overall Study|Death|1|||
23422568|NCT04979897|65288548|FG001|Overall Study|Death|8|||
23422569|NCT04979897|65288547|FG000|Overall Study|Lost to Follow-up|111|||
23422570|NCT04979897|65288548|FG001|Overall Study|Lost to Follow-up|56|||
23422571|NCT04979897|65288547|FG000|Overall Study|Withdrawal by Subject|7|||
23422572|NCT04979897|65288548|FG001|Overall Study|Withdrawal by Subject|2|||
23422573|NCT03834506|65292362|FG000|Overall Study|Death|336|||
23422574|NCT03834506|65292363|FG001|Overall Study|Death|326|||
23422575|NCT03834506|65292362|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23422576|NCT03834506|65292363|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23534862|NCT03395184|65690549|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
23534863|NCT03395184|65690550|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
23534864|NCT03395184|65690551|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
23534865|NCT03395184|65690552|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
23534866|NCT03395184|65690553|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
23534867|NCT03395184|65690554|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
23534868|NCT03395184|65690555|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
23534869|NCT03395184|65690549|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23534870|NCT03395184|65690550|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
23534871|NCT03395184|65690551|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
23534872|NCT03395184|65690552|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23534873|NCT03395184|65690553|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23615268|NCT02267746|65976410|FG002|Overall Study|Protocol Violation|1|||
23615269|NCT02267746|65976408|FG000|Overall Study|Miscellaneous|1|||
23615270|NCT02267746|65976409|FG001|Overall Study|Miscellaneous|0|||
23615271|NCT02267746|65976410|FG002|Overall Study|Miscellaneous|1|||
23615272|NCT00443755|65976418|FG000|Overall Study|Withdrawal by Subject|2|||
23615273|NCT00443755|65976419|FG001|Overall Study|Withdrawal by Subject|1|||
23311121|NCT00631657|64886461|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
23311122|NCT00631657|64886462|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
23311123|NCT00631657|64886463|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
23311124|NCT00631657|64886461|FG000|6-Month Treatment Period|Other|16|||
23311125|NCT00631657|64886462|FG001|6-Month Treatment Period|Other|0|||
23311126|NCT00631657|64886463|FG002|6-Month Treatment Period|Other|4|||
23311127|NCT00631657|64886461|FG000|6-Month Treatment Period|Not Treated|2|||
23311128|NCT00631657|64886462|FG001|6-Month Treatment Period|Not Treated|0|||
23311129|NCT00631657|64886463|FG002|6-Month Treatment Period|Not Treated|1|||
23311130|NCT00631657|64886461|FG000|7-Day Discontinuation Period|Not Treated|1|||
23311131|NCT00631657|64886462|FG001|7-Day Discontinuation Period|Not Treated|1|||
23311132|NCT00631657|64886463|FG002|7-Day Discontinuation Period|Not Treated|1|||
23311133|NCT00631657|64886461|FG000|7-Day Discontinuation Period|Other|1|||
23311134|NCT00631657|64886462|FG001|7-Day Discontinuation Period|Other|0|||
23311135|NCT00631657|64886463|FG002|7-Day Discontinuation Period|Other|0|||
23311136|NCT00186888|64886464|FG000|Overall Study|Toxicity|0|||
23311137|NCT00186888|64886465|FG001|Overall Study|Toxicity|1|||
23311138|NCT00186888|64886466|FG002|Overall Study|Toxicity|0|||
23311139|NCT00186888|64886464|FG000|Overall Study|Relapse or progression of disease|4|||
23311140|NCT00186888|64886465|FG001|Overall Study|Relapse or progression of disease|2|||
23422577|NCT03834506|65292362|FG000|Overall Study|Withdrawal by Subject|10|||
23422578|NCT03834506|65292363|FG001|Overall Study|Withdrawal by Subject|8|||
23422579|NCT03834506|65292362|FG000|Overall Study|Sponsor decision|165|||
23422580|NCT03834506|65292363|FG001|Overall Study|Sponsor decision|178|||
23422581|NCT03834506|65292362|FG000|Overall Study|Physician Decision|3|||
23422582|NCT03834506|65292363|FG001|Overall Study|Physician Decision|1|||
23422583|NCT03834506|65292362|FG000|Overall Study|Lost to Follow-up|0|||
23422584|NCT03834506|65292363|FG001|Overall Study|Lost to Follow-up|1|||
23422585|NCT02334683|65292374|FG000|First 12 Week Period|Lost to Follow-up|1|||
23422586|NCT02334683|65292375|FG001|First 12 Week Period|Lost to Follow-up|0|||
23422587|NCT02334683|65292374|FG000|Second 12 Week Period|Adverse Event|0|||
23422588|NCT02334683|65292375|FG001|Second 12 Week Period|Adverse Event|1|||
23422589|NCT01778049|65292376|FG000|Open Label Treatment Period|Adverse Event|5|||
23422590|NCT01778049|65292377|FG001|Open Label Treatment Period|Adverse Event|15|||
23422591|NCT01778049|65292378|FG002|Open Label Treatment Period|Adverse Event|0|||
23422592|NCT01778049|65292379|FG003|Open Label Treatment Period|Adverse Event|0|||
23422593|NCT01778049|65292380|FG004|Open Label Treatment Period|Adverse Event|0|||
23534874|NCT03395184|65690554|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23534875|NCT03395184|65690555|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
23534876|NCT03395184|65690549|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
23534877|NCT03395184|65690550|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
23422594|NCT01778049|65292381|FG005|Open Label Treatment Period|Adverse Event|0|||
23422595|NCT01778049|65292376|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
23422596|NCT01778049|65292377|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
23422597|NCT01778049|65292378|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
23422598|NCT01778049|65292379|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
23422599|NCT01778049|65292380|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
23422600|NCT01778049|65292381|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
23534878|NCT03395184|65690551|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23534879|NCT03395184|65690552|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23534880|NCT03395184|65690553|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23534881|NCT03395184|65690554|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23534882|NCT03395184|65690555|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23534883|NCT03395184|65690549|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23534884|NCT03395184|65690550|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
23534885|NCT03395184|65690551|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23534886|NCT03395184|65690552|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23534887|NCT03395184|65690553|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23534888|NCT03395184|65690554|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23534889|NCT03395184|65690555|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
23534890|NCT03395184|65690549|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
23534891|NCT03395184|65690550|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23534892|NCT03395184|65690551|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
23534893|NCT03395184|65690552|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23534894|NCT03395184|65690553|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23534895|NCT03395184|65690554|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23534896|NCT03395184|65690555|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23534897|NCT03395184|65690549|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
23534898|NCT03395184|65690550|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
23534899|NCT03395184|65690551|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
23534900|NCT03395184|65690552|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
23534901|NCT03395184|65690553|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
23534902|NCT03395184|65690554|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
23534903|NCT03395184|65690555|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
23534904|NCT03395184|65690549|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
23534905|NCT03395184|65690550|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
23534906|NCT03395184|65690551|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
23534907|NCT03395184|65690552|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
23534908|NCT03395184|65690553|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
23534909|NCT03395184|65690554|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
23534910|NCT03395184|65690555|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
23534911|NCT03395184|65690549|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
23534912|NCT03395184|65690550|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
23534913|NCT03395184|65690551|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
23534914|NCT03395184|65690552|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
23534915|NCT03395184|65690553|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
23534916|NCT03395184|65690554|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
23534917|NCT03395184|65690555|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
23534918|NCT03395184|65690549|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23422601|NCT01778049|65292376|FG000|Open Label Treatment Period|Protocol Violation|5|||
23422602|NCT01778049|65292377|FG001|Open Label Treatment Period|Protocol Violation|5|||
23534919|NCT03395184|65690550|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23534920|NCT03395184|65690551|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23534921|NCT03395184|65690552|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23534922|NCT03395184|65690553|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
23534923|NCT03395184|65690554|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23422603|NCT01778049|65292378|FG002|Open Label Treatment Period|Protocol Violation|0|||
23534924|NCT03395184|65690555|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
23534925|NCT03395184|65690549|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
23311141|NCT00186888|64886466|FG002|Overall Study|Relapse or progression of disease|0|||
23311142|NCT03783039|64886467|FG000|Overall Study|Death|2|||
23311143|NCT03783039|64886468|FG001|Overall Study|Death|1|||
23311144|NCT00951496|64886469|FG000|Overall Study|Did not initiate study treatment|10|||
23311145|NCT00951496|64886470|FG001|Overall Study|Did not initiate study treatment|8|||
23311146|NCT00951496|64886471|FG002|Overall Study|Did not initiate study treatment|13|||
23311147|NCT03610516|64886472|FG000|Treatment Epoch|Adverse Event|3|||
23311148|NCT03610516|64886473|FG001|Treatment Epoch|Adverse Event|1|||
23311149|NCT03610516|64886472|FG000|Treatment Epoch|Death|1|||
23311150|NCT03610516|64886473|FG001|Treatment Epoch|Death|0|||
23311151|NCT03610516|64886472|FG000|Treatment Epoch|Lack of Efficacy|0|||
23311152|NCT03610516|64886473|FG001|Treatment Epoch|Lack of Efficacy|1|||
23311153|NCT03610516|64886472|FG000|Treatment Epoch|No longer requires treatment|1|||
23311154|NCT03610516|64886473|FG001|Treatment Epoch|No longer requires treatment|0|||
23311155|NCT03610516|64886472|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
23311156|NCT03610516|64886473|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
23311157|NCT03610516|64886472|FG000|Treatment Epoch|Physician Decision|8|||
23311158|NCT03610516|64886473|FG001|Treatment Epoch|Physician Decision|5|||
23311159|NCT03610516|64886472|FG000|Treatment Epoch|Protocol Deviation|1|||
23534926|NCT03395184|65690550|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
23534927|NCT03395184|65690551|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
23208664|NCT00819585|64501018|FG000|Core Study|Subject Withdrew Consent|0|||
23208665|NCT00819585|64501019|FG001|Core Study|Subject Withdrew Consent|3|||
23208666|NCT00819585|64501020|FG002|Core Study|Subject Withdrew Consent|2|||
23208667|NCT00819585|64501021|FG003|Core Study|Subject Withdrew Consent|1|||
23208668|NCT00819585|64501022|FG004|Core Study|Subject Withdrew Consent|0|||
23208669|NCT00819585|64501023|FG005|Core Study|Subject Withdrew Consent|0|||
23208670|NCT00819585|64501024|FG006|Core Study|Subject Withdrew Consent|3|||
23208671|NCT00819585|64501025|FG007|Core Study|Subject Withdrew Consent|0|||
23208672|NCT00819585|64501026|FG008|Core Study|Subject Withdrew Consent|0|||
23208673|NCT00819585|64501027|FG009|Core Study|Subject Withdrew Consent|0|||
23208674|NCT00819585|64501028|FG010|Core Study|Subject Withdrew Consent|0|||
23208675|NCT00819585|64501018|FG000|Core Study|Lost to Follow-up|2|||
23208676|NCT00819585|64501019|FG001|Core Study|Lost to Follow-up|1|||
23208677|NCT00819585|64501020|FG002|Core Study|Lost to Follow-up|2|||
23208678|NCT00819585|64501021|FG003|Core Study|Lost to Follow-up|0|||
23208679|NCT00819585|64501022|FG004|Core Study|Lost to Follow-up|1|||
23208680|NCT00819585|64501023|FG005|Core Study|Lost to Follow-up|1|||
23208681|NCT00819585|64501024|FG006|Core Study|Lost to Follow-up|1|||
23208682|NCT00819585|64501025|FG007|Core Study|Lost to Follow-up|0|||
23208683|NCT00819585|64501026|FG008|Core Study|Lost to Follow-up|0|||
23208684|NCT00819585|64501027|FG009|Core Study|Lost to Follow-up|0|||
23208685|NCT00819585|64501028|FG010|Core Study|Lost to Follow-up|0|||
23208686|NCT00819585|64501018|FG000|Core Study|Administrative Problems|0|||
23208687|NCT00819585|64501019|FG001|Core Study|Administrative Problems|0|||
23208688|NCT00819585|64501020|FG002|Core Study|Administrative Problems|0|||
23208689|NCT00819585|64501021|FG003|Core Study|Administrative Problems|0|||
23208690|NCT00819585|64501022|FG004|Core Study|Administrative Problems|0|||
23208691|NCT00819585|64501023|FG005|Core Study|Administrative Problems|0|||
23208692|NCT00819585|64501024|FG006|Core Study|Administrative Problems|2|||
23208693|NCT00819585|64501025|FG007|Core Study|Administrative Problems|0|||
23208694|NCT00819585|64501026|FG008|Core Study|Administrative Problems|0|||
23208695|NCT00819585|64501027|FG009|Core Study|Administrative Problems|0|||
23208696|NCT00819585|64501028|FG010|Core Study|Administrative Problems|0|||
23208697|NCT00819585|64501018|FG000|Core Study|Death|0|||
23208698|NCT00819585|64501019|FG001|Core Study|Death|0|||
23208699|NCT00819585|64501020|FG002|Core Study|Death|0|||
23311160|NCT03610516|64886473|FG001|Treatment Epoch|Protocol Deviation|0|||
23311161|NCT03610516|64886472|FG000|Treatment Epoch|Withdrawal by Subject|3|||
23422604|NCT01778049|65292379|FG003|Open Label Treatment Period|Protocol Violation|0|||
23208700|NCT00819585|64501021|FG003|Core Study|Death|0|||
23208701|NCT00819585|64501022|FG004|Core Study|Death|0|||
23208702|NCT00819585|64501023|FG005|Core Study|Death|0|||
23208703|NCT00819585|64501024|FG006|Core Study|Death|1|||
23534928|NCT03395184|65690552|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
23422605|NCT01778049|65292380|FG004|Open Label Treatment Period|Protocol Violation|0|||
23422606|NCT01778049|65292381|FG005|Open Label Treatment Period|Protocol Violation|0|||
23422607|NCT01778049|65292376|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
23422608|NCT01778049|65292377|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
23422609|NCT01778049|65292378|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
23422610|NCT01778049|65292379|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
23422611|NCT01778049|65292380|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
23422612|NCT01778049|65292381|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
23422613|NCT01778049|65292376|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
23422614|NCT01778049|65292377|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
23422615|NCT01778049|65292378|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
23422616|NCT01778049|65292379|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
23422617|NCT01778049|65292380|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
23422618|NCT01778049|65292381|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
23422619|NCT01778049|65292376|FG000|Open Label Treatment Period|Not treated|2|||
23422620|NCT01778049|65292377|FG001|Open Label Treatment Period|Not treated|1|||
23422621|NCT01778049|65292378|FG002|Open Label Treatment Period|Not treated|0|||
23422622|NCT01778049|65292379|FG003|Open Label Treatment Period|Not treated|0|||
23422623|NCT01778049|65292380|FG004|Open Label Treatment Period|Not treated|0|||
23422624|NCT01778049|65292381|FG005|Open Label Treatment Period|Not treated|0|||
23422625|NCT01778049|65292376|FG000|Open Label Treatment Period|Other reason not defined above|77|||
23422626|NCT01778049|65292377|FG001|Open Label Treatment Period|Other reason not defined above|94|||
23422627|NCT01778049|65292378|FG002|Open Label Treatment Period|Other reason not defined above|0|||
23422628|NCT01778049|65292379|FG003|Open Label Treatment Period|Other reason not defined above|0|||
23422629|NCT01778049|65292380|FG004|Open Label Treatment Period|Other reason not defined above|0|||
23422630|NCT01778049|65292381|FG005|Open Label Treatment Period|Other reason not defined above|0|||
23422631|NCT01778049|65292376|FG000|Double Blind Treatment Period|Adverse Event|0|||
23422632|NCT01778049|65292377|FG001|Double Blind Treatment Period|Adverse Event|0|||
23422633|NCT01778049|65292378|FG002|Double Blind Treatment Period|Adverse Event|4|||
23422634|NCT01778049|65292379|FG003|Double Blind Treatment Period|Adverse Event|5|||
23422635|NCT01778049|65292380|FG004|Double Blind Treatment Period|Adverse Event|3|||
23422636|NCT01778049|65292381|FG005|Double Blind Treatment Period|Adverse Event|2|||
23422637|NCT01778049|65292376|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
23422638|NCT01778049|65292377|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
23422639|NCT01778049|65292378|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
23422640|NCT01778049|65292379|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
23422641|NCT01778049|65292380|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
23422642|NCT01778049|65292381|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
23422643|NCT01778049|65292376|FG000|Double Blind Treatment Period|Protocol Violation|0|||
23534929|NCT03395184|65690553|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
23534930|NCT03395184|65690554|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
23534931|NCT03395184|65690555|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
23534932|NCT03395184|65690549|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23534933|NCT03395184|65690550|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23534934|NCT03395184|65690551|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23534935|NCT03395184|65690552|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
23422644|NCT01778049|65292377|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23422645|NCT01778049|65292378|FG002|Double Blind Treatment Period|Protocol Violation|2|||
23422646|NCT01778049|65292379|FG003|Double Blind Treatment Period|Protocol Violation|0|||
23422647|NCT01778049|65292380|FG004|Double Blind Treatment Period|Protocol Violation|0|||
23422648|NCT01778049|65292381|FG005|Double Blind Treatment Period|Protocol Violation|0|||
23422649|NCT01778049|65292376|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
23422650|NCT01778049|65292377|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23422651|NCT01778049|65292378|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
23422652|NCT01778049|65292379|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
23422653|NCT01778049|65292380|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
23422654|NCT01778049|65292381|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
23422655|NCT01778049|65292376|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
23208704|NCT00819585|64501025|FG007|Core Study|Death|0|||
23208705|NCT00819585|64501026|FG008|Core Study|Death|0|||
23422656|NCT01778049|65292377|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
23422657|NCT01778049|65292378|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
23422658|NCT01778049|65292379|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
23422659|NCT01778049|65292380|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
23422660|NCT01778049|65292381|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
23422661|NCT01778049|65292376|FG000|Double Blind Treatment Period|Not treated|0|||
23422662|NCT01778049|65292377|FG001|Double Blind Treatment Period|Not treated|0|||
23422663|NCT01778049|65292378|FG002|Double Blind Treatment Period|Not treated|0|||
23422664|NCT01778049|65292379|FG003|Double Blind Treatment Period|Not treated|2|||
23534936|NCT03395184|65690553|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23534937|NCT03395184|65690554|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
23534938|NCT03395184|65690555|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
23534939|NCT03395184|65690549|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
23534940|NCT03395184|65690550|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
23534941|NCT03395184|65690551|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
23534942|NCT03395184|65690552|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
23534943|NCT03395184|65690553|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
23311162|NCT03610516|64886473|FG001|Treatment Epoch|Withdrawal by Subject|1|||
23311163|NCT03610516|64886472|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
23311164|NCT03610516|64886473|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
23311165|NCT03610516|64886472|FG000|Post-Treatment Follow-up|Death|1|||
23311166|NCT03610516|64886473|FG001|Post-Treatment Follow-up|Death|0|||
23311167|NCT02335983|64886474|FG000|Overall Study|Sponsor Decision|0|||
23311168|NCT02335983|64886475|FG001|Overall Study|Sponsor Decision|0|||
23311169|NCT02335983|64886476|FG002|Overall Study|Sponsor Decision|1|||
23311170|NCT02335983|64886477|FG003|Overall Study|Sponsor Decision|1|||
23311171|NCT02335983|64886478|FG004|Overall Study|Sponsor Decision|0|||
23311172|NCT02335983|64886479|FG005|Overall Study|Sponsor Decision|1|||
23311173|NCT02335983|64886474|FG000|Overall Study|Withdrawal by Subject|3|||
23311174|NCT02335983|64886475|FG001|Overall Study|Withdrawal by Subject|2|||
23311175|NCT02335983|64886476|FG002|Overall Study|Withdrawal by Subject|2|||
23311176|NCT02335983|64886477|FG003|Overall Study|Withdrawal by Subject|1|||
23311177|NCT02335983|64886478|FG004|Overall Study|Withdrawal by Subject|3|||
23311178|NCT02335983|64886479|FG005|Overall Study|Withdrawal by Subject|9|||
23311179|NCT02335983|64886474|FG000|Overall Study|Death|0|||
23311180|NCT02335983|64886475|FG001|Overall Study|Death|0|||
23311181|NCT02335983|64886476|FG002|Overall Study|Death|2|||
23311182|NCT02335983|64886477|FG003|Overall Study|Death|0|||
23311183|NCT02335983|64886478|FG004|Overall Study|Death|0|||
23311184|NCT02335983|64886479|FG005|Overall Study|Death|0|||
23311185|NCT02335983|64886474|FG000|Overall Study|Lost to Follow-up|0|||
23311186|NCT02335983|64886475|FG001|Overall Study|Lost to Follow-up|0|||
23311187|NCT02335983|64886476|FG002|Overall Study|Lost to Follow-up|0|||
23311188|NCT02335983|64886477|FG003|Overall Study|Lost to Follow-up|0|||
23311189|NCT02335983|64886478|FG004|Overall Study|Lost to Follow-up|0|||
23311190|NCT02335983|64886479|FG005|Overall Study|Lost to Follow-up|1|||
23311191|NCT02335983|64886474|FG000|Overall Study|Protocol Specified Criteria|5|||
23311192|NCT02335983|64886475|FG001|Overall Study|Protocol Specified Criteria|7|||
23311193|NCT02335983|64886476|FG002|Overall Study|Protocol Specified Criteria|27|||
23311194|NCT02335983|64886477|FG003|Overall Study|Protocol Specified Criteria|7|||
23311195|NCT02335983|64886478|FG004|Overall Study|Protocol Specified Criteria|5|||
23311196|NCT02335983|64886479|FG005|Overall Study|Protocol Specified Criteria|21|||
23311197|NCT01685840|64886480|FG000|Overall Study|Death|77|||
23311198|NCT01685840|64886481|FG001|Overall Study|Death|66|||
23311199|NCT01685840|64886480|FG000|Overall Study|Lost to Follow-up|27|||
23311200|NCT01685840|64886481|FG001|Overall Study|Lost to Follow-up|25|||
23311201|NCT01685840|64886480|FG000|Overall Study|Physician Decision|3|||
23311202|NCT01685840|64886481|FG001|Overall Study|Physician Decision|7|||
23311203|NCT01685840|64886480|FG000|Overall Study|Withdrawal by Subject|14|||
23311204|NCT01685840|64886481|FG001|Overall Study|Withdrawal by Subject|17|||
23422665|NCT01778049|65292380|FG004|Double Blind Treatment Period|Not treated|2|||
23422666|NCT01778049|65292381|FG005|Double Blind Treatment Period|Not treated|0|||
23422667|NCT01778049|65292376|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
23422668|NCT01778049|65292377|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
23422669|NCT01778049|65292378|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
23422670|NCT01778049|65292379|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
23422671|NCT01778049|65292380|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
23422672|NCT01778049|65292381|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
23422673|NCT02098369|65292382|FG000|Overall Study|Withdrawal by Subject|1|||
23422674|NCT02098369|65292383|FG001|Overall Study|Withdrawal by Subject|5|||
23422675|NCT02098369|65292384|FG002|Overall Study|Withdrawal by Subject|0|||
23422676|NCT02098369|65292382|FG000|Overall Study|Lost to Follow-up|5|||
23422677|NCT02098369|65292383|FG001|Overall Study|Lost to Follow-up|1|||
23422678|NCT02098369|65292384|FG002|Overall Study|Lost to Follow-up|3|||
23311205|NCT01685840|64886480|FG000|Overall Study|Futility|197|||
23422679|NCT02098369|65292382|FG000|Overall Study|Death|1|||
23422680|NCT02098369|65292383|FG001|Overall Study|Death|1|||
23422681|NCT02098369|65292384|FG002|Overall Study|Death|1|||
23311206|NCT01685840|64886481|FG001|Overall Study|Futility|200|||
23311207|NCT01685840|64886480|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
23311208|NCT01685840|64886481|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
23422682|NCT02098369|65292382|FG000|Overall Study|Other|0|||
23311209|NCT02342639|64886482|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
23311210|NCT02342639|64886483|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
23311211|NCT02342639|64886482|FG000|Overall Study|Protocol Violation|0|||
23311212|NCT02342639|64886483|FG001|Overall Study|Protocol Violation|2|||
23311213|NCT00856375|64886494|FG000|Overall Study|Other|0|||
23311214|NCT00856375|64886495|FG001|Overall Study|Other|1|||
23311215|NCT00856375|64886494|FG000|Overall Study|Death|32|||
23311216|NCT00856375|64886495|FG001|Overall Study|Death|30|||
23311217|NCT00856375|64886494|FG000|Overall Study|Sponsor Terminated Study|7|||
23311218|NCT00856375|64886495|FG001|Overall Study|Sponsor Terminated Study|7|||
23311219|NCT00856375|64886494|FG000|Overall Study|Withdrawal by Subject|2|||
23311220|NCT00856375|64886495|FG001|Overall Study|Withdrawal by Subject|1|||
23208706|NCT00819585|64501027|FG009|Core Study|Death|0|||
23208707|NCT00819585|64501028|FG010|Core Study|Death|0|||
23208708|NCT00819585|64501018|FG000|Core Study|Protocol Violation|0|||
23208709|NCT00819585|64501019|FG001|Core Study|Protocol Violation|0|||
23208710|NCT00819585|64501020|FG002|Core Study|Protocol Violation|1|||
23208711|NCT00819585|64501021|FG003|Core Study|Protocol Violation|0|||
23208712|NCT00819585|64501022|FG004|Core Study|Protocol Violation|0|||
23208713|NCT00819585|64501023|FG005|Core Study|Protocol Violation|1|||
23311221|NCT00856375|64886494|FG000|Overall Study|Lost to Follow-up|1|||
23311222|NCT00856375|64886495|FG001|Overall Study|Lost to Follow-up|2|||
23311223|NCT01094886|64886497|FG000|Overall Study|Adverse Event|2|||
23311224|NCT01094886|64886497|FG000|Overall Study|Withdrawal by Subject|5|||
23311225|NCT01709838|64886498|FG000|Overall Study|Withdrawal by Subject|21|||
23311226|NCT01709838|64886498|FG000|Overall Study|Lost to Follow-up|16|||
23311227|NCT01709838|64886498|FG000|Overall Study|Pregnancy|10|||
23311228|NCT01709838|64886498|FG000|Overall Study|Subject/guardian decision|8|||
23311229|NCT01709838|64886498|FG000|Overall Study|Adverse Event|4|||
23311230|NCT01709838|64886498|FG000|Overall Study|Physician Decision|4|||
23208714|NCT00819585|64501024|FG006|Core Study|Protocol Violation|3|||
23208715|NCT00819585|64501025|FG007|Core Study|Protocol Violation|0|||
23208716|NCT00819585|64501026|FG008|Core Study|Protocol Violation|0|||
23615274|NCT04908488|65976420|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
23311231|NCT01709838|64886498|FG000|Overall Study|Death|3|||
23311232|NCT01709838|64886498|FG000|Overall Study|Protocol Violation|1|||
23311233|NCT01755767|64886499|FG000|Overall Study|Progressive Disease|8|||
23311234|NCT01755767|64886500|FG001|Overall Study|Progressive Disease|7|||
23311235|NCT01755767|64886501|FG002|Overall Study|Progressive Disease|91|||
23311236|NCT01755767|64886502|FG003|Overall Study|Progressive Disease|43|||
23311237|NCT01755767|64886499|FG000|Overall Study|Clinical Disease Progression|4|||
23311238|NCT01755767|64886500|FG001|Overall Study|Clinical Disease Progression|2|||
23615275|NCT04908488|65976421|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
23615276|NCT04908488|65976420|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
23615277|NCT04908488|65976421|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
23615278|NCT00919061|65976422|FG000|Overall Study|Adverse Event|1|||
23615279|NCT00919061|65976422|FG000|Overall Study|Withdrawal by Subject|1|||
23615280|NCT03048058|65976425|FG000|Overall Study|Lost to Follow-up|4|||
23615281|NCT03048058|65976426|FG001|Overall Study|Lost to Follow-up|0|||
23615282|NCT03048058|65976425|FG000|Overall Study|Withdrawal by Subject|0|||
23615283|NCT03048058|65976426|FG001|Overall Study|Withdrawal by Subject|4|||
23615284|NCT01129011|65976427|FG000|Overall Study|Adverse Event|20|||
23615285|NCT01129011|65976428|FG001|Overall Study|Adverse Event|30|||
23615286|NCT01129011|65976427|FG000|Overall Study|Withdrawal by Subject|24|||
23615287|NCT01129011|65976428|FG001|Overall Study|Withdrawal by Subject|8|||
23615288|NCT01129011|65976427|FG000|Overall Study|Lost to Follow-up|6|||
23615289|NCT01129011|65976428|FG001|Overall Study|Lost to Follow-up|7|||
23615290|NCT01129011|65976427|FG000|Overall Study|Duodenal Ulcer|2|||
23615291|NCT01129011|65976428|FG001|Overall Study|Duodenal Ulcer|8|||
23615292|NCT01129011|65976427|FG000|Overall Study|misc|7|||
23615293|NCT01129011|65976428|FG001|Overall Study|misc|4|||
23208717|NCT00819585|64501027|FG009|Core Study|Protocol Violation|0|||
23208718|NCT00819585|64501028|FG010|Core Study|Protocol Violation|0|||
23208719|NCT00819585|64501018|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
23208720|NCT00819585|64501019|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
23208721|NCT00819585|64501020|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
23311239|NCT01755767|64886501|FG002|Overall Study|Clinical Disease Progression|29|||
23311240|NCT01755767|64886502|FG003|Overall Study|Clinical Disease Progression|20|||
23311241|NCT01755767|64886499|FG000|Overall Study|Radiographic Disease Progression|9|||
23311242|NCT01755767|64886500|FG001|Overall Study|Radiographic Disease Progression|4|||
23311243|NCT01755767|64886501|FG002|Overall Study|Radiographic Disease Progression|44|||
23311244|NCT01755767|64886502|FG003|Overall Study|Radiographic Disease Progression|27|||
23311245|NCT01755767|64886499|FG000|Overall Study|Adverse Event|6|||
23311246|NCT01755767|64886500|FG001|Overall Study|Adverse Event|0|||
23615294|NCT01636778|65976429|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
23208722|NCT00819585|64501021|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
23311247|NCT01755767|64886501|FG002|Overall Study|Adverse Event|28|||
23208723|NCT00819585|64501022|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
23208724|NCT00819585|64501023|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
23534944|NCT03395184|65690554|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
23534945|NCT03395184|65690555|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
23534946|NCT03120624|65690556|FG000|Overall Study|Withdrawal by Subject|0|||
23534947|NCT03120624|65690557|FG001|Overall Study|Withdrawal by Subject|1|||
23534948|NCT03120624|65690558|FG002|Overall Study|Withdrawal by Subject|0|||
23534949|NCT03120624|65690559|FG003|Overall Study|Withdrawal by Subject|0|||
23534950|NCT03120624|65690560|FG004|Overall Study|Withdrawal by Subject|0|||
23534951|NCT03120624|65690561|FG005|Overall Study|Withdrawal by Subject|0|||
23534952|NCT03120624|65690562|FG006|Overall Study|Withdrawal by Subject|0|||
23534953|NCT03120624|65690563|FG007|Overall Study|Withdrawal by Subject|0|||
23534954|NCT03528369|65690568|FG000|Overall Study|Withdrawal by Subject|2|||
23534955|NCT03528369|65690569|FG001|Overall Study|Withdrawal by Subject|0|||
23534956|NCT03528369|65690570|FG002|Overall Study|Withdrawal by Subject|0|||
23534957|NCT03528369|65690568|FG000|Overall Study|Lost to Follow-up|1|||
23534958|NCT03528369|65690569|FG001|Overall Study|Lost to Follow-up|0|||
23534959|NCT03528369|65690570|FG002|Overall Study|Lost to Follow-up|0|||
23534960|NCT03528369|65690568|FG000|Overall Study|Adverse Event|0|||
23534961|NCT03528369|65690569|FG001|Overall Study|Adverse Event|1|||
23534962|NCT03528369|65690570|FG002|Overall Study|Adverse Event|0|||
23534963|NCT01950390|65690874|FG000|Overall Study|Never started treatment|3|||
23534964|NCT01950390|65690875|FG001|Overall Study|Never started treatment|2|||
23534965|NCT01950390|65690874|FG000|Overall Study|Disease progression|45|||
23534966|NCT01950390|65690875|FG001|Overall Study|Disease progression|52|||
23534967|NCT01950390|65690874|FG000|Overall Study|Adverse Event|22|||
23534968|NCT01950390|65690875|FG001|Overall Study|Adverse Event|16|||
23534969|NCT01950390|65690874|FG000|Overall Study|Death|5|||
23534970|NCT01950390|65690875|FG001|Overall Study|Death|3|||
23534971|NCT01950390|65690874|FG000|Overall Study|Withdrawal by Subject|5|||
23534972|NCT01950390|65690875|FG001|Overall Study|Withdrawal by Subject|1|||
23534973|NCT01950390|65690874|FG000|Overall Study|Alternative therapy|0|||
23534974|NCT01950390|65690875|FG001|Overall Study|Alternative therapy|3|||
23534975|NCT01950390|65690874|FG000|Overall Study|Complicating disease|1|||
23534976|NCT01950390|65690875|FG001|Overall Study|Complicating disease|0|||
23534977|NCT01950390|65690874|FG000|Overall Study|On treatment|1|||
23534978|NCT01950390|65690875|FG001|Overall Study|On treatment|0|||
23534979|NCT01950390|65690874|FG000|Overall Study|Symptomatic deterioration|2|||
23534980|NCT01950390|65690875|FG001|Overall Study|Symptomatic deterioration|1|||
23534981|NCT01950390|65690874|FG000|Overall Study|Physician Decision|0|||
23534982|NCT01950390|65690875|FG001|Overall Study|Physician Decision|4|||
23534983|NCT01950390|65690874|FG000|Overall Study|Lack of clinical benefit|0|||
23534984|NCT01950390|65690875|FG001|Overall Study|Lack of clinical benefit|1|||
23534985|NCT01950390|65690874|FG000|Overall Study|Maintained PR and moved to observation only|0|||
23534986|NCT01950390|65690875|FG001|Overall Study|Maintained PR and moved to observation only|1|||
23534987|NCT03984188|65690882|FG000|Overall Study|Death|2|||
23534988|NCT03984188|65690883|FG001|Overall Study|Death|4|||
23534989|NCT03984188|65690882|FG000|Overall Study|Physician Decision|0|||
23534990|NCT03984188|65690883|FG001|Overall Study|Physician Decision|2|||
23534991|NCT03984188|65690882|FG000|Overall Study|Lost to Follow-up|3|||
23534992|NCT03984188|65690883|FG001|Overall Study|Lost to Follow-up|2|||
23534993|NCT03984188|65690882|FG000|Overall Study|Withdrawal by Subject|6|||
23534994|NCT03984188|65690883|FG001|Overall Study|Withdrawal by Subject|0|||
23534995|NCT03800836|65690884|FG000|Overall Study|Other|2|||
23534996|NCT03800836|65690885|FG001|Overall Study|Other|1|||
23534997|NCT03800836|65690886|FG002|Overall Study|Other|0|||
23534998|NCT03800836|65690887|FG003|Overall Study|Other|2|||
23534999|NCT03800836|65690888|FG004|Overall Study|Other|0|||
23535000|NCT03800836|65690889|FG005|Overall Study|Other|1|||
23535001|NCT03800836|65690884|FG000|Overall Study|Lost to Follow-up|2|||
23535002|NCT03800836|65690885|FG001|Overall Study|Lost to Follow-up|0|||
23535003|NCT03800836|65690886|FG002|Overall Study|Lost to Follow-up|1|||
23208725|NCT00819585|64501024|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
23535004|NCT03800836|65690887|FG003|Overall Study|Lost to Follow-up|1|||
23535005|NCT03800836|65690888|FG004|Overall Study|Lost to Follow-up|3|||
23535006|NCT03800836|65690889|FG005|Overall Study|Lost to Follow-up|0|||
23535007|NCT03800836|65690884|FG000|Overall Study|Withdrawal by Subject|1|||
23535008|NCT03800836|65690885|FG001|Overall Study|Withdrawal by Subject|0|||
23535009|NCT03800836|65690886|FG002|Overall Study|Withdrawal by Subject|0|||
23535010|NCT03800836|65690887|FG003|Overall Study|Withdrawal by Subject|0|||
23535011|NCT03800836|65690888|FG004|Overall Study|Withdrawal by Subject|0|||
23535012|NCT03800836|65690889|FG005|Overall Study|Withdrawal by Subject|0|||
23535013|NCT03800836|65690884|FG000|Overall Study|Physician Decision|31|||
23535014|NCT03800836|65690885|FG001|Overall Study|Physician Decision|3|||
23535015|NCT03800836|65690886|FG002|Overall Study|Physician Decision|6|||
23535016|NCT03800836|65690887|FG003|Overall Study|Physician Decision|4|||
23535017|NCT03800836|65690888|FG004|Overall Study|Physician Decision|4|||
23535018|NCT03800836|65690889|FG005|Overall Study|Physician Decision|5|||
23208726|NCT00819585|64501025|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
23535019|NCT03800836|65690884|FG000|Overall Study|Death|34|||
23535020|NCT03800836|65690885|FG001|Overall Study|Death|16|||
23535021|NCT03800836|65690886|FG002|Overall Study|Death|5|||
23535022|NCT03800836|65690887|FG003|Overall Study|Death|5|||
23535023|NCT03800836|65690888|FG004|Overall Study|Death|10|||
23422683|NCT02098369|65292383|FG001|Overall Study|Other|2|||
23422684|NCT02098369|65292384|FG002|Overall Study|Other|1|||
23422685|NCT02136680|65292385|FG000|Overall Study|No Longer Interested|1|||
23422686|NCT02136680|65292386|FG001|Overall Study|No Longer Interested|1|||
23422687|NCT02136680|65292385|FG000|Overall Study|No longer receiving care at clinic|3|||
23422688|NCT02136680|65292386|FG001|Overall Study|No longer receiving care at clinic|5|||
23422689|NCT02136680|65292385|FG000|Overall Study|Moved away|5|||
23422690|NCT02136680|65292386|FG001|Overall Study|Moved away|4|||
23422691|NCT02136680|65292385|FG000|Overall Study|Unable to schedule|17|||
23422692|NCT02136680|65292386|FG001|Overall Study|Unable to schedule|16|||
23422693|NCT02136680|65292385|FG000|Overall Study|Study ended before interview due|6|||
23422694|NCT02136680|65292386|FG001|Overall Study|Study ended before interview due|3|||
23422695|NCT04706273|65292391|FG000|Overall Study|Withdrawal by Subject|27|||
23422696|NCT04706273|65292391|FG000|Overall Study|Physician Decision|1|||
23422697|NCT04706273|65292391|FG000|Overall Study|Lost to Follow-up|42|||
23422698|NCT04706273|65292391|FG000|Overall Study|Death|85|||
23422699|NCT04706273|65292391|FG000|Overall Study|Amputation that removes study device|2|||
23422700|NCT04706273|65292391|FG000|Overall Study|Surgical bypass|3|||
23422701|NCT04706273|65292391|FG000|Overall Study|Changing hospital|23|||
23422702|NCT04706273|65292391|FG000|Overall Study|Unable to attend hospital|2|||
23422703|NCT01730339|65292393|FG000|Overall Study|Withdrawal by Subject|3|||
23422704|NCT01730339|65292394|FG001|Overall Study|Withdrawal by Subject|2|||
23422705|NCT01730339|65292393|FG000|Overall Study|Lost to Follow-up|1|||
23422706|NCT01730339|65292394|FG001|Overall Study|Lost to Follow-up|1|||
23422707|NCT01730339|65292393|FG000|Overall Study|Un-specified|1|||
23422708|NCT01730339|65292394|FG001|Overall Study|Un-specified|0|||
23422709|NCT01133275|65292396|FG000|Overall Study|Withdrawal by Subject|1|||
23422710|NCT01133275|65292396|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
23422711|NCT01390779|65292401|FG000|Overall Study|Physician Decision|1|||
23422712|NCT00006046|65292405|FG000|Overall Study|Adverse Event|3|||
23422713|NCT00006046|65292406|FG001|Overall Study|Adverse Event|0|||
23422714|NCT00006046|65292407|FG002|Overall Study|Adverse Event|0|||
23422715|NCT00006046|65292408|FG003|Overall Study|Adverse Event|0|||
23422716|NCT00006046|65292409|FG004|Overall Study|Adverse Event|0|||
23422717|NCT00006046|65292405|FG000|Overall Study|Disease Progression|2|||
23422718|NCT00006046|65292406|FG001|Overall Study|Disease Progression|0|||
23422719|NCT00006046|65292407|FG002|Overall Study|Disease Progression|0|||
23422720|NCT00006046|65292408|FG003|Overall Study|Disease Progression|0|||
23422721|NCT00006046|65292409|FG004|Overall Study|Disease Progression|0|||
23422722|NCT02046226|65292410|FG000|Overall Study|Lost to Follow-up|7|||
23422723|NCT01071200|65292412|FG000|Overall Study|Lack of ovarian response|1|||
23422724|NCT01071200|65292413|FG001|Overall Study|Lack of ovarian response|1|||
23422725|NCT01071200|65292412|FG000|Overall Study|No fertilization|4|||
23422726|NCT01071200|65292413|FG001|Overall Study|No fertilization|0|||
23422727|NCT01071200|65292412|FG000|Overall Study|No oocytes retrieved|1|||
23422728|NCT01071200|65292413|FG001|Overall Study|No oocytes retrieved|1|||
23422729|NCT01071200|65292412|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
23422730|NCT01071200|65292413|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
23422731|NCT01071200|65292412|FG000|Overall Study|No viable embryos|0|||
23422732|NCT01071200|65292413|FG001|Overall Study|No viable embryos|1|||
23422733|NCT03754582|65292416|FG000|Treatment Phase|Adverse Event|0|||
23422734|NCT03754582|65292417|FG001|Treatment Phase|Adverse Event|1|||
23422735|NCT03754582|65292418|FG002|Treatment Phase|Adverse Event|0|||
23422736|NCT03754582|65292416|FG000|Follow-up Phase|Other|0|||
23422737|NCT03754582|65292417|FG001|Follow-up Phase|Other|0|||
23422738|NCT03754582|65292418|FG002|Follow-up Phase|Other|1|||
23422739|NCT00693017|65292420|FG000|Overall Study|Sponsor Decision|2|||
23422740|NCT00693017|65292421|FG001|Overall Study|Sponsor Decision|1|||
23422741|NCT00693017|65292420|FG000|Overall Study|Death|0|||
23535024|NCT03800836|65690889|FG005|Overall Study|Death|0|||
23208727|NCT00819585|64501026|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
23311248|NCT01755767|64886502|FG003|Overall Study|Adverse Event|11|||
23422742|NCT00693017|65292421|FG001|Overall Study|Death|1|||
23422743|NCT00435162|65292428|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
23422744|NCT00435162|65292429|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
23422745|NCT00435162|65292430|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
23422746|NCT00435162|65292431|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
23422747|NCT00435162|65292432|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
23422748|NCT00435162|65292433|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
23422749|NCT00241631|65292435|FG000|Run in (2 Weeks)|Physician Decision|3|||
23422750|NCT00241631|65292436|FG001|Run in (2 Weeks)|Physician Decision|3|||
23535025|NCT03800836|65690884|FG000|Overall Study|Symptomatic Deterioration|1|||
23535026|NCT03800836|65690885|FG001|Overall Study|Symptomatic Deterioration|0|||
23535027|NCT03800836|65690886|FG002|Overall Study|Symptomatic Deterioration|1|||
23311249|NCT01755767|64886499|FG000|Overall Study|Death|1|||
23311250|NCT01755767|64886500|FG001|Overall Study|Death|2|||
23311251|NCT01755767|64886501|FG002|Overall Study|Death|15|||
23311252|NCT01755767|64886502|FG003|Overall Study|Death|4|||
23311253|NCT01755767|64886499|FG000|Overall Study|Subject Decision|0|||
23615295|NCT01636778|65976430|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
23615296|NCT01636778|65976431|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
23615297|NCT01636778|65976429|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
23615298|NCT01636778|65976430|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
23615299|NCT01636778|65976431|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
23615300|NCT01636778|65976429|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
23615301|NCT01636778|65976430|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
23615302|NCT01636778|65976431|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
23311254|NCT01755767|64886500|FG001|Overall Study|Subject Decision|0|||
23311255|NCT01755767|64886501|FG002|Overall Study|Subject Decision|10|||
23311256|NCT01755767|64886502|FG003|Overall Study|Subject Decision|3|||
23615303|NCT01636778|65976429|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
23311257|NCT01755767|64886499|FG000|Overall Study|Withdrawal by Subject|0|||
23311258|NCT01755767|64886500|FG001|Overall Study|Withdrawal by Subject|0|||
23311259|NCT01755767|64886501|FG002|Overall Study|Withdrawal by Subject|2|||
23422751|NCT00241631|65292435|FG000|Phase 1 (4 Weeks)|sore throat|1|||
23535028|NCT03800836|65690887|FG003|Overall Study|Symptomatic Deterioration|0|||
23535029|NCT03800836|65690888|FG004|Overall Study|Symptomatic Deterioration|0|||
23535030|NCT03800836|65690889|FG005|Overall Study|Symptomatic Deterioration|0|||
23582183|NCT02219490|65862354|FG000|Overall Study|COVID-19 logistical restrictions|33|||
23582184|NCT02219490|65862354|FG000|Overall Study|Other, not specified|57|||
23582185|NCT05824351|65862355|FG000|Overall Study|Adverse Event|6|||
23582186|NCT01740557|65862356|FG000|Overall Study|Ineligible|1|||
23582187|NCT01740557|65862356|FG000|Overall Study|Screen failure|1|||
23582188|NCT01123161|65862360|FG000|Overall Study|Lost to Follow-up|1|||
23582189|NCT01123161|65862361|FG001|Overall Study|Lost to Follow-up|0|||
23582190|NCT01123161|65862360|FG000|Overall Study|Withdrawal by Subject|1|||
23582191|NCT01123161|65862361|FG001|Overall Study|Withdrawal by Subject|0|||
23615304|NCT01636778|65976430|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
23615305|NCT01636778|65976431|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
23615306|NCT01636778|65976429|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
23615307|NCT01636778|65976430|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
23615308|NCT01636778|65976431|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
23615309|NCT01636778|65976429|FG000|Follow-up Period After Part 2|Other|0|||
23615310|NCT01636778|65976430|FG001|Follow-up Period After Part 2|Other|0|||
23615311|NCT01636778|65976431|FG002|Follow-up Period After Part 2|Other|1|||
23615312|NCT01636778|65976429|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
23615313|NCT01636778|65976430|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
23615314|NCT01636778|65976431|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
23615315|NCT01636778|65976429|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
23208728|NCT00819585|64501027|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
23615316|NCT01636778|65976430|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
23615317|NCT01636778|65976431|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
23615318|NCT02359552|65976432|FG000|Overall Study|Lost to Follow-up|3|||
23615319|NCT02359552|65976433|FG001|Overall Study|Lost to Follow-up|4|||
23615320|NCT04150250|65976434|FG000|Overall Study|Lost to Follow-up|0|||
23208729|NCT00819585|64501028|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
23208730|NCT00819585|64501018|FG000|Extension Study|Subject Withdrew Consent|0|||
23208731|NCT00819585|64501019|FG001|Extension Study|Subject Withdrew Consent|0|||
23208732|NCT00819585|64501020|FG002|Extension Study|Subject Withdrew Consent|0|||
23208733|NCT00819585|64501021|FG003|Extension Study|Subject Withdrew Consent|0|||
23208734|NCT00819585|64501022|FG004|Extension Study|Subject Withdrew Consent|0|||
23208735|NCT00819585|64501023|FG005|Extension Study|Subject Withdrew Consent|0|||
23208736|NCT00819585|64501024|FG006|Extension Study|Subject Withdrew Consent|0|||
23208737|NCT00819585|64501025|FG007|Extension Study|Subject Withdrew Consent|0|||
23208738|NCT00819585|64501026|FG008|Extension Study|Subject Withdrew Consent|3|||
23208739|NCT00819585|64501027|FG009|Extension Study|Subject Withdrew Consent|0|||
23208740|NCT00819585|64501028|FG010|Extension Study|Subject Withdrew Consent|1|||
23208741|NCT00819585|64501018|FG000|Extension Study|Lost to Follow-up|0|||
23208742|NCT00819585|64501019|FG001|Extension Study|Lost to Follow-up|0|||
23208743|NCT00819585|64501020|FG002|Extension Study|Lost to Follow-up|0|||
23208744|NCT00819585|64501021|FG003|Extension Study|Lost to Follow-up|0|||
23208745|NCT00819585|64501022|FG004|Extension Study|Lost to Follow-up|0|||
23208746|NCT00819585|64501023|FG005|Extension Study|Lost to Follow-up|0|||
23208747|NCT00819585|64501024|FG006|Extension Study|Lost to Follow-up|0|||
23208748|NCT00819585|64501025|FG007|Extension Study|Lost to Follow-up|0|||
23208749|NCT00819585|64501026|FG008|Extension Study|Lost to Follow-up|2|||
23208750|NCT00819585|64501027|FG009|Extension Study|Lost to Follow-up|1|||
23208751|NCT00819585|64501028|FG010|Extension Study|Lost to Follow-up|1|||
23208752|NCT00819585|64501018|FG000|Extension Study|Death|0|||
23208753|NCT00819585|64501019|FG001|Extension Study|Death|0|||
23208754|NCT00819585|64501020|FG002|Extension Study|Death|0|||
23208755|NCT00819585|64501021|FG003|Extension Study|Death|0|||
23208756|NCT00819585|64501022|FG004|Extension Study|Death|0|||
23208757|NCT00819585|64501023|FG005|Extension Study|Death|0|||
23208758|NCT00819585|64501024|FG006|Extension Study|Death|0|||
23208759|NCT00819585|64501025|FG007|Extension Study|Death|0|||
23208760|NCT00819585|64501026|FG008|Extension Study|Death|2|||
23208761|NCT00819585|64501027|FG009|Extension Study|Death|0|||
23208762|NCT00819585|64501028|FG010|Extension Study|Death|0|||
23208763|NCT02227108|64501031|FG000|Overall Study|Did not receive treatment|2|||
23208764|NCT02227108|64501031|FG000|Overall Study|Other|3|||
23208765|NCT02227108|64501031|FG000|Overall Study|Progressive disease|17|||
23208766|NCT02227108|64501031|FG000|Overall Study|Initiation of alternative therapy|2|||
23582192|NCT02929108|65862367|FG000|Overall Study|Hospice patient death|100|||
23582193|NCT02929108|65862368|FG001|Overall Study|Hospice patient death|64|||
23582194|NCT02929108|65862369|FG002|Overall Study|Hospice patient death|28|||
23208767|NCT02227108|64501031|FG000|Overall Study|Investigator discretion|1|||
23208768|NCT02227108|64501031|FG000|Overall Study|Adverse Event|6|||
23208769|NCT01293032|64501032|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
23582195|NCT02929108|65862370|FG003|Overall Study|Hospice patient death|46|||
23582196|NCT02929108|65862371|FG004|Overall Study|Hospice patient death|55|||
23615321|NCT04150250|65976435|FG001|Overall Study|Lost to Follow-up|2|||
23615322|NCT00981578|65976436|FG000|Overall Study|Death|1|||
23208770|NCT01293032|64501033|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
23208771|NCT01293032|64501034|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
23208772|NCT01293032|64501035|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
23208773|NCT01293032|64501032|FG000|Treatment|Adverse Event|0|||
23208774|NCT01293032|64501033|FG001|Treatment|Adverse Event|0|||
23208775|NCT01293032|64501034|FG002|Treatment|Adverse Event|1|||
23208776|NCT01293032|64501035|FG003|Treatment|Adverse Event|1|||
23208777|NCT01293032|64501032|FG000|Treatment|Withdrawal by Subject|2|||
23208778|NCT01293032|64501033|FG001|Treatment|Withdrawal by Subject|4|||
23208779|NCT01293032|64501034|FG002|Treatment|Withdrawal by Subject|0|||
23208780|NCT01293032|64501035|FG003|Treatment|Withdrawal by Subject|0|||
23208781|NCT01293032|64501032|FG000|Treatment|Disease Progression, relapse|0|||
23208782|NCT01293032|64501033|FG001|Treatment|Disease Progression, relapse|1|||
23208783|NCT01293032|64501034|FG002|Treatment|Disease Progression, relapse|0|||
23208784|NCT01293032|64501035|FG003|Treatment|Disease Progression, relapse|0|||
23311260|NCT01755767|64886502|FG003|Overall Study|Withdrawal by Subject|1|||
23422752|NCT00241631|65292436|FG001|Phase 1 (4 Weeks)|sore throat|0|||
23422753|NCT00241631|65292435|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
23422754|NCT00241631|65292436|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
23422755|NCT00241631|65292435|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
23422756|NCT00241631|65292436|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
23422757|NCT00241631|65292435|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
23422758|NCT00241631|65292436|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
23422759|NCT02460783|65292460|FG000|Overall Study|Withdrawal by Subject|1|||
23422760|NCT02460783|65292461|FG001|Overall Study|Withdrawal by Subject|3|||
23422761|NCT02460783|65292460|FG000|Overall Study|Lost to Follow-up|1|||
23422762|NCT02460783|65292461|FG001|Overall Study|Lost to Follow-up|1|||
23422763|NCT03263923|65292462|FG000|Overall Study|Withdrawal by Subject|10|||
23422764|NCT03263923|65292463|FG001|Overall Study|Withdrawal by Subject|8|||
23422765|NCT03263923|65292462|FG000|Overall Study|Lost to Follow-up|15|||
23422766|NCT03263923|65292463|FG001|Overall Study|Lost to Follow-up|13|||
23422767|NCT03351114|65292468|FG000|Overall Study|Withdrawal by Subject|1|||
23422768|NCT01187446|65292469|FG000|Overall Study|Patient started non-protocol therapy|0|||
23422769|NCT01187446|65292470|FG001|Overall Study|Patient started non-protocol therapy|1|||
23422770|NCT00445848|65292474|FG000|Overall Study|Adverse Event|14|||
23422771|NCT00445848|65292474|FG000|Overall Study|Withdrawal by Subject|4|||
23422772|NCT00445848|65292474|FG000|Overall Study|Progression|62|||
23422773|NCT00445848|65292474|FG000|Overall Study|Other-Not protocol specified|5|||
23422774|NCT02692040|65292475|FG000|Overall Study|Protocol Violation|0|||
23422775|NCT02692040|65292476|FG001|Overall Study|Protocol Violation|0|||
23422776|NCT02692040|65292477|FG002|Overall Study|Protocol Violation|0|||
23422777|NCT02692040|65292478|FG003|Overall Study|Protocol Violation|0|||
23422778|NCT02692040|65292479|FG004|Overall Study|Protocol Violation|0|||
23422779|NCT02692040|65292480|FG005|Overall Study|Protocol Violation|0|||
23422780|NCT02692040|65292481|FG006|Overall Study|Protocol Violation|0|||
23422781|NCT02692040|65292482|FG007|Overall Study|Protocol Violation|0|||
23422782|NCT02692040|65292483|FG008|Overall Study|Protocol Violation|0|||
23422783|NCT02692040|65292484|FG009|Overall Study|Protocol Violation|0|||
23422784|NCT02692040|65292485|FG010|Overall Study|Protocol Violation|0|||
23422785|NCT02692040|65292486|FG011|Overall Study|Protocol Violation|0|||
23422786|NCT02692040|65292487|FG012|Overall Study|Protocol Violation|1|||
23422787|NCT02692040|65292488|FG013|Overall Study|Protocol Violation|0|||
23422788|NCT02692040|65292489|FG014|Overall Study|Protocol Violation|0|||
23422789|NCT02692040|65292490|FG015|Overall Study|Protocol Violation|0|||
23208785|NCT00995670|64501039|FG000|Overall Study|Failed arterial cannulation|1|||
23422790|NCT02692040|65292491|FG016|Overall Study|Protocol Violation|0|||
23422791|NCT02692040|65292475|FG000|Overall Study|Adverse Event|0|||
23422792|NCT02692040|65292476|FG001|Overall Study|Adverse Event|0|||
23422793|NCT02692040|65292477|FG002|Overall Study|Adverse Event|0|||
23422794|NCT02692040|65292478|FG003|Overall Study|Adverse Event|0|||
23422795|NCT02692040|65292479|FG004|Overall Study|Adverse Event|0|||
23422796|NCT02692040|65292480|FG005|Overall Study|Adverse Event|0|||
23422797|NCT02692040|65292481|FG006|Overall Study|Adverse Event|0|||
23422798|NCT02692040|65292482|FG007|Overall Study|Adverse Event|0|||
23422799|NCT02692040|65292483|FG008|Overall Study|Adverse Event|0|||
23422800|NCT02692040|65292484|FG009|Overall Study|Adverse Event|0|||
23422801|NCT02692040|65292485|FG010|Overall Study|Adverse Event|0|||
23422802|NCT02692040|65292486|FG011|Overall Study|Adverse Event|0|||
23422803|NCT02692040|65292487|FG012|Overall Study|Adverse Event|0|||
23422804|NCT02692040|65292488|FG013|Overall Study|Adverse Event|3|||
23422805|NCT02692040|65292489|FG014|Overall Study|Adverse Event|1|||
23422806|NCT02692040|65292490|FG015|Overall Study|Adverse Event|1|||
23311261|NCT01755767|64886499|FG000|Overall Study|Other|0|||
23422807|NCT02692040|65292491|FG016|Overall Study|Adverse Event|0|||
23422808|NCT03372460|65292492|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
23422809|NCT03372460|65292493|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
23422810|NCT02226562|65292498|FG000|Overall Study|Lost to Follow-up|0|||
23422811|NCT02226562|65292499|FG001|Overall Study|Lost to Follow-up|1|||
23422812|NCT03773133|65292502|FG000|Overall Study|Screen Failure|8|||
23422813|NCT02264665|65292503|FG000|Overall Study|Other|0|||
23422814|NCT02264665|65292504|FG001|Overall Study|Other|0|||
23422815|NCT02264665|65292505|FG002|Overall Study|Other|3|||
23422816|NCT02264665|65292506|FG003|Overall Study|Other|0|||
23422817|NCT02264665|65292507|FG004|Overall Study|Other|0|||
23422818|NCT02264665|65292508|FG005|Overall Study|Other|0|||
23422819|NCT02264665|65292509|FG006|Overall Study|Other|0|||
23422820|NCT02264665|65292503|FG000|Overall Study|Death|9|||
23422821|NCT02264665|65292504|FG001|Overall Study|Death|8|||
23422822|NCT02264665|65292505|FG002|Overall Study|Death|13|||
23422823|NCT02264665|65292506|FG003|Overall Study|Death|5|||
23422824|NCT02264665|65292507|FG004|Overall Study|Death|0|||
23422825|NCT02264665|65292508|FG005|Overall Study|Death|0|||
23422826|NCT02264665|65292509|FG006|Overall Study|Death|1|||
23422827|NCT02264665|65292503|FG000|Overall Study|Lost to Follow-up|1|||
23422828|NCT02264665|65292504|FG001|Overall Study|Lost to Follow-up|0|||
23422829|NCT02264665|65292505|FG002|Overall Study|Lost to Follow-up|2|||
23422830|NCT02264665|65292506|FG003|Overall Study|Lost to Follow-up|1|||
23422831|NCT02264665|65292507|FG004|Overall Study|Lost to Follow-up|0|||
23422832|NCT02264665|65292508|FG005|Overall Study|Lost to Follow-up|0|||
23422833|NCT02264665|65292509|FG006|Overall Study|Lost to Follow-up|0|||
23422834|NCT02264665|65292503|FG000|Overall Study|Participant decision|0|||
23422835|NCT02264665|65292504|FG001|Overall Study|Participant decision|0|||
23422836|NCT02264665|65292505|FG002|Overall Study|Participant decision|0|||
23422837|NCT02264665|65292506|FG003|Overall Study|Participant decision|1|||
23422838|NCT02264665|65292507|FG004|Overall Study|Participant decision|0|||
23422839|NCT02264665|65292508|FG005|Overall Study|Participant decision|0|||
23422840|NCT02264665|65292509|FG006|Overall Study|Participant decision|0|||
23422841|NCT02264665|65292503|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
23422842|NCT02264665|65292504|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
23422843|NCT02264665|65292505|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
23422844|NCT02264665|65292506|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
23422845|NCT02264665|65292507|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
23422846|NCT02264665|65292508|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
23422847|NCT02264665|65292509|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
23422848|NCT02264665|65292503|FG000|Overall Study|Data Missing|0|||
23422849|NCT02264665|65292504|FG001|Overall Study|Data Missing|0|||
23422850|NCT02264665|65292505|FG002|Overall Study|Data Missing|1|||
23422851|NCT02264665|65292506|FG003|Overall Study|Data Missing|0|||
23208786|NCT00995670|64501040|FG001|Overall Study|Failed arterial cannulation|0|||
23208787|NCT00995670|64501041|FG002|Overall Study|Failed arterial cannulation|3|||
23208788|NCT02947022|64501042|FG000|Overall Study|Study Stopped|1|||
23208789|NCT01736254|64501045|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
23422852|NCT02264665|65292507|FG004|Overall Study|Data Missing|0|||
23422853|NCT02264665|65292508|FG005|Overall Study|Data Missing|0|||
23422854|NCT02264665|65292509|FG006|Overall Study|Data Missing|0|||
23422855|NCT03272828|65292510|FG000|Overall Study|Lost to Follow-up|7|||
23422856|NCT03272828|65292511|FG001|Overall Study|Lost to Follow-up|7|||
23311262|NCT01755767|64886500|FG001|Overall Study|Other|0|||
23422857|NCT03272828|65292510|FG000|Overall Study|Withdrawal by Subject|2|||
23422858|NCT03272828|65292511|FG001|Overall Study|Withdrawal by Subject|0|||
23422859|NCT03272828|65292510|FG000|Overall Study|Deceased|1|||
23422860|NCT03272828|65292511|FG001|Overall Study|Deceased|1|||
23422861|NCT03272828|65292510|FG000|Overall Study|Failed implant|1|||
23422862|NCT03272828|65292511|FG001|Overall Study|Failed implant|2|||
23422863|NCT00075946|65292512|FG000|Overall Study|Path ineligible: undetermined histology|0|||
23422864|NCT00075946|65292513|FG001|Overall Study|Path ineligible: undetermined histology|0|||
23422865|NCT00075946|65292514|FG002|Overall Study|Path ineligible: undetermined histology|0|||
23422866|NCT00075946|65292515|FG003|Overall Study|Path ineligible: undetermined histology|0|||
23422867|NCT00075946|65292516|FG004|Overall Study|Path ineligible: undetermined histology|6|||
23422868|NCT00075946|65292512|FG000|Overall Study|Did not achieve response after induction|0|||
23422869|NCT00075946|65292513|FG001|Overall Study|Did not achieve response after induction|0|||
23422870|NCT00075946|65292514|FG002|Overall Study|Did not achieve response after induction|0|||
23422871|NCT00075946|65292515|FG003|Overall Study|Did not achieve response after induction|0|||
23422872|NCT00075946|65292516|FG004|Overall Study|Did not achieve response after induction|182|||
23422873|NCT00075946|65292512|FG000|Overall Study|Incorrectly randomized (no response)|5|||
23422874|NCT00075946|65292513|FG001|Overall Study|Incorrectly randomized (no response)|5|||
23422875|NCT00075946|65292514|FG002|Overall Study|Incorrectly randomized (no response)|5|||
23422876|NCT00075946|65292515|FG003|Overall Study|Incorrectly randomized (no response)|1|||
23422877|NCT00075946|65292516|FG004|Overall Study|Incorrectly randomized (no response)|0|||
23422878|NCT00075946|65292512|FG000|Overall Study|Adverse Event|2|||
23422879|NCT00075946|65292513|FG001|Overall Study|Adverse Event|10|||
23422880|NCT00075946|65292514|FG002|Overall Study|Adverse Event|0|||
23422881|NCT00075946|65292515|FG003|Overall Study|Adverse Event|2|||
23422882|NCT00075946|65292516|FG004|Overall Study|Adverse Event|0|||
23422883|NCT00075946|65292512|FG000|Overall Study|Death|0|||
23422884|NCT00075946|65292513|FG001|Overall Study|Death|1|||
23422885|NCT00075946|65292514|FG002|Overall Study|Death|0|||
23422886|NCT00075946|65292515|FG003|Overall Study|Death|0|||
23422887|NCT00075946|65292516|FG004|Overall Study|Death|0|||
23422888|NCT00075946|65292512|FG000|Overall Study|Withdrawal by Subject|23|||
23422889|NCT00075946|65292513|FG001|Overall Study|Withdrawal by Subject|58|||
23422890|NCT00075946|65292514|FG002|Overall Study|Withdrawal by Subject|4|||
23422891|NCT00075946|65292515|FG003|Overall Study|Withdrawal by Subject|9|||
23422892|NCT00075946|65292516|FG004|Overall Study|Withdrawal by Subject|0|||
23422893|NCT00075946|65292512|FG000|Overall Study|Alternative therapy|16|||
23422894|NCT00075946|65292513|FG001|Overall Study|Alternative therapy|2|||
23422895|NCT00075946|65292514|FG002|Overall Study|Alternative therapy|5|||
23422896|NCT00075946|65292515|FG003|Overall Study|Alternative therapy|0|||
23422897|NCT00075946|65292516|FG004|Overall Study|Alternative therapy|0|||
23615323|NCT00981578|65976436|FG000|Overall Study|Withdrawal by Subject|2|||
23615324|NCT00443599|65976437|FG000|Overall Study|Physician Decision|2|||
23615325|NCT00443599|65976438|FG001|Overall Study|Physician Decision|1|||
23615326|NCT00443599|65976437|FG000|Overall Study|Death|1|||
23615327|NCT00443599|65976438|FG001|Overall Study|Death|1|||
23615328|NCT00443599|65976437|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
23615329|NCT00443599|65976438|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
23615330|NCT03087851|65976439|FG000|Overall Study|Withdraw on medical grounds|0|||
23615331|NCT03087851|65976440|FG001|Overall Study|Withdraw on medical grounds|1|||
23615332|NCT03087851|65976441|FG002|Overall Study|Withdraw on medical grounds|2|||
23615333|NCT02877680|65976442|FG000|Overall Study|Lost to Follow-up|1|||
23615334|NCT02877680|65976443|FG001|Overall Study|Lost to Follow-up|1|||
23615335|NCT01323309|65976444|FG000|Overall Study|Death|9|||
23615336|NCT01323309|65976445|FG001|Overall Study|Death|15|||
23615337|NCT01323309|65976446|FG002|Overall Study|Death|5|||
23615338|NCT01323309|65976444|FG000|Overall Study|Lost to Follow-up|11|||
23615339|NCT01323309|65976445|FG001|Overall Study|Lost to Follow-up|14|||
23615340|NCT01323309|65976446|FG002|Overall Study|Lost to Follow-up|24|||
23615341|NCT01323309|65976444|FG000|Overall Study|Withdrawal by Subject|14|||
23615342|NCT01323309|65976445|FG001|Overall Study|Withdrawal by Subject|14|||
23615343|NCT01323309|65976446|FG002|Overall Study|Withdrawal by Subject|18|||
23615344|NCT01323309|65976444|FG000|Overall Study|Disease progression|5|||
23615345|NCT01323309|65976445|FG001|Overall Study|Disease progression|11|||
23615346|NCT01323309|65976446|FG002|Overall Study|Disease progression|4|||
23208790|NCT01736254|64501045|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
23422898|NCT00075946|65292512|FG000|Overall Study|Other complicating disease|7|||
23422899|NCT00075946|65292513|FG001|Overall Study|Other complicating disease|13|||
23422900|NCT00075946|65292514|FG002|Overall Study|Other complicating disease|1|||
23615347|NCT03749616|65976451|FG000|Overall Study|Lost to Follow-up|4|||
23615348|NCT03749616|65976452|FG001|Overall Study|Lost to Follow-up|7|||
23615349|NCT03749616|65976451|FG000|Overall Study|Screen Failure|1|||
23615350|NCT03749616|65976452|FG001|Overall Study|Screen Failure|1|||
23422901|NCT00075946|65292515|FG003|Overall Study|Other complicating disease|4|||
23615351|NCT03749616|65976451|FG000|Overall Study|Withdrawal by Subject|2|||
23615352|NCT03749616|65976452|FG001|Overall Study|Withdrawal by Subject|0|||
23615353|NCT04372186|65976453|FG000|Overall Study|Death|24|||
23615354|NCT04372186|65976454|FG001|Overall Study|Death|11|||
23615355|NCT04372186|65976453|FG000|Overall Study|Transferred to a different facility for care|0|||
23615356|NCT04372186|65976454|FG001|Overall Study|Transferred to a different facility for care|2|||
23615357|NCT03151551|65976455|FG000|Open-Label Treatment Period|Adverse Event|0|||
23615358|NCT03151551|65976456|FG001|Open-Label Treatment Period|Adverse Event|2|||
23615359|NCT03151551|65976455|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
23615360|NCT03151551|65976456|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
23615361|NCT03151551|65976455|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
23615362|NCT03151551|65976456|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
23615363|NCT03151551|65976455|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
23615364|NCT03151551|65976456|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
23615365|NCT03151551|65976455|FG000|Open-Label Treatment Period|Physician Decision|3|||
23615366|NCT03151551|65976456|FG001|Open-Label Treatment Period|Physician Decision|0|||
23615367|NCT03151551|65976455|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
23311263|NCT01755767|64886501|FG002|Overall Study|Other|2|||
23311264|NCT01755767|64886502|FG003|Overall Study|Other|3|||
23311265|NCT01755767|64886499|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
23311266|NCT01755767|64886500|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
23311267|NCT01755767|64886501|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
23311268|NCT01755767|64886502|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
23311269|NCT03207243|64886504|FG000|Overall Study|Adverse Event|2|||
23311270|NCT03207243|64886505|FG001|Overall Study|Adverse Event|2|||
23311271|NCT03207243|64886504|FG000|Overall Study|Loss of Asthma Control|47|||
23311272|NCT03207243|64886505|FG001|Overall Study|Loss of Asthma Control|31|||
23311273|NCT03207243|64886504|FG000|Overall Study|Withdrawal by Subject|2|||
23311274|NCT03207243|64886505|FG001|Overall Study|Withdrawal by Subject|4|||
23311275|NCT03207243|64886504|FG000|Overall Study|Physician Decision|1|||
23311276|NCT03207243|64886505|FG001|Overall Study|Physician Decision|1|||
23311277|NCT03207243|64886504|FG000|Overall Study|Lost to Follow-up|0|||
23311278|NCT03207243|64886505|FG001|Overall Study|Lost to Follow-up|1|||
23311279|NCT03207243|64886504|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
23311280|NCT03207243|64886505|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
23311281|NCT03207243|64886504|FG000|Overall Study|Protocol Violation|0|||
23311282|NCT03207243|64886505|FG001|Overall Study|Protocol Violation|3|||
23422902|NCT00075946|65292516|FG004|Overall Study|Other complicating disease|0|||
23311283|NCT00000378|64886509|FG000|Overall Study|Lack of Efficacy|16|||
23311284|NCT00000378|64886510|FG001|Overall Study|Lack of Efficacy|14|||
23311285|NCT01340768|64886511|FG000|Overall Study|Lost to Follow-up|10|||
23311286|NCT01340768|64886512|FG001|Overall Study|Lost to Follow-up|4|||
23311287|NCT01340768|64886511|FG000|Overall Study|Withdrawal by Subject|5|||
23311288|NCT01340768|64886512|FG001|Overall Study|Withdrawal by Subject|1|||
23311289|NCT01340768|64886511|FG000|Overall Study|Other|2|||
23311290|NCT01340768|64886512|FG001|Overall Study|Other|0|||
23311291|NCT00282919|64886516|FG000|Overall Study|Lack of Efficacy|4|||
23311292|NCT00282919|64886516|FG000|Overall Study|Withdrawal by Subject|1|||
23311293|NCT00282919|64886516|FG000|Overall Study|Asymptomatic Parasitemia|2|||
23311294|NCT01814553|64886517|FG000|Overall Study|PD per clinical progression|6|||
23311295|NCT01814553|64886518|FG001|Overall Study|PD per clinical progression|8|||
23311296|NCT01814553|64886517|FG000|Overall Study|Other Adverse Event|4|||
23311297|NCT01814553|64886518|FG001|Overall Study|Other Adverse Event|5|||
23311298|NCT01814553|64886517|FG000|Overall Study|Withdrawal by Subject|1|||
23311299|NCT01814553|64886518|FG001|Overall Study|Withdrawal by Subject|1|||
23311300|NCT01814553|64886517|FG000|Overall Study|Other than stated|7|||
23311301|NCT01814553|64886518|FG001|Overall Study|Other than stated|8|||
23615368|NCT03151551|65976456|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
23615369|NCT03151551|65976455|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
23615370|NCT03151551|65976456|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
23615371|NCT03151551|65976455|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
23615372|NCT03151551|65976456|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23615373|NCT03151551|65976455|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
23615374|NCT03151551|65976456|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
23615375|NCT03151551|65976455|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
23615376|NCT03151551|65976456|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
23615377|NCT00702520|65976458|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
23615378|NCT00702520|65976459|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
23615379|NCT00702520|65976460|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
23615380|NCT00702520|65976461|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
23311302|NCT00368979|64886519|FG000|Overall Study|Adverse Event|9|||
23311303|NCT00368979|64886520|FG001|Overall Study|Adverse Event|16|||
23311304|NCT00368979|64886519|FG000|Overall Study|Lack of Efficacy|5|||
23311305|NCT00368979|64886520|FG001|Overall Study|Lack of Efficacy|3|||
23311306|NCT00368979|64886519|FG000|Overall Study|Other|3|||
23615381|NCT00702520|65976458|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
23615382|NCT00702520|65976459|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
23615383|NCT00702520|65976460|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
23615384|NCT00702520|65976461|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
23615385|NCT00702520|65976458|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
23615386|NCT00702520|65976459|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
23615387|NCT00702520|65976460|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
23535031|NCT04086472|65693384|FG000|Overall Study|Lost to Follow-up|1|||
23535032|NCT04086472|65693385|FG001|Overall Study|Lost to Follow-up|0|||
23535033|NCT04086472|65693386|FG002|Overall Study|Lost to Follow-up|0|||
23535034|NCT04086472|65693387|FG003|Overall Study|Lost to Follow-up|0|||
23535035|NCT04086472|65693388|FG004|Overall Study|Lost to Follow-up|1|||
23535036|NCT04086472|65693384|FG000|Overall Study|Physician Decision|0|||
23535037|NCT04086472|65693385|FG001|Overall Study|Physician Decision|1|||
23535038|NCT04086472|65693386|FG002|Overall Study|Physician Decision|1|||
23535039|NCT04086472|65693387|FG003|Overall Study|Physician Decision|0|||
23535040|NCT04086472|65693388|FG004|Overall Study|Physician Decision|0|||
23535041|NCT04086472|65693384|FG000|Overall Study|Withdrawal by Subject|1|||
23535042|NCT04086472|65693385|FG001|Overall Study|Withdrawal by Subject|1|||
23535043|NCT04086472|65693386|FG002|Overall Study|Withdrawal by Subject|1|||
23615388|NCT00702520|65976461|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
23615389|NCT04088136|65976464|FG000|Overall Study|Withdrawal by Subject|5|||
23615390|NCT04088136|65976465|FG001|Overall Study|Withdrawal by Subject|0|||
23615391|NCT04088136|65976464|FG000|Overall Study|Lack of Efficacy|0|||
23615392|NCT04088136|65976465|FG001|Overall Study|Lack of Efficacy|1|||
23615393|NCT03029234|65976466|FG000|Overall Study|Sponsor Decision|1|||
23615394|NCT03029234|65976466|FG000|Overall Study|Withdrawal by Subject|5|||
23615395|NCT03029234|65976466|FG000|Overall Study|Death|91|||
23615396|NCT03029234|65976466|FG000|Overall Study|Lost to Follow-up|2|||
23615397|NCT00734851|65976470|FG000|Overall Study|Withdrawal by Subject|2|||
23615398|NCT00734851|65976470|FG000|Overall Study|Lost to Follow-up|1|||
23615399|NCT00734851|65976470|FG000|Overall Study|Physician Decision|18|||
23615400|NCT03972137|65976475|FG000|Overall Study|Lost to Follow-up|2|||
23615401|NCT03972137|65976475|FG000|Overall Study|Withdrawal by Subject|4|||
23615402|NCT03575572|65976476|FG000|Overall Study|Withdrawal by Subject|2|||
23615403|NCT03575572|65976476|FG000|Overall Study|Physician Decision|2|||
23615404|NCT00228813|65976477|FG000|Overall Study|Death|4|||
23615405|NCT01527500|65976478|FG000|Part A|Administrative|11|||
23615406|NCT01527500|65976479|FG001|Part A|Administrative|7|||
23615407|NCT01527500|65976478|FG000|Part A|Adverse Event|4|||
23615408|NCT01527500|65976479|FG001|Part A|Adverse Event|2|||
23615409|NCT01527500|65976478|FG000|Part A|Death|4|||
23615410|NCT01527500|65976479|FG001|Part A|Death|1|||
23615411|NCT01527500|65976478|FG000|Part A|Lost to Follow-up|0|||
23615412|NCT01527500|65976479|FG001|Part A|Lost to Follow-up|1|||
23615413|NCT01527500|65976478|FG000|Part A|Protocol Deviation|9|||
23615414|NCT01527500|65976479|FG001|Part A|Protocol Deviation|2|||
23311307|NCT00368979|64886520|FG001|Overall Study|Other|1|||
23311308|NCT00368979|64886519|FG000|Overall Study|Lost to Follow-up|1|||
23311309|NCT00368979|64886520|FG001|Overall Study|Lost to Follow-up|0|||
23311310|NCT00368979|64886519|FG000|Overall Study|Protocol Violation|2|||
23311311|NCT00368979|64886520|FG001|Overall Study|Protocol Violation|1|||
23311312|NCT00368979|64886519|FG000|Overall Study|Withdrawal by Subject|5|||
23311313|NCT00368979|64886520|FG001|Overall Study|Withdrawal by Subject|9|||
23311314|NCT00229723|64886521|FG000|Concomitant Phase|Adverse Event|4|||
23311315|NCT00229723|64886522|FG001|Concomitant Phase|Adverse Event|2|||
23311316|NCT00229723|64886523|FG002|Concomitant Phase|Adverse Event|5|||
23311317|NCT00229723|64886524|FG003|Concomitant Phase|Adverse Event|2|||
23311318|NCT00229723|64886525|FG004|Concomitant Phase|Adverse Event|0|||
23311319|NCT00229723|64886526|FG005|Concomitant Phase|Adverse Event|1|||
23311320|NCT00229723|64886527|FG006|Concomitant Phase|Adverse Event|2|||
23311321|NCT00229723|64886521|FG000|Concomitant Phase|Objective disease progression|0|||
23311322|NCT00229723|64886522|FG001|Concomitant Phase|Objective disease progression|0|||
23311323|NCT00229723|64886523|FG002|Concomitant Phase|Objective disease progression|0|||
23311324|NCT00229723|64886524|FG003|Concomitant Phase|Objective disease progression|0|||
23311325|NCT00229723|64886525|FG004|Concomitant Phase|Objective disease progression|0|||
23311326|NCT00229723|64886526|FG005|Concomitant Phase|Objective disease progression|0|||
23422903|NCT00075946|65292512|FG000|Overall Study|No response to retreatment|23|||
23615415|NCT01527500|65976478|FG000|Part A|Withdrawal by Subject|2|||
23615416|NCT01527500|65976479|FG001|Part A|Withdrawal by Subject|0|||
23615417|NCT01527500|65976478|FG000|Part B|Adverse Event|1|||
23311327|NCT00229723|64886527|FG006|Concomitant Phase|Objective disease progression|0|||
23311328|NCT00229723|64886521|FG000|Concomitant Phase|Clinical progression|0|||
23535044|NCT04086472|65693387|FG003|Overall Study|Withdrawal by Subject|0|||
23615418|NCT01527500|65976479|FG001|Part B|Adverse Event|0|||
23615419|NCT01678898|65976480|FG000|PB-102-F01|Adverse Event|0|||
23615420|NCT01678898|65976481|FG001|PB-102-F01|Adverse Event|1|||
23615421|NCT01678898|65976482|FG002|PB-102-F01|Adverse Event|0|||
23311329|NCT00229723|64886522|FG001|Concomitant Phase|Clinical progression|0|||
23311330|NCT00229723|64886523|FG002|Concomitant Phase|Clinical progression|0|||
23311331|NCT00229723|64886524|FG003|Concomitant Phase|Clinical progression|0|||
23311332|NCT00229723|64886525|FG004|Concomitant Phase|Clinical progression|0|||
23311333|NCT00229723|64886526|FG005|Concomitant Phase|Clinical progression|0|||
23311334|NCT00229723|64886527|FG006|Concomitant Phase|Clinical progression|1|||
23311335|NCT00229723|64886521|FG000|Concomitant Phase|Lost to Follow-up|0|||
23311336|NCT00229723|64886522|FG001|Concomitant Phase|Lost to Follow-up|0|||
23311337|NCT00229723|64886523|FG002|Concomitant Phase|Lost to Follow-up|0|||
23311338|NCT00229723|64886524|FG003|Concomitant Phase|Lost to Follow-up|0|||
23311339|NCT00229723|64886525|FG004|Concomitant Phase|Lost to Follow-up|1|||
23311340|NCT00229723|64886526|FG005|Concomitant Phase|Lost to Follow-up|0|||
23311341|NCT00229723|64886527|FG006|Concomitant Phase|Lost to Follow-up|0|||
23311342|NCT00229723|64886521|FG000|Concomitant Phase|Informed consent withdrawn|3|||
23311343|NCT00229723|64886522|FG001|Concomitant Phase|Informed consent withdrawn|2|||
23311344|NCT00229723|64886523|FG002|Concomitant Phase|Informed consent withdrawn|0|||
23311345|NCT00229723|64886524|FG003|Concomitant Phase|Informed consent withdrawn|2|||
23311346|NCT00229723|64886525|FG004|Concomitant Phase|Informed consent withdrawn|0|||
23311347|NCT00229723|64886526|FG005|Concomitant Phase|Informed consent withdrawn|0|||
23311348|NCT00229723|64886527|FG006|Concomitant Phase|Informed consent withdrawn|0|||
23311349|NCT00229723|64886521|FG000|Concomitant Phase|Severe non-compliance|0|||
23311350|NCT00229723|64886522|FG001|Concomitant Phase|Severe non-compliance|1|||
23311351|NCT00229723|64886523|FG002|Concomitant Phase|Severe non-compliance|0|||
23311352|NCT00229723|64886524|FG003|Concomitant Phase|Severe non-compliance|0|||
23311353|NCT00229723|64886525|FG004|Concomitant Phase|Severe non-compliance|1|||
23311354|NCT00229723|64886526|FG005|Concomitant Phase|Severe non-compliance|0|||
23311355|NCT00229723|64886527|FG006|Concomitant Phase|Severe non-compliance|0|||
23311356|NCT00229723|64886521|FG000|Concomitant Phase|Other|3|||
23615422|NCT01678898|65976480|FG000|PB-102-F01|Physician Decision|0|||
23615423|NCT01678898|65976481|FG001|PB-102-F01|Physician Decision|1|||
23615424|NCT01678898|65976482|FG002|PB-102-F01|Physician Decision|0|||
23615425|NCT00464737|65976485|FG000|Overall Study|Adverse Event|12|||
23615426|NCT00464737|65976486|FG001|Overall Study|Adverse Event|17|||
23311357|NCT00229723|64886522|FG001|Concomitant Phase|Other|0|||
23311358|NCT00229723|64886523|FG002|Concomitant Phase|Other|1|||
23311359|NCT00229723|64886524|FG003|Concomitant Phase|Other|1|||
23311360|NCT00229723|64886525|FG004|Concomitant Phase|Other|0|||
23311361|NCT00229723|64886526|FG005|Concomitant Phase|Other|2|||
23311362|NCT00229723|64886527|FG006|Concomitant Phase|Other|0|||
23311363|NCT00229723|64886521|FG000|Maintenance Phase|Adverse Event|7|||
23311364|NCT00229723|64886522|FG001|Maintenance Phase|Adverse Event|2|||
23311365|NCT00229723|64886523|FG002|Maintenance Phase|Adverse Event|1|||
23311366|NCT00229723|64886524|FG003|Maintenance Phase|Adverse Event|4|||
23615427|NCT00464737|65976487|FG002|Overall Study|Adverse Event|33|||
23615428|NCT00464737|65976485|FG000|Overall Study|Lack of Efficacy|7|||
23615429|NCT00464737|65976486|FG001|Overall Study|Lack of Efficacy|7|||
23615430|NCT00464737|65976487|FG002|Overall Study|Lack of Efficacy|4|||
23615431|NCT00464737|65976485|FG000|Overall Study|Withdrawal by Subject|5|||
23615432|NCT00464737|65976486|FG001|Overall Study|Withdrawal by Subject|3|||
23615433|NCT00464737|65976487|FG002|Overall Study|Withdrawal by Subject|5|||
23615434|NCT00464737|65976485|FG000|Overall Study|Protocol Violation|1|||
23615435|NCT00464737|65976486|FG001|Overall Study|Protocol Violation|1|||
23615436|NCT00464737|65976487|FG002|Overall Study|Protocol Violation|5|||
23615437|NCT00464737|65976485|FG000|Overall Study|Non-compliance|0|||
23615438|NCT00464737|65976486|FG001|Overall Study|Non-compliance|1|||
23615439|NCT00464737|65976487|FG002|Overall Study|Non-compliance|1|||
23615440|NCT00464737|65976485|FG000|Overall Study|Lost to Follow-up|5|||
23615441|NCT00464737|65976486|FG001|Overall Study|Lost to Follow-up|2|||
23615442|NCT00464737|65976487|FG002|Overall Study|Lost to Follow-up|5|||
23615443|NCT00464737|65976485|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
23615444|NCT00464737|65976486|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
23615445|NCT00464737|65976487|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
23615446|NCT00464737|65976485|FG000|Overall Study|Other: Subject left town; family illness|1|||
23311367|NCT00229723|64886525|FG004|Maintenance Phase|Adverse Event|7|||
23311368|NCT00229723|64886526|FG005|Maintenance Phase|Adverse Event|5|||
23311369|NCT00229723|64886527|FG006|Maintenance Phase|Adverse Event|2|||
23311370|NCT00229723|64886521|FG000|Maintenance Phase|Objective disease progression|5|||
23311371|NCT00229723|64886522|FG001|Maintenance Phase|Objective disease progression|5|||
23311372|NCT00229723|64886523|FG002|Maintenance Phase|Objective disease progression|3|||
23311373|NCT00229723|64886524|FG003|Maintenance Phase|Objective disease progression|6|||
23311374|NCT00229723|64886525|FG004|Maintenance Phase|Objective disease progression|2|||
23311375|NCT00229723|64886526|FG005|Maintenance Phase|Objective disease progression|9|||
23311376|NCT00229723|64886527|FG006|Maintenance Phase|Objective disease progression|5|||
23311377|NCT00229723|64886521|FG000|Maintenance Phase|Clinical progression|4|||
23311378|NCT00229723|64886522|FG001|Maintenance Phase|Clinical progression|1|||
23615447|NCT00464737|65976486|FG001|Overall Study|Other: Subject left town; family illness|0|||
23311379|NCT00229723|64886523|FG002|Maintenance Phase|Clinical progression|2|||
23311380|NCT00229723|64886524|FG003|Maintenance Phase|Clinical progression|2|||
23311381|NCT00229723|64886525|FG004|Maintenance Phase|Clinical progression|1|||
23311382|NCT00229723|64886526|FG005|Maintenance Phase|Clinical progression|1|||
23311383|NCT00229723|64886527|FG006|Maintenance Phase|Clinical progression|1|||
23311384|NCT00229723|64886521|FG000|Maintenance Phase|Lost to Follow-up|0|||
23311385|NCT00229723|64886522|FG001|Maintenance Phase|Lost to Follow-up|1|||
23311386|NCT00229723|64886523|FG002|Maintenance Phase|Lost to Follow-up|2|||
23311387|NCT00229723|64886524|FG003|Maintenance Phase|Lost to Follow-up|2|||
23311388|NCT00229723|64886525|FG004|Maintenance Phase|Lost to Follow-up|0|||
23311389|NCT00229723|64886526|FG005|Maintenance Phase|Lost to Follow-up|0|||
23311390|NCT00229723|64886527|FG006|Maintenance Phase|Lost to Follow-up|1|||
23311391|NCT00229723|64886521|FG000|Maintenance Phase|Informed consent withdrawn|1|||
23311392|NCT00229723|64886522|FG001|Maintenance Phase|Informed consent withdrawn|0|||
23311393|NCT00229723|64886523|FG002|Maintenance Phase|Informed consent withdrawn|0|||
23311394|NCT00229723|64886524|FG003|Maintenance Phase|Informed consent withdrawn|1|||
23311395|NCT00229723|64886525|FG004|Maintenance Phase|Informed consent withdrawn|1|||
23311396|NCT00229723|64886526|FG005|Maintenance Phase|Informed consent withdrawn|1|||
23311397|NCT00229723|64886527|FG006|Maintenance Phase|Informed consent withdrawn|0|||
23311398|NCT00229723|64886521|FG000|Maintenance Phase|Severe non-compliance|3|||
23311399|NCT00229723|64886522|FG001|Maintenance Phase|Severe non-compliance|1|||
23311400|NCT00229723|64886523|FG002|Maintenance Phase|Severe non-compliance|0|||
23311401|NCT00229723|64886524|FG003|Maintenance Phase|Severe non-compliance|0|||
23311402|NCT00229723|64886525|FG004|Maintenance Phase|Severe non-compliance|1|||
23311403|NCT00229723|64886526|FG005|Maintenance Phase|Severe non-compliance|0|||
23311404|NCT00229723|64886527|FG006|Maintenance Phase|Severe non-compliance|0|||
23311405|NCT00229723|64886521|FG000|Maintenance Phase|Other|5|||
23311406|NCT00229723|64886522|FG001|Maintenance Phase|Other|4|||
23311407|NCT00229723|64886523|FG002|Maintenance Phase|Other|1|||
23311408|NCT00229723|64886524|FG003|Maintenance Phase|Other|2|||
23311409|NCT00229723|64886525|FG004|Maintenance Phase|Other|3|||
23422904|NCT00075946|65292513|FG001|Overall Study|No response to retreatment|0|||
23422905|NCT00075946|65292514|FG002|Overall Study|No response to retreatment|2|||
23422906|NCT00075946|65292515|FG003|Overall Study|No response to retreatment|0|||
23422907|NCT00075946|65292516|FG004|Overall Study|No response to retreatment|0|||
23535045|NCT04086472|65693388|FG004|Overall Study|Withdrawal by Subject|0|||
23535046|NCT04086472|65693384|FG000|Overall Study|Various reasons|2|||
23535047|NCT04086472|65693385|FG001|Overall Study|Various reasons|0|||
23615448|NCT00464737|65976487|FG002|Overall Study|Other: Subject left town; family illness|0|||
23535048|NCT04086472|65693386|FG002|Overall Study|Various reasons|0|||
23535049|NCT04086472|65693387|FG003|Overall Study|Various reasons|3|||
23535050|NCT04086472|65693388|FG004|Overall Study|Various reasons|1|||
23535051|NCT00132769|65693389|FG000|Overall Study|Withdrawal by Subject|1|||
23535052|NCT00132769|65693390|FG001|Overall Study|Withdrawal by Subject|3|||
23535053|NCT00132769|65693389|FG000|Overall Study|Lack of Efficacy|7|||
23535054|NCT00132769|65693390|FG001|Overall Study|Lack of Efficacy|6|||
23535055|NCT00132769|65693389|FG000|Overall Study|Adverse Event|2|||
23535056|NCT00132769|65693390|FG001|Overall Study|Adverse Event|1|||
23535057|NCT00132769|65693389|FG000|Overall Study|Protocol Violation|1|||
23535058|NCT00132769|65693390|FG001|Overall Study|Protocol Violation|1|||
23535059|NCT01743092|65693391|FG000|Overall Study|Lost to Follow-up|14|||
23535060|NCT01743092|65693392|FG001|Overall Study|Lost to Follow-up|15|||
23535061|NCT01430130|65693393|FG000|Overall Study|Lost to Follow-up|1|||
23535062|NCT01430130|65693393|FG000|Overall Study|Infection on Control Side of Incision|1|||
23535063|NCT01575561|65693415|FG000|Overall Study|Adverse Event|9|||
23535064|NCT01575561|65693415|FG000|Overall Study|Lack of Efficacy|8|||
23535065|NCT01575561|65693415|FG000|Overall Study|Lost to Follow-up|6|||
23535066|NCT01575561|65693415|FG000|Overall Study|Protocol Violation|4|||
23535067|NCT01575561|65693415|FG000|Overall Study|Withdrawal by Subject|11|||
23535068|NCT01575561|65693415|FG000|Overall Study|administration|1|||
23535069|NCT00781326|65693416|FG000|Phase I|Adverse Event|1|||
23311410|NCT00229723|64886526|FG005|Maintenance Phase|Other|3|||
23311411|NCT00229723|64886527|FG006|Maintenance Phase|Other|1|||
23311412|NCT00371397|64886530|FG000|Session 1|Withdrawal by Subject|1|||
23311413|NCT00371397|64886531|FG001|Session 1|Withdrawal by Subject|0|||
23311414|NCT00371397|64886532|FG002|Session 1|Withdrawal by Subject|0|||
23311415|NCT00371397|64886533|FG003|Session 1|Withdrawal by Subject|0|||
23311416|NCT00371397|64886534|FG004|Session 1|Withdrawal by Subject|0|||
23311417|NCT00371397|64886535|FG005|Session 1|Withdrawal by Subject|0|||
23311418|NCT00371397|64886536|FG006|Session 1|Withdrawal by Subject|0|||
23311419|NCT00371397|64886537|FG007|Session 1|Withdrawal by Subject|1|||
23311420|NCT00371397|64886538|FG008|Session 1|Withdrawal by Subject|0|||
23535070|NCT00781326|65693416|FG000|Phase I|Withdrawal by Subject|1|||
23535071|NCT00781326|65693416|FG000|Phase I|Physician Decision|2|||
23535072|NCT02383758|65693417|FG000|Overall Study|Withdrawal by Subject|0|||
23615449|NCT00464737|65976485|FG000|Overall Study|Other: Study demands too great|0|||
23615450|NCT00464737|65976486|FG001|Overall Study|Other: Study demands too great|1|||
23615451|NCT00464737|65976487|FG002|Overall Study|Other: Study demands too great|0|||
23615452|NCT00464737|65976485|FG000|Overall Study|Other: Personal family reasons|0|||
23615453|NCT00464737|65976486|FG001|Overall Study|Other: Personal family reasons|0|||
23615454|NCT00464737|65976487|FG002|Overall Study|Other: Personal family reasons|1|||
23615455|NCT00464737|65976485|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
23615456|NCT00464737|65976486|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
23615457|NCT00464737|65976487|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
23615458|NCT05153499|65976499|FG000|Overall Study|Withdrawal by Subject|1|||
23615459|NCT05153499|65976500|FG001|Overall Study|Withdrawal by Subject|0|||
23615460|NCT05153499|65976499|FG000|Overall Study|Clinical Hold|1|||
23615461|NCT05153499|65976500|FG001|Overall Study|Clinical Hold|0|||
23615462|NCT05153499|65976499|FG000|Overall Study|Study Termination|6|||
23615463|NCT05153499|65976500|FG001|Overall Study|Study Termination|5|||
23615464|NCT01374971|65976504|FG000|Overall Study|Withdrawal by Subject|1|||
23615465|NCT01502371|65979353|FG000|Overall Study|Withdrawal by Subject|1|||
23615466|NCT01502371|65979354|FG001|Overall Study|Withdrawal by Subject|2|||
23615467|NCT01502371|65979355|FG002|Overall Study|Withdrawal by Subject|1|||
23615468|NCT01502371|65979356|FG003|Overall Study|Withdrawal by Subject|1|||
23615469|NCT01502371|65979357|FG004|Overall Study|Withdrawal by Subject|1|||
23615470|NCT01502371|65979353|FG000|Overall Study|Adverse Event|2|||
23615471|NCT01502371|65979354|FG001|Overall Study|Adverse Event|1|||
23615472|NCT01502371|65979355|FG002|Overall Study|Adverse Event|0|||
23615473|NCT01502371|65979356|FG003|Overall Study|Adverse Event|4|||
23615474|NCT01502371|65979357|FG004|Overall Study|Adverse Event|3|||
23615475|NCT01502371|65979353|FG000|Overall Study|Treatment Failure|22|||
23615476|NCT01502371|65979354|FG001|Overall Study|Treatment Failure|20|||
23615477|NCT01502371|65979355|FG002|Overall Study|Treatment Failure|12|||
23615478|NCT01502371|65979356|FG003|Overall Study|Treatment Failure|19|||
23615479|NCT01502371|65979357|FG004|Overall Study|Treatment Failure|30|||
23615480|NCT01502371|65979353|FG000|Overall Study|Lack of Efficacy|3|||
23615481|NCT01502371|65979354|FG001|Overall Study|Lack of Efficacy|3|||
23615482|NCT01502371|65979355|FG002|Overall Study|Lack of Efficacy|2|||
23615483|NCT01502371|65979356|FG003|Overall Study|Lack of Efficacy|2|||
23615484|NCT01502371|65979357|FG004|Overall Study|Lack of Efficacy|4|||
23615485|NCT01502371|65979353|FG000|Overall Study|Physician Decision|3|||
23311421|NCT00371397|64886539|FG009|Session 1|Withdrawal by Subject|0|||
23311422|NCT00371397|64886540|FG010|Session 1|Withdrawal by Subject|0|||
23615486|NCT01502371|65979354|FG001|Overall Study|Physician Decision|0|||
23615487|NCT01502371|65979355|FG002|Overall Study|Physician Decision|0|||
23615488|NCT01502371|65979356|FG003|Overall Study|Physician Decision|0|||
23615489|NCT01502371|65979357|FG004|Overall Study|Physician Decision|1|||
23615490|NCT01502371|65979353|FG000|Overall Study|Noncompliance with Study Drug|0|||
23615491|NCT01502371|65979354|FG001|Overall Study|Noncompliance with Study Drug|0|||
23615492|NCT01502371|65979355|FG002|Overall Study|Noncompliance with Study Drug|1|||
23615493|NCT01502371|65979356|FG003|Overall Study|Noncompliance with Study Drug|2|||
23615494|NCT01502371|65979357|FG004|Overall Study|Noncompliance with Study Drug|1|||
23615495|NCT01502371|65979353|FG000|Overall Study|Technical Problems|1|||
23615496|NCT01502371|65979354|FG001|Overall Study|Technical Problems|0|||
23615497|NCT01502371|65979355|FG002|Overall Study|Technical Problems|2|||
23615498|NCT01502371|65979356|FG003|Overall Study|Technical Problems|4|||
23615499|NCT01502371|65979357|FG004|Overall Study|Technical Problems|1|||
23615500|NCT01502371|65979353|FG000|Overall Study|Protocol Violation|9|||
23615501|NCT01502371|65979354|FG001|Overall Study|Protocol Violation|5|||
23311423|NCT00371397|64886541|FG011|Session 1|Withdrawal by Subject|0|||
23311424|NCT02504671|64886542|FG000|Overall Study|Withdrawal by Subject|1|||
23311425|NCT02504671|64886543|FG001|Overall Study|Withdrawal by Subject|5|||
23311426|NCT02504671|64886544|FG002|Overall Study|Withdrawal by Subject|4|||
23311427|NCT02504671|64886545|FG003|Overall Study|Withdrawal by Subject|4|||
23311428|NCT02504671|64886546|FG004|Overall Study|Withdrawal by Subject|5|||
23311429|NCT02504671|64886547|FG005|Overall Study|Withdrawal by Subject|3|||
23311430|NCT02504671|64886542|FG000|Overall Study|Lack of Efficacy|1|||
23311431|NCT02504671|64886543|FG001|Overall Study|Lack of Efficacy|3|||
23311432|NCT02504671|64886544|FG002|Overall Study|Lack of Efficacy|1|||
23311433|NCT02504671|64886545|FG003|Overall Study|Lack of Efficacy|0|||
23311434|NCT02504671|64886546|FG004|Overall Study|Lack of Efficacy|4|||
23311435|NCT02504671|64886547|FG005|Overall Study|Lack of Efficacy|4|||
23615502|NCT01502371|65979355|FG002|Overall Study|Protocol Violation|6|||
23615503|NCT01502371|65979356|FG003|Overall Study|Protocol Violation|5|||
23311436|NCT02504671|64886542|FG000|Overall Study|Adverse Event|1|||
23311437|NCT02504671|64886543|FG001|Overall Study|Adverse Event|1|||
23311438|NCT02504671|64886544|FG002|Overall Study|Adverse Event|0|||
23422908|NCT00075946|65292512|FG000|Overall Study|Time to progression less than 6 months|15|||
23615504|NCT01502371|65979357|FG004|Overall Study|Protocol Violation|10|||
23615505|NCT01502371|65979353|FG000|Overall Study|Excluded Medication|0|||
23615506|NCT01502371|65979354|FG001|Overall Study|Excluded Medication|1|||
23615507|NCT01502371|65979355|FG002|Overall Study|Excluded Medication|1|||
23615508|NCT01502371|65979356|FG003|Overall Study|Excluded Medication|0|||
23615509|NCT01502371|65979357|FG004|Overall Study|Excluded Medication|1|||
23615510|NCT00640042|65979358|FG000|Enrollment|Did not receive study drug|83|||
23615511|NCT00473512|65979359|FG000|Period 1 (Phase 1)|Adverse Event|0|||
23615512|NCT00473512|65979360|FG001|Period 1 (Phase 1)|Adverse Event|0|||
23615513|NCT00473512|65979361|FG002|Period 1 (Phase 1)|Adverse Event|0|||
23615514|NCT00473512|65979362|FG003|Period 1 (Phase 1)|Adverse Event|5|||
23615515|NCT00473512|65979363|FG004|Period 1 (Phase 1)|Adverse Event|0|||
23615516|NCT00473512|65979359|FG000|Period 1 (Phase 1)|Death|0|||
23615517|NCT00473512|65979360|FG001|Period 1 (Phase 1)|Death|0|||
23615518|NCT00473512|65979361|FG002|Period 1 (Phase 1)|Death|0|||
23615519|NCT00473512|65979362|FG003|Period 1 (Phase 1)|Death|1|||
23615520|NCT00473512|65979363|FG004|Period 1 (Phase 1)|Death|0|||
23615521|NCT00473512|65979359|FG000|Period 1 (Phase 1)|Disease Progression|1|||
23615522|NCT00473512|65979360|FG001|Period 1 (Phase 1)|Disease Progression|1|||
23615523|NCT00473512|65979361|FG002|Period 1 (Phase 1)|Disease Progression|0|||
23615524|NCT00473512|65979362|FG003|Period 1 (Phase 1)|Disease Progression|10|||
23615525|NCT00473512|65979363|FG004|Period 1 (Phase 1)|Disease Progression|1|||
23615526|NCT00473512|65979359|FG000|Period 1 (Phase 1)|Other|0|||
23615527|NCT00473512|65979360|FG001|Period 1 (Phase 1)|Other|0|||
23615528|NCT00473512|65979361|FG002|Period 1 (Phase 1)|Other|0|||
23615529|NCT00473512|65979362|FG003|Period 1 (Phase 1)|Other|1|||
23615530|NCT00473512|65979363|FG004|Period 1 (Phase 1)|Other|0|||
23615531|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Adverse Event|0|||
23615532|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Adverse Event|0|||
23615533|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Adverse Event|0|||
23615534|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Adverse Event|1|||
23615535|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Adverse Event|0|||
23615536|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Death|0|||
23615537|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Death|0|||
23615538|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Death|0|||
23615539|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Death|1|||
23615540|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Death|1|||
23615541|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Disease Progression|0|||
23615542|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Disease Progression|2|||
23615543|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Disease Progression|2|||
23615544|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Disease Progression|17|||
23615545|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Disease Progression|1|||
23615546|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
23615547|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
23615548|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
23615549|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
23615550|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
23615551|NCT00473512|65979359|FG000|Period 2 (Phase 2)|Other|1|||
23615552|NCT00473512|65979360|FG001|Period 2 (Phase 2)|Other|0|||
23311439|NCT02504671|64886545|FG003|Overall Study|Adverse Event|1|||
23311440|NCT02504671|64886546|FG004|Overall Study|Adverse Event|0|||
23311441|NCT02504671|64886547|FG005|Overall Study|Adverse Event|2|||
23311442|NCT02504671|64886542|FG000|Overall Study|Protocol Violation|2|||
23311443|NCT02504671|64886543|FG001|Overall Study|Protocol Violation|1|||
23311444|NCT02504671|64886544|FG002|Overall Study|Protocol Violation|0|||
23311445|NCT02504671|64886545|FG003|Overall Study|Protocol Violation|0|||
23311446|NCT02504671|64886546|FG004|Overall Study|Protocol Violation|0|||
23311447|NCT02504671|64886547|FG005|Overall Study|Protocol Violation|1|||
23311448|NCT02504671|64886542|FG000|Overall Study|Lost to Follow-up|0|||
23311449|NCT02504671|64886543|FG001|Overall Study|Lost to Follow-up|0|||
23311450|NCT02504671|64886544|FG002|Overall Study|Lost to Follow-up|2|||
23615553|NCT00473512|65979361|FG002|Period 2 (Phase 2)|Other|0|||
23615554|NCT00473512|65979362|FG003|Period 2 (Phase 2)|Other|3|||
23311451|NCT02504671|64886545|FG003|Overall Study|Lost to Follow-up|0|||
23311452|NCT02504671|64886546|FG004|Overall Study|Lost to Follow-up|0|||
23311453|NCT02504671|64886547|FG005|Overall Study|Lost to Follow-up|1|||
23311454|NCT02504671|64886542|FG000|Overall Study|Protocol defined stopping criteria|7|||
23615555|NCT00473512|65979363|FG004|Period 2 (Phase 2)|Other|0|||
23615556|NCT01924806|65979364|FG000|Overall Study|Physician Decision|2|||
23615557|NCT01924806|65979365|FG001|Overall Study|Physician Decision|1|||
23615558|NCT01498445|65979372|FG000|Overall Study|Lack of Efficacy|0|||
23615559|NCT01498445|65979373|FG001|Overall Study|Lack of Efficacy|0|||
23615560|NCT01498445|65979374|FG002|Overall Study|Lack of Efficacy|1|||
23615561|NCT01498445|65979375|FG003|Overall Study|Lack of Efficacy|2|||
23615562|NCT01498445|65979376|FG004|Overall Study|Lack of Efficacy|0|||
23615563|NCT01498445|65979377|FG005|Overall Study|Lack of Efficacy|0|||
23615564|NCT01498445|65979372|FG000|Overall Study|Screen Failure|0|||
23615565|NCT01498445|65979373|FG001|Overall Study|Screen Failure|0|||
23615566|NCT01498445|65979374|FG002|Overall Study|Screen Failure|0|||
23615567|NCT01498445|65979375|FG003|Overall Study|Screen Failure|0|||
23208791|NCT01968954|64501046|FG000|Overall Study|Adverse Event|6|||
23535073|NCT02383758|65693418|FG001|Overall Study|Withdrawal by Subject|2|||
23535074|NCT02742103|65693419|FG000|Overall Study|Protocol Violation|1|||
23535075|NCT02742103|65693420|FG001|Overall Study|Protocol Violation|0|||
23535076|NCT02742103|65693419|FG000|Overall Study|Death|2|||
23535077|NCT02742103|65693420|FG001|Overall Study|Death|2|||
23535078|NCT02742103|65693419|FG000|Overall Study|Adverse Event|1|||
23535079|NCT02742103|65693420|FG001|Overall Study|Adverse Event|0|||
23535080|NCT02742103|65693419|FG000|Overall Study|Moved to another town|0|||
23535081|NCT02742103|65693420|FG001|Overall Study|Moved to another town|1|||
23208792|NCT01968954|64501047|FG001|Overall Study|Adverse Event|3|||
23208793|NCT01968954|64501046|FG000|Overall Study|Death|1|||
23208794|NCT01968954|64501047|FG001|Overall Study|Death|2|||
23208795|NCT01968954|64501046|FG000|Overall Study|Lost to Follow-up|6|||
23208796|NCT01968954|64501047|FG001|Overall Study|Lost to Follow-up|4|||
23208797|NCT01968954|64501046|FG000|Overall Study|Withdrawal by Subject|20|||
23535082|NCT02742103|65693419|FG000|Overall Study|Withdrawal by Subject|5|||
23535083|NCT02742103|65693420|FG001|Overall Study|Withdrawal by Subject|2|||
23535084|NCT00807092|65693421|FG000|Overall Study|Adverse Event|0|||
23535085|NCT00807092|65693422|FG001|Overall Study|Adverse Event|1|||
23535086|NCT00807092|65693421|FG000|Overall Study|Protocol Violation|0|||
23535087|NCT00807092|65693422|FG001|Overall Study|Protocol Violation|2|||
23535088|NCT00807092|65693421|FG000|Overall Study|Withdrawal by Subject|1|||
23535089|NCT00807092|65693422|FG001|Overall Study|Withdrawal by Subject|0|||
23535090|NCT00807092|65693421|FG000|Overall Study|CGMS data collection failed|0|||
23535091|NCT00807092|65693422|FG001|Overall Study|CGMS data collection failed|1|||
23535092|NCT04452344|65693423|FG000|Overall Study|Withdrawal by Subject|3|||
23535093|NCT04452344|65693424|FG001|Overall Study|Withdrawal by Subject|6|||
23535094|NCT04452344|65693423|FG000|Overall Study|Adverse Event|1|||
23535095|NCT04452344|65693424|FG001|Overall Study|Adverse Event|2|||
23535096|NCT04452344|65693423|FG000|Overall Study|Lost to Follow-up|2|||
23535097|NCT04452344|65693424|FG001|Overall Study|Lost to Follow-up|2|||
23535098|NCT04452344|65693423|FG000|Overall Study|No Post-Op Visit|6|||
23535099|NCT04452344|65693424|FG001|Overall Study|No Post-Op Visit|7|||
23535100|NCT00298038|65693425|FG000|Overall Study|Lost to Follow-up|0|||
23535101|NCT00298038|65693426|FG001|Overall Study|Lost to Follow-up|1|||
23535102|NCT00298038|65693425|FG000|Overall Study|Liver Transplant|0|||
23535103|NCT00298038|65693426|FG001|Overall Study|Liver Transplant|1|||
23535104|NCT00298038|65693425|FG000|Overall Study|Protocol Violation|1|||
23535105|NCT00298038|65693426|FG001|Overall Study|Protocol Violation|3|||
23535106|NCT00298038|65693425|FG000|Overall Study|Death|6|||
23535107|NCT00298038|65693426|FG001|Overall Study|Death|3|||
23535108|NCT00298038|65693425|FG000|Overall Study|Withdrawal by Subject|6|||
23535109|NCT00298038|65693426|FG001|Overall Study|Withdrawal by Subject|9|||
23535110|NCT00298038|65693425|FG000|Overall Study|Adverse Event|8|||
23535111|NCT00298038|65693426|FG001|Overall Study|Adverse Event|7|||
23535112|NCT00298038|65693425|FG000|Overall Study|Breakthrough overt HE episode|28|||
23535113|NCT00298038|65693426|FG001|Overall Study|Breakthrough overt HE episode|69|||
23535114|NCT00298038|65693425|FG000|Overall Study|Noncompliance|1|||
23535115|NCT00298038|65693426|FG001|Overall Study|Noncompliance|0|||
23535116|NCT00298038|65693425|FG000|Overall Study|Cocaine Abuse|1|||
23535117|NCT00298038|65693426|FG001|Overall Study|Cocaine Abuse|0|||
23535118|NCT00298038|65693425|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
23535119|NCT00298038|65693426|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
23535120|NCT02266381|65693431|FG000|Overall Study|Physician Decision|3|||
23535121|NCT02266381|65693432|FG001|Overall Study|Physician Decision|5|||
23535122|NCT02266381|65693433|FG002|Overall Study|Physician Decision|4|||
23535123|NCT03698773|65693434|FG000|Overall Study|Lost to Follow-up|2|||
23535124|NCT03698773|65693435|FG001|Overall Study|Lost to Follow-up|1|||
23208798|NCT01968954|64501047|FG001|Overall Study|Withdrawal by Subject|23|||
23208799|NCT01968954|64501046|FG000|Overall Study|Other|7|||
23208800|NCT01968954|64501047|FG001|Overall Study|Other|8|||
23208801|NCT01968954|64501046|FG000|Overall Study|Protocol Violation|0|||
23208802|NCT01968954|64501047|FG001|Overall Study|Protocol Violation|1|||
23208803|NCT01968954|64501046|FG000|Overall Study|Did not met inclusion criteria|0|||
23208804|NCT01968954|64501047|FG001|Overall Study|Did not met inclusion criteria|2|||
23208805|NCT01928485|64501049|FG000|Overall Study|Physician Decision|0|||
23208806|NCT01928485|64501050|FG001|Overall Study|Physician Decision|1|||
23311455|NCT02504671|64886543|FG001|Overall Study|Protocol defined stopping criteria|4|||
23535125|NCT01049919|65693441|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
23535126|NCT01049919|65693442|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
23535127|NCT01049919|65693441|FG000|Overall Study|Withdrawal by Subject|5|||
23535128|NCT01049919|65693442|FG001|Overall Study|Withdrawal by Subject|0|||
23535129|NCT01049919|65693441|FG000|Overall Study|Lost to Follow-up|6|||
23535130|NCT01049919|65693442|FG001|Overall Study|Lost to Follow-up|1|||
23535131|NCT01049919|65693441|FG000|Overall Study|Physician Decision|2|||
23208807|NCT01895452|64501054|FG000|Overall Study|Adverse Event|1|||
23535132|NCT01049919|65693442|FG001|Overall Study|Physician Decision|0|||
23615568|NCT01498445|65979376|FG004|Overall Study|Screen Failure|1|||
23535133|NCT01049919|65693441|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
23535134|NCT01049919|65693442|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
23535135|NCT01049919|65693441|FG000|Overall Study|Early study termination by sponsor.|2|||
23535136|NCT01049919|65693442|FG001|Overall Study|Early study termination by sponsor.|0|||
23535137|NCT01040871|65693443|FG000|Overall Study|Adverse Event|6|||
23535138|NCT01040871|65693444|FG001|Overall Study|Adverse Event|2|||
23535139|NCT01040871|65693443|FG000|Overall Study|Withdrawal by Subject|2|||
23535140|NCT01040871|65693444|FG001|Overall Study|Withdrawal by Subject|0|||
23535141|NCT01040871|65693443|FG000|Overall Study|Death|1|||
23535142|NCT01040871|65693444|FG001|Overall Study|Death|3|||
23535143|NCT01040871|65693443|FG000|Overall Study|Lack of Efficacy|1|||
23535144|NCT01040871|65693444|FG001|Overall Study|Lack of Efficacy|1|||
23535145|NCT01040871|65693443|FG000|Overall Study|drug supply issue|1|||
23535146|NCT01040871|65693444|FG001|Overall Study|drug supply issue|0|||
23535147|NCT01040871|65693443|FG000|Overall Study|Randomized and Not Treated|2|||
23535148|NCT01040871|65693444|FG001|Overall Study|Randomized and Not Treated|1|||
23535149|NCT01649856|65693445|FG000|Overall Study|Withdrawal by Subject|14|||
23535150|NCT01649856|65693446|FG001|Overall Study|Withdrawal by Subject|14|||
23535151|NCT01649856|65693445|FG000|Overall Study|Protocol Violation|4|||
23535152|NCT01649856|65693446|FG001|Overall Study|Protocol Violation|4|||
23535153|NCT01649856|65693445|FG000|Overall Study|Treatment Failure|1|||
23535154|NCT01649856|65693446|FG001|Overall Study|Treatment Failure|1|||
23535155|NCT01649856|65693445|FG000|Overall Study|Death|69|||
23535156|NCT01649856|65693446|FG001|Overall Study|Death|34|||
23535157|NCT01649856|65693445|FG000|Overall Study|Stable or Progressed Disease|5|||
23535158|NCT01649856|65693446|FG001|Overall Study|Stable or Progressed Disease|3|||
23535159|NCT01649856|65693445|FG000|Overall Study|Lost to Follow-up|20|||
23535160|NCT01649856|65693446|FG001|Overall Study|Lost to Follow-up|16|||
23535161|NCT01649856|65693445|FG000|Overall Study|Lack of Compliance|6|||
23535162|NCT01649856|65693446|FG001|Overall Study|Lack of Compliance|1|||
23535163|NCT01649856|65693445|FG000|Overall Study|Other|20|||
23535164|NCT01649856|65693446|FG001|Overall Study|Other|5|||
23535165|NCT00306592|65693447|FG000|Overall Study|Adverse Event|8|||
23535166|NCT00306592|65693448|FG001|Overall Study|Adverse Event|15|||
23535167|NCT00306592|65693447|FG000|Overall Study|Lost to Follow-up|1|||
23535168|NCT00306592|65693448|FG001|Overall Study|Lost to Follow-up|0|||
23535169|NCT00306592|65693447|FG000|Overall Study|Noncompliance|0|||
23535170|NCT00306592|65693448|FG001|Overall Study|Noncompliance|2|||
23535171|NCT00306592|65693447|FG000|Overall Study|Persistent Antibodies|6|||
23535172|NCT00306592|65693448|FG001|Overall Study|Persistent Antibodies|3|||
23535173|NCT00306592|65693447|FG000|Overall Study|Voluntary|10|||
23535174|NCT00306592|65693448|FG001|Overall Study|Voluntary|6|||
23535175|NCT00306592|65693447|FG000|Overall Study|Other|5|||
23535176|NCT00306592|65693448|FG001|Overall Study|Other|10|||
23535177|NCT00306592|65693447|FG000|Overall Study|Other|1|||
23535178|NCT00306592|65693448|FG001|Overall Study|Other|2|||
23535179|NCT00306592|65693447|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
23535180|NCT00306592|65693448|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
23535181|NCT03509948|65693449|FG000|Overall Study|Protocol Violation|0|||
23535182|NCT03509948|65693450|FG001|Overall Study|Protocol Violation|1|||
23535183|NCT00912405|65693451|FG000|Overall Study|Lost to Follow-up|5|||
23535184|NCT00530023|65693453|FG000|Overall Study|Withdrawal by Subject|0|||
23535185|NCT00530023|65693454|FG001|Overall Study|Withdrawal by Subject|1|||
23535186|NCT00774787|65693455|FG000|Overall Study|Lost to Follow-up|1|||
23535187|NCT00965848|65693459|FG000|Overall Study|Protocol Violation|3|||
23535188|NCT00965848|65693460|FG001|Overall Study|Protocol Violation|0|||
23535189|NCT00965848|65693461|FG002|Overall Study|Protocol Violation|1|||
23535190|NCT00965848|65693459|FG000|Overall Study|Death|11|||
23535191|NCT00965848|65693460|FG001|Overall Study|Death|1|||
23535192|NCT00965848|65693461|FG002|Overall Study|Death|5|||
23535193|NCT00965848|65693459|FG000|Overall Study|Lost to Follow-up|0|||
23535194|NCT00965848|65693460|FG001|Overall Study|Lost to Follow-up|0|||
23535195|NCT00965848|65693461|FG002|Overall Study|Lost to Follow-up|1|||
23535196|NCT00965848|65693459|FG000|Overall Study|Withdrawal by Subject|1|||
23311456|NCT02504671|64886544|FG002|Overall Study|Protocol defined stopping criteria|3|||
23535197|NCT00965848|65693460|FG001|Overall Study|Withdrawal by Subject|0|||
23535198|NCT00965848|65693461|FG002|Overall Study|Withdrawal by Subject|0|||
23535199|NCT00965848|65693459|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
23535200|NCT00965848|65693460|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
23535201|NCT00965848|65693461|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
23535202|NCT00965848|65693459|FG000|Overall Study|Not Clinically Evaluable|7|||
23535203|NCT00965848|65693460|FG001|Overall Study|Not Clinically Evaluable|1|||
23535204|NCT00965848|65693461|FG002|Overall Study|Not Clinically Evaluable|1|||
23535205|NCT00965848|65693459|FG000|Overall Study|Other|5|||
23535206|NCT00965848|65693460|FG001|Overall Study|Other|0|||
23535207|NCT00965848|65693461|FG002|Overall Study|Other|1|||
23535208|NCT01038778|65693462|FG000|Overall Study|Withdrawal by Subject|0|||
23535209|NCT01038778|65693463|FG001|Overall Study|Withdrawal by Subject|2|||
23535210|NCT01038778|65693464|FG002|Overall Study|Withdrawal by Subject|3|||
23208808|NCT01895452|64501055|FG001|Overall Study|Adverse Event|4|||
23208809|NCT01895452|64501054|FG000|Overall Study|Lost to Follow-up|1|||
23208810|NCT01895452|64501055|FG001|Overall Study|Lost to Follow-up|5|||
23208811|NCT01895452|64501054|FG000|Overall Study|Pregnancy|0|||
23208812|NCT01895452|64501055|FG001|Overall Study|Pregnancy|1|||
23208813|NCT01895452|64501054|FG000|Overall Study|Withdrawal by Subject|2|||
23208814|NCT01895452|64501055|FG001|Overall Study|Withdrawal by Subject|14|||
23208815|NCT01895452|64501054|FG000|Overall Study|Underlying disease|0|||
23208816|NCT01895452|64501055|FG001|Overall Study|Underlying disease|3|||
23208817|NCT01895452|64501054|FG000|Overall Study|Noncompliance with study drug|0|||
23208818|NCT01895452|64501055|FG001|Overall Study|Noncompliance with study drug|1|||
23208819|NCT00747617|64501059|FG000|Overall Study|Lost to Follow-up|3|||
23208820|NCT00747617|64501060|FG001|Overall Study|Lost to Follow-up|1|||
23208821|NCT01354353|64501061|FG000|Overall Study|Adverse Event|1|||
23208822|NCT01354353|64501062|FG001|Overall Study|Adverse Event|0|||
23208823|NCT01354353|64501063|FG002|Overall Study|Adverse Event|0|||
23208824|NCT01354353|64501064|FG003|Overall Study|Adverse Event|4|||
23208825|NCT01354353|64501065|FG004|Overall Study|Adverse Event|0|||
23208826|NCT01354353|64501066|FG005|Overall Study|Adverse Event|5|||
23208827|NCT01354353|64501061|FG000|Overall Study|Entry Criteria Not Met|0|||
23208828|NCT01354353|64501062|FG001|Overall Study|Entry Criteria Not Met|0|||
23208829|NCT01354353|64501063|FG002|Overall Study|Entry Criteria Not Met|0|||
23208830|NCT01354353|64501064|FG003|Overall Study|Entry Criteria Not Met|1|||
23208831|NCT01354353|64501065|FG004|Overall Study|Entry Criteria Not Met|1|||
23208832|NCT01354353|64501066|FG005|Overall Study|Entry Criteria Not Met|0|||
23208833|NCT01354353|64501061|FG000|Overall Study|Physician Decision|0|||
23208834|NCT01354353|64501062|FG001|Overall Study|Physician Decision|1|||
23208835|NCT01354353|64501063|FG002|Overall Study|Physician Decision|1|||
23208836|NCT01354353|64501064|FG003|Overall Study|Physician Decision|0|||
23208837|NCT01354353|64501065|FG004|Overall Study|Physician Decision|0|||
23208838|NCT01354353|64501066|FG005|Overall Study|Physician Decision|0|||
23208839|NCT01354353|64501061|FG000|Overall Study|Withdrawal by Subject|2|||
23208840|NCT01354353|64501062|FG001|Overall Study|Withdrawal by Subject|0|||
23208841|NCT01354353|64501063|FG002|Overall Study|Withdrawal by Subject|1|||
23208842|NCT01354353|64501064|FG003|Overall Study|Withdrawal by Subject|0|||
23208843|NCT01354353|64501065|FG004|Overall Study|Withdrawal by Subject|0|||
23208844|NCT01354353|64501066|FG005|Overall Study|Withdrawal by Subject|1|||
23208845|NCT01185249|64501067|FG000|Overall Study|Patients discharged or change in status|42|||
23208846|NCT03498287|64501077|FG000|Overall Study|Withdrawal by Subject|3|||
23208847|NCT03498287|64501078|FG001|Overall Study|Withdrawal by Subject|0|||
23208848|NCT03498287|64501077|FG000|Overall Study|Protocol Violation|0|||
23208849|NCT03498287|64501078|FG001|Overall Study|Protocol Violation|4|||
23208850|NCT03498287|64501077|FG000|Overall Study|Adverse Event|0|||
23208851|NCT03498287|64501078|FG001|Overall Study|Adverse Event|1|||
23208852|NCT02056834|64501079|FG000|Overall Study|Lost to Follow-up|7|||
23208853|NCT04017442|64501080|FG000|Overall Study|Withdrawal by Subject|0|||
23208854|NCT04017442|64501081|FG001|Overall Study|Withdrawal by Subject|3|||
23208855|NCT04017442|64501080|FG000|Overall Study|Lost to Follow-up|21|||
23208856|NCT04017442|64501081|FG001|Overall Study|Lost to Follow-up|19|||
23208857|NCT00373490|64501084|FG000|Overall Study|Adverse Event|0|||
23535211|NCT01276327|65693465|FG000|Overall Study|Adverse Event|1|||
23535212|NCT01276327|65693466|FG001|Overall Study|Adverse Event|3|||
23535213|NCT01276327|65693465|FG000|Overall Study|Withdrawal by Subject|1|||
23535214|NCT01276327|65693466|FG001|Overall Study|Withdrawal by Subject|0|||
23535215|NCT04709237|65693468|FG000|Overall Study|Lost to Follow-up|1|||
23535216|NCT04709237|65693469|FG001|Overall Study|Lost to Follow-up|0|||
23535217|NCT04709237|65693470|FG002|Overall Study|Lost to Follow-up|0|||
23535218|NCT01208233|65693473|FG000|Overall Study|Adverse Event|0|||
23535219|NCT01208233|65693474|FG001|Overall Study|Adverse Event|1|||
23535220|NCT01208233|65693475|FG002|Overall Study|Adverse Event|2|||
23535221|NCT01208233|65693476|FG003|Overall Study|Adverse Event|0|||
23535222|NCT01208233|65693477|FG004|Overall Study|Adverse Event|3|||
23535223|NCT01208233|65693478|FG005|Overall Study|Adverse Event|5|||
23535224|NCT01208233|65693473|FG000|Overall Study|Death|0|||
23535225|NCT01208233|65693474|FG001|Overall Study|Death|0|||
23535226|NCT01208233|65693475|FG002|Overall Study|Death|0|||
23535227|NCT01208233|65693476|FG003|Overall Study|Death|0|||
23535228|NCT01208233|65693477|FG004|Overall Study|Death|3|||
23535229|NCT01208233|65693478|FG005|Overall Study|Death|5|||
23535230|NCT01208233|65693473|FG000|Overall Study|Did not meet entrance criteria|2|||
23535231|NCT01208233|65693474|FG001|Overall Study|Did not meet entrance criteria|1|||
23535232|NCT01208233|65693475|FG002|Overall Study|Did not meet entrance criteria|1|||
23535233|NCT01208233|65693476|FG003|Overall Study|Did not meet entrance criteria|0|||
23208858|NCT00373490|64501085|FG001|Overall Study|Adverse Event|1|||
23208859|NCT00373490|64501084|FG000|Overall Study|Lack of Efficacy|9|||
23208860|NCT00373490|64501085|FG001|Overall Study|Lack of Efficacy|4|||
23208861|NCT00373490|64501084|FG000|Overall Study|Withdrawal by Subject|0|||
23535234|NCT01208233|65693477|FG004|Overall Study|Did not meet entrance criteria|1|||
23535235|NCT01208233|65693478|FG005|Overall Study|Did not meet entrance criteria|0|||
23422909|NCT00075946|65292513|FG001|Overall Study|Time to progression less than 6 months|30|||
23422910|NCT00075946|65292514|FG002|Overall Study|Time to progression less than 6 months|8|||
23422911|NCT00075946|65292515|FG003|Overall Study|Time to progression less than 6 months|3|||
23422912|NCT00075946|65292516|FG004|Overall Study|Time to progression less than 6 months|0|||
23422913|NCT00075946|65292512|FG000|Overall Study|Other|57|||
23422914|NCT00075946|65292513|FG001|Overall Study|Other|32|||
23422915|NCT00075946|65292514|FG002|Overall Study|Other|3|||
23535236|NCT01208233|65693473|FG000|Overall Study|Medication error without adverse event|0|||
23535237|NCT01208233|65693474|FG001|Overall Study|Medication error without adverse event|0|||
23535238|NCT01208233|65693475|FG002|Overall Study|Medication error without adverse event|0|||
23535239|NCT01208233|65693476|FG003|Overall Study|Medication error without adverse event|0|||
23535240|NCT01208233|65693477|FG004|Overall Study|Medication error without adverse event|0|||
23535241|NCT01208233|65693478|FG005|Overall Study|Medication error without adverse event|1|||
23535242|NCT01208233|65693473|FG000|Overall Study|Study terminated by sponsor|0|||
23535243|NCT01208233|65693474|FG001|Overall Study|Study terminated by sponsor|0|||
23535244|NCT01208233|65693475|FG002|Overall Study|Study terminated by sponsor|0|||
23535245|NCT01208233|65693476|FG003|Overall Study|Study terminated by sponsor|0|||
23535246|NCT01208233|65693477|FG004|Overall Study|Study terminated by sponsor|10|||
23535247|NCT01208233|65693478|FG005|Overall Study|Study terminated by sponsor|7|||
23535248|NCT01208233|65693473|FG000|Overall Study|Protocol Violation|0|||
23535249|NCT01208233|65693474|FG001|Overall Study|Protocol Violation|0|||
23535250|NCT01208233|65693475|FG002|Overall Study|Protocol Violation|0|||
23535251|NCT01208233|65693476|FG003|Overall Study|Protocol Violation|0|||
23535252|NCT01208233|65693477|FG004|Overall Study|Protocol Violation|3|||
23535253|NCT01208233|65693478|FG005|Overall Study|Protocol Violation|0|||
23535254|NCT01208233|65693473|FG000|Overall Study|Other|2|||
23535255|NCT01208233|65693474|FG001|Overall Study|Other|1|||
23535256|NCT01208233|65693475|FG002|Overall Study|Other|0|||
23535257|NCT01208233|65693476|FG003|Overall Study|Other|0|||
23535258|NCT01208233|65693477|FG004|Overall Study|Other|0|||
23535259|NCT01208233|65693478|FG005|Overall Study|Other|1|||
23535260|NCT01208233|65693473|FG000|Overall Study|Withdrawal by Subject|1|||
23535261|NCT01208233|65693474|FG001|Overall Study|Withdrawal by Subject|0|||
23535262|NCT01208233|65693475|FG002|Overall Study|Withdrawal by Subject|1|||
23535263|NCT01208233|65693476|FG003|Overall Study|Withdrawal by Subject|1|||
23535264|NCT01208233|65693477|FG004|Overall Study|Withdrawal by Subject|4|||
23535265|NCT01208233|65693478|FG005|Overall Study|Withdrawal by Subject|2|||
23535266|NCT01181895|65693479|FG000|Overall Study|Adverse Event|3|||
23535267|NCT01181895|65693480|FG001|Overall Study|Adverse Event|1|||
23535268|NCT01181895|65693481|FG002|Overall Study|Adverse Event|1|||
23535269|NCT01181895|65693479|FG000|Overall Study|Lack of Efficacy|8|||
23422916|NCT00075946|65292515|FG003|Overall Study|Other|11|||
23422917|NCT00075946|65292516|FG004|Overall Study|Other|0|||
23422918|NCT02150057|65292517|FG000|Overall Study|Lost to Follow-up|6|||
23422919|NCT02150057|65292518|FG001|Overall Study|Lost to Follow-up|4|||
23422920|NCT03733028|65292520|FG000|Overall Study|Study was stopped by PI|1|||
23422921|NCT03733028|65292521|FG001|Overall Study|Study was stopped by PI|2|||
23422922|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
23422923|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
23422924|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Death|1|||
23422925|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Death|0|||
23422926|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
23422927|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
23535270|NCT01181895|65693480|FG001|Overall Study|Lack of Efficacy|9|||
23535271|NCT01181895|65693481|FG002|Overall Study|Lack of Efficacy|9|||
23535272|NCT01181895|65693479|FG000|Overall Study|Protocol Violation|2|||
23535273|NCT01181895|65693480|FG001|Overall Study|Protocol Violation|1|||
23535274|NCT01181895|65693481|FG002|Overall Study|Protocol Violation|0|||
23535275|NCT01181895|65693479|FG000|Overall Study|Lost to Follow-up|0|||
23535276|NCT01181895|65693480|FG001|Overall Study|Lost to Follow-up|1|||
23535277|NCT01181895|65693481|FG002|Overall Study|Lost to Follow-up|2|||
23535278|NCT01181895|65693479|FG000|Overall Study|Investigator Discretion|1|||
23422928|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
23422929|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
23535279|NCT01181895|65693480|FG001|Overall Study|Investigator Discretion|2|||
23535280|NCT01181895|65693481|FG002|Overall Study|Investigator Discretion|1|||
23535281|NCT01181895|65693479|FG000|Overall Study|Withdrawal by Subject|3|||
23535282|NCT01181895|65693480|FG001|Overall Study|Withdrawal by Subject|0|||
23535283|NCT01181895|65693481|FG002|Overall Study|Withdrawal by Subject|5|||
23535284|NCT03766009|65693482|FG000|Usual Care|Death|0|||
23535285|NCT03766009|65693483|FG001|Usual Care|Death|0|||
23535286|NCT03766009|65693484|FG002|Usual Care|Death|0|||
23535287|NCT03766009|65693485|FG003|Usual Care|Death|1|||
23535288|NCT03766009|65693486|FG004|Usual Care|Death|0|||
23535289|NCT03766009|65693487|FG005|Usual Care|Death|0|||
23535290|NCT03766009|65693482|FG000|Usual Care|Lost to Follow-up|0|||
23535291|NCT03766009|65693483|FG001|Usual Care|Lost to Follow-up|0|||
23535292|NCT03766009|65693484|FG002|Usual Care|Lost to Follow-up|0|||
23535293|NCT03766009|65693485|FG003|Usual Care|Lost to Follow-up|1|||
23535294|NCT03766009|65693486|FG004|Usual Care|Lost to Follow-up|0|||
23535295|NCT03766009|65693487|FG005|Usual Care|Lost to Follow-up|0|||
23535296|NCT03766009|65693482|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
23535297|NCT03766009|65693483|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
23535298|NCT03766009|65693484|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
23535299|NCT03766009|65693485|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
23535300|NCT03766009|65693486|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
23535301|NCT03766009|65693487|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
23535302|NCT03766009|65693482|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
23535303|NCT03766009|65693483|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
23535304|NCT03766009|65693484|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
23535305|NCT03766009|65693485|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
23535306|NCT03766009|65693486|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
23535307|NCT03766009|65693487|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
23535308|NCT03766009|65693482|FG000|Usual Care|No treatment or declined surgery|0|||
23535309|NCT03766009|65693483|FG001|Usual Care|No treatment or declined surgery|0|||
23535310|NCT03766009|65693484|FG002|Usual Care|No treatment or declined surgery|0|||
23311457|NCT02504671|64886545|FG003|Overall Study|Protocol defined stopping criteria|5|||
23535311|NCT03766009|65693485|FG003|Usual Care|No treatment or declined surgery|2|||
23311458|NCT02504671|64886546|FG004|Overall Study|Protocol defined stopping criteria|3|||
23311459|NCT02504671|64886547|FG005|Overall Study|Protocol defined stopping criteria|3|||
23311460|NCT00106964|64886548|FG000|Overall Study|Lost to Follow-up|8|||
23311461|NCT00106964|64886549|FG001|Overall Study|Lost to Follow-up|6|||
23311462|NCT00106964|64886550|FG002|Overall Study|Lost to Follow-up|2|||
23311463|NCT00106964|64886548|FG000|Overall Study|Pregnancy|2|||
23311464|NCT00106964|64886549|FG001|Overall Study|Pregnancy|3|||
23311465|NCT00106964|64886550|FG002|Overall Study|Pregnancy|2|||
23311466|NCT00106964|64886548|FG000|Overall Study|Death|1|||
23311467|NCT00106964|64886549|FG001|Overall Study|Death|1|||
23311468|NCT00106964|64886550|FG002|Overall Study|Death|0|||
23311469|NCT00106964|64886548|FG000|Overall Study|Incarceration|0|||
23311470|NCT00106964|64886549|FG001|Overall Study|Incarceration|1|||
23311471|NCT00106964|64886550|FG002|Overall Study|Incarceration|0|||
23311472|NCT00106964|64886548|FG000|Overall Study|Site Funding Terminated|0|||
23311473|NCT00106964|64886549|FG001|Overall Study|Site Funding Terminated|1|||
23535312|NCT03766009|65693486|FG004|Usual Care|No treatment or declined surgery|0|||
23311474|NCT00106964|64886550|FG002|Overall Study|Site Funding Terminated|1|||
23311475|NCT00106964|64886548|FG000|Overall Study|Failure to adhere|2|||
23311476|NCT00106964|64886549|FG001|Overall Study|Failure to adhere|0|||
23311477|NCT00106964|64886550|FG002|Overall Study|Failure to adhere|0|||
23311478|NCT00106964|64886548|FG000|Overall Study|Did not meet eligibility criteria|0|||
23535313|NCT03766009|65693487|FG005|Usual Care|No treatment or declined surgery|0|||
23535314|NCT03766009|65693482|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
23535315|NCT03766009|65693483|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
23535316|NCT03766009|65693484|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
23535317|NCT03766009|65693485|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
23535318|NCT03766009|65693486|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
23535319|NCT03766009|65693487|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
23535320|NCT03766009|65693482|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23422930|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
23422931|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
23422932|NCT00350272|65292522|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
23422933|NCT00350272|65292523|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
23422934|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
23422935|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
23422936|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
23422937|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
23422938|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
23422939|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
23422940|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
23422941|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
23422942|NCT00350272|65292522|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
23422943|NCT00350272|65292523|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
23422944|NCT03610581|65292525|FG000|Overall Study|Study terminated by sponsor|2|||
23535321|NCT03766009|65693483|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
23535322|NCT03766009|65693484|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23535323|NCT03766009|65693485|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23535324|NCT03766009|65693486|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23535325|NCT03766009|65693487|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
23535326|NCT03766009|65693482|FG000|Usual Care|Ineligible|0|||
23535327|NCT03766009|65693483|FG001|Usual Care|Ineligible|1|||
23535328|NCT03766009|65693484|FG002|Usual Care|Ineligible|0|||
23535329|NCT03766009|65693485|FG003|Usual Care|Ineligible|0|||
23535330|NCT03766009|65693486|FG004|Usual Care|Ineligible|0|||
23535331|NCT03766009|65693487|FG005|Usual Care|Ineligible|0|||
23422945|NCT03610581|65292526|FG001|Overall Study|Study terminated by sponsor|0|||
23422946|NCT03610581|65292525|FG000|Overall Study|Other|0|||
23422947|NCT03610581|65292526|FG001|Overall Study|Other|1|||
23422948|NCT03610581|65292525|FG000|Overall Study|Withdrawal by Subject|1|||
23422949|NCT03610581|65292526|FG001|Overall Study|Withdrawal by Subject|0|||
23422950|NCT00758264|65292528|FG000|Active Phase|Withdrawal by Subject|0|||
23422951|NCT00758264|65292529|FG001|Active Phase|Withdrawal by Subject|0|||
23422952|NCT00758264|65292530|FG002|Active Phase|Withdrawal by Subject|1|||
23422953|NCT00758264|65292528|FG000|Active Phase|Lost to Follow-up|1|||
23422954|NCT00758264|65292529|FG001|Active Phase|Lost to Follow-up|0|||
23422955|NCT00758264|65292530|FG002|Active Phase|Lost to Follow-up|0|||
23422956|NCT00758264|65292528|FG000|Active Phase|Other|0|||
23422957|NCT00758264|65292529|FG001|Active Phase|Other|0|||
23422958|NCT00758264|65292530|FG002|Active Phase|Other|4|||
23422959|NCT04209114|65292531|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
23422960|NCT04209114|65292532|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
23422961|NCT04209114|65292533|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
23422962|NCT04209114|65292531|FG000|Pre-Treatment Phase|Other reasons|0|||
23422963|NCT04209114|65292532|FG001|Pre-Treatment Phase|Other reasons|0|||
23422964|NCT04209114|65292533|FG002|Pre-Treatment Phase|Other reasons|1|||
23422965|NCT04209114|65292531|FG000|Pre-Treatment Phase|Death|0|||
23422966|NCT04209114|65292532|FG001|Pre-Treatment Phase|Death|0|||
23422967|NCT04209114|65292533|FG002|Pre-Treatment Phase|Death|1|||
23422968|NCT04209114|65292531|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
23422969|NCT04209114|65292532|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
23422970|NCT04209114|65292533|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
23422971|NCT04209114|65292531|FG000|Treatment Phase|Other reasons|5|||
23422972|NCT04209114|65292532|FG001|Treatment Phase|Other reasons|3|||
23422973|NCT04209114|65292533|FG002|Treatment Phase|Other reasons|0|||
23422974|NCT04209114|65292531|FG000|Treatment Phase|Lost to Follow-up|1|||
23422975|NCT04209114|65292532|FG001|Treatment Phase|Lost to Follow-up|0|||
23422976|NCT04209114|65292533|FG002|Treatment Phase|Lost to Follow-up|0|||
23422977|NCT04209114|65292531|FG000|Treatment Phase|Participant withdrew consent|1|||
23422978|NCT04209114|65292532|FG001|Treatment Phase|Participant withdrew consent|0|||
23422979|NCT04209114|65292533|FG002|Treatment Phase|Participant withdrew consent|0|||
23422980|NCT04209114|65292531|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
23422981|NCT04209114|65292532|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
23422982|NCT04209114|65292533|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
23422983|NCT04209114|65292531|FG000|Treatment Phase|Death|4|||
23422984|NCT04209114|65292532|FG001|Treatment Phase|Death|1|||
23422985|NCT04209114|65292533|FG002|Treatment Phase|Death|0|||
23208862|NCT00373490|64501085|FG001|Overall Study|Withdrawal by Subject|1|||
23422986|NCT04209114|65292531|FG000|Treatment Phase|Study drug toxicity|4|||
23422987|NCT04209114|65292532|FG001|Treatment Phase|Study drug toxicity|6|||
23422988|NCT04209114|65292533|FG002|Treatment Phase|Study drug toxicity|0|||
23422989|NCT04209114|65292531|FG000|Treatment Phase|Disease progression|6|||
23422990|NCT04209114|65292532|FG001|Treatment Phase|Disease progression|9|||
23422991|NCT04209114|65292533|FG002|Treatment Phase|Disease progression|0|||
23422992|NCT02434354|65292536|FG000|Overall Study|screen fail|3|||
23422993|NCT02974855|65292537|FG000|Overall Study|Adverse Event|0|||
23422994|NCT02974855|65292538|FG001|Overall Study|Adverse Event|1|||
23422995|NCT02974855|65292539|FG002|Overall Study|Adverse Event|0|||
23422996|NCT02974855|65292540|FG003|Overall Study|Adverse Event|1|||
23422997|NCT03946124|65292543|FG000|Overall Study|Withdrawal by Subject|19|||
23422998|NCT01945216|65292544|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
23422999|NCT01945216|65292544|FG000|Overall Study|Protocol Violation|42|||
23423000|NCT01945216|65292544|FG000|Overall Study|CRF not assured by investigators|5|||
23423001|NCT00931723|65292545|FG000|Overall Study|Withdrawal by Subject|11|||
23423002|NCT00931723|65292546|FG001|Overall Study|Withdrawal by Subject|13|||
23423003|NCT00931723|65292545|FG000|Overall Study|Adverse Event|6|||
23423004|NCT00931723|65292546|FG001|Overall Study|Adverse Event|13|||
23208863|NCT03089216|64501090|FG000|Overall Study|Adverse Event|0|||
23208864|NCT03089216|64501091|FG001|Overall Study|Adverse Event|0|||
23423005|NCT00931723|65292545|FG000|Overall Study|Lithium found in blood|0|||
23423006|NCT00931723|65292546|FG001|Overall Study|Lithium found in blood|1|||
23423007|NCT00931723|65292545|FG000|Overall Study|Condition under investigation worsened|1|||
23208865|NCT03089216|64501092|FG002|Overall Study|Adverse Event|0|||
23423008|NCT00931723|65292546|FG001|Overall Study|Condition under investigation worsened|2|||
23423009|NCT00931723|65292545|FG000|Overall Study|Lost to Follow-up|1|||
23423010|NCT00931723|65292546|FG001|Overall Study|Lost to Follow-up|2|||
23423011|NCT00931723|65292545|FG000|Overall Study|Study-specific discontinuation criteria|1|||
23423012|NCT00931723|65292546|FG001|Overall Study|Study-specific discontinuation criteria|1|||
23423013|NCT00931723|65292545|FG000|Overall Study|Severe non-compliance to protocol|2|||
23423014|NCT00931723|65292546|FG001|Overall Study|Severe non-compliance to protocol|0|||
23423015|NCT00931723|65292545|FG000|Overall Study|Safety reasons|0|||
23423016|NCT00931723|65292546|FG001|Overall Study|Safety reasons|1|||
23423017|NCT00931723|65292545|FG000|Overall Study|Took prohibited concomitant medication|0|||
23423018|NCT00931723|65292546|FG001|Overall Study|Took prohibited concomitant medication|1|||
23423019|NCT00931723|65292545|FG000|Overall Study|Lack or insufficient theraputic response|2|||
23423020|NCT00931723|65292546|FG001|Overall Study|Lack or insufficient theraputic response|5|||
23423021|NCT00931723|65292545|FG000|Overall Study|Sponsor decision|1|||
23423022|NCT00931723|65292546|FG001|Overall Study|Sponsor decision|0|||
23423023|NCT00931723|65292545|FG000|Overall Study|Late hospital discharge|1|||
23423024|NCT00931723|65292546|FG001|Overall Study|Late hospital discharge|0|||
23423025|NCT02763254|65292562|FG000|Overall Study|Adverse Event|1|||
23423026|NCT02826421|65292563|FG000|Overall Study|Adverse Event|1|||
23535332|NCT03766009|65693482|FG000|Usual Care|Other: Staff turnover|0|||
23535333|NCT03766009|65693483|FG001|Usual Care|Other: Staff turnover|0|||
23423027|NCT02826421|65292564|FG001|Overall Study|Adverse Event|0|||
23423028|NCT02826421|65292565|FG002|Overall Study|Adverse Event|0|||
23423029|NCT02826421|65292566|FG003|Overall Study|Adverse Event|1|||
23423030|NCT02826421|65292563|FG000|Overall Study|Withdrawal by Subject|1|||
23423031|NCT02826421|65292564|FG001|Overall Study|Withdrawal by Subject|3|||
23423032|NCT02826421|65292565|FG002|Overall Study|Withdrawal by Subject|1|||
23423033|NCT02826421|65292566|FG003|Overall Study|Withdrawal by Subject|1|||
23423034|NCT02826421|65292563|FG000|Overall Study|Reason not given|1|||
23423035|NCT02826421|65292564|FG001|Overall Study|Reason not given|0|||
23423036|NCT02826421|65292565|FG002|Overall Study|Reason not given|1|||
23423037|NCT02826421|65292566|FG003|Overall Study|Reason not given|0|||
23423038|NCT03510468|65292571|FG000|Overall Study|Lost to Follow-up|1|||
23423039|NCT03510468|65292571|FG000|Overall Study|Adverse Event|5|||
23423040|NCT03510468|65292571|FG000|Overall Study|Physician Decision|1|||
23423041|NCT03510468|65292571|FG000|Overall Study|non-compliant with treatment|2|||
23423042|NCT03510468|65292571|FG000|Overall Study|Missed visit|1|||
23423043|NCT00076336|65292572|FG000|Overall Study|Death|13|||
23423044|NCT00076336|65292573|FG001|Overall Study|Death|17|||
23423045|NCT00076336|65292572|FG000|Overall Study|Adverse Event|4|||
23423046|NCT00076336|65292573|FG001|Overall Study|Adverse Event|4|||
23423047|NCT00076336|65292572|FG000|Overall Study|Lost to Follow-up|4|||
23423048|NCT00076336|65292573|FG001|Overall Study|Lost to Follow-up|4|||
23423049|NCT00076336|65292572|FG000|Overall Study|Non-Compliance|2|||
23423050|NCT00076336|65292573|FG001|Overall Study|Non-Compliance|0|||
23423051|NCT00076336|65292572|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
23423052|NCT00076336|65292573|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
23423053|NCT00076336|65292572|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
23423054|NCT00076336|65292573|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
23423055|NCT00076336|65292572|FG000|Overall Study|Liver Transplantation|3|||
23423056|NCT00076336|65292573|FG001|Overall Study|Liver Transplantation|3|||
23423057|NCT00076336|65292572|FG000|Overall Study|Virologic Breakthrough|14|||
23423058|NCT00076336|65292573|FG001|Overall Study|Virologic Breakthrough|16|||
23423059|NCT00076336|65292572|FG000|Overall Study|Treatment failure|4|||
23423060|NCT00076336|65292573|FG001|Overall Study|Treatment failure|5|||
23423061|NCT02312219|65292576|FG000|Overall Study|Withdrawal by Subject|1|||
23423062|NCT02312219|65292577|FG001|Overall Study|Withdrawal by Subject|2|||
23423063|NCT02312219|65292576|FG000|Overall Study|could not schedule imaging in time|0|||
23423064|NCT02312219|65292577|FG001|Overall Study|could not schedule imaging in time|2|||
23423065|NCT02312219|65292576|FG000|Overall Study|Other|0|||
23423066|NCT02312219|65292577|FG001|Overall Study|Other|1|||
23423067|NCT02312219|65292576|FG000|Overall Study|Not randomized. Ineligible|0|||
23423068|NCT02312219|65292577|FG001|Overall Study|Not randomized. Ineligible|1|||
23423069|NCT03777917|65292578|FG000|Overall Study|Withdrawal by Subject|1|||
23423070|NCT03777917|65292579|FG001|Overall Study|Withdrawal by Subject|0|||
23423071|NCT03777917|65292578|FG000|Overall Study|Physician Decision|1|||
23423072|NCT03777917|65292579|FG001|Overall Study|Physician Decision|0|||
23423073|NCT03777917|65292578|FG000|Overall Study|Lost to Follow-up|6|||
23423074|NCT03777917|65292579|FG001|Overall Study|Lost to Follow-up|2|||
23423075|NCT03777917|65292578|FG000|Overall Study|Other|1|||
23423076|NCT03777917|65292579|FG001|Overall Study|Other|0|||
23423077|NCT04569136|65292581|FG000|Overall Study|Lost to Follow-up|2|||
23423078|NCT04569136|65292582|FG001|Overall Study|Lost to Follow-up|0|||
23423079|NCT04569136|65292583|FG002|Overall Study|Lost to Follow-up|1|||
23423080|NCT02233738|65292584|FG000|Overall Study|Lost to Follow-up|5|||
23423081|NCT02233738|65292585|FG001|Overall Study|Lost to Follow-up|12|||
23423082|NCT02233738|65292584|FG000|Overall Study|Death|0|||
23423083|NCT02233738|65292585|FG001|Overall Study|Death|1|||
23423084|NCT02233738|65292584|FG000|Overall Study|Withdrawal by Subject|0|||
23423085|NCT02233738|65292585|FG001|Overall Study|Withdrawal by Subject|1|||
23423086|NCT02233738|65292584|FG000|Overall Study|Did not return after Baseline|3|||
23423087|NCT02233738|65292585|FG001|Overall Study|Did not return after Baseline|2|||
23423088|NCT01453946|65292586|FG000|Overall Study|Did not receive drug for the taper phase|1|||
23423089|NCT01453946|65292586|FG000|Overall Study|Protocol Violation|2|||
23423090|NCT01453946|65292586|FG000|Overall Study|Lack of Efficacy|3|||
23423091|NCT01453946|65292586|FG000|Overall Study|Adverse Event|3|||
23423092|NCT01779869|65292587|FG000|Overall Study|Physician Decision|2|||
23208866|NCT03089216|64501093|FG003|Overall Study|Adverse Event|1|||
23423093|NCT00608023|65292591|FG000|Overall Study|Withdrawal by Subject|8|||
23423094|NCT00608023|65292592|FG001|Overall Study|Withdrawal by Subject|10|||
23423095|NCT00608023|65292593|FG002|Overall Study|Withdrawal by Subject|7|||
23423096|NCT00608023|65292591|FG000|Overall Study|Adverse Event|1|||
23423097|NCT00608023|65292592|FG001|Overall Study|Adverse Event|4|||
23423098|NCT00608023|65292593|FG002|Overall Study|Adverse Event|5|||
23423099|NCT00608023|65292591|FG000|Overall Study|Lost to Follow-up|2|||
23423100|NCT00608023|65292592|FG001|Overall Study|Lost to Follow-up|2|||
23423101|NCT00608023|65292593|FG002|Overall Study|Lost to Follow-up|1|||
23423102|NCT00608023|65292591|FG000|Overall Study|Protocol Violation|1|||
23311479|NCT00106964|64886549|FG001|Overall Study|Did not meet eligibility criteria|2|||
23311480|NCT00106964|64886550|FG002|Overall Study|Did not meet eligibility criteria|2|||
23423103|NCT00608023|65292592|FG001|Overall Study|Protocol Violation|3|||
23423104|NCT00608023|65292593|FG002|Overall Study|Protocol Violation|1|||
23423105|NCT00608023|65292591|FG000|Overall Study|Unknown reason|0|||
23423106|NCT00608023|65292592|FG001|Overall Study|Unknown reason|3|||
23423107|NCT00608023|65292593|FG002|Overall Study|Unknown reason|0|||
23423108|NCT02210221|65292594|FG000|Overall Study|Lack of Efficacy|7|||
23423109|NCT02210221|65292594|FG000|Overall Study|Withdrawal by Subject|43|||
23423110|NCT02981407|65292597|FG000|Overall Study|Withdrawal by Subject|2|||
23423111|NCT02981407|65292598|FG001|Overall Study|Withdrawal by Subject|0|||
23423112|NCT01338610|65292601|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
23423113|NCT01338610|65292602|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
23535334|NCT03766009|65693484|FG002|Usual Care|Other: Staff turnover|0|||
23535335|NCT03766009|65693485|FG003|Usual Care|Other: Staff turnover|0|||
23535336|NCT03766009|65693486|FG004|Usual Care|Other: Staff turnover|0|||
23535337|NCT03766009|65693487|FG005|Usual Care|Other: Staff turnover|2|||
23535338|NCT00403546|65693488|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
23535339|NCT00403546|65693489|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
23535340|NCT00403546|65693490|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
23535341|NCT00403546|65693488|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
23535342|NCT00403546|65693489|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
23535343|NCT00403546|65693490|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
23535344|NCT00403546|65693488|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
23535345|NCT00403546|65693489|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
23535346|NCT00403546|65693490|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
23535347|NCT00403546|65693488|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
23535348|NCT00403546|65693489|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
23535349|NCT00403546|65693490|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
23535350|NCT00403546|65693488|FG000|Screening Phase|Screening Failure|22|||
23535351|NCT00403546|65693489|FG001|Screening Phase|Screening Failure|0|||
23535352|NCT00403546|65693490|FG002|Screening Phase|Screening Failure|0|||
23535353|NCT00403546|65693488|FG000|Screening Phase|Adverse Event|1|||
23535354|NCT00403546|65693489|FG001|Screening Phase|Adverse Event|0|||
23535355|NCT00403546|65693490|FG002|Screening Phase|Adverse Event|0|||
23535356|NCT00403546|65693488|FG000|Screening Phase|Terminated Prior to Randomization|5|||
23535357|NCT00403546|65693489|FG001|Screening Phase|Terminated Prior to Randomization|0|||
23535358|NCT00403546|65693490|FG002|Screening Phase|Terminated Prior to Randomization|0|||
23535359|NCT00403546|65693488|FG000|Randomized Trial|Early Terminations|0|||
23535360|NCT00403546|65693489|FG001|Randomized Trial|Early Terminations|17|||
23535361|NCT00403546|65693490|FG002|Randomized Trial|Early Terminations|16|||
23311481|NCT00106964|64886548|FG000|Overall Study|Required disallowed medication|0|||
23423114|NCT01338610|65292603|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
23535362|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
23423115|NCT01338610|65292601|FG000|Overall Study|Protocol Violation|1|||
23423116|NCT01338610|65292602|FG001|Overall Study|Protocol Violation|0|||
23423117|NCT01338610|65292603|FG002|Overall Study|Protocol Violation|1|||
23535363|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
23535364|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
23535365|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
23535366|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
23535367|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
23535368|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
23535369|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
23535370|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
23535371|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
23535372|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
23535373|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
23535374|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
23535375|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
23535376|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
23535377|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
23535378|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
23535379|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
23535380|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
23535381|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
23535382|NCT00813761|65693492|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
23535383|NCT00813761|65693493|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
23535384|NCT00813761|65693494|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
23535385|NCT00813761|65693495|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
23535386|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
23535387|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
23535388|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
23535389|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
23535390|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
23535391|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
23535392|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
23535393|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
23535394|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
23535395|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
23535396|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
23535397|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
23535398|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
23535399|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
23535400|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
23535401|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
23535402|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
23535403|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
23535404|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
23535405|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
23535406|NCT00813761|65693492|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
23535407|NCT00813761|65693493|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
23535408|NCT00813761|65693494|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
23535409|NCT00813761|65693495|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
23535410|NCT00796861|65693496|FG000|Overall Study|Withdrawal by Subject|2|||
23535411|NCT00796861|65693496|FG000|Overall Study|Death|2|||
23535412|NCT00377676|65693498|FG000|Overall Study|Adverse Event|498|||
23535413|NCT00377676|65693499|FG001|Overall Study|Adverse Event|107|||
23535414|NCT00377676|65693498|FG000|Overall Study|Protocol Violation|33|||
23535415|NCT00377676|65693499|FG001|Overall Study|Protocol Violation|27|||
23535416|NCT00377676|65693498|FG000|Overall Study|Death|5|||
23535417|NCT00377676|65693499|FG001|Overall Study|Death|2|||
23535418|NCT00377676|65693498|FG000|Overall Study|Withdrawal by Subject|187|||
23535419|NCT00377676|65693499|FG001|Overall Study|Withdrawal by Subject|72|||
23535420|NCT00377676|65693498|FG000|Overall Study|Lost to Follow-up|120|||
23535421|NCT00377676|65693499|FG001|Overall Study|Lost to Follow-up|56|||
23535422|NCT00377676|65693498|FG000|Overall Study|Other|118|||
23535423|NCT00377676|65693499|FG001|Overall Study|Other|58|||
23535424|NCT00991302|65693502|FG000|Overall Study|Death|0|||
23535425|NCT00991302|65693503|FG001|Overall Study|Death|1|||
23535426|NCT00991302|65693502|FG000|Overall Study|Lost to Follow-up|14|||
23535427|NCT00991302|65693503|FG001|Overall Study|Lost to Follow-up|12|||
23535428|NCT03525834|65693507|FG000|Overall Study|Progressive disease|1|||
23535429|NCT02097134|65693508|FG000|Overall Study|Physician Decision|4|||
23535430|NCT02097134|65693508|FG000|Overall Study|Non-Protocol Therapy|1|||
23535431|NCT02097134|65693508|FG000|Overall Study|Progressive Disease|3|||
23535432|NCT02097134|65693508|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
23535433|NCT04622254|65693510|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23535434|NCT04622254|65693511|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
23535435|NCT04622254|65693512|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23615569|NCT01498445|65979377|FG005|Overall Study|Screen Failure|1|||
23311482|NCT00106964|64886549|FG001|Overall Study|Required disallowed medication|1|||
23311483|NCT00106964|64886550|FG002|Overall Study|Required disallowed medication|0|||
23311484|NCT05014412|64886555|FG000|Overall Study|Death|11|||
23311485|NCT05014412|64886556|FG001|Overall Study|Death|7|||
23311486|NCT05014412|64886557|FG002|Overall Study|Death|4|||
23311487|NCT05014412|64886558|FG003|Overall Study|Death|7|||
23311488|NCT05014412|64886555|FG000|Overall Study|Withdrawal by Subject|1|||
23311489|NCT05014412|64886556|FG001|Overall Study|Withdrawal by Subject|1|||
23311490|NCT05014412|64886557|FG002|Overall Study|Withdrawal by Subject|1|||
23311491|NCT05014412|64886558|FG003|Overall Study|Withdrawal by Subject|2|||
23311492|NCT05014412|64886555|FG000|Overall Study|Ongoing|21|||
23311493|NCT05014412|64886556|FG001|Overall Study|Ongoing|4|||
23311494|NCT05014412|64886557|FG002|Overall Study|Ongoing|6|||
23615570|NCT01072396|65979380|FG000|Period One|Adverse Event|1|||
23615571|NCT01072396|65979381|FG001|Period One|Adverse Event|1|||
23615572|NCT01072396|65979380|FG000|Period One|Protocol Violation|2|||
23615573|NCT01072396|65979381|FG001|Period One|Protocol Violation|1|||
23615574|NCT01072396|65979380|FG000|Period One|Withdrawal by Subject|2|||
23615575|NCT01072396|65979381|FG001|Period One|Withdrawal by Subject|0|||
23615576|NCT01072396|65979380|FG000|Washout Period|Missing termination information|0|||
23615577|NCT01072396|65979381|FG001|Washout Period|Missing termination information|1|||
23615578|NCT01072396|65979380|FG000|Period Two|Adverse Event|0|||
23615579|NCT01072396|65979381|FG001|Period Two|Adverse Event|3|||
23615580|NCT01072396|65979380|FG000|Period Two|Lost to Follow-up|1|||
23615581|NCT01072396|65979381|FG001|Period Two|Lost to Follow-up|0|||
23615582|NCT00837096|65979385|FG000|Overall Study|Physician Decision|1|||
23615583|NCT00837096|65979386|FG001|Overall Study|Physician Decision|1|||
23615584|NCT00837096|65979385|FG000|Overall Study|Not reported|9|||
23615585|NCT00837096|65979386|FG001|Overall Study|Not reported|8|||
23615586|NCT00711555|65979389|FG000|Overall Study|Adverse Event|3|||
23615587|NCT04374253|65979393|FG000|Overall Study|Adverse Event|0|||
23615588|NCT04374253|65979394|FG001|Overall Study|Adverse Event|26|||
23615589|NCT04374253|65979395|FG002|Overall Study|Adverse Event|2|||
23615590|NCT04374253|65979396|FG003|Overall Study|Adverse Event|12|||
23615591|NCT04374253|65979393|FG000|Overall Study|Study terminated by sponsor|13|||
23615592|NCT04374253|65979394|FG001|Overall Study|Study terminated by sponsor|593|||
23615593|NCT04374253|65979395|FG002|Overall Study|Study terminated by sponsor|21|||
23615594|NCT04374253|65979396|FG003|Overall Study|Study terminated by sponsor|567|||
23615595|NCT04374253|65979393|FG000|Overall Study|Withdrawal by Subject|0|||
23615596|NCT04374253|65979394|FG001|Overall Study|Withdrawal by Subject|55|||
23615597|NCT04374253|65979395|FG002|Overall Study|Withdrawal by Subject|3|||
23615598|NCT04374253|65979396|FG003|Overall Study|Withdrawal by Subject|40|||
23615599|NCT04374253|65979393|FG000|Overall Study|Physician Decision|1|||
23615600|NCT04374253|65979394|FG001|Overall Study|Physician Decision|10|||
23615601|NCT04374253|65979395|FG002|Overall Study|Physician Decision|1|||
23615602|NCT04374253|65979396|FG003|Overall Study|Physician Decision|10|||
23615603|NCT04374253|65979393|FG000|Overall Study|Protocol Violation|0|||
23615604|NCT04374253|65979394|FG001|Overall Study|Protocol Violation|0|||
23615605|NCT04374253|65979395|FG002|Overall Study|Protocol Violation|0|||
23615606|NCT04374253|65979396|FG003|Overall Study|Protocol Violation|2|||
23615607|NCT04374253|65979393|FG000|Overall Study|Death|0|||
23615608|NCT04374253|65979394|FG001|Overall Study|Death|3|||
23615609|NCT04374253|65979395|FG002|Overall Study|Death|1|||
23615610|NCT04374253|65979396|FG003|Overall Study|Death|1|||
23615611|NCT04374253|65979393|FG000|Overall Study|Lack of Efficacy|0|||
23615612|NCT04374253|65979394|FG001|Overall Study|Lack of Efficacy|0|||
23615613|NCT04374253|65979395|FG002|Overall Study|Lack of Efficacy|0|||
23615614|NCT04374253|65979396|FG003|Overall Study|Lack of Efficacy|1|||
23615615|NCT04374253|65979393|FG000|Overall Study|Lost to Follow-up|1|||
23615616|NCT04374253|65979394|FG001|Overall Study|Lost to Follow-up|1|||
23615617|NCT04374253|65979395|FG002|Overall Study|Lost to Follow-up|0|||
23615618|NCT04374253|65979396|FG003|Overall Study|Lost to Follow-up|2|||
23615619|NCT04374253|65979393|FG000|Overall Study|Reason Not Specified|0|||
23615620|NCT04374253|65979394|FG001|Overall Study|Reason Not Specified|8|||
23615621|NCT04374253|65979395|FG002|Overall Study|Reason Not Specified|0|||
23615622|NCT04374253|65979396|FG003|Overall Study|Reason Not Specified|8|||
23615623|NCT00460577|65979398|FG000|Overall Study|Protocol Violation|2|||
23615624|NCT00460577|65979399|FG001|Overall Study|Protocol Violation|6|||
23615625|NCT01898442|65979404|FG000|Overall Study|Hemolysis/technical problems|1|||
23615626|NCT01898442|65979405|FG001|Overall Study|Hemolysis/technical problems|2|||
23615627|NCT01898442|65979406|FG002|Overall Study|Hemolysis/technical problems|2|||
23615628|NCT01898442|65979404|FG000|Overall Study|Patient vomited pills|0|||
23615629|NCT01898442|65979405|FG001|Overall Study|Patient vomited pills|0|||
23311495|NCT05014412|64886558|FG003|Overall Study|Ongoing|20|||
23311496|NCT01293539|64886560|FG000|Overall Study|Physician Decision|1|||
23311497|NCT01434810|64886564|FG000|Overall Study|Did not receive treatment|11|||
23311498|NCT01434810|64886565|FG001|Overall Study|Did not receive treatment|3|||
23311499|NCT01434810|64886564|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
23615630|NCT01898442|65979406|FG002|Overall Study|Patient vomited pills|1|||
23615631|NCT01313299|65979410|FG000|Overall Study|Adverse Event|3|||
23615632|NCT01313299|65979411|FG001|Overall Study|Adverse Event|1|||
23615633|NCT01313299|65979412|FG002|Overall Study|Adverse Event|1|||
23615634|NCT01313299|65979410|FG000|Overall Study|Lost to Follow-up|1|||
23615635|NCT01313299|65979411|FG001|Overall Study|Lost to Follow-up|0|||
23615636|NCT01313299|65979412|FG002|Overall Study|Lost to Follow-up|0|||
23615637|NCT01313299|65979410|FG000|Overall Study|Protocol Violation|2|||
23615638|NCT01313299|65979411|FG001|Overall Study|Protocol Violation|0|||
23615639|NCT01313299|65979412|FG002|Overall Study|Protocol Violation|0|||
23615640|NCT01313299|65979410|FG000|Overall Study|Withdrawal by Subject|1|||
23615641|NCT01313299|65979411|FG001|Overall Study|Withdrawal by Subject|0|||
23311500|NCT01434810|64886565|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
23311501|NCT05199090|64886569|FG000|Overall Study|Adverse Event|1|||
23311502|NCT05199090|64886570|FG001|Overall Study|Adverse Event|4|||
23311503|NCT05199090|64886571|FG002|Overall Study|Adverse Event|0|||
23311504|NCT05199090|64886572|FG003|Overall Study|Adverse Event|0|||
23311505|NCT05199090|64886573|FG004|Overall Study|Adverse Event|0|||
23311506|NCT05199090|64886574|FG005|Overall Study|Adverse Event|0|||
23311507|NCT05199090|64886569|FG000|Overall Study|Lost to Follow-up|1|||
23311508|NCT05199090|64886570|FG001|Overall Study|Lost to Follow-up|0|||
23311509|NCT05199090|64886571|FG002|Overall Study|Lost to Follow-up|1|||
23311510|NCT05199090|64886572|FG003|Overall Study|Lost to Follow-up|4|||
23311511|NCT05199090|64886573|FG004|Overall Study|Lost to Follow-up|0|||
23311512|NCT05199090|64886574|FG005|Overall Study|Lost to Follow-up|5|||
23311513|NCT05199090|64886569|FG000|Overall Study|Physician Decision|0|||
23311514|NCT05199090|64886570|FG001|Overall Study|Physician Decision|0|||
23311515|NCT05199090|64886571|FG002|Overall Study|Physician Decision|0|||
23311516|NCT05199090|64886572|FG003|Overall Study|Physician Decision|0|||
23311517|NCT05199090|64886573|FG004|Overall Study|Physician Decision|0|||
23311518|NCT05199090|64886574|FG005|Overall Study|Physician Decision|1|||
23311519|NCT05199090|64886569|FG000|Overall Study|Study terminated by sponsor|0|||
23311520|NCT05199090|64886570|FG001|Overall Study|Study terminated by sponsor|6|||
23311521|NCT05199090|64886571|FG002|Overall Study|Study terminated by sponsor|0|||
23311522|NCT05199090|64886572|FG003|Overall Study|Study terminated by sponsor|0|||
23311523|NCT05199090|64886573|FG004|Overall Study|Study terminated by sponsor|0|||
23311524|NCT05199090|64886574|FG005|Overall Study|Study terminated by sponsor|5|||
23311525|NCT05199090|64886569|FG000|Overall Study|Subject decision|0|||
23311526|NCT05199090|64886570|FG001|Overall Study|Subject decision|4|||
23311527|NCT05199090|64886571|FG002|Overall Study|Subject decision|0|||
23311528|NCT05199090|64886572|FG003|Overall Study|Subject decision|2|||
23311529|NCT05199090|64886573|FG004|Overall Study|Subject decision|5|||
23311530|NCT05199090|64886574|FG005|Overall Study|Subject decision|2|||
23311531|NCT01473524|64886577|FG000|DB Phase|Adverse Event|4|||
23311532|NCT01473524|64886578|FG001|DB Phase|Adverse Event|8|||
23311533|NCT01473524|64886579|FG002|DB Phase|Adverse Event|2|||
23311534|NCT01473524|64886580|FG003|DB Phase|Adverse Event|0|||
23311535|NCT01473524|64886581|FG004|DB Phase|Adverse Event|0|||
23615642|NCT01313299|65979412|FG002|Overall Study|Withdrawal by Subject|2|||
23311536|NCT01473524|64886582|FG005|DB Phase|Adverse Event|0|||
23311537|NCT01473524|64886577|FG000|DB Phase|Death|1|||
23423118|NCT01338610|65292601|FG000|Overall Study|Adverse Event|3|||
23423119|NCT01338610|65292602|FG001|Overall Study|Adverse Event|0|||
23615643|NCT01313299|65979410|FG000|Overall Study|Family reason and moved out of state|0|||
23615644|NCT01313299|65979411|FG001|Overall Study|Family reason and moved out of state|2|||
23311538|NCT01473524|64886578|FG001|DB Phase|Death|0|||
23311539|NCT01473524|64886579|FG002|DB Phase|Death|0|||
23311540|NCT01473524|64886580|FG003|DB Phase|Death|0|||
23311541|NCT01473524|64886581|FG004|DB Phase|Death|0|||
23311542|NCT01473524|64886582|FG005|DB Phase|Death|0|||
23311543|NCT01473524|64886577|FG000|DB Phase|Withdrawal by Subject|2|||
23311544|NCT01473524|64886578|FG001|DB Phase|Withdrawal by Subject|1|||
23311545|NCT01473524|64886579|FG002|DB Phase|Withdrawal by Subject|1|||
23311546|NCT01473524|64886580|FG003|DB Phase|Withdrawal by Subject|0|||
23311547|NCT01473524|64886581|FG004|DB Phase|Withdrawal by Subject|0|||
23423120|NCT01338610|65292603|FG002|Overall Study|Adverse Event|0|||
23311548|NCT01473524|64886582|FG005|DB Phase|Withdrawal by Subject|0|||
23311549|NCT01473524|64886577|FG000|LTSE Phase|Withdrawal by Subject|0|||
23311550|NCT01473524|64886578|FG001|LTSE Phase|Withdrawal by Subject|0|||
23311551|NCT01473524|64886579|FG002|LTSE Phase|Withdrawal by Subject|0|||
23311552|NCT01473524|64886580|FG003|LTSE Phase|Withdrawal by Subject|3|||
23311553|NCT01473524|64886581|FG004|LTSE Phase|Withdrawal by Subject|3|||
23311554|NCT01473524|64886582|FG005|LTSE Phase|Withdrawal by Subject|6|||
23423121|NCT00413920|65292604|FG000|Overall Study|Adverse Event|9|||
23423122|NCT00413920|65292605|FG001|Overall Study|Adverse Event|11|||
23311555|NCT01473524|64886577|FG000|LTSE Phase|Death|0|||
23311556|NCT01473524|64886578|FG001|LTSE Phase|Death|0|||
23311557|NCT01473524|64886579|FG002|LTSE Phase|Death|0|||
23311558|NCT01473524|64886580|FG003|LTSE Phase|Death|0|||
23311559|NCT01473524|64886581|FG004|LTSE Phase|Death|1|||
23311560|NCT01473524|64886582|FG005|LTSE Phase|Death|0|||
23615645|NCT01313299|65979412|FG002|Overall Study|Family reason and moved out of state|0|||
23311561|NCT01473524|64886577|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
23311562|NCT01473524|64886578|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
23311563|NCT01473524|64886579|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
23311564|NCT01473524|64886580|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
23311565|NCT01473524|64886581|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
23311566|NCT01473524|64886582|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
23311567|NCT01473524|64886577|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
23311568|NCT01473524|64886578|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
23311569|NCT01473524|64886579|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
23311570|NCT01473524|64886580|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
23311571|NCT01473524|64886581|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
23311572|NCT01473524|64886582|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
23311573|NCT01473524|64886577|FG000|LTSE Phase|Lost to Follow-up|0|||
23311574|NCT01473524|64886578|FG001|LTSE Phase|Lost to Follow-up|0|||
23311575|NCT01473524|64886579|FG002|LTSE Phase|Lost to Follow-up|0|||
23311576|NCT01473524|64886580|FG003|LTSE Phase|Lost to Follow-up|1|||
23311577|NCT01473524|64886581|FG004|LTSE Phase|Lost to Follow-up|3|||
23311578|NCT01473524|64886582|FG005|LTSE Phase|Lost to Follow-up|2|||
23311579|NCT01473524|64886577|FG000|LTSE Phase|Principal Investigator Decision|0|||
23311580|NCT01473524|64886578|FG001|LTSE Phase|Principal Investigator Decision|0|||
23311581|NCT01473524|64886579|FG002|LTSE Phase|Principal Investigator Decision|0|||
23311582|NCT01473524|64886580|FG003|LTSE Phase|Principal Investigator Decision|1|||
23311583|NCT01473524|64886581|FG004|LTSE Phase|Principal Investigator Decision|1|||
23311584|NCT01473524|64886582|FG005|LTSE Phase|Principal Investigator Decision|3|||
23311585|NCT01473524|64886577|FG000|LTSE Phase|Liver Transplantation|0|||
23311586|NCT01473524|64886578|FG001|LTSE Phase|Liver Transplantation|0|||
23311587|NCT01473524|64886579|FG002|LTSE Phase|Liver Transplantation|0|||
23311588|NCT01473524|64886580|FG003|LTSE Phase|Liver Transplantation|0|||
23311589|NCT01473524|64886581|FG004|LTSE Phase|Liver Transplantation|0|||
23311590|NCT01473524|64886582|FG005|LTSE Phase|Liver Transplantation|1|||
23311591|NCT01473524|64886577|FG000|LTSE Phase|Pregnancy|0|||
23311592|NCT01473524|64886578|FG001|LTSE Phase|Pregnancy|0|||
23311593|NCT01473524|64886579|FG002|LTSE Phase|Pregnancy|0|||
23311594|NCT01473524|64886580|FG003|LTSE Phase|Pregnancy|1|||
23311595|NCT01473524|64886581|FG004|LTSE Phase|Pregnancy|0|||
23311596|NCT01473524|64886582|FG005|LTSE Phase|Pregnancy|0|||
23311597|NCT01473524|64886577|FG000|LTSE Phase|Protocol Violation|0|||
23311598|NCT01473524|64886578|FG001|LTSE Phase|Protocol Violation|0|||
23311599|NCT01473524|64886579|FG002|LTSE Phase|Protocol Violation|0|||
23311600|NCT01473524|64886580|FG003|LTSE Phase|Protocol Violation|0|||
23311601|NCT01473524|64886581|FG004|LTSE Phase|Protocol Violation|0|||
23311602|NCT01473524|64886582|FG005|LTSE Phase|Protocol Violation|1|||
23311603|NCT03249792|64886583|FG000|Arms 1, 2, and 4|Death|1|||
23311604|NCT03249792|64886584|FG001|Arms 1, 2, and 4|Death|1|||
23311605|NCT03249792|64886585|FG002|Arms 1, 2, and 4|Death|0|||
23311606|NCT03249792|64886586|FG003|Arms 1, 2, and 4|Death|2|||
23311607|NCT03249792|64886587|FG004|Arms 1, 2, and 4|Death|3|||
23311608|NCT03249792|64886588|FG005|Arms 1, 2, and 4|Death|2|||
23311609|NCT03249792|64886589|FG006|Arms 1, 2, and 4|Death|2|||
23311610|NCT03249792|64886590|FG007|Arms 1, 2, and 4|Death|4|||
23311611|NCT03249792|64886591|FG008|Arms 1, 2, and 4|Death|2|||
23311612|NCT03249792|64886592|FG009|Arms 1, 2, and 4|Death|1|||
23311613|NCT03249792|64886593|FG010|Arms 1, 2, and 4|Death|7|||
23311614|NCT03249792|64886594|FG011|Arms 1, 2, and 4|Death|7|||
23311615|NCT03249792|64886595|FG012|Arms 1, 2, and 4|Death|12|||
23311616|NCT03249792|64886596|FG013|Arms 1, 2, and 4|Death|7|||
23311617|NCT03249792|64886597|FG014|Arms 1, 2, and 4|Death|0|||
23535436|NCT04622254|65693513|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23535437|NCT04622254|65693514|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23535438|NCT04622254|65693515|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
23535439|NCT04622254|65693510|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
23535440|NCT04622254|65693511|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
23535441|NCT04622254|65693512|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
23535442|NCT04622254|65693513|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23535443|NCT04622254|65693514|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23535444|NCT04622254|65693515|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23535445|NCT04622254|65693510|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
23311618|NCT03249792|64886598|FG015|Arms 1, 2, and 4|Death|4|||
23311619|NCT03249792|64886599|FG016|Arms 1, 2, and 4|Death|4|||
23311620|NCT03249792|64886600|FG017|Arms 1, 2, and 4|Death|12|||
23311621|NCT03249792|64886601|FG018|Arms 1, 2, and 4|Death|6|||
23311622|NCT03249792|64886602|FG019|Arms 1, 2, and 4|Death|4|||
23311623|NCT03249792|64886603|FG020|Arms 1, 2, and 4|Death|2|||
23311624|NCT03249792|64886604|FG021|Arms 1, 2, and 4|Death|3|||
23311625|NCT03249792|64886605|FG022|Arms 1, 2, and 4|Death|1|||
23311626|NCT03249792|64886606|FG023|Arms 1, 2, and 4|Death|1|||
23535446|NCT04622254|65693511|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23535447|NCT04622254|65693512|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23535448|NCT04622254|65693513|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23535449|NCT04622254|65693514|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23535450|NCT04622254|65693515|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
23208867|NCT03303092|64501096|FG000|Overall Study|Adverse Event|1|||
23208868|NCT03303092|64501097|FG001|Overall Study|Adverse Event|0|||
23423123|NCT00413920|65292604|FG000|Overall Study|Lack of Efficacy|11|||
23423124|NCT00413920|65292605|FG001|Overall Study|Lack of Efficacy|9|||
23423125|NCT00413920|65292604|FG000|Overall Study|Death|3|||
23423126|NCT00413920|65292605|FG001|Overall Study|Death|5|||
23423127|NCT00413920|65292604|FG000|Overall Study|Graft Loss|5|||
23423128|NCT00413920|65292605|FG001|Overall Study|Graft Loss|3|||
23423129|NCT02573246|65292606|FG000|Overall Study|Lost to Follow-up|2|||
23423130|NCT02573246|65292607|FG001|Overall Study|Lost to Follow-up|0|||
23423131|NCT02573246|65292608|FG002|Overall Study|Lost to Follow-up|0|||
23423132|NCT02573246|65292609|FG003|Overall Study|Lost to Follow-up|0|||
23423133|NCT02573246|65292610|FG004|Overall Study|Lost to Follow-up|1|||
23423134|NCT02573246|65292606|FG000|Overall Study|Withdrawal by Subject|0|||
23535451|NCT04622254|65693510|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23535452|NCT04622254|65693511|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
23535453|NCT04622254|65693512|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
23535454|NCT04622254|65693513|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23535455|NCT04622254|65693514|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23535456|NCT04622254|65693515|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23535457|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535458|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535459|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535460|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
23535461|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535462|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23535463|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23208869|NCT03303092|64501098|FG002|Overall Study|Adverse Event|1|||
23208870|NCT03303092|64501096|FG000|Overall Study|Protocol Violation|1|||
23208871|NCT03303092|64501097|FG001|Overall Study|Protocol Violation|5|||
23208872|NCT03303092|64501098|FG002|Overall Study|Protocol Violation|1|||
23208873|NCT03303092|64501096|FG000|Overall Study|Withdrawal by Subject|1|||
23208874|NCT03303092|64501097|FG001|Overall Study|Withdrawal by Subject|1|||
23208875|NCT03303092|64501098|FG002|Overall Study|Withdrawal by Subject|3|||
23208876|NCT01860534|64501099|FG000|ROP #1|Needed treatment for ROP|0|||
23208877|NCT01860534|64501100|FG001|ROP #1|Needed treatment for ROP|1|||
23208878|NCT01860534|64501099|FG000|ROP #2|discharged prior to ROP #2|1|||
23208879|NCT01860534|64501100|FG001|ROP #2|discharged prior to ROP #2|0|||
23208880|NCT00115765|64501101|FG000|Overall Study|Withdrawal by Subject|22|||
23311627|NCT03249792|64886607|FG024|Arms 1, 2, and 4|Death|4|||
23423135|NCT02573246|65292607|FG001|Overall Study|Withdrawal by Subject|0|||
23208881|NCT00115765|64501102|FG001|Overall Study|Withdrawal by Subject|53|||
23208882|NCT00115765|64501103|FG002|Overall Study|Withdrawal by Subject|76|||
23208883|NCT00115765|64501104|FG003|Overall Study|Withdrawal by Subject|15|||
23311628|NCT03249792|64886608|FG025|Arms 1, 2, and 4|Death|0|||
23311629|NCT03249792|64886609|FG026|Arms 1, 2, and 4|Death|0|||
23423136|NCT02573246|65292608|FG002|Overall Study|Withdrawal by Subject|0|||
23423137|NCT02573246|65292609|FG003|Overall Study|Withdrawal by Subject|0|||
23423138|NCT02573246|65292610|FG004|Overall Study|Withdrawal by Subject|1|||
23423139|NCT02573246|65292606|FG000|Overall Study|Physician Decision|1|||
23423140|NCT02573246|65292607|FG001|Overall Study|Physician Decision|1|||
23423141|NCT02573246|65292608|FG002|Overall Study|Physician Decision|3|||
23423142|NCT02573246|65292609|FG003|Overall Study|Physician Decision|2|||
23423143|NCT02573246|65292610|FG004|Overall Study|Physician Decision|2|||
23423144|NCT04493684|65292613|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
23423145|NCT04493684|65292614|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423146|NCT04493684|65292615|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
23423147|NCT04493684|65292616|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423148|NCT04493684|65292617|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423149|NCT04493684|65292618|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
23423150|NCT04493684|65292619|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423151|NCT04493684|65292620|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423152|NCT04493684|65292621|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423153|NCT04493684|65292622|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423154|NCT04493684|65292623|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423155|NCT04493684|65292624|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423156|NCT04493684|65292625|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423157|NCT04493684|65292626|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423158|NCT04493684|65292627|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423159|NCT04493684|65292628|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423160|NCT04493684|65292629|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
23423161|NCT04493684|65292613|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
23423162|NCT04493684|65292614|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23535464|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23423163|NCT04493684|65292615|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423164|NCT04493684|65292616|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423165|NCT04493684|65292617|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423166|NCT04493684|65292618|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423167|NCT04493684|65292619|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423168|NCT04493684|65292620|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423169|NCT04493684|65292621|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423170|NCT04493684|65292622|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423171|NCT04493684|65292623|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423172|NCT04493684|65292624|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423173|NCT04493684|65292625|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423174|NCT04493684|65292626|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423175|NCT04493684|65292627|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423176|NCT04493684|65292628|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423177|NCT04493684|65292629|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
23423178|NCT04493684|65292613|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423179|NCT04493684|65292614|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423180|NCT04493684|65292615|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423181|NCT04493684|65292616|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423182|NCT04493684|65292617|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423183|NCT04493684|65292618|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423184|NCT04493684|65292619|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
23423185|NCT04493684|65292620|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423186|NCT04493684|65292621|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423187|NCT04493684|65292622|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423188|NCT04493684|65292623|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423189|NCT04493684|65292624|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423190|NCT04493684|65292625|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423191|NCT04493684|65292626|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423192|NCT04493684|65292627|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423193|NCT04493684|65292628|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423194|NCT04493684|65292629|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
23423195|NCT04493684|65292613|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
23423196|NCT04493684|65292614|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423197|NCT04493684|65292615|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423198|NCT04493684|65292616|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423199|NCT04493684|65292617|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23535465|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23535466|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
23423200|NCT04493684|65292618|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423201|NCT04493684|65292619|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423202|NCT04493684|65292620|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423203|NCT04493684|65292621|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423204|NCT04493684|65292622|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423205|NCT04493684|65292623|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423206|NCT04493684|65292624|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423207|NCT04493684|65292625|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423208|NCT04493684|65292626|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423209|NCT04493684|65292627|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423210|NCT04493684|65292628|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423211|NCT04493684|65292629|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
23423212|NCT04493684|65292613|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423213|NCT04493684|65292614|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423214|NCT04493684|65292615|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423215|NCT04493684|65292616|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423216|NCT04493684|65292617|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423217|NCT04493684|65292618|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
23423218|NCT04493684|65292619|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423219|NCT04493684|65292620|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423220|NCT04493684|65292621|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423221|NCT04493684|65292622|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423222|NCT04493684|65292623|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423223|NCT04493684|65292624|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423224|NCT04493684|65292625|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423225|NCT04493684|65292626|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423226|NCT04493684|65292627|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423227|NCT04493684|65292628|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423228|NCT04493684|65292629|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
23423229|NCT04493684|65292613|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423230|NCT04493684|65292614|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423231|NCT04493684|65292615|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423232|NCT04493684|65292616|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423233|NCT04493684|65292617|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423234|NCT04493684|65292618|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423235|NCT04493684|65292619|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423236|NCT04493684|65292620|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423237|NCT04493684|65292621|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423238|NCT04493684|65292622|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423239|NCT04493684|65292623|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423240|NCT04493684|65292624|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
23423241|NCT04493684|65292625|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423242|NCT04493684|65292626|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423243|NCT04493684|65292627|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423244|NCT04493684|65292628|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423245|NCT04493684|65292629|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
23423246|NCT04493684|65292613|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423247|NCT04493684|65292614|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423248|NCT04493684|65292615|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423249|NCT04493684|65292616|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423250|NCT04493684|65292617|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423251|NCT04493684|65292618|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423252|NCT04493684|65292619|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423253|NCT04493684|65292620|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23535467|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23535468|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
23535469|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23535470|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23535471|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23535472|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
23535473|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23535474|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23582197|NCT02929108|65862372|FG005|Overall Study|Hospice patient death|28|||
23535475|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535476|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535477|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535478|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
23535479|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535480|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23535481|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23535482|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23535483|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23535484|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
23535485|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
23535486|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
23535487|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23535488|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23535489|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23535490|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
23535491|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
23535492|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
23535493|NCT04622254|65693510|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
23535494|NCT04622254|65693511|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
23535495|NCT04622254|65693512|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
23535496|NCT04622254|65693513|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
23535497|NCT04622254|65693514|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
23535498|NCT04622254|65693515|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
23535499|NCT02057757|65693516|FG000|Overall Study|Withdrawal by Subject|3|||
23535500|NCT02057757|65693517|FG001|Overall Study|Withdrawal by Subject|5|||
23535501|NCT02057757|65693516|FG000|Overall Study|Death|2|||
23535502|NCT02057757|65693517|FG001|Overall Study|Death|0|||
23535503|NCT02057757|65693516|FG000|Overall Study|Lost to Follow-up|8|||
23535504|NCT02057757|65693517|FG001|Overall Study|Lost to Follow-up|3|||
23535505|NCT02057757|65693516|FG000|Overall Study|Non-compliance|1|||
23535506|NCT02057757|65693517|FG001|Overall Study|Non-compliance|0|||
23535507|NCT01940705|65693518|FG000|Overall Study|Lost to Follow-up|1|||
23535508|NCT01940705|65693519|FG001|Overall Study|Lost to Follow-up|3|||
23535509|NCT01940705|65693520|FG002|Overall Study|Lost to Follow-up|2|||
23311630|NCT03249792|64886610|FG027|Arms 1, 2, and 4|Death|0|||
23535510|NCT01940705|65693521|FG003|Overall Study|Lost to Follow-up|2|||
23535511|NCT01940705|65693518|FG000|Overall Study|Withdrawal by Subject|2|||
23535512|NCT01940705|65693519|FG001|Overall Study|Withdrawal by Subject|2|||
23535513|NCT01940705|65693520|FG002|Overall Study|Withdrawal by Subject|3|||
23535514|NCT01940705|65693521|FG003|Overall Study|Withdrawal by Subject|2|||
23311631|NCT03249792|64886611|FG028|Arms 1, 2, and 4|Death|0|||
23311632|NCT03249792|64886612|FG029|Arms 1, 2, and 4|Death|0|||
23615646|NCT01313299|65979410|FG000|Overall Study|Lack of subject compliance|0|||
23615647|NCT01313299|65979411|FG001|Overall Study|Lack of subject compliance|0|||
23615648|NCT01313299|65979412|FG002|Overall Study|Lack of subject compliance|1|||
23311633|NCT03249792|64886613|FG030|Arms 1, 2, and 4|Death|0|||
23311634|NCT03249792|64886614|FG031|Arms 1, 2, and 4|Death|0|||
23311635|NCT03249792|64886615|FG032|Arms 1, 2, and 4|Death|0|||
23311636|NCT03249792|64886583|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311637|NCT03249792|64886584|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311638|NCT03249792|64886585|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23535515|NCT01940705|65693518|FG000|Overall Study|Intervention not given|0|||
23615649|NCT01762345|65979413|FG000|Overall Study|Adverse Event|5|||
23615650|NCT01762345|65979413|FG000|Overall Study|Protocol Violation|2|||
23615651|NCT03334747|65979414|FG000|Treatment Phase|Technical problems|0|||
23615652|NCT03334747|65979415|FG001|Treatment Phase|Technical problems|0|||
23615653|NCT03334747|65979416|FG002|Treatment Phase|Technical problems|0|||
23615654|NCT03334747|65979417|FG003|Treatment Phase|Technical problems|0|||
23615655|NCT03334747|65979418|FG004|Treatment Phase|Technical problems|1|||
23615656|NCT03334747|65979419|FG005|Treatment Phase|Technical problems|0|||
23615657|NCT03334747|65979420|FG006|Treatment Phase|Technical problems|0|||
23615658|NCT03334747|65979421|FG007|Treatment Phase|Technical problems|0|||
23615659|NCT03334747|65979422|FG008|Treatment Phase|Technical problems|0|||
23615660|NCT03334747|65979414|FG000|Treatment Phase|Subject/guardian decision|1|||
23615661|NCT03334747|65979415|FG001|Treatment Phase|Subject/guardian decision|0|||
23615662|NCT03334747|65979416|FG002|Treatment Phase|Subject/guardian decision|0|||
23311639|NCT03249792|64886586|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23535516|NCT01940705|65693519|FG001|Overall Study|Intervention not given|3|||
23615663|NCT03334747|65979417|FG003|Treatment Phase|Subject/guardian decision|0|||
23615664|NCT03334747|65979418|FG004|Treatment Phase|Subject/guardian decision|0|||
23615665|NCT03334747|65979419|FG005|Treatment Phase|Subject/guardian decision|1|||
23615666|NCT03334747|65979420|FG006|Treatment Phase|Subject/guardian decision|0|||
23615667|NCT03334747|65979421|FG007|Treatment Phase|Subject/guardian decision|0|||
23615668|NCT03334747|65979422|FG008|Treatment Phase|Subject/guardian decision|0|||
23615669|NCT03334747|65979414|FG000|Follow-Up Phase|Subject/guardian decision|0|||
23615670|NCT03334747|65979415|FG001|Follow-Up Phase|Subject/guardian decision|0|||
23615671|NCT03334747|65979416|FG002|Follow-Up Phase|Subject/guardian decision|0|||
23615672|NCT03334747|65979417|FG003|Follow-Up Phase|Subject/guardian decision|0|||
23615673|NCT03334747|65979418|FG004|Follow-Up Phase|Subject/guardian decision|0|||
23615674|NCT03334747|65979419|FG005|Follow-Up Phase|Subject/guardian decision|0|||
23615675|NCT03334747|65979420|FG006|Follow-Up Phase|Subject/guardian decision|1|||
23615676|NCT03334747|65979421|FG007|Follow-Up Phase|Subject/guardian decision|0|||
23615677|NCT03334747|65979422|FG008|Follow-Up Phase|Subject/guardian decision|1|||
23423254|NCT04493684|65292621|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23615678|NCT01951261|65979423|FG000|Overall Study|Death|1|||
23615679|NCT01951261|65979424|FG001|Overall Study|Death|0|||
23615680|NCT01951261|65979423|FG000|Overall Study|Lost to Follow-up|4|||
23615681|NCT01951261|65979424|FG001|Overall Study|Lost to Follow-up|3|||
23615682|NCT01951261|65979423|FG000|Overall Study|Protocol Violation|4|||
23615683|NCT01951261|65979424|FG001|Overall Study|Protocol Violation|3|||
23615684|NCT01482819|65979425|FG000|Overall Study|Lost to Follow-up|2|||
23615685|NCT00884793|65979426|FG000|Overall Study|Withdrawal by Subject|1|||
23615686|NCT00147745|65979430|FG000|Overall Study|Withdrawal by Subject|1|||
23615687|NCT00147745|65979431|FG001|Overall Study|Withdrawal by Subject|0|||
23615688|NCT00147745|65979432|FG002|Overall Study|Withdrawal by Subject|0|||
23615689|NCT02409732|65979433|FG000|Overall Study|Withdrawal by Subject|4|||
23615690|NCT02409732|65979433|FG000|Overall Study|Lost to Follow-up|2|||
23615691|NCT01012999|65979434|FG000|Overall Study|Protocol Violation|1|||
23615692|NCT04523571|65979437|FG000|Received 2 Doses|Withdrawal by Subject|0|||
23615693|NCT04523571|65979438|FG001|Received 2 Doses|Withdrawal by Subject|0|||
23615694|NCT04523571|65979439|FG002|Received 2 Doses|Withdrawal by Subject|0|||
23615695|NCT04523571|65979440|FG003|Received 2 Doses|Withdrawal by Subject|1|||
23615696|NCT04523571|65979441|FG004|Received 2 Doses|Withdrawal by Subject|1|||
23615697|NCT04523571|65979442|FG005|Received 2 Doses|Withdrawal by Subject|0|||
23615698|NCT04523571|65979437|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
23615699|NCT04523571|65979438|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
23615700|NCT04523571|65979439|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
23615701|NCT04523571|65979440|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
23615702|NCT04523571|65979441|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
23615703|NCT04523571|65979442|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
23615704|NCT04523571|65979437|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615705|NCT04523571|65979438|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615706|NCT04523571|65979439|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615707|NCT04523571|65979440|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615708|NCT04523571|65979441|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
23615709|NCT04523571|65979442|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
23615710|NCT04523571|65979437|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
23615711|NCT04523571|65979438|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
23615712|NCT04523571|65979439|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
23615713|NCT04523571|65979440|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
23615714|NCT04523571|65979441|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
23423255|NCT04493684|65292622|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423256|NCT04493684|65292623|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423257|NCT04493684|65292624|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423258|NCT04493684|65292625|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423259|NCT04493684|65292626|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423260|NCT04493684|65292627|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423261|NCT04493684|65292628|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
23423262|NCT04493684|65292629|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
23423263|NCT04493684|65292613|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423264|NCT04493684|65292614|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423265|NCT04493684|65292615|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23615715|NCT04523571|65979442|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
23615716|NCT04089332|65979443|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
23615717|NCT04089332|65979443|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
23615718|NCT04089332|65979443|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
23423266|NCT04493684|65292616|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23615719|NCT01190449|65979444|FG000|Overall Study|Ineligible|0|||
23615720|NCT01190449|65979445|FG001|Overall Study|Ineligible|4|||
23615721|NCT05294328|65979446|FG000|Overall Study|Adverse Event|1|||
23615722|NCT05294328|65979447|FG001|Overall Study|Adverse Event|0|||
23615723|NCT05294328|65979448|FG002|Overall Study|Adverse Event|0|||
23423267|NCT04493684|65292617|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423268|NCT04493684|65292618|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423269|NCT04493684|65292619|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423270|NCT04493684|65292620|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423271|NCT04493684|65292621|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423272|NCT04493684|65292622|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423273|NCT04493684|65292623|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423274|NCT04493684|65292624|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423275|NCT04493684|65292625|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423276|NCT04493684|65292626|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423277|NCT04493684|65292627|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423278|NCT04493684|65292628|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
23423279|NCT04493684|65292629|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
23423280|NCT01866423|65292630|FG000|Overall Study|Lack of Efficacy|3|||
23423281|NCT01866423|65292630|FG000|Overall Study|Sponsor Decision|1|||
23423282|NCT00790868|65292631|FG000|Overall Study|Withdrawal by Subject|4|||
23535517|NCT01940705|65693520|FG002|Overall Study|Intervention not given|3|||
23535518|NCT01940705|65693521|FG003|Overall Study|Intervention not given|0|||
23535519|NCT01940705|65693518|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
23535520|NCT01940705|65693519|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
23615724|NCT05294328|65979446|FG000|Overall Study|Physician Decision|1|||
23615725|NCT05294328|65979447|FG001|Overall Study|Physician Decision|1|||
23615726|NCT05294328|65979448|FG002|Overall Study|Physician Decision|0|||
23615727|NCT05294328|65979446|FG000|Overall Study|Withdrawal by Subject|0|||
23615728|NCT05294328|65979447|FG001|Overall Study|Withdrawal by Subject|2|||
23615729|NCT05294328|65979448|FG002|Overall Study|Withdrawal by Subject|1|||
23615730|NCT05294328|65979446|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
23615731|NCT05294328|65979447|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
23615732|NCT05294328|65979448|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
23615733|NCT02679079|65979449|FG000|Overall Study|Adverse Event|2|||
23615734|NCT02679079|65979450|FG001|Overall Study|Adverse Event|0|||
23615735|NCT02679079|65979451|FG002|Overall Study|Adverse Event|2|||
23615736|NCT02679079|65979449|FG000|Overall Study|Protocol Violation|0|||
23615737|NCT02679079|65979450|FG001|Overall Study|Protocol Violation|1|||
23615738|NCT02679079|65979451|FG002|Overall Study|Protocol Violation|0|||
23615739|NCT02679079|65979449|FG000|Overall Study|Withdrawal by Subject|2|||
23615740|NCT02679079|65979450|FG001|Overall Study|Withdrawal by Subject|1|||
23615741|NCT02679079|65979451|FG002|Overall Study|Withdrawal by Subject|0|||
23615742|NCT00130728|65979452|FG000|Overall Study|Death|258|||
23615743|NCT00130728|65979453|FG001|Overall Study|Death|258|||
23615744|NCT00130728|65979452|FG000|Overall Study|Lost to Follow-up|4|||
23615745|NCT00130728|65979453|FG001|Overall Study|Lost to Follow-up|0|||
23615746|NCT00130728|65979452|FG000|Overall Study|Withdrawal by Subject|0|||
23615747|NCT00130728|65979453|FG001|Overall Study|Withdrawal by Subject|2|||
23535521|NCT01940705|65693520|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
23535522|NCT01940705|65693521|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
23535523|NCT00563797|65693522|FG000|Overall Study|Lost to Follow-up|7|||
23535524|NCT00563797|65693523|FG001|Overall Study|Lost to Follow-up|2|||
23535525|NCT02496884|65693528|FG000|Overall Study|Counted twice as enrolled|2|||
23535526|NCT02496884|65693529|FG001|Overall Study|Counted twice as enrolled|0|||
23535527|NCT02496884|65693530|FG002|Overall Study|Counted twice as enrolled|0|||
23535528|NCT02496884|65693531|FG003|Overall Study|Counted twice as enrolled|0|||
23535529|NCT02496884|65693528|FG000|Overall Study|Withdrawal by Subject|0|||
23535530|NCT02496884|65693529|FG001|Overall Study|Withdrawal by Subject|3|||
23535531|NCT02496884|65693530|FG002|Overall Study|Withdrawal by Subject|0|||
23535532|NCT02496884|65693531|FG003|Overall Study|Withdrawal by Subject|0|||
23535533|NCT02047604|65693532|FG000|Overall Study|Withdrawal by Subject|0|||
23535534|NCT02047604|65693533|FG001|Overall Study|Withdrawal by Subject|0|||
23535535|NCT02047604|65693534|FG002|Overall Study|Withdrawal by Subject|0|||
23615748|NCT01257698|65979469|FG000|Overall Study|Protocol Violation|4|||
23615749|NCT01257698|65979470|FG001|Overall Study|Protocol Violation|0|||
23615750|NCT02515097|65979477|FG000|Overall Study|Lost to Follow-up|4|||
23615751|NCT02515097|65979478|FG001|Overall Study|Lost to Follow-up|2|||
23615752|NCT02515097|65979477|FG000|Overall Study|Withdrawal by Subject|1|||
23615753|NCT02515097|65979478|FG001|Overall Study|Withdrawal by Subject|3|||
23615754|NCT02515097|65979477|FG000|Overall Study|Adverse Event|2|||
23615755|NCT02515097|65979478|FG001|Overall Study|Adverse Event|1|||
23423283|NCT00790868|65292632|FG001|Overall Study|Withdrawal by Subject|5|||
23535536|NCT02047604|65693535|FG003|Overall Study|Withdrawal by Subject|0|||
23615756|NCT03049306|65979479|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
23615757|NCT03049306|65979480|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
23615758|NCT01485991|65979481|FG000|Overall Study|Adverse Event|0|||
23615759|NCT01485991|65979482|FG001|Overall Study|Adverse Event|4|||
23615760|NCT01485991|65979481|FG000|Overall Study|Lost to Follow-up|13|||
23615761|NCT01485991|65979482|FG001|Overall Study|Lost to Follow-up|10|||
23615762|NCT01485991|65979481|FG000|Overall Study|Withdrawal by Subject|13|||
23615763|NCT01485991|65979482|FG001|Overall Study|Withdrawal by Subject|20|||
23615764|NCT01485991|65979481|FG000|Overall Study|randomized but not treated|6|||
23615765|NCT01485991|65979482|FG001|Overall Study|randomized but not treated|2|||
23615766|NCT01032200|65979493|FG000|Overall Study|Death|1|||
23615767|NCT01032200|65979494|FG001|Overall Study|Death|1|||
23615768|NCT01032200|65979493|FG000|Overall Study|Withdrawal by Subject|1|||
23615769|NCT01032200|65979494|FG001|Overall Study|Withdrawal by Subject|3|||
23615770|NCT01032200|65979493|FG000|Overall Study|Toxicity|0|||
23615771|NCT01032200|65979494|FG001|Overall Study|Toxicity|2|||
23615772|NCT01032200|65979493|FG000|Overall Study|Progression|1|||
23615773|NCT01032200|65979494|FG001|Overall Study|Progression|0|||
23615774|NCT01032200|65979493|FG000|Overall Study|Multiple|1|||
23615775|NCT01032200|65979494|FG001|Overall Study|Multiple|1|||
23615776|NCT02161185|65979495|FG000|Treatment Phase|Administrative/Other|7|||
23615777|NCT00562484|65979498|FG000|Overall Study|Adverse Event|6|||
23615778|NCT00562484|65979499|FG001|Overall Study|Adverse Event|1|||
23615779|NCT00562484|65979498|FG000|Overall Study|Protocol Violation|11|||
23615780|NCT00562484|65979499|FG001|Overall Study|Protocol Violation|2|||
23615781|NCT00562484|65979498|FG000|Overall Study|Withdrawal by Subject|12|||
23615782|NCT00562484|65979499|FG001|Overall Study|Withdrawal by Subject|9|||
23615783|NCT00562484|65979498|FG000|Overall Study|Moved away from the study area|20|||
23615784|NCT00562484|65979499|FG001|Overall Study|Moved away from the study area|9|||
23615785|NCT00562484|65979498|FG000|Overall Study|Lost to Follow-up|132|||
23615786|NCT00562484|65979499|FG001|Overall Study|Lost to Follow-up|71|||
23615787|NCT00562484|65979498|FG000|Overall Study|Reason not provided or not specified|25|||
23615788|NCT00562484|65979499|FG001|Overall Study|Reason not provided or not specified|12|||
23615789|NCT01107912|65979500|FG000|Period 1|Adverse Event|0|||
23615790|NCT01107912|65979501|FG001|Period 1|Adverse Event|0|||
23615791|NCT01107912|65979502|FG002|Period 1|Adverse Event|0|||
23615792|NCT01107912|65979503|FG003|Period 1|Adverse Event|0|||
23615793|NCT01107912|65979504|FG004|Period 1|Adverse Event|2|||
23615794|NCT01107912|65979505|FG005|Period 1|Adverse Event|0|||
23615795|NCT01107912|65979500|FG000|Period 1|Physician Decision|0|||
23615796|NCT01107912|65979501|FG001|Period 1|Physician Decision|0|||
23615797|NCT01107912|65979502|FG002|Period 1|Physician Decision|0|||
23615798|NCT01107912|65979503|FG003|Period 1|Physician Decision|0|||
23615799|NCT01107912|65979504|FG004|Period 1|Physician Decision|1|||
23615800|NCT01107912|65979505|FG005|Period 1|Physician Decision|0|||
23615801|NCT01107912|65979500|FG000|Period 1|Withdrawal by Subject|1|||
23615802|NCT01107912|65979501|FG001|Period 1|Withdrawal by Subject|0|||
23615803|NCT01107912|65979502|FG002|Period 1|Withdrawal by Subject|0|||
23615804|NCT01107912|65979503|FG003|Period 1|Withdrawal by Subject|0|||
23615805|NCT01107912|65979504|FG004|Period 1|Withdrawal by Subject|0|||
23615806|NCT01107912|65979505|FG005|Period 1|Withdrawal by Subject|0|||
23615807|NCT01107912|65979500|FG000|Period 2|Physician Decision|0|||
23535537|NCT02047604|65693536|FG004|Overall Study|Withdrawal by Subject|1|||
23535538|NCT02047604|65693537|FG005|Overall Study|Withdrawal by Subject|1|||
23535539|NCT03285646|65693538|FG000|Overall Study|Adverse Event|1|||
23535540|NCT03285646|65693539|FG001|Overall Study|Adverse Event|0|||
23535541|NCT03285646|65693538|FG000|Overall Study|Withdrawal by Subject|10|||
23535542|NCT03285646|65693539|FG001|Overall Study|Withdrawal by Subject|2|||
23535543|NCT03285646|65693538|FG000|Overall Study|Lost to Follow-up|2|||
23535544|NCT03285646|65693539|FG001|Overall Study|Lost to Follow-up|1|||
23535545|NCT03285646|65693538|FG000|Overall Study|Investigator/Sponsor Decision|0|||
23535546|NCT03285646|65693539|FG001|Overall Study|Investigator/Sponsor Decision|1|||
23535547|NCT01175824|65693540|FG000|Overall Study|Adverse Event|2|||
23535548|NCT01175824|65693541|FG001|Overall Study|Adverse Event|1|||
23535549|NCT01175824|65693540|FG000|Overall Study|Lack of Efficacy|2|||
23535550|NCT01175824|65693541|FG001|Overall Study|Lack of Efficacy|0|||
23535551|NCT01175824|65693540|FG000|Overall Study|Lost to Follow-up|0|||
23535552|NCT01175824|65693541|FG001|Overall Study|Lost to Follow-up|1|||
23535553|NCT01175824|65693540|FG000|Overall Study|Physician Decision|0|||
23615808|NCT01107912|65979501|FG001|Period 2|Physician Decision|0|||
23615809|NCT01107912|65979502|FG002|Period 2|Physician Decision|1|||
23615810|NCT01107912|65979503|FG003|Period 2|Physician Decision|0|||
23615811|NCT01107912|65979504|FG004|Period 2|Physician Decision|0|||
23615812|NCT01107912|65979505|FG005|Period 2|Physician Decision|0|||
23615813|NCT01107912|65979500|FG000|Period 3|Adverse Event|0|||
23615814|NCT01107912|65979501|FG001|Period 3|Adverse Event|1|||
23535554|NCT01175824|65693541|FG001|Overall Study|Physician Decision|4|||
23535555|NCT01175824|65693540|FG000|Overall Study|Protocol Violation|2|||
23535556|NCT01175824|65693541|FG001|Overall Study|Protocol Violation|5|||
23535557|NCT01175824|65693540|FG000|Overall Study|Withdrawal by Subject|3|||
23615815|NCT01107912|65979502|FG002|Period 3|Adverse Event|1|||
23615816|NCT01107912|65979503|FG003|Period 3|Adverse Event|0|||
23615817|NCT01107912|65979504|FG004|Period 3|Adverse Event|0|||
23615818|NCT01107912|65979505|FG005|Period 3|Adverse Event|0|||
23615819|NCT01107912|65979500|FG000|Period 3|Withdrawal by Subject|0|||
23615820|NCT01107912|65979501|FG001|Period 3|Withdrawal by Subject|0|||
23615821|NCT01107912|65979502|FG002|Period 3|Withdrawal by Subject|0|||
23615822|NCT01107912|65979503|FG003|Period 3|Withdrawal by Subject|1|||
23615823|NCT01107912|65979504|FG004|Period 3|Withdrawal by Subject|0|||
23615824|NCT01107912|65979505|FG005|Period 3|Withdrawal by Subject|0|||
23615825|NCT02065895|65979507|FG000|Overall Study|Protocol Violation|1|||
23615826|NCT02065895|65979508|FG001|Overall Study|Protocol Violation|0|||
23615827|NCT02065895|65979509|FG002|Overall Study|Protocol Violation|0|||
23615828|NCT02065895|65979510|FG003|Overall Study|Protocol Violation|1|||
23615829|NCT02065895|65979511|FG004|Overall Study|Protocol Violation|0|||
23615830|NCT02065895|65979512|FG005|Overall Study|Protocol Violation|0|||
23615831|NCT02065895|65979507|FG000|Overall Study|Scheduling conflicts|0|||
23615832|NCT02065895|65979508|FG001|Overall Study|Scheduling conflicts|1|||
23615833|NCT02065895|65979509|FG002|Overall Study|Scheduling conflicts|0|||
23615834|NCT02065895|65979510|FG003|Overall Study|Scheduling conflicts|0|||
23615835|NCT02065895|65979511|FG004|Overall Study|Scheduling conflicts|0|||
23615836|NCT02065895|65979512|FG005|Overall Study|Scheduling conflicts|0|||
23615837|NCT02213458|65979524|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
23615838|NCT02213458|65979525|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
23615839|NCT02213458|65979524|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
23615840|NCT02213458|65979525|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
23615841|NCT02213458|65979524|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
23615842|NCT02213458|65979525|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
23615843|NCT02213458|65979524|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
23615844|NCT02213458|65979525|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
23615845|NCT02213458|65979524|FG000|Overall Study|Refused re-consent|6|||
23615846|NCT02213458|65979525|FG001|Overall Study|Refused re-consent|0|||
23615847|NCT02213458|65979524|FG000|Overall Study|Lost to Follow-up|2|||
23615848|NCT02213458|65979525|FG001|Overall Study|Lost to Follow-up|2|||
23615849|NCT02213458|65979524|FG000|Overall Study|Withdrawal by Subject|26|||
23535558|NCT01175824|65693541|FG001|Overall Study|Withdrawal by Subject|7|||
23535559|NCT01175824|65693540|FG000|Overall Study|Sponsor Decision|1|||
23535560|NCT01175824|65693541|FG001|Overall Study|Sponsor Decision|0|||
23535561|NCT01175824|65693540|FG000|Overall Study|Entry Criteria Not Met|6|||
23535562|NCT01175824|65693541|FG001|Overall Study|Entry Criteria Not Met|4|||
23535563|NCT01332149|65693544|FG000|Overall Study|Adverse Event|11|||
23535564|NCT01332149|65693545|FG001|Overall Study|Adverse Event|9|||
23535565|NCT01332149|65693544|FG000|Overall Study|Other unspecified|5|||
23535566|NCT01332149|65693545|FG001|Overall Study|Other unspecified|7|||
23535567|NCT01332149|65693544|FG000|Overall Study|Protocol Violation|1|||
23535568|NCT01332149|65693545|FG001|Overall Study|Protocol Violation|3|||
23535569|NCT01332149|65693544|FG000|Overall Study|Withdrawal by Subject|4|||
23535570|NCT01332149|65693545|FG001|Overall Study|Withdrawal by Subject|5|||
23535571|NCT01332149|65693544|FG000|Overall Study|Lost to Follow-up|1|||
23535572|NCT01332149|65693545|FG001|Overall Study|Lost to Follow-up|1|||
23535573|NCT01332149|65693544|FG000|Overall Study|Insufficient clinical response|4|||
23535574|NCT01332149|65693545|FG001|Overall Study|Insufficient clinical response|7|||
23535575|NCT01332149|65693544|FG000|Overall Study|Did not meet entrance criteria|3|||
23535576|NCT01332149|65693545|FG001|Overall Study|Did not meet entrance criteria|4|||
23535577|NCT01332149|65693544|FG000|Overall Study|Randomized but not treated|1|||
23535578|NCT01332149|65693545|FG001|Overall Study|Randomized but not treated|2|||
23208884|NCT00115765|64501101|FG000|Overall Study|Physician Decision|4|||
23208885|NCT00115765|64501102|FG001|Overall Study|Physician Decision|15|||
23535579|NCT03219333|65693546|FG000|Overall Study|Withdrawal by Subject|9|||
23535580|NCT03219333|65693547|FG001|Overall Study|Withdrawal by Subject|4|||
23535581|NCT03219333|65693546|FG000|Overall Study|Lost to Follow-up|1|||
23535582|NCT03219333|65693547|FG001|Overall Study|Lost to Follow-up|1|||
23535583|NCT03219333|65693546|FG000|Overall Study|Death|104|||
23208886|NCT00115765|64501103|FG002|Overall Study|Physician Decision|18|||
23208887|NCT00115765|64501104|FG003|Overall Study|Physician Decision|13|||
23615850|NCT02213458|65979525|FG001|Overall Study|Withdrawal by Subject|8|||
23615851|NCT00850993|65979526|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
23615852|NCT00850993|65979527|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
23615853|NCT00850993|65979528|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
23615854|NCT00850993|65979529|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
23615855|NCT03302559|65979533|FG000|Overall Study|Adverse Event|2|||
23615856|NCT03302559|65979533|FG000|Overall Study|Lost to Follow-up|1|||
23615857|NCT03302559|65979533|FG000|Overall Study|Withdrew Consent|3|||
23615858|NCT01870999|65979542|FG000|Overall Study|Adverse Event|0|||
23615859|NCT01870999|65979543|FG001|Overall Study|Adverse Event|4|||
23615860|NCT01870999|65979544|FG002|Overall Study|Adverse Event|1|||
23615861|NCT01870999|65979542|FG000|Overall Study|Subject met withdrawal criteria|3|||
23615862|NCT01870999|65979543|FG001|Overall Study|Subject met withdrawal criteria|2|||
23615863|NCT01870999|65979544|FG002|Overall Study|Subject met withdrawal criteria|0|||
23615864|NCT01870999|65979542|FG000|Overall Study|Subject withdrawn by Investigator|1|||
23615865|NCT01870999|65979543|FG001|Overall Study|Subject withdrawn by Investigator|0|||
23615866|NCT01870999|65979544|FG002|Overall Study|Subject withdrawn by Investigator|0|||
23615867|NCT01870999|65979542|FG000|Overall Study|Withdrawal by Subject|0|||
23615868|NCT01870999|65979543|FG001|Overall Study|Withdrawal by Subject|2|||
23615869|NCT01870999|65979544|FG002|Overall Study|Withdrawal by Subject|5|||
23615870|NCT01870999|65979542|FG000|Overall Study|Protocol Violation|0|||
23615871|NCT01870999|65979543|FG001|Overall Study|Protocol Violation|0|||
23208888|NCT00115765|64501101|FG000|Overall Study|Lost to Follow-up|3|||
23208889|NCT00115765|64501102|FG001|Overall Study|Lost to Follow-up|20|||
23208890|NCT00115765|64501103|FG002|Overall Study|Lost to Follow-up|18|||
23535584|NCT03219333|65693547|FG001|Overall Study|Death|72|||
23535585|NCT03219333|65693546|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
23535586|NCT03219333|65693547|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
23535587|NCT03219333|65693546|FG000|Overall Study|Other|2|||
23535588|NCT03219333|65693547|FG001|Overall Study|Other|2|||
23535589|NCT00612313|65693548|FG000|Overall Study|Withdrawal by Subject|6|||
23208891|NCT00115765|64501104|FG003|Overall Study|Lost to Follow-up|1|||
23208892|NCT00115765|64501101|FG000|Overall Study|Other|6|||
23208893|NCT00115765|64501102|FG001|Overall Study|Other|12|||
23208894|NCT00115765|64501103|FG002|Overall Study|Other|9|||
23208895|NCT00115765|64501104|FG003|Overall Study|Other|2|||
23208896|NCT00390416|64501106|FG000|Overall Study|Withdrawal by Subject|1|||
23208897|NCT00390416|64501106|FG000|Overall Study|Not treated|3|||
23208898|NCT03628417|64501107|FG000|Overall Study|Death|1|||
23208899|NCT03628417|64501108|FG001|Overall Study|Death|1|||
23208900|NCT01954251|64501115|FG000|Overall Study|Adverse Event|5|||
23208901|NCT01954251|64501116|FG001|Overall Study|Adverse Event|7|||
23535590|NCT00612313|65693549|FG001|Overall Study|Withdrawal by Subject|9|||
23535591|NCT00612313|65693548|FG000|Overall Study|Lost to Follow-up|11|||
23535592|NCT00612313|65693549|FG001|Overall Study|Lost to Follow-up|4|||
23535593|NCT02752048|65693552|FG000|Overall Study|Withdrawal by Subject|0|||
23535594|NCT02752048|65693553|FG001|Overall Study|Withdrawal by Subject|0|||
23535595|NCT02752048|65693554|FG002|Overall Study|Withdrawal by Subject|3|||
23535596|NCT01975389|65693555|FG000|Overall Study|Adverse Event|10|||
23535597|NCT01975389|65693556|FG001|Overall Study|Adverse Event|6|||
23535598|NCT01975389|65693555|FG000|Overall Study|Death|61|||
23208902|NCT01954251|64501115|FG000|Overall Study|Lost to Follow-up|6|||
23208903|NCT01954251|64501116|FG001|Overall Study|Lost to Follow-up|6|||
23208904|NCT01954251|64501115|FG000|Overall Study|Withdrawal by Subject|2|||
23208905|NCT01954251|64501116|FG001|Overall Study|Withdrawal by Subject|6|||
23535599|NCT01975389|65693556|FG001|Overall Study|Death|54|||
23535600|NCT01975389|65693555|FG000|Overall Study|Lost to Follow-up|81|||
23535601|NCT01975389|65693556|FG001|Overall Study|Lost to Follow-up|86|||
23615872|NCT01870999|65979544|FG002|Overall Study|Protocol Violation|1|||
23615873|NCT00382408|65979545|FG000|Overall Study|Did not meet protocol requirement|3|||
23208906|NCT02807363|64501117|FG000|Dosing Period|Adverse Event|0|||
23208907|NCT02807363|64501118|FG001|Dosing Period|Adverse Event|1|||
23208908|NCT02807363|64501119|FG002|Dosing Period|Adverse Event|0|||
23535602|NCT01975389|65693555|FG000|Overall Study|Withdrawal by Subject|90|||
23615874|NCT00382408|65979546|FG001|Overall Study|Did not meet protocol requirement|3|||
23615875|NCT00382408|65979545|FG000|Overall Study|Protocol Violation|2|||
23615876|NCT00382408|65979546|FG001|Overall Study|Protocol Violation|2|||
23615877|NCT00382408|65979545|FG000|Overall Study|Physician Decision|1|||
23615878|NCT00382408|65979546|FG001|Overall Study|Physician Decision|0|||
23615879|NCT00382408|65979545|FG000|Overall Study|Withdrawal by Subject|17|||
23615880|NCT00382408|65979546|FG001|Overall Study|Withdrawal by Subject|6|||
23615881|NCT00382408|65979545|FG000|Overall Study|Pregnancy|2|||
23615882|NCT00382408|65979546|FG001|Overall Study|Pregnancy|0|||
23615883|NCT00382408|65979545|FG000|Overall Study|Lost to Follow-up|19|||
23615884|NCT00382408|65979546|FG001|Overall Study|Lost to Follow-up|8|||
23615885|NCT00382408|65979545|FG000|Overall Study|Other|100|||
23615886|NCT00382408|65979546|FG001|Overall Study|Other|35|||
23615887|NCT02864342|65979550|FG000|Overall Study|Eligibility Criteria Deviation|2|||
23615888|NCT02864342|65979551|FG001|Overall Study|Eligibility Criteria Deviation|3|||
23615889|NCT02864342|65979550|FG000|Overall Study|Withdrawal by Subject|4|||
23311640|NCT03249792|64886587|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23535603|NCT01975389|65693556|FG001|Overall Study|Withdrawal by Subject|76|||
23535604|NCT01975389|65693555|FG000|Overall Study|Other|6|||
23535605|NCT01975389|65693556|FG001|Overall Study|Other|9|||
23535606|NCT01975389|65693555|FG000|Overall Study|Randomized, not treated|4|||
23535607|NCT01975389|65693556|FG001|Overall Study|Randomized, not treated|5|||
23535608|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535609|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535610|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
23535611|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535612|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535613|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
23535614|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
23535615|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
23535616|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
23535617|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
23535618|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
23535619|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
23535620|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23535621|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
23535622|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
23535623|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535624|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535625|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535626|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535627|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535628|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
23535629|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23535630|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23535631|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23535632|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23535633|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23535634|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
23535635|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23535636|NCT01573624|65693557|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
23535637|NCT01573624|65693558|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
23535638|NCT01573624|65693559|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
23535639|NCT01573624|65693560|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
23535640|NCT01573624|65693561|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
23535641|NCT01573624|65693562|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
23535642|NCT01573624|65693563|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
23535643|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535644|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535645|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535646|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535647|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23615890|NCT02864342|65979551|FG001|Overall Study|Withdrawal by Subject|2|||
23615891|NCT02864342|65979550|FG000|Overall Study|Device Technology Issue|6|||
23615892|NCT02864342|65979551|FG001|Overall Study|Device Technology Issue|7|||
23615893|NCT02864342|65979550|FG000|Overall Study|Death|0|||
23615894|NCT02864342|65979551|FG001|Overall Study|Death|1|||
23615895|NCT02864342|65979550|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
23615896|NCT02864342|65979551|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
23615897|NCT02864342|65979550|FG000|Overall Study|Lost to Follow-up|1|||
23615898|NCT02864342|65979551|FG001|Overall Study|Lost to Follow-up|5|||
23615899|NCT02864342|65979550|FG000|Overall Study|Lost Device|1|||
23615900|NCT02864342|65979551|FG001|Overall Study|Lost Device|0|||
23615901|NCT02864342|65979550|FG000|Overall Study|Adverse Event|1|||
23615902|NCT02864342|65979551|FG001|Overall Study|Adverse Event|0|||
23615903|NCT03233204|65979552|FG000|Overall Study|Adverse Event|1|||
23615904|NCT03233204|65979552|FG000|Overall Study|Death|1|||
23615905|NCT03233204|65979552|FG000|Overall Study|Withdrawal by Subject|1|||
23615906|NCT03233204|65979552|FG000|Overall Study|Progressive Disease|3|||
23615907|NCT00759681|65979554|FG000|Overall Study|Death|2|||
23615908|NCT00759681|65979555|FG001|Overall Study|Death|5|||
23615909|NCT00759681|65979554|FG000|Overall Study|Lost to Follow-up|8|||
23615910|NCT00759681|65979555|FG001|Overall Study|Lost to Follow-up|5|||
23208909|NCT02807363|64501120|FG003|Dosing Period|Adverse Event|0|||
23208910|NCT01905150|64501121|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
23208911|NCT01905150|64501122|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
23208912|NCT03956225|64501123|FG000|Overall Study|Lack of Efficacy|1|||
23208913|NCT03956225|64501124|FG001|Overall Study|Lack of Efficacy|1|||
23208914|NCT03956225|64501123|FG000|Overall Study|Lost to Follow-up|0|||
23208915|NCT03956225|64501124|FG001|Overall Study|Lost to Follow-up|1|||
23208916|NCT03956225|64501123|FG000|Overall Study|Withdrawal by Subject|2|||
23208917|NCT03956225|64501124|FG001|Overall Study|Withdrawal by Subject|1|||
23535648|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
23535649|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
23535650|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
23535651|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
23535652|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
23535653|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
23535654|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
23535655|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
23535656|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
23535657|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
23535658|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23535659|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
23535660|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
23535661|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23535662|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23535663|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
23535664|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535665|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535666|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535667|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535668|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535669|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
23535670|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
23535671|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23535672|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23535673|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23535674|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
23535675|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23535676|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
23615911|NCT01572493|65979559|FG000|Overall Study|Physician Decision|1|||
23615912|NCT01572493|65979560|FG001|Overall Study|Physician Decision|0|||
23615913|NCT01572493|65979561|FG002|Overall Study|Physician Decision|0|||
23615914|NCT01572493|65979562|FG003|Overall Study|Physician Decision|0|||
23615915|NCT01572493|65979563|FG004|Overall Study|Physician Decision|0|||
23615916|NCT01572493|65979564|FG005|Overall Study|Physician Decision|0|||
23208918|NCT03956225|64501123|FG000|Overall Study|Other Reasons|2|||
23423284|NCT00790868|65292631|FG000|Overall Study|Lost to Follow-up|2|||
23615917|NCT01572493|65979565|FG006|Overall Study|Physician Decision|0|||
23615918|NCT01572493|65979566|FG007|Overall Study|Physician Decision|0|||
23615919|NCT01572493|65979567|FG008|Overall Study|Physician Decision|0|||
23615920|NCT01572493|65979559|FG000|Overall Study|Switched to alternative treatment|0|||
23615921|NCT01572493|65979560|FG001|Overall Study|Switched to alternative treatment|1|||
23615922|NCT01572493|65979561|FG002|Overall Study|Switched to alternative treatment|2|||
23615923|NCT01572493|65979562|FG003|Overall Study|Switched to alternative treatment|1|||
23615924|NCT01572493|65979563|FG004|Overall Study|Switched to alternative treatment|2|||
23615925|NCT01572493|65979564|FG005|Overall Study|Switched to alternative treatment|0|||
23535677|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
23535678|NCT01573624|65693557|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535679|NCT01573624|65693558|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535680|NCT01573624|65693559|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535681|NCT01573624|65693560|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535682|NCT01573624|65693561|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535683|NCT01573624|65693562|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
23615926|NCT01572493|65979565|FG006|Overall Study|Switched to alternative treatment|2|||
23615927|NCT01572493|65979566|FG007|Overall Study|Switched to alternative treatment|0|||
23615928|NCT01572493|65979567|FG008|Overall Study|Switched to alternative treatment|2|||
23615929|NCT01572493|65979559|FG000|Overall Study|Death|0|||
23615930|NCT01572493|65979560|FG001|Overall Study|Death|0|||
23615931|NCT01572493|65979561|FG002|Overall Study|Death|0|||
23615932|NCT01572493|65979562|FG003|Overall Study|Death|1|||
23615933|NCT01572493|65979563|FG004|Overall Study|Death|0|||
23615934|NCT01572493|65979564|FG005|Overall Study|Death|1|||
23615935|NCT01572493|65979565|FG006|Overall Study|Death|0|||
23615936|NCT01572493|65979566|FG007|Overall Study|Death|0|||
23615937|NCT01572493|65979567|FG008|Overall Study|Death|0|||
23615938|NCT01572493|65979559|FG000|Overall Study|Adverse Event|0|||
23615939|NCT01572493|65979560|FG001|Overall Study|Adverse Event|0|||
23615940|NCT01572493|65979561|FG002|Overall Study|Adverse Event|0|||
23615941|NCT01572493|65979562|FG003|Overall Study|Adverse Event|0|||
23615942|NCT01572493|65979563|FG004|Overall Study|Adverse Event|0|||
23615943|NCT01572493|65979564|FG005|Overall Study|Adverse Event|0|||
23615944|NCT01572493|65979565|FG006|Overall Study|Adverse Event|1|||
23615945|NCT01572493|65979566|FG007|Overall Study|Adverse Event|0|||
23615946|NCT01572493|65979567|FG008|Overall Study|Adverse Event|0|||
23615947|NCT02965599|65979568|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
23615948|NCT02965599|65979569|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
23615949|NCT02706834|65979570|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23615950|NCT02706834|65979571|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23615951|NCT02706834|65979572|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23615952|NCT02706834|65979573|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
23615953|NCT02706834|65979574|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
23615954|NCT02706834|65979575|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
23615955|NCT02706834|65979576|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
23615956|NCT02706834|65979577|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
23615957|NCT02706834|65979578|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
23615958|NCT02706834|65979579|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
23615959|NCT02706834|65979580|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
23615960|NCT02706834|65979570|FG000|Overall Study|Lost to Follow-up|0|||
23615961|NCT02706834|65979571|FG001|Overall Study|Lost to Follow-up|0|||
23615962|NCT02706834|65979572|FG002|Overall Study|Lost to Follow-up|1|||
23615963|NCT02706834|65979573|FG003|Overall Study|Lost to Follow-up|0|||
23615964|NCT02706834|65979574|FG004|Overall Study|Lost to Follow-up|0|||
23615965|NCT02706834|65979575|FG005|Overall Study|Lost to Follow-up|0|||
23615966|NCT02706834|65979576|FG006|Overall Study|Lost to Follow-up|0|||
23615967|NCT02706834|65979577|FG007|Overall Study|Lost to Follow-up|0|||
23615968|NCT02706834|65979578|FG008|Overall Study|Lost to Follow-up|0|||
23615969|NCT02706834|65979579|FG009|Overall Study|Lost to Follow-up|0|||
23615970|NCT02706834|65979580|FG010|Overall Study|Lost to Follow-up|0|||
23615971|NCT02706834|65979570|FG000|Overall Study|Voluntary Withdrawal|1|||
23615972|NCT02706834|65979571|FG001|Overall Study|Voluntary Withdrawal|0|||
23615973|NCT02706834|65979572|FG002|Overall Study|Voluntary Withdrawal|0|||
23615974|NCT02706834|65979573|FG003|Overall Study|Voluntary Withdrawal|0|||
23615975|NCT02706834|65979574|FG004|Overall Study|Voluntary Withdrawal|0|||
23615976|NCT02706834|65979575|FG005|Overall Study|Voluntary Withdrawal|0|||
23615977|NCT02706834|65979576|FG006|Overall Study|Voluntary Withdrawal|0|||
23615978|NCT02706834|65979577|FG007|Overall Study|Voluntary Withdrawal|0|||
23615979|NCT02706834|65979578|FG008|Overall Study|Voluntary Withdrawal|0|||
23615980|NCT02706834|65979579|FG009|Overall Study|Voluntary Withdrawal|1|||
23615981|NCT02706834|65979580|FG010|Overall Study|Voluntary Withdrawal|0|||
23615982|NCT02706834|65979570|FG000|Overall Study|Other Reason Not Specified|1|||
23615983|NCT02706834|65979571|FG001|Overall Study|Other Reason Not Specified|0|||
23615984|NCT02706834|65979572|FG002|Overall Study|Other Reason Not Specified|0|||
23615985|NCT02706834|65979573|FG003|Overall Study|Other Reason Not Specified|0|||
23615986|NCT02706834|65979574|FG004|Overall Study|Other Reason Not Specified|1|||
23615987|NCT02706834|65979575|FG005|Overall Study|Other Reason Not Specified|0|||
23615988|NCT02706834|65979576|FG006|Overall Study|Other Reason Not Specified|0|||
23615989|NCT02706834|65979577|FG007|Overall Study|Other Reason Not Specified|0|||
23615990|NCT02706834|65979578|FG008|Overall Study|Other Reason Not Specified|0|||
23615991|NCT02706834|65979579|FG009|Overall Study|Other Reason Not Specified|0|||
23615992|NCT02706834|65979580|FG010|Overall Study|Other Reason Not Specified|0|||
23615993|NCT01177228|65979581|FG000|Overall Study|Positive tuberculosis test|0|||
23615994|NCT01177228|65979582|FG001|Overall Study|Positive tuberculosis test|1|||
23615995|NCT01177228|65979583|FG002|Overall Study|Positive tuberculosis test|0|||
23615996|NCT01177228|65979584|FG003|Overall Study|Positive tuberculosis test|0|||
23615997|NCT01177228|65979581|FG000|Overall Study|Worsening disease activity|1|||
23615998|NCT01177228|65979582|FG001|Overall Study|Worsening disease activity|0|||
23615999|NCT01177228|65979583|FG002|Overall Study|Worsening disease activity|0|||
23616000|NCT01177228|65979584|FG003|Overall Study|Worsening disease activity|0|||
23616001|NCT01177228|65979581|FG000|Overall Study|Withdrawal by Subject|0|||
23616002|NCT01177228|65979582|FG001|Overall Study|Withdrawal by Subject|1|||
23616003|NCT01177228|65979583|FG002|Overall Study|Withdrawal by Subject|0|||
23535684|NCT01573624|65693563|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535685|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
23535686|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
23535687|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
23535688|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
23535689|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
23535690|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
23423285|NCT00790868|65292632|FG001|Overall Study|Lost to Follow-up|12|||
23423286|NCT02214225|65292633|FG000|Overall Study|Lost to Follow-up|46|||
23423287|NCT02214225|65292634|FG001|Overall Study|Lost to Follow-up|18|||
23423288|NCT02214225|65292635|FG002|Overall Study|Lost to Follow-up|18|||
23423289|NCT02214225|65292633|FG000|Overall Study|Withdrawal by Subject|2|||
23423290|NCT02214225|65292634|FG001|Overall Study|Withdrawal by Subject|0|||
23423291|NCT02214225|65292635|FG002|Overall Study|Withdrawal by Subject|2|||
23423292|NCT02214225|65292633|FG000|Overall Study|Death|5|||
23423293|NCT02214225|65292634|FG001|Overall Study|Death|0|||
23423294|NCT02214225|65292635|FG002|Overall Study|Death|1|||
23423295|NCT02214225|65292633|FG000|Overall Study|randomized in error, not vaccinated|2|||
23616004|NCT01177228|65979584|FG003|Overall Study|Withdrawal by Subject|0|||
23423296|NCT02214225|65292634|FG001|Overall Study|randomized in error, not vaccinated|1|||
23423297|NCT02214225|65292635|FG002|Overall Study|randomized in error, not vaccinated|1|||
23423298|NCT00098722|65292636|FG000|Double Blind Phase|Adverse Event|7|||
23423299|NCT00098722|65292637|FG001|Double Blind Phase|Adverse Event|7|||
23616005|NCT00274846|65979592|FG000|Overall Study|Did not receive adequate NK cells|1|||
23616006|NCT02391116|65979593|FG000|Treatment|Withdrawal by Subject|1|||
23423300|NCT00098722|65292638|FG002|Double Blind Phase|Adverse Event|3|||
23423301|NCT00098722|65292639|FG003|Double Blind Phase|Adverse Event|0|||
23423302|NCT00098722|65292640|FG004|Double Blind Phase|Adverse Event|0|||
23423303|NCT00098722|65292641|FG005|Double Blind Phase|Adverse Event|0|||
23423304|NCT00098722|65292642|FG006|Double Blind Phase|Adverse Event|0|||
23423305|NCT00098722|65292636|FG000|Double Blind Phase|Death|2|||
23423306|NCT00098722|65292637|FG001|Double Blind Phase|Death|5|||
23423307|NCT00098722|65292638|FG002|Double Blind Phase|Death|0|||
23423308|NCT00098722|65292639|FG003|Double Blind Phase|Death|0|||
23423309|NCT00098722|65292640|FG004|Double Blind Phase|Death|0|||
23423310|NCT00098722|65292641|FG005|Double Blind Phase|Death|0|||
23423311|NCT00098722|65292642|FG006|Double Blind Phase|Death|0|||
23423312|NCT00098722|65292636|FG000|Double Blind Phase|Lack of Efficacy|21|||
23423313|NCT00098722|65292637|FG001|Double Blind Phase|Lack of Efficacy|23|||
23423314|NCT00098722|65292638|FG002|Double Blind Phase|Lack of Efficacy|15|||
23423315|NCT00098722|65292639|FG003|Double Blind Phase|Lack of Efficacy|0|||
23423316|NCT00098722|65292640|FG004|Double Blind Phase|Lack of Efficacy|0|||
23423317|NCT00098722|65292641|FG005|Double Blind Phase|Lack of Efficacy|0|||
23423318|NCT00098722|65292642|FG006|Double Blind Phase|Lack of Efficacy|0|||
23423319|NCT00098722|65292636|FG000|Double Blind Phase|Participant defaulted|16|||
23423320|NCT00098722|65292637|FG001|Double Blind Phase|Participant defaulted|11|||
23423321|NCT00098722|65292638|FG002|Double Blind Phase|Participant defaulted|9|||
23423322|NCT00098722|65292639|FG003|Double Blind Phase|Participant defaulted|0|||
23423323|NCT00098722|65292640|FG004|Double Blind Phase|Participant defaulted|0|||
23423324|NCT00098722|65292641|FG005|Double Blind Phase|Participant defaulted|0|||
23423325|NCT00098722|65292642|FG006|Double Blind Phase|Participant defaulted|0|||
23423326|NCT00098722|65292636|FG000|Double Blind Phase|Pregnancy|1|||
23423327|NCT00098722|65292637|FG001|Double Blind Phase|Pregnancy|0|||
23423328|NCT00098722|65292638|FG002|Double Blind Phase|Pregnancy|0|||
23423329|NCT00098722|65292639|FG003|Double Blind Phase|Pregnancy|0|||
23423330|NCT00098722|65292640|FG004|Double Blind Phase|Pregnancy|0|||
23423331|NCT00098722|65292641|FG005|Double Blind Phase|Pregnancy|0|||
23423332|NCT00098722|65292642|FG006|Double Blind Phase|Pregnancy|0|||
23423333|NCT00098722|65292636|FG000|Double Blind Phase|Randomized, not treated|4|||
23423334|NCT00098722|65292637|FG001|Double Blind Phase|Randomized, not treated|3|||
23423335|NCT00098722|65292638|FG002|Double Blind Phase|Randomized, not treated|3|||
23423336|NCT00098722|65292639|FG003|Double Blind Phase|Randomized, not treated|0|||
23423337|NCT00098722|65292640|FG004|Double Blind Phase|Randomized, not treated|0|||
23423338|NCT00098722|65292641|FG005|Double Blind Phase|Randomized, not treated|0|||
23535691|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
23535692|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535693|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
23535694|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535695|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535696|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535697|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
23535698|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
23535699|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
23535700|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535701|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535702|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535703|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535704|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535705|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
23535706|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23535707|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
23535708|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
23535709|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23535710|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23423339|NCT00098722|65292642|FG006|Double Blind Phase|Randomized, not treated|0|||
23423340|NCT00098722|65292636|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
23423341|NCT00098722|65292637|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
23423342|NCT00098722|65292638|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
23423343|NCT00098722|65292639|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
23423344|NCT00098722|65292640|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
23423345|NCT00098722|65292641|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
23423346|NCT00098722|65292642|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
23423347|NCT00098722|65292636|FG000|Double Blind Phase|Other|7|||
23423348|NCT00098722|65292637|FG001|Double Blind Phase|Other|8|||
23423349|NCT00098722|65292638|FG002|Double Blind Phase|Other|7|||
23423350|NCT00098722|65292639|FG003|Double Blind Phase|Other|0|||
23535711|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
23535712|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23535713|NCT01573624|65693557|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
23535714|NCT01573624|65693558|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535715|NCT01573624|65693559|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535716|NCT01573624|65693560|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535717|NCT01573624|65693561|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535718|NCT01573624|65693562|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535719|NCT01573624|65693563|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
23535720|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
23535721|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535722|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535723|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535724|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535725|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
23535726|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
23535727|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
23535728|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535729|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535730|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535731|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535732|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
23535733|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
23535734|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23208919|NCT03956225|64501124|FG001|Overall Study|Other Reasons|1|||
23535735|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
23535736|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23208920|NCT00280150|64501125|FG000|Overall Study|Adverse Event|0|||
23535737|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23535738|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23535739|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23535740|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
23535741|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535742|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
23535743|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535744|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535745|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535746|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535747|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
23535748|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23535749|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23535750|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23616007|NCT02391116|65979593|FG000|Treatment|Protocol Violation|1|||
23311641|NCT03249792|64886588|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23208921|NCT00280150|64501126|FG001|Overall Study|Adverse Event|1|||
23616008|NCT02391116|65979593|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
23616009|NCT02391116|65979593|FG000|Treatment|AE with Clinical PD|3|||
23616010|NCT02391116|65979593|FG000|Safety Follow-up|Adverse Event|1|||
23616011|NCT02391116|65979593|FG000|Safety Follow-up|Withdrawal by Subject|4|||
23616012|NCT02391116|65979593|FG000|Safety Follow-up|Switching to Other Therapy|4|||
23616013|NCT02391116|65979593|FG000|Safety Follow-up|No Follow Up|1|||
23616014|NCT02391116|65979593|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
23616015|NCT02391116|65979593|FG000|Active Follow-up|Withdrawal by Subject|1|||
23616016|NCT02391116|65979593|FG000|Active Follow-up|Switching to Other Therapy|2|||
23616017|NCT02391116|65979593|FG000|Survival Follow-up|Withdrawal by Subject|3|||
23208922|NCT00280150|64501127|FG002|Overall Study|Adverse Event|2|||
23311642|NCT03249792|64886589|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
23616018|NCT02391116|65979593|FG000|Survival Follow-up|Switching to Other Therapy|1|||
23616019|NCT00515112|65979597|FG000|Overall Study|Death|0|||
23616020|NCT00515112|65979598|FG001|Overall Study|Death|1|||
23311643|NCT03249792|64886590|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23535751|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23535752|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
23535753|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23535754|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
23535755|NCT01573624|65693557|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535756|NCT01573624|65693558|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535757|NCT01573624|65693559|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535758|NCT01573624|65693560|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535759|NCT01573624|65693561|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535760|NCT01573624|65693562|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
23535761|NCT01573624|65693563|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
23535762|NCT01573624|65693557|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
23535763|NCT01573624|65693558|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23535764|NCT01573624|65693559|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23535765|NCT01573624|65693560|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23535766|NCT01573624|65693561|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
23535767|NCT01573624|65693562|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
23535768|NCT01573624|65693563|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
23535769|NCT01573624|65693557|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535770|NCT01573624|65693558|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
23535771|NCT01573624|65693559|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535772|NCT01573624|65693560|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535773|NCT01573624|65693561|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535774|NCT01573624|65693562|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
23535775|NCT01573624|65693563|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
23535776|NCT01573624|65693557|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
23535777|NCT01573624|65693558|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535778|NCT01573624|65693559|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535779|NCT01573624|65693560|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535780|NCT01573624|65693561|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535781|NCT01573624|65693562|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535782|NCT01573624|65693563|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
23535783|NCT01573624|65693557|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535784|NCT01573624|65693558|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535785|NCT01573624|65693559|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535786|NCT01573624|65693560|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535787|NCT01573624|65693561|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
23535788|NCT01573624|65693562|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
23535789|NCT01573624|65693563|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
23535790|NCT01573624|65693557|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
23535791|NCT01573624|65693558|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535792|NCT01573624|65693559|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23616021|NCT00515112|65979597|FG000|Overall Study|The study was terminated|3|||
23616022|NCT00515112|65979598|FG001|Overall Study|The study was terminated|2|||
23616023|NCT02068352|65979599|FG000|Overall Study|Lost to Follow-up|0|||
23616024|NCT02068352|65979600|FG001|Overall Study|Lost to Follow-up|2|||
23616025|NCT02068352|65979601|FG002|Overall Study|Lost to Follow-up|0|||
23616026|NCT02068352|65979599|FG000|Overall Study|Adverse Event|4|||
23208923|NCT00280150|64501128|FG003|Overall Study|Adverse Event|3|||
23535793|NCT01573624|65693560|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535794|NCT01573624|65693561|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535795|NCT01573624|65693562|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535796|NCT01573624|65693563|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
23535797|NCT04448561|65693564|FG000|Overall Study|Noncompliance|1|||
23535798|NCT04448561|65693565|FG001|Overall Study|Noncompliance|0|||
23535799|NCT00304070|65693566|FG000|Overall Study|Death|0|||
23535800|NCT00304070|65693567|FG001|Overall Study|Death|0|||
23535801|NCT00304070|65693568|FG002|Overall Study|Death|3|||
23535802|NCT00304070|65693566|FG000|Overall Study|Lost to Follow-up|0|||
23535803|NCT00304070|65693567|FG001|Overall Study|Lost to Follow-up|0|||
23535804|NCT00304070|65693568|FG002|Overall Study|Lost to Follow-up|1|||
23535805|NCT00304070|65693566|FG000|Overall Study|Physician Decision|0|||
23535806|NCT00304070|65693567|FG001|Overall Study|Physician Decision|0|||
23535807|NCT00304070|65693568|FG002|Overall Study|Physician Decision|3|||
23535808|NCT00304070|65693566|FG000|Overall Study|Withdrawal by Subject|0|||
23535809|NCT00304070|65693567|FG001|Overall Study|Withdrawal by Subject|0|||
23535810|NCT00304070|65693568|FG002|Overall Study|Withdrawal by Subject|1|||
23535811|NCT00304070|65693566|FG000|Overall Study|Progressive Disease|3|||
23535812|NCT00304070|65693567|FG001|Overall Study|Progressive Disease|7|||
23535813|NCT00304070|65693568|FG002|Overall Study|Progressive Disease|4|||
23535814|NCT01101841|65693577|FG000|Overall Study|Adverse Event|15|||
23535815|NCT01101841|65693578|FG001|Overall Study|Adverse Event|15|||
23535816|NCT01101841|65693577|FG000|Overall Study|Lost to Follow-up|9|||
23535817|NCT01101841|65693578|FG001|Overall Study|Lost to Follow-up|3|||
23535818|NCT01101841|65693577|FG000|Overall Study|Withdrawal by Subject|21|||
23535819|NCT01101841|65693578|FG001|Overall Study|Withdrawal by Subject|40|||
23535820|NCT01101841|65693577|FG000|Overall Study|Protocol Violation|1|||
23535821|NCT01101841|65693578|FG001|Overall Study|Protocol Violation|1|||
23535822|NCT01101841|65693577|FG000|Overall Study|Physician Decision|0|||
23535823|NCT01101841|65693578|FG001|Overall Study|Physician Decision|2|||
23535824|NCT01101841|65693577|FG000|Overall Study|Lack of Efficacy|0|||
23535825|NCT01101841|65693578|FG001|Overall Study|Lack of Efficacy|2|||
23535826|NCT01101841|65693577|FG000|Overall Study|Other|0|||
23535827|NCT01101841|65693578|FG001|Overall Study|Other|1|||
23535828|NCT01101841|65693577|FG000|Overall Study|Suicidality Tracking Scale|3|||
23535829|NCT01101841|65693578|FG001|Overall Study|Suicidality Tracking Scale|1|||
23535830|NCT01101841|65693577|FG000|Overall Study|Eligibility Criteria|1|||
23535831|NCT01101841|65693578|FG001|Overall Study|Eligibility Criteria|2|||
23535832|NCT03100825|65693579|FG000|Overall Study|Participant/Guardian Decision|7|||
23535833|NCT03100825|65693579|FG000|Overall Study|Physician Decision|1|||
23535834|NCT00428610|65693580|FG000|Overall Study|Death Due to Adverse Event|3|||
23535835|NCT00428610|65693581|FG001|Overall Study|Death Due to Adverse Event|0|||
23535836|NCT00428610|65693582|FG002|Overall Study|Death Due to Adverse Event|5|||
23535837|NCT00428610|65693580|FG000|Overall Study|Death Due to Progressive Disease|0|||
23535838|NCT00428610|65693581|FG001|Overall Study|Death Due to Progressive Disease|0|||
23535839|NCT00428610|65693582|FG002|Overall Study|Death Due to Progressive Disease|2|||
23535840|NCT00428610|65693580|FG000|Overall Study|Adverse Event|2|||
23535841|NCT00428610|65693581|FG001|Overall Study|Adverse Event|3|||
23535842|NCT00428610|65693582|FG002|Overall Study|Adverse Event|2|||
23535843|NCT00428610|65693580|FG000|Overall Study|Investigator Decision|2|||
23535844|NCT00428610|65693581|FG001|Overall Study|Investigator Decision|1|||
23535845|NCT00428610|65693582|FG002|Overall Study|Investigator Decision|1|||
23535846|NCT00428610|65693580|FG000|Overall Study|Progressive Disease|42|||
23535847|NCT00428610|65693581|FG001|Overall Study|Progressive Disease|14|||
23535848|NCT00428610|65693582|FG002|Overall Study|Progressive Disease|22|||
23535849|NCT00428610|65693580|FG000|Overall Study|Withdrawal by Subject|4|||
23535850|NCT00428610|65693581|FG001|Overall Study|Withdrawal by Subject|0|||
23535851|NCT00428610|65693582|FG002|Overall Study|Withdrawal by Subject|0|||
23535852|NCT03662750|65693583|FG000|Overall Study|Withdrawal by Subject|1|||
23535853|NCT04442737|65693586|FG000|Overall Study|Lost to Follow-up|1|||
23535854|NCT04442737|65693587|FG001|Overall Study|Lost to Follow-up|3|||
23535855|NCT04442737|65693586|FG000|Overall Study|Withdrawal by Subject|3|||
23535856|NCT04442737|65693587|FG001|Overall Study|Withdrawal by Subject|2|||
23535857|NCT04442737|65693586|FG000|Overall Study|Adverse Event|3|||
23535858|NCT04442737|65693587|FG001|Overall Study|Adverse Event|2|||
23535859|NCT04442737|65693586|FG000|Overall Study|Death|0|||
23616027|NCT02068352|65979600|FG001|Overall Study|Adverse Event|2|||
23535860|NCT04442737|65693587|FG001|Overall Study|Death|1|||
23535861|NCT04442737|65693586|FG000|Overall Study|Protocol Violation|0|||
23535862|NCT04442737|65693587|FG001|Overall Study|Protocol Violation|2|||
23535863|NCT04442737|65693586|FG000|Overall Study|Other|1|||
23535864|NCT04442737|65693587|FG001|Overall Study|Other|1|||
23535865|NCT02337829|65693588|FG000|Overall Study|Death|0|||
23535866|NCT02337829|65693589|FG001|Overall Study|Death|1|||
23535867|NCT02337829|65693590|FG002|Overall Study|Death|0|||
23535868|NCT02337829|65693591|FG003|Overall Study|Death|0|||
23535869|NCT02337829|65693588|FG000|Overall Study|Study terminated by sponsor|12|||
23616028|NCT02068352|65979601|FG002|Overall Study|Adverse Event|7|||
23535870|NCT02337829|65693589|FG001|Overall Study|Study terminated by sponsor|10|||
23535871|NCT02337829|65693590|FG002|Overall Study|Study terminated by sponsor|5|||
23535872|NCT02337829|65693591|FG003|Overall Study|Study terminated by sponsor|6|||
23535873|NCT02337829|65693588|FG000|Overall Study|discontinued for other reasons|6|||
23535874|NCT02337829|65693589|FG001|Overall Study|discontinued for other reasons|3|||
23535875|NCT02337829|65693590|FG002|Overall Study|discontinued for other reasons|1|||
23535876|NCT02337829|65693591|FG003|Overall Study|discontinued for other reasons|4|||
23535877|NCT00120042|65693594|FG000|Overall Study|all completed protocl|0|||
23535878|NCT00120042|65693595|FG001|Overall Study|all completed protocl|0|||
23535879|NCT00120042|65693596|FG002|Overall Study|all completed protocl|0|||
23535880|NCT02566759|65693597|FG000|All Parts|Withdrawal by Subject|0|||
23535881|NCT02566759|65693598|FG001|All Parts|Withdrawal by Subject|1|||
23535882|NCT02566759|65693599|FG002|All Parts|Withdrawal by Subject|0|||
23535883|NCT02566759|65693600|FG003|All Parts|Withdrawal by Subject|0|||
23535884|NCT02566759|65693601|FG004|All Parts|Withdrawal by Subject|0|||
23535885|NCT02566759|65693602|FG005|All Parts|Withdrawal by Subject|0|||
23535886|NCT02566759|65693603|FG006|All Parts|Withdrawal by Subject|0|||
23535887|NCT02566759|65693604|FG007|All Parts|Withdrawal by Subject|0|||
23535888|NCT02566759|65693605|FG008|All Parts|Withdrawal by Subject|0|||
23535889|NCT02566759|65693606|FG009|All Parts|Withdrawal by Subject|0|||
23535890|NCT02566759|65693607|FG010|All Parts|Withdrawal by Subject|0|||
23535891|NCT02566759|65693608|FG011|All Parts|Withdrawal by Subject|0|||
23535892|NCT02566759|65693609|FG012|All Parts|Withdrawal by Subject|0|||
23535893|NCT02566759|65693610|FG013|All Parts|Withdrawal by Subject|0|||
23535894|NCT02566759|65693611|FG014|All Parts|Withdrawal by Subject|0|||
23535895|NCT02566759|65693612|FG015|All Parts|Withdrawal by Subject|0|||
23535896|NCT02566759|65693613|FG016|All Parts|Withdrawal by Subject|0|||
23535897|NCT02566759|65693597|FG000|All Parts|Adverse Event|0|||
23535898|NCT02566759|65693598|FG001|All Parts|Adverse Event|0|||
23535899|NCT02566759|65693599|FG002|All Parts|Adverse Event|0|||
23535900|NCT02566759|65693600|FG003|All Parts|Adverse Event|0|||
23535901|NCT02566759|65693601|FG004|All Parts|Adverse Event|0|||
23535902|NCT02566759|65693602|FG005|All Parts|Adverse Event|0|||
23535903|NCT02566759|65693603|FG006|All Parts|Adverse Event|0|||
23535904|NCT02566759|65693604|FG007|All Parts|Adverse Event|0|||
23535905|NCT02566759|65693605|FG008|All Parts|Adverse Event|0|||
23535906|NCT02566759|65693606|FG009|All Parts|Adverse Event|0|||
23535907|NCT02566759|65693607|FG010|All Parts|Adverse Event|0|||
23535908|NCT02566759|65693608|FG011|All Parts|Adverse Event|0|||
23535909|NCT02566759|65693609|FG012|All Parts|Adverse Event|1|||
23535910|NCT02566759|65693610|FG013|All Parts|Adverse Event|3|||
23535911|NCT02566759|65693611|FG014|All Parts|Adverse Event|0|||
23535912|NCT02566759|65693612|FG015|All Parts|Adverse Event|0|||
23535913|NCT02566759|65693613|FG016|All Parts|Adverse Event|0|||
23535914|NCT02566759|65693597|FG000|All Parts|Other|0|||
23535915|NCT02566759|65693598|FG001|All Parts|Other|0|||
23535916|NCT02566759|65693599|FG002|All Parts|Other|0|||
23535917|NCT02566759|65693600|FG003|All Parts|Other|0|||
23535918|NCT02566759|65693601|FG004|All Parts|Other|0|||
23535919|NCT02566759|65693602|FG005|All Parts|Other|0|||
23535920|NCT02566759|65693603|FG006|All Parts|Other|0|||
23535921|NCT02566759|65693604|FG007|All Parts|Other|0|||
23535922|NCT02566759|65693605|FG008|All Parts|Other|0|||
23535923|NCT02566759|65693606|FG009|All Parts|Other|0|||
23535924|NCT02566759|65693607|FG010|All Parts|Other|0|||
23535925|NCT02566759|65693608|FG011|All Parts|Other|0|||
23535926|NCT02566759|65693609|FG012|All Parts|Other|0|||
23535927|NCT02566759|65693610|FG013|All Parts|Other|2|||
23535928|NCT02566759|65693611|FG014|All Parts|Other|0|||
23535929|NCT02566759|65693612|FG015|All Parts|Other|0|||
23535930|NCT02566759|65693613|FG016|All Parts|Other|0|||
23535931|NCT02566759|65693597|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535932|NCT02566759|65693598|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535933|NCT02566759|65693599|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535934|NCT02566759|65693600|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535935|NCT02566759|65693601|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535936|NCT02566759|65693602|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535937|NCT02566759|65693603|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535938|NCT02566759|65693604|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535939|NCT02566759|65693605|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535940|NCT02566759|65693606|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535941|NCT02566759|65693607|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23208924|NCT00280150|64501125|FG000|Overall Study|Lack of Efficacy|0|||
23535942|NCT02566759|65693608|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535943|NCT02566759|65693609|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535944|NCT02566759|65693610|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535945|NCT02566759|65693611|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535946|NCT02566759|65693612|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
23535947|NCT02566759|65693613|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
23535948|NCT02984020|65693621|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
23535949|NCT02984020|65693621|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
23535950|NCT02984020|65693621|FG000|Overall Study|Other significant protocol violation|2|||
23535951|NCT04327934|65693624|FG000|Overall Study|Did not qualify|7|||
23535952|NCT04327934|65693625|FG001|Overall Study|Did not qualify|4|||
23535953|NCT04327934|65693624|FG000|Overall Study|Physician Decision|0|||
23535954|NCT04327934|65693625|FG001|Overall Study|Physician Decision|1|||
23535955|NCT01565993|65693630|FG000|Overall Study|Physician Decision|0|||
23535956|NCT01565993|65693631|FG001|Overall Study|Physician Decision|3|||
23535957|NCT02473445|65693632|FG000|Overall Study|Withdrawal by Subject|2|||
23535958|NCT02473445|65693632|FG000|Overall Study|Sponsor Decision|20|||
23535959|NCT01083433|65693634|FG000|Overall Study|Lost to Follow-up|2|||
23535960|NCT01083433|65693635|FG001|Overall Study|Lost to Follow-up|1|||
23535961|NCT01083433|65693636|FG002|Overall Study|Lost to Follow-up|1|||
23535962|NCT01083433|65693634|FG000|Overall Study|Withdrawal by Subject|0|||
23535963|NCT01083433|65693635|FG001|Overall Study|Withdrawal by Subject|5|||
23535964|NCT01083433|65693636|FG002|Overall Study|Withdrawal by Subject|3|||
23535965|NCT01083433|65693634|FG000|Overall Study|Pregnancy|0|||
23535966|NCT01083433|65693635|FG001|Overall Study|Pregnancy|0|||
23535967|NCT01083433|65693636|FG002|Overall Study|Pregnancy|1|||
23535968|NCT04369469|65693637|FG000|Overall Study|Lost to Follow-up|2|||
23535969|NCT04369469|65693638|FG001|Overall Study|Lost to Follow-up|4|||
23535970|NCT04369469|65693637|FG000|Overall Study|Physician Decision|2|||
23535971|NCT04369469|65693638|FG001|Overall Study|Physician Decision|1|||
23535972|NCT04369469|65693637|FG000|Overall Study|Withdrawal by Subject|2|||
23535973|NCT04369469|65693638|FG001|Overall Study|Withdrawal by Subject|3|||
23535974|NCT04369469|65693637|FG000|Overall Study|Adverse Event|1|||
23535975|NCT04369469|65693638|FG001|Overall Study|Adverse Event|0|||
23535976|NCT04369469|65693637|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
23535977|NCT04369469|65693638|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
23535978|NCT04369469|65693637|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
23535979|NCT04369469|65693638|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
23535980|NCT04369469|65693637|FG000|Overall Study|Unable to Provide Consent|0|||
23535981|NCT04369469|65693638|FG001|Overall Study|Unable to Provide Consent|1|||
23535982|NCT03459196|65693642|FG000|Overall Study|Subject didn't receive study catheter|2|||
23535983|NCT03495908|65693643|FG000|Overall Study|Withdrawal by Subject|3|||
23535984|NCT03495908|65693644|FG001|Overall Study|Withdrawal by Subject|1|||
23535985|NCT03495908|65693643|FG000|Overall Study|Lost to Follow-up|1|||
23535986|NCT03495908|65693644|FG001|Overall Study|Lost to Follow-up|4|||
23535987|NCT03495908|65693643|FG000|Overall Study|Adverse Event|0|||
23535988|NCT03495908|65693644|FG001|Overall Study|Adverse Event|2|||
23535989|NCT03495908|65693643|FG000|Overall Study|Death|1|||
23535990|NCT03495908|65693644|FG001|Overall Study|Death|0|||
23535991|NCT03495908|65693643|FG000|Overall Study|Physician Decision|5|||
23535992|NCT03495908|65693644|FG001|Overall Study|Physician Decision|4|||
23535993|NCT03495908|65693643|FG000|Overall Study|No documented reason|0|||
23535994|NCT03495908|65693644|FG001|Overall Study|No documented reason|2|||
23535995|NCT01110915|65693645|FG000|Overall Study|Death|2|||
23535996|NCT01110915|65693646|FG001|Overall Study|Death|1|||
23535997|NCT01110915|65693645|FG000|Overall Study|Lost to Follow-up|1|||
23535998|NCT01110915|65693646|FG001|Overall Study|Lost to Follow-up|0|||
23535999|NCT01110915|65693645|FG000|Overall Study|Withdrawal by Subject|7|||
23536000|NCT01110915|65693646|FG001|Overall Study|Withdrawal by Subject|1|||
23536001|NCT02838420|65693651|FG000|Overall Study|Ongoing in Study|113|||
23536002|NCT02838420|65693652|FG001|Overall Study|Ongoing in Study|45|||
23536003|NCT02838420|65693651|FG000|Overall Study|Lost to Follow-up|1|||
23536004|NCT02838420|65693652|FG001|Overall Study|Lost to Follow-up|0|||
23536005|NCT02838420|65693651|FG000|Overall Study|Withdrawal by Subject|3|||
23536006|NCT02838420|65693652|FG001|Overall Study|Withdrawal by Subject|4|||
23536007|NCT02838420|65693651|FG000|Overall Study|Death|8|||
23536008|NCT02838420|65693652|FG001|Overall Study|Death|13|||
23536009|NCT00061048|65693653|FG000|Overall Study|Adverse Event|2|||
23536010|NCT00061048|65693653|FG000|Overall Study|disease progression|20|||
23208925|NCT00280150|64501126|FG001|Overall Study|Lack of Efficacy|0|||
23208926|NCT00280150|64501127|FG002|Overall Study|Lack of Efficacy|0|||
23536011|NCT01752933|65693654|FG000|Treatment|Disease Progression|3|||
23536012|NCT01752933|65693655|FG001|Treatment|Disease Progression|29|||
23536013|NCT01752933|65693654|FG000|Treatment|Withdrawal by Subject|0|||
23536014|NCT01752933|65693655|FG001|Treatment|Withdrawal by Subject|5|||
23536015|NCT01752933|65693654|FG000|Treatment|Adverse Event|1|||
23536016|NCT01752933|65693655|FG001|Treatment|Adverse Event|4|||
23536017|NCT01752933|65693654|FG000|Treatment|Physician Decision|0|||
23536018|NCT01752933|65693655|FG001|Treatment|Physician Decision|3|||
23536019|NCT01752933|65693654|FG000|Treatment|Death|0|||
23536020|NCT01752933|65693655|FG001|Treatment|Death|2|||
23536021|NCT01752933|65693654|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
23536022|NCT01752933|65693655|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
23536023|NCT01752933|65693654|FG000|Treatment|Patient noncompliant|0|||
23423351|NCT00098722|65292640|FG004|Double Blind Phase|Other|0|||
23423352|NCT00098722|65292641|FG005|Double Blind Phase|Other|0|||
23208927|NCT00280150|64501128|FG003|Overall Study|Lack of Efficacy|3|||
23423353|NCT00098722|65292642|FG006|Double Blind Phase|Other|0|||
23423354|NCT00098722|65292636|FG000|Open Label Phase|Adverse Event|0|||
23423355|NCT00098722|65292637|FG001|Open Label Phase|Adverse Event|0|||
23423356|NCT00098722|65292638|FG002|Open Label Phase|Adverse Event|0|||
23423357|NCT00098722|65292639|FG003|Open Label Phase|Adverse Event|5|||
23423358|NCT00098722|65292640|FG004|Open Label Phase|Adverse Event|0|||
23536024|NCT01752933|65693655|FG001|Treatment|Patient noncompliant|1|||
23536025|NCT01752933|65693654|FG000|Treatment|Patient unable to travel to appointments|0|||
23536026|NCT01752933|65693655|FG001|Treatment|Patient unable to travel to appointments|1|||
23536027|NCT01752933|65693654|FG000|Overall Study and Follow-up|Death|4|||
23536028|NCT01752933|65693655|FG001|Overall Study and Follow-up|Death|34|||
23536029|NCT01752933|65693654|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
23536030|NCT01752933|65693655|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
23536031|NCT01752933|65693654|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
23423359|NCT00098722|65292641|FG005|Open Label Phase|Adverse Event|0|||
23536032|NCT01752933|65693655|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
23536033|NCT01752933|65693654|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
23536034|NCT01752933|65693655|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
23536035|NCT01581593|65693657|FG000|Overall Study|Withdrawal by Subject|1|||
23536036|NCT01302964|65693658|FG000|Overall Study|Adverse Event|1|||
23536037|NCT01302964|65693659|FG001|Overall Study|Adverse Event|0|||
23536038|NCT01850004|65693660|FG000|Overall Study|Poor/Non-compliance|1|||
23536039|NCT01850004|65693660|FG000|Overall Study|Participant Withdrew Consent|9|||
23536040|NCT01850004|65693660|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
23536041|NCT01850004|65693660|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
23536042|NCT01850004|65693660|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
23536043|NCT01850004|65693660|FG000|Overall Study|Other Reasons|2|||
23536044|NCT01850004|65693660|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
23536045|NCT01850004|65693660|FG000|Overall Study|Maximum Clinical Benefit|4|||
23536046|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Adverse Event|3|||
23536047|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Adverse Event|2|||
23536048|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Adverse Event|0|||
23536049|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Adverse Event|0|||
23536050|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Adverse Event|0|||
23536051|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Adverse Event|0|||
23536052|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Adverse Event|0|||
23536053|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
23536054|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
23536055|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23536056|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23536057|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23536058|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23423360|NCT00098722|65292642|FG006|Open Label Phase|Adverse Event|0|||
23423361|NCT00098722|65292636|FG000|Open Label Phase|Death|0|||
23423362|NCT00098722|65292637|FG001|Open Label Phase|Death|0|||
23423363|NCT00098722|65292638|FG002|Open Label Phase|Death|0|||
23423364|NCT00098722|65292639|FG003|Open Label Phase|Death|2|||
23423365|NCT00098722|65292640|FG004|Open Label Phase|Death|0|||
23423366|NCT00098722|65292641|FG005|Open Label Phase|Death|0|||
23423367|NCT00098722|65292642|FG006|Open Label Phase|Death|0|||
23423368|NCT00098722|65292636|FG000|Open Label Phase|Lack of Efficacy|0|||
23423369|NCT00098722|65292637|FG001|Open Label Phase|Lack of Efficacy|0|||
23423370|NCT00098722|65292638|FG002|Open Label Phase|Lack of Efficacy|0|||
23423371|NCT00098722|65292639|FG003|Open Label Phase|Lack of Efficacy|8|||
23423372|NCT00098722|65292640|FG004|Open Label Phase|Lack of Efficacy|0|||
23423373|NCT00098722|65292641|FG005|Open Label Phase|Lack of Efficacy|0|||
23423374|NCT00098722|65292642|FG006|Open Label Phase|Lack of Efficacy|0|||
23423375|NCT00098722|65292636|FG000|Open Label Phase|Pregnancy|0|||
23423376|NCT00098722|65292637|FG001|Open Label Phase|Pregnancy|0|||
23423377|NCT00098722|65292638|FG002|Open Label Phase|Pregnancy|0|||
23423378|NCT00098722|65292639|FG003|Open Label Phase|Pregnancy|1|||
23423379|NCT00098722|65292640|FG004|Open Label Phase|Pregnancy|0|||
23423380|NCT00098722|65292641|FG005|Open Label Phase|Pregnancy|0|||
23423381|NCT00098722|65292642|FG006|Open Label Phase|Pregnancy|0|||
23423382|NCT00098722|65292636|FG000|Open Label Phase|Participant defaulted|0|||
23423383|NCT00098722|65292637|FG001|Open Label Phase|Participant defaulted|0|||
23423384|NCT00098722|65292638|FG002|Open Label Phase|Participant defaulted|0|||
23423385|NCT00098722|65292639|FG003|Open Label Phase|Participant defaulted|18|||
23423386|NCT00098722|65292640|FG004|Open Label Phase|Participant defaulted|0|||
23423387|NCT00098722|65292641|FG005|Open Label Phase|Participant defaulted|0|||
23423388|NCT00098722|65292642|FG006|Open Label Phase|Participant defaulted|0|||
23423389|NCT00098722|65292636|FG000|Open Label Phase|Ongoing at cut-off date|0|||
23423390|NCT00098722|65292637|FG001|Open Label Phase|Ongoing at cut-off date|0|||
23423391|NCT00098722|65292638|FG002|Open Label Phase|Ongoing at cut-off date|0|||
23423392|NCT00098722|65292639|FG003|Open Label Phase|Ongoing at cut-off date|220|||
23423393|NCT00098722|65292640|FG004|Open Label Phase|Ongoing at cut-off date|50|||
23423394|NCT00098722|65292641|FG005|Open Label Phase|Ongoing at cut-off date|0|||
23423395|NCT00098722|65292642|FG006|Open Label Phase|Ongoing at cut-off date|0|||
23423396|NCT00098722|65292636|FG000|Open Label Phase|Other|0|||
23423397|NCT00098722|65292637|FG001|Open Label Phase|Other|0|||
23423398|NCT00098722|65292638|FG002|Open Label Phase|Other|0|||
23423399|NCT00098722|65292639|FG003|Open Label Phase|Other|18|||
23423400|NCT00098722|65292640|FG004|Open Label Phase|Other|0|||
23423401|NCT00098722|65292641|FG005|Open Label Phase|Other|0|||
23423402|NCT00098722|65292642|FG006|Open Label Phase|Other|0|||
23423403|NCT00098722|65292636|FG000|Observation Phase|Death|0|||
23423404|NCT00098722|65292637|FG001|Observation Phase|Death|0|||
23423405|NCT00098722|65292638|FG002|Observation Phase|Death|0|||
23423406|NCT00098722|65292639|FG003|Observation Phase|Death|0|||
23423407|NCT00098722|65292640|FG004|Observation Phase|Death|0|||
23208928|NCT00280150|64501125|FG000|Overall Study|Physician Decision|0|||
23423408|NCT00098722|65292641|FG005|Observation Phase|Death|5|||
23536059|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
23536060|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Physician Decision|1|||
23536061|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Physician Decision|0|||
23536062|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Physician Decision|0|||
23536063|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Physician Decision|0|||
23536064|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Physician Decision|0|||
23536065|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Physician Decision|0|||
23536066|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Physician Decision|0|||
23536067|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
23536068|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
23536069|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23536070|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23423409|NCT00098722|65292642|FG006|Observation Phase|Death|3|||
23423410|NCT00098722|65292636|FG000|Observation Phase|Lack of Efficacy|0|||
23423411|NCT00098722|65292637|FG001|Observation Phase|Lack of Efficacy|0|||
23423412|NCT00098722|65292638|FG002|Observation Phase|Lack of Efficacy|0|||
23423413|NCT00098722|65292639|FG003|Observation Phase|Lack of Efficacy|0|||
23423414|NCT00098722|65292640|FG004|Observation Phase|Lack of Efficacy|0|||
23423415|NCT00098722|65292641|FG005|Observation Phase|Lack of Efficacy|2|||
23208929|NCT00280150|64501126|FG001|Overall Study|Physician Decision|0|||
23423416|NCT00098722|65292642|FG006|Observation Phase|Lack of Efficacy|0|||
23536071|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23536072|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23536073|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
23536074|NCT02265705|65693661|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536075|NCT02265705|65693662|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
23536076|NCT02265705|65693663|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
23423417|NCT00098722|65292636|FG000|Observation Phase|Participant defaulted|0|||
23423418|NCT00098722|65292637|FG001|Observation Phase|Participant defaulted|0|||
23423419|NCT00098722|65292638|FG002|Observation Phase|Participant defaulted|0|||
23423420|NCT00098722|65292639|FG003|Observation Phase|Participant defaulted|0|||
23423421|NCT00098722|65292640|FG004|Observation Phase|Participant defaulted|0|||
23423422|NCT00098722|65292641|FG005|Observation Phase|Participant defaulted|17|||
23423423|NCT00098722|65292642|FG006|Observation Phase|Participant defaulted|4|||
23423424|NCT00098722|65292636|FG000|Observation Phase|Other|0|||
23423425|NCT00098722|65292637|FG001|Observation Phase|Other|0|||
23423426|NCT00098722|65292638|FG002|Observation Phase|Other|0|||
23423427|NCT00098722|65292639|FG003|Observation Phase|Other|0|||
23423428|NCT00098722|65292640|FG004|Observation Phase|Other|0|||
23423429|NCT00098722|65292641|FG005|Observation Phase|Other|21|||
23423430|NCT00098722|65292642|FG006|Observation Phase|Other|10|||
23423431|NCT02435680|65292645|FG000|Overall Study|Physician Decision|3|||
23423432|NCT02435680|65292646|FG001|Overall Study|Physician Decision|0|||
23423433|NCT02435680|65292647|FG002|Overall Study|Physician Decision|0|||
23423434|NCT02435680|65292645|FG000|Overall Study|subject / guardian decision|0|||
23423435|NCT02435680|65292646|FG001|Overall Study|subject / guardian decision|3|||
23423436|NCT02435680|65292647|FG002|Overall Study|subject / guardian decision|2|||
23423437|NCT02435680|65292645|FG000|Overall Study|Adverse Event|8|||
23423438|NCT02435680|65292646|FG001|Overall Study|Adverse Event|3|||
23423439|NCT02435680|65292647|FG002|Overall Study|Adverse Event|2|||
23536077|NCT02265705|65693664|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536078|NCT02265705|65693665|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536079|NCT02265705|65693666|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536080|NCT02265705|65693667|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
23536081|NCT02265705|65693661|FG000|Rescue Period|Withdrawal by Subject|0|||
23536082|NCT02265705|65693662|FG001|Rescue Period|Withdrawal by Subject|0|||
23536083|NCT02265705|65693663|FG002|Rescue Period|Withdrawal by Subject|1|||
23536084|NCT02265705|65693664|FG003|Rescue Period|Withdrawal by Subject|0|||
23536085|NCT02265705|65693665|FG004|Rescue Period|Withdrawal by Subject|0|||
23536086|NCT02265705|65693666|FG005|Rescue Period|Withdrawal by Subject|0|||
23536087|NCT02265705|65693667|FG006|Rescue Period|Withdrawal by Subject|0|||
23536088|NCT02265705|65693661|FG000|Rescue Period|Death|0|||
23536089|NCT02265705|65693662|FG001|Rescue Period|Death|0|||
23536090|NCT02265705|65693663|FG002|Rescue Period|Death|1|||
23536091|NCT02265705|65693664|FG003|Rescue Period|Death|0|||
23536092|NCT02265705|65693665|FG004|Rescue Period|Death|0|||
23536093|NCT02265705|65693666|FG005|Rescue Period|Death|0|||
23536094|NCT02265705|65693667|FG006|Rescue Period|Death|0|||
23536095|NCT02265705|65693661|FG000|Rescue Period|Lack of Efficacy|0|||
23536096|NCT02265705|65693662|FG001|Rescue Period|Lack of Efficacy|0|||
23536097|NCT02265705|65693663|FG002|Rescue Period|Lack of Efficacy|1|||
23536098|NCT02265705|65693664|FG003|Rescue Period|Lack of Efficacy|0|||
23536099|NCT02265705|65693665|FG004|Rescue Period|Lack of Efficacy|0|||
23536100|NCT02265705|65693666|FG005|Rescue Period|Lack of Efficacy|0|||
23536101|NCT02265705|65693667|FG006|Rescue Period|Lack of Efficacy|0|||
23536102|NCT02265705|65693661|FG000|Open Label Period|Adverse Event|0|||
23536103|NCT02265705|65693662|FG001|Open Label Period|Adverse Event|0|||
23536104|NCT02265705|65693663|FG002|Open Label Period|Adverse Event|0|||
23536105|NCT02265705|65693664|FG003|Open Label Period|Adverse Event|2|||
23536106|NCT02265705|65693665|FG004|Open Label Period|Adverse Event|2|||
23536107|NCT02265705|65693666|FG005|Open Label Period|Adverse Event|0|||
23536108|NCT02265705|65693667|FG006|Open Label Period|Adverse Event|0|||
23536109|NCT02265705|65693661|FG000|Open Label Period|Physician Decision|0|||
23536110|NCT02265705|65693662|FG001|Open Label Period|Physician Decision|0|||
23536111|NCT02265705|65693663|FG002|Open Label Period|Physician Decision|0|||
23536112|NCT02265705|65693664|FG003|Open Label Period|Physician Decision|0|||
23536113|NCT02265705|65693665|FG004|Open Label Period|Physician Decision|1|||
23536114|NCT02265705|65693666|FG005|Open Label Period|Physician Decision|0|||
23536115|NCT02265705|65693667|FG006|Open Label Period|Physician Decision|0|||
23536116|NCT02265705|65693661|FG000|Open Label Period|Withdrawal by Subject|0|||
23536117|NCT02265705|65693662|FG001|Open Label Period|Withdrawal by Subject|0|||
23536118|NCT02265705|65693663|FG002|Open Label Period|Withdrawal by Subject|0|||
23423440|NCT02435680|65292645|FG000|Overall Study|progressive disease|10|||
23423441|NCT02435680|65292646|FG001|Overall Study|progressive disease|7|||
23423442|NCT02435680|65292647|FG002|Overall Study|progressive disease|11|||
23423443|NCT02435680|65292645|FG000|Overall Study|not treated|0|||
23536119|NCT02265705|65693664|FG003|Open Label Period|Withdrawal by Subject|0|||
23536120|NCT02265705|65693665|FG004|Open Label Period|Withdrawal by Subject|2|||
23208930|NCT00280150|64501127|FG002|Overall Study|Physician Decision|0|||
23208931|NCT00280150|64501128|FG003|Overall Study|Physician Decision|1|||
23208932|NCT00280150|64501125|FG000|Overall Study|Protocol Violation|0|||
23208933|NCT00280150|64501126|FG001|Overall Study|Protocol Violation|0|||
23208934|NCT00280150|64501127|FG002|Overall Study|Protocol Violation|0|||
23208935|NCT00280150|64501128|FG003|Overall Study|Protocol Violation|1|||
23208936|NCT00280150|64501125|FG000|Overall Study|Withdrawal by Subject|0|||
23208937|NCT00280150|64501126|FG001|Overall Study|Withdrawal by Subject|0|||
23208938|NCT00280150|64501127|FG002|Overall Study|Withdrawal by Subject|0|||
23208939|NCT00280150|64501128|FG003|Overall Study|Withdrawal by Subject|1|||
23208940|NCT00280150|64501125|FG000|Overall Study|Did not get consolidation therapy|3|||
23208941|NCT00280150|64501126|FG001|Overall Study|Did not get consolidation therapy|0|||
23208942|NCT00280150|64501127|FG002|Overall Study|Did not get consolidation therapy|3|||
23208943|NCT00280150|64501128|FG003|Overall Study|Did not get consolidation therapy|0|||
23208944|NCT00280150|64501125|FG000|Overall Study|Declining Performance Status|0|||
23536121|NCT02265705|65693666|FG005|Open Label Period|Withdrawal by Subject|0|||
23536122|NCT02265705|65693667|FG006|Open Label Period|Withdrawal by Subject|0|||
23536123|NCT02265705|65693661|FG000|Follow-up Period|Sponsor Decision|0|||
23536124|NCT02265705|65693662|FG001|Follow-up Period|Sponsor Decision|0|||
23536125|NCT02265705|65693663|FG002|Follow-up Period|Sponsor Decision|0|||
23536126|NCT02265705|65693664|FG003|Follow-up Period|Sponsor Decision|0|||
23536127|NCT02265705|65693665|FG004|Follow-up Period|Sponsor Decision|0|||
23536128|NCT02265705|65693666|FG005|Follow-up Period|Sponsor Decision|1|||
23536129|NCT02265705|65693667|FG006|Follow-up Period|Sponsor Decision|6|||
23536130|NCT02265705|65693661|FG000|Follow-up Period|Adverse Event|0|||
23536131|NCT02265705|65693662|FG001|Follow-up Period|Adverse Event|0|||
23536132|NCT02265705|65693663|FG002|Follow-up Period|Adverse Event|0|||
23536133|NCT02265705|65693664|FG003|Follow-up Period|Adverse Event|0|||
23536134|NCT02265705|65693665|FG004|Follow-up Period|Adverse Event|0|||
23536135|NCT02265705|65693666|FG005|Follow-up Period|Adverse Event|0|||
23536136|NCT02265705|65693667|FG006|Follow-up Period|Adverse Event|3|||
23536137|NCT02265705|65693661|FG000|Follow-up Period|Physician Decision|0|||
23536138|NCT02265705|65693662|FG001|Follow-up Period|Physician Decision|0|||
23536139|NCT02265705|65693663|FG002|Follow-up Period|Physician Decision|0|||
23536140|NCT02265705|65693664|FG003|Follow-up Period|Physician Decision|0|||
23536141|NCT02265705|65693665|FG004|Follow-up Period|Physician Decision|0|||
23536142|NCT02265705|65693666|FG005|Follow-up Period|Physician Decision|0|||
23536143|NCT02265705|65693667|FG006|Follow-up Period|Physician Decision|1|||
23536144|NCT02265705|65693661|FG000|Follow-up Period|Withdrawal by Subject|0|||
23536145|NCT02265705|65693662|FG001|Follow-up Period|Withdrawal by Subject|0|||
23536146|NCT02265705|65693663|FG002|Follow-up Period|Withdrawal by Subject|0|||
23536147|NCT02265705|65693664|FG003|Follow-up Period|Withdrawal by Subject|0|||
23536148|NCT02265705|65693665|FG004|Follow-up Period|Withdrawal by Subject|0|||
23536149|NCT02265705|65693666|FG005|Follow-up Period|Withdrawal by Subject|0|||
23536150|NCT02265705|65693667|FG006|Follow-up Period|Withdrawal by Subject|1|||
23536151|NCT01599650|65693668|FG000|Overall Study|Administrative issue|1|||
23616029|NCT02068352|65979599|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
23536152|NCT01599650|65693669|FG001|Overall Study|Administrative issue|0|||
23536153|NCT01599650|65693670|FG002|Overall Study|Administrative issue|1|||
23536154|NCT01599650|65693668|FG000|Overall Study|Physician Decision|2|||
23536155|NCT01599650|65693669|FG001|Overall Study|Physician Decision|0|||
23536156|NCT01599650|65693670|FG002|Overall Study|Physician Decision|7|||
23536157|NCT01599650|65693668|FG000|Overall Study|Protocol Violation|0|||
23536158|NCT01599650|65693669|FG001|Overall Study|Protocol Violation|3|||
23208945|NCT00280150|64501126|FG001|Overall Study|Declining Performance Status|0|||
23536159|NCT01599650|65693670|FG002|Overall Study|Protocol Violation|0|||
23536160|NCT01599650|65693668|FG000|Overall Study|Death|2|||
23536161|NCT01599650|65693669|FG001|Overall Study|Death|1|||
23536162|NCT01599650|65693670|FG002|Overall Study|Death|2|||
23536163|NCT01599650|65693668|FG000|Overall Study|Lost to Follow-up|3|||
23536164|NCT01599650|65693669|FG001|Overall Study|Lost to Follow-up|3|||
23536165|NCT01599650|65693670|FG002|Overall Study|Lost to Follow-up|3|||
23536166|NCT01599650|65693668|FG000|Overall Study|Withdrawal by Subject|11|||
23536167|NCT01599650|65693669|FG001|Overall Study|Withdrawal by Subject|11|||
23536168|NCT01599650|65693670|FG002|Overall Study|Withdrawal by Subject|10|||
23536169|NCT01599650|65693668|FG000|Overall Study|Adverse Event|3|||
23536170|NCT01599650|65693669|FG001|Overall Study|Adverse Event|8|||
23536171|NCT01599650|65693670|FG002|Overall Study|Adverse Event|4|||
23536172|NCT04496258|65697411|FG000|Overall Study|Withdrawal by Subject|2|||
23536173|NCT04496258|65697412|FG001|Overall Study|Withdrawal by Subject|1|||
23536174|NCT00162136|65697413|FG000|Overall Study|Adverse Event|1|||
23536175|NCT00162136|65697413|FG000|Overall Study|Death|1|||
23536176|NCT00162136|65697413|FG000|Overall Study|Disease Progression/Relapse|23|||
23536177|NCT00162136|65697413|FG000|Overall Study|Investigator Request|5|||
23536178|NCT00162136|65697413|FG000|Overall Study|Study Drug Toxicity|4|||
23536179|NCT00162136|65697413|FG000|Overall Study|Withdrawal by Subject|1|||
23536180|NCT03003676|65697414|FG000|Overall Study|Lack of Efficacy|5|||
23536181|NCT03003676|65697415|FG001|Overall Study|Lack of Efficacy|7|||
23536182|NCT03003676|65697414|FG000|Overall Study|Withdrawal by Subject|0|||
23536183|NCT03003676|65697415|FG001|Overall Study|Withdrawal by Subject|1|||
23536184|NCT03003676|65697414|FG000|Overall Study|Hepatitis B infection|1|||
23536185|NCT03003676|65697415|FG001|Overall Study|Hepatitis B infection|0|||
23536186|NCT00129259|65697416|FG000|Overall Study|Lost to Follow-up|1|||
23536187|NCT00129259|65697417|FG001|Overall Study|Lost to Follow-up|1|||
23536188|NCT00129259|65697416|FG000|Overall Study|Withdrawal by Subject|2|||
23616030|NCT02068352|65979600|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
23536189|NCT00129259|65697417|FG001|Overall Study|Withdrawal by Subject|1|||
23536190|NCT00129259|65697416|FG000|Overall Study|Only available minimal phone assessments|0|||
23536191|NCT00129259|65697417|FG001|Overall Study|Only available minimal phone assessments|1|||
23536192|NCT01723904|65697420|FG000|Overall Study|Noncompliant|3|||
23536193|NCT01723904|65697420|FG000|Overall Study|Adverse Event|5|||
23536194|NCT01723904|65697420|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
23536195|NCT04640311|65697426|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
23536196|NCT04640311|65697427|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536197|NCT04640311|65697428|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536198|NCT04640311|65697429|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536199|NCT04640311|65697430|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536200|NCT04640311|65697431|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536201|NCT04640311|65697432|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536202|NCT04640311|65697433|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536203|NCT04640311|65697434|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536204|NCT04640311|65697435|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536205|NCT04640311|65697436|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536206|NCT04640311|65697437|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536207|NCT04640311|65697438|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536208|NCT04640311|65697426|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536209|NCT04640311|65697427|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
23536210|NCT04640311|65697428|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536211|NCT04640311|65697429|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536212|NCT04640311|65697430|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536213|NCT04640311|65697431|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536214|NCT04640311|65697432|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536215|NCT04640311|65697433|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536216|NCT04640311|65697434|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536217|NCT04640311|65697435|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536218|NCT04640311|65697436|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536219|NCT04640311|65697437|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536220|NCT04640311|65697438|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
23536221|NCT04640311|65697426|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536222|NCT04640311|65697427|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
23536223|NCT04640311|65697428|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536224|NCT04640311|65697429|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536225|NCT04640311|65697430|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536226|NCT04640311|65697431|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536227|NCT04640311|65697432|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536228|NCT04640311|65697433|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536229|NCT04640311|65697434|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536230|NCT04640311|65697435|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536231|NCT04640311|65697436|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536232|NCT04640311|65697437|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536233|NCT04640311|65697438|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536234|NCT04640311|65697426|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
23536235|NCT04640311|65697427|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
23536236|NCT04640311|65697428|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
23536237|NCT04640311|65697429|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536238|NCT04640311|65697430|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536239|NCT04640311|65697431|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536240|NCT04640311|65697432|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536241|NCT04640311|65697433|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536242|NCT04640311|65697434|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536243|NCT04640311|65697435|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536244|NCT04640311|65697436|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536245|NCT04640311|65697437|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536246|NCT04640311|65697438|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
23536247|NCT04640311|65697426|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536248|NCT04640311|65697427|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536249|NCT04640311|65697428|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
23536250|NCT04640311|65697429|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536251|NCT04640311|65697430|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536252|NCT04640311|65697431|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536253|NCT04640311|65697432|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536254|NCT04640311|65697433|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536255|NCT04640311|65697434|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536256|NCT04640311|65697435|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536257|NCT04640311|65697436|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536258|NCT04640311|65697437|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536259|NCT04640311|65697438|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
23536260|NCT04640311|65697426|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536261|NCT04640311|65697427|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536262|NCT04640311|65697428|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536263|NCT04640311|65697429|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
23536264|NCT04640311|65697430|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536265|NCT04640311|65697431|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536266|NCT04640311|65697432|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
23536267|NCT04640311|65697433|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536268|NCT04640311|65697434|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536269|NCT04640311|65697435|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536270|NCT04640311|65697436|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536271|NCT04640311|65697437|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536272|NCT04640311|65697438|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
23536273|NCT04640311|65697426|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536274|NCT04640311|65697427|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536275|NCT04640311|65697428|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536276|NCT04640311|65697429|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536277|NCT04640311|65697430|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536278|NCT04640311|65697431|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
23536279|NCT04640311|65697432|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536280|NCT04640311|65697433|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536281|NCT04640311|65697434|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
23536282|NCT04640311|65697435|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536283|NCT04640311|65697436|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536284|NCT04640311|65697437|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536285|NCT04640311|65697438|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
23536286|NCT04640311|65697426|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536287|NCT04640311|65697427|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536288|NCT04640311|65697428|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536289|NCT04640311|65697429|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536290|NCT04640311|65697430|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536291|NCT04640311|65697431|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536292|NCT04640311|65697432|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
23536293|NCT04640311|65697433|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536294|NCT04640311|65697434|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536295|NCT04640311|65697435|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536296|NCT04640311|65697436|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
23536297|NCT04640311|65697437|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536298|NCT04640311|65697438|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
23536299|NCT04640311|65697426|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536300|NCT04640311|65697427|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536301|NCT04640311|65697428|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536302|NCT04640311|65697429|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536303|NCT04640311|65697430|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536304|NCT04640311|65697431|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536305|NCT04640311|65697432|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536306|NCT04640311|65697433|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536307|NCT04640311|65697434|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536308|NCT04640311|65697435|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536309|NCT04640311|65697436|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536310|NCT04640311|65697437|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
23536311|NCT04640311|65697438|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
23536312|NCT01416805|65697444|FG000|Overall Study|Lost to Follow-up|4|||
23536313|NCT01416805|65697445|FG001|Overall Study|Lost to Follow-up|4|||
23536314|NCT00211081|65697446|FG000|Overall Study|Withdrawal by Subject|2|||
23536315|NCT01336738|65697447|FG000|Overall Study|Adverse Event|0|||
23536316|NCT01336738|65697448|FG001|Overall Study|Adverse Event|3|||
23536317|NCT01336738|65697449|FG002|Overall Study|Adverse Event|2|||
23536318|NCT01336738|65697450|FG003|Overall Study|Adverse Event|1|||
23536319|NCT01336738|65697451|FG004|Overall Study|Adverse Event|3|||
23536320|NCT01336738|65697447|FG000|Overall Study|Lost to Follow-up|2|||
23536321|NCT01336738|65697448|FG001|Overall Study|Lost to Follow-up|1|||
23536322|NCT01336738|65697449|FG002|Overall Study|Lost to Follow-up|2|||
23536323|NCT01336738|65697450|FG003|Overall Study|Lost to Follow-up|2|||
23536324|NCT01336738|65697451|FG004|Overall Study|Lost to Follow-up|2|||
23536325|NCT01336738|65697447|FG000|Overall Study|Did not meet entrance criteria|0|||
23536326|NCT01336738|65697448|FG001|Overall Study|Did not meet entrance criteria|1|||
23536327|NCT01336738|65697449|FG002|Overall Study|Did not meet entrance criteria|0|||
23536328|NCT01336738|65697450|FG003|Overall Study|Did not meet entrance criteria|0|||
23536329|NCT01336738|65697451|FG004|Overall Study|Did not meet entrance criteria|0|||
23536330|NCT01336738|65697447|FG000|Overall Study|Protocol Violation|0|||
23536331|NCT01336738|65697448|FG001|Overall Study|Protocol Violation|1|||
23536332|NCT01336738|65697449|FG002|Overall Study|Protocol Violation|0|||
23536333|NCT01336738|65697450|FG003|Overall Study|Protocol Violation|0|||
23536334|NCT01336738|65697451|FG004|Overall Study|Protocol Violation|0|||
23536335|NCT01336738|65697447|FG000|Overall Study|Withdrawal by Subject|2|||
23536336|NCT01336738|65697448|FG001|Overall Study|Withdrawal by Subject|0|||
23536337|NCT01336738|65697449|FG002|Overall Study|Withdrawal by Subject|2|||
23536338|NCT01336738|65697450|FG003|Overall Study|Withdrawal by Subject|1|||
23536339|NCT01336738|65697451|FG004|Overall Study|Withdrawal by Subject|1|||
23536340|NCT01336738|65697447|FG000|Overall Study|Other|3|||
23536341|NCT01336738|65697448|FG001|Overall Study|Other|3|||
23536342|NCT01336738|65697449|FG002|Overall Study|Other|2|||
23536343|NCT01336738|65697450|FG003|Overall Study|Other|3|||
23536344|NCT01336738|65697451|FG004|Overall Study|Other|4|||
23536345|NCT02370888|65697452|FG000|Overall Study|disease progression|2|||
23536346|NCT02370888|65697452|FG000|Overall Study|did not meet chimerism criteria|6|||
23536347|NCT05789875|65697458|FG000|Overall Study|Lost to Follow-up|6|||
23536348|NCT00534352|65697462|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
23536349|NCT00534352|65697462|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
23536350|NCT00534352|65697462|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
23536351|NCT00534352|65697462|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
23536352|NCT00534352|65697462|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
23536353|NCT00534352|65697462|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
23536354|NCT03323099|65697463|FG000|Overall Study|Withdrawal by Subject|6|||
23536355|NCT03323099|65697464|FG001|Overall Study|Withdrawal by Subject|12|||
23536356|NCT03323099|65697463|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
23536357|NCT03323099|65697464|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
23536358|NCT01994395|65697468|FG000|Overall Study|Withdrawal by Subject|1|||
23536359|NCT01994395|65697469|FG001|Overall Study|Withdrawal by Subject|2|||
23536360|NCT01802411|65697471|FG000|Overall Study|Death|2|||
23536361|NCT01802411|65697472|FG001|Overall Study|Death|1|||
23536362|NCT01802411|65697471|FG000|Overall Study|Adverse Event|2|||
23536363|NCT01802411|65697472|FG001|Overall Study|Adverse Event|7|||
23536364|NCT01802411|65697471|FG000|Overall Study|Lack of Efficacy|8|||
23536365|NCT01802411|65697472|FG001|Overall Study|Lack of Efficacy|10|||
23536366|NCT01802411|65697471|FG000|Overall Study|Withdrawal by Subject|0|||
23536367|NCT01802411|65697472|FG001|Overall Study|Withdrawal by Subject|2|||
23536368|NCT01802411|65697471|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
23536369|NCT01802411|65697472|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
23536370|NCT01802411|65697471|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
23536371|NCT01802411|65697472|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
23536372|NCT01802411|65697471|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
23536373|NCT01802411|65697472|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
23536374|NCT02720484|65697473|FG000|Treatment on Study|Adverse Event|1|||
23536375|NCT02720484|65697473|FG000|Treatment on Study|Withdrawal by Subject|1|||
23536376|NCT02720484|65697473|FG000|Treatment on Study|Progressive Disease|4|||
23536377|NCT02720484|65697473|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
23536378|NCT02720484|65697473|FG000|Follow Up for 2 Years|Death|3|||
23536379|NCT02720484|65697473|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
23536380|NCT02673697|65697476|FG000|Overall Study|Adverse Event|2|||
23536381|NCT02673697|65697477|FG001|Overall Study|Adverse Event|0|||
23536382|NCT02673697|65697476|FG000|Overall Study|Death|32|||
23536383|NCT02673697|65697477|FG001|Overall Study|Death|24|||
23536384|NCT02673697|65697476|FG000|Overall Study|Lost to Follow-up|5|||
23536385|NCT02673697|65697477|FG001|Overall Study|Lost to Follow-up|2|||
23536386|NCT02673697|65697476|FG000|Overall Study|Physician Decision|2|||
23536387|NCT02673697|65697477|FG001|Overall Study|Physician Decision|1|||
23536388|NCT02673697|65697476|FG000|Overall Study|Withdrawal by Subject|10|||
23536389|NCT02673697|65697477|FG001|Overall Study|Withdrawal by Subject|7|||
23536390|NCT02673697|65697476|FG000|Overall Study|Change subj medical status|1|||
23536391|NCT02673697|65697477|FG001|Overall Study|Change subj medical status|2|||
23536392|NCT02673697|65697476|FG000|Overall Study|Explant|10|||
23536393|NCT02673697|65697477|FG001|Overall Study|Explant|5|||
23536394|NCT02673697|65697476|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
23536395|NCT02673697|65697477|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
23536396|NCT02647359|65697478|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
23536397|NCT02647359|65697479|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
23536398|NCT02647359|65697478|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
23536399|NCT02647359|65697479|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
23536400|NCT02647359|65697478|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
23536401|NCT02647359|65697479|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
23536402|NCT02647359|65697478|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
23536403|NCT02647359|65697479|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
23536404|NCT02647359|65697478|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
23536405|NCT02647359|65697479|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
23536406|NCT02647359|65697478|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
23536407|NCT02647359|65697479|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
23536408|NCT03160703|65697484|FG000|Overall Study|Withdrawal by Subject|0|||
23536409|NCT03160703|65697485|FG001|Overall Study|Withdrawal by Subject|0|||
23536410|NCT03160703|65697486|FG002|Overall Study|Withdrawal by Subject|0|||
23536411|NCT03160703|65697487|FG003|Overall Study|Withdrawal by Subject|1|||
23536412|NCT01826825|65697491|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
23536413|NCT01826825|65697492|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
23536414|NCT00812929|65697493|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
23536415|NCT00812929|65697494|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
23536416|NCT00812929|65697495|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
23536417|NCT00812929|65697496|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
23536418|NCT00812929|65697497|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
23536419|NCT00812929|65697498|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
23536420|NCT00812929|65697499|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
23536421|NCT00812929|65697500|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
23536422|NCT00812929|65697501|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
23536423|NCT00812929|65697502|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
23536424|NCT00812929|65697493|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
23536425|NCT00812929|65697494|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
23536426|NCT00812929|65697495|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
23536427|NCT00812929|65697496|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
23536428|NCT00812929|65697497|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
23536429|NCT00812929|65697498|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
23536430|NCT00812929|65697499|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
23536431|NCT00812929|65697500|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
23536432|NCT00812929|65697501|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
23536433|NCT00812929|65697502|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
23536434|NCT00812929|65697493|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
23536435|NCT00812929|65697494|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
23536436|NCT00812929|65697495|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
23536437|NCT00812929|65697496|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
23536438|NCT00812929|65697497|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
23536439|NCT00812929|65697498|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
23536440|NCT00812929|65697499|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
23536441|NCT00812929|65697500|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
23536442|NCT00812929|65697501|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
23536443|NCT00812929|65697502|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
23536444|NCT03003520|65697509|FG000|Overall Study|Adverse Event|9|||
23536445|NCT03003520|65697510|FG001|Overall Study|Adverse Event|0|||
23536446|NCT03003520|65697509|FG000|Overall Study|Death|1|||
23536447|NCT03003520|65697510|FG001|Overall Study|Death|0|||
23536448|NCT03003520|65697509|FG000|Overall Study|Other reasons|4|||
23536449|NCT03003520|65697510|FG001|Overall Study|Other reasons|0|||
23536450|NCT03003520|65697509|FG000|Overall Study|Withdrawal by Subject|6|||
23536451|NCT03003520|65697510|FG001|Overall Study|Withdrawal by Subject|0|||
23536452|NCT03003520|65697509|FG000|Overall Study|Progressive disease|9|||
23536453|NCT03003520|65697510|FG001|Overall Study|Progressive disease|1|||
23536454|NCT01529645|65697512|FG000|Overall Study|Lost to Follow-up|0|||
23536455|NCT01529645|65697513|FG001|Overall Study|Lost to Follow-up|1|||
23536456|NCT01529645|65697514|FG002|Overall Study|Lost to Follow-up|1|||
23536457|NCT01529645|65697515|FG003|Overall Study|Lost to Follow-up|1|||
23536458|NCT01529645|65697516|FG004|Overall Study|Lost to Follow-up|1|||
23536459|NCT01529645|65697517|FG005|Overall Study|Lost to Follow-up|0|||
23536460|NCT01529645|65697518|FG006|Overall Study|Lost to Follow-up|2|||
23536461|NCT01529645|65697519|FG007|Overall Study|Lost to Follow-up|0|||
23536462|NCT01529645|65697520|FG008|Overall Study|Lost to Follow-up|1|||
23536463|NCT01529645|65697521|FG009|Overall Study|Lost to Follow-up|0|||
23536464|NCT01529645|65697512|FG000|Overall Study|SAE - Premature contractions|0|||
23536465|NCT01529645|65697513|FG001|Overall Study|SAE - Premature contractions|0|||
23536466|NCT01529645|65697514|FG002|Overall Study|SAE - Premature contractions|1|||
23536467|NCT01529645|65697515|FG003|Overall Study|SAE - Premature contractions|0|||
23536468|NCT01529645|65697516|FG004|Overall Study|SAE - Premature contractions|0|||
23536469|NCT01529645|65697517|FG005|Overall Study|SAE - Premature contractions|0|||
23536470|NCT01529645|65697518|FG006|Overall Study|SAE - Premature contractions|0|||
23536471|NCT01529645|65697519|FG007|Overall Study|SAE - Premature contractions|0|||
23536472|NCT01529645|65697520|FG008|Overall Study|SAE - Premature contractions|0|||
23536473|NCT01529645|65697521|FG009|Overall Study|SAE - Premature contractions|0|||
23536474|NCT01529645|65697512|FG000|Overall Study|Withdrawal by Subject|2|||
23536475|NCT01529645|65697513|FG001|Overall Study|Withdrawal by Subject|0|||
23536476|NCT01529645|65697514|FG002|Overall Study|Withdrawal by Subject|0|||
23536477|NCT01529645|65697515|FG003|Overall Study|Withdrawal by Subject|1|||
23536478|NCT01529645|65697516|FG004|Overall Study|Withdrawal by Subject|1|||
23536479|NCT01529645|65697517|FG005|Overall Study|Withdrawal by Subject|1|||
23536480|NCT01529645|65697518|FG006|Overall Study|Withdrawal by Subject|0|||
23536481|NCT01529645|65697519|FG007|Overall Study|Withdrawal by Subject|0|||
23536482|NCT01529645|65697520|FG008|Overall Study|Withdrawal by Subject|0|||
23536483|NCT01529645|65697521|FG009|Overall Study|Withdrawal by Subject|0|||
23536484|NCT03586869|65697522|FG000|Overall Study|Progressive Disease|3|||
23536485|NCT00087568|65697525|FG000|Overall Study|Adverse Event|4|||
23536486|NCT00087568|65697526|FG001|Overall Study|Adverse Event|0|||
23536487|NCT00087568|65697525|FG000|Overall Study|Withdrawal by Subject|1|||
23536488|NCT00087568|65697526|FG001|Overall Study|Withdrawal by Subject|1|||
23536489|NCT00087568|65697525|FG000|Overall Study|Lost to Follow-up|1|||
23536490|NCT00087568|65697526|FG001|Overall Study|Lost to Follow-up|0|||
23536491|NCT00087568|65697525|FG000|Overall Study|Lack of Efficacy|24|||
23536492|NCT00087568|65697526|FG001|Overall Study|Lack of Efficacy|1|||
23536493|NCT00718718|65697527|FG000|Prior to Week 12|Adverse Event|0|||
23536494|NCT00718718|65697528|FG001|Prior to Week 12|Adverse Event|0|||
23536495|NCT00718718|65697529|FG002|Prior to Week 12|Adverse Event|0|||
23536496|NCT00718718|65697530|FG003|Prior to Week 12|Adverse Event|0|||
23536497|NCT00718718|65697531|FG004|Prior to Week 12|Adverse Event|0|||
23536498|NCT00718718|65697532|FG005|Prior to Week 12|Adverse Event|0|||
23536499|NCT00718718|65697533|FG006|Prior to Week 12|Adverse Event|0|||
23536500|NCT00718718|65697534|FG007|Prior to Week 12|Adverse Event|1|||
23536501|NCT00718718|65697535|FG008|Prior to Week 12|Adverse Event|1|||
23536502|NCT00718718|65697536|FG009|Prior to Week 12|Adverse Event|0|||
23536503|NCT00718718|65697527|FG000|Prior to Week 12|Withdrawal by Subject|0|||
23536504|NCT00718718|65697528|FG001|Prior to Week 12|Withdrawal by Subject|0|||
23536505|NCT00718718|65697529|FG002|Prior to Week 12|Withdrawal by Subject|0|||
23536506|NCT00718718|65697530|FG003|Prior to Week 12|Withdrawal by Subject|0|||
23536507|NCT00718718|65697531|FG004|Prior to Week 12|Withdrawal by Subject|3|||
23536508|NCT00718718|65697532|FG005|Prior to Week 12|Withdrawal by Subject|0|||
23536509|NCT00718718|65697533|FG006|Prior to Week 12|Withdrawal by Subject|1|||
23536510|NCT00718718|65697534|FG007|Prior to Week 12|Withdrawal by Subject|1|||
23536511|NCT00718718|65697535|FG008|Prior to Week 12|Withdrawal by Subject|1|||
23536512|NCT00718718|65697536|FG009|Prior to Week 12|Withdrawal by Subject|0|||
23536513|NCT00718718|65697527|FG000|Prior to Week 12|Other|1|||
23536514|NCT00718718|65697528|FG001|Prior to Week 12|Other|0|||
23536515|NCT00718718|65697529|FG002|Prior to Week 12|Other|1|||
23536516|NCT00718718|65697530|FG003|Prior to Week 12|Other|0|||
23536517|NCT00718718|65697531|FG004|Prior to Week 12|Other|0|||
23536518|NCT00718718|65697532|FG005|Prior to Week 12|Other|0|||
23536519|NCT00718718|65697533|FG006|Prior to Week 12|Other|0|||
23536520|NCT00718718|65697534|FG007|Prior to Week 12|Other|0|||
23536521|NCT00718718|65697535|FG008|Prior to Week 12|Other|0|||
23536522|NCT00718718|65697536|FG009|Prior to Week 12|Other|0|||
23536523|NCT00718718|65697527|FG000|Week 12 to End of Study|Adverse Event|0|||
23536524|NCT00718718|65697528|FG001|Week 12 to End of Study|Adverse Event|0|||
23536525|NCT00718718|65697529|FG002|Week 12 to End of Study|Adverse Event|0|||
23536526|NCT00718718|65697530|FG003|Week 12 to End of Study|Adverse Event|0|||
23536527|NCT00718718|65697531|FG004|Week 12 to End of Study|Adverse Event|0|||
23536528|NCT00718718|65697532|FG005|Week 12 to End of Study|Adverse Event|0|||
23536529|NCT00718718|65697533|FG006|Week 12 to End of Study|Adverse Event|0|||
23536530|NCT00718718|65697534|FG007|Week 12 to End of Study|Adverse Event|1|||
23536531|NCT00718718|65697535|FG008|Week 12 to End of Study|Adverse Event|0|||
23536532|NCT00718718|65697536|FG009|Week 12 to End of Study|Adverse Event|0|||
23536533|NCT00718718|65697527|FG000|Week 12 to End of Study|Death|0|||
23536534|NCT00718718|65697528|FG001|Week 12 to End of Study|Death|0|||
23536535|NCT00718718|65697529|FG002|Week 12 to End of Study|Death|0|||
23536536|NCT00718718|65697530|FG003|Week 12 to End of Study|Death|0|||
23536537|NCT00718718|65697531|FG004|Week 12 to End of Study|Death|0|||
23536538|NCT00718718|65697532|FG005|Week 12 to End of Study|Death|1|||
23536539|NCT00718718|65697533|FG006|Week 12 to End of Study|Death|0|||
23536540|NCT00718718|65697534|FG007|Week 12 to End of Study|Death|0|||
23536541|NCT00718718|65697535|FG008|Week 12 to End of Study|Death|0|||
23536542|NCT00718718|65697536|FG009|Week 12 to End of Study|Death|0|||
23536543|NCT00718718|65697527|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
23536544|NCT00718718|65697528|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
23536545|NCT00718718|65697529|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
23536546|NCT00718718|65697530|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
23536547|NCT00718718|65697531|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
23536548|NCT00718718|65697532|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
23536549|NCT00718718|65697533|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
23536550|NCT00718718|65697534|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
23536551|NCT00718718|65697535|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
23536552|NCT00718718|65697536|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
23536553|NCT00718718|65697527|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
23536554|NCT00718718|65697528|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
23536555|NCT00718718|65697529|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
23536556|NCT00718718|65697530|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
23536557|NCT00718718|65697531|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
23536558|NCT00718718|65697532|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
23536559|NCT00718718|65697533|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
23536560|NCT00718718|65697534|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
23536561|NCT00718718|65697535|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
23536562|NCT00718718|65697536|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
23536563|NCT00718718|65697527|FG000|Week 12 to End of Study|Other|0|||
23536564|NCT00718718|65697528|FG001|Week 12 to End of Study|Other|1|||
23616031|NCT02068352|65979601|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
23616032|NCT02068352|65979599|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
23616033|NCT02068352|65979600|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
23616034|NCT02068352|65979601|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
23616035|NCT02068352|65979599|FG000|Overall Study|Protocol Deviation|0|||
23616036|NCT02068352|65979600|FG001|Overall Study|Protocol Deviation|0|||
23616037|NCT02068352|65979601|FG002|Overall Study|Protocol Deviation|1|||
23616038|NCT01345188|65979603|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
23616039|NCT01345188|65979603|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
23616040|NCT02029521|65979606|FG000|Overall Study|Protocol Violation|1|||
23616041|NCT02029521|65979607|FG001|Overall Study|Protocol Violation|0|||
23616042|NCT02029521|65979606|FG000|Overall Study|Withdrawal by Subject|1|||
23616043|NCT02029521|65979607|FG001|Overall Study|Withdrawal by Subject|1|||
23616044|NCT01106586|65979610|FG000|Overall Study|Adverse Event|9|||
23616045|NCT01106586|65979611|FG001|Overall Study|Adverse Event|15|||
23616046|NCT01106586|65979610|FG000|Overall Study|Death|1|||
23536565|NCT00718718|65697529|FG002|Week 12 to End of Study|Other|0|||
23536566|NCT00718718|65697530|FG003|Week 12 to End of Study|Other|1|||
23536567|NCT00718718|65697531|FG004|Week 12 to End of Study|Other|0|||
23536568|NCT00718718|65697532|FG005|Week 12 to End of Study|Other|0|||
23536569|NCT00718718|65697533|FG006|Week 12 to End of Study|Other|1|||
23536570|NCT00718718|65697534|FG007|Week 12 to End of Study|Other|0|||
23536571|NCT00718718|65697535|FG008|Week 12 to End of Study|Other|0|||
23536572|NCT00718718|65697536|FG009|Week 12 to End of Study|Other|0|||
23536573|NCT01933334|65697537|FG000|Overall Study|Adverse Event|5|||
23536574|NCT01933334|65697538|FG001|Overall Study|Adverse Event|1|||
23616047|NCT01106586|65979611|FG001|Overall Study|Death|3|||
23616048|NCT01106586|65979610|FG000|Overall Study|Pregnancy|2|||
23616049|NCT01106586|65979611|FG001|Overall Study|Pregnancy|2|||
23616050|NCT01106586|65979610|FG000|Overall Study|Lack of Efficacy|1|||
23616051|NCT01106586|65979611|FG001|Overall Study|Lack of Efficacy|0|||
23616052|NCT01106586|65979610|FG000|Overall Study|Investigator's Discretion|5|||
23616053|NCT01106586|65979611|FG001|Overall Study|Investigator's Discretion|8|||
23616054|NCT01106586|65979610|FG000|Overall Study|Withdrew Consent|18|||
23616055|NCT01106586|65979611|FG001|Overall Study|Withdrew Consent|30|||
23616056|NCT01106586|65979610|FG000|Overall Study|Lost to Follow-up|24|||
23616057|NCT01106586|65979611|FG001|Overall Study|Lost to Follow-up|20|||
23616058|NCT01106586|65979610|FG000|Overall Study|Participant Noncompliance|12|||
23616059|NCT01106586|65979611|FG001|Overall Study|Participant Noncompliance|10|||
23616060|NCT01106586|65979610|FG000|Overall Study|Protocol Violation|1|||
23616061|NCT01106586|65979611|FG001|Overall Study|Protocol Violation|0|||
23616062|NCT01106586|65979610|FG000|Overall Study|Participant Transferred to Another Study|212|||
23616063|NCT01106586|65979611|FG001|Overall Study|Participant Transferred to Another Study|197|||
23616064|NCT02056873|65979623|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
23616065|NCT01601821|65979624|FG000|Overall Study|Death|2|||
23616066|NCT01601821|65979625|FG001|Overall Study|Death|5|||
23616067|NCT01601821|65979624|FG000|Overall Study|Protocol Violation|2|||
23616068|NCT01601821|65979625|FG001|Overall Study|Protocol Violation|2|||
23616069|NCT01601821|65979624|FG000|Overall Study|Lost to Follow-up|6|||
23616070|NCT01601821|65979625|FG001|Overall Study|Lost to Follow-up|14|||
23616071|NCT01601821|65979624|FG000|Overall Study|Withdrawal by Subject|1|||
23616072|NCT01601821|65979625|FG001|Overall Study|Withdrawal by Subject|0|||
23616073|NCT01601821|65979624|FG000|Overall Study|Graft Loss|6|||
23616074|NCT01601821|65979625|FG001|Overall Study|Graft Loss|6|||
23616075|NCT01601821|65979624|FG000|Overall Study|Study Events|7|||
23616076|NCT01601821|65979625|FG001|Overall Study|Study Events|1|||
23616077|NCT01601821|65979624|FG000|Overall Study|Other|5|||
23616078|NCT01601821|65979625|FG001|Overall Study|Other|1|||
23616079|NCT00645099|65979628|FG000|Overall Study|Lack of Efficacy|15|||
23616080|NCT00645099|65979629|FG001|Overall Study|Lack of Efficacy|6|||
23616081|NCT00645099|65979628|FG000|Overall Study|Withdrawal by Subject|30|||
23616082|NCT00645099|65979629|FG001|Overall Study|Withdrawal by Subject|22|||
23616083|NCT00645099|65979628|FG000|Overall Study|Lost to Follow-up|6|||
23616084|NCT00645099|65979629|FG001|Overall Study|Lost to Follow-up|4|||
23616085|NCT00645099|65979628|FG000|Overall Study|Adverse Event|11|||
23616086|NCT00645099|65979629|FG001|Overall Study|Adverse Event|5|||
23616087|NCT00645099|65979628|FG000|Overall Study|Other|9|||
23616088|NCT00645099|65979629|FG001|Overall Study|Other|5|||
23616089|NCT03340766|65979630|FG000|Overall Study|Withdrawal by Subject|2|||
23616090|NCT03340766|65979631|FG001|Overall Study|Withdrawal by Subject|1|||
23616091|NCT03340766|65979632|FG002|Overall Study|Withdrawal by Subject|3|||
23616092|NCT03340766|65979630|FG000|Overall Study|Lost to Follow-up|0|||
23616093|NCT03340766|65979631|FG001|Overall Study|Lost to Follow-up|0|||
23616094|NCT03340766|65979632|FG002|Overall Study|Lost to Follow-up|1|||
23616095|NCT03340766|65979630|FG000|Overall Study|Death|6|||
23616096|NCT03340766|65979631|FG001|Overall Study|Death|7|||
23616097|NCT03340766|65979632|FG002|Overall Study|Death|4|||
23616098|NCT00145496|65979633|FG000|Overall Study|Adverse Event|42|||
23616099|NCT00145496|65979634|FG001|Overall Study|Adverse Event|30|||
23616100|NCT00145496|65979633|FG000|Overall Study|Lack of Efficacy|12|||
23616101|NCT00145496|65979634|FG001|Overall Study|Lack of Efficacy|7|||
23616102|NCT00145496|65979633|FG000|Overall Study|Withdrawal by Subject|32|||
23616103|NCT00145496|65979634|FG001|Overall Study|Withdrawal by Subject|26|||
23616104|NCT00145496|65979633|FG000|Overall Study|Lost to Follow-up|12|||
23616105|NCT00145496|65979634|FG001|Overall Study|Lost to Follow-up|5|||
23616106|NCT00145496|65979633|FG000|Overall Study|Other|25|||
23616107|NCT00145496|65979634|FG001|Overall Study|Other|13|||
23616108|NCT00511147|65979639|FG000|Overall Study|Withdrawal by Subject|1|||
23616109|NCT00511147|65979639|FG000|Overall Study|Disease progression|5|||
23616110|NCT00511147|65979639|FG000|Overall Study|Required platelet transfusion|1|||
23616111|NCT00348283|65979640|FG000|Induction|Adverse Event|0|||
23616112|NCT00348283|65979641|FG001|Induction|Adverse Event|2|||
23616113|NCT00348283|65979640|FG000|Induction|Protocol Violation|0|||
23616114|NCT00348283|65979641|FG001|Induction|Protocol Violation|4|||
23616115|NCT00348283|65979640|FG000|Double Blind|Adverse Event|2|||
23616116|NCT00348283|65979641|FG001|Double Blind|Adverse Event|5|||
23616117|NCT00348283|65979640|FG000|Double Blind|Withdrawal by Subject|1|||
23616118|NCT00348283|65979641|FG001|Double Blind|Withdrawal by Subject|1|||
23616119|NCT00348283|65979640|FG000|Double Blind|Protocol Violation|0|||
23616120|NCT00348283|65979641|FG001|Double Blind|Protocol Violation|1|||
23616121|NCT00348283|65979640|FG000|Double Blind|Lack of Efficacy|2|||
23616122|NCT00348283|65979641|FG001|Double Blind|Lack of Efficacy|2|||
23616123|NCT00348283|65979640|FG000|Double Blind|Pregnancy|0|||
23616124|NCT00348283|65979641|FG001|Double Blind|Pregnancy|1|||
23616125|NCT00348283|65979640|FG000|Open Label|Adverse Event|0|||
23616126|NCT00348283|65979641|FG001|Open Label|Adverse Event|8|||
23616127|NCT00348283|65979640|FG000|Open Label|Withdrawal by Subject|0|||
23616128|NCT00348283|65979641|FG001|Open Label|Withdrawal by Subject|4|||
23616129|NCT00348283|65979640|FG000|Open Label|Lost to Follow-up|0|||
23616130|NCT00348283|65979641|FG001|Open Label|Lost to Follow-up|1|||
23616131|NCT00348283|65979640|FG000|Open Label|Lack of Efficacy|0|||
23616132|NCT00348283|65979641|FG001|Open Label|Lack of Efficacy|13|||
23616133|NCT00348283|65979640|FG000|Open Label|Administrative reasons|0|||
23616134|NCT00348283|65979641|FG001|Open Label|Administrative reasons|5|||
23616135|NCT00348283|65979640|FG000|Open Label|Subject moved to the United States|0|||
23616136|NCT00348283|65979641|FG001|Open Label|Subject moved to the United States|1|||
23616137|NCT00348283|65979640|FG000|Open Label|Pregnancy|0|||
23616138|NCT00348283|65979641|FG001|Open Label|Pregnancy|1|||
23616139|NCT00348283|65979640|FG000|Open Label|Sponsor decision|0|||
23616140|NCT00348283|65979641|FG001|Open Label|Sponsor decision|1|||
23616141|NCT04393779|65979642|FG000|Overall Study|Death|1|||
23616142|NCT04393779|65979642|FG000|Overall Study|Device reintervention or explant|4|||
23616143|NCT04369664|65979646|FG000|Overall Study|Physician Decision|1|||
23616144|NCT04369664|65979647|FG001|Overall Study|Physician Decision|0|||
23616145|NCT00495612|65979649|FG000|Overall Study|Lost to Follow-up|1|||
23616146|NCT00495612|65979650|FG001|Overall Study|Lost to Follow-up|0|||
23616147|NCT00495612|65979649|FG000|Overall Study|Subject's Decision to Withdraw|3|||
23616148|NCT00495612|65979650|FG001|Overall Study|Subject's Decision to Withdraw|0|||
23616149|NCT02567227|65979655|FG000|9 Weeks|Adverse Event|5|||
23616150|NCT02567227|65979656|FG001|9 Weeks|Adverse Event|5|||
23616151|NCT02567227|65979655|FG000|9 Weeks|Withdrawal by Subject|18|||
23616152|NCT02567227|65979656|FG001|9 Weeks|Withdrawal by Subject|8|||
23616153|NCT02567227|65979655|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
23536575|NCT01933334|65697537|FG000|Overall Study|Withdrawal by Subject|0|||
23536576|NCT01933334|65697538|FG001|Overall Study|Withdrawal by Subject|1|||
23536577|NCT02348489|65697539|FG000|Overall Study|Death|336|||
23536578|NCT02348489|65697540|FG001|Overall Study|Death|335|||
23536579|NCT02348489|65697539|FG000|Overall Study|Withdrawal by Subject|14|||
23536580|NCT02348489|65697540|FG001|Overall Study|Withdrawal by Subject|27|||
23536581|NCT02348489|65697539|FG000|Overall Study|Lost to Follow-up|3|||
23536582|NCT02348489|65697540|FG001|Overall Study|Lost to Follow-up|5|||
23536583|NCT02822794|65697544|FG000|Overall Study|Withdrew Consent|1|||
23536584|NCT02822794|65697545|FG001|Overall Study|Withdrew Consent|0|||
23536585|NCT01412424|65697550|FG000|Core Treatment Period|Treatment Failure|24|||
23536586|NCT01412424|65697550|FG000|Core Treatment Period|Adverse Event|21|||
23536587|NCT01412424|65697550|FG000|Core Treatment Period|Patient Request|5|||
23536588|NCT01412424|65697550|FG000|Core Treatment Period|Lost to Follow-up|2|||
23536589|NCT01412424|65697550|FG000|Core Treatment Period|Sponsor Request|1|||
23536590|NCT01412424|65697550|FG000|Extension Treatment Period|Adverse Event|2|||
23536591|NCT01412424|65697550|FG000|Extension Treatment Period|Treatment Failure|2|||
23536592|NCT01412424|65697550|FG000|Extension Treatment Period|Patient Request|2|||
23536593|NCT00097591|65697551|FG000|Overall Study|Withdrawal of consent|342|||
23536594|NCT00097591|65697552|FG001|Overall Study|Withdrawal of consent|323|||
23536595|NCT00097591|65697551|FG000|Overall Study|Less than 6 months on study drug|9|||
23536596|NCT00097591|65697552|FG001|Overall Study|Less than 6 months on study drug|7|||
23536597|NCT00097591|65697551|FG000|Overall Study|Unable to attend termination visit|53|||
23536598|NCT00097591|65697552|FG001|Overall Study|Unable to attend termination visit|51|||
23536599|NCT00097591|65697551|FG000|Overall Study|Lost to follow up|6|||
23536600|NCT00097591|65697552|FG001|Overall Study|Lost to follow up|10|||
23536601|NCT00097591|65697551|FG000|Overall Study|Other|0|||
23536602|NCT00097591|65697552|FG001|Overall Study|Other|3|||
23536603|NCT02334748|65697553|FG000|Overall Study|Adverse Event|1|||
23536604|NCT02334748|65697553|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
23536605|NCT02334748|65697553|FG000|Overall Study|Patient no longer required study drug|2|||
23536606|NCT02334748|65697553|FG000|Overall Study|Lack of Efficacy|4|||
23536607|NCT00403455|65697554|FG000|Overall Study|Withdrawal by Subject|1|||
23536608|NCT02610192|65697555|FG000|Overall Study|Received other treatment|8|||
23536609|NCT02610192|65697555|FG000|Overall Study|Physician Decision|1|||
23536610|NCT03779841|65697556|FG000|Randomized Population|Did Not Receive Treatment|3|||
23536611|NCT03779841|65697557|FG001|Randomized Population|Did Not Receive Treatment|1|||
23536612|NCT03779841|65697558|FG002|Randomized Population|Did Not Receive Treatment|0|||
23536613|NCT03779841|65697556|FG000|Treated (Safety) Population|Adverse Event|1|||
23536614|NCT03779841|65697557|FG001|Treated (Safety) Population|Adverse Event|1|||
23536615|NCT03779841|65697558|FG002|Treated (Safety) Population|Adverse Event|0|||
23536616|NCT03779841|65697556|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
23536617|NCT03779841|65697557|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
23536618|NCT03779841|65697558|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
23536619|NCT03779841|65697556|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
23536620|NCT03779841|65697557|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
23616154|NCT02567227|65979656|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
23616155|NCT02567227|65979655|FG000|6 Month|Death|2|||
23616156|NCT02567227|65979656|FG001|6 Month|Death|0|||
23616157|NCT02567227|65979655|FG000|6 Month|Lost to Follow-up|43|||
23616158|NCT02567227|65979656|FG001|6 Month|Lost to Follow-up|40|||
23616159|NCT02567227|65979655|FG000|12 Months|Lost to Follow-up|31|||
23616160|NCT02567227|65979656|FG001|12 Months|Lost to Follow-up|32|||
23616161|NCT02567227|65979655|FG000|12 Months|Death|0|||
23616162|NCT02567227|65979656|FG001|12 Months|Death|2|||
23616163|NCT04054193|65979657|FG000|Cycle 1|Physician Decision|1|||
23616164|NCT04054193|65979657|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
23616165|NCT04054193|65979657|FG000|Cycle 1|Allocated but not treated|3|||
23616166|NCT04054193|65979657|FG000|Cycles 2-3|Physician Decision|2|||
23616167|NCT04054193|65979657|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
23616168|NCT04054193|65979657|FG000|Cycles 2-3|Various reasons|17|||
23616169|NCT02273180|65979660|FG000|Overall Study|Adverse Event|2|||
23616170|NCT02273180|65979661|FG001|Overall Study|Adverse Event|2|||
23616171|NCT02273180|65979660|FG000|Overall Study|Lack of Efficacy|1|||
23616172|NCT02273180|65979661|FG001|Overall Study|Lack of Efficacy|0|||
23616173|NCT02273180|65979660|FG000|Overall Study|Protocol Violation|1|||
23616174|NCT02273180|65979661|FG001|Overall Study|Protocol Violation|7|||
23616175|NCT02273180|65979660|FG000|Overall Study|Randomized but not treated|1|||
23616176|NCT02273180|65979661|FG001|Overall Study|Randomized but not treated|0|||
23616177|NCT02273180|65979660|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
23616178|NCT02273180|65979661|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
23536621|NCT03779841|65697558|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
23536622|NCT03779841|65697556|FG000|Treated (Safety) Population|Death|1|||
23536623|NCT03779841|65697557|FG001|Treated (Safety) Population|Death|0|||
23536624|NCT03779841|65697558|FG002|Treated (Safety) Population|Death|2|||
23536625|NCT03403634|65697559|FG000|Overall Study|Disease progression|3|||
23536626|NCT03403634|65697559|FG000|Overall Study|Did not meet eligibility criteria|4|||
23536627|NCT00767000|65697560|FG000|54-week Study|Adverse Event|4|||
23536628|NCT00767000|65697561|FG001|54-week Study|Adverse Event|6|||
23536629|NCT00767000|65697562|FG002|54-week Study|Adverse Event|6|||
23536630|NCT00767000|65697563|FG003|54-week Study|Adverse Event|8|||
23536631|NCT00767000|65697564|FG004|54-week Study|Adverse Event|4|||
23536632|NCT00767000|65697560|FG000|54-week Study|Creaninine/creatinine clearance|2|||
23536633|NCT00767000|65697561|FG001|54-week Study|Creaninine/creatinine clearance|1|||
23536634|NCT00767000|65697562|FG002|54-week Study|Creaninine/creatinine clearance|2|||
23536635|NCT00767000|65697563|FG003|54-week Study|Creaninine/creatinine clearance|2|||
23536636|NCT00767000|65697564|FG004|54-week Study|Creaninine/creatinine clearance|4|||
23536637|NCT00767000|65697560|FG000|54-week Study|Hyperglycemia|0|||
23536638|NCT00767000|65697561|FG001|54-week Study|Hyperglycemia|0|||
23536639|NCT00767000|65697562|FG002|54-week Study|Hyperglycemia|1|||
23536640|NCT00767000|65697563|FG003|54-week Study|Hyperglycemia|0|||
23536641|NCT00767000|65697564|FG004|54-week Study|Hyperglycemia|1|||
23536642|NCT00767000|65697560|FG000|54-week Study|Hypoglycemia|0|||
23536643|NCT00767000|65697561|FG001|54-week Study|Hypoglycemia|1|||
23536644|NCT00767000|65697562|FG002|54-week Study|Hypoglycemia|0|||
23536645|NCT00767000|65697563|FG003|54-week Study|Hypoglycemia|0|||
23536646|NCT00767000|65697564|FG004|54-week Study|Hypoglycemia|0|||
23536647|NCT00767000|65697560|FG000|54-week Study|Interruption of study medication|0|||
23536648|NCT00767000|65697561|FG001|54-week Study|Interruption of study medication|0|||
23536649|NCT00767000|65697562|FG002|54-week Study|Interruption of study medication|1|||
23616179|NCT02273180|65979660|FG000|Overall Study|Other than specified above|21|||
23616180|NCT02273180|65979661|FG001|Overall Study|Other than specified above|10|||
23616181|NCT02085408|65979664|FG000|Step 1: Induction|Disease Progression|19|||
23616182|NCT02085408|65979665|FG001|Step 1: Induction|Disease Progression|19|||
23616183|NCT02085408|65979664|FG000|Step 1: Induction|Adverse Event|18|||
23616184|NCT02085408|65979665|FG001|Step 1: Induction|Adverse Event|17|||
23616185|NCT02085408|65979664|FG000|Step 1: Induction|Death|33|||
23616186|NCT02085408|65979665|FG001|Step 1: Induction|Death|30|||
23536650|NCT00767000|65697563|FG003|54-week Study|Interruption of study medication|0|||
23536651|NCT00767000|65697564|FG004|54-week Study|Interruption of study medication|0|||
23536652|NCT00767000|65697560|FG000|54-week Study|Lack of Efficacy|2|||
23616187|NCT02085408|65979664|FG000|Step 1: Induction|Withdrawal by Subject|16|||
23536653|NCT00767000|65697561|FG001|54-week Study|Lack of Efficacy|0|||
23536654|NCT00767000|65697562|FG002|54-week Study|Lack of Efficacy|1|||
23616188|NCT02085408|65979665|FG001|Step 1: Induction|Withdrawal by Subject|8|||
23616189|NCT02085408|65979664|FG000|Step 1: Induction|Alternative Therapy|15|||
23616190|NCT02085408|65979665|FG001|Step 1: Induction|Alternative Therapy|19|||
23616191|NCT02085408|65979664|FG000|Step 1: Induction|Complicating Disease|2|||
23616192|NCT02085408|65979665|FG001|Step 1: Induction|Complicating Disease|3|||
23616193|NCT02085408|65979664|FG000|Step 1: Induction|Other|27|||
23616194|NCT02085408|65979665|FG001|Step 1: Induction|Other|39|||
23616195|NCT02085408|65979664|FG000|Step 1: Induction|Never started treatment|6|||
23536655|NCT00767000|65697563|FG003|54-week Study|Lack of Efficacy|0|||
23536656|NCT00767000|65697564|FG004|54-week Study|Lack of Efficacy|5|||
23536657|NCT00767000|65697560|FG000|54-week Study|Lost to Follow-up|4|||
23536658|NCT00767000|65697561|FG001|54-week Study|Lost to Follow-up|0|||
23536659|NCT00767000|65697562|FG002|54-week Study|Lost to Follow-up|1|||
23536660|NCT00767000|65697563|FG003|54-week Study|Lost to Follow-up|4|||
23536661|NCT00767000|65697564|FG004|54-week Study|Lost to Follow-up|2|||
23536662|NCT00767000|65697560|FG000|54-week Study|Physician Decision|4|||
23536663|NCT00767000|65697561|FG001|54-week Study|Physician Decision|0|||
23536664|NCT00767000|65697562|FG002|54-week Study|Physician Decision|1|||
23536665|NCT00767000|65697563|FG003|54-week Study|Physician Decision|1|||
23536666|NCT00767000|65697564|FG004|54-week Study|Physician Decision|1|||
23536667|NCT00767000|65697560|FG000|54-week Study|Progressive disease|0|||
23536668|NCT00767000|65697561|FG001|54-week Study|Progressive disease|0|||
23536669|NCT00767000|65697562|FG002|54-week Study|Progressive disease|1|||
23536670|NCT00767000|65697563|FG003|54-week Study|Progressive disease|0|||
23536671|NCT00767000|65697564|FG004|54-week Study|Progressive disease|0|||
23536672|NCT00767000|65697560|FG000|54-week Study|Protocol Violation|0|||
23536673|NCT00767000|65697561|FG001|54-week Study|Protocol Violation|0|||
23536674|NCT00767000|65697562|FG002|54-week Study|Protocol Violation|1|||
23536675|NCT00767000|65697563|FG003|54-week Study|Protocol Violation|2|||
23536676|NCT00767000|65697564|FG004|54-week Study|Protocol Violation|0|||
23536677|NCT00767000|65697560|FG000|54-week Study|Withdrawal by Subject|2|||
23536678|NCT00767000|65697561|FG001|54-week Study|Withdrawal by Subject|3|||
23536679|NCT00767000|65697562|FG002|54-week Study|Withdrawal by Subject|5|||
23536680|NCT00767000|65697563|FG003|54-week Study|Withdrawal by Subject|11|||
23536681|NCT00767000|65697564|FG004|54-week Study|Withdrawal by Subject|13|||
23536682|NCT00767000|65697560|FG000|54-week Study|Study terminated by sponsor|90|||
23536683|NCT00767000|65697561|FG001|54-week Study|Study terminated by sponsor|102|||
23536684|NCT00767000|65697562|FG002|54-week Study|Study terminated by sponsor|89|||
23536685|NCT00767000|65697563|FG003|54-week Study|Study terminated by sponsor|196|||
23536686|NCT00767000|65697564|FG004|54-week Study|Study terminated by sponsor|194|||
23536687|NCT00767000|65697560|FG000|54-week Study|Reason not reported|0|||
23536688|NCT00767000|65697561|FG001|54-week Study|Reason not reported|0|||
23536689|NCT00767000|65697562|FG002|54-week Study|Reason not reported|0|||
23536690|NCT00767000|65697563|FG003|54-week Study|Reason not reported|1|||
23536691|NCT00767000|65697564|FG004|54-week Study|Reason not reported|0|||
23536692|NCT00767000|65697560|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
23536693|NCT00767000|65697561|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
23536694|NCT00767000|65697562|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
23536695|NCT00767000|65697563|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
23536696|NCT00767000|65697564|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
23536697|NCT04382326|65697565|FG000|Overall Study|Adverse Event, not serious|1|||
23536698|NCT04382326|65697566|FG001|Overall Study|Adverse Event, not serious|2|||
23536699|NCT04382326|65697565|FG000|Overall Study|Other|1|||
23536700|NCT04382326|65697566|FG001|Overall Study|Other|0|||
23536701|NCT04382326|65697565|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
23536702|NCT04382326|65697566|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
23536703|NCT04382326|65697565|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
23536704|NCT04382326|65697566|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
23536705|NCT04382326|65697565|FG000|Overall Study|Protocol Violation|29|||
23536706|NCT04382326|65697566|FG001|Overall Study|Protocol Violation|23|||
23536707|NCT04382326|65697565|FG000|Overall Study|Physician Decision|0|||
23536708|NCT04382326|65697566|FG001|Overall Study|Physician Decision|1|||
23536709|NCT04382326|65697565|FG000|Overall Study|Lost to Follow-up|48|||
23536710|NCT04382326|65697566|FG001|Overall Study|Lost to Follow-up|63|||
23536711|NCT04382326|65697565|FG000|Overall Study|Adverse Event, non-fatal|1|||
23616196|NCT02085408|65979665|FG001|Step 1: Induction|Never started treatment|4|||
23616197|NCT02085408|65979664|FG000|Step 2: Consolidation|Disease Progression|5|||
23616198|NCT02085408|65979665|FG001|Step 2: Consolidation|Disease Progression|20|||
23536712|NCT04382326|65697566|FG001|Overall Study|Adverse Event, non-fatal|1|||
23536713|NCT02738775|65697568|FG000|Overall Study|Withdrawal by Subject|0|||
23536714|NCT02738775|65697569|FG001|Overall Study|Withdrawal by Subject|1|||
23536715|NCT02738775|65697570|FG002|Overall Study|Withdrawal by Subject|0|||
23536716|NCT02738775|65697571|FG003|Overall Study|Withdrawal by Subject|0|||
23536717|NCT02738775|65697572|FG004|Overall Study|Withdrawal by Subject|0|||
23536718|NCT02738775|65697573|FG005|Overall Study|Withdrawal by Subject|0|||
23536719|NCT02738775|65697568|FG000|Overall Study|Adverse Event|0|||
23536720|NCT02738775|65697569|FG001|Overall Study|Adverse Event|0|||
23536721|NCT02738775|65697570|FG002|Overall Study|Adverse Event|0|||
23616199|NCT02085408|65979664|FG000|Step 2: Consolidation|Adverse Event|9|||
23616200|NCT02085408|65979665|FG001|Step 2: Consolidation|Adverse Event|8|||
23616201|NCT02085408|65979664|FG000|Step 2: Consolidation|Death|4|||
23616202|NCT02085408|65979665|FG001|Step 2: Consolidation|Death|3|||
23616203|NCT02085408|65979664|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
23616204|NCT02085408|65979665|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
23616205|NCT02085408|65979664|FG000|Step 2: Consolidation|Alternative Therapy|9|||
23616206|NCT02085408|65979665|FG001|Step 2: Consolidation|Alternative Therapy|3|||
23616207|NCT02085408|65979664|FG000|Step 2: Consolidation|Complicating Disease|0|||
23616208|NCT02085408|65979665|FG001|Step 2: Consolidation|Complicating Disease|2|||
23616209|NCT02085408|65979664|FG000|Step 2: Consolidation|Other|6|||
23616210|NCT02085408|65979665|FG001|Step 2: Consolidation|Other|6|||
23616211|NCT02085408|65979664|FG000|Step 2: Consolidation|Never started treatment|4|||
23616212|NCT02085408|65979665|FG001|Step 2: Consolidation|Never started treatment|3|||
23616213|NCT02085408|65979664|FG000|Step 3: Maintenance|Disease Progression|13|||
23616214|NCT02085408|65979665|FG001|Step 3: Maintenance|Disease Progression|11|||
23616215|NCT02085408|65979664|FG000|Step 3: Maintenance|Adverse Event|2|||
23616216|NCT02085408|65979665|FG001|Step 3: Maintenance|Adverse Event|4|||
23536722|NCT02738775|65697571|FG003|Overall Study|Adverse Event|1|||
23536723|NCT02738775|65697572|FG004|Overall Study|Adverse Event|0|||
23536724|NCT02738775|65697573|FG005|Overall Study|Adverse Event|0|||
23536725|NCT02738775|65697568|FG000|Overall Study|Pregnancy|0|||
23536726|NCT02738775|65697569|FG001|Overall Study|Pregnancy|1|||
23536727|NCT02738775|65697570|FG002|Overall Study|Pregnancy|0|||
23536728|NCT02738775|65697571|FG003|Overall Study|Pregnancy|0|||
23536729|NCT02738775|65697572|FG004|Overall Study|Pregnancy|0|||
23536730|NCT02738775|65697573|FG005|Overall Study|Pregnancy|0|||
23536731|NCT02738775|65697568|FG000|Overall Study|Missing|0|||
23536732|NCT02738775|65697569|FG001|Overall Study|Missing|0|||
23536733|NCT02738775|65697570|FG002|Overall Study|Missing|0|||
23536734|NCT02738775|65697571|FG003|Overall Study|Missing|0|||
23536735|NCT02738775|65697572|FG004|Overall Study|Missing|0|||
23536736|NCT02738775|65697573|FG005|Overall Study|Missing|1|||
23536737|NCT01312467|65697574|FG000|Overall Study|Adverse Event|4|||
23536738|NCT01312467|65697574|FG000|Overall Study|Lost to Follow-up|1|||
23536739|NCT01312467|65697574|FG000|Overall Study|Withdrawal by Subject|2|||
23536740|NCT01312467|65697574|FG000|Overall Study|Deported to country of origin|1|||
23536741|NCT01312467|65697574|FG000|Overall Study|Another medical condition|1|||
23536742|NCT01312467|65697574|FG000|Overall Study|Ineligible|4|||
23536743|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
23536744|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
23536745|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
23536746|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
23536747|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
23536748|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
23536749|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
23536750|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
23536751|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
23536752|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
23536753|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
23536754|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
23536755|NCT03246529|65697575|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
23536756|NCT03246529|65697576|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
23536757|NCT03246529|65697577|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
23536758|NCT03246529|65697575|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
23536759|NCT03246529|65697576|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
23536760|NCT03246529|65697577|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
23536761|NCT03246529|65697575|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
23536762|NCT03246529|65697576|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
23536763|NCT03246529|65697577|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
23536764|NCT03246529|65697575|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
23536765|NCT03246529|65697576|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
23536766|NCT03246529|65697577|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
23536767|NCT03246529|65697575|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
23536768|NCT03246529|65697576|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
23536769|NCT03246529|65697577|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
23536770|NCT00499369|65697578|FG000|Overall Study|Adverse Event|2|||
23536771|NCT00499369|65697579|FG001|Overall Study|Adverse Event|2|||
23536772|NCT00499369|65697580|FG002|Overall Study|Adverse Event|3|||
23536773|NCT00499369|65697581|FG003|Overall Study|Adverse Event|1|||
23536774|NCT00499369|65697582|FG004|Overall Study|Adverse Event|2|||
23536775|NCT00499369|65697578|FG000|Overall Study|Withdrawal by Subject|0|||
23536776|NCT00499369|65697579|FG001|Overall Study|Withdrawal by Subject|1|||
23536777|NCT00499369|65697580|FG002|Overall Study|Withdrawal by Subject|1|||
23536778|NCT00499369|65697581|FG003|Overall Study|Withdrawal by Subject|0|||
23536779|NCT00499369|65697582|FG004|Overall Study|Withdrawal by Subject|0|||
23536780|NCT00499369|65697578|FG000|Overall Study|Progression|10|||
23536781|NCT00499369|65697579|FG001|Overall Study|Progression|12|||
23536782|NCT00499369|65697580|FG002|Overall Study|Progression|9|||
23536783|NCT00499369|65697581|FG003|Overall Study|Progression|6|||
23536784|NCT00499369|65697582|FG004|Overall Study|Progression|10|||
23536785|NCT00499369|65697578|FG000|Overall Study|Death|0|||
23536786|NCT00499369|65697579|FG001|Overall Study|Death|1|||
23536787|NCT00499369|65697580|FG002|Overall Study|Death|0|||
23536788|NCT00499369|65697581|FG003|Overall Study|Death|0|||
23536789|NCT00499369|65697582|FG004|Overall Study|Death|0|||
23536790|NCT00499369|65697578|FG000|Overall Study|Not protocol specified|2|||
23536791|NCT00499369|65697579|FG001|Overall Study|Not protocol specified|0|||
23536792|NCT00499369|65697580|FG002|Overall Study|Not protocol specified|3|||
23536793|NCT00499369|65697581|FG003|Overall Study|Not protocol specified|1|||
23536794|NCT00499369|65697582|FG004|Overall Study|Not protocol specified|0|||
23536795|NCT00499369|65697578|FG000|Overall Study|Ineligible|2|||
23536796|NCT00499369|65697579|FG001|Overall Study|Ineligible|2|||
23536797|NCT00499369|65697580|FG002|Overall Study|Ineligible|1|||
23536798|NCT00499369|65697581|FG003|Overall Study|Ineligible|1|||
23536799|NCT00499369|65697582|FG004|Overall Study|Ineligible|0|||
23536800|NCT04919499|65697583|FG000|Overall Study|Adverse Event|0|||
23536801|NCT04919499|65697584|FG001|Overall Study|Adverse Event|0|||
23536802|NCT04919499|65697585|FG002|Overall Study|Adverse Event|0|||
23536803|NCT04919499|65697586|FG003|Overall Study|Adverse Event|0|||
23536804|NCT04919499|65697587|FG004|Overall Study|Adverse Event|2|||
23536805|NCT04919499|65697583|FG000|Overall Study|Not treated|0|||
23536806|NCT04919499|65697584|FG001|Overall Study|Not treated|0|||
23536807|NCT04919499|65697585|FG002|Overall Study|Not treated|0|||
23536808|NCT04919499|65697586|FG003|Overall Study|Not treated|1|||
23536809|NCT04919499|65697587|FG004|Overall Study|Not treated|0|||
23536810|NCT03465540|65697588|FG000|Overall Study|Withdrawal by Subject|0|||
23536811|NCT03465540|65697589|FG001|Overall Study|Withdrawal by Subject|0|||
23536812|NCT03465540|65697590|FG002|Overall Study|Withdrawal by Subject|1|||
23536813|NCT03465540|65697591|FG003|Overall Study|Withdrawal by Subject|1|||
23536814|NCT03465540|65697592|FG004|Overall Study|Withdrawal by Subject|1|||
23536815|NCT03465540|65697593|FG005|Overall Study|Withdrawal by Subject|0|||
23536816|NCT03465540|65697588|FG000|Overall Study|Lost to Follow-up|0|||
23536817|NCT03465540|65697589|FG001|Overall Study|Lost to Follow-up|1|||
23536818|NCT03465540|65697590|FG002|Overall Study|Lost to Follow-up|0|||
23536819|NCT03465540|65697591|FG003|Overall Study|Lost to Follow-up|0|||
23536820|NCT03465540|65697592|FG004|Overall Study|Lost to Follow-up|1|||
23536821|NCT03465540|65697593|FG005|Overall Study|Lost to Follow-up|0|||
23536822|NCT03465540|65697588|FG000|Overall Study|Death|1|||
23536823|NCT03465540|65697589|FG001|Overall Study|Death|1|||
23536824|NCT03465540|65697590|FG002|Overall Study|Death|0|||
23536825|NCT03465540|65697591|FG003|Overall Study|Death|2|||
23536826|NCT03465540|65697592|FG004|Overall Study|Death|0|||
23536827|NCT03465540|65697593|FG005|Overall Study|Death|2|||
23536828|NCT03465540|65697588|FG000|Overall Study|Protocol specified criteria|0|||
23536829|NCT03465540|65697589|FG001|Overall Study|Protocol specified criteria|2|||
23536830|NCT03465540|65697590|FG002|Overall Study|Protocol specified criteria|2|||
23536831|NCT03465540|65697591|FG003|Overall Study|Protocol specified criteria|0|||
23536832|NCT03465540|65697592|FG004|Overall Study|Protocol specified criteria|2|||
23536833|NCT03465540|65697593|FG005|Overall Study|Protocol specified criteria|0|||
23536834|NCT01229436|65697600|FG000|Overall Study|Withdrawal by Subject|2|||
23536835|NCT01229436|65697600|FG000|Overall Study|Lost to Follow-up|3|||
23536836|NCT01431508|65697601|FG000|Overall Study|Lack of Efficacy|1|||
23536837|NCT01431508|65697601|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
23536838|NCT01243944|65697603|FG000|Overall Study|Adverse Event|15|||
23536839|NCT01243944|65697604|FG001|Overall Study|Adverse Event|13|||
23536840|NCT01243944|65697603|FG000|Overall Study|Lost to Follow-up|2|||
23536841|NCT01243944|65697604|FG001|Overall Study|Lost to Follow-up|1|||
23536842|NCT01243944|65697603|FG000|Overall Study|Physician Decision|2|||
23536843|NCT01243944|65697604|FG001|Overall Study|Physician Decision|7|||
23536844|NCT01243944|65697603|FG000|Overall Study|Disease progression|12|||
23536845|NCT01243944|65697604|FG001|Overall Study|Disease progression|11|||
23536846|NCT01243944|65697603|FG000|Overall Study|Protocol deviation|1|||
23536847|NCT01243944|65697604|FG001|Overall Study|Protocol deviation|1|||
23536848|NCT01243944|65697603|FG000|Overall Study|Participant decision|10|||
23536849|NCT01243944|65697604|FG001|Overall Study|Participant decision|15|||
23536850|NCT01243944|65697603|FG000|Overall Study|Death|2|||
23536851|NCT01243944|65697604|FG001|Overall Study|Death|3|||
23536852|NCT01243944|65697603|FG000|Overall Study|Non-compliance with study treatment|1|||
23536853|NCT01243944|65697604|FG001|Overall Study|Non-compliance with study treatment|0|||
23536854|NCT04028388|65697605|FG000|Overall Study|Evaluations missing|3|||
23536855|NCT04028388|65697606|FG001|Overall Study|Evaluations missing|6|||
23536856|NCT04028388|65697605|FG000|Overall Study|Not started|2|||
23536857|NCT04028388|65697606|FG001|Overall Study|Not started|0|||
23536858|NCT01033747|65697607|FG000|Overall Study|Adverse Event|9|||
23536859|NCT01033747|65697608|FG001|Overall Study|Adverse Event|4|||
23536860|NCT01033747|65697607|FG000|Overall Study|Abnormal Laboratory Value|1|||
23536861|NCT01033747|65697608|FG001|Overall Study|Abnormal Laboratory Value|0|||
23536862|NCT01033747|65697607|FG000|Overall Study|Abnormal test procedure|0|||
23536863|NCT01033747|65697608|FG001|Overall Study|Abnormal test procedure|1|||
23536864|NCT01033747|65697607|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
23536865|NCT01033747|65697608|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23536866|NCT01033747|65697607|FG000|Overall Study|Protocol Violation|1|||
23536867|NCT01033747|65697608|FG001|Overall Study|Protocol Violation|0|||
23536868|NCT01033747|65697607|FG000|Overall Study|Withdrawal by Subject|9|||
23536869|NCT01033747|65697608|FG001|Overall Study|Withdrawal by Subject|6|||
23536870|NCT01033747|65697607|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
23536871|NCT01033747|65697608|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
23536872|NCT01033747|65697607|FG000|Overall Study|Stopped at end of Extension 1|2|||
23536873|NCT01033747|65697608|FG001|Overall Study|Stopped at end of Extension 1|0|||
23536874|NCT04796610|65697616|FG000|Overall Study|Withdrawal by Subject|1|||
23536875|NCT04796610|65697617|FG001|Overall Study|Withdrawal by Subject|0|||
23536876|NCT04796610|65697618|FG002|Overall Study|Withdrawal by Subject|0|||
23536877|NCT04796610|65697619|FG003|Overall Study|Withdrawal by Subject|0|||
23536878|NCT04796610|65697616|FG000|Overall Study|Lost to Follow-up|2|||
23536879|NCT04796610|65697617|FG001|Overall Study|Lost to Follow-up|0|||
23536880|NCT04796610|65697618|FG002|Overall Study|Lost to Follow-up|1|||
23536881|NCT04796610|65697619|FG003|Overall Study|Lost to Follow-up|1|||
23536882|NCT01075321|65697628|FG000|Overall Study|Withdrawal by Subject|0|||
23536883|NCT01075321|65697629|FG001|Overall Study|Withdrawal by Subject|0|||
23536884|NCT01075321|65697630|FG002|Overall Study|Withdrawal by Subject|1|||
23536885|NCT01075321|65697631|FG003|Overall Study|Withdrawal by Subject|1|||
23536886|NCT01075321|65697628|FG000|Overall Study|Protocol Violation|0|||
23536887|NCT01075321|65697629|FG001|Overall Study|Protocol Violation|0|||
23536888|NCT01075321|65697630|FG002|Overall Study|Protocol Violation|1|||
23536889|NCT01075321|65697631|FG003|Overall Study|Protocol Violation|0|||
23536890|NCT01075321|65697628|FG000|Overall Study|Treatment Incomplete due to progression|1|||
23536891|NCT01075321|65697629|FG001|Overall Study|Treatment Incomplete due to progression|0|||
23536892|NCT01075321|65697630|FG002|Overall Study|Treatment Incomplete due to progression|0|||
23536893|NCT01075321|65697631|FG003|Overall Study|Treatment Incomplete due to progression|0|||
23536894|NCT01075321|65697628|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
23536895|NCT01075321|65697629|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
23536896|NCT01075321|65697630|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
23536897|NCT01075321|65697631|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
23423444|NCT02435680|65292646|FG001|Overall Study|not treated|0|||
23423445|NCT02435680|65292647|FG002|Overall Study|not treated|1|||
23536898|NCT02091167|65697632|FG000|Overall Study|Lost to Follow-up|0|||
23536899|NCT02091167|65697633|FG001|Overall Study|Lost to Follow-up|2|||
23536900|NCT02252081|65697641|FG000|Overall Study|Withdrawal by Subject|2|||
23536901|NCT02252081|65697642|FG001|Overall Study|Withdrawal by Subject|1|||
23536902|NCT02252081|65697641|FG000|Overall Study|Adverse Event|4|||
23536903|NCT02252081|65697642|FG001|Overall Study|Adverse Event|1|||
23536904|NCT02252081|65697641|FG000|Overall Study|non compliance & others|0|||
23536905|NCT02252081|65697642|FG001|Overall Study|non compliance & others|2|||
23536906|NCT03042312|65697650|FG000|Overall Study|Administrative Reason|1|||
23536907|NCT03042312|65697651|FG001|Overall Study|Administrative Reason|1|||
23536908|NCT03042312|65697650|FG000|Overall Study|Adverse Event|0|||
23536909|NCT03042312|65697651|FG001|Overall Study|Adverse Event|1|||
23536910|NCT03042312|65697650|FG000|Overall Study|Lost to Follow-up|1|||
23536911|NCT03042312|65697651|FG001|Overall Study|Lost to Follow-up|3|||
23536912|NCT03042312|65697650|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
23536913|NCT03042312|65697651|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
23536914|NCT03042312|65697650|FG000|Overall Study|Withdrawal by Subject|4|||
23536915|NCT03042312|65697651|FG001|Overall Study|Withdrawal by Subject|5|||
23536916|NCT00699699|65697652|FG000|Overall Study|Adverse Event|36|||
23536917|NCT00699699|65697652|FG000|Overall Study|Individual different reasons|21|||
23536918|NCT01532687|65697654|FG000|Overall Study|Death|2|||
23536919|NCT01532687|65697655|FG001|Overall Study|Death|0|||
23536920|NCT01532687|65697654|FG000|Overall Study|Adverse Event|6|||
23536921|NCT01532687|65697655|FG001|Overall Study|Adverse Event|1|||
23536922|NCT01532687|65697654|FG000|Overall Study|Withdrawal by Subject|1|||
23536923|NCT01532687|65697655|FG001|Overall Study|Withdrawal by Subject|0|||
23536924|NCT01532687|65697654|FG000|Overall Study|Physician Decision|2|||
23536925|NCT01532687|65697655|FG001|Overall Study|Physician Decision|1|||
23536926|NCT01532687|65697654|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
23536927|NCT01532687|65697655|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
23536928|NCT02886572|65697658|FG000|Overall Study|Death|8|||
23536929|NCT02984995|65697659|FG000|Overall Study|Required stem cell transplant|13|||
23536930|NCT02984995|65697660|FG001|Overall Study|Required stem cell transplant|2|||
23423446|NCT01596335|65292662|FG000|Overall Study|exacerbation of primary disease|5|||
23536931|NCT02984995|65697659|FG000|Overall Study|Progressive disease|11|||
23536932|NCT02984995|65697660|FG001|Overall Study|Progressive disease|1|||
23536933|NCT02984995|65697659|FG000|Overall Study|Adverse Event|1|||
23423447|NCT01596335|65292663|FG001|Overall Study|exacerbation of primary disease|9|||
23423448|NCT03362931|65292664|FG000|Overall Study|Adverse Event|1|||
23536934|NCT02984995|65697660|FG001|Overall Study|Adverse Event|0|||
23536935|NCT04121962|65697661|FG000|Overall Study|Lost to Follow-up|42|||
23536936|NCT04121962|65697662|FG001|Overall Study|Lost to Follow-up|39|||
23536937|NCT05070897|65697665|FG000|Overall Study|Protocol Violation|123|||
23536938|NCT05070897|65697666|FG001|Overall Study|Protocol Violation|68|||
23536939|NCT01018264|65697667|FG000|Overall Study|Withdrawal by Subject|1|||
23536940|NCT01018264|65697668|FG001|Overall Study|Withdrawal by Subject|0|||
23536941|NCT01018264|65697667|FG000|Overall Study|Lost to Follow-up|0|||
23536942|NCT01018264|65697668|FG001|Overall Study|Lost to Follow-up|1|||
23536943|NCT03930745|65697674|FG000|Overall Study|Lost to Follow-up|10|||
23536944|NCT03930745|65697675|FG001|Overall Study|Lost to Follow-up|5|||
23536945|NCT03930745|65697674|FG000|Overall Study|Withdrawal by Subject|1|||
23536946|NCT03930745|65697675|FG001|Overall Study|Withdrawal by Subject|2|||
23536947|NCT03930745|65697674|FG000|Overall Study|Protocol Violation|2|||
23536948|NCT03930745|65697675|FG001|Overall Study|Protocol Violation|2|||
23536949|NCT03930745|65697674|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
23536950|NCT03930745|65697675|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
23536951|NCT03930745|65697674|FG000|Overall Study|Adverse Event|0|||
23536952|NCT03930745|65697675|FG001|Overall Study|Adverse Event|1|||
23536953|NCT03930745|65697674|FG000|Overall Study|Pregnancy|0|||
23536954|NCT03930745|65697675|FG001|Overall Study|Pregnancy|1|||
23536955|NCT00533949|65697676|FG000|Overall Study|Protocol Violation|12|||
23536956|NCT00533949|65697677|FG001|Overall Study|Protocol Violation|12|||
23536957|NCT00533949|65697678|FG002|Overall Study|Protocol Violation|9|||
23536958|NCT00533949|65697679|FG003|Overall Study|Protocol Violation|9|||
23536959|NCT00533949|65697676|FG000|Overall Study|Withdrawal by Subject|3|||
23536960|NCT00533949|65697677|FG001|Overall Study|Withdrawal by Subject|2|||
23536961|NCT00533949|65697678|FG002|Overall Study|Withdrawal by Subject|1|||
23536962|NCT00533949|65697679|FG003|Overall Study|Withdrawal by Subject|1|||
23536963|NCT03952039|65697680|FG000|Overall Study|Adverse Event|22|||
23536964|NCT03952039|65697681|FG001|Overall Study|Adverse Event|8|||
23536965|NCT03952039|65697680|FG000|Overall Study|Withdrawal by Participant|17|||
23536966|NCT03952039|65697681|FG001|Overall Study|Withdrawal by Participant|12|||
23536967|NCT03952039|65697680|FG000|Overall Study|Death|13|||
23536968|NCT03952039|65697681|FG001|Overall Study|Death|6|||
23536969|NCT03952039|65697680|FG000|Overall Study|Lack of Efficacy|12|||
23536970|NCT03952039|65697681|FG001|Overall Study|Lack of Efficacy|2|||
23536971|NCT03952039|65697680|FG000|Overall Study|Physician Decision|9|||
23536972|NCT03952039|65697681|FG001|Overall Study|Physician Decision|3|||
23536973|NCT03952039|65697680|FG000|Overall Study|Progressive Disease|6|||
23536974|NCT03952039|65697681|FG001|Overall Study|Progressive Disease|4|||
23423449|NCT03362931|65292664|FG000|Overall Study|Death|2|||
23536975|NCT03952039|65697680|FG000|Overall Study|Other Reasons|12|||
23536976|NCT03952039|65697681|FG001|Overall Study|Other Reasons|4|||
23536977|NCT00274716|65697686|FG000|Phase A|Other non-reported reason|4|||
23536978|NCT00274716|65697687|FG001|Phase A|Other non-reported reason|2|||
23536979|NCT00274716|65697688|FG002|Phase A|Other non-reported reason|1|||
23536980|NCT00274716|65697689|FG003|Phase A|Other non-reported reason|2|||
23536981|NCT00274716|65697690|FG004|Phase A|Other non-reported reason|0|||
23536982|NCT00274716|65697691|FG005|Phase A|Other non-reported reason|1|||
23536983|NCT00274716|65697686|FG000|Phase A|Participant moved|0|||
23536984|NCT00274716|65697687|FG001|Phase A|Participant moved|0|||
23536985|NCT00274716|65697688|FG002|Phase A|Participant moved|1|||
23536986|NCT00274716|65697689|FG003|Phase A|Participant moved|0|||
23536987|NCT00274716|65697690|FG004|Phase A|Participant moved|0|||
23536988|NCT00274716|65697691|FG005|Phase A|Participant moved|1|||
23536989|NCT00274716|65697686|FG000|Phase A|Site Terminated|0|||
23536990|NCT00274716|65697687|FG001|Phase A|Site Terminated|0|||
23536991|NCT00274716|65697688|FG002|Phase A|Site Terminated|0|||
23536992|NCT00274716|65697689|FG003|Phase A|Site Terminated|1|||
23536993|NCT00274716|65697690|FG004|Phase A|Site Terminated|0|||
23536994|NCT00274716|65697691|FG005|Phase A|Site Terminated|0|||
23536995|NCT00274716|65697686|FG000|Phase A|Protocol Violation|1|||
23536996|NCT00274716|65697687|FG001|Phase A|Protocol Violation|0|||
23536997|NCT00274716|65697688|FG002|Phase A|Protocol Violation|0|||
23536998|NCT00274716|65697689|FG003|Phase A|Protocol Violation|1|||
23536999|NCT00274716|65697690|FG004|Phase A|Protocol Violation|0|||
23537000|NCT00274716|65697691|FG005|Phase A|Protocol Violation|0|||
23537001|NCT00274716|65697686|FG000|Phase A|Met criteria for discontinuation|1|||
23537002|NCT00274716|65697687|FG001|Phase A|Met criteria for discontinuation|1|||
23537003|NCT00274716|65697688|FG002|Phase A|Met criteria for discontinuation|0|||
23537004|NCT00274716|65697689|FG003|Phase A|Met criteria for discontinuation|0|||
23537005|NCT00274716|65697690|FG004|Phase A|Met criteria for discontinuation|0|||
23423450|NCT01819129|65292669|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
23537006|NCT00274716|65697691|FG005|Phase A|Met criteria for discontinuation|0|||
23537007|NCT00274716|65697686|FG000|Phase A|Withdrawal by Subject|2|||
23537008|NCT00274716|65697687|FG001|Phase A|Withdrawal by Subject|2|||
23537009|NCT00274716|65697688|FG002|Phase A|Withdrawal by Subject|1|||
23537010|NCT00274716|65697689|FG003|Phase A|Withdrawal by Subject|3|||
23423451|NCT01819129|65292670|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
23423452|NCT01819129|65292669|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
23537011|NCT00274716|65697690|FG004|Phase A|Withdrawal by Subject|0|||
23537012|NCT00274716|65697691|FG005|Phase A|Withdrawal by Subject|1|||
23537013|NCT00274716|65697686|FG000|Phase A|Adverse Event|2|||
23537014|NCT00274716|65697687|FG001|Phase A|Adverse Event|3|||
23537015|NCT00274716|65697688|FG002|Phase A|Adverse Event|3|||
23537016|NCT00274716|65697689|FG003|Phase A|Adverse Event|0|||
23537017|NCT00274716|65697690|FG004|Phase A|Adverse Event|2|||
23537018|NCT00274716|65697691|FG005|Phase A|Adverse Event|0|||
23537019|NCT00274716|65697686|FG000|Phase A|Completed but did not enter Phase B|1|||
23537020|NCT00274716|65697687|FG001|Phase A|Completed but did not enter Phase B|2|||
23537021|NCT00274716|65697688|FG002|Phase A|Completed but did not enter Phase B|2|||
23537022|NCT00274716|65697689|FG003|Phase A|Completed but did not enter Phase B|2|||
23537023|NCT00274716|65697690|FG004|Phase A|Completed but did not enter Phase B|1|||
23537024|NCT00274716|65697691|FG005|Phase A|Completed but did not enter Phase B|1|||
23537025|NCT00274716|65697686|FG000|Phase B|Adverse Event|0|||
23537026|NCT00274716|65697687|FG001|Phase B|Adverse Event|0|||
23537027|NCT00274716|65697688|FG002|Phase B|Adverse Event|2|||
23537028|NCT00274716|65697689|FG003|Phase B|Adverse Event|0|||
23537029|NCT00274716|65697690|FG004|Phase B|Adverse Event|0|||
23537030|NCT00274716|65697691|FG005|Phase B|Adverse Event|1|||
23537031|NCT00274716|65697686|FG000|Phase B|Protocol Violation|0|||
23423453|NCT01819129|65292670|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
23423454|NCT01819129|65292669|FG000|Overall Study|Other, Subject moved out of the country|0|||
23423455|NCT01819129|65292670|FG001|Overall Study|Other, Subject moved out of the country|1|||
23423456|NCT01819129|65292669|FG000|Overall Study|Withdrawal by Subject|15|||
23423457|NCT01819129|65292670|FG001|Overall Study|Withdrawal by Subject|15|||
23423458|NCT01819129|65292669|FG000|Overall Study|Lost to Follow-up|5|||
23423459|NCT01819129|65292670|FG001|Overall Study|Lost to Follow-up|2|||
23423460|NCT01819129|65292669|FG000|Overall Study|Lack of Efficacy|0|||
23423461|NCT01819129|65292670|FG001|Overall Study|Lack of Efficacy|1|||
23423462|NCT01819129|65292669|FG000|Overall Study|Adverse Event|1|||
23423463|NCT01819129|65292670|FG001|Overall Study|Adverse Event|4|||
23423464|NCT01819129|65292669|FG000|Overall Study|Death|1|||
23423465|NCT01819129|65292670|FG001|Overall Study|Death|1|||
23423466|NCT01819129|65292669|FG000|Overall Study|Withdrawal Criteria|20|||
23423467|NCT01819129|65292670|FG001|Overall Study|Withdrawal Criteria|15|||
23423468|NCT02791191|65292671|FG000|Overall Study|Adverse Event|2|||
23423469|NCT02791191|65292672|FG001|Overall Study|Adverse Event|4|||
23423470|NCT02791191|65292673|FG002|Overall Study|Adverse Event|5|||
23423471|NCT02791191|65292671|FG000|Overall Study|Lack of Efficacy|0|||
23423472|NCT02791191|65292672|FG001|Overall Study|Lack of Efficacy|1|||
23423473|NCT02791191|65292673|FG002|Overall Study|Lack of Efficacy|0|||
23423474|NCT02791191|65292671|FG000|Overall Study|Study Drug Non-Compliance|0|||
23423475|NCT02791191|65292672|FG001|Overall Study|Study Drug Non-Compliance|2|||
23423476|NCT02791191|65292673|FG002|Overall Study|Study Drug Non-Compliance|0|||
23537032|NCT00274716|65697687|FG001|Phase B|Protocol Violation|2|||
23537033|NCT00274716|65697688|FG002|Phase B|Protocol Violation|0|||
23537034|NCT00274716|65697689|FG003|Phase B|Protocol Violation|0|||
23537035|NCT00274716|65697690|FG004|Phase B|Protocol Violation|0|||
23537036|NCT00274716|65697691|FG005|Phase B|Protocol Violation|0|||
23537037|NCT00274716|65697686|FG000|Phase B|Withdrawal by Subject|0|||
23537038|NCT00274716|65697687|FG001|Phase B|Withdrawal by Subject|1|||
23537039|NCT00274716|65697688|FG002|Phase B|Withdrawal by Subject|0|||
23537040|NCT00274716|65697689|FG003|Phase B|Withdrawal by Subject|0|||
23537041|NCT00274716|65697690|FG004|Phase B|Withdrawal by Subject|0|||
23423477|NCT02791191|65292671|FG000|Overall Study|Site Closed by Sponsor|1|||
23423478|NCT02791191|65292672|FG001|Overall Study|Site Closed by Sponsor|1|||
23537042|NCT00274716|65697691|FG005|Phase B|Withdrawal by Subject|0|||
23537043|NCT00274716|65697686|FG000|Phase B|Participant moved|1|||
23537044|NCT00274716|65697687|FG001|Phase B|Participant moved|0|||
23537045|NCT00274716|65697688|FG002|Phase B|Participant moved|0|||
23537046|NCT00274716|65697689|FG003|Phase B|Participant moved|0|||
23537047|NCT00274716|65697690|FG004|Phase B|Participant moved|0|||
23423479|NCT02791191|65292673|FG002|Overall Study|Site Closed by Sponsor|3|||
23423480|NCT02791191|65292671|FG000|Overall Study|Progressive Disease|1|||
23423481|NCT02791191|65292672|FG001|Overall Study|Progressive Disease|0|||
23423482|NCT02791191|65292673|FG002|Overall Study|Progressive Disease|0|||
23423483|NCT02791191|65292671|FG000|Overall Study|Study Terminated by Sponsor|29|||
23537048|NCT00274716|65697691|FG005|Phase B|Participant moved|0|||
23537049|NCT00274716|65697686|FG000|Phase B|Other non-reported reason|0|||
23537050|NCT00274716|65697687|FG001|Phase B|Other non-reported reason|0|||
23537051|NCT00274716|65697688|FG002|Phase B|Other non-reported reason|1|||
23537052|NCT00274716|65697689|FG003|Phase B|Other non-reported reason|1|||
23537053|NCT00274716|65697690|FG004|Phase B|Other non-reported reason|0|||
23537054|NCT00274716|65697691|FG005|Phase B|Other non-reported reason|0|||
23537055|NCT00274716|65697686|FG000|Phase B|Lost to Follow-up|0|||
23537056|NCT00274716|65697687|FG001|Phase B|Lost to Follow-up|1|||
23423484|NCT02791191|65292672|FG001|Overall Study|Study Terminated by Sponsor|101|||
23423485|NCT02791191|65292673|FG002|Overall Study|Study Terminated by Sponsor|109|||
23423486|NCT02791191|65292671|FG000|Overall Study|Withdrawal by Subject|3|||
23423487|NCT02791191|65292672|FG001|Overall Study|Withdrawal by Subject|1|||
23423488|NCT02791191|65292673|FG002|Overall Study|Withdrawal by Subject|3|||
23423489|NCT02791191|65292671|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
23423490|NCT02791191|65292672|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
23423491|NCT02791191|65292673|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
23423492|NCT03440918|65292674|FG000|Overall Study|Protocol Violation|0|||
23423493|NCT03440918|65292675|FG001|Overall Study|Protocol Violation|16|||
23537057|NCT00274716|65697688|FG002|Phase B|Lost to Follow-up|0|||
23423494|NCT01952665|65292676|FG000|Overall Study|Physician Decision|3|||
23423495|NCT01952665|65292677|FG001|Overall Study|Physician Decision|2|||
23423496|NCT01952665|65292676|FG000|Overall Study|Lost to Follow-up|1|||
23423497|NCT01952665|65292677|FG001|Overall Study|Lost to Follow-up|2|||
23423498|NCT01952665|65292676|FG000|Overall Study|Adverse Event|2|||
23423499|NCT01952665|65292677|FG001|Overall Study|Adverse Event|1|||
23423500|NCT01952665|65292676|FG000|Overall Study|Protocol Violation|0|||
23423501|NCT01952665|65292677|FG001|Overall Study|Protocol Violation|1|||
23423502|NCT01728077|65292678|FG000|Overall Study|Lack of Efficacy|3|||
23423503|NCT01728077|65292679|FG001|Overall Study|Lack of Efficacy|1|||
23423504|NCT01728077|65292678|FG000|Overall Study|Lost to Follow-up|1|||
23423505|NCT01728077|65292679|FG001|Overall Study|Lost to Follow-up|0|||
23423506|NCT01728077|65292678|FG000|Overall Study|Subject choice|2|||
23423507|NCT01728077|65292679|FG001|Overall Study|Subject choice|3|||
23423508|NCT01728077|65292678|FG000|Overall Study|Death|0|||
23423509|NCT01728077|65292679|FG001|Overall Study|Death|1|||
23423510|NCT01728077|65292678|FG000|Overall Study|Patient moving|1|||
23423511|NCT01728077|65292679|FG001|Overall Study|Patient moving|0|||
23423512|NCT01728077|65292678|FG000|Overall Study|Non compliance|1|||
23423513|NCT01728077|65292679|FG001|Overall Study|Non compliance|0|||
23423514|NCT01571284|65292681|FG000|Overall Study|Participant's decision|84|||
23423515|NCT01571284|65292681|FG000|Overall Study|Lost to Follow-up|3|||
23423516|NCT01571284|65292681|FG000|Overall Study|Enrolled but not treated|2|||
23423517|NCT01571284|65292681|FG000|Overall Study|Other than specified above|80|||
23423518|NCT03060512|65292682|FG000|Overall Study|Adverse Event|4|||
23423519|NCT03060512|65292683|FG001|Overall Study|Adverse Event|6|||
23423520|NCT03060512|65292682|FG000|Overall Study|Lost to Follow-up|1|||
23423521|NCT03060512|65292683|FG001|Overall Study|Lost to Follow-up|1|||
23537058|NCT00274716|65697689|FG003|Phase B|Lost to Follow-up|0|||
23537059|NCT00274716|65697690|FG004|Phase B|Lost to Follow-up|0|||
23537060|NCT00274716|65697691|FG005|Phase B|Lost to Follow-up|0|||
23537061|NCT00110266|65697692|FG000|Overall Study|Adverse Event|27|||
23537062|NCT00110266|65697692|FG000|Overall Study|Abnormal laboratory value|15|||
23537063|NCT00110266|65697692|FG000|Overall Study|Withdrawal by Subject|16|||
23537064|NCT00110266|65697692|FG000|Overall Study|Death|17|||
23537065|NCT00110266|65697692|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23537066|NCT00110266|65697692|FG000|Overall Study|Participant condition no longer requires study drug|1|||
23537067|NCT02167035|65697694|FG000|Overall Study|Adverse Event|2|||
23537068|NCT02167035|65697695|FG001|Overall Study|Adverse Event|2|||
23537069|NCT02167035|65697694|FG000|Overall Study|Lost to Follow-up|3|||
23537070|NCT02167035|65697695|FG001|Overall Study|Lost to Follow-up|3|||
23537071|NCT02167035|65697694|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
23537072|NCT02167035|65697695|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
23537073|NCT04317586|65697696|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
23537074|NCT04317586|65697696|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
23537075|NCT02486406|65697697|FG000|Overall Study|Withdrew consent|1|||
23537076|NCT02486406|65697698|FG001|Overall Study|Withdrew consent|0|||
23537077|NCT02486406|65697699|FG002|Overall Study|Withdrew consent|0|||
23537078|NCT02486406|65697700|FG003|Overall Study|Withdrew consent|1|||
23537079|NCT02486406|65697697|FG000|Overall Study|Lost to Follow-up|1|||
23537080|NCT02486406|65697698|FG001|Overall Study|Lost to Follow-up|3|||
23537081|NCT02486406|65697699|FG002|Overall Study|Lost to Follow-up|1|||
23537082|NCT02486406|65697700|FG003|Overall Study|Lost to Follow-up|3|||
23537083|NCT02486406|65697697|FG000|Overall Study|Other, not specified|0|||
23537084|NCT02486406|65697698|FG001|Overall Study|Other, not specified|0|||
23537085|NCT02486406|65697699|FG002|Overall Study|Other, not specified|1|||
23537086|NCT02486406|65697700|FG003|Overall Study|Other, not specified|0|||
23537087|NCT01168999|65697701|FG000|Overall Study|Lost to Follow-up|2|||
23537088|NCT01168999|65697702|FG001|Overall Study|Lost to Follow-up|1|||
23537089|NCT01168999|65697703|FG002|Overall Study|Lost to Follow-up|0|||
23423522|NCT03060512|65292682|FG000|Overall Study|Withdrawal by Subject|1|||
23423523|NCT03060512|65292683|FG001|Overall Study|Withdrawal by Subject|0|||
23423524|NCT03060512|65292682|FG000|Overall Study|Non-compliance with study medication|1|||
23423525|NCT03060512|65292683|FG001|Overall Study|Non-compliance with study medication|2|||
23423526|NCT03770728|65296172|FG000|Overall Study|Adverse Event|1|||
23423527|NCT03770728|65296173|FG001|Overall Study|Adverse Event|0|||
23423528|NCT03770728|65296174|FG002|Overall Study|Adverse Event|1|||
23537090|NCT01168999|65697704|FG003|Overall Study|Lost to Follow-up|0|||
23537091|NCT00844545|65697705|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
23537092|NCT00844545|65697705|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
23537093|NCT00844545|65697705|FG000|Extension Treatment Period|Adverse Event|2|||
23537094|NCT00844545|65697705|FG000|Post Treatment Period|Withdrawal by Subject|1|||
23537095|NCT04661033|65697706|FG000|Overall Study|Adverse Event|0|||
23537096|NCT04661033|65697707|FG001|Overall Study|Adverse Event|0|||
23537097|NCT04661033|65697708|FG002|Overall Study|Adverse Event|1|||
23537098|NCT04661033|65697709|FG003|Overall Study|Adverse Event|0|||
23537099|NCT04661033|65697706|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
23537100|NCT04661033|65697707|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
23537101|NCT04661033|65697708|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
23537102|NCT04661033|65697709|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
23537103|NCT04661033|65697706|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
23537104|NCT04661033|65697707|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
23537105|NCT04661033|65697708|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
23537106|NCT04661033|65697709|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
23537107|NCT04661033|65697706|FG000|Overall Study|Early discontinuation as per PI|1|||
23537108|NCT04661033|65697707|FG001|Overall Study|Early discontinuation as per PI|0|||
23537109|NCT04661033|65697708|FG002|Overall Study|Early discontinuation as per PI|0|||
23537110|NCT04661033|65697709|FG003|Overall Study|Early discontinuation as per PI|0|||
23537111|NCT04982029|65697710|FG000|Overall Study|Lost to Follow-up|2|||
23537112|NCT04982029|65697711|FG001|Overall Study|Lost to Follow-up|3|||
23537113|NCT00441337|65697718|FG000|Overall Study|Disease Progression|6|||
23537114|NCT00441337|65697719|FG001|Overall Study|Disease Progression|6|||
23537115|NCT00441337|65697720|FG002|Overall Study|Disease Progression|4|||
23537116|NCT00441337|65697721|FG003|Overall Study|Disease Progression|18|||
23537117|NCT00441337|65697718|FG000|Overall Study|Lost to Follow-up|0|||
23537118|NCT00441337|65697719|FG001|Overall Study|Lost to Follow-up|0|||
23537119|NCT00441337|65697720|FG002|Overall Study|Lost to Follow-up|0|||
23537120|NCT00441337|65697721|FG003|Overall Study|Lost to Follow-up|1|||
23537121|NCT00441337|65697718|FG000|Overall Study|Sponsor Decision|0|||
23537122|NCT00441337|65697719|FG001|Overall Study|Sponsor Decision|0|||
23537123|NCT00441337|65697720|FG002|Overall Study|Sponsor Decision|1|||
23537124|NCT00441337|65697721|FG003|Overall Study|Sponsor Decision|2|||
23537125|NCT00441337|65697718|FG000|Overall Study|Did not meet inclusion criteria|0|||
23537126|NCT00441337|65697719|FG001|Overall Study|Did not meet inclusion criteria|0|||
23537127|NCT00441337|65697720|FG002|Overall Study|Did not meet inclusion criteria|1|||
23537128|NCT00441337|65697721|FG003|Overall Study|Did not meet inclusion criteria|0|||
23537129|NCT00733824|65697722|FG000|Phase I|Withdrawal by Subject|1|||
23537130|NCT00733824|65697723|FG001|Phase I|Withdrawal by Subject|0|||
23537131|NCT00733824|65697724|FG002|Phase I|Withdrawal by Subject|0|||
23537132|NCT00733824|65697725|FG003|Phase I|Withdrawal by Subject|0|||
23537133|NCT00733824|65697726|FG004|Phase I|Withdrawal by Subject|0|||
23537134|NCT00320216|65697727|FG000|Overall Study|Adverse Event|0|||
23537135|NCT00320216|65697728|FG001|Overall Study|Adverse Event|6|||
23537136|NCT00320216|65697729|FG002|Overall Study|Adverse Event|0|||
23537137|NCT00320216|65697730|FG003|Overall Study|Adverse Event|2|||
23537138|NCT00320216|65697731|FG004|Overall Study|Adverse Event|2|||
23537139|NCT00320216|65697727|FG000|Overall Study|Lack of Efficacy|6|||
23537140|NCT00320216|65697728|FG001|Overall Study|Lack of Efficacy|2|||
23537141|NCT00320216|65697729|FG002|Overall Study|Lack of Efficacy|1|||
23537142|NCT00320216|65697730|FG003|Overall Study|Lack of Efficacy|0|||
23537143|NCT00320216|65697731|FG004|Overall Study|Lack of Efficacy|1|||
23537144|NCT00320216|65697727|FG000|Overall Study|Lost to Follow-up|3|||
23537145|NCT00320216|65697728|FG001|Overall Study|Lost to Follow-up|0|||
23537146|NCT00320216|65697729|FG002|Overall Study|Lost to Follow-up|0|||
23537147|NCT00320216|65697730|FG003|Overall Study|Lost to Follow-up|0|||
23537148|NCT00320216|65697731|FG004|Overall Study|Lost to Follow-up|0|||
23537149|NCT00320216|65697727|FG000|Overall Study|Other|7|||
23537150|NCT00320216|65697728|FG001|Overall Study|Other|2|||
23537151|NCT00320216|65697729|FG002|Overall Study|Other|5|||
23537152|NCT00320216|65697730|FG003|Overall Study|Other|1|||
23537153|NCT00320216|65697731|FG004|Overall Study|Other|3|||
23537154|NCT01344057|65697735|FG000|Overall Study|Premature Withdrawal|1|||
23537155|NCT03251924|65697736|FG000|Overall Study|Disease Progression|6|||
23537156|NCT03251924|65697737|FG001|Overall Study|Disease Progression|6|||
23537157|NCT03251924|65697738|FG002|Overall Study|Disease Progression|7|||
23537158|NCT03251924|65697739|FG003|Overall Study|Disease Progression|8|||
23537159|NCT03251924|65697740|FG004|Overall Study|Disease Progression|8|||
23537160|NCT03251924|65697741|FG005|Overall Study|Disease Progression|7|||
23537161|NCT03251924|65697742|FG006|Overall Study|Disease Progression|6|||
23537162|NCT03251924|65697743|FG007|Overall Study|Disease Progression|10|||
23537163|NCT03251924|65697744|FG008|Overall Study|Disease Progression|6|||
23537164|NCT03251924|65697736|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
23537165|NCT03251924|65697737|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
23537166|NCT03251924|65697738|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
23537167|NCT03251924|65697739|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
23537168|NCT03251924|65697740|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
23537169|NCT03251924|65697741|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
23537170|NCT03251924|65697742|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
23537171|NCT03251924|65697743|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
23537172|NCT03251924|65697744|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
23537173|NCT03251924|65697736|FG000|Overall Study|Death|0|||
23537174|NCT03251924|65697737|FG001|Overall Study|Death|1|||
23537175|NCT03251924|65697738|FG002|Overall Study|Death|0|||
23537176|NCT03251924|65697739|FG003|Overall Study|Death|1|||
23537177|NCT03251924|65697740|FG004|Overall Study|Death|1|||
23537178|NCT03251924|65697741|FG005|Overall Study|Death|1|||
23537179|NCT03251924|65697742|FG006|Overall Study|Death|0|||
23537180|NCT03251924|65697743|FG007|Overall Study|Death|0|||
23537181|NCT03251924|65697744|FG008|Overall Study|Death|0|||
23537182|NCT03251924|65697736|FG000|Overall Study|Study Drug Toxicity|0|||
23537183|NCT03251924|65697737|FG001|Overall Study|Study Drug Toxicity|0|||
23537184|NCT03251924|65697738|FG002|Overall Study|Study Drug Toxicity|0|||
23537185|NCT03251924|65697739|FG003|Overall Study|Study Drug Toxicity|1|||
23537186|NCT03251924|65697740|FG004|Overall Study|Study Drug Toxicity|0|||
23537187|NCT03251924|65697741|FG005|Overall Study|Study Drug Toxicity|0|||
23537188|NCT03251924|65697742|FG006|Overall Study|Study Drug Toxicity|0|||
23537189|NCT03251924|65697743|FG007|Overall Study|Study Drug Toxicity|0|||
23537190|NCT03251924|65697744|FG008|Overall Study|Study Drug Toxicity|1|||
23537191|NCT03251924|65697736|FG000|Overall Study|Other Reasons|0|||
23537192|NCT03251924|65697737|FG001|Overall Study|Other Reasons|0|||
23537193|NCT03251924|65697738|FG002|Overall Study|Other Reasons|0|||
23537194|NCT03251924|65697739|FG003|Overall Study|Other Reasons|0|||
23537195|NCT03251924|65697740|FG004|Overall Study|Other Reasons|0|||
23537196|NCT03251924|65697741|FG005|Overall Study|Other Reasons|0|||
23537197|NCT03251924|65697742|FG006|Overall Study|Other Reasons|0|||
23537198|NCT03251924|65697743|FG007|Overall Study|Other Reasons|0|||
23537199|NCT03251924|65697744|FG008|Overall Study|Other Reasons|1|||
23537200|NCT03251924|65697736|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23537201|NCT03251924|65697737|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23537202|NCT03251924|65697738|FG002|Overall Study|Participant request to discontinue study treatment|0|||
23537203|NCT03251924|65697739|FG003|Overall Study|Participant request to discontinue study treatment|0|||
23537204|NCT03251924|65697740|FG004|Overall Study|Participant request to discontinue study treatment|0|||
23537205|NCT03251924|65697741|FG005|Overall Study|Participant request to discontinue study treatment|0|||
23537206|NCT03251924|65697742|FG006|Overall Study|Participant request to discontinue study treatment|0|||
23537207|NCT03251924|65697743|FG007|Overall Study|Participant request to discontinue study treatment|1|||
23537208|NCT03251924|65697744|FG008|Overall Study|Participant request to discontinue study treatment|0|||
23537209|NCT01827904|65697745|FG000|Main Study|Withdrawal by Subject|1|||
23537210|NCT01827904|65697746|FG001|Main Study|Withdrawal by Subject|0|||
23537211|NCT01827904|65697747|FG002|Main Study|Withdrawal by Subject|0|||
23537212|NCT01827904|65697745|FG000|Main Study|Adverse Event|1|||
23537213|NCT01827904|65697746|FG001|Main Study|Adverse Event|0|||
23537214|NCT01827904|65697747|FG002|Main Study|Adverse Event|0|||
23537215|NCT01827904|65697745|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
23537216|NCT01827904|65697746|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
23537217|NCT01827904|65697747|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
23537218|NCT01827904|65697745|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
23537219|NCT01827904|65697746|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
23537220|NCT01827904|65697747|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
23537221|NCT01827904|65697745|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
23537222|NCT01827904|65697746|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
23537223|NCT01827904|65697747|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
23537224|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
23537225|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
23537226|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
23537227|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
23537228|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
23537229|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
23537230|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
23537231|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
23537232|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
23537233|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
23537234|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
23537235|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
23537236|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Physician Decision|1|||
23537237|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Physician Decision|0|||
23537238|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Physician Decision|0|||
23537239|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
23537240|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
23537241|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
23537242|NCT01827904|65697745|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
23537243|NCT01827904|65697746|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
23537244|NCT01827904|65697747|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
23537245|NCT00827372|65697748|FG000|Overall Study|Adverse Event|5|||
23537246|NCT00827372|65697748|FG000|Overall Study|Lack of Efficacy|3|||
23537247|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
23537248|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537249|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537250|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537251|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537252|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23537253|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
23537254|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537255|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537256|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537257|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537258|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23537259|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
23537260|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23537261|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23537262|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23537263|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23208946|NCT00280150|64501127|FG002|Overall Study|Declining Performance Status|0|||
23208947|NCT00280150|64501128|FG003|Overall Study|Declining Performance Status|1|||
23208948|NCT01429077|64501129|FG000|Overall Study|Lost to Follow-up|0|||
23208949|NCT01429077|64501130|FG001|Overall Study|Lost to Follow-up|3|||
23208950|NCT01265420|64501141|FG000|Overall Study|Lost to Follow-up|1|||
23208951|NCT00567541|64501142|FG000|Overall Study|Adverse Event|0|||
23208952|NCT00567541|64501143|FG001|Overall Study|Adverse Event|1|||
23208953|NCT00190983|64501146|FG000|Overall Study|Inevaluable (never treated)|2|||
23208954|NCT00413062|64501147|FG000|Overall Study|Adverse event/serious adverse event|289|||
23208955|NCT00413062|64501148|FG001|Overall Study|Adverse event/serious adverse event|56|||
23208956|NCT00413062|64501147|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
23208957|NCT00413062|64501148|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
23208958|NCT00413062|64501147|FG000|Overall Study|Withdrawal of informed consent|111|||
23208959|NCT00413062|64501148|FG001|Overall Study|Withdrawal of informed consent|36|||
23208960|NCT00413062|64501147|FG000|Overall Study|Pregnancy|15|||
23208961|NCT00413062|64501148|FG001|Overall Study|Pregnancy|5|||
23208962|NCT00413062|64501147|FG000|Overall Study|Pregnancy wish|17|||
23208963|NCT00413062|64501148|FG001|Overall Study|Pregnancy wish|6|||
23208964|NCT00413062|64501147|FG000|Overall Study|Lost to Follow-up|175|||
23208965|NCT00413062|64501148|FG001|Overall Study|Lost to Follow-up|73|||
23208966|NCT00413062|64501147|FG000|Overall Study|Other reason|70|||
23208967|NCT00413062|64501148|FG001|Overall Study|Other reason|34|||
23208968|NCT00831441|64504420|FG000|Randomized|Death|82|||
23208969|NCT00831441|64504421|FG001|Randomized|Death|81|||
23208970|NCT00831441|64504420|FG000|Randomized|Adverse Event|248|||
23208971|NCT00831441|64504421|FG001|Randomized|Adverse Event|321|||
23208972|NCT00831441|64504420|FG000|Randomized|Emergency procedure|2|||
23208973|NCT00831441|64504421|FG001|Randomized|Emergency procedure|2|||
23208974|NCT00831441|64504420|FG000|Randomized|Elective procedure|26|||
23208975|NCT00831441|64504421|FG001|Randomized|Elective procedure|25|||
23208976|NCT00831441|64504420|FG000|Randomized|Physician Decision|26|||
23208977|NCT00831441|64504421|FG001|Randomized|Physician Decision|35|||
23208978|NCT00831441|64504420|FG000|Randomized|No longer met criteria|13|||
23208979|NCT00831441|64504421|FG001|Randomized|No longer met criteria|19|||
23208980|NCT00831441|64504420|FG000|Randomized|Withdrawal by Subject|178|||
23208981|NCT00831441|64504421|FG001|Randomized|Withdrawal by Subject|212|||
23208982|NCT00831441|64504420|FG000|Randomized|Lost to Follow-up|26|||
23208983|NCT00831441|64504421|FG001|Randomized|Lost to Follow-up|35|||
23208984|NCT00831441|64504420|FG000|Randomized|Administrative reason by sponsor|2780|||
23208985|NCT00831441|64504421|FG001|Randomized|Administrative reason by sponsor|2671|||
23208986|NCT00831441|64504420|FG000|Randomized|poor/non-compliance|30|||
23208987|NCT00831441|64504421|FG001|Randomized|poor/non-compliance|38|||
23208988|NCT00831441|64504420|FG000|Randomized|non-specified|276|||
23208989|NCT00831441|64504421|FG001|Randomized|non-specified|266|||
23208990|NCT00831441|64504420|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
23208991|NCT00831441|64504421|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
23208992|NCT00831441|64504420|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
23208993|NCT00831441|64504421|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
23208994|NCT00831441|64504420|FG000|Follow Up (30 Days)|Death|63|||
23208995|NCT00831441|64504421|FG001|Follow Up (30 Days)|Death|86|||
23208996|NCT00831441|64504420|FG000|Follow Up (30 Days)|non-specified|16|||
23208997|NCT00831441|64504421|FG001|Follow Up (30 Days)|non-specified|26|||
23208998|NCT00831441|64504420|FG000|Follow Up (30 Days)|missing end of study status|0|||
23208999|NCT00831441|64504421|FG001|Follow Up (30 Days)|missing end of study status|1|||
23537264|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23537265|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
23537266|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23537267|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23537268|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23537269|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23537270|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23209000|NCT02115113|64504433|FG000|Participants in Run-in Period|Death|0|||
23209001|NCT02115113|64504434|FG001|Participants in Run-in Period|Death|0|||
23209002|NCT02115113|64504435|FG002|Participants in Run-in Period|Death|1|||
23537271|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
23209003|NCT02115113|64504433|FG000|Participants in Run-in Period|Administrative problems|0|||
23209004|NCT02115113|64504434|FG001|Participants in Run-in Period|Administrative problems|0|||
23209005|NCT02115113|64504435|FG002|Participants in Run-in Period|Administrative problems|1|||
23209006|NCT02115113|64504433|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
23209007|NCT02115113|64504434|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
23537272|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537273|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537274|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537275|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537276|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23537277|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
23537278|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
23616217|NCT02085408|65979664|FG000|Step 3: Maintenance|Death|1|||
23616218|NCT02085408|65979665|FG001|Step 3: Maintenance|Death|2|||
23616219|NCT02085408|65979664|FG000|Step 3: Maintenance|Alternative Therapy|1|||
23616220|NCT02085408|65979665|FG001|Step 3: Maintenance|Alternative Therapy|1|||
23616221|NCT02085408|65979664|FG000|Step 3: Maintenance|Complicating Disease|0|||
23616222|NCT02085408|65979665|FG001|Step 3: Maintenance|Complicating Disease|1|||
23616223|NCT02085408|65979664|FG000|Step 3: Maintenance|Other|3|||
23616224|NCT02085408|65979665|FG001|Step 3: Maintenance|Other|2|||
23616225|NCT02085408|65979664|FG000|Step 3: Maintenance|Never started treatment|5|||
23616226|NCT02085408|65979665|FG001|Step 3: Maintenance|Never started treatment|1|||
23616227|NCT01514864|65982270|FG000|Overall Study|Disease progression|7|||
23616228|NCT01514864|65982271|FG001|Overall Study|Disease progression|5|||
23616229|NCT01514864|65982270|FG000|Overall Study|Study drug toxicity|2|||
23616230|NCT01514864|65982271|FG001|Overall Study|Study drug toxicity|0|||
23616231|NCT01882088|65982272|FG000|Overall Study|Intolerance of esophageal manometry|1|||
23616232|NCT01882088|65982272|FG000|Overall Study|no possibility to place the catheter|1|||
23616233|NCT01882088|65982272|FG000|Overall Study|Protocol Violation|1|||
23616234|NCT01882088|65982272|FG000|Overall Study|inadequate pH-impedance tracings|2|||
23616235|NCT03282799|65982274|FG000|Overall Study|Pregnancy|1|||
23616236|NCT03282799|65982275|FG001|Overall Study|Pregnancy|0|||
23616237|NCT03282799|65982274|FG000|Overall Study|Physician Decision|1|||
23616238|NCT03282799|65982275|FG001|Overall Study|Physician Decision|0|||
23616239|NCT05041439|65982276|FG000|Overall Study|Withdrawal by Subject|1|||
23616240|NCT05041439|65982277|FG001|Overall Study|Withdrawal by Subject|1|||
23616241|NCT05041439|65982276|FG000|Overall Study|Death|1|||
23616242|NCT05041439|65982277|FG001|Overall Study|Death|0|||
23616243|NCT01136733|65982278|FG000|Phase 1b|Adverse Event|0|||
23616244|NCT01136733|65982279|FG001|Phase 1b|Adverse Event|3|||
23616245|NCT01136733|65982280|FG002|Phase 1b|Adverse Event|1|||
23616246|NCT01136733|65982281|FG003|Phase 1b|Adverse Event|0|||
23616247|NCT01136733|65982282|FG004|Phase 1b|Adverse Event|0|||
23616248|NCT01136733|65982283|FG005|Phase 1b|Adverse Event|0|||
23209008|NCT02115113|64504435|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
23209009|NCT02115113|64504433|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
23616249|NCT01136733|65982284|FG006|Phase 1b|Adverse Event|0|||
23616250|NCT01136733|65982278|FG000|Phase 1b|Participant Choice|0|||
23616251|NCT01136733|65982279|FG001|Phase 1b|Participant Choice|0|||
23616252|NCT01136733|65982280|FG002|Phase 1b|Participant Choice|1|||
23616253|NCT01136733|65982281|FG003|Phase 1b|Participant Choice|0|||
23616254|NCT01136733|65982282|FG004|Phase 1b|Participant Choice|0|||
23616255|NCT01136733|65982283|FG005|Phase 1b|Participant Choice|0|||
23616256|NCT01136733|65982284|FG006|Phase 1b|Participant Choice|0|||
23616257|NCT01136733|65982278|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
23616258|NCT01136733|65982279|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
23616259|NCT01136733|65982280|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
23616260|NCT01136733|65982281|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
23616261|NCT01136733|65982282|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
23616262|NCT01136733|65982283|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
23616263|NCT01136733|65982284|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
23616264|NCT01136733|65982278|FG000|Phase 1b|Clinical Progression|1|||
23616265|NCT01136733|65982279|FG001|Phase 1b|Clinical Progression|1|||
23616266|NCT01136733|65982280|FG002|Phase 1b|Clinical Progression|0|||
23616267|NCT01136733|65982281|FG003|Phase 1b|Clinical Progression|0|||
23537279|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
23537280|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
23537281|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
23616268|NCT01136733|65982282|FG004|Phase 1b|Clinical Progression|0|||
23616269|NCT01136733|65982283|FG005|Phase 1b|Clinical Progression|0|||
23616270|NCT01136733|65982284|FG006|Phase 1b|Clinical Progression|0|||
23616271|NCT01136733|65982278|FG000|Phase 2|Disease Progression|0|||
23616272|NCT01136733|65982279|FG001|Phase 2|Disease Progression|0|||
23616273|NCT01136733|65982280|FG002|Phase 2|Disease Progression|0|||
23209010|NCT02115113|64504434|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
23616274|NCT01136733|65982281|FG003|Phase 2|Disease Progression|0|||
23616275|NCT01136733|65982282|FG004|Phase 2|Disease Progression|30|||
23616276|NCT01136733|65982283|FG005|Phase 2|Disease Progression|32|||
23537282|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
23537283|NCT02139644|65697751|FG000|Run-In Period (Pre-assignment)|Other|6|||
23537284|NCT02139644|65697752|FG001|Run-In Period (Pre-assignment)|Other|0|||
23537285|NCT02139644|65697753|FG002|Run-In Period (Pre-assignment)|Other|0|||
23209011|NCT02115113|64504435|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
23209012|NCT02115113|64504433|FG000|Participants Randomized|Lost to Follow-up|1|||
23209013|NCT02115113|64504434|FG001|Participants Randomized|Lost to Follow-up|0|||
23209014|NCT02115113|64504435|FG002|Participants Randomized|Lost to Follow-up|0|||
23209015|NCT02115113|64504433|FG000|Participants Randomized|Death|1|||
23209016|NCT02115113|64504434|FG001|Participants Randomized|Death|0|||
23209017|NCT02115113|64504435|FG002|Participants Randomized|Death|0|||
23209018|NCT00255086|64504436|FG000|Overall Study|Adverse Event|1|||
23209019|NCT00255086|64504437|FG001|Overall Study|Adverse Event|1|||
23209020|NCT00255086|64504436|FG000|Overall Study|Protocol Violation|1|||
23209021|NCT00255086|64504437|FG001|Overall Study|Protocol Violation|1|||
23209022|NCT02855450|64504438|FG000|Overall Study|Adverse Event|1|||
23209023|NCT02855450|64504439|FG001|Overall Study|Adverse Event|0|||
23209024|NCT02855450|64504438|FG000|Overall Study|Lost to Follow-up|4|||
23209025|NCT02855450|64504439|FG001|Overall Study|Lost to Follow-up|0|||
23209026|NCT00592553|64504440|FG000|Overall Study|Protocol Noncompliance|1|||
23209027|NCT00592553|64504441|FG001|Overall Study|Protocol Noncompliance|0|||
23537286|NCT02139644|65697754|FG003|Run-In Period (Pre-assignment)|Other|0|||
23537287|NCT02139644|65697755|FG004|Run-In Period (Pre-assignment)|Other|0|||
23537288|NCT02139644|65697756|FG005|Run-In Period (Pre-assignment)|Other|0|||
23537289|NCT02139644|65697751|FG000|Treatment Period|Adverse Event|0|||
23537290|NCT02139644|65697752|FG001|Treatment Period|Adverse Event|0|||
23209028|NCT00592553|64504442|FG002|Overall Study|Protocol Noncompliance|0|||
23209029|NCT03337152|64504443|FG000|Overall Study|Physician Decision|1|||
23209030|NCT03337152|64504444|FG001|Overall Study|Physician Decision|0|||
23537291|NCT02139644|65697753|FG002|Treatment Period|Adverse Event|3|||
23537292|NCT02139644|65697754|FG003|Treatment Period|Adverse Event|2|||
23537293|NCT02139644|65697755|FG004|Treatment Period|Adverse Event|1|||
23537294|NCT02139644|65697756|FG005|Treatment Period|Adverse Event|6|||
23537295|NCT02139644|65697751|FG000|Treatment Period|Withdrawal by Subject|0|||
23616277|NCT01136733|65982284|FG006|Phase 2|Disease Progression|38|||
23209031|NCT03337152|64504443|FG000|Overall Study|Lost to Follow-up|1|||
23209032|NCT03337152|64504444|FG001|Overall Study|Lost to Follow-up|3|||
23209033|NCT03337152|64504443|FG000|Overall Study|Adverse Event|3|||
23209034|NCT03337152|64504444|FG001|Overall Study|Adverse Event|1|||
23209035|NCT03337152|64504443|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
23209036|NCT03337152|64504444|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
23209037|NCT02932332|64504448|FG000|Overall Study|Withdrawal by Subject|1|||
23537296|NCT02139644|65697752|FG001|Treatment Period|Withdrawal by Subject|0|||
23537297|NCT02139644|65697753|FG002|Treatment Period|Withdrawal by Subject|2|||
23537298|NCT02139644|65697754|FG003|Treatment Period|Withdrawal by Subject|2|||
23537299|NCT02139644|65697755|FG004|Treatment Period|Withdrawal by Subject|3|||
23423529|NCT03770728|65296175|FG003|Overall Study|Adverse Event|0|||
23423530|NCT03770728|65296172|FG000|Overall Study|Poor compliance to protocol|0|||
23423531|NCT03770728|65296173|FG001|Overall Study|Poor compliance to protocol|0|||
23423532|NCT03770728|65296174|FG002|Overall Study|Poor compliance to protocol|1|||
23423533|NCT03770728|65296175|FG003|Overall Study|Poor compliance to protocol|0|||
23423534|NCT03770728|65296172|FG000|Overall Study|Withdrawal by Subject|13|||
23423535|NCT03770728|65296173|FG001|Overall Study|Withdrawal by Subject|8|||
23423536|NCT03770728|65296174|FG002|Overall Study|Withdrawal by Subject|9|||
23423537|NCT03770728|65296175|FG003|Overall Study|Withdrawal by Subject|13|||
23423538|NCT03770728|65296172|FG000|Overall Study|Other than specified|24|||
23423539|NCT03770728|65296173|FG001|Overall Study|Other than specified|23|||
23209038|NCT02932332|64504449|FG001|Overall Study|Withdrawal by Subject|1|||
23423540|NCT03770728|65296174|FG002|Overall Study|Other than specified|21|||
23423541|NCT03770728|65296175|FG003|Overall Study|Other than specified|22|||
23423542|NCT03664674|65296178|FG000|Overall Study|Adverse Event|1|||
23423543|NCT03664674|65296179|FG001|Overall Study|Adverse Event|1|||
23423544|NCT03664674|65296178|FG000|Overall Study|Physician Decision|0|||
23423545|NCT03664674|65296179|FG001|Overall Study|Physician Decision|1|||
23423546|NCT03664674|65296178|FG000|Overall Study|Withdrawal by Subject|2|||
23423547|NCT03664674|65296179|FG001|Overall Study|Withdrawal by Subject|0|||
23423548|NCT01566695|65296180|FG000|Overall Study|Lack of Efficacy|18|||
23423549|NCT01566695|65296181|FG001|Overall Study|Lack of Efficacy|45|||
23423550|NCT01566695|65296180|FG000|Overall Study|Adverse Event|28|||
23423551|NCT01566695|65296181|FG001|Overall Study|Adverse Event|27|||
23423552|NCT01566695|65296180|FG000|Overall Study|Death|20|||
23423553|NCT01566695|65296181|FG001|Overall Study|Death|8|||
23423554|NCT01566695|65296180|FG000|Overall Study|Withdrawal by Subject|14|||
23423555|NCT01566695|65296181|FG001|Overall Study|Withdrawal by Subject|7|||
23423556|NCT01566695|65296180|FG000|Overall Study|Progressive Disease|11|||
23423557|NCT01566695|65296181|FG001|Overall Study|Progressive Disease|6|||
23423558|NCT01566695|65296180|FG000|Overall Study|Miscellaneous|4|||
23423559|NCT01566695|65296181|FG001|Overall Study|Miscellaneous|6|||
23423560|NCT01799239|65296184|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
23423561|NCT01799239|65296185|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
23423562|NCT01799239|65296184|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
23423563|NCT01799239|65296185|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
23423564|NCT01799239|65296184|FG000|Period 1 (7 Days)|Protocol Violation|0|||
23423565|NCT01799239|65296185|FG001|Period 1 (7 Days)|Protocol Violation|1|||
23209039|NCT02932332|64504450|FG002|Overall Study|Withdrawal by Subject|0|||
23209040|NCT02932332|64504451|FG003|Overall Study|Withdrawal by Subject|1|||
23209041|NCT02932332|64504448|FG000|Overall Study|Chest pain|0|||
23209042|NCT02932332|64504449|FG001|Overall Study|Chest pain|0|||
23209043|NCT02932332|64504450|FG002|Overall Study|Chest pain|0|||
23209044|NCT02932332|64504451|FG003|Overall Study|Chest pain|1|||
23209045|NCT02932332|64504448|FG000|Overall Study|Not Dyspneic cough|1|||
23209046|NCT02932332|64504449|FG001|Overall Study|Not Dyspneic cough|2|||
23209047|NCT02932332|64504450|FG002|Overall Study|Not Dyspneic cough|1|||
23209048|NCT02932332|64504451|FG003|Overall Study|Not Dyspneic cough|0|||
23209049|NCT01391819|64504456|FG000|Overall Study|Withdrawal by Subject|56|||
23209050|NCT01391819|64504456|FG000|Overall Study|Migrated/moved from study area|82|||
23209051|NCT01391819|64504456|FG000|Overall Study|Lost to Follow-up|252|||
23423566|NCT01799239|65296184|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
23423567|NCT01799239|65296185|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
23423568|NCT01799239|65296184|FG000|Period 2 (7 Days)|Protocol Violation|1|||
23423569|NCT01799239|65296185|FG001|Period 2 (7 Days)|Protocol Violation|0|||
23423570|NCT03392883|65296188|FG000|Overall Study|Lost to Follow-up|122|||
23423571|NCT03392883|65296189|FG001|Overall Study|Lost to Follow-up|13|||
23423572|NCT03392883|65296190|FG002|Overall Study|Lost to Follow-up|9|||
23423573|NCT03392883|65296188|FG000|Overall Study|Death|4|||
23209052|NCT01391819|64504456|FG000|Overall Study|Death|3|||
23423574|NCT03392883|65296189|FG001|Overall Study|Death|0|||
23423575|NCT03392883|65296190|FG002|Overall Study|Death|0|||
23423576|NCT03392883|65296188|FG000|Overall Study|Lack of Efficacy|29|||
23423577|NCT03392883|65296189|FG001|Overall Study|Lack of Efficacy|0|||
23423578|NCT03392883|65296190|FG002|Overall Study|Lack of Efficacy|0|||
23423579|NCT03392883|65296188|FG000|Overall Study|Withdrawal by Subject|180|||
23209053|NCT01391819|64504456|FG000|Overall Study|Other|9|||
23209054|NCT00433446|64504461|FG000|Overall Study|Adverse Event|4|||
23209055|NCT00433446|64504461|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23209056|NCT00433446|64504461|FG000|Overall Study|Progression|44|||
23209057|NCT00433446|64504461|FG000|Overall Study|Other - Not Protocol specified|3|||
23209058|NCT00433446|64504461|FG000|Overall Study|Ineligible|9|||
23209059|NCT03550131|64504463|FG000|Overall Study|Lost to Follow-up|16|||
23209060|NCT03550131|64504464|FG001|Overall Study|Lost to Follow-up|24|||
23209061|NCT03550131|64504463|FG000|Overall Study|Withdrawal by Subject|36|||
23209062|NCT03550131|64504464|FG001|Overall Study|Withdrawal by Subject|28|||
23209063|NCT03550131|64504463|FG000|Overall Study|Illness of dyad member|10|||
23209064|NCT03550131|64504464|FG001|Overall Study|Illness of dyad member|2|||
23209065|NCT03550131|64504463|FG000|Overall Study|Death of person with dementia|4|||
23209066|NCT03550131|64504464|FG001|Overall Study|Death of person with dementia|8|||
23209067|NCT00333619|64504468|FG000|Overall Study|Death|12|||
23209068|NCT00333619|64504469|FG001|Overall Study|Death|6|||
23209069|NCT00333619|64504468|FG000|Overall Study|Withdrawal by Subject|6|||
23209070|NCT00333619|64504469|FG001|Overall Study|Withdrawal by Subject|1|||
23209071|NCT00333619|64504468|FG000|Overall Study|Lost to Follow-up|3|||
23209072|NCT00333619|64504469|FG001|Overall Study|Lost to Follow-up|3|||
23209073|NCT02680587|64504470|FG000|Overall Study|Withdrawal by Subject|1|||
23209074|NCT02680587|64504471|FG001|Overall Study|Withdrawal by Subject|0|||
23423580|NCT03392883|65296189|FG001|Overall Study|Withdrawal by Subject|0|||
23423581|NCT03392883|65296190|FG002|Overall Study|Withdrawal by Subject|0|||
23423582|NCT03392883|65296188|FG000|Overall Study|Adverse Event|1|||
23423583|NCT03392883|65296189|FG001|Overall Study|Adverse Event|0|||
23423584|NCT03392883|65296190|FG002|Overall Study|Adverse Event|0|||
23423585|NCT00866047|65296191|FG000|Treatment Period|Progressive disease|13|||
23423586|NCT00866047|65296191|FG000|Treatment Period|Adverse Event|16|||
23423587|NCT00866047|65296191|FG000|Treatment Period|Physician Decision|14|||
23423588|NCT00866047|65296191|FG000|Treatment Period|Withdrawal by Subject|5|||
23537300|NCT02139644|65697756|FG005|Treatment Period|Withdrawal by Subject|2|||
23537301|NCT02139644|65697751|FG000|Treatment Period|Non-compliance|0|||
23423589|NCT00866047|65296191|FG000|Follow-up Period|Lost to Follow-up|5|||
23423590|NCT00934947|65296192|FG000|Overall Study|Adverse Event|0|||
23423591|NCT00934947|65296193|FG001|Overall Study|Adverse Event|2|||
23423592|NCT02323204|65296194|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
23423593|NCT02323204|65296195|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
23423594|NCT02323204|65296196|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
23423595|NCT02323204|65296197|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
23537302|NCT02139644|65697752|FG001|Treatment Period|Non-compliance|0|||
23537303|NCT02139644|65697753|FG002|Treatment Period|Non-compliance|0|||
23537304|NCT02139644|65697754|FG003|Treatment Period|Non-compliance|1|||
23537305|NCT02139644|65697755|FG004|Treatment Period|Non-compliance|0|||
23537306|NCT02139644|65697756|FG005|Treatment Period|Non-compliance|0|||
23209075|NCT00565058|64504477|FG000|Overall Study|Adverse Event|1|||
23209076|NCT00565058|64504478|FG001|Overall Study|Adverse Event|0|||
23209077|NCT02208024|64504479|FG000|Overall Study|Withdrawal by Subject|1|||
23209078|NCT01086150|64504482|FG000|Overall Study|Withdrawal by Subject|0|||
23209079|NCT01086150|64504483|FG001|Overall Study|Withdrawal by Subject|4|||
23423596|NCT02323204|65296194|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
23423597|NCT02323204|65296195|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
23423598|NCT02323204|65296196|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
23423599|NCT02323204|65296197|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
23423600|NCT02323204|65296194|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
23423601|NCT02323204|65296195|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
23423602|NCT02323204|65296196|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
23423603|NCT02323204|65296197|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
23537307|NCT02139644|65697751|FG000|Treatment Period|Protocol Violation|0|||
23537308|NCT02139644|65697752|FG001|Treatment Period|Protocol Violation|0|||
23616278|NCT01136733|65982278|FG000|Phase 2|Adverse Event|0|||
23209080|NCT01086150|64504484|FG002|Overall Study|Withdrawal by Subject|1|||
23209081|NCT01086150|64504482|FG000|Overall Study|Lost to Follow-up|0|||
23537309|NCT02139644|65697753|FG002|Treatment Period|Protocol Violation|0|||
23537310|NCT02139644|65697754|FG003|Treatment Period|Protocol Violation|1|||
23537311|NCT02139644|65697755|FG004|Treatment Period|Protocol Violation|1|||
23537312|NCT02139644|65697756|FG005|Treatment Period|Protocol Violation|1|||
23537313|NCT02139644|65697751|FG000|Treatment Period|Disease progression|0|||
23537314|NCT02139644|65697752|FG001|Treatment Period|Disease progression|0|||
23423604|NCT02323204|65296194|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
23423605|NCT02323204|65296195|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
23423606|NCT02323204|65296196|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
23423607|NCT02323204|65296197|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
23423608|NCT02323204|65296194|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
23423609|NCT02323204|65296195|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
23423610|NCT02323204|65296196|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
23423611|NCT02323204|65296197|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
23423612|NCT02323204|65296194|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
23423613|NCT02323204|65296195|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
23423614|NCT02323204|65296196|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
23423615|NCT02323204|65296197|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
23423616|NCT02323204|65296194|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
23423617|NCT02323204|65296195|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
23423618|NCT02323204|65296196|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
23423619|NCT02323204|65296197|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
23423620|NCT02323204|65296194|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
23311644|NCT03249792|64886591|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
23311645|NCT03249792|64886592|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23311646|NCT03249792|64886593|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
23423621|NCT02323204|65296195|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
23423622|NCT02323204|65296196|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
23423623|NCT02323204|65296197|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
23423624|NCT02323204|65296194|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
23423625|NCT02323204|65296195|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
23423626|NCT02323204|65296196|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
23423627|NCT02323204|65296197|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
23423628|NCT04612842|65296198|FG000|Overall Study|Lost to Follow-up|20|||
23423629|NCT04612842|65296199|FG001|Overall Study|Lost to Follow-up|11|||
23423630|NCT04612842|65296198|FG000|Overall Study|Withdrawal by Subject|26|||
23423631|NCT04612842|65296199|FG001|Overall Study|Withdrawal by Subject|15|||
23423632|NCT04612842|65296198|FG000|Overall Study|Death|2|||
23423633|NCT04612842|65296199|FG001|Overall Study|Death|2|||
23423634|NCT01081301|65296200|FG000|Overall Study|Bereaved|3|||
23537315|NCT02139644|65697753|FG002|Treatment Period|Disease progression|0|||
23537316|NCT02139644|65697754|FG003|Treatment Period|Disease progression|1|||
23537317|NCT02139644|65697755|FG004|Treatment Period|Disease progression|1|||
23537318|NCT02139644|65697756|FG005|Treatment Period|Disease progression|2|||
23537319|NCT02139644|65697751|FG000|Treatment Period|Lost to Follow-up|0|||
23537320|NCT02139644|65697752|FG001|Treatment Period|Lost to Follow-up|0|||
23537321|NCT02139644|65697753|FG002|Treatment Period|Lost to Follow-up|1|||
23537322|NCT02139644|65697754|FG003|Treatment Period|Lost to Follow-up|1|||
23537323|NCT02139644|65697755|FG004|Treatment Period|Lost to Follow-up|1|||
23537324|NCT02139644|65697756|FG005|Treatment Period|Lost to Follow-up|1|||
23537325|NCT02139644|65697751|FG000|Treatment Period|Lack of Efficacy|0|||
23537326|NCT02139644|65697752|FG001|Treatment Period|Lack of Efficacy|0|||
23537327|NCT02139644|65697753|FG002|Treatment Period|Lack of Efficacy|1|||
23537328|NCT02139644|65697754|FG003|Treatment Period|Lack of Efficacy|0|||
23537329|NCT02139644|65697755|FG004|Treatment Period|Lack of Efficacy|1|||
23537330|NCT02139644|65697756|FG005|Treatment Period|Lack of Efficacy|4|||
23537331|NCT02139644|65697751|FG000|Treatment Period|Other|0|||
23423635|NCT01081301|65296200|FG000|Overall Study|Too busy|5|||
23537332|NCT02139644|65697752|FG001|Treatment Period|Other|3|||
23537333|NCT02139644|65697753|FG002|Treatment Period|Other|1|||
23537334|NCT02139644|65697754|FG003|Treatment Period|Other|1|||
23537335|NCT02139644|65697755|FG004|Treatment Period|Other|0|||
23537336|NCT02139644|65697756|FG005|Treatment Period|Other|1|||
23537337|NCT02564471|65697757|FG000|Overall Study|Adverse Event|1|||
23537338|NCT02564471|65697758|FG001|Overall Study|Adverse Event|0|||
23537339|NCT02564471|65697759|FG002|Overall Study|Adverse Event|0|||
23537340|NCT02564471|65697760|FG003|Overall Study|Adverse Event|0|||
23537341|NCT02564471|65697757|FG000|Overall Study|Withdrawal by Subject|2|||
23537342|NCT02564471|65697758|FG001|Overall Study|Withdrawal by Subject|1|||
23537343|NCT02564471|65697759|FG002|Overall Study|Withdrawal by Subject|3|||
23537344|NCT02564471|65697760|FG003|Overall Study|Withdrawal by Subject|0|||
23537345|NCT02564471|65697757|FG000|Overall Study|Lost to Follow-up|0|||
23537346|NCT02564471|65697758|FG001|Overall Study|Lost to Follow-up|2|||
23537347|NCT02564471|65697759|FG002|Overall Study|Lost to Follow-up|0|||
23537348|NCT02564471|65697760|FG003|Overall Study|Lost to Follow-up|0|||
23537349|NCT01310413|65697761|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
23537350|NCT01310413|65697762|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
23537351|NCT01310413|65697763|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
23209082|NCT01086150|64504483|FG001|Overall Study|Lost to Follow-up|1|||
23209083|NCT01086150|64504484|FG002|Overall Study|Lost to Follow-up|0|||
23209084|NCT01086150|64504482|FG000|Overall Study|Screen Failure|0|||
23209085|NCT01086150|64504483|FG001|Overall Study|Screen Failure|1|||
23209086|NCT01086150|64504484|FG002|Overall Study|Screen Failure|0|||
23209087|NCT02808312|64504485|FG000|Overall Study|Enrolled but Never Treated|0|||
23209088|NCT02808312|64504486|FG001|Overall Study|Enrolled but Never Treated|0|||
23209089|NCT02808312|64504487|FG002|Overall Study|Enrolled but Never Treated|1|||
23209090|NCT02808312|64504488|FG003|Overall Study|Enrolled but Never Treated|0|||
23209091|NCT02808312|64504489|FG004|Overall Study|Enrolled but Never Treated|0|||
23209092|NCT00844649|64504491|FG000|Overall Study|Progressive Disease|196|||
23537352|NCT01310413|65697764|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
23537353|NCT01310413|65697765|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
23537354|NCT01310413|65697766|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
23537355|NCT01310413|65697767|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
23537356|NCT01310413|65697761|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
23537357|NCT01310413|65697762|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
23537358|NCT01310413|65697763|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
23537359|NCT01310413|65697764|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
23537360|NCT01310413|65697765|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
23537361|NCT01310413|65697766|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
23537362|NCT01310413|65697767|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
23537363|NCT01310413|65697761|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
23537364|NCT01310413|65697762|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
23537365|NCT01310413|65697763|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
23537366|NCT01310413|65697764|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
23537367|NCT01310413|65697765|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
23537368|NCT01310413|65697766|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
23537369|NCT01310413|65697767|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
23537370|NCT01310413|65697761|FG000|Day 0 to Day 385|Other|1|||
23537371|NCT01310413|65697762|FG001|Day 0 to Day 385|Other|0|||
23537372|NCT01310413|65697763|FG002|Day 0 to Day 385|Other|3|||
23537373|NCT01310413|65697764|FG003|Day 0 to Day 385|Other|0|||
23537374|NCT01310413|65697765|FG004|Day 0 to Day 385|Other|0|||
23537375|NCT01310413|65697766|FG005|Day 0 to Day 385|Other|0|||
23537376|NCT01310413|65697767|FG006|Day 0 to Day 385|Other|0|||
23537377|NCT01310413|65697761|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537378|NCT01310413|65697762|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537379|NCT01310413|65697763|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537380|NCT01310413|65697764|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537381|NCT01310413|65697765|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537382|NCT01310413|65697766|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
23537383|NCT01310413|65697767|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
23537384|NCT01310413|65697761|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
23537385|NCT01310413|65697762|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
23537386|NCT01310413|65697763|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
23537387|NCT01310413|65697764|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
23537388|NCT01310413|65697765|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
23537389|NCT01310413|65697766|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
23537390|NCT01310413|65697767|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
23209093|NCT00844649|64504492|FG001|Overall Study|Progressive Disease|245|||
23209094|NCT00844649|64504491|FG000|Overall Study|Adverse Event|128|||
23537391|NCT01968434|65697768|FG000|Overall Study|Lost to Follow-up|3|||
23537392|NCT01968434|65697769|FG001|Overall Study|Lost to Follow-up|6|||
23537393|NCT00633984|65697791|FG000|Overall Study|Lost to Follow-up|0|||
23537394|NCT00633984|65697792|FG001|Overall Study|Lost to Follow-up|6|||
23537395|NCT00633984|65697791|FG000|Overall Study|Withdrawal by Subject|8|||
23537396|NCT00633984|65697792|FG001|Overall Study|Withdrawal by Subject|7|||
23537397|NCT00633984|65697791|FG000|Overall Study|Hospitalized|1|||
23537398|NCT00633984|65697792|FG001|Overall Study|Hospitalized|0|||
23537399|NCT02970968|65697798|FG000|Overall Study|Withdrawal by Subject|3|||
23537400|NCT02970968|65697799|FG001|Overall Study|Withdrawal by Subject|3|||
23537401|NCT02970968|65697798|FG000|Overall Study|Adverse Event|1|||
23537402|NCT02970968|65697799|FG001|Overall Study|Adverse Event|2|||
23537403|NCT02970968|65697798|FG000|Overall Study|Lost to Follow-up|1|||
23537404|NCT02970968|65697799|FG001|Overall Study|Lost to Follow-up|1|||
23537405|NCT02970968|65697798|FG000|Overall Study|Non-Compliance|0|||
23537406|NCT02970968|65697799|FG001|Overall Study|Non-Compliance|1|||
23537407|NCT03285477|65697800|FG000|Treatment and Response Assessment Period|Death|1|||
23537408|NCT03285477|65697801|FG001|Treatment and Response Assessment Period|Death|0|||
23537409|NCT03285477|65697800|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
23537410|NCT03285477|65697801|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
23537411|NCT03285477|65697800|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
23537412|NCT03285477|65697801|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
23537413|NCT03285477|65697800|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
23537414|NCT03285477|65697801|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
23537415|NCT03285477|65697800|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
23537416|NCT03285477|65697801|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
23537417|NCT01816139|65697806|FG000|Overall Study|Adverse Event|6|||
23537418|NCT01816139|65697807|FG001|Overall Study|Adverse Event|8|||
23537419|NCT01816139|65697806|FG000|Overall Study|Lack of Efficacy|1|||
23537420|NCT01816139|65697807|FG001|Overall Study|Lack of Efficacy|2|||
23537421|NCT01816139|65697806|FG000|Overall Study|Lost to Follow-up|5|||
23537422|NCT01816139|65697807|FG001|Overall Study|Lost to Follow-up|3|||
23537423|NCT01816139|65697806|FG000|Overall Study|Withdrew Consent|6|||
23537424|NCT01816139|65697807|FG001|Overall Study|Withdrew Consent|4|||
23537425|NCT01816139|65697806|FG000|Overall Study|Protocol Violation|6|||
23537426|NCT01816139|65697807|FG001|Overall Study|Protocol Violation|3|||
23537427|NCT01816139|65697806|FG000|Overall Study|Reason not Specified|4|||
23537428|NCT01816139|65697807|FG001|Overall Study|Reason not Specified|2|||
23537429|NCT03864614|65701977|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
23537430|NCT03864614|65701978|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
23537431|NCT03864614|65701979|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
23537432|NCT03864614|65701980|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
23537433|NCT03864614|65701977|FG000|Overall Study|Withdrawal by Subject|72|||
23537434|NCT03864614|65701978|FG001|Overall Study|Withdrawal by Subject|100|||
23537435|NCT03864614|65701979|FG002|Overall Study|Withdrawal by Subject|1|||
23537436|NCT03864614|65701980|FG003|Overall Study|Withdrawal by Subject|21|||
23537437|NCT03864614|65701977|FG000|Overall Study|Lost to Follow-up|45|||
23537438|NCT03864614|65701978|FG001|Overall Study|Lost to Follow-up|54|||
23537439|NCT03864614|65701979|FG002|Overall Study|Lost to Follow-up|0|||
23537440|NCT03864614|65701980|FG003|Overall Study|Lost to Follow-up|9|||
23537441|NCT03864614|65701977|FG000|Overall Study|Adverse Event|42|||
23537442|NCT03864614|65701978|FG001|Overall Study|Adverse Event|30|||
23537443|NCT03864614|65701979|FG002|Overall Study|Adverse Event|1|||
23537444|NCT03864614|65701980|FG003|Overall Study|Adverse Event|9|||
23537445|NCT03864614|65701977|FG000|Overall Study|Protocol Deviation|6|||
23537446|NCT03864614|65701978|FG001|Overall Study|Protocol Deviation|26|||
23537447|NCT03864614|65701979|FG002|Overall Study|Protocol Deviation|0|||
23537448|NCT03864614|65701980|FG003|Overall Study|Protocol Deviation|1|||
23537449|NCT03864614|65701977|FG000|Overall Study|Physician Decision|7|||
23537450|NCT03864614|65701978|FG001|Overall Study|Physician Decision|10|||
23537451|NCT03864614|65701979|FG002|Overall Study|Physician Decision|1|||
23537452|NCT03864614|65701980|FG003|Overall Study|Physician Decision|5|||
23537453|NCT03864614|65701977|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
23537454|NCT03864614|65701978|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
23537455|NCT03864614|65701979|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
23537456|NCT03864614|65701980|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
23537457|NCT03864614|65701977|FG000|Overall Study|Sponsor Decision|1|||
23537458|NCT03864614|65701978|FG001|Overall Study|Sponsor Decision|2|||
23537459|NCT03864614|65701979|FG002|Overall Study|Sponsor Decision|0|||
23537460|NCT03864614|65701980|FG003|Overall Study|Sponsor Decision|0|||
23537461|NCT03864614|65701977|FG000|Overall Study|Pregnancy|0|||
23537462|NCT03864614|65701978|FG001|Overall Study|Pregnancy|1|||
23537463|NCT03864614|65701979|FG002|Overall Study|Pregnancy|0|||
23537464|NCT03864614|65701980|FG003|Overall Study|Pregnancy|0|||
23537465|NCT03864614|65701977|FG000|Overall Study|Other|7|||
23537466|NCT03864614|65701978|FG001|Overall Study|Other|9|||
23537467|NCT03864614|65701979|FG002|Overall Study|Other|1|||
23209095|NCT00844649|64504492|FG001|Overall Study|Adverse Event|73|||
23537468|NCT03864614|65701980|FG003|Overall Study|Other|4|||
23537469|NCT03864614|65701977|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
23537470|NCT03864614|65701978|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
23537471|NCT03864614|65701979|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
23537472|NCT03864614|65701980|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
23537473|NCT01696032|65701981|FG000|Overall Study|Withdrawal by Subject|0|||
23537474|NCT01696032|65701982|FG001|Overall Study|Withdrawal by Subject|0|||
23537475|NCT01696032|65701983|FG002|Overall Study|Withdrawal by Subject|1|||
23537476|NCT01696032|65701984|FG003|Overall Study|Withdrawal by Subject|2|||
23423636|NCT01081301|65296200|FG000|Overall Study|Patient too ill|2|||
23537477|NCT01696032|65701981|FG000|Overall Study|Death|14|||
23423637|NCT01081301|65296200|FG000|Overall Study|Lost to Follow-up|4|||
23537478|NCT01696032|65701982|FG001|Overall Study|Death|4|||
23537479|NCT01696032|65701983|FG002|Overall Study|Death|43|||
23537480|NCT01696032|65701984|FG003|Overall Study|Death|18|||
23209096|NCT00844649|64504491|FG000|Overall Study|Physician Decision|25|||
23209097|NCT00844649|64504492|FG001|Overall Study|Physician Decision|18|||
23209098|NCT00844649|64504491|FG000|Overall Study|Protocol Violation|10|||
23537481|NCT01696032|65701981|FG000|Overall Study|Lost to Follow-up|0|||
23537482|NCT01696032|65701982|FG001|Overall Study|Lost to Follow-up|1|||
23209099|NCT00844649|64504492|FG001|Overall Study|Protocol Violation|6|||
23209100|NCT00844649|64504491|FG000|Overall Study|Withdrawal by Subject|28|||
23209101|NCT00844649|64504492|FG001|Overall Study|Withdrawal by Subject|39|||
23537483|NCT01696032|65701983|FG002|Overall Study|Lost to Follow-up|0|||
23537484|NCT01696032|65701984|FG003|Overall Study|Lost to Follow-up|0|||
23537485|NCT01696032|65701981|FG000|Overall Study|Database lock|0|||
23537486|NCT01696032|65701982|FG001|Overall Study|Database lock|1|||
23537487|NCT01696032|65701983|FG002|Overall Study|Database lock|7|||
23616279|NCT01136733|65982279|FG001|Phase 2|Adverse Event|0|||
23616280|NCT01136733|65982280|FG002|Phase 2|Adverse Event|0|||
23616281|NCT01136733|65982281|FG003|Phase 2|Adverse Event|0|||
23616282|NCT01136733|65982282|FG004|Phase 2|Adverse Event|11|||
23616283|NCT01136733|65982283|FG005|Phase 2|Adverse Event|13|||
23616284|NCT01136733|65982284|FG006|Phase 2|Adverse Event|5|||
23616285|NCT01136733|65982278|FG000|Phase 2|Participant Choice|0|||
23616286|NCT01136733|65982279|FG001|Phase 2|Participant Choice|0|||
23616287|NCT01136733|65982280|FG002|Phase 2|Participant Choice|0|||
23616288|NCT01136733|65982281|FG003|Phase 2|Participant Choice|0|||
23616289|NCT01136733|65982282|FG004|Phase 2|Participant Choice|3|||
23616290|NCT01136733|65982283|FG005|Phase 2|Participant Choice|0|||
23616291|NCT01136733|65982284|FG006|Phase 2|Participant Choice|1|||
23616292|NCT01136733|65982278|FG000|Phase 2|Administrative-Withdrew Consent|0|||
23616293|NCT01136733|65982279|FG001|Phase 2|Administrative-Withdrew Consent|0|||
23616294|NCT01136733|65982280|FG002|Phase 2|Administrative-Withdrew Consent|0|||
23616295|NCT01136733|65982281|FG003|Phase 2|Administrative-Withdrew Consent|0|||
23616296|NCT01136733|65982282|FG004|Phase 2|Administrative-Withdrew Consent|1|||
23616297|NCT01136733|65982283|FG005|Phase 2|Administrative-Withdrew Consent|0|||
23616298|NCT01136733|65982284|FG006|Phase 2|Administrative-Withdrew Consent|0|||
23616299|NCT01136733|65982278|FG000|Phase 2|Other|0|||
23616300|NCT01136733|65982279|FG001|Phase 2|Other|0|||
23616301|NCT01136733|65982280|FG002|Phase 2|Other|0|||
23616302|NCT01136733|65982281|FG003|Phase 2|Other|0|||
23616303|NCT01136733|65982282|FG004|Phase 2|Other|6|||
23616304|NCT01136733|65982283|FG005|Phase 2|Other|7|||
23616305|NCT01136733|65982284|FG006|Phase 2|Other|6|||
23616306|NCT02498418|65982285|FG000|Overall Study|Lack of Efficacy|0|||
23616307|NCT02498418|65982286|FG001|Overall Study|Lack of Efficacy|0|||
23616308|NCT02498418|65982287|FG002|Overall Study|Lack of Efficacy|1|||
23616309|NCT02498418|65982285|FG000|Overall Study|Withdrawal by Subject|2|||
23616310|NCT02498418|65982286|FG001|Overall Study|Withdrawal by Subject|0|||
23616311|NCT02498418|65982287|FG002|Overall Study|Withdrawal by Subject|3|||
23616312|NCT02498418|65982285|FG000|Overall Study|Lost to Follow-up|0|||
23616313|NCT02498418|65982286|FG001|Overall Study|Lost to Follow-up|1|||
23616314|NCT02498418|65982287|FG002|Overall Study|Lost to Follow-up|1|||
23616315|NCT02498418|65982285|FG000|Overall Study|Participant taken prohibited medication|0|||
23616316|NCT02498418|65982286|FG001|Overall Study|Participant taken prohibited medication|1|||
23616317|NCT02498418|65982287|FG002|Overall Study|Participant taken prohibited medication|1|||
23616318|NCT00092456|65982291|FG000|Overall Study|Adverse Event|0|||
23616319|NCT00092456|65982292|FG001|Overall Study|Adverse Event|0|||
23616320|NCT00092456|65982293|FG002|Overall Study|Adverse Event|1|||
23616321|NCT00092456|65982294|FG003|Overall Study|Adverse Event|1|||
23616322|NCT00092456|65982291|FG000|Overall Study|Lost to Follow-up|2|||
23616323|NCT00092456|65982292|FG001|Overall Study|Lost to Follow-up|2|||
23616324|NCT00092456|65982293|FG002|Overall Study|Lost to Follow-up|1|||
23616325|NCT00092456|65982294|FG003|Overall Study|Lost to Follow-up|2|||
23616326|NCT00092456|65982291|FG000|Overall Study|Protocol Violation|5|||
23616327|NCT00092456|65982292|FG001|Overall Study|Protocol Violation|7|||
23616328|NCT00092456|65982293|FG002|Overall Study|Protocol Violation|8|||
23616329|NCT00092456|65982294|FG003|Overall Study|Protocol Violation|6|||
23209102|NCT00844649|64504491|FG000|Overall Study|Other|7|||
23209103|NCT00844649|64504492|FG001|Overall Study|Other|10|||
23209104|NCT00844649|64504491|FG000|Overall Study|Withdrew prior to starting treatment|11|||
23537488|NCT01696032|65701984|FG003|Overall Study|Database lock|2|||
23537489|NCT01260922|65701985|FG000|First Intervention|Withdrawal by Subject|0|||
23616330|NCT00092456|65982291|FG000|Overall Study|Withdrawal by Subject|13|||
23616331|NCT00092456|65982292|FG001|Overall Study|Withdrawal by Subject|5|||
23616332|NCT00092456|65982293|FG002|Overall Study|Withdrawal by Subject|16|||
23616333|NCT00092456|65982294|FG003|Overall Study|Withdrawal by Subject|6|||
23616334|NCT00092456|65982291|FG000|Overall Study|Moved|1|||
23616335|NCT00092456|65982292|FG001|Overall Study|Moved|1|||
23616336|NCT00092456|65982293|FG002|Overall Study|Moved|0|||
23616337|NCT00092456|65982294|FG003|Overall Study|Moved|1|||
23616338|NCT00092456|65982291|FG000|Overall Study|Other|4|||
23616339|NCT00092456|65982292|FG001|Overall Study|Other|2|||
23616340|NCT00092456|65982293|FG002|Overall Study|Other|3|||
23616341|NCT00092456|65982294|FG003|Overall Study|Other|0|||
23537490|NCT01260922|65701986|FG001|First Intervention|Withdrawal by Subject|1|||
23537491|NCT01260922|65701985|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
23537492|NCT01260922|65701986|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
23537493|NCT01260922|65701985|FG000|Second Intervention|Emesis|0|||
23537494|NCT01260922|65701986|FG001|Second Intervention|Emesis|2|||
23537495|NCT01751568|65701987|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
23537496|NCT01751568|65701988|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
23537497|NCT01751568|65701989|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
23537498|NCT01578551|65701992|FG000|Overall Study|Adverse Event|1|||
23537499|NCT01578551|65701993|FG001|Overall Study|Adverse Event|0|||
23537500|NCT00459134|65701995|FG000|Overall Study|Physician Decision|1|||
23537501|NCT00459134|65701996|FG001|Overall Study|Physician Decision|1|||
23537502|NCT00459134|65701995|FG000|Overall Study|Withdrawal by Subject|8|||
23537503|NCT00459134|65701996|FG001|Overall Study|Withdrawal by Subject|7|||
23537504|NCT00459134|65701995|FG000|Overall Study|Lost to Follow-up|6|||
23537505|NCT00459134|65701996|FG001|Overall Study|Lost to Follow-up|7|||
23537506|NCT00459134|65701995|FG000|Overall Study|Surgery|1|||
23537507|NCT00459134|65701996|FG001|Overall Study|Surgery|2|||
23537508|NCT00459134|65701995|FG000|Overall Study|Toxicity|4|||
23537509|NCT00459134|65701996|FG001|Overall Study|Toxicity|5|||
23537510|NCT00459134|65701995|FG000|Overall Study|Progression|1|||
23537511|NCT00459134|65701996|FG001|Overall Study|Progression|0|||
23537512|NCT00459134|65701995|FG000|Overall Study|Multiple Reasons|2|||
23537513|NCT00459134|65701996|FG001|Overall Study|Multiple Reasons|3|||
23537514|NCT00142909|65701997|FG000|Randomization|Various Reasons|7|||
23537515|NCT00142909|65701998|FG001|Randomization|Various Reasons|10|||
23537516|NCT00142909|65701997|FG000|Medications Begin|Protocol Violation|2|||
23537517|NCT00142909|65701998|FG001|Medications Begin|Protocol Violation|0|||
23537518|NCT00142909|65701997|FG000|Medications Begin|Withdrawal by Subject|5|||
23537519|NCT00142909|65701998|FG001|Medications Begin|Withdrawal by Subject|3|||
23537520|NCT00142909|65701997|FG000|Medications Begin|Withdrawal by Subject|2|||
23537521|NCT00142909|65701998|FG001|Medications Begin|Withdrawal by Subject|0|||
23537522|NCT04666441|65702000|FG000|Overall Study|Lost to Follow-up|1|||
23537523|NCT04666441|65702001|FG001|Overall Study|Lost to Follow-up|4|||
23537524|NCT04666441|65702002|FG002|Overall Study|Lost to Follow-up|1|||
23537525|NCT04666441|65702003|FG003|Overall Study|Lost to Follow-up|3|||
23537526|NCT04666441|65702004|FG004|Overall Study|Lost to Follow-up|0|||
23537527|NCT04666441|65702005|FG005|Overall Study|Lost to Follow-up|2|||
23537528|NCT04666441|65702006|FG006|Overall Study|Lost to Follow-up|2|||
23537529|NCT04666441|65702007|FG007|Overall Study|Lost to Follow-up|2|||
23537530|NCT04666441|65702000|FG000|Overall Study|Subject Decision|1|||
23537531|NCT04666441|65702001|FG001|Overall Study|Subject Decision|1|||
23537532|NCT04666441|65702002|FG002|Overall Study|Subject Decision|3|||
23537533|NCT04666441|65702003|FG003|Overall Study|Subject Decision|1|||
23537534|NCT04666441|65702004|FG004|Overall Study|Subject Decision|0|||
23537535|NCT04666441|65702005|FG005|Overall Study|Subject Decision|1|||
23537536|NCT04666441|65702006|FG006|Overall Study|Subject Decision|3|||
23537537|NCT04666441|65702007|FG007|Overall Study|Subject Decision|2|||
23537538|NCT02158039|65702008|FG000|Overall Study|Withdrawal by Subject|1|||
23537539|NCT02158039|65702008|FG000|Overall Study|Screen Failure|9|||
23537540|NCT05008055|65702009|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
23537541|NCT05008055|65702010|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
23537542|NCT05008055|65702011|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
23537543|NCT03832192|65702015|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
23537544|NCT03832192|65702016|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
23537545|NCT01079234|65702017|FG000|Main: Week 0 to 26|Adverse Event|5|||
23537546|NCT01079234|65702018|FG001|Main: Week 0 to 26|Adverse Event|4|||
23537547|NCT01079234|65702019|FG002|Main: Week 0 to 26|Adverse Event|1|||
23537548|NCT01079234|65702020|FG003|Main: Week 0 to 26|Adverse Event|0|||
23537549|NCT01079234|65702017|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
23537550|NCT01079234|65702018|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
23423638|NCT05427539|65296201|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
23423639|NCT05427539|65296202|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
23423640|NCT05427539|65296201|FG000|Period 1|Withdrawal by Subject|1|||
23423641|NCT05427539|65296202|FG001|Period 1|Withdrawal by Subject|0|||
23423642|NCT00681564|65296203|FG000|Overall Study|Lost to Follow-up|6|||
23423643|NCT00681564|65296204|FG001|Overall Study|Lost to Follow-up|6|||
23423644|NCT00681564|65296203|FG000|Overall Study|Withdrawal by Subject|0|||
23423645|NCT00681564|65296204|FG001|Overall Study|Withdrawal by Subject|1|||
23423646|NCT00681564|65296203|FG000|Overall Study|Death|0|||
23423647|NCT00681564|65296204|FG001|Overall Study|Death|1|||
23423648|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
23423649|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
23423650|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
23423651|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
23423652|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
23423653|NCT01224821|65296205|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
23423654|NCT01224821|65296205|FG000|Long-Term Follow-Up|Death|2|||
23423655|NCT01224821|65296205|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
23423656|NCT00794365|65296206|FG000|Overall Study|Lost to Follow-up|38|||
23423657|NCT00794365|65296206|FG000|Overall Study|Other|17|||
23423658|NCT00794365|65296206|FG000|Overall Study|Poor Compliance|11|||
23423659|NCT00794365|65296206|FG000|Overall Study|Adverse Event|10|||
23537551|NCT01079234|65702019|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
23537552|NCT01079234|65702020|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
23423660|NCT00794365|65296206|FG000|Overall Study|Lack of Efficacy|3|||
23423661|NCT01688921|65296209|FG000|Overall Study|Lost to Follow-up|7|||
23423662|NCT01688921|65296210|FG001|Overall Study|Lost to Follow-up|13|||
23423663|NCT01688921|65296209|FG000|Overall Study|Physician Decision|6|||
23423664|NCT01688921|65296210|FG001|Overall Study|Physician Decision|1|||
23423665|NCT01688921|65296209|FG000|Overall Study|Protocol Violation|0|||
23423666|NCT01688921|65296210|FG001|Overall Study|Protocol Violation|1|||
23423667|NCT01688921|65296209|FG000|Overall Study|informed consent|3|||
23537553|NCT01079234|65702017|FG000|Main: Week 0 to 26|Protocol Violation|6|||
23537554|NCT01079234|65702018|FG001|Main: Week 0 to 26|Protocol Violation|2|||
23423668|NCT01688921|65296210|FG001|Overall Study|informed consent|0|||
23423669|NCT01149486|65296211|FG000|First Intervention|Adverse Event|0|||
23423670|NCT01149486|65296212|FG001|First Intervention|Adverse Event|1|||
23423671|NCT00367744|65296216|FG000|Overall Study|Lost to Follow-up|4|||
23423672|NCT00367744|65296217|FG001|Overall Study|Lost to Follow-up|5|||
23537555|NCT01079234|65702019|FG002|Main: Week 0 to 26|Protocol Violation|4|||
23537556|NCT01079234|65702020|FG003|Main: Week 0 to 26|Protocol Violation|0|||
23537557|NCT01079234|65702017|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
23537558|NCT01079234|65702018|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
23423673|NCT00521599|65296218|FG000|Overall Study|Adverse Event|5|||
23423674|NCT00521599|65296219|FG001|Overall Study|Adverse Event|7|||
23423675|NCT00521599|65296220|FG002|Overall Study|Adverse Event|6|||
23423676|NCT00521599|65296218|FG000|Overall Study|Treatment Failure|8|||
23423677|NCT00521599|65296219|FG001|Overall Study|Treatment Failure|9|||
23423678|NCT00521599|65296220|FG002|Overall Study|Treatment Failure|22|||
23423679|NCT00521599|65296218|FG000|Overall Study|Lost to Follow-up|2|||
23423680|NCT00521599|65296219|FG001|Overall Study|Lost to Follow-up|1|||
23423681|NCT00521599|65296220|FG002|Overall Study|Lost to Follow-up|2|||
23423682|NCT00521599|65296218|FG000|Overall Study|Withdrawal by Subject|3|||
23423683|NCT00521599|65296219|FG001|Overall Study|Withdrawal by Subject|5|||
23423684|NCT00521599|65296220|FG002|Overall Study|Withdrawal by Subject|1|||
23423685|NCT00521599|65296218|FG000|Overall Study|Withdrawal by subject treatment related|3|||
23423686|NCT00521599|65296219|FG001|Overall Study|Withdrawal by subject treatment related|1|||
23423687|NCT00521599|65296220|FG002|Overall Study|Withdrawal by subject treatment related|2|||
23423688|NCT00521599|65296218|FG000|Overall Study|Protocol Violation|2|||
23423689|NCT00521599|65296219|FG001|Overall Study|Protocol Violation|4|||
23423690|NCT00521599|65296220|FG002|Overall Study|Protocol Violation|2|||
23423691|NCT00521599|65296218|FG000|Overall Study|Did not meet protocol eligibility|2|||
23423692|NCT00521599|65296219|FG001|Overall Study|Did not meet protocol eligibility|2|||
23423693|NCT00521599|65296220|FG002|Overall Study|Did not meet protocol eligibility|1|||
23423694|NCT00293709|65296221|FG000|Overall Study|Other|47|||
23423695|NCT02370641|65296232|FG000|Overall Study|dropped study|4|||
23423696|NCT02370641|65296233|FG001|Overall Study|dropped study|2|||
23423697|NCT00983515|65296236|FG000|Ritonavir Alone|liver panel out of range|6|||
23423698|NCT00983515|65296236|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
23423699|NCT02387164|65296237|FG000|Overall Study|Lost to Follow-up|2|||
23423700|NCT02387164|65296238|FG001|Overall Study|Lost to Follow-up|0|||
23423701|NCT02387164|65296237|FG000|Overall Study|Diagnosed|1|||
23423702|NCT02387164|65296238|FG001|Overall Study|Diagnosed|2|||
23423703|NCT02891681|65296239|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
23423704|NCT02891681|65296240|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
23423705|NCT02891681|65296241|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
23423706|NCT02891681|65296239|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
23423707|NCT02891681|65296240|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
23423708|NCT02891681|65296241|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
23423709|NCT02891681|65296239|FG000|Overall Study|Taken off study after first imaging appointment|1|||
23423710|NCT02891681|65296240|FG001|Overall Study|Taken off study after first imaging appointment|0|||
23423711|NCT02891681|65296241|FG002|Overall Study|Taken off study after first imaging appointment|0|||
23423712|NCT03220581|65296242|FG000|Overall Study|Withdrawal by Subject|0|||
23423713|NCT03220581|65296243|FG001|Overall Study|Withdrawal by Subject|1|||
23423714|NCT03220581|65296242|FG000|Overall Study|Lost to Follow-up|3|||
23423715|NCT03220581|65296243|FG001|Overall Study|Lost to Follow-up|6|||
23423716|NCT04346108|65296248|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
23423717|NCT04346108|65296249|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
23423718|NCT04346108|65296250|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
23423719|NCT04346108|65296248|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
23423720|NCT04346108|65296249|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
23423721|NCT04346108|65296250|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
23423722|NCT01456195|65296253|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23423723|NCT01456195|65296254|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
23423724|NCT01456195|65296255|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
23423725|NCT01456195|65296253|FG000|Overall Study|Lost to Follow-up|3|||
23423726|NCT01456195|65296254|FG001|Overall Study|Lost to Follow-up|1|||
23537559|NCT01079234|65702019|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
23537560|NCT01079234|65702020|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
23537561|NCT01079234|65702017|FG000|Main: Week 0 to 26|Unclassified|7|||
23537562|NCT01079234|65702018|FG001|Main: Week 0 to 26|Unclassified|13|||
23537563|NCT01079234|65702019|FG002|Main: Week 0 to 26|Unclassified|4|||
23537564|NCT01079234|65702020|FG003|Main: Week 0 to 26|Unclassified|0|||
23537565|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Adverse Event|0|||
23537566|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Adverse Event|0|||
23537567|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Adverse Event|1|||
23537568|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Adverse Event|0|||
23537569|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
23537570|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
23537571|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
23537572|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
23537573|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
23537574|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
23537575|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
23537576|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
23423727|NCT01456195|65296255|FG002|Overall Study|Lost to Follow-up|3|||
23423728|NCT01456195|65296253|FG000|Overall Study|Voluntary Withdrawal|5|||
23423729|NCT01456195|65296254|FG001|Overall Study|Voluntary Withdrawal|3|||
23423730|NCT01456195|65296255|FG002|Overall Study|Voluntary Withdrawal|7|||
23423731|NCT01456195|65296253|FG000|Overall Study|Lack of Efficacy|0|||
23423732|NCT01456195|65296254|FG001|Overall Study|Lack of Efficacy|1|||
23423733|NCT01456195|65296255|FG002|Overall Study|Lack of Efficacy|0|||
23423734|NCT01456195|65296253|FG000|Overall Study|Other Reasons|2|||
23423735|NCT01456195|65296254|FG001|Overall Study|Other Reasons|1|||
23423736|NCT01456195|65296255|FG002|Overall Study|Other Reasons|3|||
23423737|NCT03095027|65296256|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
23423738|NCT03095027|65296257|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
23423739|NCT03553498|65296259|FG000|Overall Study|Missing primary outcome|1|||
23423740|NCT03553498|65296260|FG001|Overall Study|Missing primary outcome|2|||
23423741|NCT02969590|65296261|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
23423742|NCT02969590|65296262|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
23423743|NCT02969590|65296263|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
23423744|NCT02928029|65296264|FG000|Overall Study|Withdrawal by Subject|0|||
23423745|NCT02928029|65296265|FG001|Overall Study|Withdrawal by Subject|1|||
23423746|NCT02928029|65296264|FG000|Overall Study|Radiological progression|1|||
23423747|NCT02928029|65296265|FG001|Overall Study|Radiological progression|0|||
23423748|NCT02928029|65296264|FG000|Overall Study|Clinical progression|1|||
23423749|NCT02928029|65296265|FG001|Overall Study|Clinical progression|2|||
23423750|NCT02928029|65296264|FG000|Overall Study|AE not related to clinical progression|1|||
23423751|NCT02928029|65296265|FG001|Overall Study|AE not related to clinical progression|1|||
23423752|NCT02635347|65296266|FG000|Overall Study|Failed screening|20|||
23423753|NCT02635347|65296267|FG001|Overall Study|Failed screening|7|||
23423754|NCT03305419|65296268|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423755|NCT03305419|65296269|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
23423756|NCT03305419|65296270|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423757|NCT03305419|65296271|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423758|NCT03305419|65296272|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423759|NCT03305419|65296273|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423760|NCT03305419|65296274|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423761|NCT03305419|65296275|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
23423762|NCT03305419|65296268|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
23423763|NCT03305419|65296269|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423764|NCT03305419|65296270|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423765|NCT03305419|65296271|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423766|NCT03305419|65296272|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423767|NCT03305419|65296273|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423768|NCT03305419|65296274|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423769|NCT03305419|65296275|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
23423770|NCT03305419|65296268|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
23423771|NCT03305419|65296269|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423772|NCT03305419|65296270|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423773|NCT03305419|65296271|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423774|NCT03305419|65296272|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423775|NCT03305419|65296273|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423776|NCT03305419|65296274|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423777|NCT03305419|65296275|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
23423778|NCT03305419|65296268|FG000|Part B (14 Days)|Adverse Event|0|||
23423779|NCT03305419|65296269|FG001|Part B (14 Days)|Adverse Event|0|||
23423780|NCT03305419|65296270|FG002|Part B (14 Days)|Adverse Event|0|||
23423781|NCT03305419|65296271|FG003|Part B (14 Days)|Adverse Event|0|||
23423782|NCT03305419|65296272|FG004|Part B (14 Days)|Adverse Event|1|||
23423783|NCT03305419|65296273|FG005|Part B (14 Days)|Adverse Event|2|||
23423784|NCT03305419|65296274|FG006|Part B (14 Days)|Adverse Event|4|||
23423785|NCT03305419|65296275|FG007|Part B (14 Days)|Adverse Event|0|||
23423786|NCT03305419|65296268|FG000|Part B (14 Days)|Physician Decision|0|||
23423787|NCT03305419|65296269|FG001|Part B (14 Days)|Physician Decision|0|||
23423788|NCT03305419|65296270|FG002|Part B (14 Days)|Physician Decision|0|||
23423789|NCT03305419|65296271|FG003|Part B (14 Days)|Physician Decision|0|||
23423790|NCT03305419|65296272|FG004|Part B (14 Days)|Physician Decision|2|||
23423791|NCT03305419|65296273|FG005|Part B (14 Days)|Physician Decision|8|||
23423792|NCT03305419|65296274|FG006|Part B (14 Days)|Physician Decision|1|||
23423793|NCT03305419|65296275|FG007|Part B (14 Days)|Physician Decision|0|||
23423794|NCT01342965|65296276|FG000|Overall Study|Death|58|||
23423795|NCT01342965|65296277|FG001|Overall Study|Death|57|||
23423796|NCT01342965|65296276|FG000|Overall Study|Lost to Follow-up|5|||
23423797|NCT01342965|65296277|FG001|Overall Study|Lost to Follow-up|3|||
23423798|NCT01342965|65296276|FG000|Overall Study|Other Reasons- Unspecified|44|||
23423799|NCT01342965|65296277|FG001|Overall Study|Other Reasons- Unspecified|38|||
23423800|NCT01342965|65296276|FG000|Overall Study|Withdrawal by Subject|2|||
23423801|NCT01342965|65296277|FG001|Overall Study|Withdrawal by Subject|9|||
23423802|NCT04863248|65296278|FG000|Overall Study|Sponsor Terminated|4|||
23423803|NCT04863248|65296279|FG001|Overall Study|Sponsor Terminated|1|||
23423804|NCT04863248|65296278|FG000|Overall Study|Death|0|||
23423805|NCT04863248|65296279|FG001|Overall Study|Death|1|||
23423806|NCT04863248|65296278|FG000|Overall Study|Withdrawal by Subject|0|||
23423807|NCT04863248|65296279|FG001|Overall Study|Withdrawal by Subject|1|||
23423808|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
23423809|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
23423810|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
23423811|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
23423812|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
23423813|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
23423814|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
23423815|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
23423816|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
23423817|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
23423818|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Other|1|||
23423819|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Other|1|||
23423820|NCT02075047|65296284|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
23423821|NCT02075047|65296285|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
23423822|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
23423823|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
23423824|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
23423825|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
23423826|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
23423827|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
23423828|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
23423829|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
23423830|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
23423831|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
23423832|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Other|1|||
23423833|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Other|2|||
23423834|NCT02075047|65296284|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
23423835|NCT02075047|65296285|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
23423836|NCT00847665|65296286|FG000|Overall Study|Withdrawal by Subject|1|||
23423837|NCT00847665|65296287|FG001|Overall Study|Withdrawal by Subject|0|||
23423838|NCT01367704|65296288|FG000|Overall Study|Lost to Follow-up|47|||
23423839|NCT01367704|65296289|FG001|Overall Study|Lost to Follow-up|161|||
23423840|NCT00511433|65296291|FG000|Overall Study|Adverse Event|5|||
23423841|NCT00511433|65296292|FG001|Overall Study|Adverse Event|0|||
23423842|NCT00511433|65296291|FG000|Overall Study|Other Reason|1|||
23423843|NCT00511433|65296292|FG001|Overall Study|Other Reason|1|||
23423844|NCT01218100|65296295|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
23423845|NCT01218100|65296296|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
23423846|NCT01218100|65296297|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
23423847|NCT01218100|65296298|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
23423848|NCT01218100|65296295|FG000|Overall Study|Adverse Event|4|||
23423849|NCT01218100|65296296|FG001|Overall Study|Adverse Event|6|||
23423850|NCT01218100|65296297|FG002|Overall Study|Adverse Event|6|||
23423851|NCT01218100|65296298|FG003|Overall Study|Adverse Event|7|||
23423852|NCT01218100|65296295|FG000|Overall Study|Lack of Efficacy|9|||
23423853|NCT01218100|65296296|FG001|Overall Study|Lack of Efficacy|6|||
23423854|NCT01218100|65296297|FG002|Overall Study|Lack of Efficacy|5|||
23423855|NCT01218100|65296298|FG003|Overall Study|Lack of Efficacy|12|||
23423856|NCT01218100|65296295|FG000|Overall Study|Protocol Violation|0|||
23423857|NCT01218100|65296296|FG001|Overall Study|Protocol Violation|0|||
23423858|NCT01218100|65296297|FG002|Overall Study|Protocol Violation|1|||
23423859|NCT01218100|65296298|FG003|Overall Study|Protocol Violation|1|||
23423860|NCT01218100|65296295|FG000|Overall Study|Withdrawal by Subject|5|||
23423861|NCT01218100|65296296|FG001|Overall Study|Withdrawal by Subject|2|||
23423862|NCT01218100|65296297|FG002|Overall Study|Withdrawal by Subject|6|||
23423863|NCT01218100|65296298|FG003|Overall Study|Withdrawal by Subject|7|||
23423864|NCT01218100|65296295|FG000|Overall Study|Lost to Follow-up|3|||
23423865|NCT01218100|65296296|FG001|Overall Study|Lost to Follow-up|8|||
23423866|NCT01218100|65296297|FG002|Overall Study|Lost to Follow-up|2|||
23423867|NCT01218100|65296298|FG003|Overall Study|Lost to Follow-up|1|||
23423868|NCT01218100|65296295|FG000|Overall Study|Other Reason|2|||
23616342|NCT00246129|65982295|FG000|Overall Study|Lost to Follow-up|1|||
23423869|NCT01218100|65296296|FG001|Overall Study|Other Reason|2|||
23423870|NCT01218100|65296297|FG002|Overall Study|Other Reason|6|||
23423871|NCT01218100|65296298|FG003|Overall Study|Other Reason|4|||
23423872|NCT01089023|65296299|FG000|Overall Study|Lost to Follow-up|3|||
23423873|NCT01089023|65296299|FG000|Overall Study|Adverse Event|1|||
23423874|NCT01089023|65296299|FG000|Overall Study|Withdrawal by Subject|1|||
23423875|NCT01089023|65296299|FG000|Overall Study|Protocol Violation|1|||
23423876|NCT01089023|65296299|FG000|Overall Study|Lack of Efficacy|1|||
23537577|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
23537578|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
23537579|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
23537580|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
23537581|NCT01079234|65702017|FG000|Extension: Week 27 to 52|Unclassified|0|||
23537582|NCT01079234|65702018|FG001|Extension: Week 27 to 52|Unclassified|0|||
23537583|NCT01079234|65702019|FG002|Extension: Week 27 to 52|Unclassified|4|||
23537584|NCT01079234|65702020|FG003|Extension: Week 27 to 52|Unclassified|7|||
23537585|NCT00818441|65702023|FG000|Overall Study|Death|69|||
23537586|NCT00818441|65702024|FG001|Overall Study|Death|26|||
23423877|NCT01135914|65296300|FG000|Overall Study|Withdrawal by Subject|1|||
23423878|NCT01135914|65296301|FG001|Overall Study|Withdrawal by Subject|3|||
23423879|NCT01135914|65296302|FG002|Overall Study|Withdrawal by Subject|6|||
23423880|NCT01135914|65296300|FG000|Overall Study|Lost to Follow-up|1|||
23423881|NCT01135914|65296301|FG001|Overall Study|Lost to Follow-up|0|||
23423882|NCT01135914|65296302|FG002|Overall Study|Lost to Follow-up|1|||
23423883|NCT01135914|65296300|FG000|Overall Study|Protocol Violation|0|||
23423884|NCT01135914|65296301|FG001|Overall Study|Protocol Violation|0|||
23209105|NCT00844649|64504492|FG001|Overall Study|Withdrew prior to starting treatment|27|||
23537587|NCT00818441|65702023|FG000|Overall Study|Other|5|||
23423885|NCT01135914|65296302|FG002|Overall Study|Protocol Violation|3|||
23423886|NCT01135914|65296300|FG000|Overall Study|Lack of Efficacy|2|||
23423887|NCT01135914|65296301|FG001|Overall Study|Lack of Efficacy|1|||
23423888|NCT01135914|65296302|FG002|Overall Study|Lack of Efficacy|10|||
23423889|NCT01135914|65296300|FG000|Overall Study|Adverse Event|0|||
23537588|NCT00818441|65702024|FG001|Overall Study|Other|0|||
23537589|NCT00818441|65702023|FG000|Overall Study|Lost to Follow-up|2|||
23537590|NCT00818441|65702024|FG001|Overall Study|Lost to Follow-up|1|||
23537591|NCT00818441|65702023|FG000|Overall Study|Withdrawal by Subject|2|||
23537592|NCT00818441|65702024|FG001|Overall Study|Withdrawal by Subject|0|||
23209106|NCT01740388|64504496|FG000|Overall Study|Withdrawal by Subject|1|||
23209107|NCT01740388|64504497|FG001|Overall Study|Withdrawal by Subject|2|||
23209108|NCT01740388|64504496|FG000|Overall Study|Lost to Follow-up|2|||
23209109|NCT01740388|64504497|FG001|Overall Study|Lost to Follow-up|0|||
23209110|NCT01740388|64504496|FG000|Overall Study|Physician Decision|2|||
23209111|NCT01740388|64504497|FG001|Overall Study|Physician Decision|6|||
23423890|NCT01135914|65296301|FG001|Overall Study|Adverse Event|1|||
23423891|NCT01135914|65296302|FG002|Overall Study|Adverse Event|2|||
23423892|NCT03622112|65296303|FG000|Overall Study|Withdrawal by Subject|6|||
23423893|NCT03622112|65296304|FG001|Overall Study|Withdrawal by Subject|2|||
23423894|NCT03622112|65296305|FG002|Overall Study|Withdrawal by Subject|4|||
23423895|NCT03622112|65296306|FG003|Overall Study|Withdrawal by Subject|2|||
23423896|NCT03622112|65296307|FG004|Overall Study|Withdrawal by Subject|1|||
23423897|NCT03622112|65296308|FG005|Overall Study|Withdrawal by Subject|2|||
23423898|NCT03622112|65296309|FG006|Overall Study|Withdrawal by Subject|2|||
23423899|NCT03622112|65296303|FG000|Overall Study|Death|0|||
23423900|NCT03622112|65296304|FG001|Overall Study|Death|0|||
23311647|NCT03249792|64886594|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
23311648|NCT03249792|64886595|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
23311649|NCT03249792|64886596|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
23311650|NCT03249792|64886597|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311651|NCT03249792|64886598|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311652|NCT03249792|64886599|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
23311653|NCT03249792|64886600|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311654|NCT03249792|64886601|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23311655|NCT03249792|64886602|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311656|NCT03249792|64886603|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311657|NCT03249792|64886604|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311658|NCT03249792|64886605|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23537593|NCT00818441|65702023|FG000|Overall Study|Adverse Event|0|||
23537594|NCT00818441|65702024|FG001|Overall Study|Adverse Event|1|||
23537595|NCT00818441|65702023|FG000|Overall Study|Study terminated by sponsor|11|||
23537596|NCT00818441|65702024|FG001|Overall Study|Study terminated by sponsor|2|||
23537597|NCT01700946|65702025|FG000|Overall Study|Lost to Follow-up|1|||
23537598|NCT01700946|65702026|FG001|Overall Study|Lost to Follow-up|0|||
23537599|NCT01700946|65702025|FG000|Overall Study|Physician Decision|7|||
23537600|NCT01700946|65702026|FG001|Overall Study|Physician Decision|12|||
23537601|NCT01700946|65702025|FG000|Overall Study|Withdrawal by Subject|0|||
23209112|NCT01740388|64504496|FG000|Overall Study|Subjects missing data, completed|41|||
23311659|NCT03249792|64886606|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
23423901|NCT03622112|65296305|FG002|Overall Study|Death|0|||
23537602|NCT01700946|65702026|FG001|Overall Study|Withdrawal by Subject|2|||
23537603|NCT01700946|65702025|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
23423902|NCT03622112|65296306|FG003|Overall Study|Death|1|||
23423903|NCT03622112|65296307|FG004|Overall Study|Death|0|||
23423904|NCT03622112|65296308|FG005|Overall Study|Death|0|||
23423905|NCT03622112|65296309|FG006|Overall Study|Death|0|||
23537604|NCT01700946|65702026|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
23423906|NCT03622112|65296303|FG000|Overall Study|Lost to Follow-up|1|||
23423907|NCT03622112|65296304|FG001|Overall Study|Lost to Follow-up|1|||
23423908|NCT03622112|65296305|FG002|Overall Study|Lost to Follow-up|0|||
23423909|NCT03622112|65296306|FG003|Overall Study|Lost to Follow-up|0|||
23423910|NCT03622112|65296307|FG004|Overall Study|Lost to Follow-up|0|||
23423911|NCT03622112|65296308|FG005|Overall Study|Lost to Follow-up|0|||
23423912|NCT03622112|65296309|FG006|Overall Study|Lost to Follow-up|0|||
23423913|NCT03622112|65296303|FG000|Overall Study|Study-specific withdrawal criteria|10|||
23537605|NCT01700946|65702025|FG000|Overall Study|Relapse|2|||
23537606|NCT01700946|65702026|FG001|Overall Study|Relapse|1|||
23537607|NCT01700946|65702025|FG000|Overall Study|Unacceptable toxicity|1|||
23537608|NCT01700946|65702026|FG001|Overall Study|Unacceptable toxicity|0|||
23537609|NCT04067141|65702027|FG000|First Intervention|Withdrawal by Subject|0|||
23537610|NCT04067141|65702028|FG001|First Intervention|Withdrawal by Subject|1|||
23537611|NCT04067141|65702027|FG000|Second Intervention|Adverse Event|0|||
23537612|NCT04067141|65702028|FG001|Second Intervention|Adverse Event|2|||
23537613|NCT04934670|65702037|FG000|Overall Study|Death|4|||
23537614|NCT04934670|65702038|FG001|Overall Study|Death|0|||
23537615|NCT04934670|65702037|FG000|Overall Study|Lost to Follow-up|1|||
23537616|NCT04934670|65702038|FG001|Overall Study|Lost to Follow-up|4|||
23537617|NCT01611259|65702041|FG000|Overall Study|Physician Decision|1|||
23537618|NCT01611259|65702041|FG000|Overall Study|Lack of Efficacy|2|||
23537619|NCT01611259|65702041|FG000|Overall Study|Adverse Event|4|||
23537620|NCT01611259|65702041|FG000|Overall Study|Withdrawal by Subject|7|||
23537621|NCT01663636|65702042|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
23537622|NCT01663636|65702043|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
23537623|NCT00226941|65702045|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
23537624|NCT00226941|65702046|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
23537625|NCT00226941|65702047|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
23537626|NCT00226941|65702048|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
23537627|NCT00226941|65702045|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
23537628|NCT00226941|65702046|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
23537629|NCT00226941|65702047|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
23537630|NCT00226941|65702048|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
23537631|NCT01263873|65702049|FG000|Overall Study|One provider unable to complete numbers|1|||
23537632|NCT01263873|65702050|FG001|Overall Study|One provider unable to complete numbers|1|||
23537633|NCT00555438|65702053|FG000|10 Days Post-operative|Death|4|||
23537634|NCT00555438|65702053|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
23537635|NCT00499889|65702054|FG000|Overall Study|Infection prior to treatment|1|||
23537636|NCT02573324|65702055|FG000|Overall Study|Withdrawal by Subject|26|||
23537637|NCT02573324|65702056|FG001|Overall Study|Withdrawal by Subject|23|||
23537638|NCT02573324|65702057|FG002|Overall Study|Withdrawal by Subject|3|||
23537639|NCT02573324|65702055|FG000|Overall Study|Lost to Follow-up|4|||
23537640|NCT02573324|65702056|FG001|Overall Study|Lost to Follow-up|5|||
23537641|NCT02573324|65702057|FG002|Overall Study|Lost to Follow-up|0|||
23537642|NCT02573324|65702055|FG000|Overall Study|Study Terminated by Sponsor|107|||
23537643|NCT02573324|65702056|FG001|Overall Study|Study Terminated by Sponsor|89|||
23537644|NCT02573324|65702057|FG002|Overall Study|Study Terminated by Sponsor|2|||
23537645|NCT02573324|65702055|FG000|Overall Study|Death|182|||
23537646|NCT02573324|65702056|FG001|Overall Study|Death|200|||
23537647|NCT02573324|65702057|FG002|Overall Study|Death|1|||
23616343|NCT00246129|65982296|FG001|Overall Study|Lost to Follow-up|0|||
23423914|NCT03622112|65296304|FG001|Overall Study|Study-specific withdrawal criteria|8|||
23423915|NCT03622112|65296305|FG002|Overall Study|Study-specific withdrawal criteria|7|||
23537648|NCT02573324|65702055|FG000|Overall Study|Other, Not Specified|20|||
23537649|NCT02573324|65702056|FG001|Overall Study|Other, Not Specified|27|||
23537650|NCT02573324|65702057|FG002|Overall Study|Other, Not Specified|0|||
23537651|NCT02573324|65702055|FG000|Overall Study|Unknown Reason|2|||
23537652|NCT02573324|65702056|FG001|Overall Study|Unknown Reason|0|||
23537653|NCT02573324|65702057|FG002|Overall Study|Unknown Reason|0|||
23537654|NCT00723801|65702058|FG000|Overall Study|Lost to Follow-up|1|||
23537655|NCT00723801|65702059|FG001|Overall Study|Lost to Follow-up|2|||
23537656|NCT00723801|65702058|FG000|Overall Study|Protocol Violation|2|||
23537657|NCT00723801|65702059|FG001|Overall Study|Protocol Violation|1|||
23537658|NCT00503841|65702061|FG000|Overall Study|All screen failures|44|||
23537659|NCT00861341|65702064|FG000|Overall Study|Withdrawal by Subject|2|||
23537660|NCT01358981|65702065|FG000|Period 1|Withdrawal by Subject|0|||
23537661|NCT01358981|65702066|FG001|Period 1|Withdrawal by Subject|0|||
23537662|NCT01358981|65702067|FG002|Period 1|Withdrawal by Subject|0|||
23537663|NCT01358981|65702068|FG003|Period 1|Withdrawal by Subject|1|||
23616344|NCT00246129|65982295|FG000|Overall Study|Death|2|||
23537664|NCT01358981|65702069|FG004|Period 1|Withdrawal by Subject|0|||
23537665|NCT01358981|65702070|FG005|Period 1|Withdrawal by Subject|0|||
23423916|NCT03622112|65296306|FG003|Overall Study|Study-specific withdrawal criteria|6|||
23537666|NCT01358981|65702071|FG006|Period 1|Withdrawal by Subject|0|||
23537667|NCT04223856|65702072|FG000|Overall Study|Progressive disease|153|||
23537668|NCT04223856|65702073|FG001|Overall Study|Progressive disease|73|||
23537669|NCT04223856|65702072|FG000|Overall Study|Adverse Event|97|||
23537670|NCT04223856|65702073|FG001|Overall Study|Adverse Event|62|||
23537671|NCT04223856|65702072|FG000|Overall Study|Physician Decision|9|||
23537672|NCT04223856|65702073|FG001|Overall Study|Physician Decision|28|||
23537673|NCT04223856|65702072|FG000|Overall Study|Withdrawal by Subject|22|||
23537674|NCT04223856|65702073|FG001|Overall Study|Withdrawal by Subject|24|||
23537675|NCT04223856|65702072|FG000|Overall Study|Other|7|||
23537676|NCT04223856|65702073|FG001|Overall Study|Other|2|||
23537677|NCT04223856|65702072|FG000|Overall Study|Randomized but not treated|2|||
23537678|NCT04223856|65702073|FG001|Overall Study|Randomized but not treated|11|||
23209113|NCT01740388|64504497|FG001|Overall Study|Subjects missing data, completed|36|||
23209114|NCT02702011|64504498|FG000|Overall Study|Withdrawal by Subject|0|||
23209115|NCT02702011|64504499|FG001|Overall Study|Withdrawal by Subject|1|||
23209116|NCT02702011|64504500|FG002|Overall Study|Withdrawal by Subject|0|||
23209117|NCT02702011|64504501|FG003|Overall Study|Withdrawal by Subject|0|||
23209118|NCT03103906|64504509|FG000|Overall Study|Adverse Event|2|||
23209119|NCT03103906|64504510|FG001|Overall Study|Adverse Event|3|||
23209120|NCT03103906|64504509|FG000|Overall Study|Other|2|||
23209121|NCT03103906|64504510|FG001|Overall Study|Other|0|||
23209122|NCT00441441|64504511|FG000|Overall Study|Adverse Event|2|||
23209123|NCT00441441|64504512|FG001|Overall Study|Adverse Event|1|||
23209124|NCT00441441|64504511|FG000|Overall Study|Protocol Violation|4|||
23209125|NCT00441441|64504512|FG001|Overall Study|Protocol Violation|6|||
23209126|NCT00441441|64504511|FG000|Overall Study|Exacerbation of asthma|1|||
23209127|NCT00441441|64504512|FG001|Overall Study|Exacerbation of asthma|2|||
23209128|NCT00441441|64504511|FG000|Overall Study|Withdrawal by Subject|1|||
23209129|NCT00441441|64504512|FG001|Overall Study|Withdrawal by Subject|2|||
23209130|NCT00441441|64504511|FG000|Overall Study|Other|3|||
23209131|NCT00441441|64504512|FG001|Overall Study|Other|3|||
23209132|NCT03162055|64504513|FG000|Overall Study|Adverse Event|6|||
23209133|NCT03162055|64504514|FG001|Overall Study|Adverse Event|5|||
23209134|NCT03162055|64504513|FG000|Overall Study|Death|3|||
23209135|NCT03162055|64504514|FG001|Overall Study|Death|3|||
23209136|NCT03162055|64504513|FG000|Overall Study|Lost to Follow-up|0|||
23209137|NCT03162055|64504514|FG001|Overall Study|Lost to Follow-up|1|||
23209138|NCT03162055|64504513|FG000|Overall Study|Study-specific withdrawal criteria|22|||
23423917|NCT03622112|65296307|FG004|Overall Study|Study-specific withdrawal criteria|4|||
23423918|NCT03622112|65296308|FG005|Overall Study|Study-specific withdrawal criteria|18|||
23423919|NCT03622112|65296309|FG006|Overall Study|Study-specific withdrawal criteria|4|||
23423920|NCT03622112|65296303|FG000|Overall Study|Protocol Violation|2|||
23423921|NCT03622112|65296304|FG001|Overall Study|Protocol Violation|0|||
23423922|NCT03622112|65296305|FG002|Overall Study|Protocol Violation|1|||
23537679|NCT04223856|65702072|FG000|Overall Study|On-treatment|144|||
23537680|NCT04223856|65702073|FG001|Overall Study|On-treatment|0|||
23537681|NCT03286140|65702074|FG000|Overall Study|Withdrawal by Subject|10|||
23537682|NCT03286140|65702075|FG001|Overall Study|Withdrawal by Subject|5|||
23537683|NCT03286140|65702074|FG000|Overall Study|Lost to Follow-up|5|||
23537684|NCT03286140|65702075|FG001|Overall Study|Lost to Follow-up|10|||
23537685|NCT03286140|65702074|FG000|Overall Study|Failure to comply|0|||
23537686|NCT03286140|65702075|FG001|Overall Study|Failure to comply|1|||
23537687|NCT04079933|65702078|FG000|Overall Study|Withdrawal by Subject|3|||
23537688|NCT04079933|65702079|FG001|Overall Study|Withdrawal by Subject|4|||
23537689|NCT04079933|65702078|FG000|Overall Study|Lost to Follow-up|0|||
23616345|NCT00246129|65982296|FG001|Overall Study|Death|1|||
23616346|NCT00246129|65982295|FG000|Overall Study|suffered primary non-function|1|||
23616347|NCT00246129|65982296|FG001|Overall Study|suffered primary non-function|0|||
23616348|NCT00246129|65982295|FG000|Overall Study|grafts failed|3|||
23616349|NCT00246129|65982296|FG001|Overall Study|grafts failed|1|||
23616350|NCT01047306|65982298|FG000|Overall Study|Withdrawal by Subject|2|||
23616351|NCT01047306|65982299|FG001|Overall Study|Withdrawal by Subject|0|||
23616352|NCT01047306|65982298|FG000|Overall Study|Lost to Follow-up|1|||
23616353|NCT01047306|65982299|FG001|Overall Study|Lost to Follow-up|0|||
23616354|NCT01838499|65982301|FG000|Overall Study|Protocol Violation|0|||
23616355|NCT01838499|65982302|FG001|Overall Study|Protocol Violation|1|||
23209139|NCT03162055|64504514|FG001|Overall Study|Study-specific withdrawal criteria|14|||
23209140|NCT03162055|64504513|FG000|Overall Study|Withdrawal by Subject|17|||
23209141|NCT03162055|64504514|FG001|Overall Study|Withdrawal by Subject|2|||
23537690|NCT04079933|65702079|FG001|Overall Study|Lost to Follow-up|1|||
23537691|NCT04394351|65702088|FG000|Part A (16 Weeks)|Adverse Event|1|||
23209142|NCT03162055|64504513|FG000|Overall Study|Did not receive treatment|2|||
23209143|NCT03162055|64504514|FG001|Overall Study|Did not receive treatment|0|||
23209144|NCT03162055|64504513|FG000|Overall Study|Incorrect randomization|4|||
23311660|NCT03249792|64886607|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23423923|NCT03622112|65296306|FG003|Overall Study|Protocol Violation|1|||
23616356|NCT01838499|65982301|FG000|Overall Study|Lost to Follow-up|2|||
23616357|NCT01838499|65982302|FG001|Overall Study|Lost to Follow-up|4|||
23209145|NCT03162055|64504514|FG001|Overall Study|Incorrect randomization|3|||
23209146|NCT03162055|64504513|FG000|Overall Study|Other|8|||
23209147|NCT03162055|64504514|FG001|Overall Study|Other|15|||
23537692|NCT04394351|65702089|FG001|Part A (16 Weeks)|Adverse Event|0|||
23537693|NCT04394351|65702090|FG002|Part A (16 Weeks)|Adverse Event|0|||
23537694|NCT04394351|65702091|FG003|Part A (16 Weeks)|Adverse Event|0|||
23537695|NCT04394351|65702092|FG004|Part A (16 Weeks)|Adverse Event|0|||
23537696|NCT04394351|65702093|FG005|Part A (16 Weeks)|Adverse Event|0|||
23537697|NCT04394351|65702094|FG006|Part A (16 Weeks)|Adverse Event|0|||
23537698|NCT04394351|65702095|FG007|Part A (16 Weeks)|Adverse Event|0|||
23537699|NCT04394351|65702088|FG000|Part A (16 Weeks)|Physician Decision|0|||
23537700|NCT04394351|65702089|FG001|Part A (16 Weeks)|Physician Decision|1|||
23537701|NCT04394351|65702090|FG002|Part A (16 Weeks)|Physician Decision|0|||
23537702|NCT04394351|65702091|FG003|Part A (16 Weeks)|Physician Decision|0|||
23537703|NCT04394351|65702092|FG004|Part A (16 Weeks)|Physician Decision|0|||
23537704|NCT04394351|65702093|FG005|Part A (16 Weeks)|Physician Decision|0|||
23537705|NCT04394351|65702094|FG006|Part A (16 Weeks)|Physician Decision|0|||
23537706|NCT04394351|65702095|FG007|Part A (16 Weeks)|Physician Decision|0|||
23537707|NCT04394351|65702088|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537708|NCT04394351|65702089|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
23209148|NCT04682353|64504515|FG000|Overall Study|Lost to Follow-up|0|||
23209149|NCT04682353|64504516|FG001|Overall Study|Lost to Follow-up|1|||
23209150|NCT04682353|64504517|FG002|Overall Study|Lost to Follow-up|0|||
23209151|NCT04682353|64504518|FG003|Overall Study|Lost to Follow-up|1|||
23209152|NCT04682353|64504515|FG000|Overall Study|Personal reasons|0|||
23209153|NCT04682353|64504516|FG001|Overall Study|Personal reasons|1|||
23423924|NCT03622112|65296307|FG004|Overall Study|Protocol Violation|0|||
23423925|NCT03622112|65296308|FG005|Overall Study|Protocol Violation|0|||
23423926|NCT03622112|65296309|FG006|Overall Study|Protocol Violation|0|||
23423927|NCT03622112|65296303|FG000|Overall Study|Adverse Event|6|||
23423928|NCT03622112|65296304|FG001|Overall Study|Adverse Event|8|||
23423929|NCT03622112|65296305|FG002|Overall Study|Adverse Event|4|||
23423930|NCT03622112|65296306|FG003|Overall Study|Adverse Event|11|||
23423931|NCT03622112|65296307|FG004|Overall Study|Adverse Event|4|||
23423932|NCT03622112|65296308|FG005|Overall Study|Adverse Event|20|||
23423933|NCT03622112|65296309|FG006|Overall Study|Adverse Event|2|||
23423934|NCT03622112|65296303|FG000|Overall Study|Reason not specified|0|||
23423935|NCT03622112|65296304|FG001|Overall Study|Reason not specified|1|||
23423936|NCT03622112|65296305|FG002|Overall Study|Reason not specified|0|||
23423937|NCT03622112|65296306|FG003|Overall Study|Reason not specified|1|||
23423938|NCT03622112|65296307|FG004|Overall Study|Reason not specified|1|||
23423939|NCT03622112|65296308|FG005|Overall Study|Reason not specified|2|||
23423940|NCT03622112|65296309|FG006|Overall Study|Reason not specified|1|||
23423941|NCT01886690|65296310|FG000|Overall Study|Protocol Violation|0|||
23423942|NCT01886690|65296311|FG001|Overall Study|Protocol Violation|1|||
23423943|NCT01886690|65296310|FG000|Overall Study|Personal Reasons|0|||
23423944|NCT01886690|65296311|FG001|Overall Study|Personal Reasons|1|||
23537709|NCT04394351|65702090|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537710|NCT04394351|65702091|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537711|NCT04394351|65702092|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
23209154|NCT04682353|64504517|FG002|Overall Study|Personal reasons|0|||
23209155|NCT04682353|64504518|FG003|Overall Study|Personal reasons|0|||
23209156|NCT03695393|64504519|FG000|Overall Study|Death|3|||
23423945|NCT00977938|65296316|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
23423946|NCT00977938|65296317|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
23423947|NCT00977938|65296318|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
23537712|NCT04394351|65702093|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537713|NCT04394351|65702094|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537714|NCT04394351|65702095|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
23537715|NCT04394351|65702088|FG000|Part B (36 Weeks)|Adverse Event|0|||
23537716|NCT04394351|65702089|FG001|Part B (36 Weeks)|Adverse Event|0|||
23537717|NCT04394351|65702090|FG002|Part B (36 Weeks)|Adverse Event|0|||
23537718|NCT04394351|65702091|FG003|Part B (36 Weeks)|Adverse Event|0|||
23537719|NCT04394351|65702092|FG004|Part B (36 Weeks)|Adverse Event|0|||
23537720|NCT04394351|65702093|FG005|Part B (36 Weeks)|Adverse Event|0|||
23537721|NCT04394351|65702094|FG006|Part B (36 Weeks)|Adverse Event|1|||
23537722|NCT04394351|65702095|FG007|Part B (36 Weeks)|Adverse Event|0|||
23537723|NCT04798586|65702096|FG000|Overall Study|Death|2|||
23537724|NCT02461589|65702107|FG000|Overall Study|Withdrawal by Subject|5|||
23537725|NCT02461589|65702108|FG001|Overall Study|Withdrawal by Subject|1|||
23537726|NCT02461589|65702109|FG002|Overall Study|Withdrawal by Subject|3|||
23537727|NCT02461589|65702110|FG003|Overall Study|Withdrawal by Subject|2|||
23537728|NCT02461589|65702111|FG004|Overall Study|Withdrawal by Subject|1|||
23537729|NCT02461589|65702112|FG005|Overall Study|Withdrawal by Subject|2|||
23537730|NCT02461589|65702113|FG006|Overall Study|Withdrawal by Subject|1|||
23537731|NCT02461589|65702114|FG007|Overall Study|Withdrawal by Subject|3|||
23537732|NCT02461589|65702115|FG008|Overall Study|Withdrawal by Subject|3|||
23537733|NCT02461589|65702116|FG009|Overall Study|Withdrawal by Subject|1|||
23537734|NCT02461589|65702107|FG000|Overall Study|Lost to Follow-up|0|||
23537735|NCT02461589|65702108|FG001|Overall Study|Lost to Follow-up|0|||
23537736|NCT02461589|65702109|FG002|Overall Study|Lost to Follow-up|2|||
23537737|NCT02461589|65702110|FG003|Overall Study|Lost to Follow-up|3|||
23537738|NCT02461589|65702111|FG004|Overall Study|Lost to Follow-up|1|||
23537739|NCT02461589|65702112|FG005|Overall Study|Lost to Follow-up|1|||
23537740|NCT02461589|65702113|FG006|Overall Study|Lost to Follow-up|3|||
23537741|NCT02461589|65702114|FG007|Overall Study|Lost to Follow-up|1|||
23537742|NCT02461589|65702115|FG008|Overall Study|Lost to Follow-up|3|||
23537743|NCT02461589|65702116|FG009|Overall Study|Lost to Follow-up|1|||
23537744|NCT02461589|65702107|FG000|Overall Study|Death|0|||
23537745|NCT02461589|65702108|FG001|Overall Study|Death|0|||
23537746|NCT02461589|65702109|FG002|Overall Study|Death|0|||
23537747|NCT02461589|65702110|FG003|Overall Study|Death|0|||
23537748|NCT02461589|65702111|FG004|Overall Study|Death|0|||
23537749|NCT02461589|65702112|FG005|Overall Study|Death|0|||
23537750|NCT02461589|65702113|FG006|Overall Study|Death|0|||
23537751|NCT02461589|65702114|FG007|Overall Study|Death|1|||
23537752|NCT02461589|65702115|FG008|Overall Study|Death|0|||
23537753|NCT02461589|65702116|FG009|Overall Study|Death|0|||
23537754|NCT02461589|65702107|FG000|Overall Study|Unclassified|0|||
23537755|NCT02461589|65702108|FG001|Overall Study|Unclassified|0|||
23537756|NCT02461589|65702109|FG002|Overall Study|Unclassified|0|||
23616358|NCT01838499|65982301|FG000|Overall Study|Lack of Efficacy|1|||
23209157|NCT03695393|64504520|FG001|Overall Study|Death|1|||
23209158|NCT03695393|64504519|FG000|Overall Study|Lost to Follow-up|0|||
23209159|NCT03695393|64504520|FG001|Overall Study|Lost to Follow-up|1|||
23209160|NCT00126581|64504525|FG000|Overall Study|Adverse Event|3|||
23537757|NCT02461589|65702110|FG003|Overall Study|Unclassified|0|||
23537758|NCT02461589|65702111|FG004|Overall Study|Unclassified|0|||
23537759|NCT02461589|65702112|FG005|Overall Study|Unclassified|0|||
23537760|NCT02461589|65702113|FG006|Overall Study|Unclassified|1|||
23209161|NCT00126581|64504526|FG001|Overall Study|Adverse Event|7|||
23423948|NCT00977938|65296319|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
23537761|NCT02461589|65702114|FG007|Overall Study|Unclassified|0|||
23537762|NCT02461589|65702115|FG008|Overall Study|Unclassified|0|||
23537763|NCT02461589|65702116|FG009|Overall Study|Unclassified|2|||
23537764|NCT02461589|65702107|FG000|Overall Study|Missing follow-up information|1|||
23537765|NCT02461589|65702108|FG001|Overall Study|Missing follow-up information|1|||
23537766|NCT02461589|65702109|FG002|Overall Study|Missing follow-up information|0|||
23537767|NCT02461589|65702110|FG003|Overall Study|Missing follow-up information|0|||
23537768|NCT02461589|65702111|FG004|Overall Study|Missing follow-up information|0|||
23537769|NCT02461589|65702112|FG005|Overall Study|Missing follow-up information|0|||
23537770|NCT02461589|65702113|FG006|Overall Study|Missing follow-up information|1|||
23537771|NCT02461589|65702114|FG007|Overall Study|Missing follow-up information|0|||
23537772|NCT02461589|65702115|FG008|Overall Study|Missing follow-up information|0|||
23537773|NCT02461589|65702116|FG009|Overall Study|Missing follow-up information|0|||
23537774|NCT02461589|65702107|FG000|Overall Study|Withdrawal from trial before exposure|0|||
23537775|NCT02461589|65702108|FG001|Overall Study|Withdrawal from trial before exposure|0|||
23537776|NCT02461589|65702109|FG002|Overall Study|Withdrawal from trial before exposure|0|||
23537777|NCT02461589|65702110|FG003|Overall Study|Withdrawal from trial before exposure|0|||
23537778|NCT02461589|65702111|FG004|Overall Study|Withdrawal from trial before exposure|0|||
23537779|NCT02461589|65702112|FG005|Overall Study|Withdrawal from trial before exposure|0|||
23537780|NCT02461589|65702113|FG006|Overall Study|Withdrawal from trial before exposure|0|||
23537781|NCT02461589|65702114|FG007|Overall Study|Withdrawal from trial before exposure|0|||
23537782|NCT02461589|65702115|FG008|Overall Study|Withdrawal from trial before exposure|0|||
23537783|NCT02461589|65702116|FG009|Overall Study|Withdrawal from trial before exposure|1|||
23537784|NCT02788175|65702118|FG000|Overall Study|Protocol Violation|3|||
23537785|NCT02788175|65702118|FG000|Overall Study|Withdrawal by Subject|4|||
23537786|NCT02788175|65702118|FG000|Overall Study|Ineligible prior to study agent|6|||
23537787|NCT01513291|65702119|FG000|Treatment Period|Adverse Event|8|||
23537788|NCT01513291|65702120|FG001|Treatment Period|Adverse Event|4|||
23537789|NCT01513291|65702121|FG002|Treatment Period|Adverse Event|0|||
23537790|NCT01513291|65702122|FG003|Treatment Period|Adverse Event|0|||
23537791|NCT01513291|65702123|FG004|Treatment Period|Adverse Event|0|||
23537792|NCT01513291|65702119|FG000|Treatment Period|Lack of Efficacy|3|||
23209162|NCT00126581|64504525|FG000|Overall Study|Death|3|||
23209163|NCT00126581|64504526|FG001|Overall Study|Death|2|||
23209164|NCT00126581|64504525|FG000|Overall Study|Withdrawal by Subject|1|||
23209165|NCT00126581|64504526|FG001|Overall Study|Withdrawal by Subject|4|||
23209166|NCT00126581|64504525|FG000|Overall Study|Alternative therapy|3|||
23209167|NCT00126581|64504526|FG001|Overall Study|Alternative therapy|3|||
23209168|NCT00126581|64504525|FG000|Overall Study|Other illness/MD discretion|3|||
23423949|NCT00977938|65296316|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
23423950|NCT00977938|65296317|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
23423951|NCT00977938|65296318|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
23423952|NCT00977938|65296319|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
23423953|NCT00977938|65296316|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
23423954|NCT00977938|65296317|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
23423955|NCT00977938|65296318|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
23423956|NCT00977938|65296319|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
23423957|NCT00977938|65296316|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
23423958|NCT00977938|65296317|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
23423959|NCT00977938|65296318|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
23423960|NCT00977938|65296319|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
23423961|NCT00977938|65296316|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
23423962|NCT00977938|65296317|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
23423963|NCT00977938|65296318|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
23423964|NCT00977938|65296319|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
23423965|NCT00977938|65296316|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
23423966|NCT00977938|65296317|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
23423967|NCT00977938|65296318|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
23423968|NCT00977938|65296319|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
23423969|NCT01340937|65296320|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
23537793|NCT01513291|65702120|FG001|Treatment Period|Lack of Efficacy|0|||
23537794|NCT01513291|65702121|FG002|Treatment Period|Lack of Efficacy|0|||
23537795|NCT01513291|65702122|FG003|Treatment Period|Lack of Efficacy|0|||
23537796|NCT01513291|65702123|FG004|Treatment Period|Lack of Efficacy|0|||
23537797|NCT01513291|65702119|FG000|Treatment Period|Lost to Follow-up|2|||
23537798|NCT01513291|65702120|FG001|Treatment Period|Lost to Follow-up|3|||
23537799|NCT01513291|65702121|FG002|Treatment Period|Lost to Follow-up|0|||
23537800|NCT01513291|65702122|FG003|Treatment Period|Lost to Follow-up|0|||
23537801|NCT01513291|65702123|FG004|Treatment Period|Lost to Follow-up|0|||
23537802|NCT01513291|65702119|FG000|Treatment Period|Physician Decision|1|||
23537803|NCT01513291|65702120|FG001|Treatment Period|Physician Decision|0|||
23537804|NCT01513291|65702121|FG002|Treatment Period|Physician Decision|0|||
23537805|NCT01513291|65702122|FG003|Treatment Period|Physician Decision|0|||
23537806|NCT01513291|65702123|FG004|Treatment Period|Physician Decision|0|||
23537807|NCT01513291|65702119|FG000|Treatment Period|Protocol Violation|1|||
23537808|NCT01513291|65702120|FG001|Treatment Period|Protocol Violation|2|||
23537809|NCT01513291|65702121|FG002|Treatment Period|Protocol Violation|0|||
23537810|NCT01513291|65702122|FG003|Treatment Period|Protocol Violation|0|||
23537811|NCT01513291|65702123|FG004|Treatment Period|Protocol Violation|0|||
23537812|NCT01513291|65702119|FG000|Treatment Period|Withdrawal by Subject|8|||
23537813|NCT01513291|65702120|FG001|Treatment Period|Withdrawal by Subject|5|||
23537814|NCT01513291|65702121|FG002|Treatment Period|Withdrawal by Subject|0|||
23537815|NCT01513291|65702122|FG003|Treatment Period|Withdrawal by Subject|0|||
23537816|NCT01513291|65702123|FG004|Treatment Period|Withdrawal by Subject|0|||
23537817|NCT01513291|65702119|FG000|Treatment Period|Randomized not treated|0|||
23537818|NCT01513291|65702120|FG001|Treatment Period|Randomized not treated|2|||
23537819|NCT01513291|65702121|FG002|Treatment Period|Randomized not treated|0|||
23537820|NCT01513291|65702122|FG003|Treatment Period|Randomized not treated|0|||
23537821|NCT01513291|65702123|FG004|Treatment Period|Randomized not treated|0|||
23537822|NCT01513291|65702119|FG000|Run-out Period|Lost to Follow-up|0|||
23537823|NCT01513291|65702120|FG001|Run-out Period|Lost to Follow-up|0|||
23537824|NCT01513291|65702121|FG002|Run-out Period|Lost to Follow-up|0|||
23537825|NCT01513291|65702122|FG003|Run-out Period|Lost to Follow-up|1|||
23537826|NCT01513291|65702123|FG004|Run-out Period|Lost to Follow-up|0|||
23537827|NCT01513291|65702119|FG000|Run-out Period|Withdrawal by Subject|0|||
23537828|NCT01513291|65702120|FG001|Run-out Period|Withdrawal by Subject|0|||
23537829|NCT01513291|65702121|FG002|Run-out Period|Withdrawal by Subject|0|||
23537830|NCT01513291|65702122|FG003|Run-out Period|Withdrawal by Subject|1|||
23537831|NCT01513291|65702123|FG004|Run-out Period|Withdrawal by Subject|0|||
23537832|NCT02838017|65702131|FG000|Overall Study|Lost to Follow-up|14|||
23537833|NCT02838017|65702132|FG001|Overall Study|Lost to Follow-up|11|||
23537834|NCT02863354|65702137|FG000|Year 1|Lost to Follow-up|1|||
23537835|NCT02863354|65702138|FG001|Year 1|Lost to Follow-up|1|||
23537836|NCT02863354|65702137|FG000|Year 1|Withdrawal by Subject|3|||
23537837|NCT02863354|65702138|FG001|Year 1|Withdrawal by Subject|0|||
23537838|NCT02863354|65702137|FG000|Year 1|Death|0|||
23537839|NCT02863354|65702138|FG001|Year 1|Death|1|||
23537840|NCT02863354|65702137|FG000|Year 2|Lost to Follow-up|2|||
23537841|NCT02863354|65702138|FG001|Year 2|Lost to Follow-up|2|||
23537842|NCT01163682|65702139|FG000|Overall Study|Lost to Follow-up|6|||
23537843|NCT01163682|65702140|FG001|Overall Study|Lost to Follow-up|9|||
23537844|NCT02096835|65702141|FG000|Overall Study|Withdrawal by Subject|1|||
23537845|NCT02096835|65702142|FG001|Overall Study|Withdrawal by Subject|0|||
23537846|NCT02096835|65702143|FG002|Overall Study|Withdrawal by Subject|0|||
23537847|NCT02096835|65702141|FG000|Overall Study|converted to open procedures|1|||
23537848|NCT02096835|65702142|FG001|Overall Study|converted to open procedures|0|||
23537849|NCT02096835|65702143|FG002|Overall Study|converted to open procedures|0|||
23537850|NCT02096835|65702141|FG000|Overall Study|Lost to Follow-up|1|||
23537851|NCT02096835|65702142|FG001|Overall Study|Lost to Follow-up|0|||
23537852|NCT02096835|65702143|FG002|Overall Study|Lost to Follow-up|1|||
23537853|NCT02565381|65702144|FG000|Overall Study|Lost to Follow-up|1|||
23537854|NCT02565381|65702145|FG001|Overall Study|Lost to Follow-up|0|||
23537855|NCT02565381|65702146|FG002|Overall Study|Lost to Follow-up|1|||
23537856|NCT01775137|65702147|FG000|Overall Study|Death|1|||
23537857|NCT01775137|65702147|FG000|Overall Study|Protocol deviation|2|||
23537858|NCT01775137|65702147|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23537859|NCT01775137|65702147|FG000|Overall Study|Adverse Event|1|||
23537860|NCT01775137|65702147|FG000|Overall Study|Withdrawal by participants|5|||
23537861|NCT02443298|65702151|FG000|Overall Study|Adverse Event|3|||
23537862|NCT02443298|65702152|FG001|Overall Study|Adverse Event|3|||
23537863|NCT02443298|65702151|FG000|Overall Study|Withdrawal by Subject|1|||
23537864|NCT02443298|65702152|FG001|Overall Study|Withdrawal by Subject|2|||
23537865|NCT01312961|65702155|FG000|Overall Study|Adverse Event|3|||
23537866|NCT01312961|65702156|FG001|Overall Study|Adverse Event|3|||
23537867|NCT01312961|65702155|FG000|Overall Study|Lack of Efficacy|11|||
23537868|NCT01312961|65702156|FG001|Overall Study|Lack of Efficacy|1|||
23537869|NCT01312961|65702155|FG000|Overall Study|Poor compliance to protocol|1|||
23537870|NCT01312961|65702156|FG001|Overall Study|Poor compliance to protocol|0|||
23537871|NCT01312961|65702155|FG000|Overall Study|Other than specified above|2|||
23537872|NCT01312961|65702156|FG001|Overall Study|Other than specified above|3|||
23537873|NCT01858194|65702165|FG000|Overall Study|Total Artificial Heart Implant|0|||
23537874|NCT01858194|65702166|FG001|Overall Study|Total Artificial Heart Implant|1|||
23537875|NCT01858194|65702165|FG000|Overall Study|Lost to Follow-up|0|||
23537876|NCT01858194|65702166|FG001|Overall Study|Lost to Follow-up|1|||
23537877|NCT02660359|65702173|FG000|Overall Study|Protocol Deviation|0|||
23537878|NCT02660359|65702174|FG001|Overall Study|Protocol Deviation|0|||
23537879|NCT02660359|65702175|FG002|Overall Study|Protocol Deviation|1|||
23537880|NCT02660359|65702173|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
23537881|NCT02660359|65702174|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
23537882|NCT02660359|65702175|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
23537883|NCT02660359|65702173|FG000|Overall Study|Lack of Efficacy|1|||
23537884|NCT02660359|65702174|FG001|Overall Study|Lack of Efficacy|1|||
23537885|NCT02660359|65702175|FG002|Overall Study|Lack of Efficacy|1|||
23537886|NCT02660359|65702173|FG000|Overall Study|Adverse Event|0|||
23537887|NCT02660359|65702174|FG001|Overall Study|Adverse Event|1|||
23537888|NCT02660359|65702175|FG002|Overall Study|Adverse Event|0|||
23537889|NCT02660359|65702173|FG000|Overall Study|Other|2|||
23537890|NCT02660359|65702174|FG001|Overall Study|Other|1|||
23537891|NCT02660359|65702175|FG002|Overall Study|Other|3|||
23537892|NCT02660359|65702173|FG000|Overall Study|Withdrawal by Subject|7|||
23537893|NCT02660359|65702174|FG001|Overall Study|Withdrawal by Subject|5|||
23537894|NCT02660359|65702175|FG002|Overall Study|Withdrawal by Subject|8|||
23537895|NCT02660359|65702173|FG000|Overall Study|Lost to Follow-up|3|||
23537896|NCT02660359|65702174|FG001|Overall Study|Lost to Follow-up|3|||
23537897|NCT02660359|65702175|FG002|Overall Study|Lost to Follow-up|0|||
23537898|NCT01813019|65702176|FG000|Overall Study|Adverse Event|0|||
23537899|NCT01813019|65702177|FG001|Overall Study|Adverse Event|3|||
23537900|NCT01813019|65702176|FG000|Overall Study|Withdrawal by Subject|3|||
23537901|NCT01813019|65702177|FG001|Overall Study|Withdrawal by Subject|2|||
23537902|NCT01813019|65702176|FG000|Overall Study|administrative problems|2|||
23537903|NCT01813019|65702177|FG001|Overall Study|administrative problems|0|||
23537904|NCT01813019|65702176|FG000|Overall Study|Protocol Deviation|2|||
23537905|NCT01813019|65702177|FG001|Overall Study|Protocol Deviation|1|||
23537906|NCT02019719|65702182|FG000|Overall Study|Adverse Event|1|||
23537907|NCT02019719|65702183|FG001|Overall Study|Adverse Event|0|||
23537908|NCT02019719|65702184|FG002|Overall Study|Adverse Event|0|||
23537909|NCT02019719|65702185|FG003|Overall Study|Adverse Event|1|||
23537910|NCT02019719|65702186|FG004|Overall Study|Adverse Event|1|||
23537911|NCT02019719|65702182|FG000|Overall Study|Protocol Violation|1|||
23537912|NCT02019719|65702183|FG001|Overall Study|Protocol Violation|1|||
23537913|NCT02019719|65702184|FG002|Overall Study|Protocol Violation|0|||
23537914|NCT02019719|65702185|FG003|Overall Study|Protocol Violation|0|||
23537915|NCT02019719|65702186|FG004|Overall Study|Protocol Violation|0|||
23537916|NCT02019719|65702182|FG000|Overall Study|Protocol defined stopping criteria|2|||
23537917|NCT02019719|65702183|FG001|Overall Study|Protocol defined stopping criteria|0|||
23537918|NCT02019719|65702184|FG002|Overall Study|Protocol defined stopping criteria|0|||
23537919|NCT02019719|65702185|FG003|Overall Study|Protocol defined stopping criteria|1|||
23537920|NCT02019719|65702186|FG004|Overall Study|Protocol defined stopping criteria|1|||
23537921|NCT02019719|65702182|FG000|Overall Study|Physician Decision|2|||
23537922|NCT02019719|65702183|FG001|Overall Study|Physician Decision|0|||
23537923|NCT02019719|65702184|FG002|Overall Study|Physician Decision|0|||
23537924|NCT02019719|65702185|FG003|Overall Study|Physician Decision|0|||
23537925|NCT02019719|65702186|FG004|Overall Study|Physician Decision|0|||
23537926|NCT04354831|65702191|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
23537927|NCT04354831|65702192|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
23537928|NCT00096941|65702195|FG000|Overall Study|disease progression|3|||
23537929|NCT04027686|65702196|FG000|Overall Study|Lost to Follow-up|2|||
23537930|NCT04027686|65702197|FG001|Overall Study|Lost to Follow-up|0|||
23537931|NCT04027686|65702196|FG000|Overall Study|Withdrawal by Subject|0|||
23537932|NCT04027686|65702197|FG001|Overall Study|Withdrawal by Subject|1|||
23537933|NCT03653429|65702198|FG000|Overall Study|Physician Decision|4|||
23537934|NCT03653429|65702199|FG001|Overall Study|Physician Decision|10|||
23537935|NCT00194012|65702200|FG000|Randomized Phase|Lack of Efficacy|8|||
23537936|NCT00194012|65702201|FG001|Randomized Phase|Lack of Efficacy|18|||
23537937|NCT00194012|65702200|FG000|Randomized Phase|Study nonadherence|2|||
23537938|NCT00194012|65702201|FG001|Randomized Phase|Study nonadherence|1|||
23537939|NCT00194012|65702200|FG000|Randomized Phase|Withdrawal by Subject|3|||
23537940|NCT00194012|65702201|FG001|Randomized Phase|Withdrawal by Subject|3|||
23537941|NCT00194012|65702200|FG000|Randomized Phase|Adverse Event|2|||
23537942|NCT00194012|65702201|FG001|Randomized Phase|Adverse Event|1|||
23537943|NCT00194012|65702200|FG000|Randomized Phase|Participant reported having a rash|1|||
23537944|NCT00194012|65702201|FG001|Randomized Phase|Participant reported having a rash|0|||
23537945|NCT00194012|65702200|FG000|Randomized Phase|Emesis and enuresis|0|||
23537946|NCT00194012|65702201|FG001|Randomized Phase|Emesis and enuresis|1|||
23537947|NCT00194012|65702200|FG000|Randomized Phase|Oral/nasal twitching|0|||
23537948|NCT00194012|65702201|FG001|Randomized Phase|Oral/nasal twitching|1|||
23537949|NCT00194012|65702200|FG000|Open Label Extension (OLE)|Weight Gain|1|||
23537950|NCT00194012|65702201|FG001|Open Label Extension (OLE)|Weight Gain|0|||
23537951|NCT00194012|65702200|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
23537952|NCT00194012|65702201|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
23537953|NCT00194012|65702200|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
23537954|NCT00194012|65702201|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
23537955|NCT00194012|65702200|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
23537956|NCT00194012|65702201|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
23537957|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Adverse Event|41|||
23537958|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Adverse Event|24|||
23537959|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
23537960|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
23537961|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
23537962|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
23537963|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Physician Decision|0|||
23537964|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Physician Decision|6|||
23537965|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
23537966|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
23537967|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
23537968|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
23537969|NCT00673452|65702202|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
23537970|NCT00673452|65702203|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
23537971|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
23537972|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
23537973|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
23537974|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
23537975|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
23537976|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
23537977|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
23537978|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
23537979|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
23537980|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
23537981|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
23537982|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
23537983|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
23537984|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
23537985|NCT00673452|65702202|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
23537986|NCT00673452|65702203|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
23537987|NCT01896895|65702204|FG000|Double-blind MP|Physician Decision|0|||
23537988|NCT01896895|65702205|FG001|Double-blind MP|Physician Decision|0|||
23537989|NCT01896895|65702206|FG002|Double-blind MP|Physician Decision|1|||
23537990|NCT01896895|65702207|FG003|Double-blind MP|Physician Decision|0|||
23537991|NCT01896895|65702204|FG000|Double-blind MP|Withdrawal by Subject|0|||
23537992|NCT01896895|65702205|FG001|Double-blind MP|Withdrawal by Subject|2|||
23537993|NCT01896895|65702206|FG002|Double-blind MP|Withdrawal by Subject|1|||
23423970|NCT01340937|65296321|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
23616359|NCT01838499|65982302|FG001|Overall Study|Lack of Efficacy|2|||
23537994|NCT01896895|65702207|FG003|Double-blind MP|Withdrawal by Subject|0|||
23537995|NCT01896895|65702204|FG000|Double-blind MP|Lost to Follow-up|1|||
23537996|NCT01896895|65702205|FG001|Double-blind MP|Lost to Follow-up|0|||
23537997|NCT01896895|65702206|FG002|Double-blind MP|Lost to Follow-up|1|||
23537998|NCT01896895|65702207|FG003|Double-blind MP|Lost to Follow-up|0|||
23537999|NCT01607905|65702208|FG000|Overall Study|Withdrawal by participant|7|||
23538000|NCT01607905|65702209|FG001|Overall Study|Withdrawal by participant|2|||
23538001|NCT01607905|65702210|FG002|Overall Study|Withdrawal by participant|4|||
23538002|NCT01607905|65702211|FG003|Overall Study|Withdrawal by participant|6|||
23538003|NCT01607905|65702212|FG004|Overall Study|Withdrawal by participant|0|||
23538004|NCT01607905|65702213|FG005|Overall Study|Withdrawal by participant|4|||
23538005|NCT01607905|65702214|FG006|Overall Study|Withdrawal by participant|12|||
23538006|NCT01607905|65702208|FG000|Overall Study|Incidence or severity of AEs|5|||
23538007|NCT01607905|65702209|FG001|Overall Study|Incidence or severity of AEs|1|||
23538008|NCT01607905|65702210|FG002|Overall Study|Incidence or severity of AEs|1|||
23538009|NCT01607905|65702211|FG003|Overall Study|Incidence or severity of AEs|3|||
23538010|NCT01607905|65702212|FG004|Overall Study|Incidence or severity of AEs|0|||
23538011|NCT01607905|65702213|FG005|Overall Study|Incidence or severity of AEs|2|||
23538012|NCT01607905|65702214|FG006|Overall Study|Incidence or severity of AEs|8|||
23209169|NCT00126581|64504526|FG001|Overall Study|Other illness/MD discretion|4|||
23423971|NCT01340937|65296322|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
23538013|NCT01607905|65702208|FG000|Overall Study|Disease progression|44|||
23538014|NCT01607905|65702209|FG001|Overall Study|Disease progression|16|||
23311661|NCT03249792|64886608|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23209170|NCT01594333|64504527|FG000|Overall Study|Death|96|||
23311662|NCT03249792|64886609|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311663|NCT03249792|64886610|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311664|NCT03249792|64886611|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311665|NCT03249792|64886612|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311666|NCT03249792|64886613|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311667|NCT03249792|64886614|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311668|NCT03249792|64886615|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
23311669|NCT03249792|64886583|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
23311670|NCT03249792|64886584|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
23311671|NCT03249792|64886585|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
23311672|NCT03249792|64886586|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
23311673|NCT03249792|64886587|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
23311674|NCT03249792|64886588|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
23311675|NCT03249792|64886589|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
23311676|NCT03249792|64886590|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
23311677|NCT03249792|64886591|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
23311678|NCT03249792|64886592|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
23311679|NCT03249792|64886593|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
23311680|NCT03249792|64886594|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
23311681|NCT03249792|64886595|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
23311682|NCT03249792|64886596|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
23311683|NCT03249792|64886597|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
23311684|NCT03249792|64886598|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
23311685|NCT03249792|64886599|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
23311686|NCT03249792|64886600|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
23311687|NCT03249792|64886601|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
23311688|NCT03249792|64886602|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
23311689|NCT03249792|64886603|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
23311690|NCT03249792|64886604|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
23311691|NCT03249792|64886605|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
23311692|NCT03249792|64886606|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
23311693|NCT03249792|64886607|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
23311694|NCT03249792|64886608|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
23616360|NCT01838499|65982301|FG000|Overall Study|Adverse Event|2|||
23311695|NCT03249792|64886609|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
23311696|NCT03249792|64886610|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
23311697|NCT03249792|64886611|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
23423972|NCT01340937|65296323|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
23423973|NCT01340937|65296320|FG000|Period 1: Infant Series|Adverse Event|0|||
23423974|NCT01340937|65296321|FG001|Period 1: Infant Series|Adverse Event|1|||
23423975|NCT01340937|65296322|FG002|Period 1: Infant Series|Adverse Event|4|||
23423976|NCT01340937|65296323|FG003|Period 1: Infant Series|Adverse Event|0|||
23423977|NCT01340937|65296320|FG000|Period 1: Infant Series|Death|2|||
23423978|NCT01340937|65296321|FG001|Period 1: Infant Series|Death|0|||
23423979|NCT01340937|65296322|FG002|Period 1: Infant Series|Death|2|||
23423980|NCT01340937|65296323|FG003|Period 1: Infant Series|Death|0|||
23423981|NCT01340937|65296320|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
23423982|NCT01340937|65296321|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
23423983|NCT01340937|65296322|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
23423984|NCT01340937|65296323|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
23423985|NCT01340937|65296320|FG000|Period 1: Infant Series|Physician Decision|2|||
23423986|NCT01340937|65296321|FG001|Period 1: Infant Series|Physician Decision|3|||
23423987|NCT01340937|65296322|FG002|Period 1: Infant Series|Physician Decision|1|||
23423988|NCT01340937|65296323|FG003|Period 1: Infant Series|Physician Decision|0|||
23423989|NCT01340937|65296320|FG000|Period 1: Infant Series|Protocol Violation|1|||
23423990|NCT01340937|65296321|FG001|Period 1: Infant Series|Protocol Violation|4|||
23423991|NCT01340937|65296322|FG002|Period 1: Infant Series|Protocol Violation|4|||
23423992|NCT01340937|65296323|FG003|Period 1: Infant Series|Protocol Violation|3|||
23423993|NCT01340937|65296320|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
23423994|NCT01340937|65296321|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
23423995|NCT01340937|65296322|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
23423996|NCT01340937|65296323|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
23538015|NCT01607905|65702210|FG002|Overall Study|Disease progression|15|||
23538016|NCT01607905|65702211|FG003|Overall Study|Disease progression|11|||
23538017|NCT01607905|65702212|FG004|Overall Study|Disease progression|6|||
23538018|NCT01607905|65702213|FG005|Overall Study|Disease progression|7|||
23538019|NCT01607905|65702214|FG006|Overall Study|Disease progression|21|||
23538020|NCT01607905|65702208|FG000|Overall Study|Non-compliance with study procedures|0|||
23616361|NCT01838499|65982302|FG001|Overall Study|Adverse Event|1|||
23616362|NCT01838499|65982301|FG000|Overall Study|Withdrawal by Subject|19|||
23538021|NCT01607905|65702209|FG001|Overall Study|Non-compliance with study procedures|0|||
23616363|NCT01838499|65982302|FG001|Overall Study|Withdrawal by Subject|9|||
23616364|NCT05740371|65982303|FG000|Overall Study|Death|1|||
23616365|NCT00774306|65982304|FG000|Overall Study|Adverse Event|3|||
23616366|NCT00774306|65982305|FG001|Overall Study|Adverse Event|0|||
23616367|NCT00774306|65982306|FG002|Overall Study|Adverse Event|0|||
23616368|NCT00774306|65982307|FG003|Overall Study|Adverse Event|0|||
23616369|NCT00774306|65982304|FG000|Overall Study|Protocol Violation|2|||
23616370|NCT00774306|65982305|FG001|Overall Study|Protocol Violation|0|||
23616371|NCT00774306|65982306|FG002|Overall Study|Protocol Violation|3|||
23616372|NCT00774306|65982307|FG003|Overall Study|Protocol Violation|0|||
23209171|NCT01594333|64504528|FG001|Overall Study|Death|83|||
23423997|NCT01340937|65296320|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
23538022|NCT01607905|65702210|FG002|Overall Study|Non-compliance with study procedures|0|||
23538023|NCT01607905|65702211|FG003|Overall Study|Non-compliance with study procedures|0|||
23538024|NCT01607905|65702212|FG004|Overall Study|Non-compliance with study procedures|0|||
23538025|NCT01607905|65702213|FG005|Overall Study|Non-compliance with study procedures|0|||
23538026|NCT01607905|65702214|FG006|Overall Study|Non-compliance with study procedures|1|||
23538027|NCT01607905|65702208|FG000|Overall Study|Death|1|||
23538028|NCT01607905|65702209|FG001|Overall Study|Death|1|||
23538029|NCT01607905|65702210|FG002|Overall Study|Death|1|||
23538030|NCT01607905|65702211|FG003|Overall Study|Death|1|||
23538031|NCT01607905|65702212|FG004|Overall Study|Death|0|||
23538032|NCT01607905|65702213|FG005|Overall Study|Death|0|||
23538033|NCT01607905|65702214|FG006|Overall Study|Death|3|||
23538034|NCT01607905|65702208|FG000|Overall Study|Other treatments become available|1|||
23538035|NCT01607905|65702209|FG001|Overall Study|Other treatments become available|0|||
23538036|NCT01607905|65702210|FG002|Overall Study|Other treatments become available|0|||
23538037|NCT01607905|65702211|FG003|Overall Study|Other treatments become available|0|||
23616373|NCT00774306|65982304|FG000|Overall Study|Withdrawal by Subject|6|||
23616374|NCT00774306|65982305|FG001|Overall Study|Withdrawal by Subject|1|||
23616375|NCT00774306|65982306|FG002|Overall Study|Withdrawal by Subject|1|||
23423998|NCT01340937|65296321|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
23423999|NCT01340937|65296322|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
23538038|NCT01607905|65702212|FG004|Overall Study|Other treatments become available|0|||
23538039|NCT01607905|65702213|FG005|Overall Study|Other treatments become available|0|||
23538040|NCT01607905|65702214|FG006|Overall Study|Other treatments become available|1|||
23616376|NCT00774306|65982307|FG003|Overall Study|Withdrawal by Subject|0|||
23538041|NCT01607905|65702208|FG000|Overall Study|Investigator discretion|0|||
23424000|NCT01340937|65296323|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
23424001|NCT01340937|65296320|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
23538042|NCT01607905|65702209|FG001|Overall Study|Investigator discretion|0|||
23538043|NCT01607905|65702210|FG002|Overall Study|Investigator discretion|0|||
23538044|NCT01607905|65702211|FG003|Overall Study|Investigator discretion|0|||
23538045|NCT01607905|65702212|FG004|Overall Study|Investigator discretion|0|||
23538046|NCT01607905|65702213|FG005|Overall Study|Investigator discretion|1|||
23538047|NCT01607905|65702214|FG006|Overall Study|Investigator discretion|0|||
23538048|NCT01607905|65702208|FG000|Overall Study|Other|1|||
23538049|NCT01607905|65702209|FG001|Overall Study|Other|0|||
23538050|NCT01607905|65702210|FG002|Overall Study|Other|0|||
23538051|NCT01607905|65702211|FG003|Overall Study|Other|0|||
23538052|NCT01607905|65702212|FG004|Overall Study|Other|0|||
23538053|NCT01607905|65702213|FG005|Overall Study|Other|0|||
23538054|NCT01607905|65702214|FG006|Overall Study|Other|1|||
23538055|NCT01607905|65702208|FG000|Overall Study|Randomized but not treated|1|||
23538056|NCT01607905|65702209|FG001|Overall Study|Randomized but not treated|0|||
23538057|NCT01607905|65702210|FG002|Overall Study|Randomized but not treated|0|||
23538058|NCT01607905|65702211|FG003|Overall Study|Randomized but not treated|0|||
23538059|NCT01607905|65702212|FG004|Overall Study|Randomized but not treated|1|||
23538060|NCT01607905|65702213|FG005|Overall Study|Randomized but not treated|1|||
23538061|NCT01607905|65702214|FG006|Overall Study|Randomized but not treated|0|||
23538062|NCT01003249|65702222|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23538063|NCT01003249|65702223|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23538064|NCT01003249|65702222|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
23538065|NCT01003249|65702223|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
23538066|NCT01003249|65702222|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23538067|NCT01003249|65702223|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23538068|NCT01003249|65702222|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
23538069|NCT01003249|65702223|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
23538070|NCT03238001|65702234|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
23538071|NCT03238001|65702234|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
23538072|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
23538073|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
23538074|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
23538075|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
23538076|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
23538077|NCT03238001|65702234|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
23538078|NCT01694706|65702237|FG000|Overall Study|Adverse Event|0|||
23538079|NCT01694706|65702238|FG001|Overall Study|Adverse Event|1|||
23538080|NCT01694706|65702239|FG002|Overall Study|Adverse Event|0|||
23538081|NCT01694706|65702237|FG000|Overall Study|other reason not defined above|1|||
23538082|NCT01694706|65702238|FG001|Overall Study|other reason not defined above|0|||
23538083|NCT01694706|65702239|FG002|Overall Study|other reason not defined above|0|||
23538084|NCT01458171|65702240|FG000|Overall Study|Adverse Event|1|||
23538085|NCT00766415|65702243|FG000|Overall Study|Withdrawal by Subject|0|||
23538086|NCT00766415|65702244|FG001|Overall Study|Withdrawal by Subject|1|||
23538087|NCT02805257|65702245|FG000|Overall Study|Lost to Follow-up|7|||
23538088|NCT02805257|65702246|FG001|Overall Study|Lost to Follow-up|6|||
23538089|NCT02805257|65702245|FG000|Overall Study|Death|0|||
23538090|NCT02805257|65702246|FG001|Overall Study|Death|1|||
23538091|NCT01465334|65702247|FG000|Overall Study|Disease Progression|1|||
23538092|NCT01465334|65702248|FG001|Overall Study|Disease Progression|0|||
23538093|NCT01465334|65702247|FG000|Overall Study|Adverse Event|1|||
23538094|NCT01465334|65702248|FG001|Overall Study|Adverse Event|0|||
23538095|NCT01465334|65702247|FG000|Overall Study|Richter's transformation|0|||
23538096|NCT01465334|65702248|FG001|Overall Study|Richter's transformation|3|||
23538097|NCT01465334|65702247|FG000|Overall Study|Refractory Disease|0|||
23538098|NCT01465334|65702248|FG001|Overall Study|Refractory Disease|3|||
23538099|NCT03766646|65702256|FG000|Overall Study|Withdrawal by Subject|1|||
23538100|NCT03766646|65702257|FG001|Overall Study|Withdrawal by Subject|0|||
23538101|NCT03766646|65702256|FG000|Overall Study|Protocol Violation|0|||
23538102|NCT03766646|65702257|FG001|Overall Study|Protocol Violation|3|||
23538103|NCT04788147|65702258|FG000|Overall Study|Screen Failure|3|||
23538104|NCT04788147|65702259|FG001|Overall Study|Screen Failure|10|||
23538105|NCT04788147|65702258|FG000|Overall Study|Incomplete RMRS image session|2|||
23538106|NCT04788147|65702259|FG001|Overall Study|Incomplete RMRS image session|0|||
23538107|NCT01677195|65702260|FG000|Overall Study|Lost to Follow-up|14|||
23538108|NCT01677195|65702261|FG001|Overall Study|Lost to Follow-up|22|||
23538109|NCT01677195|65702262|FG002|Overall Study|Lost to Follow-up|22|||
23538110|NCT01677195|65702260|FG000|Overall Study|Withdrawal by Subject|1|||
23538111|NCT01677195|65702261|FG001|Overall Study|Withdrawal by Subject|0|||
23538112|NCT01677195|65702262|FG002|Overall Study|Withdrawal by Subject|1|||
23538113|NCT01677195|65702260|FG000|Overall Study|Adverse Event|6|||
23538114|NCT01677195|65702261|FG001|Overall Study|Adverse Event|4|||
23538115|NCT01677195|65702262|FG002|Overall Study|Adverse Event|1|||
23538116|NCT01677195|65702260|FG000|Overall Study|Physician Decision|1|||
23538117|NCT01677195|65702261|FG001|Overall Study|Physician Decision|2|||
23538118|NCT01677195|65702262|FG002|Overall Study|Physician Decision|2|||
23209172|NCT01594333|64504527|FG000|Overall Study|Lost to Follow-up|5|||
23209173|NCT01594333|64504528|FG001|Overall Study|Lost to Follow-up|5|||
23209174|NCT01594333|64504527|FG000|Overall Study|Withdrawal by Subject|60|||
23209175|NCT01594333|64504528|FG001|Overall Study|Withdrawal by Subject|63|||
23209176|NCT00502320|64504529|FG000|Overall Study|Lost to Follow-up|1|||
23209177|NCT00502320|64504530|FG001|Overall Study|Lost to Follow-up|1|||
23209178|NCT00502320|64504529|FG000|Overall Study|Withdrew Consent|1|||
23209179|NCT00502320|64504530|FG001|Overall Study|Withdrew Consent|0|||
23209180|NCT00502320|64504529|FG000|Overall Study|No longer met criteria|1|||
23209181|NCT00502320|64504530|FG001|Overall Study|No longer met criteria|0|||
23424002|NCT01340937|65296321|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
23424003|NCT01340937|65296322|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
23424004|NCT01340937|65296323|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
23424005|NCT01340937|65296320|FG000|Period 2: Interim Period|Adverse Event|1|||
23424006|NCT01340937|65296321|FG001|Period 2: Interim Period|Adverse Event|0|||
23424007|NCT01340937|65296322|FG002|Period 2: Interim Period|Adverse Event|1|||
23424008|NCT01340937|65296323|FG003|Period 2: Interim Period|Adverse Event|0|||
23538119|NCT01677195|65702260|FG000|Overall Study|Pregnancy|0|||
23616377|NCT00774306|65982304|FG000|Overall Study|Lost to Follow-up|6|||
23616378|NCT00774306|65982305|FG001|Overall Study|Lost to Follow-up|0|||
23616379|NCT00774306|65982306|FG002|Overall Study|Lost to Follow-up|4|||
23424009|NCT01340937|65296320|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
23424010|NCT01340937|65296321|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
23424011|NCT01340937|65296322|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
23424012|NCT01340937|65296323|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
23424013|NCT01340937|65296320|FG000|Period 2: Interim Period|Physician Decision|0|||
23424014|NCT01340937|65296321|FG001|Period 2: Interim Period|Physician Decision|1|||
23424015|NCT01340937|65296322|FG002|Period 2: Interim Period|Physician Decision|1|||
23424016|NCT01340937|65296323|FG003|Period 2: Interim Period|Physician Decision|0|||
23424017|NCT01340937|65296320|FG000|Period 2: Interim Period|Protocol Violation|5|||
23424018|NCT01340937|65296321|FG001|Period 2: Interim Period|Protocol Violation|3|||
23538120|NCT01677195|65702261|FG001|Overall Study|Pregnancy|1|||
23538121|NCT01677195|65702262|FG002|Overall Study|Pregnancy|0|||
23538122|NCT01677195|65702260|FG000|Overall Study|Protocol Violation|7|||
23538123|NCT01677195|65702261|FG001|Overall Study|Protocol Violation|3|||
23538124|NCT01677195|65702262|FG002|Overall Study|Protocol Violation|4|||
23538125|NCT03823651|65702263|FG000|Overall Study|Death|5|||
23538126|NCT03823651|65702264|FG001|Overall Study|Death|0|||
23538127|NCT03823651|65702263|FG000|Overall Study|Physician Decision|1|||
23616380|NCT00774306|65982307|FG003|Overall Study|Lost to Follow-up|5|||
23616381|NCT00774306|65982304|FG000|Overall Study|Death|1|||
23209182|NCT00502320|64504529|FG000|Overall Study|Screen Failure|0|||
23209183|NCT00502320|64504530|FG001|Overall Study|Screen Failure|1|||
23538128|NCT03823651|65702264|FG001|Overall Study|Physician Decision|0|||
23538129|NCT03823651|65702263|FG000|Overall Study|Caregiver to patient who died|0|||
23538130|NCT03823651|65702264|FG001|Overall Study|Caregiver to patient who died|5|||
23538131|NCT03823651|65702263|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
23209184|NCT00502320|64504529|FG000|Overall Study|Adverse Event|3|||
23209185|NCT00502320|64504530|FG001|Overall Study|Adverse Event|5|||
23209186|NCT01486784|64504531|FG000|Overall Study|Withdrawal by Subject|0|||
23209187|NCT01486784|64504532|FG001|Overall Study|Withdrawal by Subject|0|||
23209188|NCT01486784|64504533|FG002|Overall Study|Withdrawal by Subject|1|||
23209189|NCT01486784|64504534|FG003|Overall Study|Withdrawal by Subject|0|||
23209190|NCT01486784|64504535|FG004|Overall Study|Withdrawal by Subject|1|||
23311698|NCT03249792|64886612|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
23424019|NCT01340937|65296322|FG002|Period 2: Interim Period|Protocol Violation|6|||
23424020|NCT01340937|65296323|FG003|Period 2: Interim Period|Protocol Violation|3|||
23424021|NCT01340937|65296320|FG000|Period 2: Interim Period|Technical problems|4|||
23424022|NCT01340937|65296321|FG001|Period 2: Interim Period|Technical problems|4|||
23424023|NCT01340937|65296322|FG002|Period 2: Interim Period|Technical problems|6|||
23424024|NCT01340937|65296323|FG003|Period 2: Interim Period|Technical problems|3|||
23538132|NCT03823651|65702264|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
23538133|NCT02664038|65702269|FG000|13 Week|Lost to Follow-up|7|||
23538134|NCT02664038|65702270|FG001|13 Week|Lost to Follow-up|14|||
23538135|NCT02664038|65702269|FG000|13 Week|Withdrawal by Subject|1|||
23538136|NCT02664038|65702270|FG001|13 Week|Withdrawal by Subject|0|||
23538137|NCT02664038|65702269|FG000|26 Week|Lost to Follow-up|5|||
23538138|NCT02664038|65702270|FG001|26 Week|Lost to Follow-up|4|||
23538139|NCT05077267|65702271|FG000|Treatment Period|Lost to Follow-up|0|||
23538140|NCT05077267|65702272|FG001|Treatment Period|Lost to Follow-up|1|||
23538141|NCT05077267|65702273|FG002|Treatment Period|Lost to Follow-up|0|||
23538142|NCT05077267|65702271|FG000|Treatment Period|Withdrawal by Subject|0|||
23538143|NCT05077267|65702272|FG001|Treatment Period|Withdrawal by Subject|1|||
23538144|NCT05077267|65702273|FG002|Treatment Period|Withdrawal by Subject|0|||
23209191|NCT01486784|64504536|FG005|Overall Study|Withdrawal by Subject|2|||
23209192|NCT01486784|64504531|FG000|Overall Study|Subject did not meet entry criteria|0|||
23209193|NCT01486784|64504532|FG001|Overall Study|Subject did not meet entry criteria|0|||
23209194|NCT01486784|64504533|FG002|Overall Study|Subject did not meet entry criteria|0|||
23209195|NCT01486784|64504534|FG003|Overall Study|Subject did not meet entry criteria|0|||
23209196|NCT01486784|64504535|FG004|Overall Study|Subject did not meet entry criteria|1|||
23209197|NCT01486784|64504536|FG005|Overall Study|Subject did not meet entry criteria|0|||
23209198|NCT01486784|64504531|FG000|Overall Study|Death|0|||
23209199|NCT01486784|64504532|FG001|Overall Study|Death|0|||
23209200|NCT01486784|64504533|FG002|Overall Study|Death|0|||
23209201|NCT01486784|64504534|FG003|Overall Study|Death|0|||
23209202|NCT01486784|64504535|FG004|Overall Study|Death|0|||
23209203|NCT01486784|64504536|FG005|Overall Study|Death|1|||
23209204|NCT00363246|64504537|FG000|Overall Study|Death|40|||
23209205|NCT00363246|64504537|FG000|Overall Study|Withdrawal by Subject|19|||
23209206|NCT00363246|64504537|FG000|Overall Study|Lost to Follow-up|14|||
23209207|NCT00363246|64504537|FG000|Overall Study|Bad health|6|||
23209208|NCT00363246|64504537|FG000|Overall Study|Stopped using wheelchair|11|||
23209209|NCT00363246|64504537|FG000|Overall Study|Subject expressed security concerns|2|||
23209210|NCT00363246|64504537|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
23209211|NCT02387372|64504538|FG000|Overall Study|Not Treated|1|||
23209212|NCT02387372|64504539|FG001|Overall Study|Not Treated|0|||
23209213|NCT00507416|64504540|FG000|Overall Study|Adverse Event|58|||
23209214|NCT00507416|64504541|FG001|Overall Study|Adverse Event|67|||
23209215|NCT00507416|64504542|FG002|Overall Study|Adverse Event|65|||
23209216|NCT00507416|64504540|FG000|Overall Study|Protocol Violation|1|||
23209217|NCT00507416|64504541|FG001|Overall Study|Protocol Violation|2|||
23209218|NCT00507416|64504542|FG002|Overall Study|Protocol Violation|0|||
23209219|NCT00507416|64504540|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
23209220|NCT00507416|64504541|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
23209221|NCT00507416|64504542|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
23209222|NCT00507416|64504540|FG000|Overall Study|Progressive Disease|20|||
23209223|NCT00507416|64504541|FG001|Overall Study|Progressive Disease|10|||
23209224|NCT00507416|64504542|FG002|Overall Study|Progressive Disease|13|||
23209225|NCT00507416|64504540|FG000|Overall Study|Patient declined further treatment|18|||
23209226|NCT00507416|64504541|FG001|Overall Study|Patient declined further treatment|14|||
23209227|NCT00507416|64504542|FG002|Overall Study|Patient declined further treatment|11|||
23209228|NCT00507416|64504540|FG000|Overall Study|Other|11|||
23209229|NCT00507416|64504541|FG001|Overall Study|Other|16|||
23209230|NCT00507416|64504542|FG002|Overall Study|Other|13|||
23209231|NCT00507416|64504540|FG000|Overall Study|Did not Receive Study Treatment|3|||
23538145|NCT05077267|65702271|FG000|Follow-up Period|Lost to Follow-up|0|||
23538146|NCT05077267|65702272|FG001|Follow-up Period|Lost to Follow-up|5|||
23538147|NCT05077267|65702273|FG002|Follow-up Period|Lost to Follow-up|7|||
23209232|NCT00507416|64504541|FG001|Overall Study|Did not Receive Study Treatment|9|||
23209233|NCT00507416|64504542|FG002|Overall Study|Did not Receive Study Treatment|4|||
23209234|NCT03325556|64504543|FG000|Open-label Period|Lack of Response in OL period|70|||
23209235|NCT03325556|64504544|FG001|Open-label Period|Lack of Response in OL period|0|||
23209236|NCT03325556|64504545|FG002|Open-label Period|Lack of Response in OL period|0|||
23209237|NCT03325556|64504543|FG000|Open-label Period|Adverse Event|27|||
23209238|NCT03325556|64504544|FG001|Open-label Period|Adverse Event|0|||
23209239|NCT03325556|64504545|FG002|Open-label Period|Adverse Event|0|||
23209240|NCT03325556|64504543|FG000|Open-label Period|Death|1|||
23209241|NCT03325556|64504544|FG001|Open-label Period|Death|0|||
23209242|NCT03325556|64504545|FG002|Open-label Period|Death|0|||
23209243|NCT03325556|64504543|FG000|Open-label Period|Lost to Follow-up|1|||
23209244|NCT03325556|64504544|FG001|Open-label Period|Lost to Follow-up|0|||
23209245|NCT03325556|64504545|FG002|Open-label Period|Lost to Follow-up|0|||
23209246|NCT03325556|64504543|FG000|Open-label Period|Non-compliance with study drug|5|||
23209247|NCT03325556|64504544|FG001|Open-label Period|Non-compliance with study drug|0|||
23209248|NCT03325556|64504545|FG002|Open-label Period|Non-compliance with study drug|0|||
23209249|NCT03325556|64504543|FG000|Open-label Period|Use of prohibited medication|1|||
23209250|NCT03325556|64504544|FG001|Open-label Period|Use of prohibited medication|0|||
23209251|NCT03325556|64504545|FG002|Open-label Period|Use of prohibited medication|0|||
23209252|NCT03325556|64504543|FG000|Open-label Period|Protocol Violation|4|||
23209253|NCT03325556|64504544|FG001|Open-label Period|Protocol Violation|0|||
23209254|NCT03325556|64504545|FG002|Open-label Period|Protocol Violation|0|||
23209255|NCT03325556|64504543|FG000|Open-label Period|Withdrawal by Subject|17|||
23209256|NCT03325556|64504544|FG001|Open-label Period|Withdrawal by Subject|0|||
23209257|NCT03325556|64504545|FG002|Open-label Period|Withdrawal by Subject|0|||
23424025|NCT01340937|65296320|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
23538148|NCT05077267|65702271|FG000|Follow-up Period|Withdrawal by Subject|0|||
23538149|NCT05077267|65702272|FG001|Follow-up Period|Withdrawal by Subject|2|||
23209258|NCT03325556|64504543|FG000|Open-label Period|Not otherwise specified|8|||
23424026|NCT01340937|65296321|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
23538150|NCT05077267|65702273|FG002|Follow-up Period|Withdrawal by Subject|5|||
23209259|NCT03325556|64504544|FG001|Open-label Period|Not otherwise specified|0|||
23209260|NCT03325556|64504545|FG002|Open-label Period|Not otherwise specified|0|||
23209261|NCT03325556|64504543|FG000|Open-label Period|Administrative discont. at study termination|41|||
23311699|NCT03249792|64886613|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
23311700|NCT03249792|64886614|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
23311701|NCT03249792|64886615|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
23311702|NCT03249792|64886583|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311703|NCT03249792|64886584|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311704|NCT03249792|64886585|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
23209262|NCT03325556|64504544|FG001|Open-label Period|Administrative discont. at study termination|0|||
23209263|NCT03325556|64504545|FG002|Open-label Period|Administrative discont. at study termination|0|||
23209264|NCT03325556|64504543|FG000|Double-blind Period|Relapse|0|||
23209265|NCT03325556|64504544|FG001|Double-blind Period|Relapse|15|||
23209266|NCT03325556|64504545|FG002|Double-blind Period|Relapse|34|||
23424027|NCT01340937|65296322|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
23424028|NCT01340937|65296323|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
23538151|NCT05077267|65702271|FG000|Follow-up Period|Study terminated by sponsor|0|||
23538152|NCT05077267|65702272|FG001|Follow-up Period|Study terminated by sponsor|27|||
23538153|NCT05077267|65702273|FG002|Follow-up Period|Study terminated by sponsor|23|||
23538154|NCT05077267|65702271|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
23538155|NCT05077267|65702272|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
23538156|NCT05077267|65702273|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
23538157|NCT05077267|65702271|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
23538158|NCT05077267|65702272|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
23538159|NCT05077267|65702273|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
23538160|NCT02992899|65702274|FG000|Overall Study|Withdrawal by Subject|1|||
23209267|NCT03325556|64504543|FG000|Double-blind Period|Adverse Event|0|||
23209268|NCT03325556|64504544|FG001|Double-blind Period|Adverse Event|3|||
23209269|NCT03325556|64504545|FG002|Double-blind Period|Adverse Event|1|||
23209270|NCT03325556|64504543|FG000|Double-blind Period|Noncompliance with study drug|0|||
23209271|NCT03325556|64504544|FG001|Double-blind Period|Noncompliance with study drug|0|||
23209272|NCT03325556|64504545|FG002|Double-blind Period|Noncompliance with study drug|1|||
23209273|NCT03325556|64504543|FG000|Double-blind Period|Use of prohibited medication|0|||
23538161|NCT02992899|65702275|FG001|Overall Study|Withdrawal by Subject|0|||
23209274|NCT03325556|64504544|FG001|Double-blind Period|Use of prohibited medication|1|||
23616382|NCT00774306|65982305|FG001|Overall Study|Death|1|||
23209275|NCT03325556|64504545|FG002|Double-blind Period|Use of prohibited medication|0|||
23311705|NCT03249792|64886586|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311706|NCT03249792|64886587|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311707|NCT03249792|64886588|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311708|NCT03249792|64886589|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311709|NCT03249792|64886590|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311710|NCT03249792|64886591|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
23311711|NCT03249792|64886592|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311712|NCT03249792|64886593|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311713|NCT03249792|64886594|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311714|NCT03249792|64886595|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311715|NCT03249792|64886596|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311716|NCT03249792|64886597|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311717|NCT03249792|64886598|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311718|NCT03249792|64886599|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
23311719|NCT03249792|64886600|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
23311720|NCT03249792|64886601|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311721|NCT03249792|64886602|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
23311722|NCT03249792|64886603|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311723|NCT03249792|64886604|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311724|NCT03249792|64886605|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311725|NCT03249792|64886606|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311726|NCT03249792|64886607|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311727|NCT03249792|64886608|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311728|NCT03249792|64886609|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311729|NCT03249792|64886610|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311730|NCT03249792|64886611|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311731|NCT03249792|64886612|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311732|NCT03249792|64886613|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311733|NCT03249792|64886614|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311734|NCT03249792|64886615|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
23311735|NCT03249792|64886583|FG000|Switch Over Period|Withdrawal by Subject|0|||
23311736|NCT03249792|64886584|FG001|Switch Over Period|Withdrawal by Subject|0|||
23311737|NCT03249792|64886585|FG002|Switch Over Period|Withdrawal by Subject|0|||
23311738|NCT03249792|64886586|FG003|Switch Over Period|Withdrawal by Subject|0|||
23311739|NCT03249792|64886587|FG004|Switch Over Period|Withdrawal by Subject|0|||
23311740|NCT03249792|64886588|FG005|Switch Over Period|Withdrawal by Subject|0|||
23311741|NCT03249792|64886589|FG006|Switch Over Period|Withdrawal by Subject|0|||
23311742|NCT03249792|64886590|FG007|Switch Over Period|Withdrawal by Subject|0|||
23311743|NCT03249792|64886591|FG008|Switch Over Period|Withdrawal by Subject|0|||
23311744|NCT03249792|64886592|FG009|Switch Over Period|Withdrawal by Subject|0|||
23311745|NCT03249792|64886593|FG010|Switch Over Period|Withdrawal by Subject|0|||
23311746|NCT03249792|64886594|FG011|Switch Over Period|Withdrawal by Subject|0|||
23311747|NCT03249792|64886595|FG012|Switch Over Period|Withdrawal by Subject|0|||
23311748|NCT03249792|64886596|FG013|Switch Over Period|Withdrawal by Subject|0|||
23311749|NCT03249792|64886597|FG014|Switch Over Period|Withdrawal by Subject|0|||
23311750|NCT03249792|64886598|FG015|Switch Over Period|Withdrawal by Subject|0|||
23311751|NCT03249792|64886599|FG016|Switch Over Period|Withdrawal by Subject|0|||
23311752|NCT03249792|64886600|FG017|Switch Over Period|Withdrawal by Subject|0|||
23311753|NCT03249792|64886601|FG018|Switch Over Period|Withdrawal by Subject|0|||
23311754|NCT03249792|64886602|FG019|Switch Over Period|Withdrawal by Subject|0|||
23311755|NCT03249792|64886603|FG020|Switch Over Period|Withdrawal by Subject|0|||
23424029|NCT01340937|65296320|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
23424030|NCT01340937|65296321|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
23424031|NCT01340937|65296322|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
23538162|NCT02992899|65702274|FG000|Overall Study|Lost to Follow-up|1|||
23311756|NCT03249792|64886604|FG021|Switch Over Period|Withdrawal by Subject|0|||
23311757|NCT03249792|64886605|FG022|Switch Over Period|Withdrawal by Subject|0|||
23311758|NCT03249792|64886606|FG023|Switch Over Period|Withdrawal by Subject|0|||
23311759|NCT03249792|64886607|FG024|Switch Over Period|Withdrawal by Subject|0|||
23311760|NCT03249792|64886608|FG025|Switch Over Period|Withdrawal by Subject|0|||
23311761|NCT03249792|64886609|FG026|Switch Over Period|Withdrawal by Subject|0|||
23311762|NCT03249792|64886610|FG027|Switch Over Period|Withdrawal by Subject|0|||
23311763|NCT03249792|64886611|FG028|Switch Over Period|Withdrawal by Subject|0|||
23311764|NCT03249792|64886612|FG029|Switch Over Period|Withdrawal by Subject|0|||
23311765|NCT03249792|64886613|FG030|Switch Over Period|Withdrawal by Subject|0|||
23311766|NCT03249792|64886614|FG031|Switch Over Period|Withdrawal by Subject|1|||
23311767|NCT03249792|64886615|FG032|Switch Over Period|Withdrawal by Subject|0|||
23311768|NCT03249792|64886583|FG000|Switch Over Period|Progressive Disease|0|||
23424032|NCT01340937|65296323|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
23424033|NCT01340937|65296320|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
23424034|NCT01340937|65296321|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
23538163|NCT02992899|65702275|FG001|Overall Study|Lost to Follow-up|3|||
23538164|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
23538165|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
23538166|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
23538167|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
23538168|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
23538169|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
23538170|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Death|1|||
23538171|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Death|0|||
23538172|NCT02554773|65702276|FG000|Original Dose Regimen (SAS 1)|Other|4|||
23538173|NCT02554773|65702277|FG001|Original Dose Regimen (SAS 1)|Other|0|||
23538174|NCT02554773|65702276|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
23538175|NCT02554773|65702277|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
23538176|NCT02554773|65702276|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
23538177|NCT02554773|65702277|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
23538178|NCT02554773|65702276|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
23538179|NCT02554773|65702277|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
23538180|NCT02554773|65702276|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
23538181|NCT02554773|65702277|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
23538182|NCT02209324|65702278|FG000|Overall Study|Adverse Event|2|||
23538183|NCT02209324|65702278|FG000|Overall Study|Lack of Efficacy|1|||
23538184|NCT02209324|65702278|FG000|Overall Study|Lost to Follow-up|1|||
23538185|NCT02209324|65702278|FG000|Overall Study|Physician Decision|3|||
23538186|NCT02209324|65702278|FG000|Overall Study|Protocol Violation|14|||
23538187|NCT02209324|65702278|FG000|Overall Study|Withdrawal by Subject|8|||
23538188|NCT02209324|65702278|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
23538189|NCT02209324|65702278|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
23538190|NCT02209324|65702278|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
23538191|NCT01427712|65702279|FG000|Overall Study|Transfer to a different hospital|2|||
23538192|NCT01427712|65702279|FG000|Overall Study|Lost to Follow-up|1|||
23538193|NCT01427712|65702279|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
23538194|NCT01427712|65702279|FG000|Overall Study|Failure to visit|1|||
23538195|NCT00600821|65702280|FG000|Overall Study|Death|45|||
23538196|NCT00600821|65702281|FG001|Overall Study|Death|46|||
23538197|NCT00600821|65702280|FG000|Overall Study|Lost to Follow-up|2|||
23538198|NCT00600821|65702281|FG001|Overall Study|Lost to Follow-up|2|||
23538199|NCT00600821|65702280|FG000|Overall Study|Withdrawal by Subject|1|||
23538200|NCT00600821|65702281|FG001|Overall Study|Withdrawal by Subject|1|||
23538201|NCT00600821|65702280|FG000|Overall Study|Terminated by sponsor|8|||
23538202|NCT00600821|65702281|FG001|Overall Study|Terminated by sponsor|6|||
23538203|NCT00600821|65702280|FG000|Overall Study|Objective progression or relapse|0|||
23538204|NCT00600821|65702281|FG001|Overall Study|Objective progression or relapse|1|||
23538205|NCT00600821|65702280|FG000|Overall Study|Randomized but not treated|0|||
23538206|NCT00600821|65702281|FG001|Overall Study|Randomized but not treated|1|||
23538207|NCT00600821|65702280|FG000|Overall Study|Other|2|||
23538208|NCT00600821|65702281|FG001|Overall Study|Other|3|||
23538209|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
23538210|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
23538211|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
23538212|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
23538213|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
23538214|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
23424035|NCT01340937|65296322|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
23538215|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
23538216|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
23538217|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
23538218|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
23311769|NCT03249792|64886584|FG001|Switch Over Period|Progressive Disease|0|||
23538219|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
23538220|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
23538221|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
23538222|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
23538223|NCT03732638|65702284|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
23538224|NCT03732638|65702285|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
23538225|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
23538226|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
23538227|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
23538228|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
23538229|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
23538230|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
23538231|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
23538232|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
23538233|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
23538234|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
23538235|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
23538236|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
23538237|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
23538238|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
23538239|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
23538240|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
23538241|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
23538242|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
23538243|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
23538244|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
23538245|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
23538246|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
23538247|NCT03732638|65702284|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
23538248|NCT03732638|65702285|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
23538249|NCT03732638|65702284|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
23538250|NCT03732638|65702285|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
23538251|NCT03732638|65702284|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
23538252|NCT03732638|65702285|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
23538253|NCT03732638|65702284|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
23538254|NCT03732638|65702285|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
23538255|NCT03732638|65702284|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
23538256|NCT03732638|65702285|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
23424036|NCT01340937|65296323|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
23424037|NCT01340937|65296320|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
23424038|NCT01340937|65296321|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
23424039|NCT01340937|65296322|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
23538257|NCT02170727|65702286|FG000|Overall Study|Lost to Follow-up|1|||
23538258|NCT02170727|65702287|FG001|Overall Study|Lost to Follow-up|0|||
23538259|NCT02170727|65702286|FG000|Overall Study|Withdrawal by Subject|2|||
23538260|NCT02170727|65702287|FG001|Overall Study|Withdrawal by Subject|0|||
23538261|NCT02663128|65702290|FG000|Period 2|Physician Decision|0|||
23538262|NCT02663128|65702291|FG001|Period 2|Physician Decision|0|||
23538263|NCT02663128|65702292|FG002|Period 2|Physician Decision|0|||
23538264|NCT02663128|65702293|FG003|Period 2|Physician Decision|0|||
23538265|NCT02663128|65702294|FG004|Period 2|Physician Decision|1|||
23538266|NCT02663128|65702295|FG005|Period 2|Physician Decision|0|||
23538267|NCT01519518|65702302|FG000|Overall Study|Consent not available|7|||
23538268|NCT01519518|65702303|FG001|Overall Study|Consent not available|10|||
23538269|NCT00844194|65702304|FG000|Overall Study|Adverse Event|17|||
23538270|NCT00844194|65702305|FG001|Overall Study|Adverse Event|5|||
23538271|NCT00844194|65702304|FG000|Overall Study|Protocol Violation|1|||
23538272|NCT00844194|65702305|FG001|Overall Study|Protocol Violation|1|||
23538273|NCT00844194|65702304|FG000|Overall Study|Lost to Follow-up|1|||
23538274|NCT00844194|65702305|FG001|Overall Study|Lost to Follow-up|1|||
23538275|NCT00844194|65702304|FG000|Overall Study|Withdrawal by Subject|2|||
23538276|NCT00844194|65702305|FG001|Overall Study|Withdrawal by Subject|1|||
23538277|NCT00844194|65702304|FG000|Overall Study|Lack of Efficacy|3|||
23538278|NCT00844194|65702305|FG001|Overall Study|Lack of Efficacy|0|||
23538279|NCT00844194|65702304|FG000|Overall Study|Other reason (not specified)|1|||
23538280|NCT00844194|65702305|FG001|Overall Study|Other reason (not specified)|0|||
23538281|NCT00779246|65702307|FG000|Overall Study|Missing sufficient data for analysis|33|||
23538282|NCT00779246|65702308|FG001|Overall Study|Missing sufficient data for analysis|53|||
23538283|NCT02758236|65702309|FG000|Overall Study|Investigator discretion|43|||
23538284|NCT00968617|65702310|FG000|Overall Study|Study terminated by sponsor|6|||
23538285|NCT01959581|65702311|FG000|Overall Study|Lost to Follow-up|5|||
23538286|NCT04632940|65702312|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
23538287|NCT04632940|65702313|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
23538288|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
23538289|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
23538290|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
23538291|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
23538292|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
23538293|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
23538294|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
23538295|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
23538296|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
23538297|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
23538298|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Other than specified|0|||
23538299|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Other than specified|1|||
23538300|NCT04632940|65702312|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
23538301|NCT04632940|65702313|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
23538302|NCT00334815|65702316|FG000|Overall Study|Adverse Event|3|||
23538303|NCT00334815|65702317|FG001|Overall Study|Adverse Event|2|||
23538304|NCT00334815|65702316|FG000|Overall Study|Death|0|||
23538305|NCT00334815|65702317|FG001|Overall Study|Death|2|||
23538306|NCT00334815|65702316|FG000|Overall Study|Progression|1|||
23538307|NCT00334815|65702317|FG001|Overall Study|Progression|0|||
23616383|NCT00774306|65982306|FG002|Overall Study|Death|0|||
23209276|NCT03325556|64504543|FG000|Double-blind Period|Physician Decision|0|||
23209277|NCT03325556|64504544|FG001|Double-blind Period|Physician Decision|0|||
23538308|NCT00334815|65702316|FG000|Overall Study|ineligible|1|||
23209278|NCT03325556|64504545|FG002|Double-blind Period|Physician Decision|1|||
23616384|NCT00774306|65982307|FG003|Overall Study|Death|0|||
23538309|NCT00334815|65702317|FG001|Overall Study|ineligible|1|||
23538310|NCT00334815|65702316|FG000|Overall Study|patient refused treatment|0|||
23538311|NCT00334815|65702317|FG001|Overall Study|patient refused treatment|1|||
23538312|NCT00334815|65702316|FG000|Overall Study|Physician Decision|2|||
23538313|NCT00334815|65702317|FG001|Overall Study|Physician Decision|4|||
23538314|NCT01148810|65702318|FG000|Overall Study|Adverse Event|0|||
23538315|NCT01148810|65702319|FG001|Overall Study|Adverse Event|2|||
23538316|NCT01148810|65702318|FG000|Overall Study|Lack of Efficacy|0|||
23538317|NCT01148810|65702319|FG001|Overall Study|Lack of Efficacy|1|||
23538318|NCT01148810|65702318|FG000|Overall Study|Withdrawal by Subject|0|||
23538319|NCT01148810|65702319|FG001|Overall Study|Withdrawal by Subject|2|||
23538320|NCT01148810|65702318|FG000|Overall Study|Protocol Violation|1|||
23538321|NCT01148810|65702319|FG001|Overall Study|Protocol Violation|0|||
23538322|NCT01732835|65702320|FG000|6-month Primary Endpoint|Did not receive device|19|||
23538323|NCT01732835|65702320|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
23538324|NCT01732835|65702320|FG000|6-month Primary Endpoint|Adverse Event|3|||
23538325|NCT01732835|65702320|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
23538326|NCT01732835|65702320|FG000|2-year Extended Follow-up|Adverse Event|3|||
23538327|NCT01732835|65702320|FG000|2-year Extended Follow-up|Death|1|||
23538328|NCT03099382|65702325|FG000|Overall Study|Protocol Violation|2|||
23538329|NCT03099382|65702326|FG001|Overall Study|Protocol Violation|3|||
23538330|NCT00829621|65702327|FG000|Overall Study|Death|1|||
23538331|NCT00829621|65702328|FG001|Overall Study|Death|0|||
23538332|NCT00829621|65702327|FG000|Overall Study|Lost to Follow-up|3|||
23538333|NCT00829621|65702328|FG001|Overall Study|Lost to Follow-up|4|||
23538334|NCT01513317|65702329|FG000|Overall Study|Withdrawal by Subject|15|||
23424040|NCT01340937|65296323|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
23424041|NCT00867087|65296324|FG000|Overall Study|Other|1|||
23424042|NCT00867087|65296324|FG000|Overall Study|Withdrawal by Subject|4|||
23424043|NCT00867087|65296324|FG000|Overall Study|Death|37|||
23424044|NCT01559259|65296327|FG000|Overall Study|Withdrawal by Subject|0|||
23424045|NCT01559259|65296328|FG001|Overall Study|Withdrawal by Subject|0|||
23424046|NCT01559259|65296329|FG002|Overall Study|Withdrawal by Subject|0|||
23424047|NCT01559259|65296330|FG003|Overall Study|Withdrawal by Subject|1|||
23424048|NCT01559259|65296331|FG004|Overall Study|Withdrawal by Subject|0|||
23424049|NCT01559259|65296327|FG000|Overall Study|Adverse Event|0|||
23424050|NCT01559259|65296328|FG001|Overall Study|Adverse Event|1|||
23424051|NCT01559259|65296329|FG002|Overall Study|Adverse Event|1|||
23424052|NCT01559259|65296330|FG003|Overall Study|Adverse Event|0|||
23424053|NCT01559259|65296331|FG004|Overall Study|Adverse Event|0|||
23424054|NCT02437305|65296334|FG000|Overall Study|Lost to Follow-up|18|||
23424055|NCT02437305|65296335|FG001|Overall Study|Lost to Follow-up|12|||
23424056|NCT00856206|65296336|FG000|Overall Study|Protocol Violation|6|||
23424057|NCT00856206|65296337|FG001|Overall Study|Protocol Violation|18|||
23424058|NCT00856206|65296336|FG000|Overall Study|Adverse Event|10|||
23424059|NCT00856206|65296337|FG001|Overall Study|Adverse Event|46|||
23424060|NCT00856206|65296336|FG000|Overall Study|Lack of Efficacy|1|||
23424061|NCT00856206|65296337|FG001|Overall Study|Lack of Efficacy|2|||
23424062|NCT00856206|65296336|FG000|Overall Study|Withdrawal by Subject|15|||
23424063|NCT00856206|65296337|FG001|Overall Study|Withdrawal by Subject|36|||
23424064|NCT00856206|65296336|FG000|Overall Study|Lost to Follow-up|13|||
23424065|NCT00856206|65296337|FG001|Overall Study|Lost to Follow-up|39|||
23424066|NCT00856206|65296336|FG000|Overall Study|Death|2|||
23424067|NCT00856206|65296337|FG001|Overall Study|Death|2|||
23424068|NCT00856206|65296336|FG000|Overall Study|Decision by the Sponsor|4|||
23424069|NCT00856206|65296337|FG001|Overall Study|Decision by the Sponsor|8|||
23424070|NCT00856206|65296336|FG000|Overall Study|Other than specified above|3|||
23424071|NCT00856206|65296337|FG001|Overall Study|Other than specified above|10|||
23424072|NCT00624819|65296338|FG000|Follow-up Period: Year 4|Parents decision|0|||
23424073|NCT00624819|65296339|FG001|Follow-up Period: Year 4|Parents decision|0|||
23424074|NCT00624819|65296340|FG002|Follow-up Period: Year 4|Parents decision|1|||
23424075|NCT00624819|65296341|FG003|Follow-up Period: Year 4|Parents decision|0|||
23424076|NCT00624819|65296338|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
23538335|NCT01513317|65702330|FG001|Overall Study|Withdrawal by Subject|4|||
23538336|NCT01513317|65702329|FG000|Overall Study|Death|1|||
23538337|NCT01513317|65702330|FG001|Overall Study|Death|1|||
23424077|NCT00624819|65296339|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
23424078|NCT00624819|65296340|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
23424079|NCT00624819|65296341|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
23538338|NCT01513317|65702329|FG000|Overall Study|Study terminated by sponsor|18|||
23538339|NCT01513317|65702330|FG001|Overall Study|Study terminated by sponsor|18|||
23424080|NCT01665430|65296342|FG000|Overall Study|Adverse Event|1|||
23424081|NCT01665430|65296342|FG000|Overall Study|Withdrawal by Subject|6|||
23424082|NCT01665430|65296342|FG000|Overall Study|Other Unspecified|2|||
23424083|NCT01156389|65296343|FG000|Overall Study|Elevated liver enzymes|4|||
23538340|NCT01513317|65702329|FG000|Overall Study|Other|0|||
23538341|NCT01513317|65702330|FG001|Overall Study|Other|1|||
23538342|NCT02104557|65702331|FG000|Overall Study|Adverse Event|24|||
23538343|NCT02104557|65702331|FG000|Overall Study|Lost to Follow-up|34|||
23538344|NCT02104557|65702331|FG000|Overall Study|Violated the usage and dosage|14|||
23538345|NCT02104557|65702331|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
23538346|NCT02104557|65702331|FG000|Overall Study|Administered Sayana prior to the contract|1|||
23538347|NCT02104557|65702331|FG000|Overall Study|Other|17|||
23424084|NCT01156389|65296344|FG001|Overall Study|Elevated liver enzymes|0|||
23424085|NCT01156389|65296343|FG000|Overall Study|Vomiting|0|||
23424086|NCT01156389|65296344|FG001|Overall Study|Vomiting|1|||
23538348|NCT02104557|65702331|FG000|Overall Study|Change to other contraception methods|5|||
23538349|NCT02104557|65702331|FG000|Overall Study|Discontinuation due to no pain|1|||
23538350|NCT02104557|65702331|FG000|Overall Study|Withdrawal consent|2|||
23538351|NCT02104557|65702331|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
23538352|NCT02104557|65702331|FG000|Overall Study|Discontinuation of contraception|9|||
23538353|NCT04558346|65702332|FG000|Overall Study|Withdrawal by Subject|2|||
23538354|NCT04558346|65702333|FG001|Overall Study|Withdrawal by Subject|0|||
23538355|NCT04558346|65702332|FG000|Overall Study|Lost to Follow-up|0|||
23538356|NCT04558346|65702333|FG001|Overall Study|Lost to Follow-up|1|||
23538357|NCT04558346|65702332|FG000|Overall Study|Adverse Event|0|||
23538358|NCT04558346|65702333|FG001|Overall Study|Adverse Event|1|||
23538359|NCT03268811|65702334|FG000|Overall Study|Adverse Event|0|||
23538360|NCT03268811|65702335|FG001|Overall Study|Adverse Event|1|||
23538361|NCT03603964|65702337|FG000|Overall Study|Death|9|||
23538362|NCT03603964|65702337|FG000|Overall Study|Withdrawal by participant|7|||
23538363|NCT03603964|65702337|FG000|Overall Study|Study terminated by Sponsor|19|||
23538364|NCT02041429|65702338|FG000|Overall Study|Progressive Disease|2|||
23538365|NCT02041429|65702339|FG001|Overall Study|Progressive Disease|2|||
23538366|NCT02041429|65702340|FG002|Overall Study|Progressive Disease|3|||
23538367|NCT02041429|65702341|FG003|Overall Study|Progressive Disease|2|||
23538368|NCT02041429|65702338|FG000|Overall Study|Toxicity|0|||
23538369|NCT02041429|65702339|FG001|Overall Study|Toxicity|1|||
23538370|NCT02041429|65702340|FG002|Overall Study|Toxicity|4|||
23538371|NCT02041429|65702341|FG003|Overall Study|Toxicity|2|||
23538372|NCT02041429|65702338|FG000|Overall Study|Withdrawal by Subject|0|||
23538373|NCT02041429|65702339|FG001|Overall Study|Withdrawal by Subject|1|||
23538374|NCT02041429|65702340|FG002|Overall Study|Withdrawal by Subject|0|||
23538375|NCT02041429|65702341|FG003|Overall Study|Withdrawal by Subject|0|||
23538376|NCT02041429|65702338|FG000|Overall Study|On Maintenance Therapy|1|||
23538377|NCT02041429|65702339|FG001|Overall Study|On Maintenance Therapy|0|||
23538378|NCT02041429|65702340|FG002|Overall Study|On Maintenance Therapy|0|||
23538379|NCT02041429|65702341|FG003|Overall Study|On Maintenance Therapy|2|||
23538380|NCT00690755|65705750|FG000|Overall Study|Physician Decision|2|||
23538381|NCT00690755|65705751|FG001|Overall Study|Physician Decision|0|||
23538382|NCT00690755|65705752|FG002|Overall Study|Physician Decision|46|||
23538383|NCT00690755|65705753|FG003|Overall Study|Physician Decision|5|||
23538384|NCT00690755|65705754|FG004|Overall Study|Physician Decision|0|||
23538385|NCT00690755|65705755|FG005|Overall Study|Physician Decision|4|||
23538386|NCT00690755|65705756|FG006|Overall Study|Physician Decision|0|||
23538387|NCT04713748|65705757|FG000|Overall Study|Not enough kits allocated|35|||
23538388|NCT00022516|65705758|FG000|Overall Study|Adverse Event|0|||
23538389|NCT00022516|65705759|FG001|Overall Study|Adverse Event|59|||
23538390|NCT00022516|65705758|FG000|Overall Study|Lack of Efficacy|0|||
23538391|NCT00022516|65705759|FG001|Overall Study|Lack of Efficacy|27|||
23538392|NCT00022516|65705758|FG000|Overall Study|Physician Decision|0|||
23538393|NCT00022516|65705759|FG001|Overall Study|Physician Decision|1|||
23538394|NCT00022516|65705758|FG000|Overall Study|Protocol Violation|1|||
23538395|NCT00022516|65705759|FG001|Overall Study|Protocol Violation|3|||
23538396|NCT00022516|65705758|FG000|Overall Study|Withdrawal by Subject|2|||
23538397|NCT00022516|65705759|FG001|Overall Study|Withdrawal by Subject|113|||
23538398|NCT00022516|65705758|FG000|Overall Study|Incomplete documentation|0|||
23538399|NCT00022516|65705759|FG001|Overall Study|Incomplete documentation|27|||
23209279|NCT03325556|64504543|FG000|Double-blind Period|Withdrawal by Subject|0|||
23209280|NCT03325556|64504544|FG001|Double-blind Period|Withdrawal by Subject|6|||
23424087|NCT00837876|65296345|FG000|Overall Study|Death|2|||
23424088|NCT00837876|65296345|FG000|Overall Study|Adverse Event|7|||
23424089|NCT00837876|65296345|FG000|Overall Study|Physician Decision|1|||
23424090|NCT00837876|65296345|FG000|Overall Study|Withdrawal by Subject|3|||
23538400|NCT00614939|65705763|FG000|Overall Study|Withdrawal by Subject|10|||
23538401|NCT00614939|65705764|FG001|Overall Study|Withdrawal by Subject|17|||
23538402|NCT00614939|65705763|FG000|Overall Study|Study specific discontinuation criteris|13|||
23538403|NCT00614939|65705764|FG001|Overall Study|Study specific discontinuation criteris|16|||
23538404|NCT00614939|65705763|FG000|Overall Study|Adverse Event|2|||
23538405|NCT00614939|65705764|FG001|Overall Study|Adverse Event|5|||
23538406|NCT00614939|65705763|FG000|Overall Study|Incorrect enrollment|1|||
23538407|NCT00614939|65705764|FG001|Overall Study|Incorrect enrollment|2|||
23538408|NCT00614939|65705763|FG000|Overall Study|Death|4|||
23538409|NCT00614939|65705764|FG001|Overall Study|Death|3|||
23538410|NCT00614939|65705763|FG000|Overall Study|Poor/non-compliance|4|||
23538411|NCT00614939|65705764|FG001|Overall Study|Poor/non-compliance|0|||
23538412|NCT00614939|65705763|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
23538413|NCT00614939|65705764|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
23538414|NCT01993719|65705772|FG000|First Drug Administration|Not treated|1|||
23538415|NCT01993719|65705773|FG001|First Drug Administration|Not treated|0|||
23538416|NCT01993719|65705774|FG002|First Drug Administration|Not treated|0|||
23538417|NCT01993719|65705775|FG003|First Drug Administration|Not treated|0|||
23538418|NCT01993719|65705776|FG004|First Drug Administration|Not treated|0|||
23538419|NCT00153101|65705777|FG000|Overall Study|Lost to Follow-up|14|||
23209281|NCT03325556|64504545|FG002|Double-blind Period|Withdrawal by Subject|4|||
23209282|NCT03325556|64504543|FG000|Double-blind Period|Not otherwise specified|0|||
23209283|NCT03325556|64504544|FG001|Double-blind Period|Not otherwise specified|1|||
23209284|NCT03325556|64504545|FG002|Double-blind Period|Not otherwise specified|5|||
23209285|NCT03325556|64504543|FG000|Double-blind Period|Administrative discont. at study termination|0|||
23209286|NCT03325556|64504544|FG001|Double-blind Period|Administrative discont. at study termination|35|||
23538420|NCT00153101|65705778|FG001|Overall Study|Lost to Follow-up|14|||
23538421|NCT00153101|65705779|FG002|Overall Study|Lost to Follow-up|12|||
23538422|NCT00153101|65705780|FG003|Overall Study|Lost to Follow-up|5|||
23538423|NCT00153101|65705781|FG004|Overall Study|Lost to Follow-up|5|||
23538424|NCT00153101|65705777|FG000|Overall Study|Withdrawal by Subject|3|||
23538425|NCT00153101|65705778|FG001|Overall Study|Withdrawal by Subject|4|||
23538426|NCT00153101|65705779|FG002|Overall Study|Withdrawal by Subject|3|||
23538427|NCT00153101|65705780|FG003|Overall Study|Withdrawal by Subject|3|||
23538428|NCT00153101|65705781|FG004|Overall Study|Withdrawal by Subject|5|||
23209287|NCT03325556|64504545|FG002|Double-blind Period|Administrative discont. at study termination|31|||
23209288|NCT03722784|64504546|FG000|Overall Study|Withdrawal by Subject|1|||
23538429|NCT02293005|65705785|FG000|Overall Study|Adverse Event|2|||
23538430|NCT02293005|65705785|FG000|Overall Study|Death|4|||
23538431|NCT02293005|65705785|FG000|Overall Study|Lost to Follow-up|1|||
23538432|NCT02293005|65705785|FG000|Overall Study|Withdrawal by Subject|2|||
23538433|NCT02293005|65705785|FG000|Overall Study|Progression|17|||
23538434|NCT03231371|65705786|FG000|Overall Study|Withdrawal by Subject|1|||
23538435|NCT03231371|65705786|FG000|Overall Study|chose or were ineligible to have MRI|12|||
23538436|NCT02732847|65705787|FG000|Overall Study|some filled early|42|||
23538437|NCT02732847|65705788|FG001|Overall Study|some filled early|42|||
23538438|NCT01252251|65705789|FG000|Overall Study|Withdrawal by Subject|1|||
23538439|NCT02530619|65705790|FG000|Registered for Study|Withdrawal by Subject|2|||
23538440|NCT02530619|65705790|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
23209289|NCT03722784|64504547|FG001|Overall Study|Withdrawal by Subject|0|||
23209290|NCT03722784|64504546|FG000|Overall Study|Physician Decision|1|||
23209291|NCT03722784|64504547|FG001|Overall Study|Physician Decision|1|||
23538441|NCT02530619|65705790|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
23538442|NCT02530619|65705790|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
23209292|NCT03722784|64504546|FG000|Overall Study|Protocol Violation|0|||
23209293|NCT03722784|64504547|FG001|Overall Study|Protocol Violation|1|||
23538443|NCT02530619|65705790|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
23538444|NCT02530619|65705790|FG000|Follow-up Period (6 Months)|Death|4|||
23538445|NCT02530619|65705790|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
23209294|NCT01757405|64504548|FG000|Overall Study|Lost to Follow-up|1|||
23209295|NCT01757405|64504549|FG001|Overall Study|Lost to Follow-up|1|||
23538446|NCT02530619|65705790|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
23538447|NCT03574389|65705791|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
23538448|NCT03574389|65705792|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
23538449|NCT03574389|65705793|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
23538450|NCT03574389|65705794|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
23538451|NCT03574389|65705795|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
23538452|NCT03574389|65705796|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
23538453|NCT03574389|65705797|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
23538454|NCT03574389|65705791|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
23538455|NCT03574389|65705792|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
23538456|NCT03574389|65705793|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
23538457|NCT03574389|65705794|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
23538458|NCT03574389|65705795|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
23538459|NCT03574389|65705796|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
23538460|NCT03574389|65705797|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
23538461|NCT03574389|65705791|FG000|Vaccination Period|Other|6|||
23538462|NCT03574389|65705792|FG001|Vaccination Period|Other|0|||
23538463|NCT03574389|65705793|FG002|Vaccination Period|Other|0|||
23538464|NCT03574389|65705794|FG003|Vaccination Period|Other|0|||
23538465|NCT03574389|65705795|FG004|Vaccination Period|Other|0|||
23538466|NCT03574389|65705796|FG005|Vaccination Period|Other|0|||
23538467|NCT03574389|65705797|FG006|Vaccination Period|Other|0|||
23538468|NCT03574389|65705791|FG000|Vaccination Period|Adverse Event|0|||
23538469|NCT03574389|65705792|FG001|Vaccination Period|Adverse Event|1|||
23538470|NCT03574389|65705793|FG002|Vaccination Period|Adverse Event|0|||
23538471|NCT03574389|65705794|FG003|Vaccination Period|Adverse Event|0|||
23311770|NCT03249792|64886585|FG002|Switch Over Period|Progressive Disease|0|||
23311771|NCT03249792|64886586|FG003|Switch Over Period|Progressive Disease|0|||
23311772|NCT03249792|64886587|FG004|Switch Over Period|Progressive Disease|0|||
23311773|NCT03249792|64886588|FG005|Switch Over Period|Progressive Disease|0|||
23311774|NCT03249792|64886589|FG006|Switch Over Period|Progressive Disease|0|||
23311775|NCT03249792|64886590|FG007|Switch Over Period|Progressive Disease|0|||
23311776|NCT03249792|64886591|FG008|Switch Over Period|Progressive Disease|0|||
23311777|NCT03249792|64886592|FG009|Switch Over Period|Progressive Disease|0|||
23311778|NCT03249792|64886593|FG010|Switch Over Period|Progressive Disease|0|||
23311779|NCT03249792|64886594|FG011|Switch Over Period|Progressive Disease|0|||
23311780|NCT03249792|64886595|FG012|Switch Over Period|Progressive Disease|0|||
23311781|NCT03249792|64886596|FG013|Switch Over Period|Progressive Disease|0|||
23311782|NCT03249792|64886597|FG014|Switch Over Period|Progressive Disease|0|||
23311783|NCT03249792|64886598|FG015|Switch Over Period|Progressive Disease|0|||
23311784|NCT03249792|64886599|FG016|Switch Over Period|Progressive Disease|0|||
23311785|NCT03249792|64886600|FG017|Switch Over Period|Progressive Disease|0|||
23311786|NCT03249792|64886601|FG018|Switch Over Period|Progressive Disease|0|||
23311787|NCT03249792|64886602|FG019|Switch Over Period|Progressive Disease|0|||
23311788|NCT03249792|64886603|FG020|Switch Over Period|Progressive Disease|0|||
23311789|NCT03249792|64886604|FG021|Switch Over Period|Progressive Disease|0|||
23311790|NCT03249792|64886605|FG022|Switch Over Period|Progressive Disease|0|||
23311791|NCT03249792|64886606|FG023|Switch Over Period|Progressive Disease|0|||
23311792|NCT03249792|64886607|FG024|Switch Over Period|Progressive Disease|0|||
23311793|NCT03249792|64886608|FG025|Switch Over Period|Progressive Disease|0|||
23311794|NCT03249792|64886609|FG026|Switch Over Period|Progressive Disease|1|||
23311795|NCT03249792|64886610|FG027|Switch Over Period|Progressive Disease|0|||
23311796|NCT03249792|64886611|FG028|Switch Over Period|Progressive Disease|1|||
23311797|NCT03249792|64886612|FG029|Switch Over Period|Progressive Disease|2|||
23311798|NCT03249792|64886613|FG030|Switch Over Period|Progressive Disease|1|||
23311799|NCT03249792|64886614|FG031|Switch Over Period|Progressive Disease|0|||
23311800|NCT03249792|64886615|FG032|Switch Over Period|Progressive Disease|1|||
23311801|NCT03249792|64886583|FG000|Switch Over Period|Adverse Event|0|||
23311802|NCT03249792|64886584|FG001|Switch Over Period|Adverse Event|0|||
23311803|NCT03249792|64886585|FG002|Switch Over Period|Adverse Event|0|||
23616385|NCT02350127|65982308|FG000|4-Month Assessment|Withdrawal by Subject|10|||
23616386|NCT02350127|65982309|FG001|4-Month Assessment|Withdrawal by Subject|9|||
23616387|NCT02350127|65982308|FG000|4-Month Assessment|Death|1|||
23616388|NCT02350127|65982309|FG001|4-Month Assessment|Death|0|||
23616389|NCT02350127|65982308|FG000|8-Month Assessment|Death|1|||
23616390|NCT02350127|65982309|FG001|8-Month Assessment|Death|1|||
23616391|NCT02350127|65982308|FG000|8-Month Assessment|Withdrawal by Subject|5|||
23616392|NCT02350127|65982309|FG001|8-Month Assessment|Withdrawal by Subject|8|||
23616393|NCT03360071|65982312|FG000|Overall Study|Lost to Follow-up|1|||
23616394|NCT03360071|65982313|FG001|Overall Study|Lost to Follow-up|0|||
23616395|NCT05109117|65982319|FG000|Overall Study|Lost to Follow-up|1|||
23616396|NCT05109117|65982319|FG000|Overall Study|Discontinued for non-compliance|1|||
23311804|NCT03249792|64886586|FG003|Switch Over Period|Adverse Event|0|||
23538472|NCT03574389|65705795|FG004|Vaccination Period|Adverse Event|0|||
23538473|NCT03574389|65705796|FG005|Vaccination Period|Adverse Event|0|||
23538474|NCT03574389|65705797|FG006|Vaccination Period|Adverse Event|0|||
23538475|NCT03574389|65705791|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
23538476|NCT03574389|65705792|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
23538477|NCT03574389|65705793|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
23538478|NCT03574389|65705794|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
23538479|NCT03574389|65705795|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
23538480|NCT03574389|65705796|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
23538481|NCT03574389|65705797|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
23538482|NCT03394924|65705798|FG000|Overall Study|Adverse Event|0|||
23311805|NCT03249792|64886587|FG004|Switch Over Period|Adverse Event|0|||
23311806|NCT03249792|64886588|FG005|Switch Over Period|Adverse Event|0|||
23311807|NCT03249792|64886589|FG006|Switch Over Period|Adverse Event|0|||
23311808|NCT03249792|64886590|FG007|Switch Over Period|Adverse Event|0|||
23616397|NCT00244751|65982321|FG000|Overall Study|Adverse Event|7|||
23616398|NCT00244751|65982322|FG001|Overall Study|Adverse Event|7|||
23311809|NCT03249792|64886591|FG008|Switch Over Period|Adverse Event|0|||
23311810|NCT03249792|64886592|FG009|Switch Over Period|Adverse Event|0|||
23311811|NCT03249792|64886593|FG010|Switch Over Period|Adverse Event|0|||
23311812|NCT03249792|64886594|FG011|Switch Over Period|Adverse Event|0|||
23311813|NCT03249792|64886595|FG012|Switch Over Period|Adverse Event|0|||
23311814|NCT03249792|64886596|FG013|Switch Over Period|Adverse Event|0|||
23311815|NCT03249792|64886597|FG014|Switch Over Period|Adverse Event|0|||
23311816|NCT03249792|64886598|FG015|Switch Over Period|Adverse Event|0|||
23311817|NCT03249792|64886599|FG016|Switch Over Period|Adverse Event|0|||
23311818|NCT03249792|64886600|FG017|Switch Over Period|Adverse Event|0|||
23311819|NCT03249792|64886601|FG018|Switch Over Period|Adverse Event|0|||
23311820|NCT03249792|64886602|FG019|Switch Over Period|Adverse Event|0|||
23311821|NCT03249792|64886603|FG020|Switch Over Period|Adverse Event|0|||
23311822|NCT03249792|64886604|FG021|Switch Over Period|Adverse Event|0|||
23311823|NCT03249792|64886605|FG022|Switch Over Period|Adverse Event|0|||
23311824|NCT03249792|64886606|FG023|Switch Over Period|Adverse Event|0|||
23311825|NCT03249792|64886607|FG024|Switch Over Period|Adverse Event|0|||
23311826|NCT03249792|64886608|FG025|Switch Over Period|Adverse Event|1|||
23311827|NCT03249792|64886609|FG026|Switch Over Period|Adverse Event|0|||
23311828|NCT03249792|64886610|FG027|Switch Over Period|Adverse Event|1|||
23311829|NCT03249792|64886611|FG028|Switch Over Period|Adverse Event|0|||
23311830|NCT03249792|64886612|FG029|Switch Over Period|Adverse Event|0|||
23311831|NCT03249792|64886613|FG030|Switch Over Period|Adverse Event|0|||
23311832|NCT03249792|64886614|FG031|Switch Over Period|Adverse Event|0|||
23311833|NCT03249792|64886615|FG032|Switch Over Period|Adverse Event|0|||
23311834|NCT02393248|64886620|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311835|NCT02393248|64886621|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
23311836|NCT02393248|64886622|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311837|NCT02393248|64886623|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311838|NCT02393248|64886624|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311839|NCT02393248|64886625|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
23311840|NCT02393248|64886626|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
23311841|NCT02393248|64886627|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311842|NCT02393248|64886628|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311843|NCT02393248|64886629|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311844|NCT02393248|64886630|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311845|NCT02393248|64886631|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311846|NCT02393248|64886632|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311847|NCT02393248|64886633|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311848|NCT02393248|64886634|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311849|NCT02393248|64886635|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311850|NCT02393248|64886636|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311851|NCT02393248|64886637|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311852|NCT02393248|64886638|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311853|NCT02393248|64886639|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311854|NCT02393248|64886640|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311855|NCT02393248|64886641|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311856|NCT02393248|64886642|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311857|NCT02393248|64886643|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311858|NCT02393248|64886644|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
23311859|NCT02393248|64886620|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311860|NCT02393248|64886621|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
23311861|NCT02393248|64886622|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311862|NCT02393248|64886623|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311863|NCT02393248|64886624|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311864|NCT02393248|64886625|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311865|NCT02393248|64886626|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311866|NCT02393248|64886627|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311867|NCT02393248|64886628|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311868|NCT02393248|64886629|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311869|NCT02393248|64886630|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311870|NCT02393248|64886631|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311871|NCT02393248|64886632|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311872|NCT02393248|64886633|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311873|NCT02393248|64886634|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311874|NCT02393248|64886635|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311875|NCT02393248|64886636|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311876|NCT02393248|64886637|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311877|NCT02393248|64886638|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311878|NCT02393248|64886639|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311879|NCT02393248|64886640|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311880|NCT02393248|64886641|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311881|NCT02393248|64886642|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311882|NCT02393248|64886643|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311883|NCT02393248|64886644|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
23311884|NCT02393248|64886620|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
23311885|NCT02393248|64886621|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
23311886|NCT02393248|64886622|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
23311887|NCT02393248|64886623|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
23311888|NCT02393248|64886624|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
23311889|NCT02393248|64886625|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
23311890|NCT02393248|64886626|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
23311891|NCT02393248|64886627|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
23311892|NCT02393248|64886628|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
23311893|NCT02393248|64886629|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
23311894|NCT02393248|64886630|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
23311895|NCT02393248|64886631|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
23311896|NCT02393248|64886632|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
23311897|NCT02393248|64886633|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
23311898|NCT02393248|64886634|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
23311899|NCT02393248|64886635|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
23311900|NCT02393248|64886636|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
23311901|NCT02393248|64886637|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
23311902|NCT02393248|64886638|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
23311903|NCT02393248|64886639|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
23311904|NCT02393248|64886640|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
23311905|NCT02393248|64886641|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
23311906|NCT02393248|64886642|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
23311907|NCT02393248|64886643|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
23311908|NCT02393248|64886644|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
23311909|NCT02393248|64886620|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
23311910|NCT02393248|64886621|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311911|NCT02393248|64886622|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311912|NCT02393248|64886623|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311913|NCT02393248|64886624|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311914|NCT02393248|64886625|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311915|NCT02393248|64886626|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311916|NCT02393248|64886627|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311917|NCT02393248|64886628|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311918|NCT02393248|64886629|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311919|NCT02393248|64886630|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311920|NCT02393248|64886631|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311921|NCT02393248|64886632|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311922|NCT02393248|64886633|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311923|NCT02393248|64886634|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311924|NCT02393248|64886635|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311925|NCT02393248|64886636|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311926|NCT02393248|64886637|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311927|NCT02393248|64886638|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311928|NCT02393248|64886639|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311929|NCT02393248|64886640|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311930|NCT02393248|64886641|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311931|NCT02393248|64886642|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311932|NCT02393248|64886643|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311933|NCT02393248|64886644|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
23311934|NCT02393248|64886620|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311935|NCT02393248|64886621|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311936|NCT02393248|64886622|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311937|NCT02393248|64886623|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311938|NCT02393248|64886624|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311939|NCT02393248|64886625|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
23311940|NCT02393248|64886626|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
23311941|NCT02393248|64886627|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311942|NCT02393248|64886628|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311943|NCT02393248|64886629|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
23311944|NCT02393248|64886630|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311945|NCT02393248|64886631|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311946|NCT02393248|64886632|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311947|NCT02393248|64886633|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311948|NCT02393248|64886634|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311949|NCT02393248|64886635|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311950|NCT02393248|64886636|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311951|NCT02393248|64886637|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311952|NCT02393248|64886638|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311953|NCT02393248|64886639|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311954|NCT02393248|64886640|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311955|NCT02393248|64886641|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311956|NCT02393248|64886642|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311957|NCT02393248|64886643|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311958|NCT02393248|64886644|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
23311959|NCT02393248|64886620|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311960|NCT02393248|64886621|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311961|NCT02393248|64886622|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311962|NCT02393248|64886623|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311963|NCT02393248|64886624|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311964|NCT02393248|64886625|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311965|NCT02393248|64886626|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
23311966|NCT02393248|64886627|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311967|NCT02393248|64886628|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311968|NCT02393248|64886629|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311969|NCT02393248|64886630|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311970|NCT02393248|64886631|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311971|NCT02393248|64886632|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311972|NCT02393248|64886633|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311973|NCT02393248|64886634|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311974|NCT02393248|64886635|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311975|NCT02393248|64886636|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311976|NCT02393248|64886637|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311977|NCT02393248|64886638|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311978|NCT02393248|64886639|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311979|NCT02393248|64886640|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311980|NCT02393248|64886641|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311981|NCT02393248|64886642|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311982|NCT02393248|64886643|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311983|NCT02393248|64886644|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
23311984|NCT02393248|64886620|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311985|NCT02393248|64886621|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311986|NCT02393248|64886622|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311987|NCT02393248|64886623|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311988|NCT02393248|64886624|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311989|NCT02393248|64886625|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311990|NCT02393248|64886626|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311991|NCT02393248|64886627|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311992|NCT02393248|64886628|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311993|NCT02393248|64886629|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311994|NCT02393248|64886630|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23311995|NCT02393248|64886631|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
23311996|NCT02393248|64886632|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
23311997|NCT02393248|64886633|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
23311998|NCT02393248|64886634|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
23311999|NCT02393248|64886635|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312000|NCT02393248|64886636|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312001|NCT02393248|64886637|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312002|NCT02393248|64886638|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312003|NCT02393248|64886639|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312004|NCT02393248|64886640|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312005|NCT02393248|64886641|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312006|NCT02393248|64886642|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312007|NCT02393248|64886643|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312008|NCT02393248|64886644|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
23312009|NCT02393248|64886620|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312010|NCT02393248|64886621|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312011|NCT02393248|64886622|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312012|NCT02393248|64886623|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312013|NCT02393248|64886624|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312014|NCT02393248|64886625|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312015|NCT02393248|64886626|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312016|NCT02393248|64886627|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312017|NCT02393248|64886628|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312018|NCT02393248|64886629|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312019|NCT02393248|64886630|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
23312020|NCT02393248|64886631|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
23312021|NCT02393248|64886632|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312022|NCT02393248|64886633|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312023|NCT02393248|64886634|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312024|NCT02393248|64886635|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312025|NCT02393248|64886636|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312026|NCT02393248|64886637|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312027|NCT02393248|64886638|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312028|NCT02393248|64886639|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312029|NCT02393248|64886640|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312030|NCT02393248|64886641|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312031|NCT02393248|64886642|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312032|NCT02393248|64886643|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312033|NCT02393248|64886644|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
23312034|NCT02393248|64886620|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
23312035|NCT02393248|64886621|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
23312036|NCT02393248|64886622|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
23312037|NCT02393248|64886623|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
23312038|NCT02393248|64886624|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
23312039|NCT02393248|64886625|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
23312040|NCT02393248|64886626|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
23312041|NCT02393248|64886627|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
23312042|NCT02393248|64886628|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
23312043|NCT02393248|64886629|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
23312044|NCT02393248|64886630|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
23312045|NCT02393248|64886631|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
23312046|NCT02393248|64886632|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
23312047|NCT02393248|64886633|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
23424091|NCT00837876|65296345|FG000|Overall Study|disease progression|24|||
23424092|NCT03349645|65296347|FG000|Overall Study|Sponsor Terminated Study|75|||
23424093|NCT03349645|65296347|FG000|Overall Study|Withdrawal by Subject|4|||
23424094|NCT03349645|65296347|FG000|Overall Study|Protocol Violation|1|||
23424095|NCT03349645|65296347|FG000|Overall Study|Other|2|||
23424096|NCT02078102|65296350|FG000|Overall Study|Adverse Event|1|||
23424097|NCT02078102|65296351|FG001|Overall Study|Adverse Event|0|||
23424098|NCT02078102|65296350|FG000|Overall Study|Withdrawal by Subject|1|||
23424099|NCT02078102|65296351|FG001|Overall Study|Withdrawal by Subject|0|||
23424100|NCT02078102|65296350|FG000|Overall Study|Physician Decision|0|||
23424101|NCT02078102|65296351|FG001|Overall Study|Physician Decision|1|||
23424102|NCT00541099|65296352|FG000|Overall Study|Ineligible|3|||
23424103|NCT00405964|65296357|FG000|Overall Study|Treatment Failure|17|||
23424104|NCT00405964|65296358|FG001|Overall Study|Treatment Failure|45|||
23424105|NCT00405964|65296357|FG000|Overall Study|Adverse Event|7|||
23424106|NCT00405964|65296358|FG001|Overall Study|Adverse Event|16|||
23424107|NCT00405964|65296357|FG000|Overall Study|Lost to Follow-up|5|||
23424108|NCT00405964|65296358|FG001|Overall Study|Lost to Follow-up|5|||
23424109|NCT00405964|65296357|FG000|Overall Study|Withdrawal by Subject|19|||
23209296|NCT01757405|64504548|FG000|Overall Study|Withdrawal by Subject|0|||
23312048|NCT02393248|64886634|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
23424110|NCT00405964|65296358|FG001|Overall Study|Withdrawal by Subject|23|||
23424111|NCT00405964|65296357|FG000|Overall Study|Protocol Violation|11|||
23538483|NCT03394924|65705799|FG001|Overall Study|Adverse Event|5|||
23538484|NCT03394924|65705800|FG002|Overall Study|Adverse Event|0|||
23538485|NCT03394924|65705798|FG000|Overall Study|Withdrawal by Subject|2|||
23424112|NCT00405964|65296358|FG001|Overall Study|Protocol Violation|6|||
23424113|NCT00468676|65296359|FG000|Overall Study|Lost to Follow-up|14|||
23424114|NCT00468676|65296360|FG001|Overall Study|Lost to Follow-up|11|||
23424115|NCT00468676|65296359|FG000|Overall Study|Death|2|||
23424116|NCT00468676|65296360|FG001|Overall Study|Death|1|||
23424117|NCT03141788|65296361|FG000|Overall Study|Lost to Follow-up|1|||
23424118|NCT03141788|65296361|FG000|Overall Study|Protocol Violation|3|||
23424119|NCT03141788|65296361|FG000|Overall Study|Withdrawal by Subject|4|||
23424120|NCT03372551|65296367|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
23424121|NCT03372551|65296368|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
23424122|NCT03089944|65296369|FG000|Overall Study|Lost to Follow-up|8|||
23424123|NCT03089944|65296369|FG000|Overall Study|Withdrew Consent|2|||
23424124|NCT03089944|65296369|FG000|Overall Study|Adverse Event|1|||
23424125|NCT03089944|65296369|FG000|Overall Study|Other|1|||
23424126|NCT01643850|65296370|FG000|Overall Study|Withdrawal by Subject|0|||
23424127|NCT01643850|65296371|FG001|Overall Study|Withdrawal by Subject|0|||
23424128|NCT01643850|65296372|FG002|Overall Study|Withdrawal by Subject|0|||
23424129|NCT01643850|65296373|FG003|Overall Study|Withdrawal by Subject|0|||
23424130|NCT01643850|65296374|FG004|Overall Study|Withdrawal by Subject|1|||
23424131|NCT01643850|65296375|FG005|Overall Study|Withdrawal by Subject|0|||
23424132|NCT01643850|65296376|FG006|Overall Study|Withdrawal by Subject|0|||
23424133|NCT01643850|65296377|FG007|Overall Study|Withdrawal by Subject|0|||
23424134|NCT01643850|65296378|FG008|Overall Study|Withdrawal by Subject|0|||
23538486|NCT03394924|65705799|FG001|Overall Study|Withdrawal by Subject|0|||
23538487|NCT03394924|65705800|FG002|Overall Study|Withdrawal by Subject|0|||
23424135|NCT01643850|65296370|FG000|Overall Study|Lost to Follow-up|0|||
23424136|NCT01643850|65296371|FG001|Overall Study|Lost to Follow-up|0|||
23424137|NCT01643850|65296372|FG002|Overall Study|Lost to Follow-up|0|||
23424138|NCT01643850|65296373|FG003|Overall Study|Lost to Follow-up|0|||
23424139|NCT01643850|65296374|FG004|Overall Study|Lost to Follow-up|0|||
23424140|NCT01643850|65296375|FG005|Overall Study|Lost to Follow-up|0|||
23424141|NCT01643850|65296376|FG006|Overall Study|Lost to Follow-up|1|||
23424142|NCT01643850|65296377|FG007|Overall Study|Lost to Follow-up|0|||
23424143|NCT01643850|65296378|FG008|Overall Study|Lost to Follow-up|1|||
23538488|NCT03394924|65705798|FG000|Overall Study|Lost to Follow-up|0|||
23538489|NCT03394924|65705799|FG001|Overall Study|Lost to Follow-up|1|||
23538490|NCT03394924|65705800|FG002|Overall Study|Lost to Follow-up|0|||
23538491|NCT03394924|65705798|FG000|Overall Study|Did not meet all inclusion criteria|1|||
23538492|NCT03394924|65705799|FG001|Overall Study|Did not meet all inclusion criteria|0|||
23538493|NCT03394924|65705800|FG002|Overall Study|Did not meet all inclusion criteria|0|||
23538494|NCT00646958|65705801|FG000|Overall Study|Lack of Efficacy|1|||
23538495|NCT00646958|65705802|FG001|Overall Study|Lack of Efficacy|0|||
23538496|NCT00646958|65705803|FG002|Overall Study|Lack of Efficacy|0|||
23538497|NCT00646958|65705801|FG000|Overall Study|Adverse Event|4|||
23312049|NCT02393248|64886635|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
23312050|NCT02393248|64886636|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
23538498|NCT00646958|65705802|FG001|Overall Study|Adverse Event|0|||
23538499|NCT00646958|65705803|FG002|Overall Study|Adverse Event|0|||
23538500|NCT00646958|65705801|FG000|Overall Study|Lost to Follow-up|1|||
23538501|NCT00646958|65705802|FG001|Overall Study|Lost to Follow-up|5|||
23538502|NCT00646958|65705803|FG002|Overall Study|Lost to Follow-up|7|||
23538503|NCT00646958|65705801|FG000|Overall Study|Protocol Violation|1|||
23424144|NCT01643850|65296370|FG000|Overall Study|Adverse Event|0|||
23424145|NCT01643850|65296371|FG001|Overall Study|Adverse Event|0|||
23538504|NCT00646958|65705802|FG001|Overall Study|Protocol Violation|1|||
23538505|NCT00646958|65705803|FG002|Overall Study|Protocol Violation|0|||
23538506|NCT00646958|65705801|FG000|Overall Study|Abnormal screening lab tests|1|||
23424146|NCT01643850|65296372|FG002|Overall Study|Adverse Event|0|||
23538507|NCT00646958|65705802|FG001|Overall Study|Abnormal screening lab tests|1|||
23538508|NCT00646958|65705803|FG002|Overall Study|Abnormal screening lab tests|0|||
23424147|NCT01643850|65296373|FG003|Overall Study|Adverse Event|0|||
23424148|NCT01643850|65296374|FG004|Overall Study|Adverse Event|1|||
23424149|NCT01643850|65296375|FG005|Overall Study|Adverse Event|0|||
23538509|NCT00646958|65705801|FG000|Overall Study|Withdrawal by Subject|1|||
23538510|NCT00646958|65705802|FG001|Overall Study|Withdrawal by Subject|2|||
23538511|NCT00646958|65705803|FG002|Overall Study|Withdrawal by Subject|0|||
23538512|NCT00646958|65705801|FG000|Overall Study|Did not receive study drug|2|||
23538513|NCT00646958|65705802|FG001|Overall Study|Did not receive study drug|0|||
23538514|NCT00646958|65705803|FG002|Overall Study|Did not receive study drug|2|||
23538515|NCT02200042|65705804|FG000|Overall Study|Withdrawal by Subject|0|||
23538516|NCT02200042|65705805|FG001|Overall Study|Withdrawal by Subject|1|||
23538517|NCT02338362|65705808|FG000|Overall Study|Withdrawal by Subject|1|||
23538518|NCT02338362|65705809|FG001|Overall Study|Withdrawal by Subject|1|||
23538519|NCT00616967|65705812|FG000|Overall Study|Withdrawal by Subject|0|||
23538520|NCT00616967|65705813|FG001|Overall Study|Withdrawal by Subject|0|||
23538521|NCT00616967|65705814|FG002|Overall Study|Withdrawal by Subject|1|||
23538522|NCT02819726|65705815|FG000|Part A (All Participants)|Lost to Follow-up|0|||
23538523|NCT02819726|65705816|FG001|Part A (All Participants)|Lost to Follow-up|1|||
23538524|NCT02819726|65705817|FG002|Part A (All Participants)|Lost to Follow-up|0|||
23538525|NCT02819726|65705818|FG003|Part A (All Participants)|Lost to Follow-up|0|||
23538526|NCT02819726|65705815|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
23538527|NCT02819726|65705816|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
23538528|NCT02819726|65705817|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
23538529|NCT02819726|65705818|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
23538530|NCT02819726|65705815|FG000|Part A (All Participants)|Protocol non-compliance|3|||
23538531|NCT02819726|65705816|FG001|Part A (All Participants)|Protocol non-compliance|4|||
23538532|NCT02819726|65705817|FG002|Part A (All Participants)|Protocol non-compliance|5|||
23538533|NCT02819726|65705818|FG003|Part A (All Participants)|Protocol non-compliance|0|||
23538534|NCT02819726|65705815|FG000|Part B (All Participants)|Lost to Follow-up|1|||
23209297|NCT01757405|64504549|FG001|Overall Study|Withdrawal by Subject|1|||
23209298|NCT00946530|64504550|FG000|Overall Study|Withdrawal by Subject|0|||
23209299|NCT00946530|64504551|FG001|Overall Study|Withdrawal by Subject|3|||
23209300|NCT00946530|64504552|FG002|Overall Study|Withdrawal by Subject|0|||
23209301|NCT00946530|64504553|FG003|Overall Study|Withdrawal by Subject|3|||
23424150|NCT01643850|65296376|FG006|Overall Study|Adverse Event|0|||
23538535|NCT02819726|65705816|FG001|Part B (All Participants)|Lost to Follow-up|1|||
23538536|NCT02819726|65705817|FG002|Part B (All Participants)|Lost to Follow-up|2|||
23538537|NCT02819726|65705818|FG003|Part B (All Participants)|Lost to Follow-up|2|||
23538538|NCT02819726|65705815|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
23538539|NCT02819726|65705816|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
23538540|NCT02819726|65705817|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
23538541|NCT02819726|65705818|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
23538542|NCT02819726|65705815|FG000|Part B (All Participants)|Protocol non-compliance|0|||
23538543|NCT02819726|65705816|FG001|Part B (All Participants)|Protocol non-compliance|0|||
23538544|NCT02819726|65705817|FG002|Part B (All Participants)|Protocol non-compliance|1|||
23538545|NCT02819726|65705818|FG003|Part B (All Participants)|Protocol non-compliance|0|||
23538546|NCT03221257|65705819|FG000|Overall Study|Lost to Follow-up|0|||
23538547|NCT03221257|65705820|FG001|Overall Study|Lost to Follow-up|1|||
23538548|NCT03221257|65705819|FG000|Overall Study|Withdrawal by Subject|1|||
23538549|NCT03221257|65705820|FG001|Overall Study|Withdrawal by Subject|1|||
23538550|NCT00793910|65705823|FG000|Overall Study|discarded study pills|0|||
23538551|NCT00793910|65705824|FG001|Overall Study|discarded study pills|1|||
23538552|NCT00793910|65705823|FG000|Overall Study|did not pick up medications|1|||
23538553|NCT00793910|65705824|FG001|Overall Study|did not pick up medications|1|||
23209302|NCT00946530|64504550|FG000|Overall Study|Physician Decision|1|||
23538554|NCT00793910|65705823|FG000|Overall Study|ineligible based on entry criteria|2|||
23538555|NCT00793910|65705824|FG001|Overall Study|ineligible based on entry criteria|3|||
23538556|NCT00793910|65705823|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
23538557|NCT00793910|65705824|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
23538558|NCT00793910|65705823|FG000|Overall Study|Withdrawal by Subject|0|||
23538559|NCT00793910|65705824|FG001|Overall Study|Withdrawal by Subject|1|||
23538560|NCT00982319|65705826|FG000|Overall Study|Surgery date change|1|||
23538561|NCT00982319|65705827|FG001|Overall Study|Surgery date change|0|||
23538562|NCT00982319|65705826|FG000|Overall Study|Preop values out of acceptable range|1|||
23538563|NCT00982319|65705827|FG001|Overall Study|Preop values out of acceptable range|1|||
23538564|NCT00982319|65705826|FG000|Overall Study|Pregnancy|0|||
23538565|NCT00982319|65705827|FG001|Overall Study|Pregnancy|1|||
23538566|NCT03207750|65705828|FG000|Overall Study|Adverse Event|3|||
23538567|NCT03207750|65705829|FG001|Overall Study|Adverse Event|2|||
23538568|NCT03207750|65705828|FG000|Overall Study|Lost to Follow-up|21|||
23538569|NCT03207750|65705829|FG001|Overall Study|Lost to Follow-up|29|||
23209303|NCT00946530|64504551|FG001|Overall Study|Physician Decision|1|||
23616399|NCT00244751|65982323|FG002|Overall Study|Adverse Event|5|||
23616400|NCT00244751|65982321|FG000|Overall Study|Lost to Follow-up|0|||
23538570|NCT03207750|65705828|FG000|Overall Study|Protocol Violation|0|||
23209304|NCT00946530|64504552|FG002|Overall Study|Physician Decision|1|||
23209305|NCT00946530|64504553|FG003|Overall Study|Physician Decision|1|||
23209306|NCT00755846|64504554|FG000|Overall Study|Adverse Event|0|||
23209307|NCT00755846|64504555|FG001|Overall Study|Adverse Event|0|||
23538571|NCT03207750|65705829|FG001|Overall Study|Protocol Violation|1|||
23538572|NCT03207750|65705828|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
23538573|NCT03207750|65705829|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
23538574|NCT03207750|65705828|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
23538575|NCT03207750|65705829|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
23538576|NCT03207750|65705828|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
23538577|NCT03207750|65705829|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
23538578|NCT03207750|65705828|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
23538579|NCT03207750|65705829|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
23538580|NCT03207750|65705828|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
23538581|NCT03207750|65705829|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
23538582|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538583|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538584|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538585|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538586|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23538587|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538588|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538589|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23616401|NCT00244751|65982322|FG001|Overall Study|Lost to Follow-up|1|||
23616402|NCT00244751|65982323|FG002|Overall Study|Lost to Follow-up|0|||
23616403|NCT00244751|65982321|FG000|Overall Study|Protocol Violation|1|||
23616404|NCT00244751|65982322|FG001|Overall Study|Protocol Violation|0|||
23616405|NCT00244751|65982323|FG002|Overall Study|Protocol Violation|1|||
23616406|NCT00244751|65982321|FG000|Overall Study|Withdrawal by Subject|7|||
23616407|NCT00244751|65982322|FG001|Overall Study|Withdrawal by Subject|5|||
23616408|NCT00244751|65982323|FG002|Overall Study|Withdrawal by Subject|3|||
23616409|NCT00244751|65982321|FG000|Overall Study|Elevated liver enzymes|1|||
23616410|NCT00244751|65982322|FG001|Overall Study|Elevated liver enzymes|0|||
23616411|NCT00244751|65982323|FG002|Overall Study|Elevated liver enzymes|0|||
23616412|NCT00244751|65982321|FG000|Overall Study|Lack of compliance with protocol|0|||
23616413|NCT00244751|65982322|FG001|Overall Study|Lack of compliance with protocol|1|||
23616414|NCT00244751|65982323|FG002|Overall Study|Lack of compliance with protocol|0|||
23616415|NCT00244751|65982321|FG000|Overall Study|Safety reasons|0|||
23616416|NCT00244751|65982322|FG001|Overall Study|Safety reasons|1|||
23616417|NCT00244751|65982323|FG002|Overall Study|Safety reasons|0|||
23616418|NCT00244751|65982321|FG000|Overall Study|Participant randomized by mistake|0|||
23616419|NCT00244751|65982322|FG001|Overall Study|Participant randomized by mistake|0|||
23616420|NCT00244751|65982323|FG002|Overall Study|Participant randomized by mistake|1|||
23616421|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
23616422|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
23616423|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
23209308|NCT00755846|64504556|FG002|Overall Study|Adverse Event|0|||
23209309|NCT00755846|64504557|FG003|Overall Study|Adverse Event|1|||
23209310|NCT00755846|64504558|FG004|Overall Study|Adverse Event|3|||
23538590|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23538591|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23616424|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
23209311|NCT00755846|64504559|FG005|Overall Study|Adverse Event|2|||
23538592|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23538593|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
23538594|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538595|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538596|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538597|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
23538598|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538599|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
23538600|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
23538601|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
23538602|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
23538603|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
23538604|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
23538605|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
23538606|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
23538607|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
23538608|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
23538609|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
23538610|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538611|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538612|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538613|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
23538614|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538615|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538616|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538617|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538618|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538619|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
23538620|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
23538621|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538622|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538623|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
23538624|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
23538625|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
23538626|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538627|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538628|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538629|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
23538630|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538631|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538632|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538633|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538634|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538635|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
23538636|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538637|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538638|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538639|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538640|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538641|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
23538642|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538643|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538644|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538645|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
23538646|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538647|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538648|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538649|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538650|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538651|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
23312051|NCT02393248|64886637|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
23424151|NCT01643850|65296377|FG007|Overall Study|Adverse Event|0|||
23209312|NCT00755846|64504554|FG000|Overall Study|Protocol Violation|1|||
23424152|NCT01643850|65296378|FG008|Overall Study|Adverse Event|0|||
23538652|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538653|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538654|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538655|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538656|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538657|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538658|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538659|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538660|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538661|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
23538662|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538663|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538664|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538665|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538666|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538667|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538668|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538669|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538670|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
23538671|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538672|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538673|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538674|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538675|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538676|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538677|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
23538678|NCT01609556|65705830|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
23538679|NCT01609556|65705831|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538680|NCT01609556|65705832|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538681|NCT01609556|65705833|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538682|NCT01609556|65705834|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538683|NCT01609556|65705835|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
23538684|NCT01609556|65705836|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538685|NCT01609556|65705837|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538686|NCT01609556|65705838|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538687|NCT01609556|65705839|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538688|NCT01609556|65705840|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
23538689|NCT01609556|65705841|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538690|NCT01609556|65705842|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538691|NCT01609556|65705843|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538692|NCT01609556|65705844|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538693|NCT01609556|65705845|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
23538694|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538695|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538696|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538697|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538698|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538699|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538700|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538701|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538702|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538703|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538704|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538705|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
23538706|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
23538707|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
23538708|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
23538709|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
23538710|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538711|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538712|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538713|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538714|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538715|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23209313|NCT00755846|64504555|FG001|Overall Study|Protocol Violation|1|||
23538716|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538717|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538718|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538719|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538720|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538721|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
23538722|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
23209314|NCT00755846|64504556|FG002|Overall Study|Protocol Violation|1|||
23209315|NCT00755846|64504557|FG003|Overall Study|Protocol Violation|1|||
23538723|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
23538724|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
23538725|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
23538726|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538727|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538728|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23616425|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
23616426|NCT00500539|65982325|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
23616427|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
23616428|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
23209316|NCT00755846|64504558|FG004|Overall Study|Protocol Violation|1|||
23209317|NCT00755846|64504559|FG005|Overall Study|Protocol Violation|1|||
23209318|NCT00755846|64504554|FG000|Overall Study|Lost to Follow-up|0|||
23209319|NCT00755846|64504555|FG001|Overall Study|Lost to Follow-up|2|||
23209320|NCT00755846|64504556|FG002|Overall Study|Lost to Follow-up|1|||
23209321|NCT00755846|64504557|FG003|Overall Study|Lost to Follow-up|0|||
23312052|NCT02393248|64886638|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
23209322|NCT00755846|64504558|FG004|Overall Study|Lost to Follow-up|4|||
23209323|NCT00755846|64504559|FG005|Overall Study|Lost to Follow-up|2|||
23209324|NCT00755846|64504554|FG000|Overall Study|Withdrawal by Subject|2|||
23209325|NCT00755846|64504555|FG001|Overall Study|Withdrawal by Subject|3|||
23209326|NCT00755846|64504556|FG002|Overall Study|Withdrawal by Subject|5|||
23209327|NCT00755846|64504557|FG003|Overall Study|Withdrawal by Subject|2|||
23209328|NCT00755846|64504558|FG004|Overall Study|Withdrawal by Subject|0|||
23209329|NCT00755846|64504559|FG005|Overall Study|Withdrawal by Subject|1|||
23209330|NCT00755846|64504554|FG000|Overall Study|Hyperglycemic Rescue|21|||
23209331|NCT00755846|64504555|FG001|Overall Study|Hyperglycemic Rescue|7|||
23209332|NCT00755846|64504556|FG002|Overall Study|Hyperglycemic Rescue|5|||
23209333|NCT00755846|64504557|FG003|Overall Study|Hyperglycemic Rescue|8|||
23209334|NCT00755846|64504558|FG004|Overall Study|Hyperglycemic Rescue|8|||
23209335|NCT00755846|64504559|FG005|Overall Study|Hyperglycemic Rescue|7|||
23209336|NCT00755846|64504554|FG000|Overall Study|Physician Decision|1|||
23209337|NCT00755846|64504555|FG001|Overall Study|Physician Decision|3|||
23209338|NCT00755846|64504556|FG002|Overall Study|Physician Decision|0|||
23209339|NCT00755846|64504557|FG003|Overall Study|Physician Decision|1|||
23209340|NCT00755846|64504558|FG004|Overall Study|Physician Decision|0|||
23312053|NCT02393248|64886639|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
23209341|NCT00755846|64504559|FG005|Overall Study|Physician Decision|1|||
23209342|NCT00755846|64504554|FG000|Overall Study|Administrative Error|0|||
23209343|NCT00755846|64504555|FG001|Overall Study|Administrative Error|1|||
23538729|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23209344|NCT00755846|64504556|FG002|Overall Study|Administrative Error|0|||
23538730|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538731|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538732|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538733|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538734|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538735|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538736|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538737|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
23538738|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
23538739|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
23538740|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
23312054|NCT02393248|64886640|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
23312055|NCT02393248|64886641|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
23312056|NCT02393248|64886642|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
23312057|NCT02393248|64886643|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
23312058|NCT02393248|64886644|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
23312059|NCT02393248|64886620|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312060|NCT02393248|64886621|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312061|NCT02393248|64886622|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312062|NCT02393248|64886623|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312063|NCT02393248|64886624|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312064|NCT02393248|64886625|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312065|NCT02393248|64886626|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312066|NCT02393248|64886627|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312067|NCT02393248|64886628|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312068|NCT02393248|64886629|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312069|NCT02393248|64886630|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312070|NCT02393248|64886631|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
23312071|NCT02393248|64886632|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312072|NCT02393248|64886633|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
23312073|NCT02393248|64886634|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312074|NCT02393248|64886635|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312075|NCT02393248|64886636|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312076|NCT02393248|64886637|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312077|NCT02393248|64886638|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312078|NCT02393248|64886639|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312079|NCT02393248|64886640|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312080|NCT02393248|64886641|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312081|NCT02393248|64886642|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312082|NCT02393248|64886643|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312083|NCT02393248|64886644|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
23312084|NCT02393248|64886620|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312085|NCT02393248|64886621|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312086|NCT02393248|64886622|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312087|NCT02393248|64886623|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312088|NCT02393248|64886624|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312089|NCT02393248|64886625|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312090|NCT02393248|64886626|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23538741|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
23538742|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538743|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538744|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23312091|NCT02393248|64886627|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312092|NCT02393248|64886628|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312093|NCT02393248|64886629|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312094|NCT02393248|64886630|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312095|NCT02393248|64886631|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23538745|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538746|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538747|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538748|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538749|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538750|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538751|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23312096|NCT02393248|64886632|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312097|NCT02393248|64886633|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312098|NCT02393248|64886634|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312099|NCT02393248|64886635|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312100|NCT02393248|64886636|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312101|NCT02393248|64886637|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312102|NCT02393248|64886638|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
23312103|NCT02393248|64886639|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312104|NCT02393248|64886640|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
23312105|NCT02393248|64886641|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
23312106|NCT02393248|64886642|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312107|NCT02393248|64886643|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
23312108|NCT02393248|64886644|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
23312109|NCT02393248|64886620|FG000|Part 3: Combination Therapy|Death|0|||
23312110|NCT02393248|64886621|FG001|Part 3: Combination Therapy|Death|0|||
23312111|NCT02393248|64886622|FG002|Part 3: Combination Therapy|Death|0|||
23312112|NCT02393248|64886623|FG003|Part 3: Combination Therapy|Death|0|||
23312113|NCT02393248|64886624|FG004|Part 3: Combination Therapy|Death|0|||
23312114|NCT02393248|64886625|FG005|Part 3: Combination Therapy|Death|0|||
23312115|NCT02393248|64886626|FG006|Part 3: Combination Therapy|Death|0|||
23312116|NCT02393248|64886627|FG007|Part 3: Combination Therapy|Death|0|||
23312117|NCT02393248|64886628|FG008|Part 3: Combination Therapy|Death|0|||
23312118|NCT02393248|64886629|FG009|Part 3: Combination Therapy|Death|0|||
23312119|NCT02393248|64886630|FG010|Part 3: Combination Therapy|Death|0|||
23312120|NCT02393248|64886631|FG011|Part 3: Combination Therapy|Death|0|||
23312121|NCT02393248|64886632|FG012|Part 3: Combination Therapy|Death|0|||
23312122|NCT02393248|64886633|FG013|Part 3: Combination Therapy|Death|0|||
23312123|NCT02393248|64886634|FG014|Part 3: Combination Therapy|Death|0|||
23312124|NCT02393248|64886635|FG015|Part 3: Combination Therapy|Death|1|||
23312125|NCT02393248|64886636|FG016|Part 3: Combination Therapy|Death|7|||
23312126|NCT02393248|64886637|FG017|Part 3: Combination Therapy|Death|5|||
23312127|NCT02393248|64886638|FG018|Part 3: Combination Therapy|Death|5|||
23312128|NCT02393248|64886639|FG019|Part 3: Combination Therapy|Death|3|||
23312129|NCT02393248|64886640|FG020|Part 3: Combination Therapy|Death|7|||
23312130|NCT02393248|64886641|FG021|Part 3: Combination Therapy|Death|5|||
23312131|NCT02393248|64886642|FG022|Part 3: Combination Therapy|Death|6|||
23312132|NCT02393248|64886643|FG023|Part 3: Combination Therapy|Death|3|||
23312133|NCT02393248|64886644|FG024|Part 3: Combination Therapy|Death|0|||
23312134|NCT02393248|64886620|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312135|NCT02393248|64886621|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312136|NCT02393248|64886622|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312137|NCT02393248|64886623|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312138|NCT02393248|64886624|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312139|NCT02393248|64886625|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312140|NCT02393248|64886626|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312141|NCT02393248|64886627|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312142|NCT02393248|64886628|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312143|NCT02393248|64886629|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312144|NCT02393248|64886630|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312145|NCT02393248|64886631|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312146|NCT02393248|64886632|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312147|NCT02393248|64886633|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312148|NCT02393248|64886634|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312149|NCT02393248|64886635|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312150|NCT02393248|64886636|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312151|NCT02393248|64886637|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23312152|NCT02393248|64886638|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23312153|NCT02393248|64886639|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
23312154|NCT02393248|64886640|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23312155|NCT02393248|64886641|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23312156|NCT02393248|64886642|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23312157|NCT02393248|64886643|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
23312158|NCT02393248|64886644|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
23312159|NCT02393248|64886620|FG000|Part 3: Combination Therapy|Disease Progression|0|||
23312160|NCT02393248|64886621|FG001|Part 3: Combination Therapy|Disease Progression|0|||
23312161|NCT02393248|64886622|FG002|Part 3: Combination Therapy|Disease Progression|0|||
23312162|NCT02393248|64886623|FG003|Part 3: Combination Therapy|Disease Progression|0|||
23312163|NCT02393248|64886624|FG004|Part 3: Combination Therapy|Disease Progression|0|||
23312164|NCT02393248|64886625|FG005|Part 3: Combination Therapy|Disease Progression|0|||
23312165|NCT02393248|64886626|FG006|Part 3: Combination Therapy|Disease Progression|0|||
23312166|NCT02393248|64886627|FG007|Part 3: Combination Therapy|Disease Progression|0|||
23312167|NCT02393248|64886628|FG008|Part 3: Combination Therapy|Disease Progression|0|||
23312168|NCT02393248|64886629|FG009|Part 3: Combination Therapy|Disease Progression|0|||
23312169|NCT02393248|64886630|FG010|Part 3: Combination Therapy|Disease Progression|0|||
23312170|NCT02393248|64886631|FG011|Part 3: Combination Therapy|Disease Progression|0|||
23312171|NCT02393248|64886632|FG012|Part 3: Combination Therapy|Disease Progression|0|||
23312172|NCT02393248|64886633|FG013|Part 3: Combination Therapy|Disease Progression|0|||
23312173|NCT02393248|64886634|FG014|Part 3: Combination Therapy|Disease Progression|0|||
23312174|NCT02393248|64886635|FG015|Part 3: Combination Therapy|Disease Progression|0|||
23312175|NCT02393248|64886636|FG016|Part 3: Combination Therapy|Disease Progression|0|||
23312176|NCT02393248|64886637|FG017|Part 3: Combination Therapy|Disease Progression|0|||
23312177|NCT02393248|64886638|FG018|Part 3: Combination Therapy|Disease Progression|0|||
23312178|NCT02393248|64886639|FG019|Part 3: Combination Therapy|Disease Progression|0|||
23312179|NCT02393248|64886640|FG020|Part 3: Combination Therapy|Disease Progression|2|||
23312180|NCT02393248|64886641|FG021|Part 3: Combination Therapy|Disease Progression|1|||
23312181|NCT02393248|64886642|FG022|Part 3: Combination Therapy|Disease Progression|0|||
23312182|NCT02393248|64886643|FG023|Part 3: Combination Therapy|Disease Progression|0|||
23312183|NCT02393248|64886644|FG024|Part 3: Combination Therapy|Disease Progression|0|||
23312184|NCT02393248|64886620|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
23209345|NCT00755846|64504557|FG003|Overall Study|Administrative Error|0|||
23209346|NCT00755846|64504558|FG004|Overall Study|Administrative Error|0|||
23209347|NCT00755846|64504559|FG005|Overall Study|Administrative Error|0|||
23209348|NCT00755846|64504554|FG000|Overall Study|Participant Non-compliance|0|||
23209349|NCT00755846|64504555|FG001|Overall Study|Participant Non-compliance|0|||
23209350|NCT00755846|64504556|FG002|Overall Study|Participant Non-compliance|0|||
23209351|NCT00755846|64504557|FG003|Overall Study|Participant Non-compliance|0|||
23209352|NCT00755846|64504558|FG004|Overall Study|Participant Non-compliance|1|||
23209353|NCT00755846|64504559|FG005|Overall Study|Participant Non-compliance|0|||
23209354|NCT03943953|64504563|FG000|Trial of ITG 1|Lost to Follow-up|19|||
23209355|NCT03943953|64504564|FG001|Trial of ITG 1|Lost to Follow-up|1|||
23312185|NCT02393248|64886621|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
23538752|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538753|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538754|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
23538755|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538756|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538757|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
23538758|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538759|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538760|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538761|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538762|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538763|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538764|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538765|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538766|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538767|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23616429|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
23209356|NCT03943953|64504563|FG000|Trial of ITG 2|Lost to Follow-up|8|||
23209357|NCT03943953|64504564|FG001|Trial of ITG 2|Lost to Follow-up|0|||
23209358|NCT03943953|64504563|FG000|Trial of ITG 3|Lost to Follow-up|2|||
23209359|NCT03943953|64504564|FG001|Trial of ITG 3|Lost to Follow-up|0|||
23209360|NCT03943953|64504563|FG000|Trial of ITG 4|Lost to Follow-up|2|||
23538768|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538769|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
23538770|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
23538771|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
23538772|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
23538773|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
23538774|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538775|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538776|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538777|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538778|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538779|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538780|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538781|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538782|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538783|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538784|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538785|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538786|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538787|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538788|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
23538789|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
23538790|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538791|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538792|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538793|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538794|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538795|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538796|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538797|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538798|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538799|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538800|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538801|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538802|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
23538803|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
23538804|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
23538805|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
23538806|NCT01609556|65705830|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538807|NCT01609556|65705831|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538808|NCT01609556|65705832|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538809|NCT01609556|65705833|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538810|NCT01609556|65705834|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538811|NCT01609556|65705835|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538812|NCT01609556|65705836|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538813|NCT01609556|65705837|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23616430|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
23538814|NCT01609556|65705838|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538815|NCT01609556|65705839|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538816|NCT01609556|65705840|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538817|NCT01609556|65705841|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538818|NCT01609556|65705842|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
23538819|NCT01609556|65705843|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538820|NCT01609556|65705844|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538821|NCT01609556|65705845|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
23538822|NCT00437489|65705846|FG000|Overall Study|Study terminated by sponsor|23|||
23538823|NCT00437489|65705847|FG001|Overall Study|Study terminated by sponsor|21|||
23538824|NCT00437489|65705846|FG000|Overall Study|Lost to Follow-up|0|||
23538825|NCT00437489|65705847|FG001|Overall Study|Lost to Follow-up|1|||
23538826|NCT02613481|65705848|FG000|Overall Study|Lost to Follow-up|7|||
23538827|NCT02613481|65705848|FG000|Overall Study|Withdrawal by Subject|2|||
23538828|NCT02731131|65705849|FG000|Overall Study|Psychiatric Disorder|0|||
23538829|NCT02731131|65705850|FG001|Overall Study|Psychiatric Disorder|1|||
23538830|NCT02731131|65705849|FG000|Overall Study|Refused Therapy|0|||
23538831|NCT02731131|65705850|FG001|Overall Study|Refused Therapy|1|||
23538832|NCT02899728|65705852|FG000|Overall Study|Withdrawal by Subject|1|||
23538833|NCT02899728|65705853|FG001|Overall Study|Withdrawal by Subject|1|||
23538834|NCT02033889|65705856|FG000|Overall Study|Adverse Event|3|||
23538835|NCT02033889|65705857|FG001|Overall Study|Adverse Event|1|||
23538836|NCT02033889|65705858|FG002|Overall Study|Adverse Event|3|||
23538837|NCT02033889|65705856|FG000|Overall Study|Death|3|||
23538838|NCT02033889|65705857|FG001|Overall Study|Death|1|||
23538839|NCT02033889|65705858|FG002|Overall Study|Death|2|||
23538840|NCT02033889|65705856|FG000|Overall Study|Excluded Medication|1|||
23538841|NCT02033889|65705857|FG001|Overall Study|Excluded Medication|1|||
23538842|NCT02033889|65705858|FG002|Overall Study|Excluded Medication|0|||
23538843|NCT02033889|65705856|FG000|Overall Study|Lost to Follow-up|8|||
23538844|NCT02033889|65705857|FG001|Overall Study|Lost to Follow-up|5|||
23538845|NCT02033889|65705858|FG002|Overall Study|Lost to Follow-up|6|||
23538846|NCT02033889|65705856|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23538847|NCT02033889|65705857|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23538848|NCT02033889|65705858|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23538849|NCT02033889|65705856|FG000|Overall Study|Physician Decision|0|||
23538850|NCT02033889|65705857|FG001|Overall Study|Physician Decision|1|||
23538851|NCT02033889|65705858|FG002|Overall Study|Physician Decision|1|||
23538852|NCT02033889|65705856|FG000|Overall Study|Participant moved|0|||
23538853|NCT02033889|65705857|FG001|Overall Study|Participant moved|1|||
23538854|NCT02033889|65705858|FG002|Overall Study|Participant moved|0|||
23538855|NCT02033889|65705856|FG000|Overall Study|Withdrawal by Subject|18|||
23538856|NCT02033889|65705857|FG001|Overall Study|Withdrawal by Subject|10|||
23538857|NCT02033889|65705858|FG002|Overall Study|Withdrawal by Subject|13|||
23538858|NCT01401530|65705861|FG000|Overall Study|Disease Progression|1|||
23538859|NCT01401530|65705862|FG001|Overall Study|Disease Progression|2|||
23538860|NCT01401530|65705863|FG002|Overall Study|Disease Progression|1|||
23538861|NCT01401530|65705861|FG000|Overall Study|Adverse Event|1|||
23538862|NCT01401530|65705862|FG001|Overall Study|Adverse Event|1|||
23538863|NCT01401530|65705863|FG002|Overall Study|Adverse Event|1|||
23538864|NCT01401530|65705861|FG000|Overall Study|Participant Choice|1|||
23538865|NCT01401530|65705862|FG001|Overall Study|Participant Choice|2|||
23538866|NCT01401530|65705863|FG002|Overall Study|Participant Choice|1|||
23209361|NCT03943953|64504564|FG001|Trial of ITG 4|Lost to Follow-up|0|||
23209362|NCT00642018|64504565|FG000|Overall Study|Adverse Event|11|||
23209363|NCT00642018|64504566|FG001|Overall Study|Adverse Event|36|||
23209364|NCT00642018|64504565|FG000|Overall Study|Withdrawal by Subject|4|||
23209365|NCT00642018|64504566|FG001|Overall Study|Withdrawal by Subject|10|||
23209366|NCT00642018|64504565|FG000|Overall Study|Progressive Disease|13|||
23209367|NCT00642018|64504566|FG001|Overall Study|Progressive Disease|18|||
23312186|NCT02393248|64886622|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
23538867|NCT01401530|65705861|FG000|Overall Study|Physician Decision|0|||
23538868|NCT01401530|65705862|FG001|Overall Study|Physician Decision|1|||
23538869|NCT01401530|65705863|FG002|Overall Study|Physician Decision|0|||
23538870|NCT03348904|65705864|FG000|Overall Study|Administrative reason by the sponsor|0|||
23209368|NCT00642018|64504565|FG000|Overall Study|Physician Decision|0|||
23312187|NCT02393248|64886623|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
23538871|NCT03348904|65705865|FG001|Overall Study|Administrative reason by the sponsor|1|||
23538872|NCT03348904|65705866|FG002|Overall Study|Administrative reason by the sponsor|0|||
23538873|NCT00608829|65705867|FG000|Overall Study|Death|6|||
23538874|NCT00608829|65705867|FG000|Overall Study|Withdrawal by Subject|4|||
23538875|NCT00608829|65705867|FG000|Overall Study|Subject refuses to follow up or return.|5|||
23538876|NCT03224468|65705868|FG000|Overall Study|Did not obtain MM card|53|||
23538877|NCT03224468|65705869|FG001|Overall Study|Did not obtain MM card|0|||
23538878|NCT03224468|65705868|FG000|Overall Study|Lost to Follow-up|4|||
23538879|NCT03224468|65705869|FG001|Overall Study|Lost to Follow-up|11|||
23538880|NCT03224468|65705868|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
23209369|NCT00642018|64504566|FG001|Overall Study|Physician Decision|10|||
23538881|NCT03224468|65705869|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
23538882|NCT02031276|65705870|FG000|Period 1 Double-blind IV|Adverse Event|6|||
23538883|NCT02031276|65705871|FG001|Period 1 Double-blind IV|Adverse Event|5|||
23538884|NCT02031276|65705872|FG002|Period 1 Double-blind IV|Adverse Event|1|||
23538885|NCT02031276|65705870|FG000|Period 1 Double-blind IV|Other|0|||
23538886|NCT02031276|65705871|FG001|Period 1 Double-blind IV|Other|1|||
23538887|NCT02031276|65705872|FG002|Period 1 Double-blind IV|Other|0|||
23538888|NCT02031276|65705870|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
23209370|NCT00642018|64504565|FG000|Overall Study|Protocol Violation|0|||
23209371|NCT00642018|64504566|FG001|Overall Study|Protocol Violation|1|||
23209372|NCT00642018|64504565|FG000|Overall Study|Death|0|||
23209373|NCT00642018|64504566|FG001|Overall Study|Death|3|||
23209374|NCT00642018|64504565|FG000|Overall Study|Entry Criteria Not Met|0|||
23209375|NCT00642018|64504566|FG001|Overall Study|Entry Criteria Not Met|1|||
23209376|NCT00405821|64504569|FG000|Overall Study|Death|5|||
23209377|NCT00405821|64504570|FG001|Overall Study|Death|7|||
23209378|NCT00405821|64504569|FG000|Overall Study|Lost to Follow-up|7|||
23209379|NCT00405821|64504570|FG001|Overall Study|Lost to Follow-up|7|||
23538889|NCT02031276|65705871|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
23538890|NCT02031276|65705872|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
23538891|NCT02031276|65705870|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
23538892|NCT02031276|65705871|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
23538893|NCT02031276|65705872|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
23538894|NCT02031276|65705870|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
23538895|NCT02031276|65705871|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
23538896|NCT02031276|65705872|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
23538897|NCT02031276|65705870|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
23538898|NCT02031276|65705871|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
23538899|NCT02031276|65705872|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
23538900|NCT02031276|65705870|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
23209380|NCT00405821|64504569|FG000|Overall Study|Protocol Violation|1|||
23209381|NCT00405821|64504570|FG001|Overall Study|Protocol Violation|0|||
23209382|NCT00405821|64504569|FG000|Overall Study|initiated ART|9|||
23538901|NCT02031276|65705871|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
23209383|NCT00405821|64504570|FG001|Overall Study|initiated ART|8|||
23538902|NCT02031276|65705872|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
23538903|NCT02031276|65705870|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
23538904|NCT02031276|65705871|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
23616431|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Death|1|||
23209384|NCT03730194|64504582|FG000|First Stage Treatment|Withdrawal by Subject|1|||
23538905|NCT02031276|65705872|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
23538906|NCT02031276|65705870|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
23538907|NCT02031276|65705871|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
23538908|NCT02031276|65705872|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
23538909|NCT02029443|65705873|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
23538910|NCT02029443|65705874|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
23538911|NCT02029443|65705875|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
23538912|NCT02029443|65705876|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
23538913|NCT02029443|65705877|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
23538914|NCT02029443|65705873|FG000|Overall Study|Death|13|||
23538915|NCT02029443|65705874|FG001|Overall Study|Death|2|||
23538916|NCT02029443|65705875|FG002|Overall Study|Death|2|||
23538917|NCT02029443|65705876|FG003|Overall Study|Death|11|||
23538918|NCT02029443|65705877|FG004|Overall Study|Death|2|||
23538919|NCT02029443|65705873|FG000|Overall Study|Lost to Follow-up|1|||
23538920|NCT02029443|65705874|FG001|Overall Study|Lost to Follow-up|0|||
23209385|NCT03730194|64504583|FG001|First Stage Treatment|Withdrawal by Subject|1|||
23538921|NCT02029443|65705875|FG002|Overall Study|Lost to Follow-up|1|||
23538922|NCT02029443|65705876|FG003|Overall Study|Lost to Follow-up|1|||
23538923|NCT02029443|65705877|FG004|Overall Study|Lost to Follow-up|0|||
23538924|NCT02029443|65705873|FG000|Overall Study|Started other anti-cancer therapy|17|||
23538925|NCT02029443|65705874|FG001|Overall Study|Started other anti-cancer therapy|4|||
23538926|NCT02029443|65705875|FG002|Overall Study|Started other anti-cancer therapy|7|||
23538927|NCT02029443|65705876|FG003|Overall Study|Started other anti-cancer therapy|9|||
23538928|NCT02029443|65705877|FG004|Overall Study|Started other anti-cancer therapy|3|||
23538929|NCT02029443|65705873|FG000|Overall Study|Withdrawal by Subject|3|||
23538930|NCT02029443|65705874|FG001|Overall Study|Withdrawal by Subject|1|||
23538931|NCT02029443|65705875|FG002|Overall Study|Withdrawal by Subject|1|||
23538932|NCT02029443|65705876|FG003|Overall Study|Withdrawal by Subject|1|||
23538933|NCT02029443|65705877|FG004|Overall Study|Withdrawal by Subject|0|||
23538934|NCT02029443|65705873|FG000|Overall Study|Other|6|||
23538935|NCT02029443|65705874|FG001|Overall Study|Other|6|||
23538936|NCT02029443|65705875|FG002|Overall Study|Other|4|||
23538937|NCT02029443|65705876|FG003|Overall Study|Other|2|||
23538938|NCT02029443|65705877|FG004|Overall Study|Other|0|||
23538939|NCT04260191|65705878|FG000|Overall Study|Decision by Sponsor|0|||
23538940|NCT04260191|65705879|FG001|Overall Study|Decision by Sponsor|1|||
23538941|NCT04260191|65705880|FG002|Overall Study|Decision by Sponsor|0|||
23538942|NCT04260191|65705878|FG000|Overall Study|Withdrawal by Subject|1|||
23538943|NCT04260191|65705879|FG001|Overall Study|Withdrawal by Subject|0|||
23538944|NCT04260191|65705880|FG002|Overall Study|Withdrawal by Subject|3|||
23538945|NCT04260191|65705878|FG000|Overall Study|Death|4|||
23538946|NCT04260191|65705879|FG001|Overall Study|Death|3|||
23538947|NCT04260191|65705880|FG002|Overall Study|Death|2|||
23538948|NCT01358526|65705885|FG000|Open-label Titration Period|Adverse Event|95|||
23538949|NCT01358526|65705886|FG001|Open-label Titration Period|Adverse Event|0|||
23538950|NCT01358526|65705887|FG002|Open-label Titration Period|Adverse Event|0|||
23538951|NCT01358526|65705885|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
23538952|NCT01358526|65705886|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
23538953|NCT01358526|65705887|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
23538954|NCT01358526|65705885|FG000|Open-label Titration Period|Lost to Follow-up|25|||
23538955|NCT01358526|65705886|FG001|Open-label Titration Period|Lost to Follow-up|0|||
23538956|NCT01358526|65705887|FG002|Open-label Titration Period|Lost to Follow-up|0|||
23538957|NCT01358526|65705885|FG000|Open-label Titration Period|Lack of Efficacy|107|||
23538958|NCT01358526|65705886|FG001|Open-label Titration Period|Lack of Efficacy|0|||
23209386|NCT03730194|64504584|FG002|First Stage Treatment|Withdrawal by Subject|0|||
23209387|NCT03730194|64504585|FG003|First Stage Treatment|Withdrawal by Subject|0|||
23209388|NCT03730194|64504586|FG004|First Stage Treatment|Withdrawal by Subject|0|||
23538959|NCT01358526|65705887|FG002|Open-label Titration Period|Lack of Efficacy|0|||
23538960|NCT01358526|65705885|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
23538961|NCT01358526|65705886|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
23538962|NCT01358526|65705887|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
23538963|NCT01358526|65705885|FG000|Open-label Titration Period|Administrative|8|||
23538964|NCT01358526|65705886|FG001|Open-label Titration Period|Administrative|0|||
23538965|NCT01358526|65705887|FG002|Open-label Titration Period|Administrative|0|||
23538966|NCT01358526|65705885|FG000|Open-label Titration Period|Did not qualify|178|||
23538967|NCT01358526|65705886|FG001|Open-label Titration Period|Did not qualify|0|||
23538968|NCT01358526|65705887|FG002|Open-label Titration Period|Did not qualify|0|||
23538969|NCT01358526|65705885|FG000|Double-blind Phase|Adverse Event|0|||
23538970|NCT01358526|65705886|FG001|Double-blind Phase|Adverse Event|24|||
23538971|NCT01358526|65705887|FG002|Double-blind Phase|Adverse Event|23|||
23538972|NCT01358526|65705885|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23538973|NCT01358526|65705886|FG001|Double-blind Phase|Withdrawal by Subject|10|||
23538974|NCT01358526|65705887|FG002|Double-blind Phase|Withdrawal by Subject|8|||
23538975|NCT01358526|65705885|FG000|Double-blind Phase|Lost to Follow-up|0|||
23312188|NCT02393248|64886624|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312189|NCT02393248|64886625|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312190|NCT02393248|64886626|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312191|NCT02393248|64886627|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312192|NCT02393248|64886628|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312193|NCT02393248|64886629|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312194|NCT02393248|64886630|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312195|NCT02393248|64886631|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312196|NCT02393248|64886632|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312197|NCT02393248|64886633|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312198|NCT02393248|64886634|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312199|NCT02393248|64886635|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312200|NCT02393248|64886636|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312201|NCT02393248|64886637|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312202|NCT02393248|64886638|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312203|NCT02393248|64886639|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312204|NCT02393248|64886640|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
23312205|NCT02393248|64886641|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
23312206|NCT02393248|64886642|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312207|NCT02393248|64886643|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312208|NCT02393248|64886644|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
23312209|NCT02393248|64886620|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312210|NCT02393248|64886621|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312211|NCT02393248|64886622|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312212|NCT02393248|64886623|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312213|NCT02393248|64886624|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312214|NCT02393248|64886625|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312215|NCT02393248|64886626|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312216|NCT02393248|64886627|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312217|NCT02393248|64886628|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312218|NCT02393248|64886629|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312219|NCT02393248|64886630|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23538976|NCT01358526|65705886|FG001|Double-blind Phase|Lost to Follow-up|4|||
23538977|NCT01358526|65705887|FG002|Double-blind Phase|Lost to Follow-up|1|||
23209389|NCT03730194|64504587|FG005|First Stage Treatment|Withdrawal by Subject|0|||
23209390|NCT03730194|64504582|FG000|First Stage Treatment|Protocol Violation|3|||
23209391|NCT03730194|64504583|FG001|First Stage Treatment|Protocol Violation|3|||
23538978|NCT01358526|65705885|FG000|Double-blind Phase|Lack of Efficacy|0|||
23538979|NCT01358526|65705886|FG001|Double-blind Phase|Lack of Efficacy|31|||
23538980|NCT01358526|65705887|FG002|Double-blind Phase|Lack of Efficacy|73|||
23538981|NCT01358526|65705885|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
23538982|NCT01358526|65705886|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
23209392|NCT03730194|64504584|FG002|First Stage Treatment|Protocol Violation|0|||
23209393|NCT03730194|64504585|FG003|First Stage Treatment|Protocol Violation|0|||
23209394|NCT03730194|64504586|FG004|First Stage Treatment|Protocol Violation|0|||
23538983|NCT01358526|65705887|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
23538984|NCT01358526|65705885|FG000|Double-blind Phase|Administrative|0|||
23538985|NCT01358526|65705886|FG001|Double-blind Phase|Administrative|6|||
23538986|NCT01358526|65705887|FG002|Double-blind Phase|Administrative|10|||
23538987|NCT02480621|65705888|FG000|Randomization|Withdrawal by Subject|1|||
23538988|NCT02480621|65705889|FG001|Randomization|Withdrawal by Subject|0|||
23538989|NCT02480621|65705888|FG000|Randomization|Surgeon did not give intervention|0|||
23538990|NCT02480621|65705889|FG001|Randomization|Surgeon did not give intervention|1|||
23538991|NCT02480621|65705888|FG000|Follow Up|Lost to Follow-up|4|||
23538992|NCT02480621|65705889|FG001|Follow Up|Lost to Follow-up|2|||
23616432|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
23616433|NCT00500539|65982325|FG000|Follow-up Period (16 Weeks)|Missing|3|||
23616434|NCT02475733|65982339|FG000|Overall Study|Withdrawal by Subject|1|||
23616435|NCT02475733|65982340|FG001|Overall Study|Withdrawal by Subject|0|||
23616436|NCT02475733|65982339|FG000|Overall Study|Physician Decision|1|||
23616437|NCT02475733|65982340|FG001|Overall Study|Physician Decision|0|||
23616438|NCT03915951|65982344|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
23616439|NCT03915951|65982345|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
23616440|NCT03915951|65982344|FG000|Overall Study|Adverse Event|12|||
23616441|NCT03915951|65982345|FG001|Overall Study|Adverse Event|6|||
23538993|NCT01307501|65705890|FG000|Overall Study|Treatment Failure|1|||
23538994|NCT01307501|65705890|FG000|Overall Study|Death|20|||
23538995|NCT01307501|65705890|FG000|Overall Study|Lost to Follow-up|1|||
23538996|NCT01307501|65705890|FG000|Overall Study|Starting Hospice|1|||
23538997|NCT03029208|65705891|FG000|Overall Study|Withdrawal by Subject|2|||
23538998|NCT03029208|65705892|FG001|Overall Study|Withdrawal by Subject|3|||
23538999|NCT03029208|65705891|FG000|Overall Study|Lost to Follow-up|0|||
23539000|NCT03029208|65705892|FG001|Overall Study|Lost to Follow-up|1|||
23539001|NCT01047683|65705893|FG000|Overall Study|Adverse Event|3|||
23539002|NCT01047683|65705894|FG001|Overall Study|Adverse Event|1|||
23539003|NCT01047683|65705895|FG002|Overall Study|Adverse Event|0|||
23539004|NCT01047683|65705893|FG000|Overall Study|Withdrew Consent|1|||
23539005|NCT01047683|65705894|FG001|Overall Study|Withdrew Consent|4|||
23539006|NCT01047683|65705895|FG002|Overall Study|Withdrew Consent|2|||
23539007|NCT01047683|65705893|FG000|Overall Study|Lost to Follow-up|0|||
23539008|NCT01047683|65705894|FG001|Overall Study|Lost to Follow-up|1|||
23539009|NCT01047683|65705895|FG002|Overall Study|Lost to Follow-up|0|||
23539010|NCT01047683|65705893|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
23539011|NCT01047683|65705894|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
23539012|NCT01047683|65705895|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
23539013|NCT01343056|65705896|FG000|Overall Study|Lost to Follow-up|7|||
23539014|NCT01343056|65705897|FG001|Overall Study|Lost to Follow-up|5|||
23539015|NCT01343056|65705898|FG002|Overall Study|Lost to Follow-up|3|||
23539016|NCT01343056|65705899|FG003|Overall Study|Lost to Follow-up|9|||
23539017|NCT04808609|65705900|FG000|Overall Study|Lost to Follow-up|0|||
23539018|NCT04808609|65705901|FG001|Overall Study|Lost to Follow-up|2|||
23539019|NCT04808609|65705900|FG000|Overall Study|Administrative Withdrawal|0|||
23539020|NCT04808609|65705901|FG001|Overall Study|Administrative Withdrawal|1|||
23539021|NCT01040130|65705902|FG000|Overall Study|Adverse Event|1|||
23539022|NCT01040130|65705903|FG001|Overall Study|Adverse Event|1|||
23539023|NCT01040130|65705904|FG002|Overall Study|Adverse Event|0|||
23539024|NCT01040130|65705905|FG003|Overall Study|Adverse Event|5|||
23539025|NCT01040130|65705906|FG004|Overall Study|Adverse Event|0|||
23539026|NCT01040130|65705907|FG005|Overall Study|Adverse Event|3|||
23539027|NCT01040130|65705902|FG000|Overall Study|Protocol Violation|0|||
23539028|NCT01040130|65705903|FG001|Overall Study|Protocol Violation|0|||
23539029|NCT01040130|65705904|FG002|Overall Study|Protocol Violation|2|||
23539030|NCT01040130|65705905|FG003|Overall Study|Protocol Violation|0|||
23539031|NCT01040130|65705906|FG004|Overall Study|Protocol Violation|0|||
23539032|NCT01040130|65705907|FG005|Overall Study|Protocol Violation|0|||
23539033|NCT01040130|65705902|FG000|Overall Study|Withdrawal by Subject|0|||
23539034|NCT01040130|65705903|FG001|Overall Study|Withdrawal by Subject|2|||
23539035|NCT01040130|65705904|FG002|Overall Study|Withdrawal by Subject|0|||
23539036|NCT01040130|65705905|FG003|Overall Study|Withdrawal by Subject|0|||
23539037|NCT01040130|65705906|FG004|Overall Study|Withdrawal by Subject|0|||
23539038|NCT01040130|65705907|FG005|Overall Study|Withdrawal by Subject|1|||
23539039|NCT01040130|65705902|FG000|Overall Study|Other reasons not listed above|2|||
23539040|NCT01040130|65705903|FG001|Overall Study|Other reasons not listed above|0|||
23539041|NCT01040130|65705904|FG002|Overall Study|Other reasons not listed above|0|||
23539042|NCT01040130|65705905|FG003|Overall Study|Other reasons not listed above|0|||
23616442|NCT03915951|65982344|FG000|Overall Study|Disease progression (radiological)|17|||
23539043|NCT01040130|65705906|FG004|Overall Study|Other reasons not listed above|0|||
23539044|NCT01040130|65705907|FG005|Overall Study|Other reasons not listed above|0|||
23539045|NCT02715765|65705908|FG000|Overall Study|Study Termination|3|||
23539046|NCT02715765|65705909|FG001|Overall Study|Study Termination|0|||
23539047|NCT02715765|65705910|FG002|Overall Study|Study Termination|0|||
23539048|NCT03755765|65705911|FG000|Overall Study|Withdrawal by Subject|2|||
23539049|NCT03755765|65705912|FG001|Overall Study|Withdrawal by Subject|4|||
23539050|NCT03755765|65705913|FG002|Overall Study|Withdrawal by Subject|4|||
23539051|NCT01692197|65705924|FG000|Overall Study|Failed Screening|3|||
23539052|NCT02606136|65705925|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
23539053|NCT02606136|65705925|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
23539054|NCT02606136|65705925|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
23539055|NCT02606136|65705925|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
23539056|NCT03156023|65705926|FG000|Overall Study|Withdrawal by Subject|1|||
23539057|NCT03156023|65705927|FG001|Overall Study|Withdrawal by Subject|0|||
23539058|NCT03156023|65705928|FG002|Overall Study|Withdrawal by Subject|2|||
23539059|NCT03156023|65705929|FG003|Overall Study|Withdrawal by Subject|1|||
23539060|NCT03156023|65705930|FG004|Overall Study|Withdrawal by Subject|1|||
23539061|NCT03156023|65705926|FG000|Overall Study|Lost to Follow-up|0|||
23539062|NCT03156023|65705927|FG001|Overall Study|Lost to Follow-up|0|||
23539063|NCT03156023|65705928|FG002|Overall Study|Lost to Follow-up|0|||
23539064|NCT03156023|65705929|FG003|Overall Study|Lost to Follow-up|0|||
23539065|NCT03156023|65705930|FG004|Overall Study|Lost to Follow-up|1|||
23539066|NCT01898195|65705931|FG000|Smoking Abstinence|Did not have good measurements|35|||
23539067|NCT01898195|65705932|FG001|Smoking Abstinence|Did not have good measurements|38|||
23539068|NCT01898195|65705933|FG002|Smoking Abstinence|Did not have good measurements|36|||
23539069|NCT00023452|65705936|FG000|Overall Study|Ineligible for Study|163|||
23539070|NCT00023452|65705937|FG001|Overall Study|Ineligible for Study|159|||
23539071|NCT00023452|65705936|FG000|Overall Study|Out of Window|129|||
23539072|NCT00023452|65705937|FG001|Overall Study|Out of Window|69|||
23539073|NCT00023452|65705936|FG000|Overall Study|Death|2|||
23539074|NCT00023452|65705937|FG001|Overall Study|Death|0|||
23539075|NCT00023452|65705936|FG000|Overall Study|Withdrawal by Subject|66|||
23539076|NCT00023452|65705937|FG001|Overall Study|Withdrawal by Subject|54|||
23539077|NCT00023452|65705936|FG000|Overall Study|Adverse Event|139|||
23539078|NCT00023452|65705937|FG001|Overall Study|Adverse Event|196|||
23539079|NCT00023452|65705936|FG000|Overall Study|Lost to Follow-up|293|||
23539080|NCT00023452|65705937|FG001|Overall Study|Lost to Follow-up|60|||
23539081|NCT00023452|65705936|FG000|Overall Study|Physician Decision|49|||
23539082|NCT00023452|65705937|FG001|Overall Study|Physician Decision|21|||
23539083|NCT00023452|65705936|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
23539084|NCT00023452|65705937|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
23539085|NCT00023452|65705936|FG000|Overall Study|Pregnant|53|||
23539086|NCT00023452|65705937|FG001|Overall Study|Pregnant|20|||
23539087|NCT00023452|65705936|FG000|Overall Study|Other|204|||
23539088|NCT00023452|65705937|FG001|Overall Study|Other|69|||
23539089|NCT00642304|65705938|FG000|Overall Study|Adverse Event|1|||
23539090|NCT00642304|65705938|FG000|Overall Study|Death|1|||
23539091|NCT00642304|65705938|FG000|Overall Study|Blood transfusion|2|||
23539092|NCT00642304|65705938|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
23539093|NCT00642304|65705938|FG000|Overall Study|Transplantation|1|||
23539094|NCT02120924|65705941|FG000|Overall Study|Lack of Efficacy|1|||
23539095|NCT02120924|65705942|FG001|Overall Study|Lack of Efficacy|2|||
23539096|NCT02120924|65705943|FG002|Overall Study|Lack of Efficacy|3|||
23539097|NCT02120924|65705941|FG000|Overall Study|Adverse Event|0|||
23539098|NCT02120924|65705942|FG001|Overall Study|Adverse Event|1|||
23539099|NCT02120924|65705943|FG002|Overall Study|Adverse Event|3|||
23539100|NCT02120924|65705941|FG000|Overall Study|Withdrawal by Subject|16|||
23539101|NCT02120924|65705942|FG001|Overall Study|Withdrawal by Subject|20|||
23539102|NCT02120924|65705943|FG002|Overall Study|Withdrawal by Subject|8|||
23539103|NCT02120924|65705941|FG000|Overall Study|Lost to Follow-up|14|||
23539104|NCT02120924|65705942|FG001|Overall Study|Lost to Follow-up|14|||
23539105|NCT02120924|65705943|FG002|Overall Study|Lost to Follow-up|11|||
23539106|NCT02120924|65705941|FG000|Overall Study|Pregnancy|2|||
23539107|NCT02120924|65705942|FG001|Overall Study|Pregnancy|0|||
23539108|NCT02120924|65705943|FG002|Overall Study|Pregnancy|0|||
23539109|NCT02120924|65705941|FG000|Overall Study|Protocol Violation|3|||
23539110|NCT02120924|65705942|FG001|Overall Study|Protocol Violation|7|||
23539111|NCT02120924|65705943|FG002|Overall Study|Protocol Violation|2|||
23616443|NCT03915951|65982345|FG001|Overall Study|Disease progression (radiological)|15|||
23539112|NCT02120924|65705941|FG000|Overall Study|Physician Decision|0|||
23539113|NCT02120924|65705942|FG001|Overall Study|Physician Decision|1|||
23209395|NCT03730194|64504587|FG005|First Stage Treatment|Protocol Violation|0|||
23539114|NCT02120924|65705943|FG002|Overall Study|Physician Decision|1|||
23539115|NCT02120924|65705941|FG000|Overall Study|Death|1|||
23539116|NCT02120924|65705942|FG001|Overall Study|Death|0|||
23539117|NCT02120924|65705943|FG002|Overall Study|Death|0|||
23209396|NCT00349752|64504588|FG000|Overall Study|Adverse Event|8|||
23539118|NCT02120924|65705941|FG000|Overall Study|Compliance with IP|5|||
23539119|NCT02120924|65705942|FG001|Overall Study|Compliance with IP|1|||
23539120|NCT02120924|65705943|FG002|Overall Study|Compliance with IP|1|||
23539121|NCT00634647|65705944|FG000|Overall Study|death on study|3|||
23539122|NCT00634647|65705944|FG000|Overall Study|refused further treatment|3|||
23539123|NCT00634647|65705944|FG000|Overall Study|declined to participate before treatment|1|||
23539124|NCT01274637|65705945|FG000|Overall Study|Withdrawal by Subject|0|||
23539125|NCT01274637|65705946|FG001|Overall Study|Withdrawal by Subject|1|||
23539126|NCT01274637|65705945|FG000|Overall Study|Lost to Follow-up|0|||
23539127|NCT01274637|65705946|FG001|Overall Study|Lost to Follow-up|1|||
23539128|NCT00653224|65705949|FG000|Overall Study|Adverse Event|2|||
23539129|NCT00653224|65705950|FG001|Overall Study|Adverse Event|1|||
23539130|NCT00653224|65705949|FG000|Overall Study|Lack of Efficacy|1|||
23539131|NCT00653224|65705950|FG001|Overall Study|Lack of Efficacy|2|||
23539132|NCT00653224|65705949|FG000|Overall Study|Loss of efficacy|1|||
23539133|NCT00653224|65705950|FG001|Overall Study|Loss of efficacy|0|||
23539134|NCT00653224|65705949|FG000|Overall Study|Lost to Follow-up|1|||
23539135|NCT00653224|65705950|FG001|Overall Study|Lost to Follow-up|0|||
23539136|NCT00653224|65705949|FG000|Overall Study|Other|2|||
23539137|NCT00653224|65705950|FG001|Overall Study|Other|4|||
23539138|NCT04574362|65705951|FG000|Overall Study|Other|0|||
23209397|NCT00349752|64504589|FG001|Overall Study|Adverse Event|12|||
23209398|NCT00349752|64504588|FG000|Overall Study|Lack of Efficacy|37|||
23209399|NCT00349752|64504589|FG001|Overall Study|Lack of Efficacy|42|||
23209400|NCT00349752|64504588|FG000|Overall Study|Lost to Follow-up|4|||
23209401|NCT00349752|64504589|FG001|Overall Study|Lost to Follow-up|2|||
23209402|NCT00349752|64504588|FG000|Overall Study|Personal reasons|6|||
23209403|NCT00349752|64504589|FG001|Overall Study|Personal reasons|5|||
23209404|NCT00349752|64504588|FG000|Overall Study|Other: Required exclusionary medication|0|||
23209405|NCT00349752|64504589|FG001|Overall Study|Other: Required exclusionary medication|1|||
23209406|NCT00349752|64504588|FG000|Overall Study|Other: Non compliance|0|||
23539139|NCT04574362|65705952|FG001|Overall Study|Other|5|||
23539140|NCT04574362|65705951|FG000|Overall Study|COVID-19|0|||
23539141|NCT04574362|65705952|FG001|Overall Study|COVID-19|1|||
23539142|NCT04574362|65705951|FG000|Overall Study|Adverse Event|1|||
23539143|NCT04574362|65705952|FG001|Overall Study|Adverse Event|1|||
23209407|NCT00349752|64504589|FG001|Overall Study|Other: Non compliance|1|||
23209408|NCT00349752|64504588|FG000|Overall Study|Other: Patient stopped steroids|0|||
23209409|NCT00349752|64504589|FG001|Overall Study|Other: Patient stopped steroids|1|||
23539144|NCT04574362|65705951|FG000|Overall Study|Withdrawal by Subject|2|||
23539145|NCT04574362|65705952|FG001|Overall Study|Withdrawal by Subject|4|||
23312220|NCT02393248|64886631|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312221|NCT02393248|64886632|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312222|NCT02393248|64886633|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312223|NCT02393248|64886634|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312224|NCT02393248|64886635|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312225|NCT02393248|64886636|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312226|NCT02393248|64886637|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312227|NCT02393248|64886638|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312228|NCT02393248|64886639|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312229|NCT02393248|64886640|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
23312230|NCT02393248|64886641|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312231|NCT02393248|64886642|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312232|NCT02393248|64886643|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312233|NCT02393248|64886644|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
23312234|NCT02393248|64886620|FG000|Part 3: Combination Therapy|Adverse Event|0|||
23312235|NCT02393248|64886621|FG001|Part 3: Combination Therapy|Adverse Event|0|||
23312236|NCT02393248|64886622|FG002|Part 3: Combination Therapy|Adverse Event|0|||
23312237|NCT02393248|64886623|FG003|Part 3: Combination Therapy|Adverse Event|0|||
23312238|NCT02393248|64886624|FG004|Part 3: Combination Therapy|Adverse Event|0|||
23312239|NCT02393248|64886625|FG005|Part 3: Combination Therapy|Adverse Event|0|||
23312240|NCT02393248|64886626|FG006|Part 3: Combination Therapy|Adverse Event|0|||
23312241|NCT02393248|64886627|FG007|Part 3: Combination Therapy|Adverse Event|0|||
23312242|NCT02393248|64886628|FG008|Part 3: Combination Therapy|Adverse Event|0|||
23312243|NCT02393248|64886629|FG009|Part 3: Combination Therapy|Adverse Event|0|||
23312244|NCT02393248|64886630|FG010|Part 3: Combination Therapy|Adverse Event|0|||
23312245|NCT02393248|64886631|FG011|Part 3: Combination Therapy|Adverse Event|0|||
23312246|NCT02393248|64886632|FG012|Part 3: Combination Therapy|Adverse Event|0|||
23312247|NCT02393248|64886633|FG013|Part 3: Combination Therapy|Adverse Event|0|||
23312248|NCT02393248|64886634|FG014|Part 3: Combination Therapy|Adverse Event|0|||
23312249|NCT02393248|64886635|FG015|Part 3: Combination Therapy|Adverse Event|0|||
23312250|NCT02393248|64886636|FG016|Part 3: Combination Therapy|Adverse Event|0|||
23312251|NCT02393248|64886637|FG017|Part 3: Combination Therapy|Adverse Event|0|||
23312252|NCT02393248|64886638|FG018|Part 3: Combination Therapy|Adverse Event|0|||
23312253|NCT02393248|64886639|FG019|Part 3: Combination Therapy|Adverse Event|0|||
23312254|NCT02393248|64886640|FG020|Part 3: Combination Therapy|Adverse Event|0|||
23312255|NCT02393248|64886641|FG021|Part 3: Combination Therapy|Adverse Event|0|||
23312256|NCT02393248|64886642|FG022|Part 3: Combination Therapy|Adverse Event|0|||
23312257|NCT02393248|64886643|FG023|Part 3: Combination Therapy|Adverse Event|1|||
23312258|NCT02393248|64886644|FG024|Part 3: Combination Therapy|Adverse Event|0|||
23312259|NCT02393248|64886620|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312260|NCT02393248|64886621|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312261|NCT02393248|64886622|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312262|NCT02393248|64886623|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312263|NCT02393248|64886624|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312264|NCT02393248|64886625|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312265|NCT02393248|64886626|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312266|NCT02393248|64886627|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312267|NCT02393248|64886628|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312268|NCT02393248|64886629|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312269|NCT02393248|64886630|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23209410|NCT00349752|64504588|FG000|Overall Study|Other: Patient's steroid use|1|||
23209411|NCT00349752|64504589|FG001|Overall Study|Other: Patient's steroid use|0|||
23209412|NCT00349752|64504588|FG000|Overall Study|Other: Ineligible|1|||
23209413|NCT00349752|64504589|FG001|Overall Study|Other: Ineligible|0|||
23209414|NCT00349752|64504588|FG000|Overall Study|Other: Inadvertently unblinded|1|||
23209415|NCT00349752|64504589|FG001|Overall Study|Other: Inadvertently unblinded|0|||
23209416|NCT00349752|64504588|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
23209417|NCT00349752|64504589|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
23209418|NCT02785952|64504590|FG000|Overall Study|Adverse Event|31|||
23209419|NCT02785952|64504591|FG001|Overall Study|Adverse Event|19|||
23209420|NCT02785952|64504590|FG000|Overall Study|Refusal unrelated to adverse events|10|||
23209421|NCT02785952|64504591|FG001|Overall Study|Refusal unrelated to adverse events|5|||
23209422|NCT02785952|64504590|FG000|Overall Study|Disease progression/relapse|61|||
23539146|NCT04574362|65705951|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
23539147|NCT04574362|65705952|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
23539148|NCT04574362|65705951|FG000|Overall Study|Participant refused to come to the hospital|1|||
23539149|NCT04574362|65705952|FG001|Overall Study|Participant refused to come to the hospital|0|||
23539150|NCT04574362|65705951|FG000|Overall Study|Participant refused the visit|1|||
23539151|NCT04574362|65705952|FG001|Overall Study|Participant refused the visit|0|||
23209423|NCT02785952|64504591|FG001|Overall Study|Disease progression/relapse|89|||
23209424|NCT02785952|64504590|FG000|Overall Study|Death|11|||
23209425|NCT02785952|64504591|FG001|Overall Study|Death|7|||
23209426|NCT02785952|64504590|FG000|Overall Study|Other- not protocol specified|6|||
23312270|NCT02393248|64886631|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23539152|NCT04574362|65705951|FG000|Overall Study|Participant quit early because of business trip|1|||
23539153|NCT04574362|65705952|FG001|Overall Study|Participant quit early because of business trip|0|||
23539154|NCT01962974|65705953|FG000|Overall Study|Study termination|7|||
23539155|NCT00961259|65705954|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
23539156|NCT00961259|65705955|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
23539157|NCT00961259|65705956|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
23539158|NCT00093145|65705957|FG000|Overall Study|Unacceptable Toxicity Only|2|||
23539159|NCT00093145|65705957|FG000|Overall Study|Physician Decision|5|||
23539160|NCT00093145|65705957|FG000|Overall Study|Withdrawal by Subject|9|||
23539161|NCT00093145|65705957|FG000|Overall Study|Other|1|||
23539162|NCT03634579|65705964|FG000|Overall Study|study termination|9|||
23539163|NCT01038921|65705965|FG000|Overall Study|Withdrawal by Subject|1|||
23539164|NCT01038921|65705966|FG001|Overall Study|Withdrawal by Subject|0|||
23539165|NCT01038921|65705965|FG000|Overall Study|Physician Decision|1|||
23539166|NCT01038921|65705966|FG001|Overall Study|Physician Decision|0|||
23539167|NCT00439140|65705971|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
23539168|NCT00439140|65705972|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
23312271|NCT02393248|64886632|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23539169|NCT00439140|65705973|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
23209427|NCT02785952|64504591|FG001|Overall Study|Other- not protocol specified|4|||
23209428|NCT02785952|64504590|FG000|Overall Study|On protocol treatment|6|||
23209429|NCT02785952|64504591|FG001|Overall Study|On protocol treatment|3|||
23539170|NCT00439140|65705971|FG000|Treatment Cycle 1|Personal reasons|0|||
23539171|NCT00439140|65705972|FG001|Treatment Cycle 1|Personal reasons|2|||
23539172|NCT00439140|65705973|FG002|Treatment Cycle 1|Personal reasons|0|||
23539173|NCT00439140|65705971|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
23539174|NCT00439140|65705972|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
23539175|NCT00439140|65705973|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
23539176|NCT00439140|65705971|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
23539177|NCT00439140|65705972|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
23539178|NCT00439140|65705973|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
23539179|NCT00439140|65705971|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
23539180|NCT00439140|65705972|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
23539181|NCT00439140|65705973|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
23539182|NCT03732248|65705979|FG000|Overall Study|Withdrawal by Subject|1|||
23539183|NCT03732248|65705980|FG001|Overall Study|Withdrawal by Subject|0|||
23539184|NCT05101252|65705981|FG000|Overall Study|Unsatisfactory Test Article|1|||
23539185|NCT05101252|65705982|FG001|Overall Study|Unsatisfactory Test Article|0|||
23539186|NCT05101252|65705981|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
23539187|NCT05101252|65705982|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
23539188|NCT05101252|65705981|FG000|Overall Study|Withdrew Consent during study|0|||
23539189|NCT05101252|65705982|FG001|Overall Study|Withdrew Consent during study|1|||
23539190|NCT05101252|65705981|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
23539191|NCT05101252|65705982|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
23539192|NCT00975975|65705983|FG000|Overall Study|Death|6|||
23539193|NCT03738150|65705986|FG000|Base Study|Withdrawal by Subject|1|||
23539194|NCT03738150|65705986|FG000|Extension Study|Withdrawal by Subject|1|||
23539195|NCT04193202|65705987|FG000|Overall Study|Adverse Event|2|||
23539196|NCT04193202|65705988|FG001|Overall Study|Adverse Event|1|||
23539197|NCT04193202|65705987|FG000|Overall Study|Death|0|||
23539198|NCT04193202|65705988|FG001|Overall Study|Death|1|||
23539199|NCT04193202|65705987|FG000|Overall Study|Physician Decision|1|||
23539200|NCT04193202|65705988|FG001|Overall Study|Physician Decision|1|||
23209430|NCT00259740|64504594|FG000|Overall Study|Physician Decision|1|||
23209431|NCT00259740|64504595|FG001|Overall Study|Physician Decision|1|||
23209432|NCT00259740|64504594|FG000|Overall Study|Adverse Event|0|||
23209433|NCT00259740|64504595|FG001|Overall Study|Adverse Event|2|||
23539201|NCT04193202|65705987|FG000|Overall Study|Protocol Violation|2|||
23539202|NCT04193202|65705988|FG001|Overall Study|Protocol Violation|2|||
23539203|NCT04193202|65705987|FG000|Overall Study|Withdrawal by Subject|11|||
23539204|NCT04193202|65705988|FG001|Overall Study|Withdrawal by Subject|5|||
23539205|NCT02809976|65705989|FG000|Overall Study|Lost to Follow-up|1|||
23209434|NCT00259740|64504594|FG000|Overall Study|Withdrawal by Subject|2|||
23209435|NCT00259740|64504595|FG001|Overall Study|Withdrawal by Subject|6|||
23209436|NCT00259740|64504594|FG000|Overall Study|Death|1|||
23209437|NCT00259740|64504595|FG001|Overall Study|Death|1|||
23209438|NCT00259740|64504594|FG000|Overall Study|Disease progression|19|||
23209439|NCT00259740|64504595|FG001|Overall Study|Disease progression|36|||
23539206|NCT02809976|65705989|FG000|Overall Study|Withdrawal by Subject|1|||
23539207|NCT00812812|65705990|FG000|Overall Study|Adverse Event|2|||
23539208|NCT00812812|65705991|FG001|Overall Study|Adverse Event|1|||
23539209|NCT00812812|65705990|FG000|Overall Study|Lack of Efficacy|1|||
23539210|NCT00812812|65705991|FG001|Overall Study|Lack of Efficacy|0|||
23539211|NCT00812812|65705990|FG000|Overall Study|Lost to Follow-up|0|||
23539212|NCT00812812|65705991|FG001|Overall Study|Lost to Follow-up|1|||
23209440|NCT00259740|64504594|FG000|Overall Study|Ongoing|17|||
23209441|NCT00259740|64504595|FG001|Overall Study|Ongoing|3|||
23539213|NCT00812812|65705990|FG000|Overall Study|Withdrawal by Subject|0|||
23539214|NCT00812812|65705991|FG001|Overall Study|Withdrawal by Subject|2|||
23539215|NCT01854554|65705999|FG000|Overall Study|Denial of Insurance Coverage|12|||
23539216|NCT01854554|65706000|FG001|Overall Study|Denial of Insurance Coverage|0|||
23539217|NCT01854554|65705999|FG000|Overall Study|Decided to get treatment locally|1|||
23539218|NCT01854554|65706000|FG001|Overall Study|Decided to get treatment locally|5|||
23539219|NCT01854554|65705999|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
23539220|NCT01854554|65706000|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
23539221|NCT01854554|65705999|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
23539222|NCT01854554|65706000|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
23539223|NCT01854554|65705999|FG000|Overall Study|Progression|0|||
23539224|NCT01854554|65706000|FG001|Overall Study|Progression|1|||
23209442|NCT00259740|64504594|FG000|Overall Study|Other|3|||
23209443|NCT00259740|64504595|FG001|Overall Study|Other|0|||
23209444|NCT00259740|64504594|FG000|Overall Study|Requirement for alternative therapy|0|||
23209445|NCT00259740|64504595|FG001|Overall Study|Requirement for alternative therapy|4|||
23209446|NCT01009983|64504597|FG000|Overall Study|necessary scans not completed|1|||
23209447|NCT01956240|64504598|FG000|Overall Study|Lost to Follow-up|6|||
23209448|NCT01956240|64504599|FG001|Overall Study|Lost to Follow-up|20|||
23209449|NCT01956240|64504598|FG000|Overall Study|Adverse Event|17|||
23209450|NCT01956240|64504599|FG001|Overall Study|Adverse Event|4|||
23209451|NCT00229203|64504600|FG000|Overall Study|Progressive disease|18|||
23209452|NCT00229203|64504601|FG001|Overall Study|Progressive disease|9|||
23209453|NCT00229203|64504600|FG000|Overall Study|Toxicity|6|||
23209454|NCT00229203|64504601|FG001|Overall Study|Toxicity|1|||
23209455|NCT00229203|64504600|FG000|Overall Study|Death|4|||
23209456|NCT00229203|64504601|FG001|Overall Study|Death|2|||
23209457|NCT00229203|64504600|FG000|Overall Study|Other|3|||
23209458|NCT00229203|64504601|FG001|Overall Study|Other|3|||
23209459|NCT00229203|64504600|FG000|Overall Study|Withdrawal by Subject|1|||
23209460|NCT00229203|64504601|FG001|Overall Study|Withdrawal by Subject|4|||
23209461|NCT04543955|64504602|FG000|Overall Study|Company cancelled study|1|||
23209462|NCT04543955|64504603|FG001|Overall Study|Company cancelled study|0|||
23209463|NCT01195831|64504606|FG000|Overall Study|Lost to Follow-up|2|||
23209464|NCT01195831|64504607|FG001|Overall Study|Lost to Follow-up|4|||
23209465|NCT01195831|64504606|FG000|Overall Study|Withdrawal by Subject|2|||
23209466|NCT01195831|64504607|FG001|Overall Study|Withdrawal by Subject|2|||
23209467|NCT01195831|64504606|FG000|Overall Study|Adverse Event|4|||
23209468|NCT01195831|64504607|FG001|Overall Study|Adverse Event|2|||
23209469|NCT01195831|64504606|FG000|Overall Study|Protocol Violation|0|||
23209470|NCT01195831|64504607|FG001|Overall Study|Protocol Violation|2|||
23209471|NCT00667251|64504608|FG000|Overall Study|Adverse Event|13|||
23209472|NCT00667251|64504609|FG001|Overall Study|Adverse Event|4|||
23209473|NCT00667251|64504608|FG000|Overall Study|Withdrawal by Subject|6|||
23209474|NCT00667251|64504609|FG001|Overall Study|Withdrawal by Subject|2|||
23209475|NCT00667251|64504608|FG000|Overall Study|Other/missing|46|||
23209476|NCT00667251|64504609|FG001|Overall Study|Other/missing|84|||
23209477|NCT00667251|64504608|FG000|Overall Study|Intercurrent Illness|4|||
23209478|NCT00667251|64504609|FG001|Overall Study|Intercurrent Illness|3|||
23209479|NCT00667251|64504608|FG000|Overall Study|Symptomatic progression|1|||
23209480|NCT00667251|64504609|FG001|Overall Study|Symptomatic progression|2|||
23209481|NCT00434122|64504610|FG000|Overall Study|Non-compliance with protocol|0|||
23209482|NCT00434122|64504611|FG001|Overall Study|Non-compliance with protocol|1|||
23209483|NCT00434122|64504610|FG000|Overall Study|loss of subject contact|1|||
23209484|NCT00434122|64504611|FG001|Overall Study|loss of subject contact|1|||
23209485|NCT00434122|64504610|FG000|Overall Study|Personal reasons|1|||
23312272|NCT02393248|64886633|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23539225|NCT01854554|65705999|FG000|Overall Study|Lost to Follow-up|0|||
23209486|NCT00434122|64504611|FG001|Overall Study|Personal reasons|1|||
23209487|NCT00434122|64504610|FG000|Overall Study|Large follicle size|2|||
23209488|NCT00434122|64504611|FG001|Overall Study|Large follicle size|2|||
23209489|NCT00434122|64504610|FG000|Overall Study|Low follicular response.|1|||
23209490|NCT00434122|64504611|FG001|Overall Study|Low follicular response.|2|||
23209491|NCT00434122|64504610|FG000|Overall Study|Travelling of subject.|1|||
23209492|NCT00434122|64504611|FG001|Overall Study|Travelling of subject.|0|||
23209493|NCT01309841|64504614|FG000|Overall Study|Other|0|||
23209494|NCT01309841|64504615|FG001|Overall Study|Other|1|||
23209495|NCT01309841|64504616|FG002|Overall Study|Other|1|||
23209496|NCT01309841|64504614|FG000|Overall Study|Lost to Follow-up|7|||
23209497|NCT01309841|64504615|FG001|Overall Study|Lost to Follow-up|6|||
23209498|NCT01309841|64504616|FG002|Overall Study|Lost to Follow-up|4|||
23209499|NCT01309841|64504614|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
23209500|NCT01309841|64504615|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
23209501|NCT01309841|64504616|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
23209502|NCT01309841|64504614|FG000|Overall Study|Lack of Efficacy|0|||
23209503|NCT01309841|64504615|FG001|Overall Study|Lack of Efficacy|0|||
23209504|NCT01309841|64504616|FG002|Overall Study|Lack of Efficacy|2|||
23209505|NCT01309841|64504614|FG000|Overall Study|Adverse Event|9|||
23209506|NCT01309841|64504615|FG001|Overall Study|Adverse Event|22|||
23209507|NCT01309841|64504616|FG002|Overall Study|Adverse Event|11|||
23209508|NCT01309841|64504614|FG000|Overall Study|Death|1|||
23209509|NCT01309841|64504615|FG001|Overall Study|Death|0|||
23209510|NCT01309841|64504616|FG002|Overall Study|Death|0|||
23209511|NCT01309841|64504614|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23209512|NCT01309841|64504615|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23209513|NCT01309841|64504616|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
23209514|NCT01309841|64504614|FG000|Overall Study|Withdrawal by Subject|17|||
23209515|NCT01309841|64504615|FG001|Overall Study|Withdrawal by Subject|6|||
23209516|NCT01309841|64504616|FG002|Overall Study|Withdrawal by Subject|13|||
23209517|NCT01309841|64504614|FG000|Overall Study|Did Not Receive Treatment|2|||
23209518|NCT01309841|64504615|FG001|Overall Study|Did Not Receive Treatment|0|||
23209519|NCT01309841|64504616|FG002|Overall Study|Did Not Receive Treatment|1|||
23209520|NCT01309841|64504614|FG000|Overall Study|Severe non-compliance with protocol|0|||
23209521|NCT01309841|64504615|FG001|Overall Study|Severe non-compliance with protocol|5|||
23209522|NCT01309841|64504616|FG002|Overall Study|Severe non-compliance with protocol|2|||
23209523|NCT02648724|64504617|FG000|Overall Study|Withdrawal by Subject|0|||
23209524|NCT02648724|64504618|FG001|Overall Study|Withdrawal by Subject|1|||
23209525|NCT02648724|64504619|FG002|Overall Study|Withdrawal by Subject|1|||
23209526|NCT02648724|64504620|FG003|Overall Study|Withdrawal by Subject|0|||
23209527|NCT02648724|64504621|FG004|Overall Study|Withdrawal by Subject|1|||
23209528|NCT02648724|64504622|FG005|Overall Study|Withdrawal by Subject|0|||
23209529|NCT02648724|64504623|FG006|Overall Study|Withdrawal by Subject|0|||
23209530|NCT02648724|64504617|FG000|Overall Study|Progressive disease|2|||
23209531|NCT02648724|64504618|FG001|Overall Study|Progressive disease|2|||
23209532|NCT02648724|64504619|FG002|Overall Study|Progressive disease|2|||
23209533|NCT02648724|64504620|FG003|Overall Study|Progressive disease|3|||
23209534|NCT02648724|64504621|FG004|Overall Study|Progressive disease|22|||
23209535|NCT02648724|64504622|FG005|Overall Study|Progressive disease|7|||
23209536|NCT02648724|64504623|FG006|Overall Study|Progressive disease|8|||
23209537|NCT02648724|64504617|FG000|Overall Study|Other reason (unknown)|1|||
23209538|NCT02648724|64504618|FG001|Overall Study|Other reason (unknown)|0|||
23209539|NCT02648724|64504619|FG002|Overall Study|Other reason (unknown)|0|||
23209540|NCT02648724|64504620|FG003|Overall Study|Other reason (unknown)|0|||
23209541|NCT02648724|64504621|FG004|Overall Study|Other reason (unknown)|0|||
23209542|NCT02648724|64504622|FG005|Overall Study|Other reason (unknown)|0|||
23209543|NCT02648724|64504623|FG006|Overall Study|Other reason (unknown)|0|||
23209544|NCT02648724|64504617|FG000|Overall Study|Protocol Violation|0|||
23209545|NCT02648724|64504618|FG001|Overall Study|Protocol Violation|0|||
23209546|NCT02648724|64504619|FG002|Overall Study|Protocol Violation|0|||
23209547|NCT02648724|64504620|FG003|Overall Study|Protocol Violation|0|||
23209548|NCT02648724|64504621|FG004|Overall Study|Protocol Violation|1|||
23209549|NCT02648724|64504622|FG005|Overall Study|Protocol Violation|0|||
23209550|NCT02648724|64504623|FG006|Overall Study|Protocol Violation|0|||
23209551|NCT02648724|64504617|FG000|Overall Study|Death|0|||
23209552|NCT02648724|64504618|FG001|Overall Study|Death|0|||
23209553|NCT02648724|64504619|FG002|Overall Study|Death|0|||
23209554|NCT02648724|64504620|FG003|Overall Study|Death|0|||
23209555|NCT02648724|64504621|FG004|Overall Study|Death|0|||
23209556|NCT02648724|64504622|FG005|Overall Study|Death|0|||
23209557|NCT02648724|64504623|FG006|Overall Study|Death|3|||
23209558|NCT02648724|64504617|FG000|Overall Study|Physician Decision|0|||
23209559|NCT02648724|64504618|FG001|Overall Study|Physician Decision|0|||
23209560|NCT02648724|64504619|FG002|Overall Study|Physician Decision|0|||
23209561|NCT02648724|64504620|FG003|Overall Study|Physician Decision|0|||
23209562|NCT02648724|64504621|FG004|Overall Study|Physician Decision|1|||
23209563|NCT02648724|64504622|FG005|Overall Study|Physician Decision|0|||
23209564|NCT02648724|64504623|FG006|Overall Study|Physician Decision|1|||
23209565|NCT02648724|64504617|FG000|Overall Study|Transferred to named patient program|0|||
23209566|NCT02648724|64504618|FG001|Overall Study|Transferred to named patient program|0|||
23209567|NCT02648724|64504619|FG002|Overall Study|Transferred to named patient program|0|||
23209568|NCT02648724|64504620|FG003|Overall Study|Transferred to named patient program|0|||
23539226|NCT01854554|65706000|FG001|Overall Study|Lost to Follow-up|1|||
23539227|NCT03217136|65706001|FG000|Overall Study|Lost to Follow-up|2|||
23539228|NCT03217136|65706002|FG001|Overall Study|Lost to Follow-up|1|||
23209569|NCT02648724|64504621|FG004|Overall Study|Transferred to named patient program|0|||
23209570|NCT02648724|64504622|FG005|Overall Study|Transferred to named patient program|1|||
23209571|NCT02648724|64504623|FG006|Overall Study|Transferred to named patient program|0|||
23209572|NCT03954444|64504629|FG000|Overall Study|Withdrawal by Subject|5|||
23209573|NCT03954444|64504630|FG001|Overall Study|Withdrawal by Subject|5|||
23209574|NCT03954444|64504631|FG002|Overall Study|Withdrawal by Subject|5|||
23209575|NCT03954444|64504629|FG000|Overall Study|Adverse Event|1|||
23209576|NCT03954444|64504630|FG001|Overall Study|Adverse Event|3|||
23209577|NCT03954444|64504631|FG002|Overall Study|Adverse Event|2|||
23209578|NCT03954444|64504629|FG000|Overall Study|Protocol Violation|0|||
23209579|NCT03954444|64504630|FG001|Overall Study|Protocol Violation|3|||
23209580|NCT03954444|64504631|FG002|Overall Study|Protocol Violation|5|||
23209581|NCT03954444|64504629|FG000|Overall Study|Use of prohibited therapy|1|||
23539229|NCT03217136|65706001|FG000|Overall Study|Site Randomized Participant in Error|0|||
23539230|NCT03217136|65706002|FG001|Overall Study|Site Randomized Participant in Error|1|||
23539231|NCT03217136|65706001|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
23616444|NCT03915951|65982344|FG000|Overall Study|Disease progression (clinical)|4|||
23616445|NCT03915951|65982345|FG001|Overall Study|Disease progression (clinical)|1|||
23209582|NCT03954444|64504630|FG001|Overall Study|Use of prohibited therapy|1|||
23539232|NCT03217136|65706002|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
23539233|NCT03217136|65706001|FG000|Overall Study|Dispensing Error|1|||
23539234|NCT03217136|65706002|FG001|Overall Study|Dispensing Error|0|||
23539235|NCT03217136|65706001|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23209583|NCT03954444|64504631|FG002|Overall Study|Use of prohibited therapy|2|||
23539236|NCT03217136|65706002|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23539237|NCT01459796|65706003|FG000|Overall Study|Non compliance with protocol|2|||
23616446|NCT03915951|65982344|FG000|Overall Study|Patient decision|0|||
23209584|NCT03954444|64504629|FG000|Overall Study|Lost to Follow-up|1|||
23209585|NCT03954444|64504630|FG001|Overall Study|Lost to Follow-up|0|||
23209586|NCT03954444|64504631|FG002|Overall Study|Lost to Follow-up|1|||
23209587|NCT03954444|64504629|FG000|Overall Study|Non-compliant with study drug application|2|||
23209588|NCT03954444|64504630|FG001|Overall Study|Non-compliant with study drug application|2|||
23209589|NCT03954444|64504631|FG002|Overall Study|Non-compliant with study drug application|0|||
23209590|NCT03954444|64504629|FG000|Overall Study|Administrative reasons|0|||
23209591|NCT03954444|64504630|FG001|Overall Study|Administrative reasons|0|||
23209592|NCT03954444|64504631|FG002|Overall Study|Administrative reasons|1|||
23209593|NCT03954444|64504629|FG000|Overall Study|Miscellaneous|3|||
23209594|NCT03954444|64504630|FG001|Overall Study|Miscellaneous|2|||
23209595|NCT03954444|64504631|FG002|Overall Study|Miscellaneous|1|||
23209596|NCT03543358|64504632|FG000|Overall Study|Death|1|||
23209597|NCT03543358|64504633|FG001|Overall Study|Death|0|||
23209598|NCT03543358|64504632|FG000|Overall Study|Disease Progression|1|||
23209599|NCT03543358|64504633|FG001|Overall Study|Disease Progression|0|||
23209600|NCT03543358|64504632|FG000|Overall Study|Parent Study Closure|1|||
23209601|NCT03543358|64504633|FG001|Overall Study|Parent Study Closure|0|||
23209602|NCT02157506|64504634|FG000|Overall Study|Adverse Event|0|||
23209603|NCT02157506|64504635|FG001|Overall Study|Adverse Event|1|||
23209604|NCT02157506|64504636|FG002|Overall Study|Adverse Event|0|||
23209605|NCT02157506|64504637|FG003|Overall Study|Adverse Event|0|||
23209606|NCT02157506|64504638|FG004|Overall Study|Adverse Event|0|||
23209607|NCT02157506|64504634|FG000|Overall Study|Lost to Follow-up|0|||
23209608|NCT02157506|64504635|FG001|Overall Study|Lost to Follow-up|0|||
23209609|NCT02157506|64504636|FG002|Overall Study|Lost to Follow-up|1|||
23209610|NCT02157506|64504637|FG003|Overall Study|Lost to Follow-up|0|||
23209611|NCT02157506|64504638|FG004|Overall Study|Lost to Follow-up|0|||
23209612|NCT00781599|64504641|FG000|Overall Study|Lost to Follow-up|7|||
23209613|NCT00781599|64504642|FG001|Overall Study|Lost to Follow-up|4|||
23209614|NCT01654523|64504643|FG000|Overall Study|Withdrawal by Subject|1|||
23209615|NCT00973921|64504644|FG000|Overall Study|IVUS results were not available|9|||
23209616|NCT03017846|64504646|FG000|Overall Study|Lost to Follow-up|3|||
23209617|NCT03017846|64504646|FG000|Overall Study|Adverse Event|2|||
23209618|NCT02559206|64504650|FG000|Overall Study|Adverse Event|0|||
23209619|NCT02559206|64504651|FG001|Overall Study|Adverse Event|4|||
23209620|NCT02559206|64504652|FG002|Overall Study|Adverse Event|1|||
23209621|NCT02559206|64504653|FG003|Overall Study|Adverse Event|5|||
23209622|NCT02559206|64504654|FG004|Overall Study|Adverse Event|3|||
23209623|NCT02559206|64504655|FG005|Overall Study|Adverse Event|0|||
23209624|NCT02559206|64504656|FG006|Overall Study|Adverse Event|1|||
23209625|NCT02559206|64504657|FG007|Overall Study|Adverse Event|0|||
23209626|NCT02559206|64504650|FG000|Overall Study|Protocol Violation|1|||
23209627|NCT02559206|64504651|FG001|Overall Study|Protocol Violation|0|||
23209628|NCT02559206|64504652|FG002|Overall Study|Protocol Violation|1|||
23209629|NCT02559206|64504653|FG003|Overall Study|Protocol Violation|0|||
23209630|NCT02559206|64504654|FG004|Overall Study|Protocol Violation|0|||
23209631|NCT02559206|64504655|FG005|Overall Study|Protocol Violation|2|||
23209632|NCT02559206|64504656|FG006|Overall Study|Protocol Violation|0|||
23209633|NCT02559206|64504657|FG007|Overall Study|Protocol Violation|0|||
23209634|NCT02559206|64504650|FG000|Overall Study|Withdrawal by Subject|3|||
23209635|NCT02559206|64504651|FG001|Overall Study|Withdrawal by Subject|3|||
23209636|NCT02559206|64504652|FG002|Overall Study|Withdrawal by Subject|1|||
23209637|NCT02559206|64504653|FG003|Overall Study|Withdrawal by Subject|3|||
23209638|NCT02559206|64504654|FG004|Overall Study|Withdrawal by Subject|5|||
23209639|NCT02559206|64504655|FG005|Overall Study|Withdrawal by Subject|4|||
23209640|NCT02559206|64504656|FG006|Overall Study|Withdrawal by Subject|1|||
23209641|NCT02559206|64504657|FG007|Overall Study|Withdrawal by Subject|2|||
23209642|NCT02559206|64504650|FG000|Overall Study|Lost to Follow-up|3|||
23209643|NCT02559206|64504651|FG001|Overall Study|Lost to Follow-up|5|||
23209644|NCT02559206|64504652|FG002|Overall Study|Lost to Follow-up|3|||
23209645|NCT02559206|64504653|FG003|Overall Study|Lost to Follow-up|3|||
23424153|NCT01643850|65296370|FG000|Overall Study|Administrative Problems|0|||
23209646|NCT02559206|64504654|FG004|Overall Study|Lost to Follow-up|2|||
23209647|NCT02559206|64504655|FG005|Overall Study|Lost to Follow-up|5|||
23209648|NCT02559206|64504656|FG006|Overall Study|Lost to Follow-up|1|||
23209649|NCT02559206|64504657|FG007|Overall Study|Lost to Follow-up|4|||
23209650|NCT02559206|64504650|FG000|Overall Study|Lack of Efficacy|1|||
23209651|NCT02559206|64504651|FG001|Overall Study|Lack of Efficacy|0|||
23424154|NCT01643850|65296371|FG001|Overall Study|Administrative Problems|0|||
23209652|NCT02559206|64504652|FG002|Overall Study|Lack of Efficacy|3|||
23209653|NCT02559206|64504653|FG003|Overall Study|Lack of Efficacy|2|||
23209654|NCT02559206|64504654|FG004|Overall Study|Lack of Efficacy|2|||
23209655|NCT02559206|64504655|FG005|Overall Study|Lack of Efficacy|3|||
23209656|NCT02559206|64504656|FG006|Overall Study|Lack of Efficacy|3|||
23539238|NCT01459796|65706004|FG001|Overall Study|Non compliance with protocol|4|||
23539239|NCT01459796|65706003|FG000|Overall Study|Adverse Event|5|||
23539240|NCT01459796|65706004|FG001|Overall Study|Adverse Event|5|||
23539241|NCT01459796|65706003|FG000|Overall Study|Withdrawal by Subject|6|||
23539242|NCT01459796|65706004|FG001|Overall Study|Withdrawal by Subject|3|||
23539243|NCT01459796|65706003|FG000|Overall Study|Lost to Follow-up|5|||
23539244|NCT01459796|65706004|FG001|Overall Study|Lost to Follow-up|4|||
23539245|NCT01459796|65706003|FG000|Overall Study|Reason unspecified|1|||
23539246|NCT01459796|65706004|FG001|Overall Study|Reason unspecified|2|||
23539247|NCT01459796|65706003|FG000|Overall Study|Decision by the sponsor|75|||
23539248|NCT01459796|65706004|FG001|Overall Study|Decision by the sponsor|108|||
23539249|NCT00003457|65706005|FG000|Overall Study|Not evaluable|9|||
23539250|NCT03483623|65706006|FG000|Overall Study|43 complete sets achieved|1|||
23539251|NCT03370341|65706007|FG000|Overall Study|Lost to Follow-up|0|||
23539252|NCT03370341|65706008|FG001|Overall Study|Lost to Follow-up|1|||
23539253|NCT03169153|65706009|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
23539254|NCT03169153|65706010|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
23539255|NCT03169153|65706009|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
23539256|NCT03169153|65706010|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
23539257|NCT03169153|65706009|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
23539258|NCT03169153|65706010|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
23539259|NCT03169153|65706009|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
23539260|NCT03169153|65706010|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
23539261|NCT01060384|65706024|FG000|Overall Study|Withdrawal by Subject|0|||
23539262|NCT01060384|65706025|FG001|Overall Study|Withdrawal by Subject|1|||
23539263|NCT01060384|65706026|FG002|Overall Study|Withdrawal by Subject|0|||
23539264|NCT01060384|65706027|FG003|Overall Study|Withdrawal by Subject|0|||
23539265|NCT01060384|65706028|FG004|Overall Study|Withdrawal by Subject|0|||
23539266|NCT01060384|65706024|FG000|Overall Study|Death|0|||
23539267|NCT01060384|65706025|FG001|Overall Study|Death|0|||
23539268|NCT01060384|65706026|FG002|Overall Study|Death|0|||
23539269|NCT01060384|65706027|FG003|Overall Study|Death|0|||
23616447|NCT03915951|65982345|FG001|Overall Study|Patient decision|4|||
23539270|NCT01060384|65706028|FG004|Overall Study|Death|1|||
23539271|NCT01060384|65706024|FG000|Overall Study|Intercurrent illness|0|||
23312273|NCT02393248|64886634|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312274|NCT02393248|64886635|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312275|NCT02393248|64886636|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312276|NCT02393248|64886637|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312277|NCT02393248|64886638|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312278|NCT02393248|64886639|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312279|NCT02393248|64886640|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312280|NCT02393248|64886641|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312281|NCT02393248|64886642|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312282|NCT02393248|64886643|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
23312283|NCT02393248|64886644|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
23312284|NCT00103610|64886646|FG000|Overall Study|Entered Rescue Procedure|10|||
23312285|NCT00103610|64886647|FG001|Overall Study|Entered Rescue Procedure|52|||
23312286|NCT00103610|64886646|FG000|Overall Study|Death|16|||
23312287|NCT00103610|64886647|FG001|Overall Study|Death|12|||
23312288|NCT00103610|64886646|FG000|Overall Study|Elective Withdrawal|4|||
23312289|NCT00103610|64886647|FG001|Overall Study|Elective Withdrawal|0|||
23312290|NCT00103610|64886646|FG000|Overall Study|Lost to Follow-up|3|||
23312291|NCT00103610|64886647|FG001|Overall Study|Lost to Follow-up|1|||
23312292|NCT00103610|64886646|FG000|Overall Study|Adverse Event|2|||
23539272|NCT01060384|65706025|FG001|Overall Study|Intercurrent illness|0|||
23539273|NCT01060384|65706026|FG002|Overall Study|Intercurrent illness|0|||
23539274|NCT01060384|65706027|FG003|Overall Study|Intercurrent illness|0|||
23539275|NCT01060384|65706028|FG004|Overall Study|Intercurrent illness|1|||
23539276|NCT02602288|65706029|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
23539277|NCT02602288|65706030|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
23539278|NCT02602288|65706029|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
23539279|NCT02602288|65706030|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
23539280|NCT02602288|65706029|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
23539281|NCT02602288|65706030|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
23539282|NCT02602288|65706029|FG000|12 Month Follow-up|Lost to Follow-up|0|||
23539283|NCT02602288|65706030|FG001|12 Month Follow-up|Lost to Follow-up|4|||
23539284|NCT02602288|65706029|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
23539285|NCT02602288|65706030|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
23539286|NCT02956629|65706033|FG000|Overall Study|Adverse Event|0|||
23539287|NCT02956629|65706034|FG001|Overall Study|Adverse Event|0|||
23539288|NCT02956629|65706035|FG002|Overall Study|Adverse Event|1|||
23539289|NCT02956629|65706036|FG003|Overall Study|Adverse Event|0|||
23539290|NCT02956629|65706037|FG004|Overall Study|Adverse Event|0|||
23539291|NCT02956629|65706038|FG005|Overall Study|Adverse Event|0|||
23539292|NCT02956629|65706033|FG000|Overall Study|Lost to Follow-up|2|||
23539293|NCT02956629|65706034|FG001|Overall Study|Lost to Follow-up|5|||
23539294|NCT02956629|65706035|FG002|Overall Study|Lost to Follow-up|3|||
23539295|NCT02956629|65706036|FG003|Overall Study|Lost to Follow-up|1|||
23539296|NCT02956629|65706037|FG004|Overall Study|Lost to Follow-up|0|||
23539297|NCT02956629|65706038|FG005|Overall Study|Lost to Follow-up|1|||
23539298|NCT02956629|65706033|FG000|Overall Study|Withdrawal by Subject|3|||
23539299|NCT02956629|65706034|FG001|Overall Study|Withdrawal by Subject|1|||
23539300|NCT02956629|65706035|FG002|Overall Study|Withdrawal by Subject|0|||
23539301|NCT02956629|65706036|FG003|Overall Study|Withdrawal by Subject|0|||
23539302|NCT02956629|65706037|FG004|Overall Study|Withdrawal by Subject|0|||
23539303|NCT02956629|65706038|FG005|Overall Study|Withdrawal by Subject|0|||
23539304|NCT03893448|65706039|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
23539305|NCT03893448|65706040|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
23539306|NCT03893448|65706039|FG000|Overall Study|Physician Decision|8|||
23539307|NCT03893448|65706040|FG001|Overall Study|Physician Decision|14|||
23539308|NCT03893448|65706039|FG000|Overall Study|Lost to Follow-up|34|||
23539309|NCT03893448|65706040|FG001|Overall Study|Lost to Follow-up|27|||
23539310|NCT03893448|65706039|FG000|Overall Study|Death|1|||
23539311|NCT03893448|65706040|FG001|Overall Study|Death|0|||
23539312|NCT00803023|65706041|FG000|Overall Study|Adverse Event|5|||
23539313|NCT00803023|65706042|FG001|Overall Study|Adverse Event|4|||
23539314|NCT00803023|65706043|FG002|Overall Study|Adverse Event|8|||
23539315|NCT00803023|65706044|FG003|Overall Study|Adverse Event|6|||
23539316|NCT00803023|65706041|FG000|Overall Study|Withdrawal by Subject|0|||
23539317|NCT00803023|65706042|FG001|Overall Study|Withdrawal by Subject|2|||
23539318|NCT00803023|65706043|FG002|Overall Study|Withdrawal by Subject|0|||
23539319|NCT00803023|65706044|FG003|Overall Study|Withdrawal by Subject|0|||
23539320|NCT00803023|65706041|FG000|Overall Study|Lost to Follow-up|0|||
23539321|NCT00803023|65706042|FG001|Overall Study|Lost to Follow-up|1|||
23539322|NCT00803023|65706043|FG002|Overall Study|Lost to Follow-up|2|||
23539323|NCT00803023|65706044|FG003|Overall Study|Lost to Follow-up|1|||
23539324|NCT00803023|65706041|FG000|Overall Study|Lack of Efficacy|0|||
23539325|NCT00803023|65706042|FG001|Overall Study|Lack of Efficacy|1|||
23539326|NCT00803023|65706043|FG002|Overall Study|Lack of Efficacy|1|||
23539327|NCT00803023|65706044|FG003|Overall Study|Lack of Efficacy|1|||
23539328|NCT01794949|65706045|FG000|Overall Study|Lost to Follow-up|1|||
23539329|NCT01794949|65706046|FG001|Overall Study|Lost to Follow-up|0|||
23539330|NCT04116229|65706047|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
23539331|NCT04116229|65706048|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
23539332|NCT04116229|65706047|FG000|Overall Study|Scheduling not possible.|0|||
23539333|NCT04116229|65706048|FG001|Overall Study|Scheduling not possible.|1|||
23539334|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
23539335|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
23539336|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
23539337|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539338|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539339|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539340|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539341|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539342|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23539343|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
23539344|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
23539345|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
23539346|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539347|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539348|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539349|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539350|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539351|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23539352|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539353|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
23539354|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
23539355|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539356|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539357|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539358|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539359|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539360|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23539361|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
23539362|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
23539363|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
23539364|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539365|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539366|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539367|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539368|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539369|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23539370|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539371|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
23539372|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539373|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539374|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539375|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539376|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539377|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539378|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
23539379|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
23539380|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539381|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539382|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539383|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539384|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539385|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539386|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539387|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23539388|NCT01172938|65706056|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539389|NCT01172938|65706057|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
23539390|NCT01172938|65706058|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
23539391|NCT01172938|65706059|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539392|NCT01172938|65706060|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539393|NCT01172938|65706061|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539394|NCT01172938|65706062|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539395|NCT01172938|65706063|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539396|NCT01172938|65706064|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
23539397|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
23539398|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
23539399|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
23539400|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
23539401|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
23539402|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
23539403|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
23539404|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
23539405|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
23539406|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
23539407|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
23539408|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
23539409|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
23539410|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
23539411|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
23539412|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
23539413|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
23539414|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
23539415|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539416|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539417|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
23539418|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539419|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539420|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539421|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539422|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539423|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
23539424|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
23539425|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
23539426|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
23539427|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
23539428|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
23539429|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
23539430|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
23539431|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
23539432|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
23539433|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539434|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
23539435|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
23539436|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
23539437|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539438|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539439|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539440|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539441|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
23539442|NCT01172938|65706056|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539443|NCT01172938|65706057|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539444|NCT01172938|65706058|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539445|NCT01172938|65706059|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539446|NCT01172938|65706060|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539447|NCT01172938|65706061|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
23539448|NCT01172938|65706062|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
23539449|NCT01172938|65706063|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539450|NCT01172938|65706064|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
23539451|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539452|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
23539453|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
23616448|NCT03915951|65982344|FG000|Overall Study|Investigator decision|0|||
23312293|NCT00103610|64886647|FG001|Overall Study|Adverse Event|2|||
23539454|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539455|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539456|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539457|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
23539458|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
23539459|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
23539460|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539461|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
23539462|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
23539463|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539464|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539465|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539466|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539467|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
23539468|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
23539469|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539470|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539471|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
23616449|NCT03915951|65982345|FG001|Overall Study|Investigator decision|1|||
23616450|NCT03915951|65982344|FG000|Overall Study|Consent withdrawn|1|||
23616451|NCT03915951|65982345|FG001|Overall Study|Consent withdrawn|1|||
23616452|NCT03915951|65982344|FG000|Overall Study|Death|0|||
23616453|NCT03915951|65982345|FG001|Overall Study|Death|3|||
23616454|NCT05006703|65982348|FG000|Overall Study|Withdrawal by Subject|1|||
23616455|NCT05006703|65982349|FG001|Overall Study|Withdrawal by Subject|0|||
23616456|NCT05006703|65982348|FG000|Overall Study|Lost to Follow-up|13|||
23616457|NCT05006703|65982349|FG001|Overall Study|Lost to Follow-up|5|||
23616458|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
23616459|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
23616460|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616461|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616462|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616463|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616464|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23616465|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
23616466|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
23616467|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
23616468|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23616469|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23616470|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23616471|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23616472|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
23616473|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616474|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
23616475|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616476|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616477|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616478|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23616479|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616480|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
23616481|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616482|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616483|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616484|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616485|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23616486|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
23616487|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
23616488|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
23616489|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23616490|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23616491|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23616492|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23616493|NCT03745651|65982353|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
23616494|NCT03745651|65982354|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
23616495|NCT03745651|65982355|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
23616496|NCT03745651|65982356|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
23616497|NCT03745651|65982357|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
23616498|NCT03745651|65982358|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
23616499|NCT03745651|65982359|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
23616500|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616501|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616502|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616503|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616504|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616505|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
23616506|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23616507|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23616508|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23616509|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23616510|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
23616511|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23616512|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
23616513|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
23616514|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23616515|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23616516|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23539472|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539473|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539474|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539475|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23209657|NCT02559206|64504657|FG007|Overall Study|Lack of Efficacy|3|||
23209658|NCT02559206|64504650|FG000|Overall Study|Other Not Specified|0|||
23209659|NCT02559206|64504651|FG001|Overall Study|Other Not Specified|0|||
23209660|NCT02559206|64504652|FG002|Overall Study|Other Not Specified|0|||
23209661|NCT02559206|64504653|FG003|Overall Study|Other Not Specified|1|||
23209662|NCT02559206|64504654|FG004|Overall Study|Other Not Specified|0|||
23209663|NCT02559206|64504655|FG005|Overall Study|Other Not Specified|0|||
23209664|NCT02559206|64504656|FG006|Overall Study|Other Not Specified|0|||
23209665|NCT02559206|64504657|FG007|Overall Study|Other Not Specified|0|||
23209666|NCT00718666|64504658|FG000|Booster Phase Year 5|No active participation request|0|||
23209667|NCT00718666|64504659|FG001|Booster Phase Year 5|No active participation request|0|||
23209668|NCT00718666|64504660|FG002|Booster Phase Year 5|No active participation request|1|||
23209669|NCT00718666|64504658|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
23209670|NCT00718666|64504659|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
23209671|NCT00718666|64504660|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
23209672|NCT00718666|64504658|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
23209673|NCT00718666|64504659|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
23209674|NCT00718666|64504660|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
23209675|NCT00718666|64504658|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
23209676|NCT00718666|64504659|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
23539476|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23539477|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
23209677|NCT00718666|64504660|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
23209678|NCT00634114|64504661|FG000|Overall Study|Adverse Event|6|||
23616517|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
23616518|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
23616519|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
23616520|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
23209679|NCT00634114|64504662|FG001|Overall Study|Adverse Event|8|||
23209680|NCT00634114|64504663|FG002|Overall Study|Adverse Event|3|||
23209681|NCT00634114|64504661|FG000|Overall Study|Withdrawal by Subject|9|||
23209682|NCT00634114|64504662|FG001|Overall Study|Withdrawal by Subject|6|||
23209683|NCT00634114|64504663|FG002|Overall Study|Withdrawal by Subject|11|||
23209684|NCT00634114|64504661|FG000|Overall Study|Lost to Follow-up|0|||
23539478|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23209685|NCT00634114|64504662|FG001|Overall Study|Lost to Follow-up|0|||
23209686|NCT00634114|64504663|FG002|Overall Study|Lost to Follow-up|1|||
23616521|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23616522|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23209687|NCT00634114|64504661|FG000|Overall Study|Protocol Violation|3|||
23209688|NCT00634114|64504662|FG001|Overall Study|Protocol Violation|3|||
23209689|NCT00634114|64504663|FG002|Overall Study|Protocol Violation|1|||
23209690|NCT00634114|64504661|FG000|Overall Study|Pregnancy|1|||
23539479|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
23539480|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
23539481|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23539482|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23539483|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23539484|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
23539485|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
23539486|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
23539487|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539488|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539489|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
23539490|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539491|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23209691|NCT00634114|64504662|FG001|Overall Study|Pregnancy|0|||
23209692|NCT00634114|64504663|FG002|Overall Study|Pregnancy|0|||
23209693|NCT00634114|64504661|FG000|Overall Study|Incorrect enrolment|0|||
23209694|NCT00634114|64504662|FG001|Overall Study|Incorrect enrolment|1|||
23209695|NCT00634114|64504663|FG002|Overall Study|Incorrect enrolment|0|||
23209696|NCT00634114|64504661|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
23539492|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539493|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539494|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539495|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
23539496|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539497|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
23539498|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
23539499|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539500|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539501|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539502|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539503|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
23539504|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
23539505|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539506|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
23539507|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539508|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539509|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539510|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23209697|NCT00634114|64504662|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
23209698|NCT00634114|64504663|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
23209699|NCT00634114|64504661|FG000|Overall Study|Difficult to continue|3|||
23209700|NCT00634114|64504662|FG001|Overall Study|Difficult to continue|1|||
23209701|NCT00634114|64504663|FG002|Overall Study|Difficult to continue|1|||
23209702|NCT00634114|64504661|FG000|Overall Study|Other reason|1|||
23209703|NCT00634114|64504662|FG001|Overall Study|Other reason|1|||
23209704|NCT00634114|64504663|FG002|Overall Study|Other reason|1|||
23209705|NCT03712345|64504664|FG000|Overall Study|Failure to meet randomization criteria|0|||
23209706|NCT03712345|64504665|FG001|Overall Study|Failure to meet randomization criteria|0|||
23209707|NCT03712345|64504666|FG002|Overall Study|Failure to meet randomization criteria|1|||
23209708|NCT02193828|64504668|FG000|Overall Study|Withdrawal by Subject|0|||
23209709|NCT02193828|64504669|FG001|Overall Study|Withdrawal by Subject|0|||
23209710|NCT02193828|64504670|FG002|Overall Study|Withdrawal by Subject|1|||
23209711|NCT02193828|64504671|FG003|Overall Study|Withdrawal by Subject|1|||
23209712|NCT03457103|64504679|FG000|Overall Study|illness/hospitalization|4|||
23209713|NCT03457103|64504680|FG001|Overall Study|illness/hospitalization|2|||
23209714|NCT03457103|64504679|FG000|Overall Study|Lost to Follow-up|2|||
23209715|NCT03457103|64504680|FG001|Overall Study|Lost to Follow-up|1|||
23209716|NCT03457103|64504679|FG000|Overall Study|Withdrawal by Subject|1|||
23209717|NCT03457103|64504680|FG001|Overall Study|Withdrawal by Subject|2|||
23209718|NCT03457103|64504679|FG000|Overall Study|financial/ insurance issues|1|||
23209719|NCT03457103|64504680|FG001|Overall Study|financial/ insurance issues|1|||
23209720|NCT02310906|64504682|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
23209721|NCT02310906|64504683|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
23539511|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539512|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
23539513|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
23539514|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23616523|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23312294|NCT00103610|64886646|FG000|Overall Study|Other|2|||
23209722|NCT02310906|64504684|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
23209723|NCT02310906|64504685|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
23209724|NCT02310906|64504682|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
23209725|NCT02310906|64504683|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
23209726|NCT02310906|64504684|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
23209727|NCT02310906|64504685|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
23209728|NCT02310906|64504682|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
23209729|NCT02310906|64504683|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
23209730|NCT02310906|64504684|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
23209731|NCT02310906|64504685|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
23209732|NCT02310906|64504682|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
23209733|NCT02310906|64504683|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
23209734|NCT02310906|64504684|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
23209735|NCT02310906|64504685|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
23209736|NCT03488251|64504690|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
23209737|NCT03488251|64504691|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
23209738|NCT03488251|64504692|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
23209739|NCT03488251|64504693|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
23539515|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
23539516|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539517|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539518|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539519|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539520|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539521|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539522|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
23539523|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23312295|NCT00103610|64886647|FG001|Overall Study|Other|7|||
23424155|NCT01643850|65296372|FG002|Overall Study|Administrative Problems|1|||
23424156|NCT01643850|65296373|FG003|Overall Study|Administrative Problems|0|||
23424157|NCT01643850|65296374|FG004|Overall Study|Administrative Problems|1|||
23424158|NCT01643850|65296375|FG005|Overall Study|Administrative Problems|0|||
23424159|NCT01643850|65296376|FG006|Overall Study|Administrative Problems|0|||
23424160|NCT01643850|65296377|FG007|Overall Study|Administrative Problems|0|||
23424161|NCT01643850|65296378|FG008|Overall Study|Administrative Problems|0|||
23424162|NCT01739933|65296387|FG000|Overall Study|Death|89|||
23424163|NCT01739933|65296388|FG001|Overall Study|Death|86|||
23424164|NCT01739933|65296387|FG000|Overall Study|Withdrawal by Subject|10|||
23424165|NCT01739933|65296388|FG001|Overall Study|Withdrawal by Subject|8|||
23424166|NCT01739933|65296387|FG000|Overall Study|Lost to Follow-up|3|||
23424167|NCT01739933|65296388|FG001|Overall Study|Lost to Follow-up|10|||
23424168|NCT01739933|65296387|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
23424169|NCT01739933|65296388|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
23424170|NCT00523705|65296389|FG000|Overall Study|No time for study.|0|||
23424171|NCT00523705|65296390|FG001|Overall Study|No time for study.|1|||
23424172|NCT00966719|65296391|FG000|Overall Study|Lost to Follow-up|6|||
23424173|NCT00966719|65296392|FG001|Overall Study|Lost to Follow-up|11|||
23424174|NCT03353922|65296393|FG000|Overall Study|Withdrawal by Subject|1|||
23424175|NCT03353922|65296394|FG001|Overall Study|Withdrawal by Subject|0|||
23424176|NCT03353922|65296395|FG002|Overall Study|Withdrawal by Subject|1|||
23424177|NCT03353922|65296396|FG003|Overall Study|Withdrawal by Subject|1|||
23424178|NCT03353922|65296397|FG004|Overall Study|Withdrawal by Subject|0|||
23424179|NCT03353922|65296398|FG005|Overall Study|Withdrawal by Subject|0|||
23539524|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23616524|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
23424180|NCT03353922|65296393|FG000|Overall Study|Adverse Event|0|||
23424181|NCT03353922|65296394|FG001|Overall Study|Adverse Event|1|||
23424182|NCT03353922|65296395|FG002|Overall Study|Adverse Event|0|||
23424183|NCT03353922|65296396|FG003|Overall Study|Adverse Event|0|||
23424184|NCT03353922|65296397|FG004|Overall Study|Adverse Event|0|||
23539525|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539526|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539527|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539528|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539529|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539530|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
23539531|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
23539532|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539533|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
23539534|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
23539535|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539536|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539537|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539538|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
23539539|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
23539540|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
23539541|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23539542|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
23539543|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
23539544|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23539545|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23539546|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23539547|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
23209740|NCT03488251|64504690|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
23616525|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23616526|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
23312296|NCT00103610|64886646|FG000|Overall Study|Failed mobilization|1|||
23312297|NCT00103610|64886647|FG001|Overall Study|Failed mobilization|5|||
23312298|NCT00103610|64886646|FG000|Overall Study|Noncompliance|0|||
23312299|NCT00103610|64886647|FG001|Overall Study|Noncompliance|1|||
23312300|NCT04576923|64886651|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
23312301|NCT01145508|64886652|FG000|Overall Study|Adverse Event|1|||
23312302|NCT01145508|64886653|FG001|Overall Study|Adverse Event|0|||
23312303|NCT01145508|64886652|FG000|Overall Study|Death|1|||
23312304|NCT01145508|64886653|FG001|Overall Study|Death|0|||
23312305|NCT01145508|64886652|FG000|Overall Study|Physician Decision|2|||
23312306|NCT01145508|64886653|FG001|Overall Study|Physician Decision|1|||
23312307|NCT01145508|64886652|FG000|Overall Study|Never started treatment|1|||
23312308|NCT01145508|64886653|FG001|Overall Study|Never started treatment|1|||
23312309|NCT03172494|64886654|FG000|Overall Study|Adverse Event|5|||
23312310|NCT03172494|64886655|FG001|Overall Study|Adverse Event|1|||
23312311|NCT03172494|64886656|FG002|Overall Study|Adverse Event|15|||
23312312|NCT03172494|64886654|FG000|Overall Study|Protocol Violation|3|||
23312313|NCT03172494|64886655|FG001|Overall Study|Protocol Violation|2|||
23209741|NCT03488251|64504691|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
23209742|NCT03488251|64504692|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
23209743|NCT03488251|64504693|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
23209744|NCT03488251|64504690|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
23209745|NCT03488251|64504691|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
23209746|NCT03488251|64504692|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
23209747|NCT03488251|64504693|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
23209748|NCT03488251|64504690|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
23209749|NCT03488251|64504691|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
23209750|NCT03488251|64504692|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
23209751|NCT03488251|64504693|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
23209752|NCT03488251|64504690|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
23209753|NCT03488251|64504691|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
23209754|NCT03488251|64504692|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
23209755|NCT03488251|64504693|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
23209756|NCT02294318|64504695|FG000|Overall Study|Worsening of drinking|3|||
23209757|NCT02294318|64504696|FG001|Overall Study|Worsening of drinking|0|||
23209758|NCT02294318|64504695|FG000|Overall Study|Not exposed to intervention|0|||
23209759|NCT02294318|64504696|FG001|Overall Study|Not exposed to intervention|2|||
23209760|NCT00165646|64504697|FG000|Overall Study|Adverse Event|1|||
23209761|NCT00165646|64504698|FG001|Overall Study|Adverse Event|1|||
23209762|NCT00165646|64504699|FG002|Overall Study|Adverse Event|1|||
23209763|NCT00165646|64504697|FG000|Overall Study|Lack of Efficacy|1|||
23209764|NCT00165646|64504698|FG001|Overall Study|Lack of Efficacy|2|||
23209765|NCT00165646|64504699|FG002|Overall Study|Lack of Efficacy|0|||
23209766|NCT00165646|64504697|FG000|Overall Study|Withdrawal by Subject|0|||
23209767|NCT00165646|64504698|FG001|Overall Study|Withdrawal by Subject|2|||
23209768|NCT00165646|64504699|FG002|Overall Study|Withdrawal by Subject|1|||
23209769|NCT00165646|64504697|FG000|Overall Study|Physician Decision|2|||
23209770|NCT00165646|64504698|FG001|Overall Study|Physician Decision|0|||
23312314|NCT03172494|64886656|FG002|Overall Study|Protocol Violation|1|||
23209771|NCT00165646|64504699|FG002|Overall Study|Physician Decision|2|||
23209772|NCT00165646|64504697|FG000|Overall Study|Protocol Violation|1|||
23312315|NCT03172494|64886654|FG000|Overall Study|Lack of Efficacy|0|||
23312316|NCT03172494|64886655|FG001|Overall Study|Lack of Efficacy|0|||
23312317|NCT03172494|64886656|FG002|Overall Study|Lack of Efficacy|4|||
23312318|NCT03172494|64886654|FG000|Overall Study|Pregnancy|0|||
23312319|NCT03172494|64886655|FG001|Overall Study|Pregnancy|1|||
23312320|NCT03172494|64886656|FG002|Overall Study|Pregnancy|0|||
23312321|NCT03172494|64886654|FG000|Overall Study|Withdrawal by Subject|10|||
23312322|NCT03172494|64886655|FG001|Overall Study|Withdrawal by Subject|8|||
23312323|NCT03172494|64886656|FG002|Overall Study|Withdrawal by Subject|8|||
23312324|NCT03172494|64886654|FG000|Overall Study|Severe hypoglycaemic episode|0|||
23312325|NCT03172494|64886655|FG001|Overall Study|Severe hypoglycaemic episode|0|||
23312326|NCT03172494|64886656|FG002|Overall Study|Severe hypoglycaemic episode|1|||
23312327|NCT03172494|64886654|FG000|Overall Study|Non-compliance towards treatment|2|||
23312328|NCT03172494|64886655|FG001|Overall Study|Non-compliance towards treatment|0|||
23312329|NCT03172494|64886656|FG002|Overall Study|Non-compliance towards treatment|0|||
23312330|NCT00507130|64886657|FG000|Overall Study|Lost to Follow-up|0|||
23312331|NCT00507130|64886658|FG001|Overall Study|Lost to Follow-up|0|||
23312332|NCT00507130|64886659|FG002|Overall Study|Lost to Follow-up|1|||
23312333|NCT00507130|64886660|FG003|Overall Study|Lost to Follow-up|1|||
23312334|NCT00507130|64886657|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
23312335|NCT00507130|64886658|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
23312336|NCT00507130|64886659|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
23312337|NCT00507130|64886660|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
23312338|NCT02704403|64886661|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
23312339|NCT02704403|64886662|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
23312340|NCT02704403|64886661|FG000|Overall Study|Administrative reasons by sponsor|1251|||
23312341|NCT02704403|64886662|FG001|Overall Study|Administrative reasons by sponsor|616|||
23312342|NCT02704403|64886661|FG000|Overall Study|Death|4|||
23312343|NCT02704403|64886662|FG001|Overall Study|Death|3|||
23312344|NCT02704403|64886661|FG000|Overall Study|Endpoint event|52|||
23312345|NCT02704403|64886662|FG001|Overall Study|Endpoint event|24|||
23312346|NCT02704403|64886661|FG000|Overall Study|Lost to Follow-up|22|||
23312347|NCT02704403|64886662|FG001|Overall Study|Lost to Follow-up|11|||
23312348|NCT02704403|64886661|FG000|Overall Study|Protocol Violation|15|||
23312349|NCT02704403|64886662|FG001|Overall Study|Protocol Violation|15|||
23312350|NCT02704403|64886661|FG000|Overall Study|Adverse Event|2|||
23312351|NCT02704403|64886662|FG001|Overall Study|Adverse Event|0|||
23312352|NCT02704403|64886661|FG000|Overall Study|Withdrawal by Subject|85|||
23312353|NCT02704403|64886662|FG001|Overall Study|Withdrawal by Subject|45|||
23312354|NCT02704403|64886661|FG000|Overall Study|Investigator decision|1|||
23312355|NCT02704403|64886662|FG001|Overall Study|Investigator decision|1|||
23312356|NCT02704403|64886661|FG000|Overall Study|Follow-up not possible|1|||
23312357|NCT02704403|64886662|FG001|Overall Study|Follow-up not possible|2|||
23312358|NCT01753297|64886668|FG000|Overall Study|Lost to Follow-up|7|||
23539548|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
23539549|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
23539550|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
23312359|NCT01753297|64886669|FG001|Overall Study|Lost to Follow-up|2|||
23312360|NCT01753297|64886668|FG000|Overall Study|Withdrawal by Subject|26|||
23312361|NCT01753297|64886669|FG001|Overall Study|Withdrawal by Subject|23|||
23312362|NCT01753297|64886668|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
23312363|NCT01753297|64886669|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
23312364|NCT01753297|64886668|FG000|Overall Study|Death|0|||
23312365|NCT01753297|64886669|FG001|Overall Study|Death|2|||
23312366|NCT01753297|64886668|FG000|Overall Study|Did not attend end of study visit|7|||
23312367|NCT01753297|64886669|FG001|Overall Study|Did not attend end of study visit|8|||
23312368|NCT01085734|64886672|FG000|Overall Study|Adverse Event|0|||
23312369|NCT01085734|64886673|FG001|Overall Study|Adverse Event|2|||
23312370|NCT01085734|64886672|FG000|Overall Study|Death|1|||
23312371|NCT01085734|64886673|FG001|Overall Study|Death|0|||
23312372|NCT01085734|64886672|FG000|Overall Study|Lost to Follow-up|0|||
23312373|NCT01085734|64886673|FG001|Overall Study|Lost to Follow-up|1|||
23312374|NCT01085734|64886672|FG000|Overall Study|Withdrawal by Subject|0|||
23312375|NCT01085734|64886673|FG001|Overall Study|Withdrawal by Subject|1|||
23312376|NCT03207867|64886674|FG000|Overall Study|Adverse Event|1|||
23312377|NCT03207867|64886675|FG001|Overall Study|Adverse Event|0|||
23312378|NCT03207867|64886676|FG002|Overall Study|Adverse Event|1|||
23312379|NCT03207867|64886677|FG003|Overall Study|Adverse Event|0|||
23539551|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539552|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539553|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
23312380|NCT03207867|64886678|FG004|Overall Study|Adverse Event|0|||
23312381|NCT03207867|64886679|FG005|Overall Study|Adverse Event|2|||
23312382|NCT03207867|64886680|FG006|Overall Study|Adverse Event|1|||
23312383|NCT03207867|64886681|FG007|Overall Study|Adverse Event|1|||
23539554|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
23312384|NCT03207867|64886682|FG008|Overall Study|Adverse Event|2|||
23312385|NCT03207867|64886683|FG009|Overall Study|Adverse Event|2|||
23312386|NCT03207867|64886684|FG010|Overall Study|Adverse Event|0|||
23312387|NCT03207867|64886685|FG011|Overall Study|Adverse Event|0|||
23312388|NCT03207867|64886686|FG012|Overall Study|Adverse Event|0|||
23312389|NCT03207867|64886687|FG013|Overall Study|Adverse Event|0|||
23312390|NCT03207867|64886688|FG014|Overall Study|Adverse Event|0|||
23312391|NCT03207867|64886689|FG015|Overall Study|Adverse Event|0|||
23312392|NCT03207867|64886690|FG016|Overall Study|Adverse Event|3|||
23312393|NCT03207867|64886691|FG017|Overall Study|Adverse Event|1|||
23312394|NCT03207867|64886692|FG018|Overall Study|Adverse Event|2|||
23312395|NCT03207867|64886693|FG019|Overall Study|Adverse Event|1|||
23312396|NCT03207867|64886694|FG020|Overall Study|Adverse Event|0|||
23312397|NCT03207867|64886695|FG021|Overall Study|Adverse Event|0|||
23312398|NCT03207867|64886696|FG022|Overall Study|Adverse Event|0|||
23312399|NCT03207867|64886697|FG023|Overall Study|Adverse Event|0|||
23312400|NCT03207867|64886674|FG000|Overall Study|Death|0|||
23312401|NCT03207867|64886675|FG001|Overall Study|Death|0|||
23312402|NCT03207867|64886676|FG002|Overall Study|Death|0|||
23312403|NCT03207867|64886677|FG003|Overall Study|Death|0|||
23312404|NCT03207867|64886678|FG004|Overall Study|Death|0|||
23312405|NCT03207867|64886679|FG005|Overall Study|Death|1|||
23312406|NCT03207867|64886680|FG006|Overall Study|Death|0|||
23312407|NCT03207867|64886681|FG007|Overall Study|Death|3|||
23312408|NCT03207867|64886682|FG008|Overall Study|Death|1|||
23312409|NCT03207867|64886683|FG009|Overall Study|Death|2|||
23312410|NCT03207867|64886684|FG010|Overall Study|Death|0|||
23312411|NCT03207867|64886685|FG011|Overall Study|Death|1|||
23312412|NCT03207867|64886686|FG012|Overall Study|Death|0|||
23312413|NCT03207867|64886687|FG013|Overall Study|Death|1|||
23312414|NCT03207867|64886688|FG014|Overall Study|Death|0|||
23312415|NCT03207867|64886689|FG015|Overall Study|Death|0|||
23312416|NCT03207867|64886690|FG016|Overall Study|Death|0|||
23312417|NCT03207867|64886691|FG017|Overall Study|Death|2|||
23312418|NCT03207867|64886692|FG018|Overall Study|Death|0|||
23312419|NCT03207867|64886693|FG019|Overall Study|Death|1|||
23312420|NCT03207867|64886694|FG020|Overall Study|Death|0|||
23312421|NCT03207867|64886695|FG021|Overall Study|Death|0|||
23312422|NCT03207867|64886696|FG022|Overall Study|Death|0|||
23312423|NCT03207867|64886697|FG023|Overall Study|Death|0|||
23312424|NCT03207867|64886674|FG000|Overall Study|Physician Decision|3|||
23312425|NCT03207867|64886675|FG001|Overall Study|Physician Decision|5|||
23312426|NCT03207867|64886676|FG002|Overall Study|Physician Decision|0|||
23312427|NCT03207867|64886677|FG003|Overall Study|Physician Decision|3|||
23312428|NCT03207867|64886678|FG004|Overall Study|Physician Decision|2|||
23312429|NCT03207867|64886679|FG005|Overall Study|Physician Decision|0|||
23312430|NCT03207867|64886680|FG006|Overall Study|Physician Decision|0|||
23312431|NCT03207867|64886681|FG007|Overall Study|Physician Decision|0|||
23312432|NCT03207867|64886682|FG008|Overall Study|Physician Decision|4|||
23312433|NCT03207867|64886683|FG009|Overall Study|Physician Decision|2|||
23312434|NCT03207867|64886684|FG010|Overall Study|Physician Decision|0|||
23312435|NCT03207867|64886685|FG011|Overall Study|Physician Decision|4|||
23312436|NCT03207867|64886686|FG012|Overall Study|Physician Decision|0|||
23312437|NCT03207867|64886687|FG013|Overall Study|Physician Decision|0|||
23312438|NCT03207867|64886688|FG014|Overall Study|Physician Decision|2|||
23312439|NCT03207867|64886689|FG015|Overall Study|Physician Decision|1|||
23312440|NCT03207867|64886690|FG016|Overall Study|Physician Decision|1|||
23312441|NCT03207867|64886691|FG017|Overall Study|Physician Decision|2|||
23312442|NCT03207867|64886692|FG018|Overall Study|Physician Decision|1|||
23312443|NCT03207867|64886693|FG019|Overall Study|Physician Decision|3|||
23312444|NCT03207867|64886694|FG020|Overall Study|Physician Decision|0|||
23539555|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539556|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
23209773|NCT00165646|64504698|FG001|Overall Study|Protocol Violation|0|||
23209774|NCT00165646|64504699|FG002|Overall Study|Protocol Violation|0|||
23209775|NCT01089582|64504700|FG000|Overall Study|Death|2|||
23312445|NCT03207867|64886695|FG021|Overall Study|Physician Decision|0|||
23209776|NCT01089582|64504700|FG000|Overall Study|Adverse Event|15|||
23209777|NCT01089582|64504700|FG000|Overall Study|Lost to Follow-up|8|||
23209778|NCT01089582|64504700|FG000|Overall Study|Other|4|||
23209779|NCT01089582|64504700|FG000|Overall Study|Withdrawal by Subject|1|||
23209780|NCT01217190|64504701|FG000|Second Dosing|Withdrawal by Subject|0|||
23209781|NCT01217190|64504702|FG001|Second Dosing|Withdrawal by Subject|2|||
23209782|NCT00311181|64504703|FG000|Overall Study|Final DFTs were not obtained|96|||
23209783|NCT00264849|64504706|FG000|Overall Study|Adverse Event|7|||
23209784|NCT00264849|64504707|FG001|Overall Study|Adverse Event|2|||
23312446|NCT03207867|64886696|FG022|Overall Study|Physician Decision|0|||
23312447|NCT03207867|64886697|FG023|Overall Study|Physician Decision|0|||
23312448|NCT03207867|64886674|FG000|Overall Study|Progressive Disease|7|||
23312449|NCT03207867|64886675|FG001|Overall Study|Progressive Disease|7|||
23312450|NCT03207867|64886676|FG002|Overall Study|Progressive Disease|9|||
23312451|NCT03207867|64886677|FG003|Overall Study|Progressive Disease|10|||
23312452|NCT03207867|64886678|FG004|Overall Study|Progressive Disease|11|||
23312453|NCT03207867|64886679|FG005|Overall Study|Progressive Disease|10|||
23312454|NCT03207867|64886680|FG006|Overall Study|Progressive Disease|9|||
23312455|NCT03207867|64886681|FG007|Overall Study|Progressive Disease|8|||
23312456|NCT03207867|64886682|FG008|Overall Study|Progressive Disease|19|||
23312457|NCT03207867|64886683|FG009|Overall Study|Progressive Disease|23|||
23312458|NCT03207867|64886684|FG010|Overall Study|Progressive Disease|2|||
23312459|NCT03207867|64886685|FG011|Overall Study|Progressive Disease|24|||
23312460|NCT03207867|64886686|FG012|Overall Study|Progressive Disease|3|||
23312461|NCT03207867|64886687|FG013|Overall Study|Progressive Disease|11|||
23312462|NCT03207867|64886688|FG014|Overall Study|Progressive Disease|9|||
23312463|NCT03207867|64886689|FG015|Overall Study|Progressive Disease|5|||
23312464|NCT03207867|64886690|FG016|Overall Study|Progressive Disease|10|||
23312465|NCT03207867|64886691|FG017|Overall Study|Progressive Disease|14|||
23312466|NCT03207867|64886692|FG018|Overall Study|Progressive Disease|13|||
23312467|NCT03207867|64886693|FG019|Overall Study|Progressive Disease|14|||
23312468|NCT03207867|64886694|FG020|Overall Study|Progressive Disease|6|||
23312469|NCT03207867|64886695|FG021|Overall Study|Progressive Disease|3|||
23312470|NCT03207867|64886696|FG022|Overall Study|Progressive Disease|3|||
23312471|NCT03207867|64886697|FG023|Overall Study|Progressive Disease|3|||
23312472|NCT03207867|64886674|FG000|Overall Study|Patient/guardian Decision|0|||
23312473|NCT03207867|64886675|FG001|Overall Study|Patient/guardian Decision|0|||
23312474|NCT03207867|64886676|FG002|Overall Study|Patient/guardian Decision|1|||
23312475|NCT03207867|64886677|FG003|Overall Study|Patient/guardian Decision|1|||
23312476|NCT03207867|64886678|FG004|Overall Study|Patient/guardian Decision|1|||
23312477|NCT03207867|64886679|FG005|Overall Study|Patient/guardian Decision|2|||
23312478|NCT03207867|64886680|FG006|Overall Study|Patient/guardian Decision|1|||
23312479|NCT03207867|64886681|FG007|Overall Study|Patient/guardian Decision|0|||
23312480|NCT03207867|64886682|FG008|Overall Study|Patient/guardian Decision|1|||
23312481|NCT03207867|64886683|FG009|Overall Study|Patient/guardian Decision|0|||
23312482|NCT03207867|64886684|FG010|Overall Study|Patient/guardian Decision|0|||
23312483|NCT03207867|64886685|FG011|Overall Study|Patient/guardian Decision|1|||
23312484|NCT03207867|64886686|FG012|Overall Study|Patient/guardian Decision|0|||
23312485|NCT03207867|64886687|FG013|Overall Study|Patient/guardian Decision|1|||
23312486|NCT03207867|64886688|FG014|Overall Study|Patient/guardian Decision|2|||
23312487|NCT03207867|64886689|FG015|Overall Study|Patient/guardian Decision|0|||
23312488|NCT03207867|64886690|FG016|Overall Study|Patient/guardian Decision|1|||
23312489|NCT03207867|64886691|FG017|Overall Study|Patient/guardian Decision|3|||
23312490|NCT03207867|64886692|FG018|Overall Study|Patient/guardian Decision|4|||
23312491|NCT03207867|64886693|FG019|Overall Study|Patient/guardian Decision|1|||
23312492|NCT03207867|64886694|FG020|Overall Study|Patient/guardian Decision|0|||
23312493|NCT03207867|64886695|FG021|Overall Study|Patient/guardian Decision|0|||
23312494|NCT03207867|64886696|FG022|Overall Study|Patient/guardian Decision|0|||
23424185|NCT03353922|65296398|FG005|Overall Study|Adverse Event|0|||
23424186|NCT00789581|65296412|FG000|AC Therapy|Adverse Event|2|||
23539557|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
23539558|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
23539559|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539560|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
23539561|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539562|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539563|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23616527|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
23616528|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23616529|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23539564|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539565|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539566|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539567|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
23539568|NCT01172938|65706056|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539569|NCT01172938|65706057|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539570|NCT01172938|65706058|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
23616530|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23616531|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
23312495|NCT03207867|64886697|FG023|Overall Study|Patient/guardian Decision|0|||
23312496|NCT01778686|64886700|FG000|Overall Study|Adverse Event|0|||
23312497|NCT01778686|64886701|FG001|Overall Study|Adverse Event|0|||
23312498|NCT01778686|64886702|FG002|Overall Study|Adverse Event|1|||
23312499|NCT03167723|64886703|FG000|Overall Study|Protocol Violation|4|||
23312500|NCT03167723|64886704|FG001|Overall Study|Protocol Violation|6|||
23312501|NCT04711902|64886705|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
23312502|NCT04711902|64886706|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
23424187|NCT00789581|65296413|FG001|AC Therapy|Adverse Event|3|||
23424188|NCT00789581|65296412|FG000|AC Therapy|Withdrawal by Subject|4|||
23424189|NCT00789581|65296413|FG001|AC Therapy|Withdrawal by Subject|7|||
23424190|NCT00789581|65296412|FG000|AC Therapy|Disease recurrence|3|||
23209785|NCT00264849|64504706|FG000|Overall Study|Withdrawal by Subject|7|||
23209786|NCT00264849|64504707|FG001|Overall Study|Withdrawal by Subject|11|||
23209787|NCT00264849|64504706|FG000|Overall Study|Protocol Violation|5|||
23209788|NCT00264849|64504707|FG001|Overall Study|Protocol Violation|3|||
23209789|NCT00264849|64504706|FG000|Overall Study|Lack of Efficacy|1|||
23209790|NCT00264849|64504707|FG001|Overall Study|Lack of Efficacy|6|||
23209791|NCT00264849|64504706|FG000|Overall Study|Lost to Follow-up|0|||
23209792|NCT00264849|64504707|FG001|Overall Study|Lost to Follow-up|2|||
23424191|NCT00789581|65296413|FG001|AC Therapy|Disease recurrence|1|||
23424192|NCT00789581|65296412|FG000|AC Therapy|Intercurrent Illness|1|||
23424193|NCT00789581|65296413|FG001|AC Therapy|Intercurrent Illness|0|||
23424194|NCT00789581|65296412|FG000|AC Therapy|Never Treated|1|||
23424195|NCT00789581|65296413|FG001|AC Therapy|Never Treated|4|||
23424196|NCT00789581|65296412|FG000|AC Therapy|Other|0|||
23209793|NCT00264849|64504706|FG000|Overall Study|Death|0|||
23209794|NCT00264849|64504707|FG001|Overall Study|Death|1|||
23209795|NCT00264849|64504706|FG000|Overall Study|Administrative Problems|2|||
23209796|NCT00264849|64504707|FG001|Overall Study|Administrative Problems|0|||
23209797|NCT01303380|64504708|FG000|Overall Study|Lack of compliance to study procedures|1|||
23209798|NCT00111475|64504709|FG000|Overall Study|Lost to Follow-up|0|||
23209799|NCT00111475|64504710|FG001|Overall Study|Lost to Follow-up|0|||
23209800|NCT00111475|64504711|FG002|Overall Study|Lost to Follow-up|0|||
23209801|NCT00111475|64504712|FG003|Overall Study|Lost to Follow-up|0|||
23209802|NCT00111475|64504713|FG004|Overall Study|Lost to Follow-up|0|||
23424197|NCT00789581|65296413|FG001|AC Therapy|Other|2|||
23209803|NCT00111475|64504714|FG005|Overall Study|Lost to Follow-up|1|||
23312503|NCT04711902|64886707|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
23424198|NCT00789581|65296412|FG000|Adjuvant Therapy|Never treated|2|||
23424199|NCT00789581|65296413|FG001|Adjuvant Therapy|Never treated|2|||
23424200|NCT00789581|65296412|FG000|Adjuvant Therapy|Adverse Event|20|||
23424201|NCT00789581|65296413|FG001|Adjuvant Therapy|Adverse Event|44|||
23424202|NCT00789581|65296412|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
23424203|NCT00789581|65296413|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
23424204|NCT00789581|65296412|FG000|Adjuvant Therapy|Disease recurrence|2|||
23424205|NCT00789581|65296413|FG001|Adjuvant Therapy|Disease recurrence|1|||
23539571|NCT01172938|65706059|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539572|NCT01172938|65706060|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539573|NCT01172938|65706061|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539574|NCT01172938|65706062|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539575|NCT01172938|65706063|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539576|NCT01172938|65706064|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
23539577|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23209804|NCT00111475|64504715|FG006|Overall Study|Lost to Follow-up|0|||
23209805|NCT00111475|64504716|FG007|Overall Study|Lost to Follow-up|0|||
23312504|NCT04711902|64886708|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
23424206|NCT00789581|65296412|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
23424207|NCT00789581|65296413|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
23424208|NCT00789581|65296412|FG000|Adjuvant Therapy|Protocol Violation|1|||
23424209|NCT00789581|65296413|FG001|Adjuvant Therapy|Protocol Violation|1|||
23209806|NCT00111475|64504717|FG008|Overall Study|Lost to Follow-up|0|||
23209807|NCT00111475|64504718|FG009|Overall Study|Lost to Follow-up|0|||
23209808|NCT05590767|64504719|FG000|Overall Study|Protocol Violation|1|||
23209809|NCT05590767|64504719|FG000|Overall Study|surgery canceled|1|||
23209810|NCT05590767|64504719|FG000|Overall Study|interscalene brachial block not performed|1|||
23424210|NCT00789581|65296412|FG000|Adjuvant Therapy|Other|0|||
23616532|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23616533|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
23616534|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
23616535|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616536|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616537|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616538|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616539|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616540|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
23616541|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23616542|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23616543|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23616544|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23616545|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
23616546|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
23616547|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
23616548|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
23616549|NCT03745651|65982353|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
23616550|NCT03745651|65982354|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
23616551|NCT03745651|65982355|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
23616552|NCT03745651|65982356|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
23616553|NCT03745651|65982357|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
23616554|NCT03745651|65982358|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
23616555|NCT03745651|65982359|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
23616556|NCT03326193|65982360|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
23616557|NCT03326193|65982360|FG000|Overall Study|Death|19|||
23209811|NCT01764256|64504720|FG000|Received All Vaccinations|Adverse Event|1|||
23209812|NCT01764256|64504721|FG001|Received All Vaccinations|Adverse Event|1|||
23424211|NCT00789581|65296413|FG001|Adjuvant Therapy|Other|1|||
23424212|NCT02153346|65296414|FG000|Overall Study|Lost to Follow-up|11|||
23539578|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
23539579|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
23539580|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23539581|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23539582|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23539583|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23539584|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
23539585|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
23424213|NCT01666119|65296415|FG000|Overall Study|Adverse Event|6|||
23424214|NCT01666119|65296415|FG000|Overall Study|Withdrawal by Subject|16|||
23424215|NCT01666119|65296415|FG000|Overall Study|Lost to Follow-up|7|||
23424216|NCT01666119|65296415|FG000|Overall Study|non compliance with study medication, pa|18|||
23424217|NCT01666119|65296415|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
23424218|NCT03730012|65296416|FG000|Overall Study|Adverse Event|0|||
23424219|NCT03730012|65296417|FG001|Overall Study|Adverse Event|1|||
23424220|NCT03730012|65296416|FG000|Overall Study|Lack of Efficacy|1|||
23424221|NCT03730012|65296417|FG001|Overall Study|Lack of Efficacy|5|||
23424222|NCT03730012|65296416|FG000|Overall Study|Withdrawal by Subject|0|||
23539586|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539587|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
23539588|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
23539589|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539590|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539591|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539592|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
23539593|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
23539594|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
23539595|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539596|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
23209813|NCT01764256|64504722|FG002|Received All Vaccinations|Adverse Event|0|||
23424223|NCT03730012|65296417|FG001|Overall Study|Withdrawal by Subject|1|||
23424224|NCT03730012|65296416|FG000|Overall Study|Miscellaneous|2|||
23424225|NCT03730012|65296417|FG001|Overall Study|Miscellaneous|1|||
23424226|NCT03158272|65296420|FG000|Overall Study|Disease progression|3|||
23424227|NCT03158272|65296421|FG001|Overall Study|Disease progression|3|||
23424228|NCT03158272|65296422|FG002|Overall Study|Disease progression|4|||
23209814|NCT01764256|64504723|FG003|Received All Vaccinations|Adverse Event|0|||
23424229|NCT03158272|65296423|FG003|Overall Study|Disease progression|6|||
23539597|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
23539598|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539599|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539600|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539601|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
23539602|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
23539603|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
23539604|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539605|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539606|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
23539607|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539608|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539609|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539610|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539611|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
23539612|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
23539613|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539614|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539615|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539616|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539617|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539618|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539619|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539620|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
23539621|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
23539622|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539623|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539624|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
23539625|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539626|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539627|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539628|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
23539629|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
23539630|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
23539631|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539632|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539633|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
23539634|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539635|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539636|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539637|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539638|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539639|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
23539640|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539641|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
23539642|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539643|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539644|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539645|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539646|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539647|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
23539648|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
23539649|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539650|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
23539651|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
23539652|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539653|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539654|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539655|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23539656|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
23539657|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
23209815|NCT01764256|64504720|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
23424230|NCT03158272|65296420|FG000|Overall Study|Death|0|||
23539658|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539659|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539660|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
23539661|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539662|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539663|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539664|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539665|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539666|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
23539667|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539668|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539669|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
23539670|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539671|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539672|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539673|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539674|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539675|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
23539676|NCT01172938|65706056|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539677|NCT01172938|65706057|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539678|NCT01172938|65706058|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539679|NCT01172938|65706059|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539680|NCT01172938|65706060|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539681|NCT01172938|65706061|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539682|NCT01172938|65706062|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539683|NCT01172938|65706063|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
23539684|NCT01172938|65706064|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
23539685|NCT03892889|65706069|FG000|Overall Study|Adverse Event|17|||
23539686|NCT03892889|65706069|FG000|Overall Study|Lack of Efficacy|1|||
23539687|NCT03892889|65706069|FG000|Overall Study|Lost to Follow-up|46|||
23539688|NCT03892889|65706069|FG000|Overall Study|Non-compliance with study drug|22|||
23539689|NCT03892889|65706069|FG000|Overall Study|Pregnancy|1|||
23539690|NCT03892889|65706069|FG000|Overall Study|Protocol Deviation|3|||
23539691|NCT03892889|65706069|FG000|Overall Study|Withdrawal by Subject|50|||
23539692|NCT03892889|65706069|FG000|Overall Study|Withdrawal by Caregiver|1|||
23539693|NCT03892889|65706069|FG000|Overall Study|Study Terminated by Sponsor|50|||
23539694|NCT03892889|65706069|FG000|Overall Study|Physician Decision|8|||
23539695|NCT03892889|65706069|FG000|Overall Study|Reason not Specified|5|||
23539696|NCT02219932|65709009|FG000|Overall Study|Other|5|||
23539697|NCT02219932|65709010|FG001|Overall Study|Other|11|||
23539698|NCT02219932|65709009|FG000|Overall Study|Death|1|||
23539699|NCT02219932|65709010|FG001|Overall Study|Death|1|||
23539700|NCT02219932|65709009|FG000|Overall Study|Investigator Decision|0|||
23539701|NCT02219932|65709010|FG001|Overall Study|Investigator Decision|1|||
23539702|NCT02219932|65709009|FG000|Overall Study|Consent Withdrawn|11|||
23616558|NCT03326193|65982360|FG000|Overall Study|Withdrawal by Subject|8|||
23539703|NCT02219932|65709010|FG001|Overall Study|Consent Withdrawn|7|||
23539704|NCT02219932|65709009|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
23539705|NCT02219932|65709010|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
23539706|NCT02219932|65709009|FG000|Overall Study|Protocol Violation|10|||
23539707|NCT02219932|65709010|FG001|Overall Study|Protocol Violation|6|||
23539708|NCT02219932|65709009|FG000|Overall Study|Pregnancy|1|||
23539709|NCT02219932|65709010|FG001|Overall Study|Pregnancy|0|||
23539710|NCT02219932|65709009|FG000|Overall Study|Lost to Follow-up|4|||
23539711|NCT02219932|65709010|FG001|Overall Study|Lost to Follow-up|2|||
23539712|NCT02219932|65709009|FG000|Overall Study|Adverse Event|23|||
23539713|NCT02219932|65709010|FG001|Overall Study|Adverse Event|21|||
23539714|NCT03832946|65709013|FG000|Overall Study|Adverse Event|3|||
23539715|NCT03832946|65709014|FG001|Overall Study|Adverse Event|1|||
23539716|NCT03832946|65709013|FG000|Overall Study|Lost to Follow-up|1|||
23539717|NCT03832946|65709014|FG001|Overall Study|Lost to Follow-up|0|||
23539718|NCT03832946|65709013|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
23539719|NCT03832946|65709014|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
23539720|NCT03832946|65709013|FG000|Overall Study|Lack of Efficacy|1|||
23539721|NCT03832946|65709014|FG001|Overall Study|Lack of Efficacy|0|||
23539722|NCT03832946|65709013|FG000|Overall Study|Withdrawal by Subject|12|||
23539723|NCT03832946|65709014|FG001|Overall Study|Withdrawal by Subject|9|||
23539724|NCT01992536|65709016|FG000|Overall Study|Administrative Reason|0|||
23539725|NCT01992536|65709017|FG001|Overall Study|Administrative Reason|0|||
23539726|NCT01992536|65709018|FG002|Overall Study|Administrative Reason|0|||
23539727|NCT01992536|65709019|FG003|Overall Study|Administrative Reason|0|||
23539728|NCT01992536|65709020|FG004|Overall Study|Administrative Reason|0|||
23539729|NCT01992536|65709021|FG005|Overall Study|Administrative Reason|0|||
23539730|NCT01992536|65709022|FG006|Overall Study|Administrative Reason|7|||
23539731|NCT01992536|65709023|FG007|Overall Study|Administrative Reason|0|||
23539732|NCT01992536|65709024|FG008|Overall Study|Administrative Reason|0|||
23539733|NCT01992536|65709025|FG009|Overall Study|Administrative Reason|0|||
23539734|NCT01992536|65709016|FG000|Overall Study|Lost to Follow-up|4|||
23539735|NCT01992536|65709017|FG001|Overall Study|Lost to Follow-up|2|||
23539736|NCT01992536|65709018|FG002|Overall Study|Lost to Follow-up|1|||
23539737|NCT01992536|65709019|FG003|Overall Study|Lost to Follow-up|0|||
23539738|NCT01992536|65709020|FG004|Overall Study|Lost to Follow-up|0|||
23539739|NCT01992536|65709021|FG005|Overall Study|Lost to Follow-up|1|||
23539740|NCT01992536|65709022|FG006|Overall Study|Lost to Follow-up|0|||
23539741|NCT01992536|65709023|FG007|Overall Study|Lost to Follow-up|0|||
23539742|NCT01992536|65709024|FG008|Overall Study|Lost to Follow-up|1|||
23539743|NCT01992536|65709025|FG009|Overall Study|Lost to Follow-up|1|||
23539744|NCT01992536|65709016|FG000|Overall Study|Withdrawal by Subject|0|||
23539745|NCT01992536|65709017|FG001|Overall Study|Withdrawal by Subject|1|||
23539746|NCT01992536|65709018|FG002|Overall Study|Withdrawal by Subject|0|||
23539747|NCT01992536|65709019|FG003|Overall Study|Withdrawal by Subject|2|||
23539748|NCT01992536|65709020|FG004|Overall Study|Withdrawal by Subject|0|||
23539749|NCT01992536|65709021|FG005|Overall Study|Withdrawal by Subject|0|||
23539750|NCT01992536|65709022|FG006|Overall Study|Withdrawal by Subject|0|||
23539751|NCT01992536|65709023|FG007|Overall Study|Withdrawal by Subject|0|||
23539752|NCT01992536|65709024|FG008|Overall Study|Withdrawal by Subject|0|||
23539753|NCT01992536|65709025|FG009|Overall Study|Withdrawal by Subject|0|||
23539754|NCT01913041|65709026|FG000|Overall Study|Protocol Violation|35|||
23539755|NCT01913041|65709026|FG000|Overall Study|Withdrawal by Subject|3|||
23539756|NCT01913041|65709026|FG000|Overall Study|Physician Decision|1|||
23539757|NCT01143259|65709030|FG000|Overall Study|Withdrawal by Subject|3|||
23539758|NCT01143259|65709031|FG001|Overall Study|Withdrawal by Subject|2|||
23539759|NCT01143259|65709030|FG000|Overall Study|Protocol Violation|13|||
23539760|NCT01143259|65709031|FG001|Overall Study|Protocol Violation|9|||
23539761|NCT01143259|65709030|FG000|Overall Study|Screen Failure|7|||
23539762|NCT01143259|65709031|FG001|Overall Study|Screen Failure|9|||
23539763|NCT03136068|65709032|FG000|Overall Study|Lost to Follow-up|1|||
23539764|NCT03136068|65709033|FG001|Overall Study|Lost to Follow-up|1|||
23539765|NCT03136068|65709032|FG000|Overall Study|Protocol Violation|1|||
23539766|NCT03136068|65709033|FG001|Overall Study|Protocol Violation|0|||
23539767|NCT04102501|65709034|FG000|Overall Study|Withdrawal by Subject|7|||
23539768|NCT04102501|65709035|FG001|Overall Study|Withdrawal by Subject|9|||
23539769|NCT04102501|65709034|FG000|Overall Study|Adverse Event|1|||
23539770|NCT04102501|65709035|FG001|Overall Study|Adverse Event|3|||
23539771|NCT02318329|65709040|FG000|Overall Study|Progressive Disease|2|||
23539772|NCT02318329|65709041|FG001|Overall Study|Progressive Disease|3|||
23539773|NCT02318329|65709042|FG002|Overall Study|Progressive Disease|2|||
23539774|NCT02318329|65709043|FG003|Overall Study|Progressive Disease|3|||
23539775|NCT02318329|65709044|FG004|Overall Study|Progressive Disease|3|||
23539776|NCT02318329|65709045|FG005|Overall Study|Progressive Disease|3|||
23539777|NCT02318329|65709046|FG006|Overall Study|Progressive Disease|1|||
23539778|NCT02318329|65709047|FG007|Overall Study|Progressive Disease|1|||
23539779|NCT02318329|65709048|FG008|Overall Study|Progressive Disease|5|||
23539780|NCT02318329|65709049|FG009|Overall Study|Progressive Disease|39|||
23539781|NCT02318329|65709040|FG000|Overall Study|Death|0|||
23539782|NCT02318329|65709041|FG001|Overall Study|Death|0|||
23539783|NCT02318329|65709042|FG002|Overall Study|Death|0|||
23539784|NCT02318329|65709043|FG003|Overall Study|Death|0|||
23539785|NCT02318329|65709044|FG004|Overall Study|Death|0|||
23539786|NCT02318329|65709045|FG005|Overall Study|Death|0|||
23539787|NCT02318329|65709046|FG006|Overall Study|Death|0|||
23539788|NCT02318329|65709047|FG007|Overall Study|Death|0|||
23539789|NCT02318329|65709048|FG008|Overall Study|Death|0|||
23539790|NCT02318329|65709049|FG009|Overall Study|Death|5|||
23539791|NCT02318329|65709040|FG000|Overall Study|Lost to Follow-up|0|||
23539792|NCT02318329|65709041|FG001|Overall Study|Lost to Follow-up|0|||
23539793|NCT02318329|65709042|FG002|Overall Study|Lost to Follow-up|0|||
23539794|NCT02318329|65709043|FG003|Overall Study|Lost to Follow-up|0|||
23539795|NCT02318329|65709044|FG004|Overall Study|Lost to Follow-up|0|||
23539796|NCT02318329|65709045|FG005|Overall Study|Lost to Follow-up|0|||
23539797|NCT02318329|65709046|FG006|Overall Study|Lost to Follow-up|0|||
23539798|NCT02318329|65709047|FG007|Overall Study|Lost to Follow-up|0|||
23539799|NCT02318329|65709048|FG008|Overall Study|Lost to Follow-up|0|||
23539800|NCT02318329|65709049|FG009|Overall Study|Lost to Follow-up|1|||
23539801|NCT02318329|65709040|FG000|Overall Study|Withdrawal by Subject|0|||
23539802|NCT02318329|65709041|FG001|Overall Study|Withdrawal by Subject|0|||
23539803|NCT02318329|65709042|FG002|Overall Study|Withdrawal by Subject|0|||
23539804|NCT02318329|65709043|FG003|Overall Study|Withdrawal by Subject|0|||
23539805|NCT02318329|65709044|FG004|Overall Study|Withdrawal by Subject|0|||
23539806|NCT02318329|65709045|FG005|Overall Study|Withdrawal by Subject|0|||
23539807|NCT02318329|65709046|FG006|Overall Study|Withdrawal by Subject|0|||
23539808|NCT02318329|65709047|FG007|Overall Study|Withdrawal by Subject|0|||
23539809|NCT02318329|65709048|FG008|Overall Study|Withdrawal by Subject|0|||
23539810|NCT02318329|65709049|FG009|Overall Study|Withdrawal by Subject|6|||
23539811|NCT02318329|65709040|FG000|Overall Study|Other|1|||
23539812|NCT02318329|65709041|FG001|Overall Study|Other|1|||
23539813|NCT02318329|65709042|FG002|Overall Study|Other|1|||
23539814|NCT02318329|65709043|FG003|Overall Study|Other|0|||
23539815|NCT02318329|65709044|FG004|Overall Study|Other|0|||
23539816|NCT02318329|65709045|FG005|Overall Study|Other|0|||
23539817|NCT02318329|65709046|FG006|Overall Study|Other|0|||
23539818|NCT02318329|65709047|FG007|Overall Study|Other|0|||
23539819|NCT02318329|65709048|FG008|Overall Study|Other|1|||
23539820|NCT02318329|65709049|FG009|Overall Study|Other|1|||
23539821|NCT02447991|65709050|FG000|Overall Study|Withdrawn by subject - no data|0|||
23539822|NCT02447991|65709051|FG001|Overall Study|Withdrawn by subject - no data|2|||
23539823|NCT02447991|65709050|FG000|Overall Study|Withdrawn by Subject - with data|4|||
23539824|NCT02447991|65709051|FG001|Overall Study|Withdrawn by Subject - with data|4|||
23539825|NCT02447991|65709050|FG000|Overall Study|Lost to Follow-up - no data|3|||
23539826|NCT02447991|65709051|FG001|Overall Study|Lost to Follow-up - no data|6|||
23539827|NCT02447991|65709050|FG000|Overall Study|Lost to follow-up - with data|0|||
23539828|NCT02447991|65709051|FG001|Overall Study|Lost to follow-up - with data|3|||
23539829|NCT02447991|65709050|FG000|Overall Study|End of study - no treatment results|3|||
23539830|NCT02447991|65709051|FG001|Overall Study|End of study - no treatment results|6|||
23539831|NCT02447991|65709050|FG000|Overall Study|End of study - partial treatment results|0|||
23539832|NCT02447991|65709051|FG001|Overall Study|End of study - partial treatment results|9|||
23539833|NCT01071395|65709053|FG000|Overall Study|Withdrawal by Subject|2|||
23539834|NCT01071395|65709054|FG001|Overall Study|Withdrawal by Subject|1|||
23539835|NCT01071395|65709053|FG000|Overall Study|Adverse Event|3|||
23539836|NCT01071395|65709054|FG001|Overall Study|Adverse Event|1|||
23539837|NCT01542528|65709055|FG000|Overall Study|Lost to Follow-up|2|||
23539838|NCT01542528|65709056|FG001|Overall Study|Lost to Follow-up|1|||
23539839|NCT01542528|65709055|FG000|Overall Study|Physician Decision|1|||
23539840|NCT01542528|65709056|FG001|Overall Study|Physician Decision|0|||
23539841|NCT01542528|65709055|FG000|Overall Study|Withdrawal by Subject|9|||
23539842|NCT01542528|65709056|FG001|Overall Study|Withdrawal by Subject|6|||
23539843|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
23539844|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
23539845|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
23539846|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
23539847|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
23539848|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
23539849|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
23539850|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
23539851|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
23539852|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
23539853|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
23539854|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
23539855|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
23539856|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
23539857|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
23539858|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
23539859|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
23539860|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
23539861|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
23539862|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
23539863|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
23539864|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
23539865|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
23539866|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
23539867|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
23539868|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
23539869|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
23539870|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
23539871|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
23539872|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
23539873|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
23539874|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
23539875|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
23539876|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
23539877|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
23539878|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
23539879|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
23539880|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
23539881|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
23539882|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
23539883|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
23539884|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
23539885|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
23539886|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
23539887|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
23539888|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
23539889|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
23539890|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
23424231|NCT03158272|65296421|FG001|Overall Study|Death|0|||
23424232|NCT03158272|65296422|FG002|Overall Study|Death|1|||
23424233|NCT03158272|65296423|FG003|Overall Study|Death|0|||
23424234|NCT03158272|65296420|FG000|Overall Study|Other reasons|0|||
23424235|NCT03158272|65296421|FG001|Overall Study|Other reasons|0|||
23424236|NCT03158272|65296422|FG002|Overall Study|Other reasons|1|||
23424237|NCT03158272|65296423|FG003|Overall Study|Other reasons|0|||
23424238|NCT03158272|65296420|FG000|Overall Study|Adverse event unrelated to the drug|0|||
23424239|NCT03158272|65296421|FG001|Overall Study|Adverse event unrelated to the drug|1|||
23424240|NCT03158272|65296422|FG002|Overall Study|Adverse event unrelated to the drug|0|||
23424241|NCT03158272|65296423|FG003|Overall Study|Adverse event unrelated to the drug|0|||
23424242|NCT03215706|65296425|FG000|Randomization|Adverse Event unrelated to study drug|1|||
23424243|NCT03215706|65296426|FG001|Randomization|Adverse Event unrelated to study drug|0|||
23424244|NCT03215706|65296425|FG000|Randomization|participant withdrew consent|1|||
23539891|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
23539892|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
23539893|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
23539894|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
23539895|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
23539896|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
23539897|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
23424245|NCT03215706|65296426|FG001|Randomization|participant withdrew consent|3|||
23424246|NCT03215706|65296425|FG000|Randomization|no longer meets study criteria|1|||
23424247|NCT03215706|65296426|FG001|Randomization|no longer meets study criteria|4|||
23424248|NCT03215706|65296425|FG000|Randomization|other reasons|0|||
23424249|NCT03215706|65296426|FG001|Randomization|other reasons|2|||
23424250|NCT03215706|65296425|FG000|Treatment Period|Disease Progression|150|||
23424251|NCT03215706|65296426|FG001|Treatment Period|Disease Progression|142|||
23424252|NCT03215706|65296425|FG000|Treatment Period|Study Drug Toxicity|53|||
23539898|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
23539899|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
23539900|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
23539901|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
23539902|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
23539903|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
23539904|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
23539905|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
23539906|NCT01884350|65709057|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
23539907|NCT01884350|65709058|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
23539908|NCT01884350|65709059|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
23539909|NCT01591681|65709065|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
23539910|NCT01591681|65709065|FG000|Overall Study|Failed to use system during run-in|1|||
23539911|NCT00262834|65709066|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
23539912|NCT00262834|65709067|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
23539913|NCT01462344|65709084|FG000|Overall Study|Withdrawal by Subject|245|||
23539914|NCT01462344|65709085|FG001|Overall Study|Withdrawal by Subject|226|||
23539915|NCT01462344|65709084|FG000|Overall Study|Adverse Event|24|||
23539916|NCT01462344|65709085|FG001|Overall Study|Adverse Event|23|||
23539917|NCT01462344|65709084|FG000|Overall Study|Asthma Exacerbation|34|||
23539918|NCT01462344|65709085|FG001|Overall Study|Asthma Exacerbation|35|||
23539919|NCT01462344|65709084|FG000|Overall Study|Lack of Efficacy|5|||
23539920|NCT01462344|65709085|FG001|Overall Study|Lack of Efficacy|6|||
23539921|NCT01462344|65709084|FG000|Overall Study|Protocol Violation|68|||
23539922|NCT01462344|65709085|FG001|Overall Study|Protocol Violation|53|||
23539923|NCT01462344|65709084|FG000|Overall Study|Lost to Follow-up|7|||
23539924|NCT01462344|65709085|FG001|Overall Study|Lost to Follow-up|7|||
23539925|NCT03728582|65709086|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
23539926|NCT03728582|65709087|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
23539927|NCT03728582|65709086|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
23539928|NCT03728582|65709087|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
23539929|NCT00617240|65709089|FG000|Overall Study|Lack of Efficacy|1|||
23539930|NCT00617240|65709090|FG001|Overall Study|Lack of Efficacy|0|||
23539931|NCT01969838|65709091|FG000|Double-blind Phase|Adverse Event|10|||
23539932|NCT01969838|65709092|FG001|Double-blind Phase|Adverse Event|4|||
23539933|NCT01969838|65709093|FG002|Double-blind Phase|Adverse Event|0|||
23539934|NCT01969838|65709094|FG003|Double-blind Phase|Adverse Event|0|||
23539935|NCT01969838|65709091|FG000|Double-blind Phase|Death|5|||
23539936|NCT01969838|65709092|FG001|Double-blind Phase|Death|2|||
23539937|NCT01969838|65709093|FG002|Double-blind Phase|Death|0|||
23539938|NCT01969838|65709094|FG003|Double-blind Phase|Death|0|||
23539939|NCT01969838|65709091|FG000|Double-blind Phase|Physician Decision|5|||
23539940|NCT01969838|65709092|FG001|Double-blind Phase|Physician Decision|1|||
23539941|NCT01969838|65709093|FG002|Double-blind Phase|Physician Decision|0|||
23539942|NCT01969838|65709094|FG003|Double-blind Phase|Physician Decision|0|||
23539943|NCT01969838|65709091|FG000|Double-blind Phase|Subject Decision|4|||
23539944|NCT01969838|65709092|FG001|Double-blind Phase|Subject Decision|2|||
23539945|NCT01969838|65709093|FG002|Double-blind Phase|Subject Decision|0|||
23616559|NCT05361304|65982364|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
23616560|NCT05361304|65982365|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
23539946|NCT01969838|65709094|FG003|Double-blind Phase|Subject Decision|0|||
23539947|NCT01969838|65709091|FG000|Double-blind Phase|Disease Progression|2|||
23539948|NCT01969838|65709092|FG001|Double-blind Phase|Disease Progression|0|||
23539949|NCT01969838|65709093|FG002|Double-blind Phase|Disease Progression|0|||
23539950|NCT01969838|65709094|FG003|Double-blind Phase|Disease Progression|0|||
23539951|NCT01969838|65709091|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
23539952|NCT01969838|65709092|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
23539953|NCT01969838|65709093|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
23539954|NCT01969838|65709094|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
23539955|NCT01969838|65709091|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
23424253|NCT03215706|65296426|FG001|Treatment Period|Study Drug Toxicity|21|||
23539956|NCT01969838|65709092|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
23539957|NCT01969838|65709093|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
23539958|NCT01969838|65709094|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
23539959|NCT01969838|65709091|FG000|Open-label Phase|Adverse Event|0|||
23539960|NCT01969838|65709092|FG001|Open-label Phase|Adverse Event|0|||
23539961|NCT01969838|65709093|FG002|Open-label Phase|Adverse Event|37|||
23424254|NCT03215706|65296425|FG000|Treatment Period|Death|2|||
23539962|NCT01969838|65709094|FG003|Open-label Phase|Adverse Event|49|||
23539963|NCT01969838|65709091|FG000|Open-label Phase|Disease Progression|0|||
23539964|NCT01969838|65709092|FG001|Open-label Phase|Disease Progression|0|||
23539965|NCT01969838|65709093|FG002|Open-label Phase|Disease Progression|26|||
23539966|NCT01969838|65709094|FG003|Open-label Phase|Disease Progression|27|||
23539967|NCT01969838|65709091|FG000|Open-label Phase|Lack of Efficacy|0|||
23539968|NCT01969838|65709092|FG001|Open-label Phase|Lack of Efficacy|0|||
23539969|NCT01969838|65709093|FG002|Open-label Phase|Lack of Efficacy|17|||
23539970|NCT01969838|65709094|FG003|Open-label Phase|Lack of Efficacy|19|||
23539971|NCT01969838|65709091|FG000|Open-label Phase|Subject Decision|0|||
23539972|NCT01969838|65709092|FG001|Open-label Phase|Subject Decision|0|||
23539973|NCT01969838|65709093|FG002|Open-label Phase|Subject Decision|14|||
23539974|NCT01969838|65709094|FG003|Open-label Phase|Subject Decision|15|||
23539975|NCT01969838|65709091|FG000|Open-label Phase|Death|0|||
23539976|NCT01969838|65709092|FG001|Open-label Phase|Death|0|||
23539977|NCT01969838|65709093|FG002|Open-label Phase|Death|13|||
23539978|NCT01969838|65709094|FG003|Open-label Phase|Death|11|||
23539979|NCT01969838|65709091|FG000|Open-label Phase|Physician Decision|0|||
23539980|NCT01969838|65709092|FG001|Open-label Phase|Physician Decision|0|||
23539981|NCT01969838|65709093|FG002|Open-label Phase|Physician Decision|9|||
23539982|NCT01969838|65709094|FG003|Open-label Phase|Physician Decision|14|||
23539983|NCT01969838|65709091|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
23539984|NCT01969838|65709092|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
23539985|NCT01969838|65709093|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
23539986|NCT01969838|65709094|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
23539987|NCT01978119|65709099|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
23539988|NCT01978119|65709100|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
23539989|NCT01978119|65709099|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23539990|NCT01978119|65709100|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23539991|NCT01978119|65709099|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23539992|NCT01978119|65709100|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
23539993|NCT00659646|65709103|FG000|Overall Study|Protocol Violation|12|||
23539994|NCT00659646|65709104|FG001|Overall Study|Protocol Violation|8|||
23539995|NCT00659646|65709103|FG000|Overall Study|Adverse Event|1|||
23539996|NCT00659646|65709104|FG001|Overall Study|Adverse Event|0|||
23539997|NCT00659646|65709103|FG000|Overall Study|Lost to Follow-up|1|||
23539998|NCT00659646|65709104|FG001|Overall Study|Lost to Follow-up|0|||
23539999|NCT00659646|65709103|FG000|Overall Study|protocol noncompliance after randomized|1|||
23540000|NCT00659646|65709104|FG001|Overall Study|protocol noncompliance after randomized|0|||
23540001|NCT00660010|65709114|FG000|Overall Study|Withdrawal by Subject|2|||
23540002|NCT00660010|65709114|FG000|Overall Study|Lost to Follow-up|3|||
23540003|NCT00660010|65709114|FG000|Overall Study|Adverse Event|1|||
23540004|NCT00660010|65709114|FG000|Overall Study|Noncompliance with visit schedule|3|||
23540005|NCT01105533|65709115|FG000|Overall Study|Death|0|||
23540006|NCT01105533|65709116|FG001|Overall Study|Death|0|||
23540007|NCT01105533|65709117|FG002|Overall Study|Death|0|||
23540008|NCT01105533|65709118|FG003|Overall Study|Death|0|||
23540009|NCT01105533|65709119|FG004|Overall Study|Death|1|||
23540010|NCT01105533|65709120|FG005|Overall Study|Death|0|||
23540011|NCT01105533|65709121|FG006|Overall Study|Death|0|||
23540012|NCT01105533|65709122|FG007|Overall Study|Death|0|||
23540013|NCT01105533|65709123|FG008|Overall Study|Death|0|||
23540014|NCT01105533|65709115|FG000|Overall Study|Lack of Efficacy|1|||
23540015|NCT01105533|65709116|FG001|Overall Study|Lack of Efficacy|1|||
23540016|NCT01105533|65709117|FG002|Overall Study|Lack of Efficacy|3|||
23540017|NCT01105533|65709118|FG003|Overall Study|Lack of Efficacy|3|||
23540018|NCT01105533|65709119|FG004|Overall Study|Lack of Efficacy|4|||
23540019|NCT01105533|65709120|FG005|Overall Study|Lack of Efficacy|5|||
23540020|NCT01105533|65709121|FG006|Overall Study|Lack of Efficacy|3|||
23540021|NCT01105533|65709122|FG007|Overall Study|Lack of Efficacy|2|||
23540022|NCT01105533|65709123|FG008|Overall Study|Lack of Efficacy|9|||
23540023|NCT01105533|65709115|FG000|Overall Study|Adverse Event|0|||
23540024|NCT01105533|65709116|FG001|Overall Study|Adverse Event|0|||
23540025|NCT01105533|65709117|FG002|Overall Study|Adverse Event|0|||
23540026|NCT01105533|65709118|FG003|Overall Study|Adverse Event|0|||
23540027|NCT01105533|65709119|FG004|Overall Study|Adverse Event|1|||
23540028|NCT01105533|65709120|FG005|Overall Study|Adverse Event|2|||
23424255|NCT03215706|65296426|FG001|Treatment Period|Death|1|||
23424256|NCT03215706|65296425|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
23540029|NCT01105533|65709121|FG006|Overall Study|Adverse Event|2|||
23540030|NCT01105533|65709122|FG007|Overall Study|Adverse Event|0|||
23540031|NCT01105533|65709123|FG008|Overall Study|Adverse Event|1|||
23540032|NCT01105533|65709115|FG000|Overall Study|Other|0|||
23540033|NCT01105533|65709116|FG001|Overall Study|Other|0|||
23616561|NCT05361304|65982364|FG000|Overall Study|COVID-19 Related|1|||
23424257|NCT03215706|65296426|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
23540034|NCT01105533|65709117|FG002|Overall Study|Other|0|||
23540035|NCT01105533|65709118|FG003|Overall Study|Other|0|||
23540036|NCT01105533|65709119|FG004|Overall Study|Other|1|||
23540037|NCT01105533|65709120|FG005|Overall Study|Other|0|||
23540038|NCT01105533|65709121|FG006|Overall Study|Other|3|||
23540039|NCT01105533|65709122|FG007|Overall Study|Other|1|||
23540040|NCT01105533|65709123|FG008|Overall Study|Other|2|||
23540041|NCT01105533|65709115|FG000|Overall Study|Physician Decision|0|||
23540042|NCT01105533|65709116|FG001|Overall Study|Physician Decision|0|||
23540043|NCT01105533|65709117|FG002|Overall Study|Physician Decision|0|||
23540044|NCT01105533|65709118|FG003|Overall Study|Physician Decision|0|||
23540045|NCT01105533|65709119|FG004|Overall Study|Physician Decision|0|||
23540046|NCT01105533|65709120|FG005|Overall Study|Physician Decision|0|||
23540047|NCT01105533|65709121|FG006|Overall Study|Physician Decision|0|||
23540048|NCT01105533|65709122|FG007|Overall Study|Physician Decision|1|||
23540049|NCT01105533|65709123|FG008|Overall Study|Physician Decision|0|||
23540050|NCT00701051|65709144|FG000|Screening|Failed Screening|40|||
23540051|NCT00701051|65709145|FG001|Screening|Failed Screening|0|||
23540052|NCT00701051|65709146|FG002|Screening|Failed Screening|0|||
23540053|NCT00701051|65709144|FG000|Screening|Time conflicts|19|||
23540054|NCT00701051|65709145|FG001|Screening|Time conflicts|0|||
23540055|NCT00701051|65709146|FG002|Screening|Time conflicts|0|||
23540056|NCT00701051|65709144|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
23540057|NCT00701051|65709145|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
23540058|NCT00701051|65709146|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
23540059|NCT02610140|65709147|FG000|Randomization and Treatment Period|Radiological progression|23|||
23540060|NCT02610140|65709148|FG001|Randomization and Treatment Period|Radiological progression|15|||
23540061|NCT02610140|65709147|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
23540062|NCT02610140|65709148|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
23540063|NCT02610140|65709147|FG000|Randomization and Treatment Period|Protocol Violation|1|||
23540064|NCT02610140|65709148|FG001|Randomization and Treatment Period|Protocol Violation|0|||
23540065|NCT02610140|65709147|FG000|Randomization and Treatment Period|Physician Decision|0|||
23540066|NCT02610140|65709148|FG001|Randomization and Treatment Period|Physician Decision|1|||
23540067|NCT02610140|65709147|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
23540068|NCT02610140|65709148|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
23540069|NCT02610140|65709147|FG000|Randomization and Treatment Period|Death|7|||
23540070|NCT02610140|65709148|FG001|Randomization and Treatment Period|Death|1|||
23540071|NCT02610140|65709147|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
23540072|NCT02610140|65709148|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
23540073|NCT02610140|65709147|FG000|Randomization and Treatment Period|Adverse Event|44|||
23540074|NCT02610140|65709148|FG001|Randomization and Treatment Period|Adverse Event|13|||
23540075|NCT02610140|65709147|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
23540076|NCT02610140|65709148|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
23540077|NCT02610140|65709147|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
23540078|NCT02610140|65709148|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
23312505|NCT04711902|64886709|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
23540079|NCT02610140|65709147|FG000|Randomization and Treatment Period|Not treated|3|||
23540080|NCT02610140|65709148|FG001|Randomization and Treatment Period|Not treated|10|||
23540081|NCT02610140|65709147|FG000|Safety Follow-up|Other|0|||
23540082|NCT02610140|65709148|FG001|Safety Follow-up|Other|2|||
23540083|NCT02610140|65709147|FG000|Safety Follow-up|Lost to Follow-up|1|||
23540084|NCT02610140|65709148|FG001|Safety Follow-up|Lost to Follow-up|0|||
23540085|NCT02610140|65709147|FG000|Safety Follow-up|No follow-up|5|||
23540086|NCT02610140|65709148|FG001|Safety Follow-up|No follow-up|3|||
23540087|NCT02610140|65709147|FG000|Safety Follow-up|Death|12|||
23540088|NCT02610140|65709148|FG001|Safety Follow-up|Death|2|||
23540089|NCT02610140|65709147|FG000|Safety Follow-up|Deterioration of general conditions|15|||
23209816|NCT01764256|64504721|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
23209817|NCT01764256|64504722|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
23540090|NCT02610140|65709148|FG001|Safety Follow-up|Deterioration of general conditions|5|||
23540091|NCT02610140|65709147|FG000|Safety Follow-up|Withdrawal by Subject|12|||
23540092|NCT02610140|65709148|FG001|Safety Follow-up|Withdrawal by Subject|12|||
23616562|NCT05361304|65982365|FG001|Overall Study|COVID-19 Related|2|||
23209818|NCT01764256|64504723|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
23209819|NCT01764256|64504720|FG000|Received All Vaccinations|Lost to Follow-up|1|||
23209820|NCT01764256|64504721|FG001|Received All Vaccinations|Lost to Follow-up|0|||
23209821|NCT01764256|64504722|FG002|Received All Vaccinations|Lost to Follow-up|0|||
23540093|NCT02610140|65709147|FG000|Active Follow-up|Progressive disease - radiological|30|||
23540094|NCT02610140|65709148|FG001|Active Follow-up|Progressive disease - radiological|22|||
23540095|NCT02610140|65709147|FG000|Active Follow-up|Death|8|||
23540096|NCT02610140|65709148|FG001|Active Follow-up|Death|1|||
23540097|NCT02610140|65709147|FG000|Active Follow-up|Withdrawal by Subject|4|||
23540098|NCT02610140|65709148|FG001|Active Follow-up|Withdrawal by Subject|0|||
23540099|NCT02610140|65709147|FG000|Active Follow-up|Progressive disease - clinical|1|||
23540100|NCT02610140|65709148|FG001|Active Follow-up|Progressive disease - clinical|2|||
23540101|NCT02610140|65709147|FG000|Active Follow-up|Deterioration of general conditions|1|||
23540102|NCT02610140|65709148|FG001|Active Follow-up|Deterioration of general conditions|0|||
23540103|NCT02610140|65709147|FG000|Active Follow-up|Ongoing but not completed|4|||
23540104|NCT02610140|65709148|FG001|Active Follow-up|Ongoing but not completed|1|||
23540105|NCT02610140|65709147|FG000|Long-term Follow-up|Death|86|||
23540106|NCT02610140|65709148|FG001|Long-term Follow-up|Death|44|||
23540107|NCT02610140|65709147|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
23540108|NCT02610140|65709148|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
23540109|NCT02610140|65709147|FG000|Long-term Follow-up|Lost to Follow-up|1|||
23540110|NCT02610140|65709148|FG001|Long-term Follow-up|Lost to Follow-up|2|||
23540111|NCT02610140|65709147|FG000|Long-term Follow-up|Ongoing but not completed|30|||
23540112|NCT02610140|65709148|FG001|Long-term Follow-up|Ongoing but not completed|17|||
23540113|NCT03791398|65709150|FG000|Overall Study|Progression of Disease Under Study|2|||
23540114|NCT03791398|65709151|FG001|Overall Study|Progression of Disease Under Study|0|||
23540115|NCT03791398|65709152|FG002|Overall Study|Progression of Disease Under Study|0|||
23540116|NCT01265953|65709154|FG000|Overall Study|Non compliance|5|||
23540117|NCT01265953|65709155|FG001|Overall Study|Non compliance|3|||
23540118|NCT02604589|65709158|FG000|Overall Study|catheter dislodgement|0|||
23540119|NCT02604589|65709159|FG001|Overall Study|catheter dislodgement|0|||
23540120|NCT02604589|65709160|FG002|Overall Study|catheter dislodgement|1|||
23540121|NCT00887341|65709164|FG000|Overall Study|Refused treatment|1|||
23540122|NCT00887341|65709165|FG001|Overall Study|Refused treatment|0|||
23540123|NCT00887341|65709164|FG000|Overall Study|Withdrawal by Subject|1|||
23540124|NCT00887341|65709165|FG001|Overall Study|Withdrawal by Subject|1|||
23540125|NCT00887341|65709164|FG000|Overall Study|Adverse Event|0|||
23540126|NCT00887341|65709165|FG001|Overall Study|Adverse Event|1|||
23540127|NCT00887341|65709164|FG000|Overall Study|Lost to Follow-up|0|||
23540128|NCT00887341|65709165|FG001|Overall Study|Lost to Follow-up|1|||
23540129|NCT01640301|65709166|FG000|Overall Study|Death|0|||
23540130|NCT01640301|65709167|FG001|Overall Study|Death|8|||
23540131|NCT01709227|65709168|FG000|Overall Study|Physician Decision|1|||
23540132|NCT01709227|65709169|FG001|Overall Study|Physician Decision|0|||
23540133|NCT01709227|65709168|FG000|Overall Study|Pleural Peritoneal communication|0|||
23540134|NCT01709227|65709169|FG001|Overall Study|Pleural Peritoneal communication|9|||
23540135|NCT01332305|65709172|FG000|Overall Study|Adverse Event|1|||
23540136|NCT01332305|65709173|FG001|Overall Study|Adverse Event|4|||
23540137|NCT01332305|65709174|FG002|Overall Study|Adverse Event|6|||
23540138|NCT01332305|65709175|FG003|Overall Study|Adverse Event|3|||
23540139|NCT01332305|65709176|FG004|Overall Study|Adverse Event|5|||
23540140|NCT01332305|65709172|FG000|Overall Study|Withdrawal by Subject|6|||
23540141|NCT01332305|65709173|FG001|Overall Study|Withdrawal by Subject|5|||
23540142|NCT01332305|65709174|FG002|Overall Study|Withdrawal by Subject|4|||
23540143|NCT01332305|65709175|FG003|Overall Study|Withdrawal by Subject|1|||
23540144|NCT01332305|65709176|FG004|Overall Study|Withdrawal by Subject|0|||
23540145|NCT01332305|65709172|FG000|Overall Study|Lost to Follow-up|0|||
23540146|NCT01332305|65709173|FG001|Overall Study|Lost to Follow-up|2|||
23540147|NCT01332305|65709174|FG002|Overall Study|Lost to Follow-up|3|||
23540148|NCT01332305|65709175|FG003|Overall Study|Lost to Follow-up|2|||
23540149|NCT01332305|65709176|FG004|Overall Study|Lost to Follow-up|3|||
23540150|NCT01332305|65709172|FG000|Overall Study|Protocol Violation|1|||
23540151|NCT01332305|65709173|FG001|Overall Study|Protocol Violation|2|||
23540152|NCT01332305|65709174|FG002|Overall Study|Protocol Violation|1|||
23540153|NCT01332305|65709175|FG003|Overall Study|Protocol Violation|0|||
23540154|NCT01332305|65709176|FG004|Overall Study|Protocol Violation|3|||
23424258|NCT03215706|65296425|FG000|Treatment Period|Request to D/C treatment|1|||
23424259|NCT03215706|65296426|FG001|Treatment Period|Request to D/C treatment|6|||
23540155|NCT01332305|65709172|FG000|Overall Study|Withdrawal by Sponsor|1|||
23540156|NCT01332305|65709173|FG001|Overall Study|Withdrawal by Sponsor|0|||
23540157|NCT01332305|65709174|FG002|Overall Study|Withdrawal by Sponsor|0|||
23540158|NCT01332305|65709175|FG003|Overall Study|Withdrawal by Sponsor|1|||
23540159|NCT01332305|65709176|FG004|Overall Study|Withdrawal by Sponsor|1|||
23540160|NCT01332305|65709172|FG000|Overall Study|Treatment Failure|1|||
23540161|NCT01332305|65709173|FG001|Overall Study|Treatment Failure|1|||
23540162|NCT01332305|65709174|FG002|Overall Study|Treatment Failure|0|||
23540163|NCT01332305|65709175|FG003|Overall Study|Treatment Failure|0|||
23540164|NCT01332305|65709176|FG004|Overall Study|Treatment Failure|0|||
23540165|NCT01332305|65709172|FG000|Overall Study|Physician Decision|0|||
23540166|NCT01332305|65709173|FG001|Overall Study|Physician Decision|0|||
23540167|NCT01332305|65709174|FG002|Overall Study|Physician Decision|0|||
23616563|NCT05361304|65982364|FG000|Overall Study|Withdrawal by Subject|1|||
23424260|NCT03215706|65296425|FG000|Treatment Period|Participant withdrew consent|3|||
23424261|NCT03215706|65296426|FG001|Treatment Period|Participant withdrew consent|4|||
23424262|NCT03215706|65296425|FG000|Treatment Period|Lost to Follow-up|0|||
23424263|NCT03215706|65296426|FG001|Treatment Period|Lost to Follow-up|1|||
23424264|NCT03215706|65296425|FG000|Treatment Period|Other Reasons|4|||
23424265|NCT03215706|65296426|FG001|Treatment Period|Other Reasons|5|||
23424266|NCT03215706|65296425|FG000|Treatment Period|Ongoing in the treatment period|105|||
23540168|NCT01332305|65709175|FG003|Overall Study|Physician Decision|1|||
23540169|NCT01332305|65709176|FG004|Overall Study|Physician Decision|0|||
23540170|NCT01525082|65709177|FG000|Overall Study|Death|1|||
23540171|NCT00359762|65709182|FG000|Period II|Adverse Event|17|||
23540172|NCT00359762|65709183|FG001|Period II|Adverse Event|0|||
23540173|NCT00359762|65709184|FG002|Period II|Adverse Event|0|||
23540174|NCT00359762|65709185|FG003|Period II|Adverse Event|0|||
23540175|NCT00359762|65709186|FG004|Period II|Adverse Event|49|||
23540176|NCT00359762|65709182|FG000|Period II|Protocol Violation|18|||
23540177|NCT00359762|65709183|FG001|Period II|Protocol Violation|0|||
23540178|NCT00359762|65709184|FG002|Period II|Protocol Violation|0|||
23540179|NCT00359762|65709185|FG003|Period II|Protocol Violation|0|||
23540180|NCT00359762|65709186|FG004|Period II|Protocol Violation|11|||
23540181|NCT00359762|65709182|FG000|Period II|Physician Decision|17|||
23540182|NCT00359762|65709183|FG001|Period II|Physician Decision|0|||
23540183|NCT00359762|65709184|FG002|Period II|Physician Decision|0|||
23540184|NCT00359762|65709185|FG003|Period II|Physician Decision|0|||
23540185|NCT00359762|65709186|FG004|Period II|Physician Decision|23|||
23540186|NCT00359762|65709182|FG000|Period II|Death|2|||
23540187|NCT00359762|65709183|FG001|Period II|Death|0|||
23540188|NCT00359762|65709184|FG002|Period II|Death|0|||
23540189|NCT00359762|65709185|FG003|Period II|Death|0|||
23540190|NCT00359762|65709186|FG004|Period II|Death|4|||
23540191|NCT00359762|65709182|FG000|Period II|Lack of Efficacy|11|||
23540192|NCT00359762|65709183|FG001|Period II|Lack of Efficacy|0|||
23540193|NCT00359762|65709184|FG002|Period II|Lack of Efficacy|0|||
23540194|NCT00359762|65709185|FG003|Period II|Lack of Efficacy|0|||
23540195|NCT00359762|65709186|FG004|Period II|Lack of Efficacy|8|||
23540196|NCT00359762|65709182|FG000|Period II|Lost to follow up|5|||
23540197|NCT00359762|65709183|FG001|Period II|Lost to follow up|0|||
23540198|NCT00359762|65709184|FG002|Period II|Lost to follow up|0|||
23540199|NCT00359762|65709185|FG003|Period II|Lost to follow up|0|||
23540200|NCT00359762|65709186|FG004|Period II|Lost to follow up|5|||
23540201|NCT00359762|65709182|FG000|Period II|Entry Criteria Not Met|8|||
23540202|NCT00359762|65709183|FG001|Period II|Entry Criteria Not Met|0|||
23540203|NCT00359762|65709184|FG002|Period II|Entry Criteria Not Met|0|||
23540204|NCT00359762|65709185|FG003|Period II|Entry Criteria Not Met|0|||
23540205|NCT00359762|65709186|FG004|Period II|Entry Criteria Not Met|4|||
23540206|NCT00359762|65709182|FG000|Period II|Subject Decision|50|||
23540207|NCT00359762|65709183|FG001|Period II|Subject Decision|0|||
23540208|NCT00359762|65709184|FG002|Period II|Subject Decision|0|||
23540209|NCT00359762|65709185|FG003|Period II|Subject Decision|0|||
23540210|NCT00359762|65709186|FG004|Period II|Subject Decision|70|||
23540211|NCT00359762|65709182|FG000|Period III|Protocol Violation|0|||
23540212|NCT00359762|65709183|FG001|Period III|Protocol Violation|5|||
23540213|NCT00359762|65709184|FG002|Period III|Protocol Violation|3|||
23540214|NCT00359762|65709185|FG003|Period III|Protocol Violation|8|||
23540215|NCT00359762|65709186|FG004|Period III|Protocol Violation|0|||
23540216|NCT00359762|65709182|FG000|Period III|Adverse Event|0|||
23540217|NCT00359762|65709183|FG001|Period III|Adverse Event|3|||
23540218|NCT00359762|65709184|FG002|Period III|Adverse Event|4|||
23540219|NCT00359762|65709185|FG003|Period III|Adverse Event|10|||
23540220|NCT00359762|65709186|FG004|Period III|Adverse Event|0|||
23540221|NCT00359762|65709182|FG000|Period III|Physician Decision|0|||
23540222|NCT00359762|65709183|FG001|Period III|Physician Decision|5|||
23540223|NCT00359762|65709184|FG002|Period III|Physician Decision|9|||
23540224|NCT00359762|65709185|FG003|Period III|Physician Decision|15|||
23540225|NCT00359762|65709186|FG004|Period III|Physician Decision|0|||
23540226|NCT00359762|65709182|FG000|Period III|Lack of Efficacy|0|||
23540227|NCT00359762|65709183|FG001|Period III|Lack of Efficacy|7|||
23540228|NCT00359762|65709184|FG002|Period III|Lack of Efficacy|5|||
23540229|NCT00359762|65709185|FG003|Period III|Lack of Efficacy|9|||
23540230|NCT00359762|65709186|FG004|Period III|Lack of Efficacy|0|||
23540231|NCT00359762|65709182|FG000|Period III|Lost to follow up|0|||
23540232|NCT00359762|65709183|FG001|Period III|Lost to follow up|1|||
23540233|NCT00359762|65709184|FG002|Period III|Lost to follow up|1|||
23540234|NCT00359762|65709185|FG003|Period III|Lost to follow up|2|||
23540235|NCT00359762|65709186|FG004|Period III|Lost to follow up|0|||
23540236|NCT00359762|65709182|FG000|Period III|Entry Criteria Not Met|0|||
23540237|NCT00359762|65709183|FG001|Period III|Entry Criteria Not Met|1|||
23540238|NCT00359762|65709184|FG002|Period III|Entry Criteria Not Met|0|||
23540239|NCT00359762|65709185|FG003|Period III|Entry Criteria Not Met|1|||
23540240|NCT00359762|65709186|FG004|Period III|Entry Criteria Not Met|0|||
23540241|NCT00359762|65709182|FG000|Period III|Subject Decision|0|||
23540242|NCT00359762|65709183|FG001|Period III|Subject Decision|7|||
23540243|NCT00359762|65709184|FG002|Period III|Subject Decision|8|||
23540244|NCT00359762|65709185|FG003|Period III|Subject Decision|20|||
23540245|NCT00359762|65709186|FG004|Period III|Subject Decision|0|||
23540246|NCT00148343|65709187|FG000|Overall Study|Withdrawal by Subject|12|||
23540247|NCT00148343|65709188|FG001|Overall Study|Withdrawal by Subject|7|||
23540248|NCT00148343|65709187|FG000|Overall Study|Physician Decision|3|||
23540249|NCT00148343|65709188|FG001|Overall Study|Physician Decision|4|||
23540250|NCT01954017|65709191|FG000|Overall Study|Adverse Event|0|||
23540251|NCT01954017|65709192|FG001|Overall Study|Adverse Event|0|||
23540252|NCT01954017|65709193|FG002|Overall Study|Adverse Event|1|||
23540253|NCT01954017|65709191|FG000|Overall Study|Death|2|||
23540254|NCT01954017|65709192|FG001|Overall Study|Death|1|||
23540255|NCT01954017|65709193|FG002|Overall Study|Death|1|||
23540256|NCT01954017|65709191|FG000|Overall Study|Withdrawal by Subject|0|||
23540257|NCT01954017|65709192|FG001|Overall Study|Withdrawal by Subject|1|||
23540258|NCT01954017|65709193|FG002|Overall Study|Withdrawal by Subject|0|||
23540259|NCT01954017|65709191|FG000|Overall Study|Protocol Violation|0|||
23540260|NCT01954017|65709192|FG001|Overall Study|Protocol Violation|3|||
23424267|NCT03215706|65296426|FG001|Treatment Period|Ongoing in the treatment period|43|||
23424268|NCT02256267|65296430|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
23424269|NCT02256267|65296430|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
23424270|NCT03242772|65296431|FG000|Overall Study|Lost to Follow-up|2|||
23424271|NCT03242772|65296432|FG001|Overall Study|Lost to Follow-up|0|||
23424272|NCT03242772|65296431|FG000|Overall Study|Physician Decision|0|||
23424273|NCT03242772|65296432|FG001|Overall Study|Physician Decision|1|||
23424274|NCT03242772|65296431|FG000|Overall Study|Withdrawal by Subject|1|||
23424275|NCT03242772|65296432|FG001|Overall Study|Withdrawal by Subject|0|||
23424276|NCT02725593|65296435|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
23424277|NCT02725593|65296436|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
23424278|NCT02725593|65296435|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
23424279|NCT02725593|65296436|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
23424280|NCT02725593|65296435|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
23424281|NCT02725593|65296436|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
23424282|NCT02725593|65296435|FG000|Long Term Extension|Withdrawal by Subject|1|||
23424283|NCT02725593|65296436|FG001|Long Term Extension|Withdrawal by Subject|3|||
23424284|NCT03249935|65296441|FG000|Overall Study|Discharged from facility early|36|||
23424285|NCT03249935|65296441|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
23424286|NCT03249935|65296441|FG000|Overall Study|Protocol Violation|5|||
23424287|NCT01514240|65296442|FG000|Overall Study|Adverse Event|4|||
23424288|NCT01514240|65296443|FG001|Overall Study|Adverse Event|4|||
23424289|NCT01514240|65296442|FG000|Overall Study|Subject Decision|2|||
23540261|NCT01954017|65709193|FG002|Overall Study|Protocol Violation|2|||
23540262|NCT01954017|65709191|FG000|Overall Study|Necrotizing enterocolitis|1|||
23540263|NCT01954017|65709192|FG001|Overall Study|Necrotizing enterocolitis|0|||
23540264|NCT01954017|65709193|FG002|Overall Study|Necrotizing enterocolitis|1|||
23540265|NCT01954017|65709191|FG000|Overall Study|Enteral intake stopped >7 days|0|||
23540266|NCT01954017|65709192|FG001|Overall Study|Enteral intake stopped >7 days|1|||
23540267|NCT01954017|65709193|FG002|Overall Study|Enteral intake stopped >7 days|1|||
23540268|NCT01954017|65709191|FG000|Overall Study|All other reasons|2|||
23540269|NCT01954017|65709192|FG001|Overall Study|All other reasons|2|||
23540270|NCT01954017|65709193|FG002|Overall Study|All other reasons|7|||
23540271|NCT00113516|65709194|FG000|Part 1|Adverse Event|6|||
23540272|NCT00113516|65709195|FG001|Part 1|Adverse Event|0|||
23540273|NCT00113516|65709194|FG000|Part 1|Death|3|||
23540274|NCT00113516|65709195|FG001|Part 1|Death|0|||
23540275|NCT00113516|65709194|FG000|Part 1|Other|3|||
23540276|NCT00113516|65709195|FG001|Part 1|Other|0|||
23540277|NCT00113516|65709194|FG000|Part 1|Withdrawal by Subject|2|||
23540278|NCT00113516|65709195|FG001|Part 1|Withdrawal by Subject|0|||
23616564|NCT05361304|65982365|FG001|Overall Study|Withdrawal by Subject|0|||
23616565|NCT00111839|65982366|FG000|Overall Study|Disease Progression|30|||
23616566|NCT00111839|65982367|FG001|Overall Study|Disease Progression|33|||
23540279|NCT00113516|65709194|FG000|Part 1|Lack of Efficacy|2|||
23540280|NCT00113516|65709195|FG001|Part 1|Lack of Efficacy|0|||
23540281|NCT00113516|65709194|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
23540282|NCT00113516|65709195|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
23540283|NCT00113516|65709194|FG000|Part 1|Laboratory Abnormality|1|||
23540284|NCT00113516|65709195|FG001|Part 1|Laboratory Abnormality|0|||
23540285|NCT00113516|65709194|FG000|Part 1|Ongoing|1|||
23540286|NCT00113516|65709195|FG001|Part 1|Ongoing|0|||
23540287|NCT00113516|65709194|FG000|Part 1|Missing|65|||
23540288|NCT00113516|65709195|FG001|Part 1|Missing|0|||
23540289|NCT00113516|65709194|FG000|Part 2|Adverse Event|0|||
23540290|NCT00113516|65709195|FG001|Part 2|Adverse Event|16|||
23540291|NCT00113516|65709194|FG000|Part 2|Death|0|||
23540292|NCT00113516|65709195|FG001|Part 2|Death|5|||
23540293|NCT00113516|65709194|FG000|Part 2|Lack of Efficacy|0|||
23540294|NCT00113516|65709195|FG001|Part 2|Lack of Efficacy|37|||
23540295|NCT00113516|65709194|FG000|Part 2|Withdrawal by Subject|0|||
23540296|NCT00113516|65709195|FG001|Part 2|Withdrawal by Subject|3|||
23540297|NCT00113516|65709194|FG000|Part 2|Other|0|||
23540298|NCT00113516|65709195|FG001|Part 2|Other|3|||
23540299|NCT00113516|65709194|FG000|Part 2|Laboratory Abnormality|0|||
23540300|NCT00113516|65709195|FG001|Part 2|Laboratory Abnormality|1|||
23540301|NCT00113516|65709194|FG000|Part 2|Ongoing|0|||
23540302|NCT00113516|65709195|FG001|Part 2|Ongoing|1|||
23540303|NCT01218646|65709196|FG000|Overall Study|Adverse Event|0|||
23540304|NCT01218646|65709197|FG001|Overall Study|Adverse Event|0|||
23540305|NCT01218646|65709198|FG002|Overall Study|Adverse Event|1|||
23540306|NCT01218646|65709199|FG003|Overall Study|Adverse Event|0|||
23540307|NCT01218646|65709196|FG000|Overall Study|Lost to Follow-up|1|||
23540308|NCT01218646|65709197|FG001|Overall Study|Lost to Follow-up|0|||
23540309|NCT01218646|65709198|FG002|Overall Study|Lost to Follow-up|0|||
23540310|NCT01218646|65709199|FG003|Overall Study|Lost to Follow-up|0|||
23540311|NCT01218646|65709196|FG000|Overall Study|Protocol Violation|0|||
23540312|NCT01218646|65709197|FG001|Overall Study|Protocol Violation|0|||
23540313|NCT01218646|65709198|FG002|Overall Study|Protocol Violation|1|||
23540314|NCT01218646|65709199|FG003|Overall Study|Protocol Violation|1|||
23540315|NCT04535037|65709202|FG000|Overall Study|Protocol Violation|1|||
23540316|NCT04535037|65709203|FG001|Overall Study|Protocol Violation|0|||
23540317|NCT04535037|65709202|FG000|Overall Study|Withdrawal by Subject|8|||
23540318|NCT04535037|65709203|FG001|Overall Study|Withdrawal by Subject|9|||
23540319|NCT04535037|65709202|FG000|Overall Study|Migrated / moved from the study area|1|||
23540320|NCT04535037|65709203|FG001|Overall Study|Migrated / moved from the study area|4|||
23540321|NCT04535037|65709202|FG000|Overall Study|Other|2|||
23540322|NCT04535037|65709203|FG001|Overall Study|Other|5|||
23540323|NCT04726709|65709204|FG000|Overall Study|Withdrawal by Subject|2|||
23540324|NCT04726709|65709205|FG001|Overall Study|Withdrawal by Subject|2|||
23540325|NCT00852397|65709206|FG000|Overall Study|Adverse Event|4|||
23540326|NCT00852397|65709207|FG001|Overall Study|Adverse Event|6|||
23540327|NCT00852397|65709208|FG002|Overall Study|Adverse Event|4|||
23540328|NCT00852397|65709206|FG000|Overall Study|Death|0|||
23540329|NCT00852397|65709207|FG001|Overall Study|Death|0|||
23540330|NCT00852397|65709208|FG002|Overall Study|Death|1|||
23540331|NCT00852397|65709206|FG000|Overall Study|Withdrawal by Subject|4|||
23540332|NCT00852397|65709207|FG001|Overall Study|Withdrawal by Subject|1|||
23540333|NCT00852397|65709208|FG002|Overall Study|Withdrawal by Subject|2|||
23540334|NCT00852397|65709206|FG000|Overall Study|Study terminated by sponsor|2|||
23540335|NCT00852397|65709207|FG001|Overall Study|Study terminated by sponsor|1|||
23540336|NCT00852397|65709208|FG002|Overall Study|Study terminated by sponsor|6|||
23540337|NCT00852397|65709206|FG000|Overall Study|Difficulty in study site visit|1|||
23540338|NCT00852397|65709207|FG001|Overall Study|Difficulty in study site visit|0|||
23540339|NCT00852397|65709208|FG002|Overall Study|Difficulty in study site visit|0|||
23540340|NCT00852397|65709206|FG000|Overall Study|Protocol Violation|0|||
23540341|NCT00852397|65709207|FG001|Overall Study|Protocol Violation|0|||
23540342|NCT00852397|65709208|FG002|Overall Study|Protocol Violation|1|||
23540343|NCT02770391|65709209|FG000|Overall Study|Lost to Follow-up|2|||
23540344|NCT02770391|65709209|FG000|Overall Study|Withdrawal by Subject|1|||
23540345|NCT02770391|65709209|FG000|Overall Study|Surgery delayed unevaluable|2|||
23540346|NCT02770391|65709209|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
23540347|NCT02528214|65709210|FG000|Overall Study|Protocol Violation|0|||
23540348|NCT02528214|65709211|FG001|Overall Study|Protocol Violation|1|||
23540349|NCT02528214|65709210|FG000|Overall Study|Adverse Event|0|||
23540350|NCT02528214|65709211|FG001|Overall Study|Adverse Event|1|||
23540351|NCT02528214|65709210|FG000|Overall Study|Other than specified above|0|||
23540352|NCT02528214|65709211|FG001|Overall Study|Other than specified above|1|||
23209822|NCT01764256|64504723|FG003|Received All Vaccinations|Lost to Follow-up|0|||
23209823|NCT01764256|64504720|FG000|Completed Study|Lost to Follow-up|0|||
23540353|NCT01722331|65709212|FG000|Part 1|Adverse Event|5|||
23540354|NCT01722331|65709213|FG001|Part 1|Adverse Event|0|||
23540355|NCT01722331|65709214|FG002|Part 1|Adverse Event|0|||
23209824|NCT01764256|64504721|FG001|Completed Study|Lost to Follow-up|0|||
23540356|NCT01722331|65709215|FG003|Part 1|Adverse Event|0|||
23540357|NCT01722331|65709216|FG004|Part 1|Adverse Event|0|||
23540358|NCT01722331|65709217|FG005|Part 1|Adverse Event|0|||
23540359|NCT01722331|65709218|FG006|Part 1|Adverse Event|0|||
23540360|NCT01722331|65709212|FG000|Part 1|Lack of Efficacy|0|||
23540361|NCT01722331|65709213|FG001|Part 1|Lack of Efficacy|0|||
23540362|NCT01722331|65709214|FG002|Part 1|Lack of Efficacy|1|||
23540363|NCT01722331|65709215|FG003|Part 1|Lack of Efficacy|0|||
23540364|NCT01722331|65709216|FG004|Part 1|Lack of Efficacy|2|||
23540365|NCT01722331|65709217|FG005|Part 1|Lack of Efficacy|0|||
23540366|NCT01722331|65709218|FG006|Part 1|Lack of Efficacy|0|||
23540367|NCT01722331|65709212|FG000|Part 1|Lost to Follow-up|1|||
23424290|NCT01514240|65296443|FG001|Overall Study|Subject Decision|7|||
23312506|NCT04711902|64886710|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
23312507|NCT04630158|64886712|FG000|Overall Study|Adverse Event|1|||
23312508|NCT04630158|64886713|FG001|Overall Study|Adverse Event|1|||
23312509|NCT04630158|64886714|FG002|Overall Study|Adverse Event|1|||
23312510|NCT04630158|64886712|FG000|Overall Study|Physician Decision|0|||
23312511|NCT04630158|64886713|FG001|Overall Study|Physician Decision|2|||
23312512|NCT04630158|64886714|FG002|Overall Study|Physician Decision|0|||
23312513|NCT04630158|64886712|FG000|Overall Study|Protocol Violation|1|||
23312514|NCT04630158|64886713|FG001|Overall Study|Protocol Violation|0|||
23540368|NCT01722331|65709213|FG001|Part 1|Lost to Follow-up|0|||
23540369|NCT01722331|65709214|FG002|Part 1|Lost to Follow-up|2|||
23540370|NCT01722331|65709215|FG003|Part 1|Lost to Follow-up|0|||
23540371|NCT01722331|65709216|FG004|Part 1|Lost to Follow-up|1|||
23540372|NCT01722331|65709217|FG005|Part 1|Lost to Follow-up|0|||
23540373|NCT01722331|65709218|FG006|Part 1|Lost to Follow-up|0|||
23540374|NCT01722331|65709212|FG000|Part 1|Physician Decision|0|||
23540375|NCT01722331|65709213|FG001|Part 1|Physician Decision|0|||
23540376|NCT01722331|65709214|FG002|Part 1|Physician Decision|3|||
23540377|NCT01722331|65709215|FG003|Part 1|Physician Decision|0|||
23540378|NCT01722331|65709216|FG004|Part 1|Physician Decision|1|||
23540379|NCT01722331|65709217|FG005|Part 1|Physician Decision|0|||
23540380|NCT01722331|65709218|FG006|Part 1|Physician Decision|0|||
23540381|NCT01722331|65709212|FG000|Part 1|Pregnancy|1|||
23540382|NCT01722331|65709213|FG001|Part 1|Pregnancy|0|||
23540383|NCT01722331|65709214|FG002|Part 1|Pregnancy|0|||
23540384|NCT01722331|65709215|FG003|Part 1|Pregnancy|0|||
23540385|NCT01722331|65709216|FG004|Part 1|Pregnancy|0|||
23540386|NCT01722331|65709217|FG005|Part 1|Pregnancy|0|||
23540387|NCT01722331|65709218|FG006|Part 1|Pregnancy|0|||
23540388|NCT01722331|65709212|FG000|Part 1|Progressive Disease|0|||
23540389|NCT01722331|65709213|FG001|Part 1|Progressive Disease|0|||
23540390|NCT01722331|65709214|FG002|Part 1|Progressive Disease|0|||
23540391|NCT01722331|65709215|FG003|Part 1|Progressive Disease|0|||
23540392|NCT01722331|65709216|FG004|Part 1|Progressive Disease|1|||
23540393|NCT01722331|65709217|FG005|Part 1|Progressive Disease|0|||
23540394|NCT01722331|65709218|FG006|Part 1|Progressive Disease|0|||
23540395|NCT01722331|65709212|FG000|Part 1|Protocol Violation|1|||
23540396|NCT01722331|65709213|FG001|Part 1|Protocol Violation|0|||
23540397|NCT01722331|65709214|FG002|Part 1|Protocol Violation|0|||
23540398|NCT01722331|65709215|FG003|Part 1|Protocol Violation|0|||
23540399|NCT01722331|65709216|FG004|Part 1|Protocol Violation|1|||
23540400|NCT01722331|65709217|FG005|Part 1|Protocol Violation|0|||
23540401|NCT01722331|65709218|FG006|Part 1|Protocol Violation|0|||
23540402|NCT01722331|65709212|FG000|Part 1|Withdrawal by Subject|2|||
23540403|NCT01722331|65709213|FG001|Part 1|Withdrawal by Subject|0|||
23540404|NCT01722331|65709214|FG002|Part 1|Withdrawal by Subject|3|||
23540405|NCT01722331|65709215|FG003|Part 1|Withdrawal by Subject|0|||
23540406|NCT01722331|65709216|FG004|Part 1|Withdrawal by Subject|3|||
23540407|NCT01722331|65709217|FG005|Part 1|Withdrawal by Subject|0|||
23540408|NCT01722331|65709218|FG006|Part 1|Withdrawal by Subject|0|||
23540409|NCT01722331|65709212|FG000|Part 2|Adverse Event|3|||
23540410|NCT01722331|65709213|FG001|Part 2|Adverse Event|0|||
23540411|NCT01722331|65709214|FG002|Part 2|Adverse Event|0|||
23540412|NCT01722331|65709215|FG003|Part 2|Adverse Event|0|||
23540413|NCT01722331|65709216|FG004|Part 2|Adverse Event|0|||
23540414|NCT01722331|65709217|FG005|Part 2|Adverse Event|1|||
23540415|NCT01722331|65709218|FG006|Part 2|Adverse Event|0|||
23540416|NCT01722331|65709212|FG000|Part 2|Lack of Efficacy|3|||
23540417|NCT01722331|65709213|FG001|Part 2|Lack of Efficacy|0|||
23540418|NCT01722331|65709214|FG002|Part 2|Lack of Efficacy|11|||
23540419|NCT01722331|65709215|FG003|Part 2|Lack of Efficacy|0|||
23540420|NCT01722331|65709216|FG004|Part 2|Lack of Efficacy|0|||
23540421|NCT01722331|65709217|FG005|Part 2|Lack of Efficacy|3|||
23540422|NCT01722331|65709218|FG006|Part 2|Lack of Efficacy|3|||
23540423|NCT01722331|65709212|FG000|Part 2|Lost to Follow-up|0|||
23540424|NCT01722331|65709213|FG001|Part 2|Lost to Follow-up|0|||
23540425|NCT01722331|65709214|FG002|Part 2|Lost to Follow-up|3|||
23540426|NCT01722331|65709215|FG003|Part 2|Lost to Follow-up|0|||
23312515|NCT04630158|64886714|FG002|Overall Study|Protocol Violation|1|||
23312516|NCT04630158|64886712|FG000|Overall Study|Withdrawal by Subject|2|||
23312517|NCT04630158|64886713|FG001|Overall Study|Withdrawal by Subject|1|||
23540427|NCT01722331|65709216|FG004|Part 2|Lost to Follow-up|0|||
23540428|NCT01722331|65709217|FG005|Part 2|Lost to Follow-up|1|||
23540429|NCT01722331|65709218|FG006|Part 2|Lost to Follow-up|1|||
23540430|NCT01722331|65709212|FG000|Part 2|Non-Compliance with Study Drug|1|||
23540431|NCT01722331|65709213|FG001|Part 2|Non-Compliance with Study Drug|0|||
23540432|NCT01722331|65709214|FG002|Part 2|Non-Compliance with Study Drug|1|||
23540433|NCT01722331|65709215|FG003|Part 2|Non-Compliance with Study Drug|0|||
23540434|NCT01722331|65709216|FG004|Part 2|Non-Compliance with Study Drug|0|||
23540435|NCT01722331|65709217|FG005|Part 2|Non-Compliance with Study Drug|0|||
23540436|NCT01722331|65709218|FG006|Part 2|Non-Compliance with Study Drug|0|||
23540437|NCT01722331|65709212|FG000|Part 2|Physician Decision|0|||
23540438|NCT01722331|65709213|FG001|Part 2|Physician Decision|0|||
23540439|NCT01722331|65709214|FG002|Part 2|Physician Decision|2|||
23540440|NCT01722331|65709215|FG003|Part 2|Physician Decision|0|||
23540441|NCT01722331|65709216|FG004|Part 2|Physician Decision|0|||
23540442|NCT01722331|65709217|FG005|Part 2|Physician Decision|0|||
23540443|NCT01722331|65709218|FG006|Part 2|Physician Decision|0|||
23540444|NCT01722331|65709212|FG000|Part 2|Pregnancy|0|||
23540445|NCT01722331|65709213|FG001|Part 2|Pregnancy|0|||
23540446|NCT01722331|65709214|FG002|Part 2|Pregnancy|0|||
23540447|NCT01722331|65709215|FG003|Part 2|Pregnancy|0|||
23540448|NCT01722331|65709216|FG004|Part 2|Pregnancy|0|||
23540449|NCT01722331|65709217|FG005|Part 2|Pregnancy|1|||
23540450|NCT01722331|65709218|FG006|Part 2|Pregnancy|0|||
23540451|NCT01722331|65709212|FG000|Part 2|Progressive Disease|0|||
23540452|NCT01722331|65709213|FG001|Part 2|Progressive Disease|0|||
23540453|NCT01722331|65709214|FG002|Part 2|Progressive Disease|1|||
23540454|NCT01722331|65709215|FG003|Part 2|Progressive Disease|0|||
23540455|NCT01722331|65709216|FG004|Part 2|Progressive Disease|0|||
23540456|NCT01722331|65709217|FG005|Part 2|Progressive Disease|0|||
23540457|NCT01722331|65709218|FG006|Part 2|Progressive Disease|0|||
23540458|NCT01722331|65709212|FG000|Part 2|Protocol Violation|1|||
23209825|NCT01764256|64504722|FG002|Completed Study|Lost to Follow-up|0|||
23312518|NCT04630158|64886714|FG002|Overall Study|Withdrawal by Subject|2|||
23312519|NCT03713632|64886715|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
23540459|NCT01722331|65709213|FG001|Part 2|Protocol Violation|0|||
23540460|NCT01722331|65709214|FG002|Part 2|Protocol Violation|0|||
23209826|NCT01764256|64504723|FG003|Completed Study|Lost to Follow-up|1|||
23540461|NCT01722331|65709215|FG003|Part 2|Protocol Violation|0|||
23540462|NCT01722331|65709216|FG004|Part 2|Protocol Violation|0|||
23540463|NCT01722331|65709217|FG005|Part 2|Protocol Violation|0|||
23540464|NCT01722331|65709218|FG006|Part 2|Protocol Violation|0|||
23540465|NCT01722331|65709212|FG000|Part 2|Withdrawal by Subject|5|||
23312520|NCT03713632|64886716|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
23312521|NCT03713632|64886717|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
23312522|NCT03713632|64886718|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
23209827|NCT04176445|64504724|FG000|Overall Study|Adverse Event|0|||
23540466|NCT01722331|65709213|FG001|Part 2|Withdrawal by Subject|0|||
23540467|NCT01722331|65709214|FG002|Part 2|Withdrawal by Subject|3|||
23540468|NCT01722331|65709215|FG003|Part 2|Withdrawal by Subject|0|||
23540469|NCT01722331|65709216|FG004|Part 2|Withdrawal by Subject|0|||
23540470|NCT01722331|65709217|FG005|Part 2|Withdrawal by Subject|2|||
23540471|NCT01722331|65709218|FG006|Part 2|Withdrawal by Subject|2|||
23616567|NCT00111839|65982368|FG002|Overall Study|Disease Progression|33|||
23540472|NCT01722331|65709212|FG000|Part 2|Other Protocol Specified Criteria|6|||
23312523|NCT03713632|64886719|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
23540473|NCT01722331|65709213|FG001|Part 2|Other Protocol Specified Criteria|0|||
23312524|NCT03713632|64886715|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
23312525|NCT03713632|64886716|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
23312526|NCT03713632|64886717|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
23312527|NCT03713632|64886718|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23312528|NCT03713632|64886719|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23312529|NCT03713632|64886715|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23312530|NCT03713632|64886716|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23312531|NCT03713632|64886717|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23312532|NCT03713632|64886718|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
23312533|NCT03713632|64886719|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
23312534|NCT03713632|64886715|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
23312535|NCT03713632|64886716|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
23312536|NCT03713632|64886717|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
23312537|NCT03713632|64886718|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
23312538|NCT03713632|64886719|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
23312539|NCT03713632|64886715|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
23312540|NCT03713632|64886716|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23312541|NCT03713632|64886717|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
23312542|NCT03713632|64886718|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23312543|NCT03713632|64886719|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23312544|NCT03713632|64886715|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
23312545|NCT03713632|64886716|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
23540474|NCT01722331|65709214|FG002|Part 2|Other Protocol Specified Criteria|10|||
23540475|NCT01722331|65709215|FG003|Part 2|Other Protocol Specified Criteria|0|||
23540476|NCT01722331|65709216|FG004|Part 2|Other Protocol Specified Criteria|0|||
23540477|NCT01722331|65709217|FG005|Part 2|Other Protocol Specified Criteria|2|||
23540478|NCT01722331|65709218|FG006|Part 2|Other Protocol Specified Criteria|1|||
23540479|NCT01722331|65709212|FG000|Part 3|Adverse Event|2|||
23540480|NCT01722331|65709213|FG001|Part 3|Adverse Event|2|||
23540481|NCT01722331|65709214|FG002|Part 3|Adverse Event|0|||
23540482|NCT01722331|65709215|FG003|Part 3|Adverse Event|1|||
23540483|NCT01722331|65709216|FG004|Part 3|Adverse Event|0|||
23540484|NCT01722331|65709217|FG005|Part 3|Adverse Event|0|||
23540485|NCT01722331|65709218|FG006|Part 3|Adverse Event|0|||
23540486|NCT01722331|65709212|FG000|Part 3|Death|1|||
23540487|NCT01722331|65709213|FG001|Part 3|Death|0|||
23616568|NCT00111839|65982366|FG000|Overall Study|Adverse Event|5|||
23616569|NCT00111839|65982367|FG001|Overall Study|Adverse Event|3|||
23616570|NCT00111839|65982368|FG002|Overall Study|Adverse Event|1|||
23616571|NCT00111839|65982366|FG000|Overall Study|Protocol Violation|2|||
23616572|NCT00111839|65982367|FG001|Overall Study|Protocol Violation|4|||
23616573|NCT00111839|65982368|FG002|Overall Study|Protocol Violation|2|||
23616574|NCT00111839|65982366|FG000|Overall Study|Death|1|||
23616575|NCT00111839|65982367|FG001|Overall Study|Death|1|||
23616576|NCT00111839|65982368|FG002|Overall Study|Death|6|||
23616577|NCT00111839|65982366|FG000|Overall Study|Withdrawal by Subject|2|||
23616578|NCT00111839|65982367|FG001|Overall Study|Withdrawal by Subject|2|||
23616579|NCT00111839|65982368|FG002|Overall Study|Withdrawal by Subject|2|||
23616580|NCT00111839|65982366|FG000|Overall Study|Lost to Follow-up|1|||
23616581|NCT00111839|65982367|FG001|Overall Study|Lost to Follow-up|0|||
23616582|NCT00111839|65982368|FG002|Overall Study|Lost to Follow-up|0|||
23616583|NCT00111839|65982366|FG000|Overall Study|Logistical Constraint|1|||
23616584|NCT00111839|65982367|FG001|Overall Study|Logistical Constraint|0|||
23616585|NCT00111839|65982368|FG002|Overall Study|Logistical Constraint|0|||
23616586|NCT00111839|65982366|FG000|Overall Study|Other|6|||
23616587|NCT00111839|65982367|FG001|Overall Study|Other|3|||
23616588|NCT00111839|65982368|FG002|Overall Study|Other|3|||
23616589|NCT00111839|65982366|FG000|Overall Study|Randomized but Not Treated|0|||
23616590|NCT00111839|65982367|FG001|Overall Study|Randomized but Not Treated|0|||
23616591|NCT00111839|65982368|FG002|Overall Study|Randomized but Not Treated|2|||
23616592|NCT00126555|65982370|FG000|Overall Study|Withdrawal by Subject|1|||
23616593|NCT00126555|65982370|FG000|Overall Study|Adverse Event|2|||
23616594|NCT00126555|65982370|FG000|Overall Study|Progressive Disease|3|||
23616595|NCT01190228|65982371|FG000|Overall Study|Protocol Violation|4|||
23616596|NCT01190228|65982372|FG001|Overall Study|Protocol Violation|0|||
23312546|NCT03713632|64886717|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
23540488|NCT01722331|65709214|FG002|Part 3|Death|0|||
23540489|NCT01722331|65709215|FG003|Part 3|Death|0|||
23540490|NCT01722331|65709216|FG004|Part 3|Death|0|||
23540491|NCT01722331|65709217|FG005|Part 3|Death|0|||
23540492|NCT01722331|65709218|FG006|Part 3|Death|0|||
23540493|NCT01722331|65709212|FG000|Part 3|Lack of Efficacy|1|||
23616597|NCT01190228|65982373|FG002|Overall Study|Protocol Violation|0|||
23616598|NCT01190228|65982371|FG000|Overall Study|Withdrawal by Subject|1|||
23616599|NCT01190228|65982372|FG001|Overall Study|Withdrawal by Subject|0|||
23616600|NCT01190228|65982373|FG002|Overall Study|Withdrawal by Subject|0|||
23616601|NCT00509925|65982377|FG000|Overall Study|Personal reasons|0|||
23616602|NCT00509925|65982378|FG001|Overall Study|Personal reasons|1|||
23616603|NCT03722485|65982384|FG000|Overall Study|Withdrawal by Subject|1|||
23209828|NCT04176445|64504725|FG001|Overall Study|Adverse Event|1|||
23209829|NCT04176445|64504724|FG000|Overall Study|change plans weaning after first intervention|0|||
23209830|NCT04176445|64504725|FG001|Overall Study|change plans weaning after first intervention|1|||
23209831|NCT00964158|64504729|FG000|Overall Study|Lost to Follow-up|0|||
23209832|NCT00964158|64504730|FG001|Overall Study|Lost to Follow-up|1|||
23312547|NCT03713632|64886718|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
23312548|NCT03713632|64886719|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
23312549|NCT03713632|64886715|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
23312550|NCT03713632|64886716|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
23312551|NCT03713632|64886717|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
23312552|NCT03713632|64886718|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
23312553|NCT03713632|64886719|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
23312554|NCT03713632|64886715|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
23312555|NCT03713632|64886716|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
23312556|NCT03713632|64886717|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
23312557|NCT03713632|64886718|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
23312558|NCT03713632|64886719|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
23312559|NCT03713632|64886715|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
23312560|NCT03713632|64886716|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
23312561|NCT03713632|64886717|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
23312562|NCT03713632|64886718|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
23312563|NCT03713632|64886719|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
23312564|NCT03713632|64886715|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
23312565|NCT03713632|64886716|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
23312566|NCT03713632|64886717|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
23312567|NCT03713632|64886718|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
23312568|NCT03713632|64886719|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
23312569|NCT03713632|64886715|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
23312570|NCT03713632|64886716|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
23312571|NCT03713632|64886717|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
23312572|NCT03713632|64886718|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
23312573|NCT03713632|64886719|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
23312574|NCT03713632|64886715|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
23312575|NCT03713632|64886716|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
23312576|NCT03713632|64886717|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
23312577|NCT03713632|64886718|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
23312578|NCT03713632|64886719|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
23312579|NCT03713632|64886715|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
23209833|NCT00964158|64504731|FG002|Overall Study|Lost to Follow-up|2|||
23209834|NCT00964158|64504729|FG000|Overall Study|Withdrawal by Subject|0|||
23209835|NCT00964158|64504730|FG001|Overall Study|Withdrawal by Subject|0|||
23209836|NCT00964158|64504731|FG002|Overall Study|Withdrawal by Subject|6|||
23209837|NCT01927419|64504732|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23209838|NCT01927419|64504733|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
23209839|NCT01927419|64504732|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
23209840|NCT01927419|64504733|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
23209841|NCT01927419|64504732|FG000|Treatment Period|Disease progression|17|||
23209842|NCT01927419|64504733|FG001|Treatment Period|Disease progression|20|||
23209843|NCT01927419|64504732|FG000|Treatment Period|Study drug toxicity|48|||
23209844|NCT01927419|64504733|FG001|Treatment Period|Study drug toxicity|10|||
23209845|NCT01927419|64504732|FG000|Treatment Period|Death|0|||
23209846|NCT01927419|64504733|FG001|Treatment Period|Death|1|||
23209847|NCT01927419|64504732|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
23209848|NCT01927419|64504733|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
23209849|NCT01927419|64504732|FG000|Treatment Period|Participant request to discontinue|12|||
23209850|NCT01927419|64504733|FG001|Treatment Period|Participant request to discontinue|4|||
23209851|NCT01927419|64504732|FG000|Treatment Period|Withdrawal by Subject|1|||
23312580|NCT03713632|64886716|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
23312581|NCT03713632|64886717|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
23312582|NCT03713632|64886718|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
23312583|NCT03713632|64886719|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
23312584|NCT03713632|64886715|FG000|Treatment Period 2 (After Week 16)|Death|0|||
23312585|NCT03713632|64886716|FG001|Treatment Period 2 (After Week 16)|Death|1|||
23312586|NCT03713632|64886717|FG002|Treatment Period 2 (After Week 16)|Death|0|||
23209852|NCT01927419|64504733|FG001|Treatment Period|Withdrawal by Subject|1|||
23209853|NCT01927419|64504732|FG000|Treatment Period|Maximum Clinical Benefit|6|||
23209854|NCT01927419|64504733|FG001|Treatment Period|Maximum Clinical Benefit|2|||
23209855|NCT01927419|64504732|FG000|Treatment Period|Other reasons|3|||
23209856|NCT01927419|64504733|FG001|Treatment Period|Other reasons|4|||
23312587|NCT03713632|64886718|FG003|Treatment Period 2 (After Week 16)|Death|0|||
23312588|NCT03713632|64886719|FG004|Treatment Period 2 (After Week 16)|Death|0|||
23424291|NCT03593681|65296446|FG000|Overall Study|Inadequate sample collected|12|||
23424292|NCT03593681|65296446|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
23424293|NCT03593681|65296446|FG000|Overall Study|Protocol Violation|3|||
23424294|NCT03593681|65296446|FG000|Overall Study|Withdrawal by Subject|3|||
23424295|NCT03593681|65296446|FG000|Overall Study|Procedure not attempted|3|||
23424296|NCT03593681|65296446|FG000|Overall Study|Adverse Event|2|||
23424297|NCT03593681|65296446|FG000|Overall Study|Physician Decision|1|||
23424298|NCT00394901|65296456|FG000|Baseline Phase|Protocol Violation|0|||
23424299|NCT00394901|65296457|FG001|Baseline Phase|Protocol Violation|0|||
23424300|NCT00394901|65296458|FG002|Baseline Phase|Protocol Violation|1|||
23424301|NCT00394901|65296459|FG003|Baseline Phase|Protocol Violation|0|||
23424302|NCT00394901|65296456|FG000|Double-blind Phase|Adverse Event|5|||
23424303|NCT00394901|65296457|FG001|Double-blind Phase|Adverse Event|7|||
23424304|NCT00394901|65296458|FG002|Double-blind Phase|Adverse Event|16|||
23424305|NCT00394901|65296459|FG003|Double-blind Phase|Adverse Event|20|||
23424306|NCT00394901|65296456|FG000|Double-blind Phase|Lack of Efficacy|6|||
23424307|NCT00394901|65296457|FG001|Double-blind Phase|Lack of Efficacy|4|||
23424308|NCT00394901|65296458|FG002|Double-blind Phase|Lack of Efficacy|1|||
23424309|NCT00394901|65296459|FG003|Double-blind Phase|Lack of Efficacy|3|||
23424310|NCT00394901|65296456|FG000|Double-blind Phase|Withdrawal by Subject|2|||
23424311|NCT00394901|65296457|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23424312|NCT00394901|65296458|FG002|Double-blind Phase|Withdrawal by Subject|0|||
23424313|NCT00394901|65296459|FG003|Double-blind Phase|Withdrawal by Subject|0|||
23424314|NCT00394901|65296456|FG000|Double-blind Phase|Lost to Follow-up|0|||
23424315|NCT00394901|65296457|FG001|Double-blind Phase|Lost to Follow-up|0|||
23424316|NCT00394901|65296458|FG002|Double-blind Phase|Lost to Follow-up|0|||
23424317|NCT00394901|65296459|FG003|Double-blind Phase|Lost to Follow-up|1|||
23424318|NCT00394901|65296456|FG000|Double-blind Phase|Protocol Violation|0|||
23424319|NCT00394901|65296457|FG001|Double-blind Phase|Protocol Violation|0|||
23424320|NCT00394901|65296458|FG002|Double-blind Phase|Protocol Violation|0|||
23424321|NCT00394901|65296459|FG003|Double-blind Phase|Protocol Violation|1|||
23424322|NCT00394901|65296456|FG000|Double-blind Phase|Death|1|||
23424323|NCT00394901|65296457|FG001|Double-blind Phase|Death|0|||
23424324|NCT00394901|65296458|FG002|Double-blind Phase|Death|0|||
23540494|NCT01722331|65709213|FG001|Part 3|Lack of Efficacy|0|||
23540495|NCT01722331|65709214|FG002|Part 3|Lack of Efficacy|0|||
23540496|NCT01722331|65709215|FG003|Part 3|Lack of Efficacy|0|||
23540497|NCT01722331|65709216|FG004|Part 3|Lack of Efficacy|0|||
23540498|NCT01722331|65709217|FG005|Part 3|Lack of Efficacy|0|||
23540499|NCT01722331|65709218|FG006|Part 3|Lack of Efficacy|0|||
23540500|NCT01722331|65709212|FG000|Part 3|Lost to Follow-up|3|||
23540501|NCT01722331|65709213|FG001|Part 3|Lost to Follow-up|4|||
23540502|NCT01722331|65709214|FG002|Part 3|Lost to Follow-up|0|||
23540503|NCT01722331|65709215|FG003|Part 3|Lost to Follow-up|0|||
23540504|NCT01722331|65709216|FG004|Part 3|Lost to Follow-up|0|||
23540505|NCT01722331|65709217|FG005|Part 3|Lost to Follow-up|1|||
23540506|NCT01722331|65709218|FG006|Part 3|Lost to Follow-up|0|||
23616604|NCT03722485|65982385|FG001|Overall Study|Withdrawal by Subject|0|||
23616605|NCT03722485|65982384|FG000|Overall Study|Adverse Event|0|||
23616606|NCT03722485|65982385|FG001|Overall Study|Adverse Event|2|||
23616607|NCT03722485|65982384|FG000|Overall Study|subject discharged prior to study completion|1|||
23312589|NCT03713632|64886715|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23312590|NCT03713632|64886716|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
23312591|NCT03713632|64886717|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23312592|NCT03713632|64886718|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23312593|NCT03713632|64886719|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23312594|NCT03713619|64886720|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
23424325|NCT00394901|65296459|FG003|Double-blind Phase|Death|0|||
23424326|NCT00394901|65296456|FG000|Double-blind Phase|Subject's Personal Reason|1|||
23424327|NCT00394901|65296457|FG001|Double-blind Phase|Subject's Personal Reason|0|||
23424328|NCT00394901|65296458|FG002|Double-blind Phase|Subject's Personal Reason|0|||
23424329|NCT00394901|65296459|FG003|Double-blind Phase|Subject's Personal Reason|1|||
23424330|NCT00394901|65296456|FG000|Double-blind Phase|Lack of Compliance|0|||
23424331|NCT00394901|65296457|FG001|Double-blind Phase|Lack of Compliance|3|||
23424332|NCT00394901|65296458|FG002|Double-blind Phase|Lack of Compliance|0|||
23540507|NCT01722331|65709212|FG000|Part 3|Non-Compliance with Study Drug|0|||
23540508|NCT01722331|65709213|FG001|Part 3|Non-Compliance with Study Drug|1|||
23540509|NCT01722331|65709214|FG002|Part 3|Non-Compliance with Study Drug|0|||
23540510|NCT01722331|65709215|FG003|Part 3|Non-Compliance with Study Drug|0|||
23616608|NCT03722485|65982385|FG001|Overall Study|subject discharged prior to study completion|5|||
23616609|NCT03722485|65982384|FG000|Overall Study|eligibility criteria not met|2|||
23616610|NCT03722485|65982385|FG001|Overall Study|eligibility criteria not met|0|||
23616611|NCT03589326|65982386|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
23616612|NCT03589326|65982387|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
23616613|NCT03589326|65982386|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
23616614|NCT03589326|65982387|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
23616615|NCT03589326|65982386|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
23616616|NCT03589326|65982387|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
23616617|NCT03589326|65982386|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
23616618|NCT03589326|65982387|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
23616619|NCT03589326|65982386|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
23616620|NCT03589326|65982387|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
23616621|NCT01757171|65982388|FG000|Overall Study|Adverse Event|5|||
23616622|NCT01757171|65982389|FG001|Overall Study|Adverse Event|1|||
23616623|NCT01757171|65982388|FG000|Overall Study|Disease Progression|1|||
23616624|NCT01757171|65982389|FG001|Overall Study|Disease Progression|0|||
23616625|NCT01757171|65982388|FG000|Overall Study|Hospitalization|1|||
23616626|NCT01757171|65982389|FG001|Overall Study|Hospitalization|0|||
23616627|NCT01757171|65982388|FG000|Overall Study|ECOG decline|1|||
23616628|NCT01757171|65982389|FG001|Overall Study|ECOG decline|0|||
23616629|NCT05135156|65982392|FG000|Overall Study|Lost to Follow-up|0|||
23616630|NCT05135156|65982393|FG001|Overall Study|Lost to Follow-up|0|||
23616631|NCT05135156|65982394|FG002|Overall Study|Lost to Follow-up|2|||
23616632|NCT01901302|65982396|FG000|Overall Study|Adverse Event|2|||
23616633|NCT01901302|65982397|FG001|Overall Study|Adverse Event|1|||
23616634|NCT01901302|65982396|FG000|Overall Study|Lack of Efficacy|0|||
23616635|NCT01901302|65982397|FG001|Overall Study|Lack of Efficacy|2|||
23616636|NCT01901302|65982396|FG000|Overall Study|Study Terminated by Sponsor|23|||
23616637|NCT01901302|65982397|FG001|Overall Study|Study Terminated by Sponsor|20|||
23616638|NCT01901302|65982396|FG000|Overall Study|Withdrawal by Subject|2|||
23616639|NCT01901302|65982397|FG001|Overall Study|Withdrawal by Subject|0|||
23616640|NCT01945593|65982398|FG000|Overall Study|Adverse Event|0|||
23616641|NCT01945593|65982399|FG001|Overall Study|Adverse Event|0|||
23616642|NCT01945593|65982400|FG002|Overall Study|Adverse Event|0|||
23616643|NCT01945593|65982401|FG003|Overall Study|Adverse Event|5|||
23616644|NCT01945593|65982398|FG000|Overall Study|Physician Decision|0|||
23616645|NCT01945593|65982399|FG001|Overall Study|Physician Decision|0|||
23616646|NCT01945593|65982400|FG002|Overall Study|Physician Decision|1|||
23209857|NCT01927419|64504732|FG000|Treatment Period|Not Reported|1|||
23209858|NCT01927419|64504733|FG001|Treatment Period|Not Reported|1|||
23209859|NCT02726113|64504734|FG000|Total Enrollment|Physician Decision|0|||
23209860|NCT02726113|64504735|FG001|Total Enrollment|Physician Decision|1|||
23209861|NCT02726113|64504734|FG000|Total Enrollment|Protocol Violation|1|||
23209862|NCT02726113|64504735|FG001|Total Enrollment|Protocol Violation|0|||
23209863|NCT02726113|64504734|FG000|Total Enrollment|Withdrawal by Subject|2|||
23209864|NCT02726113|64504735|FG001|Total Enrollment|Withdrawal by Subject|1|||
23209865|NCT02726113|64504734|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
23209866|NCT02726113|64504735|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
23209867|NCT02726113|64504734|FG000|Genomic Analysis|Protocol Violation|1|||
23209868|NCT02726113|64504735|FG001|Genomic Analysis|Protocol Violation|0|||
23209869|NCT02726113|64504734|FG000|Genomic Analysis|Withdrawal by Subject|2|||
23209870|NCT02726113|64504735|FG001|Genomic Analysis|Withdrawal by Subject|1|||
23209871|NCT02726113|64504734|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
23209872|NCT02726113|64504735|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
23209873|NCT02530671|64504736|FG000|Overall Study|Lost to Follow-up|2|||
23209874|NCT02530671|64504737|FG001|Overall Study|Lost to Follow-up|0|||
23209875|NCT02530671|64504736|FG000|Overall Study|Withdrawal by Subject|1|||
23209876|NCT02530671|64504737|FG001|Overall Study|Withdrawal by Subject|0|||
23312595|NCT03713619|64886721|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23312596|NCT03713619|64886722|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
23312597|NCT03713619|64886723|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23312598|NCT03713619|64886724|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
23616647|NCT01945593|65982401|FG003|Overall Study|Physician Decision|1|||
23616648|NCT01945593|65982398|FG000|Overall Study|Withdrawal by Subject|0|||
23616649|NCT01945593|65982399|FG001|Overall Study|Withdrawal by Subject|2|||
23616650|NCT01945593|65982400|FG002|Overall Study|Withdrawal by Subject|0|||
23616651|NCT01945593|65982401|FG003|Overall Study|Withdrawal by Subject|4|||
23616652|NCT01945593|65982398|FG000|Overall Study|Protocol Violation|0|||
23616653|NCT01945593|65982399|FG001|Overall Study|Protocol Violation|2|||
23616654|NCT01945593|65982400|FG002|Overall Study|Protocol Violation|1|||
23616655|NCT01945593|65982401|FG003|Overall Study|Protocol Violation|3|||
23209877|NCT00762372|64504738|FG000|Overall Study|Adverse Event|1|||
23209878|NCT00762372|64504739|FG001|Overall Study|Adverse Event|0|||
23209879|NCT00762372|64504740|FG002|Overall Study|Adverse Event|0|||
23209880|NCT01409993|64504741|FG000|Overall Study|Adverse Event|4|||
23209881|NCT01409993|64504742|FG001|Overall Study|Adverse Event|4|||
23209882|NCT01409993|64504743|FG002|Overall Study|Adverse Event|3|||
23209883|NCT01409993|64504744|FG003|Overall Study|Adverse Event|1|||
23209884|NCT01409993|64504741|FG000|Overall Study|Withdrawal by Subject|0|||
23209885|NCT01409993|64504742|FG001|Overall Study|Withdrawal by Subject|0|||
23209886|NCT01409993|64504743|FG002|Overall Study|Withdrawal by Subject|0|||
23209887|NCT01409993|64504744|FG003|Overall Study|Withdrawal by Subject|4|||
23209888|NCT01409993|64504741|FG000|Overall Study|Lost to Follow-up|0|||
23209889|NCT01409993|64504742|FG001|Overall Study|Lost to Follow-up|1|||
23209890|NCT01409993|64504743|FG002|Overall Study|Lost to Follow-up|0|||
23209891|NCT01409993|64504744|FG003|Overall Study|Lost to Follow-up|0|||
23209892|NCT04124692|64504750|FG000|Overall Study|Medical reason|0|||
23209893|NCT04124692|64504751|FG001|Overall Study|Medical reason|1|||
23209894|NCT04124692|64504750|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
23209895|NCT04124692|64504751|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
23209896|NCT04124692|64504750|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
23209897|NCT04124692|64504751|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
23209898|NCT04124692|64504750|FG000|Overall Study|Lost to Follow-up|2|||
23209899|NCT04124692|64504751|FG001|Overall Study|Lost to Follow-up|4|||
23209900|NCT04124692|64504750|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
23209901|NCT04124692|64504751|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
23209902|NCT03558555|64504754|FG000|Overall Study|Lost to Follow-up|2|||
23209903|NCT03558555|64504755|FG001|Overall Study|Lost to Follow-up|1|||
23209904|NCT01592409|64504756|FG000|Overall Study|Withdrawal by Subject|0|||
23209905|NCT01592409|64504757|FG001|Overall Study|Withdrawal by Subject|1|||
23209906|NCT03198754|64504758|FG000|Overall Study|Withdrawal by Subject|5|||
23209907|NCT03198754|64504759|FG001|Overall Study|Withdrawal by Subject|4|||
23209908|NCT03198754|64504758|FG000|Overall Study|Lost to Follow-up|4|||
23209909|NCT03198754|64504759|FG001|Overall Study|Lost to Follow-up|3|||
23209910|NCT03198754|64504758|FG000|Overall Study|Ineligible|2|||
23209911|NCT03198754|64504759|FG001|Overall Study|Ineligible|1|||
23209912|NCT00675103|64504760|FG000|Overall Study|Lack of Efficacy|2|||
23209913|NCT00675103|64504760|FG000|Overall Study|Adverse Event|1|||
23209914|NCT00642746|64504762|FG000|Overall Study|Patient unevaluable|1|||
23209915|NCT00642746|64504763|FG001|Overall Study|Patient unevaluable|0|||
23209916|NCT01208038|64504764|FG000|Overall Study|Withdrawal by Subject|1|||
23209917|NCT00848250|64504765|FG000|Overall Study|surgery was completed without cardiopulm|0|||
23209918|NCT00848250|64504766|FG001|Overall Study|surgery was completed without cardiopulm|1|||
23209919|NCT02124707|64504767|FG000|Overall Study|Adverse Event|5|||
23209920|NCT02124707|64504767|FG000|Overall Study|Physician Decision|1|||
23209921|NCT02124707|64504767|FG000|Overall Study|Death|1|||
23209922|NCT00853489|64508985|FG000|Overall Study|Lost to Follow-up|5|||
23209923|NCT00853489|64508986|FG001|Overall Study|Lost to Follow-up|2|||
23209924|NCT01054976|64508990|FG000|Overall Study|Adverse Event|16|||
23209925|NCT01054976|64508990|FG000|Overall Study|Uncooperative participations to study|7|||
23209926|NCT01054976|64508990|FG000|Overall Study|Withdrawal by Subject|4|||
23209927|NCT01054976|64508990|FG000|Overall Study|Other|8|||
23209928|NCT00729326|64508991|FG000|Overall Study|Lost to Follow-up|2|||
23209929|NCT00729326|64508992|FG001|Overall Study|Lost to Follow-up|0|||
23209930|NCT00729326|64508991|FG000|Overall Study|Physician Decision|0|||
23209931|NCT00729326|64508992|FG001|Overall Study|Physician Decision|1|||
23209932|NCT00729326|64508991|FG000|Overall Study|Protocol Violation|3|||
23209933|NCT00729326|64508992|FG001|Overall Study|Protocol Violation|2|||
23209934|NCT00729326|64508991|FG000|Overall Study|Subject Decision|4|||
23209935|NCT00729326|64508992|FG001|Overall Study|Subject Decision|4|||
23209936|NCT00729326|64508991|FG000|Overall Study|Sponsor Decision|1|||
23209937|NCT00729326|64508992|FG001|Overall Study|Sponsor Decision|2|||
23209938|NCT03726333|64508995|FG000|Overall Study|Progressive Disease|0|||
23209939|NCT03726333|64508996|FG001|Overall Study|Progressive Disease|0|||
23209940|NCT03726333|64508997|FG002|Overall Study|Progressive Disease|1|||
23209941|NCT03726333|64508998|FG003|Overall Study|Progressive Disease|0|||
23209942|NCT03726333|64508999|FG004|Overall Study|Progressive Disease|0|||
23209943|NCT01392378|64509000|FG000|Infant Series|Adverse Event|0|||
23209944|NCT01392378|64509001|FG001|Infant Series|Adverse Event|0|||
23209945|NCT01392378|64509002|FG002|Infant Series|Adverse Event|0|||
23209946|NCT01392378|64509003|FG003|Infant Series|Adverse Event|1|||
23209947|NCT01392378|64509004|FG004|Infant Series|Adverse Event|0|||
23209948|NCT01392378|64509000|FG000|Infant Series|Lost to Follow-up|0|||
23209949|NCT01392378|64509001|FG001|Infant Series|Lost to Follow-up|0|||
23209950|NCT01392378|64509002|FG002|Infant Series|Lost to Follow-up|0|||
23209951|NCT01392378|64509003|FG003|Infant Series|Lost to Follow-up|1|||
23209952|NCT01392378|64509004|FG004|Infant Series|Lost to Follow-up|0|||
23209953|NCT01392378|64509000|FG000|Infant Series|Protocol Violation|0|||
23209954|NCT01392378|64509001|FG001|Infant Series|Protocol Violation|1|||
23209955|NCT01392378|64509002|FG002|Infant Series|Protocol Violation|0|||
23209956|NCT01392378|64509003|FG003|Infant Series|Protocol Violation|0|||
23209957|NCT01392378|64509004|FG004|Infant Series|Protocol Violation|0|||
23209958|NCT01392378|64509000|FG000|Infant Series|Withdrawal by Parent|4|||
23209959|NCT01392378|64509001|FG001|Infant Series|Withdrawal by Parent|1|||
23209960|NCT01392378|64509002|FG002|Infant Series|Withdrawal by Parent|0|||
23209961|NCT01392378|64509003|FG003|Infant Series|Withdrawal by Parent|0|||
23209962|NCT01392378|64509004|FG004|Infant Series|Withdrawal by Parent|0|||
23209963|NCT01392378|64509000|FG000|After Infant Series|Lost to Follow-up|0|||
23209964|NCT01392378|64509001|FG001|After Infant Series|Lost to Follow-up|0|||
23209965|NCT01392378|64509002|FG002|After Infant Series|Lost to Follow-up|1|||
23209966|NCT01392378|64509003|FG003|After Infant Series|Lost to Follow-up|0|||
23209967|NCT01392378|64509004|FG004|After Infant Series|Lost to Follow-up|0|||
23209968|NCT01392378|64509000|FG000|After Infant Series|Withdrawal by Parent|0|||
23209969|NCT01392378|64509001|FG001|After Infant Series|Withdrawal by Parent|1|||
23209970|NCT01392378|64509002|FG002|After Infant Series|Withdrawal by Parent|1|||
23209971|NCT01392378|64509003|FG003|After Infant Series|Withdrawal by Parent|0|||
23209972|NCT01392378|64509004|FG004|After Infant Series|Withdrawal by Parent|1|||
23209973|NCT01392378|64509000|FG000|Toddler Dose|Lost to Follow-up|0|||
23209974|NCT01392378|64509001|FG001|Toddler Dose|Lost to Follow-up|0|||
23209975|NCT01392378|64509002|FG002|Toddler Dose|Lost to Follow-up|0|||
23209976|NCT01392378|64509003|FG003|Toddler Dose|Lost to Follow-up|1|||
23209977|NCT01392378|64509004|FG004|Toddler Dose|Lost to Follow-up|0|||
23209978|NCT01392378|64509000|FG000|Toddler Dose|Withdrawal by Parent|0|||
23209979|NCT01392378|64509001|FG001|Toddler Dose|Withdrawal by Parent|1|||
23209980|NCT01392378|64509002|FG002|Toddler Dose|Withdrawal by Parent|0|||
23209981|NCT01392378|64509003|FG003|Toddler Dose|Withdrawal by Parent|1|||
23424333|NCT00394901|65296459|FG003|Double-blind Phase|Lack of Compliance|0|||
23424334|NCT00394901|65296456|FG000|Double-blind Phase|Entry into another study was found|0|||
23424335|NCT00394901|65296457|FG001|Double-blind Phase|Entry into another study was found|0|||
23424336|NCT00394901|65296458|FG002|Double-blind Phase|Entry into another study was found|1|||
23424337|NCT00394901|65296459|FG003|Double-blind Phase|Entry into another study was found|0|||
23424338|NCT00394901|65296456|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
23540511|NCT01722331|65709216|FG004|Part 3|Non-Compliance with Study Drug|0|||
23540512|NCT01722331|65709217|FG005|Part 3|Non-Compliance with Study Drug|0|||
23540513|NCT01722331|65709218|FG006|Part 3|Non-Compliance with Study Drug|0|||
23540514|NCT01722331|65709212|FG000|Part 3|Physician Decision|1|||
23424339|NCT00394901|65296457|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
23424340|NCT00394901|65296458|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
23424341|NCT00394901|65296459|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
23424342|NCT04224272|65296460|FG000|Part 1 - Dose Finding|Death|4|||
23424343|NCT04224272|65296460|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
23424344|NCT04224272|65296460|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
23424345|NCT04224272|65296460|FG000|Part 2 - Dose Expansion|Death|10|||
23424346|NCT04224272|65296460|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
23424347|NCT01328041|65296465|FG000|Overall Study|Adverse Event|7|||
23424348|NCT01328041|65296465|FG000|Overall Study|Lack of Efficacy|27|||
23424349|NCT01328041|65296465|FG000|Overall Study|Protocol Violation|7|||
23424350|NCT01328041|65296465|FG000|Overall Study|Lost to Follow-up|7|||
23424351|NCT01328041|65296465|FG000|Overall Study|Physician Decision|2|||
23424352|NCT01328041|65296465|FG000|Overall Study|Withdrawal by Subject|7|||
23424353|NCT01969500|65296468|FG000|Overall Study|Death|0|||
23424354|NCT01969500|65296469|FG001|Overall Study|Death|1|||
23424355|NCT01969500|65296468|FG000|Overall Study|extended hospitalization|1|||
23424356|NCT01969500|65296469|FG001|Overall Study|extended hospitalization|1|||
23424357|NCT00888329|65296470|FG000|Overall Study|Physician Decision|6|||
23424358|NCT00888329|65296471|FG001|Overall Study|Physician Decision|9|||
23424359|NCT01028716|65296474|FG000|Overall Study|Physician Decision|1|||
23424360|NCT00645528|65296475|FG000|Overall Study|Did not show up for Visit 2|7|||
23540515|NCT01722331|65709213|FG001|Part 3|Physician Decision|1|||
23540516|NCT01722331|65709214|FG002|Part 3|Physician Decision|0|||
23540517|NCT01722331|65709215|FG003|Part 3|Physician Decision|0|||
23540518|NCT01722331|65709216|FG004|Part 3|Physician Decision|0|||
23540519|NCT01722331|65709217|FG005|Part 3|Physician Decision|0|||
23540520|NCT01722331|65709218|FG006|Part 3|Physician Decision|1|||
23540521|NCT01722331|65709212|FG000|Part 3|Protocol Violation|2|||
23540522|NCT01722331|65709213|FG001|Part 3|Protocol Violation|1|||
23209982|NCT01392378|64509004|FG004|Toddler Dose|Withdrawal by Parent|1|||
23209983|NCT00475540|64509005|FG000|36 Months|Lost to Follow-up|4|||
23209984|NCT00475540|64509006|FG001|36 Months|Lost to Follow-up|4|||
23209985|NCT00475540|64509005|FG000|36 Months|Death|1|||
23424361|NCT00610441|65296476|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
23424362|NCT00610441|65296477|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
23540523|NCT01722331|65709214|FG002|Part 3|Protocol Violation|0|||
23540524|NCT01722331|65709215|FG003|Part 3|Protocol Violation|0|||
23209986|NCT00475540|64509006|FG001|36 Months|Death|2|||
23209987|NCT00475540|64509005|FG000|36 Months|Censored due to reoperation|3|||
23540525|NCT01722331|65709216|FG004|Part 3|Protocol Violation|0|||
23540526|NCT01722331|65709217|FG005|Part 3|Protocol Violation|0|||
23424363|NCT00610441|65296478|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
23540527|NCT01722331|65709218|FG006|Part 3|Protocol Violation|0|||
23540528|NCT01722331|65709212|FG000|Part 3|Withdrawal by Subject|4|||
23540529|NCT01722331|65709213|FG001|Part 3|Withdrawal by Subject|7|||
23540530|NCT01722331|65709214|FG002|Part 3|Withdrawal by Subject|0|||
23540531|NCT01722331|65709215|FG003|Part 3|Withdrawal by Subject|0|||
23540532|NCT01722331|65709216|FG004|Part 3|Withdrawal by Subject|0|||
23540533|NCT01722331|65709217|FG005|Part 3|Withdrawal by Subject|2|||
23540534|NCT01722331|65709218|FG006|Part 3|Withdrawal by Subject|1|||
23540535|NCT01722331|65709212|FG000|Part 3|Other Protocol Specified Criteria|1|||
23540536|NCT01722331|65709213|FG001|Part 3|Other Protocol Specified Criteria|1|||
23540537|NCT01722331|65709214|FG002|Part 3|Other Protocol Specified Criteria|0|||
23540538|NCT01722331|65709215|FG003|Part 3|Other Protocol Specified Criteria|0|||
23540539|NCT01722331|65709216|FG004|Part 3|Other Protocol Specified Criteria|0|||
23540540|NCT01722331|65709217|FG005|Part 3|Other Protocol Specified Criteria|0|||
23540541|NCT01722331|65709218|FG006|Part 3|Other Protocol Specified Criteria|0|||
23540542|NCT00346034|65709223|FG000|Overall Study|Adverse Event|34|||
23540543|NCT00346034|65709223|FG000|Overall Study|Lack of Efficacy|8|||
23540544|NCT00346034|65709223|FG000|Overall Study|Withdrawal by Subject|13|||
23540545|NCT00346034|65709223|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
23540546|NCT00346034|65709223|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
23424364|NCT00610441|65296479|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
23424365|NCT00610441|65296476|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
23424366|NCT00610441|65296477|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
23424367|NCT00610441|65296478|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
23424368|NCT00610441|65296479|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
23540547|NCT01046643|65709235|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
23540548|NCT01046643|65709236|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
23540549|NCT01046643|65709237|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
23209988|NCT00475540|64509006|FG001|36 Months|Censored due to reoperation|0|||
23424369|NCT00610441|65296476|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
23540550|NCT01046643|65709238|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
23312599|NCT03713619|64886720|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
23540551|NCT00466193|65709242|FG000|Overall Study|Adverse Event|0|||
23312600|NCT03713619|64886721|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23312601|NCT03713619|64886722|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
23312602|NCT03713619|64886723|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
23312603|NCT03713619|64886724|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
23312604|NCT03713619|64886720|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
23312605|NCT03713619|64886721|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
23312606|NCT03713619|64886722|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
23424370|NCT00610441|65296477|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
23424371|NCT00610441|65296478|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
23312607|NCT03713619|64886723|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
23312608|NCT03713619|64886724|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
23312609|NCT03713619|64886720|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
23312610|NCT03713619|64886721|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23312611|NCT03713619|64886722|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23312612|NCT03713619|64886723|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23312613|NCT03713619|64886724|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
23312614|NCT03713619|64886720|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
23312615|NCT03713619|64886721|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
23312616|NCT03713619|64886722|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
23312617|NCT03713619|64886723|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
23312618|NCT03713619|64886724|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
23312619|NCT03713619|64886720|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
23312620|NCT03713619|64886721|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
23312621|NCT03713619|64886722|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
23312622|NCT03713619|64886723|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
23312623|NCT03713619|64886724|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
23209989|NCT02853032|64509013|FG000|Overall Study|Adverse Event|4|||
23209990|NCT02853032|64509014|FG001|Overall Study|Adverse Event|0|||
23209991|NCT02853032|64509013|FG000|Overall Study|Withdrawal by Subject|3|||
23209992|NCT02853032|64509014|FG001|Overall Study|Withdrawal by Subject|1|||
23209993|NCT02853032|64509013|FG000|Overall Study|Requested to withdraw from all treatment|2|||
23209994|NCT02853032|64509014|FG001|Overall Study|Requested to withdraw from all treatment|2|||
23209995|NCT00488592|64509015|FG000|Overall Study|Withdrawal by Subject|1|||
23209996|NCT00488592|64509015|FG000|Overall Study|Disease progression|1|||
23209997|NCT00488592|64509015|FG000|Overall Study|Enrolled but not treated|1|||
23209998|NCT01529385|64509017|FG000|Overall Study|Lost to Follow-up|2|||
23209999|NCT01529385|64509018|FG001|Overall Study|Lost to Follow-up|1|||
23210000|NCT00574496|64509019|FG000|Overall Study|Withdrawal by Subject|1|||
23210001|NCT04093258|64509022|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
23210002|NCT04093258|64509023|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
23210003|NCT01315847|64509024|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
23210004|NCT01315847|64509025|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
23210005|NCT01315847|64509024|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
23210006|NCT01315847|64509025|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
23312624|NCT03713619|64886720|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
23210007|NCT01194804|64509026|FG000|Overall Study|Withdrawal by Subject|1|||
23210008|NCT01295580|64509027|FG000|Overall Study|Protocol Violation|4|||
23210009|NCT01295580|64509028|FG001|Overall Study|Protocol Violation|2|||
23210010|NCT01295580|64509027|FG000|Overall Study|Withdrawal by Subject|1|||
23210011|NCT01295580|64509028|FG001|Overall Study|Withdrawal by Subject|4|||
23312625|NCT03713619|64886721|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
23210012|NCT01295580|64509027|FG000|Overall Study|Adverse Event|2|||
23210013|NCT01295580|64509028|FG001|Overall Study|Adverse Event|1|||
23210014|NCT01295580|64509027|FG000|Overall Study|Lost to Follow-up|1|||
23210015|NCT01295580|64509028|FG001|Overall Study|Lost to Follow-up|0|||
23312626|NCT03713619|64886722|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
23540552|NCT00466193|65709243|FG001|Overall Study|Adverse Event|1|||
23540553|NCT00466193|65709242|FG000|Overall Study|Lost to Follow-up|2|||
23540554|NCT00466193|65709243|FG001|Overall Study|Lost to Follow-up|4|||
23540555|NCT00466193|65709242|FG000|Overall Study|Physician Decision|1|||
23540556|NCT00466193|65709243|FG001|Overall Study|Physician Decision|0|||
23540557|NCT00466193|65709242|FG000|Overall Study|Protocol Violation|1|||
23540558|NCT00466193|65709243|FG001|Overall Study|Protocol Violation|1|||
23540559|NCT00466193|65709242|FG000|Overall Study|Withdrawal by Subject|7|||
23540560|NCT00466193|65709243|FG001|Overall Study|Withdrawal by Subject|2|||
23540561|NCT00466193|65709242|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
23540562|NCT00466193|65709243|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
23540563|NCT00630877|65709244|FG000|Overall Study|Adverse Event|11|||
23210016|NCT01295580|64509027|FG000|Overall Study|Lack of Efficacy|1|||
23312627|NCT03713619|64886723|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
23312628|NCT03713619|64886724|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
23312629|NCT03713619|64886720|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
23540564|NCT00630877|65709245|FG001|Overall Study|Adverse Event|8|||
23540565|NCT00630877|65709246|FG002|Overall Study|Adverse Event|7|||
23210017|NCT01295580|64509028|FG001|Overall Study|Lack of Efficacy|0|||
23210018|NCT01295580|64509027|FG000|Overall Study|Other: inconvenience|1|||
23210019|NCT01295580|64509028|FG001|Overall Study|Other: inconvenience|0|||
23210020|NCT01295580|64509027|FG000|Overall Study|Other: family objection|0|||
23210021|NCT01295580|64509028|FG001|Overall Study|Other: family objection|1|||
23210022|NCT02188719|64509029|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
23210023|NCT02188719|64509030|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
23210024|NCT02188719|64509031|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
23210025|NCT02188719|64509032|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
23312630|NCT03713619|64886721|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
23540566|NCT00630877|65709244|FG000|Overall Study|Withdrawal by Subject|3|||
23540567|NCT00630877|65709245|FG001|Overall Study|Withdrawal by Subject|4|||
23540568|NCT00630877|65709246|FG002|Overall Study|Withdrawal by Subject|0|||
23540569|NCT00630877|65709244|FG000|Overall Study|Lost to Follow-up|2|||
23540570|NCT00630877|65709245|FG001|Overall Study|Lost to Follow-up|0|||
23540571|NCT00630877|65709246|FG002|Overall Study|Lost to Follow-up|0|||
23540572|NCT00630877|65709244|FG000|Overall Study|Noncompliance|2|||
23540573|NCT00630877|65709245|FG001|Overall Study|Noncompliance|3|||
23540574|NCT00630877|65709246|FG002|Overall Study|Noncompliance|1|||
23540575|NCT00630877|65709244|FG000|Overall Study|Protocol violation|1|||
23540576|NCT00630877|65709245|FG001|Overall Study|Protocol violation|0|||
23540577|NCT00630877|65709246|FG002|Overall Study|Protocol violation|1|||
23540578|NCT00630877|65709244|FG000|Overall Study|Personal reasons|0|||
23540579|NCT00630877|65709245|FG001|Overall Study|Personal reasons|0|||
23540580|NCT00630877|65709246|FG002|Overall Study|Personal reasons|1|||
23540581|NCT01324024|65709247|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
23540582|NCT01324024|65709248|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23540583|NCT00724971|65709249|FG000|Overall Study|Adverse Event|5|||
23540584|NCT00724971|65709249|FG000|Overall Study|Withdrawal by Subject|1|||
23210026|NCT01763866|64509033|FG000|Overall Study|Withdrawal by Subject|2|||
23210027|NCT01763866|64509034|FG001|Overall Study|Withdrawal by Subject|1|||
23540585|NCT00345579|65709251|FG000|Overall Study|Adverse Event|9|||
23540586|NCT00345579|65709252|FG001|Overall Study|Adverse Event|6|||
23540587|NCT00345579|65709251|FG000|Overall Study|Protocol Violation|14|||
23540588|NCT00345579|65709252|FG001|Overall Study|Protocol Violation|5|||
23540589|NCT00345579|65709251|FG000|Overall Study|Withdrawal by Subject|50|||
23540590|NCT00345579|65709252|FG001|Overall Study|Withdrawal by Subject|17|||
23616656|NCT01945593|65982398|FG000|Overall Study|Death|0|||
23210028|NCT01763866|64509035|FG002|Overall Study|Withdrawal by Subject|4|||
23210029|NCT01763866|64509036|FG003|Overall Study|Withdrawal by Subject|0|||
23210030|NCT01763866|64509037|FG004|Overall Study|Withdrawal by Subject|0|||
23210031|NCT01763866|64509038|FG005|Overall Study|Withdrawal by Subject|3|||
23540591|NCT00345579|65709251|FG000|Overall Study|Lost to Follow-up|82|||
23616657|NCT01945593|65982399|FG001|Overall Study|Death|0|||
23616658|NCT01945593|65982400|FG002|Overall Study|Death|1|||
23616659|NCT01945593|65982401|FG003|Overall Study|Death|0|||
23616660|NCT01945593|65982398|FG000|Overall Study|Other: Terminated|0|||
23616661|NCT01945593|65982399|FG001|Overall Study|Other: Terminated|0|||
23616662|NCT01945593|65982400|FG002|Overall Study|Other: Terminated|0|||
23616663|NCT01945593|65982401|FG003|Overall Study|Other: Terminated|1|||
23616664|NCT01945593|65982398|FG000|Overall Study|Other: Surgical Procedure|0|||
23616665|NCT01945593|65982399|FG001|Overall Study|Other: Surgical Procedure|2|||
23616666|NCT01945593|65982400|FG002|Overall Study|Other: Surgical Procedure|0|||
23616667|NCT01945593|65982401|FG003|Overall Study|Other: Surgical Procedure|6|||
23616668|NCT01945593|65982398|FG000|Overall Study|Other: Screen Failure|0|||
23210032|NCT01763866|64509039|FG006|Overall Study|Withdrawal by Subject|4|||
23540592|NCT00345579|65709252|FG001|Overall Study|Lost to Follow-up|36|||
23540593|NCT00345579|65709251|FG000|Overall Study|Other|9|||
23540594|NCT00345579|65709252|FG001|Overall Study|Other|1|||
23540595|NCT03855189|65709255|FG000|Overall Study|Adverse Event|5|||
23540596|NCT03855189|65709256|FG001|Overall Study|Adverse Event|2|||
23540597|NCT03855189|65709257|FG002|Overall Study|Adverse Event|4|||
23540598|NCT03855189|65709255|FG000|Overall Study|Treatment Failure|1|||
23540599|NCT03855189|65709256|FG001|Overall Study|Treatment Failure|1|||
23540600|NCT03855189|65709257|FG002|Overall Study|Treatment Failure|2|||
23540601|NCT03855189|65709255|FG000|Overall Study|Noncompliance with Protocol|0|||
23540602|NCT03855189|65709256|FG001|Overall Study|Noncompliance with Protocol|1|||
23540603|NCT03855189|65709257|FG002|Overall Study|Noncompliance with Protocol|0|||
23540604|NCT03855189|65709255|FG000|Overall Study|Did Not Return|4|||
23540605|NCT03855189|65709256|FG001|Overall Study|Did Not Return|3|||
23540606|NCT03855189|65709257|FG002|Overall Study|Did Not Return|0|||
23540607|NCT02199691|65709261|FG000|Overall Study|Protocol Violation|3|||
23540608|NCT02199691|65709262|FG001|Overall Study|Protocol Violation|3|||
23540609|NCT02199691|65709263|FG002|Overall Study|Protocol Violation|6|||
23540610|NCT02199691|65709264|FG003|Overall Study|Protocol Violation|7|||
23540611|NCT02199691|65709261|FG000|Overall Study|Withdrawal by Subject|5|||
23540612|NCT02199691|65709262|FG001|Overall Study|Withdrawal by Subject|3|||
23540613|NCT02199691|65709263|FG002|Overall Study|Withdrawal by Subject|12|||
23312631|NCT03713619|64886722|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
23312632|NCT03713619|64886723|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
23312633|NCT03713619|64886724|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
23312634|NCT03713619|64886720|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
23312635|NCT03713619|64886721|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23312636|NCT03713619|64886722|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23312637|NCT03713619|64886723|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
23312638|NCT03713619|64886724|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
23312639|NCT03713619|64886720|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
23312640|NCT03713619|64886721|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
23312641|NCT03713619|64886722|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
23312642|NCT03713619|64886723|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
23312643|NCT03713619|64886724|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
23312644|NCT03713619|64886720|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
23312645|NCT03713619|64886721|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
23424372|NCT00610441|65296479|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
23424373|NCT00610441|65296476|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
23424374|NCT00610441|65296477|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
23424375|NCT00610441|65296478|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
23424376|NCT00610441|65296479|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
23424377|NCT00610441|65296476|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
23424378|NCT00610441|65296477|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
23424379|NCT00610441|65296478|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
23424380|NCT00610441|65296479|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
23424381|NCT00610441|65296476|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
23424382|NCT00610441|65296477|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
23424383|NCT00610441|65296478|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
23424384|NCT00610441|65296479|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
23424385|NCT00610441|65296476|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
23424386|NCT00610441|65296477|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
23424387|NCT00610441|65296478|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
23424388|NCT00610441|65296479|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
23424389|NCT00610441|65296476|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
23424390|NCT00610441|65296477|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
23424391|NCT00610441|65296478|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
23424392|NCT00610441|65296479|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
23540614|NCT02199691|65709264|FG003|Overall Study|Withdrawal by Subject|13|||
23540615|NCT02199691|65709261|FG000|Overall Study|Lost to Follow-up|2|||
23540616|NCT02199691|65709262|FG001|Overall Study|Lost to Follow-up|1|||
23540617|NCT02199691|65709263|FG002|Overall Study|Lost to Follow-up|9|||
23540618|NCT02199691|65709264|FG003|Overall Study|Lost to Follow-up|10|||
23540619|NCT00612066|65709269|FG000|Overall Study|Adverse Event|1|||
23540620|NCT00572572|65709270|FG000|Overall Study|Withdrawal by Subject|3|||
23540621|NCT00572572|65709271|FG001|Overall Study|Withdrawal by Subject|6|||
23540622|NCT03036566|65709273|FG000|Overall Study|Lost to Follow-up|3|||
23540623|NCT02401672|65709274|FG000|Overall Study|Withdrawal by Subject|1|||
23540624|NCT02401672|65709275|FG001|Overall Study|Withdrawal by Subject|3|||
23540625|NCT00840970|65709278|FG000|Overall Study|Adverse Event|0|||
23540626|NCT00840970|65709279|FG001|Overall Study|Adverse Event|0|||
23540627|NCT00840970|65709280|FG002|Overall Study|Adverse Event|1|||
23540628|NCT00384085|65709284|FG000|Overall Study|Adverse Event|5|||
23540629|NCT00384085|65709285|FG001|Overall Study|Adverse Event|5|||
23540630|NCT00384085|65709286|FG002|Overall Study|Adverse Event|4|||
23540631|NCT00384085|65709284|FG000|Overall Study|Lack of Efficacy|0|||
23540632|NCT00384085|65709285|FG001|Overall Study|Lack of Efficacy|3|||
23540633|NCT00384085|65709286|FG002|Overall Study|Lack of Efficacy|2|||
23540634|NCT00384085|65709284|FG000|Overall Study|No longer Requires Study Treatment|1|||
23540635|NCT00384085|65709285|FG001|Overall Study|No longer Requires Study Treatment|0|||
23540636|NCT00384085|65709286|FG002|Overall Study|No longer Requires Study Treatment|1|||
23540637|NCT00384085|65709284|FG000|Overall Study|Protocol Violation|2|||
23540638|NCT00384085|65709285|FG001|Overall Study|Protocol Violation|2|||
23540639|NCT00384085|65709286|FG002|Overall Study|Protocol Violation|2|||
23540640|NCT00384085|65709284|FG000|Overall Study|Lost to Follow-up|9|||
23540641|NCT00384085|65709285|FG001|Overall Study|Lost to Follow-up|9|||
23540642|NCT00384085|65709286|FG002|Overall Study|Lost to Follow-up|10|||
23540643|NCT00384085|65709284|FG000|Overall Study|Progressive Disease|0|||
23540644|NCT00384085|65709285|FG001|Overall Study|Progressive Disease|1|||
23540645|NCT00384085|65709286|FG002|Overall Study|Progressive Disease|0|||
23540646|NCT00384085|65709284|FG000|Overall Study|Withdrawal by Subject|14|||
23540647|NCT00384085|65709285|FG001|Overall Study|Withdrawal by Subject|19|||
23210033|NCT01763866|64509040|FG007|Overall Study|Withdrawal by Subject|0|||
23210034|NCT01763866|64509041|FG008|Overall Study|Withdrawal by Subject|1|||
23210035|NCT01763866|64509042|FG009|Overall Study|Withdrawal by Subject|1|||
23210036|NCT01763866|64509043|FG010|Overall Study|Withdrawal by Subject|2|||
23210037|NCT01763866|64509044|FG011|Overall Study|Withdrawal by Subject|2|||
23210038|NCT01763866|64509045|FG012|Overall Study|Withdrawal by Subject|2|||
23210039|NCT01763866|64509046|FG013|Overall Study|Withdrawal by Subject|0|||
23210040|NCT01763866|64509047|FG014|Overall Study|Withdrawal by Subject|6|||
23210041|NCT01763866|64509048|FG015|Overall Study|Withdrawal by Subject|3|||
23210042|NCT01763866|64509049|FG016|Overall Study|Withdrawal by Subject|0|||
23210043|NCT01763866|64509050|FG017|Overall Study|Withdrawal by Subject|1|||
23210044|NCT01763866|64509051|FG018|Overall Study|Withdrawal by Subject|1|||
23210045|NCT01763866|64509052|FG019|Overall Study|Withdrawal by Subject|1|||
23540648|NCT00384085|65709286|FG002|Overall Study|Withdrawal by Subject|29|||
23540649|NCT00384085|65709284|FG000|Overall Study|Patient non-compliant|4|||
23540650|NCT00384085|65709285|FG001|Overall Study|Patient non-compliant|4|||
23540651|NCT00384085|65709286|FG002|Overall Study|Patient non-compliant|5|||
23540652|NCT00384085|65709284|FG000|Overall Study|Physician Decision|1|||
23540653|NCT00384085|65709285|FG001|Overall Study|Physician Decision|0|||
23540654|NCT00384085|65709286|FG002|Overall Study|Physician Decision|0|||
23540655|NCT00384085|65709284|FG000|Overall Study|Loss of site personnel|1|||
23540656|NCT00384085|65709285|FG001|Overall Study|Loss of site personnel|0|||
23540657|NCT00384085|65709286|FG002|Overall Study|Loss of site personnel|1|||
23540658|NCT00384085|65709284|FG000|Overall Study|Sponsor decision|1|||
23540659|NCT00384085|65709285|FG001|Overall Study|Sponsor decision|2|||
23540660|NCT00384085|65709286|FG002|Overall Study|Sponsor decision|1|||
23540661|NCT00384085|65709284|FG000|Overall Study|Patient moved|1|||
23540662|NCT00384085|65709285|FG001|Overall Study|Patient moved|0|||
23540663|NCT00384085|65709286|FG002|Overall Study|Patient moved|1|||
23540664|NCT00384085|65709284|FG000|Overall Study|Patient required surgery|0|||
23540665|NCT00384085|65709285|FG001|Overall Study|Patient required surgery|1|||
23540666|NCT00384085|65709286|FG002|Overall Study|Patient required surgery|0|||
23540667|NCT01785524|65709288|FG000|Overall Study|Withdrawal by Subject|2|||
23540668|NCT01785524|65709289|FG001|Overall Study|Withdrawal by Subject|2|||
23540669|NCT01539291|65709290|FG000|Study GS-US-312-0116|Adverse Event|9|||
23540670|NCT01539291|65709291|FG001|Study GS-US-312-0116|Adverse Event|0|||
23540671|NCT01539291|65709292|FG002|Study GS-US-312-0116|Adverse Event|0|||
23540672|NCT01539291|65709293|FG003|Study GS-US-312-0116|Adverse Event|0|||
23540673|NCT01539291|65709290|FG000|Study GS-US-312-0116|Physician Decision|1|||
23540674|NCT01539291|65709291|FG001|Study GS-US-312-0116|Physician Decision|0|||
23210046|NCT01763866|64509053|FG020|Overall Study|Withdrawal by Subject|2|||
23540675|NCT01539291|65709292|FG002|Study GS-US-312-0116|Physician Decision|0|||
23312646|NCT03713619|64886722|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
23312647|NCT03713619|64886723|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
23312648|NCT03713619|64886724|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
23312649|NCT03713619|64886720|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
23312650|NCT03713619|64886721|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
23312651|NCT03713619|64886722|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
23210047|NCT01763866|64509054|FG021|Overall Study|Withdrawal by Subject|1|||
23210048|NCT01763866|64509055|FG022|Overall Study|Withdrawal by Subject|2|||
23540676|NCT01539291|65709293|FG003|Study GS-US-312-0116|Physician Decision|0|||
23540677|NCT01539291|65709290|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
23540678|NCT01539291|65709291|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
23540679|NCT01539291|65709292|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
23540680|NCT01539291|65709293|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
23540681|NCT01539291|65709290|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
23540682|NCT01539291|65709291|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
23540683|NCT01539291|65709292|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
23540684|NCT01539291|65709293|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
23540685|NCT01539291|65709290|FG000|Study GS-US-312-0116|Other|1|||
23540686|NCT01539291|65709291|FG001|Study GS-US-312-0116|Other|0|||
23540687|NCT01539291|65709292|FG002|Study GS-US-312-0116|Other|0|||
23540688|NCT01539291|65709293|FG003|Study GS-US-312-0116|Other|0|||
23540689|NCT01539291|65709290|FG000|Study GS-US-312-0117|Adverse Event|22|||
23540690|NCT01539291|65709291|FG001|Study GS-US-312-0117|Adverse Event|1|||
23540691|NCT01539291|65709292|FG002|Study GS-US-312-0117|Adverse Event|9|||
23540692|NCT01539291|65709293|FG003|Study GS-US-312-0117|Adverse Event|12|||
23540693|NCT01539291|65709290|FG000|Study GS-US-312-0117|Physician Decision|9|||
23540694|NCT01539291|65709291|FG001|Study GS-US-312-0117|Physician Decision|0|||
23540695|NCT01539291|65709292|FG002|Study GS-US-312-0117|Physician Decision|6|||
23540696|NCT01539291|65709293|FG003|Study GS-US-312-0117|Physician Decision|4|||
23540697|NCT01539291|65709290|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
23540698|NCT01539291|65709291|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
23210049|NCT01763866|64509056|FG023|Overall Study|Withdrawal by Subject|1|||
23210050|NCT01763866|64509033|FG000|Overall Study|Decision by sponsor|0|||
23210051|NCT01763866|64509034|FG001|Overall Study|Decision by sponsor|0|||
23210052|NCT01763866|64509035|FG002|Overall Study|Decision by sponsor|1|||
23210053|NCT01763866|64509036|FG003|Overall Study|Decision by sponsor|0|||
23210054|NCT01763866|64509037|FG004|Overall Study|Decision by sponsor|2|||
23210055|NCT01763866|64509038|FG005|Overall Study|Decision by sponsor|0|||
23210056|NCT01763866|64509039|FG006|Overall Study|Decision by sponsor|2|||
23210057|NCT01763866|64509040|FG007|Overall Study|Decision by sponsor|0|||
23540699|NCT01539291|65709292|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
23540700|NCT01539291|65709293|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
23540701|NCT01539291|65709290|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
23540702|NCT01539291|65709291|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
23540703|NCT01539291|65709292|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
23540704|NCT01539291|65709293|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
23540705|NCT01539291|65709290|FG000|Study GS-US-312-0117|Other|2|||
23540706|NCT01539291|65709291|FG001|Study GS-US-312-0117|Other|1|||
23540707|NCT01539291|65709292|FG002|Study GS-US-312-0117|Other|1|||
23540708|NCT01539291|65709293|FG003|Study GS-US-312-0117|Other|1|||
23540709|NCT00009737|65709294|FG000|Overall Study|Adverse Event|112|||
23540710|NCT00009737|65709295|FG001|Overall Study|Adverse Event|75|||
23540711|NCT00009737|65709294|FG000|Overall Study|Death|4|||
23540712|NCT00009737|65709295|FG001|Overall Study|Death|6|||
23540713|NCT00009737|65709294|FG000|Overall Study|Lack of Efficacy|17|||
23210058|NCT01763866|64509041|FG008|Overall Study|Decision by sponsor|2|||
23210059|NCT01763866|64509042|FG009|Overall Study|Decision by sponsor|0|||
23540714|NCT00009737|65709295|FG001|Overall Study|Lack of Efficacy|15|||
23540715|NCT00009737|65709294|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
23540716|NCT00009737|65709295|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
23540717|NCT00009737|65709294|FG000|Overall Study|Other Protocol Violation|1|||
23540718|NCT00009737|65709295|FG001|Overall Study|Other Protocol Violation|0|||
23540719|NCT00009737|65709294|FG000|Overall Study|Refused Treatment|15|||
23540720|NCT00009737|65709295|FG001|Overall Study|Refused Treatment|16|||
23540721|NCT00009737|65709294|FG000|Overall Study|Lost to Follow-up|1|||
23540722|NCT00009737|65709295|FG001|Overall Study|Lost to Follow-up|1|||
23540723|NCT00009737|65709294|FG000|Overall Study|Administrative/Other Reasons|7|||
23540724|NCT00009737|65709295|FG001|Overall Study|Administrative/Other Reasons|1|||
23540725|NCT03864900|65709298|FG000|Overall Study|Withdrawal by Subject|1|||
23540726|NCT03864900|65709299|FG001|Overall Study|Withdrawal by Subject|1|||
23540727|NCT03864900|65709298|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
23540728|NCT03864900|65709299|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
23540729|NCT01669343|65709300|FG000|Part A: All Patients|Withdrawal by Subject|7|||
23540730|NCT01669343|65709300|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
23540731|NCT01669343|65709300|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
23540732|NCT01669343|65709300|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
23540733|NCT01669343|65709300|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
23540734|NCT00560833|65709301|FG000|Overall Study|Adverse Event|16|||
23540735|NCT00560833|65709302|FG001|Overall Study|Adverse Event|10|||
23540736|NCT00560833|65709303|FG002|Overall Study|Adverse Event|25|||
23540737|NCT00560833|65709304|FG003|Overall Study|Adverse Event|23|||
23540738|NCT00560833|65709305|FG004|Overall Study|Adverse Event|35|||
23540739|NCT00560833|65709301|FG000|Overall Study|Lost to Follow-up|0|||
23210060|NCT01763866|64509043|FG010|Overall Study|Decision by sponsor|6|||
23210061|NCT01763866|64509044|FG011|Overall Study|Decision by sponsor|0|||
23210062|NCT01763866|64509045|FG012|Overall Study|Decision by sponsor|1|||
23210063|NCT01763866|64509046|FG013|Overall Study|Decision by sponsor|0|||
23210064|NCT01763866|64509047|FG014|Overall Study|Decision by sponsor|5|||
23210065|NCT01763866|64509048|FG015|Overall Study|Decision by sponsor|0|||
23540740|NCT00560833|65709302|FG001|Overall Study|Lost to Follow-up|0|||
23540741|NCT00560833|65709303|FG002|Overall Study|Lost to Follow-up|1|||
23540742|NCT00560833|65709304|FG003|Overall Study|Lost to Follow-up|0|||
23540743|NCT00560833|65709305|FG004|Overall Study|Lost to Follow-up|0|||
23540744|NCT00560833|65709301|FG000|Overall Study|Lack of Efficacy|22|||
23540745|NCT00560833|65709302|FG001|Overall Study|Lack of Efficacy|9|||
23540746|NCT00560833|65709303|FG002|Overall Study|Lack of Efficacy|6|||
23540747|NCT00560833|65709304|FG003|Overall Study|Lack of Efficacy|4|||
23540748|NCT00560833|65709305|FG004|Overall Study|Lack of Efficacy|4|||
23540749|NCT00560833|65709301|FG000|Overall Study|Participant uncooperative|5|||
23540750|NCT00560833|65709302|FG001|Overall Study|Participant uncooperative|5|||
23540751|NCT00560833|65709303|FG002|Overall Study|Participant uncooperative|4|||
23540752|NCT00560833|65709304|FG003|Overall Study|Participant uncooperative|4|||
23540753|NCT00560833|65709305|FG004|Overall Study|Participant uncooperative|2|||
23540754|NCT00560833|65709301|FG000|Overall Study|Other|1|||
23540755|NCT00560833|65709302|FG001|Overall Study|Other|1|||
23540756|NCT00560833|65709303|FG002|Overall Study|Other|3|||
23540757|NCT00560833|65709304|FG003|Overall Study|Other|0|||
23540758|NCT00560833|65709305|FG004|Overall Study|Other|0|||
23540759|NCT00560833|65709301|FG000|Overall Study|Never received drug|0|||
23540760|NCT00560833|65709302|FG001|Overall Study|Never received drug|1|||
23540761|NCT00560833|65709303|FG002|Overall Study|Never received drug|0|||
23540762|NCT00560833|65709304|FG003|Overall Study|Never received drug|0|||
23540763|NCT00560833|65709305|FG004|Overall Study|Never received drug|1|||
23540764|NCT01877421|65709307|FG000|Phase 2|Lost to Follow-up|0|||
23210066|NCT01763866|64509049|FG016|Overall Study|Decision by sponsor|0|||
23210067|NCT01763866|64509050|FG017|Overall Study|Decision by sponsor|0|||
23210068|NCT01763866|64509051|FG018|Overall Study|Decision by sponsor|4|||
23210069|NCT01763866|64509052|FG019|Overall Study|Decision by sponsor|0|||
23210070|NCT01763866|64509053|FG020|Overall Study|Decision by sponsor|2|||
23210071|NCT01763866|64509054|FG021|Overall Study|Decision by sponsor|0|||
23210072|NCT01763866|64509055|FG022|Overall Study|Decision by sponsor|1|||
23210073|NCT01763866|64509056|FG023|Overall Study|Decision by sponsor|0|||
23540765|NCT01877421|65709308|FG001|Phase 2|Lost to Follow-up|0|||
23540766|NCT01877421|65709309|FG002|Phase 2|Lost to Follow-up|0|||
23540767|NCT01877421|65709310|FG003|Phase 2|Lost to Follow-up|0|||
23540768|NCT01877421|65709311|FG004|Phase 2|Lost to Follow-up|0|||
23540769|NCT01877421|65709312|FG005|Phase 2|Lost to Follow-up|0|||
23540770|NCT01877421|65709313|FG006|Phase 2|Lost to Follow-up|1|||
23540771|NCT01877421|65709314|FG007|Phase 2|Lost to Follow-up|0|||
23540772|NCT01877421|65709315|FG008|Phase 2|Lost to Follow-up|0|||
23540773|NCT01877421|65709316|FG009|Phase 2|Lost to Follow-up|0|||
23210074|NCT01763866|64509033|FG000|Overall Study|Lost to Follow-up|0|||
23210075|NCT01763866|64509034|FG001|Overall Study|Lost to Follow-up|0|||
23540774|NCT01877421|65709317|FG010|Phase 2|Lost to Follow-up|0|||
23540775|NCT01877421|65709318|FG011|Phase 2|Lost to Follow-up|0|||
23210076|NCT01763866|64509035|FG002|Overall Study|Lost to Follow-up|0|||
23210077|NCT01763866|64509036|FG003|Overall Study|Lost to Follow-up|0|||
23210078|NCT01763866|64509037|FG004|Overall Study|Lost to Follow-up|0|||
23210079|NCT01763866|64509038|FG005|Overall Study|Lost to Follow-up|0|||
23210080|NCT01763866|64509039|FG006|Overall Study|Lost to Follow-up|1|||
23210081|NCT01763866|64509040|FG007|Overall Study|Lost to Follow-up|0|||
23210082|NCT01763866|64509041|FG008|Overall Study|Lost to Follow-up|0|||
23210083|NCT01763866|64509042|FG009|Overall Study|Lost to Follow-up|0|||
23210084|NCT01763866|64509043|FG010|Overall Study|Lost to Follow-up|0|||
23210085|NCT01763866|64509044|FG011|Overall Study|Lost to Follow-up|0|||
23210086|NCT01763866|64509045|FG012|Overall Study|Lost to Follow-up|1|||
23210087|NCT01763866|64509046|FG013|Overall Study|Lost to Follow-up|0|||
23210088|NCT01763866|64509047|FG014|Overall Study|Lost to Follow-up|1|||
23210089|NCT01763866|64509048|FG015|Overall Study|Lost to Follow-up|0|||
23210090|NCT01763866|64509049|FG016|Overall Study|Lost to Follow-up|0|||
23210091|NCT01763866|64509050|FG017|Overall Study|Lost to Follow-up|0|||
23210092|NCT01763866|64509051|FG018|Overall Study|Lost to Follow-up|1|||
23210093|NCT01763866|64509052|FG019|Overall Study|Lost to Follow-up|1|||
23210094|NCT01763866|64509053|FG020|Overall Study|Lost to Follow-up|0|||
23210095|NCT01763866|64509054|FG021|Overall Study|Lost to Follow-up|0|||
23210096|NCT01763866|64509055|FG022|Overall Study|Lost to Follow-up|0|||
23210097|NCT01763866|64509056|FG023|Overall Study|Lost to Follow-up|1|||
23210098|NCT01763866|64509033|FG000|Overall Study|Death|0|||
23210099|NCT01763866|64509034|FG001|Overall Study|Death|0|||
23210100|NCT01763866|64509035|FG002|Overall Study|Death|0|||
23210101|NCT01763866|64509036|FG003|Overall Study|Death|0|||
23210102|NCT01763866|64509037|FG004|Overall Study|Death|0|||
23210103|NCT01763866|64509038|FG005|Overall Study|Death|0|||
23210104|NCT01763866|64509039|FG006|Overall Study|Death|0|||
23210105|NCT01763866|64509040|FG007|Overall Study|Death|0|||
23210106|NCT01763866|64509041|FG008|Overall Study|Death|0|||
23210107|NCT01763866|64509042|FG009|Overall Study|Death|0|||
23210108|NCT01763866|64509043|FG010|Overall Study|Death|0|||
23210109|NCT01763866|64509044|FG011|Overall Study|Death|0|||
23210110|NCT01763866|64509045|FG012|Overall Study|Death|0|||
23210111|NCT01763866|64509046|FG013|Overall Study|Death|0|||
23210112|NCT01763866|64509047|FG014|Overall Study|Death|0|||
23210113|NCT01763866|64509048|FG015|Overall Study|Death|0|||
23210114|NCT01763866|64509049|FG016|Overall Study|Death|1|||
23210115|NCT01763866|64509050|FG017|Overall Study|Death|0|||
23210116|NCT01763866|64509051|FG018|Overall Study|Death|0|||
23210117|NCT01763866|64509052|FG019|Overall Study|Death|0|||
23210118|NCT01763866|64509053|FG020|Overall Study|Death|0|||
23540776|NCT01877421|65709319|FG012|Phase 2|Lost to Follow-up|0|||
23540777|NCT01877421|65709320|FG013|Phase 2|Lost to Follow-up|0|||
23540778|NCT01877421|65709321|FG014|Phase 2|Lost to Follow-up|0|||
23540779|NCT01877421|65709322|FG015|Phase 2|Lost to Follow-up|0|||
23540780|NCT01877421|65709323|FG016|Phase 2|Lost to Follow-up|0|||
23540781|NCT01877421|65709324|FG017|Phase 2|Lost to Follow-up|0|||
23540782|NCT01877421|65709307|FG000|Phase 2|Withdrawal by Subject|0|||
23210119|NCT01763866|64509054|FG021|Overall Study|Death|0|||
23210120|NCT01763866|64509055|FG022|Overall Study|Death|0|||
23210121|NCT01763866|64509056|FG023|Overall Study|Death|0|||
23210122|NCT03094832|64509057|FG000|Overall Study|Lost to Follow-up|0|||
23210123|NCT03094832|64509058|FG001|Overall Study|Lost to Follow-up|0|||
23540783|NCT01877421|65709308|FG001|Phase 2|Withdrawal by Subject|0|||
23540784|NCT01877421|65709309|FG002|Phase 2|Withdrawal by Subject|0|||
23210124|NCT03094832|64509059|FG002|Overall Study|Lost to Follow-up|0|||
23210125|NCT03094832|64509060|FG003|Overall Study|Lost to Follow-up|1|||
23210126|NCT03094832|64509061|FG004|Overall Study|Lost to Follow-up|1|||
23210127|NCT03094832|64509057|FG000|Overall Study|Death|1|||
23210128|NCT03094832|64509058|FG001|Overall Study|Death|0|||
23210129|NCT03094832|64509059|FG002|Overall Study|Death|0|||
23210130|NCT03094832|64509060|FG003|Overall Study|Death|0|||
23210131|NCT03094832|64509061|FG004|Overall Study|Death|0|||
23210132|NCT03094832|64509057|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23540785|NCT01877421|65709310|FG003|Phase 2|Withdrawal by Subject|0|||
23540786|NCT01877421|65709311|FG004|Phase 2|Withdrawal by Subject|0|||
23540787|NCT01877421|65709312|FG005|Phase 2|Withdrawal by Subject|0|||
23540788|NCT01877421|65709313|FG006|Phase 2|Withdrawal by Subject|0|||
23540789|NCT01877421|65709314|FG007|Phase 2|Withdrawal by Subject|0|||
23540790|NCT01877421|65709315|FG008|Phase 2|Withdrawal by Subject|1|||
23540791|NCT01877421|65709316|FG009|Phase 2|Withdrawal by Subject|0|||
23540792|NCT01877421|65709317|FG010|Phase 2|Withdrawal by Subject|1|||
23540793|NCT01877421|65709318|FG011|Phase 2|Withdrawal by Subject|0|||
23540794|NCT01877421|65709319|FG012|Phase 2|Withdrawal by Subject|1|||
23540795|NCT01877421|65709320|FG013|Phase 2|Withdrawal by Subject|0|||
23540796|NCT01877421|65709321|FG014|Phase 2|Withdrawal by Subject|0|||
23540797|NCT01877421|65709322|FG015|Phase 2|Withdrawal by Subject|1|||
23540798|NCT01877421|65709323|FG016|Phase 2|Withdrawal by Subject|0|||
23540799|NCT01877421|65709324|FG017|Phase 2|Withdrawal by Subject|0|||
23540800|NCT01877421|65709307|FG000|Phase 2|Protocol Violation|0|||
23540801|NCT01877421|65709308|FG001|Phase 2|Protocol Violation|0|||
23540802|NCT01877421|65709309|FG002|Phase 2|Protocol Violation|0|||
23540803|NCT01877421|65709310|FG003|Phase 2|Protocol Violation|0|||
23540804|NCT01877421|65709311|FG004|Phase 2|Protocol Violation|0|||
23540805|NCT01877421|65709312|FG005|Phase 2|Protocol Violation|0|||
23540806|NCT01877421|65709313|FG006|Phase 2|Protocol Violation|0|||
23540807|NCT01877421|65709314|FG007|Phase 2|Protocol Violation|0|||
23540808|NCT01877421|65709315|FG008|Phase 2|Protocol Violation|0|||
23540809|NCT01877421|65709316|FG009|Phase 2|Protocol Violation|0|||
23540810|NCT01877421|65709317|FG010|Phase 2|Protocol Violation|1|||
23540811|NCT01877421|65709318|FG011|Phase 2|Protocol Violation|0|||
23540812|NCT01877421|65709319|FG012|Phase 2|Protocol Violation|0|||
23540813|NCT01877421|65709320|FG013|Phase 2|Protocol Violation|0|||
23540814|NCT01877421|65709321|FG014|Phase 2|Protocol Violation|0|||
23540815|NCT01877421|65709322|FG015|Phase 2|Protocol Violation|0|||
23540816|NCT01877421|65709323|FG016|Phase 2|Protocol Violation|0|||
23540817|NCT01877421|65709324|FG017|Phase 2|Protocol Violation|0|||
23540818|NCT01337245|65709325|FG000|Overall Study|Lost to Follow-up|1|||
23540819|NCT04321460|65709326|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
23540820|NCT04321460|65709327|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
23540821|NCT02391948|65712804|FG000|6-month Assessment|Death|0|||
23540822|NCT02391948|65712805|FG001|6-month Assessment|Death|0|||
23540823|NCT02391948|65712806|FG002|6-month Assessment|Death|0|||
23540824|NCT02391948|65712807|FG003|6-month Assessment|Death|0|||
23540825|NCT02391948|65712808|FG004|6-month Assessment|Death|1|||
23540826|NCT02391948|65712804|FG000|6-month Assessment|Withdrawal by Subject|0|||
23540827|NCT02391948|65712805|FG001|6-month Assessment|Withdrawal by Subject|0|||
23540828|NCT02391948|65712806|FG002|6-month Assessment|Withdrawal by Subject|1|||
23540829|NCT02391948|65712807|FG003|6-month Assessment|Withdrawal by Subject|2|||
23540830|NCT02391948|65712808|FG004|6-month Assessment|Withdrawal by Subject|0|||
23540831|NCT02391948|65712804|FG000|6-month Assessment|Lost to Follow-up|4|||
23540832|NCT02391948|65712805|FG001|6-month Assessment|Lost to Follow-up|5|||
23540833|NCT02391948|65712806|FG002|6-month Assessment|Lost to Follow-up|2|||
23540834|NCT02391948|65712807|FG003|6-month Assessment|Lost to Follow-up|3|||
23540835|NCT02391948|65712808|FG004|6-month Assessment|Lost to Follow-up|1|||
23540836|NCT02391948|65712804|FG000|6-month Assessment|Medical issue/illness|1|||
23540837|NCT02391948|65712805|FG001|6-month Assessment|Medical issue/illness|1|||
23540838|NCT02391948|65712806|FG002|6-month Assessment|Medical issue/illness|0|||
23540839|NCT02391948|65712807|FG003|6-month Assessment|Medical issue/illness|0|||
23540840|NCT02391948|65712808|FG004|6-month Assessment|Medical issue/illness|0|||
23540841|NCT02391948|65712804|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
23540842|NCT02391948|65712805|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
23540843|NCT02391948|65712806|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
23540844|NCT02391948|65712807|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
23540845|NCT02391948|65712808|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
23540846|NCT02391948|65712804|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
23540847|NCT02391948|65712805|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
23540848|NCT02391948|65712806|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
23540849|NCT02391948|65712807|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
23540850|NCT02391948|65712808|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
23540851|NCT02391948|65712804|FG000|12-month Assessment|Death|0|||
23540852|NCT02391948|65712805|FG001|12-month Assessment|Death|0|||
23616669|NCT01945593|65982399|FG001|Overall Study|Other: Screen Failure|2|||
23616670|NCT01945593|65982400|FG002|Overall Study|Other: Screen Failure|0|||
23540853|NCT02391948|65712806|FG002|12-month Assessment|Death|0|||
23540854|NCT02391948|65712807|FG003|12-month Assessment|Death|1|||
23540855|NCT02391948|65712808|FG004|12-month Assessment|Death|0|||
23540856|NCT02391948|65712804|FG000|12-month Assessment|Withdrawal by Subject|1|||
23540857|NCT02391948|65712805|FG001|12-month Assessment|Withdrawal by Subject|0|||
23540858|NCT02391948|65712806|FG002|12-month Assessment|Withdrawal by Subject|0|||
23540859|NCT02391948|65712807|FG003|12-month Assessment|Withdrawal by Subject|1|||
23540860|NCT02391948|65712808|FG004|12-month Assessment|Withdrawal by Subject|0|||
23616671|NCT01945593|65982401|FG003|Overall Study|Other: Screen Failure|0|||
23540861|NCT02391948|65712804|FG000|12-month Assessment|Lost to Follow-up|5|||
23540862|NCT02391948|65712805|FG001|12-month Assessment|Lost to Follow-up|4|||
23540863|NCT02391948|65712806|FG002|12-month Assessment|Lost to Follow-up|4|||
23540864|NCT02391948|65712807|FG003|12-month Assessment|Lost to Follow-up|4|||
23540865|NCT02391948|65712808|FG004|12-month Assessment|Lost to Follow-up|5|||
23540866|NCT02391948|65712804|FG000|12-month Assessment|Medical issue/illness|0|||
23540867|NCT02391948|65712805|FG001|12-month Assessment|Medical issue/illness|1|||
23540868|NCT02391948|65712806|FG002|12-month Assessment|Medical issue/illness|0|||
23540869|NCT02391948|65712807|FG003|12-month Assessment|Medical issue/illness|1|||
23540870|NCT02391948|65712808|FG004|12-month Assessment|Medical issue/illness|0|||
23540871|NCT02391948|65712804|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
23540872|NCT02391948|65712805|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
23540873|NCT02391948|65712806|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
23540874|NCT02391948|65712807|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
23540875|NCT02391948|65712808|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
23540876|NCT02391948|65712804|FG000|18-month Assessment|Death|0|||
23540877|NCT02391948|65712805|FG001|18-month Assessment|Death|0|||
23540878|NCT02391948|65712806|FG002|18-month Assessment|Death|0|||
23540879|NCT02391948|65712807|FG003|18-month Assessment|Death|1|||
23540880|NCT02391948|65712808|FG004|18-month Assessment|Death|1|||
23540881|NCT02391948|65712804|FG000|18-month Assessment|Withdrawal by Subject|1|||
23540882|NCT02391948|65712805|FG001|18-month Assessment|Withdrawal by Subject|0|||
23540883|NCT02391948|65712806|FG002|18-month Assessment|Withdrawal by Subject|0|||
23540884|NCT02391948|65712807|FG003|18-month Assessment|Withdrawal by Subject|1|||
23540885|NCT02391948|65712808|FG004|18-month Assessment|Withdrawal by Subject|0|||
23540886|NCT02391948|65712804|FG000|18-month Assessment|Lost to Follow-up|2|||
23540887|NCT02391948|65712805|FG001|18-month Assessment|Lost to Follow-up|6|||
23540888|NCT02391948|65712806|FG002|18-month Assessment|Lost to Follow-up|2|||
23540889|NCT02391948|65712807|FG003|18-month Assessment|Lost to Follow-up|2|||
23540890|NCT02391948|65712808|FG004|18-month Assessment|Lost to Follow-up|3|||
23540891|NCT02391948|65712804|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
23540892|NCT02391948|65712805|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
23540893|NCT02391948|65712806|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
23540894|NCT02391948|65712807|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
23540895|NCT02391948|65712808|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
23540896|NCT02391948|65712804|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
23540897|NCT02391948|65712805|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
23540898|NCT02391948|65712806|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
23540899|NCT02391948|65712807|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
23540900|NCT02391948|65712808|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
23540901|NCT02391948|65712804|FG000|24-month Assessment|Death|0|||
23540902|NCT02391948|65712805|FG001|24-month Assessment|Death|0|||
23540903|NCT02391948|65712806|FG002|24-month Assessment|Death|0|||
23540904|NCT02391948|65712807|FG003|24-month Assessment|Death|0|||
23540905|NCT02391948|65712808|FG004|24-month Assessment|Death|1|||
23540906|NCT02391948|65712804|FG000|24-month Assessment|Withdrawal by Subject|1|||
23540907|NCT02391948|65712805|FG001|24-month Assessment|Withdrawal by Subject|1|||
23540908|NCT02391948|65712806|FG002|24-month Assessment|Withdrawal by Subject|0|||
23540909|NCT02391948|65712807|FG003|24-month Assessment|Withdrawal by Subject|0|||
23540910|NCT02391948|65712808|FG004|24-month Assessment|Withdrawal by Subject|1|||
23540911|NCT02391948|65712804|FG000|24-month Assessment|Lost to Follow-up|5|||
23540912|NCT02391948|65712805|FG001|24-month Assessment|Lost to Follow-up|4|||
23540913|NCT02391948|65712806|FG002|24-month Assessment|Lost to Follow-up|0|||
23540914|NCT02391948|65712807|FG003|24-month Assessment|Lost to Follow-up|0|||
23540915|NCT02391948|65712808|FG004|24-month Assessment|Lost to Follow-up|0|||
23540916|NCT02391948|65712804|FG000|24-month Assessment|Medical issue/illness|0|||
23540917|NCT02391948|65712805|FG001|24-month Assessment|Medical issue/illness|0|||
23540918|NCT02391948|65712806|FG002|24-month Assessment|Medical issue/illness|1|||
23540919|NCT02391948|65712807|FG003|24-month Assessment|Medical issue/illness|0|||
23540920|NCT02391948|65712808|FG004|24-month Assessment|Medical issue/illness|0|||
23540921|NCT02391948|65712804|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
23540922|NCT02391948|65712805|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
23540923|NCT02391948|65712806|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
23540924|NCT02391948|65712807|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
23540925|NCT02391948|65712808|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
23540926|NCT01958918|65712809|FG000|Overall Study|Death|1|||
23540927|NCT01958918|65712810|FG001|Overall Study|Death|3|||
23540928|NCT01958918|65712809|FG000|Overall Study|Lost to Follow-up|4|||
23210133|NCT03094832|64509058|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23210134|NCT03094832|64509059|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23210135|NCT03094832|64509060|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23210136|NCT03094832|64509061|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23210137|NCT03094832|64509057|FG000|Overall Study|Other|13|||
23210138|NCT03094832|64509058|FG001|Overall Study|Other|20|||
23210139|NCT03094832|64509059|FG002|Overall Study|Other|1|||
23210140|NCT03094832|64509060|FG003|Overall Study|Other|7|||
23210141|NCT03094832|64509061|FG004|Overall Study|Other|1|||
23312652|NCT03713619|64886723|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
23312653|NCT03713619|64886724|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
23312654|NCT03713619|64886720|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
23540929|NCT01958918|65712810|FG001|Overall Study|Lost to Follow-up|7|||
23540930|NCT01958918|65712809|FG000|Overall Study|Withdrawal by Subject|13|||
23540931|NCT01958918|65712810|FG001|Overall Study|Withdrawal by Subject|8|||
23540932|NCT01958918|65712809|FG000|Overall Study|Lack of Efficacy|13|||
23540933|NCT01958918|65712810|FG001|Overall Study|Lack of Efficacy|10|||
23540934|NCT01958918|65712809|FG000|Overall Study|Adverse Event|12|||
23540935|NCT01958918|65712810|FG001|Overall Study|Adverse Event|12|||
23540936|NCT01958918|65712809|FG000|Overall Study|administrative problems|0|||
23540937|NCT01958918|65712810|FG001|Overall Study|administrative problems|2|||
23540938|NCT04443218|65712811|FG000|Overall Study|Exited study for other reasons|9|||
23540939|NCT04443218|65712811|FG000|Overall Study|Withdrawal by Subject|1|||
23540940|NCT04443218|65712811|FG000|Overall Study|Lost to Follow-up|4|||
23540941|NCT04443218|65712811|FG000|Overall Study|Death|19|||
23540942|NCT01610700|65712814|FG000|Overall Study|Adverse Event|3|||
23540943|NCT01610700|65712815|FG001|Overall Study|Adverse Event|1|||
23540944|NCT01610700|65712814|FG000|Overall Study|Withdrawal by Subject|0|||
23540945|NCT01610700|65712815|FG001|Overall Study|Withdrawal by Subject|1|||
23540946|NCT01610700|65712814|FG000|Overall Study|subject took one dose of street cannabis|0|||
23540947|NCT01610700|65712815|FG001|Overall Study|subject took one dose of street cannabis|1|||
23540948|NCT02032901|65712817|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
23540949|NCT02032901|65712818|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
23540950|NCT02032901|65712817|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
23540951|NCT02032901|65712818|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
23540952|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
23540953|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
23540954|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
23540955|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
23540956|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
23540957|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
23540958|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
23540959|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
23616672|NCT00116584|65982402|FG000|Overall Study|Withdrawal by Subject|1|||
23210142|NCT00699842|64509062|FG000|Overall Study|Death|0|||
23540960|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
23540961|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
23540962|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
23540963|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
23540964|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
23616673|NCT00116584|65982403|FG001|Overall Study|Withdrawal by Subject|0|||
23210143|NCT00699842|64509063|FG001|Overall Study|Death|1|||
23312655|NCT03713619|64886721|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
23312656|NCT03713619|64886722|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
23312657|NCT03713619|64886723|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
23312658|NCT03713619|64886724|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
23312659|NCT04971187|64886725|FG000|Overall Study|Screen failures|2|||
23312660|NCT04345601|64886726|FG000|Overall Study|Death|0|||
23312661|NCT04345601|64886727|FG001|Overall Study|Death|3|||
23312662|NCT04345601|64886728|FG002|Overall Study|Death|2|||
23312663|NCT04345601|64886726|FG000|Overall Study|Lost to Follow-up|0|||
23312664|NCT04345601|64886727|FG001|Overall Study|Lost to Follow-up|0|||
23312665|NCT04345601|64886728|FG002|Overall Study|Lost to Follow-up|2|||
23312666|NCT02752087|64886729|FG000|Washout|Physician Decision|1|||
23312667|NCT02752087|64886730|FG001|Washout|Physician Decision|0|||
23312668|NCT03058289|64886731|FG000|Overall Study|Radiographic Deterioration|0|||
23312669|NCT03058289|64886732|FG001|Overall Study|Radiographic Deterioration|3|||
23312670|NCT03058289|64886733|FG002|Overall Study|Radiographic Deterioration|1|||
23312671|NCT03058289|64886734|FG003|Overall Study|Radiographic Deterioration|2|||
23312672|NCT03058289|64886735|FG004|Overall Study|Radiographic Deterioration|6|||
23312673|NCT03058289|64886736|FG005|Overall Study|Radiographic Deterioration|3|||
23312674|NCT03058289|64886737|FG006|Overall Study|Radiographic Deterioration|0|||
23312675|NCT03058289|64886738|FG007|Overall Study|Radiographic Deterioration|4|||
23312676|NCT03058289|64886739|FG008|Overall Study|Radiographic Deterioration|2|||
23312677|NCT03058289|64886731|FG000|Overall Study|Adverse Event|2|||
23312678|NCT03058289|64886732|FG001|Overall Study|Adverse Event|0|||
23312679|NCT03058289|64886733|FG002|Overall Study|Adverse Event|1|||
23312680|NCT03058289|64886734|FG003|Overall Study|Adverse Event|3|||
23312681|NCT03058289|64886735|FG004|Overall Study|Adverse Event|1|||
23312682|NCT03058289|64886736|FG005|Overall Study|Adverse Event|0|||
23312683|NCT03058289|64886737|FG006|Overall Study|Adverse Event|1|||
23312684|NCT03058289|64886738|FG007|Overall Study|Adverse Event|3|||
23312685|NCT03058289|64886739|FG008|Overall Study|Adverse Event|0|||
23312686|NCT03058289|64886731|FG000|Overall Study|Withdrawal by Subject|0|||
23312687|NCT03058289|64886732|FG001|Overall Study|Withdrawal by Subject|0|||
23312688|NCT03058289|64886733|FG002|Overall Study|Withdrawal by Subject|0|||
23312689|NCT03058289|64886734|FG003|Overall Study|Withdrawal by Subject|2|||
23312690|NCT03058289|64886735|FG004|Overall Study|Withdrawal by Subject|0|||
23312691|NCT03058289|64886736|FG005|Overall Study|Withdrawal by Subject|2|||
23312692|NCT03058289|64886737|FG006|Overall Study|Withdrawal by Subject|0|||
23312693|NCT03058289|64886738|FG007|Overall Study|Withdrawal by Subject|4|||
23312694|NCT03058289|64886739|FG008|Overall Study|Withdrawal by Subject|1|||
23312695|NCT03058289|64886731|FG000|Overall Study|Physician Decision|1|||
23312696|NCT03058289|64886732|FG001|Overall Study|Physician Decision|0|||
23312697|NCT03058289|64886733|FG002|Overall Study|Physician Decision|0|||
23312698|NCT03058289|64886734|FG003|Overall Study|Physician Decision|2|||
23312699|NCT03058289|64886735|FG004|Overall Study|Physician Decision|1|||
23312700|NCT03058289|64886736|FG005|Overall Study|Physician Decision|0|||
23312701|NCT03058289|64886737|FG006|Overall Study|Physician Decision|2|||
23312702|NCT03058289|64886738|FG007|Overall Study|Physician Decision|3|||
23312703|NCT03058289|64886739|FG008|Overall Study|Physician Decision|0|||
23312704|NCT03058289|64886731|FG000|Overall Study|Clinical Deterioration|2|||
23312705|NCT03058289|64886732|FG001|Overall Study|Clinical Deterioration|0|||
23312706|NCT03058289|64886733|FG002|Overall Study|Clinical Deterioration|0|||
23312707|NCT03058289|64886734|FG003|Overall Study|Clinical Deterioration|2|||
23312708|NCT03058289|64886735|FG004|Overall Study|Clinical Deterioration|1|||
23312709|NCT03058289|64886736|FG005|Overall Study|Clinical Deterioration|1|||
23312710|NCT03058289|64886737|FG006|Overall Study|Clinical Deterioration|0|||
23312711|NCT03058289|64886738|FG007|Overall Study|Clinical Deterioration|3|||
23312712|NCT03058289|64886739|FG008|Overall Study|Clinical Deterioration|2|||
23312713|NCT03058289|64886731|FG000|Overall Study|Lost to Follow-up|0|||
23312714|NCT03058289|64886732|FG001|Overall Study|Lost to Follow-up|0|||
23312715|NCT03058289|64886733|FG002|Overall Study|Lost to Follow-up|0|||
23312716|NCT03058289|64886734|FG003|Overall Study|Lost to Follow-up|0|||
23312717|NCT03058289|64886735|FG004|Overall Study|Lost to Follow-up|1|||
23312718|NCT03058289|64886736|FG005|Overall Study|Lost to Follow-up|0|||
23312719|NCT03058289|64886737|FG006|Overall Study|Lost to Follow-up|0|||
23312720|NCT03058289|64886738|FG007|Overall Study|Lost to Follow-up|0|||
23312721|NCT03058289|64886739|FG008|Overall Study|Lost to Follow-up|0|||
23312722|NCT03058289|64886731|FG000|Overall Study|Refused Further Treatment|0|||
23312723|NCT03058289|64886732|FG001|Overall Study|Refused Further Treatment|0|||
23312724|NCT03058289|64886733|FG002|Overall Study|Refused Further Treatment|1|||
23312725|NCT03058289|64886734|FG003|Overall Study|Refused Further Treatment|0|||
23312726|NCT03058289|64886735|FG004|Overall Study|Refused Further Treatment|1|||
23312727|NCT03058289|64886736|FG005|Overall Study|Refused Further Treatment|0|||
23312728|NCT03058289|64886737|FG006|Overall Study|Refused Further Treatment|0|||
23312729|NCT03058289|64886738|FG007|Overall Study|Refused Further Treatment|0|||
23312730|NCT03058289|64886739|FG008|Overall Study|Refused Further Treatment|0|||
23312731|NCT03058289|64886731|FG000|Overall Study|Rapid Progression of Disease|0|||
23312732|NCT03058289|64886732|FG001|Overall Study|Rapid Progression of Disease|0|||
23312733|NCT03058289|64886733|FG002|Overall Study|Rapid Progression of Disease|0|||
23312734|NCT03058289|64886734|FG003|Overall Study|Rapid Progression of Disease|1|||
23312735|NCT03058289|64886735|FG004|Overall Study|Rapid Progression of Disease|0|||
23312736|NCT03058289|64886736|FG005|Overall Study|Rapid Progression of Disease|0|||
23312737|NCT03058289|64886737|FG006|Overall Study|Rapid Progression of Disease|0|||
23312738|NCT03058289|64886738|FG007|Overall Study|Rapid Progression of Disease|0|||
23312739|NCT03058289|64886739|FG008|Overall Study|Rapid Progression of Disease|0|||
23312740|NCT00919854|64886740|FG000|Overall Study|Adverse Event|1|||
23312741|NCT01421511|64886742|FG000|Overall Study|Lost to Follow-up|11|||
23312742|NCT01421511|64886743|FG001|Overall Study|Lost to Follow-up|14|||
23312743|NCT01421511|64886742|FG000|Overall Study|Randomized but didn't receive study drug|1|||
23312744|NCT01421511|64886743|FG001|Overall Study|Randomized but didn't receive study drug|7|||
23312745|NCT01421511|64886742|FG000|Overall Study|Physician Decision|0|||
23312746|NCT01421511|64886743|FG001|Overall Study|Physician Decision|1|||
23312747|NCT01421511|64886742|FG000|Overall Study|Withdrawal by Subject|6|||
23312748|NCT01421511|64886743|FG001|Overall Study|Withdrawal by Subject|5|||
23312749|NCT01421511|64886742|FG000|Overall Study|Death|1|||
23540965|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
23540966|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
23540967|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
23540968|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
23312750|NCT01421511|64886743|FG001|Overall Study|Death|1|||
23312751|NCT03317834|64886745|FG000|Overall Study|Death|2|||
23312752|NCT03317834|64886745|FG000|Overall Study|Device Revision|5|||
23312753|NCT03317834|64886745|FG000|Overall Study|Withdrawal by Subject|13|||
23312754|NCT03317834|64886745|FG000|Overall Study|Lost to Follow-up|13|||
23312755|NCT01635283|64886746|FG000|Overall Study|Tumor Progression|3|||
23312756|NCT01635283|64886746|FG000|Overall Study|Lost to Follow-up|1|||
23312757|NCT02461160|64886747|FG000|Overall Study|Lost to Follow-up|0|||
23312758|NCT02461160|64886748|FG001|Overall Study|Lost to Follow-up|0|||
23312759|NCT02461160|64886749|FG002|Overall Study|Lost to Follow-up|0|||
23312760|NCT02461160|64886750|FG003|Overall Study|Lost to Follow-up|0|||
23312761|NCT02461160|64886751|FG004|Overall Study|Lost to Follow-up|0|||
23312762|NCT02461160|64886752|FG005|Overall Study|Lost to Follow-up|0|||
23312763|NCT02461160|64886753|FG006|Overall Study|Lost to Follow-up|0|||
23312764|NCT02461160|64886754|FG007|Overall Study|Lost to Follow-up|1|||
23312765|NCT02461160|64886755|FG008|Overall Study|Lost to Follow-up|0|||
23312766|NCT02461160|64886756|FG009|Overall Study|Lost to Follow-up|0|||
23312767|NCT02461160|64886757|FG010|Overall Study|Lost to Follow-up|0|||
23312768|NCT02461160|64886758|FG011|Overall Study|Lost to Follow-up|0|||
23312769|NCT02461160|64886759|FG012|Overall Study|Lost to Follow-up|0|||
23312770|NCT00806286|64889211|FG000|Overall Study|Adverse Event|5|||
23312771|NCT00806286|64889212|FG001|Overall Study|Adverse Event|2|||
23312772|NCT00806286|64889213|FG002|Overall Study|Adverse Event|0|||
23312773|NCT00806286|64889211|FG000|Overall Study|Disease progression|31|||
23312774|NCT00806286|64889212|FG001|Overall Study|Disease progression|38|||
23312775|NCT00806286|64889213|FG002|Overall Study|Disease progression|1|||
23312776|NCT00806286|64889211|FG000|Overall Study|Death|1|||
23312777|NCT00806286|64889212|FG001|Overall Study|Death|6|||
23312778|NCT00806286|64889213|FG002|Overall Study|Death|0|||
23312779|NCT00806286|64889211|FG000|Overall Study|Lost to Follow-up|0|||
23312780|NCT00806286|64889212|FG001|Overall Study|Lost to Follow-up|1|||
23312781|NCT00806286|64889213|FG002|Overall Study|Lost to Follow-up|0|||
23540969|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
23540970|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
23540971|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
23540972|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
23540973|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
23540974|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
23540975|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
23540976|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
23540977|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
23582198|NCT02929108|65862373|FG006|Overall Study|Hospice patient death|78|||
23210144|NCT00699842|64509064|FG002|Overall Study|Death|0|||
23210145|NCT00084929|64509066|FG000|Overall Study|ineligible - medical contraindication|1|||
23210146|NCT00084929|64509066|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
23210147|NCT00084929|64509066|FG000|Overall Study|Ineligible - Medical history|6|||
23210148|NCT00084929|64509066|FG000|Overall Study|Withdrawal by Subject|10|||
23210149|NCT00084929|64509066|FG000|Overall Study|Missing/incomplete CTC exam|9|||
23210150|NCT00084929|64509066|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
23210151|NCT01033487|64509075|FG000|Fourth Intervention Period|Adverse Event|0|||
23210152|NCT01033487|64509076|FG001|Fourth Intervention Period|Adverse Event|0|||
23210153|NCT01033487|64509077|FG002|Fourth Intervention Period|Adverse Event|0|||
23210154|NCT01033487|64509078|FG003|Fourth Intervention Period|Adverse Event|0|||
23210155|NCT01033487|64509079|FG004|Fourth Intervention Period|Adverse Event|0|||
23210156|NCT01033487|64509080|FG005|Fourth Intervention Period|Adverse Event|0|||
23210157|NCT01033487|64509081|FG006|Fourth Intervention Period|Adverse Event|0|||
23210158|NCT01033487|64509082|FG007|Fourth Intervention Period|Adverse Event|0|||
23210159|NCT01033487|64509083|FG008|Fourth Intervention Period|Adverse Event|1|||
23210160|NCT01033487|64509084|FG009|Fourth Intervention Period|Adverse Event|0|||
23210161|NCT00289185|64509089|FG000|Overall Study|Withdrawal by Subject|4|||
23210162|NCT00289185|64509090|FG001|Overall Study|Withdrawal by Subject|8|||
23210163|NCT00289185|64509089|FG000|Overall Study|Lost to Follow-up|23|||
23312782|NCT00806286|64889211|FG000|Overall Study|Withdrawal by Subject|8|||
23312783|NCT00806286|64889212|FG001|Overall Study|Withdrawal by Subject|3|||
23312784|NCT00806286|64889213|FG002|Overall Study|Withdrawal by Subject|1|||
23312785|NCT00806286|64889211|FG000|Overall Study|Physician Decision|2|||
23312786|NCT00806286|64889212|FG001|Overall Study|Physician Decision|2|||
23312787|NCT00806286|64889213|FG002|Overall Study|Physician Decision|0|||
23312788|NCT00806286|64889211|FG000|Overall Study|Due to a variety of reasons|7|||
23312789|NCT00806286|64889212|FG001|Overall Study|Due to a variety of reasons|2|||
23312790|NCT00806286|64889213|FG002|Overall Study|Due to a variety of reasons|1|||
23312791|NCT03480386|64889219|FG000|Overall Study|Did not complete measures at 3-months|17|||
23312792|NCT03480386|64889220|FG001|Overall Study|Did not complete measures at 3-months|14|||
23312793|NCT03480386|64889219|FG000|Overall Study|No baseline measures|11|||
23312794|NCT03480386|64889220|FG001|Overall Study|No baseline measures|14|||
23312795|NCT03480386|64889219|FG000|Overall Study|Death|0|||
23312796|NCT03480386|64889220|FG001|Overall Study|Death|5|||
23312797|NCT03480386|64889219|FG000|Overall Study|Withdrawal by Subject|12|||
23312798|NCT03480386|64889220|FG001|Overall Study|Withdrawal by Subject|8|||
23312799|NCT03480386|64889219|FG000|Overall Study|Lost to Follow-up|2|||
23312800|NCT03480386|64889220|FG001|Overall Study|Lost to Follow-up|1|||
23312801|NCT03480386|64889219|FG000|Overall Study|Complicating disease|0|||
23312802|NCT03480386|64889220|FG001|Overall Study|Complicating disease|1|||
23312803|NCT03480386|64889219|FG000|Overall Study|Disease progression|3|||
23312804|NCT03480386|64889220|FG001|Overall Study|Disease progression|0|||
23312805|NCT03480386|64889219|FG000|Overall Study|Became ineligible|0|||
23312806|NCT03480386|64889220|FG001|Overall Study|Became ineligible|2|||
23312807|NCT04480021|64889221|FG000|Overall Study|Lost to Follow-up|3|||
23312808|NCT04480021|64889222|FG001|Overall Study|Lost to Follow-up|4|||
23312809|NCT00741286|64889223|FG000|Overall Study|Lost to Follow-up|15|||
23312810|NCT00741286|64889224|FG001|Overall Study|Lost to Follow-up|10|||
23312811|NCT00741286|64889223|FG000|Overall Study|Adverse Event|1|||
23540978|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
23540979|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
23540980|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
23540981|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
23540982|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
23540983|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
23540984|NCT04818346|65712819|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
23540985|NCT04818346|65712820|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
23540986|NCT04818346|65712821|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
23540987|NCT04818346|65712822|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
23540988|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
23540989|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
23540990|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
23540991|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
23540992|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
23540993|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
23540994|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
23540995|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
23540996|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
23540997|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
23540998|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
23312812|NCT00741286|64889224|FG001|Overall Study|Adverse Event|6|||
23312813|NCT00741286|64889223|FG000|Overall Study|Protocol Violation|3|||
23312814|NCT00741286|64889224|FG001|Overall Study|Protocol Violation|2|||
23312815|NCT00741286|64889223|FG000|Overall Study|Primary Outcome|1|||
23312816|NCT00741286|64889224|FG001|Overall Study|Primary Outcome|1|||
23312817|NCT00866658|64889227|FG000|Overall Study|Adverse Event|5|||
23312818|NCT00866658|64889228|FG001|Overall Study|Adverse Event|14|||
23312819|NCT00866658|64889227|FG000|Overall Study|Lack of Efficacy|2|||
23312820|NCT00866658|64889228|FG001|Overall Study|Lack of Efficacy|1|||
23312821|NCT00866658|64889227|FG000|Overall Study|Withdrawal by Subject|1|||
23312822|NCT00866658|64889228|FG001|Overall Study|Withdrawal by Subject|0|||
23312823|NCT00866658|64889227|FG000|Overall Study|Protocol Violation|1|||
23312824|NCT00866658|64889228|FG001|Overall Study|Protocol Violation|1|||
23312825|NCT00866658|64889227|FG000|Overall Study|Familial and Personal Reasons|4|||
23312826|NCT00866658|64889228|FG001|Overall Study|Familial and Personal Reasons|5|||
23616674|NCT00116584|65982402|FG000|Overall Study|Protocol Violation|1|||
23616675|NCT00116584|65982403|FG001|Overall Study|Protocol Violation|1|||
23312827|NCT00605540|64889229|FG000|Overall Study|Death|15|||
23312828|NCT00605540|64889229|FG000|Overall Study|Lost to Follow-up|23|||
23312829|NCT03839823|64889233|FG000|Overall Study|Adverse Event|8|||
23312830|NCT03839823|64889234|FG001|Overall Study|Adverse Event|4|||
23312831|NCT03839823|64889233|FG000|Overall Study|Death|1|||
23312832|NCT03839823|64889234|FG001|Overall Study|Death|0|||
23312833|NCT03839823|64889233|FG000|Overall Study|Physician Decision|1|||
23312834|NCT03839823|64889234|FG001|Overall Study|Physician Decision|5|||
23540999|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
23541000|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
23541001|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
23541002|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
23541003|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
23541004|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
23541005|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
23541006|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
23541007|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
23541008|NCT04818346|65712819|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
23541009|NCT04818346|65712820|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
23541010|NCT04818346|65712821|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
23541011|NCT04818346|65712822|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
23541012|NCT01165281|65712839|FG000|Overall Study|Adverse Event|12|||
23541013|NCT01165281|65712840|FG001|Overall Study|Adverse Event|14|||
23541014|NCT01165281|65712839|FG000|Overall Study|Death|3|||
23541015|NCT01165281|65712840|FG001|Overall Study|Death|4|||
23541016|NCT01165281|65712839|FG000|Overall Study|Lack of Efficacy|4|||
23541017|NCT01165281|65712840|FG001|Overall Study|Lack of Efficacy|1|||
23541018|NCT01165281|65712839|FG000|Overall Study|Lost to Follow-up|0|||
23541019|NCT01165281|65712840|FG001|Overall Study|Lost to Follow-up|1|||
23541020|NCT01165281|65712839|FG000|Overall Study|Physician Decision|8|||
23541021|NCT01165281|65712840|FG001|Overall Study|Physician Decision|1|||
23541022|NCT01165281|65712839|FG000|Overall Study|Protocol Violation|6|||
23541023|NCT01165281|65712840|FG001|Overall Study|Protocol Violation|5|||
23541024|NCT01165281|65712839|FG000|Overall Study|Withdrawal by Subject|8|||
23312835|NCT03839823|64889233|FG000|Overall Study|Progressive Disease (PD)|65|||
23312836|NCT03839823|64889234|FG001|Overall Study|Progressive Disease (PD)|65|||
23312837|NCT03839823|64889233|FG000|Overall Study|Subject Decision|2|||
23312838|NCT03839823|64889234|FG001|Overall Study|Subject Decision|9|||
23312839|NCT03839823|64889233|FG000|Overall Study|Not Treated|0|||
23312840|NCT03839823|64889234|FG001|Overall Study|Not Treated|10|||
23312841|NCT05422625|64889242|FG000|Overall Study|Withdrawal by Subject|1|||
23312842|NCT05422625|64889243|FG001|Overall Study|Withdrawal by Subject|0|||
23312843|NCT02996487|64889244|FG000|Overall Study|Lost to Follow-up|1|||
23312844|NCT02996487|64889245|FG001|Overall Study|Lost to Follow-up|1|||
23312845|NCT02996487|64889246|FG002|Overall Study|Lost to Follow-up|0|||
23312846|NCT02996487|64889244|FG000|Overall Study|Death|0|||
23312847|NCT02996487|64889245|FG001|Overall Study|Death|1|||
23312848|NCT02996487|64889246|FG002|Overall Study|Death|0|||
23541025|NCT01165281|65712840|FG001|Overall Study|Withdrawal by Subject|7|||
23541026|NCT01165281|65712839|FG000|Overall Study|Noncompliance with Study Drug|1|||
23541027|NCT01165281|65712840|FG001|Overall Study|Noncompliance with Study Drug|4|||
23541028|NCT01165281|65712839|FG000|Overall Study|Progressive Disease|10|||
23541029|NCT01165281|65712840|FG001|Overall Study|Progressive Disease|14|||
23541030|NCT01165281|65712839|FG000|Overall Study|Other|6|||
23541031|NCT01165281|65712840|FG001|Overall Study|Other|0|||
23541032|NCT02641080|65712843|FG000|Overall Study|Physician Decision|2|||
23541033|NCT02641080|65712844|FG001|Overall Study|Physician Decision|0|||
23541034|NCT02641080|65712843|FG000|Overall Study|Withdrawal by Subject|0|||
23541035|NCT02641080|65712844|FG001|Overall Study|Withdrawal by Subject|1|||
23541036|NCT02641080|65712843|FG000|Overall Study|Rehab Center denied use of pumps|0|||
23541037|NCT02641080|65712844|FG001|Overall Study|Rehab Center denied use of pumps|3|||
23541038|NCT02641080|65712843|FG000|Overall Study|Lost to Follow-up|0|||
23541039|NCT02641080|65712844|FG001|Overall Study|Lost to Follow-up|3|||
23541040|NCT01762761|65712845|FG000|Overall Study|Adverse Event|15|||
23541041|NCT01762761|65712846|FG001|Overall Study|Adverse Event|17|||
23541042|NCT01762761|65712845|FG000|Overall Study|Lack of Efficacy|9|||
23541043|NCT01762761|65712846|FG001|Overall Study|Lack of Efficacy|25|||
23541044|NCT01762761|65712845|FG000|Overall Study|Protocol Violation|1|||
23312849|NCT02996487|64889244|FG000|Overall Study|Withdrawal by Subject|2|||
23312850|NCT02996487|64889245|FG001|Overall Study|Withdrawal by Subject|3|||
23312851|NCT02996487|64889246|FG002|Overall Study|Withdrawal by Subject|0|||
23541045|NCT01762761|65712846|FG001|Overall Study|Protocol Violation|1|||
23541046|NCT01762761|65712845|FG000|Overall Study|Study closed/terminated|0|||
23541047|NCT01762761|65712846|FG001|Overall Study|Study closed/terminated|2|||
23541048|NCT01762761|65712845|FG000|Overall Study|Lost to Follow-up|3|||
23541049|NCT01762761|65712846|FG001|Overall Study|Lost to Follow-up|6|||
23541050|NCT01762761|65712845|FG000|Overall Study|Physician Decision|4|||
23541051|NCT01762761|65712846|FG001|Overall Study|Physician Decision|6|||
23541052|NCT01762761|65712845|FG000|Overall Study|Withdrawal by Subject|7|||
23312852|NCT01449812|64889247|FG000|Overall Study|Migrated/moved from study area|1|||
23541053|NCT01762761|65712846|FG001|Overall Study|Withdrawal by Subject|8|||
23312853|NCT01449812|64889248|FG001|Overall Study|Migrated/moved from study area|0|||
23424393|NCT00610441|65296476|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
23424394|NCT00610441|65296477|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
23424395|NCT00610441|65296478|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
23424396|NCT00610441|65296479|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
23424397|NCT00916058|65296480|FG000|Phase 1|Screen Failure|0|||
23424398|NCT00916058|65296481|FG001|Phase 1|Screen Failure|0|||
23424399|NCT00916058|65296482|FG002|Phase 1|Screen Failure|0|||
23424400|NCT00916058|65296483|FG003|Phase 1|Screen Failure|0|||
23424401|NCT00916058|65296484|FG004|Phase 1|Screen Failure|0|||
23424402|NCT00916058|65296485|FG005|Phase 1|Screen Failure|1|||
23424403|NCT00916058|65296486|FG006|Phase 1|Screen Failure|0|||
23424404|NCT00916058|65296480|FG000|Phase 2|Screen Failure|0|||
23424405|NCT00916058|65296481|FG001|Phase 2|Screen Failure|0|||
23424406|NCT00916058|65296482|FG002|Phase 2|Screen Failure|0|||
23424407|NCT00916058|65296483|FG003|Phase 2|Screen Failure|0|||
23424408|NCT00916058|65296484|FG004|Phase 2|Screen Failure|0|||
23424409|NCT00916058|65296485|FG005|Phase 2|Screen Failure|0|||
23424410|NCT00916058|65296486|FG006|Phase 2|Screen Failure|3|||
23424411|NCT01605227|65296487|FG000|Overall Study|Did not receive study treatment|2|||
23424412|NCT01605227|65296488|FG001|Overall Study|Did not receive study treatment|3|||
23424413|NCT01605227|65296487|FG000|Overall Study|Adverse Event|228|||
23424414|NCT01605227|65296488|FG001|Overall Study|Adverse Event|42|||
23424415|NCT01605227|65296487|FG000|Overall Study|Progressive Disease|132|||
23424416|NCT01605227|65296488|FG001|Overall Study|Progressive Disease|128|||
23424417|NCT01605227|65296487|FG000|Overall Study|Clinical Deterioration|227|||
23424418|NCT01605227|65296488|FG001|Overall Study|Clinical Deterioration|133|||
23424419|NCT01605227|65296487|FG000|Overall Study|Lost to Follow-up|1|||
23424420|NCT01605227|65296488|FG001|Overall Study|Lost to Follow-up|0|||
23424421|NCT01605227|65296487|FG000|Overall Study|Protocol Violation|1|||
23424422|NCT01605227|65296488|FG001|Overall Study|Protocol Violation|0|||
23424423|NCT01605227|65296487|FG000|Overall Study|Physician Decision|9|||
23424424|NCT01605227|65296488|FG001|Overall Study|Physician Decision|7|||
23424425|NCT01605227|65296487|FG000|Overall Study|Withdrawal by Subject|18|||
23424426|NCT01605227|65296488|FG001|Overall Study|Withdrawal by Subject|14|||
23424427|NCT01605227|65296487|FG000|Overall Study|Sponsor Decision|2|||
23424428|NCT01605227|65296488|FG001|Overall Study|Sponsor Decision|0|||
23424429|NCT01605227|65296487|FG000|Overall Study|Started New Therapy|1|||
23424430|NCT01605227|65296488|FG001|Overall Study|Started New Therapy|0|||
23424431|NCT01605227|65296487|FG000|Overall Study|Subject Decision|0|||
23424432|NCT01605227|65296488|FG001|Overall Study|Subject Decision|1|||
23424433|NCT01605227|65296487|FG000|Overall Study|Dose Held >6 weeks|0|||
23424434|NCT01605227|65296488|FG001|Overall Study|Dose Held >6 weeks|1|||
23424435|NCT03276052|65296489|FG000|Overall Study|Withdrawal by Subject|5|||
23424436|NCT03276052|65296489|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
23424437|NCT01740089|65296490|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
23424438|NCT01740089|65296491|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
23424439|NCT01740089|65296492|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
23424440|NCT01740089|65296490|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
23424441|NCT01740089|65296491|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
23424442|NCT01740089|65296492|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
23424443|NCT01740089|65296490|FG000|After 12 Weeks|Lack of Efficacy|3|||
23424444|NCT01740089|65296491|FG001|After 12 Weeks|Lack of Efficacy|1|||
23424445|NCT01740089|65296492|FG002|After 12 Weeks|Lack of Efficacy|4|||
23424446|NCT01740089|65296490|FG000|After 12 Weeks|Adverse Event|2|||
23424447|NCT01740089|65296491|FG001|After 12 Weeks|Adverse Event|0|||
23424448|NCT01740089|65296492|FG002|After 12 Weeks|Adverse Event|5|||
23424449|NCT01740089|65296490|FG000|After 12 Weeks|Protocol Violation|1|||
23424450|NCT01740089|65296491|FG001|After 12 Weeks|Protocol Violation|1|||
23424451|NCT01740089|65296492|FG002|After 12 Weeks|Protocol Violation|1|||
23424452|NCT01740089|65296490|FG000|After 12 Weeks|Withdrawal by Subject|1|||
23424453|NCT01740089|65296491|FG001|After 12 Weeks|Withdrawal by Subject|1|||
23424454|NCT01740089|65296492|FG002|After 12 Weeks|Withdrawal by Subject|1|||
23424455|NCT01515475|65299644|FG000|Overall Study|Lost to Follow-up|20|||
23424456|NCT01515475|65299645|FG001|Overall Study|Lost to Follow-up|15|||
23424457|NCT01515475|65299646|FG002|Overall Study|Lost to Follow-up|12|||
23424458|NCT01515475|65299647|FG003|Overall Study|Lost to Follow-up|12|||
23424459|NCT01360398|65299657|FG000|Overall Study|Withdrawal by Subject|14|||
23424460|NCT01360398|65299657|FG000|Overall Study|Other|7|||
23424461|NCT01360398|65299657|FG000|Overall Study|Migrated/moved from study area|1|||
23424462|NCT00919867|65299663|FG000|First Intervention|Withdrawal by Subject|0|||
23424463|NCT00919867|65299664|FG001|First Intervention|Withdrawal by Subject|0|||
23424464|NCT00919867|65299665|FG002|First Intervention|Withdrawal by Subject|1|||
23424465|NCT00919867|65299666|FG003|First Intervention|Withdrawal by Subject|0|||
23424466|NCT00919867|65299667|FG004|First Intervention|Withdrawal by Subject|0|||
23424467|NCT00919867|65299668|FG005|First Intervention|Withdrawal by Subject|0|||
23424468|NCT00919867|65299663|FG000|First Intervention|Physician Decision|0|||
23424469|NCT00919867|65299664|FG001|First Intervention|Physician Decision|0|||
23424470|NCT00919867|65299665|FG002|First Intervention|Physician Decision|0|||
23424471|NCT00919867|65299666|FG003|First Intervention|Physician Decision|0|||
23541054|NCT01272934|65712847|FG000|Overall Study|Adverse Event|0|||
23541055|NCT01272934|65712848|FG001|Overall Study|Adverse Event|1|||
23541056|NCT01272934|65712847|FG000|Overall Study|Abnormal Laboratory Value|0|||
23541057|NCT01272934|65712848|FG001|Overall Study|Abnormal Laboratory Value|1|||
23541058|NCT03943095|65712865|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
23541059|NCT03943095|65712866|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
23541060|NCT03943095|65712865|FG000|Overall Study|Withdrawal by Subject|1|||
23541061|NCT03943095|65712866|FG001|Overall Study|Withdrawal by Subject|0|||
23541062|NCT03359096|65712873|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
23541063|NCT03359096|65712874|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
23541064|NCT03359096|65712873|FG000|First Intervention (4 Weeks)|Death|1|||
23541065|NCT03359096|65712874|FG001|First Intervention (4 Weeks)|Death|0|||
23541066|NCT03359096|65712873|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
23541067|NCT03359096|65712874|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
23541068|NCT01602315|65712875|FG000|Overall Study|Protocol Violation|0|||
23541069|NCT01602315|65712876|FG001|Overall Study|Protocol Violation|0|||
23541070|NCT01602315|65712877|FG002|Overall Study|Protocol Violation|0|||
23541071|NCT01602315|65712878|FG003|Overall Study|Protocol Violation|0|||
23541072|NCT01602315|65712879|FG004|Overall Study|Protocol Violation|0|||
23541073|NCT01602315|65712880|FG005|Overall Study|Protocol Violation|1|||
23210164|NCT00289185|64509090|FG001|Overall Study|Lost to Follow-up|17|||
23210165|NCT00289185|64509089|FG000|Overall Study|Death|1|||
23210166|NCT00289185|64509090|FG001|Overall Study|Death|1|||
23541074|NCT01602315|65712881|FG006|Overall Study|Protocol Violation|0|||
23541075|NCT01602315|65712875|FG000|Overall Study|Physician Decision|2|||
23541076|NCT01602315|65712876|FG001|Overall Study|Physician Decision|0|||
23541077|NCT01602315|65712877|FG002|Overall Study|Physician Decision|0|||
23541078|NCT01602315|65712878|FG003|Overall Study|Physician Decision|0|||
23541079|NCT01602315|65712879|FG004|Overall Study|Physician Decision|2|||
23541080|NCT01602315|65712880|FG005|Overall Study|Physician Decision|1|||
23541081|NCT01602315|65712881|FG006|Overall Study|Physician Decision|1|||
23541082|NCT01602315|65712875|FG000|Overall Study|Disease progression|6|||
23541083|NCT01602315|65712876|FG001|Overall Study|Disease progression|3|||
23541084|NCT01602315|65712877|FG002|Overall Study|Disease progression|10|||
23541085|NCT01602315|65712878|FG003|Overall Study|Disease progression|1|||
23541086|NCT01602315|65712879|FG004|Overall Study|Disease progression|41|||
23541087|NCT01602315|65712880|FG005|Overall Study|Disease progression|12|||
23541088|NCT01602315|65712881|FG006|Overall Study|Disease progression|15|||
23541089|NCT01602315|65712875|FG000|Overall Study|Death|1|||
23541090|NCT01602315|65712876|FG001|Overall Study|Death|1|||
23541091|NCT01602315|65712877|FG002|Overall Study|Death|1|||
23541092|NCT01602315|65712878|FG003|Overall Study|Death|1|||
23541093|NCT01602315|65712879|FG004|Overall Study|Death|7|||
23541094|NCT01602315|65712880|FG005|Overall Study|Death|2|||
23541095|NCT01602315|65712881|FG006|Overall Study|Death|2|||
23541096|NCT01602315|65712875|FG000|Overall Study|Withdrawal by Subject|2|||
23541097|NCT01602315|65712876|FG001|Overall Study|Withdrawal by Subject|0|||
23541098|NCT01602315|65712877|FG002|Overall Study|Withdrawal by Subject|2|||
23541099|NCT01602315|65712878|FG003|Overall Study|Withdrawal by Subject|0|||
23541100|NCT01602315|65712879|FG004|Overall Study|Withdrawal by Subject|6|||
23541101|NCT01602315|65712880|FG005|Overall Study|Withdrawal by Subject|0|||
23541102|NCT01602315|65712881|FG006|Overall Study|Withdrawal by Subject|1|||
23541103|NCT01602315|65712875|FG000|Overall Study|Adverse Event|5|||
23541104|NCT01602315|65712876|FG001|Overall Study|Adverse Event|1|||
23541105|NCT01602315|65712877|FG002|Overall Study|Adverse Event|5|||
23541106|NCT01602315|65712878|FG003|Overall Study|Adverse Event|4|||
23541107|NCT01602315|65712879|FG004|Overall Study|Adverse Event|15|||
23541108|NCT01602315|65712880|FG005|Overall Study|Adverse Event|3|||
23541109|NCT01602315|65712881|FG006|Overall Study|Adverse Event|9|||
23541110|NCT01602315|65712875|FG000|Overall Study|Subject/guardian decision|0|||
23541111|NCT01602315|65712876|FG001|Overall Study|Subject/guardian decision|0|||
23541112|NCT01602315|65712877|FG002|Overall Study|Subject/guardian decision|0|||
23541113|NCT01602315|65712878|FG003|Overall Study|Subject/guardian decision|0|||
23541114|NCT01602315|65712879|FG004|Overall Study|Subject/guardian decision|0|||
23541115|NCT01602315|65712880|FG005|Overall Study|Subject/guardian decision|0|||
23541116|NCT01602315|65712881|FG006|Overall Study|Subject/guardian decision|1|||
23541117|NCT01602315|65712875|FG000|Overall Study|Cross-over patients to combo treatment|0|||
23541118|NCT01602315|65712876|FG001|Overall Study|Cross-over patients to combo treatment|0|||
23541119|NCT01602315|65712877|FG002|Overall Study|Cross-over patients to combo treatment|0|||
23541120|NCT01602315|65712878|FG003|Overall Study|Cross-over patients to combo treatment|0|||
23541121|NCT01602315|65712879|FG004|Overall Study|Cross-over patients to combo treatment|0|||
23541122|NCT01602315|65712880|FG005|Overall Study|Cross-over patients to combo treatment|16|||
23616676|NCT00747149|65982404|FG000|Overall Study|Adverse Event|0|||
23541123|NCT01602315|65712881|FG006|Overall Study|Cross-over patients to combo treatment|0|||
23541124|NCT00765245|65712884|FG000|Overall Study|disease progression|3|||
23541125|NCT00765245|65712885|FG001|Overall Study|disease progression|2|||
23541126|NCT00765245|65712884|FG000|Overall Study|Withdrawal by Subject|3|||
23541127|NCT00765245|65712885|FG001|Overall Study|Withdrawal by Subject|0|||
23541128|NCT00765245|65712884|FG000|Overall Study|Adverse Event|5|||
23541129|NCT00765245|65712885|FG001|Overall Study|Adverse Event|0|||
23541130|NCT00765245|65712884|FG000|Overall Study|Physician Decision|1|||
23541131|NCT00765245|65712885|FG001|Overall Study|Physician Decision|0|||
23541132|NCT00765245|65712884|FG000|Overall Study|Death|1|||
23541133|NCT00765245|65712885|FG001|Overall Study|Death|0|||
23541134|NCT00982020|65712886|FG000|Overall Study|Adverse Event|19|||
23541135|NCT00982020|65712887|FG001|Overall Study|Adverse Event|15|||
23541136|NCT00982020|65712886|FG000|Overall Study|Withdrawal by Subject|11|||
23541137|NCT00982020|65712887|FG001|Overall Study|Withdrawal by Subject|14|||
23541138|NCT00982020|65712886|FG000|Overall Study|Lost to Follow-up|5|||
23541139|NCT00982020|65712887|FG001|Overall Study|Lost to Follow-up|11|||
23541140|NCT00982020|65712886|FG000|Overall Study|Lack of Efficacy|10|||
23541141|NCT00982020|65712887|FG001|Overall Study|Lack of Efficacy|4|||
23541142|NCT00982020|65712886|FG000|Overall Study|Parent/Caregiver Decision|5|||
23541143|NCT00982020|65712887|FG001|Overall Study|Parent/Caregiver Decision|5|||
23541144|NCT00982020|65712886|FG000|Overall Study|Treatment Non-compliance|3|||
23541145|NCT00982020|65712887|FG001|Overall Study|Treatment Non-compliance|6|||
23541146|NCT00982020|65712886|FG000|Overall Study|Physician Decision|2|||
23541147|NCT00982020|65712887|FG001|Overall Study|Physician Decision|5|||
23541148|NCT00982020|65712886|FG000|Overall Study|Entry Criteria Not Met|2|||
23541149|NCT00982020|65712887|FG001|Overall Study|Entry Criteria Not Met|1|||
23541150|NCT00982020|65712886|FG000|Overall Study|Protocol Violation|0|||
23541151|NCT00982020|65712887|FG001|Overall Study|Protocol Violation|2|||
23541152|NCT00982020|65712886|FG000|Overall Study|Clinical Relapse|0|||
23541153|NCT00982020|65712887|FG001|Overall Study|Clinical Relapse|1|||
23541154|NCT00345397|65712888|FG000|Overall Study|Death|1|||
23541155|NCT00709722|65712891|FG000|Overall Study|Adverse Event|1|||
23541156|NCT02371369|65712894|FG000|Part 1|Physician Decision|0|||
23541157|NCT02371369|65712895|FG001|Part 1|Physician Decision|3|||
23541158|NCT02371369|65712894|FG000|Part 1|Adverse Event|8|||
23541159|NCT02371369|65712895|FG001|Part 1|Adverse Event|0|||
23541160|NCT02371369|65712894|FG000|Part 1|Withdrawal by Subject|1|||
23541161|NCT02371369|65712895|FG001|Part 1|Withdrawal by Subject|6|||
23541162|NCT02371369|65712894|FG000|Part 1|Disease progression|0|||
23541163|NCT02371369|65712895|FG001|Part 1|Disease progression|1|||
23541164|NCT02371369|65712894|FG000|Part 1|Protocol Violation|0|||
23541165|NCT02371369|65712895|FG001|Part 1|Protocol Violation|1|||
23541166|NCT02371369|65712894|FG000|Part 2|Adverse Event|6|||
23541167|NCT02371369|65712895|FG001|Part 2|Adverse Event|5|||
23541168|NCT02371369|65712894|FG000|Part 2|Withdrawal by Subject|16|||
23541169|NCT02371369|65712895|FG001|Part 2|Withdrawal by Subject|6|||
23541170|NCT02371369|65712894|FG000|Part 2|Investigator decision|1|||
23541171|NCT02371369|65712895|FG001|Part 2|Investigator decision|2|||
23541172|NCT02371369|65712894|FG000|Part 2|Death|0|||
23541173|NCT02371369|65712895|FG001|Part 2|Death|1|||
23541174|NCT02371369|65712894|FG000|Part 2|Disease progression|1|||
23541175|NCT02371369|65712895|FG001|Part 2|Disease progression|0|||
23541176|NCT02371369|65712894|FG000|Part 2|Subject Noncompliance|1|||
23541177|NCT02371369|65712895|FG001|Part 2|Subject Noncompliance|0|||
23541178|NCT02371369|65712894|FG000|Part 2|Lost to Follow-up|1|||
23541179|NCT02371369|65712895|FG001|Part 2|Lost to Follow-up|1|||
23541180|NCT02371369|65712894|FG000|Part 2|Subject transitioned to commercial supply|6|||
23541181|NCT02371369|65712895|FG001|Part 2|Subject transitioned to commercial supply|4|||
23541182|NCT02371369|65712894|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
23541183|NCT02371369|65712895|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
23541184|NCT02371369|65712894|FG000|Part 2|Surgical resection of tumor|1|||
23541185|NCT02371369|65712895|FG001|Part 2|Surgical resection of tumor|1|||
23541186|NCT02371369|65712894|FG000|Part 2|Other|0|||
23541187|NCT02371369|65712895|FG001|Part 2|Other|1|||
23541188|NCT01438411|65712896|FG000|Overall Study|Adverse Event|8|||
23541189|NCT01438411|65712896|FG000|Overall Study|Lost to Follow-up|1|||
23541190|NCT01438411|65712896|FG000|Overall Study|Lack of Efficacy|1|||
23541191|NCT01438411|65712896|FG000|Overall Study|Withdrawal by Subject|3|||
23541192|NCT04964089|65712897|FG000|Overall Study|Adverse Event|8|||
23541193|NCT04964089|65712898|FG001|Overall Study|Adverse Event|6|||
23541194|NCT04964089|65712897|FG000|Overall Study|Non-compliance with study schedule|1|||
23541195|NCT04964089|65712898|FG001|Overall Study|Non-compliance with study schedule|0|||
23541196|NCT04964089|65712897|FG000|Overall Study|Withdrawal by Subject|6|||
23541197|NCT04964089|65712898|FG001|Overall Study|Withdrawal by Subject|5|||
23541198|NCT04964089|65712897|FG000|Overall Study|Lost to Follow-up|1|||
23541199|NCT04964089|65712898|FG001|Overall Study|Lost to Follow-up|1|||
23541200|NCT04964089|65712897|FG000|Overall Study|Progressive disease|4|||
23541201|NCT04964089|65712898|FG001|Overall Study|Progressive disease|0|||
23541202|NCT04964089|65712897|FG000|Overall Study|Physician Decision|1|||
23541203|NCT04964089|65712898|FG001|Overall Study|Physician Decision|0|||
23541204|NCT04964089|65712897|FG000|Overall Study|Participant did not want to continue study treatment|1|||
23541205|NCT04964089|65712898|FG001|Overall Study|Participant did not want to continue study treatment|0|||
23582199|NCT02892409|65862380|FG000|Overall Study|Adverse Event|1|||
23541206|NCT04964089|65712897|FG000|Overall Study|Participant moved to different state|1|||
23541207|NCT04964089|65712898|FG001|Overall Study|Participant moved to different state|0|||
23541208|NCT04964089|65712897|FG000|Overall Study|Participant decided to discontinue|0|||
23541209|NCT04964089|65712898|FG001|Overall Study|Participant decided to discontinue|1|||
23541210|NCT01617629|65712899|FG000|Overall Study|Death|2|||
23541211|NCT01617629|65712899|FG000|Overall Study|Investigator's Clinical Judgement|1|||
23541212|NCT01617629|65712899|FG000|Overall Study|Reason Not Specified|1|||
23541213|NCT01617629|65712899|FG000|Overall Study|Participant Withdrew Consent|2|||
23541214|NCT02343458|65712900|FG000|Overall Study|Adverse Event|15|||
23541215|NCT02343458|65712901|FG001|Overall Study|Adverse Event|14|||
23541216|NCT02343458|65712902|FG002|Overall Study|Adverse Event|15|||
23541217|NCT02343458|65712903|FG003|Overall Study|Adverse Event|3|||
23541218|NCT02343458|65712900|FG000|Overall Study|Lack of Efficacy|3|||
23541219|NCT02343458|65712901|FG001|Overall Study|Lack of Efficacy|8|||
23541220|NCT02343458|65712902|FG002|Overall Study|Lack of Efficacy|4|||
23541221|NCT02343458|65712903|FG003|Overall Study|Lack of Efficacy|8|||
23541222|NCT02343458|65712900|FG000|Overall Study|Withdrawal by Subject|18|||
23541223|NCT02343458|65712901|FG001|Overall Study|Withdrawal by Subject|17|||
23541224|NCT02343458|65712902|FG002|Overall Study|Withdrawal by Subject|23|||
23541225|NCT02343458|65712903|FG003|Overall Study|Withdrawal by Subject|14|||
23541226|NCT02343458|65712900|FG000|Overall Study|Physician Decision|1|||
23541227|NCT02343458|65712901|FG001|Overall Study|Physician Decision|4|||
23541228|NCT02343458|65712902|FG002|Overall Study|Physician Decision|2|||
23541229|NCT02343458|65712903|FG003|Overall Study|Physician Decision|2|||
23541230|NCT02343458|65712900|FG000|Overall Study|Lost to Follow-up|5|||
23541231|NCT02343458|65712901|FG001|Overall Study|Lost to Follow-up|5|||
23541232|NCT02343458|65712902|FG002|Overall Study|Lost to Follow-up|3|||
23541233|NCT02343458|65712903|FG003|Overall Study|Lost to Follow-up|1|||
23541234|NCT02343458|65712900|FG000|Overall Study|Protocol Violation|2|||
23541235|NCT02343458|65712901|FG001|Overall Study|Protocol Violation|5|||
23541236|NCT02343458|65712902|FG002|Overall Study|Protocol Violation|2|||
23541237|NCT02343458|65712903|FG003|Overall Study|Protocol Violation|2|||
23541238|NCT02343458|65712900|FG000|Overall Study|Protocol Specified Criteria|17|||
23541239|NCT02343458|65712901|FG001|Overall Study|Protocol Specified Criteria|13|||
23541240|NCT02343458|65712902|FG002|Overall Study|Protocol Specified Criteria|14|||
23541241|NCT02343458|65712903|FG003|Overall Study|Protocol Specified Criteria|8|||
23541242|NCT01114646|65712904|FG000|Overall Study|Withdrawal by Subject|3|||
23541243|NCT01114646|65712905|FG001|Overall Study|Withdrawal by Subject|2|||
23541244|NCT01233817|65712906|FG000|Overall Study|Lost to Follow-up|1|||
23541245|NCT01233817|65712906|FG000|Overall Study|Withdrawal by Subject|2|||
23541246|NCT00406029|65712907|FG000|Overall Study|Adverse Event|12|||
23541247|NCT00406029|65712908|FG001|Overall Study|Adverse Event|2|||
23541248|NCT00406029|65712909|FG002|Overall Study|Adverse Event|5|||
23541249|NCT00406029|65712910|FG003|Overall Study|Adverse Event|10|||
23541250|NCT00406029|65712911|FG004|Overall Study|Adverse Event|7|||
23541251|NCT00406029|65712907|FG000|Overall Study|Withdrawal by Subject|3|||
23541252|NCT00406029|65712908|FG001|Overall Study|Withdrawal by Subject|4|||
23541253|NCT00406029|65712909|FG002|Overall Study|Withdrawal by Subject|2|||
23541254|NCT00406029|65712910|FG003|Overall Study|Withdrawal by Subject|2|||
23541255|NCT00406029|65712911|FG004|Overall Study|Withdrawal by Subject|0|||
23541256|NCT00406029|65712907|FG000|Overall Study|Protocol Violation|1|||
23541257|NCT00406029|65712908|FG001|Overall Study|Protocol Violation|2|||
23541258|NCT00406029|65712909|FG002|Overall Study|Protocol Violation|0|||
23541259|NCT00406029|65712910|FG003|Overall Study|Protocol Violation|2|||
23541260|NCT00406029|65712911|FG004|Overall Study|Protocol Violation|0|||
23541261|NCT00406029|65712907|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
23541262|NCT00406029|65712908|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
23541263|NCT00406029|65712909|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
23541264|NCT00406029|65712910|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
23541265|NCT00406029|65712911|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
23541266|NCT00406029|65712907|FG000|Overall Study|Randomized in Error|0|||
23541267|NCT00406029|65712908|FG001|Overall Study|Randomized in Error|0|||
23541268|NCT00406029|65712909|FG002|Overall Study|Randomized in Error|2|||
23541269|NCT00406029|65712910|FG003|Overall Study|Randomized in Error|3|||
23541270|NCT00406029|65712911|FG004|Overall Study|Randomized in Error|1|||
23541271|NCT00003498|65712912|FG000|Overall Study|Not evaluable.|4|||
23541272|NCT02086591|65712915|FG000|Overall Study|Adverse Event|1|||
23541273|NCT02086591|65712915|FG000|Overall Study|Withdrawal by Subject|1|||
23541274|NCT02086591|65712915|FG000|Overall Study|protocol terminated|3|||
23541275|NCT00182689|65712916|FG000|Overall Study|Adverse Event|8|||
23541276|NCT00182689|65712917|FG001|Overall Study|Adverse Event|11|||
23541277|NCT00182689|65712916|FG000|Overall Study|Withdrawal by Subject|2|||
23541278|NCT00182689|65712917|FG001|Overall Study|Withdrawal by Subject|2|||
23541279|NCT00182689|65712916|FG000|Overall Study|Progression|27|||
23541280|NCT00182689|65712917|FG001|Overall Study|Progression|29|||
23541281|NCT00182689|65712916|FG000|Overall Study|Death|1|||
23541282|NCT00182689|65712917|FG001|Overall Study|Death|0|||
23541283|NCT00182689|65712916|FG000|Overall Study|not protocol specified|0|||
23541284|NCT00182689|65712917|FG001|Overall Study|not protocol specified|3|||
23541285|NCT00182689|65712916|FG000|Overall Study|Ineligible|1|||
23541286|NCT00182689|65712917|FG001|Overall Study|Ineligible|4|||
23541287|NCT00182689|65712916|FG000|Overall Study|Never received treatment|1|||
23541288|NCT00182689|65712917|FG001|Overall Study|Never received treatment|0|||
23541289|NCT02799082|65712919|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
23541290|NCT02799082|65712920|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
23541291|NCT02799082|65712919|FG000|Overall Study|Protocol Violation|0|||
23541292|NCT02799082|65712920|FG001|Overall Study|Protocol Violation|1|||
23541293|NCT00932893|65712921|FG000|Overall Study|Death|115|||
23541294|NCT00932893|65712922|FG001|Overall Study|Death|24|||
23541295|NCT00932893|65712921|FG000|Overall Study|Lost to Follow-up|8|||
23541296|NCT00932893|65712922|FG001|Overall Study|Lost to Follow-up|0|||
23541297|NCT00932893|65712921|FG000|Overall Study|Withdrawal by Subject|5|||
23541298|NCT00932893|65712922|FG001|Overall Study|Withdrawal by Subject|2|||
23541299|NCT00932893|65712921|FG000|Overall Study|Other|5|||
23541300|NCT00932893|65712922|FG001|Overall Study|Other|144|||
23541301|NCT00364858|65712927|FG000|Overall Study|Adverse Event|1|||
23541302|NCT00364858|65712928|FG001|Overall Study|Adverse Event|5|||
23541303|NCT00364858|65712927|FG000|Overall Study|Withdrawal by Subject|1|||
23541304|NCT00364858|65712928|FG001|Overall Study|Withdrawal by Subject|1|||
23541305|NCT00364858|65712927|FG000|Overall Study|Pregnancy|1|||
23541306|NCT00364858|65712928|FG001|Overall Study|Pregnancy|1|||
23541307|NCT00364858|65712927|FG000|Overall Study|Clinical failure|2|||
23541308|NCT00364858|65712928|FG001|Overall Study|Clinical failure|13|||
23541309|NCT00364858|65712927|FG000|Overall Study|Discontinuation at baseline|1|||
23541310|NCT00364858|65712928|FG001|Overall Study|Discontinuation at baseline|0|||
23541311|NCT00364858|65712927|FG000|Overall Study|Non-compliant|1|||
23541312|NCT00364858|65712928|FG001|Overall Study|Non-compliant|0|||
23541313|NCT00364858|65712927|FG000|Overall Study|Return to Q2 regimen|0|||
23541314|NCT00364858|65712928|FG001|Overall Study|Return to Q2 regimen|1|||
23541315|NCT00364858|65712927|FG000|Overall Study|Clinical baseline issue|0|||
23541316|NCT00364858|65712928|FG001|Overall Study|Clinical baseline issue|1|||
23541317|NCT02766608|65712929|FG000|Overall Study|Adverse Event|27|||
23541318|NCT02766608|65712930|FG001|Overall Study|Adverse Event|22|||
23541319|NCT02766608|65712931|FG002|Overall Study|Adverse Event|17|||
23541320|NCT02766608|65712932|FG003|Overall Study|Adverse Event|13|||
23541321|NCT02766608|65712933|FG004|Overall Study|Adverse Event|12|||
23541322|NCT02766608|65712929|FG000|Overall Study|Withdrawal by Subject|21|||
23541323|NCT02766608|65712930|FG001|Overall Study|Withdrawal by Subject|20|||
23541324|NCT02766608|65712931|FG002|Overall Study|Withdrawal by Subject|24|||
23541325|NCT02766608|65712932|FG003|Overall Study|Withdrawal by Subject|13|||
23541326|NCT02766608|65712933|FG004|Overall Study|Withdrawal by Subject|10|||
23541327|NCT02766608|65712929|FG000|Overall Study|Lack of Efficacy|16|||
23541328|NCT02766608|65712930|FG001|Overall Study|Lack of Efficacy|15|||
23541329|NCT02766608|65712931|FG002|Overall Study|Lack of Efficacy|32|||
23541330|NCT02766608|65712932|FG003|Overall Study|Lack of Efficacy|8|||
23541331|NCT02766608|65712933|FG004|Overall Study|Lack of Efficacy|2|||
23541332|NCT02766608|65712929|FG000|Overall Study|Lost to Follow-up|6|||
23541333|NCT02766608|65712930|FG001|Overall Study|Lost to Follow-up|3|||
23541334|NCT02766608|65712931|FG002|Overall Study|Lost to Follow-up|5|||
23541335|NCT02766608|65712932|FG003|Overall Study|Lost to Follow-up|2|||
23541336|NCT02766608|65712933|FG004|Overall Study|Lost to Follow-up|2|||
23541337|NCT02766608|65712929|FG000|Overall Study|Physician Decision|3|||
23541338|NCT02766608|65712930|FG001|Overall Study|Physician Decision|2|||
23541339|NCT02766608|65712931|FG002|Overall Study|Physician Decision|3|||
23541340|NCT02766608|65712932|FG003|Overall Study|Physician Decision|1|||
23541341|NCT02766608|65712933|FG004|Overall Study|Physician Decision|2|||
23541342|NCT02766608|65712929|FG000|Overall Study|Protocol disc criteria|3|||
23541343|NCT02766608|65712930|FG001|Overall Study|Protocol disc criteria|3|||
23541344|NCT02766608|65712931|FG002|Overall Study|Protocol disc criteria|4|||
23541345|NCT02766608|65712932|FG003|Overall Study|Protocol disc criteria|0|||
23541346|NCT02766608|65712933|FG004|Overall Study|Protocol disc criteria|0|||
23541347|NCT02766608|65712929|FG000|Overall Study|Protocol Violation|0|||
23541348|NCT02766608|65712930|FG001|Overall Study|Protocol Violation|4|||
23541349|NCT02766608|65712931|FG002|Overall Study|Protocol Violation|4|||
23541350|NCT02766608|65712932|FG003|Overall Study|Protocol Violation|0|||
23541351|NCT02766608|65712933|FG004|Overall Study|Protocol Violation|1|||
23541352|NCT02766608|65712929|FG000|Overall Study|Administrative Reasons|3|||
23541353|NCT02766608|65712930|FG001|Overall Study|Administrative Reasons|1|||
23541354|NCT02766608|65712931|FG002|Overall Study|Administrative Reasons|1|||
23541355|NCT02766608|65712932|FG003|Overall Study|Administrative Reasons|0|||
23541356|NCT02766608|65712933|FG004|Overall Study|Administrative Reasons|0|||
23541357|NCT03299049|65712934|FG000|Overall Study|On-going|486|||
23541358|NCT03299049|65712935|FG001|Overall Study|On-going|481|||
23541359|NCT03299049|65712934|FG000|Overall Study|Withdrawal by Subject|6|||
23541360|NCT03299049|65712935|FG001|Overall Study|Withdrawal by Subject|21|||
23541361|NCT03299049|65712934|FG000|Overall Study|Physician Decision|5|||
23541362|NCT03299049|65712935|FG001|Overall Study|Physician Decision|1|||
23541363|NCT03299049|65712934|FG000|Overall Study|Lost to Follow-up|2|||
23541364|NCT03299049|65712935|FG001|Overall Study|Lost to Follow-up|0|||
23541365|NCT03299049|65712934|FG000|Overall Study|Pregnancy|1|||
23541366|NCT03299049|65712935|FG001|Overall Study|Pregnancy|3|||
23541367|NCT03299049|65712934|FG000|Overall Study|Protocol Violation|1|||
23541368|NCT03299049|65712935|FG001|Overall Study|Protocol Violation|1|||
23541369|NCT03299049|65712934|FG000|Overall Study|Lack of Efficacy|9|||
23541370|NCT03299049|65712935|FG001|Overall Study|Lack of Efficacy|3|||
23541371|NCT03299049|65712934|FG000|Overall Study|Adverse Event|12|||
23541372|NCT03299049|65712935|FG001|Overall Study|Adverse Event|13|||
23541373|NCT00512135|65712936|FG000|Overall Study|Not Treated|5|||
23541374|NCT00512135|65712936|FG000|Overall Study|Lack of Efficacy|2|||
23541375|NCT00512135|65712936|FG000|Overall Study|Adverse Event|6|||
23541376|NCT00512135|65712936|FG000|Overall Study|Withdrawal by Subject|22|||
23541377|NCT00512135|65712936|FG000|Overall Study|Lost to Follow-up|27|||
23541378|NCT00512135|65712936|FG000|Overall Study|Other|22|||
23541379|NCT02075593|65712942|FG000|Overall Study|Withdrawal by Subject|1|||
23541380|NCT02564198|65712943|FG000|Overall Study|Withdrawal by Subject|2|||
23541381|NCT02564198|65712944|FG001|Overall Study|Withdrawal by Subject|4|||
23541382|NCT02564198|65712945|FG002|Overall Study|Withdrawal by Subject|0|||
23541383|NCT02564198|65712943|FG000|Overall Study|Adverse Event|0|||
23541384|NCT02564198|65712944|FG001|Overall Study|Adverse Event|1|||
23541385|NCT02564198|65712945|FG002|Overall Study|Adverse Event|0|||
23541386|NCT00504829|65712946|FG000|Overall Study|Protocol Violation|6|||
23541387|NCT00504829|65712947|FG001|Overall Study|Protocol Violation|4|||
23541388|NCT00504829|65712948|FG002|Overall Study|Protocol Violation|10|||
23541389|NCT02348216|65712949|FG000|Overall Study|Death|5|||
23541390|NCT02348216|65712950|FG001|Overall Study|Death|53|||
23541391|NCT02348216|65712951|FG002|Overall Study|Death|11|||
23541392|NCT02348216|65712952|FG003|Overall Study|Death|20|||
23541393|NCT02348216|65712953|FG004|Overall Study|Death|16|||
23541394|NCT02348216|65712954|FG005|Overall Study|Death|32|||
23541395|NCT02348216|65712955|FG006|Overall Study|Death|17|||
23541396|NCT02348216|65712949|FG000|Overall Study|Full consent withdrawal|0|||
23541397|NCT02348216|65712950|FG001|Overall Study|Full consent withdrawal|0|||
23541398|NCT02348216|65712951|FG002|Overall Study|Full consent withdrawal|0|||
23541399|NCT02348216|65712952|FG003|Overall Study|Full consent withdrawal|1|||
23541400|NCT02348216|65712953|FG004|Overall Study|Full consent withdrawal|3|||
23541401|NCT02348216|65712954|FG005|Overall Study|Full consent withdrawal|0|||
23541402|NCT02348216|65712955|FG006|Overall Study|Full consent withdrawal|3|||
23541403|NCT02348216|65712949|FG000|Overall Study|Lost to Follow-up|0|||
23541404|NCT02348216|65712950|FG001|Overall Study|Lost to Follow-up|5|||
23541405|NCT02348216|65712951|FG002|Overall Study|Lost to Follow-up|2|||
23541406|NCT02348216|65712952|FG003|Overall Study|Lost to Follow-up|0|||
23541407|NCT02348216|65712953|FG004|Overall Study|Lost to Follow-up|1|||
23541408|NCT02348216|65712954|FG005|Overall Study|Lost to Follow-up|1|||
23541409|NCT02348216|65712955|FG006|Overall Study|Lost to Follow-up|1|||
23541410|NCT02348216|65712949|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
23541411|NCT02348216|65712950|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
23541412|NCT02348216|65712951|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
23541413|NCT02348216|65712952|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
23541414|NCT02348216|65712953|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
23541415|NCT02348216|65712954|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
23541416|NCT02348216|65712955|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
23541417|NCT02348216|65712949|FG000|Overall Study|Reason not specified|2|||
23541418|NCT02348216|65712950|FG001|Overall Study|Reason not specified|19|||
23541419|NCT02348216|65712951|FG002|Overall Study|Reason not specified|11|||
23541420|NCT02348216|65712952|FG003|Overall Study|Reason not specified|17|||
23541421|NCT02348216|65712953|FG004|Overall Study|Reason not specified|21|||
23541422|NCT02348216|65712954|FG005|Overall Study|Reason not specified|17|||
23541423|NCT02348216|65712955|FG006|Overall Study|Reason not specified|19|||
23541424|NCT00047463|65712956|FG000|Overall Study|Withdrawal by Subject|0|||
23541425|NCT00047463|65712957|FG001|Overall Study|Withdrawal by Subject|3|||
23541426|NCT03936244|65712960|FG000|Overall Study|Lost to Follow-up|5|||
23541427|NCT03936244|65712961|FG001|Overall Study|Lost to Follow-up|1|||
23541428|NCT03936244|65712960|FG000|Overall Study|Physician Decision|7|||
23541429|NCT03936244|65712961|FG001|Overall Study|Physician Decision|3|||
23541430|NCT01931839|65712962|FG000|Overall Study|Death|0|||
23541431|NCT01931839|65712963|FG001|Overall Study|Death|1|||
23541432|NCT01931839|65712964|FG002|Overall Study|Death|2|||
23541433|NCT01931839|65712965|FG003|Overall Study|Death|0|||
23541434|NCT01931839|65712966|FG004|Overall Study|Death|0|||
23541435|NCT01931839|65712967|FG005|Overall Study|Death|0|||
23541436|NCT01931839|65712968|FG006|Overall Study|Death|0|||
23541437|NCT01931839|65712962|FG000|Overall Study|Physician Decision|1|||
23541438|NCT01931839|65712963|FG001|Overall Study|Physician Decision|0|||
23541439|NCT01931839|65712964|FG002|Overall Study|Physician Decision|1|||
23541440|NCT01931839|65712965|FG003|Overall Study|Physician Decision|0|||
23541441|NCT01931839|65712966|FG004|Overall Study|Physician Decision|0|||
23541442|NCT01931839|65712967|FG005|Overall Study|Physician Decision|0|||
23541443|NCT01931839|65712968|FG006|Overall Study|Physician Decision|1|||
23541444|NCT01931839|65712962|FG000|Overall Study|Withdrawal of consent|0|||
23541445|NCT01931839|65712963|FG001|Overall Study|Withdrawal of consent|0|||
23541446|NCT01931839|65712964|FG002|Overall Study|Withdrawal of consent|0|||
23541447|NCT01931839|65712965|FG003|Overall Study|Withdrawal of consent|0|||
23541448|NCT01931839|65712966|FG004|Overall Study|Withdrawal of consent|1|||
23541449|NCT01931839|65712967|FG005|Overall Study|Withdrawal of consent|0|||
23541450|NCT01931839|65712968|FG006|Overall Study|Withdrawal of consent|0|||
23541451|NCT01931839|65712962|FG000|Overall Study|Adverse Event|9|||
23541452|NCT01931839|65712963|FG001|Overall Study|Adverse Event|4|||
23541453|NCT01931839|65712964|FG002|Overall Study|Adverse Event|1|||
23541454|NCT01931839|65712965|FG003|Overall Study|Adverse Event|3|||
23541455|NCT01931839|65712966|FG004|Overall Study|Adverse Event|0|||
23541456|NCT01931839|65712967|FG005|Overall Study|Adverse Event|0|||
23541457|NCT01931839|65712968|FG006|Overall Study|Adverse Event|1|||
23541458|NCT01931839|65712962|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
23541459|NCT01931839|65712963|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
23541460|NCT01931839|65712964|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
23541461|NCT01931839|65712965|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
23541462|NCT01931839|65712966|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
23541463|NCT01931839|65712967|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
23541464|NCT01931839|65712968|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
23541465|NCT01931839|65712962|FG000|Overall Study|Other non-compliance|15|||
23541466|NCT01931839|65712963|FG001|Overall Study|Other non-compliance|9|||
23541467|NCT01931839|65712964|FG002|Overall Study|Other non-compliance|12|||
23541468|NCT01931839|65712965|FG003|Overall Study|Other non-compliance|3|||
23541469|NCT01931839|65712966|FG004|Overall Study|Other non-compliance|0|||
23541470|NCT01931839|65712967|FG005|Overall Study|Other non-compliance|3|||
23541471|NCT01931839|65712968|FG006|Overall Study|Other non-compliance|0|||
23541472|NCT01931839|65712962|FG000|Overall Study|Lost to Follow-up|1|||
23541473|NCT01931839|65712963|FG001|Overall Study|Lost to Follow-up|2|||
23541474|NCT01931839|65712964|FG002|Overall Study|Lost to Follow-up|4|||
23541475|NCT01931839|65712965|FG003|Overall Study|Lost to Follow-up|5|||
23541476|NCT01931839|65712966|FG004|Overall Study|Lost to Follow-up|0|||
23541477|NCT01931839|65712967|FG005|Overall Study|Lost to Follow-up|0|||
23541478|NCT01931839|65712968|FG006|Overall Study|Lost to Follow-up|0|||
23541479|NCT01931839|65712962|FG000|Overall Study|Other|4|||
23541480|NCT01931839|65712963|FG001|Overall Study|Other|2|||
23541481|NCT01931839|65712964|FG002|Overall Study|Other|6|||
23541482|NCT01931839|65712965|FG003|Overall Study|Other|0|||
23541483|NCT01931839|65712966|FG004|Overall Study|Other|0|||
23541484|NCT01931839|65712967|FG005|Overall Study|Other|0|||
23541485|NCT01931839|65712968|FG006|Overall Study|Other|0|||
23541486|NCT02117570|65712969|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
23541487|NCT02117570|65712970|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
23541488|NCT02117570|65712971|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
23541489|NCT02117570|65712969|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
23541490|NCT02117570|65712970|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
23541491|NCT02117570|65712971|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
23541492|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
23541493|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
23541494|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
23541495|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
23541496|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
23541497|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
23541498|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
23541499|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
23541500|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
23541501|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
23541502|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
23541503|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
23541504|NCT02117570|65712969|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
23541505|NCT02117570|65712970|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
23541506|NCT02117570|65712971|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
23541507|NCT01557946|65712972|FG000|Overall Study|Adverse Event|3|||
23541508|NCT01557946|65712973|FG001|Overall Study|Adverse Event|0|||
23541509|NCT01731171|65712974|FG000|Overall Study|Withdrawal by Subject|4|||
23541510|NCT01731171|65712975|FG001|Overall Study|Withdrawal by Subject|1|||
23541511|NCT01731171|65712974|FG000|Overall Study|Lost to Follow-up|3|||
23541512|NCT01731171|65712975|FG001|Overall Study|Lost to Follow-up|2|||
23541513|NCT01731171|65712974|FG000|Overall Study|Moved out of Area|0|||
23541514|NCT01731171|65712975|FG001|Overall Study|Moved out of Area|2|||
23541515|NCT01731171|65712974|FG000|Overall Study|Terminated for Lack of Adherence|0|||
23541516|NCT01731171|65712975|FG001|Overall Study|Terminated for Lack of Adherence|1|||
23541517|NCT01731171|65712974|FG000|Overall Study|Terminated for Safety Reasons|0|||
23541518|NCT01731171|65712975|FG001|Overall Study|Terminated for Safety Reasons|1|||
23541519|NCT03143829|65712978|FG000|Overall Study|Withdrawal by Subject|2|||
23541520|NCT03143829|65712979|FG001|Overall Study|Withdrawal by Subject|5|||
23541521|NCT03143829|65712978|FG000|Overall Study|Lost to Follow-up|0|||
23541522|NCT03143829|65712979|FG001|Overall Study|Lost to Follow-up|2|||
23541523|NCT03143829|65712978|FG000|Overall Study|Death|1|||
23541524|NCT03143829|65712979|FG001|Overall Study|Death|1|||
23541525|NCT03143829|65712978|FG000|Overall Study|changed treatment, no longer eligible|2|||
23541526|NCT03143829|65712979|FG001|Overall Study|changed treatment, no longer eligible|2|||
23541527|NCT03346759|65712980|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
23541528|NCT03346759|65712981|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
23541529|NCT03346759|65712980|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
23541530|NCT03346759|65712981|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
23541531|NCT03346759|65712980|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
23541532|NCT03346759|65712981|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
23541533|NCT04266028|65712982|FG000|Overall Study|Adverse Event|0|||
23541534|NCT04266028|65712983|FG001|Overall Study|Adverse Event|0|||
23541535|NCT04266028|65712984|FG002|Overall Study|Adverse Event|1|||
23541536|NCT04266028|65712985|FG003|Overall Study|Adverse Event|0|||
23541537|NCT04266028|65712986|FG004|Overall Study|Adverse Event|1|||
23541538|NCT04266028|65712987|FG005|Overall Study|Adverse Event|0|||
23541539|NCT04266028|65712988|FG006|Overall Study|Adverse Event|2|||
23541540|NCT04266028|65712989|FG007|Overall Study|Adverse Event|0|||
23541541|NCT04266028|65712982|FG000|Overall Study|temporary halt of the study|0|||
23541542|NCT04266028|65712983|FG001|Overall Study|temporary halt of the study|0|||
23541543|NCT04266028|65712984|FG002|Overall Study|temporary halt of the study|0|||
23541544|NCT04266028|65712985|FG003|Overall Study|temporary halt of the study|0|||
23541545|NCT04266028|65712986|FG004|Overall Study|temporary halt of the study|0|||
23541546|NCT04266028|65712987|FG005|Overall Study|temporary halt of the study|0|||
23541547|NCT04266028|65712988|FG006|Overall Study|temporary halt of the study|2|||
23541548|NCT04266028|65712989|FG007|Overall Study|temporary halt of the study|1|||
23541549|NCT04266028|65712982|FG000|Overall Study|Onset of birch pollen season|0|||
23541550|NCT04266028|65712983|FG001|Overall Study|Onset of birch pollen season|0|||
23541551|NCT04266028|65712984|FG002|Overall Study|Onset of birch pollen season|0|||
23541552|NCT04266028|65712985|FG003|Overall Study|Onset of birch pollen season|0|||
23541553|NCT04266028|65712986|FG004|Overall Study|Onset of birch pollen season|1|||
23541554|NCT04266028|65712987|FG005|Overall Study|Onset of birch pollen season|0|||
23541555|NCT04266028|65712988|FG006|Overall Study|Onset of birch pollen season|0|||
23541556|NCT04266028|65712989|FG007|Overall Study|Onset of birch pollen season|0|||
23541557|NCT01059617|65712990|FG000|Overall Study|Other|7|||
23541558|NCT01059617|65712991|FG001|Overall Study|Other|1|||
23541559|NCT01059617|65712992|FG002|Overall Study|Other|8|||
23541560|NCT01059617|65712993|FG003|Overall Study|Other|6|||
23541561|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
23541562|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
23541563|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
23541564|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
23541565|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
23541566|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
23541567|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
23541568|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
23541569|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
23541570|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
23541571|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
23541572|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
23541573|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
23541574|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
23541575|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
23541576|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
23541577|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
23541578|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
23541579|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
23541580|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
23541581|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
23541582|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
23541583|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
23541584|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
23541585|NCT01715805|65712997|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
23541586|NCT01715805|65712998|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
23541587|NCT01715805|65712999|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
23541588|NCT01715805|65713000|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
23541589|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
23541590|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
23541591|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
23541592|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
23541593|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
23541594|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
23541595|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
23541596|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
23541597|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
23312854|NCT01449812|64889249|FG002|Overall Study|Migrated/moved from study area|0|||
23312855|NCT01449812|64889247|FG000|Overall Study|Withdrawal by Subject|0|||
23312856|NCT01449812|64889248|FG001|Overall Study|Withdrawal by Subject|0|||
23312857|NCT01449812|64889249|FG002|Overall Study|Withdrawal by Subject|1|||
23312858|NCT01449812|64889247|FG000|Overall Study|Lost to Follow-up|1|||
23312859|NCT01449812|64889248|FG001|Overall Study|Lost to Follow-up|0|||
23312860|NCT01449812|64889249|FG002|Overall Study|Lost to Follow-up|0|||
23312861|NCT05005312|64889250|FG000|Overall Study|Enrolled, but not treated|0|||
23312862|NCT05005312|64889251|FG001|Overall Study|Enrolled, but not treated|1|||
23312863|NCT00985491|64889252|FG000|Overall Study|Adverse Event|8|||
23312864|NCT00985491|64889252|FG000|Overall Study|device migration|7|||
23312865|NCT00985491|64889252|FG000|Overall Study|Withdrawal by Subject|1|||
23312866|NCT00985491|64889252|FG000|Overall Study|implant failure|3|||
23312867|NCT02643355|64889253|FG000|Overall Study|Withdrawal by Subject|1|||
23312868|NCT02643355|64889254|FG001|Overall Study|Withdrawal by Subject|3|||
23312869|NCT02643355|64889253|FG000|Overall Study|Protocol Violation|0|||
23312870|NCT02643355|64889254|FG001|Overall Study|Protocol Violation|2|||
23312871|NCT01210612|64889258|FG000|Overall Study|Withdrawal by Subject|0|||
23312872|NCT01210612|64889259|FG001|Overall Study|Withdrawal by Subject|2|||
23312873|NCT03678285|64889260|FG000|Overall Study|Adverse Event|2|||
23312874|NCT03678285|64889260|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
23312875|NCT03678285|64889260|FG000|Overall Study|Dehydrated prior to start of workout|1|||
23312876|NCT02388906|64889261|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
23312877|NCT02388906|64889262|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23312878|NCT02388906|64889261|FG000|Treatment Period|Disease progression|121|||
23312879|NCT02388906|64889262|FG001|Treatment Period|Disease progression|101|||
23312880|NCT02388906|64889261|FG000|Treatment Period|Study drug toxicity|41|||
23312881|NCT02388906|64889262|FG001|Treatment Period|Study drug toxicity|208|||
23312882|NCT02388906|64889261|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
23541598|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
23541599|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
23541600|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
23541601|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
23210167|NCT01413542|64509091|FG000|Overall Study|Physician Decision|1|||
23210168|NCT01413542|64509092|FG001|Overall Study|Physician Decision|0|||
23210169|NCT01413542|64509093|FG002|Overall Study|Physician Decision|3|||
23210170|NCT01413542|64509094|FG003|Overall Study|Physician Decision|0|||
23210171|NCT01413542|64509091|FG000|Overall Study|Adverse Event|0|||
23210172|NCT01413542|64509092|FG001|Overall Study|Adverse Event|0|||
23210173|NCT01413542|64509093|FG002|Overall Study|Adverse Event|0|||
23210174|NCT01413542|64509094|FG003|Overall Study|Adverse Event|1|||
23210175|NCT02322411|64509095|FG000|Overall Study|Lost to Follow-up|4|||
23312883|NCT02388906|64889262|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
23312884|NCT02388906|64889261|FG000|Treatment Period|Participant request to stop treatment|5|||
23312885|NCT02388906|64889262|FG001|Treatment Period|Participant request to stop treatment|9|||
23312886|NCT02388906|64889261|FG000|Treatment Period|Participant withdrew consent|2|||
23312887|NCT02388906|64889262|FG001|Treatment Period|Participant withdrew consent|3|||
23312888|NCT02388906|64889261|FG000|Treatment Period|Poor/non-compliance|0|||
23210176|NCT02322411|64509096|FG001|Overall Study|Lost to Follow-up|7|||
23210177|NCT02322411|64509095|FG000|Overall Study|Withdrawal by Subject|1|||
23424472|NCT00919867|65299667|FG004|First Intervention|Physician Decision|0|||
23424473|NCT00919867|65299668|FG005|First Intervention|Physician Decision|1|||
23424474|NCT03455829|65299669|FG000|Overall Study|Death|2|||
23424475|NCT03455829|65299670|FG001|Overall Study|Death|3|||
23424476|NCT03455829|65299671|FG002|Overall Study|Death|2|||
23424477|NCT03455829|65299672|FG003|Overall Study|Death|4|||
23424478|NCT03455829|65299673|FG004|Overall Study|Death|2|||
23424479|NCT03455829|65299669|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
23424480|NCT03455829|65299670|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
23424481|NCT03455829|65299671|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
23424482|NCT03455829|65299672|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
23424483|NCT03455829|65299673|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
23424484|NCT03455829|65299669|FG000|Overall Study|Disease progression|0|||
23424485|NCT03455829|65299670|FG001|Overall Study|Disease progression|0|||
23424486|NCT03455829|65299671|FG002|Overall Study|Disease progression|0|||
23424487|NCT03455829|65299672|FG003|Overall Study|Disease progression|1|||
23424488|NCT03455829|65299673|FG004|Overall Study|Disease progression|1|||
23424489|NCT00107315|65299674|FG000|Overall Study|Disease Progression|9|||
23424490|NCT00107315|65299674|FG000|Overall Study|Adverse Event|4|||
23424491|NCT00107315|65299674|FG000|Overall Study|Withdrawal by Subject|2|||
23424492|NCT03383783|65299678|FG000|Overall Study|Withdrawal by Subject|2|||
23424493|NCT01655381|65299679|FG000|Overall Study|Investigator Decision|1|||
23424494|NCT01655381|65299679|FG000|Overall Study|Moved to Another City|1|||
23424495|NCT01655381|65299679|FG000|Overall Study|Insufficient Treatment Response|1|||
23424496|NCT02914548|65299680|FG000|Overall Study|Adverse Event|15|||
23424497|NCT02914548|65299681|FG001|Overall Study|Adverse Event|7|||
23424498|NCT02914548|65299682|FG002|Overall Study|Adverse Event|15|||
23424499|NCT02914548|65299680|FG000|Overall Study|Physician Decision|2|||
23424500|NCT02914548|65299681|FG001|Overall Study|Physician Decision|2|||
23424501|NCT02914548|65299682|FG002|Overall Study|Physician Decision|0|||
23424502|NCT02914548|65299680|FG000|Overall Study|Protocol Violation|1|||
23424503|NCT02914548|65299681|FG001|Overall Study|Protocol Violation|0|||
23424504|NCT02914548|65299682|FG002|Overall Study|Protocol Violation|0|||
23424505|NCT02914548|65299680|FG000|Overall Study|Withdrawal by Subject|3|||
23424506|NCT02914548|65299681|FG001|Overall Study|Withdrawal by Subject|4|||
23424507|NCT02914548|65299682|FG002|Overall Study|Withdrawal by Subject|4|||
23424508|NCT02914548|65299680|FG000|Overall Study|>40% of body surface area|0|||
23424509|NCT02914548|65299681|FG001|Overall Study|>40% of body surface area|1|||
23424510|NCT02914548|65299682|FG002|Overall Study|>40% of body surface area|1|||
23424511|NCT01628367|65299683|FG000|Overall Study|Adverse Event|1|||
23424512|NCT01628367|65299684|FG001|Overall Study|Adverse Event|0|||
23424513|NCT01007123|65299687|FG000|Overall Study|Adverse Event|3|||
23424514|NCT01007123|65299688|FG001|Overall Study|Adverse Event|4|||
23424515|NCT01007123|65299689|FG002|Overall Study|Adverse Event|7|||
23424516|NCT01007123|65299690|FG003|Overall Study|Adverse Event|1|||
23424517|NCT01007123|65299687|FG000|Overall Study|Lack of Efficacy|1|||
23424518|NCT01007123|65299688|FG001|Overall Study|Lack of Efficacy|0|||
23424519|NCT01007123|65299689|FG002|Overall Study|Lack of Efficacy|1|||
23424520|NCT01007123|65299690|FG003|Overall Study|Lack of Efficacy|4|||
23424521|NCT01007123|65299687|FG000|Overall Study|Protocol Violation|1|||
23424522|NCT01007123|65299688|FG001|Overall Study|Protocol Violation|1|||
23424523|NCT01007123|65299689|FG002|Overall Study|Protocol Violation|2|||
23424524|NCT01007123|65299690|FG003|Overall Study|Protocol Violation|1|||
23424525|NCT01007123|65299687|FG000|Overall Study|Withdrawal by Subject|1|||
23424526|NCT01007123|65299688|FG001|Overall Study|Withdrawal by Subject|0|||
23424527|NCT01007123|65299689|FG002|Overall Study|Withdrawal by Subject|1|||
23424528|NCT01007123|65299690|FG003|Overall Study|Withdrawal by Subject|0|||
23424529|NCT01007123|65299687|FG000|Overall Study|Lost to Follow-up|0|||
23424530|NCT01007123|65299688|FG001|Overall Study|Lost to Follow-up|1|||
23424531|NCT01007123|65299689|FG002|Overall Study|Lost to Follow-up|0|||
23582200|NCT02892409|65862381|FG001|Overall Study|Adverse Event|0|||
23582201|NCT02892409|65862380|FG000|Overall Study|Withdrawal by Subject|2|||
23312889|NCT02388906|64889262|FG001|Treatment Period|Poor/non-compliance|1|||
23312890|NCT02388906|64889261|FG000|Treatment Period|Participant no longer meets study criteria|0|||
23312891|NCT02388906|64889262|FG001|Treatment Period|Participant no longer meets study criteria|1|||
23312892|NCT02388906|64889261|FG000|Treatment Period|Other reasons|3|||
23312893|NCT02388906|64889262|FG001|Treatment Period|Other reasons|3|||
23312894|NCT00447993|64889263|FG000|Overall Study|Lost to Follow-up|0|||
23312895|NCT00447993|64889264|FG001|Overall Study|Lost to Follow-up|0|||
23312896|NCT00447993|64889265|FG002|Overall Study|Lost to Follow-up|2|||
23312897|NCT00447993|64889266|FG003|Overall Study|Lost to Follow-up|2|||
23312898|NCT00447993|64889263|FG000|Overall Study|Withdrawal by Subject|0|||
23312899|NCT00447993|64889264|FG001|Overall Study|Withdrawal by Subject|0|||
23541602|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
23541603|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
23541604|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
23541605|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
23541606|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
23541607|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
23541608|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
23541609|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
23541610|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
23541611|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
23541612|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
23541613|NCT01715805|65712997|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
23541614|NCT01715805|65712998|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
23541615|NCT01715805|65712999|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
23541616|NCT01715805|65713000|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
23541617|NCT01055639|65713001|FG000|Overall Study|Adverse Event|0|||
23541618|NCT01055639|65713002|FG001|Overall Study|Adverse Event|1|||
23541619|NCT01055639|65713001|FG000|Overall Study|Lack of Efficacy|0|||
23541620|NCT01055639|65713002|FG001|Overall Study|Lack of Efficacy|1|||
23541621|NCT01055639|65713001|FG000|Overall Study|Lost to Follow-up|8|||
23541622|NCT01055639|65713002|FG001|Overall Study|Lost to Follow-up|11|||
23541623|NCT01055639|65713001|FG000|Overall Study|Protocol Violation|5|||
23541624|NCT01055639|65713002|FG001|Overall Study|Protocol Violation|5|||
23541625|NCT01055639|65713001|FG000|Overall Study|Withdrawal by Subject|8|||
23541626|NCT01055639|65713002|FG001|Overall Study|Withdrawal by Subject|11|||
23541627|NCT00099983|65713003|FG000|Overall Study|Lost to Follow-up|2|||
23541628|NCT00099983|65713004|FG001|Overall Study|Lost to Follow-up|3|||
23541629|NCT00099983|65713003|FG000|Overall Study|Missing Source Documents|14|||
23541630|NCT00099983|65713004|FG001|Overall Study|Missing Source Documents|15|||
23541631|NCT00099983|65713003|FG000|Overall Study|Withdrawal by Subject|3|||
23541632|NCT00099983|65713004|FG001|Overall Study|Withdrawal by Subject|2|||
23312900|NCT00447993|64889265|FG002|Overall Study|Withdrawal by Subject|2|||
23312901|NCT00447993|64889266|FG003|Overall Study|Withdrawal by Subject|2|||
23424532|NCT01007123|65299690|FG003|Overall Study|Lost to Follow-up|0|||
23424533|NCT00591149|65299691|FG000|Overall Study|Adverse Event|4|||
23424534|NCT00591149|65299691|FG000|Overall Study|Withdrawal by Subject|1|||
23424535|NCT02688088|65299692|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
23424536|NCT02688088|65299693|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
23424537|NCT02688088|65299694|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
23424538|NCT02688088|65299695|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
23424539|NCT02688088|65299696|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
23424540|NCT02688088|65299692|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
23424541|NCT02688088|65299693|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
23424542|NCT02688088|65299694|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
23424543|NCT02688088|65299695|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
23424544|NCT02688088|65299696|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
23424545|NCT02688088|65299692|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
23424546|NCT02688088|65299693|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
23541633|NCT00099983|65713003|FG000|Overall Study|Adverse Event|1|||
23541634|NCT00099983|65713004|FG001|Overall Study|Adverse Event|1|||
23541635|NCT00099983|65713003|FG000|Overall Study|Lack of Efficacy|0|||
23541636|NCT00099983|65713004|FG001|Overall Study|Lack of Efficacy|1|||
23541637|NCT00099983|65713003|FG000|Overall Study|Unable to return for appointments|1|||
23541638|NCT00099983|65713004|FG001|Overall Study|Unable to return for appointments|1|||
23424547|NCT02688088|65299694|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
23424548|NCT02688088|65299695|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
23424549|NCT02688088|65299696|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
23424550|NCT02688088|65299692|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
23424551|NCT02688088|65299693|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
23424552|NCT02688088|65299694|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
23424553|NCT02688088|65299695|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
23424554|NCT02688088|65299696|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
23424555|NCT02688088|65299692|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
23424556|NCT02688088|65299693|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
23424557|NCT02688088|65299694|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
23424558|NCT02688088|65299695|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
23424559|NCT02688088|65299696|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
23424560|NCT02688088|65299692|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
23424561|NCT02688088|65299693|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
23424562|NCT02688088|65299694|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
23424563|NCT02688088|65299695|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
23424564|NCT02688088|65299696|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
23424565|NCT02688088|65299692|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
23424566|NCT02688088|65299693|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
23424567|NCT02688088|65299694|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
23424568|NCT02688088|65299695|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
23424569|NCT02688088|65299696|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
23424570|NCT02688088|65299692|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
23424571|NCT02688088|65299693|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
23424572|NCT02688088|65299694|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
23424573|NCT02688088|65299695|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
23424574|NCT02688088|65299696|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
23424575|NCT02688088|65299692|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
23424576|NCT02688088|65299693|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
23424577|NCT02688088|65299694|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
23424578|NCT02688088|65299695|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
23424579|NCT02688088|65299696|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
23424580|NCT04143217|65299697|FG000|Overall Study|Withdrawal by Subject|42|||
23424581|NCT04143217|65299697|FG000|Overall Study|Adverse Event|29|||
23424582|NCT04143217|65299697|FG000|Overall Study|Lost to Follow-up|29|||
23424583|NCT04143217|65299697|FG000|Overall Study|Lack of Efficacy|15|||
23424584|NCT04143217|65299697|FG000|Overall Study|Physician Decision|1|||
23424585|NCT04143217|65299697|FG000|Overall Study|Non-Compliance With Study Drug|6|||
23424586|NCT04143217|65299697|FG000|Overall Study|Other, Multiple Categories|11|||
23424587|NCT02210689|65299698|FG000|Overall Study|Withdrawal by Subject|7|||
23424588|NCT02210689|65299699|FG001|Overall Study|Withdrawal by Subject|4|||
23424589|NCT02210689|65299700|FG002|Overall Study|Withdrawal by Subject|2|||
23424590|NCT02210689|65299698|FG000|Overall Study|Adverse Event|0|||
23424591|NCT02210689|65299699|FG001|Overall Study|Adverse Event|1|||
23424592|NCT02210689|65299700|FG002|Overall Study|Adverse Event|0|||
23424593|NCT02210689|65299698|FG000|Overall Study|Protocol Violation|1|||
23424594|NCT02210689|65299699|FG001|Overall Study|Protocol Violation|0|||
23424595|NCT02210689|65299700|FG002|Overall Study|Protocol Violation|0|||
23424596|NCT02210689|65299698|FG000|Overall Study|Lost to Follow-up|11|||
23424597|NCT02210689|65299699|FG001|Overall Study|Lost to Follow-up|9|||
23424598|NCT02210689|65299700|FG002|Overall Study|Lost to Follow-up|5|||
23424599|NCT02210689|65299698|FG000|Overall Study|Pregnancy|0|||
23424600|NCT02210689|65299699|FG001|Overall Study|Pregnancy|1|||
23424601|NCT02210689|65299700|FG002|Overall Study|Pregnancy|0|||
23424602|NCT02210689|65299698|FG000|Overall Study|Lack of Efficacy|0|||
23424603|NCT02210689|65299699|FG001|Overall Study|Lack of Efficacy|1|||
23424604|NCT02210689|65299700|FG002|Overall Study|Lack of Efficacy|5|||
23424605|NCT02210689|65299698|FG000|Overall Study|Prohibited medication|2|||
23424606|NCT02210689|65299699|FG001|Overall Study|Prohibited medication|8|||
23424607|NCT02210689|65299700|FG002|Overall Study|Prohibited medication|1|||
23424608|NCT02210689|65299698|FG000|Overall Study|Negative Nugent score at baseline|6|||
23424609|NCT02210689|65299699|FG001|Overall Study|Negative Nugent score at baseline|2|||
23424610|NCT02210689|65299700|FG002|Overall Study|Negative Nugent score at baseline|2|||
23424611|NCT02210689|65299698|FG000|Overall Study|Other|25|||
23424612|NCT02210689|65299699|FG001|Overall Study|Other|21|||
23424613|NCT02210689|65299700|FG002|Overall Study|Other|8|||
23424614|NCT00428220|65299701|FG000|Overall Study|Participant died|8|||
23424615|NCT00428220|65299701|FG000|Overall Study|Global deterioration of health status|7|||
23424616|NCT00428220|65299701|FG000|Overall Study|Lost to Follow-up|4|||
23424617|NCT00428220|65299701|FG000|Overall Study|Objective progression or relapse|123|||
23541639|NCT00099983|65713003|FG000|Overall Study|Moved|1|||
23541640|NCT00099983|65713004|FG001|Overall Study|Moved|0|||
23541641|NCT00099983|65713003|FG000|Overall Study|Other psychiatric problem|1|||
23541642|NCT00099983|65713004|FG001|Overall Study|Other psychiatric problem|0|||
23541643|NCT00099983|65713003|FG000|Overall Study|Incarcerated|0|||
23541644|NCT00099983|65713004|FG001|Overall Study|Incarcerated|1|||
23541645|NCT00099983|65713003|FG000|Overall Study|Intolerant of burden of visits|0|||
23541646|NCT00099983|65713004|FG001|Overall Study|Intolerant of burden of visits|1|||
23541647|NCT00099983|65713003|FG000|Overall Study|Other issue|1|||
23541648|NCT00099983|65713004|FG001|Overall Study|Other issue|0|||
23541649|NCT00835406|65713005|FG000|Period: First Intervention|Adverse Event|0|||
23541650|NCT00835406|65713006|FG001|Period: First Intervention|Adverse Event|1|||
23541651|NCT00835406|65713005|FG000|Period: First Intervention|Withdrawal by Subject|2|||
23541652|NCT00835406|65713006|FG001|Period: First Intervention|Withdrawal by Subject|0|||
23541653|NCT00835406|65713005|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
23541654|NCT00835406|65713006|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
23541655|NCT03647501|65713007|FG000|Overall Study|Lost to Follow-up|1|||
23541656|NCT03647501|65713008|FG001|Overall Study|Lost to Follow-up|1|||
23541657|NCT03647501|65713007|FG000|Overall Study|Withdrawal by Subject|0|||
23541658|NCT03647501|65713008|FG001|Overall Study|Withdrawal by Subject|1|||
23541659|NCT04755595|65713011|FG000|Overall Study|Lost to Follow-up|1|||
23541660|NCT02417246|65713023|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
23541661|NCT02417246|65713024|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
23541662|NCT02417246|65713023|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
23541663|NCT02417246|65713024|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
23541664|NCT02417246|65713023|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
23541665|NCT02417246|65713024|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
23541666|NCT02417246|65713023|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
23541667|NCT02417246|65713024|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
23541668|NCT02331134|65713027|FG000|Overall Study|Withdrawal by Subject|1|||
23541669|NCT02223390|65713032|FG000|Overall Study|Lost to Follow-up|9|||
23541670|NCT02223390|65713033|FG001|Overall Study|Lost to Follow-up|4|||
23541671|NCT00759109|65713036|FG000|Overall Study|Adverse Event|17|||
23541672|NCT00759109|65713037|FG001|Overall Study|Adverse Event|12|||
23541673|NCT00759109|65713036|FG000|Overall Study|Inability to comply|1|||
23541674|NCT00759109|65713037|FG001|Overall Study|Inability to comply|1|||
23541675|NCT00759109|65713036|FG000|Overall Study|Withdrawal by Subject|9|||
23541676|NCT00759109|65713037|FG001|Overall Study|Withdrawal by Subject|5|||
23541677|NCT00759109|65713036|FG000|Overall Study|Death|4|||
23541678|NCT00759109|65713037|FG001|Overall Study|Death|3|||
23541679|NCT00759109|65713036|FG000|Overall Study|Lost to Follow-up|4|||
23541680|NCT00759109|65713037|FG001|Overall Study|Lost to Follow-up|6|||
23541681|NCT00759109|65713036|FG000|Overall Study|Started new therapy|2|||
23541682|NCT00759109|65713037|FG001|Overall Study|Started new therapy|6|||
23541683|NCT00759109|65713036|FG000|Overall Study|HCV RNA negative|1|||
23541684|NCT00759109|65713037|FG001|Overall Study|HCV RNA negative|0|||
23541685|NCT00759109|65713036|FG000|Overall Study|Participant moved to a different city|0|||
23541686|NCT00759109|65713037|FG001|Overall Study|Participant moved to a different city|1|||
23541687|NCT00759109|65713036|FG000|Overall Study|Participant had a liver transplant|0|||
23541688|NCT00759109|65713037|FG001|Overall Study|Participant had a liver transplant|1|||
23541689|NCT00759109|65713036|FG000|Overall Study|Lost during study|1|||
23541690|NCT00759109|65713037|FG001|Overall Study|Lost during study|0|||
23541691|NCT01870843|65713040|FG000|Overall Study|Adverse Event|10|||
23541692|NCT01870843|65713040|FG000|Overall Study|Lost to Follow-up|24|||
23541693|NCT01870843|65713040|FG000|Overall Study|Death|1|||
23541694|NCT01870843|65713040|FG000|Overall Study|Withdrawal by Subject|18|||
23541695|NCT00965523|65713044|FG000|Study 221|Progressive Disease|4|||
23541696|NCT00965523|65713044|FG000|Study 221|Physician Decision|3|||
23541697|NCT00965523|65713044|FG000|Study 224|Progressive Disease|5|||
23541698|NCT00965523|65713044|FG000|Study 224|Physician Decision|1|||
23541699|NCT00127608|65713045|FG000|Overall Study|VZV DNA negative|1|||
23541700|NCT02806986|65713053|FG000|Treatment Stage 1|Adverse Event|1|||
23541701|NCT02806986|65713053|FG000|Treatment Stage 2|Adverse Event|3|||
23541702|NCT02806986|65713053|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
23541703|NCT03891524|65713054|FG000|Overall Study|Death|0|||
23541704|NCT03891524|65713055|FG001|Overall Study|Death|0|||
23541705|NCT03891524|65713056|FG002|Overall Study|Death|0|||
23541706|NCT03891524|65713057|FG003|Overall Study|Death|0|||
23541707|NCT03891524|65713058|FG004|Overall Study|Death|0|||
23541708|NCT03891524|65713059|FG005|Overall Study|Death|0|||
23541709|NCT03891524|65713060|FG006|Overall Study|Death|0|||
23541710|NCT03891524|65713061|FG007|Overall Study|Death|1|||
23541711|NCT03891524|65713054|FG000|Overall Study|Withdrawal by Subject|0|||
23541712|NCT03891524|65713055|FG001|Overall Study|Withdrawal by Subject|1|||
23541713|NCT03891524|65713056|FG002|Overall Study|Withdrawal by Subject|2|||
23541714|NCT03891524|65713057|FG003|Overall Study|Withdrawal by Subject|1|||
23541715|NCT03891524|65713058|FG004|Overall Study|Withdrawal by Subject|2|||
23541716|NCT03891524|65713059|FG005|Overall Study|Withdrawal by Subject|2|||
23541717|NCT03891524|65713060|FG006|Overall Study|Withdrawal by Subject|2|||
23541718|NCT03891524|65713061|FG007|Overall Study|Withdrawal by Subject|1|||
23541719|NCT03283670|65713062|FG000|Placebo Gas|Withdrawal by Subject|2|||
23541720|NCT03283670|65713062|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
23541721|NCT03283670|65713062|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
23541722|NCT03588572|65713063|FG000|Visitation 1|Lack of Efficacy|1|||
23541723|NCT03588572|65713064|FG001|Visitation 1|Lack of Efficacy|1|||
23541724|NCT03588572|65713063|FG000|Visitation 2|Lost to Follow-up|1|||
23541725|NCT03588572|65713064|FG001|Visitation 2|Lost to Follow-up|1|||
23541726|NCT03588572|65713063|FG000|Visitation 2|Lack of Efficacy|0|||
23541727|NCT03588572|65713064|FG001|Visitation 2|Lack of Efficacy|1|||
23541728|NCT03588572|65713063|FG000|Visitation 2|Withdrawal by Subject|1|||
23541729|NCT03588572|65713064|FG001|Visitation 2|Withdrawal by Subject|0|||
23541730|NCT03588572|65713063|FG000|Visitation 3|Lost to Follow-up|1|||
23541731|NCT03588572|65713064|FG001|Visitation 3|Lost to Follow-up|1|||
23541732|NCT03588572|65713063|FG000|Visitation 3|Physician Decision|1|||
23541733|NCT03588572|65713064|FG001|Visitation 3|Physician Decision|1|||
23541734|NCT03588572|65713063|FG000|Visitation 3|Withdrawal by Subject|1|||
23541735|NCT03588572|65713064|FG001|Visitation 3|Withdrawal by Subject|0|||
23541736|NCT01296568|65713065|FG000|Continued Access Phase|Lost to Follow-up|1|||
23541737|NCT01296568|65713065|FG000|Continued Access Phase|Withdrawal by Subject|1|||
23541738|NCT01296568|65713065|FG000|Continued Access Phase|Disease Progression|1|||
23541739|NCT01793792|65713066|FG000|Overall Study|Death|5|||
23541740|NCT01793792|65713066|FG000|Overall Study|Lost to Follow-up|5|||
23541741|NCT01793792|65713066|FG000|Overall Study|Withdrawal by Subject|1|||
23541742|NCT01793792|65713066|FG000|Overall Study|Device Not Implanted|1|||
23541743|NCT02473952|65713074|FG000|Overall Study|Adverse Event|2|||
23541744|NCT02473952|65713075|FG001|Overall Study|Adverse Event|2|||
23541745|NCT02473952|65713074|FG000|Overall Study|Withdrawal by Subject|0|||
23541746|NCT02473952|65713075|FG001|Overall Study|Withdrawal by Subject|6|||
23541747|NCT01921348|65713076|FG000|Overall Study|Withdrawal by Subject|1|||
23541748|NCT01921348|65713077|FG001|Overall Study|Withdrawal by Subject|0|||
23541749|NCT01921348|65713076|FG000|Overall Study|Lost to Follow-up|0|||
23541750|NCT01921348|65713077|FG001|Overall Study|Lost to Follow-up|2|||
23541751|NCT01313559|65713078|FG000|Overall Study|Withdrawal by Subject|1|||
23541752|NCT01313559|65713079|FG001|Overall Study|Withdrawal by Subject|2|||
23541753|NCT01313559|65713078|FG000|Overall Study|Disease progression|1|||
23541754|NCT01313559|65713079|FG001|Overall Study|Disease progression|0|||
23541755|NCT01313559|65713078|FG000|Overall Study|Rising PSA|2|||
23541756|NCT01313559|65713079|FG001|Overall Study|Rising PSA|0|||
23541757|NCT02349711|65713080|FG000|Overall Study|Withdrawal by Subject|2|||
23541758|NCT02349711|65713081|FG001|Overall Study|Withdrawal by Subject|1|||
23541759|NCT02349711|65713080|FG000|Overall Study|Lost to Follow-up|1|||
23541760|NCT02349711|65713081|FG001|Overall Study|Lost to Follow-up|1|||
23541761|NCT01193556|65713082|FG000|Overall Study|Study termination|26|||
23541762|NCT01193556|65713083|FG001|Overall Study|Study termination|25|||
23541763|NCT03073603|65713086|FG000|Overall Study|Noncompliance|3|||
23541764|NCT03073603|65713087|FG001|Overall Study|Noncompliance|1|||
23541765|NCT03073603|65713086|FG000|Overall Study|Adverse Event|5|||
23541766|NCT03073603|65713087|FG001|Overall Study|Adverse Event|3|||
23541767|NCT03073603|65713086|FG000|Overall Study|Physician Decision|1|||
23541768|NCT03073603|65713087|FG001|Overall Study|Physician Decision|2|||
23541769|NCT03073603|65713086|FG000|Overall Study|Required treatment not allowed by protocol|1|||
23541770|NCT03073603|65713087|FG001|Overall Study|Required treatment not allowed by protocol|0|||
23541771|NCT03073603|65713086|FG000|Overall Study|Financial or insurance-related|8|||
23541772|NCT03073603|65713087|FG001|Overall Study|Financial or insurance-related|0|||
23541773|NCT03073603|65713086|FG000|Overall Study|Withdrawal by Subject|0|||
23541774|NCT03073603|65713087|FG001|Overall Study|Withdrawal by Subject|1|||
23541775|NCT03073603|65713086|FG000|Overall Study|Discontinued DMT|4|||
23541776|NCT03073603|65713087|FG001|Overall Study|Discontinued DMT|0|||
23541777|NCT03073603|65713086|FG000|Overall Study|Restarted DMT|0|||
23541778|NCT03073603|65713087|FG001|Overall Study|Restarted DMT|1|||
23541779|NCT03086447|65713090|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23541780|NCT03086447|65713091|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
23541781|NCT03086447|65713090|FG000|Overall Study|Lost Lens|2|||
23541782|NCT03086447|65713091|FG001|Overall Study|Lost Lens|5|||
23541783|NCT03086447|65713090|FG000|Overall Study|Product quality complaint|0|||
23541784|NCT03086447|65713091|FG001|Overall Study|Product quality complaint|1|||
23541785|NCT03086447|65713090|FG000|Overall Study|Lens Damage|1|||
23541786|NCT03086447|65713091|FG001|Overall Study|Lens Damage|6|||
23541787|NCT03086447|65713090|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
23541788|NCT03086447|65713091|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
23541789|NCT03086447|65713090|FG000|Overall Study|Test Article No Longer Available|1|||
23541790|NCT03086447|65713091|FG001|Overall Study|Test Article No Longer Available|0|||
23541791|NCT03086447|65713090|FG000|Overall Study|Protocol Violation|2|||
23541792|NCT03086447|65713091|FG001|Overall Study|Protocol Violation|4|||
23541793|NCT03086447|65713090|FG000|Overall Study|Lost to Follow-up|0|||
23541794|NCT03086447|65713091|FG001|Overall Study|Lost to Follow-up|1|||
23541795|NCT03086447|65713090|FG000|Overall Study|Adverse Event|3|||
23541796|NCT03086447|65713091|FG001|Overall Study|Adverse Event|0|||
23541797|NCT03086447|65713090|FG000|Overall Study|Lens Discomfort|2|||
23312902|NCT01439009|64889273|FG000|Overall Study|Physician Decision|5|||
23424618|NCT00428220|65299701|FG000|Overall Study|Participant refused continued treatment|7|||
23424619|NCT00428220|65299701|FG000|Overall Study|Adverse Event|51|||
23424620|NCT00428220|65299701|FG000|Overall Study|Other|23|||
23424621|NCT00815191|65299709|FG000|Overall Study|Protocol Violation|1|||
23424622|NCT00815191|65299710|FG001|Overall Study|Protocol Violation|1|||
23424623|NCT02014480|65299711|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424624|NCT02014480|65299712|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424625|NCT02014480|65299713|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
23424626|NCT02014480|65299714|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424627|NCT02014480|65299715|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424628|NCT02014480|65299716|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
23424629|NCT02014480|65299711|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23424630|NCT02014480|65299712|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23424631|NCT02014480|65299713|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23424632|NCT02014480|65299714|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
23424633|NCT02014480|65299715|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23424634|NCT02014480|65299716|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23424635|NCT02014480|65299711|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424636|NCT02014480|65299712|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424637|NCT02014480|65299713|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
23424638|NCT02014480|65299714|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424639|NCT02014480|65299715|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424640|NCT02014480|65299716|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23424641|NCT02014480|65299711|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23424642|NCT02014480|65299712|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23424643|NCT02014480|65299713|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
23424644|NCT02014480|65299714|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23424645|NCT02014480|65299715|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23424646|NCT02014480|65299716|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23424647|NCT02014480|65299711|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424648|NCT02014480|65299712|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
23424649|NCT02014480|65299713|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424650|NCT02014480|65299714|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424651|NCT02014480|65299715|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424652|NCT02014480|65299716|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23424653|NCT02014480|65299711|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
23424654|NCT02014480|65299712|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
23424655|NCT02014480|65299713|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
23424656|NCT02014480|65299714|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
23424657|NCT02014480|65299715|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
23424658|NCT02014480|65299716|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
23424659|NCT02014480|65299711|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424660|NCT02014480|65299712|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424661|NCT02014480|65299713|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424662|NCT02014480|65299714|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424663|NCT02014480|65299715|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23424664|NCT02014480|65299716|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
23424665|NCT02851407|65299719|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23424666|NCT02851407|65299720|FG001|Overall Study|Withdrawal by parent/guardian|7|||
23424667|NCT02851407|65299719|FG000|Overall Study|Protocol deviation|0|||
23424668|NCT02851407|65299720|FG001|Overall Study|Protocol deviation|1|||
23424669|NCT02851407|65299719|FG000|Overall Study|Transferred to another hospital to continue|1|||
23424670|NCT02851407|65299720|FG001|Overall Study|Transferred to another hospital to continue|0|||
23424671|NCT02851407|65299719|FG000|Overall Study|Other Death|30|||
23424672|NCT02851407|65299720|FG001|Overall Study|Other Death|20|||
23541798|NCT03086447|65713091|FG001|Overall Study|Lens Discomfort|1|||
23541799|NCT05282004|65713092|FG000|Overall Study|Adverse Event|2|||
23541800|NCT00214136|65713096|FG000|Overall Study|Death|5|||
23541801|NCT00889421|65713097|FG000|Overall Study|Lack of Efficacy|3|||
23541802|NCT00439777|65713098|FG000|Treatment Period|Death|29|||
23541803|NCT00439777|65713099|FG001|Treatment Period|Death|21|||
23616677|NCT00747149|65982405|FG001|Overall Study|Adverse Event|15|||
23541804|NCT00439777|65713098|FG000|Treatment Period|Study terminated by sponsor|125|||
23541805|NCT00439777|65713099|FG001|Treatment Period|Study terminated by sponsor|132|||
23541806|NCT00439777|65713098|FG000|Treatment Period|Site closed by investigator|0|||
23541807|NCT00439777|65713099|FG001|Treatment Period|Site closed by investigator|1|||
23541808|NCT00439777|65713098|FG000|Treatment Period|Did not take study treatment|7|||
23541809|NCT00439777|65713099|FG001|Treatment Period|Did not take study treatment|8|||
23541810|NCT00439777|65713098|FG000|Treatment Period|Adverse Event|111|||
23541811|NCT00439777|65713099|FG001|Treatment Period|Adverse Event|92|||
23210178|NCT02322411|64509096|FG001|Overall Study|Withdrawal by Subject|0|||
23210179|NCT02158091|64509097|FG000|Overall Study|DLT|2|||
23210180|NCT02158091|64509098|FG001|Overall Study|DLT|1|||
23210181|NCT02158091|64509099|FG002|Overall Study|DLT|0|||
23210182|NCT01995136|64509100|FG000|Overall Study|Change in residence|1|||
23210183|NCT00067470|64509101|FG000|Overall Study|Withdrawal by Subject|0|||
23210184|NCT00067470|64509102|FG001|Overall Study|Withdrawal by Subject|1|||
23210185|NCT03446651|64509103|FG000|Overall Study|Lost to Follow-up|4|||
23210186|NCT03446651|64509104|FG001|Overall Study|Lost to Follow-up|0|||
23210187|NCT03446651|64509103|FG000|Overall Study|Open Label Participants|5|||
23210188|NCT03446651|64509104|FG001|Overall Study|Open Label Participants|0|||
23210189|NCT03519516|64509106|FG000|Overall Study|Adverse Event|0|||
23210190|NCT03519516|64509107|FG001|Overall Study|Adverse Event|1|||
23210191|NCT01175213|64509108|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
23210192|NCT01175213|64509109|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
23210193|NCT01175213|64509108|FG000|IGSC, 10%/rHuPH20|Death|1|||
23312903|NCT01439009|64889274|FG001|Overall Study|Physician Decision|3|||
23541812|NCT00439777|65713098|FG000|Treatment Period|Protocol Violation|23|||
23541813|NCT00439777|65713099|FG001|Treatment Period|Protocol Violation|30|||
23541814|NCT00439777|65713098|FG000|Treatment Period|Withdrawal by Subject|66|||
23541815|NCT00439777|65713099|FG001|Treatment Period|Withdrawal by Subject|118|||
23541816|NCT00439777|65713098|FG000|Treatment Period|Lack of Efficacy|1|||
23541817|NCT00439777|65713099|FG001|Treatment Period|Lack of Efficacy|4|||
23541818|NCT00439777|65713098|FG000|Treatment Period|Lost to Follow-up|8|||
23210194|NCT01175213|64509109|FG001|IGSC, 10%/rHuPH20|Death|0|||
23210195|NCT01175213|64509108|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
23210196|NCT01175213|64509109|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
23541819|NCT00439777|65713099|FG001|Treatment Period|Lost to Follow-up|10|||
23541820|NCT00439777|65713098|FG000|Treatment Period|Protocol driven decision point|1|||
23541821|NCT00439777|65713099|FG001|Treatment Period|Protocol driven decision point|3|||
23541822|NCT00439777|65713098|FG000|Treatment Period|Physician Decision|7|||
23541823|NCT00439777|65713099|FG001|Treatment Period|Physician Decision|18|||
23541824|NCT00439777|65713098|FG000|Treatment Period|Clinical endpoint reached|26|||
23541825|NCT00439777|65713099|FG001|Treatment Period|Clinical endpoint reached|13|||
23541826|NCT00439777|65713098|FG000|Treatment Period|Technical problems|3|||
23541827|NCT00439777|65713099|FG001|Treatment Period|Technical problems|1|||
23541828|NCT00439777|65713098|FG000|Treatment Period|Participant convenience|12|||
23541829|NCT00439777|65713099|FG001|Treatment Period|Participant convenience|8|||
23541830|NCT00439777|65713098|FG000|Observational Period|Protocol Violation|0|||
23541831|NCT00439777|65713099|FG001|Observational Period|Protocol Violation|2|||
23541832|NCT00439777|65713098|FG000|Observational Period|Withdrawal by Subject|9|||
23541833|NCT00439777|65713099|FG001|Observational Period|Withdrawal by Subject|5|||
23541834|NCT00439777|65713098|FG000|Observational Period|Lost to Follow-up|1|||
23541835|NCT00439777|65713099|FG001|Observational Period|Lost to Follow-up|11|||
23541836|NCT00439777|65713098|FG000|Observational Period|Death|27|||
23541837|NCT00439777|65713099|FG001|Observational Period|Death|20|||
23541838|NCT00439777|65713098|FG000|Observational Period|Study terminated by sponsor|3|||
23541839|NCT00439777|65713099|FG001|Observational Period|Study terminated by sponsor|1|||
23541840|NCT00439777|65713098|FG000|Observational Period|Protocol driven decision point|0|||
23541841|NCT00439777|65713099|FG001|Observational Period|Protocol driven decision point|1|||
23541842|NCT00439777|65713098|FG000|Observational Period|Lack of Efficacy|1|||
23541843|NCT00439777|65713099|FG001|Observational Period|Lack of Efficacy|0|||
23541844|NCT00439777|65713098|FG000|Observational Period|Technical problems|0|||
23541845|NCT00439777|65713099|FG001|Observational Period|Technical problems|1|||
23541846|NCT03062891|65713103|FG000|Overall Study|Withdrawal by Subject|2|||
23541847|NCT03062891|65713104|FG001|Overall Study|Withdrawal by Subject|0|||
23541848|NCT03062891|65713103|FG000|Overall Study|Lost to Follow-up|50|||
23541849|NCT03062891|65713104|FG001|Overall Study|Lost to Follow-up|38|||
23541850|NCT01923181|65713114|FG000|Overall Study|Protocol Violation|2|||
23541851|NCT01923181|65713115|FG001|Overall Study|Protocol Violation|2|||
23541852|NCT01923181|65713116|FG002|Overall Study|Protocol Violation|0|||
23541853|NCT01923181|65713117|FG003|Overall Study|Protocol Violation|2|||
23541854|NCT01923181|65713118|FG004|Overall Study|Protocol Violation|2|||
23541855|NCT01923181|65713119|FG005|Overall Study|Protocol Violation|1|||
23541856|NCT01923181|65713120|FG006|Overall Study|Protocol Violation|1|||
23541857|NCT01923181|65713121|FG007|Overall Study|Protocol Violation|2|||
23541858|NCT01923181|65713122|FG008|Overall Study|Protocol Violation|1|||
23541859|NCT01923181|65713114|FG000|Overall Study|Withdrawal by Subject|0|||
23541860|NCT01923181|65713115|FG001|Overall Study|Withdrawal by Subject|1|||
23541861|NCT01923181|65713116|FG002|Overall Study|Withdrawal by Subject|0|||
23541862|NCT01923181|65713117|FG003|Overall Study|Withdrawal by Subject|1|||
23541863|NCT01923181|65713118|FG004|Overall Study|Withdrawal by Subject|4|||
23541864|NCT01923181|65713119|FG005|Overall Study|Withdrawal by Subject|2|||
23541865|NCT01923181|65713120|FG006|Overall Study|Withdrawal by Subject|4|||
23541866|NCT01923181|65713121|FG007|Overall Study|Withdrawal by Subject|3|||
23541867|NCT01923181|65713122|FG008|Overall Study|Withdrawal by Subject|1|||
23541868|NCT01923181|65713114|FG000|Overall Study|Other|1|||
23541869|NCT01923181|65713115|FG001|Overall Study|Other|0|||
23541870|NCT01923181|65713116|FG002|Overall Study|Other|0|||
23541871|NCT01923181|65713117|FG003|Overall Study|Other|1|||
23541872|NCT01923181|65713118|FG004|Overall Study|Other|0|||
23541873|NCT01923181|65713119|FG005|Overall Study|Other|0|||
23541874|NCT01923181|65713120|FG006|Overall Study|Other|0|||
23541875|NCT01923181|65713121|FG007|Overall Study|Other|0|||
23541876|NCT01923181|65713122|FG008|Overall Study|Other|0|||
23541877|NCT01923181|65713114|FG000|Overall Study|Lost to Follow-up|0|||
23541878|NCT01923181|65713115|FG001|Overall Study|Lost to Follow-up|3|||
23541879|NCT01923181|65713116|FG002|Overall Study|Lost to Follow-up|2|||
23541880|NCT01923181|65713117|FG003|Overall Study|Lost to Follow-up|1|||
23541881|NCT01923181|65713118|FG004|Overall Study|Lost to Follow-up|2|||
23541882|NCT01923181|65713119|FG005|Overall Study|Lost to Follow-up|1|||
23541883|NCT01923181|65713120|FG006|Overall Study|Lost to Follow-up|3|||
23541884|NCT01923181|65713121|FG007|Overall Study|Lost to Follow-up|3|||
23541885|NCT01923181|65713122|FG008|Overall Study|Lost to Follow-up|1|||
23541886|NCT02352493|65713123|FG000|Overall Study|Pregnancy|0|||
23541887|NCT02352493|65713124|FG001|Overall Study|Pregnancy|0|||
23541888|NCT02352493|65713125|FG002|Overall Study|Pregnancy|0|||
23541889|NCT02352493|65713126|FG003|Overall Study|Pregnancy|0|||
23541890|NCT02352493|65713127|FG004|Overall Study|Pregnancy|0|||
23541891|NCT02352493|65713128|FG005|Overall Study|Pregnancy|0|||
23541892|NCT02352493|65713129|FG006|Overall Study|Pregnancy|1|||
23541893|NCT02352493|65713130|FG007|Overall Study|Pregnancy|0|||
23541894|NCT02352493|65713131|FG008|Overall Study|Pregnancy|1|||
23541895|NCT02352493|65713132|FG009|Overall Study|Pregnancy|0|||
23541896|NCT02352493|65713133|FG010|Overall Study|Pregnancy|0|||
23541897|NCT02352493|65713134|FG011|Overall Study|Pregnancy|0|||
23541898|NCT02352493|65713135|FG012|Overall Study|Pregnancy|0|||
23541899|NCT02352493|65713136|FG013|Overall Study|Pregnancy|0|||
23541900|NCT02352493|65713137|FG014|Overall Study|Pregnancy|0|||
23541901|NCT02352493|65713138|FG015|Overall Study|Pregnancy|0|||
23541902|NCT02352493|65713139|FG016|Overall Study|Pregnancy|0|||
23541903|NCT02352493|65713140|FG017|Overall Study|Pregnancy|0|||
23541904|NCT02352493|65713123|FG000|Overall Study|Withdrawal by Subject|0|||
23541905|NCT02352493|65713124|FG001|Overall Study|Withdrawal by Subject|0|||
23616678|NCT00747149|65982404|FG000|Overall Study|Lost to Follow-up|0|||
23541906|NCT02352493|65713125|FG002|Overall Study|Withdrawal by Subject|0|||
23541907|NCT02352493|65713126|FG003|Overall Study|Withdrawal by Subject|0|||
23541908|NCT02352493|65713127|FG004|Overall Study|Withdrawal by Subject|0|||
23541909|NCT02352493|65713128|FG005|Overall Study|Withdrawal by Subject|0|||
23312904|NCT01439009|64889273|FG000|Overall Study|Protocol Violation|2|||
23312905|NCT01439009|64889274|FG001|Overall Study|Protocol Violation|0|||
23312906|NCT01439009|64889273|FG000|Overall Study|Deviation of exclusion criteria|1|||
23312907|NCT01439009|64889274|FG001|Overall Study|Deviation of exclusion criteria|0|||
23312908|NCT04868968|64889275|FG000|Overall Study|Lost to Follow-up|1|||
23312909|NCT01520870|64889278|FG000|Overall Study|Withdrawal by Subject|2|||
23312910|NCT03745313|64889279|FG000|At 30 Days Follow-up|Death|2|||
23312911|NCT03745313|64889279|FG000|At 6 Months Follow-up|Death|1|||
23312912|NCT03745313|64889279|FG000|At 6 Months Follow-up|Missed Visit|1|||
23312913|NCT03745313|64889279|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
23312914|NCT03745313|64889279|FG000|At 1 Year Follow-up|Death|2|||
23312915|NCT03745313|64889279|FG000|At 1 Year Follow-up|Missed Visit|2|||
23312916|NCT03745313|64889279|FG000|At 2 Year Follow-up|Missed Visit|1|||
23312917|NCT03654599|64889280|FG000|Overall Study|Lost to Follow-up|14|||
23312918|NCT03654599|64889281|FG001|Overall Study|Lost to Follow-up|12|||
23312919|NCT03654599|64889280|FG000|Overall Study|Death|8|||
23312920|NCT03654599|64889281|FG001|Overall Study|Death|6|||
23312921|NCT03654599|64889280|FG000|Overall Study|Withdrawal by Subject|6|||
23312922|NCT03654599|64889281|FG001|Overall Study|Withdrawal by Subject|4|||
23312923|NCT01307111|64889282|FG000|IUD Insertion|Lost to Follow-up|2|||
23312924|NCT01307111|64889283|FG001|IUD Insertion|Lost to Follow-up|0|||
23312925|NCT01307111|64889282|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
23312926|NCT01307111|64889283|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
23312927|NCT00253448|64889284|FG000|Overall Study|Withdrawal by Subject|1|||
23312928|NCT03456453|64889285|FG000|Overall Study|Withdrawal by Subject|2|||
23312929|NCT03456453|64889286|FG001|Overall Study|Withdrawal by Subject|0|||
23312930|NCT03456453|64889285|FG000|Overall Study|Not released to community|1|||
23312931|NCT03456453|64889286|FG001|Overall Study|Not released to community|5|||
23312932|NCT03456453|64889285|FG000|Overall Study|Lost to Follow-up|0|||
23312933|NCT03456453|64889286|FG001|Overall Study|Lost to Follow-up|2|||
23312934|NCT04005352|64889290|FG000|Overall Study|Adverse Event|4|||
23312935|NCT04005352|64889291|FG001|Overall Study|Adverse Event|5|||
23312936|NCT04005352|64889290|FG000|Overall Study|Death|4|||
23312937|NCT04005352|64889291|FG001|Overall Study|Death|2|||
23312938|NCT04005352|64889290|FG000|Overall Study|Lost to Follow-up|6|||
23312939|NCT04005352|64889291|FG001|Overall Study|Lost to Follow-up|2|||
23312940|NCT04005352|64889290|FG000|Overall Study|Physician Decision|7|||
23312941|NCT04005352|64889291|FG001|Overall Study|Physician Decision|13|||
23312942|NCT04005352|64889290|FG000|Overall Study|Protocol Violation|0|||
23312943|NCT04005352|64889291|FG001|Overall Study|Protocol Violation|1|||
23424673|NCT02851407|65299719|FG000|Overall Study|Adverse event, serious fatal|6|||
23424674|NCT02851407|65299720|FG001|Overall Study|Adverse event, serious fatal|8|||
23424675|NCT02851407|65299719|FG000|Overall Study|Consent withdrawn by participant|5|||
23424676|NCT02851407|65299720|FG001|Overall Study|Consent withdrawn by participant|3|||
23541910|NCT02352493|65713129|FG006|Overall Study|Withdrawal by Subject|0|||
23312944|NCT04005352|64889290|FG000|Overall Study|Withdrawal by Subject|28|||
23312945|NCT04005352|64889291|FG001|Overall Study|Withdrawal by Subject|38|||
23312946|NCT02278055|64889292|FG000|Overall Study|Adverse Event|1|||
23312947|NCT02278055|64889292|FG000|Overall Study|Lost to Follow-up|1|||
23424677|NCT02851407|65299719|FG000|Overall Study|Screen failure|2|||
23312948|NCT02278055|64889292|FG000|Overall Study|Withdrawal by Subject|2|||
23312949|NCT02278055|64889292|FG000|Overall Study|Progressive Disease|4|||
23312950|NCT05307510|64889301|FG000|Overall Study|Lost to Follow-up|3|||
23541911|NCT02352493|65713130|FG007|Overall Study|Withdrawal by Subject|0|||
23541912|NCT02352493|65713131|FG008|Overall Study|Withdrawal by Subject|1|||
23541913|NCT02352493|65713132|FG009|Overall Study|Withdrawal by Subject|0|||
23541914|NCT02352493|65713133|FG010|Overall Study|Withdrawal by Subject|0|||
23541915|NCT02352493|65713134|FG011|Overall Study|Withdrawal by Subject|0|||
23541916|NCT02352493|65713135|FG012|Overall Study|Withdrawal by Subject|0|||
23541917|NCT02352493|65713136|FG013|Overall Study|Withdrawal by Subject|0|||
23541918|NCT02352493|65713137|FG014|Overall Study|Withdrawal by Subject|1|||
23541919|NCT02352493|65713138|FG015|Overall Study|Withdrawal by Subject|0|||
23541920|NCT02352493|65713139|FG016|Overall Study|Withdrawal by Subject|0|||
23541921|NCT02352493|65713140|FG017|Overall Study|Withdrawal by Subject|0|||
23541922|NCT02352493|65713123|FG000|Overall Study|Lost to Follow-up|0|||
23541923|NCT02352493|65713124|FG001|Overall Study|Lost to Follow-up|0|||
23541924|NCT02352493|65713125|FG002|Overall Study|Lost to Follow-up|0|||
23541925|NCT02352493|65713126|FG003|Overall Study|Lost to Follow-up|0|||
23424678|NCT02851407|65299720|FG001|Overall Study|Screen failure|1|||
23424679|NCT02851407|65299719|FG000|Overall Study|Disease relapse|9|||
23541926|NCT02352493|65713127|FG004|Overall Study|Lost to Follow-up|0|||
23541927|NCT02352493|65713128|FG005|Overall Study|Lost to Follow-up|0|||
23541928|NCT02352493|65713129|FG006|Overall Study|Lost to Follow-up|0|||
23541929|NCT02352493|65713130|FG007|Overall Study|Lost to Follow-up|0|||
23541930|NCT02352493|65713131|FG008|Overall Study|Lost to Follow-up|0|||
23541931|NCT02352493|65713132|FG009|Overall Study|Lost to Follow-up|1|||
23541932|NCT02352493|65713133|FG010|Overall Study|Lost to Follow-up|0|||
23541933|NCT02352493|65713134|FG011|Overall Study|Lost to Follow-up|0|||
23541934|NCT02352493|65713135|FG012|Overall Study|Lost to Follow-up|1|||
23541935|NCT02352493|65713136|FG013|Overall Study|Lost to Follow-up|2|||
23541936|NCT02352493|65713137|FG014|Overall Study|Lost to Follow-up|0|||
23541937|NCT02352493|65713138|FG015|Overall Study|Lost to Follow-up|0|||
23541938|NCT02352493|65713139|FG016|Overall Study|Lost to Follow-up|0|||
23541939|NCT02352493|65713140|FG017|Overall Study|Lost to Follow-up|0|||
23541940|NCT02546544|65715838|FG000|Overall Study|Disease Progression|14|||
23541941|NCT02546544|65715838|FG000|Overall Study|Adverse Event|1|||
23541942|NCT02546544|65715838|FG000|Overall Study|Withdrawal by Subject|1|||
23541943|NCT00782340|65715839|FG000|Open Label Titration|Adverse Event|12|||
23541944|NCT00782340|65715840|FG001|Open Label Titration|Adverse Event|0|||
23541945|NCT00782340|65715841|FG002|Open Label Titration|Adverse Event|0|||
23541946|NCT00782340|65715839|FG000|Open Label Titration|Treatment failure|50|||
23541947|NCT00782340|65715840|FG001|Open Label Titration|Treatment failure|0|||
23541948|NCT00782340|65715841|FG002|Open Label Titration|Treatment failure|0|||
23541949|NCT00782340|65715839|FG000|Open Label Titration|Protocol Violation|5|||
23541950|NCT00782340|65715840|FG001|Open Label Titration|Protocol Violation|0|||
23541951|NCT00782340|65715841|FG002|Open Label Titration|Protocol Violation|0|||
23541952|NCT00782340|65715839|FG000|Open Label Titration|Withdrawal by Subject|5|||
23541953|NCT00782340|65715840|FG001|Open Label Titration|Withdrawal by Subject|0|||
23541954|NCT00782340|65715841|FG002|Open Label Titration|Withdrawal by Subject|0|||
23541955|NCT00782340|65715839|FG000|Open Label Titration|Enrollment capped|16|||
23541956|NCT00782340|65715840|FG001|Open Label Titration|Enrollment capped|0|||
23541957|NCT00782340|65715841|FG002|Open Label Titration|Enrollment capped|0|||
23541958|NCT00782340|65715839|FG000|Open Label Titration|Did not meet responder criteria|2|||
23424680|NCT02851407|65299720|FG001|Overall Study|Disease relapse|6|||
23424681|NCT02851407|65299719|FG000|Overall Study|Physician Decision|7|||
23541959|NCT00782340|65715840|FG001|Open Label Titration|Did not meet responder criteria|0|||
23541960|NCT00782340|65715841|FG002|Open Label Titration|Did not meet responder criteria|0|||
23541961|NCT00782340|65715839|FG000|Open Label Titration|Lost to Follow-up|5|||
23541962|NCT00782340|65715840|FG001|Open Label Titration|Lost to Follow-up|0|||
23541963|NCT00782340|65715841|FG002|Open Label Titration|Lost to Follow-up|0|||
23541964|NCT00782340|65715839|FG000|Open Label Titration|Randomized in error|6|||
23424682|NCT02851407|65299720|FG001|Overall Study|Physician Decision|6|||
23541965|NCT00782340|65715840|FG001|Open Label Titration|Randomized in error|0|||
23541966|NCT00782340|65715841|FG002|Open Label Titration|Randomized in error|0|||
23541967|NCT01153633|65715842|FG000|Overall Study|Protocol Violation|1|||
23541968|NCT01153633|65715843|FG001|Overall Study|Protocol Violation|1|||
23541969|NCT01153633|65715842|FG000|Overall Study|Therapeutic failure|3|||
23541970|NCT01153633|65715843|FG001|Overall Study|Therapeutic failure|3|||
23541971|NCT01181921|65715847|FG000|Overall Study|Lost to Follow-up|1|||
23541972|NCT01226745|65715848|FG000|Overall Study|Did not complete schedule of assessments|8|||
23541973|NCT01226745|65715849|FG001|Overall Study|Did not complete schedule of assessments|3|||
23541974|NCT01226745|65715850|FG002|Overall Study|Did not complete schedule of assessments|6|||
23541975|NCT01226745|65715851|FG003|Overall Study|Did not complete schedule of assessments|0|||
23541976|NCT01226745|65715852|FG004|Overall Study|Did not complete schedule of assessments|0|||
23541977|NCT01226745|65715853|FG005|Overall Study|Did not complete schedule of assessments|1|||
23541978|NCT01226745|65715848|FG000|Overall Study|Lost to Follow-up|2|||
23541979|NCT01226745|65715849|FG001|Overall Study|Lost to Follow-up|6|||
23541980|NCT01226745|65715850|FG002|Overall Study|Lost to Follow-up|6|||
23541981|NCT01226745|65715851|FG003|Overall Study|Lost to Follow-up|1|||
23541982|NCT01226745|65715852|FG004|Overall Study|Lost to Follow-up|1|||
23541983|NCT01226745|65715853|FG005|Overall Study|Lost to Follow-up|2|||
23541984|NCT01226745|65715848|FG000|Overall Study|Death|1|||
23541985|NCT01226745|65715849|FG001|Overall Study|Death|0|||
23541986|NCT01226745|65715850|FG002|Overall Study|Death|0|||
23541987|NCT01226745|65715851|FG003|Overall Study|Death|0|||
23541988|NCT01226745|65715852|FG004|Overall Study|Death|0|||
23541989|NCT01226745|65715853|FG005|Overall Study|Death|1|||
23541990|NCT01226745|65715848|FG000|Overall Study|Other|6|||
23541991|NCT01226745|65715849|FG001|Overall Study|Other|7|||
23541992|NCT01226745|65715850|FG002|Overall Study|Other|8|||
23541993|NCT01226745|65715851|FG003|Overall Study|Other|4|||
23541994|NCT01226745|65715852|FG004|Overall Study|Other|3|||
23541995|NCT01226745|65715853|FG005|Overall Study|Other|1|||
23541996|NCT03376321|65715854|FG000|Overall Study|Other|5|||
23541997|NCT03376321|65715855|FG001|Overall Study|Other|1|||
23541998|NCT03376321|65715854|FG000|Overall Study|Withdrawal by Subject|8|||
23541999|NCT03376321|65715855|FG001|Overall Study|Withdrawal by Subject|14|||
23542000|NCT03376321|65715854|FG000|Overall Study|Lost to Follow-up|1|||
23542001|NCT03376321|65715855|FG001|Overall Study|Lost to Follow-up|7|||
23542002|NCT03376321|65715854|FG000|Overall Study|Death|4|||
23542003|NCT03376321|65715855|FG001|Overall Study|Death|0|||
23542004|NCT03376321|65715854|FG000|Overall Study|Randomized, not treated|5|||
23542005|NCT03376321|65715855|FG001|Overall Study|Randomized, not treated|3|||
23542006|NCT01046110|65715856|FG000|Overall Study|Adverse Event|9|||
23542007|NCT01046110|65715857|FG001|Overall Study|Adverse Event|2|||
23424683|NCT02851407|65299719|FG000|Overall Study|Transferred to hospital closer to home|0|||
23424684|NCT02851407|65299720|FG001|Overall Study|Transferred to hospital closer to home|1|||
23424685|NCT02851407|65299719|FG000|Overall Study|Enrolled in an investigational study|0|||
23424686|NCT02851407|65299720|FG001|Overall Study|Enrolled in an investigational study|1|||
23424687|NCT02851407|65299719|FG000|Overall Study|Early recovery|1|||
23424688|NCT02851407|65299720|FG001|Overall Study|Early recovery|0|||
23424689|NCT02851407|65299719|FG000|Overall Study|Adverse event, non-fatal|7|||
23424690|NCT02851407|65299720|FG001|Overall Study|Adverse event, non-fatal|5|||
23424691|NCT02851407|65299719|FG000|Overall Study|Lost to Follow-up|0|||
23424692|NCT02851407|65299720|FG001|Overall Study|Lost to Follow-up|2|||
23542008|NCT01046110|65715856|FG000|Overall Study|Lack of Efficacy|0|||
23542009|NCT01046110|65715857|FG001|Overall Study|Lack of Efficacy|1|||
23542010|NCT01046110|65715856|FG000|Overall Study|Protocol Violation|7|||
23542011|NCT01046110|65715857|FG001|Overall Study|Protocol Violation|12|||
23542012|NCT01046110|65715856|FG000|Overall Study|Withdrawal Criteria|3|||
23542013|NCT01046110|65715857|FG001|Overall Study|Withdrawal Criteria|5|||
23542014|NCT01046110|65715856|FG000|Overall Study|Unclassified|36|||
23542015|NCT01046110|65715857|FG001|Overall Study|Unclassified|35|||
23542016|NCT02646423|65715858|FG000|Overall Study|Adverse Event|5|||
23616679|NCT00747149|65982405|FG001|Overall Study|Lost to Follow-up|10|||
23312951|NCT05307510|64889302|FG001|Overall Study|Lost to Follow-up|6|||
23312952|NCT05307510|64889301|FG000|Overall Study|Withdrawal by Subject|0|||
23542017|NCT02646423|65715859|FG001|Overall Study|Adverse Event|7|||
23542018|NCT02646423|65715858|FG000|Overall Study|Ineligible|2|||
23542019|NCT02646423|65715859|FG001|Overall Study|Ineligible|1|||
23542020|NCT03811912|65715860|FG000|Overall Study|Withdrew Consent|4|||
23616680|NCT00747149|65982404|FG000|Overall Study|Withdrawal by Subject|0|||
23312953|NCT05307510|64889302|FG001|Overall Study|Withdrawal by Subject|1|||
23542021|NCT03811912|65715861|FG001|Overall Study|Withdrew Consent|2|||
23542022|NCT01073618|65715865|FG000|Overall Study|Death|208|||
23542023|NCT01073618|65715865|FG000|Overall Study|Adverse Event|19|||
23616681|NCT00747149|65982405|FG001|Overall Study|Withdrawal by Subject|6|||
23542024|NCT01073618|65715865|FG000|Overall Study|Other|80|||
23542025|NCT01639001|65715870|FG000|Overall Study|Refused further follow-up|9|||
23542026|NCT01639001|65715871|FG001|Overall Study|Refused further follow-up|12|||
23542027|NCT01639001|65715870|FG000|Overall Study|Lost to Follow-up|3|||
23542028|NCT01639001|65715871|FG001|Overall Study|Lost to Follow-up|0|||
23542029|NCT01639001|65715870|FG000|Overall Study|Death|62|||
23542030|NCT01639001|65715871|FG001|Overall Study|Death|61|||
23542031|NCT01639001|65715870|FG000|Overall Study|Randomized but not treated|0|||
23542032|NCT01639001|65715871|FG001|Overall Study|Randomized but not treated|2|||
23542033|NCT01639001|65715870|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
23542034|NCT01639001|65715871|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
23542035|NCT03295201|65715878|FG000|Overall Study|Lost to Follow-up|1|||
23542036|NCT03295201|65715879|FG001|Overall Study|Lost to Follow-up|1|||
23542037|NCT03295201|65715878|FG000|Overall Study|Hospital admission|0|||
23542038|NCT03295201|65715879|FG001|Overall Study|Hospital admission|1|||
23542039|NCT00389324|65715880|FG000|Run-In Phase|Adverse Event|1|||
23542040|NCT00389324|65715880|FG000|Run-In Phase|Lost to Follow-up|1|||
23542041|NCT00389324|65715880|FG000|Run-In Phase|Withdrawal by Subject|1|||
23542042|NCT00389324|65715880|FG000|Subcutaneous Phase|Adverse Event|2|||
23542043|NCT00389324|65715880|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
23424693|NCT01691014|65299723|FG000|Overall Study|Premature Termination|1|||
23424694|NCT01691014|65299724|FG001|Overall Study|Premature Termination|6|||
23542044|NCT00389324|65715880|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
23542045|NCT00389324|65715880|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
23542046|NCT02553330|65715881|FG000|Overall Study|Study Terminated by Sponsor|2|||
23542047|NCT02553330|65715882|FG001|Overall Study|Study Terminated by Sponsor|13|||
23424695|NCT01691014|65299725|FG002|Overall Study|Premature Termination|0|||
23424696|NCT01691014|65299726|FG003|Overall Study|Premature Termination|3|||
23424697|NCT01691014|65299723|FG000|Overall Study|Other|0|||
23424698|NCT01691014|65299724|FG001|Overall Study|Other|0|||
23424699|NCT01691014|65299725|FG002|Overall Study|Other|2|||
23424700|NCT01691014|65299726|FG003|Overall Study|Other|0|||
23424701|NCT01691014|65299723|FG000|Overall Study|Withdrawal by Subject|0|||
23424702|NCT01691014|65299724|FG001|Overall Study|Withdrawal by Subject|1|||
23424703|NCT01691014|65299725|FG002|Overall Study|Withdrawal by Subject|1|||
23424704|NCT01691014|65299726|FG003|Overall Study|Withdrawal by Subject|1|||
23542048|NCT02553330|65715883|FG002|Overall Study|Study Terminated by Sponsor|12|||
23542049|NCT02553330|65715881|FG000|Overall Study|Withdrawal by Subject|3|||
23542050|NCT02553330|65715882|FG001|Overall Study|Withdrawal by Subject|19|||
23542051|NCT02553330|65715883|FG002|Overall Study|Withdrawal by Subject|21|||
23542052|NCT02553330|65715881|FG000|Overall Study|Other|0|||
23542053|NCT02553330|65715882|FG001|Overall Study|Other|1|||
23542054|NCT02553330|65715883|FG002|Overall Study|Other|0|||
23542055|NCT02553330|65715881|FG000|Overall Study|Non compliance to study treatment|0|||
23542056|NCT02553330|65715882|FG001|Overall Study|Non compliance to study treatment|1|||
23542057|NCT02553330|65715883|FG002|Overall Study|Non compliance to study treatment|0|||
23542058|NCT02553330|65715881|FG000|Overall Study|Adverse Event|0|||
23542059|NCT02553330|65715882|FG001|Overall Study|Adverse Event|1|||
23542060|NCT02553330|65715883|FG002|Overall Study|Adverse Event|0|||
23542061|NCT02553330|65715881|FG000|Overall Study|Lost to Follow-up|0|||
23542062|NCT02553330|65715882|FG001|Overall Study|Lost to Follow-up|4|||
23542063|NCT02553330|65715883|FG002|Overall Study|Lost to Follow-up|4|||
23542064|NCT03701555|65715884|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
23542065|NCT03701555|65715885|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
23210197|NCT01175213|64509108|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
23424705|NCT01691014|65299723|FG000|Overall Study|Adverse Event|0|||
23424706|NCT01691014|65299724|FG001|Overall Study|Adverse Event|5|||
23424707|NCT01691014|65299725|FG002|Overall Study|Adverse Event|1|||
23424708|NCT01691014|65299726|FG003|Overall Study|Adverse Event|1|||
23424709|NCT01691014|65299723|FG000|Overall Study|Lack of Efficacy|2|||
23424710|NCT01691014|65299724|FG001|Overall Study|Lack of Efficacy|3|||
23424711|NCT01691014|65299725|FG002|Overall Study|Lack of Efficacy|7|||
23424712|NCT01691014|65299726|FG003|Overall Study|Lack of Efficacy|0|||
23424713|NCT00554619|65299727|FG000|Overall Study|Adverse Event|1|||
23424714|NCT00554619|65299727|FG000|Overall Study|Physician Decision|1|||
23424715|NCT00554619|65299727|FG000|Overall Study|Liver Function Test Abnormality|1|||
23424716|NCT00953524|65299728|FG000|Overall Study|Adverse Event|2|||
23424717|NCT00953524|65299729|FG001|Overall Study|Adverse Event|0|||
23424718|NCT00953524|65299730|FG002|Overall Study|Adverse Event|1|||
23424719|NCT00953524|65299731|FG003|Overall Study|Adverse Event|2|||
23424720|NCT00953524|65299728|FG000|Overall Study|Protocol Violation|18|||
23542066|NCT03701555|65715886|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
23312954|NCT00908310|64889303|FG000|Overall Study|Death|37|||
23424721|NCT00953524|65299729|FG001|Overall Study|Protocol Violation|10|||
23424722|NCT00953524|65299730|FG002|Overall Study|Protocol Violation|11|||
23424723|NCT00953524|65299731|FG003|Overall Study|Protocol Violation|6|||
23424724|NCT00953524|65299728|FG000|Overall Study|Lost to Follow-up|0|||
23424725|NCT00953524|65299729|FG001|Overall Study|Lost to Follow-up|1|||
23542067|NCT03701555|65715887|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
23542068|NCT03701555|65715888|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
23542069|NCT03701555|65715889|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
23542070|NCT03701555|65715890|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
23542071|NCT03701555|65715891|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
23542072|NCT03701555|65715892|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
23542073|NCT03701555|65715893|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
23542074|NCT03701555|65715894|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
23542075|NCT03701555|65715895|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
23542076|NCT03701555|65715896|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
23542077|NCT03701555|65715897|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
23542078|NCT03701555|65715898|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
23542079|NCT03701555|65715899|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
23542080|NCT03701555|65715900|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
23542081|NCT03701555|65715901|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
23542082|NCT03701555|65715902|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
23542083|NCT03701555|65715903|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
23542084|NCT03701555|65715904|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
23542085|NCT03701555|65715905|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
23542086|NCT03701555|65715906|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
23542087|NCT03701555|65715907|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
23542088|NCT03701555|65715908|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
23542089|NCT03701555|65715909|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
23542090|NCT03701555|65715910|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
23542091|NCT03701555|65715911|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
23542092|NCT03701555|65715912|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
23542093|NCT03701555|65715913|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
23542094|NCT03701555|65715914|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
23542095|NCT03701555|65715915|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
23542096|NCT03701555|65715916|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
23542097|NCT03701555|65715917|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
23542098|NCT03701555|65715918|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
23542099|NCT03701555|65715919|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
23542100|NCT03701555|65715884|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
23542101|NCT03701555|65715885|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
23542102|NCT03701555|65715886|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
23542103|NCT03701555|65715887|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
23542104|NCT03701555|65715888|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
23542105|NCT03701555|65715889|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
23542106|NCT03701555|65715890|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
23542107|NCT03701555|65715891|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
23542108|NCT03701555|65715892|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
23542109|NCT03701555|65715893|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
23542110|NCT03701555|65715894|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
23542111|NCT03701555|65715895|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
23542112|NCT03701555|65715896|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
23542113|NCT03701555|65715897|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
23542114|NCT03701555|65715898|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
23542115|NCT03701555|65715899|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
23542116|NCT03701555|65715900|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
23542117|NCT03701555|65715901|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
23542118|NCT03701555|65715902|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
23542119|NCT03701555|65715903|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
23542120|NCT03701555|65715904|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
23542121|NCT03701555|65715905|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
23542122|NCT03701555|65715906|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
23542123|NCT03701555|65715907|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
23542124|NCT03701555|65715908|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
23542125|NCT03701555|65715909|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
23542126|NCT03701555|65715910|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
23542127|NCT03701555|65715911|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
23542128|NCT03701555|65715912|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
23542129|NCT03701555|65715913|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
23542130|NCT03701555|65715914|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
23542131|NCT03701555|65715915|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
23542132|NCT03701555|65715916|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
23542133|NCT03701555|65715917|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
23542134|NCT03701555|65715918|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
23542135|NCT03701555|65715919|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
23210198|NCT01175213|64509109|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
23210199|NCT01175213|64509108|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
23542136|NCT03701555|65715884|FG000|Part 2 (Day 1)|Other|0|||
23542137|NCT03701555|65715885|FG001|Part 2 (Day 1)|Other|0|||
23542138|NCT03701555|65715886|FG002|Part 2 (Day 1)|Other|0|||
23542139|NCT03701555|65715887|FG003|Part 2 (Day 1)|Other|0|||
23210200|NCT01175213|64509109|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
23542140|NCT03701555|65715888|FG004|Part 2 (Day 1)|Other|0|||
23542141|NCT03701555|65715889|FG005|Part 2 (Day 1)|Other|0|||
23542142|NCT03701555|65715890|FG006|Part 2 (Day 1)|Other|0|||
23312955|NCT00908310|64889303|FG000|Overall Study|Withdrawal by Subject|7|||
23312956|NCT00908310|64889303|FG000|Overall Study|Lost to Follow-up|7|||
23312957|NCT00908310|64889303|FG000|Overall Study|Screening failure|5|||
23312958|NCT00908310|64889303|FG000|Overall Study|Other reasons|4|||
23312959|NCT02315196|64889304|FG000|Overall Study|Withdrew consent|9|||
23312960|NCT02927366|64889305|FG000|Overall Study|Adverse Event|1|||
23312961|NCT02927366|64889306|FG001|Overall Study|Adverse Event|0|||
23312962|NCT02927366|64889305|FG000|Overall Study|Patient schedule|1|||
23312963|NCT02927366|64889306|FG001|Overall Study|Patient schedule|0|||
23312964|NCT03275064|64889309|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
23542143|NCT03701555|65715891|FG007|Part 2 (Day 1)|Other|0|||
23542144|NCT03701555|65715892|FG008|Part 2 (Day 1)|Other|0|||
23542145|NCT03701555|65715893|FG009|Part 2 (Day 1)|Other|0|||
23542146|NCT03701555|65715894|FG010|Part 2 (Day 1)|Other|3|||
23542147|NCT03701555|65715895|FG011|Part 2 (Day 1)|Other|1|||
23542148|NCT03701555|65715896|FG012|Part 2 (Day 1)|Other|0|||
23542149|NCT03701555|65715897|FG013|Part 2 (Day 1)|Other|1|||
23542150|NCT03701555|65715898|FG014|Part 2 (Day 1)|Other|0|||
23542151|NCT03701555|65715899|FG015|Part 2 (Day 1)|Other|2|||
23542152|NCT03701555|65715900|FG016|Part 2 (Day 1)|Other|2|||
23542153|NCT03701555|65715901|FG017|Part 2 (Day 1)|Other|0|||
23542154|NCT03701555|65715902|FG018|Part 2 (Day 1)|Other|0|||
23542155|NCT03701555|65715903|FG019|Part 2 (Day 1)|Other|0|||
23542156|NCT03701555|65715904|FG020|Part 2 (Day 1)|Other|0|||
23542157|NCT03701555|65715905|FG021|Part 2 (Day 1)|Other|0|||
23542158|NCT03701555|65715906|FG022|Part 2 (Day 1)|Other|0|||
23542159|NCT03701555|65715907|FG023|Part 2 (Day 1)|Other|0|||
23542160|NCT03701555|65715908|FG024|Part 2 (Day 1)|Other|0|||
23542161|NCT03701555|65715909|FG025|Part 2 (Day 1)|Other|0|||
23542162|NCT03701555|65715910|FG026|Part 2 (Day 1)|Other|0|||
23542163|NCT03701555|65715911|FG027|Part 2 (Day 1)|Other|0|||
23542164|NCT03701555|65715912|FG028|Part 2 (Day 1)|Other|0|||
23542165|NCT03701555|65715913|FG029|Part 2 (Day 1)|Other|0|||
23542166|NCT03701555|65715914|FG030|Part 2 (Day 1)|Other|0|||
23542167|NCT03701555|65715915|FG031|Part 2 (Day 1)|Other|0|||
23542168|NCT03701555|65715916|FG032|Part 2 (Day 1)|Other|0|||
23542169|NCT03701555|65715917|FG033|Part 2 (Day 1)|Other|0|||
23542170|NCT03701555|65715918|FG034|Part 2 (Day 1)|Other|0|||
23542171|NCT03701555|65715919|FG035|Part 2 (Day 1)|Other|0|||
23542172|NCT03701555|65715884|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
23542173|NCT03701555|65715885|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
23542174|NCT03701555|65715886|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
23542175|NCT03701555|65715887|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
23542176|NCT03701555|65715888|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
23542177|NCT03701555|65715889|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
23542178|NCT03701555|65715890|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
23542179|NCT03701555|65715891|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
23542180|NCT03701555|65715892|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
23542181|NCT03701555|65715893|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
23542182|NCT03701555|65715894|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
23542183|NCT03701555|65715895|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
23542184|NCT03701555|65715896|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
23312965|NCT03275064|64889310|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
23424726|NCT00953524|65299730|FG002|Overall Study|Lost to Follow-up|1|||
23424727|NCT00953524|65299731|FG003|Overall Study|Lost to Follow-up|0|||
23312966|NCT03275064|64889311|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
23542185|NCT03701555|65715897|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
23542186|NCT03701555|65715898|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
23542187|NCT03701555|65715899|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
23542188|NCT03701555|65715900|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
23542189|NCT03701555|65715901|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
23542190|NCT03701555|65715902|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
23542191|NCT03701555|65715903|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
23542192|NCT03701555|65715904|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
23542193|NCT03701555|65715905|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
23542194|NCT03701555|65715906|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
23312967|NCT03275064|64889312|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
23312968|NCT03275064|64889313|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
23312969|NCT03275064|64889309|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
23312970|NCT03275064|64889310|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
23312971|NCT03275064|64889311|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
23312972|NCT03275064|64889312|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
23312973|NCT03275064|64889313|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
23542195|NCT03701555|65715907|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
23542196|NCT03701555|65715908|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
23542197|NCT03701555|65715909|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
23542198|NCT03701555|65715910|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
23542199|NCT03701555|65715911|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
23542200|NCT03701555|65715912|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
23542201|NCT03701555|65715913|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
23542202|NCT03701555|65715914|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
23542203|NCT03701555|65715915|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
23542204|NCT03701555|65715916|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
23542205|NCT03701555|65715917|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
23542206|NCT03701555|65715918|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
23542207|NCT03701555|65715919|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
23542208|NCT03701555|65715884|FG000|Part 3 (Day 1)|Subject Decision|0|||
23542209|NCT03701555|65715885|FG001|Part 3 (Day 1)|Subject Decision|0|||
23542210|NCT03701555|65715886|FG002|Part 3 (Day 1)|Subject Decision|0|||
23542211|NCT03701555|65715887|FG003|Part 3 (Day 1)|Subject Decision|0|||
23542212|NCT03701555|65715888|FG004|Part 3 (Day 1)|Subject Decision|0|||
23542213|NCT03701555|65715889|FG005|Part 3 (Day 1)|Subject Decision|0|||
23542214|NCT03701555|65715890|FG006|Part 3 (Day 1)|Subject Decision|0|||
23542215|NCT03701555|65715891|FG007|Part 3 (Day 1)|Subject Decision|0|||
23542216|NCT03701555|65715892|FG008|Part 3 (Day 1)|Subject Decision|0|||
23542217|NCT03701555|65715893|FG009|Part 3 (Day 1)|Subject Decision|0|||
23542218|NCT03701555|65715894|FG010|Part 3 (Day 1)|Subject Decision|0|||
23542219|NCT03701555|65715895|FG011|Part 3 (Day 1)|Subject Decision|0|||
23542220|NCT03701555|65715896|FG012|Part 3 (Day 1)|Subject Decision|0|||
23542221|NCT03701555|65715897|FG013|Part 3 (Day 1)|Subject Decision|0|||
23542222|NCT03701555|65715898|FG014|Part 3 (Day 1)|Subject Decision|0|||
23542223|NCT03701555|65715899|FG015|Part 3 (Day 1)|Subject Decision|0|||
23542224|NCT03701555|65715900|FG016|Part 3 (Day 1)|Subject Decision|0|||
23542225|NCT03701555|65715901|FG017|Part 3 (Day 1)|Subject Decision|0|||
23542226|NCT03701555|65715902|FG018|Part 3 (Day 1)|Subject Decision|0|||
23542227|NCT03701555|65715903|FG019|Part 3 (Day 1)|Subject Decision|0|||
23542228|NCT03701555|65715904|FG020|Part 3 (Day 1)|Subject Decision|0|||
23542229|NCT03701555|65715905|FG021|Part 3 (Day 1)|Subject Decision|0|||
23542230|NCT03701555|65715906|FG022|Part 3 (Day 1)|Subject Decision|0|||
23542231|NCT03701555|65715907|FG023|Part 3 (Day 1)|Subject Decision|0|||
23542232|NCT03701555|65715908|FG024|Part 3 (Day 1)|Subject Decision|0|||
23542233|NCT03701555|65715909|FG025|Part 3 (Day 1)|Subject Decision|0|||
23542234|NCT03701555|65715910|FG026|Part 3 (Day 1)|Subject Decision|1|||
23542235|NCT03701555|65715911|FG027|Part 3 (Day 1)|Subject Decision|0|||
23542236|NCT03701555|65715912|FG028|Part 3 (Day 1)|Subject Decision|0|||
23542237|NCT03701555|65715913|FG029|Part 3 (Day 1)|Subject Decision|0|||
23542238|NCT03701555|65715914|FG030|Part 3 (Day 1)|Subject Decision|0|||
23542239|NCT03701555|65715915|FG031|Part 3 (Day 1)|Subject Decision|2|||
23542240|NCT03701555|65715916|FG032|Part 3 (Day 1)|Subject Decision|1|||
23542241|NCT03701555|65715917|FG033|Part 3 (Day 1)|Subject Decision|1|||
23542242|NCT03701555|65715918|FG034|Part 3 (Day 1)|Subject Decision|0|||
23542243|NCT03701555|65715919|FG035|Part 3 (Day 1)|Subject Decision|0|||
23542244|NCT03701555|65715884|FG000|Part 3 (Day 1)|Other|0|||
23542245|NCT03701555|65715885|FG001|Part 3 (Day 1)|Other|0|||
23542246|NCT03701555|65715886|FG002|Part 3 (Day 1)|Other|0|||
23542247|NCT03701555|65715887|FG003|Part 3 (Day 1)|Other|0|||
23542248|NCT03701555|65715888|FG004|Part 3 (Day 1)|Other|0|||
23542249|NCT03701555|65715889|FG005|Part 3 (Day 1)|Other|0|||
23542250|NCT03701555|65715890|FG006|Part 3 (Day 1)|Other|0|||
23542251|NCT03701555|65715891|FG007|Part 3 (Day 1)|Other|0|||
23542252|NCT03701555|65715892|FG008|Part 3 (Day 1)|Other|0|||
23542253|NCT03701555|65715893|FG009|Part 3 (Day 1)|Other|0|||
23542254|NCT03701555|65715894|FG010|Part 3 (Day 1)|Other|0|||
23542255|NCT03701555|65715895|FG011|Part 3 (Day 1)|Other|0|||
23542256|NCT03701555|65715896|FG012|Part 3 (Day 1)|Other|0|||
23542257|NCT03701555|65715897|FG013|Part 3 (Day 1)|Other|0|||
23542258|NCT03701555|65715898|FG014|Part 3 (Day 1)|Other|0|||
23542259|NCT03701555|65715899|FG015|Part 3 (Day 1)|Other|0|||
23542260|NCT03701555|65715900|FG016|Part 3 (Day 1)|Other|0|||
23542261|NCT03701555|65715901|FG017|Part 3 (Day 1)|Other|0|||
23542262|NCT03701555|65715902|FG018|Part 3 (Day 1)|Other|0|||
23542263|NCT03701555|65715903|FG019|Part 3 (Day 1)|Other|0|||
23542264|NCT03701555|65715904|FG020|Part 3 (Day 1)|Other|0|||
23542265|NCT03701555|65715905|FG021|Part 3 (Day 1)|Other|0|||
23542266|NCT03701555|65715906|FG022|Part 3 (Day 1)|Other|0|||
23542267|NCT03701555|65715907|FG023|Part 3 (Day 1)|Other|0|||
23542268|NCT03701555|65715908|FG024|Part 3 (Day 1)|Other|1|||
23542269|NCT03701555|65715909|FG025|Part 3 (Day 1)|Other|1|||
23542270|NCT03701555|65715910|FG026|Part 3 (Day 1)|Other|0|||
23312974|NCT03275064|64889309|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
23312975|NCT03275064|64889310|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
23312976|NCT03275064|64889311|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
23312977|NCT03275064|64889312|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
23312978|NCT03275064|64889313|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
23312979|NCT03275064|64889309|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
23312980|NCT03275064|64889310|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
23312981|NCT03275064|64889311|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
23312982|NCT03275064|64889312|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
23312983|NCT03275064|64889313|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
23312984|NCT03275064|64889309|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
23312985|NCT03275064|64889310|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
23312986|NCT03275064|64889311|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
23312987|NCT03275064|64889312|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
23312988|NCT03275064|64889313|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
23312989|NCT01137071|64889314|FG000|Overall Study|Disease Progression|11|||
23312990|NCT01137071|64889314|FG000|Overall Study|Withdrawal by Subject|2|||
23312991|NCT01137071|64889314|FG000|Overall Study|Wrongly Included|1|||
23312992|NCT04386616|64889315|FG000|Overall Study|Death|22|||
23312993|NCT04386616|64889316|FG001|Overall Study|Death|22|||
23424728|NCT00953524|65299728|FG000|Overall Study|Withdrawal by Subject|2|||
23424729|NCT00953524|65299729|FG001|Overall Study|Withdrawal by Subject|4|||
23424730|NCT00953524|65299730|FG002|Overall Study|Withdrawal by Subject|1|||
23424731|NCT00953524|65299731|FG003|Overall Study|Withdrawal by Subject|0|||
23424732|NCT02741570|65299732|FG000|Pre-Treatment Period|Other reasons|0|||
23424733|NCT02741570|65299733|FG001|Pre-Treatment Period|Other reasons|3|||
23424734|NCT02741570|65299732|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
23424735|NCT02741570|65299733|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
23424736|NCT02741570|65299732|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
23424737|NCT02741570|65299733|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
23424738|NCT02741570|65299732|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
23424739|NCT02741570|65299733|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
23424740|NCT02741570|65299732|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
23424741|NCT02741570|65299733|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
23424742|NCT02741570|65299732|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
23424743|NCT02741570|65299733|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
23424744|NCT02741570|65299732|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
23424745|NCT02741570|65299733|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23424746|NCT02741570|65299732|FG000|Pre-Treatment Period|Death|0|||
23424747|NCT02741570|65299733|FG001|Pre-Treatment Period|Death|1|||
23424748|NCT02741570|65299732|FG000|Pre-Treatment Period|Disease progression|0|||
23424749|NCT02741570|65299733|FG001|Pre-Treatment Period|Disease progression|1|||
23542271|NCT03701555|65715911|FG027|Part 3 (Day 1)|Other|0|||
23542272|NCT03701555|65715912|FG028|Part 3 (Day 1)|Other|0|||
23542273|NCT03701555|65715913|FG029|Part 3 (Day 1)|Other|1|||
23542274|NCT03701555|65715914|FG030|Part 3 (Day 1)|Other|1|||
23542275|NCT03701555|65715915|FG031|Part 3 (Day 1)|Other|0|||
23542276|NCT03701555|65715916|FG032|Part 3 (Day 1)|Other|1|||
23542277|NCT03701555|65715917|FG033|Part 3 (Day 1)|Other|1|||
23542278|NCT03701555|65715918|FG034|Part 3 (Day 1)|Other|0|||
23542279|NCT03701555|65715919|FG035|Part 3 (Day 1)|Other|0|||
23542280|NCT00524134|65715924|FG000|Overall Study|Withdrawal by Subject|1|||
23542281|NCT00524134|65715924|FG000|Overall Study|Physician Decision|1|||
23542282|NCT00254982|65715925|FG000|Overall Study|Other|2|||
23312994|NCT04386616|64889317|FG002|Overall Study|Death|21|||
23424750|NCT02741570|65299732|FG000|Treatment Period|Other reasons|47|||
23424751|NCT02741570|65299733|FG001|Treatment Period|Other reasons|12|||
23542283|NCT00254982|65715926|FG001|Overall Study|Other|1|||
23542284|NCT00254982|65715925|FG000|Overall Study|Lack of Efficacy|5|||
23542285|NCT00254982|65715926|FG001|Overall Study|Lack of Efficacy|3|||
23542286|NCT00254982|65715925|FG000|Overall Study|Lost to Follow-up|5|||
23542287|NCT00254982|65715926|FG001|Overall Study|Lost to Follow-up|3|||
23542288|NCT00254982|65715925|FG000|Overall Study|Adverse Event|18|||
23542289|NCT00254982|65715926|FG001|Overall Study|Adverse Event|16|||
23542290|NCT00254982|65715925|FG000|Overall Study|Withdrawal by Subject|1|||
23542291|NCT00254982|65715926|FG001|Overall Study|Withdrawal by Subject|1|||
23542292|NCT00254982|65715925|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
23542293|NCT00254982|65715926|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
23424752|NCT02741570|65299732|FG000|Treatment Period|Poor/non-compliance|0|||
23424753|NCT02741570|65299733|FG001|Treatment Period|Poor/non-compliance|2|||
23424754|NCT02741570|65299732|FG000|Treatment Period|Maximum clinical benefit|4|||
23424755|NCT02741570|65299733|FG001|Treatment Period|Maximum clinical benefit|6|||
23424756|NCT02741570|65299732|FG000|Treatment Period|Lost to Follow-up|1|||
23424757|NCT02741570|65299733|FG001|Treatment Period|Lost to Follow-up|3|||
23424758|NCT02741570|65299732|FG000|Treatment Period|Participant withdrew consent|9|||
23424759|NCT02741570|65299733|FG001|Treatment Period|Participant withdrew consent|13|||
23424760|NCT02741570|65299732|FG000|Treatment Period|Participant request to discontinue treatment|8|||
23424761|NCT02741570|65299733|FG001|Treatment Period|Participant request to discontinue treatment|23|||
23424762|NCT02741570|65299732|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
23424763|NCT02741570|65299733|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
23424764|NCT02741570|65299732|FG000|Treatment Period|Death|9|||
23424765|NCT02741570|65299733|FG001|Treatment Period|Death|7|||
23424766|NCT02741570|65299732|FG000|Treatment Period|Study drug toxicity|55|||
23424767|NCT02741570|65299733|FG001|Treatment Period|Study drug toxicity|47|||
23542294|NCT00254982|65715925|FG000|Overall Study|Protocol deviation|1|||
23542295|NCT00254982|65715926|FG001|Overall Study|Protocol deviation|1|||
23424768|NCT02741570|65299732|FG000|Treatment Period|Disease progression|294|||
23424769|NCT02741570|65299733|FG001|Treatment Period|Disease progression|301|||
23424770|NCT02741570|65299732|FG000|Treatment Period|Administrative reason by sponsor|0|||
23424771|NCT02741570|65299733|FG001|Treatment Period|Administrative reason by sponsor|1|||
23424772|NCT00765882|65299735|FG000|Overall Study|Adverse Event|10|||
23424773|NCT00765882|65299736|FG001|Overall Study|Adverse Event|21|||
23424774|NCT00765882|65299737|FG002|Overall Study|Adverse Event|20|||
23424775|NCT00765882|65299735|FG000|Overall Study|Lack of Efficacy|4|||
23542296|NCT00254982|65715925|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
23542297|NCT00254982|65715926|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
23542298|NCT00254982|65715925|FG000|Overall Study|Malignancy|0|||
23542299|NCT00254982|65715926|FG001|Overall Study|Malignancy|2|||
23542300|NCT00254982|65715925|FG000|Overall Study|Opportunistic infection|1|||
23542301|NCT00254982|65715926|FG001|Overall Study|Opportunistic infection|0|||
23542302|NCT00254982|65715925|FG000|Overall Study|Abnormal liver function tests|2|||
23542303|NCT00254982|65715926|FG001|Overall Study|Abnormal liver function tests|1|||
23542304|NCT02317575|65715927|FG000|Period 1|Difficulty with venous cannulation|0|||
23542305|NCT02317575|65715928|FG001|Period 1|Difficulty with venous cannulation|1|||
23542306|NCT02317575|65715929|FG002|Period 1|Difficulty with venous cannulation|0|||
23542307|NCT02317575|65715930|FG003|Period 1|Difficulty with venous cannulation|0|||
23542308|NCT02317575|65715931|FG004|Period 1|Difficulty with venous cannulation|0|||
23542309|NCT02317575|65715927|FG000|Period 1|Withdrawal by Subject|1|||
23542310|NCT02317575|65715928|FG001|Period 1|Withdrawal by Subject|0|||
23542311|NCT02317575|65715929|FG002|Period 1|Withdrawal by Subject|0|||
23542312|NCT02317575|65715930|FG003|Period 1|Withdrawal by Subject|0|||
23542313|NCT02317575|65715931|FG004|Period 1|Withdrawal by Subject|0|||
23312995|NCT04386616|64889315|FG000|Overall Study|Lost to Follow-up|5|||
23312996|NCT04386616|64889316|FG001|Overall Study|Lost to Follow-up|8|||
23424776|NCT00765882|65299736|FG001|Overall Study|Lack of Efficacy|0|||
23542314|NCT01782131|65715932|FG000|Overall Study|Death|93|||
23542315|NCT01782131|65715933|FG001|Overall Study|Death|96|||
23542316|NCT01782131|65715932|FG000|Overall Study|Lost to Follow-up|1|||
23542317|NCT01782131|65715933|FG001|Overall Study|Lost to Follow-up|3|||
23542318|NCT01782131|65715932|FG000|Overall Study|Withdrawal by Subject|10|||
23542319|NCT01782131|65715933|FG001|Overall Study|Withdrawal by Subject|10|||
23542320|NCT01782131|65715932|FG000|Overall Study|Randomized but not treated|5|||
23424777|NCT00765882|65299737|FG002|Overall Study|Lack of Efficacy|1|||
23424778|NCT00765882|65299735|FG000|Overall Study|Protocol Violation|4|||
23542321|NCT01782131|65715933|FG001|Overall Study|Randomized but not treated|5|||
23542322|NCT01782131|65715932|FG000|Overall Study|Reason not provided|0|||
23542323|NCT01782131|65715933|FG001|Overall Study|Reason not provided|1|||
23542324|NCT02863991|65715934|FG000|Overall Study|Death|0|||
23542325|NCT02863991|65715935|FG001|Overall Study|Death|3|||
23542326|NCT02863991|65715934|FG000|Overall Study|Lack of Efficacy|0|||
23542327|NCT02863991|65715935|FG001|Overall Study|Lack of Efficacy|1|||
23542328|NCT02863991|65715934|FG000|Overall Study|Study Terminated|2|||
23542329|NCT02863991|65715935|FG001|Overall Study|Study Terminated|8|||
23542330|NCT00817089|65715937|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
23542331|NCT00817089|65715938|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
23424779|NCT00765882|65299736|FG001|Overall Study|Protocol Violation|3|||
23424780|NCT00765882|65299737|FG002|Overall Study|Protocol Violation|1|||
23424781|NCT00765882|65299735|FG000|Overall Study|Withdrawal by Subject|2|||
23424782|NCT00765882|65299736|FG001|Overall Study|Withdrawal by Subject|6|||
23424783|NCT00765882|65299737|FG002|Overall Study|Withdrawal by Subject|6|||
23424784|NCT00765882|65299735|FG000|Overall Study|Lost to Follow-up|1|||
23542332|NCT00817089|65715939|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
23542333|NCT00817089|65715940|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
23542334|NCT00817089|65715937|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
23542335|NCT00817089|65715938|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
23542336|NCT00817089|65715939|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
23542337|NCT00817089|65715940|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
23542338|NCT00795600|65715941|FG000|Overall Study|Adverse Event|1|||
23542339|NCT00795600|65715942|FG001|Overall Study|Adverse Event|1|||
23542340|NCT00795600|65715941|FG000|Overall Study|Protocol Violation|1|||
23542341|NCT00795600|65715942|FG001|Overall Study|Protocol Violation|2|||
23542342|NCT00795600|65715941|FG000|Overall Study|Withdrawal by Subject|1|||
23542343|NCT00795600|65715942|FG001|Overall Study|Withdrawal by Subject|0|||
23542344|NCT00795600|65715941|FG000|Overall Study|Unclassified|1|||
23542345|NCT00795600|65715942|FG001|Overall Study|Unclassified|1|||
23542346|NCT03783923|65715943|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
23542347|NCT03783923|65715944|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
23542348|NCT03783923|65715943|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
23542349|NCT03783923|65715944|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
23542350|NCT03783923|65715943|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
23542351|NCT03783923|65715944|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
23542352|NCT03783923|65715943|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
23542353|NCT03783923|65715944|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
23542354|NCT03783923|65715943|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
23542355|NCT03783923|65715944|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
23542356|NCT02866682|65715945|FG000|Overall Study|Death|0|||
23542357|NCT02866682|65715946|FG001|Overall Study|Death|1|||
23542358|NCT02866682|65715945|FG000|Overall Study|Lost to Follow-up|0|||
23424785|NCT00765882|65299736|FG001|Overall Study|Lost to Follow-up|9|||
23542359|NCT02866682|65715946|FG001|Overall Study|Lost to Follow-up|4|||
23542360|NCT02866682|65715945|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
23542361|NCT02866682|65715946|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
23542362|NCT02866682|65715945|FG000|Overall Study|Other|0|||
23542363|NCT02866682|65715946|FG001|Overall Study|Other|1|||
23542364|NCT01808313|65715947|FG000|Overall Study|Adverse Event|5|||
23542365|NCT01808313|65715947|FG000|Overall Study|Protocol Violation|2|||
23542366|NCT01808313|65715947|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23542367|NCT01808313|65715947|FG000|Overall Study|Lost to Follow-up|1|||
23542368|NCT01808313|65715947|FG000|Overall Study|Physician Decision|1|||
23542369|NCT01343082|65715949|FG000|The run-in Period|Not meeting criteria|3|||
23542370|NCT01343082|65715950|FG001|The run-in Period|Not meeting criteria|4|||
23542371|NCT01343082|65715951|FG002|The run-in Period|Not meeting criteria|5|||
23542372|NCT01343082|65715949|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
23542373|NCT01343082|65715950|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
23542374|NCT01343082|65715951|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
23542375|NCT01343082|65715949|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
23424786|NCT00765882|65299737|FG002|Overall Study|Lost to Follow-up|6|||
23542376|NCT01343082|65715950|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
23542377|NCT01343082|65715951|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
23542378|NCT01343082|65715949|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
23424787|NCT00765882|65299735|FG000|Overall Study|Other Reason|3|||
23542379|NCT01343082|65715950|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
23542380|NCT01343082|65715951|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
23542381|NCT01343082|65715949|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
23542382|NCT01343082|65715950|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
23424788|NCT00765882|65299736|FG001|Overall Study|Other Reason|1|||
23424789|NCT00765882|65299737|FG002|Overall Study|Other Reason|2|||
23424790|NCT02075632|65299738|FG000|Overall Study|Adverse Event|1|||
23542383|NCT01343082|65715951|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
23542384|NCT02696850|65715957|FG000|Overall Study|Withdrawal by Subject|3|||
23542385|NCT02696850|65715958|FG001|Overall Study|Withdrawal by Subject|3|||
23312997|NCT04386616|64889317|FG002|Overall Study|Lost to Follow-up|6|||
23312998|NCT04386616|64889315|FG000|Overall Study|Withdrawal by Subject|2|||
23542386|NCT02696850|65715957|FG000|Overall Study|Lost to Follow-up|8|||
23542387|NCT02696850|65715958|FG001|Overall Study|Lost to Follow-up|5|||
23542388|NCT00714168|65715962|FG000|Overall Study|Pregnancy|5|||
23312999|NCT04386616|64889316|FG001|Overall Study|Withdrawal by Subject|4|||
23313000|NCT04386616|64889317|FG002|Overall Study|Withdrawal by Subject|1|||
23313001|NCT04386616|64889315|FG000|Overall Study|Adverse Event|1|||
23313002|NCT04386616|64889316|FG001|Overall Study|Adverse Event|1|||
23313003|NCT04386616|64889317|FG002|Overall Study|Adverse Event|0|||
23542389|NCT00714168|65715963|FG001|Overall Study|Pregnancy|4|||
23542390|NCT00714168|65715962|FG000|Overall Study|Lost to Follow-up|32|||
23542391|NCT00714168|65715963|FG001|Overall Study|Lost to Follow-up|50|||
23542392|NCT00714168|65715962|FG000|Overall Study|Relocation|4|||
23542393|NCT00714168|65715963|FG001|Overall Study|Relocation|3|||
23542394|NCT00714168|65715962|FG000|Overall Study|Non-study medical condition|3|||
23542395|NCT00714168|65715963|FG001|Overall Study|Non-study medical condition|2|||
23542396|NCT00736996|65715964|FG000|Overall Study|Lost to Follow-up|1|||
23542397|NCT00736996|65715965|FG001|Overall Study|Lost to Follow-up|9|||
23542398|NCT00736996|65715966|FG002|Overall Study|Lost to Follow-up|2|||
23542399|NCT01076400|65715969|FG000|Overall Study|Adverse Event|2|||
23542400|NCT01076400|65715970|FG001|Overall Study|Adverse Event|0|||
23542401|NCT01076400|65715971|FG002|Overall Study|Adverse Event|0|||
23542402|NCT01076400|65715969|FG000|Overall Study|Progressive Disease|5|||
23542403|NCT01076400|65715970|FG001|Overall Study|Progressive Disease|0|||
23542404|NCT01076400|65715971|FG002|Overall Study|Progressive Disease|0|||
23542405|NCT02460991|65715974|FG000|Overall Study|Withdrawal by Subject|0|||
23542406|NCT02460991|65715975|FG001|Overall Study|Withdrawal by Subject|2|||
23542407|NCT01748994|65715976|FG000|Overall Study|Lost to Follow-up|8|||
23542408|NCT01748994|65715977|FG001|Overall Study|Lost to Follow-up|6|||
23542409|NCT00360308|65715978|FG000|Overall Study|Adverse Event|15|||
23542410|NCT00360308|65715979|FG001|Overall Study|Adverse Event|14|||
23542411|NCT00360308|65715980|FG002|Overall Study|Adverse Event|25|||
23542412|NCT00360308|65715978|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
23542413|NCT00360308|65715979|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
23542414|NCT00360308|65715980|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
23542415|NCT00360308|65715978|FG000|Overall Study|Protocol Violation|2|||
23542416|NCT00360308|65715979|FG001|Overall Study|Protocol Violation|1|||
23542417|NCT00360308|65715980|FG002|Overall Study|Protocol Violation|2|||
23542418|NCT00360308|65715978|FG000|Overall Study|Withdrawal by Subject|11|||
23542419|NCT00360308|65715979|FG001|Overall Study|Withdrawal by Subject|7|||
23542420|NCT00360308|65715980|FG002|Overall Study|Withdrawal by Subject|14|||
23542421|NCT00360308|65715978|FG000|Overall Study|Lack of Efficacy|3|||
23542422|NCT00360308|65715979|FG001|Overall Study|Lack of Efficacy|0|||
23542423|NCT00360308|65715980|FG002|Overall Study|Lack of Efficacy|2|||
23542424|NCT00360308|65715978|FG000|Overall Study|Other|2|||
23542425|NCT00360308|65715979|FG001|Overall Study|Other|1|||
23542426|NCT00360308|65715980|FG002|Overall Study|Other|1|||
23313004|NCT01982812|64889318|FG000|Overall Study|Death|1|||
23313005|NCT01982812|64889319|FG001|Overall Study|Death|5|||
23313006|NCT01982812|64889318|FG000|Overall Study|Adverse Event|0|||
23313007|NCT01982812|64889319|FG001|Overall Study|Adverse Event|5|||
23313008|NCT03646123|64889320|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
23313009|NCT03646123|64889321|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
23313010|NCT03646123|64889322|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
23313011|NCT03646123|64889320|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
23313012|NCT03646123|64889321|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
23313013|NCT03646123|64889322|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
23313014|NCT03646123|64889320|FG000|Overall Study|Non-compliance to study protocol|1|||
23313015|NCT03646123|64889321|FG001|Overall Study|Non-compliance to study protocol|0|||
23313016|NCT03646123|64889322|FG002|Overall Study|Non-compliance to study protocol|0|||
23424791|NCT02075632|65299739|FG001|Overall Study|Adverse Event|1|||
23542427|NCT00360308|65715978|FG000|Overall Study|Study termination by sponsor|43|||
23313017|NCT03646123|64889320|FG000|Overall Study|Ineligible due to progression during screening|0|||
23542428|NCT00360308|65715979|FG001|Overall Study|Study termination by sponsor|55|||
23542429|NCT00360308|65715980|FG002|Overall Study|Study termination by sponsor|44|||
23542430|NCT02239510|65715983|FG000|Overall Study|Lost to Follow-up|2|||
23542431|NCT02239510|65715984|FG001|Overall Study|Lost to Follow-up|1|||
23542432|NCT00898677|65715994|FG000|Overall Study|Adverse Event|0|||
23542433|NCT00898677|65715995|FG001|Overall Study|Adverse Event|0|||
23542434|NCT00898677|65715996|FG002|Overall Study|Adverse Event|1|||
23542435|NCT00898677|65715997|FG003|Overall Study|Adverse Event|0|||
23542436|NCT00898677|65715994|FG000|Overall Study|Lost to Follow-up|0|||
23313018|NCT03646123|64889321|FG001|Overall Study|Ineligible due to progression during screening|0|||
23313019|NCT03646123|64889322|FG002|Overall Study|Ineligible due to progression during screening|1|||
23313020|NCT03646123|64889320|FG000|Overall Study|Withdrawal by Subject|2|||
23313021|NCT03646123|64889321|FG001|Overall Study|Withdrawal by Subject|1|||
23313022|NCT03646123|64889322|FG002|Overall Study|Withdrawal by Subject|3|||
23313023|NCT03646123|64889320|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
23542437|NCT00898677|65715995|FG001|Overall Study|Lost to Follow-up|0|||
23542438|NCT00898677|65715996|FG002|Overall Study|Lost to Follow-up|2|||
23542439|NCT00898677|65715997|FG003|Overall Study|Lost to Follow-up|0|||
23542440|NCT00898677|65715994|FG000|Overall Study|Protocol Violation|1|||
23542441|NCT00898677|65715995|FG001|Overall Study|Protocol Violation|1|||
23542442|NCT00898677|65715996|FG002|Overall Study|Protocol Violation|2|||
23542443|NCT00898677|65715997|FG003|Overall Study|Protocol Violation|0|||
23542444|NCT00898677|65715994|FG000|Overall Study|Withdrawal by Subject|0|||
23542445|NCT00898677|65715995|FG001|Overall Study|Withdrawal by Subject|0|||
23542446|NCT00898677|65715996|FG002|Overall Study|Withdrawal by Subject|0|||
23542447|NCT00898677|65715997|FG003|Overall Study|Withdrawal by Subject|1|||
23542448|NCT00898677|65715994|FG000|Overall Study|Not Treated: Adverse Event|0|||
23542449|NCT00898677|65715995|FG001|Overall Study|Not Treated: Adverse Event|2|||
23542450|NCT00898677|65715996|FG002|Overall Study|Not Treated: Adverse Event|1|||
23542451|NCT00898677|65715997|FG003|Overall Study|Not Treated: Adverse Event|0|||
23542452|NCT00898677|65715994|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
23542453|NCT00898677|65715995|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
23542454|NCT00898677|65715996|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
23542455|NCT00898677|65715997|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
23542456|NCT00898677|65715994|FG000|Overall Study|Not Treated: Pregnancy|0|||
23542457|NCT00898677|65715995|FG001|Overall Study|Not Treated: Pregnancy|0|||
23542458|NCT00898677|65715996|FG002|Overall Study|Not Treated: Pregnancy|1|||
23542459|NCT00898677|65715997|FG003|Overall Study|Not Treated: Pregnancy|0|||
23542460|NCT00898677|65715994|FG000|Overall Study|Not Treated: Protocol Violation|2|||
23542461|NCT00898677|65715995|FG001|Overall Study|Not Treated: Protocol Violation|0|||
23542462|NCT00898677|65715996|FG002|Overall Study|Not Treated: Protocol Violation|2|||
23542463|NCT00898677|65715997|FG003|Overall Study|Not Treated: Protocol Violation|0|||
23542464|NCT00898677|65715994|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
23542465|NCT00898677|65715995|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
23542466|NCT00898677|65715996|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
23542467|NCT00898677|65715997|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
23542468|NCT00898677|65715994|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
23542469|NCT00898677|65715995|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
23542470|NCT00898677|65715996|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
23542471|NCT00898677|65715997|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
23542472|NCT00898677|65715994|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
23542473|NCT00898677|65715995|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
23542474|NCT00898677|65715996|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
23542475|NCT00898677|65715997|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
23542476|NCT00898677|65715994|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
23542477|NCT00898677|65715995|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
23542478|NCT00898677|65715996|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
23542479|NCT00898677|65715997|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
23542480|NCT00898677|65715994|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
23542481|NCT00898677|65715995|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
23542482|NCT00898677|65715996|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
23542483|NCT00898677|65715997|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
23542484|NCT00898677|65715994|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
23542485|NCT00898677|65715995|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
23542486|NCT00898677|65715996|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
23542487|NCT00898677|65715997|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
23542488|NCT00898677|65715994|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
23542489|NCT00898677|65715995|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
23542490|NCT00898677|65715996|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
23542491|NCT00898677|65715997|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
23542492|NCT02823145|65715998|FG000|Enrollment|Other|1|||
23542493|NCT02823145|65715999|FG001|Enrollment|Other|0|||
23210201|NCT01175213|64509108|FG000|Safety Follow-up|Adverse Event|1|||
23210202|NCT01175213|64509109|FG001|Safety Follow-up|Adverse Event|0|||
23210203|NCT01700985|64509110|FG000|Overall Study|Incarcerated|0|||
23210204|NCT01700985|64509111|FG001|Overall Study|Incarcerated|1|||
23210205|NCT00987623|64509112|FG000|Overall Study|Lost to Follow-up|2|||
23210206|NCT00987623|64509113|FG001|Overall Study|Lost to Follow-up|1|||
23210207|NCT00987623|64509112|FG000|Overall Study|Time/job conflict|2|||
23210208|NCT00987623|64509113|FG001|Overall Study|Time/job conflict|0|||
23210209|NCT00987623|64509112|FG000|Overall Study|Discomfort|1|||
23542494|NCT02823145|65715998|FG000|Treatment|Adverse Event|0|||
23542495|NCT02823145|65715999|FG001|Treatment|Adverse Event|11|||
23542496|NCT02823145|65715998|FG000|Treatment|Death|0|||
23542497|NCT02823145|65715999|FG001|Treatment|Death|3|||
23542498|NCT02823145|65715998|FG000|Treatment|Family Decision|0|||
23542499|NCT02823145|65715999|FG001|Treatment|Family Decision|1|||
23542500|NCT02823145|65715998|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
23542501|NCT02823145|65715999|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
23542502|NCT02823145|65715998|FG000|Treatment|Lack of Efficacy|0|||
23542503|NCT02823145|65715999|FG001|Treatment|Lack of Efficacy|48|||
23542504|NCT02823145|65715998|FG000|Treatment|Non-Compliance With E-Diary|0|||
23542505|NCT02823145|65715999|FG001|Treatment|Non-Compliance With E-Diary|1|||
23542506|NCT02823145|65715998|FG000|Treatment|Physician Decision|0|||
23542507|NCT02823145|65715999|FG001|Treatment|Physician Decision|2|||
23542508|NCT02823145|65715998|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
23542509|NCT02823145|65715999|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
23210210|NCT00987623|64509113|FG001|Overall Study|Discomfort|0|||
23210211|NCT00987623|64509112|FG000|Overall Study|Biomicroscopy|0|||
23210212|NCT00987623|64509113|FG001|Overall Study|Biomicroscopy|1|||
23542510|NCT02823145|65715998|FG000|Treatment|Subject needed to take prohibited medication|0|||
23542511|NCT02823145|65715999|FG001|Treatment|Subject needed to take prohibited medication|1|||
23542512|NCT02823145|65715998|FG000|Treatment|Subject transferred to direct access programme|0|||
23542513|NCT02823145|65715999|FG001|Treatment|Subject transferred to direct access programme|1|||
23542514|NCT02823145|65715998|FG000|Treatment|Switching to commercially available drug|0|||
23542515|NCT02823145|65715999|FG001|Treatment|Switching to commercially available drug|11|||
23542516|NCT02823145|65715998|FG000|Treatment|Transitioned to commercial supply of medication|0|||
23542517|NCT02823145|65715999|FG001|Treatment|Transitioned to commercial supply of medication|1|||
23542518|NCT02823145|65715998|FG000|Treatment|Withdrawal By Caregiver|0|||
23542519|NCT02823145|65715999|FG001|Treatment|Withdrawal By Caregiver|1|||
23542520|NCT02823145|65715998|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
23542521|NCT02823145|65715999|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
23542522|NCT02823145|65715998|FG000|Treatment|Withdrawal by Subject|0|||
23542523|NCT02823145|65715999|FG001|Treatment|Withdrawal by Subject|16|||
23542524|NCT02823145|65715998|FG000|Treatment|Reason unknown|0|||
23542525|NCT02823145|65715999|FG001|Treatment|Reason unknown|1|||
23542526|NCT00432380|65716000|FG000|Overall Study|Migrated/moved from study area|3|||
23542527|NCT00432380|65716001|FG001|Overall Study|Migrated/moved from study area|4|||
23542528|NCT00432380|65716002|FG002|Overall Study|Migrated/moved from study area|1|||
23210213|NCT00987623|64509112|FG000|Overall Study|Influenza|0|||
23210214|NCT00987623|64509113|FG001|Overall Study|Influenza|1|||
23210215|NCT04404010|64509120|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
23210216|NCT04404010|64509121|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
23210217|NCT00756886|64509122|FG000|Overall Study|Lost to Follow-up|1|||
23210218|NCT00756886|64509123|FG001|Overall Study|Lost to Follow-up|0|||
23210219|NCT00756886|64509122|FG000|Overall Study|Adverse Event|0|||
23210220|NCT00756886|64509123|FG001|Overall Study|Adverse Event|3|||
23542529|NCT00432380|65716000|FG000|Overall Study|Adverse Event|1|||
23542530|NCT00432380|65716001|FG001|Overall Study|Adverse Event|0|||
23542531|NCT00432380|65716002|FG002|Overall Study|Adverse Event|0|||
23542532|NCT03912259|65716003|FG000|Overall Study|Adverse Event (AE)|2|||
23542533|NCT03912259|65716004|FG001|Overall Study|Adverse Event (AE)|4|||
23542534|NCT03912259|65716003|FG000|Overall Study|Lack of Efficacy|4|||
23542535|NCT03912259|65716004|FG001|Overall Study|Lack of Efficacy|1|||
23542536|NCT03912259|65716003|FG000|Overall Study|Withdrawal by Subject|11|||
23542537|NCT03912259|65716004|FG001|Overall Study|Withdrawal by Subject|1|||
23542538|NCT03165045|65716007|FG000|Visit 1|No registration after visit 1|9|||
23542539|NCT03165045|65716007|FG000|Visit 1|No treatment documented|10|||
23542540|NCT03165045|65716007|FG000|Visit 1|No visit 1|10|||
23542541|NCT03165045|65716007|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
23542542|NCT03165045|65716007|FG000|Visit 2|No available total CCQ score at all|29|||
23542543|NCT03165045|65716007|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
23542544|NCT00462384|65716008|FG000|Overall Study|Adverse Event|2|||
23542545|NCT00462384|65716008|FG000|Overall Study|Death|2|||
23542546|NCT00462384|65716008|FG000|Overall Study|Withdrawal by Subject|1|||
23542547|NCT00462384|65716008|FG000|Overall Study|Other|4|||
23542548|NCT03095417|65716009|FG000|Overall Study|missed|1|||
23542549|NCT03095417|65716010|FG001|Overall Study|missed|2|||
23542550|NCT03095417|65716011|FG002|Overall Study|missed|0|||
23542551|NCT03095417|65716012|FG003|Overall Study|missed|1|||
23542552|NCT03095417|65716009|FG000|Overall Study|Lost to Follow-up|2|||
23542553|NCT03095417|65716010|FG001|Overall Study|Lost to Follow-up|2|||
23542554|NCT03095417|65716011|FG002|Overall Study|Lost to Follow-up|1|||
23542555|NCT03095417|65716012|FG003|Overall Study|Lost to Follow-up|0|||
23542556|NCT03095417|65716009|FG000|Overall Study|refusal|0|||
23542557|NCT03095417|65716010|FG001|Overall Study|refusal|1|||
23542558|NCT03095417|65716011|FG002|Overall Study|refusal|0|||
23542559|NCT03095417|65716012|FG003|Overall Study|refusal|1|||
23542560|NCT03095417|65716009|FG000|Overall Study|Withdrawal by Subject|8|||
23542561|NCT03095417|65716010|FG001|Overall Study|Withdrawal by Subject|2|||
23542562|NCT03095417|65716011|FG002|Overall Study|Withdrawal by Subject|5|||
23542563|NCT03095417|65716012|FG003|Overall Study|Withdrawal by Subject|4|||
23542564|NCT03095417|65716009|FG000|Overall Study|Physician Decision|1|||
23542565|NCT03095417|65716010|FG001|Overall Study|Physician Decision|2|||
23542566|NCT03095417|65716011|FG002|Overall Study|Physician Decision|2|||
23210221|NCT00756886|64509122|FG000|Overall Study|Lack of Efficacy|1|||
23210222|NCT00756886|64509123|FG001|Overall Study|Lack of Efficacy|0|||
23210223|NCT00756886|64509122|FG000|Overall Study|Ineligible|9|||
23542567|NCT03095417|65716012|FG003|Overall Study|Physician Decision|2|||
23542568|NCT03095417|65716009|FG000|Overall Study|Death|1|||
23542569|NCT03095417|65716010|FG001|Overall Study|Death|2|||
23542570|NCT03095417|65716011|FG002|Overall Study|Death|1|||
23542571|NCT03095417|65716012|FG003|Overall Study|Death|3|||
23542572|NCT00672477|65716014|FG000|Overall Study|Adverse Event|10|||
23210224|NCT00756886|64509123|FG001|Overall Study|Ineligible|4|||
23210225|NCT03115112|64509124|FG000|Overall Study|Adverse Event|5|||
23210226|NCT03115112|64509125|FG001|Overall Study|Adverse Event|1|||
23210227|NCT03115112|64509124|FG000|Overall Study|Withdrawal by Subject|4|||
23210228|NCT03115112|64509125|FG001|Overall Study|Withdrawal by Subject|2|||
23542573|NCT00672477|65716015|FG001|Overall Study|Adverse Event|7|||
23210229|NCT03115112|64509124|FG000|Overall Study|Lost to Follow-up|0|||
23210230|NCT03115112|64509125|FG001|Overall Study|Lost to Follow-up|1|||
23210231|NCT03115112|64509124|FG000|Overall Study|Death|1|||
23210232|NCT03115112|64509125|FG001|Overall Study|Death|0|||
23210233|NCT03115112|64509124|FG000|Overall Study|Pregnancy|1|||
23542574|NCT00672477|65716014|FG000|Overall Study|Death|7|||
23542575|NCT00672477|65716015|FG001|Overall Study|Death|11|||
23210234|NCT03115112|64509125|FG001|Overall Study|Pregnancy|0|||
23210235|NCT03115112|64509124|FG000|Overall Study|Site closure|1|||
23210236|NCT03115112|64509125|FG001|Overall Study|Site closure|1|||
23210237|NCT03521193|64509126|FG000|Overall Study|Withdrawal by Subject|8|||
23542576|NCT00672477|65716014|FG000|Overall Study|Physician Decision|2|||
23542577|NCT00672477|65716015|FG001|Overall Study|Physician Decision|0|||
23542578|NCT00672477|65716014|FG000|Overall Study|Protocol Violation|1|||
23542579|NCT00672477|65716015|FG001|Overall Study|Protocol Violation|1|||
23542580|NCT00672477|65716014|FG000|Overall Study|Withdrawal by Subject|5|||
23542581|NCT00672477|65716015|FG001|Overall Study|Withdrawal by Subject|3|||
23542582|NCT00672477|65716014|FG000|Overall Study|Lack of Efficacy|1|||
23542583|NCT00672477|65716015|FG001|Overall Study|Lack of Efficacy|1|||
23542584|NCT00672477|65716014|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
23210238|NCT03521193|64509127|FG001|Overall Study|Withdrawal by Subject|0|||
23542585|NCT00672477|65716015|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
23542586|NCT01490060|65716016|FG000|Cycle 1|Change of Treatment|0|||
23542587|NCT01490060|65716017|FG001|Cycle 1|Change of Treatment|1|||
23542588|NCT01490060|65716018|FG002|Cycle 1|Change of Treatment|1|||
23542589|NCT01490060|65716019|FG003|Cycle 1|Change of Treatment|1|||
23542590|NCT01490060|65716016|FG000|Cycle 1|Insurance Denied|0|||
23542591|NCT01490060|65716017|FG001|Cycle 1|Insurance Denied|0|||
23542592|NCT01490060|65716018|FG002|Cycle 1|Insurance Denied|2|||
23542593|NCT01490060|65716019|FG003|Cycle 1|Insurance Denied|0|||
23542594|NCT01490060|65716016|FG000|Cycle 1|Withdrawal by Subject|0|||
23542595|NCT01490060|65716017|FG001|Cycle 1|Withdrawal by Subject|0|||
23542596|NCT01490060|65716018|FG002|Cycle 1|Withdrawal by Subject|0|||
23542597|NCT01490060|65716019|FG003|Cycle 1|Withdrawal by Subject|1|||
23542598|NCT01490060|65716016|FG000|Cycle 1|Treatment at Another Facility|0|||
23542599|NCT01490060|65716017|FG001|Cycle 1|Treatment at Another Facility|0|||
23542600|NCT01490060|65716018|FG002|Cycle 1|Treatment at Another Facility|0|||
23424792|NCT02075632|65299738|FG000|Overall Study|Lost to Follow-up|0|||
23542601|NCT01490060|65716019|FG003|Cycle 1|Treatment at Another Facility|1|||
23542602|NCT01490060|65716016|FG000|Cycle 2|Change of Treatment|1|||
23542603|NCT01490060|65716017|FG001|Cycle 2|Change of Treatment|1|||
23210239|NCT03521193|64509126|FG000|Overall Study|non compliant to ASA treatment|8|||
23210240|NCT03521193|64509127|FG001|Overall Study|non compliant to ASA treatment|0|||
23210241|NCT01151540|64509128|FG000|Overall Study|Other|2|||
23210242|NCT01151540|64509128|FG000|Overall Study|Adverse event, non-fatal|4|||
23210243|NCT01151540|64509128|FG000|Overall Study|Withdrawal by Subject|7|||
23210244|NCT01697267|64509134|FG000|Overall Study|Death|3|||
23210245|NCT01697267|64509135|FG001|Overall Study|Death|1|||
23210246|NCT01697267|64509134|FG000|Overall Study|Withdrawal by Subject|5|||
23210247|NCT01697267|64509135|FG001|Overall Study|Withdrawal by Subject|5|||
23210248|NCT01697267|64509134|FG000|Overall Study|Adverse Event|2|||
23210249|NCT01697267|64509135|FG001|Overall Study|Adverse Event|1|||
23210250|NCT01697267|64509134|FG000|Overall Study|Lost to Follow-up|2|||
23424793|NCT02075632|65299739|FG001|Overall Study|Lost to Follow-up|3|||
23542604|NCT01490060|65716018|FG002|Cycle 2|Change of Treatment|0|||
23542605|NCT01490060|65716019|FG003|Cycle 2|Change of Treatment|0|||
23542606|NCT01490060|65716016|FG000|Cycle 2|Non-Compliance|0|||
23542607|NCT01490060|65716017|FG001|Cycle 2|Non-Compliance|0|||
23542608|NCT01490060|65716018|FG002|Cycle 2|Non-Compliance|1|||
23542609|NCT01490060|65716019|FG003|Cycle 2|Non-Compliance|0|||
23542610|NCT01490060|65716016|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
23210251|NCT01697267|64509135|FG001|Overall Study|Lost to Follow-up|4|||
23542611|NCT01490060|65716017|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
23542612|NCT01490060|65716018|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
23542613|NCT01490060|65716019|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
23542614|NCT01205685|65716020|FG000|Overall Study|Disease Progression|10|||
23542615|NCT01205685|65716020|FG000|Overall Study|Withdrawal by Subject|1|||
23542616|NCT00435370|65716024|FG000|Overall Study|Adverse Event|8|||
23542617|NCT00435370|65716025|FG001|Overall Study|Adverse Event|8|||
23542618|NCT00435370|65716024|FG000|Overall Study|Withdrawal by Subject|10|||
23542619|NCT00435370|65716025|FG001|Overall Study|Withdrawal by Subject|10|||
23542620|NCT00435370|65716024|FG000|Overall Study|Antipsychotic medication changed|4|||
23542621|NCT00435370|65716025|FG001|Overall Study|Antipsychotic medication changed|2|||
23542622|NCT01024387|65716026|FG000|Overall Study|Radiographic Progression|29|||
23542623|NCT01024387|65716026|FG000|Overall Study|Symptomatic Progression|10|||
23542624|NCT01024387|65716026|FG000|Overall Study|Physician Decision|5|||
23542625|NCT01024387|65716026|FG000|Overall Study|Withdrawal by Subject|5|||
23542626|NCT01024387|65716026|FG000|Overall Study|Death|2|||
23542627|NCT01024387|65716026|FG000|Overall Study|Prolonged Treatment Delay|1|||
23542628|NCT01024387|65716026|FG000|Overall Study|Adverse Event|3|||
23542629|NCT01024387|65716026|FG000|Overall Study|Other|5|||
23542630|NCT00661492|65716032|FG000|Overall Study|Adverse Event|16|||
23542631|NCT00661492|65716033|FG001|Overall Study|Adverse Event|13|||
23542632|NCT00661492|65716032|FG000|Overall Study|Disease Progression|44|||
23542633|NCT00661492|65716033|FG001|Overall Study|Disease Progression|14|||
23542634|NCT00661492|65716032|FG000|Overall Study|Patient Request|6|||
23616682|NCT00747149|65982404|FG000|Overall Study|Did not receive treatment|0|||
23542635|NCT00661492|65716033|FG001|Overall Study|Patient Request|1|||
23542636|NCT00661492|65716032|FG000|Overall Study|Investigator Request|1|||
23542637|NCT00661492|65716033|FG001|Overall Study|Investigator Request|0|||
23210252|NCT01697267|64509134|FG000|Overall Study|Physician Decision|2|||
23210253|NCT01697267|64509135|FG001|Overall Study|Physician Decision|4|||
23210254|NCT02475850|64509142|FG000|Overall Study|Death|155|||
23542638|NCT00661492|65716032|FG000|Overall Study|Lost to Follow-up|0|||
23542639|NCT00661492|65716033|FG001|Overall Study|Lost to Follow-up|1|||
23542640|NCT00661492|65716032|FG000|Overall Study|Other|1|||
23542641|NCT00661492|65716033|FG001|Overall Study|Other|0|||
23542642|NCT00363766|65716034|FG000|Overall Study|Progressive Disease|15|||
23542643|NCT00363766|65716035|FG001|Overall Study|Progressive Disease|9|||
23542644|NCT00363766|65716034|FG000|Overall Study|Adverse Event|10|||
23542645|NCT00363766|65716035|FG001|Overall Study|Adverse Event|2|||
23542646|NCT00363766|65716034|FG000|Overall Study|Disease Related Death|1|||
23542647|NCT00363766|65716035|FG001|Overall Study|Disease Related Death|3|||
23542648|NCT00363766|65716034|FG000|Overall Study|Not Disease Related Death|3|||
23542649|NCT00363766|65716035|FG001|Overall Study|Not Disease Related Death|4|||
23542650|NCT00363766|65716034|FG000|Overall Study|Withdrawal by Subject|2|||
23542651|NCT00363766|65716035|FG001|Overall Study|Withdrawal by Subject|0|||
23542652|NCT00363766|65716034|FG000|Overall Study|Physician Decision|1|||
23542653|NCT00363766|65716035|FG001|Overall Study|Physician Decision|2|||
23542654|NCT03870763|65716036|FG000|Overall Study|Study terminated by sponsor|0|||
23542655|NCT03870763|65716037|FG001|Overall Study|Study terminated by sponsor|2|||
23542656|NCT03870763|65716038|FG002|Overall Study|Study terminated by sponsor|0|||
23542657|NCT03870763|65716036|FG000|Overall Study|Withdrawal by Subject|0|||
23542658|NCT03870763|65716037|FG001|Overall Study|Withdrawal by Subject|1|||
23542659|NCT03870763|65716038|FG002|Overall Study|Withdrawal by Subject|0|||
23542660|NCT03870763|65716036|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
23542661|NCT03870763|65716037|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
23542662|NCT03870763|65716038|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
23542663|NCT03349710|65716039|FG000|Treatment Period|Death|0|||
23542664|NCT03349710|65716040|FG001|Treatment Period|Death|0|||
23542665|NCT03349710|65716041|FG002|Treatment Period|Death|1|||
23542666|NCT03349710|65716042|FG003|Treatment Period|Death|0|||
23542667|NCT03349710|65716039|FG000|Treatment Period|Disease Progression|0|||
23542668|NCT03349710|65716040|FG001|Treatment Period|Disease Progression|2|||
23542669|NCT03349710|65716041|FG002|Treatment Period|Disease Progression|0|||
23542670|NCT03349710|65716042|FG003|Treatment Period|Disease Progression|1|||
23542671|NCT03349710|65716039|FG000|Treatment Period|Study Drug Toxicity|1|||
23542672|NCT03349710|65716040|FG001|Treatment Period|Study Drug Toxicity|0|||
23542673|NCT03349710|65716041|FG002|Treatment Period|Study Drug Toxicity|1|||
23210255|NCT02475850|64509143|FG001|Overall Study|Death|141|||
23542674|NCT03349710|65716042|FG003|Treatment Period|Study Drug Toxicity|1|||
23542675|NCT03349710|65716039|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
23542676|NCT03349710|65716040|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
23542677|NCT03349710|65716041|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
23210256|NCT02475850|64509142|FG000|Overall Study|Lost to Follow-up|217|||
23210257|NCT02475850|64509143|FG001|Overall Study|Lost to Follow-up|188|||
23542678|NCT03349710|65716042|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
23542679|NCT03349710|65716039|FG000|Treatment Period|admin reason by sponsor|0|||
23542680|NCT03349710|65716040|FG001|Treatment Period|admin reason by sponsor|7|||
23542681|NCT03349710|65716041|FG002|Treatment Period|admin reason by sponsor|0|||
23542682|NCT03349710|65716042|FG003|Treatment Period|admin reason by sponsor|19|||
23542683|NCT03349710|65716039|FG000|Treatment Period|Other Reason|2|||
23542684|NCT03349710|65716040|FG001|Treatment Period|Other Reason|0|||
23542685|NCT03349710|65716041|FG002|Treatment Period|Other Reason|2|||
23542686|NCT03349710|65716042|FG003|Treatment Period|Other Reason|1|||
23542687|NCT03349710|65716039|FG000|Treatment Period|completed|6|||
23542688|NCT03349710|65716040|FG001|Treatment Period|completed|0|||
23542689|NCT03349710|65716041|FG002|Treatment Period|completed|18|||
23542690|NCT03349710|65716042|FG003|Treatment Period|completed|1|||
23542691|NCT03349710|65716039|FG000|Treatment Period|participant request to discontinue|0|||
23542692|NCT03349710|65716040|FG001|Treatment Period|participant request to discontinue|0|||
23542693|NCT03349710|65716041|FG002|Treatment Period|participant request to discontinue|4|||
23542694|NCT03349710|65716042|FG003|Treatment Period|participant request to discontinue|0|||
23542695|NCT03349710|65716039|FG000|Treatment Period|participant withdrew consent|1|||
23542696|NCT03349710|65716040|FG001|Treatment Period|participant withdrew consent|0|||
23542697|NCT03349710|65716041|FG002|Treatment Period|participant withdrew consent|0|||
23542698|NCT03349710|65716042|FG003|Treatment Period|participant withdrew consent|0|||
23542699|NCT02162810|65716054|FG000|Overall Study|Protocol Violation|1|||
23542700|NCT02162810|65716055|FG001|Overall Study|Protocol Violation|0|||
23542701|NCT02162810|65716054|FG000|Overall Study|patients did not report compliance|4|||
23542702|NCT02162810|65716055|FG001|Overall Study|patients did not report compliance|1|||
23542703|NCT02013765|65716057|FG000|Overall Study|Trial was terminated by sponsor|1|||
23542704|NCT02138214|65716058|FG000|Overall Study|Withdrawal by Subject|0|||
23542705|NCT02138214|65716059|FG001|Overall Study|Withdrawal by Subject|1|||
23542706|NCT02138214|65716060|FG002|Overall Study|Withdrawal by Subject|0|||
23542707|NCT02138214|65716058|FG000|Overall Study|Lost to Follow-up|0|||
23542708|NCT02138214|65716059|FG001|Overall Study|Lost to Follow-up|2|||
23542709|NCT02138214|65716060|FG002|Overall Study|Lost to Follow-up|4|||
23542710|NCT02138214|65716058|FG000|Overall Study|Screen Failure|0|||
23542711|NCT02138214|65716059|FG001|Overall Study|Screen Failure|1|||
23542712|NCT02138214|65716060|FG002|Overall Study|Screen Failure|0|||
23542713|NCT03738865|65716062|FG000|Overall Study|Withdrawal by Subject|3|||
23542714|NCT03738865|65716063|FG001|Overall Study|Withdrawal by Subject|3|||
23542715|NCT03738865|65716062|FG000|Overall Study|Adverse Event|2|||
23542716|NCT03738865|65716063|FG001|Overall Study|Adverse Event|0|||
23542717|NCT03738865|65716062|FG000|Overall Study|Physician Decision|0|||
23542718|NCT03738865|65716063|FG001|Overall Study|Physician Decision|1|||
23210258|NCT02475850|64509142|FG000|Overall Study|Withdrawal by Subject|221|||
23210259|NCT02475850|64509143|FG001|Overall Study|Withdrawal by Subject|155|||
23210260|NCT02561299|64509144|FG000|Overall Study|Death|2|||
23210261|NCT02561299|64509145|FG001|Overall Study|Death|4|||
23313024|NCT03646123|64889321|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
23313025|NCT03646123|64889322|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
23313026|NCT03646123|64889320|FG000|Overall Study|Death|2|||
23313027|NCT03646123|64889321|FG001|Overall Study|Death|1|||
23313028|NCT03646123|64889322|FG002|Overall Study|Death|1|||
23313029|NCT03646123|64889320|FG000|Overall Study|Lost to Follow-up|4|||
23313030|NCT03646123|64889321|FG001|Overall Study|Lost to Follow-up|7|||
23210262|NCT02561299|64509144|FG000|Overall Study|Lost to Follow-up|1|||
23210263|NCT02561299|64509145|FG001|Overall Study|Lost to Follow-up|0|||
23210264|NCT02561299|64509144|FG000|Overall Study|Withdrawal by Subject|2|||
23210265|NCT02561299|64509145|FG001|Overall Study|Withdrawal by Subject|2|||
23542719|NCT00581945|65716072|FG000|Overall Study|Adverse Event|4|||
23542720|NCT00581945|65716073|FG001|Overall Study|Adverse Event|4|||
23542721|NCT00581945|65716072|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23542722|NCT00581945|65716073|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23542723|NCT00581945|65716072|FG000|Overall Study|Withdrawal by Subject|2|||
23542724|NCT00581945|65716073|FG001|Overall Study|Withdrawal by Subject|6|||
23210266|NCT03428997|64509150|FG000|Overall Study|Sponsor decision.|1|||
23313031|NCT03646123|64889322|FG002|Overall Study|Lost to Follow-up|6|||
23313032|NCT03646123|64889320|FG000|Overall Study|Participants in long term follow-up|0|||
23313033|NCT03646123|64889321|FG001|Overall Study|Participants in long term follow-up|48|||
23313034|NCT03646123|64889322|FG002|Overall Study|Participants in long term follow-up|144|||
23313035|NCT01866098|64889323|FG000|Overall Study|Lost to Follow-up|11|||
23313036|NCT01866098|64889324|FG001|Overall Study|Lost to Follow-up|18|||
23313037|NCT01866098|64889325|FG002|Overall Study|Lost to Follow-up|13|||
23313038|NCT01866098|64889323|FG000|Overall Study|Physician Decision|0|||
23313039|NCT01866098|64889324|FG001|Overall Study|Physician Decision|1|||
23313040|NCT01866098|64889325|FG002|Overall Study|Physician Decision|2|||
23313041|NCT01866098|64889323|FG000|Overall Study|Adverse Event|1|||
23313042|NCT01866098|64889324|FG001|Overall Study|Adverse Event|5|||
23313043|NCT01866098|64889325|FG002|Overall Study|Adverse Event|4|||
23313044|NCT01866098|64889323|FG000|Overall Study|Protocol Violation|1|||
23313045|NCT01866098|64889324|FG001|Overall Study|Protocol Violation|0|||
23313046|NCT01866098|64889325|FG002|Overall Study|Protocol Violation|0|||
23313047|NCT01866098|64889323|FG000|Overall Study|Withdrawal by Subject|1|||
23313048|NCT01866098|64889324|FG001|Overall Study|Withdrawal by Subject|2|||
23313049|NCT01866098|64889325|FG002|Overall Study|Withdrawal by Subject|0|||
23313050|NCT01866098|64889323|FG000|Overall Study|Unrelated Hospitalization|2|||
23313051|NCT01866098|64889324|FG001|Overall Study|Unrelated Hospitalization|0|||
23313052|NCT01866098|64889325|FG002|Overall Study|Unrelated Hospitalization|1|||
23313053|NCT01866098|64889323|FG000|Overall Study|Non-compliance|1|||
23313054|NCT01866098|64889324|FG001|Overall Study|Non-compliance|0|||
23313055|NCT01866098|64889325|FG002|Overall Study|Non-compliance|1|||
23313056|NCT01866098|64889323|FG000|Overall Study|Pregnancy|2|||
23313057|NCT01866098|64889324|FG001|Overall Study|Pregnancy|0|||
23313058|NCT01866098|64889325|FG002|Overall Study|Pregnancy|0|||
23313059|NCT01866098|64889323|FG000|Overall Study|Death|0|||
23313060|NCT01866098|64889324|FG001|Overall Study|Death|1|||
23313061|NCT01866098|64889325|FG002|Overall Study|Death|0|||
23313062|NCT00086281|64889329|FG000|Phase 1|Adverse Event|0|||
23313063|NCT00086281|64889330|FG001|Phase 1|Adverse Event|0|||
23313064|NCT00086281|64889331|FG002|Phase 1|Adverse Event|0|||
23313065|NCT00086281|64889332|FG003|Phase 1|Adverse Event|0|||
23313066|NCT00086281|64889333|FG004|Phase 1|Adverse Event|0|||
23313067|NCT00086281|64889334|FG005|Phase 1|Adverse Event|0|||
23313068|NCT00086281|64889335|FG006|Phase 1|Adverse Event|0|||
23313069|NCT00086281|64889336|FG007|Phase 1|Adverse Event|0|||
23313070|NCT00086281|64889337|FG008|Phase 1|Adverse Event|0|||
23313071|NCT00086281|64889338|FG009|Phase 1|Adverse Event|1|||
23313072|NCT00086281|64889339|FG010|Phase 1|Adverse Event|2|||
23313073|NCT00086281|64889340|FG011|Phase 1|Adverse Event|1|||
23313074|NCT00086281|64889341|FG012|Phase 1|Adverse Event|1|||
23313075|NCT00086281|64889342|FG013|Phase 1|Adverse Event|1|||
23313076|NCT00086281|64889343|FG014|Phase 1|Adverse Event|2|||
23313077|NCT00086281|64889329|FG000|Phase 1|Protocol Violation|0|||
23313078|NCT00086281|64889330|FG001|Phase 1|Protocol Violation|0|||
23313079|NCT00086281|64889331|FG002|Phase 1|Protocol Violation|0|||
23313080|NCT00086281|64889332|FG003|Phase 1|Protocol Violation|0|||
23313081|NCT00086281|64889333|FG004|Phase 1|Protocol Violation|0|||
23313082|NCT00086281|64889334|FG005|Phase 1|Protocol Violation|0|||
23313083|NCT00086281|64889335|FG006|Phase 1|Protocol Violation|0|||
23313084|NCT00086281|64889336|FG007|Phase 1|Protocol Violation|0|||
23313085|NCT00086281|64889337|FG008|Phase 1|Protocol Violation|0|||
23313086|NCT00086281|64889338|FG009|Phase 1|Protocol Violation|0|||
23313087|NCT00086281|64889339|FG010|Phase 1|Protocol Violation|1|||
23313088|NCT00086281|64889340|FG011|Phase 1|Protocol Violation|0|||
23313089|NCT00086281|64889341|FG012|Phase 1|Protocol Violation|0|||
23313090|NCT00086281|64889342|FG013|Phase 1|Protocol Violation|0|||
23313091|NCT00086281|64889343|FG014|Phase 1|Protocol Violation|0|||
23313092|NCT00086281|64889329|FG000|Phase 1|Serious Adverse Event|0|||
23424794|NCT02075632|65299738|FG000|Overall Study|Withdrawal by Subject|0|||
23542725|NCT00581945|65716072|FG000|Overall Study|Death|1|||
23542726|NCT00581945|65716073|FG001|Overall Study|Death|0|||
23542727|NCT01344460|65716074|FG000|Overall Study|Withdrawal by Subject|1|||
23542728|NCT01344460|65716074|FG000|Overall Study|Lost to Follow-up|2|||
23313093|NCT00086281|64889330|FG001|Phase 1|Serious Adverse Event|0|||
23313094|NCT00086281|64889331|FG002|Phase 1|Serious Adverse Event|0|||
23313095|NCT00086281|64889332|FG003|Phase 1|Serious Adverse Event|0|||
23313096|NCT00086281|64889333|FG004|Phase 1|Serious Adverse Event|0|||
23313097|NCT00086281|64889334|FG005|Phase 1|Serious Adverse Event|0|||
23313098|NCT00086281|64889335|FG006|Phase 1|Serious Adverse Event|0|||
23313099|NCT00086281|64889336|FG007|Phase 1|Serious Adverse Event|0|||
23313100|NCT00086281|64889337|FG008|Phase 1|Serious Adverse Event|0|||
23313101|NCT00086281|64889338|FG009|Phase 1|Serious Adverse Event|0|||
23313102|NCT00086281|64889339|FG010|Phase 1|Serious Adverse Event|0|||
23313103|NCT00086281|64889340|FG011|Phase 1|Serious Adverse Event|0|||
23313104|NCT00086281|64889341|FG012|Phase 1|Serious Adverse Event|0|||
23313105|NCT00086281|64889342|FG013|Phase 1|Serious Adverse Event|0|||
23313106|NCT00086281|64889343|FG014|Phase 1|Serious Adverse Event|1|||
23313107|NCT00086281|64889329|FG000|Phase 2|Adverse Event|0|||
23313108|NCT00086281|64889330|FG001|Phase 2|Adverse Event|0|||
23313109|NCT00086281|64889331|FG002|Phase 2|Adverse Event|0|||
23313110|NCT00086281|64889332|FG003|Phase 2|Adverse Event|0|||
23313111|NCT00086281|64889333|FG004|Phase 2|Adverse Event|0|||
23313112|NCT00086281|64889334|FG005|Phase 2|Adverse Event|0|||
23313113|NCT00086281|64889335|FG006|Phase 2|Adverse Event|0|||
23313114|NCT00086281|64889336|FG007|Phase 2|Adverse Event|0|||
23313115|NCT00086281|64889337|FG008|Phase 2|Adverse Event|0|||
23313116|NCT00086281|64889338|FG009|Phase 2|Adverse Event|0|||
23313117|NCT00086281|64889339|FG010|Phase 2|Adverse Event|0|||
23313118|NCT00086281|64889340|FG011|Phase 2|Adverse Event|0|||
23313119|NCT00086281|64889341|FG012|Phase 2|Adverse Event|1|||
23313120|NCT00086281|64889342|FG013|Phase 2|Adverse Event|1|||
23313121|NCT00086281|64889343|FG014|Phase 2|Adverse Event|0|||
23313122|NCT04380961|64889344|FG000|Overall Study|Lost to Follow-up|17|||
23313123|NCT04380961|64889345|FG001|Overall Study|Lost to Follow-up|11|||
23313124|NCT04380961|64889344|FG000|Overall Study|Withdrawal by Subject|3|||
23313125|NCT04380961|64889345|FG001|Overall Study|Withdrawal by Subject|0|||
23313126|NCT04380961|64889344|FG000|Overall Study|Death|22|||
23313127|NCT04380961|64889345|FG001|Overall Study|Death|16|||
23313128|NCT04380961|64889344|FG000|Overall Study|Other|1|||
23313129|NCT04380961|64889345|FG001|Overall Study|Other|0|||
23313130|NCT04380961|64889344|FG000|Overall Study|Randomized but Not Treated|1|||
23313131|NCT04380961|64889345|FG001|Overall Study|Randomized but Not Treated|2|||
23313132|NCT01104779|64889347|FG000|Overall Study|Protocol Violation|1|||
23313133|NCT01104779|64889348|FG001|Overall Study|Protocol Violation|2|||
23313134|NCT01104779|64889349|FG002|Overall Study|Protocol Violation|2|||
23313135|NCT01104779|64889347|FG000|Overall Study|Lack of Efficacy|26|||
23313136|NCT01104779|64889348|FG001|Overall Study|Lack of Efficacy|12|||
23313137|NCT01104779|64889349|FG002|Overall Study|Lack of Efficacy|13|||
23313138|NCT01104779|64889347|FG000|Overall Study|Adverse Event|13|||
23313139|NCT01104779|64889348|FG001|Overall Study|Adverse Event|14|||
23313140|NCT01104779|64889349|FG002|Overall Study|Adverse Event|13|||
23313141|NCT01104779|64889347|FG000|Overall Study|Did not meet inc/exc criteria|1|||
23313142|NCT01104779|64889348|FG001|Overall Study|Did not meet inc/exc criteria|1|||
23313143|NCT01104779|64889349|FG002|Overall Study|Did not meet inc/exc criteria|1|||
23313144|NCT01104779|64889347|FG000|Overall Study|Other reasons|0|||
23313145|NCT01104779|64889348|FG001|Overall Study|Other reasons|1|||
23313146|NCT01104779|64889349|FG002|Overall Study|Other reasons|0|||
23313147|NCT01104779|64889347|FG000|Overall Study|Lost to Follow-up|2|||
23313148|NCT01104779|64889348|FG001|Overall Study|Lost to Follow-up|0|||
23313149|NCT01104779|64889349|FG002|Overall Study|Lost to Follow-up|1|||
23313150|NCT01104779|64889347|FG000|Overall Study|Withdrawal by Subject|16|||
23313151|NCT01104779|64889348|FG001|Overall Study|Withdrawal by Subject|25|||
23313152|NCT01104779|64889349|FG002|Overall Study|Withdrawal by Subject|32|||
23313153|NCT01884337|64889354|FG000|Treatment|Adverse Event|2|||
23313154|NCT01884337|64889355|FG001|Treatment|Adverse Event|2|||
23313155|NCT01884337|64889354|FG000|Treatment|Subj. request to discont. treatment|2|||
23542729|NCT00655980|65716075|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
23542730|NCT00655980|65716076|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
23542731|NCT00655980|65716077|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
23542732|NCT01197950|65716080|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
23542733|NCT01197950|65716081|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
23582202|NCT02892409|65862381|FG001|Overall Study|Withdrawal by Subject|1|||
23313156|NCT01884337|64889355|FG001|Treatment|Subj. request to discont. treatment|0|||
23313157|NCT01884337|64889354|FG000|Follow-up Period|Lost to Follow-up|1|||
23313158|NCT01884337|64889355|FG001|Follow-up Period|Lost to Follow-up|1|||
23313159|NCT00879411|64889356|FG000|Overall Study|lost to follow-up (non-AE)|162|||
23313160|NCT02648932|64889360|FG000|Overall Study|No transplant|3|||
23313161|NCT02648932|64889361|FG001|Overall Study|No transplant|1|||
23313162|NCT01422187|64889362|FG000|Overall Study|Personal reason|1|||
23313163|NCT01422187|64889363|FG001|Overall Study|Personal reason|0|||
23313164|NCT01422187|64889364|FG002|Overall Study|Personal reason|0|||
23313165|NCT01422187|64889362|FG000|Overall Study|Lost to Follow-up|0|||
23313166|NCT01422187|64889363|FG001|Overall Study|Lost to Follow-up|1|||
23313167|NCT01422187|64889364|FG002|Overall Study|Lost to Follow-up|0|||
23313168|NCT00789737|64889374|FG000|Overall Study|Withdrawal by Subject|13|||
23313169|NCT00789737|64889375|FG001|Overall Study|Withdrawal by Subject|22|||
23313170|NCT00789737|64889374|FG000|Overall Study|Lost to Follow-up|10|||
23313171|NCT00789737|64889375|FG001|Overall Study|Lost to Follow-up|14|||
23313172|NCT00789737|64889374|FG000|Overall Study|Adverse Event|8|||
23313173|NCT00789737|64889375|FG001|Overall Study|Adverse Event|8|||
23313174|NCT00789737|64889374|FG000|Overall Study|Protocol Violation|3|||
23313175|NCT00789737|64889375|FG001|Overall Study|Protocol Violation|0|||
23313176|NCT00789737|64889374|FG000|Overall Study|Lack of Efficacy|3|||
23313177|NCT00789737|64889375|FG001|Overall Study|Lack of Efficacy|0|||
23313178|NCT00789737|64889374|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
23313179|NCT00789737|64889375|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
23313180|NCT00789737|64889374|FG000|Overall Study|Other|11|||
23542734|NCT01197950|65716082|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
23542735|NCT02194621|65716090|FG000|Overall Study|6 withdrew prior to randomization|2|||
23542736|NCT02194621|65716091|FG001|Overall Study|6 withdrew prior to randomization|2|||
23542737|NCT02194621|65716092|FG002|Overall Study|6 withdrew prior to randomization|2|||
23542738|NCT02194621|65716090|FG000|Overall Study|Withdrawal by Subject|4|||
23542739|NCT02194621|65716091|FG001|Overall Study|Withdrawal by Subject|4|||
23542740|NCT02194621|65716092|FG002|Overall Study|Withdrawal by Subject|7|||
23542741|NCT04000165|65716097|FG000|Overall Study|Physician Decision|1|||
23313181|NCT00789737|64889375|FG001|Overall Study|Other|7|||
23313182|NCT03694327|64889376|FG000|Overall Study|Lost to Follow-up|13|||
23313183|NCT03694327|64889377|FG001|Overall Study|Lost to Follow-up|23|||
23313184|NCT04480710|64889378|FG000|Overall Study|Adverse Event|0|||
23313185|NCT04480710|64889379|FG001|Overall Study|Adverse Event|2|||
23313186|NCT04480710|64889380|FG002|Overall Study|Adverse Event|0|||
23210267|NCT03428997|64509150|FG000|Overall Study|Withdrawal by Subject|3|||
23313187|NCT04480710|64889381|FG003|Overall Study|Adverse Event|0|||
23542742|NCT04000165|65716097|FG000|Overall Study|Withdrawal by Subject|1|||
23313188|NCT04480710|64889378|FG000|Overall Study|Withdrawal by Subject|0|||
23313189|NCT04480710|64889379|FG001|Overall Study|Withdrawal by Subject|1|||
23313190|NCT04480710|64889380|FG002|Overall Study|Withdrawal by Subject|0|||
23542743|NCT03579459|65716100|FG000|Overall Study|Adverse Event|7|||
23313191|NCT04480710|64889381|FG003|Overall Study|Withdrawal by Subject|0|||
23542744|NCT03579459|65716101|FG001|Overall Study|Adverse Event|6|||
23424795|NCT02075632|65299739|FG001|Overall Study|Withdrawal by Subject|1|||
23210268|NCT03428997|64509150|FG000|Overall Study|Lost to Follow-up|4|||
23210269|NCT02921763|64509154|FG000|Overall Study|Adverse Event|4|||
23210270|NCT02921763|64509154|FG000|Overall Study|Lost to Follow-up|4|||
23210271|NCT02921763|64509154|FG000|Overall Study|Lack of Efficacy|3|||
23210272|NCT02921763|64509154|FG000|Overall Study|Protocol Violation|2|||
23210273|NCT02921763|64509154|FG000|Overall Study|Withdrawal by Subject|2|||
23210274|NCT02921763|64509154|FG000|Overall Study|Physician Decision|1|||
23210275|NCT02921763|64509154|FG000|Overall Study|No data obtained|2|||
23210276|NCT04111107|64509159|FG000|Overall Study|Withdrawal by Subject|6|||
23210277|NCT04111107|64509159|FG000|Overall Study|Declining Health|5|||
23210278|NCT01681576|64509160|FG000|Period 1|Adverse Event|1|||
23210279|NCT01681576|64509161|FG001|Period 1|Adverse Event|0|||
23210280|NCT01681576|64509160|FG000|Period 1|Protocol Deviation|1|||
23210281|NCT01681576|64509161|FG001|Period 1|Protocol Deviation|0|||
23210282|NCT01681576|64509160|FG000|Period 2|subject/guardian decision|3|||
23210283|NCT01681576|64509161|FG001|Period 2|subject/guardian decision|1|||
23210284|NCT01681576|64509160|FG000|Period 2|Non-compliance with study treatment|1|||
23210285|NCT01681576|64509161|FG001|Period 2|Non-compliance with study treatment|0|||
23210286|NCT02802878|64509162|FG000|Overall Study|Withdrawal by Subject|3|||
23210287|NCT02802878|64509163|FG001|Overall Study|Withdrawal by Subject|3|||
23210288|NCT02802878|64509162|FG000|Overall Study|Protocol Violation|1|||
23210289|NCT02802878|64509163|FG001|Overall Study|Protocol Violation|0|||
23210290|NCT02338492|64509167|FG000|Overall Study|Death|32|||
23210291|NCT02338492|64509167|FG000|Overall Study|Adverse Event|3|||
23210292|NCT02338492|64509167|FG000|Overall Study|Lost to Follow-up|4|||
23210293|NCT02338492|64509167|FG000|Overall Study|Reason not captured above|6|||
23210294|NCT01164865|64509168|FG000|Overall Study|Lost to Follow-up|2|||
23210295|NCT01164865|64509169|FG001|Overall Study|Lost to Follow-up|1|||
23210296|NCT01230749|64509170|FG000|Overall Study|Adverse Event|0|||
23210297|NCT01230749|64509171|FG001|Overall Study|Adverse Event|0|||
23210298|NCT01230749|64509172|FG002|Overall Study|Adverse Event|0|||
23210299|NCT01230749|64509173|FG003|Overall Study|Adverse Event|1|||
23210300|NCT01230749|64509170|FG000|Overall Study|Physician Decision|0|||
23210301|NCT01230749|64509171|FG001|Overall Study|Physician Decision|0|||
23210302|NCT01230749|64509172|FG002|Overall Study|Physician Decision|1|||
23210303|NCT01230749|64509173|FG003|Overall Study|Physician Decision|0|||
23210304|NCT01230749|64509170|FG000|Overall Study|Withdrawal by Subject|0|||
23210305|NCT01230749|64509171|FG001|Overall Study|Withdrawal by Subject|1|||
23210306|NCT01230749|64509172|FG002|Overall Study|Withdrawal by Subject|0|||
23210307|NCT01230749|64509173|FG003|Overall Study|Withdrawal by Subject|0|||
23210308|NCT01230749|64509170|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
23210309|NCT01230749|64509171|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
23210310|NCT01230749|64509172|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
23210311|NCT01230749|64509173|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
23210312|NCT03655717|64509178|FG000|Overall Study|Withdrawal by Subject|4|||
23210313|NCT03655717|64509179|FG001|Overall Study|Withdrawal by Subject|8|||
23210314|NCT03655717|64509180|FG002|Overall Study|Withdrawal by Subject|1|||
23210315|NCT03655717|64509181|FG003|Overall Study|Withdrawal by Subject|0|||
23210316|NCT03655717|64509182|FG004|Overall Study|Withdrawal by Subject|0|||
23210317|NCT03655717|64509183|FG005|Overall Study|Withdrawal by Subject|1|||
23210318|NCT03655717|64509184|FG006|Overall Study|Withdrawal by Subject|3|||
23210319|NCT03655717|64509185|FG007|Overall Study|Withdrawal by Subject|1|||
23210320|NCT03655717|64509186|FG008|Overall Study|Withdrawal by Subject|2|||
23210321|NCT03655717|64509187|FG009|Overall Study|Withdrawal by Subject|0|||
23210322|NCT03655717|64509188|FG010|Overall Study|Withdrawal by Subject|0|||
23210323|NCT03655717|64509189|FG011|Overall Study|Withdrawal by Subject|1|||
23210324|NCT03655717|64509190|FG012|Overall Study|Withdrawal by Subject|0|||
23210325|NCT03655717|64509191|FG013|Overall Study|Withdrawal by Subject|3|||
23210326|NCT03655717|64509192|FG014|Overall Study|Withdrawal by Subject|0|||
23210327|NCT03655717|64509193|FG015|Overall Study|Withdrawal by Subject|1|||
23210328|NCT03655717|64509194|FG016|Overall Study|Withdrawal by Subject|0|||
23210329|NCT03655717|64509195|FG017|Overall Study|Withdrawal by Subject|0|||
23210330|NCT03655717|64509196|FG018|Overall Study|Withdrawal by Subject|1|||
23210331|NCT03655717|64509197|FG019|Overall Study|Withdrawal by Subject|0|||
23210332|NCT03655717|64509198|FG020|Overall Study|Withdrawal by Subject|0|||
23210333|NCT03655717|64509199|FG021|Overall Study|Withdrawal by Subject|1|||
23210334|NCT03655717|64509200|FG022|Overall Study|Withdrawal by Subject|2|||
23424796|NCT00230282|65299740|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
23424797|NCT00230282|65299740|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
23210335|NCT03655717|64509201|FG023|Overall Study|Withdrawal by Subject|1|||
23210336|NCT03655717|64509202|FG024|Overall Study|Withdrawal by Subject|1|||
23210337|NCT03655717|64509203|FG025|Overall Study|Withdrawal by Subject|0|||
23210338|NCT03655717|64509178|FG000|Overall Study|Physician Decision|3|||
23210339|NCT03655717|64509179|FG001|Overall Study|Physician Decision|3|||
23210340|NCT03655717|64509180|FG002|Overall Study|Physician Decision|0|||
23210341|NCT03655717|64509181|FG003|Overall Study|Physician Decision|0|||
23542745|NCT03579459|65716102|FG002|Overall Study|Adverse Event|2|||
23542746|NCT03579459|65716103|FG003|Overall Study|Adverse Event|6|||
23542747|NCT03579459|65716100|FG000|Overall Study|Death|1|||
23542748|NCT03579459|65716101|FG001|Overall Study|Death|0|||
23542749|NCT03579459|65716102|FG002|Overall Study|Death|1|||
23542750|NCT03579459|65716103|FG003|Overall Study|Death|2|||
23542751|NCT03579459|65716100|FG000|Overall Study|Lost to Follow-up|6|||
23542752|NCT03579459|65716101|FG001|Overall Study|Lost to Follow-up|2|||
23542753|NCT03579459|65716102|FG002|Overall Study|Lost to Follow-up|4|||
23542754|NCT03579459|65716103|FG003|Overall Study|Lost to Follow-up|1|||
23542755|NCT03579459|65716100|FG000|Overall Study|Physician Decision|0|||
23542756|NCT03579459|65716101|FG001|Overall Study|Physician Decision|1|||
23542757|NCT03579459|65716102|FG002|Overall Study|Physician Decision|0|||
23542758|NCT03579459|65716103|FG003|Overall Study|Physician Decision|1|||
23542759|NCT03579459|65716100|FG000|Overall Study|Protocol Violation|1|||
23542760|NCT03579459|65716101|FG001|Overall Study|Protocol Violation|2|||
23542761|NCT03579459|65716102|FG002|Overall Study|Protocol Violation|3|||
23542762|NCT03579459|65716103|FG003|Overall Study|Protocol Violation|5|||
23542763|NCT03579459|65716100|FG000|Overall Study|Withdrawal by Subject|12|||
23542764|NCT03579459|65716101|FG001|Overall Study|Withdrawal by Subject|8|||
23542765|NCT03579459|65716102|FG002|Overall Study|Withdrawal by Subject|11|||
23542766|NCT03579459|65716103|FG003|Overall Study|Withdrawal by Subject|8|||
23542767|NCT03579459|65716100|FG000|Overall Study|Medication error without associated adverse event|2|||
23542768|NCT03579459|65716101|FG001|Overall Study|Medication error without associated adverse event|1|||
23542769|NCT03579459|65716102|FG002|Overall Study|Medication error without associated adverse event|1|||
23542770|NCT03579459|65716103|FG003|Overall Study|Medication error without associated adverse event|0|||
23542771|NCT03579459|65716100|FG000|Overall Study|Other|0|||
23542772|NCT03579459|65716101|FG001|Overall Study|Other|1|||
23542773|NCT03579459|65716102|FG002|Overall Study|Other|1|||
23542774|NCT03579459|65716103|FG003|Overall Study|Other|0|||
23542775|NCT03579459|65716100|FG000|Overall Study|Randomized not vaccinated|0|||
23542776|NCT03579459|65716101|FG001|Overall Study|Randomized not vaccinated|2|||
23542777|NCT03579459|65716102|FG002|Overall Study|Randomized not vaccinated|0|||
23542778|NCT03579459|65716103|FG003|Overall Study|Randomized not vaccinated|1|||
23542779|NCT02571452|65716104|FG000|Overall Study Treatment|Protocol Violation|0|||
23542780|NCT02571452|65716105|FG001|Overall Study Treatment|Protocol Violation|1|||
23542781|NCT02571452|65716104|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
23542782|NCT02571452|65716105|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
23542783|NCT02571452|65716104|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
23542784|NCT02571452|65716105|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
23542785|NCT00922428|65716106|FG000|Overall Study|retrospective/extremely implausible data|2|||
23542786|NCT00922428|65716106|FG000|Overall Study|no medication use or questionable use|13|||
23542787|NCT00352534|65716107|FG000|Initial Staging|Ineligible|8|||
23542788|NCT00352534|65716108|FG001|Initial Staging|Ineligible|9|||
23542789|NCT00352534|65716109|FG002|Initial Staging|Ineligible|0|||
23542790|NCT00352534|65716110|FG003|Initial Staging|Ineligible|0|||
23542791|NCT00352534|65716111|FG004|Initial Staging|Ineligible|0|||
23542792|NCT00352534|65716112|FG005|Initial Staging|Ineligible|0|||
23542793|NCT00352534|65716113|FG006|Initial Staging|Ineligible|0|||
23542794|NCT00352534|65716107|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
23542795|NCT00352534|65716108|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
23542796|NCT00352534|65716109|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
23542797|NCT00352534|65716110|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
23542798|NCT00352534|65716111|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
23542799|NCT00352534|65716112|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
23542800|NCT00352534|65716113|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
23542801|NCT00352534|65716107|FG000|Final Risk Group Assignment|Physician Decision|0|||
23542802|NCT00352534|65716108|FG001|Final Risk Group Assignment|Physician Decision|0|||
23542803|NCT00352534|65716109|FG002|Final Risk Group Assignment|Physician Decision|0|||
23542804|NCT00352534|65716110|FG003|Final Risk Group Assignment|Physician Decision|0|||
23542805|NCT00352534|65716111|FG004|Final Risk Group Assignment|Physician Decision|0|||
23542806|NCT00352534|65716112|FG005|Final Risk Group Assignment|Physician Decision|8|||
23542807|NCT00352534|65716113|FG006|Final Risk Group Assignment|Physician Decision|0|||
23542808|NCT00352534|65716107|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542809|NCT00352534|65716108|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542810|NCT00352534|65716109|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542811|NCT00352534|65716110|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542812|NCT00352534|65716111|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542813|NCT00352534|65716112|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
23542814|NCT00352534|65716113|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
23542815|NCT00352534|65716107|FG000|Final Risk Group Assignment|Ineligible|0|||
23542816|NCT00352534|65716108|FG001|Final Risk Group Assignment|Ineligible|0|||
23542817|NCT00352534|65716109|FG002|Final Risk Group Assignment|Ineligible|3|||
23542818|NCT00352534|65716110|FG003|Final Risk Group Assignment|Ineligible|1|||
23542819|NCT00352534|65716111|FG004|Final Risk Group Assignment|Ineligible|0|||
23542820|NCT00352534|65716112|FG005|Final Risk Group Assignment|Ineligible|13|||
23542821|NCT00352534|65716113|FG006|Final Risk Group Assignment|Ineligible|0|||
23542822|NCT00352534|65716107|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542823|NCT00352534|65716108|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542824|NCT00352534|65716109|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542825|NCT00352534|65716110|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542826|NCT00352534|65716111|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542827|NCT00352534|65716112|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
23542828|NCT00352534|65716113|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
23542829|NCT00352534|65716107|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542830|NCT00352534|65716108|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542831|NCT00352534|65716109|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542832|NCT00352534|65716110|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542833|NCT00352534|65716111|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542834|NCT00352534|65716112|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
23542835|NCT00352534|65716113|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
23542836|NCT00352534|65716107|FG000|Final Risk Group Assignment|Death|0|||
23542837|NCT00352534|65716108|FG001|Final Risk Group Assignment|Death|0|||
23542838|NCT00352534|65716109|FG002|Final Risk Group Assignment|Death|0|||
23542839|NCT00352534|65716110|FG003|Final Risk Group Assignment|Death|0|||
23542840|NCT00352534|65716111|FG004|Final Risk Group Assignment|Death|0|||
23542841|NCT00352534|65716112|FG005|Final Risk Group Assignment|Death|2|||
23542842|NCT00352534|65716113|FG006|Final Risk Group Assignment|Death|0|||
23542843|NCT01337089|65716114|FG000|Overall Study|Adverse Event|237|||
23210342|NCT03655717|64509182|FG004|Overall Study|Physician Decision|0|||
23210343|NCT03655717|64509183|FG005|Overall Study|Physician Decision|0|||
23210344|NCT03655717|64509184|FG006|Overall Study|Physician Decision|0|||
23210345|NCT03655717|64509185|FG007|Overall Study|Physician Decision|0|||
23210346|NCT03655717|64509186|FG008|Overall Study|Physician Decision|0|||
23313192|NCT04480710|64889378|FG000|Overall Study|Physician Decision|0|||
23313193|NCT04480710|64889379|FG001|Overall Study|Physician Decision|0|||
23313194|NCT04480710|64889380|FG002|Overall Study|Physician Decision|1|||
23313195|NCT04480710|64889381|FG003|Overall Study|Physician Decision|0|||
23210347|NCT03655717|64509187|FG009|Overall Study|Physician Decision|1|||
23210348|NCT03655717|64509188|FG010|Overall Study|Physician Decision|0|||
23210349|NCT03655717|64509189|FG011|Overall Study|Physician Decision|0|||
23210350|NCT03655717|64509190|FG012|Overall Study|Physician Decision|0|||
23210351|NCT03655717|64509191|FG013|Overall Study|Physician Decision|0|||
23210352|NCT03655717|64509192|FG014|Overall Study|Physician Decision|0|||
23210353|NCT03655717|64509193|FG015|Overall Study|Physician Decision|0|||
23210354|NCT03655717|64509194|FG016|Overall Study|Physician Decision|0|||
23210355|NCT03655717|64509195|FG017|Overall Study|Physician Decision|0|||
23210356|NCT03655717|64509196|FG018|Overall Study|Physician Decision|0|||
23210357|NCT03655717|64509197|FG019|Overall Study|Physician Decision|1|||
23210358|NCT03655717|64509198|FG020|Overall Study|Physician Decision|0|||
23210359|NCT03655717|64509199|FG021|Overall Study|Physician Decision|0|||
23210360|NCT03655717|64509200|FG022|Overall Study|Physician Decision|0|||
23210361|NCT03655717|64509201|FG023|Overall Study|Physician Decision|1|||
23210362|NCT03655717|64509202|FG024|Overall Study|Physician Decision|0|||
23542844|NCT01337089|65716114|FG000|Overall Study|Withdrawal by Subject|129|||
23542845|NCT01337089|65716114|FG000|Overall Study|Withdrawal by Investigator|33|||
23542846|NCT01337089|65716114|FG000|Overall Study|Met Withdrawal Criteria|3|||
23616683|NCT00747149|65982405|FG001|Overall Study|Did not receive treatment|1|||
23210363|NCT03655717|64509203|FG025|Overall Study|Physician Decision|0|||
23210364|NCT03655717|64509178|FG000|Overall Study|Lost to Follow-up|3|||
23313196|NCT02901548|64889384|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
23313197|NCT03017612|64889385|FG000|Overall Study|Adverse Event|2|||
23210365|NCT03655717|64509179|FG001|Overall Study|Lost to Follow-up|1|||
23210366|NCT03655717|64509180|FG002|Overall Study|Lost to Follow-up|0|||
23210367|NCT03655717|64509181|FG003|Overall Study|Lost to Follow-up|1|||
23210368|NCT03655717|64509182|FG004|Overall Study|Lost to Follow-up|0|||
23313198|NCT04325204|64889388|FG000|Overall Study|Death|0|||
23313199|NCT04325204|64889389|FG001|Overall Study|Death|1|||
23313200|NCT04325204|64889388|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
23313201|NCT04325204|64889389|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
23313202|NCT04325204|64889388|FG000|Overall Study|Lost to Follow-up|8|||
23313203|NCT04325204|64889389|FG001|Overall Study|Lost to Follow-up|8|||
23313204|NCT04325204|64889388|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
23313205|NCT04325204|64889389|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
23313206|NCT00660400|64889390|FG000|Overall Study|Lack of insurance approval|1|||
23313207|NCT00660400|64889390|FG000|Overall Study|Suboptimal organ function|1|||
23313208|NCT00660400|64889390|FG000|Overall Study|Intracranial hemorrhage|1|||
23313209|NCT00660400|64889390|FG000|Overall Study|Withdrawal by Subject|1|||
23313210|NCT04784533|64889391|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
23313211|NCT04784533|64889392|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
23313212|NCT04784533|64889393|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23313213|NCT04784533|64889394|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23313214|NCT04784533|64889395|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23313215|NCT04784533|64889396|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23313216|NCT04784533|64889397|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23313217|NCT04784533|64889398|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23313218|NCT04784533|64889399|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23313219|NCT04784533|64889400|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
23313220|NCT04784533|64889391|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
23313221|NCT04784533|64889392|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
23313222|NCT04784533|64889393|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23313223|NCT04784533|64889394|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23313224|NCT04784533|64889395|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23313225|NCT04784533|64889396|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23313226|NCT04784533|64889397|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23313227|NCT04784533|64889398|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23313228|NCT04784533|64889399|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23313229|NCT04784533|64889400|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
23313230|NCT04784533|64889391|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23424798|NCT00230282|65299740|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
23424799|NCT00230282|65299740|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
23542847|NCT01337089|65716114|FG000|Overall Study|Lost to Follow-up|2|||
23542848|NCT03867734|65716115|FG000|Overall Study|Lost to Follow-up|2|||
23542849|NCT03965052|65716116|FG000|Overall Study|Protocol Violation|1|||
23542850|NCT03965052|65716117|FG001|Overall Study|Protocol Violation|0|||
23542851|NCT02066298|65716118|FG000|Overall Study|Lost to Follow-up|3|||
23542852|NCT02066298|65716119|FG001|Overall Study|Lost to Follow-up|2|||
23542853|NCT02066298|65716120|FG002|Overall Study|Lost to Follow-up|3|||
23542854|NCT02066298|65716121|FG003|Overall Study|Lost to Follow-up|2|||
23542855|NCT02066298|65716122|FG004|Overall Study|Lost to Follow-up|3|||
23542856|NCT02066298|65716123|FG005|Overall Study|Lost to Follow-up|4|||
23542857|NCT02066298|65716118|FG000|Overall Study|Withdrawal by Subject|6|||
23542858|NCT02066298|65716119|FG001|Overall Study|Withdrawal by Subject|6|||
23542859|NCT02066298|65716120|FG002|Overall Study|Withdrawal by Subject|6|||
23542860|NCT02066298|65716121|FG003|Overall Study|Withdrawal by Subject|4|||
23542861|NCT02066298|65716122|FG004|Overall Study|Withdrawal by Subject|5|||
23542862|NCT02066298|65716123|FG005|Overall Study|Withdrawal by Subject|8|||
23542863|NCT02066298|65716118|FG000|Overall Study|Physician Decision|0|||
23542864|NCT02066298|65716119|FG001|Overall Study|Physician Decision|0|||
23542865|NCT02066298|65716120|FG002|Overall Study|Physician Decision|1|||
23542866|NCT02066298|65716121|FG003|Overall Study|Physician Decision|0|||
23424800|NCT02498067|65299749|FG000|Overall Study|Lost to Follow-up|22|||
23424801|NCT02498067|65299749|FG000|Overall Study|Did not meet inclusion criteria|11|||
23424802|NCT03283098|65299750|FG000|Overall Study|Withdrawal by Subject|0|||
23424803|NCT03283098|65299751|FG001|Overall Study|Withdrawal by Subject|1|||
23424804|NCT03023826|65299752|FG000|Period 1|Withdrawal by Subject|0|||
23542867|NCT02066298|65716122|FG004|Overall Study|Physician Decision|1|||
23542868|NCT02066298|65716123|FG005|Overall Study|Physician Decision|0|||
23542869|NCT01831089|65716125|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
23542870|NCT01831089|65716126|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
23542871|NCT01831089|65716127|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
23542872|NCT01831089|65716128|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
23542873|NCT01831089|65716129|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
23542874|NCT01831089|65716130|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
23542875|NCT01831089|65716125|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
23542876|NCT01831089|65716126|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
23542877|NCT01831089|65716127|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
23542878|NCT01831089|65716128|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
23542879|NCT01831089|65716129|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
23542880|NCT01831089|65716130|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
23542881|NCT01831089|65716125|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542882|NCT01831089|65716126|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
23542883|NCT01831089|65716127|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542884|NCT01831089|65716128|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542885|NCT01831089|65716129|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542886|NCT01831089|65716130|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
23542887|NCT01831089|65716125|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
23542888|NCT01831089|65716126|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
23542889|NCT01831089|65716127|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
23542890|NCT01831089|65716128|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
23542891|NCT01831089|65716129|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
23542892|NCT01831089|65716130|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
23542893|NCT01831089|65716125|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542894|NCT01831089|65716126|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542895|NCT01831089|65716127|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
23542896|NCT01831089|65716128|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542897|NCT01831089|65716129|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542898|NCT01831089|65716130|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
23542899|NCT01831089|65716125|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
23542900|NCT01831089|65716126|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
23542901|NCT01831089|65716127|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
23542902|NCT01831089|65716128|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
23542903|NCT01831089|65716129|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
23542904|NCT01831089|65716130|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
23542905|NCT01831089|65716125|FG000|Cohort III: Dose Level 3|Global end of study|0|||
23542906|NCT01831089|65716126|FG001|Cohort III: Dose Level 3|Global end of study|0|||
23542907|NCT01831089|65716127|FG002|Cohort III: Dose Level 3|Global end of study|1|||
23542908|NCT01831089|65716128|FG003|Cohort III: Dose Level 3|Global end of study|0|||
23542909|NCT01831089|65716129|FG004|Cohort III: Dose Level 3|Global end of study|0|||
23542910|NCT01831089|65716130|FG005|Cohort III: Dose Level 3|Global end of study|0|||
23542911|NCT01831089|65716125|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
23542912|NCT01831089|65716126|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
23542913|NCT01831089|65716127|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
23542914|NCT01831089|65716128|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
23542915|NCT01831089|65716129|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
23542916|NCT01831089|65716130|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
23542917|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
23542918|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
23542919|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
23542920|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
23542921|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
23542922|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
23542923|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23542924|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23542925|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23542926|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23424805|NCT03023826|65299753|FG001|Period 1|Withdrawal by Subject|0|||
23313231|NCT04784533|64889392|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
23313232|NCT04784533|64889393|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23313233|NCT04784533|64889394|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23313234|NCT04784533|64889395|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23313235|NCT04784533|64889396|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23313236|NCT04784533|64889397|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23313237|NCT04784533|64889398|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23313238|NCT04784533|64889399|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23313239|NCT04784533|64889400|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
23313240|NCT04784533|64889391|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
23313241|NCT04784533|64889392|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23313242|NCT04784533|64889393|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23313243|NCT04784533|64889394|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23313244|NCT04784533|64889395|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23313245|NCT04784533|64889396|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23313246|NCT04784533|64889397|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23313247|NCT04784533|64889398|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23424806|NCT03023826|65299754|FG002|Period 1|Withdrawal by Subject|0|||
23210369|NCT03655717|64509183|FG005|Overall Study|Lost to Follow-up|1|||
23210370|NCT03655717|64509184|FG006|Overall Study|Lost to Follow-up|0|||
23210371|NCT03655717|64509185|FG007|Overall Study|Lost to Follow-up|0|||
23313248|NCT04784533|64889399|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23313249|NCT04784533|64889400|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
23313250|NCT04784533|64889391|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
23424807|NCT03023826|65299755|FG003|Period 1|Withdrawal by Subject|0|||
23542927|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
23542928|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
23542929|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Death|0|||
23542930|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Death|0|||
23542931|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Death|0|||
23542932|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Death|0|||
23542933|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Death|1|||
23542934|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Death|0|||
23542935|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Global end of study|0|||
23542936|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Global end of study|0|||
23542937|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Global end of study|0|||
23542938|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Global end of study|0|||
23616684|NCT00747149|65982404|FG000|Overall Study|Incorrect enrollment|0|||
23616685|NCT00747149|65982405|FG001|Overall Study|Incorrect enrollment|6|||
23616686|NCT00747149|65982404|FG000|Overall Study|Severe non-compliance to protocol|0|||
23616687|NCT00747149|65982405|FG001|Overall Study|Severe non-compliance to protocol|1|||
23616688|NCT00747149|65982404|FG000|Overall Study|Not reported|1|||
23616689|NCT00747149|65982405|FG001|Overall Study|Not reported|4|||
23542939|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Global end of study|2|||
23542940|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Global end of study|0|||
23542941|NCT01831089|65716125|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542942|NCT01831089|65716126|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542943|NCT01831089|65716127|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542944|NCT01831089|65716128|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542945|NCT01831089|65716129|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
23542946|NCT01831089|65716130|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
23542947|NCT01831089|65716125|FG000|Cohort B: Arm B|Progressive disease|0|||
23542948|NCT01831089|65716126|FG001|Cohort B: Arm B|Progressive disease|0|||
23542949|NCT01831089|65716127|FG002|Cohort B: Arm B|Progressive disease|0|||
23542950|NCT01831089|65716128|FG003|Cohort B: Arm B|Progressive disease|0|||
23542951|NCT01831089|65716129|FG004|Cohort B: Arm B|Progressive disease|0|||
23542952|NCT01831089|65716130|FG005|Cohort B: Arm B|Progressive disease|8|||
23542953|NCT01831089|65716125|FG000|Cohort B: Arm B|Physician Decision|0|||
23542954|NCT01831089|65716126|FG001|Cohort B: Arm B|Physician Decision|0|||
23542955|NCT01831089|65716127|FG002|Cohort B: Arm B|Physician Decision|0|||
23542956|NCT01831089|65716128|FG003|Cohort B: Arm B|Physician Decision|0|||
23542957|NCT01831089|65716129|FG004|Cohort B: Arm B|Physician Decision|0|||
23542958|NCT01831089|65716130|FG005|Cohort B: Arm B|Physician Decision|2|||
23542959|NCT01831089|65716125|FG000|Cohort B: Arm B|Never treated|0|||
23542960|NCT01831089|65716126|FG001|Cohort B: Arm B|Never treated|0|||
23542961|NCT01831089|65716127|FG002|Cohort B: Arm B|Never treated|0|||
23542962|NCT01831089|65716128|FG003|Cohort B: Arm B|Never treated|0|||
23542963|NCT01831089|65716129|FG004|Cohort B: Arm B|Never treated|0|||
23542964|NCT01831089|65716130|FG005|Cohort B: Arm B|Never treated|2|||
23542965|NCT01831089|65716125|FG000|Cohort B: Arm B|Adverse Event|0|||
23542966|NCT01831089|65716126|FG001|Cohort B: Arm B|Adverse Event|0|||
23542967|NCT01831089|65716127|FG002|Cohort B: Arm B|Adverse Event|0|||
23542968|NCT01831089|65716128|FG003|Cohort B: Arm B|Adverse Event|0|||
23542969|NCT01831089|65716129|FG004|Cohort B: Arm B|Adverse Event|0|||
23542970|NCT01831089|65716130|FG005|Cohort B: Arm B|Adverse Event|1|||
23542971|NCT01831089|65716125|FG000|Cohort B: Arm B|Global end of study|0|||
23542972|NCT01831089|65716126|FG001|Cohort B: Arm B|Global end of study|0|||
23542973|NCT01831089|65716127|FG002|Cohort B: Arm B|Global end of study|0|||
23210372|NCT03655717|64509186|FG008|Overall Study|Lost to Follow-up|0|||
23313251|NCT04784533|64889392|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
23313252|NCT04784533|64889393|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23313253|NCT04784533|64889394|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23313254|NCT04784533|64889395|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23313255|NCT04784533|64889396|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23313256|NCT04784533|64889397|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23313257|NCT04784533|64889398|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23313258|NCT04784533|64889399|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23313259|NCT04784533|64889400|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
23313260|NCT04784533|64889391|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
23210373|NCT03655717|64509187|FG009|Overall Study|Lost to Follow-up|0|||
23210374|NCT03655717|64509188|FG010|Overall Study|Lost to Follow-up|0|||
23210375|NCT03655717|64509189|FG011|Overall Study|Lost to Follow-up|1|||
23210376|NCT03655717|64509190|FG012|Overall Study|Lost to Follow-up|0|||
23210377|NCT03655717|64509191|FG013|Overall Study|Lost to Follow-up|0|||
23210378|NCT03655717|64509192|FG014|Overall Study|Lost to Follow-up|0|||
23210379|NCT03655717|64509193|FG015|Overall Study|Lost to Follow-up|0|||
23210380|NCT03655717|64509194|FG016|Overall Study|Lost to Follow-up|0|||
23210381|NCT03655717|64509195|FG017|Overall Study|Lost to Follow-up|0|||
23210382|NCT03655717|64509196|FG018|Overall Study|Lost to Follow-up|0|||
23210383|NCT03655717|64509197|FG019|Overall Study|Lost to Follow-up|0|||
23210384|NCT03655717|64509198|FG020|Overall Study|Lost to Follow-up|0|||
23210385|NCT03655717|64509199|FG021|Overall Study|Lost to Follow-up|0|||
23210386|NCT03655717|64509200|FG022|Overall Study|Lost to Follow-up|0|||
23210387|NCT03655717|64509201|FG023|Overall Study|Lost to Follow-up|0|||
23210388|NCT03655717|64509202|FG024|Overall Study|Lost to Follow-up|0|||
23210389|NCT03655717|64509203|FG025|Overall Study|Lost to Follow-up|0|||
23313261|NCT04784533|64889392|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
23313262|NCT04784533|64889393|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23542974|NCT01831089|65716128|FG003|Cohort B: Arm B|Global end of study|0|||
23542975|NCT01831089|65716129|FG004|Cohort B: Arm B|Global end of study|0|||
23542976|NCT01831089|65716130|FG005|Cohort B: Arm B|Global end of study|1|||
23542977|NCT02080091|65716133|FG000|Overall Study|Study Terminated|22|||
23542978|NCT02080091|65716133|FG000|Overall Study|Death|1|||
23542979|NCT02080091|65716133|FG000|Overall Study|Withdrawal by Subject|1|||
23542980|NCT02080091|65716133|FG000|Overall Study|Other|1|||
23210390|NCT01120379|64509204|FG000|One Year Timepoint|Withdrawal by Subject|41|||
23210391|NCT01120379|64509204|FG000|One Year Timepoint|Lost to Follow-up|115|||
23210392|NCT01120379|64509204|FG000|One Year Timepoint|Death|108|||
23210393|NCT01120379|64509204|FG000|One Year Timepoint|Physician Decision|9|||
23542981|NCT00434057|65716136|FG000|Overall Study|Withdrawal by Subject|1|||
23542982|NCT01643473|65716143|FG000|Overall Study|Lost to Follow-up|1|||
23542983|NCT01643473|65716144|FG001|Overall Study|Lost to Follow-up|0|||
23542984|NCT01682837|65716145|FG000|Baseline|Withdrawal by Subject|5|||
23542985|NCT04572633|65716146|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
23542986|NCT00558285|65716147|FG000|Overall Study|Adverse Event|1|||
23542987|NCT00558285|65716148|FG001|Overall Study|Adverse Event|1|||
23210394|NCT01120379|64509204|FG000|One Year Timepoint|Any other reason for early termination|5|||
23210395|NCT01120379|64509204|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
23210396|NCT01120379|64509204|FG000|Two Year Timepoint|Lost to Follow-up|87|||
23210397|NCT01120379|64509204|FG000|Two Year Timepoint|Death|123|||
23210398|NCT01120379|64509204|FG000|Two Year Timepoint|Physician Decision|12|||
23210399|NCT01120379|64509204|FG000|Two Year Timepoint|Any other reason for early termination|4|||
23210400|NCT01120379|64509204|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
23210401|NCT01120379|64509204|FG000|Three Year Timepoint|Lost to Follow-up|43|||
23210402|NCT01120379|64509204|FG000|Three Year Timepoint|Death|120|||
23210403|NCT01120379|64509204|FG000|Three Year Timepoint|Physician Decision|9|||
23210404|NCT01120379|64509204|FG000|Three Year Timepoint|Any other reason for early termination|17|||
23210405|NCT01120379|64509204|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
23210406|NCT01120379|64509204|FG000|Four Year Timepoint|Lost to Follow-up|10|||
23313263|NCT04784533|64889394|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23542988|NCT00558285|65716149|FG002|Overall Study|Adverse Event|4|||
23542989|NCT00558285|65716150|FG003|Overall Study|Adverse Event|1|||
23542990|NCT00558285|65716151|FG004|Overall Study|Adverse Event|2|||
23210407|NCT01120379|64509204|FG000|Four Year Timepoint|Death|131|||
23210408|NCT01120379|64509204|FG000|Four Year Timepoint|Physician Decision|5|||
23582203|NCT01094171|65862382|FG000|Overall Study|Lost to Follow-up|2|||
23210409|NCT01120379|64509204|FG000|Four Year Timepoint|Any other reason for early termination|217|||
23210410|NCT00594204|64509205|FG000|Overall Study|Adverse Event|15|||
23210411|NCT00594204|64509206|FG001|Overall Study|Adverse Event|3|||
23210412|NCT00594204|64509205|FG000|Overall Study|Lost to Follow-up|9|||
23210413|NCT00594204|64509206|FG001|Overall Study|Lost to Follow-up|5|||
23313264|NCT04784533|64889395|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23313265|NCT04784533|64889396|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23313266|NCT04784533|64889397|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23313267|NCT04784533|64889398|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23313268|NCT04784533|64889399|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23313269|NCT04784533|64889400|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
23313270|NCT04784533|64889391|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23313271|NCT04784533|64889392|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23210414|NCT00594204|64509205|FG000|Overall Study|Withdrawal by Subject|23|||
23210415|NCT00594204|64509206|FG001|Overall Study|Withdrawal by Subject|29|||
23210416|NCT00594204|64509205|FG000|Overall Study|Other|4|||
23210417|NCT00594204|64509206|FG001|Overall Study|Other|3|||
23210418|NCT00594204|64509205|FG000|Overall Study|Lack of Efficacy|3|||
23210419|NCT00594204|64509206|FG001|Overall Study|Lack of Efficacy|4|||
23210420|NCT00594204|64509205|FG000|Overall Study|Randomized but not treated|4|||
23210421|NCT00594204|64509206|FG001|Overall Study|Randomized but not treated|1|||
23210422|NCT00892957|64509207|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
23210423|NCT00892957|64509208|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
23210424|NCT00892957|64509207|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
23210425|NCT00892957|64509208|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
23210426|NCT02709083|64509211|FG000|Overall Study|Original PI left institution|7|||
23210427|NCT01182337|64509212|FG000|Overall Study|Withdrawal by Subject|3|||
23210428|NCT01182337|64509213|FG001|Overall Study|Withdrawal by Subject|1|||
23210429|NCT01182337|64509212|FG000|Overall Study|Lost to Follow-up|0|||
23542991|NCT00558285|65716147|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23542992|NCT00558285|65716148|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23542993|NCT00558285|65716149|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23542994|NCT00558285|65716150|FG003|Overall Study|Abnormal test procedure result(s)|0|||
23542995|NCT00558285|65716151|FG004|Overall Study|Abnormal test procedure result(s)|0|||
23542996|NCT00558285|65716147|FG000|Overall Study|Subject withdrew consent|2|||
23542997|NCT00558285|65716148|FG001|Overall Study|Subject withdrew consent|0|||
23542998|NCT00558285|65716149|FG002|Overall Study|Subject withdrew consent|1|||
23542999|NCT00558285|65716150|FG003|Overall Study|Subject withdrew consent|1|||
23210430|NCT01182337|64509213|FG001|Overall Study|Lost to Follow-up|1|||
23210431|NCT00817206|64509214|FG000|Overall Study|Adverse Event|10|||
23210432|NCT00817206|64509215|FG001|Overall Study|Adverse Event|3|||
23210433|NCT00817206|64509214|FG000|Overall Study|Protocol Violation|0|||
23210434|NCT00817206|64509215|FG001|Overall Study|Protocol Violation|2|||
23210435|NCT00817206|64509214|FG000|Overall Study|Lost to Follow-up|0|||
23210436|NCT00817206|64509215|FG001|Overall Study|Lost to Follow-up|1|||
23210437|NCT00817206|64509214|FG000|Overall Study|Death|2|||
23313272|NCT04784533|64889393|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
23313273|NCT04784533|64889394|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23313274|NCT04784533|64889395|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23313275|NCT04784533|64889396|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23313276|NCT04784533|64889397|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23313277|NCT04784533|64889398|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23313278|NCT04784533|64889399|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23313279|NCT04784533|64889400|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
23313280|NCT04784533|64889391|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23313281|NCT04784533|64889392|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23313282|NCT04784533|64889393|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23313283|NCT04784533|64889394|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23313284|NCT04784533|64889395|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23313285|NCT04784533|64889396|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23313286|NCT04784533|64889397|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23313287|NCT04784533|64889398|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23313288|NCT04784533|64889399|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
23313289|NCT04784533|64889400|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
23313290|NCT04784533|64889391|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23313291|NCT04784533|64889392|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23313292|NCT04784533|64889393|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23210438|NCT00817206|64509215|FG001|Overall Study|Death|0|||
23210439|NCT00817206|64509214|FG000|Overall Study|Withdrawal by Subject|7|||
23313293|NCT04784533|64889394|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23543000|NCT00558285|65716151|FG004|Overall Study|Subject withdrew consent|1|||
23210440|NCT00817206|64509215|FG001|Overall Study|Withdrawal by Subject|3|||
23210441|NCT00817206|64509214|FG000|Overall Study|Physician Decision|2|||
23210442|NCT00817206|64509215|FG001|Overall Study|Physician Decision|0|||
23210443|NCT00830960|64509216|FG000|Overall Study|Death|5|||
23210444|NCT00830960|64509217|FG001|Overall Study|Death|4|||
23210445|NCT00830960|64509218|FG002|Overall Study|Death|3|||
23210446|NCT00830960|64509219|FG003|Overall Study|Death|2|||
23210447|NCT00830960|64509220|FG004|Overall Study|Death|6|||
23210448|NCT00830960|64509221|FG005|Overall Study|Death|1|||
23210449|NCT00830960|64509216|FG000|Overall Study|Lost to Follow-up|1|||
23210450|NCT00830960|64509217|FG001|Overall Study|Lost to Follow-up|1|||
23210451|NCT00830960|64509218|FG002|Overall Study|Lost to Follow-up|1|||
23210452|NCT00830960|64509219|FG003|Overall Study|Lost to Follow-up|0|||
23210453|NCT00830960|64509220|FG004|Overall Study|Lost to Follow-up|0|||
23210454|NCT00830960|64509221|FG005|Overall Study|Lost to Follow-up|1|||
23210455|NCT00830960|64509216|FG000|Overall Study|Withdrawal by Subject|19|||
23210456|NCT00830960|64509217|FG001|Overall Study|Withdrawal by Subject|19|||
23210457|NCT00830960|64509218|FG002|Overall Study|Withdrawal by Subject|18|||
23210458|NCT00830960|64509219|FG003|Overall Study|Withdrawal by Subject|23|||
23210459|NCT00830960|64509220|FG004|Overall Study|Withdrawal by Subject|16|||
23210460|NCT00830960|64509221|FG005|Overall Study|Withdrawal by Subject|21|||
23210461|NCT00830960|64509216|FG000|Overall Study|Sponsor Decision|1|||
23210462|NCT00830960|64509217|FG001|Overall Study|Sponsor Decision|2|||
23210463|NCT00830960|64509218|FG002|Overall Study|Sponsor Decision|3|||
23210464|NCT00830960|64509219|FG003|Overall Study|Sponsor Decision|4|||
23210465|NCT00830960|64509220|FG004|Overall Study|Sponsor Decision|5|||
23210466|NCT00830960|64509221|FG005|Overall Study|Sponsor Decision|7|||
23210467|NCT00830960|64509216|FG000|Overall Study|No study drug received|7|||
23210468|NCT00830960|64509217|FG001|Overall Study|No study drug received|2|||
23210469|NCT00830960|64509218|FG002|Overall Study|No study drug received|4|||
23210470|NCT00830960|64509219|FG003|Overall Study|No study drug received|3|||
23210471|NCT00830960|64509220|FG004|Overall Study|No study drug received|5|||
23210472|NCT00830960|64509221|FG005|Overall Study|No study drug received|7|||
23210473|NCT04656418|64509225|FG000|Overall Study|Withdrawal by Subject|1|||
23210474|NCT04656418|64509226|FG001|Overall Study|Withdrawal by Subject|3|||
23210475|NCT00668200|64509229|FG000|Overall Study|Withdrawal by Subject|2|||
23210476|NCT00668200|64509229|FG000|Overall Study|Lost to Follow-up|1|||
23210477|NCT00555906|64509230|FG000|Phase 1|Objective Progression or Relapse|3|||
23210478|NCT00555906|64509231|FG001|Phase 1|Objective Progression or Relapse|5|||
23210479|NCT00555906|64509232|FG002|Phase 1|Objective Progression or Relapse|3|||
23210480|NCT00555906|64509233|FG003|Phase 1|Objective Progression or Relapse|1|||
23210481|NCT00555906|64509234|FG004|Phase 1|Objective Progression or Relapse|0|||
23210482|NCT00555906|64509230|FG000|Phase 1|Global Deterioration of Health Status|0|||
23210483|NCT00555906|64509231|FG001|Phase 1|Global Deterioration of Health Status|1|||
23210484|NCT00555906|64509232|FG002|Phase 1|Global Deterioration of Health Status|1|||
23210485|NCT00555906|64509233|FG003|Phase 1|Global Deterioration of Health Status|1|||
23210486|NCT00555906|64509234|FG004|Phase 1|Global Deterioration of Health Status|0|||
23210487|NCT00555906|64509230|FG000|Phase 1|Adverse Event|0|||
23210488|NCT00555906|64509231|FG001|Phase 1|Adverse Event|0|||
23210489|NCT00555906|64509232|FG002|Phase 1|Adverse Event|3|||
23210490|NCT00555906|64509233|FG003|Phase 1|Adverse Event|2|||
23210491|NCT00555906|64509234|FG004|Phase 1|Adverse Event|0|||
23210492|NCT00555906|64509230|FG000|Phase 1|Withdrawal by Subject|0|||
23210493|NCT00555906|64509231|FG001|Phase 1|Withdrawal by Subject|0|||
23210494|NCT00555906|64509232|FG002|Phase 1|Withdrawal by Subject|0|||
23210495|NCT00555906|64509233|FG003|Phase 1|Withdrawal by Subject|1|||
23210496|NCT00555906|64509234|FG004|Phase 1|Withdrawal by Subject|0|||
23210497|NCT00555906|64509230|FG000|Phase 2|Adverse Event|0|||
23313294|NCT04784533|64889395|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23210498|NCT00555906|64509231|FG001|Phase 2|Adverse Event|0|||
23210499|NCT00555906|64509232|FG002|Phase 2|Adverse Event|0|||
23210500|NCT00555906|64509233|FG003|Phase 2|Adverse Event|0|||
23210501|NCT00555906|64509234|FG004|Phase 2|Adverse Event|4|||
23210502|NCT00555906|64509230|FG000|Phase 2|Global Deterioration of Health Status|0|||
23210503|NCT00555906|64509231|FG001|Phase 2|Global Deterioration of Health Status|0|||
23210504|NCT00555906|64509232|FG002|Phase 2|Global Deterioration of Health Status|0|||
23313295|NCT04784533|64889396|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23210505|NCT00555906|64509233|FG003|Phase 2|Global Deterioration of Health Status|0|||
23210506|NCT00555906|64509234|FG004|Phase 2|Global Deterioration of Health Status|2|||
23175811|NCT01926626|64386569|FG000|Overall Study|Withdrawal by Subject|15|||
23175812|NCT01926626|64386569|FG000|Overall Study|Lost to Follow-up|7|||
23175813|NCT01882907|64386570|FG000|Overall Study|Adverse Event|3|||
23175814|NCT01882907|64386571|FG001|Overall Study|Adverse Event|1|||
23175815|NCT01882907|64386570|FG000|Overall Study|Lack of Efficacy|0|||
23175816|NCT01882907|64386571|FG001|Overall Study|Lack of Efficacy|3|||
23210507|NCT00555906|64509230|FG000|Phase 2|Objective Progression or Relapse|0|||
23210508|NCT00555906|64509231|FG001|Phase 2|Objective Progression or Relapse|0|||
23210509|NCT00555906|64509232|FG002|Phase 2|Objective Progression or Relapse|0|||
23210510|NCT00555906|64509233|FG003|Phase 2|Objective Progression or Relapse|0|||
23210511|NCT00555906|64509234|FG004|Phase 2|Objective Progression or Relapse|16|||
23210512|NCT00555906|64509230|FG000|Phase 2|Withdrawal by Subject|0|||
23210513|NCT00555906|64509231|FG001|Phase 2|Withdrawal by Subject|0|||
23210514|NCT00555906|64509232|FG002|Phase 2|Withdrawal by Subject|0|||
23210515|NCT00555906|64509233|FG003|Phase 2|Withdrawal by Subject|0|||
23210516|NCT00555906|64509234|FG004|Phase 2|Withdrawal by Subject|2|||
23210517|NCT00555906|64509230|FG000|Phase 2|Other|0|||
23210518|NCT00555906|64509231|FG001|Phase 2|Other|0|||
23210519|NCT00555906|64509232|FG002|Phase 2|Other|0|||
23210520|NCT00555906|64509233|FG003|Phase 2|Other|0|||
23210521|NCT00555906|64509234|FG004|Phase 2|Other|6|||
23210522|NCT00555906|64509230|FG000|Phase 2|Randomized but not Treated|0|||
23210523|NCT00555906|64509231|FG001|Phase 2|Randomized but not Treated|0|||
23210524|NCT00555906|64509232|FG002|Phase 2|Randomized but not Treated|0|||
23210525|NCT00555906|64509233|FG003|Phase 2|Randomized but not Treated|0|||
23210526|NCT00555906|64509234|FG004|Phase 2|Randomized but not Treated|2|||
23210527|NCT02677220|64509238|FG000|Overall Study|Adverse Event|1|||
23210528|NCT03364673|64509241|FG000|Overall Study|Withdrawal by Subject|2|||
23210529|NCT03364673|64509241|FG000|Overall Study|Injury unrelated to study|3|||
23210530|NCT03334396|64509245|FG000|Overall Study|Adverse Event|1|||
23210531|NCT03334396|64509246|FG001|Overall Study|Adverse Event|0|||
23210532|NCT03334396|64509247|FG002|Overall Study|Adverse Event|1|||
23210533|NCT03334396|64509248|FG003|Overall Study|Adverse Event|0|||
23210534|NCT03334396|64509249|FG004|Overall Study|Adverse Event|0|||
23210535|NCT03334396|64509250|FG005|Overall Study|Adverse Event|0|||
23210536|NCT03334396|64509251|FG006|Overall Study|Adverse Event|0|||
23210537|NCT03334396|64509252|FG007|Overall Study|Adverse Event|0|||
23210538|NCT03334396|64509245|FG000|Overall Study|Lack of Efficacy|10|||
23210539|NCT03334396|64509246|FG001|Overall Study|Lack of Efficacy|4|||
23210540|NCT03334396|64509247|FG002|Overall Study|Lack of Efficacy|1|||
23210541|NCT03334396|64509248|FG003|Overall Study|Lack of Efficacy|3|||
23210542|NCT03334396|64509249|FG004|Overall Study|Lack of Efficacy|1|||
23210543|NCT03334396|64509250|FG005|Overall Study|Lack of Efficacy|0|||
23210544|NCT03334396|64509251|FG006|Overall Study|Lack of Efficacy|0|||
23210545|NCT03334396|64509252|FG007|Overall Study|Lack of Efficacy|1|||
23210546|NCT03334396|64509245|FG000|Overall Study|Lost to Follow-up|0|||
23175817|NCT01882907|64386570|FG000|Overall Study|Lost to Follow-up|1|||
23175818|NCT01882907|64386571|FG001|Overall Study|Lost to Follow-up|4|||
23175819|NCT01882907|64386570|FG000|Overall Study|Protocol Violation|10|||
23175820|NCT01882907|64386571|FG001|Overall Study|Protocol Violation|14|||
23175821|NCT01882907|64386570|FG000|Overall Study|Withdrawal by Subject|0|||
23175822|NCT01882907|64386571|FG001|Overall Study|Withdrawal by Subject|6|||
23175823|NCT02549339|64386584|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
23175824|NCT02549339|64386585|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
23175825|NCT02549339|64386584|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
23210547|NCT03334396|64509246|FG001|Overall Study|Lost to Follow-up|0|||
23210548|NCT03334396|64509247|FG002|Overall Study|Lost to Follow-up|1|||
23210549|NCT03334396|64509248|FG003|Overall Study|Lost to Follow-up|0|||
23210550|NCT03334396|64509249|FG004|Overall Study|Lost to Follow-up|0|||
23210551|NCT03334396|64509250|FG005|Overall Study|Lost to Follow-up|0|||
23210552|NCT03334396|64509251|FG006|Overall Study|Lost to Follow-up|1|||
23210553|NCT03334396|64509252|FG007|Overall Study|Lost to Follow-up|0|||
23210554|NCT03334396|64509245|FG000|Overall Study|Physician Decision|1|||
23175826|NCT02549339|64386585|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
23175827|NCT02549339|64386584|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
23210555|NCT03334396|64509246|FG001|Overall Study|Physician Decision|0|||
23210556|NCT03334396|64509247|FG002|Overall Study|Physician Decision|0|||
23210557|NCT03334396|64509248|FG003|Overall Study|Physician Decision|0|||
23313296|NCT04784533|64889397|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23313297|NCT04784533|64889398|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
23543001|NCT00558285|65716147|FG000|Overall Study|Lost to Follow-up|1|||
23424808|NCT03023826|65299756|FG004|Period 1|Withdrawal by Subject|1|||
23313298|NCT04784533|64889399|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
23313299|NCT04784533|64889400|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
23313300|NCT01059344|64889402|FG000|Overall Study|Adverse Event|12|||
23313301|NCT01059344|64889403|FG001|Overall Study|Adverse Event|30|||
23313302|NCT01059344|64889402|FG000|Overall Study|Withdrawal by Subject|6|||
23313303|NCT01059344|64889403|FG001|Overall Study|Withdrawal by Subject|9|||
23313304|NCT01059344|64889402|FG000|Overall Study|Lost to Follow-up|1|||
23313305|NCT01059344|64889403|FG001|Overall Study|Lost to Follow-up|1|||
23313306|NCT01059344|64889402|FG000|Overall Study|Other|3|||
23313307|NCT01059344|64889403|FG001|Overall Study|Other|6|||
23313308|NCT05478252|64889404|FG000|Overall Study|Withdrawal by Subject|2|||
23313309|NCT05478252|64889405|FG001|Overall Study|Withdrawal by Subject|3|||
23313310|NCT05478252|64889404|FG000|Overall Study|Lost to Follow-up|4|||
23313311|NCT05478252|64889405|FG001|Overall Study|Lost to Follow-up|2|||
23313312|NCT05478252|64889404|FG000|Overall Study|Physician Decision|1|||
23313313|NCT05478252|64889405|FG001|Overall Study|Physician Decision|1|||
23313314|NCT05478252|64889404|FG000|Overall Study|Death|1|||
23313315|NCT05478252|64889405|FG001|Overall Study|Death|0|||
23313316|NCT04762277|64889406|FG000|Overall Study|Withdrawal by Subject|0|||
23313317|NCT04762277|64889407|FG001|Overall Study|Withdrawal by Subject|2|||
23313318|NCT04762277|64889406|FG000|Overall Study|Protocol Violation|0|||
23313319|NCT04762277|64889407|FG001|Overall Study|Protocol Violation|1|||
23313320|NCT04762277|64889406|FG000|Overall Study|Adverse Event|1|||
23313321|NCT04762277|64889407|FG001|Overall Study|Adverse Event|0|||
23313322|NCT02294461|64889408|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
23313323|NCT02294461|64889409|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
23313324|NCT02294461|64889408|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
23313325|NCT02294461|64889409|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
23313326|NCT02294461|64889408|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
23313327|NCT02294461|64889409|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
23313328|NCT02294461|64889408|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
23313329|NCT02294461|64889409|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
23313330|NCT02294461|64889408|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
23313331|NCT02294461|64889409|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
23313332|NCT02294461|64889408|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
23313333|NCT02294461|64889409|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
23313334|NCT02294461|64889408|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
23313335|NCT02294461|64889409|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
23313336|NCT02294461|64889408|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
23313337|NCT02294461|64889409|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
23313338|NCT02294461|64889408|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
23313339|NCT02294461|64889409|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
23313340|NCT02294461|64889408|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
23313341|NCT02294461|64889409|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
23313342|NCT02294461|64889408|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
23313343|NCT02294461|64889409|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
23313344|NCT02294461|64889408|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
23313345|NCT02294461|64889409|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
23313346|NCT02294461|64889408|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
23313347|NCT02294461|64889409|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
23313348|NCT02294461|64889408|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
23313349|NCT02294461|64889409|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
23313350|NCT02294461|64889408|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
23313351|NCT02294461|64889409|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
23313352|NCT04710979|64889410|FG000|Overall Study|Lost to Follow-up|2|||
23313353|NCT04710979|64889411|FG001|Overall Study|Lost to Follow-up|4|||
23313354|NCT04710979|64889410|FG000|Overall Study|Withdrawal by Subject|1|||
23313355|NCT04710979|64889411|FG001|Overall Study|Withdrawal by Subject|0|||
23313356|NCT02552303|64889412|FG000|Allocation|Withdrawal by Subject|2|||
23313357|NCT02552303|64889413|FG001|Allocation|Withdrawal by Subject|1|||
23313358|NCT02552303|64889414|FG002|Allocation|Withdrawal by Subject|1|||
23313359|NCT02552303|64889415|FG003|Allocation|Withdrawal by Subject|1|||
23313360|NCT02552303|64889412|FG000|Allocation|ineligible|1|||
23313361|NCT02552303|64889413|FG001|Allocation|ineligible|1|||
23313362|NCT02552303|64889414|FG002|Allocation|ineligible|0|||
23313363|NCT02552303|64889415|FG003|Allocation|ineligible|0|||
23313364|NCT02552303|64889412|FG000|Follow-Up|Lost to Follow-up|0|||
23313365|NCT02552303|64889413|FG001|Follow-Up|Lost to Follow-up|0|||
23313366|NCT02552303|64889414|FG002|Follow-Up|Lost to Follow-up|1|||
23313367|NCT02552303|64889415|FG003|Follow-Up|Lost to Follow-up|0|||
23313368|NCT02552303|64889412|FG000|Follow-Up|ineligible|0|||
23313369|NCT02552303|64889413|FG001|Follow-Up|ineligible|2|||
23313370|NCT02552303|64889414|FG002|Follow-Up|ineligible|0|||
23313371|NCT02552303|64889415|FG003|Follow-Up|ineligible|0|||
23313372|NCT03196635|64889416|FG000|Overall Study|Withdrawal by Subject|1|||
23313373|NCT03276078|64889417|FG000|Overall Study|Adverse Event|1|||
23313374|NCT03047330|64889418|FG000|Sleep Block 1|Withdrawal by Subject|3|||
23313375|NCT03265288|64889419|FG000|Overall Study|Adverse Event|0|||
23313376|NCT03265288|64889420|FG001|Overall Study|Adverse Event|1|||
23313377|NCT03265288|64889419|FG000|Overall Study|Withdrawal by Subject|13|||
23313378|NCT03265288|64889420|FG001|Overall Study|Withdrawal by Subject|5|||
23313379|NCT03265288|64889419|FG000|Overall Study|Drug Withdrawn|3|||
23313380|NCT03265288|64889420|FG001|Overall Study|Drug Withdrawn|3|||
23313381|NCT03265288|64889419|FG000|Overall Study|Any Other Reason|7|||
23313382|NCT03265288|64889420|FG001|Overall Study|Any Other Reason|3|||
23313383|NCT03485352|64889422|FG000|Overall Study|Lost to Follow-up|9|||
23313384|NCT00552578|64889423|FG000|Overall Study|Lost to Follow-up|1|||
23313385|NCT00552578|64889424|FG001|Overall Study|Lost to Follow-up|1|||
23313386|NCT05314816|64889426|FG000|Overall Study|Lost to Follow-up|5|||
23313387|NCT05314816|64889427|FG001|Overall Study|Lost to Follow-up|0|||
23313388|NCT05314816|64889428|FG002|Overall Study|Lost to Follow-up|1|||
23313389|NCT05314816|64889426|FG000|Overall Study|Protocol Violation|13|||
23313390|NCT05314816|64889427|FG001|Overall Study|Protocol Violation|8|||
23313391|NCT05314816|64889428|FG002|Overall Study|Protocol Violation|0|||
23313392|NCT00528411|64889431|FG000|Overall Study|Adverse Event|4|||
23313393|NCT00528411|64889432|FG001|Overall Study|Adverse Event|0|||
23313394|NCT00528411|64889433|FG002|Overall Study|Adverse Event|1|||
23313395|NCT00528411|64889431|FG000|Overall Study|Incorrect Enrolment|1|||
23313396|NCT00528411|64889432|FG001|Overall Study|Incorrect Enrolment|1|||
23313397|NCT00528411|64889433|FG002|Overall Study|Incorrect Enrolment|0|||
23313398|NCT00528411|64889431|FG000|Overall Study|Severe non-compliance to protocol|0|||
23313399|NCT00528411|64889432|FG001|Overall Study|Severe non-compliance to protocol|1|||
23313400|NCT00528411|64889433|FG002|Overall Study|Severe non-compliance to protocol|0|||
23313401|NCT00528411|64889431|FG000|Overall Study|Prior commitment medication|0|||
23313402|NCT00528411|64889432|FG001|Overall Study|Prior commitment medication|1|||
23313403|NCT00528411|64889433|FG002|Overall Study|Prior commitment medication|0|||
23313404|NCT04839692|64889434|FG000|Overall Study|Withdrawal by Subject|0|||
23313405|NCT04839692|64889435|FG001|Overall Study|Withdrawal by Subject|3|||
23313406|NCT04839692|64889434|FG000|Overall Study|Physician Decision|1|||
23313407|NCT04839692|64889435|FG001|Overall Study|Physician Decision|0|||
23313408|NCT04400682|64889436|FG000|Period 1|Withdrawal by Subject|1|||
23313409|NCT04400682|64889437|FG001|Period 1|Withdrawal by Subject|4|||
23313410|NCT00094861|64889438|FG000|Overall Study|Adverse Event|5|||
23543002|NCT00558285|65716148|FG001|Overall Study|Lost to Follow-up|1|||
23210558|NCT03334396|64509249|FG004|Overall Study|Physician Decision|0|||
23313411|NCT00094861|64889439|FG001|Overall Study|Adverse Event|2|||
23313412|NCT00094861|64889438|FG000|Overall Study|Withdrawal by Subject|5|||
23313413|NCT00094861|64889439|FG001|Overall Study|Withdrawal by Subject|3|||
23313414|NCT00094861|64889438|FG000|Overall Study|Physician Decision|1|||
23313415|NCT00094861|64889439|FG001|Overall Study|Physician Decision|1|||
23313416|NCT00094861|64889438|FG000|Overall Study|Lost to Follow-up|0|||
23313417|NCT00094861|64889439|FG001|Overall Study|Lost to Follow-up|1|||
23313418|NCT00094861|64889438|FG000|Overall Study|Death|4|||
23313419|NCT00094861|64889439|FG001|Overall Study|Death|2|||
23313420|NCT00094861|64889438|FG000|Overall Study|Other|3|||
23313421|NCT00094861|64889439|FG001|Overall Study|Other|0|||
23313422|NCT00025259|64892036|FG000|Overall Study|Death|1|||
23313423|NCT00025259|64892037|FG001|Overall Study|Death|3|||
23313424|NCT00025259|64892038|FG002|Overall Study|Death|0|||
23313425|NCT00025259|64892039|FG003|Overall Study|Death|3|||
23313426|NCT00025259|64892040|FG004|Overall Study|Death|0|||
23313427|NCT00025259|64892041|FG005|Overall Study|Death|1|||
23313428|NCT00025259|64892042|FG006|Overall Study|Death|2|||
23313429|NCT00025259|64892036|FG000|Overall Study|Lack of Efficacy|2|||
23313430|NCT00025259|64892037|FG001|Overall Study|Lack of Efficacy|46|||
23313431|NCT00025259|64892038|FG002|Overall Study|Lack of Efficacy|60|||
23313432|NCT00025259|64892039|FG003|Overall Study|Lack of Efficacy|78|||
23313433|NCT00025259|64892040|FG004|Overall Study|Lack of Efficacy|11|||
23313434|NCT00025259|64892041|FG005|Overall Study|Lack of Efficacy|30|||
23313435|NCT00025259|64892042|FG006|Overall Study|Lack of Efficacy|38|||
23313436|NCT00025259|64892036|FG000|Overall Study|Lost to Follow-up|2|||
23313437|NCT00025259|64892037|FG001|Overall Study|Lost to Follow-up|9|||
23313438|NCT00025259|64892038|FG002|Overall Study|Lost to Follow-up|13|||
23313439|NCT00025259|64892039|FG003|Overall Study|Lost to Follow-up|13|||
23313440|NCT00025259|64892040|FG004|Overall Study|Lost to Follow-up|1|||
23313441|NCT00025259|64892041|FG005|Overall Study|Lost to Follow-up|3|||
23313442|NCT00025259|64892042|FG006|Overall Study|Lost to Follow-up|1|||
23313443|NCT00025259|64892036|FG000|Overall Study|Physician Decision|12|||
23313444|NCT00025259|64892037|FG001|Overall Study|Physician Decision|1|||
23313445|NCT00025259|64892038|FG002|Overall Study|Physician Decision|0|||
23313446|NCT00025259|64892039|FG003|Overall Study|Physician Decision|5|||
23313447|NCT00025259|64892040|FG004|Overall Study|Physician Decision|4|||
23313448|NCT00025259|64892041|FG005|Overall Study|Physician Decision|2|||
23313449|NCT00025259|64892042|FG006|Overall Study|Physician Decision|1|||
23313450|NCT00025259|64892036|FG000|Overall Study|Protocol Violation|3|||
23313451|NCT00025259|64892037|FG001|Overall Study|Protocol Violation|2|||
23313452|NCT00025259|64892038|FG002|Overall Study|Protocol Violation|2|||
23313453|NCT00025259|64892039|FG003|Overall Study|Protocol Violation|1|||
23313454|NCT00025259|64892040|FG004|Overall Study|Protocol Violation|2|||
23313455|NCT00025259|64892041|FG005|Overall Study|Protocol Violation|1|||
23313456|NCT00025259|64892042|FG006|Overall Study|Protocol Violation|3|||
23313457|NCT00025259|64892036|FG000|Overall Study|Withdrawal by Subject|9|||
23313458|NCT00025259|64892037|FG001|Overall Study|Withdrawal by Subject|27|||
23313459|NCT00025259|64892038|FG002|Overall Study|Withdrawal by Subject|6|||
23313460|NCT00025259|64892039|FG003|Overall Study|Withdrawal by Subject|14|||
23313461|NCT00025259|64892040|FG004|Overall Study|Withdrawal by Subject|11|||
23313462|NCT00025259|64892041|FG005|Overall Study|Withdrawal by Subject|8|||
23313463|NCT00025259|64892042|FG006|Overall Study|Withdrawal by Subject|3|||
23313464|NCT00025259|64892036|FG000|Overall Study|Ineligible|14|||
23313465|NCT00025259|64892037|FG001|Overall Study|Ineligible|1|||
23313466|NCT00025259|64892038|FG002|Overall Study|Ineligible|0|||
23313467|NCT00025259|64892039|FG003|Overall Study|Ineligible|0|||
23313468|NCT00025259|64892040|FG004|Overall Study|Ineligible|6|||
23313469|NCT00025259|64892041|FG005|Overall Study|Ineligible|0|||
23313470|NCT00025259|64892042|FG006|Overall Study|Ineligible|1|||
23313471|NCT00025259|64892036|FG000|Overall Study|Randomization error|1|||
23313472|NCT00025259|64892037|FG001|Overall Study|Randomization error|0|||
23313473|NCT00025259|64892038|FG002|Overall Study|Randomization error|0|||
23313474|NCT00025259|64892039|FG003|Overall Study|Randomization error|0|||
23313475|NCT00025259|64892040|FG004|Overall Study|Randomization error|1|||
23313476|NCT00025259|64892041|FG005|Overall Study|Randomization error|7|||
23313477|NCT00025259|64892042|FG006|Overall Study|Randomization error|2|||
23313478|NCT00025259|64892036|FG000|Overall Study|Adverse Event|1|||
23313479|NCT00025259|64892037|FG001|Overall Study|Adverse Event|0|||
23313480|NCT00025259|64892038|FG002|Overall Study|Adverse Event|0|||
23313481|NCT00025259|64892039|FG003|Overall Study|Adverse Event|0|||
23313482|NCT00025259|64892040|FG004|Overall Study|Adverse Event|0|||
23313483|NCT00025259|64892041|FG005|Overall Study|Adverse Event|0|||
23313484|NCT00025259|64892042|FG006|Overall Study|Adverse Event|0|||
23313485|NCT01860677|64892043|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
23313486|NCT01860677|64892044|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
23313487|NCT02125877|64892045|FG000|Overall Study|Physician Decision|1|||
23313488|NCT02125877|64892046|FG001|Overall Study|Physician Decision|0|||
23313489|NCT02125877|64892045|FG000|Overall Study|Death|0|||
23313490|NCT02125877|64892046|FG001|Overall Study|Death|1|||
23313491|NCT02125877|64892045|FG000|Overall Study|Administrative problems|0|||
23313492|NCT02125877|64892046|FG001|Overall Study|Administrative problems|1|||
23313493|NCT02125877|64892045|FG000|Overall Study|Participant/guardian decision|0|||
23313494|NCT02125877|64892046|FG001|Overall Study|Participant/guardian decision|2|||
23313495|NCT02125877|64892045|FG000|Overall Study|Withdrawal by Subject|2|||
23543003|NCT00558285|65716149|FG002|Overall Study|Lost to Follow-up|0|||
23313496|NCT02125877|64892046|FG001|Overall Study|Withdrawal by Subject|1|||
23313497|NCT02125877|64892045|FG000|Overall Study|Protocol deviation|4|||
23313498|NCT02125877|64892046|FG001|Overall Study|Protocol deviation|1|||
23313499|NCT02125877|64892045|FG000|Overall Study|Adverse Event|6|||
23313500|NCT02125877|64892046|FG001|Overall Study|Adverse Event|4|||
23313501|NCT02759692|64892047|FG000|Period 1|Test article no longer available|1|||
23313502|NCT02759692|64892048|FG001|Period 1|Test article no longer available|1|||
23313503|NCT02759692|64892047|FG000|Period 1|No longer meets eligibility criteria.|1|||
23313504|NCT02759692|64892048|FG001|Period 1|No longer meets eligibility criteria.|0|||
23313505|NCT02759692|64892047|FG000|Period 1|Miss-Randomized|1|||
23313506|NCT02759692|64892048|FG001|Period 1|Miss-Randomized|1|||
23313507|NCT02759692|64892047|FG000|Period 2|Lost to Follow-up|1|||
23313508|NCT02759692|64892048|FG001|Period 2|Lost to Follow-up|0|||
23313509|NCT02759692|64892047|FG000|Period 2|Test article no longer available|0|||
23313510|NCT02759692|64892048|FG001|Period 2|Test article no longer available|1|||
23313511|NCT04208750|64892049|FG000|Overall Study|Lost to Follow-up|16|||
23313512|NCT04208750|64892050|FG001|Overall Study|Lost to Follow-up|15|||
23210559|NCT03334396|64509250|FG005|Overall Study|Physician Decision|0|||
23210560|NCT03334396|64509251|FG006|Overall Study|Physician Decision|0|||
23210561|NCT03334396|64509252|FG007|Overall Study|Physician Decision|0|||
23210562|NCT03334396|64509245|FG000|Overall Study|Withdrawal by Subject|10|||
23210563|NCT03334396|64509246|FG001|Overall Study|Withdrawal by Subject|5|||
23210564|NCT03334396|64509247|FG002|Overall Study|Withdrawal by Subject|7|||
23210565|NCT03334396|64509248|FG003|Overall Study|Withdrawal by Subject|2|||
23210566|NCT03334396|64509249|FG004|Overall Study|Withdrawal by Subject|2|||
23210567|NCT03334396|64509250|FG005|Overall Study|Withdrawal by Subject|1|||
23210568|NCT03334396|64509251|FG006|Overall Study|Withdrawal by Subject|2|||
23210569|NCT03334396|64509252|FG007|Overall Study|Withdrawal by Subject|0|||
23210570|NCT03334396|64509245|FG000|Overall Study|Pregnancy|0|||
23210571|NCT03334396|64509246|FG001|Overall Study|Pregnancy|1|||
23210572|NCT03334396|64509247|FG002|Overall Study|Pregnancy|0|||
23210573|NCT03334396|64509248|FG003|Overall Study|Pregnancy|0|||
23210574|NCT03334396|64509249|FG004|Overall Study|Pregnancy|0|||
23210575|NCT03334396|64509250|FG005|Overall Study|Pregnancy|0|||
23210576|NCT03334396|64509251|FG006|Overall Study|Pregnancy|0|||
23210577|NCT03334396|64509252|FG007|Overall Study|Pregnancy|0|||
23210578|NCT03334396|64509245|FG000|Overall Study|Ineligible|0|||
23210579|NCT03334396|64509246|FG001|Overall Study|Ineligible|1|||
23210580|NCT03334396|64509247|FG002|Overall Study|Ineligible|0|||
23210581|NCT03334396|64509248|FG003|Overall Study|Ineligible|0|||
23210582|NCT03334396|64509249|FG004|Overall Study|Ineligible|0|||
23210583|NCT03334396|64509250|FG005|Overall Study|Ineligible|0|||
23210584|NCT03334396|64509251|FG006|Overall Study|Ineligible|0|||
23210585|NCT03334396|64509252|FG007|Overall Study|Ineligible|0|||
23210586|NCT03334396|64509245|FG000|Overall Study|Started New Job|1|||
23210587|NCT03334396|64509246|FG001|Overall Study|Started New Job|0|||
23210588|NCT03334396|64509247|FG002|Overall Study|Started New Job|0|||
23210589|NCT03334396|64509248|FG003|Overall Study|Started New Job|0|||
23210590|NCT03334396|64509249|FG004|Overall Study|Started New Job|0|||
23210591|NCT03334396|64509250|FG005|Overall Study|Started New Job|0|||
23210592|NCT03334396|64509251|FG006|Overall Study|Started New Job|0|||
23210593|NCT03334396|64509252|FG007|Overall Study|Started New Job|0|||
23210594|NCT00400712|64509253|FG000|Overall Study|Death|1|||
23210595|NCT00400712|64509254|FG001|Overall Study|Death|0|||
23210596|NCT00400712|64509253|FG000|Overall Study|Withdrawal by Subject|11|||
23210597|NCT00400712|64509254|FG001|Overall Study|Withdrawal by Subject|12|||
23210598|NCT00400712|64509253|FG000|Overall Study|Physician Decision|5|||
23210599|NCT00400712|64509254|FG001|Overall Study|Physician Decision|4|||
23210600|NCT04199793|64509261|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
23210601|NCT04199793|64509262|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
23210602|NCT04199793|64509261|FG000|Overall Study|Withdrawal by Subject|1|||
23210603|NCT04199793|64509262|FG001|Overall Study|Withdrawal by Subject|1|||
23210604|NCT01840228|64509263|FG000|Overall Study|Lost to Follow-up|1|||
23210605|NCT01840228|64509264|FG001|Overall Study|Lost to Follow-up|1|||
23210606|NCT00980980|64509267|FG000|Overall Study|Withdrawal by Hospital|0|||
23210607|NCT00980980|64509268|FG001|Overall Study|Withdrawal by Hospital|1|||
23210608|NCT00980980|64509269|FG002|Overall Study|Withdrawal by Hospital|0|||
23210609|NCT02701192|64509270|FG000|Overall Study|Protocol Violation|2|||
23210610|NCT02701192|64509270|FG000|Overall Study|Lost to Follow-up|4|||
23210611|NCT03067129|64509271|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
23210612|NCT03067129|64509272|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
23210613|NCT03067129|64509273|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
23210614|NCT03067129|64509274|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
23210615|NCT03067129|64509271|FG000|Overall Study|Withdrawal by Subject|0|||
23210616|NCT03067129|64509272|FG001|Overall Study|Withdrawal by Subject|0|||
23210617|NCT03067129|64509273|FG002|Overall Study|Withdrawal by Subject|1|||
23210618|NCT03067129|64509274|FG003|Overall Study|Withdrawal by Subject|2|||
23210619|NCT03067129|64509271|FG000|Overall Study|Lost to Follow-up|5|||
23210620|NCT03067129|64509272|FG001|Overall Study|Lost to Follow-up|5|||
23210621|NCT03067129|64509273|FG002|Overall Study|Lost to Follow-up|4|||
23313513|NCT00195338|64892066|FG000|Overall Study|Lost to Follow-up|2|||
23313514|NCT00195338|64892066|FG000|Overall Study|Adverse Event|5|||
23210622|NCT03067129|64509274|FG003|Overall Study|Lost to Follow-up|3|||
23210623|NCT01582971|64509275|FG000|Overall Study|Death|2|||
23313515|NCT00195338|64892066|FG000|Overall Study|Lack of Efficacy|1|||
23313516|NCT00195338|64892066|FG000|Overall Study|Early closure of the site|4|||
23313517|NCT00901576|64892067|FG000|Second Intervention|Withdrawal by Subject|0|||
23313518|NCT00901576|64892068|FG001|Second Intervention|Withdrawal by Subject|0|||
23313519|NCT00901576|64892069|FG002|Second Intervention|Withdrawal by Subject|0|||
23313520|NCT00901576|64892070|FG003|Second Intervention|Withdrawal by Subject|1|||
23210624|NCT01582971|64509276|FG001|Overall Study|Death|1|||
23210625|NCT01582971|64509275|FG000|Overall Study|Lost to Follow-up|18|||
23210626|NCT01582971|64509276|FG001|Overall Study|Lost to Follow-up|21|||
23210627|NCT01582971|64509275|FG000|Overall Study|Withdrawal by Subject|4|||
23210628|NCT01582971|64509276|FG001|Overall Study|Withdrawal by Subject|2|||
23210629|NCT01582971|64509275|FG000|Overall Study|Other|15|||
23210630|NCT01582971|64509276|FG001|Overall Study|Other|13|||
23543004|NCT00558285|65716150|FG003|Overall Study|Lost to Follow-up|0|||
23543005|NCT00558285|65716151|FG004|Overall Study|Lost to Follow-up|0|||
23313521|NCT00901576|64892071|FG004|Second Intervention|Withdrawal by Subject|0|||
23313522|NCT00901576|64892072|FG005|Second Intervention|Withdrawal by Subject|1|||
23313523|NCT00901576|64892067|FG000|Second Intervention|Physician Decision|1|||
23313524|NCT00901576|64892068|FG001|Second Intervention|Physician Decision|0|||
23313525|NCT00901576|64892069|FG002|Second Intervention|Physician Decision|0|||
23313526|NCT00901576|64892070|FG003|Second Intervention|Physician Decision|0|||
23313527|NCT00901576|64892071|FG004|Second Intervention|Physician Decision|0|||
23313528|NCT00901576|64892072|FG005|Second Intervention|Physician Decision|0|||
23313529|NCT00459043|64892073|FG000|Overall Study|Withdrawal by Subject|1|||
23313530|NCT00459043|64892074|FG001|Overall Study|Withdrawal by Subject|0|||
23313531|NCT02787408|64892077|FG000|Overall Study|Death|16|||
23313532|NCT02787408|64892077|FG000|Overall Study|Withdrawal by Subject|1|||
23313533|NCT02787408|64892077|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
23313534|NCT02425904|64892078|FG000|Overall Study|Lost to Follow-up|1|||
23313535|NCT02425904|64892079|FG001|Overall Study|Lost to Follow-up|0|||
23313536|NCT02425904|64892078|FG000|Overall Study|Withdrawal by Subject|2|||
23313537|NCT02425904|64892079|FG001|Overall Study|Withdrawal by Subject|0|||
23313538|NCT02425904|64892078|FG000|Overall Study|Death|0|||
23313539|NCT02425904|64892079|FG001|Overall Study|Death|3|||
23313540|NCT02806024|64892080|FG000|Overall Study|Night Delivery|1|||
23313541|NCT02806024|64892081|FG001|Overall Study|Night Delivery|1|||
23313542|NCT02806024|64892080|FG000|Overall Study|DVT during antepartum admission|0|||
23313543|NCT02806024|64892081|FG001|Overall Study|DVT during antepartum admission|1|||
23313544|NCT03496610|64892084|FG000|Overall Study|Lost to Follow-up|3|||
23313545|NCT03496610|64892085|FG001|Overall Study|Lost to Follow-up|2|||
23313546|NCT03496610|64892084|FG000|Overall Study|Physician Decision|1|||
23313547|NCT03496610|64892085|FG001|Overall Study|Physician Decision|0|||
23543006|NCT00558285|65716147|FG000|Overall Study|Administrative problems|0|||
23543007|NCT00558285|65716148|FG001|Overall Study|Administrative problems|0|||
23543008|NCT00558285|65716149|FG002|Overall Study|Administrative problems|0|||
23313548|NCT03496610|64892084|FG000|Overall Study|Withdrawal by Subject|1|||
23313549|NCT03496610|64892085|FG001|Overall Study|Withdrawal by Subject|0|||
23313550|NCT00843635|64892091|FG000|Overall Study|Adverse Event|2|||
23313551|NCT00843635|64892092|FG001|Overall Study|Adverse Event|2|||
23313552|NCT00843635|64892093|FG002|Overall Study|Adverse Event|0|||
23543009|NCT00558285|65716150|FG003|Overall Study|Administrative problems|1|||
23313553|NCT04106661|64892096|FG000|Overall Study|Protocol Violation|3|||
23543010|NCT00558285|65716151|FG004|Overall Study|Administrative problems|1|||
23543011|NCT00558285|65716147|FG000|Overall Study|Protocol deviation|1|||
23543012|NCT00558285|65716148|FG001|Overall Study|Protocol deviation|1|||
23543013|NCT00558285|65716149|FG002|Overall Study|Protocol deviation|0|||
23210639|NCT02429258|64509280|FG000|Overall Study|Withdrawal by Subject|2|||
23210640|NCT02429258|64509281|FG001|Overall Study|Withdrawal by Subject|0|||
23210641|NCT02429258|64509280|FG000|Overall Study|Protocol Violation|0|||
23210642|NCT02429258|64509281|FG001|Overall Study|Protocol Violation|1|||
23210643|NCT01586806|64509282|FG000|Overall Study|Protocol Violation|0|||
23210644|NCT01586806|64509283|FG001|Overall Study|Protocol Violation|1|||
23210645|NCT01586806|64509284|FG002|Overall Study|Protocol Violation|0|||
23210646|NCT01586806|64509282|FG000|Overall Study|Withdrawal by Subject|1|||
23210647|NCT01586806|64509283|FG001|Overall Study|Withdrawal by Subject|0|||
23210648|NCT01586806|64509284|FG002|Overall Study|Withdrawal by Subject|0|||
23210649|NCT01586806|64509282|FG000|Overall Study|Lost to Follow-up|2|||
23210650|NCT01586806|64509283|FG001|Overall Study|Lost to Follow-up|3|||
23210651|NCT01586806|64509284|FG002|Overall Study|Lost to Follow-up|2|||
23313554|NCT04106661|64892097|FG001|Overall Study|Protocol Violation|0|||
23313555|NCT04106661|64892096|FG000|Overall Study|Scheduling difficulties|1|||
23313556|NCT04106661|64892097|FG001|Overall Study|Scheduling difficulties|1|||
23313557|NCT04660331|64892098|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
23313558|NCT04660331|64892099|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
23313559|NCT04660331|64892100|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
23313560|NCT04338269|64892101|FG000|Overall Study|Death|86|||
23210652|NCT01363713|64509285|FG000|Overall Study|Adverse Event|1|||
23210653|NCT01363713|64509285|FG000|Overall Study|Protocol Violation|3|||
23210654|NCT01363713|64509285|FG000|Overall Study|Withdrawal by Subject|2|||
23210655|NCT03814590|64509286|FG000|Overall Study|Adverse Event|0|||
23210656|NCT03814590|64509287|FG001|Overall Study|Adverse Event|0|||
23313561|NCT04338269|64892102|FG001|Overall Study|Death|89|||
23313562|NCT04338269|64892101|FG000|Overall Study|Lost to Follow-up|1|||
23313563|NCT04338269|64892102|FG001|Overall Study|Lost to Follow-up|2|||
23313564|NCT04338269|64892101|FG000|Overall Study|Physician Decision|1|||
23313565|NCT04338269|64892102|FG001|Overall Study|Physician Decision|0|||
23313566|NCT04338269|64892101|FG000|Overall Study|Withdrawal by Subject|14|||
23313567|NCT04338269|64892102|FG001|Overall Study|Withdrawal by Subject|11|||
23313568|NCT04759768|64892103|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
23313569|NCT04759768|64892104|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
23313570|NCT04759768|64892103|FG000|Washout (7 Days)|Physician Decision|0|||
23313571|NCT04759768|64892104|FG001|Washout (7 Days)|Physician Decision|1|||
23210657|NCT03814590|64509288|FG002|Overall Study|Adverse Event|0|||
23210658|NCT03814590|64509289|FG003|Overall Study|Adverse Event|0|||
23210659|NCT03814590|64509290|FG004|Overall Study|Adverse Event|0|||
23210660|NCT03814590|64509291|FG005|Overall Study|Adverse Event|1|||
23210661|NCT03814590|64509292|FG006|Overall Study|Adverse Event|1|||
23210662|NCT03814590|64509293|FG007|Overall Study|Adverse Event|1|||
23210663|NCT03814590|64509294|FG008|Overall Study|Adverse Event|0|||
23210664|NCT03814590|64509295|FG009|Overall Study|Adverse Event|0|||
23210665|NCT03814590|64509296|FG010|Overall Study|Adverse Event|1|||
23210666|NCT03814590|64509297|FG011|Overall Study|Adverse Event|0|||
23210667|NCT03814590|64509298|FG012|Overall Study|Adverse Event|3|||
23210668|NCT03814590|64509299|FG013|Overall Study|Adverse Event|0|||
23210669|NCT03814590|64509286|FG000|Overall Study|Lost to Follow-up|0|||
23210670|NCT03814590|64509287|FG001|Overall Study|Lost to Follow-up|2|||
23210671|NCT03814590|64509288|FG002|Overall Study|Lost to Follow-up|1|||
23210672|NCT03814590|64509289|FG003|Overall Study|Lost to Follow-up|0|||
23313572|NCT03597464|64892107|FG000|Overall Study|Withdrawal by Subject|4|||
23313573|NCT03597464|64892108|FG001|Overall Study|Withdrawal by Subject|5|||
23313574|NCT03597464|64892107|FG000|Overall Study|Lost to Follow-up|3|||
23313575|NCT03597464|64892108|FG001|Overall Study|Lost to Follow-up|1|||
23313576|NCT03597464|64892107|FG000|Overall Study|Pregnancy|3|||
23313577|NCT03597464|64892108|FG001|Overall Study|Pregnancy|1|||
23313578|NCT03597464|64892107|FG000|Overall Study|Lack of Efficacy|2|||
23313579|NCT03597464|64892108|FG001|Overall Study|Lack of Efficacy|0|||
23313580|NCT03597464|64892107|FG000|Overall Study|Physician Decision|2|||
23313581|NCT03597464|64892108|FG001|Overall Study|Physician Decision|2|||
23313582|NCT03597464|64892107|FG000|Overall Study|Protocol Violation|1|||
23210673|NCT03814590|64509290|FG004|Overall Study|Lost to Follow-up|1|||
23210674|NCT03814590|64509291|FG005|Overall Study|Lost to Follow-up|1|||
23210675|NCT03814590|64509292|FG006|Overall Study|Lost to Follow-up|1|||
23210676|NCT03814590|64509293|FG007|Overall Study|Lost to Follow-up|1|||
23210677|NCT03814590|64509294|FG008|Overall Study|Lost to Follow-up|0|||
23210678|NCT03814590|64509295|FG009|Overall Study|Lost to Follow-up|0|||
23210679|NCT03814590|64509296|FG010|Overall Study|Lost to Follow-up|1|||
23210680|NCT03814590|64509297|FG011|Overall Study|Lost to Follow-up|0|||
23210681|NCT03814590|64509298|FG012|Overall Study|Lost to Follow-up|0|||
23210682|NCT03814590|64509299|FG013|Overall Study|Lost to Follow-up|1|||
23210683|NCT03814590|64509286|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210684|NCT03814590|64509287|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210685|NCT03814590|64509288|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210686|NCT03814590|64509289|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210687|NCT03814590|64509290|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210688|NCT03814590|64509291|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210689|NCT03814590|64509292|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210690|NCT03814590|64509293|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210691|NCT03814590|64509294|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210692|NCT03814590|64509295|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
23210693|NCT03814590|64509296|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210694|NCT03814590|64509297|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210695|NCT03814590|64509298|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210696|NCT03814590|64509299|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
23210697|NCT03814590|64509286|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23210698|NCT03814590|64509287|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23210699|NCT03814590|64509288|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23210700|NCT03814590|64509289|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23210701|NCT03814590|64509290|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23210702|NCT03814590|64509291|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
23210703|NCT03814590|64509292|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
23210704|NCT03814590|64509293|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
23210705|NCT03814590|64509294|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23210706|NCT03814590|64509295|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
23210707|NCT03814590|64509296|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
23210708|NCT03814590|64509297|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
23210709|NCT03814590|64509298|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
23210710|NCT03814590|64509299|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
23210711|NCT03814590|64509286|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210712|NCT03814590|64509287|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210713|NCT03814590|64509288|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210714|NCT03814590|64509289|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210715|NCT03814590|64509290|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210716|NCT03814590|64509291|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210717|NCT03814590|64509292|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210718|NCT03814590|64509293|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23210719|NCT03814590|64509294|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210720|NCT03814590|64509295|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23210721|NCT03814590|64509296|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210722|NCT03814590|64509297|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210723|NCT03814590|64509298|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210724|NCT03814590|64509299|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23210725|NCT03814590|64509286|FG000|Overall Study|UNKNOWN REASON|0|||
23210726|NCT03814590|64509287|FG001|Overall Study|UNKNOWN REASON|0|||
23210727|NCT03814590|64509288|FG002|Overall Study|UNKNOWN REASON|0|||
23210728|NCT03814590|64509289|FG003|Overall Study|UNKNOWN REASON|0|||
23210729|NCT03814590|64509290|FG004|Overall Study|UNKNOWN REASON|0|||
23210730|NCT03814590|64509291|FG005|Overall Study|UNKNOWN REASON|0|||
23210731|NCT03814590|64509292|FG006|Overall Study|UNKNOWN REASON|0|||
23210732|NCT03814590|64509293|FG007|Overall Study|UNKNOWN REASON|1|||
23210733|NCT03814590|64509294|FG008|Overall Study|UNKNOWN REASON|0|||
23210734|NCT03814590|64509295|FG009|Overall Study|UNKNOWN REASON|0|||
23210735|NCT03814590|64509296|FG010|Overall Study|UNKNOWN REASON|0|||
23210736|NCT03814590|64509297|FG011|Overall Study|UNKNOWN REASON|0|||
23210737|NCT03814590|64509298|FG012|Overall Study|UNKNOWN REASON|0|||
23210738|NCT03814590|64509299|FG013|Overall Study|UNKNOWN REASON|0|||
23543014|NCT00558285|65716150|FG003|Overall Study|Protocol deviation|1|||
23210739|NCT01318512|64509300|FG000|Maintenance Period (6 Months)|Death|2|||
23210740|NCT01318512|64509300|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
23210741|NCT01653158|64509301|FG000|Overall Study|Death|0|||
23210742|NCT01653158|64509302|FG001|Overall Study|Death|0|||
23210743|NCT01653158|64509303|FG002|Overall Study|Death|0|||
23210744|NCT01653158|64509304|FG003|Overall Study|Death|1|||
23210745|NCT01653158|64509305|FG004|Overall Study|Death|0|||
23424809|NCT03023826|65299757|FG005|Period 1|Withdrawal by Subject|0|||
23424810|NCT04465877|65299763|FG000|Overall Study|Noncompliant with study requirements|0|||
23543015|NCT00558285|65716151|FG004|Overall Study|Protocol deviation|0|||
23543016|NCT02055352|65716152|FG000|Overall Study|Adverse Event|0|||
23543017|NCT02055352|65716153|FG001|Overall Study|Adverse Event|1|||
23543018|NCT02055352|65716152|FG000|Overall Study|Non-eligible|0|||
23543019|NCT02055352|65716153|FG001|Overall Study|Non-eligible|1|||
23543020|NCT02055352|65716152|FG000|Overall Study|Poor compliance|1|||
23543021|NCT02055352|65716153|FG001|Overall Study|Poor compliance|1|||
23543022|NCT02055352|65716152|FG000|Overall Study|Death|1|||
23543023|NCT02055352|65716153|FG001|Overall Study|Death|2|||
23543024|NCT02055352|65716152|FG000|Overall Study|Patient decision|1|||
23543025|NCT02055352|65716153|FG001|Overall Study|Patient decision|1|||
23543026|NCT02055352|65716152|FG000|Overall Study|Use of prohibited treatment|0|||
23543027|NCT02055352|65716153|FG001|Overall Study|Use of prohibited treatment|3|||
23543028|NCT02055352|65716152|FG000|Overall Study|AE, study drug would be detrimental|1|||
23543029|NCT02055352|65716153|FG001|Overall Study|AE, study drug would be detrimental|3|||
23543030|NCT02055352|65716152|FG000|Overall Study|Withdrawal of informed consent|1|||
23543031|NCT02055352|65716153|FG001|Overall Study|Withdrawal of informed consent|0|||
23543032|NCT02055352|65716152|FG000|Overall Study|Reason unknown|1|||
23543033|NCT02055352|65716153|FG001|Overall Study|Reason unknown|5|||
23543034|NCT00766376|65716154|FG000|Overall Study|Withdrawal by Subject|27|||
23543035|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
23543036|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
23543037|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
23543038|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
23543039|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
23424811|NCT04465877|65299764|FG001|Overall Study|Noncompliant with study requirements|0|||
23424812|NCT04465877|65299765|FG002|Overall Study|Noncompliant with study requirements|1|||
23424813|NCT04465877|65299766|FG003|Overall Study|Noncompliant with study requirements|0|||
23424814|NCT01457950|65299767|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
23424815|NCT01457950|65299768|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
23424816|NCT01457950|65299769|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
23424817|NCT01457950|65299770|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
23424818|NCT01457950|65299767|FG000|Double-Blind Phase|Protocol Violation|2|||
23424819|NCT01457950|65299768|FG001|Double-Blind Phase|Protocol Violation|1|||
23424820|NCT01457950|65299769|FG002|Double-Blind Phase|Protocol Violation|0|||
23424821|NCT01457950|65299770|FG003|Double-Blind Phase|Protocol Violation|0|||
23424822|NCT01457950|65299767|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
23424823|NCT01457950|65299768|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
23424824|NCT01457950|65299769|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23424825|NCT01457950|65299770|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23424826|NCT01457950|65299767|FG000|Open-Label Phase|Adverse Event|0|||
23424827|NCT01457950|65299768|FG001|Open-Label Phase|Adverse Event|0|||
23424828|NCT01457950|65299769|FG002|Open-Label Phase|Adverse Event|0|||
23424829|NCT01457950|65299770|FG003|Open-Label Phase|Adverse Event|1|||
23424830|NCT01457950|65299767|FG000|Open-Label Phase|Protocol Violation|0|||
23424831|NCT01457950|65299768|FG001|Open-Label Phase|Protocol Violation|0|||
23424832|NCT01457950|65299769|FG002|Open-Label Phase|Protocol Violation|0|||
23424833|NCT01457950|65299770|FG003|Open-Label Phase|Protocol Violation|1|||
23424834|NCT01457950|65299767|FG000|Open-Label Phase|Withdrawal by Subject|0|||
23424835|NCT01457950|65299768|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23424836|NCT01457950|65299769|FG002|Open-Label Phase|Withdrawal by Subject|2|||
23424837|NCT01457950|65299770|FG003|Open-Label Phase|Withdrawal by Subject|0|||
23424838|NCT01703117|65299771|FG000|Overall Study|Adverse Event|4|||
23543040|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
23543041|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
23543042|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
23543043|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
23543044|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
23210746|NCT01653158|64509306|FG005|Overall Study|Death|0|||
23210747|NCT01653158|64509307|FG006|Overall Study|Death|0|||
23210748|NCT01653158|64509308|FG007|Overall Study|Death|2|||
23210749|NCT01653158|64509301|FG000|Overall Study|Adverse Event|0|||
23424839|NCT01703117|65299772|FG001|Overall Study|Adverse Event|3|||
23424840|NCT01703117|65299771|FG000|Overall Study|Withdrawal by Subject|0|||
23424841|NCT01703117|65299772|FG001|Overall Study|Withdrawal by Subject|1|||
23424842|NCT03385265|65299773|FG000|Overall Study|Withdrawal by Subject|5|||
23424843|NCT03385265|65299774|FG001|Overall Study|Withdrawal by Subject|2|||
23210750|NCT01653158|64509302|FG001|Overall Study|Adverse Event|0|||
23210751|NCT01653158|64509303|FG002|Overall Study|Adverse Event|0|||
23210752|NCT01653158|64509304|FG003|Overall Study|Adverse Event|1|||
23210753|NCT01653158|64509305|FG004|Overall Study|Adverse Event|0|||
23210754|NCT01653158|64509306|FG005|Overall Study|Adverse Event|0|||
23210755|NCT01653158|64509307|FG006|Overall Study|Adverse Event|0|||
23210756|NCT01653158|64509308|FG007|Overall Study|Adverse Event|3|||
23210757|NCT01653158|64509301|FG000|Overall Study|Other|0|||
23210758|NCT01653158|64509302|FG001|Overall Study|Other|0|||
23210759|NCT01653158|64509303|FG002|Overall Study|Other|0|||
23210760|NCT01653158|64509304|FG003|Overall Study|Other|0|||
23210761|NCT01653158|64509305|FG004|Overall Study|Other|0|||
23210762|NCT01653158|64509306|FG005|Overall Study|Other|0|||
23210763|NCT01653158|64509307|FG006|Overall Study|Other|0|||
23210764|NCT01653158|64509308|FG007|Overall Study|Other|1|||
23210765|NCT01653158|64509301|FG000|Overall Study|Progressive disease|0|||
23210766|NCT01653158|64509302|FG001|Overall Study|Progressive disease|0|||
23210767|NCT01653158|64509303|FG002|Overall Study|Progressive disease|0|||
23210768|NCT01653158|64509304|FG003|Overall Study|Progressive disease|0|||
23210769|NCT01653158|64509305|FG004|Overall Study|Progressive disease|1|||
23210770|NCT01653158|64509306|FG005|Overall Study|Progressive disease|1|||
23210771|NCT01653158|64509307|FG006|Overall Study|Progressive disease|2|||
23210772|NCT01653158|64509308|FG007|Overall Study|Progressive disease|9|||
23210773|NCT01653158|64509301|FG000|Overall Study|Withdrawal by Subject|1|||
23210774|NCT01653158|64509302|FG001|Overall Study|Withdrawal by Subject|0|||
23210775|NCT01653158|64509303|FG002|Overall Study|Withdrawal by Subject|0|||
23210776|NCT01653158|64509304|FG003|Overall Study|Withdrawal by Subject|0|||
23210777|NCT01653158|64509305|FG004|Overall Study|Withdrawal by Subject|0|||
23210778|NCT01653158|64509306|FG005|Overall Study|Withdrawal by Subject|0|||
23210779|NCT01653158|64509307|FG006|Overall Study|Withdrawal by Subject|0|||
23210780|NCT01653158|64509308|FG007|Overall Study|Withdrawal by Subject|0|||
23210781|NCT00523341|64509311|FG000|Overall Study|Withdrawal by Subject|399|||
23210782|NCT00523341|64509312|FG001|Overall Study|Withdrawal by Subject|427|||
23210783|NCT00523341|64509311|FG000|Overall Study|Other|181|||
23210784|NCT00523341|64509312|FG001|Overall Study|Other|198|||
23210785|NCT00523341|64509311|FG000|Overall Study|Adverse Event|122|||
23210786|NCT00523341|64509312|FG001|Overall Study|Adverse Event|155|||
23210787|NCT00523341|64509311|FG000|Overall Study|Death|101|||
23210788|NCT00523341|64509312|FG001|Overall Study|Death|110|||
23210789|NCT00523341|64509311|FG000|Overall Study|Lost to Follow-up|73|||
23210790|NCT00523341|64509312|FG001|Overall Study|Lost to Follow-up|61|||
23210791|NCT00523341|64509311|FG000|Overall Study|Non-compliance|20|||
23210792|NCT00523341|64509312|FG001|Overall Study|Non-compliance|13|||
23210793|NCT00523341|64509311|FG000|Overall Study|Physician Decision|14|||
23210794|NCT00523341|64509312|FG001|Overall Study|Physician Decision|13|||
23210795|NCT00523341|64509311|FG000|Overall Study|Requirement for Alternative Therapy|4|||
23210796|NCT00523341|64509312|FG001|Overall Study|Requirement for Alternative Therapy|14|||
23543045|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
23543046|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
23543047|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
23543048|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
23543049|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
23543050|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
23543051|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
23543052|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
23543053|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
23543054|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
23543055|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
23543056|NCT02161718|65719718|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
23543057|NCT02161718|65719719|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
23543058|NCT02161718|65719720|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
23210797|NCT00523341|64509311|FG000|Overall Study|Protocol Deviation|6|||
23210798|NCT00523341|64509312|FG001|Overall Study|Protocol Deviation|5|||
23210799|NCT00523341|64509311|FG000|Overall Study|Ineligibility Determined|3|||
23210800|NCT00523341|64509312|FG001|Overall Study|Ineligibility Determined|4|||
23210801|NCT00523341|64509311|FG000|Overall Study|Disease Progression|1|||
23210802|NCT00523341|64509312|FG001|Overall Study|Disease Progression|0|||
23210803|NCT01973452|64509313|FG000|Overall Study|Lack of Efficacy|0|||
23210804|NCT01973452|64509314|FG001|Overall Study|Lack of Efficacy|1|||
23210805|NCT01973452|64509313|FG000|Overall Study|Lost to Follow-up|1|||
23210806|NCT01973452|64509314|FG001|Overall Study|Lost to Follow-up|0|||
23543059|NCT02161718|65719718|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
23543060|NCT02161718|65719719|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
23210807|NCT01973452|64509313|FG000|Overall Study|Withdrawal by Subject|10|||
23210808|NCT01973452|64509314|FG001|Overall Study|Withdrawal by Subject|9|||
23210809|NCT01973452|64509313|FG000|Overall Study|Ineligible|1|||
23210810|NCT01973452|64509314|FG001|Overall Study|Ineligible|1|||
23210811|NCT01973452|64509313|FG000|Overall Study|Surgery canceled by participant|5|||
23543061|NCT02161718|65719720|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
23543062|NCT02161718|65719718|FG000|Post- Randomization Period|Lost to Follow-up|0|||
23543063|NCT02161718|65719719|FG001|Post- Randomization Period|Lost to Follow-up|9|||
23543064|NCT02161718|65719720|FG002|Post- Randomization Period|Lost to Follow-up|15|||
23543065|NCT02161718|65719718|FG000|Post- Randomization Period|Adverse Event|0|||
23543066|NCT02161718|65719719|FG001|Post- Randomization Period|Adverse Event|9|||
23543067|NCT02161718|65719720|FG002|Post- Randomization Period|Adverse Event|10|||
23543068|NCT02161718|65719718|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
23543069|NCT02161718|65719719|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
23543070|NCT02161718|65719720|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
23543071|NCT02161718|65719718|FG000|Post- Randomization Period|Physician Decision|0|||
23543072|NCT02161718|65719719|FG001|Post- Randomization Period|Physician Decision|2|||
23543073|NCT02161718|65719720|FG002|Post- Randomization Period|Physician Decision|4|||
23543074|NCT02161718|65719718|FG000|Post- Randomization Period|Protocol Violation|0|||
23543075|NCT02161718|65719719|FG001|Post- Randomization Period|Protocol Violation|2|||
23543076|NCT02161718|65719720|FG002|Post- Randomization Period|Protocol Violation|3|||
23543077|NCT02161718|65719718|FG000|Post- Randomization Period|Lack of Efficacy|0|||
23543078|NCT02161718|65719719|FG001|Post- Randomization Period|Lack of Efficacy|0|||
23543079|NCT02161718|65719720|FG002|Post- Randomization Period|Lack of Efficacy|1|||
23543080|NCT02161718|65719718|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
23543081|NCT02161718|65719719|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
23543082|NCT02161718|65719720|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
23543083|NCT02161718|65719718|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
23543084|NCT02161718|65719719|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
23543085|NCT02161718|65719720|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
23543086|NCT02161718|65719718|FG000|Post- Randomization Period|Relocation|0|||
23543087|NCT02161718|65719719|FG001|Post- Randomization Period|Relocation|3|||
23543088|NCT02161718|65719720|FG002|Post- Randomization Period|Relocation|0|||
23543089|NCT03538626|65719724|FG000|Overall Study|Withdrawal by Subject|0|||
23543090|NCT03538626|65719725|FG001|Overall Study|Withdrawal by Subject|1|||
23424844|NCT03385265|65299775|FG002|Overall Study|Withdrawal by Subject|5|||
23543091|NCT03538626|65719726|FG002|Overall Study|Withdrawal by Subject|0|||
23543092|NCT03538626|65719727|FG003|Overall Study|Withdrawal by Subject|0|||
23543093|NCT03538626|65719728|FG004|Overall Study|Withdrawal by Subject|0|||
23543094|NCT03538626|65719729|FG005|Overall Study|Withdrawal by Subject|0|||
23543095|NCT03538626|65719730|FG006|Overall Study|Withdrawal by Subject|0|||
23543096|NCT03538626|65719731|FG007|Overall Study|Withdrawal by Subject|0|||
23543097|NCT03538626|65719724|FG000|Overall Study|Lost to Follow-up|0|||
23543098|NCT03538626|65719725|FG001|Overall Study|Lost to Follow-up|0|||
23543099|NCT03538626|65719726|FG002|Overall Study|Lost to Follow-up|0|||
23543100|NCT03538626|65719727|FG003|Overall Study|Lost to Follow-up|0|||
23543101|NCT03538626|65719728|FG004|Overall Study|Lost to Follow-up|0|||
23543102|NCT03538626|65719729|FG005|Overall Study|Lost to Follow-up|0|||
23424845|NCT03385265|65299776|FG003|Overall Study|Withdrawal by Subject|2|||
23424846|NCT02813668|65299780|FG000|Overall Study|Death|4|||
23424847|NCT02813668|65299780|FG000|Overall Study|Lost to Follow-up|509|||
23424848|NCT02813668|65299780|FG000|Overall Study|Withdrawal by Subject|148|||
23424849|NCT02813668|65299780|FG000|Overall Study|No longer at worksite|85|||
23424850|NCT02813668|65299780|FG000|Overall Study|Medical reasons not related to the study|4|||
23424851|NCT03554772|65299781|FG000|Overall Study|Lost to Follow-up|0|||
23424852|NCT03554772|65299782|FG001|Overall Study|Lost to Follow-up|0|||
23424853|NCT03554772|65299783|FG002|Overall Study|Lost to Follow-up|0|||
23424854|NCT03554772|65299784|FG003|Overall Study|Lost to Follow-up|2|||
23424855|NCT02229214|65299785|FG000|Overall Study|Adverse Event|2|||
23424856|NCT02229214|65299786|FG001|Overall Study|Adverse Event|0|||
23424857|NCT02229214|65299785|FG000|Overall Study|Withdrawal by Subject|4|||
23543103|NCT03538626|65719730|FG006|Overall Study|Lost to Follow-up|1|||
23543104|NCT03538626|65719731|FG007|Overall Study|Lost to Follow-up|0|||
23543105|NCT01202773|65719732|FG000|Overall Study|Adverse Event|4|||
23543106|NCT01202773|65719733|FG001|Overall Study|Adverse Event|5|||
23543107|NCT01202773|65719734|FG002|Overall Study|Adverse Event|5|||
23543108|NCT01202773|65719732|FG000|Overall Study|Lack of Efficacy|5|||
23543109|NCT01202773|65719733|FG001|Overall Study|Lack of Efficacy|4|||
23543110|NCT01202773|65719734|FG002|Overall Study|Lack of Efficacy|9|||
23424858|NCT02229214|65299786|FG001|Overall Study|Withdrawal by Subject|0|||
23424859|NCT01442064|65299789|FG000|Overall Study|Adverse Event|2|||
23424860|NCT01442064|65299790|FG001|Overall Study|Adverse Event|2|||
23424861|NCT01442064|65299791|FG002|Overall Study|Adverse Event|2|||
23424862|NCT01442064|65299792|FG003|Overall Study|Adverse Event|1|||
23424863|NCT01442064|65299793|FG004|Overall Study|Adverse Event|2|||
23424864|NCT01442064|65299794|FG005|Overall Study|Adverse Event|0|||
23424865|NCT01442064|65299789|FG000|Overall Study|Death|0|||
23424866|NCT01442064|65299790|FG001|Overall Study|Death|1|||
23424867|NCT01442064|65299791|FG002|Overall Study|Death|3|||
23424868|NCT01442064|65299792|FG003|Overall Study|Death|3|||
23424869|NCT01442064|65299793|FG004|Overall Study|Death|1|||
23424870|NCT01442064|65299794|FG005|Overall Study|Death|3|||
23424871|NCT01442064|65299789|FG000|Overall Study|Lost to Follow-up|5|||
23424872|NCT01442064|65299790|FG001|Overall Study|Lost to Follow-up|5|||
23424873|NCT01442064|65299791|FG002|Overall Study|Lost to Follow-up|1|||
23424874|NCT01442064|65299792|FG003|Overall Study|Lost to Follow-up|1|||
23424875|NCT01442064|65299793|FG004|Overall Study|Lost to Follow-up|3|||
23424876|NCT01442064|65299794|FG005|Overall Study|Lost to Follow-up|3|||
23424877|NCT01442064|65299789|FG000|Overall Study|Physician Decision|1|||
23424878|NCT01442064|65299790|FG001|Overall Study|Physician Decision|1|||
23424879|NCT01442064|65299791|FG002|Overall Study|Physician Decision|2|||
23424880|NCT01442064|65299792|FG003|Overall Study|Physician Decision|3|||
23424881|NCT01442064|65299793|FG004|Overall Study|Physician Decision|3|||
23424882|NCT01442064|65299794|FG005|Overall Study|Physician Decision|1|||
23424883|NCT01442064|65299789|FG000|Overall Study|Withdrawal by Subject|6|||
23424884|NCT01442064|65299790|FG001|Overall Study|Withdrawal by Subject|3|||
23424885|NCT01442064|65299791|FG002|Overall Study|Withdrawal by Subject|2|||
23424886|NCT01442064|65299792|FG003|Overall Study|Withdrawal by Subject|2|||
23424887|NCT01442064|65299793|FG004|Overall Study|Withdrawal by Subject|2|||
23424888|NCT01442064|65299794|FG005|Overall Study|Withdrawal by Subject|1|||
23424889|NCT01442064|65299789|FG000|Overall Study|Sponsor decision|82|||
23424890|NCT01442064|65299790|FG001|Overall Study|Sponsor decision|88|||
23424891|NCT01442064|65299791|FG002|Overall Study|Sponsor decision|92|||
23424892|NCT01442064|65299792|FG003|Overall Study|Sponsor decision|88|||
23424893|NCT01442064|65299793|FG004|Overall Study|Sponsor decision|95|||
23424894|NCT01442064|65299794|FG005|Overall Study|Sponsor decision|87|||
23424895|NCT01442064|65299789|FG000|Overall Study|Subject non-compliance|0|||
23424896|NCT01442064|65299790|FG001|Overall Study|Subject non-compliance|0|||
23424897|NCT01442064|65299791|FG002|Overall Study|Subject non-compliance|0|||
23543111|NCT01202773|65719732|FG000|Overall Study|Entry Criteria Not Met|2|||
23543112|NCT01202773|65719733|FG001|Overall Study|Entry Criteria Not Met|0|||
23543113|NCT01202773|65719734|FG002|Overall Study|Entry Criteria Not Met|1|||
23543114|NCT01202773|65719732|FG000|Overall Study|Lost to Follow-up|1|||
23543115|NCT01202773|65719733|FG001|Overall Study|Lost to Follow-up|2|||
23543116|NCT01202773|65719734|FG002|Overall Study|Lost to Follow-up|2|||
23424898|NCT01442064|65299792|FG003|Overall Study|Subject non-compliance|0|||
23424899|NCT01442064|65299793|FG004|Overall Study|Subject non-compliance|0|||
23543117|NCT01202773|65719732|FG000|Overall Study|Withdrawal by Subject|13|||
23424900|NCT01442064|65299794|FG005|Overall Study|Subject non-compliance|2|||
23424901|NCT01442064|65299789|FG000|Overall Study|Condition mandated other intervention|1|||
23424902|NCT01442064|65299790|FG001|Overall Study|Condition mandated other intervention|1|||
23543118|NCT01202773|65719733|FG001|Overall Study|Withdrawal by Subject|6|||
23424903|NCT01442064|65299791|FG002|Overall Study|Condition mandated other intervention|2|||
23424904|NCT01442064|65299792|FG003|Overall Study|Condition mandated other intervention|0|||
23424905|NCT01442064|65299793|FG004|Overall Study|Condition mandated other intervention|0|||
23424906|NCT01442064|65299794|FG005|Overall Study|Condition mandated other intervention|2|||
23424907|NCT03627065|65299795|FG000|Overall Study|Study Terminated by sponsor|1|||
23424908|NCT03627065|65299795|FG000|Overall Study|Withdrawal by Subject|2|||
23424909|NCT05028517|65299796|FG000|Overall Study|Lost to Follow-up|13|||
23424910|NCT05028517|65299797|FG001|Overall Study|Lost to Follow-up|20|||
23424911|NCT05028517|65299798|FG002|Overall Study|Lost to Follow-up|12|||
23424912|NCT05028517|65299796|FG000|Overall Study|Withdrawal by Subject|0|||
23424913|NCT05028517|65299797|FG001|Overall Study|Withdrawal by Subject|0|||
23424914|NCT05028517|65299798|FG002|Overall Study|Withdrawal by Subject|1|||
23424915|NCT02485925|65299799|FG000|Overall Study|Withdrawal by Subject|3|||
23424916|NCT02485925|65299799|FG000|Overall Study|Death|1|||
23424917|NCT02485925|65299799|FG000|Overall Study|Lost to Follow-up|11|||
23424918|NCT01154283|65299800|FG000|0-6 Weeks|Withdrawal by Subject|7|||
23424919|NCT01154283|65299801|FG001|0-6 Weeks|Withdrawal by Subject|2|||
23424920|NCT01154283|65299800|FG000|0-6 Weeks|Death|0|||
23424921|NCT01154283|65299801|FG001|0-6 Weeks|Death|1|||
23424922|NCT01154283|65299800|FG000|7-12 Weeks|Death|1|||
23424923|NCT01154283|65299801|FG001|7-12 Weeks|Death|0|||
23424924|NCT01154283|65299800|FG000|7-12 Weeks|Withdrawal by Subject|0|||
23424925|NCT01154283|65299801|FG001|7-12 Weeks|Withdrawal by Subject|1|||
23424926|NCT01920893|65299803|FG000|Overall Study|Adverse Event|5|||
23424927|NCT01920893|65299804|FG001|Overall Study|Adverse Event|2|||
23424928|NCT01920893|65299803|FG000|Overall Study|Lack of Efficacy|2|||
23424929|NCT01920893|65299804|FG001|Overall Study|Lack of Efficacy|0|||
23424930|NCT00623545|65299805|FG000|Overall Study|Adverse Event|6|||
23424931|NCT00623545|65299805|FG000|Overall Study|Withdrawal by Subject|4|||
23424932|NCT02825420|65299806|FG000|Overall Study|Death|30|||
23424933|NCT02825420|65299807|FG001|Overall Study|Death|12|||
23424934|NCT02825420|65299806|FG000|Overall Study|Progressive disease|6|||
23424935|NCT02825420|65299807|FG001|Overall Study|Progressive disease|1|||
23424936|NCT02825420|65299806|FG000|Overall Study|Lost to Follow-up|2|||
23424937|NCT02825420|65299807|FG001|Overall Study|Lost to Follow-up|2|||
23424938|NCT02825420|65299806|FG000|Overall Study|Withdrawal by Subject|1|||
23424939|NCT02825420|65299807|FG001|Overall Study|Withdrawal by Subject|1|||
23424940|NCT02825420|65299806|FG000|Overall Study|Protocol amendment not signed|1|||
23424941|NCT02825420|65299807|FG001|Overall Study|Protocol amendment not signed|1|||
23424942|NCT02825420|65299806|FG000|Overall Study|Physician Decision|1|||
23424943|NCT02825420|65299807|FG001|Overall Study|Physician Decision|0|||
23424944|NCT02825420|65299806|FG000|Overall Study|Did not receive PLD|2|||
23424945|NCT02825420|65299807|FG001|Overall Study|Did not receive PLD|0|||
23424946|NCT00495521|65299808|FG000|Overall Study|Physician Decision|0|||
23424947|NCT00495521|65299809|FG001|Overall Study|Physician Decision|1|||
23424948|NCT01165320|65299810|FG000|Overall Study|Clinical adverse experience|2|||
23424949|NCT01165320|65299811|FG001|Overall Study|Clinical adverse experience|1|||
23424950|NCT01165320|65299812|FG002|Overall Study|Clinical adverse experience|0|||
23424951|NCT01165320|65299810|FG000|Overall Study|Laboratory adverse experience|1|||
23424952|NCT01165320|65299811|FG001|Overall Study|Laboratory adverse experience|0|||
23424953|NCT01165320|65299812|FG002|Overall Study|Laboratory adverse experience|0|||
23424954|NCT01165320|65299810|FG000|Overall Study|Lack of Efficacy|0|||
23424955|NCT01165320|65299811|FG001|Overall Study|Lack of Efficacy|2|||
23424956|NCT01165320|65299812|FG002|Overall Study|Lack of Efficacy|0|||
23424957|NCT01165320|65299810|FG000|Overall Study|Reason unknown|0|||
23424958|NCT01165320|65299811|FG001|Overall Study|Reason unknown|1|||
23424959|NCT01165320|65299812|FG002|Overall Study|Reason unknown|0|||
23424960|NCT02046174|65299813|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
23424961|NCT02046174|65299814|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
23424962|NCT02275117|65299815|FG000|Overall Study|Adverse Event|0|||
23424963|NCT02275117|65299816|FG001|Overall Study|Adverse Event|0|||
23424964|NCT02275117|65299817|FG002|Overall Study|Adverse Event|0|||
23424965|NCT02275117|65299818|FG003|Overall Study|Adverse Event|0|||
23424966|NCT02275117|65299819|FG004|Overall Study|Adverse Event|1|||
23424967|NCT02275117|65299815|FG000|Overall Study|Lack of Efficacy|6|||
23424968|NCT02275117|65299816|FG001|Overall Study|Lack of Efficacy|7|||
23424969|NCT02275117|65299817|FG002|Overall Study|Lack of Efficacy|5|||
23424970|NCT02275117|65299818|FG003|Overall Study|Lack of Efficacy|2|||
23424971|NCT02275117|65299819|FG004|Overall Study|Lack of Efficacy|10|||
23424972|NCT02275117|65299815|FG000|Overall Study|Lost to Follow-up|11|||
23424973|NCT02275117|65299816|FG001|Overall Study|Lost to Follow-up|16|||
23424974|NCT02275117|65299817|FG002|Overall Study|Lost to Follow-up|15|||
23424975|NCT02275117|65299818|FG003|Overall Study|Lost to Follow-up|16|||
23424976|NCT02275117|65299819|FG004|Overall Study|Lost to Follow-up|8|||
23424977|NCT02275117|65299815|FG000|Overall Study|Physician Decision|0|||
23424978|NCT02275117|65299816|FG001|Overall Study|Physician Decision|1|||
23424979|NCT02275117|65299817|FG002|Overall Study|Physician Decision|1|||
23424980|NCT02275117|65299818|FG003|Overall Study|Physician Decision|0|||
23424981|NCT02275117|65299819|FG004|Overall Study|Physician Decision|1|||
23543119|NCT01202773|65719734|FG002|Overall Study|Withdrawal by Subject|5|||
23543120|NCT01202773|65719732|FG000|Overall Study|Physician Decision|2|||
23543121|NCT01202773|65719733|FG001|Overall Study|Physician Decision|0|||
23543122|NCT01202773|65719734|FG002|Overall Study|Physician Decision|0|||
23543123|NCT01202773|65719732|FG000|Overall Study|Protocol Violation|11|||
23543124|NCT01202773|65719733|FG001|Overall Study|Protocol Violation|6|||
23543125|NCT01202773|65719734|FG002|Overall Study|Protocol Violation|10|||
23543126|NCT01202773|65719732|FG000|Overall Study|Sponsor Decision|19|||
23543127|NCT01202773|65719733|FG001|Overall Study|Sponsor Decision|20|||
23543128|NCT01202773|65719734|FG002|Overall Study|Sponsor Decision|23|||
23543129|NCT02647658|65719735|FG000|Overall Study|Consent refusal|15|||
23543130|NCT02647658|65719736|FG001|Overall Study|Consent refusal|24|||
23543131|NCT01925183|65719737|FG000|Overall Study|Adverse Event|1|||
23543132|NCT01925183|65719738|FG001|Overall Study|Adverse Event|0|||
23543133|NCT03387852|65719739|FG000|Overall Study|Adverse event (AE)|3|||
23543134|NCT03387852|65719740|FG001|Overall Study|Adverse event (AE)|0|||
23616690|NCT02256488|65982408|FG000|Overall Study|Lost to Follow-up|6|||
23424982|NCT02275117|65299815|FG000|Overall Study|Protocol Violation|1|||
23424983|NCT02275117|65299816|FG001|Overall Study|Protocol Violation|0|||
23424984|NCT02275117|65299817|FG002|Overall Study|Protocol Violation|1|||
23424985|NCT02275117|65299818|FG003|Overall Study|Protocol Violation|1|||
23424986|NCT02275117|65299819|FG004|Overall Study|Protocol Violation|0|||
23424987|NCT02275117|65299815|FG000|Overall Study|Withdrawal by Subject|6|||
23424988|NCT02275117|65299816|FG001|Overall Study|Withdrawal by Subject|4|||
23424989|NCT02275117|65299817|FG002|Overall Study|Withdrawal by Subject|7|||
23424990|NCT02275117|65299818|FG003|Overall Study|Withdrawal by Subject|3|||
23424991|NCT02275117|65299819|FG004|Overall Study|Withdrawal by Subject|3|||
23424992|NCT02275117|65299815|FG000|Overall Study|Terminated by Sponsor|4|||
23424993|NCT02275117|65299816|FG001|Overall Study|Terminated by Sponsor|4|||
23424994|NCT02275117|65299817|FG002|Overall Study|Terminated by Sponsor|4|||
23424995|NCT02275117|65299818|FG003|Overall Study|Terminated by Sponsor|6|||
23424996|NCT02275117|65299819|FG004|Overall Study|Terminated by Sponsor|4|||
23424997|NCT02275117|65299815|FG000|Overall Study|Worsening of Study Indication|0|||
23424998|NCT02275117|65299816|FG001|Overall Study|Worsening of Study Indication|1|||
23424999|NCT02275117|65299817|FG002|Overall Study|Worsening of Study Indication|2|||
23425000|NCT02275117|65299818|FG003|Overall Study|Worsening of Study Indication|0|||
23425001|NCT02275117|65299819|FG004|Overall Study|Worsening of Study Indication|0|||
23425002|NCT02275117|65299815|FG000|Overall Study|Study Burden|5|||
23425003|NCT02275117|65299816|FG001|Overall Study|Study Burden|4|||
23425004|NCT02275117|65299817|FG002|Overall Study|Study Burden|7|||
23425005|NCT02275117|65299818|FG003|Overall Study|Study Burden|5|||
23425006|NCT02275117|65299819|FG004|Overall Study|Study Burden|7|||
23425007|NCT02275117|65299815|FG000|Overall Study|Other|1|||
23425008|NCT02275117|65299816|FG001|Overall Study|Other|0|||
23425009|NCT02275117|65299817|FG002|Overall Study|Other|0|||
23425010|NCT02275117|65299818|FG003|Overall Study|Other|0|||
23425011|NCT02275117|65299819|FG004|Overall Study|Other|2|||
23425012|NCT01294462|65299820|FG000|Overall Study|Lost to Follow-up|1|||
23425013|NCT01294462|65299821|FG001|Overall Study|Lost to Follow-up|0|||
23425014|NCT01294462|65299820|FG000|Overall Study|Withdrawal by Subject|65|||
23425015|NCT01294462|65299821|FG001|Overall Study|Withdrawal by Subject|63|||
23543135|NCT03387852|65719741|FG002|Overall Study|Adverse event (AE)|2|||
23543136|NCT03387852|65719742|FG003|Overall Study|Adverse event (AE)|0|||
23543137|NCT03387852|65719739|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
23543138|NCT03387852|65719740|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
23425016|NCT01344538|65299822|FG000|Overall Study|Adverse Event|1|||
23425017|NCT01344538|65299823|FG001|Overall Study|Adverse Event|1|||
23425018|NCT01344538|65299822|FG000|Overall Study|Lost to Follow-up|1|||
23543139|NCT03387852|65719741|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
23210812|NCT01973452|64509314|FG001|Overall Study|Surgery canceled by participant|3|||
23210813|NCT03364335|64509320|FG000|Overall Study|Adverse Event|3|||
23210814|NCT03364335|64509321|FG001|Overall Study|Adverse Event|4|||
23210815|NCT03364335|64509322|FG002|Overall Study|Adverse Event|1|||
23210816|NCT03364335|64509323|FG003|Overall Study|Adverse Event|2|||
23210817|NCT03364335|64509324|FG004|Overall Study|Adverse Event|0|||
23210818|NCT03364335|64509320|FG000|Overall Study|Lost to Follow-up|7|||
23210819|NCT03364335|64509321|FG001|Overall Study|Lost to Follow-up|7|||
23210820|NCT03364335|64509322|FG002|Overall Study|Lost to Follow-up|10|||
23210821|NCT03364335|64509323|FG003|Overall Study|Lost to Follow-up|11|||
23210822|NCT03364335|64509324|FG004|Overall Study|Lost to Follow-up|11|||
23210823|NCT00862121|64509325|FG000|Overall Study|Adverse Event|1|||
23210824|NCT00862121|64509326|FG001|Overall Study|Adverse Event|2|||
23210825|NCT00862121|64509325|FG000|Overall Study|Lack of Efficacy|0|||
23210826|NCT00862121|64509326|FG001|Overall Study|Lack of Efficacy|3|||
23210827|NCT00862121|64509325|FG000|Overall Study|Protocol Violation|0|||
23210828|NCT00862121|64509326|FG001|Overall Study|Protocol Violation|1|||
23210829|NCT00862121|64509325|FG000|Overall Study|Exclusion criterion violation|0|||
23210830|NCT00862121|64509326|FG001|Overall Study|Exclusion criterion violation|1|||
23210831|NCT00862121|64509325|FG000|Overall Study|Incorrect randomisation|0|||
23210832|NCT00862121|64509326|FG001|Overall Study|Incorrect randomisation|1|||
23210833|NCT03297216|64509327|FG000|Overall Study|Death|0|||
23210834|NCT03297216|64509328|FG001|Overall Study|Death|1|||
23210835|NCT03297216|64509327|FG000|Overall Study|Miscarriage|0|||
23210836|NCT03297216|64509328|FG001|Overall Study|Miscarriage|2|||
23210837|NCT03297216|64509327|FG000|Overall Study|Lost to Follow-up|3|||
23210838|NCT03297216|64509328|FG001|Overall Study|Lost to Follow-up|2|||
23210839|NCT00643487|64509331|FG000|Overall Study|Technical difficulty|3|||
23210840|NCT02887859|64509335|FG000|Overall Study|Ongoing|6|||
23210841|NCT02887859|64509335|FG000|Overall Study|Adverse Event|7|||
23210842|NCT02887859|64509335|FG000|Overall Study|Death|1|||
23210843|NCT02887859|64509335|FG000|Overall Study|Physician Decision|1|||
23210844|NCT01106625|64509339|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
23210845|NCT01106625|64509340|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
23210846|NCT01106625|64509341|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
23210847|NCT01106625|64509339|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
23616691|NCT02256488|65982409|FG001|Overall Study|Lost to Follow-up|6|||
23210848|NCT01106625|64509340|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
23210849|NCT01106625|64509341|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
23210850|NCT01106625|64509339|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
23313583|NCT03597464|64892108|FG001|Overall Study|Protocol Violation|1|||
23425019|NCT01344538|65299823|FG001|Overall Study|Lost to Follow-up|0|||
23616692|NCT02256488|65982410|FG002|Overall Study|Lost to Follow-up|9|||
23210851|NCT01106625|64509340|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
23210852|NCT01106625|64509341|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
23210853|NCT01106625|64509339|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
23210854|NCT01106625|64509340|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
23210855|NCT01106625|64509341|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
23313584|NCT03597464|64892107|FG000|Overall Study|Adverse Event|0|||
23313585|NCT03597464|64892108|FG001|Overall Study|Adverse Event|2|||
23313586|NCT03597464|64892107|FG000|Overall Study|Death|0|||
23313587|NCT03597464|64892108|FG001|Overall Study|Death|3|||
23313588|NCT04974749|64892109|FG000|Overall Study|Withdrawal by Subject|2|||
23313589|NCT04974749|64892109|FG000|Overall Study|Gestation|1|||
23313590|NCT04239027|64892110|FG000|Overall Study|Adverse Event|4|||
23313591|NCT04239027|64892110|FG000|Overall Study|Withdrawal by Subject|9|||
23313592|NCT04239027|64892110|FG000|Overall Study|Death|1|||
23313593|NCT04239027|64892110|FG000|Overall Study|Physician Decision|9|||
23313594|NCT04239027|64892110|FG000|Overall Study|Lost to Follow-up|2|||
23313595|NCT04239027|64892110|FG000|Overall Study|Lack of Efficacy|1|||
23313596|NCT04076059|64892111|FG000|Double Blind Phase|Progressive disease|22|||
23313597|NCT04076059|64892112|FG001|Double Blind Phase|Progressive disease|26|||
23313598|NCT04076059|64892113|FG002|Double Blind Phase|Progressive disease|0|||
23313599|NCT04076059|64892111|FG000|Double Blind Phase|Withdrawal by Subject|4|||
23313600|NCT04076059|64892112|FG001|Double Blind Phase|Withdrawal by Subject|11|||
23313601|NCT04076059|64892113|FG002|Double Blind Phase|Withdrawal by Subject|0|||
23313602|NCT04076059|64892111|FG000|Double Blind Phase|Death|1|||
23313603|NCT04076059|64892112|FG001|Double Blind Phase|Death|1|||
23313604|NCT04076059|64892113|FG002|Double Blind Phase|Death|0|||
23313605|NCT04076059|64892111|FG000|Double Blind Phase|Lost to Follow-up|1|||
23313606|NCT04076059|64892112|FG001|Double Blind Phase|Lost to Follow-up|0|||
23313607|NCT04076059|64892113|FG002|Double Blind Phase|Lost to Follow-up|0|||
23313608|NCT04076059|64892111|FG000|Double Blind Phase|Adverse Event|5|||
23313609|NCT04076059|64892112|FG001|Double Blind Phase|Adverse Event|1|||
23313610|NCT04076059|64892113|FG002|Double Blind Phase|Adverse Event|0|||
23313611|NCT04076059|64892111|FG000|Double Blind Phase|Ongoing Participants|82|||
23313612|NCT04076059|64892112|FG001|Double Blind Phase|Ongoing Participants|18|||
23313613|NCT04076059|64892113|FG002|Double Blind Phase|Ongoing Participants|0|||
23313614|NCT04076059|64892111|FG000|Double Blind Phase|Miscellaneous|3|||
23313615|NCT04076059|64892112|FG001|Double Blind Phase|Miscellaneous|1|||
23313616|NCT04076059|64892113|FG002|Double Blind Phase|Miscellaneous|0|||
23313617|NCT04076059|64892111|FG000|Double Blind Phase|Protocol Deviation|1|||
23313618|NCT04076059|64892112|FG001|Double Blind Phase|Protocol Deviation|1|||
23313619|NCT04076059|64892113|FG002|Double Blind Phase|Protocol Deviation|0|||
23313620|NCT04076059|64892111|FG000|Double Blind Phase|Did not take study drug|1|||
23313621|NCT04076059|64892112|FG001|Double Blind Phase|Did not take study drug|1|||
23313622|NCT04076059|64892113|FG002|Double Blind Phase|Did not take study drug|0|||
23313623|NCT04076059|64892111|FG000|Open Label Phase|Progressive disease|0|||
23210856|NCT01106625|64509339|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
23313624|NCT04076059|64892112|FG001|Open Label Phase|Progressive disease|0|||
23313625|NCT04076059|64892113|FG002|Open Label Phase|Progressive disease|7|||
23313626|NCT04076059|64892111|FG000|Open Label Phase|Withdrawal by Subject|0|||
23313627|NCT04076059|64892112|FG001|Open Label Phase|Withdrawal by Subject|0|||
23616693|NCT02256488|65982411|FG003|Overall Study|Lost to Follow-up|3|||
23616694|NCT02256488|65982408|FG000|Overall Study|OTHER|1|||
23616695|NCT02256488|65982409|FG001|Overall Study|OTHER|0|||
23616696|NCT02256488|65982410|FG002|Overall Study|OTHER|1|||
23616697|NCT02256488|65982411|FG003|Overall Study|OTHER|1|||
23616698|NCT02256488|65982408|FG000|Overall Study|Withdrawal by Subject|1|||
23616699|NCT02256488|65982409|FG001|Overall Study|Withdrawal by Subject|0|||
23616700|NCT02256488|65982410|FG002|Overall Study|Withdrawal by Subject|0|||
23210857|NCT01106625|64509340|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
23210858|NCT01106625|64509341|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
23425020|NCT03532932|65299824|FG000|Overall Study|Protocol Deviation|33|||
23425021|NCT03532932|65299825|FG001|Overall Study|Protocol Deviation|31|||
23425022|NCT03532932|65299824|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
23425023|NCT03532932|65299825|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
23425024|NCT03532932|65299824|FG000|Overall Study|Withdrawal by Subject|2|||
23425025|NCT03532932|65299825|FG001|Overall Study|Withdrawal by Subject|0|||
23425026|NCT03532932|65299824|FG000|Overall Study|Lost to Follow-up|15|||
23425027|NCT03532932|65299825|FG001|Overall Study|Lost to Follow-up|9|||
23425028|NCT03532932|65299824|FG000|Overall Study|Adverse Event|4|||
23425029|NCT03532932|65299825|FG001|Overall Study|Adverse Event|3|||
23425030|NCT03532932|65299824|FG000|Overall Study|Death|0|||
23425031|NCT03532932|65299825|FG001|Overall Study|Death|2|||
23425032|NCT03532932|65299824|FG000|Overall Study|Other|11|||
23425033|NCT03532932|65299825|FG001|Overall Study|Other|16|||
23425034|NCT02743780|65299826|FG000|Part 3 (7 Days)|Adverse Event|0|||
23425035|NCT02743780|65299827|FG001|Part 3 (7 Days)|Adverse Event|0|||
23425036|NCT02743780|65299828|FG002|Part 3 (7 Days)|Adverse Event|1|||
23425037|NCT02743780|65299829|FG003|Part 3 (7 Days)|Adverse Event|0|||
23425038|NCT02743780|65299830|FG004|Part 3 (7 Days)|Adverse Event|0|||
23425039|NCT02141490|65299837|FG000|Overall Study|Screening failures|4|||
23425040|NCT02141490|65299838|FG001|Overall Study|Screening failures|0|||
23425041|NCT02141490|65299839|FG002|Overall Study|Screening failures|0|||
23425042|NCT01143051|65299840|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
23425043|NCT01143051|65299841|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
23425044|NCT01143051|65299842|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
23425045|NCT01143051|65299843|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
23425046|NCT01143051|65299844|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
23425047|NCT01143051|65299845|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
23425048|NCT01143051|65299840|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
23425049|NCT01143051|65299841|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
23425050|NCT01143051|65299842|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
23425051|NCT01143051|65299843|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
23425052|NCT01143051|65299844|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
23543140|NCT03387852|65719742|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
23543141|NCT03387852|65719739|FG000|Overall Study|Withdrawal by participant|1|||
23543142|NCT03387852|65719740|FG001|Overall Study|Withdrawal by participant|1|||
23543143|NCT03387852|65719741|FG002|Overall Study|Withdrawal by participant|3|||
23543144|NCT03387852|65719742|FG003|Overall Study|Withdrawal by participant|2|||
23543145|NCT03387852|65719739|FG000|Overall Study|Other- Unspecified|1|||
23543146|NCT03387852|65719740|FG001|Overall Study|Other- Unspecified|1|||
23543147|NCT03387852|65719741|FG002|Overall Study|Other- Unspecified|2|||
23616701|NCT02256488|65982411|FG003|Overall Study|Withdrawal by Subject|2|||
23616702|NCT01424189|65982412|FG000|Overall Study|Adverse Event|1|||
23616703|NCT01424189|65982413|FG001|Overall Study|Adverse Event|0|||
23616704|NCT01424189|65982412|FG000|Overall Study|Lost to Follow-up|4|||
23425053|NCT01143051|65299845|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
23425054|NCT02594098|65299846|FG000|Overall Study|Lack of Efficacy|17|||
23543148|NCT03387852|65719742|FG003|Overall Study|Other- Unspecified|1|||
23616705|NCT01424189|65982413|FG001|Overall Study|Lost to Follow-up|1|||
23210859|NCT01106625|64509339|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
23210860|NCT01106625|64509340|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
23210861|NCT01106625|64509341|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23210862|NCT01106625|64509339|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
23210863|NCT01106625|64509340|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
23210864|NCT01106625|64509341|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
23210865|NCT01106625|64509339|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23210866|NCT01106625|64509340|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23210867|NCT01106625|64509341|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23425055|NCT02594098|65299847|FG001|Overall Study|Lack of Efficacy|6|||
23313628|NCT04076059|64892113|FG002|Open Label Phase|Withdrawal by Subject|3|||
23313629|NCT04076059|64892111|FG000|Open Label Phase|Death|0|||
23313630|NCT04076059|64892112|FG001|Open Label Phase|Death|0|||
23313631|NCT04076059|64892113|FG002|Open Label Phase|Death|2|||
23313632|NCT04076059|64892111|FG000|Open Label Phase|Ongoing Participants|0|||
23313633|NCT04076059|64892112|FG001|Open Label Phase|Ongoing Participants|0|||
23313634|NCT04076059|64892113|FG002|Open Label Phase|Ongoing Participants|11|||
23313635|NCT05794503|64892117|FG000|Overall Study|Operation Cancelled|2|||
23313636|NCT05794503|64892118|FG001|Overall Study|Operation Cancelled|0|||
23313637|NCT05794503|64892117|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
23313638|NCT05794503|64892118|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
23313639|NCT05794503|64892117|FG000|Overall Study|Protocol Violation|1|||
23313640|NCT05794503|64892118|FG001|Overall Study|Protocol Violation|0|||
23313641|NCT00708227|64892120|FG000|Overall Study|Physician Decision|0|||
23313642|NCT00708227|64892121|FG001|Overall Study|Physician Decision|3|||
23313643|NCT00708227|64892122|FG002|Overall Study|Physician Decision|1|||
23313644|NCT00708227|64892123|FG003|Overall Study|Physician Decision|2|||
23313645|NCT00708227|64892120|FG000|Overall Study|Withdrawal by Subject|1|||
23313646|NCT00708227|64892121|FG001|Overall Study|Withdrawal by Subject|2|||
23313647|NCT00708227|64892122|FG002|Overall Study|Withdrawal by Subject|0|||
23313648|NCT00708227|64892123|FG003|Overall Study|Withdrawal by Subject|1|||
23313649|NCT04303780|64892124|FG000|Overall Study|Death|104|||
23313650|NCT04303780|64892125|FG001|Overall Study|Death|85|||
23313651|NCT04303780|64892124|FG000|Overall Study|Lost to Follow-up|5|||
23313652|NCT04303780|64892125|FG001|Overall Study|Lost to Follow-up|2|||
23313653|NCT04303780|64892124|FG000|Overall Study|Withdrawal by Subject|12|||
23313654|NCT04303780|64892125|FG001|Overall Study|Withdrawal by Subject|39|||
23313655|NCT04303780|64892124|FG000|Overall Study|Ongoing in study|50|||
23313656|NCT04303780|64892125|FG001|Overall Study|Ongoing in study|45|||
23313657|NCT03583086|64892129|FG000|Overall Study|Death|2|||
23313658|NCT03583086|64892130|FG001|Overall Study|Death|6|||
23313659|NCT03583086|64892131|FG002|Overall Study|Death|12|||
23313660|NCT03583086|64892132|FG003|Overall Study|Death|10|||
23313661|NCT03583086|64892133|FG004|Overall Study|Death|14|||
23313662|NCT03583086|64892134|FG005|Overall Study|Death|14|||
23313663|NCT03583086|64892135|FG006|Overall Study|Death|4|||
23313664|NCT03583086|64892129|FG000|Overall Study|Withdrawal by Subject|0|||
23313665|NCT03583086|64892130|FG001|Overall Study|Withdrawal by Subject|0|||
23313666|NCT03583086|64892131|FG002|Overall Study|Withdrawal by Subject|1|||
23313667|NCT03583086|64892132|FG003|Overall Study|Withdrawal by Subject|0|||
23313668|NCT03583086|64892133|FG004|Overall Study|Withdrawal by Subject|0|||
23313669|NCT03583086|64892134|FG005|Overall Study|Withdrawal by Subject|0|||
23313670|NCT03583086|64892135|FG006|Overall Study|Withdrawal by Subject|1|||
23313671|NCT03583086|64892129|FG000|Overall Study|Refused follow-up|0|||
23313672|NCT03583086|64892130|FG001|Overall Study|Refused follow-up|0|||
23313673|NCT03583086|64892131|FG002|Overall Study|Refused follow-up|1|||
23313674|NCT03583086|64892132|FG003|Overall Study|Refused follow-up|0|||
23313675|NCT03583086|64892133|FG004|Overall Study|Refused follow-up|1|||
23313676|NCT03583086|64892134|FG005|Overall Study|Refused follow-up|0|||
23313677|NCT03583086|64892135|FG006|Overall Study|Refused follow-up|0|||
23313678|NCT03583086|64892129|FG000|Overall Study|Declining Performance Status|0|||
23313679|NCT03583086|64892130|FG001|Overall Study|Declining Performance Status|0|||
23313680|NCT03583086|64892131|FG002|Overall Study|Declining Performance Status|1|||
23313681|NCT03583086|64892132|FG003|Overall Study|Declining Performance Status|0|||
23313682|NCT03583086|64892133|FG004|Overall Study|Declining Performance Status|0|||
23313683|NCT03583086|64892134|FG005|Overall Study|Declining Performance Status|0|||
23313684|NCT03583086|64892135|FG006|Overall Study|Declining Performance Status|0|||
23313685|NCT03583086|64892129|FG000|Overall Study|Still on study|0|||
23313686|NCT03583086|64892130|FG001|Overall Study|Still on study|0|||
23313687|NCT03583086|64892131|FG002|Overall Study|Still on study|0|||
23313688|NCT03583086|64892132|FG003|Overall Study|Still on study|1|||
23313689|NCT03583086|64892133|FG004|Overall Study|Still on study|0|||
23313690|NCT03583086|64892134|FG005|Overall Study|Still on study|0|||
23313691|NCT03583086|64892135|FG006|Overall Study|Still on study|1|||
23313692|NCT03583086|64892129|FG000|Overall Study|Disease progression|0|||
23313693|NCT03583086|64892130|FG001|Overall Study|Disease progression|0|||
23313694|NCT03583086|64892131|FG002|Overall Study|Disease progression|0|||
23313695|NCT03583086|64892132|FG003|Overall Study|Disease progression|0|||
23313696|NCT03583086|64892133|FG004|Overall Study|Disease progression|0|||
23313697|NCT03583086|64892134|FG005|Overall Study|Disease progression|0|||
23313698|NCT03583086|64892135|FG006|Overall Study|Disease progression|1|||
23313699|NCT03583086|64892129|FG000|Overall Study|Undergoing radiation therapy|0|||
23313700|NCT03583086|64892130|FG001|Overall Study|Undergoing radiation therapy|0|||
23313701|NCT03583086|64892131|FG002|Overall Study|Undergoing radiation therapy|0|||
23313702|NCT03583086|64892132|FG003|Overall Study|Undergoing radiation therapy|0|||
23313703|NCT03583086|64892133|FG004|Overall Study|Undergoing radiation therapy|0|||
23313704|NCT03583086|64892134|FG005|Overall Study|Undergoing radiation therapy|0|||
23313705|NCT03583086|64892135|FG006|Overall Study|Undergoing radiation therapy|1|||
23210868|NCT01106625|64509339|FG000|Core Period: Baseline to Week 26|Other|8|||
23313706|NCT03583086|64892129|FG000|Overall Study|Lost to Follow-up|0|||
23313707|NCT03583086|64892130|FG001|Overall Study|Lost to Follow-up|0|||
23313708|NCT03583086|64892131|FG002|Overall Study|Lost to Follow-up|0|||
23313709|NCT03583086|64892132|FG003|Overall Study|Lost to Follow-up|0|||
23313710|NCT03583086|64892133|FG004|Overall Study|Lost to Follow-up|0|||
23313711|NCT03583086|64892134|FG005|Overall Study|Lost to Follow-up|1|||
23313712|NCT03583086|64892135|FG006|Overall Study|Lost to Follow-up|0|||
23313713|NCT03583086|64892129|FG000|Overall Study|Adverse Event|0|||
23313714|NCT03583086|64892130|FG001|Overall Study|Adverse Event|0|||
23313715|NCT03583086|64892131|FG002|Overall Study|Adverse Event|0|||
23313716|NCT03583086|64892132|FG003|Overall Study|Adverse Event|0|||
23313717|NCT03583086|64892133|FG004|Overall Study|Adverse Event|0|||
23543149|NCT03387852|65719739|FG000|Overall Study|Poor compliance to protocol|0|||
23210869|NCT01106625|64509340|FG001|Core Period: Baseline to Week 26|Other|7|||
23210870|NCT01106625|64509341|FG002|Core Period: Baseline to Week 26|Other|4|||
23210871|NCT01106625|64509339|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
23210872|NCT01106625|64509340|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
23210873|NCT01106625|64509341|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
23210874|NCT01106625|64509339|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
23210875|NCT01106625|64509340|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
23210876|NCT01106625|64509341|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
23210877|NCT01106625|64509339|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23210878|NCT01106625|64509340|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23210879|NCT01106625|64509341|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
23210880|NCT01106625|64509339|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23210881|NCT01106625|64509340|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23313718|NCT03583086|64892134|FG005|Overall Study|Adverse Event|1|||
23543150|NCT03387852|65719740|FG001|Overall Study|Poor compliance to protocol|0|||
23543151|NCT03387852|65719741|FG002|Overall Study|Poor compliance to protocol|0|||
23543152|NCT03387852|65719742|FG003|Overall Study|Poor compliance to protocol|1|||
23543153|NCT03387852|65719739|FG000|Overall Study|Randomized and not treated|0|||
23543154|NCT03387852|65719740|FG001|Overall Study|Randomized and not treated|0|||
23543155|NCT03387852|65719741|FG002|Overall Study|Randomized and not treated|0|||
23543156|NCT03387852|65719742|FG003|Overall Study|Randomized and not treated|1|||
23543157|NCT02415400|65719743|FG000|Overall Study|Adverse Event|0|||
23543158|NCT02415400|65719744|FG001|Overall Study|Adverse Event|1|||
23543159|NCT02415400|65719745|FG002|Overall Study|Adverse Event|1|||
23543160|NCT02415400|65719746|FG003|Overall Study|Adverse Event|2|||
23543161|NCT02415400|65719743|FG000|Overall Study|Participant request to stop therapy|4|||
23543162|NCT02415400|65719744|FG001|Overall Study|Participant request to stop therapy|3|||
23543163|NCT02415400|65719745|FG002|Overall Study|Participant request to stop therapy|8|||
23543164|NCT02415400|65719746|FG003|Overall Study|Participant request to stop therapy|6|||
23543165|NCT02415400|65719743|FG000|Overall Study|Participant withdrew consent|14|||
23543166|NCT02415400|65719744|FG001|Overall Study|Participant withdrew consent|12|||
23543167|NCT02415400|65719745|FG002|Overall Study|Participant withdrew consent|30|||
23543168|NCT02415400|65719746|FG003|Overall Study|Participant withdrew consent|21|||
23543169|NCT02415400|65719743|FG000|Overall Study|Death|39|||
23543170|NCT02415400|65719744|FG001|Overall Study|Death|41|||
23543171|NCT02415400|65719745|FG002|Overall Study|Death|35|||
23543172|NCT02415400|65719746|FG003|Overall Study|Death|42|||
23543173|NCT02415400|65719743|FG000|Overall Study|Lost to Follow-up|3|||
23543174|NCT02415400|65719744|FG001|Overall Study|Lost to Follow-up|3|||
23543175|NCT02415400|65719745|FG002|Overall Study|Lost to Follow-up|2|||
23543176|NCT02415400|65719746|FG003|Overall Study|Lost to Follow-up|5|||
23543177|NCT02415400|65719743|FG000|Overall Study|Poor/Non-Compliance|0|||
23543178|NCT02415400|65719744|FG001|Overall Study|Poor/Non-Compliance|1|||
23543179|NCT02415400|65719745|FG002|Overall Study|Poor/Non-Compliance|3|||
23543180|NCT02415400|65719746|FG003|Overall Study|Poor/Non-Compliance|4|||
23543181|NCT02415400|65719743|FG000|Overall Study|Participant no longer meets criteria|2|||
23210882|NCT01106625|64509341|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23210883|NCT01106625|64509339|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
23210884|NCT01106625|64509340|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23210885|NCT01106625|64509341|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23425056|NCT02594098|65299846|FG000|Overall Study|Withdrawal by Subject|1|||
23425057|NCT02594098|65299847|FG001|Overall Study|Withdrawal by Subject|3|||
23425058|NCT02594098|65299846|FG000|Overall Study|Terminated participation|6|||
23543182|NCT02415400|65719744|FG001|Overall Study|Participant no longer meets criteria|0|||
23543183|NCT02415400|65719745|FG002|Overall Study|Participant no longer meets criteria|0|||
23543184|NCT02415400|65719746|FG003|Overall Study|Participant no longer meets criteria|1|||
23210886|NCT01106625|64509339|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
23210887|NCT01106625|64509340|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
23210888|NCT01106625|64509341|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
23210889|NCT01106625|64509339|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
23210890|NCT01106625|64509340|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
23210891|NCT01106625|64509341|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
23210892|NCT01106625|64509339|FG000|Extension Period: Week 26 to Week 52|Other|5|||
23210893|NCT01106625|64509340|FG001|Extension Period: Week 26 to Week 52|Other|5|||
23313719|NCT03583086|64892135|FG006|Overall Study|Adverse Event|0|||
23313720|NCT00952731|64892141|FG000|Overall Study|Drug supply expired|1|||
23313721|NCT00952731|64892142|FG001|Overall Study|Drug supply expired|0|||
23313722|NCT04611529|64892145|FG000|2-day Follow up|Lost to Follow-up|5|||
23313723|NCT04611529|64892146|FG001|2-day Follow up|Lost to Follow-up|6|||
23313724|NCT04611529|64892147|FG002|2-day Follow up|Lost to Follow-up|3|||
23313725|NCT02242045|64892148|FG000|Overall Study|Investigator's Discretion|1|||
23313726|NCT02242045|64892148|FG000|Overall Study|Progressive Disease|2|||
23313727|NCT02242045|64892148|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
23313728|NCT02242045|64892148|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
23313729|NCT00396565|64892149|FG000|Overall Study|Physician Decision|3|||
23313730|NCT00396565|64892150|FG001|Overall Study|Physician Decision|1|||
23543185|NCT02415400|65719743|FG000|Overall Study|Participant doesn't answer phone|1|||
23543186|NCT02415400|65719744|FG001|Overall Study|Participant doesn't answer phone|0|||
23543187|NCT02415400|65719745|FG002|Overall Study|Participant doesn't answer phone|0|||
23543188|NCT02415400|65719746|FG003|Overall Study|Participant doesn't answer phone|0|||
23543189|NCT02415400|65719743|FG000|Overall Study|Participant wanted home visits|1|||
23543190|NCT02415400|65719744|FG001|Overall Study|Participant wanted home visits|0|||
23543191|NCT02415400|65719745|FG002|Overall Study|Participant wanted home visits|0|||
23616706|NCT01424189|65982412|FG000|Overall Study|Withdrawal by Subject|4|||
23616707|NCT01424189|65982413|FG001|Overall Study|Withdrawal by Subject|4|||
23616708|NCT01424189|65982412|FG000|Overall Study|Subject moved|1|||
23616709|NCT01424189|65982413|FG001|Overall Study|Subject moved|0|||
23616710|NCT01424189|65982412|FG000|Overall Study|Death|3|||
23616711|NCT01424189|65982413|FG001|Overall Study|Death|1|||
23210894|NCT01106625|64509341|FG002|Extension Period: Week 26 to Week 52|Other|4|||
23210895|NCT02702518|64512291|FG000|Overall Study|Lost to Follow-up|3|||
23543192|NCT02415400|65719746|FG003|Overall Study|Participant wanted home visits|0|||
23543193|NCT02415400|65719743|FG000|Overall Study|Randomized in error|2|||
23543194|NCT02415400|65719744|FG001|Overall Study|Randomized in error|0|||
23543195|NCT02415400|65719745|FG002|Overall Study|Randomized in error|0|||
23616712|NCT00588341|65982418|FG000|Overall Study|Withdrawal by Subject|3|||
23616713|NCT00588341|65982418|FG000|Overall Study|Not treated due to metastatic disease|1|||
23616714|NCT00588341|65982418|FG000|Overall Study|Patient ineligible|1|||
23210896|NCT02702518|64512292|FG001|Overall Study|Lost to Follow-up|4|||
23210897|NCT02614287|64512296|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
23210898|NCT02614287|64512297|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
23210899|NCT02614287|64512296|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
23210900|NCT02614287|64512297|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
23210901|NCT02614287|64512296|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
23210902|NCT02614287|64512297|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
23210903|NCT02614287|64512296|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
23210904|NCT02614287|64512297|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
23313731|NCT00396565|64892151|FG002|Overall Study|Physician Decision|2|||
23313732|NCT00396565|64892149|FG000|Overall Study|Adverse Event|5|||
23313733|NCT00396565|64892150|FG001|Overall Study|Adverse Event|13|||
23313734|NCT00396565|64892151|FG002|Overall Study|Adverse Event|3|||
23313735|NCT00396565|64892149|FG000|Overall Study|Withdrawal by Subject|8|||
23313736|NCT00396565|64892150|FG001|Overall Study|Withdrawal by Subject|13|||
23313737|NCT00396565|64892151|FG002|Overall Study|Withdrawal by Subject|1|||
23313738|NCT00396565|64892149|FG000|Overall Study|Lack of Efficacy|32|||
23425059|NCT02594098|65299847|FG001|Overall Study|Terminated participation|2|||
23543196|NCT02415400|65719746|FG003|Overall Study|Randomized in error|0|||
23543197|NCT02415400|65719743|FG000|Overall Study|No study drug on site|0|||
23313739|NCT00396565|64892150|FG001|Overall Study|Lack of Efficacy|64|||
23313740|NCT00396565|64892151|FG002|Overall Study|Lack of Efficacy|11|||
23313741|NCT00143390|64892152|FG000|Overall Study|Death|2|||
23313742|NCT00143390|64892153|FG001|Overall Study|Death|0|||
23313743|NCT00143390|64892152|FG000|Overall Study|Not meeting entry criteria|2|||
23313744|NCT00143390|64892153|FG001|Overall Study|Not meeting entry criteria|5|||
23313745|NCT00143390|64892152|FG000|Overall Study|Withdrawal by Subject|4|||
23313746|NCT00143390|64892153|FG001|Overall Study|Withdrawal by Subject|4|||
23313747|NCT00143390|64892152|FG000|Overall Study|Progressive disease|119|||
23313748|NCT00143390|64892153|FG001|Overall Study|Progressive disease|115|||
23313749|NCT00143390|64892152|FG000|Overall Study|Protocol Violation|2|||
23313750|NCT00143390|64892153|FG001|Overall Study|Protocol Violation|0|||
23313751|NCT00143390|64892152|FG000|Overall Study|Study termination|10|||
23313752|NCT00143390|64892153|FG001|Overall Study|Study termination|15|||
23313753|NCT00143390|64892152|FG000|Overall Study|Adverse Event|9|||
23616715|NCT00705614|65982422|FG000|Initial Intervention|Adverse Event|40|||
23313754|NCT00143390|64892153|FG001|Overall Study|Adverse Event|8|||
23313755|NCT00143390|64892152|FG000|Overall Study|Other|1|||
23313756|NCT00143390|64892153|FG001|Overall Study|Other|2|||
23313757|NCT04003896|64892161|FG000|Overall Study|Withdrawal by Subject|3|||
23313758|NCT04003896|64892161|FG000|Overall Study|Physician Decision|1|||
23313759|NCT02473523|64892162|FG000|Overall Study|Death|1|||
23313760|NCT02473523|64892162|FG000|Overall Study|Lost to Follow-up|1|||
23313761|NCT03893565|64892163|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
23313762|NCT03893565|64892164|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
23616716|NCT00705614|65982423|FG001|Initial Intervention|Adverse Event|21|||
23313763|NCT03893565|64892165|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
23313764|NCT03893565|64892166|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
23313765|NCT03893565|64892167|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
23313766|NCT03893565|64892168|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
23313767|NCT03893565|64892169|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
23313768|NCT03893565|64892170|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
23313769|NCT03893565|64892171|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
23616717|NCT00705614|65982422|FG000|Initial Intervention|Lost to Follow-up|310|||
23313770|NCT03893565|64892163|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23313771|NCT03893565|64892164|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
23313772|NCT03893565|64892165|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23313773|NCT03893565|64892166|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23313774|NCT03893565|64892167|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23313775|NCT03893565|64892168|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23313776|NCT03893565|64892169|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23313777|NCT03893565|64892170|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23313778|NCT03893565|64892171|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
23313779|NCT03893565|64892163|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313780|NCT03893565|64892164|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
23313781|NCT03893565|64892165|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313782|NCT03893565|64892166|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
23313783|NCT03893565|64892167|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313784|NCT03893565|64892168|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313785|NCT03893565|64892169|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313786|NCT03893565|64892170|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313787|NCT03893565|64892171|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313788|NCT03893565|64892163|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23313789|NCT03893565|64892164|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
23313790|NCT03893565|64892165|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23313791|NCT03893565|64892166|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
23313792|NCT03893565|64892167|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23313793|NCT03893565|64892168|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23313794|NCT03893565|64892169|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23313795|NCT03893565|64892170|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23313796|NCT03893565|64892171|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
23313797|NCT03893565|64892163|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
23313798|NCT03893565|64892164|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
23313799|NCT03893565|64892165|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
23313800|NCT03893565|64892166|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313801|NCT03893565|64892167|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
23313802|NCT03893565|64892168|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313803|NCT03893565|64892169|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313804|NCT03893565|64892170|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313805|NCT03893565|64892171|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313806|NCT03893565|64892163|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23313807|NCT03893565|64892164|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
23313808|NCT03893565|64892165|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23313809|NCT03893565|64892166|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23313810|NCT03893565|64892167|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23313811|NCT03893565|64892168|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23313812|NCT03893565|64892169|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23313813|NCT03893565|64892170|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23313814|NCT03893565|64892171|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
23313815|NCT03893565|64892163|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313816|NCT03893565|64892164|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313817|NCT03893565|64892165|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313818|NCT03893565|64892166|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
23210905|NCT02614287|64512296|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
23313819|NCT03893565|64892167|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313820|NCT03893565|64892168|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23425060|NCT02594098|65299846|FG000|Overall Study|Seek alternative treatment|2|||
23210906|NCT02614287|64512297|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
23313821|NCT03893565|64892169|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23425061|NCT02594098|65299847|FG001|Overall Study|Seek alternative treatment|1|||
23425062|NCT02594098|65299846|FG000|Overall Study|Other|0|||
23210907|NCT02614287|64512296|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
23210908|NCT02614287|64512297|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
23210909|NCT02614287|64512296|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
23210910|NCT02614287|64512297|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
23210911|NCT02614287|64512296|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
23210912|NCT02614287|64512297|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
23210913|NCT03287245|64512298|FG000|Overall Study|Study terminated by sponsor|3|||
23210914|NCT03287245|64512299|FG001|Overall Study|Study terminated by sponsor|0|||
23210915|NCT03287245|64512300|FG002|Overall Study|Study terminated by sponsor|3|||
23210916|NCT03287245|64512301|FG003|Overall Study|Study terminated by sponsor|1|||
23210917|NCT03287245|64512298|FG000|Overall Study|Adverse Event|1|||
23210918|NCT03287245|64512299|FG001|Overall Study|Adverse Event|0|||
23210919|NCT03287245|64512300|FG002|Overall Study|Adverse Event|0|||
23210920|NCT03287245|64512301|FG003|Overall Study|Adverse Event|0|||
23210921|NCT03287245|64512298|FG000|Overall Study|Withdrawal by Subject|8|||
23210922|NCT03287245|64512299|FG001|Overall Study|Withdrawal by Subject|3|||
23210923|NCT03287245|64512300|FG002|Overall Study|Withdrawal by Subject|3|||
23210924|NCT03287245|64512301|FG003|Overall Study|Withdrawal by Subject|0|||
23210925|NCT03287245|64512298|FG000|Overall Study|Physician Decision|3|||
23210926|NCT03287245|64512299|FG001|Overall Study|Physician Decision|2|||
23210927|NCT03287245|64512300|FG002|Overall Study|Physician Decision|0|||
23210928|NCT03287245|64512301|FG003|Overall Study|Physician Decision|0|||
23210929|NCT02022033|64512302|FG000|Overall Study|Physician Decision|1|||
23210930|NCT03600714|64512303|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
23210931|NCT01879319|64512304|FG000|Overall Study|Withdrawal by Subject|1|||
23210932|NCT01879319|64512305|FG001|Overall Study|Withdrawal by Subject|0|||
23210933|NCT01879319|64512304|FG000|Overall Study|Lost to Follow-up|1|||
23210934|NCT01879319|64512305|FG001|Overall Study|Lost to Follow-up|5|||
23210935|NCT00843843|64512306|FG000|Overall Study|Physician Decision|1|||
23210936|NCT00843843|64512307|FG001|Overall Study|Physician Decision|1|||
23210937|NCT00843843|64512306|FG000|Overall Study|Protocol Violation|1|||
23210938|NCT00843843|64512307|FG001|Overall Study|Protocol Violation|1|||
23313822|NCT03893565|64892170|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313823|NCT03893565|64892171|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313824|NCT03893565|64892163|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23313825|NCT03893565|64892164|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
23313826|NCT03893565|64892165|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
23313827|NCT03893565|64892166|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
23210939|NCT01479374|64512308|FG000|Overall Study|Adverse Event|2|||
23210940|NCT01479374|64512309|FG001|Overall Study|Adverse Event|1|||
23210941|NCT01479374|64512310|FG002|Overall Study|Adverse Event|0|||
23210942|NCT01479374|64512308|FG000|Overall Study|Lost to Follow-up|1|||
23210943|NCT01479374|64512309|FG001|Overall Study|Lost to Follow-up|2|||
23210944|NCT01479374|64512310|FG002|Overall Study|Lost to Follow-up|0|||
23210945|NCT01479374|64512308|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
23210946|NCT01479374|64512309|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
23210947|NCT01479374|64512310|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
23210948|NCT01479374|64512308|FG000|Overall Study|Other|0|||
23210949|NCT01479374|64512309|FG001|Overall Study|Other|4|||
23210950|NCT01479374|64512310|FG002|Overall Study|Other|5|||
23210951|NCT03247413|64512311|FG000|Overall Study|Lost to Follow-up|28|||
23210952|NCT02505542|64512314|FG000|Part A: Open-Label Period|Adverse Event|31|||
23210953|NCT02505542|64512315|FG001|Part A: Open-Label Period|Adverse Event|0|||
23210954|NCT02505542|64512316|FG002|Part A: Open-Label Period|Adverse Event|0|||
23210955|NCT02505542|64512317|FG003|Part A: Open-Label Period|Adverse Event|0|||
23210956|NCT02505542|64512314|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
23210957|NCT02505542|64512315|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
23210958|NCT02505542|64512316|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
23210959|NCT02505542|64512317|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
23210960|NCT02505542|64512314|FG000|Part A: Open-Label Period|Protocol Violation|1|||
23210961|NCT02505542|64512315|FG001|Part A: Open-Label Period|Protocol Violation|0|||
23210962|NCT02505542|64512316|FG002|Part A: Open-Label Period|Protocol Violation|0|||
23210963|NCT02505542|64512317|FG003|Part A: Open-Label Period|Protocol Violation|0|||
23210964|NCT02505542|64512314|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
23210965|NCT02505542|64512315|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
23210966|NCT02505542|64512316|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
23210967|NCT02505542|64512317|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
23210968|NCT02505542|64512314|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
23210969|NCT02505542|64512315|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
23210970|NCT02505542|64512316|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
23210971|NCT02505542|64512317|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
23210972|NCT02505542|64512314|FG000|Part A: Open-Label Period|New medical history available|1|||
23210973|NCT02505542|64512315|FG001|Part A: Open-Label Period|New medical history available|0|||
23210974|NCT02505542|64512316|FG002|Part A: Open-Label Period|New medical history available|0|||
23210975|NCT02505542|64512317|FG003|Part A: Open-Label Period|New medical history available|0|||
23210976|NCT02505542|64512314|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
23210977|NCT02505542|64512315|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
23210978|NCT02505542|64512316|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
23210979|NCT02505542|64512317|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
23210980|NCT02505542|64512314|FG000|Part A: Open-Label Period|Pregnancy|2|||
23210981|NCT02505542|64512315|FG001|Part A: Open-Label Period|Pregnancy|0|||
23313828|NCT03893565|64892167|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23313829|NCT03893565|64892168|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23210982|NCT02505542|64512316|FG002|Part A: Open-Label Period|Pregnancy|0|||
23210983|NCT02505542|64512317|FG003|Part A: Open-Label Period|Pregnancy|0|||
23210984|NCT02505542|64512314|FG000|Part A: Open-Label Period|Sponsor directive|1|||
23210985|NCT02505542|64512315|FG001|Part A: Open-Label Period|Sponsor directive|0|||
23210986|NCT02505542|64512316|FG002|Part A: Open-Label Period|Sponsor directive|0|||
23313830|NCT03893565|64892169|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23313831|NCT03893565|64892170|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23313832|NCT03893565|64892171|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
23210987|NCT02505542|64512317|FG003|Part A: Open-Label Period|Sponsor directive|0|||
23210988|NCT02505542|64512314|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
23210989|NCT02505542|64512315|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
23210990|NCT02505542|64512316|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
23210991|NCT02505542|64512317|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
23210992|NCT02505542|64512314|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
23210993|NCT02505542|64512315|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
23210994|NCT02505542|64512316|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
23210995|NCT02505542|64512317|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
23210996|NCT02505542|64512314|FG000|Part A: Open-Label Period|Non-compliance|1|||
23210997|NCT02505542|64512315|FG001|Part A: Open-Label Period|Non-compliance|0|||
23210998|NCT02505542|64512316|FG002|Part A: Open-Label Period|Non-compliance|0|||
23210999|NCT02505542|64512317|FG003|Part A: Open-Label Period|Non-compliance|0|||
23211000|NCT02505542|64512314|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
23211001|NCT02505542|64512315|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
23211002|NCT02505542|64512316|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
23211003|NCT02505542|64512317|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
23211004|NCT02505542|64512314|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
23211005|NCT02505542|64512315|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
23211006|NCT02505542|64512316|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
23211007|NCT02505542|64512317|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
23211008|NCT02505542|64512314|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
23313833|NCT03893565|64892163|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
23313834|NCT03893565|64892164|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
23313835|NCT03893565|64892165|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
23313836|NCT03893565|64892166|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
23313837|NCT03893565|64892167|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
23313838|NCT03893565|64892168|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
23313839|NCT03893565|64892169|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
23313840|NCT03893565|64892170|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
23313841|NCT03893565|64892171|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
23313842|NCT03893565|64892163|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23313843|NCT03893565|64892164|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23425063|NCT02594098|65299847|FG001|Overall Study|Other|1|||
23425064|NCT00539513|65299848|FG000|Overall Study|Withdrawal by Subject|2|||
23425065|NCT00539513|65299849|FG001|Overall Study|Withdrawal by Subject|1|||
23425066|NCT00539513|65299848|FG000|Overall Study|Lost to Follow-up|0|||
23425067|NCT00539513|65299849|FG001|Overall Study|Lost to Follow-up|1|||
23425068|NCT00223977|65299850|FG000|Overall Study|Adverse Event|7|||
23425069|NCT00223977|65299851|FG001|Overall Study|Adverse Event|10|||
23425070|NCT00223977|65299852|FG002|Overall Study|Adverse Event|0|||
23425071|NCT00223977|65299850|FG000|Overall Study|Protocol Violation|0|||
23425072|NCT00223977|65299851|FG001|Overall Study|Protocol Violation|0|||
23425073|NCT00223977|65299852|FG002|Overall Study|Protocol Violation|1|||
23425074|NCT00223977|65299850|FG000|Overall Study|Withdrawal by Subject|1|||
23425075|NCT00223977|65299851|FG001|Overall Study|Withdrawal by Subject|1|||
23425076|NCT00223977|65299852|FG002|Overall Study|Withdrawal by Subject|2|||
23425077|NCT00223977|65299850|FG000|Overall Study|Other|1|||
23425078|NCT00223977|65299851|FG001|Overall Study|Other|0|||
23425079|NCT00223977|65299852|FG002|Overall Study|Other|0|||
23425080|NCT04912895|65299853|FG000|Overall Study|Unable to provide specimen|2|||
23425081|NCT04912895|65299854|FG001|Overall Study|Unable to provide specimen|0|||
23425082|NCT04912895|65299855|FG002|Overall Study|Unable to provide specimen|0|||
23425083|NCT00159913|65299856|FG000|Overall Study|Adverse Event|1|||
23425084|NCT00159913|65299857|FG001|Overall Study|Adverse Event|0|||
23425085|NCT00159913|65299858|FG002|Overall Study|Adverse Event|1|||
23425086|NCT00159913|65299859|FG003|Overall Study|Adverse Event|0|||
23425087|NCT00159913|65299856|FG000|Overall Study|Withdrawal by Subject|0|||
23425088|NCT00159913|65299857|FG001|Overall Study|Withdrawal by Subject|0|||
23425089|NCT00159913|65299858|FG002|Overall Study|Withdrawal by Subject|0|||
23425090|NCT00159913|65299859|FG003|Overall Study|Withdrawal by Subject|1|||
23425091|NCT00159913|65299856|FG000|Overall Study|Lost to Follow-up|0|||
23425092|NCT00159913|65299857|FG001|Overall Study|Lost to Follow-up|0|||
23425093|NCT00159913|65299858|FG002|Overall Study|Lost to Follow-up|0|||
23425094|NCT00159913|65299859|FG003|Overall Study|Lost to Follow-up|1|||
23425095|NCT00159913|65299856|FG000|Overall Study|Protocol Violation|1|||
23425096|NCT00159913|65299857|FG001|Overall Study|Protocol Violation|0|||
23425097|NCT00159913|65299858|FG002|Overall Study|Protocol Violation|1|||
23425098|NCT00159913|65299859|FG003|Overall Study|Protocol Violation|0|||
23425099|NCT01669421|65299860|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
23425100|NCT01669421|65299860|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
23425101|NCT00355342|65299861|FG000|Overall Study|Adverse Event|13|||
23425102|NCT00355342|65299862|FG001|Overall Study|Adverse Event|15|||
23425103|NCT00355342|65299861|FG000|Overall Study|Lost to Follow-up|4|||
23425104|NCT00355342|65299862|FG001|Overall Study|Lost to Follow-up|2|||
23425105|NCT00355342|65299861|FG000|Overall Study|Withdrawal by Subject|14|||
23425106|NCT00355342|65299862|FG001|Overall Study|Withdrawal by Subject|11|||
23425107|NCT00355342|65299861|FG000|Overall Study|Sponsor terminated study|2|||
23425108|NCT00355342|65299862|FG001|Overall Study|Sponsor terminated study|2|||
23425109|NCT00355342|65299861|FG000|Overall Study|Overcompliant-PI discretion|1|||
23425110|NCT00355342|65299862|FG001|Overall Study|Overcompliant-PI discretion|0|||
23425111|NCT00355342|65299861|FG000|Overall Study|Use of prohibited medication|1|||
23425112|NCT00355342|65299862|FG001|Overall Study|Use of prohibited medication|0|||
23425113|NCT00355342|65299861|FG000|Overall Study|COPD exacerbation|1|||
23425114|NCT00355342|65299862|FG001|Overall Study|COPD exacerbation|1|||
23425115|NCT00355342|65299861|FG000|Overall Study|Dispensed wrong study drug kit|1|||
23425116|NCT00355342|65299862|FG001|Overall Study|Dispensed wrong study drug kit|0|||
23425117|NCT00355342|65299861|FG000|Overall Study|Non-compliance with Dexa scans|1|||
23425118|NCT00355342|65299862|FG001|Overall Study|Non-compliance with Dexa scans|0|||
23425119|NCT00355342|65299861|FG000|Overall Study|Withdrawal by participant and physician|1|||
23425120|NCT00355342|65299862|FG001|Overall Study|Withdrawal by participant and physician|0|||
23425121|NCT00355342|65299861|FG000|Overall Study|Participant relocated|0|||
23425122|NCT00355342|65299862|FG001|Overall Study|Participant relocated|1|||
23425123|NCT00355342|65299861|FG000|Overall Study|Participant discontinued study drug|0|||
23425124|NCT00355342|65299862|FG001|Overall Study|Participant discontinued study drug|1|||
23425125|NCT00355342|65299861|FG000|Overall Study|Study management|0|||
23425126|NCT00355342|65299862|FG001|Overall Study|Study management|1|||
23425127|NCT00355342|65299861|FG000|Overall Study|Protocol Violation|0|||
23425128|NCT00355342|65299862|FG001|Overall Study|Protocol Violation|1|||
23425129|NCT00355342|65299861|FG000|Overall Study|Use of protocol excluded medication|0|||
23425130|NCT00355342|65299862|FG001|Overall Study|Use of protocol excluded medication|1|||
23425131|NCT01967823|65299863|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
23425132|NCT02908685|65299864|FG000|Part 1 OLE|Withdrawal by Subject|0|||
23425133|NCT02908685|65299865|FG001|Part 1 OLE|Withdrawal by Subject|0|||
23425134|NCT02908685|65299866|FG002|Part 1 OLE|Withdrawal by Subject|0|||
23425135|NCT02908685|65299867|FG003|Part 1 OLE|Withdrawal by Subject|0|||
23425136|NCT02908685|65299868|FG004|Part 1 OLE|Withdrawal by Subject|0|||
23425137|NCT02908685|65299869|FG005|Part 1 OLE|Withdrawal by Subject|0|||
23425138|NCT02908685|65299870|FG006|Part 1 OLE|Withdrawal by Subject|0|||
23425139|NCT02908685|65299871|FG007|Part 1 OLE|Withdrawal by Subject|0|||
23425140|NCT02908685|65299872|FG008|Part 1 OLE|Withdrawal by Subject|0|||
23425141|NCT02908685|65299873|FG009|Part 1 OLE|Withdrawal by Subject|0|||
23425142|NCT02908685|65299874|FG010|Part 1 OLE|Withdrawal by Subject|2|||
23543198|NCT02415400|65719744|FG001|Overall Study|No study drug on site|1|||
23543199|NCT02415400|65719745|FG002|Overall Study|No study drug on site|0|||
23425143|NCT02908685|65299875|FG011|Part 1 OLE|Withdrawal by Subject|1|||
23425144|NCT02908685|65299876|FG012|Part 1 OLE|Withdrawal by Subject|0|||
23425145|NCT02908685|65299877|FG013|Part 1 OLE|Withdrawal by Subject|0|||
23425146|NCT02908685|65299864|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425147|NCT02908685|65299865|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425148|NCT02908685|65299866|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425149|NCT02908685|65299867|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425150|NCT02908685|65299868|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425151|NCT02908685|65299869|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425152|NCT02908685|65299870|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425153|NCT02908685|65299871|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425154|NCT02908685|65299872|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425155|NCT02908685|65299873|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425156|NCT02908685|65299874|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425157|NCT02908685|65299875|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
23425158|NCT02908685|65299876|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
23425159|NCT02908685|65299877|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
23425160|NCT02908685|65299864|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425161|NCT02908685|65299865|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425162|NCT02908685|65299866|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425163|NCT02908685|65299867|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425164|NCT02908685|65299868|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425165|NCT02908685|65299869|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425166|NCT02908685|65299870|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425167|NCT02908685|65299871|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425168|NCT02908685|65299872|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425169|NCT02908685|65299873|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23543200|NCT02415400|65719746|FG003|Overall Study|No study drug on site|0|||
23425170|NCT02908685|65299874|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425171|NCT02908685|65299875|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425172|NCT02908685|65299876|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
23425173|NCT02908685|65299877|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
23425174|NCT02908685|65299864|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425175|NCT02908685|65299865|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425176|NCT02908685|65299866|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425177|NCT02908685|65299867|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23543201|NCT02415400|65719743|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
23543202|NCT02415400|65719744|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
23211009|NCT02505542|64512315|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
23543203|NCT02415400|65719745|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
23543204|NCT02415400|65719746|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
23616718|NCT00705614|65982423|FG001|Initial Intervention|Lost to Follow-up|191|||
23616719|NCT00705614|65982422|FG000|Initial Intervention|Withdrawal by Subject|114|||
23211010|NCT02505542|64512316|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
23425178|NCT02908685|65299868|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425179|NCT02908685|65299869|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425180|NCT02908685|65299870|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425181|NCT02908685|65299871|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425182|NCT02908685|65299872|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425183|NCT02908685|65299873|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425184|NCT02908685|65299874|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425185|NCT02908685|65299875|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425186|NCT02908685|65299876|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
23425187|NCT02908685|65299877|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
23425188|NCT02908685|65299864|FG000|Part 2 OLE: > Month 24|Death|0|||
23425189|NCT02908685|65299865|FG001|Part 2 OLE: > Month 24|Death|0|||
23425190|NCT02908685|65299866|FG002|Part 2 OLE: > Month 24|Death|0|||
23425191|NCT02908685|65299867|FG003|Part 2 OLE: > Month 24|Death|0|||
23425192|NCT02908685|65299868|FG004|Part 2 OLE: > Month 24|Death|0|||
23425193|NCT02908685|65299869|FG005|Part 2 OLE: > Month 24|Death|0|||
23425194|NCT02908685|65299870|FG006|Part 2 OLE: > Month 24|Death|0|||
23543205|NCT02415400|65719743|FG000|Overall Study|Coagulation values cannot be set|0|||
23543206|NCT02415400|65719744|FG001|Overall Study|Coagulation values cannot be set|0|||
23543207|NCT02415400|65719745|FG002|Overall Study|Coagulation values cannot be set|1|||
23543208|NCT02415400|65719746|FG003|Overall Study|Coagulation values cannot be set|0|||
23543209|NCT02415400|65719743|FG000|Overall Study|State regulations prevent participation|0|||
23543210|NCT02415400|65719744|FG001|Overall Study|State regulations prevent participation|0|||
23543211|NCT02415400|65719745|FG002|Overall Study|State regulations prevent participation|1|||
23543212|NCT02415400|65719746|FG003|Overall Study|State regulations prevent participation|0|||
23543213|NCT02415400|65719743|FG000|Overall Study|Poor treatment monitoring|0|||
23543214|NCT02415400|65719744|FG001|Overall Study|Poor treatment monitoring|0|||
23543215|NCT02415400|65719745|FG002|Overall Study|Poor treatment monitoring|1|||
23543216|NCT02415400|65719746|FG003|Overall Study|Poor treatment monitoring|0|||
23616720|NCT00705614|65982423|FG001|Initial Intervention|Withdrawal by Subject|71|||
23616721|NCT00705614|65982422|FG000|Initial Intervention|Administrative Reason|51|||
23211011|NCT02505542|64512317|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
23211012|NCT02505542|64512314|FG000|Part B: Double-Blind Period|Adverse Event|0|||
23211013|NCT02505542|64512315|FG001|Part B: Double-Blind Period|Adverse Event|0|||
23211014|NCT02505542|64512316|FG002|Part B: Double-Blind Period|Adverse Event|1|||
23211015|NCT02505542|64512317|FG003|Part B: Double-Blind Period|Adverse Event|3|||
23211016|NCT02505542|64512314|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
23211017|NCT02505542|64512315|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
23211018|NCT02505542|64512316|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
23211019|NCT02505542|64512317|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
23211020|NCT02505542|64512314|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
23211021|NCT02505542|64512315|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
23211022|NCT02505542|64512316|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
23211023|NCT02505542|64512317|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
23425195|NCT02908685|65299871|FG007|Part 2 OLE: > Month 24|Death|0|||
23425196|NCT02908685|65299872|FG008|Part 2 OLE: > Month 24|Death|0|||
23425197|NCT02908685|65299873|FG009|Part 2 OLE: > Month 24|Death|0|||
23425198|NCT02908685|65299874|FG010|Part 2 OLE: > Month 24|Death|0|||
23211024|NCT02505542|64512314|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
23425199|NCT02908685|65299875|FG011|Part 2 OLE: > Month 24|Death|0|||
23425200|NCT02908685|65299876|FG012|Part 2 OLE: > Month 24|Death|1|||
23211025|NCT02505542|64512315|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
23313844|NCT03893565|64892165|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23313845|NCT03893565|64892166|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23313846|NCT03893565|64892167|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23313847|NCT03893565|64892168|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23313848|NCT03893565|64892169|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
23313849|NCT03893565|64892170|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23313850|NCT03893565|64892171|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
23313851|NCT03893565|64892163|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23313852|NCT03893565|64892164|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23313853|NCT03893565|64892165|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23313854|NCT03893565|64892166|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23313855|NCT03893565|64892167|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23313856|NCT03893565|64892168|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
23313857|NCT03893565|64892169|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
23313858|NCT03893565|64892170|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23313859|NCT03893565|64892171|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
23313860|NCT03893565|64892163|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
23313861|NCT03893565|64892164|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
23313862|NCT03893565|64892165|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
23313863|NCT03893565|64892166|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
23313864|NCT03893565|64892167|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
23313865|NCT03893565|64892168|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
23313866|NCT03893565|64892169|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
23313867|NCT03893565|64892170|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
23313868|NCT03893565|64892171|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
23313869|NCT03893565|64892163|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313870|NCT03893565|64892164|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313871|NCT03893565|64892165|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313872|NCT03893565|64892166|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313873|NCT03893565|64892167|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313874|NCT03893565|64892168|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313875|NCT03893565|64892169|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313876|NCT03893565|64892170|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
23313877|NCT03893565|64892171|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
23313878|NCT03893565|64892163|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313879|NCT03893565|64892164|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313880|NCT03893565|64892165|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313881|NCT03893565|64892166|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313882|NCT03893565|64892167|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313883|NCT03893565|64892168|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313884|NCT03893565|64892169|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313885|NCT03893565|64892170|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
23313886|NCT03893565|64892171|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
23313887|NCT03893565|64892163|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313888|NCT03893565|64892164|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313889|NCT03893565|64892165|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313890|NCT03893565|64892166|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313891|NCT03893565|64892167|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313892|NCT03893565|64892168|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313893|NCT03893565|64892169|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313894|NCT03893565|64892170|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
23425201|NCT02908685|65299877|FG013|Part 2 OLE: > Month 24|Death|0|||
23211026|NCT02505542|64512316|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
23211027|NCT02505542|64512317|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
23211028|NCT02505542|64512314|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
23211029|NCT02505542|64512315|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
23211030|NCT02505542|64512316|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
23211031|NCT02505542|64512317|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
23211032|NCT02505542|64512314|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
23211033|NCT02505542|64512315|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
23211034|NCT02505542|64512316|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
23211035|NCT02505542|64512317|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
23211036|NCT02505542|64512314|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
23616722|NCT00705614|65982423|FG001|Initial Intervention|Administrative Reason|38|||
23616723|NCT00705614|65982422|FG000|Initial Intervention|Status completion unknown|3|||
23616724|NCT00705614|65982423|FG001|Initial Intervention|Status completion unknown|0|||
23616725|NCT00705614|65982422|FG000|Switch to Remicade|Adverse Event|0|||
23616726|NCT00705614|65982423|FG001|Switch to Remicade|Adverse Event|5|||
23616727|NCT00705614|65982422|FG000|Switch to Remicade|Lost to Follow-up|0|||
23616728|NCT00705614|65982423|FG001|Switch to Remicade|Lost to Follow-up|23|||
23616729|NCT00705614|65982422|FG000|Switch to Remicade|Withdrawal by Subject|0|||
23616730|NCT00705614|65982423|FG001|Switch to Remicade|Withdrawal by Subject|12|||
23616731|NCT00705614|65982422|FG000|Switch to Remicade|Administrative Reason|0|||
23211037|NCT02505542|64512315|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
23211038|NCT02505542|64512316|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
23211039|NCT02505542|64512317|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
23211040|NCT02505542|64512314|FG000|Part B: Double-Blind Period|Miscalculation|0|||
23211041|NCT02505542|64512315|FG001|Part B: Double-Blind Period|Miscalculation|1|||
23313895|NCT03893565|64892171|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
23313896|NCT03893565|64892163|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23211042|NCT02505542|64512316|FG002|Part B: Double-Blind Period|Miscalculation|0|||
23211043|NCT02505542|64512317|FG003|Part B: Double-Blind Period|Miscalculation|0|||
23313897|NCT03893565|64892164|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23313898|NCT03893565|64892165|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23313899|NCT03893565|64892166|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23313900|NCT03893565|64892167|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23313901|NCT03893565|64892168|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23313902|NCT03893565|64892169|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23313903|NCT03893565|64892170|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
23313904|NCT03893565|64892171|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
23313905|NCT01329900|64892172|FG000|Overall Study|Elevated creatinine/renal function|1|||
23313906|NCT01130597|64892175|FG000|Overall Study|Protocol-specified (High K+)|1|||
23313907|NCT01130597|64892175|FG000|Overall Study|Adverse Event|4|||
23313908|NCT01130597|64892175|FG000|Overall Study|Death|1|||
23313909|NCT01130597|64892175|FG000|Overall Study|Protocol Violation|1|||
23313910|NCT04138823|64892181|FG000|Overall Study|Clinical disease progression|0|||
23211044|NCT02505542|64512314|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
23211045|NCT02505542|64512315|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
23211046|NCT02505542|64512316|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
23211047|NCT02505542|64512317|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
23211048|NCT00225147|64512318|FG000|Open-label Phase|Lost to Follow-up|0|||
23211049|NCT00225147|64512319|FG001|Open-label Phase|Lost to Follow-up|0|||
23211050|NCT00225147|64512320|FG002|Open-label Phase|Lost to Follow-up|0|||
23211051|NCT00225147|64512321|FG003|Open-label Phase|Lost to Follow-up|4|||
23211052|NCT00225147|64512318|FG000|Open-label Phase|Withdrawal by Subject|0|||
23211053|NCT00225147|64512319|FG001|Open-label Phase|Withdrawal by Subject|0|||
23211054|NCT00225147|64512320|FG002|Open-label Phase|Withdrawal by Subject|0|||
23211055|NCT00225147|64512321|FG003|Open-label Phase|Withdrawal by Subject|6|||
23211056|NCT05254613|64512322|FG000|Overall Study|Lost to Follow-up|0|||
23211057|NCT05254613|64512323|FG001|Overall Study|Lost to Follow-up|0|||
23211058|NCT05254613|64512324|FG002|Overall Study|Lost to Follow-up|1|||
23211059|NCT01317615|64512330|FG000|Overall Study|Disease progression|25|||
23211060|NCT01317615|64512330|FG000|Overall Study|New cancer therapy|5|||
23211061|NCT01317615|64512330|FG000|Overall Study|Death|6|||
23211062|NCT01317615|64512330|FG000|Overall Study|Withdrawal by Subject|5|||
23211063|NCT01317615|64512330|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23211064|NCT01317615|64512330|FG000|Overall Study|Adverse Event|7|||
23211065|NCT02248857|64512331|FG000|3 Month|Withdrawal by Subject|9|||
23211066|NCT02248857|64512332|FG001|3 Month|Withdrawal by Subject|3|||
23211067|NCT02248857|64512333|FG002|3 Month|Withdrawal by Subject|4|||
23211068|NCT02248857|64512331|FG000|3 Month|Unable to reach for 3 month|35|||
23211069|NCT02248857|64512332|FG001|3 Month|Unable to reach for 3 month|29|||
23211070|NCT02248857|64512333|FG002|3 Month|Unable to reach for 3 month|26|||
23211071|NCT02248857|64512331|FG000|3 Month|Partially completed, unable to finish|2|||
23211072|NCT02248857|64512332|FG001|3 Month|Partially completed, unable to finish|2|||
23211073|NCT02248857|64512333|FG002|3 Month|Partially completed, unable to finish|1|||
23211074|NCT02248857|64512331|FG000|6 Month|Lost to Follow-up|27|||
23211075|NCT02248857|64512332|FG001|6 Month|Lost to Follow-up|26|||
23313911|NCT04138823|64892182|FG001|Overall Study|Clinical disease progression|0|||
23616732|NCT00705614|65982423|FG001|Switch to Remicade|Administrative Reason|9|||
23616733|NCT02809677|65982424|FG000|Overall Study|Withdrawal by Subject|8|||
23313912|NCT04138823|64892183|FG002|Overall Study|Clinical disease progression|1|||
23313913|NCT04138823|64892181|FG000|Overall Study|Objective disease progression|3|||
23313914|NCT04138823|64892182|FG001|Overall Study|Objective disease progression|2|||
23313915|NCT04138823|64892183|FG002|Overall Study|Objective disease progression|5|||
23313916|NCT03907878|64892184|FG000|Treatment Period|Withdrawal by Subject|5|||
23313917|NCT03907878|64892184|FG000|Treatment Period|Adverse Event|4|||
23313918|NCT03907878|64892184|FG000|Treatment Period|Lack of Efficacy|1|||
23313919|NCT03907878|64892184|FG000|Treatment Period|Protocol Violation|1|||
23313920|NCT03907878|64892184|FG000|Follow-up Period|Adverse Event|3|||
23313921|NCT03907878|64892184|FG000|Follow-up Period|Withdrawal by Subject|3|||
23313922|NCT03201445|64892185|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
23313923|NCT03201445|64892186|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
23313924|NCT03201445|64892185|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
23425202|NCT02908685|65299864|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
23543217|NCT02415400|65719743|FG000|Overall Study|Participant in jail|0|||
23313925|NCT03201445|64892186|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
23313926|NCT03201445|64892185|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
23313927|NCT03201445|64892186|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
23313928|NCT03201445|64892185|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
23313929|NCT03201445|64892186|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
23313930|NCT03201445|64892185|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
23313931|NCT03201445|64892186|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
23313932|NCT03201445|64892185|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
23313933|NCT03201445|64892186|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
23313934|NCT03201445|64892185|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
23313935|NCT03201445|64892186|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
23313936|NCT03201445|64892185|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
23313937|NCT03201445|64892186|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
23313938|NCT03201445|64892185|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
23313939|NCT03201445|64892186|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
23313940|NCT03201445|64892185|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
23313941|NCT03201445|64892186|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
23313942|NCT03201445|64892185|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
23313943|NCT03201445|64892186|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
23313944|NCT03201445|64892185|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
23313945|NCT03201445|64892186|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
23313946|NCT03201445|64892185|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
23313947|NCT03201445|64892186|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
23313948|NCT03201445|64892185|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
23313949|NCT03201445|64892186|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
23313950|NCT03201445|64892185|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
23313951|NCT03201445|64892186|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
23313952|NCT03201445|64892185|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
23313953|NCT03201445|64892186|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
23313954|NCT03201445|64892185|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
23543218|NCT02415400|65719744|FG001|Overall Study|Participant in jail|0|||
23543219|NCT02415400|65719745|FG002|Overall Study|Participant in jail|1|||
23543220|NCT02415400|65719746|FG003|Overall Study|Participant in jail|0|||
23543221|NCT02415400|65719743|FG000|Overall Study|Investigator decision|0|||
23543222|NCT02415400|65719744|FG001|Overall Study|Investigator decision|0|||
23543223|NCT02415400|65719745|FG002|Overall Study|Investigator decision|1|||
23543224|NCT02415400|65719746|FG003|Overall Study|Investigator decision|1|||
23543225|NCT02415400|65719743|FG000|Overall Study|Site closure; participant won't transfer|0|||
23543226|NCT02415400|65719744|FG001|Overall Study|Site closure; participant won't transfer|0|||
23616734|NCT05372913|65982425|FG000|Overall Study|Withdrawal by Subject|0|||
23616735|NCT05372913|65982426|FG001|Overall Study|Withdrawal by Subject|2|||
23616736|NCT05372913|65982425|FG000|Overall Study|Protocol Violation|2|||
23616737|NCT05372913|65982426|FG001|Overall Study|Protocol Violation|2|||
23313955|NCT03201445|64892186|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
23313956|NCT03201445|64892185|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
23313957|NCT03201445|64892186|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
23543227|NCT02415400|65719745|FG002|Overall Study|Site closure; participant won't transfer|0|||
23543228|NCT02415400|65719746|FG003|Overall Study|Site closure; participant won't transfer|1|||
23543229|NCT01660763|65719748|FG000|Overall Study|Lack of Efficacy|45|||
23543230|NCT01660763|65719749|FG001|Overall Study|Lack of Efficacy|50|||
23543231|NCT01660763|65719748|FG000|Overall Study|Adverse Event|22|||
23543232|NCT01660763|65719749|FG001|Overall Study|Adverse Event|7|||
23543233|NCT01660763|65719748|FG000|Overall Study|Protocol Violation|1|||
23543234|NCT01660763|65719749|FG001|Overall Study|Protocol Violation|0|||
23543235|NCT01660763|65719748|FG000|Overall Study|Withdrawal by Subject|4|||
23425203|NCT02908685|65299865|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
23425204|NCT02908685|65299866|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
23425205|NCT02908685|65299867|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
23425206|NCT02908685|65299868|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
23425207|NCT02908685|65299869|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
23425208|NCT02908685|65299870|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
23425209|NCT02908685|65299871|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
23425210|NCT02908685|65299872|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
23425211|NCT02908685|65299873|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
23425212|NCT02908685|65299874|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
23425213|NCT02908685|65299875|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
23425214|NCT02908685|65299876|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
23425215|NCT02908685|65299877|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
23425216|NCT02908685|65299864|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425217|NCT02908685|65299865|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425218|NCT02908685|65299866|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425219|NCT02908685|65299867|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425220|NCT02908685|65299868|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425221|NCT02908685|65299869|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425222|NCT02908685|65299870|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425223|NCT02908685|65299871|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425224|NCT02908685|65299872|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425225|NCT02908685|65299873|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425226|NCT02908685|65299874|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425227|NCT02908685|65299875|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
23425228|NCT02908685|65299876|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
23425229|NCT02908685|65299877|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
23425230|NCT00354107|65299878|FG000|Overall Study|Adverse Event|2|||
23425231|NCT00354107|65299878|FG000|Overall Study|Physician Decision|2|||
23425232|NCT00354107|65299878|FG000|Overall Study|Withdrawal by Subject|1|||
23425233|NCT00869050|65299880|FG000|Overall Study|Screen Failure|3|||
23425234|NCT02640625|65299884|FG000|Overall Study|Adverse Event|1|||
23425235|NCT01996592|65299885|FG000|Overall Study|no response to text/no diary entry|32|||
23425236|NCT01996592|65299885|FG000|Overall Study|change in surgical date|4|||
23425237|NCT01996592|65299885|FG000|Overall Study|Withdrawal by Subject|5|||
23425238|NCT01996592|65299885|FG000|Overall Study|change in mode of delivery|4|||
23425239|NCT02723006|65299886|FG000|Overall Study|Withdrawal by Subject|0|||
23425240|NCT02723006|65299887|FG001|Overall Study|Withdrawal by Subject|1|||
23425241|NCT02723006|65299888|FG002|Overall Study|Withdrawal by Subject|1|||
23425242|NCT02723006|65299886|FG000|Overall Study|Study Terminated by Sponsor|1|||
23425243|NCT02723006|65299887|FG001|Overall Study|Study Terminated by Sponsor|6|||
23425244|NCT02723006|65299888|FG002|Overall Study|Study Terminated by Sponsor|6|||
23425245|NCT01414205|65299889|FG000|Overall Study|Death|5|||
23425246|NCT01414205|65299890|FG001|Overall Study|Death|1|||
23425247|NCT01414205|65299889|FG000|Overall Study|Lost to Follow-up|1|||
23425248|NCT01414205|65299890|FG001|Overall Study|Lost to Follow-up|4|||
23425249|NCT01414205|65299889|FG000|Overall Study|Physician Decision|0|||
23425250|NCT01414205|65299890|FG001|Overall Study|Physician Decision|1|||
23425251|NCT01414205|65299889|FG000|Overall Study|Randomized but not Treated|1|||
23425252|NCT01414205|65299890|FG001|Overall Study|Randomized but not Treated|1|||
23425253|NCT04662073|65299891|FG000|Overall Study|Withdrawal by Subject|1|||
23425254|NCT04662073|65299892|FG001|Overall Study|Withdrawal by Subject|0|||
23425255|NCT01036529|65299893|FG000|Overall Study|Adverse Event|0|||
23425256|NCT01036529|65299894|FG001|Overall Study|Adverse Event|1|||
23425257|NCT01036529|65299893|FG000|Overall Study|Lost to Follow-up|0|||
23425258|NCT01036529|65299894|FG001|Overall Study|Lost to Follow-up|1|||
23425259|NCT01036529|65299893|FG000|Overall Study|Physician Decision|1|||
23425260|NCT01036529|65299894|FG001|Overall Study|Physician Decision|0|||
23425261|NCT01036529|65299893|FG000|Overall Study|Withdrawal by Subject|1|||
23425262|NCT01036529|65299894|FG001|Overall Study|Withdrawal by Subject|1|||
23425263|NCT01036529|65299893|FG000|Overall Study|Sponsor study termination|11|||
23425264|NCT01036529|65299894|FG001|Overall Study|Sponsor study termination|12|||
23425265|NCT00717522|65299895|FG000|Overall Study|Disease Progression|5|||
23425266|NCT00717522|65299895|FG000|Overall Study|Adverse Event|1|||
23425267|NCT00717522|65299895|FG000|Overall Study|Death|1|||
23425268|NCT00431951|65299899|FG000|Overall Study|Inability to follow study procedures|1|||
23425269|NCT00431951|65299900|FG001|Overall Study|Inability to follow study procedures|0|||
23425270|NCT00431951|65299901|FG002|Overall Study|Inability to follow study procedures|1|||
23425271|NCT00431951|65299902|FG003|Overall Study|Inability to follow study procedures|2|||
23425272|NCT00431951|65299899|FG000|Overall Study|Lost to Follow-up|0|||
23425273|NCT00431951|65299900|FG001|Overall Study|Lost to Follow-up|1|||
23543236|NCT01660763|65719749|FG001|Overall Study|Withdrawal by Subject|0|||
23425274|NCT00431951|65299901|FG002|Overall Study|Lost to Follow-up|0|||
23425275|NCT00431951|65299902|FG003|Overall Study|Lost to Follow-up|0|||
23425276|NCT00431951|65299899|FG000|Overall Study|Withdrawal by Subject|0|||
23425277|NCT00431951|65299900|FG001|Overall Study|Withdrawal by Subject|1|||
23425278|NCT00431951|65299901|FG002|Overall Study|Withdrawal by Subject|0|||
23425279|NCT00431951|65299902|FG003|Overall Study|Withdrawal by Subject|0|||
23425280|NCT00431951|65299899|FG000|Overall Study|Adverse Event|0|||
23425281|NCT00431951|65299900|FG001|Overall Study|Adverse Event|0|||
23425282|NCT00431951|65299901|FG002|Overall Study|Adverse Event|1|||
23425283|NCT00431951|65299902|FG003|Overall Study|Adverse Event|0|||
23425284|NCT01710527|65299903|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
23543237|NCT01660763|65719748|FG000|Overall Study|Patient ready for early discharge|28|||
23211076|NCT02248857|64512333|FG002|6 Month|Lost to Follow-up|15|||
23211077|NCT02248857|64512331|FG000|6 Month|Partially completed, unable to finish|0|||
23211078|NCT02248857|64512332|FG001|6 Month|Partially completed, unable to finish|1|||
23211079|NCT02248857|64512333|FG002|6 Month|Partially completed, unable to finish|0|||
23211080|NCT02248857|64512331|FG000|6 Month|Withdrawal by Subject|0|||
23211081|NCT02248857|64512332|FG001|6 Month|Withdrawal by Subject|2|||
23211082|NCT02248857|64512333|FG002|6 Month|Withdrawal by Subject|2|||
23211083|NCT02248857|64512331|FG000|6 Month|Death|1|||
23211084|NCT02248857|64512332|FG001|6 Month|Death|0|||
23211085|NCT02248857|64512333|FG002|6 Month|Death|0|||
23211086|NCT02919683|64512336|FG000|Post-Surgery Follow-Up|Death|2|||
23211087|NCT02919683|64512337|FG001|Post-Surgery Follow-Up|Death|2|||
23211088|NCT02919683|64512336|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
23211089|NCT02919683|64512337|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
23211090|NCT04126031|64512338|FG000|Part A|Withdrawal by Subject|0|||
23211091|NCT04126031|64512339|FG001|Part A|Withdrawal by Subject|0|||
23211092|NCT04126031|64512340|FG002|Part A|Withdrawal by Subject|1|||
23313958|NCT03201445|64892185|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
23313959|NCT03201445|64892186|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
23313960|NCT03201445|64892185|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
23313961|NCT03201445|64892186|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
23313962|NCT03201445|64892185|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
23313963|NCT03201445|64892186|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
23313964|NCT02446600|64892187|FG000|Overall Study|Never treated|20|||
23313965|NCT02446600|64892188|FG001|Overall Study|Never treated|2|||
23543238|NCT01660763|65719749|FG001|Overall Study|Patient ready for early discharge|4|||
23543239|NCT00724282|65719752|FG000|Overall Study|Withdrawal by Subject|3|||
23543240|NCT00724282|65719752|FG000|Overall Study|Physician Decision|1|||
23543241|NCT01198600|65719760|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
23543242|NCT01198600|65719761|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
23543243|NCT01198600|65719762|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
23543244|NCT01198600|65719763|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
23543245|NCT01198600|65719760|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
23543246|NCT01198600|65719761|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
23543247|NCT01198600|65719762|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
23543248|NCT01198600|65719763|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
23543249|NCT01198600|65719760|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
23543250|NCT01198600|65719761|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
23543251|NCT01198600|65719762|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
23543252|NCT01198600|65719763|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
23543253|NCT01198600|65719760|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
23543254|NCT01198600|65719761|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
23616738|NCT05372913|65982425|FG000|Overall Study|Adverse Event|0|||
23425285|NCT01710527|65299904|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
23211093|NCT04126031|64512341|FG003|Part A|Withdrawal by Subject|0|||
23211094|NCT04126031|64512342|FG004|Part A|Withdrawal by Subject|0|||
23211095|NCT04126031|64512343|FG005|Part A|Withdrawal by Subject|0|||
23211096|NCT04126031|64512338|FG000|Part A|Other|1|||
23211097|NCT04126031|64512339|FG001|Part A|Other|0|||
23211098|NCT04126031|64512340|FG002|Part A|Other|0|||
23211099|NCT04126031|64512341|FG003|Part A|Other|0|||
23211100|NCT04126031|64512342|FG004|Part A|Other|0|||
23211101|NCT04126031|64512343|FG005|Part A|Other|0|||
23211102|NCT04126031|64512338|FG000|Part B|Adverse Event|0|||
23211103|NCT04126031|64512339|FG001|Part B|Adverse Event|0|||
23211104|NCT04126031|64512340|FG002|Part B|Adverse Event|0|||
23211105|NCT04126031|64512341|FG003|Part B|Adverse Event|0|||
23211106|NCT04126031|64512342|FG004|Part B|Adverse Event|0|||
23211107|NCT04126031|64512343|FG005|Part B|Adverse Event|2|||
23211108|NCT04126031|64512338|FG000|Part B|Pre-existing hypertransaminasemia|0|||
23211109|NCT04126031|64512339|FG001|Part B|Pre-existing hypertransaminasemia|0|||
23211110|NCT04126031|64512340|FG002|Part B|Pre-existing hypertransaminasemia|0|||
23211111|NCT04126031|64512341|FG003|Part B|Pre-existing hypertransaminasemia|0|||
23211112|NCT04126031|64512342|FG004|Part B|Pre-existing hypertransaminasemia|1|||
23211113|NCT04126031|64512343|FG005|Part B|Pre-existing hypertransaminasemia|0|||
23211114|NCT05425719|64512344|FG000|Overall Study|Lost to Follow-up|4|||
23211115|NCT05425719|64512345|FG001|Overall Study|Lost to Follow-up|0|||
23211116|NCT05425719|64512344|FG000|Overall Study|Withdrew consent|1|||
23211117|NCT05425719|64512345|FG001|Overall Study|Withdrew consent|1|||
23211118|NCT00776555|64512346|FG000|Overall Study|Study terminated|3|||
23211119|NCT00776555|64512347|FG001|Overall Study|Study terminated|0|||
23211120|NCT01575899|64512348|FG000|Overall Study|Lost to Follow-up|3|||
23211121|NCT01575899|64512349|FG001|Overall Study|Lost to Follow-up|4|||
23211122|NCT01575899|64512350|FG002|Overall Study|Lost to Follow-up|2|||
23211123|NCT01575899|64512348|FG000|Overall Study|Protocol Violation|2|||
23211124|NCT01575899|64512349|FG001|Overall Study|Protocol Violation|1|||
23211125|NCT01575899|64512350|FG002|Overall Study|Protocol Violation|0|||
23211126|NCT01205451|64512353|FG000|Overall Study|Lost to Follow-up|1|||
23211127|NCT01205451|64512354|FG001|Overall Study|Lost to Follow-up|1|||
23211128|NCT01205451|64512353|FG000|Overall Study|Withdrawal by Subject|5|||
23211129|NCT01205451|64512354|FG001|Overall Study|Withdrawal by Subject|9|||
23211130|NCT04724733|64512355|FG000|Overall Study|Lost to Follow-up|1|||
23211131|NCT04724733|64512356|FG001|Overall Study|Lost to Follow-up|1|||
23211132|NCT04724733|64512357|FG002|Overall Study|Lost to Follow-up|1|||
23211133|NCT03172481|64512358|FG000|Double-blind|Withdrawal by Subject|1|||
23211134|NCT03172481|64512359|FG001|Double-blind|Withdrawal by Subject|0|||
23211135|NCT00003476|64512360|FG000|Overall Study|Not evaluable|1|||
23211136|NCT01769469|64512361|FG000|Overall Study|Consent Withdrawn|5|||
23211137|NCT01769469|64512361|FG000|Overall Study|Moved Out Of Area|3|||
23211138|NCT01769469|64512361|FG000|Overall Study|Lost to Follow-up|17|||
23211139|NCT01769469|64512361|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
23211140|NCT01769469|64512361|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
23211141|NCT02975700|64512362|FG000|Overall Study|Adverse Event|1|||
23211142|NCT02975700|64512362|FG000|Overall Study|Progressive disease|3|||
23211143|NCT02975700|64512362|FG000|Overall Study|Failed screening criteria|2|||
23211144|NCT03196193|64512363|FG000|Overall Study|Adverse Event|1|||
23211145|NCT03196193|64512364|FG001|Overall Study|Adverse Event|0|||
23211146|NCT03196193|64512363|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
23211147|NCT03196193|64512364|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
23313966|NCT02446600|64892189|FG002|Overall Study|Never treated|6|||
23543255|NCT01198600|65719762|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
23211148|NCT00039741|64512365|FG000|Overall Study|Death|0|||
23211149|NCT00039741|64512366|FG001|Overall Study|Death|1|||
23313967|NCT02446600|64892190|FG003|Overall Study|Never treated|0|||
23313968|NCT02446600|64892187|FG000|Overall Study|Withdrawal by Subject|19|||
23211150|NCT00039741|64512367|FG002|Overall Study|Death|0|||
23211151|NCT00039741|64512368|FG003|Overall Study|Death|0|||
23211152|NCT00039741|64512365|FG000|Overall Study|Lost to Follow-up|3|||
23211153|NCT00039741|64512366|FG001|Overall Study|Lost to Follow-up|1|||
23211154|NCT00039741|64512367|FG002|Overall Study|Lost to Follow-up|5|||
23211155|NCT00039741|64512368|FG003|Overall Study|Lost to Follow-up|2|||
23211156|NCT00039741|64512365|FG000|Overall Study|Confounding medical condition|1|||
23211157|NCT00039741|64512366|FG001|Overall Study|Confounding medical condition|0|||
23211158|NCT00039741|64512367|FG002|Overall Study|Confounding medical condition|0|||
23313969|NCT02446600|64892188|FG001|Overall Study|Withdrawal by Subject|5|||
23211159|NCT00039741|64512368|FG003|Overall Study|Confounding medical condition|0|||
23211160|NCT00039741|64512365|FG000|Overall Study|Not able to get to clinic|5|||
23211161|NCT00039741|64512366|FG001|Overall Study|Not able to get to clinic|2|||
23211162|NCT00039741|64512367|FG002|Overall Study|Not able to get to clinic|0|||
23616739|NCT05372913|65982426|FG001|Overall Study|Adverse Event|1|||
23616740|NCT05177770|65982429|FG000|Overall Study|Death|4|||
23616741|NCT05177770|65982429|FG000|Overall Study|Withdrawal by Subject|1|||
23616742|NCT05177770|65982429|FG000|Overall Study|Adverse Event prior to dosing|1|||
23616743|NCT01887418|65982430|FG000|Overall Study|Travelling difficulties|0|||
23616744|NCT01887418|65982431|FG001|Overall Study|Travelling difficulties|0|||
23616745|NCT01887418|65982432|FG002|Overall Study|Travelling difficulties|1|||
23616746|NCT01503515|65982433|FG000|Overall Study|Adverse Event|4|||
23616747|NCT01503515|65982434|FG001|Overall Study|Adverse Event|5|||
23616748|NCT01503515|65982433|FG000|Overall Study|Death|0|||
23616749|NCT01503515|65982434|FG001|Overall Study|Death|1|||
23616750|NCT01503515|65982433|FG000|Overall Study|Physician Decision|14|||
23616751|NCT01503515|65982434|FG001|Overall Study|Physician Decision|23|||
23616752|NCT01503515|65982433|FG000|Overall Study|Withdrawal by Subject|0|||
23616753|NCT01503515|65982434|FG001|Overall Study|Withdrawal by Subject|1|||
23616754|NCT01503515|65982433|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
23616755|NCT01503515|65982434|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
23616756|NCT01503515|65982433|FG000|Overall Study|Ineligible|1|||
23616757|NCT01503515|65982434|FG001|Overall Study|Ineligible|1|||
23616758|NCT02625922|65982436|FG000|Overall Study|Non-availability of IMP|1|||
23616759|NCT02625922|65982437|FG001|Overall Study|Non-availability of IMP|1|||
23616760|NCT02625922|65982436|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
23616761|NCT02625922|65982437|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
23616762|NCT00666835|65982444|FG000|Overall Study|Withdrawal by Subject|5|||
23616763|NCT00666835|65982445|FG001|Overall Study|Withdrawal by Subject|2|||
23616764|NCT00666835|65982444|FG000|Overall Study|Lack of Efficacy|0|||
23616765|NCT00666835|65982445|FG001|Overall Study|Lack of Efficacy|1|||
23616766|NCT00666835|65982444|FG000|Overall Study|Incl./excl. not fulfilled|7|||
23616767|NCT00666835|65982445|FG001|Overall Study|Incl./excl. not fulfilled|2|||
23616768|NCT00666835|65982444|FG000|Overall Study|Adverse Event|7|||
23616769|NCT00666835|65982445|FG001|Overall Study|Adverse Event|6|||
23616770|NCT00666835|65982444|FG000|Overall Study|Protocol Violation|2|||
23616771|NCT00666835|65982445|FG001|Overall Study|Protocol Violation|0|||
23616772|NCT00666835|65982444|FG000|Overall Study|Death|15|||
23616773|NCT00666835|65982445|FG001|Overall Study|Death|4|||
23616774|NCT00666835|65982444|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
23616775|NCT00666835|65982445|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
23616776|NCT00666835|65982444|FG000|Overall Study|Hemoglobulin concentration|4|||
23616777|NCT00666835|65982445|FG001|Overall Study|Hemoglobulin concentration|3|||
23616778|NCT00666835|65982444|FG000|Overall Study|Planned operation|2|||
23616779|NCT00666835|65982445|FG001|Overall Study|Planned operation|0|||
23616780|NCT00666835|65982444|FG000|Overall Study|Physician Decision|1|||
23616781|NCT00666835|65982445|FG001|Overall Study|Physician Decision|2|||
23616782|NCT01812837|65982446|FG000|Overall Study|Lost to Follow-up|1|||
23616783|NCT01812837|65982447|FG001|Overall Study|Lost to Follow-up|1|||
23616784|NCT01812837|65982448|FG002|Overall Study|Lost to Follow-up|0|||
23616785|NCT01812837|65982446|FG000|Overall Study|Protocol Violation|1|||
23616786|NCT01812837|65982447|FG001|Overall Study|Protocol Violation|0|||
23616787|NCT01812837|65982448|FG002|Overall Study|Protocol Violation|0|||
23616788|NCT03469258|65982459|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
23616789|NCT04175834|65982460|FG000|Overall Study|Withdrawal by Subject|1|||
23616790|NCT04175834|65982461|FG001|Overall Study|Withdrawal by Subject|0|||
23616791|NCT03786783|65982462|FG000|Overall Study|Death|1|||
23616792|NCT03786783|65982462|FG000|Overall Study|Physician Decision|6|||
23616793|NCT03786783|65982462|FG000|Overall Study|Withdrawal by Subject|2|||
23616794|NCT03786783|65982462|FG000|Overall Study|Disease Progression|7|||
23616795|NCT03786783|65982462|FG000|Overall Study|Patient/Parent Refusal|4|||
23616796|NCT02040532|65982464|FG000|Overall Study|Lost to Follow-up|1|||
23616797|NCT02040532|65982464|FG000|Overall Study|Physician Decision|4|||
23616798|NCT02040532|65982464|FG000|Overall Study|Adverse Event|4|||
23616799|NCT02040532|65982464|FG000|Overall Study|Withdrawal by Subject|3|||
23616800|NCT03794609|65982465|FG000|Overall Study|Other|10|||
23616801|NCT03794609|65982465|FG000|Overall Study|Withdrawal by Subject|66|||
23616802|NCT03794609|65982465|FG000|Overall Study|The child is enrolled in an interventional study|70|||
23616803|NCT03794609|65982465|FG000|Overall Study|Inclusion/exclusion criteria|8|||
23211163|NCT00039741|64512368|FG003|Overall Study|Not able to get to clinic|3|||
23211164|NCT00039741|64512365|FG000|Overall Study|Moved|3|||
23616804|NCT03794609|65982465|FG000|Overall Study|At sponsor's request|151|||
23616805|NCT03794609|65982465|FG000|Overall Study|Physician Decision|1|||
23616806|NCT03794609|65982465|FG000|Overall Study|Lost to Follow-up|5|||
23616807|NCT00187135|65982467|FG000|Visit One|Withdrawal by Subject|1|||
23616808|NCT00187135|65982468|FG001|Visit One|Withdrawal by Subject|0|||
23616809|NCT00187135|65982469|FG002|Visit One|Withdrawal by Subject|0|||
23616810|NCT00187135|65982470|FG003|Visit One|Withdrawal by Subject|0|||
23616811|NCT00187135|65982471|FG004|Visit One|Withdrawal by Subject|0|||
23616812|NCT00187135|65982472|FG005|Visit One|Withdrawal by Subject|1|||
23616813|NCT00187135|65982467|FG000|Visit One|Physician Decision|3|||
23616814|NCT00187135|65982468|FG001|Visit One|Physician Decision|1|||
23616815|NCT00187135|65982469|FG002|Visit One|Physician Decision|0|||
23616816|NCT00187135|65982470|FG003|Visit One|Physician Decision|0|||
23616817|NCT00187135|65982471|FG004|Visit One|Physician Decision|0|||
23616818|NCT00187135|65982472|FG005|Visit One|Physician Decision|1|||
23616819|NCT00187135|65982467|FG000|Visit Two|Death|0|||
23616820|NCT00187135|65982468|FG001|Visit Two|Death|0|||
23616821|NCT00187135|65982469|FG002|Visit Two|Death|0|||
23616822|NCT00187135|65982470|FG003|Visit Two|Death|1|||
23616823|NCT00187135|65982471|FG004|Visit Two|Death|0|||
23616824|NCT00187135|65982472|FG005|Visit Two|Death|1|||
23616825|NCT00187135|65982467|FG000|Visit Two|Physician Decision|1|||
23616826|NCT00187135|65982468|FG001|Visit Two|Physician Decision|0|||
23616827|NCT00187135|65982469|FG002|Visit Two|Physician Decision|0|||
23616828|NCT00187135|65982470|FG003|Visit Two|Physician Decision|0|||
23616829|NCT00187135|65982471|FG004|Visit Two|Physician Decision|0|||
23616830|NCT00187135|65982472|FG005|Visit Two|Physician Decision|0|||
23616831|NCT00187135|65982467|FG000|Visit Two|Withdrawal by Subject|1|||
23616832|NCT00187135|65982468|FG001|Visit Two|Withdrawal by Subject|1|||
23616833|NCT00187135|65982469|FG002|Visit Two|Withdrawal by Subject|1|||
23616834|NCT00187135|65982470|FG003|Visit Two|Withdrawal by Subject|0|||
23616835|NCT00187135|65982471|FG004|Visit Two|Withdrawal by Subject|1|||
23616836|NCT00187135|65982472|FG005|Visit Two|Withdrawal by Subject|1|||
23616837|NCT00187135|65982467|FG000|Visit Two|Study Discontinued|3|||
23616838|NCT00187135|65982468|FG001|Visit Two|Study Discontinued|2|||
23616839|NCT00187135|65982469|FG002|Visit Two|Study Discontinued|1|||
23616840|NCT00187135|65982470|FG003|Visit Two|Study Discontinued|7|||
23616841|NCT00187135|65982471|FG004|Visit Two|Study Discontinued|5|||
23616842|NCT00187135|65982472|FG005|Visit Two|Study Discontinued|6|||
23616843|NCT00187135|65982467|FG000|Visit Three|Death|0|||
23616844|NCT00187135|65982468|FG001|Visit Three|Death|0|||
23616845|NCT00187135|65982469|FG002|Visit Three|Death|1|||
23616846|NCT00187135|65982470|FG003|Visit Three|Death|0|||
23616847|NCT00187135|65982471|FG004|Visit Three|Death|1|||
23616848|NCT00187135|65982472|FG005|Visit Three|Death|0|||
23616849|NCT00187135|65982467|FG000|Visit Three|Withdrawal by Subject|0|||
23616850|NCT00187135|65982468|FG001|Visit Three|Withdrawal by Subject|1|||
23616851|NCT00187135|65982469|FG002|Visit Three|Withdrawal by Subject|1|||
23616852|NCT00187135|65982470|FG003|Visit Three|Withdrawal by Subject|2|||
23616853|NCT00187135|65982471|FG004|Visit Three|Withdrawal by Subject|0|||
23616854|NCT00187135|65982472|FG005|Visit Three|Withdrawal by Subject|0|||
23616855|NCT00187135|65982467|FG000|Visit Three|Study Discontinued|7|||
23616856|NCT00187135|65982468|FG001|Visit Three|Study Discontinued|6|||
23616857|NCT00187135|65982469|FG002|Visit Three|Study Discontinued|7|||
23616858|NCT00187135|65982470|FG003|Visit Three|Study Discontinued|7|||
23616859|NCT00187135|65982471|FG004|Visit Three|Study Discontinued|7|||
23616860|NCT00187135|65982472|FG005|Visit Three|Study Discontinued|6|||
23616861|NCT05335005|65982473|FG000|Overall Study|Lost to Follow-up|1|||
23616862|NCT05060237|65982474|FG000|Overall Study|Withdrawal by Subject|4|||
23616863|NCT05060237|65982474|FG000|Overall Study|Screening failure|8|||
23616864|NCT00385697|65982477|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
23616865|NCT00385697|65982478|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
23616866|NCT00385697|65982479|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
23616867|NCT00385697|65982480|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
23616868|NCT00385697|65982481|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
23616869|NCT00385697|65982477|FG000|Open-label Segment 1|Lost to Follow-up|1|||
23616870|NCT00385697|65982478|FG001|Open-label Segment 1|Lost to Follow-up|0|||
23616871|NCT00385697|65982479|FG002|Open-label Segment 1|Lost to Follow-up|0|||
23616872|NCT00385697|65982480|FG003|Open-label Segment 1|Lost to Follow-up|0|||
23616873|NCT00385697|65982481|FG004|Open-label Segment 1|Lost to Follow-up|0|||
23616874|NCT00385697|65982477|FG000|Double-blind Segment 2|Adverse Event|0|||
23616875|NCT00385697|65982478|FG001|Double-blind Segment 2|Adverse Event|3|||
23616876|NCT00385697|65982479|FG002|Double-blind Segment 2|Adverse Event|1|||
23616877|NCT00385697|65982480|FG003|Double-blind Segment 2|Adverse Event|0|||
23616878|NCT00385697|65982481|FG004|Double-blind Segment 2|Adverse Event|0|||
23616879|NCT00385697|65982477|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
23616880|NCT00385697|65982478|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
23616881|NCT00385697|65982479|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
23616882|NCT00385697|65982480|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
23616883|NCT00385697|65982481|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
23616884|NCT00385697|65982477|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
23616885|NCT00385697|65982478|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
23616886|NCT00385697|65982479|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
23616887|NCT00385697|65982480|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
23616888|NCT00385697|65982481|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
23616889|NCT00385697|65982477|FG000|Double-blind Segment 2|Other|0|||
23616890|NCT00385697|65982478|FG001|Double-blind Segment 2|Other|2|||
23616891|NCT00385697|65982479|FG002|Double-blind Segment 2|Other|0|||
23616892|NCT00385697|65982480|FG003|Double-blind Segment 2|Other|0|||
23616893|NCT00385697|65982481|FG004|Double-blind Segment 2|Other|0|||
23616894|NCT00762723|65982482|FG000|Overall Study|Study Terminated slow enrollement|5|||
23616895|NCT00762723|65982483|FG001|Overall Study|Study Terminated slow enrollement|5|||
23616896|NCT00762723|65982484|FG002|Overall Study|Study Terminated slow enrollement|3|||
23616897|NCT03924193|65982489|FG000|Overall Study|Adverse Event|10|||
23616898|NCT03924193|65982490|FG001|Overall Study|Adverse Event|0|||
23616899|NCT03924193|65982491|FG002|Overall Study|Adverse Event|10|||
23616900|NCT03924193|65982489|FG000|Overall Study|Withdrawal by Subject|5|||
23616901|NCT03924193|65982490|FG001|Overall Study|Withdrawal by Subject|10|||
23616902|NCT03924193|65982491|FG002|Overall Study|Withdrawal by Subject|2|||
23616903|NCT02243605|65982492|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
23616904|NCT02243605|65982493|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
23616905|NCT02243605|65982492|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
23211165|NCT00039741|64512366|FG001|Overall Study|Moved|2|||
23211166|NCT00039741|64512367|FG002|Overall Study|Moved|3|||
23211167|NCT00039741|64512368|FG003|Overall Study|Moved|6|||
23211168|NCT00039741|64512365|FG000|Overall Study|Non-compliance with protocol|1|||
23211169|NCT00039741|64512366|FG001|Overall Study|Non-compliance with protocol|0|||
23211170|NCT00039741|64512367|FG002|Overall Study|Non-compliance with protocol|1|||
23211171|NCT00039741|64512368|FG003|Overall Study|Non-compliance with protocol|0|||
23211172|NCT00039741|64512365|FG000|Overall Study|Withdrew consent|0|||
23211173|NCT00039741|64512366|FG001|Overall Study|Withdrew consent|5|||
23211174|NCT00039741|64512367|FG002|Overall Study|Withdrew consent|0|||
23211175|NCT00039741|64512368|FG003|Overall Study|Withdrew consent|1|||
23211176|NCT00039741|64512365|FG000|Overall Study|Missed final visit|2|||
23211177|NCT00039741|64512366|FG001|Overall Study|Missed final visit|1|||
23425286|NCT00694096|65299920|FG000|Overall Study|Withdrawal by Subject|5|||
23425287|NCT00953680|65299921|FG000|Period 1|Withdrawal by Subject|0|||
23425288|NCT00953680|65299922|FG001|Period 1|Withdrawal by Subject|1|||
23543256|NCT01198600|65719763|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
23543257|NCT01198600|65719760|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
23543258|NCT01198600|65719761|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
23543259|NCT01198600|65719762|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
23543260|NCT01198600|65719763|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
23543261|NCT01198600|65719760|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
23543262|NCT01198600|65719761|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
23211178|NCT00039741|64512367|FG002|Overall Study|Missed final visit|2|||
23211179|NCT00039741|64512368|FG003|Overall Study|Missed final visit|2|||
23211180|NCT00485589|64512369|FG000|Overall Study|Death|2|||
23211181|NCT00485589|64512370|FG001|Overall Study|Death|2|||
23211182|NCT00485589|64512371|FG002|Overall Study|Death|0|||
23425289|NCT02753127|65299927|FG000|Overall Study|Lost to Follow-up|13|||
23543263|NCT01198600|65719762|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
23543264|NCT01198600|65719763|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
23543265|NCT01198600|65719760|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
23543266|NCT01198600|65719761|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
23425290|NCT02753127|65299928|FG001|Overall Study|Lost to Follow-up|11|||
23425291|NCT02753127|65299927|FG000|Overall Study|Withdrawal by Subject|37|||
23425292|NCT02753127|65299928|FG001|Overall Study|Withdrawal by Subject|47|||
23425293|NCT02753127|65299927|FG000|Overall Study|Other|3|||
23543267|NCT01198600|65719762|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
23543268|NCT01198600|65719763|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
23543269|NCT01054729|65719764|FG000|Overall Study|Randomized but Not Treated|0|||
23543270|NCT01054729|65719765|FG001|Overall Study|Randomized but Not Treated|1|||
23211183|NCT00485589|64512369|FG000|Overall Study|Failure to return|6|||
23211184|NCT00485589|64512370|FG001|Overall Study|Failure to return|5|||
23211185|NCT00485589|64512371|FG002|Overall Study|Failure to return|1|||
23543271|NCT01054729|65719766|FG002|Overall Study|Randomized but Not Treated|0|||
23616906|NCT02243605|65982493|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
23616907|NCT02243605|65982492|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
23616908|NCT02243605|65982493|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
23425294|NCT02753127|65299928|FG001|Overall Study|Other|8|||
23313970|NCT02446600|64892189|FG002|Overall Study|Withdrawal by Subject|17|||
23313971|NCT02446600|64892190|FG003|Overall Study|Withdrawal by Subject|0|||
23313972|NCT02446600|64892187|FG000|Overall Study|Ineligible|1|||
23313973|NCT02446600|64892188|FG001|Overall Study|Ineligible|4|||
23313974|NCT02446600|64892189|FG002|Overall Study|Ineligible|4|||
23313975|NCT02446600|64892190|FG003|Overall Study|Ineligible|1|||
23313976|NCT02446600|64892187|FG000|Overall Study|Duplicate Enrollment|0|||
23313977|NCT02446600|64892188|FG001|Overall Study|Duplicate Enrollment|1|||
23211186|NCT00485589|64512369|FG000|Overall Study|Protocol Violation|1|||
23211187|NCT00485589|64512370|FG001|Overall Study|Protocol Violation|0|||
23211188|NCT00485589|64512371|FG002|Overall Study|Protocol Violation|0|||
23211189|NCT00485589|64512369|FG000|Overall Study|Violation of selection criteria at entry|0|||
23211190|NCT00485589|64512370|FG001|Overall Study|Violation of selection criteria at entry|3|||
23211191|NCT00485589|64512371|FG002|Overall Study|Violation of selection criteria at entry|1|||
23211192|NCT00485589|64512369|FG000|Overall Study|Administrative/Other|1|||
23211193|NCT00485589|64512370|FG001|Overall Study|Administrative/Other|2|||
23211194|NCT00485589|64512371|FG002|Overall Study|Administrative/Other|1|||
23211195|NCT00485589|64512369|FG000|Overall Study|Insufficient therapeutic response|10|||
23211196|NCT00485589|64512370|FG001|Overall Study|Insufficient therapeutic response|3|||
23313978|NCT02446600|64892189|FG002|Overall Study|Duplicate Enrollment|0|||
23313979|NCT02446600|64892190|FG003|Overall Study|Duplicate Enrollment|0|||
23313980|NCT02774642|64892191|FG000|Overall Study|Lost to Follow-up|9|||
23313981|NCT02774642|64892192|FG001|Overall Study|Lost to Follow-up|7|||
23313982|NCT00428116|64892193|FG000|Overall Study|Death|1|||
23313983|NCT00428116|64892194|FG001|Overall Study|Death|0|||
23313984|NCT00428116|64892193|FG000|Overall Study|Withdrawal by Subject|1|||
23313985|NCT00428116|64892194|FG001|Overall Study|Withdrawal by Subject|0|||
23313986|NCT00428116|64892193|FG000|Overall Study|Lost to Follow-up|1|||
23313987|NCT00428116|64892194|FG001|Overall Study|Lost to Follow-up|0|||
23313988|NCT03819049|64892195|FG000|Overall Study|Lost to Follow-up|1|||
23313989|NCT03819049|64892196|FG001|Overall Study|Lost to Follow-up|2|||
23313990|NCT03819049|64892197|FG002|Overall Study|Lost to Follow-up|9|||
23313991|NCT03819049|64892198|FG003|Overall Study|Lost to Follow-up|0|||
23313992|NCT03819049|64892199|FG004|Overall Study|Lost to Follow-up|3|||
23313993|NCT03819049|64892200|FG005|Overall Study|Lost to Follow-up|1|||
23313994|NCT03819049|64892201|FG006|Overall Study|Lost to Follow-up|0|||
23313995|NCT03819049|64892195|FG000|Overall Study|Withdrawal by Subject|0|||
23313996|NCT03819049|64892196|FG001|Overall Study|Withdrawal by Subject|0|||
23313997|NCT03819049|64892197|FG002|Overall Study|Withdrawal by Subject|18|||
23313998|NCT03819049|64892198|FG003|Overall Study|Withdrawal by Subject|0|||
23313999|NCT03819049|64892199|FG004|Overall Study|Withdrawal by Subject|10|||
23314000|NCT03819049|64892200|FG005|Overall Study|Withdrawal by Subject|9|||
23314001|NCT03819049|64892201|FG006|Overall Study|Withdrawal by Subject|1|||
23314002|NCT03819049|64892195|FG000|Overall Study|Ongoing|0|||
23543272|NCT01054729|65719767|FG003|Overall Study|Randomized but Not Treated|0|||
23543273|NCT01054729|65719764|FG000|Overall Study|Adverse Event|1|||
23543274|NCT01054729|65719765|FG001|Overall Study|Adverse Event|1|||
23314003|NCT03819049|64892196|FG001|Overall Study|Ongoing|0|||
23314004|NCT03819049|64892197|FG002|Overall Study|Ongoing|75|||
23314005|NCT03819049|64892198|FG003|Overall Study|Ongoing|0|||
23314006|NCT03819049|64892199|FG004|Overall Study|Ongoing|41|||
23314007|NCT03819049|64892200|FG005|Overall Study|Ongoing|0|||
23314008|NCT03819049|64892201|FG006|Overall Study|Ongoing|0|||
23314009|NCT03819049|64892195|FG000|Overall Study|Other|0|||
23314010|NCT03819049|64892196|FG001|Overall Study|Other|0|||
23314011|NCT03819049|64892197|FG002|Overall Study|Other|2|||
23314012|NCT03819049|64892198|FG003|Overall Study|Other|0|||
23314013|NCT03819049|64892199|FG004|Overall Study|Other|0|||
23314014|NCT03819049|64892200|FG005|Overall Study|Other|0|||
23314015|NCT03819049|64892201|FG006|Overall Study|Other|0|||
23314016|NCT03819049|64892195|FG000|Overall Study|Randomized but not vaccinated|0|||
23314017|NCT03819049|64892196|FG001|Overall Study|Randomized but not vaccinated|0|||
23314018|NCT03819049|64892197|FG002|Overall Study|Randomized but not vaccinated|0|||
23314019|NCT03819049|64892198|FG003|Overall Study|Randomized but not vaccinated|1|||
23314020|NCT03819049|64892199|FG004|Overall Study|Randomized but not vaccinated|0|||
23314021|NCT03819049|64892200|FG005|Overall Study|Randomized but not vaccinated|2|||
23314022|NCT03819049|64892201|FG006|Overall Study|Randomized but not vaccinated|1|||
23314023|NCT03819049|64892195|FG000|Overall Study|Physician Decision|0|||
23314024|NCT03819049|64892196|FG001|Overall Study|Physician Decision|0|||
23314025|NCT03819049|64892197|FG002|Overall Study|Physician Decision|0|||
23314026|NCT03819049|64892198|FG003|Overall Study|Physician Decision|0|||
23314027|NCT03819049|64892199|FG004|Overall Study|Physician Decision|0|||
23314028|NCT03819049|64892200|FG005|Overall Study|Physician Decision|0|||
23314029|NCT03819049|64892201|FG006|Overall Study|Physician Decision|1|||
23314030|NCT02052011|64892202|FG000|Overall Study|Lost to Follow-up|3|||
23314031|NCT02052011|64892203|FG001|Overall Study|Lost to Follow-up|0|||
23314032|NCT02052011|64892202|FG000|Overall Study|Withdrawal by Subject|1|||
23314033|NCT02052011|64892203|FG001|Overall Study|Withdrawal by Subject|2|||
23314034|NCT03138655|64892206|FG000|Overall Study|Adverse Event|2|||
23314035|NCT03138655|64892207|FG001|Overall Study|Adverse Event|1|||
23314036|NCT03138655|64892208|FG002|Overall Study|Adverse Event|2|||
23314037|NCT03138655|64892209|FG003|Overall Study|Adverse Event|1|||
23314038|NCT03138655|64892210|FG004|Overall Study|Adverse Event|1|||
23314039|NCT03138655|64892211|FG005|Overall Study|Adverse Event|4|||
23314040|NCT03138655|64892212|FG006|Overall Study|Adverse Event|2|||
23314041|NCT03138655|64892213|FG007|Overall Study|Adverse Event|2|||
23314042|NCT03138655|64892206|FG000|Overall Study|Withdrawal by Subject|0|||
23314043|NCT03138655|64892207|FG001|Overall Study|Withdrawal by Subject|1|||
23425295|NCT02753127|65299927|FG000|Overall Study|Hospice|0|||
23425296|NCT02753127|65299928|FG001|Overall Study|Hospice|2|||
23425297|NCT03618628|65299929|FG000|Overall Study|Death|1|||
23543275|NCT01054729|65719766|FG002|Overall Study|Adverse Event|2|||
23543276|NCT01054729|65719767|FG003|Overall Study|Adverse Event|1|||
23543277|NCT01054729|65719764|FG000|Overall Study|Withdrawal by Subject|1|||
23314044|NCT03138655|64892208|FG002|Overall Study|Withdrawal by Subject|0|||
23314045|NCT03138655|64892209|FG003|Overall Study|Withdrawal by Subject|0|||
23314046|NCT03138655|64892210|FG004|Overall Study|Withdrawal by Subject|0|||
23314047|NCT03138655|64892211|FG005|Overall Study|Withdrawal by Subject|0|||
23314048|NCT03138655|64892212|FG006|Overall Study|Withdrawal by Subject|1|||
23314049|NCT03138655|64892213|FG007|Overall Study|Withdrawal by Subject|0|||
23314050|NCT03138655|64892206|FG000|Overall Study|Reason not Specified|1|||
23314051|NCT03138655|64892207|FG001|Overall Study|Reason not Specified|0|||
23314052|NCT03138655|64892208|FG002|Overall Study|Reason not Specified|0|||
23314053|NCT03138655|64892209|FG003|Overall Study|Reason not Specified|2|||
23314054|NCT03138655|64892210|FG004|Overall Study|Reason not Specified|1|||
23314055|NCT03138655|64892211|FG005|Overall Study|Reason not Specified|1|||
23314056|NCT03138655|64892212|FG006|Overall Study|Reason not Specified|0|||
23314057|NCT03138655|64892213|FG007|Overall Study|Reason not Specified|0|||
23314058|NCT04893018|64892214|FG000|Overall Study|Lost to Follow-up|1|||
23314059|NCT04893018|64892215|FG001|Overall Study|Lost to Follow-up|0|||
23314060|NCT04893018|64892214|FG000|Overall Study|Withdrawal by Subject|2|||
23314061|NCT04893018|64892215|FG001|Overall Study|Withdrawal by Subject|0|||
23543278|NCT01054729|65719765|FG001|Overall Study|Withdrawal by Subject|0|||
23543279|NCT01054729|65719766|FG002|Overall Study|Withdrawal by Subject|1|||
23543280|NCT01054729|65719767|FG003|Overall Study|Withdrawal by Subject|0|||
23543281|NCT01054729|65719764|FG000|Overall Study|Lost to Follow-up|0|||
23314062|NCT04893018|64892214|FG000|Overall Study|Study Terminated|1|||
23314063|NCT04893018|64892215|FG001|Overall Study|Study Terminated|2|||
23314064|NCT02593110|64892216|FG000|Overall Study|Withdrawal by Subject|0|||
23314065|NCT02593110|64892217|FG001|Overall Study|Withdrawal by Subject|3|||
23314066|NCT02593110|64892218|FG002|Overall Study|Withdrawal by Subject|3|||
23314067|NCT02593110|64892219|FG003|Overall Study|Withdrawal by Subject|2|||
23314068|NCT02593110|64892216|FG000|Overall Study|Death|0|||
23314069|NCT02593110|64892217|FG001|Overall Study|Death|0|||
23314070|NCT02593110|64892218|FG002|Overall Study|Death|1|||
23314071|NCT02593110|64892219|FG003|Overall Study|Death|0|||
23314072|NCT04597632|64892223|FG000|Overall Study|Withdrawal by Subject|10|||
23314073|NCT04597632|64892223|FG000|Overall Study|Lost to Follow-up|1|||
23314074|NCT04597632|64892223|FG000|Overall Study|Death|1|||
23314075|NCT04597632|64892223|FG000|Overall Study|Adverse Event|5|||
23314076|NCT02383810|64892224|FG000|Overall Study|Physician Decision|1|||
23314077|NCT02383810|64892225|FG001|Overall Study|Physician Decision|1|||
23314078|NCT02383810|64892226|FG002|Overall Study|Physician Decision|0|||
23314079|NCT02383810|64892227|FG003|Overall Study|Physician Decision|0|||
23314080|NCT02383810|64892228|FG004|Overall Study|Physician Decision|0|||
23314081|NCT02383810|64892229|FG005|Overall Study|Physician Decision|0|||
23314082|NCT02383810|64892230|FG006|Overall Study|Physician Decision|0|||
23314083|NCT02383810|64892231|FG007|Overall Study|Physician Decision|0|||
23314084|NCT02383810|64892224|FG000|Overall Study|Withdrawal by Subject|2|||
23314085|NCT02383810|64892225|FG001|Overall Study|Withdrawal by Subject|3|||
23314086|NCT02383810|64892226|FG002|Overall Study|Withdrawal by Subject|3|||
23314087|NCT02383810|64892227|FG003|Overall Study|Withdrawal by Subject|3|||
23314088|NCT02383810|64892228|FG004|Overall Study|Withdrawal by Subject|0|||
23314089|NCT02383810|64892229|FG005|Overall Study|Withdrawal by Subject|0|||
23314090|NCT02383810|64892230|FG006|Overall Study|Withdrawal by Subject|0|||
23314091|NCT02383810|64892231|FG007|Overall Study|Withdrawal by Subject|0|||
23314092|NCT02383810|64892224|FG000|Overall Study|Adverse Event|0|||
23314093|NCT02383810|64892225|FG001|Overall Study|Adverse Event|2|||
23314094|NCT02383810|64892226|FG002|Overall Study|Adverse Event|4|||
23314095|NCT02383810|64892227|FG003|Overall Study|Adverse Event|5|||
23314096|NCT02383810|64892228|FG004|Overall Study|Adverse Event|0|||
23314097|NCT02383810|64892229|FG005|Overall Study|Adverse Event|1|||
23314098|NCT02383810|64892230|FG006|Overall Study|Adverse Event|1|||
23314099|NCT02383810|64892231|FG007|Overall Study|Adverse Event|0|||
23314100|NCT02383810|64892224|FG000|Overall Study|Lost to Follow-up|0|||
23314101|NCT02383810|64892225|FG001|Overall Study|Lost to Follow-up|1|||
23314102|NCT02383810|64892226|FG002|Overall Study|Lost to Follow-up|0|||
23314103|NCT02383810|64892227|FG003|Overall Study|Lost to Follow-up|1|||
23314104|NCT02383810|64892228|FG004|Overall Study|Lost to Follow-up|0|||
23314105|NCT02383810|64892229|FG005|Overall Study|Lost to Follow-up|0|||
23314106|NCT02383810|64892230|FG006|Overall Study|Lost to Follow-up|0|||
23314107|NCT02383810|64892231|FG007|Overall Study|Lost to Follow-up|0|||
23314108|NCT02383810|64892224|FG000|Overall Study|other|0|||
23314109|NCT02383810|64892225|FG001|Overall Study|other|0|||
23314110|NCT02383810|64892226|FG002|Overall Study|other|0|||
23543282|NCT01054729|65719765|FG001|Overall Study|Lost to Follow-up|1|||
23543283|NCT01054729|65719766|FG002|Overall Study|Lost to Follow-up|0|||
23314111|NCT02383810|64892227|FG003|Overall Study|other|2|||
23314112|NCT02383810|64892228|FG004|Overall Study|other|0|||
23543284|NCT01054729|65719767|FG003|Overall Study|Lost to Follow-up|0|||
23543285|NCT01054729|65719764|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
23314113|NCT02383810|64892229|FG005|Overall Study|other|0|||
23543286|NCT01054729|65719765|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
23314114|NCT02383810|64892230|FG006|Overall Study|other|0|||
23314115|NCT02383810|64892231|FG007|Overall Study|other|0|||
23314116|NCT02383810|64892224|FG000|Overall Study|subject did not receive study treatment|0|||
23314117|NCT02383810|64892225|FG001|Overall Study|subject did not receive study treatment|1|||
23314118|NCT02383810|64892226|FG002|Overall Study|subject did not receive study treatment|0|||
23314119|NCT02383810|64892227|FG003|Overall Study|subject did not receive study treatment|0|||
23425298|NCT03618628|65299929|FG000|Overall Study|Lost to Follow-up|1|||
23543287|NCT01054729|65719766|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
23543288|NCT01054729|65719767|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
23543289|NCT01054729|65719764|FG000|Overall Study|Non-responder|1|||
23543290|NCT01054729|65719765|FG001|Overall Study|Non-responder|0|||
23543291|NCT01054729|65719766|FG002|Overall Study|Non-responder|1|||
23543292|NCT01054729|65719767|FG003|Overall Study|Non-responder|1|||
23543293|NCT01054729|65719764|FG000|Overall Study|PEG/RBV Non-responder|1|||
23543294|NCT01054729|65719765|FG001|Overall Study|PEG/RBV Non-responder|0|||
23543295|NCT01054729|65719766|FG002|Overall Study|PEG/RBV Non-responder|1|||
23543296|NCT01054729|65719767|FG003|Overall Study|PEG/RBV Non-responder|0|||
23543297|NCT01054729|65719764|FG000|Overall Study|Personal/Obligations|0|||
23543298|NCT01054729|65719765|FG001|Overall Study|Personal/Obligations|1|||
23543299|NCT01054729|65719766|FG002|Overall Study|Personal/Obligations|0|||
23543300|NCT01054729|65719767|FG003|Overall Study|Personal/Obligations|0|||
23543301|NCT01054729|65719764|FG000|Overall Study|Subject moved|0|||
23543302|NCT01054729|65719765|FG001|Overall Study|Subject moved|0|||
23543303|NCT01054729|65719766|FG002|Overall Study|Subject moved|1|||
23543304|NCT01054729|65719767|FG003|Overall Study|Subject moved|0|||
23314120|NCT02383810|64892228|FG004|Overall Study|subject did not receive study treatment|0|||
23314121|NCT02383810|64892229|FG005|Overall Study|subject did not receive study treatment|0|||
23314122|NCT02383810|64892230|FG006|Overall Study|subject did not receive study treatment|0|||
23314123|NCT02383810|64892231|FG007|Overall Study|subject did not receive study treatment|0|||
23314124|NCT05384171|64892232|FG000|Overall Study|Lost to Follow-up|9|||
23314125|NCT05384171|64892233|FG001|Overall Study|Lost to Follow-up|9|||
23314126|NCT05384171|64892232|FG000|Overall Study|Withdrawal by Subject|3|||
23314127|NCT05384171|64892233|FG001|Overall Study|Withdrawal by Subject|0|||
23314128|NCT00805961|64892235|FG000|Modality Therapy|Withdrawal by Subject|1|||
23314129|NCT00805961|64892235|FG000|Modality Therapy|Adverse Event|1|||
23314130|NCT00805961|64892235|FG000|Modality Therapy|Disease Progression|2|||
23314131|NCT00805961|64892235|FG000|Treatment-Free Interval|Adverse Event|3|||
23314132|NCT00805961|64892235|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
23314133|NCT00805961|64892235|FG000|Treatment-Free Interval|Physician Decision|1|||
23314134|NCT00805961|64892235|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
23314135|NCT00805961|64892235|FG000|Maintenance Treatment|Lack of Efficacy|13|||
23314136|NCT00805961|64892235|FG000|Maintenance Treatment|Intercurrent Illness|7|||
23314137|NCT00805961|64892235|FG000|Maintenance Treatment|Adverse Event|6|||
23314138|NCT00805961|64892235|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
23314139|NCT00805961|64892235|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
23314140|NCT00805961|64892235|FG000|Maintenance Treatment|Withdrawn Consent|1|||
23314141|NCT02121392|64892236|FG000|Prior to Intervention|Protocol Violation|40|||
23314142|NCT02121392|64892237|FG001|Prior to Intervention|Protocol Violation|35|||
23314143|NCT02121392|64892236|FG000|Prior to Intervention|Withdrawal by Subject|8|||
23314144|NCT02121392|64892237|FG001|Prior to Intervention|Withdrawal by Subject|6|||
23314145|NCT02121392|64892236|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
23314146|NCT02121392|64892237|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
23314147|NCT02121392|64892236|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
23314148|NCT02121392|64892237|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
23314149|NCT04191499|64892238|FG000|Overall Study|Adverse Event|1|||
23314150|NCT04191499|64892239|FG001|Overall Study|Adverse Event|0|||
23314151|NCT04191499|64892238|FG000|Overall Study|Death|42|||
23314152|NCT04191499|64892239|FG001|Overall Study|Death|55|||
23314153|NCT04191499|64892238|FG000|Overall Study|Lost to Follow-up|4|||
23314154|NCT04191499|64892239|FG001|Overall Study|Lost to Follow-up|1|||
23314155|NCT04191499|64892238|FG000|Overall Study|Physician Decision|1|||
23314156|NCT04191499|64892239|FG001|Overall Study|Physician Decision|0|||
23314157|NCT04191499|64892238|FG000|Overall Study|Progressive Disease|1|||
23314158|NCT04191499|64892239|FG001|Overall Study|Progressive Disease|0|||
23314159|NCT04191499|64892238|FG000|Overall Study|Symptomatic Deterioration|1|||
23314160|NCT04191499|64892239|FG001|Overall Study|Symptomatic Deterioration|0|||
23314161|NCT04191499|64892238|FG000|Overall Study|Withdrawal by Subject|7|||
23543305|NCT01054729|65719764|FG000|Overall Study|Lack of Efficacy|0|||
23543306|NCT01054729|65719765|FG001|Overall Study|Lack of Efficacy|0|||
23543307|NCT01054729|65719766|FG002|Overall Study|Lack of Efficacy|0|||
23543308|NCT01054729|65719767|FG003|Overall Study|Lack of Efficacy|1|||
23543309|NCT01965834|65719769|FG000|Overall Study|Lack of Efficacy|4|||
23543310|NCT00408993|65719770|FG000|Overall Study|Adverse Event|15|||
23314162|NCT04191499|64892239|FG001|Overall Study|Withdrawal by Subject|11|||
23543311|NCT00408993|65719771|FG001|Overall Study|Adverse Event|4|||
23543312|NCT00408993|65719770|FG000|Overall Study|Protocol Violation|1|||
23543313|NCT00408993|65719771|FG001|Overall Study|Protocol Violation|6|||
23314163|NCT04191499|64892238|FG000|Overall Study|Ongoing in the study|104|||
23314164|NCT04191499|64892239|FG001|Overall Study|Ongoing in the study|97|||
23314165|NCT02640690|64892242|FG000|Overall Study|Lost to Follow-up|7|||
23314166|NCT02640690|64892243|FG001|Overall Study|Lost to Follow-up|7|||
23314167|NCT02640690|64892242|FG000|Overall Study|Withdrawal by Subject|16|||
23543314|NCT00408993|65719770|FG000|Overall Study|Lack of Efficacy|1|||
23314168|NCT02640690|64892243|FG001|Overall Study|Withdrawal by Subject|20|||
23314169|NCT02640690|64892242|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
23314170|NCT02640690|64892243|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
23314171|NCT05320887|64892244|FG000|Overall Study|Lost to Follow-up|0|||
23314172|NCT05320887|64892245|FG001|Overall Study|Lost to Follow-up|3|||
23314173|NCT05320887|64892246|FG002|Overall Study|Lost to Follow-up|0|||
23314174|NCT05320887|64892247|FG003|Overall Study|Lost to Follow-up|0|||
23314175|NCT04683029|64892248|FG000|Overall Study|Withdrawal by Subject|1|||
23314176|NCT04683029|64892249|FG001|Overall Study|Withdrawal by Subject|0|||
23314177|NCT01200992|64892250|FG000|Overall Study|Study terminated early|35|||
23314178|NCT01200992|64892251|FG001|Overall Study|Study terminated early|41|||
23314179|NCT01200992|64892250|FG000|Overall Study|Randomized but not treated|2|||
23314180|NCT01200992|64892251|FG001|Overall Study|Randomized but not treated|0|||
23314181|NCT00456300|64892254|FG000|Overall Study|Adverse Event|1|||
23314182|NCT00456300|64892255|FG001|Overall Study|Adverse Event|0|||
23314183|NCT03954834|64892256|FG000|Overall Study|Adverse Event|1|||
23314184|NCT03954834|64892257|FG001|Overall Study|Adverse Event|3|||
23314185|NCT03954834|64892258|FG002|Overall Study|Adverse Event|1|||
23314186|NCT03954834|64892259|FG003|Overall Study|Adverse Event|1|||
23314187|NCT03954834|64892256|FG000|Overall Study|Death|0|||
23314188|NCT03954834|64892257|FG001|Overall Study|Death|0|||
23314189|NCT03954834|64892258|FG002|Overall Study|Death|0|||
23314190|NCT03954834|64892259|FG003|Overall Study|Death|1|||
23314191|NCT03954834|64892256|FG000|Overall Study|Physician Decision|0|||
23314192|NCT03954834|64892257|FG001|Overall Study|Physician Decision|1|||
23314193|NCT03954834|64892258|FG002|Overall Study|Physician Decision|0|||
23314194|NCT03954834|64892259|FG003|Overall Study|Physician Decision|2|||
23314195|NCT03954834|64892256|FG000|Overall Study|Protocol Violation|1|||
23314196|NCT03954834|64892257|FG001|Overall Study|Protocol Violation|0|||
23314197|NCT03954834|64892258|FG002|Overall Study|Protocol Violation|0|||
23314198|NCT03954834|64892259|FG003|Overall Study|Protocol Violation|1|||
23314199|NCT03954834|64892256|FG000|Overall Study|Withdrawal by Subject|2|||
23314200|NCT03954834|64892257|FG001|Overall Study|Withdrawal by Subject|3|||
23314201|NCT03954834|64892258|FG002|Overall Study|Withdrawal by Subject|13|||
23314202|NCT03954834|64892259|FG003|Overall Study|Withdrawal by Subject|6|||
23314203|NCT03954834|64892256|FG000|Overall Study|Participant left the country|0|||
23314204|NCT03954834|64892257|FG001|Overall Study|Participant left the country|0|||
23314205|NCT03954834|64892258|FG002|Overall Study|Participant left the country|1|||
23314206|NCT03954834|64892259|FG003|Overall Study|Participant left the country|0|||
23314207|NCT03954834|64892256|FG000|Overall Study|Lost to Follow-up|3|||
23314208|NCT03954834|64892257|FG001|Overall Study|Lost to Follow-up|2|||
23314209|NCT03954834|64892258|FG002|Overall Study|Lost to Follow-up|3|||
23314210|NCT03954834|64892259|FG003|Overall Study|Lost to Follow-up|5|||
23314211|NCT00811928|64892260|FG000|Overall Study|AEs and SAEs Including Death|7|||
23314212|NCT00811928|64892261|FG001|Overall Study|AEs and SAEs Including Death|11|||
23314213|NCT00811928|64892260|FG000|Overall Study|Withdrawal by Subject|18|||
23314214|NCT00811928|64892261|FG001|Overall Study|Withdrawal by Subject|12|||
23314215|NCT00811928|64892260|FG000|Overall Study|Did Not Take Study Drug|3|||
23314216|NCT00811928|64892261|FG001|Overall Study|Did Not Take Study Drug|0|||
23314217|NCT00811928|64892260|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
23314218|NCT00811928|64892261|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
23314219|NCT00811928|64892260|FG000|Overall Study|Investigator Decision|2|||
23314220|NCT00811928|64892261|FG001|Overall Study|Investigator Decision|1|||
23314221|NCT00811928|64892260|FG000|Overall Study|Poor Compliance|2|||
23314222|NCT00811928|64892261|FG001|Overall Study|Poor Compliance|5|||
23314223|NCT04988087|64892262|FG000|Overall Study|Adverse Event|4|||
23314224|NCT04988087|64892263|FG001|Overall Study|Adverse Event|0|||
23314225|NCT04988087|64892264|FG002|Overall Study|Adverse Event|0|||
23314226|NCT04988087|64892265|FG003|Overall Study|Adverse Event|0|||
23314227|NCT04988087|64892262|FG000|Overall Study|Withdrawal by Subject|1|||
23314228|NCT04988087|64892263|FG001|Overall Study|Withdrawal by Subject|1|||
23314229|NCT04988087|64892264|FG002|Overall Study|Withdrawal by Subject|0|||
23314230|NCT04988087|64892265|FG003|Overall Study|Withdrawal by Subject|0|||
23314231|NCT04988087|64892262|FG000|Overall Study|Technical problems|7|||
23314232|NCT04988087|64892263|FG001|Overall Study|Technical problems|9|||
23314233|NCT04988087|64892264|FG002|Overall Study|Technical problems|1|||
23314234|NCT04988087|64892265|FG003|Overall Study|Technical problems|2|||
23314235|NCT00626392|64892266|FG000|Run-in Period|Adverse Event|0|||
23314236|NCT00626392|64892267|FG001|Run-in Period|Adverse Event|0|||
23314237|NCT00626392|64892268|FG002|Run-in Period|Adverse Event|1|||
23314238|NCT00626392|64892269|FG003|Run-in Period|Adverse Event|0|||
23314239|NCT00626392|64892270|FG004|Run-in Period|Adverse Event|1|||
23314240|NCT00626392|64892271|FG005|Run-in Period|Adverse Event|0|||
23543315|NCT00408993|65719771|FG001|Overall Study|Lack of Efficacy|4|||
23314241|NCT00626392|64892266|FG000|Run-in Period|Withdrawal by Subject|0|||
23314242|NCT00626392|64892267|FG001|Run-in Period|Withdrawal by Subject|1|||
23314243|NCT00626392|64892268|FG002|Run-in Period|Withdrawal by Subject|1|||
23314244|NCT00626392|64892269|FG003|Run-in Period|Withdrawal by Subject|1|||
23314245|NCT00626392|64892270|FG004|Run-in Period|Withdrawal by Subject|3|||
23314246|NCT00626392|64892271|FG005|Run-in Period|Withdrawal by Subject|1|||
23314247|NCT00626392|64892266|FG000|Run-in Period|Noncompliance|1|||
23314248|NCT00626392|64892267|FG001|Run-in Period|Noncompliance|0|||
23314249|NCT00626392|64892268|FG002|Run-in Period|Noncompliance|1|||
23314250|NCT00626392|64892269|FG003|Run-in Period|Noncompliance|0|||
23314251|NCT00626392|64892270|FG004|Run-in Period|Noncompliance|0|||
23314252|NCT00626392|64892271|FG005|Run-in Period|Noncompliance|0|||
23314253|NCT00626392|64892266|FG000|Coadministration Period|Adverse Event|3|||
23314254|NCT00626392|64892267|FG001|Coadministration Period|Adverse Event|1|||
23314255|NCT00626392|64892268|FG002|Coadministration Period|Adverse Event|7|||
23314256|NCT00626392|64892269|FG003|Coadministration Period|Adverse Event|4|||
23314257|NCT00626392|64892270|FG004|Coadministration Period|Adverse Event|3|||
23314258|NCT00626392|64892271|FG005|Coadministration Period|Adverse Event|4|||
23314259|NCT00626392|64892266|FG000|Coadministration Period|Withdrawal by Subject|1|||
23314260|NCT00626392|64892267|FG001|Coadministration Period|Withdrawal by Subject|1|||
23314261|NCT00626392|64892268|FG002|Coadministration Period|Withdrawal by Subject|0|||
23314262|NCT00626392|64892269|FG003|Coadministration Period|Withdrawal by Subject|1|||
23314263|NCT00626392|64892270|FG004|Coadministration Period|Withdrawal by Subject|0|||
23314264|NCT00626392|64892271|FG005|Coadministration Period|Withdrawal by Subject|1|||
23314265|NCT00626392|64892266|FG000|Coadministration Period|Protocol Violation|0|||
23314266|NCT00626392|64892267|FG001|Coadministration Period|Protocol Violation|1|||
23314267|NCT00626392|64892268|FG002|Coadministration Period|Protocol Violation|0|||
23314268|NCT00626392|64892269|FG003|Coadministration Period|Protocol Violation|1|||
23314269|NCT00626392|64892270|FG004|Coadministration Period|Protocol Violation|1|||
23314270|NCT00626392|64892271|FG005|Coadministration Period|Protocol Violation|0|||
23314271|NCT00626392|64892266|FG000|Coadministration Period|Other|0|||
23314272|NCT00626392|64892267|FG001|Coadministration Period|Other|2|||
23314273|NCT00626392|64892268|FG002|Coadministration Period|Other|3|||
23314274|NCT00626392|64892269|FG003|Coadministration Period|Other|1|||
23314275|NCT00626392|64892270|FG004|Coadministration Period|Other|1|||
23314276|NCT00626392|64892271|FG005|Coadministration Period|Other|1|||
23314277|NCT04874155|64892272|FG000|Overall Study|Lost to Follow-up|1|||
23314278|NCT04874155|64892273|FG001|Overall Study|Lost to Follow-up|1|||
23314279|NCT04874155|64892272|FG000|Overall Study|Withdrawal by Subject|2|||
23314280|NCT04874155|64892273|FG001|Overall Study|Withdrawal by Subject|2|||
23314281|NCT01893346|64892274|FG000|Overall Study|Lost to Follow-up|0|||
23314282|NCT01893346|64892275|FG001|Overall Study|Lost to Follow-up|1|||
23314283|NCT01893346|64892276|FG002|Overall Study|Lost to Follow-up|0|||
23314284|NCT01893346|64892277|FG003|Overall Study|Lost to Follow-up|0|||
23314285|NCT01893346|64892274|FG000|Overall Study|Protocol Violation|1|||
23314286|NCT01893346|64892275|FG001|Overall Study|Protocol Violation|0|||
23314287|NCT01893346|64892276|FG002|Overall Study|Protocol Violation|0|||
23314288|NCT01893346|64892277|FG003|Overall Study|Protocol Violation|0|||
23314289|NCT01893346|64892274|FG000|Overall Study|Withdrawal by Subject|2|||
23314290|NCT01893346|64892275|FG001|Overall Study|Withdrawal by Subject|0|||
23314291|NCT01893346|64892276|FG002|Overall Study|Withdrawal by Subject|0|||
23314292|NCT01893346|64892277|FG003|Overall Study|Withdrawal by Subject|0|||
23314293|NCT02455518|64892278|FG000|Overall Study|Protocol Violation|0|||
23314294|NCT02455518|64892279|FG001|Overall Study|Protocol Violation|1|||
23314295|NCT02455518|64892280|FG002|Overall Study|Protocol Violation|1|||
23314296|NCT02455518|64892281|FG003|Overall Study|Protocol Violation|3|||
23314297|NCT00813800|64892284|FG000|Overall Study|Screen Failure after Consent|2|||
23314298|NCT00813800|64892284|FG000|Overall Study|Adverse Event|1|||
23314299|NCT00813800|64892284|FG000|Overall Study|Worsening of depression|2|||
23314300|NCT00813800|64892284|FG000|Overall Study|Physician Decision|1|||
23314301|NCT00384930|64892285|FG000|Overall Study|Adverse Event|5|||
23314302|NCT00384930|64892286|FG001|Overall Study|Adverse Event|4|||
23314303|NCT00384930|64892287|FG002|Overall Study|Adverse Event|12|||
23314304|NCT00384930|64892288|FG003|Overall Study|Adverse Event|11|||
23314305|NCT00384930|64892289|FG004|Overall Study|Adverse Event|14|||
23543316|NCT00408993|65719770|FG000|Overall Study|Withdrawal by Subject|2|||
23314306|NCT00384930|64892285|FG000|Overall Study|Entry Criteria Not Met|2|||
23314307|NCT00384930|64892286|FG001|Overall Study|Entry Criteria Not Met|6|||
23314308|NCT00384930|64892287|FG002|Overall Study|Entry Criteria Not Met|7|||
23314309|NCT00384930|64892288|FG003|Overall Study|Entry Criteria Not Met|8|||
23314310|NCT00384930|64892289|FG004|Overall Study|Entry Criteria Not Met|4|||
23314311|NCT00384930|64892285|FG000|Overall Study|Lack of Efficacy|1|||
23543317|NCT00408993|65719771|FG001|Overall Study|Withdrawal by Subject|3|||
23543318|NCT01259713|65719772|FG000|Overall Study|Adverse Event|54|||
23543319|NCT01259713|65719773|FG001|Overall Study|Adverse Event|23|||
23314312|NCT00384930|64892286|FG001|Overall Study|Lack of Efficacy|1|||
23314313|NCT00384930|64892287|FG002|Overall Study|Lack of Efficacy|2|||
23314314|NCT00384930|64892288|FG003|Overall Study|Lack of Efficacy|1|||
23314315|NCT00384930|64892289|FG004|Overall Study|Lack of Efficacy|2|||
23314316|NCT00384930|64892285|FG000|Overall Study|Lost to Follow-up|5|||
23314317|NCT00384930|64892286|FG001|Overall Study|Lost to Follow-up|3|||
23314318|NCT00384930|64892287|FG002|Overall Study|Lost to Follow-up|0|||
23314319|NCT00384930|64892288|FG003|Overall Study|Lost to Follow-up|4|||
23314320|NCT00384930|64892289|FG004|Overall Study|Lost to Follow-up|6|||
23314321|NCT00384930|64892285|FG000|Overall Study|Physician Decision|0|||
23314322|NCT00384930|64892286|FG001|Overall Study|Physician Decision|1|||
23314323|NCT00384930|64892287|FG002|Overall Study|Physician Decision|1|||
23314324|NCT00384930|64892288|FG003|Overall Study|Physician Decision|0|||
23314325|NCT00384930|64892289|FG004|Overall Study|Physician Decision|1|||
23314326|NCT00384930|64892285|FG000|Overall Study|Protocol Violation|1|||
23314327|NCT00384930|64892286|FG001|Overall Study|Protocol Violation|0|||
23314328|NCT00384930|64892287|FG002|Overall Study|Protocol Violation|1|||
23314329|NCT00384930|64892288|FG003|Overall Study|Protocol Violation|6|||
23314330|NCT00384930|64892289|FG004|Overall Study|Protocol Violation|4|||
23314331|NCT00384930|64892285|FG000|Overall Study|Sponsor Decision|3|||
23314332|NCT00384930|64892286|FG001|Overall Study|Sponsor Decision|4|||
23314333|NCT00384930|64892287|FG002|Overall Study|Sponsor Decision|0|||
23314334|NCT00384930|64892288|FG003|Overall Study|Sponsor Decision|5|||
23314335|NCT00384930|64892289|FG004|Overall Study|Sponsor Decision|0|||
23314336|NCT00384930|64892285|FG000|Overall Study|Withdrawal by Subject|9|||
23314337|NCT00384930|64892286|FG001|Overall Study|Withdrawal by Subject|7|||
23314338|NCT00384930|64892287|FG002|Overall Study|Withdrawal by Subject|7|||
23314339|NCT00384930|64892288|FG003|Overall Study|Withdrawal by Subject|6|||
23314340|NCT00384930|64892289|FG004|Overall Study|Withdrawal by Subject|16|||
23314341|NCT00384930|64892285|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
23314342|NCT00384930|64892286|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
23314343|NCT00384930|64892287|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
23314344|NCT00384930|64892288|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
23314345|NCT00384930|64892289|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
23314346|NCT02538965|64892292|FG000|Treatment Period|Other = Death due to disease progression|1|||
23314347|NCT02538965|64892292|FG000|Treatment Period|Adverse Event|2|||
23314348|NCT02538965|64892292|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
23314349|NCT02538965|64892292|FG000|Treatment Period|Treatment Failure|9|||
23314350|NCT02538965|64892292|FG000|Treatment Period|Disease Progression|1|||
23314351|NCT02538965|64892292|FG000|Treatment Period|Physician Decision|2|||
23314352|NCT02538965|64892292|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
23314353|NCT02538965|64892292|FG000|Follow-Up Period|Withdrawal by Parent|4|||
23314354|NCT03548337|64892293|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
23314355|NCT03548337|64892294|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
23314356|NCT03548337|64892293|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
23314357|NCT03548337|64892294|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
23314358|NCT03548337|64892293|FG000|Infant Series|Lost to Follow-up|2|||
23314359|NCT03548337|64892294|FG001|Infant Series|Lost to Follow-up|1|||
23314360|NCT03548337|64892293|FG000|Infant Series|Adverse Event|0|||
23314361|NCT03548337|64892294|FG001|Infant Series|Adverse Event|2|||
23314362|NCT03548337|64892293|FG000|Infant Series|Randomized but Not Vaccinated|1|||
23314363|NCT03548337|64892294|FG001|Infant Series|Randomized but Not Vaccinated|0|||
23314364|NCT03548337|64892293|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
23314365|NCT03548337|64892294|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
23314366|NCT00577395|64892295|FG000|Overall Study|Study was terminated early by Sponsor|7|||
23314367|NCT00577395|64892296|FG001|Overall Study|Study was terminated early by Sponsor|6|||
23314368|NCT00710866|64892297|FG000|Overall Study|Protocol Violation|5|||
23314369|NCT00710866|64892298|FG001|Overall Study|Protocol Violation|4|||
23314370|NCT00710866|64892297|FG000|Overall Study|Withdrawal by Subject|2|||
23314371|NCT00710866|64892298|FG001|Overall Study|Withdrawal by Subject|1|||
23314372|NCT00710866|64892297|FG000|Overall Study|Lost to Follow-up|1|||
23314373|NCT00710866|64892298|FG001|Overall Study|Lost to Follow-up|0|||
23314374|NCT00710866|64892297|FG000|Overall Study|Failed to meet eligibility|1|||
23314375|NCT00710866|64892298|FG001|Overall Study|Failed to meet eligibility|1|||
23314376|NCT02013674|64892303|FG000|Overall Study|Death|0|||
23314377|NCT02013674|64892304|FG001|Overall Study|Death|1|||
23314378|NCT02013674|64892303|FG000|Overall Study|Lost to Follow-up|1|||
23314379|NCT02013674|64892304|FG001|Overall Study|Lost to Follow-up|0|||
23314380|NCT01831258|64892305|FG000|Overall Study|Withdrawal by Subject|2|||
23314381|NCT01831258|64892306|FG001|Overall Study|Withdrawal by Subject|1|||
23314382|NCT01831258|64892305|FG000|Overall Study|Lost to Follow-up|3|||
23314383|NCT01831258|64892306|FG001|Overall Study|Lost to Follow-up|2|||
23314384|NCT03597529|64892309|FG000|Overall Study|Lost to Follow-up|10|||
23314385|NCT03597529|64892310|FG001|Overall Study|Lost to Follow-up|12|||
23314386|NCT03597529|64892309|FG000|Overall Study|Physician Decision|3|||
23314387|NCT03597529|64892310|FG001|Overall Study|Physician Decision|1|||
23543320|NCT01259713|65719772|FG000|Overall Study|Death Not Related to IFI|8|||
23314388|NCT03597529|64892309|FG000|Overall Study|Withdrawal by Subject|6|||
23314389|NCT03597529|64892310|FG001|Overall Study|Withdrawal by Subject|3|||
23314390|NCT03597529|64892309|FG000|Overall Study|Non-compliant with study activities|1|||
23314391|NCT03597529|64892310|FG001|Overall Study|Non-compliant with study activities|2|||
23314392|NCT01994291|64892316|FG000|Overall Study|Adverse Event|4|||
23425299|NCT00787930|65299930|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
23425300|NCT03352453|65299931|FG000|Overall Study|Miscellaneous Reasons|1|||
23425301|NCT03352453|65299932|FG001|Overall Study|Miscellaneous Reasons|2|||
23425302|NCT03352453|65299931|FG000|Overall Study|Lack of Efficacy|1|||
23425303|NCT03352453|65299932|FG001|Overall Study|Lack of Efficacy|0|||
23425304|NCT03352453|65299931|FG000|Overall Study|Withdrawal by Subject|8|||
23425305|NCT03352453|65299932|FG001|Overall Study|Withdrawal by Subject|14|||
23425306|NCT03352453|65299931|FG000|Overall Study|Study Terminated by Sponsor|2|||
23425307|NCT03352453|65299932|FG001|Overall Study|Study Terminated by Sponsor|1|||
23425308|NCT03352453|65299931|FG000|Overall Study|Protocol Deviation|1|||
23425309|NCT03352453|65299932|FG001|Overall Study|Protocol Deviation|0|||
23425310|NCT03352453|65299931|FG000|Overall Study|Lost to Follow-up|7|||
23425311|NCT03352453|65299932|FG001|Overall Study|Lost to Follow-up|6|||
23425312|NCT03352453|65299931|FG000|Overall Study|Adverse Event|2|||
23425313|NCT03352453|65299932|FG001|Overall Study|Adverse Event|9|||
23425314|NCT03515551|65299935|FG000|Overall Study|Death|4|||
23425315|NCT03515551|65299936|FG001|Overall Study|Death|1|||
23425316|NCT03515551|65299937|FG002|Overall Study|Death|2|||
23425317|NCT03515551|65299938|FG003|Overall Study|Death|2|||
23425318|NCT03515551|65299939|FG004|Overall Study|Death|2|||
23425319|NCT03515551|65299940|FG005|Overall Study|Death|4|||
23425320|NCT03515551|65299941|FG006|Overall Study|Death|1|||
23425321|NCT03515551|65299935|FG000|Overall Study|Lost to Follow-up|0|||
23425322|NCT03515551|65299936|FG001|Overall Study|Lost to Follow-up|0|||
23425323|NCT03515551|65299937|FG002|Overall Study|Lost to Follow-up|1|||
23425324|NCT03515551|65299938|FG003|Overall Study|Lost to Follow-up|0|||
23425325|NCT03515551|65299939|FG004|Overall Study|Lost to Follow-up|0|||
23425326|NCT03515551|65299940|FG005|Overall Study|Lost to Follow-up|0|||
23425327|NCT03515551|65299941|FG006|Overall Study|Lost to Follow-up|0|||
23425328|NCT03515551|65299935|FG000|Overall Study|Withdrawal by Subject|0|||
23425329|NCT03515551|65299936|FG001|Overall Study|Withdrawal by Subject|1|||
23425330|NCT03515551|65299937|FG002|Overall Study|Withdrawal by Subject|0|||
23425331|NCT03515551|65299938|FG003|Overall Study|Withdrawal by Subject|0|||
23425332|NCT03515551|65299939|FG004|Overall Study|Withdrawal by Subject|0|||
23425333|NCT03515551|65299940|FG005|Overall Study|Withdrawal by Subject|0|||
23425334|NCT03515551|65299941|FG006|Overall Study|Withdrawal by Subject|1|||
23425335|NCT03515551|65299935|FG000|Overall Study|Study ended by sponsor|0|||
23425336|NCT03515551|65299936|FG001|Overall Study|Study ended by sponsor|0|||
23425337|NCT03515551|65299937|FG002|Overall Study|Study ended by sponsor|2|||
23425338|NCT03515551|65299938|FG003|Overall Study|Study ended by sponsor|1|||
23425339|NCT03515551|65299939|FG004|Overall Study|Study ended by sponsor|3|||
23425340|NCT03515551|65299940|FG005|Overall Study|Study ended by sponsor|0|||
23425341|NCT03515551|65299941|FG006|Overall Study|Study ended by sponsor|3|||
23425342|NCT03515551|65299935|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425343|NCT03515551|65299936|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
23425344|NCT03515551|65299937|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425345|NCT03515551|65299938|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425346|NCT03515551|65299939|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425347|NCT03515551|65299940|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425348|NCT03515551|65299941|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
23425349|NCT02279719|65299942|FG000|Overall Study|Patients randomized but never treated|0|||
23425350|NCT02279719|65299943|FG001|Overall Study|Patients randomized but never treated|0|||
23425351|NCT02279719|65299944|FG002|Overall Study|Patients randomized but never treated|0|||
23425352|NCT02279719|65299945|FG003|Overall Study|Patients randomized but never treated|0|||
23425353|NCT02279719|65299946|FG004|Overall Study|Patients randomized but never treated|3|||
23425354|NCT02279719|65299947|FG005|Overall Study|Patients randomized but never treated|0|||
23425355|NCT02279719|65299948|FG006|Overall Study|Patients randomized but never treated|3|||
23425356|NCT01371643|65299952|FG000|Overall Study|Withdrawal by Subject|3|||
23425357|NCT01371643|65299953|FG001|Overall Study|Withdrawal by Subject|0|||
23425358|NCT02142283|65299956|FG000|Overall Study|Death|20|||
23425359|NCT02142283|65299957|FG001|Overall Study|Death|18|||
23425360|NCT02142283|65299956|FG000|Overall Study|Withdrawal by Subject|1|||
23425361|NCT02142283|65299957|FG001|Overall Study|Withdrawal by Subject|3|||
23425362|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
23425363|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
23425364|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
23425365|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
23425366|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
23425367|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
23425368|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
23425369|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
23425370|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
23425371|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
23425372|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
23425373|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
23425374|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Adverse Event|1|||
23425375|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Adverse Event|0|||
23425376|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Adverse Event|2|||
23425377|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Adverse Event|0|||
23425378|NCT01185964|65299958|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
23425379|NCT01185964|65299959|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
23425380|NCT01185964|65299960|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
23425381|NCT01185964|65299961|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
23425382|NCT01185964|65299958|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
23425383|NCT01185964|65299959|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
23425384|NCT01185964|65299960|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
23425385|NCT01185964|65299961|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
23425386|NCT01185964|65299958|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
23425387|NCT01185964|65299959|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
23425388|NCT01185964|65299960|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
23425389|NCT01185964|65299961|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
23425390|NCT01185964|65299958|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
23425391|NCT01185964|65299959|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
23425392|NCT01185964|65299960|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
23425393|NCT01185964|65299961|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
23425394|NCT00536874|65299962|FG000|Overall Study|Adverse Event|1|||
23425395|NCT00536874|65299962|FG000|Overall Study|Death|2|||
23425396|NCT00536874|65299962|FG000|Overall Study|Withdrawal by Subject|1|||
23425397|NCT00357656|65299963|FG000|Overall Study|Other, No surgery performed|0|||
23425398|NCT00357656|65299964|FG001|Overall Study|Other, No surgery performed|3|||
23425399|NCT00235391|65299965|FG000|Overall Study|Adverse Event|4|||
23425400|NCT00235391|65299966|FG001|Overall Study|Adverse Event|5|||
23425401|NCT00235391|65299967|FG002|Overall Study|Adverse Event|10|||
23425402|NCT00235391|65299968|FG003|Overall Study|Adverse Event|72|||
23425403|NCT00235391|65299969|FG004|Overall Study|Adverse Event|5|||
23425404|NCT00235391|65299970|FG005|Overall Study|Adverse Event|2|||
23425405|NCT00235391|65299965|FG000|Overall Study|Abnormal laboratory value(s)|3|||
23425406|NCT00235391|65299966|FG001|Overall Study|Abnormal laboratory value(s)|5|||
23425407|NCT00235391|65299967|FG002|Overall Study|Abnormal laboratory value(s)|4|||
23425408|NCT00235391|65299968|FG003|Overall Study|Abnormal laboratory value(s)|27|||
23425409|NCT00235391|65299969|FG004|Overall Study|Abnormal laboratory value(s)|1|||
23425410|NCT00235391|65299970|FG005|Overall Study|Abnormal laboratory value(s)|2|||
23425411|NCT00235391|65299965|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23425412|NCT00235391|65299966|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23425413|NCT00235391|65299967|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23616909|NCT02243605|65982492|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
23616910|NCT02243605|65982493|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
23616911|NCT02243605|65982492|FG000|Stage 2 - Final Analysis Population|Progression|0|||
23425414|NCT00235391|65299968|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
23425415|NCT00235391|65299969|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
23425416|NCT00235391|65299970|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
23425417|NCT00235391|65299965|FG000|Overall Study|Condition no longer requires treatment|3|||
23425418|NCT00235391|65299966|FG001|Overall Study|Condition no longer requires treatment|0|||
23425419|NCT00235391|65299967|FG002|Overall Study|Condition no longer requires treatment|0|||
23425420|NCT00235391|65299968|FG003|Overall Study|Condition no longer requires treatment|11|||
23425421|NCT00235391|65299969|FG004|Overall Study|Condition no longer requires treatment|1|||
23425422|NCT00235391|65299970|FG005|Overall Study|Condition no longer requires treatment|0|||
23425423|NCT00235391|65299965|FG000|Overall Study|Protocol deviation|0|||
23425424|NCT00235391|65299966|FG001|Overall Study|Protocol deviation|0|||
23425425|NCT00235391|65299967|FG002|Overall Study|Protocol deviation|1|||
23425426|NCT00235391|65299968|FG003|Overall Study|Protocol deviation|11|||
23543321|NCT01259713|65719773|FG001|Overall Study|Death Not Related to IFI|1|||
23543322|NCT01259713|65719772|FG000|Overall Study|Investigators Discretion|14|||
23543323|NCT01259713|65719773|FG001|Overall Study|Investigators Discretion|6|||
23543324|NCT01259713|65719772|FG000|Overall Study|Lack of Efficacy|2|||
23543325|NCT01259713|65719773|FG001|Overall Study|Lack of Efficacy|0|||
23543326|NCT01259713|65719772|FG000|Overall Study|Protocol Violation|5|||
23543327|NCT01259713|65719773|FG001|Overall Study|Protocol Violation|4|||
23543328|NCT01259713|65719772|FG000|Overall Study|Subject Withdrew Consent|12|||
23543329|NCT01259713|65719773|FG001|Overall Study|Subject Withdrew Consent|7|||
23543330|NCT00319098|65719774|FG000|Overall Study|Serious adverse event|3|||
23543331|NCT00319098|65719775|FG001|Overall Study|Serious adverse event|0|||
23543332|NCT00319098|65719774|FG000|Overall Study|Adverse Event|20|||
23543333|NCT00319098|65719775|FG001|Overall Study|Adverse Event|1|||
23543334|NCT00319098|65719774|FG000|Overall Study|Withdrawal by Subject|37|||
23543335|NCT00319098|65719775|FG001|Overall Study|Withdrawal by Subject|8|||
23543336|NCT00319098|65719774|FG000|Overall Study|Migrated/moved from study area|2|||
23543337|NCT00319098|65719775|FG001|Overall Study|Migrated/moved from study area|1|||
23543338|NCT00319098|65719774|FG000|Overall Study|Lost to Follow-up|37|||
23543339|NCT00319098|65719775|FG001|Overall Study|Lost to Follow-up|13|||
23543340|NCT00319098|65719774|FG000|Overall Study|Others|33|||
23543341|NCT00319098|65719775|FG001|Overall Study|Others|8|||
23543342|NCT00319098|65719774|FG000|Overall Study|Protocol Violation|3|||
23543343|NCT00319098|65719775|FG001|Overall Study|Protocol Violation|1|||
23543344|NCT02276482|65719776|FG000|Overall Study|Adverse Event|1|||
23543345|NCT02276482|65719777|FG001|Overall Study|Adverse Event|0|||
23543346|NCT02276482|65719776|FG000|Overall Study|Withdrawal by Subject|1|||
23543347|NCT02276482|65719777|FG001|Overall Study|Withdrawal by Subject|0|||
23543348|NCT02276482|65719776|FG000|Overall Study|Gram-negative infection|1|||
23543349|NCT02276482|65719777|FG001|Overall Study|Gram-negative infection|0|||
23543350|NCT02276482|65719776|FG000|Overall Study|Reason not specified|0|||
23543351|NCT02276482|65719777|FG001|Overall Study|Reason not specified|1|||
23543352|NCT03669081|65719778|FG000|Overall Study|Data could not be validated|1|||
23543353|NCT03669081|65719779|FG001|Overall Study|Data could not be validated|1|||
23543354|NCT01773226|65719782|FG000|Overall Study|Withdrawal by Subject|1|||
23543355|NCT05348681|65719783|FG000|Overall Study|Study terminated by Sponsor|8|||
23543356|NCT05348681|65719784|FG001|Overall Study|Study terminated by Sponsor|3|||
23543357|NCT05348681|65719783|FG000|Overall Study|Withdrawal by Subject|1|||
23616912|NCT02243605|65982493|FG001|Stage 2 - Final Analysis Population|Progression|1|||
23616913|NCT01193283|65982494|FG000|Overall Study|Death|1|||
23616914|NCT03816332|65982496|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
23543358|NCT05348681|65719784|FG001|Overall Study|Withdrawal by Subject|1|||
23543359|NCT05348681|65719783|FG000|Overall Study|Lost to Follow-up|1|||
23543360|NCT05348681|65719784|FG001|Overall Study|Lost to Follow-up|1|||
23543361|NCT05348681|65719783|FG000|Overall Study|Adverse Event|1|||
23543362|NCT05348681|65719784|FG001|Overall Study|Adverse Event|0|||
23543363|NCT05348681|65719783|FG000|Overall Study|Other|2|||
23543364|NCT05348681|65719784|FG001|Overall Study|Other|1|||
23543365|NCT00086346|65719785|FG000|Randomization|Did not receive test article|4|||
23616915|NCT03816332|65982496|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
23616916|NCT01568112|65982497|FG000|Overall Study|Randomized But Not Treated|0|||
23616917|NCT01568112|65982498|FG001|Overall Study|Randomized But Not Treated|1|||
23616918|NCT01568112|65982499|FG002|Overall Study|Randomized But Not Treated|0|||
23616919|NCT01568112|65982500|FG003|Overall Study|Randomized But Not Treated|0|||
23616920|NCT01568112|65982497|FG000|Overall Study|Withdrew due to Adverse Event|2|||
23616921|NCT01568112|65982498|FG001|Overall Study|Withdrew due to Adverse Event|4|||
23314393|NCT01994291|64892317|FG001|Overall Study|Adverse Event|1|||
23314394|NCT01994291|64892318|FG002|Overall Study|Adverse Event|3|||
23543366|NCT00086346|65719786|FG001|Randomization|Did not receive test article|4|||
23543367|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Adverse Event|94|||
23543368|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Adverse Event|11|||
23543369|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
23543370|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
23543371|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
23543372|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
23314395|NCT01994291|64892316|FG000|Overall Study|Lost to Follow-up|1|||
23543373|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
23543374|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
23616922|NCT01568112|65982499|FG002|Overall Study|Withdrew due to Adverse Event|6|||
23425427|NCT00235391|65299969|FG004|Overall Study|Protocol deviation|0|||
23425428|NCT00235391|65299970|FG005|Overall Study|Protocol deviation|0|||
23425429|NCT00235391|65299965|FG000|Overall Study|Withdrawal by Subject|2|||
23425430|NCT00235391|65299966|FG001|Overall Study|Withdrawal by Subject|3|||
23425431|NCT00235391|65299967|FG002|Overall Study|Withdrawal by Subject|3|||
23425432|NCT00235391|65299968|FG003|Overall Study|Withdrawal by Subject|61|||
23543375|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
23543376|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
23543377|NCT00086346|65719785|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
23543378|NCT00086346|65719786|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
23543379|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
23543380|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
23543381|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
23543382|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
23543383|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
23543384|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
23543385|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
23543386|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
23543387|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
23543388|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
23543389|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
23543390|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
23543391|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
23543392|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
23543393|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
23543394|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23543395|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23543396|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23543397|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23543398|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23543399|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
23543400|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
23543401|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
23543402|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
23543403|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
23543404|NCT03152552|65719789|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
23425433|NCT00235391|65299969|FG004|Overall Study|Withdrawal by Subject|5|||
23543405|NCT03152552|65719790|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
23543406|NCT03152552|65719791|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
23543407|NCT03152552|65719792|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
23543408|NCT03152552|65719793|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
23543409|NCT03152552|65719789|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
23543410|NCT03152552|65719790|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
23425434|NCT00235391|65299970|FG005|Overall Study|Withdrawal by Subject|0|||
23425435|NCT00235391|65299965|FG000|Overall Study|Lost to Follow-up|0|||
23211197|NCT00485589|64512371|FG002|Overall Study|Insufficient therapeutic response|1|||
23211198|NCT00485589|64512369|FG000|Overall Study|Refused treatment/did not cooperate|1|||
23211199|NCT00485589|64512370|FG001|Overall Study|Refused treatment/did not cooperate|0|||
23211200|NCT00485589|64512371|FG002|Overall Study|Refused treatment/did not cooperate|2|||
23211201|NCT00485589|64512369|FG000|Overall Study|Withdrawal by Subject|3|||
23211202|NCT00485589|64512370|FG001|Overall Study|Withdrawal by Subject|2|||
23211203|NCT00485589|64512371|FG002|Overall Study|Withdrawal by Subject|2|||
23211204|NCT00485589|64512369|FG000|Overall Study|Adverse Event|3|||
23211205|NCT00485589|64512370|FG001|Overall Study|Adverse Event|3|||
23211206|NCT00485589|64512371|FG002|Overall Study|Adverse Event|10|||
23211207|NCT01601470|64512374|FG000|Period 2 - LCZ696|Physician Decision|1|||
23211208|NCT01894477|64512375|FG000|Overall Study|Protocol Violation|0|||
23211209|NCT01894477|64512376|FG001|Overall Study|Protocol Violation|1|||
23211210|NCT01894477|64512375|FG000|Overall Study|protocol changed due SC changed to cord|0|||
23211211|NCT01894477|64512376|FG001|Overall Study|protocol changed due SC changed to cord|1|||
23211212|NCT01244191|64512377|FG000|Overall Study|Progressive disease|295|||
23543411|NCT03152552|65719791|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
23543412|NCT03152552|65719792|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
23543413|NCT03152552|65719793|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
23616923|NCT01568112|65982500|FG003|Overall Study|Withdrew due to Adverse Event|3|||
23616924|NCT01568112|65982497|FG000|Overall Study|Lost to Follow-up|0|||
23616925|NCT01568112|65982498|FG001|Overall Study|Lost to Follow-up|0|||
23616926|NCT01568112|65982499|FG002|Overall Study|Lost to Follow-up|0|||
23616927|NCT01568112|65982500|FG003|Overall Study|Lost to Follow-up|1|||
23616928|NCT01568112|65982497|FG000|Overall Study|Withdrawal by Subject|2|||
23616929|NCT01568112|65982498|FG001|Overall Study|Withdrawal by Subject|3|||
23616930|NCT01568112|65982499|FG002|Overall Study|Withdrawal by Subject|0|||
23616931|NCT01568112|65982500|FG003|Overall Study|Withdrawal by Subject|7|||
23616932|NCT01568112|65982497|FG000|Overall Study|Withdrawal by Physician|1|||
23616933|NCT01568112|65982498|FG001|Overall Study|Withdrawal by Physician|0|||
23616934|NCT01568112|65982499|FG002|Overall Study|Withdrawal by Physician|1|||
23616935|NCT01568112|65982500|FG003|Overall Study|Withdrawal by Physician|1|||
23616936|NCT04783519|65982503|FG000|Overall Study|Withdrawal by Subject|2|||
23616937|NCT04783519|65982504|FG001|Overall Study|Withdrawal by Subject|7|||
23616938|NCT04783519|65982505|FG002|Overall Study|Withdrawal by Subject|3|||
23543414|NCT00627705|65719794|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
23543415|NCT00627705|65719795|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
23543416|NCT00627705|65719794|FG000|Overall Study|Adverse Event|1|||
23543417|NCT00627705|65719795|FG001|Overall Study|Adverse Event|0|||
23543418|NCT00627705|65719794|FG000|Overall Study|Withdrawal by Subject|0|||
23543419|NCT00627705|65719795|FG001|Overall Study|Withdrawal by Subject|2|||
23543420|NCT00627705|65719794|FG000|Overall Study|Lost to Follow-up|0|||
23543421|NCT00627705|65719795|FG001|Overall Study|Lost to Follow-up|1|||
23543422|NCT04001829|65719796|FG000|Overall Study|Never start protocol therapy|5|||
23211213|NCT01244191|64512378|FG001|Overall Study|Progressive disease|350|||
23211214|NCT01244191|64512377|FG000|Overall Study|Clinical disease progression|54|||
23211215|NCT01244191|64512378|FG001|Overall Study|Clinical disease progression|36|||
23543423|NCT04001829|65719797|FG001|Overall Study|Never start protocol therapy|5|||
23616939|NCT04783519|65982503|FG000|Overall Study|Lost to Follow-up|9|||
23616940|NCT04783519|65982504|FG001|Overall Study|Lost to Follow-up|7|||
23616941|NCT04783519|65982505|FG002|Overall Study|Lost to Follow-up|6|||
23543424|NCT04001829|65719796|FG000|Overall Study|Adverse Event|11|||
23543425|NCT04001829|65719797|FG001|Overall Study|Adverse Event|7|||
23543426|NCT04001829|65719796|FG000|Overall Study|Alternative therapy|1|||
23543427|NCT04001829|65719797|FG001|Overall Study|Alternative therapy|2|||
23543428|NCT04001829|65719796|FG000|Overall Study|Disease progression/relapse|2|||
23543429|NCT04001829|65719797|FG001|Overall Study|Disease progression/relapse|1|||
23543430|NCT04001829|65719796|FG000|Overall Study|Other complicating disease|1|||
23211216|NCT01244191|64512377|FG000|Overall Study|Adverse Event|65|||
23543431|NCT04001829|65719797|FG001|Overall Study|Other complicating disease|0|||
23543432|NCT04001829|65719796|FG000|Overall Study|Withdrawal by Subject|1|||
23543433|NCT04001829|65719797|FG001|Overall Study|Withdrawal by Subject|4|||
23543434|NCT04001829|65719796|FG000|Overall Study|Ineligible|2|||
23543435|NCT04001829|65719797|FG001|Overall Study|Ineligible|2|||
23543436|NCT04001829|65719796|FG000|Overall Study|Reason missing due to delinquent data|1|||
23543437|NCT04001829|65719797|FG001|Overall Study|Reason missing due to delinquent data|0|||
23543438|NCT01389973|65719799|FG000|Overall Study|Lost to Follow-up|1|||
23543439|NCT01389973|65719799|FG000|Overall Study|Trial Stopped by Sponsor|9|||
23543440|NCT01389973|65719799|FG000|Overall Study|Other|10|||
23543441|NCT02696317|65719804|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
23543442|NCT02696317|65719805|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
23543443|NCT02696317|65719804|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
23543444|NCT02696317|65719805|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
23543445|NCT00129987|65719806|FG000|1st Educational Session|Withdrawal by Subject|141|||
23543446|NCT00129987|65719807|FG001|1st Educational Session|Withdrawal by Subject|109|||
23543447|NCT00129987|65719806|FG000|1 Year|Withdrawal by Subject|32|||
23543448|NCT00129987|65719807|FG001|1 Year|Withdrawal by Subject|21|||
23543449|NCT00874029|65719810|FG000|Overall Study|Withdrawal by Subject|10|||
23543450|NCT00874029|65719810|FG000|Overall Study|Pregnancy|4|||
23543451|NCT00874029|65719810|FG000|Overall Study|Physician Decision|1|||
23543452|NCT00874029|65719810|FG000|Overall Study|Adverse Event|1|||
23543453|NCT00874029|65719810|FG000|Overall Study|Lost to Follow-up|5|||
23543454|NCT02648698|65719811|FG000|Overall Study|Protocol Violation|1|||
23543455|NCT02648698|65719812|FG001|Overall Study|Protocol Violation|5|||
23543456|NCT00784043|65719813|FG000|Overall Study|Withdrawal by Subject|8|||
23543457|NCT00784043|65719814|FG001|Overall Study|Withdrawal by Subject|5|||
23543458|NCT00784043|65719813|FG000|Overall Study|Protocol Terminated|23|||
23543459|NCT00784043|65719814|FG001|Overall Study|Protocol Terminated|1|||
23175828|NCT02549339|64386585|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
23175829|NCT02549339|64386584|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
23175830|NCT02549339|64386585|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
23314396|NCT01994291|64892317|FG001|Overall Study|Lost to Follow-up|1|||
23314397|NCT01994291|64892318|FG002|Overall Study|Lost to Follow-up|0|||
23425436|NCT00235391|65299966|FG001|Overall Study|Lost to Follow-up|3|||
23543460|NCT00924950|65719815|FG000|Overall Study|Lost to Follow-up|2|||
23175831|NCT02549339|64386584|FG000|12-month Follow-up|Lack of Efficacy|0|||
23175832|NCT02549339|64386585|FG001|12-month Follow-up|Lack of Efficacy|2|||
23175833|NCT02549339|64386584|FG000|12-month Follow-up|Withdrawal by Subject|8|||
23175834|NCT02549339|64386585|FG001|12-month Follow-up|Withdrawal by Subject|3|||
23175835|NCT02549339|64386584|FG000|12-month Follow-up|Lost to Follow-up|1|||
23175836|NCT02549339|64386585|FG001|12-month Follow-up|Lost to Follow-up|3|||
23175837|NCT02549339|64386584|FG000|12-month Follow-up|Other|0|||
23175838|NCT02549339|64386585|FG001|12-month Follow-up|Other|3|||
23425437|NCT00235391|65299967|FG002|Overall Study|Lost to Follow-up|3|||
23314398|NCT01994291|64892316|FG000|Overall Study|Does not meet entrance criteria|1|||
23314399|NCT01994291|64892317|FG001|Overall Study|Does not meet entrance criteria|0|||
23314400|NCT01994291|64892318|FG002|Overall Study|Does not meet entrance criteria|0|||
23314401|NCT01994291|64892316|FG000|Overall Study|Medication error without associated AE|1|||
23314402|NCT01994291|64892317|FG001|Overall Study|Medication error without associated AE|0|||
23314403|NCT01994291|64892318|FG002|Overall Study|Medication error without associated AE|1|||
23314404|NCT01994291|64892316|FG000|Overall Study|Protocol Violation|1|||
23616942|NCT04057937|65982506|FG000|Placebo-controlled Phase|Adverse Event|3|||
23616943|NCT04057937|65982507|FG001|Placebo-controlled Phase|Adverse Event|0|||
23616944|NCT04057937|65982506|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
23616945|NCT04057937|65982507|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
23616946|NCT04057937|65982506|FG000|Active-treatment Phase|Pregnancy|0|||
23616947|NCT04057937|65982507|FG001|Active-treatment Phase|Pregnancy|1|||
23616948|NCT04057937|65982506|FG000|Active-treatment Phase|Physician Decision|0|||
23616949|NCT04057937|65982507|FG001|Active-treatment Phase|Physician Decision|1|||
23616950|NCT01533181|65985015|FG000|Overall Study|Disease progression pre-active treatment|0|||
23616951|NCT01533181|65985016|FG001|Overall Study|Disease progression pre-active treatment|1|||
23616952|NCT01533181|65985015|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
23616953|NCT01533181|65985016|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
23616954|NCT04883541|65985019|FG000|Overall Study|Not attending regular yoga class|16|||
23616955|NCT04883541|65985020|FG001|Overall Study|Not attending regular yoga class|0|||
23616956|NCT04883541|65985019|FG000|Overall Study|Not attending the pregnancy school|0|||
23616957|NCT04883541|65985020|FG001|Overall Study|Not attending the pregnancy school|9|||
23616958|NCT00230971|65985021|FG000|Randomization|No study drug administered|3|||
23616959|NCT00230971|65985022|FG001|Randomization|No study drug administered|3|||
23616960|NCT00230971|65985021|FG000|Baseline Participants|Lost to Follow-up|5|||
23616961|NCT00230971|65985022|FG001|Baseline Participants|Lost to Follow-up|12|||
23616962|NCT00230971|65985021|FG000|Baseline Participants|Death|6|||
23616963|NCT00230971|65985022|FG001|Baseline Participants|Death|5|||
23616964|NCT00230971|65985021|FG000|Baseline Participants|Withdrawal by Subject|7|||
23616965|NCT00230971|65985022|FG001|Baseline Participants|Withdrawal by Subject|1|||
23616966|NCT00230971|65985021|FG000|Baseline Participants|Adverse Event|1|||
23616967|NCT00230971|65985022|FG001|Baseline Participants|Adverse Event|0|||
23616968|NCT00230971|65985021|FG000|Baseline Participants|No bacteria observed|1|||
23616969|NCT00230971|65985022|FG001|Baseline Participants|No bacteria observed|0|||
23616970|NCT00230971|65985021|FG000|Baseline Participants|Failure to return|1|||
23616971|NCT00230971|65985022|FG001|Baseline Participants|Failure to return|1|||
23616972|NCT00230971|65985021|FG000|Baseline Participants|Reintervention|1|||
23616973|NCT00230971|65985022|FG001|Baseline Participants|Reintervention|0|||
23616974|NCT02711553|65985023|FG000|Overall Study|Withdrawal by Subject|2|||
23616975|NCT02711553|65985024|FG001|Overall Study|Withdrawal by Subject|1|||
23616976|NCT02711553|65985025|FG002|Overall Study|Withdrawal by Subject|1|||
23616977|NCT02711553|65985026|FG003|Overall Study|Withdrawal by Subject|0|||
23616978|NCT02711553|65985023|FG000|Overall Study|Lost to Follow-up|3|||
23616979|NCT02711553|65985024|FG001|Overall Study|Lost to Follow-up|3|||
23616980|NCT02711553|65985025|FG002|Overall Study|Lost to Follow-up|6|||
23616981|NCT02711553|65985026|FG003|Overall Study|Lost to Follow-up|3|||
23616982|NCT02711553|65985023|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
23616983|NCT02711553|65985024|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
23616984|NCT02711553|65985025|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
23616985|NCT02711553|65985026|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
23616986|NCT02784535|65985029|FG000|Overall Study|Adverse Event|1|||
23616987|NCT02784535|65985030|FG001|Overall Study|Adverse Event|0|||
23616988|NCT02784535|65985029|FG000|Overall Study|Withdrawal by Subject|0|||
23616989|NCT02784535|65985030|FG001|Overall Study|Withdrawal by Subject|1|||
23616990|NCT02784535|65985029|FG000|Overall Study|Physician Decision|0|||
23616991|NCT02784535|65985030|FG001|Overall Study|Physician Decision|1|||
23616992|NCT01191697|65985031|FG000|Overall Study|Death|1|||
23616993|NCT01191697|65985031|FG000|Overall Study|Physician Decision|2|||
23616994|NCT01191697|65985031|FG000|Overall Study|Pursue chemoradiation|2|||
23616995|NCT01191697|65985031|FG000|Overall Study|Break from chemotherapy|2|||
23616996|NCT01191697|65985031|FG000|Overall Study|Withdrawal by Subject|1|||
23616997|NCT01191697|65985031|FG000|Overall Study|Surveillance|1|||
23616998|NCT01191697|65985031|FG000|Overall Study|Adverse Event|2|||
23616999|NCT01191697|65985031|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
23617000|NCT01191697|65985031|FG000|Overall Study|Not completed but analyzed|25|||
23617001|NCT01837719|65985032|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
23617002|NCT01837719|65985032|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
23617003|NCT00377312|65985035|FG000|Overall Study|Adverse Event|1|||
23617004|NCT00377312|65985036|FG001|Overall Study|Adverse Event|1|||
23617005|NCT00240097|65985037|FG000|Part I|Adverse Event|1|||
23617006|NCT00240097|65985037|FG000|Part I|Death|1|||
23617007|NCT00240097|65985037|FG000|Part I|histology|1|||
23617008|NCT00240097|65985037|FG000|Part I|unevaluable|1|||
23314405|NCT01994291|64892317|FG001|Overall Study|Protocol Violation|0|||
23314406|NCT01994291|64892318|FG002|Overall Study|Protocol Violation|0|||
23314407|NCT01994291|64892316|FG000|Overall Study|Withdrawal by Subject|6|||
23314408|NCT01994291|64892317|FG001|Overall Study|Withdrawal by Subject|3|||
23314409|NCT01994291|64892318|FG002|Overall Study|Withdrawal by Subject|5|||
23314410|NCT01994291|64892316|FG000|Overall Study|Other|1|||
23314411|NCT01994291|64892317|FG001|Overall Study|Other|2|||
23543461|NCT01312909|65719819|FG000|Overall Study|Randomized but not treated|1|||
23543462|NCT01312909|65719820|FG001|Overall Study|Randomized but not treated|3|||
23543463|NCT01312909|65719821|FG002|Overall Study|Randomized but not treated|1|||
23543464|NCT01312909|65719819|FG000|Overall Study|Adverse Event|1|||
23543465|NCT01312909|65719820|FG001|Overall Study|Adverse Event|0|||
23543466|NCT01312909|65719821|FG002|Overall Study|Adverse Event|3|||
23543467|NCT01312909|65719819|FG000|Overall Study|Protocol Violation|2|||
23543468|NCT01312909|65719820|FG001|Overall Study|Protocol Violation|0|||
23617009|NCT00240097|65985037|FG000|Part II|did not continue from Part I|23|||
23617010|NCT01024036|65985040|FG000|Blinded Treatment|Adverse Event|1|||
23617011|NCT01024036|65985041|FG001|Blinded Treatment|Adverse Event|1|||
23617012|NCT01024036|65985040|FG000|Blinded Treatment|Lack of Efficacy|16|||
23617013|NCT01024036|65985041|FG001|Blinded Treatment|Lack of Efficacy|14|||
23617014|NCT01024036|65985040|FG000|Blinded Treatment|Physician Decision|1|||
23617015|NCT01024036|65985041|FG001|Blinded Treatment|Physician Decision|0|||
23617016|NCT01024036|65985040|FG000|Blinded Treatment|Death|0|||
23617017|NCT01024036|65985041|FG001|Blinded Treatment|Death|2|||
23211217|NCT01244191|64512378|FG001|Overall Study|Adverse Event|48|||
23211218|NCT01244191|64512377|FG000|Overall Study|Death|22|||
23211219|NCT01244191|64512378|FG001|Overall Study|Death|29|||
23211220|NCT01244191|64512377|FG000|Overall Study|Lost to Follow-up|0|||
23211221|NCT01244191|64512378|FG001|Overall Study|Lost to Follow-up|2|||
23211222|NCT01244191|64512377|FG000|Overall Study|Protocol Violation|1|||
23211223|NCT01244191|64512378|FG001|Overall Study|Protocol Violation|2|||
23211224|NCT01244191|64512377|FG000|Overall Study|Withdrawal by Subject|31|||
23211225|NCT01244191|64512378|FG001|Overall Study|Withdrawal by Subject|23|||
23211226|NCT01244191|64512377|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
23211227|NCT01244191|64512378|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
23211228|NCT00600028|64512381|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23211229|NCT00600028|64512382|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
23211230|NCT00600028|64512381|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
23211231|NCT00600028|64512382|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
23211232|NCT00600028|64512381|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
23211233|NCT00600028|64512382|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
23211234|NCT00779324|64512383|FG000|Overall Study|Lost to Follow-up|2|||
23211235|NCT00779324|64512384|FG001|Overall Study|Lost to Follow-up|1|||
23211236|NCT00779324|64512383|FG000|Overall Study|Withdrawal by Subject|4|||
23211237|NCT00779324|64512384|FG001|Overall Study|Withdrawal by Subject|2|||
23211238|NCT00779324|64512383|FG000|Overall Study|Missed visit|1|||
23211239|NCT00779324|64512384|FG001|Overall Study|Missed visit|1|||
23211240|NCT02180217|64512385|FG000|Overall Study|Adverse Event|3|||
23211241|NCT02180217|64512386|FG001|Overall Study|Adverse Event|2|||
23211242|NCT02180217|64512387|FG002|Overall Study|Adverse Event|22|||
23211243|NCT02180217|64512385|FG000|Overall Study|Death|1|||
23211244|NCT02180217|64512386|FG001|Overall Study|Death|1|||
23211245|NCT02180217|64512387|FG002|Overall Study|Death|0|||
23211246|NCT02180217|64512385|FG000|Overall Study|Withdrawal by Subject|1|||
23211247|NCT02180217|64512386|FG001|Overall Study|Withdrawal by Subject|1|||
23211248|NCT02180217|64512387|FG002|Overall Study|Withdrawal by Subject|4|||
23211249|NCT02180217|64512385|FG000|Overall Study|Subject/Guardian decision|5|||
23211250|NCT02180217|64512386|FG001|Overall Study|Subject/Guardian decision|3|||
23211251|NCT02180217|64512387|FG002|Overall Study|Subject/Guardian decision|6|||
23543469|NCT01312909|65719821|FG002|Overall Study|Protocol Violation|2|||
23543470|NCT01312909|65719819|FG000|Overall Study|Other|9|||
23543471|NCT01312909|65719820|FG001|Overall Study|Other|6|||
23617018|NCT01024036|65985040|FG000|Blinded Treatment|Withdrawal by Subject|4|||
23211252|NCT02180217|64512385|FG000|Overall Study|Physician Decision|1|||
23211253|NCT02180217|64512386|FG001|Overall Study|Physician Decision|1|||
23211254|NCT02180217|64512387|FG002|Overall Study|Physician Decision|6|||
23211255|NCT02180217|64512385|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23543472|NCT01312909|65719821|FG002|Overall Study|Other|11|||
23543473|NCT01312909|65719819|FG000|Overall Study|Withdrawal by Subject|8|||
23543474|NCT01312909|65719820|FG001|Overall Study|Withdrawal by Subject|10|||
23211256|NCT02180217|64512386|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23211257|NCT02180217|64512387|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23314412|NCT01994291|64892318|FG002|Overall Study|Other|0|||
23314413|NCT01464931|64892319|FG000|Overall Study|Withdrawal by Subject|1|||
23617019|NCT01024036|65985041|FG001|Blinded Treatment|Withdrawal by Subject|3|||
23617020|NCT01024036|65985040|FG000|Unblinded Treatment|Adverse Event|0|||
23211258|NCT05563714|64512388|FG000|Overall Study|Death|2|||
23211259|NCT05563714|64512389|FG001|Overall Study|Death|2|||
23543475|NCT01312909|65719821|FG002|Overall Study|Withdrawal by Subject|7|||
23543476|NCT01312909|65719819|FG000|Overall Study|Lost to Follow-up|21|||
23543477|NCT01312909|65719820|FG001|Overall Study|Lost to Follow-up|17|||
23543478|NCT01312909|65719821|FG002|Overall Study|Lost to Follow-up|20|||
23543479|NCT01312909|65719819|FG000|Overall Study|Insufficient clinical response|0|||
23543480|NCT01312909|65719820|FG001|Overall Study|Insufficient clinical response|0|||
23543481|NCT01312909|65719821|FG002|Overall Study|Insufficient clinical response|1|||
23543482|NCT01312909|65719819|FG000|Overall Study|Entrance criteria not met|0|||
23543483|NCT01312909|65719820|FG001|Overall Study|Entrance criteria not met|0|||
23543484|NCT01312909|65719821|FG002|Overall Study|Entrance criteria not met|2|||
23543485|NCT01365494|65719822|FG000|Overall Study|Adverse Event|1|||
23543486|NCT01365494|65719823|FG001|Overall Study|Adverse Event|0|||
23543487|NCT01365494|65719822|FG000|Overall Study|Withdrawal by Subject|0|||
23543488|NCT01365494|65719823|FG001|Overall Study|Withdrawal by Subject|1|||
23543489|NCT01365494|65719822|FG000|Overall Study|Lost to Follow-up|1|||
23543490|NCT01365494|65719823|FG001|Overall Study|Lost to Follow-up|2|||
23543491|NCT02576574|65719824|FG000|Overall Study|still ongoing|65|||
23543492|NCT02576574|65719825|FG001|Overall Study|still ongoing|66|||
23543493|NCT02576574|65719826|FG002|Overall Study|still ongoing|73|||
23543494|NCT02576574|65719824|FG000|Overall Study|Randomized, not treated|5|||
23543495|NCT02576574|65719825|FG001|Overall Study|Randomized, not treated|4|||
23543496|NCT02576574|65719826|FG002|Overall Study|Randomized, not treated|26|||
23543497|NCT01774903|65719827|FG000|Overall Study|Adverse Event|7|||
23543498|NCT01774903|65719827|FG000|Overall Study|Withdrawal by Subject|2|||
23543499|NCT01774903|65719827|FG000|Overall Study|Lack of Efficacy|1|||
23543500|NCT01774903|65719827|FG000|Overall Study|Ineligible to continue the trial|1|||
23543501|NCT01568047|65719828|FG000|Overall Study|Ineligibility|1|||
23543502|NCT01568047|65719829|FG001|Overall Study|Ineligibility|0|||
23543503|NCT01568047|65719830|FG002|Overall Study|Ineligibility|0|||
23543504|NCT01568047|65719831|FG003|Overall Study|Ineligibility|0|||
23543505|NCT01568047|65719828|FG000|Overall Study|Withdrawal by Subject|0|||
23543506|NCT01568047|65719829|FG001|Overall Study|Withdrawal by Subject|1|||
23543507|NCT01568047|65719830|FG002|Overall Study|Withdrawal by Subject|0|||
23543508|NCT01568047|65719831|FG003|Overall Study|Withdrawal by Subject|0|||
23543509|NCT01568047|65719828|FG000|Overall Study|Adverse Event|0|||
23543510|NCT01568047|65719829|FG001|Overall Study|Adverse Event|0|||
23543511|NCT01568047|65719830|FG002|Overall Study|Adverse Event|1|||
23543512|NCT01568047|65719831|FG003|Overall Study|Adverse Event|1|||
23543513|NCT04862143|65719834|FG000|Overall Study|Adverse Event|1|||
23543514|NCT04862143|65719834|FG000|Overall Study|Study terminated by sponsor|1|||
23543515|NCT02265237|65719844|FG000|As Treated (Overall Study)|Adverse Event|1|||
23543516|NCT02265237|65719845|FG001|As Treated (Overall Study)|Adverse Event|1|||
23543517|NCT02265237|65719846|FG002|As Treated (Overall Study)|Adverse Event|0|||
23543518|NCT02265237|65719847|FG003|As Treated (Overall Study)|Adverse Event|0|||
23543519|NCT02265237|65719844|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
23543520|NCT02265237|65719845|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
23543521|NCT02265237|65719846|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
23543522|NCT02265237|65719847|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
23543523|NCT02265237|65719844|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
23543524|NCT02265237|65719845|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
23543525|NCT02265237|65719846|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
23543526|NCT02265237|65719847|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
23543527|NCT02265237|65719844|FG000|As Treated (Overall Study)|Other|2|||
23543528|NCT02265237|65719845|FG001|As Treated (Overall Study)|Other|0|||
23543529|NCT02265237|65719846|FG002|As Treated (Overall Study)|Other|3|||
23543530|NCT02265237|65719847|FG003|As Treated (Overall Study)|Other|1|||
23543531|NCT03674177|65719848|FG000|Overall Study|Lost to Follow-up|2|||
23543532|NCT03674177|65719849|FG001|Overall Study|Lost to Follow-up|1|||
23543533|NCT03674177|65719850|FG002|Overall Study|Lost to Follow-up|0|||
23543534|NCT03674177|65719851|FG003|Overall Study|Lost to Follow-up|2|||
23543535|NCT02114892|65719852|FG000|Overall Study|Lost to Follow-up|1|||
23543536|NCT02114892|65719853|FG001|Overall Study|Lost to Follow-up|2|||
23543537|NCT01196975|65719854|FG000|Overall Study|Adverse Event|2|||
23543538|NCT01196975|65719855|FG001|Overall Study|Adverse Event|2|||
23543539|NCT01196975|65719856|FG002|Overall Study|Adverse Event|0|||
23543540|NCT01196975|65719857|FG003|Overall Study|Adverse Event|0|||
23543541|NCT01196975|65719858|FG004|Overall Study|Adverse Event|2|||
23543542|NCT01196975|65719854|FG000|Overall Study|Withdrawal by Subject|2|||
23543543|NCT01196975|65719855|FG001|Overall Study|Withdrawal by Subject|1|||
23543544|NCT01196975|65719856|FG002|Overall Study|Withdrawal by Subject|0|||
23543545|NCT01196975|65719857|FG003|Overall Study|Withdrawal by Subject|1|||
23543546|NCT01196975|65719858|FG004|Overall Study|Withdrawal by Subject|0|||
23543547|NCT01196975|65719854|FG000|Overall Study|Lost to Follow-up|11|||
23543548|NCT01196975|65719855|FG001|Overall Study|Lost to Follow-up|6|||
23543549|NCT01196975|65719856|FG002|Overall Study|Lost to Follow-up|5|||
23617021|NCT01024036|65985041|FG001|Unblinded Treatment|Adverse Event|1|||
23425438|NCT00235391|65299968|FG003|Overall Study|Lost to Follow-up|16|||
23543550|NCT01196975|65719857|FG003|Overall Study|Lost to Follow-up|5|||
23543551|NCT01196975|65719858|FG004|Overall Study|Lost to Follow-up|11|||
23543552|NCT02979535|65719859|FG000|Overall Study|Non compliance with the protocol|78|||
23543553|NCT02979535|65719860|FG001|Overall Study|Non compliance with the protocol|82|||
23543554|NCT02979535|65719859|FG000|Overall Study|Consent withdrawn by participant|11|||
23543555|NCT02979535|65719860|FG001|Overall Study|Consent withdrawn by participant|18|||
23543556|NCT02979535|65719859|FG000|Overall Study|Lost to Follow-up|6|||
23543557|NCT02979535|65719860|FG001|Overall Study|Lost to Follow-up|1|||
23543558|NCT00237744|65719861|FG000|Overall Study|Withdrawal by Subject|3|||
23543559|NCT00237744|65719862|FG001|Overall Study|Withdrawal by Subject|1|||
23543560|NCT00237744|65719863|FG002|Overall Study|Withdrawal by Subject|0|||
23543561|NCT03277313|65719866|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
23543562|NCT03277313|65719867|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
23543563|NCT03277313|65719866|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
23543564|NCT03277313|65719867|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
23543565|NCT03277313|65719866|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
23543566|NCT03277313|65719867|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
23543567|NCT03277313|65719866|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
23543568|NCT03277313|65719867|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
23543569|NCT03277313|65719866|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
23543570|NCT03277313|65719867|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
23543571|NCT03836053|65719868|FG000|Overall Study|Protocol-specified criteria|0|||
23543572|NCT03836053|65719869|FG001|Overall Study|Protocol-specified criteria|2|||
23543573|NCT03836053|65719870|FG002|Overall Study|Protocol-specified criteria|1|||
23543574|NCT03836053|65719868|FG000|Overall Study|Death|1|||
23543575|NCT03836053|65719869|FG001|Overall Study|Death|6|||
23543576|NCT03836053|65719870|FG002|Overall Study|Death|4|||
23543577|NCT03836053|65719868|FG000|Overall Study|Withdrawal of consent from study|0|||
23543578|NCT03836053|65719869|FG001|Overall Study|Withdrawal of consent from study|0|||
23543579|NCT03836053|65719870|FG002|Overall Study|Withdrawal of consent from study|1|||
23543580|NCT03836053|65719868|FG000|Overall Study|Decision by sponsor|0|||
23543581|NCT03836053|65719869|FG001|Overall Study|Decision by sponsor|2|||
23543582|NCT03836053|65719870|FG002|Overall Study|Decision by sponsor|4|||
23543583|NCT02802345|65719871|FG000|Overall Study|Not Treated|0|||
23543584|NCT02802345|65719872|FG001|Overall Study|Not Treated|1|||
23543585|NCT02802345|65719871|FG000|Overall Study|Adverse Event|28|||
23543586|NCT02802345|65719872|FG001|Overall Study|Adverse Event|20|||
23543587|NCT02802345|65719871|FG000|Overall Study|Withdrawal by Subject|3|||
23543588|NCT02802345|65719872|FG001|Overall Study|Withdrawal by Subject|3|||
23543589|NCT02802345|65719871|FG000|Overall Study|Protocol Violation|0|||
23543590|NCT02802345|65719872|FG001|Overall Study|Protocol Violation|1|||
23543591|NCT02802345|65719871|FG000|Overall Study|Other than listed|1|||
23543592|NCT02802345|65719872|FG001|Overall Study|Other than listed|5|||
23543593|NCT02730819|65719874|FG000|Overall Study|Lost to Follow-up|9|||
23543594|NCT01519206|65719875|FG000|Overall Study|Lost to Follow-up|3|||
23543595|NCT01519206|65719875|FG000|Overall Study|Missed Visit|2|||
23543596|NCT02370602|65719876|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23543597|NCT02370602|65719877|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23543598|NCT02370602|65719878|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23543599|NCT02370602|65719879|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
23543600|NCT02370602|65719880|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
23543601|NCT02370602|65719881|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
23543602|NCT00506493|65719884|FG000|Overall Study|Death|6|||
23543603|NCT00506493|65719884|FG000|Overall Study|Withdrawal by Subject|5|||
23543604|NCT03478891|65719885|FG000|Overall Study|Enrolled, but product never administered|0|||
23543605|NCT03478891|65719886|FG001|Overall Study|Enrolled, but product never administered|0|||
23543606|NCT03478891|65719887|FG002|Overall Study|Enrolled, but product never administered|1|||
23543607|NCT03478891|65719885|FG000|Overall Study|Moved from area|0|||
23543608|NCT03478891|65719886|FG001|Overall Study|Moved from area|0|||
23543609|NCT03478891|65719887|FG002|Overall Study|Moved from area|1|||
23543610|NCT03478891|65719885|FG000|Overall Study|Lost to Follow-up|1|||
23543611|NCT03478891|65719886|FG001|Overall Study|Lost to Follow-up|0|||
23543612|NCT03478891|65719887|FG002|Overall Study|Lost to Follow-up|1|||
23543613|NCT02667912|65719888|FG000|Overall Study|Death|3|||
23543614|NCT02667912|65719889|FG001|Overall Study|Death|1|||
23543615|NCT02667912|65719888|FG000|Overall Study|Withdrawal by Subject|1|||
23543616|NCT02667912|65719889|FG001|Overall Study|Withdrawal by Subject|2|||
23543617|NCT02667912|65719888|FG000|Overall Study|Withdrawal by Subject|1|||
23543618|NCT02667912|65719889|FG001|Overall Study|Withdrawal by Subject|0|||
23543619|NCT01659021|65719892|FG000|Main Study|Adverse Event|2|||
23543620|NCT01659021|65719893|FG001|Main Study|Adverse Event|3|||
23543621|NCT01659021|65719892|FG000|Main Study|Lost to Follow-up|1|||
23425439|NCT00235391|65299969|FG004|Overall Study|Lost to Follow-up|0|||
23543622|NCT01659021|65719893|FG001|Main Study|Lost to Follow-up|0|||
23314414|NCT01464931|64892320|FG001|Overall Study|Withdrawal by Subject|0|||
23314415|NCT00340678|64892321|FG000|Overall Study|Lost to Follow-up|1|||
23314416|NCT00340678|64892322|FG001|Overall Study|Lost to Follow-up|0|||
23314417|NCT00340678|64892323|FG002|Overall Study|Lost to Follow-up|0|||
23314418|NCT00340678|64892324|FG003|Overall Study|Lost to Follow-up|0|||
23314419|NCT00576316|64892342|FG000|Overall Study|Adverse Event|9|||
23314420|NCT00576316|64892342|FG000|Overall Study|Withdrawal by Subject|2|||
23314421|NCT00576316|64892342|FG000|Overall Study|Protocol Violation|9|||
23543623|NCT01659021|65719892|FG000|Main Study|Unknown Reasons|2|||
23543624|NCT01659021|65719893|FG001|Main Study|Unknown Reasons|1|||
23543625|NCT01659021|65719892|FG000|Main Study|Physician Decision|34|||
23543626|NCT01659021|65719893|FG001|Main Study|Physician Decision|16|||
23543627|NCT01659021|65719892|FG000|Main Study|Withdrawal by Subject|19|||
23543628|NCT01659021|65719893|FG001|Main Study|Withdrawal by Subject|16|||
23543629|NCT01659021|65719892|FG000|Main Study|Study Terminated by Sponsor|16|||
23543630|NCT01659021|65719893|FG001|Main Study|Study Terminated by Sponsor|1|||
23543631|NCT01659021|65719892|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
23543632|NCT01659021|65719893|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
23543633|NCT01659021|65719892|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
23543634|NCT01659021|65719893|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
23543635|NCT00710424|65719894|FG000|Overall Study|Adverse Event|30|||
23543636|NCT00710424|65719895|FG001|Overall Study|Adverse Event|12|||
23543637|NCT00710424|65719894|FG000|Overall Study|Lack of Efficacy|4|||
23617022|NCT01024036|65985040|FG000|Unblinded Treatment|Lack of Efficacy|0|||
23175839|NCT01554579|64386588|FG000|Overall Study|Adverse Event|6|||
23211260|NCT05563714|64512390|FG002|Overall Study|Death|0|||
23211261|NCT05563714|64512391|FG003|Overall Study|Death|0|||
23211262|NCT05563714|64512388|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
23211263|NCT05563714|64512389|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
23211264|NCT05563714|64512390|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
23211265|NCT05563714|64512391|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
23211266|NCT05563714|64512388|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
23211267|NCT05563714|64512389|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
23211268|NCT05563714|64512390|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
23211269|NCT05563714|64512391|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
23211270|NCT05563714|64512388|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
23236651|NCT01249404|64608273|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
23236652|NCT01249404|64608274|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
23236653|NCT01249404|64608272|FG000|Overall Study|Adverse Event|2|||
23236654|NCT01249404|64608273|FG001|Overall Study|Adverse Event|2|||
23236655|NCT01249404|64608274|FG002|Overall Study|Adverse Event|2|||
23236656|NCT01249404|64608272|FG000|Overall Study|Withdrawal by Subject|2|||
23236657|NCT01249404|64608273|FG001|Overall Study|Withdrawal by Subject|2|||
23236658|NCT01249404|64608274|FG002|Overall Study|Withdrawal by Subject|0|||
23236659|NCT01249404|64608272|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
23236660|NCT01249404|64608273|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
23236661|NCT01249404|64608274|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
23236662|NCT01249404|64608272|FG000|Overall Study|Non compliance to visit schedule|0|||
23236663|NCT01249404|64608273|FG001|Overall Study|Non compliance to visit schedule|1|||
23236664|NCT01249404|64608274|FG002|Overall Study|Non compliance to visit schedule|0|||
23314422|NCT02954991|64895288|FG000|Overall Study|Death|92|||
23314423|NCT02954991|64895289|FG001|Overall Study|Death|11|||
23314424|NCT02954991|64895290|FG002|Overall Study|Death|2|||
23314425|NCT02954991|64895288|FG000|Overall Study|Lost to Follow-up|3|||
23314426|NCT02954991|64895289|FG001|Overall Study|Lost to Follow-up|2|||
23314427|NCT02954991|64895290|FG002|Overall Study|Lost to Follow-up|0|||
23314428|NCT02954991|64895288|FG000|Overall Study|Withdrawal by Subject|9|||
23314429|NCT02954991|64895289|FG001|Overall Study|Withdrawal by Subject|8|||
23314430|NCT02954991|64895290|FG002|Overall Study|Withdrawal by Subject|1|||
23314431|NCT02954991|64895288|FG000|Overall Study|Study Terminated by Sponsor|18|||
23314432|NCT02954991|64895289|FG001|Overall Study|Study Terminated by Sponsor|10|||
23314433|NCT02954991|64895290|FG002|Overall Study|Study Terminated by Sponsor|1|||
23314434|NCT02954991|64895288|FG000|Overall Study|Miscellaneous|2|||
23314435|NCT02954991|64895289|FG001|Overall Study|Miscellaneous|1|||
23314436|NCT02954991|64895290|FG002|Overall Study|Miscellaneous|1|||
23314437|NCT01769456|64895291|FG000|Overall Study|Lost to Follow-up|19|||
23314438|NCT01769456|64895291|FG000|Overall Study|Withdrawal by Subject|3|||
23314439|NCT01769456|64895291|FG000|Overall Study|Did not receive PCC intervention|6|||
23314440|NCT01769456|64895291|FG000|Overall Study|Moved out of the area|3|||
23314441|NCT01769456|64895291|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
23314442|NCT01769456|64895291|FG000|Overall Study|Parental request to youth to withdraw|1|||
23314443|NCT01184079|64895292|FG000|Overall Study|Lost to Follow-up|14|||
23314444|NCT01184079|64895293|FG001|Overall Study|Lost to Follow-up|2|||
23314445|NCT00799825|64895297|FG000|Overall Study|Adverse Event|1|||
23314446|NCT00799825|64895297|FG000|Overall Study|Withdrawal by Subject|6|||
23314447|NCT00799825|64895297|FG000|Overall Study|Lost to Follow-up|38|||
23314448|NCT00799825|64895297|FG000|Overall Study|Pregnancy|3|||
23314449|NCT02359994|64895298|FG000|Overall Population Study|Adverse Event|1|||
23314450|NCT02359994|64895299|FG001|Overall Population Study|Adverse Event|1|||
23314451|NCT02359994|64895298|FG000|Overall Population Study|Death|1|||
23314452|NCT02359994|64895299|FG001|Overall Population Study|Death|5|||
23314453|NCT02359994|64895298|FG000|Overall Population Study|Lost to Follow-up|1|||
23314454|NCT02359994|64895299|FG001|Overall Population Study|Lost to Follow-up|1|||
23314455|NCT02359994|64895298|FG000|Overall Population Study|Withdrawal by Subject|1|||
23314456|NCT02359994|64895299|FG001|Overall Population Study|Withdrawal by Subject|0|||
23314457|NCT02359994|64895298|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
23314458|NCT02359994|64895299|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
23314459|NCT02359994|64895298|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
23314460|NCT02359994|64895299|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
23314461|NCT02359994|64895298|FG000|Extended Oncology 24-Month Survival|Death|19|||
23314462|NCT02359994|64895299|FG001|Extended Oncology 24-Month Survival|Death|21|||
23314463|NCT02359994|64895298|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
23314464|NCT02359994|64895299|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
23314465|NCT03485365|64895300|FG000|Overall Study|Protocol Violation|0|||
23314466|NCT03485365|64895301|FG001|Overall Study|Protocol Violation|0|||
23314467|NCT03485365|64895302|FG002|Overall Study|Protocol Violation|0|||
23314468|NCT03485365|64895303|FG003|Overall Study|Protocol Violation|1|||
23314469|NCT03485365|64895304|FG004|Overall Study|Protocol Violation|0|||
23314470|NCT03485365|64895305|FG005|Overall Study|Protocol Violation|0|||
23314471|NCT03485365|64895306|FG006|Overall Study|Protocol Violation|1|||
23314472|NCT03485365|64895307|FG007|Overall Study|Protocol Violation|0|||
23314473|NCT03485365|64895308|FG008|Overall Study|Protocol Violation|0|||
23314474|NCT00721227|64895310|FG000|Overall Study|Lost to Follow-up|3|||
23314475|NCT00721227|64895311|FG001|Overall Study|Lost to Follow-up|0|||
23314476|NCT00721227|64895310|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
23425440|NCT00235391|65299970|FG005|Overall Study|Lost to Follow-up|0|||
23425441|NCT00235391|65299965|FG000|Overall Study|Administrative problems|0|||
23617023|NCT01024036|65985041|FG001|Unblinded Treatment|Lack of Efficacy|2|||
23314477|NCT00721227|64895311|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
23314478|NCT01544179|64895317|FG000|Overall Study|Death|50|||
23314479|NCT01544179|64895318|FG001|Overall Study|Death|37|||
23314480|NCT01544179|64895317|FG000|Overall Study|Lost to Follow-up|0|||
23314481|NCT01544179|64895318|FG001|Overall Study|Lost to Follow-up|1|||
23314482|NCT01544179|64895317|FG000|Overall Study|Adverse Event|0|||
23314483|NCT01544179|64895318|FG001|Overall Study|Adverse Event|1|||
23617024|NCT01024036|65985040|FG000|Follow-Up Period|Lost to Follow-up|1|||
23617025|NCT01024036|65985041|FG001|Follow-Up Period|Lost to Follow-up|1|||
23314484|NCT01544179|64895317|FG000|Overall Study|Withdrawal by Subject|12|||
23314485|NCT01544179|64895318|FG001|Overall Study|Withdrawal by Subject|7|||
23314486|NCT01544179|64895317|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
23314487|NCT01544179|64895318|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23425442|NCT00235391|65299966|FG001|Overall Study|Administrative problems|0|||
23425443|NCT00235391|65299967|FG002|Overall Study|Administrative problems|0|||
23425444|NCT00235391|65299968|FG003|Overall Study|Administrative problems|1|||
23425445|NCT00235391|65299969|FG004|Overall Study|Administrative problems|0|||
23425446|NCT00235391|65299970|FG005|Overall Study|Administrative problems|0|||
23425447|NCT00235391|65299965|FG000|Overall Study|Death|0|||
23425448|NCT00235391|65299966|FG001|Overall Study|Death|0|||
23425449|NCT00235391|65299967|FG002|Overall Study|Death|1|||
23425450|NCT00235391|65299968|FG003|Overall Study|Death|4|||
23425451|NCT00235391|65299969|FG004|Overall Study|Death|0|||
23425452|NCT00235391|65299970|FG005|Overall Study|Death|0|||
23425453|NCT00609791|65299971|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
23425454|NCT00846040|65299975|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
23425455|NCT00846040|65299976|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
23425456|NCT00846040|65299977|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
23425457|NCT00846040|65299975|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
23425458|NCT00846040|65299976|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
23425459|NCT00846040|65299977|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
23425460|NCT00824005|65299980|FG000|Overall Study|Death|0|||
23425461|NCT00824005|65299981|FG001|Overall Study|Death|1|||
23425462|NCT00824005|65299980|FG000|Overall Study|Lost to Follow-up|0|||
23425463|NCT00824005|65299981|FG001|Overall Study|Lost to Follow-up|1|||
23425464|NCT01777542|65299982|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
23425465|NCT01777542|65299983|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
23425466|NCT00853125|65299984|FG000|Overall Study|Study participant's donor was CMV +|1|||
23425467|NCT03366103|65299985|FG000|Overall Study|Disease Progression|3|||
23425468|NCT03366103|65299986|FG001|Overall Study|Disease Progression|1|||
23425469|NCT03366103|65299987|FG002|Overall Study|Disease Progression|0|||
23425470|NCT03366103|65299985|FG000|Overall Study|Adverse Event|0|||
23211271|NCT05563714|64512389|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
23211272|NCT05563714|64512390|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
23211273|NCT05563714|64512391|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
23211274|NCT05563714|64512388|FG000|Overall Study|Lost to Follow-up|22|||
23543638|NCT00710424|65719895|FG001|Overall Study|Lack of Efficacy|5|||
23543639|NCT00710424|65719894|FG000|Overall Study|Withdrawal by Subject|5|||
23543640|NCT00710424|65719895|FG001|Overall Study|Withdrawal by Subject|3|||
23543641|NCT00710424|65719894|FG000|Overall Study|Lost to Follow-up|0|||
23543642|NCT00710424|65719895|FG001|Overall Study|Lost to Follow-up|1|||
23543643|NCT00710424|65719894|FG000|Overall Study|Refused medication, no side effects|1|||
23543644|NCT00710424|65719895|FG001|Overall Study|Refused medication, no side effects|0|||
23543645|NCT00710424|65719894|FG000|Overall Study|Non-compliance with stable analgesia|1|||
23211275|NCT05563714|64512389|FG001|Overall Study|Lost to Follow-up|19|||
23211276|NCT05563714|64512390|FG002|Overall Study|Lost to Follow-up|0|||
23211277|NCT05563714|64512391|FG003|Overall Study|Lost to Follow-up|0|||
23211278|NCT00997321|64512397|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
23211279|NCT00997321|64512398|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
23425471|NCT03366103|65299986|FG001|Overall Study|Adverse Event|1|||
23543646|NCT00710424|65719895|FG001|Overall Study|Non-compliance with stable analgesia|0|||
23543647|NCT00710424|65719894|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
23211280|NCT00889681|64512402|FG000|Overall Study|Not meeting qualification Criteria|2|||
23211281|NCT00889681|64512402|FG000|Overall Study|Insurance disapproval|1|||
23211282|NCT00676208|64512423|FG000|Overall Study|Lost to Follow-up|0|||
23425472|NCT03366103|65299987|FG002|Overall Study|Adverse Event|0|||
23425473|NCT01174004|65299988|FG000|Overall Study|Adverse Event|2|||
23425474|NCT01174004|65299989|FG001|Overall Study|Adverse Event|10|||
23425475|NCT01174004|65299988|FG000|Overall Study|Withdrawal by Subject|2|||
23425476|NCT01174004|65299989|FG001|Overall Study|Withdrawal by Subject|3|||
23425477|NCT01174004|65299988|FG000|Overall Study|At Discretion of Sponsor|2|||
23425478|NCT01174004|65299989|FG001|Overall Study|At Discretion of Sponsor|2|||
23425479|NCT01174004|65299988|FG000|Overall Study|Protocol Violation|0|||
23543648|NCT00710424|65719895|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
23425480|NCT01174004|65299989|FG001|Overall Study|Protocol Violation|1|||
23425481|NCT01174004|65299988|FG000|Overall Study|Physician Decision|1|||
23425482|NCT01174004|65299989|FG001|Overall Study|Physician Decision|0|||
23425483|NCT01166958|65299990|FG000|Overall Study|Withdrawal by Subject|1|||
23425484|NCT01166958|65299991|FG001|Overall Study|Withdrawal by Subject|0|||
23425485|NCT00585546|65299992|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
23425486|NCT00585546|65299992|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
23453603|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453604|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453605|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453606|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
23453607|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
23453608|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453609|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453610|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453611|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
23453612|NCT02365649|65403362|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453613|NCT02365649|65403363|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453614|NCT02365649|65403364|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
23453615|NCT02365649|65403365|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453616|NCT02365649|65403366|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453617|NCT02365649|65403367|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453618|NCT02365649|65403368|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453619|NCT02365649|65403369|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453620|NCT02365649|65403370|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453621|NCT02365649|65403371|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
23453622|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453623|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453624|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453625|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453626|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453627|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453628|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
23175840|NCT01554579|64386589|FG001|Overall Study|Adverse Event|25|||
23211283|NCT00676208|64512424|FG001|Overall Study|Lost to Follow-up|2|||
23211284|NCT00676208|64512423|FG000|Overall Study|Incomplete data|2|||
23211285|NCT00676208|64512424|FG001|Overall Study|Incomplete data|4|||
23211286|NCT04585451|64512433|FG000|Overall Study|Withdrawal by Subject|26|||
23211287|NCT04585451|64512434|FG001|Overall Study|Withdrawal by Subject|0|||
23211288|NCT05631548|64512435|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
23236665|NCT05403502|64608282|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
23314488|NCT03340974|64895319|FG000|Completion of Study -Long Term Follow up|Death|8|||
23314489|NCT03340974|64895320|FG001|Completion of Study -Long Term Follow up|Death|5|||
23453629|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453630|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453631|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
23453632|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23453633|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23123807|NCT02232399|64204888|FG000|Overall Study|Adverse Event|1|||
23123808|NCT02232399|64204889|FG001|Overall Study|Adverse Event|0|||
23123809|NCT02232399|64204888|FG000|Overall Study|Withdrawal by Subject|0|||
23123810|NCT02232399|64204889|FG001|Overall Study|Withdrawal by Subject|1|||
23123811|NCT04120376|64204890|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
23123812|NCT04120376|64204891|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
23123813|NCT00350727|64204892|FG000|Phase I: Dose Escalation|Adverse Event|4|||
23123814|NCT00350727|64204893|FG001|Phase I: Dose Escalation|Adverse Event|0|||
23123815|NCT00350727|64204894|FG002|Phase I: Dose Escalation|Adverse Event|0|||
23123816|NCT00350727|64204892|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
23123817|NCT00350727|64204893|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
23123818|NCT00350727|64204894|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
23425487|NCT01231321|65303325|FG000|Overall Study|Adverse Event|3|||
23425488|NCT01231321|65303325|FG000|Overall Study|Lack of Efficacy|2|||
23425489|NCT03461406|65303329|FG000|Overall Study|Death|1|||
23425490|NCT03461406|65303330|FG001|Overall Study|Death|2|||
23425491|NCT03461406|65303329|FG000|Overall Study|Consent Withdrawn by Participant|0|||
23543649|NCT00710424|65719894|FG000|Overall Study|Subject thought medication changed|1|||
23543650|NCT00710424|65719895|FG001|Overall Study|Subject thought medication changed|0|||
23543651|NCT00710424|65719894|FG000|Overall Study|Ceased treatment due to travel|1|||
23543652|NCT00710424|65719895|FG001|Overall Study|Ceased treatment due to travel|0|||
23543653|NCT00710424|65719894|FG000|Overall Study|Subject preferred paracetamol|0|||
23543654|NCT00710424|65719895|FG001|Overall Study|Subject preferred paracetamol|1|||
23543655|NCT00710424|65719894|FG000|Overall Study|Felt good so stopped treatment|0|||
23543656|NCT00710424|65719895|FG001|Overall Study|Felt good so stopped treatment|1|||
23543657|NCT04287920|65719896|FG000|Overall Study|Lost to Follow-up|1|||
23543658|NCT04287920|65719897|FG001|Overall Study|Lost to Follow-up|1|||
23543659|NCT04287920|65719896|FG000|Overall Study|Withdrawal by Subject|0|||
23543660|NCT04287920|65719897|FG001|Overall Study|Withdrawal by Subject|3|||
23543661|NCT00809757|65719900|FG000|Overall Study|Adverse Event|2|||
23543662|NCT00809757|65719901|FG001|Overall Study|Adverse Event|3|||
23543663|NCT00809757|65719902|FG002|Overall Study|Adverse Event|3|||
23543664|NCT00809757|65719900|FG000|Overall Study|Lost to Follow-up|0|||
23543665|NCT00809757|65719901|FG001|Overall Study|Lost to Follow-up|0|||
23543666|NCT00809757|65719902|FG002|Overall Study|Lost to Follow-up|1|||
23543667|NCT00809757|65719900|FG000|Overall Study|Protocol Violation|1|||
23543668|NCT00809757|65719901|FG001|Overall Study|Protocol Violation|1|||
23543669|NCT00809757|65719902|FG002|Overall Study|Protocol Violation|1|||
23543670|NCT00809757|65719900|FG000|Overall Study|Withdrawal by Subject|2|||
23543671|NCT00809757|65719901|FG001|Overall Study|Withdrawal by Subject|1|||
23543672|NCT00809757|65719902|FG002|Overall Study|Withdrawal by Subject|3|||
23543673|NCT00809757|65719900|FG000|Overall Study|Subject Uncooperative|1|||
23543674|NCT00809757|65719901|FG001|Overall Study|Subject Uncooperative|0|||
23543675|NCT00809757|65719902|FG002|Overall Study|Subject Uncooperative|2|||
23543676|NCT00809757|65719900|FG000|Overall Study|Noncompliance with Medication|0|||
23543677|NCT00809757|65719901|FG001|Overall Study|Noncompliance with Medication|0|||
23543678|NCT00809757|65719902|FG002|Overall Study|Noncompliance with Medication|1|||
23543679|NCT03329092|65719903|FG000|Overall Study|Other|2|||
23543680|NCT03329092|65719904|FG001|Overall Study|Other|2|||
23543681|NCT03329092|65719903|FG000|Overall Study|Withdrawal by Subject|16|||
23543682|NCT03329092|65719904|FG001|Overall Study|Withdrawal by Subject|3|||
23543683|NCT03329092|65719903|FG000|Overall Study|Physician Decision|1|||
23543684|NCT03329092|65719904|FG001|Overall Study|Physician Decision|0|||
23123819|NCT00350727|64204892|FG000|Phase I: Dose Escalation|Death|1|||
23425492|NCT03461406|65303330|FG001|Overall Study|Consent Withdrawn by Participant|1|||
23425493|NCT03461406|65303329|FG000|Overall Study|Screen Failure|3|||
23425494|NCT03461406|65303330|FG001|Overall Study|Screen Failure|1|||
23543685|NCT03329092|65719903|FG000|Overall Study|Death|17|||
23543686|NCT03329092|65719904|FG001|Overall Study|Death|11|||
23543687|NCT03329092|65719903|FG000|Overall Study|Adverse Event|3|||
23543688|NCT03329092|65719904|FG001|Overall Study|Adverse Event|1|||
23543689|NCT03329092|65719903|FG000|Overall Study|Lost to Follow-up|1|||
23543690|NCT03329092|65719904|FG001|Overall Study|Lost to Follow-up|1|||
23543691|NCT00377819|65719908|FG000|Overall Study|Adverse Event|2|||
23543692|NCT00377819|65719909|FG001|Overall Study|Adverse Event|3|||
23543693|NCT00377819|65719908|FG000|Overall Study|Withdrawal by Subject|10|||
23543694|NCT00377819|65719909|FG001|Overall Study|Withdrawal by Subject|4|||
23543695|NCT00377819|65719908|FG000|Overall Study|Death|0|||
23543696|NCT00377819|65719909|FG001|Overall Study|Death|1|||
23617026|NCT01024036|65985040|FG000|Follow-Up Period|Withdrawal by Subject|0|||
23617027|NCT01024036|65985041|FG001|Follow-Up Period|Withdrawal by Subject|1|||
23617028|NCT01024036|65985040|FG000|Follow-Up Period|Adverse Event|4|||
23617029|NCT01024036|65985041|FG001|Follow-Up Period|Adverse Event|1|||
23617030|NCT01078584|65985042|FG000|Overall Study|Final Status Unknown|1073|||
23617031|NCT01078584|65985042|FG000|Overall Study|Lost to Follow-up|670|||
23617032|NCT01078584|65985042|FG000|Overall Study|Non-serious Adverse Event|577|||
23617033|NCT01078584|65985042|FG000|Overall Study|Withdrawal of Consent|244|||
23617034|NCT01078584|65985042|FG000|Overall Study|Physician Withdrew from Study|90|||
23617035|NCT01078584|65985042|FG000|Overall Study|Non-compliance|67|||
23617036|NCT01078584|65985042|FG000|Overall Study|Blood Pressure Controlled|49|||
23617037|NCT01078584|65985042|FG000|Overall Study|Physician Switched Medication|26|||
23617038|NCT01078584|65985042|FG000|Overall Study|Physician Discontinued Patient|12|||
23617039|NCT01078584|65985042|FG000|Overall Study|Lack of Efficacy|98|||
23617040|NCT01078584|65985042|FG000|Overall Study|Protocol Violation|75|||
23617041|NCT01078584|65985042|FG000|Overall Study|Serious Adverse Event|27|||
23617042|NCT01078584|65985042|FG000|Overall Study|Multiple Reasons|2|||
23617043|NCT05008224|65985044|FG000|Overall Study|Death|3|||
23617044|NCT05008224|65985044|FG000|Overall Study|Lost to Follow-up|2|||
23617045|NCT05008224|65985044|FG000|Overall Study|Did Not Continue on Extension Study|39|||
23543697|NCT00377819|65719908|FG000|Overall Study|Lost to Follow-up|0|||
23543698|NCT00377819|65719909|FG001|Overall Study|Lost to Follow-up|1|||
23617046|NCT05008224|65985044|FG000|Overall Study|Transferred to Extension Study|100|||
23617047|NCT05008224|65985044|FG000|Overall Study|Withdrawal by Subject|2|||
23617048|NCT04688086|65985047|FG000|Overall Study|Lost to Follow-up|164|||
23617049|NCT04688086|65985047|FG000|Overall Study|Imaging error;|64|||
23617050|NCT04661150|65985050|FG000|Overall Study|Ongoing in study|19|||
23617051|NCT04661150|65985051|FG001|Overall Study|Ongoing in study|20|||
23617052|NCT04661150|65985050|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
23617053|NCT04661150|65985051|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
23617054|NCT04661150|65985050|FG000|Overall Study|Death|2|||
23617055|NCT04661150|65985051|FG001|Overall Study|Death|0|||
23617056|NCT00946088|65985052|FG000|Overall Study|Withdrawal by Subject|0|||
23617057|NCT00946088|65985053|FG001|Overall Study|Withdrawal by Subject|1|||
23617058|NCT01075100|65985056|FG000|Overall Study|Adverse Event|15|||
23617059|NCT01075100|65985057|FG001|Overall Study|Adverse Event|18|||
23617060|NCT01075100|65985056|FG000|Overall Study|Patient Request|4|||
23617061|NCT01075100|65985057|FG001|Overall Study|Patient Request|4|||
23617062|NCT01075100|65985056|FG000|Overall Study|Investigator Request|2|||
23617063|NCT01075100|65985057|FG001|Overall Study|Investigator Request|1|||
23617064|NCT01075100|65985056|FG000|Overall Study|Disease Progression|25|||
23123820|NCT00350727|64204893|FG001|Phase I: Dose Escalation|Death|0|||
23123821|NCT00350727|64204894|FG002|Phase I: Dose Escalation|Death|0|||
23123822|NCT00350727|64204892|FG000|Phase I: Dose Escalation|Physician Decision|1|||
23543699|NCT00377819|65719908|FG000|Overall Study|Protocol Violation|1|||
23543700|NCT00377819|65719909|FG001|Overall Study|Protocol Violation|1|||
23123823|NCT00350727|64204893|FG001|Phase I: Dose Escalation|Physician Decision|0|||
23123824|NCT00350727|64204894|FG002|Phase I: Dose Escalation|Physician Decision|0|||
23123825|NCT00350727|64204892|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
23123826|NCT00350727|64204893|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
23123827|NCT00350727|64204894|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
23123828|NCT00350727|64204892|FG000|Phase II|Disease Progression|0|||
23123829|NCT00350727|64204893|FG001|Phase II|Disease Progression|15|||
23123830|NCT00350727|64204894|FG002|Phase II|Disease Progression|16|||
23123831|NCT00350727|64204892|FG000|Phase II|Clinical Deterioration|0|||
23123832|NCT00350727|64204893|FG001|Phase II|Clinical Deterioration|1|||
23123833|NCT00350727|64204894|FG002|Phase II|Clinical Deterioration|0|||
23123834|NCT00350727|64204892|FG000|Phase II|Withdrawal by Subject|0|||
23543701|NCT04095858|65719912|FG000|Overall Study|Death|1|||
23543702|NCT04095858|65719913|FG001|Overall Study|Death|0|||
23543703|NCT04095858|65719912|FG000|Overall Study|Study terminated by Sponsor|2|||
23543704|NCT04095858|65719913|FG001|Overall Study|Study terminated by Sponsor|4|||
23617065|NCT01075100|65985057|FG001|Overall Study|Disease Progression|29|||
23617066|NCT01075100|65985056|FG000|Overall Study|Other|3|||
23617067|NCT01075100|65985057|FG001|Overall Study|Other|1|||
23617068|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Adverse Event|3|||
23617069|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Adverse Event|0|||
23617070|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
23123835|NCT00350727|64204893|FG001|Phase II|Withdrawal by Subject|2|||
23543705|NCT04598152|65719914|FG000|Overall Study|Lost to Follow-up|0|||
23543706|NCT04598152|65719915|FG001|Overall Study|Lost to Follow-up|1|||
23617071|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
23617072|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Disease Progression|23|||
23617073|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Disease Progression|22|||
23211289|NCT05631548|64512436|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
23211290|NCT01283997|64512437|FG000|Overall Study|Physician Decision|8|||
23211291|NCT01283997|64512438|FG001|Overall Study|Physician Decision|10|||
23211292|NCT01283997|64512437|FG000|Overall Study|Withdrawal by Subject|3|||
23211293|NCT01283997|64512438|FG001|Overall Study|Withdrawal by Subject|2|||
23211294|NCT01283997|64512437|FG000|Overall Study|Physically unable to continue|0|||
23211295|NCT01283997|64512438|FG001|Overall Study|Physically unable to continue|1|||
23211296|NCT01283997|64512437|FG000|Overall Study|Progressive disease|1|||
23211297|NCT01283997|64512438|FG001|Overall Study|Progressive disease|0|||
23211298|NCT01283997|64512437|FG000|Overall Study|Other|4|||
23543707|NCT03985423|65719917|FG000|Overall Study|Adverse Event|1|||
23543708|NCT03985423|65719917|FG000|Overall Study|Death|2|||
23543709|NCT03985423|65719917|FG000|Overall Study|Physician Decision|1|||
23543710|NCT03985423|65719917|FG000|Overall Study|Withdrawal by Subject|2|||
23123836|NCT00350727|64204894|FG002|Phase II|Withdrawal by Subject|1|||
23123837|NCT00350727|64204892|FG000|Phase II|Adverse Event|0|||
23123838|NCT00350727|64204893|FG001|Phase II|Adverse Event|1|||
23123839|NCT00350727|64204894|FG002|Phase II|Adverse Event|1|||
23123840|NCT00350727|64204892|FG000|Phase II|Death|0|||
23123841|NCT00350727|64204893|FG001|Phase II|Death|0|||
23123842|NCT00350727|64204894|FG002|Phase II|Death|2|||
23123843|NCT00350727|64204892|FG000|Phase II|Sponsor Terminated Study|0|||
23123844|NCT00350727|64204893|FG001|Phase II|Sponsor Terminated Study|0|||
23123845|NCT00350727|64204894|FG002|Phase II|Sponsor Terminated Study|1|||
23123846|NCT00350727|64204892|FG000|Phase II|Enrolled in Rollover Study|0|||
23123847|NCT00350727|64204893|FG001|Phase II|Enrolled in Rollover Study|0|||
23123848|NCT00350727|64204894|FG002|Phase II|Enrolled in Rollover Study|1|||
23543711|NCT03985423|65719917|FG000|Overall Study|Lack of insurance and citizenship|1|||
23543712|NCT02121847|65719921|FG000|Overall Study|Administrative Reasons|1|||
23543713|NCT02121847|65719921|FG000|Overall Study|Adverse Event|2|||
23543714|NCT00856583|65719922|FG000|Overall Study|Lack of Efficacy|389|||
23543715|NCT00856583|65719923|FG001|Overall Study|Lack of Efficacy|377|||
23543716|NCT00856583|65719922|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
23543717|NCT00856583|65719923|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
23543718|NCT00856583|65719922|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
23543719|NCT00856583|65719923|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
23543720|NCT00856583|65719922|FG000|Overall Study|Non-compliance|305|||
23543721|NCT00856583|65719923|FG001|Overall Study|Non-compliance|262|||
23543722|NCT00856583|65719922|FG000|Overall Study|Withdrawal by Subject|1092|||
23543723|NCT00856583|65719923|FG001|Overall Study|Withdrawal by Subject|919|||
23543724|NCT00856583|65719922|FG000|Overall Study|Physician Decision|59|||
23543725|NCT00856583|65719923|FG001|Overall Study|Physician Decision|82|||
23543726|NCT00856583|65719922|FG000|Overall Study|Pregnancy|14|||
23543727|NCT00856583|65719923|FG001|Overall Study|Pregnancy|5|||
23543728|NCT00856583|65719922|FG000|Overall Study|Other|92|||
23543729|NCT00856583|65719923|FG001|Overall Study|Other|104|||
23543730|NCT00856583|65719922|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
23543731|NCT00856583|65719923|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
23543732|NCT04408469|65719929|FG000|Overall Study|Lost to Follow-up|6|||
23543733|NCT04408469|65719930|FG001|Overall Study|Lost to Follow-up|9|||
23543734|NCT04408469|65719929|FG000|Overall Study|Withdrawal by Subject|6|||
23543735|NCT04408469|65719930|FG001|Overall Study|Withdrawal by Subject|1|||
23543736|NCT04408469|65719929|FG000|Overall Study|Dismissal due to ineligibility|0|||
23543737|NCT04408469|65719930|FG001|Overall Study|Dismissal due to ineligibility|1|||
23543738|NCT02345512|65719938|FG000|Overall Study|Adverse Event|1|||
23543739|NCT02345512|65719938|FG000|Overall Study|Withdrawal by Subject|1|||
23617074|NCT01379521|65985058|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
23211299|NCT01283997|64512438|FG001|Overall Study|Other|4|||
23211300|NCT03371732|64512439|FG000|Overall Study|Withdrawal by Subject|9|||
23211301|NCT03371732|64512440|FG001|Overall Study|Withdrawal by Subject|3|||
23543740|NCT01592708|65719939|FG000|Overall Study|Protocol Violation|3|||
23211302|NCT03371732|64512439|FG000|Overall Study|Refusal to continue|3|||
23123853|NCT01519778|64204897|FG000|Overall Study|Withdrawal by Subject|3|||
23211303|NCT03371732|64512440|FG001|Overall Study|Refusal to continue|4|||
23211304|NCT00282568|64512446|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
23543741|NCT01592708|65719940|FG001|Overall Study|Protocol Violation|0|||
23543742|NCT00856856|65719944|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
23543743|NCT00856856|65719944|FG000|4-year Clinical Follow-up|Missed visit|1|||
23582204|NCT01094171|65862382|FG000|Overall Study|Informed consent withdrawal|4|||
23123854|NCT01519778|64204897|FG000|Overall Study|Lost to Follow-up|10|||
23543744|NCT02039505|65719945|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
23543745|NCT02039505|65719946|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
23543746|NCT02039505|65719947|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
23543747|NCT02039505|65719948|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
23543748|NCT02039505|65719949|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
23543749|NCT02039505|65719950|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
23543750|NCT02039505|65719951|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
23543751|NCT02039505|65719945|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
23543752|NCT02039505|65719946|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
23617075|NCT01379521|65985059|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
23617076|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
23617077|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
23543753|NCT02039505|65719947|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
23543754|NCT02039505|65719948|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
23543755|NCT02039505|65719949|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
23543756|NCT02039505|65719950|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
23543757|NCT02039505|65719951|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
23543758|NCT02039505|65719945|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
23543759|NCT02039505|65719946|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543760|NCT02039505|65719947|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543761|NCT02039505|65719948|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543762|NCT02039505|65719949|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543763|NCT02039505|65719950|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543764|NCT02039505|65719951|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
23543765|NCT02039505|65719945|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
23543766|NCT02039505|65719946|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
23543767|NCT02039505|65719947|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
23543768|NCT02039505|65719948|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
23543769|NCT02039505|65719949|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
23543770|NCT02039505|65719950|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
23543771|NCT02039505|65719951|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
23543772|NCT02039505|65719945|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
23543773|NCT02039505|65719946|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
23543774|NCT02039505|65719947|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
23543775|NCT02039505|65719948|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
23543776|NCT02039505|65719949|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
23543777|NCT02039505|65719950|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
23543778|NCT02039505|65719951|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
23543779|NCT02039505|65719945|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
23543780|NCT02039505|65719946|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
23543781|NCT02039505|65719947|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
23543782|NCT02039505|65719948|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
23543783|NCT02039505|65719949|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
23543784|NCT02039505|65719950|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
23543785|NCT02039505|65719951|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
23543786|NCT02039505|65719945|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543787|NCT02039505|65719946|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543788|NCT02039505|65719947|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543789|NCT02039505|65719948|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
23543790|NCT02039505|65719949|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543791|NCT02039505|65719950|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543792|NCT02039505|65719951|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
23543793|NCT02039505|65719945|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23543794|NCT02039505|65719946|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23617078|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
23617079|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
23617080|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
23617081|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
23617082|NCT01379521|65985058|FG000|Overall Study -Treatment Period|Death|2|||
23617083|NCT01379521|65985059|FG001|Overall Study -Treatment Period|Death|1|||
23617084|NCT01379521|65985058|FG000|Post-Treatment Evaluations|Disease Progression|22|||
23617085|NCT01379521|65985059|FG001|Post-Treatment Evaluations|Disease Progression|20|||
23617086|NCT01379521|65985058|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
23617087|NCT01379521|65985059|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
23123855|NCT01519778|64204897|FG000|Overall Study|Physician Decision|1|||
23123858|NCT00307047|64204900|FG000|Overall Study|Lost to Follow-up|35|||
23123859|NCT00307047|64204901|FG001|Overall Study|Lost to Follow-up|24|||
23123860|NCT00307047|64204900|FG000|Overall Study|Withdrawal by Subject|6|||
23123861|NCT00307047|64204901|FG001|Overall Study|Withdrawal by Subject|6|||
23123862|NCT00307047|64204900|FG000|Overall Study|Physician Decision|1|||
23123863|NCT00307047|64204901|FG001|Overall Study|Physician Decision|2|||
23123864|NCT00307047|64204900|FG000|Overall Study|Lost to follow-up for other reasons|0|||
23123865|NCT00307047|64204901|FG001|Overall Study|Lost to follow-up for other reasons|1|||
23123866|NCT00307047|64204900|FG000|Overall Study|All death, all MI, all Revascularization|27|||
23123867|NCT00307047|64204901|FG001|Overall Study|All death, all MI, all Revascularization|16|||
23543795|NCT02039505|65719947|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23211305|NCT00282568|64512446|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
23211306|NCT00282568|64512446|FG000|Extended Treatment Period|Adverse Event|17|||
23211307|NCT00282568|64512446|FG000|Extended Treatment Period|Non-compliance|4|||
23543796|NCT02039505|65719948|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23543797|NCT02039505|65719949|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23543798|NCT02039505|65719950|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
23543799|NCT02039505|65719951|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
23543800|NCT02039505|65719945|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543801|NCT02039505|65719946|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543802|NCT02039505|65719947|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543803|NCT02039505|65719948|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543804|NCT02039505|65719949|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23617088|NCT01379521|65985058|FG000|Post-Treatment Evaluations|Death|1|||
23617089|NCT01379521|65985059|FG001|Post-Treatment Evaluations|Death|0|||
23617090|NCT00428441|65985060|FG000|Overall Study|Lost to Follow-up|1|||
23617091|NCT02785900|65985067|FG000|Overall Study|Study Termination by Sponsor|64|||
23617092|NCT02785900|65985068|FG001|Overall Study|Study Termination by Sponsor|81|||
23617093|NCT02785900|65985067|FG000|Overall Study|Death|46|||
23617094|NCT02785900|65985068|FG001|Overall Study|Death|32|||
23617095|NCT02785900|65985067|FG000|Overall Study|Withdrawal by Subject|4|||
23543805|NCT02039505|65719950|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
23543806|NCT02039505|65719951|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
23543807|NCT02039505|65719945|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543808|NCT02039505|65719946|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543809|NCT02039505|65719947|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543810|NCT02039505|65719948|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543811|NCT02039505|65719949|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543812|NCT02039505|65719950|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
23543813|NCT02039505|65719951|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
23543814|NCT02039505|65719945|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543815|NCT02039505|65719946|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543816|NCT02039505|65719947|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543817|NCT02039505|65719948|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543818|NCT02039505|65719949|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23543819|NCT02039505|65719950|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
23617096|NCT02785900|65985068|FG001|Overall Study|Withdrawal by Subject|8|||
23617097|NCT02785900|65985067|FG000|Overall Study|Physician Decision|3|||
23617098|NCT02785900|65985068|FG001|Overall Study|Physician Decision|2|||
23617099|NCT03036124|65985069|FG000|Overall Study|Lost to Follow-up|0|||
23617100|NCT03036124|65985070|FG001|Overall Study|Lost to Follow-up|2|||
23211308|NCT00282568|64512446|FG000|Extended Treatment Period|Physician Decision|1|||
23211309|NCT00282568|64512446|FG000|Extended Treatment Period|Lost to Follow-up|2|||
23314490|NCT03340974|64895321|FG002|Completion of Study -Long Term Follow up|Death|5|||
23314491|NCT03340974|64895322|FG003|Completion of Study -Long Term Follow up|Death|7|||
23617101|NCT03036124|65985069|FG000|Overall Study|Withdrawal by Subject|5|||
23617102|NCT03036124|65985070|FG001|Overall Study|Withdrawal by Subject|4|||
23617103|NCT01107353|65985071|FG000|Overall Study|Positive Drug Screen|1|||
23617104|NCT01107353|65985072|FG001|Overall Study|Positive Drug Screen|0|||
23617105|NCT01129115|65985073|FG000|Overall Study|Adverse Event|1|||
23617106|NCT01129115|65985074|FG001|Overall Study|Adverse Event|2|||
23617107|NCT01129115|65985075|FG002|Overall Study|Adverse Event|3|||
23617108|NCT01129115|65985076|FG003|Overall Study|Adverse Event|3|||
23617109|NCT01129115|65985073|FG000|Overall Study|Withdrawal by Subject|1|||
23617110|NCT01129115|65985074|FG001|Overall Study|Withdrawal by Subject|3|||
23617111|NCT01129115|65985075|FG002|Overall Study|Withdrawal by Subject|1|||
23617112|NCT01129115|65985076|FG003|Overall Study|Withdrawal by Subject|4|||
23617113|NCT01129115|65985073|FG000|Overall Study|Protocol Violation|0|||
23617114|NCT01129115|65985074|FG001|Overall Study|Protocol Violation|2|||
23617115|NCT01129115|65985075|FG002|Overall Study|Protocol Violation|2|||
23617116|NCT01129115|65985076|FG003|Overall Study|Protocol Violation|2|||
23617117|NCT03738397|65985077|FG000|Overall Study|Adverse Event|3|||
23617118|NCT03738397|65985078|FG001|Overall Study|Adverse Event|7|||
23617119|NCT03738397|65985077|FG000|Overall Study|Withdrawal by Subject|8|||
23617120|NCT03738397|65985078|FG001|Overall Study|Withdrawal by Subject|11|||
23617121|NCT03738397|65985077|FG000|Overall Study|Lost to Follow-up|7|||
23617122|NCT03738397|65985078|FG001|Overall Study|Lost to Follow-up|5|||
23617123|NCT03738397|65985077|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
23617124|NCT03738397|65985078|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
23617125|NCT03738397|65985077|FG000|Overall Study|Other|4|||
23617126|NCT03738397|65985078|FG001|Overall Study|Other|6|||
23617127|NCT01369147|65985082|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
23617128|NCT01369147|65985083|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
23617129|NCT01369147|65985084|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
23617130|NCT00990821|65985085|FG000|Overall Study|Withdrawal by Subject|0|||
23617131|NCT00990821|65985086|FG001|Overall Study|Withdrawal by Subject|2|||
23617132|NCT00990821|65985087|FG002|Overall Study|Withdrawal by Subject|0|||
23617133|NCT00990821|65985088|FG003|Overall Study|Withdrawal by Subject|0|||
23617134|NCT00990821|65985089|FG004|Overall Study|Withdrawal by Subject|3|||
23617135|NCT00990821|65985090|FG005|Overall Study|Withdrawal by Subject|3|||
23617136|NCT00990821|65985091|FG006|Overall Study|Withdrawal by Subject|1|||
23617137|NCT00990821|65985092|FG007|Overall Study|Withdrawal by Subject|0|||
23617138|NCT00990821|65985093|FG008|Overall Study|Withdrawal by Subject|0|||
23617139|NCT00990821|65985094|FG009|Overall Study|Withdrawal by Subject|1|||
23617140|NCT00990821|65985095|FG010|Overall Study|Withdrawal by Subject|3|||
23617141|NCT00990821|65985096|FG011|Overall Study|Withdrawal by Subject|5|||
23617142|NCT00990821|65985097|FG012|Overall Study|Withdrawal by Subject|2|||
23617143|NCT00990821|65985098|FG013|Overall Study|Withdrawal by Subject|1|||
23617144|NCT02392429|65985099|FG000|Screening|Screen failure|15|||
23617145|NCT02392429|65985099|FG000|Enrolled Participants|Ineligible due to disease|3|||
23617146|NCT02392429|65985099|FG000|Enrolled Participants|Withdrawal by Subject|4|||
23617147|NCT02392429|65985099|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
23617148|NCT02392429|65985099|FG000|Evaluable|Death|5|||
23617149|NCT02392429|65985099|FG000|Evaluable|Withdrawal by Subject|1|||
23617150|NCT02392429|65985099|FG000|Evaluable|Adverse Event|1|||
23617151|NCT02392429|65985099|FG000|Evaluable|remission bone marrow biopsy|3|||
23617152|NCT05878990|65985100|FG000|Overall Study|Lost to Follow-up|7|||
23617153|NCT05878990|65985100|FG000|Overall Study|Withdrawal by Subject|1|||
23617154|NCT01321073|65985101|FG000|Overall Study|Did not attempt implant|4|||
23617155|NCT01321073|65985101|FG000|Overall Study|Death|3|||
23543820|NCT02039505|65719951|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
23543821|NCT03058679|65719952|FG000|Baseline to Week 6|Lost to Follow-up|3|||
23543822|NCT03058679|65719953|FG001|Baseline to Week 6|Lost to Follow-up|2|||
23543823|NCT03058679|65719952|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
23543824|NCT03058679|65719953|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
23543825|NCT03058679|65719952|FG000|Baseline to Week 6|Adverse Event|6|||
23543826|NCT03058679|65719953|FG001|Baseline to Week 6|Adverse Event|6|||
23543827|NCT03058679|65719952|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
23543828|NCT03058679|65719953|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
23543829|NCT03058679|65719952|FG000|Baseline to Week 6|Difficulty following the diet|0|||
23543830|NCT03058679|65719953|FG001|Baseline to Week 6|Difficulty following the diet|2|||
23543831|NCT03058679|65719952|FG000|Baseline to Week 6|Physician Decision|1|||
23543832|NCT03058679|65719953|FG001|Baseline to Week 6|Physician Decision|0|||
23543833|NCT03058679|65719952|FG000|Week 6 to Week 12|Change in medication|5|||
23543834|NCT03058679|65719953|FG001|Week 6 to Week 12|Change in medication|7|||
23543835|NCT03058679|65719952|FG000|Week 6 to Week 12|Adverse Event|4|||
23543836|NCT03058679|65719953|FG001|Week 6 to Week 12|Adverse Event|3|||
23543837|NCT03058679|65719952|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
23543838|NCT03058679|65719953|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
23543839|NCT03058679|65719952|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
23543840|NCT03058679|65719953|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
23543841|NCT00618514|65719954|FG000|Overall Study|Lost to Follow-up|11|||
23543842|NCT00618514|65719955|FG001|Overall Study|Lost to Follow-up|12|||
23543843|NCT00618514|65719956|FG002|Overall Study|Lost to Follow-up|4|||
23543844|NCT00464542|65719959|FG000|Pre-treatment|Withdrawal by Subject|2|||
23543845|NCT02056301|65719960|FG000|Overall Study|Protocol Violation|1|||
23543846|NCT02056301|65719961|FG001|Overall Study|Protocol Violation|2|||
23543847|NCT02056301|65719960|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
23543848|NCT02056301|65719961|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
23543849|NCT02056301|65719960|FG000|Overall Study|Withdrawal by Subject|0|||
23543850|NCT02056301|65719961|FG001|Overall Study|Withdrawal by Subject|1|||
23543851|NCT02056301|65719960|FG000|Overall Study|Issues with epidural|0|||
23543852|NCT02056301|65719961|FG001|Overall Study|Issues with epidural|3|||
23543853|NCT05245864|65719964|FG000|Overall Study|Withdrawal by Subject|1|||
23543854|NCT05245864|65719965|FG001|Overall Study|Withdrawal by Subject|1|||
23543855|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
23543856|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
23543857|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
23543858|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
23543859|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Adverse Event|5|||
23543860|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Adverse Event|3|||
23543861|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Adverse Event|4|||
23543862|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Adverse Event|10|||
23543863|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
23543864|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
23543865|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
23543866|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
23543867|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
23425495|NCT03461406|65303329|FG000|Overall Study|Reason not Specified|1|||
23425496|NCT03461406|65303330|FG001|Overall Study|Reason not Specified|3|||
23425497|NCT03461406|65303329|FG000|Overall Study|Lost to Follow-up|3|||
23425498|NCT03461406|65303330|FG001|Overall Study|Lost to Follow-up|0|||
23425499|NCT03630302|65303331|FG000|Surgery|hardware issue prevented LFP recordings|1|||
23425500|NCT03630302|65303331|FG000|3 Month Visit|Adverse Event|2|||
23425501|NCT03630302|65303331|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
23425502|NCT00711113|65303335|FG000|Overall Study|Lost to Follow-up|9|||
23425503|NCT00711113|65303335|FG000|Overall Study|Implant lost|2|||
23425504|NCT00747344|65303336|FG000|Controlled Period|Adverse Event|3|||
23425505|NCT00747344|65303337|FG001|Controlled Period|Adverse Event|0|||
23425506|NCT00747344|65303338|FG002|Controlled Period|Adverse Event|0|||
23425507|NCT00747344|65303339|FG003|Controlled Period|Adverse Event|0|||
23425508|NCT00747344|65303336|FG000|Controlled Period|Lack of Efficacy|2|||
23425509|NCT00747344|65303337|FG001|Controlled Period|Lack of Efficacy|1|||
23425510|NCT00747344|65303338|FG002|Controlled Period|Lack of Efficacy|0|||
23425511|NCT00747344|65303339|FG003|Controlled Period|Lack of Efficacy|0|||
23425512|NCT00747344|65303336|FG000|Controlled Period|Other|0|||
23425513|NCT00747344|65303337|FG001|Controlled Period|Other|3|||
23425514|NCT00747344|65303338|FG002|Controlled Period|Other|0|||
23543868|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
23543869|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
23425515|NCT00747344|65303339|FG003|Controlled Period|Other|0|||
23425516|NCT00747344|65303336|FG000|After Controlled Period|Adverse Event|0|||
23124011|NCT01453023|64204977|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
23124012|NCT01453023|64204978|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
23124013|NCT01453023|64204977|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
23124014|NCT01453023|64204978|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
23124015|NCT01453023|64204977|FG000|Treatment Period 2|Protocol Violation|0|||
23124016|NCT01453023|64204978|FG001|Treatment Period 2|Protocol Violation|1|||
23124023|NCT00940875|64204988|FG000|Treatment Phase|Adverse Event|9|||
23124024|NCT00940875|64204989|FG001|Treatment Phase|Adverse Event|3|||
23124025|NCT00940875|64204988|FG000|Treatment Phase|Death|3|||
23124026|NCT00940875|64204989|FG001|Treatment Phase|Death|5|||
23124027|NCT00940875|64204988|FG000|Treatment Phase|Lack of Efficacy|1|||
23124028|NCT00940875|64204989|FG001|Treatment Phase|Lack of Efficacy|0|||
23124029|NCT00940875|64204988|FG000|Treatment Phase|Withdrawal by Subject|3|||
23124030|NCT00940875|64204989|FG001|Treatment Phase|Withdrawal by Subject|0|||
23124031|NCT00940875|64204988|FG000|Treatment Phase|Disease progression|9|||
23124032|NCT00940875|64204989|FG001|Treatment Phase|Disease progression|11|||
23124033|NCT00940875|64204988|FG000|Treatment Phase|Physician Decision|1|||
23124034|NCT00940875|64204989|FG001|Treatment Phase|Physician Decision|0|||
23124035|NCT00940875|64204988|FG000|Post-Study Treatment|Death|0|||
23425517|NCT00747344|65303337|FG001|After Controlled Period|Adverse Event|0|||
23543870|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
23543871|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Pregnancy|5|||
23543872|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Pregnancy|0|||
23543873|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Pregnancy|3|||
23543874|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Pregnancy|2|||
23543875|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Non-compliance|1|||
23543876|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Non-compliance|4|||
23124036|NCT00940875|64204989|FG001|Post-Study Treatment|Death|1|||
23124037|NCT00940875|64204988|FG000|Post-Study Treatment|Disease Progression|0|||
23124038|NCT00940875|64204989|FG001|Post-Study Treatment|Disease Progression|2|||
23425518|NCT00747344|65303338|FG002|After Controlled Period|Adverse Event|0|||
23425519|NCT00747344|65303339|FG003|After Controlled Period|Adverse Event|1|||
23425520|NCT01765426|65303340|FG000|Overall Study|Lost to Follow-up|0|||
23425521|NCT01765426|65303341|FG001|Overall Study|Lost to Follow-up|1|||
23425522|NCT01765426|65303342|FG002|Overall Study|Lost to Follow-up|0|||
23175841|NCT01554579|64386588|FG000|Overall Study|Lack of Efficacy|2|||
23543877|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Non-compliance|0|||
23124053|NCT01124097|64204992|FG000|Overall Study|Withdrawal by Subject|4|||
23124054|NCT01124097|64204993|FG001|Overall Study|Withdrawal by Subject|3|||
23124055|NCT01124097|64204994|FG002|Overall Study|Withdrawal by Subject|2|||
23124056|NCT01124097|64204995|FG003|Overall Study|Withdrawal by Subject|3|||
23124057|NCT01124097|64204992|FG000|Overall Study|Lack of Efficacy|2|||
23124058|NCT01124097|64204993|FG001|Overall Study|Lack of Efficacy|3|||
23124059|NCT01124097|64204994|FG002|Overall Study|Lack of Efficacy|1|||
23124060|NCT01124097|64204995|FG003|Overall Study|Lack of Efficacy|3|||
23124061|NCT01124097|64204992|FG000|Overall Study|Adverse Event|24|||
23124062|NCT01124097|64204993|FG001|Overall Study|Adverse Event|15|||
23124063|NCT01124097|64204994|FG002|Overall Study|Adverse Event|15|||
23124064|NCT01124097|64204995|FG003|Overall Study|Adverse Event|7|||
23124065|NCT01124097|64204992|FG000|Overall Study|Protocol Violation|2|||
23124066|NCT01124097|64204993|FG001|Overall Study|Protocol Violation|0|||
23124067|NCT01124097|64204994|FG002|Overall Study|Protocol Violation|2|||
23124068|NCT01124097|64204995|FG003|Overall Study|Protocol Violation|1|||
23124069|NCT01124097|64204992|FG000|Overall Study|Physician Decision|2|||
23124070|NCT01124097|64204993|FG001|Overall Study|Physician Decision|1|||
23124071|NCT01124097|64204994|FG002|Overall Study|Physician Decision|0|||
23617156|NCT05244226|65985102|FG000|Overall Study|Adverse Event|1|||
23617157|NCT05244226|65985103|FG001|Overall Study|Adverse Event|0|||
23617158|NCT05244226|65985104|FG002|Overall Study|Adverse Event|0|||
23617159|NCT05244226|65985102|FG000|Overall Study|Lost to Follow-up|0|||
23617160|NCT05244226|65985103|FG001|Overall Study|Lost to Follow-up|0|||
23617161|NCT05244226|65985104|FG002|Overall Study|Lost to Follow-up|1|||
23617162|NCT05244226|65985102|FG000|Overall Study|Protocol Violation|0|||
23543878|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Non-compliance|3|||
23543879|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Other|0|||
23543880|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Other|3|||
23543881|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Other|3|||
23543882|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Other|1|||
23543883|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
23543884|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
23543885|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
23543886|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
23124072|NCT01124097|64204995|FG003|Overall Study|Physician Decision|0|||
23425523|NCT01765426|65303343|FG003|Overall Study|Lost to Follow-up|0|||
23425524|NCT03968159|65303344|FG000|Overall Study|Adverse Event|4|||
23124076|NCT01099917|64204999|FG000|Overall Study|Adverse Event|3|||
23124077|NCT01099917|64204999|FG000|Overall Study|Not Treated|24|||
23124082|NCT01077128|64205003|FG000|Overall Study|Adverse Event|8|||
23124083|NCT01077128|64205003|FG000|Overall Study|Lack of Efficacy|1|||
23124084|NCT01077128|64205003|FG000|Overall Study|Disease exacerbation|1|||
23124085|NCT01077128|64205003|FG000|Overall Study|Adverse event and consent withdrawal|1|||
23124086|NCT01077128|64205003|FG000|Overall Study|Adverse event and disease exacerbation|1|||
23124087|NCT01077128|64205003|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
23124088|NCT01077128|64205003|FG000|Overall Study|Other|54|||
23211310|NCT03803202|64512447|FG000|Overall Study|Other|0|||
23211311|NCT03803202|64512448|FG001|Overall Study|Other|1|||
23425525|NCT03968159|65303345|FG001|Overall Study|Adverse Event|4|||
23617163|NCT05244226|65985103|FG001|Overall Study|Protocol Violation|2|||
23617164|NCT05244226|65985104|FG002|Overall Study|Protocol Violation|2|||
23425526|NCT03968159|65303344|FG000|Overall Study|Lost to Follow-up|1|||
23617165|NCT00809783|65985106|FG000|Overall Study|Death|1|||
23617166|NCT00809783|65985107|FG001|Overall Study|Death|0|||
23617167|NCT00809783|65985108|FG002|Overall Study|Death|0|||
23617168|NCT00809783|65985106|FG000|Overall Study|Adverse Event|34|||
23617169|NCT00809783|65985107|FG001|Overall Study|Adverse Event|52|||
23617170|NCT00809783|65985108|FG002|Overall Study|Adverse Event|71|||
23617171|NCT00809783|65985106|FG000|Overall Study|Lack of Efficacy|39|||
23617172|NCT00809783|65985107|FG001|Overall Study|Lack of Efficacy|52|||
23617173|NCT00809783|65985108|FG002|Overall Study|Lack of Efficacy|63|||
23543887|NCT01760954|65719966|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
23543888|NCT01760954|65719967|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
23543889|NCT01760954|65719968|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
23543890|NCT01760954|65719969|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
23617174|NCT00809783|65985106|FG000|Overall Study|Lost to Follow-up|0|||
23617175|NCT00809783|65985107|FG001|Overall Study|Lost to Follow-up|3|||
23617176|NCT00809783|65985108|FG002|Overall Study|Lost to Follow-up|4|||
23617177|NCT00809783|65985106|FG000|Overall Study|Withdrawal by Subject|47|||
23543891|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
23543892|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
23543893|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
23543894|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
23314492|NCT03340974|64895319|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
23617178|NCT00809783|65985107|FG001|Overall Study|Withdrawal by Subject|72|||
23314493|NCT03340974|64895320|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
23314494|NCT03340974|64895321|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
23314495|NCT03340974|64895322|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
23314496|NCT03340974|64895319|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
23314497|NCT03340974|64895320|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
23314498|NCT03340974|64895321|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
23314499|NCT03340974|64895322|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
23314500|NCT03340974|64895319|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
23314501|NCT03340974|64895320|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
23314502|NCT03340974|64895321|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
23314503|NCT03340974|64895322|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
23314504|NCT04895982|64895327|FG000|Overall Study|Withdrawal by Subject|0|||
23314505|NCT04895982|64895328|FG001|Overall Study|Withdrawal by Subject|0|||
23314506|NCT04895982|64895329|FG002|Overall Study|Withdrawal by Subject|0|||
23314507|NCT04895982|64895330|FG003|Overall Study|Withdrawal by Subject|0|||
23314508|NCT04895982|64895331|FG004|Overall Study|Withdrawal by Subject|0|||
23314509|NCT04895982|64895332|FG005|Overall Study|Withdrawal by Subject|1|||
23314510|NCT04895982|64895333|FG006|Overall Study|Withdrawal by Subject|1|||
23314511|NCT04895982|64895334|FG007|Overall Study|Withdrawal by Subject|0|||
23314512|NCT04895982|64895335|FG008|Overall Study|Withdrawal by Subject|0|||
23314513|NCT04895982|64895336|FG009|Overall Study|Withdrawal by Subject|1|||
23314514|NCT04895982|64895337|FG010|Overall Study|Withdrawal by Subject|0|||
23314515|NCT04895982|64895338|FG011|Overall Study|Withdrawal by Subject|1|||
23543895|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
23543896|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
23314516|NCT04895982|64895327|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23314517|NCT04895982|64895328|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23314518|NCT04895982|64895329|FG002|Overall Study|Withdrawal by parent/guardian|3|||
23314519|NCT04895982|64895330|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23314520|NCT04895982|64895331|FG004|Overall Study|Withdrawal by parent/guardian|3|||
23314521|NCT04895982|64895332|FG005|Overall Study|Withdrawal by parent/guardian|2|||
23314522|NCT04895982|64895333|FG006|Overall Study|Withdrawal by parent/guardian|1|||
23425527|NCT03968159|65303345|FG001|Overall Study|Lost to Follow-up|1|||
23425528|NCT03968159|65303344|FG000|Overall Study|Use of prohibited medication|0|||
23425529|NCT03968159|65303345|FG001|Overall Study|Use of prohibited medication|1|||
23543897|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
23543898|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
23543899|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
23543900|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
23617179|NCT00809783|65985108|FG002|Overall Study|Withdrawal by Subject|64|||
23314523|NCT04895982|64895334|FG007|Overall Study|Withdrawal by parent/guardian|0|||
23314524|NCT04895982|64895335|FG008|Overall Study|Withdrawal by parent/guardian|3|||
23425530|NCT03968159|65303344|FG000|Overall Study|Protocol Violation|2|||
23617180|NCT00809783|65985106|FG000|Overall Study|Protocol Violation|2|||
23617181|NCT00809783|65985107|FG001|Overall Study|Protocol Violation|6|||
23617182|NCT00809783|65985108|FG002|Overall Study|Protocol Violation|5|||
23617183|NCT00809783|65985106|FG000|Overall Study|Randomized, but not treated|3|||
23617184|NCT00809783|65985107|FG001|Overall Study|Randomized, but not treated|0|||
23617185|NCT00809783|65985108|FG002|Overall Study|Randomized, but not treated|2|||
23617186|NCT00809783|65985106|FG000|Overall Study|Study Terminated by Sponsor|378|||
23617187|NCT00809783|65985107|FG001|Overall Study|Study Terminated by Sponsor|626|||
23617188|NCT00809783|65985108|FG002|Overall Study|Study Terminated by Sponsor|565|||
23617189|NCT00809783|65985106|FG000|Overall Study|Other|21|||
23617190|NCT00809783|65985107|FG001|Overall Study|Other|21|||
23617191|NCT00809783|65985108|FG002|Overall Study|Other|16|||
23617192|NCT01797705|65985109|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
23617193|NCT01797705|65985109|FG000|Overall Study|Withdrawal by Subject|1|||
23314525|NCT04895982|64895336|FG009|Overall Study|Withdrawal by parent/guardian|0|||
23314526|NCT04895982|64895337|FG010|Overall Study|Withdrawal by parent/guardian|0|||
23314527|NCT04895982|64895338|FG011|Overall Study|Withdrawal by parent/guardian|0|||
23314528|NCT04895982|64895327|FG000|Overall Study|Other|0|||
23314529|NCT04895982|64895328|FG001|Overall Study|Other|0|||
23314530|NCT04895982|64895329|FG002|Overall Study|Other|1|||
23314531|NCT04895982|64895330|FG003|Overall Study|Other|1|||
23314532|NCT04895982|64895331|FG004|Overall Study|Other|0|||
23124133|NCT02366143|64205024|FG000|Overall Study|Death|307|||
23124134|NCT02366143|64205025|FG001|Overall Study|Death|278|||
23124135|NCT02366143|64205026|FG002|Overall Study|Death|280|||
23124136|NCT02366143|64205024|FG000|Overall Study|Lost to Follow-up|2|||
23124137|NCT02366143|64205025|FG001|Overall Study|Lost to Follow-up|4|||
23124138|NCT02366143|64205026|FG002|Overall Study|Lost to Follow-up|2|||
23124139|NCT02366143|64205024|FG000|Overall Study|Physician Decision|1|||
23124140|NCT02366143|64205025|FG001|Overall Study|Physician Decision|2|||
23314533|NCT04895982|64895332|FG005|Overall Study|Other|0|||
23425531|NCT03968159|65303345|FG001|Overall Study|Protocol Violation|2|||
23124141|NCT02366143|64205026|FG002|Overall Study|Physician Decision|1|||
23124142|NCT02366143|64205024|FG000|Overall Study|Protocol Violation|0|||
23124143|NCT02366143|64205025|FG001|Overall Study|Protocol Violation|0|||
23124144|NCT02366143|64205026|FG002|Overall Study|Protocol Violation|2|||
23314534|NCT04895982|64895333|FG006|Overall Study|Other|0|||
23617194|NCT02025985|65985110|FG000|Overall Study|Consent withdrawn|0|||
23617195|NCT02025985|65985111|FG001|Overall Study|Consent withdrawn|0|||
23124145|NCT02366143|64205024|FG000|Overall Study|Withdrawal by Subject|16|||
23124146|NCT02366143|64205025|FG001|Overall Study|Withdrawal by Subject|17|||
23124147|NCT02366143|64205026|FG002|Overall Study|Withdrawal by Subject|22|||
23124148|NCT02366143|64205024|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
23124149|NCT02366143|64205025|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
23124150|NCT02366143|64205026|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
23314535|NCT04895982|64895334|FG007|Overall Study|Other|0|||
23124151|NCT02366143|64205024|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
23124152|NCT02366143|64205025|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
23124153|NCT02366143|64205026|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
23124154|NCT02366143|64205024|FG000|Overall Study|Randomization Error|1|||
23124155|NCT02366143|64205025|FG001|Overall Study|Randomization Error|0|||
23124156|NCT02366143|64205026|FG002|Overall Study|Randomization Error|0|||
23124157|NCT02366143|64205024|FG000|Overall Study|PI Move and Site Closure|1|||
23124158|NCT02366143|64205025|FG001|Overall Study|PI Move and Site Closure|0|||
23124159|NCT02366143|64205026|FG002|Overall Study|PI Move and Site Closure|1|||
23124160|NCT02366143|64205024|FG000|Overall Study|Study Terminated By Sponsor|0|||
23124161|NCT02366143|64205025|FG001|Overall Study|Study Terminated By Sponsor|0|||
23124162|NCT02366143|64205026|FG002|Overall Study|Study Terminated By Sponsor|2|||
23124163|NCT02366143|64205024|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
23124164|NCT02366143|64205025|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
23124165|NCT02366143|64205026|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
23124166|NCT02366143|64205024|FG000|Overall Study|Patient moved to roll-over study|1|||
23124167|NCT02366143|64205025|FG001|Overall Study|Patient moved to roll-over study|19|||
23124168|NCT02366143|64205026|FG002|Overall Study|Patient moved to roll-over study|28|||
23124169|NCT02366143|64205024|FG000|Overall Study|Patient moved to commercial stock|0|||
23124170|NCT02366143|64205025|FG001|Overall Study|Patient moved to commercial stock|0|||
23124171|NCT02366143|64205026|FG002|Overall Study|Patient moved to commercial stock|1|||
23124172|NCT02366143|64205024|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
23124173|NCT02366143|64205025|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
23124174|NCT02366143|64205026|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
23124175|NCT02366143|64205024|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
23124176|NCT02366143|64205025|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
23124177|NCT02366143|64205026|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
23124178|NCT02366143|64205024|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
23124179|NCT02366143|64205025|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
23124180|NCT02366143|64205026|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
23124181|NCT02366143|64205024|FG000|Overall Study|Requester's instructions|1|||
23124182|NCT02366143|64205025|FG001|Overall Study|Requester's instructions|1|||
23124183|NCT02366143|64205026|FG002|Overall Study|Requester's instructions|1|||
23124184|NCT02366143|64205024|FG000|Overall Study|Uneligible|0|||
23124185|NCT02366143|64205025|FG001|Overall Study|Uneligible|1|||
23124186|NCT02366143|64205026|FG002|Overall Study|Uneligible|0|||
23124187|NCT02366143|64205024|FG000|Overall Study|Post Trial Migration|0|||
23124188|NCT02366143|64205025|FG001|Overall Study|Post Trial Migration|1|||
23124189|NCT02366143|64205026|FG002|Overall Study|Post Trial Migration|0|||
23124190|NCT02366143|64205024|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
23124191|NCT02366143|64205025|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
23124192|NCT02366143|64205026|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
23124193|NCT02366143|64205024|FG000|Overall Study|Patient switched to PTAP|0|||
23124194|NCT02366143|64205025|FG001|Overall Study|Patient switched to PTAP|1|||
23124195|NCT02366143|64205026|FG002|Overall Study|Patient switched to PTAP|0|||
23124196|NCT02366143|64205024|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
23124197|NCT02366143|64205025|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
23124198|NCT02366143|64205026|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
23124199|NCT04210843|64205031|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
23124200|NCT04210843|64205032|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
23124201|NCT04210843|64205031|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
23211312|NCT03803202|64512449|FG002|Overall Study|Other|0|||
23211313|NCT03803202|64512450|FG003|Overall Study|Other|0|||
23211314|NCT03803202|64512451|FG004|Overall Study|Other|0|||
23211315|NCT03803202|64512452|FG005|Overall Study|Other|0|||
23124202|NCT04210843|64205032|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
23124203|NCT04210843|64205031|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
23124204|NCT04210843|64205032|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
23124205|NCT04210843|64205031|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
23211316|NCT03803202|64512453|FG006|Overall Study|Other|0|||
23617196|NCT02025985|65985112|FG002|Overall Study|Consent withdrawn|1|||
23617197|NCT02025985|65985113|FG003|Overall Study|Consent withdrawn|0|||
23617198|NCT02025985|65985114|FG004|Overall Study|Consent withdrawn|0|||
23617199|NCT02025985|65985110|FG000|Overall Study|Termination of study by Sponsor|4|||
23211317|NCT03803202|64512454|FG007|Overall Study|Other|0|||
23211318|NCT03803202|64512455|FG008|Overall Study|Other|0|||
23211319|NCT03803202|64512447|FG000|Overall Study|Death|0|||
23211320|NCT03803202|64512448|FG001|Overall Study|Death|0|||
23124206|NCT04210843|64205032|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
23124207|NCT04210843|64205031|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
23124208|NCT04210843|64205032|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
23124209|NCT04210843|64205031|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
23124210|NCT04210843|64205032|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
23124211|NCT04210843|64205031|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
23124212|NCT04210843|64205032|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
23124213|NCT04210843|64205031|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
23124214|NCT04210843|64205032|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
23124215|NCT04210843|64205031|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
23124216|NCT04210843|64205032|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
23124217|NCT04210843|64205031|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
23543901|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
23543902|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
23543903|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
23124218|NCT04210843|64205032|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
23124219|NCT04210843|64205031|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
23124220|NCT04210843|64205032|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
23124221|NCT04210843|64205031|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
23124222|NCT04210843|64205032|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
23124223|NCT04210843|64205031|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
23543904|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
23543905|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
23543906|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
23543907|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
23543908|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
23543909|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
23543910|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
23543911|NCT01760954|65719966|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
23543912|NCT01760954|65719967|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
23543913|NCT01760954|65719968|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
23543914|NCT01760954|65719969|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
23543915|NCT02493361|65719970|FG000|Overall Study|Withdrawal by Subject|3|||
23543916|NCT01045447|65719971|FG000|Overall Study|Adverse Event|0|||
23543917|NCT01045447|65719972|FG001|Overall Study|Adverse Event|1|||
23543918|NCT01045447|65719971|FG000|Overall Study|Lack of Efficacy|3|||
23543919|NCT01045447|65719972|FG001|Overall Study|Lack of Efficacy|1|||
23543920|NCT01045447|65719971|FG000|Overall Study|Protocol Violation|6|||
23543921|NCT01045447|65719972|FG001|Overall Study|Protocol Violation|3|||
23543922|NCT01045447|65719971|FG000|Overall Study|Withdrawal Criteria|10|||
23543923|NCT01045447|65719972|FG001|Overall Study|Withdrawal Criteria|10|||
23617200|NCT02025985|65985111|FG001|Overall Study|Termination of study by Sponsor|3|||
23617201|NCT02025985|65985112|FG002|Overall Study|Termination of study by Sponsor|1|||
23617202|NCT02025985|65985113|FG003|Overall Study|Termination of study by Sponsor|1|||
23617203|NCT02025985|65985114|FG004|Overall Study|Termination of study by Sponsor|3|||
23617204|NCT02025985|65985110|FG000|Overall Study|Death|21|||
23617205|NCT02025985|65985111|FG001|Overall Study|Death|20|||
23617206|NCT02025985|65985112|FG002|Overall Study|Death|23|||
23617207|NCT02025985|65985113|FG003|Overall Study|Death|20|||
23617208|NCT02025985|65985114|FG004|Overall Study|Death|17|||
23617209|NCT02998918|65985115|FG000|Overall Study|Withdrawal by Subject|1|||
23617210|NCT02998918|65985116|FG001|Overall Study|Withdrawal by Subject|0|||
23617211|NCT04872101|65985117|FG000|Overall Study|Withdrawal by Subject|10|||
23617212|NCT04872101|65985118|FG001|Overall Study|Withdrawal by Subject|16|||
23617213|NCT04872101|65985117|FG000|Overall Study|Lack of Efficacy|6|||
23617214|NCT04872101|65985118|FG001|Overall Study|Lack of Efficacy|14|||
23617215|NCT04872101|65985117|FG000|Overall Study|Adverse Event|1|||
23617216|NCT04872101|65985118|FG001|Overall Study|Adverse Event|6|||
23617217|NCT04872101|65985117|FG000|Overall Study|Lost to Follow-up|2|||
23617218|NCT04872101|65985118|FG001|Overall Study|Lost to Follow-up|1|||
23617219|NCT04872101|65985117|FG000|Overall Study|Pregnancy|2|||
23617220|NCT04872101|65985118|FG001|Overall Study|Pregnancy|0|||
23617221|NCT04872101|65985117|FG000|Overall Study|Prohibited Medication|1|||
23617222|NCT04872101|65985118|FG001|Overall Study|Prohibited Medication|0|||
23617223|NCT04872101|65985117|FG000|Overall Study|Not dosed|1|||
23617224|NCT04872101|65985118|FG001|Overall Study|Not dosed|0|||
23211321|NCT03803202|64512449|FG002|Overall Study|Death|0|||
23617225|NCT01363297|65985122|FG000|Overall Study|Other|0|||
23617226|NCT01363297|65985123|FG001|Overall Study|Other|0|||
23617227|NCT01363297|65985124|FG002|Overall Study|Other|0|||
23617228|NCT01363297|65985125|FG003|Overall Study|Other|0|||
23617229|NCT01363297|65985126|FG004|Overall Study|Other|1|||
23124224|NCT04210843|64205032|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
23124225|NCT04210843|64205031|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
23124226|NCT04210843|64205032|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
23124227|NCT04210843|64205031|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
23124228|NCT04210843|64205032|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
23124229|NCT04210843|64205031|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
23124230|NCT04210843|64205032|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
23124231|NCT04210843|64205031|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
23124232|NCT04210843|64205032|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
23124233|NCT04210843|64205031|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
23124234|NCT04210843|64205032|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
23124235|NCT04210843|64205031|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
23124236|NCT04210843|64205032|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
23124237|NCT04210843|64205031|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
23124238|NCT04210843|64205032|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
23124239|NCT04210843|64205031|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
23124240|NCT04210843|64205032|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
23124241|NCT04210843|64205031|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
23124242|NCT04210843|64205032|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
23124243|NCT04210843|64205031|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
23124244|NCT04210843|64205032|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
23124245|NCT04210843|64205031|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
23425532|NCT03968159|65303344|FG000|Overall Study|Withdrawal by Subject|4|||
23425533|NCT03968159|65303345|FG001|Overall Study|Withdrawal by Subject|6|||
23425534|NCT03968159|65303344|FG000|Overall Study|Lack of Efficacy|0|||
23425535|NCT03968159|65303345|FG001|Overall Study|Lack of Efficacy|1|||
23425536|NCT03968159|65303344|FG000|Overall Study|Not further specified|2|||
23425537|NCT03968159|65303345|FG001|Overall Study|Not further specified|0|||
23425538|NCT02608450|65303346|FG000|Overall Study|Lost to Follow-up|39|||
23425539|NCT02608450|65303347|FG001|Overall Study|Lost to Follow-up|32|||
23425540|NCT02608450|65303346|FG000|Overall Study|Withdrawal by Subject|21|||
23425541|NCT02608450|65303347|FG001|Overall Study|Withdrawal by Subject|15|||
23425542|NCT02608450|65303346|FG000|Overall Study|Adverse Event|3|||
23425543|NCT02608450|65303347|FG001|Overall Study|Adverse Event|6|||
23425544|NCT02608450|65303346|FG000|Overall Study|Withdrawal by parent|2|||
23425545|NCT02608450|65303347|FG001|Overall Study|Withdrawal by parent|3|||
23425546|NCT02608450|65303346|FG000|Overall Study|Lack of Efficacy|0|||
23425547|NCT02608450|65303347|FG001|Overall Study|Lack of Efficacy|3|||
23425548|NCT02608450|65303346|FG000|Overall Study|Noncompliance with study drug|0|||
23425549|NCT02608450|65303347|FG001|Overall Study|Noncompliance with study drug|2|||
23425550|NCT02608450|65303346|FG000|Overall Study|Physician Decision|0|||
23425551|NCT02608450|65303347|FG001|Overall Study|Physician Decision|1|||
23425552|NCT02608450|65303346|FG000|Overall Study|Pregnancy|0|||
23425553|NCT02608450|65303347|FG001|Overall Study|Pregnancy|1|||
23425554|NCT02608450|65303346|FG000|Overall Study|Progressive disease|1|||
23425555|NCT02608450|65303347|FG001|Overall Study|Progressive disease|0|||
23425556|NCT02608450|65303346|FG000|Overall Study|Multiple reasons|0|||
23425557|NCT02608450|65303347|FG001|Overall Study|Multiple reasons|2|||
23425558|NCT00652899|65303348|FG000|Overall Study|Death|1|||
23124246|NCT04210843|64205032|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
23124247|NCT03080493|64205033|FG000|Overall Study|Did not provide NRS pain results|1|||
23124248|NCT03080493|64205034|FG001|Overall Study|Did not provide NRS pain results|0|||
23124249|NCT03080493|64205033|FG000|Overall Study|Adverse Event|0|||
23124250|NCT03080493|64205034|FG001|Overall Study|Adverse Event|1|||
23124251|NCT03080493|64205033|FG000|Overall Study|Randomization error (parity group)|0|||
23124252|NCT03080493|64205034|FG001|Overall Study|Randomization error (parity group)|1|||
23617230|NCT01363297|65985122|FG000|Overall Study|Death|3|||
23425559|NCT00652899|65303348|FG000|Overall Study|Treating physician decision|1|||
23425560|NCT02446418|65303349|FG000|Overall Study|Adverse Event|4|||
23425561|NCT02446418|65303350|FG001|Overall Study|Adverse Event|8|||
23617231|NCT01363297|65985123|FG001|Overall Study|Death|6|||
23425562|NCT02446418|65303349|FG000|Overall Study|Physician Decision|5|||
23425563|NCT02446418|65303350|FG001|Overall Study|Physician Decision|1|||
23425564|NCT02446418|65303349|FG000|Overall Study|Withdrawal by Subject|3|||
23314536|NCT04895982|64895335|FG008|Overall Study|Other|0|||
23314537|NCT04895982|64895336|FG009|Overall Study|Other|1|||
23314538|NCT04895982|64895337|FG010|Overall Study|Other|0|||
23314539|NCT04895982|64895338|FG011|Overall Study|Other|0|||
23617232|NCT01363297|65985124|FG002|Overall Study|Death|6|||
23617233|NCT01363297|65985125|FG003|Overall Study|Death|10|||
23617234|NCT01363297|65985126|FG004|Overall Study|Death|30|||
23617235|NCT02136797|65985130|FG000|Overall Study|Not Treated|8|||
23617236|NCT03184519|65985132|FG000|Overall Study|Lost to Follow-up|6|||
23617237|NCT03184519|65985132|FG000|Overall Study|Physician Decision|21|||
23617238|NCT02123797|65985134|FG000|Baseline Intervention|Death|9|||
23617239|NCT02123797|65985135|FG001|Baseline Intervention|Death|16|||
23617240|NCT02123797|65985136|FG002|Baseline Intervention|Death|0|||
23617241|NCT02123797|65985137|FG003|Baseline Intervention|Death|0|||
23617242|NCT02123797|65985138|FG004|Baseline Intervention|Death|0|||
23617243|NCT02123797|65985134|FG000|Baseline Intervention|Withdrawal by Subject|2|||
23617244|NCT02123797|65985135|FG001|Baseline Intervention|Withdrawal by Subject|8|||
23617245|NCT02123797|65985136|FG002|Baseline Intervention|Withdrawal by Subject|0|||
23617246|NCT02123797|65985137|FG003|Baseline Intervention|Withdrawal by Subject|0|||
23314540|NCT04895982|64895327|FG000|Overall Study|Protocol Violation|0|||
23314541|NCT04895982|64895328|FG001|Overall Study|Protocol Violation|0|||
23314542|NCT04895982|64895329|FG002|Overall Study|Protocol Violation|1|||
23314543|NCT04895982|64895330|FG003|Overall Study|Protocol Violation|1|||
23314544|NCT04895982|64895331|FG004|Overall Study|Protocol Violation|1|||
23314545|NCT04895982|64895332|FG005|Overall Study|Protocol Violation|0|||
23314546|NCT04895982|64895333|FG006|Overall Study|Protocol Violation|0|||
23314547|NCT04895982|64895334|FG007|Overall Study|Protocol Violation|1|||
23425565|NCT02446418|65303350|FG001|Overall Study|Withdrawal by Subject|3|||
23425566|NCT02446418|65303349|FG000|Overall Study|Lost to Follow-up|2|||
23425567|NCT02446418|65303350|FG001|Overall Study|Lost to Follow-up|2|||
23425568|NCT02446418|65303349|FG000|Overall Study|Protocol Violation|1|||
23425569|NCT02446418|65303350|FG001|Overall Study|Protocol Violation|2|||
23425570|NCT02446418|65303349|FG000|Overall Study|Lack of Efficacy|2|||
23425571|NCT02446418|65303350|FG001|Overall Study|Lack of Efficacy|0|||
23425572|NCT02446418|65303349|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
23617247|NCT02123797|65985138|FG004|Baseline Intervention|Withdrawal by Subject|0|||
23617248|NCT02123797|65985134|FG000|Baseline Intervention|Relocation|2|||
23314548|NCT04895982|64895335|FG008|Overall Study|Protocol Violation|0|||
23425573|NCT02446418|65303350|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
23425574|NCT00545532|65303351|FG000|Overall Study|Withdrawal by Subject|1|||
23211322|NCT03803202|64512450|FG003|Overall Study|Death|0|||
23617249|NCT02123797|65985135|FG001|Baseline Intervention|Relocation|0|||
23617250|NCT02123797|65985136|FG002|Baseline Intervention|Relocation|0|||
23617251|NCT02123797|65985137|FG003|Baseline Intervention|Relocation|0|||
23175842|NCT01554579|64386589|FG001|Overall Study|Lack of Efficacy|1|||
23314549|NCT04895982|64895336|FG009|Overall Study|Protocol Violation|0|||
23425575|NCT00545532|65303352|FG001|Overall Study|Withdrawal by Subject|3|||
23425576|NCT00545532|65303351|FG000|Overall Study|Lost to Follow-up|5|||
23425577|NCT00545532|65303352|FG001|Overall Study|Lost to Follow-up|6|||
23425578|NCT00545532|65303351|FG000|Overall Study|Death|0|||
23425579|NCT00545532|65303352|FG001|Overall Study|Death|1|||
23425580|NCT03294135|65303354|FG000|Overall Study|Serious Adverse Event|1|||
23425581|NCT03294135|65303355|FG001|Overall Study|Serious Adverse Event|0|||
23425582|NCT03294135|65303356|FG002|Overall Study|Serious Adverse Event|0|||
23425583|NCT03294135|65303354|FG000|Overall Study|Lost to Follow-up|1|||
23425584|NCT03294135|65303355|FG001|Overall Study|Lost to Follow-up|0|||
23425585|NCT03294135|65303356|FG002|Overall Study|Lost to Follow-up|1|||
23425586|NCT03294135|65303354|FG000|Overall Study|Withdrawal by Subject|0|||
23425587|NCT03294135|65303355|FG001|Overall Study|Withdrawal by Subject|0|||
23425588|NCT03294135|65303356|FG002|Overall Study|Withdrawal by Subject|1|||
23425589|NCT03294135|65303354|FG000|Overall Study|Other|2|||
23425590|NCT03294135|65303355|FG001|Overall Study|Other|0|||
23425591|NCT03294135|65303356|FG002|Overall Study|Other|0|||
23425592|NCT02761694|65303357|FG000|Overall Study|Lack of Efficacy|0|||
23425593|NCT02761694|65303358|FG001|Overall Study|Lack of Efficacy|0|||
23425594|NCT02761694|65303359|FG002|Overall Study|Lack of Efficacy|0|||
23425595|NCT02761694|65303360|FG003|Overall Study|Lack of Efficacy|0|||
23425596|NCT02761694|65303361|FG004|Overall Study|Lack of Efficacy|0|||
23425597|NCT02761694|65303362|FG005|Overall Study|Lack of Efficacy|0|||
23425598|NCT02761694|65303363|FG006|Overall Study|Lack of Efficacy|6|||
23425599|NCT02761694|65303364|FG007|Overall Study|Lack of Efficacy|0|||
23425600|NCT02761694|65303365|FG008|Overall Study|Lack of Efficacy|0|||
23425601|NCT02761694|65303366|FG009|Overall Study|Lack of Efficacy|1|||
23425602|NCT02761694|65303367|FG010|Overall Study|Lack of Efficacy|1|||
23425603|NCT02761694|65303368|FG011|Overall Study|Lack of Efficacy|4|||
23425604|NCT02761694|65303357|FG000|Overall Study|Death|0|||
23425605|NCT02761694|65303358|FG001|Overall Study|Death|0|||
23425606|NCT02761694|65303359|FG002|Overall Study|Death|0|||
23425607|NCT02761694|65303360|FG003|Overall Study|Death|0|||
23425608|NCT02761694|65303361|FG004|Overall Study|Death|0|||
23425609|NCT02761694|65303362|FG005|Overall Study|Death|0|||
23425610|NCT02761694|65303363|FG006|Overall Study|Death|2|||
23425611|NCT02761694|65303364|FG007|Overall Study|Death|0|||
23425612|NCT02761694|65303365|FG008|Overall Study|Death|2|||
23211323|NCT03803202|64512451|FG004|Overall Study|Death|0|||
23211324|NCT03803202|64512452|FG005|Overall Study|Death|1|||
23425613|NCT02761694|65303366|FG009|Overall Study|Death|2|||
23425614|NCT02761694|65303367|FG010|Overall Study|Death|1|||
23425615|NCT02761694|65303368|FG011|Overall Study|Death|0|||
23425616|NCT02761694|65303357|FG000|Overall Study|Physician Decision|0|||
23425617|NCT02761694|65303358|FG001|Overall Study|Physician Decision|0|||
23425618|NCT02761694|65303359|FG002|Overall Study|Physician Decision|0|||
23425619|NCT02761694|65303360|FG003|Overall Study|Physician Decision|0|||
23425620|NCT02761694|65303361|FG004|Overall Study|Physician Decision|0|||
23425621|NCT02761694|65303362|FG005|Overall Study|Physician Decision|0|||
23425622|NCT02761694|65303363|FG006|Overall Study|Physician Decision|1|||
23425623|NCT02761694|65303364|FG007|Overall Study|Physician Decision|0|||
23425624|NCT02761694|65303365|FG008|Overall Study|Physician Decision|0|||
23425625|NCT02761694|65303366|FG009|Overall Study|Physician Decision|0|||
23425626|NCT02761694|65303367|FG010|Overall Study|Physician Decision|0|||
23425627|NCT02761694|65303368|FG011|Overall Study|Physician Decision|0|||
23425628|NCT02761694|65303357|FG000|Overall Study|Withdrawal by Subject|0|||
23425629|NCT02761694|65303358|FG001|Overall Study|Withdrawal by Subject|0|||
23425630|NCT02761694|65303359|FG002|Overall Study|Withdrawal by Subject|0|||
23425631|NCT02761694|65303360|FG003|Overall Study|Withdrawal by Subject|1|||
23425632|NCT02761694|65303361|FG004|Overall Study|Withdrawal by Subject|0|||
23211325|NCT03803202|64512453|FG006|Overall Study|Death|0|||
23211326|NCT03803202|64512454|FG007|Overall Study|Death|0|||
23425633|NCT02761694|65303362|FG005|Overall Study|Withdrawal by Subject|0|||
23425634|NCT02761694|65303363|FG006|Overall Study|Withdrawal by Subject|4|||
23425635|NCT02761694|65303364|FG007|Overall Study|Withdrawal by Subject|0|||
23425636|NCT02761694|65303365|FG008|Overall Study|Withdrawal by Subject|2|||
23425637|NCT02761694|65303366|FG009|Overall Study|Withdrawal by Subject|1|||
23425638|NCT02761694|65303367|FG010|Overall Study|Withdrawal by Subject|0|||
23425639|NCT02761694|65303368|FG011|Overall Study|Withdrawal by Subject|0|||
23425640|NCT02761694|65303357|FG000|Overall Study|Lost to Follow-up|0|||
23425641|NCT02761694|65303358|FG001|Overall Study|Lost to Follow-up|0|||
23425642|NCT02761694|65303359|FG002|Overall Study|Lost to Follow-up|0|||
23425643|NCT02761694|65303360|FG003|Overall Study|Lost to Follow-up|0|||
23425644|NCT02761694|65303361|FG004|Overall Study|Lost to Follow-up|0|||
23425645|NCT02761694|65303362|FG005|Overall Study|Lost to Follow-up|0|||
23425646|NCT02761694|65303363|FG006|Overall Study|Lost to Follow-up|1|||
23425647|NCT02761694|65303364|FG007|Overall Study|Lost to Follow-up|0|||
23425648|NCT02761694|65303365|FG008|Overall Study|Lost to Follow-up|0|||
23425649|NCT02761694|65303366|FG009|Overall Study|Lost to Follow-up|0|||
23425650|NCT02761694|65303367|FG010|Overall Study|Lost to Follow-up|0|||
23425651|NCT02761694|65303368|FG011|Overall Study|Lost to Follow-up|1|||
23425652|NCT02761694|65303357|FG000|Overall Study|Adverse Event|0|||
23425653|NCT02761694|65303358|FG001|Overall Study|Adverse Event|0|||
23425654|NCT02761694|65303359|FG002|Overall Study|Adverse Event|0|||
23425655|NCT02761694|65303360|FG003|Overall Study|Adverse Event|0|||
23425656|NCT02761694|65303361|FG004|Overall Study|Adverse Event|0|||
23425657|NCT02761694|65303362|FG005|Overall Study|Adverse Event|0|||
23425658|NCT02761694|65303363|FG006|Overall Study|Adverse Event|1|||
23425659|NCT02761694|65303364|FG007|Overall Study|Adverse Event|0|||
23425660|NCT02761694|65303365|FG008|Overall Study|Adverse Event|1|||
23425661|NCT02761694|65303366|FG009|Overall Study|Adverse Event|0|||
23425662|NCT02761694|65303367|FG010|Overall Study|Adverse Event|0|||
23425663|NCT02761694|65303368|FG011|Overall Study|Adverse Event|1|||
23425664|NCT02761694|65303357|FG000|Overall Study|Other|4|||
23425665|NCT02761694|65303358|FG001|Overall Study|Other|4|||
23425666|NCT02761694|65303359|FG002|Overall Study|Other|1|||
23425667|NCT02761694|65303360|FG003|Overall Study|Other|2|||
23425668|NCT02761694|65303361|FG004|Overall Study|Other|3|||
23425669|NCT02761694|65303362|FG005|Overall Study|Other|3|||
23425670|NCT02761694|65303363|FG006|Overall Study|Other|18|||
23425671|NCT02761694|65303364|FG007|Overall Study|Other|8|||
23425672|NCT02761694|65303365|FG008|Overall Study|Other|0|||
23425673|NCT02761694|65303366|FG009|Overall Study|Other|1|||
23425674|NCT02761694|65303367|FG010|Overall Study|Other|1|||
23425675|NCT02761694|65303368|FG011|Overall Study|Other|0|||
23425676|NCT00260065|65303373|FG000|Overall Study|Progressive Disease|22|||
23425677|NCT00260065|65303373|FG000|Overall Study|Adverse Event|17|||
23211327|NCT03803202|64512455|FG008|Overall Study|Death|0|||
23211328|NCT03803202|64512447|FG000|Overall Study|Withdrawal by Subject|0|||
23425678|NCT00260065|65303373|FG000|Overall Study|Death|13|||
23425679|NCT00260065|65303373|FG000|Overall Study|Withdrawal by Subject|13|||
23425680|NCT00260065|65303373|FG000|Overall Study|Physician Decision|19|||
23425681|NCT00260065|65303373|FG000|Overall Study|Not otherwise specified|8|||
23425682|NCT00260065|65303373|FG000|Overall Study|Medication Noncompliance|1|||
23425683|NCT01444027|65303374|FG000|Overall Study|Withdrawal by Subject|4|||
23425684|NCT01444027|65303375|FG001|Overall Study|Withdrawal by Subject|10|||
23425685|NCT01444027|65303376|FG002|Overall Study|Withdrawal by Subject|24|||
23425686|NCT01444027|65303374|FG000|Overall Study|Lost to Follow-up|26|||
23425687|NCT01444027|65303375|FG001|Overall Study|Lost to Follow-up|20|||
23211329|NCT03803202|64512448|FG001|Overall Study|Withdrawal by Subject|0|||
23425688|NCT01444027|65303376|FG002|Overall Study|Lost to Follow-up|14|||
23425689|NCT00664560|65303380|FG000|Overall Study|Adverse Event|19|||
23425690|NCT00664560|65303381|FG001|Overall Study|Adverse Event|16|||
23425691|NCT00664560|65303382|FG002|Overall Study|Adverse Event|7|||
23425692|NCT00664560|65303380|FG000|Overall Study|Withdrawal by Subject|9|||
23425693|NCT00664560|65303381|FG001|Overall Study|Withdrawal by Subject|13|||
23425694|NCT00664560|65303382|FG002|Overall Study|Withdrawal by Subject|7|||
23425695|NCT00664560|65303380|FG000|Overall Study|Lost to Follow-up|0|||
23425696|NCT00664560|65303381|FG001|Overall Study|Lost to Follow-up|2|||
23425697|NCT00664560|65303382|FG002|Overall Study|Lost to Follow-up|0|||
23425698|NCT00664560|65303380|FG000|Overall Study|Other|11|||
23314550|NCT04895982|64895337|FG010|Overall Study|Protocol Violation|0|||
23314551|NCT04895982|64895338|FG011|Overall Study|Protocol Violation|0|||
23314552|NCT04895982|64895327|FG000|Overall Study|Lost to Follow-up|0|||
23314553|NCT04895982|64895328|FG001|Overall Study|Lost to Follow-up|0|||
23314554|NCT04895982|64895329|FG002|Overall Study|Lost to Follow-up|1|||
23314555|NCT04895982|64895330|FG003|Overall Study|Lost to Follow-up|0|||
23314556|NCT04895982|64895331|FG004|Overall Study|Lost to Follow-up|0|||
23314557|NCT04895982|64895332|FG005|Overall Study|Lost to Follow-up|1|||
23314558|NCT04895982|64895333|FG006|Overall Study|Lost to Follow-up|0|||
23314559|NCT04895982|64895334|FG007|Overall Study|Lost to Follow-up|0|||
23314560|NCT04895982|64895335|FG008|Overall Study|Lost to Follow-up|1|||
23314561|NCT04895982|64895336|FG009|Overall Study|Lost to Follow-up|0|||
23314562|NCT04895982|64895337|FG010|Overall Study|Lost to Follow-up|0|||
23314563|NCT04895982|64895338|FG011|Overall Study|Lost to Follow-up|0|||
23314564|NCT04895982|64895327|FG000|Overall Study|Refused further study procedures|0|||
23314565|NCT04895982|64895328|FG001|Overall Study|Refused further study procedures|0|||
23314566|NCT04895982|64895329|FG002|Overall Study|Refused further study procedures|1|||
23314567|NCT04895982|64895330|FG003|Overall Study|Refused further study procedures|0|||
23314568|NCT04895982|64895331|FG004|Overall Study|Refused further study procedures|0|||
23314569|NCT04895982|64895332|FG005|Overall Study|Refused further study procedures|0|||
23314570|NCT04895982|64895333|FG006|Overall Study|Refused further study procedures|0|||
23314571|NCT04895982|64895334|FG007|Overall Study|Refused further study procedures|0|||
23314572|NCT04895982|64895335|FG008|Overall Study|Refused further study procedures|0|||
23314573|NCT04895982|64895336|FG009|Overall Study|Refused further study procedures|0|||
23314574|NCT04895982|64895337|FG010|Overall Study|Refused further study procedures|0|||
23314575|NCT04895982|64895338|FG011|Overall Study|Refused further study procedures|0|||
23314576|NCT03573830|64895340|FG000|Overall Study|Dropped without completing treatment|0|||
23314577|NCT03573830|64895341|FG001|Overall Study|Dropped without completing treatment|7|||
23314578|NCT03573830|64895340|FG000|Overall Study|Lost to Follow-up|4|||
23314579|NCT03573830|64895341|FG001|Overall Study|Lost to Follow-up|0|||
23314580|NCT00143247|64895342|FG000|Overall Study|Death|8|||
23314581|NCT00143247|64895342|FG000|Overall Study|Adverse Event|19|||
23314582|NCT00143247|64895342|FG000|Overall Study|Lack of Efficacy|3|||
23314583|NCT00143247|64895342|FG000|Overall Study|Withdrawal by Subject|55|||
23314584|NCT00143247|64895342|FG000|Overall Study|Study terminated by sponsor|31|||
23314585|NCT00143247|64895342|FG000|Overall Study|Protocol Violation|15|||
23314586|NCT00143247|64895342|FG000|Overall Study|Lost to Follow-up|12|||
23314587|NCT00143247|64895342|FG000|Overall Study|following inaccurate lab adverse event|1|||
23314588|NCT00143247|64895342|FG000|Overall Study|Other|12|||
23314589|NCT01352416|64895343|FG000|Overall Study|Physician Decision|1|||
23314590|NCT01352416|64895344|FG001|Overall Study|Physician Decision|2|||
23314591|NCT01352416|64895345|FG002|Overall Study|Physician Decision|2|||
23314592|NCT01352416|64895346|FG003|Overall Study|Physician Decision|1|||
23314593|NCT05101343|64895347|FG000|Overall Study|Withdrawal by Subject|2|||
23314594|NCT05101343|64895348|FG001|Overall Study|Withdrawal by Subject|1|||
23314595|NCT02374346|64895349|FG000|Overall Study|operated or discharged during weekend|48|||
23314596|NCT02694328|64895350|FG000|Overall Study|Adverse Event|27|||
23314597|NCT02694328|64895351|FG001|Overall Study|Adverse Event|33|||
23314598|NCT02694328|64895350|FG000|Overall Study|Withdrawal by Subject|27|||
23314599|NCT02694328|64895351|FG001|Overall Study|Withdrawal by Subject|23|||
23314600|NCT02694328|64895350|FG000|Overall Study|Lost to Follow-up|26|||
23314601|NCT02694328|64895351|FG001|Overall Study|Lost to Follow-up|22|||
23314602|NCT02694328|64895350|FG000|Overall Study|Noncompliant with study drug|11|||
23314603|NCT02694328|64895351|FG001|Overall Study|Noncompliant with study drug|8|||
23314604|NCT02694328|64895350|FG000|Overall Study|Incarceration|1|||
23314605|NCT02694328|64895351|FG001|Overall Study|Incarceration|1|||
23425699|NCT00664560|65303381|FG001|Overall Study|Other|4|||
23425700|NCT00664560|65303382|FG002|Overall Study|Other|5|||
23425701|NCT00496197|65303383|FG000|Overall Study|Discontinued study due to death|43|||
23425702|NCT00496197|65303383|FG000|Overall Study|Adverse Event|13|||
23314606|NCT02694328|64895350|FG000|Overall Study|Lack of Efficacy|1|||
23314607|NCT02694328|64895351|FG001|Overall Study|Lack of Efficacy|2|||
23314608|NCT02694328|64895350|FG000|Overall Study|Pregnancy|1|||
23314609|NCT02694328|64895351|FG001|Overall Study|Pregnancy|1|||
23314610|NCT02694328|64895350|FG000|Overall Study|Protocol Violation|6|||
23314611|NCT02694328|64895351|FG001|Overall Study|Protocol Violation|5|||
23314612|NCT02694328|64895350|FG000|Overall Study|Abnormal Laboratory Value|0|||
23425703|NCT00496197|65303383|FG000|Overall Study|Does not meet entrance criteria|5|||
23314613|NCT02694328|64895351|FG001|Overall Study|Abnormal Laboratory Value|3|||
23425704|NCT00496197|65303383|FG000|Overall Study|Insufficient clinical response|3|||
23425705|NCT00496197|65303383|FG000|Overall Study|Insufficient bacteriological response|10|||
23425706|NCT00496197|65303383|FG000|Overall Study|Lost to Follow-up|11|||
23425707|NCT00496197|65303383|FG000|Overall Study|Withdrawal by Subject|11|||
23425708|NCT00496197|65303383|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
23425709|NCT00496197|65303383|FG000|Overall Study|Other|14|||
23425710|NCT00496197|65303383|FG000|Overall Study|Protocol Violation|8|||
23425711|NCT01286987|65303384|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
23425712|NCT01286987|65303385|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
23425713|NCT01286987|65303386|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
23425714|NCT01286987|65303387|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
23425715|NCT01286987|65303388|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
23425716|NCT01286987|65303389|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
23425717|NCT01286987|65303390|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
23425718|NCT01286987|65303391|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
23425719|NCT01286987|65303392|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
23425720|NCT01286987|65303393|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
23425721|NCT01286987|65303394|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
23425722|NCT01286987|65303395|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
23425723|NCT01286987|65303396|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
23425724|NCT01286987|65303397|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
23425725|NCT01286987|65303398|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
23425726|NCT01286987|65303384|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
23425727|NCT01286987|65303385|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
23425728|NCT01286987|65303386|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
23425729|NCT01286987|65303387|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
23425730|NCT01286987|65303388|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
23425731|NCT01286987|65303389|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
23425732|NCT01286987|65303390|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
23425733|NCT01286987|65303391|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
23425734|NCT01286987|65303392|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
23425735|NCT01286987|65303393|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
23425736|NCT01286987|65303394|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
23425737|NCT01286987|65303395|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
23425738|NCT01286987|65303396|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
23425739|NCT01286987|65303397|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
23425740|NCT01286987|65303398|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
23425741|NCT01286987|65303384|FG000|Part 1: Dose Escalation|Physician Decision|0|||
23425742|NCT01286987|65303385|FG001|Part 1: Dose Escalation|Physician Decision|0|||
23425743|NCT01286987|65303386|FG002|Part 1: Dose Escalation|Physician Decision|0|||
23425744|NCT01286987|65303387|FG003|Part 1: Dose Escalation|Physician Decision|0|||
23425745|NCT01286987|65303388|FG004|Part 1: Dose Escalation|Physician Decision|1|||
23425746|NCT01286987|65303389|FG005|Part 1: Dose Escalation|Physician Decision|0|||
23425747|NCT01286987|65303390|FG006|Part 1: Dose Escalation|Physician Decision|0|||
23425748|NCT01286987|65303391|FG007|Part 1: Dose Escalation|Physician Decision|0|||
23425749|NCT01286987|65303392|FG008|Part 1: Dose Escalation|Physician Decision|0|||
23425750|NCT01286987|65303393|FG009|Part 1: Dose Escalation|Physician Decision|0|||
23425751|NCT01286987|65303394|FG010|Part 1: Dose Escalation|Physician Decision|0|||
23425752|NCT01286987|65303395|FG011|Part 1: Dose Escalation|Physician Decision|0|||
23425753|NCT01286987|65303396|FG012|Part 1: Dose Escalation|Physician Decision|0|||
23425754|NCT01286987|65303397|FG013|Part 1: Dose Escalation|Physician Decision|0|||
23425755|NCT01286987|65303398|FG014|Part 1: Dose Escalation|Physician Decision|0|||
23425756|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Death|0|||
23425757|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Death|0|||
23425758|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Death|0|||
23425759|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Death|0|||
23314614|NCT04562155|64895352|FG000|Overall Study|COVID-19 pandemic|0|||
23425760|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Death|0|||
23425761|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Death|0|||
23425762|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Death|0|||
23425763|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Death|0|||
23425764|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Death|0|||
23425765|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Death|0|||
23425766|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Death|0|||
23425767|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Death|0|||
23211330|NCT03803202|64512449|FG002|Overall Study|Withdrawal by Subject|1|||
23211331|NCT03803202|64512450|FG003|Overall Study|Withdrawal by Subject|0|||
23211332|NCT03803202|64512451|FG004|Overall Study|Withdrawal by Subject|0|||
23211333|NCT03803202|64512452|FG005|Overall Study|Withdrawal by Subject|0|||
23211334|NCT03803202|64512453|FG006|Overall Study|Withdrawal by Subject|0|||
23211335|NCT03803202|64512454|FG007|Overall Study|Withdrawal by Subject|1|||
23211336|NCT03803202|64512455|FG008|Overall Study|Withdrawal by Subject|0|||
23211337|NCT03803202|64512447|FG000|Overall Study|Lost to Follow-up|0|||
23425768|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Death|1|||
23425769|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Death|1|||
23425770|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Death|0|||
23425771|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Physician Decision|0|||
23425772|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Physician Decision|0|||
23425773|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Physician Decision|0|||
23425774|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Physician Decision|0|||
23425775|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Physician Decision|0|||
23425776|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Physician Decision|0|||
23425777|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Physician Decision|0|||
23425778|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Physician Decision|0|||
23425779|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Physician Decision|0|||
23425780|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Physician Decision|0|||
23425781|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Physician Decision|1|||
23425782|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Physician Decision|1|||
23425783|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Physician Decision|0|||
23425784|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Physician Decision|1|||
23425785|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Physician Decision|0|||
23425786|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Other|0|||
23425787|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Other|0|||
23425788|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Other|0|||
23425789|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Other|0|||
23425790|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Other|0|||
23425791|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Other|0|||
23425792|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Other|0|||
23425793|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Other|0|||
23425794|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Other|0|||
23425795|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Other|0|||
23425796|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Other|0|||
23425797|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Other|0|||
23425798|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Other|0|||
23425799|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Other|1|||
23425800|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Other|0|||
23425801|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
23425802|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
23425803|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
23425804|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
23425805|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
23425806|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
23425807|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
23425808|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
23425809|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
23425810|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
23425811|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
23425812|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
23425813|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
23425814|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
23425815|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
23425816|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
23425817|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
23425818|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
23425819|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
23425820|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
23425821|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
23425822|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
23425823|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
23543924|NCT01045447|65719971|FG000|Overall Study|Unclassified|17|||
23543925|NCT01045447|65719972|FG001|Overall Study|Unclassified|13|||
23211338|NCT03803202|64512448|FG001|Overall Study|Lost to Follow-up|0|||
23425824|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
23425825|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
23425826|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
23425827|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
23425828|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
23425829|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
23425830|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
23543926|NCT01753193|65719978|FG000|Overall Study|Withdrawal by Subject|23|||
23425831|NCT01286987|65303384|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425832|NCT01286987|65303385|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425833|NCT01286987|65303386|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425834|NCT01286987|65303387|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425835|NCT01286987|65303388|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425836|NCT01286987|65303389|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425837|NCT01286987|65303390|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425838|NCT01286987|65303391|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425839|NCT01286987|65303392|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425840|NCT01286987|65303393|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425841|NCT01286987|65303394|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
23425842|NCT01286987|65303395|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425843|NCT01286987|65303396|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425844|NCT01286987|65303397|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425845|NCT01286987|65303398|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
23425846|NCT01852825|65303399|FG000|Overall Study|Withdrawal by Subject|2|||
23425847|NCT01852825|65303400|FG001|Overall Study|Withdrawal by Subject|0|||
23425848|NCT01852825|65303401|FG002|Overall Study|Withdrawal by Subject|0|||
23425849|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
23425850|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
23425851|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
23425852|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
23425853|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
23425854|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
23425855|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
23425856|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
23425857|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
23425858|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
23425859|NCT03906656|65303403|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
23425860|NCT03906656|65303404|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
23425861|NCT03906656|65303403|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
23425862|NCT03906656|65303404|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
23425863|NCT03906656|65303403|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
23425864|NCT03906656|65303404|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
23425865|NCT03906656|65303403|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
23425866|NCT03906656|65303404|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
23425867|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
23425868|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
23425869|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
23425870|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
23425871|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
23425872|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
23425873|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
23425874|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
23425875|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
23425876|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
23425877|NCT03906656|65303403|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
23425878|NCT03906656|65303404|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
23425879|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
23425880|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
23425881|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
23425882|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
23425883|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Death|2|||
23425884|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Death|0|||
23425885|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
23425886|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
23425887|NCT03906656|65303403|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
23425888|NCT03906656|65303404|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
23425889|NCT01095653|65303405|FG000|Overall Study|Lack of Efficacy|3|||
23425890|NCT01095653|65303406|FG001|Overall Study|Lack of Efficacy|0|||
23425891|NCT01095653|65303407|FG002|Overall Study|Lack of Efficacy|0|||
23425892|NCT01095653|65303405|FG000|Overall Study|Adverse Event|1|||
23543927|NCT01753193|65719978|FG000|Overall Study|Lost to Follow-up|6|||
23543928|NCT01753193|65719978|FG000|Overall Study|Death|1|||
23543929|NCT01753193|65719978|FG000|Overall Study|Other|16|||
23543930|NCT00562159|65719979|FG000|Overall Study|Adverse Event|11|||
23425893|NCT01095653|65303406|FG001|Overall Study|Adverse Event|4|||
23425894|NCT01095653|65303407|FG002|Overall Study|Adverse Event|4|||
23425895|NCT01095653|65303405|FG000|Overall Study|Lost to Follow-up|1|||
23425896|NCT01095653|65303406|FG001|Overall Study|Lost to Follow-up|0|||
23425897|NCT01095653|65303407|FG002|Overall Study|Lost to Follow-up|4|||
23425898|NCT01095653|65303405|FG000|Overall Study|Withdrawal by Subject|4|||
23425899|NCT01095653|65303406|FG001|Overall Study|Withdrawal by Subject|5|||
23425900|NCT01095653|65303407|FG002|Overall Study|Withdrawal by Subject|3|||
23425901|NCT01095653|65303405|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
23425902|NCT01095653|65303406|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
23425903|NCT01095653|65303407|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
23425904|NCT00791557|65303408|FG000|Overall Study|Adverse Event|1|||
23425905|NCT03093974|65303409|FG000|Overall Study|Withdrawal by Subject|32|||
23425906|NCT03093974|65303410|FG001|Overall Study|Withdrawal by Subject|27|||
23425907|NCT03093974|65303409|FG000|Overall Study|Adverse Event|17|||
23425908|NCT03093974|65303410|FG001|Overall Study|Adverse Event|24|||
23425909|NCT03093974|65303409|FG000|Overall Study|Death|0|||
23425910|NCT03093974|65303410|FG001|Overall Study|Death|1|||
23425911|NCT03093974|65303409|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23425912|NCT03093974|65303410|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23425913|NCT03093974|65303409|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
23425914|NCT03093974|65303410|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
23425915|NCT03093974|65303409|FG000|Overall Study|Lost to Follow-up|0|||
23425916|NCT03093974|65303410|FG001|Overall Study|Lost to Follow-up|1|||
23425917|NCT03093974|65303409|FG000|Overall Study|Other|1|||
23425918|NCT03093974|65303410|FG001|Overall Study|Other|2|||
23425919|NCT01958021|65303411|FG000|Overall Study|Progressive disease|87|||
23617252|NCT02123797|65985138|FG004|Baseline Intervention|Relocation|0|||
23617253|NCT02123797|65985134|FG000|Baseline Intervention|Out of window for initial survey|6|||
23617254|NCT02123797|65985135|FG001|Baseline Intervention|Out of window for initial survey|13|||
23617255|NCT02123797|65985136|FG002|Baseline Intervention|Out of window for initial survey|0|||
23211339|NCT03803202|64512449|FG002|Overall Study|Lost to Follow-up|0|||
23211340|NCT03803202|64512450|FG003|Overall Study|Lost to Follow-up|1|||
23314615|NCT04562155|64895353|FG001|Overall Study|COVID-19 pandemic|0|||
23314616|NCT04562155|64895354|FG002|Overall Study|COVID-19 pandemic|0|||
23425920|NCT01958021|65303412|FG001|Overall Study|Progressive disease|146|||
23124365|NCT01327612|64205042|FG000|Overall Study|Withdrawal by Subject|0|||
23124366|NCT01327612|64205043|FG001|Overall Study|Withdrawal by Subject|0|||
23124367|NCT01327612|64205044|FG002|Overall Study|Withdrawal by Subject|0|||
23124368|NCT01327612|64205045|FG003|Overall Study|Withdrawal by Subject|0|||
23124369|NCT01327612|64205046|FG004|Overall Study|Withdrawal by Subject|0|||
23124370|NCT01327612|64205047|FG005|Overall Study|Withdrawal by Subject|1|||
23124371|NCT01327612|64205048|FG006|Overall Study|Withdrawal by Subject|0|||
23124372|NCT01327612|64205042|FG000|Overall Study|Disease Progression|1|||
23211341|NCT03803202|64512451|FG004|Overall Study|Lost to Follow-up|1|||
23425921|NCT01958021|65303411|FG000|Overall Study|Adverse Event|25|||
23425922|NCT01958021|65303412|FG001|Overall Study|Adverse Event|7|||
23425923|NCT01958021|65303411|FG000|Overall Study|Subject/guardian decision|12|||
23425924|NCT01958021|65303412|FG001|Overall Study|Subject/guardian decision|13|||
23425925|NCT01958021|65303411|FG000|Overall Study|Physician Decision|10|||
23425926|NCT01958021|65303412|FG001|Overall Study|Physician Decision|13|||
23617256|NCT02123797|65985137|FG003|Baseline Intervention|Out of window for initial survey|0|||
23124373|NCT01327612|64205043|FG001|Overall Study|Disease Progression|1|||
23124374|NCT01327612|64205044|FG002|Overall Study|Disease Progression|1|||
23124375|NCT01327612|64205045|FG003|Overall Study|Disease Progression|0|||
23124376|NCT01327612|64205046|FG004|Overall Study|Disease Progression|1|||
23124377|NCT01327612|64205047|FG005|Overall Study|Disease Progression|2|||
23124378|NCT01327612|64205048|FG006|Overall Study|Disease Progression|2|||
23124379|NCT01327612|64205042|FG000|Overall Study|Administrative Decision|0|||
23124380|NCT01327612|64205043|FG001|Overall Study|Administrative Decision|0|||
23124381|NCT01327612|64205044|FG002|Overall Study|Administrative Decision|0|||
23124382|NCT01327612|64205045|FG003|Overall Study|Administrative Decision|1|||
23124383|NCT01327612|64205046|FG004|Overall Study|Administrative Decision|0|||
23124384|NCT01327612|64205047|FG005|Overall Study|Administrative Decision|0|||
23124385|NCT01327612|64205048|FG006|Overall Study|Administrative Decision|0|||
23124386|NCT01327612|64205042|FG000|Overall Study|Death|0|||
23124387|NCT01327612|64205043|FG001|Overall Study|Death|0|||
23124388|NCT01327612|64205044|FG002|Overall Study|Death|0|||
23124389|NCT01327612|64205045|FG003|Overall Study|Death|0|||
23124390|NCT01327612|64205046|FG004|Overall Study|Death|1|||
23124391|NCT01327612|64205047|FG005|Overall Study|Death|0|||
23124392|NCT01327612|64205048|FG006|Overall Study|Death|0|||
23124407|NCT02990468|64205051|FG000|Phase 2: MTD|Change in treatment|0|||
23124408|NCT02990468|64205052|FG001|Phase 2: MTD|Change in treatment|0|||
23124409|NCT02990468|64205053|FG002|Phase 2: MTD|Change in treatment|1|||
23124419|NCT01250509|64205072|FG000|Overall Study|Lost to Follow-up|5|||
23124420|NCT01250509|64205073|FG001|Overall Study|Lost to Follow-up|2|||
23314617|NCT04562155|64895355|FG003|Overall Study|COVID-19 pandemic|1|||
23314618|NCT04562155|64895352|FG000|Overall Study|Adverse Event|7|||
23314619|NCT04562155|64895353|FG001|Overall Study|Adverse Event|3|||
23314620|NCT04562155|64895354|FG002|Overall Study|Adverse Event|8|||
23314621|NCT04562155|64895355|FG003|Overall Study|Adverse Event|1|||
23314622|NCT04562155|64895352|FG000|Overall Study|Withdrawal by Subject|3|||
23314623|NCT04562155|64895353|FG001|Overall Study|Withdrawal by Subject|6|||
23314624|NCT04562155|64895354|FG002|Overall Study|Withdrawal by Subject|3|||
23314625|NCT04562155|64895355|FG003|Overall Study|Withdrawal by Subject|3|||
23314626|NCT04562155|64895352|FG000|Overall Study|Participant personal reason|1|||
23314627|NCT04562155|64895353|FG001|Overall Study|Participant personal reason|0|||
23314628|NCT04562155|64895354|FG002|Overall Study|Participant personal reason|2|||
23314629|NCT04562155|64895355|FG003|Overall Study|Participant personal reason|1|||
23425927|NCT01958021|65303411|FG000|Overall Study|Protocol Violation|3|||
23425928|NCT01958021|65303412|FG001|Overall Study|Protocol Violation|1|||
23425929|NCT01958021|65303411|FG000|Overall Study|Death|2|||
23543931|NCT00562159|65719980|FG001|Overall Study|Adverse Event|8|||
23425930|NCT01958021|65303412|FG001|Overall Study|Death|0|||
23425931|NCT02421601|65303413|FG000|Overall Study|Adverse Event|4|||
23314630|NCT04096040|64895366|FG000|Overall Study|Protocol Violation|12|||
23314631|NCT04096040|64895366|FG000|Overall Study|Non-compliant site|4|||
23314632|NCT00426361|64895370|FG000|Overall Study|Lost to Follow-up|3|||
23425932|NCT02421601|65303413|FG000|Overall Study|Lack of Efficacy|5|||
23124440|NCT01667926|64205081|FG000|Overall Study|Withdrawal by Subject|1|||
23124441|NCT01667926|64205082|FG001|Overall Study|Withdrawal by Subject|2|||
23124442|NCT01667926|64205083|FG002|Overall Study|Withdrawal by Subject|2|||
23124443|NCT01667926|64205081|FG000|Overall Study|Physician Decision|0|||
23124444|NCT01667926|64205082|FG001|Overall Study|Physician Decision|0|||
23124445|NCT01667926|64205083|FG002|Overall Study|Physician Decision|1|||
23124446|NCT01667926|64205081|FG000|Overall Study|Time committment|0|||
23124447|NCT01667926|64205082|FG001|Overall Study|Time committment|0|||
23124448|NCT01667926|64205083|FG002|Overall Study|Time committment|2|||
23124449|NCT01667926|64205081|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
23124450|NCT01667926|64205082|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
23124451|NCT01667926|64205083|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
23124452|NCT01667926|64205081|FG000|Overall Study|Lost to Follow-up|1|||
23124453|NCT01667926|64205082|FG001|Overall Study|Lost to Follow-up|2|||
23124454|NCT01667926|64205083|FG002|Overall Study|Lost to Follow-up|1|||
23124455|NCT01667926|64205081|FG000|Overall Study|Side effects|3|||
23124456|NCT01667926|64205082|FG001|Overall Study|Side effects|0|||
23124457|NCT01667926|64205083|FG002|Overall Study|Side effects|0|||
23543932|NCT00562159|65719979|FG000|Overall Study|Lost to Follow-up|5|||
23211342|NCT03803202|64512452|FG005|Overall Study|Lost to Follow-up|0|||
23543933|NCT00562159|65719980|FG001|Overall Study|Lost to Follow-up|4|||
23425933|NCT02421601|65303413|FG000|Overall Study|Physician Decision|1|||
23425934|NCT02421601|65303413|FG000|Overall Study|Withdrawal by Subject|31|||
23425935|NCT02421601|65303413|FG000|Overall Study|Others|41|||
23617257|NCT02123797|65985138|FG004|Baseline Intervention|Out of window for initial survey|0|||
23617258|NCT02123797|65985134|FG000|Baseline Intervention|Lost to Follow-up|0|||
23617259|NCT02123797|65985135|FG001|Baseline Intervention|Lost to Follow-up|5|||
23617260|NCT02123797|65985136|FG002|Baseline Intervention|Lost to Follow-up|0|||
23617261|NCT02123797|65985137|FG003|Baseline Intervention|Lost to Follow-up|0|||
23617262|NCT02123797|65985138|FG004|Baseline Intervention|Lost to Follow-up|0|||
23617263|NCT02123797|65985134|FG000|Baseline Intervention|Other Disease|3|||
23617264|NCT02123797|65985135|FG001|Baseline Intervention|Other Disease|0|||
23617265|NCT02123797|65985136|FG002|Baseline Intervention|Other Disease|0|||
23617266|NCT02123797|65985137|FG003|Baseline Intervention|Other Disease|0|||
23617267|NCT02123797|65985138|FG004|Baseline Intervention|Other Disease|0|||
23617268|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
23617269|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
23617270|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
23617271|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
23617272|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
23617273|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
23617274|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
23617275|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
23617276|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
23617277|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
23617278|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
23617279|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
23617280|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617281|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617282|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617283|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
23617284|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
23617285|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
23617286|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
23617287|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
23617288|NCT02123797|65985134|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
23617289|NCT02123797|65985135|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
23617290|NCT02123797|65985136|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
23617291|NCT02123797|65985137|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
23617292|NCT02123797|65985138|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
23617293|NCT02123797|65985134|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
23617294|NCT02123797|65985135|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
23617295|NCT02123797|65985136|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
23617296|NCT02123797|65985137|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
23425936|NCT01420627|65303414|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
23425937|NCT03444766|65303415|FG000|Overall Study|Other Reasons|2|||
23425938|NCT03444766|65303415|FG000|Overall Study|Participant Withdrew Consent|5|||
23425939|NCT03444766|65303415|FG000|Overall Study|Lost to Follow-up|2|||
23425940|NCT03444766|65303415|FG000|Overall Study|Death|2|||
23425941|NCT03444766|65303415|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
23425942|NCT03444766|65303415|FG000|Overall Study|Disease Progression|49|||
23425943|NCT02118597|65303416|FG000|Overall Study|Sponsor terminated the study|14|||
23425944|NCT02118597|65303416|FG000|Overall Study|Serious Adverse Event|1|||
23425945|NCT02118597|65303416|FG000|Overall Study|Investigator's decision|1|||
23425946|NCT02966795|65303423|FG000|Overall Study|Patient Left the Country|0|||
23425947|NCT02966795|65303424|FG001|Overall Study|Patient Left the Country|1|||
23425948|NCT00477269|65303427|FG000|Core Study|Adverse Event|6|||
23425949|NCT00477269|65303428|FG001|Core Study|Adverse Event|4|||
23425950|NCT00477269|65303429|FG002|Core Study|Adverse Event|0|||
23425951|NCT00477269|65303427|FG000|Core Study|Death|3|||
23425952|NCT00477269|65303428|FG001|Core Study|Death|3|||
23425953|NCT00477269|65303429|FG002|Core Study|Death|0|||
23425954|NCT00477269|65303427|FG000|Core Study|Withdrawn Consent|0|||
23425955|NCT00477269|65303428|FG001|Core Study|Withdrawn Consent|1|||
23425956|NCT00477269|65303429|FG002|Core Study|Withdrawn Consent|0|||
23425957|NCT00477269|65303427|FG000|Open Label Extension|Adverse Event|0|||
23425958|NCT00477269|65303428|FG001|Open Label Extension|Adverse Event|0|||
23425959|NCT00477269|65303429|FG002|Open Label Extension|Adverse Event|4|||
23425960|NCT00477269|65303427|FG000|Open Label Extension|Abnormal laboratory values|0|||
23425961|NCT00477269|65303428|FG001|Open Label Extension|Abnormal laboratory values|0|||
23425962|NCT00477269|65303429|FG002|Open Label Extension|Abnormal laboratory values|1|||
23425963|NCT00477269|65303427|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
23425964|NCT00477269|65303428|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
23425965|NCT00477269|65303429|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
23425966|NCT00477269|65303427|FG000|Open Label Extension|Adminiatrative problems|0|||
23425967|NCT00477269|65303428|FG001|Open Label Extension|Adminiatrative problems|0|||
23425968|NCT00477269|65303429|FG002|Open Label Extension|Adminiatrative problems|2|||
23425969|NCT00477269|65303427|FG000|Open Label Extension|Death|0|||
23425970|NCT00477269|65303428|FG001|Open Label Extension|Death|0|||
23425971|NCT00477269|65303429|FG002|Open Label Extension|Death|4|||
23425972|NCT01133626|65303432|FG000|Overall Study|Adverse Event|0|||
23425973|NCT01133626|65303433|FG001|Overall Study|Adverse Event|1|||
23425974|NCT01133626|65303434|FG002|Overall Study|Adverse Event|0|||
23425975|NCT01133626|65303432|FG000|Overall Study|Withdrawal by Subject|1|||
23425976|NCT01133626|65303433|FG001|Overall Study|Withdrawal by Subject|2|||
23425977|NCT01133626|65303434|FG002|Overall Study|Withdrawal by Subject|2|||
23425978|NCT01133626|65303432|FG000|Overall Study|Other|0|||
23425979|NCT01133626|65303433|FG001|Overall Study|Other|2|||
23425980|NCT01133626|65303434|FG002|Overall Study|Other|0|||
23425981|NCT02956850|65303437|FG000|Overall Study|Withdrawal by Subject|0|||
23425982|NCT02956850|65303438|FG001|Overall Study|Withdrawal by Subject|0|||
23425983|NCT02956850|65303439|FG002|Overall Study|Withdrawal by Subject|0|||
23425984|NCT02956850|65303440|FG003|Overall Study|Withdrawal by Subject|0|||
23617297|NCT02123797|65985138|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
23617298|NCT02123797|65985134|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
23617299|NCT02123797|65985135|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
23617300|NCT02123797|65985136|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
23617301|NCT02123797|65985137|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
23617302|NCT02123797|65985138|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
23211343|NCT03803202|64512453|FG006|Overall Study|Lost to Follow-up|1|||
23211344|NCT03803202|64512454|FG007|Overall Study|Lost to Follow-up|0|||
23211345|NCT03803202|64512455|FG008|Overall Study|Lost to Follow-up|0|||
23211346|NCT02690207|64512456|FG000|Overall Study|Lost to Follow-up|48|||
23211347|NCT02690207|64512456|FG000|Overall Study|Withdrawal by Subject|46|||
23211348|NCT02690207|64512456|FG000|Overall Study|Protocol Violation|2|||
23314633|NCT00426361|64895371|FG001|Overall Study|Lost to Follow-up|2|||
23425985|NCT02956850|65303441|FG004|Overall Study|Withdrawal by Subject|0|||
23617303|NCT02123797|65985134|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
23617304|NCT02123797|65985135|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
23211349|NCT02690207|64512456|FG000|Overall Study|Serious adverse event|110|||
23425986|NCT02956850|65303442|FG005|Overall Study|Withdrawal by Subject|0|||
23425987|NCT02956850|65303443|FG006|Overall Study|Withdrawal by Subject|0|||
23425988|NCT02956850|65303444|FG007|Overall Study|Withdrawal by Subject|0|||
23425989|NCT02956850|65303445|FG008|Overall Study|Withdrawal by Subject|0|||
23425990|NCT02956850|65303446|FG009|Overall Study|Withdrawal by Subject|0|||
23425991|NCT02956850|65303447|FG010|Overall Study|Withdrawal by Subject|0|||
23425992|NCT02956850|65303448|FG011|Overall Study|Withdrawal by Subject|0|||
23425993|NCT02956850|65303449|FG012|Overall Study|Withdrawal by Subject|0|||
23425994|NCT02956850|65303450|FG013|Overall Study|Withdrawal by Subject|0|||
23425995|NCT02956850|65303451|FG014|Overall Study|Withdrawal by Subject|0|||
23211350|NCT02690207|64512456|FG000|Overall Study|Non-serious Adverse Event|18|||
23211351|NCT02690207|64512456|FG000|Overall Study|Migrated/moved from study area|5|||
23211352|NCT02690207|64512456|FG000|Overall Study|Suspected HZ Episode|1|||
23425996|NCT02956850|65303452|FG015|Overall Study|Withdrawal by Subject|0|||
23425997|NCT02956850|65303453|FG016|Overall Study|Withdrawal by Subject|0|||
23425998|NCT02956850|65303454|FG017|Overall Study|Withdrawal by Subject|1|||
23425999|NCT01269385|65303460|FG000|Overall Study|Adverse Event|1|||
23426000|NCT01269385|65303461|FG001|Overall Study|Adverse Event|1|||
23426001|NCT01269385|65303462|FG002|Overall Study|Adverse Event|0|||
23426002|NCT01269385|65303463|FG003|Overall Study|Adverse Event|0|||
23426003|NCT00106691|65303471|FG000|Overall Study|Adverse Event|60|||
23426004|NCT00106691|65303472|FG001|Overall Study|Adverse Event|64|||
23426005|NCT00106691|65303471|FG000|Overall Study|Lost to Follow-up|23|||
23426006|NCT00106691|65303472|FG001|Overall Study|Lost to Follow-up|18|||
23426007|NCT00106691|65303471|FG000|Overall Study|Physician Decision|18|||
23426008|NCT00106691|65303472|FG001|Overall Study|Physician Decision|21|||
23426009|NCT00106691|65303471|FG000|Overall Study|Protocol Violation|13|||
23426010|NCT00106691|65303472|FG001|Overall Study|Protocol Violation|18|||
23426011|NCT00106691|65303471|FG000|Overall Study|Withdrawal by Subject|75|||
23543934|NCT00562159|65719979|FG000|Overall Study|Withdrawal by Subject|9|||
23211353|NCT02690207|64512456|FG000|Overall Study|Other reasons for withdrawal|23|||
23211354|NCT01431144|64512457|FG000|Overall Study|Implant mobility and removal|2|||
23211355|NCT01431144|64512458|FG001|Overall Study|Implant mobility and removal|0|||
23211356|NCT00868166|64512460|FG000|Overall Study|Death|58|||
23426012|NCT00106691|65303472|FG001|Overall Study|Withdrawal by Subject|70|||
23617305|NCT02123797|65985136|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617306|NCT02123797|65985137|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617307|NCT02123797|65985138|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
23617308|NCT02123797|65985134|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
23617309|NCT02123797|65985135|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
23543935|NCT00562159|65719980|FG001|Overall Study|Withdrawal by Subject|8|||
23543936|NCT00562159|65719979|FG000|Overall Study|Protocol Violation|12|||
23543937|NCT00562159|65719980|FG001|Overall Study|Protocol Violation|12|||
23543938|NCT00562159|65719979|FG000|Overall Study|Did not meet protocol eligibility|1|||
23543939|NCT00562159|65719980|FG001|Overall Study|Did not meet protocol eligibility|1|||
23543940|NCT02473614|65719981|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
23543941|NCT02473614|65719982|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
23543942|NCT01178853|65719983|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
23543943|NCT01178853|65719984|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
23617310|NCT02123797|65985136|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
23617311|NCT02123797|65985137|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
23617312|NCT02123797|65985138|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
23426013|NCT00106691|65303471|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
23426014|NCT00106691|65303472|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
23426015|NCT00106691|65303471|FG000|Overall Study|QTc>480|3|||
23426016|NCT00106691|65303472|FG001|Overall Study|QTc>480|1|||
23426017|NCT00106691|65303471|FG000|Overall Study|mililtary deployment|2|||
23426018|NCT00106691|65303472|FG001|Overall Study|mililtary deployment|0|||
23426019|NCT00106691|65303471|FG000|Overall Study|Study Site Closing/PI Moved|1|||
23426020|NCT00106691|65303472|FG001|Overall Study|Study Site Closing/PI Moved|2|||
23211357|NCT00868166|64512461|FG001|Overall Study|Death|65|||
23426021|NCT00106691|65303471|FG000|Overall Study|Cardiologist recommendation|1|||
23426022|NCT00106691|65303472|FG001|Overall Study|Cardiologist recommendation|0|||
23426023|NCT00106691|65303471|FG000|Overall Study|Pt. moved to another state|1|||
23124645|NCT02559310|64208432|FG000|Overall Study|Death|4|||
23124646|NCT02559310|64208433|FG001|Overall Study|Death|3|||
23124647|NCT02559310|64208432|FG000|Overall Study|Lost to Follow-up|5|||
23124648|NCT02559310|64208433|FG001|Overall Study|Lost to Follow-up|3|||
23124649|NCT02559310|64208432|FG000|Overall Study|Physician Decision|2|||
23124650|NCT02559310|64208433|FG001|Overall Study|Physician Decision|1|||
23124651|NCT02559310|64208432|FG000|Overall Study|Withdrawal by Subject|13|||
23124652|NCT02559310|64208433|FG001|Overall Study|Withdrawal by Subject|9|||
23124653|NCT02559310|64208432|FG000|Overall Study|Sponsor Decision|0|||
23124654|NCT02559310|64208433|FG001|Overall Study|Sponsor Decision|1|||
23124655|NCT02559310|64208432|FG000|Overall Study|Randomized but not treated|3|||
23124656|NCT02559310|64208433|FG001|Overall Study|Randomized but not treated|2|||
23124657|NCT03192462|64208434|FG000|Overall Study|Death|13|||
23124658|NCT03192462|64208435|FG001|Overall Study|Death|11|||
23124659|NCT03192462|64208436|FG002|Overall Study|Death|9|||
23124660|NCT03192462|64208434|FG000|Overall Study|Lost to Follow-up|0|||
23124661|NCT03192462|64208435|FG001|Overall Study|Lost to Follow-up|1|||
23124662|NCT03192462|64208436|FG002|Overall Study|Lost to Follow-up|0|||
23124663|NCT03192462|64208434|FG000|Overall Study|On follow up|0|||
23124664|NCT03192462|64208435|FG001|Overall Study|On follow up|0|||
23124665|NCT03192462|64208436|FG002|Overall Study|On follow up|3|||
23124666|NCT05071313|64208438|FG000|Overall Study|Lost to Follow-up|17|||
23124667|NCT05071313|64208439|FG001|Overall Study|Lost to Follow-up|10|||
23124668|NCT05071313|64208438|FG000|Overall Study|Physician Decision|1|||
23124669|NCT05071313|64208439|FG001|Overall Study|Physician Decision|6|||
23124670|NCT05071313|64208438|FG000|Overall Study|Death|1|||
23124671|NCT05071313|64208439|FG001|Overall Study|Death|0|||
23124672|NCT05071313|64208438|FG000|Overall Study|Withdrawal by Subject|10|||
23124673|NCT05071313|64208439|FG001|Overall Study|Withdrawal by Subject|15|||
23124674|NCT05071313|64208438|FG000|Overall Study|Other|1|||
23124675|NCT05071313|64208439|FG001|Overall Study|Other|0|||
23124676|NCT05071313|64208438|FG000|Overall Study|Randomized but not vaccinated|4|||
23124677|NCT05071313|64208439|FG001|Overall Study|Randomized but not vaccinated|2|||
23124678|NCT01931098|64208442|FG000|Overall Study|Withdrawal by Subject|0|||
23124679|NCT01931098|64208443|FG001|Overall Study|Withdrawal by Subject|1|||
23124680|NCT01931098|64208442|FG000|Overall Study|Enrolled in different protocol|0|||
23124681|NCT01931098|64208443|FG001|Overall Study|Enrolled in different protocol|1|||
23124682|NCT01931098|64208442|FG000|Overall Study|Unable to begin trmt:active infection|0|||
23124683|NCT01931098|64208443|FG001|Overall Study|Unable to begin trmt:active infection|1|||
23124684|NCT01931098|64208442|FG000|Overall Study|Refused further treatment|0|||
23124685|NCT01931098|64208443|FG001|Overall Study|Refused further treatment|1|||
23124686|NCT02353468|64208444|FG000|Overall Study|Study terminated|3|||
23124687|NCT01736189|64208445|FG000|Overall Study|Violation of registration criteria|41|||
23124688|NCT01736189|64208445|FG000|Overall Study|Protocol Violation|4|||
23426024|NCT00106691|65303472|FG001|Overall Study|Pt. moved to another state|0|||
23426025|NCT00106691|65303471|FG000|Overall Study|Taking exclusionary avodart|1|||
23426026|NCT00106691|65303472|FG001|Overall Study|Taking exclusionary avodart|0|||
23124689|NCT01736189|64208445|FG000|Overall Study|Criteria and protocol violations|1|||
23124690|NCT03210519|64208446|FG000|Overall Study|Adverse Event|2|||
23124691|NCT03210519|64208447|FG001|Overall Study|Adverse Event|0|||
23426027|NCT00106691|65303471|FG000|Overall Study|Not able to discontinue plavix|0|||
23124692|NCT00847626|64208448|FG000|Overall Study|Adverse Event|10|||
23124693|NCT00847626|64208449|FG001|Overall Study|Adverse Event|10|||
23124694|NCT00847626|64208450|FG002|Overall Study|Adverse Event|6|||
23124695|NCT00847626|64208451|FG003|Overall Study|Adverse Event|19|||
23124696|NCT00847626|64208452|FG004|Overall Study|Adverse Event|11|||
23124697|NCT00847626|64208453|FG005|Overall Study|Adverse Event|22|||
23124698|NCT00847626|64208454|FG006|Overall Study|Adverse Event|4|||
23124699|NCT00847626|64208455|FG007|Overall Study|Adverse Event|6|||
23426028|NCT00106691|65303472|FG001|Overall Study|Not able to discontinue plavix|1|||
23124700|NCT00847626|64208456|FG008|Overall Study|Adverse Event|3|||
23124701|NCT00847626|64208457|FG009|Overall Study|Adverse Event|6|||
23124702|NCT00847626|64208458|FG010|Overall Study|Adverse Event|6|||
23124703|NCT00847626|64208448|FG000|Overall Study|Protocol Violation|2|||
23124704|NCT00847626|64208449|FG001|Overall Study|Protocol Violation|1|||
23124705|NCT00847626|64208450|FG002|Overall Study|Protocol Violation|2|||
23124706|NCT00847626|64208451|FG003|Overall Study|Protocol Violation|1|||
23124707|NCT00847626|64208452|FG004|Overall Study|Protocol Violation|1|||
23124708|NCT00847626|64208453|FG005|Overall Study|Protocol Violation|1|||
23124709|NCT00847626|64208454|FG006|Overall Study|Protocol Violation|1|||
23124710|NCT00847626|64208455|FG007|Overall Study|Protocol Violation|1|||
23124711|NCT00847626|64208456|FG008|Overall Study|Protocol Violation|0|||
23124712|NCT00847626|64208457|FG009|Overall Study|Protocol Violation|1|||
23124713|NCT00847626|64208458|FG010|Overall Study|Protocol Violation|1|||
23124714|NCT00847626|64208448|FG000|Overall Study|Lost to Follow-up|0|||
23124715|NCT00847626|64208449|FG001|Overall Study|Lost to Follow-up|1|||
23124716|NCT00847626|64208450|FG002|Overall Study|Lost to Follow-up|1|||
23124717|NCT00847626|64208451|FG003|Overall Study|Lost to Follow-up|1|||
23124718|NCT00847626|64208452|FG004|Overall Study|Lost to Follow-up|0|||
23124719|NCT00847626|64208453|FG005|Overall Study|Lost to Follow-up|3|||
23124720|NCT00847626|64208454|FG006|Overall Study|Lost to Follow-up|1|||
23124721|NCT00847626|64208455|FG007|Overall Study|Lost to Follow-up|3|||
23124722|NCT00847626|64208456|FG008|Overall Study|Lost to Follow-up|1|||
23124723|NCT00847626|64208457|FG009|Overall Study|Lost to Follow-up|0|||
23124724|NCT00847626|64208458|FG010|Overall Study|Lost to Follow-up|1|||
23124725|NCT00847626|64208448|FG000|Overall Study|Withdrawal by Subject|5|||
23124726|NCT00847626|64208449|FG001|Overall Study|Withdrawal by Subject|5|||
23124727|NCT00847626|64208450|FG002|Overall Study|Withdrawal by Subject|3|||
23124728|NCT00847626|64208451|FG003|Overall Study|Withdrawal by Subject|8|||
23124729|NCT00847626|64208452|FG004|Overall Study|Withdrawal by Subject|12|||
23124730|NCT00847626|64208453|FG005|Overall Study|Withdrawal by Subject|9|||
23124731|NCT00847626|64208454|FG006|Overall Study|Withdrawal by Subject|8|||
23124732|NCT00847626|64208455|FG007|Overall Study|Withdrawal by Subject|4|||
23124733|NCT00847626|64208456|FG008|Overall Study|Withdrawal by Subject|4|||
23124734|NCT00847626|64208457|FG009|Overall Study|Withdrawal by Subject|5|||
23124735|NCT00847626|64208458|FG010|Overall Study|Withdrawal by Subject|2|||
23124736|NCT00847626|64208448|FG000|Overall Study|Lack of Efficacy|3|||
23124737|NCT00847626|64208449|FG001|Overall Study|Lack of Efficacy|1|||
23124738|NCT00847626|64208450|FG002|Overall Study|Lack of Efficacy|0|||
23124739|NCT00847626|64208451|FG003|Overall Study|Lack of Efficacy|1|||
23124740|NCT00847626|64208452|FG004|Overall Study|Lack of Efficacy|2|||
23124741|NCT00847626|64208453|FG005|Overall Study|Lack of Efficacy|0|||
23124742|NCT00847626|64208454|FG006|Overall Study|Lack of Efficacy|6|||
23124743|NCT00847626|64208455|FG007|Overall Study|Lack of Efficacy|2|||
23124744|NCT00847626|64208456|FG008|Overall Study|Lack of Efficacy|5|||
23124745|NCT00847626|64208457|FG009|Overall Study|Lack of Efficacy|1|||
23124746|NCT00847626|64208458|FG010|Overall Study|Lack of Efficacy|7|||
23124747|NCT00847626|64208448|FG000|Overall Study|Other|1|||
23124748|NCT00847626|64208449|FG001|Overall Study|Other|5|||
23124749|NCT00847626|64208450|FG002|Overall Study|Other|4|||
23124750|NCT00847626|64208451|FG003|Overall Study|Other|1|||
23124751|NCT00847626|64208452|FG004|Overall Study|Other|2|||
23124752|NCT00847626|64208453|FG005|Overall Study|Other|2|||
23124753|NCT00847626|64208454|FG006|Overall Study|Other|2|||
23124754|NCT00847626|64208455|FG007|Overall Study|Other|3|||
23124755|NCT00847626|64208456|FG008|Overall Study|Other|1|||
23124756|NCT00847626|64208457|FG009|Overall Study|Other|1|||
23124757|NCT00847626|64208458|FG010|Overall Study|Other|3|||
23124758|NCT04887506|64208459|FG000|Overall Study|Death|1|||
23124759|NCT04887506|64208460|FG001|Overall Study|Death|1|||
23124760|NCT04887506|64208459|FG000|Overall Study|Withdrawal by Subject|0|||
23543944|NCT01178853|65719983|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
23124761|NCT04887506|64208460|FG001|Overall Study|Withdrawal by Subject|3|||
23124762|NCT04887506|64208459|FG000|Overall Study|Adverse Event|4|||
23124763|NCT04887506|64208460|FG001|Overall Study|Adverse Event|3|||
23124764|NCT04887506|64208459|FG000|Overall Study|Other - Not Reported|1|||
23124765|NCT04887506|64208460|FG001|Overall Study|Other - Not Reported|1|||
23124766|NCT03712449|64208461|FG000|Overall Study|Withdraw Consent|0|||
23124767|NCT03712449|64208462|FG001|Overall Study|Withdraw Consent|1|||
23124768|NCT02094898|64208463|FG000|Overall Study|Clinical Worsening|2|||
23124769|NCT02094898|64208463|FG000|Overall Study|Adverse Event|2|||
23211358|NCT00868166|64512460|FG000|Overall Study|Withdrawal by Subject|33|||
23124770|NCT02094898|64208463|FG000|Overall Study|Lack of Efficacy|1|||
23124771|NCT03690427|64208464|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
23124772|NCT03690427|64208465|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
23124773|NCT02125279|64208466|FG000|Overall Study|Lack of Efficacy|2|||
23124774|NCT02125279|64208466|FG000|Overall Study|Withdrawal by Subject|6|||
23124775|NCT02125279|64208466|FG000|Overall Study|Protocol Violation|1|||
23124776|NCT02125279|64208466|FG000|Overall Study|Lost to Follow-up|4|||
23543945|NCT01178853|65719984|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
23543946|NCT01178853|65719983|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
23543947|NCT01178853|65719984|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
23543948|NCT01178853|65719983|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
23543949|NCT01178853|65719984|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
23124777|NCT02031536|64208467|FG000|Overall Study|ineligible|1|||
23124778|NCT02031536|64208468|FG001|Overall Study|ineligible|0|||
23124779|NCT02127125|64208481|FG000|Overall Study|Lost to Follow-up|0|||
23124780|NCT02127125|64208482|FG001|Overall Study|Lost to Follow-up|0|||
23124781|NCT02127125|64208483|FG002|Overall Study|Lost to Follow-up|0|||
23124782|NCT02127125|64208484|FG003|Overall Study|Lost to Follow-up|0|||
23124783|NCT02127125|64208485|FG004|Overall Study|Lost to Follow-up|2|||
23124784|NCT02127125|64208486|FG005|Overall Study|Lost to Follow-up|1|||
23124785|NCT02127125|64208487|FG006|Overall Study|Lost to Follow-up|0|||
23124786|NCT02127125|64208488|FG007|Overall Study|Lost to Follow-up|0|||
23124787|NCT02127125|64208489|FG008|Overall Study|Lost to Follow-up|0|||
23124788|NCT02127125|64208481|FG000|Overall Study|Withdrawal by Subject|0|||
23124789|NCT02127125|64208482|FG001|Overall Study|Withdrawal by Subject|0|||
23124790|NCT02127125|64208483|FG002|Overall Study|Withdrawal by Subject|0|||
23124791|NCT02127125|64208484|FG003|Overall Study|Withdrawal by Subject|1|||
23124792|NCT02127125|64208485|FG004|Overall Study|Withdrawal by Subject|0|||
23124793|NCT02127125|64208486|FG005|Overall Study|Withdrawal by Subject|0|||
23124794|NCT02127125|64208487|FG006|Overall Study|Withdrawal by Subject|0|||
23124795|NCT02127125|64208488|FG007|Overall Study|Withdrawal by Subject|0|||
23124796|NCT02127125|64208489|FG008|Overall Study|Withdrawal by Subject|0|||
23124797|NCT02127125|64208481|FG000|Overall Study|Physician Decision|0|||
23543950|NCT01178853|65719983|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
23543951|NCT01178853|65719984|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
23543952|NCT00803634|65719988|FG000|Overall Study|Withdrew Consent|1|||
23543953|NCT00803634|65719989|FG001|Overall Study|Withdrew Consent|0|||
23543954|NCT00803634|65719988|FG000|Overall Study|Lost to Follow-up|2|||
23543955|NCT00803634|65719989|FG001|Overall Study|Lost to Follow-up|3|||
23543956|NCT00803634|65719988|FG000|Overall Study|Death|3|||
23543957|NCT00803634|65719989|FG001|Overall Study|Death|2|||
23124798|NCT02127125|64208482|FG001|Overall Study|Physician Decision|0|||
23124799|NCT02127125|64208483|FG002|Overall Study|Physician Decision|1|||
23124800|NCT02127125|64208484|FG003|Overall Study|Physician Decision|0|||
23124801|NCT02127125|64208485|FG004|Overall Study|Physician Decision|1|||
23124802|NCT02127125|64208486|FG005|Overall Study|Physician Decision|2|||
23124803|NCT02127125|64208487|FG006|Overall Study|Physician Decision|0|||
23124804|NCT02127125|64208488|FG007|Overall Study|Physician Decision|0|||
23124805|NCT02127125|64208489|FG008|Overall Study|Physician Decision|0|||
23124806|NCT01732549|64208490|FG000|Overall Study|Adverse Event|13|||
23124807|NCT01732549|64208491|FG001|Overall Study|Adverse Event|3|||
23124808|NCT01732549|64208490|FG000|Overall Study|Consent withdrawn|13|||
23124809|NCT01732549|64208491|FG001|Overall Study|Consent withdrawn|6|||
23124810|NCT01732549|64208490|FG000|Overall Study|Disease progression|37|||
23124811|NCT01732549|64208491|FG001|Overall Study|Disease progression|50|||
23124812|NCT01732549|64208490|FG000|Overall Study|Other|8|||
23124813|NCT01732549|64208491|FG001|Overall Study|Other|14|||
23124814|NCT02536742|64208492|FG000|Overall Study|Did not start protocol therapy|1|||
23124815|NCT02536742|64208492|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
23124816|NCT00132678|64208499|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
23124817|NCT00132678|64208500|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
23124818|NCT00132678|64208501|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
23124819|NCT00132678|64208499|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
23124820|NCT00132678|64208500|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
23124821|NCT00132678|64208501|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
23124822|NCT00132678|64208499|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
23124823|NCT00132678|64208500|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
23124824|NCT00132678|64208501|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
23124825|NCT00132678|64208499|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
23124826|NCT00132678|64208500|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
23124827|NCT00132678|64208501|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
23124828|NCT00132678|64208499|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
23124829|NCT00132678|64208500|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
23124830|NCT00132678|64208501|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
23124831|NCT00132678|64208499|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
23124832|NCT00132678|64208500|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
23124833|NCT00132678|64208501|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
23124834|NCT00132678|64208499|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
23543958|NCT04602624|65722940|FG000|Overall Study|Protocol Deviation|1|||
23543959|NCT04602624|65722940|FG000|Overall Study|Withdrawal by Participant|1|||
23543960|NCT01136291|65722945|FG000|Overall Study|Lost to Follow-up|1|||
23543961|NCT01136291|65722946|FG001|Overall Study|Lost to Follow-up|1|||
23124835|NCT00132678|64208500|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
23124836|NCT00132678|64208501|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
23124837|NCT00132678|64208499|FG000|Period III (Open-Label Stabilization)|Death|2|||
23124838|NCT00132678|64208500|FG001|Period III (Open-Label Stabilization)|Death|0|||
23124839|NCT00132678|64208501|FG002|Period III (Open-Label Stabilization)|Death|0|||
23124840|NCT00132678|64208499|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
23124841|NCT00132678|64208500|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
23124842|NCT00132678|64208501|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
23124843|NCT00132678|64208499|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
23124844|NCT00132678|64208500|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
23124845|NCT00132678|64208501|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
23124846|NCT00132678|64208499|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
23124847|NCT00132678|64208500|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
23124848|NCT00132678|64208501|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
23124849|NCT00132678|64208499|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
23124850|NCT00132678|64208500|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
23124851|NCT00132678|64208501|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
23426029|NCT00526110|65303473|FG000|Overall Study|Adverse Event|2|||
23426030|NCT00526110|65303474|FG001|Overall Study|Adverse Event|9|||
23426031|NCT00526110|65303473|FG000|Overall Study|Disease Progression|0|||
23426032|NCT00526110|65303474|FG001|Overall Study|Disease Progression|19|||
23543962|NCT04154787|65722947|FG000|Overall Study|Adverse Event|0|||
23543963|NCT04154787|65722948|FG001|Overall Study|Adverse Event|1|||
23543964|NCT04154787|65722949|FG002|Overall Study|Adverse Event|0|||
23543965|NCT04154787|65722947|FG000|Overall Study|Patient Requires Other Treatment|0|||
23543966|NCT04154787|65722948|FG001|Overall Study|Patient Requires Other Treatment|1|||
23543967|NCT04154787|65722949|FG002|Overall Study|Patient Requires Other Treatment|0|||
23543968|NCT04154787|65722947|FG000|Overall Study|Study Terminated By Sponsor|0|||
23617313|NCT00168805|65985139|FG000|Overall Study|Adverse Event|7|||
23543969|NCT04154787|65722948|FG001|Overall Study|Study Terminated By Sponsor|6|||
23543970|NCT04154787|65722949|FG002|Overall Study|Study Terminated By Sponsor|1|||
23543971|NCT04154787|65722947|FG000|Overall Study|Subject Decision|0|||
23543972|NCT04154787|65722948|FG001|Overall Study|Subject Decision|1|||
23543973|NCT04154787|65722949|FG002|Overall Study|Subject Decision|0|||
23543974|NCT04154787|65722947|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
23543975|NCT04154787|65722948|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
23543976|NCT04154787|65722949|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
23543977|NCT00253864|65722950|FG000|Overall Study|Lost to Follow-up|5|||
23543978|NCT00253864|65722951|FG001|Overall Study|Lost to Follow-up|8|||
23543979|NCT02286089|65722954|FG000|Overall Study|Ongoing in Study|1|||
23543980|NCT02286089|65722955|FG001|Overall Study|Ongoing in Study|1|||
23543981|NCT02286089|65722956|FG002|Overall Study|Ongoing in Study|4|||
23543982|NCT02286089|65722957|FG003|Overall Study|Ongoing in Study|10|||
23543983|NCT02286089|65722954|FG000|Overall Study|Withdrawal by Subject|0|||
23543984|NCT02286089|65722955|FG001|Overall Study|Withdrawal by Subject|0|||
23543985|NCT02286089|65722956|FG002|Overall Study|Withdrawal by Subject|2|||
23543986|NCT02286089|65722957|FG003|Overall Study|Withdrawal by Subject|2|||
23543987|NCT00823719|65722958|FG000|Overall Study|Adverse Event|1|||
23543988|NCT00823719|65722959|FG001|Overall Study|Adverse Event|2|||
23543989|NCT00823719|65722958|FG000|Overall Study|Physician Decision|1|||
23543990|NCT00823719|65722959|FG001|Overall Study|Physician Decision|4|||
23543991|NCT00823719|65722958|FG000|Overall Study|Withdrawal by Subject|0|||
23543992|NCT00823719|65722959|FG001|Overall Study|Withdrawal by Subject|1|||
23543993|NCT00823719|65722958|FG000|Overall Study|Disease Progression|4|||
23543994|NCT00823719|65722959|FG001|Overall Study|Disease Progression|4|||
23543995|NCT00796718|65722960|FG000|Overall Study|Adverse Event|2|||
23543996|NCT00796718|65722960|FG000|Overall Study|Exclusion Criteria|1|||
23543997|NCT00796718|65722960|FG000|Overall Study|Lost to Follow-up|5|||
23543998|NCT00796718|65722960|FG000|Overall Study|Withdrawal by Informed Consent|1|||
23543999|NCT03794089|65722962|FG000|Overall Study|Lost to Follow-up|4|||
23544000|NCT03794089|65722963|FG001|Overall Study|Lost to Follow-up|1|||
23544001|NCT03794089|65722962|FG000|Overall Study|Withdrawal by Subject|2|||
23544002|NCT03794089|65722963|FG001|Overall Study|Withdrawal by Subject|0|||
23544003|NCT00993447|65722966|FG000|Overall Study|Withdrawal by Subject|23|||
23544004|NCT00993447|65722967|FG001|Overall Study|Withdrawal by Subject|8|||
23544005|NCT00993447|65722966|FG000|Overall Study|Protocol Violation|12|||
23544006|NCT00993447|65722967|FG001|Overall Study|Protocol Violation|8|||
23544007|NCT00993447|65722966|FG000|Overall Study|Lost to Follow-up|1|||
23544008|NCT00993447|65722967|FG001|Overall Study|Lost to Follow-up|3|||
23544009|NCT00993447|65722966|FG000|Overall Study|Adverse Event|1|||
23544010|NCT00993447|65722967|FG001|Overall Study|Adverse Event|0|||
23544011|NCT00680407|65722968|FG000|Overall Study|Lost to Follow-up|3|||
23544012|NCT00680407|65722969|FG001|Overall Study|Lost to Follow-up|3|||
23544013|NCT00680407|65722970|FG002|Overall Study|Lost to Follow-up|1|||
23544014|NCT00680407|65722968|FG000|Overall Study|Withdrawal by Subject|5|||
23124852|NCT00132678|64208499|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
23124853|NCT00132678|64208500|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
23124854|NCT00132678|64208501|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
23426033|NCT00526110|65303473|FG000|Overall Study|Maximal Response|0|||
23426034|NCT00526110|65303474|FG001|Overall Study|Maximal Response|6|||
23426035|NCT00526110|65303473|FG000|Overall Study|Withdrawal by Subject|0|||
23617314|NCT00168805|65985140|FG001|Overall Study|Adverse Event|11|||
23124855|NCT00132678|64208499|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
23124856|NCT00132678|64208500|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
23124857|NCT00132678|64208501|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
23124858|NCT00132678|64208499|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
23124859|NCT00132678|64208500|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
23124860|NCT00132678|64208501|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
23124861|NCT00132678|64208499|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
23124862|NCT00132678|64208500|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
23124863|NCT00132678|64208501|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
23124864|NCT00132678|64208499|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
23124865|NCT00132678|64208500|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
23124866|NCT00132678|64208501|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
23124867|NCT00132678|64208499|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
23124868|NCT00132678|64208500|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
23124869|NCT00132678|64208501|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
23124870|NCT00132678|64208499|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
23124871|NCT00132678|64208500|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
23124872|NCT00132678|64208501|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
23124873|NCT00132678|64208499|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
23124874|NCT00132678|64208500|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
23124875|NCT00132678|64208501|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
23124876|NCT00132678|64208499|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
23124877|NCT00132678|64208500|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
23124878|NCT00132678|64208501|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
23124879|NCT00132678|64208499|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
23124880|NCT00132678|64208500|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
23124881|NCT00132678|64208501|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
23124882|NCT00132678|64208499|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
23124883|NCT00132678|64208500|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
23124884|NCT00132678|64208501|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
23124885|NCT03631407|64208503|FG000|Overall Study|Withdrawal by Subject|3|||
23124886|NCT03631407|64208504|FG001|Overall Study|Withdrawal by Subject|2|||
23124887|NCT03631407|64208503|FG000|Overall Study|Sponsor Decision|0|||
23124888|NCT03631407|64208504|FG001|Overall Study|Sponsor Decision|2|||
23124889|NCT03631407|64208503|FG000|Overall Study|Death|16|||
23124890|NCT03631407|64208504|FG001|Overall Study|Death|16|||
23124891|NCT03631407|64208503|FG000|Overall Study|Randomized by mistake without study treatment|1|||
23124892|NCT03631407|64208504|FG001|Overall Study|Randomized by mistake without study treatment|0|||
23124893|NCT01080300|64208506|FG000|Overall Study|Adverse Event|49|||
23124894|NCT01080300|64208507|FG001|Overall Study|Adverse Event|35|||
23124895|NCT01080300|64208506|FG000|Overall Study|Lack of Efficacy|12|||
23124896|NCT01080300|64208507|FG001|Overall Study|Lack of Efficacy|15|||
23124897|NCT01080300|64208506|FG000|Overall Study|Protocol Violation|7|||
23124898|NCT01080300|64208507|FG001|Overall Study|Protocol Violation|13|||
23124899|NCT01080300|64208506|FG000|Overall Study|Lost to Follow-up|10|||
23124900|NCT01080300|64208507|FG001|Overall Study|Lost to Follow-up|6|||
23124901|NCT01080300|64208506|FG000|Overall Study|Death|0|||
23124902|NCT01080300|64208507|FG001|Overall Study|Death|1|||
23124903|NCT01080300|64208506|FG000|Overall Study|Withdrawal by Subject|12|||
23124904|NCT01080300|64208507|FG001|Overall Study|Withdrawal by Subject|28|||
23124905|NCT01080300|64208506|FG000|Overall Study|Reasons not specified|4|||
23124906|NCT01080300|64208507|FG001|Overall Study|Reasons not specified|6|||
23124907|NCT05262751|64208508|FG000|Washout Period 2|Adverse Event|1|||
23124908|NCT05262751|64208509|FG001|Washout Period 2|Adverse Event|0|||
23124909|NCT05262751|64208510|FG002|Washout Period 2|Adverse Event|0|||
23124910|NCT05262751|64208511|FG003|Washout Period 2|Adverse Event|0|||
23124911|NCT05262751|64208512|FG004|Washout Period 2|Adverse Event|0|||
23124912|NCT05262751|64208513|FG005|Washout Period 2|Adverse Event|0|||
23124913|NCT05262751|64208508|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
23124914|NCT05262751|64208509|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
23124915|NCT05262751|64208510|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
23124916|NCT05262751|64208511|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
23124917|NCT05262751|64208512|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
23617315|NCT00168805|65985141|FG002|Overall Study|Adverse Event|16|||
23124918|NCT05262751|64208513|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
23124919|NCT00798434|64208514|FG000|Double-Blind|Adverse Event|22|||
23124920|NCT00798434|64208515|FG001|Double-Blind|Adverse Event|46|||
23124921|NCT00798434|64208514|FG000|Double-Blind|Death|0|||
23124922|NCT00798434|64208515|FG001|Double-Blind|Death|1|||
23124923|NCT00798434|64208514|FG000|Double-Blind|Lost to Follow-up|1|||
23124924|NCT00798434|64208515|FG001|Double-Blind|Lost to Follow-up|0|||
23124925|NCT00798434|64208514|FG000|Double-Blind|Lack of Efficacy|8|||
23124926|NCT00798434|64208515|FG001|Double-Blind|Lack of Efficacy|12|||
23124927|NCT00798434|64208514|FG000|Double-Blind|Withdrawal by Subject|17|||
23124928|NCT00798434|64208515|FG001|Double-Blind|Withdrawal by Subject|14|||
23124929|NCT00798434|64208514|FG000|Double-Blind|Protocol Violation|1|||
23124930|NCT00798434|64208515|FG001|Double-Blind|Protocol Violation|4|||
23124931|NCT00798434|64208514|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
23124932|NCT00798434|64208515|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
23124933|NCT00798434|64208514|FG000|Double-Blind|Other|1|||
23124934|NCT00798434|64208515|FG001|Double-Blind|Other|0|||
23124935|NCT00798434|64208514|FG000|Double-Blind|Not Treated|3|||
23124936|NCT00798434|64208515|FG001|Double-Blind|Not Treated|6|||
23124937|NCT00798434|64208514|FG000|Open-Label|Adverse Event|33|||
23124938|NCT00798434|64208515|FG001|Open-Label|Adverse Event|11|||
23124939|NCT00798434|64208514|FG000|Open-Label|Lack of Efficacy|5|||
23124940|NCT00798434|64208515|FG001|Open-Label|Lack of Efficacy|11|||
23314634|NCT00426361|64895372|FG002|Overall Study|Lost to Follow-up|5|||
23314635|NCT00426361|64895370|FG000|Overall Study|Withdrawal by Subject|1|||
23314636|NCT00426361|64895371|FG001|Overall Study|Withdrawal by Subject|3|||
23124941|NCT00798434|64208514|FG000|Open-Label|Withdrawal by Subject|2|||
23124942|NCT00798434|64208515|FG001|Open-Label|Withdrawal by Subject|7|||
23124943|NCT00798434|64208514|FG000|Open-Label|Protocol Violation|1|||
23124944|NCT00798434|64208515|FG001|Open-Label|Protocol Violation|0|||
23124945|NCT00798434|64208514|FG000|Open-Label|Other|1|||
23124946|NCT00798434|64208515|FG001|Open-Label|Other|2|||
23124947|NCT00798434|64208514|FG000|Open-Label|Not Treated|0|||
23124948|NCT00798434|64208515|FG001|Open-Label|Not Treated|1|||
23124949|NCT01240551|64208516|FG000|Overall Study|Refused further treatment|3|||
23124950|NCT01240551|64208517|FG001|Overall Study|Refused further treatment|2|||
23124951|NCT01240551|64208516|FG000|Overall Study|Lost to Follow-up|1|||
23124952|NCT01240551|64208517|FG001|Overall Study|Lost to Follow-up|1|||
23124953|NCT03768336|64208518|FG000|Overall Study|Lost to Follow-up|3|||
23124954|NCT03768336|64208519|FG001|Overall Study|Lost to Follow-up|2|||
23124955|NCT03768336|64208518|FG000|Overall Study|Became Ineligible|2|||
23124956|NCT03768336|64208519|FG001|Overall Study|Became Ineligible|0|||
23124957|NCT03768336|64208518|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
23314637|NCT00426361|64895372|FG002|Overall Study|Withdrawal by Subject|0|||
23314638|NCT02766283|64895373|FG000|Overall Study|Lost to Follow-up|27|||
23314639|NCT02198963|64895374|FG000|Overall Study|Adverse Event|1|||
23544015|NCT00680407|65722969|FG001|Overall Study|Withdrawal by Subject|2|||
23544016|NCT00680407|65722970|FG002|Overall Study|Withdrawal by Subject|2|||
23544017|NCT00023673|65722971|FG000|Overall Study|Ineligible / no protocol treatment|0|||
23544018|NCT00023673|65722972|FG001|Overall Study|Ineligible / no protocol treatment|0|||
23544019|NCT00023673|65722973|FG002|Overall Study|Ineligible / no protocol treatment|0|||
23544020|NCT00023673|65722974|FG003|Overall Study|Ineligible / no protocol treatment|1|||
23544021|NCT00023673|65722971|FG000|Overall Study|Patient withdrew consent|0|||
23544022|NCT00023673|65722972|FG001|Overall Study|Patient withdrew consent|0|||
23544023|NCT00023673|65722973|FG002|Overall Study|Patient withdrew consent|0|||
23544024|NCT00023673|65722974|FG003|Overall Study|Patient withdrew consent|1|||
23544025|NCT02207829|65722975|FG000|Overall Study|Adverse Event|10|||
23544026|NCT02207829|65722976|FG001|Overall Study|Adverse Event|9|||
23544027|NCT02207829|65722975|FG000|Overall Study|Lack of Efficacy|7|||
23544028|NCT02207829|65722976|FG001|Overall Study|Lack of Efficacy|5|||
23544029|NCT02207829|65722975|FG000|Overall Study|Lost to Follow-up|2|||
23544030|NCT02207829|65722976|FG001|Overall Study|Lost to Follow-up|2|||
23544031|NCT02207829|65722975|FG000|Overall Study|Protocol deviation|5|||
23544032|NCT02207829|65722976|FG001|Overall Study|Protocol deviation|4|||
23544033|NCT02207829|65722975|FG000|Overall Study|Withdrew consent|18|||
23544034|NCT02207829|65722976|FG001|Overall Study|Withdrew consent|14|||
23124958|NCT03768336|64208519|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
23124959|NCT03768336|64208518|FG000|Overall Study|Missed final survey (post-treatment|0|||
23124960|NCT03768336|64208519|FG001|Overall Study|Missed final survey (post-treatment|1|||
23544035|NCT01303627|65722977|FG000|Overall Study|the failure while performing URS|0|||
23544036|NCT01303627|65722978|FG001|Overall Study|the failure while performing URS|1|||
23544037|NCT00353704|65722979|FG000|Overall Study|Protocol Violation|3|||
23544038|NCT00353704|65722980|FG001|Overall Study|Protocol Violation|1|||
23124961|NCT01174264|64208520|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
23124962|NCT01174264|64208521|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
23124963|NCT01174264|64208522|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
23124964|NCT01174264|64208520|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
23314640|NCT02198963|64895374|FG000|Overall Study|Withdrawal by Subject|6|||
23314641|NCT04058067|64895375|FG000|Overall Study|Adverse Event|2|||
23314642|NCT04058067|64895376|FG001|Overall Study|Adverse Event|0|||
23314643|NCT04058067|64895375|FG000|Overall Study|Death|0|||
23314644|NCT04058067|64895376|FG001|Overall Study|Death|1|||
23314645|NCT04058067|64895375|FG000|Overall Study|Physician Decision|3|||
23426036|NCT00526110|65303474|FG001|Overall Study|Withdrawal by Subject|2|||
23426037|NCT00526110|65303473|FG000|Overall Study|Poor Tolerance|0|||
23544039|NCT02328326|65722983|FG000|Overall Study|Withdrawal by Subject|10|||
23544040|NCT02328326|65722984|FG001|Overall Study|Withdrawal by Subject|3|||
23544041|NCT02328326|65722983|FG000|Overall Study|Death|2|||
23544042|NCT02328326|65722984|FG001|Overall Study|Death|1|||
23544043|NCT02328326|65722983|FG000|Overall Study|Lost to Follow-up|10|||
23544044|NCT02328326|65722984|FG001|Overall Study|Lost to Follow-up|4|||
23124965|NCT01174264|64208521|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
23124966|NCT01174264|64208522|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
23124967|NCT01174264|64208520|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
23124968|NCT01174264|64208521|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
23124969|NCT01174264|64208522|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
23124970|NCT04351269|64208524|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
23124971|NCT04351269|64208525|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
23124972|NCT04351269|64208526|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
23124973|NCT04351269|64208524|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
23124974|NCT04351269|64208525|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
23124975|NCT04351269|64208526|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
23124976|NCT04351269|64208524|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
23124977|NCT04351269|64208525|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
23124978|NCT04351269|64208526|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
23124979|NCT04351269|64208524|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
23124980|NCT04351269|64208525|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
23124981|NCT04351269|64208526|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
23124982|NCT04351269|64208524|FG000|Overall Study|Lost to Follow-up|1|||
23124983|NCT04351269|64208525|FG001|Overall Study|Lost to Follow-up|3|||
23124984|NCT04351269|64208526|FG002|Overall Study|Lost to Follow-up|0|||
23124985|NCT01896557|64208529|FG000|Clopidogrel Alone|Adverse Event|1|||
23124986|NCT01896557|64208530|FG001|Clopidogrel Alone|Adverse Event|0|||
23124987|NCT01896557|64208529|FG000|Clopidogrel + GI Protector|low adherence|1|||
23124988|NCT01896557|64208530|FG001|Clopidogrel + GI Protector|low adherence|1|||
23124989|NCT01896557|64208529|FG000|Clopidogrel + GI Protector|Reading error|1|||
23314646|NCT04058067|64895376|FG001|Overall Study|Physician Decision|1|||
23426038|NCT00526110|65303474|FG001|Overall Study|Poor Tolerance|5|||
23426039|NCT02419131|65303478|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
23426040|NCT02419131|65303479|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
23426041|NCT02419131|65303480|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
23426042|NCT02419131|65303478|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
23426043|NCT02419131|65303479|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
23426044|NCT02419131|65303480|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
23426045|NCT02744612|65303489|FG000|Overall Study|Withdrawal by Subject|0|||
23426046|NCT02744612|65303490|FG001|Overall Study|Withdrawal by Subject|2|||
23426047|NCT03943550|65303491|FG000|Overall Study|Adverse Event|0|||
23426048|NCT03943550|65303492|FG001|Overall Study|Adverse Event|0|||
23426049|NCT03943550|65303493|FG002|Overall Study|Adverse Event|1|||
23426050|NCT03943550|65303491|FG000|Overall Study|Lost to Follow-up|0|||
23426051|NCT03943550|65303492|FG001|Overall Study|Lost to Follow-up|0|||
23426052|NCT03943550|65303493|FG002|Overall Study|Lost to Follow-up|1|||
23426053|NCT03943550|65303491|FG000|Overall Study|Progressive Disease|0|||
23426054|NCT03943550|65303492|FG001|Overall Study|Progressive Disease|0|||
23426055|NCT03943550|65303493|FG002|Overall Study|Progressive Disease|2|||
23426056|NCT03943550|65303491|FG000|Overall Study|Participant Moved Out of the Country|0|||
23426057|NCT03943550|65303492|FG001|Overall Study|Participant Moved Out of the Country|1|||
23426058|NCT03943550|65303493|FG002|Overall Study|Participant Moved Out of the Country|0|||
23426059|NCT00590824|65303496|FG000|Overall Study|Disease could not be resected|0|||
23426060|NCT00590824|65303497|FG001|Overall Study|Disease could not be resected|2|||
23426061|NCT00590824|65303498|FG002|Overall Study|Disease could not be resected|1|||
23426062|NCT00590824|65303499|FG003|Overall Study|Disease could not be resected|0|||
23426063|NCT00590824|65303496|FG000|Overall Study|Adverse Event|0|||
23426064|NCT00590824|65303497|FG001|Overall Study|Adverse Event|0|||
23426065|NCT00590824|65303498|FG002|Overall Study|Adverse Event|0|||
23426066|NCT00590824|65303499|FG003|Overall Study|Adverse Event|1|||
23426067|NCT02650128|65303500|FG000|Overall Study|Death|2|||
23544045|NCT02007577|65722985|FG000|Overall Study|Adverse Event|1|||
23544046|NCT02007577|65722986|FG001|Overall Study|Adverse Event|0|||
23314647|NCT04058067|64895375|FG000|Overall Study|Protocol Violation|0|||
23314648|NCT04058067|64895376|FG001|Overall Study|Protocol Violation|1|||
23314649|NCT04058067|64895375|FG000|Overall Study|Withdrawal by Subject|7|||
23314650|NCT04058067|64895376|FG001|Overall Study|Withdrawal by Subject|8|||
23314651|NCT01590277|64895377|FG000|Overall Study|Withdrawal by Subject|3|||
23314652|NCT01590277|64895377|FG000|Overall Study|Withdrawal by Subject|2|||
23314653|NCT01590277|64895377|FG000|Overall Study|Withdrawal by Subject|1|||
23314654|NCT01590277|64895377|FG000|Overall Study|Withdrawal by Subject|1|||
23314655|NCT01141205|64895378|FG000|Overall Study|Physician Decision|1|||
23314656|NCT01141205|64895379|FG001|Overall Study|Physician Decision|1|||
23314657|NCT01141205|64895378|FG000|Overall Study|Lost to Follow-up|1|||
23314658|NCT01141205|64895379|FG001|Overall Study|Lost to Follow-up|0|||
23314659|NCT01141205|64895378|FG000|Overall Study|Withdrawal by Subject|1|||
23314660|NCT01141205|64895379|FG001|Overall Study|Withdrawal by Subject|1|||
23314661|NCT01199016|64895380|FG000|Overall Study|No longer meets eligibility criteria|4|||
23314662|NCT01199016|64895380|FG000|Overall Study|Entrance criteria|5|||
23314663|NCT01199016|64895380|FG000|Overall Study|Protocol Violation|9|||
23314664|NCT01199016|64895380|FG000|Overall Study|Other|13|||
23314665|NCT01199016|64895380|FG000|Overall Study|Withdrawal by Subject|21|||
23314666|NCT01199016|64895380|FG000|Overall Study|Lost to Follow-up|25|||
23314667|NCT04388553|64895381|FG000|Overall Study|Protocol Violation|1|||
23314668|NCT04388553|64895382|FG001|Overall Study|Protocol Violation|0|||
23314669|NCT00801099|64895383|FG000|Overall Study|Lost to Follow-up|101|||
23314670|NCT00796107|64895384|FG000|Overall Study|Lack of Efficacy|1|||
23314671|NCT00796107|64895384|FG000|Overall Study|Progressive Disease|5|||
23314672|NCT04803305|64895385|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
23314673|NCT04803305|64895386|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
23314674|NCT04803305|64895385|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
23314675|NCT04803305|64895386|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
23314676|NCT04803305|64895385|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
23314677|NCT04803305|64895386|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
23314678|NCT04803305|64895385|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
23314679|NCT04803305|64895386|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
23314680|NCT04803305|64895385|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
23314681|NCT04803305|64895386|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
23314682|NCT04803305|64895385|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
23314683|NCT04803305|64895386|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
23314684|NCT04803305|64895385|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
23314685|NCT04803305|64895386|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
23314686|NCT04803305|64895385|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
23124990|NCT01896557|64208530|FG001|Clopidogrel + GI Protector|Reading error|3|||
23124991|NCT02388347|64208531|FG000|Overall Study|Withdrawal by Subject|0|||
23124992|NCT02388347|64208532|FG001|Overall Study|Withdrawal by Subject|0|||
23314687|NCT04803305|64895386|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
23314688|NCT01721317|64895388|FG000|Overall Study|Study Closed / Terminated|2|||
23314689|NCT01721317|64895389|FG001|Overall Study|Study Closed / Terminated|2|||
23314690|NCT01721317|64895388|FG000|Overall Study|Physician Decision|0|||
23314691|NCT01721317|64895389|FG001|Overall Study|Physician Decision|1|||
23314692|NCT01721317|64895388|FG000|Overall Study|Withdrawal by Subject|0|||
23426068|NCT03002623|65303501|FG000|Overall Study|Lost to Follow-up|1|||
23617316|NCT00168805|65985139|FG000|Overall Study|Protocol Violation|12|||
23617317|NCT00168805|65985140|FG001|Overall Study|Protocol Violation|11|||
23617318|NCT00168805|65985141|FG002|Overall Study|Protocol Violation|8|||
23617319|NCT00168805|65985139|FG000|Overall Study|Lost to Follow-up|12|||
23617320|NCT00168805|65985140|FG001|Overall Study|Lost to Follow-up|17|||
23617321|NCT00168805|65985141|FG002|Overall Study|Lost to Follow-up|11|||
23617322|NCT00168805|65985139|FG000|Overall Study|Withdrawal by Subject|16|||
23124993|NCT02388347|64208533|FG002|Overall Study|Withdrawal by Subject|1|||
23124994|NCT02388347|64208534|FG003|Overall Study|Withdrawal by Subject|0|||
23124995|NCT02388347|64208535|FG004|Overall Study|Withdrawal by Subject|0|||
23124996|NCT01200290|64208536|FG000|Treatment Period|Adverse Event|1|||
23211359|NCT00868166|64512461|FG001|Overall Study|Withdrawal by Subject|25|||
23314693|NCT01721317|64895389|FG001|Overall Study|Withdrawal by Subject|1|||
23314694|NCT02257385|64895390|FG000|Overall Study|Adverse Event|12|||
23314695|NCT02257385|64895391|FG001|Overall Study|Adverse Event|8|||
23314696|NCT02257385|64895390|FG000|Overall Study|Lack of Efficacy|1|||
23617323|NCT00168805|65985140|FG001|Overall Study|Withdrawal by Subject|18|||
23124997|NCT01200290|64208536|FG000|Post-Treatment Follow-Up Period|Death|2|||
23314697|NCT02257385|64895391|FG001|Overall Study|Lack of Efficacy|2|||
23314698|NCT02257385|64895390|FG000|Overall Study|Protocol Violation|5|||
23314699|NCT02257385|64895391|FG001|Overall Study|Protocol Violation|7|||
23314700|NCT02257385|64895390|FG000|Overall Study|Lost to Follow-up|0|||
23314701|NCT02257385|64895391|FG001|Overall Study|Lost to Follow-up|1|||
23314702|NCT02257385|64895390|FG000|Overall Study|Withdrawal by Subject|4|||
23314703|NCT02257385|64895391|FG001|Overall Study|Withdrawal by Subject|4|||
23314704|NCT02906358|64895392|FG000|Overall Study|Withdrawal by Subject|10|||
23314705|NCT02906358|64895393|FG001|Overall Study|Withdrawal by Subject|7|||
23314706|NCT02906358|64895392|FG000|Overall Study|Lost to Follow-up|12|||
23314707|NCT02906358|64895393|FG001|Overall Study|Lost to Follow-up|15|||
23544047|NCT02007577|65722985|FG000|Overall Study|Withdrawal by Subject|0|||
23544048|NCT02007577|65722986|FG001|Overall Study|Withdrawal by Subject|1|||
23544049|NCT01329029|65722987|FG000|Overall Study|Withdrawal by Subject|117|||
23544050|NCT01329029|65722988|FG001|Overall Study|Withdrawal by Subject|87|||
23544051|NCT01329029|65722987|FG000|Overall Study|Adverse Event|82|||
23314708|NCT00264550|64895395|FG000|Overall Study|Death|0|||
23314709|NCT00264550|64895396|FG001|Overall Study|Death|3|||
23314710|NCT00264550|64895397|FG002|Overall Study|Death|0|||
23314711|NCT00264550|64895398|FG003|Overall Study|Death|0|||
23314712|NCT00264550|64895395|FG000|Overall Study|Lost to Follow-up|3|||
23314713|NCT00264550|64895396|FG001|Overall Study|Lost to Follow-up|1|||
23314714|NCT00264550|64895397|FG002|Overall Study|Lost to Follow-up|1|||
23314715|NCT00264550|64895398|FG003|Overall Study|Lost to Follow-up|1|||
23314716|NCT00264550|64895395|FG000|Overall Study|Adverse Event|23|||
23314717|NCT00264550|64895396|FG001|Overall Study|Adverse Event|18|||
23314718|NCT00264550|64895397|FG002|Overall Study|Adverse Event|9|||
23314719|NCT00264550|64895398|FG003|Overall Study|Adverse Event|14|||
23314720|NCT00264550|64895395|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23314721|NCT00264550|64895396|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
23544052|NCT01329029|65722988|FG001|Overall Study|Adverse Event|29|||
23314722|NCT00264550|64895397|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
23314723|NCT00264550|64895398|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
23314724|NCT00264550|64895395|FG000|Overall Study|Discontinued oral study agent|0|||
23314725|NCT00264550|64895396|FG001|Overall Study|Discontinued oral study agent|1|||
23314726|NCT00264550|64895397|FG002|Overall Study|Discontinued oral study agent|0|||
23314727|NCT00264550|64895398|FG003|Overall Study|Discontinued oral study agent|0|||
23314728|NCT00264550|64895395|FG000|Overall Study|Other|13|||
23314729|NCT00264550|64895396|FG001|Overall Study|Other|7|||
23314730|NCT00264550|64895397|FG002|Overall Study|Other|3|||
23314731|NCT00264550|64895398|FG003|Overall Study|Other|9|||
23314732|NCT01338870|64895399|FG000|Overall Study|Lost to Follow-up|0|||
23314733|NCT01338870|64895400|FG001|Overall Study|Lost to Follow-up|0|||
23314734|NCT01338870|64895401|FG002|Overall Study|Lost to Follow-up|1|||
23314735|NCT01338870|64895402|FG003|Overall Study|Lost to Follow-up|0|||
23314736|NCT01338870|64895403|FG004|Overall Study|Lost to Follow-up|1|||
23314737|NCT01338870|64895404|FG005|Overall Study|Lost to Follow-up|0|||
23314738|NCT01338870|64895399|FG000|Overall Study|Withdrawal by Subject|2|||
23314739|NCT01338870|64895400|FG001|Overall Study|Withdrawal by Subject|3|||
23314740|NCT01338870|64895401|FG002|Overall Study|Withdrawal by Subject|4|||
23314741|NCT01338870|64895402|FG003|Overall Study|Withdrawal by Subject|0|||
23314742|NCT01338870|64895403|FG004|Overall Study|Withdrawal by Subject|0|||
23314743|NCT01338870|64895404|FG005|Overall Study|Withdrawal by Subject|2|||
23314744|NCT01338870|64895399|FG000|Overall Study|Other|3|||
23314745|NCT01338870|64895400|FG001|Overall Study|Other|3|||
23314746|NCT01338870|64895401|FG002|Overall Study|Other|3|||
23314747|NCT01338870|64895402|FG003|Overall Study|Other|2|||
23314748|NCT01338870|64895403|FG004|Overall Study|Other|0|||
23314749|NCT01338870|64895404|FG005|Overall Study|Other|2|||
23314750|NCT01338870|64895399|FG000|Overall Study|Protocol Violation|0|||
23314751|NCT01338870|64895400|FG001|Overall Study|Protocol Violation|2|||
23426069|NCT03002623|65303502|FG001|Overall Study|Lost to Follow-up|0|||
23544053|NCT01329029|65722987|FG000|Overall Study|Death|16|||
23544054|NCT01329029|65722988|FG001|Overall Study|Death|19|||
23544055|NCT01329029|65722987|FG000|Overall Study|Other|14|||
23544056|NCT01329029|65722988|FG001|Overall Study|Other|20|||
23544057|NCT01329029|65722987|FG000|Overall Study|COPD Exacerbation|11|||
23544058|NCT01329029|65722988|FG001|Overall Study|COPD Exacerbation|18|||
23544059|NCT01329029|65722987|FG000|Overall Study|Physician Decision|16|||
23544060|NCT01329029|65722988|FG001|Overall Study|Physician Decision|13|||
23544061|NCT01329029|65722987|FG000|Overall Study|Lost to Follow-up|8|||
23544062|NCT01329029|65722988|FG001|Overall Study|Lost to Follow-up|5|||
23544063|NCT01329029|65722987|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
23314752|NCT01338870|64895401|FG002|Overall Study|Protocol Violation|2|||
23426070|NCT03002623|65303501|FG000|Overall Study|Physician Decision|1|||
23544064|NCT01329029|65722988|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
23544065|NCT00833989|65722989|FG000|Overall Study|Physician Decision|0|||
23544066|NCT00833989|65722990|FG001|Overall Study|Physician Decision|0|||
23544067|NCT00833989|65722991|FG002|Overall Study|Physician Decision|0|||
23314753|NCT01338870|64895402|FG003|Overall Study|Protocol Violation|2|||
23314754|NCT01338870|64895403|FG004|Overall Study|Protocol Violation|1|||
23314755|NCT01338870|64895404|FG005|Overall Study|Protocol Violation|1|||
23314756|NCT01338870|64895399|FG000|Overall Study|Adverse Event|4|||
23314757|NCT01338870|64895400|FG001|Overall Study|Adverse Event|4|||
23314758|NCT01338870|64895401|FG002|Overall Study|Adverse Event|1|||
23314759|NCT01338870|64895402|FG003|Overall Study|Adverse Event|5|||
23314760|NCT01338870|64895403|FG004|Overall Study|Adverse Event|4|||
23314761|NCT01338870|64895404|FG005|Overall Study|Adverse Event|1|||
23314762|NCT02296931|64895406|FG000|Overall Study|Protocol Violation|0|||
23314763|NCT02296931|64895407|FG001|Overall Study|Protocol Violation|2|||
23314764|NCT00810511|64895408|FG000|Overall Study|Protocol Violation|0|||
23314765|NCT00810511|64895409|FG001|Overall Study|Protocol Violation|1|||
23314766|NCT00810511|64895408|FG000|Overall Study|Lack of Efficacy|9|||
23314767|NCT00810511|64895409|FG001|Overall Study|Lack of Efficacy|1|||
23314768|NCT00810511|64895408|FG000|Overall Study|death in the family|0|||
23314769|NCT00810511|64895409|FG001|Overall Study|death in the family|1|||
23314770|NCT00810511|64895408|FG000|Overall Study|Lost to Follow-up|1|||
23314771|NCT00810511|64895409|FG001|Overall Study|Lost to Follow-up|0|||
23314772|NCT00810511|64895408|FG000|Overall Study|deposits on contact lens|0|||
23314773|NCT00810511|64895409|FG001|Overall Study|deposits on contact lens|1|||
23314774|NCT04746794|64895410|FG000|Overall Study|Did not complete any study assessment|50303|||
23314775|NCT04746794|64895411|FG001|Overall Study|Did not complete any study assessment|44997|||
23314776|NCT03696953|64895412|FG000|Overall Study|Withdrawal by Subject|6|||
23314777|NCT03696953|64895413|FG001|Overall Study|Withdrawal by Subject|1|||
23314778|NCT03696953|64895412|FG000|Overall Study|missed GBS swabs|2|||
23314779|NCT03696953|64895413|FG001|Overall Study|missed GBS swabs|2|||
23314780|NCT03696953|64895412|FG000|Overall Study|lost study bottle containing capsules|2|||
23314781|NCT03696953|64895413|FG001|Overall Study|lost study bottle containing capsules|0|||
23314782|NCT03696953|64895412|FG000|Overall Study|Premature birth|1|||
23314783|NCT03696953|64895413|FG001|Overall Study|Premature birth|4|||
23314784|NCT03696953|64895412|FG000|Overall Study|Gestational hypertension|1|||
23426071|NCT03002623|65303502|FG001|Overall Study|Physician Decision|1|||
23426072|NCT01697462|65303508|FG000|Overall Study|Disease Progression|1|||
23426073|NCT01697462|65303508|FG000|Overall Study|Adverse Event|6|||
23426074|NCT01697462|65303508|FG000|Overall Study|Lost to Follow-up|21|||
23426075|NCT01697462|65303508|FG000|Overall Study|Withdrawal by Subject|12|||
23124998|NCT02172911|64208537|FG000|Overall Study|Serious Adverse Event|0|||
23124999|NCT02172911|64208538|FG001|Overall Study|Serious Adverse Event|1|||
23125000|NCT02172911|64208537|FG000|Overall Study|Progression of Disease|0|||
23125001|NCT02172911|64208538|FG001|Overall Study|Progression of Disease|1|||
23125002|NCT02172911|64208537|FG000|Overall Study|Loss of insurance coverage|1|||
23125003|NCT02172911|64208538|FG001|Overall Study|Loss of insurance coverage|0|||
23125004|NCT00358644|64208539|FG000|Overall Study|Progressive Disease|21|||
23125005|NCT00358644|64208539|FG000|Overall Study|Adverse Event|7|||
23211360|NCT00868166|64512460|FG000|Overall Study|Protocol Violation|1|||
23211361|NCT00868166|64512461|FG001|Overall Study|Protocol Violation|0|||
23211362|NCT00868166|64512460|FG000|Overall Study|Lost to Follow-up|1|||
23211363|NCT00868166|64512461|FG001|Overall Study|Lost to Follow-up|3|||
23211364|NCT00868166|64512460|FG000|Overall Study|Adverse Event|9|||
23211365|NCT00868166|64512461|FG001|Overall Study|Adverse Event|10|||
23211366|NCT00868166|64512460|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
23211367|NCT00868166|64512461|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
23211368|NCT00868166|64512460|FG000|Overall Study|Non-compliance with IMP|1|||
23211369|NCT00868166|64512461|FG001|Overall Study|Non-compliance with IMP|1|||
23211370|NCT00664209|64512462|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
23211371|NCT00664209|64512462|FG000|Study Treatment Period|Physician Decision|4|||
23211372|NCT00664209|64512462|FG000|Study Treatment Period|Withdrawal by Subject|2|||
23211373|NCT04348656|64512463|FG000|Overall Study|Withdrawal by Subject|2|||
23211374|NCT04348656|64512464|FG001|Overall Study|Withdrawal by Subject|0|||
23211375|NCT04348656|64512463|FG000|Overall Study|Lost to Follow-up|11|||
23211376|NCT04348656|64512464|FG001|Overall Study|Lost to Follow-up|6|||
23211377|NCT00418379|64512465|FG000|Year 1|Adverse Event|9|||
23211378|NCT00418379|64512466|FG001|Year 1|Adverse Event|15|||
23211379|NCT00418379|64512467|FG002|Year 1|Adverse Event|3|||
23211380|NCT00418379|64512465|FG000|Year 1|Withdrawal by Subject|7|||
23211381|NCT00418379|64512466|FG001|Year 1|Withdrawal by Subject|8|||
23211382|NCT00418379|64512467|FG002|Year 1|Withdrawal by Subject|5|||
23211383|NCT00418379|64512465|FG000|Year 1|Any other reason not above-mentioned|2|||
23211384|NCT00418379|64512466|FG001|Year 1|Any other reason not above-mentioned|5|||
23211385|NCT00418379|64512467|FG002|Year 1|Any other reason not above-mentioned|7|||
23211386|NCT00418379|64512465|FG000|Year 2|Adverse Event|5|||
23211387|NCT00418379|64512466|FG001|Year 2|Adverse Event|2|||
23426076|NCT01697462|65303508|FG000|Overall Study|Investigator Decision|21|||
23211388|NCT00418379|64512467|FG002|Year 2|Adverse Event|1|||
23211389|NCT00418379|64512465|FG000|Year 2|Withdrawal by Subject|1|||
23314785|NCT03696953|64895413|FG001|Overall Study|Gestational hypertension|1|||
23211390|NCT00418379|64512466|FG001|Year 2|Withdrawal by Subject|1|||
23211391|NCT00418379|64512467|FG002|Year 2|Withdrawal by Subject|3|||
23314786|NCT03696953|64895412|FG000|Overall Study|Gestational diabetes|2|||
23314787|NCT03696953|64895413|FG001|Overall Study|Gestational diabetes|1|||
23426077|NCT01697462|65303508|FG000|Overall Study|Death|1|||
23426078|NCT01697462|65303508|FG000|Overall Study|Other|10|||
23125006|NCT00358644|64208539|FG000|Overall Study|Death|11|||
23314788|NCT03696953|64895412|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
23314789|NCT03696953|64895413|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
23426079|NCT01697462|65303508|FG000|Overall Study|Missing|5|||
23125007|NCT00358644|64208539|FG000|Overall Study|Withdrawal by Subject|4|||
23125008|NCT00358644|64208539|FG000|Overall Study|Physician Decision|6|||
23125009|NCT00358644|64208539|FG000|Overall Study|Patient not eligible for study|1|||
23125010|NCT01646385|64208540|FG000|Overall Study|Death|202|||
23426080|NCT00875056|65303511|FG000|Overall Study|Adverse Event|6|||
23426081|NCT00875056|65303512|FG001|Overall Study|Adverse Event|1|||
23125011|NCT01646385|64208541|FG001|Overall Study|Death|222|||
23125012|NCT01646385|64208540|FG000|Overall Study|Switched to alternate biologic|636|||
23125013|NCT01646385|64208541|FG001|Overall Study|Switched to alternate biologic|649|||
23125014|NCT02375347|64208542|FG000|Overall Study|Protocol Violation|1|||
23125015|NCT02552147|64208543|FG000|First Intervention (7 Days)|Protocol Violation|1|||
23125016|NCT02552147|64208544|FG001|First Intervention (7 Days)|Protocol Violation|0|||
23125017|NCT02552147|64208543|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
23125018|NCT02552147|64208544|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
23125019|NCT02630706|64208545|FG000|Overall Study|Adverse Event|2|||
23125020|NCT02630706|64208546|FG001|Overall Study|Adverse Event|1|||
23125021|NCT02630706|64208547|FG002|Overall Study|Adverse Event|1|||
23125022|NCT02630706|64208545|FG000|Overall Study|Lost to Follow-up|0|||
23125023|NCT02630706|64208546|FG001|Overall Study|Lost to Follow-up|1|||
23125024|NCT02630706|64208547|FG002|Overall Study|Lost to Follow-up|2|||
23544068|NCT00833989|65722992|FG003|Overall Study|Physician Decision|1|||
23544069|NCT00833989|65722989|FG000|Overall Study|Withdrawal by Subject|3|||
23544070|NCT00833989|65722990|FG001|Overall Study|Withdrawal by Subject|0|||
23544071|NCT00833989|65722991|FG002|Overall Study|Withdrawal by Subject|1|||
23544072|NCT00833989|65722992|FG003|Overall Study|Withdrawal by Subject|1|||
23544073|NCT02896855|65722993|FG000|Overall Study|Death|50|||
23544074|NCT02896855|65722994|FG001|Overall Study|Death|40|||
23544075|NCT02896855|65722993|FG000|Overall Study|Lost to Follow-up|15|||
23544076|NCT02896855|65722994|FG001|Overall Study|Lost to Follow-up|9|||
23544077|NCT02896855|65722993|FG000|Overall Study|Withdrawal by Subject|7|||
23544078|NCT02896855|65722994|FG001|Overall Study|Withdrawal by Subject|4|||
23125025|NCT02630706|64208545|FG000|Overall Study|Physician Decision|1|||
23125026|NCT02630706|64208546|FG001|Overall Study|Physician Decision|1|||
23125027|NCT02630706|64208547|FG002|Overall Study|Physician Decision|0|||
23125028|NCT02630706|64208545|FG000|Overall Study|Pregnancy|0|||
23125029|NCT02630706|64208546|FG001|Overall Study|Pregnancy|1|||
23125030|NCT02630706|64208547|FG002|Overall Study|Pregnancy|0|||
23125031|NCT02630706|64208545|FG000|Overall Study|Withdrawal by Subject|4|||
23125032|NCT02630706|64208546|FG001|Overall Study|Withdrawal by Subject|5|||
23125033|NCT02630706|64208547|FG002|Overall Study|Withdrawal by Subject|7|||
23125034|NCT00634842|64208555|FG000|Overall Study|Adverse Event|2|||
23426082|NCT00875056|65303513|FG002|Overall Study|Adverse Event|2|||
23426083|NCT00875056|65303511|FG000|Overall Study|Progressive Disease|14|||
23544079|NCT03579563|65722997|FG000|Overall Study|Lost to Follow-up|0|||
23544080|NCT03579563|65722998|FG001|Overall Study|Lost to Follow-up|0|||
23544081|NCT03579563|65722999|FG002|Overall Study|Lost to Follow-up|0|||
23544082|NCT03579563|65723000|FG003|Overall Study|Lost to Follow-up|0|||
23544083|NCT03579563|65723001|FG004|Overall Study|Lost to Follow-up|1|||
23544084|NCT03579563|65723002|FG005|Overall Study|Lost to Follow-up|0|||
23544085|NCT03579563|65722997|FG000|Overall Study|Lack of Efficacy|1|||
23544086|NCT03579563|65722998|FG001|Overall Study|Lack of Efficacy|1|||
23544087|NCT03579563|65722999|FG002|Overall Study|Lack of Efficacy|4|||
23544088|NCT03579563|65723000|FG003|Overall Study|Lack of Efficacy|1|||
23544089|NCT03579563|65723001|FG004|Overall Study|Lack of Efficacy|2|||
23544090|NCT03579563|65723002|FG005|Overall Study|Lack of Efficacy|3|||
23544091|NCT03579563|65722997|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
23544092|NCT03579563|65722998|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
23544093|NCT03579563|65722999|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
23544094|NCT03579563|65723000|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
23544095|NCT03579563|65723001|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
23544096|NCT03579563|65723002|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
23544097|NCT03579563|65722997|FG000|Overall Study|Time/distance concern|0|||
23544098|NCT03579563|65722998|FG001|Overall Study|Time/distance concern|0|||
23125035|NCT00634842|64208556|FG001|Overall Study|Adverse Event|3|||
23125036|NCT00634842|64208555|FG000|Overall Study|Protocol Violation|8|||
23426084|NCT00875056|65303512|FG001|Overall Study|Progressive Disease|8|||
23544099|NCT03579563|65722999|FG002|Overall Study|Time/distance concern|1|||
23544100|NCT03579563|65723000|FG003|Overall Study|Time/distance concern|0|||
23544101|NCT03579563|65723001|FG004|Overall Study|Time/distance concern|0|||
23544102|NCT03579563|65723002|FG005|Overall Study|Time/distance concern|1|||
23544103|NCT03579563|65722997|FG000|Overall Study|COVID shutdown|2|||
23544104|NCT03579563|65722998|FG001|Overall Study|COVID shutdown|3|||
23544105|NCT03579563|65722999|FG002|Overall Study|COVID shutdown|4|||
23125037|NCT00634842|64208556|FG001|Overall Study|Protocol Violation|4|||
23125038|NCT00634842|64208555|FG000|Overall Study|Move to another state|1|||
23125039|NCT00634842|64208556|FG001|Overall Study|Move to another state|0|||
23426085|NCT00875056|65303513|FG002|Overall Study|Progressive Disease|3|||
23544106|NCT03579563|65723000|FG003|Overall Study|COVID shutdown|3|||
23544107|NCT03579563|65723001|FG004|Overall Study|COVID shutdown|1|||
23544108|NCT03579563|65723002|FG005|Overall Study|COVID shutdown|2|||
23544109|NCT03579563|65722997|FG000|Overall Study|Protocol administration error|1|||
23544110|NCT03579563|65722998|FG001|Overall Study|Protocol administration error|0|||
23544111|NCT03579563|65722999|FG002|Overall Study|Protocol administration error|1|||
23544112|NCT03579563|65723000|FG003|Overall Study|Protocol administration error|0|||
23544113|NCT03579563|65723001|FG004|Overall Study|Protocol administration error|1|||
23544114|NCT03579563|65723002|FG005|Overall Study|Protocol administration error|5|||
23544115|NCT00968669|65723012|FG000|Overall Study|Lost to Follow-up|5|||
23544116|NCT00968669|65723013|FG001|Overall Study|Lost to Follow-up|2|||
23544117|NCT00968669|65723014|FG002|Overall Study|Lost to Follow-up|1|||
23544118|NCT00968669|65723015|FG003|Overall Study|Lost to Follow-up|4|||
23544119|NCT00968669|65723012|FG000|Overall Study|Withdrawal by Subject|9|||
23544120|NCT00968669|65723013|FG001|Overall Study|Withdrawal by Subject|7|||
23544121|NCT00968669|65723014|FG002|Overall Study|Withdrawal by Subject|5|||
23544122|NCT00968669|65723015|FG003|Overall Study|Withdrawal by Subject|3|||
23544123|NCT00968669|65723012|FG000|Overall Study|Pregnancy|0|||
23544124|NCT00968669|65723013|FG001|Overall Study|Pregnancy|0|||
23544125|NCT00968669|65723014|FG002|Overall Study|Pregnancy|2|||
23544126|NCT00968669|65723015|FG003|Overall Study|Pregnancy|0|||
23544127|NCT00968669|65723012|FG000|Overall Study|AE|1|||
23544128|NCT00968669|65723013|FG001|Overall Study|AE|0|||
23125040|NCT00634842|64208555|FG000|Overall Study|Inclusion criteria were not met|1|||
23125041|NCT00634842|64208556|FG001|Overall Study|Inclusion criteria were not met|0|||
23125042|NCT00634842|64208555|FG000|Overall Study|Lost to Follow-up|1|||
23125043|NCT00634842|64208556|FG001|Overall Study|Lost to Follow-up|2|||
23125044|NCT00634842|64208555|FG000|Overall Study|Physician Decision|1|||
23125045|NCT00634842|64208556|FG001|Overall Study|Physician Decision|0|||
23125046|NCT00634842|64208555|FG000|Overall Study|Withdrawal by Subject|1|||
23125047|NCT00634842|64208556|FG001|Overall Study|Withdrawal by Subject|3|||
23125048|NCT00634842|64208555|FG000|Overall Study|Lack of time and intolerance to drug|0|||
23125049|NCT00634842|64208556|FG001|Overall Study|Lack of time and intolerance to drug|1|||
23125050|NCT00634842|64208555|FG000|Overall Study|Discontinued due to injection|0|||
23125051|NCT00634842|64208556|FG001|Overall Study|Discontinued due to injection|2|||
23125052|NCT00634842|64208555|FG000|Overall Study|No need of study drug to treat diabetes|0|||
23125053|NCT00634842|64208556|FG001|Overall Study|No need of study drug to treat diabetes|1|||
23125054|NCT00634842|64208555|FG000|Overall Study|No wish to keep taking Avandia|0|||
23125055|NCT00634842|64208556|FG001|Overall Study|No wish to keep taking Avandia|1|||
23125056|NCT00634842|64208555|FG000|Overall Study|Subject off study drug for too long|0|||
23125057|NCT00634842|64208556|FG001|Overall Study|Subject off study drug for too long|1|||
23125058|NCT04978090|64208557|FG000|Overall Study|unable to adequately fit device|2|||
23125059|NCT00664534|64208558|FG000|Overall Study|Adverse Event|2|||
23125060|NCT00664534|64208559|FG001|Overall Study|Adverse Event|3|||
23211392|NCT00418379|64512465|FG000|Year 2|Any other reason not above-mentioned|2|||
23544129|NCT00968669|65723014|FG002|Overall Study|AE|0|||
23544130|NCT00968669|65723015|FG003|Overall Study|AE|0|||
23544131|NCT00968669|65723012|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
23544132|NCT00968669|65723013|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
23544133|NCT00968669|65723014|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
23617324|NCT00168805|65985141|FG002|Overall Study|Withdrawal by Subject|21|||
23617325|NCT00168805|65985139|FG000|Overall Study|Other|24|||
23617326|NCT00168805|65985140|FG001|Overall Study|Other|21|||
23617327|NCT00168805|65985141|FG002|Overall Study|Other|22|||
23617328|NCT00168805|65985139|FG000|Treatment|Adverse Event|25|||
23617329|NCT00168805|65985140|FG001|Treatment|Adverse Event|26|||
23617330|NCT00168805|65985141|FG002|Treatment|Adverse Event|32|||
23617331|NCT00168805|65985139|FG000|Treatment|Protocol Violation|3|||
23617332|NCT00168805|65985140|FG001|Treatment|Protocol Violation|5|||
23617333|NCT00168805|65985141|FG002|Treatment|Protocol Violation|5|||
23617334|NCT00168805|65985139|FG000|Treatment|Withdrawal by Subject|3|||
23617335|NCT00168805|65985140|FG001|Treatment|Withdrawal by Subject|7|||
23544134|NCT00968669|65723015|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
23544135|NCT00968669|65723012|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
23125061|NCT00664534|64208558|FG000|Overall Study|Lost to Follow-up|6|||
23125062|NCT00664534|64208559|FG001|Overall Study|Lost to Follow-up|10|||
23544136|NCT00968669|65723013|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
23617336|NCT00168805|65985141|FG002|Treatment|Withdrawal by Subject|8|||
23617337|NCT00168805|65985139|FG000|Treatment|Other|18|||
23617338|NCT00168805|65985140|FG001|Treatment|Other|18|||
23617339|NCT00168805|65985141|FG002|Treatment|Other|17|||
23125063|NCT00664534|64208558|FG000|Overall Study|Protocol Violation|10|||
23125064|NCT00664534|64208559|FG001|Overall Study|Protocol Violation|8|||
23125065|NCT00664534|64208558|FG000|Overall Study|Withdrawal by Subject|7|||
23544137|NCT00968669|65723014|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
23617340|NCT00760877|65985143|FG000|Overall Study|Protocol Violation|1|||
23544138|NCT00968669|65723015|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
23617341|NCT00760877|65985144|FG001|Overall Study|Protocol Violation|0|||
23617342|NCT00760877|65985143|FG000|Overall Study|Non-compliance with protocol treatment|2|||
23617343|NCT00760877|65985144|FG001|Overall Study|Non-compliance with protocol treatment|1|||
23617344|NCT00760877|65985143|FG000|Overall Study|Pregnancy|1|||
23617345|NCT00760877|65985144|FG001|Overall Study|Pregnancy|4|||
23617346|NCT00760877|65985143|FG000|Overall Study|Death|2|||
23617347|NCT00760877|65985144|FG001|Overall Study|Death|1|||
23617348|NCT00760877|65985143|FG000|Overall Study|Withdrawal by Subject|7|||
23211393|NCT00418379|64512466|FG001|Year 2|Any other reason not above-mentioned|1|||
23211394|NCT00418379|64512467|FG002|Year 2|Any other reason not above-mentioned|6|||
23211395|NCT00418379|64512465|FG000|Year 3|Withdrawal by Subject|1|||
23211396|NCT00418379|64512466|FG001|Year 3|Withdrawal by Subject|1|||
23617349|NCT00760877|65985144|FG001|Overall Study|Withdrawal by Subject|3|||
23617350|NCT00760877|65985143|FG000|Overall Study|Adverse Event|19|||
23617351|NCT00760877|65985144|FG001|Overall Study|Adverse Event|12|||
23617352|NCT00760877|65985143|FG000|Overall Study|Participant diagnosed with AML|0|||
23125066|NCT00664534|64208559|FG001|Overall Study|Withdrawal by Subject|6|||
23125067|NCT00664534|64208558|FG000|Overall Study|Physician Decision|8|||
23125068|NCT00664534|64208559|FG001|Overall Study|Physician Decision|0|||
23125069|NCT00664534|64208558|FG000|Overall Study|Sponsor decision|8|||
23211397|NCT00418379|64512467|FG002|Year 3|Withdrawal by Subject|2|||
23211398|NCT00418379|64512465|FG000|Year 3|Any other reason not above-mentioned|2|||
23211399|NCT00418379|64512466|FG001|Year 3|Any other reason not above-mentioned|1|||
23211400|NCT00418379|64512467|FG002|Year 3|Any other reason not above-mentioned|1|||
23211401|NCT00418379|64512465|FG000|Year 4|Adverse Event|0|||
23211402|NCT00418379|64512466|FG001|Year 4|Adverse Event|1|||
23211403|NCT00418379|64512467|FG002|Year 4|Adverse Event|0|||
23211404|NCT00418379|64512465|FG000|Year 4|Withdrawal by Subject|2|||
23211405|NCT00418379|64512466|FG001|Year 4|Withdrawal by Subject|3|||
23211406|NCT00418379|64512467|FG002|Year 4|Withdrawal by Subject|2|||
23125070|NCT00664534|64208559|FG001|Overall Study|Sponsor decision|6|||
23125071|NCT00379769|64208560|FG000|Main Study|Death|57|||
23125072|NCT00379769|64208561|FG001|Main Study|Death|67|||
23125073|NCT00379769|64208562|FG002|Main Study|Death|54|||
23125074|NCT00379769|64208563|FG003|Main Study|Death|72|||
23125075|NCT00379769|64208564|FG004|Main Study|Death|0|||
23125076|NCT00379769|64208565|FG005|Main Study|Death|0|||
23125077|NCT00379769|64208560|FG000|Main Study|Adverse Event|5|||
23125078|NCT00379769|64208561|FG001|Main Study|Adverse Event|8|||
23125079|NCT00379769|64208562|FG002|Main Study|Adverse Event|10|||
23125080|NCT00379769|64208563|FG003|Main Study|Adverse Event|11|||
23125081|NCT00379769|64208564|FG004|Main Study|Adverse Event|0|||
23125082|NCT00379769|64208565|FG005|Main Study|Adverse Event|0|||
23125083|NCT00379769|64208560|FG000|Main Study|Lost to Follow-up|29|||
23125084|NCT00379769|64208561|FG001|Main Study|Lost to Follow-up|29|||
23125085|NCT00379769|64208562|FG002|Main Study|Lost to Follow-up|25|||
23125086|NCT00379769|64208563|FG003|Main Study|Lost to Follow-up|26|||
23125087|NCT00379769|64208564|FG004|Main Study|Lost to Follow-up|0|||
23125088|NCT00379769|64208565|FG005|Main Study|Lost to Follow-up|0|||
23125089|NCT00379769|64208560|FG000|Main Study|Withdrawal by Subject|46|||
23125090|NCT00379769|64208561|FG001|Main Study|Withdrawal by Subject|56|||
23125091|NCT00379769|64208562|FG002|Main Study|Withdrawal by Subject|72|||
23125092|NCT00379769|64208563|FG003|Main Study|Withdrawal by Subject|70|||
23125093|NCT00379769|64208564|FG004|Main Study|Withdrawal by Subject|0|||
23125094|NCT00379769|64208565|FG005|Main Study|Withdrawal by Subject|0|||
23125095|NCT00379769|64208560|FG000|Main Study|Moved to survival status follow-up only|27|||
23125096|NCT00379769|64208561|FG001|Main Study|Moved to survival status follow-up only|25|||
23125097|NCT00379769|64208562|FG002|Main Study|Moved to survival status follow-up only|32|||
23125098|NCT00379769|64208563|FG003|Main Study|Moved to survival status follow-up only|36|||
23125099|NCT00379769|64208564|FG004|Main Study|Moved to survival status follow-up only|0|||
23125100|NCT00379769|64208565|FG005|Main Study|Moved to survival status follow-up only|0|||
23125101|NCT00379769|64208560|FG000|Main Study|Participant moved|3|||
23125102|NCT00379769|64208561|FG001|Main Study|Participant moved|2|||
23125103|NCT00379769|64208562|FG002|Main Study|Participant moved|3|||
23211407|NCT00418379|64512465|FG000|Year 4|Any other reason not above-mentioned|1|||
23314790|NCT03696953|64895412|FG000|Overall Study|Changed prenatal provider|1|||
23314791|NCT03696953|64895413|FG001|Overall Study|Changed prenatal provider|1|||
23617353|NCT00760877|65985144|FG001|Overall Study|Participant diagnosed with AML|1|||
23617354|NCT00760877|65985143|FG000|Overall Study|Participant not eligible to cross-over|0|||
23125104|NCT00379769|64208563|FG003|Main Study|Participant moved|3|||
23125105|NCT00379769|64208564|FG004|Main Study|Participant moved|0|||
23125106|NCT00379769|64208565|FG005|Main Study|Participant moved|0|||
23125107|NCT00379769|64208560|FG000|Main Study|Poor compliance|3|||
23125108|NCT00379769|64208561|FG001|Main Study|Poor compliance|2|||
23125109|NCT00379769|64208562|FG002|Main Study|Poor compliance|2|||
23125110|NCT00379769|64208563|FG003|Main Study|Poor compliance|1|||
23211408|NCT00418379|64512466|FG001|Year 4|Any other reason not above-mentioned|1|||
23617355|NCT00760877|65985144|FG001|Overall Study|Participant not eligible to cross-over|1|||
23125111|NCT00379769|64208564|FG004|Main Study|Poor compliance|0|||
23211409|NCT00418379|64512467|FG002|Year 4|Any other reason not above-mentioned|0|||
23211410|NCT00418379|64512465|FG000|Year 5|Adverse Event|0|||
23211411|NCT00418379|64512466|FG001|Year 5|Adverse Event|1|||
23211412|NCT00418379|64512467|FG002|Year 5|Adverse Event|0|||
23211413|NCT00418379|64512465|FG000|Year 5|Any other reason not above-mentioned|2|||
23211414|NCT00418379|64512466|FG001|Year 5|Any other reason not above-mentioned|4|||
23211415|NCT00418379|64512467|FG002|Year 5|Any other reason not above-mentioned|3|||
23211416|NCT05319080|64512471|FG000|Overall Study|Withdrawal by Subject|2|||
23211417|NCT05319080|64512471|FG000|Overall Study|Physician Decision|4|||
23211418|NCT00618449|64512472|FG000|Overall Study|Lost to Follow-up|98|||
23211419|NCT00618449|64512473|FG001|Overall Study|Lost to Follow-up|110|||
23211420|NCT01374217|64512474|FG000|Overall Study|Lack of Efficacy|13|||
23211421|NCT01313208|64512478|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
23211422|NCT01313208|64512479|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
23211423|NCT01313208|64512478|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
23211424|NCT01313208|64512479|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
23211425|NCT01313208|64512478|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
23211426|NCT01313208|64512479|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
23211427|NCT01313208|64512478|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
23211428|NCT01313208|64512479|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
23211429|NCT01313208|64512478|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
23211430|NCT01313208|64512479|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
23211431|NCT01313208|64512478|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
23211432|NCT01313208|64512479|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
23211433|NCT01313208|64512478|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
23211434|NCT01313208|64512479|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
23211435|NCT01313208|64512478|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
23211436|NCT01313208|64512479|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
23211437|NCT01313208|64512478|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
23211438|NCT01313208|64512479|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
23211439|NCT02133742|64512485|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
23211440|NCT02133742|64512485|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
23211441|NCT02133742|64512485|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
23211442|NCT02133742|64512485|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
23211443|NCT02133742|64512485|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
23211444|NCT04603391|64512486|FG000|First Intervention (4 Days)|Adverse Event|1|||
23211445|NCT04603391|64512487|FG001|First Intervention (4 Days)|Adverse Event|0|||
23211446|NCT04603391|64512486|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
23211447|NCT04603391|64512487|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
23211448|NCT02218372|64512490|FG000|Overall Study|Adverse Event|1|||
23211449|NCT02218372|64512491|FG001|Overall Study|Adverse Event|1|||
23211450|NCT02218372|64512490|FG000|Overall Study|Miscellaneous|2|||
23211451|NCT02218372|64512491|FG001|Overall Study|Miscellaneous|1|||
23211452|NCT02218372|64512490|FG000|Overall Study|Randomized but did not receive treatment|2|||
23211453|NCT02218372|64512491|FG001|Overall Study|Randomized but did not receive treatment|3|||
23211454|NCT02218372|64512490|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23211455|NCT02218372|64512491|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23211456|NCT04577183|64512495|FG000|Overall Study|Death|1|||
23211457|NCT04577183|64512495|FG000|Overall Study|Withdrawal by Subject|3|||
23211458|NCT04577183|64512495|FG000|Overall Study|Early termination|2|||
23211459|NCT00178464|64512496|FG000|Overall Study|Withdrawal by Subject|1|||
23211460|NCT00178464|64512496|FG000|Overall Study|Physician Decision|1|||
23211461|NCT01026389|64512497|FG000|Overall Study|Withdrawal by Subject|1|||
23211462|NCT01026389|64512498|FG001|Overall Study|Withdrawal by Subject|3|||
23211463|NCT01026389|64512497|FG000|Overall Study|change of treatment, patient moved|4|||
23544139|NCT00968669|65723012|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
23544140|NCT00968669|65723013|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
23544141|NCT00968669|65723014|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
23544142|NCT00968669|65723015|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
23544143|NCT00968669|65723012|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
23544144|NCT00968669|65723013|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
23544145|NCT00968669|65723014|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
23544146|NCT00968669|65723015|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
23544147|NCT00968669|65723012|FG000|Overall Study|EARLY WITHDRAWAL|0|||
23544148|NCT00968669|65723013|FG001|Overall Study|EARLY WITHDRAWAL|1|||
23544149|NCT00968669|65723014|FG002|Overall Study|EARLY WITHDRAWAL|0|||
23544150|NCT00968669|65723015|FG003|Overall Study|EARLY WITHDRAWAL|0|||
23544151|NCT00968669|65723012|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
23211464|NCT01026389|64512498|FG001|Overall Study|change of treatment, patient moved|2|||
23211465|NCT01071096|64512501|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
23544152|NCT00968669|65723013|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
23617356|NCT00760877|65985143|FG000|Overall Study|Physician Decision|1|||
23211466|NCT01071096|64512502|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
23211467|NCT03627494|64512503|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
23211468|NCT03627494|64512504|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
23211469|NCT03627494|64512505|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
23211470|NCT03627494|64512506|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
23211471|NCT03627494|64512507|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
23211472|NCT03627494|64512508|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
23211473|NCT03627494|64512509|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
23617357|NCT00760877|65985144|FG001|Overall Study|Physician Decision|2|||
23617358|NCT00760877|65985143|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
23211474|NCT03627494|64512510|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
23211475|NCT03627494|64512511|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
23211476|NCT03627494|64512512|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
23211477|NCT03627494|64512513|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
23211478|NCT03627494|64512514|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
23211479|NCT03627494|64512503|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
23211480|NCT03627494|64512504|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
23211481|NCT03627494|64512505|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
23617359|NCT00760877|65985144|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
23617360|NCT00760877|65985143|FG000|Overall Study|Treatment failure|1|||
23617361|NCT00760877|65985144|FG001|Overall Study|Treatment failure|0|||
23617362|NCT01284634|65985145|FG000|Overall Study|Adverse Event|1|||
23617363|NCT01284634|65985146|FG001|Overall Study|Adverse Event|0|||
23617364|NCT01284634|65985147|FG002|Overall Study|Adverse Event|2|||
23617365|NCT01284634|65985148|FG003|Overall Study|Adverse Event|1|||
23617366|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
23617367|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
23617368|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
23617369|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
23617370|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
23125112|NCT00379769|64208565|FG005|Main Study|Poor compliance|0|||
23125113|NCT00379769|64208560|FG000|Main Study|Prohibited glucose lowering medication|0|||
23125114|NCT00379769|64208561|FG001|Main Study|Prohibited glucose lowering medication|3|||
23125115|NCT00379769|64208562|FG002|Main Study|Prohibited glucose lowering medication|0|||
23125116|NCT00379769|64208563|FG003|Main Study|Prohibited glucose lowering medication|1|||
23125117|NCT00379769|64208564|FG004|Main Study|Prohibited glucose lowering medication|0|||
23125118|NCT00379769|64208565|FG005|Main Study|Prohibited glucose lowering medication|0|||
23125119|NCT00379769|64208560|FG000|Main Study|Site closed|4|||
23125120|NCT00379769|64208561|FG001|Main Study|Site closed|4|||
23125121|NCT00379769|64208562|FG002|Main Study|Site closed|4|||
23125122|NCT00379769|64208563|FG003|Main Study|Site closed|8|||
23125123|NCT00379769|64208564|FG004|Main Study|Site closed|0|||
23125124|NCT00379769|64208565|FG005|Main Study|Site closed|0|||
23125125|NCT00379769|64208560|FG000|Main Study|Entry criteria violation|0|||
23125126|NCT00379769|64208561|FG001|Main Study|Entry criteria violation|0|||
23125127|NCT00379769|64208562|FG002|Main Study|Entry criteria violation|1|||
23125128|NCT00379769|64208563|FG003|Main Study|Entry criteria violation|1|||
23125129|NCT00379769|64208564|FG004|Main Study|Entry criteria violation|0|||
23125130|NCT00379769|64208565|FG005|Main Study|Entry criteria violation|0|||
23125131|NCT00379769|64208560|FG000|Main Study|Participant did not take study drug|0|||
23125132|NCT00379769|64208561|FG001|Main Study|Participant did not take study drug|0|||
23125133|NCT00379769|64208562|FG002|Main Study|Participant did not take study drug|1|||
23125134|NCT00379769|64208563|FG003|Main Study|Participant did not take study drug|0|||
23125135|NCT00379769|64208564|FG004|Main Study|Participant did not take study drug|0|||
23125136|NCT00379769|64208565|FG005|Main Study|Participant did not take study drug|0|||
23125137|NCT00379769|64208560|FG000|Main Study|Physician Decision|2|||
23125138|NCT00379769|64208561|FG001|Main Study|Physician Decision|2|||
23125139|NCT00379769|64208562|FG002|Main Study|Physician Decision|1|||
23125140|NCT00379769|64208563|FG003|Main Study|Physician Decision|1|||
23125141|NCT00379769|64208564|FG004|Main Study|Physician Decision|0|||
23125142|NCT00379769|64208565|FG005|Main Study|Physician Decision|0|||
23125143|NCT00379769|64208560|FG000|Main Study|Participant completed study at visit 27|1|||
23125144|NCT00379769|64208561|FG001|Main Study|Participant completed study at visit 27|0|||
23125145|NCT00379769|64208562|FG002|Main Study|Participant completed study at visit 27|0|||
23125146|NCT00379769|64208563|FG003|Main Study|Participant completed study at visit 27|0|||
23125147|NCT00379769|64208564|FG004|Main Study|Participant completed study at visit 27|0|||
23125148|NCT00379769|64208565|FG005|Main Study|Participant completed study at visit 27|0|||
23125149|NCT00379769|64208560|FG000|Main Study|Personal reasons|1|||
23125150|NCT00379769|64208561|FG001|Main Study|Personal reasons|0|||
23125151|NCT00379769|64208562|FG002|Main Study|Personal reasons|0|||
23125152|NCT00379769|64208563|FG003|Main Study|Personal reasons|0|||
23125153|NCT00379769|64208564|FG004|Main Study|Personal reasons|0|||
23125154|NCT00379769|64208565|FG005|Main Study|Personal reasons|0|||
23211482|NCT03627494|64512506|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
23314792|NCT00920790|64895414|FG000|Overall Study|aggravation of general condition|14|||
23125155|NCT00379769|64208560|FG000|Main Study|Risk of heart failure|0|||
23125156|NCT00379769|64208561|FG001|Main Study|Risk of heart failure|1|||
23125157|NCT00379769|64208562|FG002|Main Study|Risk of heart failure|0|||
23125158|NCT00379769|64208563|FG003|Main Study|Risk of heart failure|0|||
23125159|NCT00379769|64208564|FG004|Main Study|Risk of heart failure|0|||
23544153|NCT00968669|65723014|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
23544154|NCT00968669|65723015|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
23544155|NCT00968669|65723012|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
23544156|NCT00968669|65723013|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
23544157|NCT00968669|65723014|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
23544158|NCT00968669|65723015|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
23544159|NCT00968669|65723012|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
23544160|NCT00968669|65723013|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
23544161|NCT00968669|65723014|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
23544162|NCT00968669|65723015|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
23544163|NCT00968669|65723012|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
23617371|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
23617372|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
23617373|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
23617374|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
23617375|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
23125160|NCT00379769|64208565|FG005|Main Study|Risk of heart failure|0|||
23125161|NCT00379769|64208560|FG000|Main Study|Investigator refused to log temperature|0|||
23125162|NCT00379769|64208561|FG001|Main Study|Investigator refused to log temperature|0|||
23617376|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
23617377|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
23617378|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
23617379|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
23617380|NCT02971683|65985159|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
23617381|NCT02971683|65985160|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
23617382|NCT02971683|65985159|FG000|Open-Label|Lost to Follow-up|1|||
23617383|NCT02971683|65985160|FG001|Open-Label|Lost to Follow-up|0|||
23617384|NCT02971683|65985159|FG000|Open-Label|Participants withdrew consent|0|||
23617385|NCT02971683|65985160|FG001|Open-Label|Participants withdrew consent|2|||
23617386|NCT02971683|65985159|FG000|Open-Label|Participant request to discontinue study treatment|1|||
23617387|NCT02971683|65985160|FG001|Open-Label|Participant request to discontinue study treatment|0|||
23617388|NCT02971683|65985159|FG000|Open-Label|Lack of Efficacy|2|||
23617389|NCT02971683|65985160|FG001|Open-Label|Lack of Efficacy|0|||
23617390|NCT02971683|65985159|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
23617391|NCT02971683|65985160|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
23617392|NCT02971683|65985159|FG000|Long-Term Open Label|Participant withdrew consent|1|||
23617393|NCT02971683|65985160|FG001|Long-Term Open Label|Participant withdrew consent|0|||
23617394|NCT02971683|65985159|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
23617395|NCT02971683|65985160|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
23617396|NCT02971683|65985159|FG000|Long-Term Open Label|Adverse Event|1|||
23211483|NCT03627494|64512507|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
23211484|NCT03627494|64512508|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
23617397|NCT02971683|65985160|FG001|Long-Term Open Label|Adverse Event|2|||
23617398|NCT02971683|65985159|FG000|Long-Term Open Label|Lack of Efficacy|1|||
23617399|NCT02971683|65985160|FG001|Long-Term Open Label|Lack of Efficacy|1|||
23617400|NCT03319719|65985163|FG000|Overall Study|Lost to Follow-up|1|||
23125163|NCT00379769|64208562|FG002|Main Study|Investigator refused to log temperature|1|||
23211485|NCT03627494|64512509|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
23211486|NCT03627494|64512510|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
23211487|NCT03627494|64512511|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
23617401|NCT01126879|65985164|FG000|Overall Study|Progressive Disease|3|||
23125164|NCT00379769|64208563|FG003|Main Study|Investigator refused to log temperature|0|||
23125165|NCT00379769|64208564|FG004|Main Study|Investigator refused to log temperature|0|||
23125166|NCT00379769|64208565|FG005|Main Study|Investigator refused to log temperature|0|||
23125167|NCT00379769|64208560|FG000|Main Study|Reason unspecified|0|||
23211488|NCT03627494|64512512|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
23211489|NCT03627494|64512513|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
23544164|NCT00968669|65723013|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
23617402|NCT01126879|65985165|FG001|Overall Study|Progressive Disease|1|||
23617403|NCT01126879|65985164|FG000|Overall Study|Withdrawal by Subject|1|||
23617404|NCT01126879|65985165|FG001|Overall Study|Withdrawal by Subject|0|||
23617405|NCT01126879|65985164|FG000|Overall Study|Adverse Event|0|||
23617406|NCT01126879|65985165|FG001|Overall Study|Adverse Event|1|||
23617407|NCT01126879|65985164|FG000|Overall Study|Physician Decision|1|||
23617408|NCT01126879|65985165|FG001|Overall Study|Physician Decision|0|||
23617409|NCT02490878|65985166|FG000|Overall Study|deemed ineligible|0|||
23617410|NCT02490878|65985167|FG001|Overall Study|deemed ineligible|1|||
23125168|NCT00379769|64208561|FG001|Main Study|Reason unspecified|0|||
23125169|NCT00379769|64208562|FG002|Main Study|Reason unspecified|1|||
23125170|NCT00379769|64208563|FG003|Main Study|Reason unspecified|0|||
23125171|NCT00379769|64208564|FG004|Main Study|Reason unspecified|0|||
23125172|NCT00379769|64208565|FG005|Main Study|Reason unspecified|0|||
23125173|NCT00379769|64208560|FG000|Observational Follow-up|Death|0|||
23125174|NCT00379769|64208561|FG001|Observational Follow-up|Death|0|||
23125175|NCT00379769|64208562|FG002|Observational Follow-up|Death|0|||
23125176|NCT00379769|64208563|FG003|Observational Follow-up|Death|0|||
23125177|NCT00379769|64208564|FG004|Observational Follow-up|Death|78|||
23125178|NCT00379769|64208565|FG005|Observational Follow-up|Death|70|||
23125179|NCT00379769|64208560|FG000|Observational Follow-up|Adverse Event|0|||
23125180|NCT00379769|64208561|FG001|Observational Follow-up|Adverse Event|0|||
23125181|NCT00379769|64208562|FG002|Observational Follow-up|Adverse Event|0|||
23544165|NCT00968669|65723014|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
23544166|NCT00968669|65723015|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
23544167|NCT00968669|65723012|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
23544168|NCT00968669|65723013|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
23544169|NCT00968669|65723014|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
23544170|NCT00968669|65723015|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
23544171|NCT00968669|65723012|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
23617411|NCT02490878|65985166|FG000|Overall Study|progression prior to treatment|0|||
23617412|NCT02490878|65985167|FG001|Overall Study|progression prior to treatment|1|||
23617413|NCT02490878|65985166|FG000|Overall Study|only submitted baseline QOL|0|||
23617414|NCT02490878|65985167|FG001|Overall Study|only submitted baseline QOL|1|||
23617415|NCT01685047|65985175|FG000|Overall Study|Withdrawal by Subject|20|||
23617416|NCT01685047|65985175|FG000|Overall Study|Death|26|||
23617417|NCT01685047|65985175|FG000|Overall Study|Lost to Follow-up|8|||
23617418|NCT01685047|65985175|FG000|Overall Study|Physician Decision|25|||
23617419|NCT01685047|65985175|FG000|Overall Study|Adverse Event|5|||
23617420|NCT01685047|65985175|FG000|Overall Study|patient withdrawn by sponsor|1|||
23617421|NCT03411044|65985180|FG000|Overall Study|Death|30|||
23617422|NCT03411044|65985180|FG000|Overall Study|Withdrawal by Subject|48|||
23617423|NCT03411044|65985180|FG000|Overall Study|Lost to Follow-up|78|||
23617424|NCT03411044|65985180|FG000|Overall Study|Adverse Event|30|||
23617425|NCT03411044|65985180|FG000|Overall Study|Missing status|4|||
23617426|NCT00727259|65985181|FG000|Overall Study|Not all questionnaires completed|1055|||
23617427|NCT02865135|65985182|FG000|Overall Study|Death|0|||
23617428|NCT02865135|65985183|FG001|Overall Study|Death|1|||
23617429|NCT02865135|65985184|FG002|Overall Study|Death|0|||
23617430|NCT02865135|65985182|FG000|Overall Study|Progression|6|||
23617431|NCT02865135|65985183|FG001|Overall Study|Progression|2|||
23617432|NCT02865135|65985184|FG002|Overall Study|Progression|2|||
23617433|NCT01838447|65985185|FG000|Overall Study|Change in surgical plan|1|||
23617434|NCT01838447|65985186|FG001|Overall Study|Change in surgical plan|2|||
23617435|NCT01838447|65985185|FG000|Overall Study|Withdrawal by Subject|1|||
23617436|NCT01838447|65985186|FG001|Overall Study|Withdrawal by Subject|1|||
23617437|NCT04814992|65985188|FG000|Overall Study|Withdrawal by Subject|6|||
23617438|NCT04814992|65985189|FG001|Overall Study|Withdrawal by Subject|3|||
23617439|NCT04814992|65985188|FG000|Overall Study|Lost to Follow-up|1|||
23617440|NCT04814992|65985189|FG001|Overall Study|Lost to Follow-up|4|||
23617441|NCT01049984|65985190|FG000|Overall Study|Withdrawal by Subject|1|||
23617442|NCT01049984|65985191|FG001|Overall Study|Withdrawal by Subject|5|||
23617443|NCT01049984|65985190|FG000|Overall Study|Protocol Violation|3|||
23617444|NCT01049984|65985191|FG001|Overall Study|Protocol Violation|4|||
23617445|NCT01049984|65985190|FG000|Overall Study|Lost to Follow-up|2|||
23617446|NCT01049984|65985191|FG001|Overall Study|Lost to Follow-up|1|||
23617447|NCT01049984|65985190|FG000|Overall Study|Adverse Event|13|||
23617448|NCT01049984|65985191|FG001|Overall Study|Adverse Event|7|||
23617449|NCT01049984|65985190|FG000|Overall Study|Treatment failure|0|||
23617450|NCT01049984|65985191|FG001|Overall Study|Treatment failure|2|||
23617451|NCT01114217|65985192|FG000|Overall Study|Adverse Event|5|||
23617452|NCT01114217|65985193|FG001|Overall Study|Adverse Event|3|||
23617453|NCT01114217|65985192|FG000|Overall Study|Lost to Follow-up|17|||
23617454|NCT01114217|65985193|FG001|Overall Study|Lost to Follow-up|33|||
23125182|NCT00379769|64208563|FG003|Observational Follow-up|Adverse Event|0|||
23125183|NCT00379769|64208564|FG004|Observational Follow-up|Adverse Event|1|||
23125184|NCT00379769|64208565|FG005|Observational Follow-up|Adverse Event|0|||
23211490|NCT03627494|64512514|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
23211491|NCT03627494|64512503|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
23544172|NCT00968669|65723013|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
23617455|NCT01114217|65985192|FG000|Overall Study|Withdrawal by Subject|21|||
23617456|NCT01114217|65985193|FG001|Overall Study|Withdrawal by Subject|28|||
23617457|NCT01114217|65985192|FG000|Overall Study|Other-Clerical Error|3|||
23211492|NCT03627494|64512504|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
23617458|NCT01114217|65985193|FG001|Overall Study|Other-Clerical Error|0|||
23617459|NCT01114217|65985192|FG000|Overall Study|Other-Early termination|6|||
23125185|NCT00379769|64208560|FG000|Observational Follow-up|Lost to Follow-up|0|||
23544173|NCT00968669|65723014|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
23544174|NCT00968669|65723015|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
23617460|NCT01114217|65985193|FG001|Overall Study|Other-Early termination|10|||
23314793|NCT02540850|64895415|FG000|Overall Study|Lost to Follow-up|69|||
23314794|NCT02540850|64895416|FG001|Overall Study|Lost to Follow-up|66|||
23314795|NCT02540850|64895417|FG002|Overall Study|Lost to Follow-up|34|||
23314796|NCT03765788|64895418|FG000|Overall Study|Subject decision|2|||
23314797|NCT03765788|64895419|FG001|Overall Study|Subject decision|3|||
23314798|NCT03765788|64895418|FG000|Overall Study|Physician Decision|2|||
23314799|NCT03765788|64895419|FG001|Overall Study|Physician Decision|4|||
23314800|NCT03765788|64895418|FG000|Overall Study|Death|0|||
23314801|NCT03765788|64895419|FG001|Overall Study|Death|1|||
23314802|NCT03765788|64895418|FG000|Overall Study|Lost to Follow-up|1|||
23314803|NCT03765788|64895419|FG001|Overall Study|Lost to Follow-up|0|||
23314804|NCT02123446|64895420|FG000|Washout Period (1 Day)|Physician Decision|1|||
23314805|NCT02123446|64895421|FG001|Washout Period (1 Day)|Physician Decision|0|||
23314806|NCT02022748|64895422|FG000|Overall Study|Adverse Event|1|||
23314807|NCT02022748|64895423|FG001|Overall Study|Adverse Event|1|||
23314808|NCT02022748|64895424|FG002|Overall Study|Adverse Event|0|||
23314809|NCT02022748|64895422|FG000|Overall Study|Withdrawal by Subject|0|||
23314810|NCT02022748|64895423|FG001|Overall Study|Withdrawal by Subject|1|||
23314811|NCT02022748|64895424|FG002|Overall Study|Withdrawal by Subject|0|||
23314812|NCT02794870|64895428|FG000|Overall Study|Withdrawal by Subject|2|||
23314813|NCT02794870|64895429|FG001|Overall Study|Withdrawal by Subject|0|||
23314814|NCT02114385|64895430|FG000|Overall Study|Withdrawal by Subject|3|||
23544175|NCT00968669|65723012|FG000|Overall Study|SPONSOR DECISION|0|||
23617461|NCT01114217|65985192|FG000|Overall Study|Other-Procedure|1|||
23617462|NCT01114217|65985193|FG001|Overall Study|Other-Procedure|1|||
23617463|NCT01114217|65985192|FG000|Overall Study|Other-Pregnancy|2|||
23617464|NCT01114217|65985193|FG001|Overall Study|Other-Pregnancy|4|||
23617465|NCT01114217|65985192|FG000|Overall Study|Other-Protocol Violation|1|||
23617466|NCT01114217|65985193|FG001|Overall Study|Other-Protocol Violation|3|||
23617467|NCT01114217|65985192|FG000|Overall Study|Other-Lack of Efficacy|1|||
23211493|NCT03627494|64512505|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
23211494|NCT03627494|64512506|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
23211495|NCT03627494|64512507|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
23544176|NCT00968669|65723013|FG001|Overall Study|SPONSOR DECISION|1|||
23617468|NCT01114217|65985193|FG001|Overall Study|Other-Lack of Efficacy|0|||
23617469|NCT01114217|65985192|FG000|Overall Study|Other-Non Compliance|2|||
23617470|NCT01114217|65985193|FG001|Overall Study|Other-Non Compliance|0|||
23617471|NCT01114217|65985192|FG000|Overall Study|Other-Physician Decision|1|||
23617472|NCT01114217|65985193|FG001|Overall Study|Other-Physician Decision|1|||
23617473|NCT01114217|65985192|FG000|Overall Study|Other-Sponsor Decision|10|||
23617474|NCT01114217|65985193|FG001|Overall Study|Other-Sponsor Decision|12|||
23617475|NCT01114217|65985192|FG000|Overall Study|Other-Study Termination|0|||
23617476|NCT01114217|65985193|FG001|Overall Study|Other-Study Termination|1|||
23125186|NCT00379769|64208561|FG001|Observational Follow-up|Lost to Follow-up|0|||
23544177|NCT00968669|65723014|FG002|Overall Study|SPONSOR DECISION|0|||
23544178|NCT00968669|65723015|FG003|Overall Study|SPONSOR DECISION|0|||
23544179|NCT00968669|65723012|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
23544180|NCT00968669|65723013|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
23544181|NCT00968669|65723014|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
23544182|NCT00968669|65723015|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
23544183|NCT00968669|65723012|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
23617477|NCT01114217|65985192|FG000|Overall Study|Other-Study Withdrawn|1|||
23617478|NCT01114217|65985193|FG001|Overall Study|Other-Study Withdrawn|1|||
23125187|NCT00379769|64208562|FG002|Observational Follow-up|Lost to Follow-up|0|||
23125188|NCT00379769|64208563|FG003|Observational Follow-up|Lost to Follow-up|0|||
23125189|NCT00379769|64208564|FG004|Observational Follow-up|Lost to Follow-up|25|||
23125190|NCT00379769|64208565|FG005|Observational Follow-up|Lost to Follow-up|27|||
23125191|NCT00379769|64208560|FG000|Observational Follow-up|Withdrawal by Subject|0|||
23211496|NCT03627494|64512508|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
23617479|NCT01114217|65985192|FG000|Overall Study|Other-Site Stopped Communicating|2|||
23617480|NCT01114217|65985193|FG001|Overall Study|Other-Site Stopped Communicating|0|||
23617481|NCT01114217|65985192|FG000|Overall Study|Other-Lost to Follow-up|1|||
23125192|NCT00379769|64208561|FG001|Observational Follow-up|Withdrawal by Subject|0|||
23314815|NCT02114385|64895431|FG001|Overall Study|Withdrawal by Subject|2|||
23314816|NCT02114385|64895430|FG000|Overall Study|Lost to Follow-up|0|||
23314817|NCT02114385|64895431|FG001|Overall Study|Lost to Follow-up|6|||
23314818|NCT02552732|64895435|FG000|Overall Study|Lost to Follow-up|2|||
23617482|NCT01114217|65985193|FG001|Overall Study|Other-Lost to Follow-up|0|||
23125193|NCT00379769|64208562|FG002|Observational Follow-up|Withdrawal by Subject|0|||
23544184|NCT00968669|65723013|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
23617483|NCT01114217|65985192|FG000|Overall Study|Other-Withdrawal by Subject|1|||
23617484|NCT01114217|65985193|FG001|Overall Study|Other-Withdrawal by Subject|1|||
23617485|NCT01225159|65985194|FG000|Overall Study|Change operation|1|||
23314819|NCT02552732|64895435|FG000|Overall Study|Physician Decision|1|||
23314820|NCT02552732|64895435|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
23314821|NCT02552732|64895435|FG000|Overall Study|Withdrawal by Subject|6|||
23314822|NCT00397514|64895436|FG000|Overall Study|Withdrawal by Subject|1|||
23314823|NCT00397514|64895436|FG000|Overall Study|Pacing wire malfunction|1|||
23314824|NCT00397514|64895436|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
23314825|NCT00397514|64895436|FG000|Overall Study|early extubation|2|||
23314826|NCT00397514|64895436|FG000|Overall Study|poor echocardiographic windows|1|||
23314827|NCT01954745|64895437|FG000|Overall Study|Radiological Progression|11|||
23314828|NCT01954745|64895437|FG000|Overall Study|Clinical Progression|5|||
23314829|NCT01954745|64895437|FG000|Overall Study|Adverse Event|2|||
23426086|NCT00875056|65303511|FG000|Overall Study|Withdrawal by Subject|3|||
23125194|NCT00379769|64208563|FG003|Observational Follow-up|Withdrawal by Subject|0|||
23125195|NCT00379769|64208564|FG004|Observational Follow-up|Withdrawal by Subject|12|||
23125196|NCT00379769|64208565|FG005|Observational Follow-up|Withdrawal by Subject|12|||
23125197|NCT00379769|64208560|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
23125198|NCT00379769|64208561|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
23125199|NCT00379769|64208562|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
23125200|NCT00379769|64208563|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
23125201|NCT00379769|64208564|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
23125202|NCT00379769|64208565|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
23426087|NCT00875056|65303512|FG001|Overall Study|Withdrawal by Subject|0|||
23426088|NCT00875056|65303513|FG002|Overall Study|Withdrawal by Subject|1|||
23426089|NCT02231762|65303514|FG000|Combination Phase|Adverse Event|10|||
23125203|NCT00379769|64208560|FG000|Observational Follow-up|Physician Decision|0|||
23125204|NCT00379769|64208561|FG001|Observational Follow-up|Physician Decision|0|||
23125205|NCT00379769|64208562|FG002|Observational Follow-up|Physician Decision|0|||
23125206|NCT00379769|64208563|FG003|Observational Follow-up|Physician Decision|0|||
23125207|NCT00379769|64208564|FG004|Observational Follow-up|Physician Decision|8|||
23125208|NCT00379769|64208565|FG005|Observational Follow-up|Physician Decision|8|||
23125209|NCT00379769|64208560|FG000|Observational Follow-up|Site Closed Early|0|||
23125210|NCT00379769|64208561|FG001|Observational Follow-up|Site Closed Early|0|||
23125211|NCT00379769|64208562|FG002|Observational Follow-up|Site Closed Early|0|||
23125212|NCT00379769|64208563|FG003|Observational Follow-up|Site Closed Early|0|||
23125213|NCT00379769|64208564|FG004|Observational Follow-up|Site Closed Early|6|||
23125214|NCT00379769|64208565|FG005|Observational Follow-up|Site Closed Early|7|||
23125215|NCT00379769|64208560|FG000|Observational Follow-up|Participant Moved|0|||
23125216|NCT00379769|64208561|FG001|Observational Follow-up|Participant Moved|0|||
23125217|NCT00379769|64208562|FG002|Observational Follow-up|Participant Moved|0|||
23125218|NCT00379769|64208563|FG003|Observational Follow-up|Participant Moved|0|||
23125219|NCT00379769|64208564|FG004|Observational Follow-up|Participant Moved|0|||
23125220|NCT00379769|64208565|FG005|Observational Follow-up|Participant Moved|1|||
23426090|NCT02231762|65303515|FG001|Combination Phase|Adverse Event|0|||
23426091|NCT02231762|65303516|FG002|Combination Phase|Adverse Event|0|||
23426092|NCT02231762|65303517|FG003|Combination Phase|Adverse Event|0|||
23426093|NCT02231762|65303514|FG000|Combination Phase|Withdrawal by Subject|2|||
23426094|NCT02231762|65303515|FG001|Combination Phase|Withdrawal by Subject|0|||
23426095|NCT02231762|65303516|FG002|Combination Phase|Withdrawal by Subject|0|||
23426096|NCT02231762|65303517|FG003|Combination Phase|Withdrawal by Subject|0|||
23426097|NCT02231762|65303514|FG000|Combination Phase|Disease Progression|6|||
23426098|NCT02231762|65303515|FG001|Combination Phase|Disease Progression|0|||
23426099|NCT02231762|65303516|FG002|Combination Phase|Disease Progression|0|||
23426100|NCT02231762|65303517|FG003|Combination Phase|Disease Progression|0|||
23426101|NCT02231762|65303514|FG000|Combination Phase|Did not meet inclusion criteria|1|||
23426102|NCT02231762|65303515|FG001|Combination Phase|Did not meet inclusion criteria|0|||
23426103|NCT02231762|65303516|FG002|Combination Phase|Did not meet inclusion criteria|0|||
23426104|NCT02231762|65303517|FG003|Combination Phase|Did not meet inclusion criteria|0|||
23426105|NCT02231762|65303514|FG000|Combination Phase|Protocol Violation|1|||
23426106|NCT02231762|65303515|FG001|Combination Phase|Protocol Violation|0|||
23426107|NCT02231762|65303516|FG002|Combination Phase|Protocol Violation|0|||
23426108|NCT02231762|65303517|FG003|Combination Phase|Protocol Violation|0|||
23426109|NCT02231762|65303514|FG000|Maintenance Phase|Disease progression|0|||
23426110|NCT02231762|65303515|FG001|Maintenance Phase|Disease progression|3|||
23125221|NCT00379769|64208560|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
23314830|NCT01954745|64895437|FG000|Overall Study|Death|1|||
23544185|NCT00968669|65723014|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
23544186|NCT00968669|65723015|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
23426111|NCT02231762|65303516|FG002|Maintenance Phase|Disease progression|4|||
23426112|NCT02231762|65303517|FG003|Maintenance Phase|Disease progression|3|||
23544187|NCT00968669|65723012|FG000|Overall Study|SUBJECT INCARCERATED|0|||
23125222|NCT00379769|64208561|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
23125223|NCT00379769|64208562|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
23544188|NCT00968669|65723013|FG001|Overall Study|SUBJECT INCARCERATED|1|||
23125224|NCT00379769|64208563|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
23125225|NCT00379769|64208564|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
23125226|NCT00379769|64208565|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
23125227|NCT01867047|64208568|FG000|Overall Study|Lost to Follow-up|3|||
23125228|NCT01867047|64208569|FG001|Overall Study|Lost to Follow-up|3|||
23125229|NCT01867047|64208568|FG000|Overall Study|Withdrawal by Subject|2|||
23125230|NCT01867047|64208569|FG001|Overall Study|Withdrawal by Subject|0|||
23125231|NCT01867047|64208568|FG000|Overall Study|Physician Decision|2|||
23125232|NCT01867047|64208569|FG001|Overall Study|Physician Decision|0|||
23125233|NCT01867047|64208568|FG000|Overall Study|surgery not indicated in protocol|1|||
23125234|NCT01867047|64208569|FG001|Overall Study|surgery not indicated in protocol|2|||
23125235|NCT02417441|64208570|FG000|Overall Study|Inconclusive due to missing data|52|||
23125236|NCT02417441|64208571|FG001|Overall Study|Inconclusive due to missing data|19|||
23125237|NCT00281320|64208572|FG000|Overall Study|Adverse Event|12|||
23125238|NCT00281320|64208573|FG001|Overall Study|Adverse Event|9|||
23125239|NCT00281320|64208572|FG000|Overall Study|Lack of Efficacy|4|||
23125240|NCT00281320|64208573|FG001|Overall Study|Lack of Efficacy|3|||
23125241|NCT00281320|64208572|FG000|Overall Study|Withdrawal by Subject|5|||
23125242|NCT00281320|64208573|FG001|Overall Study|Withdrawal by Subject|6|||
23125243|NCT00281320|64208572|FG000|Overall Study|Lost to Follow-up|1|||
23125244|NCT00281320|64208573|FG001|Overall Study|Lost to Follow-up|2|||
23125245|NCT00281320|64208572|FG000|Overall Study|Other|3|||
23125246|NCT00281320|64208573|FG001|Overall Study|Other|1|||
23125247|NCT04732871|64208576|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
23125248|NCT04732871|64208577|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
23125249|NCT04732871|64208578|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
23125250|NCT04732871|64208576|FG000|Overall Study|Lost to Follow-up|7|||
23125251|NCT04732871|64208577|FG001|Overall Study|Lost to Follow-up|4|||
23125252|NCT04732871|64208578|FG002|Overall Study|Lost to Follow-up|3|||
23125253|NCT04732871|64208576|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
23125254|NCT04732871|64208577|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
23125255|NCT04732871|64208578|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
23125256|NCT04732871|64208576|FG000|Overall Study|Migrated / moved from the study area|5|||
23125257|NCT04732871|64208577|FG001|Overall Study|Migrated / moved from the study area|0|||
23125258|NCT04732871|64208578|FG002|Overall Study|Migrated / moved from the study area|0|||
23125259|NCT04732871|64208576|FG000|Overall Study|Other|1|||
23125260|NCT04732871|64208577|FG001|Overall Study|Other|0|||
23125261|NCT04732871|64208578|FG002|Overall Study|Other|1|||
23125262|NCT04732871|64208576|FG000|Overall Study|Ongoing|6|||
23125263|NCT04732871|64208577|FG001|Overall Study|Ongoing|0|||
23125264|NCT04732871|64208578|FG002|Overall Study|Ongoing|1|||
23125265|NCT04732871|64208576|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
23125266|NCT04732871|64208577|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
23125267|NCT04732871|64208578|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
23125268|NCT01592045|64208579|FG000|Overall Study|Disease Progression|1|||
23125269|NCT01592045|64208580|FG001|Overall Study|Disease Progression|1|||
23125270|NCT01592045|64208579|FG000|Overall Study|Adverse Event|1|||
23125271|NCT01592045|64208580|FG001|Overall Study|Adverse Event|1|||
23125272|NCT01592045|64208579|FG000|Overall Study|Withdrawal by Subject|1|||
23125273|NCT01592045|64208580|FG001|Overall Study|Withdrawal by Subject|0|||
23125274|NCT01592045|64208579|FG000|Overall Study|Moved out of country|2|||
23125275|NCT01592045|64208580|FG001|Overall Study|Moved out of country|0|||
23544189|NCT00968669|65723014|FG002|Overall Study|SUBJECT INCARCERATED|0|||
23544190|NCT00968669|65723015|FG003|Overall Study|SUBJECT INCARCERATED|0|||
23544191|NCT00968669|65723012|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
23544192|NCT00968669|65723013|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
23544193|NCT00968669|65723014|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
23544194|NCT00968669|65723015|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
23544195|NCT00968669|65723012|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
23544196|NCT00968669|65723013|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
23544197|NCT00968669|65723014|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
23544198|NCT00968669|65723015|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
23544199|NCT01458574|65723016|FG000|Overall Study|Adverse Event|5|||
23544200|NCT01458574|65723017|FG001|Overall Study|Adverse Event|9|||
23544201|NCT01458574|65723018|FG002|Overall Study|Adverse Event|7|||
23544202|NCT01458574|65723016|FG000|Overall Study|Lack of Efficacy|70|||
23544203|NCT01458574|65723017|FG001|Overall Study|Lack of Efficacy|53|||
23544204|NCT01458574|65723018|FG002|Overall Study|Lack of Efficacy|132|||
23544205|NCT01458574|65723016|FG000|Overall Study|Lost to Follow-up|3|||
23544206|NCT01458574|65723017|FG001|Overall Study|Lost to Follow-up|2|||
23544207|NCT01458574|65723018|FG002|Overall Study|Lost to Follow-up|1|||
23544208|NCT01458574|65723016|FG000|Overall Study|Pregnancy|1|||
23544209|NCT01458574|65723017|FG001|Overall Study|Pregnancy|1|||
23544210|NCT01458574|65723018|FG002|Overall Study|Pregnancy|0|||
23125276|NCT02493946|64208583|FG000|DB Period|Withdrawal by Subject|8|||
23125277|NCT02493946|64208584|FG001|DB Period|Withdrawal by Subject|5|||
23125278|NCT02493946|64208585|FG002|DB Period|Withdrawal by Subject|0|||
23125279|NCT02493946|64208583|FG000|Open Label Period|Withdrawal by Subject|0|||
23125280|NCT02493946|64208584|FG001|Open Label Period|Withdrawal by Subject|0|||
23426113|NCT02231762|65303514|FG000|Maintenance Phase|Adverse Event|0|||
23426114|NCT02231762|65303515|FG001|Maintenance Phase|Adverse Event|0|||
23426115|NCT02231762|65303516|FG002|Maintenance Phase|Adverse Event|1|||
23426116|NCT02231762|65303517|FG003|Maintenance Phase|Adverse Event|2|||
23426117|NCT02961790|65303518|FG000|Overall Study|Canceled|4|||
23426118|NCT02961790|65303519|FG001|Overall Study|Canceled|5|||
23426119|NCT02961790|65303520|FG002|Overall Study|Canceled|1|||
23426120|NCT02961790|65303521|FG003|Overall Study|Canceled|4|||
23426121|NCT02961790|65303518|FG000|Overall Study|without baseline data|4|||
23426122|NCT02961790|65303519|FG001|Overall Study|without baseline data|0|||
23426123|NCT02961790|65303520|FG002|Overall Study|without baseline data|1|||
23426124|NCT02961790|65303521|FG003|Overall Study|without baseline data|0|||
23426125|NCT02961790|65303518|FG000|Overall Study|without post baseline data|7|||
23426126|NCT02961790|65303519|FG001|Overall Study|without post baseline data|6|||
23426127|NCT02961790|65303520|FG002|Overall Study|without post baseline data|4|||
23426128|NCT02961790|65303521|FG003|Overall Study|without post baseline data|1|||
23426129|NCT04070326|65303522|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
23426130|NCT04070326|65303523|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
23426131|NCT02838901|65303524|FG000|Overall Study|Withdrawal by Subject|1|||
23125281|NCT02493946|64208585|FG002|Open Label Period|Withdrawal by Subject|74|||
23125282|NCT02493946|64208583|FG000|Open Label Period|Adverse Event|0|||
23125283|NCT02493946|64208584|FG001|Open Label Period|Adverse Event|0|||
23125284|NCT02493946|64208585|FG002|Open Label Period|Adverse Event|4|||
23426132|NCT02838901|65303525|FG001|Overall Study|Withdrawal by Subject|1|||
23125285|NCT02493946|64208583|FG000|Open Label Period|Lost to Follow-up|0|||
23125286|NCT02493946|64208584|FG001|Open Label Period|Lost to Follow-up|0|||
23125287|NCT02493946|64208585|FG002|Open Label Period|Lost to Follow-up|1|||
23125288|NCT02493946|64208583|FG000|Open Label Period|Investigator decision, non-compliance|0|||
23125289|NCT02493946|64208584|FG001|Open Label Period|Investigator decision, non-compliance|0|||
23125290|NCT02493946|64208585|FG002|Open Label Period|Investigator decision, non-compliance|2|||
23125291|NCT02493946|64208583|FG000|Open Label Period|Investigator decision, non-availability|0|||
23125292|NCT02493946|64208584|FG001|Open Label Period|Investigator decision, non-availability|0|||
23125293|NCT02493946|64208585|FG002|Open Label Period|Investigator decision, non-availability|1|||
23125294|NCT02493946|64208583|FG000|Open Label Period|Pregnancy|0|||
23125295|NCT02493946|64208584|FG001|Open Label Period|Pregnancy|0|||
23125296|NCT02493946|64208585|FG002|Open Label Period|Pregnancy|3|||
23125297|NCT02493946|64208583|FG000|Open Label Period|Site error|0|||
23125298|NCT02493946|64208584|FG001|Open Label Period|Site error|0|||
23125299|NCT02493946|64208585|FG002|Open Label Period|Site error|1|||
23125300|NCT01907906|64208586|FG000|Overall Study|Withdrawal by Subject|1|||
23125301|NCT01907906|64208587|FG001|Overall Study|Withdrawal by Subject|0|||
23125302|NCT01907906|64208586|FG000|Overall Study|Physician Decision|3|||
23125303|NCT01907906|64208587|FG001|Overall Study|Physician Decision|1|||
23125304|NCT00725712|64208592|FG000|Overall Study|Withdrawal by Subject|2|||
23125305|NCT00725712|64208593|FG001|Overall Study|Withdrawal by Subject|1|||
23125306|NCT00725712|64208592|FG000|Overall Study|Protocol Violation|1|||
23125307|NCT00725712|64208593|FG001|Overall Study|Protocol Violation|0|||
23125308|NCT00725712|64208592|FG000|Overall Study|Progressive disease|37|||
23125309|NCT00725712|64208593|FG001|Overall Study|Progressive disease|16|||
23125310|NCT00725712|64208592|FG000|Overall Study|Clinical progression not based on RECIST|0|||
23125311|NCT00725712|64208593|FG001|Overall Study|Clinical progression not based on RECIST|3|||
23125312|NCT00725712|64208592|FG000|Overall Study|Adverse Event|5|||
23125313|NCT00725712|64208593|FG001|Overall Study|Adverse Event|5|||
23211497|NCT03627494|64512509|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
23211498|NCT03627494|64512510|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
23211499|NCT03627494|64512511|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
23211500|NCT03627494|64512512|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
23211501|NCT03627494|64512513|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
23211502|NCT03627494|64512514|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
23426133|NCT02838901|65303524|FG000|Overall Study|Lost to Follow-up|1|||
23426134|NCT02838901|65303525|FG001|Overall Study|Lost to Follow-up|1|||
23426135|NCT01667562|65303529|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
23544211|NCT01458574|65723016|FG000|Overall Study|Protocol Violation|0|||
23544212|NCT01458574|65723017|FG001|Overall Study|Protocol Violation|1|||
23544213|NCT01458574|65723018|FG002|Overall Study|Protocol Violation|0|||
23125314|NCT00725712|64208592|FG000|Overall Study|Death|2|||
23125315|NCT00725712|64208593|FG001|Overall Study|Death|0|||
23125316|NCT00725712|64208592|FG000|Overall Study|Other: Death|1|||
23125317|NCT00725712|64208593|FG001|Overall Study|Other: Death|0|||
23125318|NCT00725712|64208592|FG000|Overall Study|Hospitalized, unable to continue|0|||
23125319|NCT00725712|64208593|FG001|Overall Study|Hospitalized, unable to continue|1|||
23426136|NCT01667562|65303530|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
23211503|NCT00293423|64512517|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
23211504|NCT00293423|64512518|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
23211505|NCT00293423|64512517|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
23211506|NCT00293423|64512518|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
23211507|NCT00293423|64512517|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
23211508|NCT00293423|64512518|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
23617486|NCT01225159|65985195|FG001|Overall Study|Change operation|0|||
23617487|NCT03325608|65985196|FG000|Overall Study|Lost to Follow-up|23|||
23617488|NCT03325608|65985197|FG001|Overall Study|Lost to Follow-up|23|||
23617489|NCT03325608|65985198|FG002|Overall Study|Lost to Follow-up|30|||
23617490|NCT03325608|65985199|FG003|Overall Study|Lost to Follow-up|30|||
23617491|NCT03325608|65985196|FG000|Overall Study|Death of Caregiver|0|||
23617492|NCT03325608|65985197|FG001|Overall Study|Death of Caregiver|0|||
23617493|NCT03325608|65985198|FG002|Overall Study|Death of Caregiver|2|||
23211509|NCT00293423|64512517|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
23211510|NCT00293423|64512518|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
23211511|NCT00293423|64512517|FG000|Surgical Resection|processing error during surgical resection|1|||
23211512|NCT00293423|64512518|FG001|Surgical Resection|processing error during surgical resection|0|||
23544214|NCT01458574|65723016|FG000|Overall Study|Withdrawal by Subject|6|||
23544215|NCT01458574|65723017|FG001|Overall Study|Withdrawal by Subject|3|||
23544216|NCT01458574|65723018|FG002|Overall Study|Withdrawal by Subject|5|||
23211513|NCT00293423|64512517|FG000|Surgical Resection|Withdrawal by Subject|4|||
23211514|NCT00293423|64512518|FG001|Surgical Resection|Withdrawal by Subject|0|||
23211515|NCT00293423|64512517|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
23211516|NCT00293423|64512518|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
23211517|NCT00839423|64512529|FG000|Overall Study|Adverse Event|4|||
23211518|NCT00839423|64512530|FG001|Overall Study|Adverse Event|3|||
23211519|NCT00839423|64512531|FG002|Overall Study|Adverse Event|7|||
23211520|NCT00839423|64512532|FG003|Overall Study|Adverse Event|16|||
23211521|NCT00839423|64512529|FG000|Overall Study|Lack of Efficacy|6|||
23211522|NCT00839423|64512530|FG001|Overall Study|Lack of Efficacy|6|||
23211523|NCT00839423|64512531|FG002|Overall Study|Lack of Efficacy|3|||
23211524|NCT00839423|64512532|FG003|Overall Study|Lack of Efficacy|2|||
23211525|NCT00839423|64512529|FG000|Overall Study|Non-compliance|0|||
23211526|NCT00839423|64512530|FG001|Overall Study|Non-compliance|0|||
23211527|NCT00839423|64512531|FG002|Overall Study|Non-compliance|0|||
23211528|NCT00839423|64512532|FG003|Overall Study|Non-compliance|1|||
23211529|NCT00839423|64512529|FG000|Overall Study|Protocol Violation|0|||
23211530|NCT00839423|64512530|FG001|Overall Study|Protocol Violation|1|||
23211531|NCT00839423|64512531|FG002|Overall Study|Protocol Violation|2|||
23211532|NCT00839423|64512532|FG003|Overall Study|Protocol Violation|0|||
23211533|NCT00839423|64512529|FG000|Overall Study|Withdrawal of consent|4|||
23544217|NCT01458574|65723016|FG000|Overall Study|Other|2|||
23544218|NCT01458574|65723017|FG001|Overall Study|Other|1|||
23544219|NCT01458574|65723018|FG002|Overall Study|Other|0|||
23544220|NCT01458574|65723016|FG000|Overall Study|Randomized but not treated|0|||
23544221|NCT01458574|65723017|FG001|Overall Study|Randomized but not treated|1|||
23544222|NCT01458574|65723018|FG002|Overall Study|Randomized but not treated|0|||
23544223|NCT00448539|65723019|FG000|Overall Study|Medication non-compliance|4|||
23544224|NCT00448539|65723020|FG001|Overall Study|Medication non-compliance|1|||
23544225|NCT00448539|65723019|FG000|Overall Study|Protocol Violation|1|||
23544226|NCT00448539|65723020|FG001|Overall Study|Protocol Violation|0|||
23617494|NCT03325608|65985199|FG003|Overall Study|Death of Caregiver|2|||
23211534|NCT00839423|64512530|FG001|Overall Study|Withdrawal of consent|0|||
23211535|NCT00839423|64512531|FG002|Overall Study|Withdrawal of consent|4|||
23211536|NCT00839423|64512532|FG003|Overall Study|Withdrawal of consent|1|||
23211537|NCT00839423|64512529|FG000|Overall Study|Lost to Follow-up|1|||
23211538|NCT00839423|64512530|FG001|Overall Study|Lost to Follow-up|0|||
23211539|NCT00839423|64512531|FG002|Overall Study|Lost to Follow-up|1|||
23211540|NCT00839423|64512532|FG003|Overall Study|Lost to Follow-up|0|||
23211541|NCT00839423|64512529|FG000|Overall Study|Administrative or other reasons|3|||
23426137|NCT01667562|65303529|FG000|Erlotinib Phase|Lost to Follow-up|0|||
23426138|NCT01667562|65303530|FG001|Erlotinib Phase|Lost to Follow-up|1|||
23426139|NCT01667562|65303529|FG000|Erlotinib Phase|Adverse Event|0|||
23544227|NCT00448539|65723019|FG000|Overall Study|Request of the investigator or sponsor|67|||
23211542|NCT00839423|64512530|FG001|Overall Study|Administrative or other reasons|0|||
23211543|NCT00839423|64512531|FG002|Overall Study|Administrative or other reasons|1|||
23544228|NCT00448539|65723020|FG001|Overall Study|Request of the investigator or sponsor|54|||
23544229|NCT00448539|65723019|FG000|Overall Study|Withdrawal by Subject|20|||
23211544|NCT00839423|64512532|FG003|Overall Study|Administrative or other reasons|0|||
23211545|NCT01184846|64512533|FG000|Overall Study|Adverse Event|2|||
23426140|NCT01667562|65303530|FG001|Erlotinib Phase|Adverse Event|1|||
23544230|NCT00448539|65723020|FG001|Overall Study|Withdrawal by Subject|24|||
23617495|NCT03325608|65985196|FG000|Overall Study|Death of Care Recipient|34|||
23617496|NCT03325608|65985197|FG001|Overall Study|Death of Care Recipient|34|||
23544231|NCT00448539|65723019|FG000|Overall Study|Diary non-compliance|1|||
23544232|NCT00448539|65723020|FG001|Overall Study|Diary non-compliance|0|||
23544233|NCT00448539|65723019|FG000|Overall Study|Adverse Event|9|||
23544234|NCT00448539|65723020|FG001|Overall Study|Adverse Event|26|||
23544235|NCT00448539|65723019|FG000|Overall Study|Lack of Efficacy|27|||
23544236|NCT00448539|65723020|FG001|Overall Study|Lack of Efficacy|40|||
23544237|NCT00448539|65723019|FG000|Overall Study|Miscellaneous|2|||
23544238|NCT00448539|65723020|FG001|Overall Study|Miscellaneous|1|||
23544239|NCT00448539|65723019|FG000|Overall Study|Change of meds|2|||
23544240|NCT00448539|65723020|FG001|Overall Study|Change of meds|3|||
23544241|NCT00448539|65723019|FG000|Overall Study|Lost to Follow-up|1|||
23544242|NCT00448539|65723020|FG001|Overall Study|Lost to Follow-up|3|||
23544243|NCT01308749|65723021|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
23544244|NCT01308749|65723022|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
23617497|NCT03325608|65985198|FG002|Overall Study|Death of Care Recipient|28|||
23617498|NCT03325608|65985199|FG003|Overall Study|Death of Care Recipient|28|||
23617499|NCT03325608|65985196|FG000|Overall Study|Withdrawal by Subject|49|||
23617500|NCT03325608|65985197|FG001|Overall Study|Withdrawal by Subject|49|||
23617501|NCT03325608|65985198|FG002|Overall Study|Withdrawal by Subject|35|||
23617502|NCT03325608|65985199|FG003|Overall Study|Withdrawal by Subject|35|||
23617503|NCT03325608|65985196|FG000|Overall Study|Ineligible|7|||
23617504|NCT03325608|65985197|FG001|Overall Study|Ineligible|7|||
23617505|NCT03325608|65985198|FG002|Overall Study|Ineligible|5|||
23617506|NCT03325608|65985199|FG003|Overall Study|Ineligible|5|||
23617507|NCT02229396|65985200|FG000|Overall Study|Adverse Event|6|||
23617508|NCT02229396|65985201|FG001|Overall Study|Adverse Event|12|||
23617509|NCT02229396|65985202|FG002|Overall Study|Adverse Event|12|||
23617510|NCT02229396|65985200|FG000|Overall Study|Death|2|||
23617511|NCT02229396|65985201|FG001|Overall Study|Death|3|||
23617512|NCT02229396|65985202|FG002|Overall Study|Death|1|||
23617513|NCT02229396|65985200|FG000|Overall Study|Lost to Follow-up|14|||
23617514|NCT02229396|65985201|FG001|Overall Study|Lost to Follow-up|14|||
23617515|NCT02229396|65985202|FG002|Overall Study|Lost to Follow-up|21|||
23617516|NCT02229396|65985200|FG000|Overall Study|Protocol Violation|2|||
23617517|NCT02229396|65985201|FG001|Overall Study|Protocol Violation|1|||
23617518|NCT02229396|65985202|FG002|Overall Study|Protocol Violation|0|||
23617519|NCT02229396|65985200|FG000|Overall Study|Patient Incorrectly Randomized|0|||
23125320|NCT02586415|64208603|FG000|Overall Study|Death|13|||
23125321|NCT02586415|64208604|FG001|Overall Study|Death|23|||
23125322|NCT02586415|64208603|FG000|Overall Study|Lost to Follow-up|1|||
23125323|NCT02586415|64208604|FG001|Overall Study|Lost to Follow-up|2|||
23125324|NCT02786004|64208605|FG000|Overall Study|Withdrawal by Subject|0|||
23125325|NCT02786004|64208606|FG001|Overall Study|Withdrawal by Subject|1|||
23125326|NCT03054337|64208607|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
23125327|NCT03054337|64208608|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
23125328|NCT03054337|64208609|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
23125329|NCT03054337|64208610|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
23125330|NCT03054337|64208611|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
23211546|NCT01184846|64512533|FG000|Overall Study|Insufficient response|1|||
23544245|NCT01308749|65723021|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
23544246|NCT01308749|65723022|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
23544247|NCT01308749|65723021|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
23314837|NCT04036110|64895443|FG000|Overall Study|Lost to Follow-up|3|||
23314838|NCT04036110|64895444|FG001|Overall Study|Lost to Follow-up|2|||
23314839|NCT04036110|64895445|FG002|Overall Study|Lost to Follow-up|1|||
23314840|NCT04036110|64895443|FG000|Overall Study|Study Suspended|4|||
23314841|NCT04036110|64895444|FG001|Overall Study|Study Suspended|5|||
23426141|NCT01667562|65303529|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
23426142|NCT01667562|65303530|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
23617520|NCT02229396|65985201|FG001|Overall Study|Patient Incorrectly Randomized|0|||
23617521|NCT02229396|65985202|FG002|Overall Study|Patient Incorrectly Randomized|1|||
23211547|NCT02207556|64512538|FG000|Overall Study|Physician Decision|1|||
23211548|NCT02207556|64512539|FG001|Overall Study|Physician Decision|0|||
23211549|NCT02207556|64512538|FG000|Overall Study|Withdrawal by Subject|1|||
23211550|NCT02207556|64512539|FG001|Overall Study|Withdrawal by Subject|0|||
23211551|NCT02207556|64512538|FG000|Overall Study|Death|0|||
23426143|NCT00413374|65303535|FG000|Overall Study|Ineligible due to screening criteria.|3|||
23617522|NCT02229396|65985200|FG000|Overall Study|Other|10|||
23617523|NCT02229396|65985201|FG001|Overall Study|Other|18|||
23617524|NCT02229396|65985202|FG002|Overall Study|Other|15|||
23125331|NCT03054337|64208612|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
23125332|NCT00909532|64208613|FG000|Overall Study|Adverse Event|4|||
23426144|NCT00413374|65303536|FG001|Overall Study|Ineligible due to screening criteria.|0|||
23426145|NCT00413374|65303535|FG000|Overall Study|Adverse Event|1|||
23426146|NCT00413374|65303536|FG001|Overall Study|Adverse Event|0|||
23617525|NCT02229396|65985200|FG000|Overall Study|Withdrawal by Subject|42|||
23617526|NCT02229396|65985201|FG001|Overall Study|Withdrawal by Subject|28|||
23544248|NCT01308749|65723022|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
23544249|NCT03998618|65723027|FG000|Overall Study|Death|7|||
23544250|NCT03998618|65723028|FG001|Overall Study|Death|11|||
23544251|NCT03998618|65723027|FG000|Overall Study|hospice enrollment|3|||
23544252|NCT03998618|65723028|FG001|Overall Study|hospice enrollment|3|||
23544253|NCT03998618|65723027|FG000|Overall Study|Not feeling well/health problems|3|||
23544254|NCT03998618|65723028|FG001|Overall Study|Not feeling well/health problems|5|||
23544255|NCT03998618|65723027|FG000|Overall Study|Lost to Follow-up|6|||
23544256|NCT03998618|65723028|FG001|Overall Study|Lost to Follow-up|6|||
23544257|NCT03998618|65723027|FG000|Overall Study|Withdrawal by Subject|0|||
23544258|NCT03998618|65723028|FG001|Overall Study|Withdrawal by Subject|4|||
23544259|NCT04265755|65723029|FG000|Overall Study|Withdrawal by Subject|39|||
23544260|NCT04265755|65723029|FG000|Overall Study|Decision by sponsor|2|||
23544261|NCT04265755|65723029|FG000|Overall Study|Lost to Follow-up|11|||
23544262|NCT04265755|65723029|FG000|Overall Study|Death|1|||
23544263|NCT01343368|65723030|FG000|Overall Study|Death|1|||
23544264|NCT01343368|65723031|FG001|Overall Study|Death|0|||
23544265|NCT01343368|65723030|FG000|Overall Study|Lost to Follow-up|1|||
23544266|NCT01343368|65723031|FG001|Overall Study|Lost to Follow-up|0|||
23544267|NCT00970502|65723032|FG000|Overall Study|Withdrawal by Subject|1|||
23544268|NCT01605617|65723033|FG000|First Intervention|Adverse Event|0|||
23544269|NCT01605617|65723034|FG001|First Intervention|Adverse Event|1|||
23544270|NCT01605617|65723033|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
23544271|NCT01605617|65723034|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
23544272|NCT04313634|65723037|FG000|Overall Study|Adverse Event|2|||
23544273|NCT04313634|65723038|FG001|Overall Study|Adverse Event|2|||
23544274|NCT04313634|65723039|FG002|Overall Study|Adverse Event|0|||
23617527|NCT02229396|65985202|FG002|Overall Study|Withdrawal by Subject|41|||
23617528|NCT02229396|65985200|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
23617529|NCT02229396|65985201|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
23617530|NCT02229396|65985202|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
23617531|NCT02229396|65985200|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
23617532|NCT02229396|65985201|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
23617533|NCT02229396|65985202|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
23617534|NCT00776984|65985203|FG000|Overall Study|Adverse Event|8|||
23617535|NCT00776984|65985204|FG001|Overall Study|Adverse Event|2|||
23617536|NCT00776984|65985203|FG000|Overall Study|Protocol Violation|4|||
23617537|NCT00776984|65985204|FG001|Overall Study|Protocol Violation|2|||
23617538|NCT00776984|65985203|FG000|Overall Study|Lost to Follow-up|2|||
23211552|NCT02207556|64512539|FG001|Overall Study|Death|5|||
23211553|NCT00369967|64512540|FG000|Overall Study|Lost to Follow-up|23|||
23211554|NCT00369967|64512541|FG001|Overall Study|Lost to Follow-up|12|||
23211555|NCT01188096|64512542|FG000|Overall Study|progression of disease|4|||
23211556|NCT01188096|64512542|FG000|Overall Study|Withdrawal by Subject|2|||
23211557|NCT02261883|64512547|FG000|Overall Study|Death|3|||
23211558|NCT02261883|64512548|FG001|Overall Study|Death|2|||
23211559|NCT02261883|64512547|FG000|Overall Study|Physician Decision|1|||
23211560|NCT02261883|64512548|FG001|Overall Study|Physician Decision|0|||
23211561|NCT02261883|64512547|FG000|Overall Study|Protocol Violation|1|||
23211562|NCT02261883|64512548|FG001|Overall Study|Protocol Violation|0|||
23211563|NCT02261883|64512547|FG000|Overall Study|Withdrawal by Subject|0|||
23211564|NCT02261883|64512548|FG001|Overall Study|Withdrawal by Subject|1|||
23211565|NCT02261883|64512547|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
23211566|NCT02261883|64512548|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
23211567|NCT01199055|64512550|FG000|Overall Study|Death|0|||
23211568|NCT01199055|64512551|FG001|Overall Study|Death|1|||
23211569|NCT01199055|64512552|FG002|Overall Study|Death|0|||
23211570|NCT01199055|64512550|FG000|Overall Study|Physician Decision|0|||
23211571|NCT01199055|64512551|FG001|Overall Study|Physician Decision|1|||
23211572|NCT01199055|64512552|FG002|Overall Study|Physician Decision|1|||
23211573|NCT01199055|64512550|FG000|Overall Study|Progressive disease|2|||
23211574|NCT01199055|64512551|FG001|Overall Study|Progressive disease|1|||
23211575|NCT01199055|64512552|FG002|Overall Study|Progressive disease|2|||
23544275|NCT04313634|65723037|FG000|Overall Study|Withdrawal by Subject|1|||
23544276|NCT04313634|65723038|FG001|Overall Study|Withdrawal by Subject|0|||
23617539|NCT00776984|65985204|FG001|Overall Study|Lost to Follow-up|0|||
23617540|NCT00776984|65985203|FG000|Overall Study|Withdrawal by Subject|12|||
23211576|NCT01199055|64512550|FG000|Overall Study|Withdrawal by Subject|0|||
23211577|NCT01199055|64512551|FG001|Overall Study|Withdrawal by Subject|0|||
23211578|NCT01199055|64512552|FG002|Overall Study|Withdrawal by Subject|1|||
23211579|NCT02293902|64512553|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
23211580|NCT02293902|64512554|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
23211581|NCT02293902|64512555|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
23544277|NCT04313634|65723039|FG002|Overall Study|Withdrawal by Subject|1|||
23544278|NCT04313634|65723037|FG000|Overall Study|Protocol Violation|0|||
23544279|NCT04313634|65723038|FG001|Overall Study|Protocol Violation|0|||
23544280|NCT04313634|65723039|FG002|Overall Study|Protocol Violation|1|||
23544281|NCT03314987|65723041|FG000|Overall Study|Lost to Follow-up|13|||
23617541|NCT00776984|65985204|FG001|Overall Study|Withdrawal by Subject|7|||
23617542|NCT00776984|65985203|FG000|Overall Study|Lack of Efficacy|0|||
23617543|NCT00776984|65985204|FG001|Overall Study|Lack of Efficacy|1|||
23617544|NCT00776984|65985203|FG000|Overall Study|Other|5|||
23617545|NCT00776984|65985204|FG001|Overall Study|Other|9|||
23617546|NCT00975130|65985205|FG000|Study Part 1|Adverse Event|150|||
23617547|NCT00975130|65985206|FG001|Study Part 1|Adverse Event|0|||
23617548|NCT00975130|65985207|FG002|Study Part 1|Adverse Event|0|||
23617549|NCT00975130|65985205|FG000|Study Part 1|Lost to Follow-up|19|||
23617550|NCT00975130|65985206|FG001|Study Part 1|Lost to Follow-up|0|||
23617551|NCT00975130|65985207|FG002|Study Part 1|Lost to Follow-up|0|||
23617552|NCT00975130|65985205|FG000|Study Part 1|Withdrawal by Subject|61|||
23617553|NCT00975130|65985206|FG001|Study Part 1|Withdrawal by Subject|0|||
23617554|NCT00975130|65985207|FG002|Study Part 1|Withdrawal by Subject|0|||
23617555|NCT00975130|65985205|FG000|Study Part 1|Protocol Violation|13|||
23617556|NCT00975130|65985206|FG001|Study Part 1|Protocol Violation|0|||
23617557|NCT00975130|65985207|FG002|Study Part 1|Protocol Violation|0|||
23617558|NCT00975130|65985205|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
23617559|NCT00975130|65985206|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
23617560|NCT00975130|65985207|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
23617561|NCT00975130|65985205|FG000|Study Part 1|Administrative|4|||
23617562|NCT00975130|65985206|FG001|Study Part 1|Administrative|0|||
23617563|NCT00975130|65985207|FG002|Study Part 1|Administrative|0|||
23617564|NCT00975130|65985205|FG000|Study Part 1|Withdrew Consent|24|||
23617565|NCT00975130|65985206|FG001|Study Part 1|Withdrew Consent|0|||
23617566|NCT00975130|65985207|FG002|Study Part 1|Withdrew Consent|0|||
23617567|NCT00975130|65985205|FG000|Study Part 2|Adverse Event|0|||
23617568|NCT00975130|65985206|FG001|Study Part 2|Adverse Event|14|||
23617569|NCT00975130|65985207|FG002|Study Part 2|Adverse Event|7|||
23617570|NCT00975130|65985205|FG000|Study Part 2|Lost to Follow-up|0|||
23617571|NCT00975130|65985206|FG001|Study Part 2|Lost to Follow-up|0|||
23617572|NCT00975130|65985207|FG002|Study Part 2|Lost to Follow-up|1|||
23617573|NCT00975130|65985205|FG000|Study Part 2|Withdrawal by Subject|0|||
23617574|NCT00975130|65985206|FG001|Study Part 2|Withdrawal by Subject|13|||
23617575|NCT00975130|65985207|FG002|Study Part 2|Withdrawal by Subject|5|||
23617576|NCT00975130|65985205|FG000|Study Part 2|Withdrew Consent|0|||
23617577|NCT00975130|65985206|FG001|Study Part 2|Withdrew Consent|6|||
23617578|NCT00975130|65985207|FG002|Study Part 2|Withdrew Consent|2|||
23617579|NCT00975130|65985205|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
23617580|NCT00975130|65985206|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
23617581|NCT00975130|65985207|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
23617582|NCT00975130|65985205|FG000|Study Part 2|Administrative|0|||
23617583|NCT00975130|65985206|FG001|Study Part 2|Administrative|1|||
23617584|NCT00975130|65985207|FG002|Study Part 2|Administrative|0|||
23617585|NCT00975130|65985205|FG000|Study Part 2|Protocol Violation|0|||
23617586|NCT00975130|65985206|FG001|Study Part 2|Protocol Violation|0|||
23617587|NCT00975130|65985207|FG002|Study Part 2|Protocol Violation|1|||
23617588|NCT04206384|65985208|FG000|Overall Study|Withdrawal by Subject|8|||
23617589|NCT04206384|65985208|FG000|Overall Study|Adverse Event|2|||
23617590|NCT02504502|65985209|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
23617591|NCT02504502|65985210|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
23617592|NCT02504502|65985209|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
23617593|NCT02504502|65985210|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
23617594|NCT03900715|65985211|FG000|Overall Study|Protocol Deviation|1|||
23617595|NCT03900715|65985211|FG000|Overall Study|Lack of Efficacy|1|||
23617596|NCT03900715|65985211|FG000|Overall Study|Progressive Disease|6|||
23617597|NCT03900715|65985211|FG000|Overall Study|Adverse Event|2|||
23617598|NCT03900715|65985211|FG000|Overall Study|Other reasons|11|||
23125333|NCT00909532|64208614|FG001|Overall Study|Adverse Event|1|||
23125334|NCT00909532|64208613|FG000|Overall Study|Pregnancy|0|||
23125335|NCT00909532|64208614|FG001|Overall Study|Pregnancy|1|||
23125336|NCT00909532|64208613|FG000|Overall Study|Prohibited Medication|2|||
23125337|NCT00909532|64208614|FG001|Overall Study|Prohibited Medication|1|||
23125338|NCT00909532|64208613|FG000|Overall Study|Withdrawal of Consent|1|||
23125339|NCT00909532|64208614|FG001|Overall Study|Withdrawal of Consent|1|||
23125340|NCT00909532|64208613|FG000|Overall Study|Noncompliance with Study Requirements|0|||
23125341|NCT00909532|64208614|FG001|Overall Study|Noncompliance with Study Requirements|2|||
23211582|NCT02293902|64512556|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
23617599|NCT02137239|65985212|FG000|Overall Study|Discontinued Study Treatment|0|||
23617600|NCT02137239|65985213|FG001|Overall Study|Discontinued Study Treatment|3|||
23617601|NCT02137239|65985212|FG000|Overall Study|Withdrew Consent|1|||
23617602|NCT02137239|65985213|FG001|Overall Study|Withdrew Consent|1|||
23617603|NCT02137239|65985212|FG000|Overall Study|Adverse Event|2|||
23125342|NCT00909532|64208613|FG000|Overall Study|Physician Decision|1|||
23125343|NCT00909532|64208614|FG001|Overall Study|Physician Decision|0|||
23125344|NCT00909532|64208613|FG000|Overall Study|Wrong Genotype|1|||
23617604|NCT02137239|65985213|FG001|Overall Study|Adverse Event|2|||
23617605|NCT01747837|65985215|FG000|Overall Study|Lost to Follow-up|5|||
23125345|NCT00909532|64208614|FG001|Overall Study|Wrong Genotype|0|||
23125346|NCT00909532|64208613|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
23125347|NCT00909532|64208614|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
23125348|NCT00730015|64208615|FG000|Overall Study|Adverse Event|11|||
23125349|NCT00730015|64208616|FG001|Overall Study|Adverse Event|10|||
23125350|NCT00730015|64208617|FG002|Overall Study|Adverse Event|8|||
23125351|NCT00730015|64208615|FG000|Overall Study|Protocol Violation|2|||
23125352|NCT00730015|64208616|FG001|Overall Study|Protocol Violation|6|||
23125353|NCT00730015|64208617|FG002|Overall Study|Protocol Violation|4|||
23125354|NCT00730015|64208615|FG000|Overall Study|Withdrawal by Subject|12|||
23125355|NCT00730015|64208616|FG001|Overall Study|Withdrawal by Subject|12|||
23125356|NCT00730015|64208617|FG002|Overall Study|Withdrawal by Subject|8|||
23125357|NCT00730015|64208615|FG000|Overall Study|Lost to Follow-up|4|||
23125358|NCT00730015|64208616|FG001|Overall Study|Lost to Follow-up|10|||
23125359|NCT00730015|64208617|FG002|Overall Study|Lost to Follow-up|3|||
23125360|NCT00730015|64208615|FG000|Overall Study|Lack of Efficacy|1|||
23125361|NCT00730015|64208616|FG001|Overall Study|Lack of Efficacy|2|||
23125362|NCT00730015|64208617|FG002|Overall Study|Lack of Efficacy|8|||
23125363|NCT00730015|64208615|FG000|Overall Study|Other Reason|1|||
23125364|NCT00730015|64208616|FG001|Overall Study|Other Reason|0|||
23125365|NCT00730015|64208617|FG002|Overall Study|Other Reason|1|||
23211583|NCT02293902|64512557|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
23211584|NCT02293902|64512553|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
23211585|NCT02293902|64512554|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
23211586|NCT02293902|64512555|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
23211587|NCT02293902|64512556|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
23211588|NCT02293902|64512557|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
23211589|NCT02293902|64512553|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
23211590|NCT02293902|64512554|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
23211591|NCT02293902|64512555|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
23211592|NCT02293902|64512556|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
23211593|NCT02293902|64512557|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
23617606|NCT01747837|65985216|FG001|Overall Study|Lost to Follow-up|2|||
23617607|NCT01747837|65985215|FG000|Overall Study|Death|4|||
23617608|NCT01747837|65985216|FG001|Overall Study|Death|4|||
23617609|NCT04482647|65985220|FG000|Overall Study|Time constraints|2|||
23617610|NCT04482647|65985220|FG000|Overall Study|Health issues|1|||
23617611|NCT04482647|65985220|FG000|Overall Study|Death in the family|1|||
23617612|NCT04482647|65985220|FG000|Overall Study|Disliked the intervention|1|||
23617613|NCT04482647|65985220|FG000|Overall Study|No reasons specified|7|||
23617614|NCT01287416|65985221|FG000|Pre-post Training|Withdrawal by Subject|17|||
23617615|NCT01287416|65985222|FG001|Pre-post Training|Withdrawal by Subject|24|||
23617616|NCT01287416|65985221|FG000|Pre-post Training|Lost to Follow-up|5|||
23617617|NCT01287416|65985222|FG001|Pre-post Training|Lost to Follow-up|1|||
23617618|NCT01287416|65985221|FG000|6 Month Follow-up|Lost to Follow-up|3|||
23617619|NCT01287416|65985222|FG001|6 Month Follow-up|Lost to Follow-up|2|||
23617620|NCT01675050|65985224|FG000|Period One Treatment|Withdrawal by Subject|1|||
23617621|NCT01675050|65985225|FG001|Period One Treatment|Withdrawal by Subject|0|||
23617622|NCT02544113|65985227|FG000|Overall Study|Death|3|||
23211594|NCT02293902|64512553|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
23211595|NCT02293902|64512554|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
23211596|NCT02293902|64512555|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
23211597|NCT02293902|64512556|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
23617623|NCT02544113|65985228|FG001|Overall Study|Death|4|||
23617624|NCT01475370|65985240|FG000|Overall Study|Exacerbation of primary disease|2|||
23617625|NCT01475370|65985241|FG001|Overall Study|Exacerbation of primary disease|2|||
23617626|NCT01475370|65985242|FG002|Overall Study|Exacerbation of primary disease|2|||
23617627|NCT01475370|65985240|FG000|Overall Study|Study drug administration difficult|0|||
23617628|NCT01475370|65985241|FG001|Overall Study|Study drug administration difficult|1|||
23617629|NCT01475370|65985242|FG002|Overall Study|Study drug administration difficult|1|||
23617630|NCT01475370|65985240|FG000|Overall Study|Other than specified|1|||
23617631|NCT01475370|65985241|FG001|Overall Study|Other than specified|0|||
23617632|NCT01475370|65985242|FG002|Overall Study|Other than specified|0|||
23617633|NCT01536535|65985244|FG000|Overall Study|Withdrawal by Subject|10|||
23617634|NCT01536535|65985245|FG001|Overall Study|Withdrawal by Subject|5|||
23125366|NCT02229227|64208618|FG000|Overall Study|Adverse Event|14|||
23125367|NCT02229227|64208619|FG001|Overall Study|Adverse Event|9|||
23125368|NCT02229227|64208618|FG000|Overall Study|Lack of Efficacy|3|||
23125369|NCT02229227|64208619|FG001|Overall Study|Lack of Efficacy|3|||
23125370|NCT02229227|64208618|FG000|Overall Study|Protocol Violation|6|||
23125371|NCT02229227|64208619|FG001|Overall Study|Protocol Violation|8|||
23125372|NCT02229227|64208618|FG000|Overall Study|Protocol defined stopping criteria|1|||
23125373|NCT02229227|64208619|FG001|Overall Study|Protocol defined stopping criteria|3|||
23125374|NCT02229227|64208618|FG000|Overall Study|Lost to Follow-up|3|||
23617635|NCT01536535|65985244|FG000|Overall Study|Lost to Follow-up|4|||
23617636|NCT01536535|65985245|FG001|Overall Study|Lost to Follow-up|6|||
23544282|NCT03314987|65723042|FG001|Overall Study|Lost to Follow-up|13|||
23544283|NCT02079805|65723043|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23544284|NCT02079805|65723044|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23544285|NCT02079805|65723043|FG000|Overall Study|Voluntary Withdrawal|0|||
23544286|NCT02079805|65723044|FG001|Overall Study|Voluntary Withdrawal|1|||
23544287|NCT00941603|65723045|FG000|Overall Study|Adverse Event|10|||
23544288|NCT00941603|65723046|FG001|Overall Study|Adverse Event|15|||
23544289|NCT00941603|65723047|FG002|Overall Study|Adverse Event|5|||
23544290|NCT00941603|65723048|FG003|Overall Study|Adverse Event|1|||
23544291|NCT00941603|65723049|FG004|Overall Study|Adverse Event|4|||
23544292|NCT00941603|65723050|FG005|Overall Study|Adverse Event|0|||
23544293|NCT00941603|65723045|FG000|Overall Study|Lost to Follow-up|0|||
23544294|NCT00941603|65723046|FG001|Overall Study|Lost to Follow-up|0|||
23544295|NCT00941603|65723047|FG002|Overall Study|Lost to Follow-up|0|||
23617637|NCT01536535|65985244|FG000|Overall Study|Physician Decision|1|||
23617638|NCT01536535|65985245|FG001|Overall Study|Physician Decision|1|||
23617639|NCT01536535|65985244|FG000|Overall Study|Participant moved|0|||
23617640|NCT01536535|65985245|FG001|Overall Study|Participant moved|1|||
23617641|NCT03740737|65985246|FG000|Overall Study|Protocol deviation|13|||
23617642|NCT03740737|65985247|FG001|Overall Study|Protocol deviation|0|||
23617643|NCT03740737|65985246|FG000|Overall Study|Adverse Event|2|||
23617644|NCT03740737|65985247|FG001|Overall Study|Adverse Event|0|||
23617645|NCT03740737|65985246|FG000|Overall Study|Lost to Follow-up|1|||
23617646|NCT03740737|65985247|FG001|Overall Study|Lost to Follow-up|0|||
23617647|NCT03740737|65985246|FG000|Overall Study|Randomization failure|1|||
23617648|NCT03740737|65985247|FG001|Overall Study|Randomization failure|0|||
23617649|NCT03740737|65985246|FG000|Overall Study|Participant withdrew consent|1|||
23617650|NCT03740737|65985247|FG001|Overall Study|Participant withdrew consent|0|||
23617651|NCT03740737|65985246|FG000|Overall Study|Participant withdrew from trial|2|||
23617652|NCT03740737|65985247|FG001|Overall Study|Participant withdrew from trial|1|||
23617653|NCT01403805|65985248|FG000|Overall Study|Withdrawal by Subject|0|||
23544296|NCT00941603|65723048|FG003|Overall Study|Lost to Follow-up|1|||
23617654|NCT01403805|65985249|FG001|Overall Study|Withdrawal by Subject|4|||
23617655|NCT01403805|65985248|FG000|Overall Study|Lost to Follow-up|0|||
23617656|NCT01403805|65985249|FG001|Overall Study|Lost to Follow-up|2|||
23617657|NCT01403805|65985248|FG000|Overall Study|Death|0|||
23617658|NCT01403805|65985249|FG001|Overall Study|Death|1|||
23617659|NCT00946998|65985250|FG000|Overall Study|Exited prior to first outcome assessment|5|||
23617660|NCT00946998|65985251|FG001|Overall Study|Exited prior to first outcome assessment|3|||
23617661|NCT02186015|65988078|FG000|Overall Study|Physician Decision|1|||
23617662|NCT02186015|65988079|FG001|Overall Study|Physician Decision|0|||
23617663|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
23617664|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
23617665|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Adverse Event|4|||
23617666|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Adverse Event|1|||
23617667|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
23617668|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
23617669|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Physician Decision|0|||
23617670|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Physician Decision|2|||
23617671|NCT02162771|65988080|FG000|Core Study Period (Part 2)|Death|1|||
23617672|NCT02162771|65988081|FG001|Core Study Period (Part 2)|Death|0|||
23211598|NCT02293902|64512557|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
23211599|NCT02293902|64512553|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
23211600|NCT02293902|64512554|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
23211601|NCT02293902|64512555|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
23211602|NCT02293902|64512556|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
23211603|NCT02293902|64512557|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
23211604|NCT00493974|64512558|FG000|Overall Study|Death|1|||
23211605|NCT00493974|64512559|FG001|Overall Study|Death|2|||
23211606|NCT00493974|64512558|FG000|Overall Study|Withdrawal by Subject|8|||
23211607|NCT00493974|64512559|FG001|Overall Study|Withdrawal by Subject|6|||
23544297|NCT00941603|65723049|FG004|Overall Study|Lost to Follow-up|0|||
23544298|NCT00941603|65723050|FG005|Overall Study|Lost to Follow-up|2|||
23544299|NCT00941603|65723045|FG000|Overall Study|Withdrawal by Subject|0|||
23617673|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
23617674|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
23211608|NCT00493974|64512558|FG000|Overall Study|Lost to Follow-up|4|||
23544300|NCT00941603|65723046|FG001|Overall Study|Withdrawal by Subject|0|||
23544301|NCT00941603|65723047|FG002|Overall Study|Withdrawal by Subject|0|||
23544302|NCT00941603|65723048|FG003|Overall Study|Withdrawal by Subject|2|||
23544303|NCT00941603|65723049|FG004|Overall Study|Withdrawal by Subject|0|||
23617675|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
23617676|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
23617677|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Death|2|||
23211609|NCT00493974|64512559|FG001|Overall Study|Lost to Follow-up|6|||
23211610|NCT01074658|64512562|FG000|Overall Study|No implant attempted|19|||
23211611|NCT03454412|64512563|FG000|Baseline Assesment|Physician Decision|12|||
23211612|NCT00426556|64512572|FG000|Phase I - Core Phase|Disease Progression|0|||
23211613|NCT00426556|64512573|FG001|Phase I - Core Phase|Disease Progression|6|||
23211614|NCT00426556|64512574|FG002|Phase I - Core Phase|Disease Progression|2|||
23211615|NCT00426556|64512575|FG003|Phase I - Core Phase|Disease Progression|0|||
23211616|NCT00426556|64512572|FG000|Phase I - Core Phase|Adverse Event|1|||
23211617|NCT00426556|64512573|FG001|Phase I - Core Phase|Adverse Event|3|||
23211618|NCT00426556|64512574|FG002|Phase I - Core Phase|Adverse Event|1|||
23211619|NCT00426556|64512575|FG003|Phase I - Core Phase|Adverse Event|0|||
23211620|NCT00426556|64512572|FG000|Phase I - Core Phase|Death|0|||
23211621|NCT00426556|64512573|FG001|Phase I - Core Phase|Death|1|||
23211622|NCT00426556|64512574|FG002|Phase I - Core Phase|Death|0|||
23211623|NCT00426556|64512575|FG003|Phase I - Core Phase|Death|0|||
23211624|NCT00426556|64512572|FG000|Phase I - Extension Phase|Adverse Event|0|||
23211625|NCT00426556|64512573|FG001|Phase I - Extension Phase|Adverse Event|1|||
23211626|NCT00426556|64512574|FG002|Phase I - Extension Phase|Adverse Event|1|||
23211627|NCT00426556|64512575|FG003|Phase I - Extension Phase|Adverse Event|0|||
23211628|NCT00426556|64512572|FG000|Phase I - Extension Phase|Disease Progression|5|||
23211629|NCT00426556|64512573|FG001|Phase I - Extension Phase|Disease Progression|5|||
23211630|NCT00426556|64512574|FG002|Phase I - Extension Phase|Disease Progression|6|||
23211631|NCT00426556|64512575|FG003|Phase I - Extension Phase|Disease Progression|0|||
23617678|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Death|1|||
23617679|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
23617680|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
23617681|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
23617682|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
23617683|NCT02162771|65988080|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
23617684|NCT02162771|65988081|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
23617685|NCT01946529|65988082|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
23617686|NCT01946529|65988083|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
23617687|NCT01946529|65988084|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
23617688|NCT01946529|65988082|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
23617689|NCT01946529|65988083|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
23617690|NCT01946529|65988084|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
23617691|NCT02250183|65988085|FG000|Overall Study|Withdrawal by Subject|2|||
23617692|NCT02250183|65988085|FG000|Overall Study|Adverse Event|5|||
23617693|NCT02250183|65988085|FG000|Overall Study|Lost to Follow-up|1|||
23617694|NCT01902381|65988086|FG000|Overall Study|Withdrawal by Subject|1|||
23617695|NCT00815919|65988087|FG000|Overall Study|Unrelated Fungal Infection|1|||
23617696|NCT00815919|65988087|FG000|Overall Study|AML Relapse|1|||
23617697|NCT00815919|65988087|FG000|Overall Study|Lack of Efficacy|2|||
23617698|NCT03721978|65988090|FG000|Overall Study|Withdrawal by Subject|6|||
23617699|NCT03721978|65988091|FG001|Overall Study|Withdrawal by Subject|1|||
23617700|NCT03721978|65988090|FG000|Overall Study|Adverse Event|1|||
23617701|NCT03721978|65988091|FG001|Overall Study|Adverse Event|1|||
23617702|NCT03721978|65988090|FG000|Overall Study|Progressive Disease|1|||
23617703|NCT03721978|65988091|FG001|Overall Study|Progressive Disease|0|||
23617704|NCT03721978|65988090|FG000|Overall Study|Lost to Follow-up|5|||
23617705|NCT03721978|65988091|FG001|Overall Study|Lost to Follow-up|1|||
23617706|NCT03721978|65988090|FG000|Overall Study|Reason not Specified|0|||
23617707|NCT03721978|65988091|FG001|Overall Study|Reason not Specified|2|||
23617708|NCT00630552|65988092|FG000|Overall Study|Adverse Event|0|||
23617709|NCT00630552|65988093|FG001|Overall Study|Adverse Event|1|||
23617710|NCT00630552|65988094|FG002|Overall Study|Adverse Event|5|||
23617711|NCT00630552|65988095|FG003|Overall Study|Adverse Event|4|||
23617712|NCT00630552|65988096|FG004|Overall Study|Adverse Event|2|||
23617713|NCT00630552|65988092|FG000|Overall Study|Disease progression|5|||
23617714|NCT00630552|65988093|FG001|Overall Study|Disease progression|6|||
23617715|NCT00630552|65988094|FG002|Overall Study|Disease progression|27|||
23617716|NCT00630552|65988095|FG003|Overall Study|Disease progression|22|||
23617717|NCT00630552|65988096|FG004|Overall Study|Disease progression|31|||
23211632|NCT00426556|64512572|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
23211633|NCT00426556|64512573|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
23211634|NCT00426556|64512574|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
23617718|NCT00630552|65988092|FG000|Overall Study|Never received IP|0|||
23617719|NCT00630552|65988093|FG001|Overall Study|Never received IP|0|||
23211635|NCT00426556|64512575|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
23211636|NCT00426556|64512572|FG000|Phase II - Core Phase|Disease Progression|0|||
23211637|NCT00426556|64512573|FG001|Phase II - Core Phase|Disease Progression|0|||
23211638|NCT00426556|64512574|FG002|Phase II - Core Phase|Disease Progression|0|||
23617720|NCT00630552|65988094|FG002|Overall Study|Never received IP|0|||
23617721|NCT00630552|65988095|FG003|Overall Study|Never received IP|2|||
23617722|NCT00630552|65988096|FG004|Overall Study|Never received IP|2|||
23617723|NCT00630552|65988092|FG000|Overall Study|Ineligibility determined|0|||
23617724|NCT00630552|65988093|FG001|Overall Study|Ineligibility determined|0|||
23617725|NCT00630552|65988094|FG002|Overall Study|Ineligibility determined|0|||
23617726|NCT00630552|65988095|FG003|Overall Study|Ineligibility determined|0|||
23617727|NCT00630552|65988096|FG004|Overall Study|Ineligibility determined|1|||
23617728|NCT00630552|65988092|FG000|Overall Study|Protocol Violation|0|||
23617729|NCT00630552|65988093|FG001|Overall Study|Protocol Violation|0|||
23617730|NCT00630552|65988094|FG002|Overall Study|Protocol Violation|0|||
23617731|NCT00630552|65988095|FG003|Overall Study|Protocol Violation|1|||
23617732|NCT00630552|65988096|FG004|Overall Study|Protocol Violation|0|||
23617733|NCT00630552|65988092|FG000|Overall Study|Physician Decision|0|||
23617734|NCT00630552|65988093|FG001|Overall Study|Physician Decision|0|||
23617735|NCT00630552|65988094|FG002|Overall Study|Physician Decision|0|||
23617736|NCT00630552|65988095|FG003|Overall Study|Physician Decision|0|||
23211639|NCT00426556|64512575|FG003|Phase II - Core Phase|Disease Progression|16|||
23211640|NCT00426556|64512572|FG000|Phase II - Core Phase|Adverse Event|0|||
23211641|NCT00426556|64512573|FG001|Phase II - Core Phase|Adverse Event|0|||
23211642|NCT00426556|64512574|FG002|Phase II - Core Phase|Adverse Event|0|||
23211643|NCT00426556|64512575|FG003|Phase II - Core Phase|Adverse Event|8|||
23211644|NCT00426556|64512572|FG000|Phase II - Extension Phase|Disease Progression|0|||
23617737|NCT00630552|65988096|FG004|Overall Study|Physician Decision|1|||
23617738|NCT00630552|65988092|FG000|Overall Study|Death|0|||
23617739|NCT00630552|65988093|FG001|Overall Study|Death|0|||
23617740|NCT00630552|65988094|FG002|Overall Study|Death|1|||
23617741|NCT00630552|65988095|FG003|Overall Study|Death|2|||
23617742|NCT00630552|65988096|FG004|Overall Study|Death|2|||
23617743|NCT00630552|65988092|FG000|Overall Study|Withdrawal by Subject|0|||
23617744|NCT00630552|65988093|FG001|Overall Study|Withdrawal by Subject|0|||
23617745|NCT00630552|65988094|FG002|Overall Study|Withdrawal by Subject|0|||
23617746|NCT00630552|65988095|FG003|Overall Study|Withdrawal by Subject|1|||
23617747|NCT00630552|65988096|FG004|Overall Study|Withdrawal by Subject|0|||
23617748|NCT00630552|65988092|FG000|Overall Study|Other|0|||
23617749|NCT00630552|65988093|FG001|Overall Study|Other|0|||
23617750|NCT00630552|65988094|FG002|Overall Study|Other|4|||
23617751|NCT00630552|65988095|FG003|Overall Study|Other|2|||
23617752|NCT00630552|65988096|FG004|Overall Study|Other|0|||
23617753|NCT05012397|65988098|FG000|Overall Study|Death|10|||
23617754|NCT05012397|65988098|FG000|Overall Study|Physician Decision|9|||
23125375|NCT02229227|64208619|FG001|Overall Study|Lost to Follow-up|3|||
23125376|NCT02229227|64208618|FG000|Overall Study|Study terminated by sponsor|11|||
23125377|NCT02229227|64208619|FG001|Overall Study|Study terminated by sponsor|11|||
23125378|NCT02229227|64208618|FG000|Overall Study|Withdrawal by Subject|8|||
23125379|NCT02229227|64208619|FG001|Overall Study|Withdrawal by Subject|12|||
23125380|NCT02229227|64208618|FG000|Overall Study|Other|0|||
23125381|NCT02229227|64208619|FG001|Overall Study|Other|1|||
23125382|NCT02229227|64208618|FG000|Overall Study|Physician Decision|5|||
23125383|NCT02229227|64208619|FG001|Overall Study|Physician Decision|12|||
23125384|NCT01371708|64208620|FG000|Overall Study|Insufficient clinical response|3|||
23125385|NCT01371708|64208621|FG001|Overall Study|Insufficient clinical response|2|||
23125386|NCT01371708|64208622|FG002|Overall Study|Insufficient clinical response|0|||
23125387|NCT01371708|64208620|FG000|Overall Study|Lost to Follow-up|5|||
23125388|NCT01371708|64208621|FG001|Overall Study|Lost to Follow-up|9|||
23125389|NCT01371708|64208622|FG002|Overall Study|Lost to Follow-up|7|||
23125390|NCT01371708|64208620|FG000|Overall Study|Protocol Violation|2|||
23125391|NCT01371708|64208621|FG001|Overall Study|Protocol Violation|1|||
23125392|NCT01371708|64208622|FG002|Overall Study|Protocol Violation|2|||
23125393|NCT01371708|64208620|FG000|Overall Study|No longer willing to participate|7|||
23125394|NCT01371708|64208621|FG001|Overall Study|No longer willing to participate|7|||
23125395|NCT01371708|64208622|FG002|Overall Study|No longer willing to participate|13|||
23125396|NCT01371708|64208620|FG000|Overall Study|Medication error/not related to AE|0|||
23125397|NCT01371708|64208621|FG001|Overall Study|Medication error/not related to AE|1|||
23125398|NCT01371708|64208622|FG002|Overall Study|Medication error/not related to AE|0|||
23125399|NCT01371708|64208620|FG000|Overall Study|Other|3|||
23125400|NCT01371708|64208621|FG001|Overall Study|Other|2|||
23125401|NCT01371708|64208622|FG002|Overall Study|Other|4|||
23125402|NCT01371708|64208620|FG000|Overall Study|Adverse Event|5|||
23125403|NCT01371708|64208621|FG001|Overall Study|Adverse Event|8|||
23125404|NCT01371708|64208622|FG002|Overall Study|Adverse Event|12|||
23125405|NCT01371708|64208620|FG000|Overall Study|Started but did not receive treatment|1|||
23125406|NCT01371708|64208621|FG001|Overall Study|Started but did not receive treatment|0|||
23125407|NCT01371708|64208622|FG002|Overall Study|Started but did not receive treatment|1|||
23125408|NCT01183390|64208629|FG000|First Intervention|Adverse Event|0|||
23125409|NCT01183390|64208630|FG001|First Intervention|Adverse Event|1|||
23125410|NCT00725543|64208631|FG000|Overall Study|Adverse Event|10|||
23617755|NCT05012397|65988098|FG000|Overall Study|Withdrawal by Subject|5|||
23617756|NCT05012397|65988098|FG000|Overall Study|Lost to Follow-up|2|||
23617757|NCT02421939|65988101|FG000|Overall Study|Progressive disease|70|||
23617758|NCT02421939|65988102|FG001|Overall Study|Progressive disease|16|||
23617759|NCT02421939|65988101|FG000|Overall Study|Lack of Efficacy|21|||
23617760|NCT02421939|65988102|FG001|Overall Study|Lack of Efficacy|31|||
23617761|NCT02421939|65988101|FG000|Overall Study|Death|36|||
23617762|NCT02421939|65988102|FG001|Overall Study|Death|10|||
23617763|NCT02421939|65988101|FG000|Overall Study|Disease relapse|33|||
23617764|NCT02421939|65988102|FG001|Overall Study|Disease relapse|2|||
23617765|NCT02421939|65988101|FG000|Overall Study|Adverse Event|28|||
23617766|NCT02421939|65988102|FG001|Overall Study|Adverse Event|5|||
23617767|NCT02421939|65988101|FG000|Overall Study|Withdrawal by Subject|5|||
23617768|NCT02421939|65988102|FG001|Overall Study|Withdrawal by Subject|24|||
23617769|NCT02421939|65988101|FG000|Overall Study|Physician Decision|11|||
23617770|NCT02421939|65988102|FG001|Overall Study|Physician Decision|11|||
23617771|NCT02421939|65988101|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
23125411|NCT00725543|64208631|FG000|Overall Study|Lack of Efficacy|3|||
23211645|NCT00426556|64512573|FG001|Phase II - Extension Phase|Disease Progression|0|||
23211646|NCT00426556|64512574|FG002|Phase II - Extension Phase|Disease Progression|0|||
23125412|NCT00725543|64208631|FG000|Overall Study|Withdrawal by Subject|10|||
23125413|NCT00725543|64208631|FG000|Overall Study|Physician Decision|5|||
23125414|NCT00725543|64208631|FG000|Overall Study|Lost to Follow-up|4|||
23125415|NCT00725543|64208631|FG000|Overall Study|Non-compliance|2|||
23125416|NCT00725543|64208631|FG000|Overall Study|Other|119|||
23125417|NCT00497874|64208632|FG000|Overall Study|Withdrawal by Subject|48|||
23125418|NCT00497874|64208633|FG001|Overall Study|Withdrawal by Subject|17|||
23125419|NCT00497874|64208632|FG000|Overall Study|Illness|8|||
23125420|NCT00497874|64208633|FG001|Overall Study|Illness|4|||
23125421|NCT00497874|64208632|FG000|Overall Study|Death|2|||
23125422|NCT00497874|64208633|FG001|Overall Study|Death|4|||
23125423|NCT00497874|64208632|FG000|Overall Study|Unable to contact|52|||
23125424|NCT00497874|64208633|FG001|Overall Study|Unable to contact|67|||
23125425|NCT00497874|64208632|FG000|Overall Study|Unable to schedule|37|||
23125426|NCT00497874|64208633|FG001|Overall Study|Unable to schedule|24|||
23125427|NCT03194867|64208634|FG000|Overall Study|Incorrect completion of end of study form|0|||
23125428|NCT03194867|64208635|FG001|Overall Study|Incorrect completion of end of study form|0|||
23125429|NCT03194867|64208636|FG002|Overall Study|Incorrect completion of end of study form|1|||
23125430|NCT03194867|64208637|FG003|Overall Study|Incorrect completion of end of study form|0|||
23125431|NCT01165177|64208638|FG000|Overall Study|Serious Adverse Event|227|||
23125432|NCT01165177|64208639|FG001|Overall Study|Serious Adverse Event|235|||
23125433|NCT01165177|64208638|FG000|Overall Study|Withdrawal by Subject|368|||
23125434|NCT01165177|64208639|FG001|Overall Study|Withdrawal by Subject|354|||
23125435|NCT01165177|64208638|FG000|Overall Study|Protocol Violation|19|||
23125436|NCT01165177|64208639|FG001|Overall Study|Protocol Violation|21|||
23125437|NCT01165177|64208638|FG000|Overall Study|Non-serious adverse event|30|||
23125438|NCT01165177|64208639|FG001|Overall Study|Non-serious adverse event|18|||
23125439|NCT01165177|64208638|FG000|Overall Study|Other unspecified reasons|47|||
23125440|NCT01165177|64208639|FG001|Overall Study|Other unspecified reasons|35|||
23125441|NCT01165177|64208638|FG000|Overall Study|Suspected HZ episode|0|||
23125442|NCT01165177|64208639|FG001|Overall Study|Suspected HZ episode|2|||
23125443|NCT01165177|64208638|FG000|Overall Study|Lost to Follow-up|183|||
23125444|NCT01165177|64208639|FG001|Overall Study|Lost to Follow-up|194|||
23125445|NCT01165177|64208638|FG000|Overall Study|Migrated/ moved from study area|48|||
23125446|NCT01165177|64208639|FG001|Overall Study|Migrated/ moved from study area|43|||
23125447|NCT00856245|64208641|FG000|Overall Study|Was not transplanted|5|||
23125448|NCT04463680|64208643|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
23125449|NCT04463680|64208643|FG000|Overall Study|Not eligible due to implant duration of use|1|||
23125450|NCT04463680|64208643|FG000|Overall Study|Withdrawal by Subject|3|||
23125451|NCT00362375|64208644|FG000|Overall Study|Lost to Follow-up|40|||
23125452|NCT00362375|64208645|FG001|Overall Study|Lost to Follow-up|35|||
23125453|NCT02820597|64208646|FG000|Overall Study|Lost to Follow-up|12|||
23125454|NCT02106195|64208649|FG000|Overall Study|Adverse Event|2|||
23125455|NCT02106195|64208649|FG000|Overall Study|Protocol Violation|1|||
23125456|NCT01663506|64208652|FG000|Overall Study|Lack of Efficacy|3|||
23617772|NCT02421939|65988102|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
23617773|NCT02421939|65988101|FG000|Overall Study|Miscellaneous|4|||
23617774|NCT02421939|65988102|FG001|Overall Study|Miscellaneous|5|||
23125457|NCT01663506|64208652|FG000|Overall Study|Consent Withdrawal by Subject|1|||
23125458|NCT01663506|64208652|FG000|Overall Study|Lost to Follow-up|1|||
23125459|NCT01663506|64208652|FG000|Overall Study|Adverse Event|1|||
23125460|NCT01663506|64208652|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
23125461|NCT01131104|64208653|FG000|Overall Study|Withdrawal by Subject|3|||
23125462|NCT01131104|64208653|FG000|Overall Study|Physician Decision|4|||
23125463|NCT01131104|64208653|FG000|Overall Study|Information Not Available|5|||
23125464|NCT01131104|64208653|FG000|Overall Study|No Information on Index Date of Onset|1|||
23125465|NCT02394665|64208657|FG000|Overall Study|Physician Decision|1|||
23125466|NCT02394665|64208658|FG001|Overall Study|Physician Decision|0|||
23125467|NCT02394665|64208659|FG002|Overall Study|Physician Decision|0|||
23125468|NCT01081886|64208663|FG000|Overall Study|Study termination|11|||
23617775|NCT02421939|65988101|FG000|Overall Study|Protocol deviation|1|||
23617776|NCT02421939|65988102|FG001|Overall Study|Protocol deviation|1|||
23125469|NCT01081886|64208664|FG001|Overall Study|Study termination|13|||
23125470|NCT00401258|64208665|FG000|Overall Study|Adverse Event|7|||
23125471|NCT00935532|64208666|FG000|Overall Study|Adverse Event|11|||
23125472|NCT00935532|64208667|FG001|Overall Study|Adverse Event|6|||
23125473|NCT00935532|64208666|FG000|Overall Study|Death|1|||
23125474|NCT00935532|64208667|FG001|Overall Study|Death|0|||
23125475|NCT00935532|64208666|FG000|Overall Study|Lost to Follow-up|1|||
23125476|NCT00935532|64208667|FG001|Overall Study|Lost to Follow-up|0|||
23125477|NCT00935532|64208666|FG000|Overall Study|Physician Decision|1|||
23125478|NCT00935532|64208667|FG001|Overall Study|Physician Decision|2|||
23125479|NCT00935532|64208666|FG000|Overall Study|Protocol Violation|2|||
23125480|NCT00935532|64208667|FG001|Overall Study|Protocol Violation|1|||
23125481|NCT00935532|64208666|FG000|Overall Study|Subject Decision|2|||
23125482|NCT00935532|64208667|FG001|Overall Study|Subject Decision|1|||
23125483|NCT00935532|64208666|FG000|Overall Study|Sponsor Decision|0|||
23125484|NCT00935532|64208667|FG001|Overall Study|Sponsor Decision|1|||
23125485|NCT00935532|64208666|FG000|Overall Study|Loss Glucose Control|4|||
23125486|NCT00935532|64208667|FG001|Overall Study|Loss Glucose Control|0|||
23125487|NCT02034162|64208668|FG000|Double-blind|Lost to Follow-up|3|||
23125488|NCT02034162|64208669|FG001|Double-blind|Lost to Follow-up|0|||
23125489|NCT02034162|64208670|FG002|Double-blind|Lost to Follow-up|0|||
23125490|NCT02034162|64208668|FG000|Double-blind|Physician Decision|1|||
23125491|NCT02034162|64208669|FG001|Double-blind|Physician Decision|0|||
23125492|NCT02034162|64208670|FG002|Double-blind|Physician Decision|0|||
23125493|NCT02034162|64208668|FG000|Double-blind|Protocol Violation|0|||
23125494|NCT02034162|64208669|FG001|Double-blind|Protocol Violation|1|||
23125495|NCT02034162|64208670|FG002|Double-blind|Protocol Violation|0|||
23125496|NCT02034162|64208668|FG000|Double-blind|Withdrawal by Subject|5|||
23125497|NCT02034162|64208669|FG001|Double-blind|Withdrawal by Subject|7|||
23125498|NCT02034162|64208670|FG002|Double-blind|Withdrawal by Subject|0|||
23125499|NCT02878603|64208671|FG000|Overall Study|Lost to Follow-up|4|||
23125500|NCT02878603|64208672|FG001|Overall Study|Lost to Follow-up|1|||
23125501|NCT02878603|64208671|FG000|Overall Study|Withdrawal by Subject|1|||
23125502|NCT02878603|64208672|FG001|Overall Study|Withdrawal by Subject|1|||
23125503|NCT02878603|64208671|FG000|Overall Study|Death|1|||
23125504|NCT02878603|64208672|FG001|Overall Study|Death|0|||
23125505|NCT02878603|64208671|FG000|Overall Study|Physician Decision|0|||
23125506|NCT02878603|64208672|FG001|Overall Study|Physician Decision|3|||
23125507|NCT02080403|64208675|FG000|Overall Study|Adverse Event|5|||
23125508|NCT02080403|64208676|FG001|Overall Study|Adverse Event|1|||
23125509|NCT02080403|64208675|FG000|Overall Study|Death|0|||
23125510|NCT02080403|64208676|FG001|Overall Study|Death|2|||
23125511|NCT02080403|64208675|FG000|Overall Study|Lost to Follow-up|2|||
23125512|NCT02080403|64208676|FG001|Overall Study|Lost to Follow-up|0|||
23125513|NCT02080403|64208675|FG000|Overall Study|Pregnancy|0|||
23125514|NCT02080403|64208676|FG001|Overall Study|Pregnancy|1|||
23125515|NCT02080403|64208675|FG000|Overall Study|Protocol Violation|3|||
23125516|NCT02080403|64208676|FG001|Overall Study|Protocol Violation|7|||
23125517|NCT02080403|64208675|FG000|Overall Study|Withdrawal by Subject|5|||
23125518|NCT02080403|64208676|FG001|Overall Study|Withdrawal by Subject|1|||
23125519|NCT00203047|64208677|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
23314842|NCT04036110|64895445|FG002|Overall Study|Study Suspended|1|||
23426147|NCT00413374|65303535|FG000|Overall Study|Lost to Follow-up|1|||
23426148|NCT00413374|65303536|FG001|Overall Study|Lost to Follow-up|0|||
23125520|NCT00203047|64208678|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
23125521|NCT00203047|64208677|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
23125522|NCT00203047|64208678|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
23125523|NCT00203047|64208677|FG000|Overall Study|Withdrawal by Subject|13|||
23125524|NCT00203047|64208678|FG001|Overall Study|Withdrawal by Subject|47|||
23125525|NCT00203047|64208677|FG000|Overall Study|Teva requested participant withdrawal|1|||
23125526|NCT00203047|64208678|FG001|Overall Study|Teva requested participant withdrawal|1|||
23125527|NCT00203047|64208677|FG000|Overall Study|Physician Decision|8|||
23125528|NCT00203047|64208678|FG001|Overall Study|Physician Decision|7|||
23125529|NCT00203047|64208677|FG000|Overall Study|Non-compliance|4|||
23125530|NCT00203047|64208678|FG001|Overall Study|Non-compliance|8|||
23125531|NCT00203047|64208677|FG000|Overall Study|Protocol Violation|1|||
23125532|NCT00203047|64208678|FG001|Overall Study|Protocol Violation|0|||
23125533|NCT00203047|64208677|FG000|Overall Study|Lost to Follow-up|11|||
23125534|NCT00203047|64208678|FG001|Overall Study|Lost to Follow-up|5|||
23125535|NCT00203047|64208677|FG000|Overall Study|Adverse Event|8|||
23125536|NCT00203047|64208678|FG001|Overall Study|Adverse Event|18|||
23125537|NCT00203047|64208677|FG000|Overall Study|Death|1|||
23125538|NCT00203047|64208678|FG001|Overall Study|Death|2|||
23125539|NCT00203047|64208677|FG000|Overall Study|Pregnancy|3|||
23125540|NCT00203047|64208678|FG001|Overall Study|Pregnancy|0|||
23125541|NCT00203047|64208677|FG000|Overall Study|Other|5|||
23125542|NCT00203047|64208678|FG001|Overall Study|Other|5|||
23125543|NCT01289210|64208681|FG000|Overall Study|Adverse Event|1|||
23125544|NCT00575042|64208682|FG000|Overall Study|Adverse Event|2|||
23125545|NCT00575042|64208682|FG000|Overall Study|Lost to Follow-up|1|||
23617777|NCT05896696|65988107|FG000|Overall Study|Screening Failure|7|||
23617778|NCT05896696|65988107|FG000|Overall Study|Withdrawal by Subject|2|||
23617779|NCT03568708|65988109|FG000|Overall Study|Withdrawal by Subject|1|||
23617780|NCT03568708|65988110|FG001|Overall Study|Withdrawal by Subject|1|||
23617781|NCT03568708|65988109|FG000|Overall Study|Lost to Follow-up|0|||
23617782|NCT03568708|65988110|FG001|Overall Study|Lost to Follow-up|1|||
23617783|NCT02402465|65988111|FG000|Overall Study|Withdrawal by Subject|0|||
23617784|NCT02402465|65988112|FG001|Overall Study|Withdrawal by Subject|0|||
23617785|NCT02402465|65988113|FG002|Overall Study|Withdrawal by Subject|0|||
23617786|NCT02402465|65988114|FG003|Overall Study|Withdrawal by Subject|0|||
23617787|NCT02402465|65988115|FG004|Overall Study|Withdrawal by Subject|0|||
23617788|NCT02402465|65988116|FG005|Overall Study|Withdrawal by Subject|1|||
23617789|NCT02402465|65988111|FG000|Overall Study|Lost to Follow-up|0|||
23125546|NCT04949802|64211655|FG000|Overall Study|Lost to Follow-up|3|||
23125547|NCT03614676|64211659|FG000|Overall Study|Delivery before planned visit|2|||
23125548|NCT03614676|64211660|FG001|Overall Study|Delivery before planned visit|0|||
23125549|NCT03614676|64211659|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
23125550|NCT03614676|64211660|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
23125551|NCT03614676|64211659|FG000|Overall Study|Migrated / moved from the study area|30|||
23125552|NCT03614676|64211660|FG001|Overall Study|Migrated / moved from the study area|22|||
23125553|NCT03614676|64211659|FG000|Overall Study|Lost to Follow-up|17|||
23617790|NCT02402465|65988112|FG001|Overall Study|Lost to Follow-up|1|||
23617791|NCT02402465|65988113|FG002|Overall Study|Lost to Follow-up|0|||
23617792|NCT02402465|65988114|FG003|Overall Study|Lost to Follow-up|0|||
23617793|NCT02402465|65988115|FG004|Overall Study|Lost to Follow-up|1|||
23617794|NCT02402465|65988116|FG005|Overall Study|Lost to Follow-up|0|||
23617795|NCT02815735|65988124|FG000|First Intervention (4 Weeks)|Discomfort|1|||
23617796|NCT02815735|65988125|FG001|First Intervention (4 Weeks)|Discomfort|0|||
23617797|NCT02815735|65988124|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
23617798|NCT02815735|65988125|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
23617799|NCT02815735|65988124|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
23617800|NCT02815735|65988125|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
23617801|NCT02815735|65988124|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
23617802|NCT02815735|65988125|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
23617803|NCT04413149|65988128|FG000|Overall Study|Death|10|||
23211647|NCT00426556|64512575|FG003|Phase II - Extension Phase|Disease Progression|21|||
23211648|NCT00426556|64512572|FG000|Phase II - Extension Phase|Adverse Event|0|||
23211649|NCT00426556|64512573|FG001|Phase II - Extension Phase|Adverse Event|0|||
23211650|NCT00426556|64512574|FG002|Phase II - Extension Phase|Adverse Event|0|||
23211651|NCT00426556|64512575|FG003|Phase II - Extension Phase|Adverse Event|2|||
23211652|NCT01464788|64512576|FG000|Overall Study|Lost to Follow-up|0|||
23617804|NCT04413149|65988129|FG001|Overall Study|Death|5|||
23617805|NCT04413149|65988128|FG000|Overall Study|Lung transplantation|1|||
23617806|NCT04413149|65988129|FG001|Overall Study|Lung transplantation|0|||
23617807|NCT00744796|65988130|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
23617808|NCT02093897|65988131|FG000|Overall Study|Physician Decision|1|||
23211653|NCT01464788|64512577|FG001|Overall Study|Lost to Follow-up|1|||
23544304|NCT00941603|65723050|FG005|Overall Study|Withdrawal by Subject|1|||
23544305|NCT00941603|65723045|FG000|Overall Study|Protocol Violation|0|||
23544306|NCT00941603|65723046|FG001|Overall Study|Protocol Violation|1|||
23544307|NCT00941603|65723047|FG002|Overall Study|Protocol Violation|0|||
23544308|NCT00941603|65723048|FG003|Overall Study|Protocol Violation|0|||
23544309|NCT00941603|65723049|FG004|Overall Study|Protocol Violation|0|||
23544310|NCT00941603|65723050|FG005|Overall Study|Protocol Violation|0|||
23544311|NCT00941603|65723045|FG000|Overall Study|Did not meet protocol eligibility|1|||
23544312|NCT00941603|65723046|FG001|Overall Study|Did not meet protocol eligibility|0|||
23544313|NCT00941603|65723047|FG002|Overall Study|Did not meet protocol eligibility|0|||
23544314|NCT00941603|65723048|FG003|Overall Study|Did not meet protocol eligibility|0|||
23544315|NCT00941603|65723049|FG004|Overall Study|Did not meet protocol eligibility|0|||
23544316|NCT00941603|65723050|FG005|Overall Study|Did not meet protocol eligibility|0|||
23544317|NCT01043874|65723051|FG000|Overall Study|Adverse Event|3|||
23544318|NCT01043874|65723051|FG000|Overall Study|Withdrawal by Subject|1|||
23544319|NCT01043874|65723051|FG000|Overall Study|Lack of Efficacy|1|||
23544320|NCT01043874|65723051|FG000|Overall Study|Administrative Problems|1|||
23544321|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
23544322|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
23544323|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
23125554|NCT03614676|64211660|FG001|Overall Study|Lost to Follow-up|42|||
23544324|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
23544325|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Death|235|||
23544326|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Death|167|||
23617809|NCT02093897|65988131|FG000|Overall Study|Planned age group closure - no's reached|17|||
23617810|NCT02093897|65988131|FG000|Overall Study|Adverse event, non-fatal|1|||
23125555|NCT03614676|64211659|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
23125556|NCT03614676|64211660|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
23125557|NCT03614676|64211659|FG000|Overall Study|Other|16|||
23125558|NCT03614676|64211660|FG001|Overall Study|Other|47|||
23125559|NCT03614676|64211659|FG000|Overall Study|Protocol Violation|0|||
23125560|NCT03614676|64211660|FG001|Overall Study|Protocol Violation|2|||
23125561|NCT03614676|64211659|FG000|Overall Study|Neonatal event of interest|0|||
23125562|NCT03614676|64211660|FG001|Overall Study|Neonatal event of interest|6|||
23125563|NCT03614676|64211659|FG000|Overall Study|Death in infant greater than 28 days old|0|||
23125564|NCT03614676|64211660|FG001|Overall Study|Death in infant greater than 28 days old|12|||
23125565|NCT03614676|64211659|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
23125566|NCT03614676|64211660|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
23125567|NCT00955708|64211661|FG000|Overall Study|Death|269|||
23125568|NCT00955708|64211661|FG000|Overall Study|Lost to Follow-up|72|||
23125569|NCT00955708|64211661|FG000|Overall Study|Physician Decision|36|||
23125570|NCT00955708|64211661|FG000|Overall Study|Protocol Violation|134|||
23125571|NCT00955708|64211661|FG000|Overall Study|Registry Conclusion|186|||
23125572|NCT00955708|64211661|FG000|Overall Study|Product removed from service|94|||
23125573|NCT00955708|64211661|FG000|Overall Study|Patient Refused to participate further|116|||
23125574|NCT00955708|64211661|FG000|Overall Study|Closure of study location|60|||
23125575|NCT00955708|64211661|FG000|Overall Study|Patient changed care provider/moved|91|||
23125576|NCT04367480|64211663|FG000|Overall Study|Adverse Event|1|||
23125577|NCT04367480|64211664|FG001|Overall Study|Adverse Event|1|||
23125578|NCT04367480|64211663|FG000|Overall Study|Death|1|||
23125579|NCT04367480|64211664|FG001|Overall Study|Death|0|||
23125580|NCT04367480|64211663|FG000|Overall Study|Lost to Follow-up|1|||
23125581|NCT04367480|64211664|FG001|Overall Study|Lost to Follow-up|1|||
23125582|NCT04367480|64211663|FG000|Overall Study|Withdrawal by Subject|0|||
23125583|NCT04367480|64211664|FG001|Overall Study|Withdrawal by Subject|3|||
23125584|NCT04367480|64211663|FG000|Overall Study|App glitch during the study|1|||
23125585|NCT04367480|64211664|FG001|Overall Study|App glitch during the study|0|||
23125586|NCT04367480|64211663|FG000|Overall Study|Device Distribution Error|0|||
23125587|NCT04367480|64211664|FG001|Overall Study|Device Distribution Error|2|||
23125588|NCT04367480|64211663|FG000|Overall Study|Ineligible after Randomization|0|||
23125589|NCT04367480|64211664|FG001|Overall Study|Ineligible after Randomization|1|||
23125590|NCT04367480|64211663|FG000|Overall Study|Other Medical Reasons|0|||
23125591|NCT04367480|64211664|FG001|Overall Study|Other Medical Reasons|2|||
23125592|NCT00731133|64211667|FG000|Overall Study|Withdrawal by Subject|10|||
23125593|NCT00966264|64211668|FG000|Overall Study|Lost to Follow-up|4|||
23125594|NCT00966264|64211669|FG001|Overall Study|Lost to Follow-up|3|||
23125595|NCT02833077|64211670|FG000|Overall Study|Adverse Event|1|||
23125596|NCT02833077|64211671|FG001|Overall Study|Adverse Event|2|||
23125597|NCT02833077|64211670|FG000|Overall Study|Lost to Follow-up|10|||
23125598|NCT02833077|64211671|FG001|Overall Study|Lost to Follow-up|1|||
23125599|NCT02833077|64211670|FG000|Overall Study|Personal Reasons|6|||
23125600|NCT02833077|64211671|FG001|Overall Study|Personal Reasons|4|||
23125601|NCT02833077|64211670|FG000|Overall Study|Protocol Deviation|0|||
23125602|NCT02833077|64211671|FG001|Overall Study|Protocol Deviation|1|||
23125603|NCT03994731|64211673|FG000|Pegloticase + IMM Period|Death|2|||
23125604|NCT03994731|64211674|FG001|Pegloticase + IMM Period|Death|0|||
23125605|NCT03994731|64211673|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
23125606|NCT03994731|64211674|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
23125607|NCT03994731|64211673|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
23125608|NCT03994731|64211674|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
23125609|NCT02514551|64211675|FG000|Overall Study|Lost to Follow-up|0|||
23125610|NCT02514551|64211676|FG001|Overall Study|Lost to Follow-up|1|||
23125611|NCT02514551|64211675|FG000|Overall Study|Participant Never Treated|0|||
23125612|NCT02514551|64211676|FG001|Overall Study|Participant Never Treated|2|||
23125613|NCT00701909|64211687|FG000|Overall Study|Withdrawal by Subject|0|||
23125614|NCT00701909|64211688|FG001|Overall Study|Withdrawal by Subject|1|||
23125615|NCT00150618|64211694|FG000|Overall Study|Adverse Event|2|||
23125616|NCT00150618|64211695|FG001|Overall Study|Adverse Event|2|||
23125617|NCT00150618|64211696|FG002|Overall Study|Adverse Event|6|||
23125618|NCT00150618|64211697|FG003|Overall Study|Adverse Event|9|||
23125619|NCT00150618|64211698|FG004|Overall Study|Adverse Event|5|||
23125620|NCT00150618|64211694|FG000|Overall Study|Withdrawal by Subject|6|||
23125621|NCT00150618|64211695|FG001|Overall Study|Withdrawal by Subject|8|||
23125622|NCT00150618|64211696|FG002|Overall Study|Withdrawal by Subject|8|||
23125623|NCT00150618|64211697|FG003|Overall Study|Withdrawal by Subject|4|||
23125624|NCT00150618|64211698|FG004|Overall Study|Withdrawal by Subject|5|||
23125625|NCT00150618|64211694|FG000|Overall Study|Lost to Follow-up|4|||
23125626|NCT00150618|64211695|FG001|Overall Study|Lost to Follow-up|1|||
23125627|NCT00150618|64211696|FG002|Overall Study|Lost to Follow-up|5|||
23125628|NCT00150618|64211697|FG003|Overall Study|Lost to Follow-up|8|||
23125629|NCT00150618|64211698|FG004|Overall Study|Lost to Follow-up|4|||
23211654|NCT01464788|64512578|FG002|Overall Study|Lost to Follow-up|0|||
23617811|NCT04491136|65988141|FG000|Overall Study|Patient withdraw informed consent|9|||
23617812|NCT04491136|65988141|FG000|Overall Study|Adverse Event|2|||
23617813|NCT04491136|65988141|FG000|Overall Study|Death|3|||
23617814|NCT04491136|65988141|FG000|Overall Study|Lost to Follow-up|3|||
23617815|NCT04491136|65988141|FG000|Overall Study|Physician Decision|45|||
23617816|NCT04491136|65988141|FG000|Overall Study|sponsor terminated the study early|16|||
23617817|NCT04491136|65988141|FG000|Overall Study|Patient/guardian's decision|1|||
23617818|NCT02394925|65988144|FG000|Overall Study|Adverse Event|1|||
23617819|NCT02394925|65988144|FG000|Overall Study|Lens Discomfort|3|||
23617820|NCT02394925|65988144|FG000|Overall Study|Lens handling difficulities|5|||
23617821|NCT02394925|65988144|FG000|Overall Study|Lost to Follow-up|9|||
23617822|NCT02394925|65988144|FG000|Overall Study|Protocol Violation|5|||
23617823|NCT02394925|65988144|FG000|Overall Study|No longer meet eligibility criteria|1|||
23617824|NCT02394925|65988144|FG000|Overall Study|Unsatisfactory Visual Response|5|||
23617825|NCT03056755|65988145|FG000|Treatment- Core Phase|Progressive disease|89|||
23617826|NCT03056755|65988146|FG001|Treatment- Core Phase|Progressive disease|88|||
23617827|NCT03056755|65988147|FG002|Treatment- Core Phase|Progressive disease|90|||
23617828|NCT03056755|65988145|FG000|Treatment- Core Phase|Adverse Event|20|||
23617829|NCT03056755|65988146|FG001|Treatment- Core Phase|Adverse Event|14|||
23617830|NCT03056755|65988147|FG002|Treatment- Core Phase|Adverse Event|13|||
23617831|NCT03056755|65988145|FG000|Treatment- Core Phase|Physician Decision|7|||
23617832|NCT03056755|65988146|FG001|Treatment- Core Phase|Physician Decision|13|||
23617833|NCT03056755|65988147|FG002|Treatment- Core Phase|Physician Decision|5|||
23617834|NCT03056755|65988145|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
23617835|NCT03056755|65988146|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
23617836|NCT03056755|65988147|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
23617837|NCT03056755|65988145|FG000|Treatment- Core Phase|Death|3|||
23617838|NCT03056755|65988146|FG001|Treatment- Core Phase|Death|2|||
23617839|NCT03056755|65988147|FG002|Treatment- Core Phase|Death|4|||
23617840|NCT03056755|65988145|FG000|Treatment- Core Phase|Protocol deviation|1|||
23617841|NCT03056755|65988146|FG001|Treatment- Core Phase|Protocol deviation|1|||
23617842|NCT03056755|65988147|FG002|Treatment- Core Phase|Protocol deviation|0|||
23617843|NCT03056755|65988145|FG000|Treatment- Core Phase|Technical problems|1|||
23617844|NCT03056755|65988146|FG001|Treatment- Core Phase|Technical problems|0|||
23617845|NCT03056755|65988147|FG002|Treatment- Core Phase|Technical problems|0|||
23617846|NCT03056755|65988145|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
23617847|NCT03056755|65988146|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
23617848|NCT03056755|65988147|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
23617849|NCT03056755|65988145|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
23617850|NCT03056755|65988146|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
23617851|NCT03056755|65988147|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
23617852|NCT03056755|65988145|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
23617853|NCT03056755|65988146|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
23617854|NCT03056755|65988147|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
23617855|NCT03056755|65988145|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
23617856|NCT03056755|65988146|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
23617857|NCT03056755|65988147|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
23617858|NCT02598934|65988148|FG000|Overall Study|Adverse Event|11|||
23617859|NCT02598934|65988149|FG001|Overall Study|Adverse Event|13|||
23617860|NCT02598934|65988148|FG000|Overall Study|Failure to Return|3|||
23617861|NCT02598934|65988149|FG001|Overall Study|Failure to Return|3|||
23617862|NCT02598934|65988148|FG000|Overall Study|Withdrawal by Subject|2|||
23617863|NCT02598934|65988149|FG001|Overall Study|Withdrawal by Subject|3|||
23617864|NCT02598934|65988148|FG000|Overall Study|Administrative|2|||
23617865|NCT02598934|65988149|FG001|Overall Study|Administrative|1|||
23617866|NCT02598934|65988148|FG000|Overall Study|Protocol Violation|1|||
23617867|NCT02598934|65988149|FG001|Overall Study|Protocol Violation|2|||
23617868|NCT02621424|65988150|FG000|Overall Study|Withdrawal by Subject|1|||
23617869|NCT02621424|65988151|FG001|Overall Study|Withdrawal by Subject|2|||
23617870|NCT03226106|65988152|FG000|Overall Study|Withdrawal by Subject|2|||
23617871|NCT03226106|65988153|FG001|Overall Study|Withdrawal by Subject|0|||
23617872|NCT03226106|65988152|FG000|Overall Study|Adverse Event|1|||
23617873|NCT03226106|65988153|FG001|Overall Study|Adverse Event|0|||
23617874|NCT03226106|65988152|FG000|Overall Study|Lost to Follow-up|2|||
23617875|NCT03226106|65988153|FG001|Overall Study|Lost to Follow-up|0|||
23617876|NCT02538471|65988154|FG000|Overall Study|Progression of disease|2|||
23617877|NCT01093222|65988155|FG000|Overall Study|Ineligible|6|||
23617878|NCT01093222|65988155|FG000|Overall Study|Adverse Event|7|||
23125630|NCT00150618|64211694|FG000|Overall Study|Protocol Violation|1|||
23125631|NCT00150618|64211695|FG001|Overall Study|Protocol Violation|0|||
23125632|NCT00150618|64211696|FG002|Overall Study|Protocol Violation|0|||
23125633|NCT00150618|64211697|FG003|Overall Study|Protocol Violation|0|||
23125634|NCT00150618|64211698|FG004|Overall Study|Protocol Violation|1|||
23125635|NCT00150618|64211694|FG000|Overall Study|Lack of Efficacy|1|||
23314843|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
23314844|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
23314845|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
23314846|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
23314847|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
23314848|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
23314849|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
23314850|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
23314851|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
23314852|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
23314853|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
23314854|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
23314855|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
23314856|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
23314857|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
23314858|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
23314859|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
23314860|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
23314861|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
23314862|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
23314863|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
23314864|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
23314865|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
23314866|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
23314867|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
23314868|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
23314869|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
23314870|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
23314871|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
23314872|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
23314873|NCT04614948|64895446|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
23314874|NCT04614948|64895447|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
23314875|NCT04614948|64895448|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
23314876|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
23314877|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
23314878|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
23314879|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
23314880|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
23314881|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
23314882|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
23314883|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
23314884|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
23314885|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
23314886|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
23314887|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
23314888|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
23314889|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
23314890|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
23314891|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
23314892|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
23314893|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
23314894|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
23314895|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
23314896|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
23314897|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
23314898|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
23314899|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
23314900|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
23314901|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
23314902|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
23314903|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
23314904|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
23314905|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
23314906|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
23125636|NCT00150618|64211695|FG001|Overall Study|Lack of Efficacy|4|||
23125637|NCT00150618|64211696|FG002|Overall Study|Lack of Efficacy|7|||
23125638|NCT00150618|64211697|FG003|Overall Study|Lack of Efficacy|4|||
23125639|NCT00150618|64211698|FG004|Overall Study|Lack of Efficacy|6|||
23125640|NCT00150618|64211694|FG000|Overall Study|No study meds|0|||
23125641|NCT00150618|64211695|FG001|Overall Study|No study meds|0|||
23125642|NCT00150618|64211696|FG002|Overall Study|No study meds|0|||
23125643|NCT00150618|64211697|FG003|Overall Study|No study meds|0|||
23125644|NCT00150618|64211698|FG004|Overall Study|No study meds|2|||
23125645|NCT00150618|64211694|FG000|Overall Study|Physician Decision|0|||
23125646|NCT00150618|64211695|FG001|Overall Study|Physician Decision|2|||
23125647|NCT00150618|64211696|FG002|Overall Study|Physician Decision|0|||
23125648|NCT00150618|64211697|FG003|Overall Study|Physician Decision|0|||
23125649|NCT00150618|64211698|FG004|Overall Study|Physician Decision|1|||
23125650|NCT00150618|64211694|FG000|Overall Study|Lack of compliance|2|||
23125651|NCT00150618|64211695|FG001|Overall Study|Lack of compliance|1|||
23125652|NCT00150618|64211696|FG002|Overall Study|Lack of compliance|1|||
23125653|NCT00150618|64211697|FG003|Overall Study|Lack of compliance|0|||
23125654|NCT00150618|64211698|FG004|Overall Study|Lack of compliance|1|||
23125655|NCT00150618|64211694|FG000|Overall Study|Abnormal ECG|1|||
23125656|NCT00150618|64211695|FG001|Overall Study|Abnormal ECG|0|||
23125657|NCT00150618|64211696|FG002|Overall Study|Abnormal ECG|0|||
23125658|NCT00150618|64211697|FG003|Overall Study|Abnormal ECG|0|||
23125659|NCT00150618|64211698|FG004|Overall Study|Abnormal ECG|0|||
23125660|NCT00150618|64211694|FG000|Overall Study|Sponsor's decision|0|||
23125661|NCT00150618|64211695|FG001|Overall Study|Sponsor's decision|0|||
23125662|NCT00150618|64211696|FG002|Overall Study|Sponsor's decision|0|||
23125663|NCT00150618|64211697|FG003|Overall Study|Sponsor's decision|1|||
23125664|NCT00150618|64211698|FG004|Overall Study|Sponsor's decision|0|||
23125665|NCT00983749|64211699|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
23125666|NCT00983749|64211700|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
23125667|NCT01602510|64211701|FG000|Open Label Phase|Adverse Event|46|||
23125668|NCT01602510|64211702|FG001|Open Label Phase|Adverse Event|0|||
23125669|NCT01602510|64211703|FG002|Open Label Phase|Adverse Event|0|||
23125670|NCT01602510|64211701|FG000|Open Label Phase|Lack of Efficacy|22|||
23125671|NCT01602510|64211702|FG001|Open Label Phase|Lack of Efficacy|0|||
23125672|NCT01602510|64211703|FG002|Open Label Phase|Lack of Efficacy|0|||
23125673|NCT01602510|64211701|FG000|Open Label Phase|Protocol Violation|15|||
23125674|NCT01602510|64211702|FG001|Open Label Phase|Protocol Violation|0|||
23125675|NCT01602510|64211703|FG002|Open Label Phase|Protocol Violation|0|||
23125676|NCT01602510|64211701|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
23125677|NCT01602510|64211702|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
23125678|NCT01602510|64211703|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
23125679|NCT01602510|64211701|FG000|Open Label Phase|Lost to Follow-up|22|||
23125680|NCT01602510|64211702|FG001|Open Label Phase|Lost to Follow-up|0|||
23125681|NCT01602510|64211703|FG002|Open Label Phase|Lost to Follow-up|0|||
23125682|NCT01602510|64211701|FG000|Open Label Phase|Physician Decision|19|||
23125683|NCT01602510|64211702|FG001|Open Label Phase|Physician Decision|0|||
23125684|NCT01602510|64211703|FG002|Open Label Phase|Physician Decision|0|||
23125685|NCT01602510|64211701|FG000|Open Label Phase|Withdrawal by Subject|57|||
23125686|NCT01602510|64211702|FG001|Open Label Phase|Withdrawal by Subject|0|||
23125687|NCT01602510|64211703|FG002|Open Label Phase|Withdrawal by Subject|0|||
23125688|NCT01602510|64211701|FG000|Randomized Phase|Adverse Event|0|||
23125689|NCT01602510|64211702|FG001|Randomized Phase|Adverse Event|2|||
23125690|NCT01602510|64211703|FG002|Randomized Phase|Adverse Event|6|||
23125691|NCT01602510|64211701|FG000|Randomized Phase|Lack of Efficacy|0|||
23125692|NCT01602510|64211702|FG001|Randomized Phase|Lack of Efficacy|4|||
23125693|NCT01602510|64211703|FG002|Randomized Phase|Lack of Efficacy|4|||
23125694|NCT01602510|64211701|FG000|Randomized Phase|Protocol Violation|0|||
23125695|NCT01602510|64211702|FG001|Randomized Phase|Protocol Violation|3|||
23125696|NCT01602510|64211703|FG002|Randomized Phase|Protocol Violation|3|||
23125697|NCT01602510|64211701|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
23125698|NCT01602510|64211702|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
23544327|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Death|1|||
23125699|NCT01602510|64211703|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
23125700|NCT01602510|64211701|FG000|Randomized Phase|Lost to Follow-up|0|||
23125701|NCT01602510|64211702|FG001|Randomized Phase|Lost to Follow-up|1|||
23125702|NCT01602510|64211703|FG002|Randomized Phase|Lost to Follow-up|3|||
23125703|NCT01602510|64211701|FG000|Randomized Phase|Physician Decision|0|||
23125704|NCT01602510|64211702|FG001|Randomized Phase|Physician Decision|0|||
23125705|NCT01602510|64211703|FG002|Randomized Phase|Physician Decision|2|||
23125706|NCT01602510|64211701|FG000|Randomized Phase|Withdrawal by Subject|0|||
23125707|NCT01602510|64211702|FG001|Randomized Phase|Withdrawal by Subject|6|||
23125708|NCT01602510|64211703|FG002|Randomized Phase|Withdrawal by Subject|7|||
23125709|NCT00334542|64211708|FG000|Overall Study|Adverse Event|3|||
23125710|NCT00334542|64211708|FG000|Overall Study|Withdrawal by Subject|1|||
23125711|NCT00334542|64211708|FG000|Overall Study|New cancer diagnosis|1|||
23544328|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Death|0|||
23544329|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
23544330|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
23125712|NCT00267098|64211709|FG000|Overall Study|Death|0|||
23125713|NCT00267098|64211710|FG001|Overall Study|Death|0|||
23125714|NCT00267098|64211711|FG002|Overall Study|Death|57|||
23125715|NCT00267098|64211712|FG003|Overall Study|Death|66|||
23125716|NCT00267098|64211713|FG004|Overall Study|Death|14|||
23125717|NCT00267098|64211714|FG005|Overall Study|Death|23|||
23125718|NCT00267098|64211715|FG006|Overall Study|Death|28|||
23314907|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
23314908|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
23314909|NCT04614948|64895446|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
23314910|NCT04614948|64895447|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
23314911|NCT04614948|64895448|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
23314912|NCT02800642|64895449|FG000|Overall Study|Death|3|||
23314913|NCT02800642|64895449|FG000|Overall Study|Other|10|||
23314914|NCT02800642|64895449|FG000|Overall Study|Physician Decision|2|||
23125719|NCT00267098|64211716|FG007|Overall Study|Death|9|||
23125720|NCT00267098|64211709|FG000|Overall Study|Lost to Follow-up|0|||
23314915|NCT02800642|64895449|FG000|Overall Study|Adverse Event|6|||
23314916|NCT02800642|64895449|FG000|Overall Study|Withdrawal by Subject|3|||
23314917|NCT02800642|64895449|FG000|Overall Study|Lost to Follow-up|1|||
23314918|NCT01475097|64895451|FG000|Overall Study|Protocol Violation|1|||
23314919|NCT01475097|64895452|FG001|Overall Study|Protocol Violation|1|||
23314920|NCT05297578|64895455|FG000|Overall Study|Lost to Follow-up|1|||
23314921|NCT05297578|64895456|FG001|Overall Study|Lost to Follow-up|1|||
23314922|NCT05297578|64895457|FG002|Overall Study|Lost to Follow-up|2|||
23125721|NCT00267098|64211710|FG001|Overall Study|Lost to Follow-up|0|||
23314923|NCT05297578|64895458|FG003|Overall Study|Lost to Follow-up|1|||
23314924|NCT05297578|64895455|FG000|Overall Study|Death|0|||
23314925|NCT05297578|64895456|FG001|Overall Study|Death|1|||
23314926|NCT05297578|64895457|FG002|Overall Study|Death|0|||
23544331|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
23544332|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
23544333|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
23544334|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
23125722|NCT00267098|64211711|FG002|Overall Study|Lost to Follow-up|6|||
23314927|NCT05297578|64895458|FG003|Overall Study|Death|0|||
23314928|NCT05297578|64895455|FG000|Overall Study|Withdrawal by Subject|0|||
23314929|NCT05297578|64895456|FG001|Overall Study|Withdrawal by Subject|0|||
23314930|NCT05297578|64895457|FG002|Overall Study|Withdrawal by Subject|1|||
23314931|NCT05297578|64895458|FG003|Overall Study|Withdrawal by Subject|0|||
23314932|NCT02542605|64895463|FG000|Part B: Challenge Phase|Sponsor decision|1|||
23314933|NCT02542605|64895464|FG001|Part B: Challenge Phase|Sponsor decision|0|||
23314934|NCT02542605|64895465|FG002|Part B: Challenge Phase|Sponsor decision|0|||
23314935|NCT02542605|64895463|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
23314936|NCT02542605|64895464|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
23314937|NCT02542605|64895465|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
23314938|NCT02045147|64895467|FG000|Overall Study|Withdrawal by Subject|2|||
23314939|NCT02045147|64895468|FG001|Overall Study|Withdrawal by Subject|0|||
23314940|NCT02045147|64895469|FG002|Overall Study|Withdrawal by Subject|0|||
23314941|NCT02045147|64895470|FG003|Overall Study|Withdrawal by Subject|0|||
23314942|NCT02045147|64895471|FG004|Overall Study|Withdrawal by Subject|0|||
23314943|NCT02045147|64895472|FG005|Overall Study|Withdrawal by Subject|0|||
23314944|NCT02045147|64895473|FG006|Overall Study|Withdrawal by Subject|0|||
23314945|NCT02045147|64895474|FG007|Overall Study|Withdrawal by Subject|1|||
23125723|NCT00267098|64211712|FG003|Overall Study|Lost to Follow-up|5|||
23125724|NCT00267098|64211713|FG004|Overall Study|Lost to Follow-up|2|||
23314946|NCT02045147|64895467|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
23314947|NCT02045147|64895468|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
23314948|NCT02045147|64895469|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
23314949|NCT02045147|64895470|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
23314950|NCT02045147|64895471|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
23314951|NCT02045147|64895472|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
23314952|NCT02045147|64895473|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
23544335|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
23125725|NCT00267098|64211714|FG005|Overall Study|Lost to Follow-up|3|||
23125726|NCT00267098|64211715|FG006|Overall Study|Lost to Follow-up|1|||
23125727|NCT00267098|64211716|FG007|Overall Study|Lost to Follow-up|1|||
23125728|NCT00267098|64211709|FG000|Overall Study|Withdrawal by Subject|8|||
23314953|NCT02045147|64895474|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
23314954|NCT00530218|64895479|FG000|Overall Study|CMV Not Detected|13|||
23314955|NCT00530218|64895479|FG000|Overall Study|Death|12|||
23314956|NCT01982448|64895480|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
23314957|NCT01982448|64895481|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
23314958|NCT01982448|64895480|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
23314959|NCT01982448|64895481|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
23314960|NCT01982448|64895480|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
23314961|NCT01982448|64895481|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
23314962|NCT01982448|64895480|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
23314963|NCT01982448|64895481|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
23314964|NCT03516513|64895485|FG000|Overall Study|Withdrawal by Subject|2|||
23314965|NCT03516513|64895486|FG001|Overall Study|Withdrawal by Subject|2|||
23314966|NCT03516513|64895487|FG002|Overall Study|Withdrawal by Subject|0|||
23314967|NCT03516513|64895488|FG003|Overall Study|Withdrawal by Subject|0|||
23314968|NCT00720382|64895489|FG000|Overall Study|Adverse Event|54|||
23314969|NCT00720382|64895490|FG001|Overall Study|Adverse Event|17|||
23314970|NCT00720382|64895489|FG000|Overall Study|Lack of Efficacy|18|||
23314971|NCT00720382|64895490|FG001|Overall Study|Lack of Efficacy|7|||
23314972|NCT00720382|64895489|FG000|Overall Study|Non-Compliance|15|||
23314973|NCT00720382|64895490|FG001|Overall Study|Non-Compliance|5|||
23314974|NCT00720382|64895489|FG000|Overall Study|Withdrawal by Subject|47|||
23314975|NCT00720382|64895490|FG001|Overall Study|Withdrawal by Subject|11|||
23314976|NCT00720382|64895489|FG000|Overall Study|Lost to Follow-up|28|||
23314977|NCT00720382|64895490|FG001|Overall Study|Lost to Follow-up|14|||
23314978|NCT00720382|64895489|FG000|Overall Study|administrative|14|||
23314979|NCT00720382|64895490|FG001|Overall Study|administrative|5|||
23314980|NCT01874353|64895491|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
23314981|NCT01874353|64895492|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
23314982|NCT01874353|64895493|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
23314983|NCT01874353|64895494|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
23314984|NCT01874353|64895491|FG000|Overall Study|Lost to Follow-up|2|||
23314985|NCT01874353|64895492|FG001|Overall Study|Lost to Follow-up|2|||
23314986|NCT01874353|64895493|FG002|Overall Study|Lost to Follow-up|2|||
23314987|NCT01874353|64895494|FG003|Overall Study|Lost to Follow-up|0|||
23314988|NCT01874353|64895491|FG000|Overall Study|Death|110|||
23314989|NCT01874353|64895492|FG001|Overall Study|Death|60|||
23314990|NCT01874353|64895493|FG002|Overall Study|Death|13|||
23314991|NCT01874353|64895494|FG003|Overall Study|Death|7|||
23314992|NCT01874353|64895491|FG000|Overall Study|Withdrawal by Subject|13|||
23314993|NCT01874353|64895492|FG001|Overall Study|Withdrawal by Subject|11|||
23314994|NCT01874353|64895493|FG002|Overall Study|Withdrawal by Subject|0|||
23314995|NCT01874353|64895494|FG003|Overall Study|Withdrawal by Subject|0|||
23314996|NCT03452137|64895501|FG000|Overall Study|Death|67|||
23314997|NCT03452137|64895502|FG001|Overall Study|Death|70|||
23314998|NCT03452137|64895501|FG000|Overall Study|Lost to Follow-up|4|||
23314999|NCT03452137|64895502|FG001|Overall Study|Lost to Follow-up|2|||
23315000|NCT03452137|64895501|FG000|Overall Study|Physician Decision|0|||
23315001|NCT03452137|64895502|FG001|Overall Study|Physician Decision|1|||
23315002|NCT03452137|64895501|FG000|Overall Study|Study Terminated by Sponsor|120|||
23315003|NCT03452137|64895502|FG001|Overall Study|Study Terminated by Sponsor|121|||
23315004|NCT03452137|64895501|FG000|Overall Study|Withdrawal by Subject|12|||
23315005|NCT03452137|64895502|FG001|Overall Study|Withdrawal by Subject|9|||
23315006|NCT02129608|64895503|FG000|Overall Study|Lost to Follow-up|0|||
23315007|NCT02129608|64895504|FG001|Overall Study|Lost to Follow-up|1|||
23315008|NCT02129608|64895505|FG002|Overall Study|Lost to Follow-up|1|||
23315009|NCT02129608|64895503|FG000|Overall Study|Withdrawal by Subject|0|||
23315010|NCT02129608|64895504|FG001|Overall Study|Withdrawal by Subject|0|||
23315011|NCT02129608|64895505|FG002|Overall Study|Withdrawal by Subject|2|||
23315012|NCT03086551|64895506|FG000|First Intervention|Failure to meet inclusion criterion|1|||
23315013|NCT03086551|64895507|FG001|First Intervention|Failure to meet inclusion criterion|0|||
23315014|NCT03086551|64895506|FG000|First Intervention|Lost to Follow-up|0|||
23617879|NCT01093222|65988155|FG000|Overall Study|Progression/relapse|24|||
23211655|NCT01464788|64512576|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
23211656|NCT01464788|64512577|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
23211657|NCT01464788|64512578|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
23211658|NCT01890512|64512579|FG000|Overall Study|Physician Decision|1|||
23211659|NCT01890512|64512579|FG000|Overall Study|Withdrawal by Subject|1|||
23211660|NCT01890512|64512579|FG000|Overall Study|Protocol Violation|1|||
23211661|NCT00168064|64516186|FG000|Overall Study|Adverse Event|26|||
23315015|NCT03086551|64895507|FG001|First Intervention|Lost to Follow-up|1|||
23315016|NCT03086551|64895506|FG000|Washout|Lost to Follow-up|1|||
23315017|NCT03086551|64895507|FG001|Washout|Lost to Follow-up|2|||
23315018|NCT03086551|64895506|FG000|Washout|Withdrawal by Subject|2|||
23315019|NCT03086551|64895507|FG001|Washout|Withdrawal by Subject|1|||
23315020|NCT03390426|64895508|FG000|Overall Study|Protocol Violation|0|||
23315021|NCT03390426|64895509|FG001|Overall Study|Protocol Violation|1|||
23315022|NCT00191165|64895510|FG000|Overall Study|Adverse Event|2|||
23315023|NCT00191165|64895511|FG001|Overall Study|Adverse Event|0|||
23315024|NCT00191165|64895510|FG000|Overall Study|Protocol Violation|0|||
23315025|NCT00191165|64895511|FG001|Overall Study|Protocol Violation|1|||
23315026|NCT00191165|64895510|FG000|Overall Study|Participant Moved Away|0|||
23315027|NCT00191165|64895511|FG001|Overall Study|Participant Moved Away|1|||
23315028|NCT01589497|64895514|FG000|Overall Study|Withdrawal by Subject|0|||
23315029|NCT01589497|64895515|FG001|Overall Study|Withdrawal by Subject|1|||
23315030|NCT01589497|64895516|FG002|Overall Study|Withdrawal by Subject|0|||
23315031|NCT01589497|64895517|FG003|Overall Study|Withdrawal by Subject|1|||
23315032|NCT01589497|64895514|FG000|Overall Study|Death|1|||
23315033|NCT01589497|64895515|FG001|Overall Study|Death|0|||
23315034|NCT01589497|64895516|FG002|Overall Study|Death|0|||
23315035|NCT01589497|64895517|FG003|Overall Study|Death|0|||
23315036|NCT01589497|64895514|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
23315037|NCT01589497|64895515|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
23315038|NCT01589497|64895516|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
23315039|NCT01589497|64895517|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
23315040|NCT01644617|64895521|FG000|Overall Study|Withdrawal by Subject|3|||
23315041|NCT01644617|64895522|FG001|Overall Study|Withdrawal by Subject|4|||
23315042|NCT01644617|64895523|FG002|Overall Study|Withdrawal by Subject|1|||
23315043|NCT01644617|64895521|FG000|Overall Study|Lost to Follow-up|0|||
23315044|NCT01644617|64895522|FG001|Overall Study|Lost to Follow-up|1|||
23315045|NCT01644617|64895523|FG002|Overall Study|Lost to Follow-up|0|||
23315046|NCT01644617|64895521|FG000|Overall Study|Adverse Event|3|||
23315047|NCT01644617|64895522|FG001|Overall Study|Adverse Event|0|||
23315048|NCT01644617|64895523|FG002|Overall Study|Adverse Event|6|||
23315049|NCT04877457|64895533|FG000|Overall Study|Early termination of study due to low enrollment|2|||
23315050|NCT04877457|64895534|FG001|Overall Study|Early termination of study due to low enrollment|1|||
23315051|NCT04707313|64895536|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
23315052|NCT04707313|64895537|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
23315053|NCT04707313|64895538|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
23315054|NCT04707313|64895539|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
23315055|NCT04707313|64895540|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
23315056|NCT04707313|64895541|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
23315057|NCT04707313|64895542|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
23315058|NCT04707313|64895543|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
23315059|NCT04707313|64895544|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
23315060|NCT04707313|64895545|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
23315061|NCT04707313|64895546|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
23315062|NCT04707313|64895547|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
23315063|NCT04707313|64895548|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
23315064|NCT04707313|64895536|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
23315065|NCT04707313|64895537|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
23315066|NCT04707313|64895538|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315067|NCT04707313|64895539|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315068|NCT04707313|64895540|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
23315069|NCT04707313|64895541|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315070|NCT04707313|64895542|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315071|NCT04707313|64895543|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315072|NCT04707313|64895544|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315073|NCT04707313|64895545|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315074|NCT04707313|64895546|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315075|NCT04707313|64895547|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315076|NCT04707313|64895548|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
23315077|NCT04707313|64895536|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
23315078|NCT04707313|64895537|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
23315079|NCT04707313|64895538|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
23315080|NCT04707313|64895539|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
23315081|NCT04707313|64895540|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
23315082|NCT04707313|64895541|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
23315083|NCT04707313|64895542|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
23315084|NCT04707313|64895543|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
23315085|NCT04707313|64895544|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
23315086|NCT04707313|64895545|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
23315087|NCT04707313|64895546|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
23617880|NCT01093222|65988155|FG000|Overall Study|Death|2|||
23315088|NCT04707313|64895547|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
23315089|NCT04707313|64895548|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
23315090|NCT04707313|64895536|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315091|NCT04707313|64895537|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
23315092|NCT04707313|64895538|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
23315093|NCT04707313|64895539|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315094|NCT04707313|64895540|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
23315095|NCT04707313|64895541|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315096|NCT04707313|64895542|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315097|NCT04707313|64895543|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315098|NCT04707313|64895544|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315099|NCT04707313|64895545|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315100|NCT04707313|64895546|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315101|NCT04707313|64895547|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315102|NCT04707313|64895548|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
23315103|NCT04707313|64895536|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
23315104|NCT04707313|64895537|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
23315105|NCT04707313|64895538|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
23315106|NCT04707313|64895539|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
23315107|NCT04707313|64895540|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
23315108|NCT04707313|64895541|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23315109|NCT04707313|64895542|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23315110|NCT04707313|64895543|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23315111|NCT04707313|64895544|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
23315112|NCT04707313|64895545|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23315113|NCT04707313|64895546|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23315114|NCT04707313|64895547|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23315115|NCT04707313|64895548|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
23315116|NCT04707313|64895536|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
23315117|NCT04707313|64895537|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23315118|NCT04707313|64895538|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23315119|NCT04707313|64895539|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23315120|NCT04707313|64895540|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23315121|NCT04707313|64895541|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
23315122|NCT04707313|64895542|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
23315123|NCT04707313|64895543|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
23315124|NCT04707313|64895544|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23315125|NCT04707313|64895545|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23315126|NCT04707313|64895546|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23315127|NCT04707313|64895547|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23315128|NCT04707313|64895548|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
23315129|NCT04707313|64895536|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
23315130|NCT04707313|64895537|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
23315131|NCT04707313|64895538|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
23315132|NCT04707313|64895539|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
23315133|NCT04707313|64895540|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
23315134|NCT04707313|64895541|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
23315135|NCT04707313|64895542|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
23315136|NCT04707313|64895543|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
23315137|NCT04707313|64895544|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
23315138|NCT04707313|64895545|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
23315139|NCT04707313|64895546|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
23315140|NCT04707313|64895547|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
23315141|NCT04707313|64895548|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
23315142|NCT04707313|64895536|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315143|NCT04707313|64895537|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315144|NCT04707313|64895538|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
23315145|NCT04707313|64895539|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315146|NCT04707313|64895540|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315147|NCT04707313|64895541|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315148|NCT04707313|64895542|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315149|NCT04707313|64895543|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
23315150|NCT04707313|64895544|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315151|NCT04707313|64895545|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315152|NCT04707313|64895546|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315153|NCT04707313|64895547|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315154|NCT04707313|64895548|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
23315155|NCT04707313|64895536|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23315156|NCT04707313|64895537|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23544336|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
23544337|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Other|1|||
23544338|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Other|2|||
23315157|NCT04707313|64895538|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23315158|NCT04707313|64895539|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23315159|NCT04707313|64895540|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23315160|NCT04707313|64895541|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23315161|NCT04707313|64895542|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23315162|NCT04707313|64895543|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23315163|NCT04707313|64895544|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23315164|NCT04707313|64895545|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
23315165|NCT04707313|64895546|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
23315166|NCT04707313|64895547|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
23315167|NCT04707313|64895548|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
23315168|NCT04707313|64895536|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315169|NCT04707313|64895537|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315170|NCT04707313|64895538|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315171|NCT04707313|64895539|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315172|NCT04707313|64895540|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315173|NCT04707313|64895541|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315174|NCT04707313|64895542|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315175|NCT04707313|64895543|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315176|NCT04707313|64895544|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315177|NCT04707313|64895545|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
23315178|NCT04707313|64895546|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
23315179|NCT04707313|64895547|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
23315180|NCT04707313|64895548|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
23315181|NCT04707313|64895536|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23315182|NCT04707313|64895537|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23315183|NCT04707313|64895538|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23315184|NCT04707313|64895539|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23315185|NCT04707313|64895540|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23315186|NCT04707313|64895541|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23315187|NCT04707313|64895542|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23315188|NCT04707313|64895543|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23315189|NCT04707313|64895544|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
23315190|NCT04707313|64895545|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
23315191|NCT04707313|64895546|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
23315192|NCT04707313|64895547|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
23315193|NCT04707313|64895548|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
23315194|NCT04707313|64895536|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315195|NCT04707313|64895537|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315196|NCT04707313|64895538|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315197|NCT04707313|64895539|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315198|NCT04707313|64895540|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315199|NCT04707313|64895541|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315200|NCT04707313|64895542|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315201|NCT04707313|64895543|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315202|NCT04707313|64895544|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
23125729|NCT00267098|64211710|FG001|Overall Study|Withdrawal by Subject|0|||
23125730|NCT00267098|64211711|FG002|Overall Study|Withdrawal by Subject|24|||
23125731|NCT00267098|64211712|FG003|Overall Study|Withdrawal by Subject|21|||
23125732|NCT00267098|64211713|FG004|Overall Study|Withdrawal by Subject|12|||
23125733|NCT00267098|64211714|FG005|Overall Study|Withdrawal by Subject|9|||
23125734|NCT00267098|64211715|FG006|Overall Study|Withdrawal by Subject|12|||
23125735|NCT00267098|64211716|FG007|Overall Study|Withdrawal by Subject|5|||
23125736|NCT00267098|64211709|FG000|Overall Study|Physician Decision|5|||
23125737|NCT00267098|64211710|FG001|Overall Study|Physician Decision|0|||
23125738|NCT00267098|64211711|FG002|Overall Study|Physician Decision|7|||
23125739|NCT00267098|64211712|FG003|Overall Study|Physician Decision|11|||
23125740|NCT00267098|64211713|FG004|Overall Study|Physician Decision|5|||
23125741|NCT00267098|64211714|FG005|Overall Study|Physician Decision|4|||
23125742|NCT00267098|64211715|FG006|Overall Study|Physician Decision|3|||
23125743|NCT00267098|64211716|FG007|Overall Study|Physician Decision|0|||
23125744|NCT00267098|64211709|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
23125745|NCT00267098|64211710|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23125746|NCT00267098|64211711|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23125747|NCT00267098|64211712|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23125748|NCT00267098|64211713|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
23315203|NCT04707313|64895545|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315204|NCT04707313|64895546|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
23315205|NCT04707313|64895547|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
23315206|NCT04707313|64895548|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
23315207|NCT04707313|64895536|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23125749|NCT00267098|64211714|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23315208|NCT04707313|64895537|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23315209|NCT04707313|64895538|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23315210|NCT04707313|64895539|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23315211|NCT04707313|64895540|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23315212|NCT04707313|64895541|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23315213|NCT04707313|64895542|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23544339|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Other|0|||
23125750|NCT00267098|64211715|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23125751|NCT00267098|64211716|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23125752|NCT00267098|64211709|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23125753|NCT00267098|64211710|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
23125754|NCT00267098|64211711|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23125755|NCT00267098|64211712|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23125756|NCT00267098|64211713|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23125757|NCT00267098|64211714|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23125758|NCT00267098|64211715|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23125759|NCT00267098|64211716|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
23125760|NCT00267098|64211709|FG000|Overall Study|Site closure|0|||
23125761|NCT00267098|64211710|FG001|Overall Study|Site closure|0|||
23125762|NCT00267098|64211711|FG002|Overall Study|Site closure|0|||
23125763|NCT00267098|64211712|FG003|Overall Study|Site closure|1|||
23125764|NCT00267098|64211713|FG004|Overall Study|Site closure|0|||
23125765|NCT00267098|64211714|FG005|Overall Study|Site closure|1|||
23125766|NCT00267098|64211715|FG006|Overall Study|Site closure|1|||
23125767|NCT00267098|64211716|FG007|Overall Study|Site closure|0|||
23125768|NCT00267098|64211709|FG000|Overall Study|Explanted Medtronic device|0|||
23125769|NCT00267098|64211710|FG001|Overall Study|Explanted Medtronic device|0|||
23125770|NCT00267098|64211711|FG002|Overall Study|Explanted Medtronic device|0|||
23125771|NCT00267098|64211712|FG003|Overall Study|Explanted Medtronic device|1|||
23125772|NCT00267098|64211713|FG004|Overall Study|Explanted Medtronic device|0|||
23125773|NCT00267098|64211714|FG005|Overall Study|Explanted Medtronic device|0|||
23125774|NCT00267098|64211715|FG006|Overall Study|Explanted Medtronic device|0|||
23125775|NCT00267098|64211716|FG007|Overall Study|Explanted Medtronic device|0|||
23125776|NCT00267098|64211709|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23125777|NCT00267098|64211710|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23125778|NCT00267098|64211711|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23125779|NCT00267098|64211712|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23125780|NCT00267098|64211713|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
23125781|NCT00267098|64211714|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23125782|NCT00267098|64211715|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23125783|NCT00267098|64211716|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
23125784|NCT00267098|64211709|FG000|Overall Study|Subject listed for heart transplant|0|||
23125785|NCT00267098|64211710|FG001|Overall Study|Subject listed for heart transplant|0|||
23125786|NCT00267098|64211711|FG002|Overall Study|Subject listed for heart transplant|0|||
23125787|NCT00267098|64211712|FG003|Overall Study|Subject listed for heart transplant|0|||
23125788|NCT00267098|64211713|FG004|Overall Study|Subject listed for heart transplant|0|||
23125789|NCT00267098|64211714|FG005|Overall Study|Subject listed for heart transplant|0|||
23125790|NCT00267098|64211715|FG006|Overall Study|Subject listed for heart transplant|1|||
23125791|NCT00267098|64211716|FG007|Overall Study|Subject listed for heart transplant|0|||
23125792|NCT00267098|64211709|FG000|Overall Study|Sponsor withdrew subject|0|||
23125793|NCT00267098|64211710|FG001|Overall Study|Sponsor withdrew subject|0|||
23125794|NCT00267098|64211711|FG002|Overall Study|Sponsor withdrew subject|0|||
23125795|NCT00267098|64211712|FG003|Overall Study|Sponsor withdrew subject|1|||
23125796|NCT00267098|64211713|FG004|Overall Study|Sponsor withdrew subject|0|||
23125797|NCT00267098|64211714|FG005|Overall Study|Sponsor withdrew subject|0|||
23125798|NCT00267098|64211715|FG006|Overall Study|Sponsor withdrew subject|0|||
23125799|NCT00267098|64211716|FG007|Overall Study|Sponsor withdrew subject|0|||
23125800|NCT03682185|64211720|FG000|Overall Study|Lost to Follow-up|4|||
23125801|NCT03682185|64211721|FG001|Overall Study|Lost to Follow-up|7|||
23125802|NCT03682185|64211722|FG002|Overall Study|Lost to Follow-up|4|||
23125803|NCT03682185|64211723|FG003|Overall Study|Lost to Follow-up|7|||
23125804|NCT03682185|64211724|FG004|Overall Study|Lost to Follow-up|1|||
23125805|NCT03682185|64211720|FG000|Overall Study|Withdrawal by Subject|7|||
23125806|NCT03682185|64211721|FG001|Overall Study|Withdrawal by Subject|3|||
23125807|NCT03682185|64211722|FG002|Overall Study|Withdrawal by Subject|7|||
23125808|NCT03682185|64211723|FG003|Overall Study|Withdrawal by Subject|3|||
23125809|NCT03682185|64211724|FG004|Overall Study|Withdrawal by Subject|0|||
23125810|NCT00520845|64211727|FG000|Overall Study|Death|3|||
23125811|NCT00520845|64211727|FG000|Overall Study|Adverse Event|4|||
23125812|NCT00520845|64211727|FG000|Overall Study|Disease Progression, relapse|13|||
23125813|NCT00520845|64211727|FG000|Overall Study|Withdrawal by Subject|1|||
23125814|NCT00520845|64211727|FG000|Overall Study|Alternative Therapy|1|||
23544340|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Other|0|||
23211662|NCT00168064|64516187|FG001|Overall Study|Adverse Event|22|||
23211663|NCT00168064|64516186|FG000|Overall Study|Withdrawal by Subject|3|||
23315214|NCT04707313|64895543|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23315215|NCT04707313|64895544|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23125815|NCT05144945|64211732|FG000|Overall Study|Withdrawal by Subject|1|||
23125816|NCT05144945|64211733|FG001|Overall Study|Withdrawal by Subject|0|||
23125817|NCT02227992|64211734|FG000|Overall Study|Lost to Follow-up|1|||
23125818|NCT02227992|64211735|FG001|Overall Study|Lost to Follow-up|1|||
23125819|NCT01647542|64211740|FG000|Overall Study|Major Protocol Deviation|1|||
23125820|NCT01647542|64211741|FG001|Overall Study|Major Protocol Deviation|0|||
23125821|NCT01647542|64211742|FG002|Overall Study|Major Protocol Deviation|0|||
23125822|NCT01647542|64211740|FG000|Overall Study|Adverse Event|4|||
23125823|NCT01647542|64211741|FG001|Overall Study|Adverse Event|5|||
23125824|NCT01647542|64211742|FG002|Overall Study|Adverse Event|4|||
23125825|NCT01647542|64211740|FG000|Overall Study|Lost to Follow-up|0|||
23125826|NCT01647542|64211741|FG001|Overall Study|Lost to Follow-up|2|||
23125827|NCT01647542|64211742|FG002|Overall Study|Lost to Follow-up|2|||
23125828|NCT01647542|64211740|FG000|Overall Study|Withdrawal by Subject|6|||
23125829|NCT01647542|64211741|FG001|Overall Study|Withdrawal by Subject|4|||
23315216|NCT04707313|64895545|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
23315217|NCT04707313|64895546|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
23315218|NCT04707313|64895547|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23315219|NCT04707313|64895548|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
23315220|NCT04707313|64895536|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23315221|NCT04707313|64895537|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23315222|NCT04707313|64895538|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23315223|NCT04707313|64895539|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23544341|NCT00673049|65723052|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
23211664|NCT00168064|64516187|FG001|Overall Study|Withdrawal by Subject|4|||
23211665|NCT00168064|64516186|FG000|Overall Study|Lack of Efficacy|4|||
23211666|NCT00168064|64516187|FG001|Overall Study|Lack of Efficacy|4|||
23211667|NCT00168064|64516186|FG000|Overall Study|Lost to Follow-up|4|||
23211668|NCT00168064|64516187|FG001|Overall Study|Lost to Follow-up|3|||
23211669|NCT00168064|64516186|FG000|Overall Study|Non-compliance|2|||
23211670|NCT00168064|64516187|FG001|Overall Study|Non-compliance|3|||
23211671|NCT00168064|64516186|FG000|Overall Study|Concurrent Illness|4|||
23211672|NCT00168064|64516187|FG001|Overall Study|Concurrent Illness|3|||
23211673|NCT00168064|64516186|FG000|Overall Study|Subject's Best interest|2|||
23211674|NCT00168064|64516187|FG001|Overall Study|Subject's Best interest|2|||
23211675|NCT00168064|64516186|FG000|Overall Study|Various|4|||
23211676|NCT00168064|64516187|FG001|Overall Study|Various|3|||
23211677|NCT02565615|64516189|FG000|Overall Study|Death|0|||
23211678|NCT02565615|64516190|FG001|Overall Study|Death|1|||
23211679|NCT02565615|64516191|FG002|Overall Study|Death|0|||
23211680|NCT02565615|64516192|FG003|Overall Study|Death|0|||
23211681|NCT02565615|64516193|FG004|Overall Study|Death|4|||
23211682|NCT02565615|64516189|FG000|Overall Study|Not willing to participate in study|2|||
23211683|NCT02565615|64516190|FG001|Overall Study|Not willing to participate in study|21|||
23211684|NCT02565615|64516191|FG002|Overall Study|Not willing to participate in study|0|||
23211685|NCT02565615|64516192|FG003|Overall Study|Not willing to participate in study|1|||
23211686|NCT02565615|64516193|FG004|Overall Study|Not willing to participate in study|169|||
23211687|NCT02565615|64516189|FG000|Overall Study|Lost to Follow-up|0|||
23211688|NCT02565615|64516190|FG001|Overall Study|Lost to Follow-up|4|||
23211689|NCT02565615|64516191|FG002|Overall Study|Lost to Follow-up|0|||
23211690|NCT02565615|64516192|FG003|Overall Study|Lost to Follow-up|1|||
23211691|NCT02565615|64516193|FG004|Overall Study|Lost to Follow-up|765|||
23211692|NCT02565615|64516189|FG000|Overall Study|Not meeting eligibility criteria|0|||
23211693|NCT02565615|64516190|FG001|Overall Study|Not meeting eligibility criteria|7|||
23211694|NCT02565615|64516191|FG002|Overall Study|Not meeting eligibility criteria|0|||
23211695|NCT02565615|64516192|FG003|Overall Study|Not meeting eligibility criteria|0|||
23211696|NCT02565615|64516193|FG004|Overall Study|Not meeting eligibility criteria|25|||
23211697|NCT02565615|64516189|FG000|Overall Study|Reason not defined|0|||
23125830|NCT01647542|64211742|FG002|Overall Study|Withdrawal by Subject|0|||
23211698|NCT02565615|64516190|FG001|Overall Study|Reason not defined|2|||
23211699|NCT02565615|64516191|FG002|Overall Study|Reason not defined|0|||
23211700|NCT02565615|64516192|FG003|Overall Study|Reason not defined|1|||
23211701|NCT02565615|64516193|FG004|Overall Study|Reason not defined|62|||
23211702|NCT02565615|64516189|FG000|Overall Study|Adverse Event|1|||
23211703|NCT02565615|64516190|FG001|Overall Study|Adverse Event|1|||
23315224|NCT04707313|64895540|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23125831|NCT01647542|64211740|FG000|Overall Study|Study Termination|64|||
23125832|NCT01647542|64211741|FG001|Overall Study|Study Termination|61|||
23125833|NCT01647542|64211742|FG002|Overall Study|Study Termination|65|||
23211704|NCT02565615|64516191|FG002|Overall Study|Adverse Event|0|||
23211705|NCT02565615|64516192|FG003|Overall Study|Adverse Event|0|||
23211706|NCT02565615|64516193|FG004|Overall Study|Adverse Event|9|||
23211707|NCT02565615|64516189|FG000|Overall Study|Untreated|0|||
23211708|NCT02565615|64516190|FG001|Overall Study|Untreated|0|||
23211709|NCT02565615|64516191|FG002|Overall Study|Untreated|0|||
23211710|NCT02565615|64516192|FG003|Overall Study|Untreated|0|||
23211711|NCT02565615|64516193|FG004|Overall Study|Untreated|567|||
23211712|NCT00205699|64516197|FG000|Overall Study|Lost to Follow-up|1|||
23211713|NCT00205699|64516198|FG001|Overall Study|Lost to Follow-up|3|||
23211714|NCT00205699|64516199|FG002|Overall Study|Lost to Follow-up|5|||
23211715|NCT00205699|64516197|FG000|Overall Study|Adverse Event|1|||
23211716|NCT00205699|64516198|FG001|Overall Study|Adverse Event|0|||
23211717|NCT00205699|64516199|FG002|Overall Study|Adverse Event|0|||
23211718|NCT00205699|64516197|FG000|Overall Study|Withdrawal by Subject|1|||
23211719|NCT00205699|64516198|FG001|Overall Study|Withdrawal by Subject|2|||
23211720|NCT00205699|64516199|FG002|Overall Study|Withdrawal by Subject|1|||
23211721|NCT00205699|64516197|FG000|Overall Study|Lack of Efficacy|0|||
23211722|NCT00205699|64516198|FG001|Overall Study|Lack of Efficacy|1|||
23211723|NCT00205699|64516199|FG002|Overall Study|Lack of Efficacy|0|||
23211724|NCT02219087|64516206|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
23211725|NCT02219087|64516207|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
23211726|NCT01116687|64516208|FG000|Overall Study|Withdrawal by Subject|4|||
23211727|NCT00844285|64516209|FG000|Overall Study|Other|0|||
23211728|NCT00844285|64516210|FG001|Overall Study|Other|1|||
23211729|NCT00844285|64516211|FG002|Overall Study|Other|0|||
23211730|NCT00844285|64516209|FG000|Overall Study|Other than specified|95|||
23211731|NCT00844285|64516210|FG001|Overall Study|Other than specified|129|||
23211732|NCT00844285|64516211|FG002|Overall Study|Other than specified|12|||
23211733|NCT00844285|64516209|FG000|Overall Study|Site closure|256|||
23211734|NCT00844285|64516210|FG001|Overall Study|Site closure|450|||
23211735|NCT00844285|64516211|FG002|Overall Study|Site closure|50|||
23211736|NCT00844285|64516209|FG000|Overall Study|Follow-up < 8 years|16|||
23211737|NCT00844285|64516210|FG001|Overall Study|Follow-up < 8 years|23|||
23211738|NCT00844285|64516211|FG002|Overall Study|Follow-up < 8 years|4|||
23211739|NCT00844285|64516209|FG000|Overall Study|Protocol Violation|26|||
23211740|NCT00844285|64516210|FG001|Overall Study|Protocol Violation|28|||
23211741|NCT00844285|64516211|FG002|Overall Study|Protocol Violation|54|||
23211742|NCT00844285|64516209|FG000|Overall Study|Death|22|||
23211743|NCT00844285|64516210|FG001|Overall Study|Death|21|||
23211744|NCT00844285|64516211|FG002|Overall Study|Death|8|||
23211745|NCT00844285|64516209|FG000|Overall Study|Withdrew Consent|344|||
23211746|NCT00844285|64516210|FG001|Overall Study|Withdrew Consent|466|||
23211747|NCT00844285|64516211|FG002|Overall Study|Withdrew Consent|70|||
23211748|NCT00844285|64516209|FG000|Overall Study|Lost to Follow-up|330|||
23211749|NCT00844285|64516210|FG001|Overall Study|Lost to Follow-up|486|||
23211750|NCT00844285|64516211|FG002|Overall Study|Lost to Follow-up|74|||
23211751|NCT02119026|64516212|FG000|1st-line Treatment|Adverse Event|9|||
23211752|NCT02119026|64516213|FG001|1st-line Treatment|Adverse Event|14|||
23211753|NCT02119026|64516212|FG000|1st-line Treatment|Physician Decision|3|||
23211754|NCT02119026|64516213|FG001|1st-line Treatment|Physician Decision|8|||
23211755|NCT02119026|64516212|FG000|1st-line Treatment|Withdrawal by Subject|4|||
23211756|NCT02119026|64516213|FG001|1st-line Treatment|Withdrawal by Subject|10|||
23211757|NCT02119026|64516212|FG000|1st-line Treatment|Patient condition or compliance|6|||
23211758|NCT02119026|64516213|FG001|1st-line Treatment|Patient condition or compliance|4|||
23211759|NCT02119026|64516212|FG000|1st-line Treatment|Surgery of metastases|2|||
23211760|NCT02119026|64516213|FG001|1st-line Treatment|Surgery of metastases|1|||
23211761|NCT02119026|64516212|FG000|1st-line Treatment|Death|2|||
23211762|NCT02119026|64516213|FG001|1st-line Treatment|Death|1|||
23211763|NCT02119026|64516212|FG000|2nd-line Treatment|Lost to Follow-up|2|||
23211764|NCT02119026|64516213|FG001|2nd-line Treatment|Lost to Follow-up|0|||
23211765|NCT02119026|64516212|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
23211766|NCT02119026|64516213|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
23211767|NCT02119026|64516212|FG000|2nd-line Treatment|Adverse Event|4|||
23211768|NCT02119026|64516213|FG001|2nd-line Treatment|Adverse Event|1|||
23211769|NCT04046341|64516214|FG000|Overall Study|Lost to Follow-up|2|||
23211770|NCT04046341|64516214|FG000|Overall Study|Withdrawal by Subject|1|||
23211771|NCT02849626|64516215|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
23211772|NCT02849626|64516216|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
23211773|NCT02849626|64516217|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
23211774|NCT02849626|64516218|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
23211775|NCT02849626|64516215|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
23211776|NCT02849626|64516216|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
23211777|NCT02849626|64516217|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
23211778|NCT02849626|64516218|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
23211779|NCT02849626|64516215|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
23211780|NCT02849626|64516216|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
23211781|NCT02849626|64516217|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
23211782|NCT02849626|64516218|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
23211783|NCT02849626|64516215|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
23211784|NCT02849626|64516216|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
23211785|NCT02849626|64516217|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
23211786|NCT02849626|64516218|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
23211787|NCT02849626|64516215|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
23211788|NCT02849626|64516216|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
23211789|NCT02849626|64516217|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
23211790|NCT02849626|64516218|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
23211791|NCT02849626|64516215|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
23211792|NCT02849626|64516216|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
23211793|NCT02849626|64516217|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
23211794|NCT02849626|64516218|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
23211795|NCT02849626|64516215|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
23211796|NCT02849626|64516216|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
23211797|NCT02849626|64516217|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
23211798|NCT02849626|64516218|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
23211799|NCT02849626|64516215|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
23211800|NCT02849626|64516216|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
23211801|NCT02849626|64516217|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
23211802|NCT02849626|64516218|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
23211803|NCT02849626|64516215|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
23211804|NCT02849626|64516216|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
23211805|NCT02849626|64516217|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
23211806|NCT02849626|64516218|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
23211807|NCT02849626|64516215|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
23211808|NCT02849626|64516216|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
23211809|NCT02849626|64516217|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
23211810|NCT02849626|64516218|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
23211811|NCT02849626|64516215|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
23211812|NCT02849626|64516216|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
23211813|NCT02849626|64516217|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
23211814|NCT02849626|64516218|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
23211815|NCT00862654|64516221|FG000|Overall Study|Lack of Efficacy|1|||
23211816|NCT00862654|64516222|FG001|Overall Study|Lack of Efficacy|0|||
23211817|NCT00862654|64516223|FG002|Overall Study|Lack of Efficacy|1|||
23211818|NCT00862654|64516224|FG003|Overall Study|Lack of Efficacy|0|||
23211819|NCT00862654|64516221|FG000|Overall Study|Lost to Follow-up|1|||
23211820|NCT00862654|64516222|FG001|Overall Study|Lost to Follow-up|2|||
23211821|NCT00862654|64516223|FG002|Overall Study|Lost to Follow-up|1|||
23211822|NCT00862654|64516224|FG003|Overall Study|Lost to Follow-up|3|||
23211823|NCT00862654|64516221|FG000|Overall Study|Adverse Event|0|||
23211824|NCT00862654|64516222|FG001|Overall Study|Adverse Event|1|||
23211825|NCT00862654|64516223|FG002|Overall Study|Adverse Event|1|||
23211826|NCT00862654|64516224|FG003|Overall Study|Adverse Event|0|||
23211827|NCT00862654|64516221|FG000|Overall Study|Pregnancy|1|||
23211828|NCT00862654|64516222|FG001|Overall Study|Pregnancy|1|||
23211829|NCT00862654|64516223|FG002|Overall Study|Pregnancy|0|||
23211830|NCT00862654|64516224|FG003|Overall Study|Pregnancy|0|||
23211831|NCT00862654|64516221|FG000|Overall Study|Withdrawal by Subject|2|||
23211832|NCT00862654|64516222|FG001|Overall Study|Withdrawal by Subject|2|||
23211833|NCT00862654|64516223|FG002|Overall Study|Withdrawal by Subject|2|||
23211834|NCT00862654|64516224|FG003|Overall Study|Withdrawal by Subject|3|||
23211835|NCT00862654|64516221|FG000|Overall Study|Subject mistake|0|||
23211836|NCT00862654|64516222|FG001|Overall Study|Subject mistake|1|||
23211837|NCT00862654|64516223|FG002|Overall Study|Subject mistake|0|||
23211838|NCT00862654|64516224|FG003|Overall Study|Subject mistake|0|||
23211839|NCT00862654|64516221|FG000|Overall Study|Familly constraint|0|||
23211840|NCT00862654|64516222|FG001|Overall Study|Familly constraint|1|||
23211841|NCT00862654|64516223|FG002|Overall Study|Familly constraint|0|||
23544342|NCT00673049|65723053|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
23544343|NCT00673049|65723054|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
23544344|NCT00673049|65723055|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
23544345|NCT00673049|65723052|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
23544346|NCT00673049|65723053|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
23211842|NCT00862654|64516224|FG003|Overall Study|Familly constraint|0|||
23544347|NCT00673049|65723054|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
23211843|NCT00862654|64516221|FG000|Overall Study|Never used study drugs|1|||
23426149|NCT00413374|65303535|FG000|Overall Study|Surgery|1|||
23426150|NCT00413374|65303536|FG001|Overall Study|Surgery|0|||
23211844|NCT00862654|64516222|FG001|Overall Study|Never used study drugs|0|||
23211845|NCT00862654|64516223|FG002|Overall Study|Never used study drugs|0|||
23211846|NCT00862654|64516224|FG003|Overall Study|Never used study drugs|0|||
23211847|NCT00862654|64516221|FG000|Overall Study|Included after end of inclusions|0|||
23426151|NCT01813721|65303537|FG000|Overall Study|Ineligibility determined|63|||
23211848|NCT00862654|64516222|FG001|Overall Study|Included after end of inclusions|0|||
23211849|NCT00862654|64516223|FG002|Overall Study|Included after end of inclusions|1|||
23544348|NCT00673049|65723055|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
23544349|NCT00673049|65723052|FG000|After Progression on Erlotinib|Death|0|||
23544350|NCT00673049|65723053|FG001|After Progression on Erlotinib|Death|0|||
23544351|NCT00673049|65723054|FG002|After Progression on Erlotinib|Death|0|||
23544352|NCT00673049|65723055|FG003|After Progression on Erlotinib|Death|71|||
23544353|NCT00673049|65723052|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
23544354|NCT00673049|65723053|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
23544355|NCT00673049|65723054|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
23544356|NCT00673049|65723055|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
23544357|NCT00673049|65723052|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
23544358|NCT00673049|65723053|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
23211850|NCT00862654|64516224|FG003|Overall Study|Included after end of inclusions|0|||
23211851|NCT02282982|64516225|FG000|Overall Study|Lost to Follow-up|15|||
23617881|NCT01093222|65988155|FG000|Overall Study|Not protocol specified|1|||
23617882|NCT00507429|65988156|FG000|Treatment Phase|Disease Progression|12|||
23617883|NCT00507429|65988157|FG001|Treatment Phase|Disease Progression|5|||
23125834|NCT01647542|64211740|FG000|Overall Study|Lack of Efficacy|1|||
23125835|NCT01647542|64211741|FG001|Overall Study|Lack of Efficacy|1|||
23544359|NCT00673049|65723054|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
23544360|NCT00673049|65723055|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
23544361|NCT00673049|65723052|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
23544362|NCT00673049|65723053|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
23544363|NCT00673049|65723054|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
23544364|NCT00673049|65723055|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
23544365|NCT02663817|65723056|FG000|Overall Study|Screen failure|2|||
23544366|NCT04757649|65723058|FG000|Overall Study|Withdrawal by Subject|1|||
23617884|NCT00507429|65988156|FG000|Treatment Phase|Adverse Event|12|||
23617885|NCT00507429|65988157|FG001|Treatment Phase|Adverse Event|5|||
23544367|NCT04757649|65723058|FG000|Overall Study|Adverse Event|1|||
23617886|NCT00507429|65988156|FG000|Treatment Phase|Withdrawal by Subject|3|||
23125836|NCT01647542|64211742|FG002|Overall Study|Lack of Efficacy|0|||
23125837|NCT01647542|64211740|FG000|Overall Study|Death|0|||
23125838|NCT01647542|64211741|FG001|Overall Study|Death|0|||
23125839|NCT01647542|64211742|FG002|Overall Study|Death|1|||
23125840|NCT01263509|64211743|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
23125841|NCT01263509|64211744|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
23211852|NCT02282982|64516225|FG000|Overall Study|Withdrew consent|2|||
23211853|NCT02282982|64516225|FG000|Overall Study|Death|4|||
23211854|NCT02282982|64516225|FG000|Overall Study|Lack of product|156|||
23211855|NCT02282982|64516225|FG000|Overall Study|Palivizumab is ended|11|||
23211856|NCT02282982|64516225|FG000|Overall Study|Other, not specified|18|||
23426152|NCT01813721|65303537|FG000|Overall Study|Withdrawal by Subject|1|||
23617887|NCT00507429|65988157|FG001|Treatment Phase|Withdrawal by Subject|3|||
23617888|NCT00507429|65988156|FG000|Treatment Phase|Physician Decision|4|||
23617889|NCT00507429|65988157|FG001|Treatment Phase|Physician Decision|2|||
23125842|NCT01263509|64211745|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
23125843|NCT01263509|64211746|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
23125844|NCT01263509|64211743|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23125845|NCT01263509|64211744|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
23125846|NCT01263509|64211745|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23125847|NCT01263509|64211746|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23125848|NCT01263509|64211743|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23125849|NCT01263509|64211744|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23125850|NCT01263509|64211745|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23211857|NCT02273037|64516226|FG000|Overall Study|Lost to Follow-up|1|||
23617890|NCT00507429|65988156|FG000|Treatment Phase|Other|6|||
23617891|NCT00507429|65988157|FG001|Treatment Phase|Other|3|||
23617892|NCT00507429|65988156|FG000|Maintenance Phase|Progressive Disease|14|||
23617893|NCT00507429|65988157|FG001|Maintenance Phase|Progressive Disease|0|||
23617894|NCT04043806|65988158|FG000|Overall Study|Commercial drug is available for participants|13|||
23617895|NCT04043806|65988158|FG000|Overall Study|Physician Decision|2|||
23617896|NCT04043806|65988158|FG000|Overall Study|Other|12|||
23211858|NCT02273037|64516227|FG001|Overall Study|Lost to Follow-up|0|||
23211859|NCT02273037|64516226|FG000|Overall Study|Delivered before monitoring initiated|1|||
23211860|NCT02273037|64516227|FG001|Overall Study|Delivered before monitoring initiated|3|||
23426153|NCT03958656|65303538|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
23544368|NCT00659269|65723061|FG000|Overall Study|Physician Decision|1|||
23544369|NCT00659269|65723062|FG001|Overall Study|Physician Decision|1|||
23544370|NCT04258020|65723065|FG000|Overall Study|Withdrawal by Subject|1|||
23544371|NCT04258020|65723066|FG001|Overall Study|Withdrawal by Subject|0|||
23544372|NCT00511004|65723067|FG000|Overall Study|Lost to Follow-up|0|||
23617897|NCT04043806|65988158|FG000|Overall Study|Adverse Event|2|||
23617898|NCT04043806|65988158|FG000|Overall Study|Lost to Follow-up|6|||
23617899|NCT04043806|65988158|FG000|Overall Study|Other non-compliance|2|||
23617900|NCT04043806|65988158|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
23617901|NCT04043806|65988158|FG000|Overall Study|Never Dosed|1|||
23617902|NCT02660034|65988162|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
23617903|NCT02660034|65988163|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
23617904|NCT02660034|65988164|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
23617905|NCT02660034|65988165|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
23617906|NCT02660034|65988166|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
23617907|NCT02660034|65988167|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
23617908|NCT02660034|65988168|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
23617909|NCT02660034|65988169|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
23617910|NCT02660034|65988170|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
23617911|NCT02660034|65988171|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
23617912|NCT02660034|65988172|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
23617913|NCT02660034|65988173|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
23211861|NCT02273037|64516226|FG000|Overall Study|Breech delivery|2|||
23211862|NCT02273037|64516227|FG001|Overall Study|Breech delivery|3|||
23211863|NCT02273037|64516226|FG000|Overall Study|Multiple delivery|2|||
23211864|NCT02273037|64516227|FG001|Overall Study|Multiple delivery|2|||
23211865|NCT02273037|64516226|FG000|Overall Study|Other complication|2|||
23211866|NCT02273037|64516227|FG001|Overall Study|Other complication|0|||
23211867|NCT02227849|64516232|FG000|Overall Study|Adverse Event|4|||
23211868|NCT02227849|64516232|FG000|Overall Study|Physician Decision|1|||
23211869|NCT02227849|64516232|FG000|Overall Study|Withdrawal by Subject|3|||
23125851|NCT01263509|64211746|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23125852|NCT01263509|64211743|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
23125853|NCT01263509|64211744|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
23125854|NCT01263509|64211745|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23125855|NCT01263509|64211746|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23125856|NCT01263509|64211743|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
23125857|NCT01263509|64211744|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
23125858|NCT01263509|64211745|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
23125859|NCT01263509|64211746|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
23125860|NCT01246999|64211747|FG000|Overall Study|Lost to Follow-up|0|||
23125861|NCT01246999|64211748|FG001|Overall Study|Lost to Follow-up|1|||
23125862|NCT01246999|64211749|FG002|Overall Study|Lost to Follow-up|0|||
23211870|NCT00792701|64516233|FG000|Overall Study|Adverse Event|0|||
23211871|NCT00792701|64516234|FG001|Overall Study|Adverse Event|22|||
23211872|NCT00792701|64516233|FG000|Overall Study|Ineligible|1|||
23211873|NCT00792701|64516234|FG001|Overall Study|Ineligible|3|||
23211874|NCT00792701|64516233|FG000|Overall Study|Withdrawal by Subject|1|||
23211875|NCT00792701|64516234|FG001|Overall Study|Withdrawal by Subject|19|||
23211876|NCT00792701|64516233|FG000|Overall Study|Not protocol specified|17|||
23426154|NCT03958656|65303539|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
23544373|NCT00511004|65723068|FG001|Overall Study|Lost to Follow-up|0|||
23544374|NCT00511004|65723069|FG002|Overall Study|Lost to Follow-up|4|||
23544375|NCT02536508|65723070|FG000|Overall Study|Withdrawal by Subject|18|||
23544376|NCT02536508|65723071|FG001|Overall Study|Withdrawal by Subject|13|||
23544377|NCT02536508|65723072|FG002|Overall Study|Withdrawal by Subject|7|||
23544378|NCT02536508|65723070|FG000|Overall Study|Adverse Event|14|||
23544379|NCT02536508|65723071|FG001|Overall Study|Adverse Event|13|||
23544380|NCT02536508|65723072|FG002|Overall Study|Adverse Event|6|||
23544381|NCT02536508|65723070|FG000|Overall Study|Lost to Follow-up|12|||
23544382|NCT02536508|65723071|FG001|Overall Study|Lost to Follow-up|4|||
23544383|NCT02536508|65723072|FG002|Overall Study|Lost to Follow-up|0|||
23544384|NCT02536508|65723070|FG000|Overall Study|Lack of Efficacy|3|||
23544385|NCT02536508|65723071|FG001|Overall Study|Lack of Efficacy|5|||
23544386|NCT02536508|65723072|FG002|Overall Study|Lack of Efficacy|4|||
23544387|NCT02536508|65723070|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
23544388|NCT02536508|65723071|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
23544389|NCT02536508|65723072|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
23544390|NCT02536508|65723070|FG000|Overall Study|Physician Decision|0|||
23617914|NCT02660034|65988174|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
23617915|NCT02660034|65988175|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
23617916|NCT02660034|65988162|FG000|Overall Study|Progressive Disease (Clinical)|7|||
23211877|NCT00792701|64516234|FG001|Overall Study|Not protocol specified|0|||
23211878|NCT02674685|64516238|FG000|Overall Study|Withdrawal by Subject|4|||
23211879|NCT02034552|64516239|FG000|Overall Study|Never treated|3|||
23211880|NCT02034552|64516240|FG001|Overall Study|Never treated|2|||
23211881|NCT02034552|64516241|FG002|Overall Study|Never treated|0|||
23544391|NCT02536508|65723071|FG001|Overall Study|Physician Decision|4|||
23544392|NCT02536508|65723072|FG002|Overall Study|Physician Decision|2|||
23544393|NCT02536508|65723070|FG000|Overall Study|Major Protocol Deviation|2|||
23544394|NCT02536508|65723071|FG001|Overall Study|Major Protocol Deviation|2|||
23617917|NCT02660034|65988163|FG001|Overall Study|Progressive Disease (Clinical)|8|||
23544395|NCT02536508|65723072|FG002|Overall Study|Major Protocol Deviation|2|||
23544396|NCT02536508|65723070|FG000|Overall Study|Administrative Reasons|0|||
23544397|NCT02536508|65723071|FG001|Overall Study|Administrative Reasons|1|||
23544398|NCT02536508|65723072|FG002|Overall Study|Administrative Reasons|0|||
23544399|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Adverse Event|4|||
23544400|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Adverse Event|1|||
23544401|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Adverse Event|1|||
23544402|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
23544403|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
23544404|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
23544405|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Pregnancy|3|||
23544406|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Pregnancy|0|||
23544407|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Pregnancy|0|||
23544408|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
23544409|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
23544410|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
23544411|NCT03328897|65723073|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
23544412|NCT03328897|65723074|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
23544413|NCT03328897|65723075|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
23544414|NCT03328897|65723073|FG000|Follow-up Epoch|Adverse Event|4|||
23544415|NCT03328897|65723074|FG001|Follow-up Epoch|Adverse Event|0|||
23544416|NCT03328897|65723075|FG002|Follow-up Epoch|Adverse Event|1|||
23544417|NCT03328897|65723073|FG000|Follow-up Epoch|Lack of Efficacy|1|||
23544418|NCT03328897|65723074|FG001|Follow-up Epoch|Lack of Efficacy|1|||
23544419|NCT03328897|65723075|FG002|Follow-up Epoch|Lack of Efficacy|1|||
23544420|NCT03328897|65723073|FG000|Follow-up Epoch|Lost to Follow-up|0|||
23544421|NCT03328897|65723074|FG001|Follow-up Epoch|Lost to Follow-up|1|||
23544422|NCT03328897|65723075|FG002|Follow-up Epoch|Lost to Follow-up|0|||
23544423|NCT03328897|65723073|FG000|Follow-up Epoch|Pregnancy|1|||
23544424|NCT03328897|65723074|FG001|Follow-up Epoch|Pregnancy|0|||
23544425|NCT03328897|65723075|FG002|Follow-up Epoch|Pregnancy|0|||
23544426|NCT03328897|65723073|FG000|Follow-up Epoch|Patient/guardian decision|2|||
23544427|NCT03328897|65723074|FG001|Follow-up Epoch|Patient/guardian decision|1|||
23544428|NCT03328897|65723075|FG002|Follow-up Epoch|Patient/guardian decision|0|||
23544429|NCT02660944|65723080|FG000|Overall Study|Adverse Event|3|||
23544430|NCT02660944|65723081|FG001|Overall Study|Adverse Event|4|||
23544431|NCT02660944|65723080|FG000|Overall Study|Physician Decision|3|||
23544432|NCT02660944|65723081|FG001|Overall Study|Physician Decision|1|||
23544433|NCT02660944|65723080|FG000|Overall Study|Withdrawal by Subject|5|||
23544434|NCT02660944|65723081|FG001|Overall Study|Withdrawal by Subject|3|||
23544435|NCT02660944|65723080|FG000|Overall Study|Lost to Follow-up|4|||
23544436|NCT02660944|65723081|FG001|Overall Study|Lost to Follow-up|1|||
23544437|NCT02660944|65723080|FG000|Overall Study|Subject schedule|0|||
23544438|NCT02660944|65723081|FG001|Overall Study|Subject schedule|1|||
23544439|NCT02660944|65723080|FG000|Overall Study|Exclusion criteria met|2|||
23544440|NCT02660944|65723081|FG001|Overall Study|Exclusion criteria met|0|||
23544441|NCT01286779|65723082|FG000|Overall Study|Withdrawal by Subject|9|||
23544442|NCT01286779|65723082|FG000|Overall Study|Protocol Violation|5|||
23544443|NCT01286779|65723082|FG000|Overall Study|Physician Decision|2|||
23544444|NCT01286779|65723082|FG000|Overall Study|Participant had scheduled surgery|1|||
23617918|NCT02660034|65988164|FG002|Overall Study|Progressive Disease (Clinical)|3|||
23617919|NCT02660034|65988165|FG003|Overall Study|Progressive Disease (Clinical)|9|||
23617920|NCT02660034|65988166|FG004|Overall Study|Progressive Disease (Clinical)|3|||
23617921|NCT02660034|65988167|FG005|Overall Study|Progressive Disease (Clinical)|0|||
23617922|NCT02660034|65988168|FG006|Overall Study|Progressive Disease (Clinical)|0|||
23617923|NCT02660034|65988169|FG007|Overall Study|Progressive Disease (Clinical)|0|||
23617924|NCT02660034|65988170|FG008|Overall Study|Progressive Disease (Clinical)|0|||
23617925|NCT02660034|65988171|FG009|Overall Study|Progressive Disease (Clinical)|0|||
23125863|NCT01246999|64211750|FG003|Overall Study|Lost to Follow-up|0|||
23125864|NCT01246999|64211747|FG000|Overall Study|Withdrawal by Subject|0|||
23125865|NCT01246999|64211748|FG001|Overall Study|Withdrawal by Subject|0|||
23125866|NCT01246999|64211749|FG002|Overall Study|Withdrawal by Subject|0|||
23125867|NCT01246999|64211750|FG003|Overall Study|Withdrawal by Subject|2|||
23426155|NCT03958656|65303540|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
23426156|NCT03958656|65303541|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
23544445|NCT01286779|65723082|FG000|Overall Study|Participant moved to another country|1|||
23544446|NCT01286779|65723082|FG000|Overall Study|Discontinued by sponsor|1|||
23544447|NCT02159482|65723087|FG000|Overall Study|Withdrawal by Subject|2|||
23544448|NCT02159482|65723087|FG000|Overall Study|Physician Decision|3|||
23544449|NCT02525133|65723088|FG000|Overall Study|Adverse Event|0|||
23544450|NCT02525133|65723089|FG001|Overall Study|Adverse Event|1|||
23544451|NCT02525133|65723088|FG000|Overall Study|Death|0|||
23544452|NCT02525133|65723089|FG001|Overall Study|Death|1|||
23544453|NCT02525133|65723088|FG000|Overall Study|did not meet randomization criteria|1|||
23544454|NCT02525133|65723089|FG001|Overall Study|did not meet randomization criteria|0|||
23544455|NCT02525133|65723088|FG000|Overall Study|Lost to Follow-up|5|||
23544456|NCT02525133|65723089|FG001|Overall Study|Lost to Follow-up|1|||
23544457|NCT02525133|65723088|FG000|Overall Study|randomized not enrolled|3|||
23544458|NCT02525133|65723089|FG001|Overall Study|randomized not enrolled|0|||
23544459|NCT02525133|65723088|FG000|Overall Study|Withdrawal by Subject|1|||
23544460|NCT02525133|65723089|FG001|Overall Study|Withdrawal by Subject|0|||
23544461|NCT02763384|65723090|FG000|Overall Study|Physician Decision|1|||
23544462|NCT02763384|65723090|FG000|Overall Study|Rapid decline - went on hospice|1|||
23544463|NCT04307186|65723091|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
23544464|NCT04307186|65723091|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
23544465|NCT04307186|65723091|FG000|Washout 3-14 Days|Progressive disease|1|||
23544466|NCT04307186|65723091|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
23544467|NCT04307186|65723091|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
23544468|NCT02043782|65723092|FG000|Period 1|Adverse Event|0|||
23544469|NCT02043782|65723093|FG001|Period 1|Adverse Event|0|||
23544470|NCT02043782|65723094|FG002|Period 1|Adverse Event|1|||
23544471|NCT02043782|65723095|FG003|Period 1|Adverse Event|0|||
23544472|NCT02043782|65723096|FG004|Period 1|Adverse Event|0|||
23544473|NCT02043782|65723097|FG005|Period 1|Adverse Event|0|||
23544474|NCT01944046|65723099|FG000|Randomized to DB|Adverse Event|5|||
23544475|NCT01944046|65723100|FG001|Randomized to DB|Adverse Event|2|||
23544476|NCT01944046|65723099|FG000|Randomized to DB|Clinical Worsening|3|||
23544477|NCT01944046|65723100|FG001|Randomized to DB|Clinical Worsening|2|||
23544478|NCT01944046|65723099|FG000|Randomized to DB|Lost to Follow-up|3|||
23544479|NCT01944046|65723100|FG001|Randomized to DB|Lost to Follow-up|3|||
23544480|NCT01944046|65723099|FG000|Randomized to DB|Withdrawal by Subject|2|||
23544481|NCT01944046|65723100|FG001|Randomized to DB|Withdrawal by Subject|4|||
23544482|NCT01944046|65723099|FG000|Randomized to DB|Physician Decision|1|||
23544483|NCT01944046|65723100|FG001|Randomized to DB|Physician Decision|2|||
23544484|NCT01944046|65723099|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
23544485|NCT01944046|65723100|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
23544486|NCT01944046|65723099|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
23544487|NCT01944046|65723100|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
23544488|NCT01944046|65723099|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
23544489|NCT01944046|65723100|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
23544490|NCT01944046|65723099|FG000|Open Label Eligible and Consented|Adverse Event|6|||
23544491|NCT01944046|65723100|FG001|Open Label Eligible and Consented|Adverse Event|1|||
23125868|NCT02473965|64211760|FG000|Overall Study|Adverse Event|6|||
23125869|NCT02473965|64211761|FG001|Overall Study|Adverse Event|4|||
23125870|NCT02473965|64211760|FG000|Overall Study|MG worsening|4|||
23125871|NCT02473965|64211761|FG001|Overall Study|MG worsening|1|||
23125872|NCT02473965|64211760|FG000|Overall Study|Withdrawal by Subject|2|||
23125873|NCT02473965|64211761|FG001|Overall Study|Withdrawal by Subject|3|||
23125874|NCT02473965|64211760|FG000|Overall Study|Physician Decision|0|||
23125875|NCT02473965|64211761|FG001|Overall Study|Physician Decision|2|||
23125876|NCT00486252|64211762|FG000|Overall Study|Adverse Event|7|||
23125877|NCT00486252|64211762|FG000|Overall Study|Lack of Efficacy|9|||
23125878|NCT00486252|64211762|FG000|Overall Study|Lost to Follow-up|24|||
23125879|NCT00486252|64211762|FG000|Overall Study|Other|18|||
23125880|NCT01067846|64211763|FG000|Overall Study|Lost to Follow-up|17|||
23125881|NCT01067846|64211764|FG001|Overall Study|Lost to Follow-up|19|||
23125882|NCT01067846|64211763|FG000|Overall Study|Withdrawal by Subject|1|||
23125883|NCT01067846|64211764|FG001|Overall Study|Withdrawal by Subject|0|||
23125884|NCT01067846|64211763|FG000|Overall Study|participation in other tx study|1|||
23125885|NCT01067846|64211764|FG001|Overall Study|participation in other tx study|0|||
23315225|NCT04707313|64895541|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23315226|NCT04707313|64895542|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23315227|NCT04707313|64895543|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23315228|NCT04707313|64895544|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
23315229|NCT04707313|64895545|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
23315230|NCT04707313|64895546|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
23315231|NCT04707313|64895547|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
23426157|NCT03958656|65303538|FG000|Overall Study|No longer meets eligibility criteria|0|||
23426158|NCT03958656|65303539|FG001|Overall Study|No longer meets eligibility criteria|0|||
23426159|NCT03958656|65303540|FG002|Overall Study|No longer meets eligibility criteria|1|||
23426160|NCT03958656|65303541|FG003|Overall Study|No longer meets eligibility criteria|0|||
23544492|NCT01944046|65723099|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
23544493|NCT01944046|65723100|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
23544494|NCT01944046|65723099|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
23544495|NCT01944046|65723100|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
23544496|NCT01934218|65723101|FG000|Double-blind Phase|Adverse Event|8|||
23544497|NCT01934218|65723102|FG001|Double-blind Phase|Adverse Event|8|||
23125886|NCT01432626|64211765|FG000|Overall Study|LV function recovered|2|||
23125887|NCT01432626|64211765|FG000|Overall Study|Withdrawal by Subject|2|||
23544498|NCT01934218|65723101|FG000|Double-blind Phase|Lack of Efficacy|6|||
23544499|NCT01934218|65723102|FG001|Double-blind Phase|Lack of Efficacy|7|||
23544500|NCT01934218|65723101|FG000|Double-blind Phase|Lost to Follow-up|7|||
23544501|NCT01934218|65723102|FG001|Double-blind Phase|Lost to Follow-up|14|||
23544502|NCT01934218|65723101|FG000|Double-blind Phase|Physician Decision|1|||
23544503|NCT01934218|65723102|FG001|Double-blind Phase|Physician Decision|2|||
23125888|NCT01432626|64211765|FG000|Overall Study|Only 1 image competed|2|||
23125889|NCT01432626|64211765|FG000|Overall Study|Imaging agent not available|1|||
23125890|NCT01516749|64211766|FG000|Active Therapy|Lost to Follow-up|1|||
23125891|NCT01516749|64211766|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
23125892|NCT01358331|64211767|FG000|Overall Study|Lost to Follow-up|0|||
23125893|NCT01358331|64211768|FG001|Overall Study|Lost to Follow-up|0|||
23125894|NCT01358331|64211769|FG002|Overall Study|Lost to Follow-up|0|||
23125895|NCT01358331|64211770|FG003|Overall Study|Lost to Follow-up|1|||
23125896|NCT01358331|64211771|FG004|Overall Study|Lost to Follow-up|0|||
23125897|NCT01358331|64211772|FG005|Overall Study|Lost to Follow-up|0|||
23125898|NCT01358331|64211767|FG000|Overall Study|Withdrawal by Subject|0|||
23125899|NCT01358331|64211768|FG001|Overall Study|Withdrawal by Subject|0|||
23125900|NCT01358331|64211769|FG002|Overall Study|Withdrawal by Subject|0|||
23125901|NCT01358331|64211770|FG003|Overall Study|Withdrawal by Subject|1|||
23315232|NCT04707313|64895548|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
23315233|NCT01559389|64895549|FG000|Overall Study|Withdrawal by Subject|20|||
23315234|NCT01559389|64895550|FG001|Overall Study|Withdrawal by Subject|20|||
23315235|NCT04975191|64895551|FG000|Overall Study|Protocol Violation|1|||
23315236|NCT04975191|64895552|FG001|Overall Study|Protocol Violation|2|||
23315237|NCT04975191|64895553|FG002|Overall Study|Protocol Violation|2|||
23315238|NCT04975191|64895554|FG003|Overall Study|Protocol Violation|2|||
23315239|NCT04975191|64895551|FG000|Overall Study|Lost to Follow-up|13|||
23315240|NCT04975191|64895552|FG001|Overall Study|Lost to Follow-up|3|||
23315241|NCT04975191|64895553|FG002|Overall Study|Lost to Follow-up|8|||
23315242|NCT04975191|64895554|FG003|Overall Study|Lost to Follow-up|8|||
23315243|NCT01332292|64895555|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
23315244|NCT01332292|64895556|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
23315245|NCT01332292|64895555|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
23315246|NCT01332292|64895556|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
23315247|NCT01332292|64895555|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
23315248|NCT01332292|64895556|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
23315249|NCT03279692|64895557|FG000|Overall Study|Withdrawal by Subject|1|||
23315250|NCT00338455|64895558|FG000|Overall Study|Death|2|||
23315251|NCT00338455|64895559|FG001|Overall Study|Death|1|||
23315252|NCT00338455|64895558|FG000|Overall Study|Physician Decision|1|||
23315253|NCT00338455|64895559|FG001|Overall Study|Physician Decision|0|||
23315254|NCT02865460|64895567|FG000|Overall Study|Adverse Event|1|||
23315255|NCT02865460|64895568|FG001|Overall Study|Adverse Event|0|||
23315256|NCT02865460|64895567|FG000|Overall Study|Withdrawal by Subject|1|||
23315257|NCT02865460|64895568|FG001|Overall Study|Withdrawal by Subject|1|||
23315258|NCT02865460|64895567|FG000|Overall Study|Lost to Follow-up|7|||
23315259|NCT02865460|64895568|FG001|Overall Study|Lost to Follow-up|4|||
23315260|NCT02865460|64895567|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
23315261|NCT02865460|64895568|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
23315262|NCT01696058|64895569|FG000|Overall Study|Adverse Event|21|||
23315263|NCT01696058|64895570|FG001|Overall Study|Adverse Event|11|||
23315264|NCT01696058|64895569|FG000|Overall Study|Lack of Efficacy|2|||
23315265|NCT01696058|64895570|FG001|Overall Study|Lack of Efficacy|3|||
23315266|NCT01696058|64895569|FG000|Overall Study|Protocol Violation|9|||
23315267|NCT01696058|64895570|FG001|Overall Study|Protocol Violation|3|||
23315268|NCT01696058|64895569|FG000|Overall Study|Lost to Follow-up|2|||
23315269|NCT01696058|64895570|FG001|Overall Study|Lost to Follow-up|5|||
23315270|NCT01696058|64895569|FG000|Overall Study|Withdrawal by Subject|4|||
23315271|NCT01696058|64895570|FG001|Overall Study|Withdrawal by Subject|6|||
23315272|NCT01696058|64895569|FG000|Overall Study|Other reason prematurely discontinued|5|||
23544504|NCT01934218|65723101|FG000|Double-blind Phase|Protocol Violation|4|||
23125902|NCT01358331|64211771|FG004|Overall Study|Withdrawal by Subject|1|||
23315273|NCT01696058|64895570|FG001|Overall Study|Other reason prematurely discontinued|3|||
23315274|NCT03247816|64895571|FG000|Overall Study|Adverse Event|12|||
23315275|NCT03247816|64895571|FG000|Overall Study|Physician Decision|3|||
23315276|NCT03247816|64895571|FG000|Overall Study|Lack of Efficacy|1|||
23315277|NCT03247816|64895571|FG000|Overall Study|Lost to Follow-up|10|||
23315278|NCT03247816|64895571|FG000|Overall Study|Missing Feraccru stop date|3|||
23315279|NCT02212379|64895572|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
23315280|NCT02212379|64895572|FG000|From Baseline to Week 48|Adverse Event|7|||
23125903|NCT01358331|64211772|FG005|Overall Study|Withdrawal by Subject|1|||
23315281|NCT02212379|64895572|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
23315282|NCT02212379|64895572|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
23544505|NCT01934218|65723102|FG001|Double-blind Phase|Protocol Violation|0|||
23544506|NCT01934218|65723101|FG000|Double-blind Phase|Withdrawal by Subject|16|||
23315283|NCT02212379|64895572|FG000|From Week 48 to Week 96|Adverse Event|1|||
23315284|NCT02212379|64895572|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
23315285|NCT00926783|64895573|FG000|Overall Study|Incomplete CFAE Procedures|3|||
23315286|NCT00926783|64895574|FG001|Overall Study|Incomplete CFAE Procedures|3|||
23211882|NCT02034552|64516239|FG000|Overall Study|Radiological progression|3|||
23211883|NCT02034552|64516240|FG001|Overall Study|Radiological progression|5|||
23211884|NCT02034552|64516241|FG002|Overall Study|Radiological progression|4|||
23211885|NCT02034552|64516239|FG000|Overall Study|AE not assoc. with disease progression|1|||
23211886|NCT02034552|64516240|FG001|Overall Study|AE not assoc. with disease progression|4|||
23211887|NCT02034552|64516241|FG002|Overall Study|AE not assoc. with disease progression|2|||
23211888|NCT02034552|64516239|FG000|Overall Study|AE associated with disease progression|0|||
23211889|NCT02034552|64516240|FG001|Overall Study|AE associated with disease progression|1|||
23211890|NCT02034552|64516241|FG002|Overall Study|AE associated with disease progression|0|||
23211891|NCT02034552|64516239|FG000|Overall Study|Withdrawal by Subject|2|||
23211892|NCT02034552|64516240|FG001|Overall Study|Withdrawal by Subject|1|||
23211893|NCT02034552|64516241|FG002|Overall Study|Withdrawal by Subject|1|||
23211894|NCT02034552|64516239|FG000|Overall Study|Non-compliance with study drug|0|||
23211895|NCT02034552|64516240|FG001|Overall Study|Non-compliance with study drug|0|||
23211896|NCT02034552|64516241|FG002|Overall Study|Non-compliance with study drug|1|||
23211897|NCT02034552|64516239|FG000|Overall Study|Clinical progression|5|||
23211898|NCT02034552|64516240|FG001|Overall Study|Clinical progression|7|||
23211899|NCT02034552|64516241|FG002|Overall Study|Clinical progression|9|||
23211900|NCT03495453|64516251|FG000|Overall Study|Withdrawal by Subject|0|||
23211901|NCT03495453|64516252|FG001|Overall Study|Withdrawal by Subject|1|||
23211902|NCT03495817|64516256|FG000|26 Week Open Label|Adverse Event|3|||
23211903|NCT03495817|64516256|FG000|26 Week Open Label|Withdrawal by Subject|4|||
23211904|NCT03495817|64516256|FG000|26 Week Open Label|Lost to Follow-up|1|||
23211905|NCT03495817|64516256|FG000|26 Week Extension|Lost to Follow-up|2|||
23211906|NCT00871377|64516258|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23211907|NCT00871377|64516259|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23211908|NCT00871377|64516260|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
23211909|NCT00871377|64516261|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23211910|NCT00871377|64516262|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23211911|NCT00871377|64516263|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23211912|NCT00871377|64516258|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23211913|NCT00871377|64516259|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23211914|NCT00871377|64516260|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23211915|NCT00871377|64516261|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23211916|NCT00871377|64516262|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
23211917|NCT00871377|64516263|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
23211918|NCT00871377|64516258|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
23211919|NCT00871377|64516259|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211920|NCT00871377|64516260|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211921|NCT00871377|64516261|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211922|NCT00871377|64516262|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211923|NCT00871377|64516263|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211924|NCT00871377|64516258|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211925|NCT00871377|64516259|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211926|NCT00871377|64516260|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211927|NCT00871377|64516261|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211928|NCT00871377|64516262|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
23211929|NCT00871377|64516263|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
23211930|NCT00871377|64516258|FG000|Third Intervention (10 Weeks)|Death|0|||
23211931|NCT00871377|64516259|FG001|Third Intervention (10 Weeks)|Death|0|||
23211932|NCT00871377|64516260|FG002|Third Intervention (10 Weeks)|Death|0|||
23211933|NCT00871377|64516261|FG003|Third Intervention (10 Weeks)|Death|1|||
23211934|NCT00871377|64516262|FG004|Third Intervention (10 Weeks)|Death|0|||
23211935|NCT00871377|64516263|FG005|Third Intervention (10 Weeks)|Death|0|||
23211936|NCT03404518|64516267|FG000|Overall Study|Lost to Follow-up|28|||
23211937|NCT03404518|64516268|FG001|Overall Study|Lost to Follow-up|30|||
23211938|NCT03404518|64516267|FG000|Overall Study|Protocol Violation|13|||
23211939|NCT03404518|64516268|FG001|Overall Study|Protocol Violation|6|||
23211940|NCT01958125|64516269|FG000|Overall Study|Missing diary data|2|||
23211941|NCT01958125|64516270|FG001|Overall Study|Missing diary data|6|||
23211942|NCT01958125|64516269|FG000|Overall Study|No headache attacks|0|||
23211943|NCT01958125|64516270|FG001|Overall Study|No headache attacks|2|||
23211944|NCT01830816|64516271|FG000|Overall Study|Progressive Disease|12|||
23211945|NCT01830816|64516272|FG001|Overall Study|Progressive Disease|7|||
23211946|NCT01830816|64516273|FG002|Overall Study|Progressive Disease|7|||
23211947|NCT01830816|64516271|FG000|Overall Study|Adverse Event|3|||
23211948|NCT01830816|64516272|FG001|Overall Study|Adverse Event|4|||
23211949|NCT01830816|64516273|FG002|Overall Study|Adverse Event|0|||
23211950|NCT01830816|64516271|FG000|Overall Study|Study Terminated by Sponsor|1|||
23211951|NCT01830816|64516272|FG001|Overall Study|Study Terminated by Sponsor|1|||
23211952|NCT01830816|64516273|FG002|Overall Study|Study Terminated by Sponsor|0|||
23211953|NCT01830816|64516271|FG000|Overall Study|Withdrawal by Subject|1|||
23315287|NCT01582152|64895575|FG000|Overall Study|Disease Progression|4|||
23315288|NCT01582152|64895576|FG001|Overall Study|Disease Progression|5|||
23315289|NCT01582152|64895575|FG000|Overall Study|Adverse Event|2|||
23315290|NCT01582152|64895576|FG001|Overall Study|Adverse Event|1|||
23315291|NCT03155945|64895577|FG000|Overall Study|Lost to Follow-up|0|||
23315292|NCT03155945|64895578|FG001|Overall Study|Lost to Follow-up|1|||
23315293|NCT03155945|64895577|FG000|Overall Study|Withdrawal by Subject|0|||
23315294|NCT03155945|64895578|FG001|Overall Study|Withdrawal by Subject|1|||
23315295|NCT03155945|64895577|FG000|Overall Study|Other Reason|0|||
23315296|NCT03155945|64895578|FG001|Overall Study|Other Reason|1|||
23315297|NCT01038297|64895579|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
23315298|NCT01038297|64895580|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
23315299|NCT01038297|64895581|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
23315300|NCT04233073|64895582|FG000|Overall Study|Death|5|||
23315301|NCT01068262|64895587|FG000|Overall Study|Adverse Event|2|||
23315302|NCT01068262|64895588|FG001|Overall Study|Adverse Event|0|||
23315303|NCT01068262|64895589|FG002|Overall Study|Adverse Event|1|||
23315304|NCT01068262|64895590|FG003|Overall Study|Adverse Event|0|||
23315305|NCT01068262|64895587|FG000|Overall Study|Protocol Violation|1|||
23315306|NCT01068262|64895588|FG001|Overall Study|Protocol Violation|0|||
23315307|NCT01068262|64895589|FG002|Overall Study|Protocol Violation|0|||
23315308|NCT01068262|64895590|FG003|Overall Study|Protocol Violation|0|||
23315309|NCT01068262|64895587|FG000|Overall Study|Withdrawal by Subject|0|||
23315310|NCT01068262|64895588|FG001|Overall Study|Withdrawal by Subject|1|||
23315311|NCT01068262|64895589|FG002|Overall Study|Withdrawal by Subject|0|||
23315312|NCT01068262|64895590|FG003|Overall Study|Withdrawal by Subject|0|||
23315313|NCT02027428|64895591|FG000|Induction|Never treated|7|||
23315314|NCT02027428|64895592|FG001|Induction|Never treated|0|||
23315315|NCT02027428|64895593|FG002|Induction|Never treated|0|||
23315316|NCT02027428|64895591|FG000|Induction|Progressive disease|77|||
23315317|NCT02027428|64895592|FG001|Induction|Progressive disease|0|||
23315318|NCT02027428|64895593|FG002|Induction|Progressive disease|0|||
23544507|NCT01934218|65723102|FG001|Double-blind Phase|Withdrawal by Subject|13|||
23544508|NCT01934218|65723101|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
23544509|NCT01934218|65723102|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
23544510|NCT01934218|65723101|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
23544511|NCT01934218|65723102|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
23544512|NCT01934218|65723101|FG000|Open-Label Phase|Adverse Event|2|||
23125904|NCT01358331|64211767|FG000|Overall Study|Adverse Events|1|||
23125905|NCT01358331|64211768|FG001|Overall Study|Adverse Events|1|||
23125906|NCT01358331|64211769|FG002|Overall Study|Adverse Events|1|||
23125907|NCT01358331|64211770|FG003|Overall Study|Adverse Events|0|||
23125908|NCT01358331|64211771|FG004|Overall Study|Adverse Events|1|||
23125909|NCT01358331|64211772|FG005|Overall Study|Adverse Events|5|||
23125910|NCT01358331|64211767|FG000|Overall Study|Symptomatic Deterioration|0|||
23125911|NCT01358331|64211768|FG001|Overall Study|Symptomatic Deterioration|0|||
23125912|NCT01358331|64211769|FG002|Overall Study|Symptomatic Deterioration|0|||
23125913|NCT01358331|64211770|FG003|Overall Study|Symptomatic Deterioration|0|||
23125914|NCT01358331|64211771|FG004|Overall Study|Symptomatic Deterioration|1|||
23125915|NCT01358331|64211772|FG005|Overall Study|Symptomatic Deterioration|0|||
23125916|NCT01358331|64211767|FG000|Overall Study|Participants did not wish to continue|0|||
23125917|NCT01358331|64211768|FG001|Overall Study|Participants did not wish to continue|0|||
23125918|NCT01358331|64211769|FG002|Overall Study|Participants did not wish to continue|0|||
23125919|NCT01358331|64211770|FG003|Overall Study|Participants did not wish to continue|0|||
23125920|NCT01358331|64211771|FG004|Overall Study|Participants did not wish to continue|1|||
23125921|NCT01358331|64211772|FG005|Overall Study|Participants did not wish to continue|0|||
23125922|NCT01358331|64211767|FG000|Overall Study|Progress of disease under investigation|1|||
23125923|NCT01358331|64211768|FG001|Overall Study|Progress of disease under investigation|2|||
23125924|NCT01358331|64211769|FG002|Overall Study|Progress of disease under investigation|3|||
23125925|NCT01358331|64211770|FG003|Overall Study|Progress of disease under investigation|1|||
23125926|NCT01358331|64211771|FG004|Overall Study|Progress of disease under investigation|3|||
23125927|NCT01358331|64211772|FG005|Overall Study|Progress of disease under investigation|0|||
23125928|NCT04596995|64211773|FG000|Overall Study|Lack of Efficacy|8|||
23125929|NCT04596995|64211773|FG000|Overall Study|Lost to Follow-up|3|||
23211954|NCT01830816|64516272|FG001|Overall Study|Withdrawal by Subject|1|||
23315319|NCT02027428|64895591|FG000|Induction|Adverse Event|51|||
23315320|NCT02027428|64895592|FG001|Induction|Adverse Event|0|||
23125930|NCT04596995|64211773|FG000|Overall Study|Withdrawal by Subject|12|||
23125931|NCT04596995|64211773|FG000|Overall Study|Sponsor decision|3|||
23211955|NCT01830816|64516273|FG002|Overall Study|Withdrawal by Subject|0|||
23315321|NCT02027428|64895593|FG002|Induction|Adverse Event|0|||
23315322|NCT02027428|64895591|FG000|Induction|Withdrawal by Subject|22|||
23426161|NCT03958656|65303538|FG000|Overall Study|Started anti-cancer treatment|0|||
23125932|NCT04596995|64211773|FG000|Overall Study|Enrolled in managed access program|3|||
23125933|NCT00658606|64211775|FG000|Overall Study|Adverse Event|2|||
23125934|NCT00658606|64211776|FG001|Overall Study|Adverse Event|1|||
23125935|NCT00658606|64211775|FG000|Overall Study|Lack of Efficacy|6|||
23125936|NCT00658606|64211776|FG001|Overall Study|Lack of Efficacy|3|||
23125937|NCT00658606|64211775|FG000|Overall Study|Lost to Follow-up|1|||
23125938|NCT00658606|64211776|FG001|Overall Study|Lost to Follow-up|0|||
23125939|NCT00658606|64211775|FG000|Overall Study|Withdrawal by Subject|7|||
23125940|NCT00658606|64211776|FG001|Overall Study|Withdrawal by Subject|16|||
23125941|NCT00658606|64211775|FG000|Overall Study|Lack of Compliance|0|||
23125942|NCT00658606|64211776|FG001|Overall Study|Lack of Compliance|3|||
23125943|NCT02601209|64211777|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
23125944|NCT02601209|64211778|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
23125945|NCT02601209|64211779|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
23125946|NCT02601209|64211780|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23125947|NCT02601209|64211781|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23125948|NCT02601209|64211782|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23125949|NCT02601209|64211783|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23125950|NCT02601209|64211784|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23125951|NCT02601209|64211785|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
23125952|NCT02601209|64211777|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23125953|NCT02601209|64211778|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23125954|NCT02601209|64211779|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23125955|NCT02601209|64211780|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23125956|NCT02601209|64211781|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
23125957|NCT02601209|64211782|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
23125958|NCT02601209|64211783|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
23125959|NCT02601209|64211784|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23125960|NCT02601209|64211785|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
23125961|NCT00943787|64211786|FG000|Overall Study|Physician Decision|4|||
23125962|NCT00943787|64211786|FG000|Overall Study|Withdrawal by Subject|3|||
23125963|NCT03898700|64211787|FG000|Overall Study|Withdrawal by Subject|2|||
23125964|NCT01234883|64211788|FG000|Overall Study|Early treatment release|8|||
23125965|NCT01234883|64211789|FG001|Overall Study|Early treatment release|10|||
23125966|NCT01234883|64211788|FG000|Overall Study|Parent/guardian withdrew consent|1|||
23125967|NCT01234883|64211789|FG001|Overall Study|Parent/guardian withdrew consent|2|||
23125968|NCT01234883|64211788|FG000|Overall Study|Technical difficulties with IV infusion|0|||
23125969|NCT01234883|64211789|FG001|Overall Study|Technical difficulties with IV infusion|1|||
23125970|NCT01234883|64211788|FG000|Overall Study|Inclusion/exclusion failure|1|||
23125971|NCT01234883|64211789|FG001|Overall Study|Inclusion/exclusion failure|0|||
23125972|NCT02053610|64211790|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
23125973|NCT02053610|64211791|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
23125974|NCT02053610|64211790|FG000|Overall Study|Withdrew Consent|2|||
23125975|NCT02053610|64211791|FG001|Overall Study|Withdrew Consent|9|||
23125976|NCT02053610|64211790|FG000|Overall Study|Death|5|||
23125977|NCT02053610|64211791|FG001|Overall Study|Death|5|||
23125978|NCT02053610|64211790|FG000|Overall Study|Administrative/Other|1|||
23125979|NCT02053610|64211791|FG001|Overall Study|Administrative/Other|1|||
23125980|NCT02053610|64211790|FG000|Overall Study|Disease Progression|2|||
23125981|NCT02053610|64211791|FG001|Overall Study|Disease Progression|3|||
23125982|NCT02053610|64211790|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
23125983|NCT02053610|64211791|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
23125984|NCT02053610|64211790|FG000|Overall Study|Did not Receive Treatment|4|||
23125985|NCT02053610|64211791|FG001|Overall Study|Did not Receive Treatment|2|||
23125986|NCT02053610|64211790|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23125987|NCT02053610|64211791|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23125988|NCT02053610|64211790|FG000|Overall Study|Violation of Selection Criteria|1|||
23125989|NCT02053610|64211791|FG001|Overall Study|Violation of Selection Criteria|0|||
23125990|NCT00127842|64211792|FG000|Overall Study|Adverse Event|15|||
23125991|NCT00127842|64211792|FG000|Overall Study|Withdrawal by Subject|3|||
23125992|NCT00127842|64211792|FG000|Overall Study|Lost to Follow-up|1|||
23125993|NCT00127842|64211792|FG000|Overall Study|Lack of Efficacy|12|||
23125994|NCT00127842|64211792|FG000|Overall Study|Noncompliance|2|||
23125995|NCT00127842|64211792|FG000|Overall Study|Protocol Violation|1|||
23125996|NCT00127842|64211792|FG000|Overall Study|Other|5|||
23315323|NCT02027428|64895592|FG001|Induction|Withdrawal by Subject|0|||
23544513|NCT01934218|65723102|FG001|Open-Label Phase|Adverse Event|4|||
23125997|NCT03197766|64211793|FG000|Overall Study|Withdrawal by Subject|2|||
23125998|NCT03197766|64211794|FG001|Overall Study|Withdrawal by Subject|0|||
23211956|NCT01830816|64516271|FG000|Overall Study|Lost to Follow-up|0|||
23426162|NCT03958656|65303539|FG001|Overall Study|Started anti-cancer treatment|0|||
23426163|NCT03958656|65303540|FG002|Overall Study|Started anti-cancer treatment|1|||
23426164|NCT03958656|65303541|FG003|Overall Study|Started anti-cancer treatment|0|||
23426165|NCT01129882|65303542|FG000|Overall Study|Adverse Event|39|||
23426166|NCT01129882|65303542|FG000|Overall Study|Death|6|||
23426167|NCT01129882|65303542|FG000|Overall Study|Lack of Efficacy|5|||
23426168|NCT01129882|65303542|FG000|Overall Study|Lost to Follow-up|13|||
23426169|NCT01129882|65303542|FG000|Overall Study|Physician Decision|27|||
23426170|NCT01129882|65303542|FG000|Overall Study|Protocol Deviation|3|||
23426171|NCT01129882|65303542|FG000|Overall Study|Withdrawal Criteria Met|19|||
23426172|NCT01129882|65303542|FG000|Overall Study|Trial Termination by Sponsor|6|||
23426173|NCT01129882|65303542|FG000|Overall Study|Withdrawal by Subject|160|||
23426174|NCT01219933|65303544|FG000|Overall Study|Adverse Event|8|||
23426175|NCT01219933|65303544|FG000|Overall Study|No LDA reached|5|||
23426176|NCT01219933|65303544|FG000|Overall Study|No LDA maintained|7|||
23426177|NCT01219933|65303544|FG000|Overall Study|Lost to Follow-up|3|||
23426178|NCT01219933|65303544|FG000|Overall Study|GC free|1|||
23426179|NCT01219933|65303544|FG000|Overall Study|Withdrawal by Subject|5|||
23426180|NCT01219933|65303544|FG000|Overall Study|Protocol Violation|8|||
23426181|NCT01219933|65303544|FG000|Overall Study|Lack of Efficacy|1|||
23426182|NCT00900146|65303551|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
23426183|NCT00900146|65303552|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
23426184|NCT00900146|65303553|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
23426185|NCT00900146|65303554|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
23426186|NCT00900146|65303555|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
23426187|NCT00900146|65303551|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
23426188|NCT00900146|65303552|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
23544514|NCT01934218|65723101|FG000|Open-Label Phase|Lack of Efficacy|1|||
23125999|NCT01327846|64211795|FG000|Core Phase|Subject decision (vital status: missing)|1|||
23126000|NCT01327846|64211796|FG001|Core Phase|Subject decision (vital status: missing)|2|||
23126001|NCT01327846|64211797|FG002|Core Phase|Subject decision (vital status: missing)|2|||
23126002|NCT01327846|64211798|FG003|Core Phase|Subject decision (vital status: missing)|1|||
23126003|NCT01327846|64211795|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
23126004|NCT01327846|64211796|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
23126005|NCT01327846|64211797|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
23126006|NCT01327846|64211798|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
23126007|NCT01327846|64211795|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
23126008|NCT01327846|64211796|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
23126009|NCT01327846|64211797|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
23126010|NCT01327846|64211798|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
23126011|NCT01327846|64211795|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
23126012|NCT01327846|64211796|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
23126013|NCT01327846|64211797|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
23126014|NCT01327846|64211798|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
23126015|NCT01327846|64211795|FG000|Core Phase|Lost to Follow-up|3|||
23126016|NCT01327846|64211796|FG001|Core Phase|Lost to Follow-up|3|||
23126017|NCT01327846|64211797|FG002|Core Phase|Lost to Follow-up|4|||
23126018|NCT01327846|64211798|FG003|Core Phase|Lost to Follow-up|5|||
23126019|NCT01327846|64211795|FG000|Extension Phase|Study terminated by sponsor|1073|||
23126020|NCT01327846|64211796|FG001|Extension Phase|Study terminated by sponsor|1124|||
23126021|NCT01327846|64211797|FG002|Extension Phase|Study terminated by sponsor|1067|||
23126022|NCT01327846|64211798|FG003|Extension Phase|Study terminated by sponsor|1660|||
23126023|NCT01327846|64211795|FG000|Extension Phase|Withdrawal by Subject|20|||
23126024|NCT01327846|64211796|FG001|Extension Phase|Withdrawal by Subject|13|||
23126025|NCT01327846|64211797|FG002|Extension Phase|Withdrawal by Subject|19|||
23126026|NCT01327846|64211798|FG003|Extension Phase|Withdrawal by Subject|37|||
23126027|NCT01327846|64211795|FG000|Extension Phase|Lost to Follow-up|4|||
23126028|NCT01327846|64211796|FG001|Extension Phase|Lost to Follow-up|3|||
23126029|NCT01327846|64211797|FG002|Extension Phase|Lost to Follow-up|4|||
23126030|NCT01327846|64211798|FG003|Extension Phase|Lost to Follow-up|7|||
23126031|NCT01327846|64211795|FG000|Extension Phase|Technical Problems|2|||
23126032|NCT01327846|64211796|FG001|Extension Phase|Technical Problems|4|||
23126033|NCT01327846|64211797|FG002|Extension Phase|Technical Problems|2|||
23544515|NCT01934218|65723102|FG001|Open-Label Phase|Lack of Efficacy|4|||
23544516|NCT01934218|65723101|FG000|Open-Label Phase|Lost to Follow-up|4|||
23126034|NCT01327846|64211798|FG003|Extension Phase|Technical Problems|2|||
23126035|NCT01681992|64211804|FG000|Overall Study|Adverse Event|3|||
23126036|NCT01681992|64211805|FG001|Overall Study|Adverse Event|2|||
23426189|NCT00900146|65303553|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
23426190|NCT00900146|65303554|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
23426191|NCT00900146|65303555|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
23544517|NCT01934218|65723102|FG001|Open-Label Phase|Lost to Follow-up|2|||
23126037|NCT01681992|64211806|FG002|Overall Study|Adverse Event|3|||
23544518|NCT01934218|65723101|FG000|Open-Label Phase|Physician Decision|1|||
23126038|NCT01681992|64211804|FG000|Overall Study|Lost to Follow-up|36|||
23126039|NCT01681992|64211805|FG001|Overall Study|Lost to Follow-up|38|||
23126040|NCT01681992|64211806|FG002|Overall Study|Lost to Follow-up|53|||
23126041|NCT01681992|64211804|FG000|Overall Study|As Per Sponsor Decision|0|||
23126042|NCT01681992|64211805|FG001|Overall Study|As Per Sponsor Decision|0|||
23126043|NCT01681992|64211806|FG002|Overall Study|As Per Sponsor Decision|1|||
23126044|NCT01681992|64211804|FG000|Overall Study|Protocol Violation|0|||
23126045|NCT01681992|64211805|FG001|Overall Study|Protocol Violation|0|||
23126046|NCT01681992|64211806|FG002|Overall Study|Protocol Violation|1|||
23126047|NCT01681992|64211804|FG000|Overall Study|Withdrawal by Subject|27|||
23544519|NCT01934218|65723102|FG001|Open-Label Phase|Physician Decision|0|||
23544520|NCT01934218|65723101|FG000|Open-Label Phase|Protocol Violation|1|||
23126048|NCT01681992|64211805|FG001|Overall Study|Withdrawal by Subject|30|||
23126049|NCT01681992|64211806|FG002|Overall Study|Withdrawal by Subject|25|||
23126050|NCT00402051|64211807|FG000|Overall Study|Progressive Disease|13|||
23126051|NCT00402051|64211808|FG001|Overall Study|Progressive Disease|20|||
23126052|NCT00402051|64211807|FG000|Overall Study|Adverse Event|11|||
23126053|NCT00402051|64211808|FG001|Overall Study|Adverse Event|4|||
23126054|NCT00402051|64211807|FG000|Overall Study|Physician Decision|7|||
23126055|NCT00402051|64211808|FG001|Overall Study|Physician Decision|3|||
23126056|NCT00402051|64211807|FG000|Overall Study|Withdrawal by Subject|3|||
23126057|NCT00402051|64211808|FG001|Overall Study|Withdrawal by Subject|3|||
23126058|NCT00402051|64211807|FG000|Overall Study|Death - Related to Study Drug|1|||
23126059|NCT00402051|64211808|FG001|Overall Study|Death - Related to Study Drug|2|||
23126060|NCT00402051|64211807|FG000|Overall Study|Death Due to Study Disease|2|||
23126061|NCT00402051|64211808|FG001|Overall Study|Death Due to Study Disease|1|||
23544521|NCT01934218|65723102|FG001|Open-Label Phase|Protocol Violation|0|||
23126062|NCT00402051|64211807|FG000|Overall Study|Death Due to Adverse Event|0|||
23544522|NCT01934218|65723101|FG000|Open-Label Phase|Withdrawal by Subject|13|||
23544523|NCT01934218|65723102|FG001|Open-Label Phase|Withdrawal by Subject|11|||
23544524|NCT01934218|65723101|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
23544525|NCT01934218|65723102|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
23544526|NCT01934218|65723101|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
23544527|NCT01934218|65723102|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
23544528|NCT03832010|65723104|FG000|Overall Study|Withdrawal by Subject|2|||
23544529|NCT03832010|65723105|FG001|Overall Study|Withdrawal by Subject|1|||
23544530|NCT03832010|65723106|FG002|Overall Study|Withdrawal by Subject|0|||
23544531|NCT03832010|65723104|FG000|Overall Study|Lost to Follow-up|2|||
23544532|NCT03832010|65723105|FG001|Overall Study|Lost to Follow-up|1|||
23544533|NCT03832010|65723106|FG002|Overall Study|Lost to Follow-up|1|||
23544534|NCT02363738|65723107|FG000|Overall Study|Adverse Event|5|||
23544535|NCT02363738|65723108|FG001|Overall Study|Adverse Event|2|||
23544536|NCT02363738|65723107|FG000|Overall Study|Lack of Efficacy|1|||
23544537|NCT02363738|65723108|FG001|Overall Study|Lack of Efficacy|2|||
23544538|NCT02363738|65723107|FG000|Overall Study|Lost to Follow-up|2|||
23544539|NCT02363738|65723108|FG001|Overall Study|Lost to Follow-up|1|||
23544540|NCT01410448|65723111|FG000|Overall Study|No conversion to everolimus|0|||
23544541|NCT01410448|65723112|FG001|Overall Study|No conversion to everolimus|24|||
23544542|NCT01410448|65723111|FG000|Overall Study|Graft loss|4|||
23544543|NCT01410448|65723112|FG001|Overall Study|Graft loss|1|||
23544544|NCT01410448|65723111|FG000|Overall Study|Administrative issues|2|||
23544545|NCT01410448|65723112|FG001|Overall Study|Administrative issues|1|||
23544546|NCT01410448|65723111|FG000|Overall Study|Lost to Follow-up|1|||
23544547|NCT01410448|65723112|FG001|Overall Study|Lost to Follow-up|0|||
23544548|NCT01410448|65723111|FG000|Overall Study|Withdrawal by Subject|3|||
23544549|NCT01410448|65723112|FG001|Overall Study|Withdrawal by Subject|2|||
23544550|NCT01410448|65723111|FG000|Overall Study|Protocol Violation|0|||
23544551|NCT01410448|65723112|FG001|Overall Study|Protocol Violation|4|||
23544552|NCT01410448|65723111|FG000|Overall Study|Death|2|||
23544553|NCT01410448|65723112|FG001|Overall Study|Death|3|||
23544554|NCT02627677|65723113|FG000|Overall Study|Adverse event (not progressive disease)|1|||
23544555|NCT02627677|65723114|FG001|Overall Study|Adverse event (not progressive disease)|4|||
23126063|NCT00402051|64211808|FG001|Overall Study|Death Due to Adverse Event|2|||
23211957|NCT01830816|64516272|FG001|Overall Study|Lost to Follow-up|1|||
23544556|NCT02627677|65723115|FG002|Overall Study|Adverse event (not progressive disease)|1|||
23544557|NCT02627677|65723113|FG000|Overall Study|Progressive disease|1|||
23544558|NCT02627677|65723114|FG001|Overall Study|Progressive disease|3|||
23544559|NCT02627677|65723115|FG002|Overall Study|Progressive disease|0|||
23544560|NCT02627677|65723113|FG000|Overall Study|Lack of Efficacy|1|||
23617926|NCT02660034|65988172|FG010|Overall Study|Progressive Disease (Clinical)|0|||
23617927|NCT02660034|65988173|FG011|Overall Study|Progressive Disease (Clinical)|0|||
23126064|NCT00402051|64211807|FG000|Overall Study|Lost to Follow-up|1|||
23126065|NCT00402051|64211808|FG001|Overall Study|Lost to Follow-up|0|||
23126066|NCT00643617|64211813|FG000|Overall Study|Death|6|||
23544561|NCT02627677|65723114|FG001|Overall Study|Lack of Efficacy|2|||
23544562|NCT02627677|65723115|FG002|Overall Study|Lack of Efficacy|0|||
23544563|NCT02627677|65723113|FG000|Overall Study|Lost to Follow-up|0|||
23544564|NCT02627677|65723114|FG001|Overall Study|Lost to Follow-up|0|||
23544565|NCT02627677|65723115|FG002|Overall Study|Lost to Follow-up|1|||
23544566|NCT02627677|65723113|FG000|Overall Study|Pregnancy|0|||
23544567|NCT02627677|65723114|FG001|Overall Study|Pregnancy|1|||
23544568|NCT02627677|65723115|FG002|Overall Study|Pregnancy|0|||
23544569|NCT02627677|65723113|FG000|Overall Study|Study Terminated by Sponsor|5|||
23544570|NCT02627677|65723114|FG001|Overall Study|Study Terminated by Sponsor|10|||
23544571|NCT02627677|65723115|FG002|Overall Study|Study Terminated by Sponsor|6|||
23544572|NCT02627677|65723113|FG000|Overall Study|Physician Decision|0|||
23544573|NCT02627677|65723114|FG001|Overall Study|Physician Decision|0|||
23544574|NCT02627677|65723115|FG002|Overall Study|Physician Decision|2|||
23544575|NCT02627677|65723113|FG000|Overall Study|Withdrawal by Subject|2|||
23544576|NCT02627677|65723114|FG001|Overall Study|Withdrawal by Subject|1|||
23544577|NCT02627677|65723115|FG002|Overall Study|Withdrawal by Subject|1|||
23126067|NCT00643617|64211814|FG001|Overall Study|Death|9|||
23126068|NCT00643617|64211813|FG000|Overall Study|Lost to Follow-up|42|||
23126069|NCT00643617|64211814|FG001|Overall Study|Lost to Follow-up|51|||
23126070|NCT02579772|64211815|FG000|Overall Study|Withdrawal by Subject|0|||
23126071|NCT02579772|64211816|FG001|Overall Study|Withdrawal by Subject|1|||
23126072|NCT02579772|64211815|FG000|Overall Study|Usage of additional antioxidants|1|||
23126073|NCT02579772|64211816|FG001|Overall Study|Usage of additional antioxidants|0|||
23126074|NCT02579772|64211815|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
23126075|NCT02579772|64211816|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
23126076|NCT00706654|64211817|FG000|Conversion Phase|Lost to Follow-up|4|||
23126077|NCT00706654|64211818|FG001|Conversion Phase|Lost to Follow-up|0|||
23126078|NCT00706654|64211819|FG002|Conversion Phase|Lost to Follow-up|0|||
23126079|NCT00706654|64211820|FG003|Conversion Phase|Lost to Follow-up|0|||
23126080|NCT00706654|64211817|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
23126081|NCT00706654|64211818|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
23126082|NCT00706654|64211819|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
23126083|NCT00706654|64211820|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
23126084|NCT00706654|64211817|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
23126085|NCT00706654|64211818|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
23126086|NCT00706654|64211819|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
23126087|NCT00706654|64211820|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
23126088|NCT00706654|64211817|FG000|Conversion Phase|Withdrawn by Investigator|14|||
23126089|NCT00706654|64211818|FG001|Conversion Phase|Withdrawn by Investigator|0|||
23126090|NCT00706654|64211819|FG002|Conversion Phase|Withdrawn by Investigator|0|||
23126091|NCT00706654|64211820|FG003|Conversion Phase|Withdrawn by Investigator|0|||
23126092|NCT00706654|64211817|FG000|Conversion Phase|Withdrew Consent|38|||
23126093|NCT00706654|64211818|FG001|Conversion Phase|Withdrew Consent|0|||
23126094|NCT00706654|64211819|FG002|Conversion Phase|Withdrew Consent|0|||
23126095|NCT00706654|64211820|FG003|Conversion Phase|Withdrew Consent|0|||
23544578|NCT02627677|65723113|FG000|Overall Study|Reason not Specified|0|||
23126096|NCT00706654|64211817|FG000|Conversion Phase|Adverse Event|18|||
23126097|NCT00706654|64211818|FG001|Conversion Phase|Adverse Event|0|||
23126098|NCT00706654|64211819|FG002|Conversion Phase|Adverse Event|0|||
23126099|NCT00706654|64211820|FG003|Conversion Phase|Adverse Event|0|||
23544579|NCT02627677|65723114|FG001|Overall Study|Reason not Specified|0|||
23544580|NCT02627677|65723115|FG002|Overall Study|Reason not Specified|1|||
23544581|NCT02627677|65723113|FG000|Overall Study|Randomized but not Treated|1|||
23126100|NCT00706654|64211817|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
23126101|NCT00706654|64211818|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23544582|NCT02627677|65723114|FG001|Overall Study|Randomized but not Treated|0|||
23544583|NCT02627677|65723115|FG002|Overall Study|Randomized but not Treated|0|||
23544584|NCT00305058|65723121|FG000|Overall Study|Participant too young|1|||
23544585|NCT00305058|65723122|FG001|Overall Study|Participant too young|0|||
23544586|NCT00305058|65723121|FG000|Overall Study|Missing data collection instrument|3|||
23544587|NCT00305058|65723122|FG001|Overall Study|Missing data collection instrument|2|||
23544588|NCT00305058|65723121|FG000|Overall Study|Missing outcome data|3|||
23544589|NCT00305058|65723122|FG001|Overall Study|Missing outcome data|2|||
23126102|NCT00706654|64211819|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23126103|NCT00706654|64211820|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23126104|NCT00706654|64211817|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
23544590|NCT02519504|65723123|FG000|Overall Study|Protocol Violation|6|||
23544591|NCT02519504|65723124|FG001|Overall Study|Protocol Violation|5|||
23126105|NCT00706654|64211818|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23544592|NCT02519504|65723123|FG000|Overall Study|Ineligible for direct testing|12|||
23544593|NCT02519504|65723124|FG001|Overall Study|Ineligible for direct testing|12|||
23544594|NCT02519504|65723123|FG000|Overall Study|Did not participate in direct testing|95|||
23544595|NCT02519504|65723124|FG001|Overall Study|Did not participate in direct testing|86|||
23544596|NCT02617589|65723125|FG000|Randomization|Request to Discontinue Study Treatment|1|||
23544597|NCT02617589|65723126|FG001|Randomization|Request to Discontinue Study Treatment|3|||
23544598|NCT02617589|65723125|FG000|Randomization|Participant Withdrew Consent|1|||
23544599|NCT02617589|65723126|FG001|Randomization|Participant Withdrew Consent|2|||
23544600|NCT02617589|65723125|FG000|Treatment|Other Reasons|3|||
23544601|NCT02617589|65723126|FG001|Treatment|Other Reasons|3|||
23544602|NCT02617589|65723125|FG000|Treatment|Poor/Non Compliance|1|||
23544603|NCT02617589|65723126|FG001|Treatment|Poor/Non Compliance|1|||
23544604|NCT02617589|65723125|FG000|Treatment|Maximum Clinical Benefit|0|||
23544605|NCT02617589|65723126|FG001|Treatment|Maximum Clinical Benefit|2|||
23544606|NCT02617589|65723125|FG000|Treatment|Participant Withdrew Consent|2|||
23544607|NCT02617589|65723126|FG001|Treatment|Participant Withdrew Consent|6|||
23544608|NCT02617589|65723125|FG000|Treatment|Participant Request to Discontinue|12|||
23544609|NCT02617589|65723126|FG001|Treatment|Participant Request to Discontinue|21|||
23544610|NCT02617589|65723125|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
23544611|NCT02617589|65723126|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
23544612|NCT02617589|65723125|FG000|Treatment|Death|1|||
23544613|NCT02617589|65723126|FG001|Treatment|Death|1|||
23544614|NCT02617589|65723125|FG000|Treatment|Study Drug Toxicity|27|||
23544615|NCT02617589|65723126|FG001|Treatment|Study Drug Toxicity|20|||
23544616|NCT02617589|65723125|FG000|Treatment|Disease Progression|216|||
23544617|NCT02617589|65723126|FG001|Treatment|Disease Progression|136|||
23544618|NCT03034577|65723127|FG000|Overall Study|Withdrawal by Subject|6|||
23544619|NCT03034577|65723128|FG001|Overall Study|Withdrawal by Subject|9|||
23544620|NCT03034577|65723127|FG000|Overall Study|Lost to Follow-up|25|||
23544621|NCT03034577|65723128|FG001|Overall Study|Lost to Follow-up|26|||
23544622|NCT01985126|65723131|FG000|Overall Study|Death|15|||
23126106|NCT00706654|64211819|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23126107|NCT00706654|64211820|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23211958|NCT01830816|64516273|FG002|Overall Study|Lost to Follow-up|0|||
23211959|NCT01830816|64516271|FG000|Overall Study|Symptomatic Deterioration|1|||
23211960|NCT01830816|64516272|FG001|Overall Study|Symptomatic Deterioration|0|||
23211961|NCT01830816|64516273|FG002|Overall Study|Symptomatic Deterioration|0|||
23211962|NCT01830816|64516271|FG000|Overall Study|Reason not Specified|2|||
23211963|NCT01830816|64516272|FG001|Overall Study|Reason not Specified|0|||
23544623|NCT01985126|65723132|FG001|Overall Study|Death|69|||
23544624|NCT01985126|65723131|FG000|Overall Study|Lost to Follow-up|0|||
23544625|NCT01985126|65723132|FG001|Overall Study|Lost to Follow-up|8|||
23544626|NCT01985126|65723131|FG000|Overall Study|Study Terminated By Sponsor|1|||
23126108|NCT00706654|64211817|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
23544627|NCT01985126|65723132|FG001|Overall Study|Study Terminated By Sponsor|22|||
23544628|NCT01985126|65723131|FG000|Overall Study|Withdrawal by Subject|2|||
23544629|NCT01985126|65723132|FG001|Overall Study|Withdrawal by Subject|7|||
23544630|NCT03646513|65723136|FG000|Overall Study|Premature study termination|4|||
23544631|NCT02504294|65723137|FG000|Overall Study|Adverse Event|15|||
23544632|NCT02504294|65723138|FG001|Overall Study|Adverse Event|12|||
23544633|NCT02504294|65723137|FG000|Overall Study|Withdrawal by Subject|7|||
23544634|NCT02504294|65723138|FG001|Overall Study|Withdrawal by Subject|1|||
23544635|NCT02504294|65723137|FG000|Overall Study|Protocol Violation|27|||
23544636|NCT02504294|65723138|FG001|Overall Study|Protocol Violation|26|||
23544637|NCT02504294|65723137|FG000|Overall Study|Physician Decision|1|||
23544638|NCT02504294|65723138|FG001|Overall Study|Physician Decision|2|||
23544639|NCT02504294|65723137|FG000|Overall Study|Lost to Follow-up|6|||
23544640|NCT02504294|65723138|FG001|Overall Study|Lost to Follow-up|7|||
23544641|NCT01660906|65723139|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
23544642|NCT00407537|65723143|FG000|Overall Study|Death|5|||
23126109|NCT00706654|64211818|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
23126110|NCT00706654|64211819|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
23126111|NCT00706654|64211820|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
23126112|NCT00706654|64211817|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
23126113|NCT00706654|64211818|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
23126114|NCT00706654|64211819|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
23126115|NCT00706654|64211820|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
23126116|NCT00706654|64211817|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
23126117|NCT00706654|64211818|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23126118|NCT00706654|64211819|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23126119|NCT00706654|64211820|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23211964|NCT01830816|64516273|FG002|Overall Study|Reason not Specified|0|||
23211965|NCT03833817|64516274|FG000|Overall Study|Withdrawal by Subject|3|||
23315324|NCT02027428|64895593|FG002|Induction|Withdrawal by Subject|0|||
23544643|NCT00407537|65723144|FG001|Overall Study|Death|2|||
23544644|NCT00407537|65723143|FG000|Overall Study|Adverse Event|36|||
23544645|NCT00407537|65723144|FG001|Overall Study|Adverse Event|0|||
23315325|NCT02027428|64895591|FG000|Induction|Death|21|||
23544646|NCT00407537|65723143|FG000|Overall Study|Lost to Follow-up|12|||
23544647|NCT00407537|65723144|FG001|Overall Study|Lost to Follow-up|19|||
23544648|NCT00407537|65723143|FG000|Overall Study|Other|6|||
23544649|NCT00407537|65723144|FG001|Overall Study|Other|7|||
23544650|NCT00407537|65723143|FG000|Overall Study|Withdrawal by Subject|34|||
23126120|NCT00706654|64211817|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
23126121|NCT00706654|64211818|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23126122|NCT00706654|64211819|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23126123|NCT00706654|64211820|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23126124|NCT00706654|64211817|FG000|Oral Stabilization Phase|Withdrew consent|55|||
23126125|NCT00706654|64211818|FG001|Oral Stabilization Phase|Withdrew consent|0|||
23126126|NCT00706654|64211819|FG002|Oral Stabilization Phase|Withdrew consent|0|||
23126127|NCT00706654|64211820|FG003|Oral Stabilization Phase|Withdrew consent|0|||
23544651|NCT00407537|65723144|FG001|Overall Study|Withdrawal by Subject|16|||
23126128|NCT00706654|64211817|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
23315326|NCT02027428|64895592|FG001|Induction|Death|0|||
23315327|NCT02027428|64895593|FG002|Induction|Death|0|||
23544652|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
23126129|NCT00706654|64211818|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
23315328|NCT02027428|64895591|FG000|Induction|Symptomatic deterioration|16|||
23315329|NCT02027428|64895592|FG001|Induction|Symptomatic deterioration|0|||
23315330|NCT02027428|64895593|FG002|Induction|Symptomatic deterioration|0|||
23315331|NCT02027428|64895591|FG000|Induction|Study terminated by sponsor|12|||
23315332|NCT02027428|64895592|FG001|Induction|Study terminated by sponsor|0|||
23315333|NCT02027428|64895593|FG002|Induction|Study terminated by sponsor|0|||
23315334|NCT02027428|64895591|FG000|Induction|Protocol Violation|1|||
23315335|NCT02027428|64895592|FG001|Induction|Protocol Violation|0|||
23315336|NCT02027428|64895593|FG002|Induction|Protocol Violation|0|||
23315337|NCT02027428|64895591|FG000|Induction|Miscellaneous|14|||
23315338|NCT02027428|64895592|FG001|Induction|Miscellaneous|0|||
23315339|NCT02027428|64895593|FG002|Induction|Miscellaneous|0|||
23315340|NCT02027428|64895591|FG000|Induction|Induction Treatment Ongoing|4|||
23544653|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
23544654|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
23544655|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
23544656|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
23544657|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
23544658|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
23544659|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
23544660|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
23544661|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
23544662|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
23544663|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
23315341|NCT02027428|64895592|FG001|Induction|Induction Treatment Ongoing|0|||
23315342|NCT02027428|64895593|FG002|Induction|Induction Treatment Ongoing|0|||
23315343|NCT02027428|64895591|FG000|Maintenance|Death|0|||
23315344|NCT02027428|64895592|FG001|Maintenance|Death|3|||
23315345|NCT02027428|64895593|FG002|Maintenance|Death|2|||
23315346|NCT02027428|64895591|FG000|Maintenance|Adverse Event|0|||
23315347|NCT02027428|64895592|FG001|Maintenance|Adverse Event|21|||
23315348|NCT02027428|64895593|FG002|Maintenance|Adverse Event|1|||
23315349|NCT02027428|64895591|FG000|Maintenance|Progressive disease|0|||
23315350|NCT02027428|64895592|FG001|Maintenance|Progressive disease|84|||
23315351|NCT02027428|64895593|FG002|Maintenance|Progressive disease|47|||
23315352|NCT02027428|64895591|FG000|Maintenance|Symptomatic deterioration|0|||
23315353|NCT02027428|64895592|FG001|Maintenance|Symptomatic deterioration|4|||
23315354|NCT02027428|64895593|FG002|Maintenance|Symptomatic deterioration|1|||
23315355|NCT02027428|64895591|FG000|Maintenance|Withdrawal by Subject|0|||
23315356|NCT02027428|64895592|FG001|Maintenance|Withdrawal by Subject|6|||
23315357|NCT02027428|64895593|FG002|Maintenance|Withdrawal by Subject|5|||
23315358|NCT02027428|64895591|FG000|Maintenance|Protocol Violation|0|||
23315359|NCT02027428|64895592|FG001|Maintenance|Protocol Violation|0|||
23315360|NCT02027428|64895593|FG002|Maintenance|Protocol Violation|1|||
23315361|NCT02027428|64895591|FG000|Maintenance|Other|0|||
23315362|NCT02027428|64895592|FG001|Maintenance|Other|6|||
23315363|NCT02027428|64895593|FG002|Maintenance|Other|3|||
23315364|NCT02027428|64895591|FG000|Survival Follow-up|Death|0|||
23315365|NCT02027428|64895592|FG001|Survival Follow-up|Death|78|||
23315366|NCT02027428|64895593|FG002|Survival Follow-up|Death|45|||
23315367|NCT02027428|64895591|FG000|Survival Follow-up|Lost to Follow-up|0|||
23315368|NCT02027428|64895592|FG001|Survival Follow-up|Lost to Follow-up|1|||
23315369|NCT02027428|64895593|FG002|Survival Follow-up|Lost to Follow-up|1|||
23126130|NCT00706654|64211819|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
23315370|NCT03203850|64898968|FG000|Overall Study|Subject/guardian decision|4|||
23315371|NCT03203850|64898969|FG001|Overall Study|Subject/guardian decision|3|||
23315372|NCT03203850|64898968|FG000|Overall Study|Adverse Event|3|||
23315373|NCT03203850|64898969|FG001|Overall Study|Adverse Event|0|||
23315374|NCT03203850|64898968|FG000|Overall Study|Death|1|||
23315375|NCT03203850|64898969|FG001|Overall Study|Death|0|||
23315376|NCT02289729|64898970|FG000|Overall Study|Lack of Efficacy|3|||
23315377|NCT02289729|64898970|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
23315378|NCT02289729|64898970|FG000|Overall Study|Withdrawal by Subject|1|||
23544664|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
23544665|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
23544666|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
23126131|NCT00706654|64211820|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
23126132|NCT00706654|64211817|FG000|Oral Stabilization Phase|Adverse Event|21|||
23126133|NCT00706654|64211818|FG001|Oral Stabilization Phase|Adverse Event|0|||
23126134|NCT00706654|64211819|FG002|Oral Stabilization Phase|Adverse Event|0|||
23126135|NCT00706654|64211820|FG003|Oral Stabilization Phase|Adverse Event|0|||
23126136|NCT00706654|64211817|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
23126137|NCT00706654|64211818|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23126138|NCT00706654|64211819|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23126139|NCT00706654|64211820|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23126140|NCT00706654|64211817|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
23126141|NCT00706654|64211818|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23126142|NCT00706654|64211819|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23126143|NCT00706654|64211820|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23126144|NCT00706654|64211817|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
23126145|NCT00706654|64211818|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
23126146|NCT00706654|64211819|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
23126147|NCT00706654|64211820|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
23126148|NCT00706654|64211817|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
23126149|NCT00706654|64211818|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
23126150|NCT00706654|64211819|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
23126151|NCT00706654|64211820|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
23126152|NCT00706654|64211817|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
23544667|NCT00355082|65723145|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
23544668|NCT00355082|65723146|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
23544669|NCT00355082|65723147|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
23544670|NCT00355082|65723145|FG000|Continuation Phase|Adverse Event|2|||
23126153|NCT00706654|64211818|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
23544671|NCT00355082|65723146|FG001|Continuation Phase|Adverse Event|0|||
23544672|NCT00355082|65723147|FG002|Continuation Phase|Adverse Event|1|||
23544673|NCT00355082|65723145|FG000|Continuation Phase|Lost to Follow-up|2|||
23544674|NCT00355082|65723146|FG001|Continuation Phase|Lost to Follow-up|0|||
23544675|NCT00355082|65723147|FG002|Continuation Phase|Lost to Follow-up|1|||
23544676|NCT00355082|65723145|FG000|Continuation Phase|Protocol Violation|1|||
23544677|NCT00355082|65723146|FG001|Continuation Phase|Protocol Violation|0|||
23315379|NCT02289729|64898970|FG000|Overall Study|Death|1|||
23315380|NCT02754856|64898971|FG000|Overall Study|Withdrawal by Subject|1|||
23544678|NCT00355082|65723147|FG002|Continuation Phase|Protocol Violation|1|||
23315381|NCT00005957|64898974|FG000|Overall Study|No treated|3|||
23544679|NCT00355082|65723145|FG000|Continuation Phase|Withdrawal by Subject|4|||
23126154|NCT00706654|64211819|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
23126155|NCT00706654|64211820|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
23126156|NCT00706654|64211817|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
23126157|NCT00706654|64211818|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
23126158|NCT00706654|64211819|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
23126159|NCT00706654|64211820|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
23126160|NCT00706654|64211817|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
23126161|NCT00706654|64211818|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
23126162|NCT00706654|64211819|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
23126163|NCT00706654|64211820|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
23126164|NCT00706654|64211817|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
23126165|NCT00706654|64211818|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
23126166|NCT00706654|64211819|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
23126167|NCT00706654|64211820|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
23126168|NCT00706654|64211817|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
23126169|NCT00706654|64211818|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
23126170|NCT00706654|64211819|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
23126171|NCT00706654|64211820|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
23126172|NCT00706654|64211817|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
23315382|NCT00005957|64898975|FG001|Overall Study|No treated|9|||
23315383|NCT00005957|64898974|FG000|Overall Study|Crossover to the other arm|5|||
23315384|NCT00005957|64898975|FG001|Overall Study|Crossover to the other arm|19|||
23315385|NCT03106987|64898987|FG000|Overall Study|Death|37|||
23126173|NCT00706654|64211818|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
23126174|NCT00706654|64211819|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
23126175|NCT00706654|64211820|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
23315386|NCT03106987|64898988|FG001|Overall Study|Death|22|||
23544680|NCT00355082|65723146|FG001|Continuation Phase|Withdrawal by Subject|0|||
23126176|NCT03809039|64211821|FG000|Part 1|Withdrawal by Subject|1|||
23126177|NCT03809039|64211822|FG001|Part 1|Withdrawal by Subject|0|||
23126178|NCT03809039|64211823|FG002|Part 1|Withdrawal by Subject|0|||
23126179|NCT03809039|64211824|FG003|Part 1|Withdrawal by Subject|1|||
23544681|NCT00355082|65723147|FG002|Continuation Phase|Withdrawal by Subject|0|||
23544682|NCT00355082|65723145|FG000|Continuation Phase|Lack of Efficacy|5|||
23544683|NCT00355082|65723146|FG001|Continuation Phase|Lack of Efficacy|0|||
23544684|NCT00355082|65723147|FG002|Continuation Phase|Lack of Efficacy|0|||
23544685|NCT00355082|65723145|FG000|Continuation Phase|Site Closed by Sponsor|8|||
23544686|NCT00355082|65723146|FG001|Continuation Phase|Site Closed by Sponsor|0|||
23126180|NCT03809039|64211825|FG004|Part 1|Withdrawal by Subject|0|||
23126181|NCT03809039|64211826|FG005|Part 1|Withdrawal by Subject|0|||
23126182|NCT03809039|64211827|FG006|Part 1|Withdrawal by Subject|0|||
23126183|NCT03809039|64211828|FG007|Part 1|Withdrawal by Subject|0|||
23126184|NCT03809039|64211829|FG008|Part 1|Withdrawal by Subject|0|||
23126185|NCT03809039|64211821|FG000|Part 3|Withdrawn by study termination|0|||
23126186|NCT03809039|64211822|FG001|Part 3|Withdrawn by study termination|0|||
23126187|NCT03809039|64211823|FG002|Part 3|Withdrawn by study termination|0|||
23126188|NCT03809039|64211824|FG003|Part 3|Withdrawn by study termination|0|||
23126189|NCT03809039|64211825|FG004|Part 3|Withdrawn by study termination|0|||
23126190|NCT03809039|64211826|FG005|Part 3|Withdrawn by study termination|0|||
23126191|NCT03809039|64211827|FG006|Part 3|Withdrawn by study termination|0|||
23126192|NCT03809039|64211828|FG007|Part 3|Withdrawn by study termination|2|||
23126193|NCT03809039|64211829|FG008|Part 3|Withdrawn by study termination|6|||
23126194|NCT00513708|64211835|FG000|Overall Study|Lost to Follow-up|4|||
23126195|NCT00513708|64211836|FG001|Overall Study|Lost to Follow-up|4|||
23126196|NCT00513708|64211837|FG002|Overall Study|Lost to Follow-up|4|||
23126197|NCT02035696|64211838|FG000|Overall Study|Lost to Follow-up|0|||
23126198|NCT02035696|64211839|FG001|Overall Study|Lost to Follow-up|3|||
23126199|NCT02035696|64211840|FG002|Overall Study|Lost to Follow-up|1|||
23544687|NCT00355082|65723147|FG002|Continuation Phase|Site Closed by Sponsor|0|||
23544688|NCT00355082|65723145|FG000|Continuation Phase|Scheduling Error|1|||
23544689|NCT00355082|65723146|FG001|Continuation Phase|Scheduling Error|0|||
23544690|NCT00355082|65723147|FG002|Continuation Phase|Scheduling Error|0|||
23544691|NCT00355082|65723145|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
23544692|NCT00355082|65723146|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
23544693|NCT00355082|65723147|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
23544694|NCT02707055|65723149|FG000|Phase 1|Withdrawal by Subject|1|||
23544695|NCT02707055|65723150|FG001|Phase 1|Withdrawal by Subject|2|||
23544696|NCT02707055|65723149|FG000|Phase 1|Physician Decision|0|||
23544697|NCT02707055|65723150|FG001|Phase 1|Physician Decision|1|||
23126200|NCT02035696|64211841|FG003|Overall Study|Lost to Follow-up|2|||
23126201|NCT02035696|64211838|FG000|Overall Study|Withdrawal by Subject|3|||
23126202|NCT02035696|64211839|FG001|Overall Study|Withdrawal by Subject|0|||
23126203|NCT02035696|64211840|FG002|Overall Study|Withdrawal by Subject|2|||
23126204|NCT02035696|64211841|FG003|Overall Study|Withdrawal by Subject|1|||
23126205|NCT02370251|64211842|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
23126206|NCT02370251|64211842|FG000|Overall Study|Death|4|||
23126207|NCT01439867|64211843|FG000|Overall Study|Non-compliance|0|||
23126208|NCT01439867|64211844|FG001|Overall Study|Non-compliance|1|||
23126209|NCT01439867|64211843|FG000|Overall Study|Withdrawal by Subject|1|||
23126210|NCT01439867|64211844|FG001|Overall Study|Withdrawal by Subject|2|||
23126211|NCT01439867|64211843|FG000|Overall Study|Administrative Decision|4|||
23126212|NCT01439867|64211844|FG001|Overall Study|Administrative Decision|5|||
23126213|NCT01439867|64211843|FG000|Overall Study|Protocol-specified Criteria|1|||
23126214|NCT01439867|64211844|FG001|Overall Study|Protocol-specified Criteria|0|||
23126215|NCT00340704|64211845|FG000|PK Study|Adverse Event|0|||
23126216|NCT00340704|64211846|FG001|PK Study|Adverse Event|1|||
23126217|NCT00340704|64211847|FG002|PK Study|Adverse Event|0|||
23126218|NCT00340704|64211848|FG003|PK Study|Adverse Event|0|||
23126219|NCT00340704|64211849|FG004|PK Study|Adverse Event|0|||
23126220|NCT00340704|64211850|FG005|PK Study|Adverse Event|0|||
23126221|NCT00340704|64211851|FG006|PK Study|Adverse Event|0|||
23126222|NCT00340704|64211852|FG007|PK Study|Adverse Event|0|||
23126223|NCT00340704|64211853|FG008|PK Study|Adverse Event|0|||
23126224|NCT00340704|64211845|FG000|PK Study|Not treated|0|||
23126225|NCT00340704|64211846|FG001|PK Study|Not treated|0|||
23544698|NCT02707055|65723149|FG000|Phase 2|Adverse Event|1|||
23126226|NCT00340704|64211847|FG002|PK Study|Not treated|1|||
23126227|NCT00340704|64211848|FG003|PK Study|Not treated|0|||
23126228|NCT00340704|64211849|FG004|PK Study|Not treated|0|||
23544699|NCT02707055|65723150|FG001|Phase 2|Adverse Event|2|||
23544700|NCT03067441|65723151|FG000|Overall Study|Withdrawal by Subject|16|||
23544701|NCT03067441|65723152|FG001|Overall Study|Withdrawal by Subject|34|||
23126229|NCT00340704|64211850|FG005|PK Study|Not treated|0|||
23126230|NCT00340704|64211851|FG006|PK Study|Not treated|0|||
23126231|NCT00340704|64211852|FG007|PK Study|Not treated|0|||
23126232|NCT00340704|64211853|FG008|PK Study|Not treated|0|||
23126233|NCT00340704|64211845|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23126234|NCT00340704|64211846|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23126235|NCT00340704|64211847|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23126236|NCT00340704|64211848|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
23126237|NCT00340704|64211849|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
23126238|NCT00340704|64211850|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23126239|NCT00340704|64211851|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
23126240|NCT00340704|64211852|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
23126241|NCT00340704|64211853|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
23126242|NCT00340704|64211845|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23126243|NCT00340704|64211846|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23126244|NCT00340704|64211847|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23126245|NCT00340704|64211848|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23126246|NCT00340704|64211849|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23126247|NCT00340704|64211850|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
23126248|NCT00340704|64211851|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23126249|NCT00340704|64211852|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23126250|NCT00340704|64211853|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
23126251|NCT00340704|64211845|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23126252|NCT00340704|64211846|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23126253|NCT00340704|64211847|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23126254|NCT00340704|64211848|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23126255|NCT00340704|64211849|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
23126256|NCT00340704|64211850|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
23126257|NCT00340704|64211851|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23126258|NCT00340704|64211852|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23126259|NCT00340704|64211853|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
23126260|NCT00340704|64211845|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23126261|NCT00340704|64211846|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23126262|NCT00340704|64211847|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23126263|NCT00340704|64211848|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23126264|NCT00340704|64211849|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
23126265|NCT00340704|64211850|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
23126266|NCT00340704|64211851|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
23126267|NCT00340704|64211852|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
23126268|NCT00340704|64211853|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
23126269|NCT03392168|64211854|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
23126270|NCT03392168|64211855|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
23126271|NCT03392168|64211856|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
23126272|NCT03392168|64211857|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
23126273|NCT03392168|64211854|FG000|Period 2: Cohort 2|Other|0|||
23126274|NCT03392168|64211855|FG001|Period 2: Cohort 2|Other|1|||
23126275|NCT03392168|64211856|FG002|Period 2: Cohort 2|Other|0|||
23315387|NCT03106987|64898989|FG002|Overall Study|Death|12|||
23315388|NCT03106987|64898990|FG003|Overall Study|Death|8|||
23315389|NCT03106987|64898987|FG000|Overall Study|Lost to Follow-up|2|||
23315390|NCT03106987|64898988|FG001|Overall Study|Lost to Follow-up|0|||
23315391|NCT03106987|64898989|FG002|Overall Study|Lost to Follow-up|2|||
23315392|NCT03106987|64898990|FG003|Overall Study|Lost to Follow-up|2|||
23315393|NCT03106987|64898987|FG000|Overall Study|Withdrawal by Subject|5|||
23315394|NCT03106987|64898988|FG001|Overall Study|Withdrawal by Subject|1|||
23315395|NCT03106987|64898989|FG002|Overall Study|Withdrawal by Subject|4|||
23426192|NCT00900146|65303551|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
23126276|NCT03392168|64211857|FG003|Period 2: Cohort 2|Other|0|||
23126277|NCT01999972|64211861|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
23126278|NCT01999972|64211862|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
23126279|NCT01999972|64211863|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
23126280|NCT01999972|64211864|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
23126281|NCT01999972|64211865|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
23126282|NCT01999972|64211866|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
23126283|NCT01999972|64211861|FG000|Dose Escalation Part|Death|0|||
23426193|NCT00900146|65303552|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
23126284|NCT01999972|64211862|FG001|Dose Escalation Part|Death|1|||
23126285|NCT01999972|64211863|FG002|Dose Escalation Part|Death|0|||
23126286|NCT01999972|64211864|FG003|Dose Escalation Part|Death|0|||
23315396|NCT03106987|64898990|FG003|Overall Study|Withdrawal by Subject|1|||
23426194|NCT00900146|65303553|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
23426195|NCT00900146|65303554|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
23126287|NCT01999972|64211865|FG004|Dose Escalation Part|Death|0|||
23126288|NCT01999972|64211866|FG005|Dose Escalation Part|Death|0|||
23126289|NCT01999972|64211861|FG000|Dose Escalation Part|Enrolled but not treated|0|||
23126290|NCT01999972|64211862|FG001|Dose Escalation Part|Enrolled but not treated|0|||
23315397|NCT00281957|64898993|FG000|Overall Study|Adverse Event|7|||
23315398|NCT00281957|64898994|FG001|Overall Study|Adverse Event|2|||
23315399|NCT00281957|64898993|FG000|Overall Study|Death|1|||
23315400|NCT00281957|64898994|FG001|Overall Study|Death|0|||
23315401|NCT00281957|64898993|FG000|Overall Study|Progression/relapse|47|||
23315402|NCT00281957|64898994|FG001|Overall Study|Progression/relapse|35|||
23315403|NCT00281957|64898993|FG000|Overall Study|Not protocol specified|8|||
23315404|NCT00281957|64898994|FG001|Overall Study|Not protocol specified|1|||
23315405|NCT00281957|64898993|FG000|Overall Study|Not eligible|1|||
23315406|NCT00281957|64898994|FG001|Overall Study|Not eligible|2|||
23315407|NCT00281957|64898993|FG000|Overall Study|Did not start treatment|3|||
23315408|NCT00281957|64898994|FG001|Overall Study|Did not start treatment|1|||
23315409|NCT00281957|64898993|FG000|Overall Study|Refusal unrelated to adverse events|0|||
23315410|NCT00281957|64898994|FG001|Overall Study|Refusal unrelated to adverse events|1|||
23315411|NCT01111825|64898997|FG000|Overall Study|Withdrawal by Subject|0|||
23315412|NCT01111825|64898998|FG001|Overall Study|Withdrawal by Subject|0|||
23315413|NCT01111825|64898999|FG002|Overall Study|Withdrawal by Subject|1|||
23315414|NCT01111825|64899000|FG003|Overall Study|Withdrawal by Subject|0|||
23315415|NCT01111825|64898997|FG000|Overall Study|Lost to Follow-up|0|||
23315416|NCT01111825|64898998|FG001|Overall Study|Lost to Follow-up|0|||
23315417|NCT01111825|64898999|FG002|Overall Study|Lost to Follow-up|3|||
23315418|NCT01111825|64899000|FG003|Overall Study|Lost to Follow-up|1|||
23315419|NCT01111825|64898997|FG000|Overall Study|Adverse Event|2|||
23315420|NCT01111825|64898998|FG001|Overall Study|Adverse Event|1|||
23315421|NCT01111825|64898999|FG002|Overall Study|Adverse Event|4|||
23315422|NCT01111825|64899000|FG003|Overall Study|Adverse Event|0|||
23315423|NCT01111825|64898997|FG000|Overall Study|Disease Progression|1|||
23315424|NCT01111825|64898998|FG001|Overall Study|Disease Progression|0|||
23315425|NCT01111825|64898999|FG002|Overall Study|Disease Progression|0|||
23315426|NCT01111825|64899000|FG003|Overall Study|Disease Progression|0|||
23315427|NCT01111825|64898997|FG000|Overall Study|Discontinuation by Sponsor|0|||
23315428|NCT01111825|64898998|FG001|Overall Study|Discontinuation by Sponsor|0|||
23315429|NCT01111825|64898999|FG002|Overall Study|Discontinuation by Sponsor|0|||
23315430|NCT01111825|64899000|FG003|Overall Study|Discontinuation by Sponsor|20|||
23315431|NCT02276807|64899001|FG000|Overall Study|Withdrawal by Subject|8|||
23315432|NCT02276807|64899002|FG001|Overall Study|Withdrawal by Subject|7|||
23315433|NCT02276807|64899001|FG000|Overall Study|Lost to Follow-up|10|||
23315434|NCT02276807|64899002|FG001|Overall Study|Lost to Follow-up|10|||
23315435|NCT02252406|64899006|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
23315436|NCT02252406|64899007|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
23315437|NCT02252406|64899006|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
23315438|NCT02252406|64899007|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
23315439|NCT02252406|64899006|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
23315440|NCT02252406|64899007|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
23315441|NCT02252406|64899006|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
23315442|NCT02252406|64899007|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
23315443|NCT02252406|64899006|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
23544702|NCT03067441|65723151|FG000|Overall Study|Lost to Follow-up|7|||
23544703|NCT03067441|65723152|FG001|Overall Study|Lost to Follow-up|5|||
23126291|NCT01999972|64211863|FG002|Dose Escalation Part|Enrolled but not treated|1|||
23126292|NCT01999972|64211864|FG003|Dose Escalation Part|Enrolled but not treated|1|||
23126293|NCT01999972|64211865|FG004|Dose Escalation Part|Enrolled but not treated|0|||
23126294|NCT01999972|64211866|FG005|Dose Escalation Part|Enrolled but not treated|0|||
23126295|NCT01999972|64211861|FG000|Dose Escalation Part|Disease progression|3|||
23126296|NCT01999972|64211862|FG001|Dose Escalation Part|Disease progression|2|||
23126297|NCT01999972|64211863|FG002|Dose Escalation Part|Disease progression|3|||
23126298|NCT01999972|64211864|FG003|Dose Escalation Part|Disease progression|6|||
23126299|NCT01999972|64211865|FG004|Dose Escalation Part|Disease progression|0|||
23126300|NCT01999972|64211866|FG005|Dose Escalation Part|Disease progression|0|||
23126301|NCT01999972|64211861|FG000|Dose Escalation Part|Adverse Event|0|||
23126302|NCT01999972|64211862|FG001|Dose Escalation Part|Adverse Event|0|||
23126303|NCT01999972|64211863|FG002|Dose Escalation Part|Adverse Event|0|||
23126304|NCT01999972|64211864|FG003|Dose Escalation Part|Adverse Event|2|||
23126305|NCT01999972|64211865|FG004|Dose Escalation Part|Adverse Event|0|||
23315444|NCT02252406|64899007|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
23126306|NCT01999972|64211866|FG005|Dose Escalation Part|Adverse Event|0|||
23315445|NCT04646005|64899008|FG000|Overall Study|Adverse Event|1|||
23315446|NCT04646005|64899008|FG000|Overall Study|Progressive Disease|60|||
23315447|NCT04646005|64899008|FG000|Overall Study|Death|19|||
23544704|NCT03067441|65723151|FG000|Overall Study|Adverse Event|7|||
23315448|NCT04646005|64899008|FG000|Overall Study|Withdrawal by Subject|9|||
23126307|NCT01999972|64211861|FG000|Dose Escalation Part|Global deterioration of health status|1|||
23315449|NCT04646005|64899008|FG000|Overall Study|Study Ongoing|24|||
23315450|NCT01121562|64899011|FG000|Overall Study|Objective progression or relapse|8|||
23315451|NCT01121562|64899011|FG000|Overall Study|Withdrawal by Subject|1|||
23315452|NCT01121562|64899011|FG000|Overall Study|Adverse Event|1|||
23315453|NCT01121562|64899011|FG000|Overall Study|Sponsor Decision|1|||
23315454|NCT01121562|64899011|FG000|Overall Study|Met study discontinuation criteria|1|||
23315455|NCT00000620|64899014|FG000|Overall Study|Death|86|||
23315456|NCT00000620|64899015|FG001|Overall Study|Death|67|||
23315457|NCT00000620|64899016|FG002|Overall Study|Death|112|||
23315458|NCT00000620|64899017|FG003|Overall Study|Death|126|||
23315459|NCT00000620|64899018|FG004|Overall Study|Death|64|||
23315460|NCT00000620|64899019|FG005|Overall Study|Death|77|||
23315461|NCT00000620|64899020|FG006|Overall Study|Death|91|||
23315462|NCT00000620|64899021|FG007|Overall Study|Death|95|||
23315463|NCT00000620|64899014|FG000|Overall Study|Lost to Follow-up|14|||
23315464|NCT00000620|64899015|FG001|Overall Study|Lost to Follow-up|14|||
23315465|NCT00000620|64899016|FG002|Overall Study|Lost to Follow-up|14|||
23315466|NCT00000620|64899017|FG003|Overall Study|Lost to Follow-up|14|||
23315467|NCT00000620|64899018|FG004|Overall Study|Lost to Follow-up|15|||
23315468|NCT00000620|64899019|FG005|Overall Study|Lost to Follow-up|15|||
23315469|NCT00000620|64899020|FG006|Overall Study|Lost to Follow-up|13|||
23315470|NCT00000620|64899021|FG007|Overall Study|Lost to Follow-up|14|||
23315471|NCT00000620|64899014|FG000|Overall Study|Withdrawal by Subject|40|||
23315472|NCT00000620|64899015|FG001|Overall Study|Withdrawal by Subject|27|||
23315473|NCT00000620|64899016|FG002|Overall Study|Withdrawal by Subject|28|||
23315474|NCT00000620|64899017|FG003|Overall Study|Withdrawal by Subject|27|||
23315475|NCT00000620|64899018|FG004|Overall Study|Withdrawal by Subject|30|||
23315476|NCT00000620|64899019|FG005|Overall Study|Withdrawal by Subject|32|||
23315477|NCT00000620|64899020|FG006|Overall Study|Withdrawal by Subject|32|||
23315478|NCT00000620|64899021|FG007|Overall Study|Withdrawal by Subject|21|||
23315479|NCT00000620|64899014|FG000|Overall Study|missed closeout visit|22|||
23315480|NCT00000620|64899015|FG001|Overall Study|missed closeout visit|28|||
23315481|NCT00000620|64899016|FG002|Overall Study|missed closeout visit|16|||
23315482|NCT00000620|64899017|FG003|Overall Study|missed closeout visit|11|||
23315483|NCT00000620|64899018|FG004|Overall Study|missed closeout visit|26|||
23315484|NCT00000620|64899019|FG005|Overall Study|missed closeout visit|28|||
23315485|NCT00000620|64899020|FG006|Overall Study|missed closeout visit|13|||
23315486|NCT00000620|64899021|FG007|Overall Study|missed closeout visit|16|||
23315487|NCT01908907|64899022|FG000|Overall Study|Physician Decision|1|||
23315488|NCT01908907|64899023|FG001|Overall Study|Physician Decision|0|||
23315489|NCT01908907|64899022|FG000|Overall Study|Protocol Violation|1|||
23126308|NCT01999972|64211862|FG001|Dose Escalation Part|Global deterioration of health status|0|||
23126309|NCT01999972|64211863|FG002|Dose Escalation Part|Global deterioration of health status|0|||
23126310|NCT01999972|64211864|FG003|Dose Escalation Part|Global deterioration of health status|1|||
23126311|NCT01999972|64211865|FG004|Dose Escalation Part|Global deterioration of health status|0|||
23126312|NCT01999972|64211866|FG005|Dose Escalation Part|Global deterioration of health status|0|||
23126313|NCT01999972|64211861|FG000|Dose Expansion Part|Death|0|||
23126314|NCT01999972|64211862|FG001|Dose Expansion Part|Death|0|||
23126315|NCT01999972|64211863|FG002|Dose Expansion Part|Death|0|||
23126316|NCT01999972|64211864|FG003|Dose Expansion Part|Death|0|||
23126317|NCT01999972|64211865|FG004|Dose Expansion Part|Death|2|||
23126318|NCT01999972|64211866|FG005|Dose Expansion Part|Death|1|||
23126319|NCT01999972|64211861|FG000|Dose Expansion Part|Disease progression|0|||
23126320|NCT01999972|64211862|FG001|Dose Expansion Part|Disease progression|0|||
23126321|NCT01999972|64211863|FG002|Dose Expansion Part|Disease progression|0|||
23126322|NCT01999972|64211864|FG003|Dose Expansion Part|Disease progression|0|||
23315490|NCT01908907|64899023|FG001|Overall Study|Protocol Violation|0|||
23315491|NCT00735397|64899025|FG000|Overall Study|Adverse Event|194|||
23315492|NCT00735397|64899025|FG000|Overall Study|Lost to Follow-up|33|||
23315493|NCT00735397|64899025|FG000|Overall Study|Participant choice|252|||
23315494|NCT00735397|64899025|FG000|Overall Study|Inadequate therapeutic effect|202|||
23544705|NCT03067441|65723152|FG001|Overall Study|Adverse Event|14|||
23126323|NCT01999972|64211865|FG004|Dose Expansion Part|Disease progression|9|||
23126324|NCT01999972|64211866|FG005|Dose Expansion Part|Disease progression|3|||
23126325|NCT01999972|64211861|FG000|Dose Expansion Part|Sponsor decision|0|||
23126326|NCT01999972|64211862|FG001|Dose Expansion Part|Sponsor decision|0|||
23126327|NCT01999972|64211863|FG002|Dose Expansion Part|Sponsor decision|0|||
23315495|NCT00735397|64899025|FG000|Overall Study|Administrative/Other|502|||
23315496|NCT02227446|64899028|FG000|Overall Study|not eligible post randomization|18|||
23315497|NCT02227446|64899029|FG001|Overall Study|not eligible post randomization|29|||
23315498|NCT02227446|64899028|FG000|Overall Study|Withdrawal by Subject|4|||
23315499|NCT02227446|64899029|FG001|Overall Study|Withdrawal by Subject|5|||
23315500|NCT03656744|64899030|FG000|Overall Study|Adverse Event|1|||
23315501|NCT03656744|64899031|FG001|Overall Study|Adverse Event|4|||
23315502|NCT03656744|64899032|FG002|Overall Study|Adverse Event|1|||
23315503|NCT03656744|64899030|FG000|Overall Study|Protocol Violation|1|||
23315504|NCT03656744|64899031|FG001|Overall Study|Protocol Violation|0|||
23315505|NCT03656744|64899032|FG002|Overall Study|Protocol Violation|0|||
23126328|NCT01999972|64211864|FG003|Dose Expansion Part|Sponsor decision|0|||
23126329|NCT01999972|64211865|FG004|Dose Expansion Part|Sponsor decision|1|||
23126330|NCT01999972|64211866|FG005|Dose Expansion Part|Sponsor decision|0|||
23126331|NCT01999972|64211861|FG000|Dose Expansion Part|Adverse Event|0|||
23126332|NCT01999972|64211862|FG001|Dose Expansion Part|Adverse Event|0|||
23126333|NCT01999972|64211863|FG002|Dose Expansion Part|Adverse Event|0|||
23126334|NCT01999972|64211864|FG003|Dose Expansion Part|Adverse Event|0|||
23126335|NCT01999972|64211865|FG004|Dose Expansion Part|Adverse Event|4|||
23126336|NCT01999972|64211866|FG005|Dose Expansion Part|Adverse Event|2|||
23126337|NCT01999972|64211861|FG000|Dose Expansion Part|Participant's non-compliance|0|||
23126338|NCT01999972|64211862|FG001|Dose Expansion Part|Participant's non-compliance|0|||
23126339|NCT01999972|64211863|FG002|Dose Expansion Part|Participant's non-compliance|0|||
23126340|NCT01999972|64211864|FG003|Dose Expansion Part|Participant's non-compliance|0|||
23126341|NCT01999972|64211865|FG004|Dose Expansion Part|Participant's non-compliance|0|||
23126342|NCT01999972|64211866|FG005|Dose Expansion Part|Participant's non-compliance|1|||
23126343|NCT01999972|64211861|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
23126344|NCT01999972|64211862|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
23126345|NCT01999972|64211863|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
23126346|NCT01999972|64211864|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
23126347|NCT01999972|64211865|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
23315506|NCT03656744|64899030|FG000|Overall Study|Lost to Follow-up|2|||
23315507|NCT03656744|64899031|FG001|Overall Study|Lost to Follow-up|2|||
23315508|NCT03656744|64899032|FG002|Overall Study|Lost to Follow-up|0|||
23315509|NCT03656744|64899030|FG000|Overall Study|Withdrawal by Subject|0|||
23126348|NCT01999972|64211866|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
23126349|NCT01999972|64211861|FG000|Dose Expansion Part|Changed to standard of care|0|||
23126350|NCT01999972|64211862|FG001|Dose Expansion Part|Changed to standard of care|0|||
23126351|NCT01999972|64211863|FG002|Dose Expansion Part|Changed to standard of care|0|||
23126352|NCT01999972|64211864|FG003|Dose Expansion Part|Changed to standard of care|0|||
23126353|NCT01999972|64211865|FG004|Dose Expansion Part|Changed to standard of care|1|||
23126354|NCT01999972|64211866|FG005|Dose Expansion Part|Changed to standard of care|0|||
23126355|NCT01888874|64211870|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
23126356|NCT01888874|64211871|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
23126357|NCT01888874|64211872|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
23126358|NCT01888874|64211873|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
23126359|NCT01888874|64211874|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
23126360|NCT01888874|64211875|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
23126361|NCT01888874|64211876|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
23126362|NCT01888874|64211870|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
23126363|NCT01888874|64211871|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
23315510|NCT03656744|64899031|FG001|Overall Study|Withdrawal by Subject|1|||
23315511|NCT03656744|64899032|FG002|Overall Study|Withdrawal by Subject|0|||
23315512|NCT03656744|64899030|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
23315513|NCT03656744|64899031|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
23315514|NCT03656744|64899032|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
23315515|NCT03760185|64899033|FG000|Overall Study|Lost to Follow-up|1|||
23315516|NCT03760185|64899034|FG001|Overall Study|Lost to Follow-up|1|||
23315517|NCT01783886|64899035|FG000|Overall Study|Lost to Follow-up|0|||
23315518|NCT01783886|64899036|FG001|Overall Study|Lost to Follow-up|3|||
23315519|NCT01783886|64899037|FG002|Overall Study|Lost to Follow-up|0|||
23315520|NCT01783886|64899035|FG000|Overall Study|Protocol deviation|0|||
23315521|NCT01783886|64899036|FG001|Overall Study|Protocol deviation|0|||
23315522|NCT01783886|64899037|FG002|Overall Study|Protocol deviation|2|||
23315523|NCT01783886|64899035|FG000|Overall Study|Withdrawal of consent by participant|1|||
23315524|NCT01783886|64899036|FG001|Overall Study|Withdrawal of consent by participant|3|||
23315525|NCT01783886|64899037|FG002|Overall Study|Withdrawal of consent by participant|4|||
23126364|NCT01888874|64211872|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
23315526|NCT01783886|64899035|FG000|Overall Study|Adverse Event|4|||
23126365|NCT01888874|64211873|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
23126366|NCT01888874|64211874|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
23126367|NCT01888874|64211875|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
23126368|NCT01888874|64211876|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
23126369|NCT01888874|64211870|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23126370|NCT01888874|64211871|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23315527|NCT01783886|64899036|FG001|Overall Study|Adverse Event|5|||
23126371|NCT01888874|64211872|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23126372|NCT01888874|64211873|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23126373|NCT01888874|64211874|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23315528|NCT01783886|64899037|FG002|Overall Study|Adverse Event|4|||
23315529|NCT04414618|64899038|FG000|Overall Study|Death|3|||
23315530|NCT04414618|64899039|FG001|Overall Study|Death|3|||
23126374|NCT01888874|64211875|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
23126375|NCT01888874|64211876|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
23126376|NCT01888874|64211870|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
23126377|NCT01888874|64211871|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
23126378|NCT01888874|64211872|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
23126379|NCT01888874|64211873|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
23126380|NCT01888874|64211874|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
23126381|NCT01888874|64211875|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
23126382|NCT01888874|64211876|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
23126383|NCT01888874|64211870|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23126384|NCT01888874|64211871|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23126385|NCT01888874|64211872|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23126386|NCT01888874|64211873|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23126387|NCT01888874|64211874|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
23126388|NCT01888874|64211875|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23126389|NCT01888874|64211876|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23126390|NCT01888874|64211870|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23126391|NCT01888874|64211871|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
23126392|NCT01888874|64211872|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23126393|NCT01888874|64211873|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23126394|NCT01888874|64211874|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23126395|NCT01888874|64211875|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23126396|NCT01888874|64211876|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
23126397|NCT01888874|64211870|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23126398|NCT01888874|64211871|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
23126399|NCT01888874|64211872|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23126400|NCT01888874|64211873|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23126401|NCT01888874|64211874|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23126402|NCT01888874|64211875|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
23126403|NCT01888874|64211876|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
23315531|NCT04414618|64899038|FG000|Overall Study|Withdrawal by Subject|2|||
23315532|NCT04414618|64899039|FG001|Overall Study|Withdrawal by Subject|1|||
23315533|NCT04414618|64899038|FG000|Overall Study|Lost to Follow-up|2|||
23315534|NCT04414618|64899039|FG001|Overall Study|Lost to Follow-up|3|||
23315535|NCT04414618|64899038|FG000|Overall Study|Physician Decision|1|||
23315536|NCT04414618|64899039|FG001|Overall Study|Physician Decision|0|||
23315537|NCT00338728|64899044|FG000|Overall Study|Screen Failure|14|||
23315538|NCT02201277|64899045|FG000|Overall Study|Death|3|||
23315539|NCT02201277|64899046|FG001|Overall Study|Death|4|||
23315540|NCT02201277|64899045|FG000|Overall Study|Lost to Follow-up|2|||
23315541|NCT02201277|64899046|FG001|Overall Study|Lost to Follow-up|1|||
23315542|NCT02201277|64899045|FG000|Overall Study|Failed retrieval|1|||
23315543|NCT02201277|64899046|FG001|Overall Study|Failed retrieval|0|||
23315544|NCT02201277|64899045|FG000|Overall Study|Physician Decision|1|||
23315545|NCT02201277|64899046|FG001|Overall Study|Physician Decision|0|||
23315546|NCT01941498|64899054|FG000|Overall Study|Relocated out of state|1|||
23315547|NCT01590797|64899055|FG000|Overall Study|Adverse Event|4|||
23315548|NCT01590797|64899056|FG001|Overall Study|Adverse Event|3|||
23315549|NCT01590797|64899055|FG000|Overall Study|Lack of Efficacy|0|||
23315550|NCT01590797|64899056|FG001|Overall Study|Lack of Efficacy|2|||
23315551|NCT01590797|64899055|FG000|Overall Study|Lost to Follow-up|0|||
23315552|NCT01590797|64899056|FG001|Overall Study|Lost to Follow-up|1|||
23315553|NCT01590797|64899055|FG000|Overall Study|Protocol Violation|4|||
23126404|NCT01888874|64211870|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
23126405|NCT01888874|64211871|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
23126406|NCT01888874|64211872|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
23315554|NCT01590797|64899056|FG001|Overall Study|Protocol Violation|1|||
23315555|NCT01590797|64899055|FG000|Overall Study|Withdrawal by Subject|7|||
23315556|NCT01590797|64899056|FG001|Overall Study|Withdrawal by Subject|5|||
23315557|NCT01590797|64899055|FG000|Overall Study|Other Protocol Specified Criteria|2|||
23315558|NCT01590797|64899056|FG001|Overall Study|Other Protocol Specified Criteria|4|||
23315559|NCT02075515|64899117|FG000|Overall Study|Serious Adverse Event|1|||
23544706|NCT03067441|65723151|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
23315560|NCT02075515|64899118|FG001|Overall Study|Serious Adverse Event|1|||
23315561|NCT02075515|64899119|FG002|Overall Study|Serious Adverse Event|1|||
23315562|NCT02075515|64899117|FG000|Overall Study|Non-Serious Adverse Event|0|||
23315563|NCT02075515|64899118|FG001|Overall Study|Non-Serious Adverse Event|1|||
23315564|NCT02075515|64899119|FG002|Overall Study|Non-Serious Adverse Event|0|||
23315565|NCT02075515|64899117|FG000|Overall Study|Withdrawal by Subject|2|||
23315566|NCT02075515|64899118|FG001|Overall Study|Withdrawal by Subject|0|||
23315567|NCT02075515|64899119|FG002|Overall Study|Withdrawal by Subject|1|||
23315568|NCT02075515|64899117|FG000|Overall Study|Lost to Follow-up|1|||
23315569|NCT02075515|64899118|FG001|Overall Study|Lost to Follow-up|3|||
23315570|NCT02075515|64899119|FG002|Overall Study|Lost to Follow-up|6|||
23315571|NCT01374269|64899120|FG000|Overall Study|Withdrawal by Subject|4|||
23315572|NCT01374269|64899121|FG001|Overall Study|Withdrawal by Subject|0|||
23315573|NCT01374269|64899120|FG000|Overall Study|Lost to Follow-up|1|||
23315574|NCT01374269|64899121|FG001|Overall Study|Lost to Follow-up|3|||
23315575|NCT01374269|64899120|FG000|Overall Study|closed research|1|||
23315576|NCT01374269|64899121|FG001|Overall Study|closed research|2|||
23315577|NCT04623086|64899122|FG000|Overall Study|Withdrawal by Subject|0|||
23315578|NCT04623086|64899123|FG001|Overall Study|Withdrawal by Subject|0|||
23315579|NCT04623086|64899124|FG002|Overall Study|Withdrawal by Subject|10|||
23315580|NCT00554190|64899132|FG000|Overall Study|Termination forms not completed|10|||
23315581|NCT01555671|64899135|FG000|Overall Study|Physician Decision|20|||
23315582|NCT01555671|64899136|FG001|Overall Study|Physician Decision|25|||
23315583|NCT02224157|64899139|FG000|Overall Study|Severe non-compliance to protocol|2|||
23315584|NCT02224157|64899140|FG001|Overall Study|Severe non-compliance to protocol|2|||
23126407|NCT01888874|64211873|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23126408|NCT01888874|64211874|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
23315585|NCT02224157|64899139|FG000|Overall Study|Other|13|||
23315586|NCT02224157|64899140|FG001|Overall Study|Other|10|||
23315587|NCT02224157|64899139|FG000|Overall Study|Subject decision|58|||
23315588|NCT02224157|64899140|FG001|Overall Study|Subject decision|50|||
23315589|NCT02224157|64899139|FG000|Overall Study|Prematurely closed site|4|||
23315590|NCT02224157|64899140|FG001|Overall Study|Prematurely closed site|2|||
23315591|NCT02224157|64899139|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
23315592|NCT02224157|64899140|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
23315593|NCT02224157|64899139|FG000|Overall Study|Lost to Follow-up|27|||
23315594|NCT02224157|64899140|FG001|Overall Study|Lost to Follow-up|35|||
23315595|NCT02224157|64899139|FG000|Overall Study|Death|1|||
23315596|NCT02224157|64899140|FG001|Overall Study|Death|1|||
23315597|NCT02224157|64899139|FG000|Overall Study|Adverse Event|1|||
23315598|NCT02224157|64899140|FG001|Overall Study|Adverse Event|3|||
23315599|NCT01998841|64899141|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
23315600|NCT01998841|64899142|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
23315601|NCT01998841|64899143|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
23315602|NCT01998841|64899144|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23315603|NCT01998841|64899145|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23315604|NCT01998841|64899141|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23315605|NCT01998841|64899142|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23315606|NCT01998841|64899143|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
23315607|NCT01998841|64899144|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
23315608|NCT01998841|64899145|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
23315609|NCT01808573|64899148|FG000|Overall Study|Death|212|||
23315610|NCT01808573|64899149|FG001|Overall Study|Death|240|||
23315611|NCT01808573|64899148|FG000|Overall Study|Withdrawal by Subject|12|||
23315612|NCT01808573|64899149|FG001|Overall Study|Withdrawal by Subject|10|||
23315613|NCT01808573|64899148|FG000|Overall Study|Lost to Follow-up|3|||
23315614|NCT01808573|64899149|FG001|Overall Study|Lost to Follow-up|0|||
23315615|NCT01808573|64899148|FG000|Overall Study|Discontinuation of study by sponsor|79|||
23315616|NCT01808573|64899149|FG001|Overall Study|Discontinuation of study by sponsor|64|||
23315617|NCT01808573|64899148|FG000|Overall Study|Randomized in Error|1|||
23315618|NCT01808573|64899149|FG001|Overall Study|Randomized in Error|0|||
23315619|NCT02859142|64899150|FG000|Overall Study|Adverse Event|1|||
23315620|NCT02859142|64899151|FG001|Overall Study|Adverse Event|2|||
23544707|NCT03067441|65723152|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
23126409|NCT01888874|64211875|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23126410|NCT01888874|64211876|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23126411|NCT01888874|64211870|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23126412|NCT01888874|64211871|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23126413|NCT01888874|64211872|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23126414|NCT01888874|64211873|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23126415|NCT01888874|64211874|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
23315621|NCT02859142|64899150|FG000|Overall Study|Lost to Follow-up|1|||
23315622|NCT02859142|64899151|FG001|Overall Study|Lost to Follow-up|4|||
23315623|NCT02859142|64899150|FG000|Overall Study|Withdrawal by Subject|2|||
23315624|NCT02859142|64899151|FG001|Overall Study|Withdrawal by Subject|0|||
23315625|NCT02859142|64899150|FG000|Overall Study|Scheduling difficulties|0|||
23315626|NCT02859142|64899151|FG001|Overall Study|Scheduling difficulties|3|||
23315627|NCT04435184|64899152|FG000|Overall Study|follow-up blood draws missing|3|||
23315628|NCT04435184|64899153|FG001|Overall Study|follow-up blood draws missing|5|||
23315629|NCT02886624|64899163|FG000|12-week Post Treatment Follow-up|Death|1|||
23315630|NCT02886624|64899163|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
23315631|NCT03097991|64899165|FG000|Overall Study|Didn't meet study criteria|8|||
23315632|NCT03097991|64899166|FG001|Overall Study|Didn't meet study criteria|0|||
23315633|NCT03097991|64899165|FG000|Overall Study|Withdrawal by Subject|12|||
23315634|NCT03097991|64899166|FG001|Overall Study|Withdrawal by Subject|6|||
23315635|NCT03097991|64899165|FG000|Overall Study|Death of Baby|3|||
23315636|NCT03097991|64899166|FG001|Overall Study|Death of Baby|1|||
23315637|NCT03097991|64899165|FG000|Overall Study|Lost to Follow-up|24|||
23315638|NCT03097991|64899166|FG001|Overall Study|Lost to Follow-up|38|||
23315639|NCT03097991|64899165|FG000|Overall Study|Adverse Event|3|||
23315640|NCT03097991|64899166|FG001|Overall Study|Adverse Event|5|||
23315641|NCT02111603|64899168|FG000|Overall Study|Withdrawal by Subject|1|||
23315642|NCT00352417|64899169|FG000|Overall Study|Adverse Event|1|||
23315643|NCT00352417|64899170|FG001|Overall Study|Adverse Event|0|||
23315644|NCT00352417|64899169|FG000|Overall Study|Protocol Violation|0|||
23315645|NCT00352417|64899170|FG001|Overall Study|Protocol Violation|2|||
23315646|NCT00352417|64899169|FG000|Overall Study|Withdrawal by Subject|1|||
23315647|NCT00352417|64899170|FG001|Overall Study|Withdrawal by Subject|2|||
23315648|NCT00352417|64899169|FG000|Overall Study|Lost to Follow-up|1|||
23315649|NCT00352417|64899170|FG001|Overall Study|Lost to Follow-up|0|||
23315650|NCT00352417|64899169|FG000|Overall Study|Schedule Change|2|||
23315651|NCT00352417|64899170|FG001|Overall Study|Schedule Change|1|||
23315652|NCT02068092|64899171|FG000|Overall Study|Physician Decision|2|||
23315653|NCT02068092|64899171|FG000|Overall Study|Adverse Event|2|||
23315654|NCT02068092|64899171|FG000|Overall Study|Lost to Follow-up|4|||
23315655|NCT02068092|64899171|FG000|Overall Study|Withdrawal by Subject|2|||
23315656|NCT00303459|64899175|FG000|Overall Study|Death|33|||
23315657|NCT00303459|64899176|FG001|Overall Study|Death|44|||
23315658|NCT00303459|64899175|FG000|Overall Study|Withdrawal of consent|32|||
23315659|NCT00303459|64899176|FG001|Overall Study|Withdrawal of consent|26|||
23315660|NCT00303459|64899175|FG000|Overall Study|Lost to Follow-up|5|||
23315661|NCT00303459|64899176|FG001|Overall Study|Lost to Follow-up|4|||
23315662|NCT00303459|64899175|FG000|Overall Study|Administrative reason|7|||
23315663|NCT00303459|64899176|FG001|Overall Study|Administrative reason|7|||
23315664|NCT00303459|64899175|FG000|Overall Study|Decision by the investigator|5|||
23315665|NCT00303459|64899176|FG001|Overall Study|Decision by the investigator|7|||
23315666|NCT00303459|64899175|FG000|Overall Study|Lung transplantation|1|||
23315667|NCT00303459|64899176|FG001|Overall Study|Lung transplantation|1|||
23315668|NCT00230178|64899177|FG000|Overall Study|Adverse Event|1|||
23315669|NCT00230178|64899178|FG001|Overall Study|Adverse Event|5|||
23315670|NCT00230178|64899179|FG002|Overall Study|Adverse Event|2|||
23315671|NCT00230178|64899177|FG000|Overall Study|Withdrawal by Subject|0|||
23315672|NCT00230178|64899178|FG001|Overall Study|Withdrawal by Subject|0|||
23315673|NCT00230178|64899179|FG002|Overall Study|Withdrawal by Subject|1|||
23315674|NCT00230178|64899177|FG000|Overall Study|Various other reasons|3|||
23315675|NCT00230178|64899178|FG001|Overall Study|Various other reasons|2|||
23315676|NCT00230178|64899179|FG002|Overall Study|Various other reasons|4|||
23315677|NCT05299528|64899180|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23315678|NCT05299528|64899181|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
23315679|NCT05299528|64899182|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23315680|NCT05299528|64899183|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23315681|NCT05299528|64899184|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23315682|NCT05299528|64899185|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23315683|NCT05299528|64899186|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
23315684|NCT05299528|64899180|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23315685|NCT05299528|64899181|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23315686|NCT05299528|64899182|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23544708|NCT03067441|65723151|FG000|Overall Study|Physician Decision|1|||
23544709|NCT03067441|65723152|FG001|Overall Study|Physician Decision|3|||
23544710|NCT03067441|65723151|FG000|Overall Study|Other|1|||
23315687|NCT05299528|64899183|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23315688|NCT05299528|64899184|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23315689|NCT05299528|64899185|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
23315690|NCT05299528|64899186|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
23315691|NCT05299528|64899180|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
23544711|NCT03067441|65723152|FG001|Overall Study|Other|1|||
23315692|NCT05299528|64899181|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
23544712|NCT00613951|65723153|FG000|Overall Study|Adverse Event|1|||
23544713|NCT00613951|65723154|FG001|Overall Study|Adverse Event|0|||
23126416|NCT01888874|64211875|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23315693|NCT05299528|64899182|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
23315694|NCT05299528|64899183|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
23315695|NCT05299528|64899184|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
23315696|NCT05299528|64899185|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
23315697|NCT05299528|64899186|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
23315698|NCT04040192|64899189|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
23315699|NCT04040192|64899190|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
23315700|NCT04040192|64899191|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
23315701|NCT04040192|64899189|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
23315702|NCT04040192|64899190|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
23315703|NCT04040192|64899191|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
23315704|NCT04040192|64899189|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
23315705|NCT04040192|64899190|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
23315706|NCT04040192|64899191|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
23315707|NCT04040192|64899189|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
23315708|NCT04040192|64899190|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
23315709|NCT04040192|64899191|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
23315710|NCT04040192|64899189|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
23315711|NCT04040192|64899190|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
23315712|NCT04040192|64899191|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
23315713|NCT04040192|64899189|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
23315714|NCT04040192|64899190|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
23315715|NCT04040192|64899191|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
23315716|NCT04040192|64899189|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
23315717|NCT04040192|64899190|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
23315718|NCT04040192|64899191|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
23315719|NCT04040192|64899189|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
23315720|NCT04040192|64899190|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
23126417|NCT01888874|64211876|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
23126418|NCT01888874|64211870|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23126419|NCT01888874|64211871|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23126420|NCT01888874|64211872|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
23126421|NCT01888874|64211873|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23126422|NCT01888874|64211874|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23126423|NCT01888874|64211875|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
23126424|NCT01888874|64211876|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
23126425|NCT01888874|64211870|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23126426|NCT01888874|64211871|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23126427|NCT01888874|64211872|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
23126428|NCT01888874|64211873|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23126429|NCT01888874|64211874|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23126430|NCT01888874|64211875|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23126431|NCT01888874|64211876|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
23126432|NCT01888874|64211870|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
23315721|NCT04040192|64899191|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
23315722|NCT04040192|64899189|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
23315723|NCT04040192|64899190|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
23315724|NCT04040192|64899191|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
23315725|NCT04040192|64899189|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
23315726|NCT04040192|64899190|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
23315727|NCT04040192|64899191|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
23315728|NCT04040192|64899189|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
23315729|NCT04040192|64899190|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
23315730|NCT04040192|64899191|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
23315731|NCT04040192|64899189|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
23315732|NCT04040192|64899190|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
23315733|NCT04040192|64899191|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
23315734|NCT04040192|64899189|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
23315735|NCT04040192|64899190|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
23315736|NCT04040192|64899191|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
23315737|NCT04040192|64899189|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
23315738|NCT04040192|64899190|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
23315739|NCT04040192|64899191|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
23315740|NCT04040192|64899189|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
23315741|NCT04040192|64899190|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
23315742|NCT04040192|64899191|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
23315743|NCT04040192|64899189|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
23315744|NCT04040192|64899190|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
23315745|NCT04040192|64899191|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
23315746|NCT04040192|64899189|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
23315747|NCT04040192|64899190|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
23315748|NCT04040192|64899191|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
23315749|NCT03700385|64899196|FG000|Overall Study|Lost to Follow-up|1|||
23315750|NCT01696279|64899200|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
23315751|NCT01696279|64899201|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
23315752|NCT01696279|64899202|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
23315753|NCT01696279|64899203|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
23315754|NCT01696279|64899200|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
23315755|NCT01696279|64899201|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
23315756|NCT01696279|64899202|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
23315757|NCT01696279|64899203|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
23315758|NCT01696279|64899200|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
23315759|NCT01696279|64899201|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
23315760|NCT01696279|64899202|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
23315761|NCT01696279|64899203|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
23315762|NCT01696279|64899200|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
23315763|NCT01696279|64899201|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
23315764|NCT01696279|64899202|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
23315765|NCT01696279|64899203|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
23315766|NCT01696279|64899200|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
23315767|NCT01696279|64899201|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
23315768|NCT01696279|64899202|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
23315769|NCT01696279|64899203|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
23315770|NCT01696279|64899200|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
23315771|NCT01696279|64899201|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
23315772|NCT01696279|64899202|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
23315773|NCT01696279|64899203|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
23315774|NCT01696279|64899200|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
23315775|NCT01696279|64899201|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
23315776|NCT01696279|64899202|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
23315777|NCT01696279|64899203|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
23315778|NCT01696279|64899200|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
23315779|NCT01696279|64899201|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
23315780|NCT01696279|64899202|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
23315781|NCT01696279|64899203|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
23315782|NCT01696279|64899200|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
23315783|NCT01696279|64899201|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
23315784|NCT01696279|64899202|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
23315785|NCT01696279|64899203|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
23315786|NCT01696279|64899200|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
23315787|NCT01696279|64899201|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
23315788|NCT01696279|64899202|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
23544714|NCT00613951|65723155|FG002|Overall Study|Adverse Event|1|||
23544715|NCT00613951|65723153|FG000|Overall Study|Lack of Efficacy|0|||
23544716|NCT00613951|65723154|FG001|Overall Study|Lack of Efficacy|1|||
23544717|NCT00613951|65723155|FG002|Overall Study|Lack of Efficacy|1|||
23544718|NCT00613951|65723153|FG000|Overall Study|Protocol Violation|1|||
23544719|NCT00613951|65723154|FG001|Overall Study|Protocol Violation|1|||
23544720|NCT00613951|65723155|FG002|Overall Study|Protocol Violation|1|||
23617928|NCT02660034|65988174|FG012|Overall Study|Progressive Disease (Clinical)|0|||
23617929|NCT02660034|65988175|FG013|Overall Study|Progressive Disease (Clinical)|0|||
23617930|NCT02660034|65988162|FG000|Overall Study|Lost to Follow-up|0|||
23315789|NCT01696279|64899203|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
23315790|NCT01696279|64899200|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
23315791|NCT01696279|64899201|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
23315792|NCT01696279|64899202|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
23315793|NCT01696279|64899203|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
23544721|NCT00613951|65723153|FG000|Overall Study|Unclassified|5|||
23544722|NCT00613951|65723154|FG001|Overall Study|Unclassified|3|||
23544723|NCT00613951|65723155|FG002|Overall Study|Unclassified|2|||
23544724|NCT01306162|65723156|FG000|Period 1|Adverse Event|0|||
23544725|NCT01306162|65723157|FG001|Period 1|Adverse Event|0|||
23211966|NCT03833817|64516275|FG001|Overall Study|Withdrawal by Subject|3|||
23211967|NCT03833817|64516274|FG000|Overall Study|Lost to Follow-up|3|||
23211968|NCT03833817|64516275|FG001|Overall Study|Lost to Follow-up|3|||
23211969|NCT03846219|64516276|FG000|Overall Study|Withdrawal by Subject|3|||
23315794|NCT03414684|64899204|FG000|First-course Treatment|Complete response|0|||
23315795|NCT03414684|64899205|FG001|First-course Treatment|Complete response|1|||
23211970|NCT03846219|64516277|FG001|Overall Study|Withdrawal by Subject|2|||
23211971|NCT03846219|64516278|FG002|Overall Study|Withdrawal by Subject|2|||
23211972|NCT03846219|64516276|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
23315796|NCT03414684|64899204|FG000|First-course Treatment|Intercurrent illness|1|||
23315797|NCT03414684|64899205|FG001|First-course Treatment|Intercurrent illness|0|||
23315798|NCT03414684|64899204|FG000|First-course Treatment|Progressive Disease|31|||
23315799|NCT03414684|64899205|FG001|First-course Treatment|Progressive Disease|32|||
23315800|NCT03414684|64899204|FG000|First-course Treatment|Adverse Event|1|||
23315801|NCT03414684|64899205|FG001|First-course Treatment|Adverse Event|2|||
23315802|NCT03414684|64899204|FG000|First-course Treatment|Physician Decision|0|||
23315803|NCT03414684|64899205|FG001|First-course Treatment|Physician Decision|1|||
23315804|NCT03414684|64899204|FG000|First-course Treatment|Withdrawal by Subject|0|||
23426196|NCT00900146|65303555|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
23544726|NCT01306162|65723158|FG002|Period 1|Adverse Event|0|||
23544727|NCT01306162|65723159|FG003|Period 1|Adverse Event|1|||
23544728|NCT01306162|65723156|FG000|Washout 1|Non-compliance to protocol|0|||
23544729|NCT01306162|65723157|FG001|Washout 1|Non-compliance to protocol|1|||
23544730|NCT01306162|65723158|FG002|Washout 1|Non-compliance to protocol|0|||
23544731|NCT01306162|65723159|FG003|Washout 1|Non-compliance to protocol|0|||
23544732|NCT01910519|65723160|FG000|Overall Study|Withdrawal by Subject|2|||
23126433|NCT01888874|64211871|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
23126434|NCT01888874|64211872|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
23126435|NCT01888874|64211873|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
23126436|NCT01888874|64211874|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
23126437|NCT01888874|64211875|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
23126438|NCT01888874|64211876|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
23126439|NCT01888874|64211870|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23126440|NCT01888874|64211871|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
23126441|NCT01888874|64211872|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23126442|NCT01888874|64211873|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23126443|NCT01888874|64211874|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23126444|NCT01888874|64211875|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
23126445|NCT01888874|64211876|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
23126446|NCT01825798|64211883|FG000|Overall Study|Adverse Event|1|||
23126447|NCT01825798|64211884|FG001|Overall Study|Adverse Event|5|||
23126448|NCT01825798|64211883|FG000|Overall Study|Lost to Follow-up|1|||
23126449|NCT01825798|64211884|FG001|Overall Study|Lost to Follow-up|0|||
23126450|NCT00129935|64211885|FG000|Overall Study|Adverse Event|18|||
23211973|NCT03846219|64516277|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
23211974|NCT03846219|64516278|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
23315805|NCT03414684|64899205|FG001|First-course Treatment|Withdrawal by Subject|1|||
23315806|NCT03414684|64899204|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
23426197|NCT00900146|65303551|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
23426198|NCT00900146|65303552|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
23426199|NCT00900146|65303553|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
23426200|NCT00900146|65303554|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
23426201|NCT00900146|65303555|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
23426202|NCT00900146|65303551|FG000|Intermediate: Period III|Lost to Follow-up|2|||
23426203|NCT00900146|65303552|FG001|Intermediate: Period III|Lost to Follow-up|0|||
23426204|NCT00900146|65303553|FG002|Intermediate: Period III|Lost to Follow-up|0|||
23426205|NCT00900146|65303554|FG003|Intermediate: Period III|Lost to Follow-up|0|||
23426206|NCT00900146|65303555|FG004|Intermediate: Period III|Lost to Follow-up|1|||
23426207|NCT00900146|65303551|FG000|Intermediate: Period III|Administrative problems|85|||
23426208|NCT00900146|65303552|FG001|Intermediate: Period III|Administrative problems|92|||
23426209|NCT00900146|65303553|FG002|Intermediate: Period III|Administrative problems|84|||
23426210|NCT00900146|65303554|FG003|Intermediate: Period III|Administrative problems|90|||
23426211|NCT00900146|65303555|FG004|Intermediate: Period III|Administrative problems|163|||
23426212|NCT01902888|65303560|FG000|Overall Study|Study Terminated|3|||
23426213|NCT03538444|65303563|FG000|Overall Study|opioid withdrawal|1|||
23426214|NCT03538444|65303564|FG001|Overall Study|opioid withdrawal|0|||
23426215|NCT00168103|65303565|FG000|Overall Study|Withdrawal by Subject|1|||
23426216|NCT00168103|65303566|FG001|Overall Study|Withdrawal by Subject|2|||
23426217|NCT00168103|65303567|FG002|Overall Study|Withdrawal by Subject|1|||
23426218|NCT00168103|65303568|FG003|Overall Study|Withdrawal by Subject|0|||
23426219|NCT00168103|65303565|FG000|Overall Study|Lost to Follow-up|1|||
23426220|NCT00168103|65303566|FG001|Overall Study|Lost to Follow-up|3|||
23544733|NCT01910519|65723161|FG001|Overall Study|Withdrawal by Subject|0|||
23211975|NCT03846219|64516276|FG000|Overall Study|Physician Decision|0|||
23211976|NCT03846219|64516277|FG001|Overall Study|Physician Decision|0|||
23211977|NCT03846219|64516278|FG002|Overall Study|Physician Decision|2|||
23211978|NCT00836277|64516284|FG000|Overall Study|Not evaluable for response|6|||
23211979|NCT02716194|64516285|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
23211980|NCT02716194|64516286|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
23211981|NCT02716194|64516287|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
23211982|NCT02483078|64516288|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
23126451|NCT00129935|64211886|FG001|Overall Study|Adverse Event|56|||
23126452|NCT00129935|64211885|FG000|Overall Study|Death|1|||
23126453|NCT00129935|64211886|FG001|Overall Study|Death|1|||
23126454|NCT00129935|64211885|FG000|Overall Study|Withdrawal by Subject|7|||
23126455|NCT00129935|64211886|FG001|Overall Study|Withdrawal by Subject|20|||
23126456|NCT00129935|64211885|FG000|Overall Study|Protocol Violation|0|||
23126457|NCT00129935|64211886|FG001|Overall Study|Protocol Violation|4|||
23126458|NCT00129935|64211885|FG000|Overall Study|Physician Decision|3|||
23126459|NCT00129935|64211886|FG001|Overall Study|Physician Decision|4|||
23211983|NCT02483078|64516289|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
23211984|NCT02483078|64516288|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
23211985|NCT02483078|64516289|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
23544734|NCT01910519|65723160|FG000|Overall Study|Adverse Event|2|||
23544735|NCT01910519|65723161|FG001|Overall Study|Adverse Event|0|||
23544736|NCT01175668|65723164|FG000|Overall Study|Withdrawal by Subject|2|||
23617931|NCT02660034|65988163|FG001|Overall Study|Lost to Follow-up|0|||
23617932|NCT02660034|65988164|FG002|Overall Study|Lost to Follow-up|1|||
23617933|NCT02660034|65988165|FG003|Overall Study|Lost to Follow-up|1|||
23617934|NCT02660034|65988166|FG004|Overall Study|Lost to Follow-up|0|||
23617935|NCT02660034|65988167|FG005|Overall Study|Lost to Follow-up|0|||
23617936|NCT02660034|65988168|FG006|Overall Study|Lost to Follow-up|0|||
23617937|NCT02660034|65988169|FG007|Overall Study|Lost to Follow-up|0|||
23617938|NCT02660034|65988170|FG008|Overall Study|Lost to Follow-up|0|||
23617939|NCT02660034|65988171|FG009|Overall Study|Lost to Follow-up|1|||
23617940|NCT02660034|65988172|FG010|Overall Study|Lost to Follow-up|1|||
23617941|NCT02660034|65988173|FG011|Overall Study|Lost to Follow-up|1|||
23126460|NCT00129935|64211885|FG000|Overall Study|Recurrence|1|||
23211986|NCT02483078|64516288|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
23544737|NCT01175668|65723165|FG001|Overall Study|Withdrawal by Subject|0|||
23544738|NCT02132611|65723166|FG000|Overall Study|Death|2|||
23544739|NCT01404312|65723167|FG000|Overall Study|Death|21|||
23544740|NCT01404312|65723168|FG001|Overall Study|Death|27|||
23544741|NCT01404312|65723167|FG000|Overall Study|Withdrawal by Subject|15|||
23544742|NCT01404312|65723168|FG001|Overall Study|Withdrawal by Subject|18|||
23544743|NCT01404312|65723167|FG000|Overall Study|Participant Unable to get to clinic|93|||
23544744|NCT01404312|65723168|FG001|Overall Study|Participant Unable to get to clinic|103|||
23544745|NCT01404312|65723167|FG000|Overall Study|Lost to Follow-up|115|||
23544746|NCT01404312|65723168|FG001|Overall Study|Lost to Follow-up|111|||
23544747|NCT01404312|65723167|FG000|Overall Study|Site closed|22|||
23544748|NCT01404312|65723168|FG001|Overall Study|Site closed|21|||
23544749|NCT01404312|65723167|FG000|Overall Study|Participant not willing to adhere to req|31|||
23544750|NCT01404312|65723168|FG001|Overall Study|Participant not willing to adhere to req|29|||
23544751|NCT01404312|65723167|FG000|Overall Study|Severe debilitation, unable to continue|1|||
23544752|NCT01404312|65723168|FG001|Overall Study|Severe debilitation, unable to continue|2|||
23544753|NCT03778294|65723173|FG000|Overall Study|Death|1|||
23544754|NCT03778294|65723173|FG000|Overall Study|Issues with insurance|1|||
23544755|NCT03778294|65723173|FG000|Overall Study|disease progression before treatment|2|||
23544756|NCT03859323|65723174|FG000|Overall Study|Lost to Follow-up|0|||
23544757|NCT03859323|65723175|FG001|Overall Study|Lost to Follow-up|0|||
23544758|NCT03859323|65723176|FG002|Overall Study|Lost to Follow-up|0|||
23544759|NCT03859323|65723177|FG003|Overall Study|Lost to Follow-up|0|||
23544760|NCT03859323|65723178|FG004|Overall Study|Lost to Follow-up|0|||
23544761|NCT03859323|65723179|FG005|Overall Study|Lost to Follow-up|0|||
23544762|NCT03859323|65723180|FG006|Overall Study|Lost to Follow-up|1|||
23617942|NCT02660034|65988174|FG012|Overall Study|Lost to Follow-up|0|||
23617943|NCT02660034|65988175|FG013|Overall Study|Lost to Follow-up|0|||
23617944|NCT02660034|65988162|FG000|Overall Study|Participant moved into special access scheme|1|||
23617945|NCT02660034|65988163|FG001|Overall Study|Participant moved into special access scheme|2|||
23126461|NCT00129935|64211886|FG001|Overall Study|Recurrence|3|||
23315807|NCT03414684|64899205|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
23544763|NCT03859323|65723181|FG007|Overall Study|Lost to Follow-up|0|||
23544764|NCT03859323|65723182|FG008|Overall Study|Lost to Follow-up|0|||
23544765|NCT03859323|65723183|FG009|Overall Study|Lost to Follow-up|0|||
23544766|NCT03859323|65723184|FG010|Overall Study|Lost to Follow-up|0|||
23544767|NCT03859323|65723185|FG011|Overall Study|Lost to Follow-up|0|||
23544768|NCT03859323|65723186|FG012|Overall Study|Lost to Follow-up|0|||
23544769|NCT03859323|65723174|FG000|Overall Study|Withdrawal by Subject|0|||
23544770|NCT03859323|65723175|FG001|Overall Study|Withdrawal by Subject|0|||
23126462|NCT00129935|64211885|FG000|Overall Study|Second primary|0|||
23126463|NCT00129935|64211886|FG001|Overall Study|Second primary|1|||
23126464|NCT00129935|64211885|FG000|Overall Study|Other|3|||
23126465|NCT00129935|64211886|FG001|Overall Study|Other|2|||
23126466|NCT00129935|64211885|FG000|Overall Study|Crossed to the other arm|2|||
23126467|NCT00129935|64211886|FG001|Overall Study|Crossed to the other arm|1|||
23126468|NCT00129935|64211885|FG000|Overall Study|Incorrect study treatment|1|||
23126469|NCT00129935|64211886|FG001|Overall Study|Incorrect study treatment|0|||
23126470|NCT00384397|64211887|FG000|Overall Study|Adverse Event|0|||
23126471|NCT00384397|64211888|FG001|Overall Study|Adverse Event|1|||
23126472|NCT00384397|64211889|FG002|Overall Study|Adverse Event|2|||
23126473|NCT00384397|64211887|FG000|Overall Study|Protocol Violation|7|||
23126474|NCT00384397|64211888|FG001|Overall Study|Protocol Violation|15|||
23126475|NCT00384397|64211889|FG002|Overall Study|Protocol Violation|13|||
23544771|NCT03859323|65723176|FG002|Overall Study|Withdrawal by Subject|1|||
23544772|NCT03859323|65723177|FG003|Overall Study|Withdrawal by Subject|0|||
23544773|NCT03859323|65723178|FG004|Overall Study|Withdrawal by Subject|0|||
23544774|NCT03859323|65723179|FG005|Overall Study|Withdrawal by Subject|1|||
23544775|NCT03859323|65723180|FG006|Overall Study|Withdrawal by Subject|0|||
23544776|NCT03859323|65723181|FG007|Overall Study|Withdrawal by Subject|0|||
23544777|NCT03859323|65723182|FG008|Overall Study|Withdrawal by Subject|0|||
23544778|NCT03859323|65723183|FG009|Overall Study|Withdrawal by Subject|1|||
23544779|NCT03859323|65723184|FG010|Overall Study|Withdrawal by Subject|1|||
23544780|NCT03859323|65723185|FG011|Overall Study|Withdrawal by Subject|2|||
23544781|NCT03859323|65723186|FG012|Overall Study|Withdrawal by Subject|1|||
23544782|NCT03859323|65723174|FG000|Overall Study|Pregnancy|0|||
23544783|NCT03859323|65723175|FG001|Overall Study|Pregnancy|0|||
23544784|NCT03859323|65723176|FG002|Overall Study|Pregnancy|0|||
23544785|NCT03859323|65723177|FG003|Overall Study|Pregnancy|0|||
23544786|NCT03859323|65723178|FG004|Overall Study|Pregnancy|0|||
23126476|NCT00384397|64211887|FG000|Overall Study|Lost to Follow-up|11|||
23126477|NCT00384397|64211888|FG001|Overall Study|Lost to Follow-up|13|||
23126478|NCT00384397|64211889|FG002|Overall Study|Lost to Follow-up|3|||
23126479|NCT00384397|64211887|FG000|Overall Study|Withdrawal by Subject|14|||
23126480|NCT00384397|64211888|FG001|Overall Study|Withdrawal by Subject|17|||
23126481|NCT00384397|64211889|FG002|Overall Study|Withdrawal by Subject|15|||
23126482|NCT01967069|64211893|FG000|Overall Study|Adverse Event|2|||
23126483|NCT01967069|64211894|FG001|Overall Study|Adverse Event|2|||
23126484|NCT01967069|64211893|FG000|Overall Study|Lost to Follow-up|5|||
23126485|NCT01967069|64211894|FG001|Overall Study|Lost to Follow-up|2|||
23544787|NCT03859323|65723179|FG005|Overall Study|Pregnancy|0|||
23544788|NCT03859323|65723180|FG006|Overall Study|Pregnancy|0|||
23544789|NCT03859323|65723181|FG007|Overall Study|Pregnancy|0|||
23544790|NCT03859323|65723182|FG008|Overall Study|Pregnancy|0|||
23544791|NCT03859323|65723183|FG009|Overall Study|Pregnancy|1|||
23544792|NCT03859323|65723184|FG010|Overall Study|Pregnancy|0|||
23544793|NCT03859323|65723185|FG011|Overall Study|Pregnancy|0|||
23544794|NCT03859323|65723186|FG012|Overall Study|Pregnancy|0|||
23544795|NCT04419493|65723187|FG000|Wash-out After Period 1|Adverse Event|1|||
23544796|NCT04419493|65723188|FG001|Wash-out After Period 1|Adverse Event|2|||
23544797|NCT04419493|65723189|FG002|Wash-out After Period 1|Adverse Event|1|||
23544798|NCT04419493|65723190|FG003|Wash-out After Period 1|Adverse Event|0|||
23544799|NCT00413153|65723191|FG000|Overall Study|Withdrawal by Subject|1|||
23544800|NCT00413153|65723192|FG001|Overall Study|Withdrawal by Subject|1|||
23544801|NCT00413153|65723191|FG000|Overall Study|Adverse Event|1|||
23544802|NCT00413153|65723192|FG001|Overall Study|Adverse Event|0|||
23544803|NCT01863680|65723193|FG000|Overall Study|Adverse Event|17|||
23544804|NCT01863680|65723193|FG000|Overall Study|Risk of OHSS|17|||
23544805|NCT01863680|65723193|FG000|Overall Study|Spontaneous pregnancy|2|||
23544806|NCT01863680|65723193|FG000|Overall Study|Withdrawal by Subject|1|||
23544807|NCT01863680|65723193|FG000|Overall Study|Did not undergo IVF/ET|14|||
23544808|NCT01863680|65723193|FG000|Overall Study|Other|6|||
23544809|NCT00566228|65723194|FG000|Overall Study|Withdrawal by Subject|1|||
23544810|NCT00566228|65723195|FG001|Overall Study|Withdrawal by Subject|0|||
23544811|NCT00566228|65723194|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
23544812|NCT00566228|65723195|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
23544813|NCT00566228|65723194|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
23126486|NCT01967069|64211893|FG000|Overall Study|Withdrawal by Subject|1|||
23544814|NCT00566228|65723195|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
23544815|NCT00566228|65723194|FG000|Overall Study|progressed before infusion could occur|0|||
23544816|NCT00566228|65723195|FG001|Overall Study|progressed before infusion could occur|1|||
23617946|NCT02660034|65988164|FG002|Overall Study|Participant moved into special access scheme|0|||
23126487|NCT01967069|64211894|FG001|Overall Study|Withdrawal by Subject|3|||
23126488|NCT01967069|64211893|FG000|Overall Study|Lack of Efficacy|0|||
23126489|NCT01967069|64211894|FG001|Overall Study|Lack of Efficacy|1|||
23126490|NCT01932762|64211897|FG000|Overall Study|Withdrawal by Subject|1|||
23544817|NCT03551938|65723196|FG000|3-Month Follow Up|Lost to Follow-up|39|||
23544818|NCT03551938|65723197|FG001|3-Month Follow Up|Lost to Follow-up|38|||
23544819|NCT03551938|65723196|FG000|6-Month Follow Up|Lost to Follow-up|46|||
23617947|NCT02660034|65988165|FG003|Overall Study|Participant moved into special access scheme|0|||
23617948|NCT02660034|65988166|FG004|Overall Study|Participant moved into special access scheme|0|||
23617949|NCT02660034|65988167|FG005|Overall Study|Participant moved into special access scheme|0|||
23617950|NCT02660034|65988168|FG006|Overall Study|Participant moved into special access scheme|0|||
23617951|NCT02660034|65988169|FG007|Overall Study|Participant moved into special access scheme|0|||
23617952|NCT02660034|65988170|FG008|Overall Study|Participant moved into special access scheme|0|||
23126491|NCT01932762|64211898|FG001|Overall Study|Withdrawal by Subject|2|||
23126492|NCT01932762|64211899|FG002|Overall Study|Withdrawal by Subject|0|||
23126493|NCT01932762|64211900|FG003|Overall Study|Withdrawal by Subject|0|||
23126494|NCT01932762|64211897|FG000|Overall Study|Lost to Follow-up|4|||
23126495|NCT01932762|64211898|FG001|Overall Study|Lost to Follow-up|0|||
23126496|NCT01932762|64211899|FG002|Overall Study|Lost to Follow-up|0|||
23126497|NCT01932762|64211900|FG003|Overall Study|Lost to Follow-up|1|||
23126498|NCT01932762|64211897|FG000|Overall Study|Physician Decision|1|||
23126499|NCT01932762|64211898|FG001|Overall Study|Physician Decision|0|||
23126500|NCT01932762|64211899|FG002|Overall Study|Physician Decision|0|||
23126501|NCT01932762|64211900|FG003|Overall Study|Physician Decision|0|||
23126502|NCT02358668|64211905|FG000|Overall Study|Adverse Event|2|||
23126503|NCT02358668|64211906|FG001|Overall Study|Adverse Event|0|||
23126504|NCT02358668|64211907|FG002|Overall Study|Adverse Event|0|||
23126505|NCT02358668|64211905|FG000|Overall Study|Withdrawal by Subject|0|||
23126506|NCT02358668|64211906|FG001|Overall Study|Withdrawal by Subject|1|||
23126507|NCT02358668|64211907|FG002|Overall Study|Withdrawal by Subject|0|||
23126508|NCT00738283|64211908|FG000|Overall Study|Death|1|||
23126509|NCT00738283|64211908|FG000|Overall Study|Transfer to another facility|2|||
23126510|NCT00738283|64211908|FG000|Overall Study|Discharge home prior to end of study|1|||
23126511|NCT04343976|64211909|FG000|Overall Study|Withdrawal by Subject|0|||
23126512|NCT04343976|64211910|FG001|Overall Study|Withdrawal by Subject|1|||
23126513|NCT04206085|64211911|FG000|Overall Study|Lost to Follow-up|0|||
23126514|NCT04206085|64211912|FG001|Overall Study|Lost to Follow-up|1|||
23126515|NCT04206085|64211913|FG002|Overall Study|Lost to Follow-up|0|||
23126516|NCT04206085|64211911|FG000|Overall Study|Lost to Follow-up|0|||
23126517|NCT04206085|64211912|FG001|Overall Study|Lost to Follow-up|0|||
23126518|NCT04206085|64211913|FG002|Overall Study|Lost to Follow-up|1|||
23126519|NCT00487825|64211914|FG000|Overall Study|Adverse Event|2|||
23126520|NCT00487825|64211915|FG001|Overall Study|Adverse Event|2|||
23126521|NCT00487825|64211914|FG000|Overall Study|Lack of Efficacy|1|||
23126522|NCT00487825|64211915|FG001|Overall Study|Lack of Efficacy|1|||
23126523|NCT00487825|64211914|FG000|Overall Study|Other|3|||
23126524|NCT00487825|64211915|FG001|Overall Study|Other|2|||
23126525|NCT00572533|64211916|FG000|Overall Study|Death|4|||
23126526|NCT00572533|64211917|FG001|Overall Study|Death|1|||
23126527|NCT00572533|64211916|FG000|Overall Study|Received Kidney Transplant|2|||
23126528|NCT00572533|64211917|FG001|Overall Study|Received Kidney Transplant|1|||
23126529|NCT00572533|64211916|FG000|Overall Study|Social Issues|1|||
23126530|NCT00572533|64211917|FG001|Overall Study|Social Issues|0|||
23126531|NCT00572533|64211916|FG000|Overall Study|Transfer out of Facility|0|||
23126532|NCT00572533|64211917|FG001|Overall Study|Transfer out of Facility|1|||
23126533|NCT00570908|64211921|FG000|Overall Study|Adverse Event|5|||
23126534|NCT00570908|64211921|FG000|Overall Study|Withdrawal by Subject|2|||
23126535|NCT00243074|64211922|FG000|Overall Study|Ineligible|6|||
23126536|NCT00243074|64211922|FG000|Overall Study|Adverse Event|6|||
23126537|NCT00243074|64211922|FG000|Overall Study|Withdrawal by Subject|2|||
23126538|NCT00243074|64211922|FG000|Overall Study|Lack of Efficacy|36|||
23126539|NCT00243074|64211922|FG000|Overall Study|Death|2|||
23126540|NCT00243074|64211922|FG000|Overall Study|not protocol specified|1|||
23126541|NCT00243074|64211922|FG000|Overall Study|Did not receive any treatment|1|||
23126542|NCT00108745|64211923|FG000|Overall Study|Withdrawal by Subject|19|||
23126543|NCT00108745|64211924|FG001|Overall Study|Withdrawal by Subject|12|||
23126544|NCT00108745|64211925|FG002|Overall Study|Withdrawal by Subject|12|||
23126545|NCT00108745|64211923|FG000|Overall Study|Never Treated|8|||
23126546|NCT00108745|64211924|FG001|Overall Study|Never Treated|10|||
23126547|NCT00108745|64211925|FG002|Overall Study|Never Treated|12|||
23126548|NCT00108745|64211923|FG000|Overall Study|Ineligible|7|||
23126549|NCT00108745|64211924|FG001|Overall Study|Ineligible|13|||
23126550|NCT00108745|64211925|FG002|Overall Study|Ineligible|13|||
23126551|NCT00594880|64211926|FG000|Overall Study|Withdrawal by Subject|1|||
23126552|NCT00594880|64211927|FG001|Overall Study|Withdrawal by Subject|1|||
23126553|NCT00594880|64211926|FG000|Overall Study|Lost to Follow-up|1|||
23126554|NCT00594880|64211927|FG001|Overall Study|Lost to Follow-up|0|||
23126555|NCT00983853|64211935|FG000|Overall Study|Lost to Follow-up|1|||
23126556|NCT00983853|64211936|FG001|Overall Study|Lost to Follow-up|1|||
23126557|NCT00983853|64211937|FG002|Overall Study|Lost to Follow-up|2|||
23126558|NCT00983853|64211938|FG003|Overall Study|Lost to Follow-up|2|||
23126559|NCT00983853|64211939|FG004|Overall Study|Lost to Follow-up|2|||
23126560|NCT00983853|64211940|FG005|Overall Study|Lost to Follow-up|1|||
23126561|NCT00983853|64211935|FG000|Overall Study|Withdrawal by Subject|0|||
23617953|NCT02660034|65988171|FG009|Overall Study|Participant moved into special access scheme|0|||
23617954|NCT02660034|65988172|FG010|Overall Study|Participant moved into special access scheme|0|||
23617955|NCT02660034|65988173|FG011|Overall Study|Participant moved into special access scheme|0|||
23126562|NCT00983853|64211936|FG001|Overall Study|Withdrawal by Subject|0|||
23126563|NCT00983853|64211937|FG002|Overall Study|Withdrawal by Subject|1|||
23315808|NCT03414684|64899204|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
23544820|NCT03551938|65723197|FG001|6-Month Follow Up|Lost to Follow-up|42|||
23544821|NCT03551938|65723196|FG000|9-Month Follow Up|Lost to Follow-up|44|||
23544822|NCT03551938|65723197|FG001|9-Month Follow Up|Lost to Follow-up|43|||
23544823|NCT04329104|65723198|FG000|Efficacy Study|Withdrawal by Subject|0|||
23544824|NCT04329104|65723199|FG001|Efficacy Study|Withdrawal by Subject|0|||
23544825|NCT04329104|65723200|FG002|Efficacy Study|Withdrawal by Subject|0|||
23544826|NCT04329104|65723201|FG003|Efficacy Study|Withdrawal by Subject|5|||
23544827|NCT04329104|65723202|FG004|Efficacy Study|Withdrawal by Subject|6|||
23544828|NCT04329104|65723203|FG005|Efficacy Study|Withdrawal by Subject|8|||
23544829|NCT01159691|65723204|FG000|Overall Study|Lost to Follow-up|2|||
23544830|NCT01159691|65723204|FG000|Overall Study|Unknown reasons|1|||
23544831|NCT01159691|65723204|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
23544832|NCT01159691|65723204|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
23544833|NCT01159691|65723204|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
23544834|NCT01159691|65723204|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
23544835|NCT01159691|65723204|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
23544836|NCT01159691|65723204|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
23544837|NCT00727272|65723208|FG000|Washout Period A|Adverse Event|0|||
23544838|NCT00727272|65723209|FG001|Washout Period A|Adverse Event|0|||
23544839|NCT00727272|65723210|FG002|Washout Period A|Adverse Event|1|||
23544840|NCT00727272|65723208|FG000|Washout Period B|Withdrawal by Subject|0|||
23544841|NCT00727272|65723209|FG001|Washout Period B|Withdrawal by Subject|0|||
23544842|NCT00727272|65723210|FG002|Washout Period B|Withdrawal by Subject|1|||
23544843|NCT03087591|65723216|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
23544844|NCT03087591|65723216|FG000|Overall Study|Withdrawal by Subject|1|||
23544845|NCT02548962|65723217|FG000|Overall Study|Withdrawal by Subject|1|||
23544846|NCT02548962|65723218|FG001|Overall Study|Withdrawal by Subject|0|||
23544847|NCT04495374|65726986|FG000|Overall Study|Protocol Violation|2|||
23544848|NCT04495374|65726987|FG001|Overall Study|Protocol Violation|1|||
23544849|NCT03321019|65726988|FG000|Overall Study|Withdrawal by Subject|0|||
23544850|NCT03321019|65726989|FG001|Overall Study|Withdrawal by Subject|6|||
23544851|NCT03321019|65726988|FG000|Overall Study|Lost to Follow-up|0|||
23544852|NCT03321019|65726989|FG001|Overall Study|Lost to Follow-up|22|||
23544853|NCT03131648|65726990|FG000|Initial Treatment Period|Not dosed|2|||
23544854|NCT03131648|65726991|FG001|Initial Treatment Period|Not dosed|2|||
23544855|NCT03131648|65726992|FG002|Initial Treatment Period|Not dosed|0|||
23544856|NCT03131648|65726993|FG003|Initial Treatment Period|Not dosed|0|||
23544857|NCT03131648|65726994|FG004|Initial Treatment Period|Not dosed|0|||
23544858|NCT03131648|65726995|FG005|Initial Treatment Period|Not dosed|0|||
23544859|NCT03131648|65726996|FG006|Initial Treatment Period|Not dosed|0|||
23544860|NCT03131648|65726997|FG007|Initial Treatment Period|Not dosed|0|||
23544861|NCT03131648|65726990|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
23126564|NCT00983853|64211938|FG003|Overall Study|Withdrawal by Subject|0|||
23126565|NCT00983853|64211939|FG004|Overall Study|Withdrawal by Subject|1|||
23126566|NCT00983853|64211940|FG005|Overall Study|Withdrawal by Subject|0|||
23126567|NCT00983853|64211935|FG000|Overall Study|Unable to come to study follow-up visits|0|||
23126568|NCT00983853|64211936|FG001|Overall Study|Unable to come to study follow-up visits|1|||
23126569|NCT00983853|64211937|FG002|Overall Study|Unable to come to study follow-up visits|0|||
23126570|NCT00983853|64211938|FG003|Overall Study|Unable to come to study follow-up visits|0|||
23126571|NCT00983853|64211939|FG004|Overall Study|Unable to come to study follow-up visits|0|||
23126572|NCT00983853|64211940|FG005|Overall Study|Unable to come to study follow-up visits|0|||
23126573|NCT04147858|64211941|FG000|Overall Study|Adverse Event|6|||
23126574|NCT04147858|64211942|FG001|Overall Study|Adverse Event|6|||
23126575|NCT04147858|64211943|FG002|Overall Study|Adverse Event|6|||
23126576|NCT04147858|64211941|FG000|Overall Study|Lack of Efficacy|3|||
23126577|NCT04147858|64211942|FG001|Overall Study|Lack of Efficacy|3|||
23126578|NCT04147858|64211943|FG002|Overall Study|Lack of Efficacy|1|||
23544862|NCT03131648|65726991|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
23544863|NCT03131648|65726992|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23617956|NCT02660034|65988174|FG012|Overall Study|Participant moved into special access scheme|0|||
23617957|NCT02660034|65988175|FG013|Overall Study|Participant moved into special access scheme|0|||
23126579|NCT04147858|64211941|FG000|Overall Study|Lost to Follow-up|1|||
23544864|NCT03131648|65726993|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23126580|NCT04147858|64211942|FG001|Overall Study|Lost to Follow-up|6|||
23126581|NCT04147858|64211943|FG002|Overall Study|Lost to Follow-up|2|||
23126582|NCT04147858|64211941|FG000|Overall Study|Withdrawal by Subject|3|||
23544865|NCT03131648|65726994|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23544866|NCT03131648|65726995|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23544867|NCT03131648|65726996|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23544868|NCT03131648|65726997|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23126583|NCT04147858|64211942|FG001|Overall Study|Withdrawal by Subject|4|||
23126584|NCT04147858|64211943|FG002|Overall Study|Withdrawal by Subject|10|||
23126585|NCT04147858|64211941|FG000|Overall Study|Subject Noncompliance, Other|4|||
23126586|NCT04147858|64211942|FG001|Overall Study|Subject Noncompliance, Other|3|||
23544869|NCT03131648|65726990|FG000|Open-label Treatment|Discontinued IMP|0|||
23544870|NCT03131648|65726991|FG001|Open-label Treatment|Discontinued IMP|0|||
23544871|NCT03131648|65726992|FG002|Open-label Treatment|Discontinued IMP|0|||
23544872|NCT03131648|65726993|FG003|Open-label Treatment|Discontinued IMP|0|||
23126587|NCT04147858|64211943|FG002|Overall Study|Subject Noncompliance, Other|1|||
23126588|NCT01777334|64211944|FG000|Overall Study|Adverse Event|18|||
23126589|NCT01777334|64211945|FG001|Overall Study|Adverse Event|14|||
23126590|NCT01777334|64211944|FG000|Overall Study|Lack of Efficacy|15|||
23126591|NCT01777334|64211945|FG001|Overall Study|Lack of Efficacy|29|||
23126592|NCT01777334|64211944|FG000|Overall Study|Protocol Violation|3|||
23544873|NCT03131648|65726994|FG004|Open-label Treatment|Discontinued IMP|0|||
23544874|NCT03131648|65726995|FG005|Open-label Treatment|Discontinued IMP|0|||
23544875|NCT03131648|65726996|FG006|Open-label Treatment|Discontinued IMP|112|||
23544876|NCT03131648|65726997|FG007|Open-label Treatment|Discontinued IMP|0|||
23544877|NCT03131648|65726990|FG000|Open-label Treatment|Completed Week 50|0|||
23544878|NCT03131648|65726991|FG001|Open-label Treatment|Completed Week 50|0|||
23544879|NCT03131648|65726992|FG002|Open-label Treatment|Completed Week 50|0|||
23544880|NCT03131648|65726993|FG003|Open-label Treatment|Completed Week 50|0|||
23544881|NCT03131648|65726994|FG004|Open-label Treatment|Completed Week 50|0|||
23617958|NCT02660034|65988162|FG000|Overall Study|Adverse Event|1|||
23617959|NCT02660034|65988163|FG001|Overall Study|Adverse Event|0|||
23617960|NCT02660034|65988164|FG002|Overall Study|Adverse Event|0|||
23126593|NCT01777334|64211945|FG001|Overall Study|Protocol Violation|7|||
23126594|NCT01777334|64211944|FG000|Overall Study|Lost to Follow-up|3|||
23126595|NCT01777334|64211945|FG001|Overall Study|Lost to Follow-up|2|||
23126596|NCT01777334|64211944|FG000|Overall Study|Withdrawal by Subject|14|||
23126597|NCT01777334|64211945|FG001|Overall Study|Withdrawal by Subject|11|||
23126598|NCT04211389|64211948|FG000|Overall Study|Adverse Event|1|||
23126599|NCT04211389|64211949|FG001|Overall Study|Adverse Event|2|||
23126600|NCT04211389|64211948|FG000|Overall Study|Lost to Follow-up|15|||
23126601|NCT04211389|64211949|FG001|Overall Study|Lost to Follow-up|7|||
23126602|NCT04211389|64211948|FG000|Overall Study|Protocol Violation|0|||
23126603|NCT04211389|64211949|FG001|Overall Study|Protocol Violation|1|||
23126604|NCT04211389|64211948|FG000|Overall Study|Withdrawal by Subject|10|||
23126605|NCT04211389|64211949|FG001|Overall Study|Withdrawal by Subject|11|||
23126606|NCT00455741|64211950|FG000|Overall Study|Physician Decision|0|||
23126607|NCT00455741|64211951|FG001|Overall Study|Physician Decision|1|||
23126608|NCT01228175|64211954|FG000|Overall Study|Lost to Follow-up|64|||
23126609|NCT01228175|64211955|FG001|Overall Study|Lost to Follow-up|50|||
23126610|NCT01228175|64211954|FG000|Overall Study|Withdrawal by Subject|1|||
23126611|NCT01228175|64211955|FG001|Overall Study|Withdrawal by Subject|2|||
23126612|NCT01228175|64211954|FG000|Overall Study|Physician Decision|1|||
23126613|NCT01228175|64211955|FG001|Overall Study|Physician Decision|1|||
23126614|NCT00633945|64211956|FG000|Overall Study|Physician Decision|2|||
23126615|NCT01261000|64211957|FG000|Overall Study|Screen failure|1|||
23126616|NCT00666198|64211958|FG000|Overall Study|Protocol Violation|10|||
23126617|NCT00666198|64211958|FG000|Overall Study|No Visit After First Day of Treatment|13|||
23126618|NCT00666198|64211958|FG000|Overall Study|Safety Not Assessable|6|||
23126619|NCT00666198|64211958|FG000|Overall Study|No Drug Administration|4|||
23126620|NCT02638103|64211961|FG000|Overall Study|Adverse Event|13|||
23126621|NCT02638103|64211962|FG001|Overall Study|Adverse Event|12|||
23126622|NCT02638103|64211963|FG002|Overall Study|Adverse Event|19|||
23315809|NCT03414684|64899205|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
23126623|NCT02638103|64211964|FG003|Overall Study|Adverse Event|12|||
23126624|NCT02638103|64211961|FG000|Overall Study|Withdrawal by Subject|43|||
23126625|NCT02638103|64211962|FG001|Overall Study|Withdrawal by Subject|53|||
23126626|NCT02638103|64211963|FG002|Overall Study|Withdrawal by Subject|30|||
23126627|NCT02638103|64211964|FG003|Overall Study|Withdrawal by Subject|61|||
23126628|NCT02638103|64211961|FG000|Overall Study|Protocol Violation|1|||
23126629|NCT02638103|64211962|FG001|Overall Study|Protocol Violation|2|||
23126630|NCT02638103|64211963|FG002|Overall Study|Protocol Violation|1|||
23126631|NCT02638103|64211964|FG003|Overall Study|Protocol Violation|4|||
23126632|NCT02638103|64211961|FG000|Overall Study|Pregnancy|2|||
23126633|NCT02638103|64211962|FG001|Overall Study|Pregnancy|3|||
23126634|NCT02638103|64211963|FG002|Overall Study|Pregnancy|0|||
23126635|NCT02638103|64211964|FG003|Overall Study|Pregnancy|1|||
23544882|NCT03131648|65726995|FG005|Open-label Treatment|Completed Week 50|0|||
23544883|NCT03131648|65726996|FG006|Open-label Treatment|Completed Week 50|6|||
23617961|NCT02660034|65988165|FG003|Overall Study|Adverse Event|0|||
23544884|NCT03131648|65726997|FG007|Open-label Treatment|Completed Week 50|0|||
23544885|NCT03131648|65726990|FG000|Maintenance Treatment Period|Not dosed|0|||
23544886|NCT03131648|65726991|FG001|Maintenance Treatment Period|Not dosed|0|||
23544887|NCT03131648|65726992|FG002|Maintenance Treatment Period|Not dosed|3|||
23544888|NCT03131648|65726993|FG003|Maintenance Treatment Period|Not dosed|2|||
23544889|NCT03131648|65726994|FG004|Maintenance Treatment Period|Not dosed|1|||
23126636|NCT02638103|64211961|FG000|Overall Study|Non-compliance to Study Procedures|2|||
23126637|NCT02638103|64211962|FG001|Overall Study|Non-compliance to Study Procedures|1|||
23126638|NCT02638103|64211963|FG002|Overall Study|Non-compliance to Study Procedures|1|||
23126639|NCT02638103|64211964|FG003|Overall Study|Non-compliance to Study Procedures|1|||
23126640|NCT02638103|64211961|FG000|Overall Study|Lost to Follow-up|26|||
23126641|NCT02638103|64211962|FG001|Overall Study|Lost to Follow-up|33|||
23126642|NCT02638103|64211963|FG002|Overall Study|Lost to Follow-up|20|||
23126643|NCT02638103|64211964|FG003|Overall Study|Lost to Follow-up|37|||
23126644|NCT02638103|64211961|FG000|Overall Study|Lack of Efficacy|14|||
23126645|NCT02638103|64211962|FG001|Overall Study|Lack of Efficacy|10|||
23126646|NCT02638103|64211963|FG002|Overall Study|Lack of Efficacy|12|||
23126647|NCT02638103|64211964|FG003|Overall Study|Lack of Efficacy|22|||
23126648|NCT02638103|64211961|FG000|Overall Study|Other than specified|5|||
23126649|NCT02638103|64211962|FG001|Overall Study|Other than specified|4|||
23126650|NCT02638103|64211963|FG002|Overall Study|Other than specified|2|||
23126651|NCT02638103|64211964|FG003|Overall Study|Other than specified|4|||
23126652|NCT00978562|64211965|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
23126653|NCT00879775|64211966|FG000|Overall Study|Lost to Follow-up|2|||
23126654|NCT00879775|64211967|FG001|Overall Study|Lost to Follow-up|1|||
23126655|NCT02614183|64211971|FG000|Double Blind Treatment Phase|Adverse Event|10|||
23126656|NCT02614183|64211972|FG001|Double Blind Treatment Phase|Adverse Event|9|||
23126657|NCT02614183|64211973|FG002|Double Blind Treatment Phase|Adverse Event|7|||
23126658|NCT02614183|64211971|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
23126659|NCT02614183|64211972|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
23126660|NCT02614183|64211973|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
23126661|NCT02614183|64211971|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
23126662|NCT02614183|64211972|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
23126663|NCT02614183|64211973|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
23126664|NCT02614183|64211971|FG000|Double Blind Treatment Phase|Physician Decision|7|||
23126665|NCT02614183|64211972|FG001|Double Blind Treatment Phase|Physician Decision|3|||
23126666|NCT02614183|64211973|FG002|Double Blind Treatment Phase|Physician Decision|2|||
23126667|NCT02614183|64211971|FG000|Double Blind Treatment Phase|Pregnancy|2|||
23126668|NCT02614183|64211972|FG001|Double Blind Treatment Phase|Pregnancy|1|||
23126669|NCT02614183|64211973|FG002|Double Blind Treatment Phase|Pregnancy|3|||
23126670|NCT02614183|64211971|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
23126671|NCT02614183|64211972|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
23126672|NCT02614183|64211973|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
23126673|NCT02614183|64211971|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
23126674|NCT02614183|64211972|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
23544890|NCT03131648|65726995|FG005|Maintenance Treatment Period|Not dosed|0|||
23544891|NCT03131648|65726996|FG006|Maintenance Treatment Period|Not dosed|0|||
23544892|NCT03131648|65726997|FG007|Maintenance Treatment Period|Not dosed|0|||
23544893|NCT03131648|65726990|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
23544894|NCT03131648|65726991|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
23544895|NCT03131648|65726992|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
23544896|NCT03131648|65726993|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
23315810|NCT03414684|64899204|FG000|First-course Treatment|Still on treatment|3|||
23315811|NCT03414684|64899205|FG001|First-course Treatment|Still on treatment|0|||
23544897|NCT03131648|65726994|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
23126675|NCT02614183|64211973|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
23126676|NCT02614183|64211971|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
23126677|NCT02614183|64211972|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
23126678|NCT02614183|64211973|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
23126679|NCT02614183|64211971|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
23126680|NCT02614183|64211972|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
23126681|NCT02614183|64211973|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
23126682|NCT02614183|64211971|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
23126683|NCT02614183|64211972|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
23126684|NCT02614183|64211973|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
23126685|NCT02614183|64211971|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
23126686|NCT02614183|64211972|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
23126687|NCT02614183|64211973|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
23315812|NCT03414684|64899204|FG000|First-course Treatment|Never started protocol therapy|2|||
23544898|NCT03131648|65726995|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
23544899|NCT03131648|65726996|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
23544900|NCT03131648|65726997|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
23126688|NCT02614183|64211971|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
23126689|NCT02614183|64211972|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
23126690|NCT02614183|64211973|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
23126691|NCT00632502|64211975|FG000|Overall Study|Adverse Event|0|||
23126692|NCT00632502|64211976|FG001|Overall Study|Adverse Event|1|||
23126693|NCT00632502|64211975|FG000|Overall Study|Randomized not treated|3|||
23126694|NCT00632502|64211976|FG001|Overall Study|Randomized not treated|0|||
23126695|NCT01721954|64211979|FG000|Overall Study|Death|58|||
23126696|NCT01721954|64211980|FG001|Overall Study|Death|64|||
23126697|NCT01721954|64211979|FG000|Overall Study|Withdrawal by Subject|8|||
23126698|NCT01721954|64211980|FG001|Overall Study|Withdrawal by Subject|4|||
23126699|NCT01721954|64211979|FG000|Overall Study|Adverse Event|2|||
23126700|NCT01721954|64211980|FG001|Overall Study|Adverse Event|0|||
23126701|NCT01721954|64211979|FG000|Overall Study|Lost to Follow-up|2|||
23126702|NCT01721954|64211980|FG001|Overall Study|Lost to Follow-up|1|||
23126703|NCT01607476|64215179|FG000|Overall Study|Withdrawal by Subject|1|||
23126704|NCT01607476|64215180|FG001|Overall Study|Withdrawal by Subject|0|||
23126705|NCT01607476|64215181|FG002|Overall Study|Withdrawal by Subject|1|||
23126706|NCT01607476|64215179|FG000|Overall Study|Lost to Follow-up|0|||
23126707|NCT01607476|64215180|FG001|Overall Study|Lost to Follow-up|0|||
23126708|NCT01607476|64215181|FG002|Overall Study|Lost to Follow-up|2|||
23126709|NCT01156376|64215182|FG000|Overall Study|Adverse Event|1|||
23126710|NCT01156376|64215183|FG001|Overall Study|Adverse Event|0|||
23426221|NCT00168103|65303567|FG002|Overall Study|Lost to Follow-up|0|||
23426222|NCT00168103|65303568|FG003|Overall Study|Lost to Follow-up|0|||
23426223|NCT01537081|65303570|FG000|Overall Study|Adverse Event|5|||
23426224|NCT01537081|65303571|FG001|Overall Study|Adverse Event|2|||
23426225|NCT01537081|65303572|FG002|Overall Study|Adverse Event|2|||
23426226|NCT01537081|65303570|FG000|Overall Study|Lack of Efficacy|2|||
23426227|NCT01537081|65303571|FG001|Overall Study|Lack of Efficacy|1|||
23426228|NCT01537081|65303572|FG002|Overall Study|Lack of Efficacy|0|||
23426229|NCT01537081|65303570|FG000|Overall Study|Lost to Follow-up|17|||
23426230|NCT01537081|65303571|FG001|Overall Study|Lost to Follow-up|15|||
23426231|NCT01537081|65303572|FG002|Overall Study|Lost to Follow-up|9|||
23426232|NCT01537081|65303570|FG000|Overall Study|Protocol Violation|3|||
23426233|NCT01537081|65303571|FG001|Overall Study|Protocol Violation|2|||
23426234|NCT01537081|65303572|FG002|Overall Study|Protocol Violation|2|||
23426235|NCT01537081|65303570|FG000|Overall Study|Withdrawal by Subject|6|||
23426236|NCT01537081|65303571|FG001|Overall Study|Withdrawal by Subject|11|||
23426237|NCT01537081|65303572|FG002|Overall Study|Withdrawal by Subject|3|||
23426238|NCT01537081|65303570|FG000|Overall Study|Physician Decision|5|||
23426239|NCT01537081|65303571|FG001|Overall Study|Physician Decision|6|||
23426240|NCT01537081|65303572|FG002|Overall Study|Physician Decision|0|||
23426241|NCT01537081|65303570|FG000|Overall Study|Sponsor decision|0|||
23426242|NCT01537081|65303571|FG001|Overall Study|Sponsor decision|1|||
23426243|NCT01537081|65303572|FG002|Overall Study|Sponsor decision|0|||
23426244|NCT01537081|65303570|FG000|Overall Study|Assigned but never dosed|1|||
23426245|NCT01537081|65303571|FG001|Overall Study|Assigned but never dosed|0|||
23426246|NCT01537081|65303572|FG002|Overall Study|Assigned but never dosed|0|||
23426247|NCT02680574|65303573|FG000|Overall Study|Death|137|||
23426248|NCT02680574|65303574|FG001|Overall Study|Death|137|||
23426249|NCT02680574|65303573|FG000|Overall Study|Withdrawal by Subject|17|||
23426250|NCT02680574|65303574|FG001|Overall Study|Withdrawal by Subject|9|||
23426251|NCT02680574|65303573|FG000|Overall Study|Lost to Follow-up|4|||
23426252|NCT02680574|65303574|FG001|Overall Study|Lost to Follow-up|6|||
23426253|NCT02818036|65303575|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
23426254|NCT02818036|65303576|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
23126711|NCT01156376|64215184|FG002|Overall Study|Adverse Event|1|||
23426255|NCT02818036|65303575|FG000|Overall Study|Withdrawal by Subject|1|||
23426256|NCT02818036|65303576|FG001|Overall Study|Withdrawal by Subject|0|||
23426257|NCT00160199|65303584|FG000|Overall Study|Adverse Event|5|||
23426258|NCT00160199|65303585|FG001|Overall Study|Adverse Event|14|||
23426259|NCT00160199|65303584|FG000|Overall Study|Lack of Efficacy|0|||
23426260|NCT00160199|65303585|FG001|Overall Study|Lack of Efficacy|1|||
23426261|NCT00160199|65303584|FG000|Overall Study|Lost to Follow-up|7|||
23126712|NCT01156376|64215182|FG000|Overall Study|Withdrawal by Subject|0|||
23126713|NCT01156376|64215183|FG001|Overall Study|Withdrawal by Subject|0|||
23126714|NCT01156376|64215184|FG002|Overall Study|Withdrawal by Subject|3|||
23126715|NCT01381575|64215185|FG000|Overall Study|Serious Adverse Event|1|||
23126716|NCT01381575|64215186|FG001|Overall Study|Serious Adverse Event|0|||
23126717|NCT01381575|64215187|FG002|Overall Study|Serious Adverse Event|0|||
23126718|NCT01381575|64215185|FG000|Overall Study|Non-Serious Adverse Event|0|||
23126719|NCT01381575|64215186|FG001|Overall Study|Non-Serious Adverse Event|0|||
23126720|NCT01381575|64215187|FG002|Overall Study|Non-Serious Adverse Event|1|||
23126721|NCT01381575|64215185|FG000|Overall Study|Protocol Violation|0|||
23126722|NCT01381575|64215186|FG001|Overall Study|Protocol Violation|1|||
23426262|NCT00160199|65303585|FG001|Overall Study|Lost to Follow-up|7|||
23544901|NCT03131648|65726990|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23426263|NCT00160199|65303584|FG000|Overall Study|Withdrawal by Subject|4|||
23426264|NCT00160199|65303585|FG001|Overall Study|Withdrawal by Subject|6|||
23426265|NCT00160199|65303584|FG000|Overall Study|Administrative|0|||
23426266|NCT00160199|65303585|FG001|Overall Study|Administrative|1|||
23426267|NCT00160199|65303584|FG000|Overall Study|Protocol Violation|8|||
23426268|NCT00160199|65303585|FG001|Overall Study|Protocol Violation|8|||
23426269|NCT00989235|65303586|FG000|Overall Study|Death|0|||
23544902|NCT03131648|65726991|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23544903|NCT03131648|65726992|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
23544904|NCT03131648|65726993|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
23126723|NCT01381575|64215187|FG002|Overall Study|Protocol Violation|1|||
23126724|NCT01381575|64215185|FG000|Overall Study|Withdrawal by Subject|15|||
23126725|NCT01381575|64215186|FG001|Overall Study|Withdrawal by Subject|9|||
23211987|NCT02483078|64516289|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
23211988|NCT02483078|64516288|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
23211989|NCT02483078|64516289|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
23211990|NCT02483078|64516288|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
23211991|NCT02483078|64516289|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
23211992|NCT02483078|64516288|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
23617962|NCT02660034|65988166|FG004|Overall Study|Adverse Event|0|||
23617963|NCT02660034|65988167|FG005|Overall Study|Adverse Event|0|||
23617964|NCT02660034|65988168|FG006|Overall Study|Adverse Event|0|||
23617965|NCT02660034|65988169|FG007|Overall Study|Adverse Event|0|||
23617966|NCT02660034|65988170|FG008|Overall Study|Adverse Event|0|||
23617967|NCT02660034|65988171|FG009|Overall Study|Adverse Event|0|||
23617968|NCT02660034|65988172|FG010|Overall Study|Adverse Event|0|||
23617969|NCT02660034|65988173|FG011|Overall Study|Adverse Event|0|||
23617970|NCT02660034|65988174|FG012|Overall Study|Adverse Event|0|||
23617971|NCT02660034|65988175|FG013|Overall Study|Adverse Event|0|||
23617972|NCT02660034|65988162|FG000|Overall Study|Sponsor Decision|0|||
23544905|NCT03131648|65726994|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
23544906|NCT03131648|65726995|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
23544907|NCT03131648|65726996|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23617973|NCT02660034|65988163|FG001|Overall Study|Sponsor Decision|1|||
23126726|NCT01381575|64215187|FG002|Overall Study|Withdrawal by Subject|7|||
23126727|NCT01381575|64215185|FG000|Overall Study|Migrated/moved from study area|2|||
23617974|NCT02660034|65988164|FG002|Overall Study|Sponsor Decision|2|||
23617975|NCT02660034|65988165|FG003|Overall Study|Sponsor Decision|2|||
23617976|NCT02660034|65988166|FG004|Overall Study|Sponsor Decision|3|||
23617977|NCT02660034|65988167|FG005|Overall Study|Sponsor Decision|0|||
23126728|NCT01381575|64215186|FG001|Overall Study|Migrated/moved from study area|12|||
23126729|NCT01381575|64215187|FG002|Overall Study|Migrated/moved from study area|2|||
23126730|NCT01381575|64215185|FG000|Overall Study|Lost to Follow-up|8|||
23126731|NCT01381575|64215186|FG001|Overall Study|Lost to Follow-up|17|||
23126732|NCT01381575|64215187|FG002|Overall Study|Lost to Follow-up|9|||
23126733|NCT02271984|64215188|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23617978|NCT02660034|65988168|FG006|Overall Study|Sponsor Decision|0|||
23617979|NCT02660034|65988169|FG007|Overall Study|Sponsor Decision|0|||
23617980|NCT02660034|65988170|FG008|Overall Study|Sponsor Decision|0|||
23617981|NCT02660034|65988171|FG009|Overall Study|Sponsor Decision|0|||
23617982|NCT02660034|65988172|FG010|Overall Study|Sponsor Decision|0|||
23617983|NCT02660034|65988173|FG011|Overall Study|Sponsor Decision|0|||
23617984|NCT02660034|65988174|FG012|Overall Study|Sponsor Decision|0|||
23617985|NCT02660034|65988175|FG013|Overall Study|Sponsor Decision|1|||
23617986|NCT02660034|65988162|FG000|Overall Study|Withdrawal by Subject|0|||
23617987|NCT02660034|65988163|FG001|Overall Study|Withdrawal by Subject|0|||
23211993|NCT02483078|64516289|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
23211994|NCT01686958|64516297|FG000|Overall Study|Withdrawal by Subject|1|||
23211995|NCT04031404|64516299|FG000|Baseline|Lost to Follow-up|0|||
23211996|NCT04031404|64516300|FG001|Baseline|Lost to Follow-up|1|||
23211997|NCT04031404|64516299|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
23211998|NCT04031404|64516300|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
23211999|NCT04031404|64516299|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
23212000|NCT04031404|64516300|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
23212001|NCT04031404|64516299|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
23212002|NCT04031404|64516300|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
23426270|NCT00989235|65303587|FG001|Overall Study|Death|1|||
23426271|NCT00989235|65303586|FG000|Overall Study|Adverse Event|0|||
23617988|NCT02660034|65988164|FG002|Overall Study|Withdrawal by Subject|0|||
23617989|NCT02660034|65988165|FG003|Overall Study|Withdrawal by Subject|0|||
23617990|NCT02660034|65988166|FG004|Overall Study|Withdrawal by Subject|0|||
23126734|NCT02271984|64215189|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23126735|NCT02271984|64215190|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23617991|NCT02660034|65988167|FG005|Overall Study|Withdrawal by Subject|0|||
23617992|NCT02660034|65988168|FG006|Overall Study|Withdrawal by Subject|1|||
23126736|NCT02271984|64215191|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23126737|NCT02271984|64215192|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23126738|NCT02271984|64215193|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
23126739|NCT02271984|64215194|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23126740|NCT02271984|64215195|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
23126741|NCT02271984|64215196|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23126742|NCT02271984|64215197|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23126743|NCT02271984|64215198|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23126744|NCT02271984|64215199|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
23126745|NCT04843579|64215200|FG000|Overall Study|Adverse Event|1|||
23126746|NCT04843579|64215200|FG000|Overall Study|Disease Progression|1|||
23126747|NCT01271504|64215205|FG000|Overall Study|Death|7|||
23126748|NCT01271504|64215206|FG001|Overall Study|Death|6|||
23126749|NCT01271504|64215207|FG002|Overall Study|Death|32|||
23126750|NCT01271504|64215208|FG003|Overall Study|Death|32|||
23126751|NCT01271504|64215205|FG000|Overall Study|Lost to Follow-up|0|||
23126752|NCT01271504|64215206|FG001|Overall Study|Lost to Follow-up|1|||
23126753|NCT01271504|64215207|FG002|Overall Study|Lost to Follow-up|3|||
23126754|NCT01271504|64215208|FG003|Overall Study|Lost to Follow-up|1|||
23126755|NCT01271504|64215205|FG000|Overall Study|Protocol Violation|0|||
23126756|NCT01271504|64215206|FG001|Overall Study|Protocol Violation|0|||
23126757|NCT01271504|64215207|FG002|Overall Study|Protocol Violation|0|||
23126758|NCT01271504|64215208|FG003|Overall Study|Protocol Violation|2|||
23126759|NCT01271504|64215205|FG000|Overall Study|Administrative Reasons|0|||
23126760|NCT01271504|64215206|FG001|Overall Study|Administrative Reasons|0|||
23126761|NCT01271504|64215207|FG002|Overall Study|Administrative Reasons|6|||
23544908|NCT03131648|65726997|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23544909|NCT03131648|65726990|FG000|Maintenance Treatment Period|Completed Week 50|0|||
23544910|NCT03131648|65726991|FG001|Maintenance Treatment Period|Completed Week 50|0|||
23126762|NCT01271504|64215208|FG003|Overall Study|Administrative Reasons|5|||
23126763|NCT01271504|64215205|FG000|Overall Study|Withdrawal by Subject|0|||
23126764|NCT01271504|64215206|FG001|Overall Study|Withdrawal by Subject|0|||
23126765|NCT01271504|64215207|FG002|Overall Study|Withdrawal by Subject|1|||
23126766|NCT01271504|64215208|FG003|Overall Study|Withdrawal by Subject|3|||
23126767|NCT01271504|64215205|FG000|Overall Study|Other|0|||
23126768|NCT01271504|64215206|FG001|Overall Study|Other|1|||
23126769|NCT01271504|64215207|FG002|Overall Study|Other|2|||
23126770|NCT01271504|64215208|FG003|Overall Study|Other|0|||
23126771|NCT01294397|64215212|FG000|Overall Study|Withdrawal by Subject|1|||
23126772|NCT01294397|64215212|FG000|Overall Study|Administrative Decision|1|||
23126773|NCT01939353|64215213|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
23126774|NCT01939353|64215213|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
23126775|NCT01939353|64215213|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
23126776|NCT01939353|64215213|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
23126777|NCT01939353|64215213|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
23126778|NCT00911768|64215214|FG000|Overall Study|Protocol Violation|5|||
23126779|NCT00911768|64215215|FG001|Overall Study|Protocol Violation|4|||
23126780|NCT00911768|64215214|FG000|Overall Study|Withdrawal by Subject|1|||
23126781|NCT00911768|64215215|FG001|Overall Study|Withdrawal by Subject|0|||
23126782|NCT00895895|64215216|FG000|Period 1|Adverse Event|7|||
23126783|NCT00895895|64215217|FG001|Period 1|Adverse Event|6|||
23126784|NCT00895895|64215218|FG002|Period 1|Adverse Event|4|||
23126785|NCT00895895|64215219|FG003|Period 1|Adverse Event|6|||
23126786|NCT00895895|64215220|FG004|Period 1|Adverse Event|7|||
23126787|NCT00895895|64215216|FG000|Period 1|Death|0|||
23126788|NCT00895895|64215217|FG001|Period 1|Death|0|||
23126789|NCT00895895|64215218|FG002|Period 1|Death|0|||
23126790|NCT00895895|64215219|FG003|Period 1|Death|0|||
23126791|NCT00895895|64215220|FG004|Period 1|Death|1|||
23126792|NCT00895895|64215216|FG000|Period 1|discontinued by sponsor|2|||
23126793|NCT00895895|64215217|FG001|Period 1|discontinued by sponsor|1|||
23126794|NCT00895895|64215218|FG002|Period 1|discontinued by sponsor|2|||
23126795|NCT00895895|64215219|FG003|Period 1|discontinued by sponsor|1|||
23426272|NCT00989235|65303587|FG001|Overall Study|Adverse Event|1|||
23544911|NCT03131648|65726992|FG002|Maintenance Treatment Period|Completed Week 50|0|||
23544912|NCT03131648|65726993|FG003|Maintenance Treatment Period|Completed Week 50|0|||
23126796|NCT00895895|64215220|FG004|Period 1|discontinued by sponsor|1|||
23126797|NCT00895895|64215216|FG000|Period 1|failed to return|0|||
23126798|NCT00895895|64215217|FG001|Period 1|failed to return|0|||
23126799|NCT00895895|64215218|FG002|Period 1|failed to return|1|||
23126800|NCT00895895|64215219|FG003|Period 1|failed to return|0|||
23126801|NCT00895895|64215220|FG004|Period 1|failed to return|1|||
23126802|NCT00895895|64215216|FG000|Period 1|investigator request|0|||
23126803|NCT00895895|64215217|FG001|Period 1|investigator request|1|||
23126804|NCT00895895|64215218|FG002|Period 1|investigator request|0|||
23126805|NCT00895895|64215219|FG003|Period 1|investigator request|0|||
23126806|NCT00895895|64215220|FG004|Period 1|investigator request|0|||
23126807|NCT00895895|64215216|FG000|Period 1|Lost to Follow-up|2|||
23126808|NCT00895895|64215217|FG001|Period 1|Lost to Follow-up|1|||
23126809|NCT00895895|64215218|FG002|Period 1|Lost to Follow-up|3|||
23126810|NCT00895895|64215219|FG003|Period 1|Lost to Follow-up|2|||
23126811|NCT00895895|64215220|FG004|Period 1|Lost to Follow-up|3|||
23126812|NCT00895895|64215216|FG000|Period 1|Other|1|||
23126813|NCT00895895|64215217|FG001|Period 1|Other|2|||
23126814|NCT00895895|64215218|FG002|Period 1|Other|1|||
23126815|NCT00895895|64215219|FG003|Period 1|Other|1|||
23126816|NCT00895895|64215220|FG004|Period 1|Other|1|||
23126817|NCT00895895|64215216|FG000|Period 1|Protocol Violation|0|||
23126818|NCT00895895|64215217|FG001|Period 1|Protocol Violation|1|||
23126819|NCT00895895|64215218|FG002|Period 1|Protocol Violation|0|||
23126820|NCT00895895|64215219|FG003|Period 1|Protocol Violation|0|||
23126821|NCT00895895|64215220|FG004|Period 1|Protocol Violation|0|||
23126822|NCT00895895|64215216|FG000|Period 1|Withdrawal by Subject|6|||
23126823|NCT00895895|64215217|FG001|Period 1|Withdrawal by Subject|6|||
23126824|NCT00895895|64215218|FG002|Period 1|Withdrawal by Subject|8|||
23126825|NCT00895895|64215219|FG003|Period 1|Withdrawal by Subject|2|||
23126826|NCT00895895|64215220|FG004|Period 1|Withdrawal by Subject|4|||
23126827|NCT00895895|64215216|FG000|Period 1|unsatisfactory response-efficacy|2|||
23126828|NCT00895895|64215217|FG001|Period 1|unsatisfactory response-efficacy|0|||
23126829|NCT00895895|64215218|FG002|Period 1|unsatisfactory response-efficacy|0|||
23126830|NCT00895895|64215219|FG003|Period 1|unsatisfactory response-efficacy|0|||
23126831|NCT00895895|64215220|FG004|Period 1|unsatisfactory response-efficacy|0|||
23126832|NCT00895895|64215216|FG000|Period 1|randomized and not treated|1|||
23126833|NCT00895895|64215217|FG001|Period 1|randomized and not treated|3|||
23126834|NCT00895895|64215218|FG002|Period 1|randomized and not treated|1|||
23126835|NCT00895895|64215219|FG003|Period 1|randomized and not treated|1|||
23212003|NCT04031404|64516299|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
23212004|NCT04031404|64516300|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
23212005|NCT02999100|64516301|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
23212006|NCT02999100|64516302|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
23315813|NCT03414684|64899205|FG001|First-course Treatment|Never started protocol therapy|1|||
23315814|NCT03414684|64899204|FG000|Crossover Treatment|Progressive disease|0|||
23315815|NCT03414684|64899205|FG001|Crossover Treatment|Progressive disease|12|||
23315816|NCT03414684|64899204|FG000|Crossover Treatment|Adverse Event|0|||
23315817|NCT03414684|64899205|FG001|Crossover Treatment|Adverse Event|3|||
23315818|NCT03414684|64899204|FG000|Crossover Treatment|Physician Decision|0|||
23315819|NCT03414684|64899205|FG001|Crossover Treatment|Physician Decision|1|||
23315820|NCT03414684|64899204|FG000|Crossover Treatment|Still on treatment|0|||
23315821|NCT03414684|64899205|FG001|Crossover Treatment|Still on treatment|2|||
23315822|NCT04602546|64899210|FG000|Overall Study|Training|2|||
23315823|NCT04602546|64899211|FG001|Overall Study|Training|2|||
23315824|NCT04602546|64899212|FG002|Overall Study|Training|1|||
23212007|NCT02999100|64516303|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
23212008|NCT02999100|64516304|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
23212009|NCT02999100|64516305|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
23212010|NCT02999100|64516306|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
23212011|NCT02999100|64516301|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23212012|NCT02999100|64516302|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23212013|NCT02999100|64516303|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23212014|NCT02999100|64516304|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23212015|NCT02999100|64516305|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
23212016|NCT02999100|64516306|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
23212017|NCT02999100|64516301|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23212018|NCT02999100|64516302|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23212019|NCT02999100|64516303|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
23212020|NCT02999100|64516304|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23212021|NCT02999100|64516305|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23212022|NCT02999100|64516306|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
23212023|NCT00818207|64516307|FG000|Overall Study|Adverse Event|6|||
23212024|NCT00818207|64516308|FG001|Overall Study|Adverse Event|0|||
23212025|NCT00818207|64516307|FG000|Overall Study|Lost to Follow-up|160|||
23212026|NCT00818207|64516308|FG001|Overall Study|Lost to Follow-up|146|||
23315825|NCT04602546|64899213|FG003|Overall Study|Training|2|||
23426273|NCT00989235|65303586|FG000|Overall Study|Lack of Efficacy|1|||
23212027|NCT00818207|64516307|FG000|Overall Study|Multiple reasons|11|||
23315826|NCT04602546|64899214|FG004|Overall Study|Training|0|||
23315827|NCT04602546|64899210|FG000|Overall Study|Randomized with disqualified data|2|||
23126836|NCT00895895|64215220|FG004|Period 1|randomized and not treated|2|||
23126837|NCT00895895|64215216|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
23126838|NCT00895895|64215217|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
23126839|NCT00895895|64215218|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
23126840|NCT00895895|64215219|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
23126841|NCT00895895|64215220|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
23315828|NCT04602546|64899211|FG001|Overall Study|Randomized with disqualified data|0|||
23126842|NCT00895895|64215216|FG000|After Period 1, Prior to Period 2|Other|0|||
23426274|NCT00989235|65303587|FG001|Overall Study|Lack of Efficacy|0|||
23426275|NCT00989235|65303586|FG000|Overall Study|Withdrawal of Consent|1|||
23426276|NCT00989235|65303587|FG001|Overall Study|Withdrawal of Consent|1|||
23426277|NCT00989235|65303586|FG000|Overall Study|Desire to Become Pregnant|1|||
23426278|NCT00989235|65303587|FG001|Overall Study|Desire to Become Pregnant|0|||
23426279|NCT00989235|65303586|FG000|Overall Study|Randomized by Mistake|0|||
23426280|NCT00989235|65303587|FG001|Overall Study|Randomized by Mistake|2|||
23426281|NCT00989235|65303586|FG000|Overall Study|Lost to Follow-up|0|||
23426282|NCT00989235|65303587|FG001|Overall Study|Lost to Follow-up|1|||
23426283|NCT02639338|65303588|FG000|Overall Study|Lost to Follow-up|2|||
23426284|NCT02639338|65303589|FG001|Overall Study|Lost to Follow-up|2|||
23426285|NCT02639338|65303588|FG000|Overall Study|Withdrew Consent|1|||
23426286|NCT02639338|65303589|FG001|Overall Study|Withdrew Consent|2|||
23426287|NCT02639338|65303588|FG000|Overall Study|Death|1|||
23426288|NCT02639338|65303589|FG001|Overall Study|Death|0|||
23126843|NCT00895895|64215217|FG001|After Period 1, Prior to Period 2|Other|0|||
23126844|NCT00895895|64215218|FG002|After Period 1, Prior to Period 2|Other|1|||
23126845|NCT00895895|64215219|FG003|After Period 1, Prior to Period 2|Other|0|||
23126846|NCT00895895|64215220|FG004|After Period 1, Prior to Period 2|Other|0|||
23426289|NCT02639338|65303588|FG000|Overall Study|Randomized but Not Treated|0|||
23426290|NCT02639338|65303589|FG001|Overall Study|Randomized but Not Treated|1|||
23426291|NCT01253265|65303595|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
23426292|NCT01253265|65303596|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
23426293|NCT01253265|65303597|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
23426294|NCT01253265|65303598|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
23426295|NCT01253265|65303599|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
23426296|NCT01253265|65303595|FG000|Overall Study|Withdrawal by Subject|0|||
23426297|NCT01253265|65303596|FG001|Overall Study|Withdrawal by Subject|0|||
23426298|NCT01253265|65303597|FG002|Overall Study|Withdrawal by Subject|0|||
23426299|NCT01253265|65303598|FG003|Overall Study|Withdrawal by Subject|0|||
23426300|NCT01253265|65303599|FG004|Overall Study|Withdrawal by Subject|1|||
23426301|NCT02590562|65303602|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
23426302|NCT02699450|65303607|FG000|Overall Study|Death|2|||
23426303|NCT02699450|65303608|FG001|Overall Study|Death|1|||
23426304|NCT02699450|65303609|FG002|Overall Study|Death|2|||
23426305|NCT02699450|65303607|FG000|Overall Study|Met Criteria for Study Exit|0|||
23426306|NCT02699450|65303608|FG001|Overall Study|Met Criteria for Study Exit|0|||
23426307|NCT02699450|65303609|FG002|Overall Study|Met Criteria for Study Exit|1|||
23426308|NCT02699450|65303607|FG000|Overall Study|Protocol Violation|4|||
23426309|NCT02699450|65303608|FG001|Overall Study|Protocol Violation|3|||
23126847|NCT00895895|64215216|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
23126848|NCT00895895|64215217|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
23426310|NCT02699450|65303609|FG002|Overall Study|Protocol Violation|5|||
23426311|NCT02699450|65303607|FG000|Overall Study|Lost to Follow-up|3|||
23426312|NCT02699450|65303608|FG001|Overall Study|Lost to Follow-up|0|||
23426313|NCT02699450|65303609|FG002|Overall Study|Lost to Follow-up|5|||
23426314|NCT02699450|65303607|FG000|Overall Study|Physician Decision|2|||
23426315|NCT02699450|65303608|FG001|Overall Study|Physician Decision|0|||
23426316|NCT02699450|65303609|FG002|Overall Study|Physician Decision|0|||
23426317|NCT02699450|65303607|FG000|Overall Study|Withdrawal by Subject|3|||
23426318|NCT02699450|65303608|FG001|Overall Study|Withdrawal by Subject|1|||
23426319|NCT02699450|65303609|FG002|Overall Study|Withdrawal by Subject|2|||
23426320|NCT02699450|65303607|FG000|Overall Study|Adverse Event|1|||
23426321|NCT02699450|65303608|FG001|Overall Study|Adverse Event|0|||
23426322|NCT02699450|65303609|FG002|Overall Study|Adverse Event|0|||
23426323|NCT01140568|65303610|FG000|Overall Study|disease progression|31|||
23426324|NCT01140568|65303610|FG000|Overall Study|Withdrawal by Subject|1|||
23426325|NCT01140568|65303610|FG000|Overall Study|Screen Fail|4|||
23426326|NCT04035564|65303616|FG000|Overall Study|Protocol Violation|1|||
23426327|NCT04035564|65303617|FG001|Overall Study|Protocol Violation|2|||
23426328|NCT04035564|65303616|FG000|Overall Study|No laboratory available|2|||
23426329|NCT04035564|65303617|FG001|Overall Study|No laboratory available|2|||
23426330|NCT04035564|65303616|FG000|Overall Study|Guardian declined consent|1|||
23426331|NCT04035564|65303617|FG001|Overall Study|Guardian declined consent|2|||
23426332|NCT00886119|65303618|FG000|Period 1|Did not meet inclusion criteria|1|||
23426333|NCT00886119|65303619|FG001|Period 1|Did not meet inclusion criteria|0|||
23426334|NCT00740714|65303622|FG000|Overall Study|Withdrawal by Subject|17|||
23426335|NCT00740714|65303623|FG001|Overall Study|Withdrawal by Subject|19|||
23426336|NCT00740714|65303624|FG002|Overall Study|Withdrawal by Subject|29|||
23126849|NCT00895895|64215218|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
23426337|NCT00525824|65303625|FG000|Overall Study|Adverse Event|7|||
23426338|NCT00525824|65303626|FG001|Overall Study|Adverse Event|11|||
23426339|NCT00525824|65303627|FG002|Overall Study|Adverse Event|6|||
23426340|NCT00525824|65303628|FG003|Overall Study|Adverse Event|7|||
23426341|NCT00525824|65303625|FG000|Overall Study|Withdrawal by Subject|5|||
23426342|NCT00525824|65303626|FG001|Overall Study|Withdrawal by Subject|9|||
23426343|NCT00525824|65303627|FG002|Overall Study|Withdrawal by Subject|3|||
23426344|NCT00525824|65303628|FG003|Overall Study|Withdrawal by Subject|4|||
23426345|NCT00525824|65303625|FG000|Overall Study|Lost to Follow-up|4|||
23426346|NCT00525824|65303626|FG001|Overall Study|Lost to Follow-up|2|||
23426347|NCT00525824|65303627|FG002|Overall Study|Lost to Follow-up|4|||
23426348|NCT00525824|65303628|FG003|Overall Study|Lost to Follow-up|0|||
23126850|NCT00895895|64215219|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
23212028|NCT00818207|64516308|FG001|Overall Study|Multiple reasons|12|||
23212029|NCT00818207|64516307|FG000|Overall Study|Withdrawal by Subject|42|||
23212030|NCT00818207|64516308|FG001|Overall Study|Withdrawal by Subject|104|||
23212031|NCT00818207|64516307|FG000|Overall Study|Death|3|||
23212032|NCT00818207|64516308|FG001|Overall Study|Death|5|||
23212033|NCT02420223|64516309|FG000|Overall Study|Adverse Event|1|||
23212034|NCT02420223|64516310|FG001|Overall Study|Adverse Event|0|||
23212035|NCT02420223|64516309|FG000|Overall Study|Physician Decision|0|||
23212036|NCT02420223|64516310|FG001|Overall Study|Physician Decision|2|||
23212037|NCT02017899|64516311|FG000|Overall Study|Withdrawal by Subject|0|||
23212038|NCT02017899|64516312|FG001|Overall Study|Withdrawal by Subject|0|||
23212039|NCT02017899|64516313|FG002|Overall Study|Withdrawal by Subject|0|||
23212040|NCT02017899|64516314|FG003|Overall Study|Withdrawal by Subject|1|||
23212041|NCT02017899|64516315|FG004|Overall Study|Withdrawal by Subject|1|||
23212042|NCT02017899|64516316|FG005|Overall Study|Withdrawal by Subject|0|||
23212043|NCT02447458|64516317|FG000|Overall Study|Other|0|||
23212044|NCT02447458|64516318|FG001|Overall Study|Other|0|||
23212045|NCT02447458|64516319|FG002|Overall Study|Other|1|||
23212046|NCT02447458|64516320|FG003|Overall Study|Other|0|||
23212047|NCT02447458|64516321|FG004|Overall Study|Other|0|||
23212048|NCT02447458|64516322|FG005|Overall Study|Other|0|||
23212049|NCT00213980|64516335|FG000|Overall Study|Withdrawal by Subject|3|||
23212050|NCT00213980|64516336|FG001|Overall Study|Withdrawal by Subject|1|||
23126851|NCT00895895|64215220|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
23126852|NCT00895895|64215216|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
23126853|NCT00895895|64215217|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
23126854|NCT00895895|64215218|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
23126855|NCT00895895|64215219|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
23126856|NCT00895895|64215220|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
23126857|NCT00895895|64215216|FG000|Period 2|Adverse Event|3|||
23126858|NCT00895895|64215217|FG001|Period 2|Adverse Event|3|||
23126859|NCT00895895|64215218|FG002|Period 2|Adverse Event|5|||
23126860|NCT00895895|64215219|FG003|Period 2|Adverse Event|2|||
23126861|NCT00895895|64215220|FG004|Period 2|Adverse Event|5|||
23126862|NCT00895895|64215216|FG000|Period 2|Death|0|||
23126863|NCT00895895|64215217|FG001|Period 2|Death|0|||
23126864|NCT00895895|64215218|FG002|Period 2|Death|1|||
23126865|NCT00895895|64215219|FG003|Period 2|Death|0|||
23126866|NCT00895895|64215220|FG004|Period 2|Death|0|||
23126867|NCT00895895|64215216|FG000|Period 2|discontinued by sponsor|44|||
23126868|NCT00895895|64215217|FG001|Period 2|discontinued by sponsor|44|||
23126869|NCT00895895|64215218|FG002|Period 2|discontinued by sponsor|38|||
23126870|NCT00895895|64215219|FG003|Period 2|discontinued by sponsor|46|||
23126871|NCT00895895|64215220|FG004|Period 2|discontinued by sponsor|37|||
23126872|NCT00895895|64215216|FG000|Period 2|failed to return|2|||
23126873|NCT00895895|64215217|FG001|Period 2|failed to return|0|||
23126874|NCT00895895|64215218|FG002|Period 2|failed to return|0|||
23126875|NCT00895895|64215219|FG003|Period 2|failed to return|0|||
23126876|NCT00895895|64215220|FG004|Period 2|failed to return|0|||
23126877|NCT00895895|64215216|FG000|Period 2|investigator request|2|||
23126878|NCT00895895|64215217|FG001|Period 2|investigator request|0|||
23126879|NCT00895895|64215218|FG002|Period 2|investigator request|0|||
23126880|NCT00895895|64215219|FG003|Period 2|investigator request|0|||
23126881|NCT00895895|64215220|FG004|Period 2|investigator request|0|||
23126882|NCT00895895|64215216|FG000|Period 2|Lost to Follow-up|1|||
23126883|NCT00895895|64215217|FG001|Period 2|Lost to Follow-up|2|||
23126884|NCT00895895|64215218|FG002|Period 2|Lost to Follow-up|1|||
23126885|NCT00895895|64215219|FG003|Period 2|Lost to Follow-up|1|||
23126886|NCT00895895|64215220|FG004|Period 2|Lost to Follow-up|0|||
23126887|NCT00895895|64215216|FG000|Period 2|Other|1|||
23126888|NCT00895895|64215217|FG001|Period 2|Other|1|||
23212051|NCT00213980|64516335|FG000|Overall Study|Adverse Event|1|||
23315829|NCT04602546|64899212|FG002|Overall Study|Randomized with disqualified data|2|||
23426349|NCT00525824|65303625|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
23426350|NCT00525824|65303626|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
23126889|NCT00895895|64215218|FG002|Period 2|Other|3|||
23126890|NCT00895895|64215219|FG003|Period 2|Other|1|||
23126891|NCT00895895|64215220|FG004|Period 2|Other|1|||
23126892|NCT00895895|64215216|FG000|Period 2|Protocol Violation|1|||
23126893|NCT00895895|64215217|FG001|Period 2|Protocol Violation|0|||
23126894|NCT00895895|64215218|FG002|Period 2|Protocol Violation|1|||
23126895|NCT00895895|64215219|FG003|Period 2|Protocol Violation|1|||
23126896|NCT00895895|64215220|FG004|Period 2|Protocol Violation|1|||
23126897|NCT00895895|64215216|FG000|Period 2|Withdrawal by Subject|0|||
23212052|NCT00213980|64516336|FG001|Overall Study|Adverse Event|1|||
23212053|NCT00213980|64516335|FG000|Overall Study|Disease progression|0|||
23212054|NCT00213980|64516336|FG001|Overall Study|Disease progression|2|||
23212055|NCT00213980|64516335|FG000|Overall Study|Developed ovarian cancer|1|||
23212056|NCT00213980|64516336|FG001|Overall Study|Developed ovarian cancer|0|||
23212057|NCT00213980|64516335|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
23212058|NCT00213980|64516336|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
23212059|NCT00631540|64516337|FG000|Overall Study|Withdrawal by Subject|5|||
23212060|NCT00631540|64516337|FG000|Overall Study|Death|4|||
23212061|NCT00631540|64516337|FG000|Overall Study|Lost to Follow-up|2|||
23212062|NCT00631540|64516337|FG000|Overall Study|Core Lab Data Unavailable|3|||
23212063|NCT00881361|64516341|FG000|Overall Study|Terminated prior to surgery|27|||
23212064|NCT00881361|64516342|FG001|Overall Study|Terminated prior to surgery|7|||
23212065|NCT00881361|64516343|FG002|Overall Study|Terminated prior to surgery|0|||
23212066|NCT00881361|64516341|FG000|Overall Study|Ineligible|17|||
23212067|NCT00881361|64516342|FG001|Overall Study|Ineligible|2|||
23212068|NCT00881361|64516343|FG002|Overall Study|Ineligible|2|||
23212069|NCT00793182|64516350|FG000|Overall Study|Adverse Event|0|||
23212070|NCT00793182|64516351|FG001|Overall Study|Adverse Event|1|||
23212071|NCT03097614|64516355|FG000|Overall Study|Adverse Event|3|||
23315830|NCT04602546|64899213|FG003|Overall Study|Randomized with disqualified data|5|||
23315831|NCT04602546|64899214|FG004|Overall Study|Randomized with disqualified data|3|||
23426351|NCT00525824|65303627|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
23426352|NCT00525824|65303628|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
23426353|NCT00525824|65303625|FG000|Overall Study|Severe non-compliance|0|||
23126898|NCT00895895|64215217|FG001|Period 2|Withdrawal by Subject|2|||
23126899|NCT00895895|64215218|FG002|Period 2|Withdrawal by Subject|0|||
23126900|NCT00895895|64215219|FG003|Period 2|Withdrawal by Subject|3|||
23126901|NCT00895895|64215220|FG004|Period 2|Withdrawal by Subject|5|||
23126902|NCT00895895|64215216|FG000|Period 2|unsatisfactory response-efficacy|2|||
23126903|NCT00895895|64215217|FG001|Period 2|unsatisfactory response-efficacy|1|||
23126904|NCT00895895|64215218|FG002|Period 2|unsatisfactory response-efficacy|0|||
23126905|NCT00895895|64215219|FG003|Period 2|unsatisfactory response-efficacy|0|||
23426354|NCT00525824|65303626|FG001|Overall Study|Severe non-compliance|1|||
23426355|NCT00525824|65303627|FG002|Overall Study|Severe non-compliance|1|||
23426356|NCT00525824|65303628|FG003|Overall Study|Severe non-compliance|1|||
23426357|NCT00525824|65303625|FG000|Overall Study|Safety reasons|1|||
23426358|NCT00525824|65303626|FG001|Overall Study|Safety reasons|0|||
23426359|NCT00525824|65303627|FG002|Overall Study|Safety reasons|1|||
23426360|NCT00525824|65303628|FG003|Overall Study|Safety reasons|0|||
23426361|NCT00525824|65303625|FG000|Overall Study|Other|1|||
23426362|NCT00525824|65303626|FG001|Overall Study|Other|3|||
23426363|NCT00525824|65303627|FG002|Overall Study|Other|3|||
23426364|NCT00525824|65303628|FG003|Overall Study|Other|1|||
23426365|NCT02351349|65303629|FG000|Overall Study|Withdrawal by Subject|2|||
23426366|NCT02351349|65303630|FG001|Overall Study|Withdrawal by Subject|3|||
23426367|NCT00445939|65303631|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
23426368|NCT00445939|65303632|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
23426369|NCT00445939|65303633|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
23426370|NCT00445939|65303634|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
23426371|NCT00445939|65303631|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
23426372|NCT00445939|65303632|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
23426373|NCT00445939|65303633|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
23426374|NCT00445939|65303634|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
23426375|NCT00353873|65303640|FG000|Overall Study|Protocol Violation|1|||
23212072|NCT04154943|64516364|FG000|Overall Study|Study Ongoing|68|||
23212073|NCT04154943|64516364|FG000|Overall Study|Lost to Follow-up|1|||
23212074|NCT04154943|64516364|FG000|Overall Study|Decision by the Investigator|1|||
23212075|NCT04154943|64516364|FG000|Overall Study|Death|5|||
23212076|NCT04154943|64516364|FG000|Overall Study|Withdrawal by Subject|4|||
23212077|NCT01204697|64516365|FG000|Overall Study|Death|26|||
23212078|NCT01204697|64516366|FG001|Overall Study|Death|27|||
23126906|NCT00895895|64215220|FG004|Period 2|unsatisfactory response-efficacy|0|||
23126907|NCT00848484|64215221|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
23126908|NCT00848484|64215222|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
23212079|NCT01204697|64516365|FG000|Overall Study|Lost to Follow-up|3|||
23212080|NCT01204697|64516366|FG001|Overall Study|Lost to Follow-up|4|||
23212081|NCT01204697|64516365|FG000|Overall Study|Withdrawal by Subject|2|||
23315832|NCT04807400|64899215|FG000|Overall Study|Adverse Event|2|||
23426376|NCT00353873|65303641|FG001|Overall Study|Protocol Violation|2|||
23426377|NCT00353873|65303640|FG000|Overall Study|Exacerbation|1|||
23126909|NCT00848484|64215221|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
23212082|NCT01204697|64516366|FG001|Overall Study|Withdrawal by Subject|4|||
23315833|NCT04807400|64899216|FG001|Overall Study|Adverse Event|3|||
23426378|NCT00353873|65303641|FG001|Overall Study|Exacerbation|0|||
23426379|NCT00353873|65303640|FG000|Overall Study|Adverse Event|1|||
23426380|NCT00353873|65303641|FG001|Overall Study|Adverse Event|0|||
23426381|NCT00353873|65303640|FG000|Overall Study|Physician Decision|2|||
23544913|NCT03131648|65726994|FG004|Maintenance Treatment Period|Completed Week 50|1|||
23426382|NCT00353873|65303641|FG001|Overall Study|Physician Decision|0|||
23426383|NCT00353873|65303640|FG000|Overall Study|Withdrawal by Subject|1|||
23426384|NCT00353873|65303641|FG001|Overall Study|Withdrawal by Subject|1|||
23426385|NCT01610596|65303644|FG000|Overall Study|Lost to Follow-up|0|||
23426386|NCT01610596|65303645|FG001|Overall Study|Lost to Follow-up|1|||
23426387|NCT01816906|65303646|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
23426388|NCT01816906|65303647|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
23426389|NCT01816906|65303646|FG000|Six Months|Lost to Follow-up|14|||
23426390|NCT01816906|65303647|FG001|Six Months|Lost to Follow-up|16|||
23426391|NCT01816906|65303646|FG000|12 Months|Adverse Event|2|||
23426392|NCT01816906|65303647|FG001|12 Months|Adverse Event|2|||
23426393|NCT01816906|65303646|FG000|12 Months|Death|0|||
23426394|NCT01816906|65303647|FG001|12 Months|Death|2|||
23426395|NCT01816906|65303646|FG000|12 Months|Lost to Follow-up|2|||
23426396|NCT01816906|65303647|FG001|12 Months|Lost to Follow-up|1|||
23426397|NCT02133664|65303651|FG000|Overall Study|Lost to Follow-up|2|||
23426398|NCT02133664|65303652|FG001|Overall Study|Lost to Follow-up|1|||
23426399|NCT02133664|65303651|FG000|Overall Study|Adverse Event|3|||
23426400|NCT02133664|65303652|FG001|Overall Study|Adverse Event|6|||
23426401|NCT00996801|65303653|FG000|Overall Study|Adverse Event|6|||
23426402|NCT00996801|65303654|FG001|Overall Study|Adverse Event|4|||
23426403|NCT00996801|65303655|FG002|Overall Study|Adverse Event|12|||
23426404|NCT00996801|65303656|FG003|Overall Study|Adverse Event|17|||
23426405|NCT00996801|65303657|FG004|Overall Study|Adverse Event|31|||
23426406|NCT00996801|65303658|FG005|Overall Study|Adverse Event|3|||
23544914|NCT03131648|65726995|FG005|Maintenance Treatment Period|Completed Week 50|0|||
23544915|NCT03131648|65726996|FG006|Maintenance Treatment Period|Completed Week 50|0|||
23544916|NCT03131648|65726997|FG007|Maintenance Treatment Period|Completed Week 50|0|||
23126910|NCT00848484|64215222|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
23126911|NCT00848484|64215221|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
23544917|NCT03131648|65726990|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544918|NCT03131648|65726991|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544919|NCT03131648|65726992|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
23126912|NCT00848484|64215222|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
23126913|NCT00848484|64215221|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
23544920|NCT03131648|65726993|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
23126914|NCT00848484|64215222|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
23126915|NCT00848484|64215221|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
23126916|NCT00848484|64215222|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
23126917|NCT03301155|64215225|FG000|Overall Study|Сompliance with exclusion criteria|8|||
23126918|NCT03301155|64215226|FG001|Overall Study|Сompliance with exclusion criteria|7|||
23126919|NCT01989169|64215228|FG000|Period 2|Adverse Event|0|||
23126920|NCT01989169|64215229|FG001|Period 2|Adverse Event|1|||
23126921|NCT01843777|64215235|FG000|Overall Study|Withdrawal by Subject|1|||
23126922|NCT01843777|64215236|FG001|Overall Study|Withdrawal by Subject|0|||
23126923|NCT01053247|64215238|FG000|Overall Study|Withdrawal by Subject|9|||
23126924|NCT01053247|64215239|FG001|Overall Study|Withdrawal by Subject|4|||
23126925|NCT01053247|64215240|FG002|Overall Study|Withdrawal by Subject|15|||
23212083|NCT01204697|64516365|FG000|Overall Study|Randomized, but not treated|0|||
23426407|NCT00996801|65303653|FG000|Overall Study|Lack of Efficacy|3|||
23315834|NCT04807400|64899217|FG002|Overall Study|Adverse Event|3|||
23126926|NCT01053247|64215238|FG000|Overall Study|Lack of Efficacy|1|||
23426408|NCT00996801|65303654|FG001|Overall Study|Lack of Efficacy|0|||
23426409|NCT00996801|65303655|FG002|Overall Study|Lack of Efficacy|1|||
23426410|NCT00996801|65303656|FG003|Overall Study|Lack of Efficacy|3|||
23426411|NCT00996801|65303657|FG004|Overall Study|Lack of Efficacy|0|||
23426412|NCT00996801|65303658|FG005|Overall Study|Lack of Efficacy|1|||
23544921|NCT03131648|65726994|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544922|NCT03131648|65726995|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544923|NCT03131648|65726996|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
23544924|NCT03131648|65726997|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
23544925|NCT04053764|65727000|FG000|Overall Study|Withdrawal by Subject|6|||
23544926|NCT04053764|65727001|FG001|Overall Study|Withdrawal by Subject|2|||
23544927|NCT04053764|65727000|FG000|Overall Study|Physician Decision|2|||
23544928|NCT04053764|65727001|FG001|Overall Study|Physician Decision|1|||
23544929|NCT04053764|65727000|FG000|Overall Study|Adverse Event|1|||
23544930|NCT04053764|65727001|FG001|Overall Study|Adverse Event|0|||
23544931|NCT04053764|65727000|FG000|Overall Study|Pregnancy|1|||
23544932|NCT04053764|65727001|FG001|Overall Study|Pregnancy|0|||
23544933|NCT01613248|65727005|FG000|Overall Study|Adverse Event|0|||
23544934|NCT01613248|65727006|FG001|Overall Study|Adverse Event|0|||
23544935|NCT01613248|65727007|FG002|Overall Study|Adverse Event|0|||
23544936|NCT01613248|65727008|FG003|Overall Study|Adverse Event|1|||
23544937|NCT01613248|65727009|FG004|Overall Study|Adverse Event|0|||
23544938|NCT01613248|65727010|FG005|Overall Study|Adverse Event|0|||
23126927|NCT01053247|64215239|FG001|Overall Study|Lack of Efficacy|0|||
23126928|NCT01053247|64215240|FG002|Overall Study|Lack of Efficacy|1|||
23126929|NCT01053247|64215238|FG000|Overall Study|Protocol Violation|2|||
23126930|NCT01053247|64215239|FG001|Overall Study|Protocol Violation|1|||
23126931|NCT01053247|64215240|FG002|Overall Study|Protocol Violation|2|||
23126932|NCT01053247|64215238|FG000|Overall Study|Lost to Follow-up|8|||
23126933|NCT01053247|64215239|FG001|Overall Study|Lost to Follow-up|5|||
23126934|NCT01053247|64215240|FG002|Overall Study|Lost to Follow-up|7|||
23126935|NCT01053247|64215238|FG000|Overall Study|Adverse Event|0|||
23126936|NCT01053247|64215239|FG001|Overall Study|Adverse Event|9|||
23126937|NCT01053247|64215240|FG002|Overall Study|Adverse Event|3|||
23126938|NCT00335140|64215241|FG000|Overall Study|Ineligible|1|||
23126939|NCT03838731|64215245|FG000|Overall Study|Pregnancy|0|||
23126940|NCT03838731|64215246|FG001|Overall Study|Pregnancy|1|||
23126941|NCT03838731|64215245|FG000|Overall Study|Withdrawal of consent|1|||
23617993|NCT02660034|65988169|FG007|Overall Study|Withdrawal by Subject|1|||
23126942|NCT03838731|64215246|FG001|Overall Study|Withdrawal of consent|0|||
23126943|NCT04071301|64215247|FG000|Overall Study|Withdrawal by Subject|6|||
23126944|NCT04071301|64215247|FG000|Overall Study|Death|1|||
23126945|NCT01245374|64215248|FG000|Overall Study|Protocol Violation|1|||
23126946|NCT01245374|64215248|FG000|Overall Study|Withdrawal by Subject|3|||
23126947|NCT01217437|64215254|FG000|Overall Study|Adverse Event|0|||
23126948|NCT01217437|64215255|FG001|Overall Study|Adverse Event|8|||
23126949|NCT01217437|64215254|FG000|Overall Study|Death|5|||
23126950|NCT01217437|64215255|FG001|Overall Study|Death|0|||
23126951|NCT01217437|64215254|FG000|Overall Study|Lack of Efficacy|29|||
23126952|NCT01217437|64215255|FG001|Overall Study|Lack of Efficacy|25|||
23126953|NCT01217437|64215254|FG000|Overall Study|Physician Decision|8|||
23126954|NCT01217437|64215255|FG001|Overall Study|Physician Decision|5|||
23126955|NCT01217437|64215254|FG000|Overall Study|Withdrawal by Subject|0|||
23126956|NCT01217437|64215255|FG001|Overall Study|Withdrawal by Subject|2|||
23126957|NCT01217437|64215254|FG000|Overall Study|Ineligible|1|||
23126958|NCT01217437|64215255|FG001|Overall Study|Ineligible|1|||
23126959|NCT01144377|64215256|FG000|52 Week Treatment Period|Adverse Event|0|||
23126960|NCT01144377|64215257|FG001|52 Week Treatment Period|Adverse Event|0|||
23126961|NCT01144377|64215258|FG002|52 Week Treatment Period|Adverse Event|3|||
23126962|NCT01144377|64215259|FG003|52 Week Treatment Period|Adverse Event|2|||
23126963|NCT01144377|64215260|FG004|52 Week Treatment Period|Adverse Event|1|||
23126964|NCT01144377|64215256|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
23126965|NCT01144377|64215257|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
23126966|NCT01144377|64215258|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
23126967|NCT01144377|64215259|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
23126968|NCT01144377|64215260|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
23126969|NCT01144377|64215256|FG000|52 Week Treatment Period|Protocol Violation|0|||
23126970|NCT01144377|64215257|FG001|52 Week Treatment Period|Protocol Violation|0|||
23126971|NCT01144377|64215258|FG002|52 Week Treatment Period|Protocol Violation|0|||
23126972|NCT01144377|64215259|FG003|52 Week Treatment Period|Protocol Violation|0|||
23126973|NCT01144377|64215260|FG004|52 Week Treatment Period|Protocol Violation|1|||
23126974|NCT01144377|64215256|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
23126975|NCT01144377|64215257|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
23126976|NCT01144377|64215258|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
23126977|NCT01144377|64215259|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
23126978|NCT01144377|64215260|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
23126979|NCT01144377|64215256|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
23126980|NCT01144377|64215257|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
23126981|NCT01144377|64215258|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
23126982|NCT01144377|64215259|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
23126983|NCT01144377|64215260|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
23126984|NCT01144377|64215256|FG000|52 Week Treatment Period|Sponsor Decision|0|||
23126985|NCT01144377|64215257|FG001|52 Week Treatment Period|Sponsor Decision|0|||
23126986|NCT01144377|64215258|FG002|52 Week Treatment Period|Sponsor Decision|0|||
23126987|NCT01144377|64215259|FG003|52 Week Treatment Period|Sponsor Decision|0|||
23126988|NCT01144377|64215260|FG004|52 Week Treatment Period|Sponsor Decision|1|||
23126989|NCT01144377|64215256|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
23126990|NCT01144377|64215257|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
23126991|NCT01144377|64215258|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
23126992|NCT01144377|64215259|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
23126993|NCT01144377|64215260|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
23126994|NCT01144377|64215256|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
23126995|NCT01144377|64215257|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
23126996|NCT01144377|64215258|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
23126997|NCT01144377|64215259|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
23126998|NCT01144377|64215260|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
23126999|NCT01144377|64215256|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
23212084|NCT01204697|64516366|FG001|Overall Study|Randomized, but not treated|1|||
23212085|NCT00673894|64516372|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
23212086|NCT00673894|64516373|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
23212087|NCT00673894|64516372|FG000|First Intervention 4 Weeks|Adverse Event|1|||
23212088|NCT00673894|64516373|FG001|First Intervention 4 Weeks|Adverse Event|0|||
23212089|NCT02247401|64516374|FG000|Overall Study|Adverse Event|1|||
23212090|NCT02247401|64516375|FG001|Overall Study|Adverse Event|0|||
23212091|NCT02247401|64516376|FG002|Overall Study|Adverse Event|0|||
23212092|NCT02247401|64516374|FG000|Overall Study|Withdrawal by Subject|4|||
23212093|NCT02247401|64516375|FG001|Overall Study|Withdrawal by Subject|1|||
23212094|NCT02247401|64516376|FG002|Overall Study|Withdrawal by Subject|1|||
23212095|NCT02247401|64516374|FG000|Overall Study|Lost to Follow-up|1|||
23212096|NCT02247401|64516375|FG001|Overall Study|Lost to Follow-up|1|||
23212097|NCT02247401|64516376|FG002|Overall Study|Lost to Follow-up|1|||
23617994|NCT02660034|65988170|FG008|Overall Study|Withdrawal by Subject|1|||
23617995|NCT02660034|65988171|FG009|Overall Study|Withdrawal by Subject|0|||
23617996|NCT02660034|65988172|FG010|Overall Study|Withdrawal by Subject|0|||
23617997|NCT02660034|65988173|FG011|Overall Study|Withdrawal by Subject|1|||
23617998|NCT02660034|65988174|FG012|Overall Study|Withdrawal by Subject|2|||
23617999|NCT02660034|65988175|FG013|Overall Study|Withdrawal by Subject|0|||
23618000|NCT02660034|65988162|FG000|Overall Study|Death|0|||
23618001|NCT02660034|65988163|FG001|Overall Study|Death|0|||
23618002|NCT02660034|65988164|FG002|Overall Study|Death|0|||
23618003|NCT02660034|65988165|FG003|Overall Study|Death|0|||
23618004|NCT02660034|65988166|FG004|Overall Study|Death|0|||
23618005|NCT02660034|65988167|FG005|Overall Study|Death|13|||
23212098|NCT02671461|64516377|FG000|Treatment|Adverse Event|0|||
23212099|NCT02671461|64516378|FG001|Treatment|Adverse Event|0|||
23544939|NCT01613248|65727005|FG000|Overall Study|Withdrawal by Subject|3|||
23544940|NCT01613248|65727006|FG001|Overall Study|Withdrawal by Subject|2|||
23544941|NCT01613248|65727007|FG002|Overall Study|Withdrawal by Subject|2|||
23544942|NCT01613248|65727008|FG003|Overall Study|Withdrawal by Subject|5|||
23544943|NCT01613248|65727009|FG004|Overall Study|Withdrawal by Subject|0|||
23544944|NCT01613248|65727010|FG005|Overall Study|Withdrawal by Subject|1|||
23544945|NCT01613248|65727005|FG000|Overall Study|Lost to Follow-up|5|||
23544946|NCT01613248|65727006|FG001|Overall Study|Lost to Follow-up|7|||
23544947|NCT01613248|65727007|FG002|Overall Study|Lost to Follow-up|4|||
23544948|NCT01613248|65727008|FG003|Overall Study|Lost to Follow-up|8|||
23544949|NCT01613248|65727009|FG004|Overall Study|Lost to Follow-up|4|||
23544950|NCT01613248|65727010|FG005|Overall Study|Lost to Follow-up|2|||
23544951|NCT01613248|65727005|FG000|Overall Study|Study Terminated by Sponsor|4|||
23544952|NCT01613248|65727006|FG001|Overall Study|Study Terminated by Sponsor|6|||
23544953|NCT01613248|65727007|FG002|Overall Study|Study Terminated by Sponsor|8|||
23544954|NCT01613248|65727008|FG003|Overall Study|Study Terminated by Sponsor|8|||
23544955|NCT01613248|65727009|FG004|Overall Study|Study Terminated by Sponsor|9|||
23544956|NCT01613248|65727010|FG005|Overall Study|Study Terminated by Sponsor|11|||
23544957|NCT01613248|65727005|FG000|Overall Study|Physician Decision|8|||
23544958|NCT01613248|65727006|FG001|Overall Study|Physician Decision|8|||
23618006|NCT02660034|65988168|FG006|Overall Study|Death|14|||
23618007|NCT02660034|65988169|FG007|Overall Study|Death|10|||
23618008|NCT02660034|65988170|FG008|Overall Study|Death|9|||
23618009|NCT02660034|65988171|FG009|Overall Study|Death|21|||
23212100|NCT02671461|64516379|FG002|Treatment|Adverse Event|1|||
23212101|NCT02671461|64516377|FG000|Treatment|Administrative Reason by Sponsor|1|||
23212102|NCT02671461|64516378|FG001|Treatment|Administrative Reason by Sponsor|3|||
23212103|NCT02671461|64516379|FG002|Treatment|Administrative Reason by Sponsor|4|||
23212104|NCT02671461|64516377|FG000|Treatment|Randomized, not treated|1|||
23426413|NCT00996801|65303653|FG000|Overall Study|Lost to Follow-up|0|||
23544959|NCT01613248|65727007|FG002|Overall Study|Physician Decision|9|||
23544960|NCT01613248|65727008|FG003|Overall Study|Physician Decision|4|||
23618010|NCT02660034|65988172|FG010|Overall Study|Death|17|||
23618011|NCT02660034|65988173|FG011|Overall Study|Death|15|||
23618012|NCT02660034|65988174|FG012|Overall Study|Death|18|||
23618013|NCT02660034|65988175|FG013|Overall Study|Death|7|||
23618014|NCT02660034|65988162|FG000|Overall Study|Physician Decision|0|||
23618015|NCT02660034|65988163|FG001|Overall Study|Physician Decision|0|||
23212105|NCT02671461|64516378|FG001|Treatment|Randomized, not treated|0|||
23212106|NCT02671461|64516379|FG002|Treatment|Randomized, not treated|0|||
23212107|NCT02671461|64516377|FG000|Follow-up|Withdrawal by Subject|1|||
23212108|NCT02671461|64516378|FG001|Follow-up|Withdrawal by Subject|0|||
23212109|NCT02671461|64516379|FG002|Follow-up|Withdrawal by Subject|0|||
23212110|NCT02671461|64516377|FG000|Follow-up|Lost to Follow-up|0|||
23212111|NCT02671461|64516378|FG001|Follow-up|Lost to Follow-up|0|||
23544961|NCT01613248|65727009|FG004|Overall Study|Physician Decision|7|||
23618016|NCT02660034|65988164|FG002|Overall Study|Physician Decision|0|||
23618017|NCT02660034|65988165|FG003|Overall Study|Physician Decision|0|||
23212112|NCT02671461|64516379|FG002|Follow-up|Lost to Follow-up|1|||
23618018|NCT02660034|65988166|FG004|Overall Study|Physician Decision|0|||
23618019|NCT02660034|65988167|FG005|Overall Study|Physician Decision|0|||
23618020|NCT02660034|65988168|FG006|Overall Study|Physician Decision|0|||
23315835|NCT04807400|64899215|FG000|Overall Study|Death|2|||
23315836|NCT04807400|64899216|FG001|Overall Study|Death|0|||
23618021|NCT02660034|65988169|FG007|Overall Study|Physician Decision|0|||
23618022|NCT02660034|65988170|FG008|Overall Study|Physician Decision|0|||
23618023|NCT02660034|65988171|FG009|Overall Study|Physician Decision|0|||
23618024|NCT02660034|65988172|FG010|Overall Study|Physician Decision|0|||
23618025|NCT02660034|65988173|FG011|Overall Study|Physician Decision|0|||
23618026|NCT02660034|65988174|FG012|Overall Study|Physician Decision|0|||
23618027|NCT02660034|65988175|FG013|Overall Study|Physician Decision|1|||
23618028|NCT02660034|65988162|FG000|Overall Study|Participants transferred to LTE|0|||
23618029|NCT02660034|65988163|FG001|Overall Study|Participants transferred to LTE|0|||
23618030|NCT02660034|65988164|FG002|Overall Study|Participants transferred to LTE|0|||
23618031|NCT02660034|65988165|FG003|Overall Study|Participants transferred to LTE|0|||
23618032|NCT02660034|65988166|FG004|Overall Study|Participants transferred to LTE|0|||
23618033|NCT02660034|65988167|FG005|Overall Study|Participants transferred to LTE|10|||
23618034|NCT02660034|65988168|FG006|Overall Study|Participants transferred to LTE|8|||
23618035|NCT02660034|65988169|FG007|Overall Study|Participants transferred to LTE|8|||
23618036|NCT02660034|65988170|FG008|Overall Study|Participants transferred to LTE|10|||
23618037|NCT02660034|65988171|FG009|Overall Study|Participants transferred to LTE|1|||
23618038|NCT02660034|65988172|FG010|Overall Study|Participants transferred to LTE|2|||
23618039|NCT02660034|65988173|FG011|Overall Study|Participants transferred to LTE|4|||
23618040|NCT02660034|65988174|FG012|Overall Study|Participants transferred to LTE|1|||
23618041|NCT02660034|65988175|FG013|Overall Study|Participants transferred to LTE|1|||
23127000|NCT01144377|64215257|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
23127001|NCT01144377|64215258|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
23127002|NCT01144377|64215259|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
23127003|NCT01144377|64215260|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
23127004|NCT01011868|64215261|FG000|After Week 18 Follow-up|Adverse Event|8|||
23127005|NCT01011868|64215262|FG001|After Week 18 Follow-up|Adverse Event|6|||
23127006|NCT01011868|64215263|FG002|After Week 18 Follow-up|Adverse Event|13|||
23127007|NCT01011868|64215261|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
23127008|NCT01011868|64215262|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
23127009|NCT01011868|64215263|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
23127010|NCT01011868|64215261|FG000|After Week 18 Follow-up|Protocol Violation|1|||
23127011|NCT01011868|64215262|FG001|After Week 18 Follow-up|Protocol Violation|1|||
23127012|NCT01011868|64215263|FG002|After Week 18 Follow-up|Protocol Violation|1|||
23127013|NCT01011868|64215261|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
23127014|NCT01011868|64215262|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
23127015|NCT01011868|64215263|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
23127016|NCT01011868|64215261|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
23127017|NCT01011868|64215262|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
23127018|NCT01011868|64215263|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
23127019|NCT01011868|64215261|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
23127020|NCT01011868|64215262|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
23127021|NCT01011868|64215263|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
23127022|NCT01011868|64215261|FG000|After Week 78 Follow-up|Adverse Event|14|||
23127023|NCT01011868|64215262|FG001|After Week 78 Follow-up|Adverse Event|18|||
23127024|NCT01011868|64215263|FG002|After Week 78 Follow-up|Adverse Event|21|||
23127025|NCT01011868|64215261|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
23127026|NCT01011868|64215262|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
23127027|NCT01011868|64215263|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
23127028|NCT01011868|64215261|FG000|After Week 78 Follow-up|Protocol Violation|9|||
23127029|NCT01011868|64215262|FG001|After Week 78 Follow-up|Protocol Violation|1|||
23127030|NCT01011868|64215263|FG002|After Week 78 Follow-up|Protocol Violation|2|||
23127031|NCT01011868|64215261|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
23127032|NCT01011868|64215262|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
23127033|NCT01011868|64215263|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
23127034|NCT01011868|64215261|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
23127035|NCT01011868|64215262|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
23127036|NCT01011868|64215263|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
23127037|NCT01011868|64215261|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
23127038|NCT01011868|64215262|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
23127039|NCT01011868|64215263|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
23127040|NCT00121667|64215264|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
23127041|NCT00121667|64215265|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
23315837|NCT04807400|64899217|FG002|Overall Study|Death|0|||
23315838|NCT04807400|64899215|FG000|Overall Study|Lost to Follow-up|8|||
23315839|NCT04807400|64899216|FG001|Overall Study|Lost to Follow-up|6|||
23315840|NCT04807400|64899217|FG002|Overall Study|Lost to Follow-up|6|||
23618042|NCT02081196|65988176|FG000|Overall Study|Lost to Follow-up|1|||
23618043|NCT03220776|65988177|FG000|Overall Study|Claustrophobia|0|||
23618044|NCT03220776|65988178|FG001|Overall Study|Claustrophobia|1|||
23618045|NCT03220776|65988179|FG002|Overall Study|Claustrophobia|1|||
23618046|NCT03220776|65988180|FG003|Overall Study|Claustrophobia|0|||
23618047|NCT03220776|65988181|FG004|Overall Study|Claustrophobia|1|||
23618048|NCT03220776|65988182|FG005|Overall Study|Claustrophobia|0|||
23618049|NCT03220776|65988177|FG000|Overall Study|MRI Equipment Failure|1|||
23618050|NCT03220776|65988178|FG001|Overall Study|MRI Equipment Failure|0|||
23618051|NCT03220776|65988179|FG002|Overall Study|MRI Equipment Failure|0|||
23618052|NCT03220776|65988180|FG003|Overall Study|MRI Equipment Failure|0|||
23618053|NCT03220776|65988181|FG004|Overall Study|MRI Equipment Failure|0|||
23618054|NCT03220776|65988182|FG005|Overall Study|MRI Equipment Failure|0|||
23618055|NCT03220776|65988177|FG000|Overall Study|Inclimate Weather|0|||
23618056|NCT03220776|65988178|FG001|Overall Study|Inclimate Weather|0|||
23618057|NCT03220776|65988179|FG002|Overall Study|Inclimate Weather|0|||
23618058|NCT03220776|65988180|FG003|Overall Study|Inclimate Weather|0|||
23618059|NCT03220776|65988181|FG004|Overall Study|Inclimate Weather|0|||
23618060|NCT03220776|65988182|FG005|Overall Study|Inclimate Weather|1|||
23618061|NCT03220776|65988177|FG000|Overall Study|Physician Decision|0|||
23618062|NCT03220776|65988178|FG001|Overall Study|Physician Decision|0|||
23618063|NCT03220776|65988179|FG002|Overall Study|Physician Decision|0|||
23618064|NCT03220776|65988180|FG003|Overall Study|Physician Decision|1|||
23618065|NCT03220776|65988181|FG004|Overall Study|Physician Decision|0|||
23618066|NCT03220776|65988182|FG005|Overall Study|Physician Decision|0|||
23618067|NCT03220776|65988177|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618068|NCT03220776|65988178|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618069|NCT03220776|65988179|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618070|NCT03220776|65988180|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
23618071|NCT03220776|65988181|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618072|NCT03220776|65988182|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
23618073|NCT03220776|65988177|FG000|Overall Study|Protocol Violation|0|||
23618074|NCT03220776|65988178|FG001|Overall Study|Protocol Violation|0|||
23618075|NCT03220776|65988179|FG002|Overall Study|Protocol Violation|0|||
23618076|NCT03220776|65988180|FG003|Overall Study|Protocol Violation|2|||
23618077|NCT03220776|65988181|FG004|Overall Study|Protocol Violation|0|||
23618078|NCT03220776|65988182|FG005|Overall Study|Protocol Violation|1|||
23618079|NCT03220776|65988177|FG000|Overall Study|Withdrawal by Subject|1|||
23618080|NCT03220776|65988178|FG001|Overall Study|Withdrawal by Subject|0|||
23618081|NCT03220776|65988179|FG002|Overall Study|Withdrawal by Subject|0|||
23618082|NCT03220776|65988180|FG003|Overall Study|Withdrawal by Subject|0|||
23618083|NCT03220776|65988181|FG004|Overall Study|Withdrawal by Subject|0|||
23618084|NCT03220776|65988182|FG005|Overall Study|Withdrawal by Subject|0|||
23618085|NCT02261285|65988183|FG000|Overall Study|Disease progression|0|||
23618086|NCT02261285|65988184|FG001|Overall Study|Disease progression|0|||
23618087|NCT02261285|65988185|FG002|Overall Study|Disease progression|1|||
23618088|NCT00489489|65988188|FG000|Overall Study|Not treated due to protocol violation|0|||
23618089|NCT00489489|65988189|FG001|Overall Study|Not treated due to protocol violation|1|||
23618090|NCT00489489|65988190|FG002|Overall Study|Not treated due to protocol violation|1|||
23618091|NCT00489489|65988188|FG000|Overall Study|Adverse Event|1|||
23618092|NCT00489489|65988189|FG001|Overall Study|Adverse Event|1|||
23618093|NCT00489489|65988190|FG002|Overall Study|Adverse Event|1|||
23618094|NCT00489489|65988188|FG000|Overall Study|Protocol Violation|1|||
23618095|NCT00489489|65988189|FG001|Overall Study|Protocol Violation|0|||
23618096|NCT00489489|65988190|FG002|Overall Study|Protocol Violation|1|||
23618097|NCT00489489|65988188|FG000|Overall Study|Progressive disease|0|||
23618098|NCT00489489|65988189|FG001|Overall Study|Progressive disease|1|||
23618099|NCT00489489|65988190|FG002|Overall Study|Progressive disease|0|||
23618100|NCT00489489|65988188|FG000|Overall Study|Participant did not wish to continue|1|||
23618101|NCT00489489|65988189|FG001|Overall Study|Participant did not wish to continue|1|||
23618102|NCT00489489|65988190|FG002|Overall Study|Participant did not wish to continue|0|||
23618103|NCT00489489|65988188|FG000|Overall Study|Other than above|0|||
23618104|NCT00489489|65988189|FG001|Overall Study|Other than above|1|||
23618105|NCT00489489|65988190|FG002|Overall Study|Other than above|0|||
23618106|NCT01020487|65988191|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
23618107|NCT01020487|65988192|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
23618108|NCT01020487|65988193|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
23618109|NCT01020487|65988191|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
23618110|NCT01020487|65988192|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
23426414|NCT00996801|65303654|FG001|Overall Study|Lost to Follow-up|0|||
23618111|NCT01020487|65988193|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
23618112|NCT01020487|65988191|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
23618113|NCT01020487|65988192|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
23618114|NCT01020487|65988193|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
23618115|NCT01020487|65988191|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
23618116|NCT01020487|65988192|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
23618117|NCT01020487|65988193|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
23618118|NCT01020487|65988191|FG000|Part 2 Open-label Period|Adverse Event|0|||
23618119|NCT01020487|65988192|FG001|Part 2 Open-label Period|Adverse Event|4|||
23618120|NCT01020487|65988193|FG002|Part 2 Open-label Period|Adverse Event|1|||
23618121|NCT03746483|65988194|FG000|Overall Study|Adverse Event|0|||
23127042|NCT00121667|64215266|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
23127043|NCT00121667|64215267|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
23127044|NCT00121667|64215264|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
23127045|NCT00121667|64215265|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
23127046|NCT00121667|64215266|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
23127047|NCT00121667|64215267|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
23127048|NCT00121667|64215264|FG000|Short Term (ST) Period|Adverse Event|5|||
23127049|NCT00121667|64215265|FG001|Short Term (ST) Period|Adverse Event|6|||
23127050|NCT00121667|64215266|FG002|Short Term (ST) Period|Adverse Event|5|||
23127051|NCT00121667|64215267|FG003|Short Term (ST) Period|Adverse Event|3|||
23212113|NCT02671461|64516377|FG000|Follow-up|Administrative Reason by Sponsor|0|||
23618122|NCT03746483|65988195|FG001|Overall Study|Adverse Event|1|||
23618123|NCT03746483|65988194|FG000|Overall Study|Lack of Efficacy|3|||
23618124|NCT03746483|65988195|FG001|Overall Study|Lack of Efficacy|2|||
23618125|NCT03746483|65988194|FG000|Overall Study|Lost to Follow-up|1|||
23618126|NCT03746483|65988195|FG001|Overall Study|Lost to Follow-up|0|||
23618127|NCT03746483|65988194|FG000|Overall Study|Protocol Violation|2|||
23618128|NCT03746483|65988195|FG001|Overall Study|Protocol Violation|0|||
23618129|NCT00577096|65988200|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
23618130|NCT00577096|65988201|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
23618131|NCT00577096|65988200|FG000|Short Term Participation|Withdrawal by Subject|3|||
23618132|NCT00577096|65988201|FG001|Short Term Participation|Withdrawal by Subject|5|||
23618133|NCT00577096|65988200|FG000|Short Term Participation|Death|1|||
23618134|NCT00577096|65988201|FG001|Short Term Participation|Death|1|||
23618135|NCT03168425|65988202|FG000|Overall Study|Lost to Follow-up|5|||
23618136|NCT03168425|65988203|FG001|Overall Study|Lost to Follow-up|8|||
23618137|NCT03168425|65988202|FG000|Overall Study|unable to confirm post op opioids|2|||
23618138|NCT03168425|65988203|FG001|Overall Study|unable to confirm post op opioids|3|||
23618139|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
23618140|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
23618141|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
23618142|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
23618143|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
23618144|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Death|1|||
23618145|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Death|0|||
23618146|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Death|0|||
23618147|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Death|0|||
23618148|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Death|0|||
23618149|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
23618150|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
23618151|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
23618152|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
23618153|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
23618154|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
23618155|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
23618156|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
23618157|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
23618158|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
23618159|NCT03974100|65988204|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
23618160|NCT03974100|65988205|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
23618161|NCT03974100|65988206|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
23618162|NCT03974100|65988207|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
23618163|NCT03974100|65988208|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
23618164|NCT03974100|65988204|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
23618165|NCT03974100|65988205|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
23618166|NCT03974100|65988206|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
23618167|NCT03974100|65988207|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
23618168|NCT03974100|65988208|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
23618169|NCT03974100|65988204|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
23618170|NCT03974100|65988205|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
23618171|NCT03974100|65988206|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
23212114|NCT02671461|64516378|FG001|Follow-up|Administrative Reason by Sponsor|1|||
23212115|NCT02671461|64516379|FG002|Follow-up|Administrative Reason by Sponsor|0|||
23212116|NCT04209530|64516380|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
23618172|NCT03974100|65988207|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
23618173|NCT03974100|65988208|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
23618174|NCT00069277|65988209|FG000|Overall Study|Adverse Event|3|||
23618175|NCT00069277|65988209|FG000|Overall Study|Withdrawal by Subject|1|||
23618176|NCT00069277|65988209|FG000|Overall Study|Progressive Disease|15|||
23618177|NCT00069277|65988209|FG000|Overall Study|Physician Decision|2|||
23127052|NCT00121667|64215264|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
23618178|NCT02030847|65988214|FG000|Overall Study|Death|10|||
23618179|NCT02030847|65988214|FG000|Overall Study|Disease Progression|15|||
23618180|NCT02030847|65988214|FG000|Overall Study|New Cancer Therapy|8|||
23618181|NCT02030847|65988214|FG000|Overall Study|Physician Decision|3|||
23618182|NCT02030847|65988214|FG000|Overall Study|Withdrawal by Subject|1|||
23618183|NCT00627523|65988217|FG000|Overall Study|Lack of Efficacy|1|||
23618184|NCT00627523|65988218|FG001|Overall Study|Lack of Efficacy|0|||
23618185|NCT00627523|65988217|FG000|Overall Study|Withdrawal by Subject|0|||
23618186|NCT00627523|65988218|FG001|Overall Study|Withdrawal by Subject|2|||
23618187|NCT00627523|65988217|FG000|Overall Study|Other|1|||
23618188|NCT00627523|65988218|FG001|Overall Study|Other|0|||
23618189|NCT03635775|65988219|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
23618190|NCT03635775|65988220|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
23618191|NCT03635775|65988221|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
23618192|NCT03635775|65988222|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
23618193|NCT01123642|65988224|FG000|Overall Study|Lost to Follow-up|23|||
23127053|NCT00121667|64215265|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
23127054|NCT00121667|64215266|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
23127055|NCT00121667|64215267|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
23127056|NCT00121667|64215264|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
23127057|NCT00121667|64215265|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
23544962|NCT01613248|65727010|FG005|Overall Study|Physician Decision|6|||
23544963|NCT01613248|65727005|FG000|Overall Study|Lack of Qualifying Event|9|||
23127058|NCT00121667|64215266|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
23127059|NCT00121667|64215267|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
23127060|NCT00121667|64215264|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
23127061|NCT00121667|64215265|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
23127062|NCT00121667|64215266|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
23127063|NCT00121667|64215267|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
23127064|NCT00121667|64215264|FG000|Short Term (ST) Period|Other Reason|3|||
23127065|NCT00121667|64215265|FG001|Short Term (ST) Period|Other Reason|0|||
23127066|NCT00121667|64215266|FG002|Short Term (ST) Period|Other Reason|0|||
23127067|NCT00121667|64215267|FG003|Short Term (ST) Period|Other Reason|0|||
23127068|NCT00121667|64215264|FG000|Short Term (ST) Period|Death|0|||
23127069|NCT00121667|64215265|FG001|Short Term (ST) Period|Death|0|||
23127070|NCT00121667|64215266|FG002|Short Term (ST) Period|Death|0|||
23127071|NCT00121667|64215267|FG003|Short Term (ST) Period|Death|1|||
23127072|NCT00121667|64215264|FG000|Short Term (ST) Period|Pregnancy|0|||
23127073|NCT00121667|64215265|FG001|Short Term (ST) Period|Pregnancy|0|||
23127074|NCT00121667|64215266|FG002|Short Term (ST) Period|Pregnancy|0|||
23127075|NCT00121667|64215267|FG003|Short Term (ST) Period|Pregnancy|1|||
23544964|NCT01613248|65727006|FG001|Overall Study|Lack of Qualifying Event|11|||
23544965|NCT01613248|65727007|FG002|Overall Study|Lack of Qualifying Event|10|||
23544966|NCT01613248|65727008|FG003|Overall Study|Lack of Qualifying Event|11|||
23544967|NCT01613248|65727009|FG004|Overall Study|Lack of Qualifying Event|15|||
23544968|NCT01613248|65727010|FG005|Overall Study|Lack of Qualifying Event|18|||
23544969|NCT01613248|65727005|FG000|Overall Study|Pregnancy|0|||
23544970|NCT01613248|65727006|FG001|Overall Study|Pregnancy|0|||
23544971|NCT01613248|65727007|FG002|Overall Study|Pregnancy|0|||
23544972|NCT01613248|65727008|FG003|Overall Study|Pregnancy|1|||
23544973|NCT01613248|65727009|FG004|Overall Study|Pregnancy|0|||
23544974|NCT01613248|65727010|FG005|Overall Study|Pregnancy|0|||
23544975|NCT04955639|65727012|FG000|Overall Study|Withdrawal by Subject|2|||
23544976|NCT04955639|65727013|FG001|Overall Study|Withdrawal by Subject|2|||
23544977|NCT04955639|65727012|FG000|Overall Study|Week 26 survey not completed|2|||
23544978|NCT04955639|65727013|FG001|Overall Study|Week 26 survey not completed|2|||
23544979|NCT03321981|65727016|FG000|Overall Study|Progressive Disease (PD)|15|||
23544980|NCT03321981|65727017|FG001|Overall Study|Progressive Disease (PD)|30|||
23544981|NCT03321981|65727018|FG002|Overall Study|Progressive Disease (PD)|47|||
23544982|NCT03321981|65727016|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
23544983|NCT03321981|65727017|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
23544984|NCT03321981|65727018|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
23544985|NCT03321981|65727016|FG000|Overall Study|Adverse Event|0|||
23544986|NCT03321981|65727017|FG001|Overall Study|Adverse Event|0|||
23544987|NCT03321981|65727018|FG002|Overall Study|Adverse Event|2|||
23544988|NCT03321981|65727016|FG000|Overall Study|symptomatic deterioration|0|||
23544989|NCT03321981|65727017|FG001|Overall Study|symptomatic deterioration|1|||
23544990|NCT03321981|65727018|FG002|Overall Study|symptomatic deterioration|1|||
23618194|NCT01123642|65988224|FG000|Overall Study|Withdrawal by Subject|9|||
23127076|NCT00121667|64215264|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
23426415|NCT00996801|65303655|FG002|Overall Study|Lost to Follow-up|0|||
23544991|NCT03321981|65727016|FG000|Overall Study|Lack of compliance|0|||
23544992|NCT03321981|65727017|FG001|Overall Study|Lack of compliance|1|||
23544993|NCT03321981|65727018|FG002|Overall Study|Lack of compliance|0|||
23212117|NCT04209530|64516381|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
23212118|NCT04209530|64516380|FG000|Overall Study|Withdrawal by Subject|0|||
23212119|NCT04209530|64516381|FG001|Overall Study|Withdrawal by Subject|1|||
23212120|NCT05101486|64516382|FG000|Overall Study|Death|1|||
23618195|NCT01123642|65988224|FG000|Overall Study|ineligible at baseline assessment|36|||
23618196|NCT01959607|65988225|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
23618197|NCT01959607|65988226|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
23618198|NCT01959607|65988227|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23618199|NCT01959607|65988228|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
23618200|NCT01730118|65988230|FG000|Dose Escalation|Death on study|5|||
23618201|NCT01730118|65988231|FG001|Dose Escalation|Death on study|7|||
23618202|NCT01730118|65988232|FG002|Dose Escalation|Death on study|2|||
23618203|NCT01730118|65988233|FG003|Dose Escalation|Death on study|6|||
23618204|NCT01730118|65988234|FG004|Dose Escalation|Death on study|0|||
23618205|NCT01730118|65988235|FG005|Dose Escalation|Death on study|0|||
23618206|NCT01730118|65988236|FG006|Dose Escalation|Death on study|0|||
23618207|NCT01730118|65988230|FG000|Dose Escalation|Died before treatment|0|||
23618208|NCT01730118|65988231|FG001|Dose Escalation|Died before treatment|0|||
23618209|NCT01730118|65988232|FG002|Dose Escalation|Died before treatment|0|||
23618210|NCT01730118|65988233|FG003|Dose Escalation|Died before treatment|0|||
23618211|NCT01730118|65988234|FG004|Dose Escalation|Died before treatment|0|||
23618212|NCT01730118|65988235|FG005|Dose Escalation|Died before treatment|0|||
23618213|NCT01730118|65988236|FG006|Dose Escalation|Died before treatment|1|||
23618214|NCT01730118|65988230|FG000|Dose Escalation|Chose to start a different treatment|1|||
23618215|NCT01730118|65988231|FG001|Dose Escalation|Chose to start a different treatment|0|||
23618216|NCT01730118|65988232|FG002|Dose Escalation|Chose to start a different treatment|0|||
23618217|NCT01730118|65988233|FG003|Dose Escalation|Chose to start a different treatment|0|||
23618218|NCT01730118|65988234|FG004|Dose Escalation|Chose to start a different treatment|0|||
23618219|NCT01730118|65988235|FG005|Dose Escalation|Chose to start a different treatment|0|||
23618220|NCT01730118|65988236|FG006|Dose Escalation|Chose to start a different treatment|0|||
23618221|NCT01730118|65988230|FG000|Dose Escalation|Withdrawal by Subject|0|||
23618222|NCT01730118|65988231|FG001|Dose Escalation|Withdrawal by Subject|0|||
23618223|NCT01730118|65988232|FG002|Dose Escalation|Withdrawal by Subject|1|||
23618224|NCT01730118|65988233|FG003|Dose Escalation|Withdrawal by Subject|0|||
23618225|NCT01730118|65988234|FG004|Dose Escalation|Withdrawal by Subject|0|||
23618226|NCT01730118|65988235|FG005|Dose Escalation|Withdrawal by Subject|0|||
23618227|NCT01730118|65988236|FG006|Dose Escalation|Withdrawal by Subject|0|||
23618228|NCT01730118|65988230|FG000|Dose Escalation|Disease progression prior to treatment|0|||
23618229|NCT01730118|65988231|FG001|Dose Escalation|Disease progression prior to treatment|0|||
23618230|NCT01730118|65988232|FG002|Dose Escalation|Disease progression prior to treatment|0|||
23618231|NCT01730118|65988233|FG003|Dose Escalation|Disease progression prior to treatment|0|||
23618232|NCT01730118|65988234|FG004|Dose Escalation|Disease progression prior to treatment|0|||
23618233|NCT01730118|65988235|FG005|Dose Escalation|Disease progression prior to treatment|0|||
23618234|NCT01730118|65988236|FG006|Dose Escalation|Disease progression prior to treatment|1|||
23618235|NCT01730118|65988230|FG000|Dose Expansion|Death|0|||
23618236|NCT01730118|65988231|FG001|Dose Expansion|Death|0|||
23618237|NCT01730118|65988232|FG002|Dose Expansion|Death|0|||
23618238|NCT01730118|65988233|FG003|Dose Expansion|Death|0|||
23618239|NCT01730118|65988234|FG004|Dose Expansion|Death|1|||
23618240|NCT01730118|65988235|FG005|Dose Expansion|Death|0|||
23618241|NCT01730118|65988236|FG006|Dose Expansion|Death|0|||
23618242|NCT01730118|65988230|FG000|Dose Expansion|Other medical condition|0|||
23618243|NCT01730118|65988231|FG001|Dose Expansion|Other medical condition|0|||
23618244|NCT01730118|65988232|FG002|Dose Expansion|Other medical condition|0|||
23618245|NCT01730118|65988233|FG003|Dose Expansion|Other medical condition|0|||
23618246|NCT01730118|65988234|FG004|Dose Expansion|Other medical condition|1|||
23618247|NCT01730118|65988235|FG005|Dose Expansion|Other medical condition|0|||
23618248|NCT01730118|65988236|FG006|Dose Expansion|Other medical condition|0|||
23618249|NCT01730118|65988230|FG000|Dose Expansion|Withdrawal by Subject|0|||
23618250|NCT01730118|65988231|FG001|Dose Expansion|Withdrawal by Subject|0|||
23618251|NCT01730118|65988232|FG002|Dose Expansion|Withdrawal by Subject|0|||
23618252|NCT01730118|65988233|FG003|Dose Expansion|Withdrawal by Subject|0|||
23212121|NCT05101486|64516383|FG001|Overall Study|Death|0|||
23618253|NCT01730118|65988234|FG004|Dose Expansion|Withdrawal by Subject|1|||
23618254|NCT01730118|65988235|FG005|Dose Expansion|Withdrawal by Subject|0|||
23618255|NCT01730118|65988236|FG006|Dose Expansion|Withdrawal by Subject|0|||
23618256|NCT01730118|65988230|FG000|Dose Expansion|Disease progression|0|||
23618257|NCT01730118|65988231|FG001|Dose Expansion|Disease progression|0|||
23618258|NCT01730118|65988232|FG002|Dose Expansion|Disease progression|0|||
23618259|NCT01730118|65988233|FG003|Dose Expansion|Disease progression|0|||
23618260|NCT01730118|65988234|FG004|Dose Expansion|Disease progression|0|||
23212122|NCT05101486|64516384|FG002|Overall Study|Death|1|||
23212123|NCT05101486|64516382|FG000|Overall Study|Lost to Follow-up|12|||
23212124|NCT05101486|64516383|FG001|Overall Study|Lost to Follow-up|8|||
23127077|NCT00121667|64215265|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
23127078|NCT00121667|64215266|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
23127079|NCT00121667|64215267|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
23127080|NCT00121667|64215264|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
23127081|NCT00121667|64215265|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
23127082|NCT00121667|64215266|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
23127083|NCT00121667|64215267|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
23127084|NCT00121667|64215264|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
23127085|NCT00121667|64215265|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
23127086|NCT00121667|64215266|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
23127087|NCT00121667|64215267|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
23127088|NCT00121667|64215264|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
23127089|NCT00121667|64215265|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
23127090|NCT00121667|64215266|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
23127091|NCT00121667|64215267|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
23127092|NCT00121667|64215264|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
23127093|NCT00121667|64215265|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
23127094|NCT00121667|64215266|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
23127095|NCT00121667|64215267|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
23127096|NCT00121667|64215264|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
23127097|NCT00121667|64215265|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
23127098|NCT00121667|64215266|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
23127099|NCT00121667|64215267|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
23127100|NCT00121667|64215264|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
23127101|NCT00121667|64215265|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
23127102|NCT00121667|64215266|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
23127103|NCT00121667|64215267|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
23127104|NCT00121667|64215264|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
23127105|NCT00121667|64215265|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
23127106|NCT00121667|64215266|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
23127107|NCT00121667|64215267|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
23127108|NCT00121667|64215264|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
23127109|NCT00121667|64215265|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
23127110|NCT00121667|64215266|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
23127111|NCT00121667|64215267|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
23127112|NCT03519204|64215268|FG000|Overall Study|Lost to Follow-up|3|||
23127113|NCT03519204|64215269|FG001|Overall Study|Lost to Follow-up|8|||
23127114|NCT03519204|64215268|FG000|Overall Study|Withdrawal by Subject|9|||
23127115|NCT03519204|64215269|FG001|Overall Study|Withdrawal by Subject|7|||
23127116|NCT03519204|64215268|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23127117|NCT03519204|64215269|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23127118|NCT01658020|64215273|FG000|Overall Study|Adverse Event|3|||
23127119|NCT01658020|64215274|FG001|Overall Study|Adverse Event|3|||
23127120|NCT01658020|64215273|FG000|Overall Study|Lost to Follow-up|1|||
23212125|NCT05101486|64516384|FG002|Overall Study|Lost to Follow-up|17|||
23212126|NCT05101486|64516382|FG000|Overall Study|Physician Decision|1|||
23127121|NCT01658020|64215274|FG001|Overall Study|Lost to Follow-up|0|||
23127122|NCT01658020|64215273|FG000|Overall Study|Withdrawal by Subject|4|||
23127123|NCT01658020|64215274|FG001|Overall Study|Withdrawal by Subject|5|||
23127124|NCT01658020|64215273|FG000|Overall Study|Protocol Violation|0|||
23127125|NCT01658020|64215274|FG001|Overall Study|Protocol Violation|1|||
23127126|NCT01040169|64215275|FG000|Overall Study|Lost to Follow-up|3|||
23127127|NCT01040169|64215276|FG001|Overall Study|Lost to Follow-up|8|||
23127128|NCT01367847|64215277|FG000|Overall Study|Withdrawal by Subject|2|||
23127129|NCT01367847|64215278|FG001|Overall Study|Withdrawal by Subject|2|||
23127130|NCT00762476|64215285|FG000|Overall Study|Adverse Event|7|||
23127131|NCT00762476|64215286|FG001|Overall Study|Adverse Event|1|||
23127132|NCT00762476|64215285|FG000|Overall Study|Lost to Follow-up|2|||
23127133|NCT00762476|64215286|FG001|Overall Study|Lost to Follow-up|0|||
23127134|NCT00762476|64215285|FG000|Overall Study|Protocol Violation|5|||
23127135|NCT00762476|64215286|FG001|Overall Study|Protocol Violation|6|||
23127136|NCT00762476|64215285|FG000|Overall Study|Physician Decision|2|||
23127137|NCT00762476|64215286|FG001|Overall Study|Physician Decision|14|||
23212127|NCT05101486|64516383|FG001|Overall Study|Physician Decision|0|||
23212128|NCT05101486|64516384|FG002|Overall Study|Physician Decision|0|||
23315841|NCT04807400|64899215|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23426416|NCT00996801|65303656|FG003|Overall Study|Lost to Follow-up|3|||
23127138|NCT00762476|64215285|FG000|Overall Study|Withdrawal by Subject|6|||
23127139|NCT00762476|64215286|FG001|Overall Study|Withdrawal by Subject|12|||
23212129|NCT05101486|64516382|FG000|Overall Study|Protocol Violation|0|||
23212130|NCT05101486|64516383|FG001|Overall Study|Protocol Violation|0|||
23127140|NCT00762476|64215285|FG000|Overall Study|antibiotic use|0|||
23127141|NCT00762476|64215286|FG001|Overall Study|antibiotic use|1|||
23127142|NCT00762476|64215285|FG000|Overall Study|non-compliance with study visits|0|||
23127143|NCT00762476|64215286|FG001|Overall Study|non-compliance with study visits|2|||
23127144|NCT00762476|64215285|FG000|Overall Study|Seasonal allergies|1|||
23127145|NCT00762476|64215286|FG001|Overall Study|Seasonal allergies|0|||
23127146|NCT03819634|64215287|FG000|Overall Study|Physician Decision|2|||
23127147|NCT01435772|64215288|FG000|Overall Study|Adverse Event|1|||
23127148|NCT01435772|64215289|FG001|Overall Study|Adverse Event|0|||
23127149|NCT01435772|64215290|FG002|Overall Study|Adverse Event|2|||
23127150|NCT01435772|64215288|FG000|Overall Study|Withdrawal by Subject|0|||
23127151|NCT01435772|64215289|FG001|Overall Study|Withdrawal by Subject|1|||
23127152|NCT01435772|64215290|FG002|Overall Study|Withdrawal by Subject|3|||
23127153|NCT01435772|64215288|FG000|Overall Study|Other - study termination|2|||
23127154|NCT01435772|64215289|FG001|Overall Study|Other - study termination|2|||
23127155|NCT01435772|64215290|FG002|Overall Study|Other - study termination|10|||
23127156|NCT00874731|64215291|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
23127157|NCT00874731|64215292|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
23127158|NCT00874731|64215293|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
23127159|NCT00874731|64215291|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
23127160|NCT00874731|64215292|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
23127161|NCT00874731|64215293|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
23127162|NCT00874731|64215291|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
23127163|NCT00874731|64215292|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
23127164|NCT00874731|64215293|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
23127165|NCT00943852|64215294|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23127166|NCT00943852|64215295|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23127167|NCT00943852|64215296|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23127168|NCT00943852|64215297|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
23127169|NCT00943852|64215298|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23127170|NCT00943852|64215299|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23127171|NCT00943852|64215300|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23127172|NCT00943852|64215301|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23127173|NCT00943852|64215302|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23127174|NCT00943852|64215303|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
23127175|NCT00943852|64215294|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23127176|NCT00943852|64215295|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23127177|NCT00943852|64215296|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23127178|NCT00943852|64215297|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23127179|NCT00943852|64215298|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23127180|NCT00943852|64215299|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
23127181|NCT00943852|64215300|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23127182|NCT00943852|64215301|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23127183|NCT00943852|64215302|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23127184|NCT00943852|64215303|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
23127185|NCT00943852|64215294|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23127186|NCT00943852|64215295|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23127187|NCT00943852|64215296|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23127188|NCT00943852|64215297|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23127189|NCT00943852|64215298|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23127190|NCT00943852|64215299|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23127191|NCT00943852|64215300|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
23127192|NCT00943852|64215301|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23127193|NCT00943852|64215302|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23127194|NCT00943852|64215303|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
23127195|NCT00943852|64215294|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23127196|NCT00943852|64215295|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23127197|NCT00943852|64215296|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23127198|NCT00943852|64215297|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23127199|NCT00943852|64215298|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23127200|NCT00943852|64215299|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23127201|NCT00943852|64215300|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23426417|NCT00996801|65303657|FG004|Overall Study|Lost to Follow-up|3|||
23127202|NCT00943852|64215301|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
23127203|NCT00943852|64215302|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23127204|NCT00943852|64215303|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
23127205|NCT00943852|64215294|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
23127206|NCT00943852|64215295|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23127207|NCT00943852|64215296|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
23127208|NCT00943852|64215297|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
23127209|NCT00943852|64215298|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23127210|NCT00943852|64215299|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23127211|NCT00943852|64215300|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
23127212|NCT00943852|64215301|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23127213|NCT00943852|64215302|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23127214|NCT00943852|64215303|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
23127215|NCT01454739|64215304|FG000|Overall Study|Protocol Violation|2|||
23127216|NCT01454739|64215305|FG001|Overall Study|Protocol Violation|3|||
23127217|NCT01454739|64215304|FG000|Overall Study|Withdrawal by Subject|2|||
23127218|NCT01454739|64215305|FG001|Overall Study|Withdrawal by Subject|6|||
23127219|NCT01454739|64215304|FG000|Overall Study|Other|3|||
23315842|NCT04807400|64899216|FG001|Overall Study|Non-Compliance With Study Drug|4|||
23315843|NCT04807400|64899217|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23315844|NCT04807400|64899215|FG000|Overall Study|Participant Decision|20|||
23315845|NCT04807400|64899216|FG001|Overall Study|Participant Decision|19|||
23315846|NCT04807400|64899217|FG002|Overall Study|Participant Decision|26|||
23315847|NCT04807400|64899215|FG000|Overall Study|Physician Decision|0|||
23315848|NCT04807400|64899216|FG001|Overall Study|Physician Decision|1|||
23315849|NCT04807400|64899217|FG002|Overall Study|Physician Decision|0|||
23315850|NCT04807400|64899215|FG000|Overall Study|Protocol Violation|4|||
23315851|NCT04807400|64899216|FG001|Overall Study|Protocol Violation|3|||
23315852|NCT04807400|64899217|FG002|Overall Study|Protocol Violation|7|||
23315853|NCT04807400|64899215|FG000|Overall Study|Withdrawal by Subject|13|||
23315854|NCT04807400|64899216|FG001|Overall Study|Withdrawal by Subject|9|||
23315855|NCT04807400|64899217|FG002|Overall Study|Withdrawal by Subject|20|||
23315856|NCT04807400|64899215|FG000|Overall Study|Mis-randomized|1|||
23315857|NCT04807400|64899216|FG001|Overall Study|Mis-randomized|0|||
23315858|NCT04807400|64899217|FG002|Overall Study|Mis-randomized|0|||
23315859|NCT04693416|64899218|FG000|Overall Study|Lost to Follow-up|13|||
23315860|NCT04693416|64899219|FG001|Overall Study|Lost to Follow-up|0|||
23315861|NCT01377012|64899224|FG000|Core Study|Study terminated by Sponsor|47|||
23544994|NCT03321981|65727016|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
23544995|NCT03321981|65727017|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
23544996|NCT03321981|65727018|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
23544997|NCT03321981|65727016|FG000|Overall Study|Death|0|||
23127220|NCT01454739|64215305|FG001|Overall Study|Other|5|||
23127221|NCT01454739|64215304|FG000|Overall Study|Physician Decision|0|||
23127222|NCT01454739|64215305|FG001|Overall Study|Physician Decision|5|||
23127223|NCT01454739|64215304|FG000|Overall Study|Lost to Follow-up|0|||
23127224|NCT01454739|64215305|FG001|Overall Study|Lost to Follow-up|1|||
23127225|NCT01454739|64215304|FG000|Overall Study|Adverse Event|0|||
23127226|NCT01454739|64215305|FG001|Overall Study|Adverse Event|1|||
23127227|NCT00971997|64215306|FG000|Overall Study|Adverse Event|2|||
23127228|NCT00971997|64215306|FG000|Overall Study|Death|1|||
23127229|NCT00971997|64215306|FG000|Overall Study|Protocol Violation|4|||
23127230|NCT00971997|64215306|FG000|Overall Study|Withdrawal by Subject|5|||
23127231|NCT00971997|64215306|FG000|Overall Study|Physician Decision|7|||
23127232|NCT00203268|64215314|FG000|Early Treatment|only treated one headache|2|||
23127233|NCT00203268|64215314|FG000|Early Treatment|Lost to Follow-up|1|||
23127234|NCT00203268|64215314|FG000|Early Treatment|Withdrawal by Subject|1|||
23127235|NCT01850030|64215317|FG000|Overall Study|Adverse Event|64|||
23127236|NCT01850030|64215318|FG001|Overall Study|Adverse Event|82|||
23127237|NCT01850030|64215317|FG000|Overall Study|Lack of Efficacy|3|||
23127238|NCT01850030|64215318|FG001|Overall Study|Lack of Efficacy|1|||
23127239|NCT01850030|64215317|FG000|Overall Study|Lost to Follow-up|5|||
23127240|NCT01850030|64215318|FG001|Overall Study|Lost to Follow-up|5|||
23127241|NCT01850030|64215317|FG000|Overall Study|Withdrawal by Subject|3|||
23127242|NCT01850030|64215318|FG001|Overall Study|Withdrawal by Subject|4|||
23426418|NCT00996801|65303658|FG005|Overall Study|Lost to Follow-up|2|||
23426419|NCT00996801|65303653|FG000|Overall Study|Physician Decision|0|||
23544998|NCT03321981|65727017|FG001|Overall Study|Death|1|||
23127243|NCT01850030|64215317|FG000|Overall Study|Protocol Violation|24|||
23127244|NCT01850030|64215318|FG001|Overall Study|Protocol Violation|28|||
23315862|NCT01377012|64899225|FG001|Core Study|Study terminated by Sponsor|54|||
23315863|NCT01377012|64899226|FG002|Core Study|Study terminated by Sponsor|46|||
23315864|NCT01377012|64899224|FG000|Core Study|Technical problems|1|||
23315865|NCT01377012|64899225|FG001|Core Study|Technical problems|0|||
23315866|NCT01377012|64899226|FG002|Core Study|Technical problems|0|||
23315867|NCT01377012|64899224|FG000|Core Study|Withdrawal by Subject|15|||
23315868|NCT01377012|64899225|FG001|Core Study|Withdrawal by Subject|23|||
23315869|NCT01377012|64899226|FG002|Core Study|Withdrawal by Subject|18|||
23315870|NCT01377012|64899224|FG000|Core Study|Protocol Violation|7|||
23426420|NCT00996801|65303654|FG001|Overall Study|Physician Decision|0|||
23426421|NCT00996801|65303655|FG002|Overall Study|Physician Decision|0|||
23426422|NCT00996801|65303656|FG003|Overall Study|Physician Decision|1|||
23127245|NCT01850030|64215317|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
23127246|NCT01850030|64215318|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
23127247|NCT00862836|64215319|FG000|Overall Study|Withdrawal by Subject|1|||
23426423|NCT00996801|65303657|FG004|Overall Study|Physician Decision|0|||
23426424|NCT00996801|65303658|FG005|Overall Study|Physician Decision|0|||
23426425|NCT00996801|65303653|FG000|Overall Study|Progressive Disease|0|||
23426426|NCT00996801|65303654|FG001|Overall Study|Progressive Disease|1|||
23426427|NCT00996801|65303655|FG002|Overall Study|Progressive Disease|0|||
23426428|NCT00996801|65303656|FG003|Overall Study|Progressive Disease|0|||
23426429|NCT00996801|65303657|FG004|Overall Study|Progressive Disease|0|||
23426430|NCT00996801|65303658|FG005|Overall Study|Progressive Disease|0|||
23426431|NCT00996801|65303653|FG000|Overall Study|Protocol Violation|3|||
23426432|NCT00996801|65303654|FG001|Overall Study|Protocol Violation|4|||
23426433|NCT00996801|65303655|FG002|Overall Study|Protocol Violation|1|||
23426434|NCT00996801|65303656|FG003|Overall Study|Protocol Violation|2|||
23426435|NCT00996801|65303657|FG004|Overall Study|Protocol Violation|3|||
23426436|NCT00996801|65303658|FG005|Overall Study|Protocol Violation|4|||
23426437|NCT00996801|65303653|FG000|Overall Study|Study Terminated by Sponsor|0|||
23426438|NCT00996801|65303654|FG001|Overall Study|Study Terminated by Sponsor|1|||
23127248|NCT01174446|64215320|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
23127249|NCT01174446|64215321|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
23127250|NCT01174446|64215322|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
23127251|NCT01174446|64215323|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
23127252|NCT01174446|64215320|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
23127253|NCT01174446|64215321|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
23127254|NCT01174446|64215322|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
23127255|NCT01174446|64215323|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
23127256|NCT01174446|64215320|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
23127257|NCT01174446|64215321|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
23127258|NCT01174446|64215322|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
23127259|NCT01174446|64215323|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
23127260|NCT01174446|64215320|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
23127261|NCT01174446|64215321|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
23426439|NCT00996801|65303655|FG002|Overall Study|Study Terminated by Sponsor|0|||
23426440|NCT00996801|65303656|FG003|Overall Study|Study Terminated by Sponsor|0|||
23426441|NCT00996801|65303657|FG004|Overall Study|Study Terminated by Sponsor|46|||
23426442|NCT00996801|65303658|FG005|Overall Study|Study Terminated by Sponsor|0|||
23426443|NCT00996801|65303653|FG000|Overall Study|Withdrawal by Subject|8|||
23426444|NCT00996801|65303654|FG001|Overall Study|Withdrawal by Subject|6|||
23544999|NCT03321981|65727018|FG002|Overall Study|Death|0|||
23545000|NCT03321981|65727016|FG000|Overall Study|Subject withdrawal of investigational product|0|||
23127262|NCT01174446|64215322|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
23127263|NCT01174446|64215323|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
23127264|NCT02354651|64215324|FG000|Overall Study|Withdrawal by Subject|2|||
23127265|NCT02354651|64215324|FG000|Overall Study|Physician Decision|1|||
23127266|NCT00246090|64215328|FG000|Overall Study|Adverse Event|25|||
23127267|NCT00246090|64215328|FG000|Overall Study|Withdrawal by Subject|7|||
23127268|NCT00246090|64215328|FG000|Overall Study|Progressive Disease|212|||
23127269|NCT00246090|64215328|FG000|Overall Study|Clinical Progression|30|||
23127270|NCT00246090|64215328|FG000|Overall Study|Physician Decision|11|||
23127271|NCT00246090|64215328|FG000|Overall Study|Not Otherwise Specified|10|||
23127272|NCT01191008|64215329|FG000|Overall Study|Protocol Violation|7|||
23127273|NCT01191008|64215329|FG000|Overall Study|Lost to Follow-up|8|||
23315871|NCT01377012|64899225|FG001|Core Study|Protocol Violation|3|||
23315872|NCT01377012|64899226|FG002|Core Study|Protocol Violation|2|||
23426445|NCT00996801|65303655|FG002|Overall Study|Withdrawal by Subject|9|||
23426446|NCT00996801|65303656|FG003|Overall Study|Withdrawal by Subject|5|||
23426447|NCT00996801|65303657|FG004|Overall Study|Withdrawal by Subject|5|||
23426448|NCT00996801|65303658|FG005|Overall Study|Withdrawal by Subject|9|||
23426449|NCT00303446|65303661|FG000|Overall Study|Withdrawal by Subject|2|||
23426450|NCT00303446|65303662|FG001|Overall Study|Withdrawal by Subject|2|||
23426451|NCT00303446|65303661|FG000|Overall Study|Death|0|||
23426452|NCT00303446|65303662|FG001|Overall Study|Death|1|||
23426453|NCT00303446|65303661|FG000|Overall Study|Physician Decision|0|||
23545001|NCT03321981|65727017|FG001|Overall Study|Subject withdrawal of investigational product|1|||
23127274|NCT03909971|64215330|FG000|Overall Study|Other Reasons Not Specified|0|||
23127275|NCT03909971|64215331|FG001|Overall Study|Other Reasons Not Specified|1|||
23127276|NCT03909971|64215330|FG000|Overall Study|Global Deterioration of Health Status|2|||
23127277|NCT03909971|64215331|FG001|Overall Study|Global Deterioration of Health Status|1|||
23127278|NCT03909971|64215330|FG000|Overall Study|Progressive Disease|6|||
23127279|NCT03909971|64215331|FG001|Overall Study|Progressive Disease|14|||
23127280|NCT03909971|64215330|FG000|Overall Study|Death|2|||
23127281|NCT03909971|64215331|FG001|Overall Study|Death|6|||
23127282|NCT03057847|64215347|FG000|Overall Study|Lost to Follow-up|16|||
23127283|NCT02138786|64215352|FG000|Overall Study|Adverse Event|0|||
23127284|NCT02138786|64215353|FG001|Overall Study|Adverse Event|2|||
23127285|NCT02138786|64215354|FG002|Overall Study|Adverse Event|1|||
23127286|NCT02138786|64215352|FG000|Overall Study|Death|1|||
23127287|NCT02138786|64215353|FG001|Overall Study|Death|7|||
23127288|NCT02138786|64215354|FG002|Overall Study|Death|2|||
23127289|NCT02138786|64215352|FG000|Overall Study|Disease Progression|1|||
23127290|NCT02138786|64215353|FG001|Overall Study|Disease Progression|1|||
23127291|NCT02138786|64215354|FG002|Overall Study|Disease Progression|3|||
23127292|NCT02138786|64215352|FG000|Overall Study|Withdrawal by Subject|1|||
23127293|NCT02138786|64215353|FG001|Overall Study|Withdrawal by Subject|2|||
23127294|NCT02138786|64215354|FG002|Overall Study|Withdrawal by Subject|0|||
23127295|NCT02138786|64215352|FG000|Overall Study|Patient's Wish|0|||
23127296|NCT02138786|64215353|FG001|Overall Study|Patient's Wish|2|||
23212131|NCT05101486|64516384|FG002|Overall Study|Protocol Violation|1|||
23212132|NCT05101486|64516382|FG000|Overall Study|Withdrawal by Subject|5|||
23212133|NCT05101486|64516383|FG001|Overall Study|Withdrawal by Subject|2|||
23212134|NCT05101486|64516384|FG002|Overall Study|Withdrawal by Subject|4|||
23212135|NCT05101486|64516382|FG000|Overall Study|Randomized but not vaccinated|1|||
23212136|NCT05101486|64516383|FG001|Overall Study|Randomized but not vaccinated|1|||
23212137|NCT05101486|64516384|FG002|Overall Study|Randomized but not vaccinated|1|||
23212138|NCT02494778|64516385|FG000|Overall Study|Death|3|||
23212139|NCT02494778|64516385|FG000|Overall Study|Other|173|||
23212140|NCT02494778|64516385|FG000|Overall Study|Lack of Efficacy|4|||
23212141|NCT02494778|64516385|FG000|Overall Study|Adverse Event|18|||
23212142|NCT02494778|64516385|FG000|Overall Study|Withdrawal by Subject|20|||
23212143|NCT02494778|64516385|FG000|Overall Study|Lost to Follow-up|2|||
23212144|NCT02494778|64516385|FG000|Overall Study|Noncompliant with study drug admin.|1|||
23212145|NCT02591238|64516386|FG000|Overall Study|Pregnancy|1|||
23212146|NCT02591238|64516387|FG001|Overall Study|Pregnancy|0|||
23212147|NCT02591238|64516388|FG002|Overall Study|Pregnancy|0|||
23212148|NCT02591238|64516389|FG003|Overall Study|Pregnancy|0|||
23212149|NCT02591238|64516386|FG000|Overall Study|Withdrawal by Subject|0|||
23618261|NCT01730118|65988235|FG005|Dose Expansion|Disease progression|1|||
23618262|NCT01730118|65988236|FG006|Dose Expansion|Disease progression|0|||
23618263|NCT01730118|65988230|FG000|Dose Expansion|Inability to return|0|||
23618264|NCT01730118|65988231|FG001|Dose Expansion|Inability to return|0|||
23618265|NCT01730118|65988232|FG002|Dose Expansion|Inability to return|0|||
23127297|NCT02138786|64215354|FG002|Overall Study|Patient's Wish|0|||
23127298|NCT02138786|64215352|FG000|Overall Study|Sponsor Terminated Study|0|||
23127299|NCT02138786|64215353|FG001|Overall Study|Sponsor Terminated Study|1|||
23127300|NCT02138786|64215354|FG002|Overall Study|Sponsor Terminated Study|1|||
23127301|NCT02138786|64215352|FG000|Overall Study|Non-Compliance|0|||
23127302|NCT02138786|64215353|FG001|Overall Study|Non-Compliance|0|||
23127303|NCT02138786|64215354|FG002|Overall Study|Non-Compliance|1|||
23127304|NCT00790400|64215355|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
23127305|NCT00790400|64215356|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
23127306|NCT00790400|64215355|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
23127307|NCT00790400|64215356|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
23127308|NCT00790400|64215355|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
23127309|NCT00790400|64215356|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
23127310|NCT00790400|64215355|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
23127311|NCT00790400|64215356|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
23127312|NCT00790400|64215355|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
23127313|NCT00790400|64215356|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
23127314|NCT00790400|64215355|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
23127315|NCT00790400|64215356|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
23212150|NCT02591238|64516387|FG001|Overall Study|Withdrawal by Subject|0|||
23212151|NCT02591238|64516388|FG002|Overall Study|Withdrawal by Subject|0|||
23212152|NCT02591238|64516389|FG003|Overall Study|Withdrawal by Subject|1|||
23618266|NCT01730118|65988233|FG003|Dose Expansion|Inability to return|0|||
23127316|NCT00790400|64215355|FG000|Double-blind Period (Core Phase)|Death|1|||
23127317|NCT00790400|64215356|FG001|Double-blind Period (Core Phase)|Death|0|||
23127318|NCT00790400|64215355|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
23127319|NCT00790400|64215356|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
23212153|NCT02591238|64516386|FG000|Overall Study|influenza|0|||
23212154|NCT02591238|64516387|FG001|Overall Study|influenza|0|||
23127320|NCT00790400|64215355|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
23127321|NCT00790400|64215356|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
23127322|NCT00790400|64215355|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
23127323|NCT00790400|64215356|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
23127324|NCT00790400|64215355|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
23127325|NCT00790400|64215356|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
23127326|NCT00790400|64215355|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
23127327|NCT00790400|64215356|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
23127328|NCT00790400|64215355|FG000|Everolimus Period (Core or Extension)|Death|1|||
23127329|NCT00790400|64215356|FG001|Everolimus Period (Core or Extension)|Death|0|||
23127330|NCT00790400|64215355|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
23127331|NCT00790400|64215356|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
23127332|NCT00790400|64215355|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
23127333|NCT00790400|64215356|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
23127334|NCT00790400|64215355|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
23127335|NCT00790400|64215356|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
23127336|NCT00422734|64215357|FG000|Overall Study|Physician Decision|1|||
23127337|NCT00422734|64215358|FG001|Overall Study|Physician Decision|1|||
23127338|NCT00422734|64215357|FG000|Overall Study|Protocol Violation|1|||
23127339|NCT00422734|64215358|FG001|Overall Study|Protocol Violation|6|||
23127340|NCT00422734|64215357|FG000|Overall Study|Withdrawal by Subject|12|||
23127341|NCT00422734|64215358|FG001|Overall Study|Withdrawal by Subject|8|||
23127342|NCT00422734|64215357|FG000|Overall Study|Adverse Event|0|||
23127343|NCT00422734|64215358|FG001|Overall Study|Adverse Event|3|||
23127344|NCT00422734|64215357|FG000|Overall Study|Partner Decision|0|||
23127345|NCT00422734|64215358|FG001|Overall Study|Partner Decision|3|||
23127346|NCT03721172|64215365|FG000|Placebo-controlled Phase|Adverse Event|7|||
23127347|NCT03721172|64215366|FG001|Placebo-controlled Phase|Adverse Event|7|||
23127348|NCT03721172|64215367|FG002|Placebo-controlled Phase|Adverse Event|0|||
23127349|NCT03721172|64215365|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
23127350|NCT03721172|64215366|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
23127351|NCT03721172|64215367|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
23127352|NCT03721172|64215365|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
23127353|NCT03721172|64215366|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
23127354|NCT03721172|64215367|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
23127355|NCT03721172|64215365|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
23127356|NCT03721172|64215366|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
23127357|NCT03721172|64215367|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
23127358|NCT03721172|64215365|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
23127359|NCT03721172|64215366|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
23127360|NCT03721172|64215367|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
23127361|NCT03721172|64215365|FG000|Placebo-controlled Phase|Other|3|||
23127362|NCT03721172|64215366|FG001|Placebo-controlled Phase|Other|0|||
23127363|NCT03721172|64215367|FG002|Placebo-controlled Phase|Other|0|||
23127364|NCT03721172|64215365|FG000|Apremilast Extension Phase|Adverse Event|0|||
23127365|NCT03721172|64215366|FG001|Apremilast Extension Phase|Adverse Event|0|||
23127366|NCT03721172|64215367|FG002|Apremilast Extension Phase|Adverse Event|10|||
23127367|NCT03721172|64215365|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
23127368|NCT03721172|64215366|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
23127369|NCT03721172|64215367|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
23127370|NCT03721172|64215365|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
23127371|NCT03721172|64215366|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
23127372|NCT03721172|64215367|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
23127373|NCT03721172|64215365|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
23127374|NCT03721172|64215366|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
23127375|NCT03721172|64215367|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
23127376|NCT03721172|64215365|FG000|Apremilast Extension Phase|Protocol Violation|0|||
23127377|NCT03721172|64215366|FG001|Apremilast Extension Phase|Protocol Violation|0|||
23127378|NCT03721172|64215367|FG002|Apremilast Extension Phase|Protocol Violation|1|||
23127379|NCT03721172|64215365|FG000|Apremilast Extension Phase|Physician Decision|0|||
23127380|NCT03721172|64215366|FG001|Apremilast Extension Phase|Physician Decision|0|||
23127381|NCT03721172|64215367|FG002|Apremilast Extension Phase|Physician Decision|1|||
23127382|NCT03721172|64215365|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
23127383|NCT03721172|64215366|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
23127384|NCT03721172|64215367|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
23127385|NCT03721172|64215365|FG000|Apremilast Extension Phase|Other|0|||
23618267|NCT01730118|65988234|FG004|Dose Expansion|Inability to return|0|||
23127386|NCT03721172|64215366|FG001|Apremilast Extension Phase|Other|0|||
23127387|NCT03721172|64215367|FG002|Apremilast Extension Phase|Other|3|||
23127388|NCT03721172|64215365|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
23127389|NCT03721172|64215366|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
23127390|NCT03721172|64215367|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
23127391|NCT01575873|64215368|FG000|Overall Study|Withdrawal by Subject|15|||
23127392|NCT01575873|64215369|FG001|Overall Study|Withdrawal by Subject|20|||
23127393|NCT01575873|64215370|FG002|Overall Study|Withdrawal by Subject|34|||
23127394|NCT01575873|64215371|FG003|Overall Study|Withdrawal by Subject|34|||
23127395|NCT01575873|64215368|FG000|Overall Study|Adverse Event|7|||
23127396|NCT01575873|64215369|FG001|Overall Study|Adverse Event|7|||
23127397|NCT01575873|64215370|FG002|Overall Study|Adverse Event|9|||
23127398|NCT01575873|64215371|FG003|Overall Study|Adverse Event|12|||
23127399|NCT01575873|64215368|FG000|Overall Study|Lost to Follow-up|1|||
23127400|NCT01575873|64215369|FG001|Overall Study|Lost to Follow-up|3|||
23127401|NCT01575873|64215370|FG002|Overall Study|Lost to Follow-up|13|||
23127402|NCT01575873|64215371|FG003|Overall Study|Lost to Follow-up|5|||
23127403|NCT01575873|64215368|FG000|Overall Study|Death|3|||
23127404|NCT01575873|64215369|FG001|Overall Study|Death|2|||
23127405|NCT01575873|64215370|FG002|Overall Study|Death|8|||
23127406|NCT01575873|64215371|FG003|Overall Study|Death|9|||
23127407|NCT01575873|64215368|FG000|Overall Study|Noncompliance|1|||
23127408|NCT01575873|64215369|FG001|Overall Study|Noncompliance|2|||
23127409|NCT01575873|64215370|FG002|Overall Study|Noncompliance|4|||
23127410|NCT01575873|64215371|FG003|Overall Study|Noncompliance|3|||
23127411|NCT01575873|64215368|FG000|Overall Study|Administrative decision|1|||
23127412|NCT01575873|64215369|FG001|Overall Study|Administrative decision|1|||
23127413|NCT01575873|64215370|FG002|Overall Study|Administrative decision|1|||
23127414|NCT01575873|64215371|FG003|Overall Study|Administrative decision|0|||
23127415|NCT01575873|64215368|FG000|Overall Study|Protocol deviation|0|||
23127416|NCT01575873|64215369|FG001|Overall Study|Protocol deviation|1|||
23127417|NCT01575873|64215370|FG002|Overall Study|Protocol deviation|0|||
23127418|NCT01575873|64215371|FG003|Overall Study|Protocol deviation|1|||
23127419|NCT01575873|64215368|FG000|Overall Study|Requirement for Alternative Therapy|0|||
23127420|NCT01575873|64215369|FG001|Overall Study|Requirement for Alternative Therapy|0|||
23127421|NCT01575873|64215370|FG002|Overall Study|Requirement for Alternative Therapy|1|||
23127422|NCT01575873|64215371|FG003|Overall Study|Requirement for Alternative Therapy|1|||
23127423|NCT01575873|64215368|FG000|Overall Study|Other|0|||
23127424|NCT01575873|64215369|FG001|Overall Study|Other|0|||
23127425|NCT01575873|64215370|FG002|Overall Study|Other|4|||
23127426|NCT01575873|64215371|FG003|Overall Study|Other|2|||
23127427|NCT01411241|64215372|FG000|Overall Study|Protocol Violation|0|||
23212155|NCT02591238|64516388|FG002|Overall Study|influenza|0|||
23212156|NCT02591238|64516389|FG003|Overall Study|influenza|1|||
23212157|NCT02591238|64516386|FG000|Overall Study|personal circumstances|0|||
23212158|NCT02591238|64516387|FG001|Overall Study|personal circumstances|0|||
23212159|NCT02591238|64516388|FG002|Overall Study|personal circumstances|0|||
23212160|NCT02591238|64516389|FG003|Overall Study|personal circumstances|1|||
23212161|NCT02591238|64516386|FG000|Overall Study|personal circumstances|0|||
23212162|NCT02591238|64516387|FG001|Overall Study|personal circumstances|1|||
23212163|NCT02591238|64516388|FG002|Overall Study|personal circumstances|0|||
23212164|NCT02591238|64516389|FG003|Overall Study|personal circumstances|0|||
23212165|NCT01626989|64516390|FG000|Screening Period|Screen Failure|15|||
23212166|NCT01626989|64516391|FG001|Screening Period|Screen Failure|0|||
23212167|NCT01626989|64516392|FG002|Screening Period|Screen Failure|0|||
23212168|NCT01626989|64516390|FG000|Screening Period|Withdrawal by Subject|2|||
23212169|NCT01626989|64516391|FG001|Screening Period|Withdrawal by Subject|0|||
23212170|NCT01626989|64516392|FG002|Screening Period|Withdrawal by Subject|0|||
23212171|NCT04142216|64516393|FG000|Overall Study|Hospitalization|0|||
23212172|NCT04142216|64516394|FG001|Overall Study|Hospitalization|2|||
23212173|NCT04142216|64516393|FG000|Overall Study|Death|3|||
23212174|NCT04142216|64516394|FG001|Overall Study|Death|1|||
23212175|NCT04142216|64516393|FG000|Overall Study|Referral to another hemodialysis unit|3|||
23212176|NCT04142216|64516394|FG001|Overall Study|Referral to another hemodialysis unit|2|||
23127428|NCT01411241|64215373|FG001|Overall Study|Protocol Violation|5|||
23127429|NCT01411241|64215372|FG000|Overall Study|Withdrawal by Subject|9|||
23127430|NCT01411241|64215373|FG001|Overall Study|Withdrawal by Subject|10|||
23127431|NCT01411241|64215372|FG000|Overall Study|Serious Adverse Event|0|||
23212177|NCT04142216|64516393|FG000|Overall Study|Use of clove|0|||
23212178|NCT04142216|64516394|FG001|Overall Study|Use of clove|1|||
23212179|NCT04096326|64516397|FG000|Overall Study|Withdrawal by Subject|0|||
23212180|NCT04096326|64516398|FG001|Overall Study|Withdrawal by Subject|0|||
23127432|NCT01411241|64215373|FG001|Overall Study|Serious Adverse Event|3|||
23127433|NCT01411241|64215372|FG000|Overall Study|Lost to Follow-up|2|||
23127434|NCT01411241|64215373|FG001|Overall Study|Lost to Follow-up|4|||
23127435|NCT02666664|64215374|FG000|Overall Study|Physician Decision|0|||
23127436|NCT02666664|64215375|FG001|Overall Study|Physician Decision|1|||
23127437|NCT02666664|64215374|FG000|Overall Study|Protocol Violation|0|||
23127438|NCT02666664|64215375|FG001|Overall Study|Protocol Violation|2|||
23212181|NCT04096326|64516399|FG002|Overall Study|Withdrawal by Subject|0|||
23212182|NCT04096326|64516400|FG003|Overall Study|Withdrawal by Subject|0|||
23212183|NCT04096326|64516401|FG004|Overall Study|Withdrawal by Subject|0|||
23315873|NCT01377012|64899224|FG000|Core Study|Pregnancy|0|||
23127439|NCT02666664|64215374|FG000|Overall Study|Other|0|||
23127440|NCT02666664|64215375|FG001|Overall Study|Other|1|||
23127441|NCT02666664|64215374|FG000|Overall Study|Adverse Event|12|||
23426454|NCT00303446|65303662|FG001|Overall Study|Physician Decision|1|||
23426455|NCT01448824|65303666|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426456|NCT01448824|65303667|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23127442|NCT02666664|64215375|FG001|Overall Study|Adverse Event|37|||
23127443|NCT02666664|64215374|FG000|Overall Study|Withdrawal by participant|23|||
23127444|NCT02666664|64215375|FG001|Overall Study|Withdrawal by participant|40|||
23127445|NCT02666664|64215374|FG000|Overall Study|Sponsor decision|0|||
23127446|NCT02666664|64215375|FG001|Overall Study|Sponsor decision|1|||
23127447|NCT02666664|64215374|FG000|Overall Study|Lost to Follow-up|1|||
23127448|NCT02666664|64215375|FG001|Overall Study|Lost to Follow-up|2|||
23127449|NCT02879383|64215381|FG000|First 24 Weeks|Physician Decision|0|||
23127450|NCT02879383|64215382|FG001|First 24 Weeks|Physician Decision|1|||
23127451|NCT02879383|64215383|FG002|First 24 Weeks|Physician Decision|0|||
23127452|NCT02879383|64215384|FG003|First 24 Weeks|Physician Decision|0|||
23127453|NCT03274453|64215394|FG000|Overall Study|Lost to Follow-up|2|||
23127454|NCT03274453|64215395|FG001|Overall Study|Lost to Follow-up|5|||
23127455|NCT03274453|64215396|FG002|Overall Study|Lost to Follow-up|4|||
23127456|NCT03274453|64215397|FG003|Overall Study|Lost to Follow-up|1|||
23127457|NCT03274453|64215394|FG000|Overall Study|Physician Decision|2|||
23127458|NCT03274453|64215395|FG001|Overall Study|Physician Decision|0|||
23127459|NCT03274453|64215396|FG002|Overall Study|Physician Decision|0|||
23127460|NCT03274453|64215397|FG003|Overall Study|Physician Decision|3|||
23127461|NCT03274453|64215394|FG000|Overall Study|Surgery Cancelled|0|||
23127462|NCT03274453|64215395|FG001|Overall Study|Surgery Cancelled|1|||
23127463|NCT03274453|64215396|FG002|Overall Study|Surgery Cancelled|0|||
23127464|NCT03274453|64215397|FG003|Overall Study|Surgery Cancelled|0|||
23127465|NCT01987895|64215398|FG000|Overall Study|Withdrawal by Subject|12|||
23127466|NCT01987895|64215399|FG001|Overall Study|Withdrawal by Subject|7|||
23426457|NCT01448824|65303668|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426458|NCT01448824|65303669|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426459|NCT01448824|65303670|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426460|NCT01448824|65303671|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23127467|NCT01987895|64215398|FG000|Overall Study|Physician Decision|8|||
23127468|NCT01987895|64215399|FG001|Overall Study|Physician Decision|10|||
23426461|NCT01448824|65303672|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
23426462|NCT01448824|65303673|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
23426463|NCT01448824|65303666|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426464|NCT01448824|65303667|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426465|NCT01448824|65303668|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426466|NCT01448824|65303669|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
23426467|NCT01448824|65303670|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
23426468|NCT01448824|65303671|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
23426469|NCT01448824|65303672|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426470|NCT01448824|65303673|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
23426471|NCT01448824|65303666|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426472|NCT01448824|65303667|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426473|NCT01448824|65303668|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426474|NCT01448824|65303669|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23545002|NCT03321981|65727018|FG002|Overall Study|Subject withdrawal of investigational product|0|||
23545003|NCT03321981|65727016|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
23127469|NCT01987895|64215398|FG000|Overall Study|Death|7|||
23127470|NCT01987895|64215399|FG001|Overall Study|Death|7|||
23127471|NCT01987895|64215398|FG000|Overall Study|Lost to Follow-up|3|||
23127472|NCT01987895|64215399|FG001|Overall Study|Lost to Follow-up|5|||
23127473|NCT01987895|64215398|FG000|Overall Study|randomized before giving IC|0|||
23127474|NCT01987895|64215399|FG001|Overall Study|randomized before giving IC|1|||
23127475|NCT03327831|64215400|FG000|Overall Study|Lost to Follow-up|2|||
23127476|NCT04954326|64215405|FG000|Overall Study|Protocol Violation|0|||
23127477|NCT04954326|64215406|FG001|Overall Study|Protocol Violation|1|||
23127478|NCT04954326|64215405|FG000|Overall Study|Death|0|||
23127479|NCT04954326|64215406|FG001|Overall Study|Death|2|||
23127480|NCT04954326|64215405|FG000|Overall Study|Physician Decision|0|||
23426475|NCT01448824|65303670|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426476|NCT01448824|65303671|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
23426477|NCT01448824|65303672|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23545004|NCT03321981|65727017|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
23127481|NCT04954326|64215406|FG001|Overall Study|Physician Decision|1|||
23127482|NCT03510455|64215409|FG000|Overall Study|Physician Decision|1|||
23127483|NCT03019640|64215410|FG000|Overall Study|Screen Failures|4|||
23127484|NCT03019640|64215410|FG000|Overall Study|Adverse Event|3|||
23426478|NCT01448824|65303673|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
23426479|NCT01448824|65303666|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
23426480|NCT01448824|65303667|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
23127485|NCT03019640|64215410|FG000|Overall Study|Participant Relapsed|1|||
23127486|NCT05186311|64215416|FG000|Part A: Serum|Withdrawal by Subject|1|||
23127487|NCT02807883|64215417|FG000|Overall Study|Withdrawal by Subject|2|||
23127488|NCT03238963|64215418|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
23127489|NCT03238963|64215419|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
23127490|NCT03238963|64215418|FG000|Overall Study|Withdrawal by Subject|1|||
23127491|NCT03238963|64215419|FG001|Overall Study|Withdrawal by Subject|1|||
23127492|NCT03238963|64215418|FG000|Overall Study|Lost to Follow-up|1|||
23127493|NCT03238963|64215419|FG001|Overall Study|Lost to Follow-up|0|||
23127494|NCT03238963|64215418|FG000|Overall Study|Protocol Violation|1|||
23127495|NCT03238963|64215419|FG001|Overall Study|Protocol Violation|1|||
23127496|NCT03238963|64215418|FG000|Overall Study|Adverse Event|1|||
23127497|NCT03238963|64215419|FG001|Overall Study|Adverse Event|0|||
23127498|NCT03041792|64215423|FG000|Overall Study|Adverse Event|4|||
23127499|NCT03041792|64215424|FG001|Overall Study|Adverse Event|0|||
23127500|NCT03041792|64215423|FG000|Overall Study|Death in the family|0|||
23127501|NCT03041792|64215424|FG001|Overall Study|Death in the family|2|||
23127502|NCT03041792|64215423|FG000|Overall Study|Randomized but not treated|0|||
23426481|NCT01448824|65303668|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
23545005|NCT03321981|65727018|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
23545006|NCT03321981|65727016|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
23545007|NCT03321981|65727017|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
23127503|NCT03041792|64215424|FG001|Overall Study|Randomized but not treated|1|||
23127504|NCT03445533|64215426|FG000|Overall Study|Progressive Disease|48|||
23127505|NCT03445533|64215427|FG001|Overall Study|Progressive Disease|81|||
23127506|NCT03445533|64215426|FG000|Overall Study|Adverse Event|60|||
23127507|NCT03445533|64215427|FG001|Overall Study|Adverse Event|64|||
23618268|NCT01730118|65988235|FG005|Dose Expansion|Inability to return|1|||
23618269|NCT01730118|65988236|FG006|Dose Expansion|Inability to return|0|||
23618270|NCT01730118|65988230|FG000|Dose Expansion|Physician Decision|0|||
23618271|NCT01730118|65988231|FG001|Dose Expansion|Physician Decision|0|||
23618272|NCT01730118|65988232|FG002|Dose Expansion|Physician Decision|0|||
23618273|NCT01730118|65988233|FG003|Dose Expansion|Physician Decision|0|||
23127508|NCT03445533|64215426|FG000|Overall Study|Death|9|||
23212184|NCT04096326|64516402|FG005|Overall Study|Withdrawal by Subject|0|||
23212185|NCT04096326|64516403|FG006|Overall Study|Withdrawal by Subject|1|||
23212186|NCT04096326|64516404|FG007|Overall Study|Withdrawal by Subject|0|||
23212187|NCT04096326|64516405|FG008|Overall Study|Withdrawal by Subject|0|||
23212188|NCT04096326|64516406|FG009|Overall Study|Withdrawal by Subject|0|||
23212189|NCT04096326|64516397|FG000|Overall Study|Lost to Follow-up|0|||
23212190|NCT04096326|64516398|FG001|Overall Study|Lost to Follow-up|1|||
23212191|NCT04096326|64516399|FG002|Overall Study|Lost to Follow-up|0|||
23212192|NCT04096326|64516400|FG003|Overall Study|Lost to Follow-up|0|||
23545008|NCT03321981|65727018|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
23545009|NCT02308033|65727021|FG000|Overall Study|Normal Gram stain at Baseline|13|||
23545010|NCT02308033|65727022|FG001|Overall Study|Normal Gram stain at Baseline|10|||
23545011|NCT02308033|65727021|FG000|Overall Study|Positive for STD at Baseline|7|||
23545012|NCT02308033|65727022|FG001|Overall Study|Positive for STD at Baseline|4|||
23545013|NCT02308033|65727021|FG000|Overall Study|Lost to Follow-up|6|||
23545014|NCT02308033|65727022|FG001|Overall Study|Lost to Follow-up|5|||
23545015|NCT01432366|65727023|FG000|Overall Study|Non-Responder|7|||
23545016|NCT01432366|65727023|FG000|Overall Study|Adverse Event|8|||
23545017|NCT01432366|65727023|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
23618274|NCT01730118|65988234|FG004|Dose Expansion|Physician Decision|0|||
23618275|NCT01730118|65988235|FG005|Dose Expansion|Physician Decision|1|||
23127509|NCT03445533|64215427|FG001|Overall Study|Death|19|||
23127510|NCT03445533|64215426|FG000|Overall Study|Miscellaneous|0|||
23127511|NCT03445533|64215427|FG001|Overall Study|Miscellaneous|16|||
23127512|NCT03445533|64215426|FG000|Overall Study|Withdrawal by Subject|3|||
23212193|NCT04096326|64516401|FG004|Overall Study|Lost to Follow-up|0|||
23212194|NCT04096326|64516402|FG005|Overall Study|Lost to Follow-up|0|||
23127513|NCT03445533|64215427|FG001|Overall Study|Withdrawal by Subject|4|||
23212195|NCT04096326|64516403|FG006|Overall Study|Lost to Follow-up|0|||
23426482|NCT01448824|65303669|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
23545018|NCT01432366|65727023|FG000|Overall Study|Pregnancy|1|||
23212196|NCT04096326|64516404|FG007|Overall Study|Lost to Follow-up|0|||
23212197|NCT04096326|64516405|FG008|Overall Study|Lost to Follow-up|0|||
23212198|NCT04096326|64516406|FG009|Overall Study|Lost to Follow-up|0|||
23127514|NCT03445533|64215426|FG000|Overall Study|Physician Decision|1|||
23127515|NCT03445533|64215427|FG001|Overall Study|Physician Decision|3|||
23127516|NCT03445533|64215426|FG000|Overall Study|Sponsor Decision|0|||
23127517|NCT03445533|64215427|FG001|Overall Study|Sponsor Decision|1|||
23545019|NCT01432366|65727023|FG000|Overall Study|Lost to Follow-up|13|||
23212199|NCT04096326|64516397|FG000|Overall Study|COVID-19-related reasons|0|||
23212200|NCT04096326|64516398|FG001|Overall Study|COVID-19-related reasons|0|||
23212201|NCT04096326|64516399|FG002|Overall Study|COVID-19-related reasons|0|||
23212202|NCT04096326|64516400|FG003|Overall Study|COVID-19-related reasons|0|||
23212203|NCT04096326|64516401|FG004|Overall Study|COVID-19-related reasons|1|||
23212204|NCT04096326|64516402|FG005|Overall Study|COVID-19-related reasons|5|||
23212205|NCT04096326|64516403|FG006|Overall Study|COVID-19-related reasons|0|||
23212206|NCT04096326|64516404|FG007|Overall Study|COVID-19-related reasons|0|||
23212207|NCT04096326|64516405|FG008|Overall Study|COVID-19-related reasons|0|||
23212208|NCT04096326|64516406|FG009|Overall Study|COVID-19-related reasons|0|||
23212209|NCT02713789|64516408|FG000|Overall Study|Lost to Follow-up|0|||
23212210|NCT02713789|64516409|FG001|Overall Study|Lost to Follow-up|1|||
23212211|NCT02713789|64516410|FG002|Overall Study|Lost to Follow-up|1|||
23212212|NCT01815580|64516411|FG000|Overall Study|Lost to Follow-up|4|||
23212213|NCT01815580|64516412|FG001|Overall Study|Lost to Follow-up|7|||
23212214|NCT01815580|64516411|FG000|Overall Study|Withdrawal by Subject|3|||
23212215|NCT01815580|64516412|FG001|Overall Study|Withdrawal by Subject|4|||
23212216|NCT01815580|64516411|FG000|Overall Study|Excluded from analysis|5|||
23212217|NCT01815580|64516412|FG001|Overall Study|Excluded from analysis|4|||
23212218|NCT00304915|64516415|FG000|Overall Study|Lost to Follow-up|11|||
23212219|NCT00304915|64516416|FG001|Overall Study|Lost to Follow-up|11|||
23212220|NCT00304915|64516415|FG000|Overall Study|Death|4|||
23212221|NCT00304915|64516416|FG001|Overall Study|Death|5|||
23212222|NCT00304915|64516415|FG000|Overall Study|Withdrawal by Subject|3|||
23212223|NCT00304915|64516416|FG001|Overall Study|Withdrawal by Subject|0|||
23212224|NCT01419015|64516417|FG000|Overall Study|Death|2|||
23212225|NCT01412060|64516420|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
23212226|NCT01412060|64516421|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
23212227|NCT01412060|64516422|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
23212228|NCT01412060|64516420|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
23545020|NCT01432366|65727023|FG000|Overall Study|Lack of Efficacy|1|||
23545021|NCT01432366|65727023|FG000|Overall Study|Site Closed|20|||
23545022|NCT01432366|65727023|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
23545023|NCT01432366|65727023|FG000|Overall Study|Other|14|||
23545024|NCT04304833|65727029|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
23545025|NCT04304833|65727030|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
23545026|NCT01808690|65727031|FG000|Overall Study|Withdrawal by Subject|1|||
23545027|NCT01808690|65727032|FG001|Overall Study|Withdrawal by Subject|2|||
23545028|NCT01939028|65727033|FG000|Overall Study|Withdrawal by Subject|5|||
23212229|NCT01412060|64516421|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
23212230|NCT01412060|64516422|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
23212231|NCT01412060|64516420|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
23212232|NCT01412060|64516421|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
23212233|NCT01412060|64516422|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
23212234|NCT01412060|64516420|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
23212235|NCT01412060|64516421|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
23212236|NCT01412060|64516422|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
23212237|NCT01412060|64516420|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
23212238|NCT01412060|64516421|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
23212239|NCT01412060|64516422|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
23212240|NCT01412060|64516420|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
23212241|NCT01412060|64516421|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
23212242|NCT01412060|64516422|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
23212243|NCT01412060|64516420|FG000|Period Between RIP and SP|Adverse Event|4|||
23212244|NCT01412060|64516421|FG001|Period Between RIP and SP|Adverse Event|0|||
23212245|NCT01412060|64516422|FG002|Period Between RIP and SP|Adverse Event|0|||
23212246|NCT01412060|64516420|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
23212247|NCT01412060|64516421|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
23212248|NCT01412060|64516422|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
23212249|NCT01412060|64516420|FG000|Period Between RIP and SP|Protocol Violation|2|||
23212250|NCT01412060|64516421|FG001|Period Between RIP and SP|Protocol Violation|0|||
23212251|NCT01412060|64516422|FG002|Period Between RIP and SP|Protocol Violation|0|||
23212252|NCT01412060|64516420|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
23212253|NCT01412060|64516421|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
23212254|NCT01412060|64516422|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
23545029|NCT01939028|65727033|FG000|Overall Study|Physician Decision|7|||
23545030|NCT02621606|65727036|FG000|Overall Study|Withdrawal by Subject|0|||
23212255|NCT01412060|64516420|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
23545031|NCT02621606|65727037|FG001|Overall Study|Withdrawal by Subject|1|||
23545032|NCT02621606|65727038|FG002|Overall Study|Withdrawal by Subject|0|||
23545033|NCT02624804|65727039|FG000|Overall Study|Screen Failure|5|||
23212256|NCT01412060|64516421|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
23212257|NCT01412060|64516422|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
23212258|NCT01412060|64516420|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
23127518|NCT03445533|64215426|FG000|Overall Study|Lost to Follow-up|0|||
23127519|NCT03445533|64215427|FG001|Overall Study|Lost to Follow-up|1|||
23127520|NCT03445533|64215426|FG000|Overall Study|Never Received any Study Treatment|7|||
23127521|NCT03445533|64215427|FG001|Overall Study|Never Received any Study Treatment|4|||
23127522|NCT01594970|64215428|FG000|Overall Study|Non-Adverse Event Related|4|||
23127523|NCT01594970|64215429|FG001|Overall Study|Non-Adverse Event Related|5|||
23127524|NCT01594970|64215430|FG002|Overall Study|Non-Adverse Event Related|6|||
23127525|NCT01594970|64215428|FG000|Overall Study|Adverse Event|17|||
23127526|NCT01594970|64215429|FG001|Overall Study|Adverse Event|23|||
23127527|NCT01594970|64215430|FG002|Overall Study|Adverse Event|23|||
23127528|NCT01594970|64215428|FG000|Overall Study|Lost to Follow-up|54|||
23212259|NCT01412060|64516421|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
23212260|NCT01412060|64516422|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
23127529|NCT01594970|64215429|FG001|Overall Study|Lost to Follow-up|54|||
23127530|NCT01594970|64215430|FG002|Overall Study|Lost to Follow-up|37|||
23127531|NCT01810939|64215435|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
23212261|NCT01412060|64516420|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
23212262|NCT01412060|64516421|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
23212263|NCT01412060|64516422|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
23212264|NCT01412060|64516420|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
23212265|NCT01412060|64516421|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
23212266|NCT01412060|64516422|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
23212267|NCT01412060|64516420|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
23212268|NCT01412060|64516421|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
23212269|NCT01412060|64516422|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
23212270|NCT01412060|64516420|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
23212271|NCT01412060|64516421|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
23212272|NCT01412060|64516422|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
23212273|NCT01412060|64516420|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
23212274|NCT01412060|64516421|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
23212275|NCT01412060|64516422|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
23212276|NCT01412060|64516420|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
23212277|NCT01412060|64516421|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
23212278|NCT01412060|64516422|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
23212279|NCT01412060|64516420|FG000|Period Between SP and DBP|Protocol Violation|2|||
23127532|NCT01810939|64215436|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
23127533|NCT01810939|64215437|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
23127534|NCT01810939|64215435|FG000|Part A Treatment Period|Protocol Violation|2|||
23127535|NCT01810939|64215436|FG001|Part A Treatment Period|Protocol Violation|0|||
23127536|NCT01810939|64215437|FG002|Part A Treatment Period|Protocol Violation|0|||
23127537|NCT01810939|64215435|FG000|Part A Treatment Period|Adverse Event|10|||
23127538|NCT01810939|64215436|FG001|Part A Treatment Period|Adverse Event|0|||
23127539|NCT01810939|64215437|FG002|Part A Treatment Period|Adverse Event|0|||
23127540|NCT01810939|64215435|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
23127541|NCT01810939|64215436|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
23212280|NCT01412060|64516421|FG001|Period Between SP and DBP|Protocol Violation|0|||
23212281|NCT01412060|64516422|FG002|Period Between SP and DBP|Protocol Violation|0|||
23212282|NCT01412060|64516420|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
23212283|NCT01412060|64516421|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
23212284|NCT01412060|64516422|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
23212285|NCT01412060|64516420|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
23212286|NCT01412060|64516421|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
23212287|NCT01412060|64516422|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
23212288|NCT01412060|64516420|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
23212289|NCT01412060|64516421|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
23212290|NCT01412060|64516422|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
23212291|NCT01412060|64516420|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
23212292|NCT01412060|64516421|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
23212293|NCT01412060|64516422|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
23212294|NCT01412060|64516420|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
23127542|NCT01810939|64215437|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
23212295|NCT01412060|64516421|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
23315874|NCT01377012|64899225|FG001|Core Study|Pregnancy|0|||
23315875|NCT01377012|64899226|FG002|Core Study|Pregnancy|1|||
23127543|NCT01810939|64215435|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
23212296|NCT01412060|64516422|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
23212297|NCT01412060|64516420|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
23212298|NCT01412060|64516421|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
23127544|NCT01810939|64215436|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
23127545|NCT01810939|64215437|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
23127546|NCT01810939|64215435|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
23127547|NCT01810939|64215436|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
23127548|NCT01810939|64215437|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
23127549|NCT01810939|64215435|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
23127550|NCT01810939|64215436|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
23127551|NCT01810939|64215437|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
23127552|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
23127553|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
23127554|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
23127555|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
23127556|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
23127557|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
23127558|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
23127559|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
23127560|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
23127561|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
23127562|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
23127563|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
23212299|NCT01412060|64516422|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
23212300|NCT01412060|64516420|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
23212301|NCT01412060|64516421|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
23212302|NCT01412060|64516422|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
23212303|NCT01412060|64516420|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
23212304|NCT01412060|64516421|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
23426483|NCT01448824|65303670|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
23426484|NCT01448824|65303671|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
23426485|NCT01448824|65303672|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
23426486|NCT01448824|65303673|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
23426487|NCT01448824|65303666|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426488|NCT01448824|65303667|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426489|NCT01448824|65303668|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426490|NCT01448824|65303669|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426491|NCT01448824|65303670|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426492|NCT01448824|65303671|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23426493|NCT01448824|65303672|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
23545034|NCT02734212|65727046|FG000|Overall Study|Lost to Follow-up|5|||
23545035|NCT02734212|65727047|FG001|Overall Study|Lost to Follow-up|10|||
23545036|NCT01310036|65727048|FG000|Overall Study|Administrative/other|10|||
23426494|NCT01448824|65303673|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
23545037|NCT01310036|65727048|FG000|Overall Study|Withdrew Consent|11|||
23545038|NCT01310036|65727048|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
23545039|NCT01310036|65727048|FG000|Overall Study|Progression of Disease|164|||
23545040|NCT01310036|65727048|FG000|Overall Study|Death|1|||
23545041|NCT01310036|65727048|FG000|Overall Study|Adverse event or intercurrent illness|12|||
23545042|NCT01255358|65727052|FG000|Overall Study|Adverse Event|2|||
23545043|NCT01255358|65727052|FG000|Overall Study|Protocol Violation|2|||
23618276|NCT01730118|65988236|FG006|Dose Expansion|Physician Decision|0|||
23618277|NCT03045302|65988238|FG000|Overall Study|Pre-treatment adverse event|1|||
23618278|NCT02744898|65988239|FG000|Overall Study|Progressive Disease|2|||
23618279|NCT02744898|65988239|FG000|Overall Study|Physician Decision|1|||
23618280|NCT02744898|65988239|FG000|Overall Study|Toxicity|1|||
23618281|NCT02642159|65988243|FG000|Overall Study|Randomized but not treated|1|||
23618282|NCT02642159|65988244|FG001|Overall Study|Randomized but not treated|0|||
23618283|NCT02642159|65988243|FG000|Overall Study|Adverse Event|10|||
23618284|NCT02642159|65988244|FG001|Overall Study|Adverse Event|4|||
23618285|NCT02642159|65988243|FG000|Overall Study|Withdrawal by Subject|9|||
23618286|NCT02642159|65988244|FG001|Overall Study|Withdrawal by Subject|1|||
23618287|NCT02642159|65988243|FG000|Overall Study|Poor compliance to study protocol|1|||
23127564|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
23426495|NCT01448824|65303666|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426496|NCT01448824|65303667|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23545044|NCT02508311|65727053|FG000|Overall Study|Withdrawal by Subject|1|||
23545045|NCT02508311|65727054|FG001|Overall Study|Withdrawal by Subject|0|||
23545046|NCT00920426|65727068|FG000|ITZ111451|Adverse Event|1|||
23545047|NCT00920426|65727069|FG001|ITZ111451|Adverse Event|0|||
23545048|NCT00920426|65727070|FG002|ITZ111451|Adverse Event|0|||
23545049|NCT00920426|65727071|FG003|ITZ111451|Adverse Event|0|||
23545050|NCT00374322|65727074|FG000|Overall Study|Lost to Follow-up|92|||
23545051|NCT00374322|65727075|FG001|Overall Study|Lost to Follow-up|90|||
23545052|NCT00374322|65727074|FG000|Overall Study|Protocol Violation|8|||
23545053|NCT00374322|65727075|FG001|Overall Study|Protocol Violation|3|||
23545054|NCT00374322|65727074|FG000|Overall Study|Withdrawal by Subject|235|||
23545055|NCT00374322|65727075|FG001|Overall Study|Withdrawal by Subject|167|||
23545056|NCT00374322|65727074|FG000|Overall Study|Sponsor Terminated Study|866|||
23545057|NCT00374322|65727075|FG001|Overall Study|Sponsor Terminated Study|990|||
23545058|NCT00374322|65727074|FG000|Overall Study|Physician Decision|36|||
23545059|NCT00374322|65727075|FG001|Overall Study|Physician Decision|32|||
23545060|NCT00374322|65727074|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
23545061|NCT00374322|65727075|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
23545062|NCT00374322|65727074|FG000|Overall Study|Sponsor Decision|2|||
23545063|NCT00374322|65727075|FG001|Overall Study|Sponsor Decision|3|||
23545064|NCT00374322|65727074|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
23545065|NCT00374322|65727075|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
23545066|NCT00374322|65727074|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
23545067|NCT00374322|65727075|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
23545068|NCT00374322|65727074|FG000|Overall Study|Severe Toxicity|1|||
23545069|NCT00374322|65727075|FG001|Overall Study|Severe Toxicity|0|||
23545070|NCT00374322|65727074|FG000|Overall Study|Site Closed|2|||
23545071|NCT00374322|65727075|FG001|Overall Study|Site Closed|2|||
23545072|NCT00374322|65727074|FG000|Overall Study|Participant Changed Physician|1|||
23545073|NCT00374322|65727075|FG001|Overall Study|Participant Changed Physician|0|||
23545074|NCT00374322|65727074|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
23545075|NCT00374322|65727075|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
23545076|NCT00374322|65727074|FG000|Overall Study|Noncompliance with Study Requirements|0|||
23545077|NCT00374322|65727075|FG001|Overall Study|Noncompliance with Study Requirements|1|||
23545078|NCT00374322|65727074|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
23545079|NCT00374322|65727075|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
23545080|NCT00374322|65727074|FG000|Overall Study|Did Not Receive Study Medication|8|||
23545081|NCT00374322|65727075|FG001|Overall Study|Did Not Receive Study Medication|6|||
23545082|NCT03447769|65727076|FG000|Overall Study|Progressive disease|138|||
23545083|NCT03447769|65727077|FG001|Overall Study|Progressive disease|148|||
23545084|NCT03447769|65727076|FG000|Overall Study|Study terminated by Sponsor|60|||
23545085|NCT03447769|65727077|FG001|Overall Study|Study terminated by Sponsor|44|||
23545086|NCT03447769|65727076|FG000|Overall Study|Adverse Event|34|||
23545087|NCT03447769|65727077|FG001|Overall Study|Adverse Event|31|||
23545088|NCT03447769|65727076|FG000|Overall Study|Patient decision|27|||
23545089|NCT03447769|65727077|FG001|Overall Study|Patient decision|27|||
23545090|NCT03447769|65727076|FG000|Overall Study|Protocol deviation|4|||
23545091|NCT03447769|65727077|FG001|Overall Study|Protocol deviation|6|||
23545092|NCT03447769|65727076|FG000|Overall Study|Death|2|||
23545093|NCT03447769|65727077|FG001|Overall Study|Death|7|||
23545094|NCT03447769|65727076|FG000|Overall Study|Technical problems|1|||
23545095|NCT03447769|65727077|FG001|Overall Study|Technical problems|0|||
23545096|NCT03447769|65727076|FG000|Overall Study|Lost to Follow-up|0|||
23545097|NCT03447769|65727077|FG001|Overall Study|Lost to Follow-up|1|||
23545098|NCT03447769|65727076|FG000|Overall Study|Physician Decision|13|||
23545099|NCT03447769|65727077|FG001|Overall Study|Physician Decision|5|||
23545100|NCT03759873|65727078|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
23545101|NCT03759873|65727079|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
23545102|NCT03759873|65727080|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
23545103|NCT03759873|65727081|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
23545104|NCT03759873|65727078|FG000|Overall Study|Moved outside eligible area|0|||
23545105|NCT03759873|65727079|FG001|Overall Study|Moved outside eligible area|2|||
23545106|NCT03759873|65727080|FG002|Overall Study|Moved outside eligible area|0|||
23545107|NCT03759873|65727081|FG003|Overall Study|Moved outside eligible area|0|||
23545108|NCT03759873|65727078|FG000|Overall Study|Withdrawal by Subject|0|||
23545109|NCT03759873|65727079|FG001|Overall Study|Withdrawal by Subject|0|||
23545110|NCT03759873|65727080|FG002|Overall Study|Withdrawal by Subject|1|||
23618288|NCT02642159|65988244|FG001|Overall Study|Poor compliance to study protocol|0|||
23545111|NCT03759873|65727081|FG003|Overall Study|Withdrawal by Subject|0|||
23545112|NCT00467870|65727082|FG000|Overall Study|Adverse Event|13|||
23545113|NCT00467870|65727083|FG001|Overall Study|Adverse Event|9|||
23545114|NCT00467870|65727084|FG002|Overall Study|Adverse Event|1|||
23545115|NCT00467870|65727085|FG003|Overall Study|Adverse Event|15|||
23545116|NCT00467870|65727086|FG004|Overall Study|Adverse Event|15|||
23618289|NCT02642159|65988243|FG000|Overall Study|Other than specified above|10|||
23545117|NCT00467870|65727087|FG005|Overall Study|Adverse Event|1|||
23545118|NCT00467870|65727082|FG000|Overall Study|Protocol Violation|2|||
23545119|NCT00467870|65727083|FG001|Overall Study|Protocol Violation|1|||
23545120|NCT00467870|65727084|FG002|Overall Study|Protocol Violation|1|||
23545121|NCT00467870|65727085|FG003|Overall Study|Protocol Violation|2|||
23212305|NCT01412060|64516422|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
23212306|NCT01412060|64516420|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
23212307|NCT01412060|64516421|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
23212308|NCT01412060|64516422|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
23212309|NCT01412060|64516420|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
23212310|NCT01412060|64516421|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
23212311|NCT01412060|64516422|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
23212312|NCT02395653|64516423|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
23212313|NCT02395653|64516423|FG000|Overall Study|Consent Withdrawn at Screening|1|||
23212314|NCT02395653|64516423|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
23212315|NCT02395653|64516423|FG000|Overall Study|Investigator Decision at Screening|1|||
23212316|NCT02395653|64516423|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
23212317|NCT02395653|64516423|FG000|Overall Study|Withdrawal by Subject|1|||
23212318|NCT02395653|64516423|FG000|Overall Study|Lost to Follow-up|1|||
23212319|NCT02555657|64516424|FG000|Overall Study|Death|274|||
23212320|NCT02555657|64516425|FG001|Overall Study|Death|262|||
23212321|NCT02555657|64516424|FG000|Overall Study|Physician Decision|0|||
23212322|NCT02555657|64516425|FG001|Overall Study|Physician Decision|1|||
23212323|NCT02555657|64516424|FG000|Overall Study|Sponsor Decision|27|||
23212324|NCT02555657|64516425|FG001|Overall Study|Sponsor Decision|15|||
23212325|NCT02555657|64516424|FG000|Overall Study|Withdrawal by Subject|11|||
23212326|NCT02555657|64516425|FG001|Overall Study|Withdrawal by Subject|32|||
23212327|NCT01359046|64516426|FG000|Overall Study|Did not receive allocated intervention|6|||
23212328|NCT01359046|64516427|FG001|Overall Study|Did not receive allocated intervention|6|||
23212329|NCT01359046|64516426|FG000|Overall Study|Physician Decision|1|||
23212330|NCT01359046|64516427|FG001|Overall Study|Physician Decision|11|||
23212331|NCT01167582|64516428|FG000|Overall Study|Lost to Follow-up|0|||
23212332|NCT01167582|64516429|FG001|Overall Study|Lost to Follow-up|1|||
23618290|NCT02642159|65988244|FG001|Overall Study|Other than specified above|3|||
23127565|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
23127566|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
23127567|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
23127568|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
23127569|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
23127570|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
23127571|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
23127572|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
23127573|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
23127574|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
23127575|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
23127576|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
23127577|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
23127578|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
23127579|NCT01810939|64215435|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
23127580|NCT01810939|64215436|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
23127581|NCT01810939|64215437|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
23127582|NCT01154140|64215438|FG000|Overall Study|Death|71|||
23127583|NCT01154140|64215439|FG001|Overall Study|Death|81|||
23127584|NCT01154140|64215438|FG000|Overall Study|Lost to Follow-up|4|||
23127585|NCT01154140|64215439|FG001|Overall Study|Lost to Follow-up|5|||
23127586|NCT01154140|64215438|FG000|Overall Study|Withdrawal by Subject|12|||
23127587|NCT01154140|64215439|FG001|Overall Study|Withdrawal by Subject|13|||
23127588|NCT01154140|64215438|FG000|Overall Study|Other|3|||
23127589|NCT01154140|64215439|FG001|Overall Study|Other|1|||
23127590|NCT01154140|64215438|FG000|Overall Study|Randomized but not treated|1|||
23127591|NCT01154140|64215439|FG001|Overall Study|Randomized but not treated|2|||
23127592|NCT01250925|64215441|FG000|Overall Study|Lost to Follow-up|1|||
23127593|NCT01250925|64215442|FG001|Overall Study|Lost to Follow-up|1|||
23127594|NCT01250925|64215443|FG002|Overall Study|Lost to Follow-up|0|||
23127595|NCT01250925|64215441|FG000|Overall Study|Withdrawal by Subject|2|||
23127596|NCT01250925|64215442|FG001|Overall Study|Withdrawal by Subject|0|||
23127597|NCT01250925|64215443|FG002|Overall Study|Withdrawal by Subject|0|||
23127598|NCT01250925|64215441|FG000|Overall Study|Protocol Violation|2|||
23127599|NCT01250925|64215442|FG001|Overall Study|Protocol Violation|0|||
23127600|NCT01250925|64215443|FG002|Overall Study|Protocol Violation|0|||
23127601|NCT01250925|64215441|FG000|Overall Study|Physician Decision|0|||
23127602|NCT01250925|64215442|FG001|Overall Study|Physician Decision|2|||
23212333|NCT01088438|64516430|FG000|Overall Study|Withdrawal by Subject|11|||
23212334|NCT01088438|64516431|FG001|Overall Study|Withdrawal by Subject|6|||
23212335|NCT01088438|64516430|FG000|Overall Study|Lost to Follow-up|18|||
23212336|NCT01088438|64516431|FG001|Overall Study|Lost to Follow-up|30|||
23212337|NCT03987919|64516432|FG000|Overall Study|Adverse Event|1|||
23426497|NCT01448824|65303668|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23545122|NCT00467870|65727086|FG004|Overall Study|Protocol Violation|0|||
23127603|NCT01250925|64215443|FG002|Overall Study|Physician Decision|1|||
23127604|NCT01250925|64215441|FG000|Overall Study|Adverse Event|0|||
23127605|NCT01250925|64215442|FG001|Overall Study|Adverse Event|0|||
23127606|NCT01250925|64215443|FG002|Overall Study|Adverse Event|1|||
23127607|NCT01151215|64215444|FG000|Overall Study|Worsening of condition under study|1|||
23127608|NCT01151215|64215445|FG001|Overall Study|Worsening of condition under study|1|||
23127609|NCT01151215|64215446|FG002|Overall Study|Worsening of condition under study|1|||
23127610|NCT01151215|64215444|FG000|Overall Study|Death|16|||
23127611|NCT01151215|64215445|FG001|Overall Study|Death|20|||
23127612|NCT01151215|64215446|FG002|Overall Study|Death|11|||
23127613|NCT01151215|64215444|FG000|Overall Study|Lost to Follow-up|0|||
23127614|NCT01151215|64215445|FG001|Overall Study|Lost to Follow-up|0|||
23127615|NCT01151215|64215446|FG002|Overall Study|Lost to Follow-up|3|||
23127616|NCT01151215|64215444|FG000|Overall Study|Withdrawal by Subject|3|||
23426498|NCT01448824|65303669|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426499|NCT01448824|65303670|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426500|NCT01448824|65303671|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426501|NCT01448824|65303672|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
23426502|NCT01448824|65303673|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
23426503|NCT01448824|65303666|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426504|NCT01448824|65303667|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23545123|NCT00467870|65727087|FG005|Overall Study|Protocol Violation|0|||
23545124|NCT00467870|65727082|FG000|Overall Study|Withdrawal by Subject|14|||
23545125|NCT00467870|65727083|FG001|Overall Study|Withdrawal by Subject|21|||
23545126|NCT00467870|65727084|FG002|Overall Study|Withdrawal by Subject|0|||
23545127|NCT00467870|65727085|FG003|Overall Study|Withdrawal by Subject|9|||
23545128|NCT00467870|65727086|FG004|Overall Study|Withdrawal by Subject|10|||
23545129|NCT00467870|65727087|FG005|Overall Study|Withdrawal by Subject|1|||
23545130|NCT00467870|65727082|FG000|Overall Study|Lost to Follow-up|5|||
23545131|NCT00467870|65727083|FG001|Overall Study|Lost to Follow-up|3|||
23545132|NCT00467870|65727084|FG002|Overall Study|Lost to Follow-up|1|||
23545133|NCT00467870|65727085|FG003|Overall Study|Lost to Follow-up|1|||
23545134|NCT00467870|65727086|FG004|Overall Study|Lost to Follow-up|3|||
23545135|NCT00467870|65727087|FG005|Overall Study|Lost to Follow-up|0|||
23545136|NCT00467870|65727082|FG000|Overall Study|Subject Non-compliance|3|||
23545137|NCT00467870|65727083|FG001|Overall Study|Subject Non-compliance|4|||
23545138|NCT00467870|65727084|FG002|Overall Study|Subject Non-compliance|0|||
23545139|NCT00467870|65727085|FG003|Overall Study|Subject Non-compliance|1|||
23545140|NCT00467870|65727086|FG004|Overall Study|Subject Non-compliance|5|||
23545141|NCT00467870|65727087|FG005|Overall Study|Subject Non-compliance|0|||
23545142|NCT00467870|65727082|FG000|Overall Study|Other/Unknown|8|||
23545143|NCT00467870|65727083|FG001|Overall Study|Other/Unknown|5|||
23545144|NCT00467870|65727084|FG002|Overall Study|Other/Unknown|1|||
23545145|NCT00467870|65727085|FG003|Overall Study|Other/Unknown|5|||
23545146|NCT00467870|65727086|FG004|Overall Study|Other/Unknown|4|||
23545147|NCT00467870|65727087|FG005|Overall Study|Other/Unknown|0|||
23545148|NCT04757753|65727088|FG000|Overall Study|Lost to Follow-up|7|||
23545149|NCT04757753|65727089|FG001|Overall Study|Lost to Follow-up|7|||
23545150|NCT04757753|65727088|FG000|Overall Study|Withdrawal by Subject|0|||
23545151|NCT04757753|65727089|FG001|Overall Study|Withdrawal by Subject|3|||
23545152|NCT04757753|65727088|FG000|Overall Study|Endodontic treatment failure|1|||
23545153|NCT04757753|65727089|FG001|Overall Study|Endodontic treatment failure|2|||
23545154|NCT04757753|65727088|FG000|Overall Study|Tooth fracture/extraction|3|||
23545155|NCT04757753|65727089|FG001|Overall Study|Tooth fracture/extraction|0|||
23545156|NCT04181762|65727090|FG000|Overall Study|Adverse Event|1|||
23545157|NCT04181762|65727091|FG001|Overall Study|Adverse Event|3|||
23545158|NCT04181762|65727090|FG000|Overall Study|Lost to Follow-up|1|||
23545159|NCT04181762|65727091|FG001|Overall Study|Lost to Follow-up|1|||
23545160|NCT04181762|65727090|FG000|Overall Study|Physician Decision|1|||
23545161|NCT04181762|65727091|FG001|Overall Study|Physician Decision|3|||
23545162|NCT04181762|65727090|FG000|Overall Study|Pregnancy|0|||
23545163|NCT04181762|65727091|FG001|Overall Study|Pregnancy|1|||
23545164|NCT04181762|65727090|FG000|Overall Study|Lack of Efficacy|2|||
23545165|NCT04181762|65727091|FG001|Overall Study|Lack of Efficacy|2|||
23545166|NCT04181762|65727090|FG000|Overall Study|Study terminated by sponsor|95|||
23545167|NCT04181762|65727091|FG001|Overall Study|Study terminated by sponsor|97|||
23545168|NCT04181762|65727090|FG000|Overall Study|Subject decision|11|||
23545169|NCT04181762|65727091|FG001|Overall Study|Subject decision|4|||
23545170|NCT04181762|65727090|FG000|Overall Study|Death|1|||
23545171|NCT04181762|65727091|FG001|Overall Study|Death|1|||
23545172|NCT04181762|65727090|FG000|Overall Study|Protocol deviation|1|||
23618291|NCT01203956|65988245|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
23127617|NCT01151215|64215445|FG001|Overall Study|Withdrawal by Subject|1|||
23545173|NCT04181762|65727091|FG001|Overall Study|Protocol deviation|0|||
23618292|NCT01203956|65988246|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
23545174|NCT04181762|65727090|FG000|Overall Study|Withdrawal of informed consent|1|||
23545175|NCT04181762|65727091|FG001|Overall Study|Withdrawal of informed consent|3|||
23545176|NCT01672801|65727094|FG000|Overall Study|Screen Failure|0|||
23545177|NCT01672801|65727095|FG001|Overall Study|Screen Failure|1|||
23545178|NCT03879798|65727098|FG000|Overall Study|Adverse Event|0|||
23545179|NCT03879798|65727099|FG001|Overall Study|Adverse Event|0|||
23545180|NCT03879798|65727100|FG002|Overall Study|Adverse Event|0|||
23545181|NCT03879798|65727101|FG003|Overall Study|Adverse Event|0|||
23545182|NCT03879798|65727102|FG004|Overall Study|Adverse Event|0|||
23545183|NCT03879798|65727103|FG005|Overall Study|Adverse Event|1|||
23545184|NCT03879798|65727098|FG000|Overall Study|Lack of Efficacy|0|||
23545185|NCT03879798|65727099|FG001|Overall Study|Lack of Efficacy|0|||
23545186|NCT03879798|65727100|FG002|Overall Study|Lack of Efficacy|0|||
23545187|NCT03879798|65727101|FG003|Overall Study|Lack of Efficacy|0|||
23545188|NCT03879798|65727102|FG004|Overall Study|Lack of Efficacy|0|||
23545189|NCT03879798|65727103|FG005|Overall Study|Lack of Efficacy|1|||
23545190|NCT03879798|65727098|FG000|Overall Study|Withdrawal by Subject|0|||
23545191|NCT03879798|65727099|FG001|Overall Study|Withdrawal by Subject|0|||
23545192|NCT03879798|65727100|FG002|Overall Study|Withdrawal by Subject|0|||
23545193|NCT03879798|65727101|FG003|Overall Study|Withdrawal by Subject|0|||
23545194|NCT03879798|65727102|FG004|Overall Study|Withdrawal by Subject|0|||
23545195|NCT03879798|65727103|FG005|Overall Study|Withdrawal by Subject|1|||
23545196|NCT02091726|65727113|FG000|Overall Study|Lost to Follow-up|6|||
23545197|NCT01174342|65727116|FG000|Overall Study|Conversion to cesarean section|4|||
23545198|NCT00990652|65727119|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
23545199|NCT00990652|65727119|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
23545200|NCT04743908|65727120|FG000|Overall Study|Death|1|||
23618293|NCT03357471|65988247|FG000|Overall Study|Adverse Event|1|||
23618294|NCT03357471|65988248|FG001|Overall Study|Adverse Event|0|||
23618295|NCT03357471|65988247|FG000|Overall Study|Lost to Follow-up|1|||
23618296|NCT03357471|65988248|FG001|Overall Study|Lost to Follow-up|0|||
23618297|NCT01116440|65988249|FG000|Treatment|Withdrawal by Subject|2|||
23618298|NCT01116440|65988250|FG001|Treatment|Withdrawal by Subject|2|||
23127618|NCT01151215|64215446|FG002|Overall Study|Withdrawal by Subject|2|||
23127619|NCT01151215|64215444|FG000|Overall Study|Disease progression|0|||
23127620|NCT01151215|64215445|FG001|Overall Study|Disease progression|1|||
23127621|NCT01151215|64215446|FG002|Overall Study|Disease progression|1|||
23127622|NCT01151215|64215444|FG000|Overall Study|Safety as judged by the investigator|0|||
23127623|NCT01151215|64215445|FG001|Overall Study|Safety as judged by the investigator|0|||
23127624|NCT01151215|64215446|FG002|Overall Study|Safety as judged by the investigator|1|||
23127625|NCT00953615|64215452|FG000|Overall Study|Adverse Event|1|||
23127626|NCT00126659|64215453|FG000|Overall Study|Adverse Event|0|||
23545201|NCT04743908|65727121|FG001|Overall Study|Death|0|||
23545202|NCT04743908|65727120|FG000|Overall Study|Lost to Follow-up|181|||
23545203|NCT04743908|65727121|FG001|Overall Study|Lost to Follow-up|180|||
23545204|NCT04743908|65727120|FG000|Overall Study|Withdrawal by Subject|1|||
23545205|NCT04743908|65727121|FG001|Overall Study|Withdrawal by Subject|2|||
23545206|NCT02843568|65727124|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
23618299|NCT01116440|65988249|FG000|Treatment|Lost to Follow-up|1|||
23618300|NCT01116440|65988250|FG001|Treatment|Lost to Follow-up|1|||
23618301|NCT01116440|65988249|FG000|Treatment|Protocol Violation|0|||
23127627|NCT00126659|64215454|FG001|Overall Study|Adverse Event|0|||
23618302|NCT01116440|65988250|FG001|Treatment|Protocol Violation|2|||
23618303|NCT01116440|65988249|FG000|Treatment|Lack of Efficacy|0|||
23618304|NCT01116440|65988250|FG001|Treatment|Lack of Efficacy|1|||
23127628|NCT00126659|64215455|FG002|Overall Study|Adverse Event|2|||
23127629|NCT03559062|64215456|FG000|Overall Study|Other|0|||
23127630|NCT03559062|64215457|FG001|Overall Study|Other|1|||
23127631|NCT03559062|64215458|FG002|Overall Study|Other|0|||
23127632|NCT00757627|64215459|FG000|Overall Study|Adverse Event|15|||
23127633|NCT00757627|64215459|FG000|Overall Study|Lack of Efficacy|10|||
23127634|NCT00757627|64215459|FG000|Overall Study|Lost to Follow-up|28|||
23127635|NCT00757627|64215459|FG000|Overall Study|Withdrawal by Subject|27|||
23127636|NCT00757627|64215459|FG000|Overall Study|Other|1|||
23127637|NCT01375673|64215463|FG000|Overall Study|Withdrawal by Subject|0|||
23127638|NCT01375673|64215464|FG001|Overall Study|Withdrawal by Subject|1|||
23127639|NCT00953147|64215465|FG000|Overall Study|Adverse Event|8|||
23127640|NCT00953147|64215466|FG001|Overall Study|Adverse Event|16|||
23127641|NCT00953147|64215467|FG002|Overall Study|Adverse Event|6|||
23127642|NCT00953147|64215465|FG000|Overall Study|Protocol Violation|2|||
23545207|NCT02843568|65727125|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
23545208|NCT02843568|65727124|FG000|Overall Study|Death|3|||
23545209|NCT02843568|65727125|FG001|Overall Study|Death|3|||
23618305|NCT01116440|65988249|FG000|Treatment|Adverse Event|0|||
23618306|NCT01116440|65988250|FG001|Treatment|Adverse Event|1|||
23127643|NCT00953147|64215466|FG001|Overall Study|Protocol Violation|8|||
23545210|NCT02843568|65727124|FG000|Overall Study|Withdrawal by Subject|1|||
23545211|NCT02843568|65727125|FG001|Overall Study|Withdrawal by Subject|1|||
23127644|NCT00953147|64215467|FG002|Overall Study|Protocol Violation|4|||
23127645|NCT00953147|64215465|FG000|Overall Study|Withdrawal by Subject|13|||
23127646|NCT00953147|64215466|FG001|Overall Study|Withdrawal by Subject|15|||
23127647|NCT00953147|64215467|FG002|Overall Study|Withdrawal by Subject|12|||
23127648|NCT00953147|64215465|FG000|Overall Study|Lost to Follow-up|8|||
23127649|NCT00953147|64215466|FG001|Overall Study|Lost to Follow-up|9|||
23127650|NCT00953147|64215467|FG002|Overall Study|Lost to Follow-up|4|||
23127651|NCT00953147|64215465|FG000|Overall Study|Physician Decision|2|||
23127652|NCT00953147|64215466|FG001|Overall Study|Physician Decision|7|||
23212338|NCT03987919|64516433|FG001|Overall Study|Adverse Event|4|||
23212339|NCT03987919|64516434|FG002|Overall Study|Adverse Event|1|||
23212340|NCT03987919|64516435|FG003|Overall Study|Adverse Event|3|||
23212341|NCT03987919|64516432|FG000|Overall Study|Death|4|||
23212342|NCT03987919|64516433|FG001|Overall Study|Death|4|||
23127653|NCT00953147|64215467|FG002|Overall Study|Physician Decision|3|||
23127654|NCT00953147|64215465|FG000|Overall Study|Other|4|||
23212343|NCT03987919|64516434|FG002|Overall Study|Death|4|||
23212344|NCT03987919|64516435|FG003|Overall Study|Death|1|||
23212345|NCT03987919|64516432|FG000|Overall Study|Lost to Follow-up|5|||
23212346|NCT03987919|64516433|FG001|Overall Study|Lost to Follow-up|6|||
23212347|NCT03987919|64516434|FG002|Overall Study|Lost to Follow-up|8|||
23212348|NCT03987919|64516435|FG003|Overall Study|Lost to Follow-up|12|||
23212349|NCT03987919|64516432|FG000|Overall Study|Physician Decision|0|||
23212350|NCT03987919|64516433|FG001|Overall Study|Physician Decision|2|||
23212351|NCT03987919|64516434|FG002|Overall Study|Physician Decision|0|||
23212352|NCT03987919|64516435|FG003|Overall Study|Physician Decision|4|||
23545212|NCT02843568|65727124|FG000|Overall Study|Lost to Follow-up|2|||
23127655|NCT00953147|64215466|FG001|Overall Study|Other|11|||
23212353|NCT03987919|64516432|FG000|Overall Study|Pregnancy|1|||
23127656|NCT00953147|64215467|FG002|Overall Study|Other|13|||
23127657|NCT01483144|64215470|FG000|Overall Study|Adverse Event|9|||
23127658|NCT01483144|64215471|FG001|Overall Study|Adverse Event|4|||
23127659|NCT01483144|64215472|FG002|Overall Study|Adverse Event|6|||
23127660|NCT01483144|64215470|FG000|Overall Study|Withdrawal by Subject|0|||
23127661|NCT01483144|64215471|FG001|Overall Study|Withdrawal by Subject|2|||
23127662|NCT01483144|64215472|FG002|Overall Study|Withdrawal by Subject|5|||
23127663|NCT01483144|64215470|FG000|Overall Study|Physician Decision|1|||
23127664|NCT01483144|64215471|FG001|Overall Study|Physician Decision|0|||
23127665|NCT01483144|64215472|FG002|Overall Study|Physician Decision|0|||
23127666|NCT01483144|64215470|FG000|Overall Study|Lost to Follow-up|2|||
23127667|NCT01483144|64215471|FG001|Overall Study|Lost to Follow-up|4|||
23127668|NCT01483144|64215472|FG002|Overall Study|Lost to Follow-up|1|||
23127669|NCT01483144|64215470|FG000|Overall Study|Protocol Violation|3|||
23127670|NCT01483144|64215471|FG001|Overall Study|Protocol Violation|3|||
23127671|NCT01483144|64215472|FG002|Overall Study|Protocol Violation|3|||
23426505|NCT01448824|65303668|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426506|NCT01448824|65303669|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426507|NCT01448824|65303670|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426508|NCT01448824|65303671|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426509|NCT01448824|65303672|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
23426510|NCT01448824|65303673|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
23426511|NCT01448824|65303666|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426512|NCT01448824|65303667|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426513|NCT01448824|65303668|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426514|NCT01448824|65303669|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426515|NCT01448824|65303670|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426516|NCT01448824|65303671|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426517|NCT01448824|65303672|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
23426518|NCT01448824|65303673|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
23426519|NCT02634606|65307350|FG000|Overall Study|unable to obtain the drug at start|13|||
23426520|NCT01920152|65307355|FG000|Overall Study|Withdrawal by Subject|1|||
23545213|NCT02843568|65727125|FG001|Overall Study|Lost to Follow-up|0|||
23545214|NCT02103439|65727134|FG000|Overall Study|Adverse Event|0|||
23545215|NCT02103439|65727135|FG001|Overall Study|Adverse Event|2|||
23545216|NCT02103439|65727134|FG000|Overall Study|Withdrawal by Subject|3|||
23545217|NCT02103439|65727135|FG001|Overall Study|Withdrawal by Subject|1|||
23545218|NCT00744653|65727137|FG000|Overall Study|antineoplastic treatment|11|||
23545219|NCT00744653|65727137|FG000|Overall Study|Death|1|||
23545220|NCT00744653|65727137|FG000|Overall Study|Lost to Follow-up|1|||
23545221|NCT00744653|65727137|FG000|Overall Study|Physician Decision|3|||
23127672|NCT00277095|64215473|FG000|Overall Study|Death|2|||
23127673|NCT00277095|64215473|FG000|Overall Study|Explanted|7|||
23212354|NCT03987919|64516433|FG001|Overall Study|Pregnancy|0|||
23212355|NCT03987919|64516434|FG002|Overall Study|Pregnancy|1|||
23212356|NCT03987919|64516435|FG003|Overall Study|Pregnancy|1|||
23212357|NCT03987919|64516432|FG000|Overall Study|Protocol Violation|0|||
23212358|NCT03987919|64516433|FG001|Overall Study|Protocol Violation|1|||
23545222|NCT02691455|65727138|FG000|Overall Study|Withdrawal by Subject|1|||
23545223|NCT02691455|65727139|FG001|Overall Study|Withdrawal by Subject|2|||
23545224|NCT02691455|65727138|FG000|Overall Study|Lost to Follow-up|15|||
23545225|NCT02691455|65727139|FG001|Overall Study|Lost to Follow-up|15|||
23545226|NCT00583557|65727142|FG000|Overall Study|Withdrawal by Subject|18|||
23545227|NCT00583557|65727142|FG000|Overall Study|Adverse Event|9|||
23545228|NCT00583557|65727142|FG000|Overall Study|Lack of Efficacy|31|||
23545229|NCT00583557|65727142|FG000|Overall Study|Lack of Compliance|5|||
23545230|NCT00583557|65727142|FG000|Overall Study|Other|5|||
23545231|NCT00583557|65727142|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
23545232|NCT03713593|65727143|FG000|Overall Study|Participants Ongoing|140|||
23545233|NCT03713593|65727144|FG001|Overall Study|Participants Ongoing|114|||
23545234|NCT03713593|65727143|FG000|Overall Study|Withdrawal by Subject|3|||
23545235|NCT03713593|65727144|FG001|Overall Study|Withdrawal by Subject|6|||
23545236|NCT03713593|65727143|FG000|Overall Study|Death|252|||
23545237|NCT03713593|65727144|FG001|Overall Study|Death|279|||
23545238|NCT01221597|65727146|FG000|Overall Study|Adverse Event|4|||
23545239|NCT01221597|65727147|FG001|Overall Study|Adverse Event|1|||
23315876|NCT01377012|64899224|FG000|Core Study|Physician Decision|5|||
23315877|NCT01377012|64899225|FG001|Core Study|Physician Decision|4|||
23315878|NCT01377012|64899226|FG002|Core Study|Physician Decision|10|||
23315879|NCT01377012|64899224|FG000|Core Study|Non-Compliant with study treatment|0|||
23315880|NCT01377012|64899225|FG001|Core Study|Non-Compliant with study treatment|0|||
23315881|NCT01377012|64899226|FG002|Core Study|Non-Compliant with study treatment|1|||
23545240|NCT01221597|65727146|FG000|Overall Study|Withdrawal by Subject|20|||
23545241|NCT01221597|65727147|FG001|Overall Study|Withdrawal by Subject|6|||
23545242|NCT01221597|65727146|FG000|Overall Study|Lost to Follow-up|6|||
23545243|NCT01221597|65727147|FG001|Overall Study|Lost to Follow-up|5|||
23545244|NCT01221597|65727146|FG000|Overall Study|Protocol Violation|1|||
23545245|NCT01221597|65727147|FG001|Overall Study|Protocol Violation|0|||
23545246|NCT01221597|65727146|FG000|Overall Study|Other|3|||
23545247|NCT01221597|65727147|FG001|Overall Study|Other|4|||
23545248|NCT01221597|65727146|FG000|Overall Study|Death|2|||
23545249|NCT01221597|65727147|FG001|Overall Study|Death|0|||
23545250|NCT03021187|65727148|FG000|Overall Study|Death|0|||
23545251|NCT03021187|65727149|FG001|Overall Study|Death|0|||
23545252|NCT03021187|65727150|FG002|Overall Study|Death|3|||
23545253|NCT03021187|65727151|FG003|Overall Study|Death|0|||
23545254|NCT03021187|65727148|FG000|Overall Study|Withdrawal by Subject|0|||
23545255|NCT03021187|65727149|FG001|Overall Study|Withdrawal by Subject|6|||
23545256|NCT03021187|65727150|FG002|Overall Study|Withdrawal by Subject|2|||
23545257|NCT03021187|65727151|FG003|Overall Study|Withdrawal by Subject|5|||
23545258|NCT03021187|65727148|FG000|Overall Study|Lost to Follow-up|10|||
23545259|NCT03021187|65727149|FG001|Overall Study|Lost to Follow-up|3|||
23545260|NCT03021187|65727150|FG002|Overall Study|Lost to Follow-up|1|||
23545261|NCT03021187|65727151|FG003|Overall Study|Lost to Follow-up|4|||
23545262|NCT01615029|65727152|FG000|Overall Study|Adverse Event|0|||
23545263|NCT01615029|65727153|FG001|Overall Study|Adverse Event|0|||
23545264|NCT01615029|65727154|FG002|Overall Study|Adverse Event|0|||
23545265|NCT01615029|65727155|FG003|Overall Study|Adverse Event|0|||
23212359|NCT03987919|64516434|FG002|Overall Study|Protocol Violation|0|||
23315882|NCT01377012|64899224|FG000|Core Study|No Longer require treatment|0|||
23426521|NCT01920152|65307356|FG001|Overall Study|Withdrawal by Subject|2|||
23426522|NCT02525939|65307359|FG000|Overall Study|Lost to Follow-up|27|||
23545266|NCT01615029|65727156|FG004|Overall Study|Adverse Event|1|||
23545267|NCT01615029|65727152|FG000|Overall Study|Death|0|||
23545268|NCT01615029|65727153|FG001|Overall Study|Death|0|||
23545269|NCT01615029|65727154|FG002|Overall Study|Death|0|||
23545270|NCT01615029|65727155|FG003|Overall Study|Death|0|||
23545271|NCT01615029|65727156|FG004|Overall Study|Death|1|||
23545272|NCT01615029|65727152|FG000|Overall Study|Lost to Follow-up|0|||
23545273|NCT01615029|65727153|FG001|Overall Study|Lost to Follow-up|0|||
23545274|NCT01615029|65727154|FG002|Overall Study|Lost to Follow-up|0|||
23545275|NCT01615029|65727155|FG003|Overall Study|Lost to Follow-up|0|||
23545276|NCT01615029|65727156|FG004|Overall Study|Lost to Follow-up|1|||
23545277|NCT01615029|65727152|FG000|Overall Study|Progressive disease|2|||
23426523|NCT02525939|65307360|FG001|Overall Study|Lost to Follow-up|24|||
23545278|NCT01615029|65727153|FG001|Overall Study|Progressive disease|1|||
23545279|NCT01615029|65727154|FG002|Overall Study|Progressive disease|1|||
23545280|NCT01615029|65727155|FG003|Overall Study|Progressive disease|1|||
23545281|NCT01615029|65727156|FG004|Overall Study|Progressive disease|5|||
23545282|NCT01615029|65727152|FG000|Overall Study|Physician Decision|0|||
23545283|NCT01615029|65727153|FG001|Overall Study|Physician Decision|0|||
23545284|NCT01615029|65727154|FG002|Overall Study|Physician Decision|0|||
23545285|NCT01615029|65727155|FG003|Overall Study|Physician Decision|0|||
23545286|NCT01615029|65727156|FG004|Overall Study|Physician Decision|1|||
23545287|NCT01615029|65727152|FG000|Overall Study|Ongoing|1|||
23545288|NCT01615029|65727153|FG001|Overall Study|Ongoing|2|||
23545289|NCT01615029|65727154|FG002|Overall Study|Ongoing|3|||
23545290|NCT01615029|65727155|FG003|Overall Study|Ongoing|2|||
23545291|NCT01615029|65727156|FG004|Overall Study|Ongoing|23|||
23127674|NCT00277095|64215473|FG000|Overall Study|Lost to Follow-up|2|||
23127675|NCT00277095|64215473|FG000|Overall Study|Missed Follow-up|9|||
23127676|NCT00277095|64215473|FG000|Overall Study|Physician Decision|1|||
23127677|NCT03548220|64215474|FG000|Overall Study|Lost to Follow-up|1|||
23127678|NCT03548220|64215475|FG001|Overall Study|Lost to Follow-up|0|||
23127679|NCT03548220|64215476|FG002|Overall Study|Lost to Follow-up|0|||
23127680|NCT03548220|64215477|FG003|Overall Study|Lost to Follow-up|0|||
23127681|NCT02993406|64215478|FG000|Overall Study|Withdrawal by Subject|170|||
23426524|NCT02525939|65307359|FG000|Overall Study|Physician Decision|0|||
23426525|NCT02525939|65307360|FG001|Overall Study|Physician Decision|1|||
23426526|NCT02525939|65307359|FG000|Overall Study|Withdrawal by Subject|24|||
23426527|NCT02525939|65307360|FG001|Overall Study|Withdrawal by Subject|39|||
23426528|NCT02525939|65307359|FG000|Overall Study|Death|180|||
23426529|NCT02525939|65307360|FG001|Overall Study|Death|179|||
23127682|NCT02993406|64215479|FG001|Overall Study|Withdrawal by Subject|196|||
23127683|NCT02993406|64215478|FG000|Overall Study|Physician Decision|3|||
23127684|NCT02993406|64215479|FG001|Overall Study|Physician Decision|5|||
23127685|NCT02993406|64215478|FG000|Overall Study|Lost to Follow-up|12|||
23127686|NCT02993406|64215479|FG001|Overall Study|Lost to Follow-up|13|||
23127687|NCT02993406|64215478|FG000|Overall Study|Unclassifiable Response|105|||
23127688|NCT02993406|64215479|FG001|Overall Study|Unclassifiable Response|139|||
23127689|NCT02993406|64215478|FG000|Overall Study|Administrative decision|1|||
23127690|NCT02993406|64215479|FG001|Overall Study|Administrative decision|0|||
23127691|NCT02993406|64215478|FG000|Overall Study|Sponsor decision|4|||
23127692|NCT02993406|64215479|FG001|Overall Study|Sponsor decision|5|||
23127693|NCT02406248|64215480|FG000|Overall Study|Death|7|||
23127694|NCT02406248|64215480|FG000|Overall Study|Withdrawal by Subject|2|||
23127695|NCT01162486|64215483|FG000|Overall Study|low ANC|1|||
23127696|NCT01162486|64215484|FG001|Overall Study|low ANC|0|||
23127697|NCT01162486|64215485|FG002|Overall Study|low ANC|0|||
23127698|NCT01162486|64215486|FG003|Overall Study|low ANC|0|||
23127699|NCT01162486|64215487|FG004|Overall Study|low ANC|0|||
23127700|NCT01162486|64215483|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
23127701|NCT01162486|64215484|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
23127702|NCT01162486|64215485|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
23127703|NCT01162486|64215486|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
23127704|NCT01162486|64215487|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
23127705|NCT01162486|64215483|FG000|Overall Study|elevated LFTs|0|||
23127706|NCT01162486|64215484|FG001|Overall Study|elevated LFTs|0|||
23127707|NCT01162486|64215485|FG002|Overall Study|elevated LFTs|1|||
23127708|NCT01162486|64215486|FG003|Overall Study|elevated LFTs|0|||
23127709|NCT01162486|64215487|FG004|Overall Study|elevated LFTs|0|||
23127710|NCT01162486|64215483|FG000|Overall Study|Pregnancy|0|||
23127711|NCT01162486|64215484|FG001|Overall Study|Pregnancy|0|||
23127712|NCT01162486|64215485|FG002|Overall Study|Pregnancy|0|||
23127713|NCT01162486|64215486|FG003|Overall Study|Pregnancy|1|||
23127714|NCT01162486|64215487|FG004|Overall Study|Pregnancy|0|||
23127715|NCT02963090|64215488|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
23127716|NCT02963090|64215489|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
23127717|NCT01031628|64215490|FG000|Overall Study|Study terminated early|0|||
23127718|NCT01031628|64215491|FG001|Overall Study|Study terminated early|1|||
23212360|NCT03987919|64516435|FG003|Overall Study|Protocol Violation|0|||
23212361|NCT03987919|64516432|FG000|Overall Study|Site terminated by Sponsor|0|||
23212362|NCT03987919|64516433|FG001|Overall Study|Site terminated by Sponsor|0|||
23212363|NCT03987919|64516434|FG002|Overall Study|Site terminated by Sponsor|0|||
23212364|NCT03987919|64516435|FG003|Overall Study|Site terminated by Sponsor|1|||
23212365|NCT03987919|64516432|FG000|Overall Study|Withdrawal by Subject|7|||
23212366|NCT03987919|64516433|FG001|Overall Study|Withdrawal by Subject|7|||
23212367|NCT03987919|64516434|FG002|Overall Study|Withdrawal by Subject|8|||
23212368|NCT03987919|64516435|FG003|Overall Study|Withdrawal by Subject|4|||
23426530|NCT01767493|65307361|FG000|Overall Study|screen failures|3|||
23426531|NCT03187834|65307365|FG000|Overall Study|Lost to Follow-up|0|||
23426532|NCT03187834|65307366|FG001|Overall Study|Lost to Follow-up|1|||
23426533|NCT03187834|65307367|FG002|Overall Study|Lost to Follow-up|2|||
23426534|NCT03187834|65307368|FG003|Overall Study|Lost to Follow-up|2|||
23212369|NCT03987919|64516432|FG000|Overall Study|Other - as reported by the investigator|1|||
23426535|NCT03187834|65307365|FG000|Overall Study|Had invalid anthropometric measurements|5|||
23426536|NCT03187834|65307366|FG001|Overall Study|Had invalid anthropometric measurements|3|||
23426537|NCT03187834|65307367|FG002|Overall Study|Had invalid anthropometric measurements|4|||
23426538|NCT03187834|65307368|FG003|Overall Study|Had invalid anthropometric measurements|2|||
23127719|NCT01031628|64215492|FG002|Overall Study|Study terminated early|3|||
23127720|NCT01031628|64215493|FG003|Overall Study|Study terminated early|0|||
23127721|NCT01784523|64215498|FG000|Overall Study|Study closed early|7|||
23127722|NCT01784523|64215499|FG001|Overall Study|Study closed early|4|||
23426539|NCT02255565|65307374|FG000|Overall Study|Withdrawal by Subject|0|||
23127723|NCT02980042|64215500|FG000|Overall Study|Lost to Follow-up|5|||
23212370|NCT03987919|64516433|FG001|Overall Study|Other - as reported by the investigator|3|||
23212371|NCT03987919|64516434|FG002|Overall Study|Other - as reported by the investigator|2|||
23212372|NCT03987919|64516435|FG003|Overall Study|Other - as reported by the investigator|0|||
23212373|NCT01989754|64516436|FG000|Overall Study|Withdrawal by Subject|10|||
23212374|NCT01989754|64516437|FG001|Overall Study|Withdrawal by Subject|14|||
23212375|NCT01989754|64516436|FG000|Overall Study|Lost to Follow-up|28|||
23212376|NCT01989754|64516437|FG001|Overall Study|Lost to Follow-up|20|||
23212377|NCT01989754|64516436|FG000|Overall Study|Closed Site|1|||
23212378|NCT01989754|64516437|FG001|Overall Study|Closed Site|1|||
23212379|NCT00643604|64516438|FG000|Overall Study|Death|1|||
23212380|NCT01928082|64516442|FG000|Overall Study|Study terminated.|1|||
23212381|NCT00599027|64516443|FG000|Overall Study|Withdrawal by Subject|1|||
23212382|NCT00599027|64516444|FG001|Overall Study|Withdrawal by Subject|1|||
23212383|NCT00599027|64516443|FG000|Overall Study|Adverse Event|0|||
23212384|NCT00599027|64516444|FG001|Overall Study|Adverse Event|1|||
23212385|NCT00599027|64516443|FG000|Overall Study|Treatment Failure|0|||
23212386|NCT00599027|64516444|FG001|Overall Study|Treatment Failure|1|||
23212387|NCT03700736|64516445|FG000|Overall Study|Pregnancy|1|||
23212388|NCT03700736|64516446|FG001|Overall Study|Pregnancy|1|||
23212389|NCT03700736|64516445|FG000|Overall Study|Withdrawal by Subject|2|||
23212390|NCT03700736|64516446|FG001|Overall Study|Withdrawal by Subject|6|||
23212391|NCT04900038|64516447|FG000|Overall Study|Adverse Event|1|||
23212392|NCT04900038|64516448|FG001|Overall Study|Adverse Event|0|||
23212393|NCT04900038|64516449|FG002|Overall Study|Adverse Event|1|||
23212394|NCT04900038|64516450|FG003|Overall Study|Adverse Event|1|||
23212395|NCT04900038|64516447|FG000|Overall Study|Withdrawal by Subject|0|||
23212396|NCT04900038|64516448|FG001|Overall Study|Withdrawal by Subject|1|||
23315883|NCT01377012|64899225|FG001|Core Study|No Longer require treatment|0|||
23315884|NCT01377012|64899226|FG002|Core Study|No Longer require treatment|1|||
23127724|NCT02980042|64215501|FG001|Overall Study|Lost to Follow-up|0|||
23127725|NCT02980042|64215500|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
23127726|NCT02980042|64215501|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
23127727|NCT01441635|64218557|FG000|Overall Study|Adverse Event|4|||
23127728|NCT01441635|64218558|FG001|Overall Study|Adverse Event|3|||
23127729|NCT01441635|64218559|FG002|Overall Study|Adverse Event|1|||
23127730|NCT01441635|64218560|FG003|Overall Study|Adverse Event|5|||
23127731|NCT01441635|64218561|FG004|Overall Study|Adverse Event|1|||
23127732|NCT01441635|64218562|FG005|Overall Study|Adverse Event|2|||
23127733|NCT01441635|64218563|FG006|Overall Study|Adverse Event|2|||
23127734|NCT01441635|64218564|FG007|Overall Study|Adverse Event|2|||
23127735|NCT01441635|64218565|FG008|Overall Study|Adverse Event|1|||
23127736|NCT01441635|64218566|FG009|Overall Study|Adverse Event|0|||
23127737|NCT01441635|64218557|FG000|Overall Study|Withdrawal by Subject|1|||
23127738|NCT01441635|64218558|FG001|Overall Study|Withdrawal by Subject|1|||
23127739|NCT01441635|64218559|FG002|Overall Study|Withdrawal by Subject|0|||
23127740|NCT01441635|64218560|FG003|Overall Study|Withdrawal by Subject|1|||
23127741|NCT01441635|64218561|FG004|Overall Study|Withdrawal by Subject|0|||
23127742|NCT01441635|64218562|FG005|Overall Study|Withdrawal by Subject|0|||
23127743|NCT01441635|64218563|FG006|Overall Study|Withdrawal by Subject|2|||
23127744|NCT01441635|64218564|FG007|Overall Study|Withdrawal by Subject|0|||
23127745|NCT01441635|64218565|FG008|Overall Study|Withdrawal by Subject|1|||
23127746|NCT01441635|64218566|FG009|Overall Study|Withdrawal by Subject|1|||
23127747|NCT01441635|64218557|FG000|Overall Study|Lost to Follow-up|0|||
23127748|NCT01441635|64218558|FG001|Overall Study|Lost to Follow-up|1|||
23127749|NCT01441635|64218559|FG002|Overall Study|Lost to Follow-up|1|||
23127750|NCT01441635|64218560|FG003|Overall Study|Lost to Follow-up|1|||
23127751|NCT01441635|64218561|FG004|Overall Study|Lost to Follow-up|1|||
23127752|NCT01441635|64218562|FG005|Overall Study|Lost to Follow-up|3|||
23127753|NCT01441635|64218563|FG006|Overall Study|Lost to Follow-up|1|||
23127754|NCT01441635|64218564|FG007|Overall Study|Lost to Follow-up|1|||
23127755|NCT01441635|64218565|FG008|Overall Study|Lost to Follow-up|0|||
23127756|NCT01441635|64218566|FG009|Overall Study|Lost to Follow-up|1|||
23127757|NCT01441635|64218557|FG000|Overall Study|Noncompliance|0|||
23127758|NCT01441635|64218558|FG001|Overall Study|Noncompliance|1|||
23127759|NCT01441635|64218559|FG002|Overall Study|Noncompliance|0|||
23315885|NCT01377012|64899224|FG000|Core Study|Lost to Follow-up|7|||
23127760|NCT01441635|64218560|FG003|Overall Study|Noncompliance|0|||
23127761|NCT01441635|64218561|FG004|Overall Study|Noncompliance|0|||
23127762|NCT01441635|64218562|FG005|Overall Study|Noncompliance|0|||
23127763|NCT01441635|64218563|FG006|Overall Study|Noncompliance|1|||
23127764|NCT01441635|64218564|FG007|Overall Study|Noncompliance|0|||
23127765|NCT01441635|64218565|FG008|Overall Study|Noncompliance|0|||
23127766|NCT01441635|64218566|FG009|Overall Study|Noncompliance|0|||
23212397|NCT04900038|64516449|FG002|Overall Study|Withdrawal by Subject|0|||
23212398|NCT04900038|64516450|FG003|Overall Study|Withdrawal by Subject|0|||
23212399|NCT04900038|64516447|FG000|Overall Study|Study terminated by sponsor|18|||
23212400|NCT04900038|64516448|FG001|Overall Study|Study terminated by sponsor|15|||
23212401|NCT04900038|64516449|FG002|Overall Study|Study terminated by sponsor|17|||
23212402|NCT04900038|64516450|FG003|Overall Study|Study terminated by sponsor|14|||
23212403|NCT04900038|64516447|FG000|Overall Study|Protocol Deviation|1|||
23618307|NCT01116440|65988249|FG000|Withdrawal|Withdrawal by Subject|0|||
23127767|NCT01441635|64218557|FG000|Overall Study|Surgery or Invasive Intervention|0|||
23127768|NCT01441635|64218558|FG001|Overall Study|Surgery or Invasive Intervention|0|||
23127769|NCT01441635|64218559|FG002|Overall Study|Surgery or Invasive Intervention|1|||
23127770|NCT01441635|64218560|FG003|Overall Study|Surgery or Invasive Intervention|0|||
23127771|NCT01441635|64218561|FG004|Overall Study|Surgery or Invasive Intervention|0|||
23127772|NCT01441635|64218562|FG005|Overall Study|Surgery or Invasive Intervention|0|||
23127773|NCT01441635|64218563|FG006|Overall Study|Surgery or Invasive Intervention|0|||
23127774|NCT01441635|64218564|FG007|Overall Study|Surgery or Invasive Intervention|0|||
23127775|NCT01441635|64218565|FG008|Overall Study|Surgery or Invasive Intervention|0|||
23127776|NCT01441635|64218566|FG009|Overall Study|Surgery or Invasive Intervention|0|||
23127777|NCT01441635|64218557|FG000|Overall Study|Received Exclusionary Medication|1|||
23127778|NCT01441635|64218558|FG001|Overall Study|Received Exclusionary Medication|0|||
23127779|NCT01441635|64218559|FG002|Overall Study|Received Exclusionary Medication|0|||
23127780|NCT01441635|64218560|FG003|Overall Study|Received Exclusionary Medication|0|||
23127781|NCT01441635|64218561|FG004|Overall Study|Received Exclusionary Medication|0|||
23127782|NCT01441635|64218562|FG005|Overall Study|Received Exclusionary Medication|0|||
23127783|NCT01441635|64218563|FG006|Overall Study|Received Exclusionary Medication|0|||
23127784|NCT01441635|64218564|FG007|Overall Study|Received Exclusionary Medication|0|||
23127785|NCT01441635|64218565|FG008|Overall Study|Received Exclusionary Medication|0|||
23315886|NCT01377012|64899225|FG001|Core Study|Lost to Follow-up|5|||
23315887|NCT01377012|64899226|FG002|Core Study|Lost to Follow-up|4|||
23315888|NCT01377012|64899224|FG000|Core Study|Lack of Efficacy|41|||
23315889|NCT01377012|64899225|FG001|Core Study|Lack of Efficacy|28|||
23315890|NCT01377012|64899226|FG002|Core Study|Lack of Efficacy|37|||
23315891|NCT01377012|64899224|FG000|Core Study|Death|1|||
23315892|NCT01377012|64899225|FG001|Core Study|Death|1|||
23315893|NCT01377012|64899226|FG002|Core Study|Death|1|||
23315894|NCT01377012|64899224|FG000|Core Study|Adverse Event|10|||
23315895|NCT01377012|64899225|FG001|Core Study|Adverse Event|14|||
23315896|NCT01377012|64899226|FG002|Core Study|Adverse Event|13|||
23315897|NCT01377012|64899224|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
23315898|NCT01377012|64899225|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
23315899|NCT01377012|64899226|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
23315900|NCT01377012|64899224|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
23315901|NCT01377012|64899225|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
23315902|NCT01377012|64899226|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
23315903|NCT01377012|64899224|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
23315904|NCT01377012|64899225|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
23315905|NCT01377012|64899226|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
23127786|NCT01441635|64218566|FG009|Overall Study|Received Exclusionary Medication|0|||
23127787|NCT01441635|64218557|FG000|Overall Study|Other|0|||
23127788|NCT01441635|64218558|FG001|Overall Study|Other|0|||
23315906|NCT01377012|64899224|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
23315907|NCT01377012|64899225|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
23315908|NCT01377012|64899226|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
23315909|NCT01377012|64899224|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
23315910|NCT01377012|64899225|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
23315911|NCT01377012|64899226|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
23315912|NCT01377012|64899224|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
23315913|NCT01377012|64899225|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
23315914|NCT01377012|64899226|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
23315915|NCT01547130|64899230|FG000|Overall Study|Lost to Follow-up|9|||
23315916|NCT01547130|64899231|FG001|Overall Study|Lost to Follow-up|5|||
23315917|NCT01661062|64899232|FG000|Overall Study|Completed Treatment Off Study|3|||
23315918|NCT01661062|64899232|FG000|Overall Study|Withdrawal by Subject|2|||
23315919|NCT01715571|64899233|FG000|Overall Study|Lost to Follow-up|8|||
23315920|NCT03999749|64899236|FG000|Overall Study|Toxicity|16|||
23315921|NCT03999749|64899236|FG000|Overall Study|Withdrawal by Subject|3|||
23315922|NCT03999749|64899236|FG000|Overall Study|Disease progression|26|||
23315923|NCT03999749|64899236|FG000|Overall Study|Physician Decision|4|||
23315924|NCT03999749|64899236|FG000|Overall Study|Death|5|||
23315925|NCT03999749|64899236|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
23315926|NCT01557517|64899237|FG000|Overall Study|Death|1|||
23315927|NCT01557517|64899238|FG001|Overall Study|Death|0|||
23315928|NCT01557517|64899237|FG000|Overall Study|Refused further treatment|0|||
23315929|NCT01557517|64899238|FG001|Overall Study|Refused further treatment|2|||
23127789|NCT01441635|64218559|FG002|Overall Study|Other|0|||
23127790|NCT01441635|64218560|FG003|Overall Study|Other|0|||
23127791|NCT01441635|64218561|FG004|Overall Study|Other|0|||
23315930|NCT01557517|64899237|FG000|Overall Study|Adverse Event|0|||
23315931|NCT01557517|64899238|FG001|Overall Study|Adverse Event|2|||
23426540|NCT02255565|65307375|FG001|Overall Study|Withdrawal by Subject|1|||
23127792|NCT01441635|64218562|FG005|Overall Study|Other|0|||
23127793|NCT01441635|64218563|FG006|Overall Study|Other|0|||
23127794|NCT01441635|64218564|FG007|Overall Study|Other|1|||
23127795|NCT01441635|64218565|FG008|Overall Study|Other|0|||
23127796|NCT01441635|64218566|FG009|Overall Study|Other|0|||
23127797|NCT00547534|64218567|FG000|Overall Study|Adverse Event|7|||
23127798|NCT00547534|64218567|FG000|Overall Study|Disease Progression|4|||
23127799|NCT01199068|64218568|FG000|Overall Study|Unacceptable toxicity|0|||
23127800|NCT01199068|64218569|FG001|Overall Study|Unacceptable toxicity|0|||
23127801|NCT01199068|64218570|FG002|Overall Study|Unacceptable toxicity|2|||
23127802|NCT01199068|64218568|FG000|Overall Study|Progressive disease|3|||
23127803|NCT01199068|64218569|FG001|Overall Study|Progressive disease|3|||
23127804|NCT01199068|64218570|FG002|Overall Study|Progressive disease|6|||
23127805|NCT01199068|64218568|FG000|Overall Study|Withdrawal by Subject|0|||
23127806|NCT01199068|64218569|FG001|Overall Study|Withdrawal by Subject|0|||
23127807|NCT01199068|64218570|FG002|Overall Study|Withdrawal by Subject|1|||
23127808|NCT03023722|64218571|FG000|Overall Study|No follow-up assessment|4|||
23127809|NCT01254747|64218573|FG000|Overall Study|Unacceptable subjective vision|0|||
23127810|NCT01254747|64218574|FG001|Overall Study|Unacceptable subjective vision|0|||
23127811|NCT01254747|64218575|FG002|Overall Study|Unacceptable subjective vision|0|||
23127812|NCT01254747|64218576|FG003|Overall Study|Unacceptable subjective vision|2|||
23127813|NCT01254747|64218573|FG000|Overall Study|Difficult removal handling|0|||
23127814|NCT01254747|64218574|FG001|Overall Study|Difficult removal handling|0|||
23127815|NCT01254747|64218575|FG002|Overall Study|Difficult removal handling|1|||
23127816|NCT01254747|64218576|FG003|Overall Study|Difficult removal handling|0|||
23127817|NCT01254747|64218573|FG000|Overall Study|Symptoms and problems|0|||
23127818|NCT01254747|64218574|FG001|Overall Study|Symptoms and problems|2|||
23127819|NCT01254747|64218575|FG002|Overall Study|Symptoms and problems|1|||
23127820|NCT01254747|64218576|FG003|Overall Study|Symptoms and problems|0|||
23127821|NCT01254747|64218573|FG000|Overall Study|Lost to Follow-up|0|||
23127822|NCT01254747|64218574|FG001|Overall Study|Lost to Follow-up|0|||
23127823|NCT01254747|64218575|FG002|Overall Study|Lost to Follow-up|1|||
23127824|NCT01254747|64218576|FG003|Overall Study|Lost to Follow-up|0|||
23127825|NCT01254747|64218573|FG000|Overall Study|Biomicroscopy|0|||
23127826|NCT01254747|64218574|FG001|Overall Study|Biomicroscopy|0|||
23127827|NCT01254747|64218575|FG002|Overall Study|Biomicroscopy|1|||
23127828|NCT01254747|64218576|FG003|Overall Study|Biomicroscopy|0|||
23127829|NCT01254747|64218573|FG000|Overall Study|Discomfort|0|||
23127830|NCT01254747|64218574|FG001|Overall Study|Discomfort|4|||
23127831|NCT01254747|64218575|FG002|Overall Study|Discomfort|0|||
23127832|NCT01254747|64218576|FG003|Overall Study|Discomfort|0|||
23127833|NCT01605019|64218578|FG000|Overall Study|pt did not meet transplant endpoint|3|||
23127834|NCT01605019|64218579|FG001|Overall Study|pt did not meet transplant endpoint|0|||
23127835|NCT00078377|64218580|FG000|Overall Study|Adverse Event|2|||
23127836|NCT00078377|64218581|FG001|Overall Study|Adverse Event|5|||
23127837|NCT00078377|64218582|FG002|Overall Study|Adverse Event|1|||
23127838|NCT00078377|64218580|FG000|Overall Study|Lack of Efficacy|2|||
23127839|NCT00078377|64218581|FG001|Overall Study|Lack of Efficacy|0|||
23127840|NCT00078377|64218582|FG002|Overall Study|Lack of Efficacy|2|||
23127841|NCT00078377|64218580|FG000|Overall Study|Lost to Follow-up|0|||
23127842|NCT00078377|64218581|FG001|Overall Study|Lost to Follow-up|1|||
23127843|NCT00078377|64218582|FG002|Overall Study|Lost to Follow-up|1|||
23127844|NCT00078377|64218580|FG000|Overall Study|Physician Decision|2|||
23127845|NCT00078377|64218581|FG001|Overall Study|Physician Decision|0|||
23127846|NCT00078377|64218582|FG002|Overall Study|Physician Decision|0|||
23127847|NCT00078377|64218580|FG000|Overall Study|Withdrawal by Subject|3|||
23127848|NCT00078377|64218581|FG001|Overall Study|Withdrawal by Subject|4|||
23127849|NCT00078377|64218582|FG002|Overall Study|Withdrawal by Subject|4|||
23127850|NCT00078377|64218580|FG000|Overall Study|Miscellaneous|2|||
23315932|NCT01557517|64899237|FG000|Overall Study|Pt declined before treatment started|1|||
23315933|NCT01557517|64899238|FG001|Overall Study|Pt declined before treatment started|0|||
23315934|NCT04546724|64899239|FG000|Overall Study|Withdrawal by Subject|145|||
23315935|NCT04546724|64899240|FG001|Overall Study|Withdrawal by Subject|41|||
23315936|NCT04546724|64899239|FG000|Overall Study|Adverse Event|1|||
23315937|NCT04546724|64899240|FG001|Overall Study|Adverse Event|1|||
23127851|NCT00078377|64218581|FG001|Overall Study|Miscellaneous|6|||
23127852|NCT00078377|64218582|FG002|Overall Study|Miscellaneous|1|||
23127853|NCT01572740|64218587|FG000|Overall Study|Adverse Event|1|||
23127854|NCT01572740|64218588|FG001|Overall Study|Adverse Event|1|||
23127855|NCT01572740|64218587|FG000|Overall Study|Withdrawal by Subject|1|||
23127856|NCT01572740|64218588|FG001|Overall Study|Withdrawal by Subject|1|||
23127857|NCT01572740|64218587|FG000|Overall Study|unclassified|4|||
23127858|NCT01572740|64218588|FG001|Overall Study|unclassified|3|||
23127859|NCT01912404|64218593|FG000|Overall Study|Due to personal reasons|1|||
23127860|NCT01912404|64218594|FG001|Overall Study|Due to personal reasons|0|||
23127861|NCT01908829|64218595|FG000|Overall Study|Adverse Event|13|||
23127862|NCT01908829|64218596|FG001|Overall Study|Adverse Event|11|||
23127863|NCT01908829|64218597|FG002|Overall Study|Adverse Event|13|||
23127864|NCT01908829|64218595|FG000|Overall Study|Lost to Follow-up|4|||
23127865|NCT01908829|64218596|FG001|Overall Study|Lost to Follow-up|2|||
23315938|NCT04546724|64899239|FG000|Overall Study|Lost to Follow-up|186|||
23315939|NCT04546724|64899240|FG001|Overall Study|Lost to Follow-up|63|||
23315940|NCT04546724|64899239|FG000|Overall Study|Physician Decision|8|||
23315941|NCT04546724|64899240|FG001|Overall Study|Physician Decision|2|||
23315942|NCT04546724|64899239|FG000|Overall Study|Death|2|||
23315943|NCT04546724|64899240|FG001|Overall Study|Death|1|||
23315944|NCT04546724|64899239|FG000|Overall Study|subject has been out of town|1|||
23315945|NCT04546724|64899240|FG001|Overall Study|subject has been out of town|0|||
23315946|NCT04546724|64899239|FG000|Overall Study|subject is incarcerated|2|||
23315947|NCT04546724|64899240|FG001|Overall Study|subject is incarcerated|0|||
23315948|NCT04546724|64899239|FG000|Overall Study|subject is relocating|12|||
23315949|NCT04546724|64899240|FG001|Overall Study|subject is relocating|4|||
23315950|NCT04546724|64899239|FG000|Overall Study|Subject in another study|1|||
23315951|NCT04546724|64899240|FG001|Overall Study|Subject in another study|1|||
23315952|NCT03136965|64899241|FG000|Overall Study|Lost to Follow-up|0|||
23315953|NCT03136965|64899242|FG001|Overall Study|Lost to Follow-up|1|||
23315954|NCT03136965|64899243|FG002|Overall Study|Lost to Follow-up|0|||
23315955|NCT00534404|64899244|FG000|Overall Study|Death|0|||
23315956|NCT00534404|64899245|FG001|Overall Study|Death|0|||
23315957|NCT00534404|64899246|FG002|Overall Study|Death|2|||
23315958|NCT00534404|64899244|FG000|Overall Study|Withdrawal by Subject|8|||
23315959|NCT00534404|64899245|FG001|Overall Study|Withdrawal by Subject|2|||
23315960|NCT00534404|64899246|FG002|Overall Study|Withdrawal by Subject|38|||
23315961|NCT00534404|64899244|FG000|Overall Study|Removed by study staff|2|||
23315962|NCT00534404|64899245|FG001|Overall Study|Removed by study staff|3|||
23315963|NCT00534404|64899246|FG002|Overall Study|Removed by study staff|1|||
23315964|NCT00534404|64899244|FG000|Overall Study|Lost to Follow-up|170|||
23315965|NCT00534404|64899245|FG001|Overall Study|Lost to Follow-up|138|||
23315966|NCT00534404|64899246|FG002|Overall Study|Lost to Follow-up|201|||
23315967|NCT02695537|64899247|FG000|Overall Study|Adverse Event|3|||
23315968|NCT02695537|64899247|FG000|Overall Study|Lack of Efficacy|28|||
23315969|NCT02695537|64899247|FG000|Overall Study|Withdrawal by Subject|4|||
23315970|NCT02695537|64899247|FG000|Overall Study|Protocol Violation|3|||
23315971|NCT02856802|64899248|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
23315972|NCT02856802|64899249|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
23315973|NCT02856802|64899248|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
23315974|NCT02856802|64899249|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
23315975|NCT02856802|64899248|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
23315976|NCT02856802|64899249|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
23315977|NCT02856802|64899248|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
23315978|NCT02856802|64899249|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
23315979|NCT02856802|64899248|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
23315980|NCT02856802|64899249|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
23315981|NCT02856802|64899248|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
23315982|NCT02856802|64899249|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
23315983|NCT02017015|64899250|FG000|Overall Study|Adverse Event|9|||
23315984|NCT02017015|64899250|FG000|Overall Study|Withdrawal by Subject|21|||
23315985|NCT02017015|64899250|FG000|Overall Study|Death|4|||
23315986|NCT02017015|64899250|FG000|Overall Study|Progressive Disease|31|||
23315987|NCT02017015|64899250|FG000|Overall Study|Non-compliance with study drug|2|||
23315988|NCT02017015|64899250|FG000|Overall Study|Physician Decision|2|||
23315989|NCT03645863|64899251|FG000|Overall Study|Withdrawal by Subject|1|||
23315990|NCT03645863|64899252|FG001|Overall Study|Withdrawal by Subject|0|||
23315991|NCT03645863|64899253|FG002|Overall Study|Withdrawal by Subject|0|||
23315992|NCT02960490|64899254|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
23315993|NCT02960490|64899255|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
23315994|NCT02960490|64899256|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23212404|NCT04900038|64516448|FG001|Overall Study|Protocol Deviation|1|||
23212405|NCT04900038|64516449|FG002|Overall Study|Protocol Deviation|0|||
23212406|NCT04900038|64516450|FG003|Overall Study|Protocol Deviation|0|||
23212407|NCT04900038|64516447|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
23212408|NCT04900038|64516448|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
23212409|NCT04900038|64516449|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
23212410|NCT04900038|64516450|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
23212411|NCT04900038|64516447|FG000|Overall Study|Lost to Follow-up|0|||
23212412|NCT04900038|64516448|FG001|Overall Study|Lost to Follow-up|0|||
23315995|NCT02960490|64899257|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23545292|NCT00096135|65727159|FG000|Overall Study|Physician Decision|20|||
23212413|NCT04900038|64516449|FG002|Overall Study|Lost to Follow-up|0|||
23315996|NCT02960490|64899258|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23315997|NCT02960490|64899259|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23315998|NCT02960490|64899260|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23545293|NCT00096135|65727160|FG001|Overall Study|Physician Decision|4|||
23212414|NCT04900038|64516450|FG003|Overall Study|Lost to Follow-up|1|||
23212415|NCT00363051|64516451|FG000|Overall Study|Adminstrative problems|1|||
23545294|NCT00096135|65727159|FG000|Overall Study|Refusal of further protocol therapy|4|||
23545295|NCT00096135|65727160|FG001|Overall Study|Refusal of further protocol therapy|1|||
23212416|NCT00363051|64516452|FG001|Overall Study|Adminstrative problems|1|||
23212417|NCT00363051|64516451|FG000|Overall Study|Adverse Event|21|||
23212418|NCT00363051|64516452|FG001|Overall Study|Adverse Event|12|||
23212419|NCT00363051|64516451|FG000|Overall Study|New Cancer Therapy|2|||
23212420|NCT00363051|64516452|FG001|Overall Study|New Cancer Therapy|1|||
23212421|NCT00363051|64516451|FG000|Overall Study|Withdrawal by Subject|11|||
23212422|NCT00363051|64516452|FG001|Overall Study|Withdrawal by Subject|3|||
23127866|NCT01908829|64218597|FG002|Overall Study|Lost to Follow-up|1|||
23127867|NCT01908829|64218595|FG000|Overall Study|Randomized no double-blind drug received|1|||
23127868|NCT01908829|64218596|FG001|Overall Study|Randomized no double-blind drug received|0|||
23127869|NCT01908829|64218597|FG002|Overall Study|Randomized no double-blind drug received|1|||
23127870|NCT01908829|64218595|FG000|Overall Study|Discontinued (no EoT page)|2|||
23127871|NCT01908829|64218596|FG001|Overall Study|Discontinued (no EoT page)|0|||
23127872|NCT01908829|64218597|FG002|Overall Study|Discontinued (no EoT page)|0|||
23127873|NCT01908829|64218595|FG000|Overall Study|Miscellaneous|0|||
23127874|NCT01908829|64218596|FG001|Overall Study|Miscellaneous|2|||
23127875|NCT01908829|64218597|FG002|Overall Study|Miscellaneous|0|||
23127876|NCT01908829|64218595|FG000|Overall Study|Protocol Violation|2|||
23127877|NCT01908829|64218596|FG001|Overall Study|Protocol Violation|2|||
23127878|NCT01908829|64218597|FG002|Overall Study|Protocol Violation|0|||
23127879|NCT01908829|64218595|FG000|Overall Study|Lack of Efficacy|1|||
23127880|NCT01908829|64218596|FG001|Overall Study|Lack of Efficacy|3|||
23127881|NCT01908829|64218597|FG002|Overall Study|Lack of Efficacy|2|||
23127882|NCT01908829|64218595|FG000|Overall Study|Withdrawal by Subject|26|||
23127883|NCT01908829|64218596|FG001|Overall Study|Withdrawal by Subject|29|||
23127884|NCT01908829|64218597|FG002|Overall Study|Withdrawal by Subject|22|||
23127885|NCT02683785|64218598|FG000|Overall Study|Withdrawal by Subject|1|||
23127886|NCT02683785|64218599|FG001|Overall Study|Withdrawal by Subject|1|||
23127887|NCT02683785|64218598|FG000|Overall Study|Lost to Follow-up|0|||
23127888|NCT02683785|64218599|FG001|Overall Study|Lost to Follow-up|1|||
23127889|NCT02683785|64218598|FG000|Overall Study|Adverse Event|0|||
23127890|NCT02683785|64218599|FG001|Overall Study|Adverse Event|2|||
23127891|NCT01252355|64218607|FG000|Overall Study|Adverse Event|9|||
23127892|NCT01252355|64218608|FG001|Overall Study|Adverse Event|17|||
23127893|NCT01252355|64218609|FG002|Overall Study|Adverse Event|22|||
23545296|NCT00096135|65727159|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
23545297|NCT00096135|65727160|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
23545298|NCT00096135|65727159|FG000|Overall Study|Other, specify|15|||
23545299|NCT00096135|65727160|FG001|Overall Study|Other, specify|3|||
23545300|NCT00096135|65727159|FG000|Overall Study|Ineligible|2|||
23545301|NCT00096135|65727160|FG001|Overall Study|Ineligible|0|||
23545302|NCT04837482|65727161|FG000|Period 2|Withdrawal by Subject|0|||
23545303|NCT04837482|65727162|FG001|Period 2|Withdrawal by Subject|1|||
23545304|NCT02044510|65727163|FG000|Overall Study|Adverse Event|1|||
23545305|NCT02044510|65727164|FG001|Overall Study|Adverse Event|2|||
23545306|NCT03515837|65727167|FG000|Overall Study|Death|219|||
23545307|NCT03515837|65727168|FG001|Overall Study|Death|227|||
23545308|NCT03515837|65727167|FG000|Overall Study|Lost to Follow-up|0|||
23545309|NCT03515837|65727168|FG001|Overall Study|Lost to Follow-up|1|||
23545310|NCT03515837|65727167|FG000|Overall Study|Withdrawal by Subject|0|||
23545311|NCT03515837|65727168|FG001|Overall Study|Withdrawal by Subject|4|||
23545312|NCT03515837|65727167|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
23545313|NCT03515837|65727168|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
23545314|NCT00622167|65727177|FG000|Overall Study|Did not meet angiographic criteria|20|||
23545315|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
23545316|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
23545317|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
23545318|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
23545319|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
23545320|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
23545321|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
23545322|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
23545323|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
23545324|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
23545325|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
23545326|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
23545327|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
23127894|NCT01252355|64218607|FG000|Overall Study|Lack of Efficacy|6|||
23127895|NCT01252355|64218608|FG001|Overall Study|Lack of Efficacy|4|||
23212423|NCT00363051|64516451|FG000|Overall Study|Lost to Follow-up|0|||
23212424|NCT00363051|64516452|FG001|Overall Study|Lost to Follow-up|1|||
23545328|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
23212425|NCT00363051|64516451|FG000|Overall Study|Protocol Violation|0|||
23212426|NCT00363051|64516452|FG001|Overall Study|Protocol Violation|2|||
23212427|NCT00363051|64516451|FG000|Overall Study|Death|3|||
23212428|NCT00363051|64516452|FG001|Overall Study|Death|2|||
23212429|NCT03444870|64516453|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
23212430|NCT03444870|64516454|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
23212431|NCT03444870|64516455|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
23212432|NCT03444870|64516456|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
23212433|NCT03444870|64516457|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
23212434|NCT03444870|64516458|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
23212435|NCT03444870|64516453|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
23212436|NCT03444870|64516454|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
23212437|NCT03444870|64516455|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
23212438|NCT03444870|64516456|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
23212439|NCT03444870|64516457|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
23212440|NCT03444870|64516458|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
23212441|NCT03444870|64516453|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
23212442|NCT03444870|64516454|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
23212443|NCT03444870|64516455|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
23212444|NCT03444870|64516456|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23212445|NCT03444870|64516457|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23212446|NCT03444870|64516458|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23212447|NCT03444870|64516453|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
23212448|NCT03444870|64516454|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
23212449|NCT03444870|64516455|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
23212450|NCT03444870|64516456|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
23212451|NCT03444870|64516457|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
23212452|NCT03444870|64516458|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
23212453|NCT03444870|64516453|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
23212454|NCT03444870|64516454|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
23212455|NCT03444870|64516455|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
23212456|NCT03444870|64516456|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
23212457|NCT03444870|64516457|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
23212458|NCT03444870|64516458|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
23212459|NCT03444870|64516453|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
23212460|NCT03444870|64516454|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23212461|NCT03444870|64516455|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23212462|NCT03444870|64516456|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23212463|NCT03444870|64516457|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23212464|NCT03444870|64516458|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
23212465|NCT03444870|64516453|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
23212466|NCT03444870|64516454|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
23212467|NCT03444870|64516455|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
23212468|NCT03444870|64516456|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
23212469|NCT03444870|64516457|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
23212470|NCT03444870|64516458|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
23212471|NCT03444870|64516453|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
23212472|NCT03444870|64516454|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
23212473|NCT03444870|64516455|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
23212474|NCT03444870|64516456|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
23212475|NCT03444870|64516457|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
23212476|NCT03444870|64516458|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
23212477|NCT03444870|64516453|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
23212478|NCT03444870|64516454|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23212479|NCT03444870|64516455|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23212480|NCT03444870|64516456|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23212481|NCT03444870|64516457|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23212482|NCT03444870|64516458|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
23212483|NCT03444870|64516453|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23212484|NCT03444870|64516454|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23212485|NCT03444870|64516455|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23212486|NCT03444870|64516456|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23426541|NCT02255565|65307376|FG002|Overall Study|Withdrawal by Subject|0|||
23212487|NCT03444870|64516457|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
23212488|NCT03444870|64516458|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
23212489|NCT03444870|64516453|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
23426542|NCT00434759|65307379|FG000|Overall Study|Lack of Efficacy|5|||
23212490|NCT03444870|64516454|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
23212491|NCT03444870|64516455|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
23212492|NCT03444870|64516456|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
23212493|NCT03444870|64516457|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
23315999|NCT02960490|64899261|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23212494|NCT03444870|64516458|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
23212495|NCT03444870|64516453|FG000|Open-Label Extension (OLE) Period|Death|0|||
23212496|NCT03444870|64516454|FG001|Open-Label Extension (OLE) Period|Death|0|||
23212497|NCT03444870|64516455|FG002|Open-Label Extension (OLE) Period|Death|0|||
23212498|NCT03444870|64516456|FG003|Open-Label Extension (OLE) Period|Death|0|||
23212499|NCT03444870|64516457|FG004|Open-Label Extension (OLE) Period|Death|1|||
23212500|NCT03444870|64516458|FG005|Open-Label Extension (OLE) Period|Death|0|||
23212501|NCT04511819|64516461|FG000|Overall Study|Non-compliance with study drug|5|||
23212502|NCT04511819|64516462|FG001|Overall Study|Non-compliance with study drug|1|||
23212503|NCT04511819|64516461|FG000|Overall Study|Withdrawal by Subject|0|||
23212504|NCT04511819|64516462|FG001|Overall Study|Withdrawal by Subject|3|||
23212505|NCT04511819|64516461|FG000|Overall Study|Adverse Event|0|||
23212506|NCT04511819|64516462|FG001|Overall Study|Adverse Event|1|||
23212507|NCT04511819|64516461|FG000|Overall Study|Protocol deviation|1|||
23212508|NCT04511819|64516462|FG001|Overall Study|Protocol deviation|0|||
23212509|NCT01578785|64516463|FG000|Overall Study|Withdrawal by Subject|0|||
23212510|NCT01578785|64516464|FG001|Overall Study|Withdrawal by Subject|1|||
23212511|NCT01578785|64516463|FG000|Overall Study|Study terminated by sponsor|59|||
23212512|NCT01578785|64516464|FG001|Overall Study|Study terminated by sponsor|118|||
23212513|NCT00795509|64516465|FG000|Overall Study|Protocol Violation|31|||
23212514|NCT00318565|64516466|FG000|Overall Study|Excluded per protocol|24|||
23212515|NCT01419080|64516467|FG000|Overall Study|Withdrawal by Subject|75|||
23212516|NCT01419080|64516467|FG000|Overall Study|Death|30|||
23212517|NCT01419080|64516467|FG000|Overall Study|Lost to Follow-up|23|||
23212518|NCT01419080|64516467|FG000|Overall Study|Too Ill|3|||
23212519|NCT00563368|64516468|FG000|Overall Study|Lost to Follow-up|14|||
23212520|NCT00563368|64516469|FG001|Overall Study|Lost to Follow-up|14|||
23212521|NCT00563368|64516470|FG002|Overall Study|Lost to Follow-up|12|||
23212522|NCT00563368|64516471|FG003|Overall Study|Lost to Follow-up|6|||
23212523|NCT00563368|64516472|FG004|Overall Study|Lost to Follow-up|9|||
23212524|NCT00563368|64516473|FG005|Overall Study|Lost to Follow-up|8|||
23212525|NCT00563368|64516474|FG006|Overall Study|Lost to Follow-up|9|||
23212526|NCT00563368|64516468|FG000|Overall Study|Adverse Event|3|||
23212527|NCT00563368|64516469|FG001|Overall Study|Adverse Event|4|||
23212528|NCT00563368|64516470|FG002|Overall Study|Adverse Event|5|||
23212529|NCT00563368|64516471|FG003|Overall Study|Adverse Event|9|||
23212530|NCT00563368|64516472|FG004|Overall Study|Adverse Event|6|||
23212531|NCT00563368|64516473|FG005|Overall Study|Adverse Event|10|||
23212532|NCT00563368|64516474|FG006|Overall Study|Adverse Event|17|||
23212533|NCT00563368|64516468|FG000|Overall Study|Withdrawal by Subject|11|||
23212534|NCT00563368|64516469|FG001|Overall Study|Withdrawal by Subject|6|||
23212535|NCT00563368|64516470|FG002|Overall Study|Withdrawal by Subject|5|||
23212536|NCT00563368|64516471|FG003|Overall Study|Withdrawal by Subject|7|||
23212537|NCT00563368|64516472|FG004|Overall Study|Withdrawal by Subject|8|||
23212538|NCT00563368|64516473|FG005|Overall Study|Withdrawal by Subject|5|||
23212539|NCT00563368|64516474|FG006|Overall Study|Withdrawal by Subject|4|||
23212540|NCT00563368|64516468|FG000|Overall Study|protocol non-compliance|1|||
23212541|NCT00563368|64516469|FG001|Overall Study|protocol non-compliance|1|||
23212542|NCT00563368|64516470|FG002|Overall Study|protocol non-compliance|2|||
23212543|NCT00563368|64516471|FG003|Overall Study|protocol non-compliance|1|||
23212544|NCT00563368|64516472|FG004|Overall Study|protocol non-compliance|0|||
23212545|NCT00563368|64516473|FG005|Overall Study|protocol non-compliance|1|||
23212546|NCT00563368|64516474|FG006|Overall Study|protocol non-compliance|3|||
23212547|NCT00563368|64516468|FG000|Overall Study|Pregnancy|1|||
23212548|NCT00563368|64516469|FG001|Overall Study|Pregnancy|0|||
23212549|NCT00563368|64516470|FG002|Overall Study|Pregnancy|1|||
23212550|NCT00563368|64516471|FG003|Overall Study|Pregnancy|2|||
23316000|NCT02960490|64899262|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23212551|NCT00563368|64516472|FG004|Overall Study|Pregnancy|1|||
23212552|NCT00563368|64516473|FG005|Overall Study|Pregnancy|2|||
23212553|NCT00563368|64516474|FG006|Overall Study|Pregnancy|0|||
23212554|NCT00563368|64516468|FG000|Overall Study|requirement for restricted medication|0|||
23212555|NCT00563368|64516469|FG001|Overall Study|requirement for restricted medication|0|||
23212556|NCT00563368|64516470|FG002|Overall Study|requirement for restricted medication|2|||
23212557|NCT00563368|64516471|FG003|Overall Study|requirement for restricted medication|0|||
23212558|NCT00563368|64516472|FG004|Overall Study|requirement for restricted medication|0|||
23212559|NCT00563368|64516473|FG005|Overall Study|requirement for restricted medication|0|||
23212560|NCT00563368|64516474|FG006|Overall Study|requirement for restricted medication|0|||
23212561|NCT00563368|64516468|FG000|Overall Study|Other|5|||
23212562|NCT00563368|64516469|FG001|Overall Study|Other|5|||
23212563|NCT00563368|64516470|FG002|Overall Study|Other|3|||
23316001|NCT02960490|64899263|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
23316002|NCT02960490|64899254|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23316003|NCT02960490|64899255|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
23316004|NCT02960490|64899256|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23316005|NCT02960490|64899257|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23316006|NCT02960490|64899258|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23316007|NCT02960490|64899259|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23316008|NCT02960490|64899260|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23316009|NCT02960490|64899261|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23316010|NCT02960490|64899262|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23618308|NCT01116440|65988250|FG001|Withdrawal|Withdrawal by Subject|1|||
23618309|NCT01116440|65988249|FG000|Withdrawal|Lost to Follow-up|0|||
23618310|NCT01116440|65988250|FG001|Withdrawal|Lost to Follow-up|1|||
23618311|NCT01116440|65988249|FG000|Follow-up|Lost to Follow-up|0|||
23618312|NCT01116440|65988250|FG001|Follow-up|Lost to Follow-up|1|||
23618313|NCT01116440|65988249|FG000|Follow-up|Withdrawal by Subject|0|||
23127896|NCT01252355|64218609|FG002|Overall Study|Lack of Efficacy|2|||
23316011|NCT02960490|64899263|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
23316012|NCT02960490|64899254|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
23316013|NCT02960490|64899255|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
23316014|NCT02960490|64899256|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23316015|NCT02960490|64899257|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23316016|NCT02960490|64899258|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23316017|NCT02960490|64899259|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23316018|NCT02960490|64899260|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23316019|NCT02960490|64899261|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23316020|NCT02960490|64899262|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23316021|NCT02960490|64899263|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
23316022|NCT02960490|64899254|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
23316023|NCT02960490|64899255|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
23316024|NCT02960490|64899256|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23316025|NCT02960490|64899257|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23316026|NCT02960490|64899258|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23316027|NCT02960490|64899259|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23316028|NCT02960490|64899260|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23316029|NCT02960490|64899261|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23316030|NCT02960490|64899262|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23316031|NCT02960490|64899263|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
23316032|NCT02960490|64899254|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23316033|NCT02960490|64899255|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23316034|NCT02960490|64899256|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
23316035|NCT02960490|64899257|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
23316036|NCT02960490|64899258|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23316037|NCT02960490|64899259|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
23316038|NCT02960490|64899260|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23618314|NCT01116440|65988250|FG001|Follow-up|Withdrawal by Subject|1|||
23618315|NCT01184859|65988251|FG000|Period 1: Single Dose|Insufficient urine production|0|||
23618316|NCT01184859|65988252|FG001|Period 1: Single Dose|Insufficient urine production|1|||
23127897|NCT01252355|64218607|FG000|Overall Study|Lost to Follow-up|0|||
23127898|NCT01252355|64218608|FG001|Overall Study|Lost to Follow-up|0|||
23127899|NCT01252355|64218609|FG002|Overall Study|Lost to Follow-up|1|||
23127900|NCT01252355|64218607|FG000|Overall Study|Poor Compliance to Protocol|1|||
23127901|NCT01252355|64218608|FG001|Overall Study|Poor Compliance to Protocol|1|||
23127902|NCT01252355|64218609|FG002|Overall Study|Poor Compliance to Protocol|1|||
23127903|NCT01252355|64218607|FG000|Overall Study|Progressive Disease|2|||
23127904|NCT01252355|64218608|FG001|Overall Study|Progressive Disease|0|||
23127905|NCT01252355|64218609|FG002|Overall Study|Progressive Disease|0|||
23127906|NCT01252355|64218607|FG000|Overall Study|Sponsor Early Termination of Study|149|||
23127907|NCT01252355|64218608|FG001|Overall Study|Sponsor Early Termination of Study|149|||
23127908|NCT01252355|64218609|FG002|Overall Study|Sponsor Early Termination of Study|146|||
23127909|NCT01252355|64218607|FG000|Overall Study|Randomized but not Treated|2|||
23127910|NCT01252355|64218608|FG001|Overall Study|Randomized but not Treated|0|||
23127911|NCT01252355|64218609|FG002|Overall Study|Randomized but not Treated|0|||
23127912|NCT01252355|64218607|FG000|Overall Study|Other Than Above|8|||
23127913|NCT01252355|64218608|FG001|Overall Study|Other Than Above|7|||
23127914|NCT01252355|64218609|FG002|Overall Study|Other Than Above|7|||
23127915|NCT02037477|64218611|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
23127916|NCT02037477|64218612|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
23127917|NCT02037477|64218613|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
23316039|NCT02960490|64899261|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23316040|NCT02960490|64899262|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23316041|NCT02960490|64899263|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
23316042|NCT02960490|64899254|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23316043|NCT02960490|64899255|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23316044|NCT02960490|64899256|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
23316045|NCT02960490|64899257|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23316046|NCT02960490|64899258|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
23316047|NCT02960490|64899259|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23316048|NCT02960490|64899260|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23316049|NCT02960490|64899261|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23316050|NCT02960490|64899262|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23316051|NCT02960490|64899263|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
23316052|NCT02960490|64899254|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
23316053|NCT02960490|64899255|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
23316054|NCT02960490|64899256|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
23316055|NCT02960490|64899257|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
23316056|NCT02960490|64899258|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
23316057|NCT02960490|64899259|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
23316058|NCT02960490|64899260|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
23316059|NCT02960490|64899261|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
23316060|NCT02960490|64899262|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
23316061|NCT02960490|64899263|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
23316062|NCT02960490|64899254|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23316063|NCT02960490|64899255|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23316064|NCT02960490|64899256|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23316065|NCT02960490|64899257|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23316066|NCT02960490|64899258|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23316067|NCT02960490|64899259|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23316068|NCT02960490|64899260|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
23316069|NCT02960490|64899261|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
23316070|NCT02960490|64899262|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
23316071|NCT02960490|64899263|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
23316072|NCT02960490|64899254|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23316073|NCT02960490|64899255|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23316074|NCT02960490|64899256|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23316075|NCT02960490|64899257|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23316076|NCT02960490|64899258|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23316077|NCT02960490|64899259|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23316078|NCT02960490|64899260|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23316079|NCT02960490|64899261|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
23316080|NCT02960490|64899262|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23316081|NCT02960490|64899263|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
23316082|NCT02960490|64899254|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23316083|NCT02960490|64899255|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23316084|NCT02960490|64899256|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23316085|NCT02960490|64899257|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23316086|NCT02960490|64899258|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23316087|NCT02960490|64899259|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
23316088|NCT02960490|64899260|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
23316089|NCT02960490|64899261|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
23316090|NCT02960490|64899262|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
23316091|NCT02960490|64899263|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
23316092|NCT02960490|64899254|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23316093|NCT02960490|64899255|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23316094|NCT02960490|64899256|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23316095|NCT02960490|64899257|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23316096|NCT02960490|64899258|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23316097|NCT02960490|64899259|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23316098|NCT02960490|64899260|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
23316099|NCT02960490|64899261|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23316100|NCT02960490|64899262|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23316101|NCT02960490|64899263|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
23316102|NCT02960490|64899254|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
23316103|NCT02960490|64899255|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
23316104|NCT02960490|64899256|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
23316105|NCT02960490|64899257|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
23316106|NCT02960490|64899258|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
23316107|NCT02960490|64899259|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
23316108|NCT02960490|64899260|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
23316109|NCT02960490|64899261|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
23316110|NCT02960490|64899262|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
23316111|NCT02960490|64899263|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
23316112|NCT01408043|64899266|FG000|Overall Study|unable to collect cells|1|||
23316113|NCT00243412|64899267|FG000|Overall Study|Death|0|||
23316114|NCT00243412|64899268|FG001|Overall Study|Death|1|||
23316115|NCT00243412|64899267|FG000|Overall Study|Adverse Event|4|||
23316116|NCT00243412|64899268|FG001|Overall Study|Adverse Event|2|||
23316117|NCT00243412|64899267|FG000|Overall Study|Lost to Follow-up|0|||
23316118|NCT00243412|64899268|FG001|Overall Study|Lost to Follow-up|1|||
23316119|NCT00243412|64899267|FG000|Overall Study|Physician Decision|1|||
23316120|NCT00243412|64899268|FG001|Overall Study|Physician Decision|1|||
23316121|NCT00243412|64899267|FG000|Overall Study|Withdrawal by Subject|4|||
23316122|NCT00243412|64899268|FG001|Overall Study|Withdrawal by Subject|5|||
23316123|NCT00243412|64899267|FG000|Overall Study|Other|1|||
23316124|NCT00243412|64899268|FG001|Overall Study|Other|1|||
23316125|NCT02764151|64899269|FG000|Overall Study|Subject refused further follow-up|0|||
23316126|NCT02764151|64899270|FG001|Overall Study|Subject refused further follow-up|0|||
23316127|NCT02764151|64899271|FG002|Overall Study|Subject refused further follow-up|0|||
23316128|NCT02764151|64899272|FG003|Overall Study|Subject refused further follow-up|1|||
23316129|NCT02764151|64899269|FG000|Overall Study|Other|0|||
23316130|NCT02764151|64899270|FG001|Overall Study|Other|0|||
23316131|NCT02764151|64899271|FG002|Overall Study|Other|0|||
23316132|NCT02764151|64899272|FG003|Overall Study|Other|2|||
23316133|NCT00660907|64899273|FG000|Overall Study|Incorrect Enrollment|1|||
23316134|NCT00660907|64899274|FG001|Overall Study|Incorrect Enrollment|1|||
23316135|NCT00660907|64899273|FG000|Overall Study|Adverse Event|33|||
23316136|NCT00660907|64899274|FG001|Overall Study|Adverse Event|19|||
23316137|NCT00660907|64899273|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
23127918|NCT02037477|64218614|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
23127919|NCT02956837|64218619|FG000|Overall Study|Serious Adverse Events|0|||
23316138|NCT00660907|64899274|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
23316139|NCT00660907|64899273|FG000|Overall Study|Withdrawal by Subject|23|||
23316140|NCT00660907|64899274|FG001|Overall Study|Withdrawal by Subject|32|||
23316141|NCT00660907|64899273|FG000|Overall Study|Lost to Follow-up|3|||
23316142|NCT00660907|64899274|FG001|Overall Study|Lost to Follow-up|3|||
23316143|NCT00660907|64899273|FG000|Overall Study|Poor/Non-Compliance|5|||
23316144|NCT00660907|64899274|FG001|Overall Study|Poor/Non-Compliance|1|||
23316145|NCT00660907|64899273|FG000|Overall Study|Safety|1|||
23316146|NCT00660907|64899274|FG001|Overall Study|Safety|0|||
23316147|NCT00660907|64899273|FG000|Overall Study|Death|1|||
23316148|NCT00660907|64899274|FG001|Overall Study|Death|3|||
23316149|NCT00660907|64899273|FG000|Overall Study|Various|11|||
23316150|NCT00660907|64899274|FG001|Overall Study|Various|8|||
23316151|NCT00696787|64899277|FG000|Overall Study|Adverse Event|1|||
23316152|NCT00696787|64899278|FG001|Overall Study|Adverse Event|0|||
23316153|NCT00696787|64899279|FG002|Overall Study|Adverse Event|6|||
23316154|NCT00696787|64899277|FG000|Overall Study|Discontinuation by Sponsor|9|||
23316155|NCT00696787|64899278|FG001|Overall Study|Discontinuation by Sponsor|13|||
23316156|NCT00696787|64899279|FG002|Overall Study|Discontinuation by Sponsor|14|||
23316157|NCT00696787|64899277|FG000|Overall Study|Lack of Efficacy|0|||
23316158|NCT00696787|64899278|FG001|Overall Study|Lack of Efficacy|1|||
23316159|NCT00696787|64899279|FG002|Overall Study|Lack of Efficacy|0|||
23316160|NCT00696787|64899277|FG000|Overall Study|Lost to Follow-up|4|||
23316161|NCT00696787|64899278|FG001|Overall Study|Lost to Follow-up|0|||
23316162|NCT00696787|64899279|FG002|Overall Study|Lost to Follow-up|3|||
23316163|NCT00696787|64899277|FG000|Overall Study|Withdrawal by Subject|0|||
23316164|NCT00696787|64899278|FG001|Overall Study|Withdrawal by Subject|3|||
23316165|NCT00696787|64899279|FG002|Overall Study|Withdrawal by Subject|2|||
23316166|NCT00696787|64899277|FG000|Overall Study|Failed to return|1|||
23127920|NCT02956837|64218620|FG001|Overall Study|Serious Adverse Events|1|||
23316167|NCT00696787|64899278|FG001|Overall Study|Failed to return|3|||
23316168|NCT00696787|64899279|FG002|Overall Study|Failed to return|1|||
23316169|NCT02047734|64899280|FG000|Overall Study|Adverse Event|18|||
23316170|NCT02047734|64899281|FG001|Overall Study|Adverse Event|13|||
23127921|NCT02956837|64218621|FG002|Overall Study|Serious Adverse Events|0|||
23316171|NCT02047734|64899282|FG002|Overall Study|Adverse Event|13|||
23316172|NCT02047734|64899280|FG000|Overall Study|Lack of Efficacy|4|||
23316173|NCT02047734|64899281|FG001|Overall Study|Lack of Efficacy|5|||
23316174|NCT02047734|64899282|FG002|Overall Study|Lack of Efficacy|1|||
23316175|NCT02047734|64899280|FG000|Overall Study|Protocol Violation|3|||
23316176|NCT02047734|64899281|FG001|Overall Study|Protocol Violation|1|||
23316177|NCT02047734|64899282|FG002|Overall Study|Protocol Violation|1|||
23316178|NCT02047734|64899280|FG000|Overall Study|Lost to Follow-up|1|||
23316179|NCT02047734|64899281|FG001|Overall Study|Lost to Follow-up|4|||
23316180|NCT02047734|64899282|FG002|Overall Study|Lost to Follow-up|0|||
23316181|NCT02047734|64899280|FG000|Overall Study|Death|0|||
23316182|NCT02047734|64899281|FG001|Overall Study|Death|1|||
23316183|NCT02047734|64899282|FG002|Overall Study|Death|0|||
23316184|NCT02047734|64899280|FG000|Overall Study|Withdrawal by Subject|30|||
23316185|NCT02047734|64899281|FG001|Overall Study|Withdrawal by Subject|31|||
23316186|NCT02047734|64899282|FG002|Overall Study|Withdrawal by Subject|19|||
23316187|NCT02047734|64899280|FG000|Overall Study|Physician Decision|7|||
23316188|NCT02047734|64899281|FG001|Overall Study|Physician Decision|6|||
23316189|NCT02047734|64899282|FG002|Overall Study|Physician Decision|5|||
23316190|NCT02047734|64899280|FG000|Overall Study|Miscellaneous|2|||
23316191|NCT02047734|64899281|FG001|Overall Study|Miscellaneous|4|||
23316192|NCT02047734|64899282|FG002|Overall Study|Miscellaneous|6|||
23316193|NCT02047734|64899280|FG000|Overall Study|Did Not Receive Study Drug|2|||
23316194|NCT02047734|64899281|FG001|Overall Study|Did Not Receive Study Drug|4|||
23316195|NCT02047734|64899282|FG002|Overall Study|Did Not Receive Study Drug|1|||
23316196|NCT01128179|64899297|FG000|Overall Study|Death|1|||
23316197|NCT01128179|64899298|FG001|Overall Study|Death|0|||
23316198|NCT01128179|64899297|FG000|Overall Study|Protocol Violation|1|||
23426543|NCT00434759|65307380|FG001|Overall Study|Lack of Efficacy|4|||
23426544|NCT00434759|65307379|FG000|Overall Study|Withdrawal by Subject|17|||
23426545|NCT00434759|65307380|FG001|Overall Study|Withdrawal by Subject|1|||
23426546|NCT00434759|65307379|FG000|Overall Study|family affairs|2|||
23426547|NCT00434759|65307380|FG001|Overall Study|family affairs|0|||
23426548|NCT02251717|65307381|FG000|Overall Study|Adverse Event|0|||
23426549|NCT02251717|65307382|FG001|Overall Study|Adverse Event|1|||
23426550|NCT02251717|65307381|FG000|Overall Study|Withdrew Consent|1|||
23426551|NCT02251717|65307382|FG001|Overall Study|Withdrew Consent|0|||
23426552|NCT01155466|65307384|FG000|Overall Study|Adverse Event|13|||
23426553|NCT01155466|65307385|FG001|Overall Study|Adverse Event|15|||
23426554|NCT01155466|65307386|FG002|Overall Study|Adverse Event|6|||
23426555|NCT01155466|65307387|FG003|Overall Study|Adverse Event|17|||
23426556|NCT01155466|65307388|FG004|Overall Study|Adverse Event|18|||
23426557|NCT01155466|65307384|FG000|Overall Study|Lost to Follow-up|0|||
23426558|NCT01155466|65307385|FG001|Overall Study|Lost to Follow-up|0|||
23426559|NCT01155466|65307386|FG002|Overall Study|Lost to Follow-up|0|||
23426560|NCT01155466|65307387|FG003|Overall Study|Lost to Follow-up|0|||
23426561|NCT01155466|65307388|FG004|Overall Study|Lost to Follow-up|2|||
23426562|NCT01155466|65307384|FG000|Overall Study|Withdrawal by Subject|7|||
23426563|NCT01155466|65307385|FG001|Overall Study|Withdrawal by Subject|5|||
23426564|NCT01155466|65307386|FG002|Overall Study|Withdrawal by Subject|9|||
23426565|NCT01155466|65307387|FG003|Overall Study|Withdrawal by Subject|4|||
23426566|NCT01155466|65307388|FG004|Overall Study|Withdrawal by Subject|4|||
23426567|NCT01155466|65307384|FG000|Overall Study|Protocol Violation|0|||
23426568|NCT01155466|65307385|FG001|Overall Study|Protocol Violation|0|||
23426569|NCT01155466|65307386|FG002|Overall Study|Protocol Violation|2|||
23426570|NCT01155466|65307387|FG003|Overall Study|Protocol Violation|0|||
23426571|NCT01155466|65307388|FG004|Overall Study|Protocol Violation|1|||
23426572|NCT01155466|65307384|FG000|Overall Study|Administrative|0|||
23426573|NCT01155466|65307385|FG001|Overall Study|Administrative|3|||
23426574|NCT01155466|65307386|FG002|Overall Study|Administrative|0|||
23426575|NCT01155466|65307387|FG003|Overall Study|Administrative|0|||
23426576|NCT01155466|65307388|FG004|Overall Study|Administrative|0|||
23426577|NCT01155466|65307384|FG000|Overall Study|Randomized not treated|2|||
23426578|NCT01155466|65307385|FG001|Overall Study|Randomized not treated|2|||
23426579|NCT01155466|65307386|FG002|Overall Study|Randomized not treated|3|||
23426580|NCT01155466|65307387|FG003|Overall Study|Randomized not treated|0|||
23426581|NCT01155466|65307388|FG004|Overall Study|Randomized not treated|2|||
23426582|NCT02776033|65307389|FG000|Overall Study|Withdrawal by Subject|0|||
23426583|NCT02776033|65307390|FG001|Overall Study|Withdrawal by Subject|0|||
23426584|NCT02776033|65307391|FG002|Overall Study|Withdrawal by Subject|2|||
23426585|NCT02776033|65307389|FG000|Overall Study|Physician Decision|2|||
23426586|NCT02776033|65307390|FG001|Overall Study|Physician Decision|0|||
23316199|NCT01128179|64899298|FG001|Overall Study|Protocol Violation|0|||
23316200|NCT00478244|64899307|FG000|Overall Study|Did not receive transplant|1|||
23316201|NCT02460679|64899308|FG000|Overall Study|Investigator Decision|1|||
23316202|NCT02460679|64899308|FG000|Overall Study|Withdrawal by Subject|4|||
23316203|NCT01308424|64899312|FG000|Baseline Eligibility|Screen Failures|71|||
23426587|NCT02776033|65307391|FG002|Overall Study|Physician Decision|0|||
23426588|NCT02776033|65307389|FG000|Overall Study|Lost to Follow-up|1|||
23426589|NCT02776033|65307390|FG001|Overall Study|Lost to Follow-up|0|||
23426590|NCT02776033|65307391|FG002|Overall Study|Lost to Follow-up|0|||
23316204|NCT01308424|64899313|FG001|Baseline Eligibility|Screen Failures|0|||
23316205|NCT01308424|64899314|FG002|Baseline Eligibility|Screen Failures|0|||
23426591|NCT02776033|65307389|FG000|Overall Study|Adverse Event|1|||
23426592|NCT02776033|65307390|FG001|Overall Study|Adverse Event|2|||
23426593|NCT02776033|65307391|FG002|Overall Study|Adverse Event|0|||
23316206|NCT01308424|64899312|FG000|Randomization|Adverse Event|0|||
23316207|NCT01308424|64899313|FG001|Randomization|Adverse Event|1|||
23316208|NCT01308424|64899314|FG002|Randomization|Adverse Event|1|||
23316209|NCT01308424|64899312|FG000|Randomization|Lost to Follow-up|0|||
23316210|NCT01308424|64899313|FG001|Randomization|Lost to Follow-up|1|||
23316211|NCT01308424|64899314|FG002|Randomization|Lost to Follow-up|0|||
23316212|NCT01308424|64899312|FG000|Randomization|Physician Decision|0|||
23316213|NCT01308424|64899313|FG001|Randomization|Physician Decision|1|||
23316214|NCT01308424|64899314|FG002|Randomization|Physician Decision|1|||
23316215|NCT00786409|64899322|FG000|Overall Study|Withdrawal by Subject|2|||
23316216|NCT00786409|64899322|FG000|Overall Study|Adverse Event|2|||
23316217|NCT00786409|64899322|FG000|Overall Study|Pregnancy|2|||
23316218|NCT00786409|64899322|FG000|Overall Study|Lost to Follow-up|1|||
23618317|NCT01184859|65988253|FG002|Period 1: Single Dose|Insufficient urine production|0|||
23618318|NCT01184859|65988254|FG003|Period 1: Single Dose|Insufficient urine production|0|||
23618319|NCT01184859|65988255|FG004|Period 1: Single Dose|Insufficient urine production|0|||
23618320|NCT01184859|65988251|FG000|Period 1: Single Dose|Protocol Violation|0|||
23618321|NCT01184859|65988252|FG001|Period 1: Single Dose|Protocol Violation|1|||
23618322|NCT01184859|65988253|FG002|Period 1: Single Dose|Protocol Violation|0|||
23618323|NCT01184859|65988254|FG003|Period 1: Single Dose|Protocol Violation|0|||
23618324|NCT01184859|65988255|FG004|Period 1: Single Dose|Protocol Violation|0|||
23618325|NCT01184859|65988251|FG000|Period 1: Single Dose|Adverse Event|0|||
23618326|NCT01184859|65988252|FG001|Period 1: Single Dose|Adverse Event|0|||
23618327|NCT01184859|65988253|FG002|Period 1: Single Dose|Adverse Event|0|||
23618328|NCT01184859|65988254|FG003|Period 1: Single Dose|Adverse Event|0|||
23618329|NCT01184859|65988255|FG004|Period 1: Single Dose|Adverse Event|1|||
23618330|NCT01184859|65988251|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
23618331|NCT01184859|65988252|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
23618332|NCT01184859|65988253|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
23618333|NCT01184859|65988254|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
23618334|NCT01184859|65988255|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
23618335|NCT01184859|65988251|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
23618336|NCT01184859|65988252|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
23618337|NCT01184859|65988253|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
23618338|NCT01184859|65988254|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
23618339|NCT01184859|65988255|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
23618340|NCT03275402|65988256|FG000|Overall Study|Death|17|||
23618341|NCT03275402|65988256|FG000|Overall Study|Study terminated by sponsor|21|||
23618342|NCT03275402|65988256|FG000|Overall Study|Withdrawal by Subject|1|||
23618343|NCT01732627|65988257|FG000|Overall Study|Withdrawal by Subject|1|||
23618344|NCT01732627|65988258|FG001|Overall Study|Withdrawal by Subject|0|||
23618345|NCT02131155|65988259|FG000|Overall Study|Adverse Event|1|||
23618346|NCT02131155|65988260|FG001|Overall Study|Adverse Event|0|||
23618347|NCT02131155|65988259|FG000|Overall Study|Treatment completed|1|||
23618348|NCT02131155|65988260|FG001|Overall Study|Treatment completed|0|||
23618349|NCT02131155|65988259|FG000|Overall Study|Primary tumour recurrence|2|||
23618350|NCT02131155|65988260|FG001|Overall Study|Primary tumour recurrence|1|||
23618351|NCT02131155|65988259|FG000|Overall Study|Refused to continue study medication|1|||
23618352|NCT02131155|65988260|FG001|Overall Study|Refused to continue study medication|0|||
23618353|NCT02131155|65988259|FG000|Overall Study|Study early termination|20|||
23618354|NCT02131155|65988260|FG001|Overall Study|Study early termination|10|||
23618355|NCT01878253|65988261|FG000|Overall Study|Death|1|||
23618356|NCT01878253|65988261|FG000|Overall Study|SIdus System Removal|3|||
23618357|NCT01878253|65988261|FG000|Overall Study|Withdrawal by Subject|1|||
23618358|NCT01878253|65988261|FG000|Overall Study|Lost to Follow-up|2|||
23618359|NCT01878253|65988261|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
23618360|NCT00372255|65988262|FG000|Overall Study|Withdrawn for other reasons|2|||
23618361|NCT00372255|65988263|FG001|Overall Study|Withdrawn for other reasons|1|||
23618362|NCT01251887|65988264|FG000|Overall Study|Scheduling conflict|1|||
23618363|NCT01251887|65988265|FG001|Overall Study|Scheduling conflict|2|||
23618364|NCT01251887|65988266|FG002|Overall Study|Scheduling conflict|2|||
23618365|NCT01251887|65988264|FG000|Overall Study|Physician Decision|0|||
23618366|NCT01251887|65988265|FG001|Overall Study|Physician Decision|1|||
23618367|NCT01251887|65988266|FG002|Overall Study|Physician Decision|0|||
23618368|NCT01026103|65988267|FG000|Overall Study|Physician Decision|1|||
23618369|NCT01026103|65988267|FG000|Overall Study|did not receive study device bc of error|1|||
23618370|NCT01732926|65988270|FG000|Overall Study|Study Terminated by Sponsor|168|||
23618371|NCT01732926|65988271|FG001|Overall Study|Study Terminated by Sponsor|80|||
23618372|NCT01732926|65988270|FG000|Overall Study|Withdrawal by Subject|46|||
23618373|NCT01732926|65988271|FG001|Overall Study|Withdrawal by Subject|8|||
23618374|NCT01732926|65988270|FG000|Overall Study|Physician Decision|24|||
23618375|NCT01732926|65988271|FG001|Overall Study|Physician Decision|11|||
23618376|NCT01732926|65988270|FG000|Overall Study|Other Reason|21|||
23618377|NCT01732926|65988271|FG001|Overall Study|Other Reason|4|||
23618378|NCT01732926|65988270|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
23426594|NCT00197145|65307392|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
23426595|NCT00197145|65307393|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
23127922|NCT02956837|64218622|FG003|Overall Study|Serious Adverse Events|0|||
23127923|NCT02956837|64218619|FG000|Overall Study|Withdrawal by Subject|0|||
23127924|NCT02956837|64218620|FG001|Overall Study|Withdrawal by Subject|1|||
23426596|NCT00197145|65307392|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
23426597|NCT00197145|65307393|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
23127925|NCT02956837|64218621|FG002|Overall Study|Withdrawal by Subject|0|||
23127926|NCT02956837|64218622|FG003|Overall Study|Withdrawal by Subject|3|||
23127927|NCT02956837|64218619|FG000|Overall Study|Lost to Follow-up|0|||
23127928|NCT02956837|64218620|FG001|Overall Study|Lost to Follow-up|1|||
23127929|NCT02956837|64218621|FG002|Overall Study|Lost to Follow-up|2|||
23426598|NCT00197145|65307392|FG000|Period 1: Randomized Treatment Phase|Other|2|||
23426599|NCT00197145|65307393|FG001|Period 1: Randomized Treatment Phase|Other|2|||
23127930|NCT02956837|64218622|FG003|Overall Study|Lost to Follow-up|0|||
23127931|NCT02838134|64218627|FG000|Overall Study|Lost to Follow-up|1|||
23127932|NCT02838134|64218628|FG001|Overall Study|Lost to Follow-up|2|||
23127933|NCT02838134|64218627|FG000|Overall Study|logistic problems|1|||
23127934|NCT02838134|64218628|FG001|Overall Study|logistic problems|1|||
23127935|NCT01377389|64218631|FG000|Overall Study|Withdrawal by Subject|1|||
23127936|NCT01377389|64218631|FG000|Overall Study|Screen failure|2|||
23127937|NCT01195623|64218633|FG000|Overall Study|Lost to Follow-up|35|||
23127938|NCT01195623|64218634|FG001|Overall Study|Lost to Follow-up|37|||
23127939|NCT03834519|64218636|FG000|Overall Study|Ongoing|234|||
23127940|NCT03834519|64218637|FG001|Overall Study|Ongoing|111|||
23127941|NCT03834519|64218636|FG000|Overall Study|Withdrawal by Subject|4|||
23127942|NCT03834519|64218637|FG001|Overall Study|Withdrawal by Subject|7|||
23127943|NCT03834519|64218636|FG000|Overall Study|Death|291|||
23127944|NCT03834519|64218637|FG001|Overall Study|Death|146|||
23127945|NCT00633880|64218638|FG000|Open Label Titration|Lack of Efficacy|1|||
23127946|NCT00633880|64218639|FG001|Open Label Titration|Lack of Efficacy|0|||
23127947|NCT00633880|64218640|FG002|Open Label Titration|Lack of Efficacy|0|||
23127948|NCT00633880|64218638|FG000|Open Label Titration|Adverse Event|13|||
23127949|NCT00633880|64218639|FG001|Open Label Titration|Adverse Event|0|||
23127950|NCT00633880|64218640|FG002|Open Label Titration|Adverse Event|0|||
23127951|NCT00633880|64218638|FG000|Open Label Titration|Treatment Failure|55|||
23127952|NCT00633880|64218639|FG001|Open Label Titration|Treatment Failure|0|||
23127953|NCT00633880|64218640|FG002|Open Label Titration|Treatment Failure|0|||
23127954|NCT00633880|64218638|FG000|Open Label Titration|Protocol Violation|6|||
23127955|NCT00633880|64218639|FG001|Open Label Titration|Protocol Violation|0|||
23127956|NCT00633880|64218640|FG002|Open Label Titration|Protocol Violation|0|||
23127957|NCT00633880|64218638|FG000|Open Label Titration|Physician Decision|1|||
23127958|NCT00633880|64218639|FG001|Open Label Titration|Physician Decision|0|||
23127959|NCT00633880|64218640|FG002|Open Label Titration|Physician Decision|0|||
23127960|NCT00633880|64218638|FG000|Open Label Titration|Withdrawal by Subject|4|||
23127961|NCT00633880|64218639|FG001|Open Label Titration|Withdrawal by Subject|0|||
23127962|NCT00633880|64218640|FG002|Open Label Titration|Withdrawal by Subject|0|||
23127963|NCT02091206|64218643|FG000|Treatment Period|Adverse Event|0|||
23127964|NCT02091206|64218644|FG001|Treatment Period|Adverse Event|1|||
23127965|NCT02091206|64218645|FG002|Treatment Period|Adverse Event|0|||
23127966|NCT02091206|64218646|FG003|Treatment Period|Adverse Event|0|||
23127967|NCT02091206|64218643|FG000|Treatment Period|Met withdrawal criteria|0|||
23127968|NCT02091206|64218644|FG001|Treatment Period|Met withdrawal criteria|0|||
23127969|NCT02091206|64218645|FG002|Treatment Period|Met withdrawal criteria|1|||
23127970|NCT02091206|64218646|FG003|Treatment Period|Met withdrawal criteria|0|||
23127971|NCT02091206|64218643|FG000|Taper Period|Participant refused study drug|1|||
23127972|NCT02091206|64218644|FG001|Taper Period|Participant refused study drug|0|||
23127973|NCT02091206|64218645|FG002|Taper Period|Participant refused study drug|0|||
23127974|NCT02091206|64218646|FG003|Taper Period|Participant refused study drug|1|||
23127975|NCT02091206|64218643|FG000|Taper Period|Lost to Follow-up|0|||
23212564|NCT00563368|64516471|FG003|Overall Study|Other|4|||
23212565|NCT00563368|64516472|FG004|Overall Study|Other|4|||
23127976|NCT02091206|64218644|FG001|Taper Period|Lost to Follow-up|0|||
23127977|NCT02091206|64218645|FG002|Taper Period|Lost to Follow-up|0|||
23127978|NCT02091206|64218646|FG003|Taper Period|Lost to Follow-up|1|||
23127979|NCT01727505|64218647|FG000|First 24 Hours|Adverse Event|0|||
23127980|NCT01727505|64218648|FG001|First 24 Hours|Adverse Event|1|||
23127981|NCT01727505|64218647|FG000|Second 24 Hours|Missing data|0|||
23127982|NCT01727505|64218648|FG001|Second 24 Hours|Missing data|1|||
23127983|NCT01736540|64218649|FG000|Overall Study|Did not complete scan within 45 days|2|||
23127984|NCT01736540|64218649|FG000|Overall Study|Death|1|||
23127985|NCT01736540|64218649|FG000|Overall Study|Abnormal test procedure|1|||
23127986|NCT01736540|64218649|FG000|Overall Study|Withdrawal by Subject|5|||
23127987|NCT01736540|64218649|FG000|Overall Study|Protocol Violation|1|||
23127988|NCT01736540|64218649|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
23127989|NCT01736540|64218649|FG000|Overall Study|No show for MRI appointment|1|||
23127990|NCT01736540|64218649|FG000|Overall Study|Unable to make MRI appointment|3|||
23127991|NCT03552523|64218652|FG000|Overall Study|Withdrawal by Subject|1|||
23127992|NCT03552523|64218653|FG001|Overall Study|Withdrawal by Subject|1|||
23127993|NCT01661205|64218654|FG000|Overall Study|Physician Decision|2|||
23127994|NCT00842244|64218655|FG000|Overall Study|Death|3|||
23127995|NCT00842244|64218655|FG000|Overall Study|Withdrawal by Subject|1|||
23127996|NCT00842244|64218655|FG000|Overall Study|Other|17|||
23127997|NCT00794924|64218656|FG000|Overall Study|Lost to Follow-up|6|||
23127998|NCT00794924|64218657|FG001|Overall Study|Lost to Follow-up|8|||
23127999|NCT00794924|64218656|FG000|Overall Study|Withdrawal by Subject|48|||
23212566|NCT00563368|64516473|FG005|Overall Study|Other|4|||
23212567|NCT00563368|64516474|FG006|Overall Study|Other|0|||
23212568|NCT03986190|64516479|FG000|Overall Study|Withdrawal by Subject|12|||
23212569|NCT03986190|64516480|FG001|Overall Study|Withdrawal by Subject|0|||
23212570|NCT01957787|64516482|FG000|Overall Study|Death|18|||
23618379|NCT01732926|65988271|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
23618380|NCT01732926|65988270|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
23618381|NCT01732926|65988271|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
23128000|NCT00794924|64218657|FG001|Overall Study|Withdrawal by Subject|60|||
23128001|NCT00794924|64218656|FG000|Overall Study|Adverse Event|6|||
23128002|NCT00794924|64218657|FG001|Overall Study|Adverse Event|2|||
23128003|NCT00709228|64218659|FG000|Overall Study|Not treated|14|||
23128004|NCT00709228|64218659|FG000|Overall Study|Eligibility criteria not met|281|||
23128005|NCT00709228|64218659|FG000|Overall Study|Adverse events|2|||
23128006|NCT00709228|64218659|FG000|Overall Study|Discontinued treatment|14|||
23128007|NCT00709228|64218659|FG000|Overall Study|Did not enter follow-up|4|||
23128008|NCT00709228|64218659|FG000|Overall Study|Discontinued follow-up|5|||
23128009|NCT00709228|64218659|FG000|Overall Study|Disease progression|1|||
23128010|NCT00709228|64218659|FG000|Overall Study|Lost to Follow-up|6|||
23128011|NCT00709228|64218659|FG000|Overall Study|Non-compliance|5|||
23426600|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
23426601|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
23128012|NCT02808975|64218660|FG000|Overall Study|Adverse Event|3|||
23128013|NCT02808975|64218661|FG001|Overall Study|Adverse Event|4|||
23128014|NCT02808975|64218660|FG000|Overall Study|Withdrew consent|9|||
23128015|NCT02808975|64218661|FG001|Overall Study|Withdrew consent|8|||
23128016|NCT02808975|64218660|FG000|Overall Study|Lost to Follow-up|4|||
23128017|NCT02808975|64218661|FG001|Overall Study|Lost to Follow-up|6|||
23128018|NCT02808975|64218660|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
23128019|NCT02808975|64218661|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
23128020|NCT02808975|64218660|FG000|Overall Study|Other, not specified|5|||
23128021|NCT02808975|64218661|FG001|Overall Study|Other, not specified|1|||
23128022|NCT04148651|64218664|FG000|Overall Study|Lost to Follow-up|2|||
23128023|NCT00504777|64218666|FG000|Overall Study|Adverse Event|1|||
23128024|NCT03017742|64218667|FG000|Overall Study|Protocol Violation|36|||
23128025|NCT03017742|64218667|FG000|Overall Study|Withdrawal by Subject|37|||
23128026|NCT01681277|64218670|FG000|Overall Study|Adverse Event|1|||
23128027|NCT01681277|64218671|FG001|Overall Study|Adverse Event|0|||
23128028|NCT01681277|64218672|FG002|Overall Study|Adverse Event|0|||
23128029|NCT01681277|64218673|FG003|Overall Study|Adverse Event|0|||
23128030|NCT01681277|64218674|FG004|Overall Study|Adverse Event|0|||
23618382|NCT02864147|65988272|FG000|Overall Study|Withdrawal by Subject|3|||
23618383|NCT02864147|65988273|FG001|Overall Study|Withdrawal by Subject|2|||
23618384|NCT02864147|65988274|FG002|Overall Study|Withdrawal by Subject|1|||
23618385|NCT02864147|65988272|FG000|Overall Study|Lost to Follow-up|0|||
23618386|NCT02864147|65988273|FG001|Overall Study|Lost to Follow-up|4|||
23618387|NCT02864147|65988274|FG002|Overall Study|Lost to Follow-up|0|||
23618388|NCT02864147|65988272|FG000|Overall Study|Adverse Event|0|||
23618389|NCT02864147|65988273|FG001|Overall Study|Adverse Event|1|||
23618390|NCT02864147|65988274|FG002|Overall Study|Adverse Event|0|||
23128031|NCT00863681|64218675|FG000|Overall Study|Other|2|||
23128032|NCT00863681|64218676|FG001|Overall Study|Other|0|||
23128033|NCT00863681|64218677|FG002|Overall Study|Other|0|||
23128034|NCT00863681|64218675|FG000|Overall Study|Missing|1|||
23618391|NCT02864147|65988272|FG000|Overall Study|Pregnancy|4|||
23618392|NCT02864147|65988273|FG001|Overall Study|Pregnancy|0|||
23128035|NCT00863681|64218676|FG001|Overall Study|Missing|0|||
23128036|NCT00863681|64218677|FG002|Overall Study|Missing|0|||
23128037|NCT00863681|64218675|FG000|Overall Study|Death|40|||
23128038|NCT00863681|64218676|FG001|Overall Study|Death|23|||
23128039|NCT00863681|64218677|FG002|Overall Study|Death|6|||
23128040|NCT00863681|64218675|FG000|Overall Study|Withdrawal by Subject|12|||
23128041|NCT00863681|64218676|FG001|Overall Study|Withdrawal by Subject|5|||
23128042|NCT00863681|64218677|FG002|Overall Study|Withdrawal by Subject|2|||
23128043|NCT00863681|64218675|FG000|Overall Study|Protocol Violation|2|||
23128044|NCT00863681|64218676|FG001|Overall Study|Protocol Violation|0|||
23212571|NCT01957787|64516482|FG000|Overall Study|Lost to Follow-up|3|||
23618393|NCT02864147|65988274|FG002|Overall Study|Pregnancy|0|||
23618394|NCT02864147|65988272|FG000|Overall Study|Physician Decision|0|||
23618395|NCT02864147|65988273|FG001|Overall Study|Physician Decision|0|||
23618396|NCT02864147|65988274|FG002|Overall Study|Physician Decision|1|||
23618397|NCT02864147|65988272|FG000|Overall Study|Opted for excisional procedures|0|||
23618398|NCT02864147|65988273|FG001|Overall Study|Opted for excisional procedures|0|||
23618399|NCT02864147|65988274|FG002|Overall Study|Opted for excisional procedures|3|||
23618400|NCT01215032|65988275|FG000|Overall Study|Adverse Event|3|||
23618401|NCT01215032|65988275|FG000|Overall Study|Lack of Efficacy|17|||
23618402|NCT02110225|65988276|FG000|Overall Study|Lost to Follow-up|0|||
23618403|NCT02110225|65988277|FG001|Overall Study|Lost to Follow-up|1|||
23618404|NCT02110225|65988278|FG002|Overall Study|Lost to Follow-up|0|||
23618405|NCT03785210|65988279|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
23618406|NCT03785210|65988280|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
23618407|NCT02996097|65988281|FG000|Overall Study|Lost to Follow-up|11|||
23618408|NCT02996097|65988282|FG001|Overall Study|Lost to Follow-up|11|||
23618409|NCT04044352|65988283|FG000|Overall Study|Lost to Follow-up|9|||
23618410|NCT04044352|65988283|FG000|Overall Study|Withdrawal by Subject|2|||
23618411|NCT01103141|65988284|FG000|Overall Study|Death|0|||
23618412|NCT01103141|65988285|FG001|Overall Study|Death|1|||
23618413|NCT01103141|65988284|FG000|Overall Study|Lost to Follow-up|2|||
23618414|NCT01103141|65988285|FG001|Overall Study|Lost to Follow-up|1|||
23618415|NCT01954771|65988286|FG000|Overall Study|Missing HbA1c of end-point|1|||
23618416|NCT01954771|65988287|FG001|Overall Study|Missing HbA1c of end-point|1|||
23618417|NCT01954771|65988288|FG002|Overall Study|Missing HbA1c of end-point|0|||
23618418|NCT01954771|65988286|FG000|Overall Study|Missing CGMS of end-point|1|||
23128045|NCT00863681|64218677|FG002|Overall Study|Protocol Violation|0|||
23128046|NCT00863681|64218675|FG000|Overall Study|Lost to Follow-up|3|||
23128047|NCT00863681|64218676|FG001|Overall Study|Lost to Follow-up|0|||
23128048|NCT00863681|64218677|FG002|Overall Study|Lost to Follow-up|3|||
23128049|NCT00863681|64218675|FG000|Overall Study|Adverse Event|28|||
23128050|NCT00863681|64218676|FG001|Overall Study|Adverse Event|10|||
23128051|NCT00863681|64218677|FG002|Overall Study|Adverse Event|6|||
23128052|NCT00863681|64218675|FG000|Overall Study|Lack of Efficacy|2|||
23128053|NCT00863681|64218676|FG001|Overall Study|Lack of Efficacy|2|||
23128054|NCT00863681|64218677|FG002|Overall Study|Lack of Efficacy|1|||
23128055|NCT00863681|64218675|FG000|Overall Study|Non-compliance with study drug|1|||
23128056|NCT00863681|64218676|FG001|Overall Study|Non-compliance with study drug|3|||
23128057|NCT00863681|64218677|FG002|Overall Study|Non-compliance with study drug|0|||
23128058|NCT02336451|64218678|FG000|Overall Study|Adverse Event|1|||
23618419|NCT01954771|65988287|FG001|Overall Study|Missing CGMS of end-point|1|||
23618420|NCT01954771|65988288|FG002|Overall Study|Missing CGMS of end-point|0|||
23426602|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
23426603|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
23426604|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
23426605|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
23426606|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
23426607|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
23426608|NCT00197145|65307392|FG000|Period 2 : Open Label Phase|Other|1|||
23426609|NCT00197145|65307393|FG001|Period 2 : Open Label Phase|Other|0|||
23426610|NCT03157583|65307398|FG000|Overall Study|Other (did not meet study criteria)|1|||
23426611|NCT05239221|65307401|FG000|Overall Study|Adverse Event|0|||
23426612|NCT05239221|65307402|FG001|Overall Study|Adverse Event|0|||
23426613|NCT05239221|65307403|FG002|Overall Study|Adverse Event|0|||
23426614|NCT05239221|65307404|FG003|Overall Study|Adverse Event|0|||
23426615|NCT05239221|65307405|FG004|Overall Study|Adverse Event|0|||
23426616|NCT05239221|65307406|FG005|Overall Study|Adverse Event|0|||
23426617|NCT05239221|65307407|FG006|Overall Study|Adverse Event|1|||
23426618|NCT05239221|65307408|FG007|Overall Study|Adverse Event|0|||
23426619|NCT05239221|65307409|FG008|Overall Study|Adverse Event|0|||
23426620|NCT05239221|65307410|FG009|Overall Study|Adverse Event|0|||
23426621|NCT05239221|65307411|FG010|Overall Study|Adverse Event|1|||
23426622|NCT05239221|65307412|FG011|Overall Study|Adverse Event|1|||
23426623|NCT05239221|65307413|FG012|Overall Study|Adverse Event|0|||
23618421|NCT01954771|65988286|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
23128059|NCT02336451|64218679|FG001|Overall Study|Adverse Event|2|||
23128060|NCT02336451|64218680|FG002|Overall Study|Adverse Event|0|||
23128061|NCT02336451|64218681|FG003|Overall Study|Adverse Event|6|||
23618422|NCT01954771|65988287|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
23618423|NCT01954771|65988288|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
23618424|NCT02212197|65988289|FG000|Overall Study|Need for radiotherapy|1|||
23618425|NCT02212197|65988290|FG001|Overall Study|Need for radiotherapy|0|||
23618426|NCT02212197|65988291|FG002|Overall Study|Need for radiotherapy|0|||
23426624|NCT05239221|65307414|FG013|Overall Study|Adverse Event|0|||
23426625|NCT05239221|65307415|FG014|Overall Study|Adverse Event|0|||
23426626|NCT05239221|65307416|FG015|Overall Study|Adverse Event|0|||
23426627|NCT05239221|65307401|FG000|Overall Study|Withdrawal by Subject|0|||
23426628|NCT05239221|65307402|FG001|Overall Study|Withdrawal by Subject|0|||
23128062|NCT02336451|64218682|FG004|Overall Study|Adverse Event|4|||
23128063|NCT02336451|64218678|FG000|Overall Study|Death|6|||
23128064|NCT02336451|64218679|FG001|Overall Study|Death|2|||
23128065|NCT02336451|64218680|FG002|Overall Study|Death|3|||
23128066|NCT02336451|64218681|FG003|Overall Study|Death|6|||
23128067|NCT02336451|64218682|FG004|Overall Study|Death|6|||
23128068|NCT02336451|64218678|FG000|Overall Study|Physician Decision|9|||
23128069|NCT02336451|64218679|FG001|Overall Study|Physician Decision|6|||
23128070|NCT02336451|64218680|FG002|Overall Study|Physician Decision|7|||
23128071|NCT02336451|64218681|FG003|Overall Study|Physician Decision|16|||
23128072|NCT02336451|64218682|FG004|Overall Study|Physician Decision|3|||
23128073|NCT02336451|64218678|FG000|Overall Study|Progressive disease|23|||
23128074|NCT02336451|64218679|FG001|Overall Study|Progressive disease|26|||
23128075|NCT02336451|64218680|FG002|Overall Study|Progressive disease|2|||
23128076|NCT02336451|64218681|FG003|Overall Study|Progressive disease|14|||
23128077|NCT02336451|64218682|FG004|Overall Study|Progressive disease|4|||
23128078|NCT02336451|64218678|FG000|Overall Study|Protocol Violation|1|||
23128079|NCT02336451|64218679|FG001|Overall Study|Protocol Violation|0|||
23128080|NCT02336451|64218680|FG002|Overall Study|Protocol Violation|0|||
23128081|NCT02336451|64218681|FG003|Overall Study|Protocol Violation|0|||
23128082|NCT02336451|64218682|FG004|Overall Study|Protocol Violation|0|||
23128083|NCT02336451|64218678|FG000|Overall Study|Patient/guardian decision|2|||
23128084|NCT02336451|64218679|FG001|Overall Study|Patient/guardian decision|4|||
23128085|NCT02336451|64218680|FG002|Overall Study|Patient/guardian decision|0|||
23128086|NCT02336451|64218681|FG003|Overall Study|Patient/guardian decision|2|||
23212572|NCT01957787|64516482|FG000|Overall Study|Withdrawal by Subject|3|||
23212573|NCT01957787|64516482|FG000|Overall Study|Entered Hospice or Similar Program|2|||
23212574|NCT01957787|64516482|FG000|Overall Study|Index Tumor(s) Resected|2|||
23212575|NCT01957787|64516482|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
23212576|NCT01957787|64516482|FG000|Overall Study|Local therapy, not cryoablation|6|||
23212577|NCT00405652|64516483|FG000|Overall Study|Adverse Event|4|||
23212578|NCT01245764|64516484|FG000|Study Phase A|Other|3|||
23212579|NCT01245764|64516485|FG001|Study Phase A|Other|2|||
23212580|NCT01245764|64516486|FG002|Study Phase A|Other|3|||
23212581|NCT01245764|64516487|FG003|Study Phase A|Other|1|||
23212582|NCT01245764|64516484|FG000|Study Phase A|Protocol Violation|6|||
23212583|NCT01245764|64516485|FG001|Study Phase A|Protocol Violation|3|||
23212584|NCT01245764|64516486|FG002|Study Phase A|Protocol Violation|2|||
23212585|NCT01245764|64516487|FG003|Study Phase A|Protocol Violation|2|||
23212586|NCT01245764|64516484|FG000|Study Phase A|Lost to Follow-up|0|||
23212587|NCT01245764|64516485|FG001|Study Phase A|Lost to Follow-up|0|||
23212588|NCT01245764|64516486|FG002|Study Phase A|Lost to Follow-up|5|||
23212589|NCT01245764|64516487|FG003|Study Phase A|Lost to Follow-up|0|||
23212590|NCT02585999|64516490|FG000|Overall Study|Lost to Follow-up|1|||
23212591|NCT02585999|64516490|FG000|Overall Study|Protocol Violation|1|||
23212592|NCT02120157|64516491|FG000|Overall Study|Death|8|||
23212593|NCT02513771|64519703|FG000|Overall Study|Lost to Follow-up|1|||
23212594|NCT02513771|64519704|FG001|Overall Study|Lost to Follow-up|1|||
23212595|NCT02513771|64519703|FG000|Overall Study|Not being able to get to clinic|1|||
23212596|NCT02513771|64519704|FG001|Overall Study|Not being able to get to clinic|0|||
23212597|NCT01677624|64519709|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
23212598|NCT00992186|64519710|FG000|Overall Study|Withdrawal by Subject|2|||
23212599|NCT00992186|64519710|FG000|Overall Study|Protocol Violation|1|||
23212600|NCT00992186|64519710|FG000|Overall Study|Physician Decision|1|||
23212601|NCT00992186|64519710|FG000|Overall Study|Adverse Event|9|||
23212602|NCT00992186|64519710|FG000|Overall Study|Progressive Disease|30|||
23212603|NCT00992186|64519710|FG000|Overall Study|Refusal To Receive Study Agent|3|||
23212604|NCT01231607|64519711|FG000|Overall Study|Adverse Event|0|||
23212605|NCT01231607|64519712|FG001|Overall Study|Adverse Event|8|||
23212606|NCT01231607|64519713|FG002|Overall Study|Adverse Event|4|||
23212607|NCT01231607|64519714|FG003|Overall Study|Adverse Event|4|||
23212608|NCT01231607|64519715|FG004|Overall Study|Adverse Event|5|||
23212609|NCT01231607|64519711|FG000|Overall Study|Lost to Follow-up|13|||
23212610|NCT01231607|64519712|FG001|Overall Study|Lost to Follow-up|11|||
23212611|NCT01231607|64519713|FG002|Overall Study|Lost to Follow-up|10|||
23212612|NCT01231607|64519714|FG003|Overall Study|Lost to Follow-up|10|||
23212613|NCT01231607|64519715|FG004|Overall Study|Lost to Follow-up|4|||
23212614|NCT01231607|64519711|FG000|Overall Study|Physician Decision|4|||
23128087|NCT02336451|64218682|FG004|Overall Study|Patient/guardian decision|1|||
23128088|NCT02336425|64218683|FG000|Overall Study|Study terminated.|2|||
23128089|NCT02336425|64218684|FG001|Overall Study|Study terminated.|2|||
23128090|NCT02336425|64218685|FG002|Overall Study|Study terminated.|3|||
23128091|NCT02336425|64218686|FG003|Overall Study|Study terminated.|3|||
23128092|NCT03926195|64218687|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
23128093|NCT03926195|64218688|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
23212615|NCT01231607|64519712|FG001|Overall Study|Physician Decision|4|||
23212616|NCT01231607|64519713|FG002|Overall Study|Physician Decision|3|||
23212617|NCT01231607|64519714|FG003|Overall Study|Physician Decision|5|||
23212618|NCT01231607|64519715|FG004|Overall Study|Physician Decision|4|||
23212619|NCT01231607|64519711|FG000|Overall Study|Protocol Violation|3|||
23128094|NCT03926195|64218687|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
23128095|NCT03926195|64218688|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
23128096|NCT03926195|64218687|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
23128097|NCT03926195|64218688|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
23128098|NCT03926195|64218687|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
23128099|NCT03926195|64218688|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
23128100|NCT03926195|64218687|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
23128101|NCT03926195|64218688|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
23128102|NCT03926195|64218687|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
23128103|NCT03926195|64218688|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
23128104|NCT01305408|64218691|FG000|Overall Study|Adverse Event|10|||
23128105|NCT01305408|64218692|FG001|Overall Study|Adverse Event|7|||
23128106|NCT01305408|64218691|FG000|Overall Study|Lack of Efficacy|3|||
23128107|NCT01305408|64218692|FG001|Overall Study|Lack of Efficacy|4|||
23128108|NCT01305408|64218691|FG000|Overall Study|Withdrawal by Subject|9|||
23128109|NCT01305408|64218692|FG001|Overall Study|Withdrawal by Subject|9|||
23128110|NCT01305408|64218691|FG000|Overall Study|Protocol Violation|4|||
23128111|NCT01305408|64218692|FG001|Overall Study|Protocol Violation|6|||
23128112|NCT01305408|64218691|FG000|Overall Study|Lost to Follow-up|5|||
23128113|NCT01305408|64218692|FG001|Overall Study|Lost to Follow-up|3|||
23128114|NCT01305408|64218691|FG000|Overall Study|Noncompliance with study medication|0|||
23128115|NCT01305408|64218692|FG001|Overall Study|Noncompliance with study medication|1|||
23128116|NCT01305408|64218691|FG000|Overall Study|Noncompliance with study procedures|0|||
23128117|NCT01305408|64218692|FG001|Overall Study|Noncompliance with study procedures|1|||
23128118|NCT01305408|64218691|FG000|Overall Study|Other|1|||
23128119|NCT01305408|64218692|FG001|Overall Study|Other|0|||
23128120|NCT04829747|64218693|FG000|Overall Study|Protocol Violation|1|||
23128121|NCT01840410|64218695|FG000|Overall Study|Physician Decision|1|||
23128122|NCT01840410|64218696|FG001|Overall Study|Physician Decision|2|||
23128123|NCT01840410|64218695|FG000|Overall Study|Pregnancy|1|||
23128124|NCT01840410|64218696|FG001|Overall Study|Pregnancy|0|||
23128125|NCT01840410|64218695|FG000|Overall Study|Protocol deviation|1|||
23128126|NCT01840410|64218696|FG001|Overall Study|Protocol deviation|0|||
23128127|NCT01840410|64218695|FG000|Overall Study|Lost to Follow-up|1|||
23212620|NCT01231607|64519712|FG001|Overall Study|Protocol Violation|2|||
23212621|NCT01231607|64519713|FG002|Overall Study|Protocol Violation|0|||
23212622|NCT01231607|64519714|FG003|Overall Study|Protocol Violation|2|||
23212623|NCT01231607|64519715|FG004|Overall Study|Protocol Violation|2|||
23212624|NCT01231607|64519711|FG000|Overall Study|Withdrawal by Subject|9|||
23212625|NCT01231607|64519712|FG001|Overall Study|Withdrawal by Subject|9|||
23212626|NCT01231607|64519713|FG002|Overall Study|Withdrawal by Subject|14|||
23212627|NCT01231607|64519714|FG003|Overall Study|Withdrawal by Subject|17|||
23618427|NCT00985621|65988292|FG000|Overall Study|Adverse Event|2|||
23618428|NCT00985621|65988293|FG001|Overall Study|Adverse Event|3|||
23618429|NCT00985621|65988294|FG002|Overall Study|Adverse Event|4|||
23618430|NCT00985621|65988295|FG003|Overall Study|Adverse Event|16|||
23618431|NCT00985621|65988292|FG000|Overall Study|Lack of Efficacy|10|||
23618432|NCT00985621|65988293|FG001|Overall Study|Lack of Efficacy|6|||
23618433|NCT00985621|65988294|FG002|Overall Study|Lack of Efficacy|5|||
23618434|NCT00985621|65988295|FG003|Overall Study|Lack of Efficacy|12|||
23618435|NCT00985621|65988292|FG000|Overall Study|Lost to Follow-up|2|||
23618436|NCT00985621|65988293|FG001|Overall Study|Lost to Follow-up|3|||
23618437|NCT00985621|65988294|FG002|Overall Study|Lost to Follow-up|4|||
23618438|NCT00985621|65988295|FG003|Overall Study|Lost to Follow-up|4|||
23618439|NCT00985621|65988292|FG000|Overall Study|Study Terminated by Sponsor|89|||
23618440|NCT00985621|65988293|FG001|Overall Study|Study Terminated by Sponsor|108|||
23618441|NCT00985621|65988294|FG002|Overall Study|Study Terminated by Sponsor|99|||
23618442|NCT00985621|65988295|FG003|Overall Study|Study Terminated by Sponsor|92|||
23618443|NCT00985621|65988292|FG000|Overall Study|Protocol Violation|1|||
23618444|NCT00985621|65988293|FG001|Overall Study|Protocol Violation|1|||
23618445|NCT00985621|65988294|FG002|Overall Study|Protocol Violation|1|||
23618446|NCT00985621|65988295|FG003|Overall Study|Protocol Violation|0|||
23618447|NCT00985621|65988292|FG000|Overall Study|Withdrawal by Subject|8|||
23618448|NCT00985621|65988293|FG001|Overall Study|Withdrawal by Subject|10|||
23128128|NCT01840410|64218696|FG001|Overall Study|Lost to Follow-up|0|||
23212628|NCT01231607|64519715|FG004|Overall Study|Withdrawal by Subject|9|||
23618449|NCT00985621|65988294|FG002|Overall Study|Withdrawal by Subject|8|||
23618450|NCT00985621|65988295|FG003|Overall Study|Withdrawal by Subject|12|||
23618451|NCT00985621|65988292|FG000|Overall Study|Other|1|||
23128129|NCT01840410|64218695|FG000|Overall Study|Withdrawal by Subject|2|||
23128130|NCT01840410|64218696|FG001|Overall Study|Withdrawal by Subject|1|||
23128131|NCT01840410|64218695|FG000|Overall Study|Adverse Event|1|||
23128132|NCT01840410|64218696|FG001|Overall Study|Adverse Event|1|||
23128133|NCT00996606|64218698|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
23128134|NCT00996606|64218698|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23212629|NCT02586077|64519720|FG000|Overall Study|Withdrawal by Subject|1|||
23618452|NCT00985621|65988293|FG001|Overall Study|Other|0|||
23128135|NCT00996606|64218698|FG000|Overall Study|Protocol Violation|1|||
23128136|NCT00996606|64218698|FG000|Overall Study|Withdrawal by Subject|3|||
23128137|NCT00968526|64218699|FG000|Overall Study|Adverse Event|2|||
23128138|NCT00968526|64218700|FG001|Overall Study|Adverse Event|0|||
23128139|NCT00968526|64218699|FG000|Overall Study|Migrated/moved from study area|1|||
23618453|NCT00985621|65988294|FG002|Overall Study|Other|0|||
23618454|NCT00985621|65988295|FG003|Overall Study|Other|0|||
23128140|NCT00968526|64218700|FG001|Overall Study|Migrated/moved from study area|0|||
23128141|NCT01509547|64218701|FG000|Overall Study|Lost to Follow-up|24|||
23128142|NCT01509547|64218702|FG001|Overall Study|Lost to Follow-up|14|||
23128143|NCT01509547|64218701|FG000|Overall Study|Withdrawal by Subject|11|||
23128144|NCT01509547|64218702|FG001|Overall Study|Withdrawal by Subject|24|||
23128145|NCT01509547|64218701|FG000|Overall Study|Physician Decision|0|||
23128146|NCT01509547|64218702|FG001|Overall Study|Physician Decision|1|||
23128147|NCT00351377|64218703|FG000|Overall Study|Adverse Event|5|||
23128148|NCT00351377|64218703|FG000|Overall Study|Death|1|||
23128149|NCT00351377|64218703|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23128150|NCT00567567|64218704|FG000|Overall Study|Adverse Event|0|||
23128151|NCT00567567|64218705|FG001|Overall Study|Adverse Event|2|||
23618455|NCT00985621|65988292|FG000|Overall Study|Randomized but not Treated|1|||
23618456|NCT00985621|65988293|FG001|Overall Study|Randomized but not Treated|0|||
23128152|NCT00567567|64218706|FG002|Overall Study|Adverse Event|5|||
23128153|NCT00567567|64218704|FG000|Overall Study|Death|8|||
23128154|NCT00567567|64218705|FG001|Overall Study|Death|1|||
23128155|NCT00567567|64218706|FG002|Overall Study|Death|5|||
23128156|NCT00567567|64218704|FG000|Overall Study|Lack of Efficacy|16|||
23128157|NCT00567567|64218705|FG001|Overall Study|Lack of Efficacy|17|||
23128158|NCT00567567|64218706|FG002|Overall Study|Lack of Efficacy|48|||
23128159|NCT00567567|64218704|FG000|Overall Study|Lost to Follow-up|0|||
23128160|NCT00567567|64218705|FG001|Overall Study|Lost to Follow-up|0|||
23128161|NCT00567567|64218706|FG002|Overall Study|Lost to Follow-up|1|||
23128162|NCT00567567|64218704|FG000|Overall Study|Physician Decision|16|||
23128163|NCT00567567|64218705|FG001|Overall Study|Physician Decision|18|||
23128164|NCT00567567|64218706|FG002|Overall Study|Physician Decision|84|||
23618457|NCT00985621|65988294|FG002|Overall Study|Randomized but not Treated|2|||
23618458|NCT00985621|65988295|FG003|Overall Study|Randomized but not Treated|1|||
23618459|NCT05600036|65988298|FG000|Overall Study|Adverse Event|0|||
23618460|NCT05600036|65988299|FG001|Overall Study|Adverse Event|2|||
23618461|NCT05600036|65988300|FG002|Overall Study|Adverse Event|1|||
23618462|NCT05600036|65988301|FG003|Overall Study|Adverse Event|0|||
23618463|NCT05600036|65988302|FG004|Overall Study|Adverse Event|1|||
23618464|NCT05600036|65988303|FG005|Overall Study|Adverse Event|0|||
23618465|NCT05600036|65988298|FG000|Overall Study|Lost to Follow-up|0|||
23618466|NCT05600036|65988299|FG001|Overall Study|Lost to Follow-up|2|||
23618467|NCT05600036|65988300|FG002|Overall Study|Lost to Follow-up|1|||
23618468|NCT05600036|65988301|FG003|Overall Study|Lost to Follow-up|1|||
23618469|NCT05600036|65988302|FG004|Overall Study|Lost to Follow-up|0|||
23618470|NCT05600036|65988303|FG005|Overall Study|Lost to Follow-up|0|||
23618471|NCT05600036|65988298|FG000|Overall Study|Protocol Violation|0|||
23618472|NCT05600036|65988299|FG001|Overall Study|Protocol Violation|0|||
23618473|NCT05600036|65988300|FG002|Overall Study|Protocol Violation|2|||
23618474|NCT05600036|65988301|FG003|Overall Study|Protocol Violation|0|||
23618475|NCT05600036|65988302|FG004|Overall Study|Protocol Violation|0|||
23618476|NCT05600036|65988303|FG005|Overall Study|Protocol Violation|0|||
23618477|NCT05600036|65988298|FG000|Overall Study|Withdrawal by Subject|0|||
23618478|NCT05600036|65988299|FG001|Overall Study|Withdrawal by Subject|1|||
23618479|NCT05600036|65988300|FG002|Overall Study|Withdrawal by Subject|2|||
23618480|NCT05600036|65988301|FG003|Overall Study|Withdrawal by Subject|0|||
23618481|NCT05600036|65988302|FG004|Overall Study|Withdrawal by Subject|3|||
23618482|NCT05600036|65988303|FG005|Overall Study|Withdrawal by Subject|5|||
23618483|NCT05600036|65988298|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23618484|NCT05600036|65988299|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23128165|NCT00567567|64218704|FG000|Overall Study|Withdrawal by Subject|0|||
23128166|NCT00567567|64218705|FG001|Overall Study|Withdrawal by Subject|0|||
23128167|NCT00567567|64218706|FG002|Overall Study|Withdrawal by Subject|2|||
23128168|NCT00567567|64218704|FG000|Overall Study|Ineligible|4|||
23618485|NCT05600036|65988300|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23618486|NCT05600036|65988301|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
23128169|NCT00567567|64218705|FG001|Overall Study|Ineligible|0|||
23618487|NCT05600036|65988302|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23618488|NCT05600036|65988303|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
23128170|NCT00567567|64218706|FG002|Overall Study|Ineligible|9|||
23128171|NCT00567567|64218704|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
23128172|NCT00567567|64218705|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
23128173|NCT00567567|64218706|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
23128174|NCT00567567|64218704|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
23128175|NCT00567567|64218705|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
23128176|NCT00567567|64218706|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
23128177|NCT00567567|64218704|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
23128178|NCT00567567|64218705|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
23128179|NCT00567567|64218706|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
23128180|NCT04497389|64218707|FG000|Overall Study|Withdrawal by Subject|1|||
23128181|NCT04497389|64218708|FG001|Overall Study|Withdrawal by Subject|0|||
23128182|NCT01754753|64218709|FG000|Overall Study|Study close|43|||
23128183|NCT01754753|64218710|FG001|Overall Study|Study close|44|||
23128184|NCT01754753|64218709|FG000|Overall Study|Lost to Follow-up|9|||
23128185|NCT01754753|64218710|FG001|Overall Study|Lost to Follow-up|5|||
23128186|NCT00863512|64218711|FG000|Overall Study|Adverse Event|2|||
23128187|NCT00863512|64218712|FG001|Overall Study|Adverse Event|0|||
23128188|NCT00863512|64218711|FG000|Overall Study|Withdrawal by Subject|11|||
23128189|NCT00863512|64218712|FG001|Overall Study|Withdrawal by Subject|0|||
23128190|NCT00863512|64218711|FG000|Overall Study|Physician Decision|1|||
23426629|NCT05239221|65307403|FG002|Overall Study|Withdrawal by Subject|0|||
23426630|NCT05239221|65307404|FG003|Overall Study|Withdrawal by Subject|0|||
23426631|NCT05239221|65307405|FG004|Overall Study|Withdrawal by Subject|0|||
23426632|NCT05239221|65307406|FG005|Overall Study|Withdrawal by Subject|0|||
23426633|NCT05239221|65307407|FG006|Overall Study|Withdrawal by Subject|0|||
23426634|NCT05239221|65307408|FG007|Overall Study|Withdrawal by Subject|0|||
23426635|NCT05239221|65307409|FG008|Overall Study|Withdrawal by Subject|0|||
23426636|NCT05239221|65307410|FG009|Overall Study|Withdrawal by Subject|0|||
23426637|NCT05239221|65307411|FG010|Overall Study|Withdrawal by Subject|1|||
23426638|NCT05239221|65307412|FG011|Overall Study|Withdrawal by Subject|0|||
23426639|NCT05239221|65307413|FG012|Overall Study|Withdrawal by Subject|0|||
23426640|NCT05239221|65307414|FG013|Overall Study|Withdrawal by Subject|0|||
23426641|NCT05239221|65307415|FG014|Overall Study|Withdrawal by Subject|0|||
23426642|NCT05239221|65307416|FG015|Overall Study|Withdrawal by Subject|1|||
23426643|NCT03356977|65307419|FG000|Overall Study|Lost to Follow-up|3|||
23128191|NCT00863512|64218712|FG001|Overall Study|Physician Decision|0|||
23128192|NCT02807272|64218713|FG000|Overall Study|Death|9|||
23128193|NCT02807272|64218714|FG001|Overall Study|Death|5|||
23128194|NCT02807272|64218715|FG002|Overall Study|Death|2|||
23128195|NCT02807272|64218716|FG003|Overall Study|Death|0|||
23128196|NCT02807272|64218717|FG004|Overall Study|Death|1|||
23128197|NCT02807272|64218713|FG000|Overall Study|Lost to Follow-up|1|||
23128198|NCT02807272|64218714|FG001|Overall Study|Lost to Follow-up|0|||
23128199|NCT02807272|64218715|FG002|Overall Study|Lost to Follow-up|0|||
23128200|NCT02807272|64218716|FG003|Overall Study|Lost to Follow-up|0|||
23128201|NCT02807272|64218717|FG004|Overall Study|Lost to Follow-up|0|||
23128202|NCT02807272|64218713|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
23128203|NCT02807272|64218714|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
23128204|NCT02807272|64218715|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
23128205|NCT02807272|64218716|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
23128206|NCT02807272|64218717|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
23545329|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
23545330|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
23128207|NCT02807272|64218713|FG000|Overall Study|Protocol-defined Disease Progression|0|||
23545331|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
23545332|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
23545333|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
23545334|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
23545335|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
23545336|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
23545337|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
23545338|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
23545339|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
23545340|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
23545341|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
23545342|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
23545343|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
23545344|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
23545345|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
23212630|NCT02586077|64519720|FG000|Overall Study|Physician Decision|4|||
23212631|NCT02586077|64519720|FG000|Overall Study|Lost to Follow-up|3|||
23426644|NCT03356977|65307419|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23426645|NCT00330928|65307420|FG000|Overall Study|Lost to Follow-up|6|||
23426646|NCT00330928|65307420|FG000|Overall Study|Physician Decision|9|||
23426647|NCT00330928|65307420|FG000|Overall Study|Death|1|||
23128208|NCT02807272|64218714|FG001|Overall Study|Protocol-defined Disease Progression|1|||
23128209|NCT02807272|64218715|FG002|Overall Study|Protocol-defined Disease Progression|0|||
23128210|NCT02807272|64218716|FG003|Overall Study|Protocol-defined Disease Progression|0|||
23128211|NCT02807272|64218717|FG004|Overall Study|Protocol-defined Disease Progression|1|||
23128212|NCT02807272|64218713|FG000|Overall Study|Study Terminated by Sponsor|1|||
23128213|NCT02807272|64218714|FG001|Overall Study|Study Terminated by Sponsor|0|||
23128214|NCT02807272|64218715|FG002|Overall Study|Study Terminated by Sponsor|0|||
23128215|NCT02807272|64218716|FG003|Overall Study|Study Terminated by Sponsor|1|||
23618489|NCT05600036|65988298|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23618490|NCT05600036|65988299|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
23426648|NCT00330928|65307420|FG000|Overall Study|IVUS could not be performed.|1|||
23426649|NCT00320255|65307421|FG000|Overall Study|Lack of Efficacy|1|||
23426650|NCT00320255|65307422|FG001|Overall Study|Lack of Efficacy|0|||
23426651|NCT00320255|65307423|FG002|Overall Study|Lack of Efficacy|0|||
23426652|NCT00320255|65307424|FG003|Overall Study|Lack of Efficacy|0|||
23426653|NCT00320255|65307425|FG004|Overall Study|Lack of Efficacy|0|||
23426654|NCT00320255|65307426|FG005|Overall Study|Lack of Efficacy|0|||
23426655|NCT00320255|65307421|FG000|Overall Study|Adverse Event|5|||
23426656|NCT00320255|65307422|FG001|Overall Study|Adverse Event|2|||
23426657|NCT00320255|65307423|FG002|Overall Study|Adverse Event|3|||
23545346|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
23545347|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
23128216|NCT02807272|64218717|FG004|Overall Study|Study Terminated by Sponsor|0|||
23618491|NCT05600036|65988300|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23545348|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
23545349|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
23545350|NCT00383435|65727178|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
23618492|NCT05600036|65988301|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23618493|NCT05600036|65988302|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23618494|NCT05600036|65988303|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
23618495|NCT05600036|65988298|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618496|NCT05600036|65988299|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618497|NCT05600036|65988300|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618498|NCT05600036|65988301|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
23618499|NCT05600036|65988302|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618500|NCT05600036|65988303|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
23618501|NCT01537120|65988306|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
23618502|NCT01537120|65988306|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
23618503|NCT03314233|65988307|FG000|Overall Study|No longer eligible at time of delivery|1|||
23618504|NCT04750577|65988310|FG000|Overall Study|Adverse Event|2|||
23618505|NCT04750577|65988311|FG001|Overall Study|Adverse Event|10|||
23618506|NCT04750577|65988312|FG002|Overall Study|Adverse Event|8|||
23618507|NCT04750577|65988313|FG003|Overall Study|Adverse Event|1|||
23618508|NCT04750577|65988310|FG000|Overall Study|Change of residence|0|||
23618509|NCT04750577|65988311|FG001|Overall Study|Change of residence|0|||
23618510|NCT04750577|65988312|FG002|Overall Study|Change of residence|1|||
23618511|NCT04750577|65988313|FG003|Overall Study|Change of residence|0|||
23545351|NCT00383435|65727179|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
23545352|NCT00383435|65727180|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
23545353|NCT00383435|65727181|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
23545354|NCT00383435|65727182|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
23545355|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
23545356|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
23545357|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
23545358|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
23545359|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
23545360|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23545361|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23545362|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23545363|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
23545364|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
23545365|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
23545366|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
23545367|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
23545368|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
23426658|NCT00320255|65307424|FG003|Overall Study|Adverse Event|2|||
23426659|NCT00320255|65307425|FG004|Overall Study|Adverse Event|0|||
23426660|NCT00320255|65307426|FG005|Overall Study|Adverse Event|0|||
23426661|NCT00320255|65307421|FG000|Overall Study|Withdrawal by Subject|1|||
23426662|NCT00320255|65307422|FG001|Overall Study|Withdrawal by Subject|2|||
23426663|NCT00320255|65307423|FG002|Overall Study|Withdrawal by Subject|2|||
23426664|NCT00320255|65307424|FG003|Overall Study|Withdrawal by Subject|4|||
23426665|NCT00320255|65307425|FG004|Overall Study|Withdrawal by Subject|0|||
23426666|NCT00320255|65307426|FG005|Overall Study|Withdrawal by Subject|0|||
23426667|NCT00320255|65307421|FG000|Overall Study|Poor compliance/noncompliance|1|||
23426668|NCT00320255|65307422|FG001|Overall Study|Poor compliance/noncompliance|1|||
23426669|NCT00320255|65307423|FG002|Overall Study|Poor compliance/noncompliance|0|||
23426670|NCT00320255|65307424|FG003|Overall Study|Poor compliance/noncompliance|1|||
23426671|NCT00320255|65307425|FG004|Overall Study|Poor compliance/noncompliance|0|||
23426672|NCT00320255|65307426|FG005|Overall Study|Poor compliance/noncompliance|0|||
23426673|NCT00320255|65307421|FG000|Overall Study|No longer meets study criteria|0|||
23426674|NCT00320255|65307422|FG001|Overall Study|No longer meets study criteria|0|||
23618512|NCT04750577|65988310|FG000|Overall Study|Burden of study procedures|0|||
23618513|NCT04750577|65988311|FG001|Overall Study|Burden of study procedures|2|||
23545369|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
23545370|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
23545371|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
23545372|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
23545373|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
23545374|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
23545375|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23545376|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
23545377|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
23545378|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
23128217|NCT02807272|64218713|FG000|Overall Study|Other|1|||
23128218|NCT02807272|64218714|FG001|Overall Study|Other|0|||
23128219|NCT02807272|64218715|FG002|Overall Study|Other|0|||
23128220|NCT02807272|64218716|FG003|Overall Study|Other|0|||
23545379|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
23545380|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
23545381|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23545382|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23545383|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
23545384|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
23545385|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23545386|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23545387|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23618514|NCT04750577|65988312|FG002|Overall Study|Burden of study procedures|2|||
23618515|NCT04750577|65988313|FG003|Overall Study|Burden of study procedures|0|||
23618516|NCT04750577|65988310|FG000|Overall Study|Prematurely discontinued|0|||
23618517|NCT04750577|65988311|FG001|Overall Study|Prematurely discontinued|0|||
23618518|NCT04750577|65988312|FG002|Overall Study|Prematurely discontinued|0|||
23618519|NCT04750577|65988313|FG003|Overall Study|Prematurely discontinued|2|||
23618520|NCT04750577|65988310|FG000|Overall Study|Protocol deviation|1|||
23618521|NCT04750577|65988311|FG001|Overall Study|Protocol deviation|1|||
23618522|NCT04750577|65988312|FG002|Overall Study|Protocol deviation|1|||
23618523|NCT04750577|65988313|FG003|Overall Study|Protocol deviation|1|||
23128221|NCT02807272|64218717|FG004|Overall Study|Other|1|||
23128222|NCT00611975|64218720|FG000|Overall Study|Withdrawal by Subject|3|||
23128223|NCT00611975|64218721|FG001|Overall Study|Withdrawal by Subject|7|||
23128224|NCT00611975|64218720|FG000|Overall Study|Pregnancy|2|||
23128225|NCT00611975|64218721|FG001|Overall Study|Pregnancy|1|||
23128226|NCT02637323|64218726|FG000|Overall Study|Lost to Follow-up|2|||
23128227|NCT02637323|64218727|FG001|Overall Study|Lost to Follow-up|0|||
23128228|NCT02637323|64218726|FG000|Overall Study|Protocol Violation|0|||
23128229|NCT02637323|64218727|FG001|Overall Study|Protocol Violation|1|||
23128230|NCT00623805|64218730|FG000|Overall Study|Adverse Event|9|||
23128231|NCT00623805|64218731|FG001|Overall Study|Adverse Event|6|||
23128232|NCT00623805|64218730|FG000|Overall Study|Death|2|||
23128233|NCT00623805|64218731|FG001|Overall Study|Death|0|||
23426675|NCT00320255|65307423|FG002|Overall Study|No longer meets study criteria|0|||
23426676|NCT00320255|65307424|FG003|Overall Study|No longer meets study criteria|1|||
23128234|NCT00623805|64218730|FG000|Overall Study|Lack of Efficacy|3|||
23128235|NCT00623805|64218731|FG001|Overall Study|Lack of Efficacy|7|||
23128236|NCT00623805|64218730|FG000|Overall Study|Lost to Follow-up|2|||
23128237|NCT00623805|64218731|FG001|Overall Study|Lost to Follow-up|2|||
23426677|NCT00320255|65307425|FG004|Overall Study|No longer meets study criteria|0|||
23128238|NCT00623805|64218730|FG000|Overall Study|Protocol Violation|1|||
23128239|NCT00623805|64218731|FG001|Overall Study|Protocol Violation|1|||
23426678|NCT00320255|65307426|FG005|Overall Study|No longer meets study criteria|0|||
23426679|NCT00320255|65307421|FG000|Overall Study|Other|3|||
23426680|NCT00320255|65307422|FG001|Overall Study|Other|2|||
23426681|NCT00320255|65307423|FG002|Overall Study|Other|1|||
23426682|NCT00320255|65307424|FG003|Overall Study|Other|0|||
23426683|NCT00320255|65307425|FG004|Overall Study|Other|0|||
23426684|NCT00320255|65307426|FG005|Overall Study|Other|0|||
23426685|NCT01962987|65307427|FG000|Overall Study|Adverse Event|4|||
23426686|NCT01962987|65307428|FG001|Overall Study|Adverse Event|4|||
23426687|NCT01962987|65307429|FG002|Overall Study|Adverse Event|0|||
23426688|NCT01962987|65307427|FG000|Overall Study|Lost to Follow-up|0|||
23426689|NCT01962987|65307428|FG001|Overall Study|Lost to Follow-up|0|||
23426690|NCT01962987|65307429|FG002|Overall Study|Lost to Follow-up|1|||
23426691|NCT01962987|65307427|FG000|Overall Study|Non compliance with dosing requirements|4|||
23426692|NCT01962987|65307428|FG001|Overall Study|Non compliance with dosing requirements|2|||
23426693|NCT01962987|65307429|FG002|Overall Study|Non compliance with dosing requirements|0|||
23426694|NCT01962987|65307427|FG000|Overall Study|Miscellaneous|1|||
23426695|NCT01962987|65307428|FG001|Overall Study|Miscellaneous|9|||
23426696|NCT01962987|65307429|FG002|Overall Study|Miscellaneous|2|||
23426697|NCT01962987|65307427|FG000|Overall Study|Restricted medication|5|||
23426698|NCT01962987|65307428|FG001|Overall Study|Restricted medication|1|||
23426699|NCT01962987|65307429|FG002|Overall Study|Restricted medication|1|||
23426700|NCT01962987|65307427|FG000|Overall Study|Serious Adverse Event|1|||
23426701|NCT01962987|65307428|FG001|Overall Study|Serious Adverse Event|0|||
23426702|NCT01962987|65307429|FG002|Overall Study|Serious Adverse Event|0|||
23426703|NCT01962987|65307427|FG000|Overall Study|Withdrawal by Subject|11|||
23426704|NCT01962987|65307428|FG001|Overall Study|Withdrawal by Subject|10|||
23426705|NCT01962987|65307429|FG002|Overall Study|Withdrawal by Subject|6|||
23128240|NCT00623805|64218730|FG000|Overall Study|Reason not Specified|3|||
23426706|NCT01962987|65307427|FG000|Overall Study|Randomized in Error|4|||
23426707|NCT01962987|65307428|FG001|Overall Study|Randomized in Error|2|||
23426708|NCT01962987|65307429|FG002|Overall Study|Randomized in Error|2|||
23426709|NCT01510184|65307431|FG000|Overall Study|Sponsor discretion|28|||
23426710|NCT01510184|65307432|FG001|Overall Study|Sponsor discretion|28|||
23426711|NCT01510184|65307431|FG000|Overall Study|Death|1|||
23426712|NCT01510184|65307432|FG001|Overall Study|Death|2|||
23426713|NCT01510184|65307431|FG000|Overall Study|Withdrawal by Subject|1|||
23426714|NCT01510184|65307432|FG001|Overall Study|Withdrawal by Subject|4|||
23426715|NCT01510184|65307431|FG000|Overall Study|Other|0|||
23426716|NCT01510184|65307432|FG001|Overall Study|Other|1|||
23426717|NCT01646203|65307433|FG000|Overall Study|Adverse Event|2|||
23426718|NCT01646203|65307434|FG001|Overall Study|Adverse Event|0|||
23426719|NCT01646203|65307435|FG002|Overall Study|Adverse Event|1|||
23545388|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
23545389|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
23545390|NCT00383435|65727178|FG000|26-Week Treatment Safety Extension|Administrative|1|||
23545391|NCT00383435|65727179|FG001|26-Week Treatment Safety Extension|Administrative|1|||
23545392|NCT00383435|65727180|FG002|26-Week Treatment Safety Extension|Administrative|0|||
23545393|NCT00383435|65727181|FG003|26-Week Treatment Safety Extension|Administrative|1|||
23545394|NCT00383435|65727182|FG004|26-Week Treatment Safety Extension|Administrative|0|||
23545395|NCT00987467|65727183|FG000|Overall Study|Lost to Follow-up|2|||
23545396|NCT01496976|65727184|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
23545397|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Adverse Event|5|||
23545398|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Adverse Event|8|||
23545399|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Adverse Event|4|||
23545400|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Adverse Event|8|||
23545401|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
23545402|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
23545403|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
23128241|NCT00623805|64218731|FG001|Overall Study|Reason not Specified|6|||
23128242|NCT04707664|64218732|FG000|Overall Study|Adverse Event|2|||
23128243|NCT04707664|64218733|FG001|Overall Study|Adverse Event|0|||
23128244|NCT04707664|64218732|FG000|Overall Study|Death|1|||
23128245|NCT04707664|64218733|FG001|Overall Study|Death|2|||
23128246|NCT04707664|64218732|FG000|Overall Study|Withdrawal by Subject|13|||
23426720|NCT01646203|65307433|FG000|Overall Study|Withdrawal by Subject|0|||
23426721|NCT01646203|65307434|FG001|Overall Study|Withdrawal by Subject|1|||
23545404|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
23128247|NCT04707664|64218733|FG001|Overall Study|Withdrawal by Subject|21|||
23128248|NCT04707664|64218732|FG000|Overall Study|Lost to Follow-up|11|||
23426722|NCT01646203|65307435|FG002|Overall Study|Withdrawal by Subject|0|||
23426723|NCT01646203|65307433|FG000|Overall Study|Physician's Decision|0|||
23426724|NCT01646203|65307434|FG001|Overall Study|Physician's Decision|1|||
23426725|NCT01646203|65307435|FG002|Overall Study|Physician's Decision|0|||
23426726|NCT00882908|65307442|FG000|Overall Study|Adverse Event|0|||
23426727|NCT00882908|65307443|FG001|Overall Study|Adverse Event|0|||
23426728|NCT00882908|65307444|FG002|Overall Study|Adverse Event|1|||
23426729|NCT00882908|65307445|FG003|Overall Study|Adverse Event|0|||
23618524|NCT04750577|65988310|FG000|Overall Study|Other than listed|3|||
23618525|NCT04750577|65988311|FG001|Overall Study|Other than listed|2|||
23618526|NCT04750577|65988312|FG002|Overall Study|Other than listed|2|||
23128249|NCT04707664|64218733|FG001|Overall Study|Lost to Follow-up|13|||
23128250|NCT04707664|64218732|FG000|Overall Study|Not treated|2|||
23128251|NCT04707664|64218733|FG001|Overall Study|Not treated|0|||
23128252|NCT03232931|64218741|FG000|Overall Study|Physician Decision|1|||
23128253|NCT03232931|64218742|FG001|Overall Study|Physician Decision|1|||
23128254|NCT03232931|64218741|FG000|Overall Study|Withdrawal by Subject|6|||
23128255|NCT03232931|64218742|FG001|Overall Study|Withdrawal by Subject|0|||
23128256|NCT03232931|64218741|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
23128257|NCT03232931|64218742|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
23128258|NCT03232931|64218741|FG000|Overall Study|Parent did not record voice|1|||
23128259|NCT03232931|64218742|FG001|Overall Study|Parent did not record voice|2|||
23128260|NCT03232931|64218741|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
23128261|NCT03232931|64218742|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
23128262|NCT01216072|64218754|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
23128263|NCT01216072|64218755|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
23128264|NCT01216072|64218754|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
23128265|NCT01216072|64218755|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
23128266|NCT01216072|64218754|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
23128267|NCT01216072|64218755|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
23128268|NCT01216072|64218754|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
23128269|NCT01216072|64218755|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
23128270|NCT01216072|64218754|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
23128271|NCT01216072|64218755|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
23128272|NCT01216072|64218754|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
23128273|NCT01216072|64218755|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
23128274|NCT01216072|64218754|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
23128275|NCT01216072|64218755|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
23128276|NCT01216072|64218754|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
23618527|NCT04750577|65988313|FG003|Overall Study|Other than listed|1|||
23618528|NCT04750577|65988310|FG000|Overall Study|Not treated|0|||
23618529|NCT04750577|65988311|FG001|Overall Study|Not treated|0|||
23618530|NCT04750577|65988312|FG002|Overall Study|Not treated|0|||
23618531|NCT04750577|65988313|FG003|Overall Study|Not treated|2|||
23618532|NCT02166047|65988314|FG000|Overall Study|Withdrawal by Participant|0|||
23618533|NCT02166047|65988315|FG001|Overall Study|Withdrawal by Participant|1|||
23618534|NCT02166047|65988316|FG002|Overall Study|Withdrawal by Participant|2|||
23618535|NCT02166047|65988317|FG003|Overall Study|Withdrawal by Participant|0|||
23618536|NCT02166047|65988318|FG004|Overall Study|Withdrawal by Participant|0|||
23618537|NCT02166047|65988319|FG005|Overall Study|Withdrawal by Participant|0|||
23618538|NCT02166047|65988320|FG006|Overall Study|Withdrawal by Participant|1|||
23618539|NCT02166047|65988321|FG007|Overall Study|Withdrawal by Participant|0|||
23618540|NCT02166047|65988322|FG008|Overall Study|Withdrawal by Participant|0|||
23618541|NCT02166047|65988323|FG009|Overall Study|Withdrawal by Participant|0|||
23618542|NCT02166047|65988324|FG010|Overall Study|Withdrawal by Participant|0|||
23618543|NCT02166047|65988325|FG011|Overall Study|Withdrawal by Participant|0|||
23618544|NCT02166047|65988314|FG000|Overall Study|Adverse Event|0|||
23618545|NCT02166047|65988315|FG001|Overall Study|Adverse Event|0|||
23618546|NCT02166047|65988316|FG002|Overall Study|Adverse Event|0|||
23618547|NCT02166047|65988317|FG003|Overall Study|Adverse Event|0|||
23618548|NCT02166047|65988318|FG004|Overall Study|Adverse Event|1|||
23618549|NCT02166047|65988319|FG005|Overall Study|Adverse Event|0|||
23618550|NCT02166047|65988320|FG006|Overall Study|Adverse Event|1|||
23618551|NCT02166047|65988321|FG007|Overall Study|Adverse Event|0|||
23618552|NCT02166047|65988322|FG008|Overall Study|Adverse Event|0|||
23618553|NCT02166047|65988323|FG009|Overall Study|Adverse Event|0|||
23618554|NCT02166047|65988324|FG010|Overall Study|Adverse Event|2|||
23618555|NCT02166047|65988325|FG011|Overall Study|Adverse Event|0|||
23618556|NCT01329419|65988328|FG000|Overall Study|Protocol Violation|235|||
23618557|NCT02254681|65988331|FG000|Overall Study|Lack of Efficacy|6|||
23128277|NCT01216072|64218755|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
23128278|NCT01216072|64218754|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
23618558|NCT01894256|65988332|FG000|Part A|Adverse Event|0|||
23618559|NCT01894256|65988333|FG001|Part A|Adverse Event|1|||
23618560|NCT01894256|65988334|FG002|Part A|Adverse Event|0|||
23128279|NCT01216072|64218755|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
23618561|NCT01894256|65988332|FG000|Part B|Death|0|||
23618562|NCT01894256|65988333|FG001|Part B|Death|1|||
23618563|NCT01894256|65988334|FG002|Part B|Death|1|||
23618564|NCT01894256|65988332|FG000|Part B|Withdrawal by Subject|0|||
23618565|NCT01894256|65988333|FG001|Part B|Withdrawal by Subject|1|||
23618566|NCT01894256|65988334|FG002|Part B|Withdrawal by Subject|0|||
23618567|NCT01894256|65988332|FG000|Part B|Lack of Efficacy|15|||
23618568|NCT01894256|65988333|FG001|Part B|Lack of Efficacy|12|||
23618569|NCT01894256|65988334|FG002|Part B|Lack of Efficacy|13|||
23618570|NCT01040403|65988335|FG000|Overall Study|Adverse Event|10|||
23618571|NCT01040403|65988335|FG000|Overall Study|Protocol Violation|2|||
23128280|NCT01216072|64218754|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
23128281|NCT01216072|64218755|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
23128282|NCT00600613|64218756|FG000|Overall Study|Protocol Deviation|1|||
23128283|NCT01825577|64218757|FG000|Overall Study|Physician Decision|2|||
23128284|NCT01825577|64218757|FG000|Overall Study|Withdrawal by Subject|1|||
23128285|NCT01825577|64218757|FG000|Overall Study|Withdrawn by family members|2|||
23128286|NCT01825577|64218757|FG000|Overall Study|Lack of Efficacy|3|||
23128287|NCT01730378|64218762|FG000|Overall Study|Lost to Follow-up|1|||
23128288|NCT01730378|64218763|FG001|Overall Study|Lost to Follow-up|0|||
23128289|NCT00609947|64218764|FG000|Overall Study|Death|1|||
23128290|NCT01208103|64218769|FG000|Overall Study|Adverse Event|1|||
23128291|NCT01208103|64218769|FG000|Overall Study|Withdrawal by Subject|1|||
23128292|NCT02975102|64218770|FG000|Overall Study|Adverse Event|2|||
23128293|NCT02975102|64218771|FG001|Overall Study|Adverse Event|1|||
23128294|NCT01475461|64218772|FG000|Run-in Period|Not meet eligibility criteria|16|||
23128295|NCT01475461|64218773|FG001|Run-in Period|Not meet eligibility criteria|0|||
23128296|NCT01475461|64218774|FG002|Run-in Period|Not meet eligibility criteria|0|||
23128297|NCT01475461|64218775|FG003|Run-in Period|Not meet eligibility criteria|0|||
23128298|NCT01475461|64218776|FG004|Run-in Period|Not meet eligibility criteria|0|||
23128299|NCT01475461|64218777|FG005|Run-in Period|Not meet eligibility criteria|0|||
23128300|NCT01475461|64218778|FG006|Run-in Period|Not meet eligibility criteria|0|||
23128301|NCT01475461|64218772|FG000|Run-in Period|Lost to Follow-up|7|||
23128302|NCT01475461|64218773|FG001|Run-in Period|Lost to Follow-up|0|||
23128303|NCT01475461|64218774|FG002|Run-in Period|Lost to Follow-up|0|||
23128304|NCT01475461|64218775|FG003|Run-in Period|Lost to Follow-up|0|||
23128305|NCT01475461|64218776|FG004|Run-in Period|Lost to Follow-up|0|||
23128306|NCT01475461|64218777|FG005|Run-in Period|Lost to Follow-up|0|||
23128307|NCT01475461|64218778|FG006|Run-in Period|Lost to Follow-up|0|||
23128308|NCT01475461|64218772|FG000|Run-in Period|Withdrawal by Subject|11|||
23128309|NCT01475461|64218773|FG001|Run-in Period|Withdrawal by Subject|0|||
23128310|NCT01475461|64218774|FG002|Run-in Period|Withdrawal by Subject|0|||
23128311|NCT01475461|64218775|FG003|Run-in Period|Withdrawal by Subject|0|||
23128312|NCT01475461|64218776|FG004|Run-in Period|Withdrawal by Subject|0|||
23128313|NCT01475461|64218777|FG005|Run-in Period|Withdrawal by Subject|0|||
23128314|NCT01475461|64218778|FG006|Run-in Period|Withdrawal by Subject|0|||
23128315|NCT01475461|64218772|FG000|Run-in Period|Other|3|||
23128316|NCT01475461|64218773|FG001|Run-in Period|Other|0|||
23545405|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
23128317|NCT01475461|64218774|FG002|Run-in Period|Other|0|||
23128318|NCT01475461|64218775|FG003|Run-in Period|Other|0|||
23128319|NCT01475461|64218776|FG004|Run-in Period|Other|0|||
23128320|NCT01475461|64218777|FG005|Run-in Period|Other|0|||
23128321|NCT01475461|64218778|FG006|Run-in Period|Other|0|||
23128322|NCT01475461|64218772|FG000|Run-in Period|Protocol Violation|4|||
23545406|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
23128323|NCT01475461|64218773|FG001|Run-in Period|Protocol Violation|0|||
23545407|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
23545408|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
23545409|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Physician Decision|1|||
23545410|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Physician Decision|0|||
23545411|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Physician Decision|0|||
23545412|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Physician Decision|0|||
23545413|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
23545414|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
23545415|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
23545416|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
23545417|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Pregnancy|0|||
23545418|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Pregnancy|1|||
23545419|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Pregnancy|0|||
23545420|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Pregnancy|0|||
23545421|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
23545422|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
23545423|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
23545424|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
23545425|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Death|0|||
23545426|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Death|1|||
23545427|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Death|0|||
23545428|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Death|0|||
23545429|NCT00071487|65727187|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
23545430|NCT00071487|65727188|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
23316406|NCT04868500|64903814|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
23316407|NCT04868500|64903815|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
23316408|NCT04868500|64903814|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
23316409|NCT04868500|64903815|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
23316410|NCT02564887|64903816|FG000|Overall Study|Lost to Follow-up|6|||
23316411|NCT02564887|64903817|FG001|Overall Study|Lost to Follow-up|0|||
23316412|NCT02108912|64903821|FG000|Overall Study|Lost to Follow-up|1|||
23316413|NCT02108912|64903822|FG001|Overall Study|Lost to Follow-up|1|||
23316414|NCT02108912|64903821|FG000|Overall Study|lack of transportation|1|||
23316415|NCT02108912|64903822|FG001|Overall Study|lack of transportation|0|||
23316416|NCT02108912|64903821|FG000|Overall Study|high blood pressure|1|||
23316417|NCT02108912|64903822|FG001|Overall Study|high blood pressure|0|||
23316418|NCT01885195|64903823|FG000|Overall Study|Adverse Event|29|||
23316419|NCT01885195|64903823|FG000|Overall Study|Death|1|||
23316420|NCT01885195|64903823|FG000|Overall Study|Disease Progression|67|||
23316421|NCT01885195|64903823|FG000|Overall Study|Protocol Deviation|2|||
23316422|NCT01885195|64903823|FG000|Overall Study|Physician Decision|3|||
23316423|NCT01885195|64903823|FG000|Overall Study|Patient/guardian decision|8|||
23316424|NCT02096744|64903824|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
23316425|NCT02096744|64903825|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
23316426|NCT02096744|64903824|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
23316427|NCT02096744|64903825|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
23316428|NCT02096744|64903824|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
23316429|NCT02096744|64903825|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
23316430|NCT02794246|64903826|FG000|Overall Study|Withdrawal by Subject|2|||
23545431|NCT00071487|65727189|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
23545432|NCT00071487|65727190|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
23545433|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
23545434|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
23545435|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
23545436|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
23545437|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23545438|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23545439|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
23545440|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
23545441|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23545442|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23545443|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23545444|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
23545445|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
23545446|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
23545447|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
23545448|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
23545449|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23545450|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23545451|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
23545452|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
23545453|NCT00071487|65727187|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23545454|NCT00071487|65727188|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23545455|NCT00071487|65727189|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
23545456|NCT00071487|65727190|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
23545457|NCT02807948|65727191|FG000|Overall Study|Physician Decision|1|||
23545458|NCT02807948|65727192|FG001|Overall Study|Physician Decision|0|||
23545459|NCT02169674|65727195|FG000|Overall Study|Withdrawal by Subject|2|||
23545460|NCT02169674|65727196|FG001|Overall Study|Withdrawal by Subject|1|||
23545461|NCT02169674|65727195|FG000|Overall Study|Seroprotected|30|||
23545462|NCT02169674|65727196|FG001|Overall Study|Seroprotected|76|||
23545463|NCT02169674|65727195|FG000|Overall Study|Lost to Follow-up|0|||
23545464|NCT02169674|65727196|FG001|Overall Study|Lost to Follow-up|1|||
23545465|NCT01730937|65727200|FG000|Overall Study|Protocol Violation|5|||
23545466|NCT01730937|65727201|FG001|Overall Study|Protocol Violation|11|||
23545467|NCT04066114|65727205|FG000|Overall Study|Adverse Event|1|||
23545468|NCT04066114|65727206|FG001|Overall Study|Adverse Event|0|||
23545469|NCT04066114|65727207|FG002|Overall Study|Adverse Event|0|||
23545470|NCT04066114|65727205|FG000|Overall Study|Withdrawal by Subject|1|||
23545471|NCT04066114|65727206|FG001|Overall Study|Withdrawal by Subject|0|||
23545472|NCT04066114|65727207|FG002|Overall Study|Withdrawal by Subject|0|||
23545473|NCT04066114|65727205|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
23545474|NCT04066114|65727206|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
23545475|NCT04066114|65727207|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
23316431|NCT02794246|64903826|FG000|Overall Study|Physician Decision|4|||
23316432|NCT05022212|64903832|FG000|Overall Study|Lost to Follow-up|0|||
23316433|NCT05022212|64903833|FG001|Overall Study|Lost to Follow-up|2|||
23316434|NCT01609023|64903834|FG000|Overall Study|Lack of Efficacy|3|||
23316435|NCT01609023|64903834|FG000|Overall Study|Withdrawal by Subject|4|||
23316436|NCT01609023|64903834|FG000|Overall Study|Lost to Follow-up|8|||
23316437|NCT01609023|64903834|FG000|Overall Study|Toxicity|3|||
23316438|NCT01609023|64903834|FG000|Overall Study|Disease progression|10|||
23316439|NCT01609023|64903834|FG000|Overall Study|Physician Decision|2|||
23316440|NCT01609023|64903834|FG000|Overall Study|Death|2|||
23316441|NCT01609023|64903834|FG000|Overall Study|Personal reasons|1|||
23316442|NCT01876446|64903840|FG000|Overall Study|Death|0|||
23316443|NCT01876446|64903841|FG001|Overall Study|Death|1|||
23316444|NCT01876446|64903840|FG000|Overall Study|Withdrawal by Subject|1|||
23128324|NCT01475461|64218774|FG002|Run-in Period|Protocol Violation|0|||
23316445|NCT01876446|64903841|FG001|Overall Study|Withdrawal by Subject|2|||
23316446|NCT01876446|64903840|FG000|Overall Study|Physician Decision|1|||
23316447|NCT01876446|64903841|FG001|Overall Study|Physician Decision|3|||
23316448|NCT01973595|64903842|FG000|Washout|Withdrawal by Subject|1|||
23316449|NCT01973595|64903843|FG001|Washout|Withdrawal by Subject|0|||
23316450|NCT01973595|64903844|FG002|Washout|Withdrawal by Subject|1|||
23316451|NCT01973595|64903845|FG003|Washout|Withdrawal by Subject|0|||
23316452|NCT01427608|64903846|FG000|Overall Study|Death|1|||
23316453|NCT01427608|64903847|FG001|Overall Study|Death|0|||
23316454|NCT01427608|64903846|FG000|Overall Study|Withdrawal by Subject|7|||
23316455|NCT01427608|64903847|FG001|Overall Study|Withdrawal by Subject|3|||
23316456|NCT01427608|64903846|FG000|Overall Study|Relapsed-all cause|13|||
23316457|NCT01427608|64903847|FG001|Overall Study|Relapsed-all cause|34|||
23316458|NCT01427608|64903846|FG000|Overall Study|Events not attributed to study meds|0|||
23316459|NCT01427608|64903847|FG001|Overall Study|Events not attributed to study meds|1|||
23316460|NCT00233948|64903848|FG000|Overall Study|Adverse Event|1|||
23316461|NCT00233948|64903849|FG001|Overall Study|Adverse Event|0|||
23316462|NCT00233948|64903850|FG002|Overall Study|Adverse Event|0|||
23316463|NCT00233948|64903851|FG003|Overall Study|Adverse Event|0|||
23316464|NCT00233948|64903852|FG004|Overall Study|Adverse Event|0|||
23316465|NCT00233948|64903853|FG005|Overall Study|Adverse Event|0|||
23316466|NCT02246114|64903854|FG000|Overall Study|miscarriage|1|||
23316467|NCT02246114|64903855|FG001|Overall Study|miscarriage|0|||
23316468|NCT03016975|64903858|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
23316469|NCT03016975|64903859|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
23316470|NCT03016975|64903860|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
23316471|NCT03016975|64903858|FG000|At 6 Months Follow-up|Death|2|||
23316472|NCT03016975|64903859|FG001|At 6 Months Follow-up|Death|0|||
23316473|NCT03016975|64903860|FG002|At 6 Months Follow-up|Death|0|||
23316474|NCT03016975|64903858|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
23316475|NCT03016975|64903859|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
23316476|NCT03016975|64903860|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
23316477|NCT03016975|64903858|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
23316478|NCT03016975|64903859|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
23316479|NCT03016975|64903860|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
23316480|NCT03016975|64903858|FG000|At 6 Months Follow-up|Aborted implant|1|||
23316481|NCT03016975|64903859|FG001|At 6 Months Follow-up|Aborted implant|0|||
23316482|NCT03016975|64903860|FG002|At 6 Months Follow-up|Aborted implant|0|||
23316483|NCT03016975|64903858|FG000|At 2 Year Follow-up|Death|1|||
23316484|NCT03016975|64903859|FG001|At 2 Year Follow-up|Death|0|||
23316485|NCT03016975|64903860|FG002|At 2 Year Follow-up|Death|0|||
23316486|NCT03016975|64903858|FG000|At 3 Year Follow-up|Death|1|||
23316487|NCT03016975|64903859|FG001|At 3 Year Follow-up|Death|0|||
23316488|NCT03016975|64903860|FG002|At 3 Year Follow-up|Death|0|||
23316489|NCT03016975|64903858|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
23128325|NCT01475461|64218775|FG003|Run-in Period|Protocol Violation|0|||
23316490|NCT03016975|64903859|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
23316491|NCT03016975|64903860|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
23316492|NCT03016975|64903858|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
23316493|NCT03016975|64903859|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
23316494|NCT03016975|64903860|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
23426730|NCT00882908|65307446|FG004|Overall Study|Adverse Event|1|||
23316495|NCT00970593|64903863|FG000|Overall Study|Adverse Event|1|||
23316496|NCT00970593|64903864|FG001|Overall Study|Adverse Event|1|||
23316497|NCT00970593|64903865|FG002|Overall Study|Adverse Event|0|||
23316498|NCT00970593|64903866|FG003|Overall Study|Adverse Event|0|||
23316499|NCT00970593|64903867|FG004|Overall Study|Adverse Event|0|||
23316500|NCT00970593|64903868|FG005|Overall Study|Adverse Event|0|||
23316501|NCT00970593|64903869|FG006|Overall Study|Adverse Event|0|||
23316502|NCT00970593|64903863|FG000|Overall Study|Discontinuation of study by sponsor|0|||
23316503|NCT00970593|64903864|FG001|Overall Study|Discontinuation of study by sponsor|0|||
23316504|NCT00970593|64903865|FG002|Overall Study|Discontinuation of study by sponsor|5|||
23316505|NCT00970593|64903866|FG003|Overall Study|Discontinuation of study by sponsor|0|||
23316506|NCT00970593|64903867|FG004|Overall Study|Discontinuation of study by sponsor|0|||
23316507|NCT00970593|64903868|FG005|Overall Study|Discontinuation of study by sponsor|0|||
23316508|NCT00970593|64903869|FG006|Overall Study|Discontinuation of study by sponsor|2|||
23316509|NCT00970593|64903863|FG000|Overall Study|Withdrawal by Subject|0|||
23316510|NCT00970593|64903864|FG001|Overall Study|Withdrawal by Subject|0|||
23316511|NCT00970593|64903865|FG002|Overall Study|Withdrawal by Subject|1|||
23316512|NCT00970593|64903866|FG003|Overall Study|Withdrawal by Subject|0|||
23316513|NCT00970593|64903867|FG004|Overall Study|Withdrawal by Subject|0|||
23316514|NCT00970593|64903868|FG005|Overall Study|Withdrawal by Subject|0|||
23316515|NCT00970593|64903869|FG006|Overall Study|Withdrawal by Subject|0|||
23316516|NCT01305044|64903871|FG000|Overall Study|Withdrawal by Subject|3|||
23316517|NCT01305044|64903872|FG001|Overall Study|Withdrawal by Subject|6|||
23316518|NCT00794339|64903878|FG000|Overall Study|Withdrawal by Subject|3|||
23316519|NCT00794339|64903878|FG000|Overall Study|Ineligible|4|||
23316520|NCT00794339|64903878|FG000|Overall Study|Tx prior to ATSM|3|||
23316521|NCT00794339|64903878|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
23316522|NCT00794339|64903878|FG000|Overall Study|Tx not per protocol|1|||
23316523|NCT03449446|64903879|FG000|Overall Study|Randomized but Never Treated|0|||
23316524|NCT03449446|64903880|FG001|Overall Study|Randomized but Never Treated|0|||
23316525|NCT03449446|64903881|FG002|Overall Study|Randomized but Never Treated|1|||
23316526|NCT03449446|64903882|FG003|Overall Study|Randomized but Never Treated|1|||
23316527|NCT03449446|64903883|FG004|Overall Study|Randomized but Never Treated|1|||
23316528|NCT03449446|64903884|FG005|Overall Study|Randomized but Never Treated|0|||
23316529|NCT03449446|64903885|FG006|Overall Study|Randomized but Never Treated|0|||
23316530|NCT03449446|64903879|FG000|Overall Study|Unknown Reason|33|||
23316531|NCT03449446|64903880|FG001|Overall Study|Unknown Reason|1|||
23316532|NCT03449446|64903881|FG002|Overall Study|Unknown Reason|1|||
23316533|NCT03449446|64903882|FG003|Overall Study|Unknown Reason|1|||
23316534|NCT03449446|64903883|FG004|Overall Study|Unknown Reason|2|||
23316535|NCT03449446|64903884|FG005|Overall Study|Unknown Reason|2|||
23316536|NCT03449446|64903885|FG006|Overall Study|Unknown Reason|0|||
23316537|NCT03449446|64903879|FG000|Overall Study|Withdrew Consent|1|||
23316538|NCT03449446|64903880|FG001|Overall Study|Withdrew Consent|3|||
23316539|NCT03449446|64903881|FG002|Overall Study|Withdrew Consent|1|||
23316540|NCT03449446|64903882|FG003|Overall Study|Withdrew Consent|4|||
23316541|NCT03449446|64903883|FG004|Overall Study|Withdrew Consent|4|||
23316542|NCT03449446|64903884|FG005|Overall Study|Withdrew Consent|4|||
23316543|NCT03449446|64903885|FG006|Overall Study|Withdrew Consent|1|||
23316544|NCT03449446|64903879|FG000|Overall Study|Adverse Event|1|||
23316545|NCT03449446|64903880|FG001|Overall Study|Adverse Event|2|||
23316546|NCT03449446|64903881|FG002|Overall Study|Adverse Event|1|||
23316547|NCT03449446|64903882|FG003|Overall Study|Adverse Event|0|||
23316548|NCT03449446|64903883|FG004|Overall Study|Adverse Event|0|||
23316549|NCT03449446|64903884|FG005|Overall Study|Adverse Event|2|||
23316550|NCT03449446|64903885|FG006|Overall Study|Adverse Event|0|||
23316551|NCT03449446|64903879|FG000|Overall Study|Lost to Follow-up|0|||
23316552|NCT03449446|64903880|FG001|Overall Study|Lost to Follow-up|0|||
23316553|NCT03449446|64903881|FG002|Overall Study|Lost to Follow-up|2|||
23316554|NCT03449446|64903882|FG003|Overall Study|Lost to Follow-up|1|||
23316555|NCT03449446|64903883|FG004|Overall Study|Lost to Follow-up|3|||
23316556|NCT03449446|64903884|FG005|Overall Study|Lost to Follow-up|0|||
23316557|NCT03449446|64903885|FG006|Overall Study|Lost to Follow-up|0|||
23316558|NCT03449446|64903879|FG000|Overall Study|Investigator's Discretion|0|||
23316559|NCT03449446|64903880|FG001|Overall Study|Investigator's Discretion|1|||
23316560|NCT03449446|64903881|FG002|Overall Study|Investigator's Discretion|1|||
23316561|NCT03449446|64903882|FG003|Overall Study|Investigator's Discretion|2|||
23316562|NCT03449446|64903883|FG004|Overall Study|Investigator's Discretion|0|||
23316563|NCT03449446|64903884|FG005|Overall Study|Investigator's Discretion|0|||
23316564|NCT03449446|64903885|FG006|Overall Study|Investigator's Discretion|0|||
23316565|NCT03449446|64903879|FG000|Overall Study|Non Compliance with Study Drug|1|||
23316566|NCT03449446|64903880|FG001|Overall Study|Non Compliance with Study Drug|0|||
23316567|NCT03449446|64903881|FG002|Overall Study|Non Compliance with Study Drug|0|||
23316568|NCT03449446|64903882|FG003|Overall Study|Non Compliance with Study Drug|0|||
23316569|NCT03449446|64903883|FG004|Overall Study|Non Compliance with Study Drug|0|||
23316570|NCT03449446|64903884|FG005|Overall Study|Non Compliance with Study Drug|0|||
23316571|NCT03449446|64903885|FG006|Overall Study|Non Compliance with Study Drug|0|||
23316572|NCT03449446|64903879|FG000|Overall Study|Protocol Violation|0|||
23316573|NCT03449446|64903880|FG001|Overall Study|Protocol Violation|0|||
23316574|NCT03449446|64903881|FG002|Overall Study|Protocol Violation|0|||
23316575|NCT03449446|64903882|FG003|Overall Study|Protocol Violation|0|||
23316576|NCT03449446|64903883|FG004|Overall Study|Protocol Violation|1|||
23316577|NCT03449446|64903884|FG005|Overall Study|Protocol Violation|1|||
23316578|NCT03449446|64903885|FG006|Overall Study|Protocol Violation|0|||
23316579|NCT03449446|64903879|FG000|Overall Study|Death|0|||
23316580|NCT03449446|64903880|FG001|Overall Study|Death|0|||
23316581|NCT03449446|64903881|FG002|Overall Study|Death|0|||
23316582|NCT03449446|64903882|FG003|Overall Study|Death|0|||
23316583|NCT03449446|64903883|FG004|Overall Study|Death|1|||
23316584|NCT03449446|64903884|FG005|Overall Study|Death|0|||
23316585|NCT03449446|64903885|FG006|Overall Study|Death|0|||
23316586|NCT03076775|64903886|FG000|Overall Study|Lost to Follow-up|1|||
23316587|NCT03076775|64903887|FG001|Overall Study|Lost to Follow-up|0|||
23316588|NCT01085357|64903888|FG000|Overall Study|Adverse Event|1|||
23316589|NCT01085357|64903889|FG001|Overall Study|Adverse Event|1|||
23316590|NCT01085357|64903888|FG000|Overall Study|Subject Decision|4|||
23316591|NCT01085357|64903889|FG001|Overall Study|Subject Decision|3|||
23316592|NCT01085357|64903888|FG000|Overall Study|Investigator Decision|1|||
23316593|NCT01085357|64903889|FG001|Overall Study|Investigator Decision|1|||
23316594|NCT01085357|64903888|FG000|Overall Study|Death|11|||
23316595|NCT01085357|64903889|FG001|Overall Study|Death|1|||
23316596|NCT01085357|64903888|FG000|Overall Study|Lost to Follow-up|2|||
23316597|NCT01085357|64903889|FG001|Overall Study|Lost to Follow-up|0|||
23316598|NCT04604795|64903890|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
23316599|NCT04604795|64903891|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
23316600|NCT04604795|64903892|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23316601|NCT04604795|64903893|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23316602|NCT04604795|64903894|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23316603|NCT04604795|64903895|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23316604|NCT04604795|64903896|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23316605|NCT04604795|64903897|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23316606|NCT04604795|64903898|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23316607|NCT04604795|64903899|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
23316608|NCT04604795|64903890|FG000|Part B: Up to Day 14|Adverse Event|0|||
23316609|NCT04604795|64903891|FG001|Part B: Up to Day 14|Adverse Event|0|||
23316610|NCT04604795|64903892|FG002|Part B: Up to Day 14|Adverse Event|0|||
23316611|NCT04604795|64903893|FG003|Part B: Up to Day 14|Adverse Event|0|||
23316612|NCT04604795|64903894|FG004|Part B: Up to Day 14|Adverse Event|2|||
23316613|NCT04604795|64903895|FG005|Part B: Up to Day 14|Adverse Event|1|||
23316614|NCT04604795|64903896|FG006|Part B: Up to Day 14|Adverse Event|0|||
23316615|NCT04604795|64903897|FG007|Part B: Up to Day 14|Adverse Event|0|||
23316616|NCT04604795|64903898|FG008|Part B: Up to Day 14|Adverse Event|0|||
23316617|NCT04604795|64903899|FG009|Part B: Up to Day 14|Adverse Event|0|||
23316618|NCT04604795|64903890|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23316619|NCT04604795|64903891|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23316620|NCT04604795|64903892|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23316621|NCT04604795|64903893|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23316622|NCT04604795|64903894|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23316623|NCT04604795|64903895|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23316624|NCT04604795|64903896|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23316625|NCT04604795|64903897|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23316626|NCT04604795|64903898|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
23316627|NCT04604795|64903899|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
23316628|NCT04604795|64903890|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23316629|NCT04604795|64903891|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23316630|NCT04604795|64903892|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23316631|NCT04604795|64903893|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23316632|NCT04604795|64903894|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23316633|NCT04604795|64903895|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23316634|NCT04604795|64903896|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23316635|NCT04604795|64903897|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23316636|NCT04604795|64903898|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
23316637|NCT04604795|64903899|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
23316638|NCT04604795|64903890|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23316639|NCT04604795|64903891|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23316640|NCT04604795|64903892|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23316641|NCT04604795|64903893|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23316642|NCT04604795|64903894|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23316643|NCT04604795|64903895|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23316644|NCT04604795|64903896|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23316645|NCT04604795|64903897|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23316646|NCT04604795|64903898|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
23316647|NCT04604795|64903899|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
23316648|NCT04604795|64903890|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
23316649|NCT04604795|64903891|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
23316650|NCT04604795|64903892|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
23128326|NCT01475461|64218776|FG004|Run-in Period|Protocol Violation|0|||
23316651|NCT04604795|64903893|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
23316652|NCT04604795|64903894|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
23316653|NCT04604795|64903895|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
23316654|NCT04604795|64903896|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
23316655|NCT04604795|64903897|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
23316656|NCT04604795|64903898|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
23316657|NCT04604795|64903899|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
23316658|NCT00749892|64903900|FG000|Overall Study|Withdrawal by Subject|3|||
23316659|NCT01855828|64903904|FG000|Overall Study|Adverse Event|1|||
23316660|NCT01855828|64903904|FG000|Overall Study|Withdrawal by Subject|1|||
23316661|NCT00948155|64903905|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
23316662|NCT00948155|64903906|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
23316663|NCT00948155|64903905|FG000|Washout 14 Days|Lost to Follow-up|1|||
23316664|NCT00948155|64903906|FG001|Washout 14 Days|Lost to Follow-up|2|||
23316665|NCT03336528|64903907|FG000|Overall Study|Protocol Violation|1|||
23316666|NCT03336528|64903908|FG001|Overall Study|Protocol Violation|1|||
23316667|NCT03336528|64903907|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
23316668|NCT03336528|64903908|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
23316669|NCT03336528|64903907|FG000|Overall Study|Did not receive study medication|1|||
23316670|NCT03336528|64903908|FG001|Overall Study|Did not receive study medication|2|||
23316671|NCT01682811|64903915|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23316672|NCT01682811|64903916|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23316673|NCT01682811|64903917|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23316674|NCT01682811|64903918|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23316675|NCT01682811|64903919|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
23316676|NCT01682811|64903920|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23316677|NCT01682811|64903921|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
23316678|NCT01682811|64903915|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
23316679|NCT01682811|64903916|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
23316680|NCT01682811|64903917|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
23316681|NCT01682811|64903918|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
23316682|NCT01682811|64903919|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
23316683|NCT01682811|64903920|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
23316684|NCT01682811|64903921|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
23316685|NCT01682811|64903915|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
23316686|NCT01682811|64903916|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
23316687|NCT01682811|64903917|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
23316688|NCT01682811|64903918|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
23316689|NCT01682811|64903919|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
23316690|NCT01682811|64903920|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
23316691|NCT01682811|64903921|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
23316692|NCT01682811|64903915|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
23316693|NCT01682811|64903916|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
23316694|NCT01682811|64903917|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
23316695|NCT01682811|64903918|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
23316696|NCT01682811|64903919|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
23316697|NCT01682811|64903920|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
23316698|NCT01682811|64903921|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
23316699|NCT01118975|64903927|FG000|Overall Study|Adverse Event|0|||
23426731|NCT00882908|65307442|FG000|Overall Study|Lost to Follow-up|3|||
23426732|NCT00882908|65307443|FG001|Overall Study|Lost to Follow-up|5|||
23426733|NCT00882908|65307444|FG002|Overall Study|Lost to Follow-up|3|||
23426734|NCT00882908|65307445|FG003|Overall Study|Lost to Follow-up|1|||
23426735|NCT00882908|65307446|FG004|Overall Study|Lost to Follow-up|2|||
23426736|NCT00882908|65307442|FG000|Overall Study|Protocol Violation|0|||
23426737|NCT00882908|65307443|FG001|Overall Study|Protocol Violation|1|||
23426738|NCT00882908|65307444|FG002|Overall Study|Protocol Violation|0|||
23426739|NCT00882908|65307445|FG003|Overall Study|Protocol Violation|0|||
23426740|NCT00882908|65307446|FG004|Overall Study|Protocol Violation|0|||
23426741|NCT00882908|65307442|FG000|Overall Study|Withdrawal by Subject|0|||
23426742|NCT00882908|65307443|FG001|Overall Study|Withdrawal by Subject|0|||
23316700|NCT01118975|64903928|FG001|Overall Study|Adverse Event|1|||
23316701|NCT01450683|64903931|FG000|Overall Study|Adverse Event|2|||
23316702|NCT00995774|64903934|FG000|Training Period 2|Withdrawal by Subject|2|||
23316703|NCT00995774|64903935|FG001|Training Period 2|Withdrawal by Subject|0|||
23316704|NCT00061932|64903938|FG000|Overall Study|Withdrawal by Subject|13|||
23316705|NCT00061932|64903939|FG001|Overall Study|Withdrawal by Subject|4|||
23316706|NCT01144715|64903940|FG000|Overall Study|Lost to Follow-up|2|||
23426743|NCT00882908|65307444|FG002|Overall Study|Withdrawal by Subject|3|||
23426744|NCT00882908|65307445|FG003|Overall Study|Withdrawal by Subject|5|||
23316707|NCT01144715|64903941|FG001|Overall Study|Lost to Follow-up|1|||
23316708|NCT01144715|64903940|FG000|Overall Study|Withdrawal by Subject|2|||
23426745|NCT00882908|65307446|FG004|Overall Study|Withdrawal by Subject|2|||
23426746|NCT00882908|65307442|FG000|Overall Study|Subject reached a virologic endpoint|0|||
23426747|NCT00882908|65307443|FG001|Overall Study|Subject reached a virologic endpoint|0|||
23545476|NCT03550313|65727208|FG000|Overall Study|Adverse Event|0|||
23426748|NCT00882908|65307444|FG002|Overall Study|Subject reached a virologic endpoint|0|||
23426749|NCT00882908|65307445|FG003|Overall Study|Subject reached a virologic endpoint|0|||
23128327|NCT01475461|64218777|FG005|Run-in Period|Protocol Violation|0|||
23128328|NCT01475461|64218778|FG006|Run-in Period|Protocol Violation|0|||
23128329|NCT01475461|64218772|FG000|Treatment Period|Death|0|||
23128330|NCT01475461|64218773|FG001|Treatment Period|Death|0|||
23128331|NCT01475461|64218774|FG002|Treatment Period|Death|0|||
23128332|NCT01475461|64218775|FG003|Treatment Period|Death|1|||
23128333|NCT01475461|64218776|FG004|Treatment Period|Death|0|||
23128334|NCT01475461|64218777|FG005|Treatment Period|Death|0|||
23128335|NCT01475461|64218778|FG006|Treatment Period|Death|0|||
23128336|NCT01475461|64218772|FG000|Treatment Period|Lost to Follow-up|0|||
23128337|NCT01475461|64218773|FG001|Treatment Period|Lost to Follow-up|3|||
23128338|NCT01475461|64218774|FG002|Treatment Period|Lost to Follow-up|2|||
23618572|NCT01040403|65988335|FG000|Overall Study|Lost to Follow-up|1|||
23618573|NCT01040403|65988335|FG000|Overall Study|Not treated|1|||
23618574|NCT01040403|65988335|FG000|Overall Study|Other reason not defined above|6|||
23618575|NCT02777242|65988336|FG000|Overall Study|Other|2|||
23618576|NCT02777242|65988336|FG000|Overall Study|Lost to Follow-up|1|||
23618577|NCT02777242|65988336|FG000|Overall Study|Multiple|1|||
23618578|NCT02777242|65988336|FG000|Overall Study|Sponsor's request|1|||
23618579|NCT02777242|65988336|FG000|Overall Study|Withdrawal by Subject|1|||
23618580|NCT03303521|65988337|FG000|Overall Study|Withdrawal by Subject|2|||
23618581|NCT03303521|65988338|FG001|Overall Study|Withdrawal by Subject|0|||
23618582|NCT03303521|65988337|FG000|Overall Study|Death|1|||
23545477|NCT03550313|65727209|FG001|Overall Study|Adverse Event|1|||
23545478|NCT03550313|65727210|FG002|Overall Study|Adverse Event|0|||
23545479|NCT03550313|65727208|FG000|Overall Study|Lost to Follow-up|5|||
23128339|NCT01475461|64218775|FG003|Treatment Period|Lost to Follow-up|3|||
23128340|NCT01475461|64218776|FG004|Treatment Period|Lost to Follow-up|1|||
23128341|NCT01475461|64218777|FG005|Treatment Period|Lost to Follow-up|2|||
23128342|NCT01475461|64218778|FG006|Treatment Period|Lost to Follow-up|1|||
23128343|NCT01475461|64218772|FG000|Treatment Period|Withdrawal by Subject|0|||
23128344|NCT01475461|64218773|FG001|Treatment Period|Withdrawal by Subject|2|||
23128345|NCT01475461|64218774|FG002|Treatment Period|Withdrawal by Subject|2|||
23128346|NCT01475461|64218775|FG003|Treatment Period|Withdrawal by Subject|0|||
23128347|NCT01475461|64218776|FG004|Treatment Period|Withdrawal by Subject|2|||
23128348|NCT01475461|64218777|FG005|Treatment Period|Withdrawal by Subject|2|||
23128349|NCT01475461|64218778|FG006|Treatment Period|Withdrawal by Subject|0|||
23545480|NCT03550313|65727209|FG001|Overall Study|Lost to Follow-up|7|||
23545481|NCT03550313|65727210|FG002|Overall Study|Lost to Follow-up|12|||
23545482|NCT03550313|65727208|FG000|Overall Study|Study terminated by sponsor|44|||
23545483|NCT03550313|65727209|FG001|Overall Study|Study terminated by sponsor|37|||
23545484|NCT03550313|65727210|FG002|Overall Study|Study terminated by sponsor|48|||
23545485|NCT03550313|65727208|FG000|Overall Study|No longer met eligibility criteria|3|||
23545486|NCT03550313|65727209|FG001|Overall Study|No longer met eligibility criteria|5|||
23128350|NCT01475461|64218772|FG000|Treatment Period|Other|0|||
23128351|NCT01475461|64218773|FG001|Treatment Period|Other|1|||
23128352|NCT01475461|64218774|FG002|Treatment Period|Other|0|||
23128353|NCT01475461|64218775|FG003|Treatment Period|Other|0|||
23128354|NCT01475461|64218776|FG004|Treatment Period|Other|0|||
23128355|NCT01475461|64218777|FG005|Treatment Period|Other|0|||
23128356|NCT01475461|64218778|FG006|Treatment Period|Other|0|||
23128357|NCT01475461|64218772|FG000|Treatment Period|Protocol Violation|0|||
23128358|NCT01475461|64218773|FG001|Treatment Period|Protocol Violation|1|||
23128359|NCT01475461|64218774|FG002|Treatment Period|Protocol Violation|0|||
23128360|NCT01475461|64218775|FG003|Treatment Period|Protocol Violation|0|||
23128361|NCT01475461|64218776|FG004|Treatment Period|Protocol Violation|0|||
23426750|NCT00882908|65307446|FG004|Overall Study|Subject reached a virologic endpoint|1|||
23545487|NCT03550313|65727210|FG002|Overall Study|No longer met eligibility criteria|6|||
23545488|NCT03550313|65727208|FG000|Overall Study|Withdrawal by parent/guardian|20|||
23545489|NCT03550313|65727209|FG001|Overall Study|Withdrawal by parent/guardian|18|||
23545490|NCT03550313|65727210|FG002|Overall Study|Withdrawal by parent/guardian|26|||
23618583|NCT03303521|65988338|FG001|Overall Study|Death|0|||
23128362|NCT01475461|64218777|FG005|Treatment Period|Protocol Violation|0|||
23128363|NCT01475461|64218778|FG006|Treatment Period|Protocol Violation|1|||
23128364|NCT01475461|64218772|FG000|Treatment Period|Lack of Efficacy|0|||
23128365|NCT01475461|64218773|FG001|Treatment Period|Lack of Efficacy|2|||
23128366|NCT01475461|64218774|FG002|Treatment Period|Lack of Efficacy|0|||
23128367|NCT01475461|64218775|FG003|Treatment Period|Lack of Efficacy|2|||
23128368|NCT01475461|64218776|FG004|Treatment Period|Lack of Efficacy|1|||
23618584|NCT03303521|65988337|FG000|Overall Study|Kidney transplantation|0|||
23618585|NCT03303521|65988338|FG001|Overall Study|Kidney transplantation|1|||
23618586|NCT03303521|65988337|FG000|Overall Study|Investigational product discontinuation|0|||
23128369|NCT01475461|64218777|FG005|Treatment Period|Lack of Efficacy|1|||
23128370|NCT01475461|64218778|FG006|Treatment Period|Lack of Efficacy|0|||
23128371|NCT01475461|64218772|FG000|Treatment Period|Medication Error|0|||
23128372|NCT01475461|64218773|FG001|Treatment Period|Medication Error|0|||
23545491|NCT03550313|65727208|FG000|Overall Study|Other|4|||
23545492|NCT03550313|65727209|FG001|Overall Study|Other|2|||
23545493|NCT03550313|65727210|FG002|Overall Study|Other|2|||
23545494|NCT03550313|65727208|FG000|Overall Study|Randomized but not vaccinated|3|||
23545495|NCT03550313|65727209|FG001|Overall Study|Randomized but not vaccinated|23|||
23545496|NCT03550313|65727210|FG002|Overall Study|Randomized but not vaccinated|2|||
23545497|NCT03550313|65727208|FG000|Overall Study|Sites terminated due to quality issues|18|||
23545498|NCT03550313|65727209|FG001|Overall Study|Sites terminated due to quality issues|17|||
23545499|NCT03550313|65727210|FG002|Overall Study|Sites terminated due to quality issues|18|||
23545500|NCT04401579|65727211|FG000|Overall Study|Death|23|||
23618587|NCT03303521|65988338|FG001|Overall Study|Investigational product discontinuation|1|||
23618588|NCT03303521|65988337|FG000|Overall Study|Transferred to non-study dialysis center|1|||
23618589|NCT03303521|65988338|FG001|Overall Study|Transferred to non-study dialysis center|0|||
23618590|NCT03303521|65988337|FG000|Overall Study|Non-comliance to study protocol|0|||
23618591|NCT03303521|65988338|FG001|Overall Study|Non-comliance to study protocol|1|||
23618592|NCT03303521|65988337|FG000|Overall Study|Adverse Event|1|||
23128373|NCT01475461|64218774|FG002|Treatment Period|Medication Error|0|||
23545501|NCT04401579|65727212|FG001|Overall Study|Death|36|||
23545502|NCT04401579|65727211|FG000|Overall Study|Lost to Follow-up|40|||
23545503|NCT04401579|65727212|FG001|Overall Study|Lost to Follow-up|41|||
23545504|NCT04401579|65727211|FG000|Overall Study|Withdrawal by Subject|8|||
23545505|NCT04401579|65727212|FG001|Overall Study|Withdrawal by Subject|16|||
23545506|NCT04401579|65727211|FG000|Overall Study|Physician Decision|1|||
23545507|NCT04401579|65727212|FG001|Overall Study|Physician Decision|2|||
23545508|NCT04401579|65727211|FG000|Overall Study|Became ineligible after enrollment|1|||
23545509|NCT04401579|65727212|FG001|Overall Study|Became ineligible after enrollment|1|||
23545510|NCT04401579|65727211|FG000|Overall Study|Enrolled but treatment not administered|7|||
23545511|NCT04401579|65727212|FG001|Overall Study|Enrolled but treatment not administered|9|||
23545512|NCT04401579|65727211|FG000|Overall Study|Adverse Event|2|||
23545513|NCT04401579|65727212|FG001|Overall Study|Adverse Event|1|||
23545514|NCT04401579|65727211|FG000|Overall Study|Scheduling error|1|||
23545515|NCT04401579|65727212|FG001|Overall Study|Scheduling error|2|||
23545516|NCT04401579|65727211|FG000|Overall Study|Transferred to another hospital|1|||
23128374|NCT01475461|64218775|FG003|Treatment Period|Medication Error|1|||
23128375|NCT01475461|64218776|FG004|Treatment Period|Medication Error|0|||
23128376|NCT01475461|64218777|FG005|Treatment Period|Medication Error|0|||
23128377|NCT01475461|64218778|FG006|Treatment Period|Medication Error|0|||
23128378|NCT01475461|64218772|FG000|Treatment Period|Adverse Event|0|||
23128379|NCT01475461|64218773|FG001|Treatment Period|Adverse Event|0|||
23128380|NCT01475461|64218774|FG002|Treatment Period|Adverse Event|0|||
23128381|NCT01475461|64218775|FG003|Treatment Period|Adverse Event|1|||
23128382|NCT01475461|64218776|FG004|Treatment Period|Adverse Event|0|||
23128383|NCT01475461|64218777|FG005|Treatment Period|Adverse Event|0|||
23128384|NCT01475461|64218778|FG006|Treatment Period|Adverse Event|0|||
23128385|NCT00822770|64218779|FG000|Overall Study|Not treated|1|||
23128386|NCT00822770|64218780|FG001|Overall Study|Not treated|0|||
23128387|NCT00822770|64218779|FG000|Overall Study|Complication/Incomplete treatment|1|||
23128388|NCT00822770|64218780|FG001|Overall Study|Complication/Incomplete treatment|0|||
23128389|NCT00822770|64218779|FG000|Overall Study|Death|1|||
23128390|NCT00822770|64218780|FG001|Overall Study|Death|1|||
23128391|NCT01399918|64218791|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
23128392|NCT01371825|64218792|FG000|Overall Study|Death|4|||
23128393|NCT00245960|64218795|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
23128394|NCT00245960|64218796|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
23128395|NCT00245960|64218795|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
23128396|NCT00245960|64218796|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
23128397|NCT00245960|64218795|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
23128398|NCT00245960|64218796|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
23128399|NCT00245960|64218795|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
23128400|NCT00245960|64218796|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
23128401|NCT00245960|64218795|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
23128402|NCT00245960|64218796|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
23128403|NCT00245960|64218795|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
23128404|NCT00245960|64218796|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
23545517|NCT04401579|65727212|FG001|Overall Study|Transferred to another hospital|2|||
23545518|NCT01435577|65727215|FG000|Overall Study|Adverse Event|10|||
23545519|NCT01435577|65727216|FG001|Overall Study|Adverse Event|0|||
23618593|NCT03303521|65988338|FG001|Overall Study|Adverse Event|0|||
23545520|NCT01435577|65727215|FG000|Overall Study|Lack of Efficacy|7|||
23128405|NCT00245960|64218795|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
23128406|NCT00245960|64218796|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
23128407|NCT00245960|64218795|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
23128408|NCT00245960|64218796|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
23128409|NCT00245960|64218795|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
23545521|NCT01435577|65727216|FG001|Overall Study|Lack of Efficacy|51|||
23545522|NCT01435577|65727215|FG000|Overall Study|Alternative treatment started|0|||
23545523|NCT01435577|65727216|FG001|Overall Study|Alternative treatment started|1|||
23545524|NCT04179032|65727217|FG000|Part B (Up to Week 52)|Adverse Event|1|||
23545525|NCT04179032|65727217|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
23545526|NCT04179032|65727217|FG000|Access Extension Phase|Ongoing|11|||
23545527|NCT01314118|65727219|FG000|Overall Study|Adverse Event|9|||
23545528|NCT01314118|65727219|FG000|Overall Study|Progressive disease|27|||
23545529|NCT01314118|65727219|FG000|Overall Study|Physician Decision|11|||
23545530|NCT01314118|65727219|FG000|Overall Study|Death|4|||
23545531|NCT01314118|65727219|FG000|Overall Study|Protocol Violation|5|||
23545532|NCT01314118|65727219|FG000|Overall Study|Withdrawal by Subject|11|||
23545533|NCT01314118|65727219|FG000|Overall Study|Other|2|||
23545534|NCT01314118|65727219|FG000|Overall Study|Ongoing|62|||
23545535|NCT01767116|65727220|FG000|Overall Study|Lost to Follow-up|2|||
23545536|NCT01767116|65727221|FG001|Overall Study|Lost to Follow-up|2|||
23545537|NCT02352948|65727222|FG000|Overall Study|Death|47|||
23545538|NCT02352948|65727223|FG001|Overall Study|Death|48|||
23545539|NCT02352948|65727224|FG002|Overall Study|Death|114|||
23545540|NCT02352948|65727225|FG003|Overall Study|Death|74|||
23545541|NCT02352948|65727226|FG004|Overall Study|Death|77|||
23545542|NCT02352948|65727227|FG005|Overall Study|Death|44|||
23545543|NCT02352948|65727222|FG000|Overall Study|Lost to Follow-up|1|||
23545544|NCT02352948|65727223|FG001|Overall Study|Lost to Follow-up|0|||
23545545|NCT02352948|65727224|FG002|Overall Study|Lost to Follow-up|2|||
23545546|NCT02352948|65727225|FG003|Overall Study|Lost to Follow-up|1|||
23545547|NCT02352948|65727226|FG004|Overall Study|Lost to Follow-up|2|||
23545548|NCT02352948|65727227|FG005|Overall Study|Lost to Follow-up|1|||
23545549|NCT02352948|65727222|FG000|Overall Study|Withdrawal by Subject|1|||
23545550|NCT02352948|65727223|FG001|Overall Study|Withdrawal by Subject|10|||
23545551|NCT02352948|65727224|FG002|Overall Study|Withdrawal by Subject|11|||
23545552|NCT02352948|65727225|FG003|Overall Study|Withdrawal by Subject|23|||
23545553|NCT02352948|65727226|FG004|Overall Study|Withdrawal by Subject|9|||
23545554|NCT02352948|65727227|FG005|Overall Study|Withdrawal by Subject|4|||
23545555|NCT02352948|65727222|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23545556|NCT02352948|65727223|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23545557|NCT02352948|65727224|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23545558|NCT02352948|65727225|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23545559|NCT02352948|65727226|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
23545560|NCT02352948|65727227|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
23545561|NCT02352948|65727222|FG000|Overall Study|Other|0|||
23545562|NCT02352948|65727223|FG001|Overall Study|Other|0|||
23545563|NCT02352948|65727224|FG002|Overall Study|Other|2|||
23545564|NCT02352948|65727225|FG003|Overall Study|Other|0|||
23545565|NCT02352948|65727226|FG004|Overall Study|Other|0|||
23545566|NCT02352948|65727227|FG005|Overall Study|Other|0|||
23545567|NCT03264989|65727228|FG000|Overall Study|Lost to Follow-up|1|||
23545568|NCT03264989|65727229|FG001|Overall Study|Lost to Follow-up|0|||
23545569|NCT03264989|65727228|FG000|Overall Study|New Therapy for study Indication|1|||
23545570|NCT03264989|65727229|FG001|Overall Study|New Therapy for study Indication|0|||
23545571|NCT03264989|65727228|FG000|Overall Study|Protocol Violation|0|||
23545572|NCT03264989|65727229|FG001|Overall Study|Protocol Violation|1|||
23545573|NCT03264989|65727228|FG000|Overall Study|Patient decision|13|||
23545574|NCT03264989|65727229|FG001|Overall Study|Patient decision|0|||
23545575|NCT03264989|65727228|FG000|Overall Study|Physician Decision|6|||
23545576|NCT03264989|65727229|FG001|Overall Study|Physician Decision|4|||
23545577|NCT03264989|65727228|FG000|Overall Study|Adverse Event|2|||
23545578|NCT03264989|65727229|FG001|Overall Study|Adverse Event|1|||
23545579|NCT03264989|65727228|FG000|Overall Study|Death|1|||
23545580|NCT03264989|65727229|FG001|Overall Study|Death|1|||
23545581|NCT03264989|65727228|FG000|Overall Study|Pregnancy|2|||
23545582|NCT03264989|65727229|FG001|Overall Study|Pregnancy|0|||
23545583|NCT03264989|65727228|FG000|Overall Study|End of Study|19|||
23545584|NCT03264989|65727229|FG001|Overall Study|End of Study|5|||
23545585|NCT03336619|65727230|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
23545586|NCT03336619|65727231|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
23545587|NCT03336619|65727230|FG000|Overall Study|Withdrawal by Subject|17|||
23545588|NCT03336619|65727231|FG001|Overall Study|Withdrawal by Subject|16|||
23545589|NCT03336619|65727230|FG000|Overall Study|Adverse Event|2|||
23545590|NCT03336619|65727231|FG001|Overall Study|Adverse Event|5|||
23545591|NCT03336619|65727230|FG000|Overall Study|Physician Decision|3|||
23545592|NCT03336619|65727231|FG001|Overall Study|Physician Decision|0|||
23545593|NCT04782323|65727234|FG000|Overall Study|Death|1|||
23545594|NCT04782323|65727235|FG001|Overall Study|Death|0|||
23545595|NCT04782323|65727236|FG002|Overall Study|Death|0|||
23545596|NCT04782323|65727237|FG003|Overall Study|Death|0|||
23545597|NCT04782323|65727238|FG004|Overall Study|Death|1|||
23545598|NCT04782323|65727239|FG005|Overall Study|Death|1|||
23545599|NCT04782323|65727240|FG006|Overall Study|Death|1|||
23545600|NCT04782323|65727241|FG007|Overall Study|Death|0|||
23545601|NCT04782323|65727234|FG000|Overall Study|Withdrawal by Subject|0|||
23545602|NCT04782323|65727235|FG001|Overall Study|Withdrawal by Subject|0|||
23545603|NCT04782323|65727236|FG002|Overall Study|Withdrawal by Subject|1|||
23545604|NCT04782323|65727237|FG003|Overall Study|Withdrawal by Subject|0|||
23545605|NCT04782323|65727238|FG004|Overall Study|Withdrawal by Subject|0|||
23545606|NCT04782323|65727239|FG005|Overall Study|Withdrawal by Subject|1|||
23545607|NCT04782323|65727240|FG006|Overall Study|Withdrawal by Subject|0|||
23545608|NCT04782323|65727241|FG007|Overall Study|Withdrawal by Subject|1|||
23545609|NCT04782323|65727234|FG000|Overall Study|Lost to Follow-up|0|||
23545610|NCT04782323|65727235|FG001|Overall Study|Lost to Follow-up|1|||
23545611|NCT04782323|65727236|FG002|Overall Study|Lost to Follow-up|1|||
23545612|NCT04782323|65727237|FG003|Overall Study|Lost to Follow-up|0|||
23545613|NCT04782323|65727238|FG004|Overall Study|Lost to Follow-up|0|||
23545614|NCT04782323|65727239|FG005|Overall Study|Lost to Follow-up|1|||
23545615|NCT04782323|65727240|FG006|Overall Study|Lost to Follow-up|1|||
23545616|NCT04782323|65727241|FG007|Overall Study|Lost to Follow-up|2|||
23545617|NCT04782323|65727234|FG000|Overall Study|randomization in error|1|||
23545618|NCT04782323|65727235|FG001|Overall Study|randomization in error|0|||
23545619|NCT04782323|65727236|FG002|Overall Study|randomization in error|0|||
23545620|NCT04782323|65727237|FG003|Overall Study|randomization in error|0|||
23545621|NCT04782323|65727238|FG004|Overall Study|randomization in error|0|||
23545622|NCT04782323|65727239|FG005|Overall Study|randomization in error|0|||
23545623|NCT04782323|65727240|FG006|Overall Study|randomization in error|0|||
23128410|NCT00245960|64218796|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
23128411|NCT00245960|64218795|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
23128412|NCT00245960|64218796|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
23128413|NCT00245960|64218795|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
23128414|NCT00245960|64218796|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
23212632|NCT03084718|64519721|FG000|Overall Study|Withdrawal by Subject|4|||
23128415|NCT00245960|64218795|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
23128416|NCT00245960|64218796|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
23128417|NCT00581477|64218797|FG000|Overall Study|Physician Decision|2|||
23128418|NCT01417104|64218802|FG000|Overall Study|Withdrawal by Subject|5|||
23128419|NCT01417104|64218803|FG001|Overall Study|Withdrawal by Subject|1|||
23128420|NCT01417104|64218802|FG000|Overall Study|Failure to make contact|0|||
23128421|NCT01417104|64218803|FG001|Overall Study|Failure to make contact|1|||
23128422|NCT01417104|64218802|FG000|Overall Study|Adverse Event|1|||
23128423|NCT01417104|64218803|FG001|Overall Study|Adverse Event|0|||
23128424|NCT01735175|64218804|FG000|Overall Study|Withdrawal by Subject|9|||
23128425|NCT01735175|64218805|FG001|Overall Study|Withdrawal by Subject|2|||
23128426|NCT01735175|64218804|FG000|Overall Study|Lost to Follow-up|4|||
23128427|NCT01735175|64218805|FG001|Overall Study|Lost to Follow-up|2|||
23128428|NCT01735175|64218804|FG000|Overall Study|Death|3|||
23128429|NCT01735175|64218805|FG001|Overall Study|Death|2|||
23128430|NCT01735175|64218804|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
23128431|NCT01735175|64218805|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
23128432|NCT01747551|64218806|FG000|Overall Study|Progressive Disease|24|||
23212633|NCT03084718|64519722|FG001|Overall Study|Withdrawal by Subject|3|||
23212634|NCT03084718|64519723|FG002|Overall Study|Withdrawal by Subject|4|||
23212635|NCT03084718|64519724|FG003|Overall Study|Withdrawal by Subject|0|||
23212636|NCT03084718|64519725|FG004|Overall Study|Withdrawal by Subject|0|||
23212637|NCT03084718|64519721|FG000|Overall Study|Physician Decision|1|||
23212638|NCT03084718|64519722|FG001|Overall Study|Physician Decision|0|||
23212639|NCT03084718|64519723|FG002|Overall Study|Physician Decision|0|||
23212640|NCT03084718|64519724|FG003|Overall Study|Physician Decision|0|||
23212641|NCT03084718|64519725|FG004|Overall Study|Physician Decision|0|||
23212642|NCT03084718|64519721|FG000|Overall Study|Adverse Event|3|||
23212643|NCT03084718|64519722|FG001|Overall Study|Adverse Event|5|||
23212644|NCT03084718|64519723|FG002|Overall Study|Adverse Event|5|||
23212645|NCT03084718|64519724|FG003|Overall Study|Adverse Event|8|||
23212646|NCT03084718|64519725|FG004|Overall Study|Adverse Event|2|||
23212647|NCT03084718|64519721|FG000|Overall Study|Lack of Efficacy|2|||
23545624|NCT04782323|65727241|FG007|Overall Study|randomization in error|0|||
23545625|NCT01627249|65727242|FG000|Overall Study|Death|3|||
23545626|NCT01627249|65727243|FG001|Overall Study|Death|5|||
23545627|NCT01627249|65727244|FG002|Overall Study|Death|3|||
23545628|NCT01627249|65727242|FG000|Overall Study|Withdrawal by Subject|12|||
23545629|NCT01627249|65727243|FG001|Overall Study|Withdrawal by Subject|6|||
23128433|NCT01747551|64218807|FG001|Overall Study|Progressive Disease|17|||
23128434|NCT01747551|64218806|FG000|Overall Study|Death|3|||
23128435|NCT01747551|64218807|FG001|Overall Study|Death|1|||
23128436|NCT01747551|64218806|FG000|Overall Study|Adverse Event|7|||
23128437|NCT01747551|64218807|FG001|Overall Study|Adverse Event|1|||
23128438|NCT01747551|64218806|FG000|Overall Study|Prolonged Treatment Delay|2|||
23128439|NCT01747551|64218807|FG001|Overall Study|Prolonged Treatment Delay|0|||
23545630|NCT01627249|65727244|FG002|Overall Study|Withdrawal by Subject|9|||
23212648|NCT03084718|64519722|FG001|Overall Study|Lack of Efficacy|0|||
23212649|NCT03084718|64519723|FG002|Overall Study|Lack of Efficacy|1|||
23212650|NCT03084718|64519724|FG003|Overall Study|Lack of Efficacy|4|||
23212651|NCT03084718|64519725|FG004|Overall Study|Lack of Efficacy|0|||
23212652|NCT03084718|64519721|FG000|Overall Study|Lost to Follow-up|0|||
23212653|NCT03084718|64519722|FG001|Overall Study|Lost to Follow-up|1|||
23212654|NCT03084718|64519723|FG002|Overall Study|Lost to Follow-up|0|||
23212655|NCT03084718|64519724|FG003|Overall Study|Lost to Follow-up|0|||
23212656|NCT03084718|64519725|FG004|Overall Study|Lost to Follow-up|2|||
23212657|NCT03084718|64519721|FG000|Overall Study|Protocol Violation|0|||
23212658|NCT03084718|64519722|FG001|Overall Study|Protocol Violation|0|||
23212659|NCT03084718|64519723|FG002|Overall Study|Protocol Violation|1|||
23212660|NCT03084718|64519724|FG003|Overall Study|Protocol Violation|0|||
23212661|NCT03084718|64519725|FG004|Overall Study|Protocol Violation|0|||
23212662|NCT03084718|64519721|FG000|Overall Study|Death|0|||
23212663|NCT03084718|64519722|FG001|Overall Study|Death|1|||
23212664|NCT03084718|64519723|FG002|Overall Study|Death|0|||
23212665|NCT03084718|64519724|FG003|Overall Study|Death|0|||
23212666|NCT03084718|64519725|FG004|Overall Study|Death|0|||
23212667|NCT03084718|64519721|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
23212668|NCT03084718|64519722|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
23212669|NCT03084718|64519723|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
23212670|NCT03084718|64519724|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
23212671|NCT03084718|64519725|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
23212672|NCT02029638|64519726|FG000|Overall Study|Death|0|||
23212673|NCT02029638|64519727|FG001|Overall Study|Death|0|||
23212674|NCT02029638|64519728|FG002|Overall Study|Death|1|||
23212675|NCT02029638|64519726|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
23212676|NCT02029638|64519727|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
23212677|NCT02029638|64519728|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
23212678|NCT00842361|64519729|FG000|Overall Study|Protocol Violation|1|||
23212679|NCT00842361|64519730|FG001|Overall Study|Protocol Violation|0|||
23212680|NCT00842361|64519729|FG000|Overall Study|Unclassified|0|||
23212681|NCT00842361|64519730|FG001|Overall Study|Unclassified|2|||
23212682|NCT01332019|64519731|FG000|Overall Study|Was Not Dosed|1|||
23212683|NCT01332019|64519732|FG001|Overall Study|Was Not Dosed|0|||
23212684|NCT01332019|64519731|FG000|Overall Study|Other|16|||
23212685|NCT01332019|64519732|FG001|Overall Study|Other|18|||
23212686|NCT01332019|64519731|FG000|Overall Study|Death|2|||
23212687|NCT01332019|64519732|FG001|Overall Study|Death|1|||
23212688|NCT01332019|64519731|FG000|Overall Study|Physician Decision|4|||
23212689|NCT01332019|64519732|FG001|Overall Study|Physician Decision|3|||
23128440|NCT01747551|64218806|FG000|Overall Study|Withdrawal by Subject|3|||
23128441|NCT01747551|64218807|FG001|Overall Study|Withdrawal by Subject|1|||
23128442|NCT01747551|64218806|FG000|Overall Study|Physician Decision|2|||
23128443|NCT01747551|64218807|FG001|Overall Study|Physician Decision|1|||
23128444|NCT01747551|64218806|FG000|Overall Study|Other|2|||
23128445|NCT01747551|64218807|FG001|Overall Study|Other|0|||
23545631|NCT01627249|65727242|FG000|Overall Study|Missed Visit|1|||
23545632|NCT01627249|65727243|FG001|Overall Study|Missed Visit|1|||
23545633|NCT01627249|65727244|FG002|Overall Study|Missed Visit|0|||
23545634|NCT04177758|65727245|FG000|Overall Study|Lost to Follow-up|19|||
23545635|NCT04177758|65727246|FG001|Overall Study|Lost to Follow-up|11|||
23545636|NCT03449030|65727247|FG000|Overall Study|Withdrawal by Subject|0|||
23545637|NCT03449030|65727248|FG001|Overall Study|Withdrawal by Subject|0|||
23128453|NCT00972322|64218809|FG000|Overall Study|Adverse Event|2|||
23128454|NCT00972322|64218810|FG001|Overall Study|Adverse Event|1|||
23128455|NCT00972322|64218809|FG000|Overall Study|Positive drug screen|0|||
23128456|NCT00972322|64218810|FG001|Overall Study|Positive drug screen|1|||
23128457|NCT00972322|64218809|FG000|Overall Study|Lost to Follow-up|0|||
23128458|NCT00972322|64218810|FG001|Overall Study|Lost to Follow-up|1|||
23128459|NCT00972322|64218809|FG000|Overall Study|Consistently high glucose values|1|||
23128460|NCT00972322|64218810|FG001|Overall Study|Consistently high glucose values|0|||
23128461|NCT00965497|64218811|FG000|Overall Study|Physician Decision|1|||
23128462|NCT03406078|64218813|FG000|Overall Study|Death|1|||
23128463|NCT03406078|64218814|FG001|Overall Study|Death|0|||
23212690|NCT01332019|64519731|FG000|Overall Study|Withdrawal by Subject|73|||
23212691|NCT01332019|64519732|FG001|Overall Study|Withdrawal by Subject|71|||
23212692|NCT01332019|64519731|FG000|Overall Study|Lost to Follow-up|4|||
23212693|NCT01332019|64519732|FG001|Overall Study|Lost to Follow-up|7|||
23212694|NCT01332019|64519731|FG000|Overall Study|Adverse Event|13|||
23212695|NCT01332019|64519732|FG001|Overall Study|Adverse Event|22|||
23128464|NCT03406078|64218813|FG000|Overall Study|Lost to Follow-up|0|||
23128465|NCT03406078|64218814|FG001|Overall Study|Lost to Follow-up|1|||
23128466|NCT03406078|64218813|FG000|Overall Study|Withdrawal by Subject|5|||
23128467|NCT03406078|64218814|FG001|Overall Study|Withdrawal by Subject|2|||
23212696|NCT00719953|64519736|FG000|Overall Study|Adverse Event|4|||
23545638|NCT03449030|65727249|FG002|Overall Study|Withdrawal by Subject|0|||
23212697|NCT01117012|64519737|FG000|Overall Study|Adverse Event|0|||
23212698|NCT01117012|64519738|FG001|Overall Study|Adverse Event|1|||
23212699|NCT01117012|64519737|FG000|Overall Study|Death|1|||
23128468|NCT02609672|64218815|FG000|Overall Study|Lost to Follow-up|3|||
23128469|NCT02609672|64218816|FG001|Overall Study|Lost to Follow-up|1|||
23128470|NCT02406677|64221944|FG000|Overall Study|Death|16|||
23128471|NCT02406677|64221945|FG001|Overall Study|Death|8|||
23128472|NCT02406677|64221944|FG000|Overall Study|Discharged without P2Y12|1|||
23128473|NCT02406677|64221945|FG001|Overall Study|Discharged without P2Y12|3|||
23128474|NCT02406677|64221944|FG000|Overall Study|Discharged on prasugrel|283|||
23128475|NCT02406677|64221945|FG001|Overall Study|Discharged on prasugrel|587|||
23128476|NCT02406677|64221944|FG000|Overall Study|Withdrawal by Subject|1|||
23128477|NCT02406677|64221945|FG001|Overall Study|Withdrawal by Subject|0|||
23128478|NCT01564277|64221946|FG000|Overall Study|Protocol Violation|0|||
23128479|NCT01564277|64221947|FG001|Overall Study|Protocol Violation|1|||
23128480|NCT01564277|64221946|FG000|Overall Study|Physician Decision|1|||
23128481|NCT01564277|64221947|FG001|Overall Study|Physician Decision|0|||
23128482|NCT01147536|64221950|FG000|Overall Study|Administrative study close|2|||
23128483|NCT01147536|64221950|FG000|Overall Study|Death|1|||
23128484|NCT02947100|64221951|FG000|Overall Study|study terminated early|3|||
23128485|NCT02947100|64221951|FG000|Overall Study|did not meet inclusion criteria|1|||
23128486|NCT00565773|64221952|FG000|Overall Study|Withdrawal by Subject|1|||
23212700|NCT01117012|64519738|FG001|Overall Study|Death|1|||
23212701|NCT01117012|64519737|FG000|Overall Study|Withdrawal by Subject|3|||
23212702|NCT01117012|64519738|FG001|Overall Study|Withdrawal by Subject|0|||
23618594|NCT03078751|65988339|FG000|Overall Study|Adverse Event|4|||
23618595|NCT03078751|65988340|FG001|Overall Study|Adverse Event|0|||
23618596|NCT03078751|65988339|FG000|Overall Study|Physician Decision|1|||
23618597|NCT03078751|65988340|FG001|Overall Study|Physician Decision|0|||
23618598|NCT03078751|65988339|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
23618599|NCT03078751|65988340|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
23618600|NCT03078751|65988339|FG000|Overall Study|Subject/guardian decision|8|||
23618601|NCT03078751|65988340|FG001|Overall Study|Subject/guardian decision|1|||
23618602|NCT03078751|65988339|FG000|Overall Study|Untreated|0|||
23618603|NCT03078751|65988340|FG001|Overall Study|Untreated|4|||
23618604|NCT01703988|65988341|FG000|Overall Study|Investigator Judgment|0|||
23618605|NCT01703988|65988342|FG001|Overall Study|Investigator Judgment|0|||
23618606|NCT01703988|65988343|FG002|Overall Study|Investigator Judgment|0|||
23618607|NCT01703988|65988344|FG003|Overall Study|Investigator Judgment|1|||
23618608|NCT02212301|65988345|FG000|Period 1|Lost to Follow-up|0|||
23618609|NCT02212301|65988346|FG001|Period 1|Lost to Follow-up|1|||
23618610|NCT02556918|65988349|FG000|Overall Study|Protocol Violation|5|||
23618611|NCT02556918|65988350|FG001|Overall Study|Protocol Violation|6|||
23618612|NCT02556918|65988349|FG000|Overall Study|Withdrawal by Subject|4|||
23618613|NCT02556918|65988350|FG001|Overall Study|Withdrawal by Subject|4|||
23618614|NCT02368691|65988351|FG000|Overall Study|Death|13|||
23618615|NCT02368691|65988351|FG000|Overall Study|Lack of Efficacy|15|||
23128487|NCT00565773|64221952|FG000|Overall Study|Physician Decision|1|||
23128488|NCT00426127|64221953|FG000|Overall Study|Adverse Event|1|||
23128489|NCT00426127|64221953|FG000|Overall Study|Removed due to disease progression|1|||
23128490|NCT02687035|64221954|FG000|Overall Study|Withdrawal by Subject|1|||
23128491|NCT02687035|64221954|FG000|Overall Study|Death|87|||
23128492|NCT02687035|64221954|FG000|Overall Study|Lost to Follow-up|1|||
23128493|NCT02687035|64221954|FG000|Overall Study|Missed Visit|87|||
23128494|NCT02687035|64221954|FG000|Overall Study|Did not receive Study Device|8|||
23128495|NCT02688530|64221955|FG000|Overall Study|Withdrawal by Subject|0|||
23128496|NCT02688530|64221956|FG001|Overall Study|Withdrawal by Subject|1|||
23128497|NCT02688530|64221957|FG002|Overall Study|Withdrawal by Subject|0|||
23128498|NCT02688530|64221958|FG003|Overall Study|Withdrawal by Subject|0|||
23128499|NCT02688530|64221955|FG000|Overall Study|Lost to Follow-up|0|||
23128500|NCT02688530|64221956|FG001|Overall Study|Lost to Follow-up|0|||
23128501|NCT02688530|64221957|FG002|Overall Study|Lost to Follow-up|2|||
23128502|NCT02688530|64221958|FG003|Overall Study|Lost to Follow-up|0|||
23212703|NCT01117012|64519737|FG000|Overall Study|Undefined|4|||
23212704|NCT01117012|64519738|FG001|Overall Study|Undefined|3|||
23618616|NCT02368691|65988351|FG000|Overall Study|Physician Decision|4|||
23618617|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
23618618|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
23128503|NCT00951015|64221962|FG000|Randomization Phase 96 Week|Adverse Event|1|||
23128504|NCT00951015|64221963|FG001|Randomization Phase 96 Week|Adverse Event|1|||
23128505|NCT00951015|64221964|FG002|Randomization Phase 96 Week|Adverse Event|2|||
23128506|NCT00951015|64221965|FG003|Randomization Phase 96 Week|Adverse Event|5|||
23128507|NCT00951015|64221966|FG004|Randomization Phase 96 Week|Adverse Event|0|||
23128508|NCT00951015|64221962|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
23128509|NCT00951015|64221963|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
23128510|NCT00951015|64221964|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
23212705|NCT00194025|64519739|FG000|Overall Study|Adverse Event|1|||
23618619|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
23618620|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
23618621|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
23618622|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
23618623|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
23618624|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
23618625|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
23618626|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
23618627|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
23618628|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
23618629|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
23618630|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
23618631|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
23618632|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
23618633|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
23618634|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
23618635|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
23618636|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
23618637|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
23618638|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
23618639|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
23128511|NCT00951015|64221965|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
23128512|NCT00951015|64221966|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
23128513|NCT00951015|64221962|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
23128514|NCT00951015|64221963|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
23545639|NCT03449030|65727250|FG003|Overall Study|Withdrawal by Subject|1|||
23545640|NCT03449030|65727251|FG004|Overall Study|Withdrawal by Subject|1|||
23545641|NCT03449030|65727252|FG005|Overall Study|Withdrawal by Subject|1|||
23545642|NCT03449030|65727253|FG006|Overall Study|Withdrawal by Subject|1|||
23545643|NCT03449030|65727254|FG007|Overall Study|Withdrawal by Subject|2|||
23128515|NCT00951015|64221964|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
23545644|NCT03449030|65727255|FG008|Overall Study|Withdrawal by Subject|0|||
23545645|NCT03449030|65727256|FG009|Overall Study|Withdrawal by Subject|0|||
23545646|NCT03449030|65727247|FG000|Overall Study|Symptomatic Deterioration|0|||
23545647|NCT03449030|65727248|FG001|Overall Study|Symptomatic Deterioration|1|||
23545648|NCT03449030|65727249|FG002|Overall Study|Symptomatic Deterioration|0|||
23128516|NCT00951015|64221965|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
23128517|NCT00951015|64221966|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
23545649|NCT03449030|65727250|FG003|Overall Study|Symptomatic Deterioration|0|||
23545650|NCT03449030|65727251|FG004|Overall Study|Symptomatic Deterioration|0|||
23545651|NCT03449030|65727252|FG005|Overall Study|Symptomatic Deterioration|1|||
23545652|NCT03449030|65727253|FG006|Overall Study|Symptomatic Deterioration|1|||
23545653|NCT03449030|65727254|FG007|Overall Study|Symptomatic Deterioration|0|||
23545654|NCT03449030|65727255|FG008|Overall Study|Symptomatic Deterioration|2|||
23545655|NCT03449030|65727256|FG009|Overall Study|Symptomatic Deterioration|0|||
23545656|NCT03449030|65727247|FG000|Overall Study|Progressive Disease|1|||
23618640|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
23128518|NCT00951015|64221962|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
23128519|NCT00951015|64221963|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
23128520|NCT00951015|64221964|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
23128521|NCT00951015|64221965|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
23128522|NCT00951015|64221966|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
23128523|NCT00951015|64221962|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
23128524|NCT00951015|64221963|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
23128525|NCT00951015|64221964|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
23128526|NCT00951015|64221965|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
23128527|NCT00951015|64221966|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
23128528|NCT00951015|64221962|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
23128529|NCT00951015|64221963|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
23128530|NCT00951015|64221964|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
23128531|NCT00951015|64221965|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
23316709|NCT01144715|64903941|FG001|Overall Study|Withdrawal by Subject|1|||
23545657|NCT03449030|65727248|FG001|Overall Study|Progressive Disease|0|||
23545658|NCT03449030|65727249|FG002|Overall Study|Progressive Disease|1|||
23545659|NCT03449030|65727250|FG003|Overall Study|Progressive Disease|4|||
23128532|NCT00951015|64221966|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
23545660|NCT03449030|65727251|FG004|Overall Study|Progressive Disease|5|||
23545661|NCT03449030|65727252|FG005|Overall Study|Progressive Disease|3|||
23545662|NCT03449030|65727253|FG006|Overall Study|Progressive Disease|0|||
23618641|NCT02269917|65988356|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
23618642|NCT02269917|65988357|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
23618643|NCT02269917|65988358|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
23618644|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
23618645|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
23618646|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
23618647|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
23618648|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
23618649|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
23618650|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
23618651|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
23618652|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
23618653|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
23618654|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
23618655|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
23618656|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
23316710|NCT01144715|64903940|FG000|Overall Study|Adverse Event|0|||
23316711|NCT01144715|64903941|FG001|Overall Study|Adverse Event|1|||
23316712|NCT00996892|64903942|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
23316713|NCT00996892|64903943|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
23545663|NCT03449030|65727254|FG007|Overall Study|Progressive Disease|1|||
23545664|NCT03449030|65727255|FG008|Overall Study|Progressive Disease|1|||
23545665|NCT03449030|65727256|FG009|Overall Study|Progressive Disease|1|||
23545666|NCT03449030|65727247|FG000|Overall Study|Adverse Event|0|||
23545667|NCT03449030|65727248|FG001|Overall Study|Adverse Event|0|||
23545668|NCT03449030|65727249|FG002|Overall Study|Adverse Event|0|||
23545669|NCT03449030|65727250|FG003|Overall Study|Adverse Event|0|||
23545670|NCT03449030|65727251|FG004|Overall Study|Adverse Event|0|||
23545671|NCT03449030|65727252|FG005|Overall Study|Adverse Event|2|||
23545672|NCT03449030|65727253|FG006|Overall Study|Adverse Event|0|||
23545673|NCT03449030|65727254|FG007|Overall Study|Adverse Event|0|||
23545674|NCT03449030|65727255|FG008|Overall Study|Adverse Event|0|||
23545675|NCT03449030|65727256|FG009|Overall Study|Adverse Event|0|||
23545676|NCT03449030|65727247|FG000|Overall Study|Death|0|||
23545677|NCT03449030|65727248|FG001|Overall Study|Death|0|||
23545678|NCT03449030|65727249|FG002|Overall Study|Death|0|||
23545679|NCT03449030|65727250|FG003|Overall Study|Death|0|||
23545680|NCT03449030|65727251|FG004|Overall Study|Death|1|||
23545681|NCT03449030|65727252|FG005|Overall Study|Death|0|||
23545682|NCT03449030|65727253|FG006|Overall Study|Death|0|||
23545683|NCT03449030|65727254|FG007|Overall Study|Death|0|||
23545684|NCT03449030|65727255|FG008|Overall Study|Death|0|||
23545685|NCT03449030|65727256|FG009|Overall Study|Death|0|||
23545686|NCT02416791|65727258|FG000|6 Months|Lost to Follow-up|0|||
23545687|NCT02416791|65727259|FG001|6 Months|Lost to Follow-up|0|||
23545688|NCT02416791|65727260|FG002|6 Months|Lost to Follow-up|1|||
23545689|NCT01218438|65727261|FG000|Epoch 1|Physician Decision|2|||
23545690|NCT01218438|65727261|FG000|Epoch 1|Adverse Event|1|||
23545691|NCT01218438|65727261|FG000|Epoch 3|Withdrawal by Subject|3|||
23545692|NCT01218438|65727261|FG000|Epoch 3|Adverse Event|1|||
23545693|NCT01218438|65727261|FG000|Epoch 4|Physician Decision|1|||
23545694|NCT01218438|65727261|FG000|Epoch 4|Withdrawal by Subject|2|||
23545695|NCT04389840|65727264|FG000|Overall Study|Adverse Event|0|||
23545696|NCT04389840|65727265|FG001|Overall Study|Adverse Event|0|||
23545697|NCT04389840|65727266|FG002|Overall Study|Adverse Event|0|||
23545698|NCT04389840|65727267|FG003|Overall Study|Adverse Event|1|||
23545699|NCT04389840|65727268|FG004|Overall Study|Adverse Event|0|||
23545700|NCT04389840|65727269|FG005|Overall Study|Adverse Event|0|||
23545701|NCT04389840|65727264|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
23545702|NCT04389840|65727265|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
23545703|NCT04389840|65727266|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
23545704|NCT04389840|65727267|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
23545705|NCT04389840|65727268|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
23545706|NCT04389840|65727269|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
23545707|NCT04389840|65727264|FG000|Overall Study|Death|0|||
23545708|NCT04389840|65727265|FG001|Overall Study|Death|1|||
23545709|NCT04389840|65727266|FG002|Overall Study|Death|0|||
23545710|NCT04389840|65727267|FG003|Overall Study|Death|0|||
23545711|NCT04389840|65727268|FG004|Overall Study|Death|0|||
23618657|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
23316714|NCT00996892|64903944|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
23618658|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
23545712|NCT04389840|65727269|FG005|Overall Study|Death|0|||
23545713|NCT04773587|65727272|FG000|Overall Study|Lost to Follow-up|11|||
23545714|NCT04773587|65727273|FG001|Overall Study|Lost to Follow-up|3|||
23545715|NCT04773587|65727272|FG000|Overall Study|Adverse Event|6|||
23545716|NCT04773587|65727273|FG001|Overall Study|Adverse Event|3|||
23316715|NCT00996892|64903945|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
23316716|NCT00996892|64903946|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
23316717|NCT00996892|64903947|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
23316718|NCT00996892|64903948|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
23316719|NCT00996892|64903949|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
23316720|NCT00996892|64903950|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
23316721|NCT00996892|64903951|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
23316722|NCT00996892|64903952|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
23316723|NCT00996892|64903953|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
23316724|NCT00996892|64903954|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
23316725|NCT00996892|64903955|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
23316726|NCT00996892|64903956|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
23128533|NCT00951015|64221962|FG000|Open-label Phase|Adverse Event|0|||
23128534|NCT00951015|64221963|FG001|Open-label Phase|Adverse Event|0|||
23128535|NCT00951015|64221964|FG002|Open-label Phase|Adverse Event|0|||
23128536|NCT00951015|64221965|FG003|Open-label Phase|Adverse Event|0|||
23316727|NCT00996892|64903957|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
23316728|NCT00996892|64903958|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
23128537|NCT00951015|64221966|FG004|Open-label Phase|Adverse Event|3|||
23128538|NCT00951015|64221962|FG000|Open-label Phase|Lack of Efficacy|0|||
23128539|NCT00951015|64221963|FG001|Open-label Phase|Lack of Efficacy|0|||
23128540|NCT00951015|64221964|FG002|Open-label Phase|Lack of Efficacy|0|||
23128541|NCT00951015|64221965|FG003|Open-label Phase|Lack of Efficacy|0|||
23128542|NCT00951015|64221966|FG004|Open-label Phase|Lack of Efficacy|1|||
23128543|NCT00951015|64221962|FG000|Open-label Phase|Protocol Violation|0|||
23128544|NCT00951015|64221963|FG001|Open-label Phase|Protocol Violation|0|||
23128545|NCT00951015|64221964|FG002|Open-label Phase|Protocol Violation|0|||
23128546|NCT00951015|64221965|FG003|Open-label Phase|Protocol Violation|0|||
23128547|NCT00951015|64221966|FG004|Open-label Phase|Protocol Violation|12|||
23128548|NCT00951015|64221962|FG000|Open-label Phase|Lost to Follow-up|0|||
23128549|NCT00951015|64221963|FG001|Open-label Phase|Lost to Follow-up|0|||
23128550|NCT00951015|64221964|FG002|Open-label Phase|Lost to Follow-up|0|||
23128551|NCT00951015|64221965|FG003|Open-label Phase|Lost to Follow-up|0|||
23128552|NCT00951015|64221966|FG004|Open-label Phase|Lost to Follow-up|12|||
23128553|NCT00951015|64221962|FG000|Open-label Phase|Withdrawal by Subject|0|||
23128554|NCT00951015|64221963|FG001|Open-label Phase|Withdrawal by Subject|0|||
23128555|NCT00951015|64221964|FG002|Open-label Phase|Withdrawal by Subject|0|||
23128556|NCT00951015|64221965|FG003|Open-label Phase|Withdrawal by Subject|0|||
23128557|NCT00951015|64221966|FG004|Open-label Phase|Withdrawal by Subject|14|||
23128558|NCT00951015|64221962|FG000|Open-label Phase|Physician Decision|0|||
23128559|NCT00951015|64221963|FG001|Open-label Phase|Physician Decision|0|||
23128560|NCT00951015|64221964|FG002|Open-label Phase|Physician Decision|0|||
23128561|NCT00951015|64221965|FG003|Open-label Phase|Physician Decision|0|||
23128562|NCT00951015|64221966|FG004|Open-label Phase|Physician Decision|8|||
23128563|NCT04942366|64221967|FG000|Overall Study|Withdrawal by Subject|5|||
23128564|NCT04942366|64221968|FG001|Overall Study|Withdrawal by Subject|5|||
23128565|NCT03149042|64221975|FG000|Overall Study|Invasive FFR not performed|21|||
23128566|NCT03149042|64221975|FG000|Overall Study|Poor CT Image Quality|1|||
23128567|NCT03149042|64221975|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
23128568|NCT02071290|64221978|FG000|Overall Study|Death|1|||
23128569|NCT02071290|64221979|FG001|Overall Study|Death|0|||
23128570|NCT02071290|64221978|FG000|Overall Study|Withdrawal by Subject|0|||
23128571|NCT02071290|64221979|FG001|Overall Study|Withdrawal by Subject|1|||
23128572|NCT02071290|64221978|FG000|Overall Study|Protocol Violation|3|||
23128573|NCT02071290|64221979|FG001|Overall Study|Protocol Violation|5|||
23128574|NCT02071290|64221978|FG000|Overall Study|Physician Decision|0|||
23128575|NCT02071290|64221979|FG001|Overall Study|Physician Decision|1|||
23128576|NCT01413503|64221981|FG000|Overall Study|Lost to Follow-up|1|||
23128577|NCT04531098|64221982|FG000|Stage I|Adverse Event|0|||
23212706|NCT00194025|64519739|FG000|Overall Study|non-adherence with study medication|4|||
23316729|NCT00996892|64903959|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
23316730|NCT00996892|64903960|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
23316731|NCT00996892|64903961|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
23316732|NCT00996892|64903942|FG000|Dose-Escalation Stage 1|Death|1|||
23545717|NCT04773587|65727272|FG000|Overall Study|Lack of Efficacy|5|||
23128578|NCT04531098|64221983|FG001|Stage I|Adverse Event|0|||
23128579|NCT04531098|64221984|FG002|Stage I|Adverse Event|3|||
23128580|NCT04531098|64221982|FG000|Stage I|Protocol Violation|0|||
23128581|NCT04531098|64221983|FG001|Stage I|Protocol Violation|0|||
23128582|NCT04531098|64221984|FG002|Stage I|Protocol Violation|5|||
23128583|NCT04531098|64221982|FG000|Stage I|Withdrawal by Subject|0|||
23128584|NCT04531098|64221983|FG001|Stage I|Withdrawal by Subject|5|||
23128585|NCT04531098|64221984|FG002|Stage I|Withdrawal by Subject|10|||
23128586|NCT04531098|64221982|FG000|Stage II|Adverse Event|1|||
23316733|NCT00996892|64903943|FG001|Dose-Escalation Stage 1|Death|0|||
23545718|NCT04773587|65727273|FG001|Overall Study|Lack of Efficacy|2|||
23545719|NCT04773587|65727272|FG000|Overall Study|Withdrawal by Subject|4|||
23545720|NCT04773587|65727273|FG001|Overall Study|Withdrawal by Subject|5|||
23128587|NCT04531098|64221983|FG001|Stage II|Adverse Event|2|||
23128588|NCT04531098|64221984|FG002|Stage II|Adverse Event|0|||
23128589|NCT04531098|64221982|FG000|Stage II|Protocol Violation|1|||
23128590|NCT04531098|64221983|FG001|Stage II|Protocol Violation|2|||
23128591|NCT04531098|64221984|FG002|Stage II|Protocol Violation|0|||
23128592|NCT04531098|64221982|FG000|Stage II|Withdrawal by Subject|3|||
23128593|NCT04531098|64221983|FG001|Stage II|Withdrawal by Subject|1|||
23128594|NCT04531098|64221984|FG002|Stage II|Withdrawal by Subject|0|||
23128595|NCT04531098|64221982|FG000|Stage II|Moved from study area|8|||
23128596|NCT04531098|64221983|FG001|Stage II|Moved from study area|5|||
23128597|NCT04531098|64221984|FG002|Stage II|Moved from study area|0|||
23128598|NCT04458922|64221985|FG000|Overall Study|Withdrawal by Subject|1|||
23128599|NCT04458922|64221986|FG001|Overall Study|Withdrawal by Subject|0|||
23128600|NCT04458922|64221987|FG002|Overall Study|Withdrawal by Subject|2|||
23128601|NCT04458922|64221985|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
23128602|NCT04458922|64221986|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
23128603|NCT04458922|64221987|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
23128604|NCT04458922|64221985|FG000|Overall Study|Adverse Event|1|||
23128605|NCT04458922|64221986|FG001|Overall Study|Adverse Event|0|||
23128606|NCT04458922|64221987|FG002|Overall Study|Adverse Event|0|||
23128607|NCT04458922|64221985|FG000|Overall Study|Started new study|0|||
23128608|NCT04458922|64221986|FG001|Overall Study|Started new study|0|||
23128609|NCT04458922|64221987|FG002|Overall Study|Started new study|1|||
23128610|NCT04458922|64221985|FG000|Overall Study|Progressive disease|6|||
23128611|NCT04458922|64221986|FG001|Overall Study|Progressive disease|8|||
23128612|NCT04458922|64221987|FG002|Overall Study|Progressive disease|2|||
23128613|NCT04458922|64221985|FG000|Overall Study|Death|1|||
23128614|NCT04458922|64221986|FG001|Overall Study|Death|0|||
23128615|NCT04458922|64221987|FG002|Overall Study|Death|2|||
23128616|NCT04458922|64221985|FG000|Overall Study|Participant started chemotherapy|0|||
23128617|NCT04458922|64221986|FG001|Overall Study|Participant started chemotherapy|1|||
23128618|NCT04458922|64221987|FG002|Overall Study|Participant started chemotherapy|0|||
23128619|NCT01443403|64221988|FG000|Overall Study|Adverse Event|1|||
23128620|NCT01443403|64221989|FG001|Overall Study|Adverse Event|1|||
23128621|NCT01443403|64221990|FG002|Overall Study|Adverse Event|4|||
23128622|NCT01443403|64221991|FG003|Overall Study|Adverse Event|5|||
23128623|NCT01443403|64221988|FG000|Overall Study|Withdrawal by Subject|0|||
23128624|NCT01443403|64221989|FG001|Overall Study|Withdrawal by Subject|1|||
23128625|NCT01443403|64221990|FG002|Overall Study|Withdrawal by Subject|2|||
23128626|NCT01443403|64221991|FG003|Overall Study|Withdrawal by Subject|1|||
23128627|NCT01443403|64221988|FG000|Overall Study|Lost to Follow-up|0|||
23128628|NCT01443403|64221989|FG001|Overall Study|Lost to Follow-up|0|||
23128629|NCT01443403|64221990|FG002|Overall Study|Lost to Follow-up|0|||
23128630|NCT01443403|64221991|FG003|Overall Study|Lost to Follow-up|1|||
23128631|NCT01443403|64221988|FG000|Overall Study|Protocol Violation|2|||
23128632|NCT01443403|64221989|FG001|Overall Study|Protocol Violation|1|||
23128633|NCT01443403|64221990|FG002|Overall Study|Protocol Violation|1|||
23128634|NCT01443403|64221991|FG003|Overall Study|Protocol Violation|1|||
23128635|NCT01443403|64221988|FG000|Overall Study|Use of Prohibited Treatment|2|||
23128636|NCT01443403|64221989|FG001|Overall Study|Use of Prohibited Treatment|3|||
23128637|NCT01443403|64221990|FG002|Overall Study|Use of Prohibited Treatment|0|||
23128638|NCT01443403|64221991|FG003|Overall Study|Use of Prohibited Treatment|0|||
23128639|NCT01443403|64221988|FG000|Overall Study|Other - Miscellaneous|1|||
23128640|NCT01443403|64221989|FG001|Overall Study|Other - Miscellaneous|0|||
23128641|NCT01443403|64221990|FG002|Overall Study|Other - Miscellaneous|0|||
23128642|NCT01443403|64221991|FG003|Overall Study|Other - Miscellaneous|1|||
23128643|NCT01793129|64221992|FG000|Overall Study|Lost to Follow-up|3|||
23128644|NCT01793129|64221993|FG001|Overall Study|Lost to Follow-up|7|||
23128645|NCT01793129|64221992|FG000|Overall Study|Withdrawal by Subject|0|||
23128646|NCT01793129|64221993|FG001|Overall Study|Withdrawal by Subject|2|||
23128647|NCT00552929|64221994|FG000|Overall Study|Lost to Follow-up|0|||
23128648|NCT00552929|64221995|FG001|Overall Study|Lost to Follow-up|0|||
23128649|NCT00552929|64221996|FG002|Overall Study|Lost to Follow-up|0|||
23128650|NCT00552929|64221997|FG003|Overall Study|Lost to Follow-up|0|||
23128651|NCT00552929|64221998|FG004|Overall Study|Lost to Follow-up|0|||
23128652|NCT00552929|64221999|FG005|Overall Study|Lost to Follow-up|0|||
23128653|NCT00552929|64222000|FG006|Overall Study|Lost to Follow-up|0|||
23128654|NCT00552929|64222001|FG007|Overall Study|Lost to Follow-up|0|||
23128655|NCT00552929|64222002|FG008|Overall Study|Lost to Follow-up|1|||
23128656|NCT00552929|64222003|FG009|Overall Study|Lost to Follow-up|0|||
23128657|NCT00552929|64221994|FG000|Overall Study|Not Eligible|0|||
23128658|NCT00552929|64221995|FG001|Overall Study|Not Eligible|0|||
23128659|NCT00552929|64221996|FG002|Overall Study|Not Eligible|0|||
23128660|NCT00552929|64221997|FG003|Overall Study|Not Eligible|0|||
23128661|NCT00552929|64221998|FG004|Overall Study|Not Eligible|0|||
23128662|NCT00552929|64221999|FG005|Overall Study|Not Eligible|1|||
23128663|NCT00552929|64222000|FG006|Overall Study|Not Eligible|0|||
23128664|NCT00552929|64222001|FG007|Overall Study|Not Eligible|0|||
23128665|NCT00552929|64222002|FG008|Overall Study|Not Eligible|0|||
23128666|NCT00552929|64222003|FG009|Overall Study|Not Eligible|0|||
23128667|NCT01850589|64222004|FG000|Overall Study|Withdrawal by Subject|8|||
23128668|NCT01850589|64222005|FG001|Overall Study|Withdrawal by Subject|0|||
23128669|NCT01020877|64222012|FG000|Second Intervention|Withdrawal by Subject|1|||
23128670|NCT01020877|64222013|FG001|Second Intervention|Withdrawal by Subject|0|||
23128671|NCT01088984|64222016|FG000|Phase 1|Death|2|||
23128672|NCT01088984|64222017|FG001|Phase 1|Death|1|||
23128673|NCT01088984|64222016|FG000|Phase 1|Disease Progression|2|||
23128674|NCT01088984|64222017|FG001|Phase 1|Disease Progression|4|||
23128675|NCT01088984|64222016|FG000|Phase 1|Other|1|||
23128676|NCT01088984|64222017|FG001|Phase 1|Other|1|||
23128677|NCT01088984|64222016|FG000|Phase 2|Death|0|||
23128678|NCT01088984|64222017|FG001|Phase 2|Death|5|||
23128679|NCT01088984|64222016|FG000|Phase 2|Withdrawal by Subject|0|||
23128680|NCT01088984|64222017|FG001|Phase 2|Withdrawal by Subject|1|||
23128681|NCT01088984|64222016|FG000|Phase 2|DIsease Progression|0|||
23128682|NCT01088984|64222017|FG001|Phase 2|DIsease Progression|25|||
23128683|NCT01088984|64222016|FG000|Phase 2|Other|0|||
23128684|NCT01088984|64222017|FG001|Phase 2|Other|1|||
23128685|NCT02737826|64222018|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
23128686|NCT02737826|64222019|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
23128687|NCT02737826|64222020|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
23128688|NCT01133418|64222021|FG000|Overall Study|Lost to Follow-up|5|||
23128689|NCT01133418|64222022|FG001|Overall Study|Lost to Follow-up|6|||
23128690|NCT02568397|64222023|FG000|Period 2|Withdrawal by Subject|0|||
23128691|NCT02568397|64222024|FG001|Period 2|Withdrawal by Subject|1|||
23128692|NCT02568397|64222023|FG000|Period 2|Physician Decision|0|||
23212707|NCT03505749|64519740|FG000|Overall Study|Lost to Follow-up|7|||
23212708|NCT03505749|64519741|FG001|Overall Study|Lost to Follow-up|11|||
23212709|NCT03505749|64519740|FG000|Overall Study|Withdrawal by Subject|6|||
23212710|NCT03505749|64519741|FG001|Overall Study|Withdrawal by Subject|0|||
23128693|NCT02568397|64222024|FG001|Period 2|Physician Decision|1|||
23128694|NCT00737698|64222025|FG000|Overall Study|Withdrawal by Subject|6|||
23128695|NCT00737698|64222026|FG001|Overall Study|Withdrawal by Subject|5|||
23128696|NCT00737698|64222027|FG002|Overall Study|Withdrawal by Subject|3|||
23128697|NCT00737698|64222025|FG000|Overall Study|Death|0|||
23128698|NCT00737698|64222026|FG001|Overall Study|Death|0|||
23128699|NCT00737698|64222027|FG002|Overall Study|Death|1|||
23128700|NCT00387426|64222028|FG000|Overall Study|Lack of Response|7|||
23128701|NCT00387426|64222028|FG000|Overall Study|Toxicities|4|||
23316734|NCT00996892|64903944|FG002|Dose-Escalation Stage 1|Death|0|||
23316735|NCT00996892|64903945|FG003|Dose-Escalation Stage 1|Death|0|||
23316736|NCT00996892|64903946|FG004|Dose-Escalation Stage 1|Death|0|||
23316737|NCT00996892|64903947|FG005|Dose-Escalation Stage 1|Death|1|||
23316738|NCT00996892|64903948|FG006|Dose-Escalation Stage 1|Death|0|||
23316739|NCT00996892|64903949|FG007|Dose-Escalation Stage 1|Death|0|||
23316740|NCT00996892|64903950|FG008|Dose-Escalation Stage 1|Death|0|||
23316741|NCT00996892|64903951|FG009|Dose-Escalation Stage 1|Death|0|||
23316742|NCT00996892|64903952|FG010|Dose-Escalation Stage 1|Death|0|||
23316743|NCT00996892|64903953|FG011|Dose-Escalation Stage 1|Death|0|||
23316744|NCT00996892|64903954|FG012|Dose-Escalation Stage 1|Death|0|||
23316745|NCT00996892|64903955|FG013|Dose-Escalation Stage 1|Death|0|||
23316746|NCT00996892|64903956|FG014|Dose-Escalation Stage 1|Death|0|||
23618659|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
23618660|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
23618661|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
23618662|NCT02269917|65988356|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
23618663|NCT02269917|65988357|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
23618664|NCT02269917|65988358|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
23618665|NCT00404547|65988362|FG000|Overall Study|Adverse Event|39|||
23618666|NCT00404547|65988363|FG001|Overall Study|Adverse Event|6|||
23618667|NCT00404547|65988362|FG000|Overall Study|Withdrawal by Subject|19|||
23618668|NCT00404547|65988363|FG001|Overall Study|Withdrawal by Subject|2|||
23618669|NCT00404547|65988362|FG000|Overall Study|Protocol Violation|0|||
23128702|NCT00387426|64222028|FG000|Overall Study|Disease Progression|3|||
23128703|NCT00527787|64222029|FG000|Overall Study|Adverse Event|14|||
23128704|NCT00527787|64222030|FG001|Overall Study|Adverse Event|24|||
23128705|NCT00527787|64222029|FG000|Overall Study|Withdrawal by Subject|13|||
23128706|NCT00527787|64222030|FG001|Overall Study|Withdrawal by Subject|25|||
23128707|NCT00527787|64222029|FG000|Overall Study|Lost to Follow-up|5|||
23128708|NCT00527787|64222030|FG001|Overall Study|Lost to Follow-up|2|||
23212711|NCT03505749|64519740|FG000|Overall Study|Discharged from treatment|3|||
23316747|NCT00996892|64903957|FG015|Dose-Escalation Stage 1|Death|0|||
23426751|NCT00882908|65307442|FG000|Overall Study|Study terminated in error|0|||
23426752|NCT00882908|65307443|FG001|Overall Study|Study terminated in error|0|||
23128709|NCT00527787|64222029|FG000|Overall Study|Duodenal Ulcer|1|||
23128710|NCT00527787|64222030|FG001|Overall Study|Duodenal Ulcer|10|||
23212712|NCT03505749|64519741|FG001|Overall Study|Discharged from treatment|6|||
23618670|NCT00404547|65988363|FG001|Overall Study|Protocol Violation|1|||
23618671|NCT00404547|65988362|FG000|Overall Study|Lost to Follow-up|20|||
23128711|NCT00527787|64222029|FG000|Overall Study|misc|5|||
23128712|NCT00527787|64222030|FG001|Overall Study|misc|2|||
23128713|NCT05383508|64222031|FG000|Overall Study|Withdrawal by Subject|1|||
23128714|NCT05383508|64222032|FG001|Overall Study|Withdrawal by Subject|0|||
23128715|NCT05383508|64222033|FG002|Overall Study|Withdrawal by Subject|1|||
23128716|NCT05383508|64222034|FG003|Overall Study|Withdrawal by Subject|1|||
23128717|NCT05383508|64222035|FG004|Overall Study|Withdrawal by Subject|2|||
23128718|NCT05383508|64222036|FG005|Overall Study|Withdrawal by Subject|0|||
23128719|NCT02920970|64222037|FG000|First Intervention|Protocol Violation|0|||
23128720|NCT02920970|64222038|FG001|First Intervention|Protocol Violation|1|||
23128721|NCT02920970|64222037|FG000|First Intervention|Adverse Event|0|||
23128722|NCT02920970|64222038|FG001|First Intervention|Adverse Event|1|||
23128723|NCT02920970|64222037|FG000|Second Intervention|Poor Lens Fit|1|||
23128724|NCT02920970|64222038|FG001|Second Intervention|Poor Lens Fit|0|||
23128725|NCT01637077|64222043|FG000|Overall Study|Cancel|1|||
23128726|NCT01637077|64222044|FG001|Overall Study|Cancel|1|||
23128727|NCT01637077|64222043|FG000|Overall Study|Withdrawal by Subject|1|||
23128728|NCT01637077|64222044|FG001|Overall Study|Withdrawal by Subject|0|||
23128729|NCT01637077|64222043|FG000|Overall Study|No cycle 1 questionnaire data|2|||
23128730|NCT01637077|64222044|FG001|Overall Study|No cycle 1 questionnaire data|0|||
23128731|NCT00412607|64222049|FG000|Overall Study|Withdrawal by Subject|9|||
23128732|NCT00412607|64222049|FG000|Overall Study|Lost to Follow-up|19|||
23128733|NCT00412607|64222049|FG000|Overall Study|Death|61|||
23128734|NCT00412607|64222049|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
23128735|NCT00737477|64222050|FG000|Overall Study|Adverse Event|9|||
23128736|NCT00737477|64222050|FG000|Overall Study|Death|9|||
23128737|NCT00737477|64222050|FG000|Overall Study|Treatment Refusal|1|||
23128738|NCT00737477|64222050|FG000|Overall Study|Withdrawal by Subject|1|||
23128739|NCT00737477|64222050|FG000|Overall Study|Renal Transplantation|10|||
23128740|NCT00737477|64222050|FG000|Overall Study|Other|4|||
23128741|NCT02591953|64222051|FG000|Overall Study|Lost to Follow-up|6|||
23128742|NCT02591953|64222052|FG001|Overall Study|Lost to Follow-up|6|||
23128743|NCT03149549|64222056|FG000|Study Discontinuation--Treatment Period|Death|0|||
23128744|NCT03149549|64222057|FG001|Study Discontinuation--Treatment Period|Death|0|||
23128745|NCT03149549|64222058|FG002|Study Discontinuation--Treatment Period|Death|0|||
23128746|NCT03149549|64222059|FG003|Study Discontinuation--Treatment Period|Death|1|||
23128747|NCT03149549|64222060|FG004|Study Discontinuation--Treatment Period|Death|2|||
23128748|NCT03149549|64222061|FG005|Study Discontinuation--Treatment Period|Death|1|||
23128749|NCT03149549|64222062|FG006|Study Discontinuation--Treatment Period|Death|1|||
23128750|NCT03149549|64222063|FG007|Study Discontinuation--Treatment Period|Death|2|||
23128751|NCT03149549|64222064|FG008|Study Discontinuation--Treatment Period|Death|4|||
23128752|NCT03149549|64222065|FG009|Study Discontinuation--Treatment Period|Death|1|||
23128753|NCT03149549|64222066|FG010|Study Discontinuation--Treatment Period|Death|0|||
23128754|NCT03149549|64222067|FG011|Study Discontinuation--Treatment Period|Death|0|||
23128755|NCT03149549|64222068|FG012|Study Discontinuation--Treatment Period|Death|1|||
23128756|NCT03149549|64222056|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128757|NCT03149549|64222057|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128758|NCT03149549|64222058|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128759|NCT03149549|64222059|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128760|NCT03149549|64222060|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128761|NCT03149549|64222061|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128762|NCT03149549|64222062|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128763|NCT03149549|64222063|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
23128764|NCT03149549|64222064|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128765|NCT03149549|64222065|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128766|NCT03149549|64222066|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128767|NCT03149549|64222067|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
23128768|NCT03149549|64222068|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
23128769|NCT03149549|64222056|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23128770|NCT03149549|64222057|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23128771|NCT03149549|64222058|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23128772|NCT03149549|64222059|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
23128773|NCT03149549|64222060|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
23128774|NCT03149549|64222061|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
23128775|NCT03149549|64222062|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
23426753|NCT00882908|65307444|FG002|Overall Study|Study terminated in error|0|||
23128776|NCT03149549|64222063|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23128777|NCT03149549|64222064|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
23128778|NCT03149549|64222065|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23426754|NCT00882908|65307445|FG003|Overall Study|Study terminated in error|1|||
23545721|NCT04773587|65727272|FG000|Overall Study|Noncompliance|1|||
23212713|NCT02871401|64519742|FG000|Overall Study|Adverse Event|1|||
23212714|NCT02871401|64519743|FG001|Overall Study|Adverse Event|0|||
23212715|NCT00196196|64519745|FG000|Overall Study|Withdrawal by Subject|2|||
23316748|NCT00996892|64903958|FG016|Dose-Escalation Stage 1|Death|0|||
23316749|NCT00996892|64903959|FG017|Dose-Escalation Stage 1|Death|0|||
23316750|NCT00996892|64903960|FG018|Dose-Escalation Stage 1|Death|0|||
23316751|NCT00996892|64903961|FG019|Dose-Escalation Stage 1|Death|0|||
23316752|NCT00996892|64903942|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
23316753|NCT00996892|64903943|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
23316754|NCT00996892|64903944|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
23316755|NCT00996892|64903945|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
23316756|NCT00996892|64903946|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
23316757|NCT00996892|64903947|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
23316758|NCT00996892|64903948|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
23316759|NCT00996892|64903949|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
23316760|NCT00996892|64903950|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
23316761|NCT00996892|64903951|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
23316762|NCT00996892|64903952|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
23316763|NCT00996892|64903953|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
23316764|NCT00996892|64903954|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
23316765|NCT00996892|64903955|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
23316766|NCT00996892|64903956|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
23128779|NCT03149549|64222066|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23128780|NCT03149549|64222067|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23128781|NCT03149549|64222068|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
23128782|NCT03149549|64222056|FG000|Study Discontinuation--Treatment Period|Other|0|||
23128783|NCT03149549|64222057|FG001|Study Discontinuation--Treatment Period|Other|0|||
23128784|NCT03149549|64222058|FG002|Study Discontinuation--Treatment Period|Other|0|||
23128785|NCT03149549|64222059|FG003|Study Discontinuation--Treatment Period|Other|0|||
23128786|NCT03149549|64222060|FG004|Study Discontinuation--Treatment Period|Other|0|||
23128787|NCT03149549|64222061|FG005|Study Discontinuation--Treatment Period|Other|0|||
23128788|NCT03149549|64222062|FG006|Study Discontinuation--Treatment Period|Other|0|||
23212716|NCT00196196|64519745|FG000|Overall Study|Did not have required condition (hydroce|5|||
23212717|NCT01406652|64519748|FG000|Overall Study|Lost-to-follow-up|3|||
23212718|NCT01406652|64519749|FG001|Overall Study|Lost-to-follow-up|4|||
23212719|NCT01406652|64519748|FG000|Overall Study|Withdrawal by Subject|2|||
23212720|NCT01406652|64519749|FG001|Overall Study|Withdrawal by Subject|2|||
23212721|NCT01406652|64519748|FG000|Overall Study|Insufficient follow-up|5|||
23212722|NCT01406652|64519749|FG001|Overall Study|Insufficient follow-up|4|||
23212723|NCT01406652|64519748|FG000|Overall Study|Infection not sure|10|||
23212724|NCT01406652|64519749|FG001|Overall Study|Infection not sure|10|||
23212725|NCT00971425|64519750|FG000|Overall Study|Adverse Event|1|||
23212726|NCT00971425|64519751|FG001|Overall Study|Adverse Event|1|||
23212727|NCT00971425|64519750|FG000|Overall Study|Withdrawal by Subject|0|||
23212728|NCT00971425|64519751|FG001|Overall Study|Withdrawal by Subject|1|||
23212729|NCT01082367|64519757|FG000|Double-blind Period|Administrative problems|0|||
23212730|NCT01082367|64519758|FG001|Double-blind Period|Administrative problems|1|||
23212731|NCT01082367|64519757|FG000|Double-blind Period|Lack of Efficacy|5|||
23212732|NCT01082367|64519758|FG001|Double-blind Period|Lack of Efficacy|11|||
23212733|NCT01082367|64519757|FG000|Double-blind Period|Adverse Event|0|||
23212734|NCT01082367|64519758|FG001|Double-blind Period|Adverse Event|1|||
23212735|NCT01082367|64519757|FG000|Follow-up (F-U) Period|Administrative problems|1|||
23212736|NCT01082367|64519758|FG001|Follow-up (F-U) Period|Administrative problems|0|||
23212737|NCT01082367|64519757|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
23212738|NCT01082367|64519758|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
23212739|NCT01082367|64519757|FG000|Follow-up (F-U) Period|Adverse Event|0|||
23212740|NCT01082367|64519758|FG001|Follow-up (F-U) Period|Adverse Event|1|||
23212741|NCT05109702|64519759|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
23212742|NCT05109702|64519760|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
23212743|NCT05109702|64519761|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
23212744|NCT05109702|64519759|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
23212745|NCT05109702|64519760|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
23212746|NCT05109702|64519761|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
23212747|NCT05109702|64519759|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
23212748|NCT05109702|64519760|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
23212749|NCT05109702|64519761|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
23212750|NCT05109702|64519759|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
23316767|NCT00996892|64903957|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
23212751|NCT05109702|64519760|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
23212752|NCT05109702|64519761|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
23212753|NCT05109702|64519759|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
23316768|NCT00996892|64903958|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
23316769|NCT00996892|64903959|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
23618672|NCT00404547|65988363|FG001|Overall Study|Lost to Follow-up|9|||
23618673|NCT00404547|65988362|FG000|Overall Study|Lack of compliance|5|||
23618674|NCT00404547|65988363|FG001|Overall Study|Lack of compliance|1|||
23618675|NCT00404547|65988362|FG000|Overall Study|Other|4|||
23618676|NCT00404547|65988363|FG001|Overall Study|Other|0|||
23618677|NCT00404547|65988362|FG000|Overall Study|Reason not stated|3|||
23618678|NCT00404547|65988363|FG001|Overall Study|Reason not stated|6|||
23618679|NCT00497198|65991309|FG000|Overall Study|Adverse Event|4|||
23618680|NCT00497198|65991310|FG001|Overall Study|Adverse Event|2|||
23618681|NCT00497198|65991309|FG000|Overall Study|Physician Decision|1|||
23316770|NCT00996892|64903960|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
23316771|NCT00996892|64903961|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
23316772|NCT00996892|64903942|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316773|NCT00996892|64903943|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
23316774|NCT00996892|64903944|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316775|NCT00996892|64903945|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
23316776|NCT00996892|64903946|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
23316777|NCT00996892|64903947|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
23316778|NCT00996892|64903948|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
23316779|NCT00996892|64903949|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316780|NCT00996892|64903950|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316781|NCT00996892|64903951|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316782|NCT00996892|64903952|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316783|NCT00996892|64903953|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316784|NCT00996892|64903954|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316785|NCT00996892|64903955|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316786|NCT00996892|64903956|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316787|NCT00996892|64903957|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316788|NCT00996892|64903958|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316789|NCT00996892|64903959|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316790|NCT00996892|64903960|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316791|NCT00996892|64903961|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
23316792|NCT00996892|64903942|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
23316793|NCT00996892|64903943|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
23316794|NCT00996892|64903944|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
23316795|NCT00996892|64903945|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
23316796|NCT00996892|64903946|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
23316797|NCT00996892|64903947|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
23316798|NCT00996892|64903948|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
23316799|NCT00996892|64903949|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
23316800|NCT00996892|64903950|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
23316801|NCT00996892|64903951|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
23316802|NCT00996892|64903952|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
23316803|NCT00996892|64903953|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
23316804|NCT00996892|64903954|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
23316805|NCT00996892|64903955|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
23426755|NCT00882908|65307446|FG004|Overall Study|Study terminated in error|0|||
23426756|NCT00276094|65307450|FG000|Overall Study|Adverse Event|15|||
23426757|NCT00276094|65307451|FG001|Overall Study|Adverse Event|13|||
23426758|NCT00276094|65307452|FG002|Overall Study|Adverse Event|11|||
23426759|NCT00276094|65307450|FG000|Overall Study|Withdrawal by Subject|14|||
23426760|NCT00276094|65307451|FG001|Overall Study|Withdrawal by Subject|14|||
23128789|NCT03149549|64222063|FG007|Study Discontinuation--Treatment Period|Other|1|||
23212754|NCT05109702|64519760|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
23128790|NCT03149549|64222064|FG008|Study Discontinuation--Treatment Period|Other|0|||
23128791|NCT03149549|64222065|FG009|Study Discontinuation--Treatment Period|Other|1|||
23128792|NCT03149549|64222066|FG010|Study Discontinuation--Treatment Period|Other|0|||
23128793|NCT03149549|64222067|FG011|Study Discontinuation--Treatment Period|Other|0|||
23212755|NCT05109702|64519761|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
23128794|NCT03149549|64222068|FG012|Study Discontinuation--Treatment Period|Other|0|||
23128795|NCT03149549|64222056|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23128796|NCT03149549|64222057|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23128797|NCT03149549|64222058|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23128798|NCT03149549|64222059|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23128799|NCT03149549|64222060|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23128800|NCT03149549|64222061|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
23128801|NCT03149549|64222062|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
23316806|NCT00996892|64903956|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
23316807|NCT00996892|64903957|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
23618682|NCT00497198|65991310|FG001|Overall Study|Physician Decision|2|||
23618683|NCT00497198|65991309|FG000|Overall Study|Withdrawal by Subject|0|||
23128802|NCT03149549|64222063|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23128803|NCT03149549|64222064|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
23128804|NCT03149549|64222065|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23426761|NCT00276094|65307452|FG002|Overall Study|Withdrawal by Subject|12|||
23426762|NCT00276094|65307450|FG000|Overall Study|Protocol Violation|16|||
23426763|NCT00276094|65307451|FG001|Overall Study|Protocol Violation|7|||
23426764|NCT00276094|65307452|FG002|Overall Study|Protocol Violation|10|||
23426765|NCT00276094|65307450|FG000|Overall Study|Lost to Follow-up|8|||
23426766|NCT00276094|65307451|FG001|Overall Study|Lost to Follow-up|6|||
23426767|NCT00276094|65307452|FG002|Overall Study|Lost to Follow-up|4|||
23426768|NCT00276094|65307450|FG000|Overall Study|Other-Subject moved out of country|1|||
23426769|NCT00276094|65307451|FG001|Overall Study|Other-Subject moved out of country|0|||
23128805|NCT03149549|64222066|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23128806|NCT03149549|64222067|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23128807|NCT03149549|64222068|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
23128808|NCT03149549|64222056|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23128809|NCT03149549|64222057|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23128810|NCT03149549|64222058|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23128811|NCT03149549|64222059|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23128812|NCT03149549|64222060|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
23128813|NCT03149549|64222061|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23128814|NCT03149549|64222062|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23128815|NCT03149549|64222063|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
23426770|NCT00276094|65307452|FG002|Overall Study|Other-Subject moved out of country|0|||
23128816|NCT03149549|64222064|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
23128817|NCT03149549|64222065|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23128818|NCT03149549|64222066|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
23128819|NCT03149549|64222067|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
23128820|NCT03149549|64222068|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
23128821|NCT03149549|64222056|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23128822|NCT03149549|64222057|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23128823|NCT03149549|64222058|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23128824|NCT03149549|64222059|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23426771|NCT00276094|65307450|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
23426772|NCT00276094|65307451|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
23426773|NCT00276094|65307452|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
23426774|NCT00276094|65307450|FG000|Overall Study|Other-Lack of efficacy|1|||
23426775|NCT00276094|65307451|FG001|Overall Study|Other-Lack of efficacy|0|||
23426776|NCT00276094|65307452|FG002|Overall Study|Other-Lack of efficacy|0|||
23426777|NCT00276094|65307450|FG000|Overall Study|Other-Refused follow-up visit|1|||
23545722|NCT04773587|65727273|FG001|Overall Study|Noncompliance|0|||
23128825|NCT03149549|64222060|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
23128826|NCT03149549|64222061|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23128827|NCT03149549|64222062|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23128828|NCT03149549|64222063|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
23128829|NCT03149549|64222064|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
23128830|NCT03149549|64222065|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
23128831|NCT03149549|64222066|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
23128832|NCT03149549|64222067|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
23128833|NCT03149549|64222068|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
23128834|NCT03149549|64222056|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
23128835|NCT03149549|64222057|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
23128836|NCT03149549|64222058|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
23128837|NCT03149549|64222059|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
23128838|NCT03149549|64222060|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
23128839|NCT03149549|64222061|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
23128840|NCT03149549|64222062|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
23128841|NCT03149549|64222063|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
23128842|NCT03149549|64222064|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
23128843|NCT03149549|64222065|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
23128844|NCT03149549|64222066|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
23128845|NCT03149549|64222067|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
23316808|NCT00996892|64903958|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
23426778|NCT00276094|65307451|FG001|Overall Study|Other-Refused follow-up visit|0|||
23426779|NCT00276094|65307452|FG002|Overall Study|Other-Refused follow-up visit|0|||
23545723|NCT04773587|65727272|FG000|Overall Study|Protocol Violation|1|||
23545724|NCT04773587|65727273|FG001|Overall Study|Protocol Violation|0|||
23128846|NCT03149549|64222068|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
23128847|NCT03149549|64222056|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
23128848|NCT03149549|64222057|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
23618684|NCT00497198|65991310|FG001|Overall Study|Withdrawal by Subject|1|||
23618685|NCT01780545|65991311|FG000|Overall Study|Withdrawal by Subject|3|||
23618686|NCT01780545|65991312|FG001|Overall Study|Withdrawal by Subject|1|||
23618687|NCT01780545|65991311|FG000|Overall Study|Lost to Follow-up|1|||
23618688|NCT01780545|65991312|FG001|Overall Study|Lost to Follow-up|1|||
23618689|NCT01157377|65991313|FG000|Overall Study|Lost to Follow-up|0|||
23128849|NCT03149549|64222058|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
23128850|NCT03149549|64222059|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
23128851|NCT03149549|64222060|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
23128852|NCT03149549|64222061|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
23128853|NCT03149549|64222062|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
23128854|NCT03149549|64222063|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
23128855|NCT03149549|64222064|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
23128856|NCT03149549|64222065|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
23128857|NCT03149549|64222066|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
23128858|NCT03149549|64222067|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
23128859|NCT03149549|64222068|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
23128860|NCT04129580|64222069|FG000|Overall Study|Lost to Follow-up|14|||
23128861|NCT04129580|64222070|FG001|Overall Study|Lost to Follow-up|25|||
23128862|NCT00945672|64222075|FG000|Overall Study|Withdrawal by Subject|0|||
23545725|NCT04773587|65727272|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
23545726|NCT04773587|65727273|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
23545727|NCT04433767|65727274|FG000|Overall Study|Adverse Event|1|||
23545728|NCT04642638|65727275|FG000|Overall Study|Withdrawal by Subject|23|||
23545729|NCT04642638|65727276|FG001|Overall Study|Withdrawal by Subject|29|||
23545730|NCT04642638|65727277|FG002|Overall Study|Withdrawal by Subject|9|||
23545731|NCT04642638|65727278|FG003|Overall Study|Withdrawal by Subject|7|||
23545732|NCT04642638|65727279|FG004|Overall Study|Withdrawal by Subject|61|||
23545733|NCT04642638|65727280|FG005|Overall Study|Withdrawal by Subject|27|||
23545734|NCT04642638|65727275|FG000|Overall Study|Lost to Follow-up|17|||
23618690|NCT01157377|65991314|FG001|Overall Study|Lost to Follow-up|0|||
23618691|NCT01157377|65991315|FG002|Overall Study|Lost to Follow-up|1|||
23618692|NCT01157377|65991316|FG003|Overall Study|Lost to Follow-up|0|||
23128863|NCT00945672|64222076|FG001|Overall Study|Withdrawal by Subject|0|||
23128864|NCT00945672|64222077|FG002|Overall Study|Withdrawal by Subject|0|||
23128865|NCT00945672|64222078|FG003|Overall Study|Withdrawal by Subject|1|||
23128866|NCT03015129|64222079|FG000|Overall Study|Death|2|||
23128867|NCT03015129|64222080|FG001|Overall Study|Death|2|||
23128868|NCT03015129|64222079|FG000|Overall Study|Lost to Follow-up|0|||
23128869|NCT03015129|64222080|FG001|Overall Study|Lost to Follow-up|1|||
23128870|NCT03015129|64222079|FG000|Overall Study|Progression of disease|38|||
23128871|NCT03015129|64222080|FG001|Overall Study|Progression of disease|33|||
23128872|NCT03015129|64222079|FG000|Overall Study|Adverse Event|0|||
23128873|NCT03015129|64222080|FG001|Overall Study|Adverse Event|4|||
23128874|NCT03361605|64222082|FG000|Overall Study|Analyzable data not available|3|||
23128875|NCT01241604|64222083|FG000|Screening Period|Screen Failure|3|||
23128876|NCT01241604|64222084|FG001|Screening Period|Screen Failure|0|||
23128877|NCT01241604|64222085|FG002|Screening Period|Screen Failure|0|||
23128878|NCT00918879|64222086|FG000|Overall Study|Withdrawal by Subject|4|||
23128879|NCT00918879|64222087|FG001|Overall Study|Withdrawal by Subject|4|||
23128880|NCT00918879|64222086|FG000|Overall Study|Lost to Follow-up|1|||
23128881|NCT00918879|64222087|FG001|Overall Study|Lost to Follow-up|1|||
23128882|NCT00918879|64222086|FG000|Overall Study|Severe non-compliance to protocol|1|||
23128883|NCT00918879|64222087|FG001|Overall Study|Severe non-compliance to protocol|1|||
23128884|NCT01016262|64222088|FG000|Double-blind Phase|Adverse Event|0|||
23128885|NCT01016262|64222089|FG001|Double-blind Phase|Adverse Event|0|||
23128886|NCT01016262|64222090|FG002|Double-blind Phase|Adverse Event|1|||
23128887|NCT01016262|64222091|FG003|Double-blind Phase|Adverse Event|0|||
23128888|NCT01016262|64222092|FG004|Double-blind Phase|Adverse Event|0|||
23128889|NCT01016262|64222093|FG005|Double-blind Phase|Adverse Event|0|||
23128890|NCT01016262|64222088|FG000|Double-blind Phase|Lack of Efficacy|1|||
23128891|NCT01016262|64222089|FG001|Double-blind Phase|Lack of Efficacy|0|||
23128892|NCT01016262|64222090|FG002|Double-blind Phase|Lack of Efficacy|5|||
23128893|NCT01016262|64222091|FG003|Double-blind Phase|Lack of Efficacy|0|||
23128894|NCT01016262|64222092|FG004|Double-blind Phase|Lack of Efficacy|0|||
23212756|NCT01646398|64519762|FG000|Overall Study|Withdrawal by Subject|1|||
23545735|NCT04642638|65727276|FG001|Overall Study|Lost to Follow-up|18|||
23128895|NCT01016262|64222093|FG005|Double-blind Phase|Lack of Efficacy|0|||
23545736|NCT04642638|65727277|FG002|Overall Study|Lost to Follow-up|5|||
23128896|NCT01016262|64222088|FG000|Double-blind Phase|Disease Progression|0|||
23212757|NCT01646398|64519763|FG001|Overall Study|Withdrawal by Subject|0|||
23618693|NCT01157377|65991317|FG004|Overall Study|Lost to Follow-up|1|||
23618694|NCT01157377|65991318|FG005|Overall Study|Lost to Follow-up|1|||
23618695|NCT01157377|65991319|FG006|Overall Study|Lost to Follow-up|0|||
23618696|NCT01157377|65991313|FG000|Overall Study|Personal Reasons|2|||
23618697|NCT01157377|65991314|FG001|Overall Study|Personal Reasons|1|||
23618698|NCT01157377|65991315|FG002|Overall Study|Personal Reasons|0|||
23128897|NCT01016262|64222089|FG001|Double-blind Phase|Disease Progression|1|||
23128898|NCT01016262|64222090|FG002|Double-blind Phase|Disease Progression|2|||
23128899|NCT01016262|64222091|FG003|Double-blind Phase|Disease Progression|0|||
23128900|NCT01016262|64222092|FG004|Double-blind Phase|Disease Progression|0|||
23128901|NCT01016262|64222093|FG005|Double-blind Phase|Disease Progression|0|||
23128902|NCT01016262|64222088|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
23128903|NCT01016262|64222089|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
23128904|NCT01016262|64222090|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
23128905|NCT01016262|64222091|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
23128906|NCT01016262|64222092|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
23128907|NCT01016262|64222093|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
23128908|NCT01016262|64222088|FG000|Open-Label Phase|Adverse Event|0|||
23618699|NCT01157377|65991316|FG003|Overall Study|Personal Reasons|1|||
23618700|NCT01157377|65991317|FG004|Overall Study|Personal Reasons|0|||
23618701|NCT01157377|65991318|FG005|Overall Study|Personal Reasons|0|||
23618702|NCT01157377|65991319|FG006|Overall Study|Personal Reasons|0|||
23618703|NCT01157377|65991313|FG000|Overall Study|Protocol Violation|0|||
23618704|NCT01157377|65991314|FG001|Overall Study|Protocol Violation|0|||
23618705|NCT01157377|65991315|FG002|Overall Study|Protocol Violation|0|||
23618706|NCT01157377|65991316|FG003|Overall Study|Protocol Violation|0|||
23618707|NCT01157377|65991317|FG004|Overall Study|Protocol Violation|0|||
23618708|NCT01157377|65991318|FG005|Overall Study|Protocol Violation|1|||
23128909|NCT01016262|64222089|FG001|Open-Label Phase|Adverse Event|0|||
23128910|NCT01016262|64222090|FG002|Open-Label Phase|Adverse Event|0|||
23128911|NCT01016262|64222091|FG003|Open-Label Phase|Adverse Event|1|||
23128912|NCT01016262|64222092|FG004|Open-Label Phase|Adverse Event|0|||
23128913|NCT01016262|64222093|FG005|Open-Label Phase|Adverse Event|0|||
23128914|NCT01016262|64222088|FG000|Open-Label Phase|Lost to Follow-up|0|||
23618709|NCT01157377|65991319|FG006|Overall Study|Protocol Violation|0|||
23618710|NCT01157377|65991313|FG000|Overall Study|Lack of Efficacy|0|||
23618711|NCT01157377|65991314|FG001|Overall Study|Lack of Efficacy|0|||
23618712|NCT01157377|65991315|FG002|Overall Study|Lack of Efficacy|0|||
23618713|NCT01157377|65991316|FG003|Overall Study|Lack of Efficacy|0|||
23618714|NCT01157377|65991317|FG004|Overall Study|Lack of Efficacy|0|||
23618715|NCT01157377|65991318|FG005|Overall Study|Lack of Efficacy|0|||
23618716|NCT01157377|65991319|FG006|Overall Study|Lack of Efficacy|1|||
23618717|NCT01157377|65991313|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23618718|NCT01157377|65991314|FG001|Overall Study|Other Miscellaneous Reasons|2|||
23618719|NCT01157377|65991315|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23618720|NCT01157377|65991316|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23618721|NCT01157377|65991317|FG004|Overall Study|Other Miscellaneous Reasons|1|||
23618722|NCT01157377|65991318|FG005|Overall Study|Other Miscellaneous Reasons|1|||
23618723|NCT01157377|65991319|FG006|Overall Study|Other Miscellaneous Reasons|1|||
23618724|NCT02775214|65991322|FG000|Overall Study|Withdrawal by Subject|2|||
23618725|NCT02775214|65991323|FG001|Overall Study|Withdrawal by Subject|0|||
23618726|NCT00105521|65991324|FG000|Overall Study|Other|1|||
23618727|NCT00105521|65991325|FG001|Overall Study|Other|1|||
23618728|NCT00105521|65991326|FG002|Overall Study|Other|2|||
23618729|NCT00105521|65991327|FG003|Overall Study|Other|0|||
23618730|NCT00105521|65991324|FG000|Overall Study|Adverse Event|10|||
23618731|NCT00105521|65991325|FG001|Overall Study|Adverse Event|4|||
23618732|NCT00105521|65991326|FG002|Overall Study|Adverse Event|10|||
23618733|NCT00105521|65991327|FG003|Overall Study|Adverse Event|8|||
23618734|NCT00105521|65991324|FG000|Overall Study|Withdrawal by Subject|1|||
23128915|NCT01016262|64222089|FG001|Open-Label Phase|Lost to Follow-up|0|||
23128916|NCT01016262|64222090|FG002|Open-Label Phase|Lost to Follow-up|0|||
23128917|NCT01016262|64222091|FG003|Open-Label Phase|Lost to Follow-up|0|||
23128918|NCT01016262|64222092|FG004|Open-Label Phase|Lost to Follow-up|1|||
23316809|NCT00996892|64903959|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
23618735|NCT00105521|65991325|FG001|Overall Study|Withdrawal by Subject|0|||
23128919|NCT01016262|64222093|FG005|Open-Label Phase|Lost to Follow-up|0|||
23128920|NCT01016262|64222088|FG000|Open-Label Phase|Lack of Efficacy|0|||
23618736|NCT00105521|65991326|FG002|Overall Study|Withdrawal by Subject|1|||
23316810|NCT00996892|64903960|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
23618737|NCT00105521|65991327|FG003|Overall Study|Withdrawal by Subject|4|||
23618738|NCT00105521|65991324|FG000|Overall Study|Lack of Efficacy|0|||
23618739|NCT00105521|65991325|FG001|Overall Study|Lack of Efficacy|0|||
23618740|NCT00105521|65991326|FG002|Overall Study|Lack of Efficacy|0|||
23618741|NCT00105521|65991327|FG003|Overall Study|Lack of Efficacy|1|||
23618742|NCT00105521|65991324|FG000|Overall Study|Protocol Violation|3|||
23618743|NCT00105521|65991325|FG001|Overall Study|Protocol Violation|5|||
23618744|NCT00105521|65991326|FG002|Overall Study|Protocol Violation|4|||
23618745|NCT00105521|65991327|FG003|Overall Study|Protocol Violation|4|||
23618746|NCT00105521|65991324|FG000|Overall Study|Lost to Follow-up|0|||
23618747|NCT00105521|65991325|FG001|Overall Study|Lost to Follow-up|1|||
23618748|NCT00105521|65991326|FG002|Overall Study|Lost to Follow-up|0|||
23618749|NCT00105521|65991327|FG003|Overall Study|Lost to Follow-up|0|||
23618750|NCT00866918|65991332|FG000|Overall Study|Death|1|||
23618751|NCT00866918|65991333|FG001|Overall Study|Death|5|||
23618752|NCT00866918|65991332|FG000|Overall Study|Lack of Efficacy|1|||
23618753|NCT00866918|65991333|FG001|Overall Study|Lack of Efficacy|1|||
23618754|NCT00866918|65991332|FG000|Overall Study|Physician Decision|10|||
23618755|NCT00866918|65991333|FG001|Overall Study|Physician Decision|2|||
23618756|NCT00866918|65991332|FG000|Overall Study|Ineligible|2|||
23128921|NCT01016262|64222089|FG001|Open-Label Phase|Lack of Efficacy|0|||
23128922|NCT01016262|64222090|FG002|Open-Label Phase|Lack of Efficacy|0|||
23128923|NCT01016262|64222091|FG003|Open-Label Phase|Lack of Efficacy|1|||
23128924|NCT01016262|64222092|FG004|Open-Label Phase|Lack of Efficacy|0|||
23128925|NCT01016262|64222093|FG005|Open-Label Phase|Lack of Efficacy|0|||
23128926|NCT01016262|64222088|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
23128927|NCT01016262|64222089|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
23128928|NCT01016262|64222090|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
23128929|NCT01016262|64222091|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
23128930|NCT01016262|64222092|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
23128931|NCT01016262|64222093|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
23128932|NCT00700778|64222094|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
23128933|NCT05172050|64222095|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
23128934|NCT05172050|64222096|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
23128935|NCT05172050|64222097|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
23128936|NCT05172050|64222095|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
23128937|NCT05172050|64222096|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
23128938|NCT05172050|64222097|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
23128939|NCT05172050|64222095|FG000|Overall Study|Other|2|||
23128940|NCT05172050|64222096|FG001|Overall Study|Other|2|||
23128941|NCT05172050|64222097|FG002|Overall Study|Other|1|||
23128942|NCT02088957|64222098|FG000|Overall Study|Lack of Efficacy|1|||
23128943|NCT02088957|64222099|FG001|Overall Study|Lack of Efficacy|0|||
23128944|NCT01370655|64222101|FG000|Period 1|Adverse Event|2|||
23128945|NCT01370655|64222102|FG001|Period 1|Adverse Event|0|||
23128946|NCT01370655|64222103|FG002|Period 1|Adverse Event|0|||
23128947|NCT01370655|64222104|FG003|Period 1|Adverse Event|0|||
23128948|NCT01370655|64222105|FG004|Period 1|Adverse Event|0|||
23128949|NCT01370655|64222106|FG005|Period 1|Adverse Event|0|||
23128950|NCT01370655|64222107|FG006|Period 1|Adverse Event|1|||
23128951|NCT01370655|64222108|FG007|Period 1|Adverse Event|0|||
23128952|NCT01370655|64222109|FG008|Period 1|Adverse Event|0|||
23128953|NCT01370655|64222110|FG009|Period 1|Adverse Event|0|||
23128954|NCT01370655|64222111|FG010|Period 1|Adverse Event|0|||
23128955|NCT01370655|64222112|FG011|Period 1|Adverse Event|0|||
23128956|NCT01370655|64222101|FG000|Period 2|Adverse Event|0|||
23128957|NCT01370655|64222102|FG001|Period 2|Adverse Event|0|||
23128958|NCT01370655|64222103|FG002|Period 2|Adverse Event|1|||
23128959|NCT01370655|64222104|FG003|Period 2|Adverse Event|0|||
23128960|NCT01370655|64222105|FG004|Period 2|Adverse Event|1|||
23128961|NCT01370655|64222106|FG005|Period 2|Adverse Event|0|||
23128962|NCT01370655|64222107|FG006|Period 2|Adverse Event|0|||
23128963|NCT01370655|64222108|FG007|Period 2|Adverse Event|1|||
23128964|NCT01370655|64222109|FG008|Period 2|Adverse Event|0|||
23128965|NCT01370655|64222110|FG009|Period 2|Adverse Event|0|||
23128966|NCT01370655|64222111|FG010|Period 2|Adverse Event|0|||
23128967|NCT01370655|64222112|FG011|Period 2|Adverse Event|0|||
23128968|NCT01370655|64222101|FG000|Period 2|met protocol specified stopping criteria|0|||
23128969|NCT01370655|64222102|FG001|Period 2|met protocol specified stopping criteria|0|||
23128970|NCT01370655|64222103|FG002|Period 2|met protocol specified stopping criteria|1|||
23128971|NCT01370655|64222104|FG003|Period 2|met protocol specified stopping criteria|0|||
23128972|NCT01370655|64222105|FG004|Period 2|met protocol specified stopping criteria|0|||
23128973|NCT01370655|64222106|FG005|Period 2|met protocol specified stopping criteria|0|||
23128974|NCT01370655|64222107|FG006|Period 2|met protocol specified stopping criteria|1|||
23618757|NCT00866918|65991333|FG001|Overall Study|Ineligible|4|||
23128975|NCT01370655|64222108|FG007|Period 2|met protocol specified stopping criteria|0|||
23128976|NCT01370655|64222109|FG008|Period 2|met protocol specified stopping criteria|1|||
23128977|NCT01370655|64222110|FG009|Period 2|met protocol specified stopping criteria|0|||
23128978|NCT01370655|64222111|FG010|Period 2|met protocol specified stopping criteria|1|||
23128979|NCT01370655|64222112|FG011|Period 2|met protocol specified stopping criteria|0|||
23128980|NCT01370655|64222101|FG000|Period 2|Withdrawal by Subject|0|||
23426780|NCT00276094|65307450|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
23618758|NCT00866918|65991332|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
23618759|NCT00866918|65991333|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
23128981|NCT01370655|64222102|FG001|Period 2|Withdrawal by Subject|0|||
23128982|NCT01370655|64222103|FG002|Period 2|Withdrawal by Subject|0|||
23128983|NCT01370655|64222104|FG003|Period 2|Withdrawal by Subject|0|||
23212758|NCT02379390|64519764|FG000|Overall Study|Adverse Event|1|||
23212759|NCT02379390|64519765|FG001|Overall Study|Adverse Event|1|||
23212760|NCT02379390|64519764|FG000|Overall Study|Investigator's decision|1|||
23212761|NCT02379390|64519765|FG001|Overall Study|Investigator's decision|0|||
23212762|NCT02379390|64519764|FG000|Overall Study|Study Termination|0|||
23212763|NCT02379390|64519765|FG001|Overall Study|Study Termination|1|||
23212764|NCT02267278|64519769|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
23212765|NCT02267278|64519769|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
23212766|NCT02267278|64519769|FG000|Overall Study|Developed new cancer diagnoses|2|||
23212767|NCT02267278|64519769|FG000|Overall Study|prescribed prohibited medication|1|||
23212768|NCT03595384|64519772|FG000|Overall Study|Other time commitments|8|||
23212769|NCT03595384|64519772|FG000|Overall Study|Changes to session time|7|||
23212770|NCT03595384|64519772|FG000|Overall Study|Relocation out of country|1|||
23212771|NCT03372603|64519776|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
23212772|NCT03372603|64519777|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
23212773|NCT03372603|64519776|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
23212774|NCT03372603|64519777|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
23212775|NCT04449276|64519778|FG000|Overall Study|Adverse Event|1|||
23212776|NCT04449276|64519779|FG001|Overall Study|Adverse Event|2|||
23212777|NCT04449276|64519780|FG002|Overall Study|Adverse Event|0|||
23212778|NCT04449276|64519781|FG003|Overall Study|Adverse Event|0|||
23212779|NCT04449276|64519782|FG004|Overall Study|Adverse Event|2|||
23212780|NCT04449276|64519783|FG005|Overall Study|Adverse Event|0|||
23316811|NCT00996892|64903961|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
23316812|NCT00996892|64903942|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
23316813|NCT00996892|64903943|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
23128984|NCT01370655|64222105|FG004|Period 2|Withdrawal by Subject|0|||
23128985|NCT01370655|64222106|FG005|Period 2|Withdrawal by Subject|0|||
23128986|NCT01370655|64222107|FG006|Period 2|Withdrawal by Subject|0|||
23128987|NCT01370655|64222108|FG007|Period 2|Withdrawal by Subject|0|||
23128988|NCT01370655|64222109|FG008|Period 2|Withdrawal by Subject|1|||
23128989|NCT01370655|64222110|FG009|Period 2|Withdrawal by Subject|0|||
23128990|NCT01370655|64222111|FG010|Period 2|Withdrawal by Subject|0|||
23128991|NCT01370655|64222112|FG011|Period 2|Withdrawal by Subject|0|||
23128992|NCT01132820|64222117|FG000|Overall Study|Ineligible: wrong cell type|1|||
23128993|NCT01132820|64222117|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
23128994|NCT01132820|64222117|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
23128995|NCT01132820|64222117|FG000|Overall Study|Never treated|1|||
23128996|NCT01132820|64222117|FG000|Overall Study|Inadequate data|1|||
23128997|NCT00604825|64222119|FG000|Overall Study|Adverse Event|2|||
23128998|NCT00604825|64222120|FG001|Overall Study|Adverse Event|6|||
23128999|NCT00604825|64222121|FG002|Overall Study|Adverse Event|7|||
23129000|NCT00604825|64222122|FG003|Overall Study|Adverse Event|4|||
23129001|NCT00604825|64222119|FG000|Overall Study|Lost to Follow-up|0|||
23129002|NCT00604825|64222120|FG001|Overall Study|Lost to Follow-up|3|||
23129003|NCT00604825|64222121|FG002|Overall Study|Lost to Follow-up|1|||
23129004|NCT00604825|64222122|FG003|Overall Study|Lost to Follow-up|0|||
23129005|NCT00604825|64222119|FG000|Overall Study|Protocol Violation|0|||
23129006|NCT00604825|64222120|FG001|Overall Study|Protocol Violation|1|||
23129007|NCT00604825|64222121|FG002|Overall Study|Protocol Violation|0|||
23129008|NCT00604825|64222122|FG003|Overall Study|Protocol Violation|0|||
23129009|NCT00604825|64222119|FG000|Overall Study|Withdrawal by Subject|4|||
23129010|NCT00604825|64222120|FG001|Overall Study|Withdrawal by Subject|3|||
23129011|NCT00604825|64222121|FG002|Overall Study|Withdrawal by Subject|5|||
23129012|NCT00604825|64222122|FG003|Overall Study|Withdrawal by Subject|5|||
23129013|NCT00604825|64222119|FG000|Overall Study|Lack of Efficacy|3|||
23129014|NCT00604825|64222120|FG001|Overall Study|Lack of Efficacy|2|||
23129015|NCT00604825|64222121|FG002|Overall Study|Lack of Efficacy|1|||
23129016|NCT00604825|64222122|FG003|Overall Study|Lack of Efficacy|0|||
23129017|NCT00604825|64222119|FG000|Overall Study|Did not meet eligibility criteria|0|||
23129018|NCT00604825|64222120|FG001|Overall Study|Did not meet eligibility criteria|0|||
23129019|NCT00604825|64222121|FG002|Overall Study|Did not meet eligibility criteria|2|||
23129020|NCT00604825|64222122|FG003|Overall Study|Did not meet eligibility criteria|0|||
23129021|NCT00604825|64222119|FG000|Overall Study|Physician Decision|0|||
23129022|NCT00604825|64222120|FG001|Overall Study|Physician Decision|0|||
23129023|NCT00604825|64222121|FG002|Overall Study|Physician Decision|0|||
23129024|NCT00604825|64222122|FG003|Overall Study|Physician Decision|1|||
23129025|NCT00604825|64222119|FG000|Overall Study|Exclusion criterion met|0|||
23129026|NCT00604825|64222120|FG001|Overall Study|Exclusion criterion met|0|||
23316814|NCT00996892|64903944|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
23212781|NCT04449276|64519784|FG006|Overall Study|Adverse Event|0|||
23212782|NCT04449276|64519785|FG007|Overall Study|Adverse Event|1|||
23129027|NCT00604825|64222121|FG002|Overall Study|Exclusion criterion met|0|||
23129028|NCT00604825|64222122|FG003|Overall Study|Exclusion criterion met|1|||
23212783|NCT04449276|64519778|FG000|Overall Study|Withdrawal by Subject|2|||
23129029|NCT00820170|64222123|FG000|Overall Study|Adverse Event|0|||
23129030|NCT00820170|64222124|FG001|Overall Study|Adverse Event|0|||
23129031|NCT00820170|64222125|FG002|Overall Study|Adverse Event|0|||
23129032|NCT00820170|64222126|FG003|Overall Study|Adverse Event|0|||
23129033|NCT00820170|64222127|FG004|Overall Study|Adverse Event|2|||
23129034|NCT00820170|64222123|FG000|Overall Study|Progressive Disease|0|||
23129035|NCT00820170|64222124|FG001|Overall Study|Progressive Disease|0|||
23129036|NCT00820170|64222125|FG002|Overall Study|Progressive Disease|0|||
23129037|NCT00820170|64222126|FG003|Overall Study|Progressive Disease|0|||
23129038|NCT00820170|64222127|FG004|Overall Study|Progressive Disease|2|||
23129039|NCT01365481|64222128|FG000|Overall Study|Adverse Event|6|||
23129040|NCT01365481|64222129|FG001|Overall Study|Adverse Event|9|||
23129041|NCT01365481|64222130|FG002|Overall Study|Adverse Event|0|||
23129042|NCT01365481|64222131|FG003|Overall Study|Adverse Event|2|||
23129043|NCT01365481|64222128|FG000|Overall Study|Withdrawal by Subject|0|||
23129044|NCT01365481|64222129|FG001|Overall Study|Withdrawal by Subject|2|||
23129045|NCT01365481|64222130|FG002|Overall Study|Withdrawal by Subject|1|||
23129046|NCT01365481|64222131|FG003|Overall Study|Withdrawal by Subject|1|||
23129047|NCT01365481|64222128|FG000|Overall Study|Lost to Follow-up|1|||
23129048|NCT01365481|64222129|FG001|Overall Study|Lost to Follow-up|1|||
23129049|NCT01365481|64222130|FG002|Overall Study|Lost to Follow-up|2|||
23129050|NCT01365481|64222131|FG003|Overall Study|Lost to Follow-up|3|||
23129051|NCT01365481|64222128|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23129052|NCT01365481|64222129|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23129053|NCT01365481|64222130|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23129054|NCT01365481|64222131|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23129055|NCT01365481|64222128|FG000|Overall Study|Administrative problems|0|||
23129056|NCT01365481|64222129|FG001|Overall Study|Administrative problems|1|||
23129057|NCT01365481|64222130|FG002|Overall Study|Administrative problems|0|||
23129058|NCT01365481|64222131|FG003|Overall Study|Administrative problems|0|||
23129059|NCT01365481|64222128|FG000|Overall Study|Protocol deviation|0|||
23129060|NCT01365481|64222129|FG001|Overall Study|Protocol deviation|1|||
23129061|NCT01365481|64222130|FG002|Overall Study|Protocol deviation|0|||
23129062|NCT01365481|64222131|FG003|Overall Study|Protocol deviation|1|||
23129063|NCT01365481|64222128|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23212784|NCT04449276|64519779|FG001|Overall Study|Withdrawal by Subject|0|||
23212785|NCT04449276|64519780|FG002|Overall Study|Withdrawal by Subject|0|||
23212786|NCT04449276|64519781|FG003|Overall Study|Withdrawal by Subject|1|||
23212787|NCT04449276|64519782|FG004|Overall Study|Withdrawal by Subject|0|||
23212788|NCT04449276|64519783|FG005|Overall Study|Withdrawal by Subject|0|||
23212789|NCT04449276|64519784|FG006|Overall Study|Withdrawal by Subject|0|||
23212790|NCT04449276|64519785|FG007|Overall Study|Withdrawal by Subject|0|||
23212791|NCT04449276|64519778|FG000|Overall Study|Other|0|||
23212792|NCT04449276|64519779|FG001|Overall Study|Other|2|||
23212793|NCT04449276|64519780|FG002|Overall Study|Other|3|||
23212794|NCT04449276|64519781|FG003|Overall Study|Other|2|||
23212795|NCT04449276|64519782|FG004|Overall Study|Other|0|||
23212796|NCT04449276|64519783|FG005|Overall Study|Other|0|||
23212797|NCT04449276|64519784|FG006|Overall Study|Other|0|||
23212798|NCT04449276|64519785|FG007|Overall Study|Other|1|||
23212799|NCT02917629|64519786|FG000|Overall Study|Withdrawal by Subject|0|||
23212800|NCT02917629|64519787|FG001|Overall Study|Withdrawal by Subject|1|||
23212801|NCT01170702|64519789|FG000|Overall Study|Exclusion criteria met after consent|1|||
23212802|NCT01170702|64519790|FG001|Overall Study|Exclusion criteria met after consent|2|||
23212803|NCT01170702|64519791|FG002|Overall Study|Exclusion criteria met after consent|0|||
23212804|NCT01170702|64519792|FG003|Overall Study|Exclusion criteria met after consent|2|||
23212805|NCT00187889|64519795|FG000|Overall Study|Withdrawal by Subject|6|||
23212806|NCT00187889|64519796|FG001|Overall Study|Withdrawal by Subject|4|||
23212807|NCT01296698|64519800|FG000|Overall Study|Adverse Event|1|||
23212808|NCT01296698|64519801|FG001|Overall Study|Adverse Event|0|||
23212809|NCT01296698|64519800|FG000|Overall Study|Death|1|||
23212810|NCT01296698|64519801|FG001|Overall Study|Death|0|||
23212811|NCT01296698|64519800|FG000|Overall Study|Lost to Follow-up|19|||
23212812|NCT01296698|64519801|FG001|Overall Study|Lost to Follow-up|1|||
23212813|NCT01296698|64519800|FG000|Overall Study|Withdrawal by Subject|12|||
23212814|NCT01296698|64519801|FG001|Overall Study|Withdrawal by Subject|0|||
23545737|NCT04642638|65727278|FG003|Overall Study|Lost to Follow-up|5|||
23129064|NCT01365481|64222129|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23212815|NCT01296698|64519800|FG000|Overall Study|Difficulty Contacting Subject|2|||
23212816|NCT01296698|64519801|FG001|Overall Study|Difficulty Contacting Subject|0|||
23212817|NCT01296698|64519800|FG000|Overall Study|Study Terminated by Sponsor|209|||
23212818|NCT01296698|64519801|FG001|Overall Study|Study Terminated by Sponsor|12|||
23212819|NCT00603733|64519802|FG000|Active Phase ITT|Adverse Event|8|||
23129065|NCT01365481|64222130|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
23129066|NCT01365481|64222131|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23129067|NCT01299480|64222132|FG000|Overall Study|No longer willing to participate|19|||
23129068|NCT01299480|64222133|FG001|Overall Study|No longer willing to participate|17|||
23129069|NCT01299480|64222134|FG002|Overall Study|No longer willing to participate|14|||
23129070|NCT01299480|64222135|FG003|Overall Study|No longer willing to participate|13|||
23129071|NCT01299480|64222136|FG004|Overall Study|No longer willing to participate|10|||
23129072|NCT01299480|64222132|FG000|Overall Study|Protocol Violation|7|||
23129073|NCT01299480|64222133|FG001|Overall Study|Protocol Violation|5|||
23129074|NCT01299480|64222134|FG002|Overall Study|Protocol Violation|8|||
23129075|NCT01299480|64222135|FG003|Overall Study|Protocol Violation|1|||
23129076|NCT01299480|64222136|FG004|Overall Study|Protocol Violation|1|||
23129077|NCT01299480|64222132|FG000|Overall Study|Withdrawal by Subject|3|||
23129078|NCT01299480|64222133|FG001|Overall Study|Withdrawal by Subject|4|||
23129079|NCT01299480|64222134|FG002|Overall Study|Withdrawal by Subject|7|||
23129080|NCT01299480|64222135|FG003|Overall Study|Withdrawal by Subject|3|||
23129081|NCT01299480|64222136|FG004|Overall Study|Withdrawal by Subject|4|||
23129082|NCT01299480|64222132|FG000|Overall Study|Adverse Event|6|||
23129083|NCT01299480|64222133|FG001|Overall Study|Adverse Event|4|||
23129084|NCT01299480|64222134|FG002|Overall Study|Adverse Event|5|||
23129085|NCT01299480|64222135|FG003|Overall Study|Adverse Event|4|||
23129086|NCT01299480|64222136|FG004|Overall Study|Adverse Event|0|||
23129087|NCT01299480|64222132|FG000|Overall Study|Withdrawal due to pregnancy|0|||
23129088|NCT01299480|64222133|FG001|Overall Study|Withdrawal due to pregnancy|1|||
23129089|NCT01299480|64222134|FG002|Overall Study|Withdrawal due to pregnancy|1|||
23129090|NCT01299480|64222135|FG003|Overall Study|Withdrawal due to pregnancy|0|||
23129091|NCT01299480|64222136|FG004|Overall Study|Withdrawal due to pregnancy|0|||
23129092|NCT01299480|64222132|FG000|Overall Study|Physician Decision|1|||
23129093|NCT01299480|64222133|FG001|Overall Study|Physician Decision|1|||
23129094|NCT01299480|64222134|FG002|Overall Study|Physician Decision|0|||
23129095|NCT01299480|64222135|FG003|Overall Study|Physician Decision|2|||
23129096|NCT01299480|64222136|FG004|Overall Study|Physician Decision|0|||
23129097|NCT01299480|64222132|FG000|Overall Study|Lost to Follow-up|3|||
23129098|NCT01299480|64222133|FG001|Overall Study|Lost to Follow-up|1|||
23129099|NCT01299480|64222134|FG002|Overall Study|Lost to Follow-up|2|||
23129100|NCT01299480|64222135|FG003|Overall Study|Lost to Follow-up|1|||
23129101|NCT01299480|64222136|FG004|Overall Study|Lost to Follow-up|2|||
23129102|NCT01299480|64222132|FG000|Overall Study|Other|3|||
23129103|NCT01299480|64222133|FG001|Overall Study|Other|2|||
23129104|NCT01299480|64222134|FG002|Overall Study|Other|3|||
23129105|NCT01299480|64222135|FG003|Overall Study|Other|0|||
23129106|NCT01299480|64222136|FG004|Overall Study|Other|3|||
23129107|NCT01299480|64222132|FG000|Overall Study|Started, but not vaccinated|0|||
23129108|NCT01299480|64222133|FG001|Overall Study|Started, but not vaccinated|0|||
23129109|NCT01299480|64222134|FG002|Overall Study|Started, but not vaccinated|1|||
23129110|NCT01299480|64222135|FG003|Overall Study|Started, but not vaccinated|1|||
23129111|NCT01299480|64222136|FG004|Overall Study|Started, but not vaccinated|0|||
23129112|NCT01696955|64222137|FG000|Main Study|Protocol Violation|1|||
23129113|NCT01696955|64222138|FG001|Main Study|Protocol Violation|0|||
23129114|NCT01696955|64222137|FG000|Main Study|Withdrawal by Subject|1|||
23129115|NCT01696955|64222138|FG001|Main Study|Withdrawal by Subject|1|||
23129116|NCT02440425|64222140|FG000|Overall Study|Death likely due to disease progression|1|||
23129117|NCT02440425|64222140|FG000|Overall Study|Withdrawal by Subject|2|||
23129118|NCT02440425|64222140|FG000|Overall Study|Adverse Event|1|||
23129119|NCT02440425|64222140|FG000|Overall Study|Adverse Event/Ineligible|1|||
23129120|NCT02489968|64222146|FG000|Open-label Treatment Period|Adverse Event|14|||
23129121|NCT02489968|64222147|FG001|Open-label Treatment Period|Adverse Event|7|||
23129122|NCT02489968|64222148|FG002|Open-label Treatment Period|Adverse Event|0|||
23129123|NCT02489968|64222149|FG003|Open-label Treatment Period|Adverse Event|0|||
23129124|NCT02489968|64222150|FG004|Open-label Treatment Period|Adverse Event|0|||
23129125|NCT02489968|64222151|FG005|Open-label Treatment Period|Adverse Event|0|||
23129126|NCT02489968|64222146|FG000|Open-label Treatment Period|Protocol Violation|2|||
23129127|NCT02489968|64222147|FG001|Open-label Treatment Period|Protocol Violation|2|||
23129128|NCT02489968|64222148|FG002|Open-label Treatment Period|Protocol Violation|0|||
23129129|NCT02489968|64222149|FG003|Open-label Treatment Period|Protocol Violation|0|||
23129130|NCT02489968|64222150|FG004|Open-label Treatment Period|Protocol Violation|0|||
23129131|NCT02489968|64222151|FG005|Open-label Treatment Period|Protocol Violation|0|||
23129132|NCT02489968|64222146|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23129133|NCT02489968|64222147|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
23129134|NCT02489968|64222148|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
23129135|NCT02489968|64222149|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
23545738|NCT04642638|65727279|FG004|Overall Study|Lost to Follow-up|6|||
23129136|NCT02489968|64222150|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
23129137|NCT02489968|64222151|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
23129138|NCT02489968|64222146|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
23129139|NCT02489968|64222147|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
23129140|NCT02489968|64222148|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
23129141|NCT02489968|64222149|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
23129142|NCT02489968|64222150|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
23129143|NCT02489968|64222151|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
23129144|NCT02489968|64222146|FG000|Open-label Treatment Period|Other than specified above|204|||
23212820|NCT00603733|64519803|FG001|Active Phase ITT|Adverse Event|7|||
23212821|NCT00603733|64519802|FG000|Active Phase ITT|Withdrawal by Subject|0|||
23212822|NCT00603733|64519803|FG001|Active Phase ITT|Withdrawal by Subject|3|||
23212823|NCT00603733|64519802|FG000|Active Phase ITT|Lost to Follow-up|0|||
23212824|NCT00603733|64519803|FG001|Active Phase ITT|Lost to Follow-up|1|||
23212825|NCT00603733|64519802|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
23212826|NCT00603733|64519803|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
23212827|NCT00603733|64519802|FG000|Active Phase ITT|Lack of Efficacy|1|||
23212828|NCT00603733|64519803|FG001|Active Phase ITT|Lack of Efficacy|2|||
23212829|NCT00603733|64519802|FG000|Active Phase ITT|Subject moved, site closed|1|||
23212830|NCT00603733|64519803|FG001|Active Phase ITT|Subject moved, site closed|1|||
23212831|NCT00603733|64519802|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
23212832|NCT00603733|64519803|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
23212833|NCT00603733|64519802|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
23212834|NCT00603733|64519803|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
23212835|NCT00603733|64519802|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
23545739|NCT04642638|65727280|FG005|Overall Study|Lost to Follow-up|3|||
23545740|NCT04642638|65727275|FG000|Overall Study|Adverse Event|0|||
23545741|NCT04642638|65727276|FG001|Overall Study|Adverse Event|0|||
23545742|NCT04642638|65727277|FG002|Overall Study|Adverse Event|1|||
23545743|NCT04642638|65727278|FG003|Overall Study|Adverse Event|0|||
23129145|NCT02489968|64222147|FG001|Open-label Treatment Period|Other than specified above|189|||
23129146|NCT02489968|64222148|FG002|Open-label Treatment Period|Other than specified above|0|||
23129147|NCT02489968|64222149|FG003|Open-label Treatment Period|Other than specified above|0|||
23129148|NCT02489968|64222150|FG004|Open-label Treatment Period|Other than specified above|0|||
23129149|NCT02489968|64222151|FG005|Open-label Treatment Period|Other than specified above|0|||
23129150|NCT02489968|64222146|FG000|Double-blind Treatment Period|Adverse Event|0|||
23129151|NCT02489968|64222147|FG001|Double-blind Treatment Period|Adverse Event|0|||
23129152|NCT02489968|64222148|FG002|Double-blind Treatment Period|Adverse Event|2|||
23129153|NCT02489968|64222149|FG003|Double-blind Treatment Period|Adverse Event|6|||
23129154|NCT02489968|64222150|FG004|Double-blind Treatment Period|Adverse Event|4|||
23129155|NCT02489968|64222151|FG005|Double-blind Treatment Period|Adverse Event|5|||
23129156|NCT02489968|64222146|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23129157|NCT02489968|64222147|FG001|Double-blind Treatment Period|Protocol Violation|0|||
23129158|NCT02489968|64222148|FG002|Double-blind Treatment Period|Protocol Violation|0|||
23129159|NCT02489968|64222149|FG003|Double-blind Treatment Period|Protocol Violation|0|||
23129160|NCT02489968|64222150|FG004|Double-blind Treatment Period|Protocol Violation|1|||
23129161|NCT02489968|64222151|FG005|Double-blind Treatment Period|Protocol Violation|1|||
23129162|NCT02489968|64222146|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
23129163|NCT02489968|64222147|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23129164|NCT02489968|64222148|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23129165|NCT02489968|64222149|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
23129166|NCT02489968|64222150|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
23129167|NCT02489968|64222151|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
23129168|NCT02489968|64222146|FG000|Double-blind Treatment Period|Other than specified above|0|||
23129169|NCT02489968|64222147|FG001|Double-blind Treatment Period|Other than specified above|0|||
23129170|NCT02489968|64222148|FG002|Double-blind Treatment Period|Other than specified above|0|||
23129171|NCT02489968|64222149|FG003|Double-blind Treatment Period|Other than specified above|0|||
23129172|NCT02489968|64222150|FG004|Double-blind Treatment Period|Other than specified above|1|||
23129173|NCT02489968|64222151|FG005|Double-blind Treatment Period|Other than specified above|0|||
23129174|NCT03853551|64222152|FG000|Overall Study|Death|2|||
23129175|NCT03853551|64222152|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
23129176|NCT01638390|64222153|FG000|Overall Study|screening failures|21|||
23129177|NCT01689857|64222154|FG000|Overall Study|Lost to Follow-up|5|||
23129178|NCT01689857|64222155|FG001|Overall Study|Lost to Follow-up|2|||
23129179|NCT01385748|64222156|FG000|Overall Study|Withdrawal by Subject|7|||
23129180|NCT01385748|64222157|FG001|Overall Study|Withdrawal by Subject|4|||
23129181|NCT01385748|64222158|FG002|Overall Study|Withdrawal by Subject|5|||
23129182|NCT01385748|64222156|FG000|Overall Study|Noncompliance|3|||
23212836|NCT00603733|64519803|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
23212837|NCT00603733|64519802|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
23212838|NCT00603733|64519803|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
23212839|NCT00603733|64519802|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
23545744|NCT04642638|65727279|FG004|Overall Study|Adverse Event|10|||
23545745|NCT04642638|65727280|FG005|Overall Study|Adverse Event|3|||
23129183|NCT01385748|64222157|FG001|Overall Study|Noncompliance|1|||
23129184|NCT01385748|64222158|FG002|Overall Study|Noncompliance|6|||
23129185|NCT01385748|64222156|FG000|Overall Study|Other|1|||
23129186|NCT01385748|64222157|FG001|Overall Study|Other|7|||
23129187|NCT01385748|64222158|FG002|Overall Study|Other|1|||
23212840|NCT00603733|64519803|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
23212841|NCT00603733|64519802|FG000|Maintenance Phase ITT|Adverse Event|3|||
23129188|NCT01385748|64222156|FG000|Overall Study|Adverse Event|4|||
23129189|NCT01385748|64222157|FG001|Overall Study|Adverse Event|2|||
23129190|NCT01385748|64222158|FG002|Overall Study|Adverse Event|1|||
23129191|NCT00368875|64222159|FG000|Overall Study|Adverse Event|0|||
23129192|NCT00368875|64222160|FG001|Overall Study|Adverse Event|12|||
23129193|NCT00368875|64222159|FG000|Overall Study|Progressive disease|3|||
23129194|NCT00368875|64222160|FG001|Overall Study|Progressive disease|27|||
23129195|NCT00368875|64222159|FG000|Overall Study|Withdrawal by Subject|2|||
23129196|NCT00368875|64222160|FG001|Overall Study|Withdrawal by Subject|6|||
23129197|NCT00368875|64222159|FG000|Overall Study|Other Reason|0|||
23129198|NCT00368875|64222160|FG001|Overall Study|Other Reason|2|||
23129199|NCT00368875|64222159|FG000|Overall Study|Alternative Therapy|1|||
23129200|NCT00368875|64222160|FG001|Overall Study|Alternative Therapy|1|||
23129201|NCT02979249|64222162|FG000|Overall Study|Lost to Follow-up|2|||
23129202|NCT02979249|64222162|FG000|Overall Study|Withdrawal by Subject|4|||
23129203|NCT01920477|64222163|FG000|Overall Study|Adverse Event|0|||
23129204|NCT01920477|64222164|FG001|Overall Study|Adverse Event|1|||
23129205|NCT01920477|64222163|FG000|Overall Study|Lack of Efficacy|1|||
23129206|NCT01920477|64222164|FG001|Overall Study|Lack of Efficacy|0|||
23129207|NCT01920477|64222163|FG000|Overall Study|Study closed/terminated|14|||
23129208|NCT01920477|64222164|FG001|Overall Study|Study closed/terminated|15|||
23129209|NCT01920477|64222163|FG000|Overall Study|Withdrawal by Subject|0|||
23129210|NCT01920477|64222164|FG001|Overall Study|Withdrawal by Subject|1|||
23129211|NCT01934790|64222165|FG000|Treatment|Adverse Event|3|||
23129212|NCT01934790|64222165|FG000|Treatment|Clinical progression|6|||
23129213|NCT01934790|64222165|FG000|Treatment|Radiological progression|4|||
23129214|NCT01934790|64222165|FG000|Treatment|Withdrawal by Subject|2|||
23129215|NCT01934790|64222165|FG000|Treatment|Study drug never administered|1|||
23129216|NCT01934790|64222165|FG000|Active Follow up|Death|20|||
23129217|NCT01934790|64222165|FG000|Active Follow up|Physician Decision|2|||
23129218|NCT01934790|64222165|FG000|Active Follow up|Progressive disease|1|||
23129219|NCT01934790|64222165|FG000|Active Follow up|Other reason|1|||
23129220|NCT05262517|64222166|FG000|Overall Study|Randomized but not treated|5|||
23129221|NCT05262517|64222167|FG001|Overall Study|Randomized but not treated|11|||
23129222|NCT00680992|64222168|FG000|Overall Study|Complete Resection (as per protocol)|25|||
23129223|NCT00680992|64222169|FG001|Overall Study|Complete Resection (as per protocol)|121|||
23129224|NCT00680992|64222170|FG002|Overall Study|Complete Resection (as per protocol)|0|||
23129225|NCT00680992|64222168|FG000|Overall Study|Administrative Decision|83|||
23129226|NCT00680992|64222169|FG001|Overall Study|Administrative Decision|42|||
23129227|NCT00680992|64222170|FG002|Overall Study|Administrative Decision|5|||
23129228|NCT00680992|64222168|FG000|Overall Study|End of Trial|32|||
23129229|NCT00680992|64222169|FG001|Overall Study|End of Trial|12|||
23129230|NCT00680992|64222170|FG002|Overall Study|End of Trial|3|||
23129231|NCT00680992|64222168|FG000|Overall Study|Withdrawal by Subject|33|||
23129232|NCT00680992|64222169|FG001|Overall Study|Withdrawal by Subject|11|||
23129233|NCT00680992|64222170|FG002|Overall Study|Withdrawal by Subject|1|||
23129234|NCT00680992|64222168|FG000|Overall Study|Adverse Event|21|||
23129235|NCT00680992|64222169|FG001|Overall Study|Adverse Event|19|||
23129236|NCT00680992|64222170|FG002|Overall Study|Adverse Event|1|||
23129237|NCT00680992|64222168|FG000|Overall Study|Other|19|||
23129238|NCT00680992|64222169|FG001|Overall Study|Other|14|||
23129239|NCT00680992|64222170|FG002|Overall Study|Other|1|||
23129240|NCT00680992|64222168|FG000|Overall Study|Disease Progression|21|||
23129241|NCT00680992|64222169|FG001|Overall Study|Disease Progression|9|||
23129242|NCT00680992|64222170|FG002|Overall Study|Disease Progression|0|||
23129243|NCT00680992|64222168|FG000|Overall Study|Lost to Follow-up|12|||
23129244|NCT00680992|64222169|FG001|Overall Study|Lost to Follow-up|14|||
23129245|NCT00680992|64222170|FG002|Overall Study|Lost to Follow-up|0|||
23129246|NCT00680992|64222168|FG000|Overall Study|Noncompliance|4|||
23129247|NCT00680992|64222169|FG001|Overall Study|Noncompliance|6|||
23129248|NCT00680992|64222170|FG002|Overall Study|Noncompliance|0|||
23129249|NCT00680992|64222168|FG000|Overall Study|Requirement for Alternative Therapy|8|||
23129250|NCT00680992|64222169|FG001|Overall Study|Requirement for Alternative Therapy|2|||
23129251|NCT00680992|64222170|FG002|Overall Study|Requirement for Alternative Therapy|0|||
23545746|NCT04642638|65727275|FG000|Overall Study|Reason Not Specified|1|||
23129252|NCT00680992|64222168|FG000|Overall Study|Pregnancy|5|||
23129253|NCT00680992|64222169|FG001|Overall Study|Pregnancy|0|||
23129254|NCT00680992|64222170|FG002|Overall Study|Pregnancy|1|||
23129255|NCT00680992|64222168|FG000|Overall Study|Death|5|||
23129256|NCT00680992|64222169|FG001|Overall Study|Death|1|||
23129257|NCT00680992|64222170|FG002|Overall Study|Death|0|||
23129258|NCT00680992|64222168|FG000|Overall Study|Ineligibility Determined|0|||
23129259|NCT00680992|64222169|FG001|Overall Study|Ineligibility Determined|1|||
23129260|NCT00680992|64222170|FG002|Overall Study|Ineligibility Determined|0|||
23545747|NCT04642638|65727276|FG001|Overall Study|Reason Not Specified|4|||
23129261|NCT00669877|64222171|FG000|Overall Study|Disease Progression/Death|4|||
23129262|NCT00607724|64222174|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
23129263|NCT00607724|64222175|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
23129264|NCT00607724|64222176|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
23129265|NCT00607724|64222177|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
23129266|NCT00607724|64222178|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
23129267|NCT00607724|64222179|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
23129268|NCT00607724|64222180|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
23129269|NCT00607724|64222174|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
23129270|NCT00607724|64222175|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
23129271|NCT00607724|64222176|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
23129272|NCT00607724|64222177|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
23129273|NCT00607724|64222178|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
23129274|NCT00607724|64222179|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
23129275|NCT00607724|64222180|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
23129276|NCT00607724|64222174|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
23129277|NCT00607724|64222175|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
23129278|NCT00607724|64222176|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
23129279|NCT00607724|64222177|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
23129280|NCT00607724|64222178|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
23129281|NCT00607724|64222179|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
23129282|NCT00607724|64222180|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
23129283|NCT00607724|64222174|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
23316815|NCT00996892|64903945|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
23316816|NCT00996892|64903946|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
23316817|NCT00996892|64903947|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
23316818|NCT00996892|64903948|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
23316819|NCT00996892|64903949|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
23316820|NCT00996892|64903950|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
23316821|NCT00996892|64903951|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
23316822|NCT00996892|64903952|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
23316823|NCT00996892|64903953|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
23316824|NCT00996892|64903954|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
23316825|NCT00996892|64903955|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
23316826|NCT00996892|64903956|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
23316827|NCT00996892|64903957|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
23316828|NCT00996892|64903958|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
23316829|NCT00996892|64903959|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
23316830|NCT00996892|64903960|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
23316831|NCT00996892|64903961|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
23316832|NCT00996892|64903942|FG000|Dose-Escalation Stage 1A|Death|0|||
23316833|NCT00996892|64903943|FG001|Dose-Escalation Stage 1A|Death|0|||
23129284|NCT00607724|64222175|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
23129285|NCT00607724|64222176|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
23212842|NCT00603733|64519803|FG001|Maintenance Phase ITT|Adverse Event|6|||
23212843|NCT00603733|64519802|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
23212844|NCT00603733|64519803|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
23212845|NCT00603733|64519802|FG000|Maintenance Phase ITT|Protocol Violation|1|||
23212846|NCT00603733|64519803|FG001|Maintenance Phase ITT|Protocol Violation|1|||
23212847|NCT00603733|64519802|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
23212848|NCT00603733|64519803|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
23212849|NCT00603733|64519802|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
23212850|NCT00603733|64519803|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
23212851|NCT00603733|64519802|FG000|Maintenance Phase ITT|Physician Decision|0|||
23316834|NCT00996892|64903944|FG002|Dose-Escalation Stage 1A|Death|0|||
23129286|NCT00607724|64222177|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
23129287|NCT00607724|64222178|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
23129288|NCT00607724|64222179|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
23129289|NCT00607724|64222180|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
23129290|NCT00607724|64222174|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23129291|NCT00607724|64222175|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23129292|NCT00607724|64222176|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23129293|NCT00607724|64222177|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
23129294|NCT00607724|64222178|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23129295|NCT00607724|64222179|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23212852|NCT00603733|64519803|FG001|Maintenance Phase ITT|Physician Decision|1|||
23316835|NCT00996892|64903945|FG003|Dose-Escalation Stage 1A|Death|0|||
23316836|NCT00996892|64903946|FG004|Dose-Escalation Stage 1A|Death|0|||
23316837|NCT00996892|64903947|FG005|Dose-Escalation Stage 1A|Death|0|||
23129296|NCT00607724|64222180|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
23212853|NCT00603733|64519802|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
23316838|NCT00996892|64903948|FG006|Dose-Escalation Stage 1A|Death|0|||
23129297|NCT02473289|64222187|FG000|Overall Study|Adverse Event|2|||
23129298|NCT02473289|64222188|FG001|Overall Study|Adverse Event|3|||
23129299|NCT02473289|64222187|FG000|Overall Study|Lost to Follow-up|1|||
23129300|NCT02473289|64222188|FG001|Overall Study|Lost to Follow-up|1|||
23129301|NCT02473289|64222187|FG000|Overall Study|Protocol Violation|0|||
23129302|NCT02473289|64222188|FG001|Overall Study|Protocol Violation|1|||
23129303|NCT02473289|64222187|FG000|Overall Study|Withdrawal of consent|6|||
23129304|NCT02473289|64222188|FG001|Overall Study|Withdrawal of consent|7|||
23129305|NCT02473289|64222187|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
23129306|NCT02473289|64222188|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
23129307|NCT02473289|64222187|FG000|Overall Study|Other|2|||
23129308|NCT02473289|64222188|FG001|Overall Study|Other|0|||
23129309|NCT00702962|64222189|FG000|Overall Study|Progressive disease|0|||
23129310|NCT00702962|64222190|FG001|Overall Study|Progressive disease|1|||
23129311|NCT00702962|64222189|FG000|Overall Study|Hospitalized for other health disorder|1|||
23129312|NCT00702962|64222190|FG001|Overall Study|Hospitalized for other health disorder|0|||
23129313|NCT00438672|64222191|FG000|Overall Study|Lost to Follow-up|7|||
23129314|NCT00438672|64222192|FG001|Overall Study|Lost to Follow-up|9|||
23129315|NCT03332784|64222195|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129316|NCT03332784|64222196|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
23129317|NCT03332784|64222197|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129318|NCT03332784|64222198|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129319|NCT03332784|64222199|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129320|NCT03332784|64222200|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129321|NCT03332784|64222201|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129322|NCT03332784|64222202|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129323|NCT03332784|64222203|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129324|NCT03332784|64222204|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129325|NCT03332784|64222205|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129326|NCT03332784|64222206|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129327|NCT03332784|64222207|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129328|NCT03332784|64222208|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129329|NCT03332784|64222209|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
23129330|NCT03332784|64222210|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129331|NCT03332784|64222211|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129332|NCT03332784|64222212|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129333|NCT03332784|64222213|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129334|NCT03332784|64222214|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
23129335|NCT00667459|64222216|FG000|Overall Study|Death|0|||
23129336|NCT00667459|64222217|FG001|Overall Study|Death|2|||
23129337|NCT00667459|64222216|FG000|Overall Study|Lost to Follow-up|8|||
23129338|NCT00667459|64222217|FG001|Overall Study|Lost to Follow-up|43|||
23129339|NCT02493062|64222221|FG000|Overall Study|Physician Decision|12|||
23129340|NCT01525238|64222222|FG000|Overall Study|Withdrawal by Subject|1|||
23129341|NCT01525238|64222223|FG001|Overall Study|Withdrawal by Subject|0|||
23129342|NCT01525238|64222224|FG002|Overall Study|Withdrawal by Subject|0|||
23129343|NCT01677767|64222225|FG000|Overall Study|Adverse Event|1|||
23129344|NCT01677767|64222225|FG000|Overall Study|Death|4|||
23129345|NCT01677767|64222225|FG000|Overall Study|Protocol Violation|4|||
23129346|NCT01677767|64222225|FG000|Overall Study|Withdrawal by Subject|10|||
23212854|NCT00603733|64519803|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
23316839|NCT00996892|64903949|FG007|Dose-Escalation Stage 1A|Death|0|||
23129347|NCT01677767|64222225|FG000|Overall Study|Non-compliance by the participants|3|||
23129348|NCT02628028|64222236|FG000|Dosing Period|Withdrawal by Subject|0|||
23129349|NCT02628028|64222237|FG001|Dosing Period|Withdrawal by Subject|0|||
23129350|NCT02628028|64222238|FG002|Dosing Period|Withdrawal by Subject|1|||
23129351|NCT02628028|64222239|FG003|Dosing Period|Withdrawal by Subject|0|||
23129352|NCT02628028|64222240|FG004|Dosing Period|Withdrawal by Subject|2|||
23129353|NCT02628028|64222241|FG005|Dosing Period|Withdrawal by Subject|4|||
23129354|NCT02628028|64222242|FG006|Dosing Period|Withdrawal by Subject|1|||
23129355|NCT02628028|64222243|FG007|Dosing Period|Withdrawal by Subject|1|||
23129356|NCT02628028|64222236|FG000|Dosing Period|Adverse Event|0|||
23129357|NCT02628028|64222237|FG001|Dosing Period|Adverse Event|0|||
23129358|NCT02628028|64222238|FG002|Dosing Period|Adverse Event|0|||
23129359|NCT02628028|64222239|FG003|Dosing Period|Adverse Event|0|||
23129360|NCT02628028|64222240|FG004|Dosing Period|Adverse Event|2|||
23129361|NCT02628028|64222241|FG005|Dosing Period|Adverse Event|1|||
23129362|NCT02628028|64222242|FG006|Dosing Period|Adverse Event|3|||
23129363|NCT02628028|64222243|FG007|Dosing Period|Adverse Event|2|||
23129364|NCT02628028|64222236|FG000|Dosing Period|Death|0|||
23129365|NCT02628028|64222237|FG001|Dosing Period|Death|0|||
23129366|NCT02628028|64222238|FG002|Dosing Period|Death|0|||
23129367|NCT02628028|64222239|FG003|Dosing Period|Death|0|||
23129368|NCT02628028|64222240|FG004|Dosing Period|Death|0|||
23129369|NCT02628028|64222241|FG005|Dosing Period|Death|0|||
23316840|NCT00996892|64903950|FG008|Dose-Escalation Stage 1A|Death|0|||
23129370|NCT02628028|64222242|FG006|Dosing Period|Death|0|||
23129371|NCT02628028|64222243|FG007|Dosing Period|Death|1|||
23129372|NCT02628028|64222236|FG000|Dosing Period|Lack of Efficacy|0|||
23129373|NCT02628028|64222237|FG001|Dosing Period|Lack of Efficacy|0|||
23129374|NCT02628028|64222238|FG002|Dosing Period|Lack of Efficacy|0|||
23129375|NCT02628028|64222239|FG003|Dosing Period|Lack of Efficacy|0|||
23129376|NCT02628028|64222240|FG004|Dosing Period|Lack of Efficacy|3|||
23129377|NCT02628028|64222241|FG005|Dosing Period|Lack of Efficacy|0|||
23129378|NCT02628028|64222242|FG006|Dosing Period|Lack of Efficacy|1|||
23129379|NCT02628028|64222243|FG007|Dosing Period|Lack of Efficacy|0|||
23129380|NCT02628028|64222236|FG000|Dosing Period|Study Terminated by Sponsor|0|||
23129381|NCT02628028|64222237|FG001|Dosing Period|Study Terminated by Sponsor|0|||
23129382|NCT02628028|64222238|FG002|Dosing Period|Study Terminated by Sponsor|0|||
23129383|NCT02628028|64222239|FG003|Dosing Period|Study Terminated by Sponsor|0|||
23129384|NCT02628028|64222240|FG004|Dosing Period|Study Terminated by Sponsor|7|||
23129385|NCT02628028|64222241|FG005|Dosing Period|Study Terminated by Sponsor|6|||
23129386|NCT02628028|64222242|FG006|Dosing Period|Study Terminated by Sponsor|7|||
23212855|NCT00424294|64519807|FG000|Overall Study|Adverse Event|4|||
23212856|NCT00424294|64519808|FG001|Overall Study|Adverse Event|10|||
23129387|NCT02628028|64222243|FG007|Dosing Period|Study Terminated by Sponsor|7|||
23129388|NCT02628028|64222236|FG000|Dosing Period|Physician Decision|0|||
23129389|NCT02628028|64222237|FG001|Dosing Period|Physician Decision|0|||
23129390|NCT02628028|64222238|FG002|Dosing Period|Physician Decision|0|||
23129391|NCT02628028|64222239|FG003|Dosing Period|Physician Decision|0|||
23129392|NCT02628028|64222240|FG004|Dosing Period|Physician Decision|0|||
23129393|NCT02628028|64222241|FG005|Dosing Period|Physician Decision|1|||
23129394|NCT02628028|64222242|FG006|Dosing Period|Physician Decision|0|||
23129395|NCT02628028|64222243|FG007|Dosing Period|Physician Decision|0|||
23212857|NCT00424294|64519807|FG000|Overall Study|Lack of Efficacy|2|||
23212858|NCT00424294|64519808|FG001|Overall Study|Lack of Efficacy|1|||
23212859|NCT00424294|64519807|FG000|Overall Study|Withdrawal by Subject|1|||
23212860|NCT00424294|64519808|FG001|Overall Study|Withdrawal by Subject|2|||
23212861|NCT00424294|64519807|FG000|Overall Study|Other|0|||
23426781|NCT00276094|65307451|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
23129396|NCT02628028|64222236|FG000|Dosing Period|Site Terminated by Sponsor|0|||
23129397|NCT02628028|64222237|FG001|Dosing Period|Site Terminated by Sponsor|0|||
23129398|NCT02628028|64222238|FG002|Dosing Period|Site Terminated by Sponsor|0|||
23129399|NCT02628028|64222239|FG003|Dosing Period|Site Terminated by Sponsor|0|||
23129400|NCT02628028|64222240|FG004|Dosing Period|Site Terminated by Sponsor|0|||
23129401|NCT02628028|64222241|FG005|Dosing Period|Site Terminated by Sponsor|1|||
23129402|NCT02628028|64222242|FG006|Dosing Period|Site Terminated by Sponsor|1|||
23129403|NCT02628028|64222243|FG007|Dosing Period|Site Terminated by Sponsor|0|||
23129404|NCT02628028|64222236|FG000|Dosing Period|Lost to Follow-up|0|||
23129405|NCT02628028|64222237|FG001|Dosing Period|Lost to Follow-up|0|||
23129406|NCT02628028|64222238|FG002|Dosing Period|Lost to Follow-up|0|||
23129407|NCT02628028|64222239|FG003|Dosing Period|Lost to Follow-up|0|||
23129408|NCT02628028|64222240|FG004|Dosing Period|Lost to Follow-up|0|||
23129409|NCT02628028|64222241|FG005|Dosing Period|Lost to Follow-up|0|||
23129410|NCT02628028|64222242|FG006|Dosing Period|Lost to Follow-up|1|||
23129411|NCT02628028|64222243|FG007|Dosing Period|Lost to Follow-up|0|||
23129412|NCT02628028|64222236|FG000|Dosing Period|Other|0|||
23129413|NCT02628028|64222237|FG001|Dosing Period|Other|0|||
23129414|NCT02628028|64222238|FG002|Dosing Period|Other|0|||
23129415|NCT02628028|64222239|FG003|Dosing Period|Other|0|||
23129416|NCT02628028|64222240|FG004|Dosing Period|Other|2|||
23129417|NCT02628028|64222241|FG005|Dosing Period|Other|1|||
23129418|NCT02628028|64222242|FG006|Dosing Period|Other|2|||
23129419|NCT02628028|64222243|FG007|Dosing Period|Other|4|||
23129420|NCT02628028|64222236|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
23129421|NCT02628028|64222237|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
23129422|NCT02628028|64222238|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
23129423|NCT02628028|64222239|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
23129424|NCT02628028|64222240|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
23129425|NCT02628028|64222241|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
23129426|NCT02628028|64222242|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
23129427|NCT02628028|64222243|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
23129428|NCT02628028|64222236|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23129429|NCT02628028|64222237|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23129430|NCT02628028|64222238|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23129431|NCT02628028|64222239|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23212862|NCT00424294|64519808|FG001|Overall Study|Other|2|||
23426782|NCT00276094|65307452|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
23426783|NCT00276094|65307450|FG000|Overall Study|Other-Relocation|0|||
23316841|NCT00996892|64903951|FG009|Dose-Escalation Stage 1A|Death|2|||
23426784|NCT00276094|65307451|FG001|Overall Study|Other-Relocation|1|||
23129432|NCT02628028|64222240|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23129433|NCT02628028|64222241|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
23129434|NCT02628028|64222242|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
23129435|NCT02628028|64222243|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
23212863|NCT00424294|64519807|FG000|Overall Study|Randomized but not Treated|1|||
23212864|NCT00424294|64519808|FG001|Overall Study|Randomized but not Treated|0|||
23129436|NCT02628028|64222236|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23129437|NCT02628028|64222237|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23129438|NCT02628028|64222238|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23129439|NCT02628028|64222239|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23129440|NCT02628028|64222240|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
23129441|NCT02628028|64222241|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
23129442|NCT02628028|64222242|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
23129443|NCT02628028|64222243|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
23129444|NCT02628028|64222236|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23129445|NCT02628028|64222237|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23129446|NCT02628028|64222238|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23129447|NCT02628028|64222239|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23129448|NCT02628028|64222240|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
23129449|NCT02628028|64222241|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
23129450|NCT02628028|64222242|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
23129451|NCT02628028|64222243|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
23129452|NCT02628028|64222236|FG000|Long-term Extension (LTE) Period|Other|0|||
23129453|NCT02628028|64222237|FG001|Long-term Extension (LTE) Period|Other|0|||
23129454|NCT02628028|64222238|FG002|Long-term Extension (LTE) Period|Other|0|||
23129455|NCT02628028|64222239|FG003|Long-term Extension (LTE) Period|Other|0|||
23129456|NCT02628028|64222240|FG004|Long-term Extension (LTE) Period|Other|0|||
23129457|NCT02628028|64222241|FG005|Long-term Extension (LTE) Period|Other|3|||
23129458|NCT02628028|64222242|FG006|Long-term Extension (LTE) Period|Other|4|||
23129459|NCT02628028|64222243|FG007|Long-term Extension (LTE) Period|Other|3|||
23129460|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
23129461|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
23129462|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
23129463|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Death|4|||
23129464|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Death|2|||
23129465|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Death|3|||
23129466|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
23129467|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
23129468|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
23129469|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
23129470|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
23129471|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
23129472|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
23129473|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
23129474|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
23129475|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
23129476|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
23129477|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
23129478|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
23129479|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
23129480|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
23129481|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
23129482|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
23129483|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
23129484|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
23129485|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
23129486|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
23129487|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
23129488|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
23129489|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
23129490|NCT02783573|64222244|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
23129491|NCT02783573|64222245|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
23129492|NCT02783573|64222246|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
23129493|NCT02783573|64222244|FG000|Delayed-Start Period|Sponsor Decision|0|||
23129494|NCT02783573|64222245|FG001|Delayed-Start Period|Sponsor Decision|17|||
23129495|NCT02783573|64222246|FG002|Delayed-Start Period|Sponsor Decision|12|||
23129496|NCT04674189|64222247|FG000|Overall Study|Adverse Event|0|||
23129497|NCT04674189|64222248|FG001|Overall Study|Adverse Event|0|||
23129498|NCT04674189|64222249|FG002|Overall Study|Adverse Event|1|||
23212865|NCT00618995|64519809|FG000|Period 1|Adverse Event|0|||
23618760|NCT00866918|65991332|FG000|Overall Study|Secondary malignancy|1|||
23129499|NCT04674189|64222247|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
23316842|NCT00996892|64903952|FG010|Dose-Escalation Stage 1A|Death|0|||
23212866|NCT00618995|64519810|FG001|Period 1|Adverse Event|0|||
23212867|NCT00618995|64519811|FG002|Period 1|Adverse Event|1|||
23212868|NCT00618995|64519812|FG003|Period 1|Adverse Event|0|||
23212869|NCT00618995|64519809|FG000|Period 1|Protocol Violation|0|||
23212870|NCT00618995|64519810|FG001|Period 1|Protocol Violation|1|||
23212871|NCT00618995|64519811|FG002|Period 1|Protocol Violation|1|||
23212872|NCT00618995|64519812|FG003|Period 1|Protocol Violation|0|||
23212873|NCT00618995|64519809|FG000|Period 2|Protocol Violation|0|||
23212874|NCT00618995|64519810|FG001|Period 2|Protocol Violation|0|||
23212875|NCT00618995|64519811|FG002|Period 2|Protocol Violation|1|||
23212876|NCT00618995|64519812|FG003|Period 2|Protocol Violation|0|||
23212877|NCT00618995|64519809|FG000|Period 4|Adverse Event|1|||
23212878|NCT00618995|64519810|FG001|Period 4|Adverse Event|0|||
23212879|NCT00618995|64519811|FG002|Period 4|Adverse Event|0|||
23212880|NCT00618995|64519812|FG003|Period 4|Adverse Event|0|||
23212881|NCT00118911|64519813|FG000|Overall Study|Withdrawal by Subject|2|||
23212882|NCT00118911|64519814|FG001|Overall Study|Withdrawal by Subject|5|||
23212883|NCT00476996|64519815|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
23212884|NCT00476996|64519816|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
23212885|NCT00476996|64519817|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
23212886|NCT00476996|64519818|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
23545748|NCT04642638|65727277|FG002|Overall Study|Reason Not Specified|0|||
23545749|NCT04642638|65727278|FG003|Overall Study|Reason Not Specified|0|||
23545750|NCT04642638|65727279|FG004|Overall Study|Reason Not Specified|38|||
23545751|NCT04642638|65727280|FG005|Overall Study|Reason Not Specified|16|||
23545752|NCT04642638|65727275|FG000|Overall Study|Physician Decision|0|||
23545753|NCT04642638|65727276|FG001|Overall Study|Physician Decision|0|||
23129500|NCT04674189|64222248|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
23129501|NCT04674189|64222249|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
23129502|NCT04674189|64222247|FG000|Overall Study|Physician Decision|1|||
23545754|NCT04642638|65727277|FG002|Overall Study|Physician Decision|0|||
23545755|NCT04642638|65727278|FG003|Overall Study|Physician Decision|0|||
23129503|NCT04674189|64222248|FG001|Overall Study|Physician Decision|0|||
23129504|NCT04674189|64222249|FG002|Overall Study|Physician Decision|0|||
23129505|NCT04674189|64222247|FG000|Overall Study|Withdrawal by Participant|83|||
23129506|NCT04674189|64222248|FG001|Overall Study|Withdrawal by Participant|71|||
23129507|NCT04674189|64222249|FG002|Overall Study|Withdrawal by Participant|142|||
23129508|NCT04674189|64222247|FG000|Overall Study|Lost to Follow-up|55|||
23129509|NCT04674189|64222248|FG001|Overall Study|Lost to Follow-up|53|||
23129510|NCT04674189|64222249|FG002|Overall Study|Lost to Follow-up|44|||
23129511|NCT04674189|64222247|FG000|Overall Study|Miscellaneous|27|||
23129512|NCT04674189|64222248|FG001|Overall Study|Miscellaneous|23|||
23129513|NCT04674189|64222249|FG002|Overall Study|Miscellaneous|207|||
23129514|NCT04674189|64222247|FG000|Overall Study|Did Not Receive Treatment|3|||
23129515|NCT04674189|64222248|FG001|Overall Study|Did Not Receive Treatment|1|||
23129516|NCT04674189|64222249|FG002|Overall Study|Did Not Receive Treatment|2|||
23129517|NCT01465763|64222250|FG000|Overall Study|Withdrawal by Subject|4|||
23129518|NCT01465763|64222251|FG001|Overall Study|Withdrawal by Subject|0|||
23129519|NCT01465763|64222252|FG002|Overall Study|Withdrawal by Subject|1|||
23129520|NCT01465763|64222250|FG000|Overall Study|Insufficient Clinical Response|11|||
23129521|NCT01465763|64222251|FG001|Overall Study|Insufficient Clinical Response|0|||
23129522|NCT01465763|64222252|FG002|Overall Study|Insufficient Clinical Response|1|||
23129523|NCT01465763|64222250|FG000|Overall Study|Adverse Event|9|||
23545756|NCT04642638|65727279|FG004|Overall Study|Physician Decision|2|||
23545757|NCT04642638|65727280|FG005|Overall Study|Physician Decision|1|||
23545758|NCT04642638|65727275|FG000|Overall Study|Protocol Deviation|0|||
23545759|NCT04642638|65727276|FG001|Overall Study|Protocol Deviation|0|||
23545760|NCT04642638|65727277|FG002|Overall Study|Protocol Deviation|0|||
23545761|NCT04642638|65727278|FG003|Overall Study|Protocol Deviation|0|||
23545762|NCT04642638|65727279|FG004|Overall Study|Protocol Deviation|1|||
23545763|NCT04642638|65727280|FG005|Overall Study|Protocol Deviation|3|||
23545764|NCT04642638|65727275|FG000|Overall Study|Study Terminated|0|||
23129524|NCT01465763|64222251|FG001|Overall Study|Adverse Event|0|||
23129525|NCT01465763|64222252|FG002|Overall Study|Adverse Event|1|||
23129526|NCT01465763|64222250|FG000|Overall Study|Other|2|||
23129527|NCT01465763|64222251|FG001|Overall Study|Other|0|||
23129528|NCT01465763|64222252|FG002|Overall Study|Other|0|||
23212887|NCT00476996|64519815|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
23212888|NCT00476996|64519816|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
23212889|NCT00476996|64519817|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
23212890|NCT00476996|64519818|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
23212891|NCT00476996|64519815|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
23212892|NCT00476996|64519816|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
23129529|NCT01465763|64222250|FG000|Overall Study|Protocol Violation|4|||
23129530|NCT01465763|64222251|FG001|Overall Study|Protocol Violation|1|||
23129531|NCT01465763|64222252|FG002|Overall Study|Protocol Violation|1|||
23618761|NCT00866918|65991333|FG001|Overall Study|Secondary malignancy|0|||
23618762|NCT00475735|65991336|FG000|Treatment Period 1|Adverse Event|2|||
23618763|NCT00475735|65991337|FG001|Treatment Period 1|Adverse Event|0|||
23618764|NCT00475735|65991338|FG002|Treatment Period 1|Adverse Event|0|||
23618765|NCT00475735|65991339|FG003|Treatment Period 1|Adverse Event|0|||
23618766|NCT00475735|65991340|FG004|Treatment Period 1|Adverse Event|0|||
23618767|NCT00475735|65991341|FG005|Treatment Period 1|Adverse Event|0|||
23618768|NCT00475735|65991336|FG000|Treatment Period 1|Lack of Efficacy|1|||
23618769|NCT00475735|65991337|FG001|Treatment Period 1|Lack of Efficacy|0|||
23618770|NCT00475735|65991338|FG002|Treatment Period 1|Lack of Efficacy|0|||
23618771|NCT00475735|65991339|FG003|Treatment Period 1|Lack of Efficacy|0|||
23618772|NCT00475735|65991340|FG004|Treatment Period 1|Lack of Efficacy|0|||
23618773|NCT00475735|65991341|FG005|Treatment Period 1|Lack of Efficacy|0|||
23618774|NCT00475735|65991336|FG000|Treatment Period 1|Lost to Follow-up|0|||
23618775|NCT00475735|65991337|FG001|Treatment Period 1|Lost to Follow-up|0|||
23618776|NCT00475735|65991338|FG002|Treatment Period 1|Lost to Follow-up|0|||
23618777|NCT00475735|65991339|FG003|Treatment Period 1|Lost to Follow-up|0|||
23618778|NCT00475735|65991340|FG004|Treatment Period 1|Lost to Follow-up|0|||
23618779|NCT00475735|65991341|FG005|Treatment Period 1|Lost to Follow-up|1|||
23618780|NCT00475735|65991336|FG000|Treatment Period 1|Protocol Violation|0|||
23618781|NCT00475735|65991337|FG001|Treatment Period 1|Protocol Violation|0|||
23618782|NCT00475735|65991338|FG002|Treatment Period 1|Protocol Violation|0|||
23129532|NCT01465763|64222250|FG000|Overall Study|Death|1|||
23129533|NCT01465763|64222251|FG001|Overall Study|Death|0|||
23129534|NCT01465763|64222252|FG002|Overall Study|Death|0|||
23129535|NCT02870972|64222254|FG000|Overall Study|Adverse Event|1|||
23129536|NCT02870972|64222255|FG001|Overall Study|Adverse Event|0|||
23129537|NCT02870972|64222256|FG002|Overall Study|Adverse Event|0|||
23129538|NCT02870972|64222257|FG003|Overall Study|Adverse Event|0|||
23212893|NCT00476996|64519817|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
23212894|NCT00476996|64519818|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
23212895|NCT00476996|64519815|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
23212896|NCT00476996|64519816|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
23212897|NCT00476996|64519817|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
23212898|NCT00476996|64519818|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
23212899|NCT00476996|64519815|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
23212900|NCT00476996|64519816|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
23212901|NCT00476996|64519817|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
23212902|NCT00476996|64519818|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
23212903|NCT00476996|64519815|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
23212904|NCT00476996|64519816|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
23212905|NCT00476996|64519817|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
23212906|NCT00476996|64519818|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
23212907|NCT00476996|64519815|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
23212908|NCT00476996|64519816|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
23212909|NCT00476996|64519817|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
23212910|NCT00476996|64519818|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
23129539|NCT02870972|64222258|FG004|Overall Study|Adverse Event|0|||
23129540|NCT00233480|64222259|FG000|Overall Study|Underwent status II heart transplant|0|||
23129541|NCT00233480|64222260|FG001|Overall Study|Underwent status II heart transplant|1|||
23316843|NCT00996892|64903953|FG011|Dose-Escalation Stage 1A|Death|1|||
23618783|NCT00475735|65991339|FG003|Treatment Period 1|Protocol Violation|1|||
23618784|NCT00475735|65991340|FG004|Treatment Period 1|Protocol Violation|0|||
23618785|NCT00475735|65991341|FG005|Treatment Period 1|Protocol Violation|0|||
23618786|NCT00475735|65991336|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23618787|NCT00475735|65991337|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23618788|NCT00475735|65991338|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23618789|NCT00475735|65991339|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23618790|NCT00475735|65991340|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23618791|NCT00475735|65991341|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23618792|NCT00475735|65991336|FG000|Treatment Period 1|DC due to AE but continuing|0|||
23618793|NCT00475735|65991337|FG001|Treatment Period 1|DC due to AE but continuing|0|||
23618794|NCT00475735|65991338|FG002|Treatment Period 1|DC due to AE but continuing|0|||
23618795|NCT00475735|65991339|FG003|Treatment Period 1|DC due to AE but continuing|1|||
23618796|NCT00475735|65991340|FG004|Treatment Period 1|DC due to AE but continuing|2|||
23618797|NCT00475735|65991341|FG005|Treatment Period 1|DC due to AE but continuing|2|||
23618798|NCT00475735|65991336|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23618799|NCT00475735|65991337|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
23618800|NCT00475735|65991338|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23618801|NCT00475735|65991339|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23618802|NCT00475735|65991340|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23129542|NCT01711853|64222261|FG000|Overall Study|Not treated|3|||
23129543|NCT01401153|64222266|FG000|First Test Day|Learning disabilities; illness|1|||
23129544|NCT01401153|64222267|FG001|First Test Day|Learning disabilities; illness|10|||
23129545|NCT01401153|64222266|FG000|Second Test Day|illness|0|||
23129546|NCT01401153|64222267|FG001|Second Test Day|illness|5|||
23129547|NCT02389764|64226327|FG000|Overall Study|Lack of Efficacy|9|||
23129548|NCT02056626|64226328|FG000|Overall Study|patient did not follow directions|3|||
23129549|NCT02056626|64226329|FG001|Overall Study|patient did not follow directions|1|||
23129550|NCT02056626|64226330|FG002|Overall Study|patient did not follow directions|0|||
23129551|NCT02056626|64226331|FG003|Overall Study|patient did not follow directions|0|||
23129552|NCT03338296|64226332|FG000|Overall Study|Adverse Event|0|||
23129553|NCT03338296|64226333|FG001|Overall Study|Adverse Event|1|||
23129554|NCT03338296|64226332|FG000|Overall Study|Withdrawal by Subject|14|||
23129555|NCT03338296|64226333|FG001|Overall Study|Withdrawal by Subject|13|||
23129556|NCT03338296|64226332|FG000|Overall Study|Lost to Follow-up|10|||
23129557|NCT03338296|64226333|FG001|Overall Study|Lost to Follow-up|10|||
23129558|NCT03338296|64226332|FG000|Overall Study|Study Terminated by Sponsor|77|||
23129559|NCT03338296|64226333|FG001|Overall Study|Study Terminated by Sponsor|76|||
23129560|NCT03338296|64226332|FG000|Overall Study|Other|2|||
23129561|NCT03338296|64226333|FG001|Overall Study|Other|7|||
23129562|NCT03338296|64226332|FG000|Overall Study|Missing|0|||
23129563|NCT03338296|64226333|FG001|Overall Study|Missing|1|||
23129564|NCT02817906|64226336|FG000|Overall Study|Adverse Event|3|||
23129565|NCT02817906|64226337|FG001|Overall Study|Adverse Event|0|||
23129566|NCT02817906|64226336|FG000|Overall Study|Lack of Efficacy|1|||
23129567|NCT02817906|64226337|FG001|Overall Study|Lack of Efficacy|0|||
23129568|NCT02817906|64226336|FG000|Overall Study|Protocol Violation|1|||
23129569|NCT02817906|64226337|FG001|Overall Study|Protocol Violation|1|||
23129570|NCT02817906|64226336|FG000|Overall Study|Study Terminated by Sponsor|2|||
23129571|NCT02817906|64226337|FG001|Overall Study|Study Terminated by Sponsor|2|||
23129572|NCT02817906|64226336|FG000|Overall Study|Withdrawal by Subject|7|||
23129573|NCT02817906|64226337|FG001|Overall Study|Withdrawal by Subject|0|||
23129574|NCT02817906|64226336|FG000|Overall Study|Other|2|||
23129575|NCT02817906|64226337|FG001|Overall Study|Other|2|||
23129576|NCT02416453|64226344|FG000|Overall Study|Adverse Event|0|||
23129577|NCT02416453|64226345|FG001|Overall Study|Adverse Event|0|||
23129578|NCT02416453|64226346|FG002|Overall Study|Adverse Event|0|||
23129579|NCT02416453|64226347|FG003|Overall Study|Adverse Event|2|||
23129580|NCT02416453|64226348|FG004|Overall Study|Adverse Event|0|||
23129581|NCT02416453|64226349|FG005|Overall Study|Adverse Event|1|||
23129582|NCT02416453|64226350|FG006|Overall Study|Adverse Event|0|||
23129583|NCT02416453|64226351|FG007|Overall Study|Adverse Event|0|||
23129584|NCT02416453|64226352|FG008|Overall Study|Adverse Event|0|||
23129585|NCT02416453|64226353|FG009|Overall Study|Adverse Event|0|||
23129586|NCT02416453|64226354|FG010|Overall Study|Adverse Event|0|||
23129587|NCT02416453|64226344|FG000|Overall Study|Lost to Follow-up|1|||
23129588|NCT02416453|64226345|FG001|Overall Study|Lost to Follow-up|3|||
23129589|NCT02416453|64226346|FG002|Overall Study|Lost to Follow-up|0|||
23129590|NCT02416453|64226347|FG003|Overall Study|Lost to Follow-up|8|||
23129591|NCT02416453|64226348|FG004|Overall Study|Lost to Follow-up|0|||
23129592|NCT02416453|64226349|FG005|Overall Study|Lost to Follow-up|5|||
23129593|NCT02416453|64226350|FG006|Overall Study|Lost to Follow-up|1|||
23129594|NCT02416453|64226351|FG007|Overall Study|Lost to Follow-up|3|||
23129595|NCT02416453|64226352|FG008|Overall Study|Lost to Follow-up|1|||
23129596|NCT02416453|64226353|FG009|Overall Study|Lost to Follow-up|0|||
23129597|NCT02416453|64226354|FG010|Overall Study|Lost to Follow-up|0|||
23129598|NCT02416453|64226344|FG000|Overall Study|Physician Decision|0|||
23129599|NCT02416453|64226345|FG001|Overall Study|Physician Decision|0|||
23129600|NCT02416453|64226346|FG002|Overall Study|Physician Decision|0|||
23129601|NCT02416453|64226347|FG003|Overall Study|Physician Decision|0|||
23129602|NCT02416453|64226348|FG004|Overall Study|Physician Decision|0|||
23129603|NCT02416453|64226349|FG005|Overall Study|Physician Decision|1|||
23129604|NCT02416453|64226350|FG006|Overall Study|Physician Decision|1|||
23129605|NCT02416453|64226351|FG007|Overall Study|Physician Decision|1|||
23129606|NCT02416453|64226352|FG008|Overall Study|Physician Decision|0|||
23129607|NCT02416453|64226353|FG009|Overall Study|Physician Decision|0|||
23129608|NCT02416453|64226354|FG010|Overall Study|Physician Decision|0|||
23316844|NCT00996892|64903954|FG012|Dose-Escalation Stage 1A|Death|1|||
23129609|NCT02416453|64226344|FG000|Overall Study|Withdrawal by Subject|2|||
23129610|NCT02416453|64226345|FG001|Overall Study|Withdrawal by Subject|0|||
23129611|NCT02416453|64226346|FG002|Overall Study|Withdrawal by Subject|0|||
23129612|NCT02416453|64226347|FG003|Overall Study|Withdrawal by Subject|5|||
23129613|NCT02416453|64226348|FG004|Overall Study|Withdrawal by Subject|1|||
23129614|NCT02416453|64226349|FG005|Overall Study|Withdrawal by Subject|8|||
23129615|NCT02416453|64226350|FG006|Overall Study|Withdrawal by Subject|0|||
23129616|NCT02416453|64226351|FG007|Overall Study|Withdrawal by Subject|8|||
23129617|NCT02416453|64226352|FG008|Overall Study|Withdrawal by Subject|4|||
23129618|NCT02416453|64226353|FG009|Overall Study|Withdrawal by Subject|0|||
23129619|NCT02416453|64226354|FG010|Overall Study|Withdrawal by Subject|0|||
23129620|NCT02416453|64226344|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129621|NCT02416453|64226345|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129622|NCT02416453|64226346|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
23129623|NCT02416453|64226347|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129624|NCT02416453|64226348|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129625|NCT02416453|64226349|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129626|NCT02416453|64226350|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129627|NCT02416453|64226351|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129628|NCT02416453|64226352|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129629|NCT02416453|64226353|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129630|NCT02416453|64226354|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
23129631|NCT02416453|64226344|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129632|NCT02416453|64226345|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129633|NCT02416453|64226346|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129634|NCT02416453|64226347|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129635|NCT02416453|64226348|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129636|NCT02416453|64226349|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
23129637|NCT02416453|64226350|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129638|NCT02416453|64226351|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129639|NCT02416453|64226352|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129640|NCT02416453|64226353|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129641|NCT02416453|64226354|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
23129642|NCT01461811|64226355|FG000|Overall Study|Adverse Event|2|||
23129643|NCT01461811|64226356|FG001|Overall Study|Adverse Event|1|||
23129644|NCT01461811|64226355|FG000|Overall Study|Subject decision unrelated to an AE|1|||
23129645|NCT01461811|64226356|FG001|Overall Study|Subject decision unrelated to an AE|1|||
23129646|NCT01461811|64226355|FG000|Overall Study|Noncompliance|1|||
23129647|NCT01461811|64226356|FG001|Overall Study|Noncompliance|1|||
23129648|NCT03603639|64226359|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23129649|NCT03603639|64226360|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23129650|NCT03603639|64226361|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23129651|NCT03603639|64226362|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
23129652|NCT03603639|64226363|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23316845|NCT00996892|64903955|FG013|Dose-Escalation Stage 1A|Death|0|||
23316846|NCT00996892|64903956|FG014|Dose-Escalation Stage 1A|Death|0|||
23316847|NCT00996892|64903957|FG015|Dose-Escalation Stage 1A|Death|0|||
23316848|NCT00996892|64903958|FG016|Dose-Escalation Stage 1A|Death|0|||
23316849|NCT00996892|64903959|FG017|Dose-Escalation Stage 1A|Death|0|||
23316850|NCT00996892|64903960|FG018|Dose-Escalation Stage 1A|Death|0|||
23316851|NCT00996892|64903961|FG019|Dose-Escalation Stage 1A|Death|0|||
23316852|NCT00996892|64903942|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
23316853|NCT00996892|64903943|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
23316854|NCT00996892|64903944|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
23129653|NCT03603639|64226364|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
23129654|NCT03603639|64226359|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
23129655|NCT03603639|64226360|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
23129656|NCT03603639|64226361|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
23129657|NCT03603639|64226362|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
23426785|NCT00276094|65307452|FG002|Overall Study|Other-Relocation|0|||
23545765|NCT04642638|65727276|FG001|Overall Study|Study Terminated|0|||
23545766|NCT04642638|65727277|FG002|Overall Study|Study Terminated|0|||
23545767|NCT04642638|65727278|FG003|Overall Study|Study Terminated|0|||
23545768|NCT04642638|65727279|FG004|Overall Study|Study Terminated|484|||
23545769|NCT04642638|65727280|FG005|Overall Study|Study Terminated|250|||
23545770|NCT04642638|65727275|FG000|Overall Study|Pregnancy|0|||
23545771|NCT04642638|65727276|FG001|Overall Study|Pregnancy|0|||
23545772|NCT04642638|65727277|FG002|Overall Study|Pregnancy|0|||
23545773|NCT04642638|65727278|FG003|Overall Study|Pregnancy|0|||
23545774|NCT04642638|65727279|FG004|Overall Study|Pregnancy|1|||
23545775|NCT04642638|65727280|FG005|Overall Study|Pregnancy|0|||
23545776|NCT05819749|65727281|FG000|Overall Study|Lost to Follow-up|1|||
23129658|NCT03603639|64226363|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
23129659|NCT03603639|64226364|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
23129660|NCT03101462|64226365|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
23129661|NCT03101462|64226366|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
23129662|NCT03738423|64226368|FG000|Overall Study|Withdrawal by Subject|9|||
23129663|NCT03738423|64226369|FG001|Overall Study|Withdrawal by Subject|12|||
23129664|NCT03738423|64226370|FG002|Overall Study|Withdrawal by Subject|9|||
23129665|NCT03738423|64226371|FG003|Overall Study|Withdrawal by Subject|12|||
23129666|NCT03738423|64226372|FG004|Overall Study|Withdrawal by Subject|10|||
23129667|NCT03738423|64226368|FG000|Overall Study|Lack of Efficacy|3|||
23129668|NCT03738423|64226369|FG001|Overall Study|Lack of Efficacy|1|||
23129669|NCT03738423|64226370|FG002|Overall Study|Lack of Efficacy|1|||
23129670|NCT03738423|64226371|FG003|Overall Study|Lack of Efficacy|1|||
23316855|NCT00996892|64903945|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
23316856|NCT00996892|64903946|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
23316857|NCT00996892|64903947|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
23316858|NCT00996892|64903948|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
23316859|NCT00996892|64903949|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
23316860|NCT00996892|64903950|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
23316861|NCT00996892|64903951|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
23316862|NCT00996892|64903952|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
23316863|NCT00996892|64903953|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
23316864|NCT00996892|64903954|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
23316865|NCT00996892|64903955|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
23316866|NCT00996892|64903956|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
23316867|NCT00996892|64903957|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
23316868|NCT00996892|64903958|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
23316869|NCT00996892|64903959|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
23316870|NCT00996892|64903960|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
23316871|NCT00996892|64903961|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
23316872|NCT00996892|64903942|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316873|NCT00996892|64903943|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316874|NCT00996892|64903944|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316875|NCT00996892|64903945|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316876|NCT00996892|64903946|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316877|NCT00996892|64903947|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316878|NCT00996892|64903948|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316879|NCT00996892|64903949|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316880|NCT00996892|64903950|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316881|NCT00996892|64903951|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
23316882|NCT00996892|64903952|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
23316883|NCT00996892|64903953|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
23316884|NCT00996892|64903954|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
23316885|NCT00996892|64903955|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316886|NCT00996892|64903956|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316887|NCT00996892|64903957|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316888|NCT00996892|64903958|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316889|NCT00996892|64903959|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316890|NCT00996892|64903960|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316891|NCT00996892|64903961|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
23316892|NCT00996892|64903942|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
23316893|NCT00996892|64903943|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
23316894|NCT00996892|64903944|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
23316895|NCT00996892|64903945|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
23316896|NCT00996892|64903946|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
23316897|NCT00996892|64903947|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
23316898|NCT00996892|64903948|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
23316899|NCT00996892|64903949|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
23316900|NCT00996892|64903950|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
23316901|NCT00996892|64903951|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
23316902|NCT00996892|64903952|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
23316903|NCT00996892|64903953|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
23316904|NCT00996892|64903954|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
23316905|NCT00996892|64903955|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
23316906|NCT00996892|64903956|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
23316907|NCT00996892|64903957|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
23316908|NCT00996892|64903958|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
23316909|NCT00996892|64903959|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
23316910|NCT00996892|64903960|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
23316911|NCT00996892|64903961|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
23316912|NCT00996892|64903942|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
23129671|NCT03738423|64226372|FG004|Overall Study|Lack of Efficacy|2|||
23129672|NCT03738423|64226368|FG000|Overall Study|Lost to Follow-up|1|||
23316913|NCT00996892|64903943|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
23316914|NCT00996892|64903944|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
23316915|NCT00996892|64903945|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
23316916|NCT00996892|64903946|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
23316917|NCT00996892|64903947|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
23316918|NCT00996892|64903948|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
23316919|NCT00996892|64903949|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
23316920|NCT00996892|64903950|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
23129673|NCT03738423|64226369|FG001|Overall Study|Lost to Follow-up|0|||
23129674|NCT03738423|64226370|FG002|Overall Study|Lost to Follow-up|1|||
23316921|NCT00996892|64903951|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
23316922|NCT00996892|64903952|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
23316923|NCT00996892|64903953|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
23316924|NCT00996892|64903954|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
23316925|NCT00996892|64903955|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
23316926|NCT00996892|64903956|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
23316927|NCT00996892|64903957|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
23316928|NCT00996892|64903958|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
23316929|NCT00996892|64903959|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
23316930|NCT00996892|64903960|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
23316931|NCT00996892|64903961|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
23316932|NCT00996892|64903942|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
23316933|NCT00996892|64903943|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
23316934|NCT00996892|64903944|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
23316935|NCT00996892|64903945|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
23316936|NCT00996892|64903946|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
23316937|NCT00996892|64903947|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
23316938|NCT00996892|64903948|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
23316939|NCT00996892|64903949|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
23316940|NCT00996892|64903950|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
23316941|NCT00996892|64903951|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
23316942|NCT00996892|64903952|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
23316943|NCT00996892|64903953|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
23316944|NCT00996892|64903954|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
23316945|NCT00996892|64903955|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
23316946|NCT00996892|64903956|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
23316947|NCT00996892|64903957|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
23316948|NCT00996892|64903958|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
23316949|NCT00996892|64903959|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
23316950|NCT00996892|64903960|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
23316951|NCT00996892|64903961|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
23316952|NCT00996892|64903942|FG000|Expansion Stage 2|Adverse Event|0|||
23316953|NCT00996892|64903943|FG001|Expansion Stage 2|Adverse Event|0|||
23316954|NCT00996892|64903944|FG002|Expansion Stage 2|Adverse Event|0|||
23316955|NCT00996892|64903945|FG003|Expansion Stage 2|Adverse Event|0|||
23316956|NCT00996892|64903946|FG004|Expansion Stage 2|Adverse Event|0|||
23316957|NCT00996892|64903947|FG005|Expansion Stage 2|Adverse Event|0|||
23316958|NCT00996892|64903948|FG006|Expansion Stage 2|Adverse Event|0|||
23316959|NCT00996892|64903949|FG007|Expansion Stage 2|Adverse Event|0|||
23316960|NCT00996892|64903950|FG008|Expansion Stage 2|Adverse Event|0|||
23316961|NCT00996892|64903951|FG009|Expansion Stage 2|Adverse Event|0|||
23316962|NCT00996892|64903952|FG010|Expansion Stage 2|Adverse Event|0|||
23316963|NCT00996892|64903953|FG011|Expansion Stage 2|Adverse Event|0|||
23316964|NCT00996892|64903954|FG012|Expansion Stage 2|Adverse Event|0|||
23316965|NCT00996892|64903955|FG013|Expansion Stage 2|Adverse Event|0|||
23316966|NCT00996892|64903956|FG014|Expansion Stage 2|Adverse Event|0|||
23316967|NCT00996892|64903957|FG015|Expansion Stage 2|Adverse Event|0|||
23316968|NCT00996892|64903958|FG016|Expansion Stage 2|Adverse Event|0|||
23316969|NCT00996892|64903959|FG017|Expansion Stage 2|Adverse Event|0|||
23316970|NCT00996892|64903960|FG018|Expansion Stage 2|Adverse Event|3|||
23316971|NCT00996892|64903961|FG019|Expansion Stage 2|Adverse Event|0|||
23316972|NCT00996892|64903942|FG000|Expansion Stage 2|Death|0|||
23316973|NCT00996892|64903943|FG001|Expansion Stage 2|Death|0|||
23316974|NCT00996892|64903944|FG002|Expansion Stage 2|Death|0|||
23316975|NCT00996892|64903945|FG003|Expansion Stage 2|Death|0|||
23316976|NCT00996892|64903946|FG004|Expansion Stage 2|Death|0|||
23316977|NCT00996892|64903947|FG005|Expansion Stage 2|Death|0|||
23316978|NCT00996892|64903948|FG006|Expansion Stage 2|Death|0|||
23316979|NCT00996892|64903949|FG007|Expansion Stage 2|Death|0|||
23545777|NCT01292603|65727284|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23316980|NCT00996892|64903950|FG008|Expansion Stage 2|Death|0|||
23316981|NCT00996892|64903951|FG009|Expansion Stage 2|Death|0|||
23316982|NCT00996892|64903952|FG010|Expansion Stage 2|Death|0|||
23316983|NCT00996892|64903953|FG011|Expansion Stage 2|Death|0|||
23316984|NCT00996892|64903954|FG012|Expansion Stage 2|Death|0|||
23316985|NCT00996892|64903955|FG013|Expansion Stage 2|Death|0|||
23545778|NCT01292603|65727285|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23545779|NCT01292603|65727286|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23545780|NCT01292603|65727287|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
23316986|NCT00996892|64903956|FG014|Expansion Stage 2|Death|0|||
23316987|NCT00996892|64903957|FG015|Expansion Stage 2|Death|0|||
23316988|NCT00996892|64903958|FG016|Expansion Stage 2|Death|0|||
23545781|NCT01292603|65727288|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23316989|NCT00996892|64903959|FG017|Expansion Stage 2|Death|0|||
23316990|NCT00996892|64903960|FG018|Expansion Stage 2|Death|2|||
23316991|NCT00996892|64903961|FG019|Expansion Stage 2|Death|0|||
23316992|NCT00996892|64903942|FG000|Expansion Stage 2|Physician Decision|0|||
23212911|NCT00476996|64519815|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
23316993|NCT00996892|64903943|FG001|Expansion Stage 2|Physician Decision|0|||
23316994|NCT00996892|64903944|FG002|Expansion Stage 2|Physician Decision|0|||
23316995|NCT00996892|64903945|FG003|Expansion Stage 2|Physician Decision|0|||
23316996|NCT00996892|64903946|FG004|Expansion Stage 2|Physician Decision|0|||
23316997|NCT00996892|64903947|FG005|Expansion Stage 2|Physician Decision|0|||
23316998|NCT00996892|64903948|FG006|Expansion Stage 2|Physician Decision|0|||
23316999|NCT00996892|64903949|FG007|Expansion Stage 2|Physician Decision|0|||
23317000|NCT00996892|64903950|FG008|Expansion Stage 2|Physician Decision|0|||
23317001|NCT00996892|64903951|FG009|Expansion Stage 2|Physician Decision|0|||
23317002|NCT00996892|64903952|FG010|Expansion Stage 2|Physician Decision|0|||
23317003|NCT00996892|64903953|FG011|Expansion Stage 2|Physician Decision|0|||
23317004|NCT00996892|64903954|FG012|Expansion Stage 2|Physician Decision|0|||
23317005|NCT00996892|64903955|FG013|Expansion Stage 2|Physician Decision|0|||
23317006|NCT00996892|64903956|FG014|Expansion Stage 2|Physician Decision|0|||
23317007|NCT00996892|64903957|FG015|Expansion Stage 2|Physician Decision|0|||
23317008|NCT00996892|64903958|FG016|Expansion Stage 2|Physician Decision|0|||
23317009|NCT00996892|64903959|FG017|Expansion Stage 2|Physician Decision|0|||
23317010|NCT00996892|64903960|FG018|Expansion Stage 2|Physician Decision|1|||
23317011|NCT00996892|64903961|FG019|Expansion Stage 2|Physician Decision|0|||
23317012|NCT00996892|64903942|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
23317013|NCT00996892|64903943|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
23317014|NCT00996892|64903944|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
23317015|NCT00996892|64903945|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
23129675|NCT03738423|64226371|FG003|Overall Study|Lost to Follow-up|1|||
23129676|NCT03738423|64226372|FG004|Overall Study|Lost to Follow-up|0|||
23129677|NCT03738423|64226368|FG000|Overall Study|Protocol Violation|1|||
23129678|NCT03738423|64226369|FG001|Overall Study|Protocol Violation|0|||
23129679|NCT03738423|64226370|FG002|Overall Study|Protocol Violation|0|||
23129680|NCT03738423|64226371|FG003|Overall Study|Protocol Violation|0|||
23212912|NCT00476996|64519816|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
23212913|NCT00476996|64519817|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
23212914|NCT00476996|64519818|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
23212915|NCT00476996|64519815|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
23212916|NCT00476996|64519816|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
23212917|NCT00476996|64519817|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
23212918|NCT00476996|64519818|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
23212919|NCT00476996|64519815|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
23317016|NCT00996892|64903946|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
23317017|NCT00996892|64903947|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
23317018|NCT00996892|64903948|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
23129681|NCT03738423|64226372|FG004|Overall Study|Protocol Violation|1|||
23129682|NCT03738423|64226368|FG000|Overall Study|Physician Decision|0|||
23129683|NCT03738423|64226369|FG001|Overall Study|Physician Decision|0|||
23129684|NCT03738423|64226370|FG002|Overall Study|Physician Decision|1|||
23129685|NCT03738423|64226371|FG003|Overall Study|Physician Decision|0|||
23129686|NCT03738423|64226372|FG004|Overall Study|Physician Decision|1|||
23129687|NCT03738423|64226368|FG000|Overall Study|Death|0|||
23129688|NCT03738423|64226369|FG001|Overall Study|Death|0|||
23129689|NCT03738423|64226370|FG002|Overall Study|Death|0|||
23129690|NCT03738423|64226371|FG003|Overall Study|Death|0|||
23129691|NCT03738423|64226372|FG004|Overall Study|Death|1|||
23129692|NCT03738423|64226368|FG000|Overall Study|Randomized but never treated|0|||
23129693|NCT03738423|64226369|FG001|Overall Study|Randomized but never treated|0|||
23129694|NCT03738423|64226370|FG002|Overall Study|Randomized but never treated|1|||
23129695|NCT03738423|64226371|FG003|Overall Study|Randomized but never treated|1|||
23129696|NCT03738423|64226372|FG004|Overall Study|Randomized but never treated|0|||
23129697|NCT01969851|64226373|FG000|Overall Study|Adverse Event|0|||
23129698|NCT01969851|64226374|FG001|Overall Study|Adverse Event|0|||
23129699|NCT01969851|64226375|FG002|Overall Study|Adverse Event|3|||
23317019|NCT00996892|64903949|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
23317020|NCT00996892|64903950|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
23129700|NCT01969851|64226373|FG000|Overall Study|Lack of Efficacy|0|||
23129701|NCT01969851|64226374|FG001|Overall Study|Lack of Efficacy|3|||
23129702|NCT01969851|64226375|FG002|Overall Study|Lack of Efficacy|1|||
23129703|NCT01969851|64226373|FG000|Overall Study|Withdrawal by Subject|1|||
23129704|NCT01969851|64226374|FG001|Overall Study|Withdrawal by Subject|0|||
23129705|NCT01969851|64226375|FG002|Overall Study|Withdrawal by Subject|1|||
23129706|NCT01969851|64226373|FG000|Overall Study|No effective dose in Titration period|0|||
23129707|NCT01969851|64226374|FG001|Overall Study|No effective dose in Titration period|0|||
23129708|NCT01969851|64226375|FG002|Overall Study|No effective dose in Titration period|1|||
23129709|NCT01969851|64226373|FG000|Overall Study|Sponsor decision|0|||
23129710|NCT01969851|64226374|FG001|Overall Study|Sponsor decision|0|||
23129711|NCT01969851|64226375|FG002|Overall Study|Sponsor decision|1|||
23317021|NCT00996892|64903951|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
23129712|NCT02242097|64226376|FG000|Ibrutinib Treatment|Adverse Event|16|||
23317022|NCT00996892|64903952|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
23317023|NCT00996892|64903953|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
23317024|NCT00996892|64903954|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
23317025|NCT00996892|64903955|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
23317026|NCT00996892|64903956|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
23317027|NCT00996892|64903957|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
23317028|NCT00996892|64903958|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
23317029|NCT00996892|64903959|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
23317030|NCT00996892|64903960|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
23317031|NCT00996892|64903961|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
23317032|NCT00996892|64903942|FG000|Expansion Stage 2|Disease Progression|0|||
23317033|NCT00996892|64903943|FG001|Expansion Stage 2|Disease Progression|0|||
23317034|NCT00996892|64903944|FG002|Expansion Stage 2|Disease Progression|0|||
23317035|NCT00996892|64903945|FG003|Expansion Stage 2|Disease Progression|0|||
23317036|NCT00996892|64903946|FG004|Expansion Stage 2|Disease Progression|0|||
23317037|NCT00996892|64903947|FG005|Expansion Stage 2|Disease Progression|0|||
23317038|NCT00996892|64903948|FG006|Expansion Stage 2|Disease Progression|0|||
23129713|NCT02242097|64226376|FG000|Ibrutinib Treatment|Physician Decision|1|||
23129714|NCT02242097|64226376|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
23426786|NCT00276094|65307450|FG000|Overall Study|Other-Study medication lost|0|||
23426787|NCT00276094|65307451|FG001|Overall Study|Other-Study medication lost|0|||
23129715|NCT02242097|64226376|FG000|Ibrutinib Treatment|Death|1|||
23129716|NCT02242097|64226376|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
23129717|NCT02242097|64226376|FG000|Post Therapy Follow Up|Death|3|||
23129718|NCT02242097|64226376|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
23129719|NCT03274895|64226377|FG000|Overall Study|Lack of Efficacy|1|||
23129720|NCT03274895|64226378|FG001|Overall Study|Lack of Efficacy|0|||
23317039|NCT00996892|64903949|FG007|Expansion Stage 2|Disease Progression|0|||
23317040|NCT00996892|64903950|FG008|Expansion Stage 2|Disease Progression|0|||
23317041|NCT00996892|64903951|FG009|Expansion Stage 2|Disease Progression|0|||
23317042|NCT00996892|64903952|FG010|Expansion Stage 2|Disease Progression|0|||
23317043|NCT00996892|64903953|FG011|Expansion Stage 2|Disease Progression|0|||
23317044|NCT00996892|64903954|FG012|Expansion Stage 2|Disease Progression|0|||
23317045|NCT00996892|64903955|FG013|Expansion Stage 2|Disease Progression|0|||
23317046|NCT00996892|64903956|FG014|Expansion Stage 2|Disease Progression|0|||
23317047|NCT00996892|64903957|FG015|Expansion Stage 2|Disease Progression|0|||
23317048|NCT00996892|64903958|FG016|Expansion Stage 2|Disease Progression|0|||
23317049|NCT00996892|64903959|FG017|Expansion Stage 2|Disease Progression|0|||
23317050|NCT00996892|64903960|FG018|Expansion Stage 2|Disease Progression|28|||
23317051|NCT00996892|64903961|FG019|Expansion Stage 2|Disease Progression|0|||
23317052|NCT00996892|64903942|FG000|Expansion Stage 2A|Adverse Event|0|||
23317053|NCT00996892|64903943|FG001|Expansion Stage 2A|Adverse Event|0|||
23317054|NCT00996892|64903944|FG002|Expansion Stage 2A|Adverse Event|0|||
23317055|NCT00996892|64903945|FG003|Expansion Stage 2A|Adverse Event|0|||
23317056|NCT00996892|64903946|FG004|Expansion Stage 2A|Adverse Event|0|||
23129721|NCT03274895|64226377|FG000|Overall Study|Adverse Event|8|||
23129722|NCT03274895|64226378|FG001|Overall Study|Adverse Event|7|||
23426788|NCT00276094|65307452|FG002|Overall Study|Other-Study medication lost|1|||
23129723|NCT03274895|64226377|FG000|Overall Study|Lost to Follow-up|1|||
23129724|NCT03274895|64226378|FG001|Overall Study|Lost to Follow-up|0|||
23129725|NCT03274895|64226377|FG000|Overall Study|Diagnosis not confirmed|3|||
23129726|NCT03274895|64226378|FG001|Overall Study|Diagnosis not confirmed|4|||
23129727|NCT03752970|64226379|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
23129728|NCT03752970|64226380|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
23129729|NCT03752970|64226381|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
23129730|NCT03752970|64226379|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
23129731|NCT03752970|64226380|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
23129732|NCT03752970|64226381|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
23129733|NCT03752970|64226379|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
23129734|NCT03752970|64226380|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
23426789|NCT00993499|65307453|FG000|Run-in Period (8 Days)|Adverse Event|0|||
23618803|NCT00475735|65991341|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
23618804|NCT00475735|65991336|FG000|Treatment Washout|Lost to Follow-up|0|||
23426790|NCT00993499|65307454|FG001|Run-in Period (8 Days)|Adverse Event|1|||
23426791|NCT00993499|65307455|FG002|Run-in Period (8 Days)|Adverse Event|0|||
23426792|NCT00993499|65307456|FG003|Run-in Period (8 Days)|Adverse Event|0|||
23618805|NCT00475735|65991337|FG001|Treatment Washout|Lost to Follow-up|1|||
23129735|NCT03752970|64226381|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
23129736|NCT03752970|64226379|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
23129737|NCT03752970|64226380|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
23317057|NCT00996892|64903947|FG005|Expansion Stage 2A|Adverse Event|0|||
23317058|NCT00996892|64903948|FG006|Expansion Stage 2A|Adverse Event|0|||
23317059|NCT00996892|64903949|FG007|Expansion Stage 2A|Adverse Event|0|||
23317060|NCT00996892|64903950|FG008|Expansion Stage 2A|Adverse Event|0|||
23317061|NCT00996892|64903951|FG009|Expansion Stage 2A|Adverse Event|0|||
23317062|NCT00996892|64903952|FG010|Expansion Stage 2A|Adverse Event|0|||
23317063|NCT00996892|64903953|FG011|Expansion Stage 2A|Adverse Event|0|||
23317064|NCT00996892|64903954|FG012|Expansion Stage 2A|Adverse Event|0|||
23317065|NCT00996892|64903955|FG013|Expansion Stage 2A|Adverse Event|0|||
23317066|NCT00996892|64903956|FG014|Expansion Stage 2A|Adverse Event|0|||
23317067|NCT00996892|64903957|FG015|Expansion Stage 2A|Adverse Event|0|||
23317068|NCT00996892|64903958|FG016|Expansion Stage 2A|Adverse Event|0|||
23317069|NCT00996892|64903959|FG017|Expansion Stage 2A|Adverse Event|0|||
23317070|NCT00996892|64903960|FG018|Expansion Stage 2A|Adverse Event|0|||
23317071|NCT00996892|64903961|FG019|Expansion Stage 2A|Adverse Event|8|||
23317072|NCT00996892|64903942|FG000|Expansion Stage 2A|Physician Decision|0|||
23212920|NCT00476996|64519816|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
23212921|NCT00476996|64519817|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
23212922|NCT00476996|64519818|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
23212923|NCT00476996|64519815|FG000|OLE Phase (From Week 48)|Death|0|||
23317073|NCT00996892|64903943|FG001|Expansion Stage 2A|Physician Decision|0|||
23317074|NCT00996892|64903944|FG002|Expansion Stage 2A|Physician Decision|0|||
23317075|NCT00996892|64903945|FG003|Expansion Stage 2A|Physician Decision|0|||
23317076|NCT00996892|64903946|FG004|Expansion Stage 2A|Physician Decision|0|||
23317077|NCT00996892|64903947|FG005|Expansion Stage 2A|Physician Decision|0|||
23317078|NCT00996892|64903948|FG006|Expansion Stage 2A|Physician Decision|0|||
23317079|NCT00996892|64903949|FG007|Expansion Stage 2A|Physician Decision|0|||
23317080|NCT00996892|64903950|FG008|Expansion Stage 2A|Physician Decision|0|||
23426793|NCT00993499|65307457|FG004|Run-in Period (8 Days)|Adverse Event|0|||
23426794|NCT00993499|65307458|FG005|Run-in Period (8 Days)|Adverse Event|0|||
23426795|NCT00993499|65307453|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
23129738|NCT03752970|64226381|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
23129739|NCT03752970|64226379|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
23129740|NCT03752970|64226380|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
23129741|NCT03752970|64226381|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
23129742|NCT03635099|64226382|FG000|Period 1|Adverse Event|1|||
23212924|NCT00476996|64519816|FG001|OLE Phase (From Week 48)|Death|0|||
23212925|NCT00476996|64519817|FG002|OLE Phase (From Week 48)|Death|0|||
23212926|NCT00476996|64519818|FG003|OLE Phase (From Week 48)|Death|7|||
23212927|NCT00476996|64519815|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
23212928|NCT00476996|64519816|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
23212929|NCT00476996|64519817|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
23212930|NCT00476996|64519818|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
23212931|NCT00476996|64519815|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
23212932|NCT00476996|64519816|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
23212933|NCT00476996|64519817|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
23212934|NCT00476996|64519818|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
23212935|NCT00476996|64519815|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
23212936|NCT00476996|64519816|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
23212937|NCT00476996|64519817|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
23317081|NCT00996892|64903951|FG009|Expansion Stage 2A|Physician Decision|0|||
23317082|NCT00996892|64903952|FG010|Expansion Stage 2A|Physician Decision|0|||
23129743|NCT03635099|64226383|FG001|Period 1|Adverse Event|0|||
23129744|NCT03635099|64226384|FG002|Period 1|Adverse Event|0|||
23129745|NCT03635099|64226385|FG003|Period 1|Adverse Event|1|||
23129746|NCT03635099|64226386|FG004|Period 1|Adverse Event|0|||
23129747|NCT03635099|64226387|FG005|Period 1|Adverse Event|0|||
23129748|NCT03635099|64226388|FG006|Period 1|Adverse Event|0|||
23129749|NCT03635099|64226389|FG007|Period 1|Adverse Event|0|||
23129750|NCT03635099|64226382|FG000|Period 1|Protocol Violation|0|||
23129751|NCT03635099|64226383|FG001|Period 1|Protocol Violation|0|||
23317083|NCT00996892|64903953|FG011|Expansion Stage 2A|Physician Decision|0|||
23426796|NCT00993499|65307454|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426797|NCT00993499|65307455|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426798|NCT00993499|65307456|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426799|NCT00993499|65307457|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426800|NCT00993499|65307458|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
23426801|NCT00993499|65307453|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
23129752|NCT03635099|64226384|FG002|Period 1|Protocol Violation|1|||
23129753|NCT03635099|64226385|FG003|Period 1|Protocol Violation|0|||
23129754|NCT03635099|64226386|FG004|Period 1|Protocol Violation|0|||
23129755|NCT03635099|64226387|FG005|Period 1|Protocol Violation|0|||
23212938|NCT00476996|64519818|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
23212939|NCT00476996|64519815|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
23212940|NCT00476996|64519816|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
23317084|NCT00996892|64903954|FG012|Expansion Stage 2A|Physician Decision|0|||
23129756|NCT03635099|64226388|FG006|Period 1|Protocol Violation|0|||
23317085|NCT00996892|64903955|FG013|Expansion Stage 2A|Physician Decision|0|||
23426802|NCT00993499|65307454|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
23426803|NCT00993499|65307455|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
23426804|NCT00993499|65307456|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
23129757|NCT03635099|64226389|FG007|Period 1|Protocol Violation|0|||
23129758|NCT03635099|64226382|FG000|Period 1|Lost to Follow-up|0|||
23129759|NCT03635099|64226383|FG001|Period 1|Lost to Follow-up|0|||
23129760|NCT03635099|64226384|FG002|Period 1|Lost to Follow-up|1|||
23129761|NCT03635099|64226385|FG003|Period 1|Lost to Follow-up|2|||
23129762|NCT03635099|64226386|FG004|Period 1|Lost to Follow-up|1|||
23129763|NCT03635099|64226387|FG005|Period 1|Lost to Follow-up|0|||
23129764|NCT03635099|64226388|FG006|Period 1|Lost to Follow-up|1|||
23426805|NCT00993499|65307457|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
23426806|NCT00993499|65307458|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
23545782|NCT01292603|65727289|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
23545783|NCT01292603|65727284|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
23545784|NCT01292603|65727285|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
23545785|NCT01292603|65727286|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
23545786|NCT01292603|65727287|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
23545787|NCT01292603|65727288|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
23618806|NCT00475735|65991338|FG002|Treatment Washout|Lost to Follow-up|0|||
23618807|NCT00475735|65991339|FG003|Treatment Washout|Lost to Follow-up|0|||
23618808|NCT00475735|65991340|FG004|Treatment Washout|Lost to Follow-up|0|||
23618809|NCT00475735|65991341|FG005|Treatment Washout|Lost to Follow-up|0|||
23618810|NCT00475735|65991336|FG000|Treatment Washout|Protocol Violation|0|||
23618811|NCT00475735|65991337|FG001|Treatment Washout|Protocol Violation|1|||
23618812|NCT00475735|65991338|FG002|Treatment Washout|Protocol Violation|0|||
23545788|NCT01292603|65727289|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
23545789|NCT01292603|65727284|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545790|NCT01292603|65727285|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545791|NCT01292603|65727286|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545792|NCT01292603|65727287|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
23545793|NCT01292603|65727288|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545794|NCT01292603|65727289|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
23545795|NCT01292603|65727284|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23545796|NCT01292603|65727285|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23545797|NCT01292603|65727286|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23618813|NCT00475735|65991339|FG003|Treatment Washout|Protocol Violation|0|||
23618814|NCT00475735|65991340|FG004|Treatment Washout|Protocol Violation|0|||
23618815|NCT00475735|65991341|FG005|Treatment Washout|Protocol Violation|0|||
23618816|NCT00475735|65991336|FG000|Treatment Period 2|Adverse Event|0|||
23618817|NCT00475735|65991337|FG001|Treatment Period 2|Adverse Event|1|||
23618818|NCT00475735|65991338|FG002|Treatment Period 2|Adverse Event|0|||
23618819|NCT00475735|65991339|FG003|Treatment Period 2|Adverse Event|2|||
23618820|NCT00475735|65991340|FG004|Treatment Period 2|Adverse Event|0|||
23618821|NCT00475735|65991341|FG005|Treatment Period 2|Adverse Event|0|||
23618822|NCT00475735|65991336|FG000|Treatment Period 2|Lack of Efficacy|0|||
23618823|NCT00475735|65991337|FG001|Treatment Period 2|Lack of Efficacy|0|||
23545798|NCT01292603|65727287|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
23545799|NCT01292603|65727288|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23545800|NCT01292603|65727289|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
23545801|NCT01292603|65727284|FG000|Part 1: Regular Follow-Up Period|Death|3|||
23545802|NCT01292603|65727285|FG001|Part 1: Regular Follow-Up Period|Death|1|||
23545803|NCT01292603|65727286|FG002|Part 1: Regular Follow-Up Period|Death|3|||
23545804|NCT01292603|65727287|FG003|Part 1: Regular Follow-Up Period|Death|1|||
23545805|NCT01292603|65727288|FG004|Part 1: Regular Follow-Up Period|Death|0|||
23545806|NCT01292603|65727289|FG005|Part 1: Regular Follow-Up Period|Death|0|||
23545807|NCT01292603|65727284|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
23545808|NCT01292603|65727285|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
23545809|NCT01292603|65727286|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
23545810|NCT01292603|65727287|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
23545811|NCT01292603|65727288|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
23545812|NCT01292603|65727289|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
23545813|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Death|0|||
23618824|NCT00475735|65991338|FG002|Treatment Period 2|Lack of Efficacy|0|||
23426807|NCT00993499|65307453|FG000|Run-in Period (8 Days)|Progressive disease|0|||
23545814|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Death|0|||
23545815|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Death|0|||
23618825|NCT00475735|65991339|FG003|Treatment Period 2|Lack of Efficacy|0|||
23618826|NCT00475735|65991340|FG004|Treatment Period 2|Lack of Efficacy|0|||
23317086|NCT00996892|64903956|FG014|Expansion Stage 2A|Physician Decision|0|||
23618827|NCT00475735|65991341|FG005|Treatment Period 2|Lack of Efficacy|1|||
23426808|NCT00993499|65307454|FG001|Run-in Period (8 Days)|Progressive disease|1|||
23618828|NCT00475735|65991336|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23129765|NCT03635099|64226389|FG007|Period 1|Lost to Follow-up|2|||
23129766|NCT03635099|64226382|FG000|Period 1|Withdrawal by Subject|3|||
23129767|NCT03635099|64226383|FG001|Period 1|Withdrawal by Subject|3|||
23129768|NCT03635099|64226384|FG002|Period 1|Withdrawal by Subject|5|||
23129769|NCT03635099|64226385|FG003|Period 1|Withdrawal by Subject|2|||
23129770|NCT03635099|64226386|FG004|Period 1|Withdrawal by Subject|2|||
23129771|NCT03635099|64226387|FG005|Period 1|Withdrawal by Subject|0|||
23129772|NCT03635099|64226388|FG006|Period 1|Withdrawal by Subject|3|||
23129773|NCT03635099|64226389|FG007|Period 1|Withdrawal by Subject|0|||
23129774|NCT03635099|64226382|FG000|Period 1|History of suicidal ideation|0|||
23129775|NCT03635099|64226383|FG001|Period 1|History of suicidal ideation|0|||
23129776|NCT03635099|64226384|FG002|Period 1|History of suicidal ideation|1|||
23129777|NCT03635099|64226385|FG003|Period 1|History of suicidal ideation|0|||
23129778|NCT03635099|64226386|FG004|Period 1|History of suicidal ideation|0|||
23129779|NCT03635099|64226387|FG005|Period 1|History of suicidal ideation|0|||
23618829|NCT00475735|65991337|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23618830|NCT00475735|65991338|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23618831|NCT00475735|65991339|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23618832|NCT00475735|65991340|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23129780|NCT03635099|64226388|FG006|Period 1|History of suicidal ideation|0|||
23129781|NCT03635099|64226389|FG007|Period 1|History of suicidal ideation|0|||
23129782|NCT03635099|64226382|FG000|Period 1|pursue other treatment options|0|||
23212941|NCT00476996|64519817|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
23212942|NCT00476996|64519818|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
23212943|NCT01207388|64519819|FG000|Overall Study|Death|67|||
23212944|NCT01207388|64519819|FG000|Overall Study|Withdrawal by Subject|1|||
23212945|NCT02270684|64519820|FG000|Overall Study|Lost to Follow-up|0|||
23212946|NCT02270684|64519821|FG001|Overall Study|Lost to Follow-up|3|||
23212947|NCT02270684|64519820|FG000|Overall Study|Study terminated|1|||
23212948|NCT02270684|64519821|FG001|Overall Study|Study terminated|0|||
23212949|NCT00174785|64519824|FG000|Overall Study|Adverse Event|293|||
23212950|NCT00174785|64519825|FG001|Overall Study|Adverse Event|191|||
23212951|NCT00174785|64519824|FG000|Overall Study|Protocol Violation|14|||
23212952|NCT00174785|64519825|FG001|Overall Study|Protocol Violation|14|||
23212953|NCT00174785|64519824|FG000|Overall Study|Withdrawal by Subject|173|||
23212954|NCT00174785|64519825|FG001|Overall Study|Withdrawal by Subject|175|||
23212955|NCT00174785|64519824|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
23212956|NCT00174785|64519825|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
23212957|NCT00174785|64519824|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
23129783|NCT03635099|64226383|FG001|Period 1|pursue other treatment options|0|||
23129784|NCT03635099|64226384|FG002|Period 1|pursue other treatment options|0|||
23129785|NCT03635099|64226385|FG003|Period 1|pursue other treatment options|0|||
23129786|NCT03635099|64226386|FG004|Period 1|pursue other treatment options|0|||
23129787|NCT03635099|64226387|FG005|Period 1|pursue other treatment options|1|||
23129788|NCT03635099|64226388|FG006|Period 1|pursue other treatment options|0|||
23129789|NCT03635099|64226389|FG007|Period 1|pursue other treatment options|0|||
23129790|NCT03635099|64226382|FG000|Not Eligible for Period 2|Pregnancy|0|||
23129791|NCT03635099|64226383|FG001|Not Eligible for Period 2|Pregnancy|0|||
23129792|NCT03635099|64226384|FG002|Not Eligible for Period 2|Pregnancy|0|||
23129793|NCT03635099|64226385|FG003|Not Eligible for Period 2|Pregnancy|1|||
23129794|NCT03635099|64226386|FG004|Not Eligible for Period 2|Pregnancy|0|||
23129795|NCT03635099|64226387|FG005|Not Eligible for Period 2|Pregnancy|0|||
23129796|NCT03635099|64226388|FG006|Not Eligible for Period 2|Pregnancy|0|||
23129797|NCT03635099|64226389|FG007|Not Eligible for Period 2|Pregnancy|0|||
23129798|NCT03635099|64226382|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
23129799|NCT03635099|64226383|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
23129800|NCT03635099|64226384|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
23129801|NCT03635099|64226385|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
23129802|NCT03635099|64226386|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
23129803|NCT03635099|64226387|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
23129804|NCT03635099|64226388|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
23129805|NCT03635099|64226389|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
23212958|NCT00174785|64519825|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
23212959|NCT00174785|64519824|FG000|Overall Study|Other prohibited medication|5|||
23212960|NCT00174785|64519825|FG001|Overall Study|Other prohibited medication|3|||
23212961|NCT00174785|64519824|FG000|Overall Study|Family request|6|||
23129806|NCT03635099|64226382|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23212962|NCT00174785|64519825|FG001|Overall Study|Family request|8|||
23212963|NCT00174785|64519824|FG000|Overall Study|Not pre-specified/Not coded|56|||
23212964|NCT00174785|64519825|FG001|Overall Study|Not pre-specified/Not coded|70|||
23129807|NCT03635099|64226383|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23129808|NCT03635099|64226384|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23129809|NCT03635099|64226385|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23618833|NCT00475735|65991341|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23129810|NCT03635099|64226386|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
23545816|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Death|0|||
23545817|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Death|1|||
23545818|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Death|0|||
23545819|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545820|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545821|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545822|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545823|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
23545824|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
23545825|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
23545826|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
23545827|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
23545828|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
23545829|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
23545830|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
23545831|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
23545832|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
23545833|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
23545834|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
23545835|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
23129811|NCT03635099|64226387|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
23129812|NCT03635099|64226388|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
23129813|NCT03635099|64226389|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
23129814|NCT03635099|64226382|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
23129815|NCT03635099|64226383|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
23129816|NCT03635099|64226384|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
23129817|NCT03635099|64226385|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
23129818|NCT03635099|64226386|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
23129819|NCT03635099|64226387|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
23129820|NCT03635099|64226388|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
23129821|NCT03635099|64226389|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
23129822|NCT03635099|64226382|FG000|Period 2|Adverse Event|0|||
23129823|NCT03635099|64226383|FG001|Period 2|Adverse Event|0|||
23129824|NCT03635099|64226384|FG002|Period 2|Adverse Event|1|||
23129825|NCT03635099|64226385|FG003|Period 2|Adverse Event|0|||
23129826|NCT03635099|64226386|FG004|Period 2|Adverse Event|1|||
23129827|NCT03635099|64226387|FG005|Period 2|Adverse Event|0|||
23129828|NCT03635099|64226388|FG006|Period 2|Adverse Event|0|||
23129829|NCT03635099|64226389|FG007|Period 2|Adverse Event|0|||
23129830|NCT03635099|64226382|FG000|Period 2|Lost to Follow-up|0|||
23129831|NCT03635099|64226383|FG001|Period 2|Lost to Follow-up|0|||
23129832|NCT03635099|64226384|FG002|Period 2|Lost to Follow-up|1|||
23129833|NCT03635099|64226385|FG003|Period 2|Lost to Follow-up|0|||
23129834|NCT03635099|64226386|FG004|Period 2|Lost to Follow-up|4|||
23129835|NCT03635099|64226387|FG005|Period 2|Lost to Follow-up|0|||
23129836|NCT03635099|64226388|FG006|Period 2|Lost to Follow-up|0|||
23129837|NCT03635099|64226389|FG007|Period 2|Lost to Follow-up|0|||
23129838|NCT03635099|64226382|FG000|Period 2|Withdrawal by Subject|0|||
23129839|NCT03635099|64226383|FG001|Period 2|Withdrawal by Subject|0|||
23129840|NCT03635099|64226384|FG002|Period 2|Withdrawal by Subject|7|||
23129841|NCT03635099|64226385|FG003|Period 2|Withdrawal by Subject|4|||
23129842|NCT03635099|64226386|FG004|Period 2|Withdrawal by Subject|7|||
23212965|NCT01819506|64519826|FG000|Overall Study|Physician Decision|5|||
23545836|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
23545837|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
23545838|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
23545839|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
23545840|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
23545841|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
23545842|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
23545843|NCT01292603|65727284|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23545844|NCT01292603|65727285|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23129843|NCT03635099|64226387|FG005|Period 2|Withdrawal by Subject|0|||
23129844|NCT03635099|64226388|FG006|Period 2|Withdrawal by Subject|0|||
23129845|NCT03635099|64226389|FG007|Period 2|Withdrawal by Subject|0|||
23129846|NCT02530970|64226390|FG000|Overall Study|Adverse Event|8|||
23129847|NCT02530970|64226390|FG000|Overall Study|Lost to Follow-up|88|||
23129848|NCT02530970|64226390|FG000|Overall Study|Physician Decision|5|||
23212966|NCT01819506|64519827|FG001|Overall Study|Physician Decision|2|||
23212967|NCT01819506|64519826|FG000|Overall Study|Withdrawal by Subject|3|||
23545845|NCT01292603|65727286|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23545846|NCT01292603|65727287|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23545847|NCT01292603|65727288|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
23545848|NCT01292603|65727289|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
23545849|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Death|0|||
23545850|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Death|0|||
23545851|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Death|0|||
23129849|NCT02530970|64226390|FG000|Overall Study|Withdrawal by Subject|14|||
23129850|NCT02530970|64226390|FG000|Overall Study|Death|6|||
23129851|NCT02530970|64226390|FG000|Overall Study|Hospitalization|1|||
23129852|NCT02530970|64226390|FG000|Overall Study|Insurance|2|||
23129853|NCT02530970|64226390|FG000|Overall Study|Explant|2|||
23129854|NCT02530970|64226390|FG000|Overall Study|Change in Provider|5|||
23545852|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Death|0|||
23545853|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Death|6|||
23545854|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Death|3|||
23545855|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
23545856|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
23545857|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
23129855|NCT02530970|64226390|FG000|Overall Study|Relocation|3|||
23129856|NCT00747227|64226391|FG000|Overall Study|Death|3|||
23129857|NCT00747227|64226392|FG001|Overall Study|Death|1|||
23129858|NCT00747227|64226391|FG000|Overall Study|Withdrawal by Subject|1|||
23129859|NCT00747227|64226392|FG001|Overall Study|Withdrawal by Subject|0|||
23129860|NCT00747227|64226391|FG000|Overall Study|Lost to Follow-up|1|||
23129861|NCT00747227|64226392|FG001|Overall Study|Lost to Follow-up|2|||
23129862|NCT00747227|64226391|FG000|Overall Study|Illness|1|||
23129863|NCT00747227|64226392|FG001|Overall Study|Illness|1|||
23129864|NCT01606670|64226393|FG000|Overall Study|Adverse Event|6|||
23129865|NCT01606670|64226393|FG000|Overall Study|Lack of Efficacy|2|||
23129866|NCT01606670|64226393|FG000|Overall Study|Lost to Follow-up|3|||
23129867|NCT01606670|64226393|FG000|Overall Study|Withdrawal by Subject|3|||
23129868|NCT01606670|64226393|FG000|Overall Study|Other Reason|2|||
23129869|NCT00604708|64226394|FG000|Overall Study|Withdrawal by Subject|9|||
23129870|NCT00604708|64226395|FG001|Overall Study|Withdrawal by Subject|10|||
23129871|NCT00604708|64226394|FG000|Overall Study|Protocol Violation|2|||
23129872|NCT00604708|64226395|FG001|Overall Study|Protocol Violation|8|||
23129873|NCT00604708|64226394|FG000|Overall Study|Lost to Follow-up|5|||
23129874|NCT00604708|64226395|FG001|Overall Study|Lost to Follow-up|5|||
23129875|NCT00604708|64226394|FG000|Overall Study|administrative reasons|9|||
23129876|NCT00604708|64226395|FG001|Overall Study|administrative reasons|11|||
23129877|NCT00604708|64226394|FG000|Overall Study|Adverse Event|6|||
23129878|NCT00604708|64226395|FG001|Overall Study|Adverse Event|6|||
23129879|NCT02175641|64226396|FG000|Overall Study|Death|3|||
23212968|NCT01819506|64519827|FG001|Overall Study|Withdrawal by Subject|3|||
23212969|NCT00479557|64519828|FG000|Overall Study|Death|0|||
23212970|NCT00479557|64519829|FG001|Overall Study|Death|0|||
23212971|NCT00479557|64519830|FG002|Overall Study|Death|0|||
23212972|NCT00479557|64519831|FG003|Overall Study|Death|0|||
23212973|NCT00479557|64519832|FG004|Overall Study|Death|0|||
23129880|NCT02175641|64226397|FG001|Overall Study|Death|4|||
23129881|NCT02175641|64226396|FG000|Overall Study|Lost to Follow-up|4|||
23129882|NCT02175641|64226397|FG001|Overall Study|Lost to Follow-up|4|||
23129883|NCT02175641|64226396|FG000|Overall Study|Withdrawal by Subject|7|||
23129884|NCT02175641|64226397|FG001|Overall Study|Withdrawal by Subject|4|||
23129885|NCT02175641|64226396|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
23129886|NCT02175641|64226397|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
23129887|NCT02175641|64226396|FG000|Overall Study|Developed Contraindicated Condition|8|||
23129888|NCT02175641|64226397|FG001|Overall Study|Developed Contraindicated Condition|0|||
23129889|NCT02233803|64226398|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
23129890|NCT02233803|64226399|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
23212974|NCT00479557|64519833|FG005|Overall Study|Death|1|||
23212975|NCT00479557|64519834|FG006|Overall Study|Death|0|||
23545858|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
23545859|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
23129891|NCT02233803|64226398|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
23129892|NCT02233803|64226399|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
23129893|NCT02233803|64226398|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
23212976|NCT00479557|64519828|FG000|Overall Study|Lack of Efficacy|1|||
23545860|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
23545861|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
23129894|NCT02233803|64226399|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
23129895|NCT02233803|64226398|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
23129896|NCT02233803|64226399|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
23129897|NCT02233803|64226398|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
23129898|NCT02233803|64226399|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
23212977|NCT00479557|64519829|FG001|Overall Study|Lack of Efficacy|0|||
23129899|NCT02233803|64226398|FG000|Washout Period (4-Wks)|Physician Decision|1|||
23129900|NCT02233803|64226399|FG001|Washout Period (4-Wks)|Physician Decision|0|||
23129901|NCT02233803|64226398|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
23129902|NCT02233803|64226399|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
23129903|NCT02233803|64226398|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
23129904|NCT02233803|64226399|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
23129905|NCT02233803|64226398|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
23129906|NCT02233803|64226399|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
23129907|NCT00964886|64226401|FG000|Overall Study|Lost to Follow-up|2|||
23129908|NCT00964886|64226402|FG001|Overall Study|Lost to Follow-up|2|||
23129909|NCT00964886|64226403|FG002|Overall Study|Lost to Follow-up|6|||
23129910|NCT00964886|64226404|FG003|Overall Study|Lost to Follow-up|4|||
23129911|NCT00964886|64226401|FG000|Overall Study|Withdrawal by Subject|6|||
23129912|NCT00964886|64226402|FG001|Overall Study|Withdrawal by Subject|2|||
23129913|NCT00964886|64226403|FG002|Overall Study|Withdrawal by Subject|5|||
23129914|NCT00964886|64226404|FG003|Overall Study|Withdrawal by Subject|3|||
23129915|NCT00964886|64226401|FG000|Overall Study|Adverse Event|3|||
23129916|NCT00964886|64226402|FG001|Overall Study|Adverse Event|1|||
23129917|NCT00964886|64226403|FG002|Overall Study|Adverse Event|5|||
23129918|NCT00964886|64226404|FG003|Overall Study|Adverse Event|2|||
23129919|NCT00964886|64226401|FG000|Overall Study|Protocol Violation|0|||
23129920|NCT00964886|64226402|FG001|Overall Study|Protocol Violation|2|||
23129921|NCT00964886|64226403|FG002|Overall Study|Protocol Violation|0|||
23129922|NCT00964886|64226404|FG003|Overall Study|Protocol Violation|0|||
23129923|NCT04617275|64226407|FG000|Treatment Period|Adverse Event|1|||
23129924|NCT04617275|64226408|FG001|Treatment Period|Adverse Event|6|||
23129925|NCT04617275|64226409|FG002|Treatment Period|Adverse Event|4|||
23129926|NCT04617275|64226410|FG003|Treatment Period|Adverse Event|6|||
23129927|NCT04617275|64226411|FG004|Treatment Period|Adverse Event|7|||
23129928|NCT04617275|64226412|FG005|Treatment Period|Adverse Event|8|||
23129929|NCT04617275|64226413|FG006|Treatment Period|Adverse Event|0|||
23129930|NCT04617275|64226414|FG007|Treatment Period|Adverse Event|12|||
23129931|NCT04617275|64226407|FG000|Treatment Period|Lost to Follow-up|0|||
23129932|NCT04617275|64226408|FG001|Treatment Period|Lost to Follow-up|0|||
23129933|NCT04617275|64226409|FG002|Treatment Period|Lost to Follow-up|2|||
23129934|NCT04617275|64226410|FG003|Treatment Period|Lost to Follow-up|0|||
23129935|NCT04617275|64226411|FG004|Treatment Period|Lost to Follow-up|0|||
23129936|NCT04617275|64226412|FG005|Treatment Period|Lost to Follow-up|3|||
23129937|NCT04617275|64226413|FG006|Treatment Period|Lost to Follow-up|0|||
23129938|NCT04617275|64226414|FG007|Treatment Period|Lost to Follow-up|2|||
23129939|NCT04617275|64226407|FG000|Treatment Period|No longer meets eligibility criteria|0|||
23129940|NCT04617275|64226408|FG001|Treatment Period|No longer meets eligibility criteria|0|||
23129941|NCT04617275|64226409|FG002|Treatment Period|No longer meets eligibility criteria|0|||
23129942|NCT04617275|64226410|FG003|Treatment Period|No longer meets eligibility criteria|1|||
23129943|NCT04617275|64226411|FG004|Treatment Period|No longer meets eligibility criteria|0|||
23129944|NCT04617275|64226412|FG005|Treatment Period|No longer meets eligibility criteria|0|||
23129945|NCT04617275|64226413|FG006|Treatment Period|No longer meets eligibility criteria|0|||
23129946|NCT04617275|64226414|FG007|Treatment Period|No longer meets eligibility criteria|0|||
23129947|NCT04617275|64226407|FG000|Treatment Period|Other|0|||
23129948|NCT04617275|64226408|FG001|Treatment Period|Other|1|||
23129949|NCT04617275|64226409|FG002|Treatment Period|Other|0|||
23129950|NCT04617275|64226410|FG003|Treatment Period|Other|0|||
23129951|NCT04617275|64226411|FG004|Treatment Period|Other|0|||
23129952|NCT04617275|64226412|FG005|Treatment Period|Other|0|||
23129953|NCT04617275|64226413|FG006|Treatment Period|Other|0|||
23129954|NCT04617275|64226414|FG007|Treatment Period|Other|0|||
23129955|NCT04617275|64226407|FG000|Treatment Period|Withdrawal by Subject|2|||
23129956|NCT04617275|64226408|FG001|Treatment Period|Withdrawal by Subject|0|||
23129957|NCT04617275|64226409|FG002|Treatment Period|Withdrawal by Subject|0|||
23129958|NCT04617275|64226410|FG003|Treatment Period|Withdrawal by Subject|2|||
23129959|NCT04617275|64226411|FG004|Treatment Period|Withdrawal by Subject|2|||
23129960|NCT04617275|64226412|FG005|Treatment Period|Withdrawal by Subject|0|||
23129961|NCT04617275|64226413|FG006|Treatment Period|Withdrawal by Subject|1|||
23129962|NCT04617275|64226414|FG007|Treatment Period|Withdrawal by Subject|2|||
23129963|NCT04617275|64226407|FG000|Follow-up Period|Adverse Event|1|||
23129964|NCT04617275|64226408|FG001|Follow-up Period|Adverse Event|1|||
23129965|NCT04617275|64226409|FG002|Follow-up Period|Adverse Event|2|||
23129966|NCT04617275|64226410|FG003|Follow-up Period|Adverse Event|3|||
23129967|NCT04617275|64226411|FG004|Follow-up Period|Adverse Event|4|||
23129968|NCT04617275|64226412|FG005|Follow-up Period|Adverse Event|3|||
23129969|NCT04617275|64226413|FG006|Follow-up Period|Adverse Event|0|||
23129970|NCT04617275|64226414|FG007|Follow-up Period|Adverse Event|3|||
23129971|NCT04617275|64226407|FG000|Follow-up Period|Lost to Follow-up|0|||
23129972|NCT04617275|64226408|FG001|Follow-up Period|Lost to Follow-up|1|||
23129973|NCT04617275|64226409|FG002|Follow-up Period|Lost to Follow-up|2|||
23129974|NCT04617275|64226410|FG003|Follow-up Period|Lost to Follow-up|0|||
23129975|NCT04617275|64226411|FG004|Follow-up Period|Lost to Follow-up|0|||
23212978|NCT00479557|64519830|FG002|Overall Study|Lack of Efficacy|0|||
23212979|NCT00479557|64519831|FG003|Overall Study|Lack of Efficacy|0|||
23212980|NCT00479557|64519832|FG004|Overall Study|Lack of Efficacy|0|||
23212981|NCT00479557|64519833|FG005|Overall Study|Lack of Efficacy|0|||
23212982|NCT00479557|64519834|FG006|Overall Study|Lack of Efficacy|0|||
23212983|NCT00479557|64519828|FG000|Overall Study|Lost to Follow-up|0|||
23212984|NCT00479557|64519829|FG001|Overall Study|Lost to Follow-up|2|||
23212985|NCT00479557|64519830|FG002|Overall Study|Lost to Follow-up|0|||
23212986|NCT00479557|64519831|FG003|Overall Study|Lost to Follow-up|2|||
23212987|NCT00479557|64519832|FG004|Overall Study|Lost to Follow-up|0|||
23212988|NCT00479557|64519833|FG005|Overall Study|Lost to Follow-up|0|||
23212989|NCT00479557|64519834|FG006|Overall Study|Lost to Follow-up|0|||
23212990|NCT00479557|64519828|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
23212991|NCT00479557|64519829|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23212992|NCT00479557|64519830|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
23212993|NCT00479557|64519831|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
23212994|NCT00479557|64519832|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23212995|NCT00479557|64519833|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
23618834|NCT04491006|65991342|FG000|Overall Study|Adverse Event|0|||
23618835|NCT04491006|65991343|FG001|Overall Study|Adverse Event|3|||
23618836|NCT04491006|65991344|FG002|Overall Study|Adverse Event|5|||
23618837|NCT04491006|65991342|FG000|Overall Study|Withdrawal by Subject|1|||
23618838|NCT04491006|65991343|FG001|Overall Study|Withdrawal by Subject|0|||
23618839|NCT04491006|65991344|FG002|Overall Study|Withdrawal by Subject|2|||
23618840|NCT02604342|65991357|FG000|Overall Study|Death|32|||
23618841|NCT02604342|65991358|FG001|Overall Study|Death|16|||
23618842|NCT02604342|65991357|FG000|Overall Study|Progression of disease|1|||
23618843|NCT02604342|65991358|FG001|Overall Study|Progression of disease|0|||
23618844|NCT02604342|65991357|FG000|Overall Study|Withdrawal by Subject|5|||
23618845|NCT02604342|65991358|FG001|Overall Study|Withdrawal by Subject|6|||
23618846|NCT02604342|65991357|FG000|Overall Study|Other|1|||
23618847|NCT02604342|65991358|FG001|Overall Study|Other|0|||
23618848|NCT02604342|65991357|FG000|Overall Study|Study Termination by Sponsor|1|||
23618849|NCT02604342|65991358|FG001|Overall Study|Study Termination by Sponsor|0|||
23129976|NCT04617275|64226412|FG005|Follow-up Period|Lost to Follow-up|4|||
23129977|NCT04617275|64226413|FG006|Follow-up Period|Lost to Follow-up|0|||
23129978|NCT04617275|64226414|FG007|Follow-up Period|Lost to Follow-up|3|||
23129979|NCT04617275|64226407|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
23212996|NCT00479557|64519834|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
23212997|NCT00479557|64519828|FG000|Overall Study|AE not related to Study Drug|1|||
23212998|NCT00479557|64519829|FG001|Overall Study|AE not related to Study Drug|3|||
23212999|NCT00479557|64519830|FG002|Overall Study|AE not related to Study Drug|0|||
23129980|NCT04617275|64226408|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
23129981|NCT04617275|64226409|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
23129982|NCT04617275|64226410|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
23129983|NCT04617275|64226411|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
23213000|NCT00479557|64519831|FG003|Overall Study|AE not related to Study Drug|0|||
23545862|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
23545863|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
23545864|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
23545865|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
23545866|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
23545867|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545868|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545869|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545870|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545871|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
23545872|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
23545873|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545874|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545875|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545876|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545877|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
23213001|NCT00479557|64519832|FG004|Overall Study|AE not related to Study Drug|2|||
23213002|NCT00479557|64519833|FG005|Overall Study|AE not related to Study Drug|2|||
23213003|NCT00479557|64519834|FG006|Overall Study|AE not related to Study Drug|1|||
23618850|NCT02604342|65991357|FG000|Overall Study|Lost to Follow-up|1|||
23618851|NCT02604342|65991358|FG001|Overall Study|Lost to Follow-up|1|||
23618852|NCT02604342|65991357|FG000|Overall Study|Physician Decision|2|||
23618853|NCT02604342|65991358|FG001|Overall Study|Physician Decision|0|||
23618854|NCT02581189|65991359|FG000|Overall Study|Failure to return|36|||
23618855|NCT02581189|65991359|FG000|Overall Study|Withdrew consent|5|||
23618856|NCT02581189|65991359|FG000|Overall Study|Death|3|||
23618857|NCT02581189|65991359|FG000|Overall Study|Insufficient virological response|2|||
23129984|NCT04617275|64226412|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
23129985|NCT04617275|64226413|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
23129986|NCT04617275|64226414|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
23129987|NCT04617275|64226407|FG000|Follow-up Period|Other|0|||
23129988|NCT04617275|64226408|FG001|Follow-up Period|Other|1|||
23129989|NCT04617275|64226409|FG002|Follow-up Period|Other|0|||
23129990|NCT04617275|64226410|FG003|Follow-up Period|Other|0|||
23129991|NCT04617275|64226411|FG004|Follow-up Period|Other|0|||
23129992|NCT04617275|64226412|FG005|Follow-up Period|Other|0|||
23129993|NCT04617275|64226413|FG006|Follow-up Period|Other|0|||
23129994|NCT04617275|64226414|FG007|Follow-up Period|Other|0|||
23129995|NCT04617275|64226407|FG000|Follow-up Period|Withdrawal by Subject|2|||
23129996|NCT04617275|64226408|FG001|Follow-up Period|Withdrawal by Subject|0|||
23129997|NCT04617275|64226409|FG002|Follow-up Period|Withdrawal by Subject|0|||
23129998|NCT04617275|64226410|FG003|Follow-up Period|Withdrawal by Subject|2|||
23129999|NCT04617275|64226411|FG004|Follow-up Period|Withdrawal by Subject|2|||
23130000|NCT04617275|64226412|FG005|Follow-up Period|Withdrawal by Subject|0|||
23130001|NCT04617275|64226413|FG006|Follow-up Period|Withdrawal by Subject|1|||
23130002|NCT04617275|64226414|FG007|Follow-up Period|Withdrawal by Subject|2|||
23130003|NCT01865747|64226419|FG000|Overall Study (ITT)|Adverse Event|32|||
23130004|NCT01865747|64226420|FG001|Overall Study (ITT)|Adverse Event|31|||
23130005|NCT01865747|64226419|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
23130006|NCT01865747|64226420|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
23130007|NCT01865747|64226419|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
23130008|NCT01865747|64226420|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
23130009|NCT01865747|64226419|FG000|Overall Study (ITT)|Protocol Violation|1|||
23130010|NCT01865747|64226420|FG001|Overall Study (ITT)|Protocol Violation|1|||
23130011|NCT01865747|64226419|FG000|Overall Study (ITT)|Physician Decision|5|||
23130012|NCT01865747|64226420|FG001|Overall Study (ITT)|Physician Decision|2|||
23130013|NCT01865747|64226419|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
23130014|NCT01865747|64226420|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
23130015|NCT01865747|64226419|FG000|Overall Study (ITT)|Sponsor Decision|0|||
23130016|NCT01865747|64226420|FG001|Overall Study (ITT)|Sponsor Decision|1|||
23130017|NCT01865747|64226419|FG000|Overall Study (ITT)|Progressive Disease|122|||
23130018|NCT01865747|64226420|FG001|Overall Study (ITT)|Progressive Disease|158|||
23130019|NCT01865747|64226419|FG000|Overall Study (ITT)|Reason Not Provided|0|||
23130020|NCT01865747|64226420|FG001|Overall Study (ITT)|Reason Not Provided|1|||
23130021|NCT01865747|64226419|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
23130022|NCT01865747|64226420|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
23130023|NCT01865747|64226419|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
23130024|NCT01865747|64226420|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
23130025|NCT01865747|64226419|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
23130026|NCT01865747|64226420|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
23130027|NCT01865747|64226419|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
23130028|NCT01865747|64226420|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
23130029|NCT01865747|64226419|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
23130030|NCT01865747|64226420|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
23130031|NCT01865747|64226419|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
23130032|NCT01865747|64226420|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
23130033|NCT01865747|64226419|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
23130034|NCT01865747|64226420|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
23130035|NCT01865747|64226419|FG000|Primary Intent to Treat (PITT)|Other|0|||
23130036|NCT01865747|64226420|FG001|Primary Intent to Treat (PITT)|Other|1|||
23130037|NCT01513330|64226421|FG000|SenSura Mio First,|Adverse Event|2|||
23130038|NCT01513330|64226422|FG001|SenSura Mio First,|Adverse Event|0|||
23130039|NCT01513330|64226421|FG000|SenSura Mio First,|Lack of Efficacy|0|||
23130040|NCT01513330|64226422|FG001|SenSura Mio First,|Lack of Efficacy|1|||
23130041|NCT01513330|64226421|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
23130042|NCT01513330|64226422|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
23130043|NCT01513330|64226421|FG000|SenSura Mio First,|Other|1|||
23130044|NCT01513330|64226422|FG001|SenSura Mio First,|Other|0|||
23130045|NCT01513330|64226421|FG000|Standard Care First,|Lack of Efficacy|2|||
23130046|NCT01513330|64226422|FG001|Standard Care First,|Lack of Efficacy|2|||
23130047|NCT01513330|64226421|FG000|Standard Care First,|Withdrawal by Subject|1|||
23130048|NCT01513330|64226422|FG001|Standard Care First,|Withdrawal by Subject|2|||
23130049|NCT01513330|64226421|FG000|Standard Care First,|Other|1|||
23130050|NCT01513330|64226422|FG001|Standard Care First,|Other|0|||
23130051|NCT01725126|64226423|FG000|Overall Study|Protocol Violation|0|||
23130052|NCT01725126|64226424|FG001|Overall Study|Protocol Violation|1|||
23130053|NCT01725126|64226425|FG002|Overall Study|Protocol Violation|0|||
23130054|NCT01725126|64226426|FG003|Overall Study|Protocol Violation|0|||
23130055|NCT01725126|64226427|FG004|Overall Study|Protocol Violation|0|||
23130056|NCT01725126|64226428|FG005|Overall Study|Protocol Violation|0|||
23130057|NCT01725126|64226423|FG000|Overall Study|Withdrawal by Subject|0|||
23130058|NCT01725126|64226424|FG001|Overall Study|Withdrawal by Subject|0|||
23130059|NCT01725126|64226425|FG002|Overall Study|Withdrawal by Subject|0|||
23130060|NCT01725126|64226426|FG003|Overall Study|Withdrawal by Subject|1|||
23130061|NCT01725126|64226427|FG004|Overall Study|Withdrawal by Subject|0|||
23130062|NCT01725126|64226428|FG005|Overall Study|Withdrawal by Subject|0|||
23130063|NCT01730950|64226431|FG000|Overall Study|Protocol Violation|6|||
23130064|NCT01730950|64226432|FG001|Overall Study|Protocol Violation|6|||
23130065|NCT03846453|64226435|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
23130066|NCT03846453|64226436|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
23130067|NCT03846453|64226437|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
23130068|NCT03846453|64226435|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
23130069|NCT03846453|64226436|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
23130070|NCT03846453|64226437|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
23130071|NCT03846453|64226435|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
23130072|NCT03846453|64226436|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
23545878|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
23545879|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
23545880|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
23545881|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
23545882|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
23545883|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
23545884|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
23545885|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
23545886|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
23545887|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
23545888|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
23545889|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
23545890|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
23545891|NCT01292603|65727284|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
23545892|NCT01292603|65727285|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
23545893|NCT01292603|65727286|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
23130073|NCT03846453|64226437|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
23130074|NCT03846453|64226435|FG000|Placebo Run-in (14 Days)|Other|2|||
23130075|NCT03846453|64226436|FG001|Placebo Run-in (14 Days)|Other|0|||
23130076|NCT03846453|64226437|FG002|Placebo Run-in (14 Days)|Other|0|||
23130077|NCT03846453|64226435|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
23130078|NCT03846453|64226436|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
23130079|NCT03846453|64226437|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
23130080|NCT03846453|64226435|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
23130081|NCT03846453|64226436|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
23130082|NCT03846453|64226437|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
23130083|NCT03846453|64226435|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
23130084|NCT03846453|64226436|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
23130085|NCT03846453|64226437|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
23130086|NCT03846453|64226435|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
23130087|NCT03846453|64226436|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
23130088|NCT03846453|64226437|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
23130089|NCT03846453|64226435|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
23130090|NCT03846453|64226436|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
23130091|NCT03846453|64226437|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
23130092|NCT00332462|64226438|FG000|Overall Study|Adverse Event|5|||
23130093|NCT00332462|64226438|FG000|Overall Study|Abnormal Lab Value|1|||
23130094|NCT00332462|64226438|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23130095|NCT00332462|64226438|FG000|Overall Study|no longer requires study drug|1|||
23130096|NCT00332462|64226438|FG000|Overall Study|Death|3|||
23130097|NCT00332462|64226438|FG000|Overall Study|Graft Loss|2|||
23130098|NCT00392925|64226447|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
23130099|NCT00392925|64226448|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
23130100|NCT00392925|64226449|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
23130101|NCT00392925|64226450|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
23130102|NCT00392925|64226447|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
23130103|NCT00392925|64226448|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
23130104|NCT00392925|64226449|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
23130105|NCT00392925|64226450|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
23130106|NCT00392925|64226447|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
23130107|NCT00392925|64226448|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
23130108|NCT00392925|64226449|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
23545894|NCT01292603|65727287|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
23545895|NCT01292603|65727288|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
23545896|NCT01292603|65727289|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
23545897|NCT01292603|65727284|FG000|Overall Survival Status|Death|3|||
23545898|NCT01292603|65727285|FG001|Overall Survival Status|Death|1|||
23130109|NCT00392925|64226450|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
23130110|NCT00392925|64226447|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
23130111|NCT00392925|64226448|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
23130112|NCT00392925|64226449|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
23130113|NCT00392925|64226450|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
23130114|NCT00392925|64226447|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
23130115|NCT00392925|64226448|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
23130116|NCT00392925|64226449|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
23130117|NCT00392925|64226450|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
23130118|NCT00392925|64226447|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
23130119|NCT00392925|64226448|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
23130120|NCT00392925|64226449|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
23130121|NCT00392925|64226450|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
23130122|NCT00392925|64226447|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
23130123|NCT00392925|64226448|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
23130124|NCT00392925|64226449|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
23130125|NCT00392925|64226450|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
23130126|NCT00392925|64226447|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
23130127|NCT00392925|64226448|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
23130128|NCT00392925|64226449|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
23130129|NCT00392925|64226450|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
23130130|NCT00392925|64226447|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
23130131|NCT00392925|64226448|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
23130132|NCT00392925|64226449|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
23130133|NCT00392925|64226450|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
23130134|NCT01008553|64226455|FG000|Period 1 (Titration Period)|Physician Decision|2|||
23130135|NCT01008553|64226456|FG001|Period 1 (Titration Period)|Physician Decision|0|||
23130136|NCT01008553|64226457|FG002|Period 1 (Titration Period)|Physician Decision|0|||
23130137|NCT01008553|64226455|FG000|Period 1 (Titration Period)|Adverse Event|33|||
23130138|NCT01008553|64226456|FG001|Period 1 (Titration Period)|Adverse Event|0|||
23130139|NCT01008553|64226457|FG002|Period 1 (Titration Period)|Adverse Event|0|||
23130140|NCT01008553|64226455|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
23130141|NCT01008553|64226456|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
23130142|NCT01008553|64226457|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
23130143|NCT01008553|64226455|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
23545899|NCT01292603|65727286|FG002|Overall Survival Status|Death|3|||
23545900|NCT01292603|65727287|FG003|Overall Survival Status|Death|1|||
23545901|NCT01292603|65727288|FG004|Overall Survival Status|Death|16|||
23545902|NCT01292603|65727289|FG005|Overall Survival Status|Death|10|||
23545903|NCT03667053|65727290|FG000|Overall Study|Withdrawal by Subject|1|||
23545904|NCT03667053|65727291|FG001|Overall Study|Withdrawal by Subject|0|||
23545905|NCT03667053|65727292|FG002|Overall Study|Withdrawal by Subject|0|||
23545906|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
23545907|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
23545908|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
23545909|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
23545910|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
23545911|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
23545912|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
23545913|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
23545914|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Other|0|||
23130144|NCT01008553|64226456|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
23130145|NCT01008553|64226457|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
23130146|NCT01008553|64226455|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
23130147|NCT01008553|64226456|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
23130148|NCT01008553|64226457|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
23130149|NCT01008553|64226455|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
23130150|NCT01008553|64226456|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
23130151|NCT01008553|64226457|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
23130152|NCT01008553|64226455|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
23130153|NCT01008553|64226456|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
23213004|NCT00479557|64519828|FG000|Overall Study|Caregiver Request|2|||
23618858|NCT02581189|65991359|FG000|Overall Study|Other, not specified|7|||
23545915|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Other|1|||
23545916|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Other|0|||
23545917|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Other|0|||
23545918|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
23545919|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
23317087|NCT00996892|64903957|FG015|Expansion Stage 2A|Physician Decision|0|||
23317088|NCT00996892|64903958|FG016|Expansion Stage 2A|Physician Decision|0|||
23317089|NCT00996892|64903959|FG017|Expansion Stage 2A|Physician Decision|0|||
23317090|NCT00996892|64903960|FG018|Expansion Stage 2A|Physician Decision|0|||
23426809|NCT00993499|65307455|FG002|Run-in Period (8 Days)|Progressive disease|1|||
23426810|NCT00993499|65307456|FG003|Run-in Period (8 Days)|Progressive disease|0|||
23426811|NCT00993499|65307457|FG004|Run-in Period (8 Days)|Progressive disease|0|||
23426812|NCT00993499|65307458|FG005|Run-in Period (8 Days)|Progressive disease|0|||
23426813|NCT00993499|65307453|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
23426814|NCT00993499|65307454|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
23426815|NCT00993499|65307455|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
23426816|NCT00993499|65307456|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
23426817|NCT00993499|65307457|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
23426818|NCT00993499|65307458|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
23426819|NCT00993499|65307453|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
23426820|NCT00993499|65307454|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
23426821|NCT00993499|65307455|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
23426822|NCT00993499|65307456|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
23426823|NCT00993499|65307457|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
23426824|NCT00993499|65307458|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
23426825|NCT00993499|65307453|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
23426826|NCT00993499|65307454|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
23426827|NCT00993499|65307455|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
23545920|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
23545921|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
23426828|NCT00993499|65307456|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
23426829|NCT00993499|65307457|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
23426830|NCT00993499|65307458|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
23426831|NCT00993499|65307453|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23426832|NCT00993499|65307454|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23426833|NCT00993499|65307455|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
23426834|NCT00993499|65307456|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23426835|NCT00993499|65307457|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23545922|NCT05799495|65727296|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
23545923|NCT05799495|65727297|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
23545924|NCT05799495|65727298|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
23545925|NCT05799495|65727299|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
23545926|NCT05799495|65727296|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23545927|NCT05799495|65727297|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23545928|NCT05799495|65727298|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
23545929|NCT05799495|65727299|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23130154|NCT01008553|64226457|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
23130155|NCT01008553|64226455|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
23130156|NCT01008553|64226456|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
23130157|NCT01008553|64226457|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
23130158|NCT01008553|64226455|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
23130159|NCT01008553|64226456|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
23130160|NCT01008553|64226457|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
23130161|NCT01008553|64226455|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
23130162|NCT01008553|64226456|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
23130163|NCT01008553|64226457|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
23130164|NCT01008553|64226455|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
23130165|NCT01008553|64226456|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
23130166|NCT01008553|64226457|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
23130167|NCT01008553|64226455|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
23130168|NCT01008553|64226456|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
23130169|NCT01008553|64226457|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
23130170|NCT01008553|64226455|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
23213005|NCT00479557|64519829|FG001|Overall Study|Caregiver Request|2|||
23317091|NCT00996892|64903961|FG019|Expansion Stage 2A|Physician Decision|2|||
23317092|NCT00996892|64903942|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
23317093|NCT00996892|64903943|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
23317094|NCT00996892|64903944|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
23426836|NCT00993499|65307458|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
23426837|NCT00993499|65307453|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426838|NCT00993499|65307454|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
23426839|NCT00993499|65307455|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426840|NCT00993499|65307456|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426841|NCT00993499|65307457|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426842|NCT00993499|65307458|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
23426843|NCT00993499|65307453|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
23426844|NCT00993499|65307454|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
23426845|NCT00993499|65307455|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
23426846|NCT00993499|65307456|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
23317095|NCT00996892|64903945|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
23317096|NCT00996892|64903946|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
23317097|NCT00996892|64903947|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
23317098|NCT00996892|64903948|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
23317099|NCT00996892|64903949|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
23317100|NCT00996892|64903950|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
23317101|NCT00996892|64903951|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
23317102|NCT00996892|64903952|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
23317103|NCT00996892|64903953|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
23317104|NCT00996892|64903954|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
23317105|NCT00996892|64903955|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
23317106|NCT00996892|64903956|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
23317107|NCT00996892|64903957|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
23317108|NCT00996892|64903958|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
23317109|NCT00996892|64903959|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
23317110|NCT00996892|64903960|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
23317111|NCT00996892|64903961|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
23317112|NCT00996892|64903942|FG000|Expansion Stage 2A|Disease Progression|0|||
23317113|NCT00996892|64903943|FG001|Expansion Stage 2A|Disease Progression|0|||
23317114|NCT00996892|64903944|FG002|Expansion Stage 2A|Disease Progression|0|||
23317115|NCT00996892|64903945|FG003|Expansion Stage 2A|Disease Progression|0|||
23317116|NCT00996892|64903946|FG004|Expansion Stage 2A|Disease Progression|0|||
23317117|NCT00996892|64903947|FG005|Expansion Stage 2A|Disease Progression|0|||
23317118|NCT00996892|64903948|FG006|Expansion Stage 2A|Disease Progression|0|||
23317119|NCT00996892|64903949|FG007|Expansion Stage 2A|Disease Progression|0|||
23317120|NCT00996892|64903950|FG008|Expansion Stage 2A|Disease Progression|0|||
23317121|NCT00996892|64903951|FG009|Expansion Stage 2A|Disease Progression|0|||
23317122|NCT00996892|64903952|FG010|Expansion Stage 2A|Disease Progression|0|||
23317123|NCT00996892|64903953|FG011|Expansion Stage 2A|Disease Progression|0|||
23317124|NCT00996892|64903954|FG012|Expansion Stage 2A|Disease Progression|0|||
23317125|NCT00996892|64903955|FG013|Expansion Stage 2A|Disease Progression|0|||
23317126|NCT00996892|64903956|FG014|Expansion Stage 2A|Disease Progression|0|||
23130171|NCT01008553|64226456|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
23130172|NCT01008553|64226457|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
23130173|NCT01008553|64226455|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
23130174|NCT01008553|64226456|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
23317127|NCT00996892|64903957|FG015|Expansion Stage 2A|Disease Progression|0|||
23317128|NCT00996892|64903958|FG016|Expansion Stage 2A|Disease Progression|0|||
23317129|NCT00996892|64903959|FG017|Expansion Stage 2A|Disease Progression|0|||
23317130|NCT00996892|64903960|FG018|Expansion Stage 2A|Disease Progression|0|||
23317131|NCT00996892|64903961|FG019|Expansion Stage 2A|Disease Progression|31|||
23545930|NCT02462876|65727300|FG000|Overall Study|Death|3|||
23317132|NCT01106014|64903963|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
23317133|NCT01106014|64903964|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
23317134|NCT01106014|64903963|FG000|Overall Study|Adverse Event|78|||
23317135|NCT01106014|64903964|FG001|Overall Study|Adverse Event|42|||
23317136|NCT01106014|64903963|FG000|Overall Study|Withdrawal by Subject|43|||
23317137|NCT01106014|64903964|FG001|Overall Study|Withdrawal by Subject|37|||
23317138|NCT01106014|64903963|FG000|Overall Study|Administrative reason|7|||
23317139|NCT01106014|64903964|FG001|Overall Study|Administrative reason|6|||
23317140|NCT01106014|64903963|FG000|Overall Study|Lost to Follow-up|2|||
23317141|NCT01106014|64903964|FG001|Overall Study|Lost to Follow-up|3|||
23317142|NCT01822366|64903973|FG000|Overall Study|Lost to Follow-up|5|||
23545931|NCT02462876|65727300|FG000|Overall Study|Lost to Follow-up|7|||
23545932|NCT02462876|65727300|FG000|Overall Study|Surgical Bypass|9|||
23545933|NCT02462876|65727300|FG000|Overall Study|Amputation Above the Metatarsals|1|||
23317143|NCT01822366|64903974|FG001|Overall Study|Lost to Follow-up|1|||
23317144|NCT01822366|64903975|FG002|Overall Study|Lost to Follow-up|5|||
23317145|NCT01822366|64903976|FG003|Overall Study|Lost to Follow-up|1|||
23317146|NCT01822366|64903973|FG000|Overall Study|Withdrawal by Subject|0|||
23317147|NCT01822366|64903974|FG001|Overall Study|Withdrawal by Subject|6|||
23130175|NCT01008553|64226457|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
23130176|NCT00677534|64226458|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
23130177|NCT00677534|64226458|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
23130178|NCT00677534|64226458|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
23130179|NCT00603525|64226459|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
23130180|NCT00603525|64226460|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
23130181|NCT00603525|64226461|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23130182|NCT00603525|64226459|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
23130183|NCT00603525|64226460|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23130184|NCT00603525|64226461|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23130185|NCT00603525|64226459|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
23130186|NCT00603525|64226460|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
23130187|NCT00603525|64226461|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23130188|NCT00603525|64226459|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23130189|NCT00603525|64226460|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
23130190|NCT00603525|64226461|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23130191|NCT00603525|64226459|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
23130192|NCT00603525|64226460|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
23130193|NCT00603525|64226461|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23130194|NCT00603525|64226459|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
23130195|NCT00603525|64226460|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
23130196|NCT00603525|64226461|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
23130197|NCT00603525|64226459|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
23130198|NCT00603525|64226460|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
23130199|NCT00603525|64226461|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
23130200|NCT00603525|64226459|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
23130201|NCT00603525|64226460|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
23130202|NCT00603525|64226461|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
23130203|NCT00603525|64226459|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
23130204|NCT00603525|64226460|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
23130205|NCT00603525|64226461|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
23130206|NCT00603525|64226459|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
23130207|NCT00603525|64226460|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
23130208|NCT00603525|64226461|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
23130209|NCT00603525|64226459|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
23130210|NCT00603525|64226460|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
23130211|NCT00603525|64226461|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
23130212|NCT00603525|64226459|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
23130213|NCT00603525|64226460|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
23130214|NCT00603525|64226461|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
23130215|NCT00603525|64226459|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
23130216|NCT00603525|64226460|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
23130217|NCT00603525|64226461|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
23130218|NCT00603525|64226459|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
23130219|NCT00603525|64226460|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
23130220|NCT00603525|64226461|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
23130221|NCT00603525|64226459|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
23130222|NCT00603525|64226460|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
23130223|NCT00603525|64226461|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
23130224|NCT00523640|64226462|FG000|Overall Study|Death|1|||
23130225|NCT00581893|64226467|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
23130226|NCT00581893|64226468|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
23130227|NCT04577001|64226476|FG000|Overall Study|Subject became ineligible|0|||
23130228|NCT04577001|64226477|FG001|Overall Study|Subject became ineligible|1|||
23130229|NCT01214642|64226478|FG000|Overall Study|Progressive Disease|3|||
23130230|NCT01214642|64226479|FG001|Overall Study|Progressive Disease|2|||
23130231|NCT01214642|64226480|FG002|Overall Study|Progressive Disease|3|||
23130232|NCT01214642|64226481|FG003|Overall Study|Progressive Disease|5|||
23130233|NCT01214642|64226482|FG004|Overall Study|Progressive Disease|5|||
23130234|NCT01214642|64226483|FG005|Overall Study|Progressive Disease|3|||
23130235|NCT01214642|64226484|FG006|Overall Study|Progressive Disease|5|||
23130236|NCT01214642|64226485|FG007|Overall Study|Progressive Disease|3|||
23130237|NCT01214642|64226486|FG008|Overall Study|Progressive Disease|10|||
23130238|NCT01214642|64226487|FG009|Overall Study|Progressive Disease|2|||
23130239|NCT01214642|64226488|FG010|Overall Study|Progressive Disease|1|||
23130240|NCT01214642|64226489|FG011|Overall Study|Progressive Disease|4|||
23130241|NCT01214642|64226478|FG000|Overall Study|Adverse Event|0|||
23130242|NCT01214642|64226479|FG001|Overall Study|Adverse Event|1|||
23213006|NCT00479557|64519830|FG002|Overall Study|Caregiver Request|2|||
23213007|NCT00479557|64519831|FG003|Overall Study|Caregiver Request|0|||
23317148|NCT01822366|64903975|FG002|Overall Study|Withdrawal by Subject|0|||
23317149|NCT01822366|64903976|FG003|Overall Study|Withdrawal by Subject|6|||
23317150|NCT01822366|64903973|FG000|Overall Study|Partial Intervention Completion|0|||
23317151|NCT01822366|64903974|FG001|Overall Study|Partial Intervention Completion|15|||
23317152|NCT01822366|64903975|FG002|Overall Study|Partial Intervention Completion|0|||
23317153|NCT01822366|64903976|FG003|Overall Study|Partial Intervention Completion|15|||
23317154|NCT02613182|64903982|FG000|Overall Study|Death|6|||
23317155|NCT02613182|64903982|FG000|Overall Study|Physician Decision|1|||
23317156|NCT02613182|64903982|FG000|Overall Study|Study Terminated by Sponsor|21|||
23317157|NCT02613182|64903982|FG000|Overall Study|Withdrawal by Subject|6|||
23317158|NCT04248829|64903986|FG000|Overall Study|Disease progression|44|||
23317159|NCT04248829|64903987|FG001|Overall Study|Disease progression|109|||
23317160|NCT04248829|64903986|FG000|Overall Study|Adverse Event|19|||
23317161|NCT04248829|64903987|FG001|Overall Study|Adverse Event|18|||
23317162|NCT04248829|64903986|FG000|Overall Study|Withdrawal by Subject|11|||
23317163|NCT04248829|64903987|FG001|Overall Study|Withdrawal by Subject|2|||
23317164|NCT04248829|64903986|FG000|Overall Study|Lost to Follow-up|0|||
23317165|NCT04248829|64903987|FG001|Overall Study|Lost to Follow-up|1|||
23317166|NCT04248829|64903986|FG000|Overall Study|Death|12|||
23317167|NCT04248829|64903987|FG001|Overall Study|Death|14|||
23426847|NCT00993499|65307457|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
23545934|NCT02462876|65727300|FG000|Overall Study|36 months follow-up visit missed|1|||
23545935|NCT02462876|65727300|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
23130243|NCT01214642|64226480|FG002|Overall Study|Adverse Event|0|||
23130244|NCT01214642|64226481|FG003|Overall Study|Adverse Event|0|||
23545936|NCT02462876|65727300|FG000|Overall Study|Patient did not come back to the vascular department|1|||
23545937|NCT02462876|65727300|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
23618859|NCT02979613|65991362|FG000|Double-Blind Phase|Withdrew Consent|2|||
23618860|NCT02979613|65991363|FG001|Double-Blind Phase|Withdrew Consent|4|||
23618861|NCT02979613|65991362|FG000|Double-Blind Phase|Pregnancy|2|||
23618862|NCT02979613|65991363|FG001|Double-Blind Phase|Pregnancy|2|||
23618863|NCT02979613|65991362|FG000|Double-Blind Phase|Adverse Event|2|||
23618864|NCT02979613|65991363|FG001|Double-Blind Phase|Adverse Event|0|||
23618865|NCT02979613|65991362|FG000|Double-Blind Phase|Lost to Follow-up|1|||
23618866|NCT02979613|65991363|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23130245|NCT01214642|64226482|FG004|Overall Study|Adverse Event|0|||
23130246|NCT01214642|64226483|FG005|Overall Study|Adverse Event|0|||
23130247|NCT01214642|64226484|FG006|Overall Study|Adverse Event|1|||
23545938|NCT02462876|65727300|FG000|Overall Study|Patient refused to come back|1|||
23545939|NCT02462876|65727300|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
23545940|NCT02462876|65727300|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
23545941|NCT01308580|65727301|FG000|Overall Study|Lost to Follow-up|12|||
23618867|NCT02979613|65991362|FG000|Double-Blind Phase|Protocol Violation|1|||
23618868|NCT02979613|65991363|FG001|Double-Blind Phase|Protocol Violation|1|||
23130248|NCT01214642|64226485|FG007|Overall Study|Adverse Event|0|||
23130249|NCT01214642|64226486|FG008|Overall Study|Adverse Event|0|||
23130250|NCT01214642|64226487|FG009|Overall Study|Adverse Event|1|||
23130251|NCT01214642|64226488|FG010|Overall Study|Adverse Event|1|||
23130252|NCT01214642|64226489|FG011|Overall Study|Adverse Event|0|||
23130253|NCT01214642|64226478|FG000|Overall Study|Death|0|||
23130254|NCT01214642|64226479|FG001|Overall Study|Death|0|||
23130255|NCT01214642|64226480|FG002|Overall Study|Death|1|||
23426848|NCT00993499|65307458|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
23426849|NCT00993499|65307453|FG000|Discontinued After Starting Course 3|DLT|1|||
23426850|NCT00993499|65307454|FG001|Discontinued After Starting Course 3|DLT|0|||
23426851|NCT00993499|65307455|FG002|Discontinued After Starting Course 3|DLT|2|||
23426852|NCT00993499|65307456|FG003|Discontinued After Starting Course 3|DLT|1|||
23426853|NCT00993499|65307457|FG004|Discontinued After Starting Course 3|DLT|0|||
23426854|NCT00993499|65307458|FG005|Discontinued After Starting Course 3|DLT|0|||
23426855|NCT00993499|65307453|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
23426856|NCT00993499|65307454|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
23426857|NCT00993499|65307455|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
23426858|NCT00993499|65307456|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
23618869|NCT02979613|65991362|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
23618870|NCT02979613|65991363|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
23618871|NCT02979613|65991362|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
23130256|NCT01214642|64226481|FG003|Overall Study|Death|0|||
23130257|NCT01214642|64226482|FG004|Overall Study|Death|0|||
23130258|NCT01214642|64226483|FG005|Overall Study|Death|0|||
23317168|NCT04248829|64903986|FG000|Overall Study|Physician Decision|2|||
23317169|NCT04248829|64903987|FG001|Overall Study|Physician Decision|4|||
23317170|NCT04248829|64903986|FG000|Overall Study|Any reason not specifically recorded|0|||
23317171|NCT04248829|64903987|FG001|Overall Study|Any reason not specifically recorded|2|||
23317172|NCT00380744|64903988|FG000|Overall Study|Death|0|||
23317173|NCT00380744|64903989|FG001|Overall Study|Death|0|||
23545942|NCT01308580|65727302|FG001|Overall Study|Lost to Follow-up|7|||
23545943|NCT02005471|65727303|FG000|Main Study|Adverse Event|0|||
23545944|NCT02005471|65727304|FG001|Main Study|Adverse Event|1|||
23545945|NCT02005471|65727305|FG002|Main Study|Adverse Event|0|||
23545946|NCT02005471|65727306|FG003|Main Study|Adverse Event|0|||
23545947|NCT02005471|65727303|FG000|Main Study|Death|83|||
23545948|NCT02005471|65727304|FG001|Main Study|Death|52|||
23545949|NCT02005471|65727305|FG002|Main Study|Death|0|||
23545950|NCT02005471|65727306|FG003|Main Study|Death|0|||
23545951|NCT02005471|65727303|FG000|Main Study|Lost to Follow-up|4|||
23545952|NCT02005471|65727304|FG001|Main Study|Lost to Follow-up|5|||
23545953|NCT02005471|65727305|FG002|Main Study|Lost to Follow-up|0|||
23545954|NCT02005471|65727306|FG003|Main Study|Lost to Follow-up|0|||
23545955|NCT02005471|65727303|FG000|Main Study|Physician Decision|3|||
23545956|NCT02005471|65727304|FG001|Main Study|Physician Decision|1|||
23545957|NCT02005471|65727305|FG002|Main Study|Physician Decision|0|||
23545958|NCT02005471|65727306|FG003|Main Study|Physician Decision|0|||
23545959|NCT02005471|65727303|FG000|Main Study|Withdrawal by Subject|26|||
23545960|NCT02005471|65727304|FG001|Main Study|Withdrawal by Subject|11|||
23545961|NCT02005471|65727305|FG002|Main Study|Withdrawal by Subject|0|||
23545962|NCT02005471|65727306|FG003|Main Study|Withdrawal by Subject|0|||
23545963|NCT02005471|65727303|FG000|Main Study|Reason not Specified|0|||
23545964|NCT02005471|65727304|FG001|Main Study|Reason not Specified|6|||
23545965|NCT02005471|65727305|FG002|Main Study|Reason not Specified|0|||
23545966|NCT02005471|65727306|FG003|Main Study|Reason not Specified|0|||
23545967|NCT02005471|65727303|FG000|Main Study|Randomized but not Dosed|8|||
23545968|NCT02005471|65727304|FG001|Main Study|Randomized but not Dosed|0|||
23545969|NCT02005471|65727305|FG002|Main Study|Randomized but not Dosed|0|||
23545970|NCT02005471|65727306|FG003|Main Study|Randomized but not Dosed|0|||
23545971|NCT02005471|65727303|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
23545972|NCT02005471|65727304|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
23545973|NCT02005471|65727305|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
23545974|NCT02005471|65727306|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
23545975|NCT02005471|65727303|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
23545976|NCT02005471|65727304|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
23545977|NCT02005471|65727305|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
23545978|NCT02005471|65727306|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
23545979|NCT02005471|65727303|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
23545980|NCT02005471|65727304|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
23545981|NCT02005471|65727305|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
23545982|NCT02005471|65727306|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
23545983|NCT02566031|65730939|FG000|Overall Study|Patient/guardian decision|14|||
23545984|NCT02566031|65730940|FG001|Overall Study|Patient/guardian decision|7|||
23545985|NCT02566031|65730939|FG000|Overall Study|Protocol deviation|2|||
23545986|NCT02566031|65730940|FG001|Overall Study|Protocol deviation|3|||
23545987|NCT02566031|65730939|FG000|Overall Study|Adverse Event|3|||
23545988|NCT02566031|65730940|FG001|Overall Study|Adverse Event|1|||
23545989|NCT02566031|65730939|FG000|Overall Study|Lost to Follow-up|1|||
23545990|NCT02566031|65730940|FG001|Overall Study|Lost to Follow-up|1|||
23545991|NCT02827877|65730941|FG000|Overall Study|Withdrawal by Subject|1|||
23545992|NCT03389802|65730944|FG000|Overall Study|Lack of Efficacy|3|||
23130259|NCT01214642|64226484|FG006|Overall Study|Death|0|||
23130260|NCT01214642|64226485|FG007|Overall Study|Death|0|||
23130261|NCT01214642|64226486|FG008|Overall Study|Death|0|||
23130262|NCT01214642|64226487|FG009|Overall Study|Death|0|||
23130263|NCT01214642|64226488|FG010|Overall Study|Death|1|||
23130264|NCT01214642|64226489|FG011|Overall Study|Death|0|||
23545993|NCT03389802|65730945|FG001|Overall Study|Lack of Efficacy|3|||
23545994|NCT03389802|65730946|FG002|Overall Study|Lack of Efficacy|13|||
23130265|NCT01214642|64226478|FG000|Overall Study|Withdrawal by Subject|0|||
23130266|NCT01214642|64226479|FG001|Overall Study|Withdrawal by Subject|0|||
23213008|NCT00479557|64519832|FG004|Overall Study|Caregiver Request|1|||
23130267|NCT01214642|64226480|FG002|Overall Study|Withdrawal by Subject|1|||
23130268|NCT01214642|64226481|FG003|Overall Study|Withdrawal by Subject|0|||
23213009|NCT00479557|64519833|FG005|Overall Study|Caregiver Request|2|||
23213010|NCT00479557|64519834|FG006|Overall Study|Caregiver Request|0|||
23545995|NCT03389802|65730947|FG003|Overall Study|Lack of Efficacy|6|||
23545996|NCT03389802|65730948|FG004|Overall Study|Lack of Efficacy|1|||
23545997|NCT03389802|65730944|FG000|Overall Study|Adverse Event|0|||
23545998|NCT03389802|65730945|FG001|Overall Study|Adverse Event|0|||
23545999|NCT03389802|65730946|FG002|Overall Study|Adverse Event|1|||
23546000|NCT03389802|65730947|FG003|Overall Study|Adverse Event|0|||
23546001|NCT03389802|65730948|FG004|Overall Study|Adverse Event|4|||
23546002|NCT03389802|65730944|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
23546003|NCT03389802|65730945|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
23546004|NCT03389802|65730946|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
23546005|NCT03389802|65730947|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
23546006|NCT03389802|65730948|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
23546007|NCT00688636|65730953|FG000|Overall Study|Adverse Event|2|||
23130269|NCT01214642|64226482|FG004|Overall Study|Withdrawal by Subject|0|||
23130270|NCT01214642|64226483|FG005|Overall Study|Withdrawal by Subject|0|||
23130271|NCT01214642|64226484|FG006|Overall Study|Withdrawal by Subject|0|||
23130272|NCT01214642|64226485|FG007|Overall Study|Withdrawal by Subject|0|||
23130273|NCT01214642|64226486|FG008|Overall Study|Withdrawal by Subject|3|||
23130274|NCT01214642|64226487|FG009|Overall Study|Withdrawal by Subject|1|||
23130275|NCT01214642|64226488|FG010|Overall Study|Withdrawal by Subject|1|||
23130276|NCT01214642|64226489|FG011|Overall Study|Withdrawal by Subject|0|||
23130277|NCT01214642|64226478|FG000|Overall Study|Physician Decision|0|||
23130278|NCT01214642|64226479|FG001|Overall Study|Physician Decision|0|||
23546008|NCT00688636|65730954|FG001|Overall Study|Adverse Event|1|||
23546009|NCT02864082|65730955|FG000|Overall Study|Adverse Event|1|||
23546010|NCT02864082|65730956|FG001|Overall Study|Adverse Event|1|||
23546011|NCT02864082|65730955|FG000|Overall Study|Lost to Follow-up|0|||
23546012|NCT02864082|65730956|FG001|Overall Study|Lost to Follow-up|1|||
23546013|NCT02864082|65730955|FG000|Overall Study|Withdrawal by Subject|2|||
23546014|NCT02864082|65730956|FG001|Overall Study|Withdrawal by Subject|2|||
23546015|NCT02535065|65730957|FG000|Overall Study|Death|13|||
23546016|NCT02535065|65730957|FG000|Overall Study|Lost to Follow-up|1|||
23546017|NCT02535065|65730957|FG000|Overall Study|Withdrawal by Subject|6|||
23546018|NCT01949480|65730960|FG000|Overall Study|Physician Decision|5|||
23546019|NCT01949480|65730961|FG001|Overall Study|Physician Decision|8|||
23546020|NCT02459574|65730962|FG000|Overall Study|Withdrawal by Subject|6|||
23546021|NCT02459574|65730963|FG001|Overall Study|Withdrawal by Subject|6|||
23546022|NCT02459574|65730964|FG002|Overall Study|Withdrawal by Subject|2|||
23546023|NCT02459574|65730962|FG000|Overall Study|Lost to Follow-up|1|||
23546024|NCT02459574|65730963|FG001|Overall Study|Lost to Follow-up|1|||
23546025|NCT02459574|65730964|FG002|Overall Study|Lost to Follow-up|0|||
23546026|NCT02459574|65730962|FG000|Overall Study|Death|0|||
23546027|NCT02459574|65730963|FG001|Overall Study|Death|1|||
23546028|NCT02459574|65730964|FG002|Overall Study|Death|0|||
23546029|NCT00121238|65730965|FG000|Overall Study|disease progression before intervention|1|||
23546030|NCT00121238|65730965|FG000|Overall Study|Protocol Violation|2|||
23546031|NCT01369342|65730966|FG000|Overall Study|Withdrawal by Subject|7|||
23546032|NCT01369342|65730967|FG001|Overall Study|Withdrawal by Subject|7|||
23546033|NCT01369342|65730968|FG002|Overall Study|Withdrawal by Subject|2|||
23213011|NCT00479557|64519828|FG000|Overall Study|Investigator Request|0|||
23426859|NCT00993499|65307457|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
23426860|NCT00993499|65307458|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
23546034|NCT01369342|65730966|FG000|Overall Study|Lost to Follow-up|5|||
23546035|NCT01369342|65730967|FG001|Overall Study|Lost to Follow-up|2|||
23546036|NCT01369342|65730968|FG002|Overall Study|Lost to Follow-up|1|||
23546037|NCT01369342|65730966|FG000|Overall Study|Not Treated|1|||
23546038|NCT01369342|65730967|FG001|Overall Study|Not Treated|0|||
23546039|NCT01369342|65730968|FG002|Overall Study|Not Treated|0|||
23546040|NCT04786444|65730973|FG000|Overall Study|Withdrawal by Subject|4|||
23546041|NCT04786444|65730974|FG001|Overall Study|Withdrawal by Subject|7|||
23546042|NCT04786444|65730975|FG002|Overall Study|Withdrawal by Subject|2|||
23546043|NCT04786444|65730973|FG000|Overall Study|Lost to Follow-up|11|||
23546044|NCT04786444|65730974|FG001|Overall Study|Lost to Follow-up|9|||
23546045|NCT04786444|65730975|FG002|Overall Study|Lost to Follow-up|10|||
23546046|NCT04786444|65730973|FG000|Overall Study|Subject would like to become pregnant|0|||
23546047|NCT04786444|65730974|FG001|Overall Study|Subject would like to become pregnant|1|||
23546048|NCT04786444|65730975|FG002|Overall Study|Subject would like to become pregnant|0|||
23546049|NCT02937545|65730976|FG000|Overall Study|Withdrawal by Subject|1|||
23546050|NCT02937545|65730977|FG001|Overall Study|Withdrawal by Subject|2|||
23546051|NCT02937545|65730978|FG002|Overall Study|Withdrawal by Subject|6|||
23546052|NCT02937545|65730979|FG003|Overall Study|Withdrawal by Subject|7|||
23546053|NCT02937545|65730976|FG000|Overall Study|Lost to Follow-up|1|||
23546054|NCT02937545|65730977|FG001|Overall Study|Lost to Follow-up|0|||
23546055|NCT02937545|65730978|FG002|Overall Study|Lost to Follow-up|0|||
23546056|NCT02937545|65730979|FG003|Overall Study|Lost to Follow-up|0|||
23546057|NCT01412944|65730980|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23546058|NCT01412944|65730981|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23546059|NCT01412944|65730982|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
23546060|NCT01412944|65730983|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23546061|NCT01412944|65730984|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23546062|NCT01412944|65730985|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
23130279|NCT01214642|64226480|FG002|Overall Study|Physician Decision|1|||
23130280|NCT01214642|64226481|FG003|Overall Study|Physician Decision|1|||
23130281|NCT01214642|64226482|FG004|Overall Study|Physician Decision|1|||
23130282|NCT01214642|64226483|FG005|Overall Study|Physician Decision|0|||
23546063|NCT01412944|65730980|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23546064|NCT01412944|65730981|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23213012|NCT00479557|64519829|FG001|Overall Study|Investigator Request|0|||
23130283|NCT01214642|64226484|FG006|Overall Study|Physician Decision|0|||
23130284|NCT01214642|64226485|FG007|Overall Study|Physician Decision|0|||
23130285|NCT01214642|64226486|FG008|Overall Study|Physician Decision|0|||
23130286|NCT01214642|64226487|FG009|Overall Study|Physician Decision|0|||
23130287|NCT01214642|64226488|FG010|Overall Study|Physician Decision|0|||
23130288|NCT01214642|64226489|FG011|Overall Study|Physician Decision|2|||
23130289|NCT00479882|64226490|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
23130290|NCT00479882|64226491|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
23130291|NCT00479882|64226492|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
23130292|NCT00479882|64226493|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
23130293|NCT00479882|64226490|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
23130294|NCT00479882|64226491|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
23130295|NCT00479882|64226492|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
23426861|NCT02358044|65307459|FG000|Overall Study|Adverse Event|0|||
23546065|NCT01412944|65730982|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23546066|NCT01412944|65730983|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23546067|NCT01412944|65730984|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
23546068|NCT01412944|65730985|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
23546069|NCT01412944|65730980|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546070|NCT01412944|65730981|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546071|NCT01412944|65730982|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546072|NCT01412944|65730983|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546073|NCT01412944|65730984|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
23546074|NCT01412944|65730985|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
23546075|NCT01412944|65730980|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
23546076|NCT01412944|65730981|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546077|NCT01412944|65730982|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546078|NCT01412944|65730983|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546079|NCT01412944|65730984|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546080|NCT01412944|65730985|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
23546081|NCT01412944|65730980|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
23546082|NCT01412944|65730981|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
23546083|NCT01412944|65730982|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
23546084|NCT01412944|65730983|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
23546085|NCT01412944|65730984|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
23546086|NCT01412944|65730985|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
23546087|NCT01412944|65730980|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546088|NCT01412944|65730981|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
23546089|NCT01412944|65730982|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546090|NCT01412944|65730983|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546091|NCT01412944|65730984|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546092|NCT01412944|65730985|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
23546093|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546094|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546095|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
23546096|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
23546097|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
23546098|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546099|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Adverse Event|0|||
23546100|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Adverse Event|0|||
23546101|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Adverse Event|0|||
23546102|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Adverse Event|0|||
23546103|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Adverse Event|1|||
23546104|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Adverse Event|0|||
23546105|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
23546106|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
23546107|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
23546108|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
23546109|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
23546110|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
23546111|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546112|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546113|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546114|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
23130296|NCT00479882|64226493|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
23130297|NCT00479882|64226490|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
23546115|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546116|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
23546117|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546118|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
23213013|NCT00479557|64519830|FG002|Overall Study|Investigator Request|1|||
23213014|NCT00479557|64519831|FG003|Overall Study|Investigator Request|0|||
23317174|NCT00380744|64903990|FG002|Overall Study|Death|0|||
23317175|NCT00380744|64903991|FG003|Overall Study|Death|0|||
23317176|NCT00380744|64903992|FG004|Overall Study|Death|0|||
23317177|NCT00380744|64903993|FG005|Overall Study|Death|0|||
23317178|NCT00380744|64903994|FG006|Overall Study|Death|1|||
23317179|NCT00380744|64903988|FG000|Overall Study|Withdrawal by Subject|1|||
23317180|NCT00380744|64903989|FG001|Overall Study|Withdrawal by Subject|0|||
23317181|NCT00380744|64903990|FG002|Overall Study|Withdrawal by Subject|0|||
23426862|NCT02358044|65307460|FG001|Overall Study|Adverse Event|1|||
23426863|NCT02358044|65307459|FG000|Overall Study|Lost to Follow-up|2|||
23426864|NCT02358044|65307460|FG001|Overall Study|Lost to Follow-up|1|||
23426865|NCT02358044|65307459|FG000|Overall Study|Physician Decision|0|||
23426866|NCT02358044|65307460|FG001|Overall Study|Physician Decision|1|||
23426867|NCT02358044|65307459|FG000|Overall Study|Withdrawal by Subject|0|||
23426868|NCT02358044|65307460|FG001|Overall Study|Withdrawal by Subject|4|||
23426869|NCT01300819|65307461|FG000|Overall Study|Adverse Event|9|||
23426870|NCT01300819|65307462|FG001|Overall Study|Adverse Event|27|||
23426871|NCT01300819|65307461|FG000|Overall Study|Lack of Efficacy|2|||
23426872|NCT01300819|65307462|FG001|Overall Study|Lack of Efficacy|1|||
23426873|NCT01300819|65307461|FG000|Overall Study|Withdrawal by Subject|10|||
23426874|NCT01300819|65307462|FG001|Overall Study|Withdrawal by Subject|12|||
23426875|NCT01300819|65307461|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
23426876|NCT01300819|65307462|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
23426877|NCT01300819|65307461|FG000|Overall Study|Refusal to down titrate study drug|0|||
23426878|NCT01300819|65307462|FG001|Overall Study|Refusal to down titrate study drug|1|||
23426879|NCT01300819|65307461|FG000|Overall Study|Administrative reason|0|||
23426880|NCT01300819|65307462|FG001|Overall Study|Administrative reason|1|||
23426881|NCT01300819|65307461|FG000|Overall Study|Safety follow up not done by mistake|0|||
23426882|NCT01300819|65307462|FG001|Overall Study|Safety follow up not done by mistake|1|||
23426883|NCT01300819|65307461|FG000|Overall Study|Follow up call was not done|1|||
23426884|NCT01300819|65307462|FG001|Overall Study|Follow up call was not done|0|||
23426885|NCT02827500|65307463|FG000|Overall Study|Death|7|||
23426886|NCT02827500|65307464|FG001|Overall Study|Death|3|||
23426887|NCT02827500|65307463|FG000|Overall Study|Lost to Follow-up|1|||
23426888|NCT02827500|65307464|FG001|Overall Study|Lost to Follow-up|1|||
23426889|NCT02827500|65307463|FG000|Overall Study|Withdrawal by Subject|3|||
23426890|NCT02827500|65307464|FG001|Overall Study|Withdrawal by Subject|1|||
23426891|NCT02827500|65307463|FG000|Overall Study|Missing primary endpoint data|3|||
23546119|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
23213015|NCT00479557|64519832|FG004|Overall Study|Investigator Request|0|||
23213016|NCT00479557|64519833|FG005|Overall Study|Investigator Request|0|||
23213017|NCT00479557|64519834|FG006|Overall Study|Investigator Request|0|||
23213018|NCT00479557|64519828|FG000|Overall Study|Subject Request|3|||
23213019|NCT00479557|64519829|FG001|Overall Study|Subject Request|0|||
23213020|NCT00479557|64519830|FG002|Overall Study|Subject Request|1|||
23213021|NCT00479557|64519831|FG003|Overall Study|Subject Request|1|||
23213022|NCT00479557|64519832|FG004|Overall Study|Subject Request|1|||
23213023|NCT00479557|64519833|FG005|Overall Study|Subject Request|4|||
23213024|NCT00479557|64519834|FG006|Overall Study|Subject Request|1|||
23213025|NCT00479557|64519828|FG000|Overall Study|Other|2|||
23213026|NCT00479557|64519829|FG001|Overall Study|Other|3|||
23213027|NCT00479557|64519830|FG002|Overall Study|Other|1|||
23213028|NCT00479557|64519831|FG003|Overall Study|Other|0|||
23213029|NCT00479557|64519832|FG004|Overall Study|Other|0|||
23213030|NCT00479557|64519833|FG005|Overall Study|Other|3|||
23213031|NCT00479557|64519834|FG006|Overall Study|Other|0|||
23213032|NCT00098020|64519835|FG000|Overall Study|Adverse Event|2|||
23213033|NCT00098020|64519835|FG000|Overall Study|Lost to Follow-up|1|||
23213034|NCT00098020|64519835|FG000|Overall Study|elevated liver enzymes|1|||
23213035|NCT00098020|64519835|FG000|Overall Study|Low urine PCR|1|||
23213036|NCT00098020|64519835|FG000|Overall Study|Low epidermal growth factor receptor|1|||
23213037|NCT01381718|64519840|FG000|Overall Study|Withdrawal by Subject|2|||
23213038|NCT01381718|64519841|FG001|Overall Study|Withdrawal by Subject|5|||
23317182|NCT00380744|64903991|FG003|Overall Study|Withdrawal by Subject|0|||
23426892|NCT02827500|65307464|FG001|Overall Study|Missing primary endpoint data|1|||
23426893|NCT02827500|65307463|FG000|Overall Study|Other|5|||
23546120|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
23426894|NCT02827500|65307464|FG001|Overall Study|Other|1|||
23426895|NCT02677844|65307465|FG000|Period 3|Withdrawal by Subject|0|||
23546121|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
23213039|NCT01381718|64519840|FG000|Overall Study|Lost to Follow-up|3|||
23213040|NCT01381718|64519841|FG001|Overall Study|Lost to Follow-up|5|||
23213041|NCT01381718|64519840|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
23213042|NCT01381718|64519841|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
23213043|NCT02260648|64519842|FG000|Overall Study|Adverse Event|3|||
23317183|NCT00380744|64903992|FG004|Overall Study|Withdrawal by Subject|0|||
23317184|NCT00380744|64903993|FG005|Overall Study|Withdrawal by Subject|0|||
23317185|NCT00380744|64903994|FG006|Overall Study|Withdrawal by Subject|0|||
23317186|NCT02682927|64903995|FG000|Overall Study|Adverse Event|0|||
23317187|NCT02682927|64903996|FG001|Overall Study|Adverse Event|0|||
23317188|NCT02682927|64903997|FG002|Overall Study|Adverse Event|5|||
23317189|NCT02682927|64903998|FG003|Overall Study|Adverse Event|1|||
23546122|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546123|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
23546124|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
23546125|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546126|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546127|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546128|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
23546129|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
23546130|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
23546131|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
23546132|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
23546133|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
23546134|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
23546135|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
23213044|NCT02260648|64519843|FG001|Overall Study|Adverse Event|0|||
23213045|NCT02260648|64519844|FG002|Overall Study|Adverse Event|1|||
23213046|NCT02260648|64519842|FG000|Overall Study|Withdrawal by Subject|1|||
23213047|NCT02260648|64519843|FG001|Overall Study|Withdrawal by Subject|1|||
23213048|NCT02260648|64519844|FG002|Overall Study|Withdrawal by Subject|0|||
23213049|NCT02260648|64519842|FG000|Overall Study|Protocol Violation|1|||
23213050|NCT02260648|64519843|FG001|Overall Study|Protocol Violation|0|||
23213051|NCT02260648|64519844|FG002|Overall Study|Protocol Violation|0|||
23213052|NCT02260648|64519842|FG000|Overall Study|Discontinue Due to Study Termination|13|||
23213053|NCT02260648|64519843|FG001|Overall Study|Discontinue Due to Study Termination|12|||
23213054|NCT02260648|64519844|FG002|Overall Study|Discontinue Due to Study Termination|7|||
23213055|NCT00506948|64519845|FG000|Overall Study|Death|4|||
23213056|NCT00506948|64519845|FG000|Overall Study|Adverse Event|5|||
23213057|NCT00506948|64519845|FG000|Overall Study|Physician Decision|1|||
23213058|NCT00108953|64519846|FG000|Follow-up|Death|18|||
23213059|NCT00108953|64519847|FG001|Follow-up|Death|26|||
23213060|NCT00108953|64519846|FG000|Follow-up|Lost to Follow-up|1|||
23213061|NCT00108953|64519847|FG001|Follow-up|Lost to Follow-up|1|||
23213062|NCT00108953|64519846|FG000|Follow-up|Study terminated by sponsor|10|||
23213063|NCT00108953|64519847|FG001|Follow-up|Study terminated by sponsor|6|||
23213064|NCT03341923|64519850|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
23213065|NCT03341923|64519851|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
23213066|NCT02758613|64519852|FG000|Treatment|Physician and Sponsor Decision|1|||
23317190|NCT02682927|64903999|FG004|Overall Study|Adverse Event|0|||
23317191|NCT02682927|64904000|FG005|Overall Study|Adverse Event|2|||
23317192|NCT02682927|64903995|FG000|Overall Study|Death|0|||
23317193|NCT02682927|64903996|FG001|Overall Study|Death|0|||
23317194|NCT02682927|64903997|FG002|Overall Study|Death|0|||
23317195|NCT02682927|64903998|FG003|Overall Study|Death|1|||
23317196|NCT02682927|64903999|FG004|Overall Study|Death|0|||
23317197|NCT02682927|64904000|FG005|Overall Study|Death|0|||
23317198|NCT02682927|64903995|FG000|Overall Study|Lack of Efficacy|1|||
23317199|NCT02682927|64903996|FG001|Overall Study|Lack of Efficacy|0|||
23317200|NCT02682927|64903997|FG002|Overall Study|Lack of Efficacy|0|||
23317201|NCT02682927|64903998|FG003|Overall Study|Lack of Efficacy|1|||
23317202|NCT02682927|64903999|FG004|Overall Study|Lack of Efficacy|0|||
23317203|NCT02682927|64904000|FG005|Overall Study|Lack of Efficacy|0|||
23317204|NCT02682927|64903995|FG000|Overall Study|Other|0|||
23317205|NCT02682927|64903996|FG001|Overall Study|Other|0|||
23317206|NCT02682927|64903997|FG002|Overall Study|Other|0|||
23317207|NCT02682927|64903998|FG003|Overall Study|Other|2|||
23317208|NCT02682927|64903999|FG004|Overall Study|Other|0|||
23317209|NCT02682927|64904000|FG005|Overall Study|Other|0|||
23317210|NCT02682927|64903995|FG000|Overall Study|Withdrawal by Subject|2|||
23546136|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
23213067|NCT02758613|64519853|FG001|Treatment|Physician and Sponsor Decision|0|||
23213068|NCT02758613|64519854|FG002|Treatment|Physician and Sponsor Decision|0|||
23317211|NCT02682927|64903996|FG001|Overall Study|Withdrawal by Subject|0|||
23317212|NCT02682927|64903997|FG002|Overall Study|Withdrawal by Subject|1|||
23317213|NCT02682927|64903998|FG003|Overall Study|Withdrawal by Subject|0|||
23317214|NCT02682927|64903999|FG004|Overall Study|Withdrawal by Subject|1|||
23317215|NCT02682927|64904000|FG005|Overall Study|Withdrawal by Subject|1|||
23317216|NCT00101283|64904001|FG000|Overall Study|Withdrawal by Subject|0|||
23317217|NCT00101283|64904002|FG001|Overall Study|Withdrawal by Subject|1|||
23213069|NCT02758613|64519855|FG003|Treatment|Physician and Sponsor Decision|0|||
23213070|NCT02758613|64519852|FG000|Treatment|Withdrawal by Subject|1|||
23317218|NCT00101283|64904001|FG000|Overall Study|Insurance Refusal|0|||
23213071|NCT02758613|64519853|FG001|Treatment|Withdrawal by Subject|0|||
23213072|NCT02758613|64519854|FG002|Treatment|Withdrawal by Subject|1|||
23213073|NCT02758613|64519855|FG003|Treatment|Withdrawal by Subject|0|||
23213074|NCT02616185|64519856|FG000|Overall Study|Death|0|||
23213075|NCT02616185|64519857|FG001|Overall Study|Death|0|||
23213076|NCT02616185|64519858|FG002|Overall Study|Death|0|||
23213077|NCT02616185|64519859|FG003|Overall Study|Death|1|||
23213078|NCT02616185|64519860|FG004|Overall Study|Death|2|||
23213079|NCT02616185|64519861|FG005|Overall Study|Death|0|||
23213080|NCT02616185|64519862|FG006|Overall Study|Death|0|||
23213081|NCT02616185|64519863|FG007|Overall Study|Death|2|||
23213082|NCT02616185|64519864|FG008|Overall Study|Death|1|||
23213083|NCT02616185|64519856|FG000|Overall Study|Study terminated by sponsor|0|||
23213084|NCT02616185|64519857|FG001|Overall Study|Study terminated by sponsor|0|||
23213085|NCT02616185|64519858|FG002|Overall Study|Study terminated by sponsor|1|||
23213086|NCT02616185|64519859|FG003|Overall Study|Study terminated by sponsor|0|||
23213087|NCT02616185|64519860|FG004|Overall Study|Study terminated by sponsor|0|||
23213088|NCT02616185|64519861|FG005|Overall Study|Study terminated by sponsor|0|||
23213089|NCT02616185|64519862|FG006|Overall Study|Study terminated by sponsor|5|||
23213090|NCT02616185|64519863|FG007|Overall Study|Study terminated by sponsor|2|||
23213091|NCT02616185|64519864|FG008|Overall Study|Study terminated by sponsor|0|||
23213092|NCT02616185|64519856|FG000|Overall Study|Participant refused further follow-up|1|||
23213093|NCT02616185|64519857|FG001|Overall Study|Participant refused further follow-up|1|||
23130298|NCT00479882|64226491|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
23130299|NCT00479882|64226492|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
23130300|NCT00479882|64226493|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
23130301|NCT00479882|64226490|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
23130302|NCT00479882|64226491|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
23130303|NCT00479882|64226492|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
23130304|NCT00479882|64226493|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
23130305|NCT00479882|64226490|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
23130306|NCT00479882|64226491|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
23130307|NCT00479882|64226492|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
23130308|NCT00479882|64226493|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
23130309|NCT00479882|64226490|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
23130310|NCT00479882|64226491|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
23130311|NCT00479882|64226492|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
23130312|NCT00479882|64226493|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
23130313|NCT00479882|64226490|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
23130314|NCT00479882|64226491|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
23130315|NCT00479882|64226492|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
23130316|NCT00479882|64226493|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
23130317|NCT00479882|64226490|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
23130318|NCT00479882|64226491|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
23130319|NCT00479882|64226492|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
23130320|NCT00479882|64226493|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
23130321|NCT00479882|64226490|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
23130322|NCT00479882|64226491|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
23130323|NCT00479882|64226492|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
23130324|NCT00479882|64226493|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
23130325|NCT00479882|64226490|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
23130326|NCT00479882|64226491|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
23130327|NCT00479882|64226492|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
23130328|NCT00479882|64226493|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
23130329|NCT00479882|64226490|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
23130330|NCT00479882|64226491|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
23130331|NCT00479882|64226492|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
23130332|NCT00479882|64226493|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
23130333|NCT00479882|64226490|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
23130334|NCT00479882|64226491|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
23130335|NCT00479882|64226492|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
23130336|NCT00479882|64226493|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
23130337|NCT00479882|64226490|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
23130338|NCT00479882|64226491|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
23130339|NCT00479882|64226492|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
23213094|NCT02616185|64519858|FG002|Overall Study|Participant refused further follow-up|2|||
23213095|NCT02616185|64519859|FG003|Overall Study|Participant refused further follow-up|3|||
23213096|NCT02616185|64519860|FG004|Overall Study|Participant refused further follow-up|4|||
23213097|NCT02616185|64519861|FG005|Overall Study|Participant refused further follow-up|0|||
23317219|NCT00101283|64904002|FG001|Overall Study|Insurance Refusal|1|||
23317220|NCT00101283|64904001|FG000|Overall Study|Prostate Cancer Recurrence|0|||
23317221|NCT00101283|64904002|FG001|Overall Study|Prostate Cancer Recurrence|1|||
23317222|NCT02439970|64904005|FG000|Overall Study|Study Terminated|2|||
23317223|NCT02439970|64904006|FG001|Overall Study|Study Terminated|3|||
23317224|NCT02088697|64904009|FG000|Period I|Physician Decision|1|||
23317225|NCT02088697|64904010|FG001|Period I|Physician Decision|4|||
23317226|NCT02088697|64904009|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
23317227|NCT02088697|64904010|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
23317228|NCT01512160|64904011|FG000|Overall Study|Lost to Follow-up|1|||
23317229|NCT01512160|64904012|FG001|Overall Study|Lost to Follow-up|0|||
23317230|NCT01512160|64904013|FG002|Overall Study|Lost to Follow-up|0|||
23317231|NCT01512160|64904014|FG003|Overall Study|Lost to Follow-up|0|||
23317232|NCT01512160|64904011|FG000|Overall Study|Withdrawal by Subject|1|||
23317233|NCT01512160|64904012|FG001|Overall Study|Withdrawal by Subject|0|||
23317234|NCT01512160|64904013|FG002|Overall Study|Withdrawal by Subject|0|||
23317235|NCT01512160|64904014|FG003|Overall Study|Withdrawal by Subject|1|||
23317236|NCT00640315|64904015|FG000|Overall Study|Withdrawal by Subject|0|||
23426896|NCT02677844|65307466|FG001|Period 3|Withdrawal by Subject|0|||
23426897|NCT02677844|65307467|FG002|Period 3|Withdrawal by Subject|0|||
23426898|NCT02677844|65307468|FG003|Period 3|Withdrawal by Subject|1|||
23426899|NCT02677844|65307469|FG004|Period 3|Withdrawal by Subject|0|||
23130340|NCT00479882|64226493|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
23130341|NCT00479882|64226490|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
23317237|NCT00640315|64904016|FG001|Overall Study|Withdrawal by Subject|1|||
23317238|NCT00447876|64904017|FG000|Overall Study|Withdrawal by Subject|1|||
23426900|NCT02677844|65307470|FG005|Period 3|Withdrawal by Subject|0|||
23426901|NCT02677844|65307471|FG006|Period 3|Withdrawal by Subject|0|||
23426902|NCT02174523|65307472|FG000|Overall Study|Withdrawal by Subject|1|||
23426903|NCT02174523|65307473|FG001|Overall Study|Withdrawal by Subject|0|||
23426904|NCT02653495|65307475|FG000|Overall Study|Lost to Follow-up|2|||
23426905|NCT02653495|65307476|FG001|Overall Study|Lost to Follow-up|0|||
23426906|NCT02653495|65307475|FG000|Overall Study|Screening Failure|10|||
23317239|NCT00447876|64904018|FG001|Overall Study|Withdrawal by Subject|4|||
23426907|NCT02653495|65307476|FG001|Overall Study|Screening Failure|0|||
23426908|NCT02536300|65307477|FG000|Overall Study|Investigator's Discretion|17|||
23426909|NCT02536300|65307478|FG001|Overall Study|Investigator's Discretion|11|||
23426910|NCT02536300|65307479|FG002|Overall Study|Investigator's Discretion|2|||
23426911|NCT02536300|65307477|FG000|Overall Study|Progressive Disease|11|||
23426912|NCT02536300|65307478|FG001|Overall Study|Progressive Disease|7|||
23426913|NCT02536300|65307479|FG002|Overall Study|Progressive Disease|6|||
23426914|NCT02536300|65307477|FG000|Overall Study|Study Terminated by Sponsor|6|||
23426915|NCT02536300|65307478|FG001|Overall Study|Study Terminated by Sponsor|4|||
23546137|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546138|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546139|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546140|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
23546141|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546142|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
23546143|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546144|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546145|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546146|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
23546147|NCT01412944|65730980|FG000|Entire: IV + Maintenance|Adverse Event|0|||
23546148|NCT01412944|65730981|FG001|Entire: IV + Maintenance|Adverse Event|1|||
23546149|NCT01412944|65730982|FG002|Entire: IV + Maintenance|Adverse Event|0|||
23546150|NCT01412944|65730983|FG003|Entire: IV + Maintenance|Adverse Event|0|||
23546151|NCT01412944|65730984|FG004|Entire: IV + Maintenance|Adverse Event|0|||
23546152|NCT01412944|65730985|FG005|Entire: IV + Maintenance|Adverse Event|0|||
23546153|NCT05073133|65730986|FG000|Overall Study|Death|2|||
23546154|NCT02493127|65730987|FG000|Overall Study|Lost to Follow-up|1|||
23546155|NCT02493127|65730988|FG001|Overall Study|Lost to Follow-up|1|||
23546156|NCT02543346|65730989|FG000|Second Priming Visit|Withdrawal by Subject|0|||
23130342|NCT00479882|64226491|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
23130343|NCT00479882|64226492|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
23426916|NCT02536300|65307479|FG002|Overall Study|Study Terminated by Sponsor|7|||
23546157|NCT02543346|65730990|FG001|Second Priming Visit|Withdrawal by Subject|2|||
23546158|NCT02543346|65730991|FG002|Second Priming Visit|Withdrawal by Subject|2|||
23546159|NCT02543346|65730992|FG003|Second Priming Visit|Withdrawal by Subject|2|||
23546160|NCT02543346|65730989|FG000|Second Priming Visit|Adverse Event|1|||
23317240|NCT00447876|64904017|FG000|Overall Study|Lost to Follow-up|1|||
23317241|NCT00447876|64904018|FG001|Overall Study|Lost to Follow-up|0|||
23317242|NCT00447876|64904017|FG000|Overall Study|Deterioration of symptomology|1|||
23317243|NCT00447876|64904018|FG001|Overall Study|Deterioration of symptomology|0|||
23317244|NCT01174043|64904021|FG000|Overall Study|Disease progression|5|||
23426917|NCT02536300|65307477|FG000|Overall Study|Death|7|||
23130344|NCT00479882|64226493|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
23130345|NCT00214019|64226494|FG000|Overall Study|Lost to Follow-up|11|||
23130346|NCT00214019|64226494|FG000|Overall Study|Withdrawal by Subject|2|||
23130347|NCT00214019|64226494|FG000|Overall Study|Screen Failed prior to randomization|17|||
23130348|NCT02597712|64226500|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
23130349|NCT02597712|64226501|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
23130350|NCT02597712|64226500|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
23130351|NCT02597712|64226501|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
23130352|NCT02597712|64226500|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
23130353|NCT02597712|64226501|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
23130354|NCT01706705|64226502|FG000|Overall Study|Death|1|||
23130355|NCT01706705|64226502|FG000|Overall Study|Lack of Efficacy|13|||
23130356|NCT01706705|64226502|FG000|Overall Study|Non-clinical|6|||
23130357|NCT00635661|64226503|FG000|Overall Study|Withdrawal by Subject|4|||
23130358|NCT03812029|64226504|FG000|Overall Study|Protocol Violation|1|||
23130359|NCT03812029|64226505|FG001|Overall Study|Protocol Violation|0|||
23130360|NCT03812029|64226506|FG002|Overall Study|Protocol Violation|0|||
23130361|NCT03812029|64226507|FG003|Overall Study|Protocol Violation|1|||
23130362|NCT03812029|64226508|FG004|Overall Study|Protocol Violation|0|||
23130363|NCT03812029|64226504|FG000|Overall Study|Withdrawal by Subject|1|||
23130364|NCT03812029|64226505|FG001|Overall Study|Withdrawal by Subject|0|||
23130365|NCT03812029|64226506|FG002|Overall Study|Withdrawal by Subject|0|||
23130366|NCT03812029|64226507|FG003|Overall Study|Withdrawal by Subject|2|||
23130367|NCT03812029|64226508|FG004|Overall Study|Withdrawal by Subject|2|||
23130368|NCT03812029|64226504|FG000|Overall Study|Stopping rules|0|||
23130369|NCT03812029|64226505|FG001|Overall Study|Stopping rules|1|||
23130370|NCT03812029|64226506|FG002|Overall Study|Stopping rules|0|||
23130371|NCT03812029|64226507|FG003|Overall Study|Stopping rules|0|||
23130372|NCT03812029|64226508|FG004|Overall Study|Stopping rules|0|||
23130373|NCT03812029|64226504|FG000|Overall Study|Adverse Event|0|||
23130374|NCT03812029|64226505|FG001|Overall Study|Adverse Event|9|||
23130375|NCT03812029|64226506|FG002|Overall Study|Adverse Event|0|||
23130376|NCT03812029|64226507|FG003|Overall Study|Adverse Event|3|||
23130377|NCT03812029|64226508|FG004|Overall Study|Adverse Event|5|||
23130378|NCT03812029|64226504|FG000|Overall Study|Lost to Follow-up|0|||
23130379|NCT03812029|64226505|FG001|Overall Study|Lost to Follow-up|0|||
23130380|NCT03812029|64226506|FG002|Overall Study|Lost to Follow-up|0|||
23130381|NCT03812029|64226507|FG003|Overall Study|Lost to Follow-up|0|||
23130382|NCT03812029|64226508|FG004|Overall Study|Lost to Follow-up|3|||
23130383|NCT04491877|64226509|FG000|Overall Study|Protocol Deviation|1|||
23130384|NCT04491877|64226510|FG001|Overall Study|Protocol Deviation|0|||
23130385|NCT04491877|64226511|FG002|Overall Study|Protocol Deviation|2|||
23130386|NCT04491877|64226512|FG003|Overall Study|Protocol Deviation|0|||
23130387|NCT04491877|64226513|FG004|Overall Study|Protocol Deviation|0|||
23130388|NCT04491877|64226514|FG005|Overall Study|Protocol Deviation|0|||
23130389|NCT04491877|64226515|FG006|Overall Study|Protocol Deviation|1|||
23130390|NCT04491877|64226516|FG007|Overall Study|Protocol Deviation|1|||
23130391|NCT04491877|64226517|FG008|Overall Study|Protocol Deviation|0|||
23130392|NCT04491877|64226509|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23130393|NCT04491877|64226510|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23130394|NCT04491877|64226511|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23130395|NCT04491877|64226512|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
23130396|NCT04491877|64226513|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23130397|NCT04491877|64226514|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
23130398|NCT04491877|64226515|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
23130399|NCT04491877|64226516|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
23130400|NCT04491877|64226517|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
23130401|NCT04491877|64226509|FG000|Overall Study|Lost to Follow-up|0|||
23130402|NCT04491877|64226510|FG001|Overall Study|Lost to Follow-up|2|||
23130403|NCT04491877|64226511|FG002|Overall Study|Lost to Follow-up|0|||
23130404|NCT04491877|64226512|FG003|Overall Study|Lost to Follow-up|0|||
23130405|NCT04491877|64226513|FG004|Overall Study|Lost to Follow-up|0|||
23130406|NCT04491877|64226514|FG005|Overall Study|Lost to Follow-up|0|||
23130407|NCT04491877|64226515|FG006|Overall Study|Lost to Follow-up|2|||
23130408|NCT04491877|64226516|FG007|Overall Study|Lost to Follow-up|1|||
23130409|NCT04491877|64226517|FG008|Overall Study|Lost to Follow-up|1|||
23618872|NCT02979613|65991363|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
23618873|NCT02979613|65991362|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
23618874|NCT02979613|65991363|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
23130410|NCT04276051|64226520|FG000|Overall Study|Lost to Follow-up|0|||
23130411|NCT04276051|64226521|FG001|Overall Study|Lost to Follow-up|1|||
23130412|NCT04276051|64226520|FG000|Overall Study|Physician Decision|0|||
23130413|NCT04276051|64226521|FG001|Overall Study|Physician Decision|1|||
23130414|NCT04276051|64226520|FG000|Overall Study|Withdrawal by Subject|1|||
23130415|NCT04276051|64226521|FG001|Overall Study|Withdrawal by Subject|1|||
23130416|NCT01782690|64226522|FG000|Overall Study|Not reported|7|||
23130417|NCT01782690|64226522|FG000|Overall Study|Toxicity of gemcitabine|1|||
23130418|NCT01782690|64226522|FG000|Overall Study|Toxicity of erlotinib|1|||
23130419|NCT01782690|64226522|FG000|Overall Study|Lost to Follow-up|31|||
23130420|NCT01782690|64226522|FG000|Overall Study|Withdrawal of informed consent|2|||
23130421|NCT01782690|64226522|FG000|Overall Study|Absent rash|9|||
23130422|NCT01782690|64226522|FG000|Overall Study|Physician Decision|13|||
23130423|NCT01782690|64226522|FG000|Overall Study|Patient's wish|21|||
23130424|NCT01782690|64226522|FG000|Overall Study|Tumor progression|74|||
23130425|NCT01782690|64226522|FG000|Overall Study|Death|133|||
23130426|NCT01782690|64226522|FG000|Overall Study|Study completion unknown|7|||
23130427|NCT02592876|64226527|FG000|Overall Study|Withdrawal by Subject|3|||
23130428|NCT02592876|64226528|FG001|Overall Study|Withdrawal by Subject|3|||
23130429|NCT02592876|64226527|FG000|Overall Study|Study Termination by Sponsor|32|||
23130430|NCT02592876|64226528|FG001|Overall Study|Study Termination by Sponsor|27|||
23130431|NCT02592876|64226527|FG000|Overall Study|Lost to Follow-up|0|||
23130432|NCT02592876|64226528|FG001|Overall Study|Lost to Follow-up|1|||
23130433|NCT02592876|64226527|FG000|Overall Study|Death|6|||
23130434|NCT02592876|64226528|FG001|Overall Study|Death|9|||
23130435|NCT00264303|64226529|FG000|Overall Study|Adverse Event|4|||
23130436|NCT00264303|64226530|FG001|Overall Study|Adverse Event|3|||
23130437|NCT00264303|64226529|FG000|Overall Study|Lack of Efficacy|10|||
23130438|NCT00264303|64226530|FG001|Overall Study|Lack of Efficacy|13|||
23130439|NCT00264303|64226529|FG000|Overall Study|Lost to Follow-up|3|||
23130440|NCT00264303|64226530|FG001|Overall Study|Lost to Follow-up|3|||
23130441|NCT00264303|64226529|FG000|Overall Study|Withdrawal by Subject|2|||
23130442|NCT00264303|64226530|FG001|Overall Study|Withdrawal by Subject|3|||
23130443|NCT00264303|64226529|FG000|Overall Study|Various reasons listed in study report|6|||
23130444|NCT00264303|64226530|FG001|Overall Study|Various reasons listed in study report|7|||
23426918|NCT02536300|65307478|FG001|Overall Study|Death|0|||
23546161|NCT02543346|65730990|FG001|Second Priming Visit|Adverse Event|0|||
23546162|NCT02543346|65730991|FG002|Second Priming Visit|Adverse Event|0|||
23546163|NCT02543346|65730992|FG003|Second Priming Visit|Adverse Event|0|||
23546164|NCT03712917|65730993|FG000|Overall Study|Pregnancy|0|||
23546165|NCT03712917|65730994|FG001|Overall Study|Pregnancy|0|||
23546166|NCT03712917|65730995|FG002|Overall Study|Pregnancy|1|||
23546167|NCT03712917|65730993|FG000|Overall Study|Adverse Event|0|||
23546168|NCT03712917|65730994|FG001|Overall Study|Adverse Event|4|||
23546169|NCT03712917|65730995|FG002|Overall Study|Adverse Event|3|||
23546170|NCT03712917|65730993|FG000|Overall Study|Lost to Follow-up|9|||
23546171|NCT03712917|65730994|FG001|Overall Study|Lost to Follow-up|4|||
23546172|NCT03712917|65730995|FG002|Overall Study|Lost to Follow-up|5|||
23546173|NCT02273141|65730996|FG000|Overall Study|Adverse Event|0|||
23546174|NCT02273141|65730997|FG001|Overall Study|Adverse Event|1|||
23546175|NCT02273141|65730996|FG000|Overall Study|Lost to Follow-up|1|||
23546176|NCT02273141|65730997|FG001|Overall Study|Lost to Follow-up|3|||
23546177|NCT02273141|65730996|FG000|Overall Study|Withdrawal by Subject|10|||
23546178|NCT02273141|65730997|FG001|Overall Study|Withdrawal by Subject|15|||
23546179|NCT02273141|65730996|FG000|Overall Study|Various|6|||
23546180|NCT02273141|65730997|FG001|Overall Study|Various|6|||
23546181|NCT05554237|65731000|FG000|Part 2 (7 Days)|Adverse Event|0|||
23546182|NCT05554237|65731001|FG001|Part 2 (7 Days)|Adverse Event|0|||
23546183|NCT05554237|65731002|FG002|Part 2 (7 Days)|Adverse Event|0|||
23546184|NCT05554237|65731003|FG003|Part 2 (7 Days)|Adverse Event|0|||
23546185|NCT05554237|65731004|FG004|Part 2 (7 Days)|Adverse Event|2|||
23546186|NCT05554237|65731005|FG005|Part 2 (7 Days)|Adverse Event|0|||
23546187|NCT05554237|65731006|FG006|Part 2 (7 Days)|Adverse Event|0|||
23546188|NCT05554237|65731007|FG007|Part 2 (7 Days)|Adverse Event|0|||
23546189|NCT05554237|65731008|FG008|Part 2 (7 Days)|Adverse Event|0|||
23546190|NCT05554237|65731009|FG009|Part 2 (7 Days)|Adverse Event|1|||
23546191|NCT05554237|65731010|FG010|Part 2 (7 Days)|Adverse Event|0|||
23546192|NCT05554237|65731011|FG011|Part 2 (7 Days)|Adverse Event|0|||
23546193|NCT05554237|65731012|FG012|Part 2 (7 Days)|Adverse Event|1|||
23130445|NCT00586612|64226532|FG000|Primary Phase|Protocol Violation|1|||
23130446|NCT00586612|64226533|FG001|Primary Phase|Protocol Violation|0|||
23130447|NCT00586612|64226532|FG000|Primary Phase|Lost to Follow-up|0|||
23130448|NCT00586612|64226533|FG001|Primary Phase|Lost to Follow-up|1|||
23130449|NCT00586612|64226532|FG000|Primary Phase|Withdrawal by Subject|0|||
23130450|NCT00586612|64226533|FG001|Primary Phase|Withdrawal by Subject|2|||
23130451|NCT00586612|64226532|FG000|Booster Phase|Lost to Follow-up|3|||
23130452|NCT00586612|64226533|FG001|Booster Phase|Lost to Follow-up|1|||
23130453|NCT02412735|64226534|FG000|Overall Study|Adverse Event|0|||
23130454|NCT02412735|64226535|FG001|Overall Study|Adverse Event|1|||
23426919|NCT02536300|65307479|FG002|Overall Study|Death|5|||
23426920|NCT02536300|65307477|FG000|Overall Study|Withdrew Consent|4|||
23546194|NCT05554237|65731013|FG013|Part 2 (7 Days)|Adverse Event|0|||
23546195|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
23546196|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
23546197|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
23546198|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
23130455|NCT02412735|64226536|FG002|Overall Study|Adverse Event|2|||
23130456|NCT02412735|64226534|FG000|Overall Study|Withdrawal by Subject|23|||
23130457|NCT02412735|64226535|FG001|Overall Study|Withdrawal by Subject|27|||
23130458|NCT02412735|64226536|FG002|Overall Study|Withdrawal by Subject|22|||
23130459|NCT02412735|64226534|FG000|Overall Study|Investigator Decision|3|||
23130460|NCT02412735|64226535|FG001|Overall Study|Investigator Decision|3|||
23130461|NCT02412735|64226536|FG002|Overall Study|Investigator Decision|2|||
23130462|NCT02412735|64226534|FG000|Overall Study|Lost to Follow-up|17|||
23130463|NCT02412735|64226535|FG001|Overall Study|Lost to Follow-up|11|||
23130464|NCT02412735|64226536|FG002|Overall Study|Lost to Follow-up|18|||
23130465|NCT02412735|64226534|FG000|Overall Study|Reason not Specified|3|||
23130466|NCT02412735|64226535|FG001|Overall Study|Reason not Specified|2|||
23130467|NCT02412735|64226536|FG002|Overall Study|Reason not Specified|2|||
23130468|NCT01436253|64226537|FG000|Overall Study|Lost to Follow-up|182|||
23130469|NCT01436253|64226537|FG000|Overall Study|Not meeting all eligibility criteria|117|||
23130470|NCT01077518|64226547|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
23130471|NCT01077518|64226548|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
23130472|NCT01077518|64226549|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
23130473|NCT01077518|64226547|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
23130474|NCT01077518|64226548|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
23130475|NCT01077518|64226549|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
23130476|NCT01077518|64226547|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
23130477|NCT01077518|64226548|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
23130478|NCT01077518|64226549|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
23130479|NCT01077518|64226547|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
23130480|NCT01077518|64226548|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
23130481|NCT01077518|64226549|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
23130482|NCT01077518|64226547|FG000|Optional Ofa Phase|Physician Decision|0|||
23130483|NCT01077518|64226548|FG001|Optional Ofa Phase|Physician Decision|0|||
23130484|NCT01077518|64226549|FG002|Optional Ofa Phase|Physician Decision|1|||
23130485|NCT01077518|64226547|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
23130486|NCT01077518|64226548|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
23130487|NCT01077518|64226549|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
23130488|NCT01077518|64226547|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
23130489|NCT01077518|64226548|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
23130490|NCT01077518|64226549|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
23130491|NCT01245140|64226550|FG000|Overall Study|Adverse Event|1|||
23130492|NCT01245140|64226551|FG001|Overall Study|Adverse Event|3|||
23130493|NCT01245140|64226550|FG000|Overall Study|Lack of Efficacy|2|||
23130494|NCT01245140|64226551|FG001|Overall Study|Lack of Efficacy|4|||
23130495|NCT01245140|64226550|FG000|Overall Study|Protocol Violation|0|||
23130496|NCT01245140|64226551|FG001|Overall Study|Protocol Violation|1|||
23130497|NCT01245140|64226550|FG000|Overall Study|Withdrawal by Subject|0|||
23130498|NCT01245140|64226551|FG001|Overall Study|Withdrawal by Subject|1|||
23130499|NCT01245140|64226550|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
23130500|NCT01245140|64226551|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
23130501|NCT00416195|64226552|FG000|Overall Study|Adverse Event|1|||
23130502|NCT00416195|64226553|FG001|Overall Study|Adverse Event|2|||
23130503|NCT00416195|64226552|FG000|Overall Study|Protocol Violation|1|||
23130504|NCT00416195|64226553|FG001|Overall Study|Protocol Violation|1|||
23130505|NCT00416195|64226552|FG000|Overall Study|Other|0|||
23130506|NCT00416195|64226553|FG001|Overall Study|Other|1|||
23130507|NCT01646177|64226554|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
23130508|NCT01646177|64226555|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
23130509|NCT01646177|64226556|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
23130510|NCT01646177|64226557|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
23130511|NCT01646177|64226558|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23130512|NCT01646177|64226559|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23130513|NCT01646177|64226560|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23213098|NCT02616185|64519862|FG006|Overall Study|Participant refused further follow-up|3|||
23546199|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
23546200|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
23546201|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
23546202|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
23130514|NCT01646177|64226561|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23130515|NCT01646177|64226562|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23130516|NCT01646177|64226563|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23130517|NCT01646177|64226564|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23130518|NCT01646177|64226565|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
23130519|NCT01646177|64226554|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
23213099|NCT02616185|64519863|FG007|Overall Study|Participant refused further follow-up|4|||
23130520|NCT01646177|64226555|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
23130521|NCT01646177|64226556|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
23130522|NCT01646177|64226557|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
23130523|NCT01646177|64226558|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23130524|NCT01646177|64226559|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23213100|NCT02616185|64519864|FG008|Overall Study|Participant refused further follow-up|3|||
23213101|NCT02616185|64519856|FG000|Overall Study|Not reported|0|||
23213102|NCT02616185|64519857|FG001|Overall Study|Not reported|0|||
23546203|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
23130525|NCT01646177|64226560|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23130526|NCT01646177|64226561|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23130527|NCT01646177|64226562|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23130528|NCT01646177|64226563|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23130529|NCT01646177|64226564|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23130530|NCT01646177|64226565|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
23130531|NCT01646177|64226554|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
23130532|NCT01646177|64226555|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
23130533|NCT01646177|64226556|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
23130534|NCT01646177|64226557|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
23130535|NCT01646177|64226558|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23130536|NCT01646177|64226559|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23130537|NCT01646177|64226560|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23130538|NCT01646177|64226561|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23130539|NCT01646177|64226562|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23130540|NCT01646177|64226563|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23130541|NCT01646177|64226564|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23130542|NCT01646177|64226565|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
23130543|NCT01646177|64226554|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
23130544|NCT01646177|64226555|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
23130545|NCT01646177|64226556|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
23130546|NCT01646177|64226557|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
23130547|NCT01646177|64226558|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23130548|NCT01646177|64226559|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23130549|NCT01646177|64226560|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23130550|NCT01646177|64226561|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23130551|NCT01646177|64226562|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23130552|NCT01646177|64226563|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23130553|NCT01646177|64226564|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23130554|NCT01646177|64226565|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
23130555|NCT01646177|64226554|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130556|NCT01646177|64226555|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130557|NCT01646177|64226556|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
23130558|NCT01646177|64226557|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
23130559|NCT01646177|64226558|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130560|NCT01646177|64226559|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130561|NCT01646177|64226560|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130562|NCT01646177|64226561|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130563|NCT01646177|64226562|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130564|NCT01646177|64226563|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130565|NCT01646177|64226564|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130566|NCT01646177|64226565|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
23130567|NCT01646177|64226554|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
23130568|NCT01646177|64226555|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
23130569|NCT01646177|64226556|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
23130570|NCT01646177|64226557|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23130571|NCT01646177|64226558|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23130572|NCT01646177|64226559|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23130573|NCT01646177|64226560|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23130574|NCT01646177|64226561|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23130575|NCT01646177|64226562|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23130576|NCT01646177|64226563|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23213103|NCT02616185|64519858|FG002|Overall Study|Not reported|0|||
23546204|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
23130577|NCT01646177|64226564|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23213104|NCT02616185|64519859|FG003|Overall Study|Not reported|1|||
23130578|NCT01646177|64226565|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
23130579|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23130580|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23130581|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23130582|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23130583|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
23130584|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
23130585|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
23130586|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
23130587|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23130588|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23130589|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23130590|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
23130591|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23130592|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23130593|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23130594|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23130595|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
23130596|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
23130597|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
23130598|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
23130599|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23130600|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23130601|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23130602|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
23130603|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23130604|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23130605|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23130606|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23130607|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
23130608|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
23130609|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
23130610|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
23130611|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23130612|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23130613|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23130614|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
23130615|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23130616|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23130617|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23130618|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23130619|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
23130620|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
23130621|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
23130622|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
23130623|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23130624|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23130625|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23130626|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
23130627|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23130628|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23130629|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23130630|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23130631|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
23130632|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
23130633|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
23130634|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
23130635|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23130636|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23130637|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23130638|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
23130639|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23130640|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23130641|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23426921|NCT02536300|65307478|FG001|Overall Study|Withdrew Consent|2|||
23426922|NCT02536300|65307479|FG002|Overall Study|Withdrew Consent|0|||
23426923|NCT02536300|65307477|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
23426924|NCT02536300|65307478|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
23426925|NCT02536300|65307479|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
23426926|NCT02536300|65307477|FG000|Overall Study|Enrolled but Never Treated|0|||
23426927|NCT02536300|65307478|FG001|Overall Study|Enrolled but Never Treated|0|||
23426928|NCT02536300|65307479|FG002|Overall Study|Enrolled but Never Treated|1|||
23426929|NCT02536300|65307477|FG000|Overall Study|Non-compliance With Study Drug|1|||
23426930|NCT02536300|65307478|FG001|Overall Study|Non-compliance With Study Drug|0|||
23426931|NCT02536300|65307479|FG002|Overall Study|Non-compliance With Study Drug|0|||
23426932|NCT02536300|65307477|FG000|Overall Study|Protocol Violation|0|||
23426933|NCT02536300|65307478|FG001|Overall Study|Protocol Violation|1|||
23426934|NCT02536300|65307479|FG002|Overall Study|Protocol Violation|0|||
23426935|NCT03099148|65307482|FG000|Wash-out|scheduling conflict|0|||
23426936|NCT03099148|65307483|FG001|Wash-out|scheduling conflict|1|||
23426937|NCT03099148|65307484|FG002|Wash-out|scheduling conflict|0|||
23426938|NCT03099148|65307485|FG003|Wash-out|scheduling conflict|0|||
23426939|NCT03099148|65307482|FG000|Wash-out|Adverse Event|0|||
23426940|NCT03099148|65307483|FG001|Wash-out|Adverse Event|1|||
23426941|NCT03099148|65307484|FG002|Wash-out|Adverse Event|0|||
23426942|NCT03099148|65307485|FG003|Wash-out|Adverse Event|0|||
23426943|NCT01873729|65307486|FG000|Overall Study|Withdrawal by Subject|1|||
23426944|NCT03697993|65307490|FG000|Overall Study|Became Ineligible after Enrollment|1|||
23426945|NCT03697993|65307491|FG001|Overall Study|Became Ineligible after Enrollment|3|||
23426946|NCT03697993|65307490|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
23426947|NCT03697993|65307491|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
23426948|NCT03697993|65307490|FG000|Overall Study|Lost to Follow-up|3|||
23426949|NCT03697993|65307491|FG001|Overall Study|Lost to Follow-up|0|||
23426950|NCT03697993|65307490|FG000|Overall Study|Physician Decision|4|||
23426951|NCT03697993|65307491|FG001|Overall Study|Physician Decision|0|||
23426952|NCT03697993|65307490|FG000|Overall Study|Initial Urine Culture Negative|0|||
23426953|NCT03697993|65307491|FG001|Overall Study|Initial Urine Culture Negative|1|||
23426954|NCT00810901|65307494|FG000|Overall Study|Lost to Follow-up|88|||
23426955|NCT00810901|65307495|FG001|Overall Study|Lost to Follow-up|58|||
23426956|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
23426957|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
23426958|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
23426959|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
23426960|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
23426961|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
23426962|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
23426963|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
23130642|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23130643|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
23130644|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
23130645|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23130646|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
23130647|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23130648|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23130649|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23130650|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
23130651|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23130652|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23130653|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23130654|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23130655|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
23130656|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
23130657|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
23130658|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
23130659|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23130660|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23130661|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23130662|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
23426964|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
23426965|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
23426966|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
23618875|NCT02979613|65991362|FG000|Open-Label Extension (OLE) Phase|Death|0|||
23426967|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
23426968|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
23426969|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
23426970|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
23426971|NCT00554099|65307496|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
23426972|NCT00554099|65307497|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
23426973|NCT00554099|65307498|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
23426974|NCT00554099|65307496|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
23426975|NCT00554099|65307497|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
23426976|NCT00554099|65307498|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
23426977|NCT00554099|65307496|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
23546205|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
23546206|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
23546207|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
23546208|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
23546209|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
23546210|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
23546211|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
23213105|NCT02616185|64519860|FG004|Overall Study|Not reported|3|||
23213106|NCT02616185|64519861|FG005|Overall Study|Not reported|1|||
23213107|NCT02616185|64519862|FG006|Overall Study|Not reported|0|||
23213108|NCT02616185|64519863|FG007|Overall Study|Not reported|5|||
23213109|NCT02616185|64519864|FG008|Overall Study|Not reported|2|||
23213110|NCT02146248|64519867|FG000|Overall Study|Withdrawal by Subject|2|||
23213111|NCT00936117|64519870|FG000|Overall Study|Adverse Event|7|||
23213112|NCT00936117|64519870|FG000|Overall Study|Unable to continue oral medication|3|||
23213113|NCT02759861|64519873|FG000|Overall Study|Death|1|||
23213114|NCT02156804|64519874|FG000|Overall Study|Withdrawal by Subject|1|||
23213115|NCT02384395|64519875|FG000|Overall Study|Physician Decision|4|||
23213116|NCT02384395|64519875|FG000|Overall Study|Withdrawal by Subject|3|||
23213117|NCT02384395|64519875|FG000|Overall Study|Lost to Follow-up|3|||
23213118|NCT03205982|64519876|FG000|Overall Study|Lost to Follow-up|20|||
23213119|NCT03205982|64519877|FG001|Overall Study|Lost to Follow-up|19|||
23213120|NCT03205982|64519876|FG000|Overall Study|Withdrawal by Subject|4|||
23213121|NCT03205982|64519877|FG001|Overall Study|Withdrawal by Subject|3|||
23213122|NCT03205982|64519876|FG000|Overall Study|Withdrawal by PI|0|||
23213123|NCT03205982|64519877|FG001|Overall Study|Withdrawal by PI|1|||
23213124|NCT03199638|64519878|FG000|Overall Study|inability to drink glutamine during regularly|0|||
23213125|NCT03199638|64519879|FG001|Overall Study|inability to drink glutamine during regularly|2|||
23213126|NCT01975246|64519880|FG000|Overall Study|Adverse Event|2|||
23213127|NCT01975246|64519881|FG001|Overall Study|Adverse Event|1|||
23213128|NCT01975246|64519880|FG000|Overall Study|Lack of Efficacy|1|||
23213129|NCT01975246|64519881|FG001|Overall Study|Lack of Efficacy|0|||
23213130|NCT01975246|64519880|FG000|Overall Study|Protocol Violation|1|||
23213131|NCT01975246|64519881|FG001|Overall Study|Protocol Violation|0|||
23213132|NCT01975246|64519880|FG000|Overall Study|Other than stated|0|||
23213133|NCT01975246|64519881|FG001|Overall Study|Other than stated|1|||
23213134|NCT00990249|64519882|FG000|Overall Study|Disease Progression|8|||
23213135|NCT00990249|64519882|FG000|Overall Study|Non-Compliance|1|||
23213136|NCT00990249|64519882|FG000|Overall Study|Death|2|||
23213137|NCT00990249|64519882|FG000|Overall Study|Not treated|2|||
23213138|NCT01337167|64519883|FG000|Infant Series|Adverse Event|1|||
23213139|NCT01337167|64519884|FG001|Infant Series|Adverse Event|1|||
23213140|NCT01337167|64519883|FG000|Infant Series|Death|1|||
23213141|NCT01337167|64519884|FG001|Infant Series|Death|1|||
23213142|NCT01337167|64519883|FG000|Infant Series|Lost to Follow-up|13|||
23213143|NCT01337167|64519884|FG001|Infant Series|Lost to Follow-up|7|||
23213144|NCT01337167|64519883|FG000|Infant Series|Non-compliance with study drug|2|||
23213145|NCT01337167|64519884|FG001|Infant Series|Non-compliance with study drug|1|||
23213146|NCT01337167|64519883|FG000|Infant Series|Physician Decision|3|||
23213147|NCT01337167|64519884|FG001|Infant Series|Physician Decision|1|||
23546212|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
23546213|NCT00833638|65731014|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
23213148|NCT01337167|64519883|FG000|Infant Series|Protocol Violation|22|||
23213149|NCT01337167|64519884|FG001|Infant Series|Protocol Violation|9|||
23213150|NCT01337167|64519883|FG000|Infant Series|Withdrawal by Subject|15|||
23213151|NCT01337167|64519884|FG001|Infant Series|Withdrawal by Subject|4|||
23213152|NCT01337167|64519883|FG000|Infant Series|Randomized but not vaccinated|5|||
23213153|NCT01337167|64519884|FG001|Infant Series|Randomized but not vaccinated|3|||
23213154|NCT01337167|64519883|FG000|Interim Period|Lost to Follow-up|51|||
23426978|NCT00554099|65307497|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
23426979|NCT00554099|65307498|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
23213155|NCT01337167|64519884|FG001|Interim Period|Lost to Follow-up|23|||
23213156|NCT01337167|64519883|FG000|Interim Period|Non-compliance with study drug|1|||
23213157|NCT01337167|64519884|FG001|Interim Period|Non-compliance with study drug|0|||
23130663|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
23130664|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
23130665|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
23130666|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
23130667|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
23130668|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
23130669|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
23130670|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
23130671|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
23130672|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
23130673|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
23130674|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
23130675|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23130676|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23130677|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23130678|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23130679|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
23130680|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
23130681|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
23130682|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
23130683|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23130684|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23130685|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23130686|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
23130687|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130688|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130689|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130690|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130691|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130692|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130693|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130694|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
23130695|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130696|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130697|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130698|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
23130699|NCT01646177|64226554|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23130700|NCT01646177|64226555|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23130701|NCT01646177|64226556|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23130702|NCT01646177|64226557|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23130703|NCT01646177|64226558|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23130704|NCT01646177|64226559|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
23130705|NCT01646177|64226560|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
23130706|NCT01646177|64226561|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
23130707|NCT01646177|64226562|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23130708|NCT01646177|64226563|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23130709|NCT01646177|64226564|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23130710|NCT01646177|64226565|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
23130711|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23130712|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23130713|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23130714|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23130715|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23130716|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23213158|NCT01337167|64519883|FG000|Interim Period|Physician Decision|6|||
23213159|NCT01337167|64519884|FG001|Interim Period|Physician Decision|3|||
23213160|NCT01337167|64519883|FG000|Interim Period|Protocol Violation|5|||
23213161|NCT01337167|64519884|FG001|Interim Period|Protocol Violation|3|||
23213162|NCT01337167|64519883|FG000|Interim Period|Withdrawal by Subject|18|||
23546214|NCT00833638|65731015|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
23130717|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23130718|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
23213163|NCT01337167|64519884|FG001|Interim Period|Withdrawal by Subject|10|||
23317245|NCT01174043|64904021|FG000|Overall Study|Adverse Event|3|||
23546215|NCT00833638|65731016|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
23426980|NCT00554099|65307496|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
23426981|NCT00554099|65307497|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
23618876|NCT02979613|65991363|FG001|Open-Label Extension (OLE) Phase|Death|1|||
23618877|NCT02979613|65991362|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
23130719|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
23130720|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
23213164|NCT01337167|64519883|FG000|Interim Period|Other protocol criterion not met|0|||
23213165|NCT01337167|64519884|FG001|Interim Period|Other protocol criterion not met|1|||
23213166|NCT01337167|64519883|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
23213167|NCT01337167|64519884|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
23213168|NCT01337167|64519883|FG000|Toddler Vaccinations|Protocol Violation|0|||
23213169|NCT01337167|64519884|FG001|Toddler Vaccinations|Protocol Violation|1|||
23213170|NCT01337167|64519883|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
23213171|NCT01337167|64519884|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
23213172|NCT04247815|64519885|FG000|Overall Study|Adverse Event|1|||
23213173|NCT04247815|64519886|FG001|Overall Study|Adverse Event|0|||
23130721|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
23130722|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
23130723|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23130724|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23130725|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23130726|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23130727|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23130728|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23130729|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23130730|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
23130731|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
23130732|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
23130733|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
23130734|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
23130735|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23130736|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23130737|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23130738|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23130739|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23130740|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23130741|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23130742|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
23130743|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
23130744|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
23130745|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
23130746|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
23130747|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23130748|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23130749|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23130750|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23130751|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23130752|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23130753|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23130754|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
23130755|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
23130756|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
23130757|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
23130758|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
23130759|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23130760|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23130761|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23130762|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23213174|NCT04247815|64519885|FG000|Overall Study|Withdrawal by Subject|1|||
23213175|NCT04247815|64519886|FG001|Overall Study|Withdrawal by Subject|0|||
23618878|NCT02979613|65991363|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
23618879|NCT03193216|65991364|FG000|Overall Study|Lost to Follow-up|1|||
23130763|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23130764|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23213176|NCT04247815|64519885|FG000|Overall Study|Protocol Violation|0|||
23213177|NCT04247815|64519886|FG001|Overall Study|Protocol Violation|1|||
23213178|NCT03310580|64519887|FG000|Overall Study|Adverse Event|0|||
23130765|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23130766|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
23130767|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
23130768|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
23130769|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
23130770|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
23130771|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23130772|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23130773|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23130774|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23130775|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23130776|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23130777|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23130778|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
23213179|NCT03310580|64519888|FG001|Overall Study|Adverse Event|1|||
23213180|NCT03310580|64519889|FG002|Overall Study|Adverse Event|0|||
23213181|NCT00617656|64519890|FG000|Overall Study|Inclusion error|4|||
23213182|NCT00617656|64519891|FG001|Overall Study|Inclusion error|4|||
23213183|NCT00617656|64519892|FG002|Overall Study|Inclusion error|0|||
23213184|NCT00617656|64519893|FG003|Overall Study|Inclusion error|0|||
23130779|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
23130780|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
23130781|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
23130782|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
23130783|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23130784|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23130785|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23130786|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23130787|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23130788|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23130789|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23130790|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23130791|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
23130792|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
23130793|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
23130794|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
23213185|NCT00617656|64519890|FG000|Overall Study|Missing data|44|||
23213186|NCT00617656|64519891|FG001|Overall Study|Missing data|30|||
23213187|NCT00617656|64519892|FG002|Overall Study|Missing data|13|||
23213188|NCT00617656|64519893|FG003|Overall Study|Missing data|6|||
23213189|NCT00617656|64519890|FG000|Overall Study|Withdrawal by Subject|0|||
23213190|NCT00617656|64519891|FG001|Overall Study|Withdrawal by Subject|2|||
23213191|NCT00617656|64519892|FG002|Overall Study|Withdrawal by Subject|0|||
23213192|NCT00617656|64519893|FG003|Overall Study|Withdrawal by Subject|0|||
23213193|NCT01203787|64519897|FG000|Overall Study|Death|12|||
23213194|NCT01203787|64519898|FG001|Overall Study|Death|10|||
23213195|NCT01203787|64519897|FG000|Overall Study|Withdrawal by Subject|6|||
23213196|NCT01203787|64519898|FG001|Overall Study|Withdrawal by Subject|2|||
23213197|NCT01203787|64519897|FG000|Overall Study|Lost to Follow-up|2|||
23213198|NCT01203787|64519898|FG001|Overall Study|Lost to Follow-up|0|||
23213199|NCT01203787|64519897|FG000|Overall Study|Adverse Event|11|||
23213200|NCT01203787|64519898|FG001|Overall Study|Adverse Event|15|||
23213201|NCT00691093|64519905|FG000|Overall Study|Adverse Event|1|||
23213202|NCT00691093|64519905|FG000|Overall Study|Lost to Follow-up|1|||
23213203|NCT00691093|64519905|FG000|Overall Study|Lack of Efficacy|1|||
23213204|NCT00691093|64519905|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
23213205|NCT03219567|64519906|FG000|Overall Study|Withdrawal by Subject|0|||
23213206|NCT03219567|64519907|FG001|Overall Study|Withdrawal by Subject|1|||
23213207|NCT01610076|64519909|FG000|Overall Study|Technical issue with video|0|||
23213208|NCT01610076|64519910|FG001|Overall Study|Technical issue with video|1|||
23213209|NCT01610076|64519909|FG000|Overall Study|Lost to Follow-up|3|||
23213210|NCT01610076|64519910|FG001|Overall Study|Lost to Follow-up|4|||
23213211|NCT03101514|64519911|FG000|Overall Study|Withdrawal by Subject|4|||
23317246|NCT01174043|64904021|FG000|Overall Study|Death|1|||
23618880|NCT03193216|65991365|FG001|Overall Study|Lost to Follow-up|0|||
23130795|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23213212|NCT03101514|64519911|FG000|Overall Study|Protocol Violation|2|||
23213213|NCT03101514|64519911|FG000|Overall Study|patient's information was incomplete|1|||
23213214|NCT02287402|64519912|FG000|Treatment Period|Adverse Event|17|||
23213215|NCT02287402|64519912|FG000|Treatment Period|Voluntary Withdrawal|10|||
23213216|NCT02287402|64519912|FG000|Follow-up|Lost to Follow-up|1|||
23213217|NCT02287402|64519912|FG000|Follow-up|Voluntary Withdrawal|2|||
23317247|NCT01174043|64904021|FG000|Overall Study|Withdrawal by Subject|2|||
23130796|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23130797|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23130798|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23130799|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23130800|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23130801|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23130802|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23130803|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
23130804|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
23130805|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
23317248|NCT01987479|64904028|FG000|Overall Study|Protocol Violation|1|||
23546216|NCT00833638|65731014|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
23546217|NCT00833638|65731015|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
23546218|NCT00833638|65731016|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
23546219|NCT00833638|65731014|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
23546220|NCT00833638|65731015|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
23546221|NCT00833638|65731016|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
23546222|NCT03564496|65731017|FG000|Overall Study|Withdrawal by Subject|1|||
23546223|NCT03564496|65731018|FG001|Overall Study|Withdrawal by Subject|1|||
23546224|NCT03564496|65731019|FG002|Overall Study|Withdrawal by Subject|0|||
23546225|NCT03564496|65731017|FG000|Overall Study|Screen failure|0|||
23546226|NCT03564496|65731018|FG001|Overall Study|Screen failure|3|||
23546227|NCT03564496|65731019|FG002|Overall Study|Screen failure|0|||
23546228|NCT03694548|65731020|FG000|Part A Survey|Protocol Violation|3|||
23546229|NCT03694548|65731021|FG001|Part A Survey|Protocol Violation|3|||
23546230|NCT03694548|65731022|FG002|Part A Survey|Protocol Violation|0|||
23130806|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
23317249|NCT01987479|64904028|FG000|Overall Study|Physician Decision|2|||
23546231|NCT03694548|65731020|FG000|Part B Yoga Program|Protocol Violation|0|||
23546232|NCT03694548|65731021|FG001|Part B Yoga Program|Protocol Violation|0|||
23546233|NCT03694548|65731022|FG002|Part B Yoga Program|Protocol Violation|3|||
23546234|NCT03694548|65731020|FG000|Part B Yoga Program|Did not attend intervention|0|||
23546235|NCT03694548|65731021|FG001|Part B Yoga Program|Did not attend intervention|0|||
23546236|NCT03694548|65731022|FG002|Part B Yoga Program|Did not attend intervention|8|||
23546237|NCT04831736|65731031|FG000|Overall Study|Withdrawal by Subject|0|||
23546238|NCT04831736|65731032|FG001|Overall Study|Withdrawal by Subject|1|||
23546239|NCT01127178|65731033|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
23546240|NCT01127178|65731034|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
23546241|NCT01127178|65731033|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
23546242|NCT01127178|65731034|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
23546243|NCT01127178|65731033|FG000|Dose Escalation: Treatment Phase|Other|2|||
23546244|NCT01127178|65731034|FG001|Dose Escalation: Treatment Phase|Other|0|||
23546245|NCT01127178|65731033|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
23546246|NCT01127178|65731034|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
23546247|NCT01127178|65731033|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
23546248|NCT01127178|65731034|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
23546249|NCT01127178|65731033|FG000|Dose Escalation: Extension Phase|Other|1|||
23546250|NCT01127178|65731034|FG001|Dose Escalation: Extension Phase|Other|0|||
23546251|NCT04139317|65731035|FG000|Overall Study|Adverse Event|10|||
23546252|NCT04139317|65731036|FG001|Overall Study|Adverse Event|2|||
23546253|NCT04139317|65731035|FG000|Overall Study|Death|6|||
23546254|NCT04139317|65731036|FG001|Overall Study|Death|4|||
23546255|NCT04139317|65731035|FG000|Overall Study|Lost to Follow-up|1|||
23546256|NCT04139317|65731036|FG001|Overall Study|Lost to Follow-up|0|||
23546257|NCT04139317|65731035|FG000|Overall Study|Physician Decision|3|||
23546258|NCT04139317|65731036|FG001|Overall Study|Physician Decision|1|||
23546259|NCT04139317|65731035|FG000|Overall Study|Progressive Disease|19|||
23546260|NCT04139317|65731036|FG001|Overall Study|Progressive Disease|9|||
23546261|NCT04139317|65731035|FG000|Overall Study|Subject Decision|2|||
23317250|NCT01987479|64904028|FG000|Overall Study|Participant/legal guardian decision|1|||
23546262|NCT04139317|65731036|FG001|Overall Study|Subject Decision|2|||
23546263|NCT04820673|65731037|FG000|Overall Study|Adverse Event|6|||
23546264|NCT04820673|65731037|FG000|Overall Study|Due to Lack of Effectiveness|1|||
23546265|NCT04820673|65731037|FG000|Overall Study|Pregnancy|1|||
23546266|NCT04820673|65731037|FG000|Overall Study|Voluntary Withdrawal|20|||
23546267|NCT04820673|65731037|FG000|Overall Study|Lost to Follow-up|10|||
23546268|NCT00288587|65731042|FG000|Overall Study|Death|4|||
23546269|NCT00288587|65731043|FG001|Overall Study|Death|4|||
23546270|NCT00288587|65731042|FG000|Overall Study|Transplant|0|||
23546271|NCT00288587|65731043|FG001|Overall Study|Transplant|3|||
23546272|NCT00288587|65731042|FG000|Overall Study|Adverse Event|0|||
23546273|NCT00288587|65731043|FG001|Overall Study|Adverse Event|1|||
23130807|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23130808|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23130809|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23130810|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23130811|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23130812|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23130813|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23130814|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23130815|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
23130816|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
23130817|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
23130818|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
23130819|NCT01646177|64226554|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130820|NCT01646177|64226555|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130821|NCT01646177|64226556|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130822|NCT01646177|64226557|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130823|NCT01646177|64226558|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130824|NCT01646177|64226559|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130825|NCT01646177|64226560|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130826|NCT01646177|64226561|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130827|NCT01646177|64226562|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130828|NCT01646177|64226563|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
23130829|NCT01646177|64226564|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
23130830|NCT01646177|64226565|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
23130831|NCT00474526|64226566|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
23130832|NCT00474526|64226567|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
23130833|NCT00474526|64226568|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
23130834|NCT00474526|64226569|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
23130835|NCT00474526|64226570|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
23130836|NCT00474526|64226571|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
23130837|NCT00474526|64226572|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
23130838|NCT00474526|64226573|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
23130839|NCT00474526|64226574|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
23130840|NCT00474526|64226575|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
23130841|NCT00474526|64226576|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
23130842|NCT00474526|64226577|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
23130843|NCT00474526|64226578|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
23130844|NCT00474526|64226579|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
23130845|NCT00474526|64226580|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
23130846|NCT00474526|64226581|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
23130847|NCT00474526|64226582|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
23130848|NCT00474526|64226566|FG000|Overall Study|Adverse Event|2|||
23546274|NCT00288587|65731042|FG000|Overall Study|Physician Decision|0|||
23546275|NCT00288587|65731043|FG001|Overall Study|Physician Decision|2|||
23546276|NCT00288587|65731042|FG000|Overall Study|Severe Aortic Stenosis|1|||
23546277|NCT00288587|65731043|FG001|Overall Study|Severe Aortic Stenosis|0|||
23546278|NCT02076009|65731044|FG000|Overall Study|Death|172|||
23546279|NCT02076009|65731045|FG001|Overall Study|Death|153|||
23130849|NCT00474526|64226567|FG001|Overall Study|Adverse Event|0|||
23130850|NCT00474526|64226568|FG002|Overall Study|Adverse Event|2|||
23130851|NCT00474526|64226569|FG003|Overall Study|Adverse Event|4|||
23130852|NCT00474526|64226570|FG004|Overall Study|Adverse Event|2|||
23130853|NCT00474526|64226571|FG005|Overall Study|Adverse Event|1|||
23130854|NCT00474526|64226572|FG006|Overall Study|Adverse Event|1|||
23130855|NCT00474526|64226573|FG007|Overall Study|Adverse Event|0|||
23130856|NCT00474526|64226574|FG008|Overall Study|Adverse Event|0|||
23546280|NCT02076009|65731044|FG000|Overall Study|Withdrawal by Subject|16|||
23546281|NCT02076009|65731045|FG001|Overall Study|Withdrawal by Subject|12|||
23130857|NCT00474526|64226575|FG009|Overall Study|Adverse Event|0|||
23130858|NCT00474526|64226576|FG010|Overall Study|Adverse Event|0|||
23130859|NCT00474526|64226577|FG011|Overall Study|Adverse Event|0|||
23130860|NCT00474526|64226578|FG012|Overall Study|Adverse Event|0|||
23130861|NCT00474526|64226579|FG013|Overall Study|Adverse Event|0|||
23317251|NCT01987479|64904028|FG000|Overall Study|Other|5|||
23317252|NCT01987479|64904028|FG000|Overall Study|Lost to Follow-up|1|||
23546282|NCT02076009|65731044|FG000|Overall Study|Lost to Follow-up|4|||
23130862|NCT00474526|64226580|FG014|Overall Study|Adverse Event|1|||
23130863|NCT00474526|64226581|FG015|Overall Study|Adverse Event|1|||
23130864|NCT00474526|64226582|FG016|Overall Study|Adverse Event|0|||
23130865|NCT00474526|64226566|FG000|Overall Study|Death|0|||
23130866|NCT00474526|64226567|FG001|Overall Study|Death|0|||
23130867|NCT00474526|64226568|FG002|Overall Study|Death|0|||
23130868|NCT00474526|64226569|FG003|Overall Study|Death|0|||
23130869|NCT00474526|64226570|FG004|Overall Study|Death|0|||
23130870|NCT00474526|64226571|FG005|Overall Study|Death|0|||
23130871|NCT00474526|64226572|FG006|Overall Study|Death|0|||
23546283|NCT02076009|65731045|FG001|Overall Study|Lost to Follow-up|2|||
23130872|NCT00474526|64226573|FG007|Overall Study|Death|0|||
23130873|NCT00474526|64226574|FG008|Overall Study|Death|0|||
23130874|NCT00474526|64226575|FG009|Overall Study|Death|0|||
23130875|NCT00474526|64226576|FG010|Overall Study|Death|0|||
23130876|NCT00474526|64226577|FG011|Overall Study|Death|0|||
23130877|NCT00474526|64226578|FG012|Overall Study|Death|0|||
23130878|NCT00474526|64226579|FG013|Overall Study|Death|3|||
23130879|NCT00474526|64226580|FG014|Overall Study|Death|0|||
23130880|NCT00474526|64226581|FG015|Overall Study|Death|0|||
23130881|NCT00474526|64226582|FG016|Overall Study|Death|0|||
23130882|NCT00474526|64226566|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130883|NCT00474526|64226567|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
23130884|NCT00474526|64226568|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130885|NCT00474526|64226569|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
23130886|NCT00474526|64226570|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
23130887|NCT00474526|64226571|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130888|NCT00474526|64226572|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130889|NCT00474526|64226573|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130890|NCT00474526|64226574|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130891|NCT00474526|64226575|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130892|NCT00474526|64226576|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130893|NCT00474526|64226577|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130894|NCT00474526|64226578|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130895|NCT00474526|64226579|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
23130896|NCT00474526|64226580|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
23130897|NCT00474526|64226581|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130898|NCT00474526|64226582|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
23130899|NCT00474526|64226566|FG000|Overall Study|Lost to Follow-up|8|||
23130900|NCT00474526|64226567|FG001|Overall Study|Lost to Follow-up|6|||
23130901|NCT00474526|64226568|FG002|Overall Study|Lost to Follow-up|13|||
23130902|NCT00474526|64226569|FG003|Overall Study|Lost to Follow-up|29|||
23130903|NCT00474526|64226570|FG004|Overall Study|Lost to Follow-up|11|||
23130904|NCT00474526|64226571|FG005|Overall Study|Lost to Follow-up|5|||
23130905|NCT00474526|64226572|FG006|Overall Study|Lost to Follow-up|8|||
23130906|NCT00474526|64226573|FG007|Overall Study|Lost to Follow-up|1|||
23130907|NCT00474526|64226574|FG008|Overall Study|Lost to Follow-up|0|||
23130908|NCT00474526|64226575|FG009|Overall Study|Lost to Follow-up|6|||
23130909|NCT00474526|64226576|FG010|Overall Study|Lost to Follow-up|2|||
23130910|NCT00474526|64226577|FG011|Overall Study|Lost to Follow-up|4|||
23130911|NCT00474526|64226578|FG012|Overall Study|Lost to Follow-up|6|||
23130912|NCT00474526|64226579|FG013|Overall Study|Lost to Follow-up|74|||
23130913|NCT00474526|64226580|FG014|Overall Study|Lost to Follow-up|29|||
23130914|NCT00474526|64226581|FG015|Overall Study|Lost to Follow-up|4|||
23130915|NCT00474526|64226582|FG016|Overall Study|Lost to Follow-up|5|||
23130916|NCT00474526|64226566|FG000|Overall Study|Protocol Violation|2|||
23130917|NCT00474526|64226567|FG001|Overall Study|Protocol Violation|6|||
23130918|NCT00474526|64226568|FG002|Overall Study|Protocol Violation|4|||
23130919|NCT00474526|64226569|FG003|Overall Study|Protocol Violation|12|||
23130920|NCT00474526|64226570|FG004|Overall Study|Protocol Violation|3|||
23130921|NCT00474526|64226571|FG005|Overall Study|Protocol Violation|1|||
23130922|NCT00474526|64226572|FG006|Overall Study|Protocol Violation|3|||
23130923|NCT00474526|64226573|FG007|Overall Study|Protocol Violation|0|||
23130924|NCT00474526|64226574|FG008|Overall Study|Protocol Violation|0|||
23130925|NCT00474526|64226575|FG009|Overall Study|Protocol Violation|4|||
23130926|NCT00474526|64226576|FG010|Overall Study|Protocol Violation|2|||
23130927|NCT00474526|64226577|FG011|Overall Study|Protocol Violation|2|||
23130928|NCT00474526|64226578|FG012|Overall Study|Protocol Violation|4|||
23130929|NCT00474526|64226579|FG013|Overall Study|Protocol Violation|19|||
23130930|NCT00474526|64226580|FG014|Overall Study|Protocol Violation|9|||
23130931|NCT00474526|64226581|FG015|Overall Study|Protocol Violation|6|||
23130932|NCT00474526|64226582|FG016|Overall Study|Protocol Violation|2|||
23130933|NCT00474526|64226566|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
23130934|NCT00474526|64226567|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
23130935|NCT00474526|64226568|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
23130936|NCT00474526|64226569|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
23130937|NCT00474526|64226570|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
23130938|NCT00474526|64226571|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
23130939|NCT00474526|64226572|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
23130940|NCT00474526|64226573|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
23130941|NCT00474526|64226574|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
23130942|NCT00474526|64226575|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
23130943|NCT00474526|64226576|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
23130944|NCT00474526|64226577|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
23130945|NCT00474526|64226578|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
23130946|NCT00474526|64226579|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
23130947|NCT00474526|64226580|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
23130948|NCT00474526|64226581|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
23130949|NCT00474526|64226582|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
23130950|NCT00474526|64226566|FG000|Overall Study|Withdrawal by Subject|9|||
23130951|NCT00474526|64226567|FG001|Overall Study|Withdrawal by Subject|24|||
23130952|NCT00474526|64226568|FG002|Overall Study|Withdrawal by Subject|21|||
23130953|NCT00474526|64226569|FG003|Overall Study|Withdrawal by Subject|52|||
23130954|NCT00474526|64226570|FG004|Overall Study|Withdrawal by Subject|38|||
23130955|NCT00474526|64226571|FG005|Overall Study|Withdrawal by Subject|6|||
23130956|NCT00474526|64226572|FG006|Overall Study|Withdrawal by Subject|12|||
23130957|NCT00474526|64226573|FG007|Overall Study|Withdrawal by Subject|4|||
23130958|NCT00474526|64226574|FG008|Overall Study|Withdrawal by Subject|4|||
23130959|NCT00474526|64226575|FG009|Overall Study|Withdrawal by Subject|13|||
23130960|NCT00474526|64226576|FG010|Overall Study|Withdrawal by Subject|5|||
23130961|NCT00474526|64226577|FG011|Overall Study|Withdrawal by Subject|4|||
23130962|NCT00474526|64226578|FG012|Overall Study|Withdrawal by Subject|4|||
23130963|NCT00474526|64226579|FG013|Overall Study|Withdrawal by Subject|37|||
23130964|NCT00474526|64226580|FG014|Overall Study|Withdrawal by Subject|22|||
23130965|NCT00474526|64226581|FG015|Overall Study|Withdrawal by Subject|1|||
23130966|NCT00474526|64226582|FG016|Overall Study|Withdrawal by Subject|1|||
23130967|NCT00078338|64226583|FG000|Overall Study|Adverse Event|31|||
23130968|NCT00078338|64226584|FG001|Overall Study|Adverse Event|24|||
23130969|NCT00078338|64226583|FG000|Overall Study|Lost to Follow-up|17|||
23130970|NCT00078338|64226584|FG001|Overall Study|Lost to Follow-up|2|||
23130971|NCT00078338|64226583|FG000|Overall Study|Protocol Violation|2|||
23130972|NCT00078338|64226584|FG001|Overall Study|Protocol Violation|2|||
23130973|NCT00078338|64226583|FG000|Overall Study|Disease Progression|4|||
23130974|NCT00078338|64226584|FG001|Overall Study|Disease Progression|7|||
23130975|NCT00078338|64226583|FG000|Overall Study|Other|28|||
23130976|NCT00078338|64226584|FG001|Overall Study|Other|16|||
23130977|NCT00078338|64226583|FG000|Overall Study|Subjects randomized, but not treated|3|||
23130978|NCT00078338|64226584|FG001|Overall Study|Subjects randomized, but not treated|3|||
23130979|NCT01006980|64226585|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
23130980|NCT01006980|64226586|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
23130981|NCT01006980|64226585|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
23130982|NCT01006980|64226586|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
23130983|NCT01006980|64226585|FG000|Vemurafenib and Dacarbazine|Death|13|||
23130984|NCT01006980|64226586|FG001|Vemurafenib and Dacarbazine|Death|12|||
23130985|NCT01006980|64226585|FG000|Vemurafenib and Dacarbazine|Progression|257|||
23130986|NCT01006980|64226586|FG001|Vemurafenib and Dacarbazine|Progression|218|||
23546284|NCT02076009|65731044|FG000|Overall Study|Progressive Disease|1|||
23546285|NCT02076009|65731045|FG001|Overall Study|Progressive Disease|0|||
23546286|NCT02076009|65731044|FG000|Overall Study|Physician Decision|0|||
23546287|NCT02076009|65731045|FG001|Overall Study|Physician Decision|1|||
23546288|NCT02076009|65731044|FG000|Overall Study|End of data collection|90|||
23546289|NCT02076009|65731045|FG001|Overall Study|End of data collection|118|||
23546290|NCT01517802|65731051|FG000|Overall Study|Death|1|||
23546291|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
23546292|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
23546293|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
23546294|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
23546295|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
23546296|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
23546297|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
23546298|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
23546299|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
23546300|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
23546301|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
23546302|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
23546303|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
23546304|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
23546305|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
23546306|NCT01571362|65731052|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
23546307|NCT01571362|65731053|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
23546308|NCT01571362|65731054|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
23546309|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23618881|NCT03193216|65991364|FG000|Overall Study|Withdrawal by Subject|5|||
23618882|NCT03193216|65991365|FG001|Overall Study|Withdrawal by Subject|0|||
23130987|NCT01006980|64226585|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
23130988|NCT01006980|64226586|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
23130989|NCT01006980|64226585|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
23130990|NCT01006980|64226586|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
23130991|NCT01006980|64226585|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
23130992|NCT01006980|64226586|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
23130993|NCT01006980|64226585|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
23130994|NCT01006980|64226586|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
23546310|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
23546311|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
23546312|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23546313|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
23546314|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
23546315|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23546316|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Adverse Event|9|||
23546317|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Adverse Event|14|||
23546318|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23546319|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
23130995|NCT01006980|64226585|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
23130996|NCT01006980|64226586|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
23546320|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
23546321|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
23546322|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
23546323|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
23130997|NCT01006980|64226585|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
23130998|NCT01006980|64226586|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
23130999|NCT01006980|64226585|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
23131000|NCT01006980|64226586|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
23131001|NCT01006980|64226585|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
23131002|NCT01006980|64226586|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
23131003|NCT01006980|64226585|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
23131004|NCT01006980|64226586|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
23131005|NCT04860297|64226587|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
23131006|NCT04860297|64226588|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
23131007|NCT04860297|64226589|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
23131008|NCT04860297|64226590|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
23131009|NCT04860297|64226591|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
23131010|NCT04860297|64226592|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
23131011|NCT04860297|64226593|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
23131012|NCT04860297|64226594|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
23131013|NCT04860297|64226587|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
23131014|NCT04860297|64226588|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
23131015|NCT04860297|64226589|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
23131016|NCT04860297|64226590|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
23131017|NCT04860297|64226591|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
23546324|NCT01571362|65731052|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
23131018|NCT04860297|64226592|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
23131019|NCT04860297|64226593|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
23131020|NCT04860297|64226594|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
23131021|NCT04860297|64226587|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
23131022|NCT04860297|64226588|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
23131023|NCT04860297|64226589|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
23131024|NCT04860297|64226590|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
23131025|NCT04860297|64226591|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
23131026|NCT04860297|64226592|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
23131027|NCT04860297|64226593|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
23131028|NCT04860297|64226594|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
23131029|NCT04860297|64226587|FG000|Part B (Booster Dose)|Other Than Specified|0|||
23131030|NCT04860297|64226588|FG001|Part B (Booster Dose)|Other Than Specified|0|||
23131031|NCT04860297|64226589|FG002|Part B (Booster Dose)|Other Than Specified|0|||
23131032|NCT04860297|64226590|FG003|Part B (Booster Dose)|Other Than Specified|0|||
23131033|NCT04860297|64226591|FG004|Part B (Booster Dose)|Other Than Specified|0|||
23131034|NCT04860297|64226592|FG005|Part B (Booster Dose)|Other Than Specified|1|||
23131035|NCT04860297|64226593|FG006|Part B (Booster Dose)|Other Than Specified|1|||
23426982|NCT00554099|65307498|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
23546325|NCT01571362|65731053|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
23546326|NCT01571362|65731054|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
23546327|NCT02014116|65731060|FG000|Overall Study|Progressive Disease|3|||
23546328|NCT02014116|65731061|FG001|Overall Study|Progressive Disease|4|||
23546329|NCT02014116|65731062|FG002|Overall Study|Progressive Disease|2|||
23546330|NCT02014116|65731063|FG003|Overall Study|Progressive Disease|6|||
23546331|NCT02014116|65731064|FG004|Overall Study|Progressive Disease|1|||
23131036|NCT04860297|64226594|FG007|Part B (Booster Dose)|Other Than Specified|0|||
23131037|NCT04860297|64226587|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
23131038|NCT04860297|64226588|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
23131039|NCT04860297|64226589|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
23131040|NCT04860297|64226590|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
23131041|NCT04860297|64226591|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
23317253|NCT01987479|64904028|FG000|Overall Study|Adverse Event|7|||
23317254|NCT00863772|64904035|FG000|Overall Study|Adverse Event|1|||
23546332|NCT02014116|65731065|FG005|Overall Study|Progressive Disease|13|||
23546333|NCT02014116|65731066|FG006|Overall Study|Progressive Disease|1|||
23546334|NCT02014116|65731067|FG007|Overall Study|Progressive Disease|3|||
23546335|NCT02014116|65731068|FG008|Overall Study|Progressive Disease|7|||
23546336|NCT02014116|65731060|FG000|Overall Study|Adverse Event|0|||
23546337|NCT02014116|65731061|FG001|Overall Study|Adverse Event|0|||
23546338|NCT02014116|65731062|FG002|Overall Study|Adverse Event|0|||
23546339|NCT02014116|65731063|FG003|Overall Study|Adverse Event|0|||
23546340|NCT02014116|65731064|FG004|Overall Study|Adverse Event|1|||
23546341|NCT02014116|65731065|FG005|Overall Study|Adverse Event|0|||
23546342|NCT02014116|65731066|FG006|Overall Study|Adverse Event|0|||
23546343|NCT02014116|65731067|FG007|Overall Study|Adverse Event|1|||
23546344|NCT02014116|65731068|FG008|Overall Study|Adverse Event|0|||
23546345|NCT02014116|65731060|FG000|Overall Study|Lost to Follow-up|0|||
23546346|NCT02014116|65731061|FG001|Overall Study|Lost to Follow-up|0|||
23546347|NCT02014116|65731062|FG002|Overall Study|Lost to Follow-up|0|||
23546348|NCT02014116|65731063|FG003|Overall Study|Lost to Follow-up|0|||
23546349|NCT02014116|65731064|FG004|Overall Study|Lost to Follow-up|0|||
23546350|NCT02014116|65731065|FG005|Overall Study|Lost to Follow-up|1|||
23546351|NCT02014116|65731066|FG006|Overall Study|Lost to Follow-up|0|||
23546352|NCT02014116|65731067|FG007|Overall Study|Lost to Follow-up|0|||
23546353|NCT02014116|65731068|FG008|Overall Study|Lost to Follow-up|1|||
23546354|NCT02014116|65731060|FG000|Overall Study|Death|0|||
23546355|NCT02014116|65731061|FG001|Overall Study|Death|0|||
23546356|NCT02014116|65731062|FG002|Overall Study|Death|0|||
23618883|NCT03193216|65991364|FG000|Overall Study|Physician Decision|4|||
23618884|NCT03193216|65991365|FG001|Overall Study|Physician Decision|0|||
23618885|NCT02299427|65991366|FG000|Overall Study|Withdrawal by Subject|1|||
23213218|NCT00630812|64519913|FG000|Randomisation to First Dose|Adverse Event|1|||
23213219|NCT00630812|64519914|FG001|Randomisation to First Dose|Adverse Event|1|||
23213220|NCT00630812|64519913|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
23213221|NCT00630812|64519914|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
23213222|NCT00630812|64519913|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
23213223|NCT00630812|64519914|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
23213224|NCT00630812|64519913|FG000|Randomisation to First Dose|Protocol Violation|4|||
23213225|NCT00630812|64519914|FG001|Randomisation to First Dose|Protocol Violation|1|||
23213226|NCT00630812|64519913|FG000|Double Blind Treatment Period|Adverse Event|13|||
23213227|NCT00630812|64519914|FG001|Double Blind Treatment Period|Adverse Event|5|||
23213228|NCT00630812|64519913|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
23213229|NCT00630812|64519914|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23213230|NCT00630812|64519913|FG000|Double Blind Treatment Period|Physician Decision|2|||
23213231|NCT00630812|64519914|FG001|Double Blind Treatment Period|Physician Decision|1|||
23213232|NCT00630812|64519913|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23213233|NCT00630812|64519914|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23213234|NCT00630812|64519913|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
23213235|NCT00630812|64519914|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
23213236|NCT00630812|64519913|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
23213237|NCT00630812|64519914|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
23213238|NCT00630812|64519913|FG000|Double Blind Treatment Period|Non-compliance|0|||
23213239|NCT00630812|64519914|FG001|Double Blind Treatment Period|Non-compliance|1|||
23213240|NCT01670656|64519915|FG000|Overall Study|Non-compliance with study drug|0|||
23213241|NCT01670656|64519916|FG001|Overall Study|Non-compliance with study drug|0|||
23213242|NCT01670656|64519917|FG002|Overall Study|Non-compliance with study drug|3|||
23213243|NCT01670656|64519918|FG003|Overall Study|Non-compliance with study drug|0|||
23213244|NCT01670656|64519919|FG004|Overall Study|Non-compliance with study drug|1|||
23213245|NCT01670656|64519915|FG000|Overall Study|Pregnancy|0|||
23213246|NCT01670656|64519916|FG001|Overall Study|Pregnancy|0|||
23213247|NCT01670656|64519917|FG002|Overall Study|Pregnancy|0|||
23213248|NCT01670656|64519918|FG003|Overall Study|Pregnancy|0|||
23213249|NCT01670656|64519919|FG004|Overall Study|Pregnancy|1|||
23426983|NCT00642369|65307501|FG000|Overall Study|Adverse Event|2|||
23546357|NCT02014116|65731063|FG003|Overall Study|Death|0|||
23546358|NCT02014116|65731064|FG004|Overall Study|Death|0|||
23546359|NCT02014116|65731065|FG005|Overall Study|Death|0|||
23546360|NCT02014116|65731066|FG006|Overall Study|Death|0|||
23618886|NCT02299427|65991367|FG001|Overall Study|Withdrawal by Subject|0|||
23618887|NCT02299427|65991366|FG000|Overall Study|Lost to Follow-up|1|||
23213250|NCT01670656|64519915|FG000|Overall Study|Withdrawal by Subject|1|||
23317255|NCT00863772|64904036|FG001|Overall Study|Adverse Event|4|||
23546361|NCT02014116|65731067|FG007|Overall Study|Death|1|||
23546362|NCT02014116|65731068|FG008|Overall Study|Death|1|||
23317256|NCT00863772|64904037|FG002|Overall Study|Adverse Event|0|||
23546363|NCT02014116|65731060|FG000|Overall Study|Withdrawal by Subject|0|||
23546364|NCT02014116|65731061|FG001|Overall Study|Withdrawal by Subject|0|||
23546365|NCT02014116|65731062|FG002|Overall Study|Withdrawal by Subject|1|||
23546366|NCT02014116|65731063|FG003|Overall Study|Withdrawal by Subject|1|||
23546367|NCT02014116|65731064|FG004|Overall Study|Withdrawal by Subject|0|||
23546368|NCT02014116|65731065|FG005|Overall Study|Withdrawal by Subject|1|||
23546369|NCT02014116|65731066|FG006|Overall Study|Withdrawal by Subject|0|||
23546370|NCT02014116|65731067|FG007|Overall Study|Withdrawal by Subject|0|||
23546371|NCT02014116|65731068|FG008|Overall Study|Withdrawal by Subject|0|||
23546372|NCT02014116|65731060|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
23546373|NCT02014116|65731061|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
23546374|NCT02014116|65731062|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
23546375|NCT02014116|65731063|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
23546376|NCT02014116|65731064|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
23546377|NCT02014116|65731065|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
23546378|NCT02014116|65731066|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
23546379|NCT02014116|65731067|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
23546380|NCT02014116|65731068|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
23546381|NCT02014116|65731060|FG000|Overall Study|Physician Decision|0|||
23131042|NCT04860297|64226592|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
23131043|NCT04860297|64226593|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
23131044|NCT04860297|64226594|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
23131045|NCT04860297|64226587|FG000|Part B (Booster Dose)|Death|0|||
23131046|NCT04860297|64226588|FG001|Part B (Booster Dose)|Death|0|||
23131047|NCT04860297|64226589|FG002|Part B (Booster Dose)|Death|0|||
23131048|NCT04860297|64226590|FG003|Part B (Booster Dose)|Death|0|||
23131049|NCT04860297|64226591|FG004|Part B (Booster Dose)|Death|1|||
23131050|NCT04860297|64226592|FG005|Part B (Booster Dose)|Death|2|||
23131051|NCT04860297|64226593|FG006|Part B (Booster Dose)|Death|1|||
23131052|NCT04860297|64226594|FG007|Part B (Booster Dose)|Death|0|||
23131053|NCT04860297|64226587|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
23131054|NCT04860297|64226588|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
23131055|NCT04860297|64226589|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
23131056|NCT04860297|64226590|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
23131057|NCT04860297|64226591|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
23131058|NCT04860297|64226592|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
23131059|NCT04860297|64226593|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
23131060|NCT04860297|64226594|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
23131061|NCT01685229|64226596|FG000|Overall Study|Subjects missing Study Exit form|3|||
23131062|NCT01685229|64226597|FG001|Overall Study|Subjects missing Study Exit form|1|||
23131063|NCT01685229|64226596|FG000|Overall Study|Lost to Follow-up|16|||
23131064|NCT01685229|64226597|FG001|Overall Study|Lost to Follow-up|10|||
23131065|NCT01685229|64226596|FG000|Overall Study|Withdrawal by Subject|6|||
23131066|NCT01685229|64226597|FG001|Overall Study|Withdrawal by Subject|5|||
23131067|NCT01685229|64226596|FG000|Overall Study|Death|1|||
23131068|NCT01685229|64226597|FG001|Overall Study|Death|0|||
23131069|NCT01277887|64226598|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
23131070|NCT01277887|64226599|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
23131071|NCT01277887|64226598|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
23546382|NCT02014116|65731061|FG001|Overall Study|Physician Decision|0|||
23546383|NCT02014116|65731062|FG002|Overall Study|Physician Decision|0|||
23546384|NCT02014116|65731063|FG003|Overall Study|Physician Decision|0|||
23546385|NCT02014116|65731064|FG004|Overall Study|Physician Decision|0|||
23546386|NCT02014116|65731065|FG005|Overall Study|Physician Decision|0|||
23546387|NCT02014116|65731066|FG006|Overall Study|Physician Decision|0|||
23546388|NCT02014116|65731067|FG007|Overall Study|Physician Decision|0|||
23546389|NCT02014116|65731068|FG008|Overall Study|Physician Decision|1|||
23546390|NCT04798781|65731069|FG000|Overall Study|Withdrawal by Subject|1|||
23546391|NCT01159938|65731074|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
23546392|NCT01159938|65731075|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
23546393|NCT01159938|65731076|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
23546394|NCT01159938|65731077|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
23546395|NCT01159938|65731078|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
23546396|NCT01434602|65731082|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
23618888|NCT02299427|65991367|FG001|Overall Study|Lost to Follow-up|3|||
23546397|NCT01434602|65731083|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
23546398|NCT01434602|65731084|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
23582205|NCT01094171|65862382|FG000|Overall Study|Migration from the study area|3|||
23131072|NCT01277887|64226599|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
23131073|NCT01277887|64226598|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
23131074|NCT01277887|64226599|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
23131075|NCT02310100|64226602|FG000|Overall Study|Physician Decision|3|||
23131076|NCT02310100|64226602|FG000|Overall Study|Withdrawal by Subject|10|||
23131077|NCT02310100|64226602|FG000|Overall Study|Enrollment closure|1|||
23131078|NCT02310100|64226602|FG000|Overall Study|Unapproved ablation operator|1|||
23546399|NCT01434602|65731085|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
23546400|NCT01434602|65731086|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
23546401|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
23546402|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
23546403|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
23546404|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
23546405|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
23546406|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
23546407|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
23546408|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
23546409|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
23213251|NCT01670656|64519916|FG001|Overall Study|Withdrawal by Subject|1|||
23213252|NCT01670656|64519917|FG002|Overall Study|Withdrawal by Subject|0|||
23131079|NCT02310100|64226602|FG000|Overall Study|Visit compliance|1|||
23131080|NCT02310100|64226602|FG000|Overall Study|Lost to Follow-up|2|||
23131081|NCT01397422|64226607|FG000|Overall Study|Adverse Event|0|||
23131082|NCT01397422|64226608|FG001|Overall Study|Adverse Event|3|||
23131083|NCT01397422|64226609|FG002|Overall Study|Adverse Event|3|||
23131084|NCT01397422|64226610|FG003|Overall Study|Adverse Event|8|||
23131085|NCT01397422|64226607|FG000|Overall Study|Withdrawal by Subject|1|||
23131086|NCT01397422|64226608|FG001|Overall Study|Withdrawal by Subject|0|||
23131087|NCT01397422|64226609|FG002|Overall Study|Withdrawal by Subject|0|||
23131088|NCT01397422|64226610|FG003|Overall Study|Withdrawal by Subject|0|||
23131089|NCT01397422|64226607|FG000|Overall Study|Increased bradykinesia related to PD|1|||
23213253|NCT01670656|64519918|FG003|Overall Study|Withdrawal by Subject|0|||
23213254|NCT01670656|64519919|FG004|Overall Study|Withdrawal by Subject|0|||
23213255|NCT01670656|64519915|FG000|Overall Study|Non-compliance with protocol|0|||
23213256|NCT01670656|64519916|FG001|Overall Study|Non-compliance with protocol|3|||
23213257|NCT01670656|64519917|FG002|Overall Study|Non-compliance with protocol|1|||
23213258|NCT01670656|64519918|FG003|Overall Study|Non-compliance with protocol|1|||
23213259|NCT01670656|64519919|FG004|Overall Study|Non-compliance with protocol|2|||
23213260|NCT01670656|64519915|FG000|Overall Study|Adverse Event|2|||
23213261|NCT01670656|64519916|FG001|Overall Study|Adverse Event|2|||
23213262|NCT01670656|64519917|FG002|Overall Study|Adverse Event|2|||
23213263|NCT01670656|64519918|FG003|Overall Study|Adverse Event|3|||
23213264|NCT01670656|64519919|FG004|Overall Study|Adverse Event|3|||
23213265|NCT01670656|64519915|FG000|Overall Study|Subject withdrew consent|0|||
23213266|NCT01670656|64519916|FG001|Overall Study|Subject withdrew consent|1|||
23213267|NCT01670656|64519917|FG002|Overall Study|Subject withdrew consent|2|||
23213268|NCT01670656|64519918|FG003|Overall Study|Subject withdrew consent|1|||
23546410|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
23618889|NCT02299427|65991366|FG000|Overall Study|not adherent to dog website use|21|||
23618890|NCT02299427|65991367|FG001|Overall Study|not adherent to dog website use|0|||
23618891|NCT00509821|65991375|FG000|Study Period 1 (Induction)|Death|0|||
23618892|NCT00509821|65991376|FG001|Study Period 1 (Induction)|Death|1|||
23618893|NCT00509821|65991375|FG000|Study Period 1 (Induction)|Adverse Event|0|||
23618894|NCT00509821|65991376|FG001|Study Period 1 (Induction)|Adverse Event|2|||
23618895|NCT00509821|65991375|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
23618896|NCT00509821|65991376|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
23618897|NCT02262364|65991377|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
23618898|NCT02329223|65991380|FG000|Overall Study|Withdrawal by Subject|1|||
23131090|NCT01397422|64226608|FG001|Overall Study|Increased bradykinesia related to PD|0|||
23213269|NCT01670656|64519919|FG004|Overall Study|Subject withdrew consent|1|||
23213270|NCT01670656|64519915|FG000|Overall Study|Lost to Follow-up|0|||
23213271|NCT01670656|64519916|FG001|Overall Study|Lost to Follow-up|0|||
23213272|NCT01670656|64519917|FG002|Overall Study|Lost to Follow-up|0|||
23213273|NCT01670656|64519918|FG003|Overall Study|Lost to Follow-up|0|||
23131091|NCT01397422|64226609|FG002|Overall Study|Increased bradykinesia related to PD|0|||
23131092|NCT01397422|64226610|FG003|Overall Study|Increased bradykinesia related to PD|0|||
23131093|NCT00667394|64226611|FG000|Overall Study|Adverse Event|3|||
23213274|NCT01670656|64519919|FG004|Overall Study|Lost to Follow-up|3|||
23213275|NCT01670656|64519915|FG000|Overall Study|Subject moved|0|||
23213276|NCT01670656|64519916|FG001|Overall Study|Subject moved|0|||
23213277|NCT01670656|64519917|FG002|Overall Study|Subject moved|0|||
23213278|NCT01670656|64519918|FG003|Overall Study|Subject moved|1|||
23213279|NCT01670656|64519919|FG004|Overall Study|Subject moved|0|||
23213280|NCT00615914|64519923|FG000|Overall Study|Adverse Event|274|||
23131094|NCT00667394|64226612|FG001|Overall Study|Adverse Event|0|||
23213281|NCT00615914|64519923|FG000|Overall Study|Death|20|||
23618899|NCT02329223|65991381|FG001|Overall Study|Withdrawal by Subject|2|||
23618900|NCT02329223|65991382|FG002|Overall Study|Withdrawal by Subject|5|||
23618901|NCT02329223|65991380|FG000|Overall Study|Physician Decision|0|||
23618902|NCT02329223|65991381|FG001|Overall Study|Physician Decision|0|||
23618903|NCT02329223|65991382|FG002|Overall Study|Physician Decision|1|||
23618904|NCT02329223|65991380|FG000|Overall Study|Adverse Event|0|||
23618905|NCT02329223|65991381|FG001|Overall Study|Adverse Event|1|||
23618906|NCT02329223|65991382|FG002|Overall Study|Adverse Event|0|||
23618907|NCT01395914|65991384|FG000|Overall Study|Unrelated to study drug AE|6|||
23618908|NCT01395914|65991385|FG001|Overall Study|Unrelated to study drug AE|1|||
23618909|NCT01395914|65991384|FG000|Overall Study|Death|23|||
23618910|NCT01395914|65991385|FG001|Overall Study|Death|17|||
23618911|NCT01395914|65991384|FG000|Overall Study|Other|9|||
23618912|NCT01395914|65991385|FG001|Overall Study|Other|3|||
23618913|NCT01395914|65991384|FG000|Overall Study|Withdrawal by patient|27|||
23618914|NCT01395914|65991385|FG001|Overall Study|Withdrawal by patient|14|||
23618915|NCT01395914|65991384|FG000|Overall Study|Study drug-related AE|1|||
23618916|NCT01395914|65991385|FG001|Overall Study|Study drug-related AE|0|||
23618917|NCT01395914|65991384|FG000|Overall Study|Lost to Follow-up|6|||
23618918|NCT01395914|65991385|FG001|Overall Study|Lost to Follow-up|2|||
23618919|NCT04362176|65991390|FG000|Overall Study|Lost to Follow-up|5|||
23618920|NCT04362176|65991391|FG001|Overall Study|Lost to Follow-up|8|||
23618921|NCT04362176|65991390|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
23618922|NCT04362176|65991391|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
23618923|NCT02930837|65991394|FG000|Overall Study|Adverse Event|6|||
23618924|NCT02930837|65991394|FG000|Overall Study|Lost to Follow-up|5|||
23213282|NCT00615914|64519923|FG000|Overall Study|Lack of Efficacy|59|||
23213283|NCT00615914|64519923|FG000|Overall Study|Lost to Follow-up|187|||
23213284|NCT00615914|64519923|FG000|Overall Study|Withdrawal by Subject|16|||
23213285|NCT00615914|64519923|FG000|Overall Study|Physician Decision|4|||
23213286|NCT00615914|64519923|FG000|Overall Study|No data was collected.|65|||
23213287|NCT00615914|64519923|FG000|Overall Study|No treatment|2|||
23213288|NCT00615914|64519923|FG000|Overall Study|Irregularly enrolled patients|10|||
23213289|NCT02007954|64519924|FG000|Overall Study|Received liver transplant|3|||
23213290|NCT02007954|64519924|FG000|Overall Study|Switch in treatment modality|2|||
23213291|NCT02007954|64519924|FG000|Overall Study|Disease progression and unrelated AE|1|||
23213292|NCT02007954|64519924|FG000|Overall Study|Death|1|||
23213293|NCT04325906|64519925|FG000|Overall Study|Withdrawal by Subject|2|||
23213294|NCT04325906|64519926|FG001|Overall Study|Withdrawal by Subject|0|||
23213295|NCT03517449|64519931|FG000|Overall Study|Death|184|||
23213296|NCT03517449|64519932|FG001|Overall Study|Death|236|||
23213297|NCT03517449|64519931|FG000|Overall Study|Lost to Follow-up|0|||
23213298|NCT03517449|64519932|FG001|Overall Study|Lost to Follow-up|2|||
23213299|NCT03517449|64519931|FG000|Overall Study|Withdrawal by Subject|7|||
23213300|NCT03517449|64519932|FG001|Overall Study|Withdrawal by Subject|26|||
23213301|NCT03517449|64519931|FG000|Overall Study|Participants Ongoing|220|||
23213302|NCT03517449|64519932|FG001|Overall Study|Participants Ongoing|152|||
23213303|NCT00085917|64519936|FG000|Overall Study|Adverse Event|4|||
23213304|NCT00085917|64519937|FG001|Overall Study|Adverse Event|3|||
23213305|NCT01079195|64519938|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
23213306|NCT01079195|64519938|FG000|Overall Study|No Documentation Available|437|||
23546411|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
23546412|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
23546413|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
23546414|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
23546415|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
23546416|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
23546417|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
23546418|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
23546419|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
23546420|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
23546421|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
23546422|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
23582206|NCT01094171|65862382|FG000|Overall Study|Other|1|||
23618925|NCT02930837|65991394|FG000|Overall Study|Withdrawal by Subject|1|||
23618926|NCT02024750|65991395|FG000|Overall Study|Withdrawal by Subject|2|||
23618927|NCT02024750|65991396|FG001|Overall Study|Withdrawal by Subject|1|||
23618928|NCT00317603|65991397|FG000|Overall Study|Progressive Disease|3|||
23618929|NCT02005029|65991403|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
23618930|NCT02005029|65991404|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
23618931|NCT01885936|65991405|FG000|Overall Study|Withdrawal by Subject|1|||
23618932|NCT01885936|65991406|FG001|Overall Study|Withdrawal by Subject|0|||
23213307|NCT01079195|64519938|FG000|Overall Study|Adverse Event|157|||
23213308|NCT01079195|64519938|FG000|Overall Study|Reason Unknown|39|||
23213309|NCT01079195|64519938|FG000|Overall Study|Withdrawal by Subject|18|||
23213310|NCT01079195|64519938|FG000|Overall Study|Financial Reasons|15|||
23213311|NCT01079195|64519938|FG000|Overall Study|Lack of Effectiveness|12|||
23618933|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
23618934|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
23618935|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
23618936|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
23618937|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
23618938|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
23618939|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
23618940|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
23618941|NCT00352053|65991408|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
23618942|NCT00352053|65991409|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
23618943|NCT00352053|65991408|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
23546423|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
23546424|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
23546425|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
23546426|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
23546427|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
23546428|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
23546429|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
23131095|NCT00667394|64226611|FG000|Overall Study|Progressive disease|1|||
23131096|NCT00667394|64226612|FG001|Overall Study|Progressive disease|0|||
23131097|NCT00798590|64226613|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
23131098|NCT00798590|64226614|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
23131099|NCT03433677|64226615|FG000|Period 1|Protocol Violation|1|||
23131100|NCT03433677|64226616|FG001|Period 1|Protocol Violation|0|||
23131101|NCT03433677|64226615|FG000|Period 2|Withdrawal by Subject|1|||
23546430|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
23546431|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
23546432|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
23546433|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
23131102|NCT03433677|64226616|FG001|Period 2|Withdrawal by Subject|1|||
23131103|NCT02671500|64226617|FG000|Overall Study|Lack of Efficacy|12|||
23131104|NCT02671500|64226617|FG000|Overall Study|Lost to Follow-up|2|||
23131105|NCT03686423|64226624|FG000|Overall Study|Withdrawal by Subject|9|||
23131106|NCT03686423|64226624|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
23213312|NCT01079195|64519938|FG000|Overall Study|Physician Decision|4|||
23213313|NCT01079195|64519938|FG000|Overall Study|Improved Status of Participant|4|||
23213314|NCT01079195|64519938|FG000|Overall Study|No Follow-up Documentation Available|4|||
23213315|NCT01079195|64519938|FG000|Overall Study|Non-compliance|2|||
23213316|NCT00753688|64519939|FG000|Overall Study|Death|102|||
23213317|NCT00753688|64519940|FG001|Overall Study|Death|203|||
23213318|NCT00753688|64519939|FG000|Overall Study|Missing|4|||
23213319|NCT00753688|64519940|FG001|Overall Study|Missing|9|||
23546434|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
23546435|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
23546436|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
23546437|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
23546438|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
23618944|NCT00352053|65991409|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
23618945|NCT00352053|65991408|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
23618946|NCT00352053|65991409|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
23618947|NCT00352053|65991408|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
23618948|NCT00352053|65991409|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
23618949|NCT00352053|65991408|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
23618950|NCT00352053|65991409|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
23618951|NCT00352053|65991408|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
23618952|NCT00352053|65991409|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
23618953|NCT00352053|65991408|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
23618954|NCT00352053|65991409|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
23131107|NCT03995316|64226627|FG000|Overall Study|Lost to Follow-up|10|||
23131108|NCT03995316|64226628|FG001|Overall Study|Lost to Follow-up|3|||
23546439|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
23546440|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
23131109|NCT03117998|64226629|FG000|Overall Study|Adverse Event|1|||
23131110|NCT03117998|64226630|FG001|Overall Study|Adverse Event|0|||
23131111|NCT03117998|64226631|FG002|Overall Study|Adverse Event|0|||
23546441|NCT01434602|65731082|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
23546442|NCT01434602|65731083|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
23546443|NCT01434602|65731084|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
23546444|NCT01434602|65731085|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
23546445|NCT01434602|65731086|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
23546446|NCT03923959|65731087|FG000|Overall Study|Death|16|||
23546447|NCT03923959|65731088|FG001|Overall Study|Death|12|||
23546448|NCT03923959|65731087|FG000|Overall Study|Lost to Follow-up|56|||
23546449|NCT03923959|65731088|FG001|Overall Study|Lost to Follow-up|56|||
23546450|NCT03923959|65731087|FG000|Overall Study|Withdrawal by Subject|1|||
23618955|NCT00352053|65991408|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
23618956|NCT00352053|65991409|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
23618957|NCT00352053|65991408|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
23618958|NCT00352053|65991409|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
23618959|NCT03410108|65991410|FG000|Overall Study|Ongoing|41|||
23618960|NCT03410108|65991410|FG000|Overall Study|Adverse Event|4|||
23618961|NCT03410108|65991410|FG000|Overall Study|Progressive Disease|58|||
23618962|NCT03410108|65991410|FG000|Overall Study|Withdrawal by Subject|1|||
23618963|NCT04167085|65991411|FG000|Baseline|Withdrawal by Subject|2|||
23618964|NCT04167085|65991412|FG001|Baseline|Withdrawal by Subject|1|||
23618965|NCT04167085|65991411|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
23618966|NCT04167085|65991412|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
23618967|NCT01002547|65991413|FG000|Overall Study|Withdrawal by Subject|4|||
23618968|NCT01002547|65991414|FG001|Overall Study|Withdrawal by Subject|0|||
23618969|NCT01002547|65991415|FG002|Overall Study|Withdrawal by Subject|5|||
23546451|NCT03923959|65731088|FG001|Overall Study|Withdrawal by Subject|1|||
23546452|NCT03923959|65731087|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
23546453|NCT03923959|65731088|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
23546454|NCT03776136|65731096|FG000|Overall Study|Death|85|||
23546455|NCT03776136|65731096|FG000|Overall Study|Withdrawal by Subject|3|||
23546456|NCT03776136|65731096|FG000|Overall Study|Sponsor Decision|15|||
23546457|NCT03972488|65731097|FG000|Overall Study|Progressive disease|42|||
23546458|NCT03972488|65731098|FG001|Overall Study|Progressive disease|44|||
23546459|NCT03972488|65731097|FG000|Overall Study|Physician Decision|13|||
23546460|NCT03972488|65731098|FG001|Overall Study|Physician Decision|7|||
23546461|NCT03972488|65731097|FG000|Overall Study|Adverse Event|8|||
23546462|NCT03972488|65731098|FG001|Overall Study|Adverse Event|1|||
23546463|NCT03972488|65731097|FG000|Overall Study|Death|4|||
23546464|NCT03972488|65731098|FG001|Overall Study|Death|4|||
23546465|NCT03972488|65731097|FG000|Overall Study|Withdrawal by Subject|3|||
23546466|NCT03972488|65731098|FG001|Overall Study|Withdrawal by Subject|4|||
23546467|NCT03972488|65731097|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
23546468|NCT03972488|65731098|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
23546469|NCT00599326|65731102|FG000|Overall Study|Lost to Follow-up|1|||
23546470|NCT00599326|65731102|FG000|Overall Study|Noncompliant|1|||
23546471|NCT03305016|65731106|FG000|Overall Study|Withdrawal by Subject|2|||
23546472|NCT01669122|65731112|FG000|Period I|Lost to Follow-up|1|||
23546473|NCT01669122|65731112|FG000|Washout Period II|Protocol Violation|2|||
23546474|NCT04899349|65731113|FG000|Overall Study|Study terminated by Sponsor|2|||
23546475|NCT04899349|65731114|FG001|Overall Study|Study terminated by Sponsor|0|||
23546476|NCT02246998|65731115|FG000|Overall Study|Adverse Event|0|||
23546477|NCT02246998|65731116|FG001|Overall Study|Adverse Event|1|||
23546478|NCT02246998|65731117|FG002|Overall Study|Adverse Event|1|||
23546479|NCT02246998|65731118|FG003|Overall Study|Adverse Event|0|||
23546480|NCT02246998|65731115|FG000|Overall Study|Lost to Follow-up|1|||
23546481|NCT02246998|65731116|FG001|Overall Study|Lost to Follow-up|0|||
23546482|NCT02246998|65731117|FG002|Overall Study|Lost to Follow-up|0|||
23546483|NCT02246998|65731118|FG003|Overall Study|Lost to Follow-up|1|||
23546484|NCT02246998|65731115|FG000|Overall Study|Randomized but Never Dosed|1|||
23618970|NCT01002547|65991413|FG000|Overall Study|Lost to Follow-up|2|||
23618971|NCT01002547|65991414|FG001|Overall Study|Lost to Follow-up|1|||
23131112|NCT03117998|64226632|FG003|Overall Study|Adverse Event|0|||
23618972|NCT01002547|65991415|FG002|Overall Study|Lost to Follow-up|1|||
23618973|NCT01002547|65991413|FG000|Overall Study|Physician Decision|1|||
23618974|NCT01002547|65991414|FG001|Overall Study|Physician Decision|0|||
23618975|NCT01002547|65991415|FG002|Overall Study|Physician Decision|0|||
23131113|NCT03117998|64226633|FG004|Overall Study|Adverse Event|0|||
23131114|NCT03117998|64226634|FG005|Overall Study|Adverse Event|0|||
23131115|NCT03117998|64226629|FG000|Overall Study|Withdrawal by Subject|0|||
23131116|NCT03117998|64226630|FG001|Overall Study|Withdrawal by Subject|0|||
23131117|NCT03117998|64226631|FG002|Overall Study|Withdrawal by Subject|2|||
23131118|NCT03117998|64226632|FG003|Overall Study|Withdrawal by Subject|3|||
23131119|NCT03117998|64226633|FG004|Overall Study|Withdrawal by Subject|3|||
23131120|NCT03117998|64226634|FG005|Overall Study|Withdrawal by Subject|0|||
23546485|NCT02246998|65731116|FG001|Overall Study|Randomized but Never Dosed|2|||
23546486|NCT02246998|65731117|FG002|Overall Study|Randomized but Never Dosed|2|||
23546487|NCT02246998|65731118|FG003|Overall Study|Randomized but Never Dosed|1|||
23546488|NCT03266588|65731129|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
23546489|NCT03266588|65731130|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
23546490|NCT03266588|65731131|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
23546491|NCT03266588|65731129|FG000|Observational Period|Withdrawal by Subject|44|||
23546492|NCT03266588|65731130|FG001|Observational Period|Withdrawal by Subject|22|||
23546493|NCT03266588|65731131|FG002|Observational Period|Withdrawal by Subject|13|||
23546494|NCT03266588|65731129|FG000|Observational Period|Non-compliance|18|||
23546495|NCT03266588|65731130|FG001|Observational Period|Non-compliance|12|||
23546496|NCT03266588|65731131|FG002|Observational Period|Non-compliance|10|||
23546497|NCT03266588|65731129|FG000|Observational Period|Lost to Follow-up|8|||
23546498|NCT03266588|65731130|FG001|Observational Period|Lost to Follow-up|12|||
23546499|NCT03266588|65731131|FG002|Observational Period|Lost to Follow-up|4|||
23546500|NCT03266588|65731129|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
23546501|NCT03266588|65731130|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
23546502|NCT03266588|65731131|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
23546503|NCT03266588|65731129|FG000|Observational Period|Protocol Deviation|1|||
23546504|NCT03266588|65731130|FG001|Observational Period|Protocol Deviation|0|||
23546505|NCT03266588|65731131|FG002|Observational Period|Protocol Deviation|0|||
23546506|NCT03266588|65731129|FG000|Observational Period|Other Reasons|3|||
23546507|NCT03266588|65731130|FG001|Observational Period|Other Reasons|0|||
23546508|NCT03266588|65731131|FG002|Observational Period|Other Reasons|1|||
23546509|NCT03266588|65731129|FG000|Long-term Treatment Period|Adverse Event|33|||
23546510|NCT03266588|65731130|FG001|Long-term Treatment Period|Adverse Event|17|||
23618976|NCT01002547|65991413|FG000|Overall Study|Death|0|||
23618977|NCT01002547|65991414|FG001|Overall Study|Death|2|||
23618978|NCT01002547|65991415|FG002|Overall Study|Death|2|||
23618979|NCT01002547|65991413|FG000|Overall Study|Adverse Event|1|||
23618980|NCT01002547|65991414|FG001|Overall Study|Adverse Event|0|||
23618981|NCT01002547|65991415|FG002|Overall Study|Adverse Event|0|||
23618982|NCT01670188|65991416|FG000|Overall Study|Death|0|||
23618983|NCT01670188|65991417|FG001|Overall Study|Death|1|||
23618984|NCT01960114|65991422|FG000|Overall Study|Adverse Event|1|||
23618985|NCT01960114|65991423|FG001|Overall Study|Adverse Event|0|||
23618986|NCT01960114|65991422|FG000|Overall Study|Could not swallow study medication|0|||
23618987|NCT01960114|65991423|FG001|Overall Study|Could not swallow study medication|1|||
23618988|NCT03214250|65991424|FG000|Overall Study|Death|5|||
23618989|NCT03214250|65991425|FG001|Overall Study|Death|5|||
23618990|NCT03214250|65991426|FG002|Overall Study|Death|7|||
23618991|NCT03214250|65991427|FG003|Overall Study|Death|4|||
23618992|NCT03214250|65991428|FG004|Overall Study|Death|23|||
23618993|NCT03214250|65991429|FG005|Overall Study|Death|23|||
23618994|NCT03214250|65991430|FG006|Overall Study|Death|24|||
23618995|NCT03214250|65991424|FG000|Overall Study|Lost to Follow-up|0|||
23618996|NCT03214250|65991425|FG001|Overall Study|Lost to Follow-up|0|||
23618997|NCT03214250|65991426|FG002|Overall Study|Lost to Follow-up|0|||
23618998|NCT03214250|65991427|FG003|Overall Study|Lost to Follow-up|1|||
23618999|NCT03214250|65991428|FG004|Overall Study|Lost to Follow-up|1|||
23619000|NCT03214250|65991429|FG005|Overall Study|Lost to Follow-up|2|||
23619001|NCT03214250|65991430|FG006|Overall Study|Lost to Follow-up|0|||
23619002|NCT03214250|65991424|FG000|Overall Study|Other|0|||
23619003|NCT03214250|65991425|FG001|Overall Study|Other|0|||
23619004|NCT03214250|65991426|FG002|Overall Study|Other|0|||
23546511|NCT03266588|65731131|FG002|Long-term Treatment Period|Adverse Event|8|||
23546512|NCT03266588|65731129|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
23546513|NCT03266588|65731130|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
23546514|NCT03266588|65731131|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
23546515|NCT03266588|65731129|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
23619005|NCT03214250|65991427|FG003|Overall Study|Other|0|||
23619006|NCT03214250|65991428|FG004|Overall Study|Other|1|||
23131121|NCT03117998|64226629|FG000|Overall Study|Physician Decision|0|||
23546516|NCT03266588|65731130|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
23546517|NCT03266588|65731131|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
23546518|NCT03266588|65731129|FG000|Long-term Treatment Period|Non-Compliance|126|||
23546519|NCT03266588|65731130|FG001|Long-term Treatment Period|Non-Compliance|57|||
23619007|NCT03214250|65991429|FG005|Overall Study|Other|1|||
23619008|NCT03214250|65991430|FG006|Overall Study|Other|2|||
23619009|NCT03214250|65991424|FG000|Overall Study|Remains on Study|2|||
23619010|NCT03214250|65991425|FG001|Overall Study|Remains on Study|2|||
23546520|NCT03266588|65731131|FG002|Long-term Treatment Period|Non-Compliance|7|||
23546521|NCT03266588|65731129|FG000|Long-term Treatment Period|Pregnancy|11|||
23619011|NCT03214250|65991426|FG002|Overall Study|Remains on Study|0|||
23619012|NCT03214250|65991427|FG003|Overall Study|Remains on Study|1|||
23619013|NCT03214250|65991428|FG004|Overall Study|Remains on Study|7|||
23619014|NCT03214250|65991429|FG005|Overall Study|Remains on Study|5|||
23619015|NCT03214250|65991430|FG006|Overall Study|Remains on Study|3|||
23213320|NCT00753688|64519939|FG000|Overall Study|Participant Withdrew Consent|2|||
23213321|NCT00753688|64519940|FG001|Overall Study|Participant Withdrew Consent|2|||
23213322|NCT00753688|64519939|FG000|Overall Study|Ongoing - in Follow-up|15|||
23213323|NCT00753688|64519940|FG001|Overall Study|Ongoing - in Follow-up|31|||
23213324|NCT00753688|64519939|FG000|Overall Study|Adverse Event|0|||
23213325|NCT00753688|64519940|FG001|Overall Study|Adverse Event|1|||
23213326|NCT03485222|64519941|FG000|Overall Study|Death|0|||
23213327|NCT03485222|64519942|FG001|Overall Study|Death|1|||
23213328|NCT03485222|64519941|FG000|Overall Study|Lost to Follow-up|2|||
23213329|NCT03485222|64519942|FG001|Overall Study|Lost to Follow-up|1|||
23213330|NCT05200455|64519945|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
23213331|NCT01280266|64519953|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
23546522|NCT03266588|65731130|FG001|Long-term Treatment Period|Pregnancy|5|||
23546523|NCT03266588|65731131|FG002|Long-term Treatment Period|Pregnancy|0|||
23546524|NCT03266588|65731129|FG000|Long-term Treatment Period|Protocol Deviation|17|||
23546525|NCT03266588|65731130|FG001|Long-term Treatment Period|Protocol Deviation|10|||
23131122|NCT03117998|64226630|FG001|Overall Study|Physician Decision|1|||
23131123|NCT03117998|64226631|FG002|Overall Study|Physician Decision|1|||
23131124|NCT03117998|64226632|FG003|Overall Study|Physician Decision|0|||
23131125|NCT03117998|64226633|FG004|Overall Study|Physician Decision|0|||
23131126|NCT03117998|64226634|FG005|Overall Study|Physician Decision|0|||
23131127|NCT03117998|64226629|FG000|Overall Study|Lost to Follow-up|0|||
23131128|NCT03117998|64226630|FG001|Overall Study|Lost to Follow-up|0|||
23131129|NCT03117998|64226631|FG002|Overall Study|Lost to Follow-up|0|||
23131130|NCT03117998|64226632|FG003|Overall Study|Lost to Follow-up|1|||
23131131|NCT03117998|64226633|FG004|Overall Study|Lost to Follow-up|4|||
23131132|NCT03117998|64226634|FG005|Overall Study|Lost to Follow-up|0|||
23131133|NCT03117998|64226629|FG000|Overall Study|Subject noncompliance|0|||
23131134|NCT03117998|64226630|FG001|Overall Study|Subject noncompliance|0|||
23131135|NCT03117998|64226631|FG002|Overall Study|Subject noncompliance|1|||
23131136|NCT03117998|64226632|FG003|Overall Study|Subject noncompliance|0|||
23131137|NCT03117998|64226633|FG004|Overall Study|Subject noncompliance|0|||
23131138|NCT03117998|64226634|FG005|Overall Study|Subject noncompliance|2|||
23131139|NCT03117998|64226629|FG000|Overall Study|Protocol Violation|0|||
23131140|NCT03117998|64226630|FG001|Overall Study|Protocol Violation|0|||
23213332|NCT01280266|64519954|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
23213333|NCT01280266|64519953|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
23546526|NCT03266588|65731131|FG002|Long-term Treatment Period|Protocol Deviation|4|||
23546527|NCT03266588|65731129|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
23546528|NCT03266588|65731130|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
23546529|NCT03266588|65731131|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
23546530|NCT03266588|65731129|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
23546531|NCT03266588|65731130|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
23546532|NCT03266588|65731131|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
23546533|NCT03266588|65731129|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
23546534|NCT03266588|65731130|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
23546535|NCT03266588|65731131|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
23546536|NCT03266588|65731129|FG000|Long-term Treatment Period|Other Reasons|5|||
23546537|NCT03266588|65731130|FG001|Long-term Treatment Period|Other Reasons|0|||
23546538|NCT03266588|65731131|FG002|Long-term Treatment Period|Other Reasons|0|||
23546539|NCT03266588|65731129|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
23546540|NCT03266588|65731130|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
23546541|NCT03266588|65731131|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
23546542|NCT03725982|65731132|FG000|First Intervention|Withdrawal by Subject|0|||
23546543|NCT03725982|65731133|FG001|First Intervention|Withdrawal by Subject|1|||
23546544|NCT03725982|65731132|FG000|First Intervention|Physician Decision|1|||
23546545|NCT03725982|65731133|FG001|First Intervention|Physician Decision|1|||
23546546|NCT02625623|65731136|FG000|Overall Study|Participants randomized but not treated|9|||
23546547|NCT02625623|65731137|FG001|Overall Study|Participants randomized but not treated|1|||
23546548|NCT02244944|65731138|FG000|Overall Study|Withdrawal by Subject|1|||
23546549|NCT02244944|65731138|FG000|Overall Study|Study Terminated|1|||
23546550|NCT04667117|65731140|FG000|Investigational Period|Lost to Follow-up|0|||
23546551|NCT04667117|65731141|FG001|Investigational Period|Lost to Follow-up|0|||
23131141|NCT03117998|64226631|FG002|Overall Study|Protocol Violation|0|||
23546552|NCT04667117|65731142|FG002|Investigational Period|Lost to Follow-up|1|||
23131142|NCT03117998|64226632|FG003|Overall Study|Protocol Violation|0|||
23131143|NCT03117998|64226633|FG004|Overall Study|Protocol Violation|0|||
23131144|NCT03117998|64226634|FG005|Overall Study|Protocol Violation|1|||
23131145|NCT01609062|64226635|FG000|Extension Phase|Terminated by Sponsor|14|||
23131146|NCT01609062|64226636|FG001|Extension Phase|Terminated by Sponsor|9|||
23131147|NCT01609062|64226635|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
23131148|NCT01609062|64226636|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
23317257|NCT00863772|64904035|FG000|Overall Study|Lack of Efficacy|4|||
23546553|NCT04667117|65731140|FG000|Investigational Period|Protocol Deviation|0|||
23546554|NCT04667117|65731141|FG001|Investigational Period|Protocol Deviation|1|||
23546555|NCT04667117|65731142|FG002|Investigational Period|Protocol Deviation|0|||
23546556|NCT04667117|65731140|FG000|Extension Period|Lost to Follow-up|1|||
23546557|NCT04667117|65731141|FG001|Extension Period|Lost to Follow-up|0|||
23546558|NCT04667117|65731142|FG002|Extension Period|Lost to Follow-up|0|||
23546559|NCT01666002|65731143|FG000|Overall Study|Lost to Follow-up|5|||
23546560|NCT01666002|65731144|FG001|Overall Study|Lost to Follow-up|0|||
23546561|NCT01075074|65731145|FG000|Overall Study|Surgeon changed to open incisional case|1|||
23619016|NCT03214250|65991424|FG000|Overall Study|Withdrawal by Subject|0|||
23619017|NCT03214250|65991425|FG001|Overall Study|Withdrawal by Subject|0|||
23619018|NCT03214250|65991426|FG002|Overall Study|Withdrawal by Subject|1|||
23619019|NCT03214250|65991427|FG003|Overall Study|Withdrawal by Subject|2|||
23619020|NCT03214250|65991428|FG004|Overall Study|Withdrawal by Subject|5|||
23619021|NCT03214250|65991429|FG005|Overall Study|Withdrawal by Subject|0|||
23619022|NCT03214250|65991430|FG006|Overall Study|Withdrawal by Subject|2|||
23619023|NCT01831726|65991431|FG000|Overall Study|Adverse Event|16|||
23619024|NCT01831726|65991431|FG000|Overall Study|Death|7|||
23619025|NCT01831726|65991431|FG000|Overall Study|Disease Progression|49|||
23619026|NCT01831726|65991431|FG000|Overall Study|Physician Decision|1|||
23426984|NCT00642369|65307502|FG001|Overall Study|Adverse Event|3|||
23619027|NCT01831726|65991431|FG000|Overall Study|Subject/guardian decision|7|||
23619028|NCT00920699|65991442|FG000|Overall Study|Withdrawal by Subject|2|||
23619029|NCT00920699|65991443|FG001|Overall Study|Withdrawal by Subject|0|||
23619030|NCT00920699|65991444|FG002|Overall Study|Withdrawal by Subject|2|||
23619031|NCT00920699|65991442|FG000|Overall Study|no longer met eligibility|0|||
23619032|NCT00920699|65991443|FG001|Overall Study|no longer met eligibility|1|||
23619033|NCT00920699|65991444|FG002|Overall Study|no longer met eligibility|0|||
23619034|NCT00920699|65991442|FG000|Overall Study|Lost to Follow-up|0|||
23619035|NCT00920699|65991443|FG001|Overall Study|Lost to Follow-up|0|||
23619036|NCT00920699|65991444|FG002|Overall Study|Lost to Follow-up|2|||
23619037|NCT00514813|65991445|FG000|Overall Study|Study terminated|14|||
23619038|NCT00514813|65991446|FG001|Overall Study|Study terminated|74|||
23619039|NCT00514813|65991447|FG002|Overall Study|Study terminated|40|||
23619040|NCT00514813|65991448|FG003|Overall Study|Study terminated|2|||
23619041|NCT00514813|65991445|FG000|Overall Study|Adverse Event|0|||
23619042|NCT00514813|65991446|FG001|Overall Study|Adverse Event|2|||
23619043|NCT00514813|65991447|FG002|Overall Study|Adverse Event|2|||
23619044|NCT00514813|65991448|FG003|Overall Study|Adverse Event|0|||
23619045|NCT00514813|65991445|FG000|Overall Study|Protocol Violation|1|||
23619046|NCT00514813|65991446|FG001|Overall Study|Protocol Violation|0|||
23619047|NCT00514813|65991447|FG002|Overall Study|Protocol Violation|0|||
23619048|NCT00514813|65991448|FG003|Overall Study|Protocol Violation|0|||
23619049|NCT00514813|65991445|FG000|Overall Study|Withdrawal by Subject|0|||
23619050|NCT00514813|65991446|FG001|Overall Study|Withdrawal by Subject|1|||
23619051|NCT00514813|65991447|FG002|Overall Study|Withdrawal by Subject|0|||
23619052|NCT00514813|65991448|FG003|Overall Study|Withdrawal by Subject|0|||
23619053|NCT00514813|65991445|FG000|Overall Study|Lack of Efficacy|0|||
23619054|NCT00514813|65991446|FG001|Overall Study|Lack of Efficacy|1|||
23619055|NCT00514813|65991447|FG002|Overall Study|Lack of Efficacy|0|||
23619056|NCT00514813|65991448|FG003|Overall Study|Lack of Efficacy|0|||
23619057|NCT00514813|65991445|FG000|Overall Study|Kidney transplant|0|||
23619058|NCT00514813|65991446|FG001|Overall Study|Kidney transplant|6|||
23619059|NCT00514813|65991447|FG002|Overall Study|Kidney transplant|2|||
23619060|NCT00514813|65991448|FG003|Overall Study|Kidney transplant|0|||
23619061|NCT00514813|65991445|FG000|Overall Study|Death|0|||
23619062|NCT00514813|65991446|FG001|Overall Study|Death|2|||
23619063|NCT00514813|65991447|FG002|Overall Study|Death|3|||
23619064|NCT00514813|65991448|FG003|Overall Study|Death|2|||
23619065|NCT04194541|65991449|FG000|Day 1 Through 13|Lost to Follow-up|3|||
23131149|NCT01609062|64226635|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
23131150|NCT01609062|64226636|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
23131151|NCT00320528|64226640|FG000|Study Period II|Adverse Event|3|||
23131152|NCT00320528|64226641|FG001|Study Period II|Adverse Event|4|||
23131153|NCT00320528|64226642|FG002|Study Period II|Adverse Event|8|||
23131154|NCT00320528|64226640|FG000|Study Period II|Parent/Caregiver Decision|8|||
23131155|NCT00320528|64226641|FG001|Study Period II|Parent/Caregiver Decision|3|||
23131156|NCT00320528|64226642|FG002|Study Period II|Parent/Caregiver Decision|11|||
23317258|NCT00863772|64904036|FG001|Overall Study|Lack of Efficacy|2|||
23546562|NCT01075074|65731146|FG001|Overall Study|Surgeon changed to open incisional case|2|||
23619066|NCT04194541|65991449|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
23131157|NCT00320528|64226640|FG000|Study Period II|Withdrawal by Subject|0|||
23131158|NCT00320528|64226641|FG001|Study Period II|Withdrawal by Subject|1|||
23131159|NCT00320528|64226642|FG002|Study Period II|Withdrawal by Subject|1|||
23619067|NCT04194541|65991449|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
23619068|NCT02600897|65991450|FG000|Overall Study|Death|1|||
23619069|NCT02600897|65991451|FG001|Overall Study|Death|2|||
23619070|NCT02600897|65991452|FG002|Overall Study|Death|1|||
23131160|NCT00320528|64226640|FG000|Study Period II|Entry Criteria Exclusion|0|||
23131161|NCT00320528|64226641|FG001|Study Period II|Entry Criteria Exclusion|2|||
23131162|NCT00320528|64226642|FG002|Study Period II|Entry Criteria Exclusion|2|||
23131163|NCT00320528|64226640|FG000|Study Period III|Adverse Event|1|||
23131164|NCT00320528|64226641|FG001|Study Period III|Adverse Event|0|||
23131165|NCT00320528|64226642|FG002|Study Period III|Adverse Event|0|||
23131166|NCT00320528|64226640|FG000|Study Period III|Lost to Follow-up|1|||
23131167|NCT00320528|64226641|FG001|Study Period III|Lost to Follow-up|0|||
23131168|NCT00320528|64226642|FG002|Study Period III|Lost to Follow-up|0|||
23131169|NCT00320528|64226640|FG000|Study Period III|Withdrawal by Subject|1|||
23131170|NCT00320528|64226641|FG001|Study Period III|Withdrawal by Subject|1|||
23131171|NCT00320528|64226642|FG002|Study Period III|Withdrawal by Subject|2|||
23131172|NCT00320528|64226640|FG000|Study Period III|Lack of Efficacy|2|||
23131173|NCT00320528|64226641|FG001|Study Period III|Lack of Efficacy|0|||
23131174|NCT00320528|64226642|FG002|Study Period III|Lack of Efficacy|0|||
23131175|NCT00320528|64226640|FG000|Study Period III|Parent/Caregiver Decision|14|||
23131176|NCT00320528|64226641|FG001|Study Period III|Parent/Caregiver Decision|3|||
23131177|NCT00320528|64226642|FG002|Study Period III|Parent/Caregiver Decision|11|||
23131178|NCT00320528|64226640|FG000|Study Period III|Protocol Violation|0|||
23131179|NCT00320528|64226641|FG001|Study Period III|Protocol Violation|1|||
23131180|NCT00320528|64226642|FG002|Study Period III|Protocol Violation|0|||
23317259|NCT00863772|64904037|FG002|Overall Study|Lack of Efficacy|4|||
23317260|NCT00863772|64904035|FG000|Overall Study|Lost to Follow-up|5|||
23317261|NCT00863772|64904036|FG001|Overall Study|Lost to Follow-up|1|||
23317262|NCT00863772|64904037|FG002|Overall Study|Lost to Follow-up|1|||
23317263|NCT00863772|64904035|FG000|Overall Study|Protocol Violation|2|||
23317264|NCT00863772|64904036|FG001|Overall Study|Protocol Violation|0|||
23317265|NCT00863772|64904037|FG002|Overall Study|Protocol Violation|2|||
23317266|NCT00863772|64904035|FG000|Overall Study|Withdrawal by Subject|4|||
23131181|NCT00320528|64226640|FG000|Study Period III|Physician Decision|0|||
23131182|NCT00320528|64226641|FG001|Study Period III|Physician Decision|1|||
23131183|NCT00320528|64226642|FG002|Study Period III|Physician Decision|2|||
23131184|NCT00320528|64226640|FG000|Study Period III|Sponsor Decision|0|||
23131185|NCT00320528|64226641|FG001|Study Period III|Sponsor Decision|0|||
23131186|NCT00320528|64226642|FG002|Study Period III|Sponsor Decision|1|||
23131187|NCT00320528|64226640|FG000|Study Period III|Atomoxetine Commercially Available|68|||
23131188|NCT00320528|64226641|FG001|Study Period III|Atomoxetine Commercially Available|25|||
23131189|NCT00320528|64226642|FG002|Study Period III|Atomoxetine Commercially Available|90|||
23213334|NCT01280266|64519954|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
23213335|NCT01410799|64519955|FG000|Overall Study|PI decision|13|||
23213336|NCT00377429|64519956|FG000|Overall Study|Withdrawal by Subject|5|||
23213337|NCT00377429|64519956|FG000|Overall Study|Adverse Event|8|||
23213338|NCT00377429|64519956|FG000|Overall Study|Physician Decision|1|||
23213339|NCT00377429|64519956|FG000|Overall Study|Patient non-compliance|1|||
23213340|NCT04354155|64519960|FG000|Overall Study|Withdrawal by Subject|1|||
23213341|NCT04354155|64519960|FG000|Overall Study|Did not meet criteria for study intervention|1|||
23213342|NCT00290589|64519963|FG000|Overall Study|Lost to Follow-up|2|||
23213343|NCT00290589|64519964|FG001|Overall Study|Lost to Follow-up|2|||
23213344|NCT00351819|64519965|FG000|Overall Study|Lost to Follow-up|4|||
23213345|NCT00351819|64519966|FG001|Overall Study|Lost to Follow-up|4|||
23213346|NCT00351819|64519965|FG000|Overall Study|Withdrawal by Subject|0|||
23213347|NCT00351819|64519966|FG001|Overall Study|Withdrawal by Subject|4|||
23213348|NCT00351819|64519965|FG000|Overall Study|Elevated PSA|1|||
23213349|NCT00351819|64519966|FG001|Overall Study|Elevated PSA|1|||
23213350|NCT00351819|64519965|FG000|Overall Study|Traumatic ankle fracture|1|||
23213351|NCT00351819|64519966|FG001|Overall Study|Traumatic ankle fracture|0|||
23213352|NCT00351819|64519965|FG000|Overall Study|Unprofessional behavior|1|||
23213353|NCT00351819|64519966|FG001|Overall Study|Unprofessional behavior|0|||
23213354|NCT00351819|64519965|FG000|Overall Study|Non-compliance|0|||
23317267|NCT00863772|64904036|FG001|Overall Study|Withdrawal by Subject|7|||
23131190|NCT03026075|64226644|FG000|Overall Study|Physician Decision|1|||
23213355|NCT00351819|64519966|FG001|Overall Study|Non-compliance|1|||
23213356|NCT00351819|64519965|FG000|Overall Study|Incarcerated|0|||
23131191|NCT01427725|64226645|FG000|Overall Study|Lost to Follow-up|17|||
23131192|NCT01427725|64226645|FG000|Overall Study|Protocol Violation|1|||
23131193|NCT01427725|64226645|FG000|Overall Study|Drug not administered|1|||
23131194|NCT01427725|64226645|FG000|Overall Study|Failure to visit|7|||
23131195|NCT01427725|64226645|FG000|Overall Study|Adverse Event|46|||
23131196|NCT01427725|64226645|FG000|Overall Study|Failure to visit after administration|40|||
23131197|NCT01427725|64226645|FG000|Overall Study|Patient's rejection|27|||
23317268|NCT00863772|64904037|FG002|Overall Study|Withdrawal by Subject|5|||
23317269|NCT00863772|64904035|FG000|Overall Study|Study terminated by sponsor|44|||
23317270|NCT00863772|64904036|FG001|Overall Study|Study terminated by sponsor|45|||
23131198|NCT01427725|64226645|FG000|Overall Study|Transfer to a different hospital|17|||
23131199|NCT01427725|64226645|FG000|Overall Study|Lack of Efficacy|8|||
23213357|NCT00351819|64519966|FG001|Overall Study|Incarcerated|1|||
23213358|NCT00351819|64519965|FG000|Overall Study|Enrolled in another trial|0|||
23213359|NCT00351819|64519966|FG001|Overall Study|Enrolled in another trial|1|||
23213360|NCT01824693|64519967|FG000|Overall Study|Death|0|||
23213361|NCT01824693|64519968|FG001|Overall Study|Death|1|||
23213362|NCT01824693|64519969|FG002|Overall Study|Death|0|||
23213363|NCT01824693|64519967|FG000|Overall Study|Physician Decision|1|||
23213364|NCT01824693|64519968|FG001|Overall Study|Physician Decision|1|||
23213365|NCT01824693|64519969|FG002|Overall Study|Physician Decision|1|||
23213366|NCT01824693|64519967|FG000|Overall Study|Withdrawal by Subject|0|||
23213367|NCT01824693|64519968|FG001|Overall Study|Withdrawal by Subject|0|||
23213368|NCT01824693|64519969|FG002|Overall Study|Withdrawal by Subject|1|||
23213369|NCT01824693|64519967|FG000|Overall Study|Progressive Disease|0|||
23213370|NCT01824693|64519968|FG001|Overall Study|Progressive Disease|5|||
23213371|NCT01824693|64519969|FG002|Overall Study|Progressive Disease|0|||
23213372|NCT01824693|64519967|FG000|Overall Study|Ineligible|0|||
23213373|NCT01824693|64519968|FG001|Overall Study|Ineligible|0|||
23213374|NCT01824693|64519969|FG002|Overall Study|Ineligible|3|||
23213375|NCT01824693|64519967|FG000|Overall Study|No Transplant Planned|0|||
23213376|NCT01824693|64519968|FG001|Overall Study|No Transplant Planned|0|||
23213377|NCT01824693|64519969|FG002|Overall Study|No Transplant Planned|10|||
23213378|NCT00089479|64519970|FG000|Overall Study|Death|108|||
23213379|NCT00089479|64519971|FG001|Overall Study|Death|75|||
23213380|NCT00089479|64519970|FG000|Overall Study|Withdrawal by Subject|86|||
23213381|NCT00089479|64519971|FG001|Overall Study|Withdrawal by Subject|107|||
23213382|NCT00089479|64519970|FG000|Overall Study|Lost to Follow-up|137|||
23213383|NCT00089479|64519971|FG001|Overall Study|Lost to Follow-up|107|||
23619071|NCT02600897|65991453|FG003|Overall Study|Death|2|||
23619072|NCT02600897|65991454|FG004|Overall Study|Death|3|||
23619073|NCT02600897|65991455|FG005|Overall Study|Death|2|||
23619074|NCT02600897|65991456|FG006|Overall Study|Death|10|||
23619075|NCT02600897|65991457|FG007|Overall Study|Death|7|||
23619076|NCT02600897|65991458|FG008|Overall Study|Death|20|||
23619077|NCT02600897|65991450|FG000|Overall Study|Lost to Follow-up|1|||
23619078|NCT02600897|65991451|FG001|Overall Study|Lost to Follow-up|0|||
23619079|NCT02600897|65991452|FG002|Overall Study|Lost to Follow-up|0|||
23619080|NCT02600897|65991453|FG003|Overall Study|Lost to Follow-up|0|||
23619081|NCT02600897|65991454|FG004|Overall Study|Lost to Follow-up|0|||
23131200|NCT01427725|64226645|FG000|Overall Study|Death|7|||
23131201|NCT01427725|64226645|FG000|Overall Study|Symptom improvement|6|||
23131202|NCT01427725|64226645|FG000|Overall Study|AE and Patient's rejection|5|||
23131203|NCT01427725|64226645|FG000|Overall Study|Physician Decision|5|||
23131204|NCT01427725|64226645|FG000|Overall Study|Exacerbation of underlying disease|5|||
23131205|NCT01427725|64226645|FG000|Overall Study|Oral feeding difficulty|5|||
23213384|NCT00441103|64519972|FG000|Overall Study|Adverse Event|2|||
23213385|NCT00441103|64519973|FG001|Overall Study|Adverse Event|1|||
23213386|NCT00441103|64519972|FG000|Overall Study|Death|1|||
23213387|NCT00441103|64519973|FG001|Overall Study|Death|0|||
23213388|NCT00441103|64519972|FG000|Overall Study|Disease Progression|2|||
23213389|NCT00441103|64519973|FG001|Overall Study|Disease Progression|0|||
23213390|NCT00441103|64519972|FG000|Overall Study|Lost to Follow-up|1|||
23131206|NCT01427725|64226645|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
23131207|NCT01427725|64226645|FG000|Overall Study|Forgetting prescription|1|||
23131208|NCT01427725|64226645|FG000|Overall Study|Other|2|||
23131209|NCT01114880|64226646|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
23131210|NCT01114880|64226647|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
23131211|NCT01114880|64226646|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
23131212|NCT01114880|64226647|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
23131213|NCT01114880|64226646|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
23131214|NCT01114880|64226647|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
23131215|NCT01114880|64226646|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
23131216|NCT01114880|64226647|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
23213391|NCT00441103|64519973|FG001|Overall Study|Lost to Follow-up|0|||
23213392|NCT00441103|64519972|FG000|Overall Study|Protocol Violation|1|||
23213393|NCT00441103|64519973|FG001|Overall Study|Protocol Violation|0|||
23619082|NCT02600897|65991455|FG005|Overall Study|Lost to Follow-up|0|||
23619083|NCT02600897|65991456|FG006|Overall Study|Lost to Follow-up|0|||
23131217|NCT01114880|64226646|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
23131218|NCT01114880|64226647|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
23131219|NCT01114880|64226646|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
23213394|NCT00441103|64519972|FG000|Overall Study|Participant unable to use Rebiject II|1|||
23213395|NCT00441103|64519973|FG001|Overall Study|Participant unable to use Rebiject II|0|||
23213396|NCT00441103|64519972|FG000|Overall Study|Participant refused MRI|1|||
23213397|NCT00441103|64519973|FG001|Overall Study|Participant refused MRI|0|||
23213398|NCT00441103|64519972|FG000|Overall Study|Inclusion criteria absent|1|||
23213399|NCT00441103|64519973|FG001|Overall Study|Inclusion criteria absent|0|||
23213400|NCT00441103|64519972|FG000|Overall Study|Non-compliant|0|||
23619084|NCT02600897|65991457|FG007|Overall Study|Lost to Follow-up|1|||
23619085|NCT02600897|65991458|FG008|Overall Study|Lost to Follow-up|0|||
23619086|NCT02600897|65991450|FG000|Overall Study|Withdrawal by Subject|0|||
23213401|NCT00441103|64519973|FG001|Overall Study|Non-compliant|1|||
23213402|NCT00441103|64519972|FG000|Overall Study|Participant decided to withdraw|1|||
23213403|NCT00441103|64519973|FG001|Overall Study|Participant decided to withdraw|0|||
23213404|NCT00441103|64519972|FG000|Overall Study|Participant's reason|0|||
23131220|NCT01114880|64226647|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
23131221|NCT02269423|64226649|FG000|Overall Study|Discontinued due to change in residence|0|||
23131222|NCT02269423|64226650|FG001|Overall Study|Discontinued due to change in residence|1|||
23131223|NCT02269423|64226651|FG002|Overall Study|Discontinued due to change in residence|0|||
23131224|NCT02269423|64226652|FG003|Overall Study|Discontinued due to change in residence|1|||
23131225|NCT00756457|64226653|FG000|Overall Study|Lost to Follow-up|1|||
23131226|NCT00756457|64226654|FG001|Overall Study|Lost to Follow-up|2|||
23131227|NCT01643044|64226655|FG000|Overall Study|Lost to Follow-up|1|||
23131228|NCT01643044|64226656|FG001|Overall Study|Lost to Follow-up|1|||
23131229|NCT01643044|64226655|FG000|Overall Study|Miscarried baby|2|||
23131230|NCT01643044|64226656|FG001|Overall Study|Miscarried baby|2|||
23131231|NCT01643044|64226655|FG000|Overall Study|Delivered outside of hospital|1|||
23131232|NCT01643044|64226656|FG001|Overall Study|Delivered outside of hospital|2|||
23131233|NCT00755105|64226657|FG000|Overall Study|Withdrawal by Subject|9|||
23131234|NCT00755105|64226658|FG001|Overall Study|Withdrawal by Subject|11|||
23131235|NCT00755105|64226659|FG002|Overall Study|Withdrawal by Subject|4|||
23131236|NCT00846807|64226660|FG000|Overall Study|Adverse Event|270|||
23131237|NCT00846807|64226660|FG000|Overall Study|Lost to Follow-up|94|||
23131238|NCT00846807|64226660|FG000|Overall Study|Withdrawal by Subject|56|||
23131239|NCT00846807|64226660|FG000|Overall Study|Non compliant with European label|7|||
23213405|NCT00441103|64519973|FG001|Overall Study|Participant's reason|1|||
23213406|NCT00441103|64519972|FG000|Overall Study|Participant decided to stop|0|||
23213407|NCT00441103|64519973|FG001|Overall Study|Participant decided to stop|1|||
23213408|NCT02293993|64519974|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
23213409|NCT02293993|64519975|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
23213410|NCT02293993|64519976|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
23213411|NCT02293993|64519977|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
23213412|NCT02293993|64519974|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
23213413|NCT02293993|64519975|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
23213414|NCT02293993|64519976|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
23213415|NCT02293993|64519977|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
23213416|NCT02293993|64519974|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
23213417|NCT02293993|64519975|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
23213418|NCT02293993|64519976|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
23213419|NCT02293993|64519977|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
23213420|NCT02293993|64519974|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
23213421|NCT02293993|64519975|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
23213422|NCT02293993|64519976|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
23213423|NCT02293993|64519977|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
23213424|NCT02293993|64519974|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
23213425|NCT02293993|64519975|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
23213426|NCT02293993|64519976|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
23213427|NCT02293993|64519977|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
23213428|NCT04929613|64519980|FG000|Overall Study|Withdrawal by Subject|12|||
23213429|NCT01354431|64519988|FG000|Pre-Treatment Period|Not reported|1|||
23426985|NCT00642369|65307501|FG000|Overall Study|Withdrawal by Subject|1|||
23426986|NCT00642369|65307502|FG001|Overall Study|Withdrawal by Subject|0|||
23546563|NCT01075074|65731147|FG002|Overall Study|Surgeon changed to open incisional case|2|||
23546564|NCT05132699|65731151|FG000|Overall Study|Withdrawal by Subject|3|||
23546565|NCT05132699|65731152|FG001|Overall Study|Withdrawal by Subject|0|||
23546566|NCT01131312|65731156|FG000|Overall Study|Lost to Follow-up|425|||
23546567|NCT01131312|65731157|FG001|Overall Study|Lost to Follow-up|229|||
23546568|NCT01131312|65731158|FG002|Overall Study|Lost to Follow-up|351|||
23546569|NCT03069482|65731159|FG000|Overall Study|Lost to Follow-up|0|||
23546570|NCT03069482|65731160|FG001|Overall Study|Lost to Follow-up|1|||
23546571|NCT03069482|65731159|FG000|Overall Study|Physician Decision|1|||
23131240|NCT00846807|64226660|FG000|Overall Study|Switch to other anticoagulants|89|||
23131241|NCT00846807|64226660|FG000|Overall Study|No prescription after hospital discharge|56|||
23131242|NCT00846807|64226660|FG000|Overall Study|Other|60|||
23131243|NCT01923467|64226661|FG000|Overall Study|Lost to Follow-up|62|||
23131244|NCT01923467|64226661|FG000|Overall Study|Subject non-interest|479|||
23131245|NCT02206061|64226662|FG000|Overall Study|Withdrawal by Subject|4|||
23131246|NCT02206061|64226663|FG001|Overall Study|Withdrawal by Subject|7|||
23131247|NCT02206061|64226664|FG002|Overall Study|Withdrawal by Subject|1|||
23131248|NCT02206061|64226662|FG000|Overall Study|Lost to Follow-up|14|||
23131249|NCT02206061|64226663|FG001|Overall Study|Lost to Follow-up|7|||
23131250|NCT02206061|64226664|FG002|Overall Study|Lost to Follow-up|20|||
23131251|NCT02797522|64226665|FG000|Overall Study|Study Terminated by Sponsor|0|||
23131252|NCT02797522|64226666|FG001|Overall Study|Study Terminated by Sponsor|0|||
23131253|NCT02797522|64226667|FG002|Overall Study|Study Terminated by Sponsor|0|||
23131254|NCT02797522|64226668|FG003|Overall Study|Study Terminated by Sponsor|0|||
23131255|NCT02797522|64226669|FG004|Overall Study|Study Terminated by Sponsor|0|||
23131256|NCT02797522|64226670|FG005|Overall Study|Study Terminated by Sponsor|0|||
23131257|NCT02797522|64226671|FG006|Overall Study|Study Terminated by Sponsor|0|||
23131258|NCT02797522|64226672|FG007|Overall Study|Study Terminated by Sponsor|4|||
23131259|NCT02797522|64226673|FG008|Overall Study|Study Terminated by Sponsor|2|||
23131260|NCT02797522|64226674|FG009|Overall Study|Study Terminated by Sponsor|4|||
23131261|NCT02797522|64226675|FG010|Overall Study|Study Terminated by Sponsor|1|||
23131262|NCT01110408|64226680|FG000|Overall Study|Protocol Violation|1|||
23546572|NCT03069482|65731160|FG001|Overall Study|Physician Decision|0|||
23546573|NCT04717596|65731164|FG000|Overall Study|Withdrawal by Subject|4|||
23546574|NCT04323436|65731165|FG000|Overall Study|Adverse Event|7|||
23546575|NCT04323436|65731166|FG001|Overall Study|Adverse Event|0|||
23546576|NCT04323436|65731167|FG002|Overall Study|Adverse Event|0|||
23546577|NCT04323436|65731165|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
23546578|NCT04323436|65731166|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
23546579|NCT04323436|65731167|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
23546580|NCT04323436|65731165|FG000|Overall Study|Death|1|||
23546581|NCT04323436|65731166|FG001|Overall Study|Death|0|||
23546582|NCT04323436|65731167|FG002|Overall Study|Death|0|||
23546583|NCT04323436|65731165|FG000|Overall Study|Physician Decision|2|||
23546584|NCT04323436|65731166|FG001|Overall Study|Physician Decision|0|||
23546585|NCT04323436|65731167|FG002|Overall Study|Physician Decision|0|||
23546586|NCT04323436|65731165|FG000|Overall Study|Progressive disease|10|||
23546587|NCT04323436|65731166|FG001|Overall Study|Progressive disease|0|||
23546588|NCT04323436|65731167|FG002|Overall Study|Progressive disease|0|||
23546589|NCT04323436|65731165|FG000|Overall Study|Subject decision|3|||
23546590|NCT04323436|65731166|FG001|Overall Study|Subject decision|0|||
23546591|NCT04323436|65731167|FG002|Overall Study|Subject decision|0|||
23546592|NCT00144339|65731172|FG000|Overall Study|Adverse Event|746|||
23546593|NCT00144339|65731173|FG001|Overall Study|Adverse Event|627|||
23546594|NCT00144339|65731172|FG000|Overall Study|Protocol Violation|75|||
23131263|NCT01110408|64226681|FG001|Overall Study|Protocol Violation|0|||
23546595|NCT00144339|65731173|FG001|Overall Study|Protocol Violation|48|||
23131264|NCT01430468|64226682|FG000|Overall Study|Physician Decision|2|||
23131265|NCT01430468|64226683|FG001|Overall Study|Physician Decision|1|||
23131266|NCT01430468|64226682|FG000|Overall Study|Withdrawal by Subject|5|||
23131267|NCT01430468|64226683|FG001|Overall Study|Withdrawal by Subject|5|||
23131268|NCT03167151|64226684|FG000|Overall Study|Withdrawal by Subject|1|||
23131269|NCT03167151|64226685|FG001|Overall Study|Withdrawal by Subject|0|||
23131270|NCT03167151|64226686|FG002|Overall Study|Withdrawal by Subject|0|||
23131271|NCT03167151|64226684|FG000|Overall Study|No evidence of tumour at surgery|0|||
23131272|NCT03167151|64226685|FG001|Overall Study|No evidence of tumour at surgery|1|||
23131273|NCT03167151|64226686|FG002|Overall Study|No evidence of tumour at surgery|1|||
23131274|NCT01125514|64229559|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
23131275|NCT01125514|64229559|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
23131276|NCT01125514|64229559|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
23131277|NCT01125514|64229559|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
23131278|NCT01125514|64229559|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
23131279|NCT01125514|64229559|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
23131280|NCT02389452|64229560|FG000|Overall Study|Lost to Follow-up|13|||
23131281|NCT02389452|64229560|FG000|Overall Study|Adverse Event|1|||
23131282|NCT02389452|64229560|FG000|Overall Study|Withdrawal by Subject|5|||
23131283|NCT02389452|64229560|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
23131284|NCT02755818|64229561|FG000|Overall Study|Withdrawal by Subject|0|||
23131285|NCT02755818|64229562|FG001|Overall Study|Withdrawal by Subject|0|||
23131286|NCT02755818|64229563|FG002|Overall Study|Withdrawal by Subject|0|||
23131287|NCT02755818|64229564|FG003|Overall Study|Withdrawal by Subject|2|||
23131288|NCT02755818|64229561|FG000|Overall Study|withdrawal by PI|0|||
23131289|NCT02755818|64229562|FG001|Overall Study|withdrawal by PI|0|||
23131290|NCT02755818|64229563|FG002|Overall Study|withdrawal by PI|1|||
23131291|NCT02755818|64229564|FG003|Overall Study|withdrawal by PI|1|||
23131292|NCT00299494|64229565|FG000|Overall Study|Withdrawal by Subject|0|||
23131293|NCT00299494|64229566|FG001|Overall Study|Withdrawal by Subject|0|||
23131294|NCT00299494|64229567|FG002|Overall Study|Withdrawal by Subject|0|||
23131295|NCT00299494|64229568|FG003|Overall Study|Withdrawal by Subject|3|||
23213430|NCT01354431|64519989|FG001|Pre-Treatment Period|Not reported|0|||
23619087|NCT02600897|65991451|FG001|Overall Study|Withdrawal by Subject|0|||
23619088|NCT02600897|65991452|FG002|Overall Study|Withdrawal by Subject|0|||
23619089|NCT02600897|65991453|FG003|Overall Study|Withdrawal by Subject|0|||
23131296|NCT00299494|64229569|FG004|Overall Study|Withdrawal by Subject|1|||
23131297|NCT00299494|64229570|FG005|Overall Study|Withdrawal by Subject|4|||
23131298|NCT00299494|64229565|FG000|Overall Study|Physician Decision|0|||
23131299|NCT00299494|64229566|FG001|Overall Study|Physician Decision|0|||
23131300|NCT00299494|64229567|FG002|Overall Study|Physician Decision|0|||
23131301|NCT00299494|64229568|FG003|Overall Study|Physician Decision|0|||
23131302|NCT00299494|64229569|FG004|Overall Study|Physician Decision|1|||
23131303|NCT00299494|64229570|FG005|Overall Study|Physician Decision|0|||
23131304|NCT00299494|64229565|FG000|Overall Study|Death|3|||
23131305|NCT00299494|64229566|FG001|Overall Study|Death|1|||
23131306|NCT00299494|64229567|FG002|Overall Study|Death|4|||
23131307|NCT00299494|64229568|FG003|Overall Study|Death|6|||
23131308|NCT00299494|64229569|FG004|Overall Study|Death|18|||
23131309|NCT00299494|64229570|FG005|Overall Study|Death|19|||
23131310|NCT00299494|64229565|FG000|Overall Study|Lost to Follow-up|0|||
23131311|NCT00299494|64229566|FG001|Overall Study|Lost to Follow-up|0|||
23131312|NCT00299494|64229567|FG002|Overall Study|Lost to Follow-up|0|||
23131313|NCT00299494|64229568|FG003|Overall Study|Lost to Follow-up|0|||
23131314|NCT00299494|64229569|FG004|Overall Study|Lost to Follow-up|3|||
23131315|NCT00299494|64229570|FG005|Overall Study|Lost to Follow-up|1|||
23131316|NCT00299494|64229565|FG000|Overall Study|Other - Unspecified|0|||
23131317|NCT00299494|64229566|FG001|Overall Study|Other - Unspecified|0|||
23131318|NCT00299494|64229567|FG002|Overall Study|Other - Unspecified|0|||
23131319|NCT00299494|64229568|FG003|Overall Study|Other - Unspecified|0|||
23131320|NCT00299494|64229569|FG004|Overall Study|Other - Unspecified|3|||
23131321|NCT00299494|64229570|FG005|Overall Study|Other - Unspecified|1|||
23131322|NCT00299494|64229565|FG000|Overall Study|Other - site closure|0|||
23131323|NCT00299494|64229566|FG001|Overall Study|Other - site closure|0|||
23131324|NCT00299494|64229567|FG002|Overall Study|Other - site closure|0|||
23131325|NCT00299494|64229568|FG003|Overall Study|Other - site closure|1|||
23131326|NCT00299494|64229569|FG004|Overall Study|Other - site closure|1|||
23131327|NCT00299494|64229570|FG005|Overall Study|Other - site closure|1|||
23131328|NCT01598662|64229571|FG000|Overall Study|Lost to Follow-up|10|||
23131329|NCT01598662|64229572|FG001|Overall Study|Lost to Follow-up|17|||
23131330|NCT01598662|64229571|FG000|Overall Study|Physician Decision|1|||
23131331|NCT01598662|64229572|FG001|Overall Study|Physician Decision|2|||
23131332|NCT01598662|64229571|FG000|Overall Study|IUD expelled before month 6|0|||
23131333|NCT01598662|64229572|FG001|Overall Study|IUD expelled before month 6|2|||
23131334|NCT00573859|64229573|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
23131335|NCT00573859|64229573|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
23131336|NCT00667225|64229576|FG000|Overall Study|Subject had no more lesions to treat.|1|||
23131337|NCT00667225|64229577|FG001|Overall Study|Subject had no more lesions to treat.|0|||
23317271|NCT00863772|64904037|FG002|Overall Study|Study terminated by sponsor|36|||
23619090|NCT02600897|65991454|FG004|Overall Study|Withdrawal by Subject|0|||
23619091|NCT02600897|65991455|FG005|Overall Study|Withdrawal by Subject|0|||
23619092|NCT02600897|65991456|FG006|Overall Study|Withdrawal by Subject|0|||
23619093|NCT02600897|65991457|FG007|Overall Study|Withdrawal by Subject|4|||
23619094|NCT02600897|65991458|FG008|Overall Study|Withdrawal by Subject|2|||
23619095|NCT02600897|65991450|FG000|Overall Study|Reason Not Specified|0|||
23619096|NCT02600897|65991451|FG001|Overall Study|Reason Not Specified|0|||
23619097|NCT02600897|65991452|FG002|Overall Study|Reason Not Specified|0|||
23619098|NCT02600897|65991453|FG003|Overall Study|Reason Not Specified|0|||
23619099|NCT02600897|65991454|FG004|Overall Study|Reason Not Specified|0|||
23619100|NCT02600897|65991455|FG005|Overall Study|Reason Not Specified|0|||
23619101|NCT02600897|65991456|FG006|Overall Study|Reason Not Specified|0|||
23131338|NCT00667225|64229576|FG000|Overall Study|Lost to Follow-up|0|||
23131339|NCT00667225|64229577|FG001|Overall Study|Lost to Follow-up|1|||
23131340|NCT03651622|64229578|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
23131341|NCT03651622|64229579|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
23131342|NCT03651622|64229580|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
23131343|NCT03651622|64229578|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
23317272|NCT00863772|64904035|FG000|Overall Study|Entered extension study|6|||
23131344|NCT03651622|64229579|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
23131345|NCT03651622|64229580|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
23619102|NCT02600897|65991457|FG007|Overall Study|Reason Not Specified|0|||
23619103|NCT02600897|65991458|FG008|Overall Study|Reason Not Specified|1|||
23619104|NCT00678899|65991459|FG000|Overall Study|Adverse Event|1|||
23131346|NCT03651622|64229578|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
23131347|NCT03651622|64229579|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
23131348|NCT03651622|64229580|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
23131349|NCT03651622|64229578|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
23131350|NCT03651622|64229579|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
23131351|NCT03651622|64229580|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
23131352|NCT03651622|64229578|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
23131353|NCT03651622|64229579|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
23131354|NCT03651622|64229580|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
23131355|NCT01022112|64229581|FG000|Overall Study|Adverse Event|1|||
23131356|NCT01022112|64229582|FG001|Overall Study|Adverse Event|2|||
23131357|NCT01022112|64229583|FG002|Overall Study|Adverse Event|0|||
23131358|NCT01022112|64229584|FG003|Overall Study|Adverse Event|1|||
23131359|NCT01022112|64229585|FG004|Overall Study|Adverse Event|0|||
23131360|NCT01022112|64229581|FG000|Overall Study|Lack of Efficacy|1|||
23131361|NCT01022112|64229582|FG001|Overall Study|Lack of Efficacy|0|||
23131362|NCT01022112|64229583|FG002|Overall Study|Lack of Efficacy|0|||
23131363|NCT01022112|64229584|FG003|Overall Study|Lack of Efficacy|0|||
23131364|NCT01022112|64229585|FG004|Overall Study|Lack of Efficacy|1|||
23131365|NCT01022112|64229581|FG000|Overall Study|Physician Decision|0|||
23131366|NCT01022112|64229582|FG001|Overall Study|Physician Decision|0|||
23131367|NCT01022112|64229583|FG002|Overall Study|Physician Decision|1|||
23131368|NCT01022112|64229584|FG003|Overall Study|Physician Decision|0|||
23131369|NCT01022112|64229585|FG004|Overall Study|Physician Decision|1|||
23131370|NCT01022112|64229581|FG000|Overall Study|Withdrawal by Subject|0|||
23131371|NCT01022112|64229582|FG001|Overall Study|Withdrawal by Subject|1|||
23131372|NCT01022112|64229583|FG002|Overall Study|Withdrawal by Subject|2|||
23131373|NCT01022112|64229584|FG003|Overall Study|Withdrawal by Subject|2|||
23131374|NCT01022112|64229585|FG004|Overall Study|Withdrawal by Subject|1|||
23131375|NCT01022112|64229581|FG000|Overall Study|Fasting plasma glucose level increased|1|||
23131376|NCT01022112|64229582|FG001|Overall Study|Fasting plasma glucose level increased|0|||
23131377|NCT01022112|64229583|FG002|Overall Study|Fasting plasma glucose level increased|0|||
23131378|NCT01022112|64229584|FG003|Overall Study|Fasting plasma glucose level increased|0|||
23131379|NCT01022112|64229585|FG004|Overall Study|Fasting plasma glucose level increased|7|||
23131380|NCT01370590|64229586|FG000|Period 1|Adverse Event|8|||
23131381|NCT01370590|64229587|FG001|Period 1|Adverse Event|4|||
23131382|NCT01370590|64229586|FG000|Period 1|Lost to Follow-up|2|||
23131383|NCT01370590|64229587|FG001|Period 1|Lost to Follow-up|2|||
23131384|NCT01370590|64229586|FG000|Period 1|Protocol Violation|2|||
23131385|NCT01370590|64229587|FG001|Period 1|Protocol Violation|2|||
23131386|NCT01370590|64229586|FG000|Period 1|Withdrawal by Subject|4|||
23131387|NCT01370590|64229587|FG001|Period 1|Withdrawal by Subject|2|||
23131388|NCT01370590|64229586|FG000|Period 1|Could not access randomization system|0|||
23131389|NCT01370590|64229587|FG001|Period 1|Could not access randomization system|1|||
23131390|NCT01370590|64229586|FG000|Crossover Washout Period|Adverse Event|1|||
23131391|NCT01370590|64229587|FG001|Crossover Washout Period|Adverse Event|4|||
23131392|NCT01370590|64229586|FG000|Crossover Washout Period|Lost to Follow-up|2|||
23131393|NCT01370590|64229587|FG001|Crossover Washout Period|Lost to Follow-up|0|||
23131394|NCT01370590|64229586|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
23131395|NCT01370590|64229587|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
23131396|NCT01370590|64229586|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
23131397|NCT01370590|64229587|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
23131398|NCT01370590|64229586|FG000|Period 2|Adverse Event|0|||
23131399|NCT01370590|64229587|FG001|Period 2|Adverse Event|1|||
23131400|NCT01370590|64229586|FG000|Period 2|Withdrawal by Subject|1|||
23131401|NCT01370590|64229587|FG001|Period 2|Withdrawal by Subject|1|||
23131402|NCT04230122|64229588|FG000|Overall Study|Lost to Follow-up|1|||
23131403|NCT04230122|64229589|FG001|Overall Study|Lost to Follow-up|0|||
23131404|NCT04531904|64229590|FG000|Overall Study|Lost to Follow-up|1|||
23131405|NCT04531904|64229590|FG000|Overall Study|Death|14|||
23546596|NCT00144339|65731172|FG000|Overall Study|Withdrawal by Subject|403|||
23546597|NCT00144339|65731173|FG001|Overall Study|Withdrawal by Subject|300|||
23546598|NCT00144339|65731172|FG000|Overall Study|Lost to Follow-up|76|||
23546599|NCT00144339|65731173|FG001|Overall Study|Lost to Follow-up|64|||
23546600|NCT00144339|65731172|FG000|Overall Study|Other|58|||
23546601|NCT00144339|65731173|FG001|Overall Study|Other|60|||
23546602|NCT01910129|65731174|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
23546603|NCT01910129|65731175|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
23546604|NCT01910129|65731176|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
23131406|NCT02815579|64229592|FG000|Overall Study|Non-payment of loan down-payment|16|||
23131407|NCT02815579|64229593|FG001|Overall Study|Non-payment of loan down-payment|0|||
23131408|NCT02815579|64229592|FG000|Overall Study|Withdrawal by Subject|7|||
23131409|NCT02815579|64229593|FG001|Overall Study|Withdrawal by Subject|1|||
23131410|NCT02815579|64229592|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
23131411|NCT02815579|64229593|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
23131412|NCT02815579|64229592|FG000|Overall Study|Lost to Follow-up|7|||
23131413|NCT02815579|64229593|FG001|Overall Study|Lost to Follow-up|4|||
23131414|NCT02815579|64229592|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
23131415|NCT02815579|64229593|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
23131416|NCT02815579|64229592|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
23131417|NCT02815579|64229593|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
23131418|NCT02815579|64229592|FG000|Overall Study|Death|5|||
23546605|NCT01910129|65731174|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
23546606|NCT01910129|65731175|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
23546607|NCT01910129|65731176|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
23546608|NCT02601313|65731177|FG000|Overall Study|Death|2|||
23546609|NCT02601313|65731178|FG001|Overall Study|Death|16|||
23546610|NCT02601313|65731179|FG002|Overall Study|Death|4|||
23546611|NCT02601313|65731177|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
23546612|NCT02601313|65731178|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
23546613|NCT02601313|65731179|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
23546614|NCT02601313|65731177|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
23546615|NCT02601313|65731178|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
23546616|NCT02601313|65731179|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
23546617|NCT02601313|65731177|FG000|Overall Study|Still on study|0|||
23546618|NCT02601313|65731178|FG001|Overall Study|Still on study|52|||
23546619|NCT02601313|65731179|FG002|Overall Study|Still on study|10|||
23546620|NCT02601313|65731177|FG000|Overall Study|Enrolled, did not initiate AC|4|||
23546621|NCT02601313|65731178|FG001|Overall Study|Enrolled, did not initiate AC|0|||
23546622|NCT02601313|65731179|FG002|Overall Study|Enrolled, did not initiate AC|0|||
23546623|NCT03043664|65731180|FG000|Overall Study|Lost to Follow-up|1|||
23619105|NCT03280108|65991460|FG000|Overall Study|Lost to Follow-up|2|||
23619106|NCT03280108|65991461|FG001|Overall Study|Lost to Follow-up|0|||
23619107|NCT02621047|65991462|FG000|Overall Study|Adverse Event|0|||
23619108|NCT02621047|65991463|FG001|Overall Study|Adverse Event|0|||
23619109|NCT02621047|65991464|FG002|Overall Study|Adverse Event|1|||
23619110|NCT00922441|65991465|FG000|Overall Study|Protocol Violation|0|||
23619111|NCT00922441|65991466|FG001|Overall Study|Protocol Violation|0|||
23619112|NCT00922441|65991467|FG002|Overall Study|Protocol Violation|2|||
23619113|NCT00922441|65991465|FG000|Overall Study|Withdrawal by Subject|0|||
23619114|NCT00922441|65991466|FG001|Overall Study|Withdrawal by Subject|0|||
23619115|NCT00922441|65991467|FG002|Overall Study|Withdrawal by Subject|1|||
23619116|NCT01494298|65991468|FG000|Overall Study|Protocol Violation|2|||
23131419|NCT02815579|64229593|FG001|Overall Study|Death|4|||
23131420|NCT02815579|64229592|FG000|Overall Study|Imprisoned|0|||
23131421|NCT02815579|64229593|FG001|Overall Study|Imprisoned|2|||
23131422|NCT02815579|64229592|FG000|Overall Study|Did not meet enrollment criteria|0|||
23131423|NCT02815579|64229593|FG001|Overall Study|Did not meet enrollment criteria|1|||
23131424|NCT01072630|64229594|FG000|Overall Study|Adverse Event|11|||
23131425|NCT01072630|64229595|FG001|Overall Study|Adverse Event|19|||
23131426|NCT01072630|64229596|FG002|Overall Study|Adverse Event|2|||
23131427|NCT01072630|64229594|FG000|Overall Study|Lack of Efficacy|10|||
23131428|NCT01072630|64229595|FG001|Overall Study|Lack of Efficacy|10|||
23131429|NCT01072630|64229596|FG002|Overall Study|Lack of Efficacy|1|||
23131430|NCT01072630|64229594|FG000|Overall Study|Withdrawal by Subject|8|||
23131431|NCT01072630|64229595|FG001|Overall Study|Withdrawal by Subject|7|||
23131432|NCT01072630|64229596|FG002|Overall Study|Withdrawal by Subject|2|||
23131433|NCT01072630|64229594|FG000|Overall Study|Protocol Violation|10|||
23131434|NCT01072630|64229595|FG001|Overall Study|Protocol Violation|8|||
23131435|NCT01072630|64229596|FG002|Overall Study|Protocol Violation|4|||
23131436|NCT01072630|64229594|FG000|Overall Study|Lost to Follow-up|11|||
23619117|NCT01494298|65991469|FG001|Overall Study|Protocol Violation|8|||
23619118|NCT00550771|65991472|FG000|Overall Study|Adverse Event|11|||
23619119|NCT00550771|65991473|FG001|Overall Study|Adverse Event|3|||
23619120|NCT00550771|65991472|FG000|Overall Study|Discontinued for study-related reasons|0|||
23619121|NCT00550771|65991473|FG001|Overall Study|Discontinued for study-related reasons|1|||
23619122|NCT00550771|65991472|FG000|Overall Study|Physician Decision|2|||
23619123|NCT00550771|65991473|FG001|Overall Study|Physician Decision|0|||
23619124|NCT00550771|65991472|FG000|Overall Study|Withdrawal by Subject|0|||
23619125|NCT00550771|65991473|FG001|Overall Study|Withdrawal by Subject|1|||
23619126|NCT00550771|65991472|FG000|Overall Study|Protocol Violation|4|||
23131437|NCT01072630|64229595|FG001|Overall Study|Lost to Follow-up|11|||
23546624|NCT03690869|65731184|FG000|Overall Study|Adverse Event|0|||
23546625|NCT03690869|65731185|FG001|Overall Study|Adverse Event|0|||
23546626|NCT03690869|65731186|FG002|Overall Study|Adverse Event|0|||
23546627|NCT03690869|65731187|FG003|Overall Study|Adverse Event|1|||
23131438|NCT01072630|64229596|FG002|Overall Study|Lost to Follow-up|1|||
23546628|NCT03690869|65731188|FG004|Overall Study|Adverse Event|0|||
23546629|NCT03690869|65731189|FG005|Overall Study|Adverse Event|0|||
23619127|NCT00550771|65991473|FG001|Overall Study|Protocol Violation|5|||
23619128|NCT03022045|65991482|FG000|Overall Study|Adverse Event|0|||
23619129|NCT03022045|65991483|FG001|Overall Study|Adverse Event|1|||
23131439|NCT01072630|64229594|FG000|Overall Study|Noncompliance with study medication|1|||
23131440|NCT01072630|64229595|FG001|Overall Study|Noncompliance with study medication|1|||
23131441|NCT01072630|64229596|FG002|Overall Study|Noncompliance with study medication|1|||
23213431|NCT01354431|64519990|FG002|Pre-Treatment Period|Not reported|0|||
23546630|NCT03690869|65731190|FG006|Overall Study|Adverse Event|0|||
23546631|NCT03690869|65731191|FG007|Overall Study|Adverse Event|1|||
23619130|NCT03022045|65991482|FG000|Overall Study|Withdrawal by Subject|1|||
23213432|NCT01354431|64519988|FG000|Treatment Period|Disease Progression|50|||
23213433|NCT01354431|64519989|FG001|Treatment Period|Disease Progression|40|||
23213434|NCT01354431|64519990|FG002|Treatment Period|Disease Progression|44|||
23213435|NCT01354431|64519988|FG000|Treatment Period|Study Drug Toxicity|5|||
23213436|NCT01354431|64519989|FG001|Treatment Period|Study Drug Toxicity|8|||
23213437|NCT01354431|64519990|FG002|Treatment Period|Study Drug Toxicity|4|||
23213438|NCT01354431|64519988|FG000|Treatment Period|Death|0|||
23213439|NCT01354431|64519989|FG001|Treatment Period|Death|1|||
23213440|NCT01354431|64519990|FG002|Treatment Period|Death|0|||
23213441|NCT01354431|64519988|FG000|Treatment Period|AE unrelated to study drug|1|||
23213442|NCT01354431|64519989|FG001|Treatment Period|AE unrelated to study drug|2|||
23213443|NCT01354431|64519990|FG002|Treatment Period|AE unrelated to study drug|5|||
23213444|NCT01354431|64519988|FG000|Treatment Period|Participant request to discontinue|2|||
23213445|NCT01354431|64519989|FG001|Treatment Period|Participant request to discontinue|2|||
23213446|NCT01354431|64519990|FG002|Treatment Period|Participant request to discontinue|1|||
23213447|NCT01354431|64519988|FG000|Treatment Period|Participant withdrew consent|0|||
23213448|NCT01354431|64519989|FG001|Treatment Period|Participant withdrew consent|1|||
23213449|NCT01354431|64519990|FG002|Treatment Period|Participant withdrew consent|0|||
23213450|NCT01354431|64519988|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
23213451|NCT01354431|64519989|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
23213452|NCT01354431|64519990|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
23213453|NCT01293006|64519992|FG000|Period 2|Lost to Follow-up|1|||
23213454|NCT01293006|64519993|FG001|Period 2|Lost to Follow-up|0|||
23213455|NCT01293006|64519994|FG002|Period 2|Lost to Follow-up|0|||
23213456|NCT01293006|64519995|FG003|Period 2|Lost to Follow-up|0|||
23213457|NCT02378883|64519996|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
23426987|NCT00642369|65307501|FG000|Overall Study|misdiagnosis|0|||
23426988|NCT00642369|65307502|FG001|Overall Study|misdiagnosis|1|||
23213458|NCT02378883|64519996|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
23213459|NCT02378883|64519996|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
23213460|NCT02378883|64519996|FG000|30 Day Follow-Up|Physician Decision|2|||
23213461|NCT02378883|64519996|FG000|30 Day Follow-Up|Missed Visit|2|||
23213462|NCT02378883|64519996|FG000|30 Day Follow-Up|Death|1|||
23213463|NCT02378883|64519996|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
23213464|NCT02378883|64519996|FG000|12 Months Follow-Up|Death|2|||
23213465|NCT01548417|64519997|FG000|Overall Study|Withdrawal by Subject|0|||
23213466|NCT01548417|64519998|FG001|Overall Study|Withdrawal by Subject|2|||
23213467|NCT01595438|64519999|FG000|Overall Study|Lost to Follow-up|20|||
23213468|NCT01595438|64520000|FG001|Overall Study|Lost to Follow-up|20|||
23213469|NCT01595438|64519999|FG000|Overall Study|Withdrawal by Subject|12|||
23213470|NCT01595438|64520000|FG001|Overall Study|Withdrawal by Subject|12|||
23213471|NCT01595438|64519999|FG000|Overall Study|Other Eligibility criteria|11|||
23213472|NCT01595438|64520000|FG001|Overall Study|Other Eligibility criteria|9|||
23213473|NCT00270998|64523305|FG000|3 Month Follow-up|Adverse Event|1|||
23213474|NCT00270998|64523306|FG001|3 Month Follow-up|Adverse Event|0|||
23213475|NCT00270998|64523307|FG002|3 Month Follow-up|Adverse Event|0|||
23426989|NCT00642369|65307501|FG000|Overall Study|Lack of Efficacy|2|||
23426990|NCT00642369|65307502|FG001|Overall Study|Lack of Efficacy|2|||
23426991|NCT03405935|65307503|FG000|Overall Study|Adverse Event|3|||
23426992|NCT03405935|65307503|FG000|Overall Study|Death|2|||
23426993|NCT03405935|65307503|FG000|Overall Study|Withdrawal by Subject|1|||
23426994|NCT03405935|65307503|FG000|Overall Study|Lost to Follow-up|2|||
23426995|NCT01479595|65307504|FG000|Overall Study|Protocol deviation|0|||
23426996|NCT01479595|65307505|FG001|Overall Study|Protocol deviation|1|||
23426997|NCT01479595|65307504|FG000|Overall Study|Adverse Event|2|||
23426998|NCT01479595|65307505|FG001|Overall Study|Adverse Event|1|||
23426999|NCT00933244|65307506|FG000|Overall Study|Withdrawal by Subject|5|||
23427000|NCT00933244|65307507|FG001|Overall Study|Withdrawal by Subject|1|||
23427001|NCT00933244|65307508|FG002|Overall Study|Withdrawal by Subject|3|||
23427002|NCT02317809|65307510|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
23427003|NCT02317809|65307511|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
23427004|NCT02317809|65307510|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
23427005|NCT02317809|65307511|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
23427006|NCT03344640|65307512|FG000|Overall Study|Adverse Event|1|||
23213476|NCT00270998|64523305|FG000|3 Month Follow-up|Lack of Efficacy|1|||
23213477|NCT00270998|64523306|FG001|3 Month Follow-up|Lack of Efficacy|2|||
23213478|NCT00270998|64523307|FG002|3 Month Follow-up|Lack of Efficacy|1|||
23213479|NCT00270998|64523305|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
23427007|NCT03344640|65307513|FG001|Overall Study|Adverse Event|0|||
23427008|NCT03344640|65307512|FG000|Overall Study|Physician Decision|1|||
23546632|NCT03690869|65731192|FG008|Overall Study|Adverse Event|0|||
23213480|NCT00270998|64523306|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
23213481|NCT00270998|64523307|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
23213482|NCT00270998|64523305|FG000|3 Month Follow-up|Pessary did not fit|12|||
23213483|NCT00270998|64523306|FG001|3 Month Follow-up|Pessary did not fit|0|||
23427009|NCT03344640|65307513|FG001|Overall Study|Physician Decision|1|||
23427010|NCT03344640|65307512|FG000|Overall Study|Withdrawal by Subject|1|||
23427011|NCT03344640|65307513|FG001|Overall Study|Withdrawal by Subject|2|||
23427012|NCT03344640|65307512|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
23427013|NCT03344640|65307513|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
23427014|NCT00520013|65307515|FG000|Overall Study|Withdrawal by Subject|0|||
23427015|NCT00520013|65307516|FG001|Overall Study|Withdrawal by Subject|0|||
23427016|NCT00520013|65307517|FG002|Overall Study|Withdrawal by Subject|1|||
23427017|NCT00520013|65307515|FG000|Overall Study|Adverse Event|2|||
23427018|NCT00520013|65307516|FG001|Overall Study|Adverse Event|10|||
23427019|NCT00520013|65307517|FG002|Overall Study|Adverse Event|7|||
23427020|NCT00520013|65307515|FG000|Overall Study|Progressive Disease|7|||
23427021|NCT00520013|65307516|FG001|Overall Study|Progressive Disease|3|||
23427022|NCT00520013|65307517|FG002|Overall Study|Progressive Disease|0|||
23427023|NCT00520013|65307515|FG000|Overall Study|Clinical Progression|3|||
23427024|NCT00520013|65307516|FG001|Overall Study|Clinical Progression|1|||
23427025|NCT00520013|65307517|FG002|Overall Study|Clinical Progression|0|||
23427026|NCT00520013|65307515|FG000|Overall Study|Death|0|||
23427027|NCT00520013|65307516|FG001|Overall Study|Death|1|||
23427028|NCT00520013|65307517|FG002|Overall Study|Death|0|||
23427029|NCT00520013|65307515|FG000|Overall Study|Physician Decision|0|||
23427030|NCT00520013|65307516|FG001|Overall Study|Physician Decision|0|||
23427031|NCT00520013|65307517|FG002|Overall Study|Physician Decision|3|||
23427032|NCT01009346|65307518|FG000|Overall Study|Adverse Event|4|||
23427033|NCT01591863|65307519|FG000|Overall Study|Adverse Event|3|||
23427034|NCT01591863|65307519|FG000|Overall Study|Withdrawal by Subject|1|||
23427035|NCT01591863|65307519|FG000|Overall Study|recurrence|9|||
23427036|NCT01591863|65307519|FG000|Overall Study|Lack of Efficacy|1|||
23427037|NCT01561755|65307520|FG000|Overall Study|Lost to Follow-up|0|||
23427038|NCT01561755|65307521|FG001|Overall Study|Lost to Follow-up|1|||
23427039|NCT04676867|65307524|FG000|Overall Study|Screen failure|0|||
23427040|NCT04676867|65307525|FG001|Overall Study|Screen failure|0|||
23427041|NCT04676867|65307526|FG002|Overall Study|Screen failure|6|||
23427042|NCT04676867|65307527|FG003|Overall Study|Screen failure|2|||
23427043|NCT04676867|65307524|FG000|Overall Study|Death|0|||
23427044|NCT04676867|65307525|FG001|Overall Study|Death|0|||
23427045|NCT04676867|65307526|FG002|Overall Study|Death|1|||
23427046|NCT04676867|65307527|FG003|Overall Study|Death|0|||
23427047|NCT04676867|65307524|FG000|Overall Study|Withdrawal by Subject|2|||
23427048|NCT04676867|65307525|FG001|Overall Study|Withdrawal by Subject|2|||
23427049|NCT04676867|65307526|FG002|Overall Study|Withdrawal by Subject|4|||
23427050|NCT04676867|65307527|FG003|Overall Study|Withdrawal by Subject|4|||
23427051|NCT04676867|65307524|FG000|Overall Study|Lost to Follow-up|1|||
23427052|NCT04676867|65307525|FG001|Overall Study|Lost to Follow-up|0|||
23427053|NCT04676867|65307526|FG002|Overall Study|Lost to Follow-up|0|||
23427054|NCT04676867|65307527|FG003|Overall Study|Lost to Follow-up|0|||
23427055|NCT03684304|65307528|FG000|Overall Study|Lost to Follow-up|19|||
23213484|NCT00270998|64523307|FG002|3 Month Follow-up|Pessary did not fit|0|||
23213485|NCT00270998|64523305|FG000|3 Month Follow-up|Personal/family health|1|||
23213486|NCT00270998|64523306|FG001|3 Month Follow-up|Personal/family health|1|||
23213487|NCT00270998|64523307|FG002|3 Month Follow-up|Personal/family health|0|||
23213488|NCT00270998|64523305|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
23213489|NCT00270998|64523306|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
23213490|NCT00270998|64523307|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
23213491|NCT00270998|64523305|FG000|12 Month Follow-up|Lack of Efficacy|5|||
23427056|NCT03684304|65307529|FG001|Overall Study|Lost to Follow-up|17|||
23427057|NCT01822535|65307535|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
23427058|NCT01822535|65307536|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
23427059|NCT01822535|65307535|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
23427060|NCT01822535|65307536|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
23427061|NCT01822535|65307535|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
23427062|NCT01822535|65307536|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
23427063|NCT01300351|65307539|FG000|Overall Study|Did not receive treatment|2|||
23427064|NCT01300351|65307540|FG001|Overall Study|Did not receive treatment|0|||
23427065|NCT01300351|65307539|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
23427066|NCT01300351|65307540|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
23213492|NCT00270998|64523306|FG001|12 Month Follow-up|Lack of Efficacy|4|||
23427067|NCT01300351|65307539|FG000|Overall Study|Lost to Follow-up|0|||
23427068|NCT01300351|65307540|FG001|Overall Study|Lost to Follow-up|1|||
23213493|NCT00270998|64523307|FG002|12 Month Follow-up|Lack of Efficacy|3|||
23213494|NCT00270998|64523305|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
23213495|NCT00270998|64523306|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
23213496|NCT00270998|64523307|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
23427069|NCT01300351|65307539|FG000|Overall Study|Adverse Event|0|||
23427070|NCT01300351|65307540|FG001|Overall Study|Adverse Event|4|||
23427071|NCT01300351|65307539|FG000|Overall Study|Withdrawal by Subject|7|||
23427072|NCT01300351|65307540|FG001|Overall Study|Withdrawal by Subject|10|||
23427073|NCT03080883|65307541|FG000|Overall Study|Withdrawal by Subject|11|||
23427074|NCT03080883|65307542|FG001|Overall Study|Withdrawal by Subject|15|||
23427075|NCT03080883|65307541|FG000|Overall Study|Adverse Event|22|||
23427076|NCT03080883|65307542|FG001|Overall Study|Adverse Event|22|||
23427077|NCT03080883|65307541|FG000|Overall Study|Alternative Therapy|0|||
23427078|NCT03080883|65307542|FG001|Overall Study|Alternative Therapy|3|||
23427079|NCT03080883|65307541|FG000|Overall Study|Other Complicating Disease|9|||
23427080|NCT03080883|65307542|FG001|Overall Study|Other Complicating Disease|5|||
23427081|NCT03080883|65307541|FG000|Overall Study|Death|21|||
23427082|NCT03080883|65307542|FG001|Overall Study|Death|16|||
23427083|NCT03080883|65307541|FG000|Overall Study|Physician Decision|2|||
23427084|NCT03080883|65307542|FG001|Overall Study|Physician Decision|2|||
23427085|NCT03080883|65307541|FG000|Overall Study|Disease Progression|2|||
23427086|NCT03080883|65307542|FG001|Overall Study|Disease Progression|8|||
23427087|NCT03080883|65307541|FG000|Overall Study|Lost to Follow-up|1|||
23427088|NCT03080883|65307542|FG001|Overall Study|Lost to Follow-up|1|||
23427089|NCT01143896|65307547|FG000|Overall Study|Did not complete Baseline Interview|5|||
23427090|NCT01143896|65307548|FG001|Overall Study|Did not complete Baseline Interview|4|||
23427091|NCT01143896|65307547|FG000|Overall Study|Lost to Follow-up|18|||
23427092|NCT01143896|65307548|FG001|Overall Study|Lost to Follow-up|13|||
23427093|NCT01143896|65307547|FG000|Overall Study|Withdrawal by Subject|13|||
23427094|NCT01143896|65307548|FG001|Overall Study|Withdrawal by Subject|5|||
23427095|NCT01143896|65307547|FG000|Overall Study|Death|6|||
23427096|NCT01143896|65307548|FG001|Overall Study|Death|3|||
23427097|NCT03323736|65307549|FG000|Overall Study|Screen Failure|14|||
23427098|NCT03323736|65307550|FG001|Overall Study|Screen Failure|9|||
23427099|NCT03323736|65307551|FG002|Overall Study|Screen Failure|1|||
23427100|NCT03323736|65307549|FG000|Overall Study|Withdrawal Before Treatment|3|||
23427101|NCT03323736|65307550|FG001|Overall Study|Withdrawal Before Treatment|1|||
23427102|NCT03323736|65307551|FG002|Overall Study|Withdrawal Before Treatment|1|||
23427103|NCT03323736|65307549|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
23427104|NCT03323736|65307550|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
23427105|NCT03323736|65307551|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
23427106|NCT04962230|65307552|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
23427107|NCT04962230|65307552|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
23427108|NCT00509093|65307553|FG000|Overall Study|Adverse Event|10|||
23427109|NCT00509093|65307553|FG000|Overall Study|Disease Progression|9|||
23427110|NCT00509093|65307553|FG000|Overall Study|Transformed into MDS|1|||
23427111|NCT00509093|65307553|FG000|Overall Study|Withdrawal by Subject|3|||
23427112|NCT00509093|65307553|FG000|Overall Study|Physician Decision|1|||
23427113|NCT00868530|65307554|FG000|Overall Study|Adverse Event|3|||
23546633|NCT03690869|65731193|FG009|Overall Study|Adverse Event|1|||
23546634|NCT03690869|65731184|FG000|Overall Study|Death|1|||
23546635|NCT03690869|65731185|FG001|Overall Study|Death|1|||
23546636|NCT03690869|65731186|FG002|Overall Study|Death|1|||
23546637|NCT03690869|65731187|FG003|Overall Study|Death|4|||
23546638|NCT03690869|65731188|FG004|Overall Study|Death|2|||
23546639|NCT03690869|65731189|FG005|Overall Study|Death|5|||
23546640|NCT03690869|65731190|FG006|Overall Study|Death|3|||
23546641|NCT03690869|65731191|FG007|Overall Study|Death|2|||
23546642|NCT03690869|65731192|FG008|Overall Study|Death|0|||
23546643|NCT03690869|65731193|FG009|Overall Study|Death|3|||
23546644|NCT03690869|65731184|FG000|Overall Study|Lost to Follow-up|0|||
23546645|NCT03690869|65731185|FG001|Overall Study|Lost to Follow-up|0|||
23546646|NCT03690869|65731186|FG002|Overall Study|Lost to Follow-up|1|||
23546647|NCT03690869|65731187|FG003|Overall Study|Lost to Follow-up|0|||
23546648|NCT03690869|65731188|FG004|Overall Study|Lost to Follow-up|0|||
23546649|NCT03690869|65731189|FG005|Overall Study|Lost to Follow-up|0|||
23546650|NCT03690869|65731190|FG006|Overall Study|Lost to Follow-up|0|||
23131442|NCT01072630|64229594|FG000|Overall Study|Noncompliance with study procedures|1|||
23131443|NCT01072630|64229595|FG001|Overall Study|Noncompliance with study procedures|2|||
23427114|NCT00868530|65307554|FG000|Overall Study|Lost to Follow-up|1|||
23427115|NCT02847858|65307555|FG000|Overall Study|Lost to Follow-up|401|||
23427116|NCT02847858|65307556|FG001|Overall Study|Lost to Follow-up|269|||
23427117|NCT01170598|65307560|FG000|Overall Study|Withdrawal by Subject|1|||
23427118|NCT01170598|65307560|FG000|Overall Study|Death|3|||
23427119|NCT01170598|65307560|FG000|Overall Study|Lost to Follow-up|1|||
23427120|NCT01170598|65307560|FG000|Overall Study|Refused|1|||
23427121|NCT02649855|65307569|FG000|Overall Study|Refused further treatment|2|||
23427122|NCT02649855|65307570|FG001|Overall Study|Refused further treatment|1|||
23546651|NCT03690869|65731191|FG007|Overall Study|Lost to Follow-up|0|||
23546652|NCT03690869|65731192|FG008|Overall Study|Lost to Follow-up|0|||
23619131|NCT03022045|65991483|FG001|Overall Study|Withdrawal by Subject|1|||
23619132|NCT02383927|65991484|FG000|Overall Study|Disease Progression|8|||
23427123|NCT02649855|65307571|FG002|Overall Study|Refused further treatment|1|||
23427124|NCT02649855|65307569|FG000|Overall Study|Withdrew consent|0|||
23546653|NCT03690869|65731193|FG009|Overall Study|Lost to Follow-up|0|||
23546654|NCT03690869|65731184|FG000|Overall Study|Other Treatment|1|||
23546655|NCT03690869|65731185|FG001|Overall Study|Other Treatment|1|||
23546656|NCT03690869|65731186|FG002|Overall Study|Other Treatment|1|||
23546657|NCT03690869|65731187|FG003|Overall Study|Other Treatment|2|||
23546658|NCT03690869|65731188|FG004|Overall Study|Other Treatment|3|||
23546659|NCT03690869|65731189|FG005|Overall Study|Other Treatment|1|||
23546660|NCT03690869|65731190|FG006|Overall Study|Other Treatment|2|||
23546661|NCT03690869|65731191|FG007|Overall Study|Other Treatment|7|||
23546662|NCT03690869|65731192|FG008|Overall Study|Other Treatment|0|||
23546663|NCT03690869|65731193|FG009|Overall Study|Other Treatment|3|||
23546664|NCT03690869|65731184|FG000|Overall Study|Physician Decision|0|||
23546665|NCT03690869|65731185|FG001|Overall Study|Physician Decision|1|||
23546666|NCT03690869|65731186|FG002|Overall Study|Physician Decision|0|||
23546667|NCT03690869|65731187|FG003|Overall Study|Physician Decision|0|||
23619133|NCT02383927|65991485|FG001|Overall Study|Disease Progression|8|||
23619134|NCT02383927|65991486|FG002|Overall Study|Disease Progression|15|||
23619135|NCT02383927|65991487|FG003|Overall Study|Disease Progression|4|||
23619136|NCT02383927|65991484|FG000|Overall Study|Physician Decision|0|||
23619137|NCT02383927|65991485|FG001|Overall Study|Physician Decision|0|||
23619138|NCT02383927|65991486|FG002|Overall Study|Physician Decision|2|||
23619139|NCT02383927|65991487|FG003|Overall Study|Physician Decision|0|||
23619140|NCT02383927|65991484|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
23619141|NCT02383927|65991485|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
23619142|NCT02383927|65991486|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
23619143|NCT02383927|65991487|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
23619144|NCT02383927|65991484|FG000|Overall Study|Adverse Event|4|||
23546668|NCT03690869|65731188|FG004|Overall Study|Physician Decision|0|||
23546669|NCT03690869|65731189|FG005|Overall Study|Physician Decision|0|||
23546670|NCT03690869|65731190|FG006|Overall Study|Physician Decision|0|||
23546671|NCT03690869|65731191|FG007|Overall Study|Physician Decision|0|||
23546672|NCT03690869|65731192|FG008|Overall Study|Physician Decision|0|||
23546673|NCT03690869|65731193|FG009|Overall Study|Physician Decision|0|||
23546674|NCT03690869|65731184|FG000|Overall Study|Progressive Disease|1|||
23546675|NCT03690869|65731185|FG001|Overall Study|Progressive Disease|2|||
23546676|NCT03690869|65731186|FG002|Overall Study|Progressive Disease|0|||
23619145|NCT02383927|65991485|FG001|Overall Study|Adverse Event|1|||
23619146|NCT02383927|65991486|FG002|Overall Study|Adverse Event|3|||
23619147|NCT02383927|65991487|FG003|Overall Study|Adverse Event|5|||
23619148|NCT02383927|65991484|FG000|Overall Study|Miscellaneous|1|||
23619149|NCT02383927|65991485|FG001|Overall Study|Miscellaneous|0|||
23619150|NCT02383927|65991486|FG002|Overall Study|Miscellaneous|0|||
23619151|NCT02383927|65991487|FG003|Overall Study|Miscellaneous|1|||
23619152|NCT02383927|65991484|FG000|Overall Study|Withdrawal by Subject|0|||
23619153|NCT02383927|65991485|FG001|Overall Study|Withdrawal by Subject|1|||
23619154|NCT02383927|65991486|FG002|Overall Study|Withdrawal by Subject|4|||
23619155|NCT02383927|65991487|FG003|Overall Study|Withdrawal by Subject|0|||
23619156|NCT02859558|65991488|FG000|Step 1|Not Eligible|0|||
23619157|NCT02859558|65991489|FG001|Step 1|Not Eligible|0|||
23619158|NCT02859558|65991490|FG002|Step 1|Not Eligible|0|||
23619159|NCT02859558|65991491|FG003|Step 1|Not Eligible|0|||
23619160|NCT02859558|65991492|FG004|Step 1|Not Eligible|3|||
23619161|NCT02859558|65991488|FG000|Step 1|Lost to Follow-up|1|||
23619162|NCT02859558|65991489|FG001|Step 1|Lost to Follow-up|3|||
23619163|NCT02859558|65991490|FG002|Step 1|Lost to Follow-up|3|||
23131444|NCT01072630|64229596|FG002|Overall Study|Noncompliance with study procedures|1|||
23131445|NCT01072630|64229594|FG000|Overall Study|Other|3|||
23131446|NCT01072630|64229595|FG001|Overall Study|Other|2|||
23131447|NCT01072630|64229596|FG002|Overall Study|Other|1|||
23131448|NCT00288639|64229597|FG000|Overall Study|Adverse Event|5|||
23131449|NCT00288639|64229597|FG000|Overall Study|Lack of Efficacy|4|||
23131450|NCT00288639|64229597|FG000|Overall Study|Withdrawal by Subject|2|||
23131451|NCT00288639|64229597|FG000|Overall Study|Other|1|||
23131452|NCT02993523|64229598|FG000|Overall Study|Withdrew Consent|0|||
23131453|NCT02993523|64229599|FG001|Overall Study|Withdrew Consent|0|||
23131454|NCT02993523|64229600|FG002|Overall Study|Withdrew Consent|2|||
23546677|NCT03690869|65731187|FG003|Overall Study|Progressive Disease|1|||
23131455|NCT02993523|64229601|FG003|Overall Study|Withdrew Consent|9|||
23546678|NCT03690869|65731188|FG004|Overall Study|Progressive Disease|0|||
23546679|NCT03690869|65731189|FG005|Overall Study|Progressive Disease|0|||
23546680|NCT03690869|65731190|FG006|Overall Study|Progressive Disease|0|||
23546681|NCT03690869|65731191|FG007|Overall Study|Progressive Disease|0|||
23619164|NCT02859558|65991491|FG003|Step 1|Lost to Follow-up|0|||
23619165|NCT02859558|65991492|FG004|Step 1|Lost to Follow-up|0|||
23619166|NCT02859558|65991488|FG000|Step 1|Did Not Return to Clinic|2|||
23619167|NCT02859558|65991489|FG001|Step 1|Did Not Return to Clinic|3|||
23619168|NCT02859558|65991490|FG002|Step 1|Did Not Return to Clinic|4|||
23619169|NCT02859558|65991491|FG003|Step 1|Did Not Return to Clinic|0|||
23619170|NCT02859558|65991492|FG004|Step 1|Did Not Return to Clinic|0|||
23619171|NCT02859558|65991488|FG000|Step 1|Moved|0|||
23619172|NCT02859558|65991489|FG001|Step 1|Moved|1|||
23131456|NCT02993523|64229602|FG004|Overall Study|Withdrew Consent|0|||
23131457|NCT02993523|64229598|FG000|Overall Study|Lost to Follow-up|0|||
23546682|NCT03690869|65731192|FG008|Overall Study|Progressive Disease|1|||
23619173|NCT02859558|65991490|FG002|Step 1|Moved|1|||
23427125|NCT02649855|65307570|FG001|Overall Study|Withdrew consent|1|||
23427126|NCT02649855|65307571|FG002|Overall Study|Withdrew consent|0|||
23546683|NCT03690869|65731193|FG009|Overall Study|Progressive Disease|1|||
23546684|NCT03690869|65731184|FG000|Overall Study|Subject Decision|0|||
23546685|NCT03690869|65731185|FG001|Overall Study|Subject Decision|0|||
23546686|NCT03690869|65731186|FG002|Overall Study|Subject Decision|0|||
23546687|NCT03690869|65731187|FG003|Overall Study|Subject Decision|1|||
23546688|NCT03690869|65731188|FG004|Overall Study|Subject Decision|0|||
23546689|NCT03690869|65731189|FG005|Overall Study|Subject Decision|0|||
23546690|NCT03690869|65731190|FG006|Overall Study|Subject Decision|0|||
23546691|NCT03690869|65731191|FG007|Overall Study|Subject Decision|1|||
23546692|NCT03690869|65731192|FG008|Overall Study|Subject Decision|0|||
23546693|NCT03690869|65731193|FG009|Overall Study|Subject Decision|0|||
23546694|NCT00110617|65731194|FG000|Overall Study|Adverse Event|2|||
23546695|NCT00110617|65731195|FG001|Overall Study|Adverse Event|4|||
23546696|NCT00110617|65731194|FG000|Overall Study|Abnormal Laboratory Value|4|||
23546697|NCT00110617|65731195|FG001|Overall Study|Abnormal Laboratory Value|2|||
23546698|NCT00110617|65731194|FG000|Overall Study|Lack of Efficacy|1|||
23546699|NCT00110617|65731195|FG001|Overall Study|Lack of Efficacy|0|||
23546700|NCT00110617|65731194|FG000|Overall Study|Patient no longer requires study drug|1|||
23546701|NCT00110617|65731195|FG001|Overall Study|Patient no longer requires study drug|0|||
23546702|NCT00110617|65731194|FG000|Overall Study|Protocol Violation|5|||
23546703|NCT00110617|65731195|FG001|Overall Study|Protocol Violation|0|||
23546704|NCT00110617|65731194|FG000|Overall Study|Withdrawal by Subject|10|||
23546705|NCT00110617|65731195|FG001|Overall Study|Withdrawal by Subject|4|||
23546706|NCT00110617|65731194|FG000|Overall Study|Lost to Follow-up|9|||
23546707|NCT00110617|65731195|FG001|Overall Study|Lost to Follow-up|1|||
23427127|NCT02649855|65307569|FG000|Overall Study|Switched to alternative treatment|0|||
23427128|NCT02649855|65307570|FG001|Overall Study|Switched to alternative treatment|1|||
23427129|NCT02649855|65307571|FG002|Overall Study|Switched to alternative treatment|1|||
23427130|NCT02649855|65307569|FG000|Overall Study|Principal investigator discretion|0|||
23546708|NCT00110617|65731194|FG000|Overall Study|Administrative problems|6|||
23546709|NCT00110617|65731195|FG001|Overall Study|Administrative problems|5|||
23546710|NCT00110617|65731194|FG000|Overall Study|Death|1|||
23546711|NCT00110617|65731195|FG001|Overall Study|Death|1|||
23546712|NCT00110617|65731194|FG000|Overall Study|Did not receive study drug|0|||
23546713|NCT00110617|65731195|FG001|Overall Study|Did not receive study drug|12|||
23546714|NCT01750268|65731196|FG000|Overall Study|Lost to Follow-up|0|||
23546715|NCT01750268|65731197|FG001|Overall Study|Lost to Follow-up|2|||
23546716|NCT01750268|65731196|FG000|Overall Study|Physician Decision|0|||
23546717|NCT01750268|65731197|FG001|Overall Study|Physician Decision|3|||
23546718|NCT01750268|65731196|FG000|Overall Study|Withdrawal by Subject|2|||
23546719|NCT01750268|65731197|FG001|Overall Study|Withdrawal by Subject|0|||
23131458|NCT02993523|64229599|FG001|Overall Study|Lost to Follow-up|0|||
23131459|NCT02993523|64229600|FG002|Overall Study|Lost to Follow-up|3|||
23131460|NCT02993523|64229601|FG003|Overall Study|Lost to Follow-up|6|||
23131461|NCT02993523|64229602|FG004|Overall Study|Lost to Follow-up|0|||
23546720|NCT03624504|65731198|FG000|Overall Study|Unsuccessful Implant|1|||
23546721|NCT04447404|65731200|FG000|Overall Study|Death|2|||
23546722|NCT04447404|65731201|FG001|Overall Study|Death|0|||
23546723|NCT02270450|65731203|FG000|Overall Study|Refusal unrelated to adverse event|3|||
23546724|NCT02270450|65731204|FG001|Overall Study|Refusal unrelated to adverse event|1|||
23546725|NCT02270450|65731205|FG002|Overall Study|Refusal unrelated to adverse event|5|||
23131462|NCT02993523|64229598|FG000|Overall Study|Death|1|||
23131463|NCT02993523|64229599|FG001|Overall Study|Death|1|||
23131464|NCT02993523|64229600|FG002|Overall Study|Death|138|||
23131465|NCT02993523|64229601|FG003|Overall Study|Death|222|||
23131466|NCT02993523|64229602|FG004|Overall Study|Death|6|||
23131467|NCT02993523|64229598|FG000|Overall Study|Reason not Specified|0|||
23546726|NCT02270450|65731206|FG003|Overall Study|Refusal unrelated to adverse event|14|||
23546727|NCT02270450|65731203|FG000|Overall Study|Progression/relapse|1|||
23546728|NCT02270450|65731204|FG001|Overall Study|Progression/relapse|2|||
23546729|NCT02270450|65731205|FG002|Overall Study|Progression/relapse|4|||
23546730|NCT02270450|65731206|FG003|Overall Study|Progression/relapse|9|||
23546731|NCT02270450|65731203|FG000|Overall Study|Death|19|||
23131468|NCT02993523|64229599|FG001|Overall Study|Reason not Specified|0|||
23131469|NCT02993523|64229600|FG002|Overall Study|Reason not Specified|1|||
23131470|NCT02993523|64229601|FG003|Overall Study|Reason not Specified|1|||
23131471|NCT02993523|64229602|FG004|Overall Study|Reason not Specified|0|||
23131472|NCT00534495|64229603|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
23131473|NCT00534495|64229604|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
23131474|NCT00534495|64229605|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
23131475|NCT00534495|64229603|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
23546732|NCT02270450|65731204|FG001|Overall Study|Death|19|||
23546733|NCT02270450|65731205|FG002|Overall Study|Death|31|||
23427131|NCT02649855|65307570|FG001|Overall Study|Principal investigator discretion|1|||
23427132|NCT02649855|65307571|FG002|Overall Study|Principal investigator discretion|1|||
23546734|NCT02270450|65731206|FG003|Overall Study|Death|59|||
23546735|NCT01953926|65731209|FG000|Overall Study|Withdrawal by Subject|23|||
23546736|NCT01953926|65731210|FG001|Overall Study|Withdrawal by Subject|3|||
23546737|NCT01953926|65731211|FG002|Overall Study|Withdrawal by Subject|3|||
23546738|NCT01953926|65731212|FG003|Overall Study|Withdrawal by Subject|5|||
23546739|NCT01953926|65731213|FG004|Overall Study|Withdrawal by Subject|6|||
23546740|NCT01953926|65731214|FG005|Overall Study|Withdrawal by Subject|0|||
23546741|NCT01953926|65731215|FG006|Overall Study|Withdrawal by Subject|1|||
23546742|NCT01953926|65731209|FG000|Overall Study|Physician Decision|1|||
23213497|NCT00270998|64523305|FG000|12 Month Follow-up|Pessary did not fit|1|||
23213498|NCT00270998|64523306|FG001|12 Month Follow-up|Pessary did not fit|0|||
23213499|NCT00270998|64523307|FG002|12 Month Follow-up|Pessary did not fit|0|||
23213500|NCT00270998|64523305|FG000|12 Month Follow-up|Personal/family health|0|||
23213501|NCT00270998|64523306|FG001|12 Month Follow-up|Personal/family health|5|||
23317273|NCT00863772|64904036|FG001|Overall Study|Entered extension study|4|||
23317274|NCT00863772|64904037|FG002|Overall Study|Entered extension study|9|||
23546743|NCT01953926|65731210|FG001|Overall Study|Physician Decision|0|||
23546744|NCT01953926|65731211|FG002|Overall Study|Physician Decision|0|||
23546745|NCT01953926|65731212|FG003|Overall Study|Physician Decision|0|||
23546746|NCT01953926|65731213|FG004|Overall Study|Physician Decision|2|||
23546747|NCT01953926|65731214|FG005|Overall Study|Physician Decision|0|||
23546748|NCT01953926|65731215|FG006|Overall Study|Physician Decision|0|||
23546749|NCT01953926|65731209|FG000|Overall Study|Lost to Follow-up|18|||
23546750|NCT01953926|65731210|FG001|Overall Study|Lost to Follow-up|3|||
23546751|NCT01953926|65731211|FG002|Overall Study|Lost to Follow-up|0|||
23546752|NCT01953926|65731212|FG003|Overall Study|Lost to Follow-up|5|||
23546753|NCT01953926|65731213|FG004|Overall Study|Lost to Follow-up|3|||
23546754|NCT01953926|65731214|FG005|Overall Study|Lost to Follow-up|0|||
23546755|NCT01953926|65731215|FG006|Overall Study|Lost to Follow-up|0|||
23546756|NCT01953926|65731209|FG000|Overall Study|Protocol Violation|1|||
23546757|NCT01953926|65731210|FG001|Overall Study|Protocol Violation|0|||
23546758|NCT01953926|65731211|FG002|Overall Study|Protocol Violation|0|||
23546759|NCT01953926|65731212|FG003|Overall Study|Protocol Violation|0|||
23546760|NCT01953926|65731213|FG004|Overall Study|Protocol Violation|0|||
23546761|NCT01953926|65731214|FG005|Overall Study|Protocol Violation|0|||
23546762|NCT01953926|65731215|FG006|Overall Study|Protocol Violation|0|||
23546763|NCT01953926|65731209|FG000|Overall Study|Other, Disease progression|2|||
23546764|NCT01953926|65731210|FG001|Overall Study|Other, Disease progression|1|||
23131476|NCT00534495|64229604|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
23131477|NCT00534495|64229605|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
23131478|NCT00534495|64229603|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
23131479|NCT00534495|64229604|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
23131480|NCT00534495|64229605|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
23131481|NCT00534495|64229603|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
23131482|NCT00534495|64229604|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
23131483|NCT00534495|64229605|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
23131484|NCT00534495|64229603|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
23131485|NCT00534495|64229604|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
23131486|NCT00534495|64229605|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
23131487|NCT00534495|64229603|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
23546765|NCT01953926|65731211|FG002|Overall Study|Other, Disease progression|0|||
23546766|NCT01953926|65731212|FG003|Overall Study|Other, Disease progression|0|||
23546767|NCT01953926|65731213|FG004|Overall Study|Other, Disease progression|1|||
23546768|NCT01953926|65731214|FG005|Overall Study|Other, Disease progression|0|||
23546769|NCT01953926|65731215|FG006|Overall Study|Other, Disease progression|0|||
23546770|NCT01953926|65731209|FG000|Overall Study|Discontinuation of study by sponsor|41|||
23546771|NCT01953926|65731210|FG001|Overall Study|Discontinuation of study by sponsor|7|||
23546772|NCT01953926|65731211|FG002|Overall Study|Discontinuation of study by sponsor|5|||
23546773|NCT01953926|65731212|FG003|Overall Study|Discontinuation of study by sponsor|12|||
23546774|NCT01953926|65731213|FG004|Overall Study|Discontinuation of study by sponsor|46|||
23546775|NCT01953926|65731214|FG005|Overall Study|Discontinuation of study by sponsor|5|||
23546776|NCT01953926|65731215|FG006|Overall Study|Discontinuation of study by sponsor|6|||
23546777|NCT01953926|65731209|FG000|Overall Study|Not Treated|1|||
23546778|NCT01953926|65731210|FG001|Overall Study|Not Treated|0|||
23546779|NCT01953926|65731211|FG002|Overall Study|Not Treated|1|||
23546780|NCT01953926|65731212|FG003|Overall Study|Not Treated|0|||
23546781|NCT01953926|65731213|FG004|Overall Study|Not Treated|0|||
23546782|NCT01953926|65731214|FG005|Overall Study|Not Treated|0|||
23131488|NCT00534495|64229604|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
23213502|NCT00270998|64523307|FG002|12 Month Follow-up|Personal/family health|1|||
23213503|NCT00270998|64523305|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
23546783|NCT01953926|65731215|FG006|Overall Study|Not Treated|0|||
23546784|NCT00586105|65731216|FG000|Overall Study|Adverse Event|4|||
23546785|NCT00586105|65731216|FG000|Overall Study|Death|2|||
23546786|NCT00586105|65731216|FG000|Overall Study|Protocol Violation|1|||
23546787|NCT00586105|65731216|FG000|Overall Study|Withdrawal by Subject|3|||
23546788|NCT00586105|65731216|FG000|Overall Study|Disease progression|19|||
23546789|NCT00586105|65731216|FG000|Overall Study|Switched to commercial drug|9|||
23546790|NCT00586105|65731216|FG000|Overall Study|Reason not reported|1|||
23546791|NCT01682460|65731217|FG000|Overall Study|Withdrawal by Subject|2|||
23131489|NCT00534495|64229605|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
23427133|NCT02649855|65307569|FG000|Overall Study|No treatment, per protocol|1|||
23427134|NCT02649855|65307570|FG001|Overall Study|No treatment, per protocol|0|||
23131490|NCT00534495|64229603|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
23131491|NCT00534495|64229604|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
23131492|NCT00534495|64229605|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
23131493|NCT00534495|64229603|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
23131494|NCT00534495|64229604|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
23131495|NCT00534495|64229605|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
23427135|NCT02649855|65307571|FG002|Overall Study|No treatment, per protocol|0|||
23427136|NCT02649855|65307569|FG000|Overall Study|Initiate new treatment|1|||
23427137|NCT02649855|65307570|FG001|Overall Study|Initiate new treatment|0|||
23427138|NCT02649855|65307571|FG002|Overall Study|Initiate new treatment|0|||
23427139|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
23427140|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
23427141|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
23131496|NCT00534495|64229603|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
23131497|NCT00534495|64229604|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
23131498|NCT00534495|64229605|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
23131499|NCT01255631|64229606|FG000|Overall Study|poor enrollment, no data analyzed|9|||
23131500|NCT01255631|64229607|FG001|Overall Study|poor enrollment, no data analyzed|6|||
23131501|NCT00699153|64229611|FG000|Overall Study|Lost to Follow-up|1|||
23131502|NCT00699153|64229612|FG001|Overall Study|Lost to Follow-up|0|||
23131503|NCT00699153|64229611|FG000|Overall Study|Adverse Event|0|||
23131504|NCT00699153|64229612|FG001|Overall Study|Adverse Event|2|||
23131505|NCT00699153|64229611|FG000|Overall Study|Protocol Violation|1|||
23131506|NCT00699153|64229612|FG001|Overall Study|Protocol Violation|0|||
23131507|NCT00699153|64229611|FG000|Overall Study|Travel Problem|1|||
23131508|NCT00699153|64229612|FG001|Overall Study|Travel Problem|0|||
23131509|NCT04546425|64229619|FG000|Overall Study|Protocol Violation|1|||
23131510|NCT04546425|64229620|FG001|Overall Study|Protocol Violation|1|||
23131511|NCT04546425|64229621|FG002|Overall Study|Protocol Violation|0|||
23131512|NCT04546425|64229622|FG003|Overall Study|Protocol Violation|0|||
23427142|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
23427143|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
23427144|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
23427145|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
23427146|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
23427147|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
23427148|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
23427149|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
23427150|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
23427151|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
23427152|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
23427153|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
23427154|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
23427155|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
23427156|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
23427157|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
23427158|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
23427159|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
23427160|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
23427161|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
23546792|NCT01682460|65731217|FG000|Overall Study|Did not meet inclusion criteria|2|||
23546793|NCT02277106|65731221|FG000|Stage 2|Adverse Event|0|||
23131513|NCT04546425|64229619|FG000|Overall Study|Adverse Event|3|||
23131514|NCT04546425|64229620|FG001|Overall Study|Adverse Event|0|||
23131515|NCT04546425|64229621|FG002|Overall Study|Adverse Event|0|||
23131516|NCT04546425|64229622|FG003|Overall Study|Adverse Event|0|||
23131517|NCT04546425|64229619|FG000|Overall Study|Lost to Follow-up|5|||
23131518|NCT04546425|64229620|FG001|Overall Study|Lost to Follow-up|4|||
23131519|NCT04546425|64229621|FG002|Overall Study|Lost to Follow-up|0|||
23131520|NCT04546425|64229622|FG003|Overall Study|Lost to Follow-up|0|||
23131521|NCT04546425|64229619|FG000|Overall Study|No Longer met eligibility criteria|3|||
23546794|NCT02277106|65731222|FG001|Stage 2|Adverse Event|0|||
23546795|NCT02277106|65731223|FG002|Stage 2|Adverse Event|1|||
23317275|NCT00863772|64904035|FG000|Overall Study|Other|1|||
23546796|NCT03166618|65731230|FG000|Overall Study|Study was Terminated|0|||
23546797|NCT03166618|65731231|FG001|Overall Study|Study was Terminated|1|||
23546798|NCT01248884|65731232|FG000|Overall Study|Withdrawal by Subject|1|||
23546799|NCT01248884|65731233|FG001|Overall Study|Withdrawal by Subject|3|||
23546800|NCT01248884|65731234|FG002|Overall Study|Withdrawal by Subject|1|||
23546801|NCT01248884|65731232|FG000|Overall Study|Adverse Event|1|||
23546802|NCT01248884|65731233|FG001|Overall Study|Adverse Event|0|||
23546803|NCT01248884|65731234|FG002|Overall Study|Adverse Event|0|||
23546804|NCT00868439|65731239|FG000|Overall Study|Adverse Event|4|||
23619174|NCT02859558|65991491|FG003|Step 1|Moved|0|||
23619175|NCT02859558|65991492|FG004|Step 1|Moved|0|||
23546805|NCT00868439|65731240|FG001|Overall Study|Adverse Event|3|||
23546806|NCT00868439|65731239|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
23317276|NCT00863772|64904036|FG001|Overall Study|Other|2|||
23546807|NCT00868439|65731240|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
23546808|NCT00868439|65731239|FG000|Overall Study|Death|0|||
23546809|NCT00868439|65731240|FG001|Overall Study|Death|1|||
23546810|NCT00868439|65731239|FG000|Overall Study|Protocol Violation|1|||
23546811|NCT00868439|65731240|FG001|Overall Study|Protocol Violation|1|||
23546812|NCT00868439|65731239|FG000|Overall Study|Physician Decision|1|||
23546813|NCT00868439|65731240|FG001|Overall Study|Physician Decision|0|||
23546814|NCT00868439|65731239|FG000|Overall Study|Withdrawal by Subject|0|||
23546815|NCT00868439|65731240|FG001|Overall Study|Withdrawal by Subject|1|||
23546816|NCT00518115|65731241|FG000|Overall Study|Adverse Event|6|||
23546817|NCT00518115|65731242|FG001|Overall Study|Adverse Event|1|||
23619176|NCT02859558|65991488|FG000|Step 1|Withdrawal By Participant|1|||
23619177|NCT02859558|65991489|FG001|Step 1|Withdrawal By Participant|2|||
23619178|NCT02859558|65991490|FG002|Step 1|Withdrawal By Participant|1|||
23619179|NCT02859558|65991491|FG003|Step 1|Withdrawal By Participant|0|||
23619180|NCT02859558|65991492|FG004|Step 1|Withdrawal By Participant|0|||
23619181|NCT02859558|65991488|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
23619182|NCT02859558|65991489|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
23619183|NCT02859558|65991490|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
23619184|NCT02859558|65991491|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
23619185|NCT02859558|65991492|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
23619186|NCT02859558|65991488|FG000|Step 1|Incarceration|0|||
23619187|NCT02859558|65991489|FG001|Step 1|Incarceration|1|||
23619188|NCT02859558|65991490|FG002|Step 1|Incarceration|0|||
23619189|NCT02859558|65991491|FG003|Step 1|Incarceration|0|||
23619190|NCT02859558|65991492|FG004|Step 1|Incarceration|0|||
23619191|NCT02859558|65991488|FG000|Step 1|Non-Adherence to Study Drug|2|||
23619192|NCT02859558|65991489|FG001|Step 1|Non-Adherence to Study Drug|0|||
23619193|NCT02859558|65991490|FG002|Step 1|Non-Adherence to Study Drug|1|||
23619194|NCT02859558|65991491|FG003|Step 1|Non-Adherence to Study Drug|0|||
23619195|NCT02859558|65991492|FG004|Step 1|Non-Adherence to Study Drug|0|||
23619196|NCT02859558|65991488|FG000|Step 1|Non-Adherence to Study Requirements|3|||
23619197|NCT02859558|65991489|FG001|Step 1|Non-Adherence to Study Requirements|1|||
23546818|NCT00518115|65731243|FG002|Overall Study|Adverse Event|5|||
23546819|NCT00518115|65731244|FG003|Overall Study|Adverse Event|6|||
23546820|NCT00518115|65731245|FG004|Overall Study|Adverse Event|5|||
23546821|NCT00518115|65731246|FG005|Overall Study|Adverse Event|5|||
23546822|NCT00518115|65731247|FG006|Overall Study|Adverse Event|5|||
23546823|NCT00518115|65731248|FG007|Overall Study|Adverse Event|10|||
23546824|NCT00518115|65731249|FG008|Overall Study|Adverse Event|2|||
23546825|NCT00518115|65731250|FG009|Overall Study|Adverse Event|9|||
23546826|NCT00518115|65731241|FG000|Overall Study|Lost to Follow-up|0|||
23546827|NCT00518115|65731242|FG001|Overall Study|Lost to Follow-up|0|||
23546828|NCT00518115|65731243|FG002|Overall Study|Lost to Follow-up|2|||
23619198|NCT02859558|65991490|FG002|Step 1|Non-Adherence to Study Requirements|0|||
23546829|NCT00518115|65731244|FG003|Overall Study|Lost to Follow-up|3|||
23546830|NCT00518115|65731245|FG004|Overall Study|Lost to Follow-up|1|||
23546831|NCT00518115|65731246|FG005|Overall Study|Lost to Follow-up|3|||
23546832|NCT00518115|65731247|FG006|Overall Study|Lost to Follow-up|0|||
23546833|NCT00518115|65731248|FG007|Overall Study|Lost to Follow-up|1|||
23546834|NCT00518115|65731249|FG008|Overall Study|Lost to Follow-up|1|||
23546835|NCT00518115|65731250|FG009|Overall Study|Lost to Follow-up|1|||
23546836|NCT00518115|65731241|FG000|Overall Study|Protocol Violation|1|||
23546837|NCT00518115|65731242|FG001|Overall Study|Protocol Violation|3|||
23546838|NCT00518115|65731243|FG002|Overall Study|Protocol Violation|1|||
23546839|NCT00518115|65731244|FG003|Overall Study|Protocol Violation|0|||
23546840|NCT00518115|65731245|FG004|Overall Study|Protocol Violation|0|||
23546841|NCT00518115|65731246|FG005|Overall Study|Protocol Violation|0|||
23546842|NCT00518115|65731247|FG006|Overall Study|Protocol Violation|0|||
23619199|NCT02859558|65991491|FG003|Step 1|Non-Adherence to Study Requirements|0|||
23619200|NCT02859558|65991492|FG004|Step 1|Non-Adherence to Study Requirements|0|||
23619201|NCT02859558|65991488|FG000|Step 1|Virologic Failure|2|||
23619202|NCT02859558|65991489|FG001|Step 1|Virologic Failure|1|||
23619203|NCT02859558|65991490|FG002|Step 1|Virologic Failure|1|||
23546843|NCT00518115|65731248|FG007|Overall Study|Protocol Violation|0|||
23546844|NCT00518115|65731249|FG008|Overall Study|Protocol Violation|0|||
23546845|NCT00518115|65731250|FG009|Overall Study|Protocol Violation|0|||
23546846|NCT00518115|65731241|FG000|Overall Study|Withdrawal by Subject|1|||
23546847|NCT00518115|65731242|FG001|Overall Study|Withdrawal by Subject|1|||
23546848|NCT00518115|65731243|FG002|Overall Study|Withdrawal by Subject|5|||
23546849|NCT00518115|65731244|FG003|Overall Study|Withdrawal by Subject|0|||
23546850|NCT00518115|65731245|FG004|Overall Study|Withdrawal by Subject|2|||
23546851|NCT00518115|65731246|FG005|Overall Study|Withdrawal by Subject|1|||
23546852|NCT00518115|65731247|FG006|Overall Study|Withdrawal by Subject|0|||
23546853|NCT00518115|65731248|FG007|Overall Study|Withdrawal by Subject|2|||
23546854|NCT00518115|65731249|FG008|Overall Study|Withdrawal by Subject|1|||
23546855|NCT00518115|65731250|FG009|Overall Study|Withdrawal by Subject|3|||
23546856|NCT00518115|65731241|FG000|Overall Study|Lack of Efficacy|1|||
23546857|NCT00518115|65731242|FG001|Overall Study|Lack of Efficacy|0|||
23546858|NCT00518115|65731243|FG002|Overall Study|Lack of Efficacy|1|||
23546859|NCT00518115|65731244|FG003|Overall Study|Lack of Efficacy|1|||
23546860|NCT00518115|65731245|FG004|Overall Study|Lack of Efficacy|0|||
23546861|NCT00518115|65731246|FG005|Overall Study|Lack of Efficacy|0|||
23546862|NCT00518115|65731247|FG006|Overall Study|Lack of Efficacy|0|||
23546863|NCT00518115|65731248|FG007|Overall Study|Lack of Efficacy|1|||
23546864|NCT00518115|65731249|FG008|Overall Study|Lack of Efficacy|0|||
23546865|NCT00518115|65731250|FG009|Overall Study|Lack of Efficacy|0|||
23546866|NCT00518115|65731241|FG000|Overall Study|Non-Compliance|1|||
23546867|NCT00518115|65731242|FG001|Overall Study|Non-Compliance|0|||
23546868|NCT00518115|65731243|FG002|Overall Study|Non-Compliance|1|||
23546869|NCT00518115|65731244|FG003|Overall Study|Non-Compliance|0|||
23546870|NCT00518115|65731245|FG004|Overall Study|Non-Compliance|1|||
23546871|NCT00518115|65731246|FG005|Overall Study|Non-Compliance|1|||
23546872|NCT00518115|65731247|FG006|Overall Study|Non-Compliance|1|||
23546873|NCT00518115|65731248|FG007|Overall Study|Non-Compliance|1|||
23546874|NCT00518115|65731249|FG008|Overall Study|Non-Compliance|0|||
23546875|NCT00518115|65731250|FG009|Overall Study|Non-Compliance|1|||
23546876|NCT00518115|65731241|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
23546877|NCT00518115|65731242|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
23546878|NCT00518115|65731243|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546879|NCT00518115|65731244|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23619204|NCT02859558|65991491|FG003|Step 1|Virologic Failure|0|||
23619205|NCT02859558|65991492|FG004|Step 1|Virologic Failure|0|||
23619206|NCT02859558|65991488|FG000|Step 2|Active On Study|23|||
23619207|NCT02859558|65991489|FG001|Step 2|Active On Study|38|||
23619208|NCT02859558|65991490|FG002|Step 2|Active On Study|20|||
23131522|NCT04546425|64229620|FG001|Overall Study|No Longer met eligibility criteria|3|||
23131523|NCT04546425|64229621|FG002|Overall Study|No Longer met eligibility criteria|1|||
23131524|NCT04546425|64229622|FG003|Overall Study|No Longer met eligibility criteria|1|||
23131525|NCT04546425|64229619|FG000|Overall Study|Withdrawal by parent/guardian|6|||
23131526|NCT04546425|64229620|FG001|Overall Study|Withdrawal by parent/guardian|5|||
23131527|NCT04546425|64229621|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23131528|NCT04546425|64229622|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23131529|NCT03738475|64229623|FG000|Overall Study|Participant Non-Compliance|1|||
23131530|NCT03738475|64229624|FG001|Overall Study|Participant Non-Compliance|0|||
23131531|NCT03980808|64229625|FG000|Overall Study|Lost to Follow-up|2|||
23131532|NCT03980808|64229626|FG001|Overall Study|Lost to Follow-up|2|||
23131533|NCT05110690|64229630|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
23131534|NCT05110690|64229630|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
23131535|NCT05110690|64229630|FG000|Completion of Intervention|Lost to Follow-up|1|||
23131536|NCT05110690|64229630|FG000|Completion of Intervention|Death|1|||
23131537|NCT05110690|64229630|FG000|Completion of Intervention|Withdrawal by Subject|2|||
23131538|NCT00415051|64229631|FG000|Overall Study|Protocol Violation|1|||
23546880|NCT00518115|65731245|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546881|NCT00518115|65731246|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
23546882|NCT00518115|65731247|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546883|NCT00518115|65731248|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546884|NCT00518115|65731249|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546885|NCT00518115|65731250|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23546886|NCT00518115|65731241|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
23546887|NCT00518115|65731242|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23619209|NCT02859558|65991491|FG003|Step 2|Active On Study|0|||
23619210|NCT02859558|65991492|FG004|Step 2|Active On Study|0|||
23619211|NCT02859558|65991488|FG000|Step 2|Did Not Return to Clinic|2|||
23619212|NCT02859558|65991489|FG001|Step 2|Did Not Return to Clinic|0|||
23619213|NCT02859558|65991490|FG002|Step 2|Did Not Return to Clinic|0|||
23546888|NCT00518115|65731243|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546889|NCT00518115|65731244|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23619214|NCT02859558|65991491|FG003|Step 2|Did Not Return to Clinic|0|||
23619215|NCT02859558|65991492|FG004|Step 2|Did Not Return to Clinic|0|||
23131539|NCT03538938|64229632|FG000|Overall Study|Death|0|||
23427162|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
23427163|NCT00624780|65307572|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
23427164|NCT00624780|65307573|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
23131540|NCT03538938|64229633|FG001|Overall Study|Death|0|||
23131541|NCT03538938|64229634|FG002|Overall Study|Death|2|||
23131542|NCT03538938|64229635|FG003|Overall Study|Death|0|||
23131543|NCT03538938|64229636|FG004|Overall Study|Death|0|||
23131544|NCT03538938|64229637|FG005|Overall Study|Death|1|||
23131545|NCT03538938|64229638|FG006|Overall Study|Death|0|||
23131546|NCT03538938|64229639|FG007|Overall Study|Death|1|||
23131547|NCT03538938|64229640|FG008|Overall Study|Death|1|||
23131548|NCT03538938|64229641|FG009|Overall Study|Death|1|||
23131549|NCT03538938|64229642|FG010|Overall Study|Death|0|||
23131550|NCT03538938|64229643|FG011|Overall Study|Death|0|||
23131551|NCT03538938|64229644|FG012|Overall Study|Death|1|||
23131552|NCT03538938|64229645|FG013|Overall Study|Death|1|||
23131553|NCT03538938|64229646|FG014|Overall Study|Death|0|||
23131554|NCT03538938|64229647|FG015|Overall Study|Death|1|||
23131555|NCT03538938|64229632|FG000|Overall Study|Withdrawal by Subject|4|||
23131556|NCT03538938|64229633|FG001|Overall Study|Withdrawal by Subject|6|||
23131557|NCT03538938|64229634|FG002|Overall Study|Withdrawal by Subject|5|||
23131558|NCT03538938|64229635|FG003|Overall Study|Withdrawal by Subject|3|||
23131559|NCT03538938|64229636|FG004|Overall Study|Withdrawal by Subject|0|||
23131560|NCT03538938|64229637|FG005|Overall Study|Withdrawal by Subject|0|||
23131561|NCT03538938|64229638|FG006|Overall Study|Withdrawal by Subject|3|||
23131562|NCT03538938|64229639|FG007|Overall Study|Withdrawal by Subject|1|||
23131563|NCT03538938|64229640|FG008|Overall Study|Withdrawal by Subject|5|||
23131564|NCT03538938|64229641|FG009|Overall Study|Withdrawal by Subject|1|||
23131565|NCT03538938|64229642|FG010|Overall Study|Withdrawal by Subject|2|||
23131566|NCT03538938|64229643|FG011|Overall Study|Withdrawal by Subject|1|||
23131567|NCT03538938|64229644|FG012|Overall Study|Withdrawal by Subject|3|||
23131568|NCT03538938|64229645|FG013|Overall Study|Withdrawal by Subject|0|||
23131569|NCT03538938|64229646|FG014|Overall Study|Withdrawal by Subject|2|||
23131570|NCT03538938|64229647|FG015|Overall Study|Withdrawal by Subject|4|||
23131571|NCT03538938|64229632|FG000|Overall Study|Incarcerated|0|||
23131572|NCT03538938|64229633|FG001|Overall Study|Incarcerated|0|||
23131573|NCT03538938|64229634|FG002|Overall Study|Incarcerated|0|||
23131574|NCT03538938|64229635|FG003|Overall Study|Incarcerated|0|||
23131575|NCT03538938|64229636|FG004|Overall Study|Incarcerated|0|||
23131576|NCT03538938|64229637|FG005|Overall Study|Incarcerated|0|||
23131577|NCT03538938|64229638|FG006|Overall Study|Incarcerated|0|||
23131578|NCT03538938|64229639|FG007|Overall Study|Incarcerated|0|||
23131579|NCT03538938|64229640|FG008|Overall Study|Incarcerated|0|||
23131580|NCT03538938|64229641|FG009|Overall Study|Incarcerated|0|||
23427165|NCT00624780|65307574|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
23427166|NCT00624780|65307575|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
23427167|NCT00624780|65307576|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
23427168|NCT00624780|65307577|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
23427169|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
23427170|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
23427171|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
23427172|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
23427173|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
23427174|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
23427175|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
23427176|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
23131581|NCT03538938|64229642|FG010|Overall Study|Incarcerated|0|||
23131582|NCT03538938|64229643|FG011|Overall Study|Incarcerated|1|||
23131583|NCT03538938|64229644|FG012|Overall Study|Incarcerated|0|||
23131584|NCT03538938|64229645|FG013|Overall Study|Incarcerated|0|||
23131585|NCT03538938|64229646|FG014|Overall Study|Incarcerated|0|||
23131586|NCT03538938|64229647|FG015|Overall Study|Incarcerated|0|||
23131587|NCT00477490|64229649|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
23131588|NCT00477490|64229650|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
23131589|NCT00477490|64229651|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
23131590|NCT00477490|64229652|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
23131591|NCT00477490|64229653|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
23427177|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
23427178|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
23619216|NCT02859558|65991488|FG000|Step 2|Unexpected Closure of Site|0|||
23131592|NCT00477490|64229654|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
23131593|NCT00477490|64229655|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
23131594|NCT00477490|64229656|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
23131595|NCT00477490|64229657|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
23131596|NCT00477490|64229649|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
23131597|NCT00477490|64229650|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23131598|NCT00477490|64229651|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23131599|NCT00477490|64229652|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
23131600|NCT00477490|64229653|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
23131601|NCT00477490|64229654|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23131602|NCT00477490|64229655|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23131603|NCT00477490|64229656|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23131604|NCT00477490|64229657|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
23131605|NCT00477490|64229649|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
23131606|NCT00477490|64229650|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
23131607|NCT00477490|64229651|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
23131608|NCT00477490|64229652|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
23131609|NCT00477490|64229653|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
23131610|NCT00477490|64229654|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
23131611|NCT00477490|64229655|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
23131612|NCT00477490|64229656|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
23131613|NCT00477490|64229657|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
23131614|NCT00477490|64229649|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
23131615|NCT00477490|64229650|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
23131616|NCT00477490|64229651|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
23131617|NCT00477490|64229652|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
23131618|NCT00477490|64229653|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
23131619|NCT00477490|64229654|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
23131620|NCT00477490|64229655|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
23131621|NCT00477490|64229656|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
23131622|NCT00477490|64229657|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
23131623|NCT00477490|64229649|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
23131624|NCT00477490|64229650|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
23131625|NCT00477490|64229651|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
23131626|NCT00477490|64229652|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
23131627|NCT00477490|64229653|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
23131628|NCT00477490|64229654|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
23131629|NCT00477490|64229655|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
23131630|NCT00477490|64229656|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
23131631|NCT00477490|64229657|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
23131632|NCT00477490|64229649|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
23131633|NCT00477490|64229650|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
23131634|NCT00477490|64229651|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
23131635|NCT00477490|64229652|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
23131636|NCT00477490|64229653|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
23131637|NCT00477490|64229654|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
23131638|NCT00477490|64229655|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
23131639|NCT00477490|64229656|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
23131640|NCT00477490|64229657|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
23131641|NCT00477490|64229649|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
23131642|NCT00477490|64229650|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
23131643|NCT00477490|64229651|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
23131644|NCT00477490|64229652|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
23131645|NCT00477490|64229653|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
23131646|NCT00477490|64229654|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
23131647|NCT00477490|64229655|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
23131648|NCT00477490|64229656|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
23131649|NCT00477490|64229657|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
23131650|NCT00477490|64229649|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
23131651|NCT00477490|64229650|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
23131652|NCT00477490|64229651|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
23131653|NCT00477490|64229652|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
23131654|NCT00477490|64229653|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
23131655|NCT00477490|64229654|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
23131656|NCT00477490|64229655|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
23317277|NCT00863772|64904037|FG002|Overall Study|Other|4|||
23131657|NCT00477490|64229656|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
23131658|NCT00477490|64229657|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
23131659|NCT00477490|64229649|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
23131660|NCT00477490|64229650|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
23131661|NCT00477490|64229651|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
23131662|NCT00477490|64229652|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23131663|NCT00477490|64229653|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23131664|NCT00477490|64229654|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23213504|NCT00270998|64523306|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
23317278|NCT00863772|64904035|FG000|Overall Study|Randomized but not Treated|1|||
23317279|NCT00863772|64904036|FG001|Overall Study|Randomized but not Treated|0|||
23427179|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
23427180|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
23427181|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
23427182|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
23131665|NCT00477490|64229655|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23131666|NCT00477490|64229656|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
23427183|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
23427184|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
23427185|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
23427186|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
23427187|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
23427188|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
23427189|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
23427190|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
23427191|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
23427192|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
23427193|NCT00624780|65307572|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
23427194|NCT00624780|65307573|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
23427195|NCT00624780|65307574|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
23427196|NCT00624780|65307575|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
23427197|NCT00624780|65307576|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
23427198|NCT00624780|65307577|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
23427199|NCT00624780|65307572|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
23427200|NCT00624780|65307573|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
23427201|NCT00624780|65307574|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
23427202|NCT00624780|65307575|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
23427203|NCT00624780|65307576|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
23427204|NCT00624780|65307577|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
23427205|NCT00624780|65307572|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
23427206|NCT00624780|65307573|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427207|NCT00624780|65307574|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427208|NCT00624780|65307575|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427209|NCT00624780|65307576|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427210|NCT00624780|65307577|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
23427211|NCT00624780|65307572|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427212|NCT00624780|65307573|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427213|NCT00624780|65307574|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
23427214|NCT00624780|65307575|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427215|NCT00624780|65307576|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427216|NCT00624780|65307577|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
23427217|NCT00624780|65307572|FG000|Follow-up (Week 26)|Death|0|||
23427218|NCT00624780|65307573|FG001|Follow-up (Week 26)|Death|0|||
23427219|NCT00624780|65307574|FG002|Follow-up (Week 26)|Death|1|||
23131667|NCT00477490|64229657|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
23131668|NCT00477490|64229649|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23131669|NCT00477490|64229650|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
23131670|NCT00477490|64229651|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
23131671|NCT00477490|64229652|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23131672|NCT00477490|64229653|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
23131673|NCT00477490|64229654|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23131674|NCT00477490|64229655|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
23131675|NCT00477490|64229656|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23131676|NCT00477490|64229657|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
23131677|NCT00477490|64229649|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23131678|NCT00477490|64229650|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23131679|NCT00477490|64229651|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23131680|NCT00477490|64229652|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23131681|NCT00477490|64229653|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
23131682|NCT00477490|64229654|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23131683|NCT00477490|64229655|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
23131684|NCT00477490|64229656|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
23131685|NCT00477490|64229657|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
23131686|NCT00477490|64229649|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23131687|NCT00477490|64229650|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
23427220|NCT00624780|65307575|FG003|Follow-up (Week 26)|Death|0|||
23427221|NCT00624780|65307576|FG004|Follow-up (Week 26)|Death|0|||
23427222|NCT00624780|65307577|FG005|Follow-up (Week 26)|Death|0|||
23619217|NCT02859558|65991489|FG001|Step 2|Unexpected Closure of Site|1|||
23131688|NCT00477490|64229651|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23131689|NCT00477490|64229652|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23131690|NCT00477490|64229653|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23131691|NCT00477490|64229654|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23131692|NCT00477490|64229655|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23131693|NCT00477490|64229656|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23131694|NCT00477490|64229657|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
23131695|NCT00477490|64229649|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
23131696|NCT00477490|64229650|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
23131697|NCT00477490|64229651|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
23131698|NCT00477490|64229652|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
23131699|NCT00477490|64229653|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
23131700|NCT00477490|64229654|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
23131701|NCT00477490|64229655|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
23131702|NCT00477490|64229656|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
23131703|NCT00477490|64229657|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
23131704|NCT00477490|64229649|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23131705|NCT00477490|64229650|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
23131706|NCT00477490|64229651|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
23131707|NCT00477490|64229652|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23131708|NCT00477490|64229653|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
23131709|NCT00477490|64229654|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23131710|NCT00477490|64229655|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23131711|NCT00477490|64229656|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23131712|NCT00477490|64229657|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
23131713|NCT02631577|64229658|FG000|Overall Study|Death|1|||
23131714|NCT02631577|64229659|FG001|Overall Study|Death|7|||
23131715|NCT02631577|64229658|FG000|Overall Study|Withdrawal by Subject|0|||
23131716|NCT02631577|64229659|FG001|Overall Study|Withdrawal by Subject|3|||
23131717|NCT00037830|64229664|FG000|Overall Study|Adverse Event|2|||
23131718|NCT00037830|64229665|FG001|Overall Study|Adverse Event|0|||
23131719|NCT00037830|64229666|FG002|Overall Study|Adverse Event|0|||
23131720|NCT00037830|64229664|FG000|Overall Study|Withdrawal by Subject|4|||
23131721|NCT00037830|64229665|FG001|Overall Study|Withdrawal by Subject|5|||
23131722|NCT00037830|64229666|FG002|Overall Study|Withdrawal by Subject|1|||
23131723|NCT00037830|64229664|FG000|Overall Study|Protocol Violation|2|||
23131724|NCT00037830|64229665|FG001|Overall Study|Protocol Violation|2|||
23131725|NCT00037830|64229666|FG002|Overall Study|Protocol Violation|0|||
23131726|NCT00037830|64229664|FG000|Overall Study|Unrelated Medical Problem|2|||
23131727|NCT00037830|64229665|FG001|Overall Study|Unrelated Medical Problem|0|||
23131728|NCT00037830|64229666|FG002|Overall Study|Unrelated Medical Problem|0|||
23131729|NCT00734591|64229667|FG000|Screening for Prospective Period|Site did not participate|1604|||
23131730|NCT00734591|64229668|FG001|Screening for Prospective Period|Site did not participate|1488|||
23131731|NCT00734591|64229667|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
23131732|NCT00734591|64229668|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
23131733|NCT00734591|64229667|FG000|Prospective Period|Withdrawal by Subject|11|||
23131734|NCT00734591|64229668|FG001|Prospective Period|Withdrawal by Subject|9|||
23131735|NCT00734591|64229667|FG000|Prospective Period|Lost to Follow-up|37|||
23131736|NCT00734591|64229668|FG001|Prospective Period|Lost to Follow-up|33|||
23131737|NCT00734591|64229667|FG000|Prospective Period|Study Terminated|1|||
23131738|NCT00734591|64229668|FG001|Prospective Period|Study Terminated|0|||
23131739|NCT00734591|64229667|FG000|Prospective Period|Other|2|||
23131740|NCT00734591|64229668|FG001|Prospective Period|Other|2|||
23131741|NCT03192475|64229669|FG000|Overall Study|Death|0|||
23131742|NCT03192475|64229670|FG001|Overall Study|Death|1|||
23131743|NCT03192475|64229669|FG000|Overall Study|Lost to Follow-up|13|||
23427223|NCT00624780|65307572|FG000|Follow-up (Week 26)|Adverse Event|0|||
23131744|NCT03192475|64229670|FG001|Overall Study|Lost to Follow-up|8|||
23131745|NCT03480932|64229674|FG000|Overall Study|Death|1|||
23131746|NCT03480932|64229675|FG001|Overall Study|Death|1|||
23131747|NCT03480932|64229676|FG002|Overall Study|Death|0|||
23131748|NCT03480932|64229674|FG000|Overall Study|Lost to Follow-up|0|||
23131749|NCT03480932|64229675|FG001|Overall Study|Lost to Follow-up|2|||
23131750|NCT03480932|64229676|FG002|Overall Study|Lost to Follow-up|3|||
23131751|NCT03480932|64229674|FG000|Overall Study|Incarcerated|2|||
23131752|NCT03480932|64229675|FG001|Overall Study|Incarcerated|2|||
23131753|NCT03480932|64229676|FG002|Overall Study|Incarcerated|2|||
23131754|NCT02159040|64229677|FG000|Overall Study|Death|1|||
23131755|NCT00338962|64229678|FG000|Overall Study|Lost to Follow-up|3|||
23131756|NCT00338962|64229679|FG001|Overall Study|Lost to Follow-up|3|||
23131757|NCT00338962|64229680|FG002|Overall Study|Lost to Follow-up|2|||
23131758|NCT00338962|64229681|FG003|Overall Study|Lost to Follow-up|3|||
23131759|NCT00338962|64229678|FG000|Overall Study|Withdrawal by Subject|1|||
23131760|NCT00338962|64229679|FG001|Overall Study|Withdrawal by Subject|0|||
23131761|NCT00338962|64229680|FG002|Overall Study|Withdrawal by Subject|0|||
23131762|NCT00338962|64229681|FG003|Overall Study|Withdrawal by Subject|0|||
23131763|NCT00338962|64229678|FG000|Overall Study|No Transportation|2|||
23131764|NCT00338962|64229679|FG001|Overall Study|No Transportation|0|||
23131765|NCT00338962|64229680|FG002|Overall Study|No Transportation|0|||
23131766|NCT00338962|64229681|FG003|Overall Study|No Transportation|0|||
23131767|NCT00338962|64229678|FG000|Overall Study|Time Constraint|2|||
23131768|NCT00338962|64229679|FG001|Overall Study|Time Constraint|0|||
23131769|NCT00338962|64229680|FG002|Overall Study|Time Constraint|0|||
23131770|NCT00338962|64229681|FG003|Overall Study|Time Constraint|0|||
23131771|NCT00338962|64229678|FG000|Overall Study|Moved|0|||
23131772|NCT00338962|64229679|FG001|Overall Study|Moved|1|||
23131773|NCT00338962|64229680|FG002|Overall Study|Moved|0|||
23131774|NCT00338962|64229681|FG003|Overall Study|Moved|0|||
23131775|NCT00338962|64229678|FG000|Overall Study|Adverse Event|0|||
23131776|NCT00338962|64229679|FG001|Overall Study|Adverse Event|0|||
23131777|NCT00338962|64229680|FG002|Overall Study|Adverse Event|2|||
23131778|NCT00338962|64229681|FG003|Overall Study|Adverse Event|0|||
23131779|NCT00338962|64229678|FG000|Overall Study|Poor Compliance|0|||
23131780|NCT00338962|64229679|FG001|Overall Study|Poor Compliance|0|||
23131781|NCT00338962|64229680|FG002|Overall Study|Poor Compliance|2|||
23131782|NCT00338962|64229681|FG003|Overall Study|Poor Compliance|0|||
23131783|NCT03381339|64229690|FG000|Overall Study|Protocol Violation|4|||
23131784|NCT03381339|64229691|FG001|Overall Study|Protocol Violation|3|||
23131785|NCT03381339|64229690|FG000|Overall Study|Lost to Follow-up|0|||
23131786|NCT03381339|64229691|FG001|Overall Study|Lost to Follow-up|1|||
23131787|NCT03214640|64229694|FG000|Overall Study|Protocol Violation|1|||
23131788|NCT03214640|64229695|FG001|Overall Study|Protocol Violation|2|||
23131789|NCT03214640|64229696|FG002|Overall Study|Protocol Violation|1|||
23131790|NCT03214640|64229697|FG003|Overall Study|Protocol Violation|4|||
23131791|NCT01495598|64229698|FG000|Overall Study|Death during follow up period|2|||
23131792|NCT01495598|64229698|FG000|Overall Study|Death on study|1|||
23131793|NCT01495598|64229698|FG000|Overall Study|Lost to Follow-up|3|||
23131794|NCT01495598|64229698|FG000|Overall Study|Physician Decision|8|||
23131795|NCT01424813|64229701|FG000|Overall Study|Withdrawal by Subject|3|||
23131796|NCT01424813|64229702|FG001|Overall Study|Withdrawal by Subject|0|||
23213505|NCT00270998|64523307|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
23213506|NCT02966353|64523310|FG000|Overall Study|Withdrawal by Subject|7|||
23213507|NCT02966353|64523310|FG000|Overall Study|Adverse Event|4|||
23213508|NCT02966353|64523310|FG000|Overall Study|Death|4|||
23213509|NCT02966353|64523310|FG000|Overall Study|Physician Decision|3|||
23213510|NCT02966353|64523310|FG000|Overall Study|Progressive disease|2|||
23427224|NCT00624780|65307573|FG001|Follow-up (Week 26)|Adverse Event|0|||
23427225|NCT00624780|65307574|FG002|Follow-up (Week 26)|Adverse Event|0|||
23427226|NCT00624780|65307575|FG003|Follow-up (Week 26)|Adverse Event|0|||
23427227|NCT00624780|65307576|FG004|Follow-up (Week 26)|Adverse Event|1|||
23427228|NCT00624780|65307577|FG005|Follow-up (Week 26)|Adverse Event|0|||
23427229|NCT00624780|65307572|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
23427230|NCT00624780|65307573|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
23427231|NCT00624780|65307574|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
23427232|NCT00624780|65307575|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
23427233|NCT00624780|65307576|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
23546890|NCT00518115|65731245|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546891|NCT00518115|65731246|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23213511|NCT02966353|64523310|FG000|Overall Study|Protocol deviation|2|||
23213512|NCT01617655|64523311|FG000|Overall Study|Adverse Event|2|||
23213513|NCT01617655|64523312|FG001|Overall Study|Adverse Event|3|||
23213514|NCT01617655|64523311|FG000|Overall Study|Poor compliance to protocol|1|||
23213515|NCT01617655|64523312|FG001|Overall Study|Poor compliance to protocol|4|||
23213516|NCT01617655|64523311|FG000|Overall Study|Participants moved|0|||
23213517|NCT01617655|64523312|FG001|Overall Study|Participants moved|4|||
23213518|NCT01617655|64523311|FG000|Overall Study|Consent withdrawn by participant|1|||
23213519|NCT01617655|64523312|FG001|Overall Study|Consent withdrawn by participant|1|||
23427234|NCT00624780|65307577|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
23131797|NCT01424813|64229701|FG000|Overall Study|Protocol Violation|1|||
23131798|NCT01424813|64229702|FG001|Overall Study|Protocol Violation|0|||
23131799|NCT01424813|64229701|FG000|Overall Study|Other|1|||
23131800|NCT01424813|64229702|FG001|Overall Study|Other|2|||
23131801|NCT04157400|64229708|FG000|Overall Study|Withdrawal by Subject|1|||
23131802|NCT04157400|64229708|FG000|Overall Study|Lost to Follow-up|3|||
23131803|NCT01162863|64229718|FG000|Overall Study|Lack of Efficacy|1|||
23131804|NCT01162863|64229719|FG001|Overall Study|Lack of Efficacy|0|||
23131805|NCT01162863|64229720|FG002|Overall Study|Lack of Efficacy|0|||
23131806|NCT01162863|64229718|FG000|Overall Study|Adverse Event|0|||
23131807|NCT01162863|64229719|FG001|Overall Study|Adverse Event|1|||
23131808|NCT01162863|64229720|FG002|Overall Study|Adverse Event|0|||
23131809|NCT01038427|64229725|FG000|Overall Study|Lost to follow up|1|||
23131810|NCT01038427|64229726|FG001|Overall Study|Lost to follow up|1|||
23131811|NCT01038427|64229727|FG002|Overall Study|Lost to follow up|0|||
23131812|NCT01038427|64229725|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
23131813|NCT01038427|64229726|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
23131814|NCT01038427|64229727|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
23131815|NCT01038427|64229725|FG000|Overall Study|Withdrew consent|0|||
23131816|NCT01038427|64229726|FG001|Overall Study|Withdrew consent|0|||
23131817|NCT01038427|64229727|FG002|Overall Study|Withdrew consent|1|||
23131818|NCT01038427|64229725|FG000|Overall Study|Adverse Event|2|||
23131819|NCT01038427|64229726|FG001|Overall Study|Adverse Event|2|||
23131820|NCT01038427|64229727|FG002|Overall Study|Adverse Event|1|||
23131821|NCT01038427|64229725|FG000|Overall Study|Enrolled in error|0|||
23131822|NCT01038427|64229726|FG001|Overall Study|Enrolled in error|1|||
23131823|NCT01038427|64229727|FG002|Overall Study|Enrolled in error|1|||
23131824|NCT01038427|64229725|FG000|Overall Study|Other|0|||
23131825|NCT01038427|64229726|FG001|Overall Study|Other|2|||
23131826|NCT01038427|64229727|FG002|Overall Study|Other|0|||
23131827|NCT00293059|64229728|FG000|Overall Study|Adverse Event|12|||
23131828|NCT00293059|64229729|FG001|Overall Study|Adverse Event|4|||
23131829|NCT00293059|64229728|FG000|Overall Study|Lack of Efficacy|2|||
23131830|NCT00293059|64229729|FG001|Overall Study|Lack of Efficacy|0|||
23131831|NCT00293059|64229728|FG000|Overall Study|Lost to Follow-up|2|||
23131832|NCT00293059|64229729|FG001|Overall Study|Lost to Follow-up|3|||
23131833|NCT00293059|64229728|FG000|Overall Study|Pregnancy|1|||
23131834|NCT00293059|64229729|FG001|Overall Study|Pregnancy|1|||
23131835|NCT00293059|64229728|FG000|Overall Study|Protocol Violation|2|||
23131836|NCT00293059|64229729|FG001|Overall Study|Protocol Violation|0|||
23131837|NCT00293059|64229728|FG000|Overall Study|Withdrawal by Subject|11|||
23131838|NCT00293059|64229729|FG001|Overall Study|Withdrawal by Subject|5|||
23131839|NCT00293059|64229728|FG000|Overall Study|Participant moved out of state|1|||
23131840|NCT00293059|64229729|FG001|Overall Study|Participant moved out of state|0|||
23131841|NCT00293059|64229728|FG000|Overall Study|Participant stopped study drug|1|||
23131842|NCT00293059|64229729|FG001|Overall Study|Participant stopped study drug|0|||
23131843|NCT00293059|64229728|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
23131844|NCT00293059|64229729|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
23131845|NCT00293059|64229728|FG000|Overall Study|missing|3|||
23131846|NCT00293059|64229729|FG001|Overall Study|missing|5|||
23131847|NCT04307940|64229730|FG000|Overall Study|Adverse Event|1|||
23131848|NCT04307940|64229731|FG001|Overall Study|Adverse Event|0|||
23131849|NCT04307940|64229732|FG002|Overall Study|Adverse Event|0|||
23131850|NCT04307940|64229730|FG000|Overall Study|Withdrawal by Subject|2|||
23131851|NCT04307940|64229731|FG001|Overall Study|Withdrawal by Subject|3|||
23131852|NCT04307940|64229732|FG002|Overall Study|Withdrawal by Subject|1|||
23131853|NCT04307940|64229730|FG000|Overall Study|Lost to Follow-up|2|||
23131854|NCT04307940|64229731|FG001|Overall Study|Lost to Follow-up|0|||
23546892|NCT00518115|65731247|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546893|NCT00518115|65731248|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546894|NCT00518115|65731249|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546895|NCT00518115|65731250|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
23546896|NCT00518115|65731241|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546897|NCT00518115|65731242|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546898|NCT00518115|65731243|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
23546899|NCT00518115|65731244|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546900|NCT00518115|65731245|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546901|NCT00518115|65731246|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546902|NCT00518115|65731247|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546903|NCT00518115|65731248|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
23546904|NCT00518115|65731249|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
23546905|NCT00518115|65731250|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
23131855|NCT04307940|64229732|FG002|Overall Study|Lost to Follow-up|1|||
23131856|NCT01232738|64229733|FG000|Overall Study|Death|3|||
23131857|NCT01232738|64229733|FG000|Overall Study|Physician Decision|2|||
23317280|NCT00863772|64904037|FG002|Overall Study|Randomized but not Treated|0|||
23546906|NCT00518115|65731241|FG000|Overall Study|Wrong Monotherapy Administered|0|||
23546907|NCT00518115|65731242|FG001|Overall Study|Wrong Monotherapy Administered|0|||
23619218|NCT02859558|65991490|FG002|Step 2|Unexpected Closure of Site|1|||
23619219|NCT02859558|65991491|FG003|Step 2|Unexpected Closure of Site|0|||
23619220|NCT02859558|65991492|FG004|Step 2|Unexpected Closure of Site|0|||
23131858|NCT01232738|64229733|FG000|Overall Study|Lost to Follow-up|1|||
23131859|NCT01232738|64229733|FG000|Overall Study|Withdrawal by Subject|2|||
23131860|NCT01232738|64229733|FG000|Overall Study|Adverse Event|5|||
23131861|NCT01200342|64229734|FG000|Overall Study|Disease Progression|1|||
23131862|NCT01294436|64229735|FG000|Overall Study|Adverse Event|10|||
23131863|NCT01294436|64229736|FG001|Overall Study|Adverse Event|17|||
23131864|NCT01294436|64229735|FG000|Overall Study|Withdrawal by Subject|11|||
23131865|NCT01294436|64229736|FG001|Overall Study|Withdrawal by Subject|28|||
23546908|NCT00518115|65731243|FG002|Overall Study|Wrong Monotherapy Administered|1|||
23546909|NCT00518115|65731244|FG003|Overall Study|Wrong Monotherapy Administered|0|||
23546910|NCT00518115|65731245|FG004|Overall Study|Wrong Monotherapy Administered|0|||
23546911|NCT00518115|65731246|FG005|Overall Study|Wrong Monotherapy Administered|0|||
23546912|NCT00518115|65731247|FG006|Overall Study|Wrong Monotherapy Administered|1|||
23546913|NCT00518115|65731248|FG007|Overall Study|Wrong Monotherapy Administered|0|||
23546914|NCT00518115|65731249|FG008|Overall Study|Wrong Monotherapy Administered|0|||
23546915|NCT00518115|65731250|FG009|Overall Study|Wrong Monotherapy Administered|0|||
23546916|NCT00518115|65731241|FG000|Overall Study|Violation of Exclusion Criteria|0|||
23546917|NCT00518115|65731242|FG001|Overall Study|Violation of Exclusion Criteria|0|||
23546918|NCT00518115|65731243|FG002|Overall Study|Violation of Exclusion Criteria|0|||
23546919|NCT00518115|65731244|FG003|Overall Study|Violation of Exclusion Criteria|1|||
23131866|NCT01294436|64229735|FG000|Overall Study|subject no longer meets study criteria|5|||
23131867|NCT01294436|64229736|FG001|Overall Study|subject no longer meets study criteria|20|||
23131868|NCT01294436|64229735|FG000|Overall Study|poor/non-compliance|2|||
23131869|NCT01294436|64229736|FG001|Overall Study|poor/non-compliance|5|||
23427235|NCT00624780|65307572|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
23427236|NCT00624780|65307573|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427237|NCT00624780|65307574|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427238|NCT00624780|65307575|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427239|NCT00624780|65307576|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427240|NCT00624780|65307577|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
23427241|NCT00624780|65307572|FG000|Follow-up (Week 26)|Other|1|||
23427242|NCT00624780|65307573|FG001|Follow-up (Week 26)|Other|1|||
23427243|NCT00624780|65307574|FG002|Follow-up (Week 26)|Other|0|||
23427244|NCT00624780|65307575|FG003|Follow-up (Week 26)|Other|0|||
23427245|NCT00624780|65307576|FG004|Follow-up (Week 26)|Other|0|||
23427246|NCT00624780|65307577|FG005|Follow-up (Week 26)|Other|0|||
23427247|NCT05590000|65307578|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
23427248|NCT00871117|65307579|FG000|Overall Study|Lost to Follow-up|5|||
23427249|NCT00871117|65307580|FG001|Overall Study|Lost to Follow-up|6|||
23427250|NCT00871117|65307579|FG000|Overall Study|Other|0|||
23427251|NCT00871117|65307580|FG001|Overall Study|Other|4|||
23427252|NCT01011933|65307581|FG000|Overall Study|Wrong cell type|1|||
23427253|NCT01011933|65307581|FG000|Overall Study|Improper pre-protocol Rx|1|||
23427254|NCT01011933|65307581|FG000|Overall Study|Inadequate pathology|1|||
23427255|NCT01011933|65307581|FG000|Overall Study|Never treated|1|||
23427256|NCT00908115|65307582|FG000|Overall Study|Other|14|||
23427257|NCT02549352|65307586|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
23427258|NCT02549352|65307587|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
23427259|NCT02549352|65307586|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
23427260|NCT02549352|65307587|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
23427261|NCT02549352|65307586|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
23427262|NCT02549352|65307587|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
23427263|NCT02549352|65307586|FG000|12-month Follow-up|Withdrawal by Subject|4|||
23427264|NCT02549352|65307587|FG001|12-month Follow-up|Withdrawal by Subject|5|||
23427265|NCT02549352|65307586|FG000|12-month Follow-up|Lost to Follow-up|3|||
23427266|NCT02549352|65307587|FG001|12-month Follow-up|Lost to Follow-up|2|||
23427267|NCT02549352|65307586|FG000|12-month Follow-up|Death|0|||
23427268|NCT02549352|65307587|FG001|12-month Follow-up|Death|1|||
23427269|NCT02549352|65307586|FG000|12-month Follow-up|Protocol Violation|0|||
23427270|NCT02549352|65307587|FG001|12-month Follow-up|Protocol Violation|1|||
23427271|NCT02549352|65307586|FG000|12-month Follow-up|Other|1|||
23427272|NCT02549352|65307587|FG001|12-month Follow-up|Other|3|||
23427273|NCT00806442|65307588|FG000|Overall Study|Lost to Follow-up|3|||
23427274|NCT00806442|65307589|FG001|Overall Study|Lost to Follow-up|2|||
23546920|NCT00518115|65731245|FG004|Overall Study|Violation of Exclusion Criteria|0|||
23546921|NCT00518115|65731246|FG005|Overall Study|Violation of Exclusion Criteria|0|||
23546922|NCT00518115|65731247|FG006|Overall Study|Violation of Exclusion Criteria|1|||
23546923|NCT00518115|65731248|FG007|Overall Study|Violation of Exclusion Criteria|0|||
23131870|NCT01641159|64229737|FG000|Overall Study|Lost to Follow-up|2|||
23427275|NCT00806442|65307588|FG000|Overall Study|Withdrawal by Subject|1|||
23427276|NCT00806442|65307589|FG001|Overall Study|Withdrawal by Subject|5|||
23427277|NCT03780959|65307590|FG000|Part 1|Adverse Event|1|||
23427278|NCT03780959|65307591|FG001|Part 1|Adverse Event|0|||
23427279|NCT03780959|65307592|FG002|Part 1|Adverse Event|0|||
23427280|NCT03780959|65307590|FG000|Part 1|Withdrawal by Subject|1|||
23427281|NCT03780959|65307591|FG001|Part 1|Withdrawal by Subject|0|||
23427282|NCT03780959|65307592|FG002|Part 1|Withdrawal by Subject|0|||
23546924|NCT00518115|65731249|FG008|Overall Study|Violation of Exclusion Criteria|0|||
23546925|NCT00518115|65731250|FG009|Overall Study|Violation of Exclusion Criteria|0|||
23427283|NCT03780959|65307590|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
23619221|NCT03494985|65991496|FG000|Overall Study|Adverse Event|3|||
23427284|NCT03780959|65307591|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
23427285|NCT03780959|65307592|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
23427286|NCT03780959|65307590|FG000|Part 1|Response Status|2|||
23427287|NCT03780959|65307591|FG001|Part 1|Response Status|0|||
23427288|NCT03780959|65307592|FG002|Part 1|Response Status|0|||
23427289|NCT03780959|65307590|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
23427290|NCT03780959|65307591|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
23427291|NCT03780959|65307592|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
23427292|NCT03780959|65307590|FG000|Part 2|Response Status|0|||
23427293|NCT03780959|65307591|FG001|Part 2|Response Status|18|||
23427294|NCT03780959|65307592|FG002|Part 2|Response Status|6|||
23427295|NCT02370095|65307593|FG000|Overall Study|Withdrawal by Subject|0|||
23427296|NCT02370095|65307594|FG001|Overall Study|Withdrawal by Subject|1|||
23427297|NCT00546260|65307598|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
23427298|NCT00546260|65307599|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
23427299|NCT00787137|65307600|FG000|Overall Study|Study Termination|0|||
23427300|NCT00787137|65307601|FG001|Overall Study|Study Termination|0|||
23427301|NCT00787137|65307602|FG002|Overall Study|Study Termination|1|||
23427302|NCT01287221|65307603|FG000|Overall Study|Lack of Perceived Benefit|1|||
23427303|NCT01287221|65307604|FG001|Overall Study|Lack of Perceived Benefit|1|||
23427304|NCT01287221|65307603|FG000|Overall Study|Adverse Event|3|||
23427305|NCT01287221|65307604|FG001|Overall Study|Adverse Event|3|||
23427306|NCT01287221|65307603|FG000|Overall Study|Withdrawal by Subject|0|||
23427307|NCT01287221|65307604|FG001|Overall Study|Withdrawal by Subject|1|||
23427308|NCT01688739|65307605|FG000|Overall Study|Administrative Decision|1|||
23427309|NCT01688739|65307606|FG001|Overall Study|Administrative Decision|0|||
23427310|NCT01688739|65307607|FG002|Overall Study|Administrative Decision|0|||
23131871|NCT01641159|64229738|FG001|Overall Study|Lost to Follow-up|1|||
23131872|NCT01641159|64229737|FG000|Overall Study|Withdrawal by Subject|0|||
23131873|NCT01641159|64229738|FG001|Overall Study|Withdrawal by Subject|1|||
23131874|NCT00780559|64229742|FG000|Overall Study|Lost to Follow-up|2|||
23131875|NCT00780559|64229743|FG001|Overall Study|Lost to Follow-up|7|||
23131876|NCT00780559|64229742|FG000|Overall Study|Death|1|||
23131877|NCT00780559|64229743|FG001|Overall Study|Death|0|||
23131878|NCT03551691|64229745|FG000|Overall Study|Withdrawal by Subject|3|||
23131879|NCT03551691|64229746|FG001|Overall Study|Withdrawal by Subject|3|||
23213520|NCT01617655|64523311|FG000|Overall Study|Last visit outside protocol visit window|1|||
23213521|NCT01617655|64523312|FG001|Overall Study|Last visit outside protocol visit window|10|||
23427311|NCT01688739|65307608|FG003|Overall Study|Administrative Decision|0|||
23427312|NCT01688739|65307609|FG004|Overall Study|Administrative Decision|0|||
23427313|NCT01688739|65307610|FG005|Overall Study|Administrative Decision|0|||
23427314|NCT01688739|65307611|FG006|Overall Study|Administrative Decision|0|||
23427315|NCT01688739|65307612|FG007|Overall Study|Administrative Decision|0|||
23427316|NCT01688739|65307613|FG008|Overall Study|Administrative Decision|0|||
23427317|NCT01688739|65307614|FG009|Overall Study|Administrative Decision|0|||
23427318|NCT00042432|65307615|FG000|Overall Study|Adverse Event|4|||
23427319|NCT00042432|65307616|FG001|Overall Study|Adverse Event|1|||
23427320|NCT00042432|65307615|FG000|Overall Study|Withdrawal by Subject|1|||
23427321|NCT00042432|65307616|FG001|Overall Study|Withdrawal by Subject|3|||
23427322|NCT00042432|65307615|FG000|Overall Study|Death|0|||
23427323|NCT00042432|65307616|FG001|Overall Study|Death|2|||
23427324|NCT00042432|65307615|FG000|Overall Study|Ineligibility determined|1|||
23427325|NCT00042432|65307616|FG001|Overall Study|Ineligibility determined|0|||
23427326|NCT00042432|65307615|FG000|Overall Study|Initiation of maintenance dialysis|1|||
23427327|NCT00042432|65307616|FG001|Overall Study|Initiation of maintenance dialysis|1|||
23427328|NCT00042432|65307615|FG000|Overall Study|Other|2|||
23427329|NCT00042432|65307616|FG001|Overall Study|Other|0|||
23427330|NCT03002818|65307617|FG000|Overall Study|Decision of the investigator|1|||
23427331|NCT02046070|65307621|FG000|Overall Study|Progressive Disease|18|||
23427332|NCT02046070|65307622|FG001|Overall Study|Progressive Disease|11|||
23427333|NCT02046070|65307623|FG002|Overall Study|Progressive Disease|40|||
23427334|NCT02046070|65307621|FG000|Overall Study|Adverse Event|8|||
23427335|NCT02046070|65307622|FG001|Overall Study|Adverse Event|10|||
23427336|NCT02046070|65307623|FG002|Overall Study|Adverse Event|17|||
23427337|NCT02046070|65307621|FG000|Overall Study|Withdrawal by Subject|1|||
23427338|NCT02046070|65307622|FG001|Overall Study|Withdrawal by Subject|2|||
23131880|NCT01559129|64229747|FG000|Treatment Phase|Adverse Event|0|||
23213522|NCT01617655|64523311|FG000|Overall Study|Site closure|3|||
23213523|NCT01617655|64523312|FG001|Overall Study|Site closure|5|||
23427339|NCT02046070|65307623|FG002|Overall Study|Withdrawal by Subject|6|||
23427340|NCT02046070|65307621|FG000|Overall Study|Study Terminated by Sponsor|1|||
23131881|NCT01559129|64229748|FG001|Treatment Phase|Adverse Event|2|||
23131882|NCT01559129|64229747|FG000|Treatment Phase|Progressive Disease|1|||
23427341|NCT02046070|65307622|FG001|Overall Study|Study Terminated by Sponsor|1|||
23427342|NCT02046070|65307623|FG002|Overall Study|Study Terminated by Sponsor|1|||
23427343|NCT02046070|65307621|FG000|Overall Study|Reason not Specified|4|||
23427344|NCT02046070|65307622|FG001|Overall Study|Reason not Specified|4|||
23427345|NCT02046070|65307623|FG002|Overall Study|Reason not Specified|6|||
23427346|NCT03831945|65307627|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
23453634|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23427347|NCT03831945|65307628|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
23427348|NCT03831945|65307627|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
23427349|NCT03831945|65307628|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
23427350|NCT03831945|65307627|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
23427351|NCT03831945|65307628|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
23427352|NCT01974752|65307646|FG000|Overall Study|Death|33|||
23427353|NCT01974752|65307647|FG001|Overall Study|Death|11|||
23427354|NCT01974752|65307646|FG000|Overall Study|Lost to Follow-up|2|||
23427355|NCT01974752|65307647|FG001|Overall Study|Lost to Follow-up|0|||
23427356|NCT01974752|65307646|FG000|Overall Study|Withdrawal by Subject|2|||
23427357|NCT01974752|65307647|FG001|Overall Study|Withdrawal by Subject|3|||
23427358|NCT01974752|65307646|FG000|Overall Study|Other Eligibility Criteria|0|||
23427359|NCT01974752|65307647|FG001|Overall Study|Other Eligibility Criteria|1|||
23427360|NCT01484834|65307648|FG000|Overall Study|Lost to Follow-up|5|||
23427361|NCT01484834|65307649|FG001|Overall Study|Lost to Follow-up|8|||
23427362|NCT01484834|65307650|FG002|Overall Study|Lost to Follow-up|1|||
23427363|NCT01484834|65307651|FG003|Overall Study|Lost to Follow-up|4|||
23427364|NCT00289198|65307652|FG000|Overall Study|Adverse Event|0|||
23427365|NCT00289198|65307653|FG001|Overall Study|Adverse Event|2|||
23427366|NCT00289198|65307652|FG000|Overall Study|Protocol Violation|2|||
23427367|NCT00289198|65307653|FG001|Overall Study|Protocol Violation|1|||
23427368|NCT00289198|65307652|FG000|Overall Study|Withdrawal by Subject|4|||
23427369|NCT00289198|65307653|FG001|Overall Study|Withdrawal by Subject|1|||
23427370|NCT00289198|65307652|FG000|Overall Study|Lack of Efficacy|2|||
23427371|NCT00289198|65307653|FG001|Overall Study|Lack of Efficacy|0|||
23427372|NCT00289198|65307652|FG000|Overall Study|Other: Low compliance|0|||
23427373|NCT00289198|65307653|FG001|Overall Study|Other: Low compliance|1|||
23427374|NCT00289198|65307652|FG000|Overall Study|Other: Physician's decision|0|||
23427375|NCT00289198|65307653|FG001|Overall Study|Other: Physician's decision|1|||
23427376|NCT00289198|65307652|FG000|Overall Study|Other: Unable to attend on schedule|2|||
23427377|NCT00289198|65307653|FG001|Overall Study|Other: Unable to attend on schedule|1|||
23427378|NCT00289198|65307652|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
23427379|NCT00289198|65307653|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
23427380|NCT00289198|65307652|FG000|Overall Study|Other: Impossible to come on visit|0|||
23427381|NCT00289198|65307653|FG001|Overall Study|Other: Impossible to come on visit|1|||
23427382|NCT00787202|65307654|FG000|Overall Study|Adverse Event|3|||
23427383|NCT00787202|65307655|FG001|Overall Study|Adverse Event|2|||
23427384|NCT00787202|65307656|FG002|Overall Study|Adverse Event|0|||
23427385|NCT00787202|65307657|FG003|Overall Study|Adverse Event|0|||
23427386|NCT00787202|65307658|FG004|Overall Study|Adverse Event|2|||
23427387|NCT00787202|65307654|FG000|Overall Study|Lack of Efficacy|5|||
23427388|NCT00787202|65307655|FG001|Overall Study|Lack of Efficacy|6|||
23427389|NCT00787202|65307656|FG002|Overall Study|Lack of Efficacy|5|||
23427390|NCT00787202|65307657|FG003|Overall Study|Lack of Efficacy|2|||
23427391|NCT00787202|65307658|FG004|Overall Study|Lack of Efficacy|1|||
23427392|NCT00787202|65307654|FG000|Overall Study|Lost to Follow-up|1|||
23427393|NCT00787202|65307655|FG001|Overall Study|Lost to Follow-up|0|||
23427394|NCT00787202|65307656|FG002|Overall Study|Lost to Follow-up|0|||
23427395|NCT00787202|65307657|FG003|Overall Study|Lost to Follow-up|0|||
23427396|NCT00787202|65307658|FG004|Overall Study|Lost to Follow-up|0|||
23427397|NCT00787202|65307654|FG000|Overall Study|Withdrawal by Subject|2|||
23427398|NCT00787202|65307655|FG001|Overall Study|Withdrawal by Subject|2|||
23427399|NCT00787202|65307656|FG002|Overall Study|Withdrawal by Subject|2|||
23427400|NCT00787202|65307657|FG003|Overall Study|Withdrawal by Subject|0|||
23427401|NCT00787202|65307658|FG004|Overall Study|Withdrawal by Subject|0|||
23427402|NCT00787202|65307654|FG000|Overall Study|Protocol Violation|2|||
23427403|NCT00787202|65307655|FG001|Overall Study|Protocol Violation|1|||
23427404|NCT00787202|65307656|FG002|Overall Study|Protocol Violation|0|||
23427405|NCT00787202|65307657|FG003|Overall Study|Protocol Violation|0|||
23427406|NCT00787202|65307658|FG004|Overall Study|Protocol Violation|1|||
23427407|NCT00787202|65307654|FG000|Overall Study|Randomized, not treated|1|||
23427408|NCT00787202|65307655|FG001|Overall Study|Randomized, not treated|0|||
23427409|NCT00787202|65307656|FG002|Overall Study|Randomized, not treated|0|||
23427410|NCT00787202|65307657|FG003|Overall Study|Randomized, not treated|0|||
23427411|NCT00787202|65307658|FG004|Overall Study|Randomized, not treated|0|||
23427412|NCT00857948|65307659|FG000|Overall Study|Withdrawal by Subject|2|||
23427413|NCT00857948|65307660|FG001|Overall Study|Withdrawal by Subject|0|||
23427414|NCT00857948|65307661|FG002|Overall Study|Withdrawal by Subject|0|||
23427415|NCT00857948|65307662|FG003|Overall Study|Withdrawal by Subject|0|||
23427416|NCT00857948|65307659|FG000|Overall Study|Protocol Violation|1|||
23427417|NCT00857948|65307660|FG001|Overall Study|Protocol Violation|0|||
23427418|NCT00857948|65307661|FG002|Overall Study|Protocol Violation|1|||
23427419|NCT00857948|65307662|FG003|Overall Study|Protocol Violation|0|||
23427420|NCT04316741|65307665|FG000|Baseline Enrollment|Lost to Follow-up|1|||
23546926|NCT00518115|65731241|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
23546927|NCT00518115|65731242|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
23546928|NCT00518115|65731243|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
23546929|NCT00518115|65731244|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
23546930|NCT00518115|65731245|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
23546931|NCT00518115|65731246|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
23546932|NCT00518115|65731247|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
23546933|NCT00518115|65731248|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
23546934|NCT00518115|65731249|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
23546935|NCT00518115|65731250|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
23546936|NCT00518115|65731241|FG000|Overall Study|Withdrew Consent|0|||
23546937|NCT00518115|65731242|FG001|Overall Study|Withdrew Consent|0|||
23546938|NCT00518115|65731243|FG002|Overall Study|Withdrew Consent|0|||
23546939|NCT00518115|65731244|FG003|Overall Study|Withdrew Consent|0|||
23546940|NCT00518115|65731245|FG004|Overall Study|Withdrew Consent|0|||
23546941|NCT00518115|65731246|FG005|Overall Study|Withdrew Consent|1|||
23546942|NCT00518115|65731247|FG006|Overall Study|Withdrew Consent|0|||
23546943|NCT00518115|65731248|FG007|Overall Study|Withdrew Consent|0|||
23546944|NCT00518115|65731249|FG008|Overall Study|Withdrew Consent|0|||
23546945|NCT00518115|65731250|FG009|Overall Study|Withdrew Consent|0|||
23546946|NCT00518115|65731241|FG000|Overall Study|Moved Out of State|0|||
23546947|NCT00518115|65731242|FG001|Overall Study|Moved Out of State|0|||
23546948|NCT00518115|65731243|FG002|Overall Study|Moved Out of State|0|||
23546949|NCT00518115|65731244|FG003|Overall Study|Moved Out of State|0|||
23546950|NCT00518115|65731245|FG004|Overall Study|Moved Out of State|0|||
23546951|NCT00518115|65731246|FG005|Overall Study|Moved Out of State|0|||
23546952|NCT00518115|65731247|FG006|Overall Study|Moved Out of State|0|||
23546953|NCT00518115|65731248|FG007|Overall Study|Moved Out of State|0|||
23546954|NCT00518115|65731249|FG008|Overall Study|Moved Out of State|0|||
23546955|NCT00518115|65731250|FG009|Overall Study|Moved Out of State|1|||
23546956|NCT03117738|65735638|FG000|Overall Study|Withdrawal by Subject|3|||
23546957|NCT03117738|65735639|FG001|Overall Study|Withdrawal by Subject|1|||
23546958|NCT03117738|65735638|FG000|Overall Study|Lost to Follow-up|1|||
23546959|NCT03117738|65735639|FG001|Overall Study|Lost to Follow-up|4|||
23546960|NCT00936390|65735640|FG000|Overall Study|Protocol Violation|21|||
23546961|NCT00936390|65735641|FG001|Overall Study|Protocol Violation|25|||
23546962|NCT03105362|65735642|FG000|Overall Study|Withdrawal by Subject|1|||
23546963|NCT03105362|65735642|FG000|Overall Study|Lost to Follow-up|1|||
23546964|NCT03826667|65735648|FG000|Overall Study|Protocol deviation|21|||
23546965|NCT03996473|65735650|FG000|Treatment Assignment|Withdrawal by Subject|1|||
23546966|NCT03996473|65735650|FG000|Treatment Assignment|Progressive disease|6|||
23546967|NCT03996473|65735650|FG000|Treatment Assignment|Study drug never administered|1|||
23546968|NCT03996473|65735650|FG000|Active Follow-up|Death|1|||
23546969|NCT03996473|65735650|FG000|Long-term Follow-up|Death|5|||
23546970|NCT02367911|65735651|FG000|Overall Study|Withdrawal by Subject|3|||
23546971|NCT02367911|65735652|FG001|Overall Study|Withdrawal by Subject|2|||
23546972|NCT02367911|65735651|FG000|Overall Study|Lost to Follow-up|2|||
23546973|NCT02367911|65735652|FG001|Overall Study|Lost to Follow-up|2|||
23546974|NCT02187991|65735653|FG000|Overall Study|Adverse Event|13|||
23546975|NCT02187991|65735654|FG001|Overall Study|Adverse Event|14|||
23546976|NCT02187991|65735655|FG002|Overall Study|Adverse Event|3|||
23546977|NCT02187991|65735656|FG003|Overall Study|Adverse Event|2|||
23546978|NCT02187991|65735653|FG000|Overall Study|Withdrawal by Subject|9|||
23546979|NCT02187991|65735654|FG001|Overall Study|Withdrawal by Subject|6|||
23546980|NCT02187991|65735655|FG002|Overall Study|Withdrawal by Subject|3|||
23546981|NCT02187991|65735656|FG003|Overall Study|Withdrawal by Subject|2|||
23546982|NCT02187991|65735653|FG000|Overall Study|Physician Decision|4|||
23546983|NCT02187991|65735654|FG001|Overall Study|Physician Decision|4|||
23546984|NCT02187991|65735655|FG002|Overall Study|Physician Decision|0|||
23546985|NCT02187991|65735656|FG003|Overall Study|Physician Decision|2|||
23546986|NCT02187991|65735653|FG000|Overall Study|Other, unrelated complication|7|||
23546987|NCT02187991|65735654|FG001|Overall Study|Other, unrelated complication|1|||
23546988|NCT02187991|65735655|FG002|Overall Study|Other, unrelated complication|1|||
23213524|NCT01617655|64523311|FG000|Overall Study|Other than specified above|1|||
23213525|NCT01617655|64523312|FG001|Overall Study|Other than specified above|2|||
23317281|NCT01449370|64904060|FG000|Overall Study|Disease Progression|5|||
23546989|NCT02187991|65735656|FG003|Overall Study|Other, unrelated complication|2|||
23546990|NCT02187991|65735653|FG000|Overall Study|Death|1|||
23546991|NCT02187991|65735654|FG001|Overall Study|Death|3|||
23546992|NCT02187991|65735655|FG002|Overall Study|Death|0|||
23546993|NCT02187991|65735656|FG003|Overall Study|Death|0|||
23546994|NCT00380068|65735659|FG000|Overall Study|Adverse Event|40|||
23546995|NCT00380068|65735659|FG000|Overall Study|Withdrawal by Subject|10|||
23546996|NCT00380068|65735659|FG000|Overall Study|Not compliant|6|||
23546997|NCT00380068|65735659|FG000|Overall Study|Lost to Follow-up|1|||
23546998|NCT00380068|65735659|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
23546999|NCT00380068|65735659|FG000|Overall Study|Lung transplant|3|||
23547000|NCT00380068|65735659|FG000|Overall Study|Physician Decision|2|||
23547001|NCT00380068|65735659|FG000|Overall Study|Partipant moved away|1|||
23547002|NCT00380068|65735659|FG000|Overall Study|Lack of Efficacy|5|||
23547003|NCT01026974|65735660|FG000|Overall Study|Withdrawal by Subject|0|||
23547004|NCT01026974|65735661|FG001|Overall Study|Withdrawal by Subject|1|||
23547005|NCT01026974|65735662|FG002|Overall Study|Withdrawal by Subject|7|||
23547006|NCT01026974|65735663|FG003|Overall Study|Withdrawal by Subject|2|||
23547007|NCT01026974|65735660|FG000|Overall Study|Lost to Follow-up|1|||
23547008|NCT01026974|65735661|FG001|Overall Study|Lost to Follow-up|1|||
23547009|NCT01026974|65735662|FG002|Overall Study|Lost to Follow-up|4|||
23547010|NCT01026974|65735663|FG003|Overall Study|Lost to Follow-up|0|||
23547011|NCT01026974|65735660|FG000|Overall Study|Adverse Event|0|||
23547012|NCT01026974|65735661|FG001|Overall Study|Adverse Event|0|||
23547013|NCT01026974|65735662|FG002|Overall Study|Adverse Event|0|||
23547014|NCT01026974|65735663|FG003|Overall Study|Adverse Event|1|||
23547015|NCT01026974|65735660|FG000|Overall Study|Inappropriate enrollment|0|||
23547016|NCT01026974|65735661|FG001|Overall Study|Inappropriate enrollment|0|||
23547017|NCT01026974|65735662|FG002|Overall Study|Inappropriate enrollment|1|||
23547018|NCT01026974|65735663|FG003|Overall Study|Inappropriate enrollment|0|||
23547019|NCT02682264|65735664|FG000|Overall Study|Withdrawal by Subject|56|||
23547020|NCT02682264|65735665|FG001|Overall Study|Withdrawal by Subject|45|||
23547021|NCT02682264|65735664|FG000|Overall Study|Lost to Follow-up|49|||
23547022|NCT02682264|65735665|FG001|Overall Study|Lost to Follow-up|41|||
23547023|NCT02682264|65735664|FG000|Overall Study|Lack of Efficacy|14|||
23547024|NCT02682264|65735665|FG001|Overall Study|Lack of Efficacy|16|||
23547025|NCT02682264|65735664|FG000|Overall Study|Withdrawal by Parent|6|||
23547026|NCT02682264|65735665|FG001|Overall Study|Withdrawal by Parent|7|||
23547027|NCT02682264|65735664|FG000|Overall Study|Adverse Event|9|||
23547028|NCT02682264|65735665|FG001|Overall Study|Adverse Event|0|||
23547029|NCT02682264|65735664|FG000|Overall Study|Noncompliance with study drug|1|||
23547030|NCT02682264|65735665|FG001|Overall Study|Noncompliance with study drug|4|||
23547031|NCT02682264|65735664|FG000|Overall Study|Pregnancy|1|||
23547032|NCT02682264|65735665|FG001|Overall Study|Pregnancy|2|||
23547033|NCT02682264|65735664|FG000|Overall Study|Recovery|1|||
23547034|NCT02682264|65735665|FG001|Overall Study|Recovery|2|||
23619222|NCT03494985|65991497|FG001|Overall Study|Adverse Event|2|||
23131883|NCT01559129|64229748|FG001|Treatment Phase|Progressive Disease|1|||
23131884|NCT01559129|64229747|FG000|Treatment Phase|Lack of Efficacy|0|||
23131885|NCT01559129|64229748|FG001|Treatment Phase|Lack of Efficacy|1|||
23131886|NCT01559129|64229747|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
23547035|NCT02682264|65735664|FG000|Overall Study|Progressive Disease|1|||
23547036|NCT02682264|65735665|FG001|Overall Study|Progressive Disease|0|||
23547037|NCT02682264|65735664|FG000|Overall Study|Technical Problems|0|||
23547038|NCT02682264|65735665|FG001|Overall Study|Technical Problems|1|||
23547039|NCT02682264|65735664|FG000|Overall Study|Moved abroad and unable to continue|0|||
23547040|NCT02682264|65735665|FG001|Overall Study|Moved abroad and unable to continue|3|||
23547041|NCT02682264|65735664|FG000|Overall Study|Stopped test article application|0|||
23547042|NCT02682264|65735665|FG001|Overall Study|Stopped test article application|1|||
23547043|NCT02590354|65735666|FG000|Phase 1|Active hepatitis B or C infection|1|||
23547044|NCT02590354|65735666|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
23547045|NCT02590354|65735666|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
23547046|NCT02590354|65735666|FG000|Phase 1|Subject does not want to participate|20|||
23547047|NCT02590354|65735666|FG000|Phase 1|Lost to Follow-up|1|||
23547048|NCT02590354|65735666|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
23547049|NCT02252211|65735668|FG000|Overall Study|Adverse Event|0|||
23547050|NCT02252211|65735669|FG001|Overall Study|Adverse Event|1|||
23547051|NCT02252211|65735670|FG002|Overall Study|Adverse Event|0|||
23547052|NCT02252211|65735668|FG000|Overall Study|Progressive disease|3|||
23547053|NCT02252211|65735669|FG001|Overall Study|Progressive disease|2|||
23547054|NCT02252211|65735670|FG002|Overall Study|Progressive disease|0|||
23547055|NCT02252211|65735668|FG000|Overall Study|Withdrawal by Subject|1|||
23547056|NCT02252211|65735669|FG001|Overall Study|Withdrawal by Subject|0|||
23547057|NCT02252211|65735670|FG002|Overall Study|Withdrawal by Subject|0|||
23547058|NCT02252211|65735668|FG000|Overall Study|Serious Adverse Event During Screening|1|||
23547059|NCT02252211|65735669|FG001|Overall Study|Serious Adverse Event During Screening|0|||
23547060|NCT02252211|65735670|FG002|Overall Study|Serious Adverse Event During Screening|1|||
23547061|NCT02096900|65735671|FG000|Overall Study|Did not receive medication|3|||
23131887|NCT01559129|64229748|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
23131888|NCT01559129|64229747|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
23547062|NCT02096900|65735672|FG001|Overall Study|Did not receive medication|1|||
23547063|NCT02096900|65735671|FG000|Overall Study|Surgery cancelled- medication received|1|||
23547064|NCT02096900|65735672|FG001|Overall Study|Surgery cancelled- medication received|1|||
23547065|NCT01775904|65735673|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
23547066|NCT01775904|65735673|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
23547067|NCT02653482|65735674|FG000|Overall Study|Death|1|||
23547068|NCT02653482|65735675|FG001|Overall Study|Death|1|||
23547069|NCT00626522|65735678|FG000|Overall Study|Protocol Violation|0|||
23547070|NCT00626522|65735679|FG001|Overall Study|Protocol Violation|0|||
23547071|NCT00626522|65735680|FG002|Overall Study|Protocol Violation|0|||
23547072|NCT00626522|65735681|FG003|Overall Study|Protocol Violation|0|||
23547073|NCT00626522|65735682|FG004|Overall Study|Protocol Violation|1|||
23547074|NCT00626522|65735683|FG005|Overall Study|Protocol Violation|0|||
23547075|NCT00626522|65735678|FG000|Overall Study|Adverse Event|2|||
23547076|NCT00626522|65735679|FG001|Overall Study|Adverse Event|1|||
23547077|NCT00626522|65735680|FG002|Overall Study|Adverse Event|2|||
23547078|NCT00626522|65735681|FG003|Overall Study|Adverse Event|0|||
23547079|NCT00626522|65735682|FG004|Overall Study|Adverse Event|1|||
23547080|NCT00626522|65735683|FG005|Overall Study|Adverse Event|1|||
23547081|NCT00626522|65735678|FG000|Overall Study|Withdrawal by Subject|2|||
23547082|NCT00626522|65735679|FG001|Overall Study|Withdrawal by Subject|5|||
23547083|NCT00626522|65735680|FG002|Overall Study|Withdrawal by Subject|5|||
23547084|NCT00626522|65735681|FG003|Overall Study|Withdrawal by Subject|0|||
23547085|NCT00626522|65735682|FG004|Overall Study|Withdrawal by Subject|4|||
23547086|NCT00626522|65735683|FG005|Overall Study|Withdrawal by Subject|1|||
23547087|NCT00626522|65735678|FG000|Overall Study|COPD exacerbation|0|||
23547088|NCT00626522|65735679|FG001|Overall Study|COPD exacerbation|0|||
23547089|NCT00626522|65735680|FG002|Overall Study|COPD exacerbation|0|||
23547090|NCT00626522|65735681|FG003|Overall Study|COPD exacerbation|1|||
23547091|NCT00626522|65735682|FG004|Overall Study|COPD exacerbation|1|||
23547092|NCT00626522|65735683|FG005|Overall Study|COPD exacerbation|0|||
23547093|NCT00626522|65735678|FG000|Overall Study|Lost to Follow-up|0|||
23547094|NCT00626522|65735679|FG001|Overall Study|Lost to Follow-up|1|||
23547095|NCT00626522|65735680|FG002|Overall Study|Lost to Follow-up|0|||
23547096|NCT00626522|65735681|FG003|Overall Study|Lost to Follow-up|0|||
23547097|NCT00626522|65735682|FG004|Overall Study|Lost to Follow-up|0|||
23547098|NCT00626522|65735683|FG005|Overall Study|Lost to Follow-up|0|||
23547099|NCT00626522|65735678|FG000|Overall Study|Inconsistent reason reported|1|||
23547100|NCT00626522|65735679|FG001|Overall Study|Inconsistent reason reported|0|||
23547101|NCT00626522|65735680|FG002|Overall Study|Inconsistent reason reported|0|||
23547102|NCT00626522|65735681|FG003|Overall Study|Inconsistent reason reported|0|||
23547103|NCT00626522|65735682|FG004|Overall Study|Inconsistent reason reported|0|||
23547104|NCT00626522|65735683|FG005|Overall Study|Inconsistent reason reported|0|||
23547105|NCT00626522|65735678|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
23547106|NCT00626522|65735679|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
23547107|NCT00626522|65735680|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
23547108|NCT00626522|65735681|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
23547109|NCT00626522|65735682|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
23547110|NCT00626522|65735683|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
23547111|NCT05553808|65735684|FG000|Overall Study|Death|25|||
23213526|NCT02137837|64523315|FG000|Overall Study|Adverse Event|0|||
23317282|NCT01449370|64904061|FG001|Overall Study|Disease Progression|4|||
23317283|NCT01449370|64904062|FG002|Overall Study|Disease Progression|8|||
23317284|NCT01449370|64904063|FG003|Overall Study|Disease Progression|3|||
23317285|NCT01449370|64904064|FG004|Overall Study|Disease Progression|3|||
23317286|NCT01449370|64904065|FG005|Overall Study|Disease Progression|3|||
23317287|NCT01449370|64904066|FG006|Overall Study|Disease Progression|3|||
23317288|NCT01449370|64904067|FG007|Overall Study|Disease Progression|2|||
23317289|NCT01449370|64904068|FG008|Overall Study|Disease Progression|9|||
23317290|NCT01449370|64904069|FG009|Overall Study|Disease Progression|1|||
23317291|NCT01449370|64904070|FG010|Overall Study|Disease Progression|3|||
23547112|NCT05553808|65735685|FG001|Overall Study|Death|62|||
23317292|NCT01449370|64904071|FG011|Overall Study|Disease Progression|3|||
23317293|NCT01449370|64904072|FG012|Overall Study|Disease Progression|2|||
23547113|NCT05553808|65735684|FG000|Overall Study|Site Closed|6|||
23547114|NCT05553808|65735685|FG001|Overall Study|Site Closed|6|||
23547115|NCT05553808|65735684|FG000|Overall Study|Lost to Follow-up|1|||
23547116|NCT05553808|65735685|FG001|Overall Study|Lost to Follow-up|0|||
23547117|NCT05553808|65735684|FG000|Overall Study|Withdrawal by Subject|3|||
23131889|NCT01559129|64229748|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
23131890|NCT01559129|64229747|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
23131891|NCT01559129|64229748|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
23131892|NCT01559129|64229747|FG000|Open-label Extension Period|Adverse Event|1|||
23131893|NCT01559129|64229748|FG001|Open-label Extension Period|Adverse Event|0|||
23131894|NCT01559129|64229747|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
23131895|NCT01559129|64229748|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
23131896|NCT01607879|64229753|FG000|Overall Study|Death|1|||
23131897|NCT01607879|64229754|FG001|Overall Study|Death|0|||
23131898|NCT01251770|64229756|FG000|Overall Study|Protocol Violation|13|||
23131899|NCT01251770|64229757|FG001|Overall Study|Protocol Violation|7|||
23131900|NCT03816761|64229759|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23317294|NCT01449370|64904073|FG013|Overall Study|Disease Progression|8|||
23547118|NCT05553808|65735685|FG001|Overall Study|Withdrawal by Subject|2|||
23547119|NCT01664078|65735690|FG000|Overall Study|Death|9|||
23547120|NCT01664078|65735690|FG000|Overall Study|Withdrawal by Subject|4|||
23547121|NCT01664078|65735690|FG000|Overall Study|Lost to Follow-up|2|||
23547122|NCT01664078|65735690|FG000|Overall Study|missed 5 year visit|1|||
23547123|NCT01664078|65735690|FG000|Overall Study|Other|53|||
23547124|NCT01154166|65735691|FG000|Overall Study|Adverse Event|14|||
23547125|NCT01154166|65735692|FG001|Overall Study|Adverse Event|9|||
23547126|NCT01154166|65735691|FG000|Overall Study|Lost to Follow-up|1|||
23547127|NCT01154166|65735692|FG001|Overall Study|Lost to Follow-up|1|||
23547128|NCT01154166|65735691|FG000|Overall Study|Protocol Violation|4|||
23547129|NCT01154166|65735692|FG001|Overall Study|Protocol Violation|1|||
23547130|NCT01154166|65735691|FG000|Overall Study|Withdrawal by Subject|10|||
23547131|NCT01154166|65735692|FG001|Overall Study|Withdrawal by Subject|1|||
23547132|NCT01154166|65735691|FG000|Overall Study|Lack of Efficacy|3|||
23547133|NCT01154166|65735692|FG001|Overall Study|Lack of Efficacy|0|||
23547134|NCT01154166|65735691|FG000|Overall Study|Disease Progression|1|||
23547135|NCT01154166|65735692|FG001|Overall Study|Disease Progression|0|||
23547136|NCT01154166|65735691|FG000|Overall Study|Poor Compliance|1|||
23547137|NCT01154166|65735692|FG001|Overall Study|Poor Compliance|0|||
23547138|NCT04575467|65735699|FG000|Overall Study|Adverse Event|0|||
23547139|NCT04575467|65735700|FG001|Overall Study|Adverse Event|1|||
23547140|NCT04575467|65735701|FG002|Overall Study|Adverse Event|0|||
23547141|NCT04575467|65735702|FG003|Overall Study|Adverse Event|0|||
23547142|NCT00839072|65735703|FG000|First Intervention Period|Withdrawal by Subject|1|||
23547143|NCT00839072|65735704|FG001|First Intervention Period|Withdrawal by Subject|0|||
23547144|NCT00839072|65735703|FG000|First Intervention Period|Adverse Event|1|||
23547145|NCT00839072|65735704|FG001|First Intervention Period|Adverse Event|1|||
23547146|NCT00839072|65735703|FG000|Second Intervention Period|Withdrawal by Subject|1|||
23547147|NCT00839072|65735704|FG001|Second Intervention Period|Withdrawal by Subject|0|||
23547148|NCT01914926|65735712|FG000|Overall Study|Adverse Event|1|||
23547149|NCT01914926|65735713|FG001|Overall Study|Adverse Event|0|||
23547150|NCT01914926|65735712|FG000|Overall Study|uncooperative, agitated and removed|0|||
23547151|NCT01914926|65735713|FG001|Overall Study|uncooperative, agitated and removed|1|||
23547152|NCT00574080|65735714|FG000|Overall Study|Death|10|||
23547153|NCT00574080|65735715|FG001|Overall Study|Death|10|||
23547154|NCT02232893|65735716|FG000|Overall Study|Withdrawal by Subject|4|||
23547155|NCT02232893|65735717|FG001|Overall Study|Withdrawal by Subject|1|||
23547156|NCT02232893|65735716|FG000|Overall Study|Adverse Event|0|||
23547157|NCT02232893|65735717|FG001|Overall Study|Adverse Event|1|||
23547158|NCT02232893|65735716|FG000|Overall Study|Sponsor request early termination|0|||
23131901|NCT03816761|64229760|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23317295|NCT01449370|64904074|FG014|Overall Study|Disease Progression|3|||
23317296|NCT01449370|64904075|FG015|Overall Study|Disease Progression|1|||
23317297|NCT01449370|64904076|FG016|Overall Study|Disease Progression|4|||
23317298|NCT01449370|64904077|FG017|Overall Study|Disease Progression|3|||
23317299|NCT01449370|64904078|FG018|Overall Study|Disease Progression|1|||
23317300|NCT01449370|64904079|FG019|Overall Study|Disease Progression|2|||
23317301|NCT01449370|64904080|FG020|Overall Study|Disease Progression|5|||
23317302|NCT01449370|64904081|FG021|Overall Study|Disease Progression|2|||
23317303|NCT01449370|64904082|FG022|Overall Study|Disease Progression|3|||
23317304|NCT01449370|64904083|FG023|Overall Study|Disease Progression|7|||
23317305|NCT01449370|64904084|FG024|Overall Study|Disease Progression|3|||
23317306|NCT01449370|64904060|FG000|Overall Study|Adverse Event|1|||
23317307|NCT01449370|64904061|FG001|Overall Study|Adverse Event|2|||
23317308|NCT01449370|64904062|FG002|Overall Study|Adverse Event|0|||
23317309|NCT01449370|64904063|FG003|Overall Study|Adverse Event|1|||
23317310|NCT01449370|64904064|FG004|Overall Study|Adverse Event|0|||
23317311|NCT01449370|64904065|FG005|Overall Study|Adverse Event|0|||
23317312|NCT01449370|64904066|FG006|Overall Study|Adverse Event|0|||
23317313|NCT01449370|64904067|FG007|Overall Study|Adverse Event|0|||
23317314|NCT01449370|64904068|FG008|Overall Study|Adverse Event|1|||
23131902|NCT03816761|64229761|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23131903|NCT03816761|64229762|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23131904|NCT03816761|64229763|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
23131905|NCT03816761|64229764|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
23131906|NCT03816761|64229759|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
23131907|NCT03816761|64229760|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
23131908|NCT03816761|64229761|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
23317315|NCT01449370|64904069|FG009|Overall Study|Adverse Event|1|||
23317316|NCT01449370|64904070|FG010|Overall Study|Adverse Event|0|||
23317317|NCT01449370|64904071|FG011|Overall Study|Adverse Event|0|||
23317318|NCT01449370|64904072|FG012|Overall Study|Adverse Event|0|||
23317319|NCT01449370|64904073|FG013|Overall Study|Adverse Event|2|||
23317320|NCT01449370|64904074|FG014|Overall Study|Adverse Event|0|||
23547159|NCT02232893|65735717|FG001|Overall Study|Sponsor request early termination|1|||
23547160|NCT02232893|65735716|FG000|Overall Study|Developed exclusion criteria|0|||
23547161|NCT02232893|65735717|FG001|Overall Study|Developed exclusion criteria|1|||
23547162|NCT02232893|65735716|FG000|Overall Study|Other|0|||
23547163|NCT02232893|65735717|FG001|Overall Study|Other|3|||
23213527|NCT02137837|64523316|FG001|Overall Study|Adverse Event|2|||
23213528|NCT02137837|64523317|FG002|Overall Study|Adverse Event|1|||
23213529|NCT02137837|64523315|FG000|Overall Study|Refusal unrelated to adverse event|2|||
23213530|NCT02137837|64523316|FG001|Overall Study|Refusal unrelated to adverse event|2|||
23213531|NCT02137837|64523317|FG002|Overall Study|Refusal unrelated to adverse event|1|||
23131909|NCT03816761|64229762|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
23131910|NCT03816761|64229763|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
23131911|NCT03816761|64229764|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
23131912|NCT01827046|64229765|FG000|Overall Study|Lost to Follow-up|1|||
23131913|NCT01827046|64229766|FG001|Overall Study|Lost to Follow-up|5|||
23131914|NCT01827046|64229765|FG000|Overall Study|Withdrawal by Subject|0|||
23213532|NCT02137837|64523315|FG000|Overall Study|Progression/relapse|9|||
23213533|NCT02137837|64523316|FG001|Overall Study|Progression/relapse|7|||
23213534|NCT02137837|64523317|FG002|Overall Study|Progression/relapse|7|||
23427421|NCT04316741|65307666|FG001|Baseline Enrollment|Lost to Follow-up|1|||
23427422|NCT04316741|65307665|FG000|Immediate Post-Test|Lost to Follow-up|5|||
23427423|NCT04316741|65307666|FG001|Immediate Post-Test|Lost to Follow-up|1|||
23427424|NCT04316741|65307665|FG000|1-month Post-test|Lost to Follow-up|7|||
23427425|NCT04316741|65307666|FG001|1-month Post-test|Lost to Follow-up|2|||
23619223|NCT03494985|65991498|FG002|Overall Study|Adverse Event|3|||
23619224|NCT03494985|65991499|FG003|Overall Study|Adverse Event|0|||
23213535|NCT02137837|64523315|FG000|Overall Study|Not protocol specified|2|||
23213536|NCT02137837|64523316|FG001|Overall Study|Not protocol specified|1|||
23213537|NCT02137837|64523317|FG002|Overall Study|Not protocol specified|3|||
23213538|NCT00453180|64523318|FG000|Overall Study|Lost to Follow-up|2|||
23213539|NCT00453180|64523319|FG001|Overall Study|Lost to Follow-up|1|||
23213540|NCT00453180|64523318|FG000|Overall Study|Adverse Event|1|||
23213541|NCT00453180|64523319|FG001|Overall Study|Adverse Event|2|||
23213542|NCT02475395|64523324|FG000|Overall Study|Protocol Violation|30|||
23213543|NCT02475395|64523325|FG001|Overall Study|Protocol Violation|3|||
23213544|NCT02581982|64523340|FG000|Overall Study|Lack of Efficacy|12|||
23213545|NCT02581982|64523340|FG000|Overall Study|Adverse Event|3|||
23213546|NCT02581982|64523340|FG000|Overall Study|Physician Decision|1|||
23213547|NCT00970268|64523342|FG000|Overall Study|Withdrawal by Subject|12|||
23213548|NCT00970268|64523343|FG001|Overall Study|Withdrawal by Subject|19|||
23213549|NCT00970268|64523342|FG000|Overall Study|Adverse Event|15|||
23427426|NCT04316741|65307665|FG000|3-month Follow-up|Lost to Follow-up|10|||
23619225|NCT03494985|65991496|FG000|Overall Study|Other (Withdrawal of consent)|2|||
23619226|NCT03494985|65991497|FG001|Overall Study|Other (Withdrawal of consent)|3|||
23619227|NCT03494985|65991498|FG002|Overall Study|Other (Withdrawal of consent)|2|||
23619228|NCT03494985|65991499|FG003|Overall Study|Other (Withdrawal of consent)|5|||
23619229|NCT03494985|65991496|FG000|Overall Study|Other (Not specified)|0|||
23619230|NCT03494985|65991497|FG001|Overall Study|Other (Not specified)|1|||
23619231|NCT03494985|65991498|FG002|Overall Study|Other (Not specified)|1|||
23619232|NCT03494985|65991499|FG003|Overall Study|Other (Not specified)|0|||
23619233|NCT02253147|65991500|FG000|Overall Study|Protocol Violation|30|||
23619234|NCT02253147|65991500|FG000|Overall Study|Did not consent to study extension|9|||
23619235|NCT02253147|65991500|FG000|Overall Study|Conditional re-treatment at W52|5|||
23619236|NCT02253147|65991500|FG000|Overall Study|Lost to Follow-up|2|||
23619237|NCT02253147|65991500|FG000|Overall Study|Withdrawal by Subject|1|||
23619238|NCT02661490|65991504|FG000|Overall Study|Lost to Follow-up|0|||
23619239|NCT02661490|65991505|FG001|Overall Study|Lost to Follow-up|1|||
23619240|NCT02661490|65991506|FG002|Overall Study|Lost to Follow-up|0|||
23619241|NCT02661490|65991507|FG003|Overall Study|Lost to Follow-up|0|||
23619242|NCT02661490|65991508|FG004|Overall Study|Lost to Follow-up|2|||
23619243|NCT02661490|65991504|FG000|Overall Study|Withdrawal by Subject|2|||
23619244|NCT02661490|65991505|FG001|Overall Study|Withdrawal by Subject|0|||
23619245|NCT02661490|65991506|FG002|Overall Study|Withdrawal by Subject|2|||
23619246|NCT02661490|65991507|FG003|Overall Study|Withdrawal by Subject|0|||
23619247|NCT02661490|65991508|FG004|Overall Study|Withdrawal by Subject|0|||
23619248|NCT02661490|65991504|FG000|Overall Study|Death|1|||
23619249|NCT02661490|65991505|FG001|Overall Study|Death|1|||
23619250|NCT02661490|65991506|FG002|Overall Study|Death|0|||
23131915|NCT01827046|64229766|FG001|Overall Study|Withdrawal by Subject|4|||
23131916|NCT00685698|64229767|FG000|Overall Study|Withdrawal by Subject|1|||
23427427|NCT04316741|65307666|FG001|3-month Follow-up|Lost to Follow-up|2|||
23427428|NCT03515941|65307669|FG000|Overall Study|Adverse Event|1|||
23619251|NCT02661490|65991507|FG003|Overall Study|Death|1|||
23213550|NCT00970268|64523343|FG001|Overall Study|Adverse Event|12|||
23213551|NCT00970268|64523342|FG000|Overall Study|Lack of Efficacy|3|||
23213552|NCT00970268|64523343|FG001|Overall Study|Lack of Efficacy|6|||
23619252|NCT02661490|65991508|FG004|Overall Study|Death|0|||
23619253|NCT02661490|65991504|FG000|Overall Study|Reason not Specified|0|||
23619254|NCT02661490|65991505|FG001|Overall Study|Reason not Specified|0|||
23619255|NCT02661490|65991506|FG002|Overall Study|Reason not Specified|0|||
23213553|NCT00970268|64523342|FG000|Overall Study|Protocol Violation|4|||
23213554|NCT00970268|64523343|FG001|Overall Study|Protocol Violation|7|||
23619256|NCT02661490|65991507|FG003|Overall Study|Reason not Specified|0|||
23619257|NCT02661490|65991508|FG004|Overall Study|Reason not Specified|1|||
23131917|NCT00685698|64229767|FG000|Overall Study|Protocol Violation|6|||
23131918|NCT00685698|64229767|FG000|Overall Study|Adverse Event|3|||
23131919|NCT00685698|64229767|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
23131920|NCT00685698|64229767|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
23131921|NCT00685698|64229767|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
23131922|NCT00589303|64229768|FG000|Overall Study|Withdrawal by Subject|2|||
23131923|NCT00589303|64229769|FG001|Overall Study|Withdrawal by Subject|1|||
23131924|NCT04514510|64229770|FG000|Overall Study|Lost to Follow-up|0|||
23131925|NCT04514510|64229771|FG001|Overall Study|Lost to Follow-up|1|||
23131926|NCT04514510|64229770|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
23131927|NCT04514510|64229771|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
23427429|NCT03515941|65307670|FG001|Overall Study|Adverse Event|0|||
23427430|NCT00493636|65307671|FG000|Overall Study|Withdrawal by Subject|1|||
23427431|NCT00493636|65307672|FG001|Overall Study|Withdrawal by Subject|0|||
23427432|NCT00493636|65307671|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
23427433|NCT00493636|65307672|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
23427434|NCT00493636|65307671|FG000|Overall Study|Mis-randomization|1|||
23619258|NCT02847637|65991509|FG000|Overall Study|Withdrawal by Subject|0|||
23619259|NCT02847637|65991510|FG001|Overall Study|Withdrawal by Subject|1|||
23619260|NCT02847637|65991511|FG002|Overall Study|Withdrawal by Subject|1|||
23131928|NCT01374568|64229772|FG000|Overall Study|Lab unable to analyze BTM|0|||
23131929|NCT01374568|64229773|FG001|Overall Study|Lab unable to analyze BTM|2|||
23131930|NCT01886287|64229774|FG000|Overall Study|Radiographic disease progression|1|||
23131931|NCT01886287|64229774|FG000|Overall Study|Clinical progression due to disease|1|||
23131932|NCT04927884|64229775|FG000|Overall Study|Progressive Disease|2|||
23131933|NCT01585155|64229776|FG000|Overall Study|Adverse Event|1|||
23131934|NCT01585155|64229776|FG000|Overall Study|Lack of Efficacy|2|||
23131935|NCT01585155|64229776|FG000|Overall Study|Worsening ulcerative colitis|2|||
23131936|NCT00763451|64229777|FG000|Overall Study|Adverse Event|4|||
23131937|NCT00763451|64229778|FG001|Overall Study|Adverse Event|6|||
23131938|NCT00763451|64229779|FG002|Overall Study|Adverse Event|19|||
23131939|NCT00763451|64229780|FG003|Overall Study|Adverse Event|14|||
23131940|NCT00763451|64229777|FG000|Overall Study|Lack of Efficacy|1|||
23131941|NCT00763451|64229778|FG001|Overall Study|Lack of Efficacy|4|||
23131942|NCT00763451|64229779|FG002|Overall Study|Lack of Efficacy|3|||
23131943|NCT00763451|64229780|FG003|Overall Study|Lack of Efficacy|2|||
23131944|NCT00763451|64229777|FG000|Overall Study|Withdrawal by Subject|1|||
23131945|NCT00763451|64229778|FG001|Overall Study|Withdrawal by Subject|6|||
23131946|NCT00763451|64229779|FG002|Overall Study|Withdrawal by Subject|9|||
23131947|NCT00763451|64229780|FG003|Overall Study|Withdrawal by Subject|7|||
23213555|NCT00970268|64523342|FG000|Overall Study|Other Reason|3|||
23213556|NCT00970268|64523343|FG001|Overall Study|Other Reason|1|||
23213557|NCT00970268|64523342|FG000|Overall Study|COPD Exacerbation|4|||
23131948|NCT00763451|64229777|FG000|Overall Study|Protocol Violation|0|||
23131949|NCT00763451|64229778|FG001|Overall Study|Protocol Violation|0|||
23131950|NCT00763451|64229779|FG002|Overall Study|Protocol Violation|1|||
23131951|NCT00763451|64229780|FG003|Overall Study|Protocol Violation|0|||
23131952|NCT00763451|64229777|FG000|Overall Study|Poor Compliance to Protocol|1|||
23131953|NCT00763451|64229778|FG001|Overall Study|Poor Compliance to Protocol|1|||
23131954|NCT00763451|64229779|FG002|Overall Study|Poor Compliance to Protocol|2|||
23131955|NCT00763451|64229780|FG003|Overall Study|Poor Compliance to Protocol|2|||
23131956|NCT00763451|64229777|FG000|Overall Study|Familial and Personal Reasons|5|||
23131957|NCT00763451|64229778|FG001|Overall Study|Familial and Personal Reasons|3|||
23131958|NCT00763451|64229779|FG002|Overall Study|Familial and Personal Reasons|5|||
23131959|NCT00763451|64229780|FG003|Overall Study|Familial and Personal Reasons|4|||
23131960|NCT00763451|64229777|FG000|Overall Study|Randomized but not Treated|1|||
23131961|NCT00763451|64229778|FG001|Overall Study|Randomized but not Treated|1|||
23131962|NCT00763451|64229779|FG002|Overall Study|Randomized but not Treated|0|||
23131963|NCT00763451|64229780|FG003|Overall Study|Randomized but not Treated|0|||
23131964|NCT00763451|64229777|FG000|Overall Study|Study Site Reason|0|||
23213558|NCT00970268|64523343|FG001|Overall Study|COPD Exacerbation|2|||
23427435|NCT00493636|65307672|FG001|Overall Study|Mis-randomization|1|||
23131965|NCT00763451|64229778|FG001|Overall Study|Study Site Reason|1|||
23131966|NCT00763451|64229779|FG002|Overall Study|Study Site Reason|1|||
23131967|NCT00763451|64229780|FG003|Overall Study|Study Site Reason|1|||
23213559|NCT00970268|64523342|FG000|Overall Study|Lost to Follow-up|1|||
23427436|NCT00657371|65307675|FG000|Overall Study|Poor bowel preparation|15|||
23213560|NCT00970268|64523343|FG001|Overall Study|Lost to Follow-up|2|||
23619261|NCT02847637|65991512|FG003|Overall Study|Withdrawal by Subject|0|||
23619262|NCT02847637|65991509|FG000|Overall Study|Lost to Follow-up|1|||
23619263|NCT02847637|65991510|FG001|Overall Study|Lost to Follow-up|1|||
23619264|NCT02847637|65991511|FG002|Overall Study|Lost to Follow-up|0|||
23131968|NCT02145468|64229785|FG000|Overall Study|Withdrawal by Subject|5|||
23131969|NCT02145468|64229786|FG001|Overall Study|Withdrawal by Subject|8|||
23317321|NCT01449370|64904075|FG015|Overall Study|Adverse Event|1|||
23131970|NCT01399697|64229789|FG000|Overall Study|Adverse Event|13|||
23131971|NCT01399697|64229790|FG001|Overall Study|Adverse Event|3|||
23131972|NCT01399697|64229791|FG002|Overall Study|Adverse Event|1|||
23131973|NCT01399697|64229789|FG000|Overall Study|Lost to Follow-up|2|||
23131974|NCT01399697|64229790|FG001|Overall Study|Lost to Follow-up|0|||
23131975|NCT01399697|64229791|FG002|Overall Study|Lost to Follow-up|0|||
23131976|NCT01399697|64229789|FG000|Overall Study|Withdrawal by Subject|8|||
23131977|NCT01399697|64229790|FG001|Overall Study|Withdrawal by Subject|0|||
23131978|NCT01399697|64229791|FG002|Overall Study|Withdrawal by Subject|0|||
23131979|NCT01399697|64229789|FG000|Overall Study|Investigator Decisión|1|||
23131980|NCT01399697|64229790|FG001|Overall Study|Investigator Decisión|0|||
23131981|NCT01399697|64229791|FG002|Overall Study|Investigator Decisión|2|||
23131982|NCT01399697|64229789|FG000|Overall Study|Lack of Efficacy|9|||
23131983|NCT01399697|64229790|FG001|Overall Study|Lack of Efficacy|0|||
23131984|NCT01399697|64229791|FG002|Overall Study|Lack of Efficacy|1|||
23131985|NCT01399697|64229789|FG000|Overall Study|Protocol Violation|2|||
23131986|NCT01399697|64229790|FG001|Overall Study|Protocol Violation|0|||
23131987|NCT01399697|64229791|FG002|Overall Study|Protocol Violation|0|||
23131988|NCT01399697|64229789|FG000|Overall Study|Non-Compliant|1|||
23131989|NCT01399697|64229790|FG001|Overall Study|Non-Compliant|0|||
23131990|NCT01399697|64229791|FG002|Overall Study|Non-Compliant|0|||
23131991|NCT01399697|64229789|FG000|Overall Study|Inclusion Error|2|||
23131992|NCT01399697|64229790|FG001|Overall Study|Inclusion Error|0|||
23131993|NCT01399697|64229791|FG002|Overall Study|Inclusion Error|0|||
23131994|NCT01399697|64229789|FG000|Overall Study|Positive result for hepatitis B|1|||
23131995|NCT01399697|64229790|FG001|Overall Study|Positive result for hepatitis B|0|||
23131996|NCT01399697|64229791|FG002|Overall Study|Positive result for hepatitis B|0|||
23131997|NCT01399697|64229789|FG000|Overall Study|Clinical RA remission|1|||
23131998|NCT01399697|64229790|FG001|Overall Study|Clinical RA remission|0|||
23131999|NCT01399697|64229791|FG002|Overall Study|Clinical RA remission|0|||
23547164|NCT05557942|65735720|FG000|Overall Study|Death|0|||
23547165|NCT05557942|65735721|FG001|Overall Study|Death|0|||
23547166|NCT05557942|65735722|FG002|Overall Study|Death|0|||
23547167|NCT05557942|65735723|FG003|Overall Study|Death|2|||
23547168|NCT05557942|65735724|FG004|Overall Study|Death|1|||
23547169|NCT05557942|65735725|FG005|Overall Study|Death|1|||
23547170|NCT05557942|65735720|FG000|Overall Study|Physician Decision|1|||
23547171|NCT05557942|65735721|FG001|Overall Study|Physician Decision|1|||
23547172|NCT05557942|65735722|FG002|Overall Study|Physician Decision|2|||
23547173|NCT05557942|65735723|FG003|Overall Study|Physician Decision|3|||
23547174|NCT05557942|65735724|FG004|Overall Study|Physician Decision|0|||
23547175|NCT05557942|65735725|FG005|Overall Study|Physician Decision|2|||
23547176|NCT05557942|65735720|FG000|Overall Study|Study terminated by sponsor|17|||
23547177|NCT05557942|65735721|FG001|Overall Study|Study terminated by sponsor|17|||
23547178|NCT05557942|65735722|FG002|Overall Study|Study terminated by sponsor|14|||
23547179|NCT05557942|65735723|FG003|Overall Study|Study terminated by sponsor|40|||
23547180|NCT05557942|65735724|FG004|Overall Study|Study terminated by sponsor|45|||
23547181|NCT05557942|65735725|FG005|Overall Study|Study terminated by sponsor|37|||
23547182|NCT05557942|65735720|FG000|Overall Study|Protocol Violation|0|||
23547183|NCT05557942|65735721|FG001|Overall Study|Protocol Violation|0|||
23547184|NCT05557942|65735722|FG002|Overall Study|Protocol Violation|0|||
23547185|NCT05557942|65735723|FG003|Overall Study|Protocol Violation|0|||
23213561|NCT00970268|64523342|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
23213562|NCT00970268|64523343|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
23547186|NCT05557942|65735724|FG004|Overall Study|Protocol Violation|0|||
23547187|NCT05557942|65735725|FG005|Overall Study|Protocol Violation|1|||
23547188|NCT05557942|65735720|FG000|Overall Study|Withdrawal by Subject|0|||
23132000|NCT01399697|64229789|FG000|Overall Study|Sponsor Decision|1|||
23132001|NCT01399697|64229790|FG001|Overall Study|Sponsor Decision|0|||
23213563|NCT04721977|64523344|FG000|Overall Study|Death|15|||
23213564|NCT04721977|64523344|FG000|Overall Study|Ongoing|51|||
23213565|NCT00525785|64523345|FG000|Overall Study|Withdrawal by Subject|1|||
23213566|NCT00525785|64523345|FG000|Overall Study|Lack of Efficacy|1|||
23213567|NCT00525785|64523345|FG000|Overall Study|Physician Decision|1|||
23213568|NCT04671342|64523352|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
23213569|NCT04671342|64523352|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
23213570|NCT04671342|64523352|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
23547189|NCT05557942|65735721|FG001|Overall Study|Withdrawal by Subject|0|||
23213571|NCT04671342|64523352|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
23547190|NCT05557942|65735722|FG002|Overall Study|Withdrawal by Subject|0|||
23547191|NCT05557942|65735723|FG003|Overall Study|Withdrawal by Subject|0|||
23547192|NCT05557942|65735724|FG004|Overall Study|Withdrawal by Subject|2|||
23547193|NCT05557942|65735725|FG005|Overall Study|Withdrawal by Subject|0|||
23132002|NCT01399697|64229791|FG002|Overall Study|Sponsor Decision|0|||
23132003|NCT03284203|64229792|FG000|Overall Study|Lost to Follow-up|3|||
23132004|NCT00468143|64229793|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
23132005|NCT00468143|64229794|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
23132006|NCT00468143|64229793|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
23132007|NCT00468143|64229794|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
23547194|NCT01556438|65735730|FG000|Overall Study|Adverse Event|4|||
23547195|NCT01556438|65735731|FG001|Overall Study|Adverse Event|2|||
23547196|NCT01556438|65735730|FG000|Overall Study|Sponsor Decision|0|||
23547197|NCT01556438|65735731|FG001|Overall Study|Sponsor Decision|2|||
23547198|NCT01556438|65735730|FG000|Overall Study|Progressive Disease|0|||
23547199|NCT01556438|65735731|FG001|Overall Study|Progressive Disease|6|||
23547200|NCT01556438|65735730|FG000|Overall Study|Death|0|||
23547201|NCT01556438|65735731|FG001|Overall Study|Death|1|||
23547202|NCT01491854|65735732|FG000|Overall Study|mainly due to premature termination|93|||
23547203|NCT01491854|65735732|FG000|Overall Study|Death|1|||
23547204|NCT01491854|65735732|FG000|Overall Study|Withdrawal by Subject|3|||
23547205|NCT01491854|65735732|FG000|Overall Study|Lost to Follow-up|33|||
23547206|NCT02828111|65735733|FG000|Overall Study|Withdrawal by Subject|0|||
23547207|NCT02828111|65735734|FG001|Overall Study|Withdrawal by Subject|0|||
23547208|NCT02828111|65735735|FG002|Overall Study|Withdrawal by Subject|2|||
23547209|NCT02828111|65735736|FG003|Overall Study|Withdrawal by Subject|0|||
23132008|NCT04055090|64229795|FG000|Overall Study|screen failure|1|||
23317322|NCT01449370|64904076|FG016|Overall Study|Adverse Event|0|||
23317323|NCT01449370|64904077|FG017|Overall Study|Adverse Event|0|||
23619265|NCT02847637|65991512|FG003|Overall Study|Lost to Follow-up|0|||
23619266|NCT00463580|65991513|FG000|Overall Study|Lost to Follow-up|1|||
23619267|NCT00463580|65991514|FG001|Overall Study|Lost to Follow-up|0|||
23619268|NCT00463580|65991513|FG000|Overall Study|Schedule conflict|2|||
23547210|NCT02828111|65735737|FG004|Overall Study|Withdrawal by Subject|0|||
23547211|NCT02828111|65735733|FG000|Overall Study|Lost to Follow-up|0|||
23547212|NCT02828111|65735734|FG001|Overall Study|Lost to Follow-up|0|||
23547213|NCT02828111|65735735|FG002|Overall Study|Lost to Follow-up|0|||
23547214|NCT02828111|65735736|FG003|Overall Study|Lost to Follow-up|1|||
23547215|NCT02828111|65735737|FG004|Overall Study|Lost to Follow-up|1|||
23547216|NCT00490646|65735741|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
23547217|NCT00490646|65735742|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
23547218|NCT00490646|65735741|FG000|Overall Study|Never Treated (had an adverse event)|1|||
23547219|NCT00490646|65735742|FG001|Overall Study|Never Treated (had an adverse event)|0|||
23547220|NCT00490646|65735741|FG000|Overall Study|Never Treated (withdrew consent)|0|||
23547221|NCT00490646|65735742|FG001|Overall Study|Never Treated (withdrew consent)|1|||
23547222|NCT02105948|65735744|FG000|Overall Study|Adverse Event|10|||
23547223|NCT02105948|65735745|FG001|Overall Study|Adverse Event|7|||
23547224|NCT02105948|65735746|FG002|Overall Study|Adverse Event|11|||
23547225|NCT02105948|65735747|FG003|Overall Study|Adverse Event|11|||
23547226|NCT02105948|65735744|FG000|Overall Study|Lack of Efficacy|0|||
23547227|NCT02105948|65735745|FG001|Overall Study|Lack of Efficacy|1|||
23547228|NCT02105948|65735746|FG002|Overall Study|Lack of Efficacy|3|||
23547229|NCT02105948|65735747|FG003|Overall Study|Lack of Efficacy|2|||
23547230|NCT02105948|65735744|FG000|Overall Study|Lost to Follow-up|0|||
23619269|NCT00463580|65991514|FG001|Overall Study|Schedule conflict|0|||
23619270|NCT00463580|65991513|FG000|Overall Study|Medical/psychiatric complications|0|||
23619271|NCT00463580|65991514|FG001|Overall Study|Medical/psychiatric complications|2|||
23619272|NCT00461123|65991515|FG000|Overall Study|Adverse Event|1|||
23619273|NCT00461123|65991516|FG001|Overall Study|Adverse Event|0|||
23619274|NCT00461123|65991515|FG000|Overall Study|Lost to Follow-up|1|||
23619275|NCT00461123|65991516|FG001|Overall Study|Lost to Follow-up|1|||
23619276|NCT00461123|65991515|FG000|Overall Study|Protocol Violation|3|||
23132009|NCT04055090|64229796|FG001|Overall Study|screen failure|0|||
23132010|NCT04055090|64229795|FG000|Overall Study|Withdrawal by Subject|1|||
23132011|NCT04055090|64229796|FG001|Overall Study|Withdrawal by Subject|0|||
23132012|NCT03043313|64229797|FG000|Overall Study|Withdrawal by Subject|4|||
23132013|NCT03043313|64229798|FG001|Overall Study|Withdrawal by Subject|1|||
23317324|NCT01449370|64904078|FG018|Overall Study|Adverse Event|1|||
23317325|NCT01449370|64904079|FG019|Overall Study|Adverse Event|1|||
23547231|NCT02105948|65735745|FG001|Overall Study|Lost to Follow-up|0|||
23547232|NCT02105948|65735746|FG002|Overall Study|Lost to Follow-up|2|||
23132014|NCT03043313|64229799|FG002|Overall Study|Withdrawal by Subject|1|||
23547233|NCT02105948|65735747|FG003|Overall Study|Lost to Follow-up|1|||
23547234|NCT02105948|65735744|FG000|Overall Study|Physician Decision|2|||
23547235|NCT02105948|65735745|FG001|Overall Study|Physician Decision|2|||
23547236|NCT02105948|65735746|FG002|Overall Study|Physician Decision|2|||
23317326|NCT01449370|64904080|FG020|Overall Study|Adverse Event|0|||
23547237|NCT02105948|65735747|FG003|Overall Study|Physician Decision|2|||
23619277|NCT00461123|65991516|FG001|Overall Study|Protocol Violation|2|||
23619278|NCT00461123|65991515|FG000|Overall Study|Withdrawal by Subject|1|||
23619279|NCT00461123|65991516|FG001|Overall Study|Withdrawal by Subject|3|||
23619280|NCT00907517|65991517|FG000|Overall Study|Progressive Disease|3|||
23619281|NCT00907517|65991518|FG001|Overall Study|Progressive Disease|3|||
23132015|NCT03043313|64229797|FG000|Overall Study|Lost to Follow-up|1|||
23317327|NCT01449370|64904081|FG021|Overall Study|Adverse Event|1|||
23317328|NCT01449370|64904082|FG022|Overall Study|Adverse Event|0|||
23317329|NCT01449370|64904083|FG023|Overall Study|Adverse Event|1|||
23317330|NCT01449370|64904084|FG024|Overall Study|Adverse Event|3|||
23317331|NCT01449370|64904060|FG000|Overall Study|Participant Decision|0|||
23317332|NCT01449370|64904061|FG001|Overall Study|Participant Decision|0|||
23317333|NCT01449370|64904062|FG002|Overall Study|Participant Decision|0|||
23547238|NCT02105948|65735744|FG000|Overall Study|Withdrawal by Subject|15|||
23547239|NCT02105948|65735745|FG001|Overall Study|Withdrawal by Subject|10|||
23317334|NCT01449370|64904063|FG003|Overall Study|Participant Decision|0|||
23317335|NCT01449370|64904064|FG004|Overall Study|Participant Decision|0|||
23317336|NCT01449370|64904065|FG005|Overall Study|Participant Decision|0|||
23317337|NCT01449370|64904066|FG006|Overall Study|Participant Decision|0|||
23547240|NCT02105948|65735746|FG002|Overall Study|Withdrawal by Subject|10|||
23547241|NCT02105948|65735747|FG003|Overall Study|Withdrawal by Subject|11|||
23547242|NCT03586648|65735748|FG000|Period 1|Withdrawal by Subject|0|||
23547243|NCT03586648|65735749|FG001|Period 1|Withdrawal by Subject|1|||
23547244|NCT03586648|65735748|FG000|Period 1|Lost to Follow-up|1|||
23547245|NCT03586648|65735749|FG001|Period 1|Lost to Follow-up|1|||
23547246|NCT03586648|65735748|FG000|Period 1|Adverse Event|1|||
23547247|NCT03586648|65735749|FG001|Period 1|Adverse Event|0|||
23547248|NCT03586648|65735748|FG000|Period 1|Study related symptoms or complaints|2|||
23547249|NCT03586648|65735749|FG001|Period 1|Study related symptoms or complaints|1|||
23547250|NCT03586648|65735748|FG000|Period 1|Physician Decision|0|||
23547251|NCT03586648|65735749|FG001|Period 1|Physician Decision|1|||
23547252|NCT03586648|65735748|FG000|Period 2|Adverse Event|1|||
23547253|NCT03586648|65735749|FG001|Period 2|Adverse Event|0|||
23547254|NCT00360529|65735761|FG000|Overall Study|Adverse Event|10|||
23547255|NCT00360529|65735762|FG001|Overall Study|Adverse Event|23|||
23547256|NCT00360529|65735763|FG002|Overall Study|Adverse Event|33|||
23547257|NCT00360529|65735761|FG000|Overall Study|Protocol Violation|3|||
23547258|NCT00360529|65735762|FG001|Overall Study|Protocol Violation|3|||
23547259|NCT00360529|65735763|FG002|Overall Study|Protocol Violation|11|||
23547260|NCT00360529|65735761|FG000|Overall Study|Lost to Follow-up|14|||
23547261|NCT00360529|65735762|FG001|Overall Study|Lost to Follow-up|10|||
23547262|NCT00360529|65735763|FG002|Overall Study|Lost to Follow-up|13|||
23547263|NCT00360529|65735761|FG000|Overall Study|Withdrawal by Subject|22|||
23547264|NCT00360529|65735762|FG001|Overall Study|Withdrawal by Subject|14|||
23547265|NCT00360529|65735763|FG002|Overall Study|Withdrawal by Subject|18|||
23547266|NCT00360529|65735761|FG000|Overall Study|Lack of Efficacy|8|||
23547267|NCT00360529|65735762|FG001|Overall Study|Lack of Efficacy|6|||
23547268|NCT00360529|65735763|FG002|Overall Study|Lack of Efficacy|5|||
23132016|NCT03043313|64229798|FG001|Overall Study|Lost to Follow-up|0|||
23132017|NCT03043313|64229799|FG002|Overall Study|Lost to Follow-up|0|||
23132018|NCT03043313|64229797|FG000|Overall Study|Death|26|||
23132019|NCT03043313|64229798|FG001|Overall Study|Death|13|||
23132020|NCT03043313|64229799|FG002|Overall Study|Death|8|||
23132021|NCT03043313|64229797|FG000|Overall Study|On Treatment|7|||
23132022|NCT03043313|64229798|FG001|Overall Study|On Treatment|12|||
23132023|NCT03043313|64229799|FG002|Overall Study|On Treatment|11|||
23132024|NCT03043313|64229797|FG000|Overall Study|In follow up|7|||
23132025|NCT03043313|64229798|FG001|Overall Study|In follow up|15|||
23132026|NCT03043313|64229799|FG002|Overall Study|In follow up|11|||
23132027|NCT01498887|64229802|FG000|Overall Study|Administrative problems|1|||
23132028|NCT01498887|64229803|FG001|Overall Study|Administrative problems|0|||
23132029|NCT01498887|64229802|FG000|Overall Study|Lost to Follow-up|1|||
23132030|NCT01498887|64229803|FG001|Overall Study|Lost to Follow-up|1|||
23132031|NCT01498887|64229802|FG000|Overall Study|Withdrawal by Subject|1|||
23132032|NCT01498887|64229803|FG001|Overall Study|Withdrawal by Subject|0|||
23132033|NCT01498887|64229802|FG000|Overall Study|Protocol Violation|1|||
23132034|NCT01498887|64229803|FG001|Overall Study|Protocol Violation|3|||
23132035|NCT01498887|64229802|FG000|Overall Study|Lack of Efficacy|5|||
23132036|NCT01498887|64229803|FG001|Overall Study|Lack of Efficacy|3|||
23132037|NCT01498887|64229802|FG000|Overall Study|Abnormal result from test procedure|1|||
23132038|NCT01498887|64229803|FG001|Overall Study|Abnormal result from test procedure|1|||
23132039|NCT01498887|64229802|FG000|Overall Study|Abnormal laboratory value|2|||
23317338|NCT01449370|64904067|FG007|Overall Study|Participant Decision|1|||
23547269|NCT00360529|65735761|FG000|Overall Study|Reason discontinued not explained above|4|||
23547270|NCT00360529|65735762|FG001|Overall Study|Reason discontinued not explained above|9|||
23547271|NCT00360529|65735763|FG002|Overall Study|Reason discontinued not explained above|11|||
23317339|NCT01449370|64904068|FG008|Overall Study|Participant Decision|1|||
23547272|NCT02347761|65735766|FG000|All Collected|Death|1|||
23547273|NCT02347761|65735767|FG001|All Collected|Death|0|||
23132040|NCT01498887|64229803|FG001|Overall Study|Abnormal laboratory value|2|||
23132041|NCT01498887|64229802|FG000|Overall Study|Adverse Event|4|||
23132042|NCT01498887|64229803|FG001|Overall Study|Adverse Event|1|||
23132043|NCT03031496|64229804|FG000|Period 1|Adverse Event|2|||
23132044|NCT03031496|64229805|FG001|Period 1|Adverse Event|0|||
23132045|NCT03031496|64229804|FG000|Period 1|Withdrawal by Subject|0|||
23132046|NCT03031496|64229805|FG001|Period 1|Withdrawal by Subject|2|||
23619282|NCT00907517|65991519|FG002|Overall Study|Progressive Disease|4|||
23317340|NCT01449370|64904069|FG009|Overall Study|Participant Decision|0|||
23317341|NCT01449370|64904070|FG010|Overall Study|Participant Decision|0|||
23317342|NCT01449370|64904071|FG011|Overall Study|Participant Decision|0|||
23317343|NCT01449370|64904072|FG012|Overall Study|Participant Decision|1|||
23317344|NCT01449370|64904073|FG013|Overall Study|Participant Decision|1|||
23317345|NCT01449370|64904074|FG014|Overall Study|Participant Decision|0|||
23317346|NCT01449370|64904075|FG015|Overall Study|Participant Decision|1|||
23317347|NCT01449370|64904076|FG016|Overall Study|Participant Decision|3|||
23317348|NCT01449370|64904077|FG017|Overall Study|Participant Decision|0|||
23317349|NCT01449370|64904078|FG018|Overall Study|Participant Decision|1|||
23317350|NCT01449370|64904079|FG019|Overall Study|Participant Decision|0|||
23317351|NCT01449370|64904080|FG020|Overall Study|Participant Decision|0|||
23317352|NCT01449370|64904081|FG021|Overall Study|Participant Decision|1|||
23317353|NCT01449370|64904082|FG022|Overall Study|Participant Decision|0|||
23427437|NCT00657371|65307675|FG000|Overall Study|Unable to intubate the cecum|5|||
23427438|NCT00657371|65307675|FG000|Overall Study|Protocol Violation|2|||
23427439|NCT00657371|65307675|FG000|Overall Study|Device- related reasons|13|||
23427440|NCT00657371|65307675|FG000|Overall Study|Pre-existing medical condition|4|||
23427441|NCT00583791|65307676|FG000|Overall Study|Other|67|||
23427442|NCT00583791|65307676|FG000|Overall Study|Death|6|||
23427443|NCT00849875|65307684|FG000|Overall Study|Death|28|||
23427444|NCT00849875|65307684|FG000|Overall Study|Ongoing (unknown completion status)|11|||
23427445|NCT00849875|65307684|FG000|Overall Study|Others|6|||
23427446|NCT00849875|65307684|FG000|Overall Study|Lost to Follow-up|2|||
23427447|NCT00259298|65307686|FG000|Overall Study|Withdrawal by Subject|1|||
23213572|NCT04671342|64523352|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
23317354|NCT01449370|64904083|FG023|Overall Study|Participant Decision|0|||
23317355|NCT01449370|64904084|FG024|Overall Study|Participant Decision|1|||
23317356|NCT01449370|64904060|FG000|Overall Study|Lost to Follow-up|0|||
23317357|NCT01449370|64904061|FG001|Overall Study|Lost to Follow-up|0|||
23317358|NCT01449370|64904062|FG002|Overall Study|Lost to Follow-up|0|||
23317359|NCT01449370|64904063|FG003|Overall Study|Lost to Follow-up|0|||
23317360|NCT01449370|64904064|FG004|Overall Study|Lost to Follow-up|0|||
23317361|NCT01449370|64904065|FG005|Overall Study|Lost to Follow-up|0|||
23317362|NCT01449370|64904066|FG006|Overall Study|Lost to Follow-up|0|||
23317363|NCT01449370|64904067|FG007|Overall Study|Lost to Follow-up|0|||
23317364|NCT01449370|64904068|FG008|Overall Study|Lost to Follow-up|0|||
23317365|NCT01449370|64904069|FG009|Overall Study|Lost to Follow-up|0|||
23317366|NCT01449370|64904070|FG010|Overall Study|Lost to Follow-up|0|||
23317367|NCT01449370|64904071|FG011|Overall Study|Lost to Follow-up|0|||
23317368|NCT01449370|64904072|FG012|Overall Study|Lost to Follow-up|0|||
23317369|NCT01449370|64904073|FG013|Overall Study|Lost to Follow-up|0|||
23317370|NCT01449370|64904074|FG014|Overall Study|Lost to Follow-up|0|||
23317371|NCT01449370|64904075|FG015|Overall Study|Lost to Follow-up|0|||
23317372|NCT01449370|64904076|FG016|Overall Study|Lost to Follow-up|0|||
23317373|NCT01449370|64904077|FG017|Overall Study|Lost to Follow-up|0|||
23317374|NCT01449370|64904078|FG018|Overall Study|Lost to Follow-up|0|||
23317375|NCT01449370|64904079|FG019|Overall Study|Lost to Follow-up|0|||
23317376|NCT01449370|64904080|FG020|Overall Study|Lost to Follow-up|1|||
23317377|NCT01449370|64904081|FG021|Overall Study|Lost to Follow-up|0|||
23317378|NCT01449370|64904082|FG022|Overall Study|Lost to Follow-up|0|||
23213573|NCT04671342|64523352|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
23213574|NCT01360762|64523354|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
23213575|NCT01360762|64523354|FG000|Main Study Period (12-month Treatment)|Death|5|||
23213576|NCT01360762|64523354|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
23213577|NCT01360762|64523354|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
23213578|NCT01360762|64523354|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
23213579|NCT01360762|64523354|FG000|Whole Study Period|Lost to Follow-up|10|||
23213580|NCT01360762|64523354|FG000|Whole Study Period|Death|7|||
23213581|NCT01360762|64523354|FG000|Whole Study Period|Patient relapsed|18|||
23213582|NCT01360762|64523354|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
23213583|NCT02767856|64523355|FG000|Overall Study|Lost to Follow-up|9|||
23213584|NCT02767856|64523356|FG001|Overall Study|Lost to Follow-up|1|||
23213585|NCT02767856|64523355|FG000|Overall Study|Withdrawal by Subject|2|||
23213586|NCT02767856|64523356|FG001|Overall Study|Withdrawal by Subject|1|||
23213587|NCT00109772|64523357|FG000|Double-blind Treatment|Adverse Event|14|||
23213588|NCT00109772|64523358|FG001|Double-blind Treatment|Adverse Event|5|||
23213589|NCT00109772|64523357|FG000|Double-blind Treatment|Lack of Efficacy|1|||
23317379|NCT01449370|64904083|FG023|Overall Study|Lost to Follow-up|0|||
23317380|NCT01449370|64904084|FG024|Overall Study|Lost to Follow-up|0|||
23317381|NCT01449370|64904060|FG000|Overall Study|Other|0|||
23317382|NCT01449370|64904061|FG001|Overall Study|Other|0|||
23317383|NCT01449370|64904062|FG002|Overall Study|Other|0|||
23317384|NCT01449370|64904063|FG003|Overall Study|Other|0|||
23427448|NCT00259298|65307686|FG000|Overall Study|Physician Decision|2|||
23427449|NCT00066469|65307687|FG000|Overall Study|Death|3|||
23427450|NCT00066469|65307687|FG000|Overall Study|Lack of Efficacy|9|||
23132047|NCT00678301|64229806|FG000|Overall Study|Non-compliance with study procedures|0|||
23132048|NCT00678301|64229807|FG001|Overall Study|Non-compliance with study procedures|1|||
23132049|NCT00678301|64229806|FG000|Overall Study|Adverse Event|1|||
23132050|NCT00678301|64229807|FG001|Overall Study|Adverse Event|0|||
23132051|NCT00678301|64229806|FG000|Overall Study|Withdrawal by Subject|4|||
23132052|NCT00678301|64229807|FG001|Overall Study|Withdrawal by Subject|0|||
23132053|NCT00678301|64229806|FG000|Overall Study|Lost to Follow-up|3|||
23132054|NCT00678301|64229807|FG001|Overall Study|Lost to Follow-up|1|||
23132055|NCT02546921|64229809|FG000|Overall Study|Adverse Event|0|||
23132056|NCT02546921|64229810|FG001|Overall Study|Adverse Event|5|||
23132057|NCT02546921|64229811|FG002|Overall Study|Adverse Event|2|||
23132058|NCT02546921|64229812|FG003|Overall Study|Adverse Event|0|||
23132059|NCT02546921|64229813|FG004|Overall Study|Adverse Event|0|||
23132060|NCT02546921|64229814|FG005|Overall Study|Adverse Event|0|||
23132061|NCT02546921|64229815|FG006|Overall Study|Adverse Event|0|||
23132062|NCT02546921|64229809|FG000|Overall Study|Evidence of Disease Progression|1|||
23132063|NCT02546921|64229810|FG001|Overall Study|Evidence of Disease Progression|0|||
23132064|NCT02546921|64229811|FG002|Overall Study|Evidence of Disease Progression|0|||
23132065|NCT02546921|64229812|FG003|Overall Study|Evidence of Disease Progression|0|||
23132066|NCT02546921|64229813|FG004|Overall Study|Evidence of Disease Progression|1|||
23132067|NCT02546921|64229814|FG005|Overall Study|Evidence of Disease Progression|0|||
23132068|NCT02546921|64229815|FG006|Overall Study|Evidence of Disease Progression|0|||
23132069|NCT02546921|64229809|FG000|Overall Study|Patient Choice|0|||
23132070|NCT02546921|64229810|FG001|Overall Study|Patient Choice|1|||
23132071|NCT02546921|64229811|FG002|Overall Study|Patient Choice|0|||
23132072|NCT02546921|64229812|FG003|Overall Study|Patient Choice|0|||
23132073|NCT02546921|64229813|FG004|Overall Study|Patient Choice|0|||
23132074|NCT02546921|64229814|FG005|Overall Study|Patient Choice|1|||
23132075|NCT02546921|64229815|FG006|Overall Study|Patient Choice|0|||
23132076|NCT01068665|64229816|FG000|Overall Study|Adverse Event|5|||
23132077|NCT01068665|64229817|FG001|Overall Study|Adverse Event|4|||
23132078|NCT01068665|64229816|FG000|Overall Study|Lack of Efficacy|0|||
23132079|NCT01068665|64229817|FG001|Overall Study|Lack of Efficacy|2|||
23132080|NCT01068665|64229816|FG000|Overall Study|Protocol Violation|5|||
23547274|NCT02347761|65735768|FG002|All Collected|Death|0|||
23547275|NCT02347761|65735766|FG000|All Collected|Lost to Follow-up|3|||
23547276|NCT02347761|65735767|FG001|All Collected|Lost to Follow-up|2|||
23547277|NCT02347761|65735768|FG002|All Collected|Lost to Follow-up|3|||
23547278|NCT02347761|65735766|FG000|All Collected|Withdrawal by Subject|11|||
23547279|NCT02347761|65735767|FG001|All Collected|Withdrawal by Subject|11|||
23547280|NCT02347761|65735768|FG002|All Collected|Withdrawal by Subject|22|||
23547281|NCT02347761|65735766|FG000|All Collected|invetigator disretion|2|||
23547282|NCT02347761|65735767|FG001|All Collected|invetigator disretion|0|||
23132081|NCT01068665|64229817|FG001|Overall Study|Protocol Violation|2|||
23132082|NCT01068665|64229816|FG000|Overall Study|Withdrawal Criteria|3|||
23132083|NCT01068665|64229817|FG001|Overall Study|Withdrawal Criteria|9|||
23132084|NCT01068665|64229816|FG000|Overall Study|Other|17|||
23132085|NCT01068665|64229817|FG001|Overall Study|Other|12|||
23132086|NCT03174431|64229820|FG000|Overall Study|Withdrawal by Subject|14|||
23132087|NCT03174431|64229821|FG001|Overall Study|Withdrawal by Subject|11|||
23132088|NCT03174431|64229820|FG000|Overall Study|alternative treatment|2|||
23132089|NCT03174431|64229821|FG001|Overall Study|alternative treatment|0|||
23132090|NCT03174431|64229820|FG000|Overall Study|Lost to Follow-up|1|||
23132091|NCT03174431|64229821|FG001|Overall Study|Lost to Follow-up|5|||
23132092|NCT00953771|64229822|FG000|Overall Study|Death|1|||
23132093|NCT00953771|64229823|FG001|Overall Study|Death|0|||
23132094|NCT02001064|64229826|FG000|Overall Study|Withdrawal by Subject|2|||
23132095|NCT02001064|64229827|FG001|Overall Study|Withdrawal by Subject|1|||
23132096|NCT02232243|64229828|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
23132097|NCT02232243|64229829|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
23132098|NCT02232243|64229830|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
23132099|NCT01152814|64229831|FG000|Overall Study|Lost to Follow-up|2|||
23132100|NCT00568178|64229832|FG000|Double Blind Base Study|Adverse Event|0|||
23132101|NCT00568178|64229833|FG001|Double Blind Base Study|Adverse Event|2|||
23132102|NCT00568178|64229834|FG002|Double Blind Base Study|Adverse Event|1|||
23132103|NCT00568178|64229835|FG003|Double Blind Base Study|Adverse Event|2|||
23132104|NCT00568178|64229836|FG004|Double Blind Base Study|Adverse Event|0|||
23132105|NCT00568178|64229837|FG005|Double Blind Base Study|Adverse Event|0|||
23132106|NCT00568178|64229832|FG000|Double Blind Base Study|Lost to Follow-up|1|||
23132107|NCT00568178|64229833|FG001|Double Blind Base Study|Lost to Follow-up|0|||
23132108|NCT00568178|64229834|FG002|Double Blind Base Study|Lost to Follow-up|0|||
23547283|NCT02347761|65735768|FG002|All Collected|invetigator disretion|0|||
23132109|NCT00568178|64229835|FG003|Double Blind Base Study|Lost to Follow-up|1|||
23132110|NCT00568178|64229836|FG004|Double Blind Base Study|Lost to Follow-up|0|||
23547284|NCT02347761|65735766|FG000|All Collected|instillation site pain|0|||
23132111|NCT00568178|64229837|FG005|Double Blind Base Study|Lost to Follow-up|0|||
23317385|NCT01449370|64904064|FG004|Overall Study|Other|0|||
23132112|NCT00568178|64229832|FG000|Double Blind Base Study|Physician Decision|1|||
23132113|NCT00568178|64229833|FG001|Double Blind Base Study|Physician Decision|1|||
23132114|NCT00568178|64229834|FG002|Double Blind Base Study|Physician Decision|0|||
23132115|NCT00568178|64229835|FG003|Double Blind Base Study|Physician Decision|1|||
23132116|NCT00568178|64229836|FG004|Double Blind Base Study|Physician Decision|0|||
23132117|NCT00568178|64229837|FG005|Double Blind Base Study|Physician Decision|0|||
23132118|NCT00568178|64229832|FG000|Double Blind Base Study|Protocol Violation|3|||
23132119|NCT00568178|64229833|FG001|Double Blind Base Study|Protocol Violation|2|||
23132120|NCT00568178|64229834|FG002|Double Blind Base Study|Protocol Violation|0|||
23132121|NCT00568178|64229835|FG003|Double Blind Base Study|Protocol Violation|0|||
23132122|NCT00568178|64229836|FG004|Double Blind Base Study|Protocol Violation|0|||
23132123|NCT00568178|64229837|FG005|Double Blind Base Study|Protocol Violation|0|||
23132124|NCT00568178|64229832|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
23132125|NCT00568178|64229833|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
23132126|NCT00568178|64229834|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
23132127|NCT00568178|64229835|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
23132128|NCT00568178|64229836|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
23132129|NCT00568178|64229837|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
23132130|NCT00568178|64229832|FG000|Double Blind Base Study|Progressive Disease|0|||
23132131|NCT00568178|64229833|FG001|Double Blind Base Study|Progressive Disease|0|||
23132132|NCT00568178|64229834|FG002|Double Blind Base Study|Progressive Disease|0|||
23132133|NCT00568178|64229835|FG003|Double Blind Base Study|Progressive Disease|1|||
23132134|NCT00568178|64229836|FG004|Double Blind Base Study|Progressive Disease|0|||
23132135|NCT00568178|64229837|FG005|Double Blind Base Study|Progressive Disease|0|||
23132136|NCT00568178|64229832|FG000|Open Label Extension|Adverse Event|0|||
23132137|NCT00568178|64229833|FG001|Open Label Extension|Adverse Event|0|||
23132138|NCT00568178|64229834|FG002|Open Label Extension|Adverse Event|0|||
23132139|NCT00568178|64229835|FG003|Open Label Extension|Adverse Event|0|||
23132140|NCT00568178|64229836|FG004|Open Label Extension|Adverse Event|11|||
23132141|NCT00568178|64229837|FG005|Open Label Extension|Adverse Event|8|||
23132142|NCT00568178|64229832|FG000|Open Label Extension|Protocol Violation|0|||
23132143|NCT00568178|64229833|FG001|Open Label Extension|Protocol Violation|0|||
23132144|NCT00568178|64229834|FG002|Open Label Extension|Protocol Violation|0|||
23213590|NCT00109772|64523358|FG001|Double-blind Treatment|Lack of Efficacy|0|||
23132145|NCT00568178|64229835|FG003|Open Label Extension|Protocol Violation|0|||
23132146|NCT00568178|64229836|FG004|Open Label Extension|Protocol Violation|1|||
23132147|NCT00568178|64229837|FG005|Open Label Extension|Protocol Violation|0|||
23132148|NCT00568178|64229832|FG000|Open Label Extension|Lost to Follow-up|0|||
23132149|NCT00568178|64229833|FG001|Open Label Extension|Lost to Follow-up|0|||
23132150|NCT00568178|64229834|FG002|Open Label Extension|Lost to Follow-up|0|||
23132151|NCT00568178|64229835|FG003|Open Label Extension|Lost to Follow-up|0|||
23132152|NCT00568178|64229836|FG004|Open Label Extension|Lost to Follow-up|6|||
23132153|NCT00568178|64229837|FG005|Open Label Extension|Lost to Follow-up|11|||
23132154|NCT00568178|64229832|FG000|Open Label Extension|Physician Decision|0|||
23132155|NCT00568178|64229833|FG001|Open Label Extension|Physician Decision|0|||
23132156|NCT00568178|64229834|FG002|Open Label Extension|Physician Decision|0|||
23132157|NCT00568178|64229835|FG003|Open Label Extension|Physician Decision|0|||
23132158|NCT00568178|64229836|FG004|Open Label Extension|Physician Decision|9|||
23132159|NCT00568178|64229837|FG005|Open Label Extension|Physician Decision|8|||
23132160|NCT00568178|64229832|FG000|Open Label Extension|Pregnancy|0|||
23132161|NCT00568178|64229833|FG001|Open Label Extension|Pregnancy|0|||
23132162|NCT00568178|64229834|FG002|Open Label Extension|Pregnancy|0|||
23132163|NCT00568178|64229835|FG003|Open Label Extension|Pregnancy|0|||
23132164|NCT00568178|64229836|FG004|Open Label Extension|Pregnancy|0|||
23132165|NCT00568178|64229837|FG005|Open Label Extension|Pregnancy|1|||
23132166|NCT00568178|64229832|FG000|Open Label Extension|Progressive Disease|0|||
23132167|NCT00568178|64229833|FG001|Open Label Extension|Progressive Disease|0|||
23132168|NCT00568178|64229834|FG002|Open Label Extension|Progressive Disease|0|||
23132169|NCT00568178|64229835|FG003|Open Label Extension|Progressive Disease|0|||
23132170|NCT00568178|64229836|FG004|Open Label Extension|Progressive Disease|3|||
23213591|NCT00109772|64523357|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
23213592|NCT00109772|64523358|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
23213593|NCT00109772|64523357|FG000|Double-blind Treatment|Lost to Follow-up|2|||
23132171|NCT00568178|64229837|FG005|Open Label Extension|Progressive Disease|1|||
23132172|NCT00568178|64229832|FG000|Open Label Extension|Termination of Trial|0|||
23132173|NCT00568178|64229833|FG001|Open Label Extension|Termination of Trial|0|||
23132174|NCT00568178|64229834|FG002|Open Label Extension|Termination of Trial|0|||
23132175|NCT00568178|64229835|FG003|Open Label Extension|Termination of Trial|0|||
23132176|NCT00568178|64229836|FG004|Open Label Extension|Termination of Trial|45|||
23132177|NCT00568178|64229837|FG005|Open Label Extension|Termination of Trial|47|||
23132178|NCT00568178|64229832|FG000|Open Label Extension|Withdrawal by Subject|0|||
23132179|NCT00568178|64229833|FG001|Open Label Extension|Withdrawal by Subject|0|||
23213594|NCT00109772|64523358|FG001|Double-blind Treatment|Lost to Follow-up|3|||
23213595|NCT00109772|64523357|FG000|Double-blind Treatment|Protocol Violation|0|||
23132180|NCT00568178|64229834|FG002|Open Label Extension|Withdrawal by Subject|0|||
23132181|NCT00568178|64229835|FG003|Open Label Extension|Withdrawal by Subject|0|||
23132182|NCT00568178|64229836|FG004|Open Label Extension|Withdrawal by Subject|4|||
23132183|NCT00568178|64229837|FG005|Open Label Extension|Withdrawal by Subject|4|||
23132184|NCT02898077|64229838|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
23132185|NCT02898077|64229839|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
23132186|NCT02898077|64229838|FG000|Overall Study|Lost to Follow-up|4|||
23132187|NCT02898077|64229839|FG001|Overall Study|Lost to Follow-up|3|||
23132188|NCT02898077|64229838|FG000|Overall Study|Physician Decision|0|||
23132189|NCT02898077|64229839|FG001|Overall Study|Physician Decision|2|||
23132190|NCT02898077|64229838|FG000|Overall Study|Sponsor Decision|32|||
23132191|NCT02898077|64229839|FG001|Overall Study|Sponsor Decision|13|||
23132192|NCT02898077|64229838|FG000|Overall Study|Withdrawal by Subject|6|||
23132193|NCT02898077|64229839|FG001|Overall Study|Withdrawal by Subject|3|||
23132194|NCT02898077|64229838|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
23132195|NCT02898077|64229839|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
23547285|NCT02347761|65735767|FG001|All Collected|instillation site pain|0|||
23547286|NCT02347761|65735768|FG002|All Collected|instillation site pain|1|||
23547287|NCT02347761|65735766|FG000|All Collected|exacerbation of COPD|0|||
23132196|NCT02898077|64229838|FG000|Overall Study|Ended extension period|3|||
23132197|NCT02898077|64229839|FG001|Overall Study|Ended extension period|0|||
23132198|NCT00515671|64229840|FG000|Overall Study|Lost to Follow-up|13|||
23132199|NCT00515671|64229841|FG001|Overall Study|Lost to Follow-up|10|||
23132200|NCT00515671|64229840|FG000|Overall Study|Withdrawal by Subject|3|||
23132201|NCT00515671|64229841|FG001|Overall Study|Withdrawal by Subject|5|||
23132202|NCT00515671|64229840|FG000|Overall Study|incarcerated|1|||
23547288|NCT02347761|65735767|FG001|All Collected|exacerbation of COPD|0|||
23547289|NCT02347761|65735768|FG002|All Collected|exacerbation of COPD|1|||
23132203|NCT00515671|64229841|FG001|Overall Study|incarcerated|2|||
23132204|NCT01228318|64229843|FG000|Overall Study|Clinic no show to receive intervention|1|||
23132205|NCT01228318|64229844|FG001|Overall Study|Clinic no show to receive intervention|0|||
23132206|NCT01228318|64229843|FG000|Overall Study|Unable to contact|2|||
23132207|NCT01228318|64229844|FG001|Overall Study|Unable to contact|5|||
23132208|NCT01228318|64229843|FG000|Overall Study|Moved|0|||
23547290|NCT02347761|65735766|FG000|All Collected|moved/travel|0|||
23132209|NCT01228318|64229844|FG001|Overall Study|Moved|2|||
23132210|NCT01228318|64229843|FG000|Overall Study|Incarcerated|1|||
23132211|NCT01228318|64229844|FG001|Overall Study|Incarcerated|0|||
23132212|NCT01023958|64229845|FG000|Overall Study|Progressive disease|48|||
23132213|NCT01023958|64229845|FG000|Overall Study|Other adverse event|1|||
23132214|NCT01023958|64229845|FG000|Overall Study|Refused to continue medication|1|||
23132215|NCT03106753|64229846|FG000|Overall Study|Withdrawal by Subject|0|||
23132216|NCT03106753|64229847|FG001|Overall Study|Withdrawal by Subject|1|||
23132217|NCT00126503|64233879|FG000|Overall Study|disease progression|23|||
23132218|NCT00126503|64233880|FG001|Overall Study|disease progression|14|||
23547291|NCT02347761|65735767|FG001|All Collected|moved/travel|1|||
23547292|NCT02347761|65735768|FG002|All Collected|moved/travel|0|||
23547293|NCT02347761|65735766|FG000|On Study Treatment|Lack of Efficacy|2|||
23547294|NCT02347761|65735767|FG001|On Study Treatment|Lack of Efficacy|3|||
23547295|NCT02347761|65735768|FG002|On Study Treatment|Lack of Efficacy|4|||
23547296|NCT02347761|65735766|FG000|On Study Treatment|non-compliance with study medication|0|||
23547297|NCT02347761|65735767|FG001|On Study Treatment|non-compliance with study medication|0|||
23547298|NCT02347761|65735768|FG002|On Study Treatment|non-compliance with study medication|2|||
23547299|NCT02347761|65735766|FG000|On Study Treatment|Withdrawal by Subject|7|||
23547300|NCT02347761|65735767|FG001|On Study Treatment|Withdrawal by Subject|3|||
23547301|NCT02347761|65735768|FG002|On Study Treatment|Withdrawal by Subject|5|||
23547302|NCT02347761|65735766|FG000|On Study Treatment|move/travel|2|||
23547303|NCT02347761|65735767|FG001|On Study Treatment|move/travel|6|||
23547304|NCT02347761|65735768|FG002|On Study Treatment|move/travel|5|||
23547305|NCT02347761|65735766|FG000|On Study Treatment|dissastisfaction with device|2|||
23132219|NCT00126503|64233879|FG000|Overall Study|Withdrawal by Subject|0|||
23132220|NCT00126503|64233880|FG001|Overall Study|Withdrawal by Subject|1|||
23132221|NCT00126503|64233879|FG000|Overall Study|alternative therapy|1|||
23132222|NCT00126503|64233880|FG001|Overall Study|alternative therapy|1|||
23132223|NCT00126503|64233879|FG000|Overall Study|other complicating disease|4|||
23132224|NCT00126503|64233880|FG001|Overall Study|other complicating disease|1|||
23132225|NCT00126503|64233879|FG000|Overall Study|Death|3|||
23132226|NCT00126503|64233880|FG001|Overall Study|Death|0|||
23132227|NCT00126503|64233879|FG000|Overall Study|Adverse Event|13|||
23132228|NCT00126503|64233880|FG001|Overall Study|Adverse Event|3|||
23132229|NCT00126503|64233879|FG000|Overall Study|non-compliant|1|||
23547306|NCT02347761|65735767|FG001|On Study Treatment|dissastisfaction with device|1|||
23547307|NCT02347761|65735768|FG002|On Study Treatment|dissastisfaction with device|4|||
23547308|NCT02347761|65735766|FG000|On Study Treatment|Lost to Follow-up|2|||
23547309|NCT02347761|65735767|FG001|On Study Treatment|Lost to Follow-up|1|||
23132230|NCT00126503|64233880|FG001|Overall Study|non-compliant|0|||
23619283|NCT00907517|65991520|FG003|Overall Study|Progressive Disease|4|||
23619284|NCT00907517|65991521|FG004|Overall Study|Progressive Disease|4|||
23619285|NCT00907517|65991517|FG000|Overall Study|Symptomatic Deterioration|0|||
23619286|NCT00907517|65991518|FG001|Overall Study|Symptomatic Deterioration|0|||
23619287|NCT00907517|65991519|FG002|Overall Study|Symptomatic Deterioration|0|||
23619288|NCT00907517|65991520|FG003|Overall Study|Symptomatic Deterioration|0|||
23619289|NCT00907517|65991521|FG004|Overall Study|Symptomatic Deterioration|1|||
23132231|NCT00126503|64233879|FG000|Overall Study|Physician Decision|2|||
23132232|NCT00126503|64233880|FG001|Overall Study|Physician Decision|1|||
23132233|NCT00468559|64233882|FG000|Open-label Treatment Phase|Adverse Event|5|||
23132234|NCT00468559|64233883|FG001|Open-label Treatment Phase|Adverse Event|0|||
23132235|NCT00468559|64233884|FG002|Open-label Treatment Phase|Adverse Event|0|||
23132236|NCT00468559|64233882|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
23132237|NCT00468559|64233883|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
23132238|NCT00468559|64233884|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
23132239|NCT00468559|64233882|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
23132240|NCT00468559|64233883|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
23132241|NCT00468559|64233884|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
23132242|NCT00468559|64233882|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
23132243|NCT00468559|64233883|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
23132244|NCT00468559|64233884|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
23132245|NCT00468559|64233882|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
23132246|NCT00468559|64233883|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
23132247|NCT00468559|64233884|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
23132248|NCT01259089|64233893|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23132249|NCT01259089|64233894|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23132250|NCT01259089|64233895|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23132251|NCT01259089|64233896|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23132252|NCT01259089|64233897|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
23132253|NCT01259089|64233898|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
23132254|NCT01259089|64233893|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
23132255|NCT01259089|64233894|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
23132256|NCT01259089|64233895|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
23132257|NCT01259089|64233896|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
23132258|NCT01259089|64233897|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
23132259|NCT01259089|64233898|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
23132260|NCT01259089|64233893|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23132261|NCT01259089|64233894|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23132262|NCT01259089|64233895|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23132263|NCT01259089|64233896|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23132264|NCT01259089|64233897|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
23132265|NCT01259089|64233898|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
23132266|NCT01259089|64233893|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
23132267|NCT01259089|64233894|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
23317386|NCT01449370|64904065|FG005|Overall Study|Other|0|||
23317387|NCT01449370|64904066|FG006|Overall Study|Other|0|||
23317388|NCT01449370|64904067|FG007|Overall Study|Other|0|||
23317389|NCT01449370|64904068|FG008|Overall Study|Other|1|||
23317390|NCT01449370|64904069|FG009|Overall Study|Other|1|||
23317391|NCT01449370|64904070|FG010|Overall Study|Other|0|||
23547310|NCT02347761|65735768|FG002|On Study Treatment|Lost to Follow-up|1|||
23547311|NCT02347761|65735766|FG000|On Study Treatment|investigator discretion|2|||
23547312|NCT02347761|65735767|FG001|On Study Treatment|investigator discretion|0|||
23547313|NCT02347761|65735768|FG002|On Study Treatment|investigator discretion|0|||
23547314|NCT02347761|65735766|FG000|On Study Treatment|durg not working|0|||
23547315|NCT02347761|65735767|FG001|On Study Treatment|durg not working|1|||
23547316|NCT02347761|65735768|FG002|On Study Treatment|durg not working|1|||
23547317|NCT02347761|65735766|FG000|On Study Treatment|Adverse Event|10|||
23547318|NCT02347761|65735767|FG001|On Study Treatment|Adverse Event|8|||
23547319|NCT02347761|65735768|FG002|On Study Treatment|Adverse Event|20|||
23317392|NCT01449370|64904071|FG011|Overall Study|Other|0|||
23427451|NCT00066469|65307687|FG000|Overall Study|Lost to Follow-up|1|||
23547320|NCT02576067|65735774|FG000|Overall Study|Death|0|||
23547321|NCT02576067|65735775|FG001|Overall Study|Death|1|||
23547322|NCT02576067|65735774|FG000|Overall Study|Lack of Efficacy|1|||
23619290|NCT00239681|65991523|FG000|Overall Study|Adverse Event|100|||
23547323|NCT02576067|65735775|FG001|Overall Study|Lack of Efficacy|0|||
23547324|NCT02576067|65735774|FG000|Overall Study|Lost to Follow-up|11|||
23547325|NCT02576067|65735775|FG001|Overall Study|Lost to Follow-up|0|||
23547326|NCT02576067|65735774|FG000|Overall Study|Withdrawal by Subject|11|||
23547327|NCT02576067|65735775|FG001|Overall Study|Withdrawal by Subject|2|||
23547328|NCT02576067|65735774|FG000|Overall Study|study closure of main CIRT trial)|0|||
23619291|NCT00239681|65991524|FG001|Overall Study|Adverse Event|99|||
23132268|NCT01259089|64233895|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
23132269|NCT01259089|64233896|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
23132270|NCT01259089|64233897|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
23213596|NCT00109772|64523358|FG001|Double-blind Treatment|Protocol Violation|1|||
23427452|NCT00066469|65307687|FG000|Overall Study|Physician Decision|1|||
23427453|NCT00066469|65307687|FG000|Overall Study|Withdrawal by Subject|1|||
23427454|NCT00066469|65307687|FG000|Overall Study|ineligible|1|||
23427455|NCT01460407|65307688|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
23427456|NCT01460407|65307689|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
23427457|NCT02513823|65307690|FG000|Overall Study|Lost to Follow-up|4|||
23427458|NCT02513823|65307690|FG000|Overall Study|Physician Decision|1|||
23427459|NCT02193087|65307691|FG000|Overall Study|Adverse Event|2|||
23427460|NCT02193087|65307692|FG001|Overall Study|Adverse Event|0|||
23547329|NCT02576067|65735775|FG001|Overall Study|study closure of main CIRT trial)|8|||
23547330|NCT02576067|65735774|FG000|Overall Study|not randomized, failed run-in|7|||
23547331|NCT02576067|65735775|FG001|Overall Study|not randomized, failed run-in|0|||
23547332|NCT02576067|65735774|FG000|Overall Study|screen failure/ re-enrolled|0|||
23547333|NCT02576067|65735775|FG001|Overall Study|screen failure/ re-enrolled|25|||
23547334|NCT02576067|65735774|FG000|Overall Study|Physician Decision|4|||
23547335|NCT02576067|65735775|FG001|Overall Study|Physician Decision|0|||
23547336|NCT01054820|65735778|FG000|Overall Study|Withdrawal by Subject|2|||
23547337|NCT02395120|65735779|FG000|Overall Study|Missed follow-up dental exam|57|||
23547338|NCT02395120|65735780|FG001|Overall Study|Missed follow-up dental exam|62|||
23213597|NCT00109772|64523357|FG000|Double-blind Treatment|Other|0|||
23213598|NCT00109772|64523358|FG001|Double-blind Treatment|Other|4|||
23213599|NCT00109772|64523357|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
23213600|NCT00109772|64523358|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
23547339|NCT02395120|65735781|FG002|Overall Study|Missed follow-up dental exam|6|||
23547340|NCT02395120|65735782|FG003|Overall Study|Missed follow-up dental exam|6|||
23547341|NCT02395120|65735783|FG004|Overall Study|Missed follow-up dental exam|51|||
23547342|NCT03743038|65735784|FG000|Overall Study|Physician Decision|1|||
23547343|NCT03727750|65735787|FG000|Overall Study|Death|45|||
23547344|NCT03727750|65735787|FG000|Overall Study|Withdrawal by Subject|2|||
23547345|NCT03727750|65735787|FG000|Overall Study|Lost to Follow-up|1|||
23547346|NCT03727750|65735787|FG000|Overall Study|Other|1|||
23547347|NCT01328574|65735788|FG000|Overall Study|Refused further treatment|1|||
23547348|NCT00321919|65735789|FG000|Overall Study|Adverse Event|17|||
23547349|NCT00321919|65735790|FG001|Overall Study|Adverse Event|10|||
23547350|NCT00321919|65735789|FG000|Overall Study|Death|21|||
23547351|NCT00321919|65735790|FG001|Overall Study|Death|17|||
23547352|NCT00321919|65735789|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23547353|NCT00321919|65735790|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23547354|NCT00321919|65735789|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23547355|NCT00321919|65735790|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23547356|NCT00321919|65735789|FG000|Overall Study|Refused Treatment|23|||
23547357|NCT00321919|65735790|FG001|Overall Study|Refused Treatment|14|||
23547358|NCT00321919|65735789|FG000|Overall Study|Other Protocol Violation|2|||
23547359|NCT00321919|65735790|FG001|Overall Study|Other Protocol Violation|3|||
23547360|NCT00321919|65735789|FG000|Overall Study|Failure to Return|3|||
23547361|NCT00321919|65735790|FG001|Overall Study|Failure to Return|1|||
23547362|NCT00321919|65735789|FG000|Overall Study|Other withdrawal reason|7|||
23132271|NCT01259089|64233898|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
23132272|NCT01259089|64233893|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
23132273|NCT01259089|64233894|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
23132274|NCT01259089|64233895|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
23132275|NCT01259089|64233896|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
23132276|NCT01259089|64233897|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
23547363|NCT00321919|65735790|FG001|Overall Study|Other withdrawal reason|6|||
23132277|NCT01259089|64233898|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
23132278|NCT01259089|64233893|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
23132279|NCT01259089|64233894|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23213601|NCT00109772|64523357|FG000|Open-label Extension|Adverse Event|10|||
23213602|NCT00109772|64523358|FG001|Open-label Extension|Adverse Event|19|||
23213603|NCT00109772|64523357|FG000|Open-label Extension|Lack of Efficacy|19|||
23427461|NCT02193087|65307693|FG002|Overall Study|Adverse Event|0|||
23547364|NCT02291614|65735798|FG000|Overall Study|Lost to Follow-up|0|||
23547365|NCT02291614|65735799|FG001|Overall Study|Lost to Follow-up|0|||
23547366|NCT02291614|65735800|FG002|Overall Study|Lost to Follow-up|0|||
23547367|NCT02291614|65735801|FG003|Overall Study|Lost to Follow-up|0|||
23132280|NCT01259089|64233895|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23132281|NCT01259089|64233896|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23427462|NCT02193087|65307694|FG003|Overall Study|Adverse Event|11|||
23547368|NCT02291614|65735802|FG004|Overall Study|Lost to Follow-up|0|||
23547369|NCT02291614|65735803|FG005|Overall Study|Lost to Follow-up|0|||
23547370|NCT02291614|65735804|FG006|Overall Study|Lost to Follow-up|0|||
23547371|NCT02291614|65735805|FG007|Overall Study|Lost to Follow-up|1|||
23547372|NCT02291614|65735806|FG008|Overall Study|Lost to Follow-up|0|||
23547373|NCT02291614|65735807|FG009|Overall Study|Lost to Follow-up|0|||
23547374|NCT02291614|65735808|FG010|Overall Study|Lost to Follow-up|0|||
23547375|NCT02291614|65735798|FG000|Overall Study|Withdrawal by Subject|0|||
23547376|NCT02291614|65735799|FG001|Overall Study|Withdrawal by Subject|1|||
23547377|NCT02291614|65735800|FG002|Overall Study|Withdrawal by Subject|0|||
23547378|NCT02291614|65735801|FG003|Overall Study|Withdrawal by Subject|0|||
23547379|NCT02291614|65735802|FG004|Overall Study|Withdrawal by Subject|0|||
23547380|NCT02291614|65735803|FG005|Overall Study|Withdrawal by Subject|0|||
23547381|NCT02291614|65735804|FG006|Overall Study|Withdrawal by Subject|0|||
23547382|NCT02291614|65735805|FG007|Overall Study|Withdrawal by Subject|0|||
23547383|NCT02291614|65735806|FG008|Overall Study|Withdrawal by Subject|0|||
23547384|NCT02291614|65735807|FG009|Overall Study|Withdrawal by Subject|2|||
23547385|NCT02291614|65735808|FG010|Overall Study|Withdrawal by Subject|2|||
23132282|NCT01259089|64233897|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23132283|NCT01259089|64233898|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
23132284|NCT01259089|64233893|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
23132285|NCT01259089|64233894|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
23132286|NCT01259089|64233895|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
23132287|NCT01259089|64233896|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
23132288|NCT01259089|64233897|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
23132289|NCT01259089|64233898|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
23132290|NCT01259089|64233893|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
23132291|NCT01259089|64233894|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
23132292|NCT01259089|64233895|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
23132293|NCT01259089|64233896|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
23132294|NCT01259089|64233897|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
23132295|NCT01259089|64233898|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
23132296|NCT01259089|64233893|FG000|Survival Follow up for Two Years|Death|3|||
23132297|NCT01259089|64233894|FG001|Survival Follow up for Two Years|Death|2|||
23132298|NCT01259089|64233895|FG002|Survival Follow up for Two Years|Death|2|||
23132299|NCT01259089|64233896|FG003|Survival Follow up for Two Years|Death|3|||
23132300|NCT01259089|64233897|FG004|Survival Follow up for Two Years|Death|6|||
23132301|NCT01259089|64233898|FG005|Survival Follow up for Two Years|Death|13|||
23132302|NCT01259089|64233893|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
23132303|NCT01259089|64233894|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
23132304|NCT01259089|64233895|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
23132305|NCT01259089|64233896|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
23132306|NCT01259089|64233897|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
23132307|NCT01259089|64233898|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
23132308|NCT01259089|64233893|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23132309|NCT01259089|64233894|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23132310|NCT01259089|64233895|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23132311|NCT01259089|64233896|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23132312|NCT01259089|64233897|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
23132313|NCT01259089|64233898|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
23132314|NCT03014011|64233908|FG000|First Intervention|Withdrawal by Subject|1|||
23132315|NCT03014011|64233909|FG001|First Intervention|Withdrawal by Subject|0|||
23132316|NCT03014011|64233908|FG000|Washout|Withdrawal by Subject|1|||
23132317|NCT03014011|64233909|FG001|Washout|Withdrawal by Subject|0|||
23132318|NCT01638429|64233913|FG000|Overall Study|Withdrawal by Subject|1|||
23132319|NCT02304705|64233916|FG000|Overall Study|Withdrawal by Subject|2|||
23132320|NCT02304705|64233917|FG001|Overall Study|Withdrawal by Subject|0|||
23132321|NCT02304705|64233916|FG000|Overall Study|Physician Decision|2|||
23132322|NCT02304705|64233917|FG001|Overall Study|Physician Decision|4|||
23132323|NCT02304705|64233916|FG000|Overall Study|Death|0|||
23132324|NCT02304705|64233917|FG001|Overall Study|Death|1|||
23132325|NCT02304705|64233916|FG000|Overall Study|Lost to Follow-up|0|||
23132326|NCT02304705|64233917|FG001|Overall Study|Lost to Follow-up|2|||
23213604|NCT00109772|64523358|FG001|Open-label Extension|Lack of Efficacy|11|||
23213605|NCT00109772|64523357|FG000|Open-label Extension|Withdrawal by Subject|9|||
23213606|NCT00109772|64523358|FG001|Open-label Extension|Withdrawal by Subject|6|||
23213607|NCT00109772|64523357|FG000|Open-label Extension|Lost to Follow-up|1|||
23547386|NCT02291614|65735798|FG000|Overall Study|Decision by sponsor|0|||
23547387|NCT02291614|65735799|FG001|Overall Study|Decision by sponsor|0|||
23619292|NCT00239681|65991523|FG000|Overall Study|Withdrawal by Subject|458|||
23132327|NCT00742326|64233918|FG000|Overall Study|Physician Decision|0|||
23132328|NCT00742326|64233919|FG001|Overall Study|Physician Decision|1|||
23132329|NCT00958841|64233920|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23132330|NCT00958841|64233920|FG000|Overall Study|Abnormal test procedure result(s)|3|||
23132331|NCT00958841|64233920|FG000|Overall Study|Administrative problems|1|||
23213608|NCT00109772|64523358|FG001|Open-label Extension|Lost to Follow-up|0|||
23213609|NCT00109772|64523357|FG000|Open-label Extension|Death|0|||
23213610|NCT00109772|64523358|FG001|Open-label Extension|Death|1|||
23547388|NCT02291614|65735800|FG002|Overall Study|Decision by sponsor|0|||
23427463|NCT02193087|65307691|FG000|Overall Study|Lost to Follow-up|14|||
23427464|NCT02193087|65307692|FG001|Overall Study|Lost to Follow-up|6|||
23427465|NCT02193087|65307693|FG002|Overall Study|Lost to Follow-up|4|||
23427466|NCT02193087|65307694|FG003|Overall Study|Lost to Follow-up|37|||
23427467|NCT02193087|65307691|FG000|Overall Study|Protocol Violation|2|||
23427468|NCT02193087|65307692|FG001|Overall Study|Protocol Violation|0|||
23427469|NCT02193087|65307693|FG002|Overall Study|Protocol Violation|1|||
23427470|NCT02193087|65307694|FG003|Overall Study|Protocol Violation|2|||
23427471|NCT02193087|65307691|FG000|Overall Study|Withdrawal by Subject|10|||
23427472|NCT02193087|65307692|FG001|Overall Study|Withdrawal by Subject|3|||
23427473|NCT02193087|65307693|FG002|Overall Study|Withdrawal by Subject|1|||
23427474|NCT02193087|65307694|FG003|Overall Study|Withdrawal by Subject|19|||
23427475|NCT02193087|65307691|FG000|Overall Study|Other Reason Not Specified|7|||
23427476|NCT02193087|65307692|FG001|Overall Study|Other Reason Not Specified|2|||
23427477|NCT02193087|65307693|FG002|Overall Study|Other Reason Not Specified|1|||
23427478|NCT02193087|65307694|FG003|Overall Study|Other Reason Not Specified|9|||
23427479|NCT02193087|65307691|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
23427480|NCT02193087|65307692|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
23427481|NCT02193087|65307693|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
23427482|NCT02193087|65307694|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
23427483|NCT02395055|65307695|FG000|Overall Study|Withdrawal by Subject|7|||
23427484|NCT02395055|65307696|FG001|Overall Study|Withdrawal by Subject|3|||
23427485|NCT01527383|65307699|FG000|Overall Study|Adverse Event|5|||
23427486|NCT01527383|65307700|FG001|Overall Study|Adverse Event|0|||
23427487|NCT01527383|65307699|FG000|Overall Study|Lost to Follow-up|3|||
23427488|NCT01527383|65307700|FG001|Overall Study|Lost to Follow-up|0|||
23547389|NCT02291614|65735801|FG003|Overall Study|Decision by sponsor|1|||
23547390|NCT02291614|65735802|FG004|Overall Study|Decision by sponsor|0|||
23547391|NCT02291614|65735803|FG005|Overall Study|Decision by sponsor|0|||
23547392|NCT02291614|65735804|FG006|Overall Study|Decision by sponsor|0|||
23547393|NCT02291614|65735805|FG007|Overall Study|Decision by sponsor|0|||
23547394|NCT02291614|65735806|FG008|Overall Study|Decision by sponsor|0|||
23547395|NCT02291614|65735807|FG009|Overall Study|Decision by sponsor|0|||
23547396|NCT02291614|65735808|FG010|Overall Study|Decision by sponsor|0|||
23547397|NCT02291614|65735798|FG000|Overall Study|Death|0|||
23547398|NCT02291614|65735799|FG001|Overall Study|Death|0|||
23547399|NCT02291614|65735800|FG002|Overall Study|Death|1|||
23547400|NCT02291614|65735801|FG003|Overall Study|Death|0|||
23547401|NCT02291614|65735802|FG004|Overall Study|Death|1|||
23547402|NCT02291614|65735803|FG005|Overall Study|Death|1|||
23547403|NCT02291614|65735804|FG006|Overall Study|Death|1|||
23547404|NCT02291614|65735805|FG007|Overall Study|Death|0|||
23547405|NCT02291614|65735806|FG008|Overall Study|Death|0|||
23547406|NCT02291614|65735807|FG009|Overall Study|Death|0|||
23547407|NCT02291614|65735808|FG010|Overall Study|Death|0|||
23547408|NCT02479412|65735809|FG000|Overall Study|Adverse Event|0|||
23547409|NCT02479412|65735810|FG001|Overall Study|Adverse Event|0|||
23547410|NCT02479412|65735811|FG002|Overall Study|Adverse Event|1|||
23547411|NCT02479412|65735812|FG003|Overall Study|Adverse Event|0|||
23547412|NCT02479412|65735813|FG004|Overall Study|Adverse Event|0|||
23547413|NCT02479412|65735814|FG005|Overall Study|Adverse Event|0|||
23547414|NCT02479412|65735815|FG006|Overall Study|Adverse Event|0|||
23547415|NCT02479412|65735816|FG007|Overall Study|Adverse Event|0|||
23547416|NCT02479412|65735817|FG008|Overall Study|Adverse Event|0|||
23547417|NCT02479412|65735809|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23547418|NCT02479412|65735810|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23619293|NCT00239681|65991524|FG001|Overall Study|Withdrawal by Subject|489|||
23619294|NCT00239681|65991523|FG000|Overall Study|Lost to Follow-up|28|||
23619295|NCT00239681|65991524|FG001|Overall Study|Lost to Follow-up|22|||
23213611|NCT00109772|64523357|FG000|Open-label Extension|Protocol Violation|2|||
23427489|NCT01527383|65307699|FG000|Overall Study|Physician Decision|2|||
23427490|NCT01527383|65307700|FG001|Overall Study|Physician Decision|0|||
23427491|NCT01527383|65307699|FG000|Overall Study|Pregnancy|1|||
23427492|NCT01527383|65307700|FG001|Overall Study|Pregnancy|0|||
23547419|NCT02479412|65735811|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23547420|NCT02479412|65735812|FG003|Overall Study|Study-specific withdrawal criteria|1|||
23547421|NCT02479412|65735813|FG004|Overall Study|Study-specific withdrawal criteria|0|||
23427493|NCT01527383|65307699|FG000|Overall Study|Protocol Violation|1|||
23427494|NCT01527383|65307700|FG001|Overall Study|Protocol Violation|0|||
23427495|NCT01527383|65307699|FG000|Overall Study|Screen failure|1|||
23427496|NCT01527383|65307700|FG001|Overall Study|Screen failure|0|||
23547422|NCT02479412|65735814|FG005|Overall Study|Study-specific withdrawal criteria|0|||
23427497|NCT01527383|65307699|FG000|Overall Study|Participant moved|0|||
23547423|NCT02479412|65735815|FG006|Overall Study|Study-specific withdrawal criteria|0|||
23547424|NCT02479412|65735816|FG007|Overall Study|Study-specific withdrawal criteria|1|||
23317393|NCT01449370|64904072|FG012|Overall Study|Other|0|||
23317394|NCT01449370|64904073|FG013|Overall Study|Other|0|||
23317395|NCT01449370|64904074|FG014|Overall Study|Other|0|||
23317396|NCT01449370|64904075|FG015|Overall Study|Other|0|||
23317397|NCT01449370|64904076|FG016|Overall Study|Other|0|||
23317398|NCT01449370|64904077|FG017|Overall Study|Other|0|||
23317399|NCT01449370|64904078|FG018|Overall Study|Other|0|||
23317400|NCT01449370|64904079|FG019|Overall Study|Other|0|||
23317401|NCT01449370|64904080|FG020|Overall Study|Other|0|||
23317402|NCT01449370|64904081|FG021|Overall Study|Other|0|||
23547425|NCT02479412|65735817|FG008|Overall Study|Study-specific withdrawal criteria|1|||
23547426|NCT02479412|65735809|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
23547427|NCT02479412|65735810|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
23547428|NCT02479412|65735811|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
23547429|NCT02479412|65735812|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
23547430|NCT02479412|65735813|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
23547431|NCT02479412|65735814|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
23547432|NCT02479412|65735815|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
23547433|NCT02479412|65735816|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
23547434|NCT02479412|65735817|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
23547435|NCT02363946|65735818|FG000|Overall Study|Lost to Follow-up|0|||
23547436|NCT02363946|65735819|FG001|Overall Study|Lost to Follow-up|0|||
23619296|NCT00239681|65991523|FG000|Overall Study|Protocol Violation|4|||
23619297|NCT00239681|65991524|FG001|Overall Study|Protocol Violation|4|||
23619298|NCT00239681|65991523|FG000|Overall Study|Physician Decision|13|||
23132332|NCT00958841|64233920|FG000|Overall Study|Adverse Event|8|||
23132333|NCT00958841|64233920|FG000|Overall Study|New cancer therapy|5|||
23132334|NCT00958841|64233920|FG000|Overall Study|Withdrawal by Subject|1|||
23317403|NCT01449370|64904082|FG022|Overall Study|Other|1|||
23317404|NCT01449370|64904083|FG023|Overall Study|Other|1|||
23317405|NCT01449370|64904084|FG024|Overall Study|Other|0|||
23317406|NCT01449370|64904060|FG000|Overall Study|Medication Prohibited by Protocol|0|||
23317407|NCT01449370|64904061|FG001|Overall Study|Medication Prohibited by Protocol|0|||
23317408|NCT01449370|64904062|FG002|Overall Study|Medication Prohibited by Protocol|0|||
23317409|NCT01449370|64904063|FG003|Overall Study|Medication Prohibited by Protocol|0|||
23317410|NCT01449370|64904064|FG004|Overall Study|Medication Prohibited by Protocol|0|||
23317411|NCT01449370|64904065|FG005|Overall Study|Medication Prohibited by Protocol|0|||
23317412|NCT01449370|64904066|FG006|Overall Study|Medication Prohibited by Protocol|0|||
23317413|NCT01449370|64904067|FG007|Overall Study|Medication Prohibited by Protocol|0|||
23317414|NCT01449370|64904068|FG008|Overall Study|Medication Prohibited by Protocol|0|||
23317415|NCT01449370|64904069|FG009|Overall Study|Medication Prohibited by Protocol|0|||
23317416|NCT01449370|64904070|FG010|Overall Study|Medication Prohibited by Protocol|0|||
23317417|NCT01449370|64904071|FG011|Overall Study|Medication Prohibited by Protocol|0|||
23317418|NCT01449370|64904072|FG012|Overall Study|Medication Prohibited by Protocol|0|||
23317419|NCT01449370|64904073|FG013|Overall Study|Medication Prohibited by Protocol|0|||
23317420|NCT01449370|64904074|FG014|Overall Study|Medication Prohibited by Protocol|0|||
23317421|NCT01449370|64904075|FG015|Overall Study|Medication Prohibited by Protocol|0|||
23317422|NCT01449370|64904076|FG016|Overall Study|Medication Prohibited by Protocol|0|||
23317423|NCT01449370|64904077|FG017|Overall Study|Medication Prohibited by Protocol|0|||
23132335|NCT00958841|64233920|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
23132336|NCT00958841|64233920|FG000|Overall Study|Completed M6/did not enter extension|27|||
23132337|NCT00958841|64233920|FG000|Overall Study|Discontinued prior to M*|28|||
23317424|NCT01449370|64904078|FG018|Overall Study|Medication Prohibited by Protocol|0|||
23317425|NCT01449370|64904079|FG019|Overall Study|Medication Prohibited by Protocol|0|||
23317426|NCT01449370|64904080|FG020|Overall Study|Medication Prohibited by Protocol|0|||
23317427|NCT01449370|64904081|FG021|Overall Study|Medication Prohibited by Protocol|0|||
23317428|NCT01449370|64904082|FG022|Overall Study|Medication Prohibited by Protocol|0|||
23317429|NCT01449370|64904083|FG023|Overall Study|Medication Prohibited by Protocol|1|||
23317430|NCT01449370|64904084|FG024|Overall Study|Medication Prohibited by Protocol|0|||
23317431|NCT01449370|64904060|FG000|Overall Study|Death|0|||
23317432|NCT01449370|64904061|FG001|Overall Study|Death|0|||
23547437|NCT02363946|65735820|FG002|Overall Study|Lost to Follow-up|0|||
23619299|NCT00239681|65991524|FG001|Overall Study|Physician Decision|17|||
23132338|NCT02559895|64233924|FG000|Overall Study|Adverse Event|3|||
23132339|NCT02559895|64233925|FG001|Overall Study|Adverse Event|3|||
23132340|NCT02559895|64233926|FG002|Overall Study|Adverse Event|2|||
23317433|NCT01449370|64904062|FG002|Overall Study|Death|0|||
23317434|NCT01449370|64904063|FG003|Overall Study|Death|0|||
23317435|NCT01449370|64904064|FG004|Overall Study|Death|0|||
23317436|NCT01449370|64904065|FG005|Overall Study|Death|0|||
23317437|NCT01449370|64904066|FG006|Overall Study|Death|0|||
23317438|NCT01449370|64904067|FG007|Overall Study|Death|0|||
23317439|NCT01449370|64904068|FG008|Overall Study|Death|0|||
23317440|NCT01449370|64904069|FG009|Overall Study|Death|0|||
23317441|NCT01449370|64904070|FG010|Overall Study|Death|0|||
23317442|NCT01449370|64904071|FG011|Overall Study|Death|0|||
23317443|NCT01449370|64904072|FG012|Overall Study|Death|0|||
23317444|NCT01449370|64904073|FG013|Overall Study|Death|0|||
23317445|NCT01449370|64904074|FG014|Overall Study|Death|0|||
23317446|NCT01449370|64904075|FG015|Overall Study|Death|0|||
23317447|NCT01449370|64904076|FG016|Overall Study|Death|0|||
23317448|NCT01449370|64904077|FG017|Overall Study|Death|0|||
23317449|NCT01449370|64904078|FG018|Overall Study|Death|0|||
23317450|NCT01449370|64904079|FG019|Overall Study|Death|0|||
23317451|NCT01449370|64904080|FG020|Overall Study|Death|0|||
23317452|NCT01449370|64904081|FG021|Overall Study|Death|0|||
23317453|NCT01449370|64904082|FG022|Overall Study|Death|0|||
23317454|NCT01449370|64904083|FG023|Overall Study|Death|0|||
23317455|NCT01449370|64904084|FG024|Overall Study|Death|1|||
23317456|NCT04102189|64904089|FG000|Overall Study|Withdrawal by Subject|1|||
23317457|NCT04102189|64904090|FG001|Overall Study|Withdrawal by Subject|2|||
23317458|NCT04102189|64904089|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23317459|NCT04102189|64904090|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23317460|NCT04102189|64904089|FG000|Overall Study|Lost to Follow-up|1|||
23317461|NCT04102189|64904090|FG001|Overall Study|Lost to Follow-up|0|||
23317462|NCT02552121|64904094|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
23317463|NCT02552121|64904095|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23317464|NCT02552121|64904096|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23317465|NCT02552121|64904097|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23317466|NCT02552121|64904098|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23213612|NCT00109772|64523358|FG001|Open-label Extension|Protocol Violation|2|||
23213613|NCT00109772|64523357|FG000|Open-label Extension|Other|4|||
23213614|NCT00109772|64523358|FG001|Open-label Extension|Other|10|||
23213615|NCT01342952|64523362|FG000|Overall Study|Adverse Event|0|||
23213616|NCT01342952|64523363|FG001|Overall Study|Adverse Event|5|||
23213617|NCT01342952|64523364|FG002|Overall Study|Adverse Event|1|||
23213618|NCT01342952|64523365|FG003|Overall Study|Adverse Event|0|||
23213619|NCT01342952|64523362|FG000|Overall Study|Lost to Follow-up|0|||
23213620|NCT01342952|64523363|FG001|Overall Study|Lost to Follow-up|2|||
23213621|NCT01342952|64523364|FG002|Overall Study|Lost to Follow-up|0|||
23213622|NCT01342952|64523365|FG003|Overall Study|Lost to Follow-up|0|||
23213623|NCT01342952|64523362|FG000|Overall Study|Withdrawal by Subject|1|||
23213624|NCT01342952|64523363|FG001|Overall Study|Withdrawal by Subject|1|||
23213625|NCT01342952|64523364|FG002|Overall Study|Withdrawal by Subject|0|||
23213626|NCT01342952|64523365|FG003|Overall Study|Withdrawal by Subject|0|||
23213627|NCT01342952|64523362|FG000|Overall Study|Physician Decision|3|||
23213628|NCT01342952|64523363|FG001|Overall Study|Physician Decision|3|||
23213629|NCT01342952|64523364|FG002|Overall Study|Physician Decision|1|||
23213630|NCT01342952|64523365|FG003|Overall Study|Physician Decision|0|||
23317467|NCT02552121|64904099|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23317468|NCT02552121|64904100|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23317469|NCT02552121|64904101|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
23317470|NCT02552121|64904094|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
23619300|NCT00239681|65991523|FG000|Overall Study|No information chacked on CaseReportForm|90|||
23619301|NCT00239681|65991524|FG001|Overall Study|No information chacked on CaseReportForm|84|||
23619302|NCT00853021|65991525|FG000|Overall Study|Adverse Event|2|||
23619303|NCT00853021|65991525|FG000|Overall Study|Withdrawal by Subject|2|||
23619304|NCT00853021|65991525|FG000|Overall Study|Death|1|||
23619305|NCT00434577|65991526|FG000|Months 0-3|Serious Adverse Event|0|||
23619306|NCT00434577|65991527|FG001|Months 0-3|Serious Adverse Event|0|||
23619307|NCT00434577|65991528|FG002|Months 0-3|Serious Adverse Event|1|||
23619308|NCT00434577|65991529|FG003|Months 0-3|Serious Adverse Event|0|||
23619309|NCT00434577|65991530|FG004|Months 0-3|Serious Adverse Event|0|||
23619310|NCT00434577|65991526|FG000|Months 0-3|Adverse Event|0|||
23619311|NCT00434577|65991527|FG001|Months 0-3|Adverse Event|1|||
23619312|NCT00434577|65991528|FG002|Months 0-3|Adverse Event|1|||
23619313|NCT00434577|65991529|FG003|Months 0-3|Adverse Event|0|||
23619314|NCT00434577|65991530|FG004|Months 0-3|Adverse Event|0|||
23619315|NCT00434577|65991526|FG000|Months 0-3|Lost to Follow-up|0|||
23619316|NCT00434577|65991527|FG001|Months 0-3|Lost to Follow-up|0|||
23619317|NCT00434577|65991528|FG002|Months 0-3|Lost to Follow-up|0|||
23619318|NCT00434577|65991529|FG003|Months 0-3|Lost to Follow-up|0|||
23213631|NCT01185704|64523366|FG000|Overall Study|Randomized but not treated|3|||
23213632|NCT01185704|64523367|FG001|Overall Study|Randomized but not treated|3|||
23427498|NCT01527383|65307700|FG001|Overall Study|Participant moved|1|||
23317471|NCT02552121|64904095|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23317472|NCT02552121|64904096|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23619319|NCT00434577|65991530|FG004|Months 0-3|Lost to Follow-up|2|||
23619320|NCT00434577|65991526|FG000|Months 0-3|Protocol Violation|1|||
23619321|NCT00434577|65991527|FG001|Months 0-3|Protocol Violation|0|||
23619322|NCT00434577|65991528|FG002|Months 0-3|Protocol Violation|1|||
23619323|NCT00434577|65991529|FG003|Months 0-3|Protocol Violation|0|||
23619324|NCT00434577|65991530|FG004|Months 0-3|Protocol Violation|0|||
23619325|NCT00434577|65991526|FG000|Months 0-3|Withdrawal by Subject|2|||
23427499|NCT01527383|65307699|FG000|Overall Study|Withdrawal by Subject|2|||
23619326|NCT00434577|65991527|FG001|Months 0-3|Withdrawal by Subject|1|||
23619327|NCT00434577|65991528|FG002|Months 0-3|Withdrawal by Subject|1|||
23619328|NCT00434577|65991529|FG003|Months 0-3|Withdrawal by Subject|1|||
23619329|NCT00434577|65991530|FG004|Months 0-3|Withdrawal by Subject|1|||
23619330|NCT02675998|65991531|FG000|8-Week Treatment Period|Adverse Event|6|||
23619331|NCT02675998|65991532|FG001|8-Week Treatment Period|Adverse Event|5|||
23619332|NCT02675998|65991533|FG002|8-Week Treatment Period|Adverse Event|6|||
23619333|NCT02675998|65991534|FG003|8-Week Treatment Period|Adverse Event|0|||
23619334|NCT02675998|65991531|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
23619335|NCT02675998|65991532|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
23619336|NCT02675998|65991533|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
23619337|NCT02675998|65991534|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
23619338|NCT02675998|65991531|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
23619339|NCT02675998|65991532|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
23619340|NCT02675998|65991533|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
23619341|NCT02675998|65991534|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
23132341|NCT02559895|64233927|FG003|Overall Study|Adverse Event|1|||
23132342|NCT02559895|64233924|FG000|Overall Study|Lack of Efficacy|2|||
23132343|NCT02559895|64233925|FG001|Overall Study|Lack of Efficacy|3|||
23132344|NCT02559895|64233926|FG002|Overall Study|Lack of Efficacy|2|||
23132345|NCT02559895|64233927|FG003|Overall Study|Lack of Efficacy|8|||
23132346|NCT02559895|64233924|FG000|Overall Study|Lost to Follow-up|22|||
23213633|NCT01185704|64523366|FG000|Overall Study|Lack of ovarian response|5|||
23213634|NCT01185704|64523367|FG001|Overall Study|Lack of ovarian response|1|||
23213635|NCT01185704|64523366|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
23213636|NCT01185704|64523367|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
23213637|NCT01185704|64523366|FG000|Overall Study|Ectopic pregnancy|0|||
23213638|NCT01185704|64523367|FG001|Overall Study|Ectopic pregnancy|1|||
23213639|NCT03657810|64523370|FG000|Overall Study|Adverse Event|0|||
23213640|NCT03657810|64523371|FG001|Overall Study|Adverse Event|1|||
23213641|NCT03657810|64523372|FG002|Overall Study|Adverse Event|0|||
23213642|NCT03657810|64523370|FG000|Overall Study|Lack of Efficacy|4|||
23213643|NCT03657810|64523371|FG001|Overall Study|Lack of Efficacy|1|||
23213644|NCT03657810|64523372|FG002|Overall Study|Lack of Efficacy|3|||
23213645|NCT03657810|64523370|FG000|Overall Study|Protocol Violation|1|||
23213646|NCT03657810|64523371|FG001|Overall Study|Protocol Violation|0|||
23213647|NCT03657810|64523372|FG002|Overall Study|Protocol Violation|0|||
23213648|NCT03657810|64523370|FG000|Overall Study|Lost to Follow-up|0|||
23213649|NCT03657810|64523371|FG001|Overall Study|Lost to Follow-up|1|||
23213650|NCT03657810|64523372|FG002|Overall Study|Lost to Follow-up|0|||
23213651|NCT03657810|64523370|FG000|Overall Study|Not provided|0|||
23213652|NCT03657810|64523371|FG001|Overall Study|Not provided|1|||
23213653|NCT03657810|64523372|FG002|Overall Study|Not provided|0|||
23213654|NCT01677507|64523373|FG000|Initial Assignment|Adverse Event|0|||
23213655|NCT01677507|64523374|FG001|Initial Assignment|Adverse Event|1|||
23213656|NCT01677507|64523373|FG000|Initial Assignment|Protocol Violation|0|||
23213657|NCT01677507|64523374|FG001|Initial Assignment|Protocol Violation|1|||
23213658|NCT01677507|64523373|FG000|Second Assigment|Withdrawal by Subject|2|||
23213659|NCT01677507|64523374|FG001|Second Assigment|Withdrawal by Subject|2|||
23213660|NCT01677507|64523373|FG000|Second Assigment|Adverse Event|1|||
23213661|NCT01677507|64523374|FG001|Second Assigment|Adverse Event|3|||
23213662|NCT01167153|64523377|FG000|Overall Study|Non-effective therapy|1|||
23213663|NCT01167153|64523378|FG001|Overall Study|Non-effective therapy|4|||
23213664|NCT01167153|64523377|FG000|Overall Study|AE including clinical laboratory AE|2|||
23213665|NCT01167153|64523378|FG001|Overall Study|AE including clinical laboratory AE|8|||
23547438|NCT02363946|65735821|FG003|Overall Study|Lost to Follow-up|0|||
23132347|NCT02559895|64233925|FG001|Overall Study|Lost to Follow-up|16|||
23132348|NCT02559895|64233926|FG002|Overall Study|Lost to Follow-up|12|||
23547439|NCT02363946|65735822|FG004|Overall Study|Lost to Follow-up|0|||
23547440|NCT02363946|65735823|FG005|Overall Study|Lost to Follow-up|0|||
23547441|NCT02363946|65735824|FG006|Overall Study|Lost to Follow-up|0|||
23547442|NCT02363946|65735825|FG007|Overall Study|Lost to Follow-up|1|||
23547443|NCT02363946|65735826|FG008|Overall Study|Lost to Follow-up|0|||
23547444|NCT02363946|65735827|FG009|Overall Study|Lost to Follow-up|0|||
23547445|NCT02363946|65735828|FG010|Overall Study|Lost to Follow-up|0|||
23547446|NCT02363946|65735829|FG011|Overall Study|Lost to Follow-up|0|||
23547447|NCT02363946|65735830|FG012|Overall Study|Lost to Follow-up|0|||
23547448|NCT02365467|65735831|FG000|Overall Study|Death|3|||
23547449|NCT02041195|65735832|FG000|Overall Study|Adverse Event|1|||
23619342|NCT02675998|65991531|FG000|8-Week Treatment Period|Physician Decision|1|||
23619343|NCT02675998|65991532|FG001|8-Week Treatment Period|Physician Decision|0|||
23132349|NCT02559895|64233927|FG003|Overall Study|Lost to Follow-up|17|||
23132350|NCT02559895|64233924|FG000|Overall Study|Physician Decision|1|||
23213666|NCT01167153|64523377|FG000|Overall Study|Hypotension|1|||
23213667|NCT01167153|64523378|FG001|Overall Study|Hypotension|0|||
23213668|NCT01167153|64523377|FG000|Overall Study|Lost to Follow-up|7|||
23213669|NCT01167153|64523378|FG001|Overall Study|Lost to Follow-up|9|||
23547450|NCT02041195|65735833|FG001|Overall Study|Adverse Event|2|||
23619344|NCT02675998|65991533|FG002|8-Week Treatment Period|Physician Decision|2|||
23619345|NCT02675998|65991534|FG003|8-Week Treatment Period|Physician Decision|0|||
23547451|NCT02041195|65735834|FG002|Overall Study|Adverse Event|0|||
23547452|NCT02041195|65735835|FG003|Overall Study|Adverse Event|0|||
23619346|NCT02675998|65991531|FG000|8-Week Treatment Period|GI side Effects|1|||
23619347|NCT02675998|65991532|FG001|8-Week Treatment Period|GI side Effects|4|||
23619348|NCT02675998|65991533|FG002|8-Week Treatment Period|GI side Effects|2|||
23619349|NCT02675998|65991534|FG003|8-Week Treatment Period|GI side Effects|0|||
23619350|NCT02675998|65991531|FG000|8-Week Treatment Period|Protocol Violation|1|||
23619351|NCT02675998|65991532|FG001|8-Week Treatment Period|Protocol Violation|1|||
23619352|NCT02675998|65991533|FG002|8-Week Treatment Period|Protocol Violation|1|||
23619353|NCT02675998|65991534|FG003|8-Week Treatment Period|Protocol Violation|0|||
23619354|NCT02675998|65991531|FG000|8-Week Treatment Period|Other|3|||
23619355|NCT02675998|65991532|FG001|8-Week Treatment Period|Other|1|||
23619356|NCT02675998|65991533|FG002|8-Week Treatment Period|Other|2|||
23619357|NCT02675998|65991534|FG003|8-Week Treatment Period|Other|0|||
23619358|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
23619359|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
23547453|NCT02041195|65735836|FG004|Overall Study|Adverse Event|0|||
23547454|NCT02041195|65735837|FG005|Overall Study|Adverse Event|0|||
23547455|NCT02041195|65735838|FG006|Overall Study|Adverse Event|3|||
23547456|NCT02041195|65735839|FG007|Overall Study|Adverse Event|0|||
23547457|NCT02041195|65735832|FG000|Overall Study|Withdrawal by Subject|1|||
23547458|NCT02041195|65735833|FG001|Overall Study|Withdrawal by Subject|0|||
23547459|NCT02041195|65735834|FG002|Overall Study|Withdrawal by Subject|0|||
23547460|NCT02041195|65735835|FG003|Overall Study|Withdrawal by Subject|0|||
23547461|NCT02041195|65735836|FG004|Overall Study|Withdrawal by Subject|0|||
23547462|NCT02041195|65735837|FG005|Overall Study|Withdrawal by Subject|0|||
23547463|NCT02041195|65735838|FG006|Overall Study|Withdrawal by Subject|4|||
23547464|NCT02041195|65735839|FG007|Overall Study|Withdrawal by Subject|3|||
23547465|NCT02041195|65735832|FG000|Overall Study|Unable to comply with study visits|0|||
23547466|NCT02041195|65735833|FG001|Overall Study|Unable to comply with study visits|1|||
23547467|NCT02041195|65735834|FG002|Overall Study|Unable to comply with study visits|0|||
23547468|NCT02041195|65735835|FG003|Overall Study|Unable to comply with study visits|0|||
23547469|NCT02041195|65735836|FG004|Overall Study|Unable to comply with study visits|1|||
23547470|NCT02041195|65735837|FG005|Overall Study|Unable to comply with study visits|0|||
23547471|NCT02041195|65735838|FG006|Overall Study|Unable to comply with study visits|0|||
23547472|NCT02041195|65735839|FG007|Overall Study|Unable to comply with study visits|0|||
23547473|NCT01983293|65735840|FG000|Overall Study|Withdrawal by Subject|29|||
23547474|NCT01983293|65735841|FG001|Overall Study|Withdrawal by Subject|15|||
23547475|NCT01983293|65735840|FG000|Overall Study|Missing 12-month visit|3|||
23547476|NCT01983293|65735841|FG001|Overall Study|Missing 12-month visit|3|||
23547477|NCT01983293|65735840|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
23547478|NCT01983293|65735841|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
23547479|NCT00116805|65735843|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
23547480|NCT00116805|65735844|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
23547481|NCT00116805|65735843|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
23547482|NCT00116805|65735844|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
23547483|NCT00116805|65735843|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
23547484|NCT00116805|65735844|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
23547485|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
23547486|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
23547487|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
23547488|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
23547489|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
23547490|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
23547491|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
23547492|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
23547493|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
23547494|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
23547495|NCT00116805|65735843|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
23619360|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
23619361|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
23547496|NCT00116805|65735844|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
23547497|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
23547498|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
23547499|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
23619362|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
23619363|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
23619364|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
23619365|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
23619366|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
23619367|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
23619368|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
23619369|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
23619370|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
23619371|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
23619372|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
23619373|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
23619374|NCT02675998|65991531|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
23619375|NCT02675998|65991532|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
23619376|NCT02675998|65991533|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
23619377|NCT02675998|65991534|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
23619378|NCT02236598|65991535|FG000|Overall Study|Adverse Event|0|||
23619379|NCT02236598|65991536|FG001|Overall Study|Adverse Event|1|||
23619380|NCT02236598|65991535|FG000|Overall Study|Withdrawal by Subject|0|||
23619381|NCT02236598|65991536|FG001|Overall Study|Withdrawal by Subject|1|||
23619382|NCT00899379|65991537|FG000|Overall Study|Adverse Event|2|||
23619383|NCT00899379|65991538|FG001|Overall Study|Adverse Event|2|||
23619384|NCT00899379|65991539|FG002|Overall Study|Adverse Event|1|||
23619385|NCT00899379|65991540|FG003|Overall Study|Adverse Event|1|||
23619386|NCT00899379|65991541|FG004|Overall Study|Adverse Event|2|||
23619387|NCT00899379|65991537|FG000|Overall Study|Lack of Efficacy|0|||
23619388|NCT00899379|65991538|FG001|Overall Study|Lack of Efficacy|4|||
23619389|NCT00899379|65991539|FG002|Overall Study|Lack of Efficacy|3|||
23619390|NCT00899379|65991540|FG003|Overall Study|Lack of Efficacy|0|||
23619391|NCT00899379|65991541|FG004|Overall Study|Lack of Efficacy|1|||
23619392|NCT00899379|65991537|FG000|Overall Study|Lost to Follow-up|9|||
23619393|NCT00899379|65991538|FG001|Overall Study|Lost to Follow-up|3|||
23619394|NCT00899379|65991539|FG002|Overall Study|Lost to Follow-up|0|||
23619395|NCT00899379|65991540|FG003|Overall Study|Lost to Follow-up|6|||
23619396|NCT00899379|65991541|FG004|Overall Study|Lost to Follow-up|2|||
23619397|NCT00899379|65991537|FG000|Overall Study|Protocol Violation|0|||
23619398|NCT00899379|65991538|FG001|Overall Study|Protocol Violation|0|||
23619399|NCT00899379|65991539|FG002|Overall Study|Protocol Violation|1|||
23619400|NCT00899379|65991540|FG003|Overall Study|Protocol Violation|1|||
23619401|NCT00899379|65991541|FG004|Overall Study|Protocol Violation|0|||
23619402|NCT00899379|65991537|FG000|Overall Study|Withdrawal by Subject|2|||
23619403|NCT00899379|65991538|FG001|Overall Study|Withdrawal by Subject|4|||
23619404|NCT00899379|65991539|FG002|Overall Study|Withdrawal by Subject|2|||
23619405|NCT00899379|65991540|FG003|Overall Study|Withdrawal by Subject|3|||
23619406|NCT00899379|65991541|FG004|Overall Study|Withdrawal by Subject|6|||
23619407|NCT00899379|65991537|FG000|Overall Study|Pregnancy|0|||
23619408|NCT00899379|65991538|FG001|Overall Study|Pregnancy|0|||
23619409|NCT00899379|65991539|FG002|Overall Study|Pregnancy|1|||
23619410|NCT00899379|65991540|FG003|Overall Study|Pregnancy|0|||
23619411|NCT00899379|65991541|FG004|Overall Study|Pregnancy|1|||
23619412|NCT00899379|65991537|FG000|Overall Study|Patient Uncooperative|0|||
23619413|NCT00899379|65991538|FG001|Overall Study|Patient Uncooperative|1|||
23619414|NCT00899379|65991539|FG002|Overall Study|Patient Uncooperative|0|||
23619415|NCT00899379|65991540|FG003|Overall Study|Patient Uncooperative|1|||
23619416|NCT00899379|65991541|FG004|Overall Study|Patient Uncooperative|2|||
23619417|NCT00899379|65991537|FG000|Overall Study|Abnormal Baseline ECG|0|||
23619418|NCT00899379|65991538|FG001|Overall Study|Abnormal Baseline ECG|0|||
23619419|NCT00899379|65991539|FG002|Overall Study|Abnormal Baseline ECG|0|||
23619420|NCT00899379|65991540|FG003|Overall Study|Abnormal Baseline ECG|1|||
23619421|NCT00899379|65991541|FG004|Overall Study|Abnormal Baseline ECG|0|||
23619422|NCT00899379|65991537|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23619423|NCT00899379|65991538|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23619424|NCT00899379|65991539|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23619425|NCT00899379|65991540|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23132351|NCT02559895|64233925|FG001|Overall Study|Physician Decision|1|||
23427500|NCT01527383|65307700|FG001|Overall Study|Withdrawal by Subject|3|||
23427501|NCT01565564|65310487|FG000|Overall Study|Lost to Follow-up|5|||
23427502|NCT01565564|65310488|FG001|Overall Study|Lost to Follow-up|1|||
23427503|NCT02981524|65310489|FG000|Overall Study|Progressive Disease|14|||
23619426|NCT00899379|65991541|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619427|NCT00899379|65991537|FG000|Overall Study|Not Completed/Entered Extn|5|||
23619428|NCT00899379|65991538|FG001|Overall Study|Not Completed/Entered Extn|1|||
23619429|NCT00899379|65991539|FG002|Overall Study|Not Completed/Entered Extn|6|||
23619430|NCT00899379|65991540|FG003|Overall Study|Not Completed/Entered Extn|4|||
23619431|NCT00899379|65991541|FG004|Overall Study|Not Completed/Entered Extn|3|||
23619432|NCT00899379|65991537|FG000|Overall Study|Study Terminated|3|||
23619433|NCT00899379|65991538|FG001|Overall Study|Study Terminated|0|||
23619434|NCT00899379|65991539|FG002|Overall Study|Study Terminated|3|||
23619435|NCT00899379|65991540|FG003|Overall Study|Study Terminated|3|||
23427504|NCT02981524|65310489|FG000|Overall Study|Death (unrelated)|1|||
23547500|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
23547501|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
23547502|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
23547503|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
23547504|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
23547505|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
23547506|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
23547507|NCT00116805|65735843|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
23547508|NCT00116805|65735844|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
23547509|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
23547510|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
23547511|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
23132352|NCT02559895|64233926|FG002|Overall Study|Physician Decision|3|||
23547512|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
23547513|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
23547514|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
23547515|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
23547516|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
23547517|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
23547518|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
23547519|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
23547520|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
23547521|NCT00116805|65735843|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
23547522|NCT00116805|65735844|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
23547523|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
23547524|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
23547525|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
23547526|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
23547527|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
23547528|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
23547529|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
23547530|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
23547531|NCT00116805|65735843|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
23547532|NCT00116805|65735844|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
23547533|NCT00116805|65735843|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
23547534|NCT00116805|65735844|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
23547535|NCT00116805|65735843|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
23547536|NCT00116805|65735844|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
23547537|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
23547538|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
23547539|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
23547540|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
23547541|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
23547542|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
23547543|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
23547544|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
23547545|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
23547546|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
23547547|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
23547548|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
23547549|NCT00116805|65735843|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
23547550|NCT00116805|65735844|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
23547551|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
23547552|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
23547553|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
23547554|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
23547555|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
23547556|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
23547557|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
23547558|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
23547559|NCT00116805|65735843|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
23547560|NCT00116805|65735844|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
23547561|NCT00116805|65735843|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
23547562|NCT00116805|65735844|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
23547563|NCT00116805|65735843|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
23547564|NCT00116805|65735844|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
23547565|NCT00116805|65735843|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
23547566|NCT00116805|65735844|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
23547567|NCT00116805|65735843|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
23547568|NCT00116805|65735844|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
23547569|NCT01302119|65735851|FG000|Overall Study|Withdrawal by Subject|30|||
23547570|NCT01302119|65735852|FG001|Overall Study|Withdrawal by Subject|20|||
23547571|NCT01302119|65735851|FG000|Overall Study|Lost to Follow-up|10|||
23547572|NCT01302119|65735852|FG001|Overall Study|Lost to Follow-up|4|||
23547573|NCT01302119|65735851|FG000|Overall Study|Adverse Event|2|||
23619436|NCT00899379|65991541|FG004|Overall Study|Study Terminated|1|||
23547574|NCT01302119|65735852|FG001|Overall Study|Adverse Event|1|||
23547575|NCT01302119|65735851|FG000|Overall Study|Non-compliance|4|||
23619437|NCT00899379|65991537|FG000|Overall Study|Lost to Follow-up|3|||
23619438|NCT00899379|65991538|FG001|Overall Study|Lost to Follow-up|1|||
23619439|NCT00899379|65991539|FG002|Overall Study|Lost to Follow-up|0|||
23619440|NCT00899379|65991540|FG003|Overall Study|Lost to Follow-up|2|||
23619441|NCT00899379|65991541|FG004|Overall Study|Lost to Follow-up|5|||
23619442|NCT00899379|65991537|FG000|Overall Study|Withdrawal by Subject|4|||
23619443|NCT00899379|65991538|FG001|Overall Study|Withdrawal by Subject|7|||
23619444|NCT00899379|65991539|FG002|Overall Study|Withdrawal by Subject|4|||
23619445|NCT00899379|65991540|FG003|Overall Study|Withdrawal by Subject|7|||
23619446|NCT00899379|65991541|FG004|Overall Study|Withdrawal by Subject|2|||
23619447|NCT00899379|65991537|FG000|Overall Study|Pregnancy|1|||
23619448|NCT00899379|65991538|FG001|Overall Study|Pregnancy|0|||
23619449|NCT00899379|65991539|FG002|Overall Study|Pregnancy|0|||
23619450|NCT00899379|65991540|FG003|Overall Study|Pregnancy|0|||
23619451|NCT00899379|65991541|FG004|Overall Study|Pregnancy|0|||
23619452|NCT00899379|65991537|FG000|Overall Study|Patient Uncooperative|0|||
23619453|NCT00899379|65991538|FG001|Overall Study|Patient Uncooperative|0|||
23619454|NCT00899379|65991539|FG002|Overall Study|Patient Uncooperative|0|||
23619455|NCT00899379|65991540|FG003|Overall Study|Patient Uncooperative|1|||
23619456|NCT00899379|65991541|FG004|Overall Study|Patient Uncooperative|0|||
23619457|NCT00899379|65991537|FG000|Overall Study|Abnormal Prestudy Labs|0|||
23619458|NCT00899379|65991538|FG001|Overall Study|Abnormal Prestudy Labs|0|||
23619459|NCT00899379|65991539|FG002|Overall Study|Abnormal Prestudy Labs|0|||
23619460|NCT00899379|65991540|FG003|Overall Study|Abnormal Prestudy Labs|0|||
23619461|NCT00899379|65991541|FG004|Overall Study|Abnormal Prestudy Labs|2|||
23619462|NCT00899379|65991537|FG000|Overall Study|Abnormal Baseline ECG|0|||
23619463|NCT00899379|65991538|FG001|Overall Study|Abnormal Baseline ECG|0|||
23619464|NCT00899379|65991539|FG002|Overall Study|Abnormal Baseline ECG|1|||
23619465|NCT00899379|65991540|FG003|Overall Study|Abnormal Baseline ECG|1|||
23619466|NCT00899379|65991541|FG004|Overall Study|Abnormal Baseline ECG|0|||
23619467|NCT00899379|65991537|FG000|Overall Study|No Attack Pretreatment|3|||
23619468|NCT00899379|65991538|FG001|Overall Study|No Attack Pretreatment|5|||
23619469|NCT00899379|65991539|FG002|Overall Study|No Attack Pretreatment|5|||
23619470|NCT00899379|65991540|FG003|Overall Study|No Attack Pretreatment|6|||
23619471|NCT00899379|65991541|FG004|Overall Study|No Attack Pretreatment|4|||
23619472|NCT00899379|65991537|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
23619473|NCT00899379|65991538|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619474|NCT00899379|65991539|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619475|NCT00899379|65991540|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619476|NCT00899379|65991541|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
23619477|NCT00899379|65991537|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
23619478|NCT00899379|65991538|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
23619479|NCT00899379|65991539|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
23619480|NCT00899379|65991540|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
23619481|NCT00899379|65991541|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
23132353|NCT02559895|64233927|FG003|Overall Study|Physician Decision|0|||
23132354|NCT02559895|64233924|FG000|Overall Study|Withdrawal by Subject|16|||
23132355|NCT02559895|64233925|FG001|Overall Study|Withdrawal by Subject|9|||
23132356|NCT02559895|64233926|FG002|Overall Study|Withdrawal by Subject|20|||
23132357|NCT02559895|64233927|FG003|Overall Study|Withdrawal by Subject|9|||
23132358|NCT02559895|64233924|FG000|Overall Study|Study Burden|10|||
23132359|NCT02559895|64233925|FG001|Overall Study|Study Burden|16|||
23132360|NCT02559895|64233926|FG002|Overall Study|Study Burden|12|||
23132361|NCT02559895|64233927|FG003|Overall Study|Study Burden|22|||
23132362|NCT02559895|64233924|FG000|Overall Study|Other|1|||
23132363|NCT02559895|64233925|FG001|Overall Study|Other|5|||
23132364|NCT02559895|64233926|FG002|Overall Study|Other|3|||
23132365|NCT02559895|64233927|FG003|Overall Study|Other|3|||
23132366|NCT02770612|64233928|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
23132367|NCT04608773|64233929|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
23132368|NCT04608773|64233930|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
23132369|NCT04608773|64233929|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
23132370|NCT04608773|64233930|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
23132371|NCT04608773|64233929|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
23132372|NCT04608773|64233930|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
23132373|NCT04608773|64233929|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
23132374|NCT04608773|64233930|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
23132375|NCT04608773|64233929|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
23213670|NCT01167153|64523377|FG000|Overall Study|Non-compliance to concomitant medication|0|||
23213671|NCT01167153|64523378|FG001|Overall Study|Non-compliance to concomitant medication|2|||
23213672|NCT01167153|64523377|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
23213673|NCT01167153|64523378|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
23213674|NCT01167153|64523377|FG000|Overall Study|Withdrawal consent|1|||
23213675|NCT01167153|64523378|FG001|Overall Study|Withdrawal consent|1|||
23213676|NCT01167153|64523377|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
23213677|NCT01167153|64523378|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
23213678|NCT02472795|64523379|FG000|Overall Study|Adverse Event|0|||
23213679|NCT02472795|64523380|FG001|Overall Study|Adverse Event|1|||
23213680|NCT02472795|64523381|FG002|Overall Study|Adverse Event|0|||
23547576|NCT01302119|65735852|FG001|Overall Study|Non-compliance|2|||
23547577|NCT01302119|65735851|FG000|Overall Study|Non-specific|4|||
23547578|NCT01302119|65735852|FG001|Overall Study|Non-specific|1|||
23547579|NCT04084314|65735853|FG000|Overall Study|Subject/guardian decision|91|||
23547580|NCT04084314|65735853|FG000|Overall Study|Adverse Event|24|||
23132376|NCT04608773|64233930|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
23132377|NCT00406692|64233931|FG000|Overall Study|Withdrawal by Subject|4|||
23132378|NCT00406692|64233931|FG000|Overall Study|Physician Decision|1|||
23132379|NCT00406692|64233931|FG000|Overall Study|Adverse Event|1|||
23132380|NCT00406692|64233931|FG000|Overall Study|Lack of Efficacy|1|||
23132381|NCT02712905|64233932|FG000|Monotherapy|Death|2|||
23132382|NCT02712905|64233933|FG001|Monotherapy|Death|5|||
23132383|NCT02712905|64233934|FG002|Monotherapy|Death|0|||
23132384|NCT02712905|64233935|FG003|Monotherapy|Death|3|||
23132385|NCT02712905|64233936|FG004|Monotherapy|Death|15|||
23132386|NCT02712905|64233937|FG005|Monotherapy|Death|1|||
23132387|NCT02712905|64233938|FG006|Monotherapy|Death|3|||
23132388|NCT02712905|64233939|FG007|Monotherapy|Death|3|||
23132389|NCT02712905|64233940|FG008|Monotherapy|Death|0|||
23132390|NCT02712905|64233941|FG009|Monotherapy|Death|27|||
23132391|NCT02712905|64233942|FG010|Monotherapy|Death|2|||
23132392|NCT02712905|64233943|FG011|Monotherapy|Death|5|||
23132393|NCT02712905|64233944|FG012|Monotherapy|Death|0|||
23132394|NCT02712905|64233945|FG013|Monotherapy|Death|0|||
23132395|NCT02712905|64233946|FG014|Monotherapy|Death|0|||
23132396|NCT02712905|64233947|FG015|Monotherapy|Death|0|||
23547581|NCT04084314|65735853|FG000|Overall Study|Lost to Follow-up|19|||
23547582|NCT04084314|65735853|FG000|Overall Study|New therapy for study indication|9|||
23547583|NCT04084314|65735853|FG000|Overall Study|Pregnancy|9|||
23547584|NCT04084314|65735853|FG000|Overall Study|Withdrawal of informed consent|8|||
23547585|NCT04084314|65735853|FG000|Overall Study|Physician Decision|4|||
23547586|NCT04084314|65735853|FG000|Overall Study|Protocol Deviation|3|||
23547587|NCT03521635|65735854|FG000|Overall Study|Adverse Event|1|||
23547588|NCT03521635|65735855|FG001|Overall Study|Adverse Event|1|||
23547589|NCT03521635|65735854|FG000|Overall Study|Refused to complete study visit|1|||
23547590|NCT03521635|65735855|FG001|Overall Study|Refused to complete study visit|0|||
23547591|NCT03521635|65735854|FG000|Overall Study|Refused to continue trial medication|2|||
23547592|NCT03521635|65735855|FG001|Overall Study|Refused to continue trial medication|2|||
23547593|NCT03521635|65735854|FG000|Overall Study|Lost to Follow-up|0|||
23547594|NCT03521635|65735855|FG001|Overall Study|Lost to Follow-up|1|||
23132397|NCT02712905|64233948|FG016|Monotherapy|Death|0|||
23213681|NCT02472795|64523382|FG003|Overall Study|Adverse Event|0|||
23213682|NCT02472795|64523383|FG004|Overall Study|Adverse Event|2|||
23213683|NCT02472795|64523379|FG000|Overall Study|Withdrawal by Subject|0|||
23213684|NCT02472795|64523380|FG001|Overall Study|Withdrawal by Subject|0|||
23547595|NCT03521635|65735854|FG000|Overall Study|Meet exclusion criteria|0|||
23547596|NCT03521635|65735855|FG001|Overall Study|Meet exclusion criteria|1|||
23132398|NCT02712905|64233949|FG017|Monotherapy|Death|0|||
23132399|NCT02712905|64233932|FG000|Monotherapy|Lost to Follow-up|0|||
23132400|NCT02712905|64233933|FG001|Monotherapy|Lost to Follow-up|1|||
23132401|NCT02712905|64233934|FG002|Monotherapy|Lost to Follow-up|0|||
23132402|NCT02712905|64233935|FG003|Monotherapy|Lost to Follow-up|1|||
23132403|NCT02712905|64233936|FG004|Monotherapy|Lost to Follow-up|0|||
23213685|NCT02472795|64523381|FG002|Overall Study|Withdrawal by Subject|0|||
23547597|NCT03521635|65735854|FG000|Overall Study|Patient not taken study medicine|0|||
23619482|NCT03226353|65991547|FG000|Overall Study|Withdrawal by Subject|1|||
23619483|NCT03226353|65991547|FG000|Overall Study|Screen Failure|5|||
23132404|NCT02712905|64233937|FG005|Monotherapy|Lost to Follow-up|0|||
23132405|NCT02712905|64233938|FG006|Monotherapy|Lost to Follow-up|0|||
23132406|NCT02712905|64233939|FG007|Monotherapy|Lost to Follow-up|0|||
23132407|NCT02712905|64233940|FG008|Monotherapy|Lost to Follow-up|0|||
23132408|NCT02712905|64233941|FG009|Monotherapy|Lost to Follow-up|2|||
23132409|NCT02712905|64233942|FG010|Monotherapy|Lost to Follow-up|0|||
23132410|NCT02712905|64233943|FG011|Monotherapy|Lost to Follow-up|0|||
23132411|NCT02712905|64233944|FG012|Monotherapy|Lost to Follow-up|0|||
23132412|NCT02712905|64233945|FG013|Monotherapy|Lost to Follow-up|0|||
23132413|NCT02712905|64233946|FG014|Monotherapy|Lost to Follow-up|0|||
23132414|NCT02712905|64233947|FG015|Monotherapy|Lost to Follow-up|0|||
23132415|NCT02712905|64233948|FG016|Monotherapy|Lost to Follow-up|0|||
23132416|NCT02712905|64233949|FG017|Monotherapy|Lost to Follow-up|0|||
23132417|NCT02712905|64233932|FG000|Monotherapy|Physician Decision|1|||
23132418|NCT02712905|64233933|FG001|Monotherapy|Physician Decision|0|||
23132419|NCT02712905|64233934|FG002|Monotherapy|Physician Decision|0|||
23132420|NCT02712905|64233935|FG003|Monotherapy|Physician Decision|1|||
23132421|NCT02712905|64233936|FG004|Monotherapy|Physician Decision|0|||
23132422|NCT02712905|64233937|FG005|Monotherapy|Physician Decision|0|||
23132423|NCT02712905|64233938|FG006|Monotherapy|Physician Decision|0|||
23132424|NCT02712905|64233939|FG007|Monotherapy|Physician Decision|0|||
23132425|NCT02712905|64233940|FG008|Monotherapy|Physician Decision|0|||
23132426|NCT02712905|64233941|FG009|Monotherapy|Physician Decision|1|||
23132427|NCT02712905|64233942|FG010|Monotherapy|Physician Decision|0|||
23132428|NCT02712905|64233943|FG011|Monotherapy|Physician Decision|0|||
23132429|NCT02712905|64233944|FG012|Monotherapy|Physician Decision|0|||
23132430|NCT02712905|64233945|FG013|Monotherapy|Physician Decision|0|||
23547598|NCT03521635|65735855|FG001|Overall Study|Patient not taken study medicine|1|||
23547599|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
23547600|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
23547601|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
23547602|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
23547603|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
23547604|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
23547605|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
23547606|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
23547607|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
23547608|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
23547609|NCT00695903|65735862|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
23547610|NCT00695903|65735863|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
23547611|NCT00695903|65735862|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
23547612|NCT00695903|65735863|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
23547613|NCT00695903|65735862|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
23547614|NCT00695903|65735863|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
23547615|NCT00695903|65735862|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
23547616|NCT00695903|65735863|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
23547617|NCT00492284|65735864|FG000|Overall Study|Adverse Event|0|||
23547618|NCT00492284|65735865|FG001|Overall Study|Adverse Event|1|||
23547619|NCT00492284|65735866|FG002|Overall Study|Adverse Event|1|||
23547620|NCT00492284|65735867|FG003|Overall Study|Adverse Event|2|||
23547621|NCT00492284|65735864|FG000|Overall Study|Lost to Follow-up|0|||
23547622|NCT00492284|65735865|FG001|Overall Study|Lost to Follow-up|0|||
23547623|NCT00492284|65735866|FG002|Overall Study|Lost to Follow-up|3|||
23547624|NCT00492284|65735867|FG003|Overall Study|Lost to Follow-up|1|||
23547625|NCT00492284|65735864|FG000|Overall Study|Death|0|||
23547626|NCT00492284|65735865|FG001|Overall Study|Death|3|||
23547627|NCT00492284|65735866|FG002|Overall Study|Death|2|||
23547628|NCT00492284|65735867|FG003|Overall Study|Death|5|||
23547629|NCT00492284|65735864|FG000|Overall Study|Withdrawal by Subject|1|||
23547630|NCT00492284|65735865|FG001|Overall Study|Withdrawal by Subject|0|||
23547631|NCT00492284|65735866|FG002|Overall Study|Withdrawal by Subject|0|||
23547632|NCT00492284|65735867|FG003|Overall Study|Withdrawal by Subject|2|||
23547633|NCT02097472|65735872|FG000|Received Vaccination 2|Adverse Event|0|||
23547634|NCT02097472|65735873|FG001|Received Vaccination 2|Adverse Event|0|||
23547635|NCT02097472|65735874|FG002|Received Vaccination 2|Adverse Event|0|||
23547636|NCT02097472|65735875|FG003|Received Vaccination 2|Adverse Event|0|||
23547637|NCT02097472|65735876|FG004|Received Vaccination 2|Adverse Event|0|||
23547638|NCT02097472|65735877|FG005|Received Vaccination 2|Adverse Event|0|||
23547639|NCT02097472|65735878|FG006|Received Vaccination 2|Adverse Event|1|||
23132431|NCT02712905|64233946|FG014|Monotherapy|Physician Decision|0|||
23213686|NCT02472795|64523382|FG003|Overall Study|Withdrawal by Subject|0|||
23132432|NCT02712905|64233947|FG015|Monotherapy|Physician Decision|0|||
23132433|NCT02712905|64233948|FG016|Monotherapy|Physician Decision|0|||
23132434|NCT02712905|64233949|FG017|Monotherapy|Physician Decision|0|||
23132435|NCT02712905|64233932|FG000|Monotherapy|Study Terminated by Sponsor|0|||
23132436|NCT02712905|64233933|FG001|Monotherapy|Study Terminated by Sponsor|0|||
23132437|NCT02712905|64233934|FG002|Monotherapy|Study Terminated by Sponsor|0|||
23132438|NCT02712905|64233935|FG003|Monotherapy|Study Terminated by Sponsor|0|||
23132439|NCT02712905|64233936|FG004|Monotherapy|Study Terminated by Sponsor|1|||
23213687|NCT02472795|64523383|FG004|Overall Study|Withdrawal by Subject|1|||
23547640|NCT02097472|65735879|FG007|Received Vaccination 2|Adverse Event|0|||
23132440|NCT02712905|64233937|FG005|Monotherapy|Study Terminated by Sponsor|0|||
23132441|NCT02712905|64233938|FG006|Monotherapy|Study Terminated by Sponsor|0|||
23132442|NCT02712905|64233939|FG007|Monotherapy|Study Terminated by Sponsor|0|||
23132443|NCT02712905|64233940|FG008|Monotherapy|Study Terminated by Sponsor|0|||
23132444|NCT02712905|64233941|FG009|Monotherapy|Study Terminated by Sponsor|2|||
23132445|NCT02712905|64233942|FG010|Monotherapy|Study Terminated by Sponsor|0|||
23132446|NCT02712905|64233943|FG011|Monotherapy|Study Terminated by Sponsor|0|||
23132447|NCT02712905|64233944|FG012|Monotherapy|Study Terminated by Sponsor|0|||
23132448|NCT02712905|64233945|FG013|Monotherapy|Study Terminated by Sponsor|0|||
23132449|NCT02712905|64233946|FG014|Monotherapy|Study Terminated by Sponsor|0|||
23132450|NCT02712905|64233947|FG015|Monotherapy|Study Terminated by Sponsor|0|||
23132451|NCT02712905|64233948|FG016|Monotherapy|Study Terminated by Sponsor|0|||
23132452|NCT02712905|64233949|FG017|Monotherapy|Study Terminated by Sponsor|0|||
23132453|NCT02712905|64233932|FG000|Monotherapy|Withdrawal by Subject|0|||
23132454|NCT02712905|64233933|FG001|Monotherapy|Withdrawal by Subject|0|||
23132455|NCT02712905|64233934|FG002|Monotherapy|Withdrawal by Subject|1|||
23132456|NCT02712905|64233935|FG003|Monotherapy|Withdrawal by Subject|0|||
23132457|NCT02712905|64233936|FG004|Monotherapy|Withdrawal by Subject|2|||
23132458|NCT02712905|64233937|FG005|Monotherapy|Withdrawal by Subject|0|||
23132459|NCT02712905|64233938|FG006|Monotherapy|Withdrawal by Subject|0|||
23547641|NCT03707977|65735880|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
23547642|NCT03707977|65735881|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
23132460|NCT02712905|64233939|FG007|Monotherapy|Withdrawal by Subject|0|||
23132461|NCT02712905|64233940|FG008|Monotherapy|Withdrawal by Subject|0|||
23132462|NCT02712905|64233941|FG009|Monotherapy|Withdrawal by Subject|4|||
23132463|NCT02712905|64233942|FG010|Monotherapy|Withdrawal by Subject|1|||
23132464|NCT02712905|64233943|FG011|Monotherapy|Withdrawal by Subject|2|||
23132465|NCT02712905|64233944|FG012|Monotherapy|Withdrawal by Subject|0|||
23132466|NCT02712905|64233945|FG013|Monotherapy|Withdrawal by Subject|0|||
23132467|NCT02712905|64233946|FG014|Monotherapy|Withdrawal by Subject|0|||
23132468|NCT02712905|64233947|FG015|Monotherapy|Withdrawal by Subject|0|||
23132469|NCT02712905|64233948|FG016|Monotherapy|Withdrawal by Subject|0|||
23132470|NCT02712905|64233949|FG017|Monotherapy|Withdrawal by Subject|0|||
23132471|NCT02712905|64233932|FG000|Monotherapy|Started New Cancer Drug|0|||
23132472|NCT02712905|64233933|FG001|Monotherapy|Started New Cancer Drug|0|||
23132473|NCT02712905|64233934|FG002|Monotherapy|Started New Cancer Drug|0|||
23132474|NCT02712905|64233935|FG003|Monotherapy|Started New Cancer Drug|0|||
23132475|NCT02712905|64233936|FG004|Monotherapy|Started New Cancer Drug|0|||
23132476|NCT02712905|64233937|FG005|Monotherapy|Started New Cancer Drug|1|||
23132477|NCT02712905|64233938|FG006|Monotherapy|Started New Cancer Drug|0|||
23132478|NCT02712905|64233939|FG007|Monotherapy|Started New Cancer Drug|0|||
23132479|NCT02712905|64233940|FG008|Monotherapy|Started New Cancer Drug|0|||
23132480|NCT02712905|64233941|FG009|Monotherapy|Started New Cancer Drug|0|||
23132481|NCT02712905|64233942|FG010|Monotherapy|Started New Cancer Drug|0|||
23132482|NCT02712905|64233943|FG011|Monotherapy|Started New Cancer Drug|0|||
23132483|NCT02712905|64233944|FG012|Monotherapy|Started New Cancer Drug|0|||
23132484|NCT02712905|64233945|FG013|Monotherapy|Started New Cancer Drug|0|||
23132485|NCT02712905|64233946|FG014|Monotherapy|Started New Cancer Drug|0|||
23132486|NCT02712905|64233947|FG015|Monotherapy|Started New Cancer Drug|0|||
23132487|NCT02712905|64233948|FG016|Monotherapy|Started New Cancer Drug|0|||
23132488|NCT02712905|64233949|FG017|Monotherapy|Started New Cancer Drug|0|||
23132489|NCT02712905|64233932|FG000|Monotherapy|Adverse Event|0|||
23132490|NCT02712905|64233933|FG001|Monotherapy|Adverse Event|0|||
23132491|NCT02712905|64233934|FG002|Monotherapy|Adverse Event|0|||
23132492|NCT02712905|64233935|FG003|Monotherapy|Adverse Event|0|||
23132493|NCT02712905|64233936|FG004|Monotherapy|Adverse Event|0|||
23213688|NCT00880763|64523390|FG000|Extension Period (Part 2)|Adverse Event|0|||
23213689|NCT00880763|64523391|FG001|Extension Period (Part 2)|Adverse Event|0|||
23213690|NCT00880763|64523392|FG002|Extension Period (Part 2)|Adverse Event|1|||
23213691|NCT00880763|64523393|FG003|Extension Period (Part 2)|Adverse Event|1|||
23132494|NCT02712905|64233937|FG005|Monotherapy|Adverse Event|0|||
23132495|NCT02712905|64233938|FG006|Monotherapy|Adverse Event|0|||
23132496|NCT02712905|64233939|FG007|Monotherapy|Adverse Event|0|||
23132497|NCT02712905|64233940|FG008|Monotherapy|Adverse Event|1|||
23132498|NCT02712905|64233941|FG009|Monotherapy|Adverse Event|0|||
23132499|NCT02712905|64233942|FG010|Monotherapy|Adverse Event|0|||
23132500|NCT02712905|64233943|FG011|Monotherapy|Adverse Event|0|||
23132501|NCT02712905|64233944|FG012|Monotherapy|Adverse Event|0|||
23132502|NCT02712905|64233945|FG013|Monotherapy|Adverse Event|0|||
23132503|NCT02712905|64233946|FG014|Monotherapy|Adverse Event|0|||
23132504|NCT02712905|64233947|FG015|Monotherapy|Adverse Event|0|||
23132505|NCT02712905|64233948|FG016|Monotherapy|Adverse Event|0|||
23132506|NCT02712905|64233949|FG017|Monotherapy|Adverse Event|0|||
23132507|NCT02712905|64233932|FG000|Combination Therapy|Death|0|||
23132508|NCT02712905|64233933|FG001|Combination Therapy|Death|0|||
23132509|NCT02712905|64233934|FG002|Combination Therapy|Death|0|||
23213692|NCT00880763|64523390|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
23213693|NCT00880763|64523391|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
23132510|NCT02712905|64233935|FG003|Combination Therapy|Death|0|||
23132511|NCT02712905|64233936|FG004|Combination Therapy|Death|0|||
23132512|NCT02712905|64233937|FG005|Combination Therapy|Death|0|||
23132513|NCT02712905|64233938|FG006|Combination Therapy|Death|0|||
23132514|NCT02712905|64233939|FG007|Combination Therapy|Death|0|||
23132515|NCT02712905|64233940|FG008|Combination Therapy|Death|0|||
23132516|NCT02712905|64233941|FG009|Combination Therapy|Death|0|||
23132517|NCT02712905|64233942|FG010|Combination Therapy|Death|0|||
23132518|NCT02712905|64233943|FG011|Combination Therapy|Death|0|||
23132519|NCT02712905|64233944|FG012|Combination Therapy|Death|5|||
23213694|NCT00880763|64523392|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
23213695|NCT00880763|64523393|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
23213696|NCT00880763|64523390|FG000|Extension Period (Part 2)|Physician Decision|0|||
23213697|NCT00880763|64523391|FG001|Extension Period (Part 2)|Physician Decision|1|||
23213698|NCT00880763|64523392|FG002|Extension Period (Part 2)|Physician Decision|1|||
23213699|NCT00880763|64523393|FG003|Extension Period (Part 2)|Physician Decision|0|||
23213700|NCT00880763|64523390|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
23213701|NCT00880763|64523391|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
23213702|NCT00880763|64523392|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
23213703|NCT00880763|64523393|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
23619484|NCT02391545|65991551|FG000|Overall Study|Death|0|||
23132520|NCT02712905|64233945|FG013|Combination Therapy|Death|6|||
23132521|NCT02712905|64233946|FG014|Combination Therapy|Death|1|||
23132522|NCT02712905|64233947|FG015|Combination Therapy|Death|3|||
23132523|NCT02712905|64233948|FG016|Combination Therapy|Death|1|||
23132524|NCT02712905|64233949|FG017|Combination Therapy|Death|3|||
23132525|NCT02712905|64233932|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
23132526|NCT02712905|64233933|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
23132527|NCT02712905|64233934|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
23132528|NCT02712905|64233935|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
23132529|NCT02712905|64233936|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
23132530|NCT02712905|64233937|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
23132531|NCT02712905|64233938|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
23132532|NCT02712905|64233939|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
23132533|NCT02712905|64233940|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
23132534|NCT02712905|64233941|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
23132535|NCT02712905|64233942|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
23132536|NCT02712905|64233943|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
23132537|NCT02712905|64233944|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
23132538|NCT02712905|64233945|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
23132539|NCT02712905|64233946|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
23132540|NCT02712905|64233947|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
23132541|NCT02712905|64233948|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
23132542|NCT02712905|64233949|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
23132543|NCT02712905|64233932|FG000|Combination Therapy|Withdrawal by Subject|0|||
23132544|NCT02712905|64233933|FG001|Combination Therapy|Withdrawal by Subject|0|||
23132545|NCT02712905|64233934|FG002|Combination Therapy|Withdrawal by Subject|0|||
23132546|NCT02712905|64233935|FG003|Combination Therapy|Withdrawal by Subject|0|||
23132547|NCT02712905|64233936|FG004|Combination Therapy|Withdrawal by Subject|0|||
23132548|NCT02712905|64233937|FG005|Combination Therapy|Withdrawal by Subject|0|||
23132549|NCT02712905|64233938|FG006|Combination Therapy|Withdrawal by Subject|0|||
23132550|NCT02712905|64233939|FG007|Combination Therapy|Withdrawal by Subject|0|||
23132551|NCT02712905|64233940|FG008|Combination Therapy|Withdrawal by Subject|0|||
23132552|NCT02712905|64233941|FG009|Combination Therapy|Withdrawal by Subject|0|||
23132553|NCT02712905|64233942|FG010|Combination Therapy|Withdrawal by Subject|0|||
23132554|NCT02712905|64233943|FG011|Combination Therapy|Withdrawal by Subject|0|||
23132555|NCT02712905|64233944|FG012|Combination Therapy|Withdrawal by Subject|0|||
23132556|NCT02712905|64233945|FG013|Combination Therapy|Withdrawal by Subject|0|||
23132557|NCT02712905|64233946|FG014|Combination Therapy|Withdrawal by Subject|0|||
23132558|NCT02712905|64233947|FG015|Combination Therapy|Withdrawal by Subject|1|||
23132559|NCT02712905|64233948|FG016|Combination Therapy|Withdrawal by Subject|0|||
23132560|NCT02712905|64233949|FG017|Combination Therapy|Withdrawal by Subject|2|||
23132561|NCT02712905|64233932|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132562|NCT02712905|64233933|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132563|NCT02712905|64233934|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132564|NCT02712905|64233935|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132565|NCT02712905|64233936|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132566|NCT02712905|64233937|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132567|NCT02712905|64233938|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132568|NCT02712905|64233939|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23213704|NCT02527148|64523396|FG000|Overall Study|Did not receive study intervention|1|||
23213705|NCT02527148|64523397|FG001|Overall Study|Did not receive study intervention|0|||
23213706|NCT03479216|64523402|FG000|Overall Study|Withdrawal by Subject|3|||
23132569|NCT02712905|64233940|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132570|NCT02712905|64233941|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132571|NCT02712905|64233942|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132572|NCT02712905|64233943|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132573|NCT02712905|64233944|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132574|NCT02712905|64233945|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132575|NCT02712905|64233946|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132576|NCT02712905|64233947|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
23132577|NCT02712905|64233948|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132578|NCT02712905|64233949|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
23132579|NCT01099215|64233956|FG000|Overall Study|Withdrawal by Subject|1|||
23132580|NCT01099215|64233957|FG001|Overall Study|Withdrawal by Subject|0|||
23619485|NCT02391545|65991552|FG001|Overall Study|Death|2|||
23547643|NCT03707977|65735882|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
23547644|NCT03707977|65735880|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
23547645|NCT03707977|65735881|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
23547646|NCT03707977|65735882|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
23547647|NCT04969250|65735884|FG000|Overall Study|Protocol Violation|0|||
23547648|NCT04969250|65735885|FG001|Overall Study|Protocol Violation|2|||
23547649|NCT04969250|65735886|FG002|Overall Study|Protocol Violation|3|||
23547650|NCT04969250|65735887|FG003|Overall Study|Protocol Violation|8|||
23547651|NCT04969250|65735884|FG000|Overall Study|Withdrawal by Subject|0|||
23547652|NCT04969250|65735885|FG001|Overall Study|Withdrawal by Subject|1|||
23547653|NCT04969250|65735886|FG002|Overall Study|Withdrawal by Subject|0|||
23547654|NCT04969250|65735887|FG003|Overall Study|Withdrawal by Subject|0|||
23547655|NCT03434119|65735888|FG000|Overall Study|Randomized but not treated|1|||
23547656|NCT03434119|65735889|FG001|Overall Study|Randomized but not treated|0|||
23619486|NCT02391545|65991551|FG000|Overall Study|Lost to Follow-up|0|||
23619487|NCT02391545|65991552|FG001|Overall Study|Lost to Follow-up|1|||
23619488|NCT02391545|65991551|FG000|Overall Study|Termination of study by sponsor|20|||
23619489|NCT02391545|65991552|FG001|Overall Study|Termination of study by sponsor|20|||
23619490|NCT02391545|65991551|FG000|Overall Study|Withdrawal by Subject|0|||
23619491|NCT02391545|65991552|FG001|Overall Study|Withdrawal by Subject|1|||
23619492|NCT02391545|65991551|FG000|Overall Study|Other Reasons|6|||
23619493|NCT02391545|65991552|FG001|Overall Study|Other Reasons|4|||
23619494|NCT03461211|65991553|FG000|Overall Study|Adverse Event|1|||
23619495|NCT03461211|65991554|FG001|Overall Study|Adverse Event|1|||
23619496|NCT03461211|65991553|FG000|Overall Study|Lack of Efficacy|0|||
23619497|NCT03461211|65991554|FG001|Overall Study|Lack of Efficacy|1|||
23619498|NCT02573883|65991555|FG000|Six Month Follow Up|Lost to Follow-up|1|||
23619499|NCT02573883|65991556|FG001|Six Month Follow Up|Lost to Follow-up|0|||
23619500|NCT02573883|65991557|FG002|Six Month Follow Up|Lost to Follow-up|0|||
23619501|NCT02573883|65991558|FG003|Six Month Follow Up|Lost to Follow-up|0|||
23619502|NCT02573883|65991555|FG000|One Year Follow Up|Lost to Follow-up|2|||
23619503|NCT02573883|65991556|FG001|One Year Follow Up|Lost to Follow-up|1|||
23619504|NCT02573883|65991557|FG002|One Year Follow Up|Lost to Follow-up|0|||
23619505|NCT02573883|65991558|FG003|One Year Follow Up|Lost to Follow-up|0|||
23619506|NCT04414397|65991561|FG000|Control Period|Withdrawal by Subject|2|||
23619507|NCT04414397|65991562|FG001|Control Period|Withdrawal by Subject|2|||
23619508|NCT04414397|65991561|FG000|Control Period|Lost to Follow-up|0|||
23132581|NCT01099215|64233956|FG000|Overall Study|Adverse Event|0|||
23132582|NCT01099215|64233957|FG001|Overall Study|Adverse Event|1|||
23132583|NCT01182441|64233968|FG000|Overall Study|Patient Still in Follow-up|152|||
23132584|NCT01182441|64233969|FG001|Overall Study|Patient Still in Follow-up|72|||
23132585|NCT01182441|64233968|FG000|Overall Study|Death|37|||
23132586|NCT01182441|64233969|FG001|Overall Study|Death|25|||
23132587|NCT01182441|64233968|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
23132588|NCT01182441|64233969|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
23132589|NCT01182441|64233968|FG000|Overall Study|Lost to Follow-up|5|||
23132590|NCT01182441|64233969|FG001|Overall Study|Lost to Follow-up|8|||
23132591|NCT01182441|64233968|FG000|Overall Study|Withdrawal by Subject|6|||
23547657|NCT03434119|65735888|FG000|Overall Study|Adverse Event|1|||
23619509|NCT04414397|65991562|FG001|Control Period|Lost to Follow-up|4|||
23619510|NCT04414397|65991561|FG000|Control Period|Protocol deviation|0|||
23132592|NCT01182441|64233969|FG001|Overall Study|Withdrawal by Subject|13|||
23132593|NCT01182441|64233968|FG000|Overall Study|Implant Not Attempted|4|||
23619511|NCT04414397|65991562|FG001|Control Period|Protocol deviation|1|||
23547658|NCT03434119|65735889|FG001|Overall Study|Adverse Event|0|||
23619512|NCT04414397|65991561|FG000|Post-Control Period|Withdrawal by Subject|3|||
23619513|NCT04414397|65991562|FG001|Post-Control Period|Withdrawal by Subject|6|||
23132594|NCT01182441|64233969|FG001|Overall Study|Implant Not Attempted|0|||
23132595|NCT01182441|64233968|FG000|Overall Study|Adverse Event|2|||
23132596|NCT01182441|64233969|FG001|Overall Study|Adverse Event|0|||
23132597|NCT01182441|64233968|FG000|Overall Study|Physician Decision|1|||
23132598|NCT01182441|64233969|FG001|Overall Study|Physician Decision|1|||
23132599|NCT00974259|64233997|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
23132600|NCT00974259|64233998|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
23132601|NCT00862719|64233999|FG000|Overall Study|Disease Progression|5|||
23132602|NCT00862719|64234000|FG001|Overall Study|Disease Progression|0|||
23132603|NCT00862719|64234001|FG002|Overall Study|Disease Progression|1|||
23132604|NCT00862719|64234002|FG003|Overall Study|Disease Progression|0|||
23132605|NCT00862719|64233999|FG000|Overall Study|Death|5|||
23132606|NCT00862719|64234000|FG001|Overall Study|Death|6|||
23132607|NCT00862719|64234001|FG002|Overall Study|Death|1|||
23132608|NCT00862719|64234002|FG003|Overall Study|Death|1|||
23132609|NCT00862719|64233999|FG000|Overall Study|Engraftment failure|0|||
23132610|NCT00862719|64234000|FG001|Overall Study|Engraftment failure|0|||
23132611|NCT00862719|64234001|FG002|Overall Study|Engraftment failure|1|||
23132612|NCT00862719|64234002|FG003|Overall Study|Engraftment failure|0|||
23547659|NCT03434119|65735888|FG000|Overall Study|Poor Compliance to Protocol|0|||
23547660|NCT03434119|65735889|FG001|Overall Study|Poor Compliance to Protocol|1|||
23547661|NCT03434119|65735888|FG000|Overall Study|Study Terminated by Sponsor|91|||
23547662|NCT03434119|65735889|FG001|Overall Study|Study Terminated by Sponsor|102|||
23547663|NCT03434119|65735888|FG000|Overall Study|Withdrawal by Subject|7|||
23547664|NCT03434119|65735889|FG001|Overall Study|Withdrawal by Subject|5|||
23132613|NCT00862719|64233999|FG000|Overall Study|Veno-Occlusive Disease|0|||
23132614|NCT00862719|64234000|FG001|Overall Study|Veno-Occlusive Disease|0|||
23132615|NCT00862719|64234001|FG002|Overall Study|Veno-Occlusive Disease|1|||
23132616|NCT00862719|64234002|FG003|Overall Study|Veno-Occlusive Disease|0|||
23132617|NCT03284229|64234004|FG000|Overall Study|Lost to Follow-up|3|||
23132618|NCT00886795|64234005|FG000|Overall Study|Lack of Efficacy|1|||
23132619|NCT02472145|64234019|FG000|Overall Study|Death|10|||
23132620|NCT02472145|64234020|FG001|Overall Study|Death|101|||
23132621|NCT02472145|64234021|FG002|Overall Study|Death|99|||
23132622|NCT02472145|64234019|FG000|Overall Study|Lost to Follow-up|0|||
23132623|NCT02472145|64234020|FG001|Overall Study|Lost to Follow-up|1|||
23132624|NCT02472145|64234021|FG002|Overall Study|Lost to Follow-up|0|||
23132625|NCT02472145|64234019|FG000|Overall Study|Withdrawal by Subject|0|||
23132626|NCT02472145|64234020|FG001|Overall Study|Withdrawal by Subject|9|||
23132627|NCT02472145|64234021|FG002|Overall Study|Withdrawal by Subject|13|||
23132628|NCT02472145|64234019|FG000|Overall Study|Sponsor decision|0|||
23132629|NCT02472145|64234020|FG001|Overall Study|Sponsor decision|3|||
23132630|NCT02472145|64234021|FG002|Overall Study|Sponsor decision|2|||
23132631|NCT02472145|64234019|FG000|Overall Study|Other|0|||
23132632|NCT02472145|64234020|FG001|Overall Study|Other|45|||
23132633|NCT02472145|64234021|FG002|Overall Study|Other|43|||
23132634|NCT02510040|64234024|FG000|Overall Study|Deemed no longer eligible|18|||
23132635|NCT02510040|64234025|FG001|Overall Study|Deemed no longer eligible|3|||
23132636|NCT02510040|64234026|FG002|Overall Study|Deemed no longer eligible|1|||
23132637|NCT02179177|64234027|FG000|Overall Study|Lost to Follow-up|1|||
23547665|NCT03434119|65735888|FG000|Overall Study|Other than specified|7|||
23547666|NCT03434119|65735889|FG001|Overall Study|Other than specified|5|||
23619514|NCT04414397|65991561|FG000|Post-Control Period|Lost to Follow-up|4|||
23619515|NCT04414397|65991562|FG001|Post-Control Period|Lost to Follow-up|9|||
23132638|NCT02179177|64234028|FG001|Overall Study|Lost to Follow-up|1|||
23132639|NCT02179177|64234027|FG000|Overall Study|Withdrawal by Subject|1|||
23132640|NCT02179177|64234028|FG001|Overall Study|Withdrawal by Subject|1|||
23132641|NCT01142115|64234029|FG000|First Intervention|Lack of Efficacy|1|||
23132642|NCT01142115|64234030|FG001|First Intervention|Lack of Efficacy|1|||
23132643|NCT01142115|64234029|FG000|First Intervention|Adverse Event|1|||
23132644|NCT01142115|64234030|FG001|First Intervention|Adverse Event|0|||
23132645|NCT01075958|64234033|FG000|Overall Study|Blood sample could not be obtained|44|||
23132646|NCT00545753|64234034|FG000|Overall Study|Withdrawal by Subject|0|||
23132647|NCT00545753|64234035|FG001|Overall Study|Withdrawal by Subject|1|||
23132648|NCT00545753|64234036|FG002|Overall Study|Withdrawal by Subject|10|||
23547667|NCT03555396|65735892|FG000|Overall Study|Death|3|||
23132649|NCT00545753|64234034|FG000|Overall Study|Lost to Follow-up|13|||
23132650|NCT00545753|64234035|FG001|Overall Study|Lost to Follow-up|3|||
23132651|NCT00545753|64234036|FG002|Overall Study|Lost to Follow-up|12|||
23132652|NCT00545753|64234034|FG000|Overall Study|Protocol Violation|3|||
23132653|NCT00545753|64234035|FG001|Overall Study|Protocol Violation|1|||
23132654|NCT00545753|64234036|FG002|Overall Study|Protocol Violation|4|||
23132655|NCT02460575|64234037|FG000|Overall Study|Lost to Follow-up|1|||
23132656|NCT02460575|64234038|FG001|Overall Study|Lost to Follow-up|0|||
23547668|NCT03555396|65735893|FG001|Overall Study|Death|1|||
23132657|NCT00357110|64234056|FG000|Overall Study|Early study termination|5|||
23132658|NCT00357110|64234057|FG001|Overall Study|Early study termination|5|||
23132659|NCT03653208|64234058|FG000|Overall Study|Withdrawal by Subject|0|||
23132660|NCT03653208|64234059|FG001|Overall Study|Withdrawal by Subject|0|||
23132661|NCT03653208|64234060|FG002|Overall Study|Withdrawal by Subject|0|||
23132662|NCT03653208|64234061|FG003|Overall Study|Withdrawal by Subject|0|||
23132663|NCT03653208|64234062|FG004|Overall Study|Withdrawal by Subject|1|||
23132664|NCT03653208|64234063|FG005|Overall Study|Withdrawal by Subject|0|||
23132665|NCT03653208|64234064|FG006|Overall Study|Withdrawal by Subject|0|||
23132666|NCT03653208|64234065|FG007|Overall Study|Withdrawal by Subject|1|||
23132667|NCT03653208|64234066|FG008|Overall Study|Withdrawal by Subject|1|||
23132668|NCT02922023|64234067|FG000|Overall Study|Lost to Follow-up|2|||
23132669|NCT02922023|64234068|FG001|Overall Study|Lost to Follow-up|0|||
23132670|NCT02842151|64234069|FG000|Overall Study|Adverse Event|1|||
23132671|NCT02842151|64234069|FG000|Overall Study|Subject moved too far away|1|||
23132672|NCT03775434|64234070|FG000|Overall Study|Adverse Event|2|||
23132673|NCT03775434|64234070|FG000|Overall Study|Withdrawal by Subject|1|||
23132674|NCT03181789|64234071|FG000|Overall Study|Withdrawal by Subject|0|||
23132675|NCT03181789|64234072|FG001|Overall Study|Withdrawal by Subject|1|||
23132676|NCT03181789|64234073|FG002|Overall Study|Withdrawal by Subject|1|||
23132677|NCT03181789|64234074|FG003|Overall Study|Withdrawal by Subject|0|||
23132678|NCT03181789|64234071|FG000|Overall Study|Lost to Follow-up|7|||
23132679|NCT03181789|64234072|FG001|Overall Study|Lost to Follow-up|1|||
23132680|NCT03181789|64234073|FG002|Overall Study|Lost to Follow-up|0|||
23132681|NCT03181789|64234074|FG003|Overall Study|Lost to Follow-up|0|||
23132682|NCT03181789|64234071|FG000|Overall Study|Participant unable to adhere to visit|0|||
23132683|NCT03181789|64234072|FG001|Overall Study|Participant unable to adhere to visit|1|||
23132684|NCT03181789|64234073|FG002|Overall Study|Participant unable to adhere to visit|0|||
23132685|NCT03181789|64234074|FG003|Overall Study|Participant unable to adhere to visit|0|||
23132686|NCT00324116|64234075|FG000|Overall Study|Adverse Event|5|||
23132687|NCT00324116|64234075|FG000|Overall Study|Lack of Efficacy|17|||
23132688|NCT00324116|64234075|FG000|Overall Study|Withdrawal by Subject|5|||
23132689|NCT00324116|64234075|FG000|Overall Study|Other|5|||
23132690|NCT02224703|64234078|FG000|Overall Study|Adverse Event|0|||
23132691|NCT02224703|64234079|FG001|Overall Study|Adverse Event|5|||
23132692|NCT02224703|64234080|FG002|Overall Study|Adverse Event|0|||
23132693|NCT02224703|64234078|FG000|Overall Study|Withdrawn by investigator|1|||
23132694|NCT02224703|64234079|FG001|Overall Study|Withdrawn by investigator|0|||
23132695|NCT02224703|64234080|FG002|Overall Study|Withdrawn by investigator|0|||
23132696|NCT02224703|64234078|FG000|Overall Study|Advised by medical monitor|1|||
23132697|NCT02224703|64234079|FG001|Overall Study|Advised by medical monitor|0|||
23132698|NCT02224703|64234080|FG002|Overall Study|Advised by medical monitor|0|||
23132699|NCT02224703|64234078|FG000|Overall Study|Withdrawn by parent/guardian|0|||
23132700|NCT02224703|64234079|FG001|Overall Study|Withdrawn by parent/guardian|1|||
23132701|NCT02224703|64234080|FG002|Overall Study|Withdrawn by parent/guardian|0|||
23132702|NCT02224703|64234078|FG000|Overall Study|Lack of Efficacy|1|||
23132703|NCT02224703|64234079|FG001|Overall Study|Lack of Efficacy|0|||
23132704|NCT02224703|64234080|FG002|Overall Study|Lack of Efficacy|0|||
23132705|NCT02202785|64234081|FG000|Overall Study|Study Terminated by Sponsor|1|||
23132706|NCT02202785|64234082|FG001|Overall Study|Study Terminated by Sponsor|6|||
23132707|NCT02202785|64234083|FG002|Overall Study|Study Terminated by Sponsor|4|||
23132708|NCT02202785|64234081|FG000|Overall Study|Withdrawal by Subject|0|||
23132709|NCT02202785|64234082|FG001|Overall Study|Withdrawal by Subject|1|||
23132710|NCT02202785|64234083|FG002|Overall Study|Withdrawal by Subject|0|||
23132711|NCT02202785|64234081|FG000|Overall Study|Lost to Follow-up|0|||
23132712|NCT02202785|64234082|FG001|Overall Study|Lost to Follow-up|1|||
23132713|NCT02202785|64234083|FG002|Overall Study|Lost to Follow-up|0|||
23132714|NCT02202785|64234081|FG000|Overall Study|Reason not Specified|10|||
23132715|NCT02202785|64234082|FG001|Overall Study|Reason not Specified|7|||
23132716|NCT02202785|64234083|FG002|Overall Study|Reason not Specified|13|||
23132717|NCT01818531|64234088|FG000|Overall Study|Withdrawn for case delay after block|1|||
23132718|NCT01818531|64234089|FG001|Overall Study|Withdrawn for case delay after block|0|||
23132719|NCT01818531|64234088|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
23132720|NCT01818531|64234089|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
23132721|NCT01818531|64234088|FG000|Overall Study|Withdrawn for failure to place block|0|||
23132722|NCT01818531|64234089|FG001|Overall Study|Withdrawn for failure to place block|1|||
23132723|NCT04546217|64234096|FG000|Overall Study|Withdrawal by Subject|2|||
23132724|NCT04546217|64234097|FG001|Overall Study|Withdrawal by Subject|0|||
23132725|NCT04546217|64234096|FG000|Overall Study|Uncontrolled hypertension|1|||
23132726|NCT04546217|64234097|FG001|Overall Study|Uncontrolled hypertension|0|||
23132727|NCT02476175|64234105|FG000|Overall Study|Adverse Event|2|||
23132728|NCT00128102|64234106|FG000|Overall Study|Site Discontinued|3|||
23132729|NCT00128102|64234107|FG001|Overall Study|Site Discontinued|6|||
23132730|NCT00128102|64234106|FG000|Overall Study|Other|0|||
23132731|NCT00128102|64234107|FG001|Overall Study|Other|1|||
23132732|NCT00128102|64234106|FG000|Overall Study|Progressive Disease|255|||
23132733|NCT00128102|64234107|FG001|Overall Study|Progressive Disease|285|||
23132734|NCT00128102|64234106|FG000|Overall Study|Adverse Event|34|||
23132735|NCT00128102|64234107|FG001|Overall Study|Adverse Event|11|||
23132736|NCT00128102|64234106|FG000|Overall Study|Death|12|||
23132737|NCT00128102|64234107|FG001|Overall Study|Death|13|||
23547669|NCT03555396|65735892|FG000|Overall Study|Lost to Follow-up|0|||
23547670|NCT03555396|65735893|FG001|Overall Study|Lost to Follow-up|2|||
23132738|NCT00128102|64234106|FG000|Overall Study|Physician Decision|3|||
23547671|NCT02477618|65735894|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
23547672|NCT02477618|65735895|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
23547673|NCT02477618|65735894|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
23547674|NCT02477618|65735895|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
23547675|NCT02477618|65735894|FG000|Overall Study|Adverse Event|1|||
23547676|NCT02477618|65735895|FG001|Overall Study|Adverse Event|1|||
23547677|NCT02477618|65735894|FG000|Overall Study|Transferred Away from Study Site|1|||
23547678|NCT02477618|65735895|FG001|Overall Study|Transferred Away from Study Site|0|||
23547679|NCT02477618|65735894|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
23547680|NCT02477618|65735895|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
23547681|NCT01220557|65735896|FG000|Overall Study|Lost to Follow-up|5|||
23547682|NCT01220557|65735897|FG001|Overall Study|Lost to Follow-up|3|||
23547683|NCT01220557|65735896|FG000|Overall Study|attended less than 6 lessons|1|||
23547684|NCT01220557|65735897|FG001|Overall Study|attended less than 6 lessons|2|||
23547685|NCT03568318|65735898|FG000|Overall Study|Adverse Event|3|||
23547686|NCT03568318|65735899|FG001|Overall Study|Adverse Event|1|||
23547687|NCT03568318|65735900|FG002|Overall Study|Adverse Event|1|||
23547688|NCT03568318|65735901|FG003|Overall Study|Adverse Event|0|||
23547689|NCT03568318|65735902|FG004|Overall Study|Adverse Event|1|||
23547690|NCT03568318|65735903|FG005|Overall Study|Adverse Event|0|||
23547691|NCT03568318|65735898|FG000|Overall Study|Withdrawal by Subject|6|||
23547692|NCT03568318|65735899|FG001|Overall Study|Withdrawal by Subject|5|||
23547693|NCT03568318|65735900|FG002|Overall Study|Withdrawal by Subject|2|||
23547694|NCT03568318|65735901|FG003|Overall Study|Withdrawal by Subject|1|||
23547695|NCT03568318|65735902|FG004|Overall Study|Withdrawal by Subject|0|||
23547696|NCT03568318|65735903|FG005|Overall Study|Withdrawal by Subject|0|||
23547697|NCT03568318|65735898|FG000|Overall Study|Lost to Follow-up|3|||
23547698|NCT03568318|65735899|FG001|Overall Study|Lost to Follow-up|2|||
23547699|NCT03568318|65735900|FG002|Overall Study|Lost to Follow-up|2|||
23547700|NCT03568318|65735901|FG003|Overall Study|Lost to Follow-up|2|||
23547701|NCT03568318|65735902|FG004|Overall Study|Lost to Follow-up|1|||
23547702|NCT03568318|65735903|FG005|Overall Study|Lost to Follow-up|0|||
23547703|NCT03568318|65735898|FG000|Overall Study|Other|3|||
23547704|NCT03568318|65735899|FG001|Overall Study|Other|1|||
23132739|NCT00128102|64234107|FG001|Overall Study|Physician Decision|3|||
23132740|NCT00128102|64234106|FG000|Overall Study|Withdrawal by Subject|19|||
23132741|NCT00128102|64234107|FG001|Overall Study|Withdrawal by Subject|11|||
23132742|NCT00128102|64234106|FG000|Overall Study|Protocol Violation|2|||
23132743|NCT00128102|64234107|FG001|Overall Study|Protocol Violation|2|||
23132744|NCT00127205|64234108|FG000|Overall Study|Adverse Event|228|||
23132745|NCT00127205|64234109|FG001|Overall Study|Adverse Event|387|||
23132746|NCT00127205|64234110|FG002|Overall Study|Adverse Event|273|||
23132747|NCT00127205|64234108|FG000|Overall Study|Death|8|||
23132748|NCT00127205|64234109|FG001|Overall Study|Death|6|||
23132749|NCT00127205|64234110|FG002|Overall Study|Death|5|||
23132750|NCT00127205|64234108|FG000|Overall Study|Withdrawal by Subject|318|||
23132751|NCT00127205|64234109|FG001|Overall Study|Withdrawal by Subject|310|||
23132752|NCT00127205|64234110|FG002|Overall Study|Withdrawal by Subject|172|||
23132753|NCT00127205|64234108|FG000|Overall Study|Other-non protocol specified|142|||
23132754|NCT00127205|64234109|FG001|Overall Study|Other-non protocol specified|129|||
23132755|NCT00127205|64234110|FG002|Overall Study|Other-non protocol specified|77|||
23132756|NCT00127205|64234108|FG000|Overall Study|Data not reported|6|||
23132757|NCT00127205|64234109|FG001|Overall Study|Data not reported|10|||
23132758|NCT00127205|64234110|FG002|Overall Study|Data not reported|1|||
23132759|NCT00127205|64234108|FG000|Overall Study|Progression|127|||
23132760|NCT00127205|64234109|FG001|Overall Study|Progression|131|||
23132761|NCT00127205|64234110|FG002|Overall Study|Progression|84|||
23132762|NCT00902746|64234116|FG000|Overall Study|Protocol Violation|7|||
23132763|NCT00902746|64234116|FG000|Overall Study|Withdrawal by Subject|16|||
23132764|NCT00902746|64234116|FG000|Overall Study|Adverse Event|8|||
23132765|NCT00902746|64234116|FG000|Overall Study|Lost to Follow-up|3|||
23213707|NCT03479216|64523403|FG001|Overall Study|Withdrawal by Subject|2|||
23547705|NCT03568318|65735900|FG002|Overall Study|Other|3|||
23547706|NCT03568318|65735901|FG003|Overall Study|Other|0|||
23547707|NCT03568318|65735902|FG004|Overall Study|Other|0|||
23132766|NCT00902746|64234116|FG000|Overall Study|Physician Decision|2|||
23132767|NCT03596762|64234117|FG000|Overall Study|Protocol Violation|0|||
23132768|NCT03596762|64234118|FG001|Overall Study|Protocol Violation|0|||
23132769|NCT03596762|64234119|FG002|Overall Study|Protocol Violation|0|||
23132770|NCT03596762|64234120|FG003|Overall Study|Protocol Violation|0|||
23213708|NCT03479216|64523402|FG000|Overall Study|Physician Decision|2|||
23132771|NCT03596762|64234121|FG004|Overall Study|Protocol Violation|1|||
23547708|NCT03568318|65735903|FG005|Overall Study|Other|0|||
23132772|NCT03596762|64234117|FG000|Overall Study|Adverse Event|2|||
23132773|NCT03596762|64234118|FG001|Overall Study|Adverse Event|0|||
23132774|NCT03596762|64234119|FG002|Overall Study|Adverse Event|1|||
23132775|NCT03596762|64234120|FG003|Overall Study|Adverse Event|0|||
23132776|NCT03596762|64234121|FG004|Overall Study|Adverse Event|5|||
23132777|NCT03596762|64234117|FG000|Overall Study|Withdrawal by Subject|2|||
23132778|NCT03596762|64234118|FG001|Overall Study|Withdrawal by Subject|1|||
23132779|NCT03596762|64234119|FG002|Overall Study|Withdrawal by Subject|0|||
23132780|NCT03596762|64234120|FG003|Overall Study|Withdrawal by Subject|1|||
23132781|NCT03596762|64234121|FG004|Overall Study|Withdrawal by Subject|1|||
23132782|NCT00513305|64234130|FG000|Overall Study|Adverse Event|6|||
23132783|NCT00513305|64234131|FG001|Overall Study|Adverse Event|2|||
23132784|NCT00513305|64234130|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
23132785|NCT00513305|64234131|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
23132786|NCT00513305|64234130|FG000|Overall Study|Lack of Efficacy|8|||
23132787|NCT00513305|64234131|FG001|Overall Study|Lack of Efficacy|13|||
23132788|NCT00513305|64234130|FG000|Overall Study|Withdrawal by Subject|1|||
23132789|NCT00513305|64234131|FG001|Overall Study|Withdrawal by Subject|2|||
23132790|NCT00513305|64234130|FG000|Overall Study|Disease progression|8|||
23132791|NCT00513305|64234131|FG001|Overall Study|Disease progression|5|||
23132792|NCT00513305|64234130|FG000|Overall Study|Eligible for stem cell transplant|1|||
23132793|NCT00513305|64234131|FG001|Overall Study|Eligible for stem cell transplant|0|||
23132794|NCT00513305|64234130|FG000|Overall Study|Hematologic counts did not recover|1|||
23132795|NCT00513305|64234131|FG001|Overall Study|Hematologic counts did not recover|0|||
23132796|NCT00513305|64234130|FG000|Overall Study|Physician Decision|1|||
23132797|NCT00513305|64234131|FG001|Overall Study|Physician Decision|0|||
23132798|NCT00513305|64234130|FG000|Overall Study|Persistent hypocellularity|0|||
23132799|NCT00513305|64234131|FG001|Overall Study|Persistent hypocellularity|1|||
23132800|NCT00513305|64234130|FG000|Overall Study|Sponsor Decision|0|||
23132801|NCT00513305|64234131|FG001|Overall Study|Sponsor Decision|2|||
23132802|NCT03683823|64234132|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
23132803|NCT03683823|64234133|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
23132804|NCT03683823|64234132|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
23132805|NCT03683823|64234133|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
23132806|NCT03683823|64234132|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
23132807|NCT03683823|64234133|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
23132808|NCT02949362|64234134|FG000|Retrospective Period|Inform consent not signed by participant|4|||
23132809|NCT02949362|64234135|FG001|Retrospective Period|Inform consent not signed by participant|1|||
23132810|NCT02949362|64234136|FG002|Retrospective Period|Inform consent not signed by participant|0|||
23132811|NCT02949362|64234137|FG003|Retrospective Period|Inform consent not signed by participant|0|||
23132812|NCT02949362|64234134|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
23132813|NCT02949362|64234135|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
23132814|NCT02949362|64234136|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
23132815|NCT02949362|64234137|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
23132816|NCT02949362|64234134|FG000|Prospective Period|Other|0|||
23132817|NCT02949362|64234135|FG001|Prospective Period|Other|0|||
23132818|NCT02949362|64234136|FG002|Prospective Period|Other|0|||
23132819|NCT02949362|64234137|FG003|Prospective Period|Other|4|||
23132820|NCT01305239|64234140|FG000|Overall Study|Adverse Event|22|||
23132821|NCT01305239|64234140|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
23132822|NCT00790205|64234141|FG000|Overall Study|Lost to Follow-up|61|||
23132823|NCT00790205|64234142|FG001|Overall Study|Lost to Follow-up|71|||
23132824|NCT00790205|64234141|FG000|Overall Study|Withdrawal by Subject|299|||
23132825|NCT00790205|64234142|FG001|Overall Study|Withdrawal by Subject|363|||
23132826|NCT01519089|64234143|FG000|Overall Study|Adverse Event|4|||
23132827|NCT01519089|64234144|FG001|Overall Study|Adverse Event|4|||
23132828|NCT01519089|64234143|FG000|Overall Study|Lack of Efficacy|0|||
23132829|NCT01519089|64234144|FG001|Overall Study|Lack of Efficacy|2|||
23132830|NCT01519089|64234143|FG000|Overall Study|Lost to Follow-up|1|||
23132831|NCT01519089|64234144|FG001|Overall Study|Lost to Follow-up|0|||
23132832|NCT01519089|64234143|FG000|Overall Study|Withdrawal by Subject|0|||
23132833|NCT01519089|64234144|FG001|Overall Study|Withdrawal by Subject|2|||
23132834|NCT01519089|64234143|FG000|Overall Study|Other|2|||
23132835|NCT01519089|64234144|FG001|Overall Study|Other|6|||
23132836|NCT01519089|64234143|FG000|Overall Study|Not received study drug|0|||
23132837|NCT01519089|64234144|FG001|Overall Study|Not received study drug|1|||
23132838|NCT00368927|64234148|FG000|Overall Study|Lost to Follow-up|2|||
23132839|NCT00368927|64234149|FG001|Overall Study|Lost to Follow-up|0|||
23427505|NCT02981524|65310489|FG000|Overall Study|Treatment Related Toxicity|1|||
23132840|NCT00368927|64234148|FG000|Overall Study|Adverse Event|1|||
23132841|NCT00368927|64234149|FG001|Overall Study|Adverse Event|1|||
23132842|NCT00368927|64234148|FG000|Overall Study|Withdrawal by Subject|1|||
23547709|NCT03568318|65735898|FG000|Overall Study|Ongoing at Time of Analysis|5|||
23132843|NCT00368927|64234149|FG001|Overall Study|Withdrawal by Subject|2|||
23132844|NCT00368927|64234148|FG000|Overall Study|Physician Decision|1|||
23427506|NCT02981524|65310489|FG000|Overall Study|Withdrawal by Subject|1|||
23427507|NCT01891344|65310490|FG000|Overall Study|Ongoing|6|||
23427508|NCT01891344|65310491|FG001|Overall Study|Ongoing|2|||
23427509|NCT01891344|65310492|FG002|Overall Study|Ongoing|0|||
23427510|NCT01891344|65310493|FG003|Overall Study|Ongoing|1|||
23427511|NCT01891344|65310494|FG004|Overall Study|Ongoing|4|||
23427512|NCT01891344|65310495|FG005|Overall Study|Ongoing|1|||
23427513|NCT01891344|65310496|FG006|Overall Study|Ongoing|0|||
23427514|NCT01891344|65310497|FG007|Overall Study|Ongoing|0|||
23427515|NCT01100567|65310498|FG000|Overall Study|Withdrawal by Subject|5|||
23427516|NCT01100567|65310499|FG001|Overall Study|Withdrawal by Subject|8|||
23427517|NCT01100567|65310498|FG000|Overall Study|Early Hospital Discharge|6|||
23547710|NCT03568318|65735899|FG001|Overall Study|Ongoing at Time of Analysis|3|||
23547711|NCT03568318|65735900|FG002|Overall Study|Ongoing at Time of Analysis|2|||
23132845|NCT00368927|64234149|FG001|Overall Study|Physician Decision|0|||
23132846|NCT00821587|64234150|FG000|Overall Study|Physician Decision|0|||
23132847|NCT00821587|64234151|FG001|Overall Study|Physician Decision|1|||
23547712|NCT03568318|65735901|FG003|Overall Study|Ongoing at Time of Analysis|1|||
23132848|NCT00858364|64234155|FG000|Overall Study|Administrative Decision|3|||
23132849|NCT00858364|64234156|FG001|Overall Study|Administrative Decision|2|||
23132850|NCT00858364|64234155|FG000|Overall Study|Adverse Event|5|||
23132851|NCT00858364|64234156|FG001|Overall Study|Adverse Event|2|||
23132852|NCT00858364|64234155|FG000|Overall Study|Withdrawal by Subject|44|||
23132853|NCT00858364|64234156|FG001|Overall Study|Withdrawal by Subject|118|||
23132854|NCT00858364|64234155|FG000|Overall Study|Ineligibility Determined|1|||
23132855|NCT00858364|64234156|FG001|Overall Study|Ineligibility Determined|10|||
23213709|NCT03479216|64523403|FG001|Overall Study|Physician Decision|3|||
23317473|NCT02552121|64904097|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23547713|NCT03568318|65735902|FG004|Overall Study|Ongoing at Time of Analysis|0|||
23547714|NCT03568318|65735903|FG005|Overall Study|Ongoing at Time of Analysis|0|||
23547715|NCT04479618|65735904|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
23547716|NCT04479618|65735905|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
23547717|NCT04479618|65735906|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
23547718|NCT04479618|65735904|FG000|Overall Study|Lack of Efficacy|1|||
23547719|NCT04479618|65735905|FG001|Overall Study|Lack of Efficacy|0|||
23547720|NCT04479618|65735906|FG002|Overall Study|Lack of Efficacy|0|||
23547721|NCT04479618|65735904|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
23547722|NCT04479618|65735905|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
23547723|NCT04479618|65735906|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
23547724|NCT04479618|65735904|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
23547725|NCT04479618|65735905|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
23547726|NCT04479618|65735906|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
23547727|NCT04479618|65735904|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
23547728|NCT04479618|65735905|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
23547729|NCT04479618|65735906|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
23547730|NCT04479618|65735904|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
23547731|NCT04479618|65735905|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
23547732|NCT04479618|65735906|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
23547733|NCT00455195|65735907|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
23547734|NCT00455195|65735908|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
23547735|NCT00455195|65735907|FG000|Double-blind Study AGLU02704|Death|1|||
23547736|NCT00455195|65735908|FG001|Double-blind Study AGLU02704|Death|0|||
23547737|NCT00455195|65735907|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
23547738|NCT00455195|65735908|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
23547739|NCT00455195|65735907|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
23547740|NCT00455195|65735908|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
23547741|NCT01572727|65735909|FG000|Overall Study|Adverse Event|43|||
23547742|NCT01572727|65735910|FG001|Overall Study|Adverse Event|15|||
23547743|NCT01572727|65735909|FG000|Overall Study|Lost to Follow-up|1|||
23547744|NCT01572727|65735910|FG001|Overall Study|Lost to Follow-up|1|||
23547745|NCT01572727|65735909|FG000|Overall Study|Physician Decision|23|||
23619516|NCT04414397|65991561|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
23317474|NCT02552121|64904098|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23132856|NCT00858364|64234155|FG000|Overall Study|Lost to Follow-up|24|||
23132857|NCT00858364|64234156|FG001|Overall Study|Lost to Follow-up|54|||
23427518|NCT01100567|65310499|FG001|Overall Study|Early Hospital Discharge|4|||
23427519|NCT01100567|65310498|FG000|Overall Study|Lost to Follow-up|1|||
23427520|NCT01100567|65310499|FG001|Overall Study|Lost to Follow-up|2|||
23427521|NCT01100567|65310498|FG000|Overall Study|Physician Decision|0|||
23547746|NCT01572727|65735910|FG001|Overall Study|Physician Decision|9|||
23547747|NCT01572727|65735909|FG000|Overall Study|Progressive disease|59|||
23547748|NCT01572727|65735910|FG001|Overall Study|Progressive disease|82|||
23547749|NCT01572727|65735909|FG000|Overall Study|Protocol Violation|0|||
23547750|NCT01572727|65735910|FG001|Overall Study|Protocol Violation|1|||
23547751|NCT01572727|65735909|FG000|Overall Study|Study terminated by sponsor|61|||
23547752|NCT01572727|65735910|FG001|Overall Study|Study terminated by sponsor|83|||
23547753|NCT01572727|65735909|FG000|Overall Study|Parent/guardian decision|14|||
23547754|NCT01572727|65735910|FG001|Overall Study|Parent/guardian decision|9|||
23547755|NCT01572727|65735909|FG000|Overall Study|Death|2|||
23547756|NCT01572727|65735910|FG001|Overall Study|Death|2|||
23547757|NCT01572727|65735909|FG000|Overall Study|Untreated|4|||
23547758|NCT01572727|65735910|FG001|Overall Study|Untreated|7|||
23547759|NCT00966940|65735914|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
23547760|NCT00966940|65735915|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
23547761|NCT00966940|65735914|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
23547762|NCT00966940|65735915|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
23619517|NCT04414397|65991562|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
23619518|NCT04414397|65991561|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
23619519|NCT04414397|65991562|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
23619520|NCT02413593|65991563|FG000|Overall Study|Lost to Follow-up|3|||
23619521|NCT02413593|65991563|FG000|Overall Study|Adverse Event|1|||
23619522|NCT03322514|65991564|FG000|Overall Study|Withdrawal by Subject|1|||
23619523|NCT03322514|65991565|FG001|Overall Study|Withdrawal by Subject|1|||
23619524|NCT00740597|65991566|FG000|Overall Study|insurance would not cover treatment|1|||
23547763|NCT00605293|65735916|FG000|Overall Study|Death|2|||
23547764|NCT00605293|65735917|FG001|Overall Study|Death|1|||
23547765|NCT00605293|65735916|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23547766|NCT00605293|65735917|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23547767|NCT00605293|65735916|FG000|Overall Study|Adverse Event|1|||
23547768|NCT00605293|65735917|FG001|Overall Study|Adverse Event|0|||
23547769|NCT00605293|65735916|FG000|Overall Study|Holidays Dialysis Out|1|||
23547770|NCT00605293|65735917|FG001|Overall Study|Holidays Dialysis Out|0|||
23547771|NCT00605293|65735916|FG000|Overall Study|Blood Transfusion|7|||
23547772|NCT00605293|65735917|FG001|Overall Study|Blood Transfusion|1|||
23547773|NCT00605293|65735916|FG000|Overall Study|Renal Transplantation|3|||
23547774|NCT00605293|65735917|FG001|Overall Study|Renal Transplantation|1|||
23547775|NCT00605293|65735916|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
23547776|NCT00605293|65735917|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
23547777|NCT00605293|65735916|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
23547778|NCT00605293|65735917|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
23547779|NCT00605293|65735916|FG000|Overall Study|Principal Investigator Decision|0|||
23547780|NCT00605293|65735917|FG001|Overall Study|Principal Investigator Decision|1|||
23547781|NCT02015676|65735918|FG000|Overall Study|Adverse Event|2|||
23547782|NCT02015676|65735919|FG001|Overall Study|Adverse Event|18|||
23547783|NCT02015676|65735920|FG002|Overall Study|Adverse Event|0|||
23547784|NCT02015676|65735918|FG000|Overall Study|Lack of Efficacy|2|||
23547785|NCT02015676|65735919|FG001|Overall Study|Lack of Efficacy|4|||
23547786|NCT02015676|65735920|FG002|Overall Study|Lack of Efficacy|0|||
23547787|NCT02015676|65735918|FG000|Overall Study|Protocol Violation|1|||
23547788|NCT02015676|65735919|FG001|Overall Study|Protocol Violation|0|||
23547789|NCT02015676|65735920|FG002|Overall Study|Protocol Violation|0|||
23547790|NCT02015676|65735918|FG000|Overall Study|Withdrawal by Subject|1|||
23547791|NCT02015676|65735919|FG001|Overall Study|Withdrawal by Subject|7|||
23547792|NCT02015676|65735920|FG002|Overall Study|Withdrawal by Subject|1|||
23547793|NCT02015676|65735918|FG000|Overall Study|Administrative reasons|0|||
23547794|NCT02015676|65735919|FG001|Overall Study|Administrative reasons|3|||
23547795|NCT02015676|65735920|FG002|Overall Study|Administrative reasons|1|||
23547796|NCT02015676|65735918|FG000|Overall Study|Death|0|||
23619525|NCT04572997|65991567|FG000|Overall Study|Adverse Event|1|||
23213710|NCT02566109|64523407|FG000|Overall Study|Withdrawal by Subject|1|||
23547797|NCT02015676|65735919|FG001|Overall Study|Death|1|||
23547798|NCT02015676|65735920|FG002|Overall Study|Death|0|||
23547799|NCT02015676|65735918|FG000|Overall Study|Disease progression|3|||
23547800|NCT02015676|65735919|FG001|Overall Study|Disease progression|1|||
23547801|NCT02015676|65735920|FG002|Overall Study|Disease progression|1|||
23547802|NCT04302350|65735921|FG000|Overall Study|Physician Decision|1|||
23547803|NCT04302350|65735922|FG001|Overall Study|Physician Decision|1|||
23547804|NCT04302350|65735923|FG002|Overall Study|Physician Decision|2|||
23547805|NCT04302350|65735921|FG000|Overall Study|Lack of Efficacy|1|||
23547806|NCT04302350|65735922|FG001|Overall Study|Lack of Efficacy|1|||
23547807|NCT04302350|65735923|FG002|Overall Study|Lack of Efficacy|4|||
23547808|NCT04302350|65735921|FG000|Overall Study|Adverse Event|0|||
23213711|NCT01641991|64523408|FG000|Overall Study|Physician Decision|0|||
23547809|NCT04302350|65735922|FG001|Overall Study|Adverse Event|1|||
23547810|NCT04302350|65735923|FG002|Overall Study|Adverse Event|2|||
23619526|NCT02427958|65991572|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
23619527|NCT02427958|65991572|FG000|Overall Study|Lost to Follow-up|6|||
23547811|NCT02834780|65735928|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
23547812|NCT02834780|65735929|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
23547813|NCT02834780|65735930|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
23547814|NCT02834780|65735931|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
23547815|NCT02834780|65735932|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
23547816|NCT02834780|65735933|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
23547817|NCT02834780|65735934|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
23547818|NCT02834780|65735935|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
23547819|NCT02834780|65735936|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
23547820|NCT02834780|65735937|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
23547821|NCT02834780|65735938|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
23547822|NCT02834780|65735939|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
23547823|NCT02834780|65735940|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
23547824|NCT02834780|65735928|FG000|Overall Study|Withdrawal by Subject|0|||
23547825|NCT02834780|65735929|FG001|Overall Study|Withdrawal by Subject|0|||
23547826|NCT02834780|65735930|FG002|Overall Study|Withdrawal by Subject|1|||
23547827|NCT02834780|65735931|FG003|Overall Study|Withdrawal by Subject|0|||
23547828|NCT02834780|65735932|FG004|Overall Study|Withdrawal by Subject|0|||
23547829|NCT02834780|65735933|FG005|Overall Study|Withdrawal by Subject|0|||
23547830|NCT02834780|65735934|FG006|Overall Study|Withdrawal by Subject|0|||
23547831|NCT02834780|65735935|FG007|Overall Study|Withdrawal by Subject|0|||
23547832|NCT02834780|65735936|FG008|Overall Study|Withdrawal by Subject|0|||
23547833|NCT02834780|65735937|FG009|Overall Study|Withdrawal by Subject|0|||
23132858|NCT00858364|64234155|FG000|Overall Study|Noncompliance|3|||
23547834|NCT02834780|65735938|FG010|Overall Study|Withdrawal by Subject|1|||
23547835|NCT02834780|65735939|FG011|Overall Study|Withdrawal by Subject|0|||
23547836|NCT02834780|65735940|FG012|Overall Study|Withdrawal by Subject|0|||
23547837|NCT02834780|65735928|FG000|Overall Study|Adverse Event|0|||
23547838|NCT02834780|65735929|FG001|Overall Study|Adverse Event|0|||
23547839|NCT02834780|65735930|FG002|Overall Study|Adverse Event|0|||
23547840|NCT02834780|65735931|FG003|Overall Study|Adverse Event|0|||
23132859|NCT00858364|64234156|FG001|Overall Study|Noncompliance|4|||
23547841|NCT02834780|65735932|FG004|Overall Study|Adverse Event|1|||
23547842|NCT02834780|65735933|FG005|Overall Study|Adverse Event|0|||
23547843|NCT02834780|65735934|FG006|Overall Study|Adverse Event|1|||
23547844|NCT02834780|65735935|FG007|Overall Study|Adverse Event|1|||
23547845|NCT02834780|65735936|FG008|Overall Study|Adverse Event|0|||
23547846|NCT02834780|65735937|FG009|Overall Study|Adverse Event|2|||
23547847|NCT02834780|65735938|FG010|Overall Study|Adverse Event|0|||
23547848|NCT02834780|65735939|FG011|Overall Study|Adverse Event|3|||
23547849|NCT02834780|65735940|FG012|Overall Study|Adverse Event|2|||
23547850|NCT02834780|65735928|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547851|NCT02834780|65735929|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
23547852|NCT02834780|65735930|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
23547853|NCT02834780|65735931|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547854|NCT02834780|65735932|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547855|NCT02834780|65735933|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
23132860|NCT00858364|64234155|FG000|Overall Study|Protocol Deviation|0|||
23132861|NCT00858364|64234156|FG001|Overall Study|Protocol Deviation|2|||
23132862|NCT00858364|64234155|FG000|Overall Study|Other|9|||
23132863|NCT00858364|64234156|FG001|Overall Study|Other|17|||
23132864|NCT00858364|64234155|FG000|Overall Study|Missing|1|||
23132865|NCT00858364|64234156|FG001|Overall Study|Missing|1|||
23132866|NCT00858364|64234155|FG000|Overall Study|Still on-study|114|||
23132867|NCT00858364|64234156|FG001|Overall Study|Still on-study|247|||
23132868|NCT02229851|64234157|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
23132869|NCT02229851|64234158|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
23132870|NCT02229851|64234159|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
23132871|NCT02229851|64234160|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
23547856|NCT02834780|65735934|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547857|NCT02834780|65735935|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
23547858|NCT02834780|65735936|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
23547859|NCT02834780|65735937|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
23547860|NCT02834780|65735938|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
23547861|NCT02834780|65735939|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
23547862|NCT02834780|65735940|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
23547863|NCT02834780|65735928|FG000|Overall Study|Other|1|||
23132872|NCT02229851|64234161|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
23132873|NCT02229851|64234162|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
23132874|NCT02229851|64234163|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
23213712|NCT01641991|64523409|FG001|Overall Study|Physician Decision|1|||
23132875|NCT02229851|64234157|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23132876|NCT02229851|64234158|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
23132877|NCT02229851|64234159|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23619528|NCT02427958|65991572|FG000|Overall Study|Withdrawal by Subject|14|||
23619529|NCT02427958|65991572|FG000|Overall Study|Lack of Efficacy|1|||
23619530|NCT01649297|65991573|FG000|Overall Study|Adverse Event|5|||
23619531|NCT01649297|65991574|FG001|Overall Study|Adverse Event|5|||
23619532|NCT01649297|65991575|FG002|Overall Study|Adverse Event|4|||
23619533|NCT01649297|65991576|FG003|Overall Study|Adverse Event|13|||
23619534|NCT01649297|65991577|FG004|Overall Study|Adverse Event|1|||
23619535|NCT01649297|65991573|FG000|Overall Study|Lack of Efficacy|0|||
23619536|NCT01649297|65991574|FG001|Overall Study|Lack of Efficacy|0|||
23619537|NCT01649297|65991575|FG002|Overall Study|Lack of Efficacy|0|||
23619538|NCT01649297|65991576|FG003|Overall Study|Lack of Efficacy|0|||
23619539|NCT01649297|65991577|FG004|Overall Study|Lack of Efficacy|1|||
23619540|NCT01649297|65991573|FG000|Overall Study|Non compliant with Protocol|1|||
23619541|NCT01649297|65991574|FG001|Overall Study|Non compliant with Protocol|0|||
23619542|NCT01649297|65991575|FG002|Overall Study|Non compliant with Protocol|3|||
23619543|NCT01649297|65991576|FG003|Overall Study|Non compliant with Protocol|2|||
23619544|NCT01649297|65991577|FG004|Overall Study|Non compliant with Protocol|1|||
23619545|NCT01649297|65991573|FG000|Overall Study|Lost to Follow-up|1|||
23619546|NCT01649297|65991574|FG001|Overall Study|Lost to Follow-up|1|||
23619547|NCT01649297|65991575|FG002|Overall Study|Lost to Follow-up|4|||
23619548|NCT01649297|65991576|FG003|Overall Study|Lost to Follow-up|3|||
23619549|NCT01649297|65991577|FG004|Overall Study|Lost to Follow-up|0|||
23619550|NCT01649297|65991573|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
23619551|NCT01649297|65991574|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
23619552|NCT01649297|65991575|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
23619553|NCT01649297|65991576|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
23619554|NCT01649297|65991577|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
23619555|NCT01649297|65991573|FG000|Overall Study|For other reason|4|||
23619556|NCT01649297|65991574|FG001|Overall Study|For other reason|1|||
23619557|NCT01649297|65991575|FG002|Overall Study|For other reason|2|||
23619558|NCT01649297|65991576|FG003|Overall Study|For other reason|0|||
23619559|NCT01649297|65991577|FG004|Overall Study|For other reason|0|||
23619560|NCT01011049|65991578|FG000|Overall Study|Protocol Violation|0|||
23619561|NCT01011049|65991579|FG001|Overall Study|Protocol Violation|0|||
23619562|NCT01011049|65991580|FG002|Overall Study|Protocol Violation|2|||
23619563|NCT01011049|65991581|FG003|Overall Study|Protocol Violation|0|||
23619564|NCT01011049|65991578|FG000|Overall Study|Lost to Follow-up|1|||
23619565|NCT01011049|65991579|FG001|Overall Study|Lost to Follow-up|2|||
23619566|NCT01011049|65991580|FG002|Overall Study|Lost to Follow-up|1|||
23619567|NCT01011049|65991581|FG003|Overall Study|Lost to Follow-up|0|||
23619568|NCT01011049|65991578|FG000|Overall Study|Withdrawal by Subject|0|||
23619569|NCT01011049|65991579|FG001|Overall Study|Withdrawal by Subject|0|||
23619570|NCT01011049|65991580|FG002|Overall Study|Withdrawal by Subject|1|||
23619571|NCT01011049|65991581|FG003|Overall Study|Withdrawal by Subject|0|||
23619572|NCT00474383|65991582|FG000|Main Study|Adverse Event|11|||
23619573|NCT00474383|65991583|FG001|Main Study|Adverse Event|0|||
23619574|NCT00474383|65991582|FG000|Main Study|Symptomatic Deterioration|1|||
23619575|NCT00474383|65991583|FG001|Main Study|Symptomatic Deterioration|0|||
23619576|NCT00474383|65991582|FG000|Main Study|Progressive Disease|23|||
23619577|NCT00474383|65991583|FG001|Main Study|Progressive Disease|0|||
23619578|NCT00474383|65991582|FG000|Main Study|Other|1|||
23619579|NCT00474383|65991583|FG001|Main Study|Other|0|||
23619580|NCT00474383|65991582|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
23619581|NCT00474383|65991583|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
23619582|NCT00474383|65991582|FG000|Extension|Progressive Disease|0|||
23619583|NCT00474383|65991583|FG001|Extension|Progressive Disease|5|||
23619584|NCT03681353|65991584|FG000|Overall Study|Lost to Follow-up|2|||
23619585|NCT03681353|65991584|FG000|Overall Study|Withdrawal by Subject|3|||
23619586|NCT03681353|65991584|FG000|Overall Study|withdrawn by PI|2|||
23619587|NCT00679549|65991585|FG000|Overall Study|dropout|2|||
23619588|NCT00679549|65991586|FG001|Overall Study|dropout|4|||
23619589|NCT00679549|65991585|FG000|Overall Study|missing outcome echocardiograms|4|||
23619590|NCT00679549|65991586|FG001|Overall Study|missing outcome echocardiograms|5|||
23619591|NCT03294941|65991587|FG000|Overall Study|Withdrawal by Subject|0|||
23619592|NCT03294941|65991588|FG001|Overall Study|Withdrawal by Subject|2|||
23619593|NCT02282059|65991591|FG000|Overall Study|Other|15|||
23619594|NCT02282059|65991592|FG001|Overall Study|Other|3|||
23619595|NCT02282059|65991591|FG000|Overall Study|Participant refused further follow-up|8|||
23619596|NCT02282059|65991592|FG001|Overall Study|Participant refused further follow-up|4|||
23619597|NCT02282059|65991591|FG000|Overall Study|Lost to Follow-up|19|||
23619598|NCT02282059|65991592|FG001|Overall Study|Lost to Follow-up|3|||
23619599|NCT02282059|65991591|FG000|Overall Study|Death|40|||
23619600|NCT02282059|65991592|FG001|Overall Study|Death|8|||
23619601|NCT00255944|65991597|FG000|Overall Study|Lost to Follow-up|797|||
23619602|NCT00255944|65991598|FG001|Overall Study|Lost to Follow-up|834|||
23619603|NCT03924947|65994671|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23619604|NCT03924947|65994672|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23619605|NCT03924947|65994673|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
23619606|NCT03924947|65994674|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23619607|NCT03924947|65994675|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23132878|NCT02229851|64234160|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23132879|NCT02229851|64234161|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23132880|NCT02229851|64234162|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23132881|NCT02229851|64234163|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
23619608|NCT03924947|65994676|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
23619609|NCT03334695|65994677|FG000|Overall Study|Lost to Follow-up|3|||
23619610|NCT03334695|65994678|FG001|Overall Study|Lost to Follow-up|3|||
23547864|NCT02834780|65735929|FG001|Overall Study|Other|0|||
23619611|NCT03334695|65994677|FG000|Overall Study|Physician Decision|1|||
23619612|NCT03334695|65994678|FG001|Overall Study|Physician Decision|2|||
23619613|NCT03334695|65994677|FG000|Overall Study|Protocol Violation|0|||
23619614|NCT03334695|65994678|FG001|Overall Study|Protocol Violation|1|||
23619615|NCT03042559|65994679|FG000|Overall Study|drop out|1|||
23619616|NCT03042559|65994680|FG001|Overall Study|drop out|1|||
23619617|NCT00858247|65994684|FG000|Baseline Assessment|Withdrawal by Subject|1|||
23619618|NCT00858247|65994685|FG001|Baseline Assessment|Withdrawal by Subject|1|||
23619619|NCT00858247|65994684|FG000|Baseline Assessment|Poor IV access|1|||
23619620|NCT00858247|65994685|FG001|Baseline Assessment|Poor IV access|0|||
23619621|NCT00858247|65994684|FG000|Baseline Assessment|Protocol Violation|0|||
23619622|NCT00858247|65994685|FG001|Baseline Assessment|Protocol Violation|1|||
23619623|NCT00858247|65994684|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
23619624|NCT00858247|65994685|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
23619625|NCT00925288|65994686|FG000|Overall Study|Lost to Follow-up|9|||
23619626|NCT00925288|65994687|FG001|Overall Study|Lost to Follow-up|7|||
23132882|NCT02229851|64234157|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
23132883|NCT02229851|64234158|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
23132884|NCT02229851|64234159|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
23132885|NCT02229851|64234160|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
23317475|NCT02552121|64904099|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23547865|NCT02834780|65735930|FG002|Overall Study|Other|1|||
23547866|NCT02834780|65735931|FG003|Overall Study|Other|2|||
23547867|NCT02834780|65735932|FG004|Overall Study|Other|0|||
23547868|NCT02834780|65735933|FG005|Overall Study|Other|0|||
23547869|NCT02834780|65735934|FG006|Overall Study|Other|0|||
23547870|NCT02834780|65735935|FG007|Overall Study|Other|0|||
23547871|NCT02834780|65735936|FG008|Overall Study|Other|0|||
23547872|NCT02834780|65735937|FG009|Overall Study|Other|0|||
23547873|NCT02834780|65735938|FG010|Overall Study|Other|0|||
23547874|NCT02834780|65735939|FG011|Overall Study|Other|0|||
23547875|NCT02834780|65735940|FG012|Overall Study|Other|1|||
23547876|NCT02925455|65735941|FG000|Overall Study|Withdrawal by Subject|2|||
23547877|NCT02925455|65735942|FG001|Overall Study|Withdrawal by Subject|0|||
23547878|NCT03019536|65735945|FG000|Overall Study|Withdrawal by Subject|1|||
23547879|NCT03019536|65735946|FG001|Overall Study|Withdrawal by Subject|1|||
23547880|NCT03019536|65735947|FG002|Overall Study|Withdrawal by Subject|0|||
23547881|NCT03019536|65735945|FG000|Overall Study|Adverse Event|0|||
23317476|NCT02552121|64904100|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23317477|NCT02552121|64904101|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
23317478|NCT02552121|64904094|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23317479|NCT02552121|64904095|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
23317480|NCT02552121|64904096|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23547882|NCT03019536|65735946|FG001|Overall Study|Adverse Event|0|||
23547883|NCT03019536|65735947|FG002|Overall Study|Adverse Event|2|||
23547884|NCT01064739|65735948|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
23547885|NCT00659334|65735949|FG000|Overall Study|Screen Failure|8|||
23547886|NCT00659334|65735950|FG001|Overall Study|Screen Failure|5|||
23547887|NCT00659334|65735951|FG002|Overall Study|Screen Failure|0|||
23547888|NCT00659334|65735952|FG003|Overall Study|Screen Failure|0|||
23619627|NCT00651937|65994690|FG000|Overall Study|Withdrawal by Subject|4|||
23619628|NCT00651937|65994691|FG001|Overall Study|Withdrawal by Subject|1|||
23619629|NCT04124471|65994696|FG000|Overall Study|screen failure|1|||
23132886|NCT02229851|64234161|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
23547889|NCT00659334|65735953|FG004|Overall Study|Screen Failure|0|||
23547890|NCT00659334|65735954|FG005|Overall Study|Screen Failure|0|||
23547891|NCT00659334|65735955|FG006|Overall Study|Screen Failure|1|||
23547892|NCT00715429|65735956|FG000|Overall Study|Did not complete the study diary|0|||
23547893|NCT00715429|65735957|FG001|Overall Study|Did not complete the study diary|1|||
23547894|NCT02053350|65735958|FG000|Overall Study|Withdrawal by Subject|1|||
23547895|NCT02053350|65735958|FG000|Overall Study|Adverse Event|4|||
23213713|NCT01641991|64523410|FG002|Overall Study|Physician Decision|7|||
23619630|NCT00468858|65994697|FG000|Overall Study|Adverse Event|0|||
23619631|NCT00468858|65994698|FG001|Overall Study|Adverse Event|1|||
23619632|NCT00468858|65994699|FG002|Overall Study|Adverse Event|0|||
23547896|NCT04348604|65735961|FG000|Week 8|Withdrawal by Subject|1|||
23547897|NCT04348604|65735962|FG001|Week 8|Withdrawal by Subject|1|||
23547898|NCT04348604|65735961|FG000|Week 8|Lost to Follow-up|1|||
23547899|NCT04348604|65735962|FG001|Week 8|Lost to Follow-up|2|||
23547900|NCT04348604|65735961|FG000|Week 8|Suspended|0|||
23547901|NCT04348604|65735962|FG001|Week 8|Suspended|1|||
23619633|NCT00468858|65994697|FG000|Overall Study|Withdrawal by Subject|7|||
23619634|NCT00468858|65994698|FG001|Overall Study|Withdrawal by Subject|4|||
23619635|NCT00468858|65994699|FG002|Overall Study|Withdrawal by Subject|5|||
23619636|NCT00468858|65994697|FG000|Overall Study|Relocation|1|||
23619637|NCT00468858|65994698|FG001|Overall Study|Relocation|3|||
23619638|NCT00468858|65994699|FG002|Overall Study|Relocation|3|||
23619639|NCT00468858|65994697|FG000|Overall Study|Lost to Follow-up|1|||
23619640|NCT00468858|65994698|FG001|Overall Study|Lost to Follow-up|2|||
23619641|NCT00468858|65994699|FG002|Overall Study|Lost to Follow-up|5|||
23619642|NCT00468858|65994697|FG000|Overall Study|Other|0|||
23619643|NCT00468858|65994698|FG001|Overall Study|Other|0|||
23619644|NCT00468858|65994699|FG002|Overall Study|Other|1|||
23619645|NCT00498433|65994700|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
23619646|NCT00498433|65994701|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
23213714|NCT01641991|64523411|FG003|Overall Study|Physician Decision|5|||
23213715|NCT01641991|64523408|FG000|Overall Study|Withdrawal by Subject|4|||
23213716|NCT01641991|64523409|FG001|Overall Study|Withdrawal by Subject|2|||
23213717|NCT01641991|64523410|FG002|Overall Study|Withdrawal by Subject|1|||
23213718|NCT01641991|64523411|FG003|Overall Study|Withdrawal by Subject|5|||
23213719|NCT01641991|64523408|FG000|Overall Study|Adverse Event|2|||
23213720|NCT01641991|64523409|FG001|Overall Study|Adverse Event|1|||
23213721|NCT01641991|64523410|FG002|Overall Study|Adverse Event|2|||
23213722|NCT01641991|64523411|FG003|Overall Study|Adverse Event|1|||
23213723|NCT01641991|64523408|FG000|Overall Study|Lost to Follow-up|0|||
23213724|NCT01641991|64523409|FG001|Overall Study|Lost to Follow-up|2|||
23213725|NCT01641991|64523410|FG002|Overall Study|Lost to Follow-up|3|||
23213726|NCT01641991|64523411|FG003|Overall Study|Lost to Follow-up|1|||
23213727|NCT01641991|64523408|FG000|Overall Study|Protocol Violation|1|||
23213728|NCT01641991|64523409|FG001|Overall Study|Protocol Violation|1|||
23547902|NCT04348604|65735961|FG000|Week 12|Lost to Follow-up|1|||
23547903|NCT04348604|65735962|FG001|Week 12|Lost to Follow-up|2|||
23547904|NCT04348604|65735961|FG000|Week 12|Withdrawal by Subject|1|||
23547905|NCT04348604|65735962|FG001|Week 12|Withdrawal by Subject|0|||
23547906|NCT04348604|65735961|FG000|Week 24|Lost to Follow-up|2|||
23547907|NCT04348604|65735962|FG001|Week 24|Lost to Follow-up|1|||
23547908|NCT00454051|65735963|FG000|Overall Study|Adverse Event|1|||
23547909|NCT00454051|65735964|FG001|Overall Study|Adverse Event|2|||
23547910|NCT00454051|65735963|FG000|Overall Study|Withdrawal by Subject|1|||
23547911|NCT00454051|65735964|FG001|Overall Study|Withdrawal by Subject|0|||
23547912|NCT00454051|65735963|FG000|Overall Study|Protocol Violation|1|||
23547913|NCT00454051|65735964|FG001|Overall Study|Protocol Violation|1|||
23547914|NCT01022762|65735965|FG000|Overall Study|Adverse Event|3|||
23619647|NCT00498433|65994702|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
23213729|NCT01641991|64523410|FG002|Overall Study|Protocol Violation|3|||
23213730|NCT01641991|64523411|FG003|Overall Study|Protocol Violation|0|||
23213731|NCT01641991|64523408|FG000|Overall Study|Pregnancy|0|||
23213732|NCT01641991|64523409|FG001|Overall Study|Pregnancy|0|||
23213733|NCT01641991|64523410|FG002|Overall Study|Pregnancy|1|||
23213734|NCT01641991|64523411|FG003|Overall Study|Pregnancy|0|||
23213735|NCT01641991|64523408|FG000|Overall Study|no longer eligible|2|||
23213736|NCT01641991|64523409|FG001|Overall Study|no longer eligible|1|||
23213737|NCT01641991|64523410|FG002|Overall Study|no longer eligible|0|||
23213738|NCT01641991|64523411|FG003|Overall Study|no longer eligible|4|||
23547915|NCT01022762|65735966|FG001|Overall Study|Adverse Event|1|||
23547916|NCT01022762|65735965|FG000|Overall Study|Lack of Efficacy|0|||
23547917|NCT01022762|65735966|FG001|Overall Study|Lack of Efficacy|1|||
23547918|NCT01022762|65735965|FG000|Overall Study|Protocol Violation|7|||
23547919|NCT01022762|65735966|FG001|Overall Study|Protocol Violation|6|||
23547920|NCT01022762|65735965|FG000|Overall Study|Unclassified|12|||
23547921|NCT01022762|65735966|FG001|Overall Study|Unclassified|20|||
23547922|NCT03581305|65735967|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
23619648|NCT00498433|65994700|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
23213739|NCT01181778|64523412|FG000|Overall Study|Physician Decision|48|||
23213740|NCT04507776|64523414|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
23213741|NCT04685499|64523415|FG000|Overall Study|Study Terminated Early|1|||
23213742|NCT02678312|64523420|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
23427522|NCT01100567|65310499|FG001|Overall Study|Physician Decision|1|||
23547923|NCT03581305|65735968|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
23547924|NCT03581305|65735967|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
23547925|NCT03581305|65735968|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
23619649|NCT00498433|65994701|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
23619650|NCT00498433|65994702|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
23619651|NCT00498433|65994700|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
23213743|NCT02678312|64523421|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
23213744|NCT02678312|64523422|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
23213745|NCT02678312|64523423|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
23213746|NCT02678312|64523424|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
23213747|NCT02678312|64523420|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
23213748|NCT02678312|64523421|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
23213749|NCT02678312|64523422|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
23213750|NCT02678312|64523423|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
23213751|NCT02678312|64523424|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
23213752|NCT02678312|64523420|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
23213753|NCT02678312|64523421|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
23213754|NCT02678312|64523422|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
23213755|NCT02678312|64523423|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
23213756|NCT02678312|64523424|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
23213757|NCT02678312|64523420|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
23213758|NCT02678312|64523421|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
23213759|NCT02678312|64523422|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
23213760|NCT02678312|64523423|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
23213761|NCT02678312|64523424|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
23213762|NCT02678312|64523420|FG000|Part 2 Double Blind Epoch|Death|0|||
23132887|NCT02229851|64234162|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
23132888|NCT02229851|64234163|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
23427523|NCT01100567|65310498|FG000|Overall Study|Deemed ineligible after consent|0|||
23427524|NCT01100567|65310499|FG001|Overall Study|Deemed ineligible after consent|1|||
23427525|NCT00711802|65310500|FG000|Overall Study|Not treated (no further detail)|2|||
23427526|NCT00711802|65310501|FG001|Overall Study|Not treated (no further detail)|1|||
23427527|NCT00711802|65310502|FG002|Overall Study|Not treated (no further detail)|2|||
23427528|NCT00711802|65310503|FG003|Overall Study|Not treated (no further detail)|0|||
23427529|NCT00711802|65310504|FG004|Overall Study|Not treated (no further detail)|2|||
23427530|NCT00711802|65310505|FG005|Overall Study|Not treated (no further detail)|0|||
23427531|NCT00711802|65310506|FG006|Overall Study|Not treated (no further detail)|0|||
23427532|NCT00711802|65310507|FG007|Overall Study|Not treated (no further detail)|0|||
23427533|NCT00711802|65310500|FG000|Overall Study|Adverse Event|0|||
23619652|NCT00498433|65994701|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
23132889|NCT02229851|64234157|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23132890|NCT02229851|64234158|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23132891|NCT02229851|64234159|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
23132892|NCT02229851|64234160|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23132893|NCT02229851|64234161|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23132894|NCT02229851|64234162|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23132895|NCT02229851|64234163|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
23132896|NCT02229851|64234157|FG000|Main Phase (Double-blind Phase)|Death|1|||
23132897|NCT02229851|64234158|FG001|Main Phase (Double-blind Phase)|Death|1|||
23132898|NCT02229851|64234159|FG002|Main Phase (Double-blind Phase)|Death|0|||
23132899|NCT02229851|64234160|FG003|Main Phase (Double-blind Phase)|Death|0|||
23213763|NCT02678312|64523421|FG001|Part 2 Double Blind Epoch|Death|0|||
23213764|NCT02678312|64523422|FG002|Part 2 Double Blind Epoch|Death|0|||
23213765|NCT02678312|64523423|FG003|Part 2 Double Blind Epoch|Death|8|||
23213766|NCT02678312|64523424|FG004|Part 2 Double Blind Epoch|Death|12|||
23213767|NCT02678312|64523420|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
23213768|NCT02678312|64523421|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
23213769|NCT02678312|64523422|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
23213770|NCT02678312|64523423|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
23213771|NCT02678312|64523424|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
23213772|NCT02678312|64523420|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
23213773|NCT02678312|64523421|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
23213774|NCT02678312|64523422|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
23213775|NCT02678312|64523423|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
23213776|NCT02678312|64523424|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
23213777|NCT02678312|64523420|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
23317481|NCT02552121|64904097|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23213778|NCT02678312|64523421|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
23213779|NCT02678312|64523422|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
23213780|NCT02678312|64523423|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
23213781|NCT02678312|64523424|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
23213782|NCT03728140|64523425|FG000|Overall Study|Abnormal embryo transfer operation|10|||
23427534|NCT00711802|65310501|FG001|Overall Study|Adverse Event|0|||
23213783|NCT03728140|64523426|FG001|Overall Study|Abnormal embryo transfer operation|7|||
23213784|NCT01576406|64523428|FG000|Overall Study|Lost to Follow-up|1|||
23213785|NCT01576406|64523429|FG001|Overall Study|Lost to Follow-up|2|||
23132900|NCT02229851|64234161|FG004|Main Phase (Double-blind Phase)|Death|0|||
23132901|NCT02229851|64234162|FG005|Main Phase (Double-blind Phase)|Death|0|||
23132902|NCT02229851|64234163|FG006|Main Phase (Double-blind Phase)|Death|0|||
23132903|NCT02229851|64234157|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
23132904|NCT02229851|64234158|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
23132905|NCT02229851|64234159|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
23132906|NCT02229851|64234160|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
23132907|NCT02229851|64234161|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
23132908|NCT02229851|64234162|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
23132909|NCT02229851|64234163|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
23132910|NCT02229851|64234157|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
23132911|NCT02229851|64234158|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
23132912|NCT02229851|64234159|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
23132913|NCT02229851|64234160|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
23132914|NCT02229851|64234161|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
23132915|NCT02229851|64234162|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
23132916|NCT02229851|64234163|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
23132917|NCT02229851|64234157|FG000|Extension Phase (Open-label Phase)|Death|0|||
23132918|NCT02229851|64234158|FG001|Extension Phase (Open-label Phase)|Death|0|||
23132919|NCT02229851|64234159|FG002|Extension Phase (Open-label Phase)|Death|0|||
23132920|NCT02229851|64234160|FG003|Extension Phase (Open-label Phase)|Death|1|||
23132921|NCT02229851|64234161|FG004|Extension Phase (Open-label Phase)|Death|0|||
23132922|NCT02229851|64234162|FG005|Extension Phase (Open-label Phase)|Death|1|||
23132923|NCT02229851|64234163|FG006|Extension Phase (Open-label Phase)|Death|1|||
23132924|NCT02535091|64234168|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
23132925|NCT02535091|64234169|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
23132926|NCT02535091|64234170|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
23132927|NCT02535091|64234168|FG000|Overall Study|Withdrawal by Subject|14|||
23132928|NCT02535091|64234169|FG001|Overall Study|Withdrawal by Subject|5|||
23132929|NCT02535091|64234170|FG002|Overall Study|Withdrawal by Subject|121|||
23132930|NCT02535091|64234168|FG000|Overall Study|Adverse Event|9|||
23132931|NCT02535091|64234169|FG001|Overall Study|Adverse Event|4|||
23132932|NCT02535091|64234170|FG002|Overall Study|Adverse Event|170|||
23132933|NCT02535091|64234168|FG000|Overall Study|Other|4|||
23132934|NCT02535091|64234169|FG001|Overall Study|Other|3|||
23132935|NCT02535091|64234170|FG002|Overall Study|Other|81|||
23132936|NCT02535091|64234168|FG000|Overall Study|Lost to Follow-up|0|||
23132937|NCT02535091|64234169|FG001|Overall Study|Lost to Follow-up|1|||
23132938|NCT02535091|64234170|FG002|Overall Study|Lost to Follow-up|19|||
23132939|NCT02535091|64234168|FG000|Overall Study|Protocol Violation|0|||
23132940|NCT02535091|64234169|FG001|Overall Study|Protocol Violation|1|||
23132941|NCT02535091|64234170|FG002|Overall Study|Protocol Violation|11|||
23132942|NCT02535091|64234168|FG000|Overall Study|Pregnancy|0|||
23132943|NCT02535091|64234169|FG001|Overall Study|Pregnancy|0|||
23132944|NCT02535091|64234170|FG002|Overall Study|Pregnancy|7|||
23132945|NCT00941070|64234180|FG000|Overall Study|Patient non-compliant|1|||
23132946|NCT00316602|64234181|FG000|Overall Study|Withdrawal by Subject|3|||
23132947|NCT00316602|64234182|FG001|Overall Study|Withdrawal by Subject|2|||
23132948|NCT00316602|64234181|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
23132949|NCT00316602|64234182|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
23132950|NCT00316602|64234181|FG000|Overall Study|Adverse Event|1|||
23132951|NCT00316602|64234182|FG001|Overall Study|Adverse Event|0|||
23132952|NCT00316602|64234181|FG000|Overall Study|Other|3|||
23132953|NCT00316602|64234182|FG001|Overall Study|Other|6|||
23132954|NCT01137578|64234183|FG000|Overall Study|Participant requested to Discontinue|3|||
23132955|NCT01137578|64234184|FG001|Overall Study|Participant requested to Discontinue|0|||
23132956|NCT01137578|64234185|FG002|Overall Study|Participant requested to Discontinue|0|||
23132957|NCT01137578|64234183|FG000|Overall Study|Withdrawal by Subject|1|||
23132958|NCT01137578|64234184|FG001|Overall Study|Withdrawal by Subject|0|||
23132959|NCT01137578|64234185|FG002|Overall Study|Withdrawal by Subject|0|||
23132960|NCT01137578|64234183|FG000|Overall Study|Other|12|||
23132961|NCT01137578|64234184|FG001|Overall Study|Other|2|||
23132962|NCT01137578|64234185|FG002|Overall Study|Other|6|||
23132963|NCT04076943|64234191|FG000|Overall Study|Withdrawal by Subject|12|||
23132964|NCT04076943|64234191|FG000|Overall Study|Adverse Event|1|||
23132965|NCT04076943|64234191|FG000|Overall Study|Progressive Disease|2|||
23132966|NCT04076943|64234191|FG000|Overall Study|Death|13|||
23132967|NCT04076943|64234191|FG000|Overall Study|Other than specified|6|||
23132968|NCT03248882|64234192|FG000|Overall Study|Adverse Event|3|||
23132969|NCT03248882|64234193|FG001|Overall Study|Adverse Event|3|||
23132970|NCT03248882|64234194|FG002|Overall Study|Adverse Event|2|||
23132971|NCT03248882|64234195|FG003|Overall Study|Adverse Event|6|||
23132972|NCT03248882|64234196|FG004|Overall Study|Adverse Event|9|||
23132973|NCT03248882|64234192|FG000|Overall Study|Lost to Follow-up|0|||
23132974|NCT03248882|64234193|FG001|Overall Study|Lost to Follow-up|0|||
23547926|NCT03581305|65735967|FG000|Serotonergic Study|Withdrawal by Subject|5|||
23547927|NCT03581305|65735968|FG001|Serotonergic Study|Withdrawal by Subject|1|||
23547928|NCT01990950|65735970|FG000|Overall Study|Death|3|||
23547929|NCT01990950|65735970|FG000|Overall Study|Lost to Follow-up|2|||
23547930|NCT01990950|65735970|FG000|Overall Study|Withdrawal by Subject|6|||
23547931|NCT00563784|65735972|FG000|Overall Study|Withdrawal by Subject|2|||
23547932|NCT00563784|65735972|FG000|Overall Study|Screen Failures|20|||
23132975|NCT03248882|64234194|FG002|Overall Study|Lost to Follow-up|0|||
23132976|NCT03248882|64234195|FG003|Overall Study|Lost to Follow-up|0|||
23132977|NCT03248882|64234196|FG004|Overall Study|Lost to Follow-up|1|||
23132978|NCT03248882|64234192|FG000|Overall Study|Protocol Violation|2|||
23132979|NCT03248882|64234193|FG001|Overall Study|Protocol Violation|0|||
23132980|NCT03248882|64234194|FG002|Overall Study|Protocol Violation|2|||
23132981|NCT03248882|64234195|FG003|Overall Study|Protocol Violation|0|||
23132982|NCT03248882|64234196|FG004|Overall Study|Protocol Violation|1|||
23132983|NCT03248882|64234192|FG000|Overall Study|Withdrawal by Subject|2|||
23132984|NCT03248882|64234193|FG001|Overall Study|Withdrawal by Subject|2|||
23132985|NCT03248882|64234194|FG002|Overall Study|Withdrawal by Subject|3|||
23132986|NCT03248882|64234195|FG003|Overall Study|Withdrawal by Subject|4|||
23132987|NCT03248882|64234196|FG004|Overall Study|Withdrawal by Subject|2|||
23132988|NCT02992691|64234197|FG000|Overall Study|Adverse Event|2|||
23132989|NCT02992691|64234197|FG000|Overall Study|Withdrawal by Subject|1|||
23132990|NCT04445987|64234205|FG000|Overall Study|Adverse Event|0|||
23132991|NCT04445987|64234206|FG001|Overall Study|Adverse Event|0|||
23132992|NCT04445987|64234207|FG002|Overall Study|Adverse Event|1|||
23132993|NCT04445987|64234208|FG003|Overall Study|Adverse Event|0|||
23132994|NCT04445987|64234209|FG004|Overall Study|Adverse Event|4|||
23132995|NCT04445987|64234210|FG005|Overall Study|Adverse Event|0|||
23132996|NCT04445987|64234205|FG000|Overall Study|Lost to Follow-up|4|||
23132997|NCT04445987|64234206|FG001|Overall Study|Lost to Follow-up|3|||
23132998|NCT04445987|64234207|FG002|Overall Study|Lost to Follow-up|1|||
23132999|NCT04445987|64234208|FG003|Overall Study|Lost to Follow-up|1|||
23133000|NCT04445987|64234209|FG004|Overall Study|Lost to Follow-up|29|||
23133001|NCT04445987|64234210|FG005|Overall Study|Lost to Follow-up|0|||
23133002|NCT04445987|64234205|FG000|Overall Study|Physician Decision|0|||
23133003|NCT04445987|64234206|FG001|Overall Study|Physician Decision|0|||
23133004|NCT04445987|64234207|FG002|Overall Study|Physician Decision|0|||
23133005|NCT04445987|64234208|FG003|Overall Study|Physician Decision|0|||
23133006|NCT04445987|64234209|FG004|Overall Study|Physician Decision|1|||
23133007|NCT04445987|64234210|FG005|Overall Study|Physician Decision|0|||
23133008|NCT04445987|64234205|FG000|Overall Study|Protocol Violation|1|||
23133009|NCT04445987|64234206|FG001|Overall Study|Protocol Violation|0|||
23133010|NCT04445987|64234207|FG002|Overall Study|Protocol Violation|0|||
23133011|NCT04445987|64234208|FG003|Overall Study|Protocol Violation|0|||
23133012|NCT04445987|64234209|FG004|Overall Study|Protocol Violation|2|||
23133013|NCT04445987|64234210|FG005|Overall Study|Protocol Violation|0|||
23133014|NCT04445987|64234205|FG000|Overall Study|Withdrawal by Subject|4|||
23133015|NCT04445987|64234206|FG001|Overall Study|Withdrawal by Subject|0|||
23133016|NCT04445987|64234207|FG002|Overall Study|Withdrawal by Subject|1|||
23133017|NCT04445987|64234208|FG003|Overall Study|Withdrawal by Subject|0|||
23133018|NCT04445987|64234209|FG004|Overall Study|Withdrawal by Subject|18|||
23133019|NCT04445987|64234210|FG005|Overall Study|Withdrawal by Subject|1|||
23133020|NCT04445987|64234205|FG000|Overall Study|Other reason|0|||
23133021|NCT04445987|64234206|FG001|Overall Study|Other reason|0|||
23133022|NCT04445987|64234207|FG002|Overall Study|Other reason|1|||
23133023|NCT04445987|64234208|FG003|Overall Study|Other reason|0|||
23133024|NCT04445987|64234209|FG004|Overall Study|Other reason|2|||
23133025|NCT04445987|64234210|FG005|Overall Study|Other reason|0|||
23133026|NCT01696045|64234211|FG000|Overall Study|Study drug toxicity|1|||
23133027|NCT01696045|64234212|FG001|Overall Study|Study drug toxicity|5|||
23133028|NCT01696045|64234211|FG000|Overall Study|Disease progression|2|||
23133029|NCT01696045|64234212|FG001|Overall Study|Disease progression|2|||
23133030|NCT02136134|64234213|FG000|Overall Study|Death|170|||
23133031|NCT02136134|64234214|FG001|Overall Study|Death|148|||
23133032|NCT02136134|64234213|FG000|Overall Study|Withdrawal by Subject|19|||
23133033|NCT02136134|64234214|FG001|Overall Study|Withdrawal by Subject|10|||
23133034|NCT02136134|64234213|FG000|Overall Study|Lost to Follow-up|3|||
23133035|NCT02136134|64234214|FG001|Overall Study|Lost to Follow-up|3|||
23133036|NCT02136134|64234213|FG000|Overall Study|Uspecified|55|||
23133037|NCT02136134|64234214|FG001|Overall Study|Uspecified|90|||
23133038|NCT04043143|64234217|FG000|Overall Study|Lost to Follow-up|5|||
23317482|NCT02552121|64904098|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23133039|NCT04043143|64234218|FG001|Overall Study|Lost to Follow-up|5|||
23133040|NCT04043143|64234217|FG000|Overall Study|screen failure|1|||
23133041|NCT04043143|64234218|FG001|Overall Study|screen failure|0|||
23133042|NCT01871805|64234239|FG000|Phase I|Death|7|||
23133043|NCT01871805|64234240|FG001|Phase I|Death|4|||
23133044|NCT01871805|64234241|FG002|Phase I|Death|6|||
23133045|NCT01871805|64234242|FG003|Phase I|Death|2|||
23133046|NCT01871805|64234243|FG004|Phase I|Death|9|||
23547933|NCT00936858|65735973|FG000|Overall Study|Death|3|||
23133047|NCT01871805|64234244|FG005|Phase I|Death|0|||
23133048|NCT01871805|64234239|FG000|Phase I|Alive in Survival Follow-up|0|||
23133049|NCT01871805|64234240|FG001|Phase I|Alive in Survival Follow-up|2|||
23133050|NCT01871805|64234241|FG002|Phase I|Alive in Survival Follow-up|4|||
23133051|NCT01871805|64234242|FG003|Phase I|Alive in Survival Follow-up|5|||
23133052|NCT01871805|64234243|FG004|Phase I|Alive in Survival Follow-up|4|||
23133053|NCT01871805|64234244|FG005|Phase I|Alive in Survival Follow-up|0|||
23133054|NCT01871805|64234239|FG000|Phase I|Lost to Follow-up|0|||
23133055|NCT01871805|64234240|FG001|Phase I|Lost to Follow-up|1|||
23133056|NCT01871805|64234241|FG002|Phase I|Lost to Follow-up|3|||
23133057|NCT01871805|64234242|FG003|Phase I|Lost to Follow-up|0|||
23133058|NCT01871805|64234243|FG004|Phase I|Lost to Follow-up|0|||
23133059|NCT01871805|64234244|FG005|Phase I|Lost to Follow-up|0|||
23133060|NCT01871805|64234239|FG000|Phase II|Death|0|||
23133061|NCT01871805|64234240|FG001|Phase II|Death|0|||
23133062|NCT01871805|64234241|FG002|Phase II|Death|0|||
23133063|NCT01871805|64234242|FG003|Phase II|Death|0|||
23133064|NCT01871805|64234243|FG004|Phase II|Death|0|||
23133065|NCT01871805|64234244|FG005|Phase II|Death|45|||
23133066|NCT01871805|64234239|FG000|Phase II|Alive in Survival Follow-up|0|||
23133067|NCT01871805|64234240|FG001|Phase II|Alive in Survival Follow-up|0|||
23133068|NCT01871805|64234241|FG002|Phase II|Alive in Survival Follow-up|0|||
23133069|NCT01871805|64234242|FG003|Phase II|Alive in Survival Follow-up|0|||
23133070|NCT01871805|64234243|FG004|Phase II|Alive in Survival Follow-up|0|||
23133071|NCT01871805|64234244|FG005|Phase II|Alive in Survival Follow-up|29|||
23133072|NCT01871805|64234239|FG000|Phase II|Lost to Follow-up|0|||
23133073|NCT01871805|64234240|FG001|Phase II|Lost to Follow-up|0|||
23133074|NCT01871805|64234241|FG002|Phase II|Lost to Follow-up|0|||
23133075|NCT01871805|64234242|FG003|Phase II|Lost to Follow-up|0|||
23213786|NCT01576406|64523430|FG002|Overall Study|Lost to Follow-up|0|||
23213787|NCT01576406|64523431|FG003|Overall Study|Lost to Follow-up|0|||
23213788|NCT01576406|64523432|FG004|Overall Study|Lost to Follow-up|0|||
23213789|NCT01576406|64523433|FG005|Overall Study|Lost to Follow-up|0|||
23213790|NCT01576406|64523428|FG000|Overall Study|Death|3|||
23213791|NCT01576406|64523429|FG001|Overall Study|Death|4|||
23213792|NCT01576406|64523430|FG002|Overall Study|Death|8|||
23213793|NCT01576406|64523431|FG003|Overall Study|Death|5|||
23213794|NCT01576406|64523432|FG004|Overall Study|Death|7|||
23213795|NCT01576406|64523433|FG005|Overall Study|Death|9|||
23213796|NCT01576406|64523428|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
23213797|NCT01576406|64523429|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
23213798|NCT01576406|64523430|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
23133076|NCT01871805|64234243|FG004|Phase II|Lost to Follow-up|0|||
23133077|NCT01871805|64234244|FG005|Phase II|Lost to Follow-up|13|||
23133078|NCT02971761|64234245|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
23133079|NCT03772587|64234249|FG000|Overall Study|COVID-19|0|||
23133080|NCT03772587|64234250|FG001|Overall Study|COVID-19|0|||
23133081|NCT03772587|64234251|FG002|Overall Study|COVID-19|1|||
23133082|NCT03772587|64234252|FG003|Overall Study|COVID-19|1|||
23133083|NCT03772587|64234253|FG004|Overall Study|COVID-19|0|||
23133084|NCT03772587|64234249|FG000|Overall Study|Withdrawal by Subject|1|||
23133085|NCT03772587|64234250|FG001|Overall Study|Withdrawal by Subject|0|||
23133086|NCT03772587|64234251|FG002|Overall Study|Withdrawal by Subject|0|||
23133087|NCT03772587|64234252|FG003|Overall Study|Withdrawal by Subject|0|||
23133088|NCT03772587|64234253|FG004|Overall Study|Withdrawal by Subject|0|||
23133089|NCT00224887|64234257|FG000|Overall Study|Pregnancy|6|||
23133090|NCT00224887|64234258|FG001|Overall Study|Pregnancy|6|||
23133091|NCT01080326|64234259|FG000|Overall Study|Patient deterioration prior to procedure|3|||
23133092|NCT01080326|64234259|FG000|Overall Study|Surgeon decision|1|||
23133093|NCT00490490|64234260|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
23133094|NCT00490490|64234260|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
23133095|NCT01879553|64237319|FG000|Overall Study|Withdrawal by Subject|1|||
23133096|NCT01879553|64237320|FG001|Overall Study|Withdrawal by Subject|0|||
23133097|NCT04145700|64237321|FG000|Overall Study|Withdrawal by Subject|8|||
23133098|NCT04145700|64237322|FG001|Overall Study|Withdrawal by Subject|3|||
23133099|NCT03762200|64237323|FG000|Overall Study|Death|2|||
23133100|NCT01125046|64237324|FG000|First 6 Months of Treatment|Death|1|||
23133101|NCT01125046|64237324|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
23213799|NCT01576406|64523431|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
23133102|NCT01125046|64237324|FG000|First 6 Months of Treatment|Non-compliance|1|||
23317483|NCT02552121|64904099|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23133103|NCT01125046|64237324|FG000|First 6 Months of Treatment|Surgery|1|||
23213800|NCT01576406|64523432|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
23213801|NCT01576406|64523433|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
23213802|NCT01576406|64523428|FG000|Overall Study|Withdrawal the consent|2|||
23133104|NCT01125046|64237324|FG000|First 6 Months of Treatment|Progressive Disease|7|||
23133105|NCT01125046|64237324|FG000|First 6 Months of Treatment|Adverse Event|2|||
23133106|NCT01125046|64237324|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
23133107|NCT01125046|64237324|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
23427535|NCT00711802|65310502|FG002|Overall Study|Adverse Event|0|||
23427536|NCT00711802|65310503|FG003|Overall Study|Adverse Event|0|||
23427537|NCT00711802|65310504|FG004|Overall Study|Adverse Event|1|||
23427538|NCT00711802|65310505|FG005|Overall Study|Adverse Event|1|||
23427539|NCT00711802|65310506|FG006|Overall Study|Adverse Event|0|||
23427540|NCT00711802|65310507|FG007|Overall Study|Adverse Event|0|||
23427541|NCT00711802|65310500|FG000|Overall Study|Microbiological failure|0|||
23427542|NCT00711802|65310501|FG001|Overall Study|Microbiological failure|1|||
23427543|NCT00711802|65310502|FG002|Overall Study|Microbiological failure|0|||
23427544|NCT00711802|65310503|FG003|Overall Study|Microbiological failure|0|||
23427545|NCT00711802|65310504|FG004|Overall Study|Microbiological failure|0|||
23427546|NCT00711802|65310505|FG005|Overall Study|Microbiological failure|1|||
23427547|NCT00711802|65310506|FG006|Overall Study|Microbiological failure|0|||
23427548|NCT00711802|65310507|FG007|Overall Study|Microbiological failure|0|||
23427549|NCT00711802|65310500|FG000|Overall Study|Protocol Violation|0|||
23427550|NCT00711802|65310501|FG001|Overall Study|Protocol Violation|0|||
23427551|NCT00711802|65310502|FG002|Overall Study|Protocol Violation|0|||
23427552|NCT00711802|65310503|FG003|Overall Study|Protocol Violation|1|||
23427553|NCT00711802|65310504|FG004|Overall Study|Protocol Violation|0|||
23427554|NCT00711802|65310505|FG005|Overall Study|Protocol Violation|0|||
23427555|NCT00711802|65310506|FG006|Overall Study|Protocol Violation|0|||
23427556|NCT00711802|65310507|FG007|Overall Study|Protocol Violation|0|||
23427557|NCT00711802|65310500|FG000|Overall Study|Physician Decision|0|||
23427558|NCT00711802|65310501|FG001|Overall Study|Physician Decision|2|||
23427559|NCT00711802|65310502|FG002|Overall Study|Physician Decision|0|||
23427560|NCT00711802|65310503|FG003|Overall Study|Physician Decision|0|||
23427561|NCT00711802|65310504|FG004|Overall Study|Physician Decision|0|||
23427562|NCT00711802|65310505|FG005|Overall Study|Physician Decision|0|||
23427563|NCT00711802|65310506|FG006|Overall Study|Physician Decision|0|||
23427564|NCT00711802|65310507|FG007|Overall Study|Physician Decision|0|||
23427565|NCT00711802|65310500|FG000|Overall Study|Withdrawal by Subject|0|||
23427566|NCT00711802|65310501|FG001|Overall Study|Withdrawal by Subject|1|||
23427567|NCT00711802|65310502|FG002|Overall Study|Withdrawal by Subject|0|||
23427568|NCT00711802|65310503|FG003|Overall Study|Withdrawal by Subject|1|||
23427569|NCT00711802|65310504|FG004|Overall Study|Withdrawal by Subject|0|||
23427570|NCT00711802|65310505|FG005|Overall Study|Withdrawal by Subject|0|||
23427571|NCT00711802|65310506|FG006|Overall Study|Withdrawal by Subject|0|||
23427572|NCT00711802|65310507|FG007|Overall Study|Withdrawal by Subject|0|||
23427573|NCT00711802|65310500|FG000|Overall Study|Lost to Follow-up|0|||
23427574|NCT00711802|65310501|FG001|Overall Study|Lost to Follow-up|0|||
23427575|NCT00711802|65310502|FG002|Overall Study|Lost to Follow-up|3|||
23427576|NCT00711802|65310503|FG003|Overall Study|Lost to Follow-up|1|||
23427577|NCT00711802|65310504|FG004|Overall Study|Lost to Follow-up|10|||
23427578|NCT00711802|65310505|FG005|Overall Study|Lost to Follow-up|6|||
23427579|NCT00711802|65310506|FG006|Overall Study|Lost to Follow-up|4|||
23427580|NCT00711802|65310507|FG007|Overall Study|Lost to Follow-up|2|||
23427581|NCT00711802|65310500|FG000|Overall Study|Reason not reported|0|||
23427582|NCT00711802|65310501|FG001|Overall Study|Reason not reported|1|||
23427583|NCT00711802|65310502|FG002|Overall Study|Reason not reported|1|||
23427584|NCT00711802|65310503|FG003|Overall Study|Reason not reported|0|||
23427585|NCT00711802|65310504|FG004|Overall Study|Reason not reported|1|||
23427586|NCT00711802|65310505|FG005|Overall Study|Reason not reported|0|||
23427587|NCT00711802|65310506|FG006|Overall Study|Reason not reported|1|||
23427588|NCT00711802|65310507|FG007|Overall Study|Reason not reported|0|||
23427589|NCT03283150|65310508|FG000|Overall Study|Withdrawal by Subject|6|||
23427590|NCT03283150|65310509|FG001|Overall Study|Withdrawal by Subject|0|||
23427591|NCT03283150|65310510|FG002|Overall Study|Withdrawal by Subject|0|||
23427592|NCT03869333|65310511|FG000|Overall Study|Lost to Follow-up|1|||
23427593|NCT03869333|65310512|FG001|Overall Study|Lost to Follow-up|0|||
23427594|NCT03869333|65310513|FG002|Overall Study|Lost to Follow-up|0|||
23427595|NCT03869333|65310514|FG003|Overall Study|Lost to Follow-up|0|||
23213803|NCT01576406|64523429|FG001|Overall Study|Withdrawal the consent|2|||
23213804|NCT01576406|64523430|FG002|Overall Study|Withdrawal the consent|5|||
23213805|NCT01576406|64523431|FG003|Overall Study|Withdrawal the consent|1|||
23427596|NCT03869333|65310511|FG000|Overall Study|Pregnancy|1|||
23427597|NCT03869333|65310512|FG001|Overall Study|Pregnancy|0|||
23427598|NCT03869333|65310513|FG002|Overall Study|Pregnancy|0|||
23427599|NCT03869333|65310514|FG003|Overall Study|Pregnancy|0|||
23427600|NCT03869333|65310511|FG000|Overall Study|Physician Decision|0|||
23213806|NCT01576406|64523432|FG004|Overall Study|Withdrawal the consent|1|||
23427601|NCT03869333|65310512|FG001|Overall Study|Physician Decision|1|||
23427602|NCT03869333|65310513|FG002|Overall Study|Physician Decision|0|||
23427603|NCT03869333|65310514|FG003|Overall Study|Physician Decision|0|||
23427604|NCT00490139|65310515|FG000|Overall Study|Death|106|||
23427605|NCT00490139|65310516|FG001|Overall Study|Death|119|||
23427606|NCT00490139|65310517|FG002|Overall Study|Death|168|||
23427607|NCT00490139|65310518|FG003|Overall Study|Death|135|||
23427608|NCT00490139|65310515|FG000|Overall Study|Lost to Follow-up|56|||
23427609|NCT00490139|65310516|FG001|Overall Study|Lost to Follow-up|46|||
23427610|NCT00490139|65310517|FG002|Overall Study|Lost to Follow-up|58|||
23213807|NCT01576406|64523433|FG005|Overall Study|Withdrawal the consent|3|||
23213808|NCT01576406|64523428|FG000|Overall Study|Other|0|||
23547934|NCT00936858|65735973|FG000|Overall Study|Progression|29|||
23547935|NCT00936858|65735973|FG000|Overall Study|Withdrawal by Subject|5|||
23547936|NCT00936858|65735973|FG000|Overall Study|Adverse Event|1|||
23547937|NCT00936858|65735973|FG000|Overall Study|Physician Decision|7|||
23547938|NCT00936858|65735973|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
23547939|NCT00936858|65735973|FG000|Overall Study|Lost to Follow-up|1|||
23547940|NCT02777593|65735974|FG000|Overall Study|Still in study|28|||
23547941|NCT02777593|65735975|FG001|Overall Study|Still in study|71|||
23547942|NCT02777593|65735976|FG002|Overall Study|Still in study|5|||
23547943|NCT02777593|65735977|FG003|Overall Study|Still in study|6|||
23547944|NCT02777593|65735978|FG004|Overall Study|Still in study|6|||
23547945|NCT02777593|65735974|FG000|Overall Study|Death|19|||
23547946|NCT02777593|65735975|FG001|Overall Study|Death|24|||
23547947|NCT02777593|65735976|FG002|Overall Study|Death|0|||
23547948|NCT02777593|65735977|FG003|Overall Study|Death|5|||
23547949|NCT02777593|65735978|FG004|Overall Study|Death|0|||
23547950|NCT02777593|65735974|FG000|Overall Study|Withdrawal by Subject|6|||
23547951|NCT02777593|65735975|FG001|Overall Study|Withdrawal by Subject|3|||
23547952|NCT02777593|65735976|FG002|Overall Study|Withdrawal by Subject|1|||
23547953|NCT02777593|65735977|FG003|Overall Study|Withdrawal by Subject|1|||
23547954|NCT02777593|65735978|FG004|Overall Study|Withdrawal by Subject|0|||
23547955|NCT02777593|65735974|FG000|Overall Study|Lost to Follow-up|4|||
23547956|NCT02777593|65735975|FG001|Overall Study|Lost to Follow-up|12|||
23547957|NCT02777593|65735976|FG002|Overall Study|Lost to Follow-up|4|||
23547958|NCT02777593|65735977|FG003|Overall Study|Lost to Follow-up|0|||
23547959|NCT02777593|65735978|FG004|Overall Study|Lost to Follow-up|0|||
23547960|NCT02777593|65735974|FG000|Overall Study|Physician Decision|2|||
23547961|NCT02777593|65735975|FG001|Overall Study|Physician Decision|2|||
23547962|NCT02777593|65735976|FG002|Overall Study|Physician Decision|0|||
23547963|NCT02777593|65735977|FG003|Overall Study|Physician Decision|0|||
23547964|NCT02777593|65735978|FG004|Overall Study|Physician Decision|0|||
23547965|NCT02777593|65735974|FG000|Overall Study|Discontinued due to Other|3|||
23547966|NCT02777593|65735975|FG001|Overall Study|Discontinued due to Other|0|||
23547967|NCT02777593|65735976|FG002|Overall Study|Discontinued due to Other|0|||
23547968|NCT02777593|65735977|FG003|Overall Study|Discontinued due to Other|0|||
23547969|NCT02777593|65735978|FG004|Overall Study|Discontinued due to Other|0|||
23547970|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
23547971|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
23547972|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
23547973|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
23547974|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
23547975|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
23547976|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
23547977|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
23547978|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
23547979|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
23547980|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
23547981|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
23547982|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
23547983|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
23547984|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
23547985|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
23547986|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
23547987|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
23547988|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
23547989|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
23547990|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
23213809|NCT01576406|64523429|FG001|Overall Study|Other|0|||
23213810|NCT01576406|64523430|FG002|Overall Study|Other|2|||
23213811|NCT01576406|64523431|FG003|Overall Study|Other|2|||
23547991|NCT01781572|65735979|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
23547992|NCT01781572|65735980|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
23547993|NCT01781572|65735981|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
23547994|NCT01781572|65735979|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
23547995|NCT01781572|65735980|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
23213812|NCT01576406|64523432|FG004|Overall Study|Other|0|||
23213813|NCT01576406|64523433|FG005|Overall Study|Other|0|||
23547996|NCT01781572|65735981|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
23547997|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
23547998|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
23547999|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
23548000|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
23548001|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
23213814|NCT02148211|64523434|FG000|Overall Study|Lost to Follow-up|352|||
23213815|NCT00628758|64523435|FG000|Overall Study|Adverse Event|2|||
23213816|NCT00628758|64523436|FG001|Overall Study|Adverse Event|3|||
23213817|NCT00628758|64523435|FG000|Overall Study|Withdrawal by Subject|6|||
23213818|NCT00628758|64523436|FG001|Overall Study|Withdrawal by Subject|3|||
23213819|NCT00628758|64523435|FG000|Overall Study|Death|1|||
23213820|NCT00628758|64523436|FG001|Overall Study|Death|0|||
23213821|NCT00628758|64523435|FG000|Overall Study|Protocol Violation|5|||
23213822|NCT00628758|64523436|FG001|Overall Study|Protocol Violation|1|||
23213823|NCT00628758|64523435|FG000|Overall Study|Lost to Follow-up|25|||
23213824|NCT00628758|64523436|FG001|Overall Study|Lost to Follow-up|31|||
23213825|NCT00628758|64523435|FG000|Overall Study|Pregnancy|2|||
23213826|NCT00628758|64523436|FG001|Overall Study|Pregnancy|2|||
23213827|NCT00628758|64523435|FG000|Overall Study|Investigator Moved|3|||
23213828|NCT00628758|64523436|FG001|Overall Study|Investigator Moved|0|||
23213829|NCT00628758|64523435|FG000|Overall Study|Treatment Failure|0|||
23213830|NCT00628758|64523436|FG001|Overall Study|Treatment Failure|2|||
23213831|NCT03805971|64523437|FG000|Overall Study|Withdrawal by Subject|1|||
23213832|NCT03805971|64523437|FG000|Overall Study|Protocol Violation|2|||
23213833|NCT00949910|64523438|FG000|Overall Study|Progressive Disease|3750|||
23213834|NCT00949910|64523438|FG000|Overall Study|Symptomatic Deterioration|1088|||
23213835|NCT00949910|64523438|FG000|Overall Study|Lost to Follow-up|100|||
23213836|NCT00949910|64523438|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
23213837|NCT00949910|64523438|FG000|Overall Study|Participant Refusal|390|||
23213838|NCT00949910|64523438|FG000|Overall Study|Death Due to Malignant Disease|456|||
23213839|NCT00949910|64523438|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
23213840|NCT00949910|64523438|FG000|Overall Study|Death Due to Adverse Event|115|||
23213841|NCT00949910|64523438|FG000|Overall Study|Death Due to Toxicity|3|||
23213842|NCT00949910|64523438|FG000|Overall Study|Death from Unknown Cause|5|||
23213843|NCT00949910|64523438|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
23213844|NCT00949910|64523438|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
23213845|NCT00949910|64523438|FG000|Overall Study|Switched to Commercial Treatment|4|||
23213846|NCT00949910|64523438|FG000|Overall Study|Violation of Eligibility|23|||
23213847|NCT00949910|64523438|FG000|Overall Study|Logistical Reasons|13|||
23213848|NCT00949910|64523438|FG000|Overall Study|Non-Compliance|10|||
23213849|NCT00949910|64523438|FG000|Overall Study|Prolonged Dosing Interruption|4|||
23213850|NCT00949910|64523438|FG000|Overall Study|Adverse Event|83|||
23213851|NCT00949910|64523438|FG000|Overall Study|Serious Adverse Event|6|||
23213852|NCT00949910|64523438|FG000|Overall Study|Physician/Participant Decision|7|||
23213853|NCT00949910|64523438|FG000|Overall Study|Other|4|||
23213854|NCT00949910|64523438|FG000|Overall Study|No Data|9|||
23213855|NCT00166517|64523439|FG000|Overall Study|Lost to Follow-up|1|||
23213856|NCT00166517|64523440|FG001|Overall Study|Lost to Follow-up|0|||
23213857|NCT00166517|64523439|FG000|Overall Study|Protocol Violation|4|||
23213858|NCT00166517|64523440|FG001|Overall Study|Protocol Violation|1|||
23213859|NCT00166517|64523439|FG000|Overall Study|Withdrawal by Subject|0|||
23213860|NCT00166517|64523440|FG001|Overall Study|Withdrawal by Subject|1|||
23213861|NCT02031432|64523441|FG000|Overall Study|Protocol Violation|1|||
23213862|NCT02031432|64523441|FG000|Overall Study|Lack of Efficacy|5|||
23213863|NCT02031432|64523441|FG000|Overall Study|Cancer Progression|2|||
23213864|NCT02031432|64523441|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
23213865|NCT02031432|64523441|FG000|Overall Study|Adverse Event|8|||
23213866|NCT02031432|64523441|FG000|Overall Study|Withdrawal by Subject|5|||
23213867|NCT02031432|64523441|FG000|Overall Study|Lost to Follow-up|1|||
23213868|NCT02031432|64523441|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
23213869|NCT02031432|64523441|FG000|Overall Study|Death|10|||
23213870|NCT00131664|64523442|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
23213871|NCT00131664|64523443|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
23213872|NCT00131664|64523444|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
23213873|NCT00131664|64523445|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
23213874|NCT00131664|64523446|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
23213875|NCT00131664|64523447|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
23213876|NCT00131664|64523442|FG000|First Period (First 6 Months)|Death|0|||
23213877|NCT00131664|64523443|FG001|First Period (First 6 Months)|Death|1|||
23619653|NCT00498433|65994702|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
23213878|NCT00131664|64523444|FG002|First Period (First 6 Months)|Death|0|||
23213879|NCT00131664|64523445|FG003|First Period (First 6 Months)|Death|0|||
23213880|NCT00131664|64523446|FG004|First Period (First 6 Months)|Death|0|||
23213881|NCT00131664|64523447|FG005|First Period (First 6 Months)|Death|0|||
23213882|NCT00131664|64523442|FG000|First Period (First 6 Months)|Protocol Violation|2|||
23213883|NCT00131664|64523443|FG001|First Period (First 6 Months)|Protocol Violation|2|||
23213884|NCT00131664|64523444|FG002|First Period (First 6 Months)|Protocol Violation|1|||
23213885|NCT00131664|64523445|FG003|First Period (First 6 Months)|Protocol Violation|0|||
23213886|NCT00131664|64523446|FG004|First Period (First 6 Months)|Protocol Violation|0|||
23213887|NCT00131664|64523447|FG005|First Period (First 6 Months)|Protocol Violation|0|||
23213888|NCT00131664|64523442|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
23427611|NCT00490139|65310518|FG003|Overall Study|Lost to Follow-up|56|||
23427612|NCT00490139|65310515|FG000|Overall Study|Participant Withdrew Consent|146|||
23427613|NCT00490139|65310516|FG001|Overall Study|Participant Withdrew Consent|110|||
23427614|NCT00490139|65310517|FG002|Overall Study|Participant Withdrew Consent|208|||
23427615|NCT00490139|65310518|FG003|Overall Study|Participant Withdrew Consent|116|||
23427616|NCT01066780|65310519|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
23427617|NCT01066780|65310520|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
23427618|NCT02876328|65310524|FG000|Overall Study|Death|2|||
23427619|NCT02876328|65310525|FG001|Overall Study|Death|1|||
23427620|NCT02876328|65310526|FG002|Overall Study|Death|3|||
23427621|NCT02876328|65310527|FG003|Overall Study|Death|0|||
23427622|NCT02876328|65310528|FG004|Overall Study|Death|0|||
23427623|NCT02876328|65310529|FG005|Overall Study|Death|0|||
23427624|NCT02876328|65310530|FG006|Overall Study|Death|1|||
23427625|NCT02876328|65310531|FG007|Overall Study|Death|3|||
23427626|NCT02876328|65310532|FG008|Overall Study|Death|0|||
23427627|NCT02876328|65310533|FG009|Overall Study|Death|1|||
23427628|NCT02876328|65310534|FG010|Overall Study|Death|1|||
23427629|NCT02876328|65310535|FG011|Overall Study|Death|0|||
23427630|NCT02876328|65310536|FG012|Overall Study|Death|0|||
23427631|NCT02876328|65310537|FG013|Overall Study|Death|0|||
23427632|NCT02876328|65310538|FG014|Overall Study|Death|0|||
23427633|NCT02876328|65310539|FG015|Overall Study|Death|0|||
23427634|NCT02876328|65310540|FG016|Overall Study|Death|1|||
23427635|NCT02876328|65310541|FG017|Overall Study|Death|1|||
23427636|NCT02876328|65310542|FG018|Overall Study|Death|0|||
23427637|NCT02876328|65310543|FG019|Overall Study|Death|0|||
23427638|NCT02876328|65310544|FG020|Overall Study|Death|0|||
23427639|NCT02876328|65310545|FG021|Overall Study|Death|1|||
23427640|NCT02876328|65310546|FG022|Overall Study|Death|0|||
23427641|NCT02876328|65310547|FG023|Overall Study|Death|0|||
23427642|NCT02876328|65310524|FG000|Overall Study|Withdrawal by Subject|0|||
23427643|NCT02876328|65310525|FG001|Overall Study|Withdrawal by Subject|2|||
23427644|NCT02876328|65310526|FG002|Overall Study|Withdrawal by Subject|3|||
23427645|NCT02876328|65310527|FG003|Overall Study|Withdrawal by Subject|3|||
23427646|NCT02876328|65310528|FG004|Overall Study|Withdrawal by Subject|0|||
23427647|NCT02876328|65310529|FG005|Overall Study|Withdrawal by Subject|1|||
23427648|NCT02876328|65310530|FG006|Overall Study|Withdrawal by Subject|0|||
23427649|NCT02876328|65310531|FG007|Overall Study|Withdrawal by Subject|1|||
23427650|NCT02876328|65310532|FG008|Overall Study|Withdrawal by Subject|1|||
23427651|NCT02876328|65310533|FG009|Overall Study|Withdrawal by Subject|2|||
23427652|NCT02876328|65310534|FG010|Overall Study|Withdrawal by Subject|0|||
23548002|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
23548003|NCT01781572|65735979|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
23548004|NCT01781572|65735980|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
23548005|NCT01781572|65735981|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
23548006|NCT01781572|65735979|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
23548007|NCT01781572|65735980|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
23548008|NCT01781572|65735981|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
23427653|NCT02876328|65310535|FG011|Overall Study|Withdrawal by Subject|0|||
23427654|NCT02876328|65310536|FG012|Overall Study|Withdrawal by Subject|0|||
23427655|NCT02876328|65310537|FG013|Overall Study|Withdrawal by Subject|0|||
23427656|NCT02876328|65310538|FG014|Overall Study|Withdrawal by Subject|0|||
23427657|NCT02876328|65310539|FG015|Overall Study|Withdrawal by Subject|0|||
23427658|NCT02876328|65310540|FG016|Overall Study|Withdrawal by Subject|1|||
23427659|NCT02876328|65310541|FG017|Overall Study|Withdrawal by Subject|3|||
23427660|NCT02876328|65310542|FG018|Overall Study|Withdrawal by Subject|0|||
23427661|NCT02876328|65310543|FG019|Overall Study|Withdrawal by Subject|0|||
23427662|NCT02876328|65310544|FG020|Overall Study|Withdrawal by Subject|1|||
23427663|NCT02876328|65310545|FG021|Overall Study|Withdrawal by Subject|0|||
23427664|NCT02876328|65310546|FG022|Overall Study|Withdrawal by Subject|0|||
23427665|NCT02876328|65310547|FG023|Overall Study|Withdrawal by Subject|0|||
23427666|NCT02876328|65310524|FG000|Overall Study|Missed 12 Month Visit|15|||
23427667|NCT02876328|65310525|FG001|Overall Study|Missed 12 Month Visit|10|||
23427668|NCT02876328|65310526|FG002|Overall Study|Missed 12 Month Visit|11|||
23427669|NCT02876328|65310527|FG003|Overall Study|Missed 12 Month Visit|6|||
23427670|NCT02876328|65310528|FG004|Overall Study|Missed 12 Month Visit|10|||
23427671|NCT02876328|65310529|FG005|Overall Study|Missed 12 Month Visit|14|||
23427672|NCT02876328|65310530|FG006|Overall Study|Missed 12 Month Visit|3|||
23427673|NCT02876328|65310531|FG007|Overall Study|Missed 12 Month Visit|8|||
23427674|NCT02876328|65310532|FG008|Overall Study|Missed 12 Month Visit|9|||
23427675|NCT02876328|65310533|FG009|Overall Study|Missed 12 Month Visit|5|||
23427676|NCT02876328|65310534|FG010|Overall Study|Missed 12 Month Visit|4|||
23427677|NCT02876328|65310535|FG011|Overall Study|Missed 12 Month Visit|1|||
23427678|NCT02876328|65310536|FG012|Overall Study|Missed 12 Month Visit|5|||
23427679|NCT02876328|65310537|FG013|Overall Study|Missed 12 Month Visit|4|||
23427680|NCT02876328|65310538|FG014|Overall Study|Missed 12 Month Visit|4|||
23427681|NCT02876328|65310539|FG015|Overall Study|Missed 12 Month Visit|4|||
23427682|NCT02876328|65310540|FG016|Overall Study|Missed 12 Month Visit|3|||
23213889|NCT00131664|64523443|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
23213890|NCT00131664|64523444|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
23213891|NCT00131664|64523445|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
23213892|NCT00131664|64523446|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
23213893|NCT00131664|64523447|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
23213894|NCT00131664|64523442|FG000|First Period (First 6 Months)|Adverse Event|9|||
23548009|NCT01781572|65735979|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
23548010|NCT01781572|65735980|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
23548011|NCT01781572|65735981|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
23548012|NCT01781572|65735979|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
23548013|NCT01781572|65735980|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
23548014|NCT01781572|65735981|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
23548015|NCT01781572|65735979|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
23548016|NCT01781572|65735980|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
23548017|NCT01781572|65735981|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
23548018|NCT01781572|65735979|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
23548019|NCT01781572|65735980|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
23548020|NCT01781572|65735981|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
23548021|NCT01781572|65735979|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
23548022|NCT01781572|65735980|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
23213895|NCT00131664|64523443|FG001|First Period (First 6 Months)|Adverse Event|4|||
23213896|NCT00131664|64523444|FG002|First Period (First 6 Months)|Adverse Event|5|||
23213897|NCT00131664|64523445|FG003|First Period (First 6 Months)|Adverse Event|0|||
23213898|NCT00131664|64523446|FG004|First Period (First 6 Months)|Adverse Event|0|||
23213899|NCT00131664|64523447|FG005|First Period (First 6 Months)|Adverse Event|0|||
23213900|NCT00131664|64523442|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
23213901|NCT00131664|64523443|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
23213902|NCT00131664|64523444|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
23213903|NCT00131664|64523445|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
23213904|NCT00131664|64523446|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
23213905|NCT00131664|64523447|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
23213906|NCT00131664|64523442|FG000|First Period (First 6 Months)|Administrative reasons|2|||
23213907|NCT00131664|64523443|FG001|First Period (First 6 Months)|Administrative reasons|0|||
23213908|NCT00131664|64523444|FG002|First Period (First 6 Months)|Administrative reasons|5|||
23213909|NCT00131664|64523445|FG003|First Period (First 6 Months)|Administrative reasons|0|||
23213910|NCT00131664|64523446|FG004|First Period (First 6 Months)|Administrative reasons|0|||
23213911|NCT00131664|64523447|FG005|First Period (First 6 Months)|Administrative reasons|0|||
23213912|NCT00131664|64523442|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
23213913|NCT00131664|64523443|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
23213914|NCT00131664|64523444|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
23213915|NCT00131664|64523445|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
23213916|NCT00131664|64523446|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
23213917|NCT00131664|64523447|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
23213918|NCT00131664|64523442|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
23213919|NCT00131664|64523443|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
23213920|NCT00131664|64523444|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
23213921|NCT00131664|64523445|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
23213922|NCT00131664|64523446|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
23213923|NCT00131664|64523447|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
23213924|NCT00131664|64523442|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
23213925|NCT00131664|64523443|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23213926|NCT00131664|64523444|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23213927|NCT00131664|64523445|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23213928|NCT00131664|64523446|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23213929|NCT00131664|64523447|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
23213930|NCT00131664|64523442|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
23213931|NCT00131664|64523443|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
23213932|NCT00131664|64523444|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
23213933|NCT00131664|64523445|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
23213934|NCT00131664|64523446|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
23213935|NCT00131664|64523447|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
23427683|NCT02876328|65310541|FG017|Overall Study|Missed 12 Month Visit|6|||
23427684|NCT02876328|65310542|FG018|Overall Study|Missed 12 Month Visit|2|||
23427685|NCT02876328|65310543|FG019|Overall Study|Missed 12 Month Visit|2|||
23619654|NCT00498433|65994700|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
23213936|NCT00131664|64523442|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23213937|NCT00131664|64523443|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23213938|NCT00131664|64523444|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23213939|NCT00131664|64523445|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
23213940|NCT00131664|64523446|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23213941|NCT00131664|64523447|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
23213942|NCT00131664|64523442|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
23213943|NCT00131664|64523443|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
23213944|NCT00131664|64523444|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
23133108|NCT01125046|64237324|FG000|Follow-up/Data Cut Off Point|Death|29|||
23133109|NCT01125046|64237324|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
23133110|NCT00506441|64237325|FG000|Period 1; Open-label Period|Adverse Event|21|||
23133111|NCT00506441|64237326|FG001|Period 1; Open-label Period|Adverse Event|0|||
23133112|NCT00506441|64237325|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
23133113|NCT00506441|64237326|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
23133114|NCT00506441|64237325|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
23133115|NCT00506441|64237326|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
23133116|NCT00506441|64237325|FG000|Period 1; Open-label Period|Physician Decision|5|||
23133117|NCT00506441|64237326|FG001|Period 1; Open-label Period|Physician Decision|0|||
23133118|NCT00506441|64237325|FG000|Period 1; Open-label Period|Protocol Violation|9|||
23548023|NCT01781572|65735981|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
23213945|NCT00131664|64523445|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
23213946|NCT00131664|64523446|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
23213947|NCT00131664|64523447|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
23213948|NCT00120289|64523448|FG000|Overall Study|Death|96|||
23213949|NCT00120289|64523449|FG001|Overall Study|Death|82|||
23213950|NCT00120289|64523448|FG000|Overall Study|Lost to Follow-up|11|||
23213951|NCT00120289|64523449|FG001|Overall Study|Lost to Follow-up|14|||
23213952|NCT00120289|64523448|FG000|Overall Study|Withdrawal by Subject|14|||
23213953|NCT00120289|64523449|FG001|Overall Study|Withdrawal by Subject|13|||
23213954|NCT01179347|64523451|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
23213955|NCT01179347|64523452|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
23213956|NCT01179347|64523451|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
23213957|NCT01179347|64523452|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
23213958|NCT01179347|64523451|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
23213959|NCT01179347|64523452|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
23548024|NCT01693120|65735982|FG000|Enrollment|Lost to Follow-up|1|||
23548025|NCT01693120|65735982|FG000|Enrollment|Withdrawal by Subject|10|||
23548026|NCT01693120|65735982|FG000|Enrollment|Protocol Violation|46|||
23548027|NCT01693120|65735982|FG000|Enrollment|Physician Decision|3|||
23548028|NCT01693120|65735982|FG000|Enrollment|Adverse Event|1|||
23548029|NCT01693120|65735982|FG000|Enrollment|Study closed|8|||
23548030|NCT01693120|65735982|FG000|Enrollment|Other|1|||
23548031|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
23548032|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
23548033|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
23548034|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
23548035|NCT01693120|65735982|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
23548036|NCT02911948|65735983|FG000|Overall Study|Protocol Violation|0|||
23213960|NCT01179347|64523451|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
23213961|NCT01179347|64523452|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
23213962|NCT01179347|64523451|FG000|Double-blind Period (12 Weeks)|Other|2|||
23213963|NCT01179347|64523452|FG001|Double-blind Period (12 Weeks)|Other|4|||
23213964|NCT01179347|64523451|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
23213965|NCT01179347|64523452|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
23317484|NCT02552121|64904100|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23317485|NCT02552121|64904101|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
23548037|NCT02911948|65735984|FG001|Overall Study|Protocol Violation|1|||
23619655|NCT00498433|65994701|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
23619656|NCT00498433|65994702|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
23619657|NCT00088452|65994703|FG000|Overall Study|Did not receive intervention|1|||
23548038|NCT02911948|65735983|FG000|Overall Study|Withdrawal by Subject|0|||
23133119|NCT00506441|64237326|FG001|Period 1; Open-label Period|Protocol Violation|0|||
23548039|NCT02911948|65735984|FG001|Overall Study|Withdrawal by Subject|2|||
23619658|NCT00088452|65994704|FG001|Overall Study|Did not receive intervention|0|||
23619659|NCT00088452|65994705|FG002|Overall Study|Did not receive intervention|1|||
23619660|NCT01772147|65994706|FG000|Overall Study|Adverse Event|13|||
23619661|NCT01772147|65994707|FG001|Overall Study|Adverse Event|10|||
23619662|NCT01772147|65994708|FG002|Overall Study|Adverse Event|6|||
23619663|NCT01772147|65994706|FG000|Overall Study|Withdrew Consent|7|||
23213966|NCT01179347|64523451|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
23213967|NCT01179347|64523452|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
23213968|NCT01179347|64523451|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
23213969|NCT01179347|64523452|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
23213970|NCT01179347|64523451|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
23213971|NCT01179347|64523452|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
23213972|NCT01179347|64523451|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
23213973|NCT01179347|64523452|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
23213974|NCT01179347|64523451|FG000|Open-label Period (12 Weeks)|Other|7|||
23213975|NCT01179347|64523452|FG001|Open-label Period (12 Weeks)|Other|4|||
23213976|NCT00179517|64523453|FG000|Overall Study|Withdrawal by Subject|2|||
23213977|NCT00179517|64523454|FG001|Overall Study|Withdrawal by Subject|1|||
23213978|NCT00804843|64523455|FG000|Overall Study|Protocol Violation|1|||
23213979|NCT00804843|64523456|FG001|Overall Study|Protocol Violation|0|||
23213980|NCT00804843|64523455|FG000|Overall Study|Adverse Event|8|||
23213981|NCT00804843|64523456|FG001|Overall Study|Adverse Event|5|||
23213982|NCT00804843|64523455|FG000|Overall Study|Withdrawal by Subject|1|||
23213983|NCT00804843|64523456|FG001|Overall Study|Withdrawal by Subject|2|||
23548040|NCT02911948|65735983|FG000|Overall Study|Lack of Efficacy|0|||
23548041|NCT02911948|65735984|FG001|Overall Study|Lack of Efficacy|1|||
23548042|NCT02911948|65735983|FG000|Overall Study|Unclassified|0|||
23548043|NCT02911948|65735984|FG001|Overall Study|Unclassified|3|||
23213984|NCT05567393|64523457|FG000|Overall Study|Voluntary Withdrawal|0|||
23213985|NCT05567393|64523458|FG001|Overall Study|Voluntary Withdrawal|0|||
23213986|NCT05567393|64523459|FG002|Overall Study|Voluntary Withdrawal|0|||
23213987|NCT05567393|64523460|FG003|Overall Study|Voluntary Withdrawal|0|||
23213988|NCT05567393|64523461|FG004|Overall Study|Voluntary Withdrawal|0|||
23213989|NCT05567393|64523462|FG005|Overall Study|Voluntary Withdrawal|0|||
23213990|NCT05567393|64523463|FG006|Overall Study|Voluntary Withdrawal|0|||
23213991|NCT05567393|64523464|FG007|Overall Study|Voluntary Withdrawal|0|||
23213992|NCT05567393|64523465|FG008|Overall Study|Voluntary Withdrawal|0|||
23213993|NCT05567393|64523466|FG009|Overall Study|Voluntary Withdrawal|0|||
23213994|NCT05567393|64523467|FG010|Overall Study|Voluntary Withdrawal|0|||
23133120|NCT00506441|64237325|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
23133121|NCT00506441|64237326|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
23133122|NCT00506441|64237325|FG000|Period 1; Open-label Period|Other Reasons|13|||
23133123|NCT00506441|64237326|FG001|Period 1; Open-label Period|Other Reasons|0|||
23133124|NCT00506441|64237325|FG000|Period 2; Double-blind Period|Adverse Event|0|||
23133125|NCT00506441|64237326|FG001|Period 2; Double-blind Period|Adverse Event|1|||
23133126|NCT00506441|64237325|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
23133127|NCT00506441|64237326|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
23133128|NCT00506441|64237325|FG000|Period 2; Double-blind Period|Physician Decision|1|||
23133129|NCT00506441|64237326|FG001|Period 2; Double-blind Period|Physician Decision|1|||
23133130|NCT00506441|64237325|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
23133131|NCT00506441|64237326|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
23133132|NCT00506441|64237325|FG000|Period 2; Double-blind Period|Other Reason|1|||
23133133|NCT00506441|64237326|FG001|Period 2; Double-blind Period|Other Reason|1|||
23133134|NCT01163292|64237329|FG000|Overall Study|Lack of Efficacy|9|||
23133135|NCT01163292|64237330|FG001|Overall Study|Lack of Efficacy|0|||
23548044|NCT01300546|65735988|FG000|Overall Study|Withdrawal by Subject|1|||
23548045|NCT01300546|65735989|FG001|Overall Study|Withdrawal by Subject|0|||
23548046|NCT01300546|65735988|FG000|Overall Study|Lost to Follow-up|0|||
23548047|NCT01300546|65735989|FG001|Overall Study|Lost to Follow-up|2|||
23548048|NCT01300546|65735988|FG000|Overall Study|Lack of Efficacy|0|||
23548049|NCT01300546|65735989|FG001|Overall Study|Lack of Efficacy|3|||
23548050|NCT01300546|65735988|FG000|Overall Study|Adverse Event|0|||
23548051|NCT01300546|65735989|FG001|Overall Study|Adverse Event|1|||
23133136|NCT01163292|64237329|FG000|Overall Study|Adverse Event|6|||
23133137|NCT01163292|64237330|FG001|Overall Study|Adverse Event|0|||
23133138|NCT01163292|64237329|FG000|Overall Study|Initiation of biological therapy|0|||
23133139|NCT01163292|64237330|FG001|Overall Study|Initiation of biological therapy|15|||
23213995|NCT05567393|64523468|FG011|Overall Study|Voluntary Withdrawal|0|||
23213996|NCT05567393|64523469|FG012|Overall Study|Voluntary Withdrawal|0|||
23213997|NCT05567393|64523470|FG013|Overall Study|Voluntary Withdrawal|1|||
23213998|NCT05567393|64523471|FG014|Overall Study|Voluntary Withdrawal|0|||
23213999|NCT05567393|64523472|FG015|Overall Study|Voluntary Withdrawal|0|||
23214000|NCT05567393|64523473|FG016|Overall Study|Voluntary Withdrawal|0|||
23214001|NCT05567393|64523474|FG017|Overall Study|Voluntary Withdrawal|0|||
23214002|NCT00141037|64523475|FG000|Overall Study|Physician Decision|1|||
23214003|NCT00141037|64523476|FG001|Overall Study|Physician Decision|2|||
23214004|NCT00141037|64523475|FG000|Overall Study|Lost to Follow-up|3|||
23214005|NCT00141037|64523476|FG001|Overall Study|Lost to Follow-up|1|||
23548052|NCT03150056|65735990|FG000|Overall Study|Withdrawal by Subject|0|||
23548053|NCT03150056|65735991|FG001|Overall Study|Withdrawal by Subject|0|||
23548054|NCT03150056|65735992|FG002|Overall Study|Withdrawal by Subject|0|||
23133140|NCT01163292|64237329|FG000|Overall Study|Sufficient response to adalimumab|8|||
23133141|NCT01163292|64237330|FG001|Overall Study|Sufficient response to adalimumab|0|||
23133142|NCT01163292|64237329|FG000|Overall Study|Refusal to receive adalimumab|7|||
23133143|NCT01163292|64237330|FG001|Overall Study|Refusal to receive adalimumab|0|||
23133144|NCT01163292|64237329|FG000|Overall Study|Economic reasons|6|||
23133145|NCT01163292|64237330|FG001|Overall Study|Economic reasons|0|||
23133146|NCT01163292|64237329|FG000|Overall Study|No further visits|5|||
23133147|NCT01163292|64237330|FG001|Overall Study|No further visits|7|||
23133148|NCT01262027|64237337|FG000|Overall Study|Adverse Event|1|||
23133149|NCT01262027|64237337|FG000|Overall Study|Withdrawal by Subject|3|||
23133150|NCT01262027|64237337|FG000|Overall Study|Protocol Violation|1|||
23133151|NCT03258723|64237339|FG000|Overall Study|COVID Interruption of study|54|||
23133152|NCT03258723|64237339|FG000|Overall Study|Lost to Follow-up|8|||
23133153|NCT02248818|64237340|FG000|Screening|Protocol Violation|0|||
23133154|NCT02248818|64237341|FG001|Screening|Protocol Violation|0|||
23133155|NCT02248818|64237342|FG002|Screening|Protocol Violation|0|||
23133156|NCT02248818|64237343|FG003|Screening|Protocol Violation|0|||
23133157|NCT02248818|64237344|FG004|Screening|Protocol Violation|0|||
23133158|NCT02248818|64237345|FG005|Screening|Protocol Violation|0|||
23133159|NCT02248818|64237346|FG006|Screening|Protocol Violation|0|||
23133160|NCT02248818|64237347|FG007|Screening|Protocol Violation|0|||
23133161|NCT02248818|64237348|FG008|Screening|Protocol Violation|7|||
23133162|NCT02248818|64237340|FG000|Screening|Study fully enrolled|0|||
23133163|NCT02248818|64237341|FG001|Screening|Study fully enrolled|0|||
23133164|NCT02248818|64237342|FG002|Screening|Study fully enrolled|0|||
23133165|NCT02248818|64237343|FG003|Screening|Study fully enrolled|0|||
23133166|NCT02248818|64237344|FG004|Screening|Study fully enrolled|0|||
23133167|NCT02248818|64237345|FG005|Screening|Study fully enrolled|0|||
23133168|NCT02248818|64237346|FG006|Screening|Study fully enrolled|0|||
23133169|NCT02248818|64237347|FG007|Screening|Study fully enrolled|0|||
23133170|NCT02248818|64237348|FG008|Screening|Study fully enrolled|14|||
23133171|NCT02248818|64237340|FG000|Screening|Physician Decision|0|||
23133172|NCT02248818|64237341|FG001|Screening|Physician Decision|0|||
23133173|NCT02248818|64237342|FG002|Screening|Physician Decision|0|||
23133174|NCT02248818|64237343|FG003|Screening|Physician Decision|0|||
23133175|NCT02248818|64237344|FG004|Screening|Physician Decision|0|||
23133176|NCT02248818|64237345|FG005|Screening|Physician Decision|0|||
23133177|NCT02248818|64237346|FG006|Screening|Physician Decision|0|||
23133178|NCT02248818|64237347|FG007|Screening|Physician Decision|0|||
23133179|NCT02248818|64237348|FG008|Screening|Physician Decision|73|||
23214006|NCT00141037|64523475|FG000|Overall Study|Protocol Violation|0|||
23214007|NCT00141037|64523476|FG001|Overall Study|Protocol Violation|2|||
23548055|NCT03150056|65735993|FG003|Overall Study|Withdrawal by Subject|0|||
23548056|NCT03150056|65735994|FG004|Overall Study|Withdrawal by Subject|0|||
23548057|NCT03150056|65735995|FG005|Overall Study|Withdrawal by Subject|2|||
23548058|NCT03150056|65735990|FG000|Overall Study|Study terminated by Sponsor|1|||
23548059|NCT03150056|65735991|FG001|Overall Study|Study terminated by Sponsor|3|||
23548060|NCT03150056|65735992|FG002|Overall Study|Study terminated by Sponsor|1|||
23548061|NCT03150056|65735993|FG003|Overall Study|Study terminated by Sponsor|1|||
23548062|NCT03150056|65735994|FG004|Overall Study|Study terminated by Sponsor|5|||
23548063|NCT03150056|65735995|FG005|Overall Study|Study terminated by Sponsor|6|||
23214008|NCT00141037|64523475|FG000|Overall Study|Withdrawal by Subject|2|||
23214009|NCT00141037|64523476|FG001|Overall Study|Withdrawal by Subject|1|||
23214010|NCT00141037|64523475|FG000|Overall Study|Other|0|||
23214011|NCT00141037|64523476|FG001|Overall Study|Other|1|||
23214012|NCT00141037|64523475|FG000|Overall Study|Moved from area|1|||
23214013|NCT00141037|64523476|FG001|Overall Study|Moved from area|7|||
23214014|NCT00141037|64523475|FG000|Overall Study|Graft Failure|3|||
23214015|NCT00141037|64523476|FG001|Overall Study|Graft Failure|4|||
23548064|NCT03150056|65735990|FG000|Overall Study|Death|9|||
23548065|NCT03150056|65735991|FG001|Overall Study|Death|2|||
23133180|NCT02248818|64237340|FG000|Screening|Withdrawal by Subject|0|||
23214016|NCT00014911|64523481|FG000|Overall Study|Adverse Event|1|||
23548066|NCT03150056|65735992|FG002|Overall Study|Death|2|||
23548067|NCT03150056|65735993|FG003|Overall Study|Death|7|||
23548068|NCT03150056|65735994|FG004|Overall Study|Death|8|||
23548069|NCT03150056|65735995|FG005|Overall Study|Death|10|||
23214017|NCT00014911|64523481|FG000|Overall Study|Lost to Follow-up|1|||
23214018|NCT00014911|64523481|FG000|Overall Study|Withdrawal by Subject|6|||
23214019|NCT00014911|64523481|FG000|Overall Study|Unknown Reasons|2|||
23133181|NCT02248818|64237341|FG001|Screening|Withdrawal by Subject|0|||
23133182|NCT02248818|64237342|FG002|Screening|Withdrawal by Subject|0|||
23133183|NCT02248818|64237343|FG003|Screening|Withdrawal by Subject|0|||
23133184|NCT02248818|64237344|FG004|Screening|Withdrawal by Subject|0|||
23133185|NCT02248818|64237345|FG005|Screening|Withdrawal by Subject|0|||
23214020|NCT00014911|64523481|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
23133186|NCT02248818|64237346|FG006|Screening|Withdrawal by Subject|0|||
23133187|NCT02248818|64237347|FG007|Screening|Withdrawal by Subject|0|||
23548070|NCT00657618|65735998|FG000|Overall Study|Adverse Event|32|||
23548071|NCT00657618|65735998|FG000|Overall Study|Withdrawal by Subject|8|||
23133188|NCT02248818|64237348|FG008|Screening|Withdrawal by Subject|6|||
23548072|NCT00657618|65735998|FG000|Overall Study|negative for leishmaniasis|2|||
23548073|NCT00657618|65735998|FG000|Overall Study|didn't start due to schedule conflicts|1|||
23427686|NCT02876328|65310544|FG020|Overall Study|Missed 12 Month Visit|11|||
23427687|NCT02876328|65310545|FG021|Overall Study|Missed 12 Month Visit|7|||
23133189|NCT02248818|64237340|FG000|Screening|Lost to Follow-up|0|||
23133190|NCT02248818|64237341|FG001|Screening|Lost to Follow-up|0|||
23133191|NCT02248818|64237342|FG002|Screening|Lost to Follow-up|0|||
23133192|NCT02248818|64237343|FG003|Screening|Lost to Follow-up|0|||
23133193|NCT02248818|64237344|FG004|Screening|Lost to Follow-up|0|||
23133194|NCT02248818|64237345|FG005|Screening|Lost to Follow-up|0|||
23133195|NCT02248818|64237346|FG006|Screening|Lost to Follow-up|0|||
23133196|NCT02248818|64237347|FG007|Screening|Lost to Follow-up|0|||
23133197|NCT02248818|64237348|FG008|Screening|Lost to Follow-up|7|||
23133198|NCT02248818|64237340|FG000|Randomised Study|Administrative - randomization error|0|||
23133199|NCT02248818|64237341|FG001|Randomised Study|Administrative - randomization error|0|||
23133200|NCT02248818|64237342|FG002|Randomised Study|Administrative - randomization error|0|||
23133201|NCT02248818|64237343|FG003|Randomised Study|Administrative - randomization error|0|||
23133202|NCT02248818|64237344|FG004|Randomised Study|Administrative - randomization error|0|||
23133203|NCT02248818|64237345|FG005|Randomised Study|Administrative - randomization error|8|||
23133204|NCT02248818|64237346|FG006|Randomised Study|Administrative - randomization error|0|||
23133205|NCT02248818|64237347|FG007|Randomised Study|Administrative - randomization error|0|||
23619664|NCT01772147|65994707|FG001|Overall Study|Withdrew Consent|8|||
23619665|NCT01772147|65994708|FG002|Overall Study|Withdrew Consent|4|||
23619666|NCT01772147|65994706|FG000|Overall Study|Lost to Follow-up|1|||
23619667|NCT01772147|65994707|FG001|Overall Study|Lost to Follow-up|0|||
23214021|NCT03447821|64523488|FG000|Overall Study|Withdrawal by Subject|1|||
23214022|NCT03447821|64523489|FG001|Overall Study|Withdrawal by Subject|1|||
23214023|NCT03447821|64523490|FG002|Overall Study|Withdrawal by Subject|0|||
23214024|NCT03447821|64523488|FG000|Overall Study|Lost to Follow-up|0|||
23214025|NCT03447821|64523489|FG001|Overall Study|Lost to Follow-up|0|||
23214026|NCT03447821|64523490|FG002|Overall Study|Lost to Follow-up|1|||
23214027|NCT02924688|64523496|FG000|Overall Study|Adverse Event|9|||
23214028|NCT02924688|64523497|FG001|Overall Study|Adverse Event|3|||
23427688|NCT02876328|65310546|FG022|Overall Study|Missed 12 Month Visit|1|||
23427689|NCT02876328|65310547|FG023|Overall Study|Missed 12 Month Visit|0|||
23427690|NCT01998893|65310548|FG000|Overall Study|Adverse Event|2|||
23427691|NCT01998893|65310548|FG000|Overall Study|Death|1|||
23619668|NCT01772147|65994708|FG002|Overall Study|Lost to Follow-up|1|||
23619669|NCT01772147|65994706|FG000|Overall Study|Protocol Deviation|2|||
23619670|NCT01772147|65994707|FG001|Overall Study|Protocol Deviation|1|||
23133206|NCT02248818|64237348|FG008|Randomised Study|Administrative - randomization error|0|||
23133207|NCT05327816|64237353|FG000|Overall Study|Lost to Follow-up|1|||
23133208|NCT05327816|64237354|FG001|Overall Study|Lost to Follow-up|0|||
23133209|NCT05327816|64237355|FG002|Overall Study|Lost to Follow-up|0|||
23133210|NCT05327816|64237356|FG003|Overall Study|Lost to Follow-up|0|||
23133211|NCT05327816|64237357|FG004|Overall Study|Lost to Follow-up|0|||
23133212|NCT05327816|64237358|FG005|Overall Study|Lost to Follow-up|0|||
23133213|NCT05327816|64237359|FG006|Overall Study|Lost to Follow-up|0|||
23133214|NCT05327816|64237360|FG007|Overall Study|Lost to Follow-up|0|||
23133215|NCT05327816|64237361|FG008|Overall Study|Lost to Follow-up|0|||
23427692|NCT01998893|65310548|FG000|Overall Study|Lost to Follow-up|8|||
23427693|NCT01998893|65310548|FG000|Overall Study|Physician Decision|2|||
23427694|NCT01998893|65310548|FG000|Overall Study|Protocol Violation|2|||
23427695|NCT01998893|65310548|FG000|Overall Study|Withdrawal by Subject|1|||
23427696|NCT01998893|65310548|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
23427697|NCT01463111|65310553|FG000|Overall Study|Withdrawal by Subject|2|||
23427698|NCT01463111|65310553|FG000|Overall Study|Lost to Follow-up|5|||
23427699|NCT01463111|65310553|FG000|Overall Study|Physician Decision|2|||
23548074|NCT01585103|65736001|FG000|Overall Study|Unable to swallow Cytosponge|6|||
23548075|NCT00058123|65739460|FG000|Overall Study|Wrong histology|9|||
23548076|NCT00058123|65739460|FG000|Overall Study|Received >3 prior treatments|1|||
23548077|NCT03695172|65739461|FG000|Overall Study|Withdrawal by Subject|1|||
23548078|NCT03695172|65739462|FG001|Overall Study|Withdrawal by Subject|1|||
23548079|NCT03695172|65739463|FG002|Overall Study|Withdrawal by Subject|0|||
23548080|NCT00321854|65739464|FG000|Overall Study|Adverse Event|41|||
23548081|NCT00321854|65739465|FG001|Overall Study|Adverse Event|43|||
23548082|NCT00321854|65739464|FG000|Overall Study|Lack of Efficacy|9|||
23548083|NCT00321854|65739465|FG001|Overall Study|Lack of Efficacy|14|||
23133216|NCT05327816|64237362|FG009|Overall Study|Lost to Follow-up|1|||
23133217|NCT05327816|64237363|FG010|Overall Study|Lost to Follow-up|0|||
23133218|NCT05327816|64237353|FG000|Overall Study|Withdrawal by Subject|0|||
23214029|NCT02924688|64523498|FG002|Overall Study|Adverse Event|2|||
23427700|NCT00823212|65310554|FG000|Overall Study|Death|8|||
23427701|NCT00823212|65310555|FG001|Overall Study|Death|10|||
23427702|NCT00823212|65310554|FG000|Overall Study|Withdrawal by Subject|6|||
23619671|NCT01772147|65994708|FG002|Overall Study|Protocol Deviation|1|||
23133219|NCT05327816|64237354|FG001|Overall Study|Withdrawal by Subject|0|||
23133220|NCT05327816|64237355|FG002|Overall Study|Withdrawal by Subject|0|||
23133221|NCT05327816|64237356|FG003|Overall Study|Withdrawal by Subject|0|||
23133222|NCT05327816|64237357|FG004|Overall Study|Withdrawal by Subject|1|||
23133223|NCT05327816|64237358|FG005|Overall Study|Withdrawal by Subject|1|||
23133224|NCT05327816|64237359|FG006|Overall Study|Withdrawal by Subject|0|||
23133225|NCT05327816|64237360|FG007|Overall Study|Withdrawal by Subject|0|||
23133226|NCT05327816|64237361|FG008|Overall Study|Withdrawal by Subject|0|||
23133227|NCT05327816|64237362|FG009|Overall Study|Withdrawal by Subject|0|||
23133228|NCT05327816|64237363|FG010|Overall Study|Withdrawal by Subject|0|||
23133229|NCT05327816|64237353|FG000|Overall Study|Study Terminated by Sponsor|11|||
23133230|NCT05327816|64237354|FG001|Overall Study|Study Terminated by Sponsor|12|||
23133231|NCT05327816|64237355|FG002|Overall Study|Study Terminated by Sponsor|12|||
23133232|NCT05327816|64237356|FG003|Overall Study|Study Terminated by Sponsor|12|||
23133233|NCT05327816|64237357|FG004|Overall Study|Study Terminated by Sponsor|11|||
23133234|NCT05327816|64237358|FG005|Overall Study|Study Terminated by Sponsor|11|||
23133235|NCT05327816|64237359|FG006|Overall Study|Study Terminated by Sponsor|11|||
23133236|NCT05327816|64237360|FG007|Overall Study|Study Terminated by Sponsor|11|||
23133237|NCT05327816|64237361|FG008|Overall Study|Study Terminated by Sponsor|11|||
23133238|NCT05327816|64237362|FG009|Overall Study|Study Terminated by Sponsor|11|||
23214030|NCT02924688|64523499|FG003|Overall Study|Adverse Event|2|||
23214031|NCT02924688|64523500|FG004|Overall Study|Adverse Event|3|||
23214032|NCT02924688|64523501|FG005|Overall Study|Adverse Event|2|||
23214033|NCT02924688|64523496|FG000|Overall Study|Lack of Efficacy|2|||
23214034|NCT02924688|64523497|FG001|Overall Study|Lack of Efficacy|3|||
23214035|NCT02924688|64523498|FG002|Overall Study|Lack of Efficacy|4|||
23427703|NCT00823212|65310555|FG001|Overall Study|Withdrawal by Subject|1|||
23427704|NCT00823212|65310554|FG000|Overall Study|Incarcerated|0|||
23427705|NCT00823212|65310555|FG001|Overall Study|Incarcerated|1|||
23427706|NCT00823212|65310554|FG000|Overall Study|Missed 12-month visit|21|||
23427707|NCT00823212|65310555|FG001|Overall Study|Missed 12-month visit|21|||
23548084|NCT00321854|65739464|FG000|Overall Study|Protocol Violation|6|||
23548085|NCT00321854|65739465|FG001|Overall Study|Protocol Violation|5|||
23548086|NCT00321854|65739464|FG000|Overall Study|Lost to Follow-up|0|||
23548087|NCT00321854|65739465|FG001|Overall Study|Lost to Follow-up|2|||
23214036|NCT02924688|64523499|FG003|Overall Study|Lack of Efficacy|2|||
23214037|NCT02924688|64523500|FG004|Overall Study|Lack of Efficacy|1|||
23214038|NCT02924688|64523501|FG005|Overall Study|Lack of Efficacy|1|||
23214039|NCT02924688|64523496|FG000|Overall Study|Protocol Violation|3|||
23214040|NCT02924688|64523497|FG001|Overall Study|Protocol Violation|7|||
23214041|NCT02924688|64523498|FG002|Overall Study|Protocol Violation|5|||
23214042|NCT02924688|64523499|FG003|Overall Study|Protocol Violation|6|||
23214043|NCT02924688|64523500|FG004|Overall Study|Protocol Violation|2|||
23214044|NCT02924688|64523501|FG005|Overall Study|Protocol Violation|2|||
23214045|NCT02924688|64523496|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
23214046|NCT02924688|64523497|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
23214047|NCT02924688|64523498|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
23214048|NCT02924688|64523499|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
23214049|NCT02924688|64523500|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
23214050|NCT02924688|64523501|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
23214051|NCT02924688|64523496|FG000|Overall Study|Lost to Follow-up|2|||
23214052|NCT02924688|64523497|FG001|Overall Study|Lost to Follow-up|4|||
23214053|NCT02924688|64523498|FG002|Overall Study|Lost to Follow-up|2|||
23214054|NCT02924688|64523499|FG003|Overall Study|Lost to Follow-up|4|||
23214055|NCT02924688|64523500|FG004|Overall Study|Lost to Follow-up|2|||
23214056|NCT02924688|64523501|FG005|Overall Study|Lost to Follow-up|4|||
23214057|NCT02924688|64523496|FG000|Overall Study|Physician Decision|2|||
23214058|NCT02924688|64523497|FG001|Overall Study|Physician Decision|1|||
23214059|NCT02924688|64523498|FG002|Overall Study|Physician Decision|0|||
23214060|NCT02924688|64523499|FG003|Overall Study|Physician Decision|1|||
23214061|NCT02924688|64523500|FG004|Overall Study|Physician Decision|1|||
23214062|NCT02924688|64523501|FG005|Overall Study|Physician Decision|1|||
23214063|NCT02924688|64523496|FG000|Overall Study|Withdrawal by Subject|14|||
23214064|NCT02924688|64523497|FG001|Overall Study|Withdrawal by Subject|13|||
23214065|NCT02924688|64523498|FG002|Overall Study|Withdrawal by Subject|9|||
23214066|NCT02924688|64523499|FG003|Overall Study|Withdrawal by Subject|12|||
23214067|NCT02924688|64523500|FG004|Overall Study|Withdrawal by Subject|13|||
23214068|NCT02924688|64523501|FG005|Overall Study|Withdrawal by Subject|14|||
23214069|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
23214070|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
23214071|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
23214072|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
23317486|NCT02552121|64904094|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23427708|NCT00378599|65310557|FG000|Overall Study|Adverse Event|38|||
23427709|NCT00378599|65310557|FG000|Overall Study|Protocol Violation|2|||
23427710|NCT00378599|65310557|FG000|Overall Study|Treatment failure|7|||
23427711|NCT00378599|65310557|FG000|Overall Study|Withdrawal by Subject|5|||
23427712|NCT03812185|65310558|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
23427713|NCT02456636|65310559|FG000|Overall Study|Death|0|||
23427714|NCT02456636|65310560|FG001|Overall Study|Death|3|||
23427715|NCT02456636|65310561|FG002|Overall Study|Death|0|||
23427716|NCT02456636|65310559|FG000|Overall Study|Pregnancy|1|||
23427717|NCT02456636|65310560|FG001|Overall Study|Pregnancy|3|||
23427718|NCT02456636|65310561|FG002|Overall Study|Pregnancy|5|||
23427719|NCT02456636|65310559|FG000|Overall Study|Physician Decision|4|||
23427720|NCT02456636|65310560|FG001|Overall Study|Physician Decision|5|||
23427721|NCT02456636|65310561|FG002|Overall Study|Physician Decision|4|||
23427722|NCT02456636|65310559|FG000|Overall Study|Withdrawal by Subject|13|||
23427723|NCT02456636|65310560|FG001|Overall Study|Withdrawal by Subject|14|||
23427724|NCT02456636|65310561|FG002|Overall Study|Withdrawal by Subject|16|||
23427725|NCT02456636|65310559|FG000|Overall Study|Lost to Follow-up|50|||
23427726|NCT02456636|65310560|FG001|Overall Study|Lost to Follow-up|44|||
23427727|NCT02456636|65310561|FG002|Overall Study|Lost to Follow-up|50|||
23427728|NCT01146288|65310562|FG000|First Intervention(1 Day)|Adverse Event|0|||
23427729|NCT01146288|65310563|FG001|First Intervention(1 Day)|Adverse Event|1|||
23427730|NCT01754194|65310564|FG000|Overall Study|Lost to Follow-up|39|||
23427731|NCT01754194|65310565|FG001|Overall Study|Lost to Follow-up|14|||
23427732|NCT01754194|65310564|FG000|Overall Study|Withdrawal by Subject|4|||
23427733|NCT01754194|65310565|FG001|Overall Study|Withdrawal by Subject|5|||
23427734|NCT01754194|65310564|FG000|Overall Study|Other|9|||
23427735|NCT01754194|65310565|FG001|Overall Study|Other|8|||
23427736|NCT02449018|65310567|FG000|Overall Study|Abnormal laboratory value|0|||
23427737|NCT02449018|65310568|FG001|Overall Study|Abnormal laboratory value|1|||
23427738|NCT02449018|65310567|FG000|Overall Study|Administrative problems|1|||
23427739|NCT02449018|65310568|FG001|Overall Study|Administrative problems|0|||
23427740|NCT02449018|65310567|FG000|Overall Study|Adverse Event|5|||
23427741|NCT02449018|65310568|FG001|Overall Study|Adverse Event|1|||
23427742|NCT02449018|65310567|FG000|Overall Study|Protocol deviation|4|||
23427743|NCT02449018|65310568|FG001|Overall Study|Protocol deviation|0|||
23427744|NCT02449018|65310567|FG000|Overall Study|Patient decision|2|||
23427745|NCT02449018|65310568|FG001|Overall Study|Patient decision|0|||
23427746|NCT02130986|65310570|FG000|Overall Study|Withdrawal by Subject|4|||
23427747|NCT02130986|65310571|FG001|Overall Study|Withdrawal by Subject|4|||
23427748|NCT02130986|65310570|FG000|Overall Study|Lost to Follow-up|151|||
23427749|NCT02130986|65310571|FG001|Overall Study|Lost to Follow-up|160|||
23427750|NCT00086502|65310572|FG000|Overall Study|Adverse Event|11|||
23427751|NCT00086502|65310573|FG001|Overall Study|Adverse Event|2|||
23427752|NCT00086502|65310572|FG000|Overall Study|Lack of Efficacy|0|||
23427753|NCT00086502|65310573|FG001|Overall Study|Lack of Efficacy|2|||
23427754|NCT00086502|65310572|FG000|Overall Study|Lost to Follow-up|3|||
23427755|NCT00086502|65310573|FG001|Overall Study|Lost to Follow-up|1|||
23427756|NCT00086502|65310572|FG000|Overall Study|Physician Decision|1|||
23427757|NCT00086502|65310573|FG001|Overall Study|Physician Decision|1|||
23427758|NCT00086502|65310572|FG000|Overall Study|Pregnancy|0|||
23427759|NCT00086502|65310573|FG001|Overall Study|Pregnancy|1|||
23427760|NCT00086502|65310572|FG000|Overall Study|Protocol Violation|3|||
23427761|NCT00086502|65310573|FG001|Overall Study|Protocol Violation|3|||
23427762|NCT00086502|65310572|FG000|Overall Study|Withdrawal by Subject|5|||
23427763|NCT00086502|65310573|FG001|Overall Study|Withdrawal by Subject|6|||
23427764|NCT00086502|65310572|FG000|Overall Study|Patient Moved|1|||
23427765|NCT00086502|65310573|FG001|Overall Study|Patient Moved|1|||
23427766|NCT00086502|65310572|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
23427767|NCT00086502|65310573|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
23427768|NCT00086502|65310572|FG000|Overall Study|Patient Accidentally Unblinded|1|||
23427769|NCT00086502|65310573|FG001|Overall Study|Patient Accidentally Unblinded|0|||
23427770|NCT02463032|65310577|FG000|Overall Study|Lack of Efficacy|61|||
23427771|NCT02463032|65310578|FG001|Overall Study|Lack of Efficacy|50|||
23427772|NCT02463032|65310577|FG000|Overall Study|Death|8|||
23427773|NCT02463032|65310578|FG001|Overall Study|Death|8|||
23427774|NCT02463032|65310577|FG000|Overall Study|Adverse Event|2|||
23427775|NCT02463032|65310578|FG001|Overall Study|Adverse Event|6|||
23427776|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
23427777|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
23427778|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
23427779|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
23427780|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
23427781|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
23427782|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
23427783|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
23427784|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
23427785|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
23427786|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
23427787|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
23427788|NCT01632241|65310585|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
23427789|NCT01632241|65310586|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
23427790|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
23427791|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
23427792|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
23427793|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
23427794|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
23427795|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
23427796|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
23427797|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
23427798|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
23427799|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
23427800|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
23427801|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
23427802|NCT01632241|65310585|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
23427803|NCT01632241|65310586|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
23427804|NCT02436408|65310589|FG000|Overall Study|Death|1|||
23427805|NCT02230683|65310593|FG000|Overall Study|Adverse Event|1|||
23427806|NCT00685373|65310594|FG000|Overall Study|Adverse Event|3|||
23427807|NCT00685373|65310594|FG000|Overall Study|Withdrawal by Subject|5|||
23427808|NCT00685373|65310594|FG000|Overall Study|Lack of Efficacy|3|||
23427809|NCT00685373|65310594|FG000|Overall Study|Condition no longer requires study drug|1|||
23427810|NCT00685373|65310594|FG000|Overall Study|Lost to Follow-up|2|||
23427811|NCT00685373|65310594|FG000|Overall Study|Protocol Violation|1|||
23427812|NCT00240110|65310595|FG000|Overall Study|Lost to Follow-up|6|||
23427813|NCT00240110|65310596|FG001|Overall Study|Lost to Follow-up|7|||
23427814|NCT00543296|65310599|FG000|Overall Study|Physician Decision|7|||
23427815|NCT04342689|65310600|FG000|Overall Study|Withdrawal by Subject|32|||
23427816|NCT04342689|65310601|FG001|Overall Study|Withdrawal by Subject|33|||
23427817|NCT04342689|65310600|FG000|Overall Study|Lost to Follow-up|10|||
23427818|NCT04342689|65310601|FG001|Overall Study|Lost to Follow-up|12|||
23427819|NCT02689076|65310605|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
23427820|NCT02689076|65310606|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
23427821|NCT02689076|65310607|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
23427822|NCT02689076|65310605|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
23427823|NCT02689076|65310606|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
23427824|NCT02689076|65310607|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
23427825|NCT02689076|65310605|FG000|Overall Study|Did not have an HIE match|2|||
23427826|NCT02689076|65310606|FG001|Overall Study|Did not have an HIE match|0|||
23427827|NCT02689076|65310607|FG002|Overall Study|Did not have an HIE match|0|||
23427828|NCT02689076|65310605|FG000|Overall Study|Death during non-VA encounter|2|||
23427829|NCT02689076|65310606|FG001|Overall Study|Death during non-VA encounter|5|||
23427830|NCT02689076|65310607|FG002|Overall Study|Death during non-VA encounter|0|||
23427831|NCT02689076|65310605|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
23427832|NCT02689076|65310606|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
23427833|NCT02689076|65310607|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
23427834|NCT02689076|65310605|FG000|Overall Study|Participant no longer active in VA system|1|||
23427835|NCT02689076|65310606|FG001|Overall Study|Participant no longer active in VA system|0|||
23427836|NCT02689076|65310607|FG002|Overall Study|Participant no longer active in VA system|0|||
23427837|NCT02689076|65310605|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
23427838|NCT02689076|65310606|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
23427839|NCT02689076|65310607|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
23427840|NCT02066415|65310608|FG000|Overall Study|Decision by Sponsor|5|||
23427841|NCT02066415|65310609|FG001|Overall Study|Decision by Sponsor|4|||
23427842|NCT02066415|65310610|FG002|Overall Study|Decision by Sponsor|2|||
23427843|NCT02066415|65310608|FG000|Overall Study|Withdrawal by Subject|9|||
23427844|NCT02066415|65310609|FG001|Overall Study|Withdrawal by Subject|1|||
23427845|NCT02066415|65310610|FG002|Overall Study|Withdrawal by Subject|4|||
23427846|NCT02066415|65310608|FG000|Overall Study|Lost to Follow-up|7|||
23214073|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
23427847|NCT02066415|65310609|FG001|Overall Study|Lost to Follow-up|2|||
23427848|NCT02066415|65310610|FG002|Overall Study|Lost to Follow-up|2|||
23427849|NCT02356887|65310611|FG000|Overall Study|poor compliance|2|||
23427850|NCT01635764|65310612|FG000|Overall Study|Adverse Event|46|||
23427851|NCT01635764|65310612|FG000|Overall Study|Lack of Efficacy|76|||
23427852|NCT01635764|65310612|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
23427853|NCT01635764|65310612|FG000|Overall Study|Protocol Deviation|1|||
23427854|NCT01635764|65310612|FG000|Overall Study|Withdrew Consent|67|||
23548088|NCT00321854|65739464|FG000|Overall Study|Withdrawal by Subject|6|||
23619672|NCT01772147|65994706|FG000|Overall Study|Lack of Efficacy|8|||
23427855|NCT01635764|65310612|FG000|Overall Study|Lost to Follow-up|53|||
23427856|NCT01635764|65310612|FG000|Overall Study|Other|28|||
23427857|NCT01416441|65310613|FG000|Overall Study|Lost to Follow-up|5|||
23427858|NCT01416441|65310613|FG000|Overall Study|Adverse Event|6|||
23427859|NCT01416441|65310613|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
23427860|NCT01416441|65310613|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
23427861|NCT01416441|65310613|FG000|Overall Study|Investigator Withdrew Subject|2|||
23427862|NCT01416441|65310613|FG000|Overall Study|Subject Withdrew Consent|12|||
23427863|NCT01416441|65310613|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
23427864|NCT00186537|65310615|FG000|Overall Study|Withdrawal by Subject|4|||
23427865|NCT00186537|65310616|FG001|Overall Study|Withdrawal by Subject|0|||
23427866|NCT00186537|65310617|FG002|Overall Study|Withdrawal by Subject|3|||
23427867|NCT00186537|65310615|FG000|Overall Study|ALT > 1.5 x ULN|3|||
23427868|NCT00186537|65310616|FG001|Overall Study|ALT > 1.5 x ULN|0|||
23427869|NCT00186537|65310617|FG002|Overall Study|ALT > 1.5 x ULN|0|||
23427870|NCT01145053|65310618|FG000|Overall Study|Adverse Event|22|||
23427871|NCT01145053|65310618|FG000|Overall Study|Lost to Follow-up|28|||
23427872|NCT01145053|65310618|FG000|Overall Study|Withdrawal by Subject|25|||
23427873|NCT01145053|65310618|FG000|Overall Study|Other|18|||
23427874|NCT04032080|65310623|FG000|Overall Study|Death|6|||
23427875|NCT02576860|65310624|FG000|Overall Study|Adverse Event|6|||
23427876|NCT02576860|65310625|FG001|Overall Study|Adverse Event|6|||
23427877|NCT02576860|65310624|FG000|Overall Study|Lost to Follow-up|5|||
23427878|NCT02576860|65310625|FG001|Overall Study|Lost to Follow-up|7|||
23427879|NCT02576860|65310624|FG000|Overall Study|Physician Decision|0|||
23427880|NCT02576860|65310625|FG001|Overall Study|Physician Decision|1|||
23427881|NCT02576860|65310624|FG000|Overall Study|Protocol Violation|0|||
23427882|NCT02576860|65310625|FG001|Overall Study|Protocol Violation|2|||
23427883|NCT02576860|65310624|FG000|Overall Study|Withdrawal by Subject|13|||
23427884|NCT02576860|65310625|FG001|Overall Study|Withdrawal by Subject|8|||
23427885|NCT02576860|65310624|FG000|Overall Study|Disallowed medication|1|||
23427886|NCT02576860|65310625|FG001|Overall Study|Disallowed medication|0|||
23427887|NCT03724981|65310628|FG000|First Device|Protocol Violation|1|||
23427888|NCT03724981|65310629|FG001|First Device|Protocol Violation|1|||
23427889|NCT00316888|65310630|FG000|Overall Study|Adverse Event|4|||
23427890|NCT00316888|65310631|FG001|Overall Study|Adverse Event|5|||
23214074|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
23214075|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Death|1|||
23214076|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Death|3|||
23214077|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
23427891|NCT00316888|65310630|FG000|Overall Study|Withdrawal by Subject|2|||
23427892|NCT00316888|65310631|FG001|Overall Study|Withdrawal by Subject|2|||
23427893|NCT00316888|65310630|FG000|Overall Study|Not start protocol therapy|0|||
23427894|NCT00316888|65310631|FG001|Overall Study|Not start protocol therapy|1|||
23214078|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
23214079|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
23214080|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
23214081|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
23214082|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
23214083|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
23548089|NCT00321854|65739465|FG001|Overall Study|Withdrawal by Subject|17|||
23548090|NCT00321854|65739464|FG000|Overall Study|Other|1|||
23548091|NCT00321854|65739465|FG001|Overall Study|Other|1|||
23214084|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
23427895|NCT01459913|65310634|FG000|Overall Study|Adverse Event|0|||
23427896|NCT01459913|65310635|FG001|Overall Study|Adverse Event|0|||
23427897|NCT01459913|65310636|FG002|Overall Study|Adverse Event|0|||
23427898|NCT01459913|65310637|FG003|Overall Study|Adverse Event|3|||
23427899|NCT01459913|65310634|FG000|Overall Study|Withdrawal by Subject|4|||
23214085|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
23214086|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
23214087|NCT02553317|64523502|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
23214088|NCT02553317|64523503|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
23427900|NCT01459913|65310635|FG001|Overall Study|Withdrawal by Subject|0|||
23427901|NCT01459913|65310636|FG002|Overall Study|Withdrawal by Subject|0|||
23427902|NCT01459913|65310637|FG003|Overall Study|Withdrawal by Subject|5|||
23427903|NCT01459913|65310634|FG000|Overall Study|Lost to Follow-up|7|||
23427904|NCT01459913|65310635|FG001|Overall Study|Lost to Follow-up|4|||
23427905|NCT01459913|65310636|FG002|Overall Study|Lost to Follow-up|1|||
23427906|NCT01459913|65310637|FG003|Overall Study|Lost to Follow-up|8|||
23427907|NCT01459913|65310634|FG000|Overall Study|Death|0|||
23427908|NCT01459913|65310635|FG001|Overall Study|Death|0|||
23427909|NCT01459913|65310636|FG002|Overall Study|Death|0|||
23427910|NCT01459913|65310637|FG003|Overall Study|Death|1|||
23427911|NCT01459913|65310634|FG000|Overall Study|Non- Compliance|0|||
23427912|NCT01459913|65310635|FG001|Overall Study|Non- Compliance|0|||
23427913|NCT01459913|65310636|FG002|Overall Study|Non- Compliance|0|||
23427914|NCT01459913|65310637|FG003|Overall Study|Non- Compliance|3|||
23427915|NCT01459913|65310634|FG000|Overall Study|Physician Decision|0|||
23427916|NCT01459913|65310635|FG001|Overall Study|Physician Decision|1|||
23427917|NCT01459913|65310636|FG002|Overall Study|Physician Decision|0|||
23427918|NCT01459913|65310637|FG003|Overall Study|Physician Decision|0|||
23427919|NCT01459913|65310634|FG000|Overall Study|Study Terminated by Sponsor|30|||
23427920|NCT01459913|65310635|FG001|Overall Study|Study Terminated by Sponsor|15|||
23427921|NCT01459913|65310636|FG002|Overall Study|Study Terminated by Sponsor|9|||
23133239|NCT05327816|64237363|FG010|Overall Study|Study Terminated by Sponsor|12|||
23133240|NCT05327816|64237353|FG000|Overall Study|Randomized but not treated|0|||
23133241|NCT05327816|64237354|FG001|Overall Study|Randomized but not treated|0|||
23133242|NCT05327816|64237355|FG002|Overall Study|Randomized but not treated|0|||
23133243|NCT05327816|64237356|FG003|Overall Study|Randomized but not treated|0|||
23133244|NCT05327816|64237357|FG004|Overall Study|Randomized but not treated|0|||
23133245|NCT05327816|64237358|FG005|Overall Study|Randomized but not treated|0|||
23133246|NCT05327816|64237359|FG006|Overall Study|Randomized but not treated|1|||
23133247|NCT05327816|64237360|FG007|Overall Study|Randomized but not treated|1|||
23133248|NCT05327816|64237361|FG008|Overall Study|Randomized but not treated|1|||
23133249|NCT05327816|64237362|FG009|Overall Study|Randomized but not treated|0|||
23133250|NCT05327816|64237363|FG010|Overall Study|Randomized but not treated|0|||
23133251|NCT03139604|64237364|FG000|Overall Study|Other|7|||
23133252|NCT03139604|64237365|FG001|Overall Study|Other|3|||
23133253|NCT03139604|64237364|FG000|Overall Study|Withdrawal by Subject|16|||
23133254|NCT03139604|64237365|FG001|Overall Study|Withdrawal by Subject|17|||
23133255|NCT03139604|64237364|FG000|Overall Study|Physician Decision|1|||
23133256|NCT03139604|64237365|FG001|Overall Study|Physician Decision|2|||
23133257|NCT03139604|64237364|FG000|Overall Study|Lost to Follow-up|3|||
23133258|NCT03139604|64237365|FG001|Overall Study|Lost to Follow-up|1|||
23427922|NCT01459913|65310637|FG003|Overall Study|Study Terminated by Sponsor|11|||
23427923|NCT01459913|65310634|FG000|Overall Study|Other|0|||
23214089|NCT01610206|64523505|FG000|Overall Study|Adverse Event|10|||
23214090|NCT01610206|64523506|FG001|Overall Study|Adverse Event|30|||
23427924|NCT01459913|65310635|FG001|Overall Study|Other|0|||
23427925|NCT01459913|65310636|FG002|Overall Study|Other|3|||
23427926|NCT01459913|65310637|FG003|Overall Study|Other|1|||
23427927|NCT01459913|65310634|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
23427928|NCT01459913|65310635|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
23427929|NCT01459913|65310636|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
23427930|NCT01459913|65310637|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
23427931|NCT02927262|65310638|FG000|Overall Study|Adverse Event|7|||
23427932|NCT02927262|65310639|FG001|Overall Study|Adverse Event|1|||
23427933|NCT02927262|65310638|FG000|Overall Study|Death|1|||
23133259|NCT03139604|64237364|FG000|Overall Study|Death|65|||
23133260|NCT03139604|64237365|FG001|Overall Study|Death|67|||
23133261|NCT03139604|64237364|FG000|Overall Study|Study Terminated by Sponsor|122|||
23214091|NCT02224638|64523507|FG000|Overall Study|Adverse Event|1|||
23427934|NCT02927262|65310639|FG001|Overall Study|Death|0|||
23427935|NCT02927262|65310638|FG000|Overall Study|Withdrawal by Subject|3|||
23427936|NCT02927262|65310639|FG001|Overall Study|Withdrawal by Subject|0|||
23427937|NCT02927262|65310638|FG000|Overall Study|Disease Relapse|23|||
23427938|NCT02927262|65310639|FG001|Overall Study|Disease Relapse|18|||
23427939|NCT02927262|65310638|FG000|Overall Study|Miscellaneous|5|||
23427940|NCT02927262|65310639|FG001|Overall Study|Miscellaneous|4|||
23548092|NCT05224050|65739466|FG000|Overall Study|Withdrawal by Subject|9|||
23548093|NCT05224050|65739466|FG000|Overall Study|Lost to Follow-up|3|||
23548094|NCT03301051|65739467|FG000|Overall Study|Adverse Event|0|||
23548095|NCT03301051|65739468|FG001|Overall Study|Adverse Event|4|||
23548096|NCT03301051|65739467|FG000|Overall Study|Withdrawal by Subject|59|||
23548097|NCT03301051|65739468|FG001|Overall Study|Withdrawal by Subject|65|||
23548098|NCT03301051|65739467|FG000|Overall Study|Lost to Follow-up|263|||
23548099|NCT03301051|65739468|FG001|Overall Study|Lost to Follow-up|282|||
23133262|NCT03139604|64237365|FG001|Overall Study|Study Terminated by Sponsor|127|||
23133263|NCT03139604|64237364|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
23427941|NCT02927262|65310638|FG000|Overall Study|Ongoing|4|||
23427942|NCT02927262|65310639|FG001|Overall Study|Ongoing|0|||
23427943|NCT02250664|65310640|FG000|Overall Study|Lost to Follow-up|18|||
23427944|NCT02250664|65310641|FG001|Overall Study|Lost to Follow-up|28|||
23133264|NCT03139604|64237365|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
23133265|NCT00350103|64237366|FG000|Overall Study|Adverse Event|12|||
23214092|NCT02224638|64523508|FG001|Overall Study|Adverse Event|1|||
23427945|NCT02250664|65310642|FG002|Overall Study|Lost to Follow-up|33|||
23427946|NCT02250664|65310640|FG000|Overall Study|Personal Reasons|7|||
23427947|NCT02250664|65310641|FG001|Overall Study|Personal Reasons|8|||
23427948|NCT02250664|65310642|FG002|Overall Study|Personal Reasons|14|||
23427949|NCT02250664|65310640|FG000|Overall Study|Adverse Event|6|||
23548100|NCT03301051|65739467|FG000|Overall Study|Protocol Violation|1|||
23427950|NCT02250664|65310641|FG001|Overall Study|Adverse Event|3|||
23427951|NCT02250664|65310642|FG002|Overall Study|Adverse Event|8|||
23427952|NCT02250664|65310640|FG000|Overall Study|Incarcerated|2|||
23427953|NCT02250664|65310641|FG001|Overall Study|Incarcerated|1|||
23427954|NCT02250664|65310642|FG002|Overall Study|Incarcerated|2|||
23427955|NCT02250664|65310640|FG000|Overall Study|Withdrawal by Subject|0|||
23427956|NCT02250664|65310641|FG001|Overall Study|Withdrawal by Subject|1|||
23427957|NCT02250664|65310642|FG002|Overall Study|Withdrawal by Subject|2|||
23427958|NCT02250664|65310640|FG000|Overall Study|Death|0|||
23427959|NCT02250664|65310641|FG001|Overall Study|Death|1|||
23427960|NCT02250664|65310642|FG002|Overall Study|Death|1|||
23427961|NCT02250664|65310640|FG000|Overall Study|Physician Decision|1|||
23427962|NCT02250664|65310641|FG001|Overall Study|Physician Decision|3|||
23427963|NCT02250664|65310642|FG002|Overall Study|Physician Decision|1|||
23427964|NCT02250664|65310640|FG000|Overall Study|Protocol Violation|1|||
23427965|NCT02250664|65310641|FG001|Overall Study|Protocol Violation|0|||
23427966|NCT02250664|65310642|FG002|Overall Study|Protocol Violation|1|||
23548101|NCT03301051|65739468|FG001|Overall Study|Protocol Violation|3|||
23548102|NCT03301051|65739467|FG000|Overall Study|Physician Decision|1|||
23548103|NCT03301051|65739468|FG001|Overall Study|Physician Decision|3|||
23548104|NCT03301051|65739467|FG000|Overall Study|Death|1|||
23548105|NCT03301051|65739468|FG001|Overall Study|Death|1|||
23548106|NCT03301051|65739467|FG000|Overall Study|Miscellaneous|8|||
23133266|NCT00350103|64237367|FG001|Overall Study|Adverse Event|29|||
23133267|NCT00350103|64237368|FG002|Overall Study|Adverse Event|17|||
23133268|NCT00350103|64237366|FG000|Overall Study|Lack of Efficacy|5|||
23133269|NCT00350103|64237367|FG001|Overall Study|Lack of Efficacy|1|||
23133270|NCT00350103|64237368|FG002|Overall Study|Lack of Efficacy|3|||
23214093|NCT02810951|64523509|FG000|Overall Study|Adverse Event|1|||
23214094|NCT00879437|64523510|FG000|Overall Study|Protocol Violation|0|||
23427967|NCT02250664|65310640|FG000|Overall Study|Reason unknown|1|||
23427968|NCT02250664|65310641|FG001|Overall Study|Reason unknown|0|||
23133271|NCT00350103|64237366|FG000|Overall Study|Withdrawal by Subject|6|||
23133272|NCT00350103|64237367|FG001|Overall Study|Withdrawal by Subject|6|||
23133273|NCT00350103|64237368|FG002|Overall Study|Withdrawal by Subject|8|||
23133274|NCT00350103|64237366|FG000|Overall Study|Protocol Violation|0|||
23133275|NCT00350103|64237367|FG001|Overall Study|Protocol Violation|0|||
23133276|NCT00350103|64237368|FG002|Overall Study|Protocol Violation|1|||
23133277|NCT00350103|64237366|FG000|Overall Study|Unsatisfactory Compliance|2|||
23133278|NCT00350103|64237367|FG001|Overall Study|Unsatisfactory Compliance|2|||
23133279|NCT00350103|64237368|FG002|Overall Study|Unsatisfactory Compliance|1|||
23133280|NCT00350103|64237366|FG000|Overall Study|Investigator´s decision|1|||
23133281|NCT00350103|64237367|FG001|Overall Study|Investigator´s decision|1|||
23133282|NCT00350103|64237368|FG002|Overall Study|Investigator´s decision|0|||
23133283|NCT00350103|64237366|FG000|Overall Study|Exclusion criteria met|0|||
23133284|NCT00350103|64237367|FG001|Overall Study|Exclusion criteria met|0|||
23133285|NCT00350103|64237368|FG002|Overall Study|Exclusion criteria met|1|||
23133286|NCT00350103|64237366|FG000|Overall Study|Patient relocated|0|||
23133287|NCT00350103|64237367|FG001|Overall Study|Patient relocated|0|||
23133288|NCT00350103|64237368|FG002|Overall Study|Patient relocated|1|||
23133289|NCT00350103|64237366|FG000|Overall Study|Need for prohibited medication|1|||
23133290|NCT00350103|64237367|FG001|Overall Study|Need for prohibited medication|0|||
23133291|NCT00350103|64237368|FG002|Overall Study|Need for prohibited medication|0|||
23133292|NCT00350103|64237366|FG000|Overall Study|Personal reasons|0|||
23133293|NCT00350103|64237367|FG001|Overall Study|Personal reasons|0|||
23133294|NCT00350103|64237368|FG002|Overall Study|Personal reasons|1|||
23133295|NCT00350103|64237366|FG000|Overall Study|Patient stopped feeling pain|1|||
23133296|NCT00350103|64237367|FG001|Overall Study|Patient stopped feeling pain|0|||
23133297|NCT00350103|64237368|FG002|Overall Study|Patient stopped feeling pain|0|||
23133298|NCT00350103|64237366|FG000|Overall Study|PR greater than 250ms|0|||
23427969|NCT02250664|65310642|FG002|Overall Study|Reason unknown|0|||
23548107|NCT03301051|65739468|FG001|Overall Study|Miscellaneous|4|||
23548108|NCT03301051|65739467|FG000|Overall Study|Randomized, not vaccinated|13|||
23548109|NCT03301051|65739468|FG001|Overall Study|Randomized, not vaccinated|10|||
23548110|NCT03147248|65739471|FG000|Overall Study|Adverse Event|0|||
23548111|NCT03147248|65739472|FG001|Overall Study|Adverse Event|2|||
23133299|NCT00350103|64237367|FG001|Overall Study|PR greater than 250ms|0|||
23427970|NCT02982018|65310644|FG000|Overall Study|Incorrect Lens Dispensed|1|||
23427971|NCT02982018|65310645|FG001|Overall Study|Incorrect Lens Dispensed|0|||
23548112|NCT03147248|65739473|FG002|Overall Study|Adverse Event|2|||
23548113|NCT03147248|65739474|FG003|Overall Study|Adverse Event|2|||
23548114|NCT03147248|65739475|FG004|Overall Study|Adverse Event|6|||
23548115|NCT03147248|65739476|FG005|Overall Study|Adverse Event|11|||
23133300|NCT00350103|64237368|FG002|Overall Study|PR greater than 250ms|1|||
23133301|NCT00350103|64237366|FG000|Overall Study|Wrong calculation of QT interval|0|||
23133302|NCT00350103|64237367|FG001|Overall Study|Wrong calculation of QT interval|0|||
23133303|NCT00350103|64237368|FG002|Overall Study|Wrong calculation of QT interval|1|||
23427972|NCT02982018|65310644|FG000|Overall Study|Protocol Violation|1|||
23427973|NCT02982018|65310645|FG001|Overall Study|Protocol Violation|1|||
23427974|NCT02982018|65310644|FG000|Overall Study|Adverse Event|1|||
23427975|NCT02982018|65310645|FG001|Overall Study|Adverse Event|1|||
23427976|NCT02982018|65310644|FG000|Overall Study|Lens Discomfort|2|||
23427977|NCT02982018|65310645|FG001|Overall Study|Lens Discomfort|0|||
23427978|NCT02982018|65310644|FG000|Overall Study|Withdrawal by Subject|0|||
23427979|NCT02982018|65310645|FG001|Overall Study|Withdrawal by Subject|1|||
23427980|NCT03987932|65310646|FG000|Overall Study|Lost to Follow-up|2|||
23427981|NCT03987932|65310647|FG001|Overall Study|Lost to Follow-up|1|||
23427982|NCT03987932|65310648|FG002|Overall Study|Lost to Follow-up|1|||
23427983|NCT03987932|65310646|FG000|Overall Study|Non-study related elective surgery|0|||
23427984|NCT03987932|65310647|FG001|Overall Study|Non-study related elective surgery|0|||
23427985|NCT03987932|65310648|FG002|Overall Study|Non-study related elective surgery|1|||
23427986|NCT02226198|65310649|FG000|Lead-in Phase|Protocol Violation|1|||
23427987|NCT02226198|65310650|FG001|Lead-in Phase|Protocol Violation|0|||
23427988|NCT02226198|65310651|FG002|Lead-in Phase|Protocol Violation|0|||
23427989|NCT02226198|65310649|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
23427990|NCT02226198|65310650|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
23427991|NCT02226198|65310651|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
23427992|NCT01636713|65310652|FG000|Overall Study|Adverse Event|16|||
23427993|NCT01636713|65310653|FG001|Overall Study|Adverse Event|16|||
23427994|NCT01636713|65310654|FG002|Overall Study|Adverse Event|7|||
23427995|NCT01636713|65310652|FG000|Overall Study|Lack of Efficacy|6|||
23427996|NCT01636713|65310653|FG001|Overall Study|Lack of Efficacy|6|||
23427997|NCT01636713|65310654|FG002|Overall Study|Lack of Efficacy|2|||
23427998|NCT01636713|65310652|FG000|Overall Study|Protocol Violation|3|||
23427999|NCT01636713|65310653|FG001|Overall Study|Protocol Violation|0|||
23428000|NCT01636713|65310654|FG002|Overall Study|Protocol Violation|1|||
23428001|NCT01636713|65310652|FG000|Overall Study|Lost to Follow-up|0|||
23428002|NCT01636713|65310653|FG001|Overall Study|Lost to Follow-up|0|||
23428003|NCT01636713|65310654|FG002|Overall Study|Lost to Follow-up|1|||
23428004|NCT01636713|65310652|FG000|Overall Study|Withdrawal by Subject|5|||
23428005|NCT01636713|65310653|FG001|Overall Study|Withdrawal by Subject|4|||
23428006|NCT01636713|65310654|FG002|Overall Study|Withdrawal by Subject|8|||
23428007|NCT01636713|65310652|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
23428008|NCT01636713|65310653|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
23428009|NCT01636713|65310654|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
23428010|NCT01945775|65310655|FG000|Overall Study|Death|214|||
23428011|NCT01945775|65310656|FG001|Overall Study|Death|98|||
23428012|NCT01945775|65310655|FG000|Overall Study|Lost to Follow-up|12|||
23428013|NCT01945775|65310656|FG001|Overall Study|Lost to Follow-up|7|||
23428014|NCT01945775|65310655|FG000|Overall Study|Withdrawal by Subject|11|||
23428015|NCT01945775|65310656|FG001|Overall Study|Withdrawal by Subject|21|||
23428016|NCT01945775|65310655|FG000|Overall Study|Other|50|||
23428017|NCT01945775|65310656|FG001|Overall Study|Other|18|||
23428018|NCT02989805|65310659|FG000|Overall Study|invalid consent|6|||
23428019|NCT02989805|65310660|FG001|Overall Study|invalid consent|4|||
23428020|NCT00700102|65310661|FG000|Overall Study|Died|394|||
23428021|NCT00700102|65310662|FG001|Overall Study|Died|385|||
23428022|NCT00700102|65310661|FG000|Overall Study|Lost to Follow-up|8|||
23428023|NCT00700102|65310662|FG001|Overall Study|Lost to Follow-up|10|||
23548116|NCT03147248|65739471|FG000|Overall Study|Disease progression|1|||
23548117|NCT03147248|65739472|FG001|Overall Study|Disease progression|0|||
23133304|NCT00350103|64237366|FG000|Overall Study|Sponsor mistake|1|||
23133305|NCT00350103|64237367|FG001|Overall Study|Sponsor mistake|0|||
23133306|NCT00350103|64237368|FG002|Overall Study|Sponsor mistake|0|||
23133307|NCT00350103|64237366|FG000|Overall Study|Randomization mistake|0|||
23133308|NCT00350103|64237367|FG001|Overall Study|Randomization mistake|1|||
23133309|NCT00350103|64237368|FG002|Overall Study|Randomization mistake|1|||
23133310|NCT00350103|64237366|FG000|Overall Study|Sponsor´s decision|0|||
23133311|NCT00350103|64237367|FG001|Overall Study|Sponsor´s decision|1|||
23133312|NCT00350103|64237368|FG002|Overall Study|Sponsor´s decision|0|||
23133313|NCT00350103|64237366|FG000|Overall Study|Lost, Reason unknown|1|||
23133314|NCT00350103|64237367|FG001|Overall Study|Lost, Reason unknown|1|||
23317487|NCT02552121|64904095|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
23317488|NCT02552121|64904096|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23428024|NCT00385723|65310663|FG000|Overall Study|Lost to Follow-up|1|||
23428025|NCT00385723|65310664|FG001|Overall Study|Lost to Follow-up|1|||
23428026|NCT00385723|65310665|FG002|Overall Study|Lost to Follow-up|0|||
23428027|NCT00385723|65310663|FG000|Overall Study|Withdrawal by Subject|1|||
23548118|NCT03147248|65739473|FG002|Overall Study|Disease progression|0|||
23133315|NCT00350103|64237368|FG002|Overall Study|Lost, Reason unknown|0|||
23133316|NCT00992225|64237369|FG000|Overall Study|Entry Criteria Not Met|8|||
23428028|NCT00385723|65310664|FG001|Overall Study|Withdrawal by Subject|0|||
23428029|NCT00385723|65310665|FG002|Overall Study|Withdrawal by Subject|2|||
23428030|NCT00364533|65310671|FG000|Overall Study|Adverse Event|8|||
23428031|NCT00364533|65310672|FG001|Overall Study|Adverse Event|7|||
23214095|NCT00879437|64523511|FG001|Overall Study|Protocol Violation|1|||
23214096|NCT00879437|64523510|FG000|Overall Study|Death|1|||
23214097|NCT00879437|64523511|FG001|Overall Study|Death|0|||
23214098|NCT01103778|64523513|FG000|Overall Study|Lost to Follow-up|1|||
23214099|NCT01103778|64523513|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
23214100|NCT01103778|64523513|FG000|Overall Study|Screen failure|1|||
23214101|NCT03365947|64523514|FG000|Overall Study|Lost to Follow-up|0|||
23214102|NCT03365947|64523515|FG001|Overall Study|Lost to Follow-up|0|||
23214103|NCT03365947|64523516|FG002|Overall Study|Lost to Follow-up|0|||
23214104|NCT03365947|64523517|FG003|Overall Study|Lost to Follow-up|0|||
23214105|NCT03365947|64523518|FG004|Overall Study|Lost to Follow-up|0|||
23214106|NCT03365947|64523519|FG005|Overall Study|Lost to Follow-up|1|||
23214107|NCT03365947|64523520|FG006|Overall Study|Lost to Follow-up|0|||
23214108|NCT03365947|64523521|FG007|Overall Study|Lost to Follow-up|0|||
23214109|NCT03365947|64523522|FG008|Overall Study|Lost to Follow-up|0|||
23214110|NCT03365947|64523523|FG009|Overall Study|Lost to Follow-up|0|||
23214111|NCT03365947|64523524|FG010|Overall Study|Lost to Follow-up|0|||
23214112|NCT03365947|64523525|FG011|Overall Study|Lost to Follow-up|0|||
23214113|NCT03365947|64523526|FG012|Overall Study|Lost to Follow-up|0|||
23214114|NCT03365947|64523527|FG013|Overall Study|Lost to Follow-up|0|||
23214115|NCT03365947|64523528|FG014|Overall Study|Lost to Follow-up|0|||
23214116|NCT03365947|64523529|FG015|Overall Study|Lost to Follow-up|0|||
23214117|NCT03365947|64523530|FG016|Overall Study|Lost to Follow-up|0|||
23214118|NCT03365947|64523531|FG017|Overall Study|Lost to Follow-up|0|||
23214119|NCT03365947|64523532|FG018|Overall Study|Lost to Follow-up|0|||
23214120|NCT02146833|64523533|FG000|Overall Study|Death|10|||
23428032|NCT00364533|65310673|FG002|Overall Study|Adverse Event|15|||
23548119|NCT03147248|65739474|FG003|Overall Study|Disease progression|0|||
23133317|NCT00992225|64237369|FG000|Overall Study|Adverse Event|2|||
23133318|NCT02285153|64237370|FG000|Overall Study|Adverse Event|1|||
23133319|NCT02285153|64237371|FG001|Overall Study|Adverse Event|0|||
23133320|NCT01011153|64237377|FG000|Overall Study|Less than 78 cases completed|8|||
23133321|NCT01011153|64237378|FG001|Overall Study|Less than 78 cases completed|11|||
23133322|NCT01011153|64237379|FG002|Overall Study|Less than 78 cases completed|9|||
23133323|NCT04655027|64237381|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
23133324|NCT04655027|64237382|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
23548120|NCT03147248|65739475|FG004|Overall Study|Disease progression|0|||
23548121|NCT03147248|65739476|FG005|Overall Study|Disease progression|2|||
23548122|NCT03147248|65739471|FG000|Overall Study|Withdrawal by Subject|0|||
23548123|NCT03147248|65739472|FG001|Overall Study|Withdrawal by Subject|0|||
23548124|NCT03147248|65739473|FG002|Overall Study|Withdrawal by Subject|0|||
23548125|NCT03147248|65739474|FG003|Overall Study|Withdrawal by Subject|0|||
23548126|NCT03147248|65739475|FG004|Overall Study|Withdrawal by Subject|12|||
23548127|NCT03147248|65739476|FG005|Overall Study|Withdrawal by Subject|9|||
23548128|NCT03147248|65739471|FG000|Overall Study|Protocol Violation|0|||
23548129|NCT03147248|65739472|FG001|Overall Study|Protocol Violation|0|||
23548130|NCT03147248|65739473|FG002|Overall Study|Protocol Violation|0|||
23548131|NCT03147248|65739474|FG003|Overall Study|Protocol Violation|0|||
23548132|NCT03147248|65739475|FG004|Overall Study|Protocol Violation|2|||
23548133|NCT03147248|65739476|FG005|Overall Study|Protocol Violation|0|||
23548134|NCT03147248|65739471|FG000|Overall Study|Lost to Follow-up|0|||
23548135|NCT03147248|65739472|FG001|Overall Study|Lost to Follow-up|0|||
23548136|NCT03147248|65739473|FG002|Overall Study|Lost to Follow-up|0|||
23548137|NCT03147248|65739474|FG003|Overall Study|Lost to Follow-up|0|||
23548138|NCT03147248|65739475|FG004|Overall Study|Lost to Follow-up|2|||
23548139|NCT03147248|65739476|FG005|Overall Study|Lost to Follow-up|0|||
23548140|NCT03147248|65739471|FG000|Overall Study|Pregnancy|0|||
23548141|NCT03147248|65739472|FG001|Overall Study|Pregnancy|0|||
23548142|NCT03147248|65739473|FG002|Overall Study|Pregnancy|0|||
23548143|NCT03147248|65739474|FG003|Overall Study|Pregnancy|0|||
23548144|NCT03147248|65739475|FG004|Overall Study|Pregnancy|1|||
23548145|NCT03147248|65739476|FG005|Overall Study|Pregnancy|0|||
23548146|NCT03147248|65739471|FG000|Overall Study|Death|0|||
23548147|NCT03147248|65739472|FG001|Overall Study|Death|0|||
23548148|NCT03147248|65739473|FG002|Overall Study|Death|0|||
23548149|NCT03147248|65739474|FG003|Overall Study|Death|0|||
23133325|NCT02672852|64237383|FG000|Part A1|Disease Worsening|1|||
23214121|NCT02146833|64523533|FG000|Overall Study|No longer consented to study treatment|1|||
23214122|NCT02151682|64523534|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23428033|NCT00364533|65310674|FG003|Overall Study|Adverse Event|5|||
23214123|NCT02151682|64523535|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
23214124|NCT02151682|64523536|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23214125|NCT02151682|64523537|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23548150|NCT03147248|65739475|FG004|Overall Study|Death|0|||
23548151|NCT03147248|65739476|FG005|Overall Study|Death|4|||
23548152|NCT03147248|65739471|FG000|Overall Study|Physician Decision|0|||
23548153|NCT03147248|65739472|FG001|Overall Study|Physician Decision|0|||
23548154|NCT03147248|65739473|FG002|Overall Study|Physician Decision|0|||
23548155|NCT03147248|65739474|FG003|Overall Study|Physician Decision|0|||
23133326|NCT02672852|64237384|FG001|Part A1|Disease Worsening|0|||
23133327|NCT02672852|64237385|FG002|Part A1|Disease Worsening|0|||
23133328|NCT02672852|64237386|FG003|Part A1|Disease Worsening|0|||
23133329|NCT02672852|64237387|FG004|Part A1|Disease Worsening|0|||
23133330|NCT02672852|64237388|FG005|Part A1|Disease Worsening|0|||
23133331|NCT02672852|64237389|FG006|Part A1|Disease Worsening|0|||
23133332|NCT02672852|64237383|FG000|Part A1|Adverse Event|0|||
23133333|NCT02672852|64237384|FG001|Part A1|Adverse Event|1|||
23133334|NCT02672852|64237385|FG002|Part A1|Adverse Event|0|||
23133335|NCT02672852|64237386|FG003|Part A1|Adverse Event|0|||
23133336|NCT02672852|64237387|FG004|Part A1|Adverse Event|0|||
23133337|NCT02672852|64237388|FG005|Part A1|Adverse Event|0|||
23133338|NCT02672852|64237389|FG006|Part A1|Adverse Event|0|||
23133339|NCT02672852|64237383|FG000|Part A1|Lost to Follow-up|1|||
23133340|NCT02672852|64237384|FG001|Part A1|Lost to Follow-up|2|||
23133341|NCT02672852|64237385|FG002|Part A1|Lost to Follow-up|0|||
23133342|NCT02672852|64237386|FG003|Part A1|Lost to Follow-up|0|||
23133343|NCT02672852|64237387|FG004|Part A1|Lost to Follow-up|0|||
23133344|NCT02672852|64237388|FG005|Part A1|Lost to Follow-up|0|||
23133345|NCT02672852|64237389|FG006|Part A1|Lost to Follow-up|0|||
23133346|NCT02672852|64237383|FG000|Part A1|Withdrawal by Subject|1|||
23133347|NCT02672852|64237384|FG001|Part A1|Withdrawal by Subject|1|||
23133348|NCT02672852|64237385|FG002|Part A1|Withdrawal by Subject|0|||
23133349|NCT02672852|64237386|FG003|Part A1|Withdrawal by Subject|0|||
23133350|NCT02672852|64237387|FG004|Part A1|Withdrawal by Subject|0|||
23133351|NCT02672852|64237388|FG005|Part A1|Withdrawal by Subject|0|||
23133352|NCT02672852|64237389|FG006|Part A1|Withdrawal by Subject|0|||
23133353|NCT02672852|64237383|FG000|Part A2|Disease worsening|0|||
23133354|NCT02672852|64237384|FG001|Part A2|Disease worsening|0|||
23133355|NCT02672852|64237385|FG002|Part A2|Disease worsening|1|||
23133356|NCT02672852|64237386|FG003|Part A2|Disease worsening|0|||
23133357|NCT02672852|64237387|FG004|Part A2|Disease worsening|0|||
23133358|NCT02672852|64237388|FG005|Part A2|Disease worsening|0|||
23133359|NCT02672852|64237389|FG006|Part A2|Disease worsening|0|||
23133360|NCT02672852|64237383|FG000|Part A2|Adverse Event|0|||
23133361|NCT02672852|64237384|FG001|Part A2|Adverse Event|0|||
23133362|NCT02672852|64237385|FG002|Part A2|Adverse Event|3|||
23133363|NCT02672852|64237386|FG003|Part A2|Adverse Event|0|||
23133364|NCT02672852|64237387|FG004|Part A2|Adverse Event|0|||
23133365|NCT02672852|64237388|FG005|Part A2|Adverse Event|0|||
23133366|NCT02672852|64237389|FG006|Part A2|Adverse Event|0|||
23133367|NCT02672852|64237383|FG000|Part A2|Lost to Follow-up|0|||
23133368|NCT02672852|64237384|FG001|Part A2|Lost to Follow-up|0|||
23133369|NCT02672852|64237385|FG002|Part A2|Lost to Follow-up|2|||
23133370|NCT02672852|64237386|FG003|Part A2|Lost to Follow-up|0|||
23133371|NCT02672852|64237387|FG004|Part A2|Lost to Follow-up|0|||
23133372|NCT02672852|64237388|FG005|Part A2|Lost to Follow-up|0|||
23133373|NCT02672852|64237389|FG006|Part A2|Lost to Follow-up|0|||
23133374|NCT02672852|64237383|FG000|Part A2|Withdrawal by Subject|0|||
23133375|NCT02672852|64237384|FG001|Part A2|Withdrawal by Subject|0|||
23133376|NCT02672852|64237385|FG002|Part A2|Withdrawal by Subject|1|||
23133377|NCT02672852|64237386|FG003|Part A2|Withdrawal by Subject|0|||
23214126|NCT02151682|64523538|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23214127|NCT02151682|64523539|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
23214128|NCT02151682|64523534|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23214129|NCT02151682|64523535|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
23214130|NCT02151682|64523536|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23214131|NCT02151682|64523537|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23214132|NCT02151682|64523538|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23214133|NCT02151682|64523539|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
23214134|NCT02151682|64523534|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23428034|NCT00364533|65310675|FG004|Overall Study|Adverse Event|2|||
23548156|NCT03147248|65739475|FG004|Overall Study|Physician Decision|2|||
23548157|NCT03147248|65739476|FG005|Overall Study|Physician Decision|4|||
23133378|NCT02672852|64237387|FG004|Part A2|Withdrawal by Subject|0|||
23133379|NCT02672852|64237388|FG005|Part A2|Withdrawal by Subject|0|||
23133380|NCT02672852|64237389|FG006|Part A2|Withdrawal by Subject|0|||
23133381|NCT02672852|64237383|FG000|Part A2|Other|0|||
23133382|NCT02672852|64237384|FG001|Part A2|Other|0|||
23133383|NCT02672852|64237385|FG002|Part A2|Other|3|||
23133384|NCT02672852|64237386|FG003|Part A2|Other|0|||
23133385|NCT02672852|64237387|FG004|Part A2|Other|0|||
23133386|NCT02672852|64237388|FG005|Part A2|Other|0|||
23133387|NCT02672852|64237389|FG006|Part A2|Other|0|||
23133388|NCT02672852|64237383|FG000|Part A2|Not entered in Part B|0|||
23133389|NCT02672852|64237384|FG001|Part A2|Not entered in Part B|0|||
23133390|NCT02672852|64237385|FG002|Part A2|Not entered in Part B|0|||
23133391|NCT02672852|64237386|FG003|Part A2|Not entered in Part B|4|||
23133392|NCT02672852|64237387|FG004|Part A2|Not entered in Part B|0|||
23133393|NCT02672852|64237388|FG005|Part A2|Not entered in Part B|0|||
23133394|NCT02672852|64237389|FG006|Part A2|Not entered in Part B|0|||
23133395|NCT02672852|64237383|FG000|Part B|Disease worsening|0|||
23133396|NCT02672852|64237384|FG001|Part B|Disease worsening|0|||
23214135|NCT02151682|64523535|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
23214136|NCT02151682|64523536|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23214137|NCT02151682|64523537|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23619673|NCT01772147|65994707|FG001|Overall Study|Lack of Efficacy|6|||
23133397|NCT02672852|64237385|FG002|Part B|Disease worsening|0|||
23133398|NCT02672852|64237386|FG003|Part B|Disease worsening|0|||
23133399|NCT02672852|64237387|FG004|Part B|Disease worsening|1|||
23133400|NCT02672852|64237388|FG005|Part B|Disease worsening|0|||
23133401|NCT02672852|64237389|FG006|Part B|Disease worsening|1|||
23133402|NCT02672852|64237383|FG000|Part B|Worsening pre-existing condition|0|||
23133403|NCT02672852|64237384|FG001|Part B|Worsening pre-existing condition|0|||
23133404|NCT02672852|64237385|FG002|Part B|Worsening pre-existing condition|0|||
23133405|NCT02672852|64237386|FG003|Part B|Worsening pre-existing condition|0|||
23133406|NCT02672852|64237387|FG004|Part B|Worsening pre-existing condition|0|||
23133407|NCT02672852|64237388|FG005|Part B|Worsening pre-existing condition|1|||
23133408|NCT02672852|64237389|FG006|Part B|Worsening pre-existing condition|0|||
23619674|NCT01772147|65994708|FG002|Overall Study|Lack of Efficacy|6|||
23619675|NCT02396758|65994712|FG000|Overall Study|Withdrawal by Subject|2|||
23619676|NCT02396758|65994713|FG001|Overall Study|Withdrawal by Subject|0|||
23619677|NCT02396758|65994714|FG002|Overall Study|Withdrawal by Subject|0|||
23619678|NCT02396758|65994715|FG003|Overall Study|Withdrawal by Subject|1|||
23619679|NCT02396758|65994712|FG000|Overall Study|Lost to Follow-up|8|||
23619680|NCT02396758|65994713|FG001|Overall Study|Lost to Follow-up|5|||
23619681|NCT02396758|65994714|FG002|Overall Study|Lost to Follow-up|3|||
23619682|NCT02396758|65994715|FG003|Overall Study|Lost to Follow-up|3|||
23619683|NCT02396758|65994712|FG000|Overall Study|Death|1|||
23619684|NCT02396758|65994713|FG001|Overall Study|Death|1|||
23619685|NCT02396758|65994714|FG002|Overall Study|Death|0|||
23619686|NCT02396758|65994715|FG003|Overall Study|Death|1|||
23133409|NCT02672852|64237383|FG000|Part B|Other adverse event|0|||
23133410|NCT02672852|64237384|FG001|Part B|Other adverse event|0|||
23133411|NCT02672852|64237385|FG002|Part B|Other adverse event|0|||
23133412|NCT02672852|64237386|FG003|Part B|Other adverse event|0|||
23133413|NCT02672852|64237387|FG004|Part B|Other adverse event|3|||
23133414|NCT02672852|64237388|FG005|Part B|Other adverse event|5|||
23133415|NCT02672852|64237389|FG006|Part B|Other adverse event|1|||
23133416|NCT02672852|64237383|FG000|Part B|Lost to Follow-up|0|||
23133417|NCT02672852|64237384|FG001|Part B|Lost to Follow-up|0|||
23133418|NCT02672852|64237385|FG002|Part B|Lost to Follow-up|0|||
23133419|NCT02672852|64237386|FG003|Part B|Lost to Follow-up|0|||
23133420|NCT02672852|64237387|FG004|Part B|Lost to Follow-up|3|||
23133421|NCT02672852|64237388|FG005|Part B|Lost to Follow-up|4|||
23133422|NCT02672852|64237389|FG006|Part B|Lost to Follow-up|1|||
23133423|NCT02672852|64237383|FG000|Part B|Withdrawal by Subject|0|||
23133424|NCT02672852|64237384|FG001|Part B|Withdrawal by Subject|0|||
23133425|NCT02672852|64237385|FG002|Part B|Withdrawal by Subject|0|||
23214138|NCT02151682|64523538|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23548158|NCT03147248|65739471|FG000|Overall Study|Prolonged Dosing Interval|0|||
23548159|NCT03147248|65739472|FG001|Overall Study|Prolonged Dosing Interval|0|||
23548160|NCT03147248|65739473|FG002|Overall Study|Prolonged Dosing Interval|0|||
23548161|NCT03147248|65739474|FG003|Overall Study|Prolonged Dosing Interval|0|||
23548162|NCT03147248|65739475|FG004|Overall Study|Prolonged Dosing Interval|1|||
23548163|NCT03147248|65739476|FG005|Overall Study|Prolonged Dosing Interval|1|||
23548164|NCT02269670|65739477|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
23548165|NCT00605280|65739478|FG000|Year 1|Protocol Violation|0|||
23548166|NCT00605280|65739479|FG001|Year 1|Protocol Violation|0|||
23548167|NCT00605280|65739480|FG002|Year 1|Protocol Violation|0|||
23548168|NCT00605280|65739481|FG003|Year 1|Protocol Violation|1|||
23548169|NCT00605280|65739478|FG000|Year 1|Adverse Event|3|||
23548170|NCT00605280|65739479|FG001|Year 1|Adverse Event|1|||
23548171|NCT00605280|65739480|FG002|Year 1|Adverse Event|1|||
23548172|NCT00605280|65739481|FG003|Year 1|Adverse Event|5|||
23548173|NCT00605280|65739478|FG000|Year 1|Physician Decision|7|||
23548174|NCT00605280|65739479|FG001|Year 1|Physician Decision|4|||
23548175|NCT00605280|65739480|FG002|Year 1|Physician Decision|0|||
23548176|NCT00605280|65739481|FG003|Year 1|Physician Decision|6|||
23548177|NCT00605280|65739478|FG000|Year 1|Withdrawal by Subject|2|||
23548178|NCT00605280|65739479|FG001|Year 1|Withdrawal by Subject|4|||
23619687|NCT02396758|65994712|FG000|Overall Study|Randomized but not treated|1|||
23619688|NCT02396758|65994713|FG001|Overall Study|Randomized but not treated|0|||
23619689|NCT02396758|65994714|FG002|Overall Study|Randomized but not treated|1|||
23619690|NCT02396758|65994715|FG003|Overall Study|Randomized but not treated|0|||
23133426|NCT02672852|64237386|FG003|Part B|Withdrawal by Subject|0|||
23133427|NCT02672852|64237387|FG004|Part B|Withdrawal by Subject|5|||
23133428|NCT02672852|64237388|FG005|Part B|Withdrawal by Subject|0|||
23133429|NCT02672852|64237389|FG006|Part B|Withdrawal by Subject|7|||
23133430|NCT02672852|64237383|FG000|Part B|Other|0|||
23133431|NCT02672852|64237384|FG001|Part B|Other|0|||
23133432|NCT02672852|64237385|FG002|Part B|Other|0|||
23133433|NCT02672852|64237386|FG003|Part B|Other|0|||
23619691|NCT00728884|65994718|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
23619692|NCT00728884|65994718|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
23619693|NCT03927222|65994719|FG000|Overall Study|Progression|3|||
23428035|NCT00364533|65310671|FG000|Overall Study|Withdrawal by Subject|4|||
23428036|NCT00364533|65310672|FG001|Overall Study|Withdrawal by Subject|8|||
23428037|NCT00364533|65310673|FG002|Overall Study|Withdrawal by Subject|6|||
23428038|NCT00364533|65310674|FG003|Overall Study|Withdrawal by Subject|6|||
23428039|NCT00364533|65310675|FG004|Overall Study|Withdrawal by Subject|6|||
23428040|NCT00364533|65310671|FG000|Overall Study|Lack of Efficacy|22|||
23428041|NCT00364533|65310672|FG001|Overall Study|Lack of Efficacy|22|||
23428042|NCT00364533|65310673|FG002|Overall Study|Lack of Efficacy|21|||
23619694|NCT03927222|65994719|FG000|Overall Study|CMV testing results inconclusive|1|||
23619695|NCT03927222|65994719|FG000|Overall Study|Unable to generate enough vaccines|1|||
23619696|NCT03927222|65994719|FG000|Overall Study|Early study termination|1|||
23619697|NCT00396097|65994725|FG000|Overall Study|Withdrawal by Subject|17|||
23428043|NCT00364533|65310674|FG003|Overall Study|Lack of Efficacy|17|||
23428044|NCT00364533|65310675|FG004|Overall Study|Lack of Efficacy|42|||
23428045|NCT00364533|65310671|FG000|Overall Study|Subject discharged from hospital|4|||
23428046|NCT00364533|65310672|FG001|Overall Study|Subject discharged from hospital|1|||
23428047|NCT00364533|65310673|FG002|Overall Study|Subject discharged from hospital|2|||
23428048|NCT00364533|65310674|FG003|Overall Study|Subject discharged from hospital|3|||
23428049|NCT00364533|65310675|FG004|Overall Study|Subject discharged from hospital|1|||
23428050|NCT00364533|65310671|FG000|Overall Study|Variations in drug compliance|2|||
23428051|NCT00364533|65310672|FG001|Overall Study|Variations in drug compliance|1|||
23428052|NCT00364533|65310673|FG002|Overall Study|Variations in drug compliance|1|||
23428053|NCT00364533|65310674|FG003|Overall Study|Variations in drug compliance|0|||
23428054|NCT00364533|65310675|FG004|Overall Study|Variations in drug compliance|0|||
23428055|NCT00364533|65310671|FG000|Overall Study|Non-compliance|1|||
23428056|NCT00364533|65310672|FG001|Overall Study|Non-compliance|0|||
23428057|NCT00364533|65310673|FG002|Overall Study|Non-compliance|0|||
23428058|NCT00364533|65310674|FG003|Overall Study|Non-compliance|0|||
23428059|NCT00364533|65310675|FG004|Overall Study|Non-compliance|0|||
23428060|NCT00364533|65310671|FG000|Overall Study|Protocol Violation|1|||
23428061|NCT00364533|65310672|FG001|Overall Study|Protocol Violation|1|||
23428062|NCT00364533|65310673|FG002|Overall Study|Protocol Violation|0|||
23428063|NCT00364533|65310674|FG003|Overall Study|Protocol Violation|0|||
23428064|NCT00364533|65310675|FG004|Overall Study|Protocol Violation|0|||
23428065|NCT02242981|65310678|FG000|Overall Study|Withdrawal by Subject|1|||
23428066|NCT00343915|65310680|FG000|Primary Study|Withdrawal by Subject|1|||
23428067|NCT00343915|65310681|FG001|Primary Study|Withdrawal by Subject|0|||
23428068|NCT00343915|65310680|FG000|Primary Study|Lost to Follow-up|2|||
23428069|NCT00343915|65310681|FG001|Primary Study|Lost to Follow-up|3|||
23428070|NCT00343915|65310680|FG000|Primary Study|Other|1|||
23428071|NCT00343915|65310681|FG001|Primary Study|Other|0|||
23428072|NCT00524589|65310682|FG000|Overall Study|Withdrawal by Subject|2|||
23428073|NCT00524589|65310682|FG000|Overall Study|Disease Progression|16|||
23428074|NCT01751776|65310683|FG000|Overall Study|Adverse Event|0|||
23428075|NCT01751776|65310684|FG001|Overall Study|Adverse Event|0|||
23428076|NCT01751776|65310685|FG002|Overall Study|Adverse Event|0|||
23428077|NCT01751776|65310686|FG003|Overall Study|Adverse Event|0|||
23428078|NCT01751776|65310687|FG004|Overall Study|Adverse Event|0|||
23428079|NCT01751776|65310688|FG005|Overall Study|Adverse Event|0|||
23428080|NCT01751776|65310689|FG006|Overall Study|Adverse Event|4|||
23428081|NCT01751776|65310690|FG007|Overall Study|Adverse Event|2|||
23428082|NCT01751776|65310683|FG000|Overall Study|Consent withdrawn|0|||
23428083|NCT01751776|65310684|FG001|Overall Study|Consent withdrawn|0|||
23428084|NCT01751776|65310685|FG002|Overall Study|Consent withdrawn|0|||
23428085|NCT01751776|65310686|FG003|Overall Study|Consent withdrawn|0|||
23428086|NCT01751776|65310687|FG004|Overall Study|Consent withdrawn|0|||
23428087|NCT01751776|65310688|FG005|Overall Study|Consent withdrawn|0|||
23428088|NCT01751776|65310689|FG006|Overall Study|Consent withdrawn|0|||
23428089|NCT01751776|65310690|FG007|Overall Study|Consent withdrawn|1|||
23428090|NCT01751776|65310683|FG000|Overall Study|Other reason not specified above|0|||
23428091|NCT01751776|65310684|FG001|Overall Study|Other reason not specified above|0|||
23428092|NCT01751776|65310685|FG002|Overall Study|Other reason not specified above|0|||
23317489|NCT02552121|64904097|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23428093|NCT01751776|65310686|FG003|Overall Study|Other reason not specified above|0|||
23619698|NCT00396097|65994726|FG001|Overall Study|Withdrawal by Subject|17|||
23619699|NCT00396097|65994725|FG000|Overall Study|Lost to Follow-up|4|||
23428094|NCT01751776|65310687|FG004|Overall Study|Other reason not specified above|0|||
23428095|NCT01751776|65310688|FG005|Overall Study|Other reason not specified above|0|||
23428096|NCT01751776|65310689|FG006|Overall Study|Other reason not specified above|0|||
23428097|NCT01751776|65310690|FG007|Overall Study|Other reason not specified above|1|||
23428098|NCT00089986|65310691|FG000|Overall Study|Adverse Event|6|||
23428099|NCT00089986|65310692|FG001|Overall Study|Adverse Event|9|||
23428100|NCT00089986|65310693|FG002|Overall Study|Adverse Event|6|||
23428101|NCT00089986|65310691|FG000|Overall Study|Lost to Follow-up|3|||
23428102|NCT00089986|65310692|FG001|Overall Study|Lost to Follow-up|1|||
23428103|NCT00089986|65310693|FG002|Overall Study|Lost to Follow-up|1|||
23428104|NCT00089986|65310691|FG000|Overall Study|Protocol Violation|0|||
23428105|NCT00089986|65310692|FG001|Overall Study|Protocol Violation|1|||
23428106|NCT00089986|65310693|FG002|Overall Study|Protocol Violation|0|||
23428107|NCT00089986|65310691|FG000|Overall Study|Patient transferred to another hospital|2|||
23428108|NCT00089986|65310692|FG001|Overall Study|Patient transferred to another hospital|1|||
23428109|NCT00089986|65310693|FG002|Overall Study|Patient transferred to another hospital|0|||
23428110|NCT00089986|65310691|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
23428111|NCT00089986|65310692|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
23428112|NCT00089986|65310693|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
23428113|NCT00089986|65310691|FG000|Overall Study|Hemohlobin stopping rule|0|||
23428114|NCT00089986|65310692|FG001|Overall Study|Hemohlobin stopping rule|1|||
23428115|NCT00089986|65310693|FG002|Overall Study|Hemohlobin stopping rule|0|||
23428116|NCT00089986|65310691|FG000|Overall Study|Investigator decision to withdrew|0|||
23428117|NCT00089986|65310692|FG001|Overall Study|Investigator decision to withdrew|1|||
23428118|NCT00089986|65310693|FG002|Overall Study|Investigator decision to withdrew|0|||
23428119|NCT00089986|65310691|FG000|Overall Study|Enrollment in another study|0|||
23428120|NCT00089986|65310692|FG001|Overall Study|Enrollment in another study|1|||
23428121|NCT00089986|65310693|FG002|Overall Study|Enrollment in another study|0|||
23428122|NCT00089986|65310691|FG000|Overall Study|Family decision|0|||
23428123|NCT00089986|65310692|FG001|Overall Study|Family decision|1|||
23428124|NCT00089986|65310693|FG002|Overall Study|Family decision|0|||
23428125|NCT00089986|65310691|FG000|Overall Study|Do not resuscitate (DNR)|0|||
23428126|NCT00089986|65310692|FG001|Overall Study|Do not resuscitate (DNR)|0|||
23428127|NCT00089986|65310693|FG002|Overall Study|Do not resuscitate (DNR)|1|||
23428128|NCT00089986|65310691|FG000|Overall Study|Withdrawal by Subject|3|||
23428129|NCT00089986|65310692|FG001|Overall Study|Withdrawal by Subject|6|||
23428130|NCT00089986|65310693|FG002|Overall Study|Withdrawal by Subject|2|||
23428131|NCT04438499|65310694|FG000|Overall Study|Lack of Efficacy|2|||
23428132|NCT03541187|65310695|FG000|Overall Study|Lost to Follow-up|2|||
23428133|NCT03541187|65310696|FG001|Overall Study|Lost to Follow-up|6|||
23428134|NCT03541187|65310695|FG000|Overall Study|Pregnancy|0|||
23428135|NCT03541187|65310696|FG001|Overall Study|Pregnancy|1|||
23428136|NCT03541187|65310695|FG000|Overall Study|Withdrawal by Subject|6|||
23428137|NCT03541187|65310696|FG001|Overall Study|Withdrawal by Subject|2|||
23428138|NCT03541187|65310695|FG000|Overall Study|Moved out of town|1|||
23428139|NCT03541187|65310696|FG001|Overall Study|Moved out of town|0|||
23428140|NCT03541187|65310695|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
23428141|NCT03541187|65310696|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
23428142|NCT03541187|65310695|FG000|Overall Study|Did not meet randomization criteria|1|||
23428143|NCT03541187|65310696|FG001|Overall Study|Did not meet randomization criteria|1|||
23428144|NCT03541187|65310695|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
23428145|NCT03541187|65310696|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
23428146|NCT03541187|65310695|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
23428147|NCT03541187|65310696|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
23428148|NCT02836873|65310697|FG000|Overall Study|Protocol Violation|0|||
23548179|NCT00605280|65739480|FG002|Year 1|Withdrawal by Subject|0|||
23548180|NCT00605280|65739481|FG003|Year 1|Withdrawal by Subject|4|||
23548181|NCT00605280|65739478|FG000|Year 1|Other|2|||
23548182|NCT00605280|65739479|FG001|Year 1|Other|1|||
23548183|NCT00605280|65739480|FG002|Year 1|Other|0|||
23548184|NCT00605280|65739481|FG003|Year 1|Other|1|||
23548185|NCT00605280|65739478|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
23214139|NCT02151682|64523539|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
23214140|NCT02151682|64523534|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
23214141|NCT02151682|64523535|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
23214142|NCT02151682|64523536|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
23214143|NCT02151682|64523537|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
23214144|NCT02151682|64523538|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
23214145|NCT02151682|64523539|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
23214146|NCT02151682|64523534|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
23548186|NCT00605280|65739479|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
23214147|NCT02151682|64523535|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23428149|NCT02836873|65310698|FG001|Overall Study|Protocol Violation|1|||
23428150|NCT02836873|65310697|FG000|Overall Study|Adverse Event|1|||
23428151|NCT02836873|65310698|FG001|Overall Study|Adverse Event|4|||
23428152|NCT02836873|65310697|FG000|Overall Study|Withdrawal by Subject|2|||
23428153|NCT02836873|65310698|FG001|Overall Study|Withdrawal by Subject|2|||
23428154|NCT02836873|65310697|FG000|Overall Study|Lost to Follow-up|1|||
23548187|NCT00605280|65739480|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
23428155|NCT02836873|65310698|FG001|Overall Study|Lost to Follow-up|3|||
23548188|NCT00605280|65739481|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
23548189|NCT00605280|65739478|FG000|Year 2|Adverse Event|4|||
23428156|NCT02836873|65310697|FG000|Overall Study|Physician Decision|0|||
23428157|NCT02836873|65310698|FG001|Overall Study|Physician Decision|1|||
23428158|NCT02836873|65310697|FG000|Overall Study|Other|1|||
23428159|NCT02836873|65310698|FG001|Overall Study|Other|0|||
23428160|NCT00283868|65310699|FG000|Overall Study|Lost to Follow-up|7|||
23619700|NCT00396097|65994726|FG001|Overall Study|Lost to Follow-up|9|||
23619701|NCT00396097|65994725|FG000|Overall Study|Other|3|||
23133434|NCT02672852|64237387|FG004|Part B|Other|4|||
23133435|NCT02672852|64237388|FG005|Part B|Other|1|||
23133436|NCT02672852|64237389|FG006|Part B|Other|2|||
23133437|NCT00867308|64237390|FG000|Overall Study|Death|1|||
23133438|NCT00867308|64237391|FG001|Overall Study|Death|0|||
23133439|NCT00867308|64237390|FG000|Overall Study|Adverse Event|1|||
23133440|NCT00867308|64237391|FG001|Overall Study|Adverse Event|4|||
23133441|NCT00867308|64237390|FG000|Overall Study|Lack of Efficacy|6|||
23133442|NCT00867308|64237391|FG001|Overall Study|Lack of Efficacy|12|||
23133443|NCT00867308|64237390|FG000|Overall Study|Withdrawal by Subject|1|||
23133444|NCT00867308|64237391|FG001|Overall Study|Withdrawal by Subject|2|||
23133445|NCT04313608|64237396|FG000|Overall Study|Death|12|||
23428161|NCT00283868|65310700|FG001|Overall Study|Lost to Follow-up|8|||
23428162|NCT01344629|65310701|FG000|Crossover Period 2|Withdrawal by Subject|0|||
23428163|NCT01344629|65310702|FG001|Crossover Period 2|Withdrawal by Subject|1|||
23428164|NCT03550404|65310707|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
23428165|NCT03550404|65310708|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
23428166|NCT03550404|65310709|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
23428167|NCT03550404|65310707|FG000|Phase 2|Vacated position|1|||
23619702|NCT00396097|65994726|FG001|Overall Study|Other|5|||
23619703|NCT00396097|65994725|FG000|Overall Study|Protocol Violation|0|||
23619704|NCT00396097|65994726|FG001|Overall Study|Protocol Violation|6|||
23619705|NCT00396097|65994725|FG000|Overall Study|Adverse Event|1|||
23619706|NCT00396097|65994726|FG001|Overall Study|Adverse Event|5|||
23619707|NCT00396097|65994725|FG000|Overall Study|Insufficient Clinical Response|1|||
23619708|NCT00396097|65994726|FG001|Overall Study|Insufficient Clinical Response|4|||
23619709|NCT00496834|65994729|FG000|Overall Study|Withdrawal by Subject|4|||
23619710|NCT00496834|65994730|FG001|Overall Study|Withdrawal by Subject|6|||
23619711|NCT00496834|65994729|FG000|Overall Study|Contraindicated medication administered|0|||
23619712|NCT00496834|65994730|FG001|Overall Study|Contraindicated medication administered|1|||
23619713|NCT00496834|65994729|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
23428168|NCT03550404|65310708|FG001|Phase 2|Vacated position|0|||
23428169|NCT03550404|65310709|FG002|Phase 2|Vacated position|0|||
23428170|NCT03285958|65310710|FG000|Overall Study|Lost to Follow-up|1|||
23428171|NCT03285958|65310711|FG001|Overall Study|Lost to Follow-up|1|||
23428172|NCT03285958|65310710|FG000|Overall Study|Withdrawal by Subject|1|||
23428173|NCT03285958|65310711|FG001|Overall Study|Withdrawal by Subject|0|||
23428174|NCT03285958|65310710|FG000|Overall Study|Not able to attend required orientation|3|||
23428175|NCT03285958|65310711|FG001|Overall Study|Not able to attend required orientation|0|||
23428176|NCT00973102|65310713|FG000|Overall Study|Protocol Violation|1|||
23428177|NCT00973102|65310714|FG001|Overall Study|Protocol Violation|0|||
23428178|NCT00973102|65310713|FG000|Overall Study|Prisoner|0|||
23428179|NCT00973102|65310714|FG001|Overall Study|Prisoner|1|||
23428180|NCT00392808|65310716|FG000|Overall Study|Lost to Follow-up|3|||
23428181|NCT00392808|65310717|FG001|Overall Study|Lost to Follow-up|2|||
23428182|NCT00392808|65310718|FG002|Overall Study|Lost to Follow-up|1|||
23428183|NCT00392808|65310719|FG003|Overall Study|Lost to Follow-up|2|||
23428184|NCT00392808|65310716|FG000|Overall Study|Unable to withdraw blood|3|||
23428185|NCT00392808|65310717|FG001|Overall Study|Unable to withdraw blood|1|||
23428186|NCT00392808|65310718|FG002|Overall Study|Unable to withdraw blood|1|||
23428187|NCT00392808|65310719|FG003|Overall Study|Unable to withdraw blood|2|||
23428188|NCT00598078|65310729|FG000|Period 2 (Day 2)|Adverse Event|1|||
23428189|NCT00598078|65310730|FG001|Period 2 (Day 2)|Adverse Event|0|||
23428190|NCT01116427|65310732|FG000|Core Phase|Adverse Event|0|||
23428191|NCT01116427|65310733|FG001|Core Phase|Adverse Event|1|||
23428192|NCT01116427|65310732|FG000|Core Phase|Lost to Follow-up|1|||
23428193|NCT01116427|65310733|FG001|Core Phase|Lost to Follow-up|0|||
23428194|NCT01116427|65310732|FG000|Core Phase|Withdrawal by Subject|3|||
23428195|NCT01116427|65310733|FG001|Core Phase|Withdrawal by Subject|0|||
23619714|NCT00496834|65994730|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
23619715|NCT00496834|65994729|FG000|Overall Study|Adverse Event|5|||
23428196|NCT01116427|65310732|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
23133446|NCT04313608|64237397|FG001|Overall Study|Death|3|||
23428197|NCT01116427|65310733|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
23428198|NCT01116427|65310732|FG000|Extension Phase|Adverse Event|1|||
23428199|NCT01116427|65310733|FG001|Extension Phase|Adverse Event|1|||
23133447|NCT03682302|64237398|FG000|Overall Study|Lost to Follow-up|1|||
23133448|NCT03682302|64237399|FG001|Overall Study|Lost to Follow-up|2|||
23133449|NCT03682302|64237400|FG002|Overall Study|Lost to Follow-up|0|||
23133450|NCT03682302|64237401|FG003|Overall Study|Lost to Follow-up|1|||
23428200|NCT01116427|65310732|FG000|Extension Phase|Lost to Follow-up|2|||
23428201|NCT01116427|65310733|FG001|Extension Phase|Lost to Follow-up|0|||
23619716|NCT00496834|65994730|FG001|Overall Study|Adverse Event|3|||
23619717|NCT00496834|65994729|FG000|Overall Study|IP administration violation|2|||
23619718|NCT00496834|65994730|FG001|Overall Study|IP administration violation|0|||
23619719|NCT00496834|65994729|FG000|Overall Study|Lost to Follow-up|2|||
23619720|NCT00496834|65994730|FG001|Overall Study|Lost to Follow-up|0|||
23619721|NCT00496834|65994729|FG000|Overall Study|Blood Pressure control failure|2|||
23619722|NCT00496834|65994730|FG001|Overall Study|Blood Pressure control failure|1|||
23619723|NCT03675308|65994731|FG000|Overall Study|Adverse Event|3|||
23619724|NCT03675308|65994732|FG001|Overall Study|Adverse Event|2|||
23619725|NCT03675308|65994731|FG000|Overall Study|Withdrawal by Subject|6|||
23619726|NCT03675308|65994732|FG001|Overall Study|Withdrawal by Subject|4|||
23619727|NCT03675308|65994731|FG000|Overall Study|Lost to Follow-up|3|||
23619728|NCT03675308|65994732|FG001|Overall Study|Lost to Follow-up|0|||
23619729|NCT03675308|65994731|FG000|Overall Study|Lack of Efficacy|1|||
23619730|NCT03675308|65994732|FG001|Overall Study|Lack of Efficacy|1|||
23619731|NCT03675308|65994731|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
23619732|NCT03675308|65994732|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
23428202|NCT01116427|65310732|FG000|Extension Phase|Withdrawal by Subject|5|||
23428203|NCT01116427|65310733|FG001|Extension Phase|Withdrawal by Subject|1|||
23428204|NCT01116427|65310732|FG000|Extension Phase|Not using appropriate birth control|1|||
23428205|NCT01116427|65310733|FG001|Extension Phase|Not using appropriate birth control|0|||
23548190|NCT00605280|65739479|FG001|Year 2|Adverse Event|0|||
23619733|NCT03675308|65994731|FG000|Overall Study|Other|0|||
23619734|NCT03675308|65994732|FG001|Overall Study|Other|1|||
23619735|NCT03723915|65994733|FG000|Screening|Failed to meet screening requirements.|2|||
23619736|NCT03723915|65994733|FG000|On Treatment|Failed to meet treatment requirements|2|||
23548191|NCT00605280|65739480|FG002|Year 2|Adverse Event|2|||
23548192|NCT00605280|65739481|FG003|Year 2|Adverse Event|4|||
23619737|NCT03175198|65994734|FG000|Overall Study|Adverse Event|480|||
23619738|NCT03175198|65994734|FG000|Overall Study|No actual visit|120|||
23619739|NCT03175198|65994734|FG000|Overall Study|Registration rule not followed|4|||
23133451|NCT03682302|64237398|FG000|Overall Study|Study drug was not administered|0|||
23133452|NCT03682302|64237399|FG001|Overall Study|Study drug was not administered|0|||
23133453|NCT03682302|64237400|FG002|Overall Study|Study drug was not administered|1|||
23133454|NCT03682302|64237401|FG003|Overall Study|Study drug was not administered|1|||
23133455|NCT00939822|64237402|FG000|Overall Study|Lost to Follow-up|1|||
23133456|NCT00939822|64237403|FG001|Overall Study|Lost to Follow-up|0|||
23133457|NCT00939822|64237402|FG000|Overall Study|withdrew from study due to busy schedule|1|||
23133458|NCT00939822|64237403|FG001|Overall Study|withdrew from study due to busy schedule|1|||
23133459|NCT00939822|64237402|FG000|Overall Study|Mental health issues|0|||
23133460|NCT00939822|64237403|FG001|Overall Study|Mental health issues|2|||
23133461|NCT05330676|64237404|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
23428206|NCT00432744|65310739|FG000|Months 0-6|Withdrawal by Subject|4|||
23548193|NCT00605280|65739478|FG000|Year 2|Physician Decision|11|||
23548194|NCT00605280|65739479|FG001|Year 2|Physician Decision|6|||
23548195|NCT00605280|65739480|FG002|Year 2|Physician Decision|4|||
23548196|NCT00605280|65739481|FG003|Year 2|Physician Decision|11|||
23548197|NCT00605280|65739478|FG000|Year 2|Withdrawal by Subject|4|||
23548198|NCT00605280|65739479|FG001|Year 2|Withdrawal by Subject|0|||
23548199|NCT00605280|65739480|FG002|Year 2|Withdrawal by Subject|0|||
23548200|NCT00605280|65739481|FG003|Year 2|Withdrawal by Subject|4|||
23548201|NCT00605280|65739478|FG000|Year 2|Other|1|||
23548202|NCT00605280|65739479|FG001|Year 2|Other|0|||
23619740|NCT03175198|65994734|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
23619741|NCT03175198|65994734|FG000|Overall Study|Other personal reason|509|||
23619742|NCT03175198|65994734|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
23214148|NCT02151682|64523536|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23428207|NCT00432744|65310740|FG001|Months 0-6|Withdrawal by Subject|4|||
23428208|NCT00432744|65310739|FG000|Months 0-6|Too disabled to score|1|||
23428209|NCT00432744|65310740|FG001|Months 0-6|Too disabled to score|0|||
23428210|NCT00432744|65310739|FG000|Months 7 - 12|Withdrawal by Subject|1|||
23428211|NCT00432744|65310740|FG001|Months 7 - 12|Withdrawal by Subject|0|||
23428212|NCT00432744|65310739|FG000|Months 7 - 12|Too disabled to score|0|||
23428213|NCT00432744|65310740|FG001|Months 7 - 12|Too disabled to score|1|||
23428214|NCT04584346|65310741|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
23428215|NCT04584346|65310742|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
23428216|NCT03757130|65310745|FG000|Overall Study|Lost to Follow-up|0|||
23428217|NCT03757130|65310746|FG001|Overall Study|Lost to Follow-up|0|||
23428218|NCT03757130|65310747|FG002|Overall Study|Lost to Follow-up|0|||
23428219|NCT03757130|65310748|FG003|Overall Study|Lost to Follow-up|1|||
23548203|NCT00605280|65739480|FG002|Year 2|Other|0|||
23548204|NCT00605280|65739481|FG003|Year 2|Other|1|||
23548205|NCT00605280|65739478|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
23548206|NCT00605280|65739479|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
23548207|NCT00605280|65739480|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
23133462|NCT05330676|64237405|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
23133463|NCT02574845|64237411|FG000|Overall Study|Consent withdrawn further participation|0|||
23133464|NCT02574845|64237412|FG001|Overall Study|Consent withdrawn further participation|0|||
23133465|NCT02574845|64237413|FG002|Overall Study|Consent withdrawn further participation|0|||
23133466|NCT02574845|64237414|FG003|Overall Study|Consent withdrawn further participation|0|||
23133467|NCT02574845|64237415|FG004|Overall Study|Consent withdrawn further participation|1|||
23133468|NCT02574845|64237416|FG005|Overall Study|Consent withdrawn further participation|0|||
23133469|NCT02574845|64237411|FG000|Overall Study|Adverse Event|0|||
23133470|NCT02574845|64237412|FG001|Overall Study|Adverse Event|1|||
23133471|NCT02574845|64237413|FG002|Overall Study|Adverse Event|0|||
23133472|NCT02574845|64237414|FG003|Overall Study|Adverse Event|0|||
23133473|NCT02574845|64237415|FG004|Overall Study|Adverse Event|0|||
23133474|NCT02574845|64237416|FG005|Overall Study|Adverse Event|1|||
23133475|NCT00503139|64237417|FG000|Overall Study|Case Report Forms were not collected|4|||
23133476|NCT00503139|64237417|FG000|Overall Study|Protocol Violation|4|||
23133477|NCT01202903|64237425|FG000|Overall Study|Administrative Probelms|1|||
23133478|NCT01202903|64237426|FG001|Overall Study|Administrative Probelms|4|||
23133479|NCT01202903|64237425|FG000|Overall Study|Protocol Violation|0|||
23133480|NCT01202903|64237426|FG001|Overall Study|Protocol Violation|1|||
23133481|NCT01202903|64237425|FG000|Overall Study|Death|1|||
23133482|NCT01202903|64237426|FG001|Overall Study|Death|0|||
23133483|NCT01202903|64237425|FG000|Overall Study|Lost to Follow-up|1|||
23133484|NCT01202903|64237426|FG001|Overall Study|Lost to Follow-up|1|||
23133485|NCT01202903|64237425|FG000|Overall Study|Lack of Efficacy|1|||
23133486|NCT01202903|64237426|FG001|Overall Study|Lack of Efficacy|3|||
23133487|NCT01202903|64237425|FG000|Overall Study|Adverse Event|3|||
23133488|NCT01202903|64237426|FG001|Overall Study|Adverse Event|3|||
23133489|NCT01202903|64237425|FG000|Overall Study|Withdrawal by Subject|4|||
23133490|NCT01202903|64237426|FG001|Overall Study|Withdrawal by Subject|4|||
23133491|NCT00663702|64237428|FG000|Overall Study|Adverse Event|8|||
23133492|NCT00663702|64237429|FG001|Overall Study|Adverse Event|4|||
23133493|NCT00663702|64237428|FG000|Overall Study|Withdrawal by Subject|3|||
23133494|NCT00663702|64237429|FG001|Overall Study|Withdrawal by Subject|1|||
23133495|NCT00663702|64237428|FG000|Overall Study|Pregnancy|0|||
23133496|NCT00663702|64237429|FG001|Overall Study|Pregnancy|1|||
23133497|NCT00663702|64237428|FG000|Overall Study|Lost to Follow-up|3|||
23133498|NCT00663702|64237429|FG001|Overall Study|Lost to Follow-up|0|||
23133499|NCT00663702|64237428|FG000|Overall Study|Death|1|||
23133500|NCT00663702|64237429|FG001|Overall Study|Death|1|||
23133501|NCT00663702|64237428|FG000|Overall Study|Lack of Efficacy|3|||
23133502|NCT00663702|64237429|FG001|Overall Study|Lack of Efficacy|3|||
23133503|NCT00929110|64237430|FG000|Overall Study|Adverse Event|40|||
23133504|NCT00929110|64237431|FG001|Overall Study|Adverse Event|29|||
23133505|NCT00929110|64237432|FG002|Overall Study|Adverse Event|18|||
23133506|NCT00929110|64237430|FG000|Overall Study|Subject withdrew consent|40|||
23133507|NCT00929110|64237431|FG001|Overall Study|Subject withdrew consent|23|||
23133508|NCT00929110|64237432|FG002|Overall Study|Subject withdrew consent|26|||
23133509|NCT00929110|64237430|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
23214149|NCT02151682|64523537|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23317490|NCT02552121|64904098|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23317491|NCT02552121|64904099|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23317492|NCT02552121|64904100|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23317493|NCT02552121|64904101|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
23317494|NCT02552121|64904094|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23317495|NCT02552121|64904095|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
23317496|NCT02552121|64904096|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23428220|NCT03757130|65310749|FG004|Overall Study|Lost to Follow-up|0|||
23428221|NCT03757130|65310750|FG005|Overall Study|Lost to Follow-up|0|||
23548208|NCT00605280|65739481|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
23548209|NCT00605280|65739478|FG000|Year 3 Extension|Adverse Event|2|||
23548210|NCT00605280|65739479|FG001|Year 3 Extension|Adverse Event|0|||
23548211|NCT00605280|65739480|FG002|Year 3 Extension|Adverse Event|0|||
23548212|NCT00605280|65739481|FG003|Year 3 Extension|Adverse Event|2|||
23548213|NCT00605280|65739478|FG000|Year 3 Extension|Physician Decision|0|||
23548214|NCT00605280|65739479|FG001|Year 3 Extension|Physician Decision|0|||
23548215|NCT00605280|65739480|FG002|Year 3 Extension|Physician Decision|0|||
23548216|NCT00605280|65739481|FG003|Year 3 Extension|Physician Decision|2|||
23133510|NCT00929110|64237431|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
23133511|NCT00929110|64237432|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
23133512|NCT00929110|64237430|FG000|Overall Study|Lost to Follow-up|7|||
23133513|NCT00929110|64237431|FG001|Overall Study|Lost to Follow-up|7|||
23133514|NCT00929110|64237432|FG002|Overall Study|Lost to Follow-up|3|||
23133515|NCT00929110|64237430|FG000|Overall Study|Protocol deviation|5|||
23133516|NCT00929110|64237431|FG001|Overall Study|Protocol deviation|2|||
23133517|NCT00929110|64237432|FG002|Overall Study|Protocol deviation|4|||
23133518|NCT00929110|64237430|FG000|Overall Study|Administrative problems|4|||
23133519|NCT00929110|64237431|FG001|Overall Study|Administrative problems|1|||
23133520|NCT00929110|64237432|FG002|Overall Study|Administrative problems|2|||
23133521|NCT00929110|64237430|FG000|Overall Study|Death|2|||
23133522|NCT00929110|64237431|FG001|Overall Study|Death|2|||
23133523|NCT00929110|64237432|FG002|Overall Study|Death|2|||
23548217|NCT00605280|65739478|FG000|Year 3 Extension|Withdrawal by Subject|2|||
23548218|NCT00605280|65739479|FG001|Year 3 Extension|Withdrawal by Subject|0|||
23548219|NCT00605280|65739480|FG002|Year 3 Extension|Withdrawal by Subject|0|||
23548220|NCT00605280|65739481|FG003|Year 3 Extension|Withdrawal by Subject|5|||
23548221|NCT00605280|65739478|FG000|Year 3 Extension|Other|2|||
23548222|NCT00605280|65739479|FG001|Year 3 Extension|Other|0|||
23548223|NCT00605280|65739480|FG002|Year 3 Extension|Other|0|||
23548224|NCT00605280|65739481|FG003|Year 3 Extension|Other|0|||
23548225|NCT00605280|65739478|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
23548226|NCT00605280|65739479|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
23548227|NCT00605280|65739480|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
23548228|NCT00605280|65739481|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
23548229|NCT00617344|65739485|FG000|Overall Study|Serious adverse event|1|||
23548230|NCT00617344|65739486|FG001|Overall Study|Serious adverse event|0|||
23548231|NCT00617344|65739487|FG002|Overall Study|Serious adverse event|0|||
23548232|NCT00617344|65739485|FG000|Overall Study|Other Adverse Event|1|||
23548233|NCT00617344|65739486|FG001|Overall Study|Other Adverse Event|1|||
23548234|NCT00617344|65739487|FG002|Overall Study|Other Adverse Event|0|||
23548235|NCT00617344|65739485|FG000|Overall Study|Protocol Violation|10|||
23548236|NCT00617344|65739486|FG001|Overall Study|Protocol Violation|8|||
23133524|NCT00929110|64237430|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23133525|NCT00929110|64237431|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23133526|NCT00929110|64237432|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23133527|NCT00929110|64237430|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23133528|NCT00929110|64237431|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23133529|NCT00929110|64237432|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23133530|NCT00929110|64237430|FG000|Overall Study|Patient inability to use the device|0|||
23133531|NCT00929110|64237431|FG001|Overall Study|Patient inability to use the device|1|||
23133532|NCT00929110|64237432|FG002|Overall Study|Patient inability to use the device|0|||
23133533|NCT02180243|64237433|FG000|Overall Study|Withdrawal by Subject|12|||
23548237|NCT00617344|65739487|FG002|Overall Study|Protocol Violation|5|||
23548238|NCT00617344|65739485|FG000|Overall Study|Lost to Follow-up|5|||
23548239|NCT00617344|65739486|FG001|Overall Study|Lost to Follow-up|4|||
23548240|NCT00617344|65739487|FG002|Overall Study|Lost to Follow-up|1|||
23548241|NCT00617344|65739485|FG000|Overall Study|Withdrawal by Subject|8|||
23548242|NCT00617344|65739486|FG001|Overall Study|Withdrawal by Subject|9|||
23548243|NCT00617344|65739487|FG002|Overall Study|Withdrawal by Subject|2|||
23548244|NCT00707031|65739488|FG000|Overall Study|Adverse Event|45|||
23548245|NCT00707031|65739489|FG001|Overall Study|Adverse Event|45|||
23548246|NCT00707031|65739488|FG000|Overall Study|Lack of Efficacy|19|||
23548247|NCT00707031|65739489|FG001|Overall Study|Lack of Efficacy|6|||
23548248|NCT00707031|65739488|FG000|Overall Study|Lost to Follow-up|2|||
23619743|NCT03175198|65994734|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
23619744|NCT03175198|65994734|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
23619745|NCT03175198|65994734|FG000|Overall Study|To conduct invasive treatment of operation|53|||
23619746|NCT03175198|65994734|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
23619747|NCT03840200|65994735|FG000|Overall Study|Death|6|||
23619748|NCT03840200|65994736|FG001|Overall Study|Death|3|||
23619749|NCT03840200|65994737|FG002|Overall Study|Death|6|||
23619750|NCT03840200|65994738|FG003|Overall Study|Death|10|||
23619751|NCT03840200|65994735|FG000|Overall Study|Reason Not Specified|2|||
23619752|NCT03840200|65994736|FG001|Overall Study|Reason Not Specified|2|||
23133534|NCT02180243|64237434|FG001|Overall Study|Withdrawal by Subject|12|||
23133535|NCT02180243|64237433|FG000|Overall Study|Lost to Follow-up|12|||
23133536|NCT02180243|64237434|FG001|Overall Study|Lost to Follow-up|2|||
23133537|NCT02706405|64237438|FG000|Overall Study|Death|3|||
23133538|NCT02706405|64237439|FG001|Overall Study|Death|2|||
23133539|NCT02706405|64237440|FG002|Overall Study|Death|0|||
23133540|NCT02706405|64237441|FG003|Overall Study|Death|1|||
23133541|NCT02706405|64237442|FG004|Overall Study|Death|0|||
23428222|NCT03757130|65310751|FG006|Overall Study|Lost to Follow-up|0|||
23428223|NCT03757130|65310752|FG007|Overall Study|Lost to Follow-up|1|||
23548249|NCT00707031|65739489|FG001|Overall Study|Lost to Follow-up|1|||
23548250|NCT00707031|65739488|FG000|Overall Study|Protocol Violation|1|||
23548251|NCT00707031|65739489|FG001|Overall Study|Protocol Violation|0|||
23548252|NCT00707031|65739488|FG000|Overall Study|Withdrawal by Subject|7|||
23548253|NCT00707031|65739489|FG001|Overall Study|Withdrawal by Subject|8|||
23548254|NCT00707031|65739488|FG000|Overall Study|Poor Compliance to Protocol|7|||
23548255|NCT00707031|65739489|FG001|Overall Study|Poor Compliance to Protocol|13|||
23548256|NCT00707031|65739488|FG000|Overall Study|Familial or Personal Reasons|12|||
23133542|NCT02706405|64237443|FG005|Overall Study|Death|0|||
23133543|NCT02706405|64237444|FG006|Overall Study|Death|3|||
23133544|NCT02706405|64237445|FG007|Overall Study|Death|4|||
23133545|NCT02706405|64237438|FG000|Overall Study|Disease progression|0|||
23133546|NCT02706405|64237439|FG001|Overall Study|Disease progression|0|||
23133547|NCT02706405|64237440|FG002|Overall Study|Disease progression|0|||
23133548|NCT02706405|64237441|FG003|Overall Study|Disease progression|0|||
23133549|NCT02706405|64237442|FG004|Overall Study|Disease progression|0|||
23133550|NCT02706405|64237443|FG005|Overall Study|Disease progression|0|||
23133551|NCT02706405|64237444|FG006|Overall Study|Disease progression|0|||
23133552|NCT02706405|64237445|FG007|Overall Study|Disease progression|1|||
23133553|NCT02706405|64237438|FG000|Overall Study|Pt moved to new therapy|0|||
23133554|NCT02706405|64237439|FG001|Overall Study|Pt moved to new therapy|0|||
23133555|NCT02706405|64237440|FG002|Overall Study|Pt moved to new therapy|0|||
23133556|NCT02706405|64237441|FG003|Overall Study|Pt moved to new therapy|0|||
23133557|NCT02706405|64237442|FG004|Overall Study|Pt moved to new therapy|0|||
23133558|NCT02706405|64237443|FG005|Overall Study|Pt moved to new therapy|1|||
23133559|NCT02706405|64237444|FG006|Overall Study|Pt moved to new therapy|0|||
23133560|NCT02706405|64237445|FG007|Overall Study|Pt moved to new therapy|1|||
23133561|NCT02706405|64237438|FG000|Overall Study|Physician Decision|1|||
23133562|NCT02706405|64237439|FG001|Overall Study|Physician Decision|0|||
23133563|NCT02706405|64237440|FG002|Overall Study|Physician Decision|0|||
23133564|NCT02706405|64237441|FG003|Overall Study|Physician Decision|0|||
23133565|NCT02706405|64237442|FG004|Overall Study|Physician Decision|0|||
23133566|NCT02706405|64237443|FG005|Overall Study|Physician Decision|0|||
23133567|NCT02706405|64237444|FG006|Overall Study|Physician Decision|0|||
23133568|NCT02706405|64237445|FG007|Overall Study|Physician Decision|0|||
23133569|NCT01593787|64237446|FG000|Overall Study|Adverse Event|1|||
23428224|NCT03757130|65310745|FG000|Overall Study|Withdrawal by Subject|0|||
23428225|NCT03757130|65310746|FG001|Overall Study|Withdrawal by Subject|0|||
23428226|NCT03757130|65310747|FG002|Overall Study|Withdrawal by Subject|0|||
23428227|NCT03757130|65310748|FG003|Overall Study|Withdrawal by Subject|0|||
23428228|NCT03757130|65310749|FG004|Overall Study|Withdrawal by Subject|0|||
23428229|NCT03757130|65310750|FG005|Overall Study|Withdrawal by Subject|0|||
23428230|NCT03757130|65310751|FG006|Overall Study|Withdrawal by Subject|1|||
23428231|NCT03757130|65310752|FG007|Overall Study|Withdrawal by Subject|0|||
23428232|NCT00499746|65310755|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
23428233|NCT00499746|65310755|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
23428234|NCT00499746|65310755|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
23428235|NCT00499746|65310755|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
23428236|NCT03899064|65310760|FG000|Overall Study|Lost to Follow-up|1|||
23428237|NCT03899064|65310760|FG000|Overall Study|Protocol Violation|2|||
23428238|NCT03899064|65310760|FG000|Overall Study|Withdrawal by Subject|2|||
23548257|NCT00707031|65739489|FG001|Overall Study|Familial or Personal Reasons|15|||
23548258|NCT00707031|65739488|FG000|Overall Study|Serious Noncompliance|2|||
23548259|NCT00707031|65739489|FG001|Overall Study|Serious Noncompliance|3|||
23548260|NCT00707031|65739488|FG000|Overall Study|Sponsor Decision|9|||
23548261|NCT00707031|65739489|FG001|Overall Study|Sponsor Decision|8|||
23548262|NCT04085328|65739492|FG000|Overall Study|Witihdrew Consent|16|||
23548263|NCT04085328|65739493|FG001|Overall Study|Witihdrew Consent|16|||
23548264|NCT04085328|65739492|FG000|Overall Study|Adverse Event|8|||
23548265|NCT04085328|65739493|FG001|Overall Study|Adverse Event|7|||
23548266|NCT04085328|65739492|FG000|Overall Study|Lost to Follow-up|7|||
23548267|NCT04085328|65739493|FG001|Overall Study|Lost to Follow-up|2|||
23548268|NCT04085328|65739492|FG000|Overall Study|Physician Decision|0|||
23548269|NCT04085328|65739493|FG001|Overall Study|Physician Decision|1|||
23619753|NCT03840200|65994737|FG002|Overall Study|Reason Not Specified|1|||
23619754|NCT03840200|65994738|FG003|Overall Study|Reason Not Specified|15|||
23619755|NCT03840200|65994735|FG000|Overall Study|Physician Decision|0|||
23619756|NCT03840200|65994736|FG001|Overall Study|Physician Decision|0|||
23619757|NCT03840200|65994737|FG002|Overall Study|Physician Decision|0|||
23133570|NCT01593787|64237447|FG001|Overall Study|Adverse Event|0|||
23619758|NCT03840200|65994738|FG003|Overall Study|Physician Decision|2|||
23619759|NCT03840200|65994735|FG000|Overall Study|Progressive Disease|0|||
23619760|NCT03840200|65994736|FG001|Overall Study|Progressive Disease|0|||
23619761|NCT03840200|65994737|FG002|Overall Study|Progressive Disease|0|||
23619762|NCT03840200|65994738|FG003|Overall Study|Progressive Disease|1|||
23619763|NCT03840200|65994735|FG000|Overall Study|Withdrawal by Subject|0|||
23133571|NCT01593787|64237448|FG002|Overall Study|Adverse Event|0|||
23133572|NCT01280357|64237449|FG000|Overall Study|Excluded no internal monitoring|14|||
23428239|NCT03899064|65310760|FG000|Overall Study|Other|2|||
23428240|NCT03779503|65310761|FG000|First Intervention|Adverse Event|0|||
23428241|NCT03779503|65310762|FG001|First Intervention|Adverse Event|1|||
23428242|NCT03779503|65310761|FG000|First Intervention|Withdrawal by Subject|1|||
23548270|NCT04085328|65739492|FG000|Overall Study|Pregnancy|0|||
23548271|NCT04085328|65739493|FG001|Overall Study|Pregnancy|1|||
23619764|NCT03840200|65994736|FG001|Overall Study|Withdrawal by Subject|1|||
23133573|NCT01280357|64237449|FG000|Overall Study|IInsufficient data/No data supplied|12|||
23133574|NCT01451827|64237450|FG000|Overall Study|Adverse Event|2|||
23133575|NCT01451827|64237451|FG001|Overall Study|Adverse Event|0|||
23133576|NCT01451827|64237452|FG002|Overall Study|Adverse Event|1|||
23548272|NCT04085328|65739492|FG000|Overall Study|Reasons Related to COVID-19|5|||
23428243|NCT03779503|65310762|FG001|First Intervention|Withdrawal by Subject|0|||
23619765|NCT03840200|65994737|FG002|Overall Study|Withdrawal by Subject|0|||
23619766|NCT03840200|65994738|FG003|Overall Study|Withdrawal by Subject|2|||
23548273|NCT04085328|65739493|FG001|Overall Study|Reasons Related to COVID-19|8|||
23548274|NCT04085328|65739492|FG000|Overall Study|Did not meet inclusion criteria|1|||
23548275|NCT04085328|65739493|FG001|Overall Study|Did not meet inclusion criteria|1|||
23548276|NCT04085328|65739492|FG000|Overall Study|Early termination|1|||
23619767|NCT01276509|65994739|FG000|Overall Study|Adverse Event|9|||
23619768|NCT01276509|65994740|FG001|Overall Study|Adverse Event|8|||
23619769|NCT01276509|65994741|FG002|Overall Study|Adverse Event|4|||
23619770|NCT01276509|65994742|FG003|Overall Study|Adverse Event|3|||
23619771|NCT01276509|65994739|FG000|Overall Study|Lack of Efficacy|2|||
23619772|NCT01276509|65994740|FG001|Overall Study|Lack of Efficacy|1|||
23619773|NCT01276509|65994741|FG002|Overall Study|Lack of Efficacy|1|||
23619774|NCT01276509|65994742|FG003|Overall Study|Lack of Efficacy|2|||
23619775|NCT01276509|65994739|FG000|Overall Study|Pregnancy|1|||
23619776|NCT01276509|65994740|FG001|Overall Study|Pregnancy|0|||
23619777|NCT01276509|65994741|FG002|Overall Study|Pregnancy|0|||
23619778|NCT01276509|65994742|FG003|Overall Study|Pregnancy|0|||
23619779|NCT01276509|65994739|FG000|Overall Study|Withdrawal by Subject|1|||
23619780|NCT01276509|65994740|FG001|Overall Study|Withdrawal by Subject|2|||
23619781|NCT01276509|65994741|FG002|Overall Study|Withdrawal by Subject|0|||
23548277|NCT04085328|65739493|FG001|Overall Study|Early termination|0|||
23548278|NCT02959437|65739495|FG000|Overall Study|Death|33|||
23548279|NCT02959437|65739496|FG001|Overall Study|Death|3|||
23548280|NCT02959437|65739497|FG002|Overall Study|Death|0|||
23548281|NCT02959437|65739498|FG003|Overall Study|Death|0|||
23548282|NCT02959437|65739495|FG000|Overall Study|Lost to Follow-up|3|||
23548283|NCT02959437|65739496|FG001|Overall Study|Lost to Follow-up|1|||
23548284|NCT02959437|65739497|FG002|Overall Study|Lost to Follow-up|0|||
23548285|NCT02959437|65739498|FG003|Overall Study|Lost to Follow-up|0|||
23548286|NCT02959437|65739495|FG000|Overall Study|Withdrawal by Subject|11|||
23548287|NCT02959437|65739496|FG001|Overall Study|Withdrawal by Subject|3|||
23548288|NCT02959437|65739497|FG002|Overall Study|Withdrawal by Subject|0|||
23548289|NCT02959437|65739498|FG003|Overall Study|Withdrawal by Subject|0|||
23548290|NCT02959437|65739495|FG000|Overall Study|Progressive Disease|9|||
23548291|NCT02959437|65739496|FG001|Overall Study|Progressive Disease|1|||
23548292|NCT02959437|65739497|FG002|Overall Study|Progressive Disease|0|||
23548293|NCT02959437|65739498|FG003|Overall Study|Progressive Disease|0|||
23548294|NCT02959437|65739495|FG000|Overall Study|Study Terminated by Sponsor|4|||
23548295|NCT02959437|65739496|FG001|Overall Study|Study Terminated by Sponsor|0|||
23548296|NCT02959437|65739497|FG002|Overall Study|Study Terminated by Sponsor|0|||
23548297|NCT02959437|65739498|FG003|Overall Study|Study Terminated by Sponsor|0|||
23548298|NCT02959437|65739495|FG000|Overall Study|Other Unspecified|2|||
23548299|NCT02959437|65739496|FG001|Overall Study|Other Unspecified|0|||
23548300|NCT02959437|65739497|FG002|Overall Study|Other Unspecified|0|||
23548301|NCT02959437|65739498|FG003|Overall Study|Other Unspecified|0|||
23548302|NCT00971048|65739511|FG000|Overall Study|Protocol Violation|1|||
23548303|NCT00971048|65739512|FG001|Overall Study|Protocol Violation|2|||
23548304|NCT00971048|65739513|FG002|Overall Study|Protocol Violation|0|||
23548305|NCT00971048|65739514|FG003|Overall Study|Protocol Violation|1|||
23548306|NCT00971048|65739511|FG000|Overall Study|Adverse Event|0|||
23548307|NCT00971048|65739512|FG001|Overall Study|Adverse Event|0|||
23548308|NCT00971048|65739513|FG002|Overall Study|Adverse Event|1|||
23548309|NCT00971048|65739514|FG003|Overall Study|Adverse Event|0|||
23548310|NCT00971048|65739511|FG000|Overall Study|Physician Decision|0|||
23548311|NCT00971048|65739512|FG001|Overall Study|Physician Decision|0|||
23548312|NCT00971048|65739513|FG002|Overall Study|Physician Decision|0|||
23548313|NCT00971048|65739514|FG003|Overall Study|Physician Decision|1|||
23548314|NCT04794803|65739515|FG000|Overall Study|Death|1|||
23548315|NCT04794803|65739516|FG001|Overall Study|Death|3|||
23548316|NCT04794803|65739515|FG000|Overall Study|Lost to Follow-up|2|||
23548317|NCT04794803|65739516|FG001|Overall Study|Lost to Follow-up|2|||
23619782|NCT01276509|65994742|FG003|Overall Study|Withdrawal by Subject|0|||
23619783|NCT01276509|65994739|FG000|Overall Study|Other|0|||
23619784|NCT01276509|65994740|FG001|Overall Study|Other|1|||
23548318|NCT04794803|65739515|FG000|Overall Study|Withdrawal by Subject|1|||
23619785|NCT01276509|65994741|FG002|Overall Study|Other|0|||
23619786|NCT01276509|65994742|FG003|Overall Study|Other|0|||
23619787|NCT01904019|65994743|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
23428244|NCT00316693|65310763|FG000|Overall Study|Adverse Event|6|||
23548319|NCT04794803|65739516|FG001|Overall Study|Withdrawal by Subject|0|||
23548320|NCT04794803|65739515|FG000|Overall Study|Physician Decision|1|||
23548321|NCT04794803|65739516|FG001|Overall Study|Physician Decision|1|||
23548322|NCT04794803|65739515|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
23548323|NCT04794803|65739516|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
23548324|NCT04794803|65739515|FG000|Overall Study|Refused to continue the treatment|1|||
23548325|NCT04794803|65739516|FG001|Overall Study|Refused to continue the treatment|0|||
23619788|NCT01904019|65994743|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
23548326|NCT04794803|65739515|FG000|Overall Study|Patient admitted to ICU|0|||
23619789|NCT01904019|65994743|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
23619790|NCT01904019|65994743|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
23619791|NCT01904019|65994743|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
23619792|NCT01904019|65994743|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
23619793|NCT02995733|65994748|FG000|Overall Study|Study site closed|9|||
23619794|NCT02995733|65994749|FG001|Overall Study|Study site closed|10|||
23619795|NCT02995733|65994748|FG000|Overall Study|Death|3|||
23619796|NCT02995733|65994749|FG001|Overall Study|Death|4|||
23428245|NCT00316693|65310764|FG001|Overall Study|Adverse Event|1|||
23428246|NCT00316693|65310763|FG000|Overall Study|Protocol Violation|1|||
23548327|NCT04794803|65739516|FG001|Overall Study|Patient admitted to ICU|1|||
23548328|NCT02105116|65739517|FG000|Overall Study|not eligible for step 2 of trial|5|||
23548329|NCT02105116|65739517|FG000|Overall Study|Death|1|||
23548330|NCT00325468|65739518|FG000|Overall Study|Adverse Event|1|||
23548331|NCT00325468|65739519|FG001|Overall Study|Adverse Event|1|||
23548332|NCT00325468|65739520|FG002|Overall Study|Adverse Event|0|||
23619797|NCT02995733|65994748|FG000|Overall Study|Withdrawal by Subject|6|||
23619798|NCT02995733|65994749|FG001|Overall Study|Withdrawal by Subject|2|||
23619799|NCT02995733|65994748|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
23619800|NCT02995733|65994749|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
23619801|NCT02995733|65994748|FG000|Overall Study|Lost to Follow-up|48|||
23619802|NCT02995733|65994749|FG001|Overall Study|Lost to Follow-up|37|||
23619803|NCT02995733|65994748|FG000|Overall Study|Other|0|||
23619804|NCT02995733|65994749|FG001|Overall Study|Other|1|||
23133577|NCT01451827|64237453|FG003|Overall Study|Adverse Event|1|||
23133578|NCT01451827|64237450|FG000|Overall Study|Protocol deviation|1|||
23619805|NCT01878383|65994752|FG000|Overall Study|Lost to Follow-up|0|||
23619806|NCT01878383|65994753|FG001|Overall Study|Lost to Follow-up|1499|||
23133579|NCT01451827|64237451|FG001|Overall Study|Protocol deviation|0|||
23619807|NCT00655668|65994754|FG000|Overall Study|Adverse Event|6|||
23619808|NCT00655668|65994754|FG000|Overall Study|Death|5|||
23619809|NCT00655668|65994754|FG000|Overall Study|Disease Progression|27|||
23619810|NCT00655668|65994754|FG000|Overall Study|Study Terminated|9|||
23619811|NCT00655668|65994754|FG000|Overall Study|Other|1|||
23619812|NCT00655668|65994754|FG000|Overall Study|New Lymphoma Treatment Started|4|||
23619813|NCT00655668|65994754|FG000|Overall Study|Withdrawal by Subject|2|||
23619814|NCT01062971|65994755|FG000|Overall Study|Protocol Violation|1|||
23619815|NCT01062971|65994756|FG001|Overall Study|Protocol Violation|3|||
23619816|NCT01062971|65994755|FG000|Overall Study|Lost to Follow-up|3|||
23619817|NCT01062971|65994756|FG001|Overall Study|Lost to Follow-up|4|||
23619818|NCT00084747|65994757|FG000|Overall Study|Relapsed|8|||
23619819|NCT00084747|65994757|FG000|Overall Study|Death|3|||
23619820|NCT00084747|65994757|FG000|Overall Study|Withdrawal by Subject|2|||
23619821|NCT01560585|65994768|FG000|Overall Study|Physician Decision|3|||
23133580|NCT01451827|64237452|FG002|Overall Study|Protocol deviation|0|||
23619822|NCT02109107|65994769|FG000|Overall Study|Lost to Follow-up|2|||
23619823|NCT01202409|65994774|FG000|Overall Study|Adverse Event|1|||
23619824|NCT01202409|65994774|FG000|Overall Study|Ineligible - KRAS mutants|7|||
23619825|NCT00676195|65994775|FG000|Overall Study|Lost to Follow-up|1|||
23619826|NCT00676195|65994775|FG000|Overall Study|Adverse Event|1|||
23619827|NCT00676195|65994775|FG000|Overall Study|Physician Decision|1|||
23619828|NCT02551692|65994779|FG000|Overall Study|Lost to Follow-up|0|||
23619829|NCT02551692|65994780|FG001|Overall Study|Lost to Follow-up|1|||
23619830|NCT02551692|65994781|FG002|Overall Study|Lost to Follow-up|4|||
23619831|NCT02551692|65994779|FG000|Overall Study|Withdrawal by Subject|1|||
23619832|NCT02551692|65994780|FG001|Overall Study|Withdrawal by Subject|0|||
23619833|NCT02551692|65994781|FG002|Overall Study|Withdrawal by Subject|1|||
23619834|NCT00361842|65994782|FG000|Overall Study|Withdrawal by Subject|2|||
23619835|NCT00361842|65994783|FG001|Overall Study|Withdrawal by Subject|3|||
23619836|NCT00361842|65994782|FG000|Overall Study|Death|2|||
23133581|NCT01451827|64237453|FG003|Overall Study|Protocol deviation|0|||
23133582|NCT01451827|64237450|FG000|Overall Study|Lost to Follow-up|0|||
23428247|NCT00316693|65310764|FG001|Overall Study|Protocol Violation|0|||
23548333|NCT00325468|65739521|FG003|Overall Study|Adverse Event|5|||
23548334|NCT00325468|65739522|FG004|Overall Study|Adverse Event|1|||
23619837|NCT00361842|65994783|FG001|Overall Study|Death|1|||
23619838|NCT00361842|65994782|FG000|Overall Study|Disease progression|19|||
23619839|NCT00361842|65994783|FG001|Overall Study|Disease progression|20|||
23619840|NCT00361842|65994782|FG000|Overall Study|Adverse Event|2|||
23619841|NCT00361842|65994783|FG001|Overall Study|Adverse Event|3|||
23619842|NCT00361842|65994782|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
23619843|NCT00361842|65994783|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
23619844|NCT00361842|65994782|FG000|Overall Study|Other|1|||
23619845|NCT00361842|65994783|FG001|Overall Study|Other|0|||
23619846|NCT00361842|65994782|FG000|Overall Study|Other|0|||
23133583|NCT01451827|64237451|FG001|Overall Study|Lost to Follow-up|3|||
23428248|NCT00316693|65310763|FG000|Overall Study|Withdrawal by Subject|6|||
23428249|NCT00316693|65310764|FG001|Overall Study|Withdrawal by Subject|6|||
23133584|NCT01451827|64237452|FG002|Overall Study|Lost to Follow-up|0|||
23133585|NCT01451827|64237453|FG003|Overall Study|Lost to Follow-up|2|||
23133586|NCT01451827|64237450|FG000|Overall Study|Participant met withdrawal criteria|0|||
23133587|NCT01451827|64237451|FG001|Overall Study|Participant met withdrawal criteria|2|||
23133588|NCT01451827|64237452|FG002|Overall Study|Participant met withdrawal criteria|0|||
23133589|NCT01451827|64237453|FG003|Overall Study|Participant met withdrawal criteria|0|||
23133590|NCT01451827|64237450|FG000|Overall Study|Withdrawal by Subject|0|||
23133591|NCT01451827|64237451|FG001|Overall Study|Withdrawal by Subject|0|||
23133592|NCT01451827|64237452|FG002|Overall Study|Withdrawal by Subject|1|||
23133593|NCT01451827|64237453|FG003|Overall Study|Withdrawal by Subject|1|||
23133594|NCT00403767|64237455|FG000|Overall Study|Adverse Event|993|||
23133595|NCT00403767|64237456|FG001|Overall Study|Adverse Event|919|||
23133596|NCT00403767|64237455|FG000|Overall Study|Non-compliant with study medication|134|||
23133597|NCT00403767|64237456|FG001|Overall Study|Non-compliant with study medication|164|||
23133598|NCT00403767|64237455|FG000|Overall Study|Consent withdrawn|671|||
23133599|NCT00403767|64237456|FG001|Overall Study|Consent withdrawn|673|||
23133600|NCT00403767|64237455|FG000|Overall Study|Investigator dec./not protocol-related|191|||
23133601|NCT00403767|64237456|FG001|Overall Study|Investigator dec./not protocol-related|178|||
23133602|NCT00403767|64237455|FG000|Overall Study|Lost to Follow-up|6|||
23133603|NCT00403767|64237456|FG001|Overall Study|Lost to Follow-up|8|||
23133604|NCT00403767|64237455|FG000|Overall Study|Protocol Violation|142|||
23214150|NCT02151682|64523538|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23214151|NCT02151682|64523539|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
23214152|NCT02151682|64523534|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23214153|NCT02151682|64523535|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23214154|NCT02151682|64523536|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
23214155|NCT02151682|64523537|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23214156|NCT02151682|64523538|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23214157|NCT02151682|64523539|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
23214158|NCT02151682|64523534|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
23214159|NCT02151682|64523535|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
23133605|NCT00403767|64237456|FG001|Overall Study|Protocol Violation|124|||
23133606|NCT00403767|64237455|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
23133607|NCT00403767|64237456|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
23133608|NCT00403767|64237455|FG000|Overall Study|Study terminated by sponsor|82|||
23133609|NCT00403767|64237456|FG001|Overall Study|Study terminated by sponsor|69|||
23133610|NCT00403767|64237455|FG000|Overall Study|Missing/incomplete data|1|||
23133611|NCT00403767|64237456|FG001|Overall Study|Missing/incomplete data|1|||
23133612|NCT02113124|64237457|FG000|Overall Study|Unable to retrieve blood sample|1|||
23133613|NCT02113124|64237458|FG001|Overall Study|Unable to retrieve blood sample|1|||
23133614|NCT01076647|64237459|FG000|Overall Study|Adverse Event|4|||
23133615|NCT01076647|64237460|FG001|Overall Study|Adverse Event|1|||
23133616|NCT01076647|64237459|FG000|Overall Study|Lack of Efficacy|0|||
23133617|NCT01076647|64237460|FG001|Overall Study|Lack of Efficacy|1|||
23133618|NCT01076647|64237459|FG000|Overall Study|Protocol Violation|7|||
23133619|NCT01076647|64237460|FG001|Overall Study|Protocol Violation|9|||
23133620|NCT01076647|64237459|FG000|Overall Study|Withdrawal criteria|2|||
23133621|NCT01076647|64237460|FG001|Overall Study|Withdrawal criteria|2|||
23133622|NCT01076647|64237459|FG000|Overall Study|Unclassified|12|||
23133623|NCT01076647|64237460|FG001|Overall Study|Unclassified|12|||
23133624|NCT00283244|64237463|FG000|Overall Study|Adverse Event|0|||
23133625|NCT00283244|64237464|FG001|Overall Study|Adverse Event|8|||
23133626|NCT00283244|64237465|FG002|Overall Study|Adverse Event|11|||
23133627|NCT00283244|64237463|FG000|Overall Study|Death|4|||
23133628|NCT00283244|64237464|FG001|Overall Study|Death|3|||
23133629|NCT00283244|64237465|FG002|Overall Study|Death|2|||
23133630|NCT00283244|64237463|FG000|Overall Study|Lack of Efficacy|8|||
23214160|NCT02151682|64523536|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
23548335|NCT00325468|65739518|FG000|Overall Study|Death|2|||
23548336|NCT00325468|65739519|FG001|Overall Study|Death|0|||
23548337|NCT00325468|65739520|FG002|Overall Study|Death|2|||
23548338|NCT00325468|65739521|FG003|Overall Study|Death|4|||
23548339|NCT00325468|65739522|FG004|Overall Study|Death|0|||
23548340|NCT00325468|65739518|FG000|Overall Study|Lost to Follow-up|0|||
23133631|NCT00283244|64237464|FG001|Overall Study|Lack of Efficacy|32|||
23548341|NCT00325468|65739519|FG001|Overall Study|Lost to Follow-up|0|||
23548342|NCT00325468|65739520|FG002|Overall Study|Lost to Follow-up|1|||
23548343|NCT00325468|65739521|FG003|Overall Study|Lost to Follow-up|2|||
23133632|NCT00283244|64237465|FG002|Overall Study|Lack of Efficacy|26|||
23133633|NCT00283244|64237463|FG000|Overall Study|Withdrawal by Subject|1|||
23133634|NCT00283244|64237464|FG001|Overall Study|Withdrawal by Subject|2|||
23133635|NCT00283244|64237465|FG002|Overall Study|Withdrawal by Subject|2|||
23133636|NCT00283244|64237463|FG000|Overall Study|Physician Decision|0|||
23133637|NCT00283244|64237464|FG001|Overall Study|Physician Decision|0|||
23133638|NCT00283244|64237465|FG002|Overall Study|Physician Decision|1|||
23133639|NCT00283244|64237463|FG000|Overall Study|Medical illness (other complicating dz)|4|||
23133640|NCT00283244|64237464|FG001|Overall Study|Medical illness (other complicating dz)|3|||
23133641|NCT00283244|64237465|FG002|Overall Study|Medical illness (other complicating dz)|6|||
23133642|NCT00283244|64237463|FG000|Overall Study|Clinical deterioration|1|||
23133643|NCT00283244|64237464|FG001|Overall Study|Clinical deterioration|3|||
23133644|NCT00283244|64237465|FG002|Overall Study|Clinical deterioration|3|||
23133645|NCT00626197|64237466|FG000|Overall Study|Did not cooperate|2|||
23133646|NCT00626197|64237467|FG001|Overall Study|Did not cooperate|6|||
23133647|NCT00626197|64237468|FG002|Overall Study|Did not cooperate|1|||
23133648|NCT00626197|64237466|FG000|Overall Study|Failure to return|6|||
23133649|NCT00626197|64237467|FG001|Overall Study|Failure to return|5|||
23133650|NCT00626197|64237468|FG002|Overall Study|Failure to return|6|||
23133651|NCT00626197|64237466|FG000|Overall Study|Adverse event, serious fatal|3|||
23133652|NCT00626197|64237467|FG001|Overall Study|Adverse event, serious fatal|6|||
23133653|NCT00626197|64237468|FG002|Overall Study|Adverse event, serious fatal|6|||
23133654|NCT00626197|64237466|FG000|Overall Study|Adverse Event|1|||
23133655|NCT00626197|64237467|FG001|Overall Study|Adverse Event|1|||
23133656|NCT00626197|64237468|FG002|Overall Study|Adverse Event|2|||
23133657|NCT00626197|64237466|FG000|Overall Study|Withdrawal by Subject|17|||
23133658|NCT00626197|64237467|FG001|Overall Study|Withdrawal by Subject|17|||
23133659|NCT00626197|64237468|FG002|Overall Study|Withdrawal by Subject|7|||
23133660|NCT00626197|64237466|FG000|Overall Study|Administrative reasons|15|||
23133661|NCT00626197|64237467|FG001|Overall Study|Administrative reasons|19|||
23133662|NCT00626197|64237468|FG002|Overall Study|Administrative reasons|55|||
23133663|NCT00772330|64237472|FG000|Overall Study|Lost to Follow-up|3|||
23133664|NCT03554629|64237473|FG000|Overall Study|Inadequate data|6|||
23133665|NCT03965351|64237475|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
23133666|NCT03965351|64237476|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
23133667|NCT03965351|64237475|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
23133668|NCT03965351|64237476|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
23133669|NCT03921723|64237477|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
23133670|NCT03921723|64237477|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
23133671|NCT02550938|64237482|FG000|Overall Study|Lost to Follow-up|8|||
23133672|NCT02550938|64237483|FG001|Overall Study|Lost to Follow-up|7|||
23133673|NCT02550938|64237484|FG002|Overall Study|Lost to Follow-up|12|||
23133674|NCT02550938|64237485|FG003|Overall Study|Lost to Follow-up|11|||
23133675|NCT03231800|64237486|FG000|Overall Study|Lost to Follow-up|0|||
23133676|NCT03231800|64237487|FG001|Overall Study|Lost to Follow-up|2|||
23133677|NCT03231800|64237486|FG000|Overall Study|Protocol Violation|1|||
23133678|NCT03231800|64237487|FG001|Overall Study|Protocol Violation|1|||
23133679|NCT03231800|64237486|FG000|Overall Study|reason not provided|2|||
23133680|NCT03231800|64237487|FG001|Overall Study|reason not provided|0|||
23133681|NCT00652327|64237488|FG000|Overall Study|Adverse Event|0|||
23133682|NCT00652327|64237489|FG001|Overall Study|Adverse Event|2|||
23133683|NCT00652327|64237488|FG000|Overall Study|Lost to Follow-up|0|||
23133684|NCT00652327|64237489|FG001|Overall Study|Lost to Follow-up|3|||
23133685|NCT01806623|64237494|FG000|Overall Study|Withdrawal by Subject|1|||
23133686|NCT01806623|64237494|FG000|Overall Study|Adverse Event|1|||
23133687|NCT01806623|64237494|FG000|Overall Study|Did not meet the inclusion criteria|56|||
23133688|NCT03046121|64237497|FG000|Overall Study|Death|32|||
23133689|NCT03046121|64237498|FG001|Overall Study|Death|60|||
23133690|NCT03046121|64237497|FG000|Overall Study|Withdrawal by Subject|14|||
23133691|NCT03046121|64237498|FG001|Overall Study|Withdrawal by Subject|12|||
23133692|NCT02311673|64237501|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
23133693|NCT02311673|64237502|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
23133694|NCT02311673|64237503|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
23133695|NCT02311673|64237504|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
23133696|NCT01901419|64237505|FG000|Overall Study|Protocol Violation|2|||
23133697|NCT01901419|64237506|FG001|Overall Study|Protocol Violation|6|||
23133698|NCT01901419|64237505|FG000|Overall Study|unavailable researchers|6|||
23133699|NCT01901419|64237506|FG001|Overall Study|unavailable researchers|3|||
23133700|NCT01803282|64237509|FG000|Overall Study|Progressive Disease|4|||
23214161|NCT02151682|64523537|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
23214162|NCT02151682|64523538|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
23133701|NCT01803282|64237510|FG001|Overall Study|Progressive Disease|3|||
23133702|NCT01803282|64237511|FG002|Overall Study|Progressive Disease|6|||
23133703|NCT01803282|64237512|FG003|Overall Study|Progressive Disease|22|||
23133704|NCT01803282|64237513|FG004|Overall Study|Progressive Disease|5|||
23133705|NCT01803282|64237514|FG005|Overall Study|Progressive Disease|8|||
23133706|NCT01803282|64237515|FG006|Overall Study|Progressive Disease|23|||
23133707|NCT01803282|64237516|FG007|Overall Study|Progressive Disease|24|||
23133708|NCT01803282|64237517|FG008|Overall Study|Progressive Disease|3|||
23133709|NCT01803282|64237518|FG009|Overall Study|Progressive Disease|29|||
23133710|NCT01803282|64237519|FG010|Overall Study|Progressive Disease|6|||
23133711|NCT01803282|64237520|FG011|Overall Study|Progressive Disease|11|||
23133712|NCT01803282|64237509|FG000|Overall Study|Death|0|||
23548344|NCT00325468|65739522|FG004|Overall Study|Lost to Follow-up|2|||
23548345|NCT00325468|65739518|FG000|Overall Study|Physician Decision|1|||
23548346|NCT00325468|65739519|FG001|Overall Study|Physician Decision|1|||
23548347|NCT00325468|65739520|FG002|Overall Study|Physician Decision|0|||
23548348|NCT00325468|65739521|FG003|Overall Study|Physician Decision|1|||
23548349|NCT00325468|65739522|FG004|Overall Study|Physician Decision|0|||
23548350|NCT00325468|65739518|FG000|Overall Study|Withdrawal by Subject|3|||
23548351|NCT00325468|65739519|FG001|Overall Study|Withdrawal by Subject|1|||
23548352|NCT00325468|65739520|FG002|Overall Study|Withdrawal by Subject|0|||
23548353|NCT00325468|65739521|FG003|Overall Study|Withdrawal by Subject|14|||
23548354|NCT00325468|65739522|FG004|Overall Study|Withdrawal by Subject|4|||
23548355|NCT00325468|65739518|FG000|Overall Study|site closure etc|4|||
23548356|NCT00325468|65739519|FG001|Overall Study|site closure etc|2|||
23428250|NCT00316693|65310763|FG000|Overall Study|Lost to Follow-up|26|||
23548357|NCT00325468|65739520|FG002|Overall Study|site closure etc|1|||
23133713|NCT01803282|64237510|FG001|Overall Study|Death|0|||
23133714|NCT01803282|64237511|FG002|Overall Study|Death|0|||
23133715|NCT01803282|64237512|FG003|Overall Study|Death|0|||
23548358|NCT00325468|65739521|FG003|Overall Study|site closure etc|8|||
23548359|NCT00325468|65739522|FG004|Overall Study|site closure etc|1|||
23548360|NCT05608629|65739523|FG000|Overall Study|Lost to Follow-up|2|||
23548361|NCT01358968|65739524|FG000|Period 2|Adverse Event|0|||
23548362|NCT01358968|65739525|FG001|Period 2|Adverse Event|1|||
23548363|NCT01358968|65739526|FG002|Period 2|Adverse Event|0|||
23548364|NCT01358968|65739527|FG003|Period 2|Adverse Event|0|||
23548365|NCT01358968|65739524|FG000|Continued Access Phase|Progression of Disease|0|||
23548366|NCT01358968|65739525|FG001|Continued Access Phase|Progression of Disease|0|||
23548367|NCT01358968|65739526|FG002|Continued Access Phase|Progression of Disease|8|||
23548368|NCT01358968|65739527|FG003|Continued Access Phase|Progression of Disease|4|||
23548369|NCT01358968|65739524|FG000|Continued Access Phase|Protocol Violation|0|||
23548370|NCT01358968|65739525|FG001|Continued Access Phase|Protocol Violation|0|||
23548371|NCT01358968|65739526|FG002|Continued Access Phase|Protocol Violation|0|||
23548372|NCT01358968|65739527|FG003|Continued Access Phase|Protocol Violation|2|||
23548373|NCT01358968|65739524|FG000|Continued Access Phase|Withdrawal by Subject|0|||
23548374|NCT01358968|65739525|FG001|Continued Access Phase|Withdrawal by Subject|0|||
23548375|NCT01358968|65739526|FG002|Continued Access Phase|Withdrawal by Subject|3|||
23548376|NCT01358968|65739527|FG003|Continued Access Phase|Withdrawal by Subject|0|||
23548377|NCT01358968|65739524|FG000|Continued Access Phase|Death|0|||
23548378|NCT01358968|65739525|FG001|Continued Access Phase|Death|0|||
23548379|NCT01358968|65739526|FG002|Continued Access Phase|Death|1|||
23548380|NCT01358968|65739527|FG003|Continued Access Phase|Death|1|||
23548381|NCT00476476|65739528|FG000|Overall Study|Adverse Event|2|||
23548382|NCT00476476|65739529|FG001|Overall Study|Adverse Event|7|||
23548383|NCT00476476|65739528|FG000|Overall Study|Progressive Disease|0|||
23548384|NCT00476476|65739529|FG001|Overall Study|Progressive Disease|17|||
23548385|NCT00896168|65739530|FG000|Overall Study|Adverse Event|4|||
23548386|NCT00896168|65739531|FG001|Overall Study|Adverse Event|7|||
23133716|NCT01803282|64237513|FG004|Overall Study|Death|2|||
23133717|NCT01803282|64237514|FG005|Overall Study|Death|1|||
23133718|NCT01803282|64237515|FG006|Overall Study|Death|1|||
23133719|NCT01803282|64237516|FG007|Overall Study|Death|5|||
23133720|NCT01803282|64237517|FG008|Overall Study|Death|1|||
23133721|NCT01803282|64237518|FG009|Overall Study|Death|1|||
23133722|NCT01803282|64237519|FG010|Overall Study|Death|0|||
23133723|NCT01803282|64237520|FG011|Overall Study|Death|0|||
23133724|NCT01803282|64237509|FG000|Overall Study|Withdrew Consent|0|||
23133725|NCT01803282|64237510|FG001|Overall Study|Withdrew Consent|0|||
23133726|NCT01803282|64237511|FG002|Overall Study|Withdrew Consent|0|||
23133727|NCT01803282|64237512|FG003|Overall Study|Withdrew Consent|6|||
23133728|NCT01803282|64237513|FG004|Overall Study|Withdrew Consent|1|||
23133729|NCT01803282|64237514|FG005|Overall Study|Withdrew Consent|0|||
23133730|NCT01803282|64237515|FG006|Overall Study|Withdrew Consent|8|||
23133731|NCT01803282|64237516|FG007|Overall Study|Withdrew Consent|3|||
23133732|NCT01803282|64237517|FG008|Overall Study|Withdrew Consent|1|||
23133733|NCT01803282|64237518|FG009|Overall Study|Withdrew Consent|5|||
23548387|NCT00896168|65739530|FG000|Overall Study|Treatment failure|8|||
23548388|NCT00896168|65739531|FG001|Overall Study|Treatment failure|10|||
23214163|NCT02151682|64523539|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
23548389|NCT00896168|65739530|FG000|Overall Study|Lost to Follow-up|1|||
23548390|NCT00896168|65739531|FG001|Overall Study|Lost to Follow-up|1|||
23548391|NCT00896168|65739530|FG000|Overall Study|Other|1|||
23548392|NCT00896168|65739531|FG001|Overall Study|Other|1|||
23548393|NCT04391023|65739532|FG000|Overall Study|Withdrawal by Subject|2|||
23548394|NCT04391023|65739533|FG001|Overall Study|Withdrawal by Subject|2|||
23133734|NCT01803282|64237519|FG010|Overall Study|Withdrew Consent|0|||
23133735|NCT01803282|64237520|FG011|Overall Study|Withdrew Consent|1|||
23133736|NCT01803282|64237509|FG000|Overall Study|Investigator's Discretion|0|||
23133737|NCT01803282|64237510|FG001|Overall Study|Investigator's Discretion|0|||
23133738|NCT01803282|64237511|FG002|Overall Study|Investigator's Discretion|0|||
23133739|NCT01803282|64237512|FG003|Overall Study|Investigator's Discretion|7|||
23548395|NCT01362140|65739534|FG000|Overall Study|Noncompliance|1|||
23548396|NCT01362140|65739535|FG001|Overall Study|Noncompliance|0|||
23548397|NCT01362140|65739534|FG000|Overall Study|Adverse Event|2|||
23548398|NCT01362140|65739535|FG001|Overall Study|Adverse Event|2|||
23548399|NCT01362140|65739534|FG000|Overall Study|Withdrawal by Subject|3|||
23548400|NCT01362140|65739535|FG001|Overall Study|Withdrawal by Subject|3|||
23548401|NCT01362140|65739534|FG000|Overall Study|Administrative Decision|0|||
23548402|NCT01362140|65739535|FG001|Overall Study|Administrative Decision|1|||
23548403|NCT01362140|65739534|FG000|Overall Study|Death|2|||
23133740|NCT01803282|64237513|FG004|Overall Study|Investigator's Discretion|2|||
23133741|NCT01803282|64237514|FG005|Overall Study|Investigator's Discretion|1|||
23133742|NCT01803282|64237515|FG006|Overall Study|Investigator's Discretion|7|||
23133743|NCT01803282|64237516|FG007|Overall Study|Investigator's Discretion|10|||
23133744|NCT01803282|64237517|FG008|Overall Study|Investigator's Discretion|6|||
23133745|NCT01803282|64237518|FG009|Overall Study|Investigator's Discretion|7|||
23133746|NCT01803282|64237519|FG010|Overall Study|Investigator's Discretion|1|||
23133747|NCT01803282|64237520|FG011|Overall Study|Investigator's Discretion|0|||
23133748|NCT01803282|64237509|FG000|Overall Study|Adverse Event|0|||
23133749|NCT01803282|64237510|FG001|Overall Study|Adverse Event|0|||
23133750|NCT01803282|64237511|FG002|Overall Study|Adverse Event|0|||
23133751|NCT01803282|64237512|FG003|Overall Study|Adverse Event|0|||
23133752|NCT01803282|64237513|FG004|Overall Study|Adverse Event|0|||
23133753|NCT01803282|64237514|FG005|Overall Study|Adverse Event|0|||
23133754|NCT01803282|64237515|FG006|Overall Study|Adverse Event|1|||
23133755|NCT01803282|64237516|FG007|Overall Study|Adverse Event|2|||
23133756|NCT01803282|64237517|FG008|Overall Study|Adverse Event|0|||
23133757|NCT01803282|64237518|FG009|Overall Study|Adverse Event|1|||
23133758|NCT01803282|64237519|FG010|Overall Study|Adverse Event|0|||
23133759|NCT01803282|64237520|FG011|Overall Study|Adverse Event|3|||
23133760|NCT01803282|64237509|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23133761|NCT01803282|64237510|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23133762|NCT01803282|64237511|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23133763|NCT01803282|64237512|FG003|Overall Study|Non-Compliance with Study Drug|1|||
23133764|NCT01803282|64237513|FG004|Overall Study|Non-Compliance with Study Drug|0|||
23133765|NCT01803282|64237514|FG005|Overall Study|Non-Compliance with Study Drug|0|||
23133766|NCT01803282|64237515|FG006|Overall Study|Non-Compliance with Study Drug|0|||
23133767|NCT01803282|64237516|FG007|Overall Study|Non-Compliance with Study Drug|0|||
23133768|NCT01803282|64237517|FG008|Overall Study|Non-Compliance with Study Drug|0|||
23133769|NCT01803282|64237518|FG009|Overall Study|Non-Compliance with Study Drug|0|||
23133770|NCT01803282|64237519|FG010|Overall Study|Non-Compliance with Study Drug|0|||
23133771|NCT01803282|64237520|FG011|Overall Study|Non-Compliance with Study Drug|0|||
23133772|NCT01803282|64237509|FG000|Overall Study|Unknown Reason|0|||
23133773|NCT01803282|64237510|FG001|Overall Study|Unknown Reason|0|||
23133774|NCT01803282|64237511|FG002|Overall Study|Unknown Reason|0|||
23133775|NCT01803282|64237512|FG003|Overall Study|Unknown Reason|0|||
23133776|NCT01803282|64237513|FG004|Overall Study|Unknown Reason|0|||
23133777|NCT01803282|64237514|FG005|Overall Study|Unknown Reason|0|||
23133778|NCT01803282|64237515|FG006|Overall Study|Unknown Reason|0|||
23133779|NCT01803282|64237516|FG007|Overall Study|Unknown Reason|1|||
23133780|NCT01803282|64237517|FG008|Overall Study|Unknown Reason|0|||
23133781|NCT01803282|64237518|FG009|Overall Study|Unknown Reason|0|||
23133782|NCT01803282|64237519|FG010|Overall Study|Unknown Reason|0|||
23133783|NCT01803282|64237520|FG011|Overall Study|Unknown Reason|0|||
23133784|NCT01803282|64237509|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
23133785|NCT01803282|64237510|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
23133786|NCT01803282|64237511|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
23133787|NCT01803282|64237512|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
23133788|NCT01803282|64237513|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
23133789|NCT01803282|64237514|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
23133790|NCT01803282|64237515|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
23133791|NCT01803282|64237516|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
23133792|NCT01803282|64237517|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
23548404|NCT01362140|65739535|FG001|Overall Study|Death|1|||
23548405|NCT01362140|65739534|FG000|Overall Study|Other|1|||
23133793|NCT01803282|64237518|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
23133794|NCT01803282|64237519|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
23133795|NCT01803282|64237520|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
23133796|NCT01803282|64237509|FG000|Overall Study|Enrolled but Never Treated|0|||
23133797|NCT01803282|64237510|FG001|Overall Study|Enrolled but Never Treated|0|||
23133798|NCT01803282|64237511|FG002|Overall Study|Enrolled but Never Treated|0|||
23133799|NCT01803282|64237512|FG003|Overall Study|Enrolled but Never Treated|0|||
23548406|NCT01362140|65739535|FG001|Overall Study|Other|1|||
23548407|NCT01362140|65739534|FG000|Overall Study|Protocol-specified Criteria|1|||
23133800|NCT01803282|64237513|FG004|Overall Study|Enrolled but Never Treated|1|||
23133801|NCT01803282|64237514|FG005|Overall Study|Enrolled but Never Treated|0|||
23133802|NCT01803282|64237515|FG006|Overall Study|Enrolled but Never Treated|1|||
23548408|NCT01362140|65739535|FG001|Overall Study|Protocol-specified Criteria|2|||
23548409|NCT01362140|65739534|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
23548410|NCT01362140|65739535|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
23548411|NCT01912612|65739538|FG000|Overall Study|Adverse Event|4|||
23548412|NCT01912612|65739539|FG001|Overall Study|Adverse Event|0|||
23548413|NCT01912612|65739540|FG002|Overall Study|Adverse Event|0|||
23548414|NCT01912612|65739538|FG000|Overall Study|Withdrew consent|1|||
23548415|NCT01912612|65739539|FG001|Overall Study|Withdrew consent|0|||
23548416|NCT01912612|65739540|FG002|Overall Study|Withdrew consent|0|||
23548417|NCT01912612|65739538|FG000|Overall Study|Study design change|0|||
23548418|NCT01912612|65739539|FG001|Overall Study|Study design change|0|||
23548419|NCT01912612|65739540|FG002|Overall Study|Study design change|3|||
23548420|NCT01764945|65739547|FG000|Overall Study|Adverse Event|0|||
23548421|NCT01764945|65739548|FG001|Overall Study|Adverse Event|1|||
23133803|NCT01803282|64237516|FG007|Overall Study|Enrolled but Never Treated|1|||
23133804|NCT01803282|64237517|FG008|Overall Study|Enrolled but Never Treated|0|||
23214164|NCT02151682|64523534|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
23214165|NCT02151682|64523535|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
23214166|NCT02151682|64523536|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
23214167|NCT02151682|64523537|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
23214168|NCT02151682|64523538|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
23214169|NCT02151682|64523539|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
23214170|NCT02151682|64523534|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23214171|NCT02151682|64523535|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23428251|NCT00316693|65310764|FG001|Overall Study|Lost to Follow-up|34|||
23428252|NCT00316693|65310763|FG000|Overall Study|Other|38|||
23133805|NCT01803282|64237518|FG009|Overall Study|Enrolled but Never Treated|1|||
23133806|NCT01803282|64237519|FG010|Overall Study|Enrolled but Never Treated|0|||
23133807|NCT01803282|64237520|FG011|Overall Study|Enrolled but Never Treated|0|||
23133808|NCT01012414|64237521|FG000|Overall Study|Withdrawal by Subject|2|||
23133809|NCT01012414|64237521|FG000|Overall Study|Lost to Follow-up|1|||
23428253|NCT00316693|65310764|FG001|Overall Study|Other|44|||
23428254|NCT04135859|65310765|FG000|Overall Study|Withdrawal by Subject|1|||
23428255|NCT04135859|65310766|FG001|Overall Study|Withdrawal by Subject|0|||
23428256|NCT04135859|65310765|FG000|Overall Study|Withdrawal due to screening failure|1|||
23428257|NCT04135859|65310766|FG001|Overall Study|Withdrawal due to screening failure|2|||
23428258|NCT04135859|65310765|FG000|Overall Study|Did not complete stress test|3|||
23428259|NCT04135859|65310766|FG001|Overall Study|Did not complete stress test|3|||
23428260|NCT04135859|65310765|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
23428261|NCT04135859|65310766|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
23428262|NCT00680368|65310767|FG000|Overall Study|not supervised, not eligible|15|||
23428263|NCT00468845|65310768|FG000|Overall Study|Adverse Event|9|||
23428264|NCT00468845|65310769|FG001|Overall Study|Adverse Event|14|||
23428265|NCT00468845|65310770|FG002|Overall Study|Adverse Event|11|||
23428266|NCT00468845|65310768|FG000|Overall Study|Lost to Follow-up|2|||
23428267|NCT00468845|65310769|FG001|Overall Study|Lost to Follow-up|1|||
23428268|NCT00468845|65310770|FG002|Overall Study|Lost to Follow-up|2|||
23428269|NCT00468845|65310768|FG000|Overall Study|Other|4|||
23428270|NCT00468845|65310769|FG001|Overall Study|Other|9|||
23428271|NCT00468845|65310770|FG002|Overall Study|Other|5|||
23428272|NCT00468845|65310768|FG000|Overall Study|No longer willing to participate|5|||
23428273|NCT00468845|65310769|FG001|Overall Study|No longer willing to participate|6|||
23428274|NCT00468845|65310770|FG002|Overall Study|No longer willing to participate|10|||
23428275|NCT00468845|65310768|FG000|Overall Study|Randomized, not treated|1|||
23428276|NCT00468845|65310769|FG001|Overall Study|Randomized, not treated|4|||
23428277|NCT00468845|65310770|FG002|Overall Study|Randomized, not treated|2|||
23428278|NCT01318070|65310771|FG000|Overall Study|Adverse Event|1|||
23428279|NCT01318070|65310772|FG001|Overall Study|Adverse Event|1|||
23428280|NCT01318070|65310773|FG002|Overall Study|Adverse Event|5|||
23428281|NCT01318070|65310771|FG000|Overall Study|Withdrawal by Subject|0|||
23428282|NCT01318070|65310772|FG001|Overall Study|Withdrawal by Subject|1|||
23428283|NCT01318070|65310773|FG002|Overall Study|Withdrawal by Subject|1|||
23619847|NCT00361842|65994783|FG001|Overall Study|Other|2|||
23133810|NCT01012414|64237521|FG000|Overall Study|Trial was stopped before completed|7|||
23214172|NCT02151682|64523536|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
23133811|NCT03141905|64237522|FG000|Overall Study|Death|3|||
23133812|NCT03141905|64237523|FG001|Overall Study|Death|2|||
23428284|NCT01318070|65310771|FG000|Overall Study|Lack of Efficacy|0|||
23428285|NCT01318070|65310772|FG001|Overall Study|Lack of Efficacy|0|||
23428286|NCT01318070|65310773|FG002|Overall Study|Lack of Efficacy|1|||
23428287|NCT01318070|65310771|FG000|Overall Study|Principal Investigator Discretion|1|||
23428288|NCT01318070|65310772|FG001|Overall Study|Principal Investigator Discretion|0|||
23548422|NCT01764945|65739549|FG002|Overall Study|Adverse Event|0|||
23548423|NCT01764945|65739550|FG003|Overall Study|Adverse Event|0|||
23548424|NCT01764945|65739551|FG004|Overall Study|Adverse Event|0|||
23214173|NCT02151682|64523537|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23214174|NCT02151682|64523538|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23214175|NCT02151682|64523539|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
23214176|NCT02151682|64523534|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23214177|NCT02151682|64523535|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23214178|NCT02151682|64523536|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
23214179|NCT02151682|64523537|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23214180|NCT02151682|64523538|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23214181|NCT02151682|64523539|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
23214182|NCT02151682|64523534|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23214183|NCT02151682|64523535|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23133813|NCT03141905|64237522|FG000|Overall Study|Withdrawal by Subject|1|||
23133814|NCT03141905|64237523|FG001|Overall Study|Withdrawal by Subject|0|||
23133815|NCT03141905|64237522|FG000|Overall Study|Lost to Follow-up|3|||
23133816|NCT03141905|64237523|FG001|Overall Study|Lost to Follow-up|7|||
23133817|NCT03141905|64237522|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
23133818|NCT03141905|64237523|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
23133819|NCT00022659|64237528|FG000|Overall Study|Ineligible: wrong primary|1|||
23133820|NCT00022659|64237528|FG000|Overall Study|Never treated|1|||
23133821|NCT00818779|64237529|FG000|Overall Study|Protocol Violation|1|||
23133822|NCT00818779|64237530|FG001|Overall Study|Protocol Violation|0|||
23133823|NCT00818779|64237529|FG000|Overall Study|Lost to Follow-up|1|||
23133824|NCT00818779|64237530|FG001|Overall Study|Lost to Follow-up|0|||
23133825|NCT00818779|64237529|FG000|Overall Study|Adverse Event|4|||
23133826|NCT00818779|64237530|FG001|Overall Study|Adverse Event|1|||
23133827|NCT00925353|64237534|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
23133828|NCT01517295|64237535|FG000|Overall Study|Physician Decision|1|||
23133829|NCT01517295|64237536|FG001|Overall Study|Physician Decision|0|||
23133830|NCT02075476|64237537|FG000|Overall Study|Death|2|||
23133831|NCT02075476|64237538|FG001|Overall Study|Death|2|||
23133832|NCT02075476|64237537|FG000|Overall Study|Lost to Follow-up|1|||
23133833|NCT02075476|64237538|FG001|Overall Study|Lost to Follow-up|3|||
23133834|NCT01036438|64237539|FG000|Overall Study|Adverse Event|7|||
23133835|NCT01036438|64237540|FG001|Overall Study|Adverse Event|8|||
23133836|NCT01036438|64237539|FG000|Overall Study|Death|0|||
23133837|NCT01036438|64237540|FG001|Overall Study|Death|1|||
23133838|NCT01036438|64237539|FG000|Overall Study|No effect of study treatment|3|||
23214184|NCT02151682|64523536|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
23214185|NCT02151682|64523537|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23619848|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
23619849|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23619850|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23619851|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23619852|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23619853|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
23619854|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23619855|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23619856|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23619857|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23619858|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
23619859|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23619860|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23619861|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23619862|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23619863|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
23619864|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23619865|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23619866|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23619867|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23619868|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
23619869|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23619870|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23619871|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23133839|NCT01036438|64237540|FG001|Overall Study|No effect of study treatment|1|||
23133840|NCT01528345|64237543|FG000|Overall Study|Adverse Event|10|||
23133841|NCT01528345|64237544|FG001|Overall Study|Adverse Event|1|||
23133842|NCT01528345|64237543|FG000|Overall Study|Death|1|||
23133843|NCT01528345|64237544|FG001|Overall Study|Death|1|||
23133844|NCT01528345|64237543|FG000|Overall Study|Non-compliance with study treatment|1|||
23133845|NCT01528345|64237544|FG001|Overall Study|Non-compliance with study treatment|0|||
23133846|NCT01528345|64237543|FG000|Overall Study|Progressive Disease|26|||
23133847|NCT01528345|64237544|FG001|Overall Study|Progressive Disease|40|||
23133848|NCT01528345|64237543|FG000|Overall Study|Study Terminated by Sponsor|4|||
23133849|NCT01528345|64237544|FG001|Overall Study|Study Terminated by Sponsor|8|||
23133850|NCT01528345|64237543|FG000|Overall Study|Subject/Guardian Decision|5|||
23133851|NCT01528345|64237544|FG001|Overall Study|Subject/Guardian Decision|0|||
23133852|NCT03014479|64237545|FG000|Overall Study|Adverse Event|0|||
23133853|NCT03014479|64237546|FG001|Overall Study|Adverse Event|1|||
23133854|NCT03014479|64237545|FG000|Overall Study|Voluntary Withdrawal|0|||
23548425|NCT01764945|65739552|FG005|Overall Study|Adverse Event|0|||
23548426|NCT01764945|65739553|FG006|Overall Study|Adverse Event|1|||
23548427|NCT01764945|65739554|FG007|Overall Study|Adverse Event|0|||
23133855|NCT03014479|64237546|FG001|Overall Study|Voluntary Withdrawal|2|||
23133856|NCT03014479|64237545|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
23133857|NCT03014479|64237546|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
23133858|NCT02738853|64237547|FG000|Enrollment|Inclusion/Exclusion not met|21|||
23133859|NCT02738853|64237547|FG000|Enrollment|Withdrawal by Subject|3|||
23133860|NCT02738853|64237547|FG000|Enrollment|Subject treated with commercially available device|6|||
23133861|NCT02738853|64237547|FG000|Enrollment|Study Enrollment Closed|3|||
23619872|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23619873|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
23619874|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23619875|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23619876|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23619877|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23619878|NCT01187407|65994784|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
23619879|NCT01187407|65994785|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23619880|NCT01187407|65994786|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23619881|NCT01187407|65994787|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23619882|NCT01187407|65994788|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23619883|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
23133862|NCT02738853|64237547|FG000|Procedure|Death|1|||
23133863|NCT02738853|64237547|FG000|1 Month|Death|2|||
23133864|NCT02738853|64237547|FG000|6 Month|Death|4|||
23133865|NCT02738853|64237547|FG000|6 Month|Withdrawal by Subject|2|||
23133866|NCT02738853|64237547|FG000|1 Year|Death|6|||
23133867|NCT02738853|64237547|FG000|1 Year|Withdrawal by Subject|1|||
23548428|NCT00838110|65739555|FG000|Overall Study|Death|0|||
23548429|NCT00838110|65739556|FG001|Overall Study|Death|0|||
23548430|NCT00838110|65739557|FG002|Overall Study|Death|1|||
23548431|NCT00838110|65739558|FG003|Overall Study|Death|2|||
23548432|NCT00838110|65739555|FG000|Overall Study|Adverse Event|11|||
23548433|NCT00838110|65739556|FG001|Overall Study|Adverse Event|10|||
23548434|NCT00838110|65739557|FG002|Overall Study|Adverse Event|8|||
23548435|NCT00838110|65739558|FG003|Overall Study|Adverse Event|7|||
23548436|NCT00838110|65739555|FG000|Overall Study|Withdrawal by Subject|5|||
23548437|NCT00838110|65739556|FG001|Overall Study|Withdrawal by Subject|6|||
23619884|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
23133868|NCT02738853|64237547|FG000|2 Year|Death|2|||
23619885|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
23133869|NCT02738853|64237547|FG000|2 Year|Lost to Follow-up|1|||
23133870|NCT02738853|64237547|FG000|3 Year|Death|2|||
23133871|NCT02738853|64237547|FG000|3 Year|Withdrawal by Subject|1|||
23133872|NCT02738853|64237547|FG000|4 Year|Death|9|||
23133873|NCT02738853|64237547|FG000|5 Year|Lost to Follow-up|4|||
23133874|NCT01056718|64237549|FG000|Overall Study|Withdrawal by Subject|2|||
23133875|NCT01056718|64237549|FG000|Overall Study|Ischemia on baseline stress test|1|||
23133876|NCT02930226|64237551|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
23133877|NCT02930226|64237552|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
23133878|NCT02930226|64237553|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
23133879|NCT02930226|64237554|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
23133880|NCT02930226|64237555|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
23133881|NCT02930226|64237556|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
23133882|NCT00095056|64237561|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
23133883|NCT00095056|64237562|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
23133884|NCT00095056|64237561|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
23133885|NCT00095056|64237562|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
23428289|NCT01318070|65310773|FG002|Overall Study|Principal Investigator Discretion|0|||
23548438|NCT00838110|65739557|FG002|Overall Study|Withdrawal by Subject|3|||
23133886|NCT00095056|64237561|FG000|Phase A (Weeks 0-12)|Death|1|||
23133887|NCT00095056|64237562|FG001|Phase A (Weeks 0-12)|Death|0|||
23133888|NCT00095056|64237561|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
23133889|NCT00095056|64237562|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
23548439|NCT00838110|65739558|FG003|Overall Study|Withdrawal by Subject|4|||
23548440|NCT00838110|65739555|FG000|Overall Study|Other|3|||
23133890|NCT00095056|64237561|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
23133891|NCT00095056|64237562|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
23133892|NCT00095056|64237561|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
23133893|NCT00095056|64237562|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
23133894|NCT00095056|64237561|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
23133895|NCT00095056|64237562|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
23133896|NCT00095056|64237561|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
23133897|NCT00095056|64237562|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
23133898|NCT00095056|64237561|FG000|Phase B (Weeks 12-54)|Death|3|||
23133899|NCT00095056|64237562|FG001|Phase B (Weeks 12-54)|Death|1|||
23133900|NCT00095056|64237561|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
23133901|NCT00095056|64237562|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
23133902|NCT00095056|64237561|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
23133903|NCT00095056|64237562|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
23133904|NCT03868787|64237563|FG000|Overall Study|Withdrawal by Subject|2|||
23133905|NCT03868787|64237564|FG001|Overall Study|Withdrawal by Subject|1|||
23133906|NCT03845140|64237567|FG000|Overall Study|Participant travelled outside study area|0|||
23133907|NCT03845140|64237568|FG001|Overall Study|Participant travelled outside study area|1|||
23133908|NCT03845140|64237569|FG002|Overall Study|Participant travelled outside study area|0|||
23133909|NCT03845140|64237570|FG003|Overall Study|Participant travelled outside study area|0|||
23133910|NCT03845140|64237571|FG004|Overall Study|Participant travelled outside study area|0|||
23133911|NCT03845140|64237572|FG005|Overall Study|Participant travelled outside study area|0|||
23133912|NCT01531673|64237573|FG000|Overall Study|Non-Compliance|0|||
23133913|NCT01531673|64237574|FG001|Overall Study|Non-Compliance|0|||
23133914|NCT01531673|64237575|FG002|Overall Study|Non-Compliance|0|||
23214186|NCT02151682|64523538|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23214187|NCT02151682|64523539|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
23214188|NCT02151682|64523534|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
23214189|NCT02151682|64523535|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
23214190|NCT02151682|64523536|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
23214191|NCT02151682|64523537|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
23214192|NCT02151682|64523538|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
23214193|NCT02151682|64523539|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
23214194|NCT02151682|64523534|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
23214195|NCT02151682|64523535|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
23214196|NCT02151682|64523536|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
23214197|NCT02151682|64523537|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
23214198|NCT02151682|64523538|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
23214199|NCT02151682|64523539|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
23214200|NCT02151682|64523534|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23548441|NCT00838110|65739556|FG001|Overall Study|Other|3|||
23548442|NCT00838110|65739557|FG002|Overall Study|Other|3|||
23548443|NCT00838110|65739558|FG003|Overall Study|Other|2|||
23548444|NCT00838110|65739555|FG000|Overall Study|Protocol Violation|0|||
23548445|NCT00838110|65739556|FG001|Overall Study|Protocol Violation|2|||
23548446|NCT00838110|65739557|FG002|Overall Study|Protocol Violation|1|||
23548447|NCT00838110|65739558|FG003|Overall Study|Protocol Violation|1|||
23619886|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
23619887|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
23619888|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
23619889|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
23619890|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
23619891|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
23619892|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
23548448|NCT00838110|65739555|FG000|Overall Study|Lost to Follow-up|3|||
23548449|NCT00838110|65739556|FG001|Overall Study|Lost to Follow-up|0|||
23548450|NCT00838110|65739557|FG002|Overall Study|Lost to Follow-up|0|||
23548451|NCT00838110|65739558|FG003|Overall Study|Lost to Follow-up|0|||
23548452|NCT00838110|65739555|FG000|Overall Study|Did not meet eligibility criteria|0|||
23548453|NCT00838110|65739556|FG001|Overall Study|Did not meet eligibility criteria|0|||
23548454|NCT00838110|65739557|FG002|Overall Study|Did not meet eligibility criteria|1|||
23548455|NCT00838110|65739558|FG003|Overall Study|Did not meet eligibility criteria|2|||
23548456|NCT00838110|65739555|FG000|Overall Study|Randomized but not treated|0|||
23619893|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
23619894|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
23548457|NCT00838110|65739556|FG001|Overall Study|Randomized but not treated|1|||
23133915|NCT01531673|64237576|FG003|Overall Study|Non-Compliance|0|||
23133916|NCT01531673|64237577|FG004|Overall Study|Non-Compliance|0|||
23133917|NCT01531673|64237578|FG005|Overall Study|Non-Compliance|1|||
23133918|NCT01531673|64237579|FG006|Overall Study|Non-Compliance|0|||
23133919|NCT01531673|64237580|FG007|Overall Study|Non-Compliance|0|||
23548458|NCT00838110|65739557|FG002|Overall Study|Randomized but not treated|0|||
23548459|NCT00838110|65739558|FG003|Overall Study|Randomized but not treated|0|||
23548460|NCT06281548|65739559|FG000|Overall Study|Lost to Follow-up|3|||
23548461|NCT00843167|65739560|FG000|Treatment Period|Adverse Event|1|||
23548462|NCT00843167|65739561|FG001|Treatment Period|Adverse Event|5|||
23548463|NCT00843167|65739560|FG000|Treatment Period|Withdrawal by Subject|2|||
23133920|NCT01531673|64237581|FG008|Overall Study|Non-Compliance|0|||
23133921|NCT01531673|64237582|FG009|Overall Study|Non-Compliance|0|||
23133922|NCT01531673|64237583|FG010|Overall Study|Non-Compliance|0|||
23133923|NCT01531673|64237584|FG011|Overall Study|Non-Compliance|0|||
23133924|NCT01531673|64237585|FG012|Overall Study|Non-Compliance|0|||
23133925|NCT01531673|64237573|FG000|Overall Study|Adverse Event|0|||
23133926|NCT01531673|64237574|FG001|Overall Study|Adverse Event|1|||
23133927|NCT01531673|64237575|FG002|Overall Study|Adverse Event|0|||
23133928|NCT01531673|64237576|FG003|Overall Study|Adverse Event|0|||
23428290|NCT01741532|65310775|FG000|Overall Study|Adverse Event|4|||
23428291|NCT01741532|65310776|FG001|Overall Study|Adverse Event|0|||
23428292|NCT01741532|65310775|FG000|Overall Study|Withdrawal by Subject|1|||
23428293|NCT01741532|65310776|FG001|Overall Study|Withdrawal by Subject|1|||
23428294|NCT01741532|65310775|FG000|Overall Study|Protocol Violation|0|||
23428295|NCT01741532|65310776|FG001|Overall Study|Protocol Violation|1|||
23428296|NCT01741532|65310775|FG000|Overall Study|Worsening of the disease|3|||
23428297|NCT01741532|65310776|FG001|Overall Study|Worsening of the disease|1|||
23428298|NCT01741532|65310775|FG000|Overall Study|Sponsor decision|1|||
23428299|NCT01741532|65310776|FG001|Overall Study|Sponsor decision|0|||
23548464|NCT00843167|65739561|FG001|Treatment Period|Withdrawal by Subject|3|||
23133929|NCT01531673|64237577|FG004|Overall Study|Adverse Event|0|||
23133930|NCT01531673|64237578|FG005|Overall Study|Adverse Event|0|||
23133931|NCT01531673|64237579|FG006|Overall Study|Adverse Event|0|||
23133932|NCT01531673|64237580|FG007|Overall Study|Adverse Event|0|||
23133933|NCT01531673|64237581|FG008|Overall Study|Adverse Event|0|||
23133934|NCT01531673|64237582|FG009|Overall Study|Adverse Event|0|||
23133935|NCT01531673|64237583|FG010|Overall Study|Adverse Event|0|||
23133936|NCT01531673|64237584|FG011|Overall Study|Adverse Event|0|||
23133937|NCT01531673|64237585|FG012|Overall Study|Adverse Event|0|||
23133938|NCT01531673|64237573|FG000|Overall Study|Lost to Follow-up|0|||
23133939|NCT01531673|64237574|FG001|Overall Study|Lost to Follow-up|0|||
23133940|NCT01531673|64237575|FG002|Overall Study|Lost to Follow-up|0|||
23133941|NCT01531673|64237576|FG003|Overall Study|Lost to Follow-up|0|||
23133942|NCT01531673|64237577|FG004|Overall Study|Lost to Follow-up|1|||
23133943|NCT01531673|64237578|FG005|Overall Study|Lost to Follow-up|0|||
23133944|NCT01531673|64237579|FG006|Overall Study|Lost to Follow-up|0|||
23133945|NCT01531673|64237580|FG007|Overall Study|Lost to Follow-up|0|||
23133946|NCT01531673|64237581|FG008|Overall Study|Lost to Follow-up|0|||
23133947|NCT01531673|64237582|FG009|Overall Study|Lost to Follow-up|0|||
23133948|NCT01531673|64237583|FG010|Overall Study|Lost to Follow-up|0|||
23133949|NCT01531673|64237584|FG011|Overall Study|Lost to Follow-up|0|||
23133950|NCT01531673|64237585|FG012|Overall Study|Lost to Follow-up|0|||
23133951|NCT01531673|64237573|FG000|Overall Study|Other|0|||
23133952|NCT01531673|64237574|FG001|Overall Study|Other|0|||
23133953|NCT01531673|64237575|FG002|Overall Study|Other|0|||
23133954|NCT01531673|64237576|FG003|Overall Study|Other|1|||
23133955|NCT01531673|64237577|FG004|Overall Study|Other|0|||
23133956|NCT01531673|64237578|FG005|Overall Study|Other|0|||
23133957|NCT01531673|64237579|FG006|Overall Study|Other|0|||
23133958|NCT01531673|64237580|FG007|Overall Study|Other|0|||
23133959|NCT01531673|64237581|FG008|Overall Study|Other|0|||
23133960|NCT01531673|64237582|FG009|Overall Study|Other|1|||
23133961|NCT01531673|64237583|FG010|Overall Study|Other|0|||
23133962|NCT01531673|64237584|FG011|Overall Study|Other|0|||
23133963|NCT01531673|64237585|FG012|Overall Study|Other|0|||
23133964|NCT01468181|64237586|FG000|Overall Study|Adverse Event|8|||
23548465|NCT00263666|65739564|FG000|Overall Study|Adverse Event|6|||
23133965|NCT01468181|64237587|FG001|Overall Study|Adverse Event|1|||
23133966|NCT01468181|64237588|FG002|Overall Study|Adverse Event|6|||
23133967|NCT01468181|64237589|FG003|Overall Study|Adverse Event|2|||
23133968|NCT01468181|64237590|FG004|Overall Study|Adverse Event|2|||
23133969|NCT01468181|64237586|FG000|Overall Study|Protocol Violation|2|||
23133970|NCT01468181|64237587|FG001|Overall Study|Protocol Violation|0|||
23133971|NCT01468181|64237588|FG002|Overall Study|Protocol Violation|1|||
23428300|NCT01741532|65310775|FG000|Overall Study|Medical event|1|||
23428301|NCT01741532|65310776|FG001|Overall Study|Medical event|0|||
23548466|NCT00263666|65739565|FG001|Overall Study|Adverse Event|8|||
23133972|NCT01468181|64237589|FG003|Overall Study|Protocol Violation|0|||
23133973|NCT01468181|64237590|FG004|Overall Study|Protocol Violation|1|||
23133974|NCT01468181|64237586|FG000|Overall Study|Physician Decision|0|||
23133975|NCT01468181|64237587|FG001|Overall Study|Physician Decision|0|||
23133976|NCT01468181|64237588|FG002|Overall Study|Physician Decision|0|||
23133977|NCT01468181|64237589|FG003|Overall Study|Physician Decision|1|||
23133978|NCT01468181|64237590|FG004|Overall Study|Physician Decision|1|||
23133979|NCT01468181|64237586|FG000|Overall Study|Lost to Follow-up|0|||
23133980|NCT01468181|64237587|FG001|Overall Study|Lost to Follow-up|0|||
23428302|NCT03322423|65310777|FG000|Period 1|Subject no longer eligible|0|||
23548467|NCT00263666|65739564|FG000|Overall Study|Lost to Follow-up|1|||
23548468|NCT00263666|65739565|FG001|Overall Study|Lost to Follow-up|2|||
23548469|NCT00263666|65739564|FG000|Overall Study|Withdrawal by Subject|0|||
23548470|NCT00263666|65739565|FG001|Overall Study|Withdrawal by Subject|1|||
23548471|NCT00251745|65739568|FG000|Overall Study|Adverse Event|7|||
23548472|NCT00251745|65739569|FG001|Overall Study|Adverse Event|9|||
23548473|NCT00251745|65739570|FG002|Overall Study|Adverse Event|11|||
23548474|NCT00251745|65739568|FG000|Overall Study|Lost to Follow-up|4|||
23428303|NCT03322423|65310778|FG001|Period 1|Subject no longer eligible|1|||
23428304|NCT03322423|65310777|FG000|Period 1|Withdrawal by Subject|0|||
23428305|NCT03322423|65310778|FG001|Period 1|Withdrawal by Subject|1|||
23428306|NCT03322423|65310777|FG000|Period 1|Incorrect Lens Dispensed|1|||
23428307|NCT03322423|65310778|FG001|Period 1|Incorrect Lens Dispensed|0|||
23428308|NCT03322423|65310777|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
23428309|NCT03322423|65310778|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
23428310|NCT03322423|65310777|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
23428311|NCT03322423|65310778|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
23428312|NCT03322423|65310777|FG000|Period 2|Protocol Violation|1|||
23548475|NCT00251745|65739569|FG001|Overall Study|Lost to Follow-up|2|||
23548476|NCT00251745|65739570|FG002|Overall Study|Lost to Follow-up|5|||
23133981|NCT01468181|64237588|FG002|Overall Study|Lost to Follow-up|1|||
23133982|NCT01468181|64237589|FG003|Overall Study|Lost to Follow-up|0|||
23133983|NCT01468181|64237590|FG004|Overall Study|Lost to Follow-up|1|||
23133984|NCT01468181|64237586|FG000|Overall Study|Withdrawal by Subject|0|||
23133985|NCT01468181|64237587|FG001|Overall Study|Withdrawal by Subject|1|||
23133986|NCT01468181|64237588|FG002|Overall Study|Withdrawal by Subject|0|||
23133987|NCT01468181|64237589|FG003|Overall Study|Withdrawal by Subject|0|||
23133988|NCT01468181|64237590|FG004|Overall Study|Withdrawal by Subject|0|||
23133989|NCT00859222|64237593|FG000|Overall Study|Adverse Event|2|||
23133990|NCT00859222|64237594|FG001|Overall Study|Adverse Event|3|||
23548477|NCT00251745|65739568|FG000|Overall Study|Withdrawal by Subject|13|||
23548478|NCT00251745|65739569|FG001|Overall Study|Withdrawal by Subject|7|||
23548479|NCT00251745|65739570|FG002|Overall Study|Withdrawal by Subject|3|||
23548480|NCT00251745|65739568|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
23548481|NCT00251745|65739569|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
23548482|NCT00251745|65739570|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
23548483|NCT00251745|65739568|FG000|Overall Study|Lack of Efficacy|3|||
23133991|NCT00859222|64237595|FG002|Overall Study|Adverse Event|6|||
23133992|NCT00859222|64237596|FG003|Overall Study|Adverse Event|24|||
23133993|NCT00859222|64237597|FG004|Overall Study|Adverse Event|15|||
23548484|NCT00251745|65739569|FG001|Overall Study|Lack of Efficacy|0|||
23548485|NCT00251745|65739570|FG002|Overall Study|Lack of Efficacy|0|||
23548486|NCT00251745|65739568|FG000|Overall Study|Noncompliant|0|||
23548487|NCT00251745|65739569|FG001|Overall Study|Noncompliant|2|||
23548488|NCT00251745|65739570|FG002|Overall Study|Noncompliant|2|||
23548489|NCT00251745|65739568|FG000|Overall Study|Pregnancy|0|||
23548490|NCT00251745|65739569|FG001|Overall Study|Pregnancy|1|||
23548491|NCT00251745|65739570|FG002|Overall Study|Pregnancy|0|||
23548492|NCT00251745|65739568|FG000|Overall Study|Per Subject Request|0|||
23548493|NCT00251745|65739569|FG001|Overall Study|Per Subject Request|0|||
23548494|NCT00251745|65739570|FG002|Overall Study|Per Subject Request|1|||
23548495|NCT00251745|65739568|FG000|Overall Study|Per Investigator Request|1|||
23548496|NCT00251745|65739569|FG001|Overall Study|Per Investigator Request|0|||
23548497|NCT00251745|65739570|FG002|Overall Study|Per Investigator Request|0|||
23548498|NCT00295750|65739579|FG000|Overall Study|Adverse Event|19|||
23548499|NCT00295750|65739580|FG001|Overall Study|Adverse Event|15|||
23548500|NCT00295750|65739581|FG002|Overall Study|Adverse Event|12|||
23548501|NCT00295750|65739579|FG000|Overall Study|Lack of Efficacy|1|||
23548502|NCT00295750|65739580|FG001|Overall Study|Lack of Efficacy|1|||
23548503|NCT00295750|65739581|FG002|Overall Study|Lack of Efficacy|0|||
23548504|NCT00295750|65739579|FG000|Overall Study|Lost to Follow-up|1|||
23548505|NCT00295750|65739580|FG001|Overall Study|Lost to Follow-up|4|||
23548506|NCT00295750|65739581|FG002|Overall Study|Lost to Follow-up|1|||
23133994|NCT00859222|64237593|FG000|Overall Study|DLT|1|||
23133995|NCT00859222|64237594|FG001|Overall Study|DLT|0|||
23133996|NCT00859222|64237595|FG002|Overall Study|DLT|0|||
23133997|NCT00859222|64237596|FG003|Overall Study|DLT|0|||
23548507|NCT00295750|65739579|FG000|Overall Study|Taking prohibited therapy|2|||
23548508|NCT00295750|65739580|FG001|Overall Study|Taking prohibited therapy|3|||
23548509|NCT00295750|65739581|FG002|Overall Study|Taking prohibited therapy|2|||
23548510|NCT00295750|65739579|FG000|Overall Study|Administrative errors|2|||
23133998|NCT00859222|64237597|FG004|Overall Study|DLT|0|||
23548511|NCT00295750|65739580|FG001|Overall Study|Administrative errors|4|||
23548512|NCT00295750|65739581|FG002|Overall Study|Administrative errors|5|||
23133999|NCT01669577|64237598|FG000|Overall Study|Death|22|||
23134000|NCT01669577|64237598|FG000|Overall Study|Lost to Follow-up|78|||
23134001|NCT01669577|64237598|FG000|Overall Study|Physician Decision|34|||
23428313|NCT03322423|65310778|FG001|Period 2|Protocol Violation|0|||
23548513|NCT00295750|65739579|FG000|Overall Study|Trial drug errors|1|||
23134002|NCT00659880|64237604|FG000|Overall Study|Lost to Follow-up|5|||
23134003|NCT01283152|64237607|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
23134004|NCT01283152|64237608|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
23134005|NCT01283152|64237607|FG000|Overall Study|Refused HESA|1|||
23134006|NCT01283152|64237608|FG001|Overall Study|Refused HESA|0|||
23134007|NCT00461981|64237609|FG000|Overall Study|Lost to Follow-up|9|||
23134008|NCT00461981|64237610|FG001|Overall Study|Lost to Follow-up|6|||
23134009|NCT00461981|64237609|FG000|Overall Study|Withdrawal by Subject|2|||
23134010|NCT00461981|64237610|FG001|Overall Study|Withdrawal by Subject|3|||
23134011|NCT00132873|64240910|FG000|Overall Study|Adverse Event|3|||
23134012|NCT00132873|64240910|FG000|Overall Study|Lost to Follow-up|1|||
23134013|NCT00132873|64240910|FG000|Overall Study|Lack of Efficacy|1|||
23134014|NCT00132873|64240910|FG000|Overall Study|Withdrawal by Subject|3|||
23134015|NCT00132873|64240910|FG000|Overall Study|Planned Pregnancy|1|||
23134016|NCT01213524|64240911|FG000|Baseline|Withdrawal by Subject|5|||
23134017|NCT01213524|64240911|FG000|Baseline|high breath alcohol levels|1|||
23134018|NCT01213524|64240911|FG000|Baseline|Physician Decision|1|||
23134019|NCT01213524|64240911|FG000|Session 2|Withdrawal by Subject|5|||
23134020|NCT01213524|64240911|FG000|Session 3|Withdrawal by Subject|4|||
23134021|NCT01213524|64240911|FG000|Session 4|Physician Decision|1|||
23134022|NCT01213524|64240911|FG000|Session 4|Withdrawal by Subject|2|||
23134023|NCT02643303|64240912|FG000|Overall Study|Progressive Disease|4|||
23134024|NCT02643303|64240913|FG001|Overall Study|Progressive Disease|4|||
23134025|NCT02643303|64240914|FG002|Overall Study|Progressive Disease|1|||
23134026|NCT02643303|64240915|FG003|Overall Study|Progressive Disease|12|||
23134027|NCT02643303|64240916|FG004|Overall Study|Progressive Disease|6|||
23134028|NCT02643303|64240917|FG005|Overall Study|Progressive Disease|4|||
23134029|NCT02643303|64240918|FG006|Overall Study|Progressive Disease|8|||
23134030|NCT02643303|64240919|FG007|Overall Study|Progressive Disease|2|||
23134031|NCT02643303|64240920|FG008|Overall Study|Progressive Disease|6|||
23134032|NCT02643303|64240912|FG000|Overall Study|Adverse Event|0|||
23134033|NCT02643303|64240913|FG001|Overall Study|Adverse Event|1|||
23134034|NCT02643303|64240914|FG002|Overall Study|Adverse Event|0|||
23134035|NCT02643303|64240915|FG003|Overall Study|Adverse Event|0|||
23134036|NCT02643303|64240916|FG004|Overall Study|Adverse Event|1|||
23428314|NCT03322423|65310777|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
23428315|NCT03322423|65310778|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
23428316|NCT01460719|65310779|FG000|Overall Study|Adverse Event|1|||
23548514|NCT00295750|65739580|FG001|Overall Study|Trial drug errors|1|||
23134037|NCT02643303|64240917|FG005|Overall Study|Adverse Event|0|||
23134038|NCT02643303|64240918|FG006|Overall Study|Adverse Event|0|||
23134039|NCT02643303|64240919|FG007|Overall Study|Adverse Event|0|||
23134040|NCT02643303|64240920|FG008|Overall Study|Adverse Event|0|||
23134041|NCT02643303|64240912|FG000|Overall Study|Withdrawal by Subject|0|||
23134042|NCT02643303|64240913|FG001|Overall Study|Withdrawal by Subject|0|||
23134043|NCT02643303|64240914|FG002|Overall Study|Withdrawal by Subject|0|||
23134044|NCT02643303|64240915|FG003|Overall Study|Withdrawal by Subject|1|||
23134045|NCT02643303|64240916|FG004|Overall Study|Withdrawal by Subject|0|||
23134046|NCT02643303|64240917|FG005|Overall Study|Withdrawal by Subject|0|||
23134047|NCT02643303|64240918|FG006|Overall Study|Withdrawal by Subject|1|||
23548515|NCT00295750|65739581|FG002|Overall Study|Trial drug errors|0|||
23548516|NCT00295750|65739579|FG000|Overall Study|Disease progression|2|||
23548517|NCT00295750|65739580|FG001|Overall Study|Disease progression|1|||
23548518|NCT00295750|65739581|FG002|Overall Study|Disease progression|0|||
23548519|NCT00295750|65739579|FG000|Overall Study|Personal reasons|0|||
23548520|NCT00295750|65739580|FG001|Overall Study|Personal reasons|1|||
23548521|NCT00295750|65739581|FG002|Overall Study|Personal reasons|0|||
23548522|NCT00295750|65739579|FG000|Overall Study|Randomized but never received trial drug|4|||
23548523|NCT00295750|65739580|FG001|Overall Study|Randomized but never received trial drug|3|||
23548524|NCT00295750|65739581|FG002|Overall Study|Randomized but never received trial drug|3|||
23548525|NCT00295750|65739579|FG000|Overall Study|Withdrawal by Subject|9|||
23548526|NCT00295750|65739580|FG001|Overall Study|Withdrawal by Subject|4|||
23548527|NCT00295750|65739581|FG002|Overall Study|Withdrawal by Subject|7|||
23548528|NCT00295750|65739579|FG000|Overall Study|Protocol Violation|2|||
23548529|NCT00295750|65739580|FG001|Overall Study|Protocol Violation|4|||
23548530|NCT00295750|65739581|FG002|Overall Study|Protocol Violation|2|||
23548531|NCT02384954|65739582|FG000|Phase 1|Progressive Disease|2|||
23134048|NCT02643303|64240919|FG007|Overall Study|Withdrawal by Subject|1|||
23134049|NCT02643303|64240920|FG008|Overall Study|Withdrawal by Subject|1|||
23134050|NCT00564889|64240921|FG000|Overall Study|Death|7|||
23134051|NCT00564889|64240921|FG000|Overall Study|Adverse Event|12|||
23214201|NCT02151682|64523535|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23548532|NCT02384954|65739583|FG001|Phase 1|Progressive Disease|0|||
23548533|NCT02384954|65739584|FG002|Phase 1|Progressive Disease|1|||
23134052|NCT00564889|64240921|FG000|Overall Study|Alternative treatment|3|||
23134053|NCT00564889|64240921|FG000|Overall Study|Disease progression|3|||
23134054|NCT00564889|64240921|FG000|Overall Study|Other, not specified|4|||
23134055|NCT00379288|64240925|FG000|Overall Study|Adverse Event|5|||
23548534|NCT02384954|65739585|FG003|Phase 1|Progressive Disease|1|||
23548535|NCT02384954|65739586|FG004|Phase 1|Progressive Disease|0|||
23548536|NCT02384954|65739587|FG005|Phase 1|Progressive Disease|0|||
23548537|NCT02384954|65739588|FG006|Phase 1|Progressive Disease|0|||
23548538|NCT02384954|65739589|FG007|Phase 1|Progressive Disease|0|||
23548539|NCT02384954|65739590|FG008|Phase 1|Progressive Disease|0|||
23548540|NCT02384954|65739582|FG000|Phase 1|Adverse Event|0|||
23548541|NCT02384954|65739583|FG001|Phase 1|Adverse Event|0|||
23548542|NCT02384954|65739584|FG002|Phase 1|Adverse Event|1|||
23548543|NCT02384954|65739585|FG003|Phase 1|Adverse Event|0|||
23548544|NCT02384954|65739586|FG004|Phase 1|Adverse Event|0|||
23548545|NCT02384954|65739587|FG005|Phase 1|Adverse Event|0|||
23548546|NCT02384954|65739588|FG006|Phase 1|Adverse Event|0|||
23548547|NCT02384954|65739589|FG007|Phase 1|Adverse Event|0|||
23548548|NCT02384954|65739590|FG008|Phase 1|Adverse Event|0|||
23548549|NCT02384954|65739582|FG000|Phase 2|Progressive Disease|0|||
23548550|NCT02384954|65739583|FG001|Phase 2|Progressive Disease|0|||
23548551|NCT02384954|65739584|FG002|Phase 2|Progressive Disease|0|||
23548552|NCT02384954|65739585|FG003|Phase 2|Progressive Disease|0|||
23548553|NCT02384954|65739586|FG004|Phase 2|Progressive Disease|0|||
23548554|NCT02384954|65739587|FG005|Phase 2|Progressive Disease|0|||
23548555|NCT02384954|65739588|FG006|Phase 2|Progressive Disease|0|||
23548556|NCT02384954|65739589|FG007|Phase 2|Progressive Disease|1|||
23548557|NCT02384954|65739590|FG008|Phase 2|Progressive Disease|2|||
23548558|NCT02384954|65739582|FG000|Phase 2|Adverse Event|0|||
23548559|NCT02384954|65739583|FG001|Phase 2|Adverse Event|0|||
23548560|NCT02384954|65739584|FG002|Phase 2|Adverse Event|0|||
23548561|NCT02384954|65739585|FG003|Phase 2|Adverse Event|0|||
23548562|NCT02384954|65739586|FG004|Phase 2|Adverse Event|0|||
23548563|NCT02384954|65739587|FG005|Phase 2|Adverse Event|0|||
23548564|NCT02384954|65739588|FG006|Phase 2|Adverse Event|0|||
23548565|NCT02384954|65739589|FG007|Phase 2|Adverse Event|1|||
23548566|NCT02384954|65739590|FG008|Phase 2|Adverse Event|1|||
23548567|NCT02384954|65739582|FG000|Phase 2|Failure to meet continuation criteria|0|||
23548568|NCT02384954|65739583|FG001|Phase 2|Failure to meet continuation criteria|0|||
23548569|NCT02384954|65739584|FG002|Phase 2|Failure to meet continuation criteria|0|||
23548570|NCT02384954|65739585|FG003|Phase 2|Failure to meet continuation criteria|0|||
23548571|NCT02384954|65739586|FG004|Phase 2|Failure to meet continuation criteria|0|||
23548572|NCT02384954|65739587|FG005|Phase 2|Failure to meet continuation criteria|0|||
23548573|NCT02384954|65739588|FG006|Phase 2|Failure to meet continuation criteria|0|||
23548574|NCT02384954|65739589|FG007|Phase 2|Failure to meet continuation criteria|1|||
23548575|NCT02384954|65739590|FG008|Phase 2|Failure to meet continuation criteria|0|||
23548576|NCT02130193|65739591|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
23548577|NCT02130193|65739592|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
23548578|NCT02130193|65739593|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
23548579|NCT02130193|65739591|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
23548580|NCT02130193|65739592|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
23619895|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
23619896|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
23619897|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
23619898|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23619899|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23619900|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23619901|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
23619902|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
23619903|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
23619904|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
23619905|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23619906|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
23214202|NCT02151682|64523536|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
23428317|NCT01460719|65310779|FG000|Overall Study|Withdrawal by Subject|1|||
23548581|NCT02130193|65739593|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
23548582|NCT02130193|65739591|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
23548583|NCT02130193|65739592|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
23548584|NCT02130193|65739593|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
23548585|NCT02130193|65739591|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
23548586|NCT02130193|65739592|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
23548587|NCT02130193|65739593|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
23548588|NCT00489970|65739594|FG000|Persistence Year 9|Lost to Follow-up|2|||
23548589|NCT00489970|65739595|FG001|Persistence Year 9|Lost to Follow-up|2|||
23548590|NCT00489970|65739596|FG002|Persistence Year 9|Lost to Follow-up|3|||
23548591|NCT00489970|65739594|FG000|Persistence Year 9|Other|1|||
23548592|NCT00489970|65739595|FG001|Persistence Year 9|Other|0|||
23548593|NCT00489970|65739596|FG002|Persistence Year 9|Other|2|||
23619907|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
23619908|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
23548594|NCT00818753|65739599|FG000|Overall Study|Protocol Violation|1|||
23548595|NCT00818753|65739600|FG001|Overall Study|Protocol Violation|0|||
23548596|NCT00818753|65739601|FG002|Overall Study|Protocol Violation|0|||
23548597|NCT00818753|65739599|FG000|Overall Study|Other reason (not specified)|0|||
23548598|NCT00818753|65739600|FG001|Overall Study|Other reason (not specified)|0|||
23548599|NCT00818753|65739601|FG002|Overall Study|Other reason (not specified)|1|||
23548600|NCT00818753|65739599|FG000|Overall Study|Randomised and not treated|2|||
23548601|NCT00818753|65739600|FG001|Overall Study|Randomised and not treated|0|||
23548602|NCT00818753|65739601|FG002|Overall Study|Randomised and not treated|0|||
23548603|NCT03762473|65739611|FG000|Overall Study|Death|1|||
23548604|NCT03762473|65739612|FG001|Overall Study|Death|0|||
23548605|NCT03595904|65739613|FG000|Overall Study|Protocol Violation|3|||
23548606|NCT03595904|65739614|FG001|Overall Study|Protocol Violation|1|||
23134056|NCT00379288|64240926|FG001|Overall Study|Adverse Event|6|||
23134057|NCT00379288|64240927|FG002|Overall Study|Adverse Event|2|||
23134058|NCT00379288|64240928|FG003|Overall Study|Adverse Event|0|||
23134059|NCT00379288|64240925|FG000|Overall Study|Treatment Failure|0|||
23134060|NCT00379288|64240926|FG001|Overall Study|Treatment Failure|1|||
23134061|NCT00379288|64240927|FG002|Overall Study|Treatment Failure|0|||
23134062|NCT00379288|64240928|FG003|Overall Study|Treatment Failure|1|||
23134063|NCT00379288|64240925|FG000|Overall Study|Lost to Follow-up|3|||
23134064|NCT00379288|64240926|FG001|Overall Study|Lost to Follow-up|3|||
23134065|NCT00379288|64240927|FG002|Overall Study|Lost to Follow-up|2|||
23134066|NCT00379288|64240928|FG003|Overall Study|Lost to Follow-up|0|||
23134067|NCT00379288|64240925|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
23134068|NCT00379288|64240926|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
23134069|NCT00379288|64240927|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
23134070|NCT00379288|64240928|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
23619909|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
23619910|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
23619911|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
23619912|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
23214203|NCT02151682|64523537|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23214204|NCT02151682|64523538|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23214205|NCT02151682|64523539|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
23214206|NCT02151682|64523534|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23214207|NCT02151682|64523535|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23214208|NCT02151682|64523536|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23548607|NCT03595904|65739613|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
23548608|NCT03595904|65739614|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
23134071|NCT00379288|64240925|FG000|Overall Study|Subject withdrew-related to study drug|1|||
23134072|NCT00379288|64240926|FG001|Overall Study|Subject withdrew-related to study drug|0|||
23134073|NCT00379288|64240927|FG002|Overall Study|Subject withdrew-related to study drug|0|||
23134074|NCT00379288|64240928|FG003|Overall Study|Subject withdrew-related to study drug|1|||
23548609|NCT03595904|65739613|FG000|Overall Study|Insurance complications|1|||
23134075|NCT00379288|64240925|FG000|Overall Study|Noncompliance with protocol|8|||
23134076|NCT00379288|64240926|FG001|Overall Study|Noncompliance with protocol|6|||
23134077|NCT00379288|64240927|FG002|Overall Study|Noncompliance with protocol|2|||
23134078|NCT00379288|64240928|FG003|Overall Study|Noncompliance with protocol|1|||
23134079|NCT00379288|64240925|FG000|Overall Study|Did not meet protocol eligibility|0|||
23134080|NCT00379288|64240926|FG001|Overall Study|Did not meet protocol eligibility|1|||
23134081|NCT00379288|64240927|FG002|Overall Study|Did not meet protocol eligibility|0|||
23134082|NCT00379288|64240928|FG003|Overall Study|Did not meet protocol eligibility|2|||
23134083|NCT00379288|64240925|FG000|Overall Study|Administrative|2|||
23134084|NCT00379288|64240926|FG001|Overall Study|Administrative|2|||
23134085|NCT00379288|64240927|FG002|Overall Study|Administrative|0|||
23134086|NCT00379288|64240928|FG003|Overall Study|Administrative|1|||
23134087|NCT01151410|64240929|FG000|Overall Study|Withdrawal by Subject|3|||
23134088|NCT01151410|64240930|FG001|Overall Study|Withdrawal by Subject|5|||
23134089|NCT01151410|64240929|FG000|Overall Study|Lost to Follow-up|3|||
23548610|NCT03595904|65739614|FG001|Overall Study|Insurance complications|0|||
23548611|NCT03595904|65739613|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
23582207|NCT01242085|65862383|FG000|Overall Study|Withdrawal by Subject|4|||
23134090|NCT01151410|64240930|FG001|Overall Study|Lost to Follow-up|4|||
23134091|NCT01151410|64240929|FG000|Overall Study|Adverse Event|1|||
23134092|NCT01151410|64240930|FG001|Overall Study|Adverse Event|2|||
23134093|NCT01151410|64240929|FG000|Overall Study|Protocol deviation|2|||
23134094|NCT01151410|64240930|FG001|Overall Study|Protocol deviation|1|||
23134095|NCT01151410|64240929|FG000|Overall Study|Administrative problems|1|||
23548612|NCT03595904|65739614|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
23548613|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
23548614|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
23548615|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
23548616|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23548617|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23548618|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
23548619|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548620|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548621|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
23548622|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548623|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548624|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
23548625|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
23548626|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
23548627|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
23548628|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
23548629|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
23548630|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
23548631|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
23548632|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
23134096|NCT01151410|64240930|FG001|Overall Study|Administrative problems|1|||
23134097|NCT01151410|64240929|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23134098|NCT01151410|64240930|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23134099|NCT01151410|64240929|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23134100|NCT01151410|64240930|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23134101|NCT02182947|64240933|FG000|Overall Study|Withdrawal by Subject|7|||
23619913|NCT01187407|65994784|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23619914|NCT01187407|65994785|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
23619915|NCT01187407|65994786|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
23619916|NCT01187407|65994787|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
23619917|NCT01187407|65994788|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
23134102|NCT02182947|64240933|FG000|Overall Study|Lost to Follow-up|3|||
23548633|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
23548634|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23548635|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23548636|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
23548637|NCT04988308|65739616|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
23548638|NCT04988308|65739617|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
23548639|NCT04988308|65739618|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
23548640|NCT04988308|65739619|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
23548641|NCT04988308|65739620|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
23548642|NCT04988308|65739621|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
23134103|NCT02182947|64240933|FG000|Overall Study|Failed screening activities|8|||
23134104|NCT01499303|64240934|FG000|Overall Study|Ongoing|2|||
23548643|NCT04988308|65739616|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23548644|NCT04988308|65739617|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23548645|NCT04988308|65739618|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
23548646|NCT04988308|65739619|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
23548647|NCT04988308|65739620|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
23548648|NCT04988308|65739621|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
23548649|NCT04988308|65739616|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23548650|NCT04988308|65739617|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23548651|NCT04988308|65739618|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
23548652|NCT04988308|65739619|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
23548653|NCT04988308|65739620|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
23548654|NCT04988308|65739621|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
23548655|NCT04988308|65739616|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23548656|NCT04988308|65739617|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23548657|NCT04988308|65739618|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
23548658|NCT04988308|65739619|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
23548659|NCT04988308|65739620|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
23548660|NCT04988308|65739621|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
23134105|NCT01499303|64240935|FG001|Overall Study|Ongoing|1|||
23134106|NCT01499303|64240934|FG000|Overall Study|Withdrawal by Subject|0|||
23134107|NCT01499303|64240935|FG001|Overall Study|Withdrawal by Subject|1|||
23548661|NCT04988308|65739616|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
23548662|NCT04988308|65739617|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
23548663|NCT04988308|65739618|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
23548664|NCT04988308|65739619|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
23548665|NCT04988308|65739620|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
23548666|NCT04988308|65739621|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
23548667|NCT00722761|65739622|FG000|Overall Study|Lost to Follow-up|1|||
23548668|NCT00722761|65739623|FG001|Overall Study|Lost to Follow-up|4|||
23548669|NCT00722761|65739622|FG000|Overall Study|Withdrawal by Subject|5|||
23548670|NCT00722761|65739623|FG001|Overall Study|Withdrawal by Subject|2|||
23548671|NCT00317772|65739628|FG000|Overall Study|Adverse Event|0|||
23548672|NCT00317772|65739629|FG001|Overall Study|Adverse Event|0|||
23548673|NCT00317772|65739630|FG002|Overall Study|Adverse Event|0|||
23548674|NCT00317772|65739631|FG003|Overall Study|Adverse Event|2|||
23548675|NCT00317772|65739628|FG000|Overall Study|Disease Progression|2|||
23548676|NCT00317772|65739629|FG001|Overall Study|Disease Progression|2|||
23548677|NCT00317772|65739630|FG002|Overall Study|Disease Progression|1|||
23548678|NCT00317772|65739631|FG003|Overall Study|Disease Progression|7|||
23548679|NCT01881620|65739632|FG000|Overall Study|Protocol Violation|4|||
23548680|NCT00553267|65739633|FG000|Overall Study|Adverse Event|8|||
23548681|NCT00553267|65739634|FG001|Overall Study|Adverse Event|10|||
23548682|NCT00553267|65739635|FG002|Overall Study|Adverse Event|5|||
23548683|NCT00553267|65739633|FG000|Overall Study|Non compliant with protocol|3|||
23548684|NCT00553267|65739634|FG001|Overall Study|Non compliant with protocol|3|||
23619918|NCT00553605|65994791|FG000|Overall Study|Did not meet entrance criteria|1|||
23619919|NCT00553605|65994792|FG001|Overall Study|Did not meet entrance criteria|3|||
23619920|NCT00553605|65994791|FG000|Overall Study|Did not receive full dose|1|||
23619921|NCT00553605|65994792|FG001|Overall Study|Did not receive full dose|0|||
23619922|NCT00553605|65994791|FG000|Overall Study|Randomized but not treated|2|||
23619923|NCT00553605|65994792|FG001|Overall Study|Randomized but not treated|0|||
23134108|NCT01499303|64240934|FG000|Overall Study|Adverse Event|1|||
23134109|NCT01499303|64240935|FG001|Overall Study|Adverse Event|4|||
23134110|NCT01499303|64240934|FG000|Overall Study|Other|0|||
23134111|NCT01499303|64240935|FG001|Overall Study|Other|1|||
23428318|NCT02726880|65310780|FG000|Overall Study|Withdrawal by Subject|2|||
23548685|NCT00553267|65739635|FG002|Overall Study|Non compliant with protocol|2|||
23134112|NCT03896152|64240939|FG000|Overall Study|Patient/guardian decision|1|||
23134113|NCT03896152|64240940|FG001|Overall Study|Patient/guardian decision|1|||
23134114|NCT03896152|64240939|FG000|Overall Study|Adverse Event|0|||
23134115|NCT03896152|64240940|FG001|Overall Study|Adverse Event|1|||
23134116|NCT03896152|64240939|FG000|Overall Study|Physician Decision|1|||
23134117|NCT03896152|64240940|FG001|Overall Study|Physician Decision|0|||
23134118|NCT03896152|64240939|FG000|Overall Study|Technical problems|1|||
23134119|NCT03896152|64240940|FG001|Overall Study|Technical problems|0|||
23134120|NCT00490724|64240941|FG000|Period I|Physician Decision|0|||
23134121|NCT00490724|64240942|FG001|Period I|Physician Decision|0|||
23134122|NCT00490724|64240943|FG002|Period I|Physician Decision|1|||
23134123|NCT00490724|64240941|FG000|Period II|Treatment Discontinuation|3|||
23134124|NCT00490724|64240942|FG001|Period II|Treatment Discontinuation|1|||
23134125|NCT00490724|64240943|FG002|Period II|Treatment Discontinuation|3|||
23134126|NCT01940939|64240944|FG000|Overall Study|Withdrawal by Subject|2|||
23134127|NCT01940939|64240945|FG001|Overall Study|Withdrawal by Subject|8|||
23134128|NCT01123070|64240946|FG000|Part B Double Blind Period|Protocol Violation|0|||
23134129|NCT01123070|64240947|FG001|Part B Double Blind Period|Protocol Violation|0|||
23134130|NCT01123070|64240948|FG002|Part B Double Blind Period|Protocol Violation|0|||
23134131|NCT01123070|64240949|FG003|Part B Double Blind Period|Protocol Violation|1|||
23134132|NCT01123070|64240946|FG000|Part B Double Blind Period|Adverse Event|0|||
23134133|NCT01123070|64240947|FG001|Part B Double Blind Period|Adverse Event|0|||
23134134|NCT01123070|64240948|FG002|Part B Double Blind Period|Adverse Event|2|||
23134135|NCT01123070|64240949|FG003|Part B Double Blind Period|Adverse Event|0|||
23134136|NCT01123070|64240946|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
23134137|NCT01123070|64240947|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
23134138|NCT01123070|64240948|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
23134139|NCT01123070|64240949|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
23134140|NCT02735577|64240950|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
23619924|NCT03449134|65994793|FG000|52-Week Treatment Period|Death|2|||
23134141|NCT02735577|64240950|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
23134142|NCT00436605|64240951|FG000|Overall Study|Protocol Violation|3|||
23134143|NCT00591851|64240952|FG000|Overall Study|Withdrawal by Subject|3|||
23548686|NCT00553267|65739633|FG000|Overall Study|Lost to Follow-up|0|||
23548687|NCT00553267|65739634|FG001|Overall Study|Lost to Follow-up|0|||
23548688|NCT00553267|65739635|FG002|Overall Study|Lost to Follow-up|1|||
23548689|NCT00553267|65739633|FG000|Overall Study|Consent withdrawn|2|||
23134144|NCT00591851|64240952|FG000|Overall Study|Adverse Event|2|||
23134145|NCT00591851|64240952|FG000|Overall Study|Progressive Disease|1|||
23548690|NCT00553267|65739634|FG001|Overall Study|Consent withdrawn|3|||
23548691|NCT00553267|65739635|FG002|Overall Study|Consent withdrawn|1|||
23548692|NCT00553267|65739633|FG000|Overall Study|Specified category|1|||
23548693|NCT00553267|65739634|FG001|Overall Study|Specified category|2|||
23548694|NCT00553267|65739635|FG002|Overall Study|Specified category|1|||
23134146|NCT01014208|64240953|FG000|Overall Study|Lost to Follow-up|2|||
23548695|NCT01217073|65739636|FG000|Base Period|Adverse Event|1|||
23548696|NCT01217073|65739637|FG001|Base Period|Adverse Event|0|||
23548697|NCT01217073|65739638|FG002|Base Period|Adverse Event|1|||
23548698|NCT01217073|65739639|FG003|Base Period|Adverse Event|0|||
23548699|NCT01217073|65739640|FG004|Base Period|Adverse Event|4|||
23548700|NCT01217073|65739641|FG005|Base Period|Adverse Event|1|||
23548701|NCT01217073|65739642|FG006|Base Period|Adverse Event|0|||
23548702|NCT01217073|65739643|FG007|Base Period|Adverse Event|0|||
23548703|NCT01217073|65739636|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
23548704|NCT01217073|65739637|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548705|NCT01217073|65739638|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548706|NCT01217073|65739639|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548707|NCT01217073|65739640|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548708|NCT01217073|65739641|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548709|NCT01217073|65739642|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23134147|NCT01014208|64240954|FG001|Overall Study|Lost to Follow-up|5|||
23134148|NCT01014208|64240953|FG000|Overall Study|Participant Withdrew Consent|12|||
23134149|NCT01014208|64240954|FG001|Overall Study|Participant Withdrew Consent|12|||
23134150|NCT01014208|64240953|FG000|Overall Study|Did Not Receive Study Drug|2|||
23134151|NCT01014208|64240954|FG001|Overall Study|Did Not Receive Study Drug|0|||
23134152|NCT01014208|64240953|FG000|Overall Study|Study Closed/terminated|78|||
23134153|NCT01014208|64240954|FG001|Overall Study|Study Closed/terminated|83|||
23134154|NCT01281839|64240955|FG000|Overall Study|Lost to Follow-up|6|||
23134155|NCT01281839|64240956|FG001|Overall Study|Lost to Follow-up|3|||
23134156|NCT01281839|64240955|FG000|Overall Study|Withdrawal by Subject|4|||
23134157|NCT01281839|64240956|FG001|Overall Study|Withdrawal by Subject|10|||
23134158|NCT01281839|64240955|FG000|Overall Study|Reason not specified|0|||
23134159|NCT01281839|64240956|FG001|Overall Study|Reason not specified|1|||
23134160|NCT01920932|64240957|FG000|Overall Study|Death|1|||
23134161|NCT01920932|64240957|FG000|Overall Study|Withdrawal of consent|1|||
23134162|NCT02636725|64240958|FG000|Overall Study|Adverse Event|1|||
23134163|NCT04276415|64240959|FG000|Overall Study|Adverse Event|0|||
23134164|NCT04276415|64240960|FG001|Overall Study|Adverse Event|0|||
23214209|NCT02151682|64523537|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23214210|NCT02151682|64523538|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
23214211|NCT02151682|64523539|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
23214212|NCT02151682|64523534|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23214213|NCT02151682|64523535|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23214214|NCT02151682|64523536|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23214215|NCT02151682|64523537|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23214216|NCT02151682|64523538|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
23214217|NCT02151682|64523539|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
23214218|NCT02151682|64523534|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23214219|NCT02151682|64523535|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23214220|NCT02151682|64523536|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23214221|NCT02151682|64523537|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23214222|NCT02151682|64523538|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
23214223|NCT02151682|64523539|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
23214224|NCT02151682|64523534|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23214225|NCT02151682|64523535|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23214226|NCT02151682|64523536|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23214227|NCT02151682|64523537|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23317497|NCT02552121|64904097|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23548710|NCT01217073|65739643|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
23548711|NCT01217073|65739636|FG000|Base Period|Excluded medication|0|||
23548712|NCT01217073|65739637|FG001|Base Period|Excluded medication|0|||
23548713|NCT01217073|65739638|FG002|Base Period|Excluded medication|0|||
23548714|NCT01217073|65739639|FG003|Base Period|Excluded medication|0|||
23134165|NCT04276415|64240961|FG002|Overall Study|Adverse Event|0|||
23134166|NCT04276415|64240962|FG003|Overall Study|Adverse Event|3|||
23134167|NCT04276415|64240963|FG004|Overall Study|Adverse Event|0|||
23134168|NCT04276415|64240964|FG005|Overall Study|Adverse Event|0|||
23134169|NCT04276415|64240959|FG000|Overall Study|Clinical progression|1|||
23134170|NCT04276415|64240960|FG001|Overall Study|Clinical progression|1|||
23317498|NCT02552121|64904098|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23134171|NCT04276415|64240961|FG002|Overall Study|Clinical progression|0|||
23548715|NCT01217073|65739640|FG004|Base Period|Excluded medication|1|||
23548716|NCT01217073|65739641|FG005|Base Period|Excluded medication|0|||
23548717|NCT01217073|65739642|FG006|Base Period|Excluded medication|0|||
23214228|NCT02151682|64523538|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
23214229|NCT02151682|64523539|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
23214230|NCT04179786|64523542|FG000|Overall Study|Withdrawal by Subject|8|||
23214231|NCT00903370|64523543|FG000|Overall Study|Death|13|||
23214232|NCT00903370|64523544|FG001|Overall Study|Death|10|||
23214233|NCT00903370|64523543|FG000|Overall Study|Withdrawal by Subject|9|||
23214234|NCT00903370|64523544|FG001|Overall Study|Withdrawal by Subject|6|||
23214235|NCT00903370|64523543|FG000|Overall Study|Lost to Follow-up|6|||
23214236|NCT00903370|64523544|FG001|Overall Study|Lost to Follow-up|8|||
23214237|NCT04095442|64523545|FG000|Overall Study|Lost to Follow-up|0|||
23214238|NCT04095442|64523546|FG001|Overall Study|Lost to Follow-up|1|||
23134172|NCT04276415|64240962|FG003|Overall Study|Clinical progression|0|||
23134173|NCT04276415|64240963|FG004|Overall Study|Clinical progression|1|||
23134174|NCT04276415|64240964|FG005|Overall Study|Clinical progression|0|||
23134175|NCT04276415|64240959|FG000|Overall Study|Other|0|||
23134176|NCT04276415|64240960|FG001|Overall Study|Other|0|||
23134177|NCT04276415|64240961|FG002|Overall Study|Other|0|||
23134178|NCT04276415|64240962|FG003|Overall Study|Other|1|||
23134179|NCT04276415|64240963|FG004|Overall Study|Other|0|||
23134180|NCT04276415|64240964|FG005|Overall Study|Other|0|||
23134181|NCT04276415|64240959|FG000|Overall Study|Physician Decision|0|||
23134182|NCT04276415|64240960|FG001|Overall Study|Physician Decision|0|||
23134183|NCT04276415|64240961|FG002|Overall Study|Physician Decision|1|||
23134184|NCT04276415|64240962|FG003|Overall Study|Physician Decision|3|||
23134185|NCT04276415|64240963|FG004|Overall Study|Physician Decision|2|||
23134186|NCT04276415|64240964|FG005|Overall Study|Physician Decision|0|||
23134187|NCT04276415|64240959|FG000|Overall Study|Progressive disease|3|||
23134188|NCT04276415|64240960|FG001|Overall Study|Progressive disease|3|||
23134189|NCT04276415|64240961|FG002|Overall Study|Progressive disease|4|||
23134190|NCT04276415|64240962|FG003|Overall Study|Progressive disease|5|||
23134191|NCT04276415|64240963|FG004|Overall Study|Progressive disease|1|||
23134192|NCT04276415|64240964|FG005|Overall Study|Progressive disease|2|||
23134193|NCT04276415|64240959|FG000|Overall Study|Withdrawal by patient|0|||
23134194|NCT04276415|64240960|FG001|Overall Study|Withdrawal by patient|0|||
23134195|NCT04276415|64240961|FG002|Overall Study|Withdrawal by patient|0|||
23134196|NCT04276415|64240962|FG003|Overall Study|Withdrawal by patient|1|||
23134197|NCT04276415|64240963|FG004|Overall Study|Withdrawal by patient|2|||
23134198|NCT04276415|64240964|FG005|Overall Study|Withdrawal by patient|0|||
23134199|NCT05032872|64240965|FG000|Overall Study|Adverse Event|1|||
23134200|NCT05032872|64240966|FG001|Overall Study|Adverse Event|0|||
23134201|NCT05032872|64240965|FG000|Overall Study|Lost to Follow-up|2|||
23134202|NCT05032872|64240966|FG001|Overall Study|Lost to Follow-up|4|||
23134203|NCT05032872|64240965|FG000|Overall Study|Withdrawal by Subject|4|||
23134204|NCT05032872|64240966|FG001|Overall Study|Withdrawal by Subject|3|||
23134205|NCT00770029|64240967|FG000|Overall Study|Lost to Follow-up|2|||
23134206|NCT00770029|64240968|FG001|Overall Study|Lost to Follow-up|0|||
23134207|NCT00770029|64240967|FG000|Overall Study|Withdrawal by Subject|3|||
23134208|NCT00770029|64240968|FG001|Overall Study|Withdrawal by Subject|3|||
23134209|NCT00770029|64240967|FG000|Overall Study|Adverse Event|1|||
23134210|NCT00770029|64240968|FG001|Overall Study|Adverse Event|0|||
23134211|NCT00548262|64240969|FG000|Overall Study|Death|21|||
23134212|NCT00548262|64240969|FG000|Overall Study|Adverse Event|2|||
23134213|NCT00548262|64240969|FG000|Overall Study|Lack of Efficacy|4|||
23134214|NCT00548262|64240969|FG000|Overall Study|Lost to Follow-up|1|||
23134215|NCT00548262|64240969|FG000|Overall Study|Other|3|||
23134216|NCT00548262|64240969|FG000|Overall Study|Withdrawal by Subject|1|||
23134217|NCT03208036|64240974|FG000|Baseline Assessment|Withdrawal by Subject|1|||
23134218|NCT03208036|64240975|FG001|Baseline Assessment|Withdrawal by Subject|1|||
23134219|NCT03208036|64240974|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
23134220|NCT03208036|64240975|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
23134221|NCT03208036|64240974|FG000|Intervention|Withdrawal by Subject|3|||
23134222|NCT03208036|64240975|FG001|Intervention|Withdrawal by Subject|2|||
23134223|NCT03208036|64240974|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
23134224|NCT03208036|64240975|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
23134225|NCT04400487|64240980|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23134226|NCT04400487|64240980|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
23134227|NCT04400487|64240980|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
23214239|NCT04095442|64523545|FG000|Overall Study|Screen failure|1|||
23134228|NCT01758900|64240981|FG000|Overall Study|difficulty for further intubation|7|||
23134229|NCT01758900|64240982|FG001|Overall Study|difficulty for further intubation|8|||
23317499|NCT02552121|64904099|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23317500|NCT02552121|64904100|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23134230|NCT02141620|64240983|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
23214240|NCT04095442|64523546|FG001|Overall Study|Screen failure|0|||
23134231|NCT02141620|64240984|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
23214241|NCT01747811|64523549|FG000|Overall Study|Lack of Efficacy|2|||
23214242|NCT01747811|64523550|FG001|Overall Study|Lack of Efficacy|4|||
23619925|NCT03449134|65994794|FG001|52-Week Treatment Period|Death|1|||
23134232|NCT03377699|64240987|FG000|Overall Study|Withdrawal by Subject|2|||
23134233|NCT03377699|64240988|FG001|Overall Study|Withdrawal by Subject|9|||
23134234|NCT03377699|64240987|FG000|Overall Study|Lost to Follow-up|1|||
23134235|NCT03377699|64240988|FG001|Overall Study|Lost to Follow-up|1|||
23134236|NCT03377699|64240987|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
23134237|NCT03377699|64240988|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
23619926|NCT03449134|65994795|FG002|52-Week Treatment Period|Death|0|||
23619927|NCT03449134|65994793|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
23619928|NCT03449134|65994794|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
23619929|NCT03449134|65994795|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
23619930|NCT03449134|65994793|FG000|52-Week Treatment Period|Physician Decision|2|||
23619931|NCT03449134|65994794|FG001|52-Week Treatment Period|Physician Decision|3|||
23428319|NCT02726880|65310781|FG001|Overall Study|Withdrawal by Subject|0|||
23428320|NCT02726880|65310780|FG000|Overall Study|Lost to Follow-up|1|||
23548718|NCT01217073|65739643|FG007|Base Period|Excluded medication|0|||
23548719|NCT01217073|65739636|FG000|Base Period|Lack of Efficacy|0|||
23548720|NCT01217073|65739637|FG001|Base Period|Lack of Efficacy|0|||
23548721|NCT01217073|65739638|FG002|Base Period|Lack of Efficacy|0|||
23548722|NCT01217073|65739639|FG003|Base Period|Lack of Efficacy|0|||
23134238|NCT03377699|64240987|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
23134239|NCT03377699|64240988|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
23428321|NCT02726880|65310781|FG001|Overall Study|Lost to Follow-up|3|||
23548723|NCT01217073|65739640|FG004|Base Period|Lack of Efficacy|0|||
23214243|NCT02939599|64523551|FG000|Overall Study|Adverse Event|1|||
23214244|NCT02939599|64523552|FG001|Overall Study|Adverse Event|0|||
23214245|NCT02939599|64523551|FG000|Overall Study|Study Terminated By Sponsor|2|||
23214246|NCT02939599|64523552|FG001|Overall Study|Study Terminated By Sponsor|2|||
23214247|NCT00436982|64523555|FG000|Overall Study|Withdrawal by Subject|3|||
23214248|NCT00436982|64523556|FG001|Overall Study|Withdrawal by Subject|1|||
23214249|NCT00436982|64523555|FG000|Overall Study|Did not receive allocated intervention|0|||
23214250|NCT00436982|64523556|FG001|Overall Study|Did not receive allocated intervention|1|||
23214251|NCT00436982|64523555|FG000|Overall Study|no RSA data|1|||
23214252|NCT00436982|64523556|FG001|Overall Study|no RSA data|2|||
23214253|NCT00856986|64523569|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
23214254|NCT00856986|64523570|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
23214255|NCT00856986|64523571|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
23214256|NCT00856986|64523572|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
23214257|NCT00856986|64523573|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
23214258|NCT00856986|64523569|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
23214259|NCT00856986|64523570|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
23214260|NCT00856986|64523571|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
23214261|NCT00856986|64523572|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
23214262|NCT00856986|64523573|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
23214263|NCT00856986|64523569|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
23214264|NCT00856986|64523570|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
23214265|NCT00856986|64523571|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
23214266|NCT00856986|64523572|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
23214267|NCT00856986|64523573|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
23214268|NCT00856986|64523569|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
23214269|NCT00856986|64523570|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
23214270|NCT00856986|64523571|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
23214271|NCT00856986|64523572|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
23214272|NCT00856986|64523573|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
23214273|NCT00856986|64523569|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
23548724|NCT01217073|65739641|FG005|Base Period|Lack of Efficacy|1|||
23214274|NCT00856986|64523570|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
23548725|NCT01217073|65739642|FG006|Base Period|Lack of Efficacy|0|||
23548726|NCT01217073|65739643|FG007|Base Period|Lack of Efficacy|0|||
23548727|NCT01217073|65739636|FG000|Base Period|Lost to Follow-up|0|||
23548728|NCT01217073|65739637|FG001|Base Period|Lost to Follow-up|0|||
23619932|NCT03449134|65994795|FG002|52-Week Treatment Period|Physician Decision|3|||
23214275|NCT00856986|64523571|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
23214276|NCT00856986|64523572|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
23214277|NCT00856986|64523573|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
23214278|NCT00856986|64523569|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
23317501|NCT02552121|64904101|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
23619933|NCT03449134|65994793|FG000|52-Week Treatment Period|Screen Failure|1|||
23548729|NCT01217073|65739638|FG002|Base Period|Lost to Follow-up|1|||
23214279|NCT00856986|64523570|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
23428322|NCT02410824|65310782|FG000|First Intervention (One Week)|Headache|0|||
23548730|NCT01217073|65739639|FG003|Base Period|Lost to Follow-up|1|||
23619934|NCT03449134|65994794|FG001|52-Week Treatment Period|Screen Failure|0|||
23134240|NCT03377699|64240987|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
23134241|NCT03377699|64240988|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
23134242|NCT03377699|64240987|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
23134243|NCT03377699|64240988|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
23134244|NCT01361594|64240989|FG000|Overall Study|Withdrawal by Subject|1|||
23134245|NCT01361594|64240990|FG001|Overall Study|Withdrawal by Subject|2|||
23134246|NCT01195948|64240991|FG000|Overall Study|Lost to Follow-up|0|||
23134247|NCT01195948|64240992|FG001|Overall Study|Lost to Follow-up|1|||
23134248|NCT01195948|64240993|FG002|Overall Study|Lost to Follow-up|2|||
23134249|NCT04155047|64240996|FG000|Overall Study|Adverse Event|1|||
23134250|NCT04155047|64240997|FG001|Overall Study|Adverse Event|0|||
23134251|NCT04155047|64240996|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
23134252|NCT04155047|64240997|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
23134253|NCT01253018|64241003|FG000|Overall Study|Lost to Follow-up|1|||
23134254|NCT01253018|64241004|FG001|Overall Study|Lost to Follow-up|1|||
23134255|NCT01253018|64241003|FG000|Overall Study|Robot Repair Issues|2|||
23134256|NCT01253018|64241004|FG001|Overall Study|Robot Repair Issues|0|||
23134257|NCT01253018|64241003|FG000|Overall Study|Withdrawal by Subject|1|||
23134258|NCT01253018|64241004|FG001|Overall Study|Withdrawal by Subject|1|||
23134259|NCT00727311|64241005|FG000|Overall Study|Did not receive drug|316|||
23134260|NCT00727311|64241005|FG000|Overall Study|Missing end of therapy data|205|||
23134261|NCT00727311|64241005|FG000|Overall Study|Adverse Event|58|||
23134262|NCT00727311|64241005|FG000|Overall Study|Lack of Efficacy|242|||
23134263|NCT00727311|64241005|FG000|Overall Study|Lost to Follow-up|73|||
23134264|NCT00727311|64241005|FG000|Overall Study|Withdrawal by Subject|77|||
23134265|NCT00727311|64241005|FG000|Overall Study|Other|97|||
23134266|NCT00727311|64241005|FG000|Overall Study|Multiple reasons|39|||
23134267|NCT02580305|64241006|FG000|Overall Study|Adverse Event|15|||
23134268|NCT02580305|64241007|FG001|Overall Study|Adverse Event|19|||
23134269|NCT02580305|64241008|FG002|Overall Study|Adverse Event|10|||
23134270|NCT02580305|64241006|FG000|Overall Study|Lack of Efficacy|5|||
23134271|NCT02580305|64241007|FG001|Overall Study|Lack of Efficacy|0|||
23134272|NCT02580305|64241008|FG002|Overall Study|Lack of Efficacy|2|||
23134273|NCT02580305|64241006|FG000|Overall Study|Protocol Violation|4|||
23134274|NCT02580305|64241007|FG001|Overall Study|Protocol Violation|9|||
23134275|NCT02580305|64241008|FG002|Overall Study|Protocol Violation|6|||
23134276|NCT02580305|64241006|FG000|Overall Study|Lost to Follow-up|4|||
23134277|NCT02580305|64241007|FG001|Overall Study|Lost to Follow-up|4|||
23214280|NCT00856986|64523571|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
23548731|NCT01217073|65739640|FG004|Base Period|Lost to Follow-up|3|||
23214281|NCT00856986|64523572|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
23548732|NCT01217073|65739641|FG005|Base Period|Lost to Follow-up|0|||
23548733|NCT01217073|65739642|FG006|Base Period|Lost to Follow-up|0|||
23548734|NCT01217073|65739643|FG007|Base Period|Lost to Follow-up|0|||
23548735|NCT01217073|65739636|FG000|Base Period|Physician Decision|0|||
23548736|NCT01217073|65739637|FG001|Base Period|Physician Decision|0|||
23548737|NCT01217073|65739638|FG002|Base Period|Physician Decision|0|||
23548738|NCT01217073|65739639|FG003|Base Period|Physician Decision|0|||
23548739|NCT01217073|65739640|FG004|Base Period|Physician Decision|1|||
23548740|NCT01217073|65739641|FG005|Base Period|Physician Decision|0|||
23548741|NCT01217073|65739642|FG006|Base Period|Physician Decision|0|||
23548742|NCT01217073|65739643|FG007|Base Period|Physician Decision|0|||
23548743|NCT01217073|65739636|FG000|Base Period|Protocol Violation|1|||
23548744|NCT01217073|65739637|FG001|Base Period|Protocol Violation|0|||
23548745|NCT01217073|65739638|FG002|Base Period|Protocol Violation|0|||
23548746|NCT01217073|65739639|FG003|Base Period|Protocol Violation|0|||
23548747|NCT01217073|65739640|FG004|Base Period|Protocol Violation|1|||
23548748|NCT01217073|65739641|FG005|Base Period|Protocol Violation|2|||
23548749|NCT01217073|65739642|FG006|Base Period|Protocol Violation|0|||
23548750|NCT01217073|65739643|FG007|Base Period|Protocol Violation|0|||
23548751|NCT01217073|65739636|FG000|Base Period|Withdrawal by Subject|4|||
23548752|NCT01217073|65739637|FG001|Base Period|Withdrawal by Subject|5|||
23548753|NCT01217073|65739638|FG002|Base Period|Withdrawal by Subject|5|||
23548754|NCT01217073|65739639|FG003|Base Period|Withdrawal by Subject|1|||
23548755|NCT01217073|65739640|FG004|Base Period|Withdrawal by Subject|5|||
23548756|NCT01217073|65739641|FG005|Base Period|Withdrawal by Subject|5|||
23548757|NCT01217073|65739642|FG006|Base Period|Withdrawal by Subject|0|||
23548758|NCT01217073|65739643|FG007|Base Period|Withdrawal by Subject|0|||
23548759|NCT01217073|65739636|FG000|Extension Period|Adverse Event|0|||
23548760|NCT01217073|65739637|FG001|Extension Period|Adverse Event|0|||
23548761|NCT01217073|65739638|FG002|Extension Period|Adverse Event|0|||
23548762|NCT01217073|65739639|FG003|Extension Period|Adverse Event|0|||
23548763|NCT01217073|65739640|FG004|Extension Period|Adverse Event|0|||
23548764|NCT01217073|65739641|FG005|Extension Period|Adverse Event|0|||
23548765|NCT01217073|65739642|FG006|Extension Period|Adverse Event|19|||
23548766|NCT01217073|65739643|FG007|Extension Period|Adverse Event|5|||
23548767|NCT01217073|65739636|FG000|Extension Period|ALT/AST|0|||
23619935|NCT03449134|65994795|FG002|52-Week Treatment Period|Screen Failure|1|||
23619936|NCT03449134|65994793|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
23619937|NCT03449134|65994794|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
23134278|NCT02580305|64241008|FG002|Overall Study|Lost to Follow-up|2|||
23134279|NCT02580305|64241006|FG000|Overall Study|Withdrawal by Subject|11|||
23134280|NCT02580305|64241007|FG001|Overall Study|Withdrawal by Subject|9|||
23548768|NCT01217073|65739637|FG001|Extension Period|ALT/AST|0|||
23548769|NCT01217073|65739638|FG002|Extension Period|ALT/AST|0|||
23548770|NCT01217073|65739639|FG003|Extension Period|ALT/AST|0|||
23548771|NCT01217073|65739640|FG004|Extension Period|ALT/AST|0|||
23548772|NCT01217073|65739641|FG005|Extension Period|ALT/AST|0|||
23548773|NCT01217073|65739642|FG006|Extension Period|ALT/AST|2|||
23548774|NCT01217073|65739643|FG007|Extension Period|ALT/AST|0|||
23548775|NCT01217073|65739636|FG000|Extension Period|Contraindication to study medication|0|||
23548776|NCT01217073|65739637|FG001|Extension Period|Contraindication to study medication|0|||
23548777|NCT01217073|65739638|FG002|Extension Period|Contraindication to study medication|0|||
23548778|NCT01217073|65739639|FG003|Extension Period|Contraindication to study medication|0|||
23548779|NCT01217073|65739640|FG004|Extension Period|Contraindication to study medication|0|||
23548780|NCT01217073|65739641|FG005|Extension Period|Contraindication to study medication|0|||
23134281|NCT02580305|64241008|FG002|Overall Study|Withdrawal by Subject|7|||
23134282|NCT02580305|64241006|FG000|Overall Study|Randomized in error and never treated|4|||
23134283|NCT02580305|64241007|FG001|Overall Study|Randomized in error and never treated|8|||
23134284|NCT02580305|64241008|FG002|Overall Study|Randomized in error and never treated|5|||
23134285|NCT04664400|64241011|FG000|Overall Study|Withdrawal by Subject|2|||
23134286|NCT03274687|64241012|FG000|Overall Study|Protocol Violation|1|||
23134287|NCT03274687|64241013|FG001|Overall Study|Protocol Violation|1|||
23134288|NCT01484431|64241014|FG000|Period 1: High Dose|Physician Decision|0|||
23134289|NCT01484431|64241015|FG001|Period 1: High Dose|Physician Decision|1|||
23134290|NCT01484431|64241016|FG002|Period 1: High Dose|Physician Decision|0|||
23134291|NCT01484431|64241014|FG000|Period 2|Death|0|||
23134292|NCT01484431|64241015|FG001|Period 2|Death|1|||
23548781|NCT01217073|65739642|FG006|Extension Period|Contraindication to study medication|1|||
23548782|NCT01217073|65739643|FG007|Extension Period|Contraindication to study medication|0|||
23548783|NCT01217073|65739636|FG000|Extension Period|Creatinine/eGFR|0|||
23548784|NCT01217073|65739637|FG001|Extension Period|Creatinine/eGFR|0|||
23548785|NCT01217073|65739638|FG002|Extension Period|Creatinine/eGFR|0|||
23548786|NCT01217073|65739639|FG003|Extension Period|Creatinine/eGFR|0|||
23548787|NCT01217073|65739640|FG004|Extension Period|Creatinine/eGFR|0|||
23548788|NCT01217073|65739641|FG005|Extension Period|Creatinine/eGFR|0|||
23548789|NCT01217073|65739642|FG006|Extension Period|Creatinine/eGFR|11|||
23548790|NCT01217073|65739643|FG007|Extension Period|Creatinine/eGFR|1|||
23548791|NCT01217073|65739636|FG000|Extension Period|Death|0|||
23548792|NCT01217073|65739637|FG001|Extension Period|Death|0|||
23548793|NCT01217073|65739638|FG002|Extension Period|Death|0|||
23548794|NCT01217073|65739639|FG003|Extension Period|Death|0|||
23548795|NCT01217073|65739640|FG004|Extension Period|Death|0|||
23548796|NCT01217073|65739641|FG005|Extension Period|Death|0|||
23548797|NCT01217073|65739642|FG006|Extension Period|Death|1|||
23548798|NCT01217073|65739643|FG007|Extension Period|Death|0|||
23548799|NCT01217073|65739636|FG000|Extension Period|Excluded medication|0|||
23548800|NCT01217073|65739637|FG001|Extension Period|Excluded medication|0|||
23548801|NCT01217073|65739638|FG002|Extension Period|Excluded medication|0|||
23548802|NCT01217073|65739639|FG003|Extension Period|Excluded medication|0|||
23548803|NCT01217073|65739640|FG004|Extension Period|Excluded medication|0|||
23548804|NCT01217073|65739641|FG005|Extension Period|Excluded medication|0|||
23548805|NCT01217073|65739642|FG006|Extension Period|Excluded medication|2|||
23134293|NCT01484431|64241016|FG002|Period 2|Death|1|||
23134294|NCT01484431|64241014|FG000|Period 2|Physician Decision|0|||
23134295|NCT01484431|64241015|FG001|Period 2|Physician Decision|0|||
23134296|NCT01484431|64241016|FG002|Period 2|Physician Decision|1|||
23134297|NCT01484431|64241014|FG000|Period 2|Non-Compliance with Study Drug|1|||
23134298|NCT01484431|64241015|FG001|Period 2|Non-Compliance with Study Drug|0|||
23134299|NCT01484431|64241016|FG002|Period 2|Non-Compliance with Study Drug|0|||
23134300|NCT00400725|64241017|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
23134301|NCT00400725|64241018|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
23134302|NCT00400725|64241019|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
23134303|NCT00400725|64241017|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
23134304|NCT00400725|64241018|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
23134305|NCT00400725|64241019|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
23134306|NCT00400725|64241017|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
23134307|NCT00400725|64241018|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
23134308|NCT00400725|64241019|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
23134309|NCT00400725|64241017|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
23134310|NCT00400725|64241018|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
23548806|NCT01217073|65739643|FG007|Extension Period|Excluded medication|0|||
23548807|NCT01217073|65739636|FG000|Extension Period|Lack of Efficacy|0|||
23548808|NCT01217073|65739637|FG001|Extension Period|Lack of Efficacy|0|||
23548809|NCT01217073|65739638|FG002|Extension Period|Lack of Efficacy|0|||
23548810|NCT01217073|65739639|FG003|Extension Period|Lack of Efficacy|0|||
23548811|NCT01217073|65739640|FG004|Extension Period|Lack of Efficacy|0|||
23548812|NCT01217073|65739641|FG005|Extension Period|Lack of Efficacy|0|||
23548813|NCT01217073|65739642|FG006|Extension Period|Lack of Efficacy|3|||
23548814|NCT01217073|65739643|FG007|Extension Period|Lack of Efficacy|0|||
23134311|NCT00400725|64241019|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
23134312|NCT00400725|64241017|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
23134313|NCT00400725|64241018|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
23134314|NCT00400725|64241019|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
23134315|NCT00400725|64241017|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
23134316|NCT00400725|64241018|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
23134317|NCT00400725|64241019|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
23134318|NCT00400725|64241017|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
23134319|NCT00400725|64241018|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
23134320|NCT00400725|64241019|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
23134321|NCT00400725|64241017|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
23134322|NCT00400725|64241018|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
23134323|NCT00400725|64241019|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
23134324|NCT00400725|64241017|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
23134325|NCT00400725|64241018|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
23134326|NCT00400725|64241019|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
23134327|NCT02153073|64241020|FG000|Overall Study|Case Report Forms Uncollected|230|||
23134328|NCT02153073|64241020|FG000|Overall Study|Protocol Deviation|68|||
23134329|NCT01305200|64241025|FG000|Overall Study|Physician Decision|4|||
23134330|NCT01305200|64241026|FG001|Overall Study|Physician Decision|6|||
23134331|NCT01305200|64241027|FG002|Overall Study|Physician Decision|1|||
23134332|NCT01305200|64241025|FG000|Overall Study|Withdrawal by Subject|24|||
23134333|NCT01305200|64241026|FG001|Overall Study|Withdrawal by Subject|21|||
23134334|NCT01305200|64241027|FG002|Overall Study|Withdrawal by Subject|1|||
23134335|NCT01305200|64241025|FG000|Overall Study|Ineligible|1|||
23134336|NCT01305200|64241026|FG001|Overall Study|Ineligible|2|||
23134337|NCT01305200|64241027|FG002|Overall Study|Ineligible|1|||
23134338|NCT01305200|64241025|FG000|Overall Study|Death|0|||
23134339|NCT01305200|64241026|FG001|Overall Study|Death|2|||
23134340|NCT01305200|64241027|FG002|Overall Study|Death|0|||
23134341|NCT00316017|64241028|FG000|Overall Study|Protocol Violation|11|||
23134342|NCT00316017|64241029|FG001|Overall Study|Protocol Violation|13|||
23134343|NCT00316017|64241030|FG002|Overall Study|Protocol Violation|19|||
23134344|NCT01416389|64241031|FG000|Overall Study|Lost to Follow-up|1|||
23134345|NCT01416389|64241032|FG001|Overall Study|Lost to Follow-up|0|||
23134346|NCT01416389|64241031|FG000|Overall Study|Started New Therapy|2|||
23134347|NCT01416389|64241032|FG001|Overall Study|Started New Therapy|0|||
23134348|NCT01655693|64241033|FG000|Overall Study|Progression of Disease|92|||
23134349|NCT01655693|64241034|FG001|Overall Study|Progression of Disease|76|||
23134350|NCT01655693|64241035|FG002|Overall Study|Progression of Disease|58|||
23134351|NCT01655693|64241033|FG000|Overall Study|Death|8|||
23214282|NCT00856986|64523573|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
23548815|NCT01217073|65739636|FG000|Extension Period|Lost to Follow-up|0|||
23134352|NCT01655693|64241034|FG001|Overall Study|Death|9|||
23134353|NCT01655693|64241035|FG002|Overall Study|Death|12|||
23134354|NCT01655693|64241033|FG000|Overall Study|Serious Adverse Event|3|||
23134355|NCT01655693|64241034|FG001|Overall Study|Serious Adverse Event|15|||
23134356|NCT01655693|64241035|FG002|Overall Study|Serious Adverse Event|11|||
23134357|NCT01655693|64241033|FG000|Overall Study|Withdrawal by Subject|3|||
23134358|NCT01655693|64241034|FG001|Overall Study|Withdrawal by Subject|2|||
23134359|NCT01655693|64241035|FG002|Overall Study|Withdrawal by Subject|20|||
23134360|NCT01655693|64241033|FG000|Overall Study|Adverse Event|3|||
23548816|NCT01217073|65739637|FG001|Extension Period|Lost to Follow-up|0|||
23134361|NCT01655693|64241034|FG001|Overall Study|Adverse Event|11|||
23134362|NCT01655693|64241035|FG002|Overall Study|Adverse Event|3|||
23134363|NCT01655693|64241033|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
23548817|NCT01217073|65739638|FG002|Extension Period|Lost to Follow-up|0|||
23548818|NCT01217073|65739639|FG003|Extension Period|Lost to Follow-up|0|||
23548819|NCT01217073|65739640|FG004|Extension Period|Lost to Follow-up|0|||
23134364|NCT01655693|64241034|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
23134365|NCT01655693|64241035|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
23134366|NCT01655693|64241033|FG000|Overall Study|Non-Compliance|0|||
23134367|NCT01655693|64241034|FG001|Overall Study|Non-Compliance|0|||
23134368|NCT01655693|64241035|FG002|Overall Study|Non-Compliance|7|||
23134369|NCT01655693|64241033|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
23134370|NCT01655693|64241034|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
23548820|NCT01217073|65739641|FG005|Extension Period|Lost to Follow-up|0|||
23134371|NCT01655693|64241035|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
23134372|NCT01655693|64241033|FG000|Overall Study|Protocol Violation|1|||
23134373|NCT01655693|64241034|FG001|Overall Study|Protocol Violation|0|||
23134374|NCT01655693|64241035|FG002|Overall Study|Protocol Violation|3|||
23134375|NCT01655693|64241033|FG000|Overall Study|Lost to Follow-up|1|||
23134376|NCT01655693|64241034|FG001|Overall Study|Lost to Follow-up|0|||
23134377|NCT01655693|64241035|FG002|Overall Study|Lost to Follow-up|1|||
23134378|NCT01655693|64241033|FG000|Overall Study|Screening Failure|1|||
23134379|NCT01655693|64241034|FG001|Overall Study|Screening Failure|0|||
23134380|NCT01655693|64241035|FG002|Overall Study|Screening Failure|0|||
23134381|NCT01655693|64241033|FG000|Overall Study|Other|8|||
23134382|NCT01655693|64241034|FG001|Overall Study|Other|6|||
23134383|NCT01655693|64241035|FG002|Overall Study|Other|15|||
23134384|NCT02060370|64241039|FG000|Overall Study|Physician Decision|1|||
23134385|NCT01373151|64241040|FG000|Period 1|Lack of Efficacy|3|||
23134386|NCT01373151|64241041|FG001|Period 1|Lack of Efficacy|0|||
23134387|NCT01373151|64241042|FG002|Period 1|Lack of Efficacy|0|||
23134388|NCT01373151|64241043|FG003|Period 1|Lack of Efficacy|0|||
23134389|NCT01373151|64241044|FG004|Period 1|Lack of Efficacy|1|||
23134390|NCT01373151|64241045|FG005|Period 1|Lack of Efficacy|0|||
23134391|NCT01373151|64241046|FG006|Period 1|Lack of Efficacy|0|||
23134392|NCT01373151|64241040|FG000|Period 1|Adverse Event|0|||
23134393|NCT01373151|64241041|FG001|Period 1|Adverse Event|0|||
23134394|NCT01373151|64241042|FG002|Period 1|Adverse Event|1|||
23134395|NCT01373151|64241043|FG003|Period 1|Adverse Event|0|||
23134396|NCT01373151|64241044|FG004|Period 1|Adverse Event|4|||
23134397|NCT01373151|64241045|FG005|Period 1|Adverse Event|3|||
23134398|NCT01373151|64241046|FG006|Period 1|Adverse Event|0|||
23134399|NCT01373151|64241040|FG000|Period 1|Withdrawal by Subject|2|||
23134400|NCT01373151|64241041|FG001|Period 1|Withdrawal by Subject|0|||
23134401|NCT01373151|64241042|FG002|Period 1|Withdrawal by Subject|3|||
23134402|NCT01373151|64241043|FG003|Period 1|Withdrawal by Subject|1|||
23134403|NCT01373151|64241044|FG004|Period 1|Withdrawal by Subject|0|||
23134404|NCT01373151|64241045|FG005|Period 1|Withdrawal by Subject|1|||
23134405|NCT01373151|64241046|FG006|Period 1|Withdrawal by Subject|0|||
23134406|NCT01373151|64241040|FG000|Period 2|Lack of Efficacy|9|||
23134407|NCT01373151|64241041|FG001|Period 2|Lack of Efficacy|0|||
23134408|NCT01373151|64241042|FG002|Period 2|Lack of Efficacy|0|||
23134409|NCT01373151|64241043|FG003|Period 2|Lack of Efficacy|1|||
23134410|NCT01373151|64241044|FG004|Period 2|Lack of Efficacy|2|||
23134411|NCT01373151|64241045|FG005|Period 2|Lack of Efficacy|0|||
23134412|NCT01373151|64241046|FG006|Period 2|Lack of Efficacy|3|||
23134413|NCT01373151|64241040|FG000|Period 2|Adverse Event|0|||
23134414|NCT01373151|64241041|FG001|Period 2|Adverse Event|0|||
23134415|NCT01373151|64241042|FG002|Period 2|Adverse Event|3|||
23134416|NCT01373151|64241043|FG003|Period 2|Adverse Event|3|||
23134417|NCT01373151|64241044|FG004|Period 2|Adverse Event|0|||
23134418|NCT01373151|64241045|FG005|Period 2|Adverse Event|0|||
23134419|NCT01373151|64241046|FG006|Period 2|Adverse Event|1|||
23134420|NCT01373151|64241040|FG000|Period 2|subject request to discontinue|0|||
23134421|NCT01373151|64241041|FG001|Period 2|subject request to discontinue|1|||
23134422|NCT01373151|64241042|FG002|Period 2|subject request to discontinue|0|||
23134423|NCT01373151|64241043|FG003|Period 2|subject request to discontinue|0|||
23134424|NCT01373151|64241044|FG004|Period 2|subject request to discontinue|0|||
23134425|NCT01373151|64241045|FG005|Period 2|subject request to discontinue|0|||
23134426|NCT01373151|64241046|FG006|Period 2|subject request to discontinue|0|||
23134427|NCT01373151|64241040|FG000|Period 2|Withdrawal by Subject|0|||
23134428|NCT01373151|64241041|FG001|Period 2|Withdrawal by Subject|0|||
23134429|NCT01373151|64241042|FG002|Period 2|Withdrawal by Subject|0|||
23428323|NCT02410824|65310783|FG001|First Intervention (One Week)|Headache|1|||
23134430|NCT01373151|64241043|FG003|Period 2|Withdrawal by Subject|1|||
23134431|NCT01373151|64241044|FG004|Period 2|Withdrawal by Subject|0|||
23134432|NCT01373151|64241045|FG005|Period 2|Withdrawal by Subject|0|||
23134433|NCT01373151|64241046|FG006|Period 2|Withdrawal by Subject|0|||
23134434|NCT01373151|64241040|FG000|Period 2|Other|0|||
23134435|NCT01373151|64241041|FG001|Period 2|Other|0|||
23134436|NCT01373151|64241042|FG002|Period 2|Other|1|||
23134437|NCT01373151|64241043|FG003|Period 2|Other|0|||
23428324|NCT00907296|65310788|FG000|Overall Study|Ineligibility Determined|1|||
23134438|NCT01373151|64241044|FG004|Period 2|Other|0|||
23134439|NCT01373151|64241045|FG005|Period 2|Other|0|||
23134440|NCT01373151|64241046|FG006|Period 2|Other|1|||
23134441|NCT02217475|64241047|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
23134442|NCT02217475|64241048|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
23134443|NCT02217475|64241049|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
23134444|NCT02217475|64241047|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
23134445|NCT02217475|64241048|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
23134446|NCT02217475|64241049|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
23134447|NCT02217475|64241047|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
23134448|NCT02217475|64241048|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
23134449|NCT02217475|64241049|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
23134450|NCT02217475|64241047|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
23134451|NCT02217475|64241048|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
23428325|NCT00907296|65310789|FG001|Overall Study|Ineligibility Determined|0|||
23548821|NCT01217073|65739642|FG006|Extension Period|Lost to Follow-up|9|||
23548822|NCT01217073|65739643|FG007|Extension Period|Lost to Follow-up|1|||
23548823|NCT01217073|65739636|FG000|Extension Period|Non-compliance with study drug|0|||
23548824|NCT01217073|65739637|FG001|Extension Period|Non-compliance with study drug|0|||
23548825|NCT01217073|65739638|FG002|Extension Period|Non-compliance with study drug|0|||
23134452|NCT02217475|64241049|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
23134453|NCT02217475|64241047|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
23134454|NCT02217475|64241048|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
23134455|NCT02217475|64241049|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
23134456|NCT02217475|64241047|FG000|Discontinued After Period 1|Adverse Event|1|||
23134457|NCT02217475|64241048|FG001|Discontinued After Period 1|Adverse Event|2|||
23134458|NCT02217475|64241049|FG002|Discontinued After Period 1|Adverse Event|0|||
23134459|NCT02217475|64241047|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
23134460|NCT02217475|64241048|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
23134461|NCT02217475|64241049|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
23134462|NCT02217475|64241047|FG000|Discontinued After Period 1|Physician Decision|0|||
23134463|NCT02217475|64241048|FG001|Discontinued After Period 1|Physician Decision|0|||
23134464|NCT02217475|64241049|FG002|Discontinued After Period 1|Physician Decision|1|||
23134465|NCT02217475|64241047|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
23134466|NCT02217475|64241048|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
23134467|NCT02217475|64241049|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
23134468|NCT02217475|64241047|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
23134469|NCT02217475|64241048|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
23134470|NCT02217475|64241049|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
23134471|NCT02217475|64241047|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
23134472|NCT02217475|64241048|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
23134473|NCT02217475|64241049|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
23134474|NCT02217475|64241047|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
23134475|NCT02217475|64241048|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
23134476|NCT02217475|64241049|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
23134477|NCT02217475|64241047|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
23134478|NCT02217475|64241048|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
23134479|NCT02217475|64241049|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
23134480|NCT03449901|64241050|FG000|Overall Study|Progression|57|||
23134481|NCT03449901|64241051|FG001|Overall Study|Progression|12|||
23134482|NCT03449901|64241050|FG000|Overall Study|Adverse Event|3|||
23134483|NCT03449901|64241051|FG001|Overall Study|Adverse Event|0|||
23134484|NCT03449901|64241050|FG000|Overall Study|Death|6|||
23134485|NCT03449901|64241051|FG001|Overall Study|Death|2|||
23134486|NCT03449901|64241050|FG000|Overall Study|Withdrawal by Subject|12|||
23134487|NCT03449901|64241051|FG001|Overall Study|Withdrawal by Subject|1|||
23134488|NCT03449901|64241050|FG000|Overall Study|Physician Decision|1|||
23134489|NCT03449901|64241051|FG001|Overall Study|Physician Decision|0|||
23134490|NCT03449901|64241050|FG000|Overall Study|Patient elected for surgical intervention|1|||
23134491|NCT03449901|64241051|FG001|Overall Study|Patient elected for surgical intervention|0|||
23134492|NCT03449901|64241050|FG000|Overall Study|Patient off for other complicating disease|1|||
23134493|NCT03449901|64241051|FG001|Overall Study|Patient off for other complicating disease|0|||
23428326|NCT00907296|65310790|FG002|Overall Study|Ineligibility Determined|0|||
23428327|NCT00907296|65310791|FG003|Overall Study|Ineligibility Determined|1|||
23428328|NCT00907296|65310792|FG004|Overall Study|Ineligibility Determined|0|||
23428329|NCT00907296|65310793|FG005|Overall Study|Ineligibility Determined|0|||
23428330|NCT00907296|65310794|FG006|Overall Study|Ineligibility Determined|0|||
23428331|NCT00907296|65310795|FG007|Overall Study|Ineligibility Determined|1|||
23134494|NCT01327495|64241054|FG000|Overall Study|Adverse Event|2|||
23214283|NCT00856986|64523569|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
23214284|NCT00856986|64523570|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
23428332|NCT00907296|65310796|FG008|Overall Study|Ineligibility Determined|0|||
23428333|NCT00907296|65310797|FG009|Overall Study|Ineligibility Determined|0|||
23428334|NCT00907296|65310788|FG000|Overall Study|Protocol Deviation|0|||
23428335|NCT00907296|65310789|FG001|Overall Study|Protocol Deviation|1|||
23548826|NCT01217073|65739639|FG003|Extension Period|Non-compliance with study drug|0|||
23548827|NCT01217073|65739640|FG004|Extension Period|Non-compliance with study drug|0|||
23428336|NCT00907296|65310790|FG002|Overall Study|Protocol Deviation|0|||
23548828|NCT01217073|65739641|FG005|Extension Period|Non-compliance with study drug|0|||
23548829|NCT01217073|65739642|FG006|Extension Period|Non-compliance with study drug|0|||
23134495|NCT01327495|64241055|FG001|Overall Study|Adverse Event|1|||
23134496|NCT01327495|64241056|FG002|Overall Study|Adverse Event|1|||
23134497|NCT01327495|64241057|FG003|Overall Study|Adverse Event|0|||
23134498|NCT01327495|64241058|FG004|Overall Study|Adverse Event|0|||
23134499|NCT01327495|64241059|FG005|Overall Study|Adverse Event|2|||
23134500|NCT01327495|64241054|FG000|Overall Study|Withdrawal by Subject|0|||
23134501|NCT01327495|64241055|FG001|Overall Study|Withdrawal by Subject|1|||
23428337|NCT00907296|65310791|FG003|Overall Study|Protocol Deviation|0|||
23134502|NCT01327495|64241056|FG002|Overall Study|Withdrawal by Subject|1|||
23134503|NCT01327495|64241057|FG003|Overall Study|Withdrawal by Subject|0|||
23134504|NCT01327495|64241058|FG004|Overall Study|Withdrawal by Subject|1|||
23134505|NCT01327495|64241059|FG005|Overall Study|Withdrawal by Subject|0|||
23134506|NCT01327495|64241054|FG000|Overall Study|Physician Decision|0|||
23134507|NCT01327495|64241055|FG001|Overall Study|Physician Decision|0|||
23134508|NCT01327495|64241056|FG002|Overall Study|Physician Decision|0|||
23134509|NCT01327495|64241057|FG003|Overall Study|Physician Decision|0|||
23134510|NCT01327495|64241058|FG004|Overall Study|Physician Decision|2|||
23134511|NCT01327495|64241059|FG005|Overall Study|Physician Decision|0|||
23134512|NCT00515853|64241064|FG000|Overall Study|Lost to Follow-up|9|||
23134513|NCT00515853|64241065|FG001|Overall Study|Lost to Follow-up|13|||
23134514|NCT00515853|64241064|FG000|Overall Study|Withdrawal by Subject|6|||
23134515|NCT00515853|64241065|FG001|Overall Study|Withdrawal by Subject|4|||
23134516|NCT00789360|64241068|FG000|Overall Study|Protocol Violation|3|||
23134517|NCT00789360|64241069|FG001|Overall Study|Protocol Violation|1|||
23134518|NCT01892540|64241070|FG000|Overall Study|Did not complete PET/MRI|0|||
23134519|NCT01892540|64241071|FG001|Overall Study|Did not complete PET/MRI|0|||
23134520|NCT01892540|64241072|FG002|Overall Study|Did not complete PET/MRI|2|||
23134521|NCT01892540|64241070|FG000|Overall Study|Did not fit in scanner|0|||
23134522|NCT01892540|64241071|FG001|Overall Study|Did not fit in scanner|0|||
23134523|NCT01892540|64241072|FG002|Overall Study|Did not fit in scanner|1|||
23134524|NCT03525392|64241075|FG000|Overall Study|Adverse Event|1|||
23134525|NCT03525392|64241076|FG001|Overall Study|Adverse Event|0|||
23134526|NCT03525392|64241077|FG002|Overall Study|Adverse Event|2|||
23134527|NCT03525392|64241078|FG003|Overall Study|Adverse Event|0|||
23134528|NCT03525392|64241079|FG004|Overall Study|Adverse Event|0|||
23134529|NCT03525392|64241075|FG000|Overall Study|Progressive disease|0|||
23134530|NCT03525392|64241076|FG001|Overall Study|Progressive disease|1|||
23134531|NCT03525392|64241077|FG002|Overall Study|Progressive disease|1|||
23134532|NCT03525392|64241078|FG003|Overall Study|Progressive disease|3|||
23134533|NCT03525392|64241079|FG004|Overall Study|Progressive disease|1|||
23134534|NCT01258595|64241082|FG000|Overall Study|Lost to Follow-up|1|||
23134535|NCT01258595|64241083|FG001|Overall Study|Lost to Follow-up|0|||
23134536|NCT01258595|64241082|FG000|Overall Study|Withdrawal by Subject|0|||
23134537|NCT01258595|64241083|FG001|Overall Study|Withdrawal by Subject|1|||
23134538|NCT01253135|64241084|FG000|Original Protocol|Protocol Amendment|15|||
23134539|NCT01253135|64241084|FG000|Amended Protocol|Non-compliance|1|||
23134540|NCT02334423|64241085|FG000|Overall Study|Protocol Violation|10|||
23428338|NCT00907296|65310792|FG004|Overall Study|Protocol Deviation|0|||
23428339|NCT00907296|65310793|FG005|Overall Study|Protocol Deviation|0|||
23428340|NCT00907296|65310794|FG006|Overall Study|Protocol Deviation|0|||
23428341|NCT00907296|65310795|FG007|Overall Study|Protocol Deviation|0|||
23428342|NCT00907296|65310796|FG008|Overall Study|Protocol Deviation|0|||
23428343|NCT00907296|65310797|FG009|Overall Study|Protocol Deviation|0|||
23428344|NCT00907296|65310788|FG000|Overall Study|Noncompliance|1|||
23428345|NCT00907296|65310789|FG001|Overall Study|Noncompliance|1|||
23428346|NCT00907296|65310790|FG002|Overall Study|Noncompliance|1|||
23428347|NCT00907296|65310791|FG003|Overall Study|Noncompliance|0|||
23428348|NCT00907296|65310792|FG004|Overall Study|Noncompliance|0|||
23428349|NCT00907296|65310793|FG005|Overall Study|Noncompliance|1|||
23428350|NCT00907296|65310794|FG006|Overall Study|Noncompliance|0|||
23428351|NCT00907296|65310795|FG007|Overall Study|Noncompliance|2|||
23428352|NCT00907296|65310796|FG008|Overall Study|Noncompliance|0|||
23428353|NCT00907296|65310797|FG009|Overall Study|Noncompliance|0|||
23428354|NCT00907296|65310788|FG000|Overall Study|Adverse Event|2|||
23428355|NCT00907296|65310789|FG001|Overall Study|Adverse Event|0|||
23428356|NCT00907296|65310790|FG002|Overall Study|Adverse Event|0|||
23428357|NCT00907296|65310791|FG003|Overall Study|Adverse Event|0|||
23134541|NCT02334423|64241086|FG001|Overall Study|Protocol Violation|3|||
23134542|NCT00488475|64241087|FG000|Overall Study|Other|1754|||
23134543|NCT00777088|64241088|FG000|Overall Study|PED Treatment not attempted|1|||
23134544|NCT01008410|64241090|FG000|Overall Study|Adverse Event|13|||
23134545|NCT01008410|64241091|FG001|Overall Study|Adverse Event|7|||
23134546|NCT01008410|64241090|FG000|Overall Study|Withdrawal by Subject|6|||
23134547|NCT01008410|64241091|FG001|Overall Study|Withdrawal by Subject|2|||
23134548|NCT01008410|64241090|FG000|Overall Study|Lost to Follow-up|1|||
23134549|NCT01008410|64241091|FG001|Overall Study|Lost to Follow-up|0|||
23134550|NCT01008410|64241090|FG000|Overall Study|Noncompliance|1|||
23134551|NCT01008410|64241091|FG001|Overall Study|Noncompliance|0|||
23134552|NCT01008410|64241090|FG000|Overall Study|Low Cortisol|2|||
23134553|NCT01008410|64241091|FG001|Overall Study|Low Cortisol|0|||
23134554|NCT01008410|64241090|FG000|Overall Study|Lack of Efficacy|2|||
23134555|NCT01008410|64241091|FG001|Overall Study|Lack of Efficacy|6|||
23134556|NCT01008410|64241090|FG000|Overall Study|Met Exclusion Criterion|0|||
23428358|NCT00907296|65310792|FG004|Overall Study|Adverse Event|0|||
23428359|NCT00907296|65310793|FG005|Overall Study|Adverse Event|0|||
23428360|NCT00907296|65310794|FG006|Overall Study|Adverse Event|1|||
23428361|NCT00907296|65310795|FG007|Overall Study|Adverse Event|0|||
23428362|NCT00907296|65310796|FG008|Overall Study|Adverse Event|0|||
23428363|NCT00907296|65310797|FG009|Overall Study|Adverse Event|1|||
23428364|NCT00907296|65310788|FG000|Overall Study|Withdrawal by Subject|7|||
23428365|NCT00907296|65310789|FG001|Overall Study|Withdrawal by Subject|2|||
23428366|NCT00907296|65310790|FG002|Overall Study|Withdrawal by Subject|1|||
23428367|NCT00907296|65310791|FG003|Overall Study|Withdrawal by Subject|1|||
23548830|NCT01217073|65739643|FG007|Extension Period|Non-compliance with study drug|1|||
23548831|NCT01217073|65739636|FG000|Extension Period|Physician Decision|0|||
23548832|NCT01217073|65739637|FG001|Extension Period|Physician Decision|0|||
23548833|NCT01217073|65739638|FG002|Extension Period|Physician Decision|0|||
23548834|NCT01217073|65739639|FG003|Extension Period|Physician Decision|0|||
23548835|NCT01217073|65739640|FG004|Extension Period|Physician Decision|0|||
23548836|NCT01217073|65739641|FG005|Extension Period|Physician Decision|0|||
23548837|NCT01217073|65739642|FG006|Extension Period|Physician Decision|4|||
23548838|NCT01217073|65739643|FG007|Extension Period|Physician Decision|1|||
23548839|NCT01217073|65739636|FG000|Extension Period|Protocol Violation|0|||
23548840|NCT01217073|65739637|FG001|Extension Period|Protocol Violation|0|||
23548841|NCT01217073|65739638|FG002|Extension Period|Protocol Violation|0|||
23548842|NCT01217073|65739639|FG003|Extension Period|Protocol Violation|0|||
23548843|NCT01217073|65739640|FG004|Extension Period|Protocol Violation|0|||
23548844|NCT01217073|65739641|FG005|Extension Period|Protocol Violation|0|||
23548845|NCT01217073|65739642|FG006|Extension Period|Protocol Violation|2|||
23548846|NCT01217073|65739643|FG007|Extension Period|Protocol Violation|1|||
23619938|NCT03449134|65994795|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
23619939|NCT03449134|65994793|FG000|52-Week Treatment Period|Site Closure|1|||
23619940|NCT03449134|65994794|FG001|52-Week Treatment Period|Site Closure|0|||
23214285|NCT00856986|64523571|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
23214286|NCT00856986|64523572|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
23214287|NCT00856986|64523573|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
23548847|NCT01217073|65739636|FG000|Extension Period|Site discontinued study participation|0|||
23548848|NCT01217073|65739637|FG001|Extension Period|Site discontinued study participation|0|||
23548849|NCT01217073|65739638|FG002|Extension Period|Site discontinued study participation|0|||
23619941|NCT03449134|65994795|FG002|52-Week Treatment Period|Site Closure|0|||
23619942|NCT01774019|65994796|FG000|Overall Study|No longer meets protocol criteria|2|||
23619943|NCT01774019|65994797|FG001|Overall Study|No longer meets protocol criteria|0|||
23619944|NCT01774019|65994796|FG000|Overall Study|Withdrawal by Subject|1|||
23134557|NCT01008410|64241091|FG001|Overall Study|Met Exclusion Criterion|1|||
23134558|NCT01789567|64241092|FG000|Overall Study|Death|6|||
23134559|NCT01205152|64241095|FG000|Overall Study|Death|1|||
23134560|NCT03339245|64241096|FG000|Overall Study|Adverse Event|1|||
23134561|NCT03339245|64241097|FG001|Overall Study|Adverse Event|1|||
23134562|NCT03339245|64241096|FG000|Overall Study|Withdrawal by Subject|1|||
23134563|NCT03339245|64241097|FG001|Overall Study|Withdrawal by Subject|0|||
23134564|NCT00414908|64241102|FG000|Overall Study|Protocol Violation|1|||
23134565|NCT00414908|64241103|FG001|Overall Study|Protocol Violation|1|||
23134566|NCT02601300|64241109|FG000|Induction Phase|Lack of Efficacy|2|||
23134567|NCT02601300|64241109|FG000|Induction Phase|Protocol Violation|1|||
23134568|NCT02601300|64241109|FG000|Extension Phase|Withdrawal by Subject|3|||
23134569|NCT02601300|64241109|FG000|Extension Phase|Adverse Event|4|||
23134570|NCT02601300|64241109|FG000|Extension Phase|Lack of Efficacy|10|||
23134571|NCT02383940|64241110|FG000|Overall Study|Adverse Event|1|||
23134572|NCT02383940|64241111|FG001|Overall Study|Adverse Event|0|||
23134573|NCT02383940|64241110|FG000|Overall Study|Lost to Follow-up|2|||
23134574|NCT02383940|64241111|FG001|Overall Study|Lost to Follow-up|2|||
23134575|NCT02383940|64241110|FG000|Overall Study|Physician Decision|2|||
23134576|NCT02383940|64241111|FG001|Overall Study|Physician Decision|0|||
23134577|NCT02383940|64241110|FG000|Overall Study|Withdrawal by Subject|1|||
23134578|NCT02383940|64241111|FG001|Overall Study|Withdrawal by Subject|1|||
23134579|NCT02383940|64241110|FG000|Overall Study|Randomized but not treated|2|||
23134580|NCT02383940|64241111|FG001|Overall Study|Randomized but not treated|0|||
23134581|NCT02383940|64241110|FG000|Overall Study|Other than specified above|1|||
23134582|NCT02383940|64241111|FG001|Overall Study|Other than specified above|0|||
23134583|NCT00436852|64241112|FG000|Overall Study|Death|23|||
23134584|NCT00436852|64241113|FG001|Overall Study|Death|34|||
23134585|NCT00436852|64241112|FG000|Overall Study|Lack of Efficacy|9|||
23428368|NCT00907296|65310792|FG004|Overall Study|Withdrawal by Subject|1|||
23428369|NCT00907296|65310793|FG005|Overall Study|Withdrawal by Subject|5|||
23619945|NCT01774019|65994797|FG001|Overall Study|Withdrawal by Subject|0|||
23619946|NCT01774019|65994796|FG000|Overall Study|Surgery delayed > 120 days|1|||
23134586|NCT00436852|64241113|FG001|Overall Study|Lack of Efficacy|7|||
23134587|NCT00436852|64241112|FG000|Overall Study|Withdrawal by Subject|2|||
23134588|NCT00436852|64241113|FG001|Overall Study|Withdrawal by Subject|4|||
23134589|NCT00436852|64241112|FG000|Overall Study|Ineligible|1|||
23134590|NCT00436852|64241113|FG001|Overall Study|Ineligible|0|||
23134591|NCT00818168|64241118|FG000|Overall Study|Lack of Efficacy|18|||
23134592|NCT00818168|64241118|FG000|Overall Study|Pregnancy|2|||
23134593|NCT00818168|64241118|FG000|Overall Study|Withdrawal by Subject|16|||
23428370|NCT00907296|65310794|FG006|Overall Study|Withdrawal by Subject|3|||
23428371|NCT00907296|65310795|FG007|Overall Study|Withdrawal by Subject|2|||
23428372|NCT00907296|65310796|FG008|Overall Study|Withdrawal by Subject|4|||
23428373|NCT00907296|65310797|FG009|Overall Study|Withdrawal by Subject|2|||
23428374|NCT00907296|65310788|FG000|Overall Study|Lost to Follow-up|9|||
23428375|NCT00907296|65310789|FG001|Overall Study|Lost to Follow-up|1|||
23428376|NCT00907296|65310790|FG002|Overall Study|Lost to Follow-up|0|||
23428377|NCT00907296|65310791|FG003|Overall Study|Lost to Follow-up|2|||
23428378|NCT00907296|65310792|FG004|Overall Study|Lost to Follow-up|0|||
23428379|NCT00907296|65310793|FG005|Overall Study|Lost to Follow-up|3|||
23428380|NCT00907296|65310794|FG006|Overall Study|Lost to Follow-up|2|||
23428381|NCT00907296|65310795|FG007|Overall Study|Lost to Follow-up|2|||
23428382|NCT00907296|65310796|FG008|Overall Study|Lost to Follow-up|0|||
23428383|NCT00907296|65310797|FG009|Overall Study|Lost to Follow-up|4|||
23428384|NCT03271047|65310798|FG000|Phase 1b: Dose Finding Period|Death|8|||
23428385|NCT03271047|65310799|FG001|Phase 1b: Dose Finding Period|Death|8|||
23428386|NCT03271047|65310800|FG002|Phase 1b: Dose Finding Period|Death|0|||
23548850|NCT01217073|65739639|FG003|Extension Period|Site discontinued study participation|0|||
23548851|NCT01217073|65739640|FG004|Extension Period|Site discontinued study participation|0|||
23548852|NCT01217073|65739641|FG005|Extension Period|Site discontinued study participation|0|||
23548853|NCT01217073|65739642|FG006|Extension Period|Site discontinued study participation|7|||
23548854|NCT01217073|65739643|FG007|Extension Period|Site discontinued study participation|2|||
23548855|NCT01217073|65739636|FG000|Extension Period|Withdrawal by Subject|0|||
23548856|NCT01217073|65739637|FG001|Extension Period|Withdrawal by Subject|0|||
23548857|NCT01217073|65739638|FG002|Extension Period|Withdrawal by Subject|0|||
23548858|NCT01217073|65739639|FG003|Extension Period|Withdrawal by Subject|0|||
23548859|NCT01217073|65739640|FG004|Extension Period|Withdrawal by Subject|0|||
23548860|NCT01217073|65739641|FG005|Extension Period|Withdrawal by Subject|0|||
23548861|NCT01217073|65739642|FG006|Extension Period|Withdrawal by Subject|30|||
23548862|NCT01217073|65739643|FG007|Extension Period|Withdrawal by Subject|8|||
23548863|NCT01640808|65739647|FG000|Overall Study|Unable to continue dynamic CT|14|||
23548864|NCT01640808|65739648|FG001|Overall Study|Unable to continue dynamic CT|4|||
23548865|NCT01640808|65739647|FG000|Overall Study|Withdrawal by Subject|12|||
23548866|NCT01640808|65739648|FG001|Overall Study|Withdrawal by Subject|4|||
23548867|NCT01640808|65739647|FG000|Overall Study|Lost to Follow-up|4|||
23548868|NCT01640808|65739648|FG001|Overall Study|Lost to Follow-up|0|||
23548869|NCT01640808|65739647|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
23548870|NCT01640808|65739648|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
23548871|NCT01640808|65739647|FG000|Overall Study|Administration of anticancer drugs|2|||
23548872|NCT01640808|65739648|FG001|Overall Study|Administration of anticancer drugs|1|||
23548873|NCT01640808|65739647|FG000|Overall Study|Physician Decision|19|||
23548874|NCT01640808|65739648|FG001|Overall Study|Physician Decision|5|||
23548875|NCT01640808|65739647|FG000|Overall Study|Randomized but not treated|4|||
23548876|NCT01640808|65739648|FG001|Overall Study|Randomized but not treated|2|||
23548877|NCT01596582|65739649|FG000|Overall Study|Deemed ineligible after study visit|3|||
23548878|NCT01596582|65739650|FG001|Overall Study|Deemed ineligible after study visit|6|||
23548879|NCT01596582|65739649|FG000|Overall Study|Missing all outcome data|1|||
23548880|NCT01596582|65739650|FG001|Overall Study|Missing all outcome data|1|||
23548881|NCT02492100|65739652|FG000|Overall Study|Death|1|||
23548882|NCT03178266|65739653|FG000|Overall Study|Death|0|||
23548883|NCT03178266|65739654|FG001|Overall Study|Death|1|||
23548884|NCT03178266|65739653|FG000|Overall Study|Disont. Early|0|||
23548885|NCT03178266|65739654|FG001|Overall Study|Disont. Early|1|||
23548886|NCT03178266|65739653|FG000|Overall Study|Withdrawal by Subject|0|||
23548887|NCT03178266|65739654|FG001|Overall Study|Withdrawal by Subject|2|||
23548888|NCT02119416|65739655|FG000|Overall Study|Protocol Violation|1|||
23548889|NCT02119416|65739656|FG001|Overall Study|Protocol Violation|1|||
23548890|NCT02119416|65739657|FG002|Overall Study|Protocol Violation|1|||
23548891|NCT02119416|65739655|FG000|Overall Study|wrong pubertal stage|1|||
23548892|NCT02119416|65739656|FG001|Overall Study|wrong pubertal stage|0|||
23548893|NCT02119416|65739657|FG002|Overall Study|wrong pubertal stage|1|||
23548894|NCT00829387|65739659|FG000|Overall Study|Withdrawal by Subject|2|||
23548895|NCT00829387|65739660|FG001|Overall Study|Withdrawal by Subject|3|||
23548896|NCT00829387|65739659|FG000|Overall Study|Disqualified by PI|1|||
23619947|NCT01774019|65994797|FG001|Overall Study|Surgery delayed > 120 days|0|||
23134594|NCT00818168|64241118|FG000|Overall Study|Lost to Follow-up|7|||
23548897|NCT00829387|65739660|FG001|Overall Study|Disqualified by PI|0|||
23548898|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
23548899|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
23619948|NCT01774019|65994796|FG000|Overall Study|Patient refused surgery|1|||
23134595|NCT00818168|64241118|FG000|Overall Study|Adverse Event|19|||
23428387|NCT03271047|65310801|FG003|Phase 1b: Dose Finding Period|Death|0|||
23428388|NCT03271047|65310798|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
23428389|NCT03271047|65310799|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
23428390|NCT03271047|65310800|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
23548900|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
23548901|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
23548902|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
23548903|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
23548904|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
23548905|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
23548906|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
23548907|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
23548908|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
23548909|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
23548910|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
23548911|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
23548912|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
23548913|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
23548914|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
23548915|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
23548916|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
23548917|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
23548918|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
23548919|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
23548920|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
23548921|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
23548922|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548923|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548924|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548925|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548926|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548927|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548928|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548929|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548930|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548931|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548932|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548933|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548934|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548935|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548936|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548937|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
23548938|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548939|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548940|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
23548941|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
23548942|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
23548943|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548944|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548945|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548946|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548947|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548948|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548949|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548950|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548951|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548952|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548953|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548954|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548955|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548956|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548957|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
23548958|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
23134596|NCT00818168|64241118|FG000|Overall Study|Reason for Non-completion Not reported|6|||
23134597|NCT00818168|64241118|FG000|Overall Study|Participant Moved|2|||
23134598|NCT01242800|64241119|FG000|Overall Study|Patient refusal|0|||
23134599|NCT01242800|64241120|FG001|Overall Study|Patient refusal|10|||
23134600|NCT01242800|64241119|FG000|Overall Study|Physician Decision|0|||
23134601|NCT01242800|64241120|FG001|Overall Study|Physician Decision|1|||
23214288|NCT00856986|64523569|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
23214289|NCT00856986|64523570|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
23134602|NCT01242800|64241119|FG000|Overall Study|Disease progression|0|||
23134603|NCT01242800|64241120|FG001|Overall Study|Disease progression|3|||
23214290|NCT00856986|64523571|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
23214291|NCT00856986|64523572|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
23214292|NCT00856986|64523573|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
23214293|NCT00856986|64523569|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
23214294|NCT00856986|64523570|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
23214295|NCT00856986|64523571|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
23214296|NCT00856986|64523572|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
23214297|NCT00856986|64523573|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
23214298|NCT00856986|64523569|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
23214299|NCT00856986|64523570|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
23214300|NCT00856986|64523571|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
23214301|NCT00856986|64523572|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
23214302|NCT00856986|64523573|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
23214303|NCT00856986|64523569|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
23214304|NCT00856986|64523570|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
23214305|NCT00856986|64523571|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
23214306|NCT00856986|64523572|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
23214307|NCT00856986|64523573|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
23214308|NCT00856986|64523569|FG000|Main Period, Weeks 0-26|Unclassified|7|||
23214309|NCT00856986|64523570|FG001|Main Period, Weeks 0-26|Unclassified|6|||
23214310|NCT00856986|64523571|FG002|Main Period, Weeks 0-26|Unclassified|7|||
23548959|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
23548960|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
23134604|NCT01242800|64241119|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
23134605|NCT01242800|64241120|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
23548961|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
23548962|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
23548963|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
23548964|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
23548965|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
23548966|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
23548967|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
23134606|NCT01242800|64241119|FG000|Overall Study|Reasons not reported|0|||
23134607|NCT01242800|64241120|FG001|Overall Study|Reasons not reported|4|||
23134608|NCT02731690|64241123|FG000|Overall Study|Adverse Event|1|||
23134609|NCT02731690|64241123|FG000|Overall Study|Withdrawal by Subject|3|||
23134610|NCT02731690|64241123|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
23134611|NCT04032613|64241124|FG000|Overall Study|Did not complete post-program assessment|5|||
23134612|NCT04032613|64241125|FG001|Overall Study|Did not complete post-program assessment|2|||
23134613|NCT02624791|64241126|FG000|Overall Study|Withdrawal by Subject|2|||
23134614|NCT02624791|64241127|FG001|Overall Study|Withdrawal by Subject|0|||
23134615|NCT02624791|64241128|FG002|Overall Study|Withdrawal by Subject|0|||
23134616|NCT02624791|64241129|FG003|Overall Study|Withdrawal by Subject|0|||
23134617|NCT02624791|64241130|FG004|Overall Study|Withdrawal by Subject|0|||
23134618|NCT02624791|64241131|FG005|Overall Study|Withdrawal by Subject|0|||
23134619|NCT01853475|64241132|FG000|Overall Study|Withdrawal by Subject|0|||
23134620|NCT01853475|64241133|FG001|Overall Study|Withdrawal by Subject|1|||
23134621|NCT01853475|64241134|FG002|Overall Study|Withdrawal by Subject|0|||
23134622|NCT01283516|64241135|FG000|Overall Study|Adverse Event|0|||
23134623|NCT01283516|64241136|FG001|Overall Study|Adverse Event|0|||
23134624|NCT01283516|64241137|FG002|Overall Study|Adverse Event|0|||
23134625|NCT01283516|64241138|FG003|Overall Study|Adverse Event|0|||
23134626|NCT01283516|64241139|FG004|Overall Study|Adverse Event|0|||
23134627|NCT01283516|64241140|FG005|Overall Study|Adverse Event|0|||
23134628|NCT01283516|64241141|FG006|Overall Study|Adverse Event|2|||
23134629|NCT01283516|64241142|FG007|Overall Study|Adverse Event|0|||
23134630|NCT01283516|64241143|FG008|Overall Study|Adverse Event|28|||
23134631|NCT01283516|64241135|FG000|Overall Study|Death|0|||
23134632|NCT01283516|64241136|FG001|Overall Study|Death|0|||
23134633|NCT01283516|64241137|FG002|Overall Study|Death|0|||
23134634|NCT01283516|64241138|FG003|Overall Study|Death|0|||
23134635|NCT01283516|64241139|FG004|Overall Study|Death|0|||
23134636|NCT01283516|64241140|FG005|Overall Study|Death|1|||
23134637|NCT01283516|64241141|FG006|Overall Study|Death|0|||
23134638|NCT01283516|64241142|FG007|Overall Study|Death|1|||
23214311|NCT00856986|64523572|FG003|Main Period, Weeks 0-26|Unclassified|0|||
23214312|NCT00856986|64523573|FG004|Main Period, Weeks 0-26|Unclassified|0|||
23214313|NCT00856986|64523569|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
23548968|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
23134639|NCT01283516|64241143|FG008|Overall Study|Death|12|||
23134640|NCT01283516|64241135|FG000|Overall Study|Disease Progression|2|||
23134641|NCT01283516|64241136|FG001|Overall Study|Disease Progression|2|||
23134642|NCT01283516|64241137|FG002|Overall Study|Disease Progression|3|||
23134643|NCT01283516|64241138|FG003|Overall Study|Disease Progression|3|||
23134644|NCT01283516|64241139|FG004|Overall Study|Disease Progression|13|||
23134645|NCT01283516|64241140|FG005|Overall Study|Disease Progression|8|||
23134646|NCT01283516|64241141|FG006|Overall Study|Disease Progression|6|||
23134647|NCT01283516|64241142|FG007|Overall Study|Disease Progression|3|||
23134648|NCT01283516|64241143|FG008|Overall Study|Disease Progression|139|||
23134649|NCT01283516|64241135|FG000|Overall Study|Withdrawal by Subject|0|||
23134650|NCT01283516|64241136|FG001|Overall Study|Withdrawal by Subject|0|||
23134651|NCT01283516|64241137|FG002|Overall Study|Withdrawal by Subject|0|||
23134652|NCT01283516|64241138|FG003|Overall Study|Withdrawal by Subject|0|||
23134653|NCT01283516|64241139|FG004|Overall Study|Withdrawal by Subject|1|||
23134654|NCT01283516|64241140|FG005|Overall Study|Withdrawal by Subject|0|||
23134655|NCT01283516|64241141|FG006|Overall Study|Withdrawal by Subject|1|||
23134656|NCT01283516|64241142|FG007|Overall Study|Withdrawal by Subject|0|||
23134657|NCT01283516|64241143|FG008|Overall Study|Withdrawal by Subject|36|||
23134658|NCT01283516|64241135|FG000|Overall Study|Administrative problems|0|||
23134659|NCT01283516|64241136|FG001|Overall Study|Administrative problems|0|||
23134660|NCT01283516|64241137|FG002|Overall Study|Administrative problems|0|||
23134661|NCT01283516|64241138|FG003|Overall Study|Administrative problems|0|||
23134662|NCT01283516|64241139|FG004|Overall Study|Administrative problems|0|||
23134663|NCT01283516|64241140|FG005|Overall Study|Administrative problems|1|||
23134664|NCT01283516|64241141|FG006|Overall Study|Administrative problems|1|||
23134665|NCT01283516|64241142|FG007|Overall Study|Administrative problems|1|||
23134666|NCT01283516|64241143|FG008|Overall Study|Administrative problems|39|||
23134667|NCT01283516|64241135|FG000|Overall Study|Lost to Follow-up|0|||
23134668|NCT01283516|64241136|FG001|Overall Study|Lost to Follow-up|0|||
23134669|NCT01283516|64241137|FG002|Overall Study|Lost to Follow-up|0|||
23134670|NCT01283516|64241138|FG003|Overall Study|Lost to Follow-up|0|||
23134671|NCT01283516|64241139|FG004|Overall Study|Lost to Follow-up|0|||
23134672|NCT01283516|64241140|FG005|Overall Study|Lost to Follow-up|0|||
23134673|NCT01283516|64241141|FG006|Overall Study|Lost to Follow-up|0|||
23134674|NCT01283516|64241142|FG007|Overall Study|Lost to Follow-up|0|||
23134675|NCT01283516|64241143|FG008|Overall Study|Lost to Follow-up|1|||
23134676|NCT02187159|64241150|FG000|Overall Study|Protocol Violation|4|||
23134677|NCT02187159|64241151|FG001|Overall Study|Protocol Violation|6|||
23134678|NCT02187159|64241152|FG002|Overall Study|Protocol Violation|3|||
23134679|NCT02187159|64241153|FG003|Overall Study|Protocol Violation|4|||
23134680|NCT02187159|64241150|FG000|Overall Study|Lack of Efficacy|10|||
23134681|NCT02187159|64241151|FG001|Overall Study|Lack of Efficacy|5|||
23134682|NCT02187159|64241152|FG002|Overall Study|Lack of Efficacy|4|||
23134683|NCT02187159|64241153|FG003|Overall Study|Lack of Efficacy|7|||
23134684|NCT02187159|64241150|FG000|Overall Study|Adverse Event|28|||
23134685|NCT02187159|64241151|FG001|Overall Study|Adverse Event|33|||
23134686|NCT02187159|64241152|FG002|Overall Study|Adverse Event|42|||
23134687|NCT02187159|64241153|FG003|Overall Study|Adverse Event|50|||
23134688|NCT02187159|64241150|FG000|Overall Study|Withdrawal by Subject|24|||
23134689|NCT02187159|64241151|FG001|Overall Study|Withdrawal by Subject|28|||
23134690|NCT02187159|64241152|FG002|Overall Study|Withdrawal by Subject|25|||
23134691|NCT02187159|64241153|FG003|Overall Study|Withdrawal by Subject|26|||
23214314|NCT00856986|64523570|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
23214315|NCT00856986|64523571|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
23214316|NCT00856986|64523572|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
23214317|NCT00856986|64523573|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
23214318|NCT00856986|64523569|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
23214319|NCT00856986|64523570|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
23214320|NCT00856986|64523571|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
23214321|NCT00856986|64523572|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
23214322|NCT00856986|64523573|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
23619949|NCT01774019|65994797|FG001|Overall Study|Patient refused surgery|1|||
23619950|NCT01774019|65994796|FG000|Overall Study|Unable to implant study device|1|||
23619951|NCT01774019|65994797|FG001|Overall Study|Unable to implant study device|0|||
23619952|NCT01774019|65994796|FG000|Overall Study|Lost to Follow-up|0|||
23619953|NCT01774019|65994797|FG001|Overall Study|Lost to Follow-up|3|||
23619954|NCT00053352|65994798|FG000|Overall Study|Lost to Follow-up|0|||
23619955|NCT00053352|65994799|FG001|Overall Study|Lost to Follow-up|1|||
23619956|NCT00053352|65994798|FG000|Overall Study|Physician Decision|11|||
23619957|NCT00053352|65994799|FG001|Overall Study|Physician Decision|1|||
23619958|NCT00053352|65994798|FG000|Overall Study|Withdrawal by Subject|1|||
23619959|NCT00053352|65994799|FG001|Overall Study|Withdrawal by Subject|0|||
23214323|NCT00856986|64523569|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
23619960|NCT00053352|65994798|FG000|Overall Study|Ineligible|8|||
23619961|NCT00053352|65994799|FG001|Overall Study|Ineligible|8|||
23619962|NCT00053352|65994798|FG000|Overall Study|Disease at new site|1|||
23214324|NCT00856986|64523570|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
23214325|NCT00856986|64523571|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
23134692|NCT02187159|64241150|FG000|Overall Study|Other|3|||
23134693|NCT02187159|64241151|FG001|Overall Study|Other|7|||
23134694|NCT02187159|64241152|FG002|Overall Study|Other|3|||
23134695|NCT02187159|64241153|FG003|Overall Study|Other|9|||
23428391|NCT03271047|65310801|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
23428392|NCT03271047|65310798|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
23428393|NCT03271047|65310799|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
23428394|NCT03271047|65310800|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
23428395|NCT03271047|65310801|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
23428396|NCT03271047|65310798|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
23428397|NCT03271047|65310799|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
23428398|NCT03271047|65310800|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
23428399|NCT03271047|65310801|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
23428400|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Other|0|||
23428401|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Other|0|||
23428402|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Other|0|||
23428403|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Other|1|||
23428404|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Death|0|||
23428405|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Death|0|||
23428406|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Death|20|||
23428407|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Death|21|||
23428408|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
23428409|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
23428410|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
23428411|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
23428412|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
23428413|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
23428414|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
23428415|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
23428416|NCT03271047|65310798|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
23428417|NCT03271047|65310799|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
23428418|NCT03271047|65310800|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
23428419|NCT03271047|65310801|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
23428420|NCT01439074|65314229|FG000|Overall Study|Lost to Follow-up|3|||
23428421|NCT01439074|65314230|FG001|Overall Study|Lost to Follow-up|4|||
23428422|NCT01439074|65314229|FG000|Overall Study|Subject shedding|1|||
23428423|NCT01439074|65314230|FG001|Overall Study|Subject shedding|0|||
23428424|NCT01439074|65314229|FG000|Overall Study|Withdrawal by Subject|1|||
23428425|NCT01439074|65314230|FG001|Overall Study|Withdrawal by Subject|5|||
23428426|NCT01439074|65314229|FG000|Overall Study|Other|4|||
23428427|NCT01439074|65314230|FG001|Overall Study|Other|4|||
23428428|NCT00746733|65314236|FG000|Second Intervention|Adverse Event|1|||
23428429|NCT00746733|65314237|FG001|Second Intervention|Adverse Event|0|||
23428430|NCT00746733|65314236|FG000|Third Intervention|Withdrawal by Subject|1|||
23428431|NCT00746733|65314237|FG001|Third Intervention|Withdrawal by Subject|1|||
23428432|NCT02012686|65314250|FG000|Overall Study|muscle contraction|0|||
23428433|NCT02012686|65314251|FG001|Overall Study|muscle contraction|1|||
23428434|NCT02012686|65314250|FG000|Overall Study|electrocardiography monitoring noise|0|||
23428435|NCT02012686|65314251|FG001|Overall Study|electrocardiography monitoring noise|1|||
23428436|NCT02241187|65314252|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
23428437|NCT04384107|65314253|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
23428438|NCT04384107|65314254|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
23428439|NCT04384107|65314253|FG000|Overall Study|Lost to Follow-up|1|||
23428440|NCT04384107|65314254|FG001|Overall Study|Lost to Follow-up|0|||
23428441|NCT01241760|65314260|FG000|Overall Study|Adverse Event|1|||
23428442|NCT01241760|65314261|FG001|Overall Study|Adverse Event|0|||
23428443|NCT01241760|65314260|FG000|Overall Study|Lost to Follow-up|18|||
23428444|NCT01241760|65314261|FG001|Overall Study|Lost to Follow-up|22|||
23428445|NCT01241760|65314260|FG000|Overall Study|Withdrawal by Subject|13|||
23428446|NCT01241760|65314261|FG001|Overall Study|Withdrawal by Subject|13|||
23428447|NCT01241760|65314260|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
23428448|NCT01241760|65314261|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
23428449|NCT01241760|65314260|FG000|Overall Study|Other|1|||
23428450|NCT01241760|65314261|FG001|Overall Study|Other|1|||
23134696|NCT01994837|64241154|FG000|Overall Study|Progressive disease per protocol|23|||
23134697|NCT01994837|64241154|FG000|Overall Study|Adv event related to progressive disease|3|||
23134698|NCT01994837|64241154|FG000|Overall Study|Fatal progressive disease|2|||
23134699|NCT01994837|64241154|FG000|Overall Study|Adverse event not related to progression|1|||
23134700|NCT01994837|64241154|FG000|Overall Study|Chose palliative care|1|||
23134701|NCT01994837|64241154|FG000|Overall Study|Proceeded to transplant|1|||
23134702|NCT01994837|64241154|FG000|Overall Study|Removed from study due to no response|1|||
23428451|NCT04258995|65314262|FG000|Overall Study|Lost to Follow-up|1|||
23428452|NCT04258995|65314263|FG001|Overall Study|Lost to Follow-up|1|||
23428453|NCT01400243|65314264|FG000|Overall Study|Protocol Violation|8|||
23428454|NCT01400243|65314265|FG001|Overall Study|Protocol Violation|11|||
23428455|NCT03242252|65314266|FG000|Overall Study|At the Participant's own Request|18|||
23428456|NCT03242252|65314267|FG001|Overall Study|At the Participant's own Request|10|||
23548969|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
23548970|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
23548971|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
23548972|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
23548973|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
23548974|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
23548975|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
23548976|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
23548977|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
23548978|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
23548979|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548980|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548981|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548982|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548983|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548984|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548985|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548986|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548987|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548988|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548989|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548990|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548991|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548992|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548993|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548994|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548995|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548996|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548997|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
23548998|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
23548999|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
23549000|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549001|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
23549002|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
23134703|NCT01639560|64241157|FG000|Overall Study|Withdrawal by Subject|9|||
23134704|NCT01639560|64241158|FG001|Overall Study|Withdrawal by Subject|14|||
23134705|NCT01639560|64241157|FG000|Overall Study|Lack of Efficacy|1|||
23134706|NCT01639560|64241158|FG001|Overall Study|Lack of Efficacy|2|||
23134707|NCT01639560|64241157|FG000|Overall Study|Lost to Follow-up|9|||
23134708|NCT01639560|64241158|FG001|Overall Study|Lost to Follow-up|11|||
23134709|NCT01639560|64241157|FG000|Overall Study|Adverse Event|0|||
23134710|NCT01639560|64241158|FG001|Overall Study|Adverse Event|2|||
23134711|NCT02703259|64241159|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
23134712|NCT02703259|64241160|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
23134713|NCT02703259|64241159|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
23134714|NCT02703259|64241160|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
23134715|NCT02703259|64241159|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
23134716|NCT02703259|64241160|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
23134717|NCT00635427|64241161|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
23134718|NCT00635427|64241162|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
23134719|NCT00635427|64241163|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
23134720|NCT00635427|64241164|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
23134721|NCT00635427|64241165|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
23134722|NCT00635427|64241161|FG000|Overall Study|Death|0|||
23134723|NCT00635427|64241162|FG001|Overall Study|Death|0|||
23134724|NCT00635427|64241163|FG002|Overall Study|Death|0|||
23134725|NCT00635427|64241164|FG003|Overall Study|Death|1|||
23134726|NCT00635427|64241165|FG004|Overall Study|Death|0|||
23134727|NCT00635427|64241161|FG000|Overall Study|Termination Of Study By Sponsor|12|||
23134728|NCT00635427|64241162|FG001|Overall Study|Termination Of Study By Sponsor|6|||
23134729|NCT00635427|64241163|FG002|Overall Study|Termination Of Study By Sponsor|10|||
23134730|NCT00635427|64241164|FG003|Overall Study|Termination Of Study By Sponsor|6|||
23549003|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549004|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549005|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549006|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23134731|NCT00635427|64241165|FG004|Overall Study|Termination Of Study By Sponsor|6|||
23134732|NCT00635427|64241161|FG000|Overall Study|Withdrawal Of Consent|0|||
23134733|NCT00635427|64241162|FG001|Overall Study|Withdrawal Of Consent|0|||
23134734|NCT00635427|64241163|FG002|Overall Study|Withdrawal Of Consent|0|||
23549007|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549008|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549009|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549010|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549011|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549012|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549013|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549014|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549015|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549016|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549017|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
23549018|NCT01490632|65739664|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549019|NCT01490632|65739665|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549020|NCT01490632|65739666|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549021|NCT01490632|65739667|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549022|NCT01490632|65739668|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
23549023|NCT01490632|65739669|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549024|NCT01490632|65739670|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549025|NCT01490632|65739671|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549026|NCT01490632|65739672|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549027|NCT01490632|65739673|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549028|NCT01490632|65739674|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549029|NCT01490632|65739675|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549030|NCT01490632|65739676|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549031|NCT01490632|65739677|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549032|NCT01490632|65739678|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549033|NCT01490632|65739679|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549034|NCT01490632|65739680|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549035|NCT01490632|65739681|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549036|NCT01490632|65739682|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23619963|NCT00053352|65994799|FG001|Overall Study|Disease at new site|0|||
23619964|NCT02878590|65994800|FG000|Overall Study|Withdrawal by Subject|2|||
23619965|NCT02986659|65994801|FG000|First Intervention Period|Adverse Event|3|||
23619966|NCT02986659|65994802|FG001|First Intervention Period|Adverse Event|1|||
23619967|NCT02986659|65994801|FG000|First Intervention Period|Lost to Follow-up|1|||
23619968|NCT02986659|65994802|FG001|First Intervention Period|Lost to Follow-up|0|||
23619969|NCT02986659|65994801|FG000|First Intervention Period|Withdrawal by Subject|0|||
23619970|NCT02986659|65994802|FG001|First Intervention Period|Withdrawal by Subject|1|||
23619971|NCT02986659|65994801|FG000|Second Intervention Period|Adverse Event|0|||
23619972|NCT02986659|65994802|FG001|Second Intervention Period|Adverse Event|6|||
23619973|NCT03318783|65994807|FG000|Overall Study|Withdrawal by Subject|0|||
23619974|NCT03318783|65994808|FG001|Overall Study|Withdrawal by Subject|1|||
23134735|NCT00635427|64241164|FG003|Overall Study|Withdrawal Of Consent|2|||
23134736|NCT00635427|64241165|FG004|Overall Study|Withdrawal Of Consent|2|||
23134737|NCT01302080|64241167|FG000|Overall Study|Withdrew Consent|92|||
23134738|NCT01302080|64241168|FG001|Overall Study|Withdrew Consent|39|||
23134739|NCT01302080|64241167|FG000|Overall Study|Patient/Family Moved|28|||
23134740|NCT01302080|64241168|FG001|Overall Study|Patient/Family Moved|3|||
23134741|NCT01302080|64241167|FG000|Overall Study|Lost to Follow-up|192|||
23134742|NCT01302080|64241168|FG001|Overall Study|Lost to Follow-up|93|||
23134743|NCT01302080|64241167|FG000|Overall Study|Death|1|||
23134744|NCT01302080|64241168|FG001|Overall Study|Death|0|||
23134745|NCT01302080|64241167|FG000|Overall Study|Other|52|||
23134746|NCT01302080|64241168|FG001|Overall Study|Other|8|||
23134747|NCT01302080|64241167|FG000|Overall Study|Reason Missing For Discontinuation|1|||
23134748|NCT01302080|64241168|FG001|Overall Study|Reason Missing For Discontinuation|0|||
23134749|NCT02235311|64241171|FG000|Overall Study|Lost to Follow-up|0|||
23134750|NCT02235311|64241172|FG001|Overall Study|Lost to Follow-up|1|||
23134751|NCT02235311|64241171|FG000|Overall Study|Protocol Violation|0|||
23134752|NCT02235311|64241172|FG001|Overall Study|Protocol Violation|1|||
23134753|NCT01552603|64241173|FG000|Overall Study|Physician Decision|1|||
23134754|NCT01977677|64241174|FG000|Overall Study|Unrelated Adverse Event|0|||
23134755|NCT01977677|64241175|FG001|Overall Study|Unrelated Adverse Event|0|||
23134756|NCT01977677|64241176|FG002|Overall Study|Unrelated Adverse Event|1|||
23134757|NCT01964924|64241180|FG000|Trametinib Monotherapy|Progression|19|||
23134758|NCT01964924|64241181|FG001|Trametinib Monotherapy|Progression|0|||
23134759|NCT00710021|64241182|FG000|Overall Study|Lost to Follow-up|1|||
23134760|NCT00710021|64241183|FG001|Overall Study|Lost to Follow-up|0|||
23134761|NCT00710021|64241184|FG002|Overall Study|Lost to Follow-up|0|||
23134762|NCT00710021|64241182|FG000|Overall Study|Subject's Decision|0|||
23134763|NCT00710021|64241183|FG001|Overall Study|Subject's Decision|1|||
23134764|NCT00710021|64241184|FG002|Overall Study|Subject's Decision|0|||
23134765|NCT00710021|64241182|FG000|Overall Study|Subject misrandomized|0|||
23134766|NCT00710021|64241183|FG001|Overall Study|Subject misrandomized|1|||
23134767|NCT00710021|64241184|FG002|Overall Study|Subject misrandomized|1|||
23134768|NCT00710021|64241182|FG000|Overall Study|Physician Decision|0|||
23134769|NCT00710021|64241183|FG001|Overall Study|Physician Decision|1|||
23428457|NCT03242252|65314268|FG002|Overall Study|At the Participant's own Request|15|||
23428458|NCT03242252|65314266|FG000|Overall Study|Adverse Event|8|||
23428459|NCT03242252|65314267|FG001|Overall Study|Adverse Event|6|||
23428460|NCT03242252|65314268|FG002|Overall Study|Adverse Event|9|||
23428461|NCT03242252|65314266|FG000|Overall Study|Poor Compliance to Protocol|0|||
23428462|NCT03242252|65314267|FG001|Overall Study|Poor Compliance to Protocol|2|||
23428463|NCT03242252|65314268|FG002|Overall Study|Poor Compliance to Protocol|3|||
23619975|NCT03318783|65994807|FG000|Overall Study|Death|0|||
23619976|NCT03318783|65994808|FG001|Overall Study|Death|1|||
23619977|NCT02956278|65994809|FG000|Overall Study|Withdrawal by Subject|6|||
23619978|NCT02956278|65994810|FG001|Overall Study|Withdrawal by Subject|2|||
23619979|NCT02956278|65994811|FG002|Overall Study|Withdrawal by Subject|0|||
23317502|NCT02552121|64904094|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23317503|NCT02552121|64904095|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
23317504|NCT02552121|64904096|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23317505|NCT02552121|64904097|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23317506|NCT02552121|64904098|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23317507|NCT02552121|64904099|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23317508|NCT02552121|64904100|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23317509|NCT02552121|64904101|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
23317510|NCT02552121|64904094|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
23317511|NCT02552121|64904095|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
23317512|NCT02552121|64904096|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
23317513|NCT02552121|64904097|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
23317514|NCT02552121|64904098|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
23317515|NCT02552121|64904099|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
23317516|NCT02552121|64904100|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
23317517|NCT02552121|64904101|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
23317518|NCT02552121|64904094|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
23317519|NCT02552121|64904095|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
23317520|NCT02552121|64904096|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
23317521|NCT02552121|64904097|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
23317522|NCT02552121|64904098|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
23317523|NCT02552121|64904099|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
23317524|NCT02552121|64904100|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
23317525|NCT02552121|64904101|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
23317526|NCT02552121|64904094|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
23317527|NCT02552121|64904095|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
23317528|NCT02552121|64904096|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
23317529|NCT02552121|64904097|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
23317530|NCT02552121|64904098|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
23317531|NCT02552121|64904099|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
23317532|NCT02552121|64904100|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
23619980|NCT01705145|65994812|FG000|Part B|Adverse Event|1|||
23619981|NCT00875615|65994813|FG000|Overall Study|Withdrawal by Subject|1|||
23619982|NCT03605368|65994814|FG000|Overall Study|Lost to Follow-up|2|||
23134770|NCT00710021|64241184|FG002|Overall Study|Physician Decision|0|||
23619983|NCT03605368|65994815|FG001|Overall Study|Lost to Follow-up|1|||
23134771|NCT03223662|64241185|FG000|Overall Study|Physician Decision|1|||
23134772|NCT03223662|64241185|FG000|Overall Study|Study closure|1|||
23134773|NCT01796548|64241188|FG000|Overall Study|Lost to Follow-up|1|||
23134774|NCT01796548|64241188|FG000|Overall Study|Other|2|||
23134775|NCT00890695|64241189|FG000|Overall Study|Protocol Violation|1|||
23134776|NCT00890695|64241190|FG001|Overall Study|Protocol Violation|0|||
23134777|NCT01332630|64241191|FG000|Overall Study|Withdrawal by Subject|3|||
23134778|NCT03507777|64241192|FG000|Overall Study|Lost to Follow-up|5|||
23317533|NCT02552121|64904101|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
23134779|NCT03507777|64241193|FG001|Overall Study|Lost to Follow-up|7|||
23317534|NCT02552121|64904094|FG000|Part 2: Cohort Expansion|Death|0|||
23317535|NCT02552121|64904095|FG001|Part 2: Cohort Expansion|Death|0|||
23317536|NCT02552121|64904096|FG002|Part 2: Cohort Expansion|Death|1|||
23317537|NCT02552121|64904097|FG003|Part 2: Cohort Expansion|Death|0|||
23428464|NCT03242252|65314266|FG000|Overall Study|Study Terminated by Sponsor|1|||
23428465|NCT03242252|65314267|FG001|Overall Study|Study Terminated by Sponsor|0|||
23134780|NCT03507777|64241192|FG000|Overall Study|Withdrawal by Subject|6|||
23134781|NCT03507777|64241193|FG001|Overall Study|Withdrawal by Subject|11|||
23619984|NCT03605368|65994816|FG002|Overall Study|Lost to Follow-up|3|||
23619985|NCT03605368|65994817|FG003|Overall Study|Lost to Follow-up|2|||
23134782|NCT03507777|64241192|FG000|Overall Study|Death|30|||
23134783|NCT03507777|64241193|FG001|Overall Study|Death|44|||
23134784|NCT03507777|64241192|FG000|Overall Study|Other Reasons|3|||
23619986|NCT03605368|65994814|FG000|Overall Study|Withdrawal by Subject|0|||
23619987|NCT03605368|65994815|FG001|Overall Study|Withdrawal by Subject|0|||
23619988|NCT03605368|65994816|FG002|Overall Study|Withdrawal by Subject|4|||
23619989|NCT03605368|65994817|FG003|Overall Study|Withdrawal by Subject|3|||
23619990|NCT01431950|65994818|FG000|Overall Study|Study Site Closed/Terminated|7|||
23619991|NCT01431950|65994819|FG001|Overall Study|Study Site Closed/Terminated|3|||
23619992|NCT01431950|65994818|FG000|Overall Study|Withdrawal by Subject|4|||
23619993|NCT01431950|65994819|FG001|Overall Study|Withdrawal by Subject|3|||
23619994|NCT01431950|65994818|FG000|Overall Study|Protocol Violation|2|||
23619995|NCT01431950|65994819|FG001|Overall Study|Protocol Violation|3|||
23619996|NCT01431950|65994818|FG000|Overall Study|Adverse Event|2|||
23619997|NCT01431950|65994819|FG001|Overall Study|Adverse Event|2|||
23619998|NCT01431950|65994818|FG000|Overall Study|Physician Decision|2|||
23619999|NCT01431950|65994819|FG001|Overall Study|Physician Decision|1|||
23620000|NCT01431950|65994818|FG000|Overall Study|Lack of Efficacy|2|||
23620001|NCT01431950|65994819|FG001|Overall Study|Lack of Efficacy|1|||
23620002|NCT01431950|65994818|FG000|Overall Study|Lost to Follow-up|0|||
23620003|NCT01431950|65994819|FG001|Overall Study|Lost to Follow-up|1|||
23620004|NCT01431950|65994818|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23620005|NCT01431950|65994819|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23620006|NCT00644332|65994829|FG000|Overall Study|Adverse Event|11|||
23620007|NCT00644332|65994829|FG000|Overall Study|Withdrawal by Subject|6|||
23620008|NCT00644332|65994829|FG000|Overall Study|Completion Status Unknown|2|||
23620009|NCT00644332|65994829|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
23620010|NCT00644332|65994829|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
23620011|NCT02257918|65994832|FG000|Overall Study|Lost to Follow-up|4|||
23620012|NCT02257918|65994833|FG001|Overall Study|Lost to Follow-up|1|||
23620013|NCT02257918|65994834|FG002|Overall Study|Lost to Follow-up|0|||
23620014|NCT02257918|65994832|FG000|Overall Study|Withdrawal by Subject|0|||
23620015|NCT02257918|65994833|FG001|Overall Study|Withdrawal by Subject|0|||
23620016|NCT02257918|65994834|FG002|Overall Study|Withdrawal by Subject|1|||
23620017|NCT02257918|65994832|FG000|Overall Study|Pregnancy|0|||
23620018|NCT02257918|65994833|FG001|Overall Study|Pregnancy|0|||
23620019|NCT02257918|65994834|FG002|Overall Study|Pregnancy|1|||
23620020|NCT00578318|65994835|FG000|Overall Study|Lost to Follow-up|2|||
23620021|NCT00578318|65994836|FG001|Overall Study|Lost to Follow-up|0|||
23620022|NCT00578318|65994835|FG000|Overall Study|Physician Decision|1|||
23620023|NCT00578318|65994836|FG001|Overall Study|Physician Decision|0|||
23620024|NCT02973477|65994842|FG000|First Intervention|Lost to Follow-up|0|||
23620025|NCT02973477|65994843|FG001|First Intervention|Lost to Follow-up|2|||
23620026|NCT02973477|65994842|FG000|Washout|Withdrawal by Subject|1|||
23620027|NCT02973477|65994843|FG001|Washout|Withdrawal by Subject|0|||
23620028|NCT02973477|65994842|FG000|Second Intervention|Lost to Follow-up|1|||
23620029|NCT02973477|65994843|FG001|Second Intervention|Lost to Follow-up|0|||
23620030|NCT02165397|65994848|FG000|Overall Study|Death|7|||
23620031|NCT02165397|65994849|FG001|Overall Study|Death|10|||
23620032|NCT02165397|65994850|FG002|Overall Study|Death|8|||
23620033|NCT02165397|65994848|FG000|Overall Study|Lost to Follow-up|1|||
23620034|NCT02165397|65994849|FG001|Overall Study|Lost to Follow-up|3|||
23620035|NCT02165397|65994850|FG002|Overall Study|Lost to Follow-up|0|||
23620036|NCT02165397|65994848|FG000|Overall Study|Withdrawal by Subject|6|||
23620037|NCT02165397|65994849|FG001|Overall Study|Withdrawal by Subject|6|||
23620038|NCT02165397|65994850|FG002|Overall Study|Withdrawal by Subject|1|||
23620039|NCT02165397|65994848|FG000|Overall Study|Other, Not Specified|0|||
23620040|NCT02165397|65994849|FG001|Overall Study|Other, Not Specified|0|||
23620041|NCT02165397|65994850|FG002|Overall Study|Other, Not Specified|1|||
23620042|NCT02469077|65994852|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
23620043|NCT02469077|65994853|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
23620044|NCT02469077|65994852|FG000|Post Randomization/Intervention Period|Relocated|1|||
23620045|NCT02469077|65994853|FG001|Post Randomization/Intervention Period|Relocated|1|||
23620046|NCT02469077|65994852|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
23620047|NCT02469077|65994853|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
23620048|NCT02469077|65994852|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
23317538|NCT02552121|64904098|FG004|Part 2: Cohort Expansion|Death|0|||
23620049|NCT02469077|65994853|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
23134785|NCT03507777|64241193|FG001|Overall Study|Other Reasons|8|||
23317539|NCT02552121|64904099|FG005|Part 2: Cohort Expansion|Death|0|||
23620050|NCT01747629|65994859|FG000|Overall Study|Adverse Event|1|||
23620051|NCT01747629|65994860|FG001|Overall Study|Adverse Event|2|||
23620052|NCT01747629|65994859|FG000|Overall Study|Withdrawal by Subject|2|||
23620053|NCT01747629|65994860|FG001|Overall Study|Withdrawal by Subject|2|||
23620054|NCT01747629|65994859|FG000|Overall Study|Noncompliance|1|||
23134786|NCT01253304|64241199|FG000|Overall Study|Adverse Event|0|||
23620055|NCT01747629|65994860|FG001|Overall Study|Noncompliance|1|||
23134787|NCT01253304|64241200|FG001|Overall Study|Adverse Event|0|||
23134788|NCT01253304|64241201|FG002|Overall Study|Adverse Event|0|||
23134789|NCT01253304|64241202|FG003|Overall Study|Adverse Event|1|||
23134790|NCT03541200|64241203|FG000|Overall Study|Adverse Event|19|||
23214326|NCT00856986|64523572|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
23214327|NCT00856986|64523573|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
23214328|NCT00856986|64523569|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
23214329|NCT00856986|64523570|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
23214330|NCT00856986|64523571|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
23214331|NCT00856986|64523572|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
23214332|NCT00856986|64523573|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
23214333|NCT00856986|64523569|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
23214334|NCT00856986|64523570|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
23214335|NCT00856986|64523571|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
23214336|NCT00856986|64523572|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
23214337|NCT00856986|64523573|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
23214338|NCT00856986|64523569|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
23134791|NCT03541200|64241203|FG000|Overall Study|Death|1|||
23134792|NCT03541200|64241203|FG000|Overall Study|Lost to Follow-up|10|||
23134793|NCT03541200|64241203|FG000|Overall Study|Physician Decision|1|||
23134794|NCT03541200|64241203|FG000|Overall Study|Protocol Violation|51|||
23134795|NCT03541200|64241203|FG000|Overall Study|Withdrawal by Subject|23|||
23134796|NCT03541200|64241203|FG000|Overall Study|other|8|||
23134797|NCT01743989|64244163|FG000|Treatment Phase|Unstable MR4.0|0|||
23134798|NCT01743989|64244164|FG001|Treatment Phase|Unstable MR4.0|6|||
23134799|NCT01743989|64244165|FG002|Treatment Phase|Unstable MR4.0|263|||
23134800|NCT01743989|64244163|FG000|Treatment Phase|Adverse Event|0|||
23134801|NCT01743989|64244164|FG001|Treatment Phase|Adverse Event|4|||
23134802|NCT01743989|64244165|FG002|Treatment Phase|Adverse Event|67|||
23134803|NCT01743989|64244163|FG000|Treatment Phase|Withdrawal by Subject|1|||
23134804|NCT01743989|64244164|FG001|Treatment Phase|Withdrawal by Subject|3|||
23134805|NCT01743989|64244165|FG002|Treatment Phase|Withdrawal by Subject|28|||
23134806|NCT01743989|64244163|FG000|Treatment Phase|Death|0|||
23134807|NCT01743989|64244164|FG001|Treatment Phase|Death|1|||
23134808|NCT01743989|64244165|FG002|Treatment Phase|Death|3|||
23134809|NCT01743989|64244163|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
23134810|NCT01743989|64244164|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
23134811|NCT01743989|64244165|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
23134812|NCT01743989|64244163|FG000|Treatment Phase|Protocol deviation|0|||
23134813|NCT01743989|64244164|FG001|Treatment Phase|Protocol deviation|0|||
23134814|NCT01743989|64244165|FG002|Treatment Phase|Protocol deviation|3|||
23134815|NCT01743989|64244163|FG000|Treatment Phase|Pregnancy|0|||
23134816|NCT01743989|64244164|FG001|Treatment Phase|Pregnancy|0|||
23134817|NCT01743989|64244165|FG002|Treatment Phase|Pregnancy|2|||
23134818|NCT01743989|64244163|FG000|Treatment Phase|Lost to Follow-up|0|||
23134819|NCT01743989|64244164|FG001|Treatment Phase|Lost to Follow-up|0|||
23134820|NCT01743989|64244165|FG002|Treatment Phase|Lost to Follow-up|2|||
23134821|NCT01743989|64244163|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
23134822|NCT01743989|64244164|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
23134823|NCT01743989|64244165|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
23134824|NCT01743989|64244163|FG000|Treatment Phase|Administrative problems|0|||
23134825|NCT01743989|64244164|FG001|Treatment Phase|Administrative problems|0|||
23134826|NCT01743989|64244165|FG002|Treatment Phase|Administrative problems|1|||
23134827|NCT01743989|64244163|FG000|Treatment Phase|New cancer (CML) therapy|0|||
23134828|NCT01743989|64244164|FG001|Treatment Phase|New cancer (CML) therapy|1|||
23134829|NCT01743989|64244165|FG002|Treatment Phase|New cancer (CML) therapy|0|||
23134830|NCT01743989|64244163|FG000|Treatment Phase|Physician Decision|0|||
23134831|NCT01743989|64244164|FG001|Treatment Phase|Physician Decision|0|||
23134832|NCT01743989|64244165|FG002|Treatment Phase|Physician Decision|3|||
23134833|NCT01743989|64244163|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
23214339|NCT00856986|64523570|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
23214340|NCT00856986|64523571|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
23549037|NCT01490632|65739683|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
23549038|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549039|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549040|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549041|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549042|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549043|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
23549044|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
23549045|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549046|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549047|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
23549048|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
23134834|NCT01743989|64244164|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
23134835|NCT01743989|64244165|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
23134836|NCT01743989|64244163|FG000|Treatment Phase|Not randomized by mistake|0|||
23134837|NCT01743989|64244164|FG001|Treatment Phase|Not randomized by mistake|0|||
23134838|NCT01743989|64244165|FG002|Treatment Phase|Not randomized by mistake|1|||
23134839|NCT01743989|64244163|FG000|Treatment Phase|Included by mistake|0|||
23134840|NCT01743989|64244164|FG001|Treatment Phase|Included by mistake|0|||
23134841|NCT01743989|64244165|FG002|Treatment Phase|Included by mistake|1|||
23134842|NCT01743989|64244163|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
23134843|NCT01743989|64244164|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
23134844|NCT01743989|64244165|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
23134845|NCT01743989|64244163|FG000|TFR Phase|Adverse Event|0|||
23134846|NCT01743989|64244164|FG001|TFR Phase|Adverse Event|1|||
23134847|NCT01743989|64244165|FG002|TFR Phase|Adverse Event|0|||
23134848|NCT01743989|64244163|FG000|TFR Phase|Lost to Follow-up|0|||
23134849|NCT01743989|64244164|FG001|TFR Phase|Lost to Follow-up|2|||
23134850|NCT01743989|64244165|FG002|TFR Phase|Lost to Follow-up|0|||
23134851|NCT01743989|64244163|FG000|TFR Phase|Physician Decision|0|||
23317540|NCT02552121|64904100|FG006|Part 2: Cohort Expansion|Death|0|||
23317541|NCT02552121|64904101|FG007|Part 2: Cohort Expansion|Death|0|||
23428466|NCT03242252|65314268|FG002|Overall Study|Study Terminated by Sponsor|0|||
23428467|NCT03242252|65314266|FG000|Overall Study|Reason not Specified|4|||
23428468|NCT03242252|65314267|FG001|Overall Study|Reason not Specified|4|||
23428469|NCT03242252|65314268|FG002|Overall Study|Reason not Specified|1|||
23428470|NCT03242252|65314266|FG000|Overall Study|Lost to Follow-up|5|||
23428471|NCT03242252|65314267|FG001|Overall Study|Lost to Follow-up|1|||
23428472|NCT03242252|65314268|FG002|Overall Study|Lost to Follow-up|4|||
23428473|NCT02528357|65314269|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428474|NCT02528357|65314270|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
23428475|NCT02528357|65314271|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428476|NCT02528357|65314272|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23620056|NCT01747629|65994859|FG000|Overall Study|Inclusion criteria not met|1|||
23620057|NCT01747629|65994860|FG001|Overall Study|Inclusion criteria not met|0|||
23620058|NCT01747629|65994859|FG000|Overall Study|Not treated|1|||
23620059|NCT01747629|65994860|FG001|Overall Study|Not treated|0|||
23620060|NCT01747629|65994859|FG000|Overall Study|Other|2|||
23620061|NCT01747629|65994860|FG001|Overall Study|Other|1|||
23620062|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
23620063|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
23620064|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
23428477|NCT02528357|65314273|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428478|NCT02528357|65314274|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428479|NCT02528357|65314275|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428480|NCT02528357|65314276|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428481|NCT02528357|65314277|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428482|NCT02528357|65314278|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428483|NCT02528357|65314279|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428484|NCT02528357|65314280|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428485|NCT02528357|65314281|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428486|NCT02528357|65314282|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428487|NCT02528357|65314283|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428488|NCT02528357|65314284|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23620065|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
23620066|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
23620067|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
23620068|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
23620069|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
23620070|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
23134852|NCT01743989|64244164|FG001|TFR Phase|Physician Decision|1|||
23134853|NCT01743989|64244165|FG002|TFR Phase|Physician Decision|0|||
23134854|NCT01743989|64244163|FG000|TFR Phase|Logistical problems|0|||
23134855|NCT01743989|64244164|FG001|TFR Phase|Logistical problems|2|||
23134856|NCT01743989|64244165|FG002|TFR Phase|Logistical problems|0|||
23134857|NCT01743989|64244163|FG000|TFR Phase|Protocol deviation|0|||
23134858|NCT01743989|64244164|FG001|TFR Phase|Protocol deviation|1|||
23134859|NCT01743989|64244165|FG002|TFR Phase|Protocol deviation|0|||
23134860|NCT01743989|64244163|FG000|TFR Phase|Withdrawal by Subject|0|||
23134861|NCT01743989|64244164|FG001|TFR Phase|Withdrawal by Subject|2|||
23134862|NCT01743989|64244165|FG002|TFR Phase|Withdrawal by Subject|0|||
23428489|NCT02528357|65314285|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23428490|NCT02528357|65314286|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23317542|NCT04015908|64904102|FG000|Overall Study|Lost to Follow-up|0|||
23134863|NCT01743989|64244163|FG000|Re-treatment Phase|Adverse Event|8|||
23134864|NCT01743989|64244164|FG001|Re-treatment Phase|Adverse Event|4|||
23428491|NCT02528357|65314287|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
23134865|NCT01743989|64244165|FG002|Re-treatment Phase|Adverse Event|0|||
23134866|NCT01743989|64244163|FG000|Re-treatment Phase|Death|1|||
23134867|NCT01743989|64244164|FG001|Re-treatment Phase|Death|1|||
23134868|NCT01743989|64244165|FG002|Re-treatment Phase|Death|0|||
23134869|NCT01743989|64244163|FG000|Re-treatment Phase|Administrative problems|1|||
23134870|NCT01743989|64244164|FG001|Re-treatment Phase|Administrative problems|1|||
23428492|NCT02528357|65314269|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428493|NCT02528357|65314270|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428494|NCT02528357|65314271|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23549049|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
23549050|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
23134871|NCT01743989|64244165|FG002|Re-treatment Phase|Administrative problems|0|||
23134872|NCT01743989|64244163|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
23134873|NCT01743989|64244164|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
23134874|NCT01743989|64244165|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
23134875|NCT01743989|64244163|FG000|Re-treatment Phase|Unstable MR|1|||
23134876|NCT01743989|64244164|FG001|Re-treatment Phase|Unstable MR|0|||
23134877|NCT01743989|64244165|FG002|Re-treatment Phase|Unstable MR|0|||
23134878|NCT01743989|64244163|FG000|Re-treatment Phase|Physician Decision|0|||
23134879|NCT01743989|64244164|FG001|Re-treatment Phase|Physician Decision|1|||
23134880|NCT01743989|64244165|FG002|Re-treatment Phase|Physician Decision|0|||
23134881|NCT01743989|64244163|FG000|Re-treatment Phase|Lost to Follow-up|0|||
23134882|NCT01743989|64244164|FG001|Re-treatment Phase|Lost to Follow-up|1|||
23134883|NCT01743989|64244165|FG002|Re-treatment Phase|Lost to Follow-up|0|||
23134884|NCT01323972|64244166|FG000|Overall Study|Withdrawal by Subject|1|||
23549051|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549052|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549053|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549054|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549055|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549056|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549057|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
23549058|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549059|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549060|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549061|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549062|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549063|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549064|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
23549065|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549066|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
23549067|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
23549068|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
23549069|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549070|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549071|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549072|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549073|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549074|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549075|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549076|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549077|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
23549078|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549079|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549080|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549081|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549082|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549083|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549084|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
23549085|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549086|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549087|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
23549088|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549089|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549090|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549091|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23428495|NCT02528357|65314272|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
23428496|NCT02528357|65314273|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428497|NCT02528357|65314274|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
23428498|NCT02528357|65314275|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428499|NCT02528357|65314276|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
23428500|NCT02528357|65314277|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23134885|NCT01323972|64244167|FG001|Overall Study|Withdrawal by Subject|0|||
23134886|NCT01323972|64244168|FG002|Overall Study|Withdrawal by Subject|1|||
23134887|NCT01323972|64244169|FG003|Overall Study|Withdrawal by Subject|0|||
23428501|NCT02528357|65314278|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23214341|NCT00856986|64523572|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
23214342|NCT00856986|64523573|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
23214343|NCT04209400|64523581|FG000|Overall Study|Withdrawal by Subject|0|||
23214344|NCT04209400|64523582|FG001|Overall Study|Withdrawal by Subject|1|||
23214345|NCT04295356|64523583|FG000|Overall Study|Physician Decision|1|||
23214346|NCT04295356|64523584|FG001|Overall Study|Physician Decision|0|||
23214347|NCT04295356|64523583|FG000|Overall Study|Lost to Follow-up|0|||
23214348|NCT04295356|64523584|FG001|Overall Study|Lost to Follow-up|3|||
23214349|NCT04295356|64523583|FG000|Overall Study|Protocol Violation|0|||
23214350|NCT04295356|64523584|FG001|Overall Study|Protocol Violation|1|||
23428502|NCT02528357|65314279|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428503|NCT02528357|65314280|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23134888|NCT01323972|64244166|FG000|Overall Study|Migrated/moved from study area|1|||
23134889|NCT01323972|64244167|FG001|Overall Study|Migrated/moved from study area|2|||
23214351|NCT01924299|64523585|FG000|Period 2|Withdrawal by Subject|1|||
23214352|NCT01924299|64523586|FG001|Period 2|Withdrawal by Subject|0|||
23134890|NCT01323972|64244168|FG002|Overall Study|Migrated/moved from study area|0|||
23214353|NCT01924299|64523585|FG000|Period 2|Adverse Event|0|||
23214354|NCT01924299|64523586|FG001|Period 2|Adverse Event|1|||
23214355|NCT01235728|64523589|FG000|Overall Study|Protocol Violation|0|||
23214356|NCT01235728|64523590|FG001|Overall Study|Protocol Violation|0|||
23134891|NCT01323972|64244169|FG003|Overall Study|Migrated/moved from study area|0|||
23134892|NCT01323972|64244166|FG000|Overall Study|Lost to Follow-up|0|||
23134893|NCT01323972|64244167|FG001|Overall Study|Lost to Follow-up|1|||
23134894|NCT01323972|64244168|FG002|Overall Study|Lost to Follow-up|1|||
23428504|NCT02528357|65314281|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428505|NCT02528357|65314282|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428506|NCT02528357|65314283|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428507|NCT02528357|65314284|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428508|NCT02528357|65314285|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23134895|NCT01323972|64244169|FG003|Overall Study|Lost to Follow-up|1|||
23134896|NCT00943111|64244171|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
23428509|NCT02528357|65314286|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428510|NCT02528357|65314287|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
23428511|NCT02528357|65314269|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428512|NCT02528357|65314270|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428513|NCT02528357|65314271|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
23428514|NCT02528357|65314272|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428515|NCT02528357|65314273|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
23428516|NCT02528357|65314274|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428517|NCT02528357|65314275|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
23428518|NCT02528357|65314276|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
23428519|NCT02528357|65314277|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428520|NCT02528357|65314278|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428521|NCT02528357|65314279|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428522|NCT02528357|65314280|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23134897|NCT00943111|64244172|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
23134898|NCT00943111|64244173|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
23134899|NCT00943111|64244171|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
23428523|NCT02528357|65314281|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428524|NCT02528357|65314282|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428525|NCT02528357|65314283|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428526|NCT02528357|65314284|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23620071|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
23620072|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
23134900|NCT00943111|64244172|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
23134901|NCT00943111|64244173|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
23214357|NCT01235728|64523591|FG002|Overall Study|Protocol Violation|0|||
23428527|NCT02528357|65314285|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428528|NCT02528357|65314286|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428529|NCT02528357|65314287|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
23428530|NCT02528357|65314269|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428531|NCT02528357|65314270|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428532|NCT02528357|65314271|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428533|NCT02528357|65314272|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428534|NCT02528357|65314273|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428535|NCT02528357|65314274|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23453635|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23549092|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549093|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549094|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549095|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549096|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23549097|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
23134902|NCT00943111|64244171|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
23134903|NCT00943111|64244172|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
23134904|NCT00943111|64244173|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
23134905|NCT00943111|64244171|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
23134906|NCT00943111|64244172|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
23134907|NCT00943111|64244173|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
23134908|NCT00943111|64244171|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
23134909|NCT00943111|64244172|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
23134910|NCT00943111|64244173|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
23134911|NCT00943111|64244171|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
23134912|NCT00943111|64244172|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
23134913|NCT00943111|64244173|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
23134914|NCT00943111|64244171|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
23134915|NCT00943111|64244172|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
23134916|NCT00943111|64244173|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
23134917|NCT00943111|64244171|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
23134918|NCT00943111|64244172|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
23134919|NCT00943111|64244173|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
23134920|NCT03140280|64244174|FG000|Overall Study|Physician Decision|5|||
23134921|NCT00998790|64244176|FG000|Overall Study|Withdrawal by Subject|21|||
23134922|NCT03500159|64244181|FG000|Overall Study|Study Terminated|2|||
23134923|NCT03500159|64244182|FG001|Overall Study|Study Terminated|1|||
23134924|NCT02514239|64244183|FG000|Overall Study|Refused to continue trial medication|0|||
23134925|NCT02514239|64244184|FG001|Overall Study|Refused to continue trial medication|0|||
23134926|NCT02514239|64244185|FG002|Overall Study|Refused to continue trial medication|0|||
23134927|NCT02514239|64244186|FG003|Overall Study|Refused to continue trial medication|0|||
23134928|NCT02514239|64244187|FG004|Overall Study|Refused to continue trial medication|0|||
23134929|NCT02514239|64244188|FG005|Overall Study|Refused to continue trial medication|0|||
23134930|NCT02514239|64244189|FG006|Overall Study|Refused to continue trial medication|0|||
23134931|NCT02514239|64244190|FG007|Overall Study|Refused to continue trial medication|0|||
23134932|NCT02514239|64244191|FG008|Overall Study|Refused to continue trial medication|0|||
23134933|NCT02514239|64244192|FG009|Overall Study|Refused to continue trial medication|1|||
23134934|NCT02514239|64244183|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
23134935|NCT02514239|64244184|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
23134936|NCT02514239|64244185|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
23134937|NCT02514239|64244186|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
23134938|NCT02514239|64244187|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
23134939|NCT02514239|64244188|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
23134940|NCT02514239|64244189|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
23134941|NCT02514239|64244190|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
23134942|NCT02514239|64244191|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
23134943|NCT02514239|64244192|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
23134944|NCT02514239|64244183|FG000|Overall Study|Not treated|0|||
23134945|NCT02514239|64244184|FG001|Overall Study|Not treated|1|||
23134946|NCT02514239|64244185|FG002|Overall Study|Not treated|0|||
23134947|NCT02514239|64244186|FG003|Overall Study|Not treated|0|||
23134948|NCT02514239|64244187|FG004|Overall Study|Not treated|0|||
23134949|NCT02514239|64244188|FG005|Overall Study|Not treated|0|||
23134950|NCT02514239|64244189|FG006|Overall Study|Not treated|0|||
23214358|NCT01235728|64523592|FG003|Overall Study|Protocol Violation|1|||
23620073|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
23620074|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
23620075|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
23620076|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
23620077|NCT00332488|65994862|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
23620078|NCT00332488|65994863|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
23620079|NCT00332488|65994864|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
23620080|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
23620081|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
23620082|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
23620083|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
23620084|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
23620085|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
23620086|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
23620087|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
23620088|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
23620089|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
23620090|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
23134951|NCT02514239|64244190|FG007|Overall Study|Not treated|0|||
23134952|NCT02514239|64244191|FG008|Overall Study|Not treated|0|||
23134953|NCT02514239|64244192|FG009|Overall Study|Not treated|0|||
23134954|NCT02514239|64244183|FG000|Overall Study|Other Adverse Events|2|||
23134955|NCT02514239|64244184|FG001|Overall Study|Other Adverse Events|0|||
23134956|NCT02514239|64244185|FG002|Overall Study|Other Adverse Events|0|||
23134957|NCT02514239|64244186|FG003|Overall Study|Other Adverse Events|1|||
23134958|NCT02514239|64244187|FG004|Overall Study|Other Adverse Events|0|||
23134959|NCT02514239|64244188|FG005|Overall Study|Other Adverse Events|1|||
23134960|NCT02514239|64244189|FG006|Overall Study|Other Adverse Events|0|||
23134961|NCT02514239|64244190|FG007|Overall Study|Other Adverse Events|1|||
23134962|NCT02514239|64244191|FG008|Overall Study|Other Adverse Events|2|||
23134963|NCT02514239|64244192|FG009|Overall Study|Other Adverse Events|0|||
23134964|NCT02514239|64244183|FG000|Overall Study|Progressive disease|3|||
23134965|NCT02514239|64244184|FG001|Overall Study|Progressive disease|3|||
23428536|NCT02528357|65314275|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428537|NCT02528357|65314276|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428538|NCT02528357|65314277|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428539|NCT02528357|65314278|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428540|NCT02528357|65314279|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428541|NCT02528357|65314280|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428542|NCT02528357|65314281|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428543|NCT02528357|65314282|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23453636|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23549098|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
23134966|NCT02514239|64244185|FG002|Overall Study|Progressive disease|2|||
23134967|NCT02514239|64244186|FG003|Overall Study|Progressive disease|2|||
23134968|NCT02514239|64244187|FG004|Overall Study|Progressive disease|3|||
23134969|NCT02514239|64244188|FG005|Overall Study|Progressive disease|3|||
23134970|NCT02514239|64244189|FG006|Overall Study|Progressive disease|4|||
23134971|NCT02514239|64244190|FG007|Overall Study|Progressive disease|2|||
23134972|NCT02514239|64244191|FG008|Overall Study|Progressive disease|5|||
23134973|NCT02514239|64244192|FG009|Overall Study|Progressive disease|0|||
23134974|NCT02314780|64244193|FG000|Overall Study|organizational reasons|0|||
23549099|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549100|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549101|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549102|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549103|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549104|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
23549105|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549106|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549107|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
23134975|NCT02314780|64244194|FG001|Overall Study|organizational reasons|2|||
23134976|NCT02314780|64244195|FG002|Overall Study|organizational reasons|0|||
23134977|NCT02314780|64244193|FG000|Overall Study|Adverse Event|0|||
23134978|NCT02314780|64244194|FG001|Overall Study|Adverse Event|1|||
23134979|NCT02314780|64244195|FG002|Overall Study|Adverse Event|0|||
23214359|NCT01235728|64523593|FG004|Overall Study|Protocol Violation|0|||
23134980|NCT01518153|64244196|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
23134981|NCT01518153|64244197|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
23134982|NCT01518153|64244198|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
23134983|NCT01518153|64244196|FG000|Stem Cell Transplant|Death|2|||
23134984|NCT01518153|64244197|FG001|Stem Cell Transplant|Death|0|||
23134985|NCT01518153|64244198|FG002|Stem Cell Transplant|Death|0|||
23134986|NCT01518153|64244196|FG000|Stem Cell Transplant|Secondary graft failure|1|||
23134987|NCT01518153|64244197|FG001|Stem Cell Transplant|Secondary graft failure|0|||
23134988|NCT01518153|64244198|FG002|Stem Cell Transplant|Secondary graft failure|0|||
23134989|NCT01518153|64244196|FG000|Stem Cell Transplant|Adverse Event|1|||
23134990|NCT01518153|64244197|FG001|Stem Cell Transplant|Adverse Event|0|||
23134991|NCT01518153|64244198|FG002|Stem Cell Transplant|Adverse Event|0|||
23134992|NCT01518153|64244196|FG000|Donor Lymphocyte Infusion|Death|0|||
23134993|NCT01518153|64244197|FG001|Donor Lymphocyte Infusion|Death|2|||
23134994|NCT01518153|64244198|FG002|Donor Lymphocyte Infusion|Death|1|||
23134995|NCT01879722|64244199|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23134996|NCT01879722|64244200|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23134997|NCT01879722|64244201|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23134998|NCT01879722|64244202|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
23134999|NCT01879722|64244203|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
23135000|NCT01879722|64244204|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
23135001|NCT01879722|64244205|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
23135002|NCT01879722|64244206|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
23135003|NCT01879722|64244207|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
23135004|NCT01879722|64244208|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
23135005|NCT01879722|64244199|FG000|Overall Study|Voluntary Withdrawal|0|||
23135006|NCT01879722|64244200|FG001|Overall Study|Voluntary Withdrawal|0|||
23135007|NCT01879722|64244201|FG002|Overall Study|Voluntary Withdrawal|0|||
23135008|NCT01879722|64244202|FG003|Overall Study|Voluntary Withdrawal|0|||
23135009|NCT01879722|64244203|FG004|Overall Study|Voluntary Withdrawal|0|||
23135010|NCT01879722|64244204|FG005|Overall Study|Voluntary Withdrawal|0|||
23135011|NCT01879722|64244205|FG006|Overall Study|Voluntary Withdrawal|0|||
23135012|NCT01879722|64244206|FG007|Overall Study|Voluntary Withdrawal|0|||
23135013|NCT01879722|64244207|FG008|Overall Study|Voluntary Withdrawal|1|||
23135014|NCT01879722|64244208|FG009|Overall Study|Voluntary Withdrawal|0|||
23135015|NCT02643472|64244218|FG000|Overall Study|Death|2|||
23135016|NCT02643472|64244219|FG001|Overall Study|Death|5|||
23135017|NCT02643472|64244218|FG000|Overall Study|Withdrawal by Subject|3|||
23135018|NCT02643472|64244219|FG001|Overall Study|Withdrawal by Subject|2|||
23135019|NCT02643472|64244218|FG000|Overall Study|Protocol Violation|0|||
23135020|NCT02643472|64244219|FG001|Overall Study|Protocol Violation|1|||
23135021|NCT02643472|64244218|FG000|Overall Study|Lost to Follow-up|22|||
23135022|NCT02643472|64244219|FG001|Overall Study|Lost to Follow-up|26|||
23135023|NCT04811131|64244220|FG000|Overall Study|Adverse Event|0|||
23135024|NCT04811131|64244221|FG001|Overall Study|Adverse Event|0|||
23135025|NCT04811131|64244222|FG002|Overall Study|Adverse Event|1|||
23135026|NCT04811131|64244223|FG003|Overall Study|Adverse Event|0|||
23135027|NCT04811131|64244220|FG000|Overall Study|Lack of Efficacy|0|||
23135028|NCT04811131|64244221|FG001|Overall Study|Lack of Efficacy|0|||
23135029|NCT04811131|64244222|FG002|Overall Study|Lack of Efficacy|0|||
23135030|NCT04811131|64244223|FG003|Overall Study|Lack of Efficacy|1|||
23135031|NCT04811131|64244220|FG000|Overall Study|Lost to Follow-up|0|||
23549108|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549109|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549110|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549111|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549112|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549113|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
23135032|NCT04811131|64244221|FG001|Overall Study|Lost to Follow-up|1|||
23135033|NCT04811131|64244222|FG002|Overall Study|Lost to Follow-up|0|||
23135034|NCT04811131|64244223|FG003|Overall Study|Lost to Follow-up|0|||
23135035|NCT04811131|64244220|FG000|Overall Study|Sponsor request|31|||
23135036|NCT04811131|64244221|FG001|Overall Study|Sponsor request|35|||
23135037|NCT04811131|64244222|FG002|Overall Study|Sponsor request|27|||
23135038|NCT04811131|64244223|FG003|Overall Study|Sponsor request|10|||
23135039|NCT04811131|64244220|FG000|Overall Study|Withdrawal by Subject|3|||
23135040|NCT04811131|64244221|FG001|Overall Study|Withdrawal by Subject|1|||
23135041|NCT04811131|64244222|FG002|Overall Study|Withdrawal by Subject|3|||
23135042|NCT04811131|64244223|FG003|Overall Study|Withdrawal by Subject|1|||
23135043|NCT00307684|64244226|FG000|Open Label Phase|Lack of Efficacy|0|||
23135044|NCT00307684|64244227|FG001|Open Label Phase|Lack of Efficacy|0|||
23135045|NCT00307684|64244228|FG002|Open Label Phase|Lack of Efficacy|3|||
23135046|NCT00307684|64244226|FG000|Open Label Phase|Adverse Event|0|||
23135047|NCT00307684|64244227|FG001|Open Label Phase|Adverse Event|0|||
23135048|NCT00307684|64244228|FG002|Open Label Phase|Adverse Event|16|||
23428544|NCT02528357|65314283|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428545|NCT02528357|65314284|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428546|NCT02528357|65314285|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428547|NCT02528357|65314286|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23214360|NCT01235728|64523594|FG005|Overall Study|Protocol Violation|0|||
23214361|NCT01235728|64523595|FG006|Overall Study|Protocol Violation|0|||
23214362|NCT01235728|64523596|FG007|Overall Study|Protocol Violation|0|||
23214363|NCT02580240|64523597|FG000|Overall Study|Physician Decision|2|||
23428548|NCT02528357|65314287|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428549|NCT02528357|65314269|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428550|NCT02528357|65314270|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428551|NCT02528357|65314271|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428552|NCT02528357|65314272|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428553|NCT02528357|65314273|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428554|NCT02528357|65314274|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428555|NCT02528357|65314275|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428556|NCT02528357|65314276|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428557|NCT02528357|65314277|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428558|NCT02528357|65314278|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428559|NCT02528357|65314279|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428560|NCT02528357|65314280|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428561|NCT02528357|65314281|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428562|NCT02528357|65314282|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
23428563|NCT02528357|65314283|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
23428564|NCT02528357|65314284|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428565|NCT02528357|65314285|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428566|NCT02528357|65314286|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23549114|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549115|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549116|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549117|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
23549118|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549119|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549120|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23214364|NCT02580240|64523598|FG001|Overall Study|Physician Decision|0|||
23214365|NCT04377672|64523599|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
23214366|NCT02168803|64523602|FG000|Overall Study|Lost to Follow-up|1|||
23214367|NCT02168803|64523603|FG001|Overall Study|Lost to Follow-up|0|||
23214368|NCT02168803|64523604|FG002|Overall Study|Lost to Follow-up|1|||
23214369|NCT02168803|64523602|FG000|Overall Study|Withdrawal by Subject|1|||
23214370|NCT02168803|64523603|FG001|Overall Study|Withdrawal by Subject|1|||
23214371|NCT02168803|64523604|FG002|Overall Study|Withdrawal by Subject|2|||
23214372|NCT02168803|64523602|FG000|Overall Study|Physician Decision|0|||
23214373|NCT02168803|64523603|FG001|Overall Study|Physician Decision|1|||
23214374|NCT02168803|64523604|FG002|Overall Study|Physician Decision|0|||
23214375|NCT02168803|64523602|FG000|Overall Study|Adverse Event|0|||
23214376|NCT02168803|64523603|FG001|Overall Study|Adverse Event|1|||
23214377|NCT02168803|64523604|FG002|Overall Study|Adverse Event|1|||
23214378|NCT02168803|64523602|FG000|Overall Study|Death|0|||
23549121|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549122|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549123|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
23135049|NCT00307684|64244226|FG000|Open Label Phase|Withdrawal by Subject|0|||
23135050|NCT00307684|64244227|FG001|Open Label Phase|Withdrawal by Subject|0|||
23135051|NCT00307684|64244228|FG002|Open Label Phase|Withdrawal by Subject|15|||
23135052|NCT00307684|64244226|FG000|Open Label Phase|Lost to Follow-up|0|||
23135053|NCT00307684|64244227|FG001|Open Label Phase|Lost to Follow-up|0|||
23135054|NCT00307684|64244228|FG002|Open Label Phase|Lost to Follow-up|11|||
23135055|NCT00307684|64244226|FG000|Open Label Phase|non compliance|0|||
23135056|NCT00307684|64244227|FG001|Open Label Phase|non compliance|0|||
23135057|NCT00307684|64244228|FG002|Open Label Phase|non compliance|5|||
23135058|NCT00307684|64244226|FG000|Open Label Phase|other|0|||
23214379|NCT02168803|64523603|FG001|Overall Study|Death|0|||
23214380|NCT02168803|64523604|FG002|Overall Study|Death|1|||
23214381|NCT02168803|64523602|FG000|Overall Study|Sponsor Decision|0|||
23135059|NCT00307684|64244227|FG001|Open Label Phase|other|0|||
23214382|NCT02168803|64523603|FG001|Overall Study|Sponsor Decision|0|||
23135060|NCT00307684|64244228|FG002|Open Label Phase|other|6|||
23135061|NCT00307684|64244226|FG000|Double Blind Phase|Lack of Efficacy|2|||
23135062|NCT00307684|64244227|FG001|Double Blind Phase|Lack of Efficacy|5|||
23135063|NCT00307684|64244228|FG002|Double Blind Phase|Lack of Efficacy|0|||
23135064|NCT03122223|64244229|FG000|Overall Study|Withdrawal by Subject|2|||
23135065|NCT03122223|64244230|FG001|Overall Study|Withdrawal by Subject|2|||
23135066|NCT03122223|64244231|FG002|Overall Study|Withdrawal by Subject|1|||
23135067|NCT03122223|64244232|FG003|Overall Study|Withdrawal by Subject|0|||
23135068|NCT03122223|64244229|FG000|Overall Study|Lost to Follow-up|0|||
23135069|NCT03122223|64244230|FG001|Overall Study|Lost to Follow-up|2|||
23135070|NCT03122223|64244231|FG002|Overall Study|Lost to Follow-up|2|||
23135071|NCT03122223|64244232|FG003|Overall Study|Lost to Follow-up|0|||
23135072|NCT03122223|64244229|FG000|Overall Study|Participant unable to adhere|1|||
23135073|NCT03122223|64244230|FG001|Overall Study|Participant unable to adhere|1|||
23135074|NCT03122223|64244231|FG002|Overall Study|Participant unable to adhere|1|||
23135075|NCT03122223|64244232|FG003|Overall Study|Participant unable to adhere|0|||
23135076|NCT01353859|64244237|FG000|Overall Study|Adverse Event|3|||
23135077|NCT01353859|64244237|FG000|Overall Study|Lack of Efficacy|1|||
23135078|NCT00446043|64244242|FG000|Overall Study|Adverse Event|9|||
23135079|NCT00446043|64244242|FG000|Overall Study|Withdrawal by Subject|70|||
23135080|NCT00446043|64244242|FG000|Overall Study|Protocol Violation|2|||
23135081|NCT00446043|64244242|FG000|Overall Study|Lost to Follow-up|42|||
23135082|NCT00446043|64244242|FG000|Overall Study|Pregnancy|2|||
23135083|NCT01877239|64244243|FG000|Overall Study|Adverse Event|4|||
23135084|NCT01877239|64244243|FG000|Overall Study|Disease Remission|1|||
23135085|NCT01877239|64244243|FG000|Overall Study|Withdrawal by Subject|4|||
23135086|NCT01877239|64244243|FG000|Overall Study|Other|2|||
23135087|NCT01877239|64244243|FG000|Overall Study|Lack of Efficacy|4|||
23135088|NCT01877239|64244243|FG000|Overall Study|Data not available|35|||
23135089|NCT02781090|64244244|FG000|3-Month Follow-Up|Missed Visit|20|||
23135090|NCT02781090|64244245|FG001|3-Month Follow-Up|Missed Visit|20|||
23214383|NCT02168803|64523604|FG002|Overall Study|Sponsor Decision|1|||
23214384|NCT00605722|64523609|FG000|Overall Study|Adverse Event|6|||
23214385|NCT00605722|64523609|FG000|Overall Study|Insufficient therapeutic response|44|||
23214386|NCT00605722|64523609|FG000|Overall Study|Failure to return|1|||
23214387|NCT02141217|64523610|FG000|Overall Study|Adverse Event|1|||
23214388|NCT02141217|64523611|FG001|Overall Study|Adverse Event|2|||
23549124|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549125|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549126|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549127|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549128|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23135091|NCT02781090|64244244|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
23135092|NCT02781090|64244245|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
23135093|NCT02781090|64244244|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
23135094|NCT02781090|64244245|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
23135095|NCT02781090|64244244|FG000|3-Month Follow-Up|Death|1|||
23214389|NCT02141217|64523610|FG000|Overall Study|Protocol Violation|1|||
23135096|NCT02781090|64244245|FG001|3-Month Follow-Up|Death|0|||
23135097|NCT02781090|64244244|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
23135098|NCT02781090|64244245|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
23135099|NCT02781090|64244244|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
23135100|NCT02781090|64244245|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
23135101|NCT02781090|64244244|FG000|6-Month Follow-Up|Death|0|||
23135102|NCT02781090|64244245|FG001|6-Month Follow-Up|Death|1|||
23135103|NCT00589121|64244246|FG000|Overall Study|Protocol Violation|2|||
23135104|NCT00589121|64244247|FG001|Overall Study|Protocol Violation|6|||
23135105|NCT00589121|64244246|FG000|Overall Study|No protocol treatment received|0|||
23214390|NCT02141217|64523611|FG001|Overall Study|Protocol Violation|4|||
23214391|NCT02141217|64523610|FG000|Overall Study|Withdrawal by Subject|6|||
23214392|NCT02141217|64523611|FG001|Overall Study|Withdrawal by Subject|0|||
23214393|NCT02141217|64523610|FG000|Overall Study|Lost to Follow-up|1|||
23214394|NCT02141217|64523611|FG001|Overall Study|Lost to Follow-up|1|||
23214395|NCT02141217|64523610|FG000|Overall Study|Physician Decision|1|||
23214396|NCT02141217|64523611|FG001|Overall Study|Physician Decision|0|||
23214397|NCT02141217|64523610|FG000|Overall Study|Surgical Intervention|1|||
23135106|NCT00589121|64244247|FG001|Overall Study|No protocol treatment received|1|||
23135107|NCT03241927|64244248|FG000|Overall Study|study terminated|1|||
23135108|NCT03241927|64244249|FG001|Overall Study|study terminated|0|||
23135109|NCT03245151|64244250|FG000|Overall Study|Withdrawal by Subject|2|||
23135110|NCT03245151|64244251|FG001|Overall Study|Withdrawal by Subject|0|||
23135111|NCT03245151|64244252|FG002|Overall Study|Withdrawal by Subject|0|||
23135112|NCT03245151|64244253|FG003|Overall Study|Withdrawal by Subject|2|||
23135113|NCT03245151|64244254|FG004|Overall Study|Withdrawal by Subject|1|||
23135114|NCT03245151|64244250|FG000|Overall Study|Death|3|||
23135115|NCT03245151|64244251|FG001|Overall Study|Death|14|||
23135116|NCT03245151|64244252|FG002|Overall Study|Death|9|||
23214398|NCT02141217|64523611|FG001|Overall Study|Surgical Intervention|1|||
23428567|NCT02528357|65314287|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
23428568|NCT02528357|65314269|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428569|NCT02528357|65314270|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428570|NCT02528357|65314271|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428571|NCT02528357|65314272|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428572|NCT02528357|65314273|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428573|NCT02528357|65314274|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23549129|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23135117|NCT03245151|64244253|FG003|Overall Study|Death|16|||
23135118|NCT03245151|64244254|FG004|Overall Study|Death|7|||
23135119|NCT03245151|64244250|FG000|Overall Study|Sponsor's decision|0|||
23135120|NCT03245151|64244251|FG001|Overall Study|Sponsor's decision|1|||
23135121|NCT03245151|64244252|FG002|Overall Study|Sponsor's decision|0|||
23135122|NCT03245151|64244253|FG003|Overall Study|Sponsor's decision|0|||
23549130|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549131|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549132|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23214399|NCT03820726|64523612|FG000|Overall Study|Other than listed|23|||
23214400|NCT03820726|64523612|FG000|Overall Study|Withdrawal by Subject|37|||
23214401|NCT03820726|64523612|FG000|Overall Study|Lost to Follow-up|3|||
23214402|NCT03820726|64523612|FG000|Overall Study|Protocol deviation|1|||
23549133|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549134|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23214403|NCT03820726|64523612|FG000|Overall Study|Adverse Event|146|||
23214404|NCT03820726|64523612|FG000|Overall Study|Not treated|1|||
23214405|NCT00851253|64523613|FG000|Overall Study|Disease Progression|1|||
23214406|NCT00851253|64523614|FG001|Overall Study|Disease Progression|0|||
23214407|NCT00669032|64523617|FG000|Overall Study|Lost to Follow-up|6|||
23549135|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23214408|NCT00669032|64523618|FG001|Overall Study|Lost to Follow-up|5|||
23549136|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549137|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
23549138|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549139|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23135123|NCT03245151|64244254|FG004|Overall Study|Sponsor's decision|0|||
23135124|NCT00979576|64244258|FG000|Combination Treatment Phase|Progressive disease|3|||
23135125|NCT00979576|64244259|FG001|Combination Treatment Phase|Progressive disease|1|||
23135126|NCT00979576|64244260|FG002|Combination Treatment Phase|Progressive disease|5|||
23549140|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549141|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23135127|NCT00979576|64244258|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
23135128|NCT00979576|64244259|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
23135129|NCT00979576|64244260|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
23135130|NCT00979576|64244258|FG000|Combination Treatment Phase|Adverse Event|0|||
23135131|NCT00979576|64244259|FG001|Combination Treatment Phase|Adverse Event|2|||
23135132|NCT00979576|64244260|FG002|Combination Treatment Phase|Adverse Event|2|||
23135133|NCT00979576|64244258|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
23135134|NCT00979576|64244259|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
23135135|NCT00979576|64244260|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
23135136|NCT03705832|64244261|FG000|Overall Study|Physician Decision|0|||
23135137|NCT03705832|64244262|FG001|Overall Study|Physician Decision|1|||
23135138|NCT03705832|64244261|FG000|Overall Study|Withdrawal by Subject|1|||
23135139|NCT03705832|64244262|FG001|Overall Study|Withdrawal by Subject|0|||
23135140|NCT00444275|64244271|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
23135141|NCT00444275|64244272|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
23135142|NCT00444275|64244273|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
23135143|NCT00444275|64244274|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
23214409|NCT00669032|64523617|FG000|Overall Study|Lack of Efficacy|8|||
23214410|NCT00669032|64523618|FG001|Overall Study|Lack of Efficacy|19|||
23214411|NCT00669032|64523617|FG000|Overall Study|Withdrawal by Subject|12|||
23549142|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549143|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549144|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
23549145|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549146|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
23549147|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549148|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
23549149|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
23135144|NCT00444275|64244275|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
23214412|NCT00669032|64523618|FG001|Overall Study|Withdrawal by Subject|13|||
23135145|NCT00444275|64244271|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
23135146|NCT00444275|64244272|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
23135147|NCT00444275|64244273|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
23135148|NCT00444275|64244274|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
23135149|NCT00444275|64244275|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
23135150|NCT00444275|64244271|FG000|Maintenance Treatment Phase|Adverse Event|0|||
23135151|NCT00444275|64244272|FG001|Maintenance Treatment Phase|Adverse Event|0|||
23135152|NCT00444275|64244273|FG002|Maintenance Treatment Phase|Adverse Event|3|||
23135153|NCT00444275|64244274|FG003|Maintenance Treatment Phase|Adverse Event|2|||
23135154|NCT00444275|64244275|FG004|Maintenance Treatment Phase|Adverse Event|13|||
23135155|NCT00444275|64244271|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
23135156|NCT00444275|64244272|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
23214413|NCT00669032|64523617|FG000|Overall Study|Adverse Event|12|||
23214414|NCT00669032|64523618|FG001|Overall Study|Adverse Event|16|||
23214415|NCT00669032|64523617|FG000|Overall Study|Physician Decision|1|||
23214416|NCT00669032|64523618|FG001|Overall Study|Physician Decision|1|||
23214417|NCT00669032|64523617|FG000|Overall Study|No fulfilment of the selection criteria|5|||
23214418|NCT00669032|64523618|FG001|Overall Study|No fulfilment of the selection criteria|5|||
23214419|NCT01162304|64523619|FG000|Overall Study|Beck scale to high|11|||
23214420|NCT01957709|64523622|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
23214421|NCT00965146|64527929|FG000|Overall Study|Death|7|||
23214422|NCT00965146|64527929|FG000|Overall Study|Lost to Follow-up|22|||
23214423|NCT00965146|64527929|FG000|Overall Study|Withdrawal by Subject|17|||
23214424|NCT00965146|64527929|FG000|Overall Study|Unable to return|1|||
23214425|NCT00965146|64527929|FG000|Overall Study|Unwilling to return|11|||
23214426|NCT00965146|64527929|FG000|Overall Study|Intercurrent illness|1|||
23214427|NCT00965146|64527929|FG000|Overall Study|Revision / Removal of Study Implant|6|||
23214428|NCT00965146|64527929|FG000|Overall Study|Overall Study Termination|145|||
23214429|NCT03434418|64527930|FG000|Overall Study|Disease Progression|11|||
23214430|NCT03434418|64527930|FG000|Overall Study|Adverse Event|2|||
23214431|NCT03434418|64527930|FG000|Overall Study|Physician Decision|1|||
23214432|NCT03434418|64527930|FG000|Overall Study|Decline in Performance Status (PS)|1|||
23214433|NCT00966693|64527937|FG000|Overall Study|Adverse Event|0|||
23214434|NCT00966693|64527938|FG001|Overall Study|Adverse Event|0|||
23214435|NCT00966693|64527939|FG002|Overall Study|Adverse Event|1|||
23214436|NCT00966693|64527940|FG003|Overall Study|Adverse Event|2|||
23214437|NCT00966693|64527937|FG000|Overall Study|Death|0|||
23214438|NCT00966693|64527938|FG001|Overall Study|Death|0|||
23214439|NCT00966693|64527939|FG002|Overall Study|Death|1|||
23214440|NCT00966693|64527940|FG003|Overall Study|Death|0|||
23214441|NCT00966693|64527937|FG000|Overall Study|Withdrawal by Subject|1|||
23214442|NCT00966693|64527938|FG001|Overall Study|Withdrawal by Subject|0|||
23214443|NCT00966693|64527939|FG002|Overall Study|Withdrawal by Subject|0|||
23214444|NCT00966693|64527940|FG003|Overall Study|Withdrawal by Subject|5|||
23214445|NCT00966693|64527937|FG000|Overall Study|Disease Progression|0|||
23214446|NCT00966693|64527938|FG001|Overall Study|Disease Progression|0|||
23214447|NCT00966693|64527939|FG002|Overall Study|Disease Progression|1|||
23214448|NCT00966693|64527940|FG003|Overall Study|Disease Progression|16|||
23214449|NCT02670915|64527941|FG000|Overall Study|Withdrawal by Subject|0|||
23214450|NCT02670915|64527942|FG001|Overall Study|Withdrawal by Subject|1|||
23214451|NCT02670915|64527943|FG002|Overall Study|Withdrawal by Subject|4|||
23214452|NCT02670915|64527941|FG000|Overall Study|Withdrawal by parent/guardian|4|||
23214453|NCT02670915|64527942|FG001|Overall Study|Withdrawal by parent/guardian|4|||
23214454|NCT02670915|64527943|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23214455|NCT02670915|64527941|FG000|Overall Study|Unclassified|0|||
23214456|NCT02670915|64527942|FG001|Overall Study|Unclassified|3|||
23214457|NCT02670915|64527943|FG002|Overall Study|Unclassified|0|||
23214458|NCT02667457|64527947|FG000|Overall Study|Withdrawal by Subject|1|||
23214459|NCT02667457|64527948|FG001|Overall Study|Withdrawal by Subject|0|||
23214460|NCT02667457|64527947|FG000|Overall Study|Other Reason|0|||
23214461|NCT02667457|64527948|FG001|Overall Study|Other Reason|2|||
23214462|NCT03039738|64527949|FG000|Overall Study|Incomplete data sets|54|||
23214463|NCT03039738|64527950|FG001|Overall Study|Incomplete data sets|0|||
23214464|NCT00376246|64527951|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
23214465|NCT00376246|64527952|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
23214466|NCT00376246|64527951|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23214467|NCT00376246|64527952|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
23214468|NCT00376246|64527951|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
23214469|NCT00376246|64527952|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23214470|NCT00326417|64527953|FG000|Overall Study|Withdrawal by Subject|0|||
23214471|NCT00326417|64527954|FG001|Overall Study|Withdrawal by Subject|0|||
23214472|NCT00326417|64527955|FG002|Overall Study|Withdrawal by Subject|1|||
23214473|NCT00326417|64527956|FG003|Overall Study|Withdrawal by Subject|0|||
23428574|NCT02528357|65314275|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428575|NCT02528357|65314276|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23135157|NCT00444275|64244273|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
23135158|NCT00444275|64244274|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
23135159|NCT00444275|64244275|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
23135160|NCT00444275|64244271|FG000|Maintenance Treatment Phase|Patient's wish|0|||
23135161|NCT00444275|64244272|FG001|Maintenance Treatment Phase|Patient's wish|0|||
23135162|NCT00444275|64244273|FG002|Maintenance Treatment Phase|Patient's wish|19|||
23135163|NCT00444275|64244274|FG003|Maintenance Treatment Phase|Patient's wish|9|||
23135164|NCT00444275|64244275|FG004|Maintenance Treatment Phase|Patient's wish|20|||
23135165|NCT00444275|64244271|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
23135166|NCT00444275|64244272|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
23135167|NCT00444275|64244273|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
23135168|NCT00444275|64244274|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
23135169|NCT00444275|64244275|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
23135170|NCT00444275|64244271|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
23135171|NCT00444275|64244272|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
23135172|NCT00444275|64244273|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
23135173|NCT00444275|64244274|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
23135174|NCT00444275|64244275|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
23135175|NCT00588692|64244276|FG000|Overall Study|Withdrawal by Subject|4|||
23135176|NCT00588692|64244277|FG001|Overall Study|Withdrawal by Subject|2|||
23135177|NCT00588692|64244276|FG000|Overall Study|Hip Surgery|0|||
23135178|NCT00588692|64244277|FG001|Overall Study|Hip Surgery|1|||
23135179|NCT00588692|64244276|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
23135180|NCT00588692|64244277|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
23135181|NCT00588692|64244276|FG000|Overall Study|Cancer|1|||
23135182|NCT00588692|64244277|FG001|Overall Study|Cancer|0|||
23135183|NCT00588692|64244276|FG000|Overall Study|Death|1|||
23135184|NCT00588692|64244277|FG001|Overall Study|Death|0|||
23135185|NCT04738292|64244278|FG000|Overall Study|Death|1|||
23135186|NCT02030002|64244279|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
23135187|NCT02030002|64244279|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
23135188|NCT02030002|64244279|FG000|Follow-up|Lost to Follow-up|2|||
23135189|NCT00837694|64244284|FG000|Overall Study|Lost to Follow-up|2|||
23135190|NCT00837694|64244285|FG001|Overall Study|Lost to Follow-up|0|||
23135191|NCT00837694|64244286|FG002|Overall Study|Lost to Follow-up|2|||
23135192|NCT00837694|64244287|FG003|Overall Study|Lost to Follow-up|1|||
23135193|NCT00837694|64244288|FG004|Overall Study|Lost to Follow-up|1|||
23135194|NCT00837694|64244289|FG005|Overall Study|Lost to Follow-up|1|||
23135195|NCT04677179|64244290|FG000|Induction Treatment Period|Adverse Event|1|||
23135196|NCT04677179|64244291|FG001|Induction Treatment Period|Adverse Event|0|||
23135197|NCT04677179|64244292|FG002|Induction Treatment Period|Adverse Event|0|||
23135198|NCT04677179|64244293|FG003|Induction Treatment Period|Adverse Event|0|||
23135199|NCT04677179|64244294|FG004|Induction Treatment Period|Adverse Event|0|||
23135200|NCT04677179|64244295|FG005|Induction Treatment Period|Adverse Event|0|||
23214474|NCT00326417|64527953|FG000|Overall Study|Arm Closed|7|||
23214475|NCT00326417|64527954|FG001|Overall Study|Arm Closed|0|||
23135201|NCT04677179|64244296|FG006|Induction Treatment Period|Adverse Event|0|||
23135202|NCT04677179|64244297|FG007|Induction Treatment Period|Adverse Event|0|||
23135203|NCT04677179|64244298|FG008|Induction Treatment Period|Adverse Event|0|||
23135204|NCT04677179|64244299|FG009|Induction Treatment Period|Adverse Event|0|||
23135205|NCT04677179|64244290|FG000|Induction Treatment Period|Physician Decision|1|||
23135206|NCT04677179|64244291|FG001|Induction Treatment Period|Physician Decision|0|||
23135207|NCT04677179|64244292|FG002|Induction Treatment Period|Physician Decision|1|||
23135208|NCT04677179|64244293|FG003|Induction Treatment Period|Physician Decision|0|||
23214476|NCT00326417|64527955|FG002|Overall Study|Arm Closed|0|||
23214477|NCT00326417|64527956|FG003|Overall Study|Arm Closed|3|||
23214478|NCT00326417|64527953|FG000|Overall Study|Death|7|||
23214479|NCT00326417|64527954|FG001|Overall Study|Death|0|||
23214480|NCT00326417|64527955|FG002|Overall Study|Death|0|||
23214481|NCT00326417|64527956|FG003|Overall Study|Death|0|||
23214482|NCT01494987|64527961|FG000|Overall Study|Adverse Event|6|||
23214483|NCT01494987|64527962|FG001|Overall Study|Adverse Event|5|||
23214484|NCT01494987|64527961|FG000|Overall Study|Hyperglycemia|6|||
23214485|NCT01494987|64527962|FG001|Overall Study|Hyperglycemia|4|||
23549150|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23135209|NCT04677179|64244294|FG004|Induction Treatment Period|Physician Decision|0|||
23214486|NCT01494987|64527961|FG000|Overall Study|Investigator's Discretion|1|||
23214487|NCT01494987|64527962|FG001|Overall Study|Investigator's Discretion|2|||
23549151|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23135210|NCT04677179|64244295|FG005|Induction Treatment Period|Physician Decision|0|||
23135211|NCT04677179|64244296|FG006|Induction Treatment Period|Physician Decision|0|||
23135212|NCT04677179|64244297|FG007|Induction Treatment Period|Physician Decision|0|||
23214488|NCT01494987|64527961|FG000|Overall Study|Lost to Follow-up|1|||
23214489|NCT01494987|64527962|FG001|Overall Study|Lost to Follow-up|1|||
23214490|NCT01494987|64527961|FG000|Overall Study|Protocol Violation|3|||
23214491|NCT01494987|64527962|FG001|Overall Study|Protocol Violation|3|||
23214492|NCT01494987|64527961|FG000|Overall Study|Subject Non-Compliance|9|||
23214493|NCT01494987|64527962|FG001|Overall Study|Subject Non-Compliance|10|||
23214494|NCT01494987|64527961|FG000|Overall Study|Subject Withdrew Consent|2|||
23214495|NCT01494987|64527962|FG001|Overall Study|Subject Withdrew Consent|3|||
23620091|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
23620092|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
23620093|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
23620094|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
23620095|NCT00332488|65994862|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
23620096|NCT00332488|65994863|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
23620097|NCT00332488|65994864|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
23620098|NCT00125853|65994869|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
23620099|NCT00125853|65994870|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
23620100|NCT01702519|65994871|FG000|Washout Period|Lost to Follow-up|1|||
23620101|NCT01702519|65994872|FG001|Washout Period|Lost to Follow-up|0|||
23214496|NCT00091026|64527963|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
23549152|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549153|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549154|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549155|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549156|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549157|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
23549158|NCT01490632|65739664|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549159|NCT01490632|65739665|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549160|NCT01490632|65739666|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549161|NCT01490632|65739667|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549162|NCT01490632|65739668|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549163|NCT01490632|65739669|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
23549164|NCT01490632|65739670|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
23549165|NCT01490632|65739671|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
23549166|NCT01490632|65739672|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
23549167|NCT01490632|65739673|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
23549168|NCT01490632|65739674|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
23549169|NCT01490632|65739675|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
23549170|NCT01490632|65739676|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549171|NCT01490632|65739677|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549172|NCT01490632|65739678|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549173|NCT01490632|65739679|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549174|NCT01490632|65739680|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549175|NCT01490632|65739681|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549176|NCT01490632|65739682|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549177|NCT01490632|65739683|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
23549178|NCT01490632|65739664|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549179|NCT01490632|65739665|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549180|NCT01490632|65739666|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549181|NCT01490632|65739667|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549182|NCT01490632|65739668|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549183|NCT01490632|65739669|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549184|NCT01490632|65739670|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549185|NCT01490632|65739671|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549186|NCT01490632|65739672|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549187|NCT01490632|65739673|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549188|NCT01490632|65739674|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549189|NCT01490632|65739675|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549190|NCT01490632|65739676|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549191|NCT01490632|65739677|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549192|NCT01490632|65739678|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
23620102|NCT01702519|65994871|FG000|Washout Period|Withdrawal by Subject|0|||
23620103|NCT01702519|65994872|FG001|Washout Period|Withdrawal by Subject|2|||
23620104|NCT02435381|65994873|FG000|Overall Study|Lost to Follow-up|2|||
23620105|NCT02435381|65994874|FG001|Overall Study|Lost to Follow-up|1|||
23214497|NCT00091026|64527964|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
23317543|NCT04015908|64904103|FG001|Overall Study|Lost to Follow-up|1|||
23549193|NCT01490632|65739679|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
23549194|NCT01490632|65739680|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549195|NCT01490632|65739681|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549196|NCT01490632|65739682|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549197|NCT01490632|65739683|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
23549198|NCT01490632|65739664|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549199|NCT01490632|65739665|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549200|NCT01490632|65739666|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549201|NCT01490632|65739667|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549202|NCT01490632|65739668|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549203|NCT01490632|65739669|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549204|NCT01490632|65739670|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549205|NCT01490632|65739671|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549206|NCT01490632|65739672|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549207|NCT01490632|65739673|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549208|NCT01490632|65739674|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549209|NCT01490632|65739675|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549210|NCT01490632|65739676|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549211|NCT01490632|65739677|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
23549212|NCT01490632|65739678|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549213|NCT01490632|65739679|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549214|NCT01490632|65739680|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549215|NCT01490632|65739681|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549216|NCT01490632|65739682|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549217|NCT01490632|65739683|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
23549218|NCT01490632|65739664|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549219|NCT01490632|65739665|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549220|NCT01490632|65739666|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549221|NCT01490632|65739667|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549222|NCT01490632|65739668|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549223|NCT01490632|65739669|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549224|NCT01490632|65739670|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549225|NCT01490632|65739671|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549226|NCT01490632|65739672|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549227|NCT01490632|65739673|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549228|NCT01490632|65739674|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549229|NCT01490632|65739675|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549230|NCT01490632|65739676|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549231|NCT01490632|65739677|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549232|NCT01490632|65739678|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
23549233|NCT01490632|65739679|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
23549234|NCT01490632|65739680|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549235|NCT01490632|65739681|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549236|NCT01490632|65739682|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549237|NCT01490632|65739683|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
23549238|NCT01490632|65739664|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549239|NCT01490632|65739665|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549240|NCT01490632|65739666|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549241|NCT01490632|65739667|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549242|NCT01490632|65739668|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549243|NCT01490632|65739669|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549244|NCT01490632|65739670|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549245|NCT01490632|65739671|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549246|NCT01490632|65739672|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23620106|NCT01177137|65994883|FG000|Overall Study|Withdrawal by Subject|10|||
23620107|NCT01177137|65994884|FG001|Overall Study|Withdrawal by Subject|10|||
23214498|NCT00091026|64527963|FG000|Overall Study|Patient withdrew and never received trea|0|||
23214499|NCT00091026|64527964|FG001|Overall Study|Patient withdrew and never received trea|2|||
23214500|NCT00091026|64527963|FG000|Overall Study|Unknown-never received treatment|0|||
23620108|NCT01177137|65994885|FG002|Overall Study|Withdrawal by Subject|2|||
23620109|NCT00817336|65994886|FG000|Overall Study|Withdrawal by Subject|1|||
23214501|NCT00091026|64527964|FG001|Overall Study|Unknown-never received treatment|1|||
23428576|NCT02528357|65314277|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23620110|NCT00817336|65994887|FG001|Overall Study|Withdrawal by Subject|1|||
23620111|NCT06247488|65994890|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
23620112|NCT06247488|65994891|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23620113|NCT06247488|65994892|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23620114|NCT06247488|65994893|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23135213|NCT04677179|64244298|FG008|Induction Treatment Period|Physician Decision|0|||
23135214|NCT04677179|64244299|FG009|Induction Treatment Period|Physician Decision|0|||
23135215|NCT04677179|64244290|FG000|Induction Treatment Period|Protocol Violation|0|||
23135216|NCT04677179|64244291|FG001|Induction Treatment Period|Protocol Violation|1|||
23135217|NCT04677179|64244292|FG002|Induction Treatment Period|Protocol Violation|0|||
23135218|NCT04677179|64244293|FG003|Induction Treatment Period|Protocol Violation|0|||
23620115|NCT06247488|65994894|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23620116|NCT06247488|65994895|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
23135219|NCT04677179|64244294|FG004|Induction Treatment Period|Protocol Violation|0|||
23549247|NCT01490632|65739673|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549248|NCT01490632|65739674|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549249|NCT01490632|65739675|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549250|NCT01490632|65739676|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
23549251|NCT01490632|65739677|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
23549252|NCT01490632|65739678|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
23549253|NCT01490632|65739679|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
23549254|NCT01490632|65739680|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549255|NCT01490632|65739681|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23620117|NCT06247488|65994890|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23135220|NCT04677179|64244295|FG005|Induction Treatment Period|Protocol Violation|0|||
23135221|NCT04677179|64244296|FG006|Induction Treatment Period|Protocol Violation|0|||
23135222|NCT04677179|64244297|FG007|Induction Treatment Period|Protocol Violation|0|||
23135223|NCT04677179|64244298|FG008|Induction Treatment Period|Protocol Violation|0|||
23135224|NCT04677179|64244299|FG009|Induction Treatment Period|Protocol Violation|0|||
23135225|NCT04677179|64244290|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
23135226|NCT04677179|64244291|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
23135227|NCT04677179|64244292|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
23135228|NCT04677179|64244293|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
23135229|NCT04677179|64244294|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
23135230|NCT04677179|64244295|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
23214502|NCT02514772|64527966|FG000|Overall Study|Adverse Event|1|||
23214503|NCT02514772|64527967|FG001|Overall Study|Adverse Event|0|||
23214504|NCT02514772|64527966|FG000|Overall Study|Death|0|||
23214505|NCT02514772|64527967|FG001|Overall Study|Death|1|||
23214506|NCT02514772|64527966|FG000|Overall Study|Withdrawal by Subject|2|||
23214507|NCT02514772|64527967|FG001|Overall Study|Withdrawal by Subject|1|||
23214508|NCT01213264|64527968|FG000|Overall Study|Adverse Event|1|||
23214509|NCT01213264|64527969|FG001|Overall Study|Adverse Event|0|||
23214510|NCT01213264|64527970|FG002|Overall Study|Adverse Event|0|||
23214511|NCT01213264|64527968|FG000|Overall Study|Lost to Follow-up|1|||
23214512|NCT01213264|64527969|FG001|Overall Study|Lost to Follow-up|2|||
23214513|NCT01213264|64527970|FG002|Overall Study|Lost to Follow-up|6|||
23214514|NCT00781963|64527971|FG000|Overall Study|Death|3|||
23214515|NCT00781963|64527972|FG001|Overall Study|Death|0|||
23214516|NCT00781963|64527971|FG000|Overall Study|Lost to Follow-up|2|||
23620118|NCT06247488|65994891|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23620119|NCT06247488|65994892|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23620120|NCT06247488|65994893|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
23620121|NCT06247488|65994894|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23620122|NCT06247488|65994895|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
23620123|NCT06247488|65994890|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
23620124|NCT06247488|65994891|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620125|NCT06247488|65994892|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620126|NCT06247488|65994893|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620127|NCT06247488|65994894|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620128|NCT06247488|65994895|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
23620129|NCT06247488|65994890|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23620130|NCT06247488|65994891|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23620131|NCT06247488|65994892|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23135231|NCT04677179|64244296|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
23214517|NCT00781963|64527972|FG001|Overall Study|Lost to Follow-up|1|||
23214518|NCT00781963|64527971|FG000|Overall Study|Withdrawal by Subject|3|||
23214519|NCT00781963|64527972|FG001|Overall Study|Withdrawal by Subject|1|||
23214520|NCT00781963|64527971|FG000|Overall Study|Refused follow-up|9|||
23135232|NCT04677179|64244297|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
23214521|NCT00781963|64527972|FG001|Overall Study|Refused follow-up|0|||
23135233|NCT04677179|64244298|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
23135234|NCT04677179|64244299|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
23135235|NCT04677179|64244290|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
23135236|NCT04677179|64244291|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
23135237|NCT04677179|64244292|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
23135238|NCT04677179|64244293|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
23135239|NCT04677179|64244294|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
23135240|NCT04677179|64244295|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
23135241|NCT04677179|64244296|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
23549256|NCT01490632|65739682|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549257|NCT01490632|65739683|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
23549258|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
23549259|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
23549260|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
23549261|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
23549262|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
23549263|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
23549264|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
23549265|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
23549266|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
23620132|NCT06247488|65994893|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
23620133|NCT06247488|65994894|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23620134|NCT06247488|65994895|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
23620135|NCT06247488|65994890|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620136|NCT06247488|65994891|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620137|NCT06247488|65994892|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620138|NCT06247488|65994893|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620139|NCT06247488|65994894|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
23620140|NCT06247488|65994895|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
23620141|NCT06247488|65994890|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
23620142|NCT06247488|65994891|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
23620143|NCT06247488|65994892|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
23135242|NCT04677179|64244297|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
23135243|NCT04677179|64244298|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
23620144|NCT06247488|65994893|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
23620145|NCT06247488|65994894|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
23549267|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
23549268|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
23549269|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
23549270|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
23549271|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
23549272|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
23549273|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
23549274|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
23549275|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
23549276|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
23620146|NCT06247488|65994895|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
23620147|NCT06247488|65994890|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23135244|NCT04677179|64244299|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
23214522|NCT01947894|64527973|FG000|Overall Study|Other|3|||
23214523|NCT01947894|64527974|FG001|Overall Study|Other|4|||
23214524|NCT01947894|64527975|FG002|Overall Study|Other|3|||
23214525|NCT01947894|64527973|FG000|Overall Study|Withdrawal by Subject|12|||
23214526|NCT01947894|64527974|FG001|Overall Study|Withdrawal by Subject|4|||
23549277|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
23549278|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Death|0|||
23135245|NCT04677179|64244290|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
23135246|NCT04677179|64244291|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
23135247|NCT04677179|64244292|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
23135248|NCT04677179|64244293|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
23135249|NCT04677179|64244294|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
23135250|NCT04677179|64244295|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
23214527|NCT01947894|64527975|FG002|Overall Study|Withdrawal by Subject|1|||
23214528|NCT01947894|64527973|FG000|Overall Study|Death|12|||
23214529|NCT01947894|64527974|FG001|Overall Study|Death|1|||
23549279|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Death|0|||
23549280|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Death|0|||
23549281|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Death|0|||
23620148|NCT06247488|65994891|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23620149|NCT06247488|65994892|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23214530|NCT01947894|64527975|FG002|Overall Study|Death|0|||
23214531|NCT01947894|64527973|FG000|Overall Study|Physician Decision|2|||
23549282|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Death|0|||
23549283|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Death|0|||
23549284|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Death|0|||
23135251|NCT04677179|64244296|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
23135252|NCT04677179|64244297|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
23135253|NCT04677179|64244298|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
23135254|NCT04677179|64244299|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
23135255|NCT04677179|64244290|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
23135256|NCT04677179|64244291|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
23135257|NCT04677179|64244292|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
23135258|NCT04677179|64244293|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
23135259|NCT04677179|64244294|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
23135260|NCT04677179|64244295|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
23135261|NCT04677179|64244296|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
23135262|NCT04677179|64244297|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
23135263|NCT04677179|64244298|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
23135264|NCT04677179|64244299|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
23214532|NCT01947894|64527974|FG001|Overall Study|Physician Decision|0|||
23214533|NCT01947894|64527975|FG002|Overall Study|Physician Decision|0|||
23214534|NCT01947894|64527973|FG000|Overall Study|Adverse Event|5|||
23549285|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Death|0|||
23549286|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Death|0|||
23549287|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Death|0|||
23549288|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Death|0|||
23549289|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Death|0|||
23549290|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Death|0|||
23549291|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Death|0|||
23549292|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Death|0|||
23549293|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Death|0|||
23549294|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Death|0|||
23549295|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Death|0|||
23549296|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Death|1|||
23549297|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Death|0|||
23549298|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549299|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549300|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549301|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549302|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549303|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549304|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549305|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549306|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549307|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549308|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549309|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549310|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549311|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549312|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549313|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549314|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
23549315|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
23549316|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
23549317|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
23549318|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549319|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549320|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549321|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549322|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549323|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549324|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549325|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549326|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549327|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549328|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549329|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23214535|NCT01947894|64527974|FG001|Overall Study|Adverse Event|1|||
23549330|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549331|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549332|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549333|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549334|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23135265|NCT04677179|64244290|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
23135266|NCT04677179|64244291|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
23135267|NCT04677179|64244292|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
23135268|NCT04677179|64244293|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
23135269|NCT04677179|64244294|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
23135270|NCT04677179|64244295|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
23135271|NCT04677179|64244296|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
23135272|NCT04677179|64244297|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
23135273|NCT04677179|64244298|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
23135274|NCT04677179|64244299|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
23549335|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549336|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
23549337|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
23549338|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
23549339|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
23549340|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
23549341|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
23549342|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
23549343|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
23549344|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
23549345|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
23549346|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
23549347|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
23549348|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
23549349|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
23549350|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
23549351|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
23428577|NCT02528357|65314278|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23549352|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
23549353|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
23214536|NCT01947894|64527975|FG002|Overall Study|Adverse Event|0|||
23214537|NCT01947894|64527973|FG000|Overall Study|Switched to other growth hormone brand|53|||
23549354|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
23549355|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
23549356|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
23549357|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
23549358|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
23549359|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
23549360|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
23549361|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
23549362|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
23549363|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
23549364|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
23549365|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
23549366|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
23549367|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
23549368|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
23549369|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
23549370|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
23549371|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
23549372|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
23549373|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
23549374|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
23214538|NCT01947894|64527974|FG001|Overall Study|Switched to other growth hormone brand|8|||
23214539|NCT01947894|64527975|FG002|Overall Study|Switched to other growth hormone brand|23|||
23214540|NCT03483116|64527976|FG000|Overall Study|Adverse Event|0|||
23214541|NCT03483116|64527977|FG001|Overall Study|Adverse Event|1|||
23214542|NCT03483116|64527978|FG002|Overall Study|Adverse Event|0|||
23214543|NCT03483116|64527979|FG003|Overall Study|Adverse Event|1|||
23214544|NCT03483116|64527976|FG000|Overall Study|Protocol Violation|1|||
23214545|NCT03483116|64527977|FG001|Overall Study|Protocol Violation|0|||
23214546|NCT03483116|64527978|FG002|Overall Study|Protocol Violation|0|||
23549375|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
23549376|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
23135275|NCT04677179|64244290|FG000|Extension Treatment Period|Lack of Efficacy|0|||
23214547|NCT03483116|64527979|FG003|Overall Study|Protocol Violation|7|||
23214548|NCT03483116|64527976|FG000|Overall Study|Lost to Follow-up|9|||
23214549|NCT03483116|64527977|FG001|Overall Study|Lost to Follow-up|4|||
23214550|NCT03483116|64527978|FG002|Overall Study|Lost to Follow-up|9|||
23428578|NCT02528357|65314279|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428579|NCT02528357|65314280|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23214551|NCT03483116|64527979|FG003|Overall Study|Lost to Follow-up|5|||
23214552|NCT03483116|64527976|FG000|Overall Study|Death|1|||
23214553|NCT03483116|64527977|FG001|Overall Study|Death|0|||
23214554|NCT03483116|64527978|FG002|Overall Study|Death|2|||
23214555|NCT03483116|64527979|FG003|Overall Study|Death|1|||
23214556|NCT03483116|64527976|FG000|Overall Study|Withdrawal by Subject|14|||
23214557|NCT03483116|64527977|FG001|Overall Study|Withdrawal by Subject|16|||
23214558|NCT03483116|64527978|FG002|Overall Study|Withdrawal by Subject|14|||
23214559|NCT03483116|64527979|FG003|Overall Study|Withdrawal by Subject|16|||
23214560|NCT03483116|64527976|FG000|Overall Study|Unknown other reason|3|||
23214561|NCT03483116|64527977|FG001|Overall Study|Unknown other reason|2|||
23214562|NCT03483116|64527978|FG002|Overall Study|Unknown other reason|1|||
23214563|NCT03483116|64527979|FG003|Overall Study|Unknown other reason|1|||
23214564|NCT01125293|64527980|FG000|Overall Study|Disease Progression|1|||
23214565|NCT01125293|64527981|FG001|Overall Study|Disease Progression|3|||
23214566|NCT01125293|64527982|FG002|Overall Study|Disease Progression|4|||
23214567|NCT01125293|64527983|FG003|Overall Study|Disease Progression|3|||
23214568|NCT01125293|64527984|FG004|Overall Study|Disease Progression|5|||
23214569|NCT01125293|64527985|FG005|Overall Study|Disease Progression|12|||
23214570|NCT01125293|64527980|FG000|Overall Study|Adverse Event|1|||
23214571|NCT01125293|64527981|FG001|Overall Study|Adverse Event|0|||
23214572|NCT01125293|64527982|FG002|Overall Study|Adverse Event|0|||
23214573|NCT01125293|64527983|FG003|Overall Study|Adverse Event|0|||
23214574|NCT01125293|64527984|FG004|Overall Study|Adverse Event|2|||
23214575|NCT01125293|64527985|FG005|Overall Study|Adverse Event|8|||
23214576|NCT01125293|64527980|FG000|Overall Study|Symptomatic Deterioration|1|||
23214577|NCT01125293|64527981|FG001|Overall Study|Symptomatic Deterioration|0|||
23214578|NCT01125293|64527982|FG002|Overall Study|Symptomatic Deterioration|0|||
23214579|NCT01125293|64527983|FG003|Overall Study|Symptomatic Deterioration|0|||
23214580|NCT01125293|64527984|FG004|Overall Study|Symptomatic Deterioration|0|||
23214581|NCT01125293|64527985|FG005|Overall Study|Symptomatic Deterioration|0|||
23214582|NCT01125293|64527980|FG000|Overall Study|Death|0|||
23214583|NCT01125293|64527981|FG001|Overall Study|Death|0|||
23214584|NCT01125293|64527982|FG002|Overall Study|Death|0|||
23214585|NCT01125293|64527983|FG003|Overall Study|Death|0|||
23214586|NCT01125293|64527984|FG004|Overall Study|Death|1|||
23214587|NCT01125293|64527985|FG005|Overall Study|Death|0|||
23214588|NCT01125293|64527980|FG000|Overall Study|Withdrawal by Subject|0|||
23214589|NCT01125293|64527981|FG001|Overall Study|Withdrawal by Subject|0|||
23214590|NCT01125293|64527982|FG002|Overall Study|Withdrawal by Subject|0|||
23214591|NCT01125293|64527983|FG003|Overall Study|Withdrawal by Subject|0|||
23214592|NCT01125293|64527984|FG004|Overall Study|Withdrawal by Subject|2|||
23214593|NCT01125293|64527985|FG005|Overall Study|Withdrawal by Subject|1|||
23214594|NCT01125293|64527980|FG000|Overall Study|Physician Decision|0|||
23214595|NCT01125293|64527981|FG001|Overall Study|Physician Decision|0|||
23214596|NCT01125293|64527982|FG002|Overall Study|Physician Decision|0|||
23214597|NCT01125293|64527983|FG003|Overall Study|Physician Decision|0|||
23214598|NCT01125293|64527984|FG004|Overall Study|Physician Decision|0|||
23214599|NCT01125293|64527985|FG005|Overall Study|Physician Decision|2|||
23214600|NCT02910583|64527986|FG000|Overall Study|Withdrawal by Subject|6|||
23214601|NCT02910583|64527987|FG001|Overall Study|Withdrawal by Subject|7|||
23549377|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
23549378|NCT01490632|65739664|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549379|NCT01490632|65739665|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549380|NCT01490632|65739666|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549381|NCT01490632|65739667|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549382|NCT01490632|65739668|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549383|NCT01490632|65739669|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549384|NCT01490632|65739670|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549385|NCT01490632|65739671|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549386|NCT01490632|65739672|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549387|NCT01490632|65739673|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549388|NCT01490632|65739674|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549389|NCT01490632|65739675|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549390|NCT01490632|65739676|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549391|NCT01490632|65739677|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549392|NCT01490632|65739678|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23549393|NCT01490632|65739679|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23620150|NCT06247488|65994893|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23214602|NCT02910583|64527986|FG000|Overall Study|Other, Not Specified|1|||
23214603|NCT02910583|64527987|FG001|Overall Study|Other, Not Specified|0|||
23214604|NCT00345540|64527988|FG000|Overall Study|Withdrawal by Subject|1|||
23214605|NCT03215667|64527991|FG000|Overall Study|Physician Decision|4|||
23214606|NCT01459068|64527994|FG000|Overall Study|Withdrawal by Subject|8|||
23214607|NCT01459068|64527995|FG001|Overall Study|Withdrawal by Subject|18|||
23214608|NCT01459068|64527994|FG000|Overall Study|Lost to Follow-up|31|||
23549394|NCT01490632|65739680|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
23214609|NCT01459068|64527995|FG001|Overall Study|Lost to Follow-up|15|||
23214610|NCT01459068|64527994|FG000|Overall Study|Death|0|||
23214611|NCT01459068|64527995|FG001|Overall Study|Death|1|||
23214612|NCT00065442|64527996|FG000|Overall Study|Lost to Follow-up|1|||
23214613|NCT00065442|64527997|FG001|Overall Study|Lost to Follow-up|1|||
23214614|NCT00065442|64527996|FG000|Overall Study|Death|121|||
23214615|NCT00065442|64527997|FG001|Overall Study|Death|210|||
23214616|NCT00065442|64527996|FG000|Overall Study|Withdrawal by Subject|3|||
23214617|NCT00065442|64527997|FG001|Overall Study|Withdrawal by Subject|9|||
23214618|NCT00636441|64527998|FG000|Overall Study|Adverse Event|0|||
23317544|NCT00993421|64904104|FG000|Overall Study|Adverse Event|2|||
23317545|NCT00993421|64904105|FG001|Overall Study|Adverse Event|7|||
23317546|NCT00993421|64904106|FG002|Overall Study|Adverse Event|6|||
23317547|NCT00993421|64904107|FG003|Overall Study|Adverse Event|9|||
23317548|NCT00993421|64904108|FG004|Overall Study|Adverse Event|5|||
23317549|NCT00993421|64904109|FG005|Overall Study|Adverse Event|7|||
23549395|NCT01490632|65739681|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
23549396|NCT01490632|65739682|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
23549397|NCT01490632|65739683|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
23549398|NCT00717860|65739686|FG000|Overall Study|Clinical adverse experience|5|||
23214619|NCT00636441|64527999|FG001|Overall Study|Adverse Event|1|||
23214620|NCT00636441|64528000|FG002|Overall Study|Adverse Event|1|||
23214621|NCT00636441|64528001|FG003|Overall Study|Adverse Event|0|||
23214622|NCT00636441|64528002|FG004|Overall Study|Adverse Event|0|||
23214623|NCT00636441|64528003|FG005|Overall Study|Adverse Event|1|||
23214624|NCT00636441|64528004|FG006|Overall Study|Adverse Event|0|||
23549399|NCT00717860|65739687|FG001|Overall Study|Clinical adverse experience|9|||
23549400|NCT00717860|65739686|FG000|Overall Study|Laboratory adverse experience|2|||
23549401|NCT00717860|65739687|FG001|Overall Study|Laboratory adverse experience|2|||
23549402|NCT00717860|65739686|FG000|Overall Study|Lack of Efficacy|7|||
23549403|NCT00717860|65739687|FG001|Overall Study|Lack of Efficacy|13|||
23549404|NCT00717860|65739686|FG000|Overall Study|Discontinued for other reason|6|||
23549405|NCT00717860|65739687|FG001|Overall Study|Discontinued for other reason|1|||
23549406|NCT00717860|65739686|FG000|Overall Study|Withdrew consent|7|||
23549407|NCT00717860|65739687|FG001|Overall Study|Withdrew consent|3|||
23135276|NCT04677179|64244291|FG001|Extension Treatment Period|Lack of Efficacy|0|||
23135277|NCT04677179|64244292|FG002|Extension Treatment Period|Lack of Efficacy|0|||
23549408|NCT04313881|65739688|FG000|Overall Study|Death|138|||
23549409|NCT04313881|65739689|FG001|Overall Study|Death|126|||
23549410|NCT04313881|65739688|FG000|Overall Study|Study terminated by sponsor|108|||
23549411|NCT04313881|65739689|FG001|Overall Study|Study terminated by sponsor|129|||
23135278|NCT04677179|64244293|FG003|Extension Treatment Period|Lack of Efficacy|0|||
23135279|NCT04677179|64244294|FG004|Extension Treatment Period|Lack of Efficacy|0|||
23135280|NCT04677179|64244295|FG005|Extension Treatment Period|Lack of Efficacy|0|||
23135281|NCT04677179|64244296|FG006|Extension Treatment Period|Lack of Efficacy|6|||
23135282|NCT04677179|64244297|FG007|Extension Treatment Period|Lack of Efficacy|0|||
23135283|NCT04677179|64244298|FG008|Extension Treatment Period|Lack of Efficacy|0|||
23135284|NCT04677179|64244299|FG009|Extension Treatment Period|Lack of Efficacy|0|||
23135285|NCT04677179|64244290|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
23135286|NCT04677179|64244291|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23135287|NCT04677179|64244292|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
23135288|NCT04677179|64244293|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
23135289|NCT04677179|64244294|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
23135290|NCT04677179|64244295|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
23135291|NCT04677179|64244296|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
23135292|NCT04677179|64244297|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
23135293|NCT04677179|64244298|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
23135294|NCT04677179|64244299|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
23135295|NCT04677179|64244290|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
23135296|NCT04677179|64244291|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
23135297|NCT04677179|64244292|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
23135298|NCT04677179|64244293|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
23135299|NCT04677179|64244294|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
23317550|NCT00993421|64904110|FG006|Overall Study|Adverse Event|1|||
23135300|NCT04677179|64244295|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
23135301|NCT04677179|64244296|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
23214625|NCT00636441|64527998|FG000|Overall Study|Late, ineligible|0|||
23214626|NCT00636441|64527999|FG001|Overall Study|Late, ineligible|0|||
23214627|NCT00636441|64528000|FG002|Overall Study|Late, ineligible|0|||
23317551|NCT00993421|64904104|FG000|Overall Study|Sponsor Decision|36|||
23317552|NCT00993421|64904105|FG001|Overall Study|Sponsor Decision|31|||
23549412|NCT04313881|65739688|FG000|Overall Study|Consent withdrawn|19|||
23549413|NCT04313881|65739689|FG001|Overall Study|Consent withdrawn|15|||
23549414|NCT04313881|65739688|FG000|Overall Study|Reason not Specified|3|||
23549415|NCT04313881|65739689|FG001|Overall Study|Reason not Specified|1|||
23620151|NCT06247488|65994894|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
23620152|NCT06247488|65994895|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
23620153|NCT01592383|65994896|FG000|Overall Study|Adverse Event|1|||
23620154|NCT02382406|65994897|FG000|Study Treatment|Disease Progression|8|||
23620155|NCT02382406|65994898|FG001|Study Treatment|Disease Progression|0|||
23620156|NCT02382406|65994899|FG002|Study Treatment|Disease Progression|20|||
23620157|NCT02382406|65994897|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
23620158|NCT02382406|65994898|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
23620159|NCT02382406|65994899|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
23620160|NCT02382406|65994897|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
23135302|NCT04677179|64244297|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
23135303|NCT04677179|64244298|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
23135304|NCT04677179|64244299|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
23135305|NCT04677179|64244290|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
23135306|NCT04677179|64244291|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
23135307|NCT04677179|64244292|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
23135308|NCT04677179|64244293|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
23135309|NCT04677179|64244294|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
23135310|NCT04677179|64244295|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
23135311|NCT04677179|64244296|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
23135312|NCT04677179|64244297|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
23135313|NCT04677179|64244298|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
23135314|NCT04677179|64244299|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
23135315|NCT04677179|64244290|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23135316|NCT04677179|64244291|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23135317|NCT04677179|64244292|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23135318|NCT04677179|64244293|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23135319|NCT04677179|64244294|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23135320|NCT04677179|64244295|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23135321|NCT04677179|64244296|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23135322|NCT04677179|64244297|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
23135323|NCT04677179|64244298|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
23135324|NCT04677179|64244299|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
23135325|NCT04677179|64244290|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23135326|NCT04677179|64244291|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23135327|NCT04677179|64244292|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23135328|NCT04677179|64244293|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23135329|NCT04677179|64244294|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23135330|NCT04677179|64244295|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23135331|NCT04677179|64244296|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23135332|NCT04677179|64244297|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
23135333|NCT04677179|64244298|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23135334|NCT04677179|64244299|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23317553|NCT00993421|64904106|FG002|Overall Study|Sponsor Decision|28|||
23428580|NCT02528357|65314281|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23620161|NCT02382406|65994898|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
23620162|NCT02382406|65994899|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
23620163|NCT02382406|65994897|FG000|Study Treatment|symptomatic deterioration|1|||
23620164|NCT02382406|65994898|FG001|Study Treatment|symptomatic deterioration|0|||
23620165|NCT02382406|65994899|FG002|Study Treatment|symptomatic deterioration|1|||
23620166|NCT02382406|65994897|FG000|Study Treatment|Death|0|||
23620167|NCT02382406|65994898|FG001|Study Treatment|Death|0|||
23620168|NCT02382406|65994899|FG002|Study Treatment|Death|2|||
23620169|NCT02382406|65994897|FG000|Follow up|Death|11|||
23620170|NCT02382406|65994898|FG001|Follow up|Death|0|||
23620171|NCT02382406|65994899|FG002|Follow up|Death|19|||
23620172|NCT02382406|65994897|FG000|Follow up|Symptomatic deterioration|1|||
23620173|NCT02382406|65994898|FG001|Follow up|Symptomatic deterioration|0|||
23620174|NCT02382406|65994899|FG002|Follow up|Symptomatic deterioration|1|||
23620175|NCT02382406|65994897|FG000|Follow up|Patient Refused Follow-up|1|||
23620176|NCT02382406|65994898|FG001|Follow up|Patient Refused Follow-up|0|||
23620177|NCT02382406|65994899|FG002|Follow up|Patient Refused Follow-up|0|||
23620178|NCT02382406|65994897|FG000|Follow up|Study Terminated|1|||
23620179|NCT02382406|65994898|FG001|Follow up|Study Terminated|0|||
23620180|NCT02382406|65994899|FG002|Follow up|Study Terminated|8|||
23620181|NCT02382406|65994897|FG000|Follow up|Withdrawal by Subject|0|||
23135335|NCT04677179|64244290|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23620182|NCT02382406|65994898|FG001|Follow up|Withdrawal by Subject|0|||
23620183|NCT02382406|65994899|FG002|Follow up|Withdrawal by Subject|2|||
23135336|NCT04677179|64244291|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23135337|NCT04677179|64244292|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23135338|NCT04677179|64244293|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23620184|NCT00451555|65994900|FG000|Overall Study|Protocol Violation|2|||
23428581|NCT02528357|65314282|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
23428582|NCT02528357|65314283|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428583|NCT02528357|65314284|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428584|NCT02528357|65314285|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428585|NCT02528357|65314286|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428586|NCT02528357|65314287|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
23428587|NCT02528357|65314269|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428588|NCT02528357|65314270|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428589|NCT02528357|65314271|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428590|NCT02528357|65314272|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428591|NCT02528357|65314273|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428592|NCT02528357|65314274|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428593|NCT02528357|65314275|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428594|NCT02528357|65314276|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428595|NCT02528357|65314277|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428596|NCT02528357|65314278|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428597|NCT02528357|65314279|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
23428598|NCT02528357|65314280|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428599|NCT02528357|65314281|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
23428600|NCT02528357|65314282|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
23428601|NCT02528357|65314283|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
23428602|NCT02528357|65314284|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428603|NCT02528357|65314285|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23549416|NCT01128413|65739690|FG000|Overall Study|Withdrawal by Subject|1|||
23549417|NCT01128413|65739691|FG001|Overall Study|Withdrawal by Subject|0|||
23549418|NCT01128413|65739690|FG000|Overall Study|NICOM Monitor Problems|2|||
23549419|NCT01128413|65739691|FG001|Overall Study|NICOM Monitor Problems|1|||
23549420|NCT01128413|65739690|FG000|Overall Study|Pt made DNR|1|||
23620185|NCT00451555|65994901|FG001|Overall Study|Protocol Violation|2|||
23620186|NCT00451555|65994900|FG000|Overall Study|Adverse Event|3|||
23620187|NCT00451555|65994901|FG001|Overall Study|Adverse Event|1|||
23620188|NCT00451555|65994900|FG000|Overall Study|Withdrawal by Subject|6|||
23620189|NCT00451555|65994901|FG001|Overall Study|Withdrawal by Subject|0|||
23620190|NCT00451555|65994900|FG000|Overall Study|Physician Decision|2|||
23620191|NCT00451555|65994901|FG001|Overall Study|Physician Decision|1|||
23620192|NCT02287883|65994902|FG000|Overall Study|Death|8|||
23620193|NCT02287883|65994903|FG001|Overall Study|Death|7|||
23620194|NCT02287883|65994902|FG000|Overall Study|No longer eligible|222|||
23620195|NCT02287883|65994903|FG001|Overall Study|No longer eligible|182|||
23620196|NCT02287883|65994902|FG000|Overall Study|Non-response to survey|229|||
23620197|NCT02287883|65994903|FG001|Overall Study|Non-response to survey|237|||
23620198|NCT01091519|65994904|FG000|Overall Study|Adverse Event|12|||
23620199|NCT01091519|65994905|FG001|Overall Study|Adverse Event|16|||
23620200|NCT01091519|65994904|FG000|Overall Study|Death|1|||
23620201|NCT01091519|65994905|FG001|Overall Study|Death|0|||
23620202|NCT01091519|65994904|FG000|Overall Study|Lack of Efficacy|16|||
23620203|NCT01091519|65994905|FG001|Overall Study|Lack of Efficacy|19|||
23620204|NCT01091519|65994904|FG000|Overall Study|Lost to Follow-up|14|||
23620205|NCT01091519|65994905|FG001|Overall Study|Lost to Follow-up|24|||
23620206|NCT01091519|65994904|FG000|Overall Study|Withdrawal by Subject|2|||
23135339|NCT04677179|64244294|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23428604|NCT02528357|65314286|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23549421|NCT01128413|65739691|FG001|Overall Study|Pt made DNR|0|||
23549422|NCT01109992|65739693|FG000|Overall Study|Withdrawal by Subject|0|||
23549423|NCT01109992|65739694|FG001|Overall Study|Withdrawal by Subject|1|||
23549424|NCT01109992|65739693|FG000|Overall Study|Movement during rest scan.|0|||
23549425|NCT01109992|65739694|FG001|Overall Study|Movement during rest scan.|1|||
23549426|NCT02862106|65739695|FG000|Overall Study|Adverse Event|4|||
23620207|NCT01091519|65994905|FG001|Overall Study|Withdrawal by Subject|2|||
23620208|NCT01091519|65994904|FG000|Overall Study|Other|6|||
23135340|NCT04677179|64244295|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23549427|NCT02862106|65739696|FG001|Overall Study|Adverse Event|0|||
23549428|NCT02862106|65739695|FG000|Overall Study|Protocol Violation|16|||
23549429|NCT02862106|65739696|FG001|Overall Study|Protocol Violation|1|||
23549430|NCT02862106|65739695|FG000|Overall Study|Lost to Follow-up|15|||
23549431|NCT02862106|65739696|FG001|Overall Study|Lost to Follow-up|5|||
23620209|NCT01091519|65994905|FG001|Overall Study|Other|8|||
23620210|NCT01091519|65994904|FG000|Overall Study|Randomized not treated|4|||
23620211|NCT01091519|65994905|FG001|Overall Study|Randomized not treated|4|||
23620212|NCT03015181|65994910|FG000|Overall Study|Enrolled, but product never administered|1|||
23620213|NCT03015181|65994911|FG001|Overall Study|Enrolled, but product never administered|0|||
23620214|NCT03015181|65994912|FG002|Overall Study|Enrolled, but product never administered|0|||
23428605|NCT02528357|65314287|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
23428606|NCT02528357|65314269|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428607|NCT02528357|65314270|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428608|NCT02528357|65314271|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428609|NCT02528357|65314272|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428610|NCT02528357|65314273|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428611|NCT02528357|65314274|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428612|NCT02528357|65314275|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428613|NCT02528357|65314276|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428614|NCT02528357|65314277|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428615|NCT02528357|65314278|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428616|NCT02528357|65314279|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428617|NCT02528357|65314280|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
23428618|NCT02528357|65314281|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
23549432|NCT02862106|65739695|FG000|Overall Study|Withdrawal by Subject|2|||
23549433|NCT02862106|65739696|FG001|Overall Study|Withdrawal by Subject|0|||
23549434|NCT02862106|65739695|FG000|Overall Study|Subjects moved to other city|1|||
23549435|NCT02862106|65739696|FG001|Overall Study|Subjects moved to other city|0|||
23549436|NCT02605954|65739697|FG000|Overall Study|Adverse Event|5|||
23549437|NCT02605954|65739698|FG001|Overall Study|Adverse Event|1|||
23549438|NCT02605954|65739697|FG000|Overall Study|Investigator's Discretion|1|||
23549439|NCT02605954|65739698|FG001|Overall Study|Investigator's Discretion|0|||
23549440|NCT02605954|65739697|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23549441|NCT02605954|65739698|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23549442|NCT02605954|65739697|FG000|Overall Study|Withdrew Consent|2|||
23549443|NCT02605954|65739698|FG001|Overall Study|Withdrew Consent|2|||
23549444|NCT02605954|65739697|FG000|Overall Study|Lost to Follow-up|3|||
23549445|NCT02605954|65739698|FG001|Overall Study|Lost to Follow-up|0|||
23549446|NCT02605954|65739697|FG000|Overall Study|Randomized but not treated|0|||
23549447|NCT02605954|65739698|FG001|Overall Study|Randomized but not treated|1|||
23549448|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
23549449|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
23135341|NCT04677179|64244296|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23135342|NCT04677179|64244297|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
23135343|NCT04677179|64244298|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
23135344|NCT04677179|64244299|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23135345|NCT04677179|64244290|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23135346|NCT04677179|64244291|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23135347|NCT04677179|64244292|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23135348|NCT04677179|64244293|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23135349|NCT04677179|64244294|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23135350|NCT04677179|64244295|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23135351|NCT04677179|64244296|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
23135352|NCT04677179|64244297|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
23428619|NCT02528357|65314282|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428620|NCT02528357|65314283|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428621|NCT02528357|65314284|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428622|NCT02528357|65314285|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428623|NCT02528357|65314286|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428624|NCT02528357|65314287|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428625|NCT02528357|65314269|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428626|NCT02528357|65314270|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428627|NCT02528357|65314271|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428628|NCT02528357|65314272|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428629|NCT02528357|65314273|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428630|NCT02528357|65314274|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428631|NCT02528357|65314275|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428632|NCT02528357|65314276|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23549450|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
23549451|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
23428633|NCT02528357|65314277|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428634|NCT02528357|65314278|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428635|NCT02528357|65314279|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428636|NCT02528357|65314280|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428637|NCT02528357|65314281|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428638|NCT02528357|65314282|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428639|NCT02528357|65314283|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428640|NCT02528357|65314284|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23549452|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
23549453|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
23549454|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
23620215|NCT03015181|65994913|FG003|Overall Study|Enrolled, but product never administered|0|||
23620216|NCT03015181|65994914|FG004|Overall Study|Enrolled, but product never administered|0|||
23620217|NCT03015181|65994915|FG005|Overall Study|Enrolled, but product never administered|0|||
23620218|NCT03015181|65994916|FG006|Overall Study|Enrolled, but product never administered|0|||
23620219|NCT03015181|65994910|FG000|Overall Study|Withdrawal by Subject|0|||
23620220|NCT03015181|65994911|FG001|Overall Study|Withdrawal by Subject|0|||
23620221|NCT03015181|65994912|FG002|Overall Study|Withdrawal by Subject|0|||
23620222|NCT03015181|65994913|FG003|Overall Study|Withdrawal by Subject|0|||
23620223|NCT03015181|65994914|FG004|Overall Study|Withdrawal by Subject|0|||
23620224|NCT03015181|65994915|FG005|Overall Study|Withdrawal by Subject|1|||
23620225|NCT03015181|65994916|FG006|Overall Study|Withdrawal by Subject|0|||
23620226|NCT03015181|65994910|FG000|Overall Study|Physician Decision|0|||
23620227|NCT03015181|65994911|FG001|Overall Study|Physician Decision|0|||
23620228|NCT03015181|65994912|FG002|Overall Study|Physician Decision|0|||
23620229|NCT03015181|65994913|FG003|Overall Study|Physician Decision|0|||
23620230|NCT03015181|65994914|FG004|Overall Study|Physician Decision|0|||
23549455|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
23549456|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
23620231|NCT03015181|65994915|FG005|Overall Study|Physician Decision|0|||
23620232|NCT03015181|65994916|FG006|Overall Study|Physician Decision|1|||
23620233|NCT00690378|65994917|FG000|Overall Study|Adverse Event|1|||
23620234|NCT00690378|65994918|FG001|Overall Study|Adverse Event|0|||
23620235|NCT00690378|65994917|FG000|Overall Study|Withdrawal by Subject|2|||
23620236|NCT00690378|65994918|FG001|Overall Study|Withdrawal by Subject|0|||
23620237|NCT00690378|65994917|FG000|Overall Study|Protocol Violation|1|||
23620238|NCT00690378|65994918|FG001|Overall Study|Protocol Violation|0|||
23620239|NCT00690378|65994917|FG000|Overall Study|Lost to Follow-up|2|||
23620240|NCT00690378|65994918|FG001|Overall Study|Lost to Follow-up|3|||
23135353|NCT04677179|64244298|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
23135354|NCT04677179|64244299|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
23135355|NCT03261700|64244314|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
23135356|NCT03261700|64244315|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
23135357|NCT00910039|64244317|FG000|Overall Study|Physician Decision|1|||
23135358|NCT00266227|64244321|FG000|Initial Treatment|Adverse Event|0|||
23135359|NCT00266227|64244322|FG001|Initial Treatment|Adverse Event|0|||
23135360|NCT00266227|64244323|FG002|Initial Treatment|Adverse Event|13|||
23135361|NCT00266227|64244321|FG000|Initial Treatment|Lost to Follow-up|0|||
23549457|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
23549458|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
23549459|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
23549460|NCT00293267|65739705|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
23549461|NCT00293267|65739706|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
23549462|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
23549463|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
23549464|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
23549465|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
23549466|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
23549467|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
23549468|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
23549469|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
23549470|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Death|3|||
23549471|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Death|0|||
23620241|NCT00690378|65994917|FG000|Overall Study|Did not meet inc/exc criteria|13|||
23620242|NCT00690378|65994918|FG001|Overall Study|Did not meet inc/exc criteria|11|||
23620243|NCT00690378|65994917|FG000|Overall Study|Social problem|1|||
23620244|NCT00690378|65994918|FG001|Overall Study|Social problem|0|||
23620245|NCT02720081|65994922|FG000|Overall Study|Adverse Event|0|||
23620246|NCT02720081|65994923|FG001|Overall Study|Adverse Event|3|||
23620247|NCT02720081|65994922|FG000|Overall Study|Protocol Violation|4|||
23428641|NCT02528357|65314285|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
23428642|NCT02528357|65314286|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428643|NCT02528357|65314287|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
23428644|NCT02528357|65314269|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428645|NCT02528357|65314270|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428646|NCT02528357|65314271|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428647|NCT02528357|65314272|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428648|NCT02528357|65314273|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428649|NCT02528357|65314274|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428650|NCT02528357|65314275|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428651|NCT02528357|65314276|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428652|NCT02528357|65314277|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428653|NCT02528357|65314278|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428654|NCT02528357|65314279|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428655|NCT02528357|65314280|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428656|NCT02528357|65314281|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428657|NCT02528357|65314282|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428658|NCT02528357|65314283|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428659|NCT02528357|65314284|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
23428660|NCT02528357|65314285|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
23428661|NCT02528357|65314286|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
23428662|NCT02528357|65314287|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
23428663|NCT02278614|65314288|FG000|Overall Study|Withdrawal by Subject|3|||
23428664|NCT02278614|65314289|FG001|Overall Study|Withdrawal by Subject|5|||
23428665|NCT02278614|65314288|FG000|Overall Study|Adverse Event|1|||
23428666|NCT02278614|65314289|FG001|Overall Study|Adverse Event|0|||
23428667|NCT02278614|65314288|FG000|Overall Study|left eye was not eligible|1|||
23428668|NCT02278614|65314289|FG001|Overall Study|left eye was not eligible|0|||
23428669|NCT02642965|65314290|FG000|Overall Study|Lack of Efficacy|4|||
23428670|NCT02642965|65314290|FG000|Overall Study|Physician Decision|9|||
23428671|NCT04047420|65314291|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
23428672|NCT04047420|65314291|FG000|Washout Period|Refused Participation|2|||
23428673|NCT00661388|65314293|FG000|Overall Study|Adverse Event|14|||
23428674|NCT00661388|65314293|FG000|Overall Study|Protocol Violation|7|||
23428675|NCT00661388|65314293|FG000|Overall Study|Renal transplantation|1|||
23428676|NCT00661388|65314293|FG000|Overall Study|Dialysis initiation|1|||
23428677|NCT00661388|65314293|FG000|Overall Study|Administrative reasons|1|||
23428678|NCT00693472|65314294|FG000|Part 1|Adverse Event|1|||
23428679|NCT00693472|65314295|FG001|Part 1|Adverse Event|1|||
23428680|NCT00693472|65314296|FG002|Part 1|Adverse Event|0|||
23428681|NCT00693472|65314297|FG003|Part 1|Adverse Event|0|||
23428682|NCT00693472|65314294|FG000|Part 1|Lost to Follow-up|0|||
23428683|NCT00693472|65314295|FG001|Part 1|Lost to Follow-up|1|||
23428684|NCT00693472|65314296|FG002|Part 1|Lost to Follow-up|0|||
23428685|NCT00693472|65314297|FG003|Part 1|Lost to Follow-up|0|||
23428686|NCT00693472|65314294|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
23428687|NCT00693472|65314295|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
23428688|NCT00693472|65314296|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
23428689|NCT00693472|65314297|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
23428690|NCT00693472|65314294|FG000|Part 2|Adverse Event|0|||
23428691|NCT00693472|65314295|FG001|Part 2|Adverse Event|0|||
23428692|NCT00693472|65314296|FG002|Part 2|Adverse Event|1|||
23428693|NCT00693472|65314297|FG003|Part 2|Adverse Event|0|||
23428694|NCT00693472|65314294|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
23428695|NCT00693472|65314295|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
23428696|NCT00693472|65314296|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
23428697|NCT00693472|65314297|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
23428698|NCT00831701|65314306|FG000|Overall Study|Withdrawal by Subject|2|||
23428699|NCT00831701|65314307|FG001|Overall Study|Withdrawal by Subject|0|||
23428700|NCT00831701|65314306|FG000|Overall Study|Stone expulsion before first medication|2|||
23428701|NCT00831701|65314307|FG001|Overall Study|Stone expulsion before first medication|2|||
23428702|NCT00831701|65314306|FG000|Overall Study|Lost to Follow-up|1|||
23428703|NCT00831701|65314307|FG001|Overall Study|Lost to Follow-up|3|||
23428704|NCT03458702|65314308|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
23428705|NCT03458702|65314309|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
23428706|NCT03458702|65314308|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
23428707|NCT03458702|65314309|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
23428708|NCT03662659|65314315|FG000|Pre-treatment|Participant no longer met study criteria|1|||
23428709|NCT03662659|65314316|FG001|Pre-treatment|Participant no longer met study criteria|1|||
23428710|NCT03662659|65314315|FG000|Pre-treatment|Other reasons|1|||
23428711|NCT03662659|65314316|FG001|Pre-treatment|Other reasons|0|||
23428712|NCT03662659|65314315|FG000|Treatment|Completed Treatment|0|||
23428713|NCT03662659|65314316|FG001|Treatment|Completed Treatment|3|||
23428714|NCT03662659|65314315|FG000|Treatment|Disease Progression|69|||
23428715|NCT03662659|65314316|FG001|Treatment|Disease Progression|78|||
23428716|NCT03662659|65314315|FG000|Treatment|Study Drug Toxicity|18|||
23428717|NCT03662659|65314316|FG001|Treatment|Study Drug Toxicity|8|||
23428718|NCT03662659|65314315|FG000|Treatment|Death|12|||
23428719|NCT03662659|65314316|FG001|Treatment|Death|7|||
23428720|NCT03662659|65314315|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
23428721|NCT03662659|65314316|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
23428722|NCT03662659|65314315|FG000|Treatment|Withdrawal by Subject|1|||
23428723|NCT03662659|65314316|FG001|Treatment|Withdrawal by Subject|1|||
23428724|NCT03662659|65314315|FG000|Treatment|Poor/Non-compliance|1|||
23428725|NCT03662659|65314316|FG001|Treatment|Poor/Non-compliance|0|||
23428726|NCT03662659|65314315|FG000|Treatment|Participant no longer meets study criteria|1|||
23428727|NCT03662659|65314316|FG001|Treatment|Participant no longer meets study criteria|0|||
23428728|NCT03662659|65314315|FG000|Treatment|Other reasons|6|||
23428729|NCT03662659|65314316|FG001|Treatment|Other reasons|5|||
23428730|NCT02788201|65314318|FG000|Overall Study|Death|1|||
23428731|NCT02788201|65314319|FG001|Overall Study|Death|1|||
23428732|NCT02788201|65314320|FG002|Overall Study|Death|1|||
23135362|NCT00266227|64244322|FG001|Initial Treatment|Lost to Follow-up|0|||
23135363|NCT00266227|64244323|FG002|Initial Treatment|Lost to Follow-up|6|||
23135364|NCT00266227|64244321|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
23135365|NCT00266227|64244322|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
23135366|NCT00266227|64244323|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
23135367|NCT00266227|64244321|FG000|Initial Treatment|Physician decision to withdraw|0|||
23135368|NCT00266227|64244322|FG001|Initial Treatment|Physician decision to withdraw|0|||
23135369|NCT00266227|64244323|FG002|Initial Treatment|Physician decision to withdraw|12|||
23135370|NCT00266227|64244321|FG000|Initial Treatment|Pregnancy|0|||
23135371|NCT00266227|64244322|FG001|Initial Treatment|Pregnancy|0|||
23135372|NCT00266227|64244323|FG002|Initial Treatment|Pregnancy|1|||
23135373|NCT00266227|64244321|FG000|Retreatment: Up to Week 48|Death|1|||
23135374|NCT00266227|64244322|FG001|Retreatment: Up to Week 48|Death|0|||
23135375|NCT00266227|64244323|FG002|Retreatment: Up to Week 48|Death|0|||
23135376|NCT00266227|64244321|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
23135377|NCT00266227|64244322|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
23428733|NCT02788201|65314321|FG003|Overall Study|Death|1|||
23428734|NCT02788201|65314322|FG004|Overall Study|Death|0|||
23428735|NCT02788201|65314323|FG005|Overall Study|Death|1|||
23428736|NCT02788201|65314318|FG000|Overall Study|Ineligible|0|||
23428737|NCT02788201|65314319|FG001|Overall Study|Ineligible|0|||
23428738|NCT02788201|65314320|FG002|Overall Study|Ineligible|0|||
23428739|NCT02788201|65314321|FG003|Overall Study|Ineligible|0|||
23549472|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
23549473|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
23549474|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
23549475|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
23549476|NCT00293267|65739705|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
23549477|NCT00293267|65739706|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
23549478|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
23549479|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
23549480|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
23549481|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
23549482|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
23549483|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
23549484|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
23549485|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
23549486|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
23549487|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
23549488|NCT00293267|65739705|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
23549489|NCT00293267|65739706|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
23549490|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
23549491|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
23428740|NCT02788201|65314322|FG004|Overall Study|Ineligible|0|||
23135378|NCT00266227|64244323|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
23135379|NCT00266227|64244321|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
23135380|NCT00266227|64244322|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
23428741|NCT02788201|65314323|FG005|Overall Study|Ineligible|1|||
23135381|NCT00266227|64244323|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
23135382|NCT00266227|64244321|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
23135383|NCT00266227|64244322|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
23135384|NCT00266227|64244323|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
23135385|NCT00266227|64244321|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
23135386|NCT00266227|64244322|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
23135387|NCT00266227|64244323|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
23135388|NCT00266227|64244321|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
23135389|NCT00266227|64244322|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
23135390|NCT00266227|64244323|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
23135391|NCT00266227|64244321|FG000|Retreatment: Week 48 to Week 72|Death|1|||
23135392|NCT00266227|64244322|FG001|Retreatment: Week 48 to Week 72|Death|1|||
23135393|NCT00266227|64244323|FG002|Retreatment: Week 48 to Week 72|Death|0|||
23135394|NCT00266227|64244321|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
23135395|NCT00266227|64244322|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
23135396|NCT00266227|64244323|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
23135397|NCT00266227|64244321|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
23135398|NCT00266227|64244322|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
23135399|NCT00266227|64244323|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
23135400|NCT00266227|64244321|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
23135401|NCT00266227|64244322|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
23135402|NCT00266227|64244323|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
23135403|NCT00266227|64244321|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
23135404|NCT00266227|64244322|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
23135405|NCT00266227|64244323|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
23135406|NCT00735475|64244328|FG000|Overall Study|Adverse Event|0|||
23135407|NCT00735475|64244329|FG001|Overall Study|Adverse Event|1|||
23135408|NCT00735475|64244328|FG000|Overall Study|Death|1|||
23135409|NCT00735475|64244329|FG001|Overall Study|Death|1|||
23135410|NCT00735475|64244328|FG000|Overall Study|Lost to Follow-up|3|||
23135411|NCT00735475|64244329|FG001|Overall Study|Lost to Follow-up|3|||
23135412|NCT00735475|64244328|FG000|Overall Study|Physician Decision|0|||
23135413|NCT00735475|64244329|FG001|Overall Study|Physician Decision|1|||
23135414|NCT00735475|64244328|FG000|Overall Study|Withdrawal by Subject|4|||
23135415|NCT00735475|64244329|FG001|Overall Study|Withdrawal by Subject|5|||
23135416|NCT04540887|64244330|FG000|Overall Study|Withdrawal by Subject|2|||
23135417|NCT02008877|64244331|FG000|Overall Study|Inevaluable|0|||
23549492|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
23549493|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
23549494|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
23549495|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
23549496|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
23549497|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
23549498|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
23549499|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
23549500|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
23549501|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
23549502|NCT00293267|65739705|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
23549503|NCT00293267|65739706|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
23549504|NCT01260350|65739708|FG000|Overall Study|Lack of Efficacy|0|||
23549505|NCT01260350|65739709|FG001|Overall Study|Lack of Efficacy|0|||
23549506|NCT01260350|65739710|FG002|Overall Study|Lack of Efficacy|0|||
23549507|NCT01260350|65739711|FG003|Overall Study|Lack of Efficacy|0|||
23549508|NCT01260350|65739712|FG004|Overall Study|Lack of Efficacy|0|||
23549509|NCT01260350|65739713|FG005|Overall Study|Lack of Efficacy|0|||
23549510|NCT01260350|65739714|FG006|Overall Study|Lack of Efficacy|0|||
23549511|NCT01260350|65739715|FG007|Overall Study|Lack of Efficacy|0|||
23549512|NCT01260350|65739716|FG008|Overall Study|Lack of Efficacy|0|||
23549513|NCT01260350|65739717|FG009|Overall Study|Lack of Efficacy|0|||
23549514|NCT01260350|65739718|FG010|Overall Study|Lack of Efficacy|0|||
23549515|NCT01260350|65739719|FG011|Overall Study|Lack of Efficacy|0|||
23549516|NCT01260350|65739720|FG012|Overall Study|Lack of Efficacy|0|||
23549517|NCT01260350|65739721|FG013|Overall Study|Lack of Efficacy|0|||
23549518|NCT01260350|65739722|FG014|Overall Study|Lack of Efficacy|0|||
23549519|NCT01260350|65739723|FG015|Overall Study|Lack of Efficacy|0|||
23549520|NCT01260350|65739724|FG016|Overall Study|Lack of Efficacy|0|||
23549521|NCT01260350|65739725|FG017|Overall Study|Lack of Efficacy|1|||
23549522|NCT01260350|65739726|FG018|Overall Study|Lack of Efficacy|0|||
23549523|NCT01260350|65739727|FG019|Overall Study|Lack of Efficacy|0|||
23549524|NCT01260350|65739728|FG020|Overall Study|Lack of Efficacy|3|||
23549525|NCT01260350|65739729|FG021|Overall Study|Lack of Efficacy|0|||
23549526|NCT01260350|65739708|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23428742|NCT02788201|65314318|FG000|Overall Study|Withdrawal by Subject|0|||
23428743|NCT02788201|65314319|FG001|Overall Study|Withdrawal by Subject|0|||
23428744|NCT02788201|65314320|FG002|Overall Study|Withdrawal by Subject|0|||
23428745|NCT02788201|65314321|FG003|Overall Study|Withdrawal by Subject|0|||
23428746|NCT02788201|65314322|FG004|Overall Study|Withdrawal by Subject|0|||
23428747|NCT02788201|65314323|FG005|Overall Study|Withdrawal by Subject|1|||
23428748|NCT00581828|65314324|FG000|Overall Study|Protocol Violation|1|||
23428749|NCT02809053|65314326|FG000|Overall Study|Death|0|||
23428750|NCT02809053|65314327|FG001|Overall Study|Death|1|||
23428751|NCT02809053|65314326|FG000|Overall Study|Lost to Follow-up|3|||
23428752|NCT02809053|65314327|FG001|Overall Study|Lost to Follow-up|1|||
23428753|NCT02809053|65314326|FG000|Overall Study|Withdrawal by Subject|2|||
23428754|NCT02809053|65314327|FG001|Overall Study|Withdrawal by Subject|3|||
23428755|NCT02809053|65314326|FG000|Overall Study|Disease Progression|2|||
23428756|NCT02809053|65314327|FG001|Overall Study|Disease Progression|1|||
23428757|NCT01100528|65314330|FG000|Overall Study|Death|1|||
23428758|NCT01100528|65314330|FG000|Overall Study|Withdrawal by Subject|2|||
23428759|NCT02616393|65314331|FG000|Overall Study|Death|5|||
23428760|NCT02616393|65314332|FG001|Overall Study|Death|12|||
23428761|NCT02616393|65314333|FG002|Overall Study|Death|1|||
23428762|NCT02616393|65314331|FG000|Overall Study|Termination by Sponsor|4|||
23428763|NCT02616393|65314332|FG001|Overall Study|Termination by Sponsor|5|||
23428764|NCT02616393|65314333|FG002|Overall Study|Termination by Sponsor|2|||
23428765|NCT02616393|65314331|FG000|Overall Study|Other|3|||
23428766|NCT02616393|65314332|FG001|Overall Study|Other|0|||
23428767|NCT02616393|65314333|FG002|Overall Study|Other|0|||
23428768|NCT02616393|65314331|FG000|Overall Study|Withdrawal by Subject|1|||
23428769|NCT02616393|65314332|FG001|Overall Study|Withdrawal by Subject|1|||
23428770|NCT02616393|65314333|FG002|Overall Study|Withdrawal by Subject|0|||
23428771|NCT02616393|65314331|FG000|Overall Study|Lost to Follow-up|0|||
23428772|NCT02616393|65314332|FG001|Overall Study|Lost to Follow-up|2|||
23428773|NCT02616393|65314333|FG002|Overall Study|Lost to Follow-up|0|||
23428774|NCT02654236|65314338|FG000|Overall Study|Withdrawal by Subject|0|||
23428775|NCT02654236|65314339|FG001|Overall Study|Withdrawal by Subject|0|||
23428776|NCT02654236|65314340|FG002|Overall Study|Withdrawal by Subject|2|||
23428777|NCT00459537|65314341|FG000|Overall Study|Adverse Event|1|||
23428778|NCT00459537|65314342|FG001|Overall Study|Adverse Event|6|||
23428779|NCT00459537|65314341|FG000|Overall Study|Lack of Efficacy|10|||
23549527|NCT01260350|65739709|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549528|NCT01260350|65739710|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549529|NCT01260350|65739711|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549530|NCT01260350|65739712|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549531|NCT01260350|65739713|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549532|NCT01260350|65739714|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549533|NCT01260350|65739715|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23214628|NCT00636441|64528001|FG003|Overall Study|Late, ineligible|0|||
23214629|NCT00636441|64528002|FG004|Overall Study|Late, ineligible|0|||
23214630|NCT00636441|64528003|FG005|Overall Study|Late, ineligible|0|||
23214631|NCT00636441|64528004|FG006|Overall Study|Late, ineligible|1|||
23214632|NCT00636441|64527998|FG000|Overall Study|Screen Failure|0|||
23214633|NCT00636441|64527999|FG001|Overall Study|Screen Failure|0|||
23214634|NCT00636441|64528000|FG002|Overall Study|Screen Failure|0|||
23549534|NCT01260350|65739716|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
23549535|NCT01260350|65739717|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549536|NCT01260350|65739718|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549537|NCT01260350|65739719|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549538|NCT01260350|65739720|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549539|NCT01260350|65739721|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549540|NCT01260350|65739722|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23135418|NCT02008877|64244332|FG001|Overall Study|Inevaluable|1|||
23135419|NCT02008877|64244333|FG002|Overall Study|Inevaluable|0|||
23135420|NCT03466073|64244337|FG000|Overall Study|Death|1|||
23135421|NCT03466073|64244338|FG001|Overall Study|Death|0|||
23135422|NCT03466073|64244339|FG002|Overall Study|Death|0|||
23135423|NCT03466073|64244340|FG003|Overall Study|Death|0|||
23135424|NCT03466073|64244341|FG004|Overall Study|Death|0|||
23135425|NCT03466073|64244342|FG005|Overall Study|Death|1|||
23135426|NCT01342341|64244343|FG000|Overall Study|Lost to Follow-up|4|||
23135427|NCT01342341|64244344|FG001|Overall Study|Lost to Follow-up|4|||
23214635|NCT00636441|64528001|FG003|Overall Study|Screen Failure|0|||
23428780|NCT00459537|65314342|FG001|Overall Study|Lack of Efficacy|11|||
23428781|NCT00459537|65314341|FG000|Overall Study|Withdrawal by Subject|20|||
23428782|NCT00459537|65314342|FG001|Overall Study|Withdrawal by Subject|26|||
23428783|NCT00459537|65314341|FG000|Overall Study|Lost to Follow-up|27|||
23428784|NCT00459537|65314342|FG001|Overall Study|Lost to Follow-up|30|||
23549541|NCT01260350|65739723|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23135428|NCT01395888|64244346|FG000|2-week Run-in Period|Adverse Event|2|||
23214636|NCT00636441|64528002|FG004|Overall Study|Screen Failure|0|||
23428785|NCT00459537|65314341|FG000|Overall Study|Administrative problems|3|||
23428786|NCT00459537|65314342|FG001|Overall Study|Administrative problems|0|||
23428787|NCT00459537|65314341|FG000|Overall Study|Protocol Violation|4|||
23428788|NCT00459537|65314342|FG001|Overall Study|Protocol Violation|3|||
23428789|NCT00459537|65314341|FG000|Overall Study|Missing|1|||
23428790|NCT00459537|65314342|FG001|Overall Study|Missing|0|||
23428791|NCT02124772|65314343|FG000|Overall Study|Lack of Efficacy|2|||
23428792|NCT02124772|65314344|FG001|Overall Study|Lack of Efficacy|0|||
23428793|NCT02124772|65314345|FG002|Overall Study|Lack of Efficacy|0|||
23428794|NCT02124772|65314346|FG003|Overall Study|Lack of Efficacy|1|||
23428795|NCT02124772|65314347|FG004|Overall Study|Lack of Efficacy|2|||
23428796|NCT02124772|65314348|FG005|Overall Study|Lack of Efficacy|3|||
23428797|NCT02124772|65314349|FG006|Overall Study|Lack of Efficacy|0|||
23428798|NCT02124772|65314350|FG007|Overall Study|Lack of Efficacy|2|||
23428799|NCT02124772|65314351|FG008|Overall Study|Lack of Efficacy|0|||
23428800|NCT02124772|65314352|FG009|Overall Study|Lack of Efficacy|1|||
23428801|NCT02124772|65314353|FG010|Overall Study|Lack of Efficacy|0|||
23428802|NCT02124772|65314354|FG011|Overall Study|Lack of Efficacy|0|||
23428803|NCT02124772|65314355|FG012|Overall Study|Lack of Efficacy|1|||
23428804|NCT02124772|65314343|FG000|Overall Study|Adverse Event|1|||
23428805|NCT02124772|65314344|FG001|Overall Study|Adverse Event|4|||
23428806|NCT02124772|65314345|FG002|Overall Study|Adverse Event|1|||
23549542|NCT01260350|65739724|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549543|NCT01260350|65739725|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549544|NCT01260350|65739726|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549545|NCT01260350|65739727|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549546|NCT01260350|65739728|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23428807|NCT02124772|65314346|FG003|Overall Study|Adverse Event|5|||
23428808|NCT02124772|65314347|FG004|Overall Study|Adverse Event|2|||
23428809|NCT02124772|65314348|FG005|Overall Study|Adverse Event|1|||
23428810|NCT02124772|65314349|FG006|Overall Study|Adverse Event|1|||
23428811|NCT02124772|65314350|FG007|Overall Study|Adverse Event|5|||
23428812|NCT02124772|65314351|FG008|Overall Study|Adverse Event|0|||
23428813|NCT02124772|65314352|FG009|Overall Study|Adverse Event|3|||
23428814|NCT02124772|65314353|FG010|Overall Study|Adverse Event|1|||
23428815|NCT02124772|65314354|FG011|Overall Study|Adverse Event|3|||
23428816|NCT02124772|65314355|FG012|Overall Study|Adverse Event|1|||
23428817|NCT02124772|65314343|FG000|Overall Study|Withdrawal consent|0|||
23428818|NCT02124772|65314344|FG001|Overall Study|Withdrawal consent|1|||
23428819|NCT02124772|65314345|FG002|Overall Study|Withdrawal consent|1|||
23428820|NCT02124772|65314346|FG003|Overall Study|Withdrawal consent|1|||
23428821|NCT02124772|65314347|FG004|Overall Study|Withdrawal consent|0|||
23428822|NCT02124772|65314348|FG005|Overall Study|Withdrawal consent|1|||
23428823|NCT02124772|65314349|FG006|Overall Study|Withdrawal consent|1|||
23428824|NCT02124772|65314350|FG007|Overall Study|Withdrawal consent|0|||
23428825|NCT02124772|65314351|FG008|Overall Study|Withdrawal consent|0|||
23428826|NCT02124772|65314352|FG009|Overall Study|Withdrawal consent|1|||
23428827|NCT02124772|65314353|FG010|Overall Study|Withdrawal consent|0|||
23428828|NCT02124772|65314354|FG011|Overall Study|Withdrawal consent|1|||
23428829|NCT02124772|65314355|FG012|Overall Study|Withdrawal consent|0|||
23428830|NCT02124772|65314343|FG000|Overall Study|Investigator discretion|0|||
23428831|NCT02124772|65314344|FG001|Overall Study|Investigator discretion|2|||
23428832|NCT02124772|65314345|FG002|Overall Study|Investigator discretion|2|||
23428833|NCT02124772|65314346|FG003|Overall Study|Investigator discretion|1|||
23428834|NCT02124772|65314347|FG004|Overall Study|Investigator discretion|1|||
23428835|NCT02124772|65314348|FG005|Overall Study|Investigator discretion|0|||
23428836|NCT02124772|65314349|FG006|Overall Study|Investigator discretion|1|||
23428837|NCT02124772|65314350|FG007|Overall Study|Investigator discretion|0|||
23428838|NCT02124772|65314351|FG008|Overall Study|Investigator discretion|0|||
23428839|NCT02124772|65314352|FG009|Overall Study|Investigator discretion|1|||
23428840|NCT02124772|65314353|FG010|Overall Study|Investigator discretion|0|||
23428841|NCT02124772|65314354|FG011|Overall Study|Investigator discretion|1|||
23428842|NCT02124772|65314355|FG012|Overall Study|Investigator discretion|0|||
23428843|NCT02124772|65314343|FG000|Overall Study|Progressive disease|0|||
23428844|NCT02124772|65314344|FG001|Overall Study|Progressive disease|0|||
23428845|NCT02124772|65314345|FG002|Overall Study|Progressive disease|0|||
23549547|NCT01260350|65739729|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
23549548|NCT01392560|65739730|FG000|Overall Study|Adverse Event|2|||
23428846|NCT02124772|65314346|FG003|Overall Study|Progressive disease|0|||
23428847|NCT02124772|65314347|FG004|Overall Study|Progressive disease|0|||
23428848|NCT02124772|65314348|FG005|Overall Study|Progressive disease|0|||
23428849|NCT02124772|65314349|FG006|Overall Study|Progressive disease|1|||
23549549|NCT01392560|65739730|FG000|Overall Study|not entered|8|||
23428850|NCT02124772|65314350|FG007|Overall Study|Progressive disease|1|||
23428851|NCT02124772|65314351|FG008|Overall Study|Progressive disease|0|||
23428852|NCT02124772|65314352|FG009|Overall Study|Progressive disease|0|||
23428853|NCT02124772|65314353|FG010|Overall Study|Progressive disease|0|||
23428854|NCT02124772|65314354|FG011|Overall Study|Progressive disease|0|||
23428855|NCT02124772|65314355|FG012|Overall Study|Progressive disease|0|||
23428856|NCT02124772|65314343|FG000|Overall Study|Other|0|||
23428857|NCT02124772|65314344|FG001|Overall Study|Other|7|||
23428858|NCT02124772|65314345|FG002|Overall Study|Other|2|||
23428859|NCT02124772|65314346|FG003|Overall Study|Other|5|||
23428860|NCT02124772|65314347|FG004|Overall Study|Other|4|||
23428861|NCT02124772|65314348|FG005|Overall Study|Other|3|||
23428862|NCT02124772|65314349|FG006|Overall Study|Other|4|||
23428863|NCT02124772|65314350|FG007|Overall Study|Other|1|||
23428864|NCT02124772|65314351|FG008|Overall Study|Other|1|||
23428865|NCT02124772|65314352|FG009|Overall Study|Other|1|||
23428866|NCT02124772|65314353|FG010|Overall Study|Other|1|||
23428867|NCT02124772|65314354|FG011|Overall Study|Other|1|||
23428868|NCT02124772|65314355|FG012|Overall Study|Other|0|||
23428869|NCT02360293|65314357|FG000|Overall Study|Lost to Follow-up|73|||
23428870|NCT02360293|65314358|FG001|Overall Study|Lost to Follow-up|95|||
23428871|NCT02360293|65314357|FG000|Overall Study|Withdrawal by Subject|2|||
23428872|NCT02360293|65314358|FG001|Overall Study|Withdrawal by Subject|1|||
23428873|NCT02360293|65314357|FG000|Overall Study|Excluded|1|||
23428874|NCT02360293|65314358|FG001|Overall Study|Excluded|0|||
23428875|NCT01842581|65314360|FG000|Overall Study|Adverse Event|6|||
23428876|NCT01842581|65314361|FG001|Overall Study|Adverse Event|4|||
23428877|NCT01842581|65314360|FG000|Overall Study|HE breakthrough|26|||
23428878|NCT01842581|65314361|FG001|Overall Study|HE breakthrough|13|||
23428879|NCT01842581|65314360|FG000|Overall Study|Liver transplant|2|||
23428880|NCT01842581|65314361|FG001|Overall Study|Liver transplant|0|||
23428881|NCT01842581|65314360|FG000|Overall Study|Lost to Follow-up|2|||
23428882|NCT01842581|65314361|FG001|Overall Study|Lost to Follow-up|5|||
23428883|NCT01842581|65314360|FG000|Overall Study|Withdrawal by Subject|5|||
23428884|NCT01842581|65314361|FG001|Overall Study|Withdrawal by Subject|7|||
23428885|NCT01842581|65314360|FG000|Overall Study|Other than specified|3|||
23428886|NCT01842581|65314361|FG001|Overall Study|Other than specified|1|||
23428887|NCT03421743|65314366|FG000|Overall Study|Lack of Efficacy|1|||
23428888|NCT03421743|65314367|FG001|Overall Study|Lack of Efficacy|0|||
23428889|NCT03421743|65314366|FG000|Overall Study|Adverse Event|2|||
23428890|NCT03421743|65314367|FG001|Overall Study|Adverse Event|1|||
23428891|NCT03421743|65314366|FG000|Overall Study|Withdrawal by Subject|0|||
23428892|NCT03421743|65314367|FG001|Overall Study|Withdrawal by Subject|1|||
23428893|NCT00687609|65314370|FG000|Overall Study|Physician Decision|1|||
23428894|NCT00687609|65314370|FG000|Overall Study|Withdrawal by Subject|2|||
23428895|NCT00673881|65314376|FG000|Overall Study|Withdrawal by Subject|1|||
23428896|NCT00657150|65314377|FG000|Overall Study|Adverse Event|19|||
23428897|NCT00657150|65314378|FG001|Overall Study|Adverse Event|10|||
23428898|NCT00657150|65314377|FG000|Overall Study|Non-compliant with protocol|5|||
23428899|NCT00657150|65314378|FG001|Overall Study|Non-compliant with protocol|9|||
23428900|NCT00657150|65314377|FG000|Overall Study|Lost to Follow-up|2|||
23428901|NCT00657150|65314378|FG001|Overall Study|Lost to Follow-up|0|||
23428902|NCT00657150|65314377|FG000|Overall Study|Withdrawal by Subject|51|||
23428903|NCT00657150|65314378|FG001|Overall Study|Withdrawal by Subject|36|||
23428904|NCT00657150|65314377|FG000|Overall Study|Other|38|||
23428905|NCT00657150|65314378|FG001|Overall Study|Other|38|||
23428906|NCT00657150|65314377|FG000|Treatment|Adverse Event|60|||
23428907|NCT00657150|65314378|FG001|Treatment|Adverse Event|53|||
23428908|NCT00657150|65314377|FG000|Treatment|Non-compliant with protocol|10|||
23428909|NCT00657150|65314378|FG001|Treatment|Non-compliant with protocol|9|||
23428910|NCT00657150|65314377|FG000|Treatment|Lost to Follow-up|1|||
23428911|NCT00657150|65314378|FG001|Treatment|Lost to Follow-up|0|||
23428912|NCT00657150|65314377|FG000|Treatment|Withdrawal by Subject|23|||
23428913|NCT00657150|65314378|FG001|Treatment|Withdrawal by Subject|20|||
23428914|NCT00657150|65314377|FG000|Treatment|Other|13|||
23620248|NCT02720081|65994923|FG001|Overall Study|Protocol Violation|1|||
23620249|NCT03132753|65994924|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
23620250|NCT03132753|65994925|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
23428915|NCT00657150|65314378|FG001|Treatment|Other|15|||
23428916|NCT01304329|65314379|FG000|Third Intervention (3 Days)|Adverse Event|0|||
23428917|NCT01304329|65314380|FG001|Third Intervention (3 Days)|Adverse Event|1|||
23428918|NCT01304329|65314381|FG002|Third Intervention (3 Days)|Adverse Event|0|||
23428919|NCT01304329|65314382|FG003|Third Intervention (3 Days)|Adverse Event|0|||
23620251|NCT03132753|65994924|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
23428920|NCT01304329|65314383|FG004|Third Intervention (3 Days)|Adverse Event|0|||
23428921|NCT01304329|65314384|FG005|Third Intervention (3 Days)|Adverse Event|0|||
23428922|NCT05291936|65314385|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
23428923|NCT05291936|65314386|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
23428924|NCT05291936|65314385|FG000|Period 1|Withdrew Consent during study|1|||
23428925|NCT05291936|65314386|FG001|Period 1|Withdrew Consent during study|0|||
23428926|NCT05291936|65314385|FG000|Period 2|Adverse Event|0|||
23428927|NCT05291936|65314386|FG001|Period 2|Adverse Event|1|||
23428928|NCT05291936|65314385|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
23428929|NCT05291936|65314386|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
23428930|NCT00033540|65314392|FG000|Overall Study|Adverse Event|14|||
23620252|NCT03132753|65994925|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
23620253|NCT04159805|65994926|FG000|Overall Study|Withdrawal by Subject|0|||
23620254|NCT04159805|65994927|FG001|Overall Study|Withdrawal by Subject|2|||
23620255|NCT04159805|65994928|FG002|Overall Study|Withdrawal by Subject|2|||
23135429|NCT01395888|64244347|FG001|2-week Run-in Period|Adverse Event|0|||
23428931|NCT00033540|65314392|FG000|Overall Study|Death|1|||
23428932|NCT00033540|65314392|FG000|Overall Study|Progression|26|||
23428933|NCT00033540|65314392|FG000|Overall Study|Withdrawal by Subject|6|||
23428934|NCT00033540|65314392|FG000|Overall Study|Other|5|||
23428935|NCT00033540|65314392|FG000|Overall Study|Ineligible|3|||
23428936|NCT00033540|65314392|FG000|Overall Study|Never received treatment|2|||
23428937|NCT00054691|65314394|FG000|Overall Study|Unmeasurable Disease|2|||
23135430|NCT01395888|64244348|FG002|2-week Run-in Period|Adverse Event|0|||
23135431|NCT01395888|64244346|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
23135432|NCT01395888|64244347|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
23135433|NCT01395888|64244348|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
23135434|NCT01395888|64244346|FG000|2-week Run-in Period|Lost to Follow-up|1|||
23135435|NCT01395888|64244347|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23135436|NCT01395888|64244348|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23135437|NCT01395888|64244346|FG000|2-week Run-in Period|Protocol Violation|2|||
23428938|NCT00054691|65314394|FG000|Overall Study|Noncompliant|1|||
23428939|NCT00654004|65314395|FG000|Overall Study|Lost to Follow-up|1|||
23428940|NCT00654004|65314396|FG001|Overall Study|Lost to Follow-up|0|||
23428941|NCT02226549|65314397|FG000|Overall Study|Randomized but Never Treated|1|||
23428942|NCT02226549|65314398|FG001|Overall Study|Randomized but Never Treated|0|||
23428943|NCT02226549|65314397|FG000|Overall Study|Lost to Follow-up|0|||
23428944|NCT02226549|65314398|FG001|Overall Study|Lost to Follow-up|1|||
23428945|NCT00199888|65314401|FG000|Overall Study|Lost to Follow-up|1|||
23428946|NCT03149003|65314402|FG000|Overall Study|Randomized but not treated|0|||
23428947|NCT03149003|65314403|FG001|Overall Study|Randomized but not treated|1|||
23428948|NCT03149003|65314404|FG002|Overall Study|Randomized but not treated|18|||
23428949|NCT01350115|65314413|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
23428950|NCT01350115|65314414|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
23428951|NCT01350115|65314413|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
23428952|NCT01350115|65314414|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
23428953|NCT01350115|65314413|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
23428954|NCT01350115|65314414|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
23428955|NCT02855944|65314415|FG000|Period 1: Treatment|Ongoing|14|||
23428956|NCT02855944|65314416|FG001|Period 1: Treatment|Ongoing|0|||
23428957|NCT02855944|65314415|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
23428958|NCT02855944|65314416|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
23428959|NCT02855944|65314415|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
23428960|NCT02855944|65314416|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
23428961|NCT00096018|65314417|FG000|Overall Study|Became Ineligible (not treated)|0|||
23428962|NCT00096018|65314418|FG001|Overall Study|Became Ineligible (not treated)|3|||
23428963|NCT00096018|65314417|FG000|Overall Study|Miscellaneous (not treated)|0|||
23428964|NCT00096018|65314418|FG001|Overall Study|Miscellaneous (not treated)|2|||
23428965|NCT00096018|65314417|FG000|Overall Study|Adverse Event|0|||
23428966|NCT00096018|65314418|FG001|Overall Study|Adverse Event|5|||
23428967|NCT00096018|65314417|FG000|Overall Study|Death|0|||
23428968|NCT00096018|65314418|FG001|Overall Study|Death|1|||
23428969|NCT00096018|65314417|FG000|Overall Study|Withdrawal by Subject|0|||
23428970|NCT00096018|65314418|FG001|Overall Study|Withdrawal by Subject|2|||
23428971|NCT00096018|65314417|FG000|Overall Study|Miscellaneous|2|||
23428972|NCT00096018|65314418|FG001|Overall Study|Miscellaneous|1|||
23428973|NCT04191135|65314419|FG000|Induction Treatment|Not Treated|2|||
23428974|NCT04191135|65314420|FG001|Induction Treatment|Not Treated|0|||
23428975|NCT04191135|65314421|FG002|Induction Treatment|Not Treated|0|||
23428976|NCT04191135|65314419|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
23428977|NCT04191135|65314420|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
23428978|NCT04191135|65314421|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
23549550|NCT01392560|65739730|FG000|Overall Study|discontinued during placebo run-in|2|||
23549551|NCT00558428|65739734|FG000|Overall Study|Adverse Event|6|||
23549552|NCT00558428|65739735|FG001|Overall Study|Adverse Event|22|||
23549553|NCT00558428|65739736|FG002|Overall Study|Adverse Event|3|||
23549554|NCT00558428|65739737|FG003|Overall Study|Adverse Event|4|||
23549555|NCT00558428|65739734|FG000|Overall Study|Lost to Follow-up|0|||
23549556|NCT00558428|65739735|FG001|Overall Study|Lost to Follow-up|1|||
23549557|NCT00558428|65739736|FG002|Overall Study|Lost to Follow-up|0|||
23549558|NCT00558428|65739737|FG003|Overall Study|Lost to Follow-up|0|||
23549559|NCT00558428|65739734|FG000|Overall Study|Lack of Efficacy|0|||
23549560|NCT00558428|65739735|FG001|Overall Study|Lack of Efficacy|0|||
23549561|NCT00558428|65739736|FG002|Overall Study|Lack of Efficacy|1|||
23549562|NCT00558428|65739737|FG003|Overall Study|Lack of Efficacy|2|||
23549563|NCT00558428|65739734|FG000|Overall Study|Non compliant with protocol|1|||
23428979|NCT04191135|65314419|FG000|Induction Treatment|Adverse Event|25|||
23428980|NCT04191135|65314420|FG001|Induction Treatment|Adverse Event|0|||
23428981|NCT04191135|65314421|FG002|Induction Treatment|Adverse Event|0|||
23428982|NCT04191135|65314419|FG000|Induction Treatment|Clinical Progression|8|||
23428983|NCT04191135|65314420|FG001|Induction Treatment|Clinical Progression|0|||
23428984|NCT04191135|65314421|FG002|Induction Treatment|Clinical Progression|0|||
23428985|NCT04191135|65314419|FG000|Induction Treatment|Excluded Medication|1|||
23428986|NCT04191135|65314420|FG001|Induction Treatment|Excluded Medication|0|||
23428987|NCT04191135|65314421|FG002|Induction Treatment|Excluded Medication|0|||
23428988|NCT04191135|65314419|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
23428989|NCT04191135|65314420|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
23428990|NCT04191135|65314421|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
23428991|NCT04191135|65314419|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
23428992|NCT04191135|65314420|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
23428993|NCT04191135|65314421|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
23428994|NCT04191135|65314419|FG000|Induction Treatment|Physician Decision|2|||
23428995|NCT04191135|65314420|FG001|Induction Treatment|Physician Decision|0|||
23428996|NCT04191135|65314421|FG002|Induction Treatment|Physician Decision|0|||
23428997|NCT04191135|65314419|FG000|Induction Treatment|Progressive Disease|135|||
23428998|NCT04191135|65314420|FG001|Induction Treatment|Progressive Disease|0|||
23428999|NCT04191135|65314421|FG002|Induction Treatment|Progressive Disease|0|||
23429000|NCT04191135|65314419|FG000|Induction Treatment|Protocol Violation|10|||
23429001|NCT04191135|65314420|FG001|Induction Treatment|Protocol Violation|0|||
23429002|NCT04191135|65314421|FG002|Induction Treatment|Protocol Violation|0|||
23429003|NCT04191135|65314419|FG000|Induction Treatment|Withdrawal by Subject|4|||
23429004|NCT04191135|65314420|FG001|Induction Treatment|Withdrawal by Subject|0|||
23135438|NCT01395888|64244347|FG001|2-week Run-in Period|Protocol Violation|0|||
23429005|NCT04191135|65314421|FG002|Induction Treatment|Withdrawal by Subject|0|||
23429006|NCT04191135|65314419|FG000|Randomized Treatment|Death|0|||
23429007|NCT04191135|65314420|FG001|Randomized Treatment|Death|50|||
23429008|NCT04191135|65314421|FG002|Randomized Treatment|Death|54|||
23429009|NCT04191135|65314419|FG000|Randomized Treatment|Lost to Follow-up|0|||
23429010|NCT04191135|65314420|FG001|Randomized Treatment|Lost to Follow-up|0|||
23429011|NCT04191135|65314421|FG002|Randomized Treatment|Lost to Follow-up|1|||
23429012|NCT04191135|65314419|FG000|Randomized Treatment|Withdrawal by Subject|0|||
23429013|NCT04191135|65314420|FG001|Randomized Treatment|Withdrawal by Subject|2|||
23429014|NCT04191135|65314421|FG002|Randomized Treatment|Withdrawal by Subject|0|||
23429015|NCT04191135|65314419|FG000|Randomized Treatment|Ongoing in Trial|0|||
23429016|NCT04191135|65314420|FG001|Randomized Treatment|Ongoing in Trial|83|||
23429017|NCT04191135|65314421|FG002|Randomized Treatment|Ongoing in Trial|81|||
23429018|NCT03761394|65314422|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
23429019|NCT03761394|65314423|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
23429020|NCT03761394|65314424|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
23429021|NCT03761394|65314425|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
23429022|NCT03761394|65314422|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
23429023|NCT03761394|65314423|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
23429024|NCT03761394|65314424|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
23429025|NCT03761394|65314425|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
23429026|NCT03761394|65314422|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
23429027|NCT03761394|65314423|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
23429028|NCT03761394|65314424|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
23429029|NCT03761394|65314425|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
23429030|NCT03761394|65314422|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
23620256|NCT03821064|65994933|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
23620257|NCT02172950|65994935|FG000|Overall Study|Physician Decision|3|||
23620258|NCT02172950|65994936|FG001|Overall Study|Physician Decision|3|||
23620259|NCT02172950|65994935|FG000|Overall Study|Lack of Efficacy|1|||
23620260|NCT02172950|65994936|FG001|Overall Study|Lack of Efficacy|0|||
23620261|NCT02172950|65994935|FG000|Overall Study|Adverse Event|4|||
23620262|NCT02172950|65994936|FG001|Overall Study|Adverse Event|1|||
23620263|NCT02172950|65994935|FG000|Overall Study|Withdrawal by Subject|10|||
23620264|NCT02172950|65994936|FG001|Overall Study|Withdrawal by Subject|0|||
23135439|NCT01395888|64244348|FG002|2-week Run-in Period|Protocol Violation|0|||
23135440|NCT01395888|64244346|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
23135441|NCT01395888|64244347|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23620265|NCT02172950|65994935|FG000|Overall Study|Protocol Violation|1|||
23620266|NCT02172950|65994936|FG001|Overall Study|Protocol Violation|0|||
23620267|NCT02172950|65994935|FG000|Overall Study|Lost to Follow-up|1|||
23620268|NCT02172950|65994936|FG001|Overall Study|Lost to Follow-up|0|||
23620269|NCT02172950|65994935|FG000|Overall Study|Death|1|||
23135442|NCT01395888|64244348|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23620270|NCT02172950|65994936|FG001|Overall Study|Death|0|||
23135443|NCT01395888|64244346|FG000|Treatment Period (TP)|Adverse Event|0|||
23135444|NCT01395888|64244347|FG001|Treatment Period (TP)|Adverse Event|7|||
23214637|NCT00636441|64528003|FG005|Overall Study|Screen Failure|0|||
23214638|NCT00636441|64528004|FG006|Overall Study|Screen Failure|17|||
23214639|NCT03559192|64528006|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
23214640|NCT03559192|64528007|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
23214641|NCT03559192|64528008|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
23214642|NCT03559192|64528006|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
23214643|NCT03559192|64528007|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
23214644|NCT03559192|64528008|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
23214645|NCT03559192|64528006|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
23214646|NCT03559192|64528007|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
23214647|NCT03559192|64528008|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
23214648|NCT03559192|64528006|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
23214649|NCT03559192|64528007|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
23214650|NCT03559192|64528008|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
23214651|NCT03559192|64528006|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
23214652|NCT03559192|64528007|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
23214653|NCT03559192|64528008|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
23214654|NCT03559192|64528006|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
23214655|NCT03559192|64528007|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
23214656|NCT03559192|64528008|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
23214657|NCT03559192|64528006|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
23214658|NCT03559192|64528007|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
23214659|NCT03559192|64528008|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
23214660|NCT03559192|64528006|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
23214661|NCT03559192|64528007|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
23214662|NCT03559192|64528008|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
23214663|NCT03559192|64528006|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
23214664|NCT03559192|64528007|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
23214665|NCT03559192|64528008|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
23214666|NCT02228564|64528010|FG000|Overall Study|Withdrawal by Subject|10|||
23214667|NCT02228564|64528010|FG000|Overall Study|Death|11|||
23214668|NCT02228564|64528010|FG000|Overall Study|Physician Decision|5|||
23214669|NCT02228564|64528010|FG000|Overall Study|Lost to Follow-up|17|||
23214670|NCT02228564|64528010|FG000|Overall Study|Other|6|||
23214671|NCT01369849|64528017|FG000|Overall Study|Ineligible prior to treatment|0|||
23214672|NCT01369849|64528018|FG001|Overall Study|Ineligible prior to treatment|0|||
23214673|NCT01369849|64528019|FG002|Overall Study|Ineligible prior to treatment|1|||
23214674|NCT01369849|64528017|FG000|Overall Study|Ineligible after receiving treatment|0|||
23214675|NCT01369849|64528018|FG001|Overall Study|Ineligible after receiving treatment|1|||
23214676|NCT01369849|64528019|FG002|Overall Study|Ineligible after receiving treatment|0|||
23214677|NCT00004732|64528020|FG000|Overall Study|Withdrawal by Subject|36|||
23214678|NCT00004732|64528021|FG001|Overall Study|Withdrawal by Subject|64|||
23214679|NCT00004732|64528020|FG000|Overall Study|Lost to Follow-up|33|||
23214680|NCT00004732|64528021|FG001|Overall Study|Lost to Follow-up|47|||
23214681|NCT04019795|64528023|FG000|Overall Study|Withdrawal by Subject|1|||
23214682|NCT04019795|64528024|FG001|Overall Study|Withdrawal by Subject|2|||
23214683|NCT04019795|64528025|FG002|Overall Study|Withdrawal by Subject|2|||
23214684|NCT04019795|64528026|FG003|Overall Study|Withdrawal by Subject|1|||
23214685|NCT04019795|64528023|FG000|Overall Study|Lost to Follow-up|0|||
23135445|NCT01395888|64244348|FG002|Treatment Period (TP)|Adverse Event|6|||
23135446|NCT01395888|64244346|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
23135447|NCT01395888|64244347|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
23135448|NCT01395888|64244348|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
23214686|NCT04019795|64528024|FG001|Overall Study|Lost to Follow-up|1|||
23135449|NCT01395888|64244346|FG000|Treatment Period (TP)|Protocol Violation|0|||
23135450|NCT01395888|64244347|FG001|Treatment Period (TP)|Protocol Violation|1|||
23135451|NCT01395888|64244348|FG002|Treatment Period (TP)|Protocol Violation|5|||
23135452|NCT01395888|64244346|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
23135453|NCT01395888|64244347|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
23135454|NCT01395888|64244348|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
23135455|NCT01395888|64244346|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
23135456|NCT01395888|64244347|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
23135457|NCT01395888|64244348|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
23135458|NCT04510090|64244349|FG000|FE-HS|Withdrawal by Subject|0|||
23317554|NCT00993421|64904107|FG003|Overall Study|Sponsor Decision|30|||
23429031|NCT03761394|65314423|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
23549564|NCT00558428|65739735|FG001|Overall Study|Non compliant with protocol|0|||
23135459|NCT04510090|64244350|FG001|FE-HS|Withdrawal by Subject|0|||
23317555|NCT00993421|64904108|FG004|Overall Study|Sponsor Decision|38|||
23214687|NCT04019795|64528025|FG002|Overall Study|Lost to Follow-up|1|||
23214688|NCT04019795|64528026|FG003|Overall Study|Lost to Follow-up|2|||
23214689|NCT04019795|64528023|FG000|Overall Study|Treatment non-compliance|3|||
23214690|NCT04019795|64528024|FG001|Overall Study|Treatment non-compliance|1|||
23214691|NCT04019795|64528025|FG002|Overall Study|Treatment non-compliance|2|||
23214692|NCT04019795|64528026|FG003|Overall Study|Treatment non-compliance|0|||
23214693|NCT04019795|64528023|FG000|Overall Study|Physician Decision|0|||
23214694|NCT04019795|64528024|FG001|Overall Study|Physician Decision|0|||
23135460|NCT04510090|64244351|FG002|FE-HS|Withdrawal by Subject|0|||
23135461|NCT04510090|64244352|FG003|FE-HS|Withdrawal by Subject|0|||
23135462|NCT04510090|64244353|FG004|FE-HS|Withdrawal by Subject|1|||
23135463|NCT04510090|64244354|FG005|FE-HS|Withdrawal by Subject|0|||
23135464|NCT04510090|64244355|FG006|FE-HS|Withdrawal by Subject|0|||
23135465|NCT04510090|64244356|FG007|FE-HS|Withdrawal by Subject|0|||
23135466|NCT03056300|64244357|FG000|Overall Study|Surgical reason per study protocol|3|||
23135467|NCT01394978|64244358|FG000|Overall Study|Withdrawal by Subject|2|||
23135468|NCT01394978|64244359|FG001|Overall Study|Withdrawal by Subject|4|||
23135469|NCT01394978|64244358|FG000|Overall Study|Lost to Follow-up|13|||
23135470|NCT01394978|64244359|FG001|Overall Study|Lost to Follow-up|20|||
23135471|NCT01394978|64244358|FG000|Overall Study|Death|6|||
23135472|NCT01394978|64244359|FG001|Overall Study|Death|7|||
23135473|NCT01127763|64244360|FG000|Overall Study|Adverse Event|2|||
23135474|NCT01127763|64244360|FG000|Overall Study|Withdrawal by Subject|1|||
23135475|NCT01127763|64244360|FG000|Overall Study|Physician Decision|2|||
23135476|NCT03889704|64244361|FG000|Overall Study|Study terminated due to pandemic|1|||
23135477|NCT03592745|64244362|FG000|Overall Study|Adverse Event|0|||
23135478|NCT03592745|64244363|FG001|Overall Study|Adverse Event|2|||
23135479|NCT03592745|64244362|FG000|Overall Study|Lost to Follow-up|2|||
23214695|NCT04019795|64528025|FG002|Overall Study|Physician Decision|1|||
23214696|NCT04019795|64528026|FG003|Overall Study|Physician Decision|0|||
23214697|NCT04019795|64528023|FG000|Overall Study|Adverse Event|1|||
23135480|NCT03592745|64244363|FG001|Overall Study|Lost to Follow-up|0|||
23135481|NCT03592745|64244362|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
23135482|NCT03592745|64244363|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
23135483|NCT04165031|64244366|FG000|Overall Study|Adverse Event|1|||
23135484|NCT04165031|64244367|FG001|Overall Study|Adverse Event|1|||
23135485|NCT04165031|64244368|FG002|Overall Study|Adverse Event|0|||
23135486|NCT04165031|64244369|FG003|Overall Study|Adverse Event|0|||
23135487|NCT04165031|64244370|FG004|Overall Study|Adverse Event|0|||
23135488|NCT04165031|64244371|FG005|Overall Study|Adverse Event|0|||
23135489|NCT04165031|64244366|FG000|Overall Study|Withdrawal by Subject|0|||
23214698|NCT04019795|64528024|FG001|Overall Study|Adverse Event|0|||
23214699|NCT04019795|64528025|FG002|Overall Study|Adverse Event|0|||
23620271|NCT02172950|65994935|FG000|Overall Study|Patient traveling|1|||
23135490|NCT04165031|64244367|FG001|Overall Study|Withdrawal by Subject|0|||
23135491|NCT04165031|64244368|FG002|Overall Study|Withdrawal by Subject|1|||
23135492|NCT04165031|64244369|FG003|Overall Study|Withdrawal by Subject|0|||
23135493|NCT04165031|64244370|FG004|Overall Study|Withdrawal by Subject|0|||
23135494|NCT04165031|64244371|FG005|Overall Study|Withdrawal by Subject|0|||
23135495|NCT00616902|64244372|FG000|Overall Study|Termination of study|6|||
23135496|NCT00616902|64244373|FG001|Overall Study|Termination of study|6|||
23135497|NCT05593445|64244374|FG000|12-Week DBVC Period|Adverse Event|1|||
23135498|NCT05593445|64244375|FG001|12-Week DBVC Period|Adverse Event|0|||
23135499|NCT05593445|64244376|FG002|12-Week DBVC Period|Adverse Event|0|||
23135500|NCT05593445|64244377|FG003|12-Week DBVC Period|Adverse Event|0|||
23135501|NCT05593445|64244374|FG000|12-Week DBVC Period|Physician Decision|0|||
23135502|NCT05593445|64244375|FG001|12-Week DBVC Period|Physician Decision|1|||
23135503|NCT05593445|64244376|FG002|12-Week DBVC Period|Physician Decision|0|||
23135504|NCT05593445|64244377|FG003|12-Week DBVC Period|Physician Decision|0|||
23135505|NCT05593445|64244374|FG000|12-Week DBVC Period|Protocol Violation|0|||
23135506|NCT05593445|64244375|FG001|12-Week DBVC Period|Protocol Violation|1|||
23135507|NCT05593445|64244376|FG002|12-Week DBVC Period|Protocol Violation|0|||
23135508|NCT05593445|64244377|FG003|12-Week DBVC Period|Protocol Violation|0|||
23135509|NCT05593445|64244374|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
23214700|NCT04019795|64528026|FG003|Overall Study|Adverse Event|0|||
23135510|NCT05593445|64244375|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
23135511|NCT05593445|64244376|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
23135512|NCT05593445|64244377|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
23135513|NCT05593445|64244374|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
23135514|NCT05593445|64244375|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
23135515|NCT05593445|64244376|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
23214701|NCT03750240|64528027|FG000|Overall Study|Technical Difficulties|2|||
23214702|NCT00924729|64528028|FG000|Overall Study|insufficient volume for analysis|1|||
23317556|NCT00993421|64904109|FG005|Overall Study|Sponsor Decision|30|||
23135516|NCT05593445|64244377|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
23135517|NCT05593445|64244374|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
23135518|NCT05593445|64244375|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
23620272|NCT02172950|65994936|FG001|Overall Study|Patient traveling|0|||
23135519|NCT05593445|64244376|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
23135520|NCT05593445|64244377|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
23135521|NCT05593445|64244374|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
23135522|NCT05593445|64244375|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
23135523|NCT05593445|64244376|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
23135524|NCT05593445|64244377|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
23135525|NCT05593445|64244374|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23135526|NCT05593445|64244375|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23135527|NCT05593445|64244376|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
23135528|NCT05593445|64244377|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
23135529|NCT00439231|64244381|FG000|Overall Study|Lack of Efficacy|28|||
23135530|NCT01631227|64244382|FG000|Overall Study|withdrawn consent|27|||
23135531|NCT01631227|64244383|FG001|Overall Study|withdrawn consent|21|||
23135532|NCT01631227|64244382|FG000|Overall Study|Adverse Event|1|||
23135533|NCT01631227|64244383|FG001|Overall Study|Adverse Event|0|||
23135534|NCT01631227|64244382|FG000|Overall Study|administrative|2|||
23135535|NCT01631227|64244383|FG001|Overall Study|administrative|1|||
23135536|NCT01605916|64244384|FG000|Overall Study|Adverse Event|1|||
23135537|NCT01605916|64244385|FG001|Overall Study|Adverse Event|0|||
23135538|NCT01605916|64244386|FG002|Overall Study|Adverse Event|0|||
23135539|NCT01605916|64244387|FG003|Overall Study|Adverse Event|1|||
23135540|NCT01605916|64244388|FG004|Overall Study|Adverse Event|0|||
23135541|NCT01605916|64244384|FG000|Overall Study|Lack of Efficacy|2|||
23135542|NCT01605916|64244385|FG001|Overall Study|Lack of Efficacy|3|||
23135543|NCT01605916|64244386|FG002|Overall Study|Lack of Efficacy|3|||
23135544|NCT01605916|64244387|FG003|Overall Study|Lack of Efficacy|5|||
23135545|NCT01605916|64244388|FG004|Overall Study|Lack of Efficacy|4|||
23135546|NCT01605916|64244384|FG000|Overall Study|Withdrawal by Subject|1|||
23135547|NCT01605916|64244385|FG001|Overall Study|Withdrawal by Subject|1|||
23135548|NCT01605916|64244386|FG002|Overall Study|Withdrawal by Subject|0|||
23135549|NCT01605916|64244387|FG003|Overall Study|Withdrawal by Subject|0|||
23135550|NCT01605916|64244388|FG004|Overall Study|Withdrawal by Subject|2|||
23135551|NCT02081417|64244389|FG000|Overall Study|Lost to Follow-up|26|||
23135552|NCT02081417|64244390|FG001|Overall Study|Lost to Follow-up|23|||
23135553|NCT02081417|64244389|FG000|Overall Study|Moved Away|1|||
23135554|NCT02081417|64244390|FG001|Overall Study|Moved Away|2|||
23135555|NCT02081417|64244389|FG000|Overall Study|Incarcerated|2|||
23135556|NCT02081417|64244390|FG001|Overall Study|Incarcerated|2|||
23135557|NCT02081417|64244389|FG000|Overall Study|Death|4|||
23135558|NCT02081417|64244390|FG001|Overall Study|Death|3|||
23135559|NCT02081417|64244389|FG000|Overall Study|Withdrawal by Subject|4|||
23549565|NCT00558428|65739736|FG002|Overall Study|Non compliant with protocol|0|||
23549566|NCT00558428|65739737|FG003|Overall Study|Non compliant with protocol|3|||
23549567|NCT00558428|65739734|FG000|Overall Study|Consent withdrawn|2|||
23549568|NCT00558428|65739735|FG001|Overall Study|Consent withdrawn|1|||
23549569|NCT00558428|65739736|FG002|Overall Study|Consent withdrawn|0|||
23549570|NCT00558428|65739737|FG003|Overall Study|Consent withdrawn|1|||
23549571|NCT00558428|65739734|FG000|Overall Study|Other|3|||
23549572|NCT00558428|65739735|FG001|Overall Study|Other|0|||
23549573|NCT00558428|65739736|FG002|Overall Study|Other|0|||
23549574|NCT00558428|65739737|FG003|Overall Study|Other|1|||
23549575|NCT05239039|65739738|FG000|Overall Study|Withdrawal by Subject|0|||
23549576|NCT05239039|65739739|FG001|Overall Study|Withdrawal by Subject|1|||
23549577|NCT02298192|65739743|FG000|Overall Study|Unclassified|3|||
23549578|NCT02298192|65739744|FG001|Overall Study|Unclassified|2|||
23549579|NCT02298192|65739743|FG000|Overall Study|Withdrawal criteria|2|||
23620273|NCT02172950|65994935|FG000|Overall Study|Patient went to other country|1|||
23620274|NCT02172950|65994936|FG001|Overall Study|Patient went to other country|0|||
23620275|NCT02172950|65994935|FG000|Overall Study|Patient relocated overseas|1|||
23620276|NCT02172950|65994936|FG001|Overall Study|Patient relocated overseas|1|||
23620277|NCT02172950|65994935|FG000|Overall Study|Patient moving|1|||
23135560|NCT02081417|64244390|FG001|Overall Study|Withdrawal by Subject|0|||
23135561|NCT02081417|64244389|FG000|Overall Study|Admitted to Residential Treatment|2|||
23135562|NCT02081417|64244390|FG001|Overall Study|Admitted to Residential Treatment|0|||
23135563|NCT02081417|64244389|FG000|Overall Study|Did not start treatment|17|||
23135564|NCT02081417|64244390|FG001|Overall Study|Did not start treatment|21|||
23135565|NCT02964325|64244391|FG000|Overall Study|Lost to Follow-up|3|||
23135566|NCT02964325|64244392|FG001|Overall Study|Lost to Follow-up|3|||
23135567|NCT02964325|64244391|FG000|Overall Study|Physician Decision|5|||
23135568|NCT02964325|64244392|FG001|Overall Study|Physician Decision|4|||
23135569|NCT02964325|64244391|FG000|Overall Study|Death|1|||
23135570|NCT02964325|64244392|FG001|Overall Study|Death|3|||
23317557|NCT00993421|64904110|FG006|Overall Study|Sponsor Decision|29|||
23549580|NCT02298192|65739744|FG001|Overall Study|Withdrawal criteria|0|||
23549581|NCT02298192|65739743|FG000|Overall Study|Withdrawal by Subject|6|||
23549582|NCT02298192|65739744|FG001|Overall Study|Withdrawal by Subject|1|||
23620278|NCT02172950|65994936|FG001|Overall Study|Patient moving|0|||
23620279|NCT01232569|65994937|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
23620280|NCT01232569|65994938|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
23620281|NCT01232569|65994939|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23620282|NCT01232569|65994940|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
23620283|NCT01232569|65994937|FG000|Double-blind Treatment Period|Escape|2|||
23135571|NCT02964325|64244391|FG000|Overall Study|Withdrawal by Subject|2|||
23135572|NCT02964325|64244392|FG001|Overall Study|Withdrawal by Subject|1|||
23549583|NCT02298192|65739743|FG000|Overall Study|Lost to Follow-up|2|||
23429032|NCT03761394|65314424|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
23429033|NCT03761394|65314425|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
23429034|NCT02068118|65314426|FG000|18-month Comparative Study Period|Death|90|||
23429035|NCT02068118|65314427|FG001|18-month Comparative Study Period|Death|97|||
23429036|NCT02068118|65314426|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
23429037|NCT02068118|65314427|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
23549584|NCT02298192|65739744|FG001|Overall Study|Lost to Follow-up|1|||
23549585|NCT02298192|65739743|FG000|Overall Study|Adverse Event|6|||
23429038|NCT02068118|65314426|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
23429039|NCT02068118|65314427|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
23429040|NCT02068118|65314426|FG000|18-month Comparative Study Period|Heart transplant|9|||
23429041|NCT02068118|65314427|FG001|18-month Comparative Study Period|Heart transplant|15|||
23549586|NCT02298192|65739744|FG001|Overall Study|Adverse Event|2|||
23549587|NCT00725296|65739745|FG000|Overall Study|Adverse Event|11|||
23135573|NCT02964325|64244391|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
23135574|NCT02964325|64244392|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
23135575|NCT00935818|64244393|FG000|Overall Study|Withdrawal by Subject|45|||
23135576|NCT00935818|64244394|FG001|Overall Study|Withdrawal by Subject|50|||
23135577|NCT00935818|64244393|FG000|Overall Study|Lost to Follow-up|40|||
23135578|NCT00935818|64244394|FG001|Overall Study|Lost to Follow-up|42|||
23135579|NCT00935818|64244393|FG000|Overall Study|Adverse Event|6|||
23135580|NCT00935818|64244394|FG001|Overall Study|Adverse Event|7|||
23135581|NCT00935818|64244393|FG000|Overall Study|Physician Decision|0|||
23135582|NCT00935818|64244394|FG001|Overall Study|Physician Decision|1|||
23135583|NCT00760474|64244395|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
23135584|NCT00760474|64244396|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
23135585|NCT00760474|64244395|FG000|Placebo Washout Period|Other|0|||
23135586|NCT00760474|64244396|FG001|Placebo Washout Period|Other|1|||
23549588|NCT00725296|65739745|FG000|Overall Study|Lack of Efficacy|7|||
23549589|NCT00725296|65739745|FG000|Overall Study|Withdrawal by Subject|3|||
23549590|NCT00725296|65739745|FG000|Overall Study|Non-Compliance|2|||
23549591|NCT00725296|65739745|FG000|Overall Study|Lost to Follow-up|1|||
23549592|NCT00725296|65739745|FG000|Overall Study|Other|38|||
23549593|NCT01540851|65739749|FG000|Overall Study|Lost to Follow-up|14|||
23549594|NCT01540851|65739750|FG001|Overall Study|Lost to Follow-up|15|||
23549595|NCT01540851|65739749|FG000|Overall Study|Withdrawal by Subject|7|||
23549596|NCT01540851|65739750|FG001|Overall Study|Withdrawal by Subject|3|||
23549597|NCT04827212|65739751|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
23549598|NCT04827212|65739752|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
23549599|NCT04827212|65739751|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
23549600|NCT04827212|65739752|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
23549601|NCT01962493|65739753|FG000|Overall Study|Adverse Event|1|||
23135587|NCT00760474|64244395|FG000|Period 2 (P2)|Lost to Follow-up|1|||
23135588|NCT00760474|64244396|FG001|Period 2 (P2)|Lost to Follow-up|0|||
23135589|NCT00760474|64244395|FG000|Period 2 (P2)|Adverse Event|0|||
23135590|NCT00760474|64244396|FG001|Period 2 (P2)|Adverse Event|1|||
23135591|NCT02124811|64244404|FG000|Overall Study|Early termination|2|||
23135592|NCT02124811|64244405|FG001|Overall Study|Early termination|2|||
23135593|NCT02124811|64244404|FG000|Overall Study|Withdrawal by Subject|1|||
23135594|NCT02124811|64244405|FG001|Overall Study|Withdrawal by Subject|0|||
23135595|NCT00704405|64244408|FG000|Overall Study (NC Population)|Adverse Event|1|||
23429042|NCT02068118|65314426|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
23549602|NCT01962493|65739754|FG001|Overall Study|Adverse Event|2|||
23549603|NCT01962493|65739753|FG000|Overall Study|Protocol Violation|0|||
23549604|NCT01962493|65739754|FG001|Overall Study|Protocol Violation|1|||
23135596|NCT00704405|64244409|FG001|Overall Study (NC Population)|Adverse Event|0|||
23135597|NCT00704405|64244410|FG002|Overall Study (NC Population)|Adverse Event|0|||
23135598|NCT00704405|64244411|FG003|Overall Study (NC Population)|Adverse Event|0|||
23135599|NCT00704405|64244412|FG004|Overall Study (NC Population)|Adverse Event|0|||
23549605|NCT01962493|65739753|FG000|Overall Study|Withdrawal by Subject|4|||
23549606|NCT01962493|65739754|FG001|Overall Study|Withdrawal by Subject|2|||
23549607|NCT00127101|65739762|FG000|Base Protocol|Adverse Event|0|||
23549608|NCT00127101|65739763|FG001|Base Protocol|Adverse Event|2|||
23549609|NCT00127101|65739764|FG002|Base Protocol|Adverse Event|1|||
23549610|NCT00127101|65739765|FG003|Base Protocol|Adverse Event|0|||
23549611|NCT00127101|65739766|FG004|Base Protocol|Adverse Event|0|||
23549612|NCT00127101|65739767|FG005|Base Protocol|Adverse Event|0|||
23429043|NCT02068118|65314427|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
23429044|NCT02068118|65314426|FG000|18-month Comparative Study Period|Hemiplegia|0|||
23429045|NCT02068118|65314427|FG001|18-month Comparative Study Period|Hemiplegia|1|||
23429046|NCT02068118|65314426|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
23429047|NCT02068118|65314427|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
23429048|NCT02068118|65314426|FG000|18-month Comparative Study Period|Move|0|||
23429049|NCT02068118|65314427|FG001|18-month Comparative Study Period|Move|1|||
23429050|NCT02068118|65314426|FG000|18-month Comparative Study Period|Hearing loss|0|||
23429051|NCT02068118|65314427|FG001|18-month Comparative Study Period|Hearing loss|1|||
23429052|NCT02068118|65314426|FG000|Extension Period|Death|0|||
23429053|NCT02068118|65314427|FG001|Extension Period|Death|2|||
23429054|NCT02068118|65314426|FG000|Extension Period|Withdrawal by Subject|1|||
23429055|NCT02068118|65314427|FG001|Extension Period|Withdrawal by Subject|0|||
23429056|NCT02068118|65314426|FG000|Extension Period|Heart transplant|1|||
23429057|NCT02068118|65314427|FG001|Extension Period|Heart transplant|0|||
23429058|NCT02068118|65314426|FG000|Extension Period|Wrong device use|0|||
23429059|NCT02068118|65314427|FG001|Extension Period|Wrong device use|1|||
23429060|NCT01703065|65314428|FG000|Overall Study|Lack of Efficacy|1|||
23429061|NCT01703065|65314429|FG001|Overall Study|Lack of Efficacy|0|||
23429062|NCT01806064|65314438|FG000|Overall Study|Randomized Not Enrolled|0|||
23429063|NCT01806064|65314439|FG001|Overall Study|Randomized Not Enrolled|0|||
23429064|NCT01806064|65314440|FG002|Overall Study|Randomized Not Enrolled|0|||
23429065|NCT01806064|65314441|FG003|Overall Study|Randomized Not Enrolled|1|||
23429066|NCT01806064|65314442|FG004|Overall Study|Randomized Not Enrolled|2|||
23429067|NCT02120365|65314448|FG000|Overall Study|Withdrawal by Subject|0|||
23429068|NCT02120365|65314449|FG001|Overall Study|Withdrawal by Subject|0|||
23429069|NCT02120365|65314450|FG002|Overall Study|Withdrawal by Subject|2|||
23429070|NCT02120365|65314451|FG003|Overall Study|Withdrawal by Subject|4|||
23429071|NCT02120365|65314452|FG004|Overall Study|Withdrawal by Subject|0|||
23429072|NCT02120365|65314453|FG005|Overall Study|Withdrawal by Subject|2|||
23429073|NCT03077698|65314454|FG000|Progestin Monotherapy|Stable Disease|8|||
23429074|NCT03077698|65314455|FG001|Progestin Monotherapy|Stable Disease|0|||
23429075|NCT03077698|65314454|FG000|Progestin Monotherapy|Adverse Event|1|||
23429076|NCT03077698|65314455|FG001|Progestin Monotherapy|Adverse Event|0|||
23429077|NCT03077698|65314454|FG000|Progestin Monotherapy|Death|1|||
23429078|NCT03077698|65314455|FG001|Progestin Monotherapy|Death|0|||
23429079|NCT03077698|65314454|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
23429080|NCT03077698|65314455|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
23429081|NCT03077698|65314454|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
23429082|NCT03077698|65314455|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
23429083|NCT03077698|65314454|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
23429084|NCT03077698|65314455|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
23429085|NCT03077698|65314454|FG000|Safety Follow Up|Withdrawal by Subject|2|||
23429086|NCT03077698|65314455|FG001|Safety Follow Up|Withdrawal by Subject|1|||
23429087|NCT03077698|65314454|FG000|Safety Follow Up|Transfer of care to hospice|1|||
23429088|NCT03077698|65314455|FG001|Safety Follow Up|Transfer of care to hospice|0|||
23429089|NCT02119156|65314456|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
23429090|NCT02119156|65314457|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
23429091|NCT02119156|65314458|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
23429092|NCT02119156|65314456|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
23429093|NCT02119156|65314457|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
23429094|NCT02119156|65314458|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
23429095|NCT02119156|65314456|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
23429096|NCT02119156|65314457|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
23135600|NCT00704405|64244408|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
23135601|NCT00704405|64244409|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
23135602|NCT00704405|64244410|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
23135603|NCT00704405|64244411|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
23135604|NCT00704405|64244412|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
23135605|NCT00704405|64244408|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
23135606|NCT00704405|64244409|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
23135607|NCT00704405|64244410|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
23135608|NCT00704405|64244411|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
23135609|NCT00704405|64244412|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
23317558|NCT00993421|64904104|FG000|Overall Study|Lost to Follow-up|3|||
23317559|NCT00993421|64904105|FG001|Overall Study|Lost to Follow-up|5|||
23135610|NCT00704405|64244408|FG000|Overall Study (NC Population)|Other|0|||
23135611|NCT00704405|64244409|FG001|Overall Study (NC Population)|Other|0|||
23317560|NCT00993421|64904106|FG002|Overall Study|Lost to Follow-up|5|||
23429097|NCT02119156|65314458|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
23429098|NCT02119156|65314456|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
23549613|NCT00127101|65739762|FG000|Base Protocol|Lack of Efficacy|1|||
23429099|NCT02119156|65314457|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
23429100|NCT02119156|65314458|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
23429101|NCT02119156|65314456|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
23429102|NCT02119156|65314457|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
23429103|NCT02119156|65314458|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
23429104|NCT02080260|65314462|FG000|Overall Study|Death|18|||
23429105|NCT02080260|65314462|FG000|Overall Study|Withdrawal by Subject|1|||
23429106|NCT00276614|65314468|FG000|Overall Study|Progression of disease under study|3|||
23429107|NCT00707746|65314471|FG000|Treatment Period|Adverse Event|2|||
23429108|NCT00707746|65314472|FG001|Treatment Period|Adverse Event|4|||
23429109|NCT00707746|65314471|FG000|Treatment Period|Ineligibility|0|||
23429110|NCT00707746|65314472|FG001|Treatment Period|Ineligibility|1|||
23429111|NCT02581930|65314473|FG000|Overall Study|Withdrawal by Subject|1|||
23429112|NCT02581930|65314473|FG000|Overall Study|patient declined further treatment|1|||
23429113|NCT05136898|65314474|FG000|Overall Study|Adverse Event|2|||
23429114|NCT03529110|65314475|FG000|Overall Study|Progressive Disease|66|||
23429115|NCT03529110|65314476|FG001|Overall Study|Progressive Disease|158|||
23429116|NCT03529110|65314475|FG000|Overall Study|Clinical Progression|4|||
23429117|NCT03529110|65314476|FG001|Overall Study|Clinical Progression|12|||
23429118|NCT03529110|65314475|FG000|Overall Study|Adverse Event|35|||
23429119|NCT03529110|65314476|FG001|Overall Study|Adverse Event|17|||
23429120|NCT03529110|65314475|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
23429121|NCT03529110|65314476|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
23429122|NCT03529110|65314475|FG000|Overall Study|Lack of Efficacy|3|||
23429123|NCT03529110|65314476|FG001|Overall Study|Lack of Efficacy|3|||
23429124|NCT03529110|65314475|FG000|Overall Study|Physician Decision|2|||
23429125|NCT03529110|65314476|FG001|Overall Study|Physician Decision|8|||
23429126|NCT03529110|65314475|FG000|Overall Study|Miscellaneous|2|||
23429127|NCT03529110|65314476|FG001|Overall Study|Miscellaneous|5|||
23429128|NCT00424190|65314483|FG000|Overall Study|Withdrew consent|3|||
23429129|NCT00424190|65314484|FG001|Overall Study|Withdrew consent|4|||
23429130|NCT00424190|65314483|FG000|Overall Study|Death|3|||
23429131|NCT00424190|65314484|FG001|Overall Study|Death|0|||
23429132|NCT00424190|65314483|FG000|Overall Study|Noncompliance|1|||
23429133|NCT00424190|65314484|FG001|Overall Study|Noncompliance|2|||
23429134|NCT00424190|65314483|FG000|Overall Study|Request of sponsor or investigator|0|||
23429135|NCT00424190|65314484|FG001|Overall Study|Request of sponsor or investigator|2|||
23429136|NCT00424190|65314483|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
23429137|NCT00424190|65314484|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
23429138|NCT00424190|65314483|FG000|Overall Study|Other|15|||
23429139|NCT00424190|65314484|FG001|Overall Study|Other|21|||
23429140|NCT01048866|65314486|FG000|Overall Study|Adverse Event|1|||
23429141|NCT01048866|65314487|FG001|Overall Study|Adverse Event|0|||
23429142|NCT01048866|65314486|FG000|Overall Study|Protocol Violation|1|||
23429143|NCT01048866|65314487|FG001|Overall Study|Protocol Violation|0|||
23429144|NCT01048866|65314486|FG000|Overall Study|Physician Decision|1|||
23429145|NCT01048866|65314487|FG001|Overall Study|Physician Decision|0|||
23429146|NCT01048866|65314486|FG000|Overall Study|Withdrawal by Subject|0|||
23429147|NCT01048866|65314487|FG001|Overall Study|Withdrawal by Subject|2|||
23429148|NCT01048866|65314486|FG000|Overall Study|Lost to Follow-up|0|||
23429149|NCT01048866|65314487|FG001|Overall Study|Lost to Follow-up|2|||
23429150|NCT01048866|65314486|FG000|Overall Study|Other|1|||
23429151|NCT01048866|65314487|FG001|Overall Study|Other|1|||
23429152|NCT00930969|65314490|FG000|Overall Study|Death|5|||
23429153|NCT00930969|65314490|FG000|Overall Study|Lost to Follow-up|1|||
23429154|NCT00930969|65314490|FG000|Overall Study|Physician Decision|13|||
23429155|NCT00930969|65314490|FG000|Overall Study|Withdrawal by Subject|19|||
23429156|NCT00334282|65314497|FG000|Overall Study|Lost to Follow-up|11|||
23429157|NCT00334282|65314498|FG001|Overall Study|Lost to Follow-up|5|||
23429158|NCT00334282|65314497|FG000|Overall Study|Withdrawal by Subject|17|||
23429159|NCT00334282|65314498|FG001|Overall Study|Withdrawal by Subject|3|||
23429160|NCT00334282|65314497|FG000|Overall Study|Death|194|||
23429161|NCT00334282|65314498|FG001|Overall Study|Death|100|||
23429162|NCT02308488|65314499|FG000|Overall Study|Withdrawal by Subject|2|||
23429163|NCT02966015|65314500|FG000|Inclusion Visit|did not answer questionnaire|8|||
23429164|NCT02966015|65314501|FG001|Inclusion Visit|did not answer questionnaire|3|||
23429165|NCT04957758|65314502|FG000|Overall Study|Adverse Event|1|||
23429166|NCT04957758|65314503|FG001|Overall Study|Adverse Event|0|||
23429167|NCT04957758|65314502|FG000|Overall Study|Lost to Follow-up|0|||
23135612|NCT00704405|64244410|FG002|Overall Study (NC Population)|Other|0|||
23429168|NCT04957758|65314503|FG001|Overall Study|Lost to Follow-up|2|||
23429169|NCT04957758|65314502|FG000|Overall Study|Withdrawal by Subject|4|||
23429170|NCT04957758|65314503|FG001|Overall Study|Withdrawal by Subject|2|||
23429171|NCT04957758|65314502|FG000|Overall Study|Protocol Violation|0|||
23429172|NCT04957758|65314503|FG001|Overall Study|Protocol Violation|1|||
23429173|NCT01443130|65314510|FG000|Overall Study|Lost to Follow-up|44|||
23429174|NCT01443130|65314511|FG001|Overall Study|Lost to Follow-up|42|||
23429175|NCT01443130|65314512|FG002|Overall Study|Lost to Follow-up|50|||
23429176|NCT01443130|65314513|FG003|Overall Study|Lost to Follow-up|23|||
23429177|NCT01443130|65314514|FG004|Overall Study|Lost to Follow-up|25|||
23429178|NCT01443130|65314515|FG005|Overall Study|Lost to Follow-up|21|||
23429179|NCT01443130|65314510|FG000|Overall Study|Death|0|||
23429180|NCT01443130|65314511|FG001|Overall Study|Death|1|||
23429181|NCT01443130|65314512|FG002|Overall Study|Death|0|||
23429182|NCT01443130|65314513|FG003|Overall Study|Death|7|||
23429183|NCT01443130|65314514|FG004|Overall Study|Death|10|||
23429184|NCT01443130|65314515|FG005|Overall Study|Death|8|||
23429185|NCT01443130|65314510|FG000|Overall Study|Adverse Event|2|||
23429186|NCT01443130|65314511|FG001|Overall Study|Adverse Event|1|||
23429187|NCT01443130|65314512|FG002|Overall Study|Adverse Event|1|||
23429188|NCT01443130|65314513|FG003|Overall Study|Adverse Event|0|||
23429189|NCT01443130|65314514|FG004|Overall Study|Adverse Event|0|||
23429190|NCT01443130|65314515|FG005|Overall Study|Adverse Event|0|||
23429191|NCT01443130|65314510|FG000|Overall Study|Protocol Violation|2|||
23429192|NCT01443130|65314511|FG001|Overall Study|Protocol Violation|1|||
23429193|NCT01443130|65314512|FG002|Overall Study|Protocol Violation|3|||
23429194|NCT01443130|65314513|FG003|Overall Study|Protocol Violation|2|||
23429195|NCT01443130|65314514|FG004|Overall Study|Protocol Violation|2|||
23549614|NCT00127101|65739763|FG001|Base Protocol|Lack of Efficacy|0|||
23549615|NCT00127101|65739764|FG002|Base Protocol|Lack of Efficacy|0|||
23549616|NCT00127101|65739765|FG003|Base Protocol|Lack of Efficacy|0|||
23549617|NCT00127101|65739766|FG004|Base Protocol|Lack of Efficacy|2|||
23549618|NCT00127101|65739767|FG005|Base Protocol|Lack of Efficacy|0|||
23549619|NCT00127101|65739762|FG000|Base Protocol|Withdrawal by Subject|1|||
23549620|NCT00127101|65739763|FG001|Base Protocol|Withdrawal by Subject|2|||
23549621|NCT00127101|65739764|FG002|Base Protocol|Withdrawal by Subject|1|||
23549622|NCT00127101|65739765|FG003|Base Protocol|Withdrawal by Subject|0|||
23549623|NCT00127101|65739766|FG004|Base Protocol|Withdrawal by Subject|0|||
23549624|NCT00127101|65739767|FG005|Base Protocol|Withdrawal by Subject|1|||
23549625|NCT00127101|65739762|FG000|Continuation Phase|Adverse Event|0|||
23549626|NCT00127101|65739763|FG001|Continuation Phase|Adverse Event|0|||
23549627|NCT00127101|65739764|FG002|Continuation Phase|Adverse Event|0|||
23549628|NCT00127101|65739765|FG003|Continuation Phase|Adverse Event|0|||
23549629|NCT00127101|65739766|FG004|Continuation Phase|Adverse Event|1|||
23549630|NCT00127101|65739767|FG005|Continuation Phase|Adverse Event|1|||
23549631|NCT00127101|65739762|FG000|Continuation Phase|Lack of Efficacy|0|||
23549632|NCT00127101|65739763|FG001|Continuation Phase|Lack of Efficacy|0|||
23549633|NCT00127101|65739764|FG002|Continuation Phase|Lack of Efficacy|0|||
23549634|NCT00127101|65739765|FG003|Continuation Phase|Lack of Efficacy|0|||
23549635|NCT00127101|65739766|FG004|Continuation Phase|Lack of Efficacy|0|||
23549636|NCT00127101|65739767|FG005|Continuation Phase|Lack of Efficacy|1|||
23549637|NCT00127101|65739762|FG000|Continuation Phase|Withdrawal by Subject|0|||
23549638|NCT00127101|65739763|FG001|Continuation Phase|Withdrawal by Subject|0|||
23549639|NCT00127101|65739764|FG002|Continuation Phase|Withdrawal by Subject|1|||
23549640|NCT00127101|65739765|FG003|Continuation Phase|Withdrawal by Subject|0|||
23317561|NCT00993421|64904107|FG003|Overall Study|Lost to Follow-up|0|||
23429196|NCT01443130|65314515|FG005|Overall Study|Protocol Violation|3|||
23429197|NCT01443130|65314510|FG000|Overall Study|Withdrawal by Subject|15|||
23429198|NCT01443130|65314511|FG001|Overall Study|Withdrawal by Subject|14|||
23429199|NCT01443130|65314512|FG002|Overall Study|Withdrawal by Subject|12|||
23429200|NCT01443130|65314513|FG003|Overall Study|Withdrawal by Subject|7|||
23429201|NCT01443130|65314514|FG004|Overall Study|Withdrawal by Subject|7|||
23429202|NCT01443130|65314515|FG005|Overall Study|Withdrawal by Subject|2|||
23429203|NCT01443130|65314510|FG000|Overall Study|Death of Subject's Infant|5|||
23429204|NCT01443130|65314511|FG001|Overall Study|Death of Subject's Infant|10|||
23429205|NCT01443130|65314512|FG002|Overall Study|Death of Subject's Infant|11|||
23429206|NCT01443130|65314513|FG003|Overall Study|Death of Subject's Infant|0|||
23429207|NCT01443130|65314514|FG004|Overall Study|Death of Subject's Infant|0|||
23429208|NCT01443130|65314515|FG005|Overall Study|Death of Subject's Infant|0|||
23429209|NCT02771626|65314516|FG000|Overall Study|Adverse Event|1|||
23429210|NCT02771626|65314517|FG001|Overall Study|Adverse Event|5|||
23549641|NCT00127101|65739766|FG004|Continuation Phase|Withdrawal by Subject|2|||
23549642|NCT00127101|65739767|FG005|Continuation Phase|Withdrawal by Subject|1|||
23549643|NCT00698646|65739768|FG000|Overall Study|Adverse Event|8|||
23549644|NCT00698646|65739769|FG001|Overall Study|Adverse Event|7|||
23317562|NCT00993421|64904108|FG004|Overall Study|Lost to Follow-up|0|||
23429211|NCT02771626|65314518|FG002|Overall Study|Adverse Event|3|||
23549645|NCT00698646|65739770|FG002|Overall Study|Adverse Event|8|||
23549646|NCT00698646|65739768|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
23429212|NCT02771626|65314519|FG003|Overall Study|Adverse Event|0|||
23429213|NCT02771626|65314520|FG004|Overall Study|Adverse Event|1|||
23429214|NCT02771626|65314521|FG005|Overall Study|Adverse Event|1|||
23429215|NCT02771626|65314516|FG000|Overall Study|Radiologic Disease Progression|6|||
23429216|NCT02771626|65314517|FG001|Overall Study|Radiologic Disease Progression|13|||
23429217|NCT02771626|65314518|FG002|Overall Study|Radiologic Disease Progression|10|||
23429218|NCT02771626|65314519|FG003|Overall Study|Radiologic Disease Progression|7|||
23429219|NCT02771626|65314520|FG004|Overall Study|Radiologic Disease Progression|28|||
23429220|NCT02771626|65314521|FG005|Overall Study|Radiologic Disease Progression|15|||
23429221|NCT02771626|65314516|FG000|Overall Study|Symptomatic Deterioration|0|||
23429222|NCT02771626|65314517|FG001|Overall Study|Symptomatic Deterioration|4|||
23429223|NCT02771626|65314518|FG002|Overall Study|Symptomatic Deterioration|2|||
23429224|NCT02771626|65314519|FG003|Overall Study|Symptomatic Deterioration|0|||
23429225|NCT02771626|65314520|FG004|Overall Study|Symptomatic Deterioration|5|||
23429226|NCT02771626|65314521|FG005|Overall Study|Symptomatic Deterioration|2|||
23429227|NCT02771626|65314516|FG000|Overall Study|Participant Request|0|||
23429228|NCT02771626|65314517|FG001|Overall Study|Participant Request|1|||
23429229|NCT02771626|65314518|FG002|Overall Study|Participant Request|0|||
23429230|NCT02771626|65314519|FG003|Overall Study|Participant Request|2|||
23429231|NCT02771626|65314520|FG004|Overall Study|Participant Request|0|||
23429232|NCT02771626|65314521|FG005|Overall Study|Participant Request|1|||
23429233|NCT02771626|65314516|FG000|Overall Study|Investigator Decision|0|||
23429234|NCT02771626|65314517|FG001|Overall Study|Investigator Decision|1|||
23429235|NCT02771626|65314518|FG002|Overall Study|Investigator Decision|0|||
23429236|NCT02771626|65314519|FG003|Overall Study|Investigator Decision|0|||
23429237|NCT02771626|65314520|FG004|Overall Study|Investigator Decision|1|||
23429238|NCT02771626|65314521|FG005|Overall Study|Investigator Decision|0|||
23429239|NCT02771626|65314516|FG000|Overall Study|Study Termination by Sponsor|0|||
23429240|NCT02771626|65314517|FG001|Overall Study|Study Termination by Sponsor|2|||
23429241|NCT02771626|65314518|FG002|Overall Study|Study Termination by Sponsor|1|||
23429242|NCT02771626|65314519|FG003|Overall Study|Study Termination by Sponsor|0|||
23429243|NCT02771626|65314520|FG004|Overall Study|Study Termination by Sponsor|1|||
23429244|NCT02771626|65314521|FG005|Overall Study|Study Termination by Sponsor|0|||
23429245|NCT02771626|65314516|FG000|Overall Study|Informed Consent Withdrawn|0|||
23429246|NCT02771626|65314517|FG001|Overall Study|Informed Consent Withdrawn|0|||
23429247|NCT02771626|65314518|FG002|Overall Study|Informed Consent Withdrawn|1|||
23429248|NCT02771626|65314519|FG003|Overall Study|Informed Consent Withdrawn|0|||
23429249|NCT02771626|65314520|FG004|Overall Study|Informed Consent Withdrawn|1|||
23429250|NCT02771626|65314521|FG005|Overall Study|Informed Consent Withdrawn|1|||
23429251|NCT02771626|65314516|FG000|Overall Study|Other, Not Specified|1|||
23429252|NCT02771626|65314517|FG001|Overall Study|Other, Not Specified|0|||
23429253|NCT02771626|65314518|FG002|Overall Study|Other, Not Specified|0|||
23429254|NCT02771626|65314519|FG003|Overall Study|Other, Not Specified|0|||
23429255|NCT02771626|65314520|FG004|Overall Study|Other, Not Specified|0|||
23429256|NCT02771626|65314521|FG005|Overall Study|Other, Not Specified|1|||
23429257|NCT00664326|65314522|FG000|Overall Study|Adverse Event|14|||
23429258|NCT00664326|65314522|FG000|Overall Study|Noncompliance with study medication|3|||
23429259|NCT00664326|65314522|FG000|Overall Study|Withdrawal by Subject|1|||
23429260|NCT00664326|65314522|FG000|Overall Study|Physician Decision|1|||
23429261|NCT00664326|65314522|FG000|Overall Study|Other Reasons|3|||
23429262|NCT00664326|65314522|FG000|Overall Study|Death|2|||
23429263|NCT00664326|65314522|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
23429264|NCT02713529|65314523|FG000|Overall Study|Withdrawal by Subject|3|||
23429265|NCT02713529|65314524|FG001|Overall Study|Withdrawal by Subject|1|||
23429266|NCT02713529|65314525|FG002|Overall Study|Withdrawal by Subject|4|||
23429267|NCT02713529|65314526|FG003|Overall Study|Withdrawal by Subject|2|||
23429268|NCT02713529|65314527|FG004|Overall Study|Withdrawal by Subject|0|||
23429269|NCT02713529|65314528|FG005|Overall Study|Withdrawal by Subject|1|||
23429270|NCT02713529|65314529|FG006|Overall Study|Withdrawal by Subject|1|||
23429271|NCT02713529|65314523|FG000|Overall Study|Lost to Follow-up|1|||
23429272|NCT02713529|65314524|FG001|Overall Study|Lost to Follow-up|0|||
23429273|NCT02713529|65314525|FG002|Overall Study|Lost to Follow-up|1|||
23429274|NCT02713529|65314526|FG003|Overall Study|Lost to Follow-up|0|||
23429275|NCT02713529|65314527|FG004|Overall Study|Lost to Follow-up|0|||
23429276|NCT02713529|65314528|FG005|Overall Study|Lost to Follow-up|0|||
23429277|NCT02713529|65314529|FG006|Overall Study|Lost to Follow-up|0|||
23429278|NCT02713529|65314523|FG000|Overall Study|Death|3|||
23429279|NCT02713529|65314524|FG001|Overall Study|Death|3|||
23429280|NCT02713529|65314525|FG002|Overall Study|Death|26|||
23429281|NCT02713529|65314526|FG003|Overall Study|Death|27|||
23429282|NCT02713529|65314527|FG004|Overall Study|Death|3|||
23429283|NCT02713529|65314528|FG005|Overall Study|Death|13|||
23429284|NCT02713529|65314529|FG006|Overall Study|Death|3|||
23429285|NCT00031460|65314530|FG000|Overall Study|Lost to Follow-up|0|||
23429286|NCT00031460|65314531|FG001|Overall Study|Lost to Follow-up|1|||
23429287|NCT00031460|65314530|FG000|Overall Study|Withdrawal by Subject|1|||
23429288|NCT00031460|65314531|FG001|Overall Study|Withdrawal by Subject|1|||
23429289|NCT00031460|65314530|FG000|Overall Study|Non-Compliant|1|||
23429290|NCT00031460|65314531|FG001|Overall Study|Non-Compliant|1|||
23429291|NCT00031460|65314530|FG000|Overall Study|Death|0|||
23429292|NCT00031460|65314531|FG001|Overall Study|Death|1|||
23429293|NCT00031460|65314530|FG000|Overall Study|Reactivation of Disease|5|||
23429294|NCT00031460|65314531|FG001|Overall Study|Reactivation of Disease|9|||
23429295|NCT00031460|65314530|FG000|Overall Study|Disruption of blinded drug supply|2|||
23429296|NCT00031460|65314531|FG001|Overall Study|Disruption of blinded drug supply|0|||
23429297|NCT00031460|65314530|FG000|Overall Study|Confirmed unevaluable|0|||
23429298|NCT00031460|65314531|FG001|Overall Study|Confirmed unevaluable|1|||
23429299|NCT02428413|65314532|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
23429300|NCT02428413|65314533|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
23429301|NCT02428413|65314532|FG000|Overall Study|Protocol Violation|1|||
23429302|NCT02428413|65314533|FG001|Overall Study|Protocol Violation|2|||
23429303|NCT02428413|65314532|FG000|Overall Study|Case Cancelled|2|||
23429304|NCT02428413|65314533|FG001|Overall Study|Case Cancelled|0|||
23429305|NCT02428413|65314532|FG000|Overall Study|Missed Cases|1|||
23429306|NCT02428413|65314533|FG001|Overall Study|Missed Cases|2|||
23429307|NCT02428413|65314532|FG000|Overall Study|Nurse Refusal|1|||
23429308|NCT02428413|65314533|FG001|Overall Study|Nurse Refusal|0|||
23429309|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
23429310|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
23429311|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
23429312|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
23429313|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
23429314|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
23429315|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
23429316|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
23429317|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
23429318|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
23429319|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
23429320|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
23429321|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
23429322|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
23549647|NCT00698646|65739769|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
23549648|NCT00698646|65739770|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
23549649|NCT00698646|65739768|FG000|Overall Study|Protocol Deviation|6|||
23549650|NCT00698646|65739769|FG001|Overall Study|Protocol Deviation|2|||
23549651|NCT00698646|65739770|FG002|Overall Study|Protocol Deviation|3|||
23549652|NCT00698646|65739768|FG000|Overall Study|Withdrawal by Subject|10|||
23549653|NCT00698646|65739769|FG001|Overall Study|Withdrawal by Subject|11|||
23549654|NCT00698646|65739770|FG002|Overall Study|Withdrawal by Subject|8|||
23549655|NCT00698646|65739768|FG000|Overall Study|Lost to Follow-up|0|||
23549656|NCT00698646|65739769|FG001|Overall Study|Lost to Follow-up|0|||
23549657|NCT00698646|65739770|FG002|Overall Study|Lost to Follow-up|2|||
23549658|NCT00698646|65739768|FG000|Overall Study|Administrative problems|1|||
23549659|NCT00698646|65739769|FG001|Overall Study|Administrative problems|0|||
23549660|NCT00698646|65739770|FG002|Overall Study|Administrative problems|1|||
23549661|NCT01349569|65739774|FG000|Overall Study|Lack of Efficacy|4|||
23549662|NCT02216123|65739775|FG000|Overall Study|Lost to Follow-up|4|||
23549663|NCT02216123|65739776|FG001|Overall Study|Lost to Follow-up|2|||
23549664|NCT02216123|65739775|FG000|Overall Study|Withdrawal by Subject|2|||
23549665|NCT02216123|65739776|FG001|Overall Study|Withdrawal by Subject|0|||
23549666|NCT03643952|65739777|FG000|Overall Study|Lack of Efficacy|1|||
23549667|NCT02239679|65739785|FG000|Overall Study|Lost to Follow-up|1|||
23549668|NCT02239679|65739786|FG001|Overall Study|Lost to Follow-up|0|||
23549669|NCT02239679|65739787|FG002|Overall Study|Lost to Follow-up|0|||
23549670|NCT02239679|65739785|FG000|Overall Study|Withdrawal by Subject|2|||
23620284|NCT01232569|65994938|FG001|Double-blind Treatment Period|Escape|2|||
23620285|NCT01232569|65994939|FG002|Double-blind Treatment Period|Escape|0|||
23620286|NCT01232569|65994940|FG003|Double-blind Treatment Period|Escape|0|||
23620287|NCT01232569|65994937|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
23620288|NCT01232569|65994938|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23620289|NCT01232569|65994939|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23620290|NCT01232569|65994940|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23214703|NCT00924729|64528029|FG001|Overall Study|insufficient volume for analysis|0|||
23214704|NCT00924729|64528028|FG000|Overall Study|Protocol Violation|1|||
23214705|NCT00924729|64528029|FG001|Overall Study|Protocol Violation|0|||
23214706|NCT01135017|64528030|FG000|Overall Study|Adverse Event|3|||
23429323|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
23549671|NCT02239679|65739786|FG001|Overall Study|Withdrawal by Subject|3|||
23549672|NCT02239679|65739787|FG002|Overall Study|Withdrawal by Subject|1|||
23429324|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
23214707|NCT01135017|64528031|FG001|Overall Study|Adverse Event|8|||
23429325|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
23429326|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
23429327|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
23429328|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
23549673|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
23549674|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
23214708|NCT01135017|64528030|FG000|Overall Study|Other than above|3|||
23549675|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
23549676|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
23549677|NCT00983073|65739788|FG000|Titration and Optimal Dose Period|Other reason|4|||
23549678|NCT00983073|65739788|FG000|Maintenance Period|Adverse Event|5|||
23549679|NCT00983073|65739788|FG000|Maintenance Period|Withdrawal by Subject|2|||
23549680|NCT00983073|65739788|FG000|Maintenance Period|Lack of Efficacy|2|||
23549681|NCT00983073|65739788|FG000|Maintenance Period|Other Reason|7|||
23549682|NCT01178086|65739789|FG000|Overall Study|Participant refusal|7|||
23549683|NCT01178086|65739789|FG000|Overall Study|Physician Decision|44|||
23549684|NCT01178086|65739789|FG000|Overall Study|Switch to other CLL therapy|113|||
23549685|NCT01178086|65739789|FG000|Overall Study|Death|59|||
23549686|NCT01178086|65739789|FG000|Overall Study|Other unspecified|89|||
23549687|NCT01178086|65739789|FG000|Overall Study|Excluded from EAS|20|||
23549688|NCT00700401|65739790|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
23549689|NCT00700401|65739790|FG000|Overall Study|Adverse Event|5|||
23549690|NCT00700401|65739790|FG000|Overall Study|Refused Treatment|2|||
23549691|NCT00700401|65739790|FG000|Overall Study|Lost to Follow-up|1|||
23549692|NCT00700401|65739790|FG000|Overall Study|Treatment never started|1|||
23549693|NCT00700401|65739790|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
23549694|NCT00700401|65739790|FG000|Overall Study|Withdrawal by Subject|2|||
23549695|NCT01343407|65739792|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
23549696|NCT01343407|65739793|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
23549697|NCT01343407|65739794|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
23549698|NCT01343407|65739795|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
23549699|NCT01343407|65739796|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
23549700|NCT01343407|65739797|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
23549701|NCT01343407|65739792|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549702|NCT01343407|65739793|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549703|NCT01343407|65739794|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
23549704|NCT01343407|65739795|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549705|NCT01343407|65739796|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549706|NCT01343407|65739797|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
23549707|NCT00450411|65739801|FG000|Overall Study|Protocol Violation|6|||
23549708|NCT00450411|65739801|FG000|Overall Study|No protocol treatment|2|||
23549709|NCT00996996|65739804|FG000|Overall Study|Progressive Disease|10|||
23549710|NCT00996996|65739804|FG000|Overall Study|Non-compliance|8|||
23549711|NCT00996996|65739804|FG000|Overall Study|Lost to Follow-up|9|||
23549712|NCT00996996|65739804|FG000|Overall Study|Death|5|||
23549713|NCT00996996|65739804|FG000|Overall Study|Did Not Receive Study Medications|1|||
23549714|NCT02511431|65739805|FG000|Treatment|Lost to Follow-up|0|||
23549715|NCT02511431|65739806|FG001|Treatment|Lost to Follow-up|0|||
23549716|NCT02511431|65739807|FG002|Treatment|Lost to Follow-up|1|||
23549717|NCT02511431|65739808|FG003|Treatment|Lost to Follow-up|0|||
23549718|NCT02511431|65739809|FG004|Treatment|Lost to Follow-up|0|||
23549719|NCT02511431|65739810|FG005|Treatment|Lost to Follow-up|1|||
23549720|NCT01650259|65739811|FG000|Overall Study|Improvement|105|||
23549721|NCT01650259|65739812|FG001|Overall Study|Improvement|0|||
23549722|NCT01650259|65739811|FG000|Overall Study|Adverse Event|127|||
23549723|NCT01650259|65739812|FG001|Overall Study|Adverse Event|0|||
23549724|NCT01650259|65739811|FG000|Overall Study|Lack of Efficacy|143|||
23549725|NCT01650259|65739812|FG001|Overall Study|Lack of Efficacy|0|||
23549726|NCT01650259|65739811|FG000|Overall Study|Lost to Follow-up|435|||
23549727|NCT01650259|65739812|FG001|Overall Study|Lost to Follow-up|0|||
23549728|NCT01650259|65739811|FG000|Overall Study|Patients had no visit after entry|70|||
23549729|NCT01650259|65739812|FG001|Overall Study|Patients had no visit after entry|0|||
23214709|NCT01135017|64528031|FG001|Overall Study|Other than above|4|||
23214710|NCT00802867|64528032|FG000|Overall Study|Lost to Follow-up|6|||
23214711|NCT00802867|64528032|FG000|Overall Study|Protocol Violation|6|||
23214712|NCT00802867|64528032|FG000|Overall Study|Withdrawal by Subject|1|||
23214713|NCT02394795|64528033|FG000|Overall Study|Adverse Event|92|||
23214714|NCT02394795|64528034|FG001|Overall Study|Adverse Event|70|||
23214715|NCT02394795|64528033|FG000|Overall Study|Lost to Follow-up|0|||
23214716|NCT02394795|64528034|FG001|Overall Study|Lost to Follow-up|1|||
23214717|NCT02394795|64528033|FG000|Overall Study|Withdrawal by Subject|17|||
23214718|NCT02394795|64528034|FG001|Overall Study|Withdrawal by Subject|26|||
23214719|NCT02394795|64528033|FG000|Overall Study|Lack of Efficacy|181|||
23317563|NCT00993421|64904109|FG005|Overall Study|Lost to Follow-up|0|||
23549730|NCT01650259|65739811|FG000|Overall Study|CRF not collected|98|||
23549731|NCT01650259|65739812|FG001|Overall Study|CRF not collected|82|||
23549732|NCT01650259|65739811|FG000|Overall Study|Not treated|1|||
23549733|NCT01650259|65739812|FG001|Overall Study|Not treated|7|||
23549734|NCT01650259|65739811|FG000|Overall Study|Other than listed|64|||
23549735|NCT01650259|65739812|FG001|Overall Study|Other than listed|146|||
23549736|NCT00047879|65743010|FG000|Overall Study|Progressive disease|4|||
23549737|NCT00047879|65743011|FG001|Overall Study|Progressive disease|3|||
23214720|NCT02394795|64528034|FG001|Overall Study|Lack of Efficacy|211|||
23214721|NCT02394795|64528033|FG000|Overall Study|Death|4|||
23214722|NCT02394795|64528034|FG001|Overall Study|Death|5|||
23429329|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
23429330|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
23429331|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
23429332|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
23429333|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
23429334|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
23429335|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
23429336|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
23429337|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
23429338|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
23429339|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
23429340|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
23429341|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
23429342|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
23429343|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
23429344|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
23429345|NCT02198794|65314537|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
23429346|NCT02198794|65314538|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
23429347|NCT02198794|65314539|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
23429348|NCT02198794|65314540|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
23429349|NCT02198794|65314537|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
23429350|NCT02198794|65314538|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
23429351|NCT02198794|65314539|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
23429352|NCT02198794|65314540|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
23429353|NCT02198794|65314537|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
23429354|NCT02198794|65314538|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
23429355|NCT02198794|65314539|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
23429356|NCT02198794|65314540|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
23429357|NCT02198794|65314537|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
23429358|NCT02198794|65314538|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
23429359|NCT02198794|65314539|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
23429360|NCT02198794|65314540|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
23429361|NCT02198794|65314537|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
23429362|NCT02198794|65314538|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
23429363|NCT02198794|65314539|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
23549738|NCT02570126|65743016|FG000|Overall Study|Lost to Follow-up|2|||
23549739|NCT02570126|65743017|FG001|Overall Study|Lost to Follow-up|0|||
23549740|NCT02570126|65743016|FG000|Overall Study|Unable To Arrange Visit 3|1|||
23549741|NCT02570126|65743017|FG001|Overall Study|Unable To Arrange Visit 3|0|||
23549742|NCT02570126|65743016|FG000|Overall Study|Violation Of Procedures GSK|0|||
23549743|NCT02570126|65743017|FG001|Overall Study|Violation Of Procedures GSK|1|||
23549744|NCT02570126|65743016|FG000|Overall Study|Protocol Violation|0|||
23549745|NCT02570126|65743017|FG001|Overall Study|Protocol Violation|1|||
23549746|NCT02570126|65743016|FG000|Overall Study|Withdrawal by Subject|3|||
23549747|NCT02570126|65743017|FG001|Overall Study|Withdrawal by Subject|7|||
23135613|NCT00704405|64244411|FG003|Overall Study (NC Population)|Other|0|||
23135614|NCT00704405|64244412|FG004|Overall Study (NC Population)|Other|1|||
23135615|NCT00704405|64244408|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
23135616|NCT00704405|64244409|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
23135617|NCT00704405|64244410|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
23135618|NCT00704405|64244411|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
23135619|NCT00704405|64244412|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
23135620|NCT00704405|64244408|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
23135621|NCT00704405|64244409|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
23135622|NCT00704405|64244410|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
23135623|NCT00704405|64244411|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
23135624|NCT00704405|64244412|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
23135625|NCT03291288|64244415|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
23135626|NCT03291288|64244416|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
23135627|NCT03291288|64244415|FG000|Drug-drug Interaction Phase|Disease progression|1|||
23135628|NCT03291288|64244416|FG001|Drug-drug Interaction Phase|Disease progression|0|||
23135629|NCT03291288|64244415|FG000|Drug-drug Interaction Phase|Other|3|||
23135630|NCT03291288|64244416|FG001|Drug-drug Interaction Phase|Other|0|||
23135631|NCT03291288|64244415|FG000|Pexidartinib Only|Ongoing|0|||
23135632|NCT03291288|64244416|FG001|Pexidartinib Only|Ongoing|2|||
23135633|NCT00608868|64244425|FG000|Overall Study|Withdrawal by Subject|7|||
23135634|NCT00608868|64244425|FG000|Overall Study|Protocol Violation|3|||
23429364|NCT02198794|65314540|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
23429365|NCT02198794|65314537|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
23429366|NCT02198794|65314538|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
23429367|NCT02198794|65314539|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
23429368|NCT02198794|65314540|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
23429369|NCT04284813|65314542|FG000|Overall Study|Withdrawal by Subject|1|||
23429370|NCT00203021|65314543|FG000|Overall Study|Death|4|||
23429371|NCT00203021|65314544|FG001|Overall Study|Death|1|||
23429372|NCT00203021|65314543|FG000|Overall Study|Adverse Event|10|||
23429373|NCT00203021|65314544|FG001|Overall Study|Adverse Event|5|||
23429374|NCT00203021|65314543|FG000|Overall Study|Withdrawal by Subject|45|||
23429375|NCT00203021|65314544|FG001|Overall Study|Withdrawal by Subject|48|||
23429376|NCT00203021|65314543|FG000|Overall Study|Lost to Follow-up|9|||
23429377|NCT00203021|65314544|FG001|Overall Study|Lost to Follow-up|7|||
23429378|NCT00203021|65314543|FG000|Overall Study|Other than specified|11|||
23429379|NCT00203021|65314544|FG001|Overall Study|Other than specified|16|||
23429380|NCT01440517|65314545|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
23429381|NCT02266875|65314548|FG000|Overall Study|Withdrawal by Subject|9|||
23429382|NCT02266875|65314549|FG001|Overall Study|Withdrawal by Subject|0|||
23429383|NCT02266875|65314548|FG000|Overall Study|Lost to Follow-up|2|||
23429384|NCT02266875|65314549|FG001|Overall Study|Lost to Follow-up|0|||
23429385|NCT03691779|65314550|FG000|Part B (24 Weeks)|Adverse Event|0|||
23429386|NCT03691779|65314551|FG001|Part B (24 Weeks)|Adverse Event|1|||
23429387|NCT03691779|65314550|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
23429388|NCT03691779|65314551|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
23429389|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
23429390|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
23429391|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
23429392|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
23429393|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
23429394|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
23429395|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
23429396|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
23429397|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
23429398|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
23429399|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
23429400|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
23429401|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
23429402|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
23429403|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
23429404|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
23429405|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
23429406|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
23429407|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
23429408|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
23429409|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
23429410|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
23429411|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
23429412|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
23549748|NCT03137303|65743018|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
23549749|NCT03137303|65743019|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
23549750|NCT03137303|65743018|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
23549751|NCT03137303|65743019|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
23549752|NCT03137303|65743018|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
23135635|NCT00608868|64244425|FG000|Overall Study|Lost to Follow-up|2|||
23135636|NCT00608868|64244425|FG000|Overall Study|Adverse Event|1|||
23429413|NCT01672866|65314555|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
23429414|NCT01672866|65314556|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
23429415|NCT01672866|65314557|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
23429416|NCT01672866|65314555|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
23429417|NCT01672866|65314556|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
23429418|NCT01672866|65314557|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
23549753|NCT03137303|65743019|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
23549754|NCT03137303|65743018|FG000|T3: 9-month Follow-up|Death|1|||
23135637|NCT00608868|64244425|FG000|Overall Study|Physician Decision|2|||
23135638|NCT02236988|64244426|FG000|Overall Study|Lost to Follow-up|0|||
23429419|NCT01672866|65314555|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
23429420|NCT01672866|65314556|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
23429421|NCT01672866|65314557|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
23429422|NCT01672866|65314555|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
23429423|NCT01672866|65314556|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
23549755|NCT03137303|65743019|FG001|T3: 9-month Follow-up|Death|0|||
23135639|NCT02236988|64244427|FG001|Overall Study|Lost to Follow-up|0|||
23429424|NCT01672866|65314557|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
23429425|NCT01672866|65314555|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
23429426|NCT01672866|65314556|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
23429427|NCT01672866|65314557|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
23429428|NCT02739321|65314558|FG000|Overall Study|Lack of Efficacy|1|||
23429429|NCT02739321|65314559|FG001|Overall Study|Lack of Efficacy|1|||
23429430|NCT02739321|65314558|FG000|Overall Study|Lost to Follow-up|1|||
23429431|NCT02739321|65314559|FG001|Overall Study|Lost to Follow-up|1|||
23429432|NCT02739321|65314558|FG000|Overall Study|Withdrawal by Subject|1|||
23429433|NCT02739321|65314559|FG001|Overall Study|Withdrawal by Subject|2|||
23429434|NCT01282294|65314560|FG000|Overall Study|Lost to Follow-up|14|||
23429435|NCT01282294|65314560|FG000|Overall Study|Screening failure|1|||
23429436|NCT01282294|65314560|FG000|Overall Study|Adverse Event|1|||
23429437|NCT01282294|65314560|FG000|Overall Study|Patient non-compliance|2|||
23429438|NCT01282294|65314560|FG000|Overall Study|Physician Decision|1|||
23429439|NCT02782325|65314561|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
23429440|NCT02782325|65314562|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
23429441|NCT02782325|65314563|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
23429442|NCT02782325|65314561|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
23429443|NCT02782325|65314562|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
23429444|NCT02782325|65314563|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
23429445|NCT01288612|65314574|FG000|Overall Study|Unable to contact|11|||
23429446|NCT01288612|65314575|FG001|Overall Study|Unable to contact|16|||
23429447|NCT01288612|65314576|FG002|Overall Study|Unable to contact|20|||
23429448|NCT01288612|65314574|FG000|Overall Study|Declined|78|||
23429449|NCT01288612|65314575|FG001|Overall Study|Declined|63|||
23429450|NCT01288612|65314576|FG002|Overall Study|Declined|62|||
23429451|NCT01288612|65314574|FG000|Overall Study|Unable to intubate|0|||
23429452|NCT01288612|65314575|FG001|Overall Study|Unable to intubate|3|||
23429453|NCT01288612|65314576|FG002|Overall Study|Unable to intubate|0|||
23429454|NCT03426631|65314577|FG000|Overall Study|Lost to Follow-up|0|||
23429455|NCT03426631|65314578|FG001|Overall Study|Lost to Follow-up|1|||
23429456|NCT00844805|65314584|FG000|Treatment Phase|Adverse Event|5|||
23429457|NCT00844805|65314585|FG001|Treatment Phase|Adverse Event|1|||
23429458|NCT00844805|65314586|FG002|Treatment Phase|Adverse Event|0|||
23429459|NCT00844805|65314587|FG003|Treatment Phase|Adverse Event|0|||
23429460|NCT00844805|65314584|FG000|Treatment Phase|Withdrawal by Subject|3|||
23429461|NCT00844805|65314585|FG001|Treatment Phase|Withdrawal by Subject|4|||
23429462|NCT00844805|65314586|FG002|Treatment Phase|Withdrawal by Subject|0|||
23429463|NCT00844805|65314587|FG003|Treatment Phase|Withdrawal by Subject|0|||
23429464|NCT00844805|65314584|FG000|Treatment Phase|Noncompliance With Protocol|1|||
23429465|NCT00844805|65314585|FG001|Treatment Phase|Noncompliance With Protocol|0|||
23429466|NCT00844805|65314586|FG002|Treatment Phase|Noncompliance With Protocol|0|||
23429467|NCT00844805|65314587|FG003|Treatment Phase|Noncompliance With Protocol|0|||
23429468|NCT00844805|65314584|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
23429469|NCT00844805|65314585|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
23429470|NCT00844805|65314586|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
23429471|NCT00844805|65314587|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
23429472|NCT00844805|65314584|FG000|Follow-Up Phase|Adverse Event|0|||
23429473|NCT00844805|65314585|FG001|Follow-Up Phase|Adverse Event|0|||
23429474|NCT00844805|65314586|FG002|Follow-Up Phase|Adverse Event|1|||
23429475|NCT00844805|65314587|FG003|Follow-Up Phase|Adverse Event|0|||
23429476|NCT00844805|65314584|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
23429477|NCT00844805|65314585|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
23429478|NCT00844805|65314586|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
23429479|NCT00844805|65314587|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
23429480|NCT00844805|65314584|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
23429481|NCT00844805|65314585|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
23429482|NCT00844805|65314586|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
23429483|NCT00844805|65314587|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
23429484|NCT00844805|65314584|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
23429485|NCT00844805|65314585|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
23429486|NCT00844805|65314586|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
23429487|NCT00844805|65314587|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
23429488|NCT00844805|65314584|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
23429489|NCT00844805|65314585|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
23429490|NCT00844805|65314586|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
23429491|NCT00844805|65314587|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
23429492|NCT00461305|65317398|FG000|Treatment|Adverse Event|26|||
23429493|NCT00461305|65317399|FG001|Treatment|Adverse Event|3|||
23429494|NCT00461305|65317398|FG000|Treatment|Lost to Follow-up|4|||
23429495|NCT00461305|65317399|FG001|Treatment|Lost to Follow-up|2|||
23135640|NCT02236988|64244428|FG002|Overall Study|Lost to Follow-up|0|||
23135641|NCT02236988|64244429|FG003|Overall Study|Lost to Follow-up|1|||
23429496|NCT00461305|65317398|FG000|Treatment|Protocol Violation|13|||
23429497|NCT00461305|65317399|FG001|Treatment|Protocol Violation|2|||
23549756|NCT03137303|65743018|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
23549757|NCT03137303|65743019|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
23549758|NCT03137303|65743018|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
23549759|NCT03137303|65743019|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
23549760|NCT03137303|65743018|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
23549761|NCT03137303|65743019|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
23549762|NCT01627327|65743020|FG000|Overall Study|Adverse Event|6|||
23429498|NCT00461305|65317398|FG000|Treatment|Withdrawal by Subject|48|||
23429499|NCT00461305|65317399|FG001|Treatment|Withdrawal by Subject|2|||
23429500|NCT00461305|65317398|FG000|Treatment|Never dispensed|5|||
23429501|NCT00461305|65317399|FG001|Treatment|Never dispensed|0|||
23429502|NCT00461305|65317398|FG000|Treatment|Study drug not taken|1|||
23429503|NCT00461305|65317399|FG001|Treatment|Study drug not taken|0|||
23429504|NCT00461305|65317398|FG000|Treatment|Partially missing diary|2|||
23429505|NCT00461305|65317399|FG001|Treatment|Partially missing diary|0|||
23429506|NCT00461305|65317398|FG000|Treatment|Other (missing drug etc)|2|||
23429507|NCT00461305|65317399|FG001|Treatment|Other (missing drug etc)|0|||
23429508|NCT00461305|65317398|FG000|Continued Treatment|Adverse Event|26|||
23549763|NCT01627327|65743021|FG001|Overall Study|Adverse Event|12|||
23549764|NCT01627327|65743020|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
23549765|NCT01627327|65743021|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
23549766|NCT01627327|65743020|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
23549767|NCT01627327|65743021|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
23549768|NCT01627327|65743020|FG000|Overall Study|Protocol Violation|4|||
23549769|NCT01627327|65743021|FG001|Overall Study|Protocol Violation|10|||
23549770|NCT01627327|65743020|FG000|Overall Study|Lost to Follow-up|1|||
23549771|NCT01627327|65743021|FG001|Overall Study|Lost to Follow-up|3|||
23549772|NCT01627327|65743020|FG000|Overall Study|Physician Decision|1|||
23549773|NCT01627327|65743021|FG001|Overall Study|Physician Decision|0|||
23549774|NCT01627327|65743020|FG000|Overall Study|Withdrawal by Subject|3|||
23549775|NCT01627327|65743021|FG001|Overall Study|Withdrawal by Subject|3|||
23549776|NCT03077724|65743022|FG000|Overall Study|Lost to Follow-up|5|||
23549777|NCT03077724|65743023|FG001|Overall Study|Lost to Follow-up|1|||
23549778|NCT03077724|65743022|FG000|Overall Study|Withdrawal by Subject|3|||
23549779|NCT03077724|65743023|FG001|Overall Study|Withdrawal by Subject|1|||
23549780|NCT03492281|65743024|FG000|Overall Study|Withdrawal by Subject|21|||
23549781|NCT03492281|65743025|FG001|Overall Study|Withdrawal by Subject|14|||
23549782|NCT03492281|65743026|FG002|Overall Study|Withdrawal by Subject|13|||
23549783|NCT03492281|65743024|FG000|Overall Study|Lost to Follow-up|14|||
23549784|NCT03492281|65743025|FG001|Overall Study|Lost to Follow-up|15|||
23549785|NCT03492281|65743026|FG002|Overall Study|Lost to Follow-up|10|||
23549786|NCT03492281|65743024|FG000|Overall Study|Adverse Event|6|||
23549787|NCT03492281|65743025|FG001|Overall Study|Adverse Event|8|||
23549788|NCT03492281|65743026|FG002|Overall Study|Adverse Event|13|||
23549789|NCT03492281|65743024|FG000|Overall Study|Lack of Efficacy|3|||
23549790|NCT03492281|65743025|FG001|Overall Study|Lack of Efficacy|0|||
23549791|NCT03492281|65743026|FG002|Overall Study|Lack of Efficacy|1|||
23549792|NCT03492281|65743024|FG000|Overall Study|Physician Decision|1|||
23549793|NCT03492281|65743025|FG001|Overall Study|Physician Decision|0|||
23549794|NCT03492281|65743026|FG002|Overall Study|Physician Decision|3|||
23549795|NCT03492281|65743024|FG000|Overall Study|Protocol Violation|0|||
23135642|NCT02236988|64244426|FG000|Overall Study|Unable to Comply with Study Visits|0|||
23135643|NCT02236988|64244427|FG001|Overall Study|Unable to Comply with Study Visits|0|||
23135644|NCT02236988|64244428|FG002|Overall Study|Unable to Comply with Study Visits|0|||
23135645|NCT02236988|64244429|FG003|Overall Study|Unable to Comply with Study Visits|2|||
23135646|NCT02766777|64244430|FG000|Overall Study|Adverse Event|12|||
23135647|NCT02766777|64244430|FG000|Overall Study|Lost to Follow-up|16|||
23135648|NCT02766777|64244430|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23135649|NCT02766777|64244430|FG000|Overall Study|Protocol Violation|1|||
23135650|NCT02766777|64244430|FG000|Overall Study|Withdrawal by Subject|4|||
23135651|NCT00653523|64244431|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
23135652|NCT00653523|64244431|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
23135653|NCT00653523|64244431|FG000|Overall Study|Adverse Event|7|||
23135654|NCT00653523|64244431|FG000|Overall Study|Withdrawal by Subject|6|||
23429509|NCT00461305|65317399|FG001|Continued Treatment|Adverse Event|0|||
23549796|NCT03492281|65743025|FG001|Overall Study|Protocol Violation|2|||
23549797|NCT03492281|65743026|FG002|Overall Study|Protocol Violation|1|||
23549798|NCT03492281|65743024|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
23549799|NCT03492281|65743025|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
23214723|NCT02394795|64528033|FG000|Overall Study|Physician Decision|109|||
23549800|NCT03492281|65743026|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
23549801|NCT03492281|65743024|FG000|Overall Study|Death|0|||
23549802|NCT03492281|65743025|FG001|Overall Study|Death|0|||
23549803|NCT03492281|65743026|FG002|Overall Study|Death|1|||
23549804|NCT03492281|65743024|FG000|Overall Study|Captured as Other in Database|8|||
23549805|NCT03492281|65743025|FG001|Overall Study|Captured as Other in Database|6|||
23429510|NCT00461305|65317398|FG000|Continued Treatment|Lost to Follow-up|4|||
23549806|NCT03492281|65743026|FG002|Overall Study|Captured as Other in Database|3|||
23549807|NCT01371851|65743027|FG000|Overall Study|Lost to Follow-up|5|||
23549808|NCT01371851|65743028|FG001|Overall Study|Lost to Follow-up|8|||
23549809|NCT01371851|65743027|FG000|Overall Study|was arrested and put in jail|0|||
23549810|NCT01371851|65743028|FG001|Overall Study|was arrested and put in jail|1|||
23549811|NCT01371851|65743027|FG000|Overall Study|non study related adverse event|1|||
23549812|NCT01371851|65743028|FG001|Overall Study|non study related adverse event|0|||
23549813|NCT01371851|65743027|FG000|Overall Study|Blood Pressure outside study parameters|2|||
23549814|NCT01371851|65743028|FG001|Overall Study|Blood Pressure outside study parameters|0|||
23549815|NCT03213158|65743031|FG000|Overall Study|Withdrawal by Subject|1|||
23549816|NCT03213158|65743031|FG000|Overall Study|Physician Decision|2|||
23549817|NCT00201006|65743032|FG000|Overall Study|Withdrawal by Subject|7|||
23549818|NCT00201006|65743033|FG001|Overall Study|Withdrawal by Subject|2|||
23549819|NCT00201006|65743034|FG002|Overall Study|Withdrawal by Subject|3|||
23549820|NCT00201006|65743032|FG000|Overall Study|Adverse Event|1|||
23549821|NCT00201006|65743033|FG001|Overall Study|Adverse Event|0|||
23135655|NCT00653523|64244431|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
23135656|NCT00653523|64244431|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
23549822|NCT00201006|65743034|FG002|Overall Study|Adverse Event|1|||
23549823|NCT02077166|65743039|FG000|Overall Study|Death|6|||
23549824|NCT02077166|65743040|FG001|Overall Study|Death|7|||
23549825|NCT02077166|65743041|FG002|Overall Study|Death|5|||
23549826|NCT02077166|65743042|FG003|Overall Study|Death|6|||
23549827|NCT02077166|65743043|FG004|Overall Study|Death|4|||
23549828|NCT02077166|65743044|FG005|Overall Study|Death|32|||
23549829|NCT02077166|65743045|FG006|Overall Study|Death|22|||
23549830|NCT02077166|65743039|FG000|Overall Study|Study Closure by Sponsor|3|||
23549831|NCT02077166|65743040|FG001|Overall Study|Study Closure by Sponsor|0|||
23549832|NCT02077166|65743041|FG002|Overall Study|Study Closure by Sponsor|2|||
23549833|NCT02077166|65743042|FG003|Overall Study|Study Closure by Sponsor|2|||
23549834|NCT02077166|65743043|FG004|Overall Study|Study Closure by Sponsor|2|||
23549835|NCT02077166|65743044|FG005|Overall Study|Study Closure by Sponsor|12|||
23549836|NCT02077166|65743045|FG006|Overall Study|Study Closure by Sponsor|4|||
23549837|NCT02077166|65743039|FG000|Overall Study|Lost to Follow-up|0|||
23549838|NCT02077166|65743040|FG001|Overall Study|Lost to Follow-up|0|||
23549839|NCT02077166|65743041|FG002|Overall Study|Lost to Follow-up|0|||
23549840|NCT02077166|65743042|FG003|Overall Study|Lost to Follow-up|0|||
23549841|NCT02077166|65743043|FG004|Overall Study|Lost to Follow-up|0|||
23549842|NCT02077166|65743044|FG005|Overall Study|Lost to Follow-up|1|||
23549843|NCT02077166|65743045|FG006|Overall Study|Lost to Follow-up|0|||
23549844|NCT02077166|65743039|FG000|Overall Study|Withdrawal by Subject|3|||
23549845|NCT02077166|65743040|FG001|Overall Study|Withdrawal by Subject|0|||
23549846|NCT02077166|65743041|FG002|Overall Study|Withdrawal by Subject|1|||
23549847|NCT02077166|65743042|FG003|Overall Study|Withdrawal by Subject|1|||
23549848|NCT02077166|65743043|FG004|Overall Study|Withdrawal by Subject|1|||
23549849|NCT02077166|65743044|FG005|Overall Study|Withdrawal by Subject|3|||
23549850|NCT02077166|65743045|FG006|Overall Study|Withdrawal by Subject|0|||
23549851|NCT02077166|65743039|FG000|Overall Study|Other, Not Specified|0|||
23549852|NCT02077166|65743040|FG001|Overall Study|Other, Not Specified|0|||
23549853|NCT02077166|65743041|FG002|Overall Study|Other, Not Specified|1|||
23549854|NCT02077166|65743042|FG003|Overall Study|Other, Not Specified|0|||
23549855|NCT02077166|65743043|FG004|Overall Study|Other, Not Specified|1|||
23549856|NCT02077166|65743044|FG005|Overall Study|Other, Not Specified|7|||
23549857|NCT02077166|65743045|FG006|Overall Study|Other, Not Specified|8|||
23135657|NCT03001076|64244435|FG000|Overall Study|Withdrawal by patient|2|||
23135658|NCT03001076|64244436|FG001|Overall Study|Withdrawal by patient|0|||
23135659|NCT03001076|64244435|FG000|Overall Study|Other|1|||
23317564|NCT00993421|64904110|FG006|Overall Study|Lost to Follow-up|6|||
23549858|NCT03565887|65743046|FG000|Overall Study|Adverse Event|1|||
23549859|NCT03565887|65743047|FG001|Overall Study|Adverse Event|0|||
23549860|NCT03565887|65743046|FG000|Overall Study|Withdrawal by Subject|0|||
23549861|NCT03565887|65743047|FG001|Overall Study|Withdrawal by Subject|2|||
23549862|NCT03896035|65743048|FG000|Overall Study|Lost to Follow-up|2|||
23549863|NCT03896035|65743049|FG001|Overall Study|Lost to Follow-up|6|||
23549864|NCT03896035|65743048|FG000|Overall Study|Withdrawal by Subject|0|||
23549865|NCT03896035|65743049|FG001|Overall Study|Withdrawal by Subject|1|||
23549866|NCT03896035|65743048|FG000|Overall Study|Health/family health issues during COVID|0|||
23549867|NCT03896035|65743049|FG001|Overall Study|Health/family health issues during COVID|4|||
23549868|NCT00784810|65743050|FG000|Overall Study|Adverse Event|32|||
23549869|NCT00784810|65743051|FG001|Overall Study|Adverse Event|20|||
23135660|NCT03001076|64244436|FG001|Overall Study|Other|0|||
23549870|NCT00784810|65743050|FG000|Overall Study|Lack of Efficacy|14|||
23549871|NCT00784810|65743051|FG001|Overall Study|Lack of Efficacy|11|||
23549872|NCT00784810|65743050|FG000|Overall Study|Withdrawal by Subject|11|||
23549873|NCT00784810|65743051|FG001|Overall Study|Withdrawal by Subject|9|||
23549874|NCT00784810|65743050|FG000|Overall Study|Administrative|5|||
23549875|NCT00784810|65743051|FG001|Overall Study|Administrative|8|||
23549876|NCT00784810|65743050|FG000|Overall Study|Lost to Follow-up|1|||
23549877|NCT00784810|65743051|FG001|Overall Study|Lost to Follow-up|1|||
23549878|NCT03265600|65743052|FG000|Overall Study|Lost to Follow-up|17|||
23549879|NCT03265600|65743053|FG001|Overall Study|Lost to Follow-up|5|||
23549880|NCT03265600|65743052|FG000|Overall Study|Withdrawal by Subject|4|||
23549881|NCT03265600|65743053|FG001|Overall Study|Withdrawal by Subject|2|||
23549882|NCT03265600|65743052|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
23549883|NCT03265600|65743053|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
23620291|NCT01232569|65994937|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
23620292|NCT01232569|65994938|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
23620293|NCT01232569|65994939|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
23620294|NCT01232569|65994940|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
23620295|NCT01232569|65994937|FG000|Double-blind Treatment Period|Physician Decision|1|||
23620296|NCT01232569|65994938|FG001|Double-blind Treatment Period|Physician Decision|0|||
23620297|NCT01232569|65994939|FG002|Double-blind Treatment Period|Physician Decision|0|||
23620298|NCT01232569|65994940|FG003|Double-blind Treatment Period|Physician Decision|0|||
23620299|NCT01232569|65994937|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
23620300|NCT01232569|65994938|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
23620301|NCT01232569|65994939|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
23620302|NCT01232569|65994940|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
23620303|NCT01232569|65994937|FG000|Double-blind Treatment Period|Death|2|||
23620304|NCT01232569|65994938|FG001|Double-blind Treatment Period|Death|0|||
23620305|NCT01232569|65994939|FG002|Double-blind Treatment Period|Death|0|||
23620306|NCT01232569|65994940|FG003|Double-blind Treatment Period|Death|0|||
23620307|NCT01260142|65994942|FG000|Treatment Period 1|Study on hold|1|||
23620308|NCT01260142|65994943|FG001|Treatment Period 1|Study on hold|1|||
23620309|NCT01260142|65994944|FG002|Treatment Period 1|Study on hold|0|||
23620310|NCT01260142|65994945|FG003|Treatment Period 1|Study on hold|0|||
23620311|NCT01260142|65994946|FG004|Treatment Period 1|Study on hold|1|||
23620312|NCT01260142|65994947|FG005|Treatment Period 1|Study on hold|2|||
23620313|NCT01260142|65994942|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620314|NCT01260142|65994943|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620315|NCT01260142|65994944|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620316|NCT01260142|65994945|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620317|NCT01260142|65994946|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
23620318|NCT01260142|65994947|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
23620319|NCT01260142|65994942|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23620320|NCT01260142|65994943|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23620321|NCT01260142|65994944|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23620322|NCT01260142|65994945|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23620323|NCT01260142|65994946|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23549884|NCT02388724|65743056|FG000|Overall Study|Reason not Specified|0|||
23549885|NCT02388724|65743057|FG001|Overall Study|Reason not Specified|1|||
23549886|NCT02388724|65743056|FG000|Overall Study|Major Protocol Deviation|3|||
23549887|NCT02388724|65743057|FG001|Overall Study|Major Protocol Deviation|3|||
23549888|NCT02388724|65743056|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
23549889|NCT02388724|65743057|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
23549890|NCT02388724|65743056|FG000|Overall Study|Voluntary Withdrawal|6|||
23549891|NCT02388724|65743057|FG001|Overall Study|Voluntary Withdrawal|5|||
23549892|NCT02388724|65743056|FG000|Overall Study|Randomized but not Treated|0|||
23549893|NCT02388724|65743057|FG001|Overall Study|Randomized but not Treated|2|||
23620324|NCT01260142|65994947|FG005|Treatment Period 1|Withdrawal by Subject|1|||
23620325|NCT01220856|65994951|FG000|Overall Study|graft loss|3|||
23620326|NCT01220856|65994952|FG001|Overall Study|graft loss|3|||
23620327|NCT01220856|65994951|FG000|Overall Study|Lost to Follow-up|1|||
23620328|NCT01220856|65994952|FG001|Overall Study|Lost to Follow-up|0|||
23620329|NCT00931918|65994953|FG000|Overall Study|Adverse Event|4|||
23620330|NCT00931918|65994954|FG001|Overall Study|Adverse Event|6|||
23620331|NCT00931918|65994953|FG000|Overall Study|Progressive Disease|2|||
23620332|NCT00931918|65994954|FG001|Overall Study|Progressive Disease|1|||
23620333|NCT00931918|65994953|FG000|Overall Study|Symptomatic Deterioration|1|||
23620334|NCT00931918|65994954|FG001|Overall Study|Symptomatic Deterioration|0|||
23620335|NCT00931918|65994953|FG000|Overall Study|Withdrawal by Patient|3|||
23135661|NCT03001076|64244435|FG000|Overall Study|Adverse Event|3|||
23135662|NCT03001076|64244436|FG001|Overall Study|Adverse Event|3|||
23135663|NCT03001076|64244435|FG000|Overall Study|Sponsor decision|1|||
23135664|NCT03001076|64244436|FG001|Overall Study|Sponsor decision|0|||
23135665|NCT03001076|64244435|FG000|Overall Study|Lost to Follow-up|0|||
23135666|NCT03001076|64244436|FG001|Overall Study|Lost to Follow-up|2|||
23135667|NCT01888900|64244439|FG000|Overall Study|failed treatment|0|||
23135668|NCT01888900|64244440|FG001|Overall Study|failed treatment|2|||
23135669|NCT05398237|64244441|FG000|Overall Study|Withdrawal by Subject|1|||
23135670|NCT01276379|64244449|FG000|Overall Study|Screening failure|40|||
23135671|NCT01144052|64244453|FG000|Overall Study|Withdrawal by Subject|1|||
23135672|NCT01144052|64244454|FG001|Overall Study|Withdrawal by Subject|1|||
23549894|NCT01625897|65743058|FG000|Overall Study|Adverse Event|27|||
23549895|NCT01625897|65743059|FG001|Overall Study|Adverse Event|10|||
23549896|NCT01625897|65743058|FG000|Overall Study|Physician Decision|0|||
23549897|NCT01625897|65743059|FG001|Overall Study|Physician Decision|1|||
23549898|NCT01625897|65743058|FG000|Overall Study|Withdrawal by Subject|25|||
23549899|NCT01625897|65743059|FG001|Overall Study|Withdrawal by Subject|3|||
23549900|NCT01816594|65743062|FG000|Overall Study|Local Progress|0|||
23549901|NCT01816594|65743063|FG001|Overall Study|Local Progress|2|||
23549902|NCT01816594|65743062|FG000|Overall Study|Adverse Event|9|||
23549903|NCT01816594|65743063|FG001|Overall Study|Adverse Event|0|||
23549904|NCT01816594|65743062|FG000|Overall Study|Withdrawal by Subject|1|||
23549905|NCT01816594|65743063|FG001|Overall Study|Withdrawal by Subject|0|||
23549906|NCT01816594|65743062|FG000|Overall Study|Physician Decision|1|||
23549907|NCT01816594|65743063|FG001|Overall Study|Physician Decision|0|||
23549908|NCT00514735|65743064|FG000|Overall Study|Withdrawal by Subject|13|||
23549909|NCT00514735|65743065|FG001|Overall Study|Withdrawal by Subject|5|||
23549910|NCT00514735|65743064|FG000|Overall Study|Death|1|||
23549911|NCT00514735|65743065|FG001|Overall Study|Death|0|||
23549912|NCT00514735|65743064|FG000|Overall Study|Lost to Follow-up|0|||
23549913|NCT00514735|65743065|FG001|Overall Study|Lost to Follow-up|1|||
23549914|NCT00674986|65743066|FG000|Overall Study|Adverse Event|2|||
23214724|NCT02394795|64528034|FG001|Overall Study|Physician Decision|93|||
23214725|NCT03654755|64528035|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
23214726|NCT03654755|64528036|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
23214727|NCT03654755|64528037|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
23214728|NCT03654755|64528035|FG000|Overall Study|Withdrawal by Subject|2|||
23214729|NCT03654755|64528036|FG001|Overall Study|Withdrawal by Subject|4|||
23214730|NCT03654755|64528037|FG002|Overall Study|Withdrawal by Subject|8|||
23214731|NCT03654755|64528035|FG000|Overall Study|Lost to Follow-up|1|||
23214732|NCT03654755|64528036|FG001|Overall Study|Lost to Follow-up|3|||
23214733|NCT03654755|64528037|FG002|Overall Study|Lost to Follow-up|7|||
23214734|NCT03654755|64528035|FG000|Overall Study|Physician Decision|0|||
23214735|NCT03654755|64528036|FG001|Overall Study|Physician Decision|1|||
23214736|NCT03654755|64528037|FG002|Overall Study|Physician Decision|0|||
23214737|NCT03654755|64528035|FG000|Overall Study|Adverse Event|0|||
23214738|NCT03654755|64528036|FG001|Overall Study|Adverse Event|0|||
23214739|NCT03654755|64528037|FG002|Overall Study|Adverse Event|4|||
23214740|NCT03654755|64528035|FG000|Overall Study|Lack of Efficacy|0|||
23214741|NCT03654755|64528036|FG001|Overall Study|Lack of Efficacy|0|||
23214742|NCT03654755|64528037|FG002|Overall Study|Lack of Efficacy|1|||
23214743|NCT01181102|64528038|FG000|Overall Study|Adverse Event|28|||
23214744|NCT01181102|64528039|FG001|Overall Study|Adverse Event|26|||
23214745|NCT01181102|64528038|FG000|Overall Study|Lack of Efficacy|3|||
23214746|NCT01181102|64528039|FG001|Overall Study|Lack of Efficacy|1|||
23214747|NCT01181102|64528038|FG000|Overall Study|Lost to Follow-up|2|||
23214748|NCT01181102|64528039|FG001|Overall Study|Lost to Follow-up|0|||
23214749|NCT01181102|64528038|FG000|Overall Study|Physician Decision|3|||
23214750|NCT01181102|64528039|FG001|Overall Study|Physician Decision|1|||
23214751|NCT01181102|64528038|FG000|Overall Study|Protocol Violation|5|||
23214752|NCT01181102|64528039|FG001|Overall Study|Protocol Violation|6|||
23214753|NCT01181102|64528038|FG000|Overall Study|Withdrawal by Subject|10|||
23214754|NCT01181102|64528039|FG001|Overall Study|Withdrawal by Subject|12|||
23214755|NCT00422903|64528040|FG000|Overall Study|Disease Progression|3|||
23214756|NCT00422903|64528041|FG001|Overall Study|Disease Progression|1|||
23214757|NCT00422903|64528040|FG000|Overall Study|Adverse Event|0|||
23214758|NCT00422903|64528041|FG001|Overall Study|Adverse Event|2|||
23214759|NCT00422903|64528040|FG000|Overall Study|Informed Consent Withdrawn|1|||
23214760|NCT00422903|64528041|FG001|Overall Study|Informed Consent Withdrawn|2|||
23214761|NCT02177175|64528042|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
23214762|NCT02177175|64528043|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
23214763|NCT04024462|64528044|FG000|Overall Study|Withdrawal by Subject|6|||
23214764|NCT04024462|64528045|FG001|Overall Study|Withdrawal by Subject|7|||
23214765|NCT04024462|64528044|FG000|Overall Study|Progressive Disease|0|||
23214766|NCT04024462|64528045|FG001|Overall Study|Progressive Disease|1|||
23214767|NCT04024462|64528044|FG000|Overall Study|Adverse Event|0|||
23214768|NCT04024462|64528045|FG001|Overall Study|Adverse Event|1|||
23214769|NCT04024462|64528044|FG000|Overall Study|Death|0|||
23214770|NCT04024462|64528045|FG001|Overall Study|Death|1|||
23214771|NCT04024462|64528044|FG000|Overall Study|Lost to Follow-up|1|||
23549915|NCT00674986|65743067|FG001|Overall Study|Adverse Event|1|||
23549916|NCT00674986|65743066|FG000|Overall Study|Subject withdrew consent|12|||
23214772|NCT04024462|64528045|FG001|Overall Study|Lost to Follow-up|0|||
23549917|NCT00674986|65743067|FG001|Overall Study|Subject withdrew consent|19|||
23214773|NCT04024462|64528044|FG000|Overall Study|Ongoing in the Study|94|||
23214774|NCT04024462|64528045|FG001|Overall Study|Ongoing in the Study|89|||
23214775|NCT00996593|64528047|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
23549918|NCT00674986|65743066|FG000|Overall Study|Lost to Follow-up|25|||
23549919|NCT00674986|65743067|FG001|Overall Study|Lost to Follow-up|53|||
23549920|NCT00674986|65743066|FG000|Overall Study|Other reasons|4|||
23549921|NCT00674986|65743067|FG001|Overall Study|Other reasons|8|||
23549922|NCT04764396|65743069|FG000|Overall Study|Physician Decision|1|||
23549923|NCT04764396|65743070|FG001|Overall Study|Physician Decision|0|||
23549924|NCT02862457|65743077|FG000|Overall Study|Death|1|||
23549925|NCT02862457|65743078|FG001|Overall Study|Death|3|||
23549926|NCT02862457|65743079|FG002|Overall Study|Death|2|||
23549927|NCT02862457|65743080|FG003|Overall Study|Death|3|||
23549928|NCT02862457|65743081|FG004|Overall Study|Death|0|||
23549929|NCT02862457|65743082|FG005|Overall Study|Death|2|||
23549930|NCT02862457|65743083|FG006|Overall Study|Death|1|||
23549931|NCT02862457|65743077|FG000|Overall Study|Lost to Follow-up|1|||
23549932|NCT02862457|65743078|FG001|Overall Study|Lost to Follow-up|0|||
23549933|NCT02862457|65743079|FG002|Overall Study|Lost to Follow-up|0|||
23549934|NCT02862457|65743080|FG003|Overall Study|Lost to Follow-up|1|||
23549935|NCT02862457|65743081|FG004|Overall Study|Lost to Follow-up|0|||
23549936|NCT02862457|65743082|FG005|Overall Study|Lost to Follow-up|0|||
23135673|NCT01769326|64247915|FG000|Overall Study|Lost to Follow-up|1|||
23135674|NCT01769326|64247916|FG001|Overall Study|Lost to Follow-up|2|||
23135675|NCT01769326|64247917|FG002|Overall Study|Lost to Follow-up|0|||
23135676|NCT01769326|64247918|FG003|Overall Study|Lost to Follow-up|0|||
23135677|NCT01769326|64247915|FG000|Overall Study|unrelated injry|1|||
23135678|NCT01769326|64247916|FG001|Overall Study|unrelated injry|1|||
23135679|NCT01769326|64247917|FG002|Overall Study|unrelated injry|0|||
23135680|NCT01769326|64247918|FG003|Overall Study|unrelated injry|0|||
23549937|NCT02862457|65743083|FG006|Overall Study|Lost to Follow-up|0|||
23549938|NCT02862457|65743077|FG000|Overall Study|Withdrawal by Subject|0|||
23549939|NCT02862457|65743078|FG001|Overall Study|Withdrawal by Subject|0|||
23549940|NCT02862457|65743079|FG002|Overall Study|Withdrawal by Subject|1|||
23549941|NCT02862457|65743080|FG003|Overall Study|Withdrawal by Subject|0|||
23549942|NCT02862457|65743081|FG004|Overall Study|Withdrawal by Subject|0|||
23549943|NCT02862457|65743082|FG005|Overall Study|Withdrawal by Subject|1|||
23549944|NCT02862457|65743083|FG006|Overall Study|Withdrawal by Subject|0|||
23549945|NCT01798927|65743084|FG000|Overall Study|Withdrawal by Subject|1|||
23135681|NCT01769326|64247915|FG000|Overall Study|got a job|0|||
23135682|NCT01769326|64247916|FG001|Overall Study|got a job|1|||
23135683|NCT01769326|64247917|FG002|Overall Study|got a job|0|||
23135684|NCT01769326|64247918|FG003|Overall Study|got a job|0|||
23135685|NCT01769326|64247915|FG000|Overall Study|Got sick and could not complete study|0|||
23135686|NCT01769326|64247916|FG001|Overall Study|Got sick and could not complete study|0|||
23135687|NCT01769326|64247917|FG002|Overall Study|Got sick and could not complete study|1|||
23135688|NCT01769326|64247918|FG003|Overall Study|Got sick and could not complete study|0|||
23135689|NCT00201643|64247919|FG000|Overall Study|Withdrawal by Subject|5|||
23135690|NCT00201643|64247920|FG001|Overall Study|Withdrawal by Subject|4|||
23135691|NCT02399254|64247930|FG000|Overall Study|Physician Decision|2|||
23135692|NCT03020576|64247931|FG000|Overall Study|Withdrawal by Subject|1|||
23135693|NCT03020576|64247932|FG001|Overall Study|Withdrawal by Subject|2|||
23135694|NCT02019667|64247933|FG000|First Intervention (6 Months)|Adverse Event|0|||
23135695|NCT02019667|64247934|FG001|First Intervention (6 Months)|Adverse Event|1|||
23135696|NCT02019667|64247933|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
23135697|NCT02019667|64247934|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
23135698|NCT02019667|64247933|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
23135699|NCT02019667|64247934|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
23135700|NCT03432260|64247940|FG000|Overall Study|Lost to Follow-up|1|||
23135701|NCT03432260|64247941|FG001|Overall Study|Lost to Follow-up|1|||
23135702|NCT03432260|64247942|FG002|Overall Study|Lost to Follow-up|0|||
23135703|NCT03432260|64247943|FG003|Overall Study|Lost to Follow-up|0|||
23135704|NCT03432260|64247944|FG004|Overall Study|Lost to Follow-up|1|||
23135705|NCT02349425|64247950|FG000|Period 1|Adverse Event|1|||
23135706|NCT02349425|64247951|FG001|Period 1|Adverse Event|1|||
23135707|NCT02349425|64247952|FG002|Period 1|Adverse Event|0|||
23135708|NCT02349425|64247953|FG003|Period 1|Adverse Event|0|||
23135709|NCT02349425|64247950|FG000|Period 2|Adverse Event|0|||
23135710|NCT02349425|64247951|FG001|Period 2|Adverse Event|1|||
23135711|NCT02349425|64247952|FG002|Period 2|Adverse Event|1|||
23317565|NCT00993421|64904104|FG000|Overall Study|Withdrawal by Subject|3|||
23549946|NCT02063828|65743085|FG000|Overall Study|Withdrawal by Subject|4|||
23549947|NCT02063828|65743086|FG001|Overall Study|Withdrawal by Subject|6|||
23549948|NCT02063828|65743087|FG002|Overall Study|Withdrawal by Subject|3|||
23135712|NCT02349425|64247953|FG003|Period 2|Adverse Event|0|||
23549949|NCT02063828|65743085|FG000|Overall Study|Death|0|||
23549950|NCT02063828|65743086|FG001|Overall Study|Death|0|||
23549951|NCT02063828|65743087|FG002|Overall Study|Death|1|||
23549952|NCT00743366|65743091|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
23135713|NCT01012817|64247954|FG000|Overall Study|Withdrawal by Subject|0|||
23135714|NCT01012817|64247955|FG001|Overall Study|Withdrawal by Subject|0|||
23135715|NCT01012817|64247956|FG002|Overall Study|Withdrawal by Subject|0|||
23135716|NCT01012817|64247957|FG003|Overall Study|Withdrawal by Subject|1|||
23135717|NCT01012817|64247958|FG004|Overall Study|Withdrawal by Subject|0|||
23549953|NCT00743366|65743092|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
23549954|NCT01917526|65743095|FG000|Overall Study|Protocol Violation|1|||
23214776|NCT00996593|64528047|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
23549955|NCT01917526|65743096|FG001|Overall Study|Protocol Violation|1|||
23549956|NCT00344461|65743098|FG000|Overall Study|Adverse Event|6|||
23549957|NCT00344461|65743098|FG000|Overall Study|Death|1|||
23549958|NCT00344461|65743098|FG000|Overall Study|Lack of Efficacy|2|||
23549959|NCT00344461|65743098|FG000|Overall Study|Lost to Follow-up|2|||
23549960|NCT00344461|65743098|FG000|Overall Study|Physician Decision|2|||
23549961|NCT00344461|65743098|FG000|Overall Study|Protocol Violation|6|||
23549962|NCT00344461|65743098|FG000|Overall Study|Withdrawal by Subject|2|||
23549963|NCT01353313|65743099|FG000|Overall Study|Lost to Follow-up|22|||
23549964|NCT01353313|65743100|FG001|Overall Study|Lost to Follow-up|23|||
23549965|NCT01353313|65743099|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
23549966|NCT01353313|65743100|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
23549967|NCT01018394|65743101|FG000|Overall Study|Withdrawal by Subject|5|||
23549968|NCT01018394|65743102|FG001|Overall Study|Withdrawal by Subject|5|||
23549969|NCT01018394|65743101|FG000|Overall Study|Lost to Follow-up|4|||
23549970|NCT01018394|65743102|FG001|Overall Study|Lost to Follow-up|3|||
23549971|NCT00529399|65743106|FG000|Overall Study|Lost to Follow-up|1|||
23549972|NCT00529399|65743107|FG001|Overall Study|Lost to Follow-up|0|||
23549973|NCT00529399|65743108|FG002|Overall Study|Lost to Follow-up|1|||
23549974|NCT00529399|65743106|FG000|Overall Study|Withdrawal by Subject|1|||
23549975|NCT00529399|65743107|FG001|Overall Study|Withdrawal by Subject|0|||
23549976|NCT00529399|65743108|FG002|Overall Study|Withdrawal by Subject|1|||
23549977|NCT00529399|65743106|FG000|Overall Study|Non-compliant|0|||
23549978|NCT00529399|65743107|FG001|Overall Study|Non-compliant|1|||
23549979|NCT00529399|65743108|FG002|Overall Study|Non-compliant|0|||
23549980|NCT00335322|65743112|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
23549981|NCT00335322|65743113|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
23549982|NCT00335322|65743114|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
23549983|NCT02065336|65743118|FG000|Extension Phase|Study Terminated by Sponsor|0|||
23549984|NCT02065336|65743119|FG001|Extension Phase|Study Terminated by Sponsor|0|||
23549985|NCT02065336|65743120|FG002|Extension Phase|Study Terminated by Sponsor|0|||
23549986|NCT02065336|65743121|FG003|Extension Phase|Study Terminated by Sponsor|0|||
23549987|NCT02065336|65743122|FG004|Extension Phase|Study Terminated by Sponsor|0|||
23549988|NCT02065336|65743123|FG005|Extension Phase|Study Terminated by Sponsor|0|||
23549989|NCT02065336|65743124|FG006|Extension Phase|Study Terminated by Sponsor|0|||
23549990|NCT02065336|65743125|FG007|Extension Phase|Study Terminated by Sponsor|0|||
23549991|NCT02065336|65743126|FG008|Extension Phase|Study Terminated by Sponsor|2|||
23549992|NCT02065336|65743127|FG009|Extension Phase|Study Terminated by Sponsor|8|||
23549993|NCT00381940|65743128|FG000|Overall Study|Lack of Efficacy|3|||
23549994|NCT00381940|65743128|FG000|Overall Study|Protocol Violation|1|||
23549995|NCT00381940|65743128|FG000|Overall Study|Ineligible|1|||
23549996|NCT01453595|65743129|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23549997|NCT01453595|65743130|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23549998|NCT01453595|65743131|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23549999|NCT01388816|65743132|FG000|Overall Study|Adverse Event|0|||
23550000|NCT01388816|65743133|FG001|Overall Study|Adverse Event|2|||
23550001|NCT01388816|65743134|FG002|Overall Study|Adverse Event|0|||
23550002|NCT01388816|65743135|FG003|Overall Study|Adverse Event|0|||
23550003|NCT01388816|65743132|FG000|Overall Study|Lost to Follow-up|0|||
23550004|NCT01388816|65743133|FG001|Overall Study|Lost to Follow-up|1|||
23550005|NCT01388816|65743134|FG002|Overall Study|Lost to Follow-up|0|||
23550006|NCT01388816|65743135|FG003|Overall Study|Lost to Follow-up|0|||
23550007|NCT01388816|65743132|FG000|Overall Study|Withdrawal by Subject|2|||
23550008|NCT01388816|65743133|FG001|Overall Study|Withdrawal by Subject|1|||
23550009|NCT01388816|65743134|FG002|Overall Study|Withdrawal by Subject|1|||
23550010|NCT01388816|65743135|FG003|Overall Study|Withdrawal by Subject|0|||
23550011|NCT01388816|65743132|FG000|Overall Study|Protocol Violation|0|||
23214777|NCT00996593|64528047|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
23214778|NCT00996593|64528047|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
23214779|NCT00996593|64528047|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
23214780|NCT00996593|64528047|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
23214781|NCT00996593|64528047|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
23214782|NCT00996593|64528047|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
23550012|NCT01388816|65743133|FG001|Overall Study|Protocol Violation|0|||
23550013|NCT01388816|65743134|FG002|Overall Study|Protocol Violation|2|||
23550014|NCT01388816|65743135|FG003|Overall Study|Protocol Violation|0|||
23550015|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
23550016|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
23214783|NCT00996593|64528047|FG000|Long-Term Follow-Up|Site Closed|1|||
23214784|NCT00865189|64528056|FG000|Overall Study|Other|1|||
23214785|NCT00865189|64528057|FG001|Overall Study|Other|2|||
23550017|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
23550018|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
23550019|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
23550020|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
23550021|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
23550022|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
23550023|NCT02332590|65743136|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
23550024|NCT02332590|65743137|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
23550025|NCT02332590|65743136|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
23550026|NCT02332590|65743137|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
23550027|NCT02332590|65743136|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
23550028|NCT02332590|65743137|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
23550029|NCT02332590|65743136|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
23550030|NCT02332590|65743137|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
23550031|NCT02332590|65743136|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
23550032|NCT02332590|65743137|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
23550033|NCT02495025|65743138|FG000|Overall Study|Lost to Follow-up|21|||
23550034|NCT02495025|65743139|FG001|Overall Study|Lost to Follow-up|14|||
23550035|NCT02495025|65743138|FG000|Overall Study|Withdrawal by Subject|5|||
23550036|NCT02495025|65743139|FG001|Overall Study|Withdrawal by Subject|0|||
23550037|NCT01786512|65743140|FG000|Overall Study|Lost to Follow-up|0|||
23550038|NCT01786512|65743141|FG001|Overall Study|Lost to Follow-up|0|||
23550039|NCT01786512|65743142|FG002|Overall Study|Lost to Follow-up|0|||
23550040|NCT01786512|65743143|FG003|Overall Study|Lost to Follow-up|0|||
23550041|NCT01786512|65743144|FG004|Overall Study|Lost to Follow-up|0|||
23550042|NCT01786512|65743145|FG005|Overall Study|Lost to Follow-up|0|||
23550043|NCT01786512|65743146|FG006|Overall Study|Lost to Follow-up|0|||
23550044|NCT01786512|65743147|FG007|Overall Study|Lost to Follow-up|0|||
23550045|NCT01786512|65743148|FG008|Overall Study|Lost to Follow-up|0|||
23550046|NCT01786512|65743149|FG009|Overall Study|Lost to Follow-up|1|||
23550047|NCT01786512|65743150|FG010|Overall Study|Lost to Follow-up|0|||
23550048|NCT01786512|65743140|FG000|Overall Study|Decision by sponsor|0|||
23550049|NCT01786512|65743141|FG001|Overall Study|Decision by sponsor|0|||
23550050|NCT01786512|65743142|FG002|Overall Study|Decision by sponsor|0|||
23550051|NCT01786512|65743143|FG003|Overall Study|Decision by sponsor|0|||
23550052|NCT01786512|65743144|FG004|Overall Study|Decision by sponsor|0|||
23550053|NCT01786512|65743145|FG005|Overall Study|Decision by sponsor|0|||
23550054|NCT01786512|65743146|FG006|Overall Study|Decision by sponsor|0|||
23550055|NCT01786512|65743147|FG007|Overall Study|Decision by sponsor|0|||
23550056|NCT01786512|65743148|FG008|Overall Study|Decision by sponsor|0|||
23550057|NCT01786512|65743149|FG009|Overall Study|Decision by sponsor|0|||
23550058|NCT01786512|65743150|FG010|Overall Study|Decision by sponsor|2|||
23550059|NCT01786512|65743140|FG000|Overall Study|Withdrawal by Subject|0|||
23550060|NCT01786512|65743141|FG001|Overall Study|Withdrawal by Subject|1|||
23550061|NCT01786512|65743142|FG002|Overall Study|Withdrawal by Subject|0|||
23550062|NCT01786512|65743143|FG003|Overall Study|Withdrawal by Subject|0|||
23550063|NCT01786512|65743144|FG004|Overall Study|Withdrawal by Subject|0|||
23550064|NCT01786512|65743145|FG005|Overall Study|Withdrawal by Subject|0|||
23550065|NCT01786512|65743146|FG006|Overall Study|Withdrawal by Subject|1|||
23550066|NCT01786512|65743147|FG007|Overall Study|Withdrawal by Subject|0|||
23550067|NCT01786512|65743148|FG008|Overall Study|Withdrawal by Subject|0|||
23550068|NCT01786512|65743149|FG009|Overall Study|Withdrawal by Subject|3|||
23550069|NCT01786512|65743150|FG010|Overall Study|Withdrawal by Subject|7|||
23550070|NCT01786512|65743140|FG000|Overall Study|Death|0|||
23550071|NCT01786512|65743141|FG001|Overall Study|Death|0|||
23550072|NCT01786512|65743142|FG002|Overall Study|Death|0|||
23550073|NCT01786512|65743143|FG003|Overall Study|Death|0|||
23550074|NCT01786512|65743144|FG004|Overall Study|Death|0|||
23550075|NCT01786512|65743145|FG005|Overall Study|Death|0|||
23317566|NCT00993421|64904105|FG001|Overall Study|Withdrawal by Subject|2|||
23550076|NCT01786512|65743146|FG006|Overall Study|Death|0|||
23550077|NCT01786512|65743147|FG007|Overall Study|Death|0|||
23550078|NCT01786512|65743148|FG008|Overall Study|Death|4|||
23550079|NCT01786512|65743149|FG009|Overall Study|Death|1|||
23550080|NCT01786512|65743150|FG010|Overall Study|Death|3|||
23550081|NCT00951483|65743152|FG000|Overall Study|Physician Decision|4|||
23550082|NCT00951483|65743153|FG001|Overall Study|Physician Decision|0|||
23550083|NCT00951483|65743152|FG000|Overall Study|Withdrawal by Subject|15|||
23550084|NCT00951483|65743153|FG001|Overall Study|Withdrawal by Subject|0|||
23550085|NCT02137369|65743154|FG000|Overall Study|Withdrawal by Subject|3|||
23550086|NCT02137369|65743155|FG001|Overall Study|Withdrawal by Subject|2|||
23550087|NCT02137369|65743154|FG000|Overall Study|Adverse Event|2|||
23550088|NCT02137369|65743155|FG001|Overall Study|Adverse Event|0|||
23550089|NCT02137369|65743154|FG000|Overall Study|Lost to Follow-up|1|||
23550090|NCT02137369|65743155|FG001|Overall Study|Lost to Follow-up|0|||
23550091|NCT02137369|65743154|FG000|Overall Study|Moved away|2|||
23550092|NCT02137369|65743155|FG001|Overall Study|Moved away|0|||
23550093|NCT00726752|65743168|FG000|Overall Study|Lack of Efficacy|6|||
23550094|NCT02148250|65743169|FG000|Screening|Withdrawal by Subject|5|||
23550095|NCT02148250|65743170|FG001|Screening|Withdrawal by Subject|0|||
23550096|NCT00449176|65743171|FG000|Overall Study|Withdrawal by Subject|39|||
23550097|NCT00449176|65743172|FG001|Overall Study|Withdrawal by Subject|43|||
23550098|NCT00449176|65743173|FG002|Overall Study|Withdrawal by Subject|59|||
23550099|NCT00449176|65743171|FG000|Overall Study|Lost to Follow-up|13|||
23550100|NCT00449176|65743172|FG001|Overall Study|Lost to Follow-up|8|||
23550101|NCT00449176|65743173|FG002|Overall Study|Lost to Follow-up|12|||
23550102|NCT00449176|65743171|FG000|Overall Study|Adverse Event|51|||
23550103|NCT00449176|65743172|FG001|Overall Study|Adverse Event|107|||
23550104|NCT00449176|65743173|FG002|Overall Study|Adverse Event|15|||
23550105|NCT00449176|65743171|FG000|Overall Study|Lack of Efficacy|13|||
23550106|NCT00449176|65743172|FG001|Overall Study|Lack of Efficacy|7|||
23550107|NCT00449176|65743173|FG002|Overall Study|Lack of Efficacy|50|||
23550108|NCT00449176|65743171|FG000|Overall Study|Study drug non-compliant|14|||
23550109|NCT00449176|65743172|FG001|Overall Study|Study drug non-compliant|11|||
23550110|NCT00449176|65743173|FG002|Overall Study|Study drug non-compliant|11|||
23550111|NCT00449176|65743171|FG000|Overall Study|all other|22|||
23135718|NCT01012817|64247959|FG005|Overall Study|Withdrawal by Subject|0|||
23135719|NCT01012817|64247960|FG006|Overall Study|Withdrawal by Subject|0|||
23135720|NCT01012817|64247961|FG007|Overall Study|Withdrawal by Subject|1|||
23135721|NCT01012817|64247962|FG008|Overall Study|Withdrawal by Subject|0|||
23135722|NCT01012817|64247963|FG009|Overall Study|Withdrawal by Subject|0|||
23135723|NCT01012817|64247964|FG010|Overall Study|Withdrawal by Subject|1|||
23135724|NCT01012817|64247965|FG011|Overall Study|Withdrawal by Subject|1|||
23135725|NCT01012817|64247966|FG012|Overall Study|Withdrawal by Subject|0|||
23135726|NCT01012817|64247967|FG013|Overall Study|Withdrawal by Subject|1|||
23135727|NCT01012817|64247954|FG000|Overall Study|Adverse Event|0|||
23135728|NCT01012817|64247955|FG001|Overall Study|Adverse Event|0|||
23135729|NCT01012817|64247956|FG002|Overall Study|Adverse Event|0|||
23135730|NCT01012817|64247957|FG003|Overall Study|Adverse Event|0|||
23135731|NCT01012817|64247958|FG004|Overall Study|Adverse Event|0|||
23135732|NCT01012817|64247959|FG005|Overall Study|Adverse Event|1|||
23135733|NCT01012817|64247960|FG006|Overall Study|Adverse Event|0|||
23135734|NCT01012817|64247961|FG007|Overall Study|Adverse Event|0|||
23135735|NCT01012817|64247962|FG008|Overall Study|Adverse Event|0|||
23135736|NCT01012817|64247963|FG009|Overall Study|Adverse Event|0|||
23135737|NCT01012817|64247964|FG010|Overall Study|Adverse Event|1|||
23135738|NCT01012817|64247965|FG011|Overall Study|Adverse Event|0|||
23135739|NCT01012817|64247966|FG012|Overall Study|Adverse Event|0|||
23135740|NCT01012817|64247967|FG013|Overall Study|Adverse Event|1|||
23135741|NCT00297427|64247970|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
23135742|NCT00297427|64247971|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
23135743|NCT00297427|64247970|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
23135744|NCT00297427|64247971|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
23135745|NCT00297427|64247970|FG000|Phase 1: Initial Intervention|Death|0|||
23135746|NCT00297427|64247971|FG001|Phase 1: Initial Intervention|Death|1|||
23135747|NCT00297427|64247970|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
23135748|NCT00297427|64247971|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
23135749|NCT00297427|64247970|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
23135750|NCT00297427|64247971|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
23135751|NCT00297427|64247970|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
23135752|NCT00297427|64247971|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
23135753|NCT00297427|64247970|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
23135754|NCT00297427|64247971|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
23135755|NCT00297427|64247970|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
23135756|NCT00297427|64247971|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
23135757|NCT00836745|64247972|FG000|Overall Study|Death|2|||
23135758|NCT00836745|64247972|FG000|Overall Study|Lost to Follow-up|10|||
23135759|NCT00836745|64247972|FG000|Overall Study|Adverse Event|3|||
23135760|NCT00836745|64247972|FG000|Overall Study|Objective progression or relapse|4|||
23135761|NCT00836745|64247972|FG000|Overall Study|Other|2|||
23135762|NCT00287690|64247973|FG000|Overall Study|Protocol Violation|20|||
23135763|NCT00287690|64247974|FG001|Overall Study|Protocol Violation|26|||
23135764|NCT03053518|64247975|FG000|Overall Study|Withdrawal by Subject|3|||
23135765|NCT03053518|64247975|FG000|Overall Study|Lost to Follow-up|2|||
23135766|NCT03053518|64247975|FG000|Overall Study|Ineligible|5|||
23135767|NCT01081132|64247980|FG000|Overall Study|Lack of Efficacy|25|||
23135768|NCT01081132|64247981|FG001|Overall Study|Lack of Efficacy|9|||
23550112|NCT00449176|65743172|FG001|Overall Study|all other|19|||
23550113|NCT00449176|65743173|FG002|Overall Study|all other|20|||
23214786|NCT00865189|64528056|FG000|Overall Study|Death|4|||
23214787|NCT00865189|64528057|FG001|Overall Study|Death|11|||
23550114|NCT03282227|65743175|FG000|Overall Study|Exposure Goals Achieved|60|||
23550115|NCT03282227|65743175|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
23550116|NCT03282227|65743175|FG000|Overall Study|Adverse Event|15|||
23550117|NCT03282227|65743175|FG000|Overall Study|Lost to Follow-up|21|||
23429511|NCT00461305|65317399|FG001|Continued Treatment|Lost to Follow-up|0|||
23429512|NCT00461305|65317398|FG000|Continued Treatment|Protocol Violation|13|||
23429513|NCT00461305|65317399|FG001|Continued Treatment|Protocol Violation|0|||
23429514|NCT00461305|65317398|FG000|Continued Treatment|Withdrawal by Subject|48|||
23429515|NCT00461305|65317399|FG001|Continued Treatment|Withdrawal by Subject|0|||
23429516|NCT00461305|65317398|FG000|Continued Treatment|Partially missing diary|2|||
23429517|NCT00461305|65317399|FG001|Continued Treatment|Partially missing diary|0|||
23429518|NCT00461305|65317398|FG000|Continued Treatment|Other (missing drug etc)|2|||
23429519|NCT00461305|65317399|FG001|Continued Treatment|Other (missing drug etc)|0|||
23429520|NCT01533922|65317400|FG000|Overall Study|Adverse Event|5|||
23429521|NCT01533922|65317401|FG001|Overall Study|Adverse Event|8|||
23429522|NCT01533922|65317402|FG002|Overall Study|Adverse Event|6|||
23429523|NCT01533922|65317403|FG003|Overall Study|Adverse Event|3|||
23429524|NCT01533922|65317404|FG004|Overall Study|Adverse Event|4|||
23429525|NCT01533922|65317400|FG000|Overall Study|Lack of Efficacy|0|||
23429526|NCT01533922|65317401|FG001|Overall Study|Lack of Efficacy|0|||
23550118|NCT03282227|65743175|FG000|Overall Study|Withdrawal by Subject|20|||
23550119|NCT03282227|65743175|FG000|Overall Study|Lack of Efficacy|12|||
23550120|NCT03282227|65743175|FG000|Overall Study|Sponsor decision|3|||
23550121|NCT03282227|65743175|FG000|Overall Study|Physician Decision|2|||
23550122|NCT03282227|65743175|FG000|Overall Study|Pregnancy|2|||
23550123|NCT03282227|65743175|FG000|Overall Study|Other|1|||
23550124|NCT01581281|65743176|FG000|Overall Study|Early Study Closure|15|||
23550125|NCT01581281|65743177|FG001|Overall Study|Early Study Closure|6|||
23550126|NCT01581281|65743178|FG002|Overall Study|Early Study Closure|12|||
23550127|NCT04137380|65743179|FG000|Overall Study|Physician Decision|0|||
23550128|NCT04137380|65743180|FG001|Overall Study|Physician Decision|0|||
23550129|NCT04137380|65743181|FG002|Overall Study|Physician Decision|0|||
23550130|NCT04137380|65743182|FG003|Overall Study|Physician Decision|1|||
23550131|NCT04137380|65743183|FG004|Overall Study|Physician Decision|0|||
23550132|NCT04137380|65743184|FG005|Overall Study|Physician Decision|0|||
23550133|NCT04137380|65743185|FG006|Overall Study|Physician Decision|0|||
23550134|NCT03905655|65743189|FG000|Overall Study|Adverse Event|1|||
23550135|NCT03905655|65743190|FG001|Overall Study|Adverse Event|0|||
23550136|NCT03905655|65743191|FG002|Overall Study|Adverse Event|1|||
23620336|NCT00931918|65994954|FG001|Overall Study|Withdrawal by Patient|4|||
23620337|NCT00931918|65994953|FG000|Overall Study|Other Reason not Specified|4|||
23620338|NCT00931918|65994954|FG001|Overall Study|Other Reason not Specified|4|||
23620339|NCT00931918|65994953|FG000|Overall Study|Did not receive study drug|3|||
23620340|NCT00931918|65994954|FG001|Overall Study|Did not receive study drug|2|||
23620341|NCT00118703|65994955|FG000|Overall Study|Protocol Violation|1|||
23620342|NCT00118703|65994956|FG001|Overall Study|Protocol Violation|0|||
23620343|NCT00118703|65994955|FG000|Overall Study|Adverse Event|1|||
23620344|NCT00118703|65994956|FG001|Overall Study|Adverse Event|1|||
23620345|NCT00118703|65994955|FG000|Overall Study|Participant took two different treatment|0|||
23620346|NCT00118703|65994956|FG001|Overall Study|Participant took two different treatment|1|||
23135769|NCT01081132|64247980|FG000|Overall Study|Withdrawal by Subject|13|||
23135770|NCT01081132|64247981|FG001|Overall Study|Withdrawal by Subject|16|||
23135771|NCT01081132|64247980|FG000|Overall Study|Lost to Follow-up|4|||
23429527|NCT01533922|65317402|FG002|Overall Study|Lack of Efficacy|1|||
23429528|NCT01533922|65317403|FG003|Overall Study|Lack of Efficacy|0|||
23429529|NCT01533922|65317404|FG004|Overall Study|Lack of Efficacy|0|||
23429530|NCT01533922|65317400|FG000|Overall Study|Protocol Violation|0|||
23429531|NCT01533922|65317401|FG001|Overall Study|Protocol Violation|3|||
23429532|NCT01533922|65317402|FG002|Overall Study|Protocol Violation|0|||
23429533|NCT01533922|65317403|FG003|Overall Study|Protocol Violation|0|||
23429534|NCT01533922|65317404|FG004|Overall Study|Protocol Violation|1|||
23550137|NCT03905655|65743192|FG003|Overall Study|Adverse Event|1|||
23550138|NCT00423176|65743193|FG000|Overall Study|Adverse Event|4|||
23620347|NCT00118703|65994955|FG000|Overall Study|Withdrawal by Subject|2|||
23620348|NCT00118703|65994956|FG001|Overall Study|Withdrawal by Subject|5|||
23135772|NCT01081132|64247981|FG001|Overall Study|Lost to Follow-up|11|||
23135773|NCT01081132|64247980|FG000|Overall Study|Adverse Event|3|||
23135774|NCT01081132|64247981|FG001|Overall Study|Adverse Event|9|||
23135775|NCT01081132|64247980|FG000|Overall Study|Non Compliance|4|||
23135776|NCT01081132|64247981|FG001|Overall Study|Non Compliance|2|||
23135777|NCT01081132|64247980|FG000|Overall Study|Lack Of Compliance|0|||
23135778|NCT01081132|64247981|FG001|Overall Study|Lack Of Compliance|1|||
23135779|NCT01081132|64247980|FG000|Overall Study|Missed Visits|1|||
23135780|NCT01081132|64247981|FG001|Overall Study|Missed Visits|1|||
23135781|NCT01081132|64247980|FG000|Overall Study|Stopped Taking Meds|2|||
23135782|NCT01081132|64247981|FG001|Overall Study|Stopped Taking Meds|0|||
23135783|NCT01081132|64247980|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
23135784|NCT01081132|64247981|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
23135785|NCT01081132|64247980|FG000|Overall Study|Declined Taper Phase|0|||
23135786|NCT01081132|64247981|FG001|Overall Study|Declined Taper Phase|1|||
23135787|NCT01081132|64247980|FG000|Overall Study|Protocol Violation|3|||
23135788|NCT01081132|64247981|FG001|Overall Study|Protocol Violation|1|||
23620349|NCT00118703|65994955|FG000|Overall Study|Lost to Follow-up|1|||
23620350|NCT00118703|65994956|FG001|Overall Study|Lost to Follow-up|2|||
23620351|NCT00961298|65994957|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
23620352|NCT00961298|65994957|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
23620353|NCT00961298|65994957|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
23620354|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
23620355|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
23620356|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
23620357|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
23620358|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
23620359|NCT00520403|65994958|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
23620360|NCT00520403|65994958|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
23620361|NCT00520403|65994958|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
23620362|NCT01201915|65994960|FG000|Overall Study|Adverse Event|2|||
23620363|NCT01201915|65994961|FG001|Overall Study|Adverse Event|1|||
23620364|NCT01201915|65994962|FG002|Overall Study|Adverse Event|1|||
23620365|NCT01201915|65994960|FG000|Overall Study|Lost to Follow-up|0|||
23620366|NCT01201915|65994961|FG001|Overall Study|Lost to Follow-up|4|||
23620367|NCT01201915|65994962|FG002|Overall Study|Lost to Follow-up|0|||
23620368|NCT01201915|65994960|FG000|Overall Study|Physician Decision|3|||
23620369|NCT01201915|65994961|FG001|Overall Study|Physician Decision|0|||
23620370|NCT01201915|65994962|FG002|Overall Study|Physician Decision|0|||
23620371|NCT01201915|65994960|FG000|Overall Study|Subject Decision|3|||
23620372|NCT01201915|65994961|FG001|Overall Study|Subject Decision|3|||
23620373|NCT01201915|65994962|FG002|Overall Study|Subject Decision|5|||
23214788|NCT00865189|64528056|FG000|Overall Study|Lost to Follow-up|6|||
23214789|NCT00865189|64528057|FG001|Overall Study|Lost to Follow-up|6|||
23214790|NCT00865189|64528056|FG000|Overall Study|Withdrawal by Subject|1|||
23214791|NCT00865189|64528057|FG001|Overall Study|Withdrawal by Subject|0|||
23214792|NCT01357980|64528063|FG000|Overall Study|Lack of Efficacy|0|||
23214793|NCT01357980|64528064|FG001|Overall Study|Lack of Efficacy|1|||
23214794|NCT01357980|64528065|FG002|Overall Study|Lack of Efficacy|0|||
23214795|NCT01357980|64528066|FG003|Overall Study|Lack of Efficacy|0|||
23214796|NCT01357980|64528063|FG000|Overall Study|Consent withdrawn|0|||
23214797|NCT01357980|64528064|FG001|Overall Study|Consent withdrawn|0|||
23214798|NCT01357980|64528065|FG002|Overall Study|Consent withdrawn|1|||
23550139|NCT00423176|65743194|FG001|Overall Study|Adverse Event|6|||
23550140|NCT00423176|65743193|FG000|Overall Study|Treatment Failure|1|||
23550141|NCT00423176|65743194|FG001|Overall Study|Treatment Failure|6|||
23550142|NCT00423176|65743193|FG000|Overall Study|Lost to Follow-up|4|||
23550143|NCT00423176|65743194|FG001|Overall Study|Lost to Follow-up|7|||
23550144|NCT00423176|65743193|FG000|Overall Study|Withdrawal by Subject|4|||
23550145|NCT00423176|65743194|FG001|Overall Study|Withdrawal by Subject|3|||
23550146|NCT00423176|65743193|FG000|Overall Study|Protocol Violation|1|||
23550147|NCT00423176|65743194|FG001|Overall Study|Protocol Violation|3|||
23550148|NCT00423176|65743193|FG000|Overall Study|Did not meet protocol eligibility|2|||
23550149|NCT00423176|65743194|FG001|Overall Study|Did not meet protocol eligibility|4|||
23550150|NCT03182868|65743197|FG000|Overall Study|Protocol Violation|3|||
23550151|NCT03182868|65743198|FG001|Overall Study|Protocol Violation|0|||
23550152|NCT03182868|65743199|FG002|Overall Study|Protocol Violation|4|||
23550153|NCT03182868|65743200|FG003|Overall Study|Protocol Violation|1|||
23550154|NCT03182868|65743201|FG004|Overall Study|Protocol Violation|8|||
23550155|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
23550156|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
23550157|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|disease progression|58|||
23550158|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|disease progression|47|||
23550159|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Death|3|||
23550160|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Death|6|||
23550161|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
23550162|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
23214799|NCT01357980|64528066|FG003|Overall Study|Consent withdrawn|0|||
23214800|NCT01807949|64528067|FG000|Overall Study|Adverse Event|1|||
23214801|NCT01807949|64528068|FG001|Overall Study|Adverse Event|2|||
23214802|NCT01807949|64528069|FG002|Overall Study|Adverse Event|2|||
23214803|NCT01807949|64528067|FG000|Overall Study|Withdrawal by Subject|1|||
23550163|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
23620374|NCT01201915|65994960|FG000|Overall Study|Target Lesion Progression|0|||
23214804|NCT01807949|64528068|FG001|Overall Study|Withdrawal by Subject|2|||
23550164|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
23550165|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
23550166|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
23550167|NCT02472964|65743203|FG000|Part 1 (up to Week 24)|Other|2|||
23550168|NCT02472964|65743204|FG001|Part 1 (up to Week 24)|Other|1|||
23550169|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
23620375|NCT01201915|65994961|FG001|Overall Study|Target Lesion Progression|3|||
23620376|NCT01201915|65994962|FG002|Overall Study|Target Lesion Progression|0|||
23550170|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
23550171|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
23550172|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
23550173|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Death|0|||
23550174|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Death|1|||
23550175|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
23550176|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
23550177|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
23550178|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
23550179|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
23550180|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
23550181|NCT02472964|65743203|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
23135789|NCT01153321|64247982|FG000|Overall Study|Development of study withdrawal criteria|0|||
23214805|NCT01807949|64528069|FG002|Overall Study|Withdrawal by Subject|2|||
23214806|NCT01807949|64528067|FG000|Overall Study|Non-Compliance|0|||
23214807|NCT01807949|64528068|FG001|Overall Study|Non-Compliance|0|||
23135790|NCT01153321|64247983|FG001|Overall Study|Development of study withdrawal criteria|1|||
23135791|NCT01153321|64247982|FG000|Overall Study|Withdrawal by Subject|0|||
23135792|NCT01153321|64247983|FG001|Overall Study|Withdrawal by Subject|1|||
23135793|NCT01153321|64247982|FG000|Overall Study|Adverse Event|1|||
23135794|NCT01153321|64247983|FG001|Overall Study|Adverse Event|1|||
23135795|NCT04797650|64247984|FG000|Overall Study|Reason Not Specified|5|||
23135796|NCT04797650|64247985|FG001|Overall Study|Reason Not Specified|12|||
23135797|NCT04797650|64247986|FG002|Overall Study|Reason Not Specified|5|||
23135798|NCT04797650|64247984|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
23135799|NCT04797650|64247985|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
23135800|NCT04797650|64247986|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
23135801|NCT04797650|64247984|FG000|Overall Study|Lack of Efficacy|1|||
23135802|NCT04797650|64247985|FG001|Overall Study|Lack of Efficacy|0|||
23135803|NCT04797650|64247986|FG002|Overall Study|Lack of Efficacy|1|||
23135804|NCT04797650|64247984|FG000|Overall Study|Non-compliance with Study Drug|0|||
23135805|NCT04797650|64247985|FG001|Overall Study|Non-compliance with Study Drug|0|||
23135806|NCT04797650|64247986|FG002|Overall Study|Non-compliance with Study Drug|2|||
23135807|NCT04797650|64247984|FG000|Overall Study|Lost to Follow-up|4|||
23135808|NCT04797650|64247985|FG001|Overall Study|Lost to Follow-up|6|||
23135809|NCT04797650|64247986|FG002|Overall Study|Lost to Follow-up|1|||
23135810|NCT02207569|64247989|FG000|1-Month|Death|6|||
23135811|NCT02207569|64247989|FG000|1-Month|Withdrawal by Subject|2|||
23135812|NCT02207569|64247989|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
23135813|NCT02207569|64247989|FG000|6-Month|Death|8|||
23135814|NCT02207569|64247989|FG000|6-Month|Withdrawal by Subject|2|||
23135815|NCT02207569|64247989|FG000|12-Month|Death|14|||
23135816|NCT02207569|64247989|FG000|12-Month|Withdrawal by Subject|2|||
23135817|NCT02207569|64247989|FG000|24-Month|Death|23|||
23135818|NCT02207569|64247989|FG000|24-Month|Withdrawal by Subject|3|||
23135819|NCT02207569|64247989|FG000|36-Month|Death|23|||
23135820|NCT02207569|64247989|FG000|36-Month|Withdrawal by Subject|4|||
23135821|NCT02207569|64247989|FG000|48-Month|Death|25|||
23135822|NCT02207569|64247989|FG000|48-Month|Withdrawal by Subject|2|||
23135823|NCT02207569|64247989|FG000|48-Month|Lost to Follow-up|4|||
23135824|NCT02207569|64247989|FG000|60-Month|Death|1|||
23135825|NCT02207569|64247989|FG000|60-Month|Lost to Follow-up|1|||
23135826|NCT02207569|64247989|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
23135827|NCT02207569|64247989|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
23135828|NCT05062759|64247992|FG000|Overall Study|Death|0|||
23135829|NCT05062759|64247993|FG001|Overall Study|Death|1|||
23135830|NCT05062759|64247992|FG000|Overall Study|Lost to Follow-up|1|||
23135831|NCT05062759|64247993|FG001|Overall Study|Lost to Follow-up|0|||
23135832|NCT01895101|64247994|FG000|Overall Study|OPCAB procedure|1|||
23135833|NCT01895101|64247995|FG001|Overall Study|OPCAB procedure|1|||
23135834|NCT01895101|64247996|FG002|Overall Study|OPCAB procedure|3|||
23135835|NCT01895101|64247994|FG000|Overall Study|Withdrawal by Subject|0|||
23135836|NCT01895101|64247995|FG001|Overall Study|Withdrawal by Subject|1|||
23135837|NCT01895101|64247996|FG002|Overall Study|Withdrawal by Subject|2|||
23135838|NCT01895101|64247994|FG000|Overall Study|another study, enrolled in other study|0|||
23135839|NCT01895101|64247995|FG001|Overall Study|another study, enrolled in other study|1|||
23135840|NCT01895101|64247996|FG002|Overall Study|another study, enrolled in other study|0|||
23214808|NCT01807949|64528069|FG002|Overall Study|Non-Compliance|1|||
23550182|NCT02472964|65743204|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
23620377|NCT01121185|65994963|FG000|Overall Study|Not infused|0|||
23135841|NCT01895101|64247994|FG000|Overall Study|Death|0|||
23135842|NCT01895101|64247995|FG001|Overall Study|Death|1|||
23135843|NCT01895101|64247996|FG002|Overall Study|Death|0|||
23135844|NCT01895101|64247994|FG000|Overall Study|coagulation disorder|0|||
23135845|NCT01895101|64247995|FG001|Overall Study|coagulation disorder|1|||
23214809|NCT01807949|64528067|FG000|Overall Study|Undefined|0|||
23620378|NCT01121185|65994964|FG001|Overall Study|Not infused|1|||
23620379|NCT01121185|65994963|FG000|Overall Study|Not transplanted|1|||
23620380|NCT01121185|65994964|FG001|Overall Study|Not transplanted|0|||
23620381|NCT01746108|65994965|FG000|Overall Study|Migrated /moved from study area|0|||
23620382|NCT01746108|65994966|FG001|Overall Study|Migrated /moved from study area|1|||
23620383|NCT01746108|65994967|FG002|Overall Study|Migrated /moved from study area|0|||
23620384|NCT01746108|65994965|FG000|Overall Study|Adverse event, non-fatal|0|||
23620385|NCT01746108|65994966|FG001|Overall Study|Adverse event, non-fatal|1|||
23620386|NCT01746108|65994967|FG002|Overall Study|Adverse event, non-fatal|0|||
23620387|NCT01746108|65994965|FG000|Overall Study|Withdrawal by Subject|0|||
23620388|NCT01746108|65994966|FG001|Overall Study|Withdrawal by Subject|1|||
23620389|NCT01746108|65994967|FG002|Overall Study|Withdrawal by Subject|0|||
23620390|NCT01746108|65994965|FG000|Overall Study|Lost to Follow-up|0|||
23620391|NCT01746108|65994966|FG001|Overall Study|Lost to Follow-up|1|||
23620392|NCT01746108|65994967|FG002|Overall Study|Lost to Follow-up|0|||
23620393|NCT02168478|65994972|FG000|Overall Study|Withdrawal by Subject|1|||
23620394|NCT02168478|65994972|FG000|Overall Study|Did Not Consent to Participation|2|||
23620395|NCT02168478|65994972|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
23135846|NCT01895101|64247996|FG002|Overall Study|coagulation disorder|0|||
23135847|NCT01215188|64247997|FG000|Overall Study|Lost to Follow-up|22|||
23135848|NCT01215188|64247998|FG001|Overall Study|Lost to Follow-up|22|||
23135849|NCT01215188|64247999|FG002|Overall Study|Lost to Follow-up|16|||
23135850|NCT01215188|64247997|FG000|Overall Study|Adverse Event|1|||
23135851|NCT01215188|64247998|FG001|Overall Study|Adverse Event|1|||
23135852|NCT01215188|64247999|FG002|Overall Study|Adverse Event|3|||
23550183|NCT01669629|65743205|FG000|Period 1|protocol deviation|1|||
23550184|NCT01669629|65743206|FG001|Period 1|protocol deviation|2|||
23550185|NCT03230916|65743210|FG000|Overall Study|Withdrawal by Subject|0|||
23550186|NCT03230916|65743211|FG001|Overall Study|Withdrawal by Subject|0|||
23550187|NCT03230916|65743212|FG002|Overall Study|Withdrawal by Subject|0|||
23550188|NCT03230916|65743213|FG003|Overall Study|Withdrawal by Subject|0|||
23550189|NCT03230916|65743214|FG004|Overall Study|Withdrawal by Subject|0|||
23550190|NCT03230916|65743215|FG005|Overall Study|Withdrawal by Subject|1|||
23550191|NCT03230916|65743216|FG006|Overall Study|Withdrawal by Subject|0|||
23550192|NCT03230916|65743217|FG007|Overall Study|Withdrawal by Subject|0|||
23550193|NCT03230916|65743218|FG008|Overall Study|Withdrawal by Subject|0|||
23550194|NCT03230916|65743219|FG009|Overall Study|Withdrawal by Subject|0|||
23620396|NCT00510783|65994973|FG000|Overall Study|Lost to Follow-up|29|||
23620397|NCT00510783|65994974|FG001|Overall Study|Lost to Follow-up|25|||
23135853|NCT01215188|64247997|FG000|Overall Study|Physician Decision|2|||
23135854|NCT01215188|64247998|FG001|Overall Study|Physician Decision|1|||
23135855|NCT01215188|64247999|FG002|Overall Study|Physician Decision|0|||
23135856|NCT01215188|64247997|FG000|Overall Study|Lack of Efficacy|0|||
23135857|NCT01215188|64247998|FG001|Overall Study|Lack of Efficacy|0|||
23135858|NCT01215188|64247999|FG002|Overall Study|Lack of Efficacy|1|||
23135859|NCT01215188|64247997|FG000|Overall Study|Protocol Violation|1|||
23135860|NCT01215188|64247998|FG001|Overall Study|Protocol Violation|1|||
23135861|NCT01215188|64247999|FG002|Overall Study|Protocol Violation|1|||
23135862|NCT01215188|64247997|FG000|Overall Study|Withdrawal by Subject|32|||
23135863|NCT01215188|64247998|FG001|Overall Study|Withdrawal by Subject|34|||
23135864|NCT01215188|64247999|FG002|Overall Study|Withdrawal by Subject|31|||
23135865|NCT01204710|64248004|FG000|Randomization Treatment|Lost to Follow-up|1|||
23135866|NCT01204710|64248005|FG001|Randomization Treatment|Lost to Follow-up|0|||
23135867|NCT01204710|64248004|FG000|Randomization Treatment|Withdrawal by Subject|6|||
23135868|NCT01204710|64248005|FG001|Randomization Treatment|Withdrawal by Subject|5|||
23135869|NCT01204710|64248004|FG000|Randomization Treatment|Physician Decision|3|||
23135870|NCT01204710|64248005|FG001|Randomization Treatment|Physician Decision|2|||
23135871|NCT01204710|64248004|FG000|Randomization Treatment|Entry criteria not met|0|||
23135872|NCT01204710|64248005|FG001|Randomization Treatment|Entry criteria not met|1|||
23135873|NCT01204710|64248004|FG000|Randomization Treatment|Adverse Event|4|||
23135874|NCT01204710|64248005|FG001|Randomization Treatment|Adverse Event|2|||
23135875|NCT01204710|64248004|FG000|Randomization Treatment|Sponsor Decision|0|||
23135876|NCT01204710|64248005|FG001|Randomization Treatment|Sponsor Decision|1|||
23550195|NCT03230916|65743220|FG010|Overall Study|Withdrawal by Subject|0|||
23550196|NCT00791765|65743221|FG000|Weeks 1 to 12|Adverse Event|0|||
23620398|NCT00510783|65994973|FG000|Overall Study|Withdrawal by Subject|2|||
23620399|NCT00510783|65994974|FG001|Overall Study|Withdrawal by Subject|3|||
23135877|NCT01204710|64248004|FG000|Randomization Treatment|Worsening of General condition|0|||
23135878|NCT01204710|64248005|FG001|Randomization Treatment|Worsening of General condition|1|||
23135879|NCT01204710|64248004|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
23135880|NCT01204710|64248005|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
23214810|NCT01807949|64528068|FG001|Overall Study|Undefined|1|||
23135881|NCT01204710|64248004|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
23620400|NCT00510783|65994973|FG000|Overall Study|Protocol Violation|0|||
23620401|NCT00510783|65994974|FG001|Overall Study|Protocol Violation|1|||
23135882|NCT01204710|64248005|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
23550197|NCT00791765|65743222|FG001|Weeks 1 to 12|Adverse Event|1|||
23550198|NCT00791765|65743221|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
23550199|NCT00791765|65743222|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
23550200|NCT00791765|65743221|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
23550201|NCT00791765|65743222|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
23550202|NCT00791765|65743221|FG000|Weeks 1 to 12|Physician Decision|1|||
23135883|NCT01204710|64248004|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
23135884|NCT01204710|64248005|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
23135885|NCT01204710|64248004|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
23135886|NCT01204710|64248005|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
23135887|NCT00618618|64248009|FG000|Overall Study|Patient Request|0|||
23135888|NCT00618618|64248010|FG001|Overall Study|Patient Request|0|||
23135889|NCT00618618|64248011|FG002|Overall Study|Patient Request|2|||
23135890|NCT00618618|64248012|FG003|Overall Study|Patient Request|0|||
23135891|NCT00618618|64248009|FG000|Overall Study|Inability to Complete Study Procedures|0|||
23135892|NCT00618618|64248010|FG001|Overall Study|Inability to Complete Study Procedures|1|||
23135893|NCT00618618|64248011|FG002|Overall Study|Inability to Complete Study Procedures|0|||
23135894|NCT00618618|64248012|FG003|Overall Study|Inability to Complete Study Procedures|0|||
23135895|NCT00618618|64248009|FG000|Overall Study|Lost to Follow-up|3|||
23135896|NCT00618618|64248010|FG001|Overall Study|Lost to Follow-up|0|||
23135897|NCT00618618|64248011|FG002|Overall Study|Lost to Follow-up|0|||
23135898|NCT00618618|64248012|FG003|Overall Study|Lost to Follow-up|1|||
23135899|NCT00618618|64248009|FG000|Overall Study|Non-compliance|1|||
23135900|NCT00618618|64248010|FG001|Overall Study|Non-compliance|1|||
23135901|NCT00618618|64248011|FG002|Overall Study|Non-compliance|0|||
23135902|NCT00618618|64248012|FG003|Overall Study|Non-compliance|0|||
23135903|NCT00618618|64248009|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
23135904|NCT00618618|64248010|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
23135905|NCT00618618|64248011|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
23135906|NCT00618618|64248012|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
23135907|NCT00618618|64248009|FG000|Overall Study|Death|0|||
23135908|NCT00618618|64248010|FG001|Overall Study|Death|1|||
23135909|NCT00618618|64248011|FG002|Overall Study|Death|0|||
23135910|NCT00618618|64248012|FG003|Overall Study|Death|0|||
23135911|NCT01732822|64248013|FG000|Overall Study|Withdrawal by Subject|123|||
23135912|NCT01732822|64248014|FG001|Overall Study|Withdrawal by Subject|113|||
23135913|NCT01204398|64248015|FG000|Overall Study|Adverse Event|1|||
23135914|NCT03534284|64248022|FG000|Overall Study|Death|2|||
23135915|NCT03534284|64248023|FG001|Overall Study|Death|3|||
23135916|NCT03534284|64248024|FG002|Overall Study|Death|3|||
23135917|NCT03534284|64248022|FG000|Overall Study|Withdrawal by Subject|5|||
23135918|NCT03534284|64248023|FG001|Overall Study|Withdrawal by Subject|0|||
23135919|NCT03534284|64248024|FG002|Overall Study|Withdrawal by Subject|0|||
23135920|NCT01621568|64248025|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
23135921|NCT01621568|64248026|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
23135922|NCT01621568|64248025|FG000|Week 5-6 No Treatment|Death|1|||
23135923|NCT01621568|64248026|FG001|Week 5-6 No Treatment|Death|0|||
23135924|NCT02495792|64248027|FG000|Overall Study|Lost to Follow-up|5|||
23135925|NCT02495792|64248028|FG001|Overall Study|Lost to Follow-up|9|||
23135926|NCT02495792|64248027|FG000|Overall Study|Protocol Violation|32|||
23135927|NCT02495792|64248028|FG001|Overall Study|Protocol Violation|31|||
23135928|NCT01699503|64248038|FG000|Overall Study|Death|31|||
23135929|NCT01699503|64248039|FG001|Overall Study|Death|40|||
23135930|NCT01699503|64248038|FG000|Overall Study|Withdrawal by Subject|65|||
23135931|NCT01699503|64248039|FG001|Overall Study|Withdrawal by Subject|57|||
23135932|NCT01699503|64248038|FG000|Overall Study|Lost to Follow-up|121|||
23135933|NCT01699503|64248039|FG001|Overall Study|Lost to Follow-up|117|||
23135934|NCT01699503|64248038|FG000|Overall Study|Excluded due to quality|783|||
23135935|NCT01699503|64248039|FG001|Overall Study|Excluded due to quality|791|||
23135936|NCT01050790|64248043|FG000|Overall Study|Adverse Event|1|||
23135937|NCT03167359|64248044|FG000|Overall Study|Physician Decision|1|||
23135938|NCT03167359|64248044|FG000|Overall Study|Lost to Follow-up|1|||
23135939|NCT01470001|64248048|FG000|Overall Study|Lost to Follow-up|1|||
23135940|NCT01470001|64248049|FG001|Overall Study|Lost to Follow-up|1|||
23135941|NCT01470001|64248048|FG000|Overall Study|Physician Decision|2|||
23135942|NCT01470001|64248049|FG001|Overall Study|Physician Decision|0|||
23135943|NCT01470001|64248048|FG000|Overall Study|Withdrawal by Subject|2|||
23214811|NCT01807949|64528069|FG002|Overall Study|Undefined|2|||
23135944|NCT01470001|64248049|FG001|Overall Study|Withdrawal by Subject|1|||
23550203|NCT00791765|65743222|FG001|Weeks 1 to 12|Physician Decision|0|||
23214812|NCT01807949|64528067|FG000|Overall Study|Randomized But Not Treated|0|||
23214813|NCT01807949|64528068|FG001|Overall Study|Randomized But Not Treated|2|||
23214814|NCT01807949|64528069|FG002|Overall Study|Randomized But Not Treated|2|||
23214815|NCT03841526|64528070|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
23135945|NCT03932812|64248051|FG000|Overall Study|Lost to Follow-up|12|||
23135946|NCT03932812|64248052|FG001|Overall Study|Lost to Follow-up|14|||
23550204|NCT00791765|65743221|FG000|Weeks 1 to 12|Disease progression|3|||
23550205|NCT00791765|65743222|FG001|Weeks 1 to 12|Disease progression|0|||
23550206|NCT00791765|65743221|FG000|Weeks 1 to 12|Ineligibility determined|0|||
23550207|NCT00791765|65743222|FG001|Weeks 1 to 12|Ineligibility determined|3|||
23550208|NCT00791765|65743221|FG000|Weeks 13 to 24|Protocol deviation|2|||
23550209|NCT00791765|65743222|FG001|Weeks 13 to 24|Protocol deviation|0|||
23550210|NCT00791765|65743221|FG000|Weeks 13 to 24|Adverse Event|0|||
23550211|NCT00791765|65743222|FG001|Weeks 13 to 24|Adverse Event|3|||
23550212|NCT00791765|65743221|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
23550213|NCT00791765|65743222|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
23550214|NCT00791765|65743221|FG000|Weeks 13 to 24|Disease progression|0|||
23550215|NCT00791765|65743222|FG001|Weeks 13 to 24|Disease progression|1|||
23550216|NCT00791765|65743221|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
23550217|NCT00791765|65743222|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
23550218|NCT00791765|65743221|FG000|Weeks 13 to 24|Other|0|||
23550219|NCT00791765|65743222|FG001|Weeks 13 to 24|Other|1|||
23550220|NCT01549613|65743231|FG000|Overall Study|Lost to Follow-up|11|||
23550221|NCT01549613|65743232|FG001|Overall Study|Lost to Follow-up|11|||
23550222|NCT02099838|65743233|FG000|Overall Study|Death|1|||
23550223|NCT02099838|65743234|FG001|Overall Study|Death|0|||
23550224|NCT02099838|65743233|FG000|Overall Study|Lost to Follow-up|3|||
23550225|NCT02099838|65743234|FG001|Overall Study|Lost to Follow-up|1|||
23550226|NCT02099838|65743233|FG000|Overall Study|Withdrawal by Subject|0|||
23550227|NCT02099838|65743234|FG001|Overall Study|Withdrawal by Subject|1|||
23550228|NCT00328510|65743235|FG000|Overall Study|Gag disorder, could not use frame|4|||
23550229|NCT00328510|65743236|FG001|Overall Study|Gag disorder, could not use frame|0|||
23550230|NCT00328510|65743235|FG000|Overall Study|Dentition problems, could not use frame|1|||
23550231|NCT00328510|65743236|FG001|Overall Study|Dentition problems, could not use frame|0|||
23550232|NCT00328510|65743235|FG000|Overall Study|Withdrawal by Subject|4|||
23550233|NCT00328510|65743236|FG001|Overall Study|Withdrawal by Subject|2|||
23550234|NCT00328510|65743235|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
23550235|NCT00328510|65743236|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
23550236|NCT00328510|65743235|FG000|Overall Study|Treatment changed to a single fraction|1|||
23550237|NCT00328510|65743236|FG001|Overall Study|Treatment changed to a single fraction|1|||
23550238|NCT02301143|65743238|FG000|Induction Period|Enrolled But Not Treated|1|||
23550239|NCT02301143|65743239|FG001|Induction Period|Enrolled But Not Treated|0|||
23550240|NCT02301143|65743238|FG000|Induction Period|Death|1|||
23550241|NCT02301143|65743239|FG001|Induction Period|Death|0|||
23550242|NCT02301143|65743238|FG000|Induction Period|Adverse Event|22|||
23550243|NCT02301143|65743239|FG001|Induction Period|Adverse Event|0|||
23550244|NCT02301143|65743238|FG000|Induction Period|Progressive Disease|8|||
23550245|NCT02301143|65743239|FG001|Induction Period|Progressive Disease|0|||
23550246|NCT02301143|65743238|FG000|Induction Period|Withdrawal by Subject|3|||
23550247|NCT02301143|65743239|FG001|Induction Period|Withdrawal by Subject|0|||
23550248|NCT02301143|65743238|FG000|Induction Period|Noncompliance with Study Drug|1|||
23135947|NCT03932812|64248051|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
23135948|NCT03932812|64248052|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
23135949|NCT02665338|64248053|FG000|Overall Study|Withdrawal by Subject|0|||
23135950|NCT02665338|64248054|FG001|Overall Study|Withdrawal by Subject|1|||
23135951|NCT03218397|64248055|FG000|Overall Study|Prior positive blood culture|8|||
23135952|NCT03218397|64248056|FG001|Overall Study|Prior positive blood culture|13|||
23135953|NCT03218397|64248055|FG000|Overall Study|Comfort care|8|||
23135954|NCT03218397|64248056|FG001|Overall Study|Comfort care|5|||
23135955|NCT03218397|64248055|FG000|Overall Study|Comfort care and positive blood culture|1|||
23135956|NCT03218397|64248056|FG001|Overall Study|Comfort care and positive blood culture|0|||
23135957|NCT03218397|64248055|FG000|Overall Study|Comfort care and mixed culture|0|||
23135958|NCT03218397|64248056|FG001|Overall Study|Comfort care and mixed culture|1|||
23550249|NCT02301143|65743239|FG001|Induction Period|Noncompliance with Study Drug|0|||
23550250|NCT02301143|65743238|FG000|Induction Period|Physician Decision|4|||
23550251|NCT02301143|65743239|FG001|Induction Period|Physician Decision|0|||
23317567|NCT00993421|64904106|FG002|Overall Study|Withdrawal by Subject|3|||
23550252|NCT02301143|65743238|FG000|Induction Period|Symptomatic Deterioration|2|||
23550253|NCT02301143|65743239|FG001|Induction Period|Symptomatic Deterioration|0|||
23550254|NCT02301143|65743238|FG000|Induction Period|Protocol Violation|2|||
23550255|NCT02301143|65743239|FG001|Induction Period|Protocol Violation|0|||
23550256|NCT02301143|65743238|FG000|Induction Period|Other|1|||
23550257|NCT02301143|65743239|FG001|Induction Period|Other|0|||
23550258|NCT02301143|65743238|FG000|Investigator's Choice|Adverse Event|0|||
23550259|NCT02301143|65743239|FG001|Investigator's Choice|Adverse Event|3|||
23550260|NCT02301143|65743238|FG000|Investigator's Choice|Progressive Disease|0|||
23550261|NCT02301143|65743239|FG001|Investigator's Choice|Progressive Disease|3|||
23550262|NCT02301143|65743238|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
23135959|NCT03218397|64248055|FG000|Overall Study|Mixed culture|2|||
23135960|NCT03218397|64248056|FG001|Overall Study|Mixed culture|2|||
23135961|NCT03218397|64248055|FG000|Overall Study|Inaccessible hospital records|2|||
23550263|NCT02301143|65743239|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
23135962|NCT03218397|64248056|FG001|Overall Study|Inaccessible hospital records|5|||
23135963|NCT03218397|64248055|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
23135964|NCT03218397|64248056|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
23135965|NCT03218397|64248055|FG000|Overall Study|Randomized during laboratory off hours|2|||
23214816|NCT03841526|64528071|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
23214817|NCT03841526|64528072|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
23214818|NCT03841526|64528073|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
23214819|NCT03841526|64528074|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
23214820|NCT03841526|64528075|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
23214821|NCT03841526|64528070|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
23214822|NCT03841526|64528071|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
23214823|NCT03841526|64528072|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
23214824|NCT03841526|64528073|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
23214825|NCT03841526|64528074|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
23214826|NCT03841526|64528075|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
23214827|NCT03841526|64528070|FG000|Outpatient Phase Treatment|Physician Decision|0|||
23214828|NCT03841526|64528071|FG001|Outpatient Phase Treatment|Physician Decision|1|||
23214829|NCT03841526|64528072|FG002|Outpatient Phase Treatment|Physician Decision|0|||
23214830|NCT03841526|64528073|FG003|Outpatient Phase Treatment|Physician Decision|0|||
23550264|NCT02301143|65743238|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
23550265|NCT02301143|65743239|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
23550266|NCT02301143|65743238|FG000|Investigator's Choice|Other|0|||
23550267|NCT02301143|65743239|FG001|Investigator's Choice|Other|1|||
23550268|NCT02301143|65743238|FG000|Investigator's Choice|Unresectable Surgery|0|||
23550269|NCT02301143|65743239|FG001|Investigator's Choice|Unresectable Surgery|1|||
23550270|NCT03581981|65743240|FG000|Overall Study|Withdrawal by Subject|12|||
23550271|NCT03581981|65743241|FG001|Overall Study|Withdrawal by Subject|13|||
23135966|NCT03218397|64248056|FG001|Overall Study|Randomized during laboratory off hours|1|||
23214831|NCT03841526|64528074|FG004|Outpatient Phase Treatment|Physician Decision|0|||
23214832|NCT03841526|64528075|FG005|Outpatient Phase Treatment|Physician Decision|0|||
23214833|NCT03841526|64528070|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
23214834|NCT03841526|64528071|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
23214835|NCT03841526|64528072|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
23214836|NCT03841526|64528073|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
23214837|NCT03841526|64528074|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
23214838|NCT03841526|64528075|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
23214839|NCT03911869|64528076|FG000|Safety Lead-in Phase|Death|7|||
23214840|NCT03911869|64528077|FG001|Safety Lead-in Phase|Death|0|||
23214841|NCT03911869|64528078|FG002|Safety Lead-in Phase|Death|0|||
23214842|NCT03911869|64528076|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
23214843|NCT03911869|64528077|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
23214844|NCT03911869|64528078|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
23214845|NCT03911869|64528076|FG000|Safety Lead-in Phase|Other|1|||
23214846|NCT03911869|64528077|FG001|Safety Lead-in Phase|Other|0|||
23214847|NCT03911869|64528078|FG002|Safety Lead-in Phase|Other|0|||
23214848|NCT03911869|64528076|FG000|Phase 2|Death|0|||
23214849|NCT03911869|64528077|FG001|Phase 2|Death|3|||
23214850|NCT03911869|64528078|FG002|Phase 2|Death|0|||
23214851|NCT00505752|64528079|FG000|Overall Study|Adverse Event|1|||
23214852|NCT00505752|64528080|FG001|Overall Study|Adverse Event|0|||
23214853|NCT00505752|64528081|FG002|Overall Study|Adverse Event|1|||
23214854|NCT00505752|64528082|FG003|Overall Study|Adverse Event|0|||
23214855|NCT00505752|64528079|FG000|Overall Study|Lost to Follow-up|1|||
23214856|NCT00505752|64528080|FG001|Overall Study|Lost to Follow-up|0|||
23214857|NCT00505752|64528081|FG002|Overall Study|Lost to Follow-up|0|||
23135967|NCT02412371|64248057|FG000|Overall Study|Withdrawal by Subject|0|||
23135968|NCT02412371|64248058|FG001|Overall Study|Withdrawal by Subject|2|||
23135969|NCT02412371|64248059|FG002|Overall Study|Withdrawal by Subject|0|||
23135970|NCT02412371|64248060|FG003|Overall Study|Withdrawal by Subject|1|||
23135971|NCT02412371|64248061|FG004|Overall Study|Withdrawal by Subject|1|||
23214858|NCT00505752|64528082|FG003|Overall Study|Lost to Follow-up|0|||
23214859|NCT00505752|64528079|FG000|Overall Study|Lack of ovarian response|1|||
23214860|NCT00505752|64528080|FG001|Overall Study|Lack of ovarian response|3|||
23214861|NCT00505752|64528081|FG002|Overall Study|Lack of ovarian response|0|||
23214862|NCT00505752|64528082|FG003|Overall Study|Lack of ovarian response|0|||
23214863|NCT00505752|64528079|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23214864|NCT00505752|64528080|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23214865|NCT00505752|64528081|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
23214866|NCT00505752|64528082|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
23550272|NCT03581981|65743240|FG000|Overall Study|Physician Decision|1|||
23135972|NCT02412371|64248062|FG005|Overall Study|Withdrawal by Subject|0|||
23135973|NCT02412371|64248057|FG000|Overall Study|Sponsor Discontinued Study|1|||
23135974|NCT02412371|64248058|FG001|Overall Study|Sponsor Discontinued Study|4|||
23135975|NCT02412371|64248059|FG002|Overall Study|Sponsor Discontinued Study|6|||
23550273|NCT03581981|65743241|FG001|Overall Study|Physician Decision|2|||
23550274|NCT03581981|65743240|FG000|Overall Study|Lost to Follow-up|0|||
23550275|NCT03581981|65743241|FG001|Overall Study|Lost to Follow-up|4|||
23550276|NCT00175825|65743245|FG000|Overall Study|Adverse Event|3|||
23135976|NCT02412371|64248060|FG003|Overall Study|Sponsor Discontinued Study|4|||
23135977|NCT02412371|64248061|FG004|Overall Study|Sponsor Discontinued Study|5|||
23135978|NCT02412371|64248062|FG005|Overall Study|Sponsor Discontinued Study|0|||
23135979|NCT02412371|64248057|FG000|Overall Study|Death|4|||
23135980|NCT02412371|64248058|FG001|Overall Study|Death|2|||
23135981|NCT02412371|64248059|FG002|Overall Study|Death|1|||
23135982|NCT02412371|64248060|FG003|Overall Study|Death|3|||
23135983|NCT02412371|64248061|FG004|Overall Study|Death|5|||
23135984|NCT02412371|64248062|FG005|Overall Study|Death|2|||
23135985|NCT02412371|64248057|FG000|Overall Study|Other|2|||
23135986|NCT02412371|64248058|FG001|Overall Study|Other|1|||
23429535|NCT01533922|65317400|FG000|Overall Study|Withdrawal by Subject|3|||
23429536|NCT01533922|65317401|FG001|Overall Study|Withdrawal by Subject|1|||
23429537|NCT01533922|65317402|FG002|Overall Study|Withdrawal by Subject|2|||
23429538|NCT01533922|65317403|FG003|Overall Study|Withdrawal by Subject|2|||
23429539|NCT01533922|65317404|FG004|Overall Study|Withdrawal by Subject|1|||
23550277|NCT00175825|65743246|FG001|Overall Study|Adverse Event|2|||
23550278|NCT00175825|65743247|FG002|Overall Study|Adverse Event|1|||
23550279|NCT00175825|65743248|FG003|Overall Study|Adverse Event|1|||
23550280|NCT00175825|65743245|FG000|Overall Study|Lost to Follow-up|1|||
23550281|NCT00175825|65743246|FG001|Overall Study|Lost to Follow-up|2|||
23550282|NCT00175825|65743247|FG002|Overall Study|Lost to Follow-up|0|||
23550283|NCT00175825|65743248|FG003|Overall Study|Lost to Follow-up|0|||
23550284|NCT00175825|65743245|FG000|Overall Study|Withdrawal by Subject|1|||
23550285|NCT00175825|65743246|FG001|Overall Study|Withdrawal by Subject|0|||
23550286|NCT00175825|65743247|FG002|Overall Study|Withdrawal by Subject|0|||
23550287|NCT00175825|65743248|FG003|Overall Study|Withdrawal by Subject|0|||
23550288|NCT00487162|65743253|FG000|Overall Study|Adverse Event|0|||
23550289|NCT00487162|65743254|FG001|Overall Study|Adverse Event|1|||
23550290|NCT00487162|65743253|FG000|Overall Study|Physician Decision|0|||
23550291|NCT00487162|65743254|FG001|Overall Study|Physician Decision|1|||
23550292|NCT00487162|65743253|FG000|Overall Study|Withdrawal by Subject|2|||
23550293|NCT00487162|65743254|FG001|Overall Study|Withdrawal by Subject|3|||
23550294|NCT01587651|65743255|FG000|Overall Study|Adverse Event|0|||
23550295|NCT01587651|65743256|FG001|Overall Study|Adverse Event|1|||
23550296|NCT01587651|65743257|FG002|Overall Study|Adverse Event|0|||
23550297|NCT01587651|65743255|FG000|Overall Study|Protocol Violation|0|||
23550298|NCT01587651|65743256|FG001|Overall Study|Protocol Violation|1|||
23550299|NCT01587651|65743257|FG002|Overall Study|Protocol Violation|1|||
23550300|NCT01587651|65743255|FG000|Overall Study|Withdrawal by Subject|0|||
23550301|NCT01587651|65743256|FG001|Overall Study|Withdrawal by Subject|1|||
23550302|NCT01587651|65743257|FG002|Overall Study|Withdrawal by Subject|0|||
23550303|NCT03966157|65743258|FG000|Overall Study|Physician Decision|1|||
23550304|NCT03966157|65743259|FG001|Overall Study|Physician Decision|0|||
23550305|NCT02526693|65743260|FG000|Overall Study|Physician Decision|3|||
23550306|NCT02526693|65743261|FG001|Overall Study|Physician Decision|1|||
23550307|NCT01857531|65743267|FG000|Overall Study|Withdrawal by Subject|4|||
23550308|NCT03053050|65743268|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
23550309|NCT03053050|65743269|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
23550310|NCT03053050|65743270|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
23550311|NCT03053050|65743271|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
23550312|NCT03053050|65743268|FG000|Randomized Phase|Withdrew Consent|16|||
23550313|NCT03053050|65743269|FG001|Randomized Phase|Withdrew Consent|8|||
23550314|NCT03053050|65743270|FG002|Randomized Phase|Withdrew Consent|9|||
23550315|NCT03053050|65743271|FG003|Randomized Phase|Withdrew Consent|0|||
23429540|NCT01533922|65317400|FG000|Overall Study|Other reason not defined above|2|||
23429541|NCT01533922|65317401|FG001|Overall Study|Other reason not defined above|0|||
23550316|NCT03053050|65743268|FG000|Randomized Phase|Investigator's Discretion|6|||
23550317|NCT03053050|65743269|FG001|Randomized Phase|Investigator's Discretion|6|||
23550318|NCT03053050|65743270|FG002|Randomized Phase|Investigator's Discretion|3|||
23550319|NCT03053050|65743271|FG003|Randomized Phase|Investigator's Discretion|0|||
23550320|NCT03053050|65743268|FG000|Randomized Phase|Lost to Follow-up|5|||
23550321|NCT03053050|65743269|FG001|Randomized Phase|Lost to Follow-up|1|||
23550322|NCT03053050|65743270|FG002|Randomized Phase|Lost to Follow-up|1|||
23550323|NCT03053050|65743271|FG003|Randomized Phase|Lost to Follow-up|0|||
23550324|NCT03053050|65743268|FG000|Randomized Phase|Adverse Event|0|||
23550325|NCT03053050|65743269|FG001|Randomized Phase|Adverse Event|1|||
23550326|NCT03053050|65743270|FG002|Randomized Phase|Adverse Event|0|||
23550327|NCT03053050|65743271|FG003|Randomized Phase|Adverse Event|0|||
23550328|NCT03053050|65743268|FG000|Randomized Phase|Randomized but Never Treated|2|||
23135987|NCT02412371|64248059|FG002|Overall Study|Other|0|||
23135988|NCT02412371|64248060|FG003|Overall Study|Other|0|||
23135989|NCT02412371|64248061|FG004|Overall Study|Other|1|||
23135990|NCT02412371|64248062|FG005|Overall Study|Other|3|||
23429542|NCT01533922|65317402|FG002|Overall Study|Other reason not defined above|1|||
23429543|NCT01533922|65317403|FG003|Overall Study|Other reason not defined above|0|||
23429544|NCT01533922|65317404|FG004|Overall Study|Other reason not defined above|0|||
23429545|NCT02698371|65317406|FG000|All Participants Flow|Lost to Follow-up|3|||
23550329|NCT03053050|65743269|FG001|Randomized Phase|Randomized but Never Treated|2|||
23550330|NCT03053050|65743270|FG002|Randomized Phase|Randomized but Never Treated|2|||
23550331|NCT03053050|65743271|FG003|Randomized Phase|Randomized but Never Treated|0|||
23550332|NCT03053050|65743268|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
23550333|NCT03053050|65743269|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
23550334|NCT03053050|65743270|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
23550335|NCT03053050|65743271|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
23550336|NCT03053050|65743268|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
23550337|NCT03053050|65743269|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
23550338|NCT03053050|65743270|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
23550339|NCT03053050|65743271|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
23550340|NCT03053050|65743268|FG000|Open-label Phase|Withdrew Consent|0|||
23550341|NCT03053050|65743269|FG001|Open-label Phase|Withdrew Consent|0|||
23550342|NCT03053050|65743270|FG002|Open-label Phase|Withdrew Consent|0|||
23550343|NCT03053050|65743271|FG003|Open-label Phase|Withdrew Consent|6|||
23550344|NCT03053050|65743268|FG000|Open-label Phase|Investigator's Discretion|0|||
23550345|NCT03053050|65743269|FG001|Open-label Phase|Investigator's Discretion|0|||
23620402|NCT00143598|65994977|FG000|Overall Study|Lost to Follow-up|23|||
23135991|NCT00532493|64248063|FG000|Overall Study|Death|1|||
23135992|NCT00532493|64248064|FG001|Overall Study|Death|1|||
23135993|NCT00532493|64248063|FG000|Overall Study|Lost to Follow-up|10|||
23135994|NCT00532493|64248064|FG001|Overall Study|Lost to Follow-up|7|||
23135995|NCT00532493|64248063|FG000|Overall Study|Withdrawal by Subject|7|||
23135996|NCT00532493|64248064|FG001|Overall Study|Withdrawal by Subject|9|||
23135997|NCT00532493|64248063|FG000|Overall Study|Physician Decision|1|||
23135998|NCT00532493|64248064|FG001|Overall Study|Physician Decision|6|||
23135999|NCT00532493|64248063|FG000|Overall Study|Adverse Event|6|||
23136000|NCT00532493|64248064|FG001|Overall Study|Adverse Event|5|||
23136001|NCT00532493|64248063|FG000|Overall Study|Protocol Deviation|1|||
23136002|NCT00532493|64248064|FG001|Overall Study|Protocol Deviation|0|||
23136003|NCT00532493|64248063|FG000|Overall Study|Subject Moved Away|3|||
23136004|NCT00532493|64248064|FG001|Overall Study|Subject Moved Away|1|||
23136005|NCT00532493|64248063|FG000|Overall Study|Contraindicative Medication|1|||
23136006|NCT00532493|64248064|FG001|Overall Study|Contraindicative Medication|0|||
23136007|NCT04958642|64248065|FG000|Overall Study|Transferred to OLEX program|3|||
23136008|NCT04958642|64248066|FG001|Overall Study|Transferred to OLEX program|0|||
23136009|NCT04958642|64248067|FG002|Overall Study|Transferred to OLEX program|5|||
23136010|NCT04958642|64248065|FG000|Overall Study|Death|0|||
23136011|NCT04958642|64248066|FG001|Overall Study|Death|0|||
23136012|NCT04958642|64248067|FG002|Overall Study|Death|1|||
23136013|NCT04958642|64248065|FG000|Overall Study|Withdrawal by Subject|4|||
23136014|NCT04958642|64248066|FG001|Overall Study|Withdrawal by Subject|9|||
23136015|NCT04958642|64248067|FG002|Overall Study|Withdrawal by Subject|13|||
23136016|NCT04958642|64248065|FG000|Overall Study|Investigator's Decision|0|||
23136017|NCT04958642|64248066|FG001|Overall Study|Investigator's Decision|0|||
23136018|NCT04958642|64248067|FG002|Overall Study|Investigator's Decision|1|||
23136019|NCT04958642|64248065|FG000|Overall Study|Adverse Event|1|||
23136020|NCT04958642|64248066|FG001|Overall Study|Adverse Event|0|||
23136021|NCT04958642|64248067|FG002|Overall Study|Adverse Event|1|||
23136022|NCT04958642|64248065|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
23136023|NCT04958642|64248066|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
23136024|NCT04958642|64248067|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
23136025|NCT04958642|64248065|FG000|Overall Study|Lost to Follow-up|1|||
23136026|NCT04958642|64248066|FG001|Overall Study|Lost to Follow-up|0|||
23136027|NCT04958642|64248067|FG002|Overall Study|Lost to Follow-up|0|||
23136028|NCT04958642|64248065|FG000|Overall Study|Transferred to EAP following study termination|0|||
23214867|NCT00505752|64528079|FG000|Overall Study|No oocytes retrieved|0|||
23214868|NCT00505752|64528080|FG001|Overall Study|No oocytes retrieved|2|||
23214869|NCT00505752|64528081|FG002|Overall Study|No oocytes retrieved|0|||
23214870|NCT00505752|64528082|FG003|Overall Study|No oocytes retrieved|1|||
23214871|NCT00505752|64528079|FG000|Overall Study|No Fertilization|1|||
23214872|NCT00505752|64528080|FG001|Overall Study|No Fertilization|1|||
23429546|NCT02698371|65317406|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
23136029|NCT04958642|64248066|FG001|Overall Study|Transferred to EAP following study termination|0|||
23136030|NCT04958642|64248067|FG002|Overall Study|Transferred to EAP following study termination|1|||
23429547|NCT02698371|65317406|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
23550346|NCT03053050|65743270|FG002|Open-label Phase|Investigator's Discretion|0|||
23136031|NCT04958642|64248065|FG000|Overall Study|Transferred to Expanded Access Program|1|||
23136032|NCT04958642|64248066|FG001|Overall Study|Transferred to Expanded Access Program|0|||
23214873|NCT00505752|64528081|FG002|Overall Study|No Fertilization|2|||
23136033|NCT04958642|64248067|FG002|Overall Study|Transferred to Expanded Access Program|0|||
23136034|NCT00831129|64248070|FG000|Overall Study|Adverse Event|0|||
23136035|NCT00831129|64248071|FG001|Overall Study|Adverse Event|1|||
23136036|NCT00831129|64248070|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
23136037|NCT00831129|64248071|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
23136038|NCT01160289|64248075|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
23136039|NCT01160289|64248076|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23136040|NCT01160289|64248077|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23136041|NCT01160289|64248078|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23136042|NCT01160289|64248079|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23136043|NCT01160289|64248080|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
23136044|NCT01160289|64248075|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
23214874|NCT00505752|64528082|FG003|Overall Study|No Fertilization|1|||
23550347|NCT03053050|65743271|FG003|Open-label Phase|Investigator's Discretion|4|||
23620403|NCT00143598|65994978|FG001|Overall Study|Lost to Follow-up|21|||
23550348|NCT02081846|65743273|FG000|Overall Study|Withdrawal by Subject|1|||
23550349|NCT02081846|65743274|FG001|Overall Study|Withdrawal by Subject|0|||
23550350|NCT02081846|65743273|FG000|Overall Study|invalid consent|1|||
23550351|NCT02081846|65743274|FG001|Overall Study|invalid consent|0|||
23550352|NCT01454583|65743275|FG000|1st Year|Lost to Follow-up|1057|||
23550353|NCT01454583|65743276|FG001|1st Year|Lost to Follow-up|318|||
23550354|NCT01454583|65743277|FG002|1st Year|Lost to Follow-up|180|||
23550355|NCT01454583|65743275|FG000|2nd Year|Lost to Follow-up|3965|||
23550356|NCT01454583|65743276|FG001|2nd Year|Lost to Follow-up|1049|||
23550357|NCT01454583|65743277|FG002|2nd Year|Lost to Follow-up|737|||
23550358|NCT01454583|65743275|FG000|3rd Year|Lost to Follow-up|1959|||
23550359|NCT01454583|65743276|FG001|3rd Year|Lost to Follow-up|512|||
23550360|NCT01454583|65743277|FG002|3rd Year|Lost to Follow-up|297|||
23550361|NCT03585244|65743279|FG000|Overall Study|Withdrawal by Subject|15|||
23550362|NCT03422250|65743280|FG000|Intervention|Adverse Event|0|||
23550363|NCT03422250|65743281|FG001|Intervention|Adverse Event|1|||
23550364|NCT03422250|65743282|FG002|Intervention|Adverse Event|0|||
23550365|NCT03422250|65743283|FG003|Intervention|Adverse Event|1|||
23550366|NCT03422250|65743280|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
23550367|NCT03422250|65743281|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
23550368|NCT03422250|65743282|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
23550369|NCT03422250|65743283|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
23550370|NCT03422250|65743280|FG000|Follow-up|Withdrawal by Subject|0|||
23550371|NCT03422250|65743281|FG001|Follow-up|Withdrawal by Subject|0|||
23550372|NCT03422250|65743282|FG002|Follow-up|Withdrawal by Subject|0|||
23550373|NCT03422250|65743283|FG003|Follow-up|Withdrawal by Subject|1|||
23550374|NCT03422250|65743280|FG000|Follow-up|Adverse Event|0|||
23550375|NCT03422250|65743281|FG001|Follow-up|Adverse Event|0|||
23620404|NCT00143598|65994977|FG000|Overall Study|Withdrawal by Subject|33|||
23620405|NCT00143598|65994978|FG001|Overall Study|Withdrawal by Subject|37|||
23620406|NCT00143598|65994977|FG000|Overall Study|Death|36|||
23620407|NCT00143598|65994978|FG001|Overall Study|Death|36|||
23620408|NCT02512861|65994979|FG000|Overall Study|Protocol Violation|3|||
23620409|NCT02512861|65994980|FG001|Overall Study|Protocol Violation|7|||
23620410|NCT02512861|65994979|FG000|Overall Study|Physician Decision|3|||
23620411|NCT02512861|65994980|FG001|Overall Study|Physician Decision|1|||
23620412|NCT02512861|65994979|FG000|Overall Study|Withdrawal by Subject|0|||
23620413|NCT02512861|65994980|FG001|Overall Study|Withdrawal by Subject|1|||
23620414|NCT00115336|65994981|FG000|Overall Study|Hospital discharge before study drug|0|||
23620415|NCT00115336|65994982|FG001|Overall Study|Hospital discharge before study drug|1|||
23620416|NCT00582114|65994983|FG000|Overall Study|Death|4|||
23620417|NCT00582114|65994984|FG001|Overall Study|Death|4|||
23620418|NCT00582114|65994983|FG000|Overall Study|Kidney Transplant|3|||
23620419|NCT00582114|65994984|FG001|Overall Study|Kidney Transplant|1|||
23620420|NCT00582114|65994983|FG000|Overall Study|Lost to Follow-up|7|||
23620421|NCT00582114|65994984|FG001|Overall Study|Lost to Follow-up|6|||
23620422|NCT00582114|65994983|FG000|Overall Study|Withdrawal by Subject|8|||
23620423|NCT00582114|65994984|FG001|Overall Study|Withdrawal by Subject|16|||
23620424|NCT00582114|65994983|FG000|Overall Study|Adverse Event|1|||
23620425|NCT00582114|65994984|FG001|Overall Study|Adverse Event|1|||
23620426|NCT00582114|65994983|FG000|Overall Study|Physician Decision|0|||
23620427|NCT00582114|65994984|FG001|Overall Study|Physician Decision|6|||
23620428|NCT00582114|65994983|FG000|Overall Study|Stopped by data safety monitoring board|19|||
23550376|NCT03422250|65743282|FG002|Follow-up|Adverse Event|0|||
23550377|NCT03422250|65743283|FG003|Follow-up|Adverse Event|1|||
23550378|NCT01597050|65743284|FG000|Overall Study|Withdrawal by Subject|1|||
23550379|NCT01597050|65743285|FG001|Overall Study|Withdrawal by Subject|0|||
23550380|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
23550381|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
23550382|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
23550383|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
23550384|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
23550385|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
23550386|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
23550387|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
23550388|NCT00679939|65743286|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
23550389|NCT00679939|65743287|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
23550390|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
23550391|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
23550392|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
23550393|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
23550394|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
23550395|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
23550396|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
23550397|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
23550398|NCT00679939|65743286|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
23550399|NCT00679939|65743287|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
23550400|NCT03320070|65743288|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
23550401|NCT03320070|65743289|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
23550402|NCT03320070|65743288|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
23550403|NCT03320070|65743289|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
23550404|NCT03320070|65743288|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
23550405|NCT03320070|65743289|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
23550406|NCT03320070|65743288|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
23550407|NCT03320070|65743289|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
23550408|NCT03320070|65743288|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
23550409|NCT03320070|65743289|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
23550410|NCT03320070|65743288|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
23550411|NCT03320070|65743289|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
23550412|NCT02564523|65743290|FG000|Overall Study|Withdrawal by Subject|3|||
23550413|NCT02564523|65743291|FG001|Overall Study|Withdrawal by Subject|0|||
23550414|NCT02564523|65743292|FG002|Overall Study|Withdrawal by Subject|1|||
23550415|NCT02564523|65743293|FG003|Overall Study|Withdrawal by Subject|0|||
23550416|NCT02564523|65743294|FG004|Overall Study|Withdrawal by Subject|1|||
23550417|NCT02564523|65743295|FG005|Overall Study|Withdrawal by Subject|0|||
23550418|NCT02564523|65743296|FG006|Overall Study|Withdrawal by Subject|1|||
23550419|NCT02564523|65743297|FG007|Overall Study|Withdrawal by Subject|0|||
23550420|NCT02564523|65743298|FG008|Overall Study|Withdrawal by Subject|0|||
23550421|NCT02564523|65743299|FG009|Overall Study|Withdrawal by Subject|0|||
23550422|NCT02564523|65743300|FG010|Overall Study|Withdrawal by Subject|1|||
23550423|NCT02564523|65743301|FG011|Overall Study|Withdrawal by Subject|0|||
23550424|NCT02564523|65743302|FG012|Overall Study|Withdrawal by Subject|1|||
23550425|NCT02564523|65743303|FG013|Overall Study|Withdrawal by Subject|0|||
23550426|NCT02564523|65743304|FG014|Overall Study|Withdrawal by Subject|0|||
23550427|NCT02564523|65743305|FG015|Overall Study|Withdrawal by Subject|0|||
23550428|NCT02564523|65743306|FG016|Overall Study|Withdrawal by Subject|0|||
23550429|NCT02564523|65743307|FG017|Overall Study|Withdrawal by Subject|0|||
23550430|NCT02564523|65743290|FG000|Overall Study|Adverse Event|0|||
23550431|NCT02564523|65743291|FG001|Overall Study|Adverse Event|0|||
23550432|NCT02564523|65743292|FG002|Overall Study|Adverse Event|0|||
23550433|NCT02564523|65743293|FG003|Overall Study|Adverse Event|0|||
23550434|NCT02564523|65743294|FG004|Overall Study|Adverse Event|0|||
23550435|NCT02564523|65743295|FG005|Overall Study|Adverse Event|0|||
23550436|NCT02564523|65743296|FG006|Overall Study|Adverse Event|0|||
23550437|NCT02564523|65743297|FG007|Overall Study|Adverse Event|0|||
23550438|NCT02564523|65743298|FG008|Overall Study|Adverse Event|0|||
23550439|NCT02564523|65743299|FG009|Overall Study|Adverse Event|0|||
23550440|NCT02564523|65743300|FG010|Overall Study|Adverse Event|0|||
23550441|NCT02564523|65743301|FG011|Overall Study|Adverse Event|0|||
23550442|NCT02564523|65743302|FG012|Overall Study|Adverse Event|0|||
23550443|NCT02564523|65743303|FG013|Overall Study|Adverse Event|0|||
23550444|NCT02564523|65743304|FG014|Overall Study|Adverse Event|0|||
23550445|NCT02564523|65743305|FG015|Overall Study|Adverse Event|0|||
23550446|NCT02564523|65743306|FG016|Overall Study|Adverse Event|0|||
23550447|NCT02564523|65743307|FG017|Overall Study|Adverse Event|1|||
23550448|NCT02564523|65743290|FG000|Overall Study|Death|0|||
23550449|NCT02564523|65743291|FG001|Overall Study|Death|0|||
23550450|NCT02564523|65743292|FG002|Overall Study|Death|0|||
23550451|NCT02564523|65743293|FG003|Overall Study|Death|0|||
23550452|NCT02564523|65743294|FG004|Overall Study|Death|0|||
23550453|NCT02564523|65743295|FG005|Overall Study|Death|0|||
23550454|NCT02564523|65743296|FG006|Overall Study|Death|1|||
23550455|NCT02564523|65743297|FG007|Overall Study|Death|0|||
23550456|NCT02564523|65743298|FG008|Overall Study|Death|0|||
23550457|NCT02564523|65743299|FG009|Overall Study|Death|0|||
23550458|NCT02564523|65743300|FG010|Overall Study|Death|1|||
23136045|NCT01160289|64248076|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23136046|NCT01160289|64248077|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23136047|NCT01160289|64248078|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23214875|NCT00505752|64528079|FG000|Overall Study|All embryos/blastocysts discarded|0|||
23214876|NCT00505752|64528080|FG001|Overall Study|All embryos/blastocysts discarded|0|||
23214877|NCT00505752|64528081|FG002|Overall Study|All embryos/blastocysts discarded|1|||
23214878|NCT00505752|64528082|FG003|Overall Study|All embryos/blastocysts discarded|1|||
23214879|NCT00505752|64528079|FG000|Overall Study|Other|1|||
23214880|NCT00505752|64528080|FG001|Overall Study|Other|2|||
23214881|NCT00505752|64528081|FG002|Overall Study|Other|1|||
23136048|NCT01160289|64248079|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23136049|NCT01160289|64248080|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
23136050|NCT01160289|64248075|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
23136051|NCT01160289|64248076|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23136052|NCT01160289|64248077|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23136053|NCT01160289|64248078|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23136054|NCT01160289|64248079|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23136055|NCT01160289|64248080|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
23136056|NCT01160289|64248075|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
23136057|NCT01160289|64248076|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23136058|NCT01160289|64248077|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23136059|NCT01160289|64248078|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23136060|NCT01160289|64248079|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23136061|NCT01160289|64248080|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
23136062|NCT01160289|64248075|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
23136063|NCT01160289|64248076|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23136064|NCT01160289|64248077|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23136065|NCT01160289|64248078|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23136066|NCT01160289|64248079|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23136067|NCT01160289|64248080|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
23136068|NCT01160289|64248075|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
23136069|NCT01160289|64248076|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23136070|NCT01160289|64248077|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23136071|NCT01160289|64248078|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23136072|NCT01160289|64248079|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23136073|NCT01160289|64248080|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
23136074|NCT01160289|64248075|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
23136075|NCT01160289|64248076|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23136076|NCT01160289|64248077|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23136077|NCT01160289|64248078|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23136078|NCT01160289|64248079|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23136079|NCT01160289|64248080|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
23136080|NCT01160289|64248075|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
23429548|NCT02698371|65317406|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
23429549|NCT02698371|65317406|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
23429550|NCT02698371|65317406|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
23136081|NCT01160289|64248076|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23214882|NCT00505752|64528082|FG003|Overall Study|Other|2|||
23214883|NCT02501902|64528083|FG000|Overall Study|Subject Refused Further Follow-up|0|||
23214884|NCT02501902|64528084|FG001|Overall Study|Subject Refused Further Follow-up|0|||
23214885|NCT02501902|64528085|FG002|Overall Study|Subject Refused Further Follow-up|0|||
23214886|NCT02501902|64528086|FG003|Overall Study|Subject Refused Further Follow-up|0|||
23214887|NCT02501902|64528087|FG004|Overall Study|Subject Refused Further Follow-up|0|||
23214888|NCT02501902|64528088|FG005|Overall Study|Subject Refused Further Follow-up|0|||
23214889|NCT02501902|64528089|FG006|Overall Study|Subject Refused Further Follow-up|0|||
23214890|NCT02501902|64528090|FG007|Overall Study|Subject Refused Further Follow-up|1|||
23214891|NCT02501902|64528083|FG000|Overall Study|Study Terminated by Sponsor|0|||
23214892|NCT02501902|64528084|FG001|Overall Study|Study Terminated by Sponsor|3|||
23214893|NCT02501902|64528085|FG002|Overall Study|Study Terminated by Sponsor|0|||
23214894|NCT02501902|64528086|FG003|Overall Study|Study Terminated by Sponsor|1|||
23429551|NCT02698371|65317406|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
23429552|NCT00582738|65317407|FG000|Overall Study|Administrative Problems|7|||
23429553|NCT00582738|65317408|FG001|Overall Study|Administrative Problems|8|||
23429554|NCT00582738|65317407|FG000|Overall Study|Adverse Event|0|||
23429555|NCT00582738|65317408|FG001|Overall Study|Adverse Event|5|||
23429556|NCT00582738|65317407|FG000|Overall Study|Graft Lost|0|||
23550459|NCT02564523|65743301|FG011|Overall Study|Death|0|||
23550460|NCT02564523|65743302|FG012|Overall Study|Death|0|||
23429557|NCT00582738|65317408|FG001|Overall Study|Graft Lost|1|||
23429558|NCT00582738|65317407|FG000|Overall Study|Other|1|||
23429559|NCT00582738|65317408|FG001|Overall Study|Other|0|||
23429560|NCT00582738|65317407|FG000|Overall Study|Protocol Violation|1|||
23429561|NCT00582738|65317408|FG001|Overall Study|Protocol Violation|1|||
23429562|NCT00582738|65317407|FG000|Overall Study|Withdrawal by Subject|0|||
23429563|NCT00582738|65317408|FG001|Overall Study|Withdrawal by Subject|3|||
23429564|NCT00350623|65317409|FG000|Overall Study|Lost to Follow-up|8|||
23429565|NCT00350623|65317410|FG001|Overall Study|Lost to Follow-up|3|||
23429566|NCT00350623|65317411|FG002|Overall Study|Lost to Follow-up|4|||
23429567|NCT00350623|65317409|FG000|Overall Study|Withdrawal by Subject|0|||
23429568|NCT00350623|65317410|FG001|Overall Study|Withdrawal by Subject|1|||
23429569|NCT00350623|65317411|FG002|Overall Study|Withdrawal by Subject|1|||
23429570|NCT00350623|65317409|FG000|Overall Study|patient traveling outside the country|0|||
23429571|NCT00350623|65317410|FG001|Overall Study|patient traveling outside the country|0|||
23429572|NCT00350623|65317411|FG002|Overall Study|patient traveling outside the country|1|||
23429573|NCT00762996|65317412|FG000|Period One|Protocol Violation|0|||
23429574|NCT00762996|65317413|FG001|Period One|Protocol Violation|0|||
23429575|NCT00762996|65317414|FG002|Period One|Protocol Violation|1|||
23429576|NCT00762996|65317415|FG003|Period One|Protocol Violation|0|||
23429577|NCT00762996|65317412|FG000|Period One|ineligible|0|||
23429578|NCT00762996|65317413|FG001|Period One|ineligible|0|||
23429579|NCT00762996|65317414|FG002|Period One|ineligible|1|||
23429580|NCT00762996|65317415|FG003|Period One|ineligible|1|||
23429581|NCT00762996|65317412|FG000|Period One|Adverse Event|0|||
23429582|NCT00762996|65317413|FG001|Period One|Adverse Event|0|||
23429583|NCT00762996|65317414|FG002|Period One|Adverse Event|1|||
23429584|NCT00762996|65317415|FG003|Period One|Adverse Event|0|||
23429585|NCT00762996|65317412|FG000|Period One|Withdrawal by Subject|0|||
23429586|NCT00762996|65317413|FG001|Period One|Withdrawal by Subject|0|||
23429587|NCT00762996|65317414|FG002|Period One|Withdrawal by Subject|1|||
23429588|NCT00762996|65317415|FG003|Period One|Withdrawal by Subject|0|||
23429589|NCT03689712|65317416|FG000|Overall Study|Adverse Event|1|||
23429590|NCT03689712|65317417|FG001|Overall Study|Adverse Event|0|||
23429591|NCT03689712|65317416|FG000|Overall Study|Death|20|||
23429592|NCT03689712|65317417|FG001|Overall Study|Death|10|||
23429593|NCT03689712|65317416|FG000|Overall Study|Lost to Follow-up|6|||
23429594|NCT03689712|65317417|FG001|Overall Study|Lost to Follow-up|6|||
23429595|NCT03689712|65317416|FG000|Overall Study|Other|1|||
23429596|NCT03689712|65317417|FG001|Overall Study|Other|0|||
23429597|NCT03689712|65317416|FG000|Overall Study|Patient Non-Compliance|0|||
23429598|NCT03689712|65317417|FG001|Overall Study|Patient Non-Compliance|1|||
23429599|NCT03689712|65317416|FG000|Overall Study|Withdrawal by Subject|20|||
23429600|NCT03689712|65317417|FG001|Overall Study|Withdrawal by Subject|4|||
23429601|NCT03689712|65317416|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
23429602|NCT03689712|65317417|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
23429603|NCT03689712|65317416|FG000|Overall Study|Randomized but not Treated|13|||
23429604|NCT03689712|65317417|FG001|Overall Study|Randomized but not Treated|7|||
23429605|NCT03689712|65317416|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
23429606|NCT03689712|65317417|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
23429607|NCT05943990|65317418|FG000|Overall Study|Study Terminated by Sponsor|0|||
23429608|NCT05943990|65317419|FG001|Overall Study|Study Terminated by Sponsor|0|||
23429609|NCT05943990|65317420|FG002|Overall Study|Study Terminated by Sponsor|1|||
23429610|NCT01995552|65317422|FG000|Overall Study|Protocol Violation|1|||
23429611|NCT01995552|65317422|FG000|Overall Study|Lack of Efficacy|15|||
23429612|NCT01995552|65317422|FG000|Overall Study|Death|1|||
23429613|NCT03262116|65317423|FG000|Overall Study|Physician Decision|0|||
23429614|NCT03262116|65317424|FG001|Overall Study|Physician Decision|2|||
23429615|NCT03262116|65317425|FG002|Overall Study|Physician Decision|1|||
23429616|NCT03262116|65317426|FG003|Overall Study|Physician Decision|1|||
23429617|NCT03262116|65317427|FG004|Overall Study|Physician Decision|1|||
23136082|NCT01160289|64248077|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23136083|NCT01160289|64248078|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23429618|NCT03262116|65317428|FG005|Overall Study|Physician Decision|2|||
23429619|NCT03266172|65317429|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
23429620|NCT03266172|65317430|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
23429621|NCT03266172|65317431|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
23429622|NCT03266172|65317429|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
23429623|NCT03266172|65317430|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
23429624|NCT03266172|65317431|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
23136084|NCT01160289|64248079|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23136085|NCT01160289|64248080|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
23429625|NCT03266172|65317429|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
23429626|NCT03266172|65317430|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
23429627|NCT03266172|65317431|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
23429628|NCT03266172|65317429|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
23136086|NCT01160289|64248075|FG000|Post-Randomization Period|Adverse Event|0|||
23136087|NCT01160289|64248076|FG001|Post-Randomization Period|Adverse Event|4|||
23136088|NCT01160289|64248077|FG002|Post-Randomization Period|Adverse Event|4|||
23136089|NCT01160289|64248078|FG003|Post-Randomization Period|Adverse Event|2|||
23136090|NCT01160289|64248079|FG004|Post-Randomization Period|Adverse Event|0|||
23136091|NCT01160289|64248080|FG005|Post-Randomization Period|Adverse Event|0|||
23136092|NCT01160289|64248075|FG000|Post-Randomization Period|Death|0|||
23136093|NCT01160289|64248076|FG001|Post-Randomization Period|Death|0|||
23136094|NCT01160289|64248077|FG002|Post-Randomization Period|Death|0|||
23136095|NCT01160289|64248078|FG003|Post-Randomization Period|Death|1|||
23136096|NCT01160289|64248079|FG004|Post-Randomization Period|Death|0|||
23136097|NCT01160289|64248080|FG005|Post-Randomization Period|Death|0|||
23136098|NCT01160289|64248075|FG000|Post-Randomization Period|Lack of Efficacy|0|||
23136099|NCT01160289|64248076|FG001|Post-Randomization Period|Lack of Efficacy|1|||
23136100|NCT01160289|64248077|FG002|Post-Randomization Period|Lack of Efficacy|0|||
23136101|NCT01160289|64248078|FG003|Post-Randomization Period|Lack of Efficacy|3|||
23136102|NCT01160289|64248079|FG004|Post-Randomization Period|Lack of Efficacy|0|||
23136103|NCT01160289|64248080|FG005|Post-Randomization Period|Lack of Efficacy|0|||
23136104|NCT01160289|64248075|FG000|Post-Randomization Period|Lost to Follow-up|0|||
23136105|NCT01160289|64248076|FG001|Post-Randomization Period|Lost to Follow-up|3|||
23136106|NCT01160289|64248077|FG002|Post-Randomization Period|Lost to Follow-up|2|||
23136107|NCT01160289|64248078|FG003|Post-Randomization Period|Lost to Follow-up|5|||
23136108|NCT01160289|64248079|FG004|Post-Randomization Period|Lost to Follow-up|3|||
23136109|NCT01160289|64248080|FG005|Post-Randomization Period|Lost to Follow-up|4|||
23136110|NCT01160289|64248075|FG000|Post-Randomization Period|Physician Decision|0|||
23136111|NCT01160289|64248076|FG001|Post-Randomization Period|Physician Decision|0|||
23136112|NCT01160289|64248077|FG002|Post-Randomization Period|Physician Decision|1|||
23136113|NCT01160289|64248078|FG003|Post-Randomization Period|Physician Decision|0|||
23136114|NCT01160289|64248079|FG004|Post-Randomization Period|Physician Decision|0|||
23136115|NCT01160289|64248080|FG005|Post-Randomization Period|Physician Decision|0|||
23136116|NCT01160289|64248075|FG000|Post-Randomization Period|Protocol Violation|0|||
23136117|NCT01160289|64248076|FG001|Post-Randomization Period|Protocol Violation|4|||
23136118|NCT01160289|64248077|FG002|Post-Randomization Period|Protocol Violation|2|||
23136119|NCT01160289|64248078|FG003|Post-Randomization Period|Protocol Violation|0|||
23136120|NCT01160289|64248079|FG004|Post-Randomization Period|Protocol Violation|1|||
23136121|NCT01160289|64248080|FG005|Post-Randomization Period|Protocol Violation|3|||
23136122|NCT01160289|64248075|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
23136123|NCT01160289|64248076|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
23136124|NCT01160289|64248077|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
23136125|NCT01160289|64248078|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
23136126|NCT01160289|64248079|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
23136127|NCT01160289|64248080|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
23136128|NCT01160289|64248075|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
23136129|NCT01160289|64248076|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
23136130|NCT01160289|64248077|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
23136131|NCT01160289|64248078|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
23136132|NCT01160289|64248079|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
23136133|NCT01160289|64248080|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
23136134|NCT01160289|64248075|FG000|Post-Randomization Period|Sponsor Decision|0|||
23136135|NCT01160289|64248076|FG001|Post-Randomization Period|Sponsor Decision|1|||
23136136|NCT01160289|64248077|FG002|Post-Randomization Period|Sponsor Decision|0|||
23136137|NCT01160289|64248078|FG003|Post-Randomization Period|Sponsor Decision|0|||
23136138|NCT01160289|64248079|FG004|Post-Randomization Period|Sponsor Decision|0|||
23136139|NCT01160289|64248080|FG005|Post-Randomization Period|Sponsor Decision|0|||
23136140|NCT04101318|64248082|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
23136141|NCT04101318|64248083|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
23136142|NCT04101318|64248082|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
23136143|NCT04101318|64248083|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
23136144|NCT04101318|64248082|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
23136145|NCT04101318|64248083|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
23136146|NCT01691768|64248085|FG000|Overall Study|Death|0|||
23136147|NCT01691768|64248086|FG001|Overall Study|Death|2|||
23136148|NCT01691768|64248085|FG000|Overall Study|Lost to Follow-up|4|||
23136149|NCT01691768|64248086|FG001|Overall Study|Lost to Follow-up|3|||
23136150|NCT01691768|64248085|FG000|Overall Study|Withdrawal by Subject|10|||
23136151|NCT01691768|64248086|FG001|Overall Study|Withdrawal by Subject|9|||
23136152|NCT01691768|64248085|FG000|Overall Study|Relocated|0|||
23136153|NCT01691768|64248086|FG001|Overall Study|Relocated|1|||
23136154|NCT01691768|64248085|FG000|Overall Study|Investigator decision|1|||
23136155|NCT01691768|64248086|FG001|Overall Study|Investigator decision|1|||
23317568|NCT00993421|64904107|FG003|Overall Study|Withdrawal by Subject|3|||
23317569|NCT00993421|64904108|FG004|Overall Study|Withdrawal by Subject|3|||
23136156|NCT00528931|64248087|FG000|Overall Study|Lost to Follow-up|1|||
23136157|NCT01307579|64248088|FG000|Overall Study|Death|3|||
23136158|NCT01307579|64248089|FG001|Overall Study|Death|6|||
23136159|NCT01307579|64248088|FG000|Overall Study|Physician Decision|26|||
23136160|NCT01307579|64248089|FG001|Overall Study|Physician Decision|29|||
23136161|NCT01307579|64248088|FG000|Overall Study|Withdrawal by Subject|7|||
23136162|NCT01307579|64248089|FG001|Overall Study|Withdrawal by Subject|3|||
23136163|NCT01307579|64248088|FG000|Overall Study|Institutional diagnosis of IFD|21|||
23136164|NCT01307579|64248089|FG001|Overall Study|Institutional diagnosis of IFD|36|||
23136165|NCT01307579|64248088|FG000|Overall Study|Begin conditioning for HSCT|42|||
23136166|NCT01307579|64248089|FG001|Overall Study|Begin conditioning for HSCT|44|||
23136167|NCT01307579|64248088|FG000|Overall Study|Refractory or relapsed AML|38|||
23429629|NCT03266172|65317430|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
23429630|NCT03266172|65317431|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
23429631|NCT03266172|65317429|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
23429632|NCT03266172|65317430|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
23429633|NCT03266172|65317431|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
23429634|NCT03266172|65317429|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
23429635|NCT03266172|65317430|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
23429636|NCT03266172|65317431|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
23429637|NCT02525094|65317432|FG000|Overall Study|Lost to Follow-up|2|||
23429638|NCT02525094|65317433|FG001|Overall Study|Lost to Follow-up|1|||
23429639|NCT02525094|65317432|FG000|Overall Study|Withdrawal by Subject|5|||
23429640|NCT02525094|65317433|FG001|Overall Study|Withdrawal by Subject|6|||
23429641|NCT02525094|65317432|FG000|Overall Study|Not Treated|1|||
23429642|NCT02525094|65317433|FG001|Overall Study|Not Treated|1|||
23429643|NCT01617447|65317435|FG000|Overall Study|Adverse Event|0|||
23429644|NCT01617447|65317436|FG001|Overall Study|Adverse Event|1|||
23429645|NCT01617447|65317435|FG000|Overall Study|Physician Decision|0|||
23429646|NCT01617447|65317436|FG001|Overall Study|Physician Decision|2|||
23429647|NCT00689793|65317438|FG000|Overall Study|Lost to Follow-up|4|||
23429648|NCT00689793|65317439|FG001|Overall Study|Lost to Follow-up|5|||
23429649|NCT01038713|65317440|FG000|Overall Study|Patient to hospice|1|||
23429650|NCT01038713|65317441|FG001|Overall Study|Patient to hospice|1|||
23429651|NCT01038713|65317442|FG002|Overall Study|Patient to hospice|1|||
23429652|NCT01038713|65317440|FG000|Overall Study|Lost to Follow-up|3|||
23429653|NCT01038713|65317441|FG001|Overall Study|Lost to Follow-up|0|||
23429654|NCT01038713|65317442|FG002|Overall Study|Lost to Follow-up|0|||
23429655|NCT01038713|65317440|FG000|Overall Study|Neuroendocrine Tumor|0|||
23429656|NCT01038713|65317441|FG001|Overall Study|Neuroendocrine Tumor|1|||
23429657|NCT01038713|65317442|FG002|Overall Study|Neuroendocrine Tumor|0|||
23429658|NCT01038713|65317440|FG000|Overall Study|died from PEP|0|||
23429659|NCT01038713|65317441|FG001|Overall Study|died from PEP|1|||
23429660|NCT01038713|65317442|FG002|Overall Study|died from PEP|0|||
23429661|NCT01038713|65317440|FG000|Overall Study|Autoimmune Pancreatitis|1|||
23429662|NCT01038713|65317441|FG001|Overall Study|Autoimmune Pancreatitis|0|||
23429663|NCT01038713|65317442|FG002|Overall Study|Autoimmune Pancreatitis|0|||
23429664|NCT00413010|65317443|FG000|Overall Study|Adverse Event|8|||
23429665|NCT00413010|65317444|FG001|Overall Study|Adverse Event|4|||
23429666|NCT00413010|65317443|FG000|Overall Study|Laboratory abnormality|0|||
23429667|NCT00413010|65317444|FG001|Overall Study|Laboratory abnormality|2|||
23429668|NCT00413010|65317443|FG000|Overall Study|Lack of Efficacy|0|||
23429669|NCT00413010|65317444|FG001|Overall Study|Lack of Efficacy|3|||
23429670|NCT00413010|65317443|FG000|Overall Study|Lost to Follow-up|3|||
23429671|NCT00413010|65317444|FG001|Overall Study|Lost to Follow-up|0|||
23429672|NCT00413010|65317443|FG000|Overall Study|Withdrawal by Subject|7|||
23429673|NCT00413010|65317444|FG001|Overall Study|Withdrawal by Subject|2|||
23429674|NCT00413010|65317443|FG000|Overall Study|Due to termination of the study|54|||
23429675|NCT00413010|65317444|FG001|Overall Study|Due to termination of the study|52|||
23429676|NCT00416715|65317450|FG000|Overall Study|Not evaluable for joint aches|7|||
23429677|NCT00416715|65317450|FG000|Overall Study|Vitamin D levels not evaluable|8|||
23429678|NCT02258529|65317454|FG000|Overall Study|Study Terminated by Sponsor|9|||
23429679|NCT02258529|65317454|FG000|Overall Study|Adverse Event|1|||
23429680|NCT00430937|65317455|FG000|Overall Study|Adverse Event|3|||
23429681|NCT00430937|65317456|FG001|Overall Study|Adverse Event|8|||
23429682|NCT00430937|65317455|FG000|Overall Study|Death|0|||
23429683|NCT00430937|65317456|FG001|Overall Study|Death|1|||
23429684|NCT00430937|65317455|FG000|Overall Study|Lost to Follow-up|6|||
23429685|NCT00430937|65317456|FG001|Overall Study|Lost to Follow-up|6|||
23429686|NCT00430937|65317455|FG000|Overall Study|Withdrawal by Subject|5|||
23429687|NCT00430937|65317456|FG001|Overall Study|Withdrawal by Subject|2|||
23429688|NCT00430937|65317455|FG000|Overall Study|Protocol Violation|3|||
23136168|NCT01307579|64248089|FG001|Overall Study|Refractory or relapsed AML|23|||
23429689|NCT00430937|65317456|FG001|Overall Study|Protocol Violation|2|||
23550461|NCT02564523|65743303|FG013|Overall Study|Death|0|||
23136169|NCT01307579|64248088|FG000|Overall Study|Ineligible|3|||
23429690|NCT00430937|65317455|FG000|Overall Study|Lack of Efficacy|6|||
23550462|NCT02564523|65743304|FG014|Overall Study|Death|0|||
23429691|NCT00430937|65317456|FG001|Overall Study|Lack of Efficacy|5|||
23429692|NCT00430937|65317455|FG000|Overall Study|Inappropriate enrollment|2|||
23429693|NCT00430937|65317456|FG001|Overall Study|Inappropriate enrollment|1|||
23429694|NCT00430937|65317455|FG000|Overall Study|Administrative reasons|1|||
23429695|NCT00430937|65317456|FG001|Overall Study|Administrative reasons|0|||
23429696|NCT00430937|65317455|FG000|Overall Study|Protocol discontinuation criteria met|1|||
23429697|NCT00430937|65317456|FG001|Overall Study|Protocol discontinuation criteria met|2|||
23429698|NCT00430937|65317455|FG000|Overall Study|Unable to classify|0|||
23429699|NCT00430937|65317456|FG001|Overall Study|Unable to classify|1|||
23429700|NCT00454649|65317457|FG000|Overall Study|Lack of Efficacy|2|||
23429701|NCT00454649|65317458|FG001|Overall Study|Lack of Efficacy|2|||
23429702|NCT00454649|65317459|FG002|Overall Study|Lack of Efficacy|10|||
23429703|NCT00454649|65317460|FG003|Overall Study|Lack of Efficacy|3|||
23429704|NCT00454649|65317461|FG004|Overall Study|Lack of Efficacy|0|||
23429705|NCT00454649|65317462|FG005|Overall Study|Lack of Efficacy|4|||
23429706|NCT00454649|65317463|FG006|Overall Study|Lack of Efficacy|5|||
23429707|NCT00454649|65317464|FG007|Overall Study|Lack of Efficacy|13|||
23429708|NCT00454649|65317465|FG008|Overall Study|Lack of Efficacy|10|||
23429709|NCT00454649|65317466|FG009|Overall Study|Lack of Efficacy|2|||
23429710|NCT00454649|65317457|FG000|Overall Study|Adverse Event|0|||
23429711|NCT00454649|65317458|FG001|Overall Study|Adverse Event|1|||
23429712|NCT00454649|65317459|FG002|Overall Study|Adverse Event|3|||
23429713|NCT00454649|65317460|FG003|Overall Study|Adverse Event|0|||
23429714|NCT00454649|65317461|FG004|Overall Study|Adverse Event|1|||
23429715|NCT00454649|65317462|FG005|Overall Study|Adverse Event|2|||
23429716|NCT00454649|65317463|FG006|Overall Study|Adverse Event|3|||
23429717|NCT00454649|65317464|FG007|Overall Study|Adverse Event|4|||
23136170|NCT01307579|64248089|FG001|Overall Study|Ineligible|4|||
23136171|NCT01034163|64248090|FG000|Overall Study|Treatment completed as per protocol|8|||
23136172|NCT01034163|64248091|FG001|Overall Study|Treatment completed as per protocol|7|||
23136173|NCT01034163|64248090|FG000|Overall Study|Withdrawal by Subject|8|||
23136174|NCT01034163|64248091|FG001|Overall Study|Withdrawal by Subject|2|||
23136175|NCT01034163|64248090|FG000|Overall Study|Protocol deviation|1|||
23136176|NCT01034163|64248091|FG001|Overall Study|Protocol deviation|0|||
23136177|NCT01034163|64248090|FG000|Overall Study|Disease progression|3|||
23214895|NCT02501902|64528087|FG004|Overall Study|Study Terminated by Sponsor|1|||
23214896|NCT02501902|64528088|FG005|Overall Study|Study Terminated by Sponsor|0|||
23214897|NCT02501902|64528089|FG006|Overall Study|Study Terminated by Sponsor|2|||
23214898|NCT02501902|64528090|FG007|Overall Study|Study Terminated by Sponsor|4|||
23214899|NCT02501902|64528083|FG000|Overall Study|Death|3|||
23214900|NCT02501902|64528084|FG001|Overall Study|Death|4|||
23214901|NCT02501902|64528085|FG002|Overall Study|Death|4|||
23214902|NCT02501902|64528086|FG003|Overall Study|Death|10|||
23214903|NCT02501902|64528087|FG004|Overall Study|Death|10|||
23620429|NCT00582114|65994984|FG001|Overall Study|Stopped by data safety monitoring board|20|||
23620430|NCT00496626|65994985|FG000|Overall Study|Lost to Follow-up|0|||
23620431|NCT00496626|65994986|FG001|Overall Study|Lost to Follow-up|1|||
23214904|NCT02501902|64528088|FG005|Overall Study|Death|11|||
23214905|NCT02501902|64528089|FG006|Overall Study|Death|7|||
23214906|NCT02501902|64528090|FG007|Overall Study|Death|15|||
23214907|NCT00387348|64528091|FG000|Overall Study|Death|1|||
23214908|NCT00387348|64528092|FG001|Overall Study|Death|1|||
23214909|NCT00387348|64528093|FG002|Overall Study|Death|0|||
23214910|NCT00387348|64528091|FG000|Overall Study|Physician Decision|1|||
23214911|NCT00387348|64528092|FG001|Overall Study|Physician Decision|0|||
23214912|NCT00387348|64528093|FG002|Overall Study|Physician Decision|1|||
23214913|NCT00387348|64528091|FG000|Overall Study|Withdrawal by Subject|0|||
23214914|NCT00387348|64528092|FG001|Overall Study|Withdrawal by Subject|2|||
23214915|NCT00387348|64528093|FG002|Overall Study|Withdrawal by Subject|2|||
23214916|NCT00387348|64528091|FG000|Overall Study|Adverse Event|1|||
23214917|NCT00387348|64528092|FG001|Overall Study|Adverse Event|0|||
23214918|NCT00387348|64528093|FG002|Overall Study|Adverse Event|1|||
23429718|NCT00454649|65317465|FG008|Overall Study|Adverse Event|6|||
23429719|NCT00454649|65317466|FG009|Overall Study|Adverse Event|2|||
23429720|NCT00454649|65317457|FG000|Overall Study|Lost to Follow-up|0|||
23429721|NCT00454649|65317458|FG001|Overall Study|Lost to Follow-up|0|||
23429722|NCT00454649|65317459|FG002|Overall Study|Lost to Follow-up|1|||
23136178|NCT01034163|64248091|FG001|Overall Study|Disease progression|4|||
23136179|NCT01034163|64248090|FG000|Overall Study|Adverse Event|6|||
23136180|NCT01034163|64248091|FG001|Overall Study|Adverse Event|0|||
23214919|NCT01068717|64528099|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
23214920|NCT01068717|64528100|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
23214921|NCT01068717|64528101|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
23214922|NCT01068717|64528102|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
23214923|NCT02126670|64528103|FG000|Overall Study|Withdrawal by Subject|1|||
23214924|NCT02126670|64528104|FG001|Overall Study|Withdrawal by Subject|0|||
23429723|NCT00454649|65317460|FG003|Overall Study|Lost to Follow-up|0|||
23429724|NCT00454649|65317461|FG004|Overall Study|Lost to Follow-up|0|||
23429725|NCT00454649|65317462|FG005|Overall Study|Lost to Follow-up|0|||
23429726|NCT00454649|65317463|FG006|Overall Study|Lost to Follow-up|1|||
23429727|NCT00454649|65317464|FG007|Overall Study|Lost to Follow-up|0|||
23429728|NCT00454649|65317465|FG008|Overall Study|Lost to Follow-up|0|||
23429729|NCT00454649|65317466|FG009|Overall Study|Lost to Follow-up|0|||
23429730|NCT00454649|65317457|FG000|Overall Study|Other|1|||
23429731|NCT00454649|65317458|FG001|Overall Study|Other|1|||
23429732|NCT00454649|65317459|FG002|Overall Study|Other|5|||
23429733|NCT00454649|65317460|FG003|Overall Study|Other|3|||
23429734|NCT00454649|65317461|FG004|Overall Study|Other|0|||
23429735|NCT00454649|65317462|FG005|Overall Study|Other|0|||
23429736|NCT00454649|65317463|FG006|Overall Study|Other|0|||
23429737|NCT00454649|65317464|FG007|Overall Study|Other|0|||
23429738|NCT00454649|65317465|FG008|Overall Study|Other|3|||
23429739|NCT00454649|65317466|FG009|Overall Study|Other|1|||
23429740|NCT00454649|65317457|FG000|Overall Study|Withdrawal by Subject|0|||
23429741|NCT00454649|65317458|FG001|Overall Study|Withdrawal by Subject|0|||
23429742|NCT00454649|65317459|FG002|Overall Study|Withdrawal by Subject|0|||
23429743|NCT00454649|65317460|FG003|Overall Study|Withdrawal by Subject|0|||
23429744|NCT00454649|65317461|FG004|Overall Study|Withdrawal by Subject|0|||
23429745|NCT00454649|65317462|FG005|Overall Study|Withdrawal by Subject|1|||
23429746|NCT00454649|65317463|FG006|Overall Study|Withdrawal by Subject|0|||
23429747|NCT00454649|65317464|FG007|Overall Study|Withdrawal by Subject|2|||
23429748|NCT00454649|65317465|FG008|Overall Study|Withdrawal by Subject|1|||
23429749|NCT00454649|65317466|FG009|Overall Study|Withdrawal by Subject|0|||
23429750|NCT00613080|65317472|FG000|Overall Study|Ineligible / no protocol treatment|11|||
23429751|NCT02091284|65317476|FG000|Overall Study|Withdrawal by Subject|2|||
23429752|NCT02091284|65317477|FG001|Overall Study|Withdrawal by Subject|1|||
23429753|NCT02091284|65317476|FG000|Overall Study|unreliable data|1|||
23429754|NCT02091284|65317477|FG001|Overall Study|unreliable data|0|||
23429755|NCT03474081|65317480|FG000|Overall Study|Adverse Event|6|||
23429756|NCT03474081|65317481|FG001|Overall Study|Adverse Event|3|||
23429757|NCT03474081|65317480|FG000|Overall Study|Lost to Follow-up|2|||
23429758|NCT03474081|65317481|FG001|Overall Study|Lost to Follow-up|1|||
23429759|NCT03474081|65317480|FG000|Overall Study|Physician Decision|3|||
23429760|NCT03474081|65317481|FG001|Overall Study|Physician Decision|2|||
23429761|NCT03474081|65317480|FG000|Overall Study|Withdrawal by Subject|5|||
23429762|NCT03474081|65317481|FG001|Overall Study|Withdrawal by Subject|7|||
23429763|NCT03474081|65317480|FG000|Overall Study|Investigator site closed|1|||
23429764|NCT03474081|65317481|FG001|Overall Study|Investigator site closed|0|||
23429765|NCT04109976|65317484|FG000|Overall Study|Withdrawal by Subject|1|||
23429766|NCT04109976|65317485|FG001|Overall Study|Withdrawal by Subject|0|||
23429767|NCT00475865|65317488|FG000|Overall Study|Adverse Event|0|||
23429768|NCT00475865|65317489|FG001|Overall Study|Adverse Event|3|||
23429769|NCT00475865|65317490|FG002|Overall Study|Adverse Event|4|||
23429770|NCT00475865|65317488|FG000|Overall Study|Lack of Efficacy|1|||
23429771|NCT00475865|65317489|FG001|Overall Study|Lack of Efficacy|0|||
23429772|NCT00475865|65317490|FG002|Overall Study|Lack of Efficacy|0|||
23429773|NCT00475865|65317488|FG000|Overall Study|Progressive disease|0|||
23429774|NCT00475865|65317489|FG001|Overall Study|Progressive disease|1|||
23429775|NCT00475865|65317490|FG002|Overall Study|Progressive disease|2|||
23429776|NCT00475865|65317488|FG000|Overall Study|Participant did not wish to continue|1|||
23429777|NCT00475865|65317489|FG001|Overall Study|Participant did not wish to continue|0|||
23429778|NCT00475865|65317490|FG002|Overall Study|Participant did not wish to continue|0|||
23429779|NCT00475865|65317488|FG000|Overall Study|Other than above|0|||
23429780|NCT00475865|65317489|FG001|Overall Study|Other than above|1|||
23429781|NCT00475865|65317490|FG002|Overall Study|Other than above|0|||
23429782|NCT03374202|65317493|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
23429783|NCT03374202|65317494|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
23429784|NCT03374202|65317495|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
23429785|NCT03374202|65317493|FG000|Five Year Long Term Follow Up|Death|0|||
23429786|NCT03374202|65317494|FG001|Five Year Long Term Follow Up|Death|1|||
23429787|NCT03374202|65317495|FG002|Five Year Long Term Follow Up|Death|0|||
23429788|NCT00409344|65317496|FG000|Overall Study|no enrollment|0|||
23429789|NCT00409344|65317497|FG001|Overall Study|no enrollment|0|||
23429790|NCT03412604|65317498|FG000|Overall Study|Withdrawal by Subject|1|||
23429791|NCT02210832|65317499|FG000|Overall Study|Pregnancy termination .|3|||
23429792|NCT02210832|65317500|FG001|Overall Study|Pregnancy termination .|4|||
23429793|NCT02210832|65317501|FG002|Overall Study|Pregnancy termination .|1|||
23429794|NCT02210832|65317499|FG000|Overall Study|Lost to Follow-up|26|||
23429795|NCT02210832|65317500|FG001|Overall Study|Lost to Follow-up|32|||
23429796|NCT02210832|65317501|FG002|Overall Study|Lost to Follow-up|17|||
23429797|NCT03135210|65317502|FG000|Overall Study|Death|0|||
23550463|NCT02564523|65743305|FG015|Overall Study|Death|0|||
23550464|NCT02564523|65743306|FG016|Overall Study|Death|0|||
23429798|NCT03135210|65317503|FG001|Overall Study|Death|1|||
23429799|NCT03883113|65317504|FG000|Overall Study|Physician Decision|4|||
23429800|NCT03883113|65317505|FG001|Overall Study|Physician Decision|2|||
23550465|NCT02564523|65743307|FG017|Overall Study|Death|0|||
23214925|NCT02126670|64528105|FG002|Overall Study|Withdrawal by Subject|0|||
23214926|NCT02126670|64528106|FG003|Overall Study|Withdrawal by Subject|1|||
23214927|NCT01270958|64528111|FG000|Overall Study|Lost to Follow-up|2|||
23214928|NCT01270958|64528111|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
23214929|NCT03034057|64528112|FG000|Overall Study|Withdrawal by Subject|10|||
23214930|NCT03034057|64528112|FG000|Overall Study|Protocol Violation|1|||
23214931|NCT03034057|64528112|FG000|Overall Study|Not defined|2|||
23214932|NCT03034057|64528112|FG000|Overall Study|Lost to Follow-up|19|||
23214933|NCT03034057|64528112|FG000|Overall Study|Adverse Event|22|||
23214934|NCT03034057|64528112|FG000|Overall Study|Medication error without associated AE|1|||
23214935|NCT00871572|64528113|FG000|Overall Study|Adverse Event|0|||
23214936|NCT00871572|64528114|FG001|Overall Study|Adverse Event|2|||
23214937|NCT00871572|64528115|FG002|Overall Study|Adverse Event|0|||
23550466|NCT02564523|65743290|FG000|Overall Study|Lost to Follow-up|2|||
23550467|NCT02564523|65743291|FG001|Overall Study|Lost to Follow-up|1|||
23214938|NCT00871572|64528116|FG003|Overall Study|Adverse Event|3|||
23214939|NCT00871572|64528113|FG000|Overall Study|Investigator Decision|0|||
23214940|NCT00871572|64528114|FG001|Overall Study|Investigator Decision|1|||
23214941|NCT00871572|64528115|FG002|Overall Study|Investigator Decision|0|||
23214942|NCT00871572|64528116|FG003|Overall Study|Investigator Decision|1|||
23214943|NCT00871572|64528113|FG000|Overall Study|Lost to Follow-up|0|||
23214944|NCT00871572|64528114|FG001|Overall Study|Lost to Follow-up|1|||
23214945|NCT00871572|64528115|FG002|Overall Study|Lost to Follow-up|0|||
23214946|NCT00871572|64528116|FG003|Overall Study|Lost to Follow-up|1|||
23214947|NCT00871572|64528113|FG000|Overall Study|Protocol Violation|0|||
23214948|NCT00871572|64528114|FG001|Overall Study|Protocol Violation|0|||
23214949|NCT00871572|64528115|FG002|Overall Study|Protocol Violation|1|||
23214950|NCT00871572|64528116|FG003|Overall Study|Protocol Violation|1|||
23214951|NCT00871572|64528113|FG000|Overall Study|Sponsor Decision|1|||
23214952|NCT00871572|64528114|FG001|Overall Study|Sponsor Decision|0|||
23214953|NCT00871572|64528115|FG002|Overall Study|Sponsor Decision|0|||
23214954|NCT00871572|64528116|FG003|Overall Study|Sponsor Decision|0|||
23214955|NCT00871572|64528113|FG000|Overall Study|Withdrawal by Subject|1|||
23214956|NCT00871572|64528114|FG001|Overall Study|Withdrawal by Subject|2|||
23214957|NCT00871572|64528115|FG002|Overall Study|Withdrawal by Subject|3|||
23214958|NCT00871572|64528116|FG003|Overall Study|Withdrawal by Subject|1|||
23214959|NCT02528253|64528117|FG000|Overall Study|Adverse Event|3|||
23550468|NCT02564523|65743292|FG002|Overall Study|Lost to Follow-up|4|||
23550469|NCT02564523|65743293|FG003|Overall Study|Lost to Follow-up|0|||
23550470|NCT02564523|65743294|FG004|Overall Study|Lost to Follow-up|1|||
23550471|NCT02564523|65743295|FG005|Overall Study|Lost to Follow-up|0|||
23550472|NCT02564523|65743296|FG006|Overall Study|Lost to Follow-up|1|||
23550473|NCT02564523|65743297|FG007|Overall Study|Lost to Follow-up|0|||
23214960|NCT02528253|64528118|FG001|Overall Study|Adverse Event|4|||
23214961|NCT02528253|64528119|FG002|Overall Study|Adverse Event|4|||
23214962|NCT02528253|64528120|FG003|Overall Study|Adverse Event|8|||
23214963|NCT02528253|64528121|FG004|Overall Study|Adverse Event|18|||
23214964|NCT02528253|64528117|FG000|Overall Study|Death|2|||
23214965|NCT02528253|64528118|FG001|Overall Study|Death|2|||
23214966|NCT02528253|64528119|FG002|Overall Study|Death|1|||
23214967|NCT02528253|64528120|FG003|Overall Study|Death|0|||
23214968|NCT02528253|64528121|FG004|Overall Study|Death|1|||
23214969|NCT02528253|64528117|FG000|Overall Study|Insufficient clinical response|7|||
23214970|NCT02528253|64528118|FG001|Overall Study|Insufficient clinical response|10|||
23214971|NCT02528253|64528119|FG002|Overall Study|Insufficient clinical response|13|||
23214972|NCT02528253|64528120|FG003|Overall Study|Insufficient clinical response|12|||
23214973|NCT02528253|64528121|FG004|Overall Study|Insufficient clinical response|16|||
23214974|NCT02528253|64528117|FG000|Overall Study|Lost to Follow-up|16|||
23429801|NCT03883113|65317504|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
23429802|NCT03883113|65317505|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
23550474|NCT02564523|65743298|FG008|Overall Study|Lost to Follow-up|0|||
23550475|NCT02564523|65743299|FG009|Overall Study|Lost to Follow-up|0|||
23214975|NCT02528253|64528118|FG001|Overall Study|Lost to Follow-up|9|||
23214976|NCT02528253|64528119|FG002|Overall Study|Lost to Follow-up|31|||
23214977|NCT02528253|64528120|FG003|Overall Study|Lost to Follow-up|16|||
23214978|NCT02528253|64528121|FG004|Overall Study|Lost to Follow-up|34|||
23214979|NCT02528253|64528117|FG000|Overall Study|Other|21|||
23214980|NCT02528253|64528118|FG001|Overall Study|Other|22|||
23214981|NCT02528253|64528119|FG002|Overall Study|Other|58|||
23214982|NCT02528253|64528120|FG003|Overall Study|Other|52|||
23214983|NCT02528253|64528121|FG004|Overall Study|Other|76|||
23214984|NCT02528253|64528117|FG000|Overall Study|Withdrawal by Subject|25|||
23214985|NCT02528253|64528118|FG001|Overall Study|Withdrawal by Subject|20|||
23550476|NCT02564523|65743300|FG010|Overall Study|Lost to Follow-up|0|||
23214986|NCT02528253|64528119|FG002|Overall Study|Withdrawal by Subject|29|||
23214987|NCT02528253|64528120|FG003|Overall Study|Withdrawal by Subject|48|||
23214988|NCT02528253|64528121|FG004|Overall Study|Withdrawal by Subject|73|||
23214989|NCT02528253|64528117|FG000|Overall Study|Protocol Violation|1|||
23214990|NCT02528253|64528118|FG001|Overall Study|Protocol Violation|2|||
23214991|NCT02528253|64528119|FG002|Overall Study|Protocol Violation|4|||
23214992|NCT02528253|64528120|FG003|Overall Study|Protocol Violation|0|||
23214993|NCT02528253|64528121|FG004|Overall Study|Protocol Violation|4|||
23214994|NCT02528253|64528117|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
23214995|NCT02528253|64528118|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
23214996|NCT02528253|64528119|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
23214997|NCT02528253|64528120|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
23214998|NCT02528253|64528121|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
23550477|NCT02564523|65743301|FG011|Overall Study|Lost to Follow-up|1|||
23214999|NCT03271307|64528122|FG000|Overall Study|Lost to Follow-up|0|||
23215000|NCT03271307|64528123|FG001|Overall Study|Lost to Follow-up|0|||
23215001|NCT03271307|64528124|FG002|Overall Study|Lost to Follow-up|0|||
23215002|NCT03271307|64528125|FG003|Overall Study|Lost to Follow-up|28|||
23215003|NCT03271307|64528126|FG004|Overall Study|Lost to Follow-up|91|||
23215004|NCT01688635|64528127|FG000|Washout 1|Withdrawal by Subject|1|||
23215005|NCT01688635|64528128|FG001|Washout 1|Withdrawal by Subject|0|||
23215006|NCT01688635|64528127|FG000|Washout 1|Adverse Event|0|||
23215007|NCT01688635|64528128|FG001|Washout 1|Adverse Event|1|||
23215008|NCT01688635|64528127|FG000|Washout 1|Physician Decision|0|||
23215009|NCT01688635|64528128|FG001|Washout 1|Physician Decision|1|||
23215010|NCT01688635|64528127|FG000|Washout 2|Physician Decision|1|||
23550478|NCT02564523|65743302|FG012|Overall Study|Lost to Follow-up|1|||
23550479|NCT02564523|65743303|FG013|Overall Study|Lost to Follow-up|0|||
23550480|NCT02564523|65743304|FG014|Overall Study|Lost to Follow-up|0|||
23550481|NCT02564523|65743305|FG015|Overall Study|Lost to Follow-up|0|||
23550482|NCT02564523|65743306|FG016|Overall Study|Lost to Follow-up|0|||
23550483|NCT02564523|65743307|FG017|Overall Study|Lost to Follow-up|0|||
23215011|NCT01688635|64528128|FG001|Washout 2|Physician Decision|0|||
23215012|NCT01688635|64528127|FG000|Washout 2|Withdrawal by Subject|1|||
23550484|NCT02564523|65743290|FG000|Overall Study|Physician Decision|0|||
23550485|NCT02564523|65743291|FG001|Overall Study|Physician Decision|0|||
23550486|NCT02564523|65743292|FG002|Overall Study|Physician Decision|0|||
23550487|NCT02564523|65743293|FG003|Overall Study|Physician Decision|0|||
23550488|NCT02564523|65743294|FG004|Overall Study|Physician Decision|1|||
23550489|NCT02564523|65743295|FG005|Overall Study|Physician Decision|0|||
23550490|NCT02564523|65743296|FG006|Overall Study|Physician Decision|0|||
23620432|NCT00496626|65994985|FG000|Overall Study|Protocol Violation|1|||
23620433|NCT00496626|65994986|FG001|Overall Study|Protocol Violation|0|||
23620434|NCT00496626|65994985|FG000|Overall Study|Withdrawal by Subject|5|||
23550491|NCT02564523|65743297|FG007|Overall Study|Physician Decision|0|||
23550492|NCT02564523|65743298|FG008|Overall Study|Physician Decision|0|||
23550493|NCT02564523|65743299|FG009|Overall Study|Physician Decision|0|||
23550494|NCT02564523|65743300|FG010|Overall Study|Physician Decision|1|||
23550495|NCT02564523|65743301|FG011|Overall Study|Physician Decision|0|||
23620435|NCT00496626|65994986|FG001|Overall Study|Withdrawal by Subject|4|||
23620436|NCT00496626|65994985|FG000|Overall Study|Relocated|0|||
23550496|NCT02564523|65743302|FG012|Overall Study|Physician Decision|0|||
23550497|NCT02564523|65743303|FG013|Overall Study|Physician Decision|0|||
23550498|NCT02564523|65743304|FG014|Overall Study|Physician Decision|0|||
23550499|NCT02564523|65743305|FG015|Overall Study|Physician Decision|0|||
23550500|NCT02564523|65743306|FG016|Overall Study|Physician Decision|0|||
23550501|NCT02564523|65743307|FG017|Overall Study|Physician Decision|0|||
23550502|NCT02564523|65743290|FG000|Overall Study|Protocol Violation|2|||
23550503|NCT02564523|65743291|FG001|Overall Study|Protocol Violation|2|||
23550504|NCT02564523|65743292|FG002|Overall Study|Protocol Violation|5|||
23620437|NCT00496626|65994986|FG001|Overall Study|Relocated|1|||
23620438|NCT01393613|65994988|FG000|Overall Study|Adverse Event|11|||
23620439|NCT01393613|65994989|FG001|Overall Study|Adverse Event|11|||
23620440|NCT01393613|65994990|FG002|Overall Study|Adverse Event|13|||
23620441|NCT01393613|65994991|FG003|Overall Study|Adverse Event|22|||
23620442|NCT01393613|65994988|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
23620443|NCT01393613|65994989|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
23620444|NCT01393613|65994990|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
23215013|NCT01688635|64528128|FG001|Washout 2|Withdrawal by Subject|0|||
23215014|NCT01688635|64528127|FG000|Washout 2|Sponsor Decision|1|||
23215015|NCT01688635|64528128|FG001|Washout 2|Sponsor Decision|2|||
23215016|NCT01688635|64528127|FG000|Washout 3|Withdrawal by Subject|1|||
23215017|NCT01688635|64528128|FG001|Washout 3|Withdrawal by Subject|0|||
23215018|NCT00425113|64528129|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
23550505|NCT02564523|65743293|FG003|Overall Study|Protocol Violation|0|||
23550506|NCT02564523|65743294|FG004|Overall Study|Protocol Violation|1|||
23550507|NCT02564523|65743295|FG005|Overall Study|Protocol Violation|0|||
23550508|NCT02564523|65743296|FG006|Overall Study|Protocol Violation|0|||
23215019|NCT00425113|64528130|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
23550509|NCT02564523|65743297|FG007|Overall Study|Protocol Violation|0|||
23620445|NCT01393613|65994991|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
23215020|NCT00425113|64528129|FG000|Overall Study|diagnosis of abdominal TB|0|||
23550510|NCT02564523|65743298|FG008|Overall Study|Protocol Violation|0|||
23550511|NCT02564523|65743299|FG009|Overall Study|Protocol Violation|0|||
23550512|NCT02564523|65743300|FG010|Overall Study|Protocol Violation|0|||
23550513|NCT02564523|65743301|FG011|Overall Study|Protocol Violation|0|||
23550514|NCT02564523|65743302|FG012|Overall Study|Protocol Violation|0|||
23550515|NCT02564523|65743303|FG013|Overall Study|Protocol Violation|0|||
23550516|NCT02564523|65743304|FG014|Overall Study|Protocol Violation|0|||
23136181|NCT01034163|64248090|FG000|Overall Study|Administrative problems|0|||
23136182|NCT01034163|64248091|FG001|Overall Study|Administrative problems|1|||
23136183|NCT01034163|64248090|FG000|Overall Study|Abnormal laboratory value|1|||
23136184|NCT01034163|64248091|FG001|Overall Study|Abnormal laboratory value|0|||
23136185|NCT00688870|64248099|FG000|Infant Series|Parent or legal guardian request|4|||
23136186|NCT00688870|64248100|FG001|Infant Series|Parent or legal guardian request|0|||
23136187|NCT01679405|64248101|FG000|Overall Study|Death|2|||
23136188|NCT01679405|64248102|FG001|Overall Study|Death|5|||
23136189|NCT00688103|64248103|FG000|Overall Study|Adverse Event|4|||
23136190|NCT00688103|64248104|FG001|Overall Study|Adverse Event|1|||
23136191|NCT00688103|64248103|FG000|Overall Study|Lack of Efficacy|11|||
23136192|NCT00688103|64248104|FG001|Overall Study|Lack of Efficacy|1|||
23136193|NCT00688103|64248103|FG000|Overall Study|Withdrawal by Subject|4|||
23136194|NCT00688103|64248104|FG001|Overall Study|Withdrawal by Subject|2|||
23136195|NCT00688103|64248103|FG000|Overall Study|complex reasons|11|||
23136196|NCT00688103|64248104|FG001|Overall Study|complex reasons|9|||
23136197|NCT04772898|64248107|FG000|Overall Study|Withdrawal by Subject|0|||
23136198|NCT04772898|64248108|FG001|Overall Study|Withdrawal by Subject|1|||
23136199|NCT01302067|64248110|FG000|Overall Study|Death|0|||
23136200|NCT01302067|64248111|FG001|Overall Study|Death|0|||
23136201|NCT01302067|64248112|FG002|Overall Study|Death|1|||
23136202|NCT01302067|64248110|FG000|Overall Study|Physician Decision|9|||
23136203|NCT01302067|64248111|FG001|Overall Study|Physician Decision|5|||
23136204|NCT01302067|64248112|FG002|Overall Study|Physician Decision|14|||
23136205|NCT01302067|64248110|FG000|Overall Study|Lack of Efficacy|8|||
23550517|NCT02564523|65743305|FG015|Overall Study|Protocol Violation|0|||
23550518|NCT02564523|65743306|FG016|Overall Study|Protocol Violation|0|||
23550519|NCT02564523|65743307|FG017|Overall Study|Protocol Violation|0|||
23550520|NCT02564523|65743290|FG000|Overall Study|Other|3|||
23550521|NCT02564523|65743291|FG001|Overall Study|Other|0|||
23550522|NCT02564523|65743292|FG002|Overall Study|Other|0|||
23550523|NCT02564523|65743293|FG003|Overall Study|Other|1|||
23550524|NCT02564523|65743294|FG004|Overall Study|Other|0|||
23550525|NCT02564523|65743295|FG005|Overall Study|Other|0|||
23550526|NCT02564523|65743296|FG006|Overall Study|Other|0|||
23550527|NCT02564523|65743297|FG007|Overall Study|Other|0|||
23550528|NCT02564523|65743298|FG008|Overall Study|Other|0|||
23550529|NCT02564523|65743299|FG009|Overall Study|Other|0|||
23550530|NCT02564523|65743300|FG010|Overall Study|Other|0|||
23550531|NCT02564523|65743301|FG011|Overall Study|Other|0|||
23550532|NCT02564523|65743302|FG012|Overall Study|Other|0|||
23550533|NCT02564523|65743303|FG013|Overall Study|Other|0|||
23550534|NCT02564523|65743304|FG014|Overall Study|Other|0|||
23550535|NCT02564523|65743305|FG015|Overall Study|Other|0|||
23550536|NCT02564523|65743306|FG016|Overall Study|Other|0|||
23550537|NCT02564523|65743307|FG017|Overall Study|Other|0|||
23550538|NCT00162370|65743312|FG000|Efficacy Population|Lost to Follow-up|51|||
23550539|NCT02062632|65743313|FG000|Overall Study|No treatment data|1|||
23550540|NCT02621931|65743314|FG000|Overall Study|Death|0|||
23550541|NCT02621931|65743315|FG001|Overall Study|Death|1|||
23550542|NCT02621931|65743316|FG002|Overall Study|Death|0|||
23550543|NCT02621931|65743314|FG000|Overall Study|Adverse Event|8|||
23550544|NCT02621931|65743315|FG001|Overall Study|Adverse Event|5|||
23550545|NCT02621931|65743316|FG002|Overall Study|Adverse Event|7|||
23550546|NCT02621931|65743314|FG000|Overall Study|Withdrawal by Subject|12|||
23550547|NCT02621931|65743315|FG001|Overall Study|Withdrawal by Subject|10|||
23550548|NCT02621931|65743316|FG002|Overall Study|Withdrawal by Subject|11|||
23550549|NCT02621931|65743314|FG000|Overall Study|Protocol Violation|2|||
23136206|NCT01302067|64248111|FG001|Overall Study|Lack of Efficacy|4|||
23136207|NCT01302067|64248112|FG002|Overall Study|Lack of Efficacy|2|||
23550550|NCT02621931|65743315|FG001|Overall Study|Protocol Violation|2|||
23550551|NCT02621931|65743316|FG002|Overall Study|Protocol Violation|2|||
23550552|NCT02621931|65743314|FG000|Overall Study|Pregnancy|2|||
23550553|NCT02621931|65743315|FG001|Overall Study|Pregnancy|0|||
23550554|NCT02621931|65743316|FG002|Overall Study|Pregnancy|0|||
23550555|NCT02621931|65743314|FG000|Overall Study|Noncompliance to study procedures|0|||
23136208|NCT01302067|64248110|FG000|Overall Study|Lost to Follow-up|9|||
23136209|NCT01302067|64248111|FG001|Overall Study|Lost to Follow-up|4|||
23136210|NCT01302067|64248112|FG002|Overall Study|Lost to Follow-up|15|||
23136211|NCT01302067|64248110|FG000|Overall Study|Withdrawal by Subject|13|||
23550556|NCT02621931|65743315|FG001|Overall Study|Noncompliance to study procedures|1|||
23550557|NCT02621931|65743316|FG002|Overall Study|Noncompliance to study procedures|2|||
23550558|NCT02621931|65743314|FG000|Overall Study|Lost to Follow-up|8|||
23550559|NCT02621931|65743315|FG001|Overall Study|Lost to Follow-up|7|||
23550560|NCT02621931|65743316|FG002|Overall Study|Lost to Follow-up|10|||
23550561|NCT02621931|65743314|FG000|Overall Study|Lack of Efficacy|0|||
23550562|NCT02621931|65743315|FG001|Overall Study|Lack of Efficacy|0|||
23550563|NCT02621931|65743316|FG002|Overall Study|Lack of Efficacy|1|||
23620446|NCT01393613|65994988|FG000|Overall Study|Physician Decision|2|||
23620447|NCT01393613|65994989|FG001|Overall Study|Physician Decision|0|||
23620448|NCT01393613|65994990|FG002|Overall Study|Physician Decision|0|||
23620449|NCT01393613|65994991|FG003|Overall Study|Physician Decision|1|||
23620450|NCT01393613|65994988|FG000|Overall Study|Withdrawal by Subject|15|||
23620451|NCT01393613|65994989|FG001|Overall Study|Withdrawal by Subject|25|||
23136212|NCT01302067|64248111|FG001|Overall Study|Withdrawal by Subject|6|||
23136213|NCT01302067|64248112|FG002|Overall Study|Withdrawal by Subject|10|||
23136214|NCT01302067|64248110|FG000|Overall Study|Other|1|||
23136215|NCT01302067|64248111|FG001|Overall Study|Other|1|||
23136216|NCT01302067|64248112|FG002|Overall Study|Other|3|||
23136217|NCT01302067|64248110|FG000|Overall Study|Protocol Violation|11|||
23136218|NCT01302067|64248111|FG001|Overall Study|Protocol Violation|0|||
23136219|NCT01302067|64248112|FG002|Overall Study|Protocol Violation|8|||
23136220|NCT01302067|64248110|FG000|Overall Study|Adverse Event|27|||
23136221|NCT01302067|64248111|FG001|Overall Study|Adverse Event|14|||
23136222|NCT01302067|64248112|FG002|Overall Study|Adverse Event|45|||
23136223|NCT03330405|64248113|FG000|Overall Study|Other|1|||
23136224|NCT03330405|64248114|FG001|Overall Study|Other|3|||
23136225|NCT03330405|64248115|FG002|Overall Study|Other|1|||
23136226|NCT03330405|64248116|FG003|Overall Study|Other|0|||
23136227|NCT03330405|64248117|FG004|Overall Study|Other|2|||
23136228|NCT03330405|64248118|FG005|Overall Study|Other|0|||
23136229|NCT03330405|64248119|FG006|Overall Study|Other|1|||
23136230|NCT03330405|64248120|FG007|Overall Study|Other|0|||
23429803|NCT03883113|65317504|FG000|Overall Study|Pregnancy|1|||
23429804|NCT03883113|65317505|FG001|Overall Study|Pregnancy|0|||
23429805|NCT03883113|65317504|FG000|Overall Study|Adverse Event|0|||
23429806|NCT03883113|65317505|FG001|Overall Study|Adverse Event|1|||
23429807|NCT03883113|65317504|FG000|Overall Study|Withdrawal by Subject|1|||
23429808|NCT03883113|65317505|FG001|Overall Study|Withdrawal by Subject|2|||
23429809|NCT03883113|65317504|FG000|Overall Study|Lost to Follow-up|1|||
23429810|NCT03883113|65317505|FG001|Overall Study|Lost to Follow-up|0|||
23429811|NCT00576576|65317508|FG000|Overall Study|Lost to Follow-up|6|||
23429812|NCT00576576|65317508|FG000|Overall Study|Protocol Violation|1|||
23429813|NCT00343382|65317509|FG000|Overall Study|Adverse Event|2|||
23429814|NCT00343382|65317510|FG001|Overall Study|Adverse Event|10|||
23429815|NCT00343382|65317511|FG002|Overall Study|Adverse Event|7|||
23429816|NCT00343382|65317509|FG000|Overall Study|Withdrawal by Subject|1|||
23429817|NCT00343382|65317510|FG001|Overall Study|Withdrawal by Subject|2|||
23429818|NCT00343382|65317511|FG002|Overall Study|Withdrawal by Subject|6|||
23429819|NCT00343382|65317509|FG000|Overall Study|Other Reason Not Specified|1|||
23429820|NCT00343382|65317510|FG001|Overall Study|Other Reason Not Specified|2|||
23429821|NCT00343382|65317511|FG002|Overall Study|Other Reason Not Specified|4|||
23429822|NCT03002311|65317512|FG000|Overall Study|Lost to Follow-up|13|||
23429823|NCT03002311|65317513|FG001|Overall Study|Lost to Follow-up|26|||
23429824|NCT03002311|65317512|FG000|Overall Study|Referral provider called to schedule app|3|||
23429825|NCT03002311|65317513|FG001|Overall Study|Referral provider called to schedule app|3|||
23429826|NCT03002311|65317512|FG000|Overall Study|Physician Decision|3|||
23429827|NCT03002311|65317513|FG001|Overall Study|Physician Decision|1|||
23429828|NCT01827332|65317514|FG000|Overall Study|Lost to Follow-up|2|||
23429829|NCT01827332|65317515|FG001|Overall Study|Lost to Follow-up|1|||
23429830|NCT00864851|65317525|FG000|Overall Study|Withdrawal by Subject|0|||
23429831|NCT00864851|65317526|FG001|Overall Study|Withdrawal by Subject|1|||
23429832|NCT00864851|65317527|FG002|Overall Study|Withdrawal by Subject|0|||
23429833|NCT00864851|65317525|FG000|Overall Study|Physician Decision|1|||
23429834|NCT00864851|65317526|FG001|Overall Study|Physician Decision|0|||
23429835|NCT00864851|65317527|FG002|Overall Study|Physician Decision|0|||
23429836|NCT00864851|65317525|FG000|Overall Study|Death|1|||
23429837|NCT00864851|65317526|FG001|Overall Study|Death|0|||
23429838|NCT00864851|65317527|FG002|Overall Study|Death|0|||
23429839|NCT00864851|65317525|FG000|Overall Study|Patient uncooperative|1|||
23429840|NCT00864851|65317526|FG001|Overall Study|Patient uncooperative|0|||
23429841|NCT00864851|65317527|FG002|Overall Study|Patient uncooperative|0|||
23620452|NCT01393613|65994990|FG002|Overall Study|Withdrawal by Subject|23|||
23136231|NCT03330405|64248121|FG008|Overall Study|Other|0|||
23136232|NCT03330405|64248122|FG009|Overall Study|Other|0|||
23620453|NCT01393613|65994991|FG003|Overall Study|Withdrawal by Subject|21|||
23620454|NCT01393613|65994988|FG000|Overall Study|Protocol Deviation|2|||
23136233|NCT03330405|64248123|FG010|Overall Study|Other|0|||
23136234|NCT03330405|64248113|FG000|Overall Study|Progressive disease|8|||
23136235|NCT03330405|64248114|FG001|Overall Study|Progressive disease|27|||
23136236|NCT03330405|64248115|FG002|Overall Study|Progressive disease|4|||
23429842|NCT05086510|65317528|FG000|Overall Study|Lost to Follow-up|0|||
23429843|NCT05086510|65317529|FG001|Overall Study|Lost to Follow-up|2|||
23429844|NCT05086510|65317528|FG000|Overall Study|Death|0|||
23429845|NCT05086510|65317529|FG001|Overall Study|Death|2|||
23136237|NCT03330405|64248116|FG003|Overall Study|Progressive disease|18|||
23136238|NCT03330405|64248117|FG004|Overall Study|Progressive disease|16|||
23429846|NCT01595581|65317536|FG000|Overall Study|Withdrawal by Subject|1|||
23429847|NCT01595581|65317537|FG001|Overall Study|Withdrawal by Subject|0|||
23550564|NCT02621931|65743314|FG000|Overall Study|Other|1|||
23550565|NCT02621931|65743315|FG001|Overall Study|Other|1|||
23620455|NCT01393613|65994989|FG001|Overall Study|Protocol Deviation|1|||
23620456|NCT01393613|65994990|FG002|Overall Study|Protocol Deviation|0|||
23620457|NCT01393613|65994991|FG003|Overall Study|Protocol Deviation|0|||
23550566|NCT02621931|65743316|FG002|Overall Study|Other|3|||
23550567|NCT03750552|65743317|FG000|Overall Study|Adverse Event|5|||
23550568|NCT03750552|65743318|FG001|Overall Study|Adverse Event|1|||
23550569|NCT03750552|65743317|FG000|Overall Study|Withdrawal by Subject|1|||
23550570|NCT03750552|65743318|FG001|Overall Study|Withdrawal by Subject|1|||
23550571|NCT03750552|65743317|FG000|Overall Study|Other|2|||
23550572|NCT03750552|65743318|FG001|Overall Study|Other|0|||
23550573|NCT01227889|65743319|FG000|Randomized Phase (RP)|Adverse Event|13|||
23550574|NCT01227889|65743320|FG001|Randomized Phase (RP)|Adverse Event|0|||
23550575|NCT01227889|65743319|FG000|Randomized Phase (RP)|Physician Decision|13|||
23550576|NCT01227889|65743320|FG001|Randomized Phase (RP)|Physician Decision|5|||
23550577|NCT01227889|65743319|FG000|Randomized Phase (RP)|Progressive Disease|135|||
23550578|NCT01227889|65743320|FG001|Randomized Phase (RP)|Progressive Disease|52|||
23550579|NCT01227889|65743319|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
23550580|NCT01227889|65743320|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
23550581|NCT01227889|65743319|FG000|Randomized Phase (RP)|Missing|1|||
23550582|NCT01227889|65743320|FG001|Randomized Phase (RP)|Missing|3|||
23550583|NCT01227889|65743319|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
23550584|NCT01227889|65743320|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
23550585|NCT01227889|65743319|FG000|Crossover Phase|Adverse Event|0|||
23550586|NCT01227889|65743320|FG001|Crossover Phase|Adverse Event|1|||
23550587|NCT01227889|65743319|FG000|Crossover Phase|Physician Decision|0|||
23550588|NCT01227889|65743320|FG001|Crossover Phase|Physician Decision|3|||
23550589|NCT01227889|65743319|FG000|Crossover Phase|Progressive Disease|0|||
23550590|NCT01227889|65743320|FG001|Crossover Phase|Progressive Disease|31|||
23550591|NCT01227889|65743319|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
23550592|NCT01227889|65743320|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
23550593|NCT01227889|65743319|FG000|Crossover Phase|Withdrawal by Subject|0|||
23550594|NCT01227889|65743320|FG001|Crossover Phase|Withdrawal by Subject|1|||
23136239|NCT03330405|64248118|FG005|Overall Study|Progressive disease|14|||
23136240|NCT03330405|64248119|FG006|Overall Study|Progressive disease|7|||
23136241|NCT03330405|64248120|FG007|Overall Study|Progressive disease|29|||
23136242|NCT03330405|64248121|FG008|Overall Study|Progressive disease|9|||
23136243|NCT03330405|64248122|FG009|Overall Study|Progressive disease|11|||
23136244|NCT03330405|64248123|FG010|Overall Study|Progressive disease|5|||
23136245|NCT03330405|64248113|FG000|Overall Study|Withdrawal by Subject|1|||
23136246|NCT03330405|64248114|FG001|Overall Study|Withdrawal by Subject|4|||
23136247|NCT03330405|64248115|FG002|Overall Study|Withdrawal by Subject|0|||
23620458|NCT01393613|65994988|FG000|Overall Study|Lack of Efficacy|9|||
23620459|NCT01393613|65994989|FG001|Overall Study|Lack of Efficacy|20|||
23620460|NCT01393613|65994990|FG002|Overall Study|Lack of Efficacy|16|||
23620461|NCT01393613|65994991|FG003|Overall Study|Lack of Efficacy|21|||
23620462|NCT00797511|65994992|FG000|Overall Study|Withdrawal by Subject|1|||
23136248|NCT03330405|64248116|FG003|Overall Study|Withdrawal by Subject|1|||
23550595|NCT00352365|65743321|FG000|Induction Therapy|Adverse Event|7|||
23136249|NCT03330405|64248117|FG004|Overall Study|Withdrawal by Subject|1|||
23136250|NCT03330405|64248118|FG005|Overall Study|Withdrawal by Subject|1|||
23136251|NCT03330405|64248119|FG006|Overall Study|Withdrawal by Subject|0|||
23136252|NCT03330405|64248120|FG007|Overall Study|Withdrawal by Subject|2|||
23136253|NCT03330405|64248121|FG008|Overall Study|Withdrawal by Subject|2|||
23136254|NCT03330405|64248122|FG009|Overall Study|Withdrawal by Subject|1|||
23136255|NCT03330405|64248123|FG010|Overall Study|Withdrawal by Subject|1|||
23136256|NCT03330405|64248113|FG000|Overall Study|Global deterioration of health status|2|||
23215021|NCT00425113|64528130|FG001|Overall Study|diagnosis of abdominal TB|1|||
23550596|NCT00352365|65743321|FG000|Induction Therapy|Progression/Relapse|8|||
23550597|NCT00352365|65743321|FG000|Induction Therapy|Death|7|||
23550598|NCT00352365|65743321|FG000|Induction Therapy|Not protocol specified|1|||
23550599|NCT00352365|65743321|FG000|Induction Therapy|Not eligible|3|||
23550600|NCT00352365|65743321|FG000|Induction Therapy|Death before starting protocol therapy|1|||
23550601|NCT00352365|65743321|FG000|Maintenance Therapy|Progression/Relapse|3|||
23550602|NCT00352365|65743321|FG000|Maintenance Therapy|Death|2|||
23550603|NCT00352365|65743321|FG000|Maintenance Therapy|Not protocol specified|3|||
23550604|NCT00352365|65743321|FG000|Maintenance Therapy|Not eligible|4|||
23550605|NCT04393441|65743326|FG000|Overall Study|Adverse Event|0|||
23550606|NCT04393441|65743327|FG001|Overall Study|Adverse Event|3|||
23620463|NCT01222078|65997479|FG000|Overall Study|Early termination of the study|1|||
23620464|NCT01990664|65997480|FG000|Overall Study|Lost to Follow-up|2|||
23620465|NCT01990664|65997481|FG001|Overall Study|Lost to Follow-up|6|||
23620466|NCT01990664|65997480|FG000|Overall Study|Withdrawal by Subject|2|||
23136257|NCT03330405|64248114|FG001|Overall Study|Global deterioration of health status|3|||
23215022|NCT00425113|64528129|FG000|Overall Study|missing study drug more than 14 days|0|||
23550607|NCT04393441|65743326|FG000|Overall Study|Withdrawal by Subject|5|||
23136258|NCT03330405|64248115|FG002|Overall Study|Global deterioration of health status|0|||
23136259|NCT03330405|64248116|FG003|Overall Study|Global deterioration of health status|2|||
23136260|NCT03330405|64248117|FG004|Overall Study|Global deterioration of health status|3|||
23136261|NCT03330405|64248118|FG005|Overall Study|Global deterioration of health status|3|||
23136262|NCT03330405|64248119|FG006|Overall Study|Global deterioration of health status|0|||
23136263|NCT03330405|64248120|FG007|Overall Study|Global deterioration of health status|2|||
23136264|NCT03330405|64248121|FG008|Overall Study|Global deterioration of health status|8|||
23136265|NCT03330405|64248122|FG009|Overall Study|Global deterioration of health status|4|||
23136266|NCT03330405|64248123|FG010|Overall Study|Global deterioration of health status|1|||
23136267|NCT03330405|64248113|FG000|Overall Study|Adverse Event|0|||
23136268|NCT03330405|64248114|FG001|Overall Study|Adverse Event|1|||
23136269|NCT03330405|64248115|FG002|Overall Study|Adverse Event|0|||
23136270|NCT03330405|64248116|FG003|Overall Study|Adverse Event|1|||
23136271|NCT03330405|64248117|FG004|Overall Study|Adverse Event|1|||
23136272|NCT03330405|64248118|FG005|Overall Study|Adverse Event|1|||
23136273|NCT03330405|64248119|FG006|Overall Study|Adverse Event|3|||
23136274|NCT03330405|64248120|FG007|Overall Study|Adverse Event|4|||
23136275|NCT03330405|64248121|FG008|Overall Study|Adverse Event|2|||
23136276|NCT03330405|64248122|FG009|Overall Study|Adverse Event|2|||
23136277|NCT03330405|64248123|FG010|Overall Study|Adverse Event|2|||
23136278|NCT03330405|64248113|FG000|Overall Study|Death|0|||
23136279|NCT03330405|64248114|FG001|Overall Study|Death|4|||
23136280|NCT03330405|64248115|FG002|Overall Study|Death|0|||
23136281|NCT03330405|64248116|FG003|Overall Study|Death|0|||
23136282|NCT03330405|64248117|FG004|Overall Study|Death|0|||
23136283|NCT03330405|64248118|FG005|Overall Study|Death|1|||
23136284|NCT03330405|64248119|FG006|Overall Study|Death|0|||
23136285|NCT03330405|64248120|FG007|Overall Study|Death|2|||
23136286|NCT03330405|64248121|FG008|Overall Study|Death|0|||
23136287|NCT03330405|64248122|FG009|Overall Study|Death|0|||
23136288|NCT03330405|64248123|FG010|Overall Study|Death|0|||
23136289|NCT03330405|64248113|FG000|Overall Study|Physician Decision|0|||
23136290|NCT03330405|64248114|FG001|Overall Study|Physician Decision|0|||
23136291|NCT03330405|64248115|FG002|Overall Study|Physician Decision|0|||
23136292|NCT03330405|64248116|FG003|Overall Study|Physician Decision|0|||
23136293|NCT03330405|64248117|FG004|Overall Study|Physician Decision|0|||
23136294|NCT03330405|64248118|FG005|Overall Study|Physician Decision|0|||
23136295|NCT03330405|64248119|FG006|Overall Study|Physician Decision|0|||
23136296|NCT03330405|64248120|FG007|Overall Study|Physician Decision|1|||
23136297|NCT03330405|64248121|FG008|Overall Study|Physician Decision|0|||
23136298|NCT03330405|64248122|FG009|Overall Study|Physician Decision|0|||
23136299|NCT03330405|64248123|FG010|Overall Study|Physician Decision|0|||
23136300|NCT01131182|64248125|FG000|Overall Study|Withdrawal by Subject|1|||
23136301|NCT01131182|64248126|FG001|Overall Study|Withdrawal by Subject|1|||
23136302|NCT01131182|64248125|FG000|Overall Study|Lost to Follow-up|14|||
23136303|NCT01131182|64248126|FG001|Overall Study|Lost to Follow-up|15|||
23136304|NCT01131182|64248125|FG000|Overall Study|Other Reason|1|||
23136305|NCT01131182|64248126|FG001|Overall Study|Other Reason|0|||
23136306|NCT01536015|64248127|FG000|Overall Study|Adverse Event|1|||
23136307|NCT01536015|64248128|FG001|Overall Study|Adverse Event|4|||
23136308|NCT01536015|64248127|FG000|Overall Study|Lost to Follow-up|0|||
23136309|NCT01536015|64248128|FG001|Overall Study|Lost to Follow-up|1|||
23136310|NCT01536015|64248127|FG000|Overall Study|Inclusion Criterion not met|2|||
23136311|NCT01536015|64248128|FG001|Overall Study|Inclusion Criterion not met|0|||
23136312|NCT01536015|64248127|FG000|Overall Study|Study closure|5|||
23136313|NCT01536015|64248128|FG001|Overall Study|Study closure|5|||
23136314|NCT03333876|64248130|FG000|Screening Period|Screen Failure|4|||
23136315|NCT03333876|64248130|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
23136316|NCT03333876|64248130|FG000|Mandibular Advancement|Adverse Event|2|||
23136317|NCT03333876|64248130|FG000|Mandibular Advancement|Product Damage|2|||
23136318|NCT00928018|64248131|FG000|Overall Study|Withdrawal by Subject|1|||
23136319|NCT00928018|64248132|FG001|Overall Study|Withdrawal by Subject|0|||
23136320|NCT04189952|64248135|FG000|Follow-up Period|Death|1|||
23136321|NCT04189952|64248135|FG000|Follow-up Period|Withdrawal by Subject|1|||
23136322|NCT00620282|64248136|FG000|Overall Study|Adverse Event|0|||
23136323|NCT00620282|64248137|FG001|Overall Study|Adverse Event|1|||
23136324|NCT00620282|64248138|FG002|Overall Study|Adverse Event|0|||
23215023|NCT00425113|64528130|FG001|Overall Study|missing study drug more than 14 days|1|||
23429848|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
23550608|NCT04393441|65743327|FG001|Overall Study|Withdrawal by Subject|7|||
23136325|NCT00620282|64248136|FG000|Overall Study|Arterial line unable to be placed|0|||
23136326|NCT00620282|64248137|FG001|Overall Study|Arterial line unable to be placed|0|||
23136327|NCT00620282|64248138|FG002|Overall Study|Arterial line unable to be placed|1|||
23136328|NCT00620282|64248136|FG000|Overall Study|Withdrawal by Subject|0|||
23136329|NCT00620282|64248137|FG001|Overall Study|Withdrawal by Subject|1|||
23136330|NCT00620282|64248138|FG002|Overall Study|Withdrawal by Subject|0|||
23136331|NCT02787044|64248150|FG000|Overall Study|Lost to Follow-up|15|||
23136332|NCT02787044|64248151|FG001|Overall Study|Lost to Follow-up|19|||
23136333|NCT03900416|64248154|FG000|Six Week Follow-up|Lost to Follow-up|1|||
23136334|NCT03900416|64248155|FG001|Six Week Follow-up|Lost to Follow-up|0|||
23136335|NCT03900416|64248154|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
23136336|NCT03900416|64248155|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
23136337|NCT03900416|64248154|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
23136338|NCT03900416|64248155|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
23136339|NCT03900416|64248154|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
23136340|NCT03900416|64248155|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
23136341|NCT03900416|64248154|FG000|Twelve Week Follow-up|Adverse Event|1|||
23136342|NCT03900416|64248155|FG001|Twelve Week Follow-up|Adverse Event|1|||
23136343|NCT03900416|64248154|FG000|Six Month Follow-up|Lost to Follow-up|4|||
23136344|NCT03900416|64248155|FG001|Six Month Follow-up|Lost to Follow-up|3|||
23136345|NCT03900416|64248154|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
23136346|NCT03900416|64248155|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
23136347|NCT01712659|64248156|FG000|Dose Escalation|Physician Decision|0|||
23136348|NCT01712659|64248157|FG001|Dose Escalation|Physician Decision|1|||
23429849|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
23550609|NCT04393441|65743326|FG000|Overall Study|Lost to Follow-up|0|||
23550610|NCT04393441|65743327|FG001|Overall Study|Lost to Follow-up|2|||
23550611|NCT04393441|65743326|FG000|Overall Study|Protocol Deviation|2|||
23550612|NCT04393441|65743327|FG001|Overall Study|Protocol Deviation|1|||
23550613|NCT04393441|65743326|FG000|Overall Study|Reason not Specified|1|||
23550614|NCT04393441|65743327|FG001|Overall Study|Reason not Specified|1|||
23550615|NCT01667432|65743332|FG000|Overall Study|Premature Study Termination|26|||
23550616|NCT01667432|65743332|FG000|Overall Study|Failure to Return|10|||
23550617|NCT01667432|65743332|FG000|Overall Study|Moved to Another Center|3|||
23550618|NCT01667432|65743332|FG000|Overall Study|Lost to Follow-up|3|||
23550619|NCT01667432|65743332|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
23550620|NCT01667432|65743332|FG000|Overall Study|Insufficient Therapeutic Response|4|||
23550621|NCT01667432|65743332|FG000|Overall Study|Adverse Event|1|||
23550622|NCT01667432|65743332|FG000|Overall Study|Protocol Deviation|2|||
23550623|NCT01667432|65743332|FG000|Overall Study|Principal Investigator Decision|1|||
23550624|NCT01667432|65743332|FG000|Overall Study|Reason Not Specified|2|||
23550625|NCT01667432|65743332|FG000|Overall Study|Missing Information|4|||
23550626|NCT02618967|65743334|FG000|Overall Study|Lost to Follow-up|0|||
23550627|NCT02618967|65743335|FG001|Overall Study|Lost to Follow-up|0|||
23550628|NCT02618967|65743336|FG002|Overall Study|Lost to Follow-up|1|||
23550629|NCT02618967|65743337|FG003|Overall Study|Lost to Follow-up|0|||
23550630|NCT02618967|65743338|FG004|Overall Study|Lost to Follow-up|2|||
23550631|NCT02618967|65743339|FG005|Overall Study|Lost to Follow-up|0|||
23550632|NCT02618967|65743340|FG006|Overall Study|Lost to Follow-up|0|||
23550633|NCT02618967|65743341|FG007|Overall Study|Lost to Follow-up|0|||
23550634|NCT02618967|65743334|FG000|Overall Study|Withdrawal by Subject|1|||
23550635|NCT02618967|65743335|FG001|Overall Study|Withdrawal by Subject|0|||
23550636|NCT02618967|65743336|FG002|Overall Study|Withdrawal by Subject|0|||
23550637|NCT02618967|65743337|FG003|Overall Study|Withdrawal by Subject|0|||
23550638|NCT02618967|65743338|FG004|Overall Study|Withdrawal by Subject|0|||
23550639|NCT02618967|65743339|FG005|Overall Study|Withdrawal by Subject|0|||
23550640|NCT02618967|65743340|FG006|Overall Study|Withdrawal by Subject|0|||
23550641|NCT02618967|65743341|FG007|Overall Study|Withdrawal by Subject|0|||
23550642|NCT01261338|65743344|FG000|Overall Study|Withdrawal by Subject|3|||
23550643|NCT01261338|65743345|FG001|Overall Study|Withdrawal by Subject|2|||
23550644|NCT01275625|65743346|FG000|Overall Study|Death|1|||
23550645|NCT01275625|65743346|FG000|Overall Study|Lack of Efficacy|2|||
23550646|NCT01275625|65743346|FG000|Overall Study|Lost to Follow-up|1|||
23550647|NCT01275625|65743346|FG000|Overall Study|Withdrawal by Subject|3|||
23550648|NCT01275625|65743346|FG000|Overall Study|Protocol Violation|1|||
23550649|NCT01275625|65743346|FG000|Overall Study|Adverse Event|4|||
23550650|NCT01275625|65743346|FG000|Overall Study|Other|1|||
23550651|NCT02097108|65743350|FG000|Overall Study|Adverse Event|1|||
23550652|NCT02097108|65743350|FG000|Overall Study|patient was abroad for 6 months|1|||
23550653|NCT00636610|65743351|FG000|Overall Study|Adverse Event|4|||
23550654|NCT00636610|65743352|FG001|Overall Study|Adverse Event|4|||
23550655|NCT00636610|65743351|FG000|Overall Study|Death|6|||
23550656|NCT00636610|65743352|FG001|Overall Study|Death|3|||
23550657|NCT00636610|65743351|FG000|Overall Study|Physician decision to withdraw patient|15|||
23550658|NCT00636610|65743352|FG001|Overall Study|Physician decision to withdraw patient|9|||
23550659|NCT00636610|65743351|FG000|Overall Study|Subject decision to withdraw|15|||
23550660|NCT00636610|65743352|FG001|Overall Study|Subject decision to withdraw|11|||
23136349|NCT01712659|64248158|FG002|Dose Escalation|Physician Decision|0|||
23136350|NCT01712659|64248159|FG003|Dose Escalation|Physician Decision|0|||
23136351|NCT01712659|64248160|FG004|Dose Escalation|Physician Decision|0|||
23550661|NCT00636610|65743351|FG000|Overall Study|Disease progression - radiographic|41|||
23550662|NCT00636610|65743352|FG001|Overall Study|Disease progression - radiographic|51|||
23550663|NCT00636610|65743351|FG000|Overall Study|Disease progression - clinical|8|||
23550664|NCT00636610|65743352|FG001|Overall Study|Disease progression - clinical|3|||
23550665|NCT00636610|65743351|FG000|Overall Study|Reason for discontinuation not available|3|||
23550666|NCT00636610|65743352|FG001|Overall Study|Reason for discontinuation not available|2|||
23550667|NCT00113568|65743357|FG000|Overall Study|Adverse Event|97|||
23550668|NCT00113568|65743357|FG000|Overall Study|Death|1|||
23550669|NCT00113568|65743357|FG000|Overall Study|Lack of Efficacy|30|||
23550670|NCT00113568|65743357|FG000|Overall Study|Lost to Follow-up|156|||
23550671|NCT00113568|65743357|FG000|Overall Study|Protocol Violation|32|||
23550672|NCT00113568|65743357|FG000|Overall Study|Withdrawal by Subject|117|||
23550673|NCT00113568|65743357|FG000|Overall Study|Other|112|||
23550674|NCT04072159|65743360|FG000|Overall Study|Lost to Follow-up|6|||
23550675|NCT04072159|65743361|FG001|Overall Study|Lost to Follow-up|6|||
23550676|NCT04072159|65743360|FG000|Overall Study|Withdrawal by Subject|2|||
23550677|NCT04072159|65743361|FG001|Overall Study|Withdrawal by Subject|0|||
23550678|NCT01618838|65743362|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
23550679|NCT01297062|65743363|FG000|Overall Study|Adverse Event|2|||
23550680|NCT01297062|65743364|FG001|Overall Study|Adverse Event|0|||
23550681|NCT01297062|65743365|FG002|Overall Study|Adverse Event|1|||
23550682|NCT01297062|65743366|FG003|Overall Study|Adverse Event|0|||
23550683|NCT01297062|65743367|FG004|Overall Study|Adverse Event|0|||
23550684|NCT01297062|65743368|FG005|Overall Study|Adverse Event|0|||
23550685|NCT01297062|65743369|FG006|Overall Study|Adverse Event|0|||
23550686|NCT01297062|65743363|FG000|Overall Study|Physician Decision|1|||
23550687|NCT01297062|65743364|FG001|Overall Study|Physician Decision|0|||
23550688|NCT01297062|65743365|FG002|Overall Study|Physician Decision|1|||
23550689|NCT01297062|65743366|FG003|Overall Study|Physician Decision|0|||
23550690|NCT01297062|65743367|FG004|Overall Study|Physician Decision|0|||
23620467|NCT01990664|65997481|FG001|Overall Study|Withdrawal by Subject|3|||
23620468|NCT01990664|65997480|FG000|Overall Study|Protocol Violation|1|||
23620469|NCT01990664|65997481|FG001|Overall Study|Protocol Violation|0|||
23620470|NCT01990664|65997480|FG000|Overall Study|Lens Discomfort|1|||
23550691|NCT01297062|65743368|FG005|Overall Study|Physician Decision|0|||
23550692|NCT01297062|65743369|FG006|Overall Study|Physician Decision|6|||
23550693|NCT01297062|65743363|FG000|Overall Study|Protocol Violation|0|||
23550694|NCT01297062|65743364|FG001|Overall Study|Protocol Violation|0|||
23620471|NCT01990664|65997481|FG001|Overall Study|Lens Discomfort|1|||
23620472|NCT01990664|65997480|FG000|Overall Study|Lens Handling Difficulties|1|||
23550695|NCT01297062|65743365|FG002|Overall Study|Protocol Violation|0|||
23550696|NCT01297062|65743366|FG003|Overall Study|Protocol Violation|0|||
23550697|NCT01297062|65743367|FG004|Overall Study|Protocol Violation|1|||
23550698|NCT01297062|65743368|FG005|Overall Study|Protocol Violation|0|||
23550699|NCT01297062|65743369|FG006|Overall Study|Protocol Violation|0|||
23550700|NCT01297062|65743363|FG000|Overall Study|Subject Decision|1|||
23550701|NCT01297062|65743364|FG001|Overall Study|Subject Decision|1|||
23550702|NCT01297062|65743365|FG002|Overall Study|Subject Decision|0|||
23550703|NCT01297062|65743366|FG003|Overall Study|Subject Decision|1|||
23550704|NCT01297062|65743367|FG004|Overall Study|Subject Decision|1|||
23550705|NCT01297062|65743368|FG005|Overall Study|Subject Decision|1|||
23550706|NCT01297062|65743369|FG006|Overall Study|Subject Decision|2|||
23550707|NCT01090453|65747450|FG000|Overall Study|Withdrawal by Subject|1|||
23550708|NCT01090453|65747451|FG001|Overall Study|Withdrawal by Subject|2|||
23550709|NCT01090453|65747450|FG000|Overall Study|Lost to Follow-up|7|||
23550710|NCT01090453|65747451|FG001|Overall Study|Lost to Follow-up|7|||
23550711|NCT01090453|65747450|FG000|Overall Study|Non serious AEs|1|||
23550712|NCT01090453|65747451|FG001|Overall Study|Non serious AEs|0|||
23620473|NCT01990664|65997481|FG001|Overall Study|Lens Handling Difficulties|0|||
23136352|NCT01712659|64248156|FG000|Dose Escalation|Unable to take study drug|0|||
23136353|NCT01712659|64248157|FG001|Dose Escalation|Unable to take study drug|1|||
23136354|NCT01712659|64248158|FG002|Dose Escalation|Unable to take study drug|0|||
23136355|NCT01712659|64248159|FG003|Dose Escalation|Unable to take study drug|0|||
23136356|NCT01712659|64248160|FG004|Dose Escalation|Unable to take study drug|0|||
23136357|NCT01712659|64248156|FG000|Dose Expansion|Early disease progression|1|||
23136358|NCT01712659|64248157|FG001|Dose Expansion|Early disease progression|0|||
23136359|NCT01712659|64248158|FG002|Dose Expansion|Early disease progression|0|||
23136360|NCT01712659|64248159|FG003|Dose Expansion|Early disease progression|0|||
23136361|NCT01712659|64248160|FG004|Dose Expansion|Early disease progression|0|||
23136362|NCT01712659|64248156|FG000|Dose Expansion|Physician Decision|1|||
23136363|NCT01712659|64248157|FG001|Dose Expansion|Physician Decision|0|||
23136364|NCT01712659|64248158|FG002|Dose Expansion|Physician Decision|0|||
23136365|NCT01712659|64248159|FG003|Dose Expansion|Physician Decision|0|||
23136366|NCT01712659|64248160|FG004|Dose Expansion|Physician Decision|0|||
23136367|NCT02576587|64248161|FG000|Baseline|Equipment failure|0|||
23550713|NCT01090453|65747450|FG000|Overall Study|Protocol Violation|2|||
23550714|NCT01090453|65747451|FG001|Overall Study|Protocol Violation|0|||
23550715|NCT01090453|65747450|FG000|Overall Study|Other|2|||
23550716|NCT01090453|65747451|FG001|Overall Study|Other|4|||
23550717|NCT01090453|65747450|FG000|Overall Study|Eligibility Criteria|0|||
23550718|NCT01090453|65747451|FG001|Overall Study|Eligibility Criteria|1|||
23620474|NCT01990664|65997480|FG000|Overall Study|Unsatisfactory Visual Response|0|||
23620475|NCT01990664|65997481|FG001|Overall Study|Unsatisfactory Visual Response|1|||
23136368|NCT02576587|64248162|FG001|Baseline|Equipment failure|1|||
23136369|NCT02576587|64248161|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
23136370|NCT02576587|64248162|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
23136371|NCT02576587|64248161|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
23136372|NCT02576587|64248162|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
23136373|NCT02576587|64248161|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
23136374|NCT02576587|64248162|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
23136375|NCT01081665|64248163|FG000|Overall Study|Death|41|||
23136376|NCT01081665|64248163|FG000|Overall Study|Lost to Follow-up|18|||
23136377|NCT01081665|64248163|FG000|Overall Study|Withdrawal by Subject|17|||
23136378|NCT01081665|64248163|FG000|Overall Study|Change of dialysis unit|10|||
23136379|NCT01081665|64248163|FG000|Overall Study|Regulation of iPTH|5|||
23136380|NCT01081665|64248163|FG000|Overall Study|Change in renal replacement therapy|2|||
23136381|NCT01081665|64248163|FG000|Overall Study|Adverse Event|1|||
23136382|NCT01081665|64248163|FG000|Overall Study|Lack of Efficacy|1|||
23136383|NCT02432196|64248164|FG000|Overall Study|Exit - did not receive study device|1|||
23136384|NCT02432196|64248164|FG000|Overall Study|Death|2|||
23136385|NCT02432196|64248164|FG000|Overall Study|Reoperation|3|||
23136386|NCT00371683|64248165|FG000|DB Treatment Period-Randomized Patients|Death|1|||
23136387|NCT00371683|64248166|FG001|DB Treatment Period-Randomized Patients|Death|1|||
23136388|NCT00371683|64248165|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
23136389|NCT00371683|64248166|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
23136390|NCT00371683|64248165|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
23136391|NCT00371683|64248166|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
23136392|NCT00371683|64248165|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
23136393|NCT00371683|64248166|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
23136394|NCT00371683|64248165|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
23136395|NCT00371683|64248166|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
23136396|NCT00371683|64248165|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
23136397|NCT00371683|64248166|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
23136398|NCT00371683|64248165|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
23136399|NCT00371683|64248166|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
23136400|NCT00371683|64248165|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
23136401|NCT00371683|64248166|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
23136402|NCT00371683|64248165|FG000|Follow-Up Period - Randomized Patients|Death|0|||
23136403|NCT00371683|64248166|FG001|Follow-Up Period - Randomized Patients|Death|2|||
23136404|NCT00371683|64248165|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
23136405|NCT00371683|64248166|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
23317570|NCT00993421|64904109|FG005|Overall Study|Withdrawal by Subject|5|||
23136406|NCT00371683|64248165|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
23136407|NCT00371683|64248166|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
23136408|NCT01656200|64248167|FG000|Overall Study|Withdrawal by Subject|1|||
23136409|NCT03339583|64248168|FG000|First Intervention (14 Days)|Adverse Event|1|||
23136410|NCT03339583|64248169|FG001|First Intervention (14 Days)|Adverse Event|0|||
23136411|NCT03339583|64248168|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
23136412|NCT03339583|64248169|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
23136413|NCT03339583|64248168|FG000|Second Intervention (14 Days)|Adverse Event|0|||
23136414|NCT03339583|64248169|FG001|Second Intervention (14 Days)|Adverse Event|1|||
23136415|NCT03339583|64248168|FG000|Follow-up (14 Days)|Physician Decision|6|||
23136416|NCT03339583|64248169|FG001|Follow-up (14 Days)|Physician Decision|3|||
23136417|NCT05007080|64248170|FG000|Overall Study|Lost to Follow-up|0|||
23550719|NCT00989287|65747454|FG000|Overall Study|Adverse Event|1|||
23550720|NCT00989287|65747455|FG001|Overall Study|Adverse Event|0|||
23550721|NCT00989287|65747454|FG000|Overall Study|Lost to Follow-up|0|||
23550722|NCT00989287|65747455|FG001|Overall Study|Lost to Follow-up|1|||
23550723|NCT01218126|65747456|FG000|Overall Study|Adverse Event|8|||
23550724|NCT01218126|65747457|FG001|Overall Study|Adverse Event|10|||
23550725|NCT01218126|65747458|FG002|Overall Study|Adverse Event|12|||
23550726|NCT01218126|65747459|FG003|Overall Study|Adverse Event|16|||
23550727|NCT01218126|65747456|FG000|Overall Study|Lack of Efficacy|7|||
23550728|NCT01218126|65747457|FG001|Overall Study|Lack of Efficacy|2|||
23550729|NCT01218126|65747458|FG002|Overall Study|Lack of Efficacy|2|||
23550730|NCT01218126|65747459|FG003|Overall Study|Lack of Efficacy|6|||
23550731|NCT01218126|65747456|FG000|Overall Study|Protocol Violation|5|||
23550732|NCT01218126|65747457|FG001|Overall Study|Protocol Violation|2|||
23550733|NCT01218126|65747458|FG002|Overall Study|Protocol Violation|2|||
23550734|NCT01218126|65747459|FG003|Overall Study|Protocol Violation|3|||
23550735|NCT01218126|65747456|FG000|Overall Study|Protocol-defined stopping criteria|1|||
23550736|NCT01218126|65747457|FG001|Overall Study|Protocol-defined stopping criteria|1|||
23550737|NCT01218126|65747458|FG002|Overall Study|Protocol-defined stopping criteria|0|||
23550738|NCT01218126|65747459|FG003|Overall Study|Protocol-defined stopping criteria|0|||
23136418|NCT05007080|64248171|FG001|Overall Study|Lost to Follow-up|1|||
23136419|NCT05007080|64248172|FG002|Overall Study|Lost to Follow-up|0|||
23136420|NCT05007080|64248173|FG003|Overall Study|Lost to Follow-up|1|||
23136421|NCT05007080|64248174|FG004|Overall Study|Lost to Follow-up|1|||
23136422|NCT05007080|64248175|FG005|Overall Study|Lost to Follow-up|1|||
23136423|NCT05007080|64248170|FG000|Overall Study|Death|0|||
23136424|NCT05007080|64248171|FG001|Overall Study|Death|1|||
23136425|NCT05007080|64248172|FG002|Overall Study|Death|0|||
23136426|NCT05007080|64248173|FG003|Overall Study|Death|0|||
23136427|NCT05007080|64248174|FG004|Overall Study|Death|0|||
23550739|NCT01218126|65747456|FG000|Overall Study|Lost to Follow-up|0|||
23550740|NCT01218126|65747457|FG001|Overall Study|Lost to Follow-up|0|||
23550741|NCT01218126|65747458|FG002|Overall Study|Lost to Follow-up|0|||
23550742|NCT01218126|65747459|FG003|Overall Study|Lost to Follow-up|2|||
23550743|NCT01218126|65747456|FG000|Overall Study|Physician Decision|1|||
23550744|NCT01218126|65747457|FG001|Overall Study|Physician Decision|2|||
23550745|NCT01218126|65747458|FG002|Overall Study|Physician Decision|4|||
23550746|NCT01218126|65747459|FG003|Overall Study|Physician Decision|2|||
23550747|NCT01218126|65747456|FG000|Overall Study|Withdrawal by Subject|2|||
23550748|NCT01218126|65747457|FG001|Overall Study|Withdrawal by Subject|5|||
23550749|NCT01218126|65747458|FG002|Overall Study|Withdrawal by Subject|4|||
23550750|NCT01218126|65747459|FG003|Overall Study|Withdrawal by Subject|6|||
23550751|NCT00608582|65747466|FG000|Overall Study|Lost to Follow-up|2|||
23550752|NCT00608582|65747467|FG001|Overall Study|Lost to Follow-up|0|||
23136428|NCT05007080|64248175|FG005|Overall Study|Death|0|||
23136429|NCT05007080|64248170|FG000|Overall Study|Withdrawal by Subject|1|||
23136430|NCT05007080|64248171|FG001|Overall Study|Withdrawal by Subject|2|||
23136431|NCT05007080|64248172|FG002|Overall Study|Withdrawal by Subject|0|||
23136432|NCT05007080|64248173|FG003|Overall Study|Withdrawal by Subject|2|||
23136433|NCT05007080|64248174|FG004|Overall Study|Withdrawal by Subject|1|||
23136434|NCT05007080|64248175|FG005|Overall Study|Withdrawal by Subject|1|||
23136435|NCT05007080|64248170|FG000|Overall Study|Other|1|||
23136436|NCT05007080|64248171|FG001|Overall Study|Other|0|||
23136437|NCT05007080|64248172|FG002|Overall Study|Other|1|||
23136438|NCT05007080|64248173|FG003|Overall Study|Other|1|||
23136439|NCT05007080|64248174|FG004|Overall Study|Other|0|||
23136440|NCT05007080|64248175|FG005|Overall Study|Other|2|||
23136441|NCT05007080|64248170|FG000|Overall Study|Randomized not vaccinated|0|||
23136442|NCT05007080|64248171|FG001|Overall Study|Randomized not vaccinated|0|||
23136443|NCT05007080|64248172|FG002|Overall Study|Randomized not vaccinated|0|||
23136444|NCT05007080|64248173|FG003|Overall Study|Randomized not vaccinated|0|||
23136445|NCT05007080|64248174|FG004|Overall Study|Randomized not vaccinated|0|||
23136446|NCT05007080|64248175|FG005|Overall Study|Randomized not vaccinated|1|||
23136447|NCT03727438|64248176|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
23136448|NCT03727438|64248177|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
23136449|NCT03727438|64248176|FG000|Intervention Period|Excluded (health)|1|||
23136450|NCT03727438|64248177|FG001|Intervention Period|Excluded (health)|0|||
23136451|NCT03727438|64248176|FG000|Intervention Period|Withdrawal by Subject|3|||
23136452|NCT03727438|64248177|FG001|Intervention Period|Withdrawal by Subject|1|||
23136453|NCT03727438|64248176|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
23136454|NCT03727438|64248177|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
23136455|NCT03727438|64248176|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
23215024|NCT00425113|64528129|FG000|Overall Study|Withdrawal by Subject|1|||
23215025|NCT00425113|64528130|FG001|Overall Study|Withdrawal by Subject|0|||
23136456|NCT03727438|64248177|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
23136457|NCT03727438|64248176|FG000|8 Week Assessment|Withdrawal by Subject|6|||
23136458|NCT03727438|64248177|FG001|8 Week Assessment|Withdrawal by Subject|1|||
23136459|NCT03727438|64248176|FG000|6 mo Assessment|did not complete assessment|10|||
23136460|NCT03727438|64248177|FG001|6 mo Assessment|did not complete assessment|11|||
23550753|NCT00608582|65747466|FG000|Overall Study|No Best Response in Phase 1 located|1|||
23550754|NCT00608582|65747467|FG001|Overall Study|No Best Response in Phase 1 located|1|||
23550755|NCT00608582|65747466|FG000|Overall Study|Illicit Drug Use|1|||
23550756|NCT00608582|65747467|FG001|Overall Study|Illicit Drug Use|0|||
23550757|NCT00608582|65747466|FG000|Overall Study|Early stage Design Change|0|||
23550758|NCT00608582|65747467|FG001|Overall Study|Early stage Design Change|3|||
23550759|NCT01854827|65747468|FG000|Overall Study|Death|1|||
23550760|NCT00937924|65747469|FG000|Overall Study|Lost to Follow-up|44|||
23136461|NCT02040259|64248178|FG000|Overall Study|Death|280|||
23136462|NCT02040259|64248178|FG000|Overall Study|Lost to Follow-up|76|||
23136463|NCT02040259|64248178|FG000|Overall Study|Assessment not completed|3|||
23136464|NCT02040259|64248178|FG000|Overall Study|Withdrawal by Subject|4|||
23136465|NCT00743431|64248179|FG000|Overall Study|Toxicity|6|||
23136466|NCT00743431|64248179|FG000|Overall Study|Tumor progression|56|||
23550761|NCT00937924|65747470|FG001|Overall Study|Lost to Follow-up|44|||
23550762|NCT00937924|65747471|FG002|Overall Study|Lost to Follow-up|41|||
23550763|NCT01328080|65747479|FG000|Overall Study|Lost to Follow-up|5|||
23550764|NCT01140880|65747484|FG000|Overall Study|Death|0|||
23136467|NCT00743431|64248179|FG000|Overall Study|Withdrawal by Subject|13|||
23136468|NCT00743431|64248179|FG000|Overall Study|Death|9|||
23136469|NCT00743431|64248179|FG000|Overall Study|Reason for discontinuation not specified|29|||
23136470|NCT00743431|64248179|FG000|Overall Study|No documentation available|13|||
23136471|NCT03292432|64248180|FG000|Overall Study|Lost to Follow-up|11|||
23136472|NCT03292432|64248181|FG001|Overall Study|Lost to Follow-up|8|||
23136473|NCT03292432|64248180|FG000|Overall Study|Death|2|||
23136474|NCT03292432|64248181|FG001|Overall Study|Death|1|||
23136475|NCT03292432|64248180|FG000|Overall Study|Withdrawal by Subject|1|||
23136476|NCT03292432|64248181|FG001|Overall Study|Withdrawal by Subject|2|||
23136477|NCT03292432|64248180|FG000|Overall Study|Site closed before any data collected|1|||
23136478|NCT03292432|64248181|FG001|Overall Study|Site closed before any data collected|0|||
23136479|NCT04552899|64248182|FG000|Overall Study|Adverse Event|4|||
23136480|NCT04552899|64248183|FG001|Overall Study|Adverse Event|3|||
23136481|NCT04552899|64248182|FG000|Overall Study|Death|4|||
23136482|NCT04552899|64248183|FG001|Overall Study|Death|4|||
23136483|NCT04552899|64248182|FG000|Overall Study|Lost to Follow-up|8|||
23136484|NCT04552899|64248183|FG001|Overall Study|Lost to Follow-up|13|||
23136485|NCT04552899|64248182|FG000|Overall Study|Lung Transplant|4|||
23136486|NCT04552899|64248183|FG001|Overall Study|Lung Transplant|3|||
23136487|NCT04552899|64248182|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
23136488|NCT04552899|64248183|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
23136489|NCT04552899|64248182|FG000|Overall Study|Physician Decision|3|||
23136490|NCT04552899|64248183|FG001|Overall Study|Physician Decision|4|||
23136491|NCT04552899|64248182|FG000|Overall Study|Study Terminated By Sponsor|237|||
23136492|NCT04552899|64248183|FG001|Overall Study|Study Terminated By Sponsor|239|||
23136493|NCT04552899|64248182|FG000|Overall Study|Withdrawal by Subject|15|||
23136494|NCT04552899|64248183|FG001|Overall Study|Withdrawal by Subject|17|||
23136495|NCT01757197|64248184|FG000|Overall Study|Death|2|||
23136496|NCT02544451|64248187|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
23136497|NCT02544451|64248188|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
23136498|NCT02544451|64248189|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
23136499|NCT02544451|64248190|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
23136500|NCT02544451|64248187|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
23136501|NCT02544451|64248188|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
23136502|NCT02544451|64248189|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
23136503|NCT02544451|64248190|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
23136504|NCT02544451|64248187|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
23136505|NCT02544451|64248188|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
23136506|NCT02544451|64248189|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
23136507|NCT02544451|64248190|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
23136508|NCT02544451|64248187|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
23136509|NCT02544451|64248188|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
23136510|NCT02544451|64248189|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
23136511|NCT02544451|64248190|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
23136512|NCT02544451|64248187|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
23136513|NCT02544451|64248188|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
23136514|NCT02544451|64248189|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
23136515|NCT02544451|64248190|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
23136516|NCT02544451|64248187|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
23136517|NCT02544451|64248188|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
23136518|NCT02544451|64248189|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
23136519|NCT02544451|64248190|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
23136520|NCT01867333|64248192|FG000|Overall Study|Withdrawal by Subject|1|||
23136521|NCT01867333|64248193|FG001|Overall Study|Withdrawal by Subject|0|||
23136522|NCT01867333|64248192|FG000|Overall Study|Adverse Event|1|||
23136523|NCT01867333|64248193|FG001|Overall Study|Adverse Event|0|||
23136524|NCT01867333|64248192|FG000|Overall Study|Participant choice|1|||
23136525|NCT01867333|64248193|FG001|Overall Study|Participant choice|2|||
23136526|NCT01867333|64248192|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
23136527|NCT01867333|64248193|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
23136528|NCT01867333|64248192|FG000|Overall Study|Death|0|||
23136529|NCT01867333|64248193|FG001|Overall Study|Death|1|||
23136530|NCT01867333|64248192|FG000|Overall Study|Physician Decision|3|||
23136531|NCT01867333|64248193|FG001|Overall Study|Physician Decision|2|||
23136532|NCT01867333|64248192|FG000|Overall Study|Switched to alternative treatment|1|||
23136533|NCT01867333|64248193|FG001|Overall Study|Switched to alternative treatment|0|||
23136534|NCT01859988|64248194|FG000|Overall Study|Withdrawal by Subject|6|||
23136535|NCT01859988|64248195|FG001|Overall Study|Withdrawal by Subject|3|||
23136536|NCT01859988|64248196|FG002|Overall Study|Withdrawal by Subject|4|||
23136537|NCT01859988|64248197|FG003|Overall Study|Withdrawal by Subject|3|||
23136538|NCT01859988|64248198|FG004|Overall Study|Withdrawal by Subject|2|||
23136539|NCT01859988|64248199|FG005|Overall Study|Withdrawal by Subject|2|||
23136540|NCT01859988|64248194|FG000|Overall Study|Lack of Efficacy|1|||
23136541|NCT01859988|64248195|FG001|Overall Study|Lack of Efficacy|1|||
23136542|NCT01859988|64248196|FG002|Overall Study|Lack of Efficacy|5|||
23136543|NCT01859988|64248197|FG003|Overall Study|Lack of Efficacy|0|||
23136544|NCT01859988|64248198|FG004|Overall Study|Lack of Efficacy|7|||
23136545|NCT01859988|64248199|FG005|Overall Study|Lack of Efficacy|9|||
23136546|NCT01859988|64248194|FG000|Overall Study|Physician Decision|1|||
23136547|NCT01859988|64248195|FG001|Overall Study|Physician Decision|3|||
23136548|NCT01859988|64248196|FG002|Overall Study|Physician Decision|1|||
23550765|NCT01140880|65747485|FG001|Overall Study|Death|1|||
23550766|NCT01140880|65747484|FG000|Overall Study|Withdrawal by Subject|6|||
23550767|NCT01140880|65747485|FG001|Overall Study|Withdrawal by Subject|3|||
23550768|NCT01140880|65747484|FG000|Overall Study|Lost to Follow-up|8|||
23550769|NCT01140880|65747485|FG001|Overall Study|Lost to Follow-up|10|||
23550770|NCT01140880|65747484|FG000|Overall Study|Protocol Violation|0|||
23550771|NCT01140880|65747485|FG001|Overall Study|Protocol Violation|30|||
23550772|NCT04205630|65747491|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
23550773|NCT04205630|65747491|FG000|Overall Study|Disease clinical progression|7|||
23550774|NCT04205630|65747491|FG000|Overall Study|Withdrawal by Subject|2|||
23550775|NCT04205630|65747491|FG000|Overall Study|Adverse Event|17|||
23550776|NCT04205630|65747491|FG000|Overall Study|Other|1|||
23550777|NCT00773968|65747492|FG000|Overall Study|Adverse Event|2|||
23550778|NCT00773968|65747492|FG000|Overall Study|Death|1|||
23550779|NCT00773968|65747492|FG000|Overall Study|Failure to Return|2|||
23550780|NCT00773968|65747492|FG000|Overall Study|Lack of Efficacy|3|||
23550781|NCT00773968|65747492|FG000|Overall Study|Protocol Violation|1|||
23550782|NCT00773968|65747492|FG000|Overall Study|Withdrawal by Subject|11|||
23550783|NCT00773968|65747492|FG000|Overall Study|Screen Failure|17|||
23550784|NCT00773968|65747492|FG000|Overall Study|Other|8|||
23550785|NCT01475136|65747495|FG000|Overall Study|Sponsor Decision|0|||
23550786|NCT01475136|65747496|FG001|Overall Study|Sponsor Decision|1|||
23550787|NCT01475136|65747497|FG002|Overall Study|Sponsor Decision|0|||
23550788|NCT01475136|65747498|FG003|Overall Study|Sponsor Decision|0|||
23550789|NCT01475136|65747495|FG000|Overall Study|Entry Criteria Not Met|0|||
23550790|NCT01475136|65747496|FG001|Overall Study|Entry Criteria Not Met|2|||
23550791|NCT01475136|65747497|FG002|Overall Study|Entry Criteria Not Met|3|||
23550792|NCT01475136|65747498|FG003|Overall Study|Entry Criteria Not Met|1|||
23550793|NCT01475136|65747495|FG000|Overall Study|Withdrawal by Subject|0|||
23550794|NCT01475136|65747496|FG001|Overall Study|Withdrawal by Subject|0|||
23550795|NCT01475136|65747497|FG002|Overall Study|Withdrawal by Subject|0|||
23550796|NCT01475136|65747498|FG003|Overall Study|Withdrawal by Subject|2|||
23550797|NCT01475136|65747495|FG000|Overall Study|Adverse Event|1|||
23550798|NCT01475136|65747496|FG001|Overall Study|Adverse Event|0|||
23550799|NCT01475136|65747497|FG002|Overall Study|Adverse Event|0|||
23550800|NCT01475136|65747498|FG003|Overall Study|Adverse Event|1|||
23550801|NCT01475136|65747495|FG000|Overall Study|Death|0|||
23550802|NCT01475136|65747496|FG001|Overall Study|Death|0|||
23550803|NCT01475136|65747497|FG002|Overall Study|Death|0|||
23550804|NCT01475136|65747498|FG003|Overall Study|Death|1|||
23550805|NCT02012491|65747499|FG000|Overall Study|Lost to Follow-up|1|||
23550806|NCT02012491|65747500|FG001|Overall Study|Lost to Follow-up|0|||
23550807|NCT02012491|65747499|FG000|Overall Study|Protocol Violation|0|||
23550808|NCT02012491|65747500|FG001|Overall Study|Protocol Violation|1|||
23550809|NCT02012491|65747499|FG000|Overall Study|Withdrawal by Subject|1|||
23550810|NCT02012491|65747500|FG001|Overall Study|Withdrawal by Subject|0|||
23550811|NCT02310750|65747501|FG000|HP Period 1|Lost to Follow-up|0|||
23550812|NCT02310750|65747502|FG001|HP Period 1|Lost to Follow-up|0|||
23550813|NCT02310750|65747503|FG002|HP Period 1|Lost to Follow-up|0|||
23550814|NCT02310750|65747504|FG003|HP Period 1|Lost to Follow-up|0|||
23550815|NCT02310750|65747505|FG004|HP Period 1|Lost to Follow-up|0|||
23550816|NCT02310750|65747506|FG005|HP Period 1|Lost to Follow-up|0|||
23550817|NCT02310750|65747507|FG006|HP Period 1|Lost to Follow-up|1|||
23136549|NCT01859988|64248197|FG003|Overall Study|Physician Decision|3|||
23136550|NCT01859988|64248198|FG004|Overall Study|Physician Decision|4|||
23136551|NCT01859988|64248199|FG005|Overall Study|Physician Decision|1|||
23550818|NCT02310750|65747508|FG007|HP Period 1|Lost to Follow-up|0|||
23550819|NCT02310750|65747509|FG008|HP Period 1|Lost to Follow-up|0|||
23550820|NCT02310750|65747510|FG009|HP Period 1|Lost to Follow-up|0|||
23550821|NCT02310750|65747511|FG010|HP Period 1|Lost to Follow-up|0|||
23550822|NCT02310750|65747512|FG011|HP Period 1|Lost to Follow-up|0|||
23550823|NCT02310750|65747513|FG012|HP Period 1|Lost to Follow-up|0|||
23550824|NCT02310750|65747514|FG013|HP Period 1|Lost to Follow-up|0|||
23550825|NCT02310750|65747515|FG014|HP Period 1|Lost to Follow-up|0|||
23136552|NCT01859988|64248194|FG000|Overall Study|Adverse Event|2|||
23550826|NCT02310750|65747516|FG015|HP Period 1|Lost to Follow-up|0|||
23550827|NCT02310750|65747501|FG000|HP Period 1|Withdrawal by Subject|1|||
23550828|NCT02310750|65747502|FG001|HP Period 1|Withdrawal by Subject|0|||
23550829|NCT02310750|65747503|FG002|HP Period 1|Withdrawal by Subject|0|||
23550830|NCT02310750|65747504|FG003|HP Period 1|Withdrawal by Subject|1|||
23550831|NCT02310750|65747505|FG004|HP Period 1|Withdrawal by Subject|0|||
23136553|NCT01859988|64248195|FG001|Overall Study|Adverse Event|1|||
23136554|NCT01859988|64248196|FG002|Overall Study|Adverse Event|3|||
23136555|NCT01859988|64248197|FG003|Overall Study|Adverse Event|1|||
23136556|NCT01859988|64248198|FG004|Overall Study|Adverse Event|2|||
23136557|NCT01859988|64248199|FG005|Overall Study|Adverse Event|2|||
23136558|NCT01859988|64248194|FG000|Overall Study|Lost to Follow-up|1|||
23136559|NCT01859988|64248195|FG001|Overall Study|Lost to Follow-up|2|||
23136560|NCT01859988|64248196|FG002|Overall Study|Lost to Follow-up|3|||
23136561|NCT01859988|64248197|FG003|Overall Study|Lost to Follow-up|0|||
23136562|NCT01859988|64248198|FG004|Overall Study|Lost to Follow-up|3|||
23136563|NCT01859988|64248199|FG005|Overall Study|Lost to Follow-up|2|||
23136564|NCT01859988|64248194|FG000|Overall Study|Protocol Violation|0|||
23136565|NCT01859988|64248195|FG001|Overall Study|Protocol Violation|0|||
23136566|NCT01859988|64248196|FG002|Overall Study|Protocol Violation|1|||
23136567|NCT01859988|64248197|FG003|Overall Study|Protocol Violation|0|||
23136568|NCT01859988|64248198|FG004|Overall Study|Protocol Violation|0|||
23136569|NCT01859988|64248199|FG005|Overall Study|Protocol Violation|0|||
23136570|NCT01859988|64248194|FG000|Overall Study|Other than specified above|0|||
23136571|NCT01859988|64248195|FG001|Overall Study|Other than specified above|2|||
23136572|NCT01859988|64248196|FG002|Overall Study|Other than specified above|11|||
23136573|NCT01859988|64248197|FG003|Overall Study|Other than specified above|3|||
23136574|NCT01859988|64248198|FG004|Overall Study|Other than specified above|5|||
23429850|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
23429851|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
23429852|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
23429853|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
23429854|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
23429855|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
23429856|NCT02636946|65317538|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
23429857|NCT02636946|65317539|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
23429858|NCT02636946|65317538|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
23317571|NCT00993421|64904110|FG006|Overall Study|Withdrawal by Subject|3|||
23317572|NCT00993421|64904104|FG000|Overall Study|Death|0|||
23317573|NCT00993421|64904105|FG001|Overall Study|Death|0|||
23317574|NCT00993421|64904106|FG002|Overall Study|Death|0|||
23317575|NCT00993421|64904107|FG003|Overall Study|Death|0|||
23317576|NCT00993421|64904108|FG004|Overall Study|Death|0|||
23317577|NCT00993421|64904109|FG005|Overall Study|Death|0|||
23317578|NCT00993421|64904110|FG006|Overall Study|Death|1|||
23317579|NCT00993421|64904104|FG000|Overall Study|Entry Criteria Exclusion|0|||
23429859|NCT02636946|65317539|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
23429860|NCT05219669|65317540|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
23429861|NCT05219669|65317541|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
23429862|NCT05219669|65317542|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
23429863|NCT05219669|65317543|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
23136575|NCT01859988|64248199|FG005|Overall Study|Other than specified above|3|||
23136576|NCT03435692|64248200|FG000|Overall Study|Lack of Efficacy|2|||
23136577|NCT03435692|64248201|FG001|Overall Study|Lack of Efficacy|2|||
23136578|NCT03435692|64248202|FG002|Overall Study|Lack of Efficacy|0|||
23136579|NCT04476251|64248204|FG000|Overall Study|Not treated|1|||
23136580|NCT00888927|64248208|FG000|Overall Study|Adverse Event|0|||
23136581|NCT00888927|64248209|FG001|Overall Study|Adverse Event|0|||
23136582|NCT00888927|64248210|FG002|Overall Study|Adverse Event|0|||
23136583|NCT00888927|64248211|FG003|Overall Study|Adverse Event|1|||
23136584|NCT00888927|64248208|FG000|Overall Study|Withdrawal of consent|0|||
23136585|NCT00888927|64248209|FG001|Overall Study|Withdrawal of consent|0|||
23136586|NCT00888927|64248210|FG002|Overall Study|Withdrawal of consent|0|||
23136587|NCT00888927|64248211|FG003|Overall Study|Withdrawal of consent|1|||
23136588|NCT02053792|64248212|FG000|Overall Study|Physician Decision|0|||
23136589|NCT02053792|64248213|FG001|Overall Study|Physician Decision|1|||
23136590|NCT02053792|64248212|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
23136591|NCT02053792|64248213|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
23429864|NCT05219669|65317544|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
23429865|NCT05219669|65317545|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
23429866|NCT00748709|65317546|FG000|Overall Study|Progressive disease|15|||
23429867|NCT00748709|65317546|FG000|Overall Study|Drug reducing Toxity|2|||
23429868|NCT00748709|65317546|FG000|Overall Study|Other Adverse Event|1|||
23136592|NCT02053792|64248212|FG000|Overall Study|Lack of Efficacy|1|||
23136593|NCT02053792|64248213|FG001|Overall Study|Lack of Efficacy|0|||
23136594|NCT02053792|64248212|FG000|Overall Study|Adverse Event|1|||
23136595|NCT02053792|64248213|FG001|Overall Study|Adverse Event|0|||
23136596|NCT02053792|64248212|FG000|Overall Study|Withdrawal by Subject|2|||
23136597|NCT02053792|64248213|FG001|Overall Study|Withdrawal by Subject|2|||
23136598|NCT02053792|64248212|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
23215026|NCT01188538|64528132|FG000|Overall Study|Lost to Follow-up|0|||
23317580|NCT00993421|64904105|FG001|Overall Study|Entry Criteria Exclusion|0|||
23317581|NCT00993421|64904106|FG002|Overall Study|Entry Criteria Exclusion|1|||
23317582|NCT00993421|64904107|FG003|Overall Study|Entry Criteria Exclusion|3|||
23429869|NCT00748709|65317546|FG000|Overall Study|Withdrawal by Subject|1|||
23429870|NCT00748709|65317546|FG000|Overall Study|Other Reasons|1|||
23429871|NCT01064687|65317549|FG000|Overall Study|Adverse Event|9|||
23429872|NCT01064687|65317550|FG001|Overall Study|Adverse Event|4|||
23429873|NCT01064687|65317551|FG002|Overall Study|Adverse Event|10|||
23429874|NCT01064687|65317552|FG003|Overall Study|Adverse Event|3|||
23429875|NCT01064687|65317549|FG000|Overall Study|Death|1|||
23429876|NCT01064687|65317550|FG001|Overall Study|Death|1|||
23429877|NCT01064687|65317551|FG002|Overall Study|Death|0|||
23429878|NCT01064687|65317552|FG003|Overall Study|Death|0|||
23429879|NCT01064687|65317549|FG000|Overall Study|Entry Criteria Not Met|3|||
23429880|NCT01064687|65317550|FG001|Overall Study|Entry Criteria Not Met|0|||
23429881|NCT01064687|65317551|FG002|Overall Study|Entry Criteria Not Met|0|||
23429882|NCT01064687|65317552|FG003|Overall Study|Entry Criteria Not Met|0|||
23429883|NCT01064687|65317549|FG000|Overall Study|Lack of Efficacy|1|||
23429884|NCT01064687|65317550|FG001|Overall Study|Lack of Efficacy|0|||
23429885|NCT01064687|65317551|FG002|Overall Study|Lack of Efficacy|2|||
23429886|NCT01064687|65317552|FG003|Overall Study|Lack of Efficacy|3|||
23429887|NCT01064687|65317549|FG000|Overall Study|Lost to Follow-up|7|||
23429888|NCT01064687|65317550|FG001|Overall Study|Lost to Follow-up|10|||
23429889|NCT01064687|65317551|FG002|Overall Study|Lost to Follow-up|13|||
23429890|NCT01064687|65317552|FG003|Overall Study|Lost to Follow-up|5|||
23429891|NCT01064687|65317549|FG000|Overall Study|Physician Decision|2|||
23429892|NCT01064687|65317550|FG001|Overall Study|Physician Decision|2|||
23429893|NCT01064687|65317551|FG002|Overall Study|Physician Decision|0|||
23429894|NCT01064687|65317552|FG003|Overall Study|Physician Decision|0|||
23429895|NCT01064687|65317549|FG000|Overall Study|Protocol Violation|1|||
23429896|NCT01064687|65317550|FG001|Overall Study|Protocol Violation|1|||
23429897|NCT01064687|65317551|FG002|Overall Study|Protocol Violation|0|||
23429898|NCT01064687|65317552|FG003|Overall Study|Protocol Violation|1|||
23429899|NCT01064687|65317549|FG000|Overall Study|Sponsor Decision|0|||
23429900|NCT01064687|65317550|FG001|Overall Study|Sponsor Decision|0|||
23429901|NCT01064687|65317551|FG002|Overall Study|Sponsor Decision|3|||
23429902|NCT01064687|65317552|FG003|Overall Study|Sponsor Decision|0|||
23429903|NCT01064687|65317549|FG000|Overall Study|Withdrawal by Subject|9|||
23550832|NCT02310750|65747506|FG005|HP Period 1|Withdrawal by Subject|0|||
23550833|NCT02310750|65747507|FG006|HP Period 1|Withdrawal by Subject|0|||
23317583|NCT00993421|64904108|FG004|Overall Study|Entry Criteria Exclusion|0|||
23317584|NCT00993421|64904109|FG005|Overall Study|Entry Criteria Exclusion|1|||
23317585|NCT00993421|64904110|FG006|Overall Study|Entry Criteria Exclusion|0|||
23317586|NCT00993421|64904104|FG000|Overall Study|Physician Decision|0|||
23317587|NCT00993421|64904105|FG001|Overall Study|Physician Decision|0|||
23317588|NCT00993421|64904106|FG002|Overall Study|Physician Decision|0|||
23317589|NCT00993421|64904107|FG003|Overall Study|Physician Decision|0|||
23317590|NCT00993421|64904108|FG004|Overall Study|Physician Decision|0|||
23317591|NCT00993421|64904109|FG005|Overall Study|Physician Decision|1|||
23317592|NCT00993421|64904110|FG006|Overall Study|Physician Decision|1|||
23317593|NCT00993421|64904104|FG000|Overall Study|Protocol Violation|0|||
23317594|NCT00993421|64904105|FG001|Overall Study|Protocol Violation|0|||
23317595|NCT00993421|64904106|FG002|Overall Study|Protocol Violation|0|||
23317596|NCT00993421|64904107|FG003|Overall Study|Protocol Violation|0|||
23317597|NCT00993421|64904108|FG004|Overall Study|Protocol Violation|0|||
23317598|NCT00993421|64904109|FG005|Overall Study|Protocol Violation|2|||
23317599|NCT00993421|64904110|FG006|Overall Study|Protocol Violation|1|||
23317600|NCT01862484|64904111|FG000|Overall Study|Lack of Efficacy|1|||
23317601|NCT01862484|64904112|FG001|Overall Study|Lack of Efficacy|1|||
23317602|NCT01862484|64904111|FG000|Overall Study|Lost to Follow-up|1|||
23317603|NCT01862484|64904112|FG001|Overall Study|Lost to Follow-up|2|||
23317604|NCT01862484|64904111|FG000|Overall Study|Protocol Violation|0|||
23317605|NCT01862484|64904112|FG001|Overall Study|Protocol Violation|2|||
23317606|NCT01862484|64904111|FG000|Overall Study|Withdrawal by Subject|0|||
23317607|NCT01862484|64904112|FG001|Overall Study|Withdrawal by Subject|3|||
23317608|NCT00663026|64904113|FG000|Overall Study|Lost to Follow-up|1|||
23317609|NCT00663026|64904114|FG001|Overall Study|Lost to Follow-up|0|||
23429904|NCT01064687|65317550|FG001|Overall Study|Withdrawal by Subject|7|||
23429905|NCT01064687|65317551|FG002|Overall Study|Withdrawal by Subject|12|||
23429906|NCT01064687|65317552|FG003|Overall Study|Withdrawal by Subject|5|||
23429907|NCT01064687|65317549|FG000|Overall Study|Treatment Noncompliance|1|||
23429908|NCT01064687|65317550|FG001|Overall Study|Treatment Noncompliance|1|||
23429909|NCT01064687|65317551|FG002|Overall Study|Treatment Noncompliance|1|||
23317610|NCT00663026|64904115|FG002|Overall Study|Lost to Follow-up|0|||
23317611|NCT00663026|64904113|FG000|Overall Study|Other|1|||
23317612|NCT00663026|64904114|FG001|Overall Study|Other|2|||
23317613|NCT00663026|64904115|FG002|Overall Study|Other|0|||
23317614|NCT00663026|64904113|FG000|Overall Study|Adverse Event|0|||
23429910|NCT01064687|65317552|FG003|Overall Study|Treatment Noncompliance|0|||
23429911|NCT00969436|65317553|FG000|Overall Study|Protocol Violation|1|||
23317615|NCT00663026|64904114|FG001|Overall Study|Adverse Event|2|||
23550834|NCT02310750|65747508|FG007|HP Period 1|Withdrawal by Subject|0|||
23429912|NCT00969436|65317554|FG001|Overall Study|Protocol Violation|3|||
23429913|NCT00969436|65317555|FG002|Overall Study|Protocol Violation|0|||
23429914|NCT00969436|65317553|FG000|Overall Study|Migrated/moved from study area|12|||
23429915|NCT00969436|65317554|FG001|Overall Study|Migrated/moved from study area|10|||
23429916|NCT00969436|65317555|FG002|Overall Study|Migrated/moved from study area|2|||
23429917|NCT00969436|65317553|FG000|Overall Study|Father - serious health problem|0|||
23429918|NCT00969436|65317554|FG001|Overall Study|Father - serious health problem|0|||
23429919|NCT00969436|65317555|FG002|Overall Study|Father - serious health problem|1|||
23429920|NCT00969436|65317553|FG000|Overall Study|Parents personal problem|0|||
23429921|NCT00969436|65317554|FG001|Overall Study|Parents personal problem|0|||
23429922|NCT00969436|65317555|FG002|Overall Study|Parents personal problem|1|||
23429923|NCT00969436|65317553|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
23429924|NCT00969436|65317554|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
23429925|NCT00969436|65317555|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
23429926|NCT00969436|65317553|FG000|Overall Study|Withdrawal by Subject|3|||
23429927|NCT00969436|65317554|FG001|Overall Study|Withdrawal by Subject|0|||
23429928|NCT00969436|65317555|FG002|Overall Study|Withdrawal by Subject|2|||
23429929|NCT00969436|65317553|FG000|Overall Study|Lost to Follow-up|8|||
23429930|NCT00969436|65317554|FG001|Overall Study|Lost to Follow-up|8|||
23429931|NCT00969436|65317555|FG002|Overall Study|Lost to Follow-up|5|||
23429932|NCT01439126|65317556|FG000|Overall Study|Adverse Event|2|||
23429933|NCT01439126|65317557|FG001|Overall Study|Adverse Event|0|||
23429934|NCT01439126|65317556|FG000|Overall Study|Withdrawal by Subject|5|||
23429935|NCT01439126|65317557|FG001|Overall Study|Withdrawal by Subject|21|||
23429936|NCT01439126|65317556|FG000|Overall Study|Protocol Violation|6|||
23429937|NCT01439126|65317557|FG001|Overall Study|Protocol Violation|4|||
23429938|NCT01439126|65317556|FG000|Overall Study|Lost to Follow-up|6|||
23429939|NCT01439126|65317557|FG001|Overall Study|Lost to Follow-up|3|||
23429940|NCT01439126|65317556|FG000|Overall Study|Other-Use of prohibited treatment|0|||
23429941|NCT01439126|65317557|FG001|Overall Study|Other-Use of prohibited treatment|2|||
23429942|NCT01439126|65317556|FG000|Overall Study|Other-Miscellaneous|12|||
23429943|NCT01439126|65317557|FG001|Overall Study|Other-Miscellaneous|12|||
23429944|NCT01299571|65317560|FG000|Overall Study|Protocol Violation|107|||
23429945|NCT01561963|65317561|FG000|Overall Study|Adverse Event|1|||
23429946|NCT01930890|65317564|FG000|Overall Study|Study Termination|14|||
23429947|NCT01930890|65317565|FG001|Overall Study|Study Termination|28|||
23429948|NCT01930890|65317566|FG002|Overall Study|Study Termination|13|||
23429949|NCT01930890|65317567|FG003|Overall Study|Study Termination|25|||
23429950|NCT01930890|65317564|FG000|Overall Study|Death|0|||
23429951|NCT01930890|65317565|FG001|Overall Study|Death|0|||
23429952|NCT01930890|65317566|FG002|Overall Study|Death|0|||
23429953|NCT01930890|65317567|FG003|Overall Study|Death|1|||
23429954|NCT01930890|65317564|FG000|Overall Study|Investigator Decision|0|||
23429955|NCT01930890|65317565|FG001|Overall Study|Investigator Decision|1|||
23429956|NCT01930890|65317566|FG002|Overall Study|Investigator Decision|0|||
23429957|NCT01930890|65317567|FG003|Overall Study|Investigator Decision|0|||
23429958|NCT01930890|65317564|FG000|Overall Study|Consent Withdrawn|0|||
23429959|NCT01930890|65317565|FG001|Overall Study|Consent Withdrawn|3|||
23429960|NCT01930890|65317566|FG002|Overall Study|Consent Withdrawn|0|||
23429961|NCT01930890|65317567|FG003|Overall Study|Consent Withdrawn|1|||
23429962|NCT01930890|65317564|FG000|Overall Study|Adverse Event|0|||
23429963|NCT01930890|65317565|FG001|Overall Study|Adverse Event|1|||
23429964|NCT01930890|65317566|FG002|Overall Study|Adverse Event|0|||
23429965|NCT01930890|65317567|FG003|Overall Study|Adverse Event|0|||
23429966|NCT00117793|65317568|FG000|Overall Study|Withdrawal by Subject|12|||
23429967|NCT03230292|65317569|FG000|Overall Study|Adverse Event|1|||
23429968|NCT03230292|65317569|FG000|Overall Study|Protocol Violation|1|||
23429969|NCT03230292|65317569|FG000|Overall Study|Lost to Follow-up|1|||
23429970|NCT03230292|65317569|FG000|Overall Study|Withdrawal by Subject|3|||
23429971|NCT03559699|65317570|FG000|Overall Study|Withdrawal by Subject|6|||
23429972|NCT03559699|65317570|FG000|Overall Study|Lost to Follow-up|1|||
23429973|NCT01369680|65317573|FG000|Overall Study|Lost to Follow-up|0|||
23429974|NCT01369680|65317574|FG001|Overall Study|Lost to Follow-up|0|||
23429975|NCT01369680|65317575|FG002|Overall Study|Lost to Follow-up|1|||
23429976|NCT01369680|65317576|FG003|Overall Study|Lost to Follow-up|2|||
23429977|NCT04376827|65317580|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
23429978|NCT04376827|65317581|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
23429979|NCT04376827|65317580|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
23429980|NCT04376827|65317581|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
23429981|NCT04376827|65317580|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
23429982|NCT04376827|65317581|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
23429983|NCT04376827|65317580|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
23429984|NCT04376827|65317581|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
23429985|NCT04376827|65317580|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
23429986|NCT04376827|65317581|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
23429987|NCT00489736|65317582|FG000|Overall Study|Lack of Efficacy|53|||
23429988|NCT00489736|65317583|FG001|Overall Study|Lack of Efficacy|14|||
23429989|NCT00489736|65317582|FG000|Overall Study|Adverse Event|32|||
23429990|NCT00489736|65317583|FG001|Overall Study|Adverse Event|45|||
23429991|NCT00489736|65317582|FG000|Overall Study|Poor compliance|6|||
23429992|NCT00489736|65317583|FG001|Overall Study|Poor compliance|2|||
23429993|NCT00489736|65317582|FG000|Overall Study|Not coded/ Not pre-specified|5|||
23429994|NCT00489736|65317583|FG001|Overall Study|Not coded/ Not pre-specified|8|||
23429995|NCT02683668|65317584|FG000|Period 2|Withdrawal by Subject|0|||
23429996|NCT02683668|65317585|FG001|Period 2|Withdrawal by Subject|1|||
23429997|NCT02683668|65317586|FG002|Period 2|Withdrawal by Subject|0|||
23429998|NCT00530920|65317589|FG000|Overall Study|Randomized but not treated|0|||
23429999|NCT00530920|65317590|FG001|Overall Study|Randomized but not treated|2|||
23430000|NCT00530920|65317591|FG002|Overall Study|Randomized but not treated|0|||
23430001|NCT00530920|65317589|FG000|Overall Study|Adverse Event|0|||
23430002|NCT00530920|65317590|FG001|Overall Study|Adverse Event|0|||
23430003|NCT00530920|65317591|FG002|Overall Study|Adverse Event|3|||
23430004|NCT00530920|65317589|FG000|Overall Study|Withdrawal by Subject|0|||
23430005|NCT00530920|65317590|FG001|Overall Study|Withdrawal by Subject|0|||
23430006|NCT00530920|65317591|FG002|Overall Study|Withdrawal by Subject|1|||
23430007|NCT04208087|65317592|FG000|Overall Study|Adverse Event|1|||
23430008|NCT04208087|65317593|FG001|Overall Study|Adverse Event|0|||
23430009|NCT04208087|65317594|FG002|Overall Study|Adverse Event|0|||
23430010|NCT04208087|65317595|FG003|Overall Study|Adverse Event|0|||
23430011|NCT04208087|65317596|FG004|Overall Study|Adverse Event|0|||
23430012|NCT04208087|65317592|FG000|Overall Study|Withdrawal by Subject|0|||
23430013|NCT04208087|65317593|FG001|Overall Study|Withdrawal by Subject|0|||
23430014|NCT04208087|65317594|FG002|Overall Study|Withdrawal by Subject|1|||
23550835|NCT02310750|65747509|FG008|HP Period 1|Withdrawal by Subject|0|||
23430015|NCT04208087|65317595|FG003|Overall Study|Withdrawal by Subject|0|||
23430016|NCT04208087|65317596|FG004|Overall Study|Withdrawal by Subject|0|||
23430017|NCT04208087|65317592|FG000|Overall Study|Other|0|||
23430018|NCT04208087|65317593|FG001|Overall Study|Other|0|||
23430019|NCT04208087|65317594|FG002|Overall Study|Other|0|||
23430020|NCT04208087|65317595|FG003|Overall Study|Other|0|||
23430021|NCT04208087|65317596|FG004|Overall Study|Other|1|||
23430022|NCT02644356|65317597|FG000|Overall Study|Withdrawal by Subject|2|||
23430023|NCT00490022|65317598|FG000|Overall Study|Adverse Event|0|||
23430024|NCT00490022|65317599|FG001|Overall Study|Adverse Event|2|||
23430025|NCT00490022|65317598|FG000|Overall Study|Withdrawal by Subject|1|||
23430026|NCT00490022|65317599|FG001|Overall Study|Withdrawal by Subject|0|||
23430027|NCT00490022|65317598|FG000|Overall Study|Subject failed to disclose concommitant|0|||
23430028|NCT00490022|65317599|FG001|Overall Study|Subject failed to disclose concommitant|1|||
23430029|NCT02084238|65317600|FG000|Overall Study|Lost to Follow-up|2|||
23430030|NCT01719003|65317601|FG000|Overall Study|Non compliant with protocol|1|||
23430031|NCT01719003|65317602|FG001|Overall Study|Non compliant with protocol|1|||
23430032|NCT01719003|65317603|FG002|Overall Study|Non compliant with protocol|0|||
23430033|NCT01719003|65317604|FG003|Overall Study|Non compliant with protocol|1|||
23430034|NCT01719003|65317605|FG004|Overall Study|Non compliant with protocol|2|||
23430035|NCT01719003|65317606|FG005|Overall Study|Non compliant with protocol|1|||
23430036|NCT01719003|65317607|FG006|Overall Study|Non compliant with protocol|2|||
23430037|NCT01719003|65317608|FG007|Overall Study|Non compliant with protocol|3|||
23430038|NCT01719003|65317609|FG008|Overall Study|Non compliant with protocol|0|||
23430039|NCT01719003|65317601|FG000|Overall Study|Adverse Event|6|||
23430040|NCT01719003|65317602|FG001|Overall Study|Adverse Event|5|||
23550836|NCT02310750|65747510|FG009|HP Period 1|Withdrawal by Subject|0|||
23550837|NCT02310750|65747511|FG010|HP Period 1|Withdrawal by Subject|0|||
23430041|NCT01719003|65317603|FG002|Overall Study|Adverse Event|4|||
23430042|NCT01719003|65317604|FG003|Overall Study|Adverse Event|3|||
23430043|NCT01719003|65317605|FG004|Overall Study|Adverse Event|4|||
23430044|NCT01719003|65317606|FG005|Overall Study|Adverse Event|3|||
23430045|NCT01719003|65317607|FG006|Overall Study|Adverse Event|6|||
23430046|NCT01719003|65317608|FG007|Overall Study|Adverse Event|5|||
23430047|NCT01719003|65317609|FG008|Overall Study|Adverse Event|0|||
23430048|NCT01719003|65317601|FG000|Overall Study|Lost to Follow-up|0|||
23430049|NCT01719003|65317602|FG001|Overall Study|Lost to Follow-up|6|||
23430050|NCT01719003|65317603|FG002|Overall Study|Lost to Follow-up|7|||
23430051|NCT01719003|65317604|FG003|Overall Study|Lost to Follow-up|2|||
23430052|NCT01719003|65317605|FG004|Overall Study|Lost to Follow-up|3|||
23430053|NCT01719003|65317606|FG005|Overall Study|Lost to Follow-up|4|||
23430054|NCT01719003|65317607|FG006|Overall Study|Lost to Follow-up|3|||
23550838|NCT02310750|65747512|FG011|HP Period 1|Withdrawal by Subject|0|||
23550839|NCT02310750|65747513|FG012|HP Period 1|Withdrawal by Subject|0|||
23550840|NCT02310750|65747514|FG013|HP Period 1|Withdrawal by Subject|0|||
23430055|NCT01719003|65317608|FG007|Overall Study|Lost to Follow-up|2|||
23430056|NCT01719003|65317609|FG008|Overall Study|Lost to Follow-up|2|||
23430057|NCT01719003|65317601|FG000|Overall Study|Refusal to continue, not due to AE|2|||
23430058|NCT01719003|65317602|FG001|Overall Study|Refusal to continue, not due to AE|5|||
23550841|NCT02310750|65747515|FG014|HP Period 1|Withdrawal by Subject|0|||
23430059|NCT01719003|65317603|FG002|Overall Study|Refusal to continue, not due to AE|4|||
23430060|NCT01719003|65317604|FG003|Overall Study|Refusal to continue, not due to AE|4|||
23430061|NCT01719003|65317605|FG004|Overall Study|Refusal to continue, not due to AE|4|||
23430062|NCT01719003|65317606|FG005|Overall Study|Refusal to continue, not due to AE|3|||
23430063|NCT01719003|65317607|FG006|Overall Study|Refusal to continue, not due to AE|8|||
23430064|NCT01719003|65317608|FG007|Overall Study|Refusal to continue, not due to AE|7|||
23430065|NCT01719003|65317609|FG008|Overall Study|Refusal to continue, not due to AE|1|||
23430066|NCT01719003|65317601|FG000|Overall Study|Reason other than those specified|0|||
23430067|NCT01719003|65317602|FG001|Overall Study|Reason other than those specified|0|||
23430068|NCT01719003|65317603|FG002|Overall Study|Reason other than those specified|2|||
23430069|NCT01719003|65317604|FG003|Overall Study|Reason other than those specified|3|||
23430070|NCT01719003|65317605|FG004|Overall Study|Reason other than those specified|4|||
23430071|NCT01719003|65317606|FG005|Overall Study|Reason other than those specified|1|||
23430072|NCT01719003|65317607|FG006|Overall Study|Reason other than those specified|0|||
23430073|NCT01719003|65317608|FG007|Overall Study|Reason other than those specified|3|||
23430074|NCT01719003|65317609|FG008|Overall Study|Reason other than those specified|1|||
23430075|NCT01719003|65317601|FG000|Overall Study|Lack of Efficacy|0|||
23430076|NCT01719003|65317602|FG001|Overall Study|Lack of Efficacy|0|||
23430077|NCT01719003|65317603|FG002|Overall Study|Lack of Efficacy|0|||
23430078|NCT01719003|65317604|FG003|Overall Study|Lack of Efficacy|0|||
23430079|NCT01719003|65317605|FG004|Overall Study|Lack of Efficacy|0|||
23430080|NCT01719003|65317606|FG005|Overall Study|Lack of Efficacy|0|||
23430081|NCT01719003|65317607|FG006|Overall Study|Lack of Efficacy|1|||
23430082|NCT01719003|65317608|FG007|Overall Study|Lack of Efficacy|0|||
23430083|NCT01719003|65317609|FG008|Overall Study|Lack of Efficacy|0|||
23430084|NCT03464422|65317611|FG000|Overall Study|Lost to Follow-up|2|||
23430085|NCT03464422|65317611|FG000|Overall Study|Withdrawal by Subject|2|||
23430086|NCT00320372|65317612|FG000|Overall Study|Physician Decision|4|||
23430087|NCT00320372|65317613|FG001|Overall Study|Physician Decision|7|||
23430088|NCT00320372|65317612|FG000|Overall Study|Death|7|||
23430089|NCT00320372|65317613|FG001|Overall Study|Death|8|||
23430090|NCT00320372|65317612|FG000|Overall Study|Withdrawal by Subject|55|||
23430091|NCT00320372|65317613|FG001|Overall Study|Withdrawal by Subject|37|||
23430092|NCT00320372|65317612|FG000|Overall Study|Non-Compliance|40|||
23430093|NCT00320372|65317613|FG001|Overall Study|Non-Compliance|39|||
23430094|NCT00320372|65317612|FG000|Overall Study|Did not Meet (I/E)|3|||
23430095|NCT00320372|65317613|FG001|Overall Study|Did not Meet (I/E)|1|||
23430096|NCT00320372|65317612|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
23430097|NCT00320372|65317613|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
23430098|NCT02017522|65317614|FG000|Overall Study|Withdrawal by Subject|1|||
23430099|NCT01685983|65317617|FG000|Overall Study|Adverse Event|7|||
23430100|NCT01685983|65317617|FG000|Overall Study|Death|1|||
23430101|NCT01685983|65317617|FG000|Overall Study|Withdrawal by Subject|19|||
23430102|NCT01685983|65317617|FG000|Overall Study|Protocol Violation|2|||
23430103|NCT01685983|65317617|FG000|Overall Study|Physician Decision|13|||
23430104|NCT01685983|65317617|FG000|Overall Study|Other|7|||
23430105|NCT01685983|65317617|FG000|Overall Study|Progressive Disease|32|||
23430106|NCT01685983|65317617|FG000|Overall Study|Noncompliance with Study Drug|1|||
23430107|NCT02437409|65317618|FG000|Overall Study|Withdrawal by Subject|3|||
23430108|NCT02437409|65317618|FG000|Overall Study|Screening failure|12|||
23430109|NCT04021524|65317619|FG000|Overall Study|Change in surgical intervention|0|||
23430110|NCT04021524|65317620|FG001|Overall Study|Change in surgical intervention|1|||
23430111|NCT03759041|65317623|FG000|Overall Study|Withdrawal by Subject|4|||
23550842|NCT02310750|65747516|FG015|HP Period 1|Withdrawal by Subject|0|||
23550843|NCT02310750|65747501|FG000|HP Washout 1|Lost to Follow-up|0|||
23550844|NCT02310750|65747502|FG001|HP Washout 1|Lost to Follow-up|0|||
23550845|NCT02310750|65747503|FG002|HP Washout 1|Lost to Follow-up|1|||
23550846|NCT02310750|65747504|FG003|HP Washout 1|Lost to Follow-up|1|||
23550847|NCT02310750|65747505|FG004|HP Washout 1|Lost to Follow-up|2|||
23550848|NCT02310750|65747506|FG005|HP Washout 1|Lost to Follow-up|2|||
23550849|NCT02310750|65747507|FG006|HP Washout 1|Lost to Follow-up|3|||
23550850|NCT02310750|65747508|FG007|HP Washout 1|Lost to Follow-up|0|||
23550851|NCT02310750|65747509|FG008|HP Washout 1|Lost to Follow-up|0|||
23550852|NCT02310750|65747510|FG009|HP Washout 1|Lost to Follow-up|0|||
23550853|NCT02310750|65747511|FG010|HP Washout 1|Lost to Follow-up|0|||
23550854|NCT02310750|65747512|FG011|HP Washout 1|Lost to Follow-up|0|||
23550855|NCT02310750|65747513|FG012|HP Washout 1|Lost to Follow-up|0|||
23550856|NCT02310750|65747514|FG013|HP Washout 1|Lost to Follow-up|0|||
23550857|NCT02310750|65747515|FG014|HP Washout 1|Lost to Follow-up|0|||
23215027|NCT01188538|64528133|FG001|Overall Study|Lost to Follow-up|1|||
23430112|NCT03759041|65317624|FG001|Overall Study|Withdrawal by Subject|10|||
23430113|NCT03759041|65317625|FG002|Overall Study|Withdrawal by Subject|10|||
23430114|NCT03759041|65317623|FG000|Overall Study|Adverse Event|1|||
23430115|NCT03759041|65317624|FG001|Overall Study|Adverse Event|3|||
23430116|NCT03759041|65317625|FG002|Overall Study|Adverse Event|4|||
23430117|NCT03759041|65317623|FG000|Overall Study|Lack of Efficacy|0|||
23550858|NCT02310750|65747516|FG015|HP Washout 1|Lost to Follow-up|0|||
23550859|NCT02310750|65747501|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550860|NCT02310750|65747502|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550861|NCT02310750|65747503|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550862|NCT02310750|65747504|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
23550863|NCT02310750|65747505|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550864|NCT02310750|65747506|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
23550865|NCT02310750|65747507|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550866|NCT02310750|65747508|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550867|NCT02310750|65747509|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
23550868|NCT02310750|65747510|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
23550869|NCT02310750|65747511|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550870|NCT02310750|65747512|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550871|NCT02310750|65747513|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550872|NCT02310750|65747514|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550873|NCT02310750|65747515|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550874|NCT02310750|65747516|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
23550875|NCT02310750|65747501|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550876|NCT02310750|65747502|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550877|NCT02310750|65747503|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550878|NCT02310750|65747504|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550879|NCT02310750|65747505|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23620476|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
23620477|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
23620478|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
23620479|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
23620480|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
23550880|NCT02310750|65747506|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550881|NCT02310750|65747507|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550882|NCT02310750|65747508|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550883|NCT02310750|65747509|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550884|NCT02310750|65747510|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
23550885|NCT02310750|65747511|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550886|NCT02310750|65747512|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550887|NCT02310750|65747513|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550888|NCT02310750|65747514|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550889|NCT02310750|65747515|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550890|NCT02310750|65747516|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
23550891|NCT02310750|65747501|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550892|NCT02310750|65747502|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620481|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
23620482|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
23620483|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
23620484|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
23620485|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
23620486|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
23620487|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
23620488|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
23620489|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
23620490|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
23620491|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
23620492|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
23620493|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
23620494|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
23620495|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
23620496|NCT02637856|65997482|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
23620497|NCT02637856|65997483|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
23620498|NCT02637856|65997482|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
23620499|NCT02637856|65997483|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
23620500|NCT02637856|65997482|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
23620501|NCT02637856|65997483|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
23620502|NCT04052997|65997484|FG000|Overall Study|Withdrawal by Subject|17|||
23620503|NCT04052997|65997484|FG000|Overall Study|Physician Decision|50|||
23620504|NCT04052997|65997484|FG000|Overall Study|Death|43|||
23620505|NCT04052997|65997484|FG000|Overall Study|Lost to Follow-up|5|||
23620506|NCT04052997|65997484|FG000|Overall Study|Progression of Disease|1|||
23317616|NCT00663026|64904115|FG002|Overall Study|Adverse Event|3|||
23550893|NCT02310750|65747503|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620507|NCT04984278|65997491|FG000|Period 1|Withdrawal by Subject|1|||
23620508|NCT04984278|65997492|FG001|Period 1|Withdrawal by Subject|0|||
23620509|NCT04984278|65997491|FG000|Period 1|Other|0|||
23620510|NCT04984278|65997492|FG001|Period 1|Other|1|||
23620511|NCT04984278|65997491|FG000|Period 2|Adverse Event|1|||
23620512|NCT04984278|65997492|FG001|Period 2|Adverse Event|0|||
23620513|NCT04984278|65997491|FG000|Period 2|Other|0|||
23620514|NCT04984278|65997492|FG001|Period 2|Other|1|||
23620515|NCT01180790|65997493|FG000|Overall Study|Adverse Event|1|||
23620516|NCT01180790|65997494|FG001|Overall Study|Adverse Event|1|||
23620517|NCT01180790|65997495|FG002|Overall Study|Adverse Event|2|||
23620518|NCT01180790|65997496|FG003|Overall Study|Adverse Event|0|||
23620519|NCT01180790|65997497|FG004|Overall Study|Adverse Event|1|||
23620520|NCT01180790|65997498|FG005|Overall Study|Adverse Event|3|||
23620521|NCT01180790|65997499|FG006|Overall Study|Adverse Event|0|||
23620522|NCT01180790|65997493|FG000|Overall Study|Withdrawal by Subject|3|||
23620523|NCT01180790|65997494|FG001|Overall Study|Withdrawal by Subject|0|||
23620524|NCT01180790|65997495|FG002|Overall Study|Withdrawal by Subject|5|||
23620525|NCT01180790|65997496|FG003|Overall Study|Withdrawal by Subject|0|||
23620526|NCT01180790|65997497|FG004|Overall Study|Withdrawal by Subject|2|||
23620527|NCT01180790|65997498|FG005|Overall Study|Withdrawal by Subject|1|||
23620528|NCT01180790|65997499|FG006|Overall Study|Withdrawal by Subject|0|||
23550894|NCT02310750|65747504|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550895|NCT02310750|65747505|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550896|NCT02310750|65747506|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550897|NCT02310750|65747507|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620529|NCT01180790|65997493|FG000|Overall Study|Lost to Follow-up|3|||
23620530|NCT01180790|65997494|FG001|Overall Study|Lost to Follow-up|1|||
23620531|NCT01180790|65997495|FG002|Overall Study|Lost to Follow-up|0|||
23620532|NCT01180790|65997496|FG003|Overall Study|Lost to Follow-up|2|||
23620533|NCT01180790|65997497|FG004|Overall Study|Lost to Follow-up|1|||
23620534|NCT01180790|65997498|FG005|Overall Study|Lost to Follow-up|0|||
23550898|NCT02310750|65747508|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
23550899|NCT02310750|65747509|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
23550900|NCT02310750|65747510|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
23550901|NCT02310750|65747511|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550902|NCT02310750|65747512|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620535|NCT01180790|65997499|FG006|Overall Study|Lost to Follow-up|1|||
23620536|NCT01180790|65997493|FG000|Overall Study|Physician Decision|1|||
23620537|NCT01180790|65997494|FG001|Overall Study|Physician Decision|0|||
23620538|NCT01180790|65997495|FG002|Overall Study|Physician Decision|0|||
23620539|NCT01180790|65997496|FG003|Overall Study|Physician Decision|1|||
23620540|NCT01180790|65997497|FG004|Overall Study|Physician Decision|0|||
23620541|NCT01180790|65997498|FG005|Overall Study|Physician Decision|0|||
23620542|NCT01180790|65997499|FG006|Overall Study|Physician Decision|0|||
23620543|NCT01180790|65997493|FG000|Overall Study|Lack of Efficacy|1|||
23620544|NCT01180790|65997494|FG001|Overall Study|Lack of Efficacy|2|||
23620545|NCT01180790|65997495|FG002|Overall Study|Lack of Efficacy|5|||
23620546|NCT01180790|65997496|FG003|Overall Study|Lack of Efficacy|6|||
23620547|NCT01180790|65997497|FG004|Overall Study|Lack of Efficacy|1|||
23620548|NCT01180790|65997498|FG005|Overall Study|Lack of Efficacy|3|||
23620549|NCT01180790|65997499|FG006|Overall Study|Lack of Efficacy|0|||
23620550|NCT01180790|65997493|FG000|Overall Study|compliance|0|||
23620551|NCT01180790|65997494|FG001|Overall Study|compliance|1|||
23620552|NCT01180790|65997495|FG002|Overall Study|compliance|0|||
23620553|NCT01180790|65997496|FG003|Overall Study|compliance|0|||
23620554|NCT01180790|65997497|FG004|Overall Study|compliance|0|||
23620555|NCT01180790|65997498|FG005|Overall Study|compliance|0|||
23620556|NCT01180790|65997499|FG006|Overall Study|compliance|0|||
23620557|NCT01180790|65997493|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620558|NCT01180790|65997494|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620559|NCT01180790|65997495|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
23620560|NCT01180790|65997496|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620561|NCT01180790|65997497|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620562|NCT01180790|65997498|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
23620563|NCT01180790|65997499|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
23317617|NCT00663026|64904113|FG000|Overall Study|Caregiver Request|0|||
23550903|NCT02310750|65747513|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23620564|NCT00551135|65997500|FG000|Overall Study|Adverse Event|1|||
23620565|NCT00551135|65997501|FG001|Overall Study|Adverse Event|0|||
23620566|NCT00551135|65997502|FG002|Overall Study|Adverse Event|1|||
23620567|NCT00551135|65997503|FG003|Overall Study|Adverse Event|1|||
23620568|NCT00551135|65997500|FG000|Overall Study|Lost to Follow-up|0|||
23620569|NCT00551135|65997501|FG001|Overall Study|Lost to Follow-up|0|||
23620570|NCT00551135|65997502|FG002|Overall Study|Lost to Follow-up|0|||
23620571|NCT00551135|65997503|FG003|Overall Study|Lost to Follow-up|1|||
23620572|NCT00551135|65997500|FG000|Overall Study|Other|3|||
23620573|NCT00551135|65997501|FG001|Overall Study|Other|2|||
23620574|NCT00551135|65997502|FG002|Overall Study|Other|1|||
23430118|NCT03759041|65317624|FG001|Overall Study|Lack of Efficacy|0|||
23430119|NCT03759041|65317625|FG002|Overall Study|Lack of Efficacy|1|||
23430120|NCT03759041|65317623|FG000|Overall Study|Study Terminated by Sponsor|15|||
23430121|NCT03759041|65317624|FG001|Overall Study|Study Terminated by Sponsor|16|||
23430122|NCT03759041|65317625|FG002|Overall Study|Study Terminated by Sponsor|10|||
23430123|NCT03759041|65317623|FG000|Overall Study|Other reason for discontinuation|0|||
23430124|NCT03759041|65317624|FG001|Overall Study|Other reason for discontinuation|2|||
23430125|NCT03759041|65317625|FG002|Overall Study|Other reason for discontinuation|1|||
23430126|NCT03759041|65317623|FG000|Overall Study|Lost to Follow-up|7|||
23430127|NCT03759041|65317624|FG001|Overall Study|Lost to Follow-up|2|||
23430128|NCT03759041|65317625|FG002|Overall Study|Lost to Follow-up|2|||
23430129|NCT03759041|65317623|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
23430130|NCT03759041|65317624|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
23430131|NCT03759041|65317625|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
23430132|NCT01167907|65317626|FG000|Overall Study|Protocol Violation|1|||
23430133|NCT01167907|65317627|FG001|Overall Study|Protocol Violation|0|||
23430134|NCT01167907|65317626|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
23430135|NCT01167907|65317627|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
23430136|NCT01522404|65317628|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
23430137|NCT01522404|65317629|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
23430138|NCT01522404|65317628|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
23430139|NCT01522404|65317629|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
23430140|NCT01522404|65317628|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
23430141|NCT01522404|65317629|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
23430142|NCT03602885|65317633|FG000|Overall Study|Lost to Follow-up|3|||
23430143|NCT03602885|65317634|FG001|Overall Study|Lost to Follow-up|0|||
23430144|NCT02383433|65317637|FG000|Overall Study|Disease progression|2|||
23430145|NCT03242018|65317639|FG000|Overall Study|Adverse Event|7|||
23430146|NCT03242018|65317640|FG001|Overall Study|Adverse Event|7|||
23430147|NCT03242018|65317641|FG002|Overall Study|Adverse Event|6|||
23430148|NCT03242018|65317639|FG000|Overall Study|Lost to Follow-up|2|||
23430149|NCT03242018|65317640|FG001|Overall Study|Lost to Follow-up|2|||
23430150|NCT03242018|65317641|FG002|Overall Study|Lost to Follow-up|2|||
23430151|NCT03242018|65317639|FG000|Overall Study|At the Participant's Own Request|5|||
23430152|NCT03242018|65317640|FG001|Overall Study|At the Participant's Own Request|1|||
23430153|NCT03242018|65317641|FG002|Overall Study|At the Participant's Own Request|4|||
23430154|NCT03242018|65317639|FG000|Overall Study|Reason Not Specified|3|||
23430155|NCT03242018|65317640|FG001|Overall Study|Reason Not Specified|4|||
23430156|NCT03242018|65317641|FG002|Overall Study|Reason Not Specified|1|||
23430157|NCT03242018|65317639|FG000|Overall Study|Study Terminated by Sponsor|1|||
23430158|NCT03242018|65317640|FG001|Overall Study|Study Terminated by Sponsor|0|||
23430159|NCT03242018|65317641|FG002|Overall Study|Study Terminated by Sponsor|1|||
23430160|NCT01638559|65317654|FG000|Overall Study|Lost to Follow-up|1|||
23430161|NCT01638559|65317654|FG000|Overall Study|Withdrawal by Subject|1|||
23430162|NCT01638559|65317654|FG000|Overall Study|Subject declined to travel for biopsy|1|||
23430163|NCT01739803|65320515|FG000|Overall Study|Lost to Follow-up|9|||
23430164|NCT01739803|65320516|FG001|Overall Study|Lost to Follow-up|6|||
23430165|NCT00635089|65320517|FG000|Overall Study|Adverse Event|7|||
23430166|NCT00635089|65320517|FG000|Overall Study|Lack of Efficacy|28|||
23430167|NCT00635089|65320517|FG000|Overall Study|Protocol Deviation|4|||
23550904|NCT02310750|65747514|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550905|NCT02310750|65747515|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550906|NCT02310750|65747516|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
23550907|NCT02310750|65747501|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23620575|NCT00551135|65997503|FG003|Overall Study|Other|2|||
23620576|NCT00551135|65997500|FG000|Overall Study|Withdrawal by Subject|1|||
23550908|NCT02310750|65747502|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550909|NCT02310750|65747503|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550910|NCT02310750|65747504|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550911|NCT02310750|65747505|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550912|NCT02310750|65747506|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550913|NCT02310750|65747507|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550914|NCT02310750|65747508|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
23620577|NCT00551135|65997501|FG001|Overall Study|Withdrawal by Subject|0|||
23620578|NCT00551135|65997502|FG002|Overall Study|Withdrawal by Subject|3|||
23430168|NCT00635089|65320517|FG000|Overall Study|Lost to Follow-up|8|||
23430169|NCT00635089|65320517|FG000|Overall Study|Other|31|||
23430170|NCT00046930|65320518|FG000|Overall Study|Ineligible|12|||
23620579|NCT00551135|65997503|FG003|Overall Study|Withdrawal by Subject|1|||
23620580|NCT00961896|65997504|FG000|Overall Study|Abnormal laboratory value|0|||
23430171|NCT00046930|65320519|FG001|Overall Study|Ineligible|4|||
23430172|NCT03626545|65320520|FG000|Overall Study|Progressive disease|3|||
23430173|NCT03626545|65320521|FG001|Overall Study|Progressive disease|82|||
23620581|NCT00961896|65997505|FG001|Overall Study|Abnormal laboratory value|0|||
23550915|NCT02310750|65747509|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
23550916|NCT02310750|65747510|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550917|NCT02310750|65747511|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550918|NCT02310750|65747512|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550919|NCT02310750|65747513|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550920|NCT02310750|65747514|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23620582|NCT00961896|65997506|FG002|Overall Study|Abnormal laboratory value|1|||
23620583|NCT03511378|65997508|FG000|Overall Study|Withdrawal by Subject|2|||
23620584|NCT03511378|65997509|FG001|Overall Study|Withdrawal by Subject|2|||
23620585|NCT03511378|65997508|FG000|Overall Study|Patient not coming or schedule visit|1|||
23620586|NCT03511378|65997509|FG001|Overall Study|Patient not coming or schedule visit|0|||
23620587|NCT01182181|65997511|FG000|First Intervention|Adverse Event|1|||
23620588|NCT01182181|65997512|FG001|First Intervention|Adverse Event|0|||
23620589|NCT01182181|65997511|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
23550921|NCT02310750|65747515|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550922|NCT02310750|65747516|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
23550923|NCT02310750|65747501|FG000|HP Washout 2|Lost to Follow-up|0|||
23550924|NCT02310750|65747502|FG001|HP Washout 2|Lost to Follow-up|0|||
23550925|NCT02310750|65747503|FG002|HP Washout 2|Lost to Follow-up|0|||
23550926|NCT02310750|65747504|FG003|HP Washout 2|Lost to Follow-up|0|||
23550927|NCT02310750|65747505|FG004|HP Washout 2|Lost to Follow-up|1|||
23550928|NCT02310750|65747506|FG005|HP Washout 2|Lost to Follow-up|0|||
23550929|NCT02310750|65747507|FG006|HP Washout 2|Lost to Follow-up|7|||
23550930|NCT02310750|65747508|FG007|HP Washout 2|Lost to Follow-up|0|||
23550931|NCT02310750|65747509|FG008|HP Washout 2|Lost to Follow-up|0|||
23550932|NCT02310750|65747510|FG009|HP Washout 2|Lost to Follow-up|0|||
23550933|NCT02310750|65747511|FG010|HP Washout 2|Lost to Follow-up|0|||
23620590|NCT01182181|65997512|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
23620591|NCT02388932|65997513|FG000|Overall Study|Death|1|||
23620592|NCT00523549|65997516|FG000|Overall Study|Adverse Event|6|||
23620593|NCT00523549|65997517|FG001|Overall Study|Adverse Event|3|||
23620594|NCT00523549|65997516|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23620595|NCT00523549|65997517|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23550934|NCT02310750|65747512|FG011|HP Washout 2|Lost to Follow-up|0|||
23620596|NCT00523549|65997516|FG000|Overall Study|Protocol Deviation|3|||
23620597|NCT00523549|65997517|FG001|Overall Study|Protocol Deviation|1|||
23620598|NCT00523549|65997516|FG000|Overall Study|Patient withdrew consent|7|||
23620599|NCT00523549|65997517|FG001|Overall Study|Patient withdrew consent|6|||
23620600|NCT00523549|65997516|FG000|Overall Study|Lost to Follow-up|3|||
23620601|NCT00523549|65997517|FG001|Overall Study|Lost to Follow-up|5|||
23620602|NCT01059526|65997518|FG000|Overall Study|Patient enrolled but not treated|20|||
23620603|NCT01059526|65997519|FG001|Overall Study|Patient enrolled but not treated|17|||
23620604|NCT01059526|65997518|FG000|Overall Study|Adverse Event|2|||
23620605|NCT01059526|65997519|FG001|Overall Study|Adverse Event|2|||
23620606|NCT01059526|65997518|FG000|Overall Study|Protocol Violation|0|||
23620607|NCT01059526|65997519|FG001|Overall Study|Protocol Violation|1|||
23620608|NCT01059526|65997518|FG000|Overall Study|Withdrawal by Subject|3|||
23620609|NCT01059526|65997519|FG001|Overall Study|Withdrawal by Subject|1|||
23620610|NCT01059526|65997518|FG000|Overall Study|Lost to Follow-up|4|||
23620611|NCT01059526|65997519|FG001|Overall Study|Lost to Follow-up|1|||
23620612|NCT01059526|65997518|FG000|Overall Study|Patient found to be dermatographic|1|||
23620613|NCT01059526|65997519|FG001|Overall Study|Patient found to be dermatographic|0|||
23620614|NCT01837797|65997521|FG000|Period 1|Adverse Event|9|||
23620615|NCT01837797|65997522|FG001|Period 1|Adverse Event|0|||
23620616|NCT01837797|65997523|FG002|Period 1|Adverse Event|0|||
23620617|NCT01837797|65997524|FG003|Period 1|Adverse Event|0|||
23620618|NCT01837797|65997525|FG004|Period 1|Adverse Event|0|||
23620619|NCT01837797|65997521|FG000|Period 1|Withdrawal by Subject|6|||
23620620|NCT01837797|65997522|FG001|Period 1|Withdrawal by Subject|0|||
23620621|NCT01837797|65997523|FG002|Period 1|Withdrawal by Subject|0|||
23620622|NCT01837797|65997524|FG003|Period 1|Withdrawal by Subject|0|||
23620623|NCT01837797|65997525|FG004|Period 1|Withdrawal by Subject|0|||
23620624|NCT01837797|65997521|FG000|Period 1|Administrative reasons|76|||
23620625|NCT01837797|65997522|FG001|Period 1|Administrative reasons|0|||
23620626|NCT01837797|65997523|FG002|Period 1|Administrative reasons|0|||
23620627|NCT01837797|65997524|FG003|Period 1|Administrative reasons|0|||
23620628|NCT01837797|65997525|FG004|Period 1|Administrative reasons|0|||
23620629|NCT01837797|65997521|FG000|Period 1|Withdrawal of consent before treatment|1|||
23620630|NCT01837797|65997522|FG001|Period 1|Withdrawal of consent before treatment|0|||
23620631|NCT01837797|65997523|FG002|Period 1|Withdrawal of consent before treatment|0|||
23620632|NCT01837797|65997524|FG003|Period 1|Withdrawal of consent before treatment|0|||
23620633|NCT01837797|65997525|FG004|Period 1|Withdrawal of consent before treatment|0|||
23550935|NCT02310750|65747513|FG012|HP Washout 2|Lost to Follow-up|0|||
23620634|NCT01837797|65997521|FG000|Period 1|Other|10|||
23620635|NCT01837797|65997522|FG001|Period 1|Other|0|||
23215028|NCT02198651|64528137|FG000|Lead-in Period|Withdrew consent|13|||
23620636|NCT01837797|65997523|FG002|Period 1|Other|0|||
23620637|NCT01837797|65997524|FG003|Period 1|Other|0|||
23620638|NCT01837797|65997525|FG004|Period 1|Other|0|||
23620639|NCT01837797|65997521|FG000|Period 2|Administrative or other reasons|0|||
23620640|NCT01837797|65997522|FG001|Period 2|Administrative or other reasons|5|||
23620641|NCT01837797|65997523|FG002|Period 2|Administrative or other reasons|2|||
23620642|NCT01837797|65997524|FG003|Period 2|Administrative or other reasons|4|||
23620643|NCT01837797|65997525|FG004|Period 2|Administrative or other reasons|0|||
23620644|NCT01837797|65997521|FG000|Period 2|Adverse Event|0|||
23620645|NCT01837797|65997522|FG001|Period 2|Adverse Event|0|||
23620646|NCT01837797|65997523|FG002|Period 2|Adverse Event|0|||
23620647|NCT01837797|65997524|FG003|Period 2|Adverse Event|1|||
23620648|NCT01837797|65997525|FG004|Period 2|Adverse Event|0|||
23620649|NCT01837797|65997521|FG000|Period 3|Adverse Event|0|||
23620650|NCT01837797|65997522|FG001|Period 3|Adverse Event|0|||
23620651|NCT01837797|65997523|FG002|Period 3|Adverse Event|0|||
23620652|NCT01837797|65997524|FG003|Period 3|Adverse Event|0|||
23620653|NCT01837797|65997525|FG004|Period 3|Adverse Event|1|||
23620654|NCT01837797|65997521|FG000|Period 3|Administrative reasons|0|||
23620655|NCT01837797|65997522|FG001|Period 3|Administrative reasons|0|||
23620656|NCT01837797|65997523|FG002|Period 3|Administrative reasons|0|||
23620657|NCT01837797|65997524|FG003|Period 3|Administrative reasons|0|||
23620658|NCT01837797|65997525|FG004|Period 3|Administrative reasons|20|||
23620659|NCT01837797|65997521|FG000|Period 3|Other|0|||
23620660|NCT01837797|65997522|FG001|Period 3|Other|0|||
23620661|NCT01837797|65997523|FG002|Period 3|Other|0|||
23620662|NCT01837797|65997524|FG003|Period 3|Other|0|||
23620663|NCT01837797|65997525|FG004|Period 3|Other|2|||
23620664|NCT00292981|65997528|FG000|Overall Study|Adverse Event|1|||
23620665|NCT00292981|65997528|FG000|Overall Study|Lost to Follow-up|13|||
23620666|NCT00292981|65997528|FG000|Overall Study|Withdrawal by Subject|22|||
23620667|NCT00292981|65997528|FG000|Overall Study|Other|3|||
23620668|NCT02720198|65997529|FG000|Overall Study|Withdrawal by Subject|0|||
23620669|NCT02720198|65997530|FG001|Overall Study|Withdrawal by Subject|1|||
23620670|NCT01145417|65997533|FG000|Overall Study|Death|1|||
23620671|NCT01145417|65997534|FG001|Overall Study|Death|0|||
23620672|NCT01145417|65997533|FG000|Overall Study|Lost to Follow-up|2|||
23620673|NCT01145417|65997534|FG001|Overall Study|Lost to Follow-up|1|||
23620674|NCT01145417|65997533|FG000|Overall Study|Withdrawal by Subject|1|||
23620675|NCT01145417|65997534|FG001|Overall Study|Withdrawal by Subject|2|||
23620676|NCT01145417|65997533|FG000|Overall Study|Pregnancy|1|||
23620677|NCT01145417|65997534|FG001|Overall Study|Pregnancy|0|||
23620678|NCT01145417|65997533|FG000|Overall Study|Adverse Event|0|||
23620679|NCT01145417|65997534|FG001|Overall Study|Adverse Event|1|||
23620680|NCT01145417|65997533|FG000|Overall Study|Study terminated by sponsor|35|||
23620681|NCT01145417|65997534|FG001|Overall Study|Study terminated by sponsor|43|||
23620682|NCT01145417|65997533|FG000|Overall Study|Other|1|||
23620683|NCT01145417|65997534|FG001|Overall Study|Other|0|||
23620684|NCT01370018|65997535|FG000|Overall Study|Did not meet criteria for analysis|1|||
23550936|NCT02310750|65747514|FG013|HP Washout 2|Lost to Follow-up|0|||
23550937|NCT02310750|65747515|FG014|HP Washout 2|Lost to Follow-up|0|||
23550938|NCT02310750|65747516|FG015|HP Washout 2|Lost to Follow-up|0|||
23550939|NCT03273946|65747517|FG000|Overall Study|Withdrawal by Subject|5|||
23550940|NCT03273946|65747517|FG000|Overall Study|Unwillingness of the guardian|1|||
23620685|NCT00546078|65997536|FG000|Overall Study|Lost to Follow-up|1|||
23620686|NCT00546078|65997537|FG001|Overall Study|Lost to Follow-up|3|||
23620687|NCT00546078|65997536|FG000|Overall Study|Withdrawal by Subject|2|||
23620688|NCT00546078|65997537|FG001|Overall Study|Withdrawal by Subject|3|||
23620689|NCT00546078|65997536|FG000|Overall Study|Other reason|1|||
23550941|NCT03273946|65747517|FG000|Overall Study|Participant refused to use the drug|2|||
23550942|NCT03273946|65747517|FG000|Overall Study|Participant relative refused to use drug|1|||
23550943|NCT00262821|65747518|FG000|Overall Study|Ineligible - wrong stage|0|||
23550944|NCT00262821|65747519|FG001|Overall Study|Ineligible - wrong stage|3|||
23550945|NCT00262821|65747518|FG000|Overall Study|Ineligible - wrong cell type|2|||
23550946|NCT00262821|65747519|FG001|Overall Study|Ineligible - wrong cell type|2|||
23550947|NCT00262821|65747518|FG000|Overall Study|Ineligible - wrong primary|0|||
23550948|NCT00262821|65747519|FG001|Overall Study|Ineligible - wrong primary|1|||
23620690|NCT00546078|65997537|FG001|Overall Study|Other reason|1|||
23620691|NCT01209286|65997539|FG000|Overall Study|Adverse Event|4|||
23620692|NCT01209286|65997540|FG001|Overall Study|Adverse Event|3|||
23550949|NCT00262821|65747518|FG000|Overall Study|Ineligible - inadequate pathology|1|||
23620693|NCT01209286|65997541|FG002|Overall Study|Adverse Event|1|||
23620694|NCT01209286|65997539|FG000|Overall Study|Hematological Relapse After Remission|0|||
23620695|NCT01209286|65997540|FG001|Overall Study|Hematological Relapse After Remission|1|||
23620696|NCT01209286|65997541|FG002|Overall Study|Hematological Relapse After Remission|1|||
23620697|NCT01209286|65997539|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
23620698|NCT01209286|65997540|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
23620699|NCT01209286|65997541|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
23620700|NCT01209286|65997539|FG000|Overall Study|Physician Decision|0|||
23620701|NCT01209286|65997540|FG001|Overall Study|Physician Decision|2|||
23550950|NCT00262821|65747519|FG001|Overall Study|Ineligible - inadequate pathology|3|||
23550951|NCT00262821|65747518|FG000|Overall Study|Ineligible - elevated creatinine|0|||
23550952|NCT00262821|65747519|FG001|Overall Study|Ineligible - elevated creatinine|2|||
23550953|NCT00262821|65747518|FG000|Overall Study|Ineligible - required test not done|1|||
23550954|NCT00262821|65747519|FG001|Overall Study|Ineligible - required test not done|4|||
23550955|NCT00262821|65747518|FG000|Overall Study|Inevaluable - inadequate data|0|||
23550956|NCT00262821|65747519|FG001|Overall Study|Inevaluable - inadequate data|4|||
23550957|NCT01830127|65747520|FG000|Overall Study|Adverse Event|1|||
23550958|NCT01830127|65747521|FG001|Overall Study|Adverse Event|6|||
23550959|NCT01830127|65747520|FG000|Overall Study|Lack of Efficacy|3|||
23550960|NCT01830127|65747521|FG001|Overall Study|Lack of Efficacy|0|||
23620702|NCT01209286|65997541|FG002|Overall Study|Physician Decision|0|||
23620703|NCT01209286|65997539|FG000|Overall Study|Other|0|||
23620704|NCT01209286|65997540|FG001|Overall Study|Other|1|||
23620705|NCT01209286|65997541|FG002|Overall Study|Other|0|||
23620706|NCT01978236|65997542|FG000|Overall Study|Discontinued due to study close|2|||
23620707|NCT01084239|65997543|FG000|28-Day Follow-up|Lost to Follow-up|4|||
23620708|NCT01084239|65997544|FG001|28-Day Follow-up|Lost to Follow-up|9|||
23620709|NCT01435798|65997547|FG000|Overall Study|Withdrawal by Subject|1|||
23620710|NCT02158247|65997548|FG000|Overall Study|Invisible vocal cords|5|||
23620711|NCT01172639|65997551|FG000|Overall Study|Death|1|||
23620712|NCT01172639|65997552|FG001|Overall Study|Death|1|||
23620713|NCT01172639|65997553|FG002|Overall Study|Death|0|||
23620714|NCT01172639|65997554|FG003|Overall Study|Death|0|||
23620715|NCT01172639|65997555|FG004|Overall Study|Death|0|||
23620716|NCT01172639|65997551|FG000|Overall Study|Lost to Follow-up|9|||
23620717|NCT01172639|65997552|FG001|Overall Study|Lost to Follow-up|7|||
23620718|NCT01172639|65997553|FG002|Overall Study|Lost to Follow-up|11|||
23620719|NCT01172639|65997554|FG003|Overall Study|Lost to Follow-up|6|||
23620720|NCT01172639|65997555|FG004|Overall Study|Lost to Follow-up|6|||
23620721|NCT01172639|65997551|FG000|Overall Study|Withdrawal by Subject|3|||
23620722|NCT01172639|65997552|FG001|Overall Study|Withdrawal by Subject|3|||
23620723|NCT01172639|65997553|FG002|Overall Study|Withdrawal by Subject|5|||
23620724|NCT01172639|65997554|FG003|Overall Study|Withdrawal by Subject|5|||
23620725|NCT01172639|65997555|FG004|Overall Study|Withdrawal by Subject|0|||
23620726|NCT00796614|65997558|FG000|Overall Study|Adverse Event|1|||
23620727|NCT00796614|65997559|FG001|Overall Study|Adverse Event|2|||
23620728|NCT00796614|65997560|FG002|Overall Study|Adverse Event|0|||
23620729|NCT00796614|65997561|FG003|Overall Study|Adverse Event|0|||
23620730|NCT00796614|65997558|FG000|Overall Study|Protocol Violation|0|||
23620731|NCT00796614|65997559|FG001|Overall Study|Protocol Violation|0|||
23620732|NCT00796614|65997560|FG002|Overall Study|Protocol Violation|2|||
23620733|NCT00796614|65997561|FG003|Overall Study|Protocol Violation|0|||
23620734|NCT00796614|65997558|FG000|Overall Study|Lost to Follow-up|2|||
23620735|NCT00796614|65997559|FG001|Overall Study|Lost to Follow-up|2|||
23620736|NCT00796614|65997560|FG002|Overall Study|Lost to Follow-up|1|||
23620737|NCT00796614|65997561|FG003|Overall Study|Lost to Follow-up|0|||
23620738|NCT00796614|65997558|FG000|Overall Study|Withdrawal by Subject|1|||
23136599|NCT02053792|64248213|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
23136600|NCT02053792|64248212|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
23136601|NCT02053792|64248213|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
23215029|NCT02198651|64528138|FG001|Lead-in Period|Withdrew consent|0|||
23620739|NCT00796614|65997559|FG001|Overall Study|Withdrawal by Subject|0|||
23620740|NCT00796614|65997560|FG002|Overall Study|Withdrawal by Subject|0|||
23136602|NCT00766363|64248216|FG000|Overall Study|Withdrawal by Subject|1|||
23136603|NCT00766363|64248217|FG001|Overall Study|Withdrawal by Subject|0|||
23136604|NCT00766363|64248218|FG002|Overall Study|Withdrawal by Subject|0|||
23136605|NCT00766363|64248219|FG003|Overall Study|Withdrawal by Subject|0|||
23136606|NCT00766363|64248216|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
23136607|NCT00766363|64248217|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
23136608|NCT00766363|64248218|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
23136609|NCT00766363|64248219|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
23136610|NCT00872989|64248220|FG000|Overall Study|Adverse Event|7|||
23136611|NCT00872989|64248221|FG001|Overall Study|Adverse Event|15|||
23136612|NCT00872989|64248220|FG000|Overall Study|Withdrawal by Subject|8|||
23136613|NCT00872989|64248221|FG001|Overall Study|Withdrawal by Subject|5|||
23215030|NCT02198651|64528139|FG002|Lead-in Period|Withdrew consent|0|||
23620741|NCT00796614|65997561|FG003|Overall Study|Withdrawal by Subject|1|||
23136614|NCT00872989|64248220|FG000|Overall Study|Progression/relapse|47|||
23550961|NCT01830127|65747520|FG000|Overall Study|Withdrawal by Subject|1|||
23550962|NCT01830127|65747521|FG001|Overall Study|Withdrawal by Subject|1|||
23550963|NCT01830127|65747520|FG000|Overall Study|Other reason not defined above|0|||
23620742|NCT00796614|65997558|FG000|Overall Study|Other than stated|1|||
23620743|NCT00796614|65997559|FG001|Overall Study|Other than stated|0|||
23620744|NCT00796614|65997560|FG002|Overall Study|Other than stated|0|||
23620745|NCT00796614|65997561|FG003|Overall Study|Other than stated|0|||
23215031|NCT02198651|64528140|FG003|Lead-in Period|Withdrew consent|0|||
23215032|NCT02198651|64528141|FG004|Lead-in Period|Withdrew consent|0|||
23215033|NCT02198651|64528137|FG000|Lead-in Period|Adverse Event|2|||
23215034|NCT02198651|64528138|FG001|Lead-in Period|Adverse Event|0|||
23215035|NCT02198651|64528139|FG002|Lead-in Period|Adverse Event|0|||
23215036|NCT02198651|64528140|FG003|Lead-in Period|Adverse Event|0|||
23215037|NCT02198651|64528141|FG004|Lead-in Period|Adverse Event|0|||
23215038|NCT02198651|64528137|FG000|Lead-in Period|Other, not specified|22|||
23215039|NCT02198651|64528138|FG001|Lead-in Period|Other, not specified|0|||
23215040|NCT02198651|64528139|FG002|Lead-in Period|Other, not specified|0|||
23215041|NCT02198651|64528140|FG003|Lead-in Period|Other, not specified|0|||
23215042|NCT02198651|64528141|FG004|Lead-in Period|Other, not specified|0|||
23215043|NCT02198651|64528137|FG000|Double-blind Period|Withdrew consent|0|||
23215044|NCT02198651|64528138|FG001|Double-blind Period|Withdrew consent|4|||
23215045|NCT02198651|64528139|FG002|Double-blind Period|Withdrew consent|0|||
23215046|NCT02198651|64528140|FG003|Double-blind Period|Withdrew consent|0|||
23215047|NCT02198651|64528141|FG004|Double-blind Period|Withdrew consent|0|||
23215048|NCT02198651|64528137|FG000|Double-blind Period|Adverse Event|0|||
23215049|NCT02198651|64528138|FG001|Double-blind Period|Adverse Event|1|||
23215050|NCT02198651|64528139|FG002|Double-blind Period|Adverse Event|0|||
23215051|NCT02198651|64528140|FG003|Double-blind Period|Adverse Event|0|||
23215052|NCT02198651|64528141|FG004|Double-blind Period|Adverse Event|0|||
23215053|NCT02198651|64528137|FG000|Double-blind Period|Other, not specified|0|||
23215054|NCT02198651|64528138|FG001|Double-blind Period|Other, not specified|4|||
23215055|NCT02198651|64528139|FG002|Double-blind Period|Other, not specified|1|||
23215056|NCT02198651|64528140|FG003|Double-blind Period|Other, not specified|0|||
23215057|NCT02198651|64528141|FG004|Double-blind Period|Other, not specified|0|||
23215058|NCT02198651|64528137|FG000|Open-label Rescue Period|Withdrew consent|0|||
23215059|NCT02198651|64528138|FG001|Open-label Rescue Period|Withdrew consent|0|||
23215060|NCT02198651|64528139|FG002|Open-label Rescue Period|Withdrew consent|0|||
23215061|NCT02198651|64528140|FG003|Open-label Rescue Period|Withdrew consent|2|||
23215062|NCT02198651|64528141|FG004|Open-label Rescue Period|Withdrew consent|0|||
23215063|NCT02198651|64528137|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
23215064|NCT02198651|64528138|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
23215065|NCT02198651|64528139|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
23215066|NCT02198651|64528140|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
23215067|NCT02198651|64528141|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
23215068|NCT00719862|64528145|FG000|Overall Study|Adverse Event|1|||
23215069|NCT00719862|64528146|FG001|Overall Study|Adverse Event|2|||
23215070|NCT00719862|64528145|FG000|Overall Study|Lack of Efficacy|3|||
23215071|NCT00719862|64528146|FG001|Overall Study|Lack of Efficacy|0|||
23215072|NCT00719862|64528145|FG000|Overall Study|Non-Compliance|1|||
23215073|NCT00719862|64528146|FG001|Overall Study|Non-Compliance|0|||
23215074|NCT00719862|64528145|FG000|Overall Study|Withdrawal by Subject|1|||
23215075|NCT00719862|64528146|FG001|Overall Study|Withdrawal by Subject|0|||
23215076|NCT00719862|64528145|FG000|Overall Study|Lost to Follow-up|0|||
23215077|NCT00719862|64528146|FG001|Overall Study|Lost to Follow-up|1|||
23215078|NCT00719862|64528145|FG000|Overall Study|Other|2|||
23215079|NCT00719862|64528146|FG001|Overall Study|Other|3|||
23215080|NCT01444898|64528147|FG000|Overall Study|Withdrawal by Subject|1|||
23215081|NCT01624506|64528148|FG000|Overall Study|Lost to Follow-up|29|||
23215082|NCT01624506|64528149|FG001|Overall Study|Lost to Follow-up|15|||
23215083|NCT01624506|64528148|FG000|Overall Study|Withdrawal by Subject|9|||
23215084|NCT01624506|64528149|FG001|Overall Study|Withdrawal by Subject|2|||
23215085|NCT01624506|64528148|FG000|Overall Study|Death|1|||
23215086|NCT01624506|64528149|FG001|Overall Study|Death|0|||
23215087|NCT01624506|64528148|FG000|Overall Study|LINX explants|23|||
23215088|NCT01624506|64528149|FG001|Overall Study|LINX explants|0|||
23215089|NCT01624506|64528148|FG000|Overall Study|Adverse Event|3|||
23317618|NCT00663026|64904114|FG001|Overall Study|Caregiver Request|2|||
23136615|NCT00872989|64248221|FG001|Overall Study|Progression/relapse|35|||
23136616|NCT00872989|64248220|FG000|Overall Study|Not protocol specified|3|||
23136617|NCT00872989|64248221|FG001|Overall Study|Not protocol specified|8|||
23136618|NCT00864253|64248226|FG000|Overall Study|Adverse Event|56|||
23136619|NCT00864253|64248227|FG001|Overall Study|Adverse Event|11|||
23136620|NCT00864253|64248226|FG000|Overall Study|Unrelated Adverse Event|3|||
23136621|NCT00864253|64248227|FG001|Overall Study|Unrelated Adverse Event|1|||
23620746|NCT00802438|65997562|FG000|Overall Study|Screen Failure|20|||
23620747|NCT00802438|65997562|FG000|Overall Study|Withdrawal by Subject|7|||
23215090|NCT01624506|64528149|FG001|Overall Study|Adverse Event|0|||
23317619|NCT00663026|64904115|FG002|Overall Study|Caregiver Request|0|||
23317620|NCT00663026|64904113|FG000|Overall Study|Withdrawal by Subject|0|||
23620748|NCT00802438|65997562|FG000|Overall Study|Physician Decision|1|||
23136622|NCT00864253|64248226|FG000|Overall Study|Physician Decision|11|||
23136623|NCT00864253|64248227|FG001|Overall Study|Physician Decision|15|||
23215091|NCT00062647|64528150|FG000|Overall Study|Death|2|||
23215092|NCT00062647|64528151|FG001|Overall Study|Death|2|||
23215093|NCT00062647|64528150|FG000|Overall Study|Adverse Event|1|||
23136624|NCT00864253|64248226|FG000|Overall Study|Protocol Violation|0|||
23136625|NCT00864253|64248227|FG001|Overall Study|Protocol Violation|2|||
23136626|NCT00864253|64248226|FG000|Overall Study|Lost to Follow-up|1|||
23136627|NCT00864253|64248227|FG001|Overall Study|Lost to Follow-up|1|||
23136628|NCT00864253|64248226|FG000|Overall Study|Withdrawal by Subject|18|||
23136629|NCT00864253|64248227|FG001|Overall Study|Withdrawal by Subject|18|||
23136630|NCT00864253|64248226|FG000|Overall Study|Death|1|||
23136631|NCT00864253|64248227|FG001|Overall Study|Death|0|||
23136632|NCT00864253|64248226|FG000|Overall Study|Ongoing|2|||
23136633|NCT00864253|64248227|FG001|Overall Study|Ongoing|3|||
23136634|NCT00864253|64248226|FG000|Overall Study|Untreated|7|||
23136635|NCT00864253|64248227|FG001|Overall Study|Untreated|7|||
23136636|NCT00440999|64251926|FG000|Overall Study|Adverse Event|0|||
23136637|NCT00440999|64251927|FG001|Overall Study|Adverse Event|2|||
23136638|NCT00440999|64251926|FG000|Overall Study|Lack of Efficacy|6|||
23136639|NCT00440999|64251927|FG001|Overall Study|Lack of Efficacy|7|||
23136640|NCT00440999|64251926|FG000|Overall Study|Lost to Follow-up|19|||
23136641|NCT00440999|64251927|FG001|Overall Study|Lost to Follow-up|12|||
23136642|NCT00440999|64251926|FG000|Overall Study|Protocol Violation|1|||
23136643|NCT00440999|64251927|FG001|Overall Study|Protocol Violation|0|||
23136644|NCT00440999|64251926|FG000|Overall Study|Withdrawal by Subject|2|||
23136645|NCT00440999|64251927|FG001|Overall Study|Withdrawal by Subject|5|||
23136646|NCT00440999|64251926|FG000|Overall Study|Subjets missed the visit|1|||
23136647|NCT00440999|64251927|FG001|Overall Study|Subjets missed the visit|0|||
23136648|NCT00440999|64251926|FG000|Overall Study|Mixed infection at entry|1|||
23136649|NCT00440999|64251927|FG001|Overall Study|Mixed infection at entry|0|||
23136650|NCT00440999|64251926|FG000|Overall Study|P. falciparum malaria|5|||
23550964|NCT01830127|65747521|FG001|Overall Study|Other reason not defined above|2|||
23550965|NCT02280044|65747524|FG000|Overall Study|Planned alternate|0|||
23550966|NCT02280044|65747525|FG001|Overall Study|Planned alternate|2|||
23550967|NCT02261493|65747526|FG000|Overall Study|Noncompliance|0|||
23550968|NCT02261493|65747527|FG001|Overall Study|Noncompliance|0|||
23550969|NCT02261493|65747528|FG002|Overall Study|Noncompliance|2|||
23550970|NCT02261493|65747526|FG000|Overall Study|Physician Decision|0|||
23550971|NCT02261493|65747527|FG001|Overall Study|Physician Decision|1|||
23550972|NCT02261493|65747528|FG002|Overall Study|Physician Decision|0|||
23550973|NCT02261493|65747526|FG000|Overall Study|Undisclosed alcohol abuse|0|||
23550974|NCT02261493|65747527|FG001|Overall Study|Undisclosed alcohol abuse|1|||
23550975|NCT02261493|65747528|FG002|Overall Study|Undisclosed alcohol abuse|0|||
23550976|NCT02261493|65747526|FG000|Overall Study|Protocol Violation|1|||
23550977|NCT02261493|65747527|FG001|Overall Study|Protocol Violation|0|||
23550978|NCT02261493|65747528|FG002|Overall Study|Protocol Violation|0|||
23550979|NCT02261493|65747526|FG000|Overall Study|Personal Reasons|14|||
23550980|NCT02261493|65747527|FG001|Overall Study|Personal Reasons|14|||
23550981|NCT02261493|65747528|FG002|Overall Study|Personal Reasons|16|||
23550982|NCT02261493|65747526|FG000|Overall Study|Lost to Follow-up|14|||
23550983|NCT02261493|65747527|FG001|Overall Study|Lost to Follow-up|27|||
23550984|NCT02261493|65747528|FG002|Overall Study|Lost to Follow-up|8|||
23550985|NCT02261493|65747526|FG000|Overall Study|Pregnancy|1|||
23550986|NCT02261493|65747527|FG001|Overall Study|Pregnancy|2|||
23550987|NCT02261493|65747528|FG002|Overall Study|Pregnancy|0|||
23550988|NCT02261493|65747526|FG000|Overall Study|Lack of Efficacy|0|||
23550989|NCT02261493|65747527|FG001|Overall Study|Lack of Efficacy|1|||
23550990|NCT02261493|65747528|FG002|Overall Study|Lack of Efficacy|0|||
23550991|NCT02261493|65747526|FG000|Overall Study|Adverse Event|0|||
23550992|NCT02261493|65747527|FG001|Overall Study|Adverse Event|1|||
23550993|NCT02261493|65747528|FG002|Overall Study|Adverse Event|0|||
23550994|NCT04402866|65747531|FG000|Overall Study|Discontinued Prior to Treatment|0|||
23550995|NCT04402866|65747532|FG001|Overall Study|Discontinued Prior to Treatment|0|||
23550996|NCT04402866|65747533|FG002|Overall Study|Discontinued Prior to Treatment|0|||
23550997|NCT04402866|65747534|FG003|Overall Study|Discontinued Prior to Treatment|0|||
23550998|NCT04402866|65747535|FG004|Overall Study|Discontinued Prior to Treatment|2|||
23317621|NCT00663026|64904114|FG001|Overall Study|Withdrawal by Subject|0|||
23550999|NCT04402866|65747536|FG005|Overall Study|Discontinued Prior to Treatment|3|||
23551000|NCT04402866|65747531|FG000|Overall Study|Adverse Event|2|||
23551001|NCT04402866|65747532|FG001|Overall Study|Adverse Event|1|||
23551002|NCT04402866|65747533|FG002|Overall Study|Adverse Event|0|||
23551003|NCT04402866|65747534|FG003|Overall Study|Adverse Event|0|||
23551004|NCT04402866|65747535|FG004|Overall Study|Adverse Event|13|||
23551005|NCT04402866|65747536|FG005|Overall Study|Adverse Event|8|||
23551006|NCT04402866|65747531|FG000|Overall Study|Miscellaneous|0|||
23551007|NCT04402866|65747532|FG001|Overall Study|Miscellaneous|0|||
23136651|NCT00440999|64251927|FG001|Overall Study|P. falciparum malaria|14|||
23136652|NCT00440999|64251926|FG000|Overall Study|Subj left hosp without inform staff|0|||
23136653|NCT00440999|64251927|FG001|Overall Study|Subj left hosp without inform staff|1|||
23136654|NCT01901432|64251930|FG000|Overall Study|Adverse Event|0|||
23136655|NCT01901432|64251931|FG001|Overall Study|Adverse Event|1|||
23136656|NCT01901432|64251932|FG002|Overall Study|Adverse Event|1|||
23317622|NCT00663026|64904115|FG002|Overall Study|Withdrawal by Subject|1|||
23136657|NCT01901432|64251933|FG003|Overall Study|Adverse Event|0|||
23136658|NCT01901432|64251934|FG004|Overall Study|Adverse Event|1|||
23136659|NCT01901432|64251930|FG000|Overall Study|Withdrawal by Subject|0|||
23136660|NCT01901432|64251931|FG001|Overall Study|Withdrawal by Subject|0|||
23430174|NCT03626545|65320522|FG002|Overall Study|Progressive disease|85|||
23430175|NCT03626545|65320520|FG000|Overall Study|Adverse Event|3|||
23620749|NCT00087555|65997566|FG000|Overall Study|Adverse Event|3|||
23620750|NCT00087555|65997567|FG001|Overall Study|Adverse Event|6|||
23620751|NCT00087555|65997568|FG002|Overall Study|Adverse Event|14|||
23620752|NCT00087555|65997566|FG000|Overall Study|Lost to Follow-up|0|||
23620753|NCT00087555|65997567|FG001|Overall Study|Lost to Follow-up|1|||
23620754|NCT00087555|65997568|FG002|Overall Study|Lost to Follow-up|1|||
23620755|NCT00087555|65997566|FG000|Overall Study|Non - Compliance|1|||
23620756|NCT00087555|65997567|FG001|Overall Study|Non - Compliance|0|||
23620757|NCT00087555|65997568|FG002|Overall Study|Non - Compliance|0|||
23620758|NCT00087555|65997566|FG000|Overall Study|Protocol Violation|0|||
23620759|NCT00087555|65997567|FG001|Overall Study|Protocol Violation|0|||
23620760|NCT00087555|65997568|FG002|Overall Study|Protocol Violation|2|||
23620761|NCT00087555|65997566|FG000|Overall Study|Screen Failure|1|||
23620762|NCT00087555|65997567|FG001|Overall Study|Screen Failure|1|||
23620763|NCT00087555|65997568|FG002|Overall Study|Screen Failure|0|||
23620764|NCT00087555|65997566|FG000|Overall Study|Pregnancy|0|||
23620765|NCT00087555|65997567|FG001|Overall Study|Pregnancy|1|||
23620766|NCT00087555|65997568|FG002|Overall Study|Pregnancy|1|||
23620767|NCT00087555|65997566|FG000|Overall Study|Withdrawal by Subject|3|||
23620768|NCT00087555|65997567|FG001|Overall Study|Withdrawal by Subject|2|||
23620769|NCT00087555|65997568|FG002|Overall Study|Withdrawal by Subject|1|||
23620770|NCT00087555|65997566|FG000|Overall Study|Lack of Efficacy|2|||
23620771|NCT00087555|65997567|FG001|Overall Study|Lack of Efficacy|0|||
23620772|NCT00087555|65997568|FG002|Overall Study|Lack of Efficacy|1|||
23620773|NCT00087555|65997566|FG000|Overall Study|Non Compliance|0|||
23620774|NCT00087555|65997567|FG001|Overall Study|Non Compliance|0|||
23620775|NCT00087555|65997568|FG002|Overall Study|Non Compliance|1|||
23620776|NCT00087555|65997566|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
23620777|NCT00087555|65997567|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
23620778|NCT00087555|65997568|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
23620779|NCT00087555|65997566|FG000|Overall Study|Patient wanted to go back on Med|1|||
23620780|NCT00087555|65997567|FG001|Overall Study|Patient wanted to go back on Med|0|||
23620781|NCT00087555|65997568|FG002|Overall Study|Patient wanted to go back on Med|0|||
23620782|NCT05523219|65997569|FG000|Overall Study|Wrong inclusion|1|||
23620783|NCT05523219|65997569|FG000|Overall Study|Lost to Follow-up|7|||
23620784|NCT00439647|65997570|FG000|Overall Study|Withdrawal by Subject|25|||
23620785|NCT00439647|65997571|FG001|Overall Study|Withdrawal by Subject|22|||
23620786|NCT00439647|65997570|FG000|Overall Study|Death|15|||
23620787|NCT00439647|65997571|FG001|Overall Study|Death|18|||
23620788|NCT00439647|65997570|FG000|Overall Study|Adverse Event|11|||
23620789|NCT00439647|65997571|FG001|Overall Study|Adverse Event|11|||
23620790|NCT00439647|65997570|FG000|Overall Study|Lost to Follow-up|4|||
23136661|NCT01901432|64251932|FG002|Overall Study|Withdrawal by Subject|1|||
23136662|NCT01901432|64251933|FG003|Overall Study|Withdrawal by Subject|0|||
23136663|NCT01901432|64251934|FG004|Overall Study|Withdrawal by Subject|5|||
23136664|NCT01901432|64251930|FG000|Overall Study|Physician Decision|0|||
23136665|NCT01901432|64251931|FG001|Overall Study|Physician Decision|0|||
23136666|NCT01901432|64251932|FG002|Overall Study|Physician Decision|0|||
23136667|NCT01901432|64251933|FG003|Overall Study|Physician Decision|0|||
23136668|NCT01901432|64251934|FG004|Overall Study|Physician Decision|2|||
23136669|NCT01901432|64251930|FG000|Overall Study|Patient decision to stop study drug|0|||
23136670|NCT01901432|64251931|FG001|Overall Study|Patient decision to stop study drug|0|||
23136671|NCT01901432|64251932|FG002|Overall Study|Patient decision to stop study drug|0|||
23136672|NCT01901432|64251933|FG003|Overall Study|Patient decision to stop study drug|0|||
23136673|NCT01901432|64251934|FG004|Overall Study|Patient decision to stop study drug|1|||
23136674|NCT00994682|64251935|FG000|Double Bilnd|Withdrawal by Subject|5|||
23136675|NCT00994682|64251936|FG001|Double Bilnd|Withdrawal by Subject|6|||
23136676|NCT00994682|64251935|FG000|Double Bilnd|Lost to Follow-up|3|||
23136677|NCT00994682|64251936|FG001|Double Bilnd|Lost to Follow-up|3|||
23136678|NCT00994682|64251935|FG000|Double Bilnd|Adverse Event|1|||
23430176|NCT03626545|65320521|FG001|Overall Study|Adverse Event|13|||
23430177|NCT03626545|65320522|FG002|Overall Study|Adverse Event|10|||
23430178|NCT03626545|65320520|FG000|Overall Study|Physician Decision|1|||
23136679|NCT00994682|64251936|FG001|Double Bilnd|Adverse Event|0|||
23136680|NCT00994682|64251935|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
23136681|NCT00994682|64251936|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
23620791|NCT00439647|65997571|FG001|Overall Study|Lost to Follow-up|12|||
23620792|NCT00439647|65997570|FG000|Overall Study|Protocol Violation|3|||
23620793|NCT00439647|65997571|FG001|Overall Study|Protocol Violation|4|||
23620794|NCT00439647|65997570|FG000|Overall Study|Lack of Efficacy|0|||
23620795|NCT00439647|65997571|FG001|Overall Study|Lack of Efficacy|4|||
23620796|NCT00381888|65997574|FG000|Overall Study|Death|1|||
23136682|NCT00994682|64251935|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
23136683|NCT00994682|64251936|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
23136684|NCT00994682|64251935|FG000|Pioglitazone Open Label|Physician Decision|6|||
23136685|NCT00994682|64251936|FG001|Pioglitazone Open Label|Physician Decision|1|||
23136686|NCT01493427|64251937|FG000|Overall Study|Adverse Event|10|||
23136687|NCT01493427|64251937|FG000|Overall Study|Personal Reasons|4|||
23551008|NCT04402866|65747533|FG002|Overall Study|Miscellaneous|1|||
23551009|NCT04402866|65747534|FG003|Overall Study|Miscellaneous|0|||
23551010|NCT04402866|65747535|FG004|Overall Study|Miscellaneous|0|||
23551011|NCT04402866|65747536|FG005|Overall Study|Miscellaneous|0|||
23551012|NCT04402866|65747531|FG000|Overall Study|Lost to Follow-up|0|||
23551013|NCT04402866|65747532|FG001|Overall Study|Lost to Follow-up|0|||
23551014|NCT04402866|65747533|FG002|Overall Study|Lost to Follow-up|0|||
23136688|NCT01493427|64251937|FG000|Overall Study|Lost to Follow-up|2|||
23551015|NCT04402866|65747534|FG003|Overall Study|Lost to Follow-up|0|||
23551016|NCT04402866|65747535|FG004|Overall Study|Lost to Follow-up|0|||
23551017|NCT04402866|65747536|FG005|Overall Study|Lost to Follow-up|1|||
23551018|NCT04402866|65747531|FG000|Overall Study|Withdrawal by Subject|0|||
23551019|NCT04402866|65747532|FG001|Overall Study|Withdrawal by Subject|0|||
23551020|NCT04402866|65747533|FG002|Overall Study|Withdrawal by Subject|0|||
23551021|NCT04402866|65747534|FG003|Overall Study|Withdrawal by Subject|0|||
23551022|NCT04402866|65747535|FG004|Overall Study|Withdrawal by Subject|0|||
23551023|NCT04402866|65747536|FG005|Overall Study|Withdrawal by Subject|2|||
23136689|NCT01493427|64251937|FG000|Overall Study|Inability to Follow Instructions|2|||
23136690|NCT01493427|64251937|FG000|Overall Study|Other|2|||
23136691|NCT02233543|64251938|FG000|Period 1|Withdrawal by Subject|1|||
23136692|NCT02233543|64251939|FG001|Period 1|Withdrawal by Subject|0|||
23136693|NCT02233543|64251938|FG000|Period 1|Participants required other treatment.|2|||
23136694|NCT02233543|64251939|FG001|Period 1|Participants required other treatment.|3|||
23136695|NCT02233543|64251938|FG000|Period 2|Adverse Event|1|||
23215094|NCT00062647|64528151|FG001|Overall Study|Adverse Event|1|||
23215095|NCT00062647|64528150|FG000|Overall Study|Withdrawal by Subject|2|||
23215096|NCT00062647|64528151|FG001|Overall Study|Withdrawal by Subject|1|||
23215097|NCT00062647|64528150|FG000|Overall Study|Protocol Violation|1|||
23215098|NCT00062647|64528151|FG001|Overall Study|Protocol Violation|0|||
23215099|NCT00062647|64528150|FG000|Overall Study|Lost to Follow-up|1|||
23215100|NCT00062647|64528151|FG001|Overall Study|Lost to Follow-up|2|||
23215101|NCT00062647|64528150|FG000|Overall Study|Failed continuation criteria|4|||
23215102|NCT00062647|64528151|FG001|Overall Study|Failed continuation criteria|2|||
23215103|NCT00062647|64528150|FG000|Overall Study|Other|4|||
23215104|NCT00062647|64528151|FG001|Overall Study|Other|4|||
23215105|NCT00062647|64528150|FG000|Overall Study|Never received study treatment|1|||
23215106|NCT00062647|64528151|FG001|Overall Study|Never received study treatment|1|||
23215107|NCT01993615|64528152|FG000|Overall Study|Death|1|||
23215108|NCT01993615|64528153|FG001|Overall Study|Death|0|||
23215109|NCT03814005|64528154|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
23215110|NCT03814005|64528155|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
23551024|NCT01292239|65747537|FG000|Overall Study|Other|1|||
23551025|NCT01292239|65747538|FG001|Overall Study|Other|1|||
23551026|NCT01292239|65747537|FG000|Overall Study|Withdrawal by Subject|3|||
23551027|NCT01292239|65747538|FG001|Overall Study|Withdrawal by Subject|6|||
23551028|NCT02372396|65747541|FG000|Overall Study|Lost to Follow-up|7|||
23136696|NCT02233543|64251939|FG001|Period 2|Adverse Event|0|||
23136697|NCT02233543|64251938|FG000|Period 2|Participant required other treatment.|0|||
23136698|NCT02233543|64251939|FG001|Period 2|Participant required other treatment.|1|||
23136699|NCT02233543|64251938|FG000|Period 2|COPD exacerbation|1|||
23136700|NCT02233543|64251939|FG001|Period 2|COPD exacerbation|0|||
23215111|NCT03814005|64528156|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
23430179|NCT03626545|65320521|FG001|Overall Study|Physician Decision|18|||
23551029|NCT02372396|65747542|FG001|Overall Study|Lost to Follow-up|9|||
23551030|NCT02522494|65747545|FG000|Overall Study|Lost to Follow-up|6|||
23551031|NCT02522494|65747546|FG001|Overall Study|Lost to Follow-up|2|||
23551032|NCT02522494|65747545|FG000|Overall Study|Withdrawal by Subject|1|||
23551033|NCT02522494|65747546|FG001|Overall Study|Withdrawal by Subject|0|||
23551034|NCT02522494|65747545|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
23551035|NCT02522494|65747546|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
23551036|NCT02522494|65747545|FG000|Overall Study|Participant did not watch the video|1|||
23551037|NCT02522494|65747546|FG001|Overall Study|Participant did not watch the video|0|||
23551038|NCT02522494|65747545|FG000|Overall Study|Death|0|||
23136701|NCT00189488|64251940|FG000|Overall Study|Ineligibility determined|1|||
23136702|NCT00189488|64251941|FG001|Overall Study|Ineligibility determined|0|||
23215112|NCT03814005|64528154|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
23215113|NCT03814005|64528155|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
23551039|NCT02522494|65747546|FG001|Overall Study|Death|1|||
23551040|NCT02638948|65747547|FG000|Overall Study|Withdrawal by Subject|4|||
23551041|NCT02638948|65747548|FG001|Overall Study|Withdrawal by Subject|5|||
23551042|NCT02638948|65747549|FG002|Overall Study|Withdrawal by Subject|3|||
23551043|NCT02638948|65747550|FG003|Overall Study|Withdrawal by Subject|1|||
23551044|NCT02638948|65747547|FG000|Overall Study|Administrative Reason by Sponsor|0|||
23551045|NCT02638948|65747548|FG001|Overall Study|Administrative Reason by Sponsor|1|||
23551046|NCT02638948|65747549|FG002|Overall Study|Administrative Reason by Sponsor|0|||
23551047|NCT02638948|65747550|FG003|Overall Study|Administrative Reason by Sponsor|4|||
23551048|NCT02638948|65747547|FG000|Overall Study|Adverse Event|0|||
23551049|NCT02638948|65747548|FG001|Overall Study|Adverse Event|0|||
23551050|NCT02638948|65747549|FG002|Overall Study|Adverse Event|1|||
23551051|NCT02638948|65747550|FG003|Overall Study|Adverse Event|1|||
23551052|NCT02638948|65747547|FG000|Overall Study|Lack of Efficacy|1|||
23551053|NCT02638948|65747548|FG001|Overall Study|Lack of Efficacy|1|||
23551054|NCT02638948|65747549|FG002|Overall Study|Lack of Efficacy|0|||
23551055|NCT02638948|65747550|FG003|Overall Study|Lack of Efficacy|0|||
23551056|NCT02638948|65747547|FG000|Overall Study|Lost to Follow-up|0|||
23551057|NCT02638948|65747548|FG001|Overall Study|Lost to Follow-up|0|||
23551058|NCT02638948|65747549|FG002|Overall Study|Lost to Follow-up|1|||
23551059|NCT02638948|65747550|FG003|Overall Study|Lost to Follow-up|1|||
23551060|NCT02638948|65747547|FG000|Overall Study|Poor/Non-Compliance|0|||
23551061|NCT02638948|65747548|FG001|Overall Study|Poor/Non-Compliance|2|||
23551062|NCT02638948|65747549|FG002|Overall Study|Poor/Non-Compliance|1|||
23551063|NCT02638948|65747550|FG003|Overall Study|Poor/Non-Compliance|0|||
23551064|NCT02638948|65747547|FG000|Overall Study|Participant no longer met study criteria|0|||
23551065|NCT02638948|65747548|FG001|Overall Study|Participant no longer met study criteria|1|||
23551066|NCT02638948|65747549|FG002|Overall Study|Participant no longer met study criteria|0|||
23551067|NCT02638948|65747550|FG003|Overall Study|Participant no longer met study criteria|0|||
23551068|NCT02638948|65747547|FG000|Overall Study|Other than specified above|4|||
23551069|NCT02638948|65747548|FG001|Overall Study|Other than specified above|1|||
23551070|NCT02638948|65747549|FG002|Overall Study|Other than specified above|1|||
23551071|NCT02638948|65747550|FG003|Overall Study|Other than specified above|1|||
23551072|NCT00695669|65747551|FG000|Overall Study|Adverse Event|0|||
23551073|NCT00695669|65747552|FG001|Overall Study|Adverse Event|0|||
23551074|NCT00695669|65747553|FG002|Overall Study|Adverse Event|2|||
23551075|NCT00695669|65747554|FG003|Overall Study|Adverse Event|0|||
23551076|NCT00695669|65747551|FG000|Overall Study|Lost to Follow-up|4|||
23551077|NCT00695669|65747552|FG001|Overall Study|Lost to Follow-up|4|||
23551078|NCT00695669|65747553|FG002|Overall Study|Lost to Follow-up|1|||
23551079|NCT00695669|65747554|FG003|Overall Study|Lost to Follow-up|4|||
23551080|NCT00651664|65747557|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
23551081|NCT00651664|65747558|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
23551082|NCT00651664|65747559|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
23551083|NCT00651664|65747560|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
23551084|NCT00651664|65747561|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
23551085|NCT00651664|65747562|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
23551086|NCT00651664|65747563|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
23551087|NCT00651664|65747564|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
23551088|NCT00651664|65747565|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
23551089|NCT00651664|65747566|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
23551090|NCT00651664|65747557|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551091|NCT00651664|65747558|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551092|NCT00651664|65747559|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551093|NCT00651664|65747560|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
23136703|NCT00189488|64251940|FG000|Overall Study|Protocol deviation|2|||
23136704|NCT00189488|64251941|FG001|Overall Study|Protocol deviation|1|||
23136705|NCT00189488|64251940|FG000|Overall Study|Adverse Event|2|||
23136706|NCT00189488|64251941|FG001|Overall Study|Adverse Event|1|||
23136707|NCT00189488|64251940|FG000|Overall Study|Withdrawal by Subject|2|||
23136708|NCT00189488|64251941|FG001|Overall Study|Withdrawal by Subject|6|||
23136709|NCT00189488|64251940|FG000|Overall Study|Disease progression|2|||
23136710|NCT00189488|64251941|FG001|Overall Study|Disease progression|4|||
23136711|NCT00189488|64251940|FG000|Overall Study|Administrative Decision|0|||
23136712|NCT00189488|64251941|FG001|Overall Study|Administrative Decision|2|||
23136713|NCT00189488|64251940|FG000|Overall Study|Death|5|||
23136714|NCT00189488|64251941|FG001|Overall Study|Death|8|||
23551094|NCT00651664|65747561|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
23551095|NCT00651664|65747562|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
23551096|NCT00651664|65747563|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551097|NCT00651664|65747564|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
23551098|NCT00651664|65747565|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
23551099|NCT00651664|65747566|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
23551100|NCT00651664|65747557|FG000|Overall Study|Progressive Disease|3|||
23551101|NCT00651664|65747558|FG001|Overall Study|Progressive Disease|3|||
23551102|NCT00651664|65747559|FG002|Overall Study|Progressive Disease|3|||
23136715|NCT00189488|64251940|FG000|Overall Study|Other|1|||
23136716|NCT00189488|64251941|FG001|Overall Study|Other|0|||
23136717|NCT01171807|64251944|FG000|Overall Study|Treatment failure|2|||
23136718|NCT01171807|64251945|FG001|Overall Study|Treatment failure|4|||
23136719|NCT01171807|64251944|FG000|Overall Study|Non compliance|1|||
23136720|NCT01171807|64251945|FG001|Overall Study|Non compliance|0|||
23136721|NCT01171807|64251944|FG000|Overall Study|Lost to Follow-up|3|||
23136722|NCT01171807|64251945|FG001|Overall Study|Lost to Follow-up|0|||
23136723|NCT03756129|64251946|FG000|Overall Study|Adverse Event|1|||
23136724|NCT03756129|64251947|FG001|Overall Study|Adverse Event|1|||
23136725|NCT03756129|64251948|FG002|Overall Study|Adverse Event|0|||
23136726|NCT03756129|64251949|FG003|Overall Study|Adverse Event|2|||
23136727|NCT03756129|64251950|FG004|Overall Study|Adverse Event|0|||
23136728|NCT03756129|64251951|FG005|Overall Study|Adverse Event|0|||
23136729|NCT03756129|64251946|FG000|Overall Study|Withdrawal by Subject|2|||
23136730|NCT03756129|64251947|FG001|Overall Study|Withdrawal by Subject|1|||
23136731|NCT03756129|64251948|FG002|Overall Study|Withdrawal by Subject|3|||
23136732|NCT03756129|64251949|FG003|Overall Study|Withdrawal by Subject|1|||
23136733|NCT03756129|64251950|FG004|Overall Study|Withdrawal by Subject|1|||
23136734|NCT03756129|64251951|FG005|Overall Study|Withdrawal by Subject|3|||
23136735|NCT03756129|64251946|FG000|Overall Study|Lost to Follow-up|0|||
23136736|NCT03756129|64251947|FG001|Overall Study|Lost to Follow-up|0|||
23136737|NCT03756129|64251948|FG002|Overall Study|Lost to Follow-up|0|||
23136738|NCT03756129|64251949|FG003|Overall Study|Lost to Follow-up|0|||
23136739|NCT03756129|64251950|FG004|Overall Study|Lost to Follow-up|0|||
23136740|NCT03756129|64251951|FG005|Overall Study|Lost to Follow-up|1|||
23136741|NCT03756129|64251946|FG000|Overall Study|Physician Decision|0|||
23136742|NCT03756129|64251947|FG001|Overall Study|Physician Decision|0|||
23136743|NCT03756129|64251948|FG002|Overall Study|Physician Decision|0|||
23136744|NCT03756129|64251949|FG003|Overall Study|Physician Decision|0|||
23136745|NCT03756129|64251950|FG004|Overall Study|Physician Decision|0|||
23136746|NCT03756129|64251951|FG005|Overall Study|Physician Decision|1|||
23136747|NCT01293487|64251952|FG000|Overall Study|Lost to Follow-up|0|||
23136748|NCT01293487|64251953|FG001|Overall Study|Lost to Follow-up|0|||
23136749|NCT01293487|64251954|FG002|Overall Study|Lost to Follow-up|0|||
23136750|NCT01293487|64251955|FG003|Overall Study|Lost to Follow-up|1|||
23430180|NCT03626545|65320522|FG002|Overall Study|Physician Decision|14|||
23551103|NCT00651664|65747560|FG003|Overall Study|Progressive Disease|12|||
23551104|NCT00651664|65747561|FG004|Overall Study|Progressive Disease|4|||
23551105|NCT00651664|65747562|FG005|Overall Study|Progressive Disease|1|||
23551106|NCT00651664|65747563|FG006|Overall Study|Progressive Disease|3|||
23551107|NCT00651664|65747564|FG007|Overall Study|Progressive Disease|6|||
23551108|NCT00651664|65747565|FG008|Overall Study|Progressive Disease|5|||
23551109|NCT00651664|65747566|FG009|Overall Study|Progressive Disease|5|||
23551110|NCT00651664|65747557|FG000|Overall Study|Patient Declined Further Treatment|0|||
23551111|NCT00651664|65747558|FG001|Overall Study|Patient Declined Further Treatment|0|||
23551112|NCT00651664|65747559|FG002|Overall Study|Patient Declined Further Treatment|0|||
23551113|NCT00651664|65747560|FG003|Overall Study|Patient Declined Further Treatment|1|||
23551114|NCT00651664|65747561|FG004|Overall Study|Patient Declined Further Treatment|1|||
23551115|NCT00651664|65747562|FG005|Overall Study|Patient Declined Further Treatment|1|||
23551116|NCT00651664|65747563|FG006|Overall Study|Patient Declined Further Treatment|0|||
23551117|NCT00651664|65747564|FG007|Overall Study|Patient Declined Further Treatment|0|||
23551118|NCT00651664|65747565|FG008|Overall Study|Patient Declined Further Treatment|0|||
23551119|NCT00651664|65747566|FG009|Overall Study|Patient Declined Further Treatment|1|||
23551120|NCT00651664|65747557|FG000|Overall Study|Symptomatic Deterioration|0|||
23551121|NCT00651664|65747558|FG001|Overall Study|Symptomatic Deterioration|0|||
23551122|NCT00651664|65747559|FG002|Overall Study|Symptomatic Deterioration|0|||
23551123|NCT00651664|65747560|FG003|Overall Study|Symptomatic Deterioration|1|||
23620797|NCT00381888|65997574|FG000|Overall Study|Withdrawal by Subject|1|||
23620798|NCT00381888|65997574|FG000|Overall Study|Physician Decision|1|||
23620799|NCT00381888|65997574|FG000|Overall Study|Protocol Violation|9|||
23620800|NCT00381888|65997574|FG000|Overall Study|Had laparoscopic surgery|2|||
23620801|NCT00381888|65997574|FG000|Overall Study|Surgery was cancelled|2|||
23620802|NCT00381888|65997574|FG000|Overall Study|Adverse Event|1|||
23620803|NCT01037413|65997575|FG000|Part A: Skin Testing|Adverse Event|1|||
23620804|NCT01037413|65997576|FG001|Part A: Skin Testing|Adverse Event|0|||
23620805|NCT01037413|65997575|FG000|Part A: Skin Testing|Protocol Violation|1|||
23620806|NCT01037413|65997576|FG001|Part A: Skin Testing|Protocol Violation|0|||
23620807|NCT01037413|65997575|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
23136751|NCT01293487|64251956|FG004|Overall Study|Lost to Follow-up|0|||
23136752|NCT01293487|64251957|FG005|Overall Study|Lost to Follow-up|0|||
23136753|NCT01293487|64251958|FG006|Overall Study|Lost to Follow-up|0|||
23136754|NCT01293487|64251959|FG007|Overall Study|Lost to Follow-up|0|||
23551124|NCT00651664|65747561|FG004|Overall Study|Symptomatic Deterioration|0|||
23551125|NCT00651664|65747562|FG005|Overall Study|Symptomatic Deterioration|0|||
23551126|NCT00651664|65747563|FG006|Overall Study|Symptomatic Deterioration|1|||
23620808|NCT01037413|65997576|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
23620809|NCT01037413|65997575|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
23136755|NCT01293487|64251952|FG000|Overall Study|Withdrawal by Subject|0|||
23136756|NCT01293487|64251953|FG001|Overall Study|Withdrawal by Subject|0|||
23136757|NCT01293487|64251954|FG002|Overall Study|Withdrawal by Subject|0|||
23551127|NCT00651664|65747564|FG007|Overall Study|Symptomatic Deterioration|0|||
23551128|NCT00651664|65747565|FG008|Overall Study|Symptomatic Deterioration|1|||
23551129|NCT00651664|65747566|FG009|Overall Study|Symptomatic Deterioration|0|||
23551130|NCT00651664|65747557|FG000|Overall Study|Reason not Specified|0|||
23551131|NCT00651664|65747558|FG001|Overall Study|Reason not Specified|0|||
23136758|NCT01293487|64251955|FG003|Overall Study|Withdrawal by Subject|0|||
23136759|NCT01293487|64251956|FG004|Overall Study|Withdrawal by Subject|0|||
23136760|NCT01293487|64251957|FG005|Overall Study|Withdrawal by Subject|0|||
23136761|NCT01293487|64251958|FG006|Overall Study|Withdrawal by Subject|0|||
23136762|NCT01293487|64251959|FG007|Overall Study|Withdrawal by Subject|2|||
23136763|NCT01346475|64251960|FG000|First Intervention|Lost to Follow-up|4|||
23136764|NCT01346475|64251961|FG001|First Intervention|Lost to Follow-up|3|||
23136765|NCT00577577|64251962|FG000|Overall Study|Adverse Event|3|||
23136766|NCT00577577|64251963|FG001|Overall Study|Adverse Event|2|||
23136767|NCT00577577|64251962|FG000|Overall Study|Lost to Follow-up|1|||
23136768|NCT00577577|64251963|FG001|Overall Study|Lost to Follow-up|0|||
23136769|NCT00577577|64251962|FG000|Overall Study|Protocol Violation|0|||
23136770|NCT00577577|64251963|FG001|Overall Study|Protocol Violation|3|||
23136771|NCT00577577|64251962|FG000|Overall Study|Transportation|1|||
23136772|NCT00577577|64251963|FG001|Overall Study|Transportation|0|||
23136773|NCT02217501|64251964|FG000|Overall Study|Death|3|||
23551132|NCT00651664|65747559|FG002|Overall Study|Reason not Specified|0|||
23551133|NCT00651664|65747560|FG003|Overall Study|Reason not Specified|0|||
23551134|NCT00651664|65747561|FG004|Overall Study|Reason not Specified|0|||
23551135|NCT00651664|65747562|FG005|Overall Study|Reason not Specified|0|||
23551136|NCT00651664|65747563|FG006|Overall Study|Reason not Specified|1|||
23551137|NCT00651664|65747564|FG007|Overall Study|Reason not Specified|0|||
23551138|NCT00651664|65747565|FG008|Overall Study|Reason not Specified|0|||
23551139|NCT00651664|65747566|FG009|Overall Study|Reason not Specified|0|||
23551140|NCT02778100|65747567|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
23551141|NCT02778100|65747568|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
23551142|NCT04269889|65747573|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
23551143|NCT04269889|65747573|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
23551144|NCT02278328|65747574|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
23551145|NCT02278328|65747575|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
23551146|NCT02278328|65747576|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
23551147|NCT02278328|65747574|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
23551148|NCT02278328|65747575|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
23551149|NCT02278328|65747576|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
23551150|NCT02278328|65747574|FG000|Neuropsych Screening|incomplete consent|0|||
23551151|NCT02278328|65747575|FG001|Neuropsych Screening|incomplete consent|0|||
23551152|NCT02278328|65747576|FG002|Neuropsych Screening|incomplete consent|2|||
23551153|NCT02491671|65747577|FG000|Overall Study|Adverse Event|6|||
23551154|NCT02491671|65747578|FG001|Overall Study|Adverse Event|8|||
23551155|NCT02491671|65747577|FG000|Overall Study|Death|0|||
23551156|NCT02491671|65747578|FG001|Overall Study|Death|2|||
23551157|NCT02491671|65747577|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
23551158|NCT02491671|65747578|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
23551159|NCT01262651|65747582|FG000|Overall Study|Adverse Event|40|||
23551160|NCT01262651|65747583|FG001|Overall Study|Adverse Event|35|||
23136774|NCT02217501|64251965|FG001|Overall Study|Death|4|||
23136775|NCT02663518|64251966|FG000|Part 1: Phase 1a Escalation|Death|0|||
23136776|NCT02663518|64251967|FG001|Part 1: Phase 1a Escalation|Death|0|||
23136777|NCT02663518|64251968|FG002|Part 1: Phase 1a Escalation|Death|1|||
23215114|NCT03814005|64528156|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
23551161|NCT01262651|65747582|FG000|Overall Study|Withdrawal by Subject|15|||
23551162|NCT01262651|65747583|FG001|Overall Study|Withdrawal by Subject|11|||
23551163|NCT01262651|65747582|FG000|Overall Study|Withdrawal by Investigator|2|||
23551164|NCT01262651|65747583|FG001|Overall Study|Withdrawal by Investigator|2|||
23551165|NCT01262651|65747582|FG000|Overall Study|Met Withdrawal Criteria|1|||
23551166|NCT01262651|65747583|FG001|Overall Study|Met Withdrawal Criteria|0|||
23551167|NCT01474681|65747584|FG000|Overall Study|Death|0|||
23551168|NCT01474681|65747585|FG001|Overall Study|Death|3|||
23551169|NCT01474681|65747586|FG002|Overall Study|Death|2|||
23551170|NCT01474681|65747587|FG003|Overall Study|Death|6|||
23136778|NCT02663518|64251969|FG003|Part 1: Phase 1a Escalation|Death|0|||
23136779|NCT02663518|64251970|FG004|Part 1: Phase 1a Escalation|Death|0|||
23136780|NCT02663518|64251971|FG005|Part 1: Phase 1a Escalation|Death|0|||
23551171|NCT03031938|65747588|FG000|Overall Study|Death|1|||
23136781|NCT02663518|64251972|FG006|Part 1: Phase 1a Escalation|Death|0|||
23136782|NCT02663518|64251973|FG007|Part 1: Phase 1a Escalation|Death|0|||
23136783|NCT02663518|64251974|FG008|Part 1: Phase 1a Escalation|Death|0|||
23136784|NCT02663518|64251975|FG009|Part 1: Phase 1a Escalation|Death|0|||
23551172|NCT03031938|65747589|FG001|Overall Study|Death|0|||
23551173|NCT02515279|65747590|FG000|Overall Study|Adverse Event|7|||
23551174|NCT02515279|65747590|FG000|Overall Study|Lack of Efficacy|31|||
23551175|NCT02515279|65747590|FG000|Overall Study|Lost to Follow-up|9|||
23136785|NCT02663518|64251976|FG010|Part 1: Phase 1a Escalation|Death|0|||
23136786|NCT02663518|64251977|FG011|Part 1: Phase 1a Escalation|Death|0|||
23136787|NCT02663518|64251978|FG012|Part 1: Phase 1a Escalation|Death|0|||
23136788|NCT02663518|64251979|FG013|Part 1: Phase 1a Escalation|Death|0|||
23136789|NCT02663518|64251966|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136790|NCT02663518|64251967|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136791|NCT02663518|64251968|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
23136792|NCT02663518|64251969|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23551176|NCT02515279|65747590|FG000|Overall Study|Withdrawal by Subject|18|||
23551177|NCT02515279|65747590|FG000|Overall Study|End-of-treatment visit not attended|17|||
23551178|NCT02515279|65747590|FG000|Overall Study|Other|22|||
23551179|NCT00126438|65747591|FG000|Overall Study|Withdrawal due to adverse event|1|||
23551180|NCT00126438|65747592|FG001|Overall Study|Withdrawal due to adverse event|0|||
23551181|NCT00126438|65747591|FG000|Overall Study|Lost to Follow-up|22|||
23551182|NCT00126438|65747592|FG001|Overall Study|Lost to Follow-up|0|||
23551183|NCT00126438|65747591|FG000|Overall Study|Protocol Violation|8|||
23551184|NCT00126438|65747592|FG001|Overall Study|Protocol Violation|8|||
23551185|NCT00126438|65747591|FG000|Overall Study|Withdrawal by Subject|3|||
23551186|NCT00126438|65747592|FG001|Overall Study|Withdrawal by Subject|2|||
23136793|NCT02663518|64251970|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136794|NCT02663518|64251971|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136795|NCT02663518|64251972|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136796|NCT02663518|64251973|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136797|NCT02663518|64251974|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136798|NCT02663518|64251975|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136799|NCT02663518|64251976|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23551187|NCT04050865|65747593|FG000|Overall Study|Adverse Event|1|||
23551188|NCT04050865|65747594|FG001|Overall Study|Adverse Event|0|||
23551189|NCT04050865|65747593|FG000|Overall Study|no insert|1|||
23551190|NCT04050865|65747594|FG001|Overall Study|no insert|0|||
23551191|NCT04050865|65747593|FG000|Overall Study|Only 1 insert|2|||
23551192|NCT04050865|65747594|FG001|Overall Study|Only 1 insert|3|||
23551193|NCT04050865|65747593|FG000|Overall Study|Physician Decision|0|||
23551194|NCT04050865|65747594|FG001|Overall Study|Physician Decision|1|||
23551195|NCT04050865|65747593|FG000|Overall Study|Withdrawal by Subject|0|||
23551196|NCT04050865|65747594|FG001|Overall Study|Withdrawal by Subject|1|||
23551197|NCT01332227|65747595|FG000|Overall Study|Adverse Event|4|||
23551198|NCT01332227|65747596|FG001|Overall Study|Adverse Event|1|||
23551199|NCT01332227|65747595|FG000|Overall Study|Withdrawal by Subject|5|||
23551200|NCT01332227|65747596|FG001|Overall Study|Withdrawal by Subject|1|||
23551201|NCT01332227|65747595|FG000|Overall Study|Lost to Follow-up|2|||
23551202|NCT01332227|65747596|FG001|Overall Study|Lost to Follow-up|0|||
23551203|NCT01332227|65747595|FG000|Overall Study|Lack of Efficacy|3|||
23551204|NCT01332227|65747596|FG001|Overall Study|Lack of Efficacy|1|||
23551205|NCT01332227|65747595|FG000|Overall Study|Poor compliance/noncompliance|1|||
23551206|NCT01332227|65747596|FG001|Overall Study|Poor compliance/noncompliance|1|||
23551207|NCT01332227|65747595|FG000|Overall Study|Patient moved from area|1|||
23551208|NCT01332227|65747596|FG001|Overall Study|Patient moved from area|0|||
23551209|NCT01332227|65747595|FG000|Overall Study|Patient began prohibited medication|0|||
23551210|NCT01332227|65747596|FG001|Overall Study|Patient began prohibited medication|1|||
23551211|NCT05374421|65747597|FG000|Overall Study|Withdrawal by Subject|3|||
23551212|NCT05374421|65747598|FG001|Overall Study|Withdrawal by Subject|4|||
23551213|NCT00675766|65747599|FG000|Overall Study|Lost to Follow-up|6|||
23551214|NCT00675766|65747600|FG001|Overall Study|Lost to Follow-up|5|||
23551215|NCT00675766|65747601|FG002|Overall Study|Lost to Follow-up|21|||
23551216|NCT00675766|65747602|FG003|Overall Study|Lost to Follow-up|26|||
23551217|NCT01477853|65747603|FG000|Phase A|Adverse Event|1|||
23551218|NCT01477853|65747604|FG001|Phase A|Adverse Event|2|||
23551219|NCT01477853|65747605|FG002|Phase A|Adverse Event|2|||
23551220|NCT01477853|65747603|FG000|Phase A|Lost to Follow-up|4|||
23551221|NCT01477853|65747604|FG001|Phase A|Lost to Follow-up|3|||
23551222|NCT01477853|65747605|FG002|Phase A|Lost to Follow-up|2|||
23551223|NCT01477853|65747603|FG000|Phase A|Physician Decision|1|||
23551224|NCT01477853|65747604|FG001|Phase A|Physician Decision|0|||
23551225|NCT01477853|65747605|FG002|Phase A|Physician Decision|1|||
23551226|NCT01477853|65747603|FG000|Phase A|Study terminated by sponsor|37|||
23136800|NCT02663518|64251977|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136801|NCT02663518|64251978|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23551227|NCT01477853|65747604|FG001|Phase A|Study terminated by sponsor|40|||
23551228|NCT01477853|65747605|FG002|Phase A|Study terminated by sponsor|39|||
23136802|NCT02663518|64251979|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
23136803|NCT02663518|64251966|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
23551229|NCT01477853|65747603|FG000|Phase B|Lost to Follow-up|0|||
23551230|NCT01477853|65747604|FG001|Phase B|Lost to Follow-up|1|||
23551231|NCT01477853|65747605|FG002|Phase B|Lost to Follow-up|0|||
23551232|NCT01477853|65747603|FG000|Phase B|Study terminated by sponsor|12|||
23551233|NCT01477853|65747604|FG001|Phase B|Study terminated by sponsor|10|||
23551234|NCT01477853|65747605|FG002|Phase B|Study terminated by sponsor|11|||
23136804|NCT02663518|64251967|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
23136805|NCT02663518|64251968|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
23136806|NCT02663518|64251969|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
23136807|NCT02663518|64251970|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23136808|NCT02663518|64251971|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23136809|NCT02663518|64251972|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23136810|NCT02663518|64251973|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23136811|NCT02663518|64251974|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23136812|NCT02663518|64251975|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23551235|NCT00322348|65747606|FG000|Overall Study|Adverse Event|0|||
23551236|NCT00322348|65747607|FG001|Overall Study|Adverse Event|1|||
23551237|NCT00322348|65747606|FG000|Overall Study|Withdrawal by Subject|1|||
23551238|NCT00322348|65747607|FG001|Overall Study|Withdrawal by Subject|4|||
23551239|NCT00322348|65747606|FG000|Overall Study|Lost to Follow-up|1|||
23551240|NCT00322348|65747607|FG001|Overall Study|Lost to Follow-up|0|||
23551241|NCT00322348|65747606|FG000|Overall Study|Death|0|||
23551242|NCT00322348|65747607|FG001|Overall Study|Death|2|||
23551243|NCT00322348|65747606|FG000|Overall Study|Disease Progression|30|||
23551244|NCT00322348|65747607|FG001|Overall Study|Disease Progression|25|||
23551245|NCT00322348|65747606|FG000|Overall Study|Reasons not specified|5|||
23551246|NCT00322348|65747607|FG001|Overall Study|Reasons not specified|1|||
23551247|NCT00902304|65747608|FG000|Overall Study|Adverse Event|4|||
23551248|NCT00902304|65747609|FG001|Overall Study|Adverse Event|10|||
23551249|NCT00902304|65747610|FG002|Overall Study|Adverse Event|25|||
23551250|NCT00902304|65747608|FG000|Overall Study|Investigator discretion|3|||
23551251|NCT00902304|65747609|FG001|Overall Study|Investigator discretion|5|||
23551252|NCT00902304|65747610|FG002|Overall Study|Investigator discretion|13|||
23551253|NCT00902304|65747608|FG000|Overall Study|Lost to Follow-up|7|||
23551254|NCT00902304|65747609|FG001|Overall Study|Lost to Follow-up|7|||
23551255|NCT00902304|65747610|FG002|Overall Study|Lost to Follow-up|7|||
23551256|NCT00902304|65747608|FG000|Overall Study|Protocol Violation|9|||
23551257|NCT00902304|65747609|FG001|Overall Study|Protocol Violation|18|||
23551258|NCT00902304|65747610|FG002|Overall Study|Protocol Violation|20|||
23551259|NCT00902304|65747608|FG000|Overall Study|Withdrawal by Subject|32|||
23551260|NCT00902304|65747609|FG001|Overall Study|Withdrawal by Subject|22|||
23551261|NCT00902304|65747610|FG002|Overall Study|Withdrawal by Subject|43|||
23551262|NCT00902304|65747608|FG000|Overall Study|includes pregnancy|3|||
23551263|NCT00902304|65747609|FG001|Overall Study|includes pregnancy|9|||
23551264|NCT00902304|65747610|FG002|Overall Study|includes pregnancy|2|||
23551265|NCT02962908|65747611|FG000|Overall Study|Lost to Follow-up|0|||
23551266|NCT02962908|65747612|FG001|Overall Study|Lost to Follow-up|3|||
23551267|NCT02962908|65747613|FG002|Overall Study|Lost to Follow-up|0|||
23551268|NCT02962908|65747614|FG003|Overall Study|Lost to Follow-up|1|||
23551269|NCT02962908|65747611|FG000|Overall Study|Withdrawal by Subject|0|||
23551270|NCT02962908|65747612|FG001|Overall Study|Withdrawal by Subject|3|||
23551271|NCT02962908|65747613|FG002|Overall Study|Withdrawal by Subject|0|||
23551272|NCT02962908|65747614|FG003|Overall Study|Withdrawal by Subject|2|||
23551273|NCT02962908|65747611|FG000|Overall Study|Protocol Violation|0|||
23551274|NCT02962908|65747612|FG001|Overall Study|Protocol Violation|1|||
23551275|NCT02962908|65747613|FG002|Overall Study|Protocol Violation|0|||
23551276|NCT02962908|65747614|FG003|Overall Study|Protocol Violation|0|||
23551277|NCT02962908|65747611|FG000|Overall Study|Physician Decision|0|||
23551278|NCT02962908|65747612|FG001|Overall Study|Physician Decision|1|||
23136813|NCT02663518|64251976|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23136814|NCT02663518|64251977|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23136815|NCT02663518|64251978|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23136816|NCT02663518|64251979|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
23136817|NCT02663518|64251966|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
23136818|NCT02663518|64251967|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23136819|NCT02663518|64251968|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
23136820|NCT02663518|64251969|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
23136821|NCT02663518|64251970|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23136822|NCT02663518|64251971|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23136823|NCT02663518|64251972|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23136824|NCT02663518|64251973|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23551279|NCT02962908|65747613|FG002|Overall Study|Physician Decision|0|||
23136825|NCT02663518|64251974|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23317623|NCT03132155|64904116|FG000|Overall Study|Lack of Efficacy|6|||
23551280|NCT02962908|65747614|FG003|Overall Study|Physician Decision|0|||
23551281|NCT00917579|65747615|FG000|Washout >= 2 Weeks|Adverse Event|1|||
23551282|NCT00917579|65747616|FG001|Washout >= 2 Weeks|Adverse Event|0|||
23551283|NCT00917579|65747615|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
23551284|NCT00917579|65747616|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
23551285|NCT03593655|65747617|FG000|First Product Use Period|Withdrawal by Subject|1|||
23136826|NCT02663518|64251975|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23136827|NCT02663518|64251976|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23136828|NCT02663518|64251977|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23136829|NCT02663518|64251978|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23136830|NCT02663518|64251979|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
23136831|NCT02663518|64251966|FG000|Part 1: Phase 1a Escalation|Other|0|||
23136832|NCT02663518|64251967|FG001|Part 1: Phase 1a Escalation|Other|0|||
23136833|NCT02663518|64251968|FG002|Part 1: Phase 1a Escalation|Other|2|||
23136834|NCT02663518|64251969|FG003|Part 1: Phase 1a Escalation|Other|0|||
23136835|NCT02663518|64251970|FG004|Part 1: Phase 1a Escalation|Other|0|||
23136836|NCT02663518|64251971|FG005|Part 1: Phase 1a Escalation|Other|0|||
23136837|NCT02663518|64251972|FG006|Part 1: Phase 1a Escalation|Other|0|||
23136838|NCT02663518|64251973|FG007|Part 1: Phase 1a Escalation|Other|0|||
23136839|NCT02663518|64251974|FG008|Part 1: Phase 1a Escalation|Other|0|||
23136840|NCT02663518|64251975|FG009|Part 1: Phase 1a Escalation|Other|0|||
23136841|NCT02663518|64251976|FG010|Part 1: Phase 1a Escalation|Other|0|||
23136842|NCT02663518|64251977|FG011|Part 1: Phase 1a Escalation|Other|0|||
23136843|NCT02663518|64251978|FG012|Part 1: Phase 1a Escalation|Other|0|||
23136844|NCT02663518|64251979|FG013|Part 1: Phase 1a Escalation|Other|0|||
23136845|NCT02663518|64251966|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136846|NCT02663518|64251967|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136847|NCT02663518|64251968|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136848|NCT02663518|64251969|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136849|NCT02663518|64251970|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
23136850|NCT02663518|64251971|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136851|NCT02663518|64251972|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
23136852|NCT02663518|64251973|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
23136853|NCT02663518|64251974|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136854|NCT02663518|64251975|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136855|NCT02663518|64251976|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136856|NCT02663518|64251977|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136857|NCT02663518|64251978|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136858|NCT02663518|64251979|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
23136859|NCT02663518|64251966|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136860|NCT02663518|64251967|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136861|NCT02663518|64251968|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136862|NCT02663518|64251969|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136863|NCT02663518|64251970|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
23136864|NCT02663518|64251971|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136865|NCT02663518|64251972|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
23136866|NCT02663518|64251973|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
23136867|NCT02663518|64251974|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136868|NCT02663518|64251975|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136869|NCT02663518|64251976|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136870|NCT02663518|64251977|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136871|NCT02663518|64251978|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23430181|NCT03626545|65320520|FG000|Overall Study|Subject Decision|0|||
23430182|NCT03626545|65320521|FG001|Overall Study|Subject Decision|5|||
23430183|NCT03626545|65320522|FG002|Overall Study|Subject Decision|5|||
23430184|NCT03626545|65320520|FG000|Overall Study|Death|1|||
23430185|NCT03626545|65320521|FG001|Overall Study|Death|1|||
23430186|NCT03626545|65320522|FG002|Overall Study|Death|1|||
23430187|NCT03626545|65320520|FG000|Overall Study|Protocol Deviation|0|||
23430188|NCT03626545|65320521|FG001|Overall Study|Protocol Deviation|1|||
23430189|NCT03626545|65320522|FG002|Overall Study|Protocol Deviation|1|||
23430190|NCT03626545|65320520|FG000|Overall Study|Guardian Decision|0|||
23430191|NCT03626545|65320521|FG001|Overall Study|Guardian Decision|0|||
23430192|NCT03626545|65320522|FG002|Overall Study|Guardian Decision|1|||
23430193|NCT01818492|65320523|FG000|Overall Study|Adverse Event|2|||
23430194|NCT01818492|65320523|FG000|Overall Study|Death|3|||
23430195|NCT01818492|65320523|FG000|Overall Study|Withdrawal by Subject|1|||
23430196|NCT01818492|65320523|FG000|Overall Study|Additional therapy when not allowed PP|4|||
23430197|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
23430198|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
23136872|NCT02663518|64251979|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
23136873|NCT02663518|64251966|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136874|NCT02663518|64251967|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136875|NCT02663518|64251968|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136876|NCT02663518|64251969|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136877|NCT02663518|64251970|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
23317624|NCT03132155|64904116|FG000|Overall Study|Lost to Follow-up|1|||
23430199|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
23430200|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
23430201|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
23430202|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
23430203|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430204|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430205|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430206|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430207|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
23430208|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
23430209|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
23430210|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
23430211|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430212|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
23430213|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
23430214|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430215|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430216|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430217|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430218|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
23430219|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430220|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
23430221|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
23430222|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
23430223|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
23430224|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
23430225|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430226|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430227|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430228|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430229|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
23430230|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
23136878|NCT02663518|64251971|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136879|NCT02663518|64251972|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136880|NCT02663518|64251973|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136881|NCT02663518|64251974|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136882|NCT02663518|64251975|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136883|NCT02663518|64251976|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136884|NCT02663518|64251977|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136885|NCT02663518|64251978|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136886|NCT02663518|64251979|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
23136887|NCT02663518|64251966|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23136888|NCT02663518|64251967|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23136889|NCT02663518|64251968|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23136890|NCT02663518|64251969|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23136891|NCT02663518|64251970|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
23136892|NCT02663518|64251971|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
23136893|NCT02663518|64251972|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
23136894|NCT02663518|64251973|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
23136895|NCT02663518|64251974|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23136896|NCT02663518|64251975|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23136897|NCT02663518|64251976|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23430231|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
23551286|NCT03593655|65747618|FG001|First Product Use Period|Withdrawal by Subject|1|||
23551287|NCT03593655|65747617|FG000|First Product Use Period|Lost to Follow-up|1|||
23551288|NCT03593655|65747618|FG001|First Product Use Period|Lost to Follow-up|3|||
23551289|NCT03593655|65747617|FG000|Second Product Use Period|Withdrawal by Subject|1|||
23551290|NCT03593655|65747618|FG001|Second Product Use Period|Withdrawal by Subject|1|||
23551291|NCT03593655|65747617|FG000|Second Product Use Period|Lost to Follow-up|1|||
23136898|NCT02663518|64251977|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23136899|NCT02663518|64251978|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23136900|NCT02663518|64251979|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
23136901|NCT02663518|64251966|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
23551292|NCT03593655|65747618|FG001|Second Product Use Period|Lost to Follow-up|0|||
23551293|NCT03593655|65747617|FG000|Third Product Use Period|Lost to Follow-up|1|||
23551294|NCT03593655|65747618|FG001|Third Product Use Period|Lost to Follow-up|2|||
23551295|NCT03593655|65747617|FG000|Third Product Use Period|Physician Decision|0|||
23136902|NCT02663518|64251967|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
23551296|NCT03593655|65747618|FG001|Third Product Use Period|Physician Decision|1|||
23551297|NCT03593655|65747617|FG000|Third Product Use Period|Withdrawal by Subject|0|||
23551298|NCT03593655|65747618|FG001|Third Product Use Period|Withdrawal by Subject|1|||
23551299|NCT03583554|65747623|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
23551300|NCT03583554|65747624|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
23551301|NCT03583554|65747625|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
23551302|NCT02527798|65747626|FG000|Overall Study|Physician Decision|1|||
23620810|NCT01037413|65997576|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
23620811|NCT01713998|65997580|FG000|Overall Study|Lost to Follow-up|2|||
23620812|NCT01713998|65997581|FG001|Overall Study|Lost to Follow-up|0|||
23620813|NCT01713998|65997582|FG002|Overall Study|Lost to Follow-up|2|||
23136903|NCT02663518|64251968|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
23620814|NCT01713998|65997580|FG000|Overall Study|Withdrawal by Subject|1|||
23620815|NCT01713998|65997581|FG001|Overall Study|Withdrawal by Subject|0|||
23620816|NCT01713998|65997582|FG002|Overall Study|Withdrawal by Subject|0|||
23620817|NCT02316847|65997594|FG000|Overall Study|Adverse Event|0|||
23620818|NCT02316847|65997595|FG001|Overall Study|Adverse Event|3|||
23620819|NCT02316847|65997594|FG000|Overall Study|Lost to Follow-up|0|||
23620820|NCT02316847|65997595|FG001|Overall Study|Lost to Follow-up|2|||
23620821|NCT02316847|65997594|FG000|Overall Study|Physician Decision|0|||
23620822|NCT02316847|65997595|FG001|Overall Study|Physician Decision|1|||
23620823|NCT02316847|65997594|FG000|Overall Study|Pregnancy|0|||
23620824|NCT02316847|65997595|FG001|Overall Study|Pregnancy|1|||
23620825|NCT02316847|65997594|FG000|Overall Study|Withdrawal by Subject|2|||
23620826|NCT02316847|65997595|FG001|Overall Study|Withdrawal by Subject|9|||
23620827|NCT02316847|65997594|FG000|Overall Study|Noncompliance with study drug|0|||
23620828|NCT02316847|65997595|FG001|Overall Study|Noncompliance with study drug|3|||
23620829|NCT02316847|65997594|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
23620830|NCT02316847|65997595|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
23620831|NCT00634049|65997598|FG000|Overall Study|Never received study drug|1|||
23620832|NCT00634049|65997598|FG000|Overall Study|Died prior to receiving study drug|1|||
23620833|NCT00634049|65997598|FG000|Overall Study|Screening failure|1|||
23620834|NCT04772313|65997599|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
23620835|NCT04772313|65997599|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
23620836|NCT01967719|65997602|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
23620837|NCT01967719|65997603|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
23620838|NCT01967719|65997604|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23620839|NCT01967719|65997605|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
23620840|NCT01967719|65997602|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
23620841|NCT01967719|65997603|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
23620842|NCT01967719|65997604|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
23620843|NCT01967719|65997605|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
23620844|NCT03918447|65997606|FG000|Overall Study|Death|1|||
23620845|NCT03918447|65997607|FG001|Overall Study|Death|0|||
23620846|NCT03918447|65997606|FG000|Overall Study|Lost to Follow-up|13|||
23620847|NCT03918447|65997607|FG001|Overall Study|Lost to Follow-up|6|||
23620848|NCT03918447|65997606|FG000|Overall Study|Withdrawal by Subject|19|||
23620849|NCT03918447|65997607|FG001|Overall Study|Withdrawal by Subject|17|||
23620850|NCT03918447|65997606|FG000|Overall Study|Study Terminated by Sponsor|195|||
23620851|NCT03918447|65997607|FG001|Overall Study|Study Terminated by Sponsor|197|||
23620852|NCT03918447|65997606|FG000|Overall Study|Reason not Specified|0|||
23620853|NCT03918447|65997607|FG001|Overall Study|Reason not Specified|1|||
23620854|NCT00297778|65997610|FG000|Overall Study|Adverse Event|16|||
23620855|NCT00297778|65997611|FG001|Overall Study|Adverse Event|10|||
23620856|NCT00297778|65997610|FG000|Overall Study|Withdrawal by Subject|1|||
23620857|NCT00297778|65997611|FG001|Overall Study|Withdrawal by Subject|5|||
23620858|NCT00297778|65997610|FG000|Overall Study|Lack of Efficacy|2|||
23620859|NCT00297778|65997611|FG001|Overall Study|Lack of Efficacy|1|||
23620860|NCT00297778|65997610|FG000|Overall Study|Non-compliant with trial protocol|0|||
23620861|NCT00297778|65997611|FG001|Overall Study|Non-compliant with trial protocol|3|||
23136904|NCT02663518|64251969|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
23136905|NCT02663518|64251970|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
23136906|NCT02663518|64251971|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
23136907|NCT02663518|64251972|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
23430232|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
23430233|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430234|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
23551303|NCT02527798|65747627|FG001|Overall Study|Physician Decision|0|||
23551304|NCT02527798|65747628|FG002|Overall Study|Physician Decision|1|||
23551305|NCT02527798|65747629|FG003|Overall Study|Physician Decision|1|||
23551306|NCT02527798|65747630|FG004|Overall Study|Physician Decision|0|||
23620862|NCT00297778|65997610|FG000|Overall Study|Other|0|||
23620863|NCT00297778|65997611|FG001|Overall Study|Other|1|||
23620864|NCT00988117|65997617|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
23620865|NCT00988117|65997617|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
23551307|NCT02527798|65747631|FG005|Overall Study|Physician Decision|0|||
23551308|NCT02527798|65747626|FG000|Overall Study|Death|0|||
23551309|NCT02527798|65747627|FG001|Overall Study|Death|0|||
23551310|NCT02527798|65747628|FG002|Overall Study|Death|1|||
23551311|NCT02527798|65747629|FG003|Overall Study|Death|0|||
23551312|NCT02527798|65747630|FG004|Overall Study|Death|0|||
23551313|NCT02527798|65747631|FG005|Overall Study|Death|0|||
23551314|NCT02527798|65747626|FG000|Overall Study|Withdrawal by Subject|0|||
23551315|NCT02527798|65747627|FG001|Overall Study|Withdrawal by Subject|1|||
23551316|NCT02527798|65747628|FG002|Overall Study|Withdrawal by Subject|2|||
23136908|NCT02663518|64251973|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
23136909|NCT02663518|64251974|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
23136910|NCT02663518|64251975|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
23136911|NCT02663518|64251976|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
23136912|NCT02663518|64251977|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
23136913|NCT02663518|64251978|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
23136914|NCT02663518|64251979|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
23136915|NCT02663518|64251966|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136916|NCT02663518|64251967|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136917|NCT02663518|64251968|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136918|NCT02663518|64251969|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136919|NCT02663518|64251970|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136920|NCT02663518|64251971|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136921|NCT02663518|64251972|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
23136922|NCT02663518|64251973|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136923|NCT02663518|64251974|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136924|NCT02663518|64251975|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136925|NCT02663518|64251976|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23551317|NCT02527798|65747629|FG003|Overall Study|Withdrawal by Subject|0|||
23551318|NCT02527798|65747630|FG004|Overall Study|Withdrawal by Subject|0|||
23551319|NCT02527798|65747631|FG005|Overall Study|Withdrawal by Subject|0|||
23551320|NCT02527798|65747626|FG000|Overall Study|Reason undisclosed|1|||
23551321|NCT02527798|65747627|FG001|Overall Study|Reason undisclosed|0|||
23551322|NCT02527798|65747628|FG002|Overall Study|Reason undisclosed|1|||
23551323|NCT02527798|65747629|FG003|Overall Study|Reason undisclosed|0|||
23551324|NCT02527798|65747630|FG004|Overall Study|Reason undisclosed|0|||
23551325|NCT02527798|65747631|FG005|Overall Study|Reason undisclosed|0|||
23551326|NCT02527798|65747626|FG000|Overall Study|Did not receive intervention|1|||
23551327|NCT02527798|65747627|FG001|Overall Study|Did not receive intervention|1|||
23551328|NCT02527798|65747628|FG002|Overall Study|Did not receive intervention|0|||
23551329|NCT02527798|65747629|FG003|Overall Study|Did not receive intervention|0|||
23551330|NCT02527798|65747630|FG004|Overall Study|Did not receive intervention|0|||
23551331|NCT02527798|65747631|FG005|Overall Study|Did not receive intervention|0|||
23551332|NCT00092534|65747635|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
23551333|NCT00092534|65747636|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
23136926|NCT02663518|64251977|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23136927|NCT02663518|64251978|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23551334|NCT00092534|65747637|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23551335|NCT00092534|65747638|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23136928|NCT02663518|64251979|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
23215115|NCT03814005|64528154|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
23215116|NCT03814005|64528155|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
23551336|NCT00092534|65747639|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23551337|NCT00092534|65747635|FG000|Base Study Vaccination Period|Adverse Event|3|||
23551338|NCT00092534|65747636|FG001|Base Study Vaccination Period|Adverse Event|1|||
23551339|NCT00092534|65747637|FG002|Base Study Vaccination Period|Adverse Event|0|||
23551340|NCT00092534|65747638|FG003|Base Study Vaccination Period|Adverse Event|0|||
23551341|NCT00092534|65747639|FG004|Base Study Vaccination Period|Adverse Event|0|||
23551342|NCT00092534|65747635|FG000|Base Study Vaccination Period|Death|5|||
23551343|NCT00092534|65747636|FG001|Base Study Vaccination Period|Death|4|||
23551344|NCT00092534|65747637|FG002|Base Study Vaccination Period|Death|0|||
23551345|NCT00092534|65747638|FG003|Base Study Vaccination Period|Death|0|||
23551346|NCT00092534|65747639|FG004|Base Study Vaccination Period|Death|0|||
23551347|NCT00092534|65747635|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
23551348|NCT00092534|65747636|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
23551349|NCT00092534|65747637|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
23551350|NCT00092534|65747638|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
23551351|NCT00092534|65747639|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
23551352|NCT00092534|65747635|FG000|Base Study Vaccination Period|Physician Decision|1|||
23215117|NCT03814005|64528156|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
23551353|NCT00092534|65747636|FG001|Base Study Vaccination Period|Physician Decision|0|||
23551354|NCT00092534|65747637|FG002|Base Study Vaccination Period|Physician Decision|0|||
23136929|NCT02663518|64251966|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
23136930|NCT02663518|64251967|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
23620866|NCT02720185|65997618|FG000|Overall Study|Lost to Follow-up|1|||
23620867|NCT01525641|65997624|FG000|Overall Study|Case report form not collected|25|||
23620868|NCT01525641|65997624|FG000|Overall Study|No visit since the first visit|16|||
23136931|NCT02663518|64251968|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
23136932|NCT02663518|64251969|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
23136933|NCT02663518|64251970|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
23136934|NCT02663518|64251971|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
23136935|NCT02663518|64251972|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
23136936|NCT02663518|64251973|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
23136937|NCT02663518|64251974|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
23136938|NCT02663518|64251975|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
23136939|NCT02663518|64251976|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
23136940|NCT02663518|64251977|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
23136941|NCT02663518|64251978|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
23136942|NCT02663518|64251979|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
23136943|NCT02663518|64251966|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136944|NCT02663518|64251967|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136945|NCT02663518|64251968|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136946|NCT02663518|64251969|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136947|NCT02663518|64251970|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136948|NCT02663518|64251971|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136949|NCT02663518|64251972|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136950|NCT02663518|64251973|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136951|NCT02663518|64251974|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136952|NCT02663518|64251975|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136953|NCT02663518|64251976|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136954|NCT02663518|64251977|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136955|NCT02663518|64251978|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
23136956|NCT02663518|64251979|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
23136957|NCT02663518|64251966|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136958|NCT02663518|64251967|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136959|NCT02663518|64251968|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136960|NCT02663518|64251969|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136961|NCT02663518|64251970|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136962|NCT02663518|64251971|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136963|NCT02663518|64251972|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136964|NCT02663518|64251973|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136965|NCT02663518|64251974|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136966|NCT02663518|64251975|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136967|NCT02663518|64251976|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136968|NCT02663518|64251977|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
23136969|NCT02663518|64251978|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136970|NCT02663518|64251979|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
23136971|NCT02663518|64251966|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136972|NCT02663518|64251967|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136973|NCT02663518|64251968|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136974|NCT02663518|64251969|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136975|NCT02663518|64251970|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136976|NCT02663518|64251971|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136977|NCT02663518|64251972|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136978|NCT02663518|64251973|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136979|NCT02663518|64251974|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136980|NCT02663518|64251975|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
23136981|NCT02663518|64251976|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
23136982|NCT02663518|64251977|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
23136983|NCT02663518|64251978|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
23136984|NCT02663518|64251979|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
23136985|NCT02663518|64251966|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
23136986|NCT02663518|64251967|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
23136987|NCT02663518|64251968|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
23136988|NCT02663518|64251969|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
23136989|NCT02663518|64251970|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
23620869|NCT01525641|65997624|FG000|Overall Study|Adverse Event|73|||
23136990|NCT02663518|64251971|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
23620870|NCT01525641|65997624|FG000|Overall Study|Lack of Efficacy|24|||
23620871|NCT01525641|65997624|FG000|Overall Study|Improvement|5|||
23136991|NCT02663518|64251972|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
23136992|NCT02663518|64251973|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
23136993|NCT02663518|64251974|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
23136994|NCT02663518|64251975|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
23136995|NCT02663518|64251976|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
23136996|NCT02663518|64251977|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
23136997|NCT02663518|64251978|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
23136998|NCT02663518|64251979|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
23136999|NCT02663518|64251966|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137000|NCT02663518|64251967|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137001|NCT02663518|64251968|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137002|NCT02663518|64251969|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137003|NCT02663518|64251970|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137004|NCT02663518|64251971|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137005|NCT02663518|64251972|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137006|NCT02663518|64251973|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137007|NCT02663518|64251974|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137008|NCT02663518|64251975|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137009|NCT02663518|64251976|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137010|NCT02663518|64251977|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23620872|NCT01525641|65997624|FG000|Overall Study|Lost to follow-up (relocation)|1|||
23620873|NCT01525641|65997624|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
23620874|NCT01525641|65997624|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
23137011|NCT02663518|64251978|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
23137012|NCT02663518|64251979|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
23137013|NCT00700258|64251984|FG000|Overall Study|Premature discontinuation of documentation|136|||
23137014|NCT00700258|64251984|FG000|Overall Study|Type of study end not documented|1|||
23137015|NCT00700258|64251984|FG000|Overall Study|Lost to Follow-up|81|||
23137016|NCT00700258|64251984|FG000|Overall Study|Premature discontinuation of therapy|1013|||
23620875|NCT01525641|65997624|FG000|Overall Study|Other than stated above|7|||
23620876|NCT00957996|65997625|FG000|Overall Study|Death|4|||
23620877|NCT00957996|65997626|FG001|Overall Study|Death|10|||
23620878|NCT00957996|65997625|FG000|Overall Study|Lost to Follow-up|4|||
23620879|NCT00957996|65997626|FG001|Overall Study|Lost to Follow-up|7|||
23620880|NCT00957996|65997625|FG000|Overall Study|Withdrawal by Subject|9|||
23137027|NCT00345293|64251989|FG000|Overall Study|Unable to access line for sample|1|||
23137028|NCT00345293|64251990|FG001|Overall Study|Unable to access line for sample|0|||
23137029|NCT00345293|64251989|FG000|Overall Study|Withdrawal by Subject|1|||
23137030|NCT00345293|64251990|FG001|Overall Study|Withdrawal by Subject|0|||
23137031|NCT02766465|64251991|FG000|Overall Study|Withdrawal by Subject|0|||
23137032|NCT02766465|64251992|FG001|Overall Study|Withdrawal by Subject|10|||
23137033|NCT01775475|64251993|FG000|Overall Study|Death|3|||
23137034|NCT01775475|64251994|FG001|Overall Study|Death|3|||
23137035|NCT00738894|64251998|FG000|Overall Study|Lost to Follow-up|23|||
23137036|NCT00738894|64251999|FG001|Overall Study|Lost to Follow-up|13|||
23137037|NCT00738894|64251998|FG000|Overall Study|Withdrawal by Subject|10|||
23137038|NCT00738894|64251999|FG001|Overall Study|Withdrawal by Subject|15|||
23137039|NCT00738894|64251998|FG000|Overall Study|Physician Decision|4|||
23137040|NCT00738894|64251999|FG001|Overall Study|Physician Decision|5|||
23137041|NCT00738894|64251998|FG000|Overall Study|Death|2|||
23137042|NCT00738894|64251999|FG001|Overall Study|Death|0|||
23137043|NCT00291642|64252002|FG000|Overall Study|Adverse Event|1|||
23137044|NCT00291642|64252003|FG001|Overall Study|Adverse Event|0|||
23137045|NCT00291642|64252004|FG002|Overall Study|Adverse Event|1|||
23137046|NCT00291642|64252005|FG003|Overall Study|Adverse Event|0|||
23137047|NCT00291642|64252006|FG004|Overall Study|Adverse Event|1|||
23137048|NCT00291642|64252002|FG000|Overall Study|Patient missed visit|0|||
23137049|NCT00291642|64252003|FG001|Overall Study|Patient missed visit|0|||
23137050|NCT00291642|64252004|FG002|Overall Study|Patient missed visit|1|||
23137051|NCT00291642|64252005|FG003|Overall Study|Patient missed visit|0|||
23430235|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
23430236|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23137052|NCT00291642|64252006|FG004|Overall Study|Patient missed visit|0|||
23137053|NCT00291642|64252002|FG000|Overall Study|Intake of prohibited medication|1|||
23551355|NCT00092534|65747638|FG003|Base Study Vaccination Period|Physician Decision|0|||
23551356|NCT00092534|65747639|FG004|Base Study Vaccination Period|Physician Decision|0|||
23551357|NCT00092534|65747635|FG000|Base Study Vaccination Period|Pregnancy|9|||
23551358|NCT00092534|65747636|FG001|Base Study Vaccination Period|Pregnancy|7|||
23551359|NCT00092534|65747637|FG002|Base Study Vaccination Period|Pregnancy|0|||
23551360|NCT00092534|65747638|FG003|Base Study Vaccination Period|Pregnancy|0|||
23551361|NCT00092534|65747639|FG004|Base Study Vaccination Period|Pregnancy|0|||
23551362|NCT00092534|65747635|FG000|Base Study Vaccination Period|Protocol Violation|2|||
23137054|NCT00291642|64252003|FG001|Overall Study|Intake of prohibited medication|0|||
23137055|NCT00291642|64252004|FG002|Overall Study|Intake of prohibited medication|0|||
23137056|NCT00291642|64252005|FG003|Overall Study|Intake of prohibited medication|0|||
23137057|NCT00291642|64252006|FG004|Overall Study|Intake of prohibited medication|0|||
23137058|NCT04833127|64252007|FG000|Overall Study|Lost to Follow-up|1|||
23137059|NCT04833127|64252008|FG001|Overall Study|Lost to Follow-up|1|||
23137060|NCT02738203|64252011|FG000|Overall Study|Failed IUD Insertion|2|||
23137061|NCT02738203|64252012|FG001|Overall Study|Failed IUD Insertion|2|||
23551363|NCT00092534|65747636|FG001|Base Study Vaccination Period|Protocol Violation|1|||
23551364|NCT00092534|65747637|FG002|Base Study Vaccination Period|Protocol Violation|0|||
23551365|NCT00092534|65747638|FG003|Base Study Vaccination Period|Protocol Violation|0|||
23551366|NCT00092534|65747639|FG004|Base Study Vaccination Period|Protocol Violation|0|||
23551367|NCT00092534|65747635|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
23551368|NCT00092534|65747636|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
23551369|NCT00092534|65747637|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
23551370|NCT00092534|65747638|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
23551371|NCT00092534|65747639|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
23551372|NCT00092534|65747635|FG000|Base Study Vaccination Period|Moved|14|||
23620881|NCT00957996|65997626|FG001|Overall Study|Withdrawal by Subject|2|||
23620882|NCT00957996|65997625|FG000|Overall Study|Adverse Event|2|||
23620883|NCT00957996|65997626|FG001|Overall Study|Adverse Event|1|||
23620884|NCT00957996|65997625|FG000|Overall Study|Physician Decision|1|||
23620885|NCT00957996|65997626|FG001|Overall Study|Physician Decision|1|||
23620886|NCT00957996|65997625|FG000|Overall Study|Influenza-related complication|0|||
23620887|NCT00957996|65997626|FG001|Overall Study|Influenza-related complication|1|||
23620888|NCT00957996|65997625|FG000|Overall Study|Missing|1|||
23620889|NCT00957996|65997626|FG001|Overall Study|Missing|0|||
23620890|NCT00957996|65997625|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
23620891|NCT00957996|65997626|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
23620892|NCT01274559|65997627|FG000|Overall Study|Adverse Event|57|||
23551373|NCT00092534|65747636|FG001|Base Study Vaccination Period|Moved|12|||
23137062|NCT02738203|64252011|FG000|Overall Study|Protocol Violation|0|||
23137063|NCT02738203|64252012|FG001|Overall Study|Protocol Violation|1|||
23137064|NCT02045875|64252013|FG000|Overall Study|Lost to Follow-up|3|||
23137065|NCT02045875|64252014|FG001|Overall Study|Lost to Follow-up|0|||
23137066|NCT02045875|64252013|FG000|Overall Study|Withdrawal by Subject|4|||
23137067|NCT02045875|64252014|FG001|Overall Study|Withdrawal by Subject|3|||
23137068|NCT02366468|64252015|FG000|Overall Study|Adverse Event|2|||
23137069|NCT02366468|64252016|FG001|Overall Study|Adverse Event|0|||
23137070|NCT02366468|64252015|FG000|Overall Study|Withdrawal by Subject|1|||
23137071|NCT02366468|64252016|FG001|Overall Study|Withdrawal by Subject|5|||
23551374|NCT00092534|65747637|FG002|Base Study Vaccination Period|Moved|0|||
23551375|NCT00092534|65747638|FG003|Base Study Vaccination Period|Moved|0|||
23551376|NCT00092534|65747639|FG004|Base Study Vaccination Period|Moved|0|||
23551377|NCT00092534|65747635|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
23551378|NCT00092534|65747636|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
23551379|NCT00092534|65747637|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
23551380|NCT00092534|65747638|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
23551381|NCT00092534|65747639|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
23551382|NCT00092534|65747635|FG000|Base Study Vaccination Period|Travel|1|||
23551383|NCT00092534|65747636|FG001|Base Study Vaccination Period|Travel|0|||
23551384|NCT00092534|65747637|FG002|Base Study Vaccination Period|Travel|0|||
23551385|NCT00092534|65747638|FG003|Base Study Vaccination Period|Travel|0|||
23551386|NCT00092534|65747639|FG004|Base Study Vaccination Period|Travel|0|||
23551387|NCT00092534|65747635|FG000|Base Study Vaccination Period|Site Closed|0|||
23551388|NCT00092534|65747636|FG001|Base Study Vaccination Period|Site Closed|1|||
23620893|NCT01274559|65997628|FG001|Overall Study|Adverse Event|13|||
23620894|NCT01274559|65997627|FG000|Overall Study|Death|1|||
23620895|NCT01274559|65997628|FG001|Overall Study|Death|1|||
23620896|NCT01274559|65997627|FG000|Overall Study|Lost to Follow-up|3|||
23620897|NCT01274559|65997628|FG001|Overall Study|Lost to Follow-up|3|||
23620898|NCT01274559|65997627|FG000|Overall Study|Non-compliance with Study Drug|2|||
23620899|NCT01274559|65997628|FG001|Overall Study|Non-compliance with Study Drug|4|||
23137072|NCT02366468|64252015|FG000|Overall Study|Lost to Follow-up|2|||
23137073|NCT02366468|64252016|FG001|Overall Study|Lost to Follow-up|0|||
23620900|NCT01274559|65997627|FG000|Overall Study|Physician Decision|2|||
23620901|NCT01274559|65997628|FG001|Overall Study|Physician Decision|1|||
23137074|NCT02366468|64252015|FG000|Overall Study|Death|1|||
23137075|NCT02366468|64252016|FG001|Overall Study|Death|2|||
23137076|NCT02366468|64252015|FG000|Overall Study|Other|0|||
23137077|NCT02366468|64252016|FG001|Overall Study|Other|2|||
23620902|NCT01274559|65997627|FG000|Overall Study|Protocol Violation|28|||
23620903|NCT01274559|65997628|FG001|Overall Study|Protocol Violation|23|||
23620904|NCT01274559|65997627|FG000|Overall Study|Study Terminated by Sponsor|79|||
23620905|NCT01274559|65997628|FG001|Overall Study|Study Terminated by Sponsor|87|||
23620906|NCT01274559|65997627|FG000|Overall Study|Withdrawal by Subject|25|||
23620907|NCT01274559|65997628|FG001|Overall Study|Withdrawal by Subject|13|||
23620908|NCT00826228|65997629|FG000|Overall Study|Withdrawal by Subject|1|||
23620909|NCT00935259|65997630|FG000|Period 1|Administrative (scheduling conflict)|1|||
23620910|NCT00935259|65997631|FG001|Period 1|Administrative (scheduling conflict)|1|||
23620911|NCT01530087|65997632|FG000|Overall Study|Physician Decision|2|||
23620912|NCT00511797|65997635|FG000|Overall Study|Adverse Event|1|||
23620913|NCT00511797|65997636|FG001|Overall Study|Adverse Event|2|||
23620914|NCT00511797|65997637|FG002|Overall Study|Adverse Event|2|||
23620915|NCT00511797|65997638|FG003|Overall Study|Adverse Event|2|||
23620916|NCT00511797|65997635|FG000|Overall Study|Lost to Follow-up|1|||
23137078|NCT02859324|64252017|FG000|Overall Study|Death|4|||
23137079|NCT02859324|64252018|FG001|Overall Study|Death|6|||
23137080|NCT02859324|64252019|FG002|Overall Study|Death|5|||
23137081|NCT02859324|64252017|FG000|Overall Study|Other reasons|3|||
23620917|NCT00511797|65997636|FG001|Overall Study|Lost to Follow-up|0|||
23620918|NCT00511797|65997637|FG002|Overall Study|Lost to Follow-up|0|||
23620919|NCT00511797|65997638|FG003|Overall Study|Lost to Follow-up|1|||
23620920|NCT00511797|65997635|FG000|Overall Study|Pregnancy|0|||
23620921|NCT00511797|65997636|FG001|Overall Study|Pregnancy|0|||
23620922|NCT00511797|65997637|FG002|Overall Study|Pregnancy|0|||
23620923|NCT00511797|65997638|FG003|Overall Study|Pregnancy|1|||
23137082|NCT02859324|64252018|FG001|Overall Study|Other reasons|3|||
23137083|NCT02859324|64252019|FG002|Overall Study|Other reasons|0|||
23137084|NCT00572039|64252020|FG000|Overall Study|Withdrawal by Subject|9|||
23137085|NCT00572039|64252021|FG001|Overall Study|Withdrawal by Subject|6|||
23137086|NCT00572039|64252020|FG000|Overall Study|Death|2|||
23137087|NCT00572039|64252021|FG001|Overall Study|Death|3|||
23137088|NCT00572039|64252020|FG000|Overall Study|Ill|5|||
23215118|NCT03814005|64528154|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
23620924|NCT00511797|65997635|FG000|Overall Study|Protocol Violation|0|||
23620925|NCT00511797|65997636|FG001|Overall Study|Protocol Violation|2|||
23620926|NCT00511797|65997637|FG002|Overall Study|Protocol Violation|2|||
23620927|NCT00511797|65997638|FG003|Overall Study|Protocol Violation|3|||
23620928|NCT00511797|65997635|FG000|Overall Study|Withdrawal by Subject|3|||
23620929|NCT00511797|65997636|FG001|Overall Study|Withdrawal by Subject|3|||
23620930|NCT00511797|65997637|FG002|Overall Study|Withdrawal by Subject|4|||
23620931|NCT00511797|65997638|FG003|Overall Study|Withdrawal by Subject|2|||
23620932|NCT00511797|65997635|FG000|Overall Study|Never dispensed|1|||
23137089|NCT00572039|64252021|FG001|Overall Study|Ill|1|||
23137090|NCT00470366|64252024|FG000|Overall Study|Adverse Event|3|||
23137091|NCT00470366|64252024|FG000|Overall Study|Poor compliance|1|||
23137092|NCT00658788|64252027|FG000|Overall Study|Adverse Event|11|||
23137093|NCT00658788|64252027|FG000|Overall Study|Withdrawal by Subject|13|||
23137094|NCT00658788|64252027|FG000|Overall Study|Lost to Follow-up|18|||
23137095|NCT00658788|64252027|FG000|Overall Study|Treatment Discontinuation|32|||
23137096|NCT00116753|64252029|FG000|Overall Study|Adverse Event|16|||
23137097|NCT00116753|64252030|FG001|Overall Study|Adverse Event|10|||
23137098|NCT00116753|64252031|FG002|Overall Study|Adverse Event|7|||
23137099|NCT00116753|64252029|FG000|Overall Study|Withdrawal by Subject|11|||
23137100|NCT00116753|64252030|FG001|Overall Study|Withdrawal by Subject|12|||
23137101|NCT00116753|64252031|FG002|Overall Study|Withdrawal by Subject|8|||
23137102|NCT00116753|64252029|FG000|Overall Study|Lost to Follow-up|0|||
23137103|NCT00116753|64252030|FG001|Overall Study|Lost to Follow-up|2|||
23137104|NCT00116753|64252031|FG002|Overall Study|Lost to Follow-up|1|||
23137105|NCT00116753|64252029|FG000|Overall Study|Protocol Violation|0|||
23137106|NCT00116753|64252030|FG001|Overall Study|Protocol Violation|0|||
23137107|NCT00116753|64252031|FG002|Overall Study|Protocol Violation|1|||
23137108|NCT00116753|64252029|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
23137109|NCT00116753|64252030|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
23137110|NCT00116753|64252031|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
23137111|NCT00116753|64252029|FG000|Overall Study|Disease Progression|3|||
23620933|NCT00511797|65997636|FG001|Overall Study|Never dispensed|0|||
23620934|NCT00511797|65997637|FG002|Overall Study|Never dispensed|1|||
23137112|NCT00116753|64252030|FG001|Overall Study|Disease Progression|4|||
23137113|NCT00116753|64252031|FG002|Overall Study|Disease Progression|3|||
23137114|NCT00116753|64252029|FG000|Overall Study|Abnormal Echocardiogram|0|||
23215119|NCT03814005|64528155|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
23137115|NCT00116753|64252030|FG001|Overall Study|Abnormal Echocardiogram|0|||
23137116|NCT00116753|64252031|FG002|Overall Study|Abnormal Echocardiogram|1|||
23620935|NCT00511797|65997638|FG003|Overall Study|Never dispensed|3|||
23620936|NCT00511797|65997635|FG000|Overall Study|Study drug not taken|0|||
23620937|NCT00511797|65997636|FG001|Overall Study|Study drug not taken|1|||
23137117|NCT00116753|64252029|FG000|Overall Study|Progressive Parkinson's Disease|1|||
23137118|NCT00116753|64252030|FG001|Overall Study|Progressive Parkinson's Disease|0|||
23620938|NCT00511797|65997637|FG002|Overall Study|Study drug not taken|0|||
23137119|NCT00116753|64252031|FG002|Overall Study|Progressive Parkinson's Disease|0|||
23620939|NCT00511797|65997638|FG003|Overall Study|Study drug not taken|1|||
23620940|NCT00511797|65997635|FG000|Overall Study|Partially missing diary|0|||
23551389|NCT00092534|65747637|FG002|Base Study Vaccination Period|Site Closed|0|||
23137120|NCT00116753|64252029|FG000|Overall Study|Dosing Error|0|||
23137121|NCT00116753|64252030|FG001|Overall Study|Dosing Error|1|||
23137122|NCT00116753|64252031|FG002|Overall Study|Dosing Error|0|||
23137123|NCT01177800|64252035|FG000|Overall Study|Adverse Event|9|||
23137124|NCT01177800|64252036|FG001|Overall Study|Adverse Event|3|||
23137125|NCT01177800|64252035|FG000|Overall Study|Protocol Violation|0|||
23137126|NCT01177800|64252036|FG001|Overall Study|Protocol Violation|1|||
23137127|NCT01177800|64252035|FG000|Overall Study|Physician Decision|1|||
23137128|NCT01177800|64252036|FG001|Overall Study|Physician Decision|0|||
23137129|NCT01177800|64252035|FG000|Overall Study|Withdrawal of informed consent|0|||
23137130|NCT01177800|64252036|FG001|Overall Study|Withdrawal of informed consent|1|||
23430237|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430238|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430239|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430240|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
23430241|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430242|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430243|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
23430244|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430245|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430246|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
23430247|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430248|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430249|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23551390|NCT00092534|65747638|FG003|Base Study Vaccination Period|Site Closed|0|||
23551391|NCT00092534|65747639|FG004|Base Study Vaccination Period|Site Closed|0|||
23551392|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Adverse Event|2|||
23551393|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Adverse Event|4|||
23551394|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Adverse Event|0|||
23551395|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Adverse Event|0|||
23551396|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Adverse Event|0|||
23551397|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Death|2|||
23551398|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Death|1|||
23551399|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Death|0|||
23551400|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Death|0|||
23551401|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Death|0|||
23551402|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
23551403|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
23551404|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
23551405|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
23551406|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
23551407|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Pregnancy|6|||
23551408|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Pregnancy|10|||
23551409|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Pregnancy|0|||
23551410|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Pregnancy|0|||
23551411|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Pregnancy|0|||
23551412|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
23551413|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
23551414|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
23551415|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
23551416|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
23551417|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
23551418|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
23551419|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
23551420|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
23551421|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
23551422|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Moved|62|||
23551423|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Moved|58|||
23551424|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Moved|0|||
23551425|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Moved|0|||
23551426|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Moved|0|||
23551427|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Travel|10|||
23137131|NCT01004848|64252037|FG000|Overall Study|Lost to Follow-up|55|||
23137132|NCT01004848|64252038|FG001|Overall Study|Lost to Follow-up|45|||
23137133|NCT01077271|64252039|FG000|Overall Study|Parental desire|8|||
23137134|NCT01077271|64252039|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
23430250|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23551428|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Travel|7|||
23551429|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Travel|0|||
23551430|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Travel|0|||
23551431|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Travel|0|||
23551432|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Site Closed|0|||
23137135|NCT01077271|64252039|FG000|Overall Study|Noncompliance|2|||
23137136|NCT01077271|64252039|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
23137137|NCT01077271|64252039|FG000|Overall Study|Changed doctors|2|||
23137138|NCT01077271|64252039|FG000|Overall Study|Parents thought too many injections|2|||
23137139|NCT01077271|64252039|FG000|Overall Study|End of RSV season nearly reached|1|||
23137140|NCT01077271|64252039|FG000|Overall Study|Mother unconvinced of the necessity|1|||
23137141|NCT02641496|64252040|FG000|Overall Study|Lost to Follow-up|13|||
23317625|NCT03132155|64904116|FG000|Overall Study|Withdrawal by Subject|1|||
23317626|NCT03464630|64904118|FG000|Overall Study|Lost to Follow-up|62|||
23620941|NCT00511797|65997636|FG001|Overall Study|Partially missing diary|0|||
23620942|NCT00511797|65997637|FG002|Overall Study|Partially missing diary|1|||
23620943|NCT00511797|65997638|FG003|Overall Study|Partially missing diary|0|||
23551433|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Site Closed|2|||
23551434|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Site Closed|0|||
23551435|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Site Closed|0|||
23551436|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Site Closed|0|||
23551437|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
23551438|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
23551439|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
23551440|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
23551441|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
23551442|NCT00092534|65747635|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
23551443|NCT00092534|65747636|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
23551444|NCT00092534|65747637|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
23551445|NCT00092534|65747638|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
23551446|NCT00092534|65747639|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
23551447|NCT00092534|65747635|FG000|Base Study EXT|Lost to Follow-up|0|||
23551448|NCT00092534|65747636|FG001|Base Study EXT|Lost to Follow-up|0|||
23551449|NCT00092534|65747637|FG002|Base Study EXT|Lost to Follow-up|41|||
23551450|NCT00092534|65747638|FG003|Base Study EXT|Lost to Follow-up|0|||
23551451|NCT00092534|65747639|FG004|Base Study EXT|Lost to Follow-up|0|||
23551452|NCT00092534|65747635|FG000|Base Study EXT|Physician Decision|0|||
23551453|NCT00092534|65747636|FG001|Base Study EXT|Physician Decision|0|||
23551454|NCT00092534|65747637|FG002|Base Study EXT|Physician Decision|1|||
23551455|NCT00092534|65747638|FG003|Base Study EXT|Physician Decision|0|||
23551456|NCT00092534|65747639|FG004|Base Study EXT|Physician Decision|0|||
23551457|NCT00092534|65747635|FG000|Base Study EXT|Pregnancy|0|||
23551458|NCT00092534|65747636|FG001|Base Study EXT|Pregnancy|0|||
23551459|NCT00092534|65747637|FG002|Base Study EXT|Pregnancy|12|||
23551460|NCT00092534|65747638|FG003|Base Study EXT|Pregnancy|0|||
23551461|NCT00092534|65747639|FG004|Base Study EXT|Pregnancy|0|||
23551462|NCT00092534|65747635|FG000|Base Study EXT|Withdrawal by Subject|0|||
23551463|NCT00092534|65747636|FG001|Base Study EXT|Withdrawal by Subject|0|||
23551464|NCT00092534|65747637|FG002|Base Study EXT|Withdrawal by Subject|18|||
23551465|NCT00092534|65747638|FG003|Base Study EXT|Withdrawal by Subject|0|||
23551466|NCT00092534|65747639|FG004|Base Study EXT|Withdrawal by Subject|0|||
23551467|NCT00092534|65747635|FG000|Base Study EXT|Participant moved|0|||
23551468|NCT00092534|65747636|FG001|Base Study EXT|Participant moved|0|||
23551469|NCT00092534|65747637|FG002|Base Study EXT|Participant moved|6|||
23551470|NCT00092534|65747638|FG003|Base Study EXT|Participant moved|0|||
23551471|NCT00092534|65747639|FG004|Base Study EXT|Participant moved|0|||
23551472|NCT00092534|65747635|FG000|Base Study EXT|Travel|0|||
23551473|NCT00092534|65747636|FG001|Base Study EXT|Travel|0|||
23551474|NCT00092534|65747637|FG002|Base Study EXT|Travel|2|||
23551475|NCT00092534|65747638|FG003|Base Study EXT|Travel|0|||
23551476|NCT00092534|65747639|FG004|Base Study EXT|Travel|0|||
23551477|NCT00092534|65747635|FG000|Base Study EXT|Site closed|0|||
23551478|NCT00092534|65747636|FG001|Base Study EXT|Site closed|0|||
23551479|NCT00092534|65747637|FG002|Base Study EXT|Site closed|21|||
23551480|NCT00092534|65747638|FG003|Base Study EXT|Site closed|0|||
23551481|NCT00092534|65747639|FG004|Base Study EXT|Site closed|0|||
23551482|NCT00092534|65747635|FG000|Base Study EXT|Study ended|0|||
23551483|NCT00092534|65747636|FG001|Base Study EXT|Study ended|0|||
23551484|NCT00092534|65747637|FG002|Base Study EXT|Study ended|29|||
23551485|NCT00092534|65747638|FG003|Base Study EXT|Study ended|0|||
23551486|NCT00092534|65747639|FG004|Base Study EXT|Study ended|0|||
23551487|NCT00092534|65747635|FG000|Base Study EXT|Protocol Violation|0|||
23551488|NCT00092534|65747636|FG001|Base Study EXT|Protocol Violation|0|||
23551489|NCT00092534|65747637|FG002|Base Study EXT|Protocol Violation|15|||
23620944|NCT00511797|65997635|FG000|Overall Study|Other (moving etc)|1|||
23137142|NCT02641496|64252041|FG001|Overall Study|Lost to Follow-up|12|||
23137143|NCT02641496|64252040|FG000|Overall Study|Withdrawal by Subject|1|||
23137144|NCT02641496|64252041|FG001|Overall Study|Withdrawal by Subject|0|||
23137145|NCT03828747|64252042|FG000|Double-Blind Treatment Period|Adverse Event|6|||
23551490|NCT00092534|65747638|FG003|Base Study EXT|Protocol Violation|0|||
23551491|NCT00092534|65747639|FG004|Base Study EXT|Protocol Violation|0|||
23551492|NCT00092534|65747635|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
23551493|NCT00092534|65747636|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
23620945|NCT00511797|65997636|FG001|Overall Study|Other (moving etc)|0|||
23620946|NCT00511797|65997637|FG002|Overall Study|Other (moving etc)|1|||
23620947|NCT00511797|65997638|FG003|Overall Study|Other (moving etc)|2|||
23620948|NCT02101983|65997639|FG000|Overall Study|Physician Decision|1|||
23620949|NCT02101983|65997640|FG001|Overall Study|Physician Decision|0|||
23620950|NCT00814632|65997641|FG000|Overall Study|Lack of Efficacy|2|||
23620951|NCT01077622|65997642|FG000|Overall Study|Physician Decision|2|||
23620952|NCT01077622|65997642|FG000|Overall Study|Withdrawal by Subject|1|||
23620953|NCT00726388|65997643|FG000|Overall Study|Withdrawal by Subject|5|||
23620954|NCT00726388|65997643|FG000|Overall Study|Adverse Event|3|||
23620955|NCT00726388|65997643|FG000|Overall Study|Lost to Follow-up|10|||
23620956|NCT00726388|65997643|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
23620957|NCT00726388|65997643|FG000|Overall Study|Other|5|||
23620958|NCT00726388|65997643|FG000|Overall Study|Enrolled, Not Treated|79|||
23620959|NCT03098797|65997644|FG000|Part 2 Open Label Extension|Adverse Event|2|||
23620960|NCT03098797|65997645|FG001|Part 2 Open Label Extension|Adverse Event|0|||
23620961|NCT02705625|65997656|FG000|Overall Study|Protocol Violation|1|||
23620962|NCT02705625|65997657|FG001|Overall Study|Protocol Violation|0|||
23620963|NCT02705625|65997658|FG002|Overall Study|Protocol Violation|0|||
23620964|NCT02705625|65997656|FG000|Overall Study|Adverse Event|6|||
23620965|NCT02705625|65997657|FG001|Overall Study|Adverse Event|5|||
23620966|NCT02705625|65997658|FG002|Overall Study|Adverse Event|2|||
23620967|NCT02705625|65997656|FG000|Overall Study|Death|0|||
23620968|NCT02705625|65997657|FG001|Overall Study|Death|0|||
23620969|NCT02705625|65997658|FG002|Overall Study|Death|1|||
23620970|NCT02705625|65997656|FG000|Overall Study|Withdrawal by Subject|1|||
23620971|NCT02705625|65997657|FG001|Overall Study|Withdrawal by Subject|4|||
23620972|NCT02705625|65997658|FG002|Overall Study|Withdrawal by Subject|5|||
23620973|NCT02705625|65997656|FG000|Overall Study|Lost to Follow-up|0|||
23620974|NCT02705625|65997657|FG001|Overall Study|Lost to Follow-up|0|||
23620975|NCT02705625|65997658|FG002|Overall Study|Lost to Follow-up|1|||
23620976|NCT02705625|65997656|FG000|Overall Study|Non-compliance|0|||
23620977|NCT02705625|65997657|FG001|Overall Study|Non-compliance|1|||
23620978|NCT02705625|65997658|FG002|Overall Study|Non-compliance|1|||
23620979|NCT02705625|65997656|FG000|Overall Study|Overdosing|0|||
23620980|NCT02705625|65997657|FG001|Overall Study|Overdosing|0|||
23620981|NCT02705625|65997658|FG002|Overall Study|Overdosing|1|||
23620982|NCT01820637|65997659|FG000|Overall Study|Death|2|||
23620983|NCT01820637|65997659|FG000|Overall Study|Withdrawal by Subject|1|||
23620984|NCT03891641|65997662|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
23620985|NCT03891641|65997663|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
23620986|NCT00819013|65997664|FG000|Overall Study|Not meeting continuing study eligibility|2|||
23620987|NCT00819013|65997665|FG001|Overall Study|Not meeting continuing study eligibility|1|||
23620988|NCT00819013|65997666|FG002|Overall Study|Not meeting continuing study eligibility|2|||
23620989|NCT00819013|65997667|FG003|Overall Study|Not meeting continuing study eligibility|1|||
23620990|NCT00819013|65997664|FG000|Overall Study|Adverse Event|0|||
23620991|NCT00819013|65997665|FG001|Overall Study|Adverse Event|0|||
23620992|NCT00819013|65997666|FG002|Overall Study|Adverse Event|1|||
23620993|NCT00819013|65997667|FG003|Overall Study|Adverse Event|0|||
23620994|NCT00819013|65997664|FG000|Overall Study|Withdrawal by Subject|1|||
23620995|NCT00819013|65997665|FG001|Overall Study|Withdrawal by Subject|0|||
23620996|NCT00819013|65997666|FG002|Overall Study|Withdrawal by Subject|1|||
23620997|NCT00819013|65997667|FG003|Overall Study|Withdrawal by Subject|0|||
23620998|NCT00819013|65997664|FG000|Overall Study|Lost to Follow-up|0|||
23620999|NCT00819013|65997665|FG001|Overall Study|Lost to Follow-up|0|||
23621000|NCT00819013|65997666|FG002|Overall Study|Lost to Follow-up|1|||
23621001|NCT00819013|65997667|FG003|Overall Study|Lost to Follow-up|2|||
23551494|NCT00092534|65747637|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
23551495|NCT00092534|65747638|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
23551496|NCT00092534|65747639|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
23551497|NCT02293538|65747640|FG000|Overall Study|Adverse Event|0|||
23551498|NCT02293538|65747641|FG001|Overall Study|Adverse Event|1|||
23551499|NCT02293538|65747640|FG000|Overall Study|Lost to Follow-up|1|||
23551500|NCT02293538|65747641|FG001|Overall Study|Lost to Follow-up|0|||
23551501|NCT02293538|65747640|FG000|Overall Study|Withdrawal by Subject|0|||
23551502|NCT02293538|65747641|FG001|Overall Study|Withdrawal by Subject|1|||
23621002|NCT00819013|65997664|FG000|Overall Study|Death|0|||
23621003|NCT00819013|65997665|FG001|Overall Study|Death|0|||
23621004|NCT00819013|65997666|FG002|Overall Study|Death|0|||
23621005|NCT00819013|65997667|FG003|Overall Study|Death|1|||
23621006|NCT01904136|65997669|FG000|Overall Study|Physician Decision|0|||
23621007|NCT01904136|65997670|FG001|Overall Study|Physician Decision|0|||
23621008|NCT01904136|65997671|FG002|Overall Study|Physician Decision|0|||
23621009|NCT01904136|65997672|FG003|Overall Study|Physician Decision|0|||
23621010|NCT01904136|65997673|FG004|Overall Study|Physician Decision|0|||
23621011|NCT01904136|65997674|FG005|Overall Study|Physician Decision|1|||
23621012|NCT01904136|65997675|FG006|Overall Study|Physician Decision|0|||
23621013|NCT01904136|65997676|FG007|Overall Study|Physician Decision|0|||
23621014|NCT01904136|65997677|FG008|Overall Study|Physician Decision|0|||
23621015|NCT04545476|65997678|FG000|Overall Study|Lost to Follow-up|1|||
23621016|NCT04545476|65997679|FG001|Overall Study|Lost to Follow-up|1|||
23621017|NCT04545476|65997680|FG002|Overall Study|Lost to Follow-up|0|||
23137146|NCT03828747|64252043|FG001|Double-Blind Treatment Period|Adverse Event|6|||
23137147|NCT03828747|64252042|FG000|Double-Blind Treatment Period|Death|1|||
23137148|NCT03828747|64252043|FG001|Double-Blind Treatment Period|Death|1|||
23137149|NCT03828747|64252042|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23137150|NCT03828747|64252043|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23137151|NCT03828747|64252042|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
23137152|NCT03828747|64252043|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
23137153|NCT03828747|64252042|FG000|Double-Blind Treatment Period|Physician Decision|1|||
23137154|NCT03828747|64252043|FG001|Double-Blind Treatment Period|Physician Decision|4|||
23137155|NCT03828747|64252042|FG000|Double-Blind Treatment Period|Various reasons|5|||
23621018|NCT04545476|65997681|FG003|Overall Study|Lost to Follow-up|0|||
23621019|NCT01704547|65997682|FG000|Overall Study|Physician Decision|4|||
23621020|NCT01704547|65997682|FG000|Overall Study|Withdrawal by Subject|1|||
23621021|NCT01161628|65997683|FG000|Overall Study|Death|6|||
23621022|NCT01161628|65997683|FG000|Overall Study|Lack of Efficacy|2|||
23621023|NCT05239598|65997684|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
23621024|NCT05239598|65997685|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
23621025|NCT05239598|65997684|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
23621026|NCT05239598|65997685|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
23621027|NCT03028012|65997690|FG000|Overall Study|Lost to Follow-up|2|||
23621028|NCT03028012|65997691|FG001|Overall Study|Lost to Follow-up|3|||
23621029|NCT03028012|65997692|FG002|Overall Study|Lost to Follow-up|3|||
23621030|NCT01171183|65997695|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
23621031|NCT01171183|65997696|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
23621032|NCT01171183|65997695|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
23621033|NCT01171183|65997696|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
23621034|NCT01171183|65997695|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
23621035|NCT01171183|65997696|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
23621036|NCT01171183|65997695|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
23621037|NCT01171183|65997696|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
23621038|NCT01171183|65997695|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
23621039|NCT01171183|65997696|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
23621040|NCT01171183|65997695|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
23621041|NCT01171183|65997696|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
23621042|NCT02412111|65997697|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
23621043|NCT02412111|65997698|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
23621044|NCT02412111|65997699|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
23621045|NCT02412111|65997697|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
23621046|NCT02412111|65997698|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
23621047|NCT02412111|65997699|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
23621048|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
23621049|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
23621050|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
23621051|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
23621052|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
23621053|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
23621054|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
23621055|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
23621056|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
23621057|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
23621058|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
23621059|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
23621060|NCT02412111|65997697|FG000|Active Comparator Period (8 Weeks)|Other|0|||
23621061|NCT02412111|65997698|FG001|Active Comparator Period (8 Weeks)|Other|0|||
23621062|NCT02412111|65997699|FG002|Active Comparator Period (8 Weeks)|Other|2|||
23621063|NCT02154347|65997700|FG000|Double-blind Period|Adverse Event|1|||
23621064|NCT02154347|65997701|FG001|Double-blind Period|Adverse Event|2|||
23621065|NCT02154347|65997700|FG000|Double-blind Period|Lack of Efficacy|1|||
23621066|NCT02154347|65997701|FG001|Double-blind Period|Lack of Efficacy|0|||
23137156|NCT03828747|64252043|FG001|Double-Blind Treatment Period|Various reasons|3|||
23137157|NCT03828747|64252042|FG000|Open-Label Extension|Adverse Event|9|||
23137158|NCT03828747|64252043|FG001|Open-Label Extension|Adverse Event|7|||
23137159|NCT03828747|64252042|FG000|Open-Label Extension|Death|0|||
23137160|NCT03828747|64252043|FG001|Open-Label Extension|Death|2|||
23137161|NCT03828747|64252042|FG000|Open-Label Extension|Lost to Follow-up|4|||
23137162|NCT03828747|64252043|FG001|Open-Label Extension|Lost to Follow-up|0|||
23137163|NCT03828747|64252042|FG000|Open-Label Extension|Withdrawal by Subject|31|||
23137164|NCT03828747|64252043|FG001|Open-Label Extension|Withdrawal by Subject|30|||
23137165|NCT03828747|64252042|FG000|Open-Label Extension|Various reasons|4|||
23137166|NCT03828747|64252043|FG001|Open-Label Extension|Various reasons|4|||
23137167|NCT03828747|64252042|FG000|Open-Label Extension|Physician Decision|6|||
23137168|NCT03828747|64252043|FG001|Open-Label Extension|Physician Decision|2|||
23137169|NCT01942590|64252046|FG000|Overall Study|Withdrawal by Subject|0|||
23137170|NCT01942590|64252047|FG001|Overall Study|Withdrawal by Subject|1|||
23137171|NCT01942590|64252046|FG000|Overall Study|Adverse Event|1|||
23137172|NCT01942590|64252047|FG001|Overall Study|Adverse Event|0|||
23137173|NCT00166712|64252048|FG000|Overall Study|Death|0|||
23137174|NCT00166712|64252049|FG001|Overall Study|Death|1|||
23137175|NCT00166712|64252048|FG000|Overall Study|Adverse Event|1|||
23137176|NCT00166712|64252049|FG001|Overall Study|Adverse Event|0|||
23137177|NCT00166712|64252048|FG000|Overall Study|Withdrawal by Subject|1|||
23137178|NCT00166712|64252049|FG001|Overall Study|Withdrawal by Subject|2|||
23137179|NCT00166712|64252048|FG000|Overall Study|Physician Decision|0|||
23137180|NCT00166712|64252049|FG001|Overall Study|Physician Decision|2|||
23137181|NCT00948766|64252050|FG000|Core Study|Adverse Event|73|||
23137182|NCT00948766|64252051|FG001|Core Study|Adverse Event|51|||
23137183|NCT00948766|64252050|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
23137184|NCT00948766|64252051|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
23137185|NCT00948766|64252050|FG000|Core Study|Patient Withdrew Consent|27|||
23137186|NCT00948766|64252051|FG001|Core Study|Patient Withdrew Consent|46|||
23137187|NCT00948766|64252050|FG000|Core Study|Lost to Follow-up|3|||
23137188|NCT00948766|64252051|FG001|Core Study|Lost to Follow-up|2|||
23137189|NCT00948766|64252050|FG000|Core Study|Administrative Problems|2|||
23137190|NCT00948766|64252051|FG001|Core Study|Administrative Problems|2|||
23137191|NCT00948766|64252050|FG000|Core Study|Death|1|||
23137192|NCT00948766|64252051|FG001|Core Study|Death|1|||
23137193|NCT00948766|64252050|FG000|Core Study|Protocol Deviation|8|||
23137194|NCT00948766|64252051|FG001|Core Study|Protocol Deviation|10|||
23137195|NCT00948766|64252050|FG000|Extension Study|Adverse Event|43|||
23137196|NCT00948766|64252051|FG001|Extension Study|Adverse Event|0|||
23137197|NCT00948766|64252050|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
23137198|NCT00948766|64252051|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
23137199|NCT00948766|64252050|FG000|Extension Study|Study Drug No Longer Required|1|||
23137200|NCT00948766|64252051|FG001|Extension Study|Study Drug No Longer Required|0|||
23137201|NCT00948766|64252050|FG000|Extension Study|Patient Withdrew Consent|32|||
23137202|NCT00948766|64252051|FG001|Extension Study|Patient Withdrew Consent|0|||
23137203|NCT00948766|64252050|FG000|Extension Study|Lost to Follow-up|8|||
23137204|NCT00948766|64252051|FG001|Extension Study|Lost to Follow-up|0|||
23137205|NCT00948766|64252050|FG000|Extension Study|Administrative Problems|1|||
23137206|NCT00948766|64252051|FG001|Extension Study|Administrative Problems|0|||
23137207|NCT00948766|64252050|FG000|Extension Study|Death|4|||
23137208|NCT00948766|64252051|FG001|Extension Study|Death|0|||
23137209|NCT00953745|64252054|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
23137210|NCT00953745|64252055|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
23137211|NCT00953745|64252054|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
23137212|NCT00953745|64252055|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
23137213|NCT00953745|64252054|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
23137214|NCT00953745|64252055|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
23137215|NCT00953745|64252054|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
23137216|NCT00953745|64252055|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
23137217|NCT00953745|64252054|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
23137218|NCT00953745|64252055|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
23137219|NCT00953745|64252054|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
23137220|NCT00953745|64252055|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
23137221|NCT03582943|64252056|FG000|Allocated to Groups|Withdrawal by Subject|1|||
23137222|NCT03582943|64252057|FG001|Allocated to Groups|Withdrawal by Subject|1|||
23137223|NCT03582943|64252056|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
23137224|NCT03582943|64252057|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
23137225|NCT03582943|64252056|FG000|Analyzed|Protocol Violation|4|||
23137226|NCT03582943|64252057|FG001|Analyzed|Protocol Violation|1|||
23137227|NCT04138576|64252058|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
23137228|NCT00306670|64252059|FG000|Overall Study|patients recruited; Genentech, the st|0|||
23137229|NCT00306670|64252060|FG001|Overall Study|patients recruited; Genentech, the st|2|||
23137230|NCT04289051|64252061|FG000|Overall Study|Lost to Follow-up|0|||
23137231|NCT04289051|64252062|FG001|Overall Study|Lost to Follow-up|0|||
23137232|NCT04289051|64252063|FG002|Overall Study|Lost to Follow-up|2|||
23137233|NCT01238900|64252064|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
23137234|NCT01238900|64252064|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
23137235|NCT02914275|64252065|FG000|Overall Study|Lost to Follow-up|84|||
23137236|NCT02914275|64252066|FG001|Overall Study|Lost to Follow-up|29|||
23317627|NCT03464630|64904119|FG001|Overall Study|Lost to Follow-up|52|||
23137237|NCT02914275|64252065|FG000|Overall Study|Withdrawal by Subject|26|||
23137238|NCT02914275|64252066|FG001|Overall Study|Withdrawal by Subject|10|||
23137239|NCT02914275|64252065|FG000|Overall Study|Protocol Violation|1|||
23137240|NCT02914275|64252066|FG001|Overall Study|Protocol Violation|1|||
23137241|NCT02914275|64252065|FG000|Overall Study|Physician Decision|3|||
23137242|NCT02914275|64252066|FG001|Overall Study|Physician Decision|1|||
23137243|NCT02914275|64252065|FG000|Overall Study|Other|4|||
23137244|NCT02914275|64252066|FG001|Overall Study|Other|1|||
23137245|NCT02914275|64252065|FG000|Overall Study|Excluded due to invalid informed consent|3|||
23137246|NCT02914275|64252066|FG001|Overall Study|Excluded due to invalid informed consent|0|||
23137247|NCT01445301|64252067|FG000|Overall Study|Adverse Event|15|||
23137248|NCT01445301|64252068|FG001|Overall Study|Adverse Event|25|||
23137249|NCT01445301|64252069|FG002|Overall Study|Adverse Event|4|||
23137250|NCT01445301|64252067|FG000|Overall Study|Lack of Efficacy|0|||
23137251|NCT01445301|64252068|FG001|Overall Study|Lack of Efficacy|1|||
23137252|NCT01445301|64252069|FG002|Overall Study|Lack of Efficacy|0|||
23137253|NCT01445301|64252067|FG000|Overall Study|Protocol Violation|1|||
23137254|NCT01445301|64252068|FG001|Overall Study|Protocol Violation|0|||
23137255|NCT01445301|64252069|FG002|Overall Study|Protocol Violation|0|||
23137256|NCT01445301|64252067|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
23137257|NCT01445301|64252068|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
23137258|NCT01445301|64252069|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
23137259|NCT01445301|64252067|FG000|Overall Study|Physician Decision|0|||
23137260|NCT01445301|64252068|FG001|Overall Study|Physician Decision|2|||
23137261|NCT01445301|64252069|FG002|Overall Study|Physician Decision|0|||
23137262|NCT01445301|64252067|FG000|Overall Study|Withdrawal by Subject|5|||
23137263|NCT01445301|64252068|FG001|Overall Study|Withdrawal by Subject|6|||
23137264|NCT01445301|64252069|FG002|Overall Study|Withdrawal by Subject|4|||
23137265|NCT00844532|64252070|FG000|Overall Study|Death|16|||
23137266|NCT00844532|64252070|FG000|Overall Study|Withdrawal by Subject|16|||
23621067|NCT02154347|65997700|FG000|Double-blind Period|Physician Decision|0|||
23137267|NCT00844532|64252070|FG000|Overall Study|Lost to Follow-up|7|||
23137268|NCT02112708|64252071|FG000|Baseline|Physician Decision|16|||
23137269|NCT02112708|64252072|FG001|Baseline|Physician Decision|11|||
23137270|NCT02112708|64252071|FG000|Baseline|Lost to Follow-up|12|||
23137271|NCT02112708|64252072|FG001|Baseline|Lost to Follow-up|0|||
23137272|NCT02112708|64252071|FG000|4 Month|Death|0|||
23137273|NCT02112708|64252072|FG001|4 Month|Death|1|||
23317628|NCT03464630|64904118|FG000|Overall Study|Withdrawal by Subject|16|||
23551503|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
23551504|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
23551505|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
23551506|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551507|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551508|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551509|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551510|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551511|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23551512|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
23551513|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
23551514|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
23551515|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551516|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551517|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551518|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551519|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551520|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23551521|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
23551522|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
23621068|NCT02154347|65997701|FG001|Double-blind Period|Physician Decision|1|||
23621069|NCT02154347|65997700|FG000|Double-blind Period|Withdrawal by Subject|1|||
23621070|NCT02154347|65997701|FG001|Double-blind Period|Withdrawal by Subject|1|||
23621071|NCT02154347|65997700|FG000|Open-label Period|Adverse Event|3|||
23621072|NCT02154347|65997701|FG001|Open-label Period|Adverse Event|4|||
23621073|NCT02154347|65997700|FG000|Open-label Period|Lack of Efficacy|4|||
23621074|NCT02154347|65997701|FG001|Open-label Period|Lack of Efficacy|19|||
23137274|NCT02112708|64252071|FG000|4 Month|Withdrawal by Subject|12|||
23137275|NCT02112708|64252072|FG001|4 Month|Withdrawal by Subject|0|||
23137276|NCT03446781|64252073|FG000|Overall Study|Lost to Follow-up|11|||
23137277|NCT03446781|64252074|FG001|Overall Study|Lost to Follow-up|5|||
23137278|NCT03446781|64252073|FG000|Overall Study|Withdrawal by Subject|9|||
23137279|NCT03446781|64252074|FG001|Overall Study|Withdrawal by Subject|7|||
23137280|NCT03446781|64252073|FG000|Overall Study|Adverse Event|8|||
23137281|NCT03446781|64252074|FG001|Overall Study|Adverse Event|2|||
23137282|NCT03446781|64252073|FG000|Overall Study|Protocol Violation|0|||
23137283|NCT03446781|64252074|FG001|Overall Study|Protocol Violation|3|||
23137284|NCT01153958|64252075|FG000|Overall Study|Study Terminated|36|||
23137285|NCT01153958|64252076|FG001|Overall Study|Study Terminated|32|||
23137286|NCT00151281|64252080|FG000|Overall Study|Not evaluable|3|||
23137287|NCT00215137|64252081|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
23137288|NCT00215137|64252082|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
23137289|NCT00215137|64252083|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
23137290|NCT00215137|64252081|FG000|Randomization Period|Lost to Follow-up|0|||
23137291|NCT00215137|64252082|FG001|Randomization Period|Lost to Follow-up|1|||
23137292|NCT00215137|64252083|FG002|Randomization Period|Lost to Follow-up|0|||
23137293|NCT00215137|64252081|FG000|Randomization Period|Withdrawal by Subject|0|||
23137294|NCT00215137|64252082|FG001|Randomization Period|Withdrawal by Subject|1|||
23137295|NCT00215137|64252083|FG002|Randomization Period|Withdrawal by Subject|0|||
23137296|NCT01239043|64252084|FG000|Overall Study|Protocol Violation|2|||
23137297|NCT01239043|64252085|FG001|Overall Study|Protocol Violation|1|||
23137298|NCT01076153|64252086|FG000|Overall Study|Symptoms improved/resolved|10|||
23137299|NCT01076153|64252086|FG000|Overall Study|Adverse Event|1|||
23137300|NCT03075410|64252087|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
23137301|NCT03075410|64252088|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
23137302|NCT03075410|64252089|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
23137303|NCT03075410|64252090|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
23137304|NCT03075410|64252091|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
23137305|NCT03075410|64252092|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
23137306|NCT03075410|64252093|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
23137307|NCT03075410|64252094|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
23137308|NCT03075410|64252095|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
23137309|NCT03075410|64252087|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
23137310|NCT03075410|64252088|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23137311|NCT03075410|64252089|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23137312|NCT03075410|64252090|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23137313|NCT03075410|64252091|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23137314|NCT03075410|64252092|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23137315|NCT03075410|64252093|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23137316|NCT03075410|64252094|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23137317|NCT03075410|64252095|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
23137318|NCT05180500|64252096|FG000|Overall Study|Adverse Event|1|||
23137319|NCT05180500|64252097|FG001|Overall Study|Adverse Event|0|||
23137320|NCT05180500|64252096|FG000|Overall Study|Withdrawal by Subject|2|||
23137321|NCT05180500|64252097|FG001|Overall Study|Withdrawal by Subject|0|||
23137322|NCT03482466|64252098|FG000|Overall Study|Protocol Violation|2|||
23137323|NCT03694275|64252099|FG000|Overall Study|Adverse Event|0|||
23137324|NCT03694275|64252100|FG001|Overall Study|Adverse Event|1|||
23137325|NCT03694275|64252099|FG000|Overall Study|Reason not Specified|0|||
23137326|NCT03694275|64252100|FG001|Overall Study|Reason not Specified|1|||
23137327|NCT00581555|64252102|FG000|Overall Study|Adverse Event|4|||
23430251|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
23430252|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
23430253|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23137328|NCT00581555|64252103|FG001|Overall Study|Adverse Event|3|||
23137329|NCT00581555|64252102|FG000|Overall Study|Physician Decision|3|||
23137330|NCT00581555|64252103|FG001|Overall Study|Physician Decision|2|||
23137331|NCT00581555|64252102|FG000|Overall Study|Withdrawal by Subject|18|||
23137332|NCT00581555|64252103|FG001|Overall Study|Withdrawal by Subject|9|||
23137333|NCT00581555|64252102|FG000|Overall Study|Lost to Follow-up|2|||
23137334|NCT00581555|64252103|FG001|Overall Study|Lost to Follow-up|2|||
23137335|NCT00581555|64252102|FG000|Overall Study|Other reasons|16|||
23137336|NCT00581555|64252103|FG001|Overall Study|Other reasons|4|||
23137337|NCT03965689|64252104|FG000|Overall Study|Too sick to get study intervention|2|||
23137338|NCT04488770|64252105|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137339|NCT04488770|64252106|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137340|NCT04488770|64252107|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137341|NCT04488770|64252108|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
23137342|NCT04488770|64252109|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137343|NCT04488770|64252110|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137344|NCT04488770|64252111|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137345|NCT04488770|64252112|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137346|NCT04488770|64252113|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23430254|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23137347|NCT04488770|64252114|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137348|NCT04488770|64252115|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23430255|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23137349|NCT04488770|64252116|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137350|NCT04488770|64252117|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
23137351|NCT04488770|64252105|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
23137352|NCT04488770|64252106|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137353|NCT04488770|64252107|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137354|NCT04488770|64252108|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137355|NCT04488770|64252109|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137356|NCT04488770|64252110|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137357|NCT04488770|64252111|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137358|NCT04488770|64252112|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137359|NCT04488770|64252113|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137360|NCT04488770|64252114|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137361|NCT04488770|64252115|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137362|NCT04488770|64252116|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137363|NCT04488770|64252117|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
23137364|NCT04488770|64252105|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137365|NCT04488770|64252106|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137366|NCT04488770|64252107|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137367|NCT04488770|64252108|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137368|NCT04488770|64252109|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137369|NCT04488770|64252110|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
23137370|NCT04488770|64252111|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
23137371|NCT04488770|64252112|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137372|NCT04488770|64252113|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137373|NCT04488770|64252114|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137374|NCT04488770|64252115|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137375|NCT04488770|64252116|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137376|NCT04488770|64252117|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
23137377|NCT04488770|64252105|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137378|NCT04488770|64252106|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137379|NCT04488770|64252107|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137380|NCT04488770|64252108|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137381|NCT04488770|64252109|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
23137382|NCT04488770|64252110|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137383|NCT04488770|64252111|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137384|NCT04488770|64252112|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137385|NCT04488770|64252113|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137386|NCT04488770|64252114|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137387|NCT04488770|64252115|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137388|NCT04488770|64252116|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137389|NCT04488770|64252117|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
23137390|NCT04725240|64252118|FG000|Overall Study|Adverse Event|2|||
23137391|NCT03940703|64252119|FG000|Overall Study|Still under treatment|31|||
23137392|NCT03940703|64252120|FG001|Overall Study|Still under treatment|0|||
23137393|NCT00903006|64252121|FG000|Overall Study|Withdrawal by Subject|2|||
23137394|NCT00903006|64252122|FG001|Overall Study|Withdrawal by Subject|0|||
23137395|NCT00903006|64252123|FG002|Overall Study|Withdrawal by Subject|0|||
23430256|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430257|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430258|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430259|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430260|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430261|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430262|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
23430263|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430264|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430265|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
23430266|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430267|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430268|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430269|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430270|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23621075|NCT02154347|65997700|FG000|Open-label Period|Protocol Violation|0|||
23621076|NCT02154347|65997701|FG001|Open-label Period|Protocol Violation|1|||
23430271|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23137396|NCT00903006|64252124|FG003|Overall Study|Withdrawal by Subject|0|||
23137397|NCT00903006|64252121|FG000|Overall Study|Progressive Disease|0|||
23137398|NCT00903006|64252122|FG001|Overall Study|Progressive Disease|3|||
23137399|NCT00903006|64252123|FG002|Overall Study|Progressive Disease|1|||
23215120|NCT03814005|64528156|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
23215121|NCT03814005|64528154|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
23215122|NCT03814005|64528155|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
23215123|NCT03814005|64528156|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
23215124|NCT03814005|64528154|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
23215125|NCT03814005|64528155|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
23317629|NCT03464630|64904119|FG001|Overall Study|Withdrawal by Subject|10|||
23317630|NCT03464630|64904118|FG000|Overall Study|Passive Disengagement|8|||
23137400|NCT00903006|64252124|FG003|Overall Study|Progressive Disease|0|||
23137401|NCT00730275|64252128|FG000|Overall Study|Withdrawal by Subject|0|||
23137402|NCT00730275|64252129|FG001|Overall Study|Withdrawal by Subject|0|||
23137403|NCT00730275|64252130|FG002|Overall Study|Withdrawal by Subject|0|||
23137404|NCT00730275|64252131|FG003|Overall Study|Withdrawal by Subject|1|||
23137405|NCT00006011|64252132|FG000|Overall Study|Disease progression|13|||
23137406|NCT00006011|64252133|FG001|Overall Study|Disease progression|6|||
23137407|NCT00006011|64252134|FG002|Overall Study|Disease progression|26|||
23137408|NCT00006011|64252132|FG000|Overall Study|Refused further treatment|15|||
23137409|NCT00006011|64252133|FG001|Overall Study|Refused further treatment|13|||
23137410|NCT00006011|64252134|FG002|Overall Study|Refused further treatment|26|||
23137411|NCT00006011|64252132|FG000|Overall Study|Adverse Event|15|||
23137412|NCT00006011|64252133|FG001|Overall Study|Adverse Event|39|||
23137413|NCT00006011|64252134|FG002|Overall Study|Adverse Event|5|||
23137414|NCT00006011|64252132|FG000|Overall Study|Death|0|||
23137415|NCT00006011|64252133|FG001|Overall Study|Death|1|||
23137416|NCT00006011|64252134|FG002|Overall Study|Death|2|||
23137417|NCT00006011|64252132|FG000|Overall Study|Other|4|||
23137418|NCT00006011|64252133|FG001|Overall Study|Other|2|||
23137419|NCT00006011|64252134|FG002|Overall Study|Other|5|||
23137420|NCT00006011|64252132|FG000|Overall Study|Ineligible|18|||
23137421|NCT00006011|64252133|FG001|Overall Study|Ineligible|16|||
23137422|NCT00006011|64252134|FG002|Overall Study|Ineligible|9|||
23137423|NCT03316300|64252138|FG000|Overall Study|Withdrawal by Subject|3|||
23137424|NCT03316300|64252139|FG001|Overall Study|Withdrawal by Subject|2|||
23137425|NCT03316300|64252138|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
23137426|NCT03316300|64252139|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
23137427|NCT03316300|64252138|FG000|Overall Study|Adverse Event|1|||
23137428|NCT03316300|64252139|FG001|Overall Study|Adverse Event|0|||
23137429|NCT03316300|64252138|FG000|Overall Study|COVID-19|0|||
23137430|NCT03316300|64252139|FG001|Overall Study|COVID-19|1|||
23137431|NCT05020327|64252140|FG000|Overall Study|Physician Decision|3|||
23137432|NCT05020327|64252141|FG001|Overall Study|Physician Decision|0|||
23137433|NCT05020327|64252142|FG002|Overall Study|Physician Decision|0|||
23430272|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430273|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
23430274|NCT02914561|65320524|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
23430275|NCT02914561|65320525|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430276|NCT02914561|65320526|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
23430277|NCT02914561|65320527|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
23430278|NCT02914561|65320528|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
23137434|NCT05020327|64252140|FG000|Overall Study|Withdrawal by Subject|1|||
23137435|NCT05020327|64252141|FG001|Overall Study|Withdrawal by Subject|1|||
23137436|NCT05020327|64252142|FG002|Overall Study|Withdrawal by Subject|0|||
23137437|NCT05020327|64252140|FG000|Overall Study|personal/cultural, ineligible|12|||
23137438|NCT05020327|64252141|FG001|Overall Study|personal/cultural, ineligible|0|||
23137439|NCT05020327|64252142|FG002|Overall Study|personal/cultural, ineligible|0|||
23137440|NCT01910181|64252143|FG000|Overall Study|Death|37|||
23317631|NCT03464630|64904119|FG001|Overall Study|Passive Disengagement|4|||
23317632|NCT00625872|64904122|FG000|Overall Study|Withdrawal by Subject|1|||
23317633|NCT00625872|64904123|FG001|Overall Study|Withdrawal by Subject|0|||
23317634|NCT00625872|64904122|FG000|Overall Study|Does not meet inclusion criteria|1|||
23317635|NCT00625872|64904123|FG001|Overall Study|Does not meet inclusion criteria|0|||
23317636|NCT00625872|64904122|FG000|Overall Study|Terminated by sponsor|2|||
23430279|NCT02914561|65320529|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
23430280|NCT02914561|65320530|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23137441|NCT01910181|64252143|FG000|Overall Study|Lost to Follow-up|3|||
23137442|NCT01910181|64252143|FG000|Overall Study|Study Terminated by Sponsor|6|||
23137443|NCT03330847|64252144|FG000|Overall Study|Patients ongoing study|62|||
23137444|NCT03330847|64252145|FG001|Overall Study|Patients ongoing study|65|||
23137445|NCT03330847|64252146|FG002|Overall Study|Patients ongoing study|15|||
23137446|NCT01993927|64252147|FG000|Overall Study|Case Report Forms Uncollected|18|||
23137447|NCT01993927|64252147|FG000|Overall Study|Protocol Violation|11|||
23137448|NCT02150343|64252150|FG000|Overall Study|Adverse Event|2|||
23137449|NCT02150343|64252151|FG001|Overall Study|Adverse Event|0|||
23137450|NCT02150343|64252152|FG002|Overall Study|Adverse Event|1|||
23137451|NCT02150343|64252153|FG003|Overall Study|Adverse Event|1|||
23137452|NCT02150343|64252150|FG000|Overall Study|Withdrawal by Subject|13|||
23137453|NCT02150343|64252151|FG001|Overall Study|Withdrawal by Subject|10|||
23137454|NCT02150343|64252152|FG002|Overall Study|Withdrawal by Subject|9|||
23137455|NCT02150343|64252153|FG003|Overall Study|Withdrawal by Subject|4|||
23137456|NCT02150343|64252150|FG000|Overall Study|Lost to Follow-up|4|||
23137457|NCT02150343|64252151|FG001|Overall Study|Lost to Follow-up|4|||
23137458|NCT02150343|64252152|FG002|Overall Study|Lost to Follow-up|2|||
23137459|NCT02150343|64252153|FG003|Overall Study|Lost to Follow-up|3|||
23137460|NCT02150343|64252150|FG000|Overall Study|Other|2|||
23137461|NCT02150343|64252151|FG001|Overall Study|Other|6|||
23137462|NCT02150343|64252152|FG002|Overall Study|Other|0|||
23137463|NCT02150343|64252153|FG003|Overall Study|Other|2|||
23137464|NCT00998335|64252154|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
23137465|NCT00998335|64252155|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
23137466|NCT00700427|64252160|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
23137467|NCT00700427|64252161|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
23137468|NCT00700427|64252162|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
23137469|NCT00700427|64252163|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
23137470|NCT00700427|64252164|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
23137471|NCT00700427|64252160|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
23137472|NCT00700427|64252161|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
23137473|NCT00700427|64252162|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
23137474|NCT00700427|64252163|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
23137475|NCT00700427|64252164|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
23137476|NCT00700427|64252160|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
23137477|NCT00700427|64252161|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
23137478|NCT00700427|64252162|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
23137479|NCT00700427|64252163|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
23137480|NCT00700427|64252164|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
23137481|NCT00700427|64252160|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
23137482|NCT00700427|64252161|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
23137483|NCT00700427|64252162|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
23137484|NCT00700427|64252163|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
23137485|NCT00700427|64252164|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
23137486|NCT00700427|64252160|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
23137487|NCT00700427|64252161|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
23137488|NCT00700427|64252162|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
23137489|NCT00700427|64252163|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
23137490|NCT00700427|64252164|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
23137491|NCT00700427|64252160|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
23137492|NCT00700427|64252161|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
23137493|NCT00700427|64252162|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
23137494|NCT00700427|64252163|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
23137495|NCT00700427|64252164|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
23137496|NCT00700427|64252160|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
23137497|NCT00700427|64252161|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
23137498|NCT00700427|64252162|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
23137499|NCT00700427|64252163|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
23137500|NCT00700427|64252164|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
23137501|NCT00700427|64252160|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
23137502|NCT00700427|64252161|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
23137503|NCT00700427|64252162|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
23137504|NCT00700427|64252163|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
23137505|NCT00700427|64252164|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
23137506|NCT00700427|64252160|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
23137507|NCT00700427|64252161|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
23137508|NCT00700427|64252162|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
23137509|NCT00700427|64252163|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
23621077|NCT02154347|65997700|FG000|Open-label Period|Withdrawal by Subject|0|||
23137510|NCT00700427|64252164|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
23137511|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
23137512|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
23621078|NCT02154347|65997701|FG001|Open-label Period|Withdrawal by Subject|1|||
23137513|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
23137514|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
23137515|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
23137516|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
23137517|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
23137518|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
23137519|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
23137520|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
23137521|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
23137522|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
23137523|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
23137524|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
23137525|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
23137526|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
23137527|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
23137528|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
23137529|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
23137530|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
23137531|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
23137532|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
23137533|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
23137534|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
23137535|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
23137536|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
23137537|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
23137538|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
23137539|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
23137540|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
23137541|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
23137542|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
23137543|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
23137544|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
23137545|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
23137546|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
23137547|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
23137548|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
23137549|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
23137550|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
23137551|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
23137552|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
23137553|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
23137554|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
23137555|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
23137556|NCT00700427|64252160|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
23137557|NCT00700427|64252161|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
23137558|NCT00700427|64252162|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
23137559|NCT00700427|64252163|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
23137560|NCT00700427|64252164|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
23137561|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
23137562|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
23137563|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
23137564|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
23137565|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
23137566|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
23137567|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
23137568|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
23137569|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
23137570|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
23137571|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
23137572|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
23137573|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
23137574|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
23137575|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
23137576|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
23137577|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
23137578|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
23215126|NCT03814005|64528156|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
23215127|NCT00637377|64528157|FG000|Overall Study|Adverse Event|2|||
23215128|NCT00637377|64528158|FG001|Overall Study|Adverse Event|6|||
23215129|NCT00637377|64528159|FG002|Overall Study|Adverse Event|8|||
23215130|NCT00637377|64528160|FG003|Overall Study|Adverse Event|9|||
23215131|NCT00637377|64528157|FG000|Overall Study|Death|1|||
23215132|NCT00637377|64528158|FG001|Overall Study|Death|3|||
23215133|NCT00637377|64528159|FG002|Overall Study|Death|2|||
23215134|NCT00637377|64528160|FG003|Overall Study|Death|1|||
23215135|NCT00637377|64528157|FG000|Overall Study|Lack of Efficacy|0|||
23215136|NCT00637377|64528158|FG001|Overall Study|Lack of Efficacy|0|||
23215137|NCT00637377|64528159|FG002|Overall Study|Lack of Efficacy|1|||
23215138|NCT00637377|64528160|FG003|Overall Study|Lack of Efficacy|1|||
23215139|NCT00637377|64528157|FG000|Overall Study|Lost to Follow-up|4|||
23215140|NCT00637377|64528158|FG001|Overall Study|Lost to Follow-up|1|||
23215141|NCT00637377|64528159|FG002|Overall Study|Lost to Follow-up|2|||
23215142|NCT00637377|64528160|FG003|Overall Study|Lost to Follow-up|2|||
23215143|NCT00637377|64528157|FG000|Overall Study|Protocol Violation|2|||
23215144|NCT00637377|64528158|FG001|Overall Study|Protocol Violation|1|||
23215145|NCT00637377|64528159|FG002|Overall Study|Protocol Violation|1|||
23215146|NCT00637377|64528160|FG003|Overall Study|Protocol Violation|0|||
23215147|NCT00637377|64528157|FG000|Overall Study|Withdrawal by Subject|11|||
23215148|NCT00637377|64528158|FG001|Overall Study|Withdrawal by Subject|15|||
23215149|NCT00637377|64528159|FG002|Overall Study|Withdrawal by Subject|13|||
23215150|NCT00637377|64528160|FG003|Overall Study|Withdrawal by Subject|11|||
23215151|NCT00637377|64528157|FG000|Overall Study|Other (no further information available)|7|||
23430281|NCT02914561|65320531|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430282|NCT02914561|65320532|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430283|NCT02914561|65320533|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430284|NCT02914561|65320534|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
23430285|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430286|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23137579|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
23137580|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
23137581|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
23137582|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
23137583|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
23137584|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
23137585|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
23430287|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430288|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430289|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430290|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
23430291|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
23430292|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
23430293|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
23430294|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
23430295|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
23430296|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430297|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430298|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430299|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430300|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430301|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
23430302|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
23430303|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
23430304|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
23430305|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
23430306|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
23215152|NCT00637377|64528158|FG001|Overall Study|Other (no further information available)|6|||
23215153|NCT00637377|64528159|FG002|Overall Study|Other (no further information available)|10|||
23215154|NCT00637377|64528160|FG003|Overall Study|Other (no further information available)|5|||
23621079|NCT01085812|65997702|FG000|Open-Label Period|Adverse Event|0|||
23215155|NCT00050960|64528161|FG000|Overall Study|Progressive Disease|137|||
23215156|NCT00050960|64528162|FG001|Overall Study|Progressive Disease|93|||
23215157|NCT00050960|64528161|FG000|Overall Study|Stable Disease|19|||
23215158|NCT00050960|64528162|FG001|Overall Study|Stable Disease|48|||
23430307|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430308|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430309|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430310|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430311|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430312|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
23430313|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
23430314|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
23430315|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
23430316|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
23430317|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
23430318|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430319|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430320|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430321|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430322|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430323|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430324|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
23430325|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430326|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
23430327|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
23430328|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
23430329|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430330|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430331|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430332|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430333|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430334|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430335|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
23430336|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
23430337|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
23430338|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
23430339|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
23430340|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23551523|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
23551524|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551525|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551526|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551527|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551528|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551529|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23551530|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23551531|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551532|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
23551533|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551534|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551535|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551536|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551537|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551538|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23551539|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551540|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551541|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23551542|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551543|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551544|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551545|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551546|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551547|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23551548|NCT01212770|65747642|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
23551549|NCT01212770|65747643|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
23551550|NCT01212770|65747644|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
23551551|NCT01212770|65747645|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23430341|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430342|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430343|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430344|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23621080|NCT01085812|65997703|FG001|Open-Label Period|Adverse Event|80|||
23621081|NCT01085812|65997702|FG000|Open-Label Period|Lack of Efficacy|0|||
23621082|NCT01085812|65997703|FG001|Open-Label Period|Lack of Efficacy|26|||
23621083|NCT01085812|65997702|FG000|Open-Label Period|Protocol Violation|0|||
23621084|NCT01085812|65997703|FG001|Open-Label Period|Protocol Violation|39|||
23621085|NCT01085812|65997702|FG000|Open-Label Period|Withdrawal by Subject|0|||
23621086|NCT01085812|65997703|FG001|Open-Label Period|Withdrawal by Subject|53|||
23621087|NCT01085812|65997702|FG000|Open-Label Period|Lost to Follow-up|0|||
23621088|NCT01085812|65997703|FG001|Open-Label Period|Lost to Follow-up|42|||
23621089|NCT01085812|65997702|FG000|Double-Blind Period|Adverse Event|3|||
23621090|NCT01085812|65997703|FG001|Double-Blind Period|Adverse Event|8|||
23621091|NCT01085812|65997702|FG000|Double-Blind Period|Protocol Violation|2|||
23621092|NCT01085812|65997703|FG001|Double-Blind Period|Protocol Violation|7|||
23621093|NCT01085812|65997702|FG000|Double-Blind Period|Withdrawal by Subject|11|||
23621094|NCT01085812|65997703|FG001|Double-Blind Period|Withdrawal by Subject|24|||
23621095|NCT01085812|65997702|FG000|Double-Blind Period|Lost to Follow-up|5|||
23621096|NCT01085812|65997703|FG001|Double-Blind Period|Lost to Follow-up|17|||
23621097|NCT01085812|65997702|FG000|Double-Blind Period|Other Reasons|0|||
23621098|NCT01085812|65997703|FG001|Double-Blind Period|Other Reasons|2|||
23621099|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
23621100|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
23621101|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
23621102|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
23621103|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
23621104|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
23621105|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
23621106|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
23621107|NCT01085812|65997702|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
23621108|NCT01085812|65997703|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
23621109|NCT01208870|65997704|FG000|Overall Study|Lost to Follow-up|2|||
23621110|NCT01208870|65997705|FG001|Overall Study|Lost to Follow-up|8|||
23621111|NCT00487552|65997706|FG000|Overall Study|Unsuccessful magnet placements|3|||
23621112|NCT00487552|65997706|FG000|Overall Study|Death due to progressive malignancy|2|||
23621113|NCT00487552|65997706|FG000|Overall Study|Stent not placed|1|||
23621114|NCT02108652|65997708|FG000|Overall Study|Death|253|||
23621115|NCT02108652|65997708|FG000|Overall Study|Lost to Follow-up|2|||
23621116|NCT02108652|65997708|FG000|Overall Study|Withdrawal by Subject|16|||
23621117|NCT02108652|65997708|FG000|Overall Study|Study Terminated By Sponsor|31|||
23621118|NCT02108652|65997708|FG000|Overall Study|Non-Compliance|1|||
23621119|NCT02108652|65997708|FG000|Overall Study|Physician Decision|6|||
23621120|NCT02108652|65997708|FG000|Overall Study|Progression Of Disease|1|||
23621121|NCT02624869|65997709|FG000|Overall Study|Lost to Follow-up|0|||
23621122|NCT02624869|65997710|FG001|Overall Study|Lost to Follow-up|0|||
23621123|NCT02624869|65997711|FG002|Overall Study|Lost to Follow-up|1|||
23621124|NCT02624869|65997709|FG000|Overall Study|Withdrawal by Subject|1|||
23621125|NCT02624869|65997710|FG001|Overall Study|Withdrawal by Subject|3|||
23621126|NCT02624869|65997711|FG002|Overall Study|Withdrawal by Subject|1|||
23621127|NCT03772613|66000556|FG000|Overall Study|Lost to Follow-up|0|||
23621128|NCT03772613|66000557|FG001|Overall Study|Lost to Follow-up|1|||
23621129|NCT03772613|66000558|FG002|Overall Study|Lost to Follow-up|1|||
23621130|NCT00594178|66000559|FG000|Overall Study|Physician Decision|5|||
23621131|NCT00605566|66000560|FG000|Overall Study|Adverse Event|1|||
23621132|NCT00605566|66000560|FG000|Overall Study|Clinical deterioration|1|||
23137586|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
23137587|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
23137588|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
23137589|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
23137590|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
23137591|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
23621133|NCT00605566|66000560|FG000|Overall Study|Poor compliance in run-in period|1|||
23621134|NCT02725008|66000561|FG000|Overall Study|Lost to Follow-up|7|||
23621135|NCT02725008|66000562|FG001|Overall Study|Lost to Follow-up|9|||
23621136|NCT02725008|66000561|FG000|Overall Study|Withdrawal by Subject|2|||
23621137|NCT02725008|66000562|FG001|Overall Study|Withdrawal by Subject|2|||
23621138|NCT02725008|66000561|FG000|Overall Study|Admitted to hospital|0|||
23621139|NCT02725008|66000562|FG001|Overall Study|Admitted to hospital|1|||
23621140|NCT04225039|66000563|FG000|Overall Study|Withdrawal by Subject|1|||
23621141|NCT04225039|66000564|FG001|Overall Study|Withdrawal by Subject|0|||
23621142|NCT04225039|66000565|FG002|Overall Study|Withdrawal by Subject|0|||
23621143|NCT04225039|66000566|FG003|Overall Study|Withdrawal by Subject|1|||
23551552|NCT01212770|65747646|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23551553|NCT01212770|65747647|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23137592|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
23137593|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
23551554|NCT01212770|65747648|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23551555|NCT01212770|65747649|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23551556|NCT01212770|65747650|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
23551557|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551558|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
23551559|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
23551560|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
23551561|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551562|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551563|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
23551564|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551565|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
23551566|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
23551567|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
23551568|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
23551569|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
23551570|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
23551571|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
23551572|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
23551573|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
23551574|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
23551575|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
23551576|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
23551577|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
23551578|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
23551579|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
23551580|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
23551581|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
23551582|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
23551583|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
23551584|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551585|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551586|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
23551587|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551588|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551589|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551590|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551591|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551592|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
23551593|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551594|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23137594|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
23137595|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
23137596|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
23137597|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
23137598|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
23137599|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
23137600|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
23137601|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
23137602|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
23137603|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
23137604|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
23137605|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
23137606|NCT00700427|64252160|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
23137607|NCT00700427|64252161|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
23137608|NCT00700427|64252162|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
23137609|NCT00700427|64252163|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
23137610|NCT00700427|64252164|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
23137611|NCT00700427|64252160|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
23621144|NCT04225039|66000563|FG000|Overall Study|Currently active on study treatment|0|||
23621145|NCT04225039|66000564|FG001|Overall Study|Currently active on study treatment|1|||
23621146|NCT04225039|66000565|FG002|Overall Study|Currently active on study treatment|0|||
23621147|NCT04225039|66000566|FG003|Overall Study|Currently active on study treatment|0|||
23621148|NCT04225039|66000563|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
23621149|NCT04225039|66000564|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
23621150|NCT04225039|66000565|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
23621151|NCT04225039|66000566|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
23621152|NCT04225039|66000563|FG000|Overall Study|Ineligible for treatment|0|||
23621153|NCT04225039|66000564|FG001|Overall Study|Ineligible for treatment|0|||
23621154|NCT04225039|66000565|FG002|Overall Study|Ineligible for treatment|0|||
23621155|NCT04225039|66000566|FG003|Overall Study|Ineligible for treatment|4|||
23621156|NCT00510198|66000571|FG000|Overall Study|Withdrawal by Subject|5|||
23621157|NCT00510198|66000572|FG001|Overall Study|Withdrawal by Subject|4|||
23621158|NCT02101268|66000578|FG000|Randomized Treatment Phase|Subject Decision|8|||
23621159|NCT02101268|66000579|FG001|Randomized Treatment Phase|Subject Decision|4|||
23621160|NCT02101268|66000580|FG002|Randomized Treatment Phase|Subject Decision|0|||
23621161|NCT02101268|66000581|FG003|Randomized Treatment Phase|Subject Decision|0|||
23621162|NCT02101268|66000578|FG000|Randomized Treatment Phase|Physician Decision|4|||
23621163|NCT02101268|66000579|FG001|Randomized Treatment Phase|Physician Decision|1|||
23621164|NCT02101268|66000580|FG002|Randomized Treatment Phase|Physician Decision|0|||
23621165|NCT02101268|66000581|FG003|Randomized Treatment Phase|Physician Decision|0|||
23621166|NCT02101268|66000578|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
23621167|NCT02101268|66000579|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
23621168|NCT02101268|66000580|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
23621169|NCT02101268|66000581|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
23621170|NCT02101268|66000578|FG000|Randomized Treatment Phase|Adverse Event|6|||
23621171|NCT02101268|66000579|FG001|Randomized Treatment Phase|Adverse Event|0|||
23621172|NCT02101268|66000580|FG002|Randomized Treatment Phase|Adverse Event|0|||
23551595|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551596|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
23551597|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551598|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551599|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551600|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551601|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
23551602|NCT01212770|65747642|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551603|NCT01212770|65747643|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551604|NCT01212770|65747644|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
23551605|NCT01212770|65747645|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
23551606|NCT01212770|65747646|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551607|NCT01212770|65747647|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23621173|NCT02101268|66000581|FG003|Randomized Treatment Phase|Adverse Event|0|||
23621174|NCT02101268|66000578|FG000|Randomized Treatment Phase|Death|5|||
23621175|NCT02101268|66000579|FG001|Randomized Treatment Phase|Death|4|||
23621176|NCT02101268|66000580|FG002|Randomized Treatment Phase|Death|0|||
23621177|NCT02101268|66000581|FG003|Randomized Treatment Phase|Death|0|||
23621178|NCT02101268|66000578|FG000|Randomized Treatment Phase|Disease Progression|4|||
23621179|NCT02101268|66000579|FG001|Randomized Treatment Phase|Disease Progression|1|||
23621180|NCT02101268|66000580|FG002|Randomized Treatment Phase|Disease Progression|0|||
23621181|NCT02101268|66000581|FG003|Randomized Treatment Phase|Disease Progression|0|||
23621182|NCT02101268|66000578|FG000|Extended Treatment Phase|Subject Decision|0|||
23621183|NCT02101268|66000579|FG001|Extended Treatment Phase|Subject Decision|0|||
23621184|NCT02101268|66000580|FG002|Extended Treatment Phase|Subject Decision|3|||
23621185|NCT02101268|66000581|FG003|Extended Treatment Phase|Subject Decision|2|||
23621186|NCT02101268|66000578|FG000|Extended Treatment Phase|Physician Decision|0|||
23621187|NCT02101268|66000579|FG001|Extended Treatment Phase|Physician Decision|0|||
23621188|NCT02101268|66000580|FG002|Extended Treatment Phase|Physician Decision|5|||
23621189|NCT02101268|66000581|FG003|Extended Treatment Phase|Physician Decision|2|||
23621190|NCT02101268|66000578|FG000|Extended Treatment Phase|Adverse Event|0|||
23621191|NCT02101268|66000579|FG001|Extended Treatment Phase|Adverse Event|0|||
23621192|NCT02101268|66000580|FG002|Extended Treatment Phase|Adverse Event|14|||
23621193|NCT02101268|66000581|FG003|Extended Treatment Phase|Adverse Event|18|||
23621194|NCT02101268|66000578|FG000|Extended Treatment Phase|Death|0|||
23621195|NCT02101268|66000579|FG001|Extended Treatment Phase|Death|0|||
23621196|NCT02101268|66000580|FG002|Extended Treatment Phase|Death|5|||
23621197|NCT02101268|66000581|FG003|Extended Treatment Phase|Death|1|||
23621198|NCT02101268|66000578|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
23621199|NCT02101268|66000579|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
23621200|NCT02101268|66000580|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
23621201|NCT02101268|66000581|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
23621202|NCT02101268|66000578|FG000|Extended Treatment Phase|Disease Progression|0|||
23551608|NCT01212770|65747648|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551609|NCT01212770|65747649|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551610|NCT01212770|65747650|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
23551611|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551612|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
23551613|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
23551614|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551615|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551616|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551617|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551618|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23551619|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
23551620|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551621|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
23551622|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
23551623|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551624|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551625|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551626|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23551627|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
23551628|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
23551629|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551630|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
23551631|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551632|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551633|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551634|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551635|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23621203|NCT02101268|66000579|FG001|Extended Treatment Phase|Disease Progression|0|||
23551636|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551637|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
23551638|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23551639|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
23621204|NCT02101268|66000580|FG002|Extended Treatment Phase|Disease Progression|13|||
23621205|NCT02101268|66000581|FG003|Extended Treatment Phase|Disease Progression|6|||
23621206|NCT02101268|66000578|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
23621207|NCT02101268|66000579|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
23621208|NCT02101268|66000580|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
23621209|NCT02101268|66000581|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
23621210|NCT03845075|66000582|FG000|Part 1 - DB|Withdrawal by Subject|1|||
23621211|NCT03845075|66000583|FG001|Part 1 - DB|Withdrawal by Subject|1|||
23621212|NCT03845075|66000584|FG002|Part 1 - DB|Withdrawal by Subject|0|||
23621213|NCT03845075|66000585|FG003|Part 1 - DB|Withdrawal by Subject|0|||
23621214|NCT03845075|66000582|FG000|Part 1 - DB|Adverse Event|0|||
23621215|NCT03845075|66000583|FG001|Part 1 - DB|Adverse Event|1|||
23551640|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
23551641|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23551642|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23551643|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23621216|NCT03845075|66000584|FG002|Part 1 - DB|Adverse Event|0|||
23551644|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23551645|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
23551646|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
23551647|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23551648|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
23551649|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
23551650|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23551651|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23551652|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23621217|NCT03845075|66000585|FG003|Part 1 - DB|Adverse Event|0|||
23621218|NCT03845075|66000582|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
23621219|NCT03845075|66000583|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
23551653|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
23621220|NCT03845075|66000584|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
23551654|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
23551655|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
23551656|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23621221|NCT03845075|66000585|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
23621222|NCT03029819|66000586|FG000|Overall Study|Lost to Follow-up|3|||
23551657|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
23551658|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23551659|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551660|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551661|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551662|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551663|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23551664|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23551665|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551666|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
23551667|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
23551668|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551669|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551670|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551671|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23551672|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
23551673|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
23551674|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551675|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
23551676|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
23551677|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551678|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551679|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551680|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23551681|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
23551682|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
23551683|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551684|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
23551685|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
23551686|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551687|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551688|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551689|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23551690|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23551691|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23551692|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551693|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
23621223|NCT03029819|66000587|FG001|Overall Study|Lost to Follow-up|5|||
23621224|NCT03029819|66000586|FG000|Overall Study|Removed due to disruptive behavior|0|||
23621225|NCT03029819|66000587|FG001|Overall Study|Removed due to disruptive behavior|1|||
23621226|NCT03464383|66000588|FG000|Overall Study|Lost to Follow-up|1|||
23621227|NCT03464383|66000589|FG001|Overall Study|Lost to Follow-up|0|||
23621228|NCT03464383|66000590|FG002|Overall Study|Lost to Follow-up|0|||
23621229|NCT03464383|66000588|FG000|Overall Study|Withdrawal by Subject|0|||
23621230|NCT03464383|66000589|FG001|Overall Study|Withdrawal by Subject|1|||
23621231|NCT03464383|66000590|FG002|Overall Study|Withdrawal by Subject|0|||
23621232|NCT02803593|66000591|FG000|Overall Study|Lost to Follow-up|17|||
23621233|NCT02803593|66000592|FG001|Overall Study|Lost to Follow-up|35|||
23621234|NCT03845023|66000594|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
23621235|NCT03845023|66000595|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
23621236|NCT03845023|66000596|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
23621237|NCT03845023|66000597|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
23621238|NCT03845023|66000594|FG000|Follow-Up (14 Days)|Adverse Event|0|||
23621239|NCT03845023|66000595|FG001|Follow-Up (14 Days)|Adverse Event|0|||
23621240|NCT03845023|66000596|FG002|Follow-Up (14 Days)|Adverse Event|1|||
23621241|NCT03845023|66000597|FG003|Follow-Up (14 Days)|Adverse Event|1|||
23621242|NCT04816708|66000598|FG000|Overall Study|Lost to Follow-up|10|||
23621243|NCT04816708|66000599|FG001|Overall Study|Lost to Follow-up|4|||
23621244|NCT02592707|66000600|FG000|Overall Study|Consent Withdrawn|0|||
23621245|NCT02592707|66000601|FG001|Overall Study|Consent Withdrawn|1|||
23621246|NCT02592707|66000602|FG002|Overall Study|Consent Withdrawn|2|||
23621247|NCT02592707|66000603|FG003|Overall Study|Consent Withdrawn|0|||
23621248|NCT02592707|66000600|FG000|Overall Study|Death|1|||
23551694|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551695|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551696|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23621249|NCT02592707|66000601|FG001|Overall Study|Death|0|||
23621250|NCT02592707|66000602|FG002|Overall Study|Death|0|||
23621251|NCT02592707|66000603|FG003|Overall Study|Death|0|||
23621252|NCT02592707|66000600|FG000|Overall Study|Progressive Disease|4|||
23621253|NCT02592707|66000601|FG001|Overall Study|Progressive Disease|4|||
23621254|NCT02592707|66000602|FG002|Overall Study|Progressive Disease|3|||
23621255|NCT02592707|66000603|FG003|Overall Study|Progressive Disease|3|||
23621256|NCT02592707|66000600|FG000|Overall Study|Other|0|||
23551697|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551698|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551699|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551700|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23551701|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551702|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551703|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551704|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551705|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551706|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551707|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551708|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
23551709|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
23551710|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551711|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
23551712|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23551713|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551714|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551715|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551716|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23551717|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23621257|NCT02592707|66000601|FG001|Overall Study|Other|0|||
23551718|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23621258|NCT02592707|66000602|FG002|Overall Study|Other|1|||
23621259|NCT02592707|66000603|FG003|Overall Study|Other|2|||
23621260|NCT02592707|66000600|FG000|Overall Study|Never entered LTFU period|1|||
23621261|NCT02592707|66000601|FG001|Overall Study|Never entered LTFU period|0|||
23621262|NCT02592707|66000602|FG002|Overall Study|Never entered LTFU period|0|||
23621263|NCT02592707|66000603|FG003|Overall Study|Never entered LTFU period|2|||
23621264|NCT04270747|66000604|FG000|Through Week 16|Adverse Event|1|||
23621265|NCT04270747|66000605|FG001|Through Week 16|Adverse Event|2|||
23621266|NCT04270747|66000606|FG002|Through Week 16|Adverse Event|0|||
23621267|NCT04270747|66000604|FG000|Through Week 16|Death|0|||
23621268|NCT04270747|66000605|FG001|Through Week 16|Death|2|||
23621269|NCT04270747|66000606|FG002|Through Week 16|Death|0|||
23621270|NCT04270747|66000604|FG000|Through Week 16|Consent Withdrawn|3|||
23621271|NCT04270747|66000605|FG001|Through Week 16|Consent Withdrawn|3|||
23621272|NCT04270747|66000606|FG002|Through Week 16|Consent Withdrawn|0|||
23621273|NCT04270747|66000604|FG000|Through Week 16|Physician Decision|1|||
23621274|NCT04270747|66000605|FG001|Through Week 16|Physician Decision|1|||
23621275|NCT04270747|66000606|FG002|Through Week 16|Physician Decision|0|||
23621276|NCT04270747|66000604|FG000|Through Week 16|Lost to Follow-up|2|||
23621277|NCT04270747|66000605|FG001|Through Week 16|Lost to Follow-up|0|||
23621278|NCT04270747|66000606|FG002|Through Week 16|Lost to Follow-up|0|||
23621279|NCT04270747|66000604|FG000|Through Week 16|Protocol Violation|1|||
23621280|NCT04270747|66000605|FG001|Through Week 16|Protocol Violation|2|||
23621281|NCT04270747|66000606|FG002|Through Week 16|Protocol Violation|0|||
23621282|NCT04270747|66000604|FG000|Through Week 16|Protocol Specified Criteria|6|||
23621283|NCT04270747|66000605|FG001|Through Week 16|Protocol Specified Criteria|7|||
23621284|NCT04270747|66000606|FG002|Through Week 16|Protocol Specified Criteria|0|||
23621285|NCT04270747|66000604|FG000|Through Week 16|Miscellaneous|1|||
23621286|NCT04270747|66000605|FG001|Through Week 16|Miscellaneous|1|||
23621287|NCT04270747|66000606|FG002|Through Week 16|Miscellaneous|0|||
23621288|NCT04270747|66000604|FG000|Post Week 16|Adverse Event|7|||
23621289|NCT04270747|66000605|FG001|Post Week 16|Adverse Event|5|||
23621290|NCT04270747|66000606|FG002|Post Week 16|Adverse Event|1|||
23621291|NCT04270747|66000604|FG000|Post Week 16|Death|2|||
23621292|NCT04270747|66000605|FG001|Post Week 16|Death|0|||
23621293|NCT04270747|66000606|FG002|Post Week 16|Death|2|||
23137612|NCT00700427|64252161|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
23137613|NCT00700427|64252162|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
23137614|NCT00700427|64252163|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
23137615|NCT00700427|64252164|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
23137616|NCT00700427|64252160|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
23137617|NCT00700427|64252161|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
23137618|NCT00700427|64252162|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
23137619|NCT00700427|64252163|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
23137620|NCT00700427|64252164|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
23551719|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23621294|NCT04270747|66000604|FG000|Post Week 16|Consent Withdrawn|4|||
23621295|NCT04270747|66000605|FG001|Post Week 16|Consent Withdrawn|3|||
23621296|NCT04270747|66000606|FG002|Post Week 16|Consent Withdrawn|6|||
23621297|NCT04270747|66000604|FG000|Post Week 16|Physician Decision|3|||
23621298|NCT04270747|66000605|FG001|Post Week 16|Physician Decision|1|||
23430345|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430346|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
23430347|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430348|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
23430349|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23551720|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
23551721|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
23551722|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23551723|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23551724|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23551725|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23430350|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
23430351|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23551726|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23551727|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
23551728|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551729|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
23430352|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430353|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430354|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430355|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430356|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430357|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430358|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430359|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
23430360|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430361|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
23430362|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430363|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430364|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430365|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430366|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430367|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430368|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
23430369|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430370|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430371|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430372|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
23430373|NCT02914561|65320524|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430374|NCT02914561|65320525|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430375|NCT02914561|65320526|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430376|NCT02914561|65320527|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430377|NCT02914561|65320528|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430378|NCT02914561|65320529|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430379|NCT02914561|65320530|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430380|NCT02914561|65320531|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
23430381|NCT02914561|65320532|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
23430382|NCT02914561|65320533|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
23430383|NCT02914561|65320534|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
23551730|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
23551731|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551732|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23215159|NCT00050960|64528161|FG000|Overall Study|Partial Response|14|||
23215160|NCT00050960|64528162|FG001|Overall Study|Partial Response|19|||
23215161|NCT00050960|64528161|FG000|Overall Study|Complete Response|0|||
23215162|NCT00050960|64528162|FG001|Overall Study|Complete Response|2|||
23215163|NCT00050960|64528161|FG000|Overall Study|Adverse Event|62|||
23430384|NCT02804750|65320537|FG000|Period 1|Adverse Event|0|||
23430385|NCT02804750|65320538|FG001|Period 1|Adverse Event|2|||
23430386|NCT02804750|65320537|FG000|Period 1|Withdrawal by Subject|0|||
23430387|NCT02804750|65320538|FG001|Period 1|Withdrawal by Subject|1|||
23551733|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551734|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551735|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
23551736|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23551737|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23215164|NCT00050960|64528162|FG001|Overall Study|Adverse Event|61|||
23215165|NCT00050960|64528161|FG000|Overall Study|Lost to Follow-up|0|||
23551738|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
23551739|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
23551740|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551741|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551742|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551743|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551744|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
23551745|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
23551746|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551747|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
23551748|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
23551749|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551750|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551751|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551752|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551753|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551754|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23551755|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551756|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551757|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
23551758|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551759|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551760|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551761|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551762|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551763|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23551764|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551765|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
23551766|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551767|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551768|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551769|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551770|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551771|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23551772|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
23551773|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
23551774|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
23551775|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
23551776|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
23551777|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
23551778|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
23551779|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
23551780|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
23551781|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
23551782|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551783|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551784|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
23551785|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551786|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551787|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551788|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551789|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551790|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23551791|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551792|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551793|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
23551794|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551795|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551796|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551797|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551798|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23551799|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
23551800|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551801|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23215166|NCT00050960|64528162|FG001|Overall Study|Lost to Follow-up|1|||
23551802|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
23551803|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551804|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551805|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551806|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551807|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551808|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23551809|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551810|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
23551811|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23551812|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551813|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551814|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551815|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551816|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23551817|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23551818|NCT01212770|65747642|FG000|Long-term Safety Phase (Year 5)|Death|0|||
23551819|NCT01212770|65747643|FG001|Long-term Safety Phase (Year 5)|Death|0|||
23551820|NCT01212770|65747644|FG002|Long-term Safety Phase (Year 5)|Death|0|||
23551821|NCT01212770|65747645|FG003|Long-term Safety Phase (Year 5)|Death|0|||
23551822|NCT01212770|65747646|FG004|Long-term Safety Phase (Year 5)|Death|0|||
23551823|NCT01212770|65747647|FG005|Long-term Safety Phase (Year 5)|Death|0|||
23551824|NCT01212770|65747648|FG006|Long-term Safety Phase (Year 5)|Death|0|||
23551825|NCT01212770|65747649|FG007|Long-term Safety Phase (Year 5)|Death|1|||
23551826|NCT01212770|65747650|FG008|Long-term Safety Phase (Year 5)|Death|0|||
23551827|NCT00377234|65747651|FG000|Overall Study|Adverse Event|14|||
23551828|NCT00377234|65747652|FG001|Overall Study|Adverse Event|17|||
23551829|NCT00377234|65747651|FG000|Overall Study|Withdrawal by Subject|11|||
23551830|NCT00377234|65747652|FG001|Overall Study|Withdrawal by Subject|9|||
23551831|NCT00377234|65747651|FG000|Overall Study|Lost to Follow-up|4|||
23551832|NCT00377234|65747652|FG001|Overall Study|Lost to Follow-up|2|||
23551833|NCT00377234|65747651|FG000|Overall Study|Administrative|2|||
23551834|NCT00377234|65747652|FG001|Overall Study|Administrative|1|||
23551835|NCT00377234|65747651|FG000|Overall Study|Not assigned|3|||
23551836|NCT00377234|65747652|FG001|Overall Study|Not assigned|2|||
23551837|NCT02693743|65747653|FG000|Overall Study|Physician Decision|1|||
23551838|NCT02693743|65747654|FG001|Overall Study|Physician Decision|0|||
23551839|NCT01800968|65747657|FG000|Overall Study|Death|23|||
23551840|NCT01800968|65747658|FG001|Overall Study|Death|16|||
23551841|NCT01800968|65747657|FG000|Overall Study|Lost to Follow-up|5|||
23551842|NCT01800968|65747658|FG001|Overall Study|Lost to Follow-up|7|||
23551843|NCT01800968|65747657|FG000|Overall Study|Withdrawal by Subject|7|||
23551844|NCT01800968|65747658|FG001|Overall Study|Withdrawal by Subject|9|||
23551845|NCT01800968|65747657|FG000|Overall Study|Physician Decision|1|||
23551846|NCT01800968|65747658|FG001|Overall Study|Physician Decision|0|||
23551847|NCT00522275|65747659|FG000|Overall Study|Adverse Event|35|||
23551848|NCT00522275|65747659|FG000|Overall Study|Lack of Efficacy|80|||
23551849|NCT00522275|65747659|FG000|Overall Study|Subject withdrew consent|16|||
23551850|NCT00522275|65747659|FG000|Overall Study|Protocol deviation|1|||
23551851|NCT00522275|65747659|FG000|Overall Study|Unsatisfactory compliance|11|||
23551852|NCT00522275|65747659|FG000|Overall Study|Lost to Follow-up|8|||
23551853|NCT00522275|65747659|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
23551854|NCT00522275|65747659|FG000|Overall Study|Other: Subject is pregnant|2|||
23551855|NCT00522275|65747659|FG000|Overall Study|Other: Subject relocated|2|||
23551856|NCT00522275|65747659|FG000|Overall Study|Other: Subject arrested|1|||
23551857|NCT00522275|65747659|FG000|Overall Study|Other: Site / clinic closed|4|||
23551858|NCT00522275|65747659|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
23551859|NCT00522275|65747659|FG000|Overall Study|Other: Sponsor request|2|||
23551860|NCT00522275|65747659|FG000|Overall Study|Other: Subject ran out of medication|1|||
23551861|NCT00522275|65747659|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
23551862|NCT01422408|65747660|FG000|Overall Study|Adverse Event|1|||
23551863|NCT01422408|65747660|FG000|Overall Study|Withdrawal by Subject|3|||
23551864|NCT02576678|65747662|FG000|Overall Study|Adverse Event|0|||
23551865|NCT02576678|65747663|FG001|Overall Study|Adverse Event|0|||
23551866|NCT02576678|65747664|FG002|Overall Study|Adverse Event|2|||
23621299|NCT04270747|66000606|FG002|Post Week 16|Physician Decision|1|||
23621300|NCT04270747|66000604|FG000|Post Week 16|Lost to Follow-up|2|||
23621301|NCT04270747|66000605|FG001|Post Week 16|Lost to Follow-up|1|||
23621302|NCT04270747|66000606|FG002|Post Week 16|Lost to Follow-up|0|||
23621303|NCT04270747|66000604|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
23621304|NCT04270747|66000605|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
23551867|NCT02576678|65747662|FG000|Overall Study|Withdrawal by Subject|3|||
23551868|NCT02576678|65747663|FG001|Overall Study|Withdrawal by Subject|1|||
23551869|NCT02576678|65747664|FG002|Overall Study|Withdrawal by Subject|2|||
23551870|NCT02576678|65747662|FG000|Overall Study|Lost to Follow-up|0|||
23137621|NCT00700427|64252160|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
23551871|NCT02576678|65747663|FG001|Overall Study|Lost to Follow-up|0|||
23551872|NCT02576678|65747664|FG002|Overall Study|Lost to Follow-up|1|||
23621305|NCT04270747|66000606|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
23137622|NCT00700427|64252161|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
23137623|NCT00700427|64252162|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
23137624|NCT00700427|64252163|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
23137625|NCT00700427|64252164|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
23137626|NCT00700427|64252160|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
23137627|NCT00700427|64252161|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
23551873|NCT02576678|65747662|FG000|Overall Study|Miscellaneous|2|||
23551874|NCT02576678|65747663|FG001|Overall Study|Miscellaneous|0|||
23551875|NCT02576678|65747664|FG002|Overall Study|Miscellaneous|0|||
23551876|NCT04537923|65747665|FG000|Overall Study|Adverse Event|2|||
23551877|NCT04537923|65747666|FG001|Overall Study|Adverse Event|1|||
23551878|NCT04537923|65747667|FG002|Overall Study|Adverse Event|2|||
23551879|NCT04537923|65747668|FG003|Overall Study|Adverse Event|4|||
23551880|NCT04537923|65747665|FG000|Overall Study|Death|3|||
23551881|NCT04537923|65747666|FG001|Overall Study|Death|3|||
23551882|NCT04537923|65747667|FG002|Overall Study|Death|1|||
23551883|NCT04537923|65747668|FG003|Overall Study|Death|11|||
23551884|NCT04537923|65747665|FG000|Overall Study|Lost to Follow-up|1|||
23551885|NCT04537923|65747666|FG001|Overall Study|Lost to Follow-up|2|||
23551886|NCT04537923|65747667|FG002|Overall Study|Lost to Follow-up|1|||
23551887|NCT04537923|65747668|FG003|Overall Study|Lost to Follow-up|6|||
23551888|NCT04537923|65747665|FG000|Overall Study|Physician Decision|1|||
23551889|NCT04537923|65747666|FG001|Overall Study|Physician Decision|0|||
23551890|NCT04537923|65747667|FG002|Overall Study|Physician Decision|2|||
23551891|NCT04537923|65747668|FG003|Overall Study|Physician Decision|5|||
23551892|NCT04537923|65747665|FG000|Overall Study|Pregnancy|1|||
23551893|NCT04537923|65747666|FG001|Overall Study|Pregnancy|0|||
23551894|NCT04537923|65747667|FG002|Overall Study|Pregnancy|0|||
23551895|NCT04537923|65747668|FG003|Overall Study|Pregnancy|0|||
23551896|NCT04537923|65747665|FG000|Overall Study|Withdrawal by Subject|4|||
23551897|NCT04537923|65747666|FG001|Overall Study|Withdrawal by Subject|4|||
23551898|NCT04537923|65747667|FG002|Overall Study|Withdrawal by Subject|4|||
23551899|NCT04537923|65747668|FG003|Overall Study|Withdrawal by Subject|58|||
23551900|NCT04537923|65747665|FG000|Overall Study|Missed study visits|2|||
23551901|NCT04537923|65747666|FG001|Overall Study|Missed study visits|0|||
23551902|NCT04537923|65747667|FG002|Overall Study|Missed study visits|0|||
23551903|NCT04537923|65747668|FG003|Overall Study|Missed study visits|3|||
23551904|NCT04537923|65747665|FG000|Overall Study|Sponsor's decision|0|||
23551905|NCT04537923|65747666|FG001|Overall Study|Sponsor's decision|0|||
23551906|NCT04537923|65747667|FG002|Overall Study|Sponsor's decision|1|||
23551907|NCT04537923|65747668|FG003|Overall Study|Sponsor's decision|1|||
23551908|NCT04537923|65747665|FG000|Overall Study|Safety reasons|1|||
23551909|NCT04537923|65747666|FG001|Overall Study|Safety reasons|0|||
23551910|NCT04537923|65747667|FG002|Overall Study|Safety reasons|0|||
23551911|NCT04537923|65747668|FG003|Overall Study|Safety reasons|0|||
23551912|NCT03969719|65747669|FG000|Overall Study|Other reasons not specified|1|||
23551913|NCT03969719|65747670|FG001|Overall Study|Other reasons not specified|1|||
23551914|NCT03969719|65747671|FG002|Overall Study|Other reasons not specified|3|||
23137628|NCT00700427|64252162|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
23430388|NCT02804750|65320537|FG000|Period 2|Adverse Event|1|||
23430389|NCT02804750|65320538|FG001|Period 2|Adverse Event|0|||
23430390|NCT02804750|65320537|FG000|Period 3|Adverse Event|0|||
23430391|NCT02804750|65320538|FG001|Period 3|Adverse Event|2|||
23430392|NCT02804750|65320537|FG000|Period 4|Adverse Event|0|||
23430393|NCT02804750|65320538|FG001|Period 4|Adverse Event|5|||
23430394|NCT02559414|65320539|FG000|Overall Study|Lost to Follow-up|0|||
23430395|NCT02559414|65320540|FG001|Overall Study|Lost to Follow-up|1|||
23430396|NCT02559414|65320541|FG002|Overall Study|Lost to Follow-up|0|||
23430397|NCT02559414|65320539|FG000|Overall Study|Withdrawal by Subject|1|||
23430398|NCT02559414|65320540|FG001|Overall Study|Withdrawal by Subject|0|||
23430399|NCT02559414|65320541|FG002|Overall Study|Withdrawal by Subject|1|||
23430400|NCT02559414|65320539|FG000|Overall Study|Other|0|||
23430401|NCT02559414|65320540|FG001|Overall Study|Other|1|||
23430402|NCT02559414|65320541|FG002|Overall Study|Other|1|||
23551915|NCT03969719|65747669|FG000|Overall Study|Withdrawal by Subject|2|||
23137629|NCT00700427|64252163|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
23430403|NCT05545644|65320542|FG000|Overall Study|Lost to Follow-up|4|||
23430404|NCT05545644|65320543|FG001|Overall Study|Lost to Follow-up|3|||
23551916|NCT03969719|65747670|FG001|Overall Study|Withdrawal by Subject|3|||
23551917|NCT03969719|65747671|FG002|Overall Study|Withdrawal by Subject|2|||
23430405|NCT02758301|65320545|FG000|Overall Study|Death|12|||
23430406|NCT02758301|65320546|FG001|Overall Study|Death|0|||
23551918|NCT03969719|65747669|FG000|Overall Study|Protocol Violation|1|||
23551919|NCT03969719|65747670|FG001|Overall Study|Protocol Violation|2|||
23551920|NCT03969719|65747671|FG002|Overall Study|Protocol Violation|0|||
23551921|NCT03969719|65747669|FG000|Overall Study|Adverse Event|0|||
23551922|NCT03969719|65747670|FG001|Overall Study|Adverse Event|2|||
23551923|NCT03969719|65747671|FG002|Overall Study|Adverse Event|0|||
23551924|NCT03969719|65747669|FG000|Overall Study|Lost to Follow-up|0|||
23551925|NCT03969719|65747670|FG001|Overall Study|Lost to Follow-up|1|||
23551926|NCT03969719|65747671|FG002|Overall Study|Lost to Follow-up|0|||
23551927|NCT01618162|65747673|FG000|Overall Study|Protocol Violation|13|||
23551928|NCT01618162|65747674|FG001|Overall Study|Protocol Violation|10|||
23551929|NCT01618162|65747673|FG000|Overall Study|Adverse Event|9|||
23551930|NCT01618162|65747674|FG001|Overall Study|Adverse Event|2|||
23551931|NCT01618162|65747673|FG000|Overall Study|Withdrawal Criteria|2|||
23551932|NCT01618162|65747674|FG001|Overall Study|Withdrawal Criteria|10|||
23551933|NCT01618162|65747673|FG000|Overall Study|Unclassified|14|||
23551934|NCT01618162|65747674|FG001|Overall Study|Unclassified|13|||
23551935|NCT01747772|65747675|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
23551936|NCT03461003|65747676|FG000|Overall Study|Lost to Follow-up|2|||
23551937|NCT03461003|65747677|FG001|Overall Study|Lost to Follow-up|2|||
23551938|NCT03461003|65747676|FG000|Overall Study|Withdrawal by Subject|3|||
23551939|NCT03461003|65747677|FG001|Overall Study|Withdrawal by Subject|1|||
23551940|NCT00808808|65747678|FG000|Overall Study|Vaccinated; survey not completed|131|||
23551941|NCT00808808|65747679|FG001|Overall Study|Vaccinated; survey not completed|169|||
23551942|NCT00808808|65747680|FG002|Overall Study|Vaccinated; survey not completed|302|||
23551943|NCT00808808|65747678|FG000|Overall Study|Employee was not vaccinated.|2686|||
23551944|NCT00808808|65747679|FG001|Overall Study|Employee was not vaccinated.|2268|||
23551945|NCT00808808|65747680|FG002|Overall Study|Employee was not vaccinated.|2255|||
23551946|NCT01380327|65747687|FG000|Overall Study|Lost to Follow-up|0|||
23137630|NCT00700427|64252164|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
23137631|NCT00700427|64252160|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
23137632|NCT00700427|64252161|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
23137633|NCT00700427|64252162|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
23137634|NCT00700427|64252163|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
23137635|NCT00700427|64252164|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
23137636|NCT00700427|64252160|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
23137637|NCT00700427|64252161|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
23137638|NCT00700427|64252162|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
23137639|NCT00700427|64252163|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
23137640|NCT00700427|64252164|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
23137641|NCT00700427|64252160|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
23137642|NCT00700427|64252161|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
23137643|NCT00700427|64252162|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
23137644|NCT00700427|64252163|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
23137645|NCT00700427|64252164|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
23137646|NCT00700427|64252160|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
23137647|NCT00700427|64252161|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
23137648|NCT00700427|64252162|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
23137649|NCT00700427|64252163|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
23137650|NCT00700427|64252164|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
23137651|NCT00700427|64252160|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
23137652|NCT00700427|64252161|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
23137653|NCT00700427|64252162|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
23215167|NCT00050960|64528161|FG000|Overall Study|Withdrawal by Subject|23|||
23215168|NCT00050960|64528162|FG001|Overall Study|Withdrawal by Subject|18|||
23215169|NCT00050960|64528161|FG000|Overall Study|Administrative|31|||
23317637|NCT00625872|64904123|FG001|Overall Study|Terminated by sponsor|5|||
23317638|NCT00625872|64904122|FG000|Overall Study|Randomized but not treated|0|||
23317639|NCT00625872|64904123|FG001|Overall Study|Randomized but not treated|1|||
23317640|NCT01523002|64904124|FG000|Period 1|Withdrawal by Subject|1|||
23317641|NCT01523002|64904125|FG001|Period 1|Withdrawal by Subject|3|||
23317642|NCT01523002|64904124|FG000|Period 1|Lost to Follow-up|1|||
23317643|NCT01523002|64904125|FG001|Period 1|Lost to Follow-up|0|||
23317644|NCT01523002|64904124|FG000|Period 1|Adverse Event|0|||
23317645|NCT01523002|64904125|FG001|Period 1|Adverse Event|8|||
23317646|NCT01523002|64904124|FG000|Period 2|Withdrawal by Subject|4|||
23317647|NCT01523002|64904125|FG001|Period 2|Withdrawal by Subject|1|||
23317648|NCT01523002|64904124|FG000|Period 2|Adverse Event|2|||
23317649|NCT01523002|64904125|FG001|Period 2|Adverse Event|5|||
23317650|NCT01523002|64904124|FG000|Period 3|Withdrawal by Subject|1|||
23551947|NCT01380327|65747688|FG001|Overall Study|Lost to Follow-up|1|||
23317651|NCT01523002|64904125|FG001|Period 3|Withdrawal by Subject|0|||
23317652|NCT01523002|64904124|FG000|Period 3|Adverse Event|3|||
23317653|NCT01523002|64904125|FG001|Period 3|Adverse Event|0|||
23551948|NCT01380327|65747689|FG002|Overall Study|Lost to Follow-up|1|||
23551949|NCT01380327|65747687|FG000|Overall Study|Protocol Violation|3|||
23551950|NCT01380327|65747688|FG001|Overall Study|Protocol Violation|2|||
23551951|NCT01380327|65747689|FG002|Overall Study|Protocol Violation|3|||
23551952|NCT01380327|65747687|FG000|Overall Study|Withdrawal by Subject|0|||
23551953|NCT01380327|65747688|FG001|Overall Study|Withdrawal by Subject|0|||
23551954|NCT01380327|65747689|FG002|Overall Study|Withdrawal by Subject|1|||
23137654|NCT00700427|64252163|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
23137655|NCT00700427|64252164|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
23137656|NCT00774930|64252165|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
23137657|NCT00774930|64252166|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
23137658|NCT00774930|64252165|FG000|DB Phase|Adverse Event|1|||
23137659|NCT00774930|64252166|FG001|DB Phase|Adverse Event|2|||
23137660|NCT00774930|64252165|FG000|DB Phase|Subject Decision|1|||
23137661|NCT00774930|64252166|FG001|DB Phase|Subject Decision|5|||
23137662|NCT00774930|64252165|FG000|DB Phase|Sponsor Decision|0|||
23137663|NCT00774930|64252166|FG001|DB Phase|Sponsor Decision|1|||
23137664|NCT00774930|64252165|FG000|DB Phase|Disease Progression|1|||
23137665|NCT00774930|64252166|FG001|DB Phase|Disease Progression|1|||
23137666|NCT00774930|64252165|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
23137667|NCT00774930|64252166|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
23137668|NCT00774930|64252165|FG000|IOL Phase|Adverse Event|1|||
23137669|NCT00774930|64252166|FG001|IOL Phase|Adverse Event|1|||
23137670|NCT00774930|64252165|FG000|IOL Phase|Subject Decision|4|||
23430407|NCT02758301|65320545|FG000|Overall Study|Physician Decision|10|||
23430408|NCT02758301|65320546|FG001|Overall Study|Physician Decision|1|||
23430409|NCT02758301|65320545|FG000|Overall Study|Withdrawal by Subject|5|||
23430410|NCT02758301|65320546|FG001|Overall Study|Withdrawal by Subject|6|||
23430411|NCT02758301|65320545|FG000|Overall Study|Lost to Follow-up|7|||
23430412|NCT02758301|65320546|FG001|Overall Study|Lost to Follow-up|0|||
23430413|NCT02758301|65320545|FG000|Overall Study|Protocol Violation|0|||
23430414|NCT02758301|65320546|FG001|Overall Study|Protocol Violation|1|||
23430415|NCT02408523|65320547|FG000|Overall Study|Adverse Event|4|||
23430416|NCT02408523|65320548|FG001|Overall Study|Adverse Event|10|||
23430417|NCT02408523|65320547|FG000|Overall Study|Lack of Efficacy|0|||
23430418|NCT02408523|65320548|FG001|Overall Study|Lack of Efficacy|1|||
23430419|NCT02408523|65320547|FG000|Overall Study|Protocol Violation|1|||
23430420|NCT02408523|65320548|FG001|Overall Study|Protocol Violation|2|||
23430421|NCT02408523|65320547|FG000|Overall Study|Lost to Follow-up|2|||
23430422|NCT02408523|65320548|FG001|Overall Study|Lost to Follow-up|3|||
23430423|NCT02408523|65320547|FG000|Overall Study|Withdrawal by Subject|3|||
23430424|NCT02408523|65320548|FG001|Overall Study|Withdrawal by Subject|1|||
23430425|NCT02408523|65320547|FG000|Overall Study|Sponsor request|1|||
23430426|NCT02408523|65320548|FG001|Overall Study|Sponsor request|0|||
23430427|NCT02408523|65320547|FG000|Overall Study|Did not satisfy extension conditions|0|||
23430428|NCT02408523|65320548|FG001|Overall Study|Did not satisfy extension conditions|1|||
23430429|NCT02210091|65320550|FG000|Overall Study|Physician Decision|0|||
23430430|NCT02210091|65320551|FG001|Overall Study|Physician Decision|1|||
23430431|NCT02210091|65320550|FG000|Overall Study|Withdrawal by Sponsor|0|||
23430432|NCT02210091|65320551|FG001|Overall Study|Withdrawal by Sponsor|1|||
23430433|NCT02613169|65320557|FG000|Overall Study|Withdrawal by Subject|4|||
23430434|NCT02613169|65320558|FG001|Overall Study|Withdrawal by Subject|1|||
23430435|NCT02613169|65320557|FG000|Overall Study|Lost to Follow-up|0|||
23430436|NCT02613169|65320558|FG001|Overall Study|Lost to Follow-up|5|||
23430437|NCT02613169|65320557|FG000|Overall Study|HIV|0|||
23430438|NCT02613169|65320558|FG001|Overall Study|HIV|2|||
23430439|NCT02613169|65320557|FG000|Overall Study|No TB infection endpoint|14|||
23430440|NCT02613169|65320558|FG001|Overall Study|No TB infection endpoint|9|||
23430441|NCT02558400|65320561|FG000|Overall Study|Adverse Event|47|||
23430442|NCT02558400|65320562|FG001|Overall Study|Adverse Event|53|||
23430443|NCT02558400|65320563|FG002|Overall Study|Adverse Event|4|||
23430444|NCT02558400|65320561|FG000|Overall Study|Withdrawal by Subject|13|||
23430445|NCT02558400|65320562|FG001|Overall Study|Withdrawal by Subject|9|||
23430446|NCT02558400|65320563|FG002|Overall Study|Withdrawal by Subject|8|||
23430447|NCT02558400|65320561|FG000|Overall Study|Non-Compliant|0|||
23430448|NCT02558400|65320562|FG001|Overall Study|Non-Compliant|1|||
23430449|NCT02558400|65320563|FG002|Overall Study|Non-Compliant|3|||
23430450|NCT02558400|65320561|FG000|Overall Study|Lost to Follow-up|5|||
23430451|NCT02558400|65320562|FG001|Overall Study|Lost to Follow-up|5|||
23430452|NCT02558400|65320563|FG002|Overall Study|Lost to Follow-up|4|||
23430453|NCT02558400|65320561|FG000|Overall Study|Lack of Efficacy|0|||
23430454|NCT02558400|65320562|FG001|Overall Study|Lack of Efficacy|13|||
23137671|NCT00774930|64252166|FG001|IOL Phase|Subject Decision|3|||
23137672|NCT00774930|64252165|FG000|IOL Phase|Physician Decision|3|||
23137673|NCT00774930|64252166|FG001|IOL Phase|Physician Decision|2|||
23430455|NCT02558400|65320563|FG002|Overall Study|Lack of Efficacy|1|||
23430456|NCT02558400|65320561|FG000|Overall Study|Disallowed Concurrent Medication|6|||
23430457|NCT02558400|65320562|FG001|Overall Study|Disallowed Concurrent Medication|7|||
23430458|NCT02558400|65320563|FG002|Overall Study|Disallowed Concurrent Medication|5|||
23430459|NCT02558400|65320561|FG000|Overall Study|Physician Decision|2|||
23430460|NCT02558400|65320562|FG001|Overall Study|Physician Decision|2|||
23430461|NCT02558400|65320563|FG002|Overall Study|Physician Decision|0|||
23430462|NCT02558400|65320561|FG000|Overall Study|Protocol Violation|6|||
23317654|NCT01000961|64904126|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
23430463|NCT02558400|65320562|FG001|Overall Study|Protocol Violation|3|||
23430464|NCT02558400|65320563|FG002|Overall Study|Protocol Violation|8|||
23430465|NCT02558400|65320561|FG000|Overall Study|Death|0|||
23430466|NCT02558400|65320562|FG001|Overall Study|Death|1|||
23430467|NCT02558400|65320563|FG002|Overall Study|Death|0|||
23430468|NCT02558400|65320561|FG000|Overall Study|Ineligible for the study|0|||
23430469|NCT02558400|65320562|FG001|Overall Study|Ineligible for the study|2|||
23430470|NCT02558400|65320563|FG002|Overall Study|Ineligible for the study|0|||
23430471|NCT02366767|65320564|FG000|Overall Study|left for home after 1 day at camp|1|||
23430472|NCT02366767|65320565|FG001|Overall Study|left for home after 1 day at camp|0|||
23430473|NCT02565810|65320567|FG000|Overall Study|Withdrawal by Subject|1|||
23430474|NCT02365285|65320570|FG000|Overall Study|Physician Decision|0|||
23430475|NCT02365285|65320571|FG001|Overall Study|Physician Decision|1|||
23430476|NCT02365285|65320572|FG002|Overall Study|Physician Decision|1|||
23430477|NCT02365285|65320573|FG003|Overall Study|Physician Decision|0|||
23430478|NCT02365285|65320570|FG000|Overall Study|Adverse Event|0|||
23430479|NCT02365285|65320571|FG001|Overall Study|Adverse Event|0|||
23430480|NCT02365285|65320572|FG002|Overall Study|Adverse Event|0|||
23430481|NCT02365285|65320573|FG003|Overall Study|Adverse Event|2|||
23430482|NCT02096263|65320574|FG000|Overall Study|Adverse Event|1|||
23430483|NCT02096263|65320575|FG001|Overall Study|Adverse Event|0|||
23430484|NCT02096263|65320576|FG002|Overall Study|Adverse Event|1|||
23430485|NCT02096263|65320574|FG000|Overall Study|Lost to Follow-up|14|||
23430486|NCT02096263|65320575|FG001|Overall Study|Lost to Follow-up|18|||
23430487|NCT02096263|65320576|FG002|Overall Study|Lost to Follow-up|15|||
23430488|NCT02096263|65320574|FG000|Overall Study|Other|7|||
23430489|NCT02096263|65320575|FG001|Overall Study|Other|9|||
23551955|NCT01380327|65747687|FG000|Overall Study|Housing situation precluded ability to k|0|||
23551956|NCT01380327|65747688|FG001|Overall Study|Housing situation precluded ability to k|0|||
23551957|NCT01380327|65747689|FG002|Overall Study|Housing situation precluded ability to k|1|||
23551958|NCT01380327|65747687|FG000|Overall Study|Questionable onset of epilepsy|0|||
23551959|NCT01380327|65747688|FG001|Overall Study|Questionable onset of epilepsy|0|||
23551960|NCT01380327|65747689|FG002|Overall Study|Questionable onset of epilepsy|1|||
23551961|NCT01563536|65747691|FG000|Overall Study|Withdrawal by Subject|0|||
23137674|NCT00774930|64252165|FG000|IOL Phase|Sponsor Decision|1|||
23317655|NCT01000961|64904127|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23317656|NCT01000961|64904126|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
23317657|NCT01000961|64904127|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
23317658|NCT01128543|64904128|FG000|Overall Study|Withdrawal by Subject|3|||
23317659|NCT01128543|64904128|FG000|Overall Study|Protocol Violation|1|||
23317660|NCT00445146|64904129|FG000|Overall Study|Withdrew Consent|29|||
23317661|NCT00445146|64904129|FG000|Overall Study|Lack of Efficacy|28|||
23137675|NCT00774930|64252166|FG001|IOL Phase|Sponsor Decision|0|||
23137676|NCT00774930|64252165|FG000|IOL Phase|Disease Progression|2|||
23137677|NCT00774930|64252166|FG001|IOL Phase|Disease Progression|1|||
23137678|NCT00774930|64252165|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
23137679|NCT00774930|64252166|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
23137680|NCT00774930|64252165|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
23137681|NCT00774930|64252166|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
23317662|NCT00445146|64904129|FG000|Overall Study|Investigator's Discretion|22|||
23317663|NCT00445146|64904129|FG000|Overall Study|Adverse Event|13|||
23317664|NCT00445146|64904129|FG000|Overall Study|Lost to Follow-up|13|||
23317665|NCT00445146|64904129|FG000|Overall Study|Death|9|||
23317666|NCT00445146|64904129|FG000|Overall Study|Protocol Violation|4|||
23137682|NCT00774930|64252165|FG000|IOL Phase|Other|1|||
23137683|NCT00774930|64252166|FG001|IOL Phase|Other|0|||
23137684|NCT00774930|64252165|FG000|IOL Phase|Brain radiation|0|||
23137685|NCT00774930|64252166|FG001|IOL Phase|Brain radiation|1|||
23137686|NCT00774930|64252165|FG000|LTOLE Phase|Adverse Event|7|||
23137687|NCT00774930|64252166|FG001|LTOLE Phase|Adverse Event|3|||
23317667|NCT00445146|64904129|FG000|Overall Study|Pregnancy|1|||
23317668|NCT03510598|64904130|FG000|Overall Study|Withdrawal by Subject|1|||
23317669|NCT00626561|64904131|FG000|Overall Study|Withdrawal by Subject|2|||
23317670|NCT00626561|64904131|FG000|Overall Study|Disease Progression|2|||
23317671|NCT02290223|64904132|FG000|6 Months|Lost to Follow-up|9|||
23430490|NCT02096263|65320576|FG002|Overall Study|Other|6|||
23430491|NCT02096263|65320574|FG000|Overall Study|Sponsor study termination|0|||
23430492|NCT02096263|65320575|FG001|Overall Study|Sponsor study termination|0|||
23430493|NCT02096263|65320576|FG002|Overall Study|Sponsor study termination|1|||
23430494|NCT02096263|65320574|FG000|Overall Study|Protocol Violation|7|||
23430495|NCT02096263|65320575|FG001|Overall Study|Protocol Violation|2|||
23317672|NCT02290223|64904133|FG001|6 Months|Lost to Follow-up|6|||
23317673|NCT02290223|64904132|FG000|6 Months|Withdrawal by Subject|5|||
23317674|NCT02290223|64904133|FG001|6 Months|Withdrawal by Subject|0|||
23430496|NCT02096263|65320576|FG002|Overall Study|Protocol Violation|8|||
23430497|NCT02096263|65320574|FG000|Overall Study|Withdrawal by Subject|5|||
23430498|NCT02096263|65320575|FG001|Overall Study|Withdrawal by Subject|7|||
23137688|NCT00774930|64252165|FG000|LTOLE Phase|Subject decision|0|||
23317675|NCT02290223|64904132|FG000|6 Months|deceased (not related to study)|2|||
23430499|NCT02096263|65320576|FG002|Overall Study|Withdrawal by Subject|8|||
23317676|NCT02290223|64904133|FG001|6 Months|deceased (not related to study)|0|||
23317677|NCT02290223|64904132|FG000|12 Months|Lost to Follow-up|16|||
23317678|NCT02290223|64904133|FG001|12 Months|Lost to Follow-up|10|||
23317679|NCT02290223|64904132|FG000|12 Months|Refusal|0|||
23317680|NCT02290223|64904133|FG001|12 Months|Refusal|1|||
23317681|NCT00875797|64904134|FG000|Overall Study|Protocol Violation|6|||
23317682|NCT00875797|64904135|FG001|Overall Study|Protocol Violation|3|||
23317683|NCT01346293|64904146|FG000|Overall Study|Protocol Violation|30|||
23317684|NCT01346293|64904147|FG001|Overall Study|Protocol Violation|9|||
23317685|NCT01346293|64904146|FG000|Overall Study|Lost to Follow-up|21|||
23317686|NCT01346293|64904147|FG001|Overall Study|Lost to Follow-up|8|||
23317687|NCT01346293|64904146|FG000|Overall Study|Withdrawal by Subject|15|||
23430500|NCT00351273|65320577|FG000|Overall Study|Lost to Follow-up|1|||
23621306|NCT04270747|66000604|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
23621307|NCT04270747|66000605|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
23621308|NCT04270747|66000606|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
23621309|NCT04270747|66000604|FG000|Post Week 16|Miscellaneous|1|||
23621310|NCT04270747|66000605|FG001|Post Week 16|Miscellaneous|0|||
23621311|NCT04270747|66000606|FG002|Post Week 16|Miscellaneous|1|||
23621312|NCT03041701|66000611|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
23621313|NCT03041701|66000612|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
23621314|NCT03041701|66000613|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
23621315|NCT03041701|66000611|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
23621316|NCT03041701|66000612|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
23621317|NCT03041701|66000613|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
23621318|NCT00874497|66000623|FG000|Overall Study|Lost to Follow-up|2|||
23621319|NCT00874497|66000624|FG001|Overall Study|Lost to Follow-up|4|||
23621320|NCT00874497|66000623|FG000|Overall Study|Adverse Event|9|||
23621321|NCT00874497|66000624|FG001|Overall Study|Adverse Event|4|||
23621322|NCT00874497|66000623|FG000|Overall Study|Sponsor Discontinued Trial|7|||
23621323|NCT00874497|66000624|FG001|Overall Study|Sponsor Discontinued Trial|3|||
23621324|NCT00874497|66000623|FG000|Overall Study|Met Withdrawal Criteria|4|||
23621325|NCT00874497|66000624|FG001|Overall Study|Met Withdrawal Criteria|2|||
23621326|NCT00874497|66000623|FG000|Overall Study|Physician Decision|1|||
23621327|NCT00874497|66000624|FG001|Overall Study|Physician Decision|1|||
23621328|NCT00874497|66000623|FG000|Overall Study|Withdrawal by Subject|5|||
23621329|NCT00874497|66000624|FG001|Overall Study|Withdrawal by Subject|4|||
23621330|NCT03811834|66000625|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
23621331|NCT01920178|66000626|FG000|Overall Study|Lost to Follow-up|2|||
23621332|NCT01920178|66000627|FG001|Overall Study|Lost to Follow-up|1|||
23621333|NCT00766142|66000635|FG000|Overall Study|Protocol Violation|4|||
23621334|NCT00427778|66000641|FG000|First Intervention (4 Weeks)|no longer interested|1|||
23621335|NCT00427778|66000642|FG001|First Intervention (4 Weeks)|no longer interested|0|||
23621336|NCT00427778|66000641|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
23621337|NCT00427778|66000642|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
23621338|NCT00427778|66000641|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
23621339|NCT00427778|66000642|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
23621340|NCT00427778|66000641|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
23621341|NCT00427778|66000642|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
23621342|NCT00745121|66000644|FG000|Overall Study|Death|3|||
23621343|NCT00745121|66000645|FG001|Overall Study|Death|0|||
23621344|NCT00745121|66000644|FG000|Overall Study|Adverse Event|1|||
23621345|NCT00745121|66000645|FG001|Overall Study|Adverse Event|0|||
23621346|NCT00745121|66000644|FG000|Overall Study|Lost to Follow-up|1|||
23621347|NCT00745121|66000645|FG001|Overall Study|Lost to Follow-up|0|||
23621348|NCT00745121|66000644|FG000|Overall Study|Withdrawal by Subject|4|||
23621349|NCT00745121|66000645|FG001|Overall Study|Withdrawal by Subject|2|||
23137689|NCT00774930|64252166|FG001|LTOLE Phase|Subject decision|5|||
23137690|NCT00774930|64252165|FG000|LTOLE Phase|Physician Decision|4|||
23137691|NCT00774930|64252166|FG001|LTOLE Phase|Physician Decision|1|||
23137692|NCT00774930|64252165|FG000|LTOLE Phase|Sponsor decision|2|||
23137693|NCT00774930|64252166|FG001|LTOLE Phase|Sponsor decision|1|||
23137694|NCT00774930|64252165|FG000|LTOLE Phase|Disease Progression|2|||
23137695|NCT00774930|64252166|FG001|LTOLE Phase|Disease Progression|5|||
23137696|NCT00774930|64252165|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
23430501|NCT00351273|65320578|FG001|Overall Study|Lost to Follow-up|2|||
23430502|NCT00351273|65320579|FG002|Overall Study|Lost to Follow-up|5|||
23137697|NCT00774930|64252166|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
23137698|NCT00774930|64252165|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
23317688|NCT01346293|64904147|FG001|Overall Study|Withdrawal by Subject|4|||
23317689|NCT01346293|64904146|FG000|Overall Study|Other|1|||
23317690|NCT01346293|64904147|FG001|Overall Study|Other|0|||
23317691|NCT01964976|64904152|FG000|Overall Study|Protocol Violation|31|||
23621350|NCT00904722|66000646|FG000|Overall Study|Physician Decision|1|||
23621351|NCT01891890|66000648|FG000|Overall Study|Lost to Follow-up|0|||
23137699|NCT00774930|64252166|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
23137700|NCT03248492|64252168|FG000|Overall Study|Ongoing|23|||
23137701|NCT03248492|64252169|FG001|Overall Study|Ongoing|26|||
23137702|NCT03248492|64252170|FG002|Overall Study|Ongoing|3|||
23621352|NCT01891890|66000649|FG001|Overall Study|Lost to Follow-up|0|||
23621353|NCT01891890|66000650|FG002|Overall Study|Lost to Follow-up|1|||
23621354|NCT01891890|66000648|FG000|Overall Study|Study ended before endpoint reached|7|||
23621355|NCT01891890|66000649|FG001|Overall Study|Study ended before endpoint reached|3|||
23621356|NCT01891890|66000650|FG002|Overall Study|Study ended before endpoint reached|6|||
23621357|NCT00583115|66000651|FG000|Overall Study|Death|1|||
23621358|NCT04358068|66000654|FG000|Overall Study|Did not initiate study treatment|2|||
23621359|NCT04358068|66000655|FG001|Overall Study|Did not initiate study treatment|2|||
23621360|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
23621361|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
23621362|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
23621363|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
23621364|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
23621365|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
23621366|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
23621367|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
23621368|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
23621369|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
23621370|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
23621371|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
23621372|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
23621373|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
23621374|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
23621375|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
23621376|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
23621377|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
23621378|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
23621379|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
23621380|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
23621381|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
23621382|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
23621383|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
23621384|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
23621385|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
23621386|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
23621387|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
23621388|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
23621389|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
23621390|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
23621391|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
23621392|NCT00092521|66000656|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
23137703|NCT03248492|64252171|FG003|Overall Study|Ongoing|85|||
23137704|NCT03248492|64252172|FG004|Overall Study|Ongoing|2|||
23621393|NCT00092521|66000657|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
23621394|NCT00092521|66000658|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
23137705|NCT03248492|64252168|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
23137706|NCT03248492|64252169|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
23137707|NCT03248492|64252170|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
23621395|NCT00092521|66000659|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
23621396|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
23621397|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
23621398|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
23621399|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
23621400|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
23621401|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
23621402|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
23621403|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
23137708|NCT03248492|64252171|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
23137709|NCT03248492|64252172|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
23137710|NCT03248492|64252168|FG000|Overall Study|Adverse Event|6|||
23137711|NCT03248492|64252169|FG001|Overall Study|Adverse Event|6|||
23137712|NCT03248492|64252170|FG002|Overall Study|Adverse Event|8|||
23137713|NCT03248492|64252171|FG003|Overall Study|Adverse Event|8|||
23137714|NCT03248492|64252172|FG004|Overall Study|Adverse Event|1|||
23621404|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
23621405|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
23137715|NCT03248492|64252168|FG000|Overall Study|Withdrawal by Subject|3|||
23621406|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
23621407|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
23621408|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Death|2|||
23621409|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Death|0|||
23621410|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Death|1|||
23621411|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Death|0|||
23621412|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
23621413|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
23621414|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
23621415|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
23621416|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
23621417|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
23621418|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
23621419|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
23621420|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
23621421|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
23621422|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
23621423|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
23621424|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Moved|32|||
23621425|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Moved|2|||
23621426|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Moved|28|||
23621427|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Moved|0|||
23621428|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
23137716|NCT03248492|64252169|FG001|Overall Study|Withdrawal by Subject|3|||
23137717|NCT03248492|64252170|FG002|Overall Study|Withdrawal by Subject|0|||
23137718|NCT03248492|64252171|FG003|Overall Study|Withdrawal by Subject|3|||
23137719|NCT03248492|64252172|FG004|Overall Study|Withdrawal by Subject|1|||
23137720|NCT03248492|64252168|FG000|Overall Study|Physician Decision|1|||
23137721|NCT03248492|64252169|FG001|Overall Study|Physician Decision|0|||
23137722|NCT03248492|64252170|FG002|Overall Study|Physician Decision|1|||
23137723|NCT03248492|64252171|FG003|Overall Study|Physician Decision|2|||
23137724|NCT03248492|64252172|FG004|Overall Study|Physician Decision|0|||
23137725|NCT03248492|64252168|FG000|Overall Study|Death|1|||
23137726|NCT03248492|64252169|FG001|Overall Study|Death|0|||
23317692|NCT01266031|64904153|FG000|Overall Study|Not treated|0|||
23317693|NCT01266031|64904154|FG001|Overall Study|Not treated|3|||
23317694|NCT01266031|64904155|FG002|Overall Study|Not treated|2|||
23317695|NCT00683657|64904165|FG000|Overall Study|Adverse Event|0|||
23551962|NCT01563536|65747692|FG001|Overall Study|Withdrawal by Subject|2|||
23551963|NCT01563536|65747691|FG000|Overall Study|Lost to Follow-up|1|||
23551964|NCT01563536|65747692|FG001|Overall Study|Lost to Follow-up|0|||
23551965|NCT00729833|65747694|FG000|Overall Study|Death|5|||
23551966|NCT00729833|65747695|FG001|Overall Study|Death|1|||
23551967|NCT00729833|65747696|FG002|Overall Study|Death|3|||
23551968|NCT00729833|65747697|FG003|Overall Study|Death|5|||
23551969|NCT00729833|65747694|FG000|Overall Study|Study Terminated by Sponsor|0|||
23551970|NCT00729833|65747695|FG001|Overall Study|Study Terminated by Sponsor|0|||
23551971|NCT00729833|65747696|FG002|Overall Study|Study Terminated by Sponsor|1|||
23551972|NCT00729833|65747697|FG003|Overall Study|Study Terminated by Sponsor|0|||
23551973|NCT00729833|65747694|FG000|Overall Study|Lost to Follow-up|1|||
23551974|NCT00729833|65747695|FG001|Overall Study|Lost to Follow-up|0|||
23551975|NCT00729833|65747696|FG002|Overall Study|Lost to Follow-up|0|||
23551976|NCT00729833|65747697|FG003|Overall Study|Lost to Follow-up|0|||
23551977|NCT00729833|65747694|FG000|Overall Study|Withdrawal by Subject|3|||
23551978|NCT00729833|65747695|FG001|Overall Study|Withdrawal by Subject|1|||
23551979|NCT00729833|65747696|FG002|Overall Study|Withdrawal by Subject|3|||
23551980|NCT00729833|65747697|FG003|Overall Study|Withdrawal by Subject|0|||
23551981|NCT00729833|65747694|FG000|Overall Study|Unspecified Reasons|11|||
23551982|NCT00729833|65747695|FG001|Overall Study|Unspecified Reasons|5|||
23551983|NCT00729833|65747696|FG002|Overall Study|Unspecified Reasons|5|||
23551984|NCT00729833|65747697|FG003|Overall Study|Unspecified Reasons|1|||
23551985|NCT01880424|65747702|FG000|Overall Study|Adverse Event|7|||
23551986|NCT01880424|65747703|FG001|Overall Study|Adverse Event|6|||
23551987|NCT01880424|65747702|FG000|Overall Study|Lack of Efficacy|1|||
23551988|NCT01880424|65747703|FG001|Overall Study|Lack of Efficacy|4|||
23551989|NCT01880424|65747702|FG000|Overall Study|Lost to Follow-up|3|||
23551990|NCT01880424|65747703|FG001|Overall Study|Lost to Follow-up|2|||
23551991|NCT01880424|65747702|FG000|Overall Study|Protocol Violation|11|||
23551992|NCT01880424|65747703|FG001|Overall Study|Protocol Violation|13|||
23551993|NCT01880424|65747702|FG000|Overall Study|Withdrawal by Subject|10|||
23551994|NCT01880424|65747703|FG001|Overall Study|Withdrawal by Subject|30|||
23551995|NCT01880424|65747702|FG000|Overall Study|Other|1|||
23551996|NCT01880424|65747703|FG001|Overall Study|Other|0|||
23551997|NCT02477111|65747704|FG000|Overall Study|Death|28|||
23551998|NCT02477111|65747704|FG000|Overall Study|Withdrawal by Subject|19|||
23551999|NCT02477111|65747704|FG000|Overall Study|Lost to Follow-up|4|||
23137727|NCT03248492|64252170|FG002|Overall Study|Death|0|||
23137728|NCT03248492|64252171|FG003|Overall Study|Death|6|||
23317696|NCT00683657|64904166|FG001|Overall Study|Adverse Event|1|||
23215170|NCT00050960|64528162|FG001|Overall Study|Administrative|46|||
23215171|NCT00050960|64528161|FG000|Overall Study|Non-compliance|3|||
23215172|NCT00050960|64528162|FG001|Overall Study|Non-compliance|1|||
23215173|NCT00050960|64528161|FG000|Overall Study|Death|13|||
23215174|NCT00050960|64528162|FG001|Overall Study|Death|15|||
23215175|NCT01828099|64528165|FG000|Overall Study|Adverse Event|15|||
23215176|NCT01828099|64528166|FG001|Overall Study|Adverse Event|18|||
23215177|NCT01828099|64528165|FG000|Overall Study|Death|9|||
23215178|NCT01828099|64528166|FG001|Overall Study|Death|11|||
23215179|NCT01828099|64528165|FG000|Overall Study|Lost to Follow-up|2|||
23215180|NCT01828099|64528166|FG001|Overall Study|Lost to Follow-up|0|||
23215181|NCT01828099|64528165|FG000|Overall Study|Non-compliance with study treatment|2|||
23215182|NCT01828099|64528166|FG001|Overall Study|Non-compliance with study treatment|0|||
23215183|NCT01828099|64528165|FG000|Overall Study|Physician Decision|7|||
23215184|NCT01828099|64528166|FG001|Overall Study|Physician Decision|11|||
23215185|NCT01828099|64528165|FG000|Overall Study|Progressive disease|51|||
23215186|NCT01828099|64528166|FG001|Overall Study|Progressive disease|94|||
23552000|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
23552001|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
23552002|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
23552003|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552004|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552005|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552006|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552007|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552008|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552009|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552010|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552011|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552012|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552013|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
23552014|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
23552015|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
23552016|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
23552017|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552018|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552019|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552020|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552021|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552022|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552023|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552024|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552025|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552026|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23552027|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
23137729|NCT03248492|64252172|FG004|Overall Study|Death|0|||
23137730|NCT03248492|64252168|FG000|Overall Study|Other|0|||
23137731|NCT03248492|64252169|FG001|Overall Study|Other|1|||
23137732|NCT03248492|64252170|FG002|Overall Study|Other|0|||
23137733|NCT03248492|64252171|FG003|Overall Study|Other|4|||
23137734|NCT03248492|64252172|FG004|Overall Study|Other|0|||
23137735|NCT03412747|64252173|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
23137736|NCT03412747|64252174|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
23137737|NCT03412747|64252175|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
23137738|NCT03412747|64252173|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
23137739|NCT03412747|64252174|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
23137740|NCT03412747|64252175|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
23137741|NCT03412747|64252173|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
23137742|NCT03412747|64252174|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
23137743|NCT03412747|64252175|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
23137744|NCT03412747|64252173|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
23137745|NCT03412747|64252174|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
23137746|NCT03412747|64252175|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
23137747|NCT03412747|64252173|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
23552028|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
23137748|NCT03412747|64252174|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
23137749|NCT03412747|64252175|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
23137750|NCT03412747|64252173|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
23215187|NCT01828099|64528165|FG000|Overall Study|Protocol Violation|1|||
23215188|NCT01828099|64528166|FG001|Overall Study|Protocol Violation|0|||
23215189|NCT01828099|64528165|FG000|Overall Study|Subject/guardian decision|7|||
23215190|NCT01828099|64528166|FG001|Overall Study|Subject/guardian decision|23|||
23215191|NCT02807844|64528167|FG000|Overall Study|Physician Decision|0|||
23215192|NCT02807844|64528168|FG001|Overall Study|Physician Decision|0|||
23215193|NCT02807844|64528169|FG002|Overall Study|Physician Decision|0|||
23215194|NCT02807844|64528170|FG003|Overall Study|Physician Decision|0|||
23215195|NCT02807844|64528171|FG004|Overall Study|Physician Decision|0|||
23215196|NCT02807844|64528172|FG005|Overall Study|Physician Decision|0|||
23215197|NCT02807844|64528173|FG006|Overall Study|Physician Decision|3|||
23215198|NCT02807844|64528174|FG007|Overall Study|Physician Decision|0|||
23137751|NCT03412747|64252174|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
23137752|NCT03412747|64252175|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
23137753|NCT03412747|64252173|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
23137754|NCT03412747|64252174|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
23137755|NCT03412747|64252175|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
23137756|NCT03412747|64252173|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
23137757|NCT03412747|64252174|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
23137758|NCT03412747|64252175|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
23137759|NCT03412747|64252173|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
23137760|NCT03412747|64252174|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
23137761|NCT03412747|64252175|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
23215199|NCT02807844|64528175|FG008|Overall Study|Physician Decision|1|||
23215200|NCT02807844|64528176|FG009|Overall Study|Physician Decision|2|||
23215201|NCT02807844|64528167|FG000|Overall Study|Death|0|||
23215202|NCT02807844|64528168|FG001|Overall Study|Death|0|||
23215203|NCT02807844|64528169|FG002|Overall Study|Death|2|||
23215204|NCT02807844|64528170|FG003|Overall Study|Death|4|||
23215205|NCT02807844|64528171|FG004|Overall Study|Death|1|||
23215206|NCT02807844|64528172|FG005|Overall Study|Death|2|||
23215207|NCT02807844|64528173|FG006|Overall Study|Death|1|||
23215208|NCT02807844|64528174|FG007|Overall Study|Death|2|||
23215209|NCT02807844|64528175|FG008|Overall Study|Death|0|||
23621429|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
23621430|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
23621431|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
23621432|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Travel|2|||
23621433|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Travel|0|||
23621434|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Travel|0|||
23621435|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Travel|0|||
23621436|NCT00092521|66000656|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
23137762|NCT03412747|64252173|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
23137763|NCT03412747|64252174|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
23137764|NCT03412747|64252175|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
23215210|NCT02807844|64528176|FG009|Overall Study|Death|1|||
23215211|NCT02807844|64528167|FG000|Overall Study|Withdrawal by Subject|0|||
23215212|NCT02807844|64528168|FG001|Overall Study|Withdrawal by Subject|0|||
23215213|NCT02807844|64528169|FG002|Overall Study|Withdrawal by Subject|2|||
23137765|NCT03412747|64252173|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
23137766|NCT03412747|64252174|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
23137767|NCT03412747|64252175|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
23137768|NCT03412747|64252173|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
23137769|NCT03412747|64252174|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
23137770|NCT03412747|64252175|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
23137771|NCT03412747|64252173|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
23137772|NCT03412747|64252174|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
23137773|NCT03412747|64252175|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
23215214|NCT02807844|64528170|FG003|Overall Study|Withdrawal by Subject|1|||
23215215|NCT02807844|64528171|FG004|Overall Study|Withdrawal by Subject|1|||
23215216|NCT02807844|64528172|FG005|Overall Study|Withdrawal by Subject|0|||
23215217|NCT02807844|64528173|FG006|Overall Study|Withdrawal by Subject|1|||
23215218|NCT02807844|64528174|FG007|Overall Study|Withdrawal by Subject|0|||
23215219|NCT02807844|64528175|FG008|Overall Study|Withdrawal by Subject|0|||
23215220|NCT02807844|64528176|FG009|Overall Study|Withdrawal by Subject|0|||
23215221|NCT02807844|64528167|FG000|Overall Study|Progressive disease|5|||
23621437|NCT00092521|66000657|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
23621438|NCT00092521|66000658|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
23215222|NCT02807844|64528168|FG001|Overall Study|Progressive disease|12|||
23215223|NCT02807844|64528169|FG002|Overall Study|Progressive disease|8|||
23215224|NCT02807844|64528170|FG003|Overall Study|Progressive disease|8|||
23621439|NCT00092521|66000659|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
23215225|NCT02807844|64528171|FG004|Overall Study|Progressive disease|3|||
23215226|NCT02807844|64528172|FG005|Overall Study|Progressive disease|8|||
23215227|NCT02807844|64528173|FG006|Overall Study|Progressive disease|14|||
23215228|NCT02807844|64528174|FG007|Overall Study|Progressive disease|17|||
23215229|NCT02807844|64528175|FG008|Overall Study|Progressive disease|19|||
23621440|NCT00092521|66000656|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
23215230|NCT02807844|64528176|FG009|Overall Study|Progressive disease|15|||
23215231|NCT02807844|64528167|FG000|Overall Study|Adverse Event|1|||
23215232|NCT02807844|64528168|FG001|Overall Study|Adverse Event|0|||
23215233|NCT02807844|64528169|FG002|Overall Study|Adverse Event|0|||
23215234|NCT02807844|64528170|FG003|Overall Study|Adverse Event|0|||
23215235|NCT02807844|64528171|FG004|Overall Study|Adverse Event|1|||
23215236|NCT02807844|64528172|FG005|Overall Study|Adverse Event|1|||
23215237|NCT02807844|64528173|FG006|Overall Study|Adverse Event|1|||
23215238|NCT02807844|64528174|FG007|Overall Study|Adverse Event|1|||
23215239|NCT02807844|64528175|FG008|Overall Study|Adverse Event|1|||
23215240|NCT02807844|64528176|FG009|Overall Study|Adverse Event|2|||
23215241|NCT00732641|64528184|FG000|Overall Study|Relapse or Progressive Disease|65|||
23215242|NCT00732641|64528185|FG001|Overall Study|Relapse or Progressive Disease|101|||
23215243|NCT00732641|64528184|FG000|Overall Study|Serious Adverse Events|12|||
23215244|NCT00732641|64528185|FG001|Overall Study|Serious Adverse Events|3|||
23215245|NCT00732641|64528184|FG000|Overall Study|Physician Decision|6|||
23215246|NCT00732641|64528185|FG001|Overall Study|Physician Decision|0|||
23215247|NCT00732641|64528184|FG000|Overall Study|Withdrawal by Subject|4|||
23215248|NCT00732641|64528185|FG001|Overall Study|Withdrawal by Subject|2|||
23215249|NCT00732641|64528184|FG000|Overall Study|Unable to Complete|1|||
23215250|NCT00732641|64528185|FG001|Overall Study|Unable to Complete|1|||
23215251|NCT00732641|64528184|FG000|Overall Study|Other|18|||
23215252|NCT00732641|64528185|FG001|Overall Study|Other|5|||
23215253|NCT01225172|64528186|FG000|Overall Study|Subject decision to stop|1|||
23215254|NCT01225172|64528187|FG001|Overall Study|Subject decision to stop|0|||
23215255|NCT01225172|64528186|FG000|Overall Study|Subject request to discontinue treatment|3|||
23215256|NCT01225172|64528187|FG001|Overall Study|Subject request to discontinue treatment|1|||
23215257|NCT01225172|64528186|FG000|Overall Study|Subject no longer meets study criteria|1|||
23215258|NCT01225172|64528187|FG001|Overall Study|Subject no longer meets study criteria|0|||
23215259|NCT01225172|64528186|FG000|Overall Study|Withdrawal by Subject|1|||
23215260|NCT01225172|64528187|FG001|Overall Study|Withdrawal by Subject|0|||
23215261|NCT01453998|64528191|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
23215262|NCT01453998|64528192|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
23215263|NCT01453998|64528193|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
23215264|NCT03549429|64528194|FG000|Overall Study|Protocol Violation|5|||
23215265|NCT03549429|64528195|FG001|Overall Study|Protocol Violation|3|||
23215266|NCT01532570|64528196|FG000|Overall Study|Lack of Efficacy|1|||
23215267|NCT01532570|64528197|FG001|Overall Study|Lack of Efficacy|0|||
23215268|NCT01532570|64528198|FG002|Overall Study|Lack of Efficacy|0|||
23215269|NCT01532570|64528199|FG003|Overall Study|Lack of Efficacy|0|||
23215270|NCT01532570|64528196|FG000|Overall Study|Withdrawal by Subject|0|||
23215271|NCT01532570|64528197|FG001|Overall Study|Withdrawal by Subject|1|||
23215272|NCT01532570|64528198|FG002|Overall Study|Withdrawal by Subject|0|||
23215273|NCT01532570|64528199|FG003|Overall Study|Withdrawal by Subject|0|||
23215274|NCT01544478|64528200|FG000|Overall Study|Adverse Event|1|||
23215275|NCT01544478|64528200|FG000|Overall Study|Death|1|||
23215276|NCT01544478|64528200|FG000|Overall Study|Lost to Follow-up|48|||
23215277|NCT01544478|64528200|FG000|Overall Study|Physician Decision|15|||
23215278|NCT01544478|64528200|FG000|Overall Study|Pregnancy|1|||
23137774|NCT03412747|64252173|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
23137775|NCT03412747|64252174|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
23137776|NCT03412747|64252175|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
23137777|NCT03412747|64252173|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
23137778|NCT03412747|64252174|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
23137779|NCT03412747|64252175|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
23137780|NCT03412747|64252173|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
23137781|NCT03412747|64252174|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
23137782|NCT03412747|64252175|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
23137783|NCT03538301|64252176|FG000|Overall Study|Adverse Event|1|||
23137784|NCT03538301|64252177|FG001|Overall Study|Adverse Event|4|||
23137785|NCT03538301|64252178|FG002|Overall Study|Adverse Event|4|||
23137786|NCT03538301|64252176|FG000|Overall Study|Death|1|||
23137787|NCT03538301|64252177|FG001|Overall Study|Death|1|||
23137788|NCT03538301|64252178|FG002|Overall Study|Death|0|||
23215279|NCT01544478|64528200|FG000|Overall Study|Withdrawal by Subject|52|||
23317697|NCT00683657|64904165|FG000|Overall Study|Subject Withdrew Consent|1|||
23430503|NCT03361189|65320584|FG000|Overall Study|Received heart transplant|1|||
23137789|NCT03538301|64252176|FG000|Overall Study|Physician Decision|0|||
23137790|NCT03538301|64252177|FG001|Overall Study|Physician Decision|1|||
23215280|NCT00796003|64528201|FG000|Overall Study|Disease Progression|2|||
23215281|NCT00796003|64528202|FG001|Overall Study|Disease Progression|13|||
23215282|NCT00796003|64528201|FG000|Overall Study|Adverse Event|1|||
23215283|NCT00796003|64528202|FG001|Overall Study|Adverse Event|7|||
23215284|NCT00796003|64528201|FG000|Overall Study|Specified organ function not met|0|||
23215285|NCT00796003|64528202|FG001|Overall Study|Specified organ function not met|1|||
23215286|NCT00796003|64528201|FG000|Overall Study|Physician Decision|0|||
23215287|NCT00796003|64528202|FG001|Overall Study|Physician Decision|4|||
23215288|NCT00796003|64528201|FG000|Overall Study|Withdrawal by Subject|0|||
23215289|NCT00796003|64528202|FG001|Overall Study|Withdrawal by Subject|1|||
23215290|NCT00796003|64528201|FG000|Overall Study|Other|0|||
23215291|NCT00796003|64528202|FG001|Overall Study|Other|1|||
23215292|NCT00796003|64528201|FG000|Overall Study|Participants Not treated|0|||
23215293|NCT00796003|64528202|FG001|Overall Study|Participants Not treated|2|||
23430504|NCT03361189|65320585|FG001|Overall Study|Received heart transplant|0|||
23552029|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
23621441|NCT00092521|66000657|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
23621442|NCT00092521|66000658|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
23621443|NCT00092521|66000659|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
23621444|NCT00092521|66000656|FG000|Extension Study (Group 4)|Adverse Event|0|||
23621445|NCT00092521|66000657|FG001|Extension Study (Group 4)|Adverse Event|0|||
23621446|NCT00092521|66000658|FG002|Extension Study (Group 4)|Adverse Event|0|||
23621447|NCT00092521|66000659|FG003|Extension Study (Group 4)|Adverse Event|2|||
23621448|NCT00092521|66000656|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
23137791|NCT03538301|64252178|FG002|Overall Study|Physician Decision|0|||
23137792|NCT03538301|64252176|FG000|Overall Study|Protocol Violation|0|||
23137793|NCT03538301|64252177|FG001|Overall Study|Protocol Violation|0|||
23137794|NCT03538301|64252178|FG002|Overall Study|Protocol Violation|1|||
23552030|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
23552031|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552032|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552033|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552034|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552035|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552036|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552037|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552038|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552039|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552040|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552041|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
23552042|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
23621449|NCT00092521|66000657|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
23137795|NCT03538301|64252176|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
23137796|NCT03538301|64252177|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
23137797|NCT03538301|64252178|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
23137798|NCT00621777|64252179|FG000|Open Phase|Adverse Event|20|||
23137799|NCT00621777|64252180|FG001|Open Phase|Adverse Event|0|||
23137800|NCT00621777|64252179|FG000|Open Phase|Did not abstain during open phase|56|||
23137801|NCT00621777|64252180|FG001|Open Phase|Did not abstain during open phase|0|||
23137802|NCT00621777|64252179|FG000|Open Phase|Withdrawal by Subject|17|||
23137803|NCT00621777|64252180|FG001|Open Phase|Withdrawal by Subject|0|||
23137804|NCT00621777|64252179|FG000|Open Phase|administrative|13|||
23137805|NCT00621777|64252180|FG001|Open Phase|administrative|0|||
23137806|NCT00621777|64252179|FG000|Open Phase|Lost to Follow-up|10|||
23137807|NCT00621777|64252180|FG001|Open Phase|Lost to Follow-up|0|||
23137808|NCT00621777|64252179|FG000|Randomized Phase|Adverse Event|3|||
23137809|NCT00621777|64252180|FG001|Randomized Phase|Adverse Event|3|||
23137810|NCT00621777|64252179|FG000|Randomized Phase|Lost to Follow-up|3|||
23137811|NCT00621777|64252180|FG001|Randomized Phase|Lost to Follow-up|3|||
23137812|NCT00621777|64252179|FG000|Randomized Phase|Withdrawal by Subject|1|||
23137813|NCT00621777|64252180|FG001|Randomized Phase|Withdrawal by Subject|9|||
23137814|NCT00621777|64252179|FG000|Randomized Phase|administrative|0|||
23137815|NCT00621777|64252180|FG001|Randomized Phase|administrative|3|||
23137816|NCT00621777|64252179|FG000|Randomized Phase|Death|0|||
23137817|NCT00621777|64252180|FG001|Randomized Phase|Death|1|||
23137818|NCT02549196|64252181|FG000|Overall Study|Protocol Violation|0|||
23137819|NCT02549196|64252182|FG001|Overall Study|Protocol Violation|0|||
23137820|NCT02549196|64252183|FG002|Overall Study|Protocol Violation|0|||
23137821|NCT02549196|64252184|FG003|Overall Study|Protocol Violation|1|||
23137822|NCT02549196|64252181|FG000|Overall Study|Withdrawal by Subject|1|||
23137823|NCT02549196|64252182|FG001|Overall Study|Withdrawal by Subject|0|||
23137824|NCT02549196|64252183|FG002|Overall Study|Withdrawal by Subject|1|||
23137825|NCT02549196|64252184|FG003|Overall Study|Withdrawal by Subject|0|||
23137826|NCT04606771|64252185|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
23215294|NCT02174861|64528208|FG000|Overall Study|Decision by sponsor|8|||
23137827|NCT04606771|64252186|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
23137828|NCT04606771|64252185|FG000|Overall Study|Death|5|||
23215295|NCT02174861|64528208|FG000|Overall Study|Withdrawal by Subject|124|||
23215296|NCT02174861|64528208|FG000|Overall Study|Lost to Follow-up|26|||
23430505|NCT03361189|65320584|FG000|Overall Study|Pacemake replacement|0|||
23621450|NCT00092521|66000658|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
23621451|NCT00092521|66000659|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
23621452|NCT00092521|66000656|FG000|Extension Study (Group 4)|Pregnancy|0|||
23621453|NCT00092521|66000657|FG001|Extension Study (Group 4)|Pregnancy|0|||
23621454|NCT00092521|66000658|FG002|Extension Study (Group 4)|Pregnancy|0|||
23621455|NCT00092521|66000659|FG003|Extension Study (Group 4)|Pregnancy|4|||
23621456|NCT00092521|66000656|FG000|Extension Study (Group 4)|Protocol Violation|0|||
23621457|NCT00092521|66000657|FG001|Extension Study (Group 4)|Protocol Violation|0|||
23621458|NCT00092521|66000658|FG002|Extension Study (Group 4)|Protocol Violation|0|||
23621459|NCT00092521|66000659|FG003|Extension Study (Group 4)|Protocol Violation|2|||
23621460|NCT00092521|66000656|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
23621461|NCT00092521|66000657|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
23621462|NCT00092521|66000658|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
23621463|NCT00092521|66000659|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
23621464|NCT00092521|66000656|FG000|Extension Study (Group 4)|Moved|0|||
23621465|NCT00092521|66000657|FG001|Extension Study (Group 4)|Moved|0|||
23621466|NCT00092521|66000658|FG002|Extension Study (Group 4)|Moved|0|||
23621467|NCT00092521|66000659|FG003|Extension Study (Group 4)|Moved|16|||
23621468|NCT00092521|66000656|FG000|Extension Study (Group 4)|Site Terminated|0|||
23621469|NCT00092521|66000657|FG001|Extension Study (Group 4)|Site Terminated|0|||
23621470|NCT00092521|66000658|FG002|Extension Study (Group 4)|Site Terminated|0|||
23621471|NCT00092521|66000659|FG003|Extension Study (Group 4)|Site Terminated|4|||
23621472|NCT00092521|66000656|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
23621473|NCT00092521|66000657|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
23621474|NCT00092521|66000658|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
23621475|NCT00092521|66000659|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
23621476|NCT00225277|66000662|FG000|Overall Study|Adverse Event|30|||
23621477|NCT00225277|66000663|FG001|Overall Study|Adverse Event|34|||
23621478|NCT00225277|66000662|FG000|Overall Study|Lack of Efficacy|4|||
23621479|NCT00225277|66000663|FG001|Overall Study|Lack of Efficacy|1|||
23621480|NCT00225277|66000662|FG000|Overall Study|Lost to Follow-up|4|||
23621481|NCT00225277|66000663|FG001|Overall Study|Lost to Follow-up|6|||
23621482|NCT00225277|66000662|FG000|Overall Study|Physician Decision|6|||
23621483|NCT00225277|66000663|FG001|Overall Study|Physician Decision|8|||
23621484|NCT00225277|66000662|FG000|Overall Study|Protocol Violation|6|||
23621485|NCT00225277|66000663|FG001|Overall Study|Protocol Violation|3|||
23621486|NCT00225277|66000662|FG000|Overall Study|Withdrawal by Subject|40|||
23621487|NCT00225277|66000663|FG001|Overall Study|Withdrawal by Subject|34|||
23621488|NCT00225277|66000662|FG000|Overall Study|Other|7|||
23621489|NCT00225277|66000663|FG001|Overall Study|Other|9|||
23621490|NCT04191148|66000664|FG000|Overall Study|Withdrawal by Subject|1|||
23621491|NCT04191148|66000665|FG001|Overall Study|Withdrawal by Subject|0|||
23621492|NCT04191148|66000664|FG000|Overall Study|Adverse Event|1|||
23621493|NCT04191148|66000665|FG001|Overall Study|Adverse Event|0|||
23621494|NCT04531813|66000666|FG000|Overall Study|Protocol Violation|1|||
23621495|NCT04531813|66000666|FG000|Overall Study|Withdrawal by Subject|1|||
23621496|NCT02230306|66000672|FG000|Overall Study|Did not receive study treatment|1|||
23621497|NCT03036150|66000680|FG000|Overall Study|Withdrawal by Subject|8|||
23621498|NCT03036150|66000681|FG001|Overall Study|Withdrawal by Subject|3|||
23621499|NCT03036150|66000680|FG000|Overall Study|Lost to Follow-up|2|||
23621500|NCT03036150|66000681|FG001|Overall Study|Lost to Follow-up|2|||
23621501|NCT02330562|66000682|FG000|Overall Study|Adverse Event|0|||
23621502|NCT02330562|66000683|FG001|Overall Study|Adverse Event|0|||
23621503|NCT02330562|66000684|FG002|Overall Study|Adverse Event|3|||
23137829|NCT04606771|64252186|FG001|Overall Study|Death|6|||
23137830|NCT04606771|64252185|FG000|Overall Study|Wrong randomisation|0|||
23137831|NCT04606771|64252186|FG001|Overall Study|Wrong randomisation|1|||
23137832|NCT01200589|64252190|FG000|Overall Study|Withdrawal by Subject|13|||
23621504|NCT02330562|66000685|FG003|Overall Study|Adverse Event|0|||
23621505|NCT02330562|66000686|FG004|Overall Study|Adverse Event|3|||
23621506|NCT02330562|66000687|FG005|Overall Study|Adverse Event|1|||
23621507|NCT02330562|66000688|FG006|Overall Study|Adverse Event|0|||
23621508|NCT02330562|66000689|FG007|Overall Study|Adverse Event|0|||
23137833|NCT01200589|64252191|FG001|Overall Study|Withdrawal by Subject|11|||
23137834|NCT01200589|64252190|FG000|Overall Study|Physician Decision|2|||
23137835|NCT01200589|64252191|FG001|Overall Study|Physician Decision|2|||
23137836|NCT01200589|64252190|FG000|Overall Study|Lost to Follow-up|5|||
23621509|NCT02330562|66000690|FG008|Overall Study|Adverse Event|0|||
23621510|NCT02330562|66000691|FG009|Overall Study|Adverse Event|1|||
23621511|NCT02330562|66000692|FG010|Overall Study|Adverse Event|1|||
23621512|NCT02330562|66000682|FG000|Overall Study|Participant decision|1|||
23621513|NCT02330562|66000683|FG001|Overall Study|Participant decision|0|||
23621514|NCT02330562|66000684|FG002|Overall Study|Participant decision|4|||
23621515|NCT02330562|66000685|FG003|Overall Study|Participant decision|1|||
23621516|NCT02330562|66000686|FG004|Overall Study|Participant decision|5|||
23621517|NCT02330562|66000687|FG005|Overall Study|Participant decision|2|||
23621518|NCT02330562|66000688|FG006|Overall Study|Participant decision|0|||
23621519|NCT02330562|66000689|FG007|Overall Study|Participant decision|0|||
23621520|NCT02330562|66000690|FG008|Overall Study|Participant decision|0|||
23621521|NCT02330562|66000691|FG009|Overall Study|Participant decision|3|||
23621522|NCT02330562|66000692|FG010|Overall Study|Participant decision|0|||
23621523|NCT02330562|66000682|FG000|Overall Study|Disease progression|5|||
23621524|NCT02330562|66000683|FG001|Overall Study|Disease progression|3|||
23621525|NCT02330562|66000684|FG002|Overall Study|Disease progression|20|||
23621526|NCT02330562|66000685|FG003|Overall Study|Disease progression|28|||
23621527|NCT02330562|66000686|FG004|Overall Study|Disease progression|23|||
23621528|NCT02330562|66000687|FG005|Overall Study|Disease progression|7|||
23621529|NCT02330562|66000688|FG006|Overall Study|Disease progression|1|||
23621530|NCT02330562|66000689|FG007|Overall Study|Disease progression|1|||
23621531|NCT02330562|66000690|FG008|Overall Study|Disease progression|1|||
23621532|NCT02330562|66000691|FG009|Overall Study|Disease progression|0|||
23621533|NCT02330562|66000692|FG010|Overall Study|Disease progression|5|||
23621534|NCT02330562|66000682|FG000|Overall Study|Other reasons|0|||
23621535|NCT02330562|66000683|FG001|Overall Study|Other reasons|0|||
23621536|NCT02330562|66000684|FG002|Overall Study|Other reasons|0|||
23621537|NCT02330562|66000685|FG003|Overall Study|Other reasons|1|||
23621538|NCT02330562|66000686|FG004|Overall Study|Other reasons|0|||
23137837|NCT01200589|64252191|FG001|Overall Study|Lost to Follow-up|4|||
23137838|NCT01200589|64252190|FG000|Overall Study|Study terminated|170|||
23137839|NCT01200589|64252191|FG001|Overall Study|Study terminated|172|||
23137840|NCT04371198|64252193|FG000|Overall Study|inadequate sample|4|||
23137841|NCT00721149|64252194|FG000|Overall Study|Physician Decision|1|||
23137842|NCT05132127|64252195|FG000|Overall Study|Adverse Event|1|||
23137843|NCT01983254|64252197|FG000|Overall Study|Death|6|||
23137844|NCT01983254|64252198|FG001|Overall Study|Death|6|||
23137845|NCT01983254|64252197|FG000|Overall Study|Lost to Follow-up|17|||
23137846|NCT01983254|64252198|FG001|Overall Study|Lost to Follow-up|16|||
23137847|NCT01983254|64252197|FG000|Overall Study|too ill|11|||
23137848|NCT01983254|64252198|FG001|Overall Study|too ill|8|||
23137849|NCT01850446|64252201|FG000|Overall Study|Lack of Efficacy|1|||
23137850|NCT01850446|64252202|FG001|Overall Study|Lack of Efficacy|0|||
23137851|NCT01850446|64252201|FG000|Overall Study|Withdrawal by Subject|4|||
23137852|NCT01850446|64252202|FG001|Overall Study|Withdrawal by Subject|0|||
23137853|NCT01850446|64252201|FG000|Overall Study|Protocol Violation|0|||
23137854|NCT01850446|64252202|FG001|Overall Study|Protocol Violation|2|||
23137855|NCT00540046|64252203|FG000|Overall Study|Lost to Follow-up|33|||
23552043|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
23552044|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
23552045|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552046|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552047|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552048|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552049|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552050|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552051|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552052|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552053|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552054|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552055|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
23552056|NCT02349295|65747705|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552057|NCT02349295|65747706|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
23552058|NCT02349295|65747707|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
23552059|NCT02349295|65747708|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552060|NCT02349295|65747709|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552061|NCT02349295|65747710|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552062|NCT02349295|65747711|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552063|NCT02349295|65747712|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23621539|NCT02330562|66000687|FG005|Overall Study|Other reasons|0|||
23621540|NCT02330562|66000688|FG006|Overall Study|Other reasons|0|||
23621541|NCT02330562|66000689|FG007|Overall Study|Other reasons|0|||
23621542|NCT02330562|66000690|FG008|Overall Study|Other reasons|0|||
23621543|NCT02330562|66000691|FG009|Overall Study|Other reasons|0|||
23621544|NCT02330562|66000692|FG010|Overall Study|Other reasons|0|||
23621545|NCT02330562|66000682|FG000|Overall Study|Withdrawal by Subject|0|||
23137856|NCT00540046|64252204|FG001|Overall Study|Lost to Follow-up|23|||
23137857|NCT03282240|64252205|FG000|Overall Study|Adverse Event|2|||
23137858|NCT03282240|64252206|FG001|Overall Study|Adverse Event|2|||
23137859|NCT03282240|64252207|FG002|Overall Study|Adverse Event|0|||
23137860|NCT03282240|64252205|FG000|Overall Study|Lost to Follow-up|3|||
23137861|NCT03282240|64252206|FG001|Overall Study|Lost to Follow-up|0|||
23137862|NCT03282240|64252207|FG002|Overall Study|Lost to Follow-up|0|||
23137863|NCT03282240|64252205|FG000|Overall Study|Protocol Deviation|4|||
23137864|NCT03282240|64252206|FG001|Overall Study|Protocol Deviation|1|||
23137865|NCT03282240|64252207|FG002|Overall Study|Protocol Deviation|2|||
23137866|NCT03282240|64252205|FG000|Overall Study|Withdrawal by Subject|1|||
23137867|NCT03282240|64252206|FG001|Overall Study|Withdrawal by Subject|0|||
23137868|NCT03282240|64252207|FG002|Overall Study|Withdrawal by Subject|1|||
23137869|NCT03527550|64252208|FG000|Overall Study|Lost to Follow-up|4|||
23137870|NCT03527550|64252209|FG001|Overall Study|Lost to Follow-up|2|||
23137871|NCT03527550|64252208|FG000|Overall Study|Withdrawal by Subject|4|||
23137872|NCT03527550|64252209|FG001|Overall Study|Withdrawal by Subject|1|||
23137873|NCT03527550|64252208|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
23552064|NCT02349295|65747713|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552065|NCT02349295|65747714|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552066|NCT02349295|65747715|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552067|NCT02349295|65747716|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552068|NCT02349295|65747717|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552069|NCT02349295|65747718|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
23552070|NCT02349295|65747705|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
23552071|NCT02349295|65747706|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
23552072|NCT02349295|65747707|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
23552073|NCT02349295|65747708|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
23552074|NCT02349295|65747709|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
23552075|NCT02349295|65747710|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
23137874|NCT03527550|64252209|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
23137875|NCT01427751|64252210|FG000|Overall Study|Adverse Event|18|||
23137876|NCT01427751|64252211|FG001|Overall Study|Adverse Event|2|||
23137877|NCT01427751|64252210|FG000|Overall Study|No further treatment benefit expected|5|||
23137878|NCT01427751|64252211|FG001|Overall Study|No further treatment benefit expected|1|||
23137879|NCT01427751|64252210|FG000|Overall Study|Lost to Follow-up|3|||
23137880|NCT01427751|64252211|FG001|Overall Study|Lost to Follow-up|1|||
23137881|NCT01427751|64252210|FG000|Overall Study|Withdrawal of consent|2|||
23137882|NCT01427751|64252211|FG001|Overall Study|Withdrawal of consent|2|||
23137883|NCT01427751|64252210|FG000|Overall Study|Protocol Violation|6|||
23137884|NCT01427751|64252211|FG001|Overall Study|Protocol Violation|4|||
23137885|NCT01427751|64252210|FG000|Overall Study|Death|2|||
23137886|NCT01427751|64252211|FG001|Overall Study|Death|0|||
23137887|NCT01427751|64252210|FG000|Overall Study|Other miscellaneous reasons|6|||
23137888|NCT01427751|64252211|FG001|Overall Study|Other miscellaneous reasons|4|||
23137889|NCT04737187|64252212|FG000|Overall Study|Switched to marketed drug|32|||
23137890|NCT04737187|64252213|FG001|Overall Study|Switched to marketed drug|4|||
23137891|NCT04737187|64252212|FG000|Overall Study|Radiological Progressive Disease|145|||
23137892|NCT04737187|64252213|FG001|Overall Study|Radiological Progressive Disease|146|||
23137893|NCT04737187|64252212|FG000|Overall Study|Clinical Progressive Disease|20|||
23137894|NCT04737187|64252213|FG001|Overall Study|Clinical Progressive Disease|20|||
23137895|NCT04737187|64252212|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
23137896|NCT04737187|64252213|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
23137897|NCT04737187|64252212|FG000|Overall Study|Adverse Event|16|||
23137898|NCT04737187|64252213|FG001|Overall Study|Adverse Event|16|||
23137899|NCT04737187|64252212|FG000|Overall Study|Physician Decision|2|||
23137900|NCT04737187|64252213|FG001|Overall Study|Physician Decision|0|||
23137901|NCT04737187|64252212|FG000|Overall Study|Withdrawal by Subject|5|||
23137902|NCT04737187|64252213|FG001|Overall Study|Withdrawal by Subject|8|||
23137903|NCT01737827|64252214|FG000|Overall Study|Adverse Event|3|||
23137904|NCT01737827|64252215|FG001|Overall Study|Adverse Event|6|||
23137905|NCT01737827|64252216|FG002|Overall Study|Adverse Event|0|||
23137906|NCT01737827|64252214|FG000|Overall Study|Lost to Follow-up|0|||
23137907|NCT01737827|64252215|FG001|Overall Study|Lost to Follow-up|1|||
23137908|NCT01737827|64252216|FG002|Overall Study|Lost to Follow-up|0|||
23137909|NCT01737827|64252214|FG000|Overall Study|Physician Decision|0|||
23137910|NCT01737827|64252215|FG001|Overall Study|Physician Decision|2|||
23137911|NCT01737827|64252216|FG002|Overall Study|Physician Decision|0|||
23137912|NCT01737827|64252214|FG000|Overall Study|Progressive Disease|5|||
23215297|NCT01018511|64528212|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
23137913|NCT01737827|64252215|FG001|Overall Study|Progressive Disease|16|||
23137914|NCT01737827|64252216|FG002|Overall Study|Progressive Disease|2|||
23215298|NCT01018511|64528213|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
23137915|NCT01737827|64252214|FG000|Overall Study|Study Terminated by Sponsor|0|||
23137916|NCT01737827|64252215|FG001|Overall Study|Study Terminated by Sponsor|1|||
23137917|NCT01737827|64252216|FG002|Overall Study|Study Terminated by Sponsor|0|||
23137918|NCT01737827|64252214|FG000|Overall Study|Subject/Guardian Decision|0|||
23137919|NCT01737827|64252215|FG001|Overall Study|Subject/Guardian Decision|2|||
23137920|NCT01737827|64252216|FG002|Overall Study|Subject/Guardian Decision|0|||
23137921|NCT00658684|64255340|FG000|Overall Study|Adverse Event|10|||
23137922|NCT00658684|64255341|FG001|Overall Study|Adverse Event|8|||
23137923|NCT00658684|64255342|FG002|Overall Study|Adverse Event|2|||
23552076|NCT02349295|65747711|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
23430506|NCT03361189|65320585|FG001|Overall Study|Pacemake replacement|1|||
23430507|NCT01977690|65320588|FG000|Overall Study|Withdrawal by Subject|0|||
23430508|NCT01977690|65320589|FG001|Overall Study|Withdrawal by Subject|4|||
23430509|NCT03582813|65320590|FG000|Overall Study|Lost to Follow-up|18|||
23430510|NCT03582813|65320591|FG001|Overall Study|Lost to Follow-up|21|||
23430511|NCT03582813|65320590|FG000|Overall Study|Withdrawal by Subject|1|||
23430512|NCT03582813|65320591|FG001|Overall Study|Withdrawal by Subject|0|||
23430513|NCT02760810|65320596|FG000|Overall Study|Protocol Violation|1|||
23430514|NCT02976103|65320601|FG000|Overall Study|Withdrawal by Subject|1|||
23430515|NCT02976103|65320602|FG001|Overall Study|Withdrawal by Subject|0|||
23430516|NCT02976103|65320601|FG000|Overall Study|Lost to Follow-up|12|||
23552077|NCT02349295|65747712|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
23552078|NCT02349295|65747713|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
23552079|NCT02349295|65747714|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
23552080|NCT02349295|65747715|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
23552081|NCT02349295|65747716|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
23552082|NCT02349295|65747717|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
23552083|NCT02349295|65747718|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
23552084|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552085|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552086|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552087|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552088|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552089|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552090|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552091|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
23552092|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
23552093|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
23552094|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
23552095|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552096|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552097|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
23552098|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552099|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552100|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552101|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552102|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552103|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552104|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552105|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
23552106|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
23552107|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
23552108|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
23552109|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552110|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552111|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
23552112|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552113|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552114|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552115|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552116|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552117|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552118|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552119|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
23552120|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552121|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
23552122|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552123|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552124|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552125|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
23552126|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
23552127|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
23552128|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
23137924|NCT00658684|64255343|FG003|Overall Study|Adverse Event|0|||
23430517|NCT02976103|65320602|FG001|Overall Study|Lost to Follow-up|8|||
23552129|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
23137925|NCT00658684|64255340|FG000|Overall Study|Withdrawal by Subject|6|||
23430518|NCT00758589|65320603|FG000|Overall Study|Adverse Event|3|||
23430519|NCT00758589|65320604|FG001|Overall Study|Adverse Event|2|||
23430520|NCT00758589|65320605|FG002|Overall Study|Adverse Event|5|||
23137926|NCT00658684|64255341|FG001|Overall Study|Withdrawal by Subject|4|||
23137927|NCT00658684|64255342|FG002|Overall Study|Withdrawal by Subject|1|||
23137928|NCT00658684|64255343|FG003|Overall Study|Withdrawal by Subject|1|||
23137929|NCT00658684|64255340|FG000|Overall Study|Lack of Efficacy|1|||
23137930|NCT00658684|64255341|FG001|Overall Study|Lack of Efficacy|1|||
23137931|NCT00658684|64255342|FG002|Overall Study|Lack of Efficacy|0|||
23137932|NCT00658684|64255343|FG003|Overall Study|Lack of Efficacy|0|||
23137933|NCT00658684|64255340|FG000|Overall Study|Protocol Violation|1|||
23137934|NCT00658684|64255341|FG001|Overall Study|Protocol Violation|1|||
23137935|NCT00658684|64255342|FG002|Overall Study|Protocol Violation|0|||
23137936|NCT00658684|64255343|FG003|Overall Study|Protocol Violation|0|||
23137937|NCT00658684|64255340|FG000|Overall Study|Pregnancy|1|||
23137938|NCT00658684|64255341|FG001|Overall Study|Pregnancy|1|||
23137939|NCT00658684|64255342|FG002|Overall Study|Pregnancy|0|||
23137940|NCT00658684|64255343|FG003|Overall Study|Pregnancy|0|||
23137941|NCT00356408|64255344|FG000|Overall Study|Adverse Event|9|||
23137942|NCT00356408|64255344|FG000|Overall Study|Lack of Efficacy|36|||
23137943|NCT00356408|64255344|FG000|Overall Study|Lost to Follow-up|2|||
23137944|NCT00356408|64255344|FG000|Overall Study|Withdrawal by Subject|6|||
23137945|NCT00356408|64255344|FG000|Overall Study|Other: Principal investigator discretion|3|||
23137946|NCT00356408|64255344|FG000|Overall Study|Other: Sponsor request|1|||
23137947|NCT00356408|64255344|FG000|Overall Study|Other: Azathioprine stopped|1|||
23137948|NCT00356408|64255344|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
23137949|NCT00356408|64255344|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
23137950|NCT00924027|64255345|FG000|Overall Study|Lost to Further Follow-Up|4|||
23137951|NCT00924027|64255346|FG001|Overall Study|Lost to Further Follow-Up|0|||
23137952|NCT00924027|64255347|FG002|Overall Study|Lost to Further Follow-Up|0|||
23137953|NCT00924027|64255348|FG003|Overall Study|Lost to Further Follow-Up|0|||
23137954|NCT00924027|64255345|FG000|Overall Study|Physician Decision|1|||
23137955|NCT00924027|64255346|FG001|Overall Study|Physician Decision|0|||
23137956|NCT00924027|64255347|FG002|Overall Study|Physician Decision|0|||
23137957|NCT00924027|64255348|FG003|Overall Study|Physician Decision|1|||
23137958|NCT00924027|64255345|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
23137959|NCT00924027|64255346|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
23137960|NCT00924027|64255347|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
23137961|NCT00924027|64255348|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
23137962|NCT00924027|64255345|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
23137963|NCT00924027|64255346|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
23137964|NCT00924027|64255347|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
23137965|NCT00924027|64255348|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
23137966|NCT00924027|64255345|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
23137967|NCT00924027|64255346|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
23137968|NCT00924027|64255347|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
23137969|NCT00924027|64255348|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
23137970|NCT00384189|64255349|FG000|Overall Study|Reason Not Specified|50|||
23137971|NCT00384189|64255350|FG001|Overall Study|Reason Not Specified|57|||
23137972|NCT00384189|64255351|FG002|Overall Study|Reason Not Specified|58|||
23137973|NCT00384189|64255352|FG003|Overall Study|Reason Not Specified|40|||
23137974|NCT00925132|64255356|FG000|Overall Study|Withdrawal by Subject|2|||
23137975|NCT00925132|64255357|FG001|Overall Study|Withdrawal by Subject|0|||
23137976|NCT00925132|64255358|FG002|Overall Study|Withdrawal by Subject|0|||
23137977|NCT00925132|64255359|FG003|Overall Study|Withdrawal by Subject|0|||
23137978|NCT00925132|64255360|FG004|Overall Study|Withdrawal by Subject|1|||
23137979|NCT00925132|64255356|FG000|Overall Study|Removed due to disease progression|0|||
23137980|NCT00925132|64255357|FG001|Overall Study|Removed due to disease progression|0|||
23137981|NCT00925132|64255358|FG002|Overall Study|Removed due to disease progression|0|||
23137982|NCT00925132|64255359|FG003|Overall Study|Removed due to disease progression|0|||
23137983|NCT00925132|64255360|FG004|Overall Study|Removed due to disease progression|4|||
23137984|NCT01901341|64255364|FG000|Overall Study|Adverse Event|4|||
23137985|NCT01901341|64255365|FG001|Overall Study|Adverse Event|2|||
23137986|NCT01901341|64255364|FG000|Overall Study|Lack of Efficacy|0|||
23137987|NCT01901341|64255365|FG001|Overall Study|Lack of Efficacy|2|||
23137988|NCT01901341|64255364|FG000|Overall Study|Lost to Follow-up|0|||
23137989|NCT01901341|64255365|FG001|Overall Study|Lost to Follow-up|1|||
23137990|NCT01901341|64255364|FG000|Overall Study|Protocol Violation|2|||
23137991|NCT01901341|64255365|FG001|Overall Study|Protocol Violation|0|||
23137992|NCT01901341|64255364|FG000|Overall Study|Study Terminated by Sponsor|13|||
23137993|NCT01901341|64255365|FG001|Overall Study|Study Terminated by Sponsor|15|||
23137994|NCT01901341|64255364|FG000|Overall Study|Withdrawal by Subject|1|||
23137995|NCT01901341|64255365|FG001|Overall Study|Withdrawal by Subject|1|||
23137996|NCT05087979|64255366|FG000|Overall Study|Converted to general anesthesia|1|||
23137997|NCT05087979|64255367|FG001|Overall Study|Converted to general anesthesia|0|||
23137998|NCT02297139|64255377|FG000|Overall Study|Disease progression|0|||
23137999|NCT02297139|64255378|FG001|Overall Study|Disease progression|1|||
23138000|NCT02297139|64255377|FG000|Overall Study|Study drug toxicity|0|||
23138001|NCT02297139|64255378|FG001|Overall Study|Study drug toxicity|4|||
23138002|NCT02297139|64255377|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23138003|NCT02297139|64255378|FG001|Overall Study|Participant request to discontinue study treatment|1|||
23138004|NCT02297139|64255377|FG000|Overall Study|Maximum clinical benefit|1|||
23138005|NCT02297139|64255378|FG001|Overall Study|Maximum clinical benefit|0|||
23138006|NCT02297139|64255377|FG000|Overall Study|Administrative reason by sponsor|0|||
23138007|NCT02297139|64255378|FG001|Overall Study|Administrative reason by sponsor|2|||
23138008|NCT02297139|64255377|FG000|Overall Study|Other reasons|0|||
23138009|NCT02297139|64255378|FG001|Overall Study|Other reasons|8|||
23138010|NCT01281969|64255379|FG000|Overall Study|not randomized didn't meet criteria|0|||
23138011|NCT01281969|64255380|FG001|Overall Study|not randomized didn't meet criteria|0|||
23138012|NCT01281969|64255381|FG002|Overall Study|not randomized didn't meet criteria|7|||
23138013|NCT01281969|64255379|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
23138014|NCT01281969|64255380|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
23138015|NCT01281969|64255381|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
23138016|NCT01281969|64255379|FG000|Overall Study|not randomized, child consent not given|0|||
23138017|NCT01281969|64255380|FG001|Overall Study|not randomized, child consent not given|0|||
23138018|NCT01281969|64255381|FG002|Overall Study|not randomized, child consent not given|2|||
23138019|NCT01127893|64255382|FG000|Overall Study|Study Termination by the Sponsor|1|||
23138020|NCT00895154|64255383|FG000|Overall Study|Lost to Follow-up|1|||
23138021|NCT00895154|64255384|FG001|Overall Study|Lost to Follow-up|1|||
23138022|NCT00895154|64255383|FG000|Overall Study|Withdrawal by Subject|0|||
23138023|NCT00895154|64255384|FG001|Overall Study|Withdrawal by Subject|1|||
23138024|NCT00918580|64255391|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
23138025|NCT00918580|64255391|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
23138026|NCT00918580|64255391|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
23138027|NCT00918580|64255391|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
23138028|NCT00918580|64255391|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
23138029|NCT00918580|64255391|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
23138030|NCT00918580|64255391|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
23138031|NCT01489891|64255402|FG000|Overall Study|Endoscopy failure|1|||
23138032|NCT01489891|64255403|FG001|Overall Study|Endoscopy failure|0|||
23138033|NCT05114473|64255410|FG000|Overall Study|Lost to Follow-up|2|||
23138034|NCT05114473|64255411|FG001|Overall Study|Lost to Follow-up|2|||
23138035|NCT05114473|64255412|FG002|Overall Study|Lost to Follow-up|0|||
23138036|NCT00923260|64255413|FG000|Overall Study|Lost to Follow-up|1|||
23138037|NCT00923260|64255414|FG001|Overall Study|Lost to Follow-up|1|||
23552130|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
23552131|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
23552132|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
23552133|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
23552134|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
23552135|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
23552136|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
23552137|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
23552138|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
23552139|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
23552140|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552141|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552142|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552143|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552144|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552145|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23138038|NCT00847808|64255415|FG000|Overall Study|Adverse Event|7|||
23138039|NCT00847808|64255415|FG000|Overall Study|Protocol Violation|1|||
23138040|NCT00847808|64255415|FG000|Overall Study|Lost to Follow-up|1|||
23138041|NCT00847808|64255415|FG000|Overall Study|Withdrawal by Subject|4|||
23138042|NCT00847808|64255415|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
23138043|NCT00847808|64255415|FG000|Overall Study|Participant Took Excluded Medication|1|||
23138044|NCT02874924|64255416|FG000|Overall Study|Adverse Event|2|||
23138045|NCT02874924|64255417|FG001|Overall Study|Adverse Event|0|||
23138046|NCT02874924|64255418|FG002|Overall Study|Adverse Event|0|||
23138047|NCT02874924|64255416|FG000|Overall Study|Withdrawal by Subject|1|||
23552146|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23138048|NCT02874924|64255417|FG001|Overall Study|Withdrawal by Subject|0|||
23138049|NCT02874924|64255418|FG002|Overall Study|Withdrawal by Subject|0|||
23138050|NCT02317432|64255419|FG000|Overall Study|Death|4|||
23138051|NCT02317432|64255420|FG001|Overall Study|Death|1|||
23138052|NCT02317432|64255419|FG000|Overall Study|Lost to Follow-up|0|||
23138053|NCT02317432|64255420|FG001|Overall Study|Lost to Follow-up|5|||
23175843|NCT01554579|64386588|FG000|Overall Study|Withdrawal by Subject|2|||
23552147|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
23138054|NCT02317432|64255419|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
23138055|NCT02317432|64255420|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
23138056|NCT01415531|64255421|FG000|Overall Study|Adverse Event|7|||
23138057|NCT01415531|64255422|FG001|Overall Study|Adverse Event|10|||
23138058|NCT01415531|64255421|FG000|Overall Study|Lack of Efficacy|3|||
23138059|NCT01415531|64255422|FG001|Overall Study|Lack of Efficacy|2|||
23138060|NCT01415531|64255421|FG000|Overall Study|Protocol Violation|0|||
23138061|NCT01415531|64255422|FG001|Overall Study|Protocol Violation|1|||
23138062|NCT01415531|64255421|FG000|Overall Study|Withdrawal by Subject|5|||
23138063|NCT01415531|64255422|FG001|Overall Study|Withdrawal by Subject|4|||
23138064|NCT01415531|64255421|FG000|Overall Study|Lost to Follow-up|6|||
23138065|NCT01415531|64255422|FG001|Overall Study|Lost to Follow-up|14|||
23138066|NCT01415531|64255421|FG000|Overall Study|Lack of Compliance|1|||
23138067|NCT01415531|64255422|FG001|Overall Study|Lack of Compliance|4|||
23138068|NCT01415531|64255421|FG000|Overall Study|Other Reasons|3|||
23138069|NCT01415531|64255422|FG001|Overall Study|Other Reasons|2|||
23138070|NCT02729753|64255423|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
23138071|NCT02729753|64255424|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
23138072|NCT03319849|64255425|FG000|Overall Study|Adverse Event|1|||
23138073|NCT03319849|64255426|FG001|Overall Study|Adverse Event|0|||
23138074|NCT03319849|64255425|FG000|Overall Study|Physician Decision|0|||
23138075|NCT03319849|64255426|FG001|Overall Study|Physician Decision|1|||
23138076|NCT03319849|64255425|FG000|Overall Study|Withdrawal by Subject|0|||
23138077|NCT03319849|64255426|FG001|Overall Study|Withdrawal by Subject|1|||
23138078|NCT03319849|64255425|FG000|Overall Study|COVID-19|0|||
23138079|NCT03319849|64255426|FG001|Overall Study|COVID-19|1|||
23138080|NCT03319849|64255425|FG000|Overall Study|Other|1|||
23138081|NCT03319849|64255426|FG001|Overall Study|Other|2|||
23138082|NCT03319849|64255425|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
23138083|NCT03319849|64255426|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
23552148|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
23552149|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
23552150|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
23552151|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552152|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552153|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
23552154|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552155|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552156|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552157|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552158|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552159|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552160|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552161|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
23552162|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
23552163|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552164|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552165|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552166|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23138084|NCT03319849|64255425|FG000|Overall Study|Lost to Follow-up|0|||
23138085|NCT03319849|64255426|FG001|Overall Study|Lost to Follow-up|2|||
23138086|NCT00473265|64255427|FG000|Overall Study|Unrelated adverse event|5|||
23138087|NCT00473265|64255427|FG000|Overall Study|Off treatment early|15|||
23138088|NCT01080716|64255428|FG000|Part 1|Physician Decision|1|||
23138089|NCT01080716|64255429|FG001|Part 1|Physician Decision|0|||
23138090|NCT01080716|64255430|FG002|Part 1|Physician Decision|0|||
23138091|NCT01080716|64255431|FG003|Part 1|Physician Decision|0|||
23138092|NCT00626990|64255432|FG000|Overall Study|Lack of Efficacy|6|||
23138093|NCT00626990|64255433|FG001|Overall Study|Lack of Efficacy|7|||
23138094|NCT00626990|64255434|FG002|Overall Study|Lack of Efficacy|49|||
23138095|NCT00626990|64255435|FG003|Overall Study|Lack of Efficacy|40|||
23138096|NCT00626990|64255432|FG000|Overall Study|Adverse Event|1|||
23138097|NCT00626990|64255433|FG001|Overall Study|Adverse Event|7|||
23552167|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
23552168|NCT02349295|65747705|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552169|NCT02349295|65747706|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552170|NCT02349295|65747707|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23215299|NCT01018511|64528214|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
23138098|NCT00626990|64255434|FG002|Overall Study|Adverse Event|14|||
23138099|NCT00626990|64255435|FG003|Overall Study|Adverse Event|28|||
23138100|NCT00626990|64255432|FG000|Overall Study|Death|0|||
23138101|NCT00626990|64255433|FG001|Overall Study|Death|1|||
23552171|NCT02349295|65747708|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552172|NCT02349295|65747709|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552173|NCT02349295|65747710|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23138102|NCT00626990|64255434|FG002|Overall Study|Death|0|||
23138103|NCT00626990|64255435|FG003|Overall Study|Death|0|||
23138104|NCT00626990|64255432|FG000|Overall Study|Withdrawal by Subject|3|||
23138105|NCT00626990|64255433|FG001|Overall Study|Withdrawal by Subject|1|||
23138106|NCT00626990|64255434|FG002|Overall Study|Withdrawal by Subject|5|||
23138107|NCT00626990|64255435|FG003|Overall Study|Withdrawal by Subject|11|||
23138108|NCT00626990|64255432|FG000|Overall Study|Protocol Violation|0|||
23138109|NCT00626990|64255433|FG001|Overall Study|Protocol Violation|1|||
23138110|NCT00626990|64255434|FG002|Overall Study|Protocol Violation|1|||
23138111|NCT00626990|64255435|FG003|Overall Study|Protocol Violation|0|||
23138112|NCT00626990|64255432|FG000|Overall Study|Various different reasons/missing|4|||
23138113|NCT00626990|64255433|FG001|Overall Study|Various different reasons/missing|8|||
23430521|NCT00758589|65320606|FG003|Overall Study|Adverse Event|4|||
23430522|NCT00758589|65320603|FG000|Overall Study|Withdrawal by Subject|0|||
23552174|NCT02349295|65747711|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552175|NCT02349295|65747712|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
23552176|NCT02349295|65747713|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
23552177|NCT02349295|65747714|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552178|NCT02349295|65747715|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552179|NCT02349295|65747716|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552180|NCT02349295|65747717|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552181|NCT02349295|65747718|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
23552182|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552183|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552184|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552185|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552186|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552187|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552188|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552189|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23430523|NCT00758589|65320604|FG001|Overall Study|Withdrawal by Subject|1|||
23430524|NCT00758589|65320605|FG002|Overall Study|Withdrawal by Subject|1|||
23552190|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552191|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552192|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
23552193|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
23138114|NCT00626990|64255434|FG002|Overall Study|Various different reasons/missing|8|||
23138115|NCT00626990|64255435|FG003|Overall Study|Various different reasons/missing|16|||
23138116|NCT00141219|64255438|FG000|Overall Study|Protocol violations|5|||
23138117|NCT00141219|64255439|FG001|Overall Study|Protocol violations|4|||
23138118|NCT00141219|64255438|FG000|Overall Study|Adverse Event|8|||
23138119|NCT00141219|64255439|FG001|Overall Study|Adverse Event|6|||
23138120|NCT00141219|64255438|FG000|Overall Study|Lack of Efficacy|5|||
23215300|NCT01018511|64528215|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
23215301|NCT01018511|64528212|FG000|Overall Study|Adverse Event|5|||
23430525|NCT00758589|65320606|FG003|Overall Study|Withdrawal by Subject|1|||
23430526|NCT00758589|65320603|FG000|Overall Study|Palm stopped to work|0|||
23430527|NCT00758589|65320604|FG001|Overall Study|Palm stopped to work|0|||
23430528|NCT00758589|65320605|FG002|Overall Study|Palm stopped to work|0|||
23430529|NCT00758589|65320606|FG003|Overall Study|Palm stopped to work|1|||
23430530|NCT00286221|65320607|FG000|Overall Study|Protocol Violation|2|||
23430531|NCT00286221|65320608|FG001|Overall Study|Protocol Violation|1|||
23430532|NCT00286221|65320609|FG002|Overall Study|Protocol Violation|6|||
23430533|NCT00286221|65320610|FG003|Overall Study|Protocol Violation|4|||
23430534|NCT00286221|65320607|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
23430535|NCT00286221|65320608|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
23552194|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
23552195|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
23552196|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552197|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552198|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552199|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23138121|NCT00141219|64255439|FG001|Overall Study|Lack of Efficacy|4|||
23138122|NCT00141219|64255438|FG000|Overall Study|Withdrawal by Subject|6|||
23138123|NCT00141219|64255439|FG001|Overall Study|Withdrawal by Subject|2|||
23430536|NCT00286221|65320609|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
23215302|NCT01018511|64528213|FG001|Overall Study|Adverse Event|9|||
23430537|NCT00286221|65320610|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
23138124|NCT03573583|64255442|FG000|Overall Study|Lost to Follow-up|1|||
23138125|NCT03573583|64255443|FG001|Overall Study|Lost to Follow-up|0|||
23138126|NCT03573583|64255442|FG000|Overall Study|Withdrawal by Subject|1|||
23138127|NCT03573583|64255443|FG001|Overall Study|Withdrawal by Subject|1|||
23138128|NCT00910689|64255446|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
23138129|NCT00910689|64255447|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
23138130|NCT00910689|64255448|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
23138131|NCT00910689|64255449|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
23215303|NCT01018511|64528214|FG002|Overall Study|Adverse Event|13|||
23430538|NCT00286221|65320607|FG000|Overall Study|Inability to trigger PCA|2|||
23430539|NCT00286221|65320608|FG001|Overall Study|Inability to trigger PCA|0|||
23430540|NCT00286221|65320609|FG002|Overall Study|Inability to trigger PCA|0|||
23430541|NCT00286221|65320610|FG003|Overall Study|Inability to trigger PCA|0|||
23430542|NCT00286221|65320607|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
23430543|NCT00286221|65320608|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
23430544|NCT00286221|65320609|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
23430545|NCT00286221|65320610|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
23430546|NCT02434328|65320611|FG000|Overall Study|Adverse Event|9|||
23430547|NCT02434328|65320612|FG001|Overall Study|Adverse Event|4|||
23430548|NCT02434328|65320611|FG000|Overall Study|Lack of Efficacy|0|||
23552200|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23430549|NCT02434328|65320612|FG001|Overall Study|Lack of Efficacy|2|||
23430550|NCT02434328|65320611|FG000|Overall Study|Physician Decision|0|||
23430551|NCT02434328|65320612|FG001|Overall Study|Physician Decision|1|||
23430552|NCT02434328|65320611|FG000|Overall Study|Withdrawal by Subject|12|||
23430553|NCT02434328|65320612|FG001|Overall Study|Withdrawal by Subject|21|||
23430554|NCT02434328|65320611|FG000|Overall Study|Death|4|||
23430555|NCT02434328|65320612|FG001|Overall Study|Death|7|||
23430556|NCT02434328|65320611|FG000|Overall Study|Lost to Follow-up|1|||
23430557|NCT02434328|65320612|FG001|Overall Study|Lost to Follow-up|6|||
23430558|NCT02434328|65320611|FG000|Overall Study|Other|4|||
23430559|NCT02434328|65320612|FG001|Overall Study|Other|1|||
23430560|NCT03743064|65320613|FG000|Overall Study|Adverse Event|7|||
23430561|NCT03743064|65320614|FG001|Overall Study|Adverse Event|9|||
23430562|NCT03743064|65320613|FG000|Overall Study|Death|25|||
23430563|NCT03743064|65320614|FG001|Overall Study|Death|28|||
23430564|NCT03743064|65320613|FG000|Overall Study|Lost to Follow-up|3|||
23430565|NCT03743064|65320614|FG001|Overall Study|Lost to Follow-up|6|||
23430566|NCT03743064|65320613|FG000|Overall Study|Withdrawal by Subject|28|||
23430567|NCT03743064|65320614|FG001|Overall Study|Withdrawal by Subject|25|||
23430568|NCT03743064|65320613|FG000|Overall Study|Physician Decision|2|||
23430569|NCT03743064|65320614|FG001|Overall Study|Physician Decision|4|||
23430570|NCT03743064|65320613|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
23430571|NCT03743064|65320614|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
23430572|NCT00514020|65320615|FG000|Overall Study|Adverse Event|6|||
23430573|NCT00514020|65320615|FG000|Overall Study|Withdrawal by Subject|3|||
23430574|NCT00514020|65320615|FG000|Overall Study|Physician Decision|1|||
23430575|NCT00514020|65320615|FG000|Overall Study|disease progression|9|||
23430576|NCT00514020|65320615|FG000|Overall Study|other complicating disease|2|||
23430577|NCT00514020|65320615|FG000|Overall Study|patient went to radiation treatment|1|||
23430578|NCT00514020|65320615|FG000|Overall Study|"patients moved to the no tx group"|6|||
23430579|NCT00162266|65320618|FG000|Double-Blind Period|Adverse Event|5|||
23430580|NCT00162266|65320619|FG001|Double-Blind Period|Adverse Event|9|||
23430581|NCT00162266|65320620|FG002|Double-Blind Period|Adverse Event|11|||
23430582|NCT00162266|65320621|FG003|Double-Blind Period|Adverse Event|0|||
23430583|NCT00162266|65320618|FG000|Double-Blind Period|Death|0|||
23430584|NCT00162266|65320619|FG001|Double-Blind Period|Death|1|||
23430585|NCT00162266|65320620|FG002|Double-Blind Period|Death|0|||
23552201|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23430586|NCT00162266|65320621|FG003|Double-Blind Period|Death|0|||
23430587|NCT00162266|65320618|FG000|Double-Blind Period|Lost to Follow-up|1|||
23430588|NCT00162266|65320619|FG001|Double-Blind Period|Lost to Follow-up|2|||
23430589|NCT00162266|65320620|FG002|Double-Blind Period|Lost to Follow-up|0|||
23138132|NCT00910689|64255446|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
23215304|NCT01018511|64528215|FG003|Overall Study|Adverse Event|10|||
23430590|NCT00162266|65320621|FG003|Double-Blind Period|Lost to Follow-up|0|||
23430591|NCT00162266|65320618|FG000|Double-Blind Period|Other Reason|1|||
23430592|NCT00162266|65320619|FG001|Double-Blind Period|Other Reason|0|||
23430593|NCT00162266|65320620|FG002|Double-Blind Period|Other Reason|1|||
23430594|NCT00162266|65320621|FG003|Double-Blind Period|Other Reason|0|||
23430595|NCT00162266|65320618|FG000|Double-Blind Period|Lack of Efficacy|13|||
23430596|NCT00162266|65320619|FG001|Double-Blind Period|Lack of Efficacy|17|||
23430597|NCT00162266|65320620|FG002|Double-Blind Period|Lack of Efficacy|30|||
23430598|NCT00162266|65320621|FG003|Double-Blind Period|Lack of Efficacy|0|||
23430599|NCT00162266|65320618|FG000|Double-Blind Period|Withdrawal by Subject|5|||
23430600|NCT00162266|65320619|FG001|Double-Blind Period|Withdrawal by Subject|2|||
23430601|NCT00162266|65320620|FG002|Double-Blind Period|Withdrawal by Subject|6|||
23430602|NCT00162266|65320621|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23430603|NCT00162266|65320618|FG000|Open-Label Period|Death|0|||
23430604|NCT00162266|65320619|FG001|Open-Label Period|Death|0|||
23430605|NCT00162266|65320620|FG002|Open-Label Period|Death|0|||
23430606|NCT00162266|65320621|FG003|Open-Label Period|Death|7|||
23430607|NCT00162266|65320618|FG000|Open-Label Period|Adverse Event|0|||
23430608|NCT00162266|65320619|FG001|Open-Label Period|Adverse Event|0|||
23430609|NCT00162266|65320620|FG002|Open-Label Period|Adverse Event|0|||
23430610|NCT00162266|65320621|FG003|Open-Label Period|Adverse Event|46|||
23430611|NCT00162266|65320618|FG000|Open-Label Period|Lack of Efficacy|0|||
23430612|NCT00162266|65320619|FG001|Open-Label Period|Lack of Efficacy|0|||
23430613|NCT00162266|65320620|FG002|Open-Label Period|Lack of Efficacy|0|||
23430614|NCT00162266|65320621|FG003|Open-Label Period|Lack of Efficacy|26|||
23430615|NCT00162266|65320618|FG000|Open-Label Period|Lost to Follow-up|0|||
23430616|NCT00162266|65320619|FG001|Open-Label Period|Lost to Follow-up|0|||
23430617|NCT00162266|65320620|FG002|Open-Label Period|Lost to Follow-up|0|||
23430618|NCT00162266|65320621|FG003|Open-Label Period|Lost to Follow-up|3|||
23430619|NCT00162266|65320618|FG000|Open-Label Period|Withdrawal by Subject|0|||
23430620|NCT00162266|65320619|FG001|Open-Label Period|Withdrawal by Subject|0|||
23430621|NCT00162266|65320620|FG002|Open-Label Period|Withdrawal by Subject|0|||
23430622|NCT00162266|65320621|FG003|Open-Label Period|Withdrawal by Subject|31|||
23430623|NCT00162266|65320618|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
23430624|NCT00162266|65320619|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
23430625|NCT00162266|65320620|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
23430626|NCT00162266|65320621|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
23430627|NCT00162266|65320618|FG000|Open-Label Period|Other Reasons|0|||
23430628|NCT00162266|65320619|FG001|Open-Label Period|Other Reasons|0|||
23430629|NCT00162266|65320620|FG002|Open-Label Period|Other Reasons|0|||
23430630|NCT00162266|65320621|FG003|Open-Label Period|Other Reasons|15|||
23430631|NCT02772978|65320626|FG000|Overall Study|Withdrawal by Subject|1|||
23430632|NCT02772978|65320627|FG001|Overall Study|Withdrawal by Subject|1|||
23430633|NCT00885482|65320628|FG000|Overall Study|Pregnancy|1|||
23430634|NCT00885482|65320628|FG000|Overall Study|Lack of Efficacy|1|||
23430635|NCT00885482|65320628|FG000|Overall Study|Death|1|||
23430636|NCT00885482|65320628|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
23430637|NCT00780273|65320629|FG000|Overall Study|Death|1|||
23430638|NCT00780273|65320629|FG000|Overall Study|Lost to Follow-up|1|||
23430639|NCT00440310|65320634|FG000|Overall Study|Lost to Follow-up|4|||
23430640|NCT00440310|65320635|FG001|Overall Study|Lost to Follow-up|5|||
23430641|NCT00440310|65320634|FG000|Overall Study|Protocol Violation|0|||
23430642|NCT00440310|65320635|FG001|Overall Study|Protocol Violation|1|||
23430643|NCT00440310|65320634|FG000|Overall Study|Withdrawal by Subject|15|||
23430644|NCT00440310|65320635|FG001|Overall Study|Withdrawal by Subject|14|||
23430645|NCT00440310|65320634|FG000|Overall Study|No Reply at EOS|7|||
23430646|NCT00440310|65320635|FG001|Overall Study|No Reply at EOS|7|||
23430647|NCT00440310|65320634|FG000|Overall Study|Other|1|||
23430648|NCT00440310|65320635|FG001|Overall Study|Other|0|||
23430649|NCT00440310|65320634|FG000|Overall Study|Status Unknown|1|||
23430650|NCT00440310|65320635|FG001|Overall Study|Status Unknown|3|||
23430651|NCT03734029|65320640|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
23430652|NCT03734029|65320641|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
23430653|NCT03734029|65320640|FG000|Overall Study|Adverse Event|60|||
23430654|NCT03734029|65320641|FG001|Overall Study|Adverse Event|14|||
23430655|NCT03734029|65320640|FG000|Overall Study|Withdrawal by Subject|12|||
23430656|NCT03734029|65320641|FG001|Overall Study|Withdrawal by Subject|11|||
23430657|NCT03734029|65320640|FG000|Overall Study|Clinical progression by investigator|10|||
23430658|NCT03734029|65320641|FG001|Overall Study|Clinical progression by investigator|8|||
23430659|NCT03734029|65320640|FG000|Overall Study|Death|5|||
23430660|NCT03734029|65320641|FG001|Overall Study|Death|2|||
23430661|NCT03734029|65320640|FG000|Overall Study|Physician Decision|4|||
23430662|NCT03734029|65320641|FG001|Overall Study|Physician Decision|3|||
23430663|NCT03734029|65320640|FG000|Overall Study|Other|2|||
23430664|NCT03734029|65320641|FG001|Overall Study|Other|0|||
23215305|NCT01018511|64528212|FG000|Overall Study|Lack of Efficacy|4|||
23430665|NCT03734029|65320640|FG000|Overall Study|Lost to Follow-up|0|||
23430666|NCT03734029|65320641|FG001|Overall Study|Lost to Follow-up|1|||
23430667|NCT03734029|65320640|FG000|Overall Study|Randomized, but not treated|2|||
23430668|NCT03734029|65320641|FG001|Overall Study|Randomized, but not treated|12|||
23430669|NCT03836677|65320648|FG000|Period 1|Adverse Event|0|||
23430670|NCT03836677|65320649|FG001|Period 1|Adverse Event|1|||
23430671|NCT03836677|65320648|FG000|Period 2|Severe non-compliance to protocol|1|||
23430672|NCT03836677|65320649|FG001|Period 2|Severe non-compliance to protocol|0|||
23430673|NCT00456599|65320651|FG000|Overall Study|Non-compliance|1|||
23430674|NCT00456599|65320651|FG000|Overall Study|Withdrawal by Subject|2|||
23430675|NCT01378429|65320655|FG000|Overall Study|Noncompliance with study drug|1|||
23430676|NCT01378429|65320656|FG001|Overall Study|Noncompliance with study drug|0|||
23430677|NCT03204890|65320657|FG000|Overall Study|Withdrawal by Subject|1|||
23430678|NCT04063787|65320658|FG000|Overall Study|Inadequate Doppler data|4|||
23430679|NCT04063787|65320658|FG000|Overall Study|Lost to Follow-up|2|||
23430680|NCT04063787|65320658|FG000|Overall Study|Death|3|||
23430681|NCT01657760|65320661|FG000|Overall Study|Withdrawal by Subject|0|||
23430682|NCT01657760|65320662|FG001|Overall Study|Withdrawal by Subject|0|||
23430683|NCT01657760|65320663|FG002|Overall Study|Withdrawal by Subject|0|||
23430684|NCT01657760|65320664|FG003|Overall Study|Withdrawal by Subject|1|||
23430685|NCT01657760|65320661|FG000|Overall Study|Physician Decision|1|||
23430686|NCT01657760|65320662|FG001|Overall Study|Physician Decision|1|||
23430687|NCT01657760|65320663|FG002|Overall Study|Physician Decision|1|||
23430688|NCT01657760|65320664|FG003|Overall Study|Physician Decision|2|||
23430689|NCT02391961|65320665|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
23430690|NCT02391961|65320666|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
23430691|NCT02391961|65320665|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
23430692|NCT02391961|65320666|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
23430693|NCT02391961|65320665|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23430694|NCT02391961|65320666|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23430695|NCT00443781|65320667|FG000|Overall Study|Lost to Follow-up|10|||
23430696|NCT00443781|65320667|FG000|Overall Study|Physician Decision|2|||
23430697|NCT00443781|65320667|FG000|Overall Study|Protocol Violation|1|||
23430698|NCT00443781|65320667|FG000|Overall Study|Withdrawal by Subject|6|||
23430699|NCT00443781|65320667|FG000|Overall Study|Unable to comply with study follow up|2|||
23430700|NCT00443781|65320667|FG000|Overall Study|Investigator terminated participation|1|||
23430701|NCT00443781|65320667|FG000|Overall Study|Insurance not covered|2|||
23430702|NCT00443781|65320667|FG000|Overall Study|PD/FAD not done|1|||
23430703|NCT02621073|65320674|FG000|Overall Study|Lost to Follow-up|0|||
23430704|NCT02621073|65320675|FG001|Overall Study|Lost to Follow-up|1|||
23430705|NCT02621073|65320674|FG000|Overall Study|Physician Decision|3|||
23430706|NCT02621073|65320675|FG001|Overall Study|Physician Decision|2|||
23430707|NCT02299076|65320676|FG000|Overall Study|Fraudulent Entries|20|||
23430708|NCT02299076|65320677|FG001|Overall Study|Fraudulent Entries|14|||
23430709|NCT02117349|65320681|FG000|Overall Study|Withdrawal by Subject|1|||
23430710|NCT02117349|65320682|FG001|Overall Study|Withdrawal by Subject|0|||
23430711|NCT02117349|65320681|FG000|Overall Study|Lost to Follow-up|1|||
23430712|NCT02117349|65320682|FG001|Overall Study|Lost to Follow-up|1|||
23430713|NCT02117349|65320681|FG000|Overall Study|Death|1|||
23430714|NCT02117349|65320682|FG001|Overall Study|Death|0|||
23430715|NCT00295932|65320683|FG000|Overall Study|Not Treated|0|||
23430716|NCT00295932|65320684|FG001|Overall Study|Not Treated|0|||
23430717|NCT00295932|65320685|FG002|Overall Study|Not Treated|0|||
23430718|NCT00295932|65320686|FG003|Overall Study|Not Treated|0|||
23430719|NCT00295932|65320687|FG004|Overall Study|Not Treated|0|||
23430720|NCT00295932|65320688|FG005|Overall Study|Not Treated|0|||
23430721|NCT00295932|65320689|FG006|Overall Study|Not Treated|0|||
23430722|NCT00295932|65320690|FG007|Overall Study|Not Treated|0|||
23430723|NCT00295932|65320691|FG008|Overall Study|Not Treated|0|||
23430724|NCT00295932|65320692|FG009|Overall Study|Not Treated|0|||
23430725|NCT00295932|65320693|FG010|Overall Study|Not Treated|1|||
23430726|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
23430727|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
23430728|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
23430729|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
23430730|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
23430731|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
23430732|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
23430733|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
23430734|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
23430735|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
23430736|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
23430737|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
23430738|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
23552202|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552203|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552204|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552205|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552206|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23430739|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
23430740|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
23430741|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
23430742|NCT03689244|65320694|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
23430743|NCT03689244|65320695|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
23430744|NCT03689244|65320696|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
23430745|NCT03689244|65320697|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
23430746|NCT03689244|65320694|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
23430747|NCT03689244|65320695|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
23430748|NCT03689244|65320696|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
23430749|NCT03689244|65320697|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
23430750|NCT03689244|65320694|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
23430751|NCT03689244|65320695|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
23430752|NCT03689244|65320696|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
23430753|NCT03689244|65320697|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
23430754|NCT03689244|65320694|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
23430755|NCT03689244|65320695|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
23430756|NCT03689244|65320696|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
23430757|NCT03689244|65320697|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
23430758|NCT01267175|65320698|FG000|Overall Study|Withdrawal by Subject|1|||
23430759|NCT01267175|65320698|FG000|Overall Study|Lost to Follow-up|1|||
23430760|NCT00084656|65320699|FG000|Overall Study|Other reasons|0|||
23430761|NCT00084656|65320700|FG001|Overall Study|Other reasons|12|||
23430762|NCT00084656|65320701|FG002|Overall Study|Other reasons|11|||
23430763|NCT00084656|65320699|FG000|Overall Study|Withdrawal by Subject|15|||
23430764|NCT00084656|65320700|FG001|Overall Study|Withdrawal by Subject|4|||
23430765|NCT00084656|65320701|FG002|Overall Study|Withdrawal by Subject|4|||
23430766|NCT00084656|65320699|FG000|Overall Study|Disease relapse|0|||
23430767|NCT00084656|65320700|FG001|Overall Study|Disease relapse|9|||
23430768|NCT00084656|65320701|FG002|Overall Study|Disease relapse|10|||
23430769|NCT00084656|65320699|FG000|Overall Study|Disease progression|9|||
23430770|NCT00084656|65320700|FG001|Overall Study|Disease progression|0|||
23430771|NCT00084656|65320701|FG002|Overall Study|Disease progression|0|||
23430772|NCT00084656|65320699|FG000|Overall Study|Lost to Follow-up|1|||
23430773|NCT00084656|65320700|FG001|Overall Study|Lost to Follow-up|0|||
23430774|NCT00084656|65320701|FG002|Overall Study|Lost to Follow-up|1|||
23430775|NCT00391391|65320704|FG000|Overall Study|Adverse Event|0|||
23430776|NCT00391391|65320705|FG001|Overall Study|Adverse Event|0|||
23430777|NCT00391391|65320706|FG002|Overall Study|Adverse Event|0|||
23430778|NCT00391391|65320707|FG003|Overall Study|Adverse Event|1|||
23430779|NCT00391391|65320704|FG000|Overall Study|Lost to Follow-up|1|||
23430780|NCT00391391|65320705|FG001|Overall Study|Lost to Follow-up|3|||
23430781|NCT00391391|65320706|FG002|Overall Study|Lost to Follow-up|7|||
23430782|NCT00391391|65320707|FG003|Overall Study|Lost to Follow-up|4|||
23430783|NCT00391391|65320704|FG000|Overall Study|Protocol Violation|2|||
23430784|NCT00391391|65320705|FG001|Overall Study|Protocol Violation|3|||
23430785|NCT00391391|65320706|FG002|Overall Study|Protocol Violation|6|||
23430786|NCT00391391|65320707|FG003|Overall Study|Protocol Violation|7|||
23430787|NCT00391391|65320704|FG000|Overall Study|Withdrawal by Subject|6|||
23430788|NCT00391391|65320705|FG001|Overall Study|Withdrawal by Subject|4|||
23430789|NCT00391391|65320706|FG002|Overall Study|Withdrawal by Subject|10|||
23430790|NCT00391391|65320707|FG003|Overall Study|Withdrawal by Subject|7|||
23430791|NCT04094584|65320708|FG000|Overall Study|No interest in study|88|||
23430792|NCT04094584|65320708|FG000|Overall Study|Unwilling to undergo screening tests|36|||
23430793|NCT04094584|65320708|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
23430794|NCT04094584|65320708|FG000|Overall Study|Opioid use|7|||
23552207|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
23552208|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
23552209|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
23552210|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552211|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552212|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552213|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552214|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552215|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23621546|NCT02330562|66000683|FG001|Overall Study|Withdrawal by Subject|0|||
23621547|NCT02330562|66000684|FG002|Overall Study|Withdrawal by Subject|0|||
23215306|NCT01018511|64528213|FG001|Overall Study|Lack of Efficacy|1|||
23430795|NCT04094584|65320708|FG000|Overall Study|Need for major surgery in study period|4|||
23430796|NCT04094584|65320708|FG000|Overall Study|eligible but declined enrollment|4|||
23430797|NCT04094584|65320708|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
23430798|NCT04094584|65320708|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
23430799|NCT04094584|65320708|FG000|Overall Study|Lost to Follow-up|3|||
23552216|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552217|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552218|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23215307|NCT01018511|64528214|FG002|Overall Study|Lack of Efficacy|1|||
23138133|NCT00910689|64255447|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
23138134|NCT00910689|64255448|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
23138135|NCT00910689|64255449|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
23138136|NCT00910689|64255446|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
23138137|NCT00910689|64255447|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
23138138|NCT00910689|64255448|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
23138139|NCT00910689|64255449|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
23138140|NCT00910689|64255446|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
23138141|NCT00910689|64255447|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
23138142|NCT00910689|64255448|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
23138143|NCT00910689|64255449|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
23138144|NCT00910689|64255446|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
23138145|NCT00910689|64255447|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
23138146|NCT00910689|64255448|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
23138147|NCT00910689|64255449|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
23138148|NCT00910689|64255446|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
23138149|NCT00910689|64255447|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
23138150|NCT00910689|64255448|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
23138151|NCT00910689|64255449|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
23138152|NCT00910689|64255446|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
23138153|NCT00910689|64255447|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
23138154|NCT00910689|64255448|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
23138155|NCT00910689|64255449|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
23138156|NCT00910689|64255446|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
23138157|NCT00910689|64255447|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
23138158|NCT00910689|64255448|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
23138159|NCT00910689|64255449|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
23138160|NCT00910689|64255446|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
23138161|NCT00910689|64255447|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
23138162|NCT00910689|64255448|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
23138163|NCT00910689|64255449|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
23138164|NCT00910689|64255446|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
23138165|NCT00910689|64255447|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
23138166|NCT00910689|64255448|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
23138167|NCT00910689|64255449|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
23138168|NCT00910689|64255446|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
23138169|NCT00910689|64255447|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
23138170|NCT00910689|64255448|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
23138171|NCT00910689|64255449|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
23138172|NCT00910689|64255446|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
23138173|NCT00910689|64255447|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
23138174|NCT00910689|64255448|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
23138175|NCT00910689|64255449|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
23138176|NCT00910689|64255446|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
23138177|NCT00910689|64255447|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
23138178|NCT00910689|64255448|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
23138179|NCT00910689|64255449|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
23138180|NCT00910689|64255446|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
23138181|NCT00910689|64255447|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
23138182|NCT00910689|64255448|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
23138183|NCT00910689|64255449|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
23138184|NCT00910689|64255446|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
23138185|NCT00910689|64255447|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
23138186|NCT00910689|64255448|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
23138187|NCT00910689|64255449|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
23138188|NCT00910689|64255446|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
23138189|NCT00910689|64255447|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
23138190|NCT00910689|64255448|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
23138191|NCT00910689|64255449|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
23621548|NCT02330562|66000685|FG003|Overall Study|Withdrawal by Subject|0|||
23138192|NCT00910689|64255446|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
23138193|NCT00910689|64255447|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
23138194|NCT00910689|64255448|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
23138195|NCT00910689|64255449|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
23138196|NCT00910689|64255446|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
23138197|NCT00910689|64255447|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
23138198|NCT00910689|64255448|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
23138199|NCT00910689|64255449|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
23138200|NCT00910689|64255446|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
23552219|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552220|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552221|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
23552222|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
23552223|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
23552224|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552225|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552226|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552227|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552228|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23138201|NCT00910689|64255447|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
23138202|NCT00910689|64255448|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
23138203|NCT00910689|64255449|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
23138204|NCT00910689|64255446|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
23552229|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552230|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552231|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552232|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552233|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552234|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552235|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
23552236|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552237|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
23552238|NCT02349295|65747705|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552239|NCT02349295|65747706|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552240|NCT02349295|65747707|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552241|NCT02349295|65747708|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552242|NCT02349295|65747709|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552243|NCT02349295|65747710|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552244|NCT02349295|65747711|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552245|NCT02349295|65747712|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552246|NCT02349295|65747713|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552247|NCT02349295|65747714|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552248|NCT02349295|65747715|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552249|NCT02349295|65747716|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
23552250|NCT02349295|65747717|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552251|NCT02349295|65747718|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
23552252|NCT02341417|65747724|FG000|Overall Study|Withdrawal by Subject|0|||
23552253|NCT02341417|65747725|FG001|Overall Study|Withdrawal by Subject|2|||
23552254|NCT02341417|65747726|FG002|Overall Study|Withdrawal by Subject|0|||
23552255|NCT02341417|65747724|FG000|Overall Study|Decision by sponsor|2|||
23552256|NCT02341417|65747725|FG001|Overall Study|Decision by sponsor|0|||
23552257|NCT02341417|65747726|FG002|Overall Study|Decision by sponsor|0|||
23138205|NCT00910689|64255447|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
23138206|NCT00910689|64255448|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
23138207|NCT00910689|64255449|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
23138208|NCT00910689|64255446|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
23138209|NCT00910689|64255447|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
23138210|NCT00910689|64255448|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
23138211|NCT00910689|64255449|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
23138212|NCT00996476|64255450|FG000|Overall Study|Withdrawal by Subject|1|||
23138213|NCT00996476|64255451|FG001|Overall Study|Withdrawal by Subject|2|||
23138214|NCT00996476|64255452|FG002|Overall Study|Withdrawal by Subject|1|||
23138215|NCT00996476|64255453|FG003|Overall Study|Withdrawal by Subject|0|||
23138216|NCT00996476|64255454|FG004|Overall Study|Withdrawal by Subject|1|||
23138217|NCT00996476|64255450|FG000|Overall Study|Adverse Event|0|||
23138218|NCT00996476|64255451|FG001|Overall Study|Adverse Event|1|||
23138219|NCT00996476|64255452|FG002|Overall Study|Adverse Event|0|||
23138220|NCT00996476|64255453|FG003|Overall Study|Adverse Event|0|||
23138221|NCT00996476|64255454|FG004|Overall Study|Adverse Event|1|||
23138222|NCT05559476|64255455|FG000|Overall Study|Adverse Event|2|||
23552258|NCT02341417|65747724|FG000|Overall Study|Death|0|||
23552259|NCT02341417|65747725|FG001|Overall Study|Death|0|||
23552260|NCT02341417|65747726|FG002|Overall Study|Death|1|||
23552261|NCT02308748|65747727|FG000|Period 1|Withdrawal by Subject|0|||
23552262|NCT02308748|65747728|FG001|Period 1|Withdrawal by Subject|0|||
23552263|NCT02308748|65747729|FG002|Period 1|Withdrawal by Subject|1|||
23552264|NCT02308748|65747730|FG003|Period 1|Withdrawal by Subject|0|||
23138223|NCT05559476|64255456|FG001|Overall Study|Adverse Event|0|||
23552265|NCT02308748|65747731|FG004|Period 1|Withdrawal by Subject|0|||
23138224|NCT05559476|64255455|FG000|Overall Study|Lost to Follow-up|13|||
23138225|NCT05559476|64255456|FG001|Overall Study|Lost to Follow-up|12|||
23138226|NCT05559476|64255455|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
23138227|NCT05559476|64255456|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
23138228|NCT05559476|64255455|FG000|Overall Study|Other|0|||
23138229|NCT05559476|64255456|FG001|Overall Study|Other|2|||
23138230|NCT02101385|64255457|FG000|Study Treatment|Disease Progression|9|||
23138231|NCT02101385|64255458|FG001|Study Treatment|Disease Progression|3|||
23138232|NCT02101385|64255457|FG000|Study Treatment|Alternative therapy|0|||
23138233|NCT02101385|64255458|FG001|Study Treatment|Alternative therapy|1|||
23138234|NCT02101385|64255457|FG000|Study Treatment|No treatment, per protocol criteria|0|||
23138235|NCT02101385|64255458|FG001|Study Treatment|No treatment, per protocol criteria|4|||
23138236|NCT02101385|64255457|FG000|Study Treatment|Patient Non compliance|0|||
23138237|NCT02101385|64255458|FG001|Study Treatment|Patient Non compliance|2|||
23138238|NCT02101385|64255457|FG000|Study Treatment|Withdrawal by Subject|5|||
23138239|NCT02101385|64255458|FG001|Study Treatment|Withdrawal by Subject|2|||
23138240|NCT02101385|64255457|FG000|Study Treatment|screen failure|1|||
23138241|NCT02101385|64255458|FG001|Study Treatment|screen failure|0|||
23138242|NCT02101385|64255457|FG000|Study Treatment|AE/Side Effects/Complications|8|||
23138243|NCT02101385|64255458|FG001|Study Treatment|AE/Side Effects/Complications|0|||
23138244|NCT02101385|64255457|FG000|Study Treatment|Lost to Follow-up|1|||
23138245|NCT02101385|64255458|FG001|Study Treatment|Lost to Follow-up|0|||
23138246|NCT02101385|64255457|FG000|Study Treatment|Disease Progression before treatment|1|||
23138247|NCT02101385|64255458|FG001|Study Treatment|Disease Progression before treatment|0|||
23138248|NCT02101385|64255457|FG000|Study Treatment|Death|1|||
23138249|NCT02101385|64255458|FG001|Study Treatment|Death|0|||
23138250|NCT02101385|64255457|FG000|Follow up|Lost to Follow-up|4|||
23138251|NCT02101385|64255458|FG001|Follow up|Lost to Follow-up|9|||
23138252|NCT02101385|64255457|FG000|Follow up|Refused to follow up|5|||
23138253|NCT02101385|64255458|FG001|Follow up|Refused to follow up|4|||
23138254|NCT02101385|64255457|FG000|Follow up|Death|21|||
23138255|NCT02101385|64255458|FG001|Follow up|Death|39|||
23138256|NCT02101385|64255457|FG000|Follow up|study completed|33|||
23138257|NCT02101385|64255458|FG001|Follow up|study completed|52|||
23552266|NCT02308748|65747732|FG005|Period 1|Withdrawal by Subject|0|||
23552267|NCT02308748|65747733|FG006|Period 1|Withdrawal by Subject|0|||
23552268|NCT02308748|65747734|FG007|Period 1|Withdrawal by Subject|0|||
23552269|NCT02308748|65747735|FG008|Period 1|Withdrawal by Subject|0|||
23552270|NCT02308748|65747736|FG009|Period 1|Withdrawal by Subject|0|||
23552271|NCT02308748|65747727|FG000|Period 2|Adverse Event|0|||
23552272|NCT02308748|65747728|FG001|Period 2|Adverse Event|0|||
23552273|NCT02308748|65747729|FG002|Period 2|Adverse Event|0|||
23552274|NCT02308748|65747730|FG003|Period 2|Adverse Event|0|||
23138258|NCT02101385|64255457|FG000|Follow up|screen failure|2|||
23138259|NCT02101385|64255458|FG001|Follow up|screen failure|0|||
23138260|NCT02101385|64255457|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
23138261|NCT02101385|64255458|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
23138262|NCT02101385|64255457|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
23138263|NCT02101385|64255458|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
23138264|NCT02101385|64255457|FG000|Follow up|Withdrawal by Subject|2|||
23138265|NCT02101385|64255458|FG001|Follow up|Withdrawal by Subject|2|||
23138266|NCT02101385|64255457|FG000|Follow up|PI requested closure of site|0|||
23138267|NCT02101385|64255458|FG001|Follow up|PI requested closure of site|5|||
23138268|NCT02516332|64255459|FG000|Overall Study|Withdrawal by Subject|2|||
23138269|NCT02516332|64255460|FG001|Overall Study|Withdrawal by Subject|1|||
23138270|NCT02516332|64255461|FG002|Overall Study|Withdrawal by Subject|2|||
23138271|NCT01142232|64255462|FG000|Overall Study|Adverse Event|1|||
23138272|NCT01142232|64255463|FG001|Overall Study|Adverse Event|2|||
23138273|NCT01142232|64255464|FG002|Overall Study|Adverse Event|1|||
23138274|NCT01142232|64255465|FG003|Overall Study|Adverse Event|0|||
23138275|NCT01142232|64255466|FG004|Overall Study|Adverse Event|4|||
23138276|NCT01142232|64255462|FG000|Overall Study|Death|0|||
23138277|NCT01142232|64255463|FG001|Overall Study|Death|0|||
23138278|NCT01142232|64255464|FG002|Overall Study|Death|0|||
23138279|NCT01142232|64255465|FG003|Overall Study|Death|0|||
23138280|NCT01142232|64255466|FG004|Overall Study|Death|1|||
23552275|NCT02308748|65747731|FG004|Period 2|Adverse Event|0|||
23552276|NCT02308748|65747732|FG005|Period 2|Adverse Event|0|||
23552277|NCT02308748|65747733|FG006|Period 2|Adverse Event|0|||
23138281|NCT01142232|64255462|FG000|Overall Study|Disease Progression|2|||
23552278|NCT02308748|65747734|FG007|Period 2|Adverse Event|1|||
23552279|NCT02308748|65747735|FG008|Period 2|Adverse Event|0|||
23138282|NCT01142232|64255463|FG001|Overall Study|Disease Progression|0|||
23138283|NCT01142232|64255464|FG002|Overall Study|Disease Progression|1|||
23138284|NCT01142232|64255465|FG003|Overall Study|Disease Progression|2|||
23138285|NCT01142232|64255466|FG004|Overall Study|Disease Progression|12|||
23552280|NCT02308748|65747736|FG009|Period 2|Adverse Event|0|||
23552281|NCT02308748|65747727|FG000|Period 3|Protocol Violation|0|||
23138286|NCT01142232|64255462|FG000|Overall Study|Withdrawal by Subject|0|||
23138287|NCT01142232|64255463|FG001|Overall Study|Withdrawal by Subject|0|||
23138288|NCT01142232|64255464|FG002|Overall Study|Withdrawal by Subject|0|||
23138289|NCT01142232|64255465|FG003|Overall Study|Withdrawal by Subject|1|||
23552282|NCT02308748|65747728|FG001|Period 3|Protocol Violation|0|||
23552283|NCT02308748|65747729|FG002|Period 3|Protocol Violation|0|||
23552284|NCT02308748|65747730|FG003|Period 3|Protocol Violation|0|||
23552285|NCT02308748|65747731|FG004|Period 3|Protocol Violation|0|||
23552286|NCT02308748|65747732|FG005|Period 3|Protocol Violation|0|||
23552287|NCT02308748|65747733|FG006|Period 3|Protocol Violation|0|||
23552288|NCT02308748|65747734|FG007|Period 3|Protocol Violation|0|||
23552289|NCT02308748|65747735|FG008|Period 3|Protocol Violation|0|||
23552290|NCT02308748|65747736|FG009|Period 3|Protocol Violation|1|||
23552291|NCT02308748|65747727|FG000|Period 5|Adverse Event|1|||
23552292|NCT02308748|65747728|FG001|Period 5|Adverse Event|0|||
23552293|NCT02308748|65747729|FG002|Period 5|Adverse Event|0|||
23552294|NCT02308748|65747730|FG003|Period 5|Adverse Event|0|||
23552295|NCT02308748|65747731|FG004|Period 5|Adverse Event|0|||
23552296|NCT02308748|65747732|FG005|Period 5|Adverse Event|0|||
23552297|NCT02308748|65747733|FG006|Period 5|Adverse Event|0|||
23552298|NCT02308748|65747734|FG007|Period 5|Adverse Event|0|||
23552299|NCT02308748|65747735|FG008|Period 5|Adverse Event|1|||
23552300|NCT02308748|65747736|FG009|Period 5|Adverse Event|0|||
23552301|NCT00802074|65747743|FG000|Overall Study|Adverse Event|1|||
23552302|NCT00802074|65747744|FG001|Overall Study|Adverse Event|1|||
23552303|NCT00802074|65747745|FG002|Overall Study|Adverse Event|1|||
23552304|NCT00802074|65747746|FG003|Overall Study|Adverse Event|0|||
23552305|NCT00802074|65747747|FG004|Overall Study|Adverse Event|0|||
23552306|NCT00802074|65747748|FG005|Overall Study|Adverse Event|0|||
23552307|NCT00802074|65747743|FG000|Overall Study|Withdrawal by Subject|1|||
23552308|NCT00802074|65747744|FG001|Overall Study|Withdrawal by Subject|0|||
23552309|NCT00802074|65747745|FG002|Overall Study|Withdrawal by Subject|0|||
23552310|NCT00802074|65747746|FG003|Overall Study|Withdrawal by Subject|0|||
23552311|NCT00802074|65747747|FG004|Overall Study|Withdrawal by Subject|0|||
23552312|NCT00802074|65747748|FG005|Overall Study|Withdrawal by Subject|0|||
23552313|NCT01814371|65747749|FG000|Overall Study|Lost to Follow-up|30|||
23552314|NCT01814371|65747750|FG001|Overall Study|Lost to Follow-up|27|||
23552315|NCT00535730|65747751|FG000|Overall Study|Adverse Event|1|||
23552316|NCT00535730|65747752|FG001|Overall Study|Adverse Event|1|||
23552317|NCT00535730|65747751|FG000|Overall Study|Lost to Follow-up|0|||
23552318|NCT00535730|65747752|FG001|Overall Study|Lost to Follow-up|1|||
23552319|NCT00535730|65747751|FG000|Overall Study|Physician Decision|0|||
23552320|NCT00535730|65747752|FG001|Overall Study|Physician Decision|1|||
23552321|NCT00535730|65747751|FG000|Overall Study|Protocol Violation|1|||
23552322|NCT00535730|65747752|FG001|Overall Study|Protocol Violation|0|||
23552323|NCT00535730|65747751|FG000|Overall Study|Withdrawal by Subject|0|||
23552324|NCT00535730|65747752|FG001|Overall Study|Withdrawal by Subject|4|||
23552325|NCT03519854|65747753|FG000|Overall Study|Technical Error|0|||
23552326|NCT03519854|65747754|FG001|Overall Study|Technical Error|0|||
23552327|NCT03519854|65747755|FG002|Overall Study|Technical Error|1|||
23552328|NCT03519854|65747756|FG003|Overall Study|Technical Error|0|||
23552329|NCT03519854|65747757|FG004|Overall Study|Technical Error|0|||
23552330|NCT03519854|65747758|FG005|Overall Study|Technical Error|0|||
23552331|NCT03519854|65747759|FG006|Overall Study|Technical Error|0|||
23552332|NCT03519854|65747760|FG007|Overall Study|Technical Error|0|||
23552333|NCT03519854|65747761|FG008|Overall Study|Technical Error|0|||
23138290|NCT01142232|64255466|FG004|Overall Study|Withdrawal by Subject|3|||
23138291|NCT01142232|64255462|FG000|Overall Study|Physician Decision|0|||
23138292|NCT01142232|64255463|FG001|Overall Study|Physician Decision|1|||
23138293|NCT01142232|64255464|FG002|Overall Study|Physician Decision|0|||
23138294|NCT01142232|64255465|FG003|Overall Study|Physician Decision|2|||
23138295|NCT01142232|64255466|FG004|Overall Study|Physician Decision|10|||
23138296|NCT01142232|64255462|FG000|Overall Study|Alternative Therapy|0|||
23552334|NCT03519854|65747762|FG009|Overall Study|Technical Error|0|||
23552335|NCT03519854|65747763|FG010|Overall Study|Technical Error|0|||
23552336|NCT03519854|65747764|FG011|Overall Study|Technical Error|0|||
23552337|NCT03519854|65747765|FG012|Overall Study|Technical Error|0|||
23138297|NCT01142232|64255463|FG001|Overall Study|Alternative Therapy|1|||
23552338|NCT03519854|65747766|FG013|Overall Study|Technical Error|0|||
23138298|NCT01142232|64255464|FG002|Overall Study|Alternative Therapy|1|||
23138299|NCT01142232|64255465|FG003|Overall Study|Alternative Therapy|0|||
23138300|NCT01142232|64255466|FG004|Overall Study|Alternative Therapy|1|||
23138301|NCT01142232|64255462|FG000|Overall Study|Off Trt for other complicating disease|0|||
23552339|NCT03519854|65747767|FG014|Overall Study|Technical Error|0|||
23552340|NCT03519854|65747768|FG015|Overall Study|Technical Error|0|||
23552341|NCT03519854|65747769|FG016|Overall Study|Technical Error|0|||
23552342|NCT03519854|65747770|FG017|Overall Study|Technical Error|0|||
23552343|NCT01654549|65747772|FG000|Overall Study|H.pylori eradication not successful|0|||
23552344|NCT01654549|65747773|FG001|Overall Study|H.pylori eradication not successful|1|||
23552345|NCT00941330|65747774|FG000|Overall Study|Other|1|||
23552346|NCT00941330|65747775|FG001|Overall Study|Other|0|||
23552347|NCT00941330|65747774|FG000|Overall Study|Physician Decision|0|||
23552348|NCT00941330|65747775|FG001|Overall Study|Physician Decision|2|||
23552349|NCT04672941|65747793|FG000|Overall Study|Investigator decision|1|||
23552350|NCT04672941|65747793|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
23552351|NCT04672941|65747793|FG000|Overall Study|COVID-19 related but no adverse event|1|||
23552352|NCT04672941|65747793|FG000|Overall Study|Adverse Event|2|||
23552353|NCT04672941|65747793|FG000|Overall Study|Lost to Follow-up|2|||
23552354|NCT02975973|65747794|FG000|Overall Study|Adverse Event|1|||
23552355|NCT02975973|65747795|FG001|Overall Study|Adverse Event|1|||
23552356|NCT02975973|65747796|FG002|Overall Study|Adverse Event|1|||
23552357|NCT02975973|65747797|FG003|Overall Study|Adverse Event|0|||
23552358|NCT01994954|65747798|FG000|Overall Study|Death|1|||
23552359|NCT01994954|65747799|FG001|Overall Study|Death|0|||
23552360|NCT01994954|65747798|FG000|Overall Study|Withdrawal by Subject|9|||
23552361|NCT01994954|65747799|FG001|Overall Study|Withdrawal by Subject|14|||
23552362|NCT01994954|65747798|FG000|Overall Study|Physician Decision|2|||
23552363|NCT01994954|65747799|FG001|Overall Study|Physician Decision|2|||
23552364|NCT01994954|65747798|FG000|Overall Study|Lost to Follow-up|8|||
23552365|NCT01994954|65747799|FG001|Overall Study|Lost to Follow-up|10|||
23552366|NCT01994954|65747798|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
23552367|NCT01994954|65747799|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
23552368|NCT03657277|65747800|FG000|Overall Study|Physician Decision|2|||
23552369|NCT03657277|65747800|FG000|Overall Study|Lost to Follow-up|1|||
23552370|NCT03657277|65747800|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
23552371|NCT03325712|65747801|FG000|Overall Study|Protocol Violation|0|||
23552372|NCT03325712|65747802|FG001|Overall Study|Protocol Violation|0|||
23552373|NCT03325712|65747803|FG002|Overall Study|Protocol Violation|0|||
23552374|NCT03325712|65747804|FG003|Overall Study|Protocol Violation|0|||
23552375|NCT03325712|65747805|FG004|Overall Study|Protocol Violation|1|||
23552376|NCT03325712|65747806|FG005|Overall Study|Protocol Violation|0|||
23552377|NCT03325712|65747807|FG006|Overall Study|Protocol Violation|0|||
23552378|NCT03325712|65747808|FG007|Overall Study|Protocol Violation|0|||
23552379|NCT03325712|65747801|FG000|Overall Study|Adverse Event|0|||
23552380|NCT03325712|65747802|FG001|Overall Study|Adverse Event|0|||
23552381|NCT03325712|65747803|FG002|Overall Study|Adverse Event|0|||
23552382|NCT03325712|65747804|FG003|Overall Study|Adverse Event|0|||
23552383|NCT03325712|65747805|FG004|Overall Study|Adverse Event|1|||
23552384|NCT03325712|65747806|FG005|Overall Study|Adverse Event|0|||
23552385|NCT03325712|65747807|FG006|Overall Study|Adverse Event|0|||
23552386|NCT03325712|65747808|FG007|Overall Study|Adverse Event|0|||
23552387|NCT00771810|65747811|FG000|Overall Study|Adverse Event|3|||
23552388|NCT00771810|65747812|FG001|Overall Study|Adverse Event|0|||
23552389|NCT00771810|65747813|FG002|Overall Study|Adverse Event|2|||
23552390|NCT00771810|65747811|FG000|Overall Study|Lost to Follow-up|0|||
23552391|NCT00771810|65747812|FG001|Overall Study|Lost to Follow-up|0|||
23552392|NCT00771810|65747813|FG002|Overall Study|Lost to Follow-up|1|||
23552393|NCT00771810|65747811|FG000|Overall Study|Physician Decision|1|||
23552394|NCT00771810|65747812|FG001|Overall Study|Physician Decision|2|||
23552395|NCT00771810|65747813|FG002|Overall Study|Physician Decision|2|||
23552396|NCT00771810|65747811|FG000|Overall Study|Protocol Violation|0|||
23552397|NCT00771810|65747812|FG001|Overall Study|Protocol Violation|1|||
23138302|NCT01142232|64255463|FG001|Overall Study|Off Trt for other complicating disease|0|||
23138303|NCT01142232|64255464|FG002|Overall Study|Off Trt for other complicating disease|0|||
23138304|NCT01142232|64255465|FG003|Overall Study|Off Trt for other complicating disease|0|||
23138305|NCT01142232|64255466|FG004|Overall Study|Off Trt for other complicating disease|1|||
23138306|NCT01142232|64255462|FG000|Overall Study|Noncompliance|0|||
23138307|NCT01142232|64255463|FG001|Overall Study|Noncompliance|0|||
23138308|NCT01142232|64255464|FG002|Overall Study|Noncompliance|0|||
23138309|NCT01142232|64255465|FG003|Overall Study|Noncompliance|0|||
23552398|NCT00771810|65747813|FG002|Overall Study|Protocol Violation|1|||
23552399|NCT00771810|65747811|FG000|Overall Study|Withdrawal by Subject|1|||
23138310|NCT01142232|64255466|FG004|Overall Study|Noncompliance|2|||
23138311|NCT01156792|64255470|FG000|Overall Study|Adverse Event|1|||
23138312|NCT01156792|64255470|FG000|Overall Study|Lack of Efficacy|36|||
23138313|NCT01156792|64255470|FG000|Overall Study|Protocol Violation|6|||
23552400|NCT00771810|65747812|FG001|Overall Study|Withdrawal by Subject|2|||
23552401|NCT00771810|65747813|FG002|Overall Study|Withdrawal by Subject|0|||
23552402|NCT00771810|65747811|FG000|Overall Study|Other|0|||
23552403|NCT00771810|65747812|FG001|Overall Study|Other|0|||
23552404|NCT00771810|65747813|FG002|Overall Study|Other|1|||
23552405|NCT01967732|65747814|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
23552406|NCT01967732|65747815|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
23552407|NCT01967732|65747816|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
23552408|NCT01967732|65747817|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
23552409|NCT01967732|65747814|FG000|First Intervention (Day 1)|Poor venous access|0|||
23552410|NCT01967732|65747815|FG001|First Intervention (Day 1)|Poor venous access|1|||
23552411|NCT01967732|65747816|FG002|First Intervention (Day 1)|Poor venous access|0|||
23317698|NCT00683657|64904166|FG001|Overall Study|Subject Withdrew Consent|0|||
23317699|NCT05513391|64904167|FG000|Overall Study|Adverse Event|1|||
23317700|NCT05513391|64904168|FG001|Overall Study|Adverse Event|0|||
23317701|NCT05513391|64904167|FG000|Overall Study|Protocol Deviation|0|||
23317702|NCT05513391|64904168|FG001|Overall Study|Protocol Deviation|1|||
23317703|NCT05513391|64904167|FG000|Overall Study|Withdrawal by Subject|3|||
23317704|NCT05513391|64904168|FG001|Overall Study|Withdrawal by Subject|1|||
23317705|NCT05513391|64904167|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23317706|NCT05513391|64904168|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23317707|NCT05513391|64904167|FG000|Overall Study|Lost to Follow-up|0|||
23317708|NCT05513391|64904168|FG001|Overall Study|Lost to Follow-up|2|||
23317709|NCT01461538|64908110|FG000|Overall Study|Death|15|||
23430800|NCT04094584|65320708|FG000|Overall Study|Withdrawal by Subject|2|||
23430801|NCT02535416|65320711|FG000|Overall Study|Family bereavement overseas|1|||
23430802|NCT02535416|65320712|FG001|Overall Study|Family bereavement overseas|0|||
23430803|NCT02535416|65320713|FG002|Overall Study|Family bereavement overseas|0|||
23138314|NCT01156792|64255470|FG000|Overall Study|Lost to Follow-up|3|||
23138315|NCT01156792|64255470|FG000|Overall Study|Physician Decision|3|||
23430804|NCT02535416|65320714|FG003|Overall Study|Family bereavement overseas|0|||
23430805|NCT02535416|65320715|FG004|Overall Study|Family bereavement overseas|0|||
23430806|NCT02535416|65320716|FG005|Overall Study|Family bereavement overseas|0|||
23430807|NCT02535416|65320717|FG006|Overall Study|Family bereavement overseas|0|||
23430808|NCT02535416|65320718|FG007|Overall Study|Family bereavement overseas|0|||
23430809|NCT02535416|65320719|FG008|Overall Study|Family bereavement overseas|0|||
23430810|NCT02598128|65320720|FG000|Period A: Days -7 to -1|Adverse Event|1|||
23138316|NCT01156792|64255470|FG000|Overall Study|Withdrawal by Subject|9|||
23430811|NCT02598128|65320721|FG001|Period A: Days -7 to -1|Adverse Event|0|||
23430812|NCT02598128|65320722|FG002|Period A: Days -7 to -1|Adverse Event|0|||
23430813|NCT02598128|65320723|FG003|Period A: Days -7 to -1|Adverse Event|0|||
23138317|NCT01156792|64255470|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
23138318|NCT01775124|64255471|FG000|Core Period|Disease Progression|0|||
23138319|NCT01775124|64255472|FG001|Core Period|Disease Progression|1|||
23317710|NCT01461538|64908111|FG001|Overall Study|Death|6|||
23317711|NCT01461538|64908112|FG002|Overall Study|Death|2|||
23430814|NCT02920957|65320724|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
23430815|NCT02920957|65320725|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
23430816|NCT02920957|65320724|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
23430817|NCT02920957|65320725|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
23430818|NCT02920957|65320724|FG000|First Intervention : 1 Month|Adverse Event|1|||
23430819|NCT02920957|65320725|FG001|First Intervention : 1 Month|Adverse Event|0|||
23430820|NCT02920957|65320724|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
23430821|NCT02920957|65320725|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
23430822|NCT00521222|65320726|FG000|Overall Study|Lost to Follow-up|0|||
23430823|NCT00521222|65320727|FG001|Overall Study|Lost to Follow-up|0|||
23430824|NCT00521222|65320728|FG002|Overall Study|Lost to Follow-up|1|||
23430825|NCT00521222|65320729|FG003|Overall Study|Lost to Follow-up|1|||
23430826|NCT00521222|65320726|FG000|Overall Study|Withdrawal by Subject|0|||
23430827|NCT00521222|65320727|FG001|Overall Study|Withdrawal by Subject|0|||
23430828|NCT00521222|65320728|FG002|Overall Study|Withdrawal by Subject|2|||
23430829|NCT00521222|65320729|FG003|Overall Study|Withdrawal by Subject|0|||
23430830|NCT00521222|65320726|FG000|Overall Study|Physician Decision|0|||
23430831|NCT00521222|65320727|FG001|Overall Study|Physician Decision|1|||
23430832|NCT00521222|65320728|FG002|Overall Study|Physician Decision|0|||
23430833|NCT00521222|65320729|FG003|Overall Study|Physician Decision|1|||
23430834|NCT02290938|65320732|FG000|Overall Study|Lost to Follow-up|14|||
23430835|NCT02290938|65320733|FG001|Overall Study|Lost to Follow-up|43|||
23552412|NCT01967732|65747817|FG003|First Intervention (Day 1)|Poor venous access|0|||
23317712|NCT01461538|64908110|FG000|Overall Study|Study Stopped by Sponsor|2|||
23317713|NCT01461538|64908111|FG001|Overall Study|Study Stopped by Sponsor|1|||
23317714|NCT01461538|64908112|FG002|Overall Study|Study Stopped by Sponsor|0|||
23317715|NCT01461538|64908110|FG000|Overall Study|Withdrawal by Subject|1|||
23317716|NCT01461538|64908111|FG001|Overall Study|Withdrawal by Subject|1|||
23317717|NCT01461538|64908112|FG002|Overall Study|Withdrawal by Subject|0|||
23317718|NCT00403585|64908113|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
23430836|NCT02712424|65320734|FG000|Overall Study|Lost to Follow-up|34|||
23430837|NCT02712424|65320735|FG001|Overall Study|Lost to Follow-up|32|||
23430838|NCT00308074|65320737|FG000|Overall Study|Withdrawal by Subject|1|||
23430839|NCT01711866|65320740|FG000|Overall Study|Noncompliant|3|||
23430840|NCT01711866|65320740|FG000|Overall Study|Withdrawal by Subject|3|||
23430841|NCT01711866|65320740|FG000|Overall Study|Adverse Event|2|||
23430842|NCT00798317|65320741|FG000|Overall Study|Physician Decision|0|||
23430843|NCT00798317|65320742|FG001|Overall Study|Physician Decision|1|||
23138320|NCT01775124|64255471|FG000|Core Period|Physician Decision|1|||
23138321|NCT01775124|64255472|FG001|Core Period|Physician Decision|1|||
23317719|NCT00403585|64908113|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
23430844|NCT00798317|65320741|FG000|Overall Study|Withdrawal by Subject|5|||
23317720|NCT00403585|64908113|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
23317721|NCT00258960|64908114|FG000|Overall Study|Death|2|||
23430845|NCT00798317|65320742|FG001|Overall Study|Withdrawal by Subject|4|||
23430846|NCT00798317|65320741|FG000|Overall Study|Lost to Follow-up|2|||
23430847|NCT00798317|65320742|FG001|Overall Study|Lost to Follow-up|2|||
23430848|NCT00798317|65320741|FG000|Overall Study|Adverse Event|2|||
23430849|NCT00798317|65320742|FG001|Overall Study|Adverse Event|0|||
23430850|NCT00798317|65320741|FG000|Overall Study|Death|1|||
23430851|NCT00798317|65320742|FG001|Overall Study|Death|0|||
23430852|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
23430853|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
23430854|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
23430855|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
23430856|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
23430857|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
23430858|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
23430859|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
23430860|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
23430861|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
23430862|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
23430863|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
23430864|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
23430865|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
23430866|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
23430867|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
23430868|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
23430869|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
23430870|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
23430871|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
23430872|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
23430873|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
23430874|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
23430875|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
23430876|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
23430877|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
23430878|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
23430879|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
23430880|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
23430881|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
23430882|NCT00121641|65320743|FG000|24-week Short-term Treatment Period|Other Reason|1|||
23430883|NCT00121641|65320744|FG001|24-week Short-term Treatment Period|Other Reason|0|||
23430884|NCT00121641|65320745|FG002|24-week Short-term Treatment Period|Other Reason|0|||
23430885|NCT00121641|65320746|FG003|24-week Short-term Treatment Period|Other Reason|0|||
23430886|NCT00121641|65320747|FG004|24-week Short-term Treatment Period|Other Reason|0|||
23430887|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
23430888|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
23430889|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
23430890|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
23430891|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
23430892|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
23430893|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
23430894|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
23430895|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
23430896|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
23430897|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
23430898|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
23430899|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
23430900|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
23430901|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
23430902|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
23430903|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
23430904|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
23430905|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
23430906|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
23430907|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
23430908|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
23430909|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
23430910|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
23430911|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
23430912|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
23430913|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
23430914|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
23430915|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
23430916|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
23430917|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
23430918|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
23430919|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
23430920|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
23430921|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
23430922|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
23430923|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
23430924|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
23430925|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
23430926|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
23552413|NCT05054374|65747818|FG000|Overall Study|Withdrawal by Subject|1|||
23552414|NCT05054374|65747819|FG001|Overall Study|Withdrawal by Subject|0|||
23552415|NCT05054374|65747820|FG002|Overall Study|Withdrawal by Subject|0|||
23552416|NCT05054374|65747821|FG003|Overall Study|Withdrawal by Subject|0|||
23552417|NCT05054374|65747818|FG000|Overall Study|Progressive Disease|5|||
23552418|NCT05054374|65747819|FG001|Overall Study|Progressive Disease|0|||
23552419|NCT05054374|65747820|FG002|Overall Study|Progressive Disease|0|||
23552420|NCT05054374|65747821|FG003|Overall Study|Progressive Disease|0|||
23552421|NCT04058353|65747824|FG000|Overall Study|Adverse Event|2|||
23430927|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Death|0|||
23430928|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Death|0|||
23430929|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Death|0|||
23430930|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Death|1|||
23430931|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Death|0|||
23430932|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Missing|0|||
23215308|NCT01018511|64528215|FG003|Overall Study|Lack of Efficacy|2|||
23215309|NCT01018511|64528212|FG000|Overall Study|Withdrawal by Subject|6|||
23430933|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Missing|0|||
23430934|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Missing|1|||
23430935|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Missing|0|||
23430936|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Missing|0|||
23430937|NCT00121641|65320743|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
23430938|NCT00121641|65320744|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
23430939|NCT00121641|65320745|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
23430940|NCT00121641|65320746|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
23430941|NCT00121641|65320747|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
23430942|NCT01519674|65320748|FG000|Overall Study|Adverse Event|3|||
23430943|NCT01519674|65320749|FG001|Overall Study|Adverse Event|3|||
23430944|NCT01519674|65320750|FG002|Overall Study|Adverse Event|0|||
23430945|NCT01519674|65320748|FG000|Overall Study|Lack of Efficacy|1|||
23430946|NCT01519674|65320749|FG001|Overall Study|Lack of Efficacy|1|||
23430947|NCT01519674|65320750|FG002|Overall Study|Lack of Efficacy|1|||
23430948|NCT01519674|65320748|FG000|Overall Study|Protocol Violation|0|||
23430949|NCT01519674|65320749|FG001|Overall Study|Protocol Violation|3|||
23430950|NCT01519674|65320750|FG002|Overall Study|Protocol Violation|1|||
23430951|NCT01519674|65320748|FG000|Overall Study|Withdrawal Criteria|7|||
23430952|NCT01519674|65320749|FG001|Overall Study|Withdrawal Criteria|2|||
23430953|NCT01519674|65320750|FG002|Overall Study|Withdrawal Criteria|7|||
23430954|NCT01519674|65320748|FG000|Overall Study|Unsclassified|10|||
23430955|NCT01519674|65320749|FG001|Overall Study|Unsclassified|4|||
23430956|NCT01519674|65320750|FG002|Overall Study|Unsclassified|3|||
23430957|NCT02279498|65320752|FG000|Overall Study|Adverse Event|3|||
23430958|NCT02279498|65320753|FG001|Overall Study|Adverse Event|0|||
23552422|NCT04058353|65747825|FG001|Overall Study|Adverse Event|1|||
23215310|NCT01018511|64528213|FG001|Overall Study|Withdrawal by Subject|5|||
23317722|NCT00258960|64908114|FG000|Overall Study|Disease Progression|7|||
23430959|NCT02279498|65320752|FG000|Overall Study|Lack of Efficacy|4|||
23430960|NCT02279498|65320753|FG001|Overall Study|Lack of Efficacy|0|||
23552423|NCT04058353|65747824|FG000|Overall Study|Physician Decision|1|||
23552424|NCT04058353|65747825|FG001|Overall Study|Physician Decision|0|||
23552425|NCT04058353|65747824|FG000|Overall Study|Other|1|||
23215311|NCT01018511|64528214|FG002|Overall Study|Withdrawal by Subject|11|||
23552426|NCT04058353|65747825|FG001|Overall Study|Other|0|||
23552427|NCT03204279|65747826|FG000|Overall Study|Withdrawal by Subject|0|||
23430961|NCT02279498|65320752|FG000|Overall Study|Lost to Follow-up|0|||
23430962|NCT02279498|65320753|FG001|Overall Study|Lost to Follow-up|1|||
23430963|NCT02279498|65320752|FG000|Overall Study|Withdrawal by Subject|9|||
23430964|NCT02279498|65320753|FG001|Overall Study|Withdrawal by Subject|2|||
23430965|NCT02279498|65320752|FG000|Overall Study|Undefined|2|||
23430966|NCT02279498|65320753|FG001|Overall Study|Undefined|1|||
23430967|NCT01565941|65320754|FG000|Overall Study|Withdrawn by parent/guardian|3|||
23430968|NCT01565941|65320755|FG001|Overall Study|Withdrawn by parent/guardian|2|||
23430969|NCT01565941|65320754|FG000|Overall Study|Randomized; did not receive intevention|8|||
23430970|NCT01565941|65320755|FG001|Overall Study|Randomized; did not receive intevention|2|||
23430971|NCT05059977|65320756|FG000|Overall Study|Withdrawal by Subject|0|||
23430972|NCT05059977|65320757|FG001|Overall Study|Withdrawal by Subject|0|||
23430973|NCT05059977|65320758|FG002|Overall Study|Withdrawal by Subject|1|||
23430974|NCT01319721|65320759|FG000|Overall Study|Lost to Follow-up|1|||
23430975|NCT01319721|65320760|FG001|Overall Study|Lost to Follow-up|6|||
23430976|NCT01198509|65320761|FG000|Overall Study|Withdrawal by Subject|1|||
23430977|NCT01198509|65320762|FG001|Overall Study|Withdrawal by Subject|0|||
23430978|NCT01198509|65320763|FG002|Overall Study|Withdrawal by Subject|0|||
23430979|NCT01198509|65320764|FG003|Overall Study|Withdrawal by Subject|0|||
23430980|NCT01198509|65320765|FG004|Overall Study|Withdrawal by Subject|0|||
23430981|NCT01198509|65320766|FG005|Overall Study|Withdrawal by Subject|0|||
23430982|NCT00587847|65320769|FG000|Overall Study|Lack of Efficacy|5|||
23430983|NCT00587847|65320769|FG000|Overall Study|Adverse Event|2|||
23430984|NCT00160654|65320770|FG000|Overall Study|Adverse Event|14|||
23430985|NCT00160654|65320770|FG000|Overall Study|Lack of Efficacy|4|||
23430986|NCT00160654|65320770|FG000|Overall Study|Lost to Follow-up|2|||
23430987|NCT00160654|65320770|FG000|Overall Study|Intake of expired drug|7|||
23430988|NCT00160654|65320770|FG000|Overall Study|Psychological trauma|1|||
23430989|NCT00160654|65320770|FG000|Overall Study|Sponsor decision|1|||
23430990|NCT00160654|65320770|FG000|Overall Study|Patient met exclusion criteria|1|||
23430991|NCT00160654|65320770|FG000|Overall Study|Patient decision|1|||
23430992|NCT00160654|65320770|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
23430993|NCT00160654|65320770|FG000|Overall Study|Met exclusion criteria|1|||
23430994|NCT00870194|65320771|FG000|Overall Study|Adverse Event|10|||
23430995|NCT00870194|65320772|FG001|Overall Study|Adverse Event|5|||
23430996|NCT00870194|65320771|FG000|Overall Study|Lack of Efficacy|0|||
23430997|NCT00870194|65320772|FG001|Overall Study|Lack of Efficacy|1|||
23430998|NCT00870194|65320771|FG000|Overall Study|Lost to Follow-up|2|||
23430999|NCT00870194|65320772|FG001|Overall Study|Lost to Follow-up|0|||
23431000|NCT00870194|65320771|FG000|Overall Study|Physician Decision|3|||
23431001|NCT00870194|65320772|FG001|Overall Study|Physician Decision|1|||
23431002|NCT00870194|65320771|FG000|Overall Study|Protocol Violation|3|||
23431003|NCT00870194|65320772|FG001|Overall Study|Protocol Violation|3|||
23431004|NCT00870194|65320771|FG000|Overall Study|Entry Criteria Not Met|1|||
23431005|NCT00870194|65320772|FG001|Overall Study|Entry Criteria Not Met|2|||
23431006|NCT00870194|65320771|FG000|Overall Study|Subject Decision|7|||
23431007|NCT00870194|65320772|FG001|Overall Study|Subject Decision|2|||
23431008|NCT02544373|65320773|FG000|Overall Study|Lost to Follow-up|5|||
23431009|NCT02544373|65320774|FG001|Overall Study|Lost to Follow-up|3|||
23431010|NCT02544373|65320773|FG000|Overall Study|Withdrawal by Subject|8|||
23431011|NCT02544373|65320774|FG001|Overall Study|Withdrawal by Subject|2|||
23431012|NCT01831817|65320775|FG000|Overall Study|Lost to Follow-up|1|||
23431013|NCT01831817|65320776|FG001|Overall Study|Lost to Follow-up|0|||
23431014|NCT01831817|65320777|FG002|Overall Study|Lost to Follow-up|0|||
23431015|NCT01831817|65320778|FG003|Overall Study|Lost to Follow-up|0|||
23431016|NCT01831817|65320775|FG000|Overall Study|Withdrawl of Consent|3|||
23552428|NCT03204279|65747827|FG001|Overall Study|Withdrawal by Subject|1|||
23552429|NCT04528069|65747828|FG000|Overall Study|Adverse Event|1|||
23552430|NCT04528069|65747828|FG000|Overall Study|Lost to Follow-up|1|||
23552431|NCT04528069|65747828|FG000|Overall Study|Patient Unable to Come|1|||
23552432|NCT04528069|65747828|FG000|Overall Study|Patient Unable to Attend|1|||
23431017|NCT01831817|65320776|FG001|Overall Study|Withdrawl of Consent|0|||
23431018|NCT01831817|65320777|FG002|Overall Study|Withdrawl of Consent|0|||
23552433|NCT00626028|65747829|FG000|Overall Study|Adverse Event|1|||
23431019|NCT01831817|65320778|FG003|Overall Study|Withdrawl of Consent|0|||
23431020|NCT04375397|65320779|FG000|Overall Study|Death|1|||
23431021|NCT04375397|65320780|FG001|Overall Study|Death|1|||
23431022|NCT04375397|65320779|FG000|Overall Study|Withdrew consent|2|||
23431023|NCT04375397|65320780|FG001|Overall Study|Withdrew consent|0|||
23621549|NCT02330562|66000686|FG004|Overall Study|Withdrawal by Subject|0|||
23431024|NCT04375397|65320779|FG000|Overall Study|Lost to Follow-up|6|||
23431025|NCT04375397|65320780|FG001|Overall Study|Lost to Follow-up|4|||
23431026|NCT04375397|65320779|FG000|Overall Study|Other, not specified|0|||
23431027|NCT04375397|65320780|FG001|Overall Study|Other, not specified|1|||
23431028|NCT00869401|65320781|FG000|Overall Study|Withdrawal by Subject|0|||
23431029|NCT00869401|65320782|FG001|Overall Study|Withdrawal by Subject|0|||
23552434|NCT00626028|65747830|FG001|Overall Study|Adverse Event|1|||
23552435|NCT00626028|65747829|FG000|Overall Study|Device Failure|0|||
23552436|NCT00626028|65747830|FG001|Overall Study|Device Failure|1|||
23552437|NCT00626028|65747829|FG000|Overall Study|Physician Decision|2|||
23552438|NCT00626028|65747830|FG001|Overall Study|Physician Decision|1|||
23552439|NCT00626028|65747829|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
23552440|NCT00626028|65747830|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
23552441|NCT00763958|65747835|FG000|Overall Study|did not meet final criteria|4|||
23552442|NCT00763958|65747836|FG001|Overall Study|did not meet final criteria|4|||
23552443|NCT00763958|65747835|FG000|Overall Study|Lost to Follow-up|10|||
23138322|NCT01775124|64255471|FG000|Core Period|Death|0|||
23138323|NCT01775124|64255472|FG001|Core Period|Death|1|||
23138324|NCT01775124|64255471|FG000|Core Period|Administrative problems|1|||
23138325|NCT01775124|64255472|FG001|Core Period|Administrative problems|0|||
23138326|NCT01775124|64255471|FG000|Core Period|Withdrawal by Subject|4|||
23138327|NCT01775124|64255472|FG001|Core Period|Withdrawal by Subject|2|||
23138328|NCT01775124|64255471|FG000|Core Period|Adverse Event|5|||
23138329|NCT01775124|64255472|FG001|Core Period|Adverse Event|5|||
23138330|NCT01775124|64255471|FG000|Extension Period|Adverse Event|3|||
23138331|NCT01775124|64255472|FG001|Extension Period|Adverse Event|2|||
23138332|NCT01775124|64255471|FG000|Extension Period|Physician Decision|0|||
23215312|NCT01018511|64528215|FG003|Overall Study|Withdrawal by Subject|9|||
23317723|NCT00258960|64908114|FG000|Overall Study|Adverse Event|4|||
23317724|NCT00258960|64908114|FG000|Overall Study|Physician Decision|1|||
23317725|NCT00258960|64908114|FG000|Overall Study|Withdrawal by Subject|1|||
23317726|NCT00258960|64908114|FG000|Overall Study|Mistake|2|||
23317727|NCT04825912|64908115|FG000|Overall Study|Death|3|||
23317728|NCT04825912|64908115|FG000|Overall Study|Withdrawal by Subject|1|||
23317729|NCT02256436|64908116|FG000|Overall Study|Adverse Event|9|||
23317730|NCT02256436|64908117|FG001|Overall Study|Adverse Event|14|||
23317731|NCT02256436|64908116|FG000|Overall Study|Death|216|||
23317732|NCT02256436|64908117|FG001|Overall Study|Death|208|||
23317733|NCT02256436|64908116|FG000|Overall Study|Lost to Follow-up|1|||
23552444|NCT00763958|65747836|FG001|Overall Study|Lost to Follow-up|2|||
23215313|NCT01018511|64528212|FG000|Overall Study|Lost to Follow-up|0|||
23215314|NCT01018511|64528213|FG001|Overall Study|Lost to Follow-up|0|||
23215315|NCT01018511|64528214|FG002|Overall Study|Lost to Follow-up|1|||
23215316|NCT01018511|64528215|FG003|Overall Study|Lost to Follow-up|0|||
23215317|NCT01018511|64528212|FG000|Overall Study|Protocol Violation|5|||
23215318|NCT01018511|64528213|FG001|Overall Study|Protocol Violation|8|||
23215319|NCT01018511|64528214|FG002|Overall Study|Protocol Violation|7|||
23215320|NCT01018511|64528215|FG003|Overall Study|Protocol Violation|9|||
23215321|NCT01018511|64528212|FG000|Overall Study|Miscellaneous|0|||
23215322|NCT01018511|64528213|FG001|Overall Study|Miscellaneous|2|||
23215323|NCT01018511|64528214|FG002|Overall Study|Miscellaneous|0|||
23215324|NCT01018511|64528215|FG003|Overall Study|Miscellaneous|0|||
23215325|NCT02727660|64528216|FG000|Overall Study|Lack of Efficacy|40|||
23215326|NCT02727660|64528217|FG001|Overall Study|Lack of Efficacy|40|||
23215327|NCT02727660|64528218|FG002|Overall Study|Lack of Efficacy|70|||
23317734|NCT02256436|64908117|FG001|Overall Study|Lost to Follow-up|2|||
23317735|NCT02256436|64908116|FG000|Overall Study|Physician Decision|1|||
23552445|NCT00763958|65747835|FG000|Overall Study|Believed they were receiving placebo|0|||
23552446|NCT00763958|65747836|FG001|Overall Study|Believed they were receiving placebo|5|||
23138333|NCT01775124|64255472|FG001|Extension Period|Physician Decision|2|||
23138334|NCT01775124|64255471|FG000|Extension Period|Administrative problems|0|||
23138335|NCT01775124|64255472|FG001|Extension Period|Administrative problems|1|||
23138336|NCT01775124|64255471|FG000|Extension Period|Lost to Follow-up|0|||
23215328|NCT02727660|64528216|FG000|Overall Study|Adverse Event|28|||
23552447|NCT02858895|65747842|FG000|Overall Study|Disease progression|31|||
23552448|NCT02858895|65747842|FG000|Overall Study|Death|2|||
23552449|NCT02858895|65747842|FG000|Overall Study|Adverse Event|1|||
23552450|NCT02858895|65747842|FG000|Overall Study|Withdrawal by Subject|3|||
23552451|NCT02858895|65747842|FG000|Overall Study|hospice,|1|||
23552452|NCT02858895|65747842|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
23138337|NCT01775124|64255472|FG001|Extension Period|Lost to Follow-up|1|||
23138338|NCT01775124|64255471|FG000|Extension Period|Withdrawal by Subject|9|||
23138339|NCT01775124|64255472|FG001|Extension Period|Withdrawal by Subject|12|||
23215329|NCT02727660|64528217|FG001|Overall Study|Adverse Event|21|||
23215330|NCT02727660|64528218|FG002|Overall Study|Adverse Event|32|||
23317736|NCT02256436|64908117|FG001|Overall Study|Physician Decision|0|||
23317737|NCT02256436|64908116|FG000|Overall Study|Protocol Violation|0|||
23138340|NCT04279392|64255473|FG000|Overall Study|Physician Decision|1|||
23138341|NCT04279392|64255474|FG001|Overall Study|Physician Decision|0|||
23138342|NCT01034176|64255481|FG000|Overall Study|Physician Decision|2|||
23215331|NCT02727660|64528216|FG000|Overall Study|Withdrawal by Subject|26|||
23215332|NCT02727660|64528217|FG001|Overall Study|Withdrawal by Subject|25|||
23317738|NCT02256436|64908117|FG001|Overall Study|Protocol Violation|1|||
23552453|NCT01749982|65747843|FG000|Overall Study|Physician Decision|0|||
23552454|NCT01749982|65747844|FG001|Overall Study|Physician Decision|0|||
23552455|NCT01749982|65747845|FG002|Overall Study|Physician Decision|0|||
23552456|NCT01749982|65747846|FG003|Overall Study|Physician Decision|1|||
23552457|NCT01749982|65747843|FG000|Overall Study|Lost to Follow-up|0|||
23552458|NCT01749982|65747844|FG001|Overall Study|Lost to Follow-up|0|||
23552459|NCT01749982|65747845|FG002|Overall Study|Lost to Follow-up|0|||
23552460|NCT01749982|65747846|FG003|Overall Study|Lost to Follow-up|1|||
23552461|NCT01749982|65747843|FG000|Overall Study|Withdrawal by Subject|0|||
23552462|NCT01749982|65747844|FG001|Overall Study|Withdrawal by Subject|0|||
23552463|NCT01749982|65747845|FG002|Overall Study|Withdrawal by Subject|0|||
23552464|NCT01749982|65747846|FG003|Overall Study|Withdrawal by Subject|1|||
23552465|NCT02820623|65747847|FG000|Overall Study|Withdrawal by Subject|1|||
23138343|NCT01034176|64255482|FG001|Overall Study|Physician Decision|0|||
23138344|NCT01034176|64255481|FG000|Overall Study|Withdrawal by Subject|0|||
23138345|NCT01034176|64255482|FG001|Overall Study|Withdrawal by Subject|1|||
23138346|NCT01034176|64255481|FG000|Overall Study|Lost to Follow-up|0|||
23138347|NCT01034176|64255482|FG001|Overall Study|Lost to Follow-up|1|||
23138348|NCT01097707|64255483|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23138349|NCT01097707|64255484|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23138350|NCT01097707|64255485|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23138351|NCT01097707|64255486|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23138352|NCT01097707|64255487|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23552466|NCT02820623|65747848|FG001|Overall Study|Withdrawal by Subject|3|||
23552467|NCT02820623|65747849|FG002|Overall Study|Withdrawal by Subject|3|||
23552468|NCT02820623|65747847|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
23138353|NCT01097707|64255483|FG000|Overall Study|Adverse Event|4|||
23138354|NCT01097707|64255484|FG001|Overall Study|Adverse Event|2|||
23138355|NCT01097707|64255485|FG002|Overall Study|Adverse Event|3|||
23138356|NCT01097707|64255486|FG003|Overall Study|Adverse Event|1|||
23138357|NCT01097707|64255487|FG004|Overall Study|Adverse Event|3|||
23138358|NCT01097707|64255483|FG000|Overall Study|Entry Criteria Not Met|2|||
23138359|NCT01097707|64255484|FG001|Overall Study|Entry Criteria Not Met|1|||
23138360|NCT01097707|64255485|FG002|Overall Study|Entry Criteria Not Met|1|||
23138361|NCT01097707|64255486|FG003|Overall Study|Entry Criteria Not Met|0|||
23138362|NCT01097707|64255487|FG004|Overall Study|Entry Criteria Not Met|1|||
23138363|NCT01097707|64255483|FG000|Overall Study|Lack of Efficacy|1|||
23138364|NCT01097707|64255484|FG001|Overall Study|Lack of Efficacy|0|||
23138365|NCT01097707|64255485|FG002|Overall Study|Lack of Efficacy|0|||
23138366|NCT01097707|64255486|FG003|Overall Study|Lack of Efficacy|1|||
23138367|NCT01097707|64255487|FG004|Overall Study|Lack of Efficacy|0|||
23138368|NCT01097707|64255483|FG000|Overall Study|Lost to Follow-up|1|||
23138369|NCT01097707|64255484|FG001|Overall Study|Lost to Follow-up|1|||
23138370|NCT01097707|64255485|FG002|Overall Study|Lost to Follow-up|2|||
23138371|NCT01097707|64255486|FG003|Overall Study|Lost to Follow-up|0|||
23138372|NCT01097707|64255487|FG004|Overall Study|Lost to Follow-up|3|||
23138373|NCT01097707|64255483|FG000|Overall Study|Protocol Violation|2|||
23138374|NCT01097707|64255484|FG001|Overall Study|Protocol Violation|2|||
23138375|NCT01097707|64255485|FG002|Overall Study|Protocol Violation|3|||
23138376|NCT01097707|64255486|FG003|Overall Study|Protocol Violation|2|||
23138377|NCT01097707|64255487|FG004|Overall Study|Protocol Violation|2|||
23138378|NCT01097707|64255483|FG000|Overall Study|Sponsor Decision|31|||
23138379|NCT01097707|64255484|FG001|Overall Study|Sponsor Decision|31|||
23138380|NCT01097707|64255485|FG002|Overall Study|Sponsor Decision|34|||
23138381|NCT01097707|64255486|FG003|Overall Study|Sponsor Decision|35|||
23138382|NCT01097707|64255487|FG004|Overall Study|Sponsor Decision|36|||
23138383|NCT01097707|64255483|FG000|Overall Study|Withdrawal by Subject|3|||
23138384|NCT01097707|64255484|FG001|Overall Study|Withdrawal by Subject|6|||
23138385|NCT01097707|64255485|FG002|Overall Study|Withdrawal by Subject|1|||
23138386|NCT01097707|64255486|FG003|Overall Study|Withdrawal by Subject|4|||
23138387|NCT01097707|64255487|FG004|Overall Study|Withdrawal by Subject|3|||
23138388|NCT01097707|64255483|FG000|Overall Study|Reason unknown|0|||
23138389|NCT01097707|64255484|FG001|Overall Study|Reason unknown|0|||
23138390|NCT01097707|64255485|FG002|Overall Study|Reason unknown|0|||
23138391|NCT01097707|64255486|FG003|Overall Study|Reason unknown|0|||
23138392|NCT01097707|64255487|FG004|Overall Study|Reason unknown|1|||
23138393|NCT01723254|64255488|FG000|Overall Study|Conflict with work schedule|0|||
23552469|NCT02820623|65747848|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
23138394|NCT01723254|64255489|FG001|Overall Study|Conflict with work schedule|0|||
23138395|NCT01723254|64255490|FG002|Overall Study|Conflict with work schedule|0|||
23138396|NCT01723254|64255491|FG003|Overall Study|Conflict with work schedule|0|||
23138397|NCT01723254|64255492|FG004|Overall Study|Conflict with work schedule|0|||
23215333|NCT02727660|64528218|FG002|Overall Study|Withdrawal by Subject|30|||
23317739|NCT02256436|64908116|FG000|Overall Study|Withdrawal by Subject|26|||
23138398|NCT01723254|64255493|FG005|Overall Study|Conflict with work schedule|0|||
23138399|NCT01723254|64255494|FG006|Overall Study|Conflict with work schedule|0|||
23138400|NCT01723254|64255495|FG007|Overall Study|Conflict with work schedule|1|||
23138401|NCT01723254|64255488|FG000|Overall Study|Personal issues|0|||
23552470|NCT02820623|65747849|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
23552471|NCT02820623|65747847|FG000|Overall Study|Therapist unable to enroll clients|1|||
23552472|NCT02820623|65747848|FG001|Overall Study|Therapist unable to enroll clients|1|||
23431030|NCT00869401|65320783|FG002|Overall Study|Withdrawal by Subject|0|||
23431031|NCT00869401|65320784|FG003|Overall Study|Withdrawal by Subject|5|||
23431032|NCT00869401|65320785|FG004|Overall Study|Withdrawal by Subject|3|||
23431033|NCT02337725|65320786|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
23431034|NCT02337725|65320787|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
23431035|NCT02337725|65320786|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
23431036|NCT02337725|65320787|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
23431037|NCT02337725|65320786|FG000|Overall Study|Major Protocol Deviation|0|||
23431038|NCT02337725|65320787|FG001|Overall Study|Major Protocol Deviation|1|||
23431039|NCT02337725|65320786|FG000|Overall Study|Voluntary Withdrawal|14|||
23431040|NCT02337725|65320787|FG001|Overall Study|Voluntary Withdrawal|3|||
23431041|NCT02337725|65320786|FG000|Overall Study|Lack of Efficacy|4|||
23431042|NCT02337725|65320787|FG001|Overall Study|Lack of Efficacy|0|||
23431043|NCT00548717|65320790|FG000|Overall Study|Death|5|||
23431044|NCT00548717|65320791|FG001|Overall Study|Death|2|||
23431045|NCT00548717|65320790|FG000|Overall Study|Relapse|3|||
23431046|NCT00548717|65320791|FG001|Overall Study|Relapse|0|||
23431047|NCT00548717|65320790|FG000|Overall Study|Alternative treatment for GVHD|1|||
23138402|NCT01723254|64255489|FG001|Overall Study|Personal issues|0|||
23138403|NCT01723254|64255490|FG002|Overall Study|Personal issues|0|||
23138404|NCT01723254|64255491|FG003|Overall Study|Personal issues|0|||
23138405|NCT01723254|64255492|FG004|Overall Study|Personal issues|0|||
23138406|NCT01723254|64255493|FG005|Overall Study|Personal issues|1|||
23138407|NCT01723254|64255494|FG006|Overall Study|Personal issues|0|||
23138408|NCT01723254|64255495|FG007|Overall Study|Personal issues|0|||
23138409|NCT01723254|64255488|FG000|Overall Study|No longer have time to participate|0|||
23138410|NCT01723254|64255489|FG001|Overall Study|No longer have time to participate|0|||
23431048|NCT00548717|65320791|FG001|Overall Study|Alternative treatment for GVHD|0|||
23431049|NCT02455076|65320798|FG000|Inpatient|Withdrawal by Subject|1|||
23431050|NCT02455076|65320799|FG001|Inpatient|Withdrawal by Subject|0|||
23431051|NCT02455076|65320800|FG002|Inpatient|Withdrawal by Subject|0|||
23431052|NCT02455076|65320801|FG003|Inpatient|Withdrawal by Subject|0|||
23431053|NCT02455076|65320802|FG004|Inpatient|Withdrawal by Subject|0|||
23431054|NCT02455076|65320798|FG000|Inpatient|Discharged <24 h after admission|0|||
23431055|NCT02455076|65320799|FG001|Inpatient|Discharged <24 h after admission|1|||
23431056|NCT02455076|65320800|FG002|Inpatient|Discharged <24 h after admission|0|||
23431057|NCT02455076|65320801|FG003|Inpatient|Discharged <24 h after admission|0|||
23431058|NCT02455076|65320802|FG004|Inpatient|Discharged <24 h after admission|0|||
23431059|NCT02455076|65320798|FG000|Inpatient|Adverse Event|3|||
23431060|NCT02455076|65320799|FG001|Inpatient|Adverse Event|0|||
23431061|NCT02455076|65320800|FG002|Inpatient|Adverse Event|0|||
23431062|NCT02455076|65320801|FG003|Inpatient|Adverse Event|0|||
23431063|NCT02455076|65320802|FG004|Inpatient|Adverse Event|0|||
23431064|NCT02455076|65320798|FG000|Outpatient|Adverse Event|0|||
23431065|NCT02455076|65320799|FG001|Outpatient|Adverse Event|0|||
23431066|NCT02455076|65320800|FG002|Outpatient|Adverse Event|0|||
23431067|NCT02455076|65320801|FG003|Outpatient|Adverse Event|5|||
23431068|NCT02455076|65320802|FG004|Outpatient|Adverse Event|0|||
23431069|NCT02455076|65320798|FG000|Outpatient|Lost to Follow-up|0|||
23431070|NCT02455076|65320799|FG001|Outpatient|Lost to Follow-up|0|||
23431071|NCT02455076|65320800|FG002|Outpatient|Lost to Follow-up|0|||
23431072|NCT02455076|65320801|FG003|Outpatient|Lost to Follow-up|1|||
23431073|NCT02455076|65320802|FG004|Outpatient|Lost to Follow-up|12|||
23431074|NCT00581360|65323952|FG000|Overall Study|Withdrawal by Subject|1|||
23431075|NCT01300455|65323953|FG000|Washout|Withdrawal by Subject|1|||
23431076|NCT01300455|65323954|FG001|Washout|Withdrawal by Subject|0|||
23431077|NCT00453973|65323955|FG000|Overall Study|Adverse Event|4|||
23431078|NCT00453973|65323956|FG001|Overall Study|Adverse Event|9|||
23431079|NCT00453973|65323955|FG000|Overall Study|Withdrawal by Subject|7|||
23431080|NCT00453973|65323956|FG001|Overall Study|Withdrawal by Subject|6|||
23138411|NCT01723254|64255490|FG002|Overall Study|No longer have time to participate|0|||
23138412|NCT01723254|64255491|FG003|Overall Study|No longer have time to participate|1|||
23317740|NCT02256436|64908117|FG001|Overall Study|Withdrawal by Subject|10|||
23431081|NCT00453973|65323955|FG000|Overall Study|PI Decision|0|||
23431082|NCT00453973|65323956|FG001|Overall Study|PI Decision|2|||
23431083|NCT00453973|65323955|FG000|Overall Study|Relocation|1|||
23431084|NCT00453973|65323956|FG001|Overall Study|Relocation|0|||
23431085|NCT00453973|65323955|FG000|Overall Study|Renal transplant|1|||
23431086|NCT00453973|65323956|FG001|Overall Study|Renal transplant|1|||
23431087|NCT00453973|65323955|FG000|Overall Study|Site closed by sponsor|3|||
23431088|NCT00453973|65323956|FG001|Overall Study|Site closed by sponsor|0|||
23431089|NCT00453973|65323955|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
23431090|NCT00453973|65323956|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
23431091|NCT00300365|65323957|FG000|Overall Study|Lost to Follow-up|1|||
23431092|NCT00300365|65323958|FG001|Overall Study|Lost to Follow-up|0|||
23431093|NCT00300365|65323957|FG000|Overall Study|Physician Decision|2|||
23431094|NCT00300365|65323958|FG001|Overall Study|Physician Decision|0|||
23431095|NCT00300365|65323957|FG000|Overall Study|Withdrawal by Subject|1|||
23215334|NCT02727660|64528216|FG000|Overall Study|Physician Decision|3|||
23138413|NCT01723254|64255492|FG004|Overall Study|No longer have time to participate|0|||
23138414|NCT01723254|64255493|FG005|Overall Study|No longer have time to participate|0|||
23138415|NCT01723254|64255494|FG006|Overall Study|No longer have time to participate|0|||
23138416|NCT01723254|64255495|FG007|Overall Study|No longer have time to participate|0|||
23138417|NCT01723254|64255488|FG000|Overall Study|Move/Left to another country/city|0|||
23138418|NCT01723254|64255489|FG001|Overall Study|Move/Left to another country/city|0|||
23138419|NCT01723254|64255490|FG002|Overall Study|Move/Left to another country/city|2|||
23138420|NCT01723254|64255491|FG003|Overall Study|Move/Left to another country/city|1|||
23138421|NCT01723254|64255492|FG004|Overall Study|Move/Left to another country/city|1|||
23138422|NCT01723254|64255493|FG005|Overall Study|Move/Left to another country/city|0|||
23138423|NCT01723254|64255494|FG006|Overall Study|Move/Left to another country/city|0|||
23138424|NCT01723254|64255495|FG007|Overall Study|Move/Left to another country/city|0|||
23138425|NCT01723254|64255488|FG000|Overall Study|Protocol Violation|0|||
23138426|NCT01723254|64255489|FG001|Overall Study|Protocol Violation|1|||
23138427|NCT01723254|64255490|FG002|Overall Study|Protocol Violation|0|||
23138428|NCT01723254|64255491|FG003|Overall Study|Protocol Violation|0|||
23138429|NCT01723254|64255492|FG004|Overall Study|Protocol Violation|0|||
23138430|NCT01723254|64255493|FG005|Overall Study|Protocol Violation|0|||
23138431|NCT01723254|64255494|FG006|Overall Study|Protocol Violation|0|||
23138432|NCT01723254|64255495|FG007|Overall Study|Protocol Violation|0|||
23138433|NCT01723254|64255488|FG000|Overall Study|Withdrawal by Subject|1|||
23138434|NCT01723254|64255489|FG001|Overall Study|Withdrawal by Subject|2|||
23138435|NCT01723254|64255490|FG002|Overall Study|Withdrawal by Subject|1|||
23138436|NCT01723254|64255491|FG003|Overall Study|Withdrawal by Subject|0|||
23138437|NCT01723254|64255492|FG004|Overall Study|Withdrawal by Subject|1|||
23138438|NCT01723254|64255493|FG005|Overall Study|Withdrawal by Subject|1|||
23138439|NCT01723254|64255494|FG006|Overall Study|Withdrawal by Subject|1|||
23138440|NCT01723254|64255495|FG007|Overall Study|Withdrawal by Subject|2|||
23138441|NCT00833833|64255496|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
23138442|NCT00833833|64255497|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
23138443|NCT00833833|64255498|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
23138444|NCT00833833|64255499|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
23431096|NCT00300365|65323958|FG001|Overall Study|Withdrawal by Subject|0|||
23431097|NCT00300365|65323957|FG000|Overall Study|Adverse Event|0|||
23431098|NCT00300365|65323958|FG001|Overall Study|Adverse Event|2|||
23431099|NCT00129467|65323959|FG000|Received Intervention|Death|1|||
23431100|NCT00129467|65323960|FG001|Received Intervention|Death|1|||
23431101|NCT00129467|65323959|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
23431102|NCT00129467|65323960|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
23431103|NCT00129467|65323959|FG000|Received Intervention|Delirium|2|||
23431104|NCT00129467|65323960|FG001|Received Intervention|Delirium|0|||
23431105|NCT00129467|65323959|FG000|Received Intervention|Withdrawal by Subject|1|||
23431106|NCT00129467|65323960|FG001|Received Intervention|Withdrawal by Subject|0|||
23431107|NCT00129467|65323959|FG000|Received Intervention|Nausea|1|||
23431108|NCT00129467|65323960|FG001|Received Intervention|Nausea|0|||
23431109|NCT00129467|65323959|FG000|Received Intervention|Intolerance to citalopram|0|||
23431110|NCT00129467|65323960|FG001|Received Intervention|Intolerance to citalopram|1|||
23431111|NCT00129467|65323959|FG000|Received Intervention|Dizzyness, fatigue|0|||
23431112|NCT00129467|65323960|FG001|Received Intervention|Dizzyness, fatigue|1|||
23431113|NCT00129467|65323959|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
23431114|NCT00129467|65323960|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
23431115|NCT00129467|65323959|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
23431116|NCT00129467|65323960|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
23431117|NCT00903331|65323961|FG000|Overall Study|Death|4|||
23431118|NCT00903331|65323962|FG001|Overall Study|Death|8|||
23431119|NCT00903331|65323961|FG000|Overall Study|Withdrawal of consent|1|||
23431120|NCT00903331|65323962|FG001|Overall Study|Withdrawal of consent|8|||
23431121|NCT00903331|65323961|FG000|Overall Study|Lung transplant|0|||
23431122|NCT00903331|65323962|FG001|Overall Study|Lung transplant|2|||
23431123|NCT00708734|65323965|FG000|Overall Study|scheduling conflict|2|||
23431124|NCT00708734|65323965|FG000|Overall Study|moved|1|||
23138445|NCT00833833|64255500|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
23138446|NCT00833833|64255501|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
23317741|NCT02256436|64908116|FG000|Overall Study|Transferred to Extension Study|11|||
23317742|NCT02256436|64908117|FG001|Overall Study|Transferred to Extension Study|23|||
23431125|NCT00708734|65323965|FG000|Overall Study|leg injury|1|||
23431126|NCT00708734|65323965|FG000|Overall Study|knee replacement|1|||
23431127|NCT00708734|65323965|FG000|Overall Study|vertigo|1|||
23431128|NCT00708734|65323965|FG000|Overall Study|leg fracture|1|||
23431129|NCT01969721|65323966|FG000|Overall Study|Adverse Event|3|||
23431130|NCT01969721|65323967|FG001|Overall Study|Adverse Event|8|||
23431131|NCT01969721|65323968|FG002|Overall Study|Adverse Event|3|||
23431132|NCT01969721|65323969|FG003|Overall Study|Adverse Event|2|||
23317743|NCT02256436|64908116|FG000|Overall Study|Did Not Continue on Extension Study|8|||
23431133|NCT01969721|65323966|FG000|Overall Study|Lack of Efficacy|0|||
23431134|NCT01969721|65323967|FG001|Overall Study|Lack of Efficacy|0|||
23431135|NCT01969721|65323968|FG002|Overall Study|Lack of Efficacy|1|||
23431136|NCT01969721|65323969|FG003|Overall Study|Lack of Efficacy|0|||
23431137|NCT01969721|65323966|FG000|Overall Study|Non compliant with protocol|1|||
23431138|NCT01969721|65323967|FG001|Overall Study|Non compliant with protocol|1|||
23431139|NCT01969721|65323968|FG002|Overall Study|Non compliant with protocol|0|||
23431140|NCT01969721|65323969|FG003|Overall Study|Non compliant with protocol|2|||
23431141|NCT01969721|65323966|FG000|Overall Study|Other not defined above|0|||
23431142|NCT01969721|65323967|FG001|Overall Study|Other not defined above|2|||
23431143|NCT01969721|65323968|FG002|Overall Study|Other not defined above|0|||
23431144|NCT01969721|65323969|FG003|Overall Study|Other not defined above|0|||
23431145|NCT01969721|65323966|FG000|Overall Study|Discontinued during washout periods.|0|||
23431146|NCT01969721|65323967|FG001|Overall Study|Discontinued during washout periods.|1|||
23431147|NCT01969721|65323968|FG002|Overall Study|Discontinued during washout periods.|1|||
23431148|NCT01969721|65323969|FG003|Overall Study|Discontinued during washout periods.|2|||
23431149|NCT03429543|65323970|FG000|Overall Study|Adverse Event|1|||
23431150|NCT03429543|65323971|FG001|Overall Study|Adverse Event|1|||
23431151|NCT03429543|65323972|FG002|Overall Study|Adverse Event|0|||
23431152|NCT03429543|65323973|FG003|Overall Study|Adverse Event|0|||
23431153|NCT03429543|65323974|FG004|Overall Study|Adverse Event|0|||
23431154|NCT03429543|65323975|FG005|Overall Study|Adverse Event|2|||
23431155|NCT03429543|65323976|FG006|Overall Study|Adverse Event|0|||
23431156|NCT03429543|65323970|FG000|Overall Study|Lost to Follow-up|1|||
23431157|NCT03429543|65323971|FG001|Overall Study|Lost to Follow-up|0|||
23431158|NCT03429543|65323972|FG002|Overall Study|Lost to Follow-up|0|||
23431159|NCT03429543|65323973|FG003|Overall Study|Lost to Follow-up|0|||
23431160|NCT03429543|65323974|FG004|Overall Study|Lost to Follow-up|1|||
23431161|NCT03429543|65323975|FG005|Overall Study|Lost to Follow-up|0|||
23431162|NCT03429543|65323976|FG006|Overall Study|Lost to Follow-up|0|||
23431163|NCT03429543|65323970|FG000|Overall Study|Withdrawal by Subject|5|||
23431164|NCT03429543|65323971|FG001|Overall Study|Withdrawal by Subject|0|||
23431165|NCT03429543|65323972|FG002|Overall Study|Withdrawal by Subject|1|||
23431166|NCT03429543|65323973|FG003|Overall Study|Withdrawal by Subject|2|||
23431167|NCT03429543|65323974|FG004|Overall Study|Withdrawal by Subject|6|||
23431168|NCT03429543|65323975|FG005|Overall Study|Withdrawal by Subject|3|||
23431169|NCT03429543|65323976|FG006|Overall Study|Withdrawal by Subject|1|||
23431170|NCT03429543|65323970|FG000|Overall Study|Other reason than listed|0|||
23431171|NCT03429543|65323971|FG001|Overall Study|Other reason than listed|1|||
23431172|NCT03429543|65323972|FG002|Overall Study|Other reason than listed|0|||
23431173|NCT03429543|65323973|FG003|Overall Study|Other reason than listed|0|||
23431174|NCT03429543|65323974|FG004|Overall Study|Other reason than listed|4|||
23431175|NCT03429543|65323975|FG005|Overall Study|Other reason than listed|4|||
23431176|NCT03429543|65323976|FG006|Overall Study|Other reason than listed|0|||
23431177|NCT03429543|65323970|FG000|Overall Study|Not treated|0|||
23431178|NCT03429543|65323971|FG001|Overall Study|Not treated|0|||
23431179|NCT03429543|65323972|FG002|Overall Study|Not treated|0|||
23431180|NCT03429543|65323973|FG003|Overall Study|Not treated|0|||
23431181|NCT03429543|65323974|FG004|Overall Study|Not treated|1|||
23431182|NCT03429543|65323975|FG005|Overall Study|Not treated|0|||
23431183|NCT03429543|65323976|FG006|Overall Study|Not treated|0|||
23431184|NCT00895661|65323977|FG000|Overall Study|Death|1|||
23431185|NCT00895661|65323977|FG000|Overall Study|reason unknown|2|||
23431186|NCT03233438|65323982|FG000|Overall Study|Lost to Follow-up|4|||
23431187|NCT03233438|65323983|FG001|Overall Study|Lost to Follow-up|9|||
23431188|NCT03233438|65323982|FG000|Overall Study|Withdrawal by Subject|2|||
23431189|NCT03233438|65323983|FG001|Overall Study|Withdrawal by Subject|1|||
23431190|NCT03233438|65323982|FG000|Overall Study|No recording of dalbavancin|0|||
23431191|NCT03233438|65323983|FG001|Overall Study|No recording of dalbavancin|1|||
23431192|NCT00924404|65323984|FG000|Overall Study|Lost to Follow-up|6|||
23431193|NCT00924404|65323985|FG001|Overall Study|Lost to Follow-up|4|||
23552473|NCT02820623|65747849|FG002|Overall Study|Therapist unable to enroll clients|3|||
23431194|NCT03769311|65323986|FG000|Overall Study|Withdrawal by Subject|1|||
23431195|NCT00612508|65323987|FG000|Overall Study|Withdrawal by Subject|3|||
23431196|NCT00612508|65323988|FG001|Overall Study|Withdrawal by Subject|4|||
23431197|NCT00845065|65323989|FG000|Overall Study|Adverse Event|3|||
23431198|NCT00845065|65323990|FG001|Overall Study|Adverse Event|23|||
23431199|NCT00845065|65323989|FG000|Overall Study|Lack of Efficacy|43|||
23431200|NCT00845065|65323990|FG001|Overall Study|Lack of Efficacy|21|||
23431201|NCT00845065|65323989|FG000|Overall Study|Non-Medical Reasons|1|||
23431202|NCT00845065|65323990|FG001|Overall Study|Non-Medical Reasons|11|||
23431203|NCT03332160|65323992|FG000|Overall Study|Withdrawal by Subject|1|||
23431204|NCT03332160|65323993|FG001|Overall Study|Withdrawal by Subject|1|||
23431205|NCT03332160|65323992|FG000|Overall Study|Adverse Event|0|||
23431206|NCT03332160|65323993|FG001|Overall Study|Adverse Event|1|||
23431207|NCT03332160|65323992|FG000|Overall Study|Developed Exclusion Criteria|0|||
23431208|NCT03332160|65323993|FG001|Overall Study|Developed Exclusion Criteria|1|||
23431209|NCT03332160|65323992|FG000|Overall Study|Non-adherence to treatment|0|||
23431210|NCT03332160|65323993|FG001|Overall Study|Non-adherence to treatment|2|||
23431211|NCT00881504|65323996|FG000|Overall Study|Withdrawal by Subject|1|||
23431212|NCT01009086|65323997|FG000|Overall Study|Lack of Efficacy|16|||
23431213|NCT01009086|65323998|FG001|Overall Study|Lack of Efficacy|15|||
23431214|NCT01009086|65323999|FG002|Overall Study|Lack of Efficacy|9|||
23431215|NCT01009086|65323997|FG000|Overall Study|Lost to Follow-up|4|||
23431216|NCT01009086|65323998|FG001|Overall Study|Lost to Follow-up|5|||
23431217|NCT01009086|65323999|FG002|Overall Study|Lost to Follow-up|3|||
23431218|NCT01009086|65323997|FG000|Overall Study|Adverse Event|12|||
23431219|NCT01009086|65323998|FG001|Overall Study|Adverse Event|11|||
23431220|NCT01009086|65323999|FG002|Overall Study|Adverse Event|8|||
23431221|NCT01009086|65323997|FG000|Overall Study|Withdrawal by Subject|9|||
23431222|NCT01009086|65323998|FG001|Overall Study|Withdrawal by Subject|11|||
23431223|NCT01009086|65323999|FG002|Overall Study|Withdrawal by Subject|13|||
23431224|NCT01009086|65323997|FG000|Overall Study|Other|3|||
23431225|NCT01009086|65323998|FG001|Overall Study|Other|5|||
23431226|NCT01009086|65323999|FG002|Overall Study|Other|1|||
23431227|NCT02963701|65324000|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
23431228|NCT02963701|65324001|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
23431229|NCT00771615|65324002|FG000|Overall Study|Withdrawal by Subject|0|||
23215335|NCT02727660|64528217|FG001|Overall Study|Physician Decision|8|||
23215336|NCT02727660|64528218|FG002|Overall Study|Physician Decision|14|||
23215337|NCT02727660|64528216|FG000|Overall Study|Lost to Follow-up|5|||
23215338|NCT02727660|64528217|FG001|Overall Study|Lost to Follow-up|9|||
23431230|NCT00771615|65324003|FG001|Overall Study|Withdrawal by Subject|1|||
23431231|NCT00771615|65324004|FG002|Overall Study|Withdrawal by Subject|0|||
23431232|NCT00771615|65324005|FG003|Overall Study|Withdrawal by Subject|0|||
23431233|NCT00771615|65324006|FG004|Overall Study|Withdrawal by Subject|0|||
23431234|NCT00771615|65324007|FG005|Overall Study|Withdrawal by Subject|0|||
23431235|NCT00771615|65324008|FG006|Overall Study|Withdrawal by Subject|0|||
23431236|NCT00771615|65324009|FG007|Overall Study|Withdrawal by Subject|1|||
23431237|NCT00771615|65324010|FG008|Overall Study|Withdrawal by Subject|0|||
23431238|NCT00771615|65324002|FG000|Overall Study|Lost to Follow-up|1|||
23431239|NCT00771615|65324003|FG001|Overall Study|Lost to Follow-up|1|||
23431240|NCT00771615|65324004|FG002|Overall Study|Lost to Follow-up|1|||
23431241|NCT00771615|65324005|FG003|Overall Study|Lost to Follow-up|1|||
23431242|NCT00771615|65324006|FG004|Overall Study|Lost to Follow-up|0|||
23431243|NCT00771615|65324007|FG005|Overall Study|Lost to Follow-up|1|||
23431244|NCT00771615|65324008|FG006|Overall Study|Lost to Follow-up|1|||
23431245|NCT00771615|65324009|FG007|Overall Study|Lost to Follow-up|0|||
23431246|NCT00771615|65324010|FG008|Overall Study|Lost to Follow-up|0|||
23431247|NCT03596450|65324011|FG000|Overall Study|Death|9|||
23431248|NCT03596450|65324012|FG001|Overall Study|Death|9|||
23431249|NCT03596450|65324011|FG000|Overall Study|Protocol Violation|18|||
23431250|NCT03596450|65324012|FG001|Overall Study|Protocol Violation|26|||
23431251|NCT03596450|65324011|FG000|Overall Study|Lost to Follow-up|50|||
23431252|NCT03596450|65324012|FG001|Overall Study|Lost to Follow-up|56|||
23431253|NCT03596450|65324011|FG000|Overall Study|Adverse Event|14|||
23431254|NCT03596450|65324012|FG001|Overall Study|Adverse Event|7|||
23431255|NCT03596450|65324011|FG000|Overall Study|Withdrawal by Subject|38|||
23431256|NCT03596450|65324012|FG001|Overall Study|Withdrawal by Subject|36|||
23431257|NCT03596450|65324011|FG000|Overall Study|Accidentally Randomized|2|||
23431258|NCT03596450|65324012|FG001|Overall Study|Accidentally Randomized|0|||
23431259|NCT03596450|65324011|FG000|Overall Study|Other reasons|48|||
23431260|NCT03596450|65324012|FG001|Overall Study|Other reasons|53|||
23431261|NCT03596450|65324011|FG000|Overall Study|Pregnancy|2|||
23431262|NCT03596450|65324012|FG001|Overall Study|Pregnancy|0|||
23431263|NCT02438813|65324013|FG000|Overall Study|Patient Decision|59|||
23431264|NCT02438813|65324013|FG000|Overall Study|Patient Lost to Follow-Up|137|||
23431265|NCT02438813|65324013|FG000|Overall Study|Study Ended by Sponsor|80|||
23431266|NCT02438813|65324013|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
23431267|NCT03927404|65324014|FG000|Overall Study|Withdrawal by Subject|1|||
23431268|NCT00778895|65324015|FG000|Active Phase|Adverse Event|3|||
23621550|NCT02330562|66000687|FG005|Overall Study|Withdrawal by Subject|0|||
23215339|NCT02727660|64528218|FG002|Overall Study|Lost to Follow-up|8|||
23431269|NCT00778895|65324016|FG001|Active Phase|Adverse Event|1|||
23431270|NCT00778895|65324017|FG002|Active Phase|Adverse Event|0|||
23431271|NCT00778895|65324015|FG000|Active Phase|Withdrawal by Subject|1|||
23431272|NCT00778895|65324016|FG001|Active Phase|Withdrawal by Subject|4|||
23431273|NCT00778895|65324017|FG002|Active Phase|Withdrawal by Subject|0|||
23431274|NCT00778895|65324015|FG000|Active Phase|Lost to Follow-up|1|||
23431275|NCT00778895|65324016|FG001|Active Phase|Lost to Follow-up|1|||
23215340|NCT02727660|64528216|FG000|Overall Study|Protocol Violation|7|||
23215341|NCT02727660|64528217|FG001|Overall Study|Protocol Violation|5|||
23431276|NCT00778895|65324017|FG002|Active Phase|Lost to Follow-up|0|||
23431277|NCT00778895|65324015|FG000|Active Phase|Other|2|||
23431278|NCT00778895|65324016|FG001|Active Phase|Other|0|||
23431279|NCT00778895|65324017|FG002|Active Phase|Other|0|||
23431280|NCT00778895|65324015|FG000|ESFU Phase|Adverse Event|2|||
23431281|NCT00778895|65324016|FG001|ESFU Phase|Adverse Event|1|||
23431282|NCT00778895|65324017|FG002|ESFU Phase|Adverse Event|0|||
23431283|NCT00778895|65324015|FG000|ESFU Phase|Withdrawal by Subject|1|||
23431284|NCT00778895|65324016|FG001|ESFU Phase|Withdrawal by Subject|4|||
23431285|NCT00778895|65324017|FG002|ESFU Phase|Withdrawal by Subject|0|||
23431286|NCT00778895|65324015|FG000|ESFU Phase|Lost to Follow-up|6|||
23431287|NCT00778895|65324016|FG001|ESFU Phase|Lost to Follow-up|7|||
23431288|NCT00778895|65324017|FG002|ESFU Phase|Lost to Follow-up|2|||
23431289|NCT00778895|65324015|FG000|ESFU Phase|Other|2|||
23431290|NCT00778895|65324016|FG001|ESFU Phase|Other|0|||
23431291|NCT00778895|65324017|FG002|ESFU Phase|Other|0|||
23431292|NCT01177969|65324019|FG000|Overall Study|Protocol Violation|2|||
23431293|NCT01177969|65324020|FG001|Overall Study|Protocol Violation|1|||
23431294|NCT01177969|65324019|FG000|Overall Study|Withdrawal by Subject|1|||
23431295|NCT01177969|65324020|FG001|Overall Study|Withdrawal by Subject|2|||
23431296|NCT01030874|65324029|FG000|Overall Study|Withdrawal by Subject|1|||
23431297|NCT01030874|65324030|FG001|Overall Study|Withdrawal by Subject|0|||
23431298|NCT01030874|65324029|FG000|Overall Study|Discharged in first 2 weeks|17|||
23431299|NCT01030874|65324030|FG001|Overall Study|Discharged in first 2 weeks|16|||
23431300|NCT02759315|65324038|FG000|Overall Study|Adverse Event|0|||
23431301|NCT02759315|65324039|FG001|Overall Study|Adverse Event|0|||
23431302|NCT02759315|65324040|FG002|Overall Study|Adverse Event|0|||
23431303|NCT02759315|65324041|FG003|Overall Study|Adverse Event|1|||
23431304|NCT02759315|65324042|FG004|Overall Study|Adverse Event|0|||
23431305|NCT02759315|65324038|FG000|Overall Study|Death|0|||
23431306|NCT02759315|65324039|FG001|Overall Study|Death|0|||
23431307|NCT02759315|65324040|FG002|Overall Study|Death|1|||
23431308|NCT02759315|65324041|FG003|Overall Study|Death|0|||
23431309|NCT02759315|65324042|FG004|Overall Study|Death|0|||
23431310|NCT02759315|65324038|FG000|Overall Study|Lost to Follow-up|2|||
23431311|NCT02759315|65324039|FG001|Overall Study|Lost to Follow-up|0|||
23431312|NCT02759315|65324040|FG002|Overall Study|Lost to Follow-up|4|||
23431313|NCT02759315|65324041|FG003|Overall Study|Lost to Follow-up|0|||
23431314|NCT02759315|65324042|FG004|Overall Study|Lost to Follow-up|0|||
23431315|NCT02759315|65324038|FG000|Overall Study|Protocol Violation|0|||
23431316|NCT02759315|65324039|FG001|Overall Study|Protocol Violation|1|||
23431317|NCT02759315|65324040|FG002|Overall Study|Protocol Violation|0|||
23431318|NCT02759315|65324041|FG003|Overall Study|Protocol Violation|0|||
23431319|NCT02759315|65324042|FG004|Overall Study|Protocol Violation|0|||
23431320|NCT02759315|65324038|FG000|Overall Study|Study terminated prior to completion|2|||
23431321|NCT02759315|65324039|FG001|Overall Study|Study terminated prior to completion|0|||
23431322|NCT02759315|65324040|FG002|Overall Study|Study terminated prior to completion|5|||
23431323|NCT02759315|65324041|FG003|Overall Study|Study terminated prior to completion|0|||
23431324|NCT02759315|65324042|FG004|Overall Study|Study terminated prior to completion|1|||
23431325|NCT00671437|65324050|FG000|Overall Study|Progressive disease before C1 week 8|8|||
23431326|NCT00671437|65324050|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
23431327|NCT00671437|65324050|FG000|Overall Study|Adverse Event|3|||
23431328|NCT00671437|65324050|FG000|Overall Study|Ineligible post-hoc|1|||
23431329|NCT01606787|65324051|FG000|Overall Study|Withdrawal by Subject|4|||
23431330|NCT01606787|65324052|FG001|Overall Study|Withdrawal by Subject|5|||
23552474|NCT02820623|65747847|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
23552475|NCT02820623|65747848|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
23552476|NCT02820623|65747849|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
23552477|NCT00417079|65747853|FG000|Overall Study|Disease progression|267|||
23431331|NCT01606787|65324051|FG000|Overall Study|Surgery canceled|0|||
23431332|NCT01606787|65324052|FG001|Overall Study|Surgery canceled|2|||
23431333|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
23552478|NCT00417079|65747854|FG001|Overall Study|Disease progression|180|||
23552479|NCT00417079|65747853|FG000|Overall Study|Adverse Event|32|||
23431334|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
23552480|NCT00417079|65747854|FG001|Overall Study|Adverse Event|67|||
23431335|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
23431336|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
23431337|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
23431338|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
23431339|NCT01389323|65324055|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
23431340|NCT01389323|65324055|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
23431341|NCT01389323|65324055|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
23431342|NCT01389323|65324055|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
23431343|NCT01389323|65324055|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
23431344|NCT03959982|65324056|FG000|Overall Study|Withdrawal by Subject|1|||
23431345|NCT03959982|65324057|FG001|Overall Study|Withdrawal by Subject|0|||
23431346|NCT03959982|65324056|FG000|Overall Study|Physician Decision|2|||
23431347|NCT03959982|65324057|FG001|Overall Study|Physician Decision|0|||
23552481|NCT00417079|65747853|FG000|Overall Study|Non-compliance to protocol|0|||
23552482|NCT00417079|65747854|FG001|Overall Study|Non-compliance to protocol|1|||
23431348|NCT03959982|65324056|FG000|Overall Study|Lost to Follow-up|1|||
23431349|NCT03959982|65324057|FG001|Overall Study|Lost to Follow-up|0|||
23431350|NCT02211313|65324058|FG000|Overall Study|Treatment Failure|5|||
23431351|NCT02211313|65324059|FG001|Overall Study|Treatment Failure|2|||
23431352|NCT02211313|65324058|FG000|Overall Study|No Follow up Questionnaires|1|||
23431353|NCT02211313|65324059|FG001|Overall Study|No Follow up Questionnaires|1|||
23431354|NCT01659255|65324060|FG000|Overall Study|Adverse Event|0|||
23431355|NCT01659255|65324061|FG001|Overall Study|Adverse Event|0|||
23431356|NCT01659255|65324062|FG002|Overall Study|Adverse Event|0|||
23431357|NCT01659255|65324063|FG003|Overall Study|Adverse Event|0|||
23431358|NCT01659255|65324064|FG004|Overall Study|Adverse Event|0|||
23431359|NCT01659255|65324065|FG005|Overall Study|Adverse Event|1|||
23431360|NCT01659255|65324066|FG006|Overall Study|Adverse Event|1|||
23431361|NCT01659255|65324067|FG007|Overall Study|Adverse Event|0|||
23431362|NCT01659255|65324068|FG008|Overall Study|Adverse Event|0|||
23431363|NCT01659255|65324069|FG009|Overall Study|Adverse Event|1|||
23431364|NCT01659255|65324070|FG010|Overall Study|Adverse Event|0|||
23431365|NCT01659255|65324071|FG011|Overall Study|Adverse Event|1|||
23431366|NCT01659255|65324072|FG012|Overall Study|Adverse Event|0|||
23431367|NCT01659255|65324073|FG013|Overall Study|Adverse Event|2|||
23431368|NCT01659255|65324074|FG014|Overall Study|Adverse Event|0|||
23431369|NCT01659255|65324075|FG015|Overall Study|Adverse Event|1|||
23431370|NCT01659255|65324076|FG016|Overall Study|Adverse Event|0|||
23431371|NCT01659255|65324060|FG000|Overall Study|Death|0|||
23431372|NCT01659255|65324061|FG001|Overall Study|Death|1|||
23431373|NCT01659255|65324062|FG002|Overall Study|Death|0|||
23431374|NCT01659255|65324063|FG003|Overall Study|Death|0|||
23431375|NCT01659255|65324064|FG004|Overall Study|Death|0|||
23431376|NCT01659255|65324065|FG005|Overall Study|Death|0|||
23431377|NCT01659255|65324066|FG006|Overall Study|Death|0|||
23431378|NCT01659255|65324067|FG007|Overall Study|Death|1|||
23431379|NCT01659255|65324068|FG008|Overall Study|Death|1|||
23431380|NCT01659255|65324069|FG009|Overall Study|Death|0|||
23431381|NCT01659255|65324070|FG010|Overall Study|Death|0|||
23431382|NCT01659255|65324071|FG011|Overall Study|Death|0|||
23431383|NCT01659255|65324072|FG012|Overall Study|Death|1|||
23431384|NCT01659255|65324073|FG013|Overall Study|Death|1|||
23431385|NCT01659255|65324074|FG014|Overall Study|Death|2|||
23431386|NCT01659255|65324075|FG015|Overall Study|Death|1|||
23431387|NCT01659255|65324076|FG016|Overall Study|Death|0|||
23431388|NCT01659255|65324060|FG000|Overall Study|Progressive Disease|2|||
23431389|NCT01659255|65324061|FG001|Overall Study|Progressive Disease|0|||
23431390|NCT01659255|65324062|FG002|Overall Study|Progressive Disease|0|||
23431391|NCT01659255|65324063|FG003|Overall Study|Progressive Disease|0|||
23431392|NCT01659255|65324064|FG004|Overall Study|Progressive Disease|0|||
23431393|NCT01659255|65324065|FG005|Overall Study|Progressive Disease|0|||
23431394|NCT01659255|65324066|FG006|Overall Study|Progressive Disease|0|||
23431395|NCT01659255|65324067|FG007|Overall Study|Progressive Disease|1|||
23431396|NCT01659255|65324068|FG008|Overall Study|Progressive Disease|0|||
23431397|NCT01659255|65324069|FG009|Overall Study|Progressive Disease|2|||
23431398|NCT01659255|65324070|FG010|Overall Study|Progressive Disease|2|||
23431399|NCT01659255|65324071|FG011|Overall Study|Progressive Disease|3|||
23431400|NCT01659255|65324072|FG012|Overall Study|Progressive Disease|5|||
23431401|NCT01659255|65324073|FG013|Overall Study|Progressive Disease|13|||
23431402|NCT01659255|65324074|FG014|Overall Study|Progressive Disease|6|||
23431403|NCT01659255|65324075|FG015|Overall Study|Progressive Disease|2|||
23431404|NCT01659255|65324076|FG016|Overall Study|Progressive Disease|3|||
23317744|NCT02256436|64908117|FG001|Overall Study|Did Not Continue on Extension Study|12|||
23317745|NCT03151304|64908118|FG000|Overall Study|Termination of study by Sponsor|23|||
23317746|NCT03151304|64908118|FG000|Overall Study|missing|3|||
23317747|NCT03151304|64908118|FG000|Overall Study|Withdrawal by Subject|8|||
23431405|NCT01659255|65324060|FG000|Overall Study|Withdrew Consent|0|||
23138447|NCT00833833|64255496|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
23431406|NCT01659255|65324061|FG001|Overall Study|Withdrew Consent|0|||
23431407|NCT01659255|65324062|FG002|Overall Study|Withdrew Consent|0|||
23431408|NCT01659255|65324063|FG003|Overall Study|Withdrew Consent|0|||
23431409|NCT01659255|65324064|FG004|Overall Study|Withdrew Consent|0|||
23431410|NCT01659255|65324065|FG005|Overall Study|Withdrew Consent|0|||
23431411|NCT01659255|65324066|FG006|Overall Study|Withdrew Consent|0|||
23431412|NCT01659255|65324067|FG007|Overall Study|Withdrew Consent|0|||
23431413|NCT01659255|65324068|FG008|Overall Study|Withdrew Consent|0|||
23431414|NCT01659255|65324069|FG009|Overall Study|Withdrew Consent|0|||
23431415|NCT01659255|65324070|FG010|Overall Study|Withdrew Consent|1|||
23431416|NCT01659255|65324071|FG011|Overall Study|Withdrew Consent|0|||
23431417|NCT01659255|65324072|FG012|Overall Study|Withdrew Consent|0|||
23317748|NCT03151304|64908118|FG000|Overall Study|multiple reasons|30|||
23431418|NCT01659255|65324073|FG013|Overall Study|Withdrew Consent|1|||
23431419|NCT01659255|65324074|FG014|Overall Study|Withdrew Consent|0|||
23431420|NCT01659255|65324075|FG015|Overall Study|Withdrew Consent|0|||
23431421|NCT01659255|65324076|FG016|Overall Study|Withdrew Consent|0|||
23431422|NCT01659255|65324060|FG000|Overall Study|Investigator Decision|0|||
23431423|NCT01659255|65324061|FG001|Overall Study|Investigator Decision|0|||
23431424|NCT01659255|65324062|FG002|Overall Study|Investigator Decision|0|||
23431425|NCT01659255|65324063|FG003|Overall Study|Investigator Decision|0|||
23431426|NCT01659255|65324064|FG004|Overall Study|Investigator Decision|0|||
23431427|NCT01659255|65324065|FG005|Overall Study|Investigator Decision|0|||
23431428|NCT01659255|65324066|FG006|Overall Study|Investigator Decision|0|||
23431429|NCT01659255|65324067|FG007|Overall Study|Investigator Decision|0|||
23138448|NCT00833833|64255497|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
23138449|NCT00833833|64255498|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
23138450|NCT00833833|64255499|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
23431430|NCT01659255|65324068|FG008|Overall Study|Investigator Decision|0|||
23431431|NCT01659255|65324069|FG009|Overall Study|Investigator Decision|0|||
23431432|NCT01659255|65324070|FG010|Overall Study|Investigator Decision|0|||
23431433|NCT01659255|65324071|FG011|Overall Study|Investigator Decision|0|||
23431434|NCT01659255|65324072|FG012|Overall Study|Investigator Decision|1|||
23431435|NCT01659255|65324073|FG013|Overall Study|Investigator Decision|1|||
23431436|NCT01659255|65324074|FG014|Overall Study|Investigator Decision|0|||
23431437|NCT01659255|65324075|FG015|Overall Study|Investigator Decision|0|||
23431438|NCT01659255|65324076|FG016|Overall Study|Investigator Decision|0|||
23431439|NCT01659255|65324060|FG000|Overall Study|Sponsor's Decision|0|||
23431440|NCT01659255|65324061|FG001|Overall Study|Sponsor's Decision|0|||
23431441|NCT01659255|65324062|FG002|Overall Study|Sponsor's Decision|0|||
23431442|NCT01659255|65324063|FG003|Overall Study|Sponsor's Decision|0|||
23431443|NCT01659255|65324064|FG004|Overall Study|Sponsor's Decision|0|||
23431444|NCT01659255|65324065|FG005|Overall Study|Sponsor's Decision|0|||
23431445|NCT01659255|65324066|FG006|Overall Study|Sponsor's Decision|1|||
23317749|NCT02015065|64908122|FG000|Overall Study|Death on study|1|||
23317750|NCT02015065|64908123|FG001|Overall Study|Death on study|2|||
23317751|NCT02015065|64908124|FG002|Overall Study|Death on study|1|||
23317752|NCT01890434|64908132|FG000|Overall Study|Adverse Event|8|||
23317753|NCT01890434|64908132|FG000|Overall Study|PCI at external hospital|1|||
23317754|NCT01890434|64908132|FG000|Overall Study|Assessment discrepancy|1|||
23317755|NCT01890434|64908132|FG000|Overall Study|CRC didn't contact participant for FU|1|||
23317756|NCT01890434|64908132|FG000|Overall Study|Could not get whole set of images|1|||
23317757|NCT01890434|64908132|FG000|Overall Study|Decline to return for GSPECT|1|||
23431446|NCT01659255|65324067|FG007|Overall Study|Sponsor's Decision|0|||
23431447|NCT01659255|65324068|FG008|Overall Study|Sponsor's Decision|0|||
23431448|NCT01659255|65324069|FG009|Overall Study|Sponsor's Decision|0|||
23431449|NCT01659255|65324070|FG010|Overall Study|Sponsor's Decision|0|||
23431450|NCT01659255|65324071|FG011|Overall Study|Sponsor's Decision|0|||
23431451|NCT01659255|65324072|FG012|Overall Study|Sponsor's Decision|0|||
23431452|NCT01659255|65324073|FG013|Overall Study|Sponsor's Decision|0|||
23431453|NCT01659255|65324074|FG014|Overall Study|Sponsor's Decision|0|||
23431454|NCT01659255|65324075|FG015|Overall Study|Sponsor's Decision|0|||
23431455|NCT01659255|65324076|FG016|Overall Study|Sponsor's Decision|0|||
23431456|NCT01659255|65324060|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431457|NCT01659255|65324061|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431458|NCT01659255|65324062|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431459|NCT01659255|65324063|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431460|NCT01659255|65324064|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431461|NCT01659255|65324065|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431462|NCT01659255|65324066|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431463|NCT01659255|65324067|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431464|NCT01659255|65324068|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431465|NCT01659255|65324069|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431466|NCT01659255|65324070|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431467|NCT01659255|65324071|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431468|NCT01659255|65324072|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431469|NCT01659255|65324073|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23552483|NCT00417079|65747853|FG000|Overall Study|Lost to Follow-up|2|||
23552484|NCT00417079|65747854|FG001|Overall Study|Lost to Follow-up|0|||
23552485|NCT00417079|65747853|FG000|Overall Study|Withdrawal by Subject|17|||
23138451|NCT00833833|64255500|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
23138452|NCT00833833|64255501|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
23138453|NCT00833833|64255496|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
23431470|NCT01659255|65324074|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431471|NCT01659255|65324075|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
23431472|NCT01659255|65324076|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
23431473|NCT01659255|65324060|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
23431474|NCT01659255|65324061|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
23431475|NCT01659255|65324062|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
23552486|NCT00417079|65747854|FG001|Overall Study|Withdrawal by Subject|8|||
23552487|NCT00417079|65747853|FG000|Overall Study|Not treated|6|||
23431476|NCT01659255|65324063|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
23431477|NCT01659255|65324064|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
23431478|NCT01659255|65324065|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
23431479|NCT01659255|65324066|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
23431480|NCT01659255|65324067|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
23431481|NCT01659255|65324068|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
23431482|NCT01659255|65324069|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
23431483|NCT01659255|65324070|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
23431484|NCT01659255|65324071|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
23431485|NCT01659255|65324072|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
23431486|NCT01659255|65324073|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
23431487|NCT01659255|65324074|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
23431488|NCT01659255|65324075|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
23431489|NCT01659255|65324076|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
23431490|NCT01571232|65324077|FG000|Overall Study|Lost to Follow-up|0|||
23431491|NCT01571232|65324078|FG001|Overall Study|Lost to Follow-up|1|||
23431492|NCT01571232|65324077|FG000|Overall Study|Withdrawal by Subject|1|||
23215342|NCT02727660|64528218|FG002|Overall Study|Protocol Violation|5|||
23431493|NCT01571232|65324078|FG001|Overall Study|Withdrawal by Subject|0|||
23431494|NCT03134183|65324079|FG000|Overall Study|Withdrawal by Subject|1|||
23431495|NCT03134183|65324080|FG001|Overall Study|Withdrawal by Subject|1|||
23552488|NCT00417079|65747854|FG001|Overall Study|Not treated|7|||
23552489|NCT00417079|65747853|FG000|Overall Study|Screened failure|2|||
23552490|NCT00417079|65747854|FG001|Overall Study|Screened failure|1|||
23552491|NCT00417079|65747853|FG000|Overall Study|Investigator's decision|1|||
23552492|NCT00417079|65747854|FG001|Overall Study|Investigator's decision|4|||
23552493|NCT00417079|65747853|FG000|Overall Study|Non-confirmed Disease progression|1|||
23552494|NCT00417079|65747854|FG001|Overall Study|Non-confirmed Disease progression|1|||
23552495|NCT00417079|65747853|FG000|Overall Study|Clinical deterioration|1|||
23552496|NCT00417079|65747854|FG001|Overall Study|Clinical deterioration|0|||
23552497|NCT00417079|65747853|FG000|Overall Study|Screening error|2|||
23552498|NCT00417079|65747854|FG001|Overall Study|Screening error|1|||
23552499|NCT00417079|65747853|FG000|Overall Study|Withdrawal by subject's family|0|||
23552500|NCT00417079|65747854|FG001|Overall Study|Withdrawal by subject's family|1|||
23552501|NCT00417079|65747853|FG000|Overall Study|Patient unable to come to the clinic|0|||
23552502|NCT00417079|65747854|FG001|Overall Study|Patient unable to come to the clinic|1|||
23552503|NCT00417079|65747853|FG000|Overall Study|abnormal liver function tests|0|||
23552504|NCT00417079|65747854|FG001|Overall Study|abnormal liver function tests|1|||
23552505|NCT01428076|65747855|FG000|Overall Study|Adverse Event|0|||
23552506|NCT01428076|65747856|FG001|Overall Study|Adverse Event|1|||
23552507|NCT01618864|65747857|FG000|Overall Study|Withdrawal by Subject|2|||
23552508|NCT01618864|65747857|FG000|Overall Study|Lost to Follow-up|2|||
23552509|NCT01754467|65747858|FG000|Overall Study|Lost to Follow-up|1|||
23582208|NCT01242085|65862384|FG001|Overall Study|Withdrawal by Subject|2|||
23582209|NCT01242085|65862385|FG002|Overall Study|Withdrawal by Subject|0|||
23582210|NCT01242085|65862383|FG000|Overall Study|medically unable to have surgery|4|||
23582211|NCT01242085|65862384|FG001|Overall Study|medically unable to have surgery|5|||
23582212|NCT01242085|65862385|FG002|Overall Study|medically unable to have surgery|0|||
23582213|NCT00828945|65862386|FG000|Overall Study|Death|4|||
23582214|NCT00828945|65862386|FG000|Overall Study|Participant was missing|1|||
23582215|NCT00828945|65862386|FG000|Overall Study|Other|36|||
23582216|NCT03102242|65862387|FG000|Overall Study|Adverse Event|2|||
23582217|NCT02334306|65862392|FG000|Double-blind Period|Adverse Event|0|||
23215343|NCT02727660|64528216|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
23431496|NCT00290498|65324081|FG000|Overall Study|Death|2|||
23431497|NCT00290498|65324082|FG001|Overall Study|Death|0|||
23431498|NCT00290498|65324081|FG000|Overall Study|Physician Decision|1|||
23582218|NCT02334306|65862393|FG001|Double-blind Period|Adverse Event|1|||
23582219|NCT02334306|65862392|FG000|Double-blind Period|Withdrawal by Subject|1|||
23582220|NCT02334306|65862393|FG001|Double-blind Period|Withdrawal by Subject|1|||
23582221|NCT04759131|65862396|FG000|Overall Study|Investigator's discretion|1|||
23582222|NCT04759131|65862397|FG001|Overall Study|Investigator's discretion|0|||
23582223|NCT04759131|65862396|FG000|Overall Study|Subject withdrawal|1|||
23582224|NCT04759131|65862397|FG001|Overall Study|Subject withdrawal|0|||
23582225|NCT03441984|65862398|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23317758|NCT01890434|64908132|FG000|Overall Study|GSPECT at rest was not done|1|||
23582226|NCT03441984|65862399|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582227|NCT03441984|65862400|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
23582228|NCT03441984|65862401|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23431499|NCT00290498|65324082|FG001|Overall Study|Physician Decision|0|||
23431500|NCT00290498|65324081|FG000|Overall Study|Withdrawal by Subject|1|||
23317759|NCT01890434|64908132|FG000|Overall Study|Participant didn't complete MRI|1|||
23431501|NCT00290498|65324082|FG001|Overall Study|Withdrawal by Subject|0|||
23431502|NCT00290498|65324081|FG000|Overall Study|Ineligible|3|||
23431503|NCT00290498|65324082|FG001|Overall Study|Ineligible|0|||
23431504|NCT00290498|65324081|FG000|Overall Study|Non-Compliance|1|||
23431505|NCT00290498|65324082|FG001|Overall Study|Non-Compliance|0|||
23431506|NCT02726945|65324083|FG000|Overall Study|Withdrawal by Subject|0|||
23431507|NCT02726945|65324084|FG001|Overall Study|Withdrawal by Subject|0|||
23431508|NCT02726945|65324085|FG002|Overall Study|Withdrawal by Subject|1|||
23431509|NCT02726945|65324083|FG000|Overall Study|Elected to have total knee replacement|0|||
23431510|NCT02726945|65324084|FG001|Overall Study|Elected to have total knee replacement|1|||
23431511|NCT02726945|65324085|FG002|Overall Study|Elected to have total knee replacement|0|||
23431512|NCT00619489|65324086|FG000|Overall Study|Adverse Event|0|||
23431513|NCT00619489|65324087|FG001|Overall Study|Adverse Event|7|||
23431514|NCT00619489|65324086|FG000|Overall Study|Withdrawal by Subject|1|||
23431515|NCT00619489|65324087|FG001|Overall Study|Withdrawal by Subject|1|||
23431516|NCT00619489|65324086|FG000|Overall Study|Lack of Efficacy|0|||
23431517|NCT00619489|65324087|FG001|Overall Study|Lack of Efficacy|11|||
23431518|NCT00619489|65324086|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
23431519|NCT00619489|65324087|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
23431520|NCT01287195|65324088|FG000|Overall Study|Withdrawal by Subject|2|||
23431521|NCT01114360|65324089|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
23138454|NCT00833833|64255497|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
23138455|NCT00833833|64255498|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
23138456|NCT00833833|64255499|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
23138457|NCT00833833|64255500|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
23138458|NCT00833833|64255501|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
23138459|NCT00833833|64255496|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
23138460|NCT00833833|64255497|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
23138461|NCT00833833|64255498|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
23138462|NCT00833833|64255499|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
23138463|NCT00833833|64255500|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
23138464|NCT00833833|64255501|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
23138465|NCT00833833|64255496|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
23138466|NCT00833833|64255497|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23138467|NCT00833833|64255498|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
23138468|NCT00833833|64255499|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23138469|NCT00833833|64255500|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23138470|NCT00833833|64255501|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23138471|NCT00833833|64255496|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
23138472|NCT00833833|64255497|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
23215344|NCT02727660|64528217|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
23215345|NCT02727660|64528218|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
23215346|NCT02727660|64528216|FG000|Overall Study|Administrative Reasons|2|||
23215347|NCT02727660|64528217|FG001|Overall Study|Administrative Reasons|3|||
23215348|NCT02727660|64528218|FG002|Overall Study|Administrative Reasons|4|||
23215349|NCT03625141|64528230|FG000|Overall Study|Adverse Event|0|||
23215350|NCT03625141|64528231|FG001|Overall Study|Adverse Event|2|||
23215351|NCT03625141|64528230|FG000|Overall Study|Study Terminated By Sponsor|1|||
23215352|NCT03625141|64528231|FG001|Overall Study|Study Terminated By Sponsor|13|||
23215353|NCT03625141|64528230|FG000|Overall Study|Withdrawal by Subject|3|||
23215354|NCT03625141|64528231|FG001|Overall Study|Withdrawal by Subject|0|||
23215355|NCT03625141|64528230|FG000|Overall Study|Withdrawal Of Consent|0|||
23431522|NCT01114360|65324090|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
23215356|NCT03625141|64528231|FG001|Overall Study|Withdrawal Of Consent|1|||
23215357|NCT03625141|64528230|FG000|Overall Study|Death|11|||
23215358|NCT03625141|64528231|FG001|Overall Study|Death|47|||
23215359|NCT03625141|64528230|FG000|Overall Study|Progressive Disease|0|||
23215360|NCT03625141|64528231|FG001|Overall Study|Progressive Disease|2|||
23215361|NCT01061567|64528235|FG000|Overall Study|Adverse Event|32|||
23431523|NCT01062061|65324091|FG000|Overall Study|Enrolled more than once|2|||
23431524|NCT01062061|65324091|FG000|Overall Study|Investigated before study start|13|||
23431525|NCT01062061|65324091|FG000|Overall Study|Outside chief indications|10|||
23138473|NCT00833833|64255498|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
23138474|NCT00833833|64255499|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
23215362|NCT01061567|64528235|FG000|Overall Study|Death|2|||
23215363|NCT01061567|64528235|FG000|Overall Study|Lack of Efficacy|3|||
23215364|NCT01061567|64528235|FG000|Overall Study|Lost to Follow-up|24|||
23215365|NCT01061567|64528235|FG000|Overall Study|Protocol Violation|1|||
23431526|NCT01062061|65324091|FG000|Overall Study|Failed to meet inclusion criteria|2|||
23431527|NCT00495755|65324092|FG000|Overall Study|Adverse Event|3|||
23431528|NCT02717130|65324093|FG000|Overall Study|Withdrawal by Subject|1|||
23431529|NCT02717130|65324093|FG000|Overall Study|Adverse Event|1|||
23431530|NCT02717130|65324093|FG000|Overall Study|Physician Decision|1|||
23552510|NCT00092131|65751118|FG000|Treatment Period I|Adverse Event|1|||
23552511|NCT00092131|65751119|FG001|Treatment Period I|Adverse Event|0|||
23552512|NCT00092131|65751118|FG000|Treatment Period II|Adverse Event|0|||
23552513|NCT00092131|65751119|FG001|Treatment Period II|Adverse Event|1|||
23552514|NCT00907153|65751121|FG000|Overall Study|Lost to Follow-up|1|||
23552515|NCT00907153|65751122|FG001|Overall Study|Lost to Follow-up|1|||
23552516|NCT00907153|65751121|FG000|Overall Study|Withdrawal by Subject|1|||
23552517|NCT00907153|65751122|FG001|Overall Study|Withdrawal by Subject|3|||
23552518|NCT01995461|65751123|FG000|Overall Study|Death|1|||
23552519|NCT01995461|65751123|FG000|Overall Study|Lost to Follow-up|2|||
23552520|NCT01995461|65751123|FG000|Overall Study|Withdrawal by Subject|2|||
23552521|NCT00265889|65751129|FG000|Overall Study|Physician Decision|1|||
23552522|NCT00265889|65751129|FG000|Overall Study|Protocol Violation|1|||
23552523|NCT00265889|65751129|FG000|Overall Study|Insurance denied the request|3|||
23552524|NCT02453685|65751138|FG000|Overall Study|Adverse Event|0|||
23552525|NCT02453685|65751139|FG001|Overall Study|Adverse Event|1|||
23552526|NCT02453685|65751138|FG000|Overall Study|Protocol Violation|7|||
23552527|NCT02453685|65751139|FG001|Overall Study|Protocol Violation|4|||
23552528|NCT02453685|65751138|FG000|Overall Study|Lost to Follow-up|0|||
23552529|NCT02453685|65751139|FG001|Overall Study|Lost to Follow-up|1|||
23552530|NCT02453685|65751138|FG000|Overall Study|Withdrawal by Subject|8|||
23552531|NCT02453685|65751139|FG001|Overall Study|Withdrawal by Subject|4|||
23552532|NCT02453685|65751138|FG000|Overall Study|Unclassified|4|||
23552533|NCT02453685|65751139|FG001|Overall Study|Unclassified|2|||
23552534|NCT02300220|65751140|FG000|Overall Study|Lost to Follow-up|1|||
23552535|NCT02300220|65751141|FG001|Overall Study|Lost to Follow-up|2|||
23552536|NCT02300220|65751140|FG000|Overall Study|Death|1|||
23552537|NCT02300220|65751141|FG001|Overall Study|Death|1|||
23552538|NCT02300220|65751140|FG000|Overall Study|Adverse Event|1|||
23552539|NCT02300220|65751141|FG001|Overall Study|Adverse Event|1|||
23552540|NCT02300220|65751140|FG000|Overall Study|Protocol Violation|1|||
23552541|NCT02300220|65751141|FG001|Overall Study|Protocol Violation|0|||
23552542|NCT02300220|65751140|FG000|Overall Study|Withdrawal by Subject|0|||
23552543|NCT02300220|65751141|FG001|Overall Study|Withdrawal by Subject|2|||
23552544|NCT02300220|65751140|FG000|Overall Study|Did not tolerate IMP|0|||
23552545|NCT02300220|65751141|FG001|Overall Study|Did not tolerate IMP|1|||
23552546|NCT00781391|65751143|FG000|Overall Study|never received study drug|24|||
23552547|NCT00781391|65751144|FG001|Overall Study|never received study drug|23|||
23552548|NCT00781391|65751145|FG002|Overall Study|never received study drug|32|||
23552549|NCT00781391|65751143|FG000|Overall Study|Protocol Violation|19|||
23552550|NCT00781391|65751144|FG001|Overall Study|Protocol Violation|17|||
23552551|NCT00781391|65751145|FG002|Overall Study|Protocol Violation|20|||
23552552|NCT00781391|65751143|FG000|Overall Study|Death|789|||
23552553|NCT00781391|65751144|FG001|Overall Study|Death|730|||
23552554|NCT00781391|65751145|FG002|Overall Study|Death|706|||
23552555|NCT00781391|65751143|FG000|Overall Study|Withdrawal by Subject|47|||
23552556|NCT00781391|65751144|FG001|Overall Study|Withdrawal by Subject|37|||
23552557|NCT00781391|65751145|FG002|Overall Study|Withdrawal by Subject|25|||
23552558|NCT00781391|65751143|FG000|Overall Study|Lost to Follow-up|0|||
23552559|NCT00781391|65751144|FG001|Overall Study|Lost to Follow-up|0|||
23552560|NCT00781391|65751145|FG002|Overall Study|Lost to Follow-up|1|||
23552561|NCT04435665|65751146|FG000|Overall Study|Lost to Follow-up|0|||
23552562|NCT04435665|65751147|FG001|Overall Study|Lost to Follow-up|0|||
23552563|NCT04435665|65751148|FG002|Overall Study|Lost to Follow-up|0|||
23621551|NCT02330562|66000688|FG006|Overall Study|Withdrawal by Subject|0|||
23138475|NCT00833833|64255500|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
23138476|NCT00833833|64255501|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
23138477|NCT00833833|64255496|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
23138478|NCT00833833|64255497|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
23138479|NCT00833833|64255498|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
23552564|NCT04435665|65751149|FG003|Overall Study|Lost to Follow-up|1|||
23552565|NCT03252587|65751157|FG000|Overall Study|Adverse Event|3|||
23552566|NCT03252587|65751158|FG001|Overall Study|Adverse Event|8|||
23552567|NCT03252587|65751159|FG002|Overall Study|Adverse Event|6|||
23552568|NCT03252587|65751160|FG003|Overall Study|Adverse Event|12|||
23552569|NCT03252587|65751157|FG000|Overall Study|Lack of Efficacy|7|||
23552570|NCT03252587|65751158|FG001|Overall Study|Lack of Efficacy|2|||
23552571|NCT03252587|65751159|FG002|Overall Study|Lack of Efficacy|2|||
23552572|NCT03252587|65751160|FG003|Overall Study|Lack of Efficacy|4|||
23552573|NCT03252587|65751157|FG000|Overall Study|Lost to Follow-up|2|||
23621552|NCT02330562|66000689|FG007|Overall Study|Withdrawal by Subject|0|||
23621553|NCT02330562|66000690|FG008|Overall Study|Withdrawal by Subject|0|||
23552574|NCT03252587|65751158|FG001|Overall Study|Lost to Follow-up|0|||
23552575|NCT03252587|65751159|FG002|Overall Study|Lost to Follow-up|0|||
23552576|NCT03252587|65751160|FG003|Overall Study|Lost to Follow-up|2|||
23552577|NCT03252587|65751157|FG000|Overall Study|Pregnancy|2|||
23552578|NCT03252587|65751158|FG001|Overall Study|Pregnancy|1|||
23552579|NCT03252587|65751159|FG002|Overall Study|Pregnancy|0|||
23552580|NCT03252587|65751160|FG003|Overall Study|Pregnancy|1|||
23552581|NCT03252587|65751157|FG000|Overall Study|Withdrawal by Subject|8|||
23552582|NCT03252587|65751158|FG001|Overall Study|Withdrawal by Subject|4|||
23552583|NCT03252587|65751159|FG002|Overall Study|Withdrawal by Subject|4|||
23552584|NCT03252587|65751160|FG003|Overall Study|Withdrawal by Subject|4|||
23552585|NCT03252587|65751157|FG000|Overall Study|Other Reasons|2|||
23552586|NCT03252587|65751158|FG001|Overall Study|Other Reasons|5|||
23552587|NCT03252587|65751159|FG002|Overall Study|Other Reasons|5|||
23552588|NCT03252587|65751160|FG003|Overall Study|Other Reasons|4|||
23552589|NCT01777854|65751161|FG000|Overall Study|Physician Decision|3|||
23552590|NCT01777854|65751162|FG001|Overall Study|Physician Decision|3|||
23552591|NCT01483924|65751164|FG000|Overall Study|Withdrawal by Subject|2|||
23552592|NCT01483924|65751165|FG001|Overall Study|Withdrawal by Subject|0|||
23552593|NCT01483924|65751166|FG002|Overall Study|Withdrawal by Subject|0|||
23552594|NCT01483924|65751167|FG003|Overall Study|Withdrawal by Subject|1|||
23552595|NCT01483924|65751168|FG004|Overall Study|Withdrawal by Subject|1|||
23552596|NCT01483924|65751164|FG000|Overall Study|Adverse Event|0|||
23552597|NCT01483924|65751165|FG001|Overall Study|Adverse Event|0|||
23552598|NCT01483924|65751166|FG002|Overall Study|Adverse Event|1|||
23552599|NCT01483924|65751167|FG003|Overall Study|Adverse Event|1|||
23552600|NCT01483924|65751168|FG004|Overall Study|Adverse Event|0|||
23552601|NCT01483924|65751164|FG000|Overall Study|Non-compliance|0|||
23552602|NCT01483924|65751165|FG001|Overall Study|Non-compliance|0|||
23552603|NCT01483924|65751166|FG002|Overall Study|Non-compliance|0|||
23552604|NCT01483924|65751167|FG003|Overall Study|Non-compliance|1|||
23552605|NCT01483924|65751168|FG004|Overall Study|Non-compliance|1|||
23552606|NCT01483924|65751164|FG000|Overall Study|Sponsor concern over ECG result|0|||
23552607|NCT01483924|65751165|FG001|Overall Study|Sponsor concern over ECG result|0|||
23552608|NCT01483924|65751166|FG002|Overall Study|Sponsor concern over ECG result|0|||
23552609|NCT01483924|65751167|FG003|Overall Study|Sponsor concern over ECG result|1|||
23552610|NCT01483924|65751168|FG004|Overall Study|Sponsor concern over ECG result|0|||
23552611|NCT01152580|65751170|FG000|Overall Study|Withdrawal by Subject|0|||
23552612|NCT01152580|65751171|FG001|Overall Study|Withdrawal by Subject|1|||
23552613|NCT00289887|65751173|FG000|Overall Study|Adverse Event|3|||
23552614|NCT00289887|65751174|FG001|Overall Study|Adverse Event|3|||
23552615|NCT00289887|65751173|FG000|Overall Study|Lack of Efficacy|3|||
23552616|NCT00289887|65751174|FG001|Overall Study|Lack of Efficacy|11|||
23552617|NCT00289887|65751173|FG000|Overall Study|Lost to Follow-up|3|||
23552618|NCT00289887|65751174|FG001|Overall Study|Lost to Follow-up|3|||
23552619|NCT00289887|65751173|FG000|Overall Study|Protocol Violation|3|||
23552620|NCT00289887|65751174|FG001|Overall Study|Protocol Violation|1|||
23552621|NCT00289887|65751173|FG000|Overall Study|Withdrawal by Subject|3|||
23552622|NCT00289887|65751174|FG001|Overall Study|Withdrawal by Subject|8|||
23552623|NCT00289887|65751173|FG000|Overall Study|Other|7|||
23552624|NCT00289887|65751174|FG001|Overall Study|Other|3|||
23552625|NCT00686166|65751180|FG000|Overall Study|Adverse Event|7|||
23552626|NCT00686166|65751180|FG000|Overall Study|Withdrawal by Subject|1|||
23552627|NCT00686166|65751180|FG000|Overall Study|Progression/Relapse|1|||
23552628|NCT00686166|65751180|FG000|Overall Study|Death|1|||
23552629|NCT00686166|65751180|FG000|Overall Study|Not Protocol Specified|1|||
23552630|NCT00686166|65751180|FG000|Overall Study|Ineligible|5|||
23552631|NCT00686166|65751180|FG000|Overall Study|Did not begin protocol therapy|4|||
23552632|NCT03162224|65751186|FG000|Overall Study|Death|4|||
23552633|NCT03162224|65751187|FG001|Overall Study|Death|5|||
23552634|NCT03162224|65751188|FG002|Overall Study|Death|8|||
23552635|NCT03162224|65751186|FG000|Overall Study|Withdrawal by Subject|1|||
23552636|NCT03162224|65751187|FG001|Overall Study|Withdrawal by Subject|0|||
23621554|NCT02330562|66000691|FG009|Overall Study|Withdrawal by Subject|1|||
23621555|NCT02330562|66000692|FG010|Overall Study|Withdrawal by Subject|0|||
23621556|NCT00635570|66000696|FG000|Overall Study|Lost to Follow-up|8|||
23621557|NCT00635570|66000697|FG001|Overall Study|Lost to Follow-up|8|||
23621558|NCT00635570|66000696|FG000|Overall Study|Withdrawal by Subject|1|||
23621559|NCT00635570|66000697|FG001|Overall Study|Withdrawal by Subject|1|||
23621560|NCT00635570|66000696|FG000|Overall Study|Adverse Event|2|||
23621561|NCT00635570|66000697|FG001|Overall Study|Adverse Event|0|||
23621562|NCT00635570|66000696|FG000|Overall Study|Physician Decision|1|||
23621563|NCT00635570|66000697|FG001|Overall Study|Physician Decision|0|||
23552637|NCT03162224|65751188|FG002|Overall Study|Withdrawal by Subject|1|||
23552638|NCT03162224|65751186|FG000|Overall Study|Lost to Follow-up|0|||
23552639|NCT03162224|65751187|FG001|Overall Study|Lost to Follow-up|1|||
23552640|NCT03162224|65751188|FG002|Overall Study|Lost to Follow-up|0|||
23552641|NCT03162224|65751186|FG000|Overall Study|Other|6|||
23552642|NCT03162224|65751187|FG001|Overall Study|Other|2|||
23552643|NCT03162224|65751188|FG002|Overall Study|Other|1|||
23552644|NCT02182973|65751191|FG000|Overall Study|Withdrawal by Subject|3|||
23552645|NCT02182973|65751192|FG001|Overall Study|Withdrawal by Subject|0|||
23552646|NCT02008890|65751198|FG000|Period 1|Withdrawal by Subject|7|||
23552647|NCT02008890|65751199|FG001|Period 1|Withdrawal by Subject|7|||
23552648|NCT02008890|65751200|FG002|Period 1|Withdrawal by Subject|5|||
23552649|NCT02008890|65751201|FG003|Period 1|Withdrawal by Subject|0|||
23621564|NCT00635570|66000696|FG000|Overall Study|Did not complete survey|2|||
23431531|NCT02717130|65324093|FG000|Overall Study|Study Closure|4|||
23431532|NCT00541346|65324104|FG000|Follow-up|Adverse Event|1|||
23431533|NCT04524455|65324105|FG000|Overall Study|Death|3|||
23431534|NCT04524455|65324106|FG001|Overall Study|Death|3|||
23431535|NCT04524455|65324105|FG000|Overall Study|Decision by Sponsor|0|||
23431536|NCT04524455|65324106|FG001|Overall Study|Decision by Sponsor|2|||
23431537|NCT04524455|65324105|FG000|Overall Study|Withdrawal of Consent From Study|1|||
23431538|NCT04524455|65324106|FG001|Overall Study|Withdrawal of Consent From Study|0|||
23431539|NCT04524455|65324105|FG000|Overall Study|Lost to Follow-up|0|||
23431540|NCT04524455|65324106|FG001|Overall Study|Lost to Follow-up|1|||
23431541|NCT01498185|65324107|FG000|Overall Study|Adverse Event|0|||
23431542|NCT01498185|65324108|FG001|Overall Study|Adverse Event|0|||
23431543|NCT01498185|65324109|FG002|Overall Study|Adverse Event|0|||
23552650|NCT02008890|65751202|FG004|Period 1|Withdrawal by Subject|0|||
23552651|NCT02008890|65751198|FG000|Period 1|Pregnancy|1|||
23552652|NCT02008890|65751199|FG001|Period 1|Pregnancy|0|||
23552653|NCT02008890|65751200|FG002|Period 1|Pregnancy|0|||
23552654|NCT02008890|65751201|FG003|Period 1|Pregnancy|0|||
23552655|NCT02008890|65751202|FG004|Period 1|Pregnancy|0|||
23552656|NCT02008890|65751198|FG000|Period 1|Physician Decision|1|||
23552657|NCT02008890|65751199|FG001|Period 1|Physician Decision|0|||
23552658|NCT02008890|65751200|FG002|Period 1|Physician Decision|1|||
23552659|NCT02008890|65751201|FG003|Period 1|Physician Decision|0|||
23552660|NCT02008890|65751202|FG004|Period 1|Physician Decision|0|||
23552661|NCT02008890|65751198|FG000|Period 1|Adverse Event|6|||
23552662|NCT02008890|65751199|FG001|Period 1|Adverse Event|8|||
23552663|NCT02008890|65751200|FG002|Period 1|Adverse Event|6|||
23552664|NCT02008890|65751201|FG003|Period 1|Adverse Event|0|||
23552665|NCT02008890|65751202|FG004|Period 1|Adverse Event|0|||
23552666|NCT02008890|65751198|FG000|Period 2|Adverse Event|12|||
23552667|NCT02008890|65751199|FG001|Period 2|Adverse Event|7|||
23138480|NCT00833833|64255499|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
23138481|NCT00833833|64255500|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
23431544|NCT01498185|65324110|FG003|Overall Study|Adverse Event|1|||
23138482|NCT00833833|64255501|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
23138483|NCT00833833|64255496|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
23138484|NCT00833833|64255497|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
23138485|NCT00833833|64255498|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
23138486|NCT00833833|64255499|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
23138487|NCT00833833|64255500|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
23138488|NCT00833833|64255501|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
23138489|NCT00833833|64255496|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
23138490|NCT00833833|64255497|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
23138491|NCT00833833|64255498|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
23138492|NCT00833833|64255499|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
23138493|NCT00833833|64255500|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
23138494|NCT00833833|64255501|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
23138495|NCT00833833|64255496|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23138496|NCT00833833|64255497|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23138497|NCT00833833|64255498|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23138498|NCT00833833|64255499|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
23138499|NCT00833833|64255500|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
23138500|NCT00833833|64255501|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
23138501|NCT00833833|64255496|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
23138502|NCT00833833|64255497|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
23138503|NCT00833833|64255498|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
23138504|NCT00833833|64255499|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
23138505|NCT00833833|64255500|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
23138506|NCT00833833|64255501|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
23138507|NCT00833833|64255496|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
23138508|NCT00833833|64255497|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
23138509|NCT00833833|64255498|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
23138510|NCT00833833|64255499|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
23138511|NCT00833833|64255500|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
23215366|NCT01061567|64528235|FG000|Overall Study|Withdrawal by Subject|11|||
23431545|NCT01498185|65324111|FG004|Overall Study|Adverse Event|0|||
23431546|NCT01498185|65324107|FG000|Overall Study|Withdrawal by Subject|1|||
23431547|NCT01498185|65324108|FG001|Overall Study|Withdrawal by Subject|1|||
23431548|NCT01498185|65324109|FG002|Overall Study|Withdrawal by Subject|0|||
23552668|NCT02008890|65751200|FG002|Period 2|Adverse Event|0|||
23552669|NCT02008890|65751201|FG003|Period 2|Adverse Event|5|||
23552670|NCT02008890|65751202|FG004|Period 2|Adverse Event|5|||
23552671|NCT02008890|65751198|FG000|Period 2|Withdrawal by Subject|11|||
23552672|NCT02008890|65751199|FG001|Period 2|Withdrawal by Subject|8|||
23552673|NCT02008890|65751200|FG002|Period 2|Withdrawal by Subject|0|||
23552674|NCT02008890|65751201|FG003|Period 2|Withdrawal by Subject|7|||
23552675|NCT02008890|65751202|FG004|Period 2|Withdrawal by Subject|2|||
23552676|NCT02008890|65751198|FG000|Period 2|Physician Decision|4|||
23552677|NCT02008890|65751199|FG001|Period 2|Physician Decision|0|||
23552678|NCT02008890|65751200|FG002|Period 2|Physician Decision|0|||
23552679|NCT02008890|65751201|FG003|Period 2|Physician Decision|2|||
23552680|NCT02008890|65751202|FG004|Period 2|Physician Decision|1|||
23552681|NCT02008890|65751198|FG000|Period 2|Lost to Follow-up|0|||
23552682|NCT02008890|65751199|FG001|Period 2|Lost to Follow-up|0|||
23552683|NCT02008890|65751200|FG002|Period 2|Lost to Follow-up|1|||
23215367|NCT01061567|64528235|FG000|Overall Study|Other reason than stated above|3|||
23431549|NCT01498185|65324110|FG003|Overall Study|Withdrawal by Subject|2|||
23431550|NCT01498185|65324111|FG004|Overall Study|Withdrawal by Subject|1|||
23431551|NCT01498185|65324107|FG000|Overall Study|No longer met criteria, etc|0|||
23431552|NCT01498185|65324108|FG001|Overall Study|No longer met criteria, etc|0|||
23431553|NCT01498185|65324109|FG002|Overall Study|No longer met criteria, etc|0|||
23431554|NCT01498185|65324110|FG003|Overall Study|No longer met criteria, etc|0|||
23431555|NCT01498185|65324111|FG004|Overall Study|No longer met criteria, etc|2|||
23431556|NCT01853072|65324112|FG000|Overall Study|Adverse event prior to treatment|0|||
23431557|NCT01853072|65324113|FG001|Overall Study|Adverse event prior to treatment|1|||
23431558|NCT01853072|65324112|FG000|Overall Study|Adverse Event|0|||
23431559|NCT01853072|65324113|FG001|Overall Study|Adverse Event|3|||
23431560|NCT01853072|65324112|FG000|Overall Study|Death|1|||
23431561|NCT01853072|65324113|FG001|Overall Study|Death|4|||
23431562|NCT01853072|65324112|FG000|Overall Study|Lost to Follow-up|0|||
23431563|NCT01853072|65324113|FG001|Overall Study|Lost to Follow-up|3|||
23431564|NCT01853072|65324112|FG000|Overall Study|Non-compliance with study drug|0|||
23431565|NCT01853072|65324113|FG001|Overall Study|Non-compliance with study drug|1|||
23431566|NCT01853072|65324112|FG000|Overall Study|Physician Decision|1|||
23431567|NCT01853072|65324113|FG001|Overall Study|Physician Decision|1|||
23431568|NCT01853072|65324112|FG000|Overall Study|Withdrawal by Subject|1|||
23431569|NCT01853072|65324113|FG001|Overall Study|Withdrawal by Subject|2|||
23431570|NCT01853072|65324112|FG000|Overall Study|Reason not specified|9|||
23431571|NCT01853072|65324113|FG001|Overall Study|Reason not specified|6|||
23431572|NCT00483041|65324117|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
23431573|NCT00483041|65324118|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
23431574|NCT00549770|65324119|FG000|Overall Study|Protocol deviation|1|||
23431575|NCT00549770|65324120|FG001|Overall Study|Protocol deviation|1|||
23431576|NCT00549770|65324121|FG002|Overall Study|Protocol deviation|1|||
23431577|NCT00549770|65324122|FG003|Overall Study|Protocol deviation|2|||
23552684|NCT02008890|65751201|FG003|Period 2|Lost to Follow-up|0|||
23215368|NCT02394808|64528238|FG000|Period 1|Unsatisfactory lens fitting|0|||
23215369|NCT02394808|64528239|FG001|Period 1|Unsatisfactory lens fitting|1|||
23215370|NCT02394808|64528238|FG000|Period 2|Lost to Follow-up|1|||
23215371|NCT02394808|64528239|FG001|Period 2|Lost to Follow-up|0|||
23215372|NCT02016898|64528240|FG000|Overall Study|Death|1|||
23215373|NCT02016898|64528241|FG001|Overall Study|Death|1|||
23215374|NCT02016898|64528240|FG000|Overall Study|Lost to Follow-up|4|||
23215375|NCT02016898|64528241|FG001|Overall Study|Lost to Follow-up|4|||
23215376|NCT02685995|64528242|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
23215377|NCT02685995|64528243|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
23215378|NCT01797445|64528244|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
23215379|NCT01797445|64528245|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
23215380|NCT01797445|64528244|FG000|Double-Blind Phase|Adverse Event|3|||
23215381|NCT01797445|64528245|FG001|Double-Blind Phase|Adverse Event|0|||
23215382|NCT01797445|64528244|FG000|Double-Blind Phase|Death|5|||
23215383|NCT01797445|64528245|FG001|Double-Blind Phase|Death|4|||
23215384|NCT01797445|64528244|FG000|Double-Blind Phase|Pregnancy|0|||
23215385|NCT01797445|64528245|FG001|Double-Blind Phase|Pregnancy|1|||
23215386|NCT01797445|64528244|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23215387|NCT01797445|64528245|FG001|Double-Blind Phase|Lack of Efficacy|2|||
23215388|NCT01797445|64528244|FG000|Double-Blind Phase|Investigator's Discretion|15|||
23215389|NCT01797445|64528245|FG001|Double-Blind Phase|Investigator's Discretion|17|||
23215390|NCT01797445|64528244|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
23215391|NCT01797445|64528245|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
23431578|NCT00549770|65324123|FG004|Overall Study|Protocol deviation|2|||
23431579|NCT00549770|65324124|FG005|Overall Study|Protocol deviation|2|||
23431580|NCT00549770|65324125|FG006|Overall Study|Protocol deviation|1|||
23431581|NCT00549770|65324126|FG007|Overall Study|Protocol deviation|2|||
23431582|NCT00549770|65324119|FG000|Overall Study|Administrative problems|0|||
23431583|NCT00549770|65324120|FG001|Overall Study|Administrative problems|1|||
23431584|NCT00549770|65324121|FG002|Overall Study|Administrative problems|0|||
23431585|NCT00549770|65324122|FG003|Overall Study|Administrative problems|0|||
23431586|NCT00549770|65324123|FG004|Overall Study|Administrative problems|0|||
23431587|NCT00549770|65324124|FG005|Overall Study|Administrative problems|0|||
23431588|NCT00549770|65324125|FG006|Overall Study|Administrative problems|0|||
23552685|NCT02008890|65751202|FG004|Period 2|Lost to Follow-up|0|||
23552686|NCT02008890|65751198|FG000|Extension Period|Withdrawal by Subject|3|||
23215392|NCT01797445|64528244|FG000|Double-Blind Phase|Protocol Violation|0|||
23215393|NCT01797445|64528245|FG001|Double-Blind Phase|Protocol Violation|1|||
23215394|NCT01797445|64528244|FG000|Double-Blind Phase|Withdrew Consent|20|||
23215395|NCT01797445|64528245|FG001|Double-Blind Phase|Withdrew Consent|35|||
23431589|NCT00549770|65324126|FG007|Overall Study|Administrative problems|1|||
23431590|NCT00549770|65324119|FG000|Overall Study|Lost to Follow-up|0|||
23431591|NCT00549770|65324120|FG001|Overall Study|Lost to Follow-up|0|||
23431592|NCT00549770|65324121|FG002|Overall Study|Lost to Follow-up|2|||
23431593|NCT00549770|65324122|FG003|Overall Study|Lost to Follow-up|2|||
23431594|NCT00549770|65324123|FG004|Overall Study|Lost to Follow-up|3|||
23431595|NCT00549770|65324124|FG005|Overall Study|Lost to Follow-up|2|||
23431596|NCT00549770|65324125|FG006|Overall Study|Lost to Follow-up|0|||
23431597|NCT00549770|65324126|FG007|Overall Study|Lost to Follow-up|0|||
23431598|NCT00549770|65324119|FG000|Overall Study|Withdrawal by Subject|4|||
23431599|NCT00549770|65324120|FG001|Overall Study|Withdrawal by Subject|6|||
23431600|NCT00549770|65324121|FG002|Overall Study|Withdrawal by Subject|4|||
23431601|NCT00549770|65324122|FG003|Overall Study|Withdrawal by Subject|5|||
23431602|NCT00549770|65324123|FG004|Overall Study|Withdrawal by Subject|6|||
23431603|NCT00549770|65324124|FG005|Overall Study|Withdrawal by Subject|6|||
23431604|NCT00549770|65324125|FG006|Overall Study|Withdrawal by Subject|4|||
23431605|NCT00549770|65324126|FG007|Overall Study|Withdrawal by Subject|9|||
23431606|NCT00549770|65324119|FG000|Overall Study|Lack of Efficacy|1|||
23431607|NCT00549770|65324120|FG001|Overall Study|Lack of Efficacy|0|||
23431608|NCT00549770|65324121|FG002|Overall Study|Lack of Efficacy|2|||
23431609|NCT00549770|65324122|FG003|Overall Study|Lack of Efficacy|3|||
23552687|NCT02008890|65751199|FG001|Extension Period|Withdrawal by Subject|2|||
23552688|NCT02008890|65751200|FG002|Extension Period|Withdrawal by Subject|0|||
23552689|NCT02008890|65751201|FG003|Extension Period|Withdrawal by Subject|4|||
23215396|NCT01797445|64528244|FG000|Double-Blind Phase|Lost to Follow-up|34|||
23215397|NCT01797445|64528245|FG001|Double-Blind Phase|Lost to Follow-up|26|||
23215398|NCT01797445|64528244|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
23215399|NCT01797445|64528245|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
23215400|NCT00973622|64528246|FG000|Overall Study|did not attend MRI|14|||
23215401|NCT00973622|64528247|FG001|Overall Study|did not attend MRI|3|||
23215402|NCT00973622|64528246|FG000|Overall Study|did not pass MRI screen|6|||
23215403|NCT00973622|64528247|FG001|Overall Study|did not pass MRI screen|0|||
23215404|NCT00973622|64528246|FG000|Overall Study|did not complete rTMS sessions|11|||
23215405|NCT00973622|64528247|FG001|Overall Study|did not complete rTMS sessions|2|||
23215406|NCT01838590|64528248|FG000|Overall Study|Lack of Efficacy|12|||
23215407|NCT01838590|64528249|FG001|Overall Study|Lack of Efficacy|4|||
23215408|NCT01838590|64528248|FG000|Overall Study|Lost to Follow-up|0|||
23215409|NCT01838590|64528249|FG001|Overall Study|Lost to Follow-up|1|||
23215410|NCT02896192|64528256|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
23215411|NCT02896192|64528256|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
23215412|NCT02896192|64528256|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
23215413|NCT01425749|64528257|FG000|Overall Study|progression of melanoma|0|||
23215414|NCT01425749|64528258|FG001|Overall Study|progression of melanoma|1|||
23215415|NCT02700919|64528259|FG000|Overall Study|Physician Decision|1|||
23215416|NCT02700919|64528260|FG001|Overall Study|Physician Decision|0|||
23215417|NCT02700919|64528261|FG002|Overall Study|Physician Decision|0|||
23215418|NCT02700919|64528259|FG000|Overall Study|Protocol Violation|1|||
23215419|NCT02700919|64528260|FG001|Overall Study|Protocol Violation|0|||
23215420|NCT02700919|64528261|FG002|Overall Study|Protocol Violation|0|||
23215421|NCT02700919|64528259|FG000|Overall Study|Adverse Event|1|||
23215422|NCT02700919|64528260|FG001|Overall Study|Adverse Event|3|||
23215423|NCT02700919|64528261|FG002|Overall Study|Adverse Event|1|||
23215424|NCT02700919|64528259|FG000|Overall Study|Withdrawal by Subject|5|||
23215425|NCT02700919|64528260|FG001|Overall Study|Withdrawal by Subject|8|||
23215426|NCT02700919|64528261|FG002|Overall Study|Withdrawal by Subject|2|||
23215427|NCT02700919|64528259|FG000|Overall Study|Lost to Follow-up|2|||
23215428|NCT02700919|64528260|FG001|Overall Study|Lost to Follow-up|0|||
23215429|NCT02700919|64528261|FG002|Overall Study|Lost to Follow-up|0|||
23215430|NCT02700919|64528259|FG000|Overall Study|Other|2|||
23215431|NCT02700919|64528260|FG001|Overall Study|Other|1|||
23215432|NCT02700919|64528261|FG002|Overall Study|Other|1|||
23215433|NCT02899377|64531182|FG000|Overall Study|Adverse Event|1|||
23215434|NCT02899377|64531183|FG001|Overall Study|Adverse Event|0|||
23431610|NCT00549770|65324123|FG004|Overall Study|Lack of Efficacy|5|||
23431611|NCT00549770|65324124|FG005|Overall Study|Lack of Efficacy|1|||
23431612|NCT00549770|65324125|FG006|Overall Study|Lack of Efficacy|3|||
23431613|NCT00549770|65324126|FG007|Overall Study|Lack of Efficacy|8|||
23431614|NCT00549770|65324119|FG000|Overall Study|Abnormal test procedure results|0|||
23431615|NCT00549770|65324120|FG001|Overall Study|Abnormal test procedure results|0|||
23215435|NCT00587301|64531184|FG000|Overall Study|Screen Failure|9|||
23215436|NCT00587301|64531184|FG000|Overall Study|Lost to Follow-up|22|||
23431616|NCT00549770|65324121|FG002|Overall Study|Abnormal test procedure results|0|||
23431617|NCT00549770|65324122|FG003|Overall Study|Abnormal test procedure results|2|||
23621565|NCT00635570|66000697|FG001|Overall Study|Did not complete survey|1|||
23621566|NCT00635570|66000696|FG000|Overall Study|Early termination(No sexual activity)|1|||
23621567|NCT00635570|66000697|FG001|Overall Study|Early termination(No sexual activity)|1|||
23621568|NCT00853229|66000700|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
23621569|NCT00853229|66000701|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
23621570|NCT04150341|66000702|FG000|Overall Study|Physician Decision|0|||
23621571|NCT04150341|66000703|FG001|Overall Study|Physician Decision|0|||
23552690|NCT02008890|65751202|FG004|Extension Period|Withdrawal by Subject|2|||
23552691|NCT02008890|65751198|FG000|Extension Period|Lost to Follow-up|1|||
23552692|NCT02008890|65751199|FG001|Extension Period|Lost to Follow-up|0|||
23552693|NCT02008890|65751200|FG002|Extension Period|Lost to Follow-up|0|||
23552694|NCT02008890|65751201|FG003|Extension Period|Lost to Follow-up|0|||
23552695|NCT02008890|65751202|FG004|Extension Period|Lost to Follow-up|0|||
23621572|NCT04150341|66000704|FG002|Overall Study|Physician Decision|1|||
23621573|NCT04150341|66000705|FG003|Overall Study|Physician Decision|0|||
23621574|NCT04150341|66000706|FG004|Overall Study|Physician Decision|0|||
23621575|NCT04150341|66000707|FG005|Overall Study|Physician Decision|0|||
23621576|NCT04150341|66000702|FG000|Overall Study|Adverse Event|0|||
23621577|NCT04150341|66000703|FG001|Overall Study|Adverse Event|0|||
23621578|NCT04150341|66000704|FG002|Overall Study|Adverse Event|0|||
23621579|NCT04150341|66000705|FG003|Overall Study|Adverse Event|0|||
23621580|NCT04150341|66000706|FG004|Overall Study|Adverse Event|1|||
23621581|NCT04150341|66000707|FG005|Overall Study|Adverse Event|0|||
23621582|NCT01101997|66000711|FG000|Overall Study|Withdrawal by Subject|2|||
23552696|NCT02008890|65751198|FG000|Extension Period|Adverse Event|1|||
23621583|NCT00721214|66000712|FG000|Overall Study|Chose another center for transplant|1|||
23552697|NCT02008890|65751199|FG001|Extension Period|Adverse Event|3|||
23552698|NCT02008890|65751200|FG002|Extension Period|Adverse Event|0|||
23552699|NCT02008890|65751201|FG003|Extension Period|Adverse Event|0|||
23552700|NCT02008890|65751202|FG004|Extension Period|Adverse Event|2|||
23552701|NCT00683644|65751203|FG000|Overall Study|Withdrawal by Subject|4|||
23552702|NCT00683644|65751204|FG001|Overall Study|Withdrawal by Subject|2|||
23552703|NCT00683644|65751203|FG000|Overall Study|Lost to Follow-up|1|||
23552704|NCT00683644|65751204|FG001|Overall Study|Lost to Follow-up|4|||
23552705|NCT00683644|65751203|FG000|Overall Study|Adverse Event|1|||
23552706|NCT00683644|65751204|FG001|Overall Study|Adverse Event|2|||
23552707|NCT00683644|65751203|FG000|Overall Study|Low copper, other health problems,|7|||
23552708|NCT00683644|65751204|FG001|Overall Study|Low copper, other health problems,|6|||
23552709|NCT00003298|65751207|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
23552710|NCT00003298|65751207|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
23552711|NCT00003298|65751207|FG000|Surgery|Unresectable at surgery|3|||
23552712|NCT00003298|65751207|FG000|Surgery|Progression before surgery|2|||
23552713|NCT00003298|65751207|FG000|Surgery|Unevaluable and off study|2|||
23552714|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
23552715|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
23552716|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
23552717|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
23552718|NCT00003298|65751207|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
23552719|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
23552720|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
23552721|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
23552722|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
23552723|NCT00003298|65751207|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
23552724|NCT01258608|65751208|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
23552725|NCT01258608|65751209|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
23621584|NCT00721214|66000712|FG000|Overall Study|Death|3|||
23138512|NCT00833833|64255501|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
23138513|NCT00833833|64255496|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23138514|NCT00833833|64255497|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23138515|NCT00833833|64255498|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23138516|NCT00833833|64255499|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23138517|NCT00833833|64255500|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
23138518|NCT00833833|64255501|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
23138519|NCT03207451|64255502|FG000|Overall Study|scheduling conflict|1|||
23317760|NCT01890434|64908132|FG000|Overall Study|Uncontactable by phone|1|||
23317761|NCT01890434|64908132|FG000|Overall Study|Moved out of position|1|||
23621585|NCT02554383|66000713|FG000|Overall Study|Ineligible|3|||
23621586|NCT02554383|66000714|FG001|Overall Study|Ineligible|2|||
23317762|NCT01890434|64908132|FG000|Overall Study|Unable to contact|1|||
23552726|NCT01258608|65751208|FG000|Overall Study|Clinical progression|1|||
23552727|NCT01258608|65751209|FG001|Overall Study|Clinical progression|0|||
23552728|NCT01258608|65751208|FG000|Overall Study|Sponsor decision|0|||
23552729|NCT01258608|65751209|FG001|Overall Study|Sponsor decision|1|||
23552730|NCT01258608|65751208|FG000|Overall Study|Physician Decision|6|||
23552731|NCT01258608|65751209|FG001|Overall Study|Physician Decision|1|||
23552732|NCT01258608|65751208|FG000|Overall Study|Lost to Follow-up|0|||
23552733|NCT01258608|65751209|FG001|Overall Study|Lost to Follow-up|1|||
23552734|NCT01258608|65751208|FG000|Overall Study|Lack of compliance|1|||
23552735|NCT01258608|65751209|FG001|Overall Study|Lack of compliance|0|||
23552736|NCT01258608|65751208|FG000|Overall Study|Lack of Efficacy|0|||
23552737|NCT01258608|65751209|FG001|Overall Study|Lack of Efficacy|1|||
23552738|NCT01258608|65751208|FG000|Overall Study|Adverse Event|6|||
23552739|NCT01258608|65751209|FG001|Overall Study|Adverse Event|10|||
23552740|NCT01258608|65751208|FG000|Overall Study|Withdrawal by Subject|6|||
23552741|NCT01258608|65751209|FG001|Overall Study|Withdrawal by Subject|5|||
23552742|NCT03982186|65751213|FG000|Overall Study|Lost to Follow-up|0|||
23552743|NCT03982186|65751214|FG001|Overall Study|Lost to Follow-up|1|||
23552744|NCT03982186|65751215|FG002|Overall Study|Lost to Follow-up|2|||
23552745|NCT03982186|65751216|FG003|Overall Study|Lost to Follow-up|1|||
23552746|NCT03982186|65751217|FG004|Overall Study|Lost to Follow-up|1|||
23552747|NCT03982186|65751218|FG005|Overall Study|Lost to Follow-up|0|||
23552748|NCT03982186|65751213|FG000|Overall Study|Physician Decision|0|||
23552749|NCT03982186|65751214|FG001|Overall Study|Physician Decision|1|||
23552750|NCT03982186|65751215|FG002|Overall Study|Physician Decision|0|||
23552751|NCT03982186|65751216|FG003|Overall Study|Physician Decision|0|||
23552752|NCT03982186|65751217|FG004|Overall Study|Physician Decision|0|||
23552753|NCT03982186|65751218|FG005|Overall Study|Physician Decision|0|||
23552754|NCT03982186|65751213|FG000|Overall Study|Withdrawal by Subject|3|||
23552755|NCT03982186|65751214|FG001|Overall Study|Withdrawal by Subject|4|||
23552756|NCT03982186|65751215|FG002|Overall Study|Withdrawal by Subject|1|||
23552757|NCT03982186|65751216|FG003|Overall Study|Withdrawal by Subject|7|||
23552758|NCT03982186|65751217|FG004|Overall Study|Withdrawal by Subject|2|||
23552759|NCT03982186|65751218|FG005|Overall Study|Withdrawal by Subject|0|||
23317763|NCT01890434|64908132|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
23317764|NCT00822692|64908134|FG000|Overall Study|Lost to Follow-up|17|||
23317765|NCT00822692|64908135|FG001|Overall Study|Lost to Follow-up|25|||
23552760|NCT03982186|65751213|FG000|Overall Study|Randomized and not treated|0|||
23552761|NCT03982186|65751214|FG001|Overall Study|Randomized and not treated|0|||
23552762|NCT03982186|65751215|FG002|Overall Study|Randomized and not treated|0|||
23552763|NCT03982186|65751216|FG003|Overall Study|Randomized and not treated|1|||
23552764|NCT03982186|65751217|FG004|Overall Study|Randomized and not treated|0|||
23552765|NCT03982186|65751218|FG005|Overall Study|Randomized and not treated|0|||
23552766|NCT01814748|65751219|FG000|Overall Study|Lost to Follow-up|1|||
23552767|NCT01814748|65751220|FG001|Overall Study|Lost to Follow-up|2|||
23552768|NCT01814748|65751219|FG000|Overall Study|Study site terminated by sponsor|1|||
23552769|NCT01814748|65751220|FG001|Overall Study|Study site terminated by sponsor|1|||
23552770|NCT01814748|65751219|FG000|Overall Study|Withdrawal by Subject|6|||
23552771|NCT01814748|65751220|FG001|Overall Study|Withdrawal by Subject|4|||
23552772|NCT02030015|65751223|FG000|Overall Study|Withdrawal by Subject|3|||
23552773|NCT02030015|65751223|FG000|Overall Study|Death|13|||
23552774|NCT01928719|65751224|FG000|Overall Study|Lost to Follow-up|26|||
23552775|NCT01928719|65751225|FG001|Overall Study|Lost to Follow-up|11|||
23552776|NCT01928719|65751224|FG000|Overall Study|Withdrawal by Subject|22|||
23552777|NCT01928719|65751225|FG001|Overall Study|Withdrawal by Subject|7|||
23552778|NCT01928719|65751224|FG000|Overall Study|Protocol Violation|3|||
23552779|NCT01928719|65751225|FG001|Overall Study|Protocol Violation|1|||
23552780|NCT01928719|65751224|FG000|Overall Study|Adverse Event|1|||
23552781|NCT01928719|65751225|FG001|Overall Study|Adverse Event|0|||
23552782|NCT03364751|65751226|FG000|Overall Study|Withdrawal by Subject|1|||
23552783|NCT03364751|65751227|FG001|Overall Study|Withdrawal by Subject|0|||
23552784|NCT03364751|65751228|FG002|Overall Study|Withdrawal by Subject|0|||
23552785|NCT03364751|65751229|FG003|Overall Study|Withdrawal by Subject|0|||
23552786|NCT03364751|65751226|FG000|Overall Study|Lost to Follow-up|0|||
23138520|NCT03207451|64255503|FG001|Overall Study|scheduling conflict|0|||
23317766|NCT02289456|64908138|FG000|Induction Period|Death|2|||
23431618|NCT00549770|65324123|FG004|Overall Study|Abnormal test procedure results|0|||
23552787|NCT03364751|65751227|FG001|Overall Study|Lost to Follow-up|1|||
23552788|NCT03364751|65751228|FG002|Overall Study|Lost to Follow-up|0|||
23552789|NCT03364751|65751229|FG003|Overall Study|Lost to Follow-up|0|||
23431619|NCT00549770|65324124|FG005|Overall Study|Abnormal test procedure results|1|||
23552790|NCT00929162|65751230|FG000|Overall Study|Adverse Event|8|||
23552791|NCT00929162|65751231|FG001|Overall Study|Adverse Event|5|||
23552792|NCT00929162|65751230|FG000|Overall Study|Withdrawal by Subject|3|||
23552793|NCT00929162|65751231|FG001|Overall Study|Withdrawal by Subject|1|||
23552794|NCT00929162|65751230|FG000|Overall Study|Protocol Violation|32|||
23552795|NCT00929162|65751231|FG001|Overall Study|Protocol Violation|30|||
23552796|NCT00929162|65751230|FG000|Overall Study|Other termination reason|5|||
23552797|NCT00929162|65751231|FG001|Overall Study|Other termination reason|6|||
23552798|NCT02677116|65751232|FG000|Overall Study|Adverse Event|0|||
23552799|NCT02677116|65751233|FG001|Overall Study|Adverse Event|1|||
23552800|NCT02677116|65751234|FG002|Overall Study|Adverse Event|0|||
23552801|NCT02677116|65751235|FG003|Overall Study|Adverse Event|0|||
23552802|NCT02677116|65751236|FG004|Overall Study|Adverse Event|0|||
23552803|NCT02677116|65751237|FG005|Overall Study|Adverse Event|1|||
23552804|NCT02677116|65751238|FG006|Overall Study|Adverse Event|1|||
23552805|NCT02677116|65751239|FG007|Overall Study|Adverse Event|0|||
23552806|NCT02677116|65751240|FG008|Overall Study|Adverse Event|0|||
23552807|NCT02677116|65751232|FG000|Overall Study|Physician Decision|0|||
23552808|NCT02677116|65751233|FG001|Overall Study|Physician Decision|2|||
23552809|NCT02677116|65751234|FG002|Overall Study|Physician Decision|3|||
23552810|NCT02677116|65751235|FG003|Overall Study|Physician Decision|2|||
23552811|NCT02677116|65751236|FG004|Overall Study|Physician Decision|1|||
23552812|NCT02677116|65751237|FG005|Overall Study|Physician Decision|3|||
23552813|NCT02677116|65751238|FG006|Overall Study|Physician Decision|1|||
23552814|NCT02677116|65751239|FG007|Overall Study|Physician Decision|1|||
23552815|NCT02677116|65751240|FG008|Overall Study|Physician Decision|2|||
23552816|NCT02677116|65751232|FG000|Overall Study|Withdrawal by parent or guardian|2|||
23552817|NCT02677116|65751233|FG001|Overall Study|Withdrawal by parent or guardian|1|||
23552818|NCT02677116|65751234|FG002|Overall Study|Withdrawal by parent or guardian|0|||
23552819|NCT02677116|65751235|FG003|Overall Study|Withdrawal by parent or guardian|1|||
23552820|NCT02677116|65751236|FG004|Overall Study|Withdrawal by parent or guardian|0|||
23552821|NCT02677116|65751237|FG005|Overall Study|Withdrawal by parent or guardian|0|||
23552822|NCT02677116|65751238|FG006|Overall Study|Withdrawal by parent or guardian|2|||
23317767|NCT02289456|64908138|FG000|Induction Period|Adverse Event|11|||
23621587|NCT02554383|66000713|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
23621588|NCT02554383|66000714|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
23621589|NCT02554383|66000713|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
23621590|NCT02554383|66000714|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
23621591|NCT02554383|66000713|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
23621592|NCT02554383|66000714|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
23621593|NCT00843115|66000715|FG000|Overall Study|Death|4|||
23621594|NCT00843115|66000715|FG000|Overall Study|Adverse Event|30|||
23431620|NCT00549770|65324125|FG006|Overall Study|Abnormal test procedure results|1|||
23431621|NCT00549770|65324126|FG007|Overall Study|Abnormal test procedure results|1|||
23431622|NCT00549770|65324119|FG000|Overall Study|Abnormal laboratory values|0|||
23431623|NCT00549770|65324120|FG001|Overall Study|Abnormal laboratory values|0|||
23431624|NCT00549770|65324121|FG002|Overall Study|Abnormal laboratory values|0|||
23431625|NCT00549770|65324122|FG003|Overall Study|Abnormal laboratory values|0|||
23621595|NCT00843115|66000715|FG000|Overall Study|Lost to Follow-up|4|||
23621596|NCT00843115|66000715|FG000|Overall Study|Withdrawal by Subject|17|||
23621597|NCT00843115|66000715|FG000|Overall Study|Family wanted meds stopped|1|||
23621598|NCT00843115|66000715|FG000|Overall Study|Family does not want continuation|1|||
23621599|NCT00843115|66000715|FG000|Overall Study|Patient forgot to take meds|1|||
23621600|NCT00843115|66000715|FG000|Overall Study|Does not meet entrance criteria|1|||
23621601|NCT00843115|66000715|FG000|Overall Study|Physician Decision|1|||
23621602|NCT00843115|66000715|FG000|Overall Study|Family discontinued meds|1|||
23621603|NCT00843115|66000715|FG000|Overall Study|patient took for 2 days then stopped|1|||
23621604|NCT00843115|66000715|FG000|Overall Study|patient never took the medication|1|||
23621605|NCT00843115|66000715|FG000|Overall Study|hospitalized due to deterioration|1|||
23621606|NCT00843115|66000715|FG000|Overall Study|week 12 not done|1|||
23621607|NCT00843115|66000715|FG000|Overall Study|Syndrome De Glissement|1|||
23621608|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621609|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621610|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
23431626|NCT00549770|65324123|FG004|Overall Study|Abnormal laboratory values|0|||
23431627|NCT00549770|65324124|FG005|Overall Study|Abnormal laboratory values|1|||
23552823|NCT02677116|65751239|FG007|Overall Study|Withdrawal by parent or guardian|1|||
23552824|NCT02677116|65751240|FG008|Overall Study|Withdrawal by parent or guardian|0|||
23552825|NCT02677116|65751232|FG000|Overall Study|Withdrawal by Subject|1|||
23552826|NCT02677116|65751233|FG001|Overall Study|Withdrawal by Subject|0|||
23552827|NCT02677116|65751234|FG002|Overall Study|Withdrawal by Subject|0|||
23552828|NCT02677116|65751235|FG003|Overall Study|Withdrawal by Subject|0|||
23552829|NCT02677116|65751236|FG004|Overall Study|Withdrawal by Subject|0|||
23552830|NCT02677116|65751237|FG005|Overall Study|Withdrawal by Subject|0|||
23552831|NCT02677116|65751238|FG006|Overall Study|Withdrawal by Subject|0|||
23552832|NCT02677116|65751239|FG007|Overall Study|Withdrawal by Subject|0|||
23552833|NCT02677116|65751240|FG008|Overall Study|Withdrawal by Subject|0|||
23552834|NCT01292876|65751242|FG000|Overall Study|Physician Decision|4|||
23552835|NCT02131272|65751243|FG000|Overall Study|Withdrawal by parent|0|||
23552836|NCT02131272|65751244|FG001|Overall Study|Withdrawal by parent|1|||
23431628|NCT00549770|65324125|FG006|Overall Study|Abnormal laboratory values|0|||
23431629|NCT00549770|65324126|FG007|Overall Study|Abnormal laboratory values|0|||
23552837|NCT02131272|65751243|FG000|Overall Study|Withdrawal by Subject|0|||
23552838|NCT02131272|65751244|FG001|Overall Study|Withdrawal by Subject|1|||
23552839|NCT02131272|65751243|FG000|Overall Study|Withdrawal Criteria|1|||
23431630|NCT00549770|65324119|FG000|Overall Study|Adverse Event|1|||
23431631|NCT00549770|65324120|FG001|Overall Study|Adverse Event|3|||
23431632|NCT00549770|65324121|FG002|Overall Study|Adverse Event|1|||
23431633|NCT00549770|65324122|FG003|Overall Study|Adverse Event|2|||
23317768|NCT02289456|64908138|FG000|Induction Period|Progressive Disease (PD)|4|||
23317769|NCT02289456|64908138|FG000|Induction Period|Symptomatic Deterioration|4|||
23317770|NCT02289456|64908138|FG000|Induction Period|Withdrawal by Subject|2|||
23317771|NCT02289456|64908138|FG000|Induction Period|Miscellaneous|1|||
23317772|NCT02289456|64908138|FG000|Monotherapy Period|Death|1|||
23317773|NCT02289456|64908138|FG000|Monotherapy Period|Adverse Event|1|||
23317774|NCT02289456|64908138|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
23317775|NCT02289456|64908138|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
23317776|NCT02289456|64908138|FG000|Monotherapy Period|Withdrawal by Subject|2|||
23317777|NCT02289456|64908138|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
23317778|NCT02289456|64908138|FG000|Monotherapy Period|Miscellaneous|1|||
23317779|NCT01632280|64908144|FG000|Overall Study|Withdrawal by Subject|1|||
23431634|NCT00549770|65324123|FG004|Overall Study|Adverse Event|1|||
23431635|NCT00549770|65324124|FG005|Overall Study|Adverse Event|0|||
23431636|NCT00549770|65324125|FG006|Overall Study|Adverse Event|5|||
23431637|NCT00549770|65324126|FG007|Overall Study|Adverse Event|4|||
23431638|NCT00552760|65324127|FG000|Overall Study|Adverse Event|3|||
23431639|NCT00552760|65324128|FG001|Overall Study|Adverse Event|5|||
23431640|NCT00552760|65324127|FG000|Overall Study|Relapsed- Depressed Event|10|||
23431641|NCT00552760|65324128|FG001|Overall Study|Relapsed- Depressed Event|16|||
23431642|NCT00552760|65324127|FG000|Overall Study|Relapse- Manic Event|3|||
23431643|NCT00552760|65324128|FG001|Overall Study|Relapse- Manic Event|3|||
23431644|NCT00552760|65324127|FG000|Overall Study|Relapsed- Mixed Event|3|||
23431645|NCT00552760|65324128|FG001|Overall Study|Relapsed- Mixed Event|5|||
23431646|NCT00552760|65324127|FG000|Overall Study|Protocol Violation|0|||
23431647|NCT00552760|65324128|FG001|Overall Study|Protocol Violation|1|||
23431648|NCT00552760|65324127|FG000|Overall Study|Lost to Follow-up|1|||
23431649|NCT00552760|65324128|FG001|Overall Study|Lost to Follow-up|1|||
23431650|NCT00552760|65324127|FG000|Overall Study|Non-compliance|1|||
23431651|NCT00552760|65324128|FG001|Overall Study|Non-compliance|1|||
23431652|NCT00552760|65324127|FG000|Overall Study|Medical Condition|1|||
23431653|NCT00552760|65324128|FG001|Overall Study|Medical Condition|1|||
23431654|NCT00552760|65324127|FG000|Overall Study|Withdrawal by Subject|3|||
23431655|NCT00552760|65324128|FG001|Overall Study|Withdrawal by Subject|0|||
23431656|NCT00552760|65324127|FG000|Overall Study|Medication Change|1|||
23431657|NCT00552760|65324128|FG001|Overall Study|Medication Change|0|||
23431658|NCT02715726|65324129|FG000|Overall Study|Adverse Event|2|||
23431659|NCT02715726|65324130|FG001|Overall Study|Adverse Event|6|||
23431660|NCT02715726|65324129|FG000|Overall Study|Protocol Violation|1|||
23431661|NCT02715726|65324130|FG001|Overall Study|Protocol Violation|0|||
23431662|NCT02715726|65324129|FG000|Overall Study|Death|2|||
23431663|NCT02715726|65324130|FG001|Overall Study|Death|1|||
23431664|NCT02715726|65324129|FG000|Overall Study|Participant moved|1|||
23431665|NCT02715726|65324130|FG001|Overall Study|Participant moved|3|||
23431666|NCT02715726|65324129|FG000|Overall Study|Other than specified above|11|||
23552840|NCT02131272|65751244|FG001|Overall Study|Withdrawal Criteria|0|||
23552841|NCT00815295|65751245|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
23552842|NCT00815295|65751246|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
23552843|NCT00815295|65751247|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
23552844|NCT03543254|65751248|FG000|Overall Study|Lost to Follow-up|1|||
23552845|NCT00313820|65751249|FG000|Assigned to Treatment|Other|1|||
23138521|NCT03207451|64255504|FG002|Overall Study|scheduling conflict|2|||
23138522|NCT03207451|64255505|FG003|Overall Study|scheduling conflict|2|||
23138523|NCT03207451|64255502|FG000|Overall Study|Adverse Event|0|||
23138524|NCT03207451|64255503|FG001|Overall Study|Adverse Event|0|||
23138525|NCT03207451|64255504|FG002|Overall Study|Adverse Event|0|||
23317780|NCT01632280|64908145|FG001|Overall Study|Withdrawal by Subject|0|||
23317781|NCT04138043|64908150|FG000|Overall Study|Withdrawal by Subject|0|||
23317782|NCT04138043|64908151|FG001|Overall Study|Withdrawal by Subject|1|||
23317783|NCT00550459|64908154|FG000|Overall Study|Adverse Event|0|||
23431667|NCT02715726|65324130|FG001|Overall Study|Other than specified above|15|||
23431668|NCT02715726|65324129|FG000|Overall Study|Randomized but not treated|1|||
23431669|NCT02715726|65324130|FG001|Overall Study|Randomized but not treated|2|||
23431670|NCT02049138|65324133|FG000|Overall Study|Adverse Event|46|||
23431671|NCT02049138|65324134|FG001|Overall Study|Adverse Event|25|||
23431672|NCT02049138|65324135|FG002|Overall Study|Adverse Event|1|||
23431673|NCT02049138|65324133|FG000|Overall Study|Withdrawal by Subject|57|||
23431674|NCT02049138|65324134|FG001|Overall Study|Withdrawal by Subject|21|||
23431675|NCT02049138|65324135|FG002|Overall Study|Withdrawal by Subject|5|||
23431676|NCT02049138|65324133|FG000|Overall Study|Lost to Follow-up|18|||
23431677|NCT02049138|65324134|FG001|Overall Study|Lost to Follow-up|5|||
23431678|NCT02049138|65324135|FG002|Overall Study|Lost to Follow-up|1|||
23138526|NCT03207451|64255505|FG003|Overall Study|Adverse Event|1|||
23431679|NCT02049138|65324133|FG000|Overall Study|Lack of Efficacy|10|||
23552846|NCT00313820|65751250|FG001|Assigned to Treatment|Other|0|||
23552847|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
23552848|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
23552849|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
23552850|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
23552851|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
23552852|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
23552853|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
23552854|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
23552855|NCT00313820|65751249|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
23552856|NCT00313820|65751250|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
23552857|NCT04004611|65751258|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552858|NCT04004611|65751259|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552859|NCT04004611|65751260|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552860|NCT04004611|65751261|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552861|NCT04004611|65751262|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552862|NCT04004611|65751263|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552863|NCT04004611|65751264|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552864|NCT04004611|65751265|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
23552865|NCT04004611|65751266|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
23552866|NCT04004611|65751258|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552867|NCT04004611|65751259|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552868|NCT04004611|65751260|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552869|NCT04004611|65751261|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552870|NCT04004611|65751262|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552871|NCT04004611|65751263|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
23552872|NCT04004611|65751264|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
23552873|NCT04004611|65751265|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
23552874|NCT04004611|65751266|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
23552875|NCT04004611|65751258|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552876|NCT04004611|65751259|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552877|NCT04004611|65751260|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23138527|NCT02003573|64255506|FG000|Overall Study|Progressive disease|2|||
23138528|NCT02003573|64255507|FG001|Overall Study|Progressive disease|0|||
23138529|NCT02003573|64255508|FG002|Overall Study|Progressive disease|1|||
23138530|NCT02003573|64255506|FG000|Overall Study|Other Adverse event|0|||
23138531|NCT02003573|64255507|FG001|Overall Study|Other Adverse event|1|||
23138532|NCT02003573|64255508|FG002|Overall Study|Other Adverse event|1|||
23138533|NCT02003573|64255506|FG000|Overall Study|Refuse to take trial medication|0|||
23138534|NCT02003573|64255507|FG001|Overall Study|Refuse to take trial medication|1|||
23138535|NCT02003573|64255508|FG002|Overall Study|Refuse to take trial medication|1|||
23215437|NCT00587301|64531184|FG000|Overall Study|Withdrawal by Subject|7|||
23215438|NCT00587301|64531184|FG000|Overall Study|Protocol Violation|7|||
23552878|NCT04004611|65751261|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552879|NCT04004611|65751262|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
23552880|NCT04004611|65751263|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552881|NCT04004611|65751264|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552882|NCT04004611|65751265|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552883|NCT04004611|65751266|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
23552884|NCT04004611|65751258|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
23552885|NCT04004611|65751259|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
23552886|NCT04004611|65751260|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
23552887|NCT04004611|65751261|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
23552888|NCT04004611|65751262|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
23552889|NCT04004611|65751263|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
23552890|NCT04004611|65751264|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
23552891|NCT04004611|65751265|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
23552892|NCT04004611|65751266|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
23552893|NCT04004611|65751258|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
23552894|NCT04004611|65751259|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552895|NCT04004611|65751260|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
23552896|NCT04004611|65751261|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552897|NCT04004611|65751262|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552898|NCT04004611|65751263|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23215439|NCT00105560|64531185|FG000|Overall Study|Lost to Follow-up|1|||
23215440|NCT03097029|64531189|FG000|Overall Study|Withdrawal by Subject|1|||
23215441|NCT00391807|64531192|FG000|Overall Study|Did not receive study medication|23|||
23215442|NCT00391807|64531192|FG000|Overall Study|Adverse Event|177|||
23138536|NCT02003573|64255506|FG000|Overall Study|Other than specified|1|||
23215443|NCT00391807|64531192|FG000|Overall Study|Pregnancy|25|||
23431680|NCT02049138|65324134|FG001|Overall Study|Lack of Efficacy|26|||
23431681|NCT02049138|65324135|FG002|Overall Study|Lack of Efficacy|1|||
23317784|NCT00550459|64908155|FG001|Overall Study|Adverse Event|2|||
23317785|NCT00550459|64908154|FG000|Overall Study|Withdrawal by Subject|1|||
23215444|NCT00391807|64531192|FG000|Overall Study|Lost to Follow-up|227|||
23215445|NCT00391807|64531192|FG000|Overall Study|Withdrawal by Subject|147|||
23215446|NCT00391807|64531192|FG000|Overall Study|Protocol Violation|20|||
23215447|NCT00391807|64531192|FG000|Overall Study|Various|96|||
23215448|NCT02980692|64531193|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
23215449|NCT02980692|64531194|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
23138537|NCT02003573|64255507|FG001|Overall Study|Other than specified|2|||
23138538|NCT02003573|64255508|FG002|Overall Study|Other than specified|3|||
23138539|NCT03309813|64255509|FG000|Main Randomized Study|Withdrawal by Subject|1|||
23138540|NCT03309813|64255510|FG001|Main Randomized Study|Withdrawal by Subject|0|||
23138541|NCT00370682|64255511|FG000|Overall Study|Moved from area|0|||
23138542|NCT00370682|64255512|FG001|Overall Study|Moved from area|2|||
23138543|NCT00370682|64255513|FG002|Overall Study|Moved from area|0|||
23138544|NCT00370682|64255511|FG000|Overall Study|Lost to Follow-up|0|||
23138545|NCT00370682|64255512|FG001|Overall Study|Lost to Follow-up|1|||
23215450|NCT02980692|64531195|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
23215451|NCT02980692|64531196|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
23215452|NCT02980692|64531197|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
23215453|NCT02980692|64531193|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
23215454|NCT02980692|64531194|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
23215455|NCT02980692|64531195|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
23215456|NCT02980692|64531196|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
23215457|NCT02980692|64531197|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
23215458|NCT02980692|64531193|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
23215459|NCT02980692|64531194|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
23215460|NCT02980692|64531195|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
23215461|NCT02980692|64531196|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
23215462|NCT02980692|64531197|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
23431682|NCT02049138|65324133|FG000|Overall Study|Non-Compliance|15|||
23431683|NCT02049138|65324134|FG001|Overall Study|Non-Compliance|6|||
23431684|NCT02049138|65324135|FG002|Overall Study|Non-Compliance|0|||
23431685|NCT02049138|65324133|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
23431686|NCT02049138|65324134|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
23431687|NCT02049138|65324135|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
23431688|NCT02049138|65324133|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
23431689|NCT02049138|65324134|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23431690|NCT02049138|65324135|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23431691|NCT02049138|65324133|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
23431692|NCT02049138|65324134|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
23431693|NCT02049138|65324135|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
23621611|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621612|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621613|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621614|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
23138546|NCT00370682|64255513|FG002|Overall Study|Lost to Follow-up|1|||
23138547|NCT01820585|64255514|FG000|Overall Study|Adverse Event|9|||
23138548|NCT01820585|64255515|FG001|Overall Study|Adverse Event|13|||
23138549|NCT01820585|64255516|FG002|Overall Study|Adverse Event|23|||
23138550|NCT01820585|64255517|FG003|Overall Study|Adverse Event|34|||
23138551|NCT01820585|64255514|FG000|Overall Study|Lack of Efficacy|9|||
23138552|NCT01820585|64255515|FG001|Overall Study|Lack of Efficacy|7|||
23138553|NCT01820585|64255516|FG002|Overall Study|Lack of Efficacy|5|||
23138554|NCT01820585|64255517|FG003|Overall Study|Lack of Efficacy|1|||
23138555|NCT01820585|64255514|FG000|Overall Study|Withdrawal by Subject|3|||
23138556|NCT01820585|64255515|FG001|Overall Study|Withdrawal by Subject|7|||
23138557|NCT01820585|64255516|FG002|Overall Study|Withdrawal by Subject|3|||
23215463|NCT02980692|64531193|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
23215464|NCT02980692|64531194|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
23215465|NCT02980692|64531195|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
23317786|NCT00550459|64908155|FG001|Overall Study|Withdrawal by Subject|1|||
23431694|NCT02049138|65324133|FG000|Overall Study|Other|15|||
23431695|NCT02049138|65324134|FG001|Overall Study|Other|13|||
23431696|NCT02049138|65324135|FG002|Overall Study|Other|0|||
23431697|NCT02049138|65324133|FG000|Overall Study|Missing|0|||
23431698|NCT02049138|65324134|FG001|Overall Study|Missing|1|||
23138558|NCT01820585|64255517|FG003|Overall Study|Withdrawal by Subject|8|||
23138559|NCT01820585|64255514|FG000|Overall Study|Lost to Follow-up|3|||
23138560|NCT01820585|64255515|FG001|Overall Study|Lost to Follow-up|3|||
23431699|NCT02049138|65324135|FG002|Overall Study|Missing|0|||
23621615|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
23621616|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
23621617|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
23215466|NCT02980692|64531196|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
23215467|NCT02980692|64531197|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
23215468|NCT02980692|64531193|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
23215469|NCT02980692|64531194|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
23215470|NCT02980692|64531195|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
23215471|NCT02980692|64531196|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
23215472|NCT02980692|64531197|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
23215473|NCT02980692|64531193|FG000|Double Blind Placebo Controlled Period|Other|1|||
23215474|NCT02980692|64531194|FG001|Double Blind Placebo Controlled Period|Other|0|||
23215475|NCT02980692|64531195|FG002|Double Blind Placebo Controlled Period|Other|0|||
23621618|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
23621619|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
23138561|NCT01820585|64255516|FG002|Overall Study|Lost to Follow-up|0|||
23138562|NCT01820585|64255517|FG003|Overall Study|Lost to Follow-up|3|||
23215476|NCT02980692|64531196|FG003|Double Blind Placebo Controlled Period|Other|0|||
23215477|NCT02980692|64531197|FG004|Double Blind Placebo Controlled Period|Other|1|||
23215478|NCT02980692|64531193|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
23215479|NCT02980692|64531194|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
23215480|NCT02980692|64531195|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
23215481|NCT02980692|64531196|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
23215482|NCT02980692|64531197|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
23215483|NCT02980692|64531193|FG000|Double-blind Follow-up Period|Adverse Event|0|||
23215484|NCT02980692|64531194|FG001|Double-blind Follow-up Period|Adverse Event|0|||
23215485|NCT02980692|64531195|FG002|Double-blind Follow-up Period|Adverse Event|0|||
23215486|NCT02980692|64531196|FG003|Double-blind Follow-up Period|Adverse Event|1|||
23215487|NCT02980692|64531197|FG004|Double-blind Follow-up Period|Adverse Event|1|||
23215488|NCT02980692|64531193|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
23215489|NCT02980692|64531194|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
23215490|NCT02980692|64531195|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
23215491|NCT02980692|64531196|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
23215492|NCT02980692|64531197|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
23215493|NCT02980692|64531193|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
23215494|NCT02980692|64531194|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
23215495|NCT02980692|64531195|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
23215496|NCT02980692|64531196|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
23215497|NCT02980692|64531197|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
23215498|NCT02980692|64531193|FG000|Double-blind Follow-up Period|Pregnancy|0|||
23215499|NCT02980692|64531194|FG001|Double-blind Follow-up Period|Pregnancy|0|||
23215500|NCT02980692|64531195|FG002|Double-blind Follow-up Period|Pregnancy|1|||
23215501|NCT02980692|64531196|FG003|Double-blind Follow-up Period|Pregnancy|1|||
23215502|NCT02980692|64531197|FG004|Double-blind Follow-up Period|Pregnancy|0|||
23431700|NCT04969198|65324138|FG000|Overall Study|Withdrawal by Subject|20|||
23431701|NCT04969198|65324138|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
23431702|NCT04969198|65324138|FG000|Overall Study|Lost to Follow-up|20|||
23431703|NCT00007020|65324139|FG000|Overall Study|Death|16|||
23138563|NCT01820585|64255514|FG000|Overall Study|Protocol Violation|3|||
23138564|NCT01820585|64255515|FG001|Overall Study|Protocol Violation|1|||
23138565|NCT01820585|64255516|FG002|Overall Study|Protocol Violation|1|||
23138566|NCT01820585|64255517|FG003|Overall Study|Protocol Violation|1|||
23138567|NCT01820585|64255514|FG000|Overall Study|Subject non-compliance|0|||
23138568|NCT01820585|64255515|FG001|Overall Study|Subject non-compliance|0|||
23138569|NCT01820585|64255516|FG002|Overall Study|Subject non-compliance|1|||
23138570|NCT01820585|64255517|FG003|Overall Study|Subject non-compliance|2|||
23138571|NCT01820585|64255514|FG000|Overall Study|at sponsor request|0|||
23138572|NCT01820585|64255515|FG001|Overall Study|at sponsor request|0|||
23138573|NCT01820585|64255516|FG002|Overall Study|at sponsor request|1|||
23138574|NCT01820585|64255517|FG003|Overall Study|at sponsor request|0|||
23138575|NCT01820585|64255514|FG000|Overall Study|Pregnancy|0|||
23138576|NCT01820585|64255515|FG001|Overall Study|Pregnancy|1|||
23340855|NCT01936181|64992872|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
23431704|NCT00007020|65324139|FG000|Overall Study|Lost to Follow-up|13|||
23621620|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
23138577|NCT01820585|64255516|FG002|Overall Study|Pregnancy|0|||
23138578|NCT01820585|64255517|FG003|Overall Study|Pregnancy|0|||
23215503|NCT02980692|64531193|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
23215504|NCT02980692|64531194|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
23215505|NCT02980692|64531195|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
23215506|NCT02980692|64531196|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
23215507|NCT02980692|64531197|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
23215508|NCT02980692|64531193|FG000|Double-blind Follow-up Period|Other|0|||
23215509|NCT02980692|64531194|FG001|Double-blind Follow-up Period|Other|0|||
23215510|NCT02980692|64531195|FG002|Double-blind Follow-up Period|Other|1|||
23215511|NCT02980692|64531196|FG003|Double-blind Follow-up Period|Other|1|||
23215512|NCT02980692|64531197|FG004|Double-blind Follow-up Period|Other|3|||
23215513|NCT00888615|64531198|FG000|Overall Study|No treatment|2|||
23215514|NCT00830115|64531199|FG000|Overall Study|Adverse Event|2|||
23215515|NCT00830115|64531199|FG000|Overall Study|Improvement/recovery|1|||
23215516|NCT02088541|64531200|FG000|Overall Study|Adverse Event|3|||
23215517|NCT02088541|64531201|FG001|Overall Study|Adverse Event|0|||
23215518|NCT02088541|64531202|FG002|Overall Study|Adverse Event|3|||
23215519|NCT02088541|64531203|FG003|Overall Study|Adverse Event|3|||
23215520|NCT02088541|64531204|FG004|Overall Study|Adverse Event|0|||
23340856|NCT01936181|64992873|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
23431705|NCT00007020|65324139|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
23431706|NCT00007020|65324139|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
23431707|NCT00007020|65324139|FG000|Overall Study|Pt cared for by outside physician|4|||
23431708|NCT00007020|65324139|FG000|Overall Study|No evidence of treatment|6|||
23138579|NCT02442336|64255521|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
23138580|NCT02442336|64255521|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
23138581|NCT02442336|64255521|FG000|Overall Study|Lost to Follow-up|11|||
23431709|NCT04496453|65324140|FG000|Overall Study|Lost to Follow-up|6|||
23431710|NCT00637572|65324141|FG000|Overall Study|Adverse Event|1|||
23431711|NCT00637572|65324142|FG001|Overall Study|Adverse Event|2|||
23431712|NCT00637572|65324141|FG000|Overall Study|Death|0|||
23431713|NCT00637572|65324142|FG001|Overall Study|Death|1|||
23431714|NCT00637572|65324141|FG000|Overall Study|Lost to Follow-up|0|||
23431715|NCT00637572|65324142|FG001|Overall Study|Lost to Follow-up|1|||
23431716|NCT00637572|65324141|FG000|Overall Study|Physician Decision|1|||
23431717|NCT00637572|65324142|FG001|Overall Study|Physician Decision|1|||
23431718|NCT00637572|65324141|FG000|Overall Study|Withdrawal by Subject|0|||
23431719|NCT00637572|65324142|FG001|Overall Study|Withdrawal by Subject|2|||
23431720|NCT00637572|65324141|FG000|Overall Study|Illicit Drug Use|1|||
23431721|NCT00637572|65324142|FG001|Overall Study|Illicit Drug Use|0|||
23431722|NCT02404649|65324143|FG000|Overall Study|Adverse Event|1|||
23431723|NCT02404649|65324144|FG001|Overall Study|Adverse Event|2|||
23431724|NCT00840060|65324145|FG000|Overall Study|Withdrawal by Subject|1|||
23431725|NCT00840060|65324146|FG001|Overall Study|Withdrawal by Subject|0|||
23431726|NCT00840060|65324145|FG000|Overall Study|Change in emotional/behavioral status|0|||
23431727|NCT00840060|65324146|FG001|Overall Study|Change in emotional/behavioral status|1|||
23431728|NCT01927055|65324147|FG000|Open-label|Adverse Event|6|||
23431729|NCT01927055|65324148|FG001|Open-label|Adverse Event|0|||
23431730|NCT01927055|65324149|FG002|Open-label|Adverse Event|0|||
23431731|NCT01927055|65324147|FG000|Open-label|Withdrawal by Subject|1|||
23431732|NCT01927055|65324148|FG001|Open-label|Withdrawal by Subject|0|||
23431733|NCT01927055|65324149|FG002|Open-label|Withdrawal by Subject|0|||
23431734|NCT01927055|65324147|FG000|Open-label|Study Stopped|4|||
23138582|NCT02581631|64255522|FG000|Overall Study|Disease progression|29|||
23138583|NCT02581631|64255523|FG001|Overall Study|Disease progression|19|||
23138584|NCT02581631|64255524|FG002|Overall Study|Disease progression|13|||
23138585|NCT02581631|64255525|FG003|Overall Study|Disease progression|5|||
23138586|NCT02581631|64255526|FG004|Overall Study|Disease progression|8|||
23138587|NCT02581631|64255522|FG000|Overall Study|Study drug toxicity|4|||
23138588|NCT02581631|64255523|FG001|Overall Study|Study drug toxicity|6|||
23138589|NCT02581631|64255524|FG002|Overall Study|Study drug toxicity|7|||
23138590|NCT02581631|64255525|FG003|Overall Study|Study drug toxicity|0|||
23138591|NCT02581631|64255526|FG004|Overall Study|Study drug toxicity|3|||
23138592|NCT02581631|64255522|FG000|Overall Study|AE unrelated to study drug|3|||
23138593|NCT02581631|64255523|FG001|Overall Study|AE unrelated to study drug|1|||
23431735|NCT01927055|65324148|FG001|Open-label|Study Stopped|0|||
23431736|NCT01927055|65324149|FG002|Open-label|Study Stopped|0|||
23431737|NCT01927055|65324147|FG000|Open-label|Supine Hypertension|4|||
23431738|NCT01927055|65324148|FG001|Open-label|Supine Hypertension|0|||
23431739|NCT01927055|65324149|FG002|Open-label|Supine Hypertension|0|||
23431740|NCT01927055|65324147|FG000|Open-label|Difficulty attending study visits|1|||
23431741|NCT01927055|65324148|FG001|Open-label|Difficulty attending study visits|0|||
23431742|NCT01927055|65324149|FG002|Open-label|Difficulty attending study visits|0|||
23431743|NCT01927055|65324147|FG000|Double-Blind|Adverse Event|0|||
23431744|NCT01927055|65324148|FG001|Double-Blind|Adverse Event|1|||
23431745|NCT01927055|65324149|FG002|Double-Blind|Adverse Event|1|||
23431746|NCT01927055|65324147|FG000|Double-Blind|Protocol Violation|0|||
23215521|NCT02088541|64531200|FG000|Overall Study|Death|51|||
23215522|NCT02088541|64531201|FG001|Overall Study|Death|21|||
23215523|NCT02088541|64531202|FG002|Overall Study|Death|85|||
23215524|NCT02088541|64531203|FG003|Overall Study|Death|28|||
23215525|NCT02088541|64531204|FG004|Overall Study|Death|38|||
23215526|NCT02088541|64531200|FG000|Overall Study|Lost to Follow-up|2|||
23138594|NCT02581631|64255524|FG002|Overall Study|AE unrelated to study drug|1|||
23138595|NCT02581631|64255525|FG003|Overall Study|AE unrelated to study drug|0|||
23317787|NCT00489255|64908156|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
23317788|NCT00489255|64908157|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
23317789|NCT00489255|64908156|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
23317790|NCT00489255|64908157|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
23138596|NCT02581631|64255526|FG004|Overall Study|AE unrelated to study drug|2|||
23138597|NCT02581631|64255522|FG000|Overall Study|Request to discontinue|1|||
23138598|NCT02581631|64255523|FG001|Overall Study|Request to discontinue|0|||
23138599|NCT02581631|64255524|FG002|Overall Study|Request to discontinue|3|||
23138600|NCT02581631|64255525|FG003|Overall Study|Request to discontinue|0|||
23138601|NCT02581631|64255526|FG004|Overall Study|Request to discontinue|1|||
23138602|NCT02581631|64255522|FG000|Overall Study|participant withdrew consent|3|||
23138603|NCT02581631|64255523|FG001|Overall Study|participant withdrew consent|0|||
23138604|NCT02581631|64255524|FG002|Overall Study|participant withdrew consent|1|||
23215527|NCT02088541|64531201|FG001|Overall Study|Lost to Follow-up|0|||
23215528|NCT02088541|64531202|FG002|Overall Study|Lost to Follow-up|1|||
23317791|NCT00489255|64908156|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
23317792|NCT00489255|64908157|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
23317793|NCT00489255|64908156|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
23552899|NCT04004611|65751264|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552900|NCT04004611|65751265|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552901|NCT04004611|65751266|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
23552902|NCT04004611|65751258|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23317794|NCT00489255|64908157|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
23317795|NCT00489255|64908156|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
23317796|NCT00489255|64908157|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
23431747|NCT01927055|65324148|FG001|Double-Blind|Protocol Violation|0|||
23552903|NCT04004611|65751259|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
23552904|NCT04004611|65751260|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552905|NCT04004611|65751261|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552906|NCT04004611|65751262|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552907|NCT04004611|65751263|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552908|NCT04004611|65751264|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552909|NCT04004611|65751265|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552910|NCT04004611|65751266|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
23552911|NCT00419263|65751267|FG000|Overall Study|Lost to Follow-up|2|||
23552912|NCT00419263|65751268|FG001|Overall Study|Lost to Follow-up|1|||
23552913|NCT00419263|65751269|FG002|Overall Study|Lost to Follow-up|1|||
23552914|NCT00419263|65751267|FG000|Overall Study|Randomized in Error, Not Treated|1|||
23552915|NCT00419263|65751268|FG001|Overall Study|Randomized in Error, Not Treated|1|||
23552916|NCT00419263|65751269|FG002|Overall Study|Randomized in Error, Not Treated|0|||
23552917|NCT00419263|65751267|FG000|Overall Study|Adverse Event|0|||
23552918|NCT00419263|65751268|FG001|Overall Study|Adverse Event|0|||
23552919|NCT00419263|65751269|FG002|Overall Study|Adverse Event|1|||
23552920|NCT00419263|65751267|FG000|Overall Study|Withdrawal by Subject|0|||
23552921|NCT00419263|65751268|FG001|Overall Study|Withdrawal by Subject|0|||
23552922|NCT00419263|65751269|FG002|Overall Study|Withdrawal by Subject|1|||
23552923|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
23552924|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
23552925|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
23552926|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
23552927|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
23552928|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
23552929|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
23317797|NCT00489255|64908156|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
23317798|NCT00489255|64908157|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
23317799|NCT00489255|64908156|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
23431748|NCT01927055|65324149|FG002|Double-Blind|Protocol Violation|1|||
23138605|NCT02581631|64255525|FG003|Overall Study|participant withdrew consent|0|||
23138606|NCT02581631|64255526|FG004|Overall Study|participant withdrew consent|0|||
23552930|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
23138607|NCT02581631|64255522|FG000|Overall Study|Maximum clinical benefit|1|||
23138608|NCT02581631|64255523|FG001|Overall Study|Maximum clinical benefit|7|||
23138609|NCT02581631|64255524|FG002|Overall Study|Maximum clinical benefit|1|||
23215529|NCT02088541|64531203|FG003|Overall Study|Lost to Follow-up|0|||
23215530|NCT02088541|64531204|FG004|Overall Study|Lost to Follow-up|0|||
23215531|NCT02088541|64531200|FG000|Overall Study|Physician Decision|2|||
23215532|NCT02088541|64531201|FG001|Overall Study|Physician Decision|1|||
23215533|NCT02088541|64531202|FG002|Overall Study|Physician Decision|2|||
23621621|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
23621622|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
23621623|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
23621624|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23215534|NCT02088541|64531203|FG003|Overall Study|Physician Decision|0|||
23215535|NCT02088541|64531204|FG004|Overall Study|Physician Decision|2|||
23215536|NCT02088541|64531200|FG000|Overall Study|Disease progression|7|||
23621625|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23138610|NCT02581631|64255525|FG003|Overall Study|Maximum clinical benefit|3|||
23138611|NCT02581631|64255526|FG004|Overall Study|Maximum clinical benefit|13|||
23138612|NCT02581631|64255522|FG000|Overall Study|Other Reasons|1|||
23138613|NCT02581631|64255523|FG001|Overall Study|Other Reasons|0|||
23138614|NCT02581631|64255524|FG002|Overall Study|Other Reasons|2|||
23138615|NCT02581631|64255525|FG003|Overall Study|Other Reasons|2|||
23138616|NCT02581631|64255526|FG004|Overall Study|Other Reasons|3|||
23138617|NCT02581631|64255522|FG000|Overall Study|Poor/Non-Compliance|0|||
23138618|NCT02581631|64255523|FG001|Overall Study|Poor/Non-Compliance|0|||
23138619|NCT02581631|64255524|FG002|Overall Study|Poor/Non-Compliance|1|||
23138620|NCT02581631|64255525|FG003|Overall Study|Poor/Non-Compliance|0|||
23138621|NCT02581631|64255526|FG004|Overall Study|Poor/Non-Compliance|0|||
23138622|NCT03459443|64255527|FG000|Overall Study|Lack of Efficacy|3|||
23138623|NCT03459443|64255527|FG000|Overall Study|Adverse Event|1|||
23138624|NCT03459443|64255527|FG000|Overall Study|Sponsor's decision to close the study|18|||
23138625|NCT03606668|64255531|FG000|Overall Study|Screen Failure|1|||
23138626|NCT03606668|64255531|FG000|Overall Study|Lost to Follow-up|1|||
23138627|NCT00346632|64255534|FG000|Overall Study|Progressive Disease|2|||
23138628|NCT00346632|64255535|FG001|Overall Study|Progressive Disease|2|||
23138629|NCT00346632|64255536|FG002|Overall Study|Progressive Disease|4|||
23138630|NCT00346632|64255537|FG003|Overall Study|Progressive Disease|3|||
23138631|NCT00346632|64255538|FG004|Overall Study|Progressive Disease|3|||
23138632|NCT00346632|64255539|FG005|Overall Study|Progressive Disease|1|||
23138633|NCT00346632|64255540|FG006|Overall Study|Progressive Disease|2|||
23138634|NCT00346632|64255541|FG007|Overall Study|Progressive Disease|2|||
23138635|NCT00346632|64255542|FG008|Overall Study|Progressive Disease|2|||
23138636|NCT00346632|64255543|FG009|Overall Study|Progressive Disease|2|||
23138637|NCT00346632|64255534|FG000|Overall Study|Adverse Event|0|||
23138638|NCT00346632|64255535|FG001|Overall Study|Adverse Event|0|||
23138639|NCT00346632|64255536|FG002|Overall Study|Adverse Event|0|||
23138640|NCT00346632|64255537|FG003|Overall Study|Adverse Event|0|||
23138641|NCT00346632|64255538|FG004|Overall Study|Adverse Event|1|||
23138642|NCT00346632|64255539|FG005|Overall Study|Adverse Event|1|||
23138643|NCT00346632|64255540|FG006|Overall Study|Adverse Event|1|||
23138644|NCT00346632|64255541|FG007|Overall Study|Adverse Event|0|||
23138645|NCT00346632|64255542|FG008|Overall Study|Adverse Event|0|||
23138646|NCT00346632|64255543|FG009|Overall Study|Adverse Event|0|||
23138647|NCT00346632|64255534|FG000|Overall Study|Death|0|||
23138648|NCT00346632|64255535|FG001|Overall Study|Death|0|||
23138649|NCT00346632|64255536|FG002|Overall Study|Death|1|||
23138650|NCT00346632|64255537|FG003|Overall Study|Death|0|||
23138651|NCT00346632|64255538|FG004|Overall Study|Death|0|||
23138652|NCT00346632|64255539|FG005|Overall Study|Death|0|||
23138653|NCT00346632|64255540|FG006|Overall Study|Death|0|||
23138654|NCT00346632|64255541|FG007|Overall Study|Death|0|||
23138655|NCT00346632|64255542|FG008|Overall Study|Death|0|||
23215537|NCT02088541|64531201|FG001|Overall Study|Disease progression|1|||
23215538|NCT02088541|64531202|FG002|Overall Study|Disease progression|2|||
23215539|NCT02088541|64531203|FG003|Overall Study|Disease progression|3|||
23215540|NCT02088541|64531204|FG004|Overall Study|Disease progression|1|||
23215541|NCT02088541|64531200|FG000|Overall Study|Study terminated by sponsor|1|||
23215542|NCT02088541|64531201|FG001|Overall Study|Study terminated by sponsor|1|||
23138656|NCT00346632|64255543|FG009|Overall Study|Death|0|||
23138657|NCT00346632|64255534|FG000|Overall Study|Protocol Violation|0|||
23138658|NCT00346632|64255535|FG001|Overall Study|Protocol Violation|0|||
23138659|NCT00346632|64255536|FG002|Overall Study|Protocol Violation|0|||
23138660|NCT00346632|64255537|FG003|Overall Study|Protocol Violation|0|||
23138661|NCT00346632|64255538|FG004|Overall Study|Protocol Violation|0|||
23138662|NCT00346632|64255539|FG005|Overall Study|Protocol Violation|0|||
23138663|NCT00346632|64255540|FG006|Overall Study|Protocol Violation|1|||
23138664|NCT00346632|64255541|FG007|Overall Study|Protocol Violation|0|||
23138665|NCT00346632|64255542|FG008|Overall Study|Protocol Violation|0|||
23138666|NCT00346632|64255543|FG009|Overall Study|Protocol Violation|0|||
23138667|NCT00346632|64255534|FG000|Overall Study|Withdrawal by Subject|0|||
23138668|NCT00346632|64255535|FG001|Overall Study|Withdrawal by Subject|0|||
23138669|NCT00346632|64255536|FG002|Overall Study|Withdrawal by Subject|0|||
23621626|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
23621627|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
23621628|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23621629|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23621630|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23621631|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
23621632|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
23621633|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
23621634|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
23621635|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
23621636|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
23621637|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
23621638|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
23621639|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
23621640|NCT00937521|66000724|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
23621641|NCT00937521|66000725|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621642|NCT00937521|66000726|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621643|NCT00937521|66000727|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621644|NCT00937521|66000728|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621645|NCT00937521|66000729|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621646|NCT00937521|66000730|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
23621647|NCT00937521|66000731|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
23621648|NCT00937521|66000724|FG000|Booster Phase|Adverse Event|0|||
23621649|NCT00937521|66000725|FG001|Booster Phase|Adverse Event|0|||
23621650|NCT00937521|66000726|FG002|Booster Phase|Adverse Event|0|||
23621651|NCT00937521|66000727|FG003|Booster Phase|Adverse Event|0|||
23621652|NCT00937521|66000728|FG004|Booster Phase|Adverse Event|0|||
23621653|NCT00937521|66000729|FG005|Booster Phase|Adverse Event|0|||
23621654|NCT00937521|66000730|FG006|Booster Phase|Adverse Event|1|||
23621655|NCT00937521|66000731|FG007|Booster Phase|Adverse Event|0|||
23621656|NCT00937521|66000724|FG000|Booster Phase|Withdrawal by Subject|1|||
23621657|NCT00937521|66000725|FG001|Booster Phase|Withdrawal by Subject|0|||
23621658|NCT00937521|66000726|FG002|Booster Phase|Withdrawal by Subject|0|||
23431749|NCT01927055|65324147|FG000|Double-Blind|Withdrawal by Subject|0|||
23431750|NCT01927055|65324148|FG001|Double-Blind|Withdrawal by Subject|2|||
23621659|NCT00937521|66000727|FG003|Booster Phase|Withdrawal by Subject|1|||
23621660|NCT00937521|66000728|FG004|Booster Phase|Withdrawal by Subject|0|||
23621661|NCT00937521|66000729|FG005|Booster Phase|Withdrawal by Subject|0|||
23621662|NCT00937521|66000730|FG006|Booster Phase|Withdrawal by Subject|0|||
23621663|NCT00937521|66000731|FG007|Booster Phase|Withdrawal by Subject|2|||
23621664|NCT00937521|66000724|FG000|Booster Phase|Lost to Follow-up|2|||
23621665|NCT00937521|66000725|FG001|Booster Phase|Lost to Follow-up|2|||
23621666|NCT00937521|66000726|FG002|Booster Phase|Lost to Follow-up|4|||
23621667|NCT00937521|66000727|FG003|Booster Phase|Lost to Follow-up|2|||
23138670|NCT00346632|64255537|FG003|Overall Study|Withdrawal by Subject|0|||
23138671|NCT00346632|64255538|FG004|Overall Study|Withdrawal by Subject|0|||
23138672|NCT00346632|64255539|FG005|Overall Study|Withdrawal by Subject|0|||
23138673|NCT00346632|64255540|FG006|Overall Study|Withdrawal by Subject|1|||
23138674|NCT00346632|64255541|FG007|Overall Study|Withdrawal by Subject|0|||
23138675|NCT00346632|64255542|FG008|Overall Study|Withdrawal by Subject|0|||
23138676|NCT00346632|64255543|FG009|Overall Study|Withdrawal by Subject|0|||
23138677|NCT00346632|64255534|FG000|Overall Study|Switched to alternative treatment|0|||
23138678|NCT00346632|64255535|FG001|Overall Study|Switched to alternative treatment|0|||
23138679|NCT00346632|64255536|FG002|Overall Study|Switched to alternative treatment|1|||
23138680|NCT00346632|64255537|FG003|Overall Study|Switched to alternative treatment|0|||
23138681|NCT00346632|64255538|FG004|Overall Study|Switched to alternative treatment|0|||
23138682|NCT00346632|64255539|FG005|Overall Study|Switched to alternative treatment|0|||
23138683|NCT00346632|64255540|FG006|Overall Study|Switched to alternative treatment|0|||
23138684|NCT00346632|64255541|FG007|Overall Study|Switched to alternative treatment|0|||
23138685|NCT00346632|64255542|FG008|Overall Study|Switched to alternative treatment|0|||
23138686|NCT00346632|64255543|FG009|Overall Study|Switched to alternative treatment|0|||
23138687|NCT00346632|64255534|FG000|Overall Study|Not Stated|1|||
23138688|NCT00346632|64255535|FG001|Overall Study|Not Stated|1|||
23138689|NCT00346632|64255536|FG002|Overall Study|Not Stated|0|||
23138690|NCT00346632|64255537|FG003|Overall Study|Not Stated|0|||
23431751|NCT01927055|65324149|FG002|Double-Blind|Withdrawal by Subject|3|||
23431752|NCT01927055|65324147|FG000|Double-Blind|Study Stopped|0|||
23621668|NCT00937521|66000728|FG004|Booster Phase|Lost to Follow-up|4|||
23621669|NCT00937521|66000729|FG005|Booster Phase|Lost to Follow-up|4|||
23138691|NCT00346632|64255538|FG004|Overall Study|Not Stated|0|||
23138692|NCT00346632|64255539|FG005|Overall Study|Not Stated|0|||
23138693|NCT00346632|64255540|FG006|Overall Study|Not Stated|0|||
23138694|NCT00346632|64255541|FG007|Overall Study|Not Stated|2|||
23215543|NCT02088541|64531202|FG002|Overall Study|Study terminated by sponsor|12|||
23215544|NCT02088541|64531203|FG003|Overall Study|Study terminated by sponsor|2|||
23215545|NCT02088541|64531204|FG004|Overall Study|Study terminated by sponsor|6|||
23215546|NCT02088541|64531200|FG000|Overall Study|Withdrawal by Subject|3|||
23215547|NCT02088541|64531201|FG001|Overall Study|Withdrawal by Subject|2|||
23215548|NCT02088541|64531202|FG002|Overall Study|Withdrawal by Subject|9|||
23215549|NCT02088541|64531203|FG003|Overall Study|Withdrawal by Subject|7|||
23215550|NCT02088541|64531204|FG004|Overall Study|Withdrawal by Subject|10|||
23215551|NCT02088541|64531200|FG000|Overall Study|Other|2|||
23215552|NCT02088541|64531201|FG001|Overall Study|Other|1|||
23317800|NCT00489255|64908157|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
23317801|NCT00489255|64908156|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
23317802|NCT00489255|64908157|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
23552931|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
23138695|NCT00346632|64255542|FG008|Overall Study|Not Stated|2|||
23138696|NCT00346632|64255543|FG009|Overall Study|Not Stated|1|||
23138697|NCT02075073|64255545|FG000|Overall Study|Withdrawal by Subject|0|||
23138698|NCT02075073|64255546|FG001|Overall Study|Withdrawal by Subject|1|||
23138699|NCT02075073|64255547|FG002|Overall Study|Withdrawal by Subject|0|||
23138700|NCT00744757|64255548|FG000|Overall Study|Objective disease progression|7|||
23138701|NCT00744757|64255548|FG000|Overall Study|Physician Decision|5|||
23138702|NCT00744757|64255548|FG000|Overall Study|Withdrawal by Subject|1|||
23138703|NCT00744757|64255548|FG000|Overall Study|Death|6|||
23138704|NCT00744757|64255548|FG000|Overall Study|Adverse Event|2|||
23138705|NCT02245737|64255549|FG000|Overall Study|Adverse Event|23|||
23138706|NCT02245737|64255550|FG001|Overall Study|Adverse Event|26|||
23138707|NCT02245737|64255551|FG002|Overall Study|Adverse Event|33|||
23138708|NCT02245737|64255549|FG000|Overall Study|Condition Worsened|9|||
23138709|NCT02245737|64255550|FG001|Overall Study|Condition Worsened|10|||
23138710|NCT02245737|64255551|FG002|Overall Study|Condition Worsened|9|||
23138711|NCT02245737|64255549|FG000|Overall Study|Death|2|||
23138712|NCT02245737|64255550|FG001|Overall Study|Death|4|||
23138713|NCT02245737|64255551|FG002|Overall Study|Death|4|||
23138714|NCT02245737|64255549|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
23138715|NCT02245737|64255550|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
23138716|NCT02245737|64255551|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
23138717|NCT02245737|64255549|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
23138718|NCT02245737|64255550|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
23138719|NCT02245737|64255551|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
23138720|NCT02245737|64255549|FG000|Overall Study|Lost to Follow-up|2|||
23138721|NCT02245737|64255550|FG001|Overall Study|Lost to Follow-up|5|||
23138722|NCT02245737|64255551|FG002|Overall Study|Lost to Follow-up|4|||
23138723|NCT02245737|64255549|FG000|Overall Study|Other-determined by Investigator|9|||
23138724|NCT02245737|64255550|FG001|Overall Study|Other-determined by Investigator|10|||
23138725|NCT02245737|64255551|FG002|Overall Study|Other-determined by Investigator|10|||
23138726|NCT02245737|64255549|FG000|Overall Study|Physician Decision|6|||
23138727|NCT02245737|64255550|FG001|Overall Study|Physician Decision|3|||
23138728|NCT02245737|64255551|FG002|Overall Study|Physician Decision|6|||
23138729|NCT02245737|64255549|FG000|Overall Study|Protocol Violation|3|||
23138730|NCT02245737|64255550|FG001|Overall Study|Protocol Violation|2|||
23138731|NCT02245737|64255551|FG002|Overall Study|Protocol Violation|3|||
23138732|NCT02245737|64255549|FG000|Overall Study|Withdrawal by Subject|40|||
23138733|NCT02245737|64255550|FG001|Overall Study|Withdrawal by Subject|41|||
23215553|NCT02088541|64531202|FG002|Overall Study|Other|3|||
23552932|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
23552933|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
23552934|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
23552935|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
23552936|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
23552937|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
23552938|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
23552939|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
23552940|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
23552941|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
23552942|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
23552943|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
23552944|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
23552945|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
23552946|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
23552947|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
23138734|NCT02245737|64255551|FG002|Overall Study|Withdrawal by Subject|44|||
23138735|NCT02245737|64255549|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
23138736|NCT02245737|64255550|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
23138737|NCT02245737|64255551|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
23552948|NCT01662310|65751270|FG000|Run-In or Stabilization Phase|Other|1|||
23431753|NCT01927055|65324148|FG001|Double-Blind|Study Stopped|7|||
23431754|NCT01927055|65324149|FG002|Double-Blind|Study Stopped|7|||
23552949|NCT01662310|65751271|FG001|Run-In or Stabilization Phase|Other|0|||
23552950|NCT01662310|65751272|FG002|Run-In or Stabilization Phase|Other|0|||
23552951|NCT01662310|65751273|FG003|Run-In or Stabilization Phase|Other|0|||
23552952|NCT01662310|65751274|FG004|Run-In or Stabilization Phase|Other|0|||
23552953|NCT01662310|65751270|FG000|Double-Blind Phase|Adverse Event|0|||
23552954|NCT01662310|65751271|FG001|Double-Blind Phase|Adverse Event|0|||
23138738|NCT02245737|64255549|FG000|Overall Study|Sponsor Decision|445|||
23138739|NCT02245737|64255550|FG001|Overall Study|Sponsor Decision|430|||
23138740|NCT02245737|64255551|FG002|Overall Study|Sponsor Decision|432|||
23138741|NCT03702231|64255552|FG000|Overall Study|Withdrawal by Subject|1|||
23138742|NCT03702231|64255553|FG001|Overall Study|Withdrawal by Subject|0|||
23138743|NCT03702231|64255554|FG002|Overall Study|Withdrawal by Subject|0|||
23138744|NCT03702231|64255552|FG000|Overall Study|Protocol Violation|0|||
23138745|NCT03702231|64255553|FG001|Overall Study|Protocol Violation|0|||
23138746|NCT03702231|64255554|FG002|Overall Study|Protocol Violation|1|||
23138747|NCT03702231|64255552|FG000|Overall Study|Change in CLL Treatment|0|||
23138748|NCT03702231|64255553|FG001|Overall Study|Change in CLL Treatment|0|||
23138749|NCT03702231|64255554|FG002|Overall Study|Change in CLL Treatment|1|||
23138750|NCT03702231|64255552|FG000|Overall Study|COVID Pandemic|1|||
23138751|NCT03702231|64255553|FG001|Overall Study|COVID Pandemic|4|||
23138752|NCT03702231|64255554|FG002|Overall Study|COVID Pandemic|1|||
23138753|NCT03702231|64255552|FG000|Overall Study|Non-compliance|0|||
23138754|NCT03702231|64255553|FG001|Overall Study|Non-compliance|0|||
23138755|NCT03702231|64255554|FG002|Overall Study|Non-compliance|1|||
23138756|NCT00993668|64255557|FG000|Single-Blind Period|Adverse Event|1|||
23138757|NCT00993668|64255558|FG001|Single-Blind Period|Adverse Event|1|||
23215554|NCT02088541|64531203|FG003|Overall Study|Other|1|||
23215555|NCT02088541|64531204|FG004|Overall Study|Other|1|||
23215556|NCT01255306|64531215|FG000|Overall Study|Physician Decision|1|||
23215557|NCT01255306|64531216|FG001|Overall Study|Physician Decision|1|||
23215558|NCT04992546|64531217|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
23215559|NCT04992546|64531217|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
23215560|NCT04992546|64531217|FG000|Open-Label Treatment Period|Adverse Event|3|||
23215561|NCT04992546|64531217|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
23215562|NCT00884221|64531218|FG000|Overall Study|Withdrawal by Subject|0|||
23215563|NCT00884221|64531219|FG001|Overall Study|Withdrawal by Subject|3|||
23215564|NCT00884221|64531218|FG000|Overall Study|Adverse Event|6|||
23215565|NCT00884221|64531219|FG001|Overall Study|Adverse Event|3|||
23215566|NCT00884221|64531218|FG000|Overall Study|Protocol Violation|16|||
23215567|NCT00884221|64531219|FG001|Overall Study|Protocol Violation|13|||
23215568|NCT00884221|64531218|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
23215569|NCT00884221|64531219|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
23215570|NCT01148693|64531220|FG000|Overall Study|Attempts for cannulation were failed|13|||
23215571|NCT01148693|64531221|FG001|Overall Study|Attempts for cannulation were failed|10|||
23215572|NCT00089999|64531222|FG000|Overall Study|Adverse Event|4|||
23215573|NCT00089999|64531223|FG001|Overall Study|Adverse Event|7|||
23215574|NCT00089999|64531222|FG000|Overall Study|Withdrawal by Subject|0|||
23215575|NCT00089999|64531223|FG001|Overall Study|Withdrawal by Subject|4|||
23215576|NCT00089999|64531222|FG000|Overall Study|Lost to Follow-up|2|||
23215577|NCT00089999|64531223|FG001|Overall Study|Lost to Follow-up|1|||
23215578|NCT00089999|64531222|FG000|Overall Study|Radiological Progression of Cancer|52|||
23215579|NCT00089999|64531223|FG001|Overall Study|Radiological Progression of Cancer|44|||
23215580|NCT00089999|64531222|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
23215581|NCT00089999|64531223|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
23215582|NCT00089999|64531222|FG000|Overall Study|Death|3|||
23215583|NCT00089999|64531223|FG001|Overall Study|Death|3|||
23215584|NCT00089999|64531222|FG000|Overall Study|Poor General Condition|1|||
23215585|NCT00089999|64531223|FG001|Overall Study|Poor General Condition|0|||
23215586|NCT00089999|64531222|FG000|Overall Study|Clinical Progression|1|||
23138758|NCT00993668|64255557|FG000|Single-Blind Period|Lack of Efficacy|0|||
23138759|NCT00993668|64255558|FG001|Single-Blind Period|Lack of Efficacy|1|||
23215587|NCT00089999|64531223|FG001|Overall Study|Clinical Progression|2|||
23215588|NCT00089999|64531222|FG000|Overall Study|Physician Decision|2|||
23552955|NCT01662310|65751272|FG002|Double-Blind Phase|Adverse Event|1|||
23552956|NCT01662310|65751273|FG003|Double-Blind Phase|Adverse Event|0|||
23138760|NCT00993668|64255557|FG000|Single-Blind Period|Lost to Follow-up|3|||
23138761|NCT00993668|64255558|FG001|Single-Blind Period|Lost to Follow-up|1|||
23138762|NCT00993668|64255557|FG000|Open-Label Period|Adverse Event|9|||
23138763|NCT00993668|64255558|FG001|Open-Label Period|Adverse Event|8|||
23138764|NCT00993668|64255557|FG000|Open-Label Period|Lack of Efficacy|4|||
23215589|NCT00089999|64531223|FG001|Overall Study|Physician Decision|2|||
23215590|NCT00089999|64531222|FG000|Overall Study|Patient Underwent Surgery|2|||
23215591|NCT00089999|64531223|FG001|Overall Study|Patient Underwent Surgery|0|||
23552957|NCT01662310|65751274|FG004|Double-Blind Phase|Adverse Event|0|||
23552958|NCT01662310|65751270|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23552959|NCT01662310|65751271|FG001|Double-Blind Phase|Lost to Follow-up|3|||
23552960|NCT01662310|65751272|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23552961|NCT01662310|65751273|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23552962|NCT01662310|65751274|FG004|Double-Blind Phase|Lost to Follow-up|0|||
23552963|NCT01662310|65751270|FG000|Double-Blind Phase|Pregnancy|0|||
23552964|NCT01662310|65751271|FG001|Double-Blind Phase|Pregnancy|2|||
23552965|NCT01662310|65751272|FG002|Double-Blind Phase|Pregnancy|0|||
23552966|NCT01662310|65751273|FG003|Double-Blind Phase|Pregnancy|0|||
23552967|NCT01662310|65751274|FG004|Double-Blind Phase|Pregnancy|0|||
23552968|NCT01662310|65751270|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23552969|NCT01662310|65751271|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
23552970|NCT01662310|65751272|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
23552971|NCT01662310|65751273|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23552972|NCT01662310|65751274|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23552973|NCT01662310|65751270|FG000|Double-Blind Phase|Other|0|||
23552974|NCT01662310|65751271|FG001|Double-Blind Phase|Other|0|||
23552975|NCT01662310|65751272|FG002|Double-Blind Phase|Other|1|||
23552976|NCT01662310|65751273|FG003|Double-Blind Phase|Other|0|||
23552977|NCT01662310|65751274|FG004|Double-Blind Phase|Other|0|||
23552978|NCT01662310|65751270|FG000|Double-Blind Phase|Randomized but not treated|0|||
23552979|NCT01662310|65751271|FG001|Double-Blind Phase|Randomized but not treated|1|||
23138765|NCT00993668|64255558|FG001|Open-Label Period|Lack of Efficacy|3|||
23138766|NCT00993668|64255557|FG000|Open-Label Period|Withdrawal by Subject|4|||
23138767|NCT00993668|64255558|FG001|Open-Label Period|Withdrawal by Subject|3|||
23138768|NCT00993668|64255557|FG000|Open-Label Period|Lost to Follow-up|6|||
23138769|NCT00993668|64255558|FG001|Open-Label Period|Lost to Follow-up|1|||
23138770|NCT01278173|64255559|FG000|Overall Study|Lack of Efficacy|13|||
23138771|NCT01278173|64255559|FG000|Overall Study|Adverse Event|8|||
23138772|NCT01278173|64255559|FG000|Overall Study|Administrative or other reason|4|||
23138773|NCT01278173|64255559|FG000|Overall Study|Protocol Violation|1|||
23138774|NCT01278173|64255559|FG000|Overall Study|Withdrawal by Subject|1|||
23138775|NCT02387970|64255560|FG000|Overall Study|Did not complete 1-year follow up|1|||
23138776|NCT02387970|64255561|FG001|Overall Study|Did not complete 1-year follow up|2|||
23138777|NCT04971681|64255570|FG000|Followup|Lost to Follow-up|1|||
23138778|NCT04971681|64255571|FG001|Followup|Lost to Follow-up|0|||
23138779|NCT00434213|64255572|FG000|Overall Study|Adverse Event|12|||
23138780|NCT00434213|64255572|FG000|Overall Study|Lack of Efficacy|9|||
23138781|NCT00434213|64255572|FG000|Overall Study|Lost to Follow-up|14|||
23138782|NCT00434213|64255572|FG000|Overall Study|Withdrawal by Subject|7|||
23215592|NCT00089999|64531222|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
23215593|NCT00089999|64531223|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
23215594|NCT03363919|64531224|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
23215595|NCT03363919|64531225|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
23215596|NCT03363919|64531224|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
23215597|NCT03363919|64531225|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
23215598|NCT00877006|64531228|FG000|Treatment Period|Death|2|||
23215599|NCT00877006|64531229|FG001|Treatment Period|Death|1|||
23215600|NCT00877006|64531228|FG000|Treatment Period|Adverse Event|10|||
23215601|NCT00877006|64531229|FG001|Treatment Period|Adverse Event|3|||
23215602|NCT00877006|64531228|FG000|Treatment Period|Withdrawal by Subject|2|||
23215603|NCT00877006|64531229|FG001|Treatment Period|Withdrawal by Subject|3|||
23215604|NCT00877006|64531228|FG000|Treatment Period|Protocol Violation|1|||
23215605|NCT00877006|64531229|FG001|Treatment Period|Protocol Violation|0|||
23215606|NCT00877006|64531228|FG000|Treatment Period|Lost to Follow-up|0|||
23215607|NCT00877006|64531229|FG001|Treatment Period|Lost to Follow-up|1|||
23215608|NCT00877006|64531228|FG000|Treatment Period|Disease Progression|1|||
23215609|NCT00877006|64531229|FG001|Treatment Period|Disease Progression|2|||
23215610|NCT00877006|64531228|FG000|Treatment Period|Started New Treatment Regimen|2|||
23215611|NCT00877006|64531229|FG001|Treatment Period|Started New Treatment Regimen|5|||
23215612|NCT00877006|64531228|FG000|Treatment Period|Other|4|||
23215613|NCT00877006|64531229|FG001|Treatment Period|Other|4|||
23215614|NCT00877006|64531228|FG000|Treatment Period|Randomized but Not Treated|3|||
23215615|NCT00877006|64531229|FG001|Treatment Period|Randomized but Not Treated|8|||
23215616|NCT00877006|64531228|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
23552980|NCT01662310|65751272|FG002|Double-Blind Phase|Randomized but not treated|0|||
23552981|NCT01662310|65751273|FG003|Double-Blind Phase|Randomized but not treated|0|||
23552982|NCT01662310|65751274|FG004|Double-Blind Phase|Randomized but not treated|0|||
23138783|NCT00434213|64255572|FG000|Overall Study|Protocol Violation|3|||
23138784|NCT00434213|64255572|FG000|Overall Study|Unable to comply with study visit window|2|||
23138785|NCT00434213|64255572|FG000|Overall Study|Application site reaction|1|||
23138786|NCT00434213|64255572|FG000|Overall Study|Non-compliant to study schedule|1|||
23552983|NCT01662310|65751270|FG000|Open-Label Extension Phase|Adverse Event|0|||
23552984|NCT01662310|65751271|FG001|Open-Label Extension Phase|Adverse Event|0|||
23552985|NCT01662310|65751272|FG002|Open-Label Extension Phase|Adverse Event|0|||
23552986|NCT01662310|65751273|FG003|Open-Label Extension Phase|Adverse Event|3|||
23552987|NCT01662310|65751274|FG004|Open-Label Extension Phase|Adverse Event|0|||
23552988|NCT01662310|65751270|FG000|Open-Label Extension Phase|Death|0|||
23552989|NCT01662310|65751271|FG001|Open-Label Extension Phase|Death|0|||
23552990|NCT01662310|65751272|FG002|Open-Label Extension Phase|Death|0|||
23317803|NCT00489255|64908156|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
23621670|NCT00937521|66000730|FG006|Booster Phase|Lost to Follow-up|3|||
23317804|NCT00489255|64908157|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
23552991|NCT01662310|65751273|FG003|Open-Label Extension Phase|Death|1|||
23552992|NCT01662310|65751274|FG004|Open-Label Extension Phase|Death|0|||
23552993|NCT01662310|65751270|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
23552994|NCT01662310|65751271|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
23552995|NCT01662310|65751272|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
23552996|NCT01662310|65751273|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
23552997|NCT01662310|65751274|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
23552998|NCT01662310|65751270|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23552999|NCT01662310|65751271|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23553000|NCT01662310|65751272|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23553001|NCT01662310|65751273|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
23553002|NCT01662310|65751274|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
23621671|NCT00937521|66000731|FG007|Booster Phase|Lost to Follow-up|0|||
23621672|NCT00937521|66000724|FG000|Booster Phase|Administrative Reason|0|||
23621673|NCT00937521|66000725|FG001|Booster Phase|Administrative Reason|0|||
23621674|NCT00937521|66000726|FG002|Booster Phase|Administrative Reason|1|||
23621675|NCT00937521|66000727|FG003|Booster Phase|Administrative Reason|0|||
23621676|NCT00937521|66000728|FG004|Booster Phase|Administrative Reason|1|||
23621677|NCT00937521|66000729|FG005|Booster Phase|Administrative Reason|1|||
23621678|NCT00937521|66000730|FG006|Booster Phase|Administrative Reason|0|||
23621679|NCT00937521|66000731|FG007|Booster Phase|Administrative Reason|0|||
23621680|NCT00937521|66000724|FG000|Booster Phase|Protocol Deviation|0|||
23621681|NCT00937521|66000725|FG001|Booster Phase|Protocol Deviation|0|||
23621682|NCT00937521|66000726|FG002|Booster Phase|Protocol Deviation|0|||
23138787|NCT00752557|64255573|FG000|Overall Study|Withdrawal by Subject|4|||
23138788|NCT00752557|64255574|FG001|Overall Study|Withdrawal by Subject|3|||
23138789|NCT00752557|64255575|FG002|Overall Study|Withdrawal by Subject|3|||
23138790|NCT00752557|64255573|FG000|Overall Study|Unspecified resaons|0|||
23138791|NCT00752557|64255574|FG001|Overall Study|Unspecified resaons|2|||
23138792|NCT00752557|64255575|FG002|Overall Study|Unspecified resaons|2|||
23138793|NCT00752557|64255573|FG000|Overall Study|Lost to Follow-up|1|||
23138794|NCT00752557|64255574|FG001|Overall Study|Lost to Follow-up|0|||
23553003|NCT01662310|65751270|FG000|Open-Label Extension Phase|Pregnancy|0|||
23553004|NCT01662310|65751271|FG001|Open-Label Extension Phase|Pregnancy|0|||
23553005|NCT01662310|65751272|FG002|Open-Label Extension Phase|Pregnancy|0|||
23553006|NCT01662310|65751273|FG003|Open-Label Extension Phase|Pregnancy|1|||
23553007|NCT01662310|65751274|FG004|Open-Label Extension Phase|Pregnancy|0|||
23553008|NCT01662310|65751270|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
23553009|NCT01662310|65751271|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
23553010|NCT01662310|65751272|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
23553011|NCT01662310|65751273|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
23553012|NCT01662310|65751274|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
23553013|NCT05045625|65751275|FG000|Overall Study|Lost to Follow-up|3|||
23553014|NCT00955357|65751276|FG000|Titration Phase|Adverse Event|9|||
23553015|NCT00955357|65751277|FG001|Titration Phase|Adverse Event|46|||
23553016|NCT00955357|65751276|FG000|Titration Phase|Lack of Efficacy|0|||
23553017|NCT00955357|65751277|FG001|Titration Phase|Lack of Efficacy|2|||
23553018|NCT00955357|65751276|FG000|Titration Phase|Protocol Violation|3|||
23138795|NCT00752557|64255575|FG002|Overall Study|Lost to Follow-up|1|||
23138796|NCT03035201|64255576|FG000|Overall Study|Death|9|||
23138797|NCT03035201|64255577|FG001|Overall Study|Death|12|||
23138798|NCT03035201|64255578|FG002|Overall Study|Death|9|||
23138799|NCT03035201|64255579|FG003|Overall Study|Death|10|||
23138800|NCT03035201|64255576|FG000|Overall Study|Withdrawal by Subject|51|||
23138801|NCT03035201|64255577|FG001|Overall Study|Withdrawal by Subject|49|||
23553019|NCT00955357|65751277|FG001|Titration Phase|Protocol Violation|7|||
23553020|NCT00955357|65751276|FG000|Titration Phase|Lost to Follow-up|1|||
23553021|NCT00955357|65751277|FG001|Titration Phase|Lost to Follow-up|3|||
23553022|NCT00955357|65751276|FG000|Titration Phase|Withdrawal by Subject|3|||
23553023|NCT00955357|65751277|FG001|Titration Phase|Withdrawal by Subject|5|||
23317805|NCT00489255|64908156|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
23553024|NCT00955357|65751276|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
23621683|NCT00937521|66000727|FG003|Booster Phase|Protocol Deviation|0|||
23621684|NCT00937521|66000728|FG004|Booster Phase|Protocol Deviation|0|||
23621685|NCT00937521|66000729|FG005|Booster Phase|Protocol Deviation|0|||
23621686|NCT00937521|66000730|FG006|Booster Phase|Protocol Deviation|1|||
23621687|NCT00937521|66000731|FG007|Booster Phase|Protocol Deviation|0|||
23621688|NCT00264498|66000734|FG000|Randomized Treatment|Death|0|||
23621689|NCT00264498|66000735|FG001|Randomized Treatment|Death|3|||
23621690|NCT00264498|66000734|FG000|Randomized Treatment|Withdrawal by Subject|0|||
23621691|NCT00264498|66000735|FG001|Randomized Treatment|Withdrawal by Subject|1|||
23621692|NCT00264498|66000734|FG000|Randomized Treatment|Objective disease Progression|13|||
23621693|NCT00264498|66000735|FG001|Randomized Treatment|Objective disease Progression|14|||
23621694|NCT00264498|66000734|FG000|Randomized Treatment|Physician Decision|1|||
23621695|NCT00264498|66000735|FG001|Randomized Treatment|Physician Decision|0|||
23621696|NCT00264498|66000734|FG000|Randomized Treatment|Incorrectly randomized|1|||
23138802|NCT03035201|64255578|FG002|Overall Study|Withdrawal by Subject|37|||
23138803|NCT03035201|64255579|FG003|Overall Study|Withdrawal by Subject|46|||
23138804|NCT03035201|64255576|FG000|Overall Study|Lost to Follow-up|67|||
23138805|NCT03035201|64255577|FG001|Overall Study|Lost to Follow-up|51|||
23553025|NCT00955357|65751277|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
23553026|NCT00955357|65751276|FG000|Titration Phase|Study medication not tolerated|0|||
23553027|NCT00955357|65751277|FG001|Titration Phase|Study medication not tolerated|1|||
23553028|NCT00955357|65751276|FG000|Titration Phase|Non compliance to study procedures|0|||
23553029|NCT00955357|65751277|FG001|Titration Phase|Non compliance to study procedures|1|||
23553030|NCT00955357|65751276|FG000|Maintenance Phase|Adverse Event|3|||
23553031|NCT00955357|65751277|FG001|Maintenance Phase|Adverse Event|23|||
23553032|NCT00955357|65751276|FG000|Maintenance Phase|Lack of Efficacy|0|||
23553033|NCT00955357|65751277|FG001|Maintenance Phase|Lack of Efficacy|4|||
23553034|NCT00955357|65751276|FG000|Maintenance Phase|Protocol Violation|2|||
23553035|NCT00955357|65751277|FG001|Maintenance Phase|Protocol Violation|6|||
23553036|NCT00955357|65751276|FG000|Maintenance Phase|Lost to Follow-up|2|||
23553037|NCT00955357|65751277|FG001|Maintenance Phase|Lost to Follow-up|7|||
23138806|NCT03035201|64255578|FG002|Overall Study|Lost to Follow-up|64|||
23138807|NCT03035201|64255579|FG003|Overall Study|Lost to Follow-up|69|||
23138808|NCT01014533|64255580|FG000|Overall Study|Protocol Violation|3|||
23138809|NCT01014533|64255581|FG001|Overall Study|Protocol Violation|2|||
23138810|NCT01014533|64255580|FG000|Overall Study|Withdrawal by Subject|2|||
23138811|NCT01014533|64255581|FG001|Overall Study|Withdrawal by Subject|0|||
23138812|NCT01014533|64255580|FG000|Overall Study|unable to come to appointment|0|||
23138813|NCT01014533|64255581|FG001|Overall Study|unable to come to appointment|3|||
23138814|NCT00712673|64255582|FG000|Overall Study|Adverse Event|3|||
23138815|NCT00712673|64255583|FG001|Overall Study|Adverse Event|3|||
23138816|NCT00712673|64255584|FG002|Overall Study|Adverse Event|21|||
23138817|NCT00712673|64255585|FG003|Overall Study|Adverse Event|26|||
23138818|NCT00712673|64255582|FG000|Overall Study|Lack of Efficacy|2|||
23138819|NCT00712673|64255583|FG001|Overall Study|Lack of Efficacy|8|||
23138820|NCT00712673|64255584|FG002|Overall Study|Lack of Efficacy|8|||
23138821|NCT00712673|64255585|FG003|Overall Study|Lack of Efficacy|6|||
23138822|NCT00712673|64255582|FG000|Overall Study|Poor Compliance to Protocol|3|||
23138823|NCT00712673|64255583|FG001|Overall Study|Poor Compliance to Protocol|3|||
23138824|NCT00712673|64255584|FG002|Overall Study|Poor Compliance to Protocol|4|||
23138825|NCT00712673|64255585|FG003|Overall Study|Poor Compliance to Protocol|16|||
23138826|NCT00712673|64255582|FG000|Overall Study|Lost to Follow-up|1|||
23138827|NCT00712673|64255583|FG001|Overall Study|Lost to Follow-up|0|||
23138828|NCT00712673|64255584|FG002|Overall Study|Lost to Follow-up|2|||
23138829|NCT00712673|64255585|FG003|Overall Study|Lost to Follow-up|0|||
23138830|NCT00712673|64255582|FG000|Overall Study|Withdrawal by Subject|6|||
23138831|NCT00712673|64255583|FG001|Overall Study|Withdrawal by Subject|7|||
23138832|NCT00712673|64255584|FG002|Overall Study|Withdrawal by Subject|15|||
23138833|NCT00712673|64255585|FG003|Overall Study|Withdrawal by Subject|20|||
23138834|NCT00712673|64255582|FG000|Overall Study|Familial and Personal Reasons|5|||
23138835|NCT00712673|64255583|FG001|Overall Study|Familial and Personal Reasons|0|||
23138836|NCT00712673|64255584|FG002|Overall Study|Familial and Personal Reasons|5|||
23138837|NCT00712673|64255585|FG003|Overall Study|Familial and Personal Reasons|2|||
23138838|NCT00712673|64255582|FG000|Overall Study|Investigator's Decision|1|||
23138839|NCT00712673|64255583|FG001|Overall Study|Investigator's Decision|0|||
23138840|NCT00712673|64255584|FG002|Overall Study|Investigator's Decision|0|||
23138841|NCT00712673|64255585|FG003|Overall Study|Investigator's Decision|0|||
23138842|NCT00712673|64255582|FG000|Overall Study|Protocol Violation|0|||
23138843|NCT00712673|64255583|FG001|Overall Study|Protocol Violation|0|||
23553038|NCT00955357|65751276|FG000|Maintenance Phase|Withdrawal by Subject|4|||
23138844|NCT00712673|64255584|FG002|Overall Study|Protocol Violation|2|||
23138845|NCT00712673|64255585|FG003|Overall Study|Protocol Violation|0|||
23138846|NCT01182194|64255587|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
23138847|NCT01182194|64255588|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
23138848|NCT05326815|64255590|FG000|Overall Study|Withdrawal by Subject|3|||
23317806|NCT00489255|64908157|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
23317807|NCT05013008|64908160|FG000|Overall Study|Exclusion from mBFAS|5|||
23553039|NCT00955357|65751277|FG001|Maintenance Phase|Withdrawal by Subject|4|||
23621697|NCT00264498|66000735|FG001|Randomized Treatment|Incorrectly randomized|0|||
23621698|NCT00264498|66000734|FG000|Randomized Treatment|Study Closure|1|||
23621699|NCT00264498|66000735|FG001|Randomized Treatment|Study Closure|0|||
23138849|NCT05326815|64255590|FG000|Overall Study|Did not complete required labs|6|||
23553040|NCT00955357|65751276|FG000|Maintenance Phase|Patient moving out of area|0|||
23553041|NCT00955357|65751277|FG001|Maintenance Phase|Patient moving out of area|1|||
23553042|NCT00955357|65751276|FG000|Maintenance Phase|Non compliance to study procedures|1|||
23553043|NCT00955357|65751277|FG001|Maintenance Phase|Non compliance to study procedures|0|||
23553044|NCT01988779|65751280|FG000|Overall Study|Withdrawal by Subject|2|||
23553045|NCT01988779|65751281|FG001|Overall Study|Withdrawal by Subject|2|||
23553046|NCT01988779|65751280|FG000|Overall Study|Protocol Violation|1|||
23431755|NCT01927055|65324147|FG000|Double-Blind|Supine Hypertension|0|||
23431756|NCT01927055|65324148|FG001|Double-Blind|Supine Hypertension|0|||
23431757|NCT01927055|65324149|FG002|Double-Blind|Supine Hypertension|1|||
23431758|NCT01927055|65324147|FG000|Double-Blind|Extended Vacation|0|||
23553047|NCT01988779|65751281|FG001|Overall Study|Protocol Violation|0|||
23553048|NCT04546581|65751282|FG000|Overall Study|Adverse Event|9|||
23553049|NCT04546581|65751283|FG001|Overall Study|Adverse Event|3|||
23215617|NCT00877006|64531229|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
23215618|NCT00877006|64531228|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
23215619|NCT00877006|64531229|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
23215620|NCT00877006|64531228|FG000|Long-Term Follow-up Period|Death|26|||
23215621|NCT00877006|64531229|FG001|Long-Term Follow-up Period|Death|18|||
23215622|NCT00877006|64531228|FG000|Long-Term Follow-up Period|Other|7|||
23215623|NCT00877006|64531229|FG001|Long-Term Follow-up Period|Other|9|||
23215624|NCT00305604|64531230|FG000|Overall Study|Adverse Event|6|||
23215625|NCT00305604|64531231|FG001|Overall Study|Adverse Event|3|||
23215626|NCT00305604|64531230|FG000|Overall Study|Lack of Efficacy|11|||
23215627|NCT00305604|64531231|FG001|Overall Study|Lack of Efficacy|18|||
23215628|NCT00305604|64531230|FG000|Overall Study|Lost to Follow-up|0|||
23215629|NCT00305604|64531231|FG001|Overall Study|Lost to Follow-up|4|||
23215630|NCT00305604|64531230|FG000|Overall Study|Protocol Violation|2|||
23215631|NCT00305604|64531231|FG001|Overall Study|Protocol Violation|1|||
23431759|NCT01927055|65324148|FG001|Double-Blind|Extended Vacation|1|||
23431760|NCT01927055|65324149|FG002|Double-Blind|Extended Vacation|0|||
23553050|NCT04546581|65751282|FG000|Overall Study|Physician Decision|0|||
23553051|NCT04546581|65751283|FG001|Overall Study|Physician Decision|1|||
23553052|NCT04546581|65751282|FG000|Overall Study|Protocol Violation|1|||
23553053|NCT04546581|65751283|FG001|Overall Study|Protocol Violation|2|||
23553054|NCT04546581|65751282|FG000|Overall Study|Withdrawal by Subject|3|||
23553055|NCT04546581|65751283|FG001|Overall Study|Withdrawal by Subject|7|||
23553056|NCT03561090|65751284|FG000|Overall Study|Adverse Event|11|||
23553057|NCT03561090|65751285|FG001|Overall Study|Adverse Event|7|||
23553058|NCT03561090|65751284|FG000|Overall Study|Non-Compliance With Study Drug|2|||
23553059|NCT03561090|65751285|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23553060|NCT03561090|65751284|FG000|Overall Study|Protocol Violation|2|||
23553061|NCT03561090|65751285|FG001|Overall Study|Protocol Violation|2|||
23553062|NCT03561090|65751284|FG000|Overall Study|Withdrawal by Subject|7|||
23553063|NCT03561090|65751285|FG001|Overall Study|Withdrawal by Subject|7|||
23553064|NCT03561090|65751284|FG000|Overall Study|Lost to Follow-up|7|||
23553065|NCT03561090|65751285|FG001|Overall Study|Lost to Follow-up|2|||
23553066|NCT03561090|65751284|FG000|Overall Study|Study Terminated by Sponsor|10|||
23553067|NCT03561090|65751285|FG001|Overall Study|Study Terminated by Sponsor|15|||
23553068|NCT03561090|65751284|FG000|Overall Study|Randomized by Mistake|1|||
23553069|NCT03561090|65751285|FG001|Overall Study|Randomized by Mistake|1|||
23553070|NCT03561090|65751284|FG000|Overall Study|Other Not Specified|0|||
23553071|NCT03561090|65751285|FG001|Overall Study|Other Not Specified|2|||
23553072|NCT01881126|65751289|FG000|Overall Study|Non-compliance|1|||
23553073|NCT01881126|65751290|FG001|Overall Study|Non-compliance|1|||
23553074|NCT01881126|65751289|FG000|Overall Study|Adverse Event|0|||
23553075|NCT01881126|65751290|FG001|Overall Study|Adverse Event|1|||
23553076|NCT04368429|65751292|FG000|Overall Study|Adverse Event|1|||
23553077|NCT04368429|65751293|FG001|Overall Study|Adverse Event|0|||
23215632|NCT00305604|64531230|FG000|Overall Study|Withdrawal by Subject|12|||
23431761|NCT03369431|65324157|FG000|Overall Study|Lost to Follow-up|1|||
23431762|NCT03369431|65324158|FG001|Overall Study|Lost to Follow-up|3|||
23431763|NCT03369431|65324157|FG000|Overall Study|Withdrawal by Subject|2|||
23431764|NCT03369431|65324158|FG001|Overall Study|Withdrawal by Subject|3|||
23431765|NCT03369431|65324157|FG000|Overall Study|Protocol Violation|1|||
23431766|NCT03369431|65324158|FG001|Overall Study|Protocol Violation|1|||
23553078|NCT03834779|65751294|FG000|Overall Study|Death|1|||
23553079|NCT03834779|65751295|FG001|Overall Study|Death|2|||
23553080|NCT03834779|65751294|FG000|Overall Study|Lost to Follow-up|6|||
23553081|NCT03834779|65751295|FG001|Overall Study|Lost to Follow-up|4|||
23553082|NCT05763628|65751302|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
23553083|NCT05763628|65751303|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
23553084|NCT05763628|65751302|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
23215633|NCT00305604|64531231|FG001|Overall Study|Withdrawal by Subject|21|||
23215634|NCT00305604|64531230|FG000|Overall Study|Patient moved|1|||
23215635|NCT00305604|64531231|FG001|Overall Study|Patient moved|0|||
23215636|NCT01455415|64531232|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
23553085|NCT05763628|65751303|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
23553086|NCT05763628|65751302|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
23553087|NCT05763628|65751303|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
23553088|NCT02794285|65751306|FG000|Overall Study|Adverse Event|11|||
23553089|NCT02794285|65751307|FG001|Overall Study|Adverse Event|4|||
23553090|NCT02794285|65751308|FG002|Overall Study|Adverse Event|5|||
23553091|NCT02794285|65751309|FG003|Overall Study|Adverse Event|8|||
23553092|NCT02794285|65751306|FG000|Overall Study|Condition Under Investigation Improved|1|||
23621700|NCT00264498|66000734|FG000|Randomized Treatment|Protocol Violation|1|||
23621701|NCT00264498|66000735|FG001|Randomized Treatment|Protocol Violation|0|||
23621702|NCT00264498|66000734|FG000|Crossover Treatment|Death|1|||
23215637|NCT01455415|64531233|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
23215638|NCT01455415|64531232|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
23215639|NCT01455415|64531233|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
23215640|NCT01455415|64531232|FG000|Period 1|Drug Error not Associated to AE|0|||
23215641|NCT01455415|64531233|FG001|Period 1|Drug Error not Associated to AE|1|||
23215642|NCT01455415|64531232|FG000|Period 1|AE Not Related to Study Drug|2|||
23215643|NCT01455415|64531233|FG001|Period 1|AE Not Related to Study Drug|6|||
23215644|NCT01455415|64531232|FG000|Period 1|Withdrawal by Subject|4|||
23215645|NCT01455415|64531233|FG001|Period 1|Withdrawal by Subject|5|||
23215646|NCT01455415|64531232|FG000|Period 1|Unspecified Reason|1|||
23215647|NCT01455415|64531233|FG001|Period 1|Unspecified Reason|1|||
23317808|NCT05013008|64908161|FG001|Overall Study|Exclusion from mBFAS|25|||
23317809|NCT00492778|64908162|FG000|Overall Study|Ineligible by Pathology Review|8|||
23317810|NCT00492778|64908163|FG001|Overall Study|Ineligible by Pathology Review|1|||
23317811|NCT00852202|64908164|FG000|Overall Study|Adverse Event|2|||
23317812|NCT00852202|64908165|FG001|Overall Study|Adverse Event|3|||
23317813|NCT00852202|64908166|FG002|Overall Study|Adverse Event|7|||
23317814|NCT00852202|64908164|FG000|Overall Study|Lack of Efficacy|4|||
23317815|NCT00852202|64908165|FG001|Overall Study|Lack of Efficacy|1|||
23317816|NCT00852202|64908166|FG002|Overall Study|Lack of Efficacy|2|||
23317817|NCT00852202|64908164|FG000|Overall Study|Protocol Violation|2|||
23317818|NCT00852202|64908165|FG001|Overall Study|Protocol Violation|2|||
23317819|NCT00852202|64908166|FG002|Overall Study|Protocol Violation|7|||
23317820|NCT00852202|64908164|FG000|Overall Study|Withdrawal by Subject|3|||
23317821|NCT00852202|64908165|FG001|Overall Study|Withdrawal by Subject|1|||
23317822|NCT00852202|64908166|FG002|Overall Study|Withdrawal by Subject|2|||
23317823|NCT00852202|64908164|FG000|Overall Study|Lost to Follow-up|5|||
23317824|NCT00852202|64908165|FG001|Overall Study|Lost to Follow-up|5|||
23317825|NCT00852202|64908166|FG002|Overall Study|Lost to Follow-up|6|||
23317826|NCT00852202|64908164|FG000|Overall Study|pregnancy,moving away and surgery|1|||
23317827|NCT00852202|64908165|FG001|Overall Study|pregnancy,moving away and surgery|0|||
23317828|NCT00852202|64908166|FG002|Overall Study|pregnancy,moving away and surgery|2|||
23317829|NCT00450801|64908167|FG000|Overall Study|Death|1|||
23317830|NCT00911300|64908168|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
23317831|NCT00911300|64908169|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
23317832|NCT00911300|64908168|FG000|Overall Study|Death|1|||
23317833|NCT00911300|64908169|FG001|Overall Study|Death|0|||
23317834|NCT00911300|64908168|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
23317835|NCT00911300|64908169|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
23317836|NCT00911300|64908168|FG000|Overall Study|Adverse Event|14|||
23317837|NCT00911300|64908169|FG001|Overall Study|Adverse Event|6|||
23317838|NCT00911300|64908168|FG000|Overall Study|Protocol Violation|3|||
23317839|NCT00911300|64908169|FG001|Overall Study|Protocol Violation|2|||
23317840|NCT00911300|64908168|FG000|Overall Study|Consent Withdrawn|4|||
23317841|NCT00911300|64908169|FG001|Overall Study|Consent Withdrawn|12|||
23317842|NCT00911300|64908168|FG000|Overall Study|Coronary Angiography Performed|1|||
23317843|NCT00911300|64908169|FG001|Overall Study|Coronary Angiography Performed|0|||
23317844|NCT00911300|64908168|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
23317845|NCT00911300|64908169|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
23317846|NCT00911300|64908168|FG000|Overall Study|Received Commercial Treatment|1|||
23317847|NCT00911300|64908169|FG001|Overall Study|Received Commercial Treatment|0|||
23317848|NCT00911300|64908168|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
23317849|NCT00911300|64908169|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
23317850|NCT00911300|64908168|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
23553093|NCT02794285|65751307|FG001|Overall Study|Condition Under Investigation Improved|0|||
23553094|NCT02794285|65751308|FG002|Overall Study|Condition Under Investigation Improved|0|||
23621703|NCT00264498|66000735|FG001|Crossover Treatment|Death|3|||
23215648|NCT01455415|64531232|FG000|Period 1|Protocol Violation|0|||
23215649|NCT01455415|64531233|FG001|Period 1|Protocol Violation|2|||
23317851|NCT00911300|64908169|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
23317852|NCT00911300|64908168|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
23317853|NCT00911300|64908169|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
23317854|NCT00911300|64908168|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
23317855|NCT00911300|64908169|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
23317856|NCT00911300|64908168|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
23317857|NCT00911300|64908169|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
23317858|NCT00911300|64908168|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
23317859|NCT00911300|64908169|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
23317860|NCT00911300|64908168|FG000|Overall Study|International Normalized Ratio Too High|0|||
23317861|NCT00911300|64908169|FG001|Overall Study|International Normalized Ratio Too High|1|||
23317862|NCT00911300|64908168|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
23317863|NCT00911300|64908169|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
23317864|NCT00911300|64908168|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
23317865|NCT00911300|64908169|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
23317866|NCT00911300|64908168|FG000|Overall Study|Physician Decision|0|||
23317867|NCT00911300|64908169|FG001|Overall Study|Physician Decision|1|||
23317868|NCT00911300|64908168|FG000|Overall Study|Treatment Stopped by Mistake|0|||
23317869|NCT00911300|64908169|FG001|Overall Study|Treatment Stopped by Mistake|1|||
23317870|NCT00911300|64908168|FG000|Overall Study|Randomized; No Study Medication Received|0|||
23317871|NCT00911300|64908169|FG001|Overall Study|Randomized; No Study Medication Received|2|||
23317872|NCT05093829|64908174|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
23317873|NCT05093829|64908175|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
23317874|NCT05093829|64908176|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
23317875|NCT05093829|64908177|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
23317876|NCT05093829|64908178|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
23317877|NCT02046603|64908179|FG000|Overall Study|Other|11|||
23317878|NCT02046603|64908180|FG001|Overall Study|Other|66|||
23317879|NCT02046603|64908179|FG000|Overall Study|Protocol Violation|0|||
23317880|NCT02046603|64908180|FG001|Overall Study|Protocol Violation|1|||
23317881|NCT02046603|64908179|FG000|Overall Study|Participant/legal guardian decision|1|||
23317882|NCT02046603|64908180|FG001|Overall Study|Participant/legal guardian decision|3|||
23317883|NCT02046603|64908179|FG000|Overall Study|Physician Decision|2|||
23317884|NCT02046603|64908180|FG001|Overall Study|Physician Decision|1|||
23317885|NCT02046603|64908179|FG000|Overall Study|Lost to Follow-up|1|||
23317886|NCT02046603|64908180|FG001|Overall Study|Lost to Follow-up|2|||
23317887|NCT02046603|64908179|FG000|Overall Study|Death|0|||
23317888|NCT02046603|64908180|FG001|Overall Study|Death|1|||
23138850|NCT05326815|64255590|FG000|Overall Study|Screen fail- abnormal labs|5|||
23138851|NCT01656733|64255591|FG000|Overall Study|No permission to collect birth outcomes|0|||
23138852|NCT01656733|64255592|FG001|Overall Study|No permission to collect birth outcomes|1|||
23138853|NCT01656733|64255591|FG000|Overall Study|Delivery at another hospital|0|||
23138854|NCT01656733|64255592|FG001|Overall Study|Delivery at another hospital|2|||
23138855|NCT01656733|64255591|FG000|Overall Study|Spontaneous abortion|0|||
23138856|NCT01656733|64255592|FG001|Overall Study|Spontaneous abortion|1|||
23138857|NCT00185965|64255593|FG000|Overall Study|Adverse Event|0|||
23138858|NCT00185965|64255594|FG001|Overall Study|Adverse Event|1|||
23138859|NCT04410523|64255595|FG000|Overall Study|Study terminated by sponsor|1|||
23138860|NCT04410523|64255596|FG001|Overall Study|Study terminated by sponsor|3|||
23138861|NCT04410523|64255597|FG002|Overall Study|Study terminated by sponsor|2|||
23138862|NCT04410523|64255598|FG003|Overall Study|Study terminated by sponsor|6|||
23138863|NCT04410523|64255599|FG004|Overall Study|Study terminated by sponsor|3|||
23138864|NCT04410523|64255600|FG005|Overall Study|Study terminated by sponsor|4|||
23138865|NCT04410523|64255595|FG000|Overall Study|Adverse Event|1|||
23138866|NCT04410523|64255596|FG001|Overall Study|Adverse Event|0|||
23138867|NCT04410523|64255597|FG002|Overall Study|Adverse Event|0|||
23138868|NCT04410523|64255598|FG003|Overall Study|Adverse Event|0|||
23138869|NCT04410523|64255599|FG004|Overall Study|Adverse Event|0|||
23138870|NCT04410523|64255600|FG005|Overall Study|Adverse Event|2|||
23138871|NCT04410523|64255595|FG000|Overall Study|Lost to Follow-up|0|||
23215650|NCT01455415|64531232|FG000|Washout|AE Related to Study Drug|2|||
23215651|NCT01455415|64531233|FG001|Washout|AE Related to Study Drug|0|||
23215652|NCT01455415|64531232|FG000|Washout|Lost to Follow-up|1|||
23215653|NCT01455415|64531233|FG001|Washout|Lost to Follow-up|0|||
23215654|NCT01455415|64531232|FG000|Washout|Drug Error not Associated to AE|2|||
23215655|NCT01455415|64531233|FG001|Washout|Drug Error not Associated to AE|1|||
23215656|NCT01455415|64531232|FG000|Washout|AE Not Related to Study Drug|2|||
23215657|NCT01455415|64531233|FG001|Washout|AE Not Related to Study Drug|3|||
23215658|NCT01455415|64531232|FG000|Washout|Unspecified Reason|1|||
23215659|NCT01455415|64531233|FG001|Washout|Unspecified Reason|2|||
23215660|NCT01455415|64531232|FG000|Washout|Protocol Violation|0|||
23215661|NCT01455415|64531233|FG001|Washout|Protocol Violation|1|||
23215662|NCT01455415|64531232|FG000|Period 2|AE Related to Study Drug|1|||
23215663|NCT01455415|64531233|FG001|Period 2|AE Related to Study Drug|2|||
23215664|NCT01455415|64531232|FG000|Period 2|Lost to Follow-up|2|||
23215665|NCT01455415|64531233|FG001|Period 2|Lost to Follow-up|1|||
23317889|NCT02046603|64908179|FG000|Overall Study|Adverse Event|0|||
23317890|NCT02046603|64908180|FG001|Overall Study|Adverse Event|1|||
23317891|NCT02213510|64908181|FG000|Overall Study|Death|0|||
23553095|NCT02794285|65751309|FG003|Overall Study|Condition Under Investigation Improved|0|||
23553096|NCT02794285|65751306|FG000|Overall Study|Condition Under Investigation Worsened|0|||
23553097|NCT02794285|65751307|FG001|Overall Study|Condition Under Investigation Worsened|2|||
23138872|NCT04410523|64255596|FG001|Overall Study|Lost to Follow-up|1|||
23138873|NCT04410523|64255597|FG002|Overall Study|Lost to Follow-up|0|||
23138874|NCT04410523|64255598|FG003|Overall Study|Lost to Follow-up|0|||
23138875|NCT04410523|64255599|FG004|Overall Study|Lost to Follow-up|0|||
23138876|NCT04410523|64255600|FG005|Overall Study|Lost to Follow-up|0|||
23138877|NCT04410523|64255595|FG000|Overall Study|Physician Decision|0|||
23138878|NCT04410523|64255596|FG001|Overall Study|Physician Decision|1|||
23138879|NCT04410523|64255597|FG002|Overall Study|Physician Decision|0|||
23138880|NCT04410523|64255598|FG003|Overall Study|Physician Decision|0|||
23138881|NCT04410523|64255599|FG004|Overall Study|Physician Decision|0|||
23138882|NCT04410523|64255600|FG005|Overall Study|Physician Decision|0|||
23138883|NCT04410523|64255595|FG000|Overall Study|Pregnancy|0|||
23138884|NCT04410523|64255596|FG001|Overall Study|Pregnancy|0|||
23138885|NCT04410523|64255597|FG002|Overall Study|Pregnancy|0|||
23138886|NCT04410523|64255598|FG003|Overall Study|Pregnancy|0|||
23138887|NCT04410523|64255599|FG004|Overall Study|Pregnancy|0|||
23138888|NCT04410523|64255600|FG005|Overall Study|Pregnancy|1|||
23138889|NCT04410523|64255595|FG000|Overall Study|Protocol deviation|0|||
23138890|NCT04410523|64255596|FG001|Overall Study|Protocol deviation|0|||
23138891|NCT04410523|64255597|FG002|Overall Study|Protocol deviation|0|||
23138892|NCT04410523|64255598|FG003|Overall Study|Protocol deviation|0|||
23138893|NCT04410523|64255599|FG004|Overall Study|Protocol deviation|0|||
23138894|NCT04410523|64255600|FG005|Overall Study|Protocol deviation|2|||
23138895|NCT04410523|64255595|FG000|Overall Study|Subject decision|2|||
23138896|NCT04410523|64255596|FG001|Overall Study|Subject decision|0|||
23138897|NCT04410523|64255597|FG002|Overall Study|Subject decision|0|||
23138898|NCT04410523|64255598|FG003|Overall Study|Subject decision|1|||
23553098|NCT02794285|65751308|FG002|Overall Study|Condition Under Investigation Worsened|1|||
23553099|NCT02794285|65751309|FG003|Overall Study|Condition Under Investigation Worsened|0|||
23138899|NCT04410523|64255599|FG004|Overall Study|Subject decision|0|||
23138900|NCT04410523|64255600|FG005|Overall Study|Subject decision|1|||
23138901|NCT01021215|64255601|FG000|Overall Study|Lost to Follow-up|3|||
23215666|NCT01455415|64531232|FG000|Period 2|AE Not Related to Study Drug|2|||
23215667|NCT01455415|64531233|FG001|Period 2|AE Not Related to Study Drug|1|||
23215668|NCT01455415|64531232|FG000|Period 2|Lack of Efficacy|2|||
23215669|NCT01455415|64531233|FG001|Period 2|Lack of Efficacy|0|||
23215670|NCT01455415|64531232|FG000|Period 2|Withdrawal by Subject|2|||
23215671|NCT01455415|64531233|FG001|Period 2|Withdrawal by Subject|3|||
23215672|NCT01455415|64531232|FG000|Period 2|Unspecified Reason|2|||
23215673|NCT01455415|64531233|FG001|Period 2|Unspecified Reason|3|||
23215674|NCT01455415|64531232|FG000|Period 2|Protocol Violation|2|||
23215675|NCT01455415|64531233|FG001|Period 2|Protocol Violation|0|||
23215676|NCT01455415|64531232|FG000|Follow-up|AE Related to Study Drug|0|||
23215677|NCT01455415|64531233|FG001|Follow-up|AE Related to Study Drug|1|||
23215678|NCT01455415|64531232|FG000|Follow-up|Lack of Efficacy|0|||
23215679|NCT01455415|64531233|FG001|Follow-up|Lack of Efficacy|1|||
23215680|NCT01455415|64531232|FG000|Follow-up|Withdrawal by Subject|2|||
23215681|NCT01455415|64531233|FG001|Follow-up|Withdrawal by Subject|0|||
23215682|NCT01455415|64531232|FG000|Follow-up|Unspecified Reason|1|||
23215683|NCT01455415|64531233|FG001|Follow-up|Unspecified Reason|0|||
23215684|NCT04681729|64531234|FG000|Overall Study|Lack of Efficacy|2|||
23215685|NCT04681729|64531235|FG001|Overall Study|Lack of Efficacy|2|||
23215686|NCT04681729|64531234|FG000|Overall Study|Withdrawal by Subject|8|||
23215687|NCT04681729|64531235|FG001|Overall Study|Withdrawal by Subject|9|||
23215688|NCT00282867|64531240|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
23215689|NCT00282867|64531241|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
23215690|NCT00282867|64531242|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
23215691|NCT02661464|64531243|FG000|Overall Study|Lost to Follow-up|28|||
23215692|NCT02661464|64531244|FG001|Overall Study|Lost to Follow-up|0|||
23215693|NCT02661464|64531245|FG002|Overall Study|Lost to Follow-up|0|||
23215694|NCT02661464|64531246|FG003|Overall Study|Lost to Follow-up|0|||
23553100|NCT02794285|65751306|FG000|Overall Study|Death|2|||
23553101|NCT02794285|65751307|FG001|Overall Study|Death|1|||
23138902|NCT01021215|64255602|FG001|Overall Study|Lost to Follow-up|0|||
23138903|NCT03189745|64255605|FG000|Overall Study|Conflict in work schedule of participant|1|||
23138904|NCT03189745|64255606|FG001|Overall Study|Conflict in work schedule of participant|1|||
23138905|NCT01959334|64255607|FG000|Second Dose|Adverse Event|1|||
23138906|NCT01959334|64255608|FG001|Second Dose|Adverse Event|0|||
23138907|NCT01959334|64255607|FG000|Third Dose|Adverse Event|0|||
23138908|NCT01959334|64255608|FG001|Third Dose|Adverse Event|1|||
23138909|NCT00603304|64255609|FG000|Overall Study|Lost to Follow-up|5|||
23138910|NCT00603304|64255610|FG001|Overall Study|Lost to Follow-up|7|||
23215695|NCT02661464|64531243|FG000|Overall Study|Withdrawal by Subject|3|||
23215696|NCT02661464|64531244|FG001|Overall Study|Withdrawal by Subject|1|||
23215697|NCT02661464|64531245|FG002|Overall Study|Withdrawal by Subject|0|||
23215698|NCT02661464|64531246|FG003|Overall Study|Withdrawal by Subject|0|||
23553102|NCT02794285|65751308|FG002|Overall Study|Death|2|||
23553103|NCT02794285|65751309|FG003|Overall Study|Death|0|||
23553104|NCT02794285|65751306|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
23553105|NCT02794285|65751307|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
23553106|NCT02794285|65751308|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
23553107|NCT02794285|65751309|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
23553108|NCT02794285|65751306|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
23553109|NCT02794285|65751307|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
23553110|NCT02794285|65751308|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
23553111|NCT02794285|65751309|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
23553112|NCT02794285|65751306|FG000|Overall Study|Lack of Efficacy|10|||
23553113|NCT02794285|65751307|FG001|Overall Study|Lack of Efficacy|6|||
23553114|NCT02794285|65751308|FG002|Overall Study|Lack of Efficacy|3|||
23553115|NCT02794285|65751309|FG003|Overall Study|Lack of Efficacy|3|||
23553116|NCT02794285|65751306|FG000|Overall Study|Lost to Follow-up|5|||
23138911|NCT00603304|64255609|FG000|Overall Study|Withdrawal by Subject|8|||
23553117|NCT02794285|65751307|FG001|Overall Study|Lost to Follow-up|6|||
23553118|NCT02794285|65751308|FG002|Overall Study|Lost to Follow-up|3|||
23138912|NCT00603304|64255610|FG001|Overall Study|Withdrawal by Subject|5|||
23553119|NCT02794285|65751309|FG003|Overall Study|Lost to Follow-up|1|||
23553120|NCT02794285|65751306|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
23138913|NCT00603304|64255609|FG000|Overall Study|Protocol Violation|1|||
23138914|NCT00603304|64255610|FG001|Overall Study|Protocol Violation|0|||
23138915|NCT00603304|64255609|FG000|Overall Study|Adverse Event|4|||
23138916|NCT00603304|64255610|FG001|Overall Study|Adverse Event|2|||
23138917|NCT00603304|64255609|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
23138918|NCT00603304|64255610|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
23138919|NCT00603304|64255609|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
23138920|NCT00603304|64255610|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
23138921|NCT00603304|64255609|FG000|Overall Study|Exclusionary Medication|2|||
23138922|NCT00603304|64255610|FG001|Overall Study|Exclusionary Medication|3|||
23215699|NCT02661464|64531243|FG000|Overall Study|Participants terminated prematurely|288|||
23215700|NCT02661464|64531244|FG001|Overall Study|Participants terminated prematurely|52|||
23215701|NCT02661464|64531245|FG002|Overall Study|Participants terminated prematurely|1|||
23215702|NCT02661464|64531246|FG003|Overall Study|Participants terminated prematurely|1|||
23621704|NCT00264498|66000734|FG000|Crossover Treatment|Objective disease progression|4|||
23138923|NCT00603304|64255609|FG000|Overall Study|Non-Compliant|0|||
23138924|NCT00603304|64255610|FG001|Overall Study|Non-Compliant|1|||
23138925|NCT00603304|64255609|FG000|Overall Study|Moved Away|0|||
23138926|NCT00603304|64255610|FG001|Overall Study|Moved Away|2|||
23138927|NCT00603304|64255609|FG000|Overall Study|Other|2|||
23138928|NCT00603304|64255610|FG001|Overall Study|Other|0|||
23138929|NCT00603304|64255609|FG000|Overall Study|Patient Decision|2|||
23138930|NCT00603304|64255610|FG001|Overall Study|Patient Decision|0|||
23138931|NCT01052103|64255611|FG000|Overall Study|Adverse Event|10|||
23138932|NCT01052103|64255612|FG001|Overall Study|Adverse Event|6|||
23138933|NCT01052103|64255611|FG000|Overall Study|Entry Criteria Not Met|3|||
23138934|NCT01052103|64255612|FG001|Overall Study|Entry Criteria Not Met|1|||
23138935|NCT01052103|64255611|FG000|Overall Study|Lost to Follow-up|3|||
23138936|NCT01052103|64255612|FG001|Overall Study|Lost to Follow-up|5|||
23138937|NCT01052103|64255611|FG000|Overall Study|Protocol Violation|10|||
23138938|NCT01052103|64255612|FG001|Overall Study|Protocol Violation|4|||
23138939|NCT01052103|64255611|FG000|Overall Study|Scheduling conflict|2|||
23138940|NCT01052103|64255612|FG001|Overall Study|Scheduling conflict|1|||
23138941|NCT01052103|64255611|FG000|Overall Study|Sponsor Decision|2|||
23138942|NCT01052103|64255612|FG001|Overall Study|Sponsor Decision|0|||
23138943|NCT01052103|64255611|FG000|Overall Study|Withdrawal by Subject|3|||
23138944|NCT01052103|64255612|FG001|Overall Study|Withdrawal by Subject|6|||
23138945|NCT01052103|64255611|FG000|Overall Study|Perceived Lack of Efficacy|1|||
23138946|NCT01052103|64255612|FG001|Overall Study|Perceived Lack of Efficacy|0|||
23621705|NCT00264498|66000735|FG001|Crossover Treatment|Objective disease progression|5|||
23138947|NCT01014143|64255614|FG000|Second Intervention|Lost to Follow-up|2|||
23138948|NCT01014143|64255615|FG001|Second Intervention|Lost to Follow-up|0|||
23138949|NCT01014143|64255616|FG002|Second Intervention|Lost to Follow-up|0|||
23138950|NCT03212989|64255617|FG000|Overall Study|Physician Decision|8|||
23138951|NCT00196976|64255618|FG000|Primary Study|Migrated from study area|0|||
23215703|NCT02661464|64531243|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
23317892|NCT02213510|64908182|FG001|Overall Study|Death|1|||
23553121|NCT02794285|65751307|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
23553122|NCT02794285|65751308|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
23553123|NCT02794285|65751309|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
23553124|NCT02794285|65751306|FG000|Overall Study|Withdrawal by Subject|38|||
23553125|NCT02794285|65751307|FG001|Overall Study|Withdrawal by Subject|29|||
23621706|NCT00264498|66000734|FG000|Crossover Treatment|Study closure|0|||
23138952|NCT00196976|64255619|FG001|Primary Study|Migrated from study area|0|||
23553126|NCT02794285|65751308|FG002|Overall Study|Withdrawal by Subject|20|||
23553127|NCT02794285|65751309|FG003|Overall Study|Withdrawal by Subject|12|||
23553128|NCT02794285|65751306|FG000|Overall Study|Missing|1|||
23553129|NCT02794285|65751307|FG001|Overall Study|Missing|0|||
23553130|NCT02794285|65751308|FG002|Overall Study|Missing|0|||
23553131|NCT02794285|65751309|FG003|Overall Study|Missing|0|||
23553132|NCT02794285|65751306|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
23553133|NCT02794285|65751307|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
23553134|NCT02794285|65751308|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
23553135|NCT02794285|65751309|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
23553136|NCT02794285|65751306|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
23553137|NCT02794285|65751307|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
23138953|NCT00196976|64255620|FG002|Primary Study|Migrated from study area|0|||
23138954|NCT00196976|64255621|FG003|Primary Study|Migrated from study area|0|||
23138955|NCT00196976|64255622|FG004|Primary Study|Migrated from study area|0|||
23138956|NCT00196976|64255623|FG005|Primary Study|Migrated from study area|0|||
23138957|NCT00196976|64255624|FG006|Primary Study|Migrated from study area|0|||
23138958|NCT00196976|64255625|FG007|Primary Study|Migrated from study area|1|||
23138959|NCT00196976|64255626|FG008|Primary Study|Migrated from study area|0|||
23138960|NCT00196976|64255627|FG009|Primary Study|Migrated from study area|0|||
23138961|NCT00196976|64255628|FG010|Primary Study|Migrated from study area|0|||
23138962|NCT00196976|64255629|FG011|Primary Study|Migrated from study area|0|||
23138963|NCT00196976|64255630|FG012|Primary Study|Migrated from study area|0|||
23138964|NCT00196976|64255631|FG013|Primary Study|Migrated from study area|0|||
23138965|NCT00196976|64255618|FG000|Primary Study|Protocol Violation|0|||
23138966|NCT00196976|64255619|FG001|Primary Study|Protocol Violation|1|||
23138967|NCT00196976|64255620|FG002|Primary Study|Protocol Violation|1|||
23138968|NCT00196976|64255621|FG003|Primary Study|Protocol Violation|0|||
23553138|NCT02794285|65751308|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
23553139|NCT02794285|65751309|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
23553140|NCT01822587|65751310|FG000|Overall Study|Lost to Follow-up|7|||
23553141|NCT01822587|65751311|FG001|Overall Study|Lost to Follow-up|9|||
23553142|NCT01822587|65751312|FG002|Overall Study|Lost to Follow-up|12|||
23553143|NCT01822587|65751310|FG000|Overall Study|Physician Decision|9|||
23138969|NCT00196976|64255622|FG004|Primary Study|Protocol Violation|0|||
23138970|NCT00196976|64255623|FG005|Primary Study|Protocol Violation|0|||
23138971|NCT00196976|64255624|FG006|Primary Study|Protocol Violation|0|||
23215704|NCT02661464|64531244|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
23215705|NCT02661464|64531245|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
23215706|NCT02661464|64531246|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
23553144|NCT01822587|65751311|FG001|Overall Study|Physician Decision|6|||
23553145|NCT01822587|65751312|FG002|Overall Study|Physician Decision|6|||
23553146|NCT03086330|65751315|FG000|Overall Study|Withdrawal by Subject|3|||
23553147|NCT03086330|65751316|FG001|Overall Study|Withdrawal by Subject|2|||
23553148|NCT03086330|65751315|FG000|Overall Study|Lost to Follow-up|1|||
23215707|NCT01779648|64531247|FG000|Overall Study|Protocol Violation|1|||
23431767|NCT01490294|65324159|FG000|Overall Study|Prematurely discontinuation|4|||
23431768|NCT01490294|65324160|FG001|Overall Study|Prematurely discontinuation|0|||
23431769|NCT01490294|65324161|FG002|Overall Study|Prematurely discontinuation|1|||
23431770|NCT01490294|65324162|FG003|Overall Study|Prematurely discontinuation|1|||
23431771|NCT01490294|65324159|FG000|Overall Study|Adverse Event|1|||
23431772|NCT01490294|65324160|FG001|Overall Study|Adverse Event|0|||
23431773|NCT01490294|65324161|FG002|Overall Study|Adverse Event|0|||
23431774|NCT01490294|65324162|FG003|Overall Study|Adverse Event|0|||
23431775|NCT01541917|65324171|FG000|Overall Study|Lost to Follow-up|2|||
23431776|NCT01541917|65324172|FG001|Overall Study|Lost to Follow-up|2|||
23431777|NCT01541917|65324171|FG000|Overall Study|Withdrawal by Subject|13|||
23431778|NCT01541917|65324172|FG001|Overall Study|Withdrawal by Subject|7|||
23431779|NCT01475162|65324180|FG000|Overall Study|Physician Decision|1|||
23431780|NCT01475162|65324180|FG000|Overall Study|Death|10|||
23431781|NCT01475162|65324180|FG000|Overall Study|Study closed for safety|3|||
23431782|NCT02456857|65324183|FG000|Overall Study|Disease Progression|4|||
23431783|NCT02723175|65324187|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
23138972|NCT00196976|64255625|FG007|Primary Study|Protocol Violation|0|||
23138973|NCT00196976|64255626|FG008|Primary Study|Protocol Violation|0|||
23138974|NCT00196976|64255627|FG009|Primary Study|Protocol Violation|0|||
23138975|NCT00196976|64255628|FG010|Primary Study|Protocol Violation|0|||
23138976|NCT00196976|64255629|FG011|Primary Study|Protocol Violation|0|||
23138977|NCT00196976|64255630|FG012|Primary Study|Protocol Violation|0|||
23431784|NCT02723175|65324188|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
23431785|NCT02723175|65324187|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
23553149|NCT03086330|65751316|FG001|Overall Study|Lost to Follow-up|2|||
23553150|NCT02753595|65751317|FG000|Overall Study|Sponsor termination|2|||
23553151|NCT02753595|65751318|FG001|Overall Study|Sponsor termination|2|||
23553152|NCT02782169|65751319|FG000|Overall Study|Lost to Follow-up|1|||
23553153|NCT02782169|65751320|FG001|Overall Study|Lost to Follow-up|2|||
23553154|NCT02489500|65751321|FG000|Overall Study|Death|1|||
23553155|NCT02489500|65751322|FG001|Overall Study|Death|1|||
23215708|NCT01779648|64531248|FG001|Overall Study|Protocol Violation|0|||
23215709|NCT01946412|64531251|FG000|Overall Study|Adverse Event|1|||
23215710|NCT01946412|64531251|FG000|Overall Study|Non-Compliance|1|||
23215711|NCT01946412|64531251|FG000|Overall Study|Continued with commercial Kalydeco|2|||
23215712|NCT01946412|64531251|FG000|Overall Study|Difficulty in swallowing|1|||
23215713|NCT02079519|64531252|FG000|Overall Study|Disease Progression|9|||
23215714|NCT02079519|64531252|FG000|Overall Study|Adverse Event|1|||
23215715|NCT00023712|64531253|FG000|Overall Study|Not platinum sensitive|1|||
23215716|NCT00023712|64531254|FG001|Overall Study|Not platinum sensitive|0|||
23215717|NCT00023712|64531253|FG000|Overall Study|Never treated|1|||
23215718|NCT00023712|64531254|FG001|Overall Study|Never treated|1|||
23215719|NCT00340834|64531255|FG000|Core Phase of Study|Adverse Event|26|||
23215720|NCT00340834|64531256|FG001|Core Phase of Study|Adverse Event|9|||
23215721|NCT00340834|64531257|FG002|Core Phase of Study|Adverse Event|9|||
23215722|NCT00340834|64531258|FG003|Core Phase of Study|Adverse Event|0|||
23215723|NCT00340834|64531259|FG004|Core Phase of Study|Adverse Event|0|||
23215724|NCT00340834|64531255|FG000|Core Phase of Study|Withdrawal by Subject|11|||
23215725|NCT00340834|64531256|FG001|Core Phase of Study|Withdrawal by Subject|9|||
23215726|NCT00340834|64531257|FG002|Core Phase of Study|Withdrawal by Subject|16|||
23215727|NCT00340834|64531258|FG003|Core Phase of Study|Withdrawal by Subject|0|||
23215728|NCT00340834|64531259|FG004|Core Phase of Study|Withdrawal by Subject|0|||
23215729|NCT00340834|64531255|FG000|Core Phase of Study|Administrative Problems|6|||
23215730|NCT00340834|64531256|FG001|Core Phase of Study|Administrative Problems|2|||
23215731|NCT00340834|64531257|FG002|Core Phase of Study|Administrative Problems|7|||
23215732|NCT00340834|64531258|FG003|Core Phase of Study|Administrative Problems|0|||
23215733|NCT00340834|64531259|FG004|Core Phase of Study|Administrative Problems|0|||
23215734|NCT00340834|64531255|FG000|Core Phase of Study|Lack of Efficacy|3|||
23215735|NCT00340834|64531256|FG001|Core Phase of Study|Lack of Efficacy|3|||
23215736|NCT00340834|64531257|FG002|Core Phase of Study|Lack of Efficacy|7|||
23215737|NCT00340834|64531258|FG003|Core Phase of Study|Lack of Efficacy|0|||
23215738|NCT00340834|64531259|FG004|Core Phase of Study|Lack of Efficacy|0|||
23215739|NCT00340834|64531255|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
23215740|NCT00340834|64531256|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
23215741|NCT00340834|64531257|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
23215742|NCT00340834|64531258|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
23215743|NCT00340834|64531259|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
23215744|NCT00340834|64531255|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
23553156|NCT01506193|65751323|FG000|Overall Study|Protocol Violation|1|||
23553157|NCT01506193|65751324|FG001|Overall Study|Protocol Violation|0|||
23553158|NCT01506193|65751325|FG002|Overall Study|Protocol Violation|1|||
23553159|NCT01506193|65751323|FG000|Overall Study|Migrated/moved from study area|0|||
23553160|NCT01506193|65751324|FG001|Overall Study|Migrated/moved from study area|0|||
23553161|NCT01506193|65751325|FG002|Overall Study|Migrated/moved from study area|1|||
23553162|NCT01506193|65751323|FG000|Overall Study|Adverse event, non-fatal|0|||
23553163|NCT01506193|65751324|FG001|Overall Study|Adverse event, non-fatal|0|||
23553164|NCT01506193|65751325|FG002|Overall Study|Adverse event, non-fatal|1|||
23553165|NCT01506193|65751323|FG000|Overall Study|Withdrawal by Subject|5|||
23553166|NCT01506193|65751324|FG001|Overall Study|Withdrawal by Subject|1|||
23553167|NCT01506193|65751325|FG002|Overall Study|Withdrawal by Subject|8|||
23553168|NCT01506193|65751323|FG000|Overall Study|Lost to Follow-up|8|||
23553169|NCT01506193|65751324|FG001|Overall Study|Lost to Follow-up|3|||
23553170|NCT01506193|65751325|FG002|Overall Study|Lost to Follow-up|3|||
23553171|NCT01261611|65751326|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
23553172|NCT01261611|65751327|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
23553173|NCT01261611|65751328|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
23553174|NCT01261611|65751326|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
23553175|NCT01261611|65751327|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
23553176|NCT01261611|65751328|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
23553177|NCT01261611|65751326|FG000|Treatment Cycle 1|Adverse Event|0|||
23553178|NCT01261611|65751327|FG001|Treatment Cycle 1|Adverse Event|1|||
23553179|NCT01261611|65751328|FG002|Treatment Cycle 1|Adverse Event|0|||
23553180|NCT01261611|65751326|FG000|Treatment Cycle 1|Protocol Violation|0|||
23553181|NCT01261611|65751327|FG001|Treatment Cycle 1|Protocol Violation|0|||
23553182|NCT01261611|65751328|FG002|Treatment Cycle 1|Protocol Violation|2|||
23215745|NCT00340834|64531256|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
23215746|NCT00340834|64531257|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
23215747|NCT00340834|64531258|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
23553183|NCT01261611|65751326|FG000|Treatment Cycle 2|Completed study|4|||
23553184|NCT01261611|65751327|FG001|Treatment Cycle 2|Completed study|0|||
23553185|NCT01261611|65751328|FG002|Treatment Cycle 2|Completed study|0|||
23553186|NCT01261611|65751326|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
23553187|NCT01261611|65751327|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
23553188|NCT01261611|65751328|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
23553189|NCT01261611|65751326|FG000|Treatment Cycle 2|Adverse Event|1|||
23553190|NCT01261611|65751327|FG001|Treatment Cycle 2|Adverse Event|0|||
23431786|NCT02723175|65324188|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
23431787|NCT02704689|65324191|FG000|Overall Study|Physician Decision|1|||
23431788|NCT02704689|65324191|FG000|Overall Study|Study device not implanted|2|||
23431789|NCT02191605|65324192|FG000|Overall Study|Lost to Follow-up|9|||
23431790|NCT02191605|65324193|FG001|Overall Study|Lost to Follow-up|4|||
23431791|NCT02191605|65324194|FG002|Overall Study|Lost to Follow-up|7|||
23431792|NCT02191605|65324195|FG003|Overall Study|Lost to Follow-up|3|||
23431793|NCT02191605|65324196|FG004|Overall Study|Lost to Follow-up|4|||
23431794|NCT00897390|65324197|FG000|Overall Study|Adverse Event|2|||
23431795|NCT00897390|65324197|FG000|Overall Study|No Longer Met Study Criteria|1|||
23431796|NCT00897390|65324197|FG000|Overall Study|Personal Reasons|1|||
23431797|NCT00897390|65324197|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
23431798|NCT00257660|65324198|FG000|Overall Study|Lack of Efficacy|5|||
23431799|NCT00257660|65324199|FG001|Overall Study|Lack of Efficacy|23|||
23431800|NCT00257660|65324198|FG000|Overall Study|Withdrawal by Subject|2|||
23431801|NCT00257660|65324199|FG001|Overall Study|Withdrawal by Subject|0|||
23431802|NCT00257660|65324198|FG000|Overall Study|Lost to Follow-up|1|||
23431803|NCT00257660|65324199|FG001|Overall Study|Lost to Follow-up|0|||
23431804|NCT00257660|65324198|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
23431805|NCT00257660|65324199|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
23431806|NCT00257660|65324198|FG000|Overall Study|No longer wanted to do blood draws|1|||
23431807|NCT00257660|65324199|FG001|Overall Study|No longer wanted to do blood draws|0|||
23431808|NCT02006069|65324200|FG000|Overall Study|MPP other programming|239|||
23431809|NCT02006069|65324201|FG001|Overall Study|MPP other programming|0|||
23431810|NCT02006069|65324200|FG000|Overall Study|RV only pacing|0|||
23431811|NCT02006069|65324201|FG001|Overall Study|RV only pacing|3|||
23431812|NCT01839656|65324204|FG000|Overall Study|Withdrawal by Subject|1|||
23431813|NCT01839656|65324205|FG001|Overall Study|Withdrawal by Subject|1|||
23431814|NCT01839656|65324204|FG000|Overall Study|Adverse event, serious fatal|1|||
23431815|NCT01839656|65324205|FG001|Overall Study|Adverse event, serious fatal|4|||
23431816|NCT01839656|65324204|FG000|Overall Study|Early study closure|0|||
23431817|NCT01839656|65324205|FG001|Overall Study|Early study closure|11|||
23431818|NCT01839656|65324204|FG000|Overall Study|Adverse Event|1|||
23431819|NCT01839656|65324205|FG001|Overall Study|Adverse Event|0|||
23431820|NCT04033068|65324206|FG000|Overall Study|Withdrawal by Subject|0|||
23431821|NCT04033068|65324207|FG001|Overall Study|Withdrawal by Subject|0|||
23431822|NCT04033068|65324208|FG002|Overall Study|Withdrawal by Subject|1|||
23431823|NCT04033068|65324209|FG003|Overall Study|Withdrawal by Subject|0|||
23431824|NCT04033068|65324206|FG000|Overall Study|Lost to Follow-up|0|||
23431825|NCT04033068|65324207|FG001|Overall Study|Lost to Follow-up|1|||
23431826|NCT04033068|65324208|FG002|Overall Study|Lost to Follow-up|0|||
23431827|NCT04033068|65324209|FG003|Overall Study|Lost to Follow-up|0|||
23431828|NCT04033068|65324206|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
23431829|NCT04033068|65324207|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
23431830|NCT04033068|65324208|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
23431831|NCT04033068|65324209|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
23431832|NCT03199391|65324211|FG000|Overall Study|Death|1|||
23431833|NCT03199391|65324211|FG000|Overall Study|Lost to Follow-up|3|||
23431834|NCT03199391|65324211|FG000|Overall Study|Adverse Event|2|||
23215748|NCT00340834|64531259|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
23215749|NCT00340834|64531255|FG000|Core Phase of Study|Lost to Follow-up|1|||
23215750|NCT00340834|64531256|FG001|Core Phase of Study|Lost to Follow-up|1|||
23215751|NCT00340834|64531257|FG002|Core Phase of Study|Lost to Follow-up|4|||
23215752|NCT00340834|64531258|FG003|Core Phase of Study|Lost to Follow-up|0|||
23215753|NCT00340834|64531259|FG004|Core Phase of Study|Lost to Follow-up|0|||
23215754|NCT00340834|64531255|FG000|Core Phase of Study|Death|2|||
23215755|NCT00340834|64531256|FG001|Core Phase of Study|Death|0|||
23215756|NCT00340834|64531257|FG002|Core Phase of Study|Death|0|||
23215757|NCT00340834|64531258|FG003|Core Phase of Study|Death|0|||
23215758|NCT00340834|64531259|FG004|Core Phase of Study|Death|0|||
23215759|NCT00340834|64531255|FG000|Core Phase of Study|Protocol Violation|0|||
23215760|NCT00340834|64531256|FG001|Core Phase of Study|Protocol Violation|0|||
23215761|NCT00340834|64531257|FG002|Core Phase of Study|Protocol Violation|2|||
23431835|NCT03199391|65324211|FG000|Overall Study|Withdrawal by Subject|10|||
23215762|NCT00340834|64531258|FG003|Core Phase of Study|Protocol Violation|0|||
23215763|NCT00340834|64531259|FG004|Core Phase of Study|Protocol Violation|0|||
23215764|NCT00340834|64531255|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
23215765|NCT00340834|64531256|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
23431836|NCT02177838|65324212|FG000|Overall Study|Withdrawal by Subject|1|||
23215766|NCT00340834|64531257|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
23431837|NCT02177838|65324212|FG000|Overall Study|Physician Decision|1|||
23431838|NCT02177838|65324212|FG000|Overall Study|Death|1|||
23431839|NCT01545050|65324217|FG000|Overall Study|Lack of Efficacy|0|||
23431840|NCT01545050|65324218|FG001|Overall Study|Lack of Efficacy|0|||
23431841|NCT01545050|65324219|FG002|Overall Study|Lack of Efficacy|0|||
23431842|NCT01545050|65324220|FG003|Overall Study|Lack of Efficacy|3|||
23138978|NCT00196976|64255631|FG013|Primary Study|Protocol Violation|0|||
23553191|NCT01261611|65751328|FG002|Treatment Cycle 2|Adverse Event|0|||
23553192|NCT01261611|65751326|FG000|Treatment Cycle 2|Protocol Violation|2|||
23553193|NCT01261611|65751327|FG001|Treatment Cycle 2|Protocol Violation|0|||
23553194|NCT01261611|65751328|FG002|Treatment Cycle 2|Protocol Violation|0|||
23553195|NCT01261611|65751326|FG000|Treatment Cycle 2|Not otherwise specified|2|||
23553196|NCT01261611|65751327|FG001|Treatment Cycle 2|Not otherwise specified|0|||
23553197|NCT01261611|65751328|FG002|Treatment Cycle 2|Not otherwise specified|0|||
23553198|NCT01261611|65751326|FG000|Treatment Cycle 3|Completed study|24|||
23553199|NCT01261611|65751327|FG001|Treatment Cycle 3|Completed study|0|||
23553200|NCT01261611|65751328|FG002|Treatment Cycle 3|Completed study|0|||
23553201|NCT01261611|65751326|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
23553202|NCT01261611|65751327|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
23553203|NCT01261611|65751328|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
23553204|NCT01261611|65751326|FG000|Treatment Cycle 3|Adverse Event|1|||
23553205|NCT01261611|65751327|FG001|Treatment Cycle 3|Adverse Event|0|||
23553206|NCT01261611|65751328|FG002|Treatment Cycle 3|Adverse Event|0|||
23553207|NCT01261611|65751326|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
23553208|NCT01261611|65751327|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
23553209|NCT01261611|65751328|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
23553210|NCT01261611|65751326|FG000|Treatment Cycle 4|Completed study|87|||
23553211|NCT01261611|65751327|FG001|Treatment Cycle 4|Completed study|0|||
23553212|NCT01261611|65751328|FG002|Treatment Cycle 4|Completed study|0|||
23553213|NCT01261611|65751326|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
23553214|NCT01261611|65751327|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
23553215|NCT01261611|65751328|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
23553216|NCT01261611|65751326|FG000|Treatment Cycle 4|Adverse Event|1|||
23553217|NCT01261611|65751327|FG001|Treatment Cycle 4|Adverse Event|0|||
23553218|NCT01261611|65751328|FG002|Treatment Cycle 4|Adverse Event|0|||
23553219|NCT01261611|65751326|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
23553220|NCT01261611|65751327|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
23553221|NCT01261611|65751328|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
23553222|NCT01261611|65751326|FG000|Treatment Cycle 4|Not otherwise specified|3|||
23553223|NCT01261611|65751327|FG001|Treatment Cycle 4|Not otherwise specified|0|||
23553224|NCT01261611|65751328|FG002|Treatment Cycle 4|Not otherwise specified|0|||
23553225|NCT01261611|65751326|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
23553226|NCT01261611|65751327|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
23553227|NCT01261611|65751328|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
23553228|NCT01261611|65751326|FG000|Treatment Cycle 5|Adverse Event|1|||
23553229|NCT01261611|65751327|FG001|Treatment Cycle 5|Adverse Event|0|||
23553230|NCT01261611|65751328|FG002|Treatment Cycle 5|Adverse Event|0|||
23553231|NCT01261611|65751326|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
23553232|NCT01261611|65751327|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
23553233|NCT01261611|65751328|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
23553234|NCT01925950|65751329|FG000|Part 2|Withdrawal by Subject|1|||
23553235|NCT01925950|65751330|FG001|Part 2|Withdrawal by Subject|0|||
23553236|NCT03342638|65751331|FG000|Overall Study|Withdrawal by Subject|1|||
23553237|NCT03342638|65751332|FG001|Overall Study|Withdrawal by Subject|0|||
23553238|NCT03342638|65751331|FG000|Overall Study|Physician Decision|0|||
23553239|NCT03342638|65751332|FG001|Overall Study|Physician Decision|1|||
23553240|NCT02943408|65751334|FG000|Overall Study|Lost to Follow-up|7|||
23553241|NCT02943408|65751335|FG001|Overall Study|Lost to Follow-up|1|||
23553242|NCT02943408|65751334|FG000|Overall Study|Withdrawal by Subject|0|||
23553243|NCT02943408|65751335|FG001|Overall Study|Withdrawal by Subject|1|||
23553244|NCT03221387|65751338|FG000|Overall Study|Lost to Follow-up|1|||
23553245|NCT03221387|65751338|FG000|Overall Study|Lung transplant|1|||
23553246|NCT02454101|65751339|FG000|Overall Study|Adverse Event|2|||
23553247|NCT02454101|65751340|FG001|Overall Study|Adverse Event|3|||
23553248|NCT02454101|65751339|FG000|Overall Study|Lost to Follow-up|3|||
23553249|NCT02454101|65751340|FG001|Overall Study|Lost to Follow-up|4|||
23553250|NCT00827918|65751348|FG000|Overall Study|Adverse Event|4|||
23553251|NCT00827918|65751349|FG001|Overall Study|Adverse Event|0|||
23138979|NCT00196976|64255618|FG000|Primary Study|Withdrawal by Subject|1|||
23138980|NCT00196976|64255619|FG001|Primary Study|Withdrawal by Subject|0|||
23553252|NCT00827918|65751350|FG002|Overall Study|Adverse Event|0|||
23553253|NCT00827918|65751348|FG000|Overall Study|Lack of Efficacy|16|||
23553254|NCT00827918|65751349|FG001|Overall Study|Lack of Efficacy|4|||
23553255|NCT00827918|65751350|FG002|Overall Study|Lack of Efficacy|15|||
23553256|NCT00827918|65751348|FG000|Overall Study|Physician Decision|1|||
23553257|NCT00827918|65751349|FG001|Overall Study|Physician Decision|0|||
23553258|NCT00827918|65751350|FG002|Overall Study|Physician Decision|0|||
23553259|NCT00827918|65751348|FG000|Overall Study|Pregnancy|0|||
23553260|NCT00827918|65751349|FG001|Overall Study|Pregnancy|1|||
23553261|NCT00827918|65751350|FG002|Overall Study|Pregnancy|0|||
23553262|NCT00827918|65751348|FG000|Overall Study|Progressive Disease|1|||
23553263|NCT00827918|65751349|FG001|Overall Study|Progressive Disease|1|||
23553264|NCT00827918|65751350|FG002|Overall Study|Progressive Disease|0|||
23553265|NCT00827918|65751348|FG000|Overall Study|Protocol Violation|0|||
23553266|NCT00827918|65751349|FG001|Overall Study|Protocol Violation|1|||
23138981|NCT00196976|64255620|FG002|Primary Study|Withdrawal by Subject|1|||
23138982|NCT00196976|64255621|FG003|Primary Study|Withdrawal by Subject|1|||
23138983|NCT00196976|64255622|FG004|Primary Study|Withdrawal by Subject|2|||
23138984|NCT00196976|64255623|FG005|Primary Study|Withdrawal by Subject|1|||
23138985|NCT00196976|64255624|FG006|Primary Study|Withdrawal by Subject|0|||
23138986|NCT00196976|64255625|FG007|Primary Study|Withdrawal by Subject|0|||
23138987|NCT00196976|64255626|FG008|Primary Study|Withdrawal by Subject|0|||
23138988|NCT00196976|64255627|FG009|Primary Study|Withdrawal by Subject|1|||
23138989|NCT00196976|64255628|FG010|Primary Study|Withdrawal by Subject|0|||
23138990|NCT00196976|64255629|FG011|Primary Study|Withdrawal by Subject|0|||
23138991|NCT00196976|64255630|FG012|Primary Study|Withdrawal by Subject|0|||
23138992|NCT00196976|64255631|FG013|Primary Study|Withdrawal by Subject|0|||
23138993|NCT00196976|64255618|FG000|Primary Study|Lost to Follow-up|0|||
23138994|NCT00196976|64255619|FG001|Primary Study|Lost to Follow-up|0|||
23138995|NCT00196976|64255620|FG002|Primary Study|Lost to Follow-up|0|||
23138996|NCT00196976|64255621|FG003|Primary Study|Lost to Follow-up|0|||
23138997|NCT00196976|64255622|FG004|Primary Study|Lost to Follow-up|1|||
23138998|NCT00196976|64255623|FG005|Primary Study|Lost to Follow-up|1|||
23138999|NCT00196976|64255624|FG006|Primary Study|Lost to Follow-up|0|||
23139000|NCT00196976|64255625|FG007|Primary Study|Lost to Follow-up|2|||
23139001|NCT00196976|64255626|FG008|Primary Study|Lost to Follow-up|0|||
23215767|NCT00340834|64531258|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
23215768|NCT00340834|64531259|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
23215769|NCT00340834|64531255|FG000|Extension Phase of Study|Subject withdrew consent|26|||
23215770|NCT00340834|64531256|FG001|Extension Phase of Study|Subject withdrew consent|31|||
23215771|NCT00340834|64531257|FG002|Extension Phase of Study|Subject withdrew consent|0|||
23215772|NCT00340834|64531258|FG003|Extension Phase of Study|Subject withdrew consent|12|||
23215773|NCT00340834|64531259|FG004|Extension Phase of Study|Subject withdrew consent|15|||
23215774|NCT00340834|64531255|FG000|Extension Phase of Study|Adverse Event|21|||
23215775|NCT00340834|64531256|FG001|Extension Phase of Study|Adverse Event|22|||
23215776|NCT00340834|64531257|FG002|Extension Phase of Study|Adverse Event|0|||
23215777|NCT00340834|64531258|FG003|Extension Phase of Study|Adverse Event|19|||
23215778|NCT00340834|64531259|FG004|Extension Phase of Study|Adverse Event|7|||
23317893|NCT02213510|64908181|FG000|Overall Study|Lost to Follow-up|1|||
23553267|NCT00827918|65751350|FG002|Overall Study|Protocol Violation|0|||
23553268|NCT00827918|65751348|FG000|Overall Study|Withdrawal by Subject|6|||
23553269|NCT00827918|65751349|FG001|Overall Study|Withdrawal by Subject|2|||
23553270|NCT00827918|65751350|FG002|Overall Study|Withdrawal by Subject|6|||
23553271|NCT00862134|65751351|FG000|Overall Study|Death|1|||
23553272|NCT00862134|65751352|FG001|Overall Study|Death|0|||
23553273|NCT00862134|65751351|FG000|Overall Study|Physician Decision|0|||
23553274|NCT00862134|65751352|FG001|Overall Study|Physician Decision|1|||
23553275|NCT00862134|65751351|FG000|Overall Study|Withdrawal by Subject|1|||
23553276|NCT00862134|65751352|FG001|Overall Study|Withdrawal by Subject|2|||
23553277|NCT00862134|65751351|FG000|Overall Study|Sponsor terminated study|5|||
23553278|NCT00862134|65751352|FG001|Overall Study|Sponsor terminated study|7|||
23553279|NCT00862134|65751351|FG000|Overall Study|Adverse Event|2|||
23553280|NCT00862134|65751352|FG001|Overall Study|Adverse Event|2|||
23553281|NCT00862134|65751351|FG000|Overall Study|Withdrew prior to dosing|2|||
23553282|NCT00862134|65751352|FG001|Overall Study|Withdrew prior to dosing|0|||
23553283|NCT00584727|65751357|FG000|First Intervention|Discontinuation|0|||
23553284|NCT00584727|65751358|FG001|First Intervention|Discontinuation|0|||
23553285|NCT00584727|65751359|FG002|First Intervention|Discontinuation|1|||
23553286|NCT00584727|65751360|FG003|First Intervention|Discontinuation|0|||
23553287|NCT00584727|65751361|FG004|First Intervention|Discontinuation|0|||
23553288|NCT00584727|65751362|FG005|First Intervention|Discontinuation|0|||
23553289|NCT00584727|65751357|FG000|Third Intervention|Protocol Violation|0|||
23553290|NCT00584727|65751358|FG001|Third Intervention|Protocol Violation|0|||
23553291|NCT00584727|65751359|FG002|Third Intervention|Protocol Violation|1|||
23553292|NCT00584727|65751360|FG003|Third Intervention|Protocol Violation|0|||
23553293|NCT00584727|65751361|FG004|Third Intervention|Protocol Violation|4|||
23553294|NCT00584727|65751362|FG005|Third Intervention|Protocol Violation|2|||
23553295|NCT03835533|65751363|FG000|Overall Study|Death|5|||
23553296|NCT03835533|65751364|FG001|Overall Study|Death|10|||
23553297|NCT03835533|65751365|FG002|Overall Study|Death|9|||
23139002|NCT00196976|64255627|FG009|Primary Study|Lost to Follow-up|0|||
23139003|NCT00196976|64255628|FG010|Primary Study|Lost to Follow-up|0|||
23139004|NCT00196976|64255629|FG011|Primary Study|Lost to Follow-up|0|||
23139005|NCT00196976|64255630|FG012|Primary Study|Lost to Follow-up|0|||
23139006|NCT00196976|64255631|FG013|Primary Study|Lost to Follow-up|0|||
23553298|NCT03835533|65751363|FG000|Overall Study|Withdrawal by Subject|2|||
23553299|NCT03835533|65751364|FG001|Overall Study|Withdrawal by Subject|2|||
23553300|NCT03835533|65751365|FG002|Overall Study|Withdrawal by Subject|2|||
23553301|NCT03835533|65751363|FG000|Overall Study|Lost to Follow-up|1|||
23553302|NCT03835533|65751364|FG001|Overall Study|Lost to Follow-up|0|||
23553303|NCT03835533|65751365|FG002|Overall Study|Lost to Follow-up|0|||
23553304|NCT00530855|65751368|FG000|Overall Study|Lack of Efficacy|20|||
23621707|NCT00264498|66000735|FG001|Crossover Treatment|Study closure|1|||
23139007|NCT00196976|64255618|FG000|Primary Study|Other|0|||
23139008|NCT00196976|64255619|FG001|Primary Study|Other|0|||
23139009|NCT00196976|64255620|FG002|Primary Study|Other|2|||
23139010|NCT00196976|64255621|FG003|Primary Study|Other|0|||
23139011|NCT00196976|64255622|FG004|Primary Study|Other|0|||
23215779|NCT00340834|64531255|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
23215780|NCT00340834|64531256|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
23215781|NCT00340834|64531257|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
23215782|NCT00340834|64531258|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
23215783|NCT00340834|64531259|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
23215784|NCT00340834|64531255|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
23215785|NCT00340834|64531256|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
23215786|NCT00340834|64531257|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
23215787|NCT00340834|64531258|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
23215788|NCT00340834|64531259|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
23215789|NCT00340834|64531255|FG000|Extension Phase of Study|Lost to Follow-up|1|||
23215790|NCT00340834|64531256|FG001|Extension Phase of Study|Lost to Follow-up|1|||
23317894|NCT02213510|64908182|FG001|Overall Study|Lost to Follow-up|0|||
23317895|NCT02309138|64908183|FG000|Overall Study|Withdrawal by Subject|44|||
23317896|NCT02309138|64908184|FG001|Overall Study|Withdrawal by Subject|15|||
23317897|NCT02309138|64908183|FG000|Overall Study|Protocol Violation|4|||
23431843|NCT01545050|65324221|FG004|Overall Study|Lack of Efficacy|2|||
23215791|NCT00340834|64531257|FG002|Extension Phase of Study|Lost to Follow-up|0|||
23215792|NCT00340834|64531258|FG003|Extension Phase of Study|Lost to Follow-up|2|||
23215793|NCT00340834|64531259|FG004|Extension Phase of Study|Lost to Follow-up|3|||
23215794|NCT00340834|64531255|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
23215795|NCT00340834|64531256|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
23215796|NCT00340834|64531257|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
23431844|NCT01545050|65324217|FG000|Overall Study|Adverse Event|1|||
23431845|NCT01545050|65324218|FG001|Overall Study|Adverse Event|1|||
23431846|NCT01545050|65324219|FG002|Overall Study|Adverse Event|2|||
23431847|NCT01545050|65324220|FG003|Overall Study|Adverse Event|2|||
23431848|NCT01545050|65324221|FG004|Overall Study|Adverse Event|0|||
23431849|NCT01545050|65324217|FG000|Overall Study|Discontinued study treatment|1|||
23139012|NCT00196976|64255623|FG005|Primary Study|Other|0|||
23139013|NCT00196976|64255624|FG006|Primary Study|Other|0|||
23139014|NCT00196976|64255625|FG007|Primary Study|Other|0|||
23139015|NCT00196976|64255626|FG008|Primary Study|Other|0|||
23139016|NCT00196976|64255627|FG009|Primary Study|Other|0|||
23139017|NCT00196976|64255628|FG010|Primary Study|Other|0|||
23139018|NCT00196976|64255629|FG011|Primary Study|Other|0|||
23139019|NCT00196976|64255630|FG012|Primary Study|Other|0|||
23139020|NCT00196976|64255631|FG013|Primary Study|Other|0|||
23139021|NCT00196976|64255618|FG000|Booster Study|Withdrawal by Subject|0|||
23139022|NCT00196976|64255619|FG001|Booster Study|Withdrawal by Subject|0|||
23139023|NCT00196976|64255620|FG002|Booster Study|Withdrawal by Subject|0|||
23139024|NCT00196976|64255621|FG003|Booster Study|Withdrawal by Subject|0|||
23215797|NCT00340834|64531258|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
23215798|NCT00340834|64531259|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
23215799|NCT00340834|64531255|FG000|Extension Phase of Study|Administrative problems|3|||
23317898|NCT02309138|64908184|FG001|Overall Study|Protocol Violation|2|||
23317899|NCT02309138|64908183|FG000|Overall Study|delivered before visit 2|0|||
23431850|NCT01545050|65324218|FG001|Overall Study|Discontinued study treatment|0|||
23431851|NCT01545050|65324219|FG002|Overall Study|Discontinued study treatment|0|||
23431852|NCT01545050|65324220|FG003|Overall Study|Discontinued study treatment|0|||
23431853|NCT01545050|65324221|FG004|Overall Study|Discontinued study treatment|0|||
23431854|NCT01545050|65324217|FG000|Overall Study|Withdrawal by Subject|1|||
23431855|NCT01545050|65324218|FG001|Overall Study|Withdrawal by Subject|0|||
23431856|NCT01545050|65324219|FG002|Overall Study|Withdrawal by Subject|0|||
23553305|NCT00530855|65751368|FG000|Overall Study|Withdrawal by Subject|30|||
23553306|NCT00530855|65751368|FG000|Overall Study|Fatal Serious AE|3|||
23553307|NCT00530855|65751368|FG000|Overall Study|Non Fatal Serious AE|7|||
23553308|NCT00530855|65751368|FG000|Overall Study|Non Fatal Non Serious AE|12|||
23553309|NCT00530855|65751368|FG000|Overall Study|Protocol Violation|3|||
23553310|NCT00530855|65751368|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
23553311|NCT00530855|65751368|FG000|Overall Study|Lost to Follow-up|9|||
23553312|NCT00530855|65751368|FG000|Overall Study|Other reason for premature termination|17|||
23553313|NCT01860703|65751369|FG000|Overall Study|Adverse Event|1|||
23553314|NCT01860703|65751370|FG001|Overall Study|Adverse Event|4|||
23553315|NCT01860703|65751371|FG002|Overall Study|Adverse Event|0|||
23553316|NCT01860703|65751372|FG003|Overall Study|Adverse Event|2|||
23553317|NCT01860703|65751369|FG000|Overall Study|Withdrawal by Subject|0|||
23553318|NCT01860703|65751370|FG001|Overall Study|Withdrawal by Subject|1|||
23621708|NCT00264498|66000734|FG000|Crossover Treatment|Withdrawal by Subject|1|||
23621709|NCT00264498|66000735|FG001|Crossover Treatment|Withdrawal by Subject|0|||
23621710|NCT01349036|66000736|FG000|Overall Study|Disease progression|13|||
23621711|NCT01349036|66000737|FG001|Overall Study|Disease progression|22|||
23621712|NCT01349036|66000736|FG000|Overall Study|Other|1|||
23621713|NCT01349036|66000737|FG001|Overall Study|Other|0|||
23621714|NCT01349036|66000736|FG000|Overall Study|Withdrawal by Subject|0|||
23621715|NCT01349036|66000737|FG001|Overall Study|Withdrawal by Subject|2|||
23621716|NCT00706914|66000738|FG000|Overall Study|Lack of Efficacy|0|||
23621717|NCT00706914|66000739|FG001|Overall Study|Lack of Efficacy|1|||
23621718|NCT00706914|66000740|FG002|Overall Study|Lack of Efficacy|0|||
23621719|NCT00706914|66000738|FG000|Overall Study|Lost to Follow-up|1|||
23621720|NCT00706914|66000739|FG001|Overall Study|Lost to Follow-up|0|||
23621721|NCT00706914|66000740|FG002|Overall Study|Lost to Follow-up|0|||
23621722|NCT00706914|66000738|FG000|Overall Study|Adverse Event|2|||
23621723|NCT00706914|66000739|FG001|Overall Study|Adverse Event|2|||
23621724|NCT00706914|66000740|FG002|Overall Study|Adverse Event|0|||
23621725|NCT00706914|66000738|FG000|Overall Study|Protocol Violation|3|||
23621726|NCT00706914|66000739|FG001|Overall Study|Protocol Violation|1|||
23621727|NCT00706914|66000740|FG002|Overall Study|Protocol Violation|1|||
23621728|NCT00730847|66000744|FG000|Overall Study|Adverse Event|1|||
23621729|NCT00730847|66000744|FG000|Overall Study|Protocol Violation|2|||
23621730|NCT00730847|66000744|FG000|Overall Study|Withdrawal by Subject|16|||
23621731|NCT00730847|66000744|FG000|Overall Study|Lost to Follow-up|67|||
23621732|NCT00730847|66000744|FG000|Overall Study|Unknown completion status|21|||
23621733|NCT00730847|66000744|FG000|Overall Study|Other|24|||
23621734|NCT00233389|66000745|FG000|Overall Study|Adverse Event|5|||
23621735|NCT00233389|66000746|FG001|Overall Study|Adverse Event|5|||
23621736|NCT00233389|66000745|FG000|Overall Study|Lack of Efficacy|11|||
23621737|NCT00233389|66000746|FG001|Overall Study|Lack of Efficacy|8|||
23621738|NCT00233389|66000745|FG000|Overall Study|Lost to Follow-up|1|||
23621739|NCT00233389|66000746|FG001|Overall Study|Lost to Follow-up|1|||
23139025|NCT00196976|64255622|FG004|Booster Study|Withdrawal by Subject|0|||
23139026|NCT00196976|64255623|FG005|Booster Study|Withdrawal by Subject|0|||
23139027|NCT00196976|64255624|FG006|Booster Study|Withdrawal by Subject|0|||
23139028|NCT00196976|64255625|FG007|Booster Study|Withdrawal by Subject|0|||
23139029|NCT00196976|64255626|FG008|Booster Study|Withdrawal by Subject|0|||
23139030|NCT00196976|64255627|FG009|Booster Study|Withdrawal by Subject|0|||
23139031|NCT00196976|64255628|FG010|Booster Study|Withdrawal by Subject|1|||
23139032|NCT00196976|64255629|FG011|Booster Study|Withdrawal by Subject|0|||
23139033|NCT00196976|64255630|FG012|Booster Study|Withdrawal by Subject|0|||
23139034|NCT00196976|64255631|FG013|Booster Study|Withdrawal by Subject|0|||
23139035|NCT00196976|64255618|FG000|Booster Study|Lost to Follow-up|0|||
23139036|NCT00196976|64255619|FG001|Booster Study|Lost to Follow-up|0|||
23139037|NCT00196976|64255620|FG002|Booster Study|Lost to Follow-up|0|||
23139038|NCT00196976|64255621|FG003|Booster Study|Lost to Follow-up|0|||
23139039|NCT00196976|64255622|FG004|Booster Study|Lost to Follow-up|0|||
23139040|NCT00196976|64255623|FG005|Booster Study|Lost to Follow-up|0|||
23139041|NCT00196976|64255624|FG006|Booster Study|Lost to Follow-up|0|||
23139042|NCT00196976|64255625|FG007|Booster Study|Lost to Follow-up|0|||
23139043|NCT00196976|64255626|FG008|Booster Study|Lost to Follow-up|0|||
23139044|NCT00196976|64255627|FG009|Booster Study|Lost to Follow-up|0|||
23139045|NCT00196976|64255628|FG010|Booster Study|Lost to Follow-up|1|||
23139046|NCT00196976|64255629|FG011|Booster Study|Lost to Follow-up|2|||
23139047|NCT00196976|64255630|FG012|Booster Study|Lost to Follow-up|0|||
23139048|NCT00196976|64255631|FG013|Booster Study|Lost to Follow-up|0|||
23139049|NCT01946438|64255633|FG000|Overall Study|Adverse Event|0|||
23139050|NCT01946438|64255634|FG001|Overall Study|Adverse Event|0|||
23139051|NCT01946438|64255635|FG002|Overall Study|Adverse Event|0|||
23139052|NCT01946438|64255636|FG003|Overall Study|Adverse Event|1|||
23139053|NCT01946438|64255633|FG000|Overall Study|Serious Adverse event|1|||
23139054|NCT01946438|64255634|FG001|Overall Study|Serious Adverse event|0|||
23139055|NCT01946438|64255635|FG002|Overall Study|Serious Adverse event|0|||
23139056|NCT01946438|64255636|FG003|Overall Study|Serious Adverse event|0|||
23621740|NCT00233389|66000745|FG000|Overall Study|Physician Decision|1|||
23621741|NCT00233389|66000746|FG001|Overall Study|Physician Decision|0|||
23621742|NCT00233389|66000745|FG000|Overall Study|Protocol Violation|0|||
23621743|NCT00233389|66000746|FG001|Overall Study|Protocol Violation|1|||
23621744|NCT00233389|66000745|FG000|Overall Study|Withdrawal by Subject|0|||
23621745|NCT00233389|66000746|FG001|Overall Study|Withdrawal by Subject|1|||
23621746|NCT01960348|66000749|FG000|Overall Study|Adverse event, not serious|2|||
23621747|NCT01960348|66000750|FG001|Overall Study|Adverse event, not serious|2|||
23621748|NCT01960348|66000749|FG000|Overall Study|Adverse event, serious fatal|6|||
23621749|NCT01960348|66000750|FG001|Overall Study|Adverse event, serious fatal|5|||
23621750|NCT01960348|66000749|FG000|Overall Study|Adverse event, serious non-fatal|0|||
23621751|NCT01960348|66000750|FG001|Overall Study|Adverse event, serious non-fatal|3|||
23621752|NCT01960348|66000749|FG000|Overall Study|Withdrawal by Subject|1|||
23621753|NCT01960348|66000750|FG001|Overall Study|Withdrawal by Subject|11|||
23621754|NCT01960348|66000749|FG000|Overall Study|Physician Decision|0|||
23215800|NCT00340834|64531256|FG001|Extension Phase of Study|Administrative problems|0|||
23215801|NCT00340834|64531257|FG002|Extension Phase of Study|Administrative problems|0|||
23139057|NCT01946438|64255633|FG000|Overall Study|Protocol Violation|0|||
23621755|NCT01960348|66000750|FG001|Overall Study|Physician Decision|1|||
23621756|NCT01960348|66000749|FG000|Overall Study|Protocol Violation|1|||
23621757|NCT01960348|66000750|FG001|Overall Study|Protocol Violation|0|||
23139058|NCT01946438|64255634|FG001|Overall Study|Protocol Violation|0|||
23139059|NCT01946438|64255635|FG002|Overall Study|Protocol Violation|1|||
23215802|NCT00340834|64531258|FG003|Extension Phase of Study|Administrative problems|1|||
23215803|NCT00340834|64531259|FG004|Extension Phase of Study|Administrative problems|1|||
23215804|NCT00340834|64531255|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
23215805|NCT00340834|64531256|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
23215806|NCT00340834|64531257|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
23317900|NCT02309138|64908184|FG001|Overall Study|delivered before visit 2|1|||
23431857|NCT01545050|65324220|FG003|Overall Study|Withdrawal by Subject|2|||
23139060|NCT01946438|64255636|FG003|Overall Study|Protocol Violation|0|||
23139061|NCT01946438|64255633|FG000|Overall Study|Withdrawal by Subject|1|||
23139062|NCT01946438|64255634|FG001|Overall Study|Withdrawal by Subject|0|||
23139063|NCT01946438|64255635|FG002|Overall Study|Withdrawal by Subject|0|||
23139064|NCT01946438|64255636|FG003|Overall Study|Withdrawal by Subject|0|||
23139065|NCT02004353|64255644|FG000|Overall Study|Voluntary participation|1334|||
23431858|NCT01545050|65324221|FG004|Overall Study|Withdrawal by Subject|1|||
23431859|NCT01545050|65324217|FG000|Overall Study|Participant no longer meets study criteria|0|||
23431860|NCT01545050|65324218|FG001|Overall Study|Participant no longer meets study criteria|2|||
23431861|NCT01545050|65324219|FG002|Overall Study|Participant no longer meets study criteria|0|||
23431862|NCT01545050|65324220|FG003|Overall Study|Participant no longer meets study criteria|0|||
23431863|NCT01545050|65324221|FG004|Overall Study|Participant no longer meets study criteria|1|||
23431864|NCT01545050|65324217|FG000|Overall Study|Administrative reason by sponsor|4|||
23431865|NCT01545050|65324218|FG001|Overall Study|Administrative reason by sponsor|2|||
23431866|NCT01545050|65324219|FG002|Overall Study|Administrative reason by sponsor|3|||
23431867|NCT01545050|65324220|FG003|Overall Study|Administrative reason by sponsor|5|||
23431868|NCT01545050|65324221|FG004|Overall Study|Administrative reason by sponsor|5|||
23431869|NCT00462748|65324222|FG000|Overall Study|Adverse Event|7|||
23431870|NCT00462748|65324223|FG001|Overall Study|Adverse Event|5|||
23431871|NCT00462748|65324224|FG002|Overall Study|Adverse Event|9|||
23431872|NCT00462748|65324222|FG000|Overall Study|Protocol Violation|0|||
23431873|NCT00462748|65324223|FG001|Overall Study|Protocol Violation|2|||
23553319|NCT01860703|65751371|FG002|Overall Study|Withdrawal by Subject|0|||
23553320|NCT01860703|65751372|FG003|Overall Study|Withdrawal by Subject|0|||
23553321|NCT01860703|65751369|FG000|Overall Study|Personal reason|1|||
23553322|NCT01860703|65751370|FG001|Overall Study|Personal reason|0|||
23553323|NCT01860703|65751371|FG002|Overall Study|Personal reason|1|||
23553324|NCT01860703|65751372|FG003|Overall Study|Personal reason|0|||
23553325|NCT00924287|65751376|FG000|Overall Study|Death|1|||
23553326|NCT05711641|65751377|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
23553327|NCT05711641|65751378|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
23553328|NCT05711641|65751377|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
23553329|NCT05711641|65751378|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
23553330|NCT01588184|65751379|FG000|Overall Study|Death|1|||
23553331|NCT01588184|65751380|FG001|Overall Study|Death|0|||
23553332|NCT01588184|65751381|FG002|Overall Study|Death|0|||
23553333|NCT01588184|65751382|FG003|Overall Study|Death|1|||
23553334|NCT01588184|65751383|FG004|Overall Study|Death|1|||
23553335|NCT01588184|65751384|FG005|Overall Study|Death|1|||
23553336|NCT01588184|65751379|FG000|Overall Study|Withdrawal by Subject|2|||
23553337|NCT01588184|65751380|FG001|Overall Study|Withdrawal by Subject|4|||
23553338|NCT01588184|65751381|FG002|Overall Study|Withdrawal by Subject|0|||
23553339|NCT01588184|65751382|FG003|Overall Study|Withdrawal by Subject|1|||
23553340|NCT01588184|65751383|FG004|Overall Study|Withdrawal by Subject|0|||
23553341|NCT01588184|65751384|FG005|Overall Study|Withdrawal by Subject|0|||
23553342|NCT01588184|65751379|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
23553343|NCT01588184|65751380|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
23553344|NCT01588184|65751381|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
23553345|NCT01588184|65751382|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
23553346|NCT01588184|65751383|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
23553347|NCT01588184|65751384|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
23553348|NCT01588184|65751379|FG000|Overall Study|multiple reasons|0|||
23553349|NCT01588184|65751380|FG001|Overall Study|multiple reasons|3|||
23553350|NCT01588184|65751381|FG002|Overall Study|multiple reasons|0|||
23553351|NCT01588184|65751382|FG003|Overall Study|multiple reasons|1|||
23553352|NCT01588184|65751383|FG004|Overall Study|multiple reasons|0|||
23553353|NCT01588184|65751384|FG005|Overall Study|multiple reasons|0|||
23621758|NCT01821729|66000751|FG000|Overall Study|Withdrawal by Subject|1|||
23621759|NCT00280683|66000761|FG000|Overall Study|Withdrawal by Subject|1|||
23621760|NCT00280683|66000762|FG001|Overall Study|Withdrawal by Subject|2|||
23621761|NCT00280683|66000761|FG000|Overall Study|Adverse Event|1|||
23621762|NCT00280683|66000762|FG001|Overall Study|Adverse Event|1|||
23621763|NCT00746356|66000763|FG000|Overall Study|Withdrawal by Subject|2|||
23621764|NCT00746356|66000764|FG001|Overall Study|Withdrawal by Subject|3|||
23621765|NCT00746356|66000763|FG000|Overall Study|Death|7|||
23139066|NCT01157676|64255645|FG000|Randomization|Death|1|||
23139067|NCT01157676|64255646|FG001|Randomization|Death|1|||
23139068|NCT01157676|64255645|FG000|Randomization|unresectable|2|||
23139069|NCT01157676|64255646|FG001|Randomization|unresectable|3|||
23553354|NCT03263429|65751386|FG000|Overall Study|Withdrawal by Subject|0|||
23553355|NCT03263429|65751387|FG001|Overall Study|Withdrawal by Subject|1|||
23553356|NCT03263429|65751388|FG002|Overall Study|Withdrawal by Subject|0|||
23553357|NCT03263429|65751386|FG000|Overall Study|Follow-Up Period Completed|0|||
23553358|NCT03263429|65751387|FG001|Overall Study|Follow-Up Period Completed|2|||
23553359|NCT03263429|65751388|FG002|Overall Study|Follow-Up Period Completed|0|||
23553360|NCT03263429|65751386|FG000|Overall Study|Death|3|||
23553361|NCT03263429|65751387|FG001|Overall Study|Death|5|||
23553362|NCT03263429|65751388|FG002|Overall Study|Death|16|||
23553363|NCT03263429|65751386|FG000|Overall Study|Participant unable to return|0|||
23553364|NCT03263429|65751387|FG001|Overall Study|Participant unable to return|0|||
23553365|NCT03263429|65751388|FG002|Overall Study|Participant unable to return|1|||
23553366|NCT03263429|65751386|FG000|Overall Study|Study Closed|0|||
23139070|NCT01157676|64255645|FG000|Randomization|Withdrawal by Subject|17|||
23139071|NCT01157676|64255646|FG001|Randomization|Withdrawal by Subject|13|||
23139072|NCT01157676|64255645|FG000|Randomization|Physician Decision|1|||
23139073|NCT01157676|64255646|FG001|Randomization|Physician Decision|0|||
23139074|NCT01157676|64255645|FG000|Surgery|underwent open cystectomy|0|||
23139075|NCT01157676|64255646|FG001|Surgery|underwent open cystectomy|4|||
23139076|NCT01157676|64255645|FG000|Surgery|converted to open procedure|0|||
23553367|NCT03263429|65751387|FG001|Overall Study|Study Closed|0|||
23553368|NCT03263429|65751388|FG002|Overall Study|Study Closed|1|||
23553369|NCT03822533|65751391|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
23553370|NCT03822533|65751392|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
23553371|NCT03822533|65751391|FG000|3 Month Follow-up|Lost to Follow-up|2|||
23553372|NCT03822533|65751392|FG001|3 Month Follow-up|Lost to Follow-up|2|||
23553373|NCT03822533|65751391|FG000|6 Month Follow-up|Lost to Follow-up|3|||
23553374|NCT03822533|65751392|FG001|6 Month Follow-up|Lost to Follow-up|0|||
23553375|NCT03822533|65751391|FG000|12 Month Follow-up|Lost to Follow-up|2|||
23553376|NCT03822533|65751392|FG001|12 Month Follow-up|Lost to Follow-up|3|||
23553377|NCT03822533|65751391|FG000|12 Month Follow-up|Pregnancy|0|||
23553378|NCT03822533|65751392|FG001|12 Month Follow-up|Pregnancy|1|||
23553379|NCT03822533|65751391|FG000|12 Month Follow-up|Surgery|2|||
23553380|NCT03822533|65751392|FG001|12 Month Follow-up|Surgery|0|||
23553381|NCT03822533|65751391|FG000|12 Month Follow-up|Wrong address|1|||
23553382|NCT03822533|65751392|FG001|12 Month Follow-up|Wrong address|0|||
23553383|NCT03822533|65751391|FG000|12 Month Follow-up|No symptoms|1|||
23553384|NCT03822533|65751392|FG001|12 Month Follow-up|No symptoms|0|||
23553385|NCT03822533|65751391|FG000|12 Month Follow-up|Changed primary care center|0|||
23553386|NCT03822533|65751392|FG001|12 Month Follow-up|Changed primary care center|1|||
23553387|NCT02844946|65751395|FG000|Overall Study|Lost to Follow-up|7|||
23553388|NCT02844946|65751396|FG001|Overall Study|Lost to Follow-up|0|||
23553389|NCT01738984|65751405|FG000|Overall Study|Pregnancy|4|||
23553390|NCT01738984|65751406|FG001|Overall Study|Pregnancy|0|||
23553391|NCT01738984|65751405|FG000|Overall Study|Withdrawal by Subject|1|||
23553392|NCT01738984|65751406|FG001|Overall Study|Withdrawal by Subject|0|||
23553393|NCT01738984|65751405|FG000|Overall Study|Lost to Follow-up|59|||
23553394|NCT01738984|65751406|FG001|Overall Study|Lost to Follow-up|39|||
23553395|NCT00701038|65751407|FG000|Overall Study|study amended pilot group of patients|4|||
23553396|NCT00701038|65751408|FG001|Overall Study|study amended pilot group of patients|4|||
23553397|NCT01059175|65751414|FG000|Overall Study|Death|17|||
23553398|NCT01059175|65751415|FG001|Overall Study|Death|17|||
23553399|NCT01059175|65751414|FG000|Overall Study|Adverse Event|4|||
23553400|NCT01059175|65751415|FG001|Overall Study|Adverse Event|2|||
23139077|NCT01157676|64255646|FG001|Surgery|converted to open procedure|5|||
23139078|NCT01157676|64255645|FG000|Surgery|underwent robotic cystectomy|1|||
23139079|NCT01157676|64255646|FG001|Surgery|underwent robotic cystectomy|0|||
23553401|NCT01059175|65751414|FG000|Overall Study|Lost to Follow-up|0|||
23553402|NCT01059175|65751415|FG001|Overall Study|Lost to Follow-up|1|||
23553403|NCT01939548|65751416|FG000|Overall Study|Non compliance|0|||
23553404|NCT01939548|65751417|FG001|Overall Study|Non compliance|2|||
23553405|NCT01939548|65751418|FG002|Overall Study|Non compliance|0|||
23553406|NCT01939548|65751416|FG000|Overall Study|Study Terminated by Sponsor|17|||
23621766|NCT00746356|66000764|FG001|Overall Study|Death|3|||
23621767|NCT00746356|66000763|FG000|Overall Study|Lost to Follow-up|1|||
23621768|NCT00746356|66000764|FG001|Overall Study|Lost to Follow-up|0|||
23553407|NCT01939548|65751417|FG001|Overall Study|Study Terminated by Sponsor|19|||
23553408|NCT01939548|65751418|FG002|Overall Study|Study Terminated by Sponsor|12|||
23621769|NCT00746356|66000763|FG000|Overall Study|Removal of Device|0|||
23553409|NCT01939548|65751416|FG000|Overall Study|Insufficient Clinical Response|1|||
23553410|NCT01939548|65751417|FG001|Overall Study|Insufficient Clinical Response|0|||
23553411|NCT01939548|65751418|FG002|Overall Study|Insufficient Clinical Response|0|||
23553412|NCT01939548|65751416|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23553413|NCT01939548|65751417|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
23553414|NCT01939548|65751418|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
23553415|NCT01939548|65751416|FG000|Overall Study|Withdrawal by Subject|4|||
23553416|NCT01939548|65751417|FG001|Overall Study|Withdrawal by Subject|4|||
23553417|NCT01939548|65751418|FG002|Overall Study|Withdrawal by Subject|1|||
23553418|NCT01939548|65751416|FG000|Overall Study|Protocol Violation|7|||
23553419|NCT01939548|65751417|FG001|Overall Study|Protocol Violation|6|||
23553420|NCT01939548|65751418|FG002|Overall Study|Protocol Violation|5|||
23553421|NCT01939548|65751416|FG000|Overall Study|Lost to Follow-up|5|||
23553422|NCT01939548|65751417|FG001|Overall Study|Lost to Follow-up|5|||
23553423|NCT01939548|65751418|FG002|Overall Study|Lost to Follow-up|3|||
23553424|NCT01939548|65751416|FG000|Overall Study|Adverse Event|2|||
23553425|NCT01939548|65751417|FG001|Overall Study|Adverse Event|9|||
23553426|NCT01939548|65751418|FG002|Overall Study|Adverse Event|7|||
23553427|NCT01939548|65751416|FG000|Overall Study|Death|0|||
23553428|NCT01939548|65751417|FG001|Overall Study|Death|0|||
23553429|NCT01939548|65751418|FG002|Overall Study|Death|1|||
23553430|NCT01939548|65751416|FG000|Overall Study|Participant dropped|0|||
23553431|NCT01939548|65751417|FG001|Overall Study|Participant dropped|0|||
23553432|NCT01939548|65751418|FG002|Overall Study|Participant dropped|1|||
23553433|NCT01939548|65751416|FG000|Overall Study|Participant unwilling to continue|0|||
23553434|NCT01939548|65751417|FG001|Overall Study|Participant unwilling to continue|1|||
23553435|NCT01939548|65751418|FG002|Overall Study|Participant unwilling to continue|0|||
23553436|NCT01939548|65751416|FG000|Overall Study|Participant withdrew consent|0|||
23553437|NCT01939548|65751417|FG001|Overall Study|Participant withdrew consent|2|||
23553438|NCT01939548|65751418|FG002|Overall Study|Participant withdrew consent|0|||
23553439|NCT01939548|65751416|FG000|Overall Study|Did not complete follow-up|0|||
23553440|NCT01939548|65751417|FG001|Overall Study|Did not complete follow-up|1|||
23553441|NCT01939548|65751418|FG002|Overall Study|Did not complete follow-up|0|||
23553442|NCT00713648|65751422|FG000|Overall Study|Adverse Event|1|||
23553443|NCT00713648|65751422|FG000|Overall Study|Unclassified|2|||
23553444|NCT00713648|65751422|FG000|Overall Study|According to Protocol|2|||
23553445|NCT00713648|65751422|FG000|Overall Study|Development of antibodies|3|||
23553446|NCT00483184|65751423|FG000|Overall Study|Withdrawal by Subject|2|||
23553447|NCT00483184|65751424|FG001|Overall Study|Withdrawal by Subject|2|||
23553448|NCT00483184|65751425|FG002|Overall Study|Withdrawal by Subject|0|||
23553449|NCT00483184|65751423|FG000|Overall Study|Lost to Follow-up|1|||
23553450|NCT00483184|65751424|FG001|Overall Study|Lost to Follow-up|0|||
23553451|NCT00483184|65751425|FG002|Overall Study|Lost to Follow-up|0|||
23553452|NCT00483184|65751423|FG000|Overall Study|Adverse Event|1|||
23553453|NCT00483184|65751424|FG001|Overall Study|Adverse Event|2|||
23553454|NCT00483184|65751425|FG002|Overall Study|Adverse Event|2|||
23553455|NCT00483184|65751423|FG000|Overall Study|Protocol Violation|1|||
23553456|NCT00483184|65751424|FG001|Overall Study|Protocol Violation|0|||
23553457|NCT00483184|65751425|FG002|Overall Study|Protocol Violation|1|||
23553458|NCT03311373|65751428|FG000|Overall Study|Adverse Event|1|||
23553459|NCT03311373|65751428|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
23553460|NCT03311373|65751428|FG000|Overall Study|Lost to Follow-up|1|||
23553461|NCT03311373|65751428|FG000|Overall Study|Physician Decision|1|||
23553462|NCT03311373|65751428|FG000|Overall Study|Withdrawal by Subject|3|||
23553463|NCT02207816|65751431|FG000|Overall Study|Serious Adverse Event|0|||
23553464|NCT02207816|65751432|FG001|Overall Study|Serious Adverse Event|5|||
23553465|NCT02207816|65751433|FG002|Overall Study|Serious Adverse Event|2|||
23553466|NCT02207816|65751431|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
23553467|NCT02207816|65751432|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
23553468|NCT02207816|65751433|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
23139080|NCT00412061|64255647|FG000|Double Blind Phase|Disease Progression|101|||
23139081|NCT00412061|64255648|FG001|Double Blind Phase|Disease Progression|154|||
23139082|NCT00412061|64255647|FG000|Double Blind Phase|Adverse Event|61|||
23553469|NCT02207816|65751431|FG000|Overall Study|Withdrawal by Subject|4|||
23553470|NCT02207816|65751432|FG001|Overall Study|Withdrawal by Subject|9|||
23553471|NCT02207816|65751433|FG002|Overall Study|Withdrawal by Subject|7|||
23553472|NCT02207816|65751431|FG000|Overall Study|Migrated/Moved From Study Area|41|||
23553473|NCT02207816|65751432|FG001|Overall Study|Migrated/Moved From Study Area|60|||
23553474|NCT02207816|65751433|FG002|Overall Study|Migrated/Moved From Study Area|51|||
23553475|NCT02207816|65751431|FG000|Overall Study|Lost to Follow-up|3|||
23553476|NCT02207816|65751432|FG001|Overall Study|Lost to Follow-up|9|||
23139083|NCT00412061|64255648|FG001|Double Blind Phase|Adverse Event|16|||
23553477|NCT02207816|65751433|FG002|Overall Study|Lost to Follow-up|1|||
23553478|NCT02207816|65751431|FG000|Overall Study|Other|1|||
23553479|NCT02207816|65751432|FG001|Overall Study|Other|2|||
23553480|NCT02207816|65751433|FG002|Overall Study|Other|4|||
23553481|NCT02085252|65751437|FG000|Overall Study|Withdrawal of Consent|1|||
23431874|NCT00462748|65324224|FG002|Overall Study|Protocol Violation|1|||
23431875|NCT00462748|65324222|FG000|Overall Study|Withdrew consent|3|||
23431876|NCT00462748|65324223|FG001|Overall Study|Withdrew consent|3|||
23431877|NCT00462748|65324224|FG002|Overall Study|Withdrew consent|0|||
23431878|NCT00462748|65324222|FG000|Overall Study|Lost to Follow-up|1|||
23431879|NCT00462748|65324223|FG001|Overall Study|Lost to Follow-up|1|||
23431880|NCT00462748|65324224|FG002|Overall Study|Lost to Follow-up|1|||
23431881|NCT00462748|65324222|FG000|Overall Study|Discontinued after 41 days Rx|1|||
23431882|NCT00462748|65324223|FG001|Overall Study|Discontinued after 41 days Rx|0|||
23431883|NCT00462748|65324224|FG002|Overall Study|Discontinued after 41 days Rx|0|||
23431884|NCT00025155|65324225|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
23431885|NCT00025155|65324225|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
23431886|NCT00444067|65324234|FG000|Overall Study|Lost to Follow-up|0|||
23431887|NCT00444067|65324235|FG001|Overall Study|Lost to Follow-up|1|||
23431888|NCT00975143|65324236|FG000|Overall Study|Adverse Event|19|||
23431889|NCT00975143|65324237|FG001|Overall Study|Adverse Event|15|||
23431890|NCT00975143|65324236|FG000|Overall Study|Withdrawal by Subject|15|||
23431891|NCT00975143|65324237|FG001|Overall Study|Withdrawal by Subject|15|||
23431892|NCT00975143|65324236|FG000|Overall Study|Lost to Follow-up|20|||
23431893|NCT00975143|65324237|FG001|Overall Study|Lost to Follow-up|16|||
23431894|NCT00975143|65324236|FG000|Overall Study|Non-compliance|5|||
23431895|NCT00975143|65324237|FG001|Overall Study|Non-compliance|8|||
23431896|NCT00975143|65324236|FG000|Overall Study|Physician Decision|1|||
23431897|NCT00975143|65324237|FG001|Overall Study|Physician Decision|2|||
23431898|NCT00975143|65324236|FG000|Overall Study|Details not available|10|||
23431899|NCT00975143|65324237|FG001|Overall Study|Details not available|4|||
23431900|NCT00871923|65324241|FG000|Overall Study|Death|1|||
23431901|NCT00871923|65324241|FG000|Overall Study|Withdrawal by Subject|1|||
23431902|NCT04881747|65324242|FG000|Period 2 Washout|Adverse Event|1|||
23431903|NCT04881747|65324243|FG001|Period 2 Washout|Adverse Event|0|||
23431904|NCT04881747|65324244|FG002|Period 2 Washout|Adverse Event|0|||
23431905|NCT04881747|65324245|FG003|Period 2 Washout|Adverse Event|0|||
23431906|NCT04881747|65324246|FG004|Period 2 Washout|Adverse Event|1|||
23431907|NCT04881747|65324247|FG005|Period 2 Washout|Adverse Event|0|||
23431908|NCT04881747|65324242|FG000|Period 2 Washout|Withdrawal by Subject|1|||
23431909|NCT04881747|65324243|FG001|Period 2 Washout|Withdrawal by Subject|0|||
23431910|NCT04881747|65324244|FG002|Period 2 Washout|Withdrawal by Subject|0|||
23431911|NCT04881747|65324245|FG003|Period 2 Washout|Withdrawal by Subject|1|||
23431912|NCT04881747|65324246|FG004|Period 2 Washout|Withdrawal by Subject|0|||
23431913|NCT04881747|65324247|FG005|Period 2 Washout|Withdrawal by Subject|0|||
23431914|NCT02469415|65324248|FG000|Overall Study|Withdrawal by Subject|1|||
23431915|NCT02469415|65324248|FG000|Overall Study|Investigational agent placed on hold|2|||
23431916|NCT03159104|65324249|FG000|Overall Study|Violation of inclusion criteria|1|||
23431917|NCT03159104|65324250|FG001|Overall Study|Violation of inclusion criteria|2|||
23139084|NCT00412061|64255647|FG000|Double Blind Phase|Final Primary Analysis|26|||
23139085|NCT00412061|64255648|FG001|Double Blind Phase|Final Primary Analysis|14|||
23139086|NCT00412061|64255647|FG000|Double Blind Phase|Withdrawal by Subject|18|||
23431918|NCT00454584|65327453|FG000|Controlled Period|Adverse Event|5|||
23431919|NCT00454584|65327454|FG001|Controlled Period|Adverse Event|2|||
23431920|NCT00454584|65327455|FG002|Controlled Period|Adverse Event|1|||
23431921|NCT00454584|65327456|FG003|Controlled Period|Adverse Event|0|||
23431922|NCT00454584|65327457|FG004|Controlled Period|Adverse Event|0|||
23431923|NCT00454584|65327458|FG005|Controlled Period|Adverse Event|0|||
23431924|NCT00454584|65327453|FG000|Controlled Period|Lost to Follow-up|1|||
23139087|NCT00412061|64255648|FG001|Double Blind Phase|Withdrawal by Subject|20|||
23139088|NCT00412061|64255647|FG000|Double Blind Phase|Death|6|||
23139089|NCT00412061|64255648|FG001|Double Blind Phase|Death|3|||
23139090|NCT00412061|64255647|FG000|Double Blind Phase|Protocol Violation|3|||
23139091|NCT00412061|64255648|FG001|Double Blind Phase|Protocol Violation|4|||
23139092|NCT00412061|64255647|FG000|Double Blind Phase|New Cander Therapy|1|||
23139093|NCT00412061|64255648|FG001|Double Blind Phase|New Cander Therapy|1|||
23139094|NCT00412061|64255647|FG000|Double Blind Phase|Lost to Follow-up|0|||
23139095|NCT00412061|64255648|FG001|Double Blind Phase|Lost to Follow-up|1|||
23139096|NCT00412061|64255647|FG000|Open Label Phase|Disease Progression|0|||
23139097|NCT00412061|64255648|FG001|Open Label Phase|Disease Progression|86|||
23431925|NCT00454584|65327454|FG001|Controlled Period|Lost to Follow-up|2|||
23431926|NCT00454584|65327455|FG002|Controlled Period|Lost to Follow-up|2|||
23431927|NCT00454584|65327456|FG003|Controlled Period|Lost to Follow-up|0|||
23431928|NCT00454584|65327457|FG004|Controlled Period|Lost to Follow-up|0|||
23431929|NCT00454584|65327458|FG005|Controlled Period|Lost to Follow-up|0|||
23431930|NCT00454584|65327453|FG000|Controlled Period|Other|5|||
23431931|NCT00454584|65327454|FG001|Controlled Period|Other|4|||
23431932|NCT00454584|65327455|FG002|Controlled Period|Other|2|||
23431933|NCT00454584|65327456|FG003|Controlled Period|Other|0|||
23431934|NCT00454584|65327457|FG004|Controlled Period|Other|0|||
23431935|NCT00454584|65327458|FG005|Controlled Period|Other|0|||
23431936|NCT00454584|65327453|FG000|After Controlled Period|Adverse Event|0|||
23431937|NCT00454584|65327454|FG001|After Controlled Period|Adverse Event|0|||
23215807|NCT00340834|64531258|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
23215808|NCT00340834|64531259|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
23553482|NCT02085252|65751438|FG001|Overall Study|Withdrawal of Consent|0|||
23553483|NCT02085252|65751437|FG000|Overall Study|Adverse Event|0|||
23553484|NCT02085252|65751438|FG001|Overall Study|Adverse Event|1|||
23215809|NCT00340834|64531255|FG000|Extension Phase of Study|Protocol Violation|3|||
23215810|NCT00340834|64531256|FG001|Extension Phase of Study|Protocol Violation|0|||
23215811|NCT00340834|64531257|FG002|Extension Phase of Study|Protocol Violation|0|||
23215812|NCT00340834|64531258|FG003|Extension Phase of Study|Protocol Violation|0|||
23215813|NCT00340834|64531259|FG004|Extension Phase of Study|Protocol Violation|0|||
23431938|NCT00454584|65327455|FG002|After Controlled Period|Adverse Event|0|||
23621770|NCT00746356|66000764|FG001|Overall Study|Removal of Device|1|||
23621771|NCT00746356|66000763|FG000|Overall Study|Patient relocated|1|||
23621772|NCT00746356|66000764|FG001|Overall Study|Patient relocated|0|||
23621773|NCT00001941|66000765|FG000|Overall Study|not treated- rapidly progressing disease|0|||
23621774|NCT00001941|66000766|FG001|Overall Study|not treated- rapidly progressing disease|0|||
23621775|NCT00001941|66000767|FG002|Overall Study|not treated- rapidly progressing disease|0|||
23621776|NCT00001941|66000768|FG003|Overall Study|not treated- rapidly progressing disease|0|||
23621777|NCT00001941|66000769|FG004|Overall Study|not treated- rapidly progressing disease|1|||
23621778|NCT00619983|66000770|FG000|Test Drug Alone|Withdrawal by Subject|1|||
23621779|NCT00619983|66000771|FG001|Test Drug Alone|Withdrawal by Subject|0|||
23621780|NCT00619983|66000772|FG002|Test Drug Alone|Withdrawal by Subject|0|||
23139098|NCT00412061|64255647|FG000|Open Label Phase|Adverse Event|0|||
23139099|NCT00412061|64255648|FG001|Open Label Phase|Adverse Event|46|||
23139100|NCT00412061|64255647|FG000|Open Label Phase|Withdrawal by Subject|0|||
23139101|NCT00412061|64255648|FG001|Open Label Phase|Withdrawal by Subject|15|||
23139102|NCT00412061|64255647|FG000|Open Label Phase|Administrative Problems|0|||
23431939|NCT00454584|65327456|FG003|After Controlled Period|Adverse Event|9|||
23431940|NCT00454584|65327457|FG004|After Controlled Period|Adverse Event|3|||
23431941|NCT00454584|65327458|FG005|After Controlled Period|Adverse Event|9|||
23431942|NCT00454584|65327453|FG000|After Controlled Period|Lack of Efficacy|0|||
23431943|NCT00454584|65327454|FG001|After Controlled Period|Lack of Efficacy|0|||
23431944|NCT00454584|65327455|FG002|After Controlled Period|Lack of Efficacy|0|||
23553485|NCT02085252|65751437|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
23553486|NCT02085252|65751438|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
23553487|NCT02085252|65751437|FG000|Overall Study|Reason Not Specified|0|||
23553488|NCT02085252|65751438|FG001|Overall Study|Reason Not Specified|1|||
23553489|NCT02085252|65751437|FG000|Overall Study|Reason Unknown|0|||
23553490|NCT02085252|65751438|FG001|Overall Study|Reason Unknown|1|||
23139103|NCT00412061|64255648|FG001|Open Label Phase|Administrative Problems|13|||
23139104|NCT00412061|64255647|FG000|Open Label Phase|Death|0|||
23553491|NCT01003899|65751439|FG000|Overall Study|Other Adverse Event|8|||
23553492|NCT01003899|65751439|FG000|Overall Study|Not entered|4|||
23553493|NCT01003899|65751439|FG000|Overall Study|Not treated|1|||
23553494|NCT01003899|65751439|FG000|Overall Study|Progressive disease|34|||
23553495|NCT03141359|65751451|FG000|Overall Study|Death|32|||
23139105|NCT00412061|64255648|FG001|Open Label Phase|Death|7|||
23215814|NCT00340834|64531255|FG000|Extension Phase of Study|Death|0|||
23215815|NCT00340834|64531256|FG001|Extension Phase of Study|Death|0|||
23215816|NCT00340834|64531257|FG002|Extension Phase of Study|Death|0|||
23215817|NCT00340834|64531258|FG003|Extension Phase of Study|Death|0|||
23215818|NCT00340834|64531259|FG004|Extension Phase of Study|Death|1|||
23215819|NCT00912340|64531260|FG000|Overall Study|Adverse Event|2|||
23215820|NCT00912340|64531261|FG001|Overall Study|Adverse Event|4|||
23215821|NCT00912340|64531262|FG002|Overall Study|Adverse Event|0|||
23215822|NCT00912340|64531260|FG000|Overall Study|Protocol revised to remove arm|0|||
23215823|NCT00912340|64531261|FG001|Overall Study|Protocol revised to remove arm|0|||
23215824|NCT00912340|64531262|FG002|Overall Study|Protocol revised to remove arm|4|||
23215825|NCT01896856|64531265|FG000|Overall Study|Transportation issues / Non-compliance|0|||
23317901|NCT00587860|64908185|FG000|Overall Study|Lost to Follow-up|2|||
23431945|NCT00454584|65327456|FG003|After Controlled Period|Lack of Efficacy|1|||
23431946|NCT00454584|65327457|FG004|After Controlled Period|Lack of Efficacy|0|||
23431947|NCT00454584|65327458|FG005|After Controlled Period|Lack of Efficacy|0|||
23431948|NCT00454584|65327453|FG000|After Controlled Period|Lost to Follow-up|0|||
23553496|NCT03141359|65751451|FG000|Overall Study|Still On Study (in follow up)|29|||
23553497|NCT00499031|65751452|FG000|Overall Study|Improper pre-protocol treatment|1|||
23553498|NCT00499031|65751452|FG000|Overall Study|Required test not done|1|||
23553499|NCT00499031|65751452|FG000|Overall Study|Never treated|1|||
23553500|NCT04570436|65754510|FG000|Overall Study|Adverse Event|0|||
23621781|NCT00619983|66000773|FG003|Test Drug Alone|Withdrawal by Subject|1|||
23621782|NCT00619983|66000770|FG000|Test Drug Alone|Failure of daily diary device|1|||
23621783|NCT00619983|66000771|FG001|Test Drug Alone|Failure of daily diary device|1|||
23621784|NCT00619983|66000772|FG002|Test Drug Alone|Failure of daily diary device|2|||
23621785|NCT00619983|66000773|FG003|Test Drug Alone|Failure of daily diary device|2|||
23139106|NCT00412061|64255647|FG000|Open Label Phase|Lost to Follow-up|0|||
23139107|NCT00412061|64255648|FG001|Open Label Phase|Lost to Follow-up|2|||
23139108|NCT00412061|64255647|FG000|Open Label Phase|New Cancer Therapy|0|||
23139109|NCT00412061|64255648|FG001|Open Label Phase|New Cancer Therapy|1|||
23139110|NCT02390245|64258899|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
23139111|NCT02390245|64258900|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
23139112|NCT02390245|64258901|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
23139113|NCT02390245|64258899|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
23139114|NCT02390245|64258900|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
23139115|NCT02390245|64258901|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
23139116|NCT05086276|64258902|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
23139117|NCT05086276|64258903|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
23139118|NCT03590366|64258908|FG000|Overall Study|Adverse Event|0|||
23139119|NCT03590366|64258909|FG001|Overall Study|Adverse Event|3|||
23139120|NCT03590366|64258908|FG000|Overall Study|Lost to Follow-up|3|||
23139121|NCT03590366|64258909|FG001|Overall Study|Lost to Follow-up|3|||
23621786|NCT00702650|66000784|FG000|Overall Study|Withdrawal by Subject|9|||
23621787|NCT00702650|66000784|FG000|Overall Study|Non-Compliance of Study Drug|3|||
23139122|NCT03590366|64258908|FG000|Overall Study|Withdrawal by Subject|0|||
23139123|NCT03590366|64258909|FG001|Overall Study|Withdrawal by Subject|2|||
23139124|NCT01146782|64258910|FG000|Screening Cohort|Screen Failure|187|||
23139125|NCT01146782|64258910|FG000|Screening Cohort|Lost to Follow-up|4|||
23139126|NCT01146782|64258910|FG000|Screening Cohort|Physician Decision|1|||
23139127|NCT01146782|64258910|FG000|Screening Cohort|Withdrawal by Subject|29|||
23139128|NCT01146782|64258910|FG000|Safety Cohort|Screen Failure|61|||
23431949|NCT00454584|65327454|FG001|After Controlled Period|Lost to Follow-up|0|||
23431950|NCT00454584|65327455|FG002|After Controlled Period|Lost to Follow-up|0|||
23431951|NCT00454584|65327456|FG003|After Controlled Period|Lost to Follow-up|2|||
23431952|NCT00454584|65327457|FG004|After Controlled Period|Lost to Follow-up|4|||
23431953|NCT00454584|65327458|FG005|After Controlled Period|Lost to Follow-up|6|||
23431954|NCT00454584|65327453|FG000|After Controlled Period|Other|0|||
23431955|NCT00454584|65327454|FG001|After Controlled Period|Other|0|||
23431956|NCT00454584|65327455|FG002|After Controlled Period|Other|0|||
23431957|NCT00454584|65327456|FG003|After Controlled Period|Other|1|||
23431958|NCT00454584|65327457|FG004|After Controlled Period|Other|0|||
23431959|NCT00454584|65327458|FG005|After Controlled Period|Other|0|||
23431960|NCT00454584|65327453|FG000|After Controlled Period|Other|0|||
23431961|NCT00454584|65327454|FG001|After Controlled Period|Other|0|||
23431962|NCT00454584|65327455|FG002|After Controlled Period|Other|0|||
23431963|NCT00454584|65327456|FG003|After Controlled Period|Other|13|||
23431964|NCT00454584|65327457|FG004|After Controlled Period|Other|5|||
23431965|NCT00454584|65327458|FG005|After Controlled Period|Other|17|||
23431966|NCT00330668|65327459|FG000|BID Dosing Period|Adverse Event|1|||
23431967|NCT00330668|65327459|FG000|BID Dosing Period|Lost to Follow-up|7|||
23431968|NCT00330668|65327459|FG000|BID Dosing Period|Non-Compliance|5|||
23431969|NCT00330668|65327459|FG000|BID Dosing Period|Withdrawal by Subject|19|||
23431970|NCT00330668|65327459|FG000|BID Dosing Period|Sponsor's decision|1|||
23621788|NCT00702650|66000784|FG000|Overall Study|Lost to Follow-up|2|||
23139129|NCT01146782|64258910|FG000|Safety Cohort|Withdrawal by Subject|4|||
23139130|NCT01146782|64258910|FG000|Safety Cohort|Control AHI <5|4|||
23139131|NCT01146782|64258910|FG000|Safety Cohort|TST <4 hrs|14|||
23139132|NCT01146782|64258910|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
23139133|NCT01146782|64258910|FG000|Primary Endpoint Cohort|Physician Decision|1|||
23139134|NCT03207009|64258911|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
23139135|NCT02413333|64258912|FG000|Period 1|Adverse Event|1|||
23139136|NCT02413333|64258913|FG001|Period 1|Adverse Event|0|||
23139137|NCT02413333|64258912|FG000|Period 1|Reason Not Specified|0|||
23139138|NCT02413333|64258913|FG001|Period 1|Reason Not Specified|1|||
23139139|NCT02413333|64258912|FG000|Period 2|Protocol Deviation|1|||
23139140|NCT02413333|64258913|FG001|Period 2|Protocol Deviation|0|||
23139141|NCT01590082|64258914|FG000|Overall Study|Withdrawal by Subject|1|||
23139142|NCT01590082|64258915|FG001|Overall Study|Withdrawal by Subject|0|||
23139143|NCT01590082|64258914|FG000|Overall Study|Ineligible|1|||
23139144|NCT01590082|64258915|FG001|Overall Study|Ineligible|0|||
23139145|NCT04493502|64258916|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
23139146|NCT04493502|64258917|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
23139147|NCT04493502|64258916|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
23139148|NCT04493502|64258917|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
23139149|NCT04493502|64258916|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
23139150|NCT04493502|64258917|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
23431971|NCT00330668|65327459|FG000|BID Dosing Period|Other|3|||
23431972|NCT00330668|65327459|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
23431973|NCT00330668|65327459|FG000|QD Dosing Period|Other|1|||
23431974|NCT00330668|65327459|FG000|QD Dosing Period|Withdrawal by Subject|1|||
23431975|NCT00330668|65327459|FG000|QD Dosing Period|Lost to Follow-up|2|||
23431976|NCT00387647|65327460|FG000|Overall Study|Death|18|||
23621789|NCT00702650|66000784|FG000|Overall Study|Non-Compliance with Site Directives|1|||
23139151|NCT04493502|64258916|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
23139152|NCT04493502|64258917|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
23139153|NCT04493502|64258916|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
23139154|NCT04493502|64258917|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
23139155|NCT04493502|64258916|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
23139156|NCT04493502|64258917|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
23139157|NCT04493502|64258916|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
23139158|NCT04493502|64258917|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
23139159|NCT04493502|64258916|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
23139160|NCT04493502|64258917|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
23139161|NCT04493502|64258916|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
23139162|NCT04493502|64258917|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
23139163|NCT04493502|64258916|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
23139164|NCT04493502|64258917|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
23139165|NCT04493502|64258916|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
23139166|NCT04493502|64258917|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
23553501|NCT04570436|65754511|FG001|Overall Study|Adverse Event|0|||
23553502|NCT04570436|65754512|FG002|Overall Study|Adverse Event|1|||
23553503|NCT04570436|65754513|FG003|Overall Study|Adverse Event|0|||
23553504|NCT04570436|65754514|FG004|Overall Study|Adverse Event|0|||
23553505|NCT04570436|65754515|FG005|Overall Study|Adverse Event|0|||
23553506|NCT04570436|65754516|FG006|Overall Study|Adverse Event|0|||
23553507|NCT04570436|65754517|FG007|Overall Study|Adverse Event|0|||
23553508|NCT04570436|65754518|FG008|Overall Study|Adverse Event|0|||
23553509|NCT04570436|65754519|FG009|Overall Study|Adverse Event|0|||
23553510|NCT04570436|65754510|FG000|Overall Study|Physician Decision|1|||
23553511|NCT04570436|65754511|FG001|Overall Study|Physician Decision|0|||
23553512|NCT04570436|65754512|FG002|Overall Study|Physician Decision|0|||
23553513|NCT04570436|65754513|FG003|Overall Study|Physician Decision|0|||
23553514|NCT04570436|65754514|FG004|Overall Study|Physician Decision|0|||
23553515|NCT04570436|65754515|FG005|Overall Study|Physician Decision|0|||
23553516|NCT04570436|65754516|FG006|Overall Study|Physician Decision|0|||
23553517|NCT04570436|65754517|FG007|Overall Study|Physician Decision|0|||
23139167|NCT04493502|64258916|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
23139168|NCT04493502|64258917|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
23139169|NCT04493502|64258916|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
23139170|NCT04493502|64258917|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
23139171|NCT04343872|64258918|FG000|Overall Study|Lost to Follow-up|6|||
23139172|NCT04343872|64258919|FG001|Overall Study|Lost to Follow-up|3|||
23139173|NCT04602221|64258920|FG000|Overall Study|Discontinuation of trial treatment|0|||
23139174|NCT04602221|64258921|FG001|Overall Study|Discontinuation of trial treatment|0|||
23139175|NCT04602221|64258922|FG002|Overall Study|Discontinuation of trial treatment|1|||
23139176|NCT04602221|64258923|FG003|Overall Study|Discontinuation of trial treatment|0|||
23139177|NCT04602221|64258924|FG004|Overall Study|Discontinuation of trial treatment|0|||
23139178|NCT04602221|64258925|FG005|Overall Study|Discontinuation of trial treatment|0|||
23139179|NCT04602221|64258926|FG006|Overall Study|Discontinuation of trial treatment|0|||
23139180|NCT04602221|64258927|FG007|Overall Study|Discontinuation of trial treatment|0|||
23139181|NCT04602221|64258928|FG008|Overall Study|Discontinuation of trial treatment|0|||
23139182|NCT04602221|64258929|FG009|Overall Study|Discontinuation of trial treatment|0|||
23139183|NCT04602221|64258930|FG010|Overall Study|Discontinuation of trial treatment|0|||
23139184|NCT04602221|64258931|FG011|Overall Study|Discontinuation of trial treatment|0|||
23139185|NCT04602221|64258932|FG012|Overall Study|Discontinuation of trial treatment|0|||
23139186|NCT04602221|64258933|FG013|Overall Study|Discontinuation of trial treatment|0|||
23139187|NCT04602221|64258934|FG014|Overall Study|Discontinuation of trial treatment|0|||
23139188|NCT04602221|64258935|FG015|Overall Study|Discontinuation of trial treatment|0|||
23139189|NCT04602221|64258936|FG016|Overall Study|Discontinuation of trial treatment|0|||
23139190|NCT04602221|64258937|FG017|Overall Study|Discontinuation of trial treatment|0|||
23139191|NCT04602221|64258920|FG000|Overall Study|Other than listed|0|||
23139192|NCT04602221|64258921|FG001|Overall Study|Other than listed|0|||
23139193|NCT04602221|64258922|FG002|Overall Study|Other than listed|0|||
23139194|NCT04602221|64258923|FG003|Overall Study|Other than listed|0|||
23139195|NCT04602221|64258924|FG004|Overall Study|Other than listed|0|||
23139196|NCT04602221|64258925|FG005|Overall Study|Other than listed|0|||
23139197|NCT04602221|64258926|FG006|Overall Study|Other than listed|0|||
23139198|NCT04602221|64258927|FG007|Overall Study|Other than listed|0|||
23553518|NCT04570436|65754518|FG008|Overall Study|Physician Decision|0|||
23553519|NCT04570436|65754519|FG009|Overall Study|Physician Decision|0|||
23139199|NCT04602221|64258928|FG008|Overall Study|Other than listed|0|||
23431977|NCT01440881|65327461|FG000|Overall Study|Death|0|||
23431978|NCT01440881|65327462|FG001|Overall Study|Death|1|||
23553520|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
23553521|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
23553522|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
23431979|NCT01141478|65327463|FG000|Overall Study|Withdrawal by Subject|1|||
23139200|NCT04602221|64258929|FG009|Overall Study|Other than listed|0|||
23139201|NCT04602221|64258930|FG010|Overall Study|Other than listed|0|||
23431980|NCT01141478|65327464|FG001|Overall Study|Withdrawal by Subject|1|||
23431981|NCT03480009|65327465|FG000|Overall Study|Lost to Follow-up|4|||
23431982|NCT03480009|65327466|FG001|Overall Study|Lost to Follow-up|5|||
23431983|NCT03480009|65327467|FG002|Overall Study|Lost to Follow-up|4|||
23431984|NCT03480009|65327468|FG003|Overall Study|Lost to Follow-up|0|||
23431985|NCT02745535|65327469|FG000|Overall Study|Death|1|||
23431986|NCT02745535|65327469|FG000|Overall Study|Adverse Event|3|||
23431987|NCT02745535|65327469|FG000|Overall Study|Lost to Follow-up|2|||
23431988|NCT03238924|65327470|FG000|Overall Study|Withdrawal by Subject|2|||
23431989|NCT03238924|65327471|FG001|Overall Study|Withdrawal by Subject|2|||
23431990|NCT02445573|65327477|FG000|Overall Study|Withdrawal by Subject|1|||
23431991|NCT02445573|65327478|FG001|Overall Study|Withdrawal by Subject|1|||
23431992|NCT02445573|65327477|FG000|Overall Study|Lost to Follow-up|0|||
23431993|NCT02445573|65327478|FG001|Overall Study|Lost to Follow-up|1|||
23431994|NCT00491608|65327479|FG000|Overall Study|Death|2|||
23431995|NCT00491608|65327479|FG000|Overall Study|Withdrawal by Subject|1|||
23431996|NCT01331291|65327481|FG000|Overall Study|Lack of Efficacy|2|||
23431997|NCT01331291|65327482|FG001|Overall Study|Lack of Efficacy|8|||
23431998|NCT01331291|65327481|FG000|Overall Study|Death|0|||
23431999|NCT01331291|65327482|FG001|Overall Study|Death|1|||
23432000|NCT02198235|65327488|FG000|Overall Study|Lost to Follow-up|3|||
23432001|NCT02198235|65327489|FG001|Overall Study|Lost to Follow-up|2|||
23432002|NCT02198235|65327490|FG002|Overall Study|Lost to Follow-up|2|||
23432003|NCT03238248|65327492|FG000|Overall Study|Death|5|||
23432004|NCT03238248|65327492|FG000|Overall Study|Withdrawal by Subject|7|||
23432005|NCT03238248|65327492|FG000|Overall Study|Participant proceeding to transplant|10|||
23432006|NCT03238248|65327492|FG000|Overall Study|Lack of Efficacy|4|||
23432007|NCT03238248|65327492|FG000|Overall Study|Physician Decision|3|||
23432008|NCT03238248|65327492|FG000|Overall Study|Transitioning to another study|1|||
23432009|NCT03238248|65327492|FG000|Overall Study|No longer benefiting|1|||
23432010|NCT03238248|65327492|FG000|Overall Study|Other complicating disease|1|||
23432011|NCT03238248|65327492|FG000|Overall Study|Adverse Event|5|||
23432012|NCT03238248|65327492|FG000|Overall Study|Disease progression|26|||
23139202|NCT04602221|64258931|FG011|Overall Study|Other than listed|0|||
23139203|NCT04602221|64258932|FG012|Overall Study|Other than listed|0|||
23139204|NCT04602221|64258933|FG013|Overall Study|Other than listed|0|||
23139205|NCT04602221|64258934|FG014|Overall Study|Other than listed|0|||
23139206|NCT04602221|64258935|FG015|Overall Study|Other than listed|1|||
23139207|NCT04602221|64258936|FG016|Overall Study|Other than listed|0|||
23139208|NCT04602221|64258937|FG017|Overall Study|Other than listed|1|||
23139209|NCT04602221|64258920|FG000|Overall Study|Withdrawal by Subject|0|||
23139210|NCT04602221|64258921|FG001|Overall Study|Withdrawal by Subject|0|||
23139211|NCT04602221|64258922|FG002|Overall Study|Withdrawal by Subject|0|||
23139212|NCT04602221|64258923|FG003|Overall Study|Withdrawal by Subject|0|||
23139213|NCT04602221|64258924|FG004|Overall Study|Withdrawal by Subject|0|||
23139214|NCT04602221|64258925|FG005|Overall Study|Withdrawal by Subject|0|||
23139215|NCT04602221|64258926|FG006|Overall Study|Withdrawal by Subject|0|||
23139216|NCT04602221|64258927|FG007|Overall Study|Withdrawal by Subject|0|||
23139217|NCT04602221|64258928|FG008|Overall Study|Withdrawal by Subject|0|||
23139218|NCT04602221|64258929|FG009|Overall Study|Withdrawal by Subject|0|||
23139219|NCT04602221|64258930|FG010|Overall Study|Withdrawal by Subject|0|||
23139220|NCT04602221|64258931|FG011|Overall Study|Withdrawal by Subject|0|||
23139221|NCT04602221|64258932|FG012|Overall Study|Withdrawal by Subject|1|||
23139222|NCT04602221|64258933|FG013|Overall Study|Withdrawal by Subject|0|||
23139223|NCT04602221|64258934|FG014|Overall Study|Withdrawal by Subject|0|||
23139224|NCT04602221|64258935|FG015|Overall Study|Withdrawal by Subject|0|||
23139225|NCT04602221|64258936|FG016|Overall Study|Withdrawal by Subject|0|||
23139226|NCT04602221|64258937|FG017|Overall Study|Withdrawal by Subject|0|||
23139227|NCT04602221|64258920|FG000|Overall Study|Lost to Follow-up|0|||
23139228|NCT04602221|64258921|FG001|Overall Study|Lost to Follow-up|0|||
23139229|NCT04602221|64258922|FG002|Overall Study|Lost to Follow-up|0|||
23139230|NCT04602221|64258923|FG003|Overall Study|Lost to Follow-up|0|||
23139231|NCT04602221|64258924|FG004|Overall Study|Lost to Follow-up|0|||
23139232|NCT04602221|64258925|FG005|Overall Study|Lost to Follow-up|1|||
23139233|NCT04602221|64258926|FG006|Overall Study|Lost to Follow-up|0|||
23139234|NCT04602221|64258927|FG007|Overall Study|Lost to Follow-up|0|||
23139235|NCT04602221|64258928|FG008|Overall Study|Lost to Follow-up|0|||
23139236|NCT04602221|64258929|FG009|Overall Study|Lost to Follow-up|0|||
23139237|NCT04602221|64258930|FG010|Overall Study|Lost to Follow-up|0|||
23139238|NCT04602221|64258931|FG011|Overall Study|Lost to Follow-up|0|||
23139239|NCT04602221|64258932|FG012|Overall Study|Lost to Follow-up|0|||
23139240|NCT04602221|64258933|FG013|Overall Study|Lost to Follow-up|0|||
23139241|NCT04602221|64258934|FG014|Overall Study|Lost to Follow-up|0|||
23139242|NCT04602221|64258935|FG015|Overall Study|Lost to Follow-up|0|||
23432013|NCT03238248|65327492|FG000|Overall Study|N/A participant is still on treatment|1|||
23432014|NCT03238248|65327492|FG000|Overall Study|Decline in condition|1|||
23139243|NCT04602221|64258936|FG016|Overall Study|Lost to Follow-up|0|||
23139244|NCT04602221|64258937|FG017|Overall Study|Lost to Follow-up|0|||
23139245|NCT01642251|64258943|FG000|Overall Study|Progressive disease|0|||
23139246|NCT01642251|64258944|FG001|Overall Study|Progressive disease|0|||
23139247|NCT01642251|64258945|FG002|Overall Study|Progressive disease|3|||
23139248|NCT01642251|64258946|FG003|Overall Study|Progressive disease|3|||
23139249|NCT01642251|64258943|FG000|Overall Study|Adverse Event|0|||
23139250|NCT01642251|64258944|FG001|Overall Study|Adverse Event|0|||
23139251|NCT01642251|64258945|FG002|Overall Study|Adverse Event|5|||
23139252|NCT01642251|64258946|FG003|Overall Study|Adverse Event|4|||
23139253|NCT01642251|64258943|FG000|Overall Study|Death|0|||
23139254|NCT01642251|64258944|FG001|Overall Study|Death|0|||
23139255|NCT01642251|64258945|FG002|Overall Study|Death|1|||
23139256|NCT01642251|64258946|FG003|Overall Study|Death|3|||
23139257|NCT01642251|64258943|FG000|Overall Study|Withdrawal by Subject|0|||
23139258|NCT01642251|64258944|FG001|Overall Study|Withdrawal by Subject|0|||
23139259|NCT01642251|64258945|FG002|Overall Study|Withdrawal by Subject|1|||
23139260|NCT01642251|64258946|FG003|Overall Study|Withdrawal by Subject|3|||
23139261|NCT01642251|64258943|FG000|Overall Study|Alternative therapy|0|||
23139262|NCT01642251|64258944|FG001|Overall Study|Alternative therapy|0|||
23139263|NCT01642251|64258945|FG002|Overall Study|Alternative therapy|0|||
23139264|NCT01642251|64258946|FG003|Overall Study|Alternative therapy|2|||
23139265|NCT01642251|64258943|FG000|Overall Study|Other complicating disease|0|||
23139266|NCT01642251|64258944|FG001|Overall Study|Other complicating disease|0|||
23139267|NCT01642251|64258945|FG002|Overall Study|Other complicating disease|1|||
23139268|NCT01642251|64258946|FG003|Overall Study|Other complicating disease|0|||
23139269|NCT01642251|64258943|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
23139270|NCT01642251|64258944|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
23139271|NCT01642251|64258945|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
23139272|NCT01642251|64258946|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
23139273|NCT00816400|64258953|FG000|Overall Study|Death|2|||
23139274|NCT00816400|64258954|FG001|Overall Study|Death|3|||
23139275|NCT00816400|64258955|FG002|Overall Study|Death|3|||
23139276|NCT00816400|64258956|FG003|Overall Study|Death|3|||
23139277|NCT00816400|64258957|FG004|Overall Study|Death|2|||
23139278|NCT00816400|64258958|FG005|Overall Study|Death|3|||
23139279|NCT00816400|64258959|FG006|Overall Study|Death|2|||
23139280|NCT00816400|64258960|FG007|Overall Study|Death|5|||
23139281|NCT00816400|64258961|FG008|Overall Study|Death|6|||
23139282|NCT00816400|64258953|FG000|Overall Study|In hospice care at the end of the study|0|||
23215826|NCT01896856|64531266|FG001|Overall Study|Transportation issues / Non-compliance|0|||
23553523|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
23553524|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
23553525|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
23553526|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
23553527|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
23553528|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Other|18|||
23553529|NCT02565914|65754520|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
23553530|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
23553531|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Other|1|||
23553532|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
23553533|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
23553534|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
23553535|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
23553536|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
23553537|NCT02565914|65754520|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
23553538|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
23553539|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
23553540|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
23553541|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
23621790|NCT00702650|66000784|FG000|Overall Study|Sponsor Request|1|||
23553542|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
23553543|NCT02565914|65754520|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
23553544|NCT02816138|65754521|FG000|Overall Study|Adverse Event|1|||
23553545|NCT02883062|65754522|FG000|Overall Study|Withdrawal by Subject|6|||
23553546|NCT02883062|65754523|FG001|Overall Study|Withdrawal by Subject|0|||
23553547|NCT04026165|65754530|FG000|Run-in Placebo Period|Enrollment Error|13|||
23553548|NCT04026165|65754531|FG001|Run-in Placebo Period|Enrollment Error|0|||
23553549|NCT04026165|65754532|FG002|Run-in Placebo Period|Enrollment Error|0|||
23553550|NCT04026165|65754533|FG003|Run-in Placebo Period|Enrollment Error|0|||
23553551|NCT04026165|65754530|FG000|Run-in Placebo Period|Run-in Failure|4|||
23621791|NCT00702650|66000784|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
23139283|NCT00816400|64258954|FG001|Overall Study|In hospice care at the end of the study|0|||
23139284|NCT00816400|64258955|FG002|Overall Study|In hospice care at the end of the study|2|||
23553552|NCT04026165|65754531|FG001|Run-in Placebo Period|Run-in Failure|0|||
23553553|NCT04026165|65754532|FG002|Run-in Placebo Period|Run-in Failure|0|||
23553554|NCT04026165|65754533|FG003|Run-in Placebo Period|Run-in Failure|0|||
23553555|NCT04026165|65754530|FG000|Run-in Placebo Period|Protocol Violation|2|||
23432015|NCT03238248|65327492|FG000|Overall Study|Alternative therapy|2|||
23432016|NCT01300260|65327494|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
23432017|NCT01300260|65327495|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
23432018|NCT01300260|65327494|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
23432019|NCT01300260|65327495|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
23432020|NCT01300260|65327494|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
23432021|NCT01300260|65327495|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
23432022|NCT02265796|65327501|FG000|Overall Study|Death|1|||
23432023|NCT02265796|65327502|FG001|Overall Study|Death|0|||
23432024|NCT02265796|65327501|FG000|Overall Study|started on excluded medication|1|||
23432025|NCT02265796|65327502|FG001|Overall Study|started on excluded medication|0|||
23432026|NCT02265796|65327501|FG000|Overall Study|Withdrawal by Subject|1|||
23432027|NCT02265796|65327502|FG001|Overall Study|Withdrawal by Subject|1|||
23432028|NCT00701805|65327503|FG000|Overall Study|Withdrawal by Subject|3|||
23432029|NCT00701805|65327504|FG001|Overall Study|Withdrawal by Subject|1|||
23432030|NCT00701805|65327505|FG002|Overall Study|Withdrawal by Subject|4|||
23432031|NCT00701805|65327506|FG003|Overall Study|Withdrawal by Subject|3|||
23432032|NCT00701805|65327503|FG000|Overall Study|Adverse Event|0|||
23432033|NCT00701805|65327504|FG001|Overall Study|Adverse Event|1|||
23432034|NCT00701805|65327505|FG002|Overall Study|Adverse Event|1|||
23432035|NCT00701805|65327506|FG003|Overall Study|Adverse Event|0|||
23432036|NCT00701805|65327503|FG000|Overall Study|Missed 7 consecutive doses|0|||
23432037|NCT00701805|65327504|FG001|Overall Study|Missed 7 consecutive doses|1|||
23432038|NCT00701805|65327505|FG002|Overall Study|Missed 7 consecutive doses|0|||
23432039|NCT00701805|65327506|FG003|Overall Study|Missed 7 consecutive doses|0|||
23621792|NCT00702650|66000784|FG000|Overall Study|Adverse Event|3|||
23553556|NCT04026165|65754531|FG001|Run-in Placebo Period|Protocol Violation|0|||
23553557|NCT04026165|65754532|FG002|Run-in Placebo Period|Protocol Violation|0|||
23553558|NCT04026165|65754533|FG003|Run-in Placebo Period|Protocol Violation|0|||
23553559|NCT04026165|65754530|FG000|Run-in Placebo Period|Withdrew Consent|2|||
23553560|NCT04026165|65754531|FG001|Run-in Placebo Period|Withdrew Consent|0|||
23553561|NCT04026165|65754532|FG002|Run-in Placebo Period|Withdrew Consent|0|||
23553562|NCT04026165|65754533|FG003|Run-in Placebo Period|Withdrew Consent|0|||
23553563|NCT04026165|65754530|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
23553564|NCT04026165|65754531|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
23553565|NCT04026165|65754532|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
23553566|NCT04026165|65754533|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
23553567|NCT04026165|65754530|FG000|Run-in SEL Period|Run-in Failure|0|||
23553568|NCT04026165|65754531|FG001|Run-in SEL Period|Run-in Failure|26|||
23553569|NCT04026165|65754532|FG002|Run-in SEL Period|Run-in Failure|0|||
23553570|NCT04026165|65754533|FG003|Run-in SEL Period|Run-in Failure|0|||
23553571|NCT04026165|65754530|FG000|Run-in SEL Period|Withdrew Consent|0|||
23553572|NCT04026165|65754531|FG001|Run-in SEL Period|Withdrew Consent|10|||
23553573|NCT04026165|65754532|FG002|Run-in SEL Period|Withdrew Consent|0|||
23553574|NCT04026165|65754533|FG003|Run-in SEL Period|Withdrew Consent|0|||
23553575|NCT04026165|65754530|FG000|Run-in SEL Period|Enrollment Error|0|||
23553576|NCT04026165|65754531|FG001|Run-in SEL Period|Enrollment Error|4|||
23553577|NCT04026165|65754532|FG002|Run-in SEL Period|Enrollment Error|0|||
23553578|NCT04026165|65754533|FG003|Run-in SEL Period|Enrollment Error|0|||
23553579|NCT04026165|65754530|FG000|Run-in SEL Period|Protocol Violation|0|||
23553580|NCT04026165|65754531|FG001|Run-in SEL Period|Protocol Violation|3|||
23553581|NCT04026165|65754532|FG002|Run-in SEL Period|Protocol Violation|0|||
23553582|NCT04026165|65754533|FG003|Run-in SEL Period|Protocol Violation|0|||
23553583|NCT04026165|65754530|FG000|Run-in SEL Period|Investigator's Discretion|0|||
23553584|NCT04026165|65754531|FG001|Run-in SEL Period|Investigator's Discretion|2|||
23553585|NCT04026165|65754532|FG002|Run-in SEL Period|Investigator's Discretion|0|||
23553586|NCT04026165|65754533|FG003|Run-in SEL Period|Investigator's Discretion|0|||
23553587|NCT04026165|65754530|FG000|Run-in SEL Period|Death|0|||
23553588|NCT04026165|65754531|FG001|Run-in SEL Period|Death|1|||
23553589|NCT04026165|65754532|FG002|Run-in SEL Period|Death|0|||
23553590|NCT04026165|65754533|FG003|Run-in SEL Period|Death|0|||
23553591|NCT04026165|65754530|FG000|Randomized Period|Withdrew Consent|0|||
23553592|NCT04026165|65754531|FG001|Randomized Period|Withdrew Consent|0|||
23432040|NCT00701805|65327503|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
23432041|NCT00701805|65327504|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
23553593|NCT04026165|65754532|FG002|Randomized Period|Withdrew Consent|5|||
23553594|NCT04026165|65754533|FG003|Randomized Period|Withdrew Consent|8|||
23553595|NCT04026165|65754530|FG000|Randomized Period|Death|0|||
23432042|NCT00701805|65327505|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
23432043|NCT00701805|65327506|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
23432044|NCT00701805|65327503|FG000|Overall Study|Physician decision, change of therapy|0|||
23432045|NCT00701805|65327504|FG001|Overall Study|Physician decision, change of therapy|0|||
23432046|NCT00701805|65327505|FG002|Overall Study|Physician decision, change of therapy|0|||
23432047|NCT00701805|65327506|FG003|Overall Study|Physician decision, change of therapy|1|||
23432048|NCT00701805|65327503|FG000|Overall Study|Difficult to travel to dialysis site|0|||
23432049|NCT00701805|65327504|FG001|Overall Study|Difficult to travel to dialysis site|0|||
23432050|NCT00701805|65327505|FG002|Overall Study|Difficult to travel to dialysis site|1|||
23432051|NCT00701805|65327506|FG003|Overall Study|Difficult to travel to dialysis site|0|||
23432052|NCT00701805|65327503|FG000|Overall Study|Resumption criteria were not met|0|||
23432053|NCT00701805|65327504|FG001|Overall Study|Resumption criteria were not met|1|||
23432054|NCT00701805|65327505|FG002|Overall Study|Resumption criteria were not met|0|||
23432055|NCT00701805|65327506|FG003|Overall Study|Resumption criteria were not met|0|||
23432056|NCT01110382|65327508|FG000|Overall Study|Withdrawal by Subject|0|||
23432057|NCT01110382|65327509|FG001|Overall Study|Withdrawal by Subject|1|||
23432058|NCT01110382|65327508|FG000|Overall Study|Protocol Violation|0|||
23432059|NCT01110382|65327509|FG001|Overall Study|Protocol Violation|1|||
23432060|NCT01716104|65327510|FG000|Overall Study|Do not meet inclusion criteria|6|||
23432061|NCT01716104|65327511|FG001|Overall Study|Do not meet inclusion criteria|7|||
23432062|NCT03729245|65327514|FG000|Overall Study|Lost to Follow-up|5|||
23432063|NCT03729245|65327515|FG001|Overall Study|Lost to Follow-up|6|||
23432064|NCT03729245|65327514|FG000|Overall Study|Withdrawal by Subject|16|||
23432065|NCT03729245|65327515|FG001|Overall Study|Withdrawal by Subject|19|||
23432066|NCT03729245|65327514|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
23432067|NCT03729245|65327515|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
23432068|NCT00249613|65327525|FG000|12 Month Follow-up|Death|1|||
23432069|NCT00249613|65327526|FG001|12 Month Follow-up|Death|1|||
23432070|NCT00249613|65327525|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
23432071|NCT00249613|65327526|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
23432072|NCT00249613|65327525|FG000|12 Month Follow-up|Lost to Follow-up|10|||
23432073|NCT00249613|65327526|FG001|12 Month Follow-up|Lost to Follow-up|8|||
23432074|NCT02228096|65327527|FG000|Overall Study|Study terminated by Sponsor|24|||
23432075|NCT02228096|65327527|FG000|Overall Study|Lack of Efficacy|18|||
23432076|NCT02228096|65327527|FG000|Overall Study|Death|12|||
23432077|NCT02228096|65327527|FG000|Overall Study|Physician Decision|3|||
23432078|NCT02228096|65327527|FG000|Overall Study|Subject/guardian decision|2|||
23432079|NCT02228096|65327527|FG000|Overall Study|New therapy for study indication|1|||
23432080|NCT02228096|65327527|FG000|Overall Study|Enrolled, not infused|11|||
23432081|NCT03442296|65327530|FG000|3 Month Follow-up|Death|3|||
23432082|NCT03442296|65327531|FG001|3 Month Follow-up|Death|1|||
23432083|NCT03442296|65327530|FG000|3 Month Follow-up|Lost to Follow-up|1|||
23553596|NCT04026165|65754531|FG001|Randomized Period|Death|0|||
23553597|NCT04026165|65754532|FG002|Randomized Period|Death|5|||
23553598|NCT04026165|65754533|FG003|Randomized Period|Death|7|||
23553599|NCT04026165|65754530|FG000|Randomized Period|Investigator's Discretion|0|||
23553600|NCT04026165|65754531|FG001|Randomized Period|Investigator's Discretion|0|||
23553601|NCT04026165|65754532|FG002|Randomized Period|Investigator's Discretion|2|||
23553602|NCT04026165|65754533|FG003|Randomized Period|Investigator's Discretion|2|||
23553603|NCT04026165|65754530|FG000|Randomized Period|Lost to Follow-up|0|||
23553604|NCT04026165|65754531|FG001|Randomized Period|Lost to Follow-up|0|||
23553605|NCT04026165|65754532|FG002|Randomized Period|Lost to Follow-up|2|||
23553606|NCT04026165|65754533|FG003|Randomized Period|Lost to Follow-up|2|||
23553607|NCT03240692|65754534|FG000|Overall Study|Physician Decision|1|||
23553608|NCT03240692|65754534|FG000|Overall Study|Withdrawal by Subject|1|||
23553609|NCT05072080|65754537|FG000|Overall Study|Death|0|||
23553610|NCT05072080|65754538|FG001|Overall Study|Death|0|||
23553611|NCT05072080|65754539|FG002|Overall Study|Death|1|||
23553612|NCT05072080|65754540|FG003|Overall Study|Death|0|||
23553613|NCT05072080|65754537|FG000|Overall Study|Lost to Follow-up|65|||
23621793|NCT00338949|66000785|FG000|Subject Screening|Screen failures|11|||
23432084|NCT03442296|65327531|FG001|3 Month Follow-up|Lost to Follow-up|1|||
23553614|NCT05072080|65754538|FG001|Overall Study|Lost to Follow-up|70|||
23553615|NCT05072080|65754539|FG002|Overall Study|Lost to Follow-up|58|||
23553616|NCT05072080|65754540|FG003|Overall Study|Lost to Follow-up|23|||
23553617|NCT05072080|65754537|FG000|Overall Study|Physician Decision|2|||
23553618|NCT05072080|65754538|FG001|Overall Study|Physician Decision|1|||
23553619|NCT05072080|65754539|FG002|Overall Study|Physician Decision|1|||
23432085|NCT03442296|65327530|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
23432086|NCT03442296|65327531|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
23553620|NCT05072080|65754540|FG003|Overall Study|Physician Decision|0|||
23553621|NCT05072080|65754537|FG000|Overall Study|Withdrawal by Subject|45|||
23553622|NCT05072080|65754538|FG001|Overall Study|Withdrawal by Subject|30|||
23553623|NCT05072080|65754539|FG002|Overall Study|Withdrawal by Subject|27|||
23317902|NCT00587860|64908186|FG001|Overall Study|Lost to Follow-up|2|||
23553624|NCT05072080|65754540|FG003|Overall Study|Withdrawal by Subject|7|||
23553625|NCT05072080|65754537|FG000|Overall Study|Sponsor Decision|0|||
23553626|NCT05072080|65754538|FG001|Overall Study|Sponsor Decision|1|||
23553627|NCT05072080|65754539|FG002|Overall Study|Sponsor Decision|0|||
23553628|NCT05072080|65754540|FG003|Overall Study|Sponsor Decision|0|||
23553629|NCT05072080|65754537|FG000|Overall Study|Subject moved|1|||
23553630|NCT05072080|65754538|FG001|Overall Study|Subject moved|3|||
23553631|NCT05072080|65754539|FG002|Overall Study|Subject moved|5|||
23553632|NCT05072080|65754540|FG003|Overall Study|Subject moved|2|||
23553633|NCT05072080|65754537|FG000|Overall Study|Withdrawal by parent|0|||
23553634|NCT05072080|65754538|FG001|Overall Study|Withdrawal by parent|0|||
23553635|NCT05072080|65754539|FG002|Overall Study|Withdrawal by parent|1|||
23553636|NCT05072080|65754540|FG003|Overall Study|Withdrawal by parent|0|||
23553637|NCT05072080|65754537|FG000|Overall Study|Subject was deployed|0|||
23553638|NCT05072080|65754538|FG001|Overall Study|Subject was deployed|1|||
23553639|NCT05072080|65754539|FG002|Overall Study|Subject was deployed|0|||
23553640|NCT05072080|65754540|FG003|Overall Study|Subject was deployed|0|||
23553641|NCT05072080|65754537|FG000|Overall Study|Subject left site without receiving dose|0|||
23553642|NCT05072080|65754538|FG001|Overall Study|Subject left site without receiving dose|1|||
23553643|NCT05072080|65754539|FG002|Overall Study|Subject left site without receiving dose|0|||
23553644|NCT05072080|65754540|FG003|Overall Study|Subject left site without receiving dose|0|||
23553645|NCT05072080|65754537|FG000|Overall Study|Subject incarcerated|0|||
23553646|NCT05072080|65754538|FG001|Overall Study|Subject incarcerated|1|||
23553647|NCT05072080|65754539|FG002|Overall Study|Subject incarcerated|0|||
23553648|NCT05072080|65754540|FG003|Overall Study|Subject incarcerated|1|||
23553649|NCT05072080|65754537|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
23553650|NCT05072080|65754538|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
23553651|NCT05072080|65754539|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
23553652|NCT05072080|65754540|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
23553653|NCT05072080|65754537|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
23553654|NCT05072080|65754538|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
23553655|NCT05072080|65754539|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
23553656|NCT05072080|65754540|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
23553657|NCT03365882|65754541|FG000|Randomization|Still Receiving Protocol Treatment|2|||
23553658|NCT03365882|65754542|FG001|Randomization|Still Receiving Protocol Treatment|0|||
23553659|NCT03365882|65754541|FG000|Randomization|Adverse Event|1|||
23553660|NCT03365882|65754542|FG001|Randomization|Adverse Event|2|||
23553661|NCT03365882|65754541|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
23553662|NCT03365882|65754542|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
23553663|NCT03365882|65754541|FG000|Randomization|Progression/Relapse|21|||
23139285|NCT00816400|64258956|FG003|Overall Study|In hospice care at the end of the study|0|||
23139286|NCT00816400|64258957|FG004|Overall Study|In hospice care at the end of the study|0|||
23139287|NCT00816400|64258958|FG005|Overall Study|In hospice care at the end of the study|0|||
23139288|NCT00816400|64258959|FG006|Overall Study|In hospice care at the end of the study|0|||
23139289|NCT00816400|64258960|FG007|Overall Study|In hospice care at the end of the study|0|||
23139290|NCT00816400|64258961|FG008|Overall Study|In hospice care at the end of the study|0|||
23139291|NCT02891408|64258962|FG000|Overall Study|Lost to Follow-up|0|||
23139292|NCT02891408|64258963|FG001|Overall Study|Lost to Follow-up|0|||
23139293|NCT02891408|64258964|FG002|Overall Study|Lost to Follow-up|1|||
23139294|NCT02891408|64258965|FG003|Overall Study|Lost to Follow-up|0|||
23139295|NCT02891408|64258966|FG004|Overall Study|Lost to Follow-up|0|||
23139296|NCT02891408|64258967|FG005|Overall Study|Lost to Follow-up|0|||
23139297|NCT02891408|64258968|FG006|Overall Study|Lost to Follow-up|0|||
23139298|NCT00081497|64258969|FG000|Overall Study|Adverse Event|2|||
23139299|NCT00081497|64258970|FG001|Overall Study|Adverse Event|0|||
23139300|NCT00081497|64258969|FG000|Overall Study|Death|0|||
23139301|NCT00081497|64258970|FG001|Overall Study|Death|1|||
23139302|NCT00081497|64258969|FG000|Overall Study|Withdrawal by Subject|1|||
23139303|NCT00081497|64258970|FG001|Overall Study|Withdrawal by Subject|0|||
23139304|NCT00081497|64258969|FG000|Overall Study|Non-compliance|0|||
23139305|NCT00081497|64258970|FG001|Overall Study|Non-compliance|1|||
23139306|NCT03656510|64258972|FG000|Overall Study|Lost to Follow-up|1|||
23139307|NCT03656510|64258973|FG001|Overall Study|Lost to Follow-up|0|||
23139308|NCT03656510|64258974|FG002|Overall Study|Lost to Follow-up|0|||
23139309|NCT03656510|64258975|FG003|Overall Study|Lost to Follow-up|0|||
23317903|NCT00587860|64908185|FG000|Overall Study|Withdrawal by Subject|3|||
23139310|NCT03656510|64258976|FG004|Overall Study|Lost to Follow-up|0|||
23139311|NCT03656510|64258977|FG005|Overall Study|Lost to Follow-up|0|||
23139312|NCT03656510|64258972|FG000|Overall Study|Withdrawal by Subject|1|||
23317904|NCT00587860|64908186|FG001|Overall Study|Withdrawal by Subject|3|||
23553664|NCT03365882|65754542|FG001|Randomization|Progression/Relapse|3|||
23553665|NCT03365882|65754541|FG000|Randomization|Death|1|||
23553666|NCT03365882|65754542|FG001|Randomization|Death|0|||
23553667|NCT03365882|65754541|FG000|Randomization|Other - Not Protocol Specified|1|||
23553668|NCT03365882|65754542|FG001|Randomization|Other - Not Protocol Specified|1|||
23553669|NCT03365882|65754541|FG000|Randomization|Major Protocol Deviation|0|||
23139313|NCT03656510|64258973|FG001|Overall Study|Withdrawal by Subject|1|||
23139314|NCT03656510|64258974|FG002|Overall Study|Withdrawal by Subject|0|||
23139315|NCT03656510|64258975|FG003|Overall Study|Withdrawal by Subject|1|||
23139316|NCT03656510|64258976|FG004|Overall Study|Withdrawal by Subject|0|||
23139317|NCT03656510|64258977|FG005|Overall Study|Withdrawal by Subject|0|||
23139318|NCT01090427|64258978|FG000|After Controlled Period|Death|0|||
23139319|NCT01090427|64258979|FG001|After Controlled Period|Death|0|||
23139320|NCT01090427|64258980|FG002|After Controlled Period|Death|0|||
23139321|NCT01090427|64258981|FG003|After Controlled Period|Death|0|||
23139322|NCT01090427|64258982|FG004|After Controlled Period|Death|0|||
23139323|NCT01090427|64258983|FG005|After Controlled Period|Death|1|||
23139324|NCT01090427|64258984|FG006|After Controlled Period|Death|0|||
23139325|NCT01090427|64258978|FG000|After Controlled Period|Lack of Efficacy|0|||
23139326|NCT01090427|64258979|FG001|After Controlled Period|Lack of Efficacy|0|||
23139327|NCT01090427|64258980|FG002|After Controlled Period|Lack of Efficacy|0|||
23139328|NCT01090427|64258981|FG003|After Controlled Period|Lack of Efficacy|0|||
23139329|NCT01090427|64258982|FG004|After Controlled Period|Lack of Efficacy|0|||
23139330|NCT01090427|64258983|FG005|After Controlled Period|Lack of Efficacy|3|||
23139331|NCT01090427|64258984|FG006|After Controlled Period|Lack of Efficacy|2|||
23139332|NCT01090427|64258978|FG000|After Controlled Period|Adverse Event|0|||
23139333|NCT01090427|64258979|FG001|After Controlled Period|Adverse Event|0|||
23139334|NCT01090427|64258980|FG002|After Controlled Period|Adverse Event|0|||
23139335|NCT01090427|64258981|FG003|After Controlled Period|Adverse Event|2|||
23139336|NCT01090427|64258982|FG004|After Controlled Period|Adverse Event|0|||
23139337|NCT01090427|64258983|FG005|After Controlled Period|Adverse Event|1|||
23317905|NCT02203331|64908187|FG000|Overall Study|Pregnancy|1|||
23317906|NCT02203331|64908188|FG001|Overall Study|Pregnancy|0|||
23317907|NCT02203331|64908189|FG002|Overall Study|Pregnancy|0|||
23317908|NCT02203331|64908190|FG003|Overall Study|Pregnancy|0|||
23317909|NCT02203331|64908191|FG004|Overall Study|Pregnancy|2|||
23553670|NCT03365882|65754542|FG001|Randomization|Major Protocol Deviation|1|||
23553671|NCT03365882|65754541|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
23553672|NCT03365882|65754542|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
23553673|NCT03365882|65754541|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
23553674|NCT03365882|65754542|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
23553675|NCT03365882|65754541|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
23553676|NCT03365882|65754542|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
23553677|NCT03365882|65754541|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
23553678|NCT03365882|65754542|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
23553679|NCT04330638|65754543|FG000|Overall Study|Adverse Event|9|||
23553680|NCT04330638|65754544|FG001|Overall Study|Adverse Event|10|||
23553681|NCT04330638|65754545|FG002|Overall Study|Adverse Event|15|||
23553682|NCT04330638|65754546|FG003|Overall Study|Adverse Event|6|||
23553683|NCT04330638|65754547|FG004|Overall Study|Adverse Event|10|||
23553684|NCT04330638|65754548|FG005|Overall Study|Adverse Event|5|||
23553685|NCT04330638|65754543|FG000|Overall Study|Other|2|||
23553686|NCT04330638|65754544|FG001|Overall Study|Other|2|||
23553687|NCT04330638|65754545|FG002|Overall Study|Other|5|||
23553688|NCT04330638|65754546|FG003|Overall Study|Other|1|||
23553689|NCT04330638|65754547|FG004|Overall Study|Other|3|||
23553690|NCT04330638|65754548|FG005|Overall Study|Other|2|||
23553691|NCT04330638|65754543|FG000|Overall Study|Withdrawal by Subject|4|||
23553692|NCT04330638|65754544|FG001|Overall Study|Withdrawal by Subject|0|||
23553693|NCT04330638|65754545|FG002|Overall Study|Withdrawal by Subject|0|||
23553694|NCT04330638|65754546|FG003|Overall Study|Withdrawal by Subject|0|||
23553695|NCT04330638|65754547|FG004|Overall Study|Withdrawal by Subject|0|||
23553696|NCT04330638|65754548|FG005|Overall Study|Withdrawal by Subject|0|||
23553697|NCT04330638|65754543|FG000|Overall Study|Lost to Follow-up|3|||
23553698|NCT04330638|65754544|FG001|Overall Study|Lost to Follow-up|2|||
23553699|NCT04330638|65754545|FG002|Overall Study|Lost to Follow-up|3|||
23553700|NCT04330638|65754546|FG003|Overall Study|Lost to Follow-up|2|||
23553701|NCT04330638|65754547|FG004|Overall Study|Lost to Follow-up|3|||
23553702|NCT04330638|65754548|FG005|Overall Study|Lost to Follow-up|0|||
23139338|NCT01090427|64258984|FG006|After Controlled Period|Adverse Event|0|||
23139339|NCT00598273|64258985|FG000|Overall Study|Adverse Event|4|||
23139340|NCT00598273|64258986|FG001|Overall Study|Adverse Event|5|||
23139341|NCT00598273|64258987|FG002|Overall Study|Adverse Event|2|||
23139342|NCT00598273|64258985|FG000|Overall Study|Death|6|||
23432087|NCT03442296|65327530|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
23139343|NCT00598273|64258986|FG001|Overall Study|Death|12|||
23553703|NCT01112579|65754552|FG000|Overall Study|Missed Visit|1|||
23553704|NCT01112579|65754553|FG001|Overall Study|Missed Visit|1|||
23553705|NCT01112579|65754552|FG000|Overall Study|Death|0|||
23553706|NCT01112579|65754553|FG001|Overall Study|Death|2|||
23553707|NCT02134587|65754554|FG000|Overall Study|Did not completed all meetings|30|||
23317910|NCT02203331|64908192|FG005|Overall Study|Pregnancy|0|||
23317911|NCT02203331|64908187|FG000|Overall Study|Withdrawal by Subject|1|||
23621794|NCT00338949|66000786|FG001|Subject Screening|Screen failures|11|||
23553708|NCT02660827|65754558|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
23553709|NCT02660827|65754558|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
23553710|NCT02660827|65754558|FG000|From Study to End of Continued Access|Adverse Event|3|||
23553711|NCT02660827|65754558|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
23553712|NCT02660827|65754558|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
23553713|NCT02660827|65754558|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
23553714|NCT02660827|65754558|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
23553715|NCT02660827|65754558|FG000|Period 2: Continued Access Period|Adverse Event|3|||
23553716|NCT03538951|65754559|FG000|Overall Study|Withdrawal by Subject|1|||
23553717|NCT03538951|65754560|FG001|Overall Study|Withdrawal by Subject|2|||
23553718|NCT03832595|65754563|FG000|Overall Study|Death|142|||
23553719|NCT03832595|65754564|FG001|Overall Study|Death|130|||
23553720|NCT03832595|65754563|FG000|Overall Study|Medical management without dialysis|37|||
23553721|NCT03832595|65754564|FG001|Overall Study|Medical management without dialysis|1|||
23553722|NCT00160680|65754565|FG000|Overall Study|Adverse Event|0|||
23553723|NCT00160680|65754566|FG001|Overall Study|Adverse Event|1|||
23553724|NCT00160680|65754565|FG000|Overall Study|Lack of Efficacy|2|||
23553725|NCT00160680|65754566|FG001|Overall Study|Lack of Efficacy|1|||
23553726|NCT00160680|65754565|FG000|Overall Study|Lost to Follow-up|3|||
23553727|NCT00160680|65754566|FG001|Overall Study|Lost to Follow-up|2|||
23553728|NCT00160680|65754565|FG000|Overall Study|Withdrawal by Subject|4|||
23553729|NCT00160680|65754566|FG001|Overall Study|Withdrawal by Subject|9|||
23553730|NCT00951275|65754573|FG000|Overall Study|Administrative Reason|1|||
23553731|NCT00951275|65754573|FG000|Overall Study|Adverse Event|7|||
23553732|NCT00951275|65754573|FG000|Overall Study|Withdrawal by Subject|4|||
23553733|NCT00951275|65754573|FG000|Overall Study|Protocol Violation|1|||
23553734|NCT00045110|65754574|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
23553735|NCT00045110|65754575|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
23553736|NCT00045110|65754576|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
23553737|NCT00045110|65754574|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
23553738|NCT00045110|65754575|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
23553739|NCT00045110|65754576|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
23553740|NCT00045110|65754574|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
23553741|NCT00045110|65754575|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
23621795|NCT00338949|66000785|FG000|Randomization|Withdrawal by Subject|1|||
23621796|NCT00338949|66000786|FG001|Randomization|Withdrawal by Subject|0|||
23621797|NCT00338949|66000785|FG000|Randomization|Adverse Event|0|||
23621798|NCT00338949|66000786|FG001|Randomization|Adverse Event|5|||
23621799|NCT01194271|66000787|FG000|Overall Study|Withdrawal by Subject|1|||
23621800|NCT01194271|66000787|FG000|Overall Study|Ineligible, Screen Failure|1|||
23621801|NCT01194271|66000787|FG000|Overall Study|Death|1|||
23621802|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
23621803|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
23621804|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
23621805|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
23215827|NCT01896856|64531267|FG002|Overall Study|Transportation issues / Non-compliance|1|||
23215828|NCT01896856|64531268|FG003|Overall Study|Transportation issues / Non-compliance|0|||
23215829|NCT01896856|64531269|FG004|Overall Study|Transportation issues / Non-compliance|0|||
23215830|NCT01896856|64531270|FG005|Overall Study|Transportation issues / Non-compliance|0|||
23215831|NCT02806947|64531271|FG000|Overall Study|Withdrawal by Subject|5|||
23317912|NCT02203331|64908188|FG001|Overall Study|Withdrawal by Subject|0|||
23553742|NCT00045110|65754576|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
23553743|NCT03321396|65754577|FG000|Overall Study|Physician Decision|1|||
23553744|NCT02195986|65754580|FG000|Overall Study|Adverse Event|3|||
23553745|NCT02195986|65754581|FG001|Overall Study|Adverse Event|0|||
23553746|NCT02195986|65754582|FG002|Overall Study|Adverse Event|0|||
23553747|NCT02195986|65754580|FG000|Overall Study|Withdrawal by Subject|0|||
23553748|NCT02195986|65754581|FG001|Overall Study|Withdrawal by Subject|3|||
23553749|NCT02195986|65754582|FG002|Overall Study|Withdrawal by Subject|0|||
23553750|NCT02195986|65754580|FG000|Overall Study|Family Emergency|0|||
23553751|NCT02195986|65754581|FG001|Overall Study|Family Emergency|0|||
23621806|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
23553752|NCT02195986|65754582|FG002|Overall Study|Family Emergency|1|||
23553753|NCT02195986|65754580|FG000|Overall Study|Protocol Violation|0|||
23553754|NCT02195986|65754581|FG001|Overall Study|Protocol Violation|1|||
23553755|NCT02195986|65754582|FG002|Overall Study|Protocol Violation|1|||
23553756|NCT02195986|65754580|FG000|Overall Study|Non-compliance|0|||
23553757|NCT02195986|65754581|FG001|Overall Study|Non-compliance|1|||
23553758|NCT02195986|65754582|FG002|Overall Study|Non-compliance|0|||
23553759|NCT00602667|65754590|FG000|Overall Study|Still on Therapy|0|||
23553760|NCT00602667|65754591|FG001|Overall Study|Still on Therapy|2|||
23553761|NCT00602667|65754592|FG002|Overall Study|Still on Therapy|2|||
23621807|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
23621808|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
23139344|NCT00598273|64258987|FG002|Overall Study|Death|8|||
23139345|NCT00598273|64258985|FG000|Overall Study|Lost to Follow-up|8|||
23139346|NCT00598273|64258986|FG001|Overall Study|Lost to Follow-up|3|||
23215832|NCT02806947|64531272|FG001|Overall Study|Withdrawal by Subject|1|||
23215833|NCT04605159|64531278|FG000|Overall Study|Adverse Event|6|||
23215834|NCT04605159|64531279|FG001|Overall Study|Adverse Event|3|||
23215835|NCT04605159|64531280|FG002|Overall Study|Adverse Event|21|||
23215836|NCT04605159|64531281|FG003|Overall Study|Adverse Event|4|||
23215837|NCT04605159|64531278|FG000|Overall Study|Lost to Follow-up|74|||
23215838|NCT04605159|64531279|FG001|Overall Study|Lost to Follow-up|45|||
23215839|NCT04605159|64531280|FG002|Overall Study|Lost to Follow-up|119|||
23215840|NCT04605159|64531281|FG003|Overall Study|Lost to Follow-up|80|||
23215841|NCT04605159|64531278|FG000|Overall Study|Protocol Violation|4|||
23215842|NCT04605159|64531279|FG001|Overall Study|Protocol Violation|5|||
23215843|NCT04605159|64531280|FG002|Overall Study|Protocol Violation|2|||
23215844|NCT04605159|64531281|FG003|Overall Study|Protocol Violation|0|||
23215845|NCT04605159|64531278|FG000|Overall Study|Withdrawal by Subject|66|||
23215846|NCT04605159|64531279|FG001|Overall Study|Withdrawal by Subject|37|||
23215847|NCT04605159|64531280|FG002|Overall Study|Withdrawal by Subject|68|||
23215848|NCT04605159|64531281|FG003|Overall Study|Withdrawal by Subject|50|||
23215849|NCT04605159|64531278|FG000|Overall Study|Migrated / moved from the study area|32|||
23215850|NCT04605159|64531279|FG001|Overall Study|Migrated / moved from the study area|22|||
23215851|NCT04605159|64531280|FG002|Overall Study|Migrated / moved from the study area|41|||
23215852|NCT04605159|64531281|FG003|Overall Study|Migrated / moved from the study area|21|||
23215853|NCT04605159|64531278|FG000|Overall Study|Other|1|||
23215854|NCT04605159|64531279|FG001|Overall Study|Other|2|||
23215855|NCT04605159|64531280|FG002|Overall Study|Other|7|||
23215856|NCT04605159|64531281|FG003|Overall Study|Other|3|||
23215857|NCT00260429|64531288|FG000|Overall Study|failure to follow appointments|1|||
23215858|NCT00260429|64531289|FG001|Overall Study|failure to follow appointments|0|||
23215859|NCT00260429|64531288|FG000|Overall Study|scheduled hand surgery|1|||
23621809|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
23621810|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
23621811|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
23621812|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
23553762|NCT00602667|65754590|FG000|Overall Study|Death|0|||
23553763|NCT00602667|65754591|FG001|Overall Study|Death|1|||
23553764|NCT00602667|65754592|FG002|Overall Study|Death|1|||
23553765|NCT00602667|65754590|FG000|Overall Study|Family request|3|||
23553766|NCT00602667|65754591|FG001|Overall Study|Family request|25|||
23553767|NCT00602667|65754592|FG002|Overall Study|Family request|6|||
23621813|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
23317913|NCT02203331|64908189|FG002|Overall Study|Withdrawal by Subject|1|||
23317914|NCT02203331|64908190|FG003|Overall Study|Withdrawal by Subject|0|||
23553768|NCT00602667|65754590|FG000|Overall Study|Excessive toxicity|1|||
23553769|NCT00602667|65754591|FG001|Overall Study|Excessive toxicity|1|||
23553770|NCT00602667|65754592|FG002|Overall Study|Excessive toxicity|0|||
23553771|NCT00602667|65754590|FG000|Overall Study|Second malignancy|0|||
23139347|NCT00598273|64258987|FG002|Overall Study|Lost to Follow-up|5|||
23139348|NCT00598273|64258985|FG000|Overall Study|Physician Decision|0|||
23139349|NCT00598273|64258986|FG001|Overall Study|Physician Decision|0|||
23139350|NCT00598273|64258987|FG002|Overall Study|Physician Decision|1|||
23139351|NCT00598273|64258985|FG000|Overall Study|Withdrawal by Subject|12|||
23139352|NCT00598273|64258986|FG001|Overall Study|Withdrawal by Subject|10|||
23139353|NCT00598273|64258987|FG002|Overall Study|Withdrawal by Subject|10|||
23139354|NCT00598273|64258985|FG000|Overall Study|Noncompliance|3|||
23139355|NCT00598273|64258986|FG001|Overall Study|Noncompliance|2|||
23139356|NCT00598273|64258987|FG002|Overall Study|Noncompliance|3|||
23139357|NCT00598273|64258985|FG000|Overall Study|Relocation|0|||
23139358|NCT00598273|64258986|FG001|Overall Study|Relocation|2|||
23139359|NCT00598273|64258987|FG002|Overall Study|Relocation|4|||
23139360|NCT00598273|64258985|FG000|Overall Study|Renal transplant|1|||
23139361|NCT00598273|64258986|FG001|Overall Study|Renal transplant|0|||
23139362|NCT00598273|64258987|FG002|Overall Study|Renal transplant|1|||
23215860|NCT00260429|64531289|FG001|Overall Study|scheduled hand surgery|0|||
23215861|NCT00961116|64531293|FG000|Washout Period of 7 Days|Adverse Event|1|||
23215862|NCT00961116|64531294|FG001|Washout Period of 7 Days|Adverse Event|1|||
23215863|NCT00961116|64531293|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
23215864|NCT00961116|64531294|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23215865|NCT00961116|64531293|FG000|Washout Period of 7 Days|Protocol Violation|0|||
23553772|NCT00602667|65754591|FG001|Overall Study|Second malignancy|1|||
23553773|NCT00602667|65754592|FG002|Overall Study|Second malignancy|0|||
23553774|NCT00602667|65754590|FG000|Overall Study|Physician Decision|2|||
23215866|NCT00961116|64531294|FG001|Washout Period of 7 Days|Protocol Violation|1|||
23317915|NCT02203331|64908191|FG004|Overall Study|Withdrawal by Subject|0|||
23317916|NCT02203331|64908192|FG005|Overall Study|Withdrawal by Subject|3|||
23317917|NCT02203331|64908187|FG000|Overall Study|Adverse Event|4|||
23621814|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
23621815|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
23621816|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
23621817|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
23621818|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
23621819|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
23621820|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
23621821|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
23621822|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
23621823|NCT01125566|66000788|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
23621824|NCT01125566|66000789|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
23621825|NCT01125566|66000790|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
23621826|NCT01125566|66000788|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
23621827|NCT01125566|66000789|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
23621828|NCT01125566|66000790|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
23621829|NCT01125566|66000788|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
23621830|NCT01125566|66000789|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
23621831|NCT01125566|66000790|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
23621832|NCT01125566|66000788|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
23621833|NCT01125566|66000789|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
23621834|NCT01125566|66000790|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
23621835|NCT01125566|66000788|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
23621836|NCT01125566|66000789|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
23621837|NCT01125566|66000790|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
23621838|NCT03463577|66000791|FG000|Overall Study|Lost to Follow-up|238|||
23139363|NCT00598273|64258985|FG000|Overall Study|Site elected to close|1|||
23139364|NCT00598273|64258986|FG001|Overall Study|Site elected to close|0|||
23139365|NCT00598273|64258987|FG002|Overall Study|Site elected to close|0|||
23139366|NCT00598273|64258985|FG000|Overall Study|Started dialysis|6|||
23139367|NCT00598273|64258986|FG001|Overall Study|Started dialysis|4|||
23139368|NCT00598273|64258987|FG002|Overall Study|Started dialysis|5|||
23139369|NCT04988867|64258988|FG000|Overall Study|Study terminated by Sponsor|12|||
23139370|NCT04988867|64258988|FG000|Overall Study|Adverse Event|2|||
23139371|NCT04988867|64258988|FG000|Overall Study|Study drug noncompliance|1|||
23139372|NCT01290029|64258989|FG000|Overall Study|Other|2|||
23139373|NCT02929329|64258990|FG000|Overall Study|Withdrawal by Subject|24|||
23139374|NCT02929329|64258991|FG001|Overall Study|Withdrawal by Subject|21|||
23139375|NCT02929329|64258990|FG000|Overall Study|Lost to Follow-up|26|||
23139376|NCT02929329|64258991|FG001|Overall Study|Lost to Follow-up|20|||
23139377|NCT02929329|64258990|FG000|Overall Study|Death|1054|||
23139378|NCT02929329|64258991|FG001|Overall Study|Death|1051|||
23139379|NCT00558259|64258992|FG000|Overall Study|Adverse Event|50|||
23139380|NCT00558259|64258993|FG001|Overall Study|Adverse Event|81|||
23139381|NCT00558259|64258992|FG000|Overall Study|Protocol Violation|9|||
23139382|NCT00558259|64258993|FG001|Overall Study|Protocol Violation|5|||
23139383|NCT00558259|64258992|FG000|Overall Study|Withdrawal by Subject|12|||
23139384|NCT00558259|64258993|FG001|Overall Study|Withdrawal by Subject|13|||
23139385|NCT00446992|64258997|FG000|Overall Study|Adverse Event|11|||
23139386|NCT00446992|64258997|FG000|Overall Study|Lost to Follow-up|5|||
23139387|NCT04075994|64258998|FG000|Overall Study|Withdrawal by Subject|8|||
23139388|NCT04075994|64258999|FG001|Overall Study|Withdrawal by Subject|9|||
23139389|NCT04075994|64258998|FG000|Overall Study|Adverse Event|2|||
23139390|NCT04075994|64258999|FG001|Overall Study|Adverse Event|2|||
23139391|NCT04075994|64258998|FG000|Overall Study|Investigator withdrew|3|||
23139392|NCT04075994|64258999|FG001|Overall Study|Investigator withdrew|1|||
23139393|NCT01198756|64259000|FG000|Overall Study|Adverse Event|0|||
23139394|NCT01198756|64259001|FG001|Overall Study|Adverse Event|0|||
23139395|NCT01198756|64259002|FG002|Overall Study|Adverse Event|0|||
23139396|NCT01198756|64259003|FG003|Overall Study|Adverse Event|1|||
23139397|NCT01198756|64259000|FG000|Overall Study|Protocol Violation|0|||
23139398|NCT01198756|64259001|FG001|Overall Study|Protocol Violation|0|||
23139399|NCT01198756|64259002|FG002|Overall Study|Protocol Violation|0|||
23139400|NCT01198756|64259003|FG003|Overall Study|Protocol Violation|2|||
23139401|NCT01198756|64259000|FG000|Overall Study|Withdrawal by Subject|9|||
23139402|NCT01198756|64259001|FG001|Overall Study|Withdrawal by Subject|4|||
23139403|NCT01198756|64259002|FG002|Overall Study|Withdrawal by Subject|7|||
23139404|NCT01198756|64259003|FG003|Overall Study|Withdrawal by Subject|5|||
23139405|NCT01198756|64259000|FG000|Overall Study|Lost to Follow-up|29|||
23317918|NCT02203331|64908188|FG001|Overall Study|Adverse Event|8|||
23621839|NCT03463577|66000792|FG001|Overall Study|Lost to Follow-up|435|||
23621840|NCT03463577|66000793|FG002|Overall Study|Lost to Follow-up|0|||
23621841|NCT03463577|66000794|FG003|Overall Study|Lost to Follow-up|0|||
23621842|NCT03463577|66000795|FG004|Overall Study|Lost to Follow-up|0|||
23621843|NCT03463577|66000796|FG005|Overall Study|Lost to Follow-up|0|||
23215867|NCT03326869|64531295|FG000|Overall Study|Study data has been lost to natural disa|1|||
23215868|NCT03326869|64531296|FG001|Overall Study|Study data has been lost to natural disa|1|||
23215869|NCT01019252|64531297|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
23215870|NCT01019252|64531298|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
23215871|NCT01019252|64531297|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
23215872|NCT01019252|64531298|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
23215873|NCT01019252|64531297|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
23215874|NCT01019252|64531298|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
23215875|NCT01019252|64531297|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
23215876|NCT01019252|64531298|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
23215877|NCT03032510|64531299|FG000|Overall Study|Adverse Event|5|||
23215878|NCT03032510|64531300|FG001|Overall Study|Adverse Event|2|||
23215879|NCT03032510|64531299|FG000|Overall Study|Lost to Follow-up|8|||
23215880|NCT03032510|64531300|FG001|Overall Study|Lost to Follow-up|7|||
23215881|NCT03032510|64531299|FG000|Overall Study|Withdrawal by Subject|8|||
23215882|NCT03032510|64531300|FG001|Overall Study|Withdrawal by Subject|7|||
23215883|NCT03032510|64531299|FG000|Overall Study|Subject noncompliance|4|||
23215884|NCT03032510|64531300|FG001|Overall Study|Subject noncompliance|2|||
23553775|NCT00602667|65754591|FG001|Overall Study|Physician Decision|3|||
23553776|NCT00602667|65754592|FG002|Overall Study|Physician Decision|8|||
23553777|NCT00602667|65754590|FG000|Overall Study|Progressive disease|13|||
23621844|NCT03463577|66000791|FG000|Overall Study|With unknown pregnancy outcome|0|||
23621845|NCT03463577|66000792|FG001|Overall Study|With unknown pregnancy outcome|5|||
23621846|NCT03463577|66000793|FG002|Overall Study|With unknown pregnancy outcome|0|||
23621847|NCT03463577|66000794|FG003|Overall Study|With unknown pregnancy outcome|0|||
23621848|NCT03463577|66000795|FG004|Overall Study|With unknown pregnancy outcome|0|||
23621849|NCT03463577|66000796|FG005|Overall Study|With unknown pregnancy outcome|0|||
23621850|NCT03463577|66000791|FG000|Overall Study|Maternal death|2|||
23621851|NCT03463577|66000792|FG001|Overall Study|Maternal death|0|||
23621852|NCT03463577|66000793|FG002|Overall Study|Maternal death|0|||
23621853|NCT03463577|66000794|FG003|Overall Study|Maternal death|0|||
23621854|NCT03463577|66000795|FG004|Overall Study|Maternal death|0|||
23621855|NCT03463577|66000796|FG005|Overall Study|Maternal death|0|||
23621856|NCT03463577|66000791|FG000|Overall Study|Neonatal death|0|||
23621857|NCT03463577|66000792|FG001|Overall Study|Neonatal death|0|||
23621858|NCT03463577|66000793|FG002|Overall Study|Neonatal death|0|||
23621859|NCT03463577|66000794|FG003|Overall Study|Neonatal death|15|||
23215885|NCT03032510|64531299|FG000|Overall Study|Physician Decision|2|||
23215886|NCT03032510|64531300|FG001|Overall Study|Physician Decision|0|||
23553778|NCT00602667|65754591|FG001|Overall Study|Progressive disease|48|||
23553779|NCT00602667|65754592|FG002|Overall Study|Progressive disease|45|||
23553780|NCT00602667|65754590|FG000|Overall Study|Progressive disease prior to therapy|0|||
23553781|NCT00602667|65754591|FG001|Overall Study|Progressive disease prior to therapy|0|||
23553782|NCT00602667|65754592|FG002|Overall Study|Progressive disease prior to therapy|1|||
23553783|NCT00951041|65754593|FG000|Overall Study|Withdrawal by Subject|1|||
23553784|NCT00951041|65754594|FG001|Overall Study|Withdrawal by Subject|1|||
23553785|NCT00951041|65754593|FG000|Overall Study|Lost to Follow-up|1|||
23553786|NCT00951041|65754594|FG001|Overall Study|Lost to Follow-up|0|||
23553787|NCT00951041|65754593|FG000|Overall Study|Other|3|||
23553788|NCT00951041|65754594|FG001|Overall Study|Other|0|||
23553789|NCT03355326|65754595|FG000|Overall Study|Protocol Violation|3|||
23553790|NCT03355326|65754596|FG001|Overall Study|Protocol Violation|3|||
23553791|NCT02395042|65754597|FG000|Treatment 1 Period|Adverse Event|1|||
23553792|NCT02395042|65754598|FG001|Treatment 1 Period|Adverse Event|3|||
23553793|NCT02395042|65754599|FG002|Treatment 1 Period|Adverse Event|1|||
23553794|NCT02395042|65754597|FG000|Treatment 1 Period|Lack of Efficacy|1|||
23553795|NCT02395042|65754598|FG001|Treatment 1 Period|Lack of Efficacy|1|||
23553796|NCT02395042|65754599|FG002|Treatment 1 Period|Lack of Efficacy|0|||
23553797|NCT02395042|65754597|FG000|Treatment 1 Period|Lost to Follow-up|1|||
23621860|NCT03463577|66000795|FG004|Overall Study|Neonatal death|17|||
23215887|NCT01090102|64531305|FG000|First 12 Weeks|Withdrawal by Subject|1|||
23215888|NCT01090102|64531306|FG001|First 12 Weeks|Withdrawal by Subject|1|||
23215889|NCT01090102|64531305|FG000|First 12 Weeks|Adverse Event|2|||
23215890|NCT01090102|64531306|FG001|First 12 Weeks|Adverse Event|0|||
23553798|NCT02395042|65754598|FG001|Treatment 1 Period|Lost to Follow-up|0|||
23621861|NCT03463577|66000796|FG005|Overall Study|Neonatal death|0|||
23621862|NCT01182207|66000797|FG000|First Intervention|Positive Hepatitis Results|0|||
23621863|NCT01182207|66000798|FG001|First Intervention|Positive Hepatitis Results|1|||
23621864|NCT01182207|66000797|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
23553799|NCT02395042|65754599|FG002|Treatment 1 Period|Lost to Follow-up|0|||
23553800|NCT02395042|65754597|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
23553801|NCT02395042|65754598|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
23553802|NCT02395042|65754599|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
23553803|NCT02395042|65754597|FG000|Treatment 2 Period|Lack of Efficacy|1|||
23553804|NCT02395042|65754598|FG001|Treatment 2 Period|Lack of Efficacy|1|||
23553805|NCT02395042|65754599|FG002|Treatment 2 Period|Lack of Efficacy|0|||
23553806|NCT01041638|65754601|FG000|Overall Study|Adverse Event|4|||
23553807|NCT01041638|65754601|FG000|Overall Study|Death|1|||
23553808|NCT01041638|65754601|FG000|Overall Study|Lack of Efficacy|7|||
23553809|NCT01041638|65754601|FG000|Overall Study|Physician Decision|4|||
23553810|NCT01041638|65754601|FG000|Overall Study|Withdrawal by Subject|11|||
23553811|NCT02123108|65754602|FG000|Overall Study|Death|2|||
23553812|NCT02123108|65754603|FG001|Overall Study|Death|3|||
23553813|NCT00831779|65754607|FG000|Overall Study|Lost to Follow-up|1|||
23553814|NCT00831779|65754608|FG001|Overall Study|Lost to Follow-up|0|||
23553815|NCT00831779|65754607|FG000|Overall Study|No longer met criteria|0|||
23553816|NCT00831779|65754608|FG001|Overall Study|No longer met criteria|1|||
23139406|NCT01198756|64259001|FG001|Overall Study|Lost to Follow-up|36|||
23139407|NCT01198756|64259002|FG002|Overall Study|Lost to Follow-up|23|||
23139408|NCT01198756|64259003|FG003|Overall Study|Lost to Follow-up|18|||
23139409|NCT03625895|64259005|FG000|Overall Study|Protocol Violation|585|||
23139410|NCT01049217|64259009|FG000|Overall Study|Adverse Event|2|||
23139411|NCT01049217|64259010|FG001|Overall Study|Adverse Event|1|||
23139412|NCT01049217|64259009|FG000|Overall Study|Lack of Efficacy|1|||
23139413|NCT01049217|64259010|FG001|Overall Study|Lack of Efficacy|1|||
23139414|NCT01049217|64259009|FG000|Overall Study|Lost to Follow-up|3|||
23139415|NCT01049217|64259010|FG001|Overall Study|Lost to Follow-up|8|||
23139416|NCT01049217|64259009|FG000|Overall Study|Withdrawal by Subject|4|||
23139417|NCT01049217|64259010|FG001|Overall Study|Withdrawal by Subject|3|||
23139418|NCT01049217|64259009|FG000|Overall Study|Protocol Violation|1|||
23139419|NCT01049217|64259010|FG001|Overall Study|Protocol Violation|3|||
23139420|NCT01049217|64259009|FG000|Overall Study|Pregnancy|1|||
23139421|NCT01049217|64259010|FG001|Overall Study|Pregnancy|0|||
23139422|NCT01049217|64259009|FG000|Overall Study|Study Terminated by Sponsor|43|||
23139423|NCT01049217|64259010|FG001|Overall Study|Study Terminated by Sponsor|43|||
23139424|NCT01049217|64259009|FG000|Overall Study|Other|1|||
23139425|NCT01049217|64259010|FG001|Overall Study|Other|2|||
23139426|NCT01049217|64259009|FG000|Overall Study|Randomized but not Treated|0|||
23139427|NCT01049217|64259010|FG001|Overall Study|Randomized but not Treated|2|||
23139428|NCT02121301|64259012|FG000|Overall Study|Protocol Violation|1|||
23139429|NCT02121301|64259013|FG001|Overall Study|Protocol Violation|4|||
23139430|NCT02121301|64259014|FG002|Overall Study|Protocol Violation|1|||
23139431|NCT01323647|64259017|FG000|Overall Study|Migrated/moved from study area|2|||
23139432|NCT01323647|64259018|FG001|Overall Study|Migrated/moved from study area|0|||
23139433|NCT01323647|64259017|FG000|Overall Study|Withdrawal by Subject|5|||
23139434|NCT01323647|64259018|FG001|Overall Study|Withdrawal by Subject|0|||
23139435|NCT01323647|64259017|FG000|Overall Study|Lost to Follow-up|2|||
23139436|NCT01323647|64259018|FG001|Overall Study|Lost to Follow-up|0|||
23139437|NCT01474434|64259019|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
23139438|NCT01474434|64259020|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
23139439|NCT01474434|64259021|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
23139440|NCT01474434|64259022|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
23139441|NCT01474434|64259019|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
23139442|NCT01474434|64259020|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
23139443|NCT01474434|64259021|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
23139444|NCT01474434|64259022|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
23139445|NCT01474434|64259019|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
23139446|NCT01474434|64259020|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
23139447|NCT01474434|64259021|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
23139448|NCT01474434|64259022|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
23139449|NCT03256851|64259023|FG000|Overall Study|Withdrawal by Subject|1|||
23139450|NCT03256851|64259024|FG001|Overall Study|Withdrawal by Subject|0|||
23139451|NCT00978627|64259028|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
23139452|NCT00978627|64259029|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
23139453|NCT00978627|64259028|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
23139454|NCT00978627|64259029|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
23553817|NCT01381692|65754610|FG000|Overall Study|Adverse Event|1|||
23553818|NCT01381692|65754611|FG001|Overall Study|Adverse Event|0|||
23553819|NCT01381692|65754612|FG002|Overall Study|Adverse Event|0|||
23139455|NCT00978627|64259028|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
23139456|NCT00978627|64259029|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
23139457|NCT00978627|64259028|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
23139458|NCT00978627|64259029|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
23553820|NCT01381692|65754613|FG003|Overall Study|Adverse Event|0|||
23553821|NCT01381692|65754614|FG004|Overall Study|Adverse Event|0|||
23317919|NCT02203331|64908189|FG002|Overall Study|Adverse Event|3|||
23139459|NCT00978627|64259028|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
23139460|NCT00978627|64259029|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
23139461|NCT00978627|64259028|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
23139462|NCT00978627|64259029|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
23139463|NCT00978627|64259028|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
23139464|NCT00978627|64259029|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
23139465|NCT00978627|64259028|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
23139466|NCT00978627|64259029|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
23139467|NCT00978627|64259028|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
23139468|NCT00978627|64259029|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
23139469|NCT00734097|64259030|FG000|Screening|Protocol Violation|12|||
23139470|NCT00734097|64259030|FG000|Screening|Withdrawal by Subject|5|||
23139471|NCT00734097|64259030|FG000|Screening|Lost to Follow-up|2|||
23139472|NCT00734097|64259030|FG000|Screening|Unconfirmed pregnancy|1|||
23139473|NCT00734097|64259030|FG000|Open Label|Lost to Follow-up|7|||
23139474|NCT00734097|64259030|FG000|Open Label|Withdrawal by Subject|5|||
23553822|NCT01381692|65754615|FG005|Overall Study|Adverse Event|0|||
23553823|NCT00677352|65754616|FG000|Treatment Phase|Adverse Event|14|||
23553824|NCT00677352|65754617|FG001|Treatment Phase|Adverse Event|22|||
23553825|NCT00677352|65754616|FG000|Treatment Phase|Lack of Efficacy|2|||
23553826|NCT00677352|65754617|FG001|Treatment Phase|Lack of Efficacy|3|||
23139475|NCT00734097|64259030|FG000|Open Label|Protocol Violation|4|||
23139476|NCT04227704|64259031|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
23139477|NCT04227704|64259032|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
23139478|NCT04227704|64259033|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
23139479|NCT04227704|64259031|FG000|Overall Study|due to C/S being cancelled|1|||
23139480|NCT04227704|64259032|FG001|Overall Study|due to C/S being cancelled|0|||
23139481|NCT04227704|64259033|FG002|Overall Study|due to C/S being cancelled|0|||
23139482|NCT02424734|64259034|FG000|Overall Study|Treatment stopped to be discharged home|2|||
23139483|NCT02424734|64259035|FG001|Overall Study|Treatment stopped to be discharged home|2|||
23139484|NCT02424734|64259036|FG002|Overall Study|Treatment stopped to be discharged home|0|||
23139485|NCT01465347|64259037|FG000|Overall Study|Withdrawal by Subject|1|||
23139486|NCT01465347|64259038|FG001|Overall Study|Withdrawal by Subject|1|||
23139487|NCT01465347|64259037|FG000|Overall Study|Physician Decision|0|||
23139488|NCT01465347|64259038|FG001|Overall Study|Physician Decision|1|||
23139489|NCT01465347|64259037|FG000|Overall Study|Admitted to hospice|0|||
23139490|NCT01465347|64259038|FG001|Overall Study|Admitted to hospice|1|||
23139491|NCT00381615|64259040|FG000|Overall Study|Withdrawal by Subject|1|||
23139492|NCT00381615|64259041|FG001|Overall Study|Withdrawal by Subject|3|||
23139493|NCT00381615|64259042|FG002|Overall Study|Withdrawal by Subject|0|||
23139494|NCT00381615|64259043|FG003|Overall Study|Withdrawal by Subject|1|||
23139495|NCT00381615|64259040|FG000|Overall Study|Lost to Follow-up|3|||
23139496|NCT00381615|64259041|FG001|Overall Study|Lost to Follow-up|2|||
23317920|NCT02203331|64908190|FG003|Overall Study|Adverse Event|4|||
23139497|NCT00381615|64259042|FG002|Overall Study|Lost to Follow-up|0|||
23139498|NCT00381615|64259043|FG003|Overall Study|Lost to Follow-up|1|||
23139499|NCT00381615|64259040|FG000|Overall Study|Protocol Violation|0|||
23139500|NCT00381615|64259041|FG001|Overall Study|Protocol Violation|0|||
23139501|NCT00381615|64259042|FG002|Overall Study|Protocol Violation|1|||
23139502|NCT00381615|64259043|FG003|Overall Study|Protocol Violation|0|||
23139503|NCT02988622|64259046|FG000|Overall Study|Lost to Follow-up|17|||
23139504|NCT00194987|64259047|FG000|Overall Study|Withdrawal by Subject|0|||
23139505|NCT00194987|64259048|FG001|Overall Study|Withdrawal by Subject|3|||
23139506|NCT00296400|64259053|FG000|Overall Study|Adverse Event|7|||
23317921|NCT02203331|64908191|FG004|Overall Study|Adverse Event|3|||
23317922|NCT02203331|64908192|FG005|Overall Study|Adverse Event|3|||
23317923|NCT02203331|64908187|FG000|Overall Study|Other Reasons|1|||
23553827|NCT00677352|65754616|FG000|Treatment Phase|Lost to Follow-up|0|||
23553828|NCT00677352|65754617|FG001|Treatment Phase|Lost to Follow-up|1|||
23553829|NCT00677352|65754616|FG000|Treatment Phase|Withdrawal by Subject|7|||
23553830|NCT00677352|65754617|FG001|Treatment Phase|Withdrawal by Subject|7|||
23553831|NCT00677352|65754616|FG000|Treatment Phase|Physician Decision|1|||
23621865|NCT01182207|66000798|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
23139507|NCT00296400|64259054|FG001|Overall Study|Adverse Event|7|||
23139508|NCT00296400|64259055|FG002|Overall Study|Adverse Event|7|||
23139509|NCT00296400|64259053|FG000|Overall Study|Withdrawal by Subject|5|||
23139510|NCT00296400|64259054|FG001|Overall Study|Withdrawal by Subject|6|||
23139511|NCT00296400|64259055|FG002|Overall Study|Withdrawal by Subject|2|||
23553832|NCT00677352|65754617|FG001|Treatment Phase|Physician Decision|0|||
23139512|NCT00296400|64259053|FG000|Overall Study|Incorrect enrollment|2|||
23139513|NCT00296400|64259054|FG001|Overall Study|Incorrect enrollment|0|||
23139514|NCT00296400|64259055|FG002|Overall Study|Incorrect enrollment|0|||
23139515|NCT00296400|64259053|FG000|Overall Study|Protocol Violation|1|||
23317924|NCT02203331|64908188|FG001|Overall Study|Other Reasons|2|||
23621866|NCT00002597|66000799|FG000|Overall Study|Protocol Violation|19|||
23621867|NCT00002597|66000800|FG001|Overall Study|Protocol Violation|17|||
23621868|NCT00002597|66000799|FG000|Overall Study|Withdrawal by Subject|7|||
23621869|NCT00002597|66000800|FG001|Overall Study|Withdrawal by Subject|6|||
23621870|NCT04334278|66000801|FG000|Overall Study|Lost to Follow-up|0|||
23621871|NCT04334278|66000802|FG001|Overall Study|Lost to Follow-up|3|||
23621872|NCT04334278|66000801|FG000|Overall Study|Withdrawal by Subject|4|||
23621873|NCT04334278|66000802|FG001|Overall Study|Withdrawal by Subject|2|||
23621874|NCT01183013|66000803|FG000|Overall Study|Adverse Event|6|||
23621875|NCT01183013|66000804|FG001|Overall Study|Adverse Event|8|||
23215891|NCT01090102|64531305|FG000|First 12 Weeks|Death|1|||
23215892|NCT01090102|64531306|FG001|First 12 Weeks|Death|1|||
23553833|NCT00677352|65754616|FG000|Treatment Phase|Pregnancy|0|||
23317925|NCT02203331|64908189|FG002|Overall Study|Other Reasons|0|||
23317926|NCT02203331|64908190|FG003|Overall Study|Other Reasons|2|||
23317927|NCT02203331|64908191|FG004|Overall Study|Other Reasons|0|||
23553834|NCT00677352|65754617|FG001|Treatment Phase|Pregnancy|1|||
23553835|NCT00677352|65754616|FG000|Treatment Phase|Protocol Violation|1|||
23553836|NCT00677352|65754617|FG001|Treatment Phase|Protocol Violation|1|||
23553837|NCT00677352|65754616|FG000|Treatment Phase|Transference or work related matter|0|||
23553838|NCT00677352|65754617|FG001|Treatment Phase|Transference or work related matter|5|||
23553839|NCT00677352|65754616|FG000|Treatment Phase|Not treated|0|||
23553840|NCT00677352|65754617|FG001|Treatment Phase|Not treated|2|||
23553841|NCT00677352|65754616|FG000|Tapering Phase|Adverse Event|1|||
23553842|NCT00677352|65754617|FG001|Tapering Phase|Adverse Event|5|||
23553843|NCT00677352|65754616|FG000|Tapering Phase|Withdrawal by Subject|5|||
23553844|NCT00677352|65754617|FG001|Tapering Phase|Withdrawal by Subject|3|||
23553845|NCT00677352|65754616|FG000|Tapering Phase|Pregnancy|0|||
23553846|NCT00677352|65754617|FG001|Tapering Phase|Pregnancy|1|||
23553847|NCT00677352|65754616|FG000|Tapering Phase|Job transfer|0|||
23553848|NCT00677352|65754617|FG001|Tapering Phase|Job transfer|1|||
23553849|NCT04089865|65754618|FG000|Overall Study|Withdrawal by Subject|2|||
23553850|NCT04089865|65754619|FG001|Overall Study|Withdrawal by Subject|2|||
23553851|NCT04089865|65754620|FG002|Overall Study|Withdrawal by Subject|7|||
23553852|NCT04089865|65754621|FG003|Overall Study|Withdrawal by Subject|2|||
23553853|NCT03015402|65754622|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
23553854|NCT03015402|65754623|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
23553855|NCT03015402|65754622|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
23553856|NCT03015402|65754623|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
23553857|NCT01292928|65754624|FG000|Overall Study|Death|8|||
23553858|NCT01292928|65754624|FG000|Overall Study|Withdrawal by Subject|8|||
23553859|NCT01292928|65754624|FG000|Overall Study|Lost to Follow-up|6|||
23553860|NCT01292928|65754624|FG000|Overall Study|Physician Decision|2|||
23553861|NCT01592370|65754625|FG000|Overall Study|Disease Progression|62|||
23553862|NCT01592370|65754626|FG001|Overall Study|Disease Progression|16|||
23553863|NCT01592370|65754627|FG002|Overall Study|Disease Progression|52|||
23553864|NCT01592370|65754628|FG003|Overall Study|Disease Progression|3|||
23553865|NCT01592370|65754629|FG004|Overall Study|Disease Progression|3|||
23553866|NCT01592370|65754630|FG005|Overall Study|Disease Progression|31|||
23553867|NCT01592370|65754631|FG006|Overall Study|Disease Progression|14|||
23553868|NCT01592370|65754625|FG000|Overall Study|Study Drug Toxicity|14|||
23553869|NCT01592370|65754626|FG001|Overall Study|Study Drug Toxicity|3|||
23553870|NCT01592370|65754627|FG002|Overall Study|Study Drug Toxicity|0|||
23553871|NCT01592370|65754628|FG003|Overall Study|Study Drug Toxicity|0|||
23553872|NCT01592370|65754629|FG004|Overall Study|Study Drug Toxicity|0|||
23553873|NCT01592370|65754630|FG005|Overall Study|Study Drug Toxicity|0|||
23553874|NCT01592370|65754631|FG006|Overall Study|Study Drug Toxicity|1|||
23317928|NCT02203331|64908192|FG005|Overall Study|Other Reasons|0|||
23317929|NCT02203331|64908187|FG000|Overall Study|Lack of Efficacy|0|||
23317930|NCT02203331|64908188|FG001|Overall Study|Lack of Efficacy|2|||
23317931|NCT02203331|64908189|FG002|Overall Study|Lack of Efficacy|1|||
23317932|NCT02203331|64908190|FG003|Overall Study|Lack of Efficacy|0|||
23317933|NCT02203331|64908191|FG004|Overall Study|Lack of Efficacy|0|||
23553875|NCT01592370|65754625|FG000|Overall Study|AE unrelated to study drug|4|||
23553876|NCT01592370|65754626|FG001|Overall Study|AE unrelated to study drug|3|||
23553877|NCT01592370|65754627|FG002|Overall Study|AE unrelated to study drug|0|||
23553878|NCT01592370|65754628|FG003|Overall Study|AE unrelated to study drug|0|||
23621876|NCT01183013|66000805|FG002|Overall Study|Adverse Event|5|||
23553879|NCT01592370|65754629|FG004|Overall Study|AE unrelated to study drug|0|||
23553880|NCT01592370|65754630|FG005|Overall Study|AE unrelated to study drug|0|||
23553881|NCT01592370|65754631|FG006|Overall Study|AE unrelated to study drug|1|||
23621877|NCT01183013|66000806|FG003|Overall Study|Adverse Event|5|||
23621878|NCT01183013|66000807|FG004|Overall Study|Adverse Event|10|||
23621879|NCT01183013|66000808|FG005|Overall Study|Adverse Event|10|||
23621880|NCT01183013|66000809|FG006|Overall Study|Adverse Event|6|||
23317934|NCT02203331|64908192|FG005|Overall Study|Lack of Efficacy|1|||
23317935|NCT02203331|64908187|FG000|Overall Study|Protocol Violation|0|||
23317936|NCT02203331|64908188|FG001|Overall Study|Protocol Violation|2|||
23553882|NCT01592370|65754625|FG000|Overall Study|Request to discontinue study treatment|5|||
23621881|NCT01183013|66000803|FG000|Overall Study|Lack of Efficacy|3|||
23621882|NCT01183013|66000804|FG001|Overall Study|Lack of Efficacy|2|||
23621883|NCT01183013|66000805|FG002|Overall Study|Lack of Efficacy|1|||
23621884|NCT01183013|66000806|FG003|Overall Study|Lack of Efficacy|2|||
23621885|NCT01183013|66000807|FG004|Overall Study|Lack of Efficacy|1|||
23621886|NCT01183013|66000808|FG005|Overall Study|Lack of Efficacy|2|||
23621887|NCT01183013|66000809|FG006|Overall Study|Lack of Efficacy|0|||
23621888|NCT01183013|66000803|FG000|Overall Study|Protocol Violation|5|||
23621889|NCT01183013|66000804|FG001|Overall Study|Protocol Violation|2|||
23621890|NCT01183013|66000805|FG002|Overall Study|Protocol Violation|4|||
23621891|NCT01183013|66000806|FG003|Overall Study|Protocol Violation|0|||
23621892|NCT01183013|66000807|FG004|Overall Study|Protocol Violation|4|||
23621893|NCT01183013|66000808|FG005|Overall Study|Protocol Violation|3|||
23215893|NCT01090102|64531305|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
23215894|NCT01090102|64531306|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
23215895|NCT03351478|64531307|FG000|Overall Study|At the subject's own request|11|||
23215896|NCT03351478|64531308|FG001|Overall Study|At the subject's own request|12|||
23215897|NCT03351478|64531309|FG002|Overall Study|At the subject's own request|5|||
23215898|NCT03351478|64531307|FG000|Overall Study|Adverse Event|1|||
23432088|NCT03442296|65327531|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
23432089|NCT03442296|65327530|FG000|12 Month Follow-up|Incomplete measurement|1|||
23432090|NCT03442296|65327531|FG001|12 Month Follow-up|Incomplete measurement|1|||
23432091|NCT00884832|65327532|FG000|Overall Study|Withdrawal by Subject|0|||
23432092|NCT00884832|65327533|FG001|Overall Study|Withdrawal by Subject|1|||
23432093|NCT00752726|65327534|FG000|Overall Study|Lost to Follow-up|2|||
23432094|NCT00752726|65327535|FG001|Overall Study|Lost to Follow-up|1|||
23432095|NCT00752726|65327534|FG000|Overall Study|Adverse Event|3|||
23432096|NCT00752726|65327535|FG001|Overall Study|Adverse Event|0|||
23432097|NCT00752726|65327534|FG000|Overall Study|Withdrawal by Subject|5|||
23432098|NCT00752726|65327535|FG001|Overall Study|Withdrawal by Subject|10|||
23553883|NCT01592370|65754626|FG001|Overall Study|Request to discontinue study treatment|0|||
23553884|NCT01592370|65754627|FG002|Overall Study|Request to discontinue study treatment|2|||
23553885|NCT01592370|65754628|FG003|Overall Study|Request to discontinue study treatment|0|||
23553886|NCT01592370|65754629|FG004|Overall Study|Request to discontinue study treatment|1|||
23553887|NCT01592370|65754630|FG005|Overall Study|Request to discontinue study treatment|2|||
23215899|NCT03351478|64531308|FG001|Overall Study|Adverse Event|2|||
23553888|NCT01592370|65754631|FG006|Overall Study|Request to discontinue study treatment|0|||
23553889|NCT01592370|65754625|FG000|Overall Study|Withdrew consent|1|||
23553890|NCT01592370|65754626|FG001|Overall Study|Withdrew consent|2|||
23553891|NCT01592370|65754627|FG002|Overall Study|Withdrew consent|1|||
23553892|NCT01592370|65754628|FG003|Overall Study|Withdrew consent|1|||
23553893|NCT01592370|65754629|FG004|Overall Study|Withdrew consent|0|||
23553894|NCT01592370|65754630|FG005|Overall Study|Withdrew consent|0|||
23553895|NCT01592370|65754631|FG006|Overall Study|Withdrew consent|0|||
23553896|NCT01592370|65754625|FG000|Overall Study|Maximum clinical benefit|11|||
23553897|NCT01592370|65754626|FG001|Overall Study|Maximum clinical benefit|1|||
23553898|NCT01592370|65754627|FG002|Overall Study|Maximum clinical benefit|7|||
23553899|NCT01592370|65754628|FG003|Overall Study|Maximum clinical benefit|1|||
23553900|NCT01592370|65754629|FG004|Overall Study|Maximum clinical benefit|0|||
23553901|NCT01592370|65754630|FG005|Overall Study|Maximum clinical benefit|0|||
23553902|NCT01592370|65754631|FG006|Overall Study|Maximum clinical benefit|0|||
23553903|NCT01592370|65754625|FG000|Overall Study|No longer meets study criteria|1|||
23553904|NCT01592370|65754626|FG001|Overall Study|No longer meets study criteria|0|||
23553905|NCT01592370|65754627|FG002|Overall Study|No longer meets study criteria|0|||
23553906|NCT01592370|65754628|FG003|Overall Study|No longer meets study criteria|0|||
23553907|NCT01592370|65754629|FG004|Overall Study|No longer meets study criteria|0|||
23553908|NCT01592370|65754630|FG005|Overall Study|No longer meets study criteria|0|||
23553909|NCT01592370|65754631|FG006|Overall Study|No longer meets study criteria|0|||
23553910|NCT01592370|65754625|FG000|Overall Study|Other Reasons|6|||
23553911|NCT01592370|65754626|FG001|Overall Study|Other Reasons|0|||
23215900|NCT03351478|64531309|FG002|Overall Study|Adverse Event|1|||
23215901|NCT03351478|64531307|FG000|Overall Study|Poor compliance to protocol|1|||
23432099|NCT00752726|65327534|FG000|Overall Study|Other Reason|1|||
23432100|NCT00752726|65327535|FG001|Overall Study|Other Reason|2|||
23432101|NCT01999218|65327537|FG000|Overall Study|Hyperglycemia|18|||
23553912|NCT01592370|65754627|FG002|Overall Study|Other Reasons|10|||
23432102|NCT01999218|65327538|FG001|Overall Study|Hyperglycemia|17|||
23553913|NCT01592370|65754628|FG003|Overall Study|Other Reasons|0|||
23553914|NCT01592370|65754629|FG004|Overall Study|Other Reasons|0|||
23432103|NCT01999218|65327539|FG002|Overall Study|Hyperglycemia|17|||
23553915|NCT01592370|65754630|FG005|Overall Study|Other Reasons|1|||
23621894|NCT01183013|66000809|FG006|Overall Study|Protocol Violation|3|||
23621895|NCT01183013|66000803|FG000|Overall Study|Lost to Follow-up|7|||
23621896|NCT01183013|66000804|FG001|Overall Study|Lost to Follow-up|3|||
23621897|NCT01183013|66000805|FG002|Overall Study|Lost to Follow-up|4|||
23621898|NCT01183013|66000806|FG003|Overall Study|Lost to Follow-up|3|||
23621899|NCT01183013|66000807|FG004|Overall Study|Lost to Follow-up|2|||
23215902|NCT03351478|64531308|FG001|Overall Study|Poor compliance to protocol|0|||
23215903|NCT03351478|64531309|FG002|Overall Study|Poor compliance to protocol|0|||
23215904|NCT03351478|64531307|FG000|Overall Study|Reason not Specified|1|||
23215905|NCT03351478|64531308|FG001|Overall Study|Reason not Specified|3|||
23215906|NCT03351478|64531309|FG002|Overall Study|Reason not Specified|0|||
23553916|NCT01592370|65754631|FG006|Overall Study|Other Reasons|0|||
23553917|NCT00810264|65754632|FG000|Overall Study|Lost to Follow-up|191|||
23553918|NCT00810264|65754632|FG000|Overall Study|Withdrawal by subject or physician|721|||
23553919|NCT00810264|65754632|FG000|Overall Study|Death|641|||
23553920|NCT01207102|65754637|FG000|Overall Study|Withdrawal by Subject|5|||
23553921|NCT01207102|65754637|FG000|Overall Study|Adverse Event|2|||
23553922|NCT01207102|65754637|FG000|Overall Study|progression|2|||
23553923|NCT01207102|65754637|FG000|Overall Study|Withdrawal by Treating Physician|1|||
23553924|NCT01864564|65754638|FG000|Overall Study|Lost to Follow-up|17|||
23553925|NCT01864564|65754639|FG001|Overall Study|Lost to Follow-up|23|||
23553926|NCT01864564|65754638|FG000|Overall Study|Withdrawal by Subject|20|||
23215907|NCT03351478|64531307|FG000|Overall Study|Lost to Follow-up|0|||
23215908|NCT03351478|64531308|FG001|Overall Study|Lost to Follow-up|0|||
23553927|NCT01864564|65754639|FG001|Overall Study|Withdrawal by Subject|11|||
23553928|NCT01864564|65754638|FG000|Overall Study|Protocol Violation|0|||
23553929|NCT01864564|65754639|FG001|Overall Study|Protocol Violation|27|||
23553930|NCT01864564|65754638|FG000|Overall Study|not reported|0|||
23553931|NCT01864564|65754639|FG001|Overall Study|not reported|34|||
23553932|NCT01692782|65754640|FG000|Overall Study|Adverse Event|12|||
23553933|NCT01692782|65754641|FG001|Overall Study|Adverse Event|32|||
23553934|NCT01692782|65754642|FG002|Overall Study|Adverse Event|2|||
23553935|NCT01692782|65754640|FG000|Overall Study|Lack of Efficacy|1|||
23553936|NCT01692782|65754641|FG001|Overall Study|Lack of Efficacy|2|||
23553937|NCT01692782|65754642|FG002|Overall Study|Lack of Efficacy|0|||
23553938|NCT01692782|65754640|FG000|Overall Study|Lost to Follow-up|2|||
23553939|NCT01692782|65754641|FG001|Overall Study|Lost to Follow-up|7|||
23553940|NCT01692782|65754642|FG002|Overall Study|Lost to Follow-up|1|||
23553941|NCT01692782|65754640|FG000|Overall Study|Pregnancy|1|||
23553942|NCT01692782|65754641|FG001|Overall Study|Pregnancy|0|||
23553943|NCT01692782|65754642|FG002|Overall Study|Pregnancy|0|||
23553944|NCT01692782|65754640|FG000|Overall Study|Protocol Violation|1|||
23553945|NCT01692782|65754641|FG001|Overall Study|Protocol Violation|0|||
23553946|NCT01692782|65754642|FG002|Overall Study|Protocol Violation|2|||
23553947|NCT01692782|65754640|FG000|Overall Study|Non-complance with study drug|0|||
23553948|NCT01692782|65754641|FG001|Overall Study|Non-complance with study drug|4|||
23215909|NCT03351478|64531309|FG002|Overall Study|Lost to Follow-up|1|||
23215910|NCT00047008|64531310|FG000|Overall Study|Withdrawn consent|2|||
23215911|NCT00047008|64531311|FG001|Overall Study|Withdrawn consent|3|||
23215912|NCT00047008|64531310|FG000|Overall Study|Ineligible|9|||
23215913|NCT00047008|64531311|FG001|Overall Study|Ineligible|8|||
23215914|NCT01925612|64531315|FG000|Overall Study|Progressive Disease|1|||
23215915|NCT01925612|64531316|FG001|Overall Study|Progressive Disease|1|||
23215916|NCT01925612|64531317|FG002|Overall Study|Progressive Disease|1|||
23553949|NCT01692782|65754642|FG002|Overall Study|Non-complance with study drug|1|||
23553950|NCT01692782|65754640|FG000|Overall Study|Non-compliant with study visits|0|||
23553951|NCT01692782|65754641|FG001|Overall Study|Non-compliant with study visits|0|||
23553952|NCT01692782|65754642|FG002|Overall Study|Non-compliant with study visits|1|||
23553953|NCT01692782|65754640|FG000|Overall Study|SAE not related to study drug|0|||
23553954|NCT01692782|65754641|FG001|Overall Study|SAE not related to study drug|1|||
23553955|NCT01692782|65754642|FG002|Overall Study|SAE not related to study drug|0|||
23553956|NCT01692782|65754640|FG000|Overall Study|Withdrawal by Subject|3|||
23215917|NCT01925612|64531318|FG003|Overall Study|Progressive Disease|0|||
23215918|NCT01925612|64531319|FG004|Overall Study|Progressive Disease|0|||
23215919|NCT01925612|64531315|FG000|Overall Study|Adverse Event|3|||
23215920|NCT01925612|64531316|FG001|Overall Study|Adverse Event|3|||
23215921|NCT01925612|64531317|FG002|Overall Study|Adverse Event|0|||
23215922|NCT01925612|64531318|FG003|Overall Study|Adverse Event|1|||
23215923|NCT01925612|64531319|FG004|Overall Study|Adverse Event|2|||
23215924|NCT01814826|64531320|FG000|Overall Study|Other|3|||
23215925|NCT01814826|64531321|FG001|Overall Study|Other|5|||
23215926|NCT01814826|64531322|FG002|Overall Study|Other|0|||
23215927|NCT01814826|64531320|FG000|Overall Study|Death|29|||
23621900|NCT01183013|66000808|FG005|Overall Study|Lost to Follow-up|6|||
23215928|NCT01814826|64531321|FG001|Overall Study|Death|24|||
23553957|NCT01692782|65754641|FG001|Overall Study|Withdrawal by Subject|10|||
23553958|NCT01692782|65754642|FG002|Overall Study|Withdrawal by Subject|3|||
23553959|NCT00279201|65754647|FG000|Initiation|Death|1|||
23553960|NCT00279201|65754648|FG001|Initiation|Death|5|||
23553961|NCT00279201|65754649|FG002|Initiation|Death|0|||
23215929|NCT01814826|64531322|FG002|Overall Study|Death|3|||
23215930|NCT01451398|64531331|FG000|Overall Study|Adverse Event|7|||
23215931|NCT01451398|64531332|FG001|Overall Study|Adverse Event|9|||
23215932|NCT01451398|64531331|FG000|Overall Study|Protocol Violation|1|||
23215933|NCT01451398|64531332|FG001|Overall Study|Protocol Violation|2|||
23215934|NCT01451398|64531331|FG000|Overall Study|Physician Decision|1|||
23139516|NCT00296400|64259054|FG001|Overall Study|Protocol Violation|1|||
23139517|NCT00296400|64259055|FG002|Overall Study|Protocol Violation|1|||
23139518|NCT00296400|64259053|FG000|Overall Study|Lost to Follow-up|1|||
23139519|NCT00296400|64259054|FG001|Overall Study|Lost to Follow-up|1|||
23139520|NCT00296400|64259055|FG002|Overall Study|Lost to Follow-up|2|||
23139521|NCT00296400|64259053|FG000|Overall Study|Study specific discontinuation criteria|0|||
23139522|NCT00296400|64259054|FG001|Overall Study|Study specific discontinuation criteria|0|||
23139523|NCT00296400|64259055|FG002|Overall Study|Study specific discontinuation criteria|1|||
23139524|NCT00296400|64259053|FG000|Overall Study|Visit 10 was performed earlier|0|||
23139525|NCT00296400|64259054|FG001|Overall Study|Visit 10 was performed earlier|1|||
23317937|NCT02203331|64908189|FG002|Overall Study|Protocol Violation|0|||
23317938|NCT02203331|64908190|FG003|Overall Study|Protocol Violation|1|||
23317939|NCT02203331|64908191|FG004|Overall Study|Protocol Violation|1|||
23317940|NCT02203331|64908192|FG005|Overall Study|Protocol Violation|0|||
23317941|NCT02203331|64908187|FG000|Overall Study|Lost to Follow-up|0|||
23317942|NCT02203331|64908188|FG001|Overall Study|Lost to Follow-up|0|||
23317943|NCT02203331|64908189|FG002|Overall Study|Lost to Follow-up|0|||
23317944|NCT02203331|64908190|FG003|Overall Study|Lost to Follow-up|0|||
23317945|NCT02203331|64908191|FG004|Overall Study|Lost to Follow-up|1|||
23317946|NCT02203331|64908192|FG005|Overall Study|Lost to Follow-up|0|||
23317947|NCT01098487|64908201|FG000|Overall Study|Adverse Event|22|||
23317948|NCT01098487|64908201|FG000|Overall Study|Lack of Efficacy|11|||
23317949|NCT01098487|64908201|FG000|Overall Study|Withdrawal by Subject|7|||
23317950|NCT01098487|64908201|FG000|Overall Study|Lost to Follow-up|3|||
23317951|NCT01098487|64908201|FG000|Overall Study|Physician Decision|1|||
23139526|NCT00296400|64259055|FG002|Overall Study|Visit 10 was performed earlier|0|||
23139527|NCT00296400|64259053|FG000|Overall Study|Pregnancy|1|||
23139528|NCT00296400|64259054|FG001|Overall Study|Pregnancy|2|||
23139529|NCT00296400|64259055|FG002|Overall Study|Pregnancy|0|||
23139530|NCT01768637|64259064|FG000|Overall Study|Lost to Follow-up|2|||
23139531|NCT01768637|64259065|FG001|Overall Study|Lost to Follow-up|7|||
23139532|NCT01768637|64259064|FG000|Overall Study|Difficult blood draw|1|||
23139533|NCT01768637|64259065|FG001|Overall Study|Difficult blood draw|0|||
23139534|NCT03567434|64259066|FG000|Overall Study|Lost to Follow-up|1|||
23215935|NCT01451398|64531332|FG001|Overall Study|Physician Decision|1|||
23215936|NCT01451398|64531331|FG000|Overall Study|Withdrawal by Subject|10|||
23317952|NCT00345631|64908202|FG000|Overall Study|Withdrawal by Subject|1|||
23432104|NCT01999218|65327537|FG000|Overall Study|Lack of Efficacy|1|||
23215937|NCT01451398|64531332|FG001|Overall Study|Withdrawal by Subject|14|||
23215938|NCT01451398|64531331|FG000|Overall Study|Lost to Follow-up|6|||
23215939|NCT01451398|64531332|FG001|Overall Study|Lost to Follow-up|4|||
23215940|NCT01451398|64531331|FG000|Overall Study|Non-compliance with study drug|1|||
23215941|NCT01451398|64531332|FG001|Overall Study|Non-compliance with study drug|3|||
23215942|NCT01451398|64531331|FG000|Overall Study|Non-compliance with protocol|1|||
23215943|NCT01451398|64531332|FG001|Overall Study|Non-compliance with protocol|1|||
23215944|NCT01451398|64531331|FG000|Overall Study|Moved out of country|0|||
23215945|NCT01451398|64531332|FG001|Overall Study|Moved out of country|1|||
23215946|NCT01451398|64531331|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
23215947|NCT01451398|64531332|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
23215948|NCT01451398|64531331|FG000|Overall Study|Lack of Efficacy|0|||
23215949|NCT01451398|64531332|FG001|Overall Study|Lack of Efficacy|1|||
23215950|NCT03258593|64531338|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
23215951|NCT03258593|64531339|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
23215952|NCT03258593|64531340|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
23215953|NCT03258593|64531341|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
23215954|NCT03258593|64531338|FG000|Run-In Maintenance Phase|Disease progression|3|||
23215955|NCT03258593|64531339|FG001|Run-In Maintenance Phase|Disease progression|0|||
23215956|NCT03258593|64531340|FG002|Run-In Maintenance Phase|Disease progression|0|||
23215957|NCT03258593|64531341|FG003|Run-In Maintenance Phase|Disease progression|0|||
23215958|NCT03258593|64531338|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
23215959|NCT03258593|64531339|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
23215960|NCT03258593|64531340|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
23432105|NCT01999218|65327538|FG001|Overall Study|Lack of Efficacy|0|||
23139535|NCT03567434|64259067|FG001|Overall Study|Lost to Follow-up|3|||
23139536|NCT01139580|64259072|FG000|Overall Study|Adverse Event|5|||
23139537|NCT01139580|64259073|FG001|Overall Study|Adverse Event|4|||
23139538|NCT01139580|64259072|FG000|Overall Study|Lost to Follow-up|9|||
23139539|NCT01139580|64259073|FG001|Overall Study|Lost to Follow-up|1|||
23139540|NCT01139580|64259072|FG000|Overall Study|Lack of Efficacy|0|||
23215961|NCT03258593|64531341|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
23215962|NCT03258593|64531338|FG000|Expansion Maintenance Phase|Physician Decision|0|||
23215963|NCT03258593|64531339|FG001|Expansion Maintenance Phase|Physician Decision|1|||
23317953|NCT00345631|64908203|FG001|Overall Study|Withdrawal by Subject|0|||
23317954|NCT00345631|64908204|FG002|Overall Study|Withdrawal by Subject|1|||
23317955|NCT00345631|64908202|FG000|Overall Study|Adverse Event|0|||
23317956|NCT00345631|64908203|FG001|Overall Study|Adverse Event|1|||
23215964|NCT03258593|64531340|FG002|Expansion Maintenance Phase|Physician Decision|0|||
23215965|NCT03258593|64531341|FG003|Expansion Maintenance Phase|Physician Decision|0|||
23215966|NCT04294095|64531343|FG000|Overall Study|Adverse Event|1|||
23215967|NCT04294095|64531344|FG001|Overall Study|Adverse Event|0|||
23215968|NCT01153841|64531345|FG000|Overall Study|Adverse Event|1|||
23215969|NCT01153841|64531346|FG001|Overall Study|Adverse Event|0|||
23215970|NCT01153841|64531345|FG000|Overall Study|Withdrawal by Subject|1|||
23553962|NCT00279201|65754650|FG003|Initiation|Death|0|||
23553963|NCT00279201|65754651|FG004|Initiation|Death|0|||
23553964|NCT00279201|65754652|FG005|Initiation|Death|0|||
23553965|NCT00279201|65754647|FG000|Initiation|Adverse Event|6|||
23553966|NCT00279201|65754648|FG001|Initiation|Adverse Event|15|||
23553967|NCT00279201|65754649|FG002|Initiation|Adverse Event|0|||
23553968|NCT00279201|65754650|FG003|Initiation|Adverse Event|0|||
23553969|NCT00279201|65754651|FG004|Initiation|Adverse Event|0|||
23553970|NCT00279201|65754652|FG005|Initiation|Adverse Event|0|||
23553971|NCT00279201|65754647|FG000|Initiation|Lost to Follow-up|42|||
23553972|NCT00279201|65754648|FG001|Initiation|Lost to Follow-up|41|||
23553973|NCT00279201|65754649|FG002|Initiation|Lost to Follow-up|0|||
23553974|NCT00279201|65754650|FG003|Initiation|Lost to Follow-up|0|||
23553975|NCT00279201|65754651|FG004|Initiation|Lost to Follow-up|0|||
23553976|NCT00279201|65754652|FG005|Initiation|Lost to Follow-up|0|||
23553977|NCT00279201|65754647|FG000|Initiation|Entry Criteria Exclusion|7|||
23553978|NCT00279201|65754648|FG001|Initiation|Entry Criteria Exclusion|9|||
23553979|NCT00279201|65754649|FG002|Initiation|Entry Criteria Exclusion|0|||
23553980|NCT00279201|65754650|FG003|Initiation|Entry Criteria Exclusion|0|||
23553981|NCT00279201|65754651|FG004|Initiation|Entry Criteria Exclusion|0|||
23553982|NCT00279201|65754652|FG005|Initiation|Entry Criteria Exclusion|0|||
23553983|NCT00279201|65754647|FG000|Initiation|Protocol Violation|9|||
23553984|NCT00279201|65754648|FG001|Initiation|Protocol Violation|10|||
23553985|NCT00279201|65754649|FG002|Initiation|Protocol Violation|0|||
23553986|NCT00279201|65754650|FG003|Initiation|Protocol Violation|0|||
23553987|NCT00279201|65754651|FG004|Initiation|Protocol Violation|0|||
23553988|NCT00279201|65754652|FG005|Initiation|Protocol Violation|0|||
23553989|NCT00279201|65754647|FG000|Initiation|Withdrawal by Subject|35|||
23553990|NCT00279201|65754648|FG001|Initiation|Withdrawal by Subject|41|||
23553991|NCT00279201|65754649|FG002|Initiation|Withdrawal by Subject|0|||
23553992|NCT00279201|65754650|FG003|Initiation|Withdrawal by Subject|0|||
23553993|NCT00279201|65754651|FG004|Initiation|Withdrawal by Subject|0|||
23553994|NCT00279201|65754652|FG005|Initiation|Withdrawal by Subject|0|||
23553995|NCT00279201|65754647|FG000|Initiation|Physician Decision|15|||
23553996|NCT00279201|65754648|FG001|Initiation|Physician Decision|18|||
23553997|NCT00279201|65754649|FG002|Initiation|Physician Decision|0|||
23553998|NCT00279201|65754650|FG003|Initiation|Physician Decision|0|||
23553999|NCT00279201|65754651|FG004|Initiation|Physician Decision|0|||
23554000|NCT00279201|65754652|FG005|Initiation|Physician Decision|0|||
23554001|NCT00279201|65754647|FG000|Initiation|Sponsor Decision|13|||
23554002|NCT00279201|65754648|FG001|Initiation|Sponsor Decision|5|||
23554003|NCT00279201|65754649|FG002|Initiation|Sponsor Decision|0|||
23554004|NCT00279201|65754650|FG003|Initiation|Sponsor Decision|0|||
23554005|NCT00279201|65754651|FG004|Initiation|Sponsor Decision|0|||
23554006|NCT00279201|65754652|FG005|Initiation|Sponsor Decision|0|||
23554007|NCT00279201|65754647|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554008|NCT00279201|65754648|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
23554009|NCT00279201|65754649|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554010|NCT00279201|65754650|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554011|NCT00279201|65754651|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554012|NCT00279201|65754652|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
23554013|NCT00279201|65754647|FG000|Maintenance|Lack of Efficacy|32|||
23554014|NCT00279201|65754648|FG001|Maintenance|Lack of Efficacy|30|||
23554015|NCT00279201|65754649|FG002|Maintenance|Lack of Efficacy|0|||
23554016|NCT00279201|65754650|FG003|Maintenance|Lack of Efficacy|0|||
23554017|NCT00279201|65754651|FG004|Maintenance|Lack of Efficacy|0|||
23554018|NCT00279201|65754652|FG005|Maintenance|Lack of Efficacy|0|||
23621901|NCT01183013|66000809|FG006|Overall Study|Lost to Follow-up|5|||
23554019|NCT00279201|65754647|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
23554020|NCT00279201|65754648|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
23554021|NCT00279201|65754649|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
23554022|NCT00279201|65754650|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
23554023|NCT00279201|65754651|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
23554024|NCT00279201|65754652|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
23554025|NCT00279201|65754647|FG000|Maintenance|Adverse Event|4|||
23554026|NCT00279201|65754648|FG001|Maintenance|Adverse Event|4|||
23554027|NCT00279201|65754649|FG002|Maintenance|Adverse Event|0|||
23554028|NCT00279201|65754650|FG003|Maintenance|Adverse Event|0|||
23554029|NCT00279201|65754651|FG004|Maintenance|Adverse Event|0|||
23554030|NCT00279201|65754652|FG005|Maintenance|Adverse Event|0|||
23215971|NCT01153841|64531346|FG001|Overall Study|Withdrawal by Subject|0|||
23215972|NCT01153841|64531345|FG000|Overall Study|Protocol Violation|2|||
23554031|NCT00279201|65754647|FG000|Maintenance|Death|4|||
23554032|NCT00279201|65754648|FG001|Maintenance|Death|4|||
23554033|NCT00279201|65754649|FG002|Maintenance|Death|0|||
23215973|NCT01153841|64531346|FG001|Overall Study|Protocol Violation|0|||
23215974|NCT01153841|64531345|FG000|Overall Study|Lost to Follow-up|2|||
23215975|NCT01153841|64531346|FG001|Overall Study|Lost to Follow-up|0|||
23215976|NCT01705587|64531347|FG000|Overall Study|Withdrawal by Subject|0|||
23554034|NCT00279201|65754650|FG003|Maintenance|Death|0|||
23554035|NCT00279201|65754651|FG004|Maintenance|Death|0|||
23554036|NCT00279201|65754652|FG005|Maintenance|Death|0|||
23554037|NCT00279201|65754647|FG000|Maintenance|Lost to Follow-up|17|||
23554038|NCT00279201|65754648|FG001|Maintenance|Lost to Follow-up|13|||
23554039|NCT00279201|65754649|FG002|Maintenance|Lost to Follow-up|0|||
23554040|NCT00279201|65754650|FG003|Maintenance|Lost to Follow-up|0|||
23554041|NCT00279201|65754651|FG004|Maintenance|Lost to Follow-up|0|||
23215977|NCT01705587|64531348|FG001|Overall Study|Withdrawal by Subject|1|||
23215978|NCT02633046|64531351|FG000|Overall Study|Adverse Event|8|||
23554042|NCT00279201|65754652|FG005|Maintenance|Lost to Follow-up|0|||
23554043|NCT00279201|65754647|FG000|Maintenance|Entry Criteria Exclusion|1|||
23554044|NCT00279201|65754648|FG001|Maintenance|Entry Criteria Exclusion|4|||
23554045|NCT00279201|65754649|FG002|Maintenance|Entry Criteria Exclusion|0|||
23317957|NCT00345631|64908204|FG002|Overall Study|Adverse Event|0|||
23317958|NCT00345631|64908202|FG000|Overall Study|Lost to Follow-up|3|||
23317959|NCT00345631|64908203|FG001|Overall Study|Lost to Follow-up|7|||
23317960|NCT00345631|64908204|FG002|Overall Study|Lost to Follow-up|4|||
23554046|NCT00279201|65754650|FG003|Maintenance|Entry Criteria Exclusion|0|||
23554047|NCT00279201|65754651|FG004|Maintenance|Entry Criteria Exclusion|0|||
23554048|NCT00279201|65754652|FG005|Maintenance|Entry Criteria Exclusion|0|||
23554049|NCT00279201|65754647|FG000|Maintenance|Protocol Violation|16|||
23554050|NCT00279201|65754648|FG001|Maintenance|Protocol Violation|24|||
23554051|NCT00279201|65754649|FG002|Maintenance|Protocol Violation|0|||
23554052|NCT00279201|65754650|FG003|Maintenance|Protocol Violation|0|||
23554053|NCT00279201|65754651|FG004|Maintenance|Protocol Violation|0|||
23554054|NCT00279201|65754652|FG005|Maintenance|Protocol Violation|0|||
23554055|NCT00279201|65754647|FG000|Maintenance|Withdrawal by Subject|18|||
23554056|NCT00279201|65754648|FG001|Maintenance|Withdrawal by Subject|18|||
23554057|NCT00279201|65754649|FG002|Maintenance|Withdrawal by Subject|0|||
23554058|NCT00279201|65754650|FG003|Maintenance|Withdrawal by Subject|0|||
23554059|NCT00279201|65754651|FG004|Maintenance|Withdrawal by Subject|0|||
23554060|NCT00279201|65754652|FG005|Maintenance|Withdrawal by Subject|0|||
23621902|NCT01183013|66000803|FG000|Overall Study|Withdrawal by Subject|9|||
23621903|NCT01183013|66000804|FG001|Overall Study|Withdrawal by Subject|13|||
23621904|NCT01183013|66000805|FG002|Overall Study|Withdrawal by Subject|10|||
23139541|NCT01139580|64259073|FG001|Overall Study|Lack of Efficacy|2|||
23215979|NCT02633046|64531351|FG000|Overall Study|Physician Decision|7|||
23215980|NCT02633046|64531351|FG000|Overall Study|Withdrawal by Subject|8|||
23215981|NCT02633046|64531351|FG000|Overall Study|Increased proteinuria|2|||
23215982|NCT02633046|64531351|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
23215983|NCT02633046|64531351|FG000|Overall Study|Mutual decision patient and physician|1|||
23215984|NCT00861380|64531356|FG000|Overall Study|Withdrawal Information not recorded|8427|||
23432106|NCT01999218|65327539|FG002|Overall Study|Lack of Efficacy|1|||
23554061|NCT00279201|65754647|FG000|Maintenance|Physician Decision|9|||
23554062|NCT00279201|65754648|FG001|Maintenance|Physician Decision|9|||
23554063|NCT00279201|65754649|FG002|Maintenance|Physician Decision|0|||
23554064|NCT00279201|65754650|FG003|Maintenance|Physician Decision|0|||
23554065|NCT00279201|65754651|FG004|Maintenance|Physician Decision|0|||
23554066|NCT00279201|65754652|FG005|Maintenance|Physician Decision|0|||
23554067|NCT00279201|65754647|FG000|Maintenance|Sponsor Decision|4|||
23554068|NCT00279201|65754648|FG001|Maintenance|Sponsor Decision|0|||
23554069|NCT00279201|65754649|FG002|Maintenance|Sponsor Decision|0|||
23139542|NCT01139580|64259072|FG000|Overall Study|Withdrawal by Subject|6|||
23139543|NCT01139580|64259073|FG001|Overall Study|Withdrawal by Subject|9|||
23139544|NCT01139580|64259072|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
23139545|NCT01139580|64259073|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
23139546|NCT01139580|64259072|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
23139547|NCT01139580|64259073|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
23139548|NCT01139580|64259072|FG000|Overall Study|Misrandomized|1|||
23139549|NCT01139580|64259073|FG001|Overall Study|Misrandomized|0|||
23139550|NCT01139580|64259072|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
23215985|NCT00861380|64531357|FG001|Overall Study|Withdrawal Information not recorded|9112|||
23554070|NCT00279201|65754650|FG003|Maintenance|Sponsor Decision|0|||
23554071|NCT00279201|65754651|FG004|Maintenance|Sponsor Decision|0|||
23621905|NCT01183013|66000806|FG003|Overall Study|Withdrawal by Subject|8|||
23215986|NCT00861380|64531358|FG002|Overall Study|Withdrawal Information not recorded|8872|||
23215987|NCT00861380|64531359|FG003|Overall Study|Withdrawal Information not recorded|3689|||
23317961|NCT00345631|64908202|FG000|Overall Study|Other reasons|0|||
23554072|NCT00279201|65754652|FG005|Maintenance|Sponsor Decision|0|||
23554073|NCT00279201|65754647|FG000|Maintenance|HbA1c>7.5%|123|||
23621906|NCT01183013|66000807|FG004|Overall Study|Withdrawal by Subject|7|||
23554074|NCT00279201|65754648|FG001|Maintenance|HbA1c>7.5%|126|||
23554075|NCT00279201|65754649|FG002|Maintenance|HbA1c>7.5%|0|||
23554076|NCT00279201|65754650|FG003|Maintenance|HbA1c>7.5%|0|||
23554077|NCT00279201|65754651|FG004|Maintenance|HbA1c>7.5%|0|||
23554078|NCT00279201|65754652|FG005|Maintenance|HbA1c>7.5%|0|||
23554079|NCT00279201|65754647|FG000|Intensification Addendum|Withdrawal by Subject|0|||
23554080|NCT00279201|65754648|FG001|Intensification Addendum|Withdrawal by Subject|0|||
23554081|NCT00279201|65754649|FG002|Intensification Addendum|Withdrawal by Subject|12|||
23554082|NCT00279201|65754650|FG003|Intensification Addendum|Withdrawal by Subject|14|||
23554083|NCT00279201|65754651|FG004|Intensification Addendum|Withdrawal by Subject|9|||
23554084|NCT00279201|65754652|FG005|Intensification Addendum|Withdrawal by Subject|18|||
23554085|NCT00279201|65754647|FG000|Intensification Addendum|Lost to Follow-up|0|||
23554086|NCT00279201|65754648|FG001|Intensification Addendum|Lost to Follow-up|0|||
23554087|NCT00279201|65754649|FG002|Intensification Addendum|Lost to Follow-up|4|||
23554088|NCT00279201|65754650|FG003|Intensification Addendum|Lost to Follow-up|6|||
23554089|NCT00279201|65754651|FG004|Intensification Addendum|Lost to Follow-up|7|||
23554090|NCT00279201|65754652|FG005|Intensification Addendum|Lost to Follow-up|7|||
23554091|NCT00279201|65754647|FG000|Intensification Addendum|Protocol Violation|0|||
23554092|NCT00279201|65754648|FG001|Intensification Addendum|Protocol Violation|0|||
23554093|NCT00279201|65754649|FG002|Intensification Addendum|Protocol Violation|2|||
23554094|NCT00279201|65754650|FG003|Intensification Addendum|Protocol Violation|2|||
23554095|NCT00279201|65754651|FG004|Intensification Addendum|Protocol Violation|6|||
23554096|NCT00279201|65754652|FG005|Intensification Addendum|Protocol Violation|6|||
23554097|NCT00279201|65754647|FG000|Intensification Addendum|Adverse Event|0|||
23554098|NCT00279201|65754648|FG001|Intensification Addendum|Adverse Event|0|||
23554099|NCT00279201|65754649|FG002|Intensification Addendum|Adverse Event|0|||
23554100|NCT00279201|65754650|FG003|Intensification Addendum|Adverse Event|4|||
23554101|NCT00279201|65754651|FG004|Intensification Addendum|Adverse Event|1|||
23554102|NCT00279201|65754652|FG005|Intensification Addendum|Adverse Event|3|||
23554103|NCT00279201|65754647|FG000|Intensification Addendum|Physician Decision|0|||
23554104|NCT00279201|65754648|FG001|Intensification Addendum|Physician Decision|0|||
23554105|NCT00279201|65754649|FG002|Intensification Addendum|Physician Decision|4|||
23554106|NCT00279201|65754650|FG003|Intensification Addendum|Physician Decision|1|||
23554107|NCT00279201|65754651|FG004|Intensification Addendum|Physician Decision|3|||
23554108|NCT00279201|65754652|FG005|Intensification Addendum|Physician Decision|2|||
23554109|NCT00279201|65754647|FG000|Intensification Addendum|Sponsor Decision|0|||
23554110|NCT00279201|65754648|FG001|Intensification Addendum|Sponsor Decision|0|||
23554111|NCT00279201|65754649|FG002|Intensification Addendum|Sponsor Decision|0|||
23554112|NCT00279201|65754650|FG003|Intensification Addendum|Sponsor Decision|0|||
23554113|NCT00279201|65754651|FG004|Intensification Addendum|Sponsor Decision|1|||
23554114|NCT00279201|65754652|FG005|Intensification Addendum|Sponsor Decision|1|||
23554115|NCT00279201|65754647|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
23554116|NCT00279201|65754648|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
23554117|NCT00279201|65754649|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
23554118|NCT00279201|65754650|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
23621907|NCT01183013|66000808|FG005|Overall Study|Withdrawal by Subject|9|||
23621908|NCT01183013|66000809|FG006|Overall Study|Withdrawal by Subject|10|||
23621909|NCT01183013|66000803|FG000|Overall Study|Reasons other than stated above|15|||
23621910|NCT01183013|66000804|FG001|Overall Study|Reasons other than stated above|11|||
23554119|NCT00279201|65754651|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
23554120|NCT00279201|65754652|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
23554121|NCT00279201|65754647|FG000|Intensification Addendum|Lack of Efficacy|0|||
23554122|NCT00279201|65754648|FG001|Intensification Addendum|Lack of Efficacy|0|||
23554123|NCT00279201|65754649|FG002|Intensification Addendum|Lack of Efficacy|0|||
23554124|NCT00279201|65754650|FG003|Intensification Addendum|Lack of Efficacy|1|||
23554125|NCT00279201|65754651|FG004|Intensification Addendum|Lack of Efficacy|1|||
23554126|NCT00279201|65754652|FG005|Intensification Addendum|Lack of Efficacy|0|||
23621911|NCT01183013|66000805|FG002|Overall Study|Reasons other than stated above|17|||
23621912|NCT01183013|66000806|FG003|Overall Study|Reasons other than stated above|12|||
23621913|NCT01183013|66000807|FG004|Overall Study|Reasons other than stated above|12|||
23621914|NCT01183013|66000808|FG005|Overall Study|Reasons other than stated above|15|||
23621915|NCT01183013|66000809|FG006|Overall Study|Reasons other than stated above|13|||
23621916|NCT02564718|66000810|FG000|Overall Study|Withdrew from treatment|0|||
23317962|NCT00345631|64908203|FG001|Overall Study|Other reasons|0|||
23554127|NCT00279201|65754647|FG000|Intensification Addendum|Death|0|||
23554128|NCT00279201|65754648|FG001|Intensification Addendum|Death|0|||
23554129|NCT00279201|65754649|FG002|Intensification Addendum|Death|0|||
23554130|NCT00279201|65754650|FG003|Intensification Addendum|Death|0|||
23554131|NCT00279201|65754651|FG004|Intensification Addendum|Death|1|||
23621917|NCT02564718|66000811|FG001|Overall Study|Withdrew from treatment|1|||
23621918|NCT00424177|66000812|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
23621919|NCT00424177|66000812|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
23621920|NCT00424177|66000812|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
23621921|NCT00424177|66000812|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
23621922|NCT00424177|66000812|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
23621923|NCT00424177|66000812|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
23621924|NCT00424177|66000812|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
23621925|NCT00424177|66000812|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
23621926|NCT00424177|66000812|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
23621927|NCT00424177|66000812|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
23621928|NCT02845375|66000813|FG000|Overall Study|upper airway obstruction|1|||
23621929|NCT02845375|66000814|FG001|Overall Study|upper airway obstruction|2|||
23215988|NCT00861380|64531360|FG004|Overall Study|Withdrawal Information not recorded|1812|||
23215989|NCT00861380|64531361|FG005|Overall Study|Withdrawal Information not recorded|6249|||
23215990|NCT00861380|64531362|FG006|Overall Study|Withdrawal Information not recorded|3020|||
23215991|NCT03395223|64531363|FG000|Overall Study|Lost to Follow-up|3|||
23215992|NCT03395223|64531363|FG000|Overall Study|Other|1|||
23215993|NCT04857892|64531364|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
23215994|NCT04857892|64531365|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
23215995|NCT04857892|64531366|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
23215996|NCT04857892|64531367|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
23215997|NCT04857892|64531368|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
23215998|NCT04857892|64531364|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
23215999|NCT04857892|64531365|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
23216000|NCT04857892|64531366|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
23216001|NCT04857892|64531367|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
23216002|NCT04857892|64531368|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
23216003|NCT04857892|64531364|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
23216004|NCT04857892|64531365|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
23216005|NCT04857892|64531366|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
23216006|NCT04857892|64531367|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
23216007|NCT04857892|64531368|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
23216008|NCT01504971|64531372|FG000|Overall Study|Physician Decision|13|||
23216009|NCT02571972|64531373|FG000|Overall Study|Protocol Violation|2|||
23216010|NCT02571972|64531373|FG000|Overall Study|Withdrawal by Subject|2|||
23554132|NCT00279201|65754652|FG005|Intensification Addendum|Death|0|||
23554133|NCT00765388|65754661|FG000|Period 1|Lack of Efficacy|1|||
23554134|NCT00765388|65754662|FG001|Period 1|Lack of Efficacy|2|||
23554135|NCT00765388|65754661|FG000|Period 1|Lost to Follow-up|0|||
23554136|NCT00765388|65754662|FG001|Period 1|Lost to Follow-up|1|||
23554137|NCT00765388|65754661|FG000|Period 1|Herpes Zoster|0|||
23554138|NCT00765388|65754662|FG001|Period 1|Herpes Zoster|1|||
23554139|NCT00765388|65754661|FG000|Period 1|Hip operation|0|||
23554140|NCT00765388|65754662|FG001|Period 1|Hip operation|1|||
23554141|NCT01368965|65754675|FG000|Overall Study|Lost to Follow-up|12|||
23554142|NCT01970982|65754676|FG000|Overall Study|Withdrawal by Subject|0|||
23554143|NCT01970982|65754677|FG001|Overall Study|Withdrawal by Subject|0|||
23554144|NCT01970982|65754678|FG002|Overall Study|Withdrawal by Subject|2|||
23554145|NCT02013622|65754683|FG000|Overall Study|Lost to Follow-up|10|||
23554146|NCT02013622|65754683|FG000|Overall Study|Adverse Event|3|||
23554147|NCT02013622|65754683|FG000|Overall Study|Met Withdrawal Criteria|3|||
23554148|NCT02013622|65754683|FG000|Overall Study|Withdrawal by Subject|6|||
23554149|NCT02013622|65754683|FG000|Overall Study|Protocol Deviation|1|||
23554150|NCT02013622|65754683|FG000|Overall Study|Lack of Efficacy|1|||
23554151|NCT01783418|65754684|FG000|Overall Study|Withdrawal by Subject|1|||
23554152|NCT01783418|65754685|FG001|Overall Study|Withdrawal by Subject|0|||
23554153|NCT02080871|65754686|FG000|Overall Study|Death|1|||
23554154|NCT02080871|65754686|FG000|Overall Study|Lost to Follow-up|1|||
23554155|NCT01059565|65754703|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
23554156|NCT01059565|65754704|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
23554157|NCT01059565|65754703|FG000|24-Week Randomized Phase|Adverse Event|5|||
23554158|NCT01059565|65754704|FG001|24-Week Randomized Phase|Adverse Event|0|||
23554159|NCT01059565|65754703|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
23554160|NCT01059565|65754704|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
23554161|NCT01059565|65754703|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
23554162|NCT01059565|65754704|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
23554163|NCT01059565|65754703|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
23216011|NCT03819218|64531374|FG000|Overall Study|Protocol Violation|1|||
23216012|NCT00653328|64531375|FG000|Overall Study|Withdrawal by Subject|1|||
23216013|NCT00653328|64531375|FG000|Overall Study|Adverse Event|2|||
23216014|NCT00653328|64531375|FG000|Overall Study|Disease progression|10|||
23554164|NCT01059565|65754704|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
23554165|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Adverse Event|2|||
23554166|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Adverse Event|0|||
23621930|NCT02845375|66000815|FG002|Overall Study|upper airway obstruction|1|||
23621931|NCT01816685|66000824|FG000|Overall Study|Lost to Follow-up|7|||
23554167|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
23554168|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
23554169|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
23554170|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
23554171|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
23554172|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
23554173|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
23554174|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
23554175|NCT01059565|65754703|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
23554176|NCT01059565|65754704|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
23554177|NCT02436330|65754708|FG000|Cohort 1|Lost to Follow-up|5|||
23216015|NCT00653328|64531375|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
23216016|NCT01253187|64531378|FG000|Period 2|Withdrawal by Subject|0|||
23216017|NCT01253187|64531379|FG001|Period 2|Withdrawal by Subject|0|||
23216018|NCT01253187|64531380|FG002|Period 2|Withdrawal by Subject|0|||
23216019|NCT01253187|64531381|FG003|Period 2|Withdrawal by Subject|0|||
23621932|NCT01816685|66000825|FG001|Overall Study|Lost to Follow-up|9|||
23621933|NCT01816685|66000824|FG000|Overall Study|Surgery Cancelled|3|||
23621934|NCT01816685|66000825|FG001|Overall Study|Surgery Cancelled|2|||
23621935|NCT03503162|66000826|FG000|Overall Study|did not meet eligibility|1|||
23621936|NCT01087814|66000827|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
23554178|NCT02436330|65754709|FG001|Cohort 1|Lost to Follow-up|2|||
23554179|NCT02436330|65754708|FG000|Cohort 1|Withdrawal by Subject|0|||
23554180|NCT02436330|65754709|FG001|Cohort 1|Withdrawal by Subject|1|||
23554181|NCT02436330|65754708|FG000|Cohort 2|Lost to Follow-up|2|||
23554182|NCT02436330|65754709|FG001|Cohort 2|Lost to Follow-up|0|||
23554183|NCT02436330|65754708|FG000|Cohort 2|Withdrawal by Subject|2|||
23554184|NCT02436330|65754709|FG001|Cohort 2|Withdrawal by Subject|3|||
23554185|NCT02436330|65754708|FG000|Cohort 3|Lost to Follow-up|1|||
23554186|NCT02436330|65754709|FG001|Cohort 3|Lost to Follow-up|0|||
23554187|NCT02436330|65754708|FG000|Cohort 3|Withdrawal by Subject|4|||
23554188|NCT02436330|65754709|FG001|Cohort 3|Withdrawal by Subject|0|||
23554189|NCT02436330|65754708|FG000|Cohort 4|Lost to Follow-up|1|||
23554190|NCT02436330|65754709|FG001|Cohort 4|Lost to Follow-up|0|||
23554191|NCT02436330|65754708|FG000|Cohort 4|Withdrawal by Subject|1|||
23554192|NCT02436330|65754709|FG001|Cohort 4|Withdrawal by Subject|0|||
23554193|NCT02436330|65754708|FG000|Cohort 5|Lost to Follow-up|3|||
23554194|NCT02436330|65754709|FG001|Cohort 5|Lost to Follow-up|2|||
23554195|NCT02436330|65754708|FG000|Cohort 5|Withdrawal by Subject|3|||
23554196|NCT02436330|65754709|FG001|Cohort 5|Withdrawal by Subject|2|||
23554197|NCT02436330|65754708|FG000|Cohort 6|Lost to Follow-up|2|||
23554198|NCT02436330|65754709|FG001|Cohort 6|Lost to Follow-up|0|||
23554199|NCT02436330|65754708|FG000|Cohort 6|Withdrawal by Subject|1|||
23554200|NCT02436330|65754709|FG001|Cohort 6|Withdrawal by Subject|1|||
23554201|NCT00074282|65754710|FG000|Step 1|Adverse Event|32|||
23554202|NCT00074282|65754711|FG001|Step 1|Adverse Event|0|||
23621937|NCT01087814|66000828|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
23621938|NCT01087814|66000827|FG000|Second Intervention (5 Days)|Physician Decision|1|||
23554203|NCT00074282|65754712|FG002|Step 1|Adverse Event|0|||
23554204|NCT00074282|65754710|FG000|Step 1|Death|6|||
23621939|NCT01087814|66000828|FG001|Second Intervention (5 Days)|Physician Decision|0|||
23621940|NCT04357964|66000829|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
23621941|NCT04357964|66000830|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
23621942|NCT04357964|66000829|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
23216020|NCT01253187|64531382|FG004|Period 2|Withdrawal by Subject|1|||
23216021|NCT01253187|64531383|FG005|Period 2|Withdrawal by Subject|0|||
23216022|NCT01253187|64531378|FG000|Period 3|Pregnancy|1|||
23554205|NCT00074282|65754711|FG001|Step 1|Death|0|||
23216023|NCT01253187|64531379|FG001|Period 3|Pregnancy|0|||
23216024|NCT01253187|64531380|FG002|Period 3|Pregnancy|0|||
23216025|NCT01253187|64531381|FG003|Period 3|Pregnancy|0|||
23216026|NCT01253187|64531382|FG004|Period 3|Pregnancy|0|||
23216027|NCT01253187|64531383|FG005|Period 3|Pregnancy|0|||
23216028|NCT01253187|64531378|FG000|Period 3|difficulty with blood sampling|0|||
23216029|NCT01253187|64531379|FG001|Period 3|difficulty with blood sampling|1|||
23216030|NCT01253187|64531380|FG002|Period 3|difficulty with blood sampling|0|||
23216031|NCT01253187|64531381|FG003|Period 3|difficulty with blood sampling|0|||
23216032|NCT01253187|64531382|FG004|Period 3|difficulty with blood sampling|0|||
23554206|NCT00074282|65754712|FG002|Step 1|Death|0|||
23554207|NCT00074282|65754710|FG000|Step 1|Withdrawal by Subject|7|||
23554208|NCT00074282|65754711|FG001|Step 1|Withdrawal by Subject|0|||
23554209|NCT00074282|65754712|FG002|Step 1|Withdrawal by Subject|0|||
23621943|NCT04357964|66000830|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
23216033|NCT01253187|64531383|FG005|Period 3|difficulty with blood sampling|0|||
23554210|NCT00074282|65754710|FG000|Step 1|Disease progression|2|||
23554211|NCT00074282|65754711|FG001|Step 1|Disease progression|0|||
23554212|NCT00074282|65754712|FG002|Step 1|Disease progression|0|||
23554213|NCT00074282|65754710|FG000|Step 1|Alternative therapy|2|||
23554214|NCT00074282|65754711|FG001|Step 1|Alternative therapy|0|||
23554215|NCT00074282|65754712|FG002|Step 1|Alternative therapy|0|||
23554216|NCT00074282|65754710|FG000|Step 1|Other complicating disease|2|||
23554217|NCT00074282|65754711|FG001|Step 1|Other complicating disease|0|||
23554218|NCT00074282|65754712|FG002|Step 1|Other complicating disease|0|||
23554219|NCT00074282|65754710|FG000|Step 1|Physician Decision|1|||
23554220|NCT00074282|65754711|FG001|Step 1|Physician Decision|0|||
23554221|NCT00074282|65754712|FG002|Step 1|Physician Decision|0|||
23554222|NCT00074282|65754710|FG000|Step 1|Ineligible|4|||
23554223|NCT00074282|65754711|FG001|Step 1|Ineligible|0|||
23554224|NCT00074282|65754712|FG002|Step 1|Ineligible|0|||
23554225|NCT00074282|65754710|FG000|Step 1|Never started treatment|2|||
23554226|NCT00074282|65754711|FG001|Step 1|Never started treatment|0|||
23554227|NCT00074282|65754712|FG002|Step 1|Never started treatment|0|||
23554228|NCT00074282|65754710|FG000|Step 2|Adverse Event|0|||
23554229|NCT00074282|65754711|FG001|Step 2|Adverse Event|2|||
23554230|NCT00074282|65754712|FG002|Step 2|Adverse Event|12|||
23554231|NCT00074282|65754710|FG000|Step 2|Disease progression|0|||
23554232|NCT00074282|65754711|FG001|Step 2|Disease progression|0|||
23554233|NCT00074282|65754712|FG002|Step 2|Disease progression|5|||
23554234|NCT00074282|65754710|FG000|Step 2|Death|0|||
23554235|NCT00074282|65754711|FG001|Step 2|Death|0|||
23554236|NCT00074282|65754712|FG002|Step 2|Death|3|||
23554237|NCT00074282|65754710|FG000|Step 2|Withdrawal by Subject|0|||
23554238|NCT00074282|65754711|FG001|Step 2|Withdrawal by Subject|0|||
23554239|NCT00074282|65754712|FG002|Step 2|Withdrawal by Subject|2|||
23554240|NCT00074282|65754710|FG000|Step 2|Physician Decision|0|||
23554241|NCT00074282|65754711|FG001|Step 2|Physician Decision|0|||
23554242|NCT00074282|65754712|FG002|Step 2|Physician Decision|1|||
23554243|NCT00074282|65754710|FG000|Step 2|Ineligible|0|||
23554244|NCT00074282|65754711|FG001|Step 2|Ineligible|0|||
23139551|NCT01139580|64259073|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
23139552|NCT01139580|64259072|FG000|Overall Study|Participant Randomization in Error|0|||
23139553|NCT01139580|64259073|FG001|Overall Study|Participant Randomization in Error|1|||
23139554|NCT00461032|64259074|FG000|Overall Study|Adverse Event|5|||
23139555|NCT00461032|64259075|FG001|Overall Study|Adverse Event|6|||
23139556|NCT00461032|64259074|FG000|Overall Study|Lack of Efficacy|5|||
23139557|NCT00461032|64259075|FG001|Overall Study|Lack of Efficacy|1|||
23139558|NCT00461032|64259074|FG000|Overall Study|Lost to Follow-up|7|||
23139559|NCT00461032|64259075|FG001|Overall Study|Lost to Follow-up|12|||
23139560|NCT00461032|64259074|FG000|Overall Study|Protocol Violation|4|||
23139561|NCT00461032|64259075|FG001|Overall Study|Protocol Violation|4|||
23139562|NCT00461032|64259074|FG000|Overall Study|Withdrawal by Subject|7|||
23139563|NCT00461032|64259075|FG001|Overall Study|Withdrawal by Subject|15|||
23139564|NCT00461032|64259074|FG000|Overall Study|Patient Moved or Relocated|2|||
23139565|NCT00461032|64259075|FG001|Overall Study|Patient Moved or Relocated|1|||
23139566|NCT00461032|64259074|FG000|Overall Study|Other|7|||
23139567|NCT00461032|64259075|FG001|Overall Study|Other|5|||
23139568|NCT02924064|64259082|FG000|Overall Study|Adverse Event|2|||
23139569|NCT02924064|64259083|FG001|Overall Study|Adverse Event|2|||
23139570|NCT02924064|64259082|FG000|Overall Study|Lost to Follow-up|0|||
23139571|NCT02924064|64259083|FG001|Overall Study|Lost to Follow-up|2|||
23139572|NCT02924064|64259082|FG000|Overall Study|Physician Decision|0|||
23139573|NCT02924064|64259083|FG001|Overall Study|Physician Decision|2|||
23139574|NCT02924064|64259082|FG000|Overall Study|Protocol Violation|1|||
23139575|NCT02924064|64259083|FG001|Overall Study|Protocol Violation|3|||
23139576|NCT02924064|64259082|FG000|Overall Study|Withdrawal by Subject|4|||
23139577|NCT02924064|64259083|FG001|Overall Study|Withdrawal by Subject|5|||
23139578|NCT02924064|64259082|FG000|Overall Study|Other|17|||
23139579|NCT02924064|64259083|FG001|Overall Study|Other|29|||
23139580|NCT02751320|64259096|FG000|Overall Study|Adverse Event|2|||
23554245|NCT00074282|65754712|FG002|Step 2|Ineligible|1|||
23554246|NCT00130533|65754713|FG000|Overall Study|Withdrawal by Subject|33|||
23554247|NCT00130533|65754714|FG001|Overall Study|Withdrawal by Subject|6|||
23554248|NCT00130533|65754713|FG000|Overall Study|Adverse Event|34|||
23554249|NCT00130533|65754714|FG001|Overall Study|Adverse Event|1|||
23139581|NCT02751320|64259096|FG000|Overall Study|Withdrawal by Subject|1|||
23554250|NCT00130533|65754713|FG000|Overall Study|Disease relapse|9|||
23139582|NCT02947087|64259097|FG000|Overall Study|Withdrawal by Subject|3|||
23139583|NCT02947087|64259098|FG001|Overall Study|Withdrawal by Subject|2|||
23139584|NCT02533531|64259100|FG000|Overall Study|Device did not turn on|1|||
23139585|NCT02414932|64259101|FG000|Overall Study|Withdrawal by Subject|2|||
23139586|NCT02414932|64259102|FG001|Overall Study|Withdrawal by Subject|3|||
23139587|NCT02414932|64259101|FG000|Overall Study|Adverse Event|1|||
23554251|NCT00130533|65754714|FG001|Overall Study|Disease relapse|13|||
23554252|NCT00130533|65754713|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
23554253|NCT00130533|65754714|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
23554254|NCT00130533|65754713|FG000|Overall Study|Death|4|||
23554255|NCT00130533|65754714|FG001|Overall Study|Death|2|||
23317963|NCT00345631|64908204|FG002|Overall Study|Other reasons|1|||
23317964|NCT00658879|64908207|FG000|Overall Study|Protocol Violation|1|||
23317965|NCT02871492|64908213|FG000|Overall Study|Lost to Follow-up|6|||
23317966|NCT02871492|64908214|FG001|Overall Study|Lost to Follow-up|3|||
23317967|NCT02871492|64908215|FG002|Overall Study|Lost to Follow-up|5|||
23317968|NCT02871492|64908213|FG000|Overall Study|Withdrawal by Subject|0|||
23317969|NCT02871492|64908214|FG001|Overall Study|Withdrawal by Subject|0|||
23317970|NCT02871492|64908215|FG002|Overall Study|Withdrawal by Subject|1|||
23621944|NCT04357964|66000829|FG000|Overall Study|Adipose sample was insufficient quality|0|||
23621945|NCT04357964|66000830|FG001|Overall Study|Adipose sample was insufficient quality|1|||
23621946|NCT00560313|66000831|FG000|Overall Study|Adverse Events or Death|2|||
23621947|NCT00560313|66000831|FG000|Overall Study|Withdrawal by Subject|2|||
23621948|NCT00560313|66000831|FG000|Overall Study|Lost to Follow-up|1|||
23621949|NCT00560313|66000831|FG000|Overall Study|Protocol Violation|1|||
23621950|NCT00857233|66000834|FG000|Overall Study|Adverse Event|24|||
23621951|NCT00857233|66000834|FG000|Overall Study|Lack of Efficacy|1|||
23621952|NCT00857233|66000834|FG000|Overall Study|Non-compliance|1|||
23621953|NCT00857233|66000834|FG000|Overall Study|Withdrawal of Consent|9|||
23621954|NCT00857233|66000834|FG000|Overall Study|Lost to Follow-up|4|||
23621955|NCT00857233|66000834|FG000|Overall Study|Nursing Home Placement|14|||
23621956|NCT00857233|66000834|FG000|Overall Study|Other Reasons|2|||
23621957|NCT01379703|66000835|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
23621958|NCT01379703|66000836|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
23621959|NCT01379703|66000837|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
23621960|NCT01379703|66000835|FG000|Study Start Through 9 Months|Adverse Event|0|||
23621961|NCT01379703|66000836|FG001|Study Start Through 9 Months|Adverse Event|14|||
23621962|NCT01379703|66000837|FG002|Study Start Through 9 Months|Adverse Event|10|||
23621963|NCT01379703|66000835|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
23139588|NCT02414932|64259102|FG001|Overall Study|Adverse Event|0|||
23139589|NCT00979134|64259103|FG000|Overall Study|Disease progression|18|||
23139590|NCT00979134|64259104|FG001|Overall Study|Disease progression|2|||
23139591|NCT00979134|64259105|FG002|Overall Study|Disease progression|5|||
23139592|NCT00979134|64259103|FG000|Overall Study|Adverse Event|0|||
23139593|NCT00979134|64259104|FG001|Overall Study|Adverse Event|0|||
23139594|NCT00979134|64259105|FG002|Overall Study|Adverse Event|2|||
23139595|NCT00979134|64259103|FG000|Overall Study|Withdrawal by Subject|1|||
23139596|NCT00979134|64259104|FG001|Overall Study|Withdrawal by Subject|1|||
23139597|NCT00979134|64259105|FG002|Overall Study|Withdrawal by Subject|2|||
23139598|NCT00979134|64259103|FG000|Overall Study|Lost to Follow-up|2|||
23139599|NCT00979134|64259104|FG001|Overall Study|Lost to Follow-up|2|||
23139600|NCT00979134|64259105|FG002|Overall Study|Lost to Follow-up|0|||
23139601|NCT00979134|64259103|FG000|Overall Study|Death|4|||
23139602|NCT00979134|64259104|FG001|Overall Study|Death|0|||
23139603|NCT00979134|64259105|FG002|Overall Study|Death|26|||
23139604|NCT00979134|64259103|FG000|Overall Study|Other|8|||
23139605|NCT00979134|64259104|FG001|Overall Study|Other|1|||
23139606|NCT00979134|64259105|FG002|Overall Study|Other|5|||
23139607|NCT02523599|64259106|FG000|Overall Study|Adverse Event|1|||
23139608|NCT02523599|64259107|FG001|Overall Study|Adverse Event|0|||
23139609|NCT02523599|64259106|FG000|Overall Study|Physician Decision|1|||
23139610|NCT02523599|64259107|FG001|Overall Study|Physician Decision|0|||
23139611|NCT02523599|64259106|FG000|Overall Study|Lost to Follow-up|4|||
23139612|NCT02523599|64259107|FG001|Overall Study|Lost to Follow-up|1|||
23139613|NCT02523599|64259106|FG000|Overall Study|Did not return for Day 30 visit|2|||
23139614|NCT02523599|64259107|FG001|Overall Study|Did not return for Day 30 visit|0|||
23139615|NCT02781844|64259112|FG000|Treatment Period 1|Adverse Event|0|||
23139616|NCT02781844|64259113|FG001|Treatment Period 1|Adverse Event|0|||
23139617|NCT02781844|64259114|FG002|Treatment Period 1|Adverse Event|0|||
23139618|NCT02781844|64259115|FG003|Treatment Period 1|Adverse Event|0|||
23139619|NCT02781844|64259116|FG004|Treatment Period 1|Adverse Event|0|||
23139620|NCT02781844|64259117|FG005|Treatment Period 1|Adverse Event|1|||
23139621|NCT02781844|64259118|FG006|Treatment Period 1|Adverse Event|0|||
23139622|NCT02781844|64259119|FG007|Treatment Period 1|Adverse Event|0|||
23139623|NCT01886378|64259122|FG000|Overall Study|Adverse Event|1|||
23317971|NCT01191944|64908220|FG000|Overall Study|Adverse Event|11|||
23317972|NCT01191944|64908221|FG001|Overall Study|Adverse Event|12|||
23621964|NCT01379703|66000836|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
23621965|NCT01379703|66000837|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
23621966|NCT01379703|66000835|FG000|Study Start Through 9 Months|Treatment Failure|0|||
23621967|NCT01379703|66000836|FG001|Study Start Through 9 Months|Treatment Failure|2|||
23621968|NCT01379703|66000837|FG002|Study Start Through 9 Months|Treatment Failure|2|||
23621969|NCT01379703|66000835|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
23139624|NCT01886378|64259122|FG000|Overall Study|Withdrawal by Subject|4|||
23139625|NCT02884908|64259123|FG000|Overall Study|Lost to Follow-up|13|||
23139626|NCT02884908|64259124|FG001|Overall Study|Lost to Follow-up|18|||
23317973|NCT01191944|64908220|FG000|Overall Study|Protocol Violation|1|||
23317974|NCT01191944|64908221|FG001|Overall Study|Protocol Violation|2|||
23432107|NCT01999218|65327537|FG000|Overall Study|Lost to Follow-up|22|||
23554256|NCT00130533|65754713|FG000|Overall Study|Protocol Violation|5|||
23554257|NCT00130533|65754714|FG001|Overall Study|Protocol Violation|1|||
23554258|NCT00130533|65754713|FG000|Overall Study|Lost to Follow-up|1|||
23554259|NCT00130533|65754714|FG001|Overall Study|Lost to Follow-up|1|||
23554260|NCT00130533|65754713|FG000|Overall Study|Sponsor´s decision|2|||
23554261|NCT00130533|65754714|FG001|Overall Study|Sponsor´s decision|0|||
23554262|NCT00130533|65754713|FG000|Overall Study|Second Primary Malignancy|0|||
23554263|NCT00130533|65754714|FG001|Overall Study|Second Primary Malignancy|1|||
23554264|NCT00130533|65754713|FG000|Overall Study|Other|12|||
23554265|NCT00130533|65754714|FG001|Overall Study|Other|5|||
23554266|NCT00760929|65754715|FG000|Overall Study|Adverse Event|2|||
23621970|NCT01379703|66000836|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
23139627|NCT01676909|64259125|FG000|Overall Study|Withdrawal by Subject|3|||
23139628|NCT01676909|64259126|FG001|Overall Study|Withdrawal by Subject|5|||
23139629|NCT01676909|64259125|FG000|Overall Study|Lost to Follow-up|15|||
23139630|NCT01676909|64259126|FG001|Overall Study|Lost to Follow-up|9|||
23139631|NCT02224690|64259128|FG000|Overall Study|Adverse Event|8|||
23139632|NCT02224690|64259129|FG001|Overall Study|Adverse Event|1|||
23139633|NCT02224690|64259128|FG000|Overall Study|Met Withdrawal Criteria|4|||
23317975|NCT01191944|64908220|FG000|Overall Study|Withdrawal by Subject|4|||
23317976|NCT01191944|64908221|FG001|Overall Study|Withdrawal by Subject|2|||
23139634|NCT02224690|64259129|FG001|Overall Study|Met Withdrawal Criteria|0|||
23139635|NCT02224690|64259128|FG000|Overall Study|Use of G-tube|1|||
23139636|NCT02224690|64259129|FG001|Overall Study|Use of G-tube|0|||
23139637|NCT02224690|64259128|FG000|Overall Study|Did not meet eligibility criteria|1|||
23139638|NCT02224690|64259129|FG001|Overall Study|Did not meet eligibility criteria|0|||
23139639|NCT00545051|64259130|FG000|Overall Study|Adverse Event|7|||
23139640|NCT00545051|64259131|FG001|Overall Study|Adverse Event|3|||
23139641|NCT00545051|64259130|FG000|Overall Study|Death|1|||
23317977|NCT01191944|64908220|FG000|Overall Study|Other|1|||
23317978|NCT01191944|64908221|FG001|Overall Study|Other|3|||
23139642|NCT00545051|64259131|FG001|Overall Study|Death|0|||
23139643|NCT00545051|64259130|FG000|Overall Study|Violation of inclusion/exclusion|0|||
23139644|NCT00545051|64259131|FG001|Overall Study|Violation of inclusion/exclusion|2|||
23139645|NCT00545051|64259130|FG000|Overall Study|Protocol Violation|1|||
23139646|NCT00545051|64259131|FG001|Overall Study|Protocol Violation|0|||
23139647|NCT00545051|64259130|FG000|Overall Study|Withdrawal by Subject|0|||
23139648|NCT00545051|64259131|FG001|Overall Study|Withdrawal by Subject|1|||
23139649|NCT00545051|64259130|FG000|Overall Study|Administrative reasons|0|||
23139650|NCT00545051|64259131|FG001|Overall Study|Administrative reasons|1|||
23139651|NCT01981473|64259133|FG000|Overall Study|Incorrect diagnosis of RA|0|||
23139652|NCT01981473|64259134|FG001|Overall Study|Incorrect diagnosis of RA|0|||
23139653|NCT01981473|64259135|FG002|Overall Study|Incorrect diagnosis of RA|1|||
23139654|NCT01981473|64259133|FG000|Overall Study|Received treatment for < 6 months|0|||
23139655|NCT01981473|64259134|FG001|Overall Study|Received treatment for < 6 months|0|||
23139656|NCT01981473|64259135|FG002|Overall Study|Received treatment for < 6 months|1|||
23139657|NCT01981473|64259133|FG000|Overall Study|Received treatment for >24 months|2|||
23139658|NCT01981473|64259134|FG001|Overall Study|Received treatment for >24 months|0|||
23139659|NCT01981473|64259135|FG002|Overall Study|Received treatment for >24 months|6|||
23317979|NCT04052620|64908222|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
23432108|NCT01999218|65327538|FG001|Overall Study|Lost to Follow-up|17|||
23432109|NCT01999218|65327539|FG002|Overall Study|Lost to Follow-up|18|||
23432110|NCT01999218|65327537|FG000|Overall Study|Non-Compliance With Study Drug|6|||
23432111|NCT01999218|65327538|FG001|Overall Study|Non-Compliance With Study Drug|4|||
23432112|NCT01999218|65327539|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23432113|NCT01999218|65327537|FG000|Overall Study|Physician Decision|1|||
23432114|NCT01999218|65327538|FG001|Overall Study|Physician Decision|4|||
23432115|NCT01999218|65327539|FG002|Overall Study|Physician Decision|6|||
23432116|NCT01999218|65327537|FG000|Overall Study|Protocol Violation|4|||
23432117|NCT01999218|65327538|FG001|Overall Study|Protocol Violation|5|||
23432118|NCT01999218|65327539|FG002|Overall Study|Protocol Violation|4|||
23432119|NCT01999218|65327537|FG000|Overall Study|Screen failure|0|||
23432120|NCT01999218|65327538|FG001|Overall Study|Screen failure|1|||
23554267|NCT00760929|65754716|FG001|Overall Study|Adverse Event|0|||
23621971|NCT01379703|66000837|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
23139660|NCT00911937|64259139|FG000|Overall Study|Death|1|||
23139661|NCT00911937|64259140|FG001|Overall Study|Death|0|||
23432121|NCT01999218|65327539|FG002|Overall Study|Screen failure|0|||
23432122|NCT01999218|65327537|FG000|Overall Study|Study Terminated By Sponsor|7|||
23432123|NCT01999218|65327538|FG001|Overall Study|Study Terminated By Sponsor|5|||
23554268|NCT00760929|65754717|FG002|Overall Study|Adverse Event|6|||
23554269|NCT00760929|65754718|FG003|Overall Study|Adverse Event|10|||
23139662|NCT00911937|64259139|FG000|Overall Study|Lost to Follow-up|8|||
23139663|NCT00911937|64259140|FG001|Overall Study|Lost to Follow-up|5|||
23139664|NCT00911937|64259139|FG000|Overall Study|Withdrawal by Subject|10|||
23554270|NCT00760929|65754715|FG000|Overall Study|Lack of Efficacy|0|||
23554271|NCT00760929|65754716|FG001|Overall Study|Lack of Efficacy|2|||
23317980|NCT04052620|64908223|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
23317981|NCT04052620|64908222|FG000|Overall Study|Withdrawal by Subject|1|||
23317982|NCT04052620|64908223|FG001|Overall Study|Withdrawal by Subject|0|||
23317983|NCT04052620|64908222|FG000|Overall Study|Lost to Follow-up|1|||
23317984|NCT04052620|64908223|FG001|Overall Study|Lost to Follow-up|1|||
23317985|NCT04052620|64908222|FG000|Overall Study|Adverse Event|1|||
23317986|NCT04052620|64908223|FG001|Overall Study|Adverse Event|0|||
23317987|NCT04052620|64908222|FG000|Overall Study|Subject did not meet study Criteria|0|||
23317988|NCT04052620|64908223|FG001|Overall Study|Subject did not meet study Criteria|1|||
23621972|NCT01379703|66000835|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
23621973|NCT01379703|66000836|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
23621974|NCT01379703|66000837|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
23216034|NCT01253187|64531378|FG000|Period 3|non-compliance|0|||
23216035|NCT01253187|64531379|FG001|Period 3|non-compliance|0|||
23216036|NCT01253187|64531380|FG002|Period 3|non-compliance|0|||
23216037|NCT01253187|64531381|FG003|Period 3|non-compliance|0|||
23216038|NCT01253187|64531382|FG004|Period 3|non-compliance|1|||
23216039|NCT01253187|64531383|FG005|Period 3|non-compliance|0|||
23216040|NCT02337686|64531387|FG000|Overall Study|Adverse Event|1|||
23216041|NCT02023112|64531390|FG000|Overall Study|Withdrawal by Subject|2|||
23216042|NCT02023112|64531391|FG001|Overall Study|Withdrawal by Subject|1|||
23216043|NCT05742841|64531392|FG000|Overall Study|Withdrawal by Subject|1|||
23216044|NCT05742841|64531392|FG000|Overall Study|Lost to Follow-up|1|||
23216045|NCT00764946|64531393|FG000|Overall Study|Lack of Efficacy|1|||
23216046|NCT00764946|64531394|FG001|Overall Study|Lack of Efficacy|0|||
23216047|NCT00764946|64531395|FG002|Overall Study|Lack of Efficacy|0|||
23216048|NCT00764946|64531393|FG000|Overall Study|Lost to Follow-up|3|||
23216049|NCT00764946|64531394|FG001|Overall Study|Lost to Follow-up|4|||
23216050|NCT00764946|64531395|FG002|Overall Study|Lost to Follow-up|0|||
23216051|NCT00764946|64531393|FG000|Overall Study|Physician Decision|2|||
23216052|NCT00764946|64531394|FG001|Overall Study|Physician Decision|4|||
23216053|NCT00764946|64531395|FG002|Overall Study|Physician Decision|0|||
23216054|NCT00764946|64531393|FG000|Overall Study|Adverse Event|3|||
23216055|NCT00764946|64531394|FG001|Overall Study|Adverse Event|2|||
23216056|NCT00764946|64531395|FG002|Overall Study|Adverse Event|1|||
23216057|NCT00764946|64531393|FG000|Overall Study|Withdrawal by Subject|3|||
23216058|NCT00764946|64531394|FG001|Overall Study|Withdrawal by Subject|6|||
23216059|NCT00764946|64531395|FG002|Overall Study|Withdrawal by Subject|2|||
23216060|NCT00764946|64531393|FG000|Overall Study|Never Treated|1|||
23216061|NCT00764946|64531394|FG001|Overall Study|Never Treated|1|||
23216062|NCT00764946|64531395|FG002|Overall Study|Never Treated|1|||
23216063|NCT01072448|64531396|FG000|Overall Study|Adverse Event|9|||
23216064|NCT01072448|64531397|FG001|Overall Study|Adverse Event|10|||
23216065|NCT01072448|64531396|FG000|Overall Study|Subject withdrew consent|4|||
23317989|NCT04052620|64908222|FG000|Overall Study|Screened failure, randomized by mistake|0|||
23554272|NCT00760929|65754717|FG002|Overall Study|Lack of Efficacy|1|||
23216066|NCT01072448|64531397|FG001|Overall Study|Subject withdrew consent|9|||
23216067|NCT01072448|64531396|FG000|Overall Study|Protocol deviation|3|||
23317990|NCT04052620|64908223|FG001|Overall Study|Screened failure, randomized by mistake|1|||
23554273|NCT00760929|65754718|FG003|Overall Study|Lack of Efficacy|0|||
23554274|NCT00760929|65754715|FG000|Overall Study|Withdrawal by Subject|1|||
23554275|NCT00760929|65754716|FG001|Overall Study|Withdrawal by Subject|0|||
23554276|NCT00760929|65754717|FG002|Overall Study|Withdrawal by Subject|9|||
23554277|NCT00760929|65754718|FG003|Overall Study|Withdrawal by Subject|1|||
23554278|NCT00760929|65754715|FG000|Overall Study|Lost to Follow-up|0|||
23554279|NCT00760929|65754716|FG001|Overall Study|Lost to Follow-up|0|||
23554280|NCT00760929|65754717|FG002|Overall Study|Lost to Follow-up|1|||
23554281|NCT00760929|65754718|FG003|Overall Study|Lost to Follow-up|0|||
23554282|NCT00760929|65754715|FG000|Overall Study|Progression of Disease|21|||
23554283|NCT00760929|65754716|FG001|Overall Study|Progression of Disease|26|||
23554284|NCT00760929|65754717|FG002|Overall Study|Progression of Disease|38|||
23554285|NCT00760929|65754718|FG003|Overall Study|Progression of Disease|42|||
23554286|NCT00760929|65754715|FG000|Overall Study|Other|2|||
23554287|NCT00760929|65754716|FG001|Overall Study|Other|0|||
23554288|NCT00760929|65754717|FG002|Overall Study|Other|2|||
23554289|NCT00760929|65754718|FG003|Overall Study|Other|1|||
23554290|NCT00760929|65754715|FG000|Overall Study|Death|0|||
23554291|NCT00760929|65754716|FG001|Overall Study|Death|0|||
23554292|NCT00760929|65754717|FG002|Overall Study|Death|1|||
23554293|NCT00760929|65754718|FG003|Overall Study|Death|0|||
23554294|NCT00760929|65754715|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
23554295|NCT00760929|65754716|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
23554296|NCT00760929|65754717|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
23554297|NCT00760929|65754718|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
23554298|NCT00528775|65754720|FG000|Overall Study|Other not specified|1|||
23554299|NCT00828984|65754721|FG000|Overall Study|Adverse Event|2|||
23554300|NCT00828984|65754722|FG001|Overall Study|Adverse Event|3|||
23554301|NCT00828984|65754723|FG002|Overall Study|Adverse Event|0|||
23554302|NCT00828984|65754721|FG000|Overall Study|Lost to Follow-up|5|||
23554303|NCT00828984|65754722|FG001|Overall Study|Lost to Follow-up|3|||
23554304|NCT00828984|65754723|FG002|Overall Study|Lost to Follow-up|1|||
23554305|NCT00828984|65754721|FG000|Overall Study|Withdrawal by Subject|4|||
23554306|NCT00828984|65754722|FG001|Overall Study|Withdrawal by Subject|4|||
23554307|NCT00828984|65754723|FG002|Overall Study|Withdrawal by Subject|4|||
23554308|NCT00828984|65754721|FG000|Overall Study|Ineligable|1|||
23554309|NCT00828984|65754722|FG001|Overall Study|Ineligable|2|||
23554310|NCT00828984|65754723|FG002|Overall Study|Ineligable|0|||
23554311|NCT00828984|65754721|FG000|Overall Study|Medical Contraindication|0|||
23554312|NCT00828984|65754722|FG001|Overall Study|Medical Contraindication|1|||
23554313|NCT00828984|65754723|FG002|Overall Study|Medical Contraindication|0|||
23554314|NCT00828984|65754721|FG000|Overall Study|Noncompliant|1|||
23554315|NCT00828984|65754722|FG001|Overall Study|Noncompliant|2|||
23554316|NCT00828984|65754723|FG002|Overall Study|Noncompliant|3|||
23554317|NCT00828984|65754721|FG000|Overall Study|ConMed|1|||
23554318|NCT00828984|65754722|FG001|Overall Study|ConMed|1|||
23554319|NCT00828984|65754723|FG002|Overall Study|ConMed|1|||
23554320|NCT01400503|65754724|FG000|Overall Study|Withdrawal by Subject|1|||
23554321|NCT01400503|65754724|FG000|Overall Study|Study Terminated by Sponsor|58|||
23554322|NCT01400503|65754724|FG000|Overall Study|Other|1|||
23554323|NCT04683926|65754725|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
23554324|NCT04683926|65754726|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
23554325|NCT04683926|65754727|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
23554326|NCT04683926|65754728|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
23554327|NCT03152526|65754729|FG000|Overall Study|Withdrawal by Subject|0|||
23554328|NCT03152526|65754730|FG001|Overall Study|Withdrawal by Subject|1|||
23554329|NCT01239030|65754731|FG000|Double Blind|Adverse Event|0|||
23554330|NCT01239030|65754732|FG001|Double Blind|Adverse Event|1|||
23554331|NCT01239030|65754733|FG002|Double Blind|Adverse Event|0|||
23554332|NCT01239030|65754734|FG003|Double Blind|Adverse Event|2|||
23554333|NCT01239030|65754735|FG004|Double Blind|Adverse Event|0|||
23554334|NCT01239030|65754731|FG000|Double Blind|Withdrawal by Subject|0|||
23554335|NCT01239030|65754732|FG001|Double Blind|Withdrawal by Subject|1|||
23554336|NCT01239030|65754733|FG002|Double Blind|Withdrawal by Subject|1|||
23554337|NCT01239030|65754734|FG003|Double Blind|Withdrawal by Subject|0|||
23554338|NCT01239030|65754735|FG004|Double Blind|Withdrawal by Subject|1|||
23554339|NCT01239030|65754731|FG000|Double Blind|Lost to Follow-up|1|||
23554340|NCT01239030|65754732|FG001|Double Blind|Lost to Follow-up|1|||
23554341|NCT01239030|65754733|FG002|Double Blind|Lost to Follow-up|0|||
23554342|NCT01239030|65754734|FG003|Double Blind|Lost to Follow-up|0|||
23554343|NCT01239030|65754735|FG004|Double Blind|Lost to Follow-up|0|||
23554344|NCT01239030|65754731|FG000|Double Blind|Physician Decision|0|||
23621975|NCT01379703|66000835|FG000|Study Start Through 9 Months|Medication not available|0|||
23139665|NCT00911937|64259140|FG001|Overall Study|Withdrawal by Subject|7|||
23139666|NCT00911937|64259139|FG000|Overall Study|Withdrawn due to pregnancy|1|||
23139667|NCT00911937|64259140|FG001|Overall Study|Withdrawn due to pregnancy|0|||
23139668|NCT00911937|64259139|FG000|Overall Study|Adverse Event|11|||
23139669|NCT00911937|64259140|FG001|Overall Study|Adverse Event|25|||
23139670|NCT00911937|64259139|FG000|Overall Study|Lack of Efficacy|11|||
23139671|NCT00911937|64259140|FG001|Overall Study|Lack of Efficacy|6|||
23139672|NCT00911937|64259139|FG000|Overall Study|Did not meet inclusion criteria|9|||
23139673|NCT00911937|64259140|FG001|Overall Study|Did not meet inclusion criteria|11|||
23139674|NCT00911937|64259139|FG000|Overall Study|Protocol Violation|14|||
23139675|NCT00911937|64259140|FG001|Overall Study|Protocol Violation|23|||
23139676|NCT00911937|64259139|FG000|Overall Study|Randomized but not treated|13|||
23139677|NCT00911937|64259140|FG001|Overall Study|Randomized but not treated|13|||
23139678|NCT00911937|64259139|FG000|Overall Study|Other|9|||
23139679|NCT00911937|64259140|FG001|Overall Study|Other|5|||
23139680|NCT01248065|64259142|FG000|Overall Study|Lost to Follow-up|3|||
23554345|NCT01239030|65754732|FG001|Double Blind|Physician Decision|1|||
23554346|NCT01239030|65754733|FG002|Double Blind|Physician Decision|0|||
23554347|NCT01239030|65754734|FG003|Double Blind|Physician Decision|0|||
23139681|NCT01248065|64259143|FG001|Overall Study|Lost to Follow-up|5|||
23139682|NCT01248065|64259142|FG000|Overall Study|Withdrawal by Subject|14|||
23139683|NCT01248065|64259143|FG001|Overall Study|Withdrawal by Subject|11|||
23139684|NCT01248065|64259142|FG000|Overall Study|Adverse Event|3|||
23139685|NCT01248065|64259143|FG001|Overall Study|Adverse Event|0|||
23554348|NCT01239030|65754735|FG004|Double Blind|Physician Decision|0|||
23554349|NCT01239030|65754731|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
23554350|NCT01239030|65754732|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
23554351|NCT01239030|65754733|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
23554352|NCT01239030|65754734|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
23554353|NCT01239030|65754735|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
23554354|NCT01239030|65754731|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
23554355|NCT01239030|65754732|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
23216068|NCT01072448|64531397|FG001|Overall Study|Protocol deviation|4|||
23216069|NCT01072448|64531396|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23216070|NCT01072448|64531397|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23216071|NCT01072448|64531396|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23216072|NCT01072448|64531397|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23216073|NCT01072448|64531396|FG000|Overall Study|Lost to Follow-up|1|||
23216074|NCT01072448|64531397|FG001|Overall Study|Lost to Follow-up|1|||
23216075|NCT01072448|64531396|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23216076|NCT01072448|64531397|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23216077|NCT01072448|64531396|FG000|Overall Study|Death|0|||
23216078|NCT01072448|64531397|FG001|Overall Study|Death|2|||
23216079|NCT01061736|64531402|FG000|Overall Study|Dose regimen not selected|0|||
23216080|NCT01061736|64531403|FG001|Overall Study|Dose regimen not selected|0|||
23216081|NCT01061736|64531404|FG002|Overall Study|Dose regimen not selected|0|||
23216082|NCT01061736|64531405|FG003|Overall Study|Dose regimen not selected|0|||
23216083|NCT01061736|64531406|FG004|Overall Study|Dose regimen not selected|0|||
23216084|NCT01061736|64531407|FG005|Overall Study|Dose regimen not selected|0|||
23216085|NCT01061736|64531408|FG006|Overall Study|Dose regimen not selected|79|||
23216086|NCT01061736|64531409|FG007|Overall Study|Dose regimen not selected|0|||
23216087|NCT01061736|64531410|FG008|Overall Study|Dose regimen not selected|0|||
23216088|NCT01061736|64531411|FG009|Overall Study|Dose regimen not selected|0|||
23216089|NCT01061736|64531402|FG000|Overall Study|Adverse Event|13|||
23139686|NCT01248065|64259142|FG000|Overall Study|Third treatment failure event|3|||
23139687|NCT01248065|64259143|FG001|Overall Study|Third treatment failure event|1|||
23139688|NCT01248065|64259142|FG000|Overall Study|Other|3|||
23139689|NCT01248065|64259143|FG001|Overall Study|Other|5|||
23139690|NCT03581825|64259144|FG000|Period 1|Lens Discomfort|1|||
23139691|NCT03581825|64259145|FG001|Period 1|Lens Discomfort|0|||
23139692|NCT03581825|64259144|FG000|Period 2|Unsatisfactory Vision to Test|0|||
23139693|NCT03581825|64259145|FG001|Period 2|Unsatisfactory Vision to Test|1|||
23139694|NCT04275089|64259147|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
23139695|NCT03981861|64259148|FG000|Overall Study|Withdrawal by Subject|3|||
23139696|NCT05330312|64259149|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
23139697|NCT05330312|64259150|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
23139698|NCT05330312|64259151|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
23139699|NCT05330312|64259149|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
23139700|NCT05330312|64259150|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
23216090|NCT01061736|64531403|FG001|Overall Study|Adverse Event|1|||
23216091|NCT01061736|64531404|FG002|Overall Study|Adverse Event|3|||
23216092|NCT01061736|64531405|FG003|Overall Study|Adverse Event|2|||
23554356|NCT01239030|65754733|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
23554357|NCT01239030|65754734|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
23554358|NCT01239030|65754735|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
23554359|NCT01239030|65754731|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
23554360|NCT01239030|65754732|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
23554361|NCT01239030|65754733|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
23554362|NCT01239030|65754734|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
23554363|NCT01239030|65754735|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
23554364|NCT01239030|65754731|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
23554365|NCT01239030|65754732|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
23554366|NCT01239030|65754733|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
23554367|NCT01239030|65754734|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
23554368|NCT01239030|65754735|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
23554369|NCT01812655|65754738|FG000|Overall Study|Protocol Violation|1|||
23554370|NCT01812655|65754739|FG001|Overall Study|Protocol Violation|1|||
23554371|NCT01812655|65754740|FG002|Overall Study|Protocol Violation|0|||
23554372|NCT02251990|65754741|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
23554373|NCT02251990|65754742|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
23554374|NCT02251990|65754741|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
23554375|NCT02251990|65754742|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
23554376|NCT02251990|65754741|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
23554377|NCT02251990|65754742|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
23554378|NCT02251990|65754741|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
23554379|NCT02251990|65754742|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
23216093|NCT01061736|64531406|FG004|Overall Study|Adverse Event|4|||
23216094|NCT01061736|64531407|FG005|Overall Study|Adverse Event|1|||
23139701|NCT05330312|64259151|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
23139702|NCT05330312|64259149|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
23139703|NCT05330312|64259150|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
23139704|NCT05330312|64259151|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
23216095|NCT01061736|64531408|FG006|Overall Study|Adverse Event|4|||
23554380|NCT02251990|65754741|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
23554381|NCT02251990|65754742|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
23554382|NCT02251990|65754741|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
23554383|NCT02251990|65754742|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
23554384|NCT02313428|65754743|FG000|Overall Study|Lost to Follow-up|1|||
23554385|NCT02313428|65754744|FG001|Overall Study|Lost to Follow-up|1|||
23554386|NCT04052204|65754748|FG000|Overall Study|Death|1|||
23554387|NCT04052204|65754749|FG001|Overall Study|Death|0|||
23554388|NCT04052204|65754750|FG002|Overall Study|Death|0|||
23554389|NCT04052204|65754748|FG000|Overall Study|Progressive disease|1|||
23554390|NCT04052204|65754749|FG001|Overall Study|Progressive disease|0|||
23621976|NCT01379703|66000836|FG001|Study Start Through 9 Months|Medication not available|2|||
23621977|NCT01379703|66000837|FG002|Study Start Through 9 Months|Medication not available|1|||
23621978|NCT01379703|66000835|FG000|Study Start Through 9 Months|Poor general condition|0|||
23621979|NCT01379703|66000836|FG001|Study Start Through 9 Months|Poor general condition|1|||
23621980|NCT01379703|66000837|FG002|Study Start Through 9 Months|Poor general condition|0|||
23621981|NCT01379703|66000835|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
23621982|NCT01379703|66000836|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
23621983|NCT01379703|66000837|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
23621984|NCT01379703|66000835|FG000|Study Start Through 9 Months|Reason unknown|2|||
23621985|NCT01379703|66000836|FG001|Study Start Through 9 Months|Reason unknown|31|||
23621986|NCT01379703|66000837|FG002|Study Start Through 9 Months|Reason unknown|24|||
23621987|NCT01379703|66000835|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
23621988|NCT01379703|66000836|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
23621989|NCT01379703|66000837|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
23621990|NCT01379703|66000835|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
23621991|NCT01379703|66000836|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
23621992|NCT01379703|66000837|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
23621993|NCT01379703|66000835|FG000|9 Months Through 18 Months|Adverse Event|0|||
23621994|NCT01379703|66000836|FG001|9 Months Through 18 Months|Adverse Event|6|||
23621995|NCT01379703|66000837|FG002|9 Months Through 18 Months|Adverse Event|0|||
23621996|NCT01379703|66000835|FG000|9 Months Through 18 Months|Treatment failure|0|||
23621997|NCT01379703|66000836|FG001|9 Months Through 18 Months|Treatment failure|5|||
23621998|NCT01379703|66000837|FG002|9 Months Through 18 Months|Treatment failure|0|||
23621999|NCT01379703|66000835|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
23622000|NCT01379703|66000836|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
23622001|NCT01379703|66000837|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
23622002|NCT01379703|66000835|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
23622003|NCT01379703|66000836|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
23622004|NCT01379703|66000837|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
23622005|NCT01379703|66000835|FG000|9 Months Through 18 Months|Fatigue|0|||
23622006|NCT01379703|66000836|FG001|9 Months Through 18 Months|Fatigue|1|||
23622007|NCT01379703|66000837|FG002|9 Months Through 18 Months|Fatigue|0|||
23622008|NCT01379703|66000835|FG000|9 Months Through 18 Months|Reason Unknown|0|||
23622009|NCT01379703|66000836|FG001|9 Months Through 18 Months|Reason Unknown|23|||
23622010|NCT01379703|66000837|FG002|9 Months Through 18 Months|Reason Unknown|0|||
23622011|NCT02176356|66000839|FG000|Overall Study|Screen Failure|14|||
23622012|NCT02176356|66000839|FG000|Overall Study|Lost to Follow-up|4|||
23622013|NCT02176356|66000839|FG000|Overall Study|Personal Reasons|3|||
23622014|NCT02176356|66000839|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23622015|NCT00905359|66000840|FG000|Overall Study|Lost to Follow-up|17|||
23622016|NCT00905359|66000841|FG001|Overall Study|Lost to Follow-up|10|||
23622017|NCT00905359|66000840|FG000|Overall Study|Death|2|||
23622018|NCT00905359|66000841|FG001|Overall Study|Death|0|||
23622019|NCT00905359|66000840|FG000|Overall Study|Withdrawal consent|5|||
23622020|NCT00905359|66000841|FG001|Overall Study|Withdrawal consent|6|||
23622021|NCT03807700|66000842|FG000|Overall Study|Withdrawal by Subject|2|||
23622022|NCT03807700|66000843|FG001|Overall Study|Withdrawal by Subject|1|||
23622023|NCT02201771|66000851|FG000|Overall Study|Death|3|||
23622024|NCT02201771|66000852|FG001|Overall Study|Death|2|||
23622025|NCT02201771|66000853|FG002|Overall Study|Death|0|||
23622026|NCT02201771|66000851|FG000|Overall Study|Protocol Violation|10|||
23622027|NCT02201771|66000852|FG001|Overall Study|Protocol Violation|8|||
23622028|NCT02201771|66000853|FG002|Overall Study|Protocol Violation|10|||
23622029|NCT00691678|66000856|FG000|Overall Study|Adverse Event|5|||
23622030|NCT00691678|66000856|FG000|Overall Study|life events, pain|11|||
23622031|NCT01128114|66000857|FG000|Overall Study|Treatment Withdrawn|6|||
23622032|NCT01128114|66000857|FG000|Overall Study|Screening Failed|2|||
23622033|NCT01990313|66000858|FG000|Overall Study|Lost to Follow-up|1|||
23622034|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
23622035|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
23622036|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
23622037|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
23622038|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
23622039|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
23622040|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Rejections|0|||
23139705|NCT05330312|64259149|FG000|Pivotal Investigation - Part 2|Death|1|||
23139706|NCT05330312|64259150|FG001|Pivotal Investigation - Part 2|Death|4|||
23139707|NCT05330312|64259151|FG002|Pivotal Investigation - Part 2|Death|0|||
23139708|NCT00574873|64259152|FG000|Overall Study|Withdrawal by Subject|18|||
23139709|NCT00574873|64259153|FG001|Overall Study|Withdrawal by Subject|19|||
23139710|NCT00574873|64259152|FG000|Overall Study|Investigator request|18|||
23139711|NCT00574873|64259153|FG001|Overall Study|Investigator request|8|||
23139712|NCT00574873|64259152|FG000|Overall Study|Death|15|||
23139713|NCT00574873|64259153|FG001|Overall Study|Death|14|||
23139714|NCT00574873|64259152|FG000|Overall Study|Lost to Follow-up|14|||
23139715|NCT00574873|64259153|FG001|Overall Study|Lost to Follow-up|5|||
23139716|NCT00574873|64259152|FG000|Overall Study|Other|40|||
23139717|NCT00574873|64259153|FG001|Overall Study|Other|4|||
23139718|NCT00574873|64259152|FG000|Overall Study|Discontinuation of study by sponsor|5|||
23432124|NCT01999218|65327539|FG002|Overall Study|Study Terminated By Sponsor|12|||
23432125|NCT01999218|65327537|FG000|Overall Study|Participant moves|2|||
23432126|NCT01999218|65327538|FG001|Overall Study|Participant moves|5|||
23432127|NCT01999218|65327539|FG002|Overall Study|Participant moves|3|||
23554391|NCT04052204|65754750|FG002|Overall Study|Progressive disease|0|||
23554392|NCT04052204|65754748|FG000|Overall Study|Other|1|||
23554393|NCT04052204|65754749|FG001|Overall Study|Other|0|||
23622041|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Rejections|0|||
23622042|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Rejections|55|||
23622043|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
23622044|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
23622045|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
23622046|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
23622047|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
23622048|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
23139719|NCT00574873|64259153|FG001|Overall Study|Discontinuation of study by sponsor|199|||
23139720|NCT00574873|64259152|FG000|Overall Study|Blank, site closed per local regulations|2|||
23139721|NCT00574873|64259153|FG001|Overall Study|Blank, site closed per local regulations|2|||
23139722|NCT00574873|64259152|FG000|Overall Study|Extension Study|126|||
23139723|NCT00574873|64259153|FG001|Overall Study|Extension Study|0|||
23139724|NCT01880528|64259154|FG000|Overall Study|Other|1|||
23139725|NCT01880528|64259155|FG001|Overall Study|Other|1|||
23432128|NCT01999218|65327537|FG000|Overall Study|Withdrawal by Subject|28|||
23554394|NCT04052204|65754750|FG002|Overall Study|Other|0|||
23554395|NCT00765674|65754751|FG000|Overall Study|Adverse Event|7|||
23554396|NCT00765674|65754752|FG001|Overall Study|Adverse Event|2|||
23622049|NCT00634920|66000861|FG000|Period 1 - Pre-Randomization|Other issues|0|||
23622050|NCT00634920|66000862|FG001|Period 1 - Pre-Randomization|Other issues|0|||
23622051|NCT00634920|66000863|FG002|Period 1 - Pre-Randomization|Other issues|6|||
23622052|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
23622053|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
23622054|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
23622055|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|Rejection|11|||
23622056|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|Rejection|5|||
23622057|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|Rejection|0|||
23622058|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|Death|2|||
23622059|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|Death|5|||
23622060|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|Death|0|||
23622061|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
23622062|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
23554397|NCT00765674|65754753|FG002|Overall Study|Adverse Event|8|||
23554398|NCT00765674|65754754|FG003|Overall Study|Adverse Event|11|||
23554399|NCT00765674|65754751|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
23554400|NCT00765674|65754752|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
23554401|NCT00765674|65754753|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
23554402|NCT00765674|65754754|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
23554403|NCT00765674|65754751|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
23554404|NCT00765674|65754752|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
23622063|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
23622064|NCT00634920|66000861|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
23622065|NCT00634920|66000862|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
23139726|NCT01815138|64259158|FG000|Overall Study|Withdrawal by Subject|0|||
23139727|NCT01815138|64259159|FG001|Overall Study|Withdrawal by Subject|1|||
23139728|NCT01815138|64259158|FG000|Overall Study|Physician Decision|8|||
23139729|NCT01815138|64259159|FG001|Overall Study|Physician Decision|5|||
23139730|NCT01009580|64259160|FG000|Overall Study|Adverse Event|4|||
23139731|NCT01009580|64259161|FG001|Overall Study|Adverse Event|4|||
23139732|NCT01009580|64259160|FG000|Overall Study|Lack of Efficacy|0|||
23139733|NCT01009580|64259161|FG001|Overall Study|Lack of Efficacy|1|||
23554405|NCT00765674|65754753|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
23554406|NCT00765674|65754754|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
23139734|NCT01009580|64259160|FG000|Overall Study|Protocol Violation|2|||
23139735|NCT01009580|64259161|FG001|Overall Study|Protocol Violation|3|||
23139736|NCT01009580|64259160|FG000|Overall Study|Withdrawal Criteria|4|||
23139737|NCT01009580|64259161|FG001|Overall Study|Withdrawal Criteria|6|||
23139738|NCT01009580|64259160|FG000|Overall Study|Unclassified|17|||
23317991|NCT04052620|64908222|FG000|Overall Study|Personal reasons|2|||
23317992|NCT04052620|64908223|FG001|Overall Study|Personal reasons|4|||
23317993|NCT04052620|64908222|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
23317994|NCT04052620|64908223|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
23317995|NCT01473407|64908226|FG000|Overall Study|Physician Decision|1|||
23317996|NCT01473407|64908227|FG001|Overall Study|Physician Decision|4|||
23317997|NCT01473407|64908226|FG000|Overall Study|Lost to Follow-up|10|||
23317998|NCT01473407|64908227|FG001|Overall Study|Lost to Follow-up|4|||
23317999|NCT01473407|64908226|FG000|Overall Study|Adverse Event|8|||
23318000|NCT01473407|64908227|FG001|Overall Study|Adverse Event|8|||
23318001|NCT01473407|64908226|FG000|Overall Study|Randomization Error|3|||
23318002|NCT01473407|64908227|FG001|Overall Study|Randomization Error|1|||
23318003|NCT01473407|64908226|FG000|Overall Study|Withdrawal by Subject|4|||
23318004|NCT01473407|64908227|FG001|Overall Study|Withdrawal by Subject|7|||
23318005|NCT01473407|64908226|FG000|Overall Study|Kidney Transplant|7|||
23318006|NCT01473407|64908227|FG001|Overall Study|Kidney Transplant|6|||
23318007|NCT01473407|64908226|FG000|Overall Study|Vacation/Travel|1|||
23318008|NCT01473407|64908227|FG001|Overall Study|Vacation/Travel|1|||
23318009|NCT01473407|64908226|FG000|Overall Study|Elevated Hemoglobin|1|||
23318010|NCT01473407|64908227|FG001|Overall Study|Elevated Hemoglobin|0|||
23318011|NCT01473407|64908226|FG000|Overall Study|Patient Received Aranesp|1|||
23318012|NCT01473407|64908227|FG001|Overall Study|Patient Received Aranesp|0|||
23318013|NCT01473407|64908226|FG000|Overall Study|Patient Lost Green Card Status|1|||
23318014|NCT01473407|64908227|FG001|Overall Study|Patient Lost Green Card Status|0|||
23318015|NCT01473407|64908226|FG000|Overall Study|Temperature Excursion|2|||
23318016|NCT01473407|64908227|FG001|Overall Study|Temperature Excursion|3|||
23318017|NCT01473407|64908226|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
23318018|NCT01473407|64908227|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
23318019|NCT01473407|64908226|FG000|Overall Study|Sponsor's Decision|10|||
23318020|NCT01473407|64908227|FG001|Overall Study|Sponsor's Decision|10|||
23318021|NCT01473407|64908226|FG000|Overall Study|Site Closure|1|||
23318022|NCT01473407|64908227|FG001|Overall Study|Site Closure|0|||
23318023|NCT01098474|64908230|FG000|Active Phase|Other|0|||
23318024|NCT01098474|64908231|FG001|Active Phase|Other|0|||
23318025|NCT01098474|64908232|FG002|Active Phase|Other|3|||
23318026|NCT01098474|64908233|FG003|Active Phase|Other|0|||
23139739|NCT01009580|64259161|FG001|Overall Study|Unclassified|21|||
23139740|NCT01659853|64259162|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
23139741|NCT01659853|64259163|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
23139742|NCT01659853|64259162|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
23139743|NCT01659853|64259163|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
23139744|NCT00297232|64259164|FG000|Overall Study|Lack of Efficacy|7|||
23139745|NCT00297232|64259164|FG000|Overall Study|Lost to Follow-up|10|||
23139746|NCT00297232|64259164|FG000|Overall Study|Adverse Event|63|||
23139747|NCT00297232|64259164|FG000|Overall Study|Voluntary Withdrawal|120|||
23139748|NCT00297232|64259164|FG000|Overall Study|Subject was Noncompliant|9|||
23139749|NCT00297232|64259164|FG000|Overall Study|Death|9|||
23139750|NCT00297232|64259164|FG000|Overall Study|Anti-natalizumab Positive|8|||
23139751|NCT00297232|64259164|FG000|Overall Study|Switched to Commercial Tysabri|22|||
23139752|NCT00297232|64259164|FG000|Overall Study|Disease Progression|8|||
23139753|NCT00297232|64259164|FG000|Overall Study|Fear of PML|10|||
23139754|NCT00297232|64259164|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
23139755|NCT00297232|64259164|FG000|Overall Study|Miscellaneous|5|||
23139756|NCT00297232|64259164|FG000|Overall Study|Sponsor Decision|34|||
23139757|NCT00297232|64259164|FG000|Overall Study|Subject Relocated|7|||
23318027|NCT01098474|64908234|FG004|Active Phase|Other|0|||
23318028|NCT01098474|64908235|FG005|Active Phase|Other|0|||
23318029|NCT01098474|64908230|FG000|Active Phase|Withdrawal by Subject|1|||
23318030|NCT01098474|64908231|FG001|Active Phase|Withdrawal by Subject|1|||
23318031|NCT01098474|64908232|FG002|Active Phase|Withdrawal by Subject|2|||
23318032|NCT01098474|64908233|FG003|Active Phase|Withdrawal by Subject|0|||
23318033|NCT01098474|64908234|FG004|Active Phase|Withdrawal by Subject|0|||
23318034|NCT01098474|64908235|FG005|Active Phase|Withdrawal by Subject|0|||
23318035|NCT01098474|64908230|FG000|Active Phase|Lost to Follow-up|1|||
23139758|NCT00297232|64259164|FG000|Overall Study|Subject Withdrew Consent|37|||
23139759|NCT00297232|64259164|FG000|Overall Study|Persistently Positive Antibodies|11|||
23139760|NCT00297232|64259164|FG000|Overall Study|Investigator Withdrew From Program|19|||
23139761|NCT00297232|64259164|FG000|Overall Study|Did Not Enroll to Week 264|34|||
23318036|NCT01098474|64908231|FG001|Active Phase|Lost to Follow-up|0|||
23432129|NCT01999218|65327538|FG001|Overall Study|Withdrawal by Subject|29|||
23139762|NCT00297232|64259164|FG000|Overall Study|Did Not Enroll to Week 480|17|||
23139763|NCT00297232|64259164|FG000|Overall Study|No data available after Week 264|161|||
23139764|NCT00297232|64259164|FG000|Overall Study|Other|1|||
23318037|NCT01098474|64908232|FG002|Active Phase|Lost to Follow-up|0|||
23318038|NCT01098474|64908233|FG003|Active Phase|Lost to Follow-up|0|||
23318039|NCT01098474|64908234|FG004|Active Phase|Lost to Follow-up|0|||
23318040|NCT01098474|64908235|FG005|Active Phase|Lost to Follow-up|0|||
23554407|NCT00765674|65754751|FG000|Overall Study|Lack of Efficacy|2|||
23139765|NCT02996474|64259165|FG000|Overall Study|Physician Decision|5|||
23139766|NCT00657020|64259168|FG000|PERIOD 1|Adverse Event|0|||
23139767|NCT00657020|64259169|FG001|PERIOD 1|Adverse Event|1|||
23139768|NCT01535560|64259170|FG000|Overall Study|Adverse Event|12|||
23139769|NCT01535560|64259171|FG001|Overall Study|Adverse Event|7|||
23139770|NCT01535560|64259170|FG000|Overall Study|Lost to Follow-up|1|||
23139771|NCT01535560|64259171|FG001|Overall Study|Lost to Follow-up|3|||
23139772|NCT01535560|64259170|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
23139773|NCT01535560|64259171|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
23139774|NCT01535560|64259170|FG000|Overall Study|Treatment Failure|21|||
23139775|NCT01535560|64259171|FG001|Overall Study|Treatment Failure|83|||
23139776|NCT01535560|64259170|FG000|Overall Study|Other|0|||
23139777|NCT01535560|64259171|FG001|Overall Study|Other|1|||
23139778|NCT01535560|64259170|FG000|Overall Study|Randomized in Error|0|||
23139779|NCT01535560|64259171|FG001|Overall Study|Randomized in Error|1|||
23139780|NCT02270515|64259172|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
23139781|NCT02270515|64259172|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
23139782|NCT02270515|64259172|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
23139783|NCT02270515|64259172|FG000|Intervention Period 1: 0-6 Months|Death|7|||
23139784|NCT02270515|64259172|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
23139785|NCT02270515|64259172|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
23139786|NCT02270515|64259172|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
23139787|NCT02270515|64259172|FG000|Intervention Period 2: 6-12 Months|Death|5|||
23139788|NCT02270515|64259172|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
23139789|NCT02270515|64259172|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
23139790|NCT02270515|64259172|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
23139791|NCT02270515|64259172|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
23139792|NCT02270515|64259172|FG000|Intervention Period 3: 12-18 Months|Death|3|||
23139793|NCT02270515|64259172|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
23139794|NCT01774487|64259173|FG000|Overall Study|Did not tolerate taste|4|||
23139795|NCT01774487|64259174|FG001|Overall Study|Did not tolerate taste|4|||
23139796|NCT01236534|64263613|FG000|Overall Study|Adverse Event|3|||
23139797|NCT01236534|64263614|FG001|Overall Study|Adverse Event|0|||
23139798|NCT01675479|64263615|FG000|Overall Study|Lost to Follow-up|11|||
23139799|NCT02337751|64263616|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
23139800|NCT02337751|64263617|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
23139801|NCT02337751|64263616|FG000|Overall Study|Voluntary Withdrawal|6|||
23139802|NCT02337751|64263617|FG001|Overall Study|Voluntary Withdrawal|8|||
23139803|NCT02337751|64263616|FG000|Overall Study|Lack of Efficacy|2|||
23139804|NCT02337751|64263617|FG001|Overall Study|Lack of Efficacy|5|||
23139805|NCT02337751|64263616|FG000|Overall Study|Investigator's Judgement|1|||
23139806|NCT02337751|64263617|FG001|Overall Study|Investigator's Judgement|0|||
23139807|NCT02047903|64263621|FG000|Overall Study|Adverse Event|14|||
23139808|NCT02047903|64263621|FG000|Overall Study|Serious adverse event|10|||
23139809|NCT02047903|64263621|FG000|Overall Study|Withdrawal by Subject|16|||
23139810|NCT02047903|64263621|FG000|Overall Study|Lost to Follow-up|4|||
23139811|NCT02047903|64263621|FG000|Overall Study|Reason not listed|6|||
23139812|NCT02047903|64263621|FG000|Overall Study|Not Treated|9|||
23139813|NCT03866473|64263622|FG000|Phase 1|Death|1|||
23139814|NCT03866473|64263623|FG001|Phase 1|Death|0|||
23139815|NCT03866473|64263622|FG000|Phase 2|Death|0|||
23139816|NCT03866473|64263623|FG001|Phase 2|Death|2|||
23139817|NCT03866473|64263622|FG000|Phase 2|Dropped|1|||
23139818|NCT03866473|64263623|FG001|Phase 2|Dropped|1|||
23216096|NCT01061736|64531409|FG007|Overall Study|Adverse Event|63|||
23554408|NCT00765674|65754752|FG001|Overall Study|Lack of Efficacy|3|||
23554409|NCT00765674|65754753|FG002|Overall Study|Lack of Efficacy|1|||
23139819|NCT03866473|64263622|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
23318041|NCT01098474|64908230|FG000|Follow Up Phase|Travelled out of study area|0|||
23318042|NCT01098474|64908231|FG001|Follow Up Phase|Travelled out of study area|0|||
23139820|NCT03866473|64263623|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
23139821|NCT01119105|64263624|FG000|Overall Study|Withdrawal by Subject|1|||
23139822|NCT01119105|64263625|FG001|Overall Study|Withdrawal by Subject|1|||
23139823|NCT01119105|64263626|FG002|Overall Study|Withdrawal by Subject|1|||
23139824|NCT01119105|64263624|FG000|Overall Study|Lost to Follow-up|0|||
23139825|NCT01119105|64263625|FG001|Overall Study|Lost to Follow-up|2|||
23139826|NCT01119105|64263626|FG002|Overall Study|Lost to Follow-up|5|||
23139827|NCT01119105|64263624|FG000|Overall Study|Adverse Event|1|||
23139828|NCT01119105|64263625|FG001|Overall Study|Adverse Event|0|||
23139829|NCT01119105|64263626|FG002|Overall Study|Adverse Event|1|||
23554410|NCT00765674|65754754|FG003|Overall Study|Lack of Efficacy|2|||
23139830|NCT01119105|64263624|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
23139831|NCT01119105|64263625|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
23139832|NCT01119105|64263626|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
23139833|NCT01119105|64263624|FG000|Overall Study|Other|1|||
23139834|NCT01119105|64263625|FG001|Overall Study|Other|1|||
23139835|NCT01119105|64263626|FG002|Overall Study|Other|0|||
23139836|NCT00986973|64263627|FG000|Overall Study|Withdrawn by study team|1|||
23554411|NCT00765674|65754751|FG000|Overall Study|Protocol Violation|2|||
23554412|NCT00765674|65754752|FG001|Overall Study|Protocol Violation|0|||
23554413|NCT00765674|65754753|FG002|Overall Study|Protocol Violation|1|||
23554414|NCT00765674|65754754|FG003|Overall Study|Protocol Violation|0|||
23554415|NCT00765674|65754751|FG000|Overall Study|Withdrawal by Subject|5|||
23554416|NCT00765674|65754752|FG001|Overall Study|Withdrawal by Subject|7|||
23554417|NCT00765674|65754753|FG002|Overall Study|Withdrawal by Subject|3|||
23554418|NCT00765674|65754754|FG003|Overall Study|Withdrawal by Subject|8|||
23554419|NCT00765674|65754751|FG000|Overall Study|Lost to Follow-up|4|||
23554420|NCT00765674|65754752|FG001|Overall Study|Lost to Follow-up|6|||
23554421|NCT00765674|65754753|FG002|Overall Study|Lost to Follow-up|2|||
23554422|NCT00765674|65754754|FG003|Overall Study|Lost to Follow-up|1|||
23554423|NCT00765674|65754751|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
23554424|NCT00765674|65754752|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
23554425|NCT00765674|65754753|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
23139837|NCT05323396|64263628|FG000|Overall Study|Lost to Follow-up|1|||
23139838|NCT05323396|64263629|FG001|Overall Study|Lost to Follow-up|31|||
23139839|NCT05323396|64263628|FG000|Overall Study|Pregnancy|1|||
23139840|NCT05323396|64263629|FG001|Overall Study|Pregnancy|0|||
23139841|NCT01990560|64263635|FG000|Overall Study|Withdrawal by Subject|1|||
23139842|NCT01668667|64263636|FG000|Overall Study|Adverse Event|3|||
23622066|NCT00634920|66000863|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
23622067|NCT00545571|66000864|FG000|Overall Study|Administrative Reasons|1|||
23139843|NCT01668667|64263637|FG001|Overall Study|Adverse Event|6|||
23139844|NCT01668667|64263638|FG002|Overall Study|Adverse Event|4|||
23139845|NCT01668667|64263639|FG003|Overall Study|Adverse Event|4|||
23139846|NCT01668667|64263636|FG000|Overall Study|Lack of Efficacy|3|||
23139847|NCT01668667|64263637|FG001|Overall Study|Lack of Efficacy|2|||
23139848|NCT01668667|64263638|FG002|Overall Study|Lack of Efficacy|2|||
23139849|NCT01668667|64263639|FG003|Overall Study|Lack of Efficacy|3|||
23139850|NCT01668667|64263636|FG000|Overall Study|Protocol Violation|6|||
23139851|NCT01668667|64263637|FG001|Overall Study|Protocol Violation|10|||
23139852|NCT01668667|64263638|FG002|Overall Study|Protocol Violation|12|||
23139853|NCT01668667|64263639|FG003|Overall Study|Protocol Violation|5|||
23139854|NCT01668667|64263636|FG000|Overall Study|Lost to Follow-up|9|||
23139855|NCT01668667|64263637|FG001|Overall Study|Lost to Follow-up|4|||
23139856|NCT01668667|64263638|FG002|Overall Study|Lost to Follow-up|7|||
23139857|NCT01668667|64263639|FG003|Overall Study|Lost to Follow-up|6|||
23139858|NCT01668667|64263636|FG000|Overall Study|Physician Decision|3|||
23139859|NCT01668667|64263637|FG001|Overall Study|Physician Decision|0|||
23139860|NCT01668667|64263638|FG002|Overall Study|Physician Decision|1|||
23139861|NCT01668667|64263639|FG003|Overall Study|Physician Decision|0|||
23139862|NCT01668667|64263636|FG000|Overall Study|Withdrawal by Subject|7|||
23139863|NCT01668667|64263637|FG001|Overall Study|Withdrawal by Subject|4|||
23139864|NCT01668667|64263638|FG002|Overall Study|Withdrawal by Subject|5|||
23139865|NCT01668667|64263639|FG003|Overall Study|Withdrawal by Subject|5|||
23139866|NCT01970345|64263644|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
23139867|NCT01970345|64263645|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
23139868|NCT01970345|64263644|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
23139869|NCT01970345|64263645|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
23139870|NCT02374671|64263649|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
23139871|NCT02374671|64263650|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
23139872|NCT02374671|64263651|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
23139873|NCT02374671|64263649|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
23318043|NCT01098474|64908232|FG002|Follow Up Phase|Travelled out of study area|0|||
23622068|NCT00545571|66000864|FG000|Overall Study|Adverse Event|2|||
23139874|NCT02374671|64263650|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
23139875|NCT02374671|64263651|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
23139876|NCT02374671|64263649|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
23139877|NCT02374671|64263650|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
23139878|NCT02374671|64263651|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
23139879|NCT02374671|64263649|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
23139880|NCT02374671|64263650|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
23139881|NCT02374671|64263651|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
23554426|NCT00765674|65754754|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
23554427|NCT02366910|65754755|FG000|Overall Study|Withdrawal by Subject|2|||
23554428|NCT02366910|65754755|FG000|Overall Study|Screen Failure|3|||
23554429|NCT03804710|65754760|FG000|Overall Study|Adverse Event|0|||
23139882|NCT02374671|64263649|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
23139883|NCT02374671|64263650|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
23139884|NCT02374671|64263651|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
23139885|NCT02724969|64263652|FG000|Overall Study|Lost to Follow-up|12|||
23139886|NCT02724969|64263653|FG001|Overall Study|Lost to Follow-up|6|||
23139887|NCT02724969|64263652|FG000|Overall Study|Withdrawal by Subject|3|||
23139888|NCT02724969|64263653|FG001|Overall Study|Withdrawal by Subject|3|||
23139889|NCT02724969|64263652|FG000|Overall Study|Infant demise|0|||
23139890|NCT02724969|64263653|FG001|Overall Study|Infant demise|2|||
23139891|NCT00833261|64263656|FG000|Overall Study|Withdrawal by Subject|4|||
23432130|NCT01999218|65327539|FG002|Overall Study|Withdrawal by Subject|34|||
23432131|NCT01999218|65327537|FG000|Overall Study|Creatinine/eGFR|0|||
23432132|NCT01999218|65327538|FG001|Overall Study|Creatinine/eGFR|0|||
23432133|NCT01999218|65327539|FG002|Overall Study|Creatinine/eGFR|1|||
23432134|NCT01999218|65327537|FG000|Overall Study|Death|7|||
23432135|NCT01999218|65327538|FG001|Overall Study|Death|1|||
23432136|NCT01999218|65327539|FG002|Overall Study|Death|2|||
23432137|NCT01999218|65327537|FG000|Overall Study|Excluded Medication|1|||
23432138|NCT01999218|65327538|FG001|Overall Study|Excluded Medication|1|||
23432139|NCT01999218|65327539|FG002|Overall Study|Excluded Medication|2|||
23432140|NCT01999218|65327537|FG000|Overall Study|Adverse Event|9|||
23432141|NCT01999218|65327538|FG001|Overall Study|Adverse Event|7|||
23432142|NCT01999218|65327539|FG002|Overall Study|Adverse Event|7|||
23432143|NCT01999218|65327537|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
23432144|NCT01999218|65327538|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
23432145|NCT01999218|65327539|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
23432146|NCT05026853|65327540|FG000|Overall Study|Cancelled appointment|1|||
23432147|NCT05026853|65327541|FG001|Overall Study|Cancelled appointment|0|||
23432148|NCT05026853|65327540|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
23432149|NCT05026853|65327541|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
23432150|NCT05026853|65327540|FG000|Overall Study|Did not complete 12-week survey|16|||
23432151|NCT05026853|65327541|FG001|Overall Study|Did not complete 12-week survey|16|||
23432152|NCT00262847|65327543|FG000|Overall Study|Disease Progression|309|||
23432153|NCT00262847|65327544|FG001|Overall Study|Disease Progression|274|||
23432154|NCT00262847|65327545|FG002|Overall Study|Disease Progression|195|||
23432155|NCT00262847|65327543|FG000|Overall Study|Patient Refusal|41|||
23432156|NCT00262847|65327544|FG001|Overall Study|Patient Refusal|52|||
23432157|NCT00262847|65327545|FG002|Overall Study|Patient Refusal|47|||
23432158|NCT00262847|65327543|FG000|Overall Study|Adverse Event|74|||
23554430|NCT03804710|65754761|FG001|Overall Study|Adverse Event|3|||
23554431|NCT03804710|65754760|FG000|Overall Study|Withdrawal by Subject|2|||
23554432|NCT03804710|65754761|FG001|Overall Study|Withdrawal by Subject|1|||
23554433|NCT03804710|65754760|FG000|Overall Study|Other|0|||
23554434|NCT03804710|65754761|FG001|Overall Study|Other|1|||
23554435|NCT03185481|65754762|FG000|Overall Study|Adverse Event|1|||
23139892|NCT02585232|64263657|FG000|Overall Study|Lost to Follow-up|8|||
23139893|NCT02585232|64263658|FG001|Overall Study|Lost to Follow-up|8|||
23432159|NCT00262847|65327544|FG001|Overall Study|Adverse Event|88|||
23432160|NCT00262847|65327545|FG002|Overall Study|Adverse Event|108|||
23432161|NCT00262847|65327543|FG000|Overall Study|Death|8|||
23432162|NCT00262847|65327544|FG001|Overall Study|Death|8|||
23432163|NCT00262847|65327545|FG002|Overall Study|Death|11|||
23432164|NCT00262847|65327543|FG000|Overall Study|Concomitant disease|3|||
23432165|NCT00262847|65327544|FG001|Overall Study|Concomitant disease|2|||
23432166|NCT00262847|65327545|FG002|Overall Study|Concomitant disease|4|||
23432167|NCT00262847|65327543|FG000|Overall Study|Other Reasons|79|||
23554436|NCT03185481|65754762|FG000|Overall Study|Study Terminated by Sponsor|4|||
23554437|NCT00686881|65754763|FG000|Overall Study|Withdrawal by Subject|11|||
23139894|NCT02585232|64263657|FG000|Overall Study|Withdrawal by Subject|4|||
23139895|NCT02585232|64263658|FG001|Overall Study|Withdrawal by Subject|8|||
23139896|NCT01145898|64263663|FG000|3-year Treatment|medication change by treating physician|3|||
23139897|NCT01145898|64263664|FG001|3-year Treatment|medication change by treating physician|16|||
23216097|NCT01061736|64531410|FG008|Overall Study|Adverse Event|67|||
23432168|NCT00262847|65327544|FG001|Overall Study|Other Reasons|88|||
23432169|NCT00262847|65327545|FG002|Overall Study|Other Reasons|27|||
23432170|NCT00262847|65327543|FG000|Overall Study|Did not receive study treatment|4|||
23554438|NCT00686881|65754764|FG001|Overall Study|Withdrawal by Subject|18|||
23139898|NCT01967147|64263665|FG000|Overall Study|Adverse Event|5|||
23139899|NCT01967147|64263666|FG001|Overall Study|Adverse Event|2|||
23139900|NCT01967147|64263665|FG000|Overall Study|Lack of Efficacy|1|||
23216098|NCT01061736|64531411|FG009|Overall Study|Adverse Event|34|||
23432171|NCT00262847|65327544|FG001|Overall Study|Did not receive study treatment|1|||
23432172|NCT00262847|65327545|FG002|Overall Study|Did not receive study treatment|4|||
23432173|NCT00946322|65327546|FG000|Pre-treatment|participant failure to follow up|1|||
23554439|NCT00686881|65754763|FG000|Overall Study|Lost to Follow-up|0|||
23554440|NCT00686881|65754764|FG001|Overall Study|Lost to Follow-up|1|||
23554441|NCT00686881|65754763|FG000|Overall Study|Treatment-related adverse event|10|||
23432174|NCT00946322|65327546|FG000|Post-treatment|participant failure to follow up|2|||
23432175|NCT01345682|65327547|FG000|Overall Study|Progressive disease per RECIST|226|||
23432176|NCT01345682|65327548|FG001|Overall Study|Progressive disease per RECIST|93|||
23432177|NCT01345682|65327547|FG000|Overall Study|Worsening of underlying cancer disease|23|||
23432178|NCT01345682|65327548|FG001|Overall Study|Worsening of underlying cancer disease|12|||
23139901|NCT01967147|64263666|FG001|Overall Study|Lack of Efficacy|4|||
23216099|NCT01061736|64531402|FG000|Overall Study|Lack of Efficacy|0|||
23216100|NCT01061736|64531403|FG001|Overall Study|Lack of Efficacy|2|||
23216101|NCT01061736|64531404|FG002|Overall Study|Lack of Efficacy|1|||
23216102|NCT01061736|64531405|FG003|Overall Study|Lack of Efficacy|1|||
23432179|NCT01345682|65327547|FG000|Overall Study|Adverse Event|51|||
23139902|NCT01967147|64263665|FG000|Overall Study|Lost to Follow-up|1|||
23139903|NCT01967147|64263666|FG001|Overall Study|Lost to Follow-up|2|||
23139904|NCT01967147|64263665|FG000|Overall Study|Withdrawal by Subject|2|||
23139905|NCT01967147|64263666|FG001|Overall Study|Withdrawal by Subject|4|||
23139906|NCT01967147|64263665|FG000|Overall Study|Non-compliance with Study Drug|0|||
23139907|NCT01967147|64263666|FG001|Overall Study|Non-compliance with Study Drug|3|||
23139908|NCT01967147|64263665|FG000|Overall Study|Other|4|||
23139909|NCT01967147|64263666|FG001|Overall Study|Other|5|||
23139910|NCT00605215|64263670|FG000|Overall Study|Death|0|||
23139911|NCT00605215|64263671|FG001|Overall Study|Death|0|||
23139912|NCT00605215|64263672|FG002|Overall Study|Death|1|||
23139913|NCT00605215|64263670|FG000|Overall Study|Adverse Event|19|||
23139914|NCT00605215|64263671|FG001|Overall Study|Adverse Event|21|||
23139915|NCT00605215|64263672|FG002|Overall Study|Adverse Event|26|||
23139916|NCT00605215|64263670|FG000|Overall Study|Refusal to sign the re-consent form|8|||
23139917|NCT00605215|64263671|FG001|Overall Study|Refusal to sign the re-consent form|3|||
23139918|NCT00605215|64263672|FG002|Overall Study|Refusal to sign the re-consent form|3|||
23139919|NCT00605215|64263670|FG000|Overall Study|Withdrawal by Subject|39|||
23139920|NCT00605215|64263671|FG001|Overall Study|Withdrawal by Subject|37|||
23139921|NCT00605215|64263672|FG002|Overall Study|Withdrawal by Subject|27|||
23139922|NCT00605215|64263670|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
23139923|NCT00605215|64263671|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
23139924|NCT00605215|64263672|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
23139925|NCT00605215|64263670|FG000|Overall Study|Protocol Violation|3|||
23139926|NCT00605215|64263671|FG001|Overall Study|Protocol Violation|4|||
23139927|NCT00605215|64263672|FG002|Overall Study|Protocol Violation|1|||
23139928|NCT00605215|64263670|FG000|Overall Study|Pregnancy|8|||
23139929|NCT00605215|64263671|FG001|Overall Study|Pregnancy|5|||
23139930|NCT00605215|64263672|FG002|Overall Study|Pregnancy|4|||
23139931|NCT00605215|64263670|FG000|Overall Study|Lost to Follow-up|8|||
23139932|NCT00605215|64263671|FG001|Overall Study|Lost to Follow-up|5|||
23139933|NCT00605215|64263672|FG002|Overall Study|Lost to Follow-up|2|||
23139934|NCT00605215|64263670|FG000|Overall Study|Other than specified|0|||
23139935|NCT00605215|64263671|FG001|Overall Study|Other than specified|2|||
23139936|NCT00605215|64263672|FG002|Overall Study|Other than specified|1|||
23139937|NCT00309959|64263677|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
23139938|NCT02146326|64263680|FG000|Overall Study|Lost to Follow-up|3|||
23139939|NCT02146326|64263681|FG001|Overall Study|Lost to Follow-up|3|||
23139940|NCT02146326|64263682|FG002|Overall Study|Lost to Follow-up|11|||
23139941|NCT02146326|64263683|FG003|Overall Study|Lost to Follow-up|19|||
23139942|NCT02146326|64263680|FG000|Overall Study|Withdrawal by Subject|2|||
23139943|NCT02146326|64263681|FG001|Overall Study|Withdrawal by Subject|1|||
23139944|NCT02146326|64263682|FG002|Overall Study|Withdrawal by Subject|15|||
23139945|NCT02146326|64263683|FG003|Overall Study|Withdrawal by Subject|11|||
23139946|NCT02146326|64263680|FG000|Overall Study|Separated from mental health center|23|||
23139947|NCT02146326|64263681|FG001|Overall Study|Separated from mental health center|33|||
23139948|NCT02146326|64263682|FG002|Overall Study|Separated from mental health center|0|||
23139949|NCT02146326|64263683|FG003|Overall Study|Separated from mental health center|0|||
23139950|NCT02146326|64263680|FG000|Overall Study|Incarcerated|0|||
23139951|NCT02146326|64263681|FG001|Overall Study|Incarcerated|0|||
23139952|NCT02146326|64263682|FG002|Overall Study|Incarcerated|3|||
23139953|NCT02146326|64263683|FG003|Overall Study|Incarcerated|8|||
23139954|NCT02146326|64263680|FG000|Overall Study|Death|0|||
23139955|NCT02146326|64263681|FG001|Overall Study|Death|0|||
23139956|NCT02146326|64263682|FG002|Overall Study|Death|4|||
23216103|NCT01061736|64531406|FG004|Overall Study|Lack of Efficacy|1|||
23139957|NCT02146326|64263683|FG003|Overall Study|Death|4|||
23139958|NCT02146326|64263680|FG000|Overall Study|Unable to complete interview|0|||
23139959|NCT02146326|64263681|FG001|Overall Study|Unable to complete interview|0|||
23139960|NCT02146326|64263682|FG002|Overall Study|Unable to complete interview|10|||
23139961|NCT02146326|64263683|FG003|Overall Study|Unable to complete interview|6|||
23139962|NCT02689518|64263686|FG000|Overall Study|Withdrawal by Subject|3|||
23139963|NCT00522873|64263687|FG000|Overall Study|Adverse Event|41|||
23139964|NCT00522873|64263688|FG001|Overall Study|Adverse Event|26|||
23139965|NCT00522873|64263687|FG000|Overall Study|Withdrawal by Subject|20|||
23216104|NCT01061736|64531407|FG005|Overall Study|Lack of Efficacy|2|||
23139966|NCT00522873|64263688|FG001|Overall Study|Withdrawal by Subject|9|||
23139967|NCT00522873|64263687|FG000|Overall Study|Protocol Violation|14|||
23139968|NCT00522873|64263688|FG001|Overall Study|Protocol Violation|4|||
23139969|NCT00522873|64263687|FG000|Overall Study|Lost to Follow-up|11|||
23139970|NCT00522873|64263688|FG001|Overall Study|Lost to Follow-up|3|||
23139971|NCT00522873|64263687|FG000|Overall Study|Personal Reasons|8|||
23139972|NCT00522873|64263688|FG001|Overall Study|Personal Reasons|1|||
23139973|NCT00522873|64263687|FG000|Overall Study|Medication Errors|1|||
23139974|NCT00522873|64263688|FG001|Overall Study|Medication Errors|1|||
23139975|NCT00522873|64263687|FG000|Overall Study|Never Received Medication|1|||
23139976|NCT00522873|64263688|FG001|Overall Study|Never Received Medication|0|||
23139977|NCT05543187|64263689|FG000|Overall Study|Ongoing|3|||
23139978|NCT05543187|64263690|FG001|Overall Study|Ongoing|2|||
23139979|NCT02518490|64263693|FG000|Overall Study|Withdrawal by Subject|1|||
23139980|NCT02518490|64263694|FG001|Overall Study|Withdrawal by Subject|1|||
23139981|NCT01191268|64263696|FG000|Overall Study|Withdrawal by Subject|19|||
23139982|NCT01191268|64263697|FG001|Overall Study|Withdrawal by Subject|25|||
23139983|NCT01191268|64263698|FG002|Overall Study|Withdrawal by Subject|21|||
23139984|NCT01191268|64263696|FG000|Overall Study|Adverse Event|21|||
23139985|NCT01191268|64263697|FG001|Overall Study|Adverse Event|13|||
23139986|NCT01191268|64263698|FG002|Overall Study|Adverse Event|8|||
23139987|NCT01191268|64263696|FG000|Overall Study|Physician Decision|6|||
23139988|NCT01191268|64263697|FG001|Overall Study|Physician Decision|8|||
23139989|NCT01191268|64263698|FG002|Overall Study|Physician Decision|9|||
23139990|NCT01191268|64263696|FG000|Overall Study|Lost to Follow-up|8|||
23139991|NCT01191268|64263697|FG001|Overall Study|Lost to Follow-up|5|||
23216105|NCT01061736|64531408|FG006|Overall Study|Lack of Efficacy|1|||
23216106|NCT01061736|64531409|FG007|Overall Study|Lack of Efficacy|9|||
23216107|NCT01061736|64531410|FG008|Overall Study|Lack of Efficacy|9|||
23432180|NCT01345682|65327548|FG001|Overall Study|Adverse Event|41|||
23432181|NCT01345682|65327547|FG000|Overall Study|Non-compliance with protocol|0|||
23432182|NCT01345682|65327548|FG001|Overall Study|Non-compliance with protocol|1|||
23432183|NCT01345682|65327547|FG000|Overall Study|Lost to Follow-up|0|||
23432184|NCT01345682|65327548|FG001|Overall Study|Lost to Follow-up|1|||
23432185|NCT01345682|65327547|FG000|Overall Study|Refused to continue trial medication|16|||
23432186|NCT01345682|65327548|FG001|Overall Study|Refused to continue trial medication|9|||
23432187|NCT01345682|65327547|FG000|Overall Study|Not treated|2|||
23432188|NCT01345682|65327548|FG001|Overall Study|Not treated|1|||
23432189|NCT01345682|65327547|FG000|Overall Study|Reason other than those specified above|4|||
23432190|NCT01345682|65327548|FG001|Overall Study|Reason other than those specified above|3|||
23432191|NCT01985360|65327551|FG000|Overall Study|Withdrawal by Subject|4|||
23432192|NCT01985360|65327552|FG001|Overall Study|Withdrawal by Subject|0|||
23432193|NCT01985360|65327551|FG000|Overall Study|Lost to Follow-up|5|||
23432194|NCT01985360|65327552|FG001|Overall Study|Lost to Follow-up|3|||
23432195|NCT00760838|65327555|FG000|Overall Study|Adverse Event|1|||
23432196|NCT00760838|65327556|FG001|Overall Study|Adverse Event|1|||
23432197|NCT00760838|65327555|FG000|Overall Study|Lack of Efficacy|1|||
23432198|NCT00760838|65327556|FG001|Overall Study|Lack of Efficacy|0|||
23432199|NCT00760838|65327555|FG000|Overall Study|Lost to Follow-up|2|||
23432200|NCT00760838|65327556|FG001|Overall Study|Lost to Follow-up|0|||
23432201|NCT00760838|65327555|FG000|Overall Study|Withdrawal by Subject|1|||
23432202|NCT00760838|65327556|FG001|Overall Study|Withdrawal by Subject|1|||
23432203|NCT03847909|65327562|FG000|Overall Study|Withdrawal by Subject|1|||
23432204|NCT03847909|65327563|FG001|Overall Study|Withdrawal by Subject|1|||
23432205|NCT00844558|65327567|FG000|Overall Study|Withdrawal by Subject|9|||
23432206|NCT00844558|65327568|FG001|Overall Study|Withdrawal by Subject|2|||
23432207|NCT00844558|65327567|FG000|Overall Study|Death|1|||
23432208|NCT00844558|65327568|FG001|Overall Study|Death|0|||
23139992|NCT01191268|64263698|FG002|Overall Study|Lost to Follow-up|9|||
23139993|NCT01191268|64263696|FG000|Overall Study|Entry Criteria Not Met|3|||
23139994|NCT01191268|64263697|FG001|Overall Study|Entry Criteria Not Met|1|||
23139995|NCT01191268|64263698|FG002|Overall Study|Entry Criteria Not Met|1|||
23139996|NCT01191268|64263696|FG000|Overall Study|Death|0|||
23139997|NCT01191268|64263697|FG001|Overall Study|Death|1|||
23139998|NCT01191268|64263698|FG002|Overall Study|Death|3|||
23139999|NCT01191268|64263696|FG000|Overall Study|Protocol Violation|1|||
23140000|NCT01191268|64263697|FG001|Overall Study|Protocol Violation|0|||
23140001|NCT01191268|64263698|FG002|Overall Study|Protocol Violation|1|||
23140002|NCT01191268|64263696|FG000|Overall Study|Sponsor Decision|0|||
23216108|NCT01061736|64531411|FG009|Overall Study|Lack of Efficacy|10|||
23140003|NCT01191268|64263697|FG001|Overall Study|Sponsor Decision|2|||
23432209|NCT00844558|65327567|FG000|Overall Study|Protocol Violation|1|||
23432210|NCT00844558|65327568|FG001|Overall Study|Protocol Violation|1|||
23432211|NCT00844558|65327567|FG000|Overall Study|Lost to Follow-up|0|||
23432212|NCT00844558|65327568|FG001|Overall Study|Lost to Follow-up|1|||
23432213|NCT00844558|65327567|FG000|Overall Study|Physician Decision|1|||
23432214|NCT00844558|65327568|FG001|Overall Study|Physician Decision|0|||
23432215|NCT04311463|65327569|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
23622069|NCT00545571|66000864|FG000|Overall Study|Death|5|||
23432216|NCT04311463|65327570|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
23432217|NCT04311463|65327569|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
23432218|NCT04311463|65327570|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
23432219|NCT04311463|65327569|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
23432220|NCT04311463|65327570|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
23432221|NCT01423916|65327582|FG000|Overall Study|Adverse Event|5|||
23432222|NCT01423916|65327583|FG001|Overall Study|Adverse Event|9|||
23432223|NCT01423916|65327584|FG002|Overall Study|Adverse Event|2|||
23432224|NCT01423916|65327582|FG000|Overall Study|Met Withdrawal Criteria|1|||
23432225|NCT01423916|65327583|FG001|Overall Study|Met Withdrawal Criteria|1|||
23432226|NCT01423916|65327584|FG002|Overall Study|Met Withdrawal Criteria|1|||
23432227|NCT01423916|65327582|FG000|Overall Study|Physician Decision|1|||
23432228|NCT01423916|65327583|FG001|Overall Study|Physician Decision|0|||
23432229|NCT01423916|65327584|FG002|Overall Study|Physician Decision|1|||
23432230|NCT01423916|65327582|FG000|Overall Study|Withdrawal by Subject|3|||
23554442|NCT00686881|65754764|FG001|Overall Study|Treatment-related adverse event|9|||
23554443|NCT00686881|65754763|FG000|Overall Study|Met discontinuation criteria|5|||
23140004|NCT01191268|64263698|FG002|Overall Study|Sponsor Decision|0|||
23140005|NCT04447846|64263705|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
23140006|NCT00192647|64263706|FG000|Overall Study|Death|1|||
23140007|NCT00192647|64263707|FG001|Overall Study|Death|1|||
23140008|NCT00192647|64263706|FG000|Overall Study|Adverse Event|35|||
23140009|NCT00192647|64263707|FG001|Overall Study|Adverse Event|29|||
23432231|NCT01423916|65327583|FG001|Overall Study|Withdrawal by Subject|10|||
23432232|NCT01423916|65327584|FG002|Overall Study|Withdrawal by Subject|3|||
23554444|NCT00686881|65754764|FG001|Overall Study|Met discontinuation criteria|0|||
23554445|NCT00686881|65754763|FG000|Overall Study|Onset of malignant tumor|11|||
23554446|NCT00686881|65754764|FG001|Overall Study|Onset of malignant tumor|11|||
23554447|NCT00686881|65754763|FG000|Overall Study|Lack of Efficacy|4|||
23554448|NCT00686881|65754764|FG001|Overall Study|Lack of Efficacy|3|||
23554449|NCT00686881|65754763|FG000|Overall Study|Physician Decision|1|||
23554450|NCT00686881|65754764|FG001|Overall Study|Physician Decision|0|||
23554451|NCT00686881|65754763|FG000|Overall Study|Circumstances of site|1|||
23554452|NCT00686881|65754764|FG001|Overall Study|Circumstances of site|1|||
23554453|NCT00686881|65754763|FG000|Overall Study|Did not meet protocol eligibility|1|||
23554454|NCT00686881|65754764|FG001|Overall Study|Did not meet protocol eligibility|0|||
23554455|NCT00686881|65754763|FG000|Overall Study|Irregular visits|1|||
23554456|NCT00686881|65754764|FG001|Overall Study|Irregular visits|0|||
23554457|NCT00686881|65754763|FG000|Overall Study|Study discontinuation|35|||
23554458|NCT00686881|65754764|FG001|Overall Study|Study discontinuation|32|||
23554459|NCT00686881|65754763|FG000|Overall Study|Never received study drug|2|||
23554460|NCT00686881|65754764|FG001|Overall Study|Never received study drug|6|||
23554461|NCT02199028|65754771|FG000|Week 1|Adverse Event|1|||
23554462|NCT02199028|65754772|FG001|Week 1|Adverse Event|0|||
23554463|NCT02199028|65754771|FG000|Week 3|Adverse Event|1|||
23554464|NCT02199028|65754772|FG001|Week 3|Adverse Event|0|||
23554465|NCT00643916|65754773|FG000|Overall Study|Protocol Violation|0|||
23554466|NCT00643916|65754774|FG001|Overall Study|Protocol Violation|1|||
23554467|NCT00643916|65754775|FG002|Overall Study|Protocol Violation|1|||
23554468|NCT00643916|65754776|FG003|Overall Study|Protocol Violation|1|||
23554469|NCT00643916|65754777|FG004|Overall Study|Protocol Violation|0|||
23554470|NCT00643916|65754778|FG005|Overall Study|Protocol Violation|0|||
23554471|NCT00643916|65754773|FG000|Overall Study|Lost to Follow-up|0|||
23554472|NCT00643916|65754774|FG001|Overall Study|Lost to Follow-up|1|||
23554473|NCT00643916|65754775|FG002|Overall Study|Lost to Follow-up|0|||
23554474|NCT00643916|65754776|FG003|Overall Study|Lost to Follow-up|0|||
23554475|NCT00643916|65754777|FG004|Overall Study|Lost to Follow-up|0|||
23554476|NCT00643916|65754778|FG005|Overall Study|Lost to Follow-up|0|||
23554477|NCT00643916|65754773|FG000|Overall Study|Withdrawal by Subject|2|||
23554478|NCT00643916|65754774|FG001|Overall Study|Withdrawal by Subject|2|||
23140010|NCT00192647|64263706|FG000|Overall Study|Laboratory Test Abnormality|4|||
23140011|NCT00192647|64263707|FG001|Overall Study|Laboratory Test Abnormality|2|||
23140012|NCT00192647|64263706|FG000|Overall Study|Insufficient Therapeutic Response|53|||
23554479|NCT00643916|65754775|FG002|Overall Study|Withdrawal by Subject|2|||
23554480|NCT00643916|65754776|FG003|Overall Study|Withdrawal by Subject|1|||
23554481|NCT00643916|65754777|FG004|Overall Study|Withdrawal by Subject|0|||
23554482|NCT00643916|65754778|FG005|Overall Study|Withdrawal by Subject|1|||
23554483|NCT00643916|65754773|FG000|Overall Study|Not Vaccinated|2|||
23554484|NCT00643916|65754774|FG001|Overall Study|Not Vaccinated|2|||
23554485|NCT00643916|65754775|FG002|Overall Study|Not Vaccinated|3|||
23554486|NCT00643916|65754776|FG003|Overall Study|Not Vaccinated|0|||
23554487|NCT00643916|65754777|FG004|Overall Study|Not Vaccinated|2|||
23554488|NCT00643916|65754778|FG005|Overall Study|Not Vaccinated|0|||
23554489|NCT03923933|65754779|FG000|Overall Study|Lost to Follow-up|1|||
23554490|NCT03923933|65754780|FG001|Overall Study|Lost to Follow-up|0|||
23140013|NCT00192647|64263707|FG001|Overall Study|Insufficient Therapeutic Response|83|||
23554491|NCT03923933|65754779|FG000|Overall Study|Withdrawal by Subject|0|||
23554492|NCT03923933|65754780|FG001|Overall Study|Withdrawal by Subject|1|||
23554493|NCT00234052|65754782|FG000|Treatment|Withdrawal by Subject|3|||
23554494|NCT00234052|65754782|FG000|Treatment|Adverse Event|5|||
23554495|NCT00234052|65754782|FG000|Treatment|Death|2|||
23554496|NCT00234052|65754782|FG000|Treatment|Progressive Disease|11|||
23554497|NCT00234052|65754782|FG000|Follow-up for 5 Years|Death|41|||
23554498|NCT00234052|65754782|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
23554499|NCT00234052|65754782|FG000|Follow-up for 5 Years|Other|7|||
23554500|NCT03393000|65754785|FG000|Overall Study|Death|11|||
23554501|NCT03393000|65754785|FG000|Overall Study|Withdrawal by Subject|2|||
23554502|NCT03393000|65754785|FG000|Overall Study|Physician Decision|1|||
23554503|NCT02633800|65754790|FG000|Overall Study|Death|3|||
23554504|NCT02633800|65754791|FG001|Overall Study|Death|3|||
23554505|NCT02633800|65754790|FG000|Overall Study|Reason not provided|1|||
23554506|NCT02633800|65754791|FG001|Overall Study|Reason not provided|0|||
23554507|NCT02633800|65754790|FG000|Overall Study|Radiologic(al) progression|23|||
23554508|NCT02633800|65754791|FG001|Overall Study|Radiologic(al) progression|23|||
23554509|NCT02633800|65754790|FG000|Overall Study|Clinical progression|3|||
23554510|NCT02633800|65754791|FG001|Overall Study|Clinical progression|6|||
23554511|NCT02633800|65754790|FG000|Overall Study|Study terminated by sponsor|6|||
23554512|NCT02633800|65754791|FG001|Overall Study|Study terminated by sponsor|5|||
23554513|NCT02633800|65754790|FG000|Overall Study|Adverse event, non-fatal|7|||
23554514|NCT02633800|65754791|FG001|Overall Study|Adverse event, non-fatal|2|||
23554515|NCT02633800|65754790|FG000|Overall Study|Withdrawal by Subject|0|||
23554516|NCT02633800|65754791|FG001|Overall Study|Withdrawal by Subject|3|||
23554517|NCT02633800|65754790|FG000|Overall Study|Patient Request|1|||
23140014|NCT00192647|64263706|FG000|Overall Study|Entry Criteria Violation|6|||
23140015|NCT00192647|64263707|FG001|Overall Study|Entry Criteria Violation|6|||
23140016|NCT00192647|64263706|FG000|Overall Study|Protocol Violation|3|||
23140017|NCT00192647|64263707|FG001|Overall Study|Protocol Violation|1|||
23140018|NCT00192647|64263706|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
23140019|NCT00192647|64263707|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
23140020|NCT00192647|64263706|FG000|Overall Study|Failure to Return|11|||
23140021|NCT00192647|64263707|FG001|Overall Study|Failure to Return|13|||
23140022|NCT00192647|64263706|FG000|Overall Study|Other/Administrative|5|||
23140023|NCT00192647|64263707|FG001|Overall Study|Other/Administrative|3|||
23140024|NCT01060540|64263708|FG000|Overall Study|Withdrawal by Subject|10|||
23140025|NCT01060540|64263709|FG001|Overall Study|Withdrawal by Subject|20|||
23140026|NCT01060540|64263708|FG000|Overall Study|Lost to Follow-up|52|||
23140027|NCT01060540|64263709|FG001|Overall Study|Lost to Follow-up|43|||
23140028|NCT01060540|64263708|FG000|Overall Study|Death|2|||
23140029|NCT01060540|64263709|FG001|Overall Study|Death|1|||
23140030|NCT01060540|64263708|FG000|Overall Study|Physician Decision|0|||
23140031|NCT01060540|64263709|FG001|Overall Study|Physician Decision|1|||
23140032|NCT00432666|64263710|FG000|Main Period|Adverse Event|1|||
23140033|NCT00432666|64263711|FG001|Main Period|Adverse Event|1|||
23140034|NCT00432666|64263710|FG000|Main Period|Consent Withdrawn|1|||
23140035|NCT00432666|64263711|FG001|Main Period|Consent Withdrawn|0|||
23140036|NCT00432666|64263710|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
23318044|NCT01098474|64908233|FG003|Follow Up Phase|Travelled out of study area|0|||
23554518|NCT02633800|65754791|FG001|Overall Study|Patient Request|1|||
23554519|NCT00594854|65754794|FG000|Overall Study|Study terminated|7|||
23554520|NCT00594854|65754795|FG001|Overall Study|Study terminated|10|||
23554521|NCT01813474|65754799|FG000|Overall Study|Withdrawal by Subject|0|||
23554522|NCT01813474|65754800|FG001|Overall Study|Withdrawal by Subject|0|||
23554523|NCT01813474|65754801|FG002|Overall Study|Withdrawal by Subject|1|||
23554524|NCT01813474|65754799|FG000|Overall Study|Adverse Event|1|||
23554525|NCT01813474|65754800|FG001|Overall Study|Adverse Event|1|||
23554526|NCT01813474|65754801|FG002|Overall Study|Adverse Event|0|||
23554527|NCT01813474|65754799|FG000|Overall Study|Lack of Efficacy|2|||
23554528|NCT01813474|65754800|FG001|Overall Study|Lack of Efficacy|6|||
23554529|NCT01813474|65754801|FG002|Overall Study|Lack of Efficacy|9|||
23140037|NCT00432666|64263711|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
23140038|NCT00432666|64263710|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
23140039|NCT00432666|64263711|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
23140040|NCT00432666|64263710|FG000|Open-Label Extension Period|Adverse Event|5|||
23140041|NCT00432666|64263711|FG001|Open-Label Extension Period|Adverse Event|0|||
23318045|NCT01098474|64908234|FG004|Follow Up Phase|Travelled out of study area|1|||
23554530|NCT01813474|65754799|FG000|Overall Study|Death|0|||
23554531|NCT01813474|65754800|FG001|Overall Study|Death|0|||
23554532|NCT01813474|65754801|FG002|Overall Study|Death|1|||
23554533|NCT00911534|65754802|FG000|Overall Study|Adverse Event|4|||
23554534|NCT00911534|65754803|FG001|Overall Study|Adverse Event|4|||
23554535|NCT00911534|65754802|FG000|Overall Study|Lost to Follow-up|2|||
23140042|NCT00432666|64263710|FG000|Open-Label Extension Period|Consent withdrawn|10|||
23140043|NCT00432666|64263711|FG001|Open-Label Extension Period|Consent withdrawn|0|||
23554536|NCT00911534|65754803|FG001|Overall Study|Lost to Follow-up|4|||
23554537|NCT00911534|65754802|FG000|Overall Study|Withdrawal by Subject|2|||
23554538|NCT00911534|65754803|FG001|Overall Study|Withdrawal by Subject|1|||
23554539|NCT00911534|65754802|FG000|Overall Study|Lack of Efficacy|4|||
23554540|NCT00911534|65754803|FG001|Overall Study|Lack of Efficacy|1|||
23554541|NCT00911534|65754802|FG000|Overall Study|Withdrawal of consent|1|||
23554542|NCT00911534|65754803|FG001|Overall Study|Withdrawal of consent|4|||
23554543|NCT00911534|65754802|FG000|Overall Study|Other|2|||
23554544|NCT00911534|65754803|FG001|Overall Study|Other|2|||
23554545|NCT02061202|65754806|FG000|Overall Study|Lost to Follow-up|1|||
23554546|NCT02061202|65754807|FG001|Overall Study|Lost to Follow-up|1|||
23554547|NCT02525874|65754808|FG000|Overall Study|Other|1|||
23554548|NCT02525874|65754808|FG000|Overall Study|Investigator Decision|1|||
23140044|NCT00432666|64263710|FG000|Open-Label Extension Period|Physician Decision|3|||
23140045|NCT00432666|64263711|FG001|Open-Label Extension Period|Physician Decision|0|||
23140046|NCT02457559|64263712|FG000|Overall Study|Progressive Disease|1|||
23140047|NCT02457559|64263713|FG001|Overall Study|Progressive Disease|2|||
23140048|NCT02457559|64263714|FG002|Overall Study|Progressive Disease|3|||
23140049|NCT02457559|64263715|FG003|Overall Study|Progressive Disease|0|||
23140050|NCT02457559|64263716|FG004|Overall Study|Progressive Disease|0|||
23140051|NCT02457559|64263717|FG005|Overall Study|Progressive Disease|2|||
23140052|NCT02457559|64263718|FG006|Overall Study|Progressive Disease|1|||
23140053|NCT02457559|64263719|FG007|Overall Study|Progressive Disease|0|||
23140054|NCT02457559|64263720|FG008|Overall Study|Progressive Disease|1|||
23140055|NCT02457559|64263721|FG009|Overall Study|Progressive Disease|1|||
23140056|NCT02457559|64263722|FG010|Overall Study|Progressive Disease|1|||
23140057|NCT02457559|64263712|FG000|Overall Study|Investigator's Discretion|0|||
23140058|NCT02457559|64263713|FG001|Overall Study|Investigator's Discretion|0|||
23140059|NCT02457559|64263714|FG002|Overall Study|Investigator's Discretion|2|||
23140060|NCT02457559|64263715|FG003|Overall Study|Investigator's Discretion|0|||
23140061|NCT02457559|64263716|FG004|Overall Study|Investigator's Discretion|1|||
23140062|NCT02457559|64263717|FG005|Overall Study|Investigator's Discretion|0|||
23140063|NCT02457559|64263718|FG006|Overall Study|Investigator's Discretion|1|||
23140064|NCT02457559|64263719|FG007|Overall Study|Investigator's Discretion|0|||
23140065|NCT02457559|64263720|FG008|Overall Study|Investigator's Discretion|1|||
23140066|NCT02457559|64263721|FG009|Overall Study|Investigator's Discretion|0|||
23216109|NCT01061736|64531402|FG000|Overall Study|Poor compliance to protocol|0|||
23216110|NCT01061736|64531403|FG001|Overall Study|Poor compliance to protocol|0|||
23216111|NCT01061736|64531404|FG002|Overall Study|Poor compliance to protocol|0|||
23216112|NCT01061736|64531405|FG003|Overall Study|Poor compliance to protocol|0|||
23216113|NCT01061736|64531406|FG004|Overall Study|Poor compliance to protocol|0|||
23216114|NCT01061736|64531407|FG005|Overall Study|Poor compliance to protocol|0|||
23216115|NCT01061736|64531408|FG006|Overall Study|Poor compliance to protocol|0|||
23216116|NCT01061736|64531409|FG007|Overall Study|Poor compliance to protocol|2|||
23216117|NCT01061736|64531410|FG008|Overall Study|Poor compliance to protocol|5|||
23216118|NCT01061736|64531411|FG009|Overall Study|Poor compliance to protocol|9|||
23216119|NCT01061736|64531402|FG000|Overall Study|Not treated|0|||
23216120|NCT01061736|64531403|FG001|Overall Study|Not treated|0|||
23216121|NCT01061736|64531404|FG002|Overall Study|Not treated|0|||
23216122|NCT01061736|64531405|FG003|Overall Study|Not treated|0|||
23216123|NCT01061736|64531406|FG004|Overall Study|Not treated|1|||
23216124|NCT01061736|64531407|FG005|Overall Study|Not treated|0|||
23216125|NCT01061736|64531408|FG006|Overall Study|Not treated|0|||
23216126|NCT01061736|64531409|FG007|Overall Study|Not treated|2|||
23216127|NCT01061736|64531410|FG008|Overall Study|Not treated|1|||
23216128|NCT01061736|64531411|FG009|Overall Study|Not treated|0|||
23216129|NCT01061736|64531402|FG000|Overall Study|Other than specified above|0|||
23554549|NCT02525874|65754808|FG000|Overall Study|Consent withdrawn|22|||
23554550|NCT02525874|65754808|FG000|Overall Study|Non-compliance with study drug|3|||
23140067|NCT02457559|64263722|FG010|Overall Study|Investigator's Discretion|1|||
23140068|NCT02457559|64263712|FG000|Overall Study|Adverse Event|0|||
23140069|NCT02457559|64263713|FG001|Overall Study|Adverse Event|1|||
23140070|NCT02457559|64263714|FG002|Overall Study|Adverse Event|2|||
23140071|NCT02457559|64263715|FG003|Overall Study|Adverse Event|0|||
23140072|NCT02457559|64263716|FG004|Overall Study|Adverse Event|0|||
23216130|NCT01061736|64531403|FG001|Overall Study|Other than specified above|1|||
23216131|NCT01061736|64531404|FG002|Overall Study|Other than specified above|2|||
23216132|NCT01061736|64531405|FG003|Overall Study|Other than specified above|0|||
23216133|NCT01061736|64531406|FG004|Overall Study|Other than specified above|1|||
23554551|NCT02525874|65754808|FG000|Overall Study|Adverse Event|17|||
23554552|NCT02525874|65754808|FG000|Overall Study|Lost to Follow-up|7|||
23140073|NCT02457559|64263717|FG005|Overall Study|Adverse Event|0|||
23140074|NCT02457559|64263718|FG006|Overall Study|Adverse Event|0|||
23140075|NCT02457559|64263719|FG007|Overall Study|Adverse Event|0|||
23140076|NCT02457559|64263720|FG008|Overall Study|Adverse Event|0|||
23140077|NCT02457559|64263721|FG009|Overall Study|Adverse Event|0|||
23216134|NCT01061736|64531407|FG005|Overall Study|Other than specified above|0|||
23216135|NCT01061736|64531408|FG006|Overall Study|Other than specified above|0|||
23216136|NCT01061736|64531409|FG007|Overall Study|Other than specified above|18|||
23554553|NCT02525874|65754808|FG000|Overall Study|Disease progression, defined by protocol|2|||
23140078|NCT02457559|64263722|FG010|Overall Study|Adverse Event|0|||
23140079|NCT02457559|64263712|FG000|Overall Study|Reason not Specified|1|||
23140080|NCT02457559|64263713|FG001|Overall Study|Reason not Specified|0|||
23140081|NCT02457559|64263714|FG002|Overall Study|Reason not Specified|0|||
23140082|NCT02457559|64263715|FG003|Overall Study|Reason not Specified|0|||
23140083|NCT02457559|64263716|FG004|Overall Study|Reason not Specified|0|||
23140084|NCT02457559|64263717|FG005|Overall Study|Reason not Specified|0|||
23140085|NCT02457559|64263718|FG006|Overall Study|Reason not Specified|0|||
23140086|NCT02457559|64263719|FG007|Overall Study|Reason not Specified|0|||
23140087|NCT02457559|64263720|FG008|Overall Study|Reason not Specified|0|||
23140088|NCT02457559|64263721|FG009|Overall Study|Reason not Specified|2|||
23140089|NCT02457559|64263722|FG010|Overall Study|Reason not Specified|0|||
23140090|NCT02457559|64263712|FG000|Overall Study|Death|0|||
23140091|NCT02457559|64263713|FG001|Overall Study|Death|0|||
23140092|NCT02457559|64263714|FG002|Overall Study|Death|0|||
23140093|NCT02457559|64263715|FG003|Overall Study|Death|0|||
23140094|NCT02457559|64263716|FG004|Overall Study|Death|0|||
23140095|NCT02457559|64263717|FG005|Overall Study|Death|0|||
23140096|NCT02457559|64263718|FG006|Overall Study|Death|0|||
23140097|NCT02457559|64263719|FG007|Overall Study|Death|0|||
23140098|NCT02457559|64263720|FG008|Overall Study|Death|1|||
23140099|NCT02457559|64263721|FG009|Overall Study|Death|1|||
23140100|NCT02457559|64263722|FG010|Overall Study|Death|0|||
23140101|NCT01383499|64263723|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
23140102|NCT01383499|64263724|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23140103|NCT01383499|64263725|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23140104|NCT01383499|64263726|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23140105|NCT00906945|64263727|FG000|Overall Study|Found to be not eligible|0|||
23140106|NCT00906945|64263728|FG001|Overall Study|Found to be not eligible|0|||
23140107|NCT00906945|64263729|FG002|Overall Study|Found to be not eligible|0|||
23140108|NCT00906945|64263730|FG003|Overall Study|Found to be not eligible|1|||
23140109|NCT00906945|64263731|FG004|Overall Study|Found to be not eligible|1|||
23140110|NCT00906945|64263732|FG005|Overall Study|Found to be not eligible|1|||
23140111|NCT00906945|64263727|FG000|Overall Study|Physician Decision|0|||
23140112|NCT00906945|64263728|FG001|Overall Study|Physician Decision|0|||
23140113|NCT00906945|64263729|FG002|Overall Study|Physician Decision|0|||
23140114|NCT00906945|64263730|FG003|Overall Study|Physician Decision|0|||
23140115|NCT00906945|64263731|FG004|Overall Study|Physician Decision|0|||
23140116|NCT00906945|64263732|FG005|Overall Study|Physician Decision|1|||
23140117|NCT03938545|64263735|FG000|Overall Study|Lost to Follow-up|0|||
23140118|NCT03938545|64263736|FG001|Overall Study|Lost to Follow-up|0|||
23140119|NCT03938545|64263737|FG002|Overall Study|Lost to Follow-up|0|||
23140120|NCT03938545|64263738|FG003|Overall Study|Lost to Follow-up|1|||
23140121|NCT03938545|64263735|FG000|Overall Study|Non-compliance with study drug|0|||
23140122|NCT03938545|64263736|FG001|Overall Study|Non-compliance with study drug|0|||
23140123|NCT03938545|64263737|FG002|Overall Study|Non-compliance with study drug|1|||
23140124|NCT03938545|64263738|FG003|Overall Study|Non-compliance with study drug|0|||
23140125|NCT03938545|64263735|FG000|Overall Study|Pregnancy|1|||
23140126|NCT03938545|64263736|FG001|Overall Study|Pregnancy|0|||
23554554|NCT02525874|65754808|FG000|Overall Study|Disease relapse|4|||
23554555|NCT02525874|65754808|FG000|Overall Study|Alternative Treatment for MS|2|||
23554556|NCT02525874|65754808|FG000|Overall Study|New lesions in Brain|1|||
23554557|NCT00447057|65754809|FG000|Overall Study|Adverse Event|4|||
23554558|NCT00447057|65754810|FG001|Overall Study|Adverse Event|10|||
23554559|NCT00447057|65754811|FG002|Overall Study|Adverse Event|0|||
23554560|NCT00447057|65754812|FG003|Overall Study|Adverse Event|3|||
23140127|NCT03938545|64263737|FG002|Overall Study|Pregnancy|0|||
23140128|NCT03938545|64263738|FG003|Overall Study|Pregnancy|0|||
23140129|NCT03938545|64263735|FG000|Overall Study|Study terminated by sponsor|6|||
23554561|NCT00447057|65754809|FG000|Overall Study|Death due to study disease|6|||
23554562|NCT00447057|65754810|FG001|Overall Study|Death due to study disease|4|||
23140130|NCT03938545|64263736|FG001|Overall Study|Study terminated by sponsor|4|||
23140131|NCT03938545|64263737|FG002|Overall Study|Study terminated by sponsor|2|||
23140132|NCT03938545|64263738|FG003|Overall Study|Study terminated by sponsor|4|||
23140133|NCT03938545|64263735|FG000|Overall Study|Withdrawal by Subject|0|||
23140134|NCT03938545|64263736|FG001|Overall Study|Withdrawal by Subject|1|||
23140135|NCT03938545|64263737|FG002|Overall Study|Withdrawal by Subject|0|||
23140136|NCT03938545|64263738|FG003|Overall Study|Withdrawal by Subject|0|||
23140137|NCT03938545|64263735|FG000|Overall Study|Adverse Event|1|||
23140138|NCT03938545|64263736|FG001|Overall Study|Adverse Event|0|||
23140139|NCT03938545|64263737|FG002|Overall Study|Adverse Event|0|||
23140140|NCT03938545|64263738|FG003|Overall Study|Adverse Event|0|||
23140141|NCT00112047|64263739|FG000|Randomized Phase|Lost to Follow-up|26|||
23140142|NCT00112047|64263740|FG001|Randomized Phase|Lost to Follow-up|33|||
23140143|NCT00112047|64263739|FG000|Randomized Phase|Adverse Event|10|||
23140144|NCT00112047|64263740|FG001|Randomized Phase|Adverse Event|10|||
23140145|NCT00112047|64263739|FG000|Randomized Phase|Withrawal of consent|10|||
23140146|NCT00112047|64263740|FG001|Randomized Phase|Withrawal of consent|18|||
23140147|NCT00112047|64263739|FG000|Randomized Phase|Sub-optimal virological response|3|||
23140148|NCT00112047|64263740|FG001|Randomized Phase|Sub-optimal virological response|13|||
23140149|NCT00112047|64263739|FG000|Randomized Phase|Noncompliance|8|||
23140150|NCT00112047|64263740|FG001|Randomized Phase|Noncompliance|4|||
23140151|NCT00112047|64263739|FG000|Randomized Phase|Protocol Violation|2|||
23140152|NCT00112047|64263740|FG001|Randomized Phase|Protocol Violation|0|||
23140153|NCT00112047|64263739|FG000|Randomized Phase|Pregnancy|3|||
23140154|NCT00112047|64263740|FG001|Randomized Phase|Pregnancy|1|||
23554563|NCT00447057|65754811|FG002|Overall Study|Death due to study disease|1|||
23554564|NCT00447057|65754812|FG003|Overall Study|Death due to study disease|1|||
23554565|NCT00447057|65754809|FG000|Overall Study|Lost to Follow-up|0|||
23554566|NCT00447057|65754810|FG001|Overall Study|Lost to Follow-up|1|||
23554567|NCT00447057|65754811|FG002|Overall Study|Lost to Follow-up|0|||
23554568|NCT00447057|65754812|FG003|Overall Study|Lost to Follow-up|0|||
23554569|NCT00447057|65754809|FG000|Overall Study|Entry criteria not met|1|||
23554570|NCT00447057|65754810|FG001|Overall Study|Entry criteria not met|1|||
23554571|NCT00447057|65754811|FG002|Overall Study|Entry criteria not met|0|||
23554572|NCT00447057|65754812|FG003|Overall Study|Entry criteria not met|0|||
23554573|NCT00447057|65754809|FG000|Overall Study|Protocol Violation|0|||
23554574|NCT00447057|65754810|FG001|Overall Study|Protocol Violation|1|||
23554575|NCT00447057|65754811|FG002|Overall Study|Protocol Violation|0|||
23554576|NCT00447057|65754812|FG003|Overall Study|Protocol Violation|0|||
23554577|NCT00447057|65754809|FG000|Overall Study|Withdrawal by Subject|4|||
23554578|NCT00447057|65754810|FG001|Overall Study|Withdrawal by Subject|5|||
23554579|NCT00447057|65754811|FG002|Overall Study|Withdrawal by Subject|1|||
23554580|NCT00447057|65754812|FG003|Overall Study|Withdrawal by Subject|1|||
23554581|NCT00447057|65754809|FG000|Overall Study|Physician Decision|9|||
23554582|NCT00447057|65754810|FG001|Overall Study|Physician Decision|6|||
23554583|NCT00447057|65754811|FG002|Overall Study|Physician Decision|3|||
23554584|NCT00447057|65754812|FG003|Overall Study|Physician Decision|1|||
23554585|NCT00447057|65754809|FG000|Overall Study|Sponsor decision|1|||
23554586|NCT00447057|65754810|FG001|Overall Study|Sponsor decision|1|||
23554587|NCT00447057|65754811|FG002|Overall Study|Sponsor decision|0|||
23554588|NCT00447057|65754812|FG003|Overall Study|Sponsor decision|0|||
23554589|NCT00447057|65754809|FG000|Overall Study|Progressive disease|58|||
23554590|NCT00447057|65754810|FG001|Overall Study|Progressive disease|43|||
23554591|NCT00447057|65754811|FG002|Overall Study|Progressive disease|13|||
23554592|NCT00447057|65754812|FG003|Overall Study|Progressive disease|18|||
23554593|NCT00447057|65754809|FG000|Overall Study|Death due to adverse event|0|||
23554594|NCT00447057|65754810|FG001|Overall Study|Death due to adverse event|0|||
23554595|NCT00447057|65754811|FG002|Overall Study|Death due to adverse event|1|||
23554596|NCT00447057|65754812|FG003|Overall Study|Death due to adverse event|2|||
23554597|NCT00447057|65754809|FG000|Overall Study|Death, study drug related|0|||
23554598|NCT00447057|65754810|FG001|Overall Study|Death, study drug related|1|||
23554599|NCT00447057|65754811|FG002|Overall Study|Death, study drug related|0|||
23554600|NCT00447057|65754812|FG003|Overall Study|Death, study drug related|0|||
23554601|NCT00234065|65757852|FG000|Overall Study|Adverse Event|268|||
23554602|NCT00234065|65757853|FG001|Overall Study|Adverse Event|166|||
23554603|NCT00234065|65757852|FG000|Overall Study|Withdrawal by Subject|73|||
23554604|NCT00234065|65757853|FG001|Overall Study|Withdrawal by Subject|56|||
23554605|NCT00234065|65757852|FG000|Overall Study|Physician Decision|23|||
23554606|NCT00234065|65757853|FG001|Overall Study|Physician Decision|22|||
23554607|NCT00234065|65757852|FG000|Overall Study|Not Classified|111|||
23554608|NCT00234065|65757853|FG001|Overall Study|Not Classified|112|||
23554609|NCT00724152|65757854|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
23554610|NCT00724152|65757855|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
23554611|NCT00724152|65757856|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
23554612|NCT00724152|65757854|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
23554613|NCT00724152|65757855|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
23554614|NCT00724152|65757856|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
23554615|NCT03599349|65757857|FG000|Overall Study|Lost to Follow-up|1|||
23140155|NCT00112047|64263739|FG000|Randomized Phase|Death|1|||
23554616|NCT01298999|65757858|FG000|Overall Study|Physician Decision|0|||
23554617|NCT01298999|65757859|FG001|Overall Study|Physician Decision|1|||
23140156|NCT00112047|64263740|FG001|Randomized Phase|Death|3|||
23140157|NCT00112047|64263739|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
23554618|NCT01298999|65757858|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
23554619|NCT01298999|65757859|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
23554620|NCT00224874|65757860|FG000|Overall Study|Withdrawal by Subject|0|||
23554621|NCT00224874|65757861|FG001|Overall Study|Withdrawal by Subject|0|||
23554622|NCT00224874|65757862|FG002|Overall Study|Withdrawal by Subject|1|||
23554623|NCT00224874|65757863|FG003|Overall Study|Withdrawal by Subject|0|||
23554624|NCT02985866|65757864|FG000|Overall Study|Poor CGM data|1|||
23554625|NCT02985866|65757865|FG001|Overall Study|Poor CGM data|1|||
23554626|NCT01064297|65757866|FG000|Overall Study|Lost to Follow-up|791|||
23554627|NCT01064297|65757867|FG001|Overall Study|Lost to Follow-up|48|||
23140158|NCT00112047|64263740|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
23622070|NCT00545571|66000864|FG000|Overall Study|Lack of Efficacy|1|||
23622071|NCT00545571|66000864|FG000|Overall Study|Protocol Violation|2|||
23622072|NCT00545571|66000864|FG000|Overall Study|Refused Treatment|1|||
23622073|NCT00545571|66000864|FG000|Overall Study|Screen Failure|16|||
23622074|NCT00545571|66000864|FG000|Overall Study|Transfusion|12|||
23622075|NCT00545571|66000864|FG000|Overall Study|Early Termination of Study|24|||
23622076|NCT00545571|66000864|FG000|Overall Study|Kidney Transplantation|3|||
23622077|NCT04969224|66000865|FG000|Overall Study|Adverse Event|1|||
23622078|NCT04969224|66000865|FG000|Overall Study|Enrolled but never dosed|1|||
23622079|NCT02647788|66004823|FG000|Overall Study|Lost to Follow-up|13|||
23622080|NCT02647788|66004824|FG001|Overall Study|Lost to Follow-up|11|||
23622081|NCT02647788|66004823|FG000|Overall Study|Did not want opiate|0|||
23622082|NCT02647788|66004824|FG001|Overall Study|Did not want opiate|1|||
23622083|NCT02647788|66004823|FG000|Overall Study|Withdrawal by Subject|1|||
23622084|NCT02647788|66004824|FG001|Overall Study|Withdrawal by Subject|0|||
23622085|NCT02647788|66004823|FG000|Overall Study|Felt itchy with assigned medication|1|||
23622086|NCT02647788|66004824|FG001|Overall Study|Felt itchy with assigned medication|0|||
23622087|NCT02647788|66004823|FG000|Overall Study|Felt nauseous with assigned medication|1|||
23622088|NCT02647788|66004824|FG001|Overall Study|Felt nauseous with assigned medication|1|||
23622089|NCT02973802|66004828|FG000|Overall Study|Lost to Follow-up|1|||
23622090|NCT02973802|66004828|FG000|Overall Study|Withdrawal by Subject|1|||
23622091|NCT01560871|66004831|FG000|Overall Study|transportation issues|2|||
23622092|NCT01560871|66004832|FG001|Overall Study|transportation issues|1|||
23622093|NCT01560871|66004831|FG000|Overall Study|relocation|1|||
23622094|NCT01560871|66004832|FG001|Overall Study|relocation|0|||
23622095|NCT01560871|66004831|FG000|Overall Study|readmission to a hospital|2|||
23622096|NCT01560871|66004832|FG001|Overall Study|readmission to a hospital|1|||
23622097|NCT01560871|66004831|FG000|Overall Study|Lost to Follow-up|1|||
23622098|NCT01560871|66004832|FG001|Overall Study|Lost to Follow-up|0|||
23622099|NCT01644188|66004833|FG000|Overall Study|Adverse Event|44|||
23622100|NCT01644188|66004834|FG001|Overall Study|Adverse Event|20|||
23622101|NCT01644188|66004833|FG000|Overall Study|Poor compliance to protocol|26|||
23622102|NCT01644188|66004834|FG001|Overall Study|Poor compliance to protocol|14|||
23622103|NCT01644188|66004833|FG000|Overall Study|Physician Decision|1|||
23622104|NCT01644188|66004834|FG001|Overall Study|Physician Decision|3|||
23622105|NCT01644188|66004833|FG000|Overall Study|Participant moved|7|||
23622106|NCT01644188|66004834|FG001|Overall Study|Participant moved|2|||
23140159|NCT00112047|64263739|FG000|Randomized Phase|Inability to swallow pills|0|||
23140160|NCT00112047|64263740|FG001|Randomized Phase|Inability to swallow pills|1|||
23140161|NCT00112047|64263739|FG000|Randomized Phase|Incarceration|3|||
23140162|NCT00112047|64263740|FG001|Randomized Phase|Incarceration|2|||
23140163|NCT00112047|64263739|FG000|Randomized Phase|Moved out of State|0|||
23140164|NCT00112047|64263740|FG001|Randomized Phase|Moved out of State|1|||
23140165|NCT00112047|64263739|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
23140166|NCT00112047|64263740|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
23140167|NCT00112047|64263739|FG000|Randomized Phase|High Hepatitis B DNA|0|||
23140168|NCT00112047|64263740|FG001|Randomized Phase|High Hepatitis B DNA|1|||
23140169|NCT00112047|64263739|FG000|Atripla Phase|Adverse Event|2|||
23140170|NCT00112047|64263740|FG001|Atripla Phase|Adverse Event|1|||
23140171|NCT00112047|64263739|FG000|Atripla Phase|Lost to Follow-up|5|||
23140172|NCT00112047|64263740|FG001|Atripla Phase|Lost to Follow-up|7|||
23554628|NCT01064297|65757868|FG002|Overall Study|Lost to Follow-up|133|||
23554629|NCT01896869|65757871|FG000|Overall Study|Withdrawal by Subject|0|||
23554630|NCT01896869|65757872|FG001|Overall Study|Withdrawal by Subject|6|||
23554631|NCT01896869|65757871|FG000|Overall Study|Lost to Follow-up|1|||
23554632|NCT01896869|65757872|FG001|Overall Study|Lost to Follow-up|0|||
23554633|NCT02255357|65757873|FG000|Overall Study|Physician Decision|10|||
23554634|NCT02255357|65757874|FG001|Overall Study|Physician Decision|24|||
23554635|NCT02275065|65757875|FG000|Overall Study|Randomized but not treated|1|||
23554636|NCT02275065|65757876|FG001|Overall Study|Randomized but not treated|0|||
23554637|NCT02275065|65757877|FG002|Overall Study|Randomized but not treated|1|||
23622107|NCT01644188|66004833|FG000|Overall Study|Related to auto-injector administration|2|||
23622108|NCT01644188|66004834|FG001|Overall Study|Related to auto-injector administration|2|||
23622109|NCT01644188|66004833|FG000|Overall Study|Consent withdrawn by participant|14|||
23622110|NCT01644188|66004834|FG001|Overall Study|Consent withdrawn by participant|7|||
23140173|NCT00112047|64263739|FG000|Atripla Phase|Pregnancy|0|||
23554638|NCT02275065|65757878|FG003|Overall Study|Randomized but not treated|1|||
23622111|NCT01644188|66004833|FG000|Overall Study|Selection criteria finally not met|2|||
23554639|NCT02275065|65757879|FG004|Overall Study|Randomized but not treated|0|||
23622112|NCT01644188|66004834|FG001|Overall Study|Selection criteria finally not met|0|||
23622113|NCT01644188|66004833|FG000|Overall Study|Lost to Follow-up|1|||
23140174|NCT00112047|64263740|FG001|Atripla Phase|Pregnancy|1|||
23140175|NCT00112047|64263739|FG000|Atripla Phase|Death|0|||
23140176|NCT00112047|64263740|FG001|Atripla Phase|Death|2|||
23140177|NCT00112047|64263739|FG000|Atripla Phase|Withdrew consent|7|||
23554640|NCT03494166|65757880|FG000|Overall Study|Death|0|||
23140178|NCT00112047|64263740|FG001|Atripla Phase|Withdrew consent|7|||
23140179|NCT00112047|64263739|FG000|Atripla Phase|Sub-optimal virological response|0|||
23140180|NCT00112047|64263740|FG001|Atripla Phase|Sub-optimal virological response|1|||
23140181|NCT00112047|64263739|FG000|Atripla Phase|Non-compliance|1|||
23140182|NCT00112047|64263740|FG001|Atripla Phase|Non-compliance|0|||
23140183|NCT00112047|64263739|FG000|Atripla Phase|Other|3|||
23140184|NCT00112047|64263740|FG001|Atripla Phase|Other|1|||
23140185|NCT00819390|64263741|FG000|Overall Study|Lost to Follow-up|1|||
23140186|NCT00819390|64263742|FG001|Overall Study|Lost to Follow-up|1|||
23140187|NCT00819390|64263743|FG002|Overall Study|Lost to Follow-up|0|||
23140188|NCT00819390|64263744|FG003|Overall Study|Lost to Follow-up|0|||
23140189|NCT00819390|64263741|FG000|Overall Study|Withdrawal by Subject|2|||
23140190|NCT00819390|64263742|FG001|Overall Study|Withdrawal by Subject|0|||
23140191|NCT00819390|64263743|FG002|Overall Study|Withdrawal by Subject|0|||
23140192|NCT00819390|64263744|FG003|Overall Study|Withdrawal by Subject|0|||
23140193|NCT00819390|64263741|FG000|Overall Study|Adverse Event|0|||
23140194|NCT00819390|64263742|FG001|Overall Study|Adverse Event|0|||
23140195|NCT00819390|64263743|FG002|Overall Study|Adverse Event|1|||
23140196|NCT00819390|64263744|FG003|Overall Study|Adverse Event|0|||
23140197|NCT01771107|64263745|FG000|Overall Study|Adverse Event|1|||
23140198|NCT01771107|64263746|FG001|Overall Study|Adverse Event|3|||
23140199|NCT01771107|64263745|FG000|Overall Study|Withdrawal by Subject|0|||
23140200|NCT01771107|64263746|FG001|Overall Study|Withdrawal by Subject|2|||
23140201|NCT01771107|64263745|FG000|Overall Study|Lost to Follow-up|0|||
23140202|NCT01771107|64263746|FG001|Overall Study|Lost to Follow-up|1|||
23140203|NCT01771107|64263745|FG000|Overall Study|participant moved|0|||
23140204|NCT01771107|64263746|FG001|Overall Study|participant moved|1|||
23140205|NCT01771107|64263745|FG000|Overall Study|Other|0|||
23140206|NCT01771107|64263746|FG001|Overall Study|Other|1|||
23140207|NCT00249002|64263747|FG000|Overall Study|Adverse Event|2|||
23140208|NCT00249002|64263747|FG000|Overall Study|Study cancellation|3|||
23140209|NCT00249002|64263747|FG000|Overall Study|Other|2|||
23140210|NCT00211185|64263749|FG000|Overall Study|Death|2|||
23140211|NCT00211185|64263749|FG000|Overall Study|Disease progression|7|||
23140212|NCT00211185|64263749|FG000|Overall Study|Withdrawal by Subject|6|||
23140213|NCT00211185|64263749|FG000|Overall Study|Physician Decision|5|||
23140214|NCT00232544|64263750|FG000|Overall Study|Lost to Follow-up|20|||
23140215|NCT00232544|64263751|FG001|Overall Study|Lost to Follow-up|15|||
23140216|NCT02891837|64263757|FG000|Overall Study|Lost to Follow-up|2|||
23140217|NCT02891837|64263758|FG001|Overall Study|Lost to Follow-up|0|||
23140218|NCT02891837|64263757|FG000|Overall Study|Withdrawal by Subject|1|||
23140219|NCT02891837|64263758|FG001|Overall Study|Withdrawal by Subject|0|||
23140220|NCT00477334|64263759|FG000|Overall Study|Discontinued prior to taking study drug|106|||
23140221|NCT00477334|64263760|FG001|Overall Study|Discontinued prior to taking study drug|53|||
23140222|NCT00477334|64263759|FG000|Overall Study|Adverse Event|1|||
23140223|NCT00477334|64263760|FG001|Overall Study|Adverse Event|2|||
23216137|NCT01061736|64531410|FG008|Overall Study|Other than specified above|15|||
23216138|NCT01061736|64531411|FG009|Overall Study|Other than specified above|21|||
23216139|NCT03024255|64531412|FG000|Overall Study|Adverse Event|1|||
23216140|NCT03024255|64531413|FG001|Overall Study|Adverse Event|4|||
23216141|NCT03024255|64531414|FG002|Overall Study|Adverse Event|8|||
23140224|NCT00477334|64263759|FG000|Overall Study|Withdrawal by Subject|2|||
23140225|NCT00477334|64263760|FG001|Overall Study|Withdrawal by Subject|1|||
23140226|NCT00477334|64263759|FG000|Overall Study|Lost to Follow-up|15|||
23140227|NCT00477334|64263760|FG001|Overall Study|Lost to Follow-up|4|||
23216142|NCT03024255|64531415|FG003|Overall Study|Adverse Event|0|||
23216143|NCT03024255|64531412|FG000|Overall Study|Withdrawal by Subject|3|||
23622114|NCT01644188|66004834|FG001|Overall Study|Lost to Follow-up|0|||
23622115|NCT01644188|66004833|FG000|Overall Study|Death|4|||
23622116|NCT01644188|66004834|FG001|Overall Study|Death|3|||
23140228|NCT00477334|64263759|FG000|Overall Study|Administrative Problems|39|||
23140229|NCT00477334|64263760|FG001|Overall Study|Administrative Problems|15|||
23140230|NCT00477334|64263759|FG000|Overall Study|Protocol Violation|7|||
23140231|NCT00477334|64263760|FG001|Overall Study|Protocol Violation|1|||
23140232|NCT00528645|64263761|FG000|Overall Study|Adverse Event|3|||
23140233|NCT02980731|64263762|FG000|Overall Study|Death|63|||
23140234|NCT02980731|64263762|FG000|Overall Study|Withdrawal by Subject|6|||
23140235|NCT02980731|64263762|FG000|Overall Study|Lost to Follow-up|5|||
23140236|NCT02980731|64263762|FG000|Overall Study|Study terminated by Sponsor|4|||
23140237|NCT02980731|64263762|FG000|Overall Study|Completed survival follow-up period|65|||
23140238|NCT02980731|64263762|FG000|Overall Study|COVID-19 infection|1|||
23140239|NCT02980731|64263762|FG000|Overall Study|Other, not specified|66|||
23140240|NCT01262677|64263763|FG000|Overall Study|Does not meet entrance criteria|0|||
23140241|NCT01262677|64263764|FG001|Overall Study|Does not meet entrance criteria|2|||
23140242|NCT01262677|64263765|FG002|Overall Study|Does not meet entrance criteria|0|||
23140243|NCT01262677|64263763|FG000|Overall Study|Insufficient clinical response|0|||
23140244|NCT01262677|64263764|FG001|Overall Study|Insufficient clinical response|0|||
23140245|NCT01262677|64263765|FG002|Overall Study|Insufficient clinical response|1|||
23216144|NCT03024255|64531413|FG001|Overall Study|Withdrawal by Subject|1|||
23140246|NCT01262677|64263763|FG000|Overall Study|Lost to Follow-up|1|||
23140247|NCT01262677|64263764|FG001|Overall Study|Lost to Follow-up|0|||
23140248|NCT01262677|64263765|FG002|Overall Study|Lost to Follow-up|2|||
23140249|NCT01262677|64263763|FG000|Overall Study|No longer willing to participate|3|||
23140250|NCT01262677|64263764|FG001|Overall Study|No longer willing to participate|3|||
23140251|NCT01262677|64263765|FG002|Overall Study|No longer willing to participate|2|||
23140252|NCT01262677|64263763|FG000|Overall Study|Reason not provided|2|||
23140253|NCT01262677|64263764|FG001|Overall Study|Reason not provided|1|||
23140254|NCT01262677|64263765|FG002|Overall Study|Reason not provided|3|||
23140255|NCT01262677|64263763|FG000|Overall Study|Protocol Violation|0|||
23140256|NCT01262677|64263764|FG001|Overall Study|Protocol Violation|1|||
23140257|NCT01262677|64263765|FG002|Overall Study|Protocol Violation|1|||
23140258|NCT01262677|64263763|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
23140259|NCT01262677|64263764|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
23140260|NCT01262677|64263765|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
23140261|NCT01328717|64263767|FG000|Overall Study|Adverse Event|1|||
23140262|NCT03836716|64263781|FG000|Overall Study|Adverse Event|3|||
23140263|NCT03836716|64263781|FG000|Overall Study|Death|22|||
23140264|NCT03836716|64263781|FG000|Overall Study|Withdrawal by Subject|8|||
23140265|NCT03836716|64263781|FG000|Overall Study|Study terminated by sponsor|87|||
23140266|NCT00818649|64263782|FG000|Overall Study|Declining performance status|2|||
23140267|NCT00818649|64263782|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
23140268|NCT00818649|64263782|FG000|Overall Study|Adverse Event|1|||
23140269|NCT00195091|64263786|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
23140270|NCT00095498|64263787|FG000|Overall Study|Physician Decision|9|||
23140271|NCT00095498|64263788|FG001|Overall Study|Physician Decision|10|||
23140272|NCT00095498|64263789|FG002|Overall Study|Physician Decision|8|||
23140273|NCT00095498|64263787|FG000|Overall Study|Adverse Event|1|||
23140274|NCT00095498|64263788|FG001|Overall Study|Adverse Event|0|||
23554641|NCT03494166|65757881|FG001|Overall Study|Death|0|||
23554642|NCT03494166|65757882|FG002|Overall Study|Death|0|||
23140275|NCT00095498|64263789|FG002|Overall Study|Adverse Event|1|||
23140276|NCT00095498|64263787|FG000|Overall Study|Withdrawal by Subject|15|||
23140277|NCT00095498|64263788|FG001|Overall Study|Withdrawal by Subject|16|||
23140278|NCT00095498|64263789|FG002|Overall Study|Withdrawal by Subject|15|||
23140279|NCT00095498|64263787|FG000|Overall Study|Disease progression|0|||
23140280|NCT00095498|64263788|FG001|Overall Study|Disease progression|1|||
23140281|NCT00095498|64263789|FG002|Overall Study|Disease progression|1|||
23140282|NCT00095498|64263787|FG000|Overall Study|Ineligibility determined|3|||
23140283|NCT00095498|64263788|FG001|Overall Study|Ineligibility determined|0|||
23140284|NCT00095498|64263789|FG002|Overall Study|Ineligibility determined|2|||
23140285|NCT00095498|64263787|FG000|Overall Study|Lost to Follow-up|1|||
23140286|NCT00095498|64263788|FG001|Overall Study|Lost to Follow-up|1|||
23140287|NCT00095498|64263789|FG002|Overall Study|Lost to Follow-up|2|||
23140288|NCT00095498|64263787|FG000|Overall Study|Noncompliance|1|||
23140289|NCT00095498|64263788|FG001|Overall Study|Noncompliance|0|||
23140290|NCT00095498|64263789|FG002|Overall Study|Noncompliance|1|||
23140291|NCT00095498|64263787|FG000|Overall Study|Other|6|||
23140292|NCT00095498|64263788|FG001|Overall Study|Other|7|||
23140293|NCT00095498|64263789|FG002|Overall Study|Other|6|||
23140294|NCT00095498|64263787|FG000|Overall Study|Protocol Violation|0|||
23140295|NCT00095498|64263788|FG001|Overall Study|Protocol Violation|0|||
23140296|NCT00095498|64263789|FG002|Overall Study|Protocol Violation|1|||
23140297|NCT00095498|64263787|FG000|Overall Study|Requirement for alternative therapy|1|||
23140298|NCT00095498|64263788|FG001|Overall Study|Requirement for alternative therapy|0|||
23554643|NCT03494166|65757883|FG003|Overall Study|Death|1|||
23140299|NCT00095498|64263789|FG002|Overall Study|Requirement for alternative therapy|2|||
23140300|NCT02433340|64263790|FG000|Overall Study|Adverse Event|0|||
23140301|NCT02433340|64263791|FG001|Overall Study|Adverse Event|0|||
23140302|NCT02433340|64263792|FG002|Overall Study|Adverse Event|1|||
23140303|NCT02433340|64263793|FG003|Overall Study|Adverse Event|0|||
23140304|NCT02433340|64263790|FG000|Overall Study|Withdrawal by Subject|1|||
23140305|NCT02433340|64263791|FG001|Overall Study|Withdrawal by Subject|0|||
23140306|NCT02433340|64263792|FG002|Overall Study|Withdrawal by Subject|1|||
23140307|NCT02433340|64263793|FG003|Overall Study|Withdrawal by Subject|2|||
23140308|NCT02433340|64263790|FG000|Overall Study|Lost to Follow-up|0|||
23140309|NCT02433340|64263791|FG001|Overall Study|Lost to Follow-up|1|||
23554644|NCT03494166|65757884|FG004|Overall Study|Death|3|||
23140310|NCT02433340|64263792|FG002|Overall Study|Lost to Follow-up|0|||
23140311|NCT02433340|64263793|FG003|Overall Study|Lost to Follow-up|0|||
23140312|NCT02433340|64263790|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
23140313|NCT02433340|64263791|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
23140314|NCT02433340|64263792|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
23554645|NCT03494166|65757885|FG005|Overall Study|Death|0|||
23554646|NCT03494166|65757880|FG000|Overall Study|Lost to Follow-up|2|||
23554647|NCT03494166|65757881|FG001|Overall Study|Lost to Follow-up|2|||
23140315|NCT02433340|64263793|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
23554648|NCT03494166|65757882|FG002|Overall Study|Lost to Follow-up|2|||
23140316|NCT02433340|64263790|FG000|Overall Study|Other|0|||
23140317|NCT02433340|64263791|FG001|Overall Study|Other|1|||
23140318|NCT02433340|64263792|FG002|Overall Study|Other|0|||
23140319|NCT02433340|64263793|FG003|Overall Study|Other|0|||
23140320|NCT03647488|64263794|FG000|Overall Study|Progressive disease|10|||
23140321|NCT03647488|64263795|FG001|Overall Study|Progressive disease|0|||
23140322|NCT03647488|64263796|FG002|Overall Study|Progressive disease|0|||
23140323|NCT03647488|64263794|FG000|Overall Study|Adverse Event|5|||
23140324|NCT03647488|64263795|FG001|Overall Study|Adverse Event|0|||
23140325|NCT03647488|64263796|FG002|Overall Study|Adverse Event|0|||
23140326|NCT03647488|64263794|FG000|Overall Study|Clinical progression|2|||
23140327|NCT03647488|64263795|FG001|Overall Study|Clinical progression|0|||
23140328|NCT03647488|64263796|FG002|Overall Study|Clinical progression|0|||
23140329|NCT03647488|64263794|FG000|Overall Study|Participant refused to take investigational product|1|||
23140330|NCT03647488|64263795|FG001|Overall Study|Participant refused to take investigational product|0|||
23140331|NCT03647488|64263796|FG002|Overall Study|Participant refused to take investigational product|0|||
23140332|NCT01744392|64263797|FG000|Overall Study|Physician Decision|1|||
23140333|NCT01315353|64263802|FG000|Overall Study|Death|2|||
23140334|NCT01315353|64263803|FG001|Overall Study|Death|1|||
23140335|NCT01315353|64263804|FG002|Overall Study|Death|0|||
23140336|NCT01315353|64263802|FG000|Overall Study|Withdrawal by Subject|2|||
23140337|NCT01315353|64263803|FG001|Overall Study|Withdrawal by Subject|6|||
23554649|NCT03494166|65757883|FG003|Overall Study|Lost to Follow-up|2|||
23554650|NCT03494166|65757884|FG004|Overall Study|Lost to Follow-up|14|||
23554651|NCT03494166|65757885|FG005|Overall Study|Lost to Follow-up|0|||
23140338|NCT01315353|64263804|FG002|Overall Study|Withdrawal by Subject|1|||
23140339|NCT01315353|64263802|FG000|Overall Study|Lost to Follow-up|13|||
23140340|NCT01315353|64263803|FG001|Overall Study|Lost to Follow-up|6|||
23140341|NCT01315353|64263804|FG002|Overall Study|Lost to Follow-up|6|||
23140342|NCT01315353|64263802|FG000|Overall Study|Unwilling to adhere to requirements|5|||
23140343|NCT01315353|64263803|FG001|Overall Study|Unwilling to adhere to requirements|5|||
23140344|NCT01315353|64263804|FG002|Overall Study|Unwilling to adhere to requirements|4|||
23140345|NCT01315353|64263802|FG000|Overall Study|Site closing|7|||
23140346|NCT01315353|64263803|FG001|Overall Study|Site closing|4|||
23140347|NCT01315353|64263804|FG002|Overall Study|Site closing|0|||
23140348|NCT01315353|64263802|FG000|Overall Study|Taken off study by site in error|0|||
23140349|NCT01315353|64263803|FG001|Overall Study|Taken off study by site in error|1|||
23140350|NCT01315353|64263804|FG002|Overall Study|Taken off study by site in error|0|||
23140351|NCT01315353|64263802|FG000|Overall Study|Inadvertent randomization/assignment|0|||
23140352|NCT01315353|64263803|FG001|Overall Study|Inadvertent randomization/assignment|0|||
23140353|NCT01315353|64263804|FG002|Overall Study|Inadvertent randomization/assignment|2|||
23140354|NCT01263665|64263805|FG000|Overall Study|Withdrew Consent|1|||
23140355|NCT01263665|64263805|FG000|Overall Study|Lost to Follow-up|3|||
23140356|NCT01263665|64263805|FG000|Overall Study|Death|2|||
23140357|NCT01263665|64263805|FG000|Overall Study|Amputation above the ankle|1|||
23140358|NCT01263665|64263805|FG000|Overall Study|Surgical Bypass|2|||
23140359|NCT01022268|64263806|FG000|Overall Study|Withdrawal by Subject|1|||
23140360|NCT01022268|64263807|FG001|Overall Study|Withdrawal by Subject|0|||
23140361|NCT01022268|64263806|FG000|Overall Study|Withdrawal by Subject|1|||
23140362|NCT01022268|64263807|FG001|Overall Study|Withdrawal by Subject|0|||
23140363|NCT04675151|64263810|FG000|Overall Study|Protocol Violation|1|||
23140364|NCT04675151|64263811|FG001|Overall Study|Protocol Violation|0|||
23140365|NCT04675151|64263812|FG002|Overall Study|Protocol Violation|0|||
23140366|NCT04675151|64263813|FG003|Overall Study|Protocol Violation|1|||
23140367|NCT03814187|64263814|FG000|Overall Study|Sponsor's Administrative Decision|0|||
23140368|NCT03814187|64263815|FG001|Overall Study|Sponsor's Administrative Decision|0|||
23140369|NCT03814187|64263816|FG002|Overall Study|Sponsor's Administrative Decision|272|||
23554652|NCT03494166|65757880|FG000|Overall Study|Withdrawal by Subject|10|||
23140370|NCT03814187|64263814|FG000|Overall Study|Death|80|||
23140371|NCT03814187|64263815|FG001|Overall Study|Death|81|||
23140372|NCT03814187|64263816|FG002|Overall Study|Death|4|||
23140373|NCT03814187|64263814|FG000|Overall Study|Withdrew Consent|77|||
23140374|NCT03814187|64263815|FG001|Overall Study|Withdrew Consent|78|||
23140375|NCT03814187|64263816|FG002|Overall Study|Withdrew Consent|2|||
23140376|NCT03814187|64263814|FG000|Overall Study|Lost to Follow-up|47|||
23140377|NCT03814187|64263815|FG001|Overall Study|Lost to Follow-up|52|||
23140378|NCT03814187|64263816|FG002|Overall Study|Lost to Follow-up|1|||
23140379|NCT03814187|64263814|FG000|Overall Study|Adverse Event|22|||
23140380|NCT03814187|64263815|FG001|Overall Study|Adverse Event|23|||
23140381|NCT03814187|64263816|FG002|Overall Study|Adverse Event|0|||
23140382|NCT03814187|64263814|FG000|Overall Study|Physician Decision|7|||
23554653|NCT03494166|65757881|FG001|Overall Study|Withdrawal by Subject|7|||
23554654|NCT03494166|65757882|FG002|Overall Study|Withdrawal by Subject|0|||
23140383|NCT03814187|64263815|FG001|Overall Study|Physician Decision|4|||
23140384|NCT03814187|64263816|FG002|Overall Study|Physician Decision|2|||
23140385|NCT03814187|64263814|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
23140386|NCT03814187|64263815|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
23140387|NCT03814187|64263816|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
23140388|NCT03814187|64263814|FG000|Overall Study|Other reasons|34|||
23140389|NCT03814187|64263815|FG001|Overall Study|Other reasons|40|||
23140390|NCT03814187|64263816|FG002|Overall Study|Other reasons|2|||
23140391|NCT02040584|64263818|FG000|Overall Study|Adverse Event|13|||
23140392|NCT02040584|64263819|FG001|Overall Study|Adverse Event|6|||
23140393|NCT02040584|64263818|FG000|Overall Study|Protocol Violation|9|||
23140394|NCT02040584|64263819|FG001|Overall Study|Protocol Violation|11|||
23140395|NCT02040584|64263818|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23140396|NCT02040584|64263819|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23140397|NCT02040584|64263818|FG000|Overall Study|Death|6|||
23140398|NCT02040584|64263819|FG001|Overall Study|Death|3|||
23140399|NCT02040584|64263818|FG000|Overall Study|Transplant rejection/retransplant|0|||
23140400|NCT02040584|64263819|FG001|Overall Study|Transplant rejection/retransplant|1|||
23140401|NCT02040584|64263818|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
23140402|NCT02040584|64263819|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
23140403|NCT03545503|64263821|FG000|Overall Study|Protocol Violation|14|||
23140404|NCT03545503|64263822|FG001|Overall Study|Protocol Violation|16|||
23140405|NCT00513604|64263823|FG000|Overall Study|Not treated|2|||
23140406|NCT00513604|64263824|FG001|Overall Study|Not treated|0|||
23140407|NCT00513604|64263825|FG002|Overall Study|Not treated|1|||
23140408|NCT00513604|64263826|FG003|Overall Study|Not treated|0|||
23140409|NCT00513604|64263827|FG004|Overall Study|Not treated|0|||
23140410|NCT00513604|64263823|FG000|Overall Study|Death during treatment|0|||
23140411|NCT00513604|64263824|FG001|Overall Study|Death during treatment|3|||
23140412|NCT00513604|64263825|FG002|Overall Study|Death during treatment|2|||
23140413|NCT00513604|64263826|FG003|Overall Study|Death during treatment|0|||
23140414|NCT00513604|64263827|FG004|Overall Study|Death during treatment|0|||
23140415|NCT02003222|64263829|FG000|Induction|Never started treatment|0|||
23140416|NCT02003222|64263830|FG001|Induction|Never started treatment|0|||
23140417|NCT02003222|64263831|FG002|Induction|Never started treatment|0|||
23140418|NCT02003222|64263832|FG003|Induction|Never started treatment|0|||
23140419|NCT02003222|64263833|FG004|Induction|Never started treatment|8|||
23140420|NCT02003222|64263829|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
23140421|NCT02003222|64263830|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
23140422|NCT02003222|64263831|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
23140423|NCT02003222|64263832|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
23140424|NCT02003222|64263833|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
23140425|NCT02003222|64263829|FG000|Induction|Adverse Event|0|||
23140426|NCT02003222|64263830|FG001|Induction|Adverse Event|0|||
23140427|NCT02003222|64263831|FG002|Induction|Adverse Event|0|||
23140428|NCT02003222|64263832|FG003|Induction|Adverse Event|0|||
23140429|NCT02003222|64263833|FG004|Induction|Adverse Event|13|||
23140430|NCT02003222|64263829|FG000|Induction|Alternative therapy|0|||
23140431|NCT02003222|64263830|FG001|Induction|Alternative therapy|0|||
23140432|NCT02003222|64263831|FG002|Induction|Alternative therapy|0|||
23140433|NCT02003222|64263832|FG003|Induction|Alternative therapy|0|||
23140434|NCT02003222|64263833|FG004|Induction|Alternative therapy|12|||
23140435|NCT02003222|64263829|FG000|Induction|Disease progression|0|||
23140436|NCT02003222|64263830|FG001|Induction|Disease progression|0|||
23140437|NCT02003222|64263831|FG002|Induction|Disease progression|0|||
23140438|NCT02003222|64263832|FG003|Induction|Disease progression|0|||
23140439|NCT02003222|64263833|FG004|Induction|Disease progression|22|||
23140440|NCT02003222|64263829|FG000|Induction|Death|0|||
23140441|NCT02003222|64263830|FG001|Induction|Death|0|||
23140442|NCT02003222|64263831|FG002|Induction|Death|0|||
23140443|NCT02003222|64263832|FG003|Induction|Death|0|||
23140444|NCT02003222|64263833|FG004|Induction|Death|3|||
23140445|NCT02003222|64263829|FG000|Induction|Withdrawal by Subject|0|||
23140446|NCT02003222|64263830|FG001|Induction|Withdrawal by Subject|0|||
23140447|NCT02003222|64263831|FG002|Induction|Withdrawal by Subject|0|||
23140448|NCT02003222|64263832|FG003|Induction|Withdrawal by Subject|0|||
23140449|NCT02003222|64263833|FG004|Induction|Withdrawal by Subject|8|||
23140450|NCT02003222|64263829|FG000|Induction|Other reasons|0|||
23140451|NCT02003222|64263830|FG001|Induction|Other reasons|0|||
23140452|NCT02003222|64263831|FG002|Induction|Other reasons|0|||
23140453|NCT02003222|64263832|FG003|Induction|Other reasons|0|||
23140454|NCT02003222|64263833|FG004|Induction|Other reasons|22|||
23140455|NCT02003222|64263829|FG000|Intensification|Never started treatment|0|||
23140456|NCT02003222|64263830|FG001|Intensification|Never started treatment|0|||
23140457|NCT02003222|64263831|FG002|Intensification|Never started treatment|0|||
23140458|NCT02003222|64263832|FG003|Intensification|Never started treatment|0|||
23140459|NCT02003222|64263833|FG004|Intensification|Never started treatment|2|||
23140460|NCT02003222|64263829|FG000|Intensification|Adverse Event|0|||
23216145|NCT03024255|64531414|FG002|Overall Study|Withdrawal by Subject|0|||
23140461|NCT02003222|64263830|FG001|Intensification|Adverse Event|0|||
23140462|NCT02003222|64263831|FG002|Intensification|Adverse Event|0|||
23140463|NCT02003222|64263832|FG003|Intensification|Adverse Event|0|||
23432233|NCT01423916|65327582|FG000|Overall Study|Protocol Deviation|1|||
23140464|NCT02003222|64263833|FG004|Intensification|Adverse Event|6|||
23140465|NCT02003222|64263829|FG000|Intensification|Alternative therapy|0|||
23140466|NCT02003222|64263830|FG001|Intensification|Alternative therapy|0|||
23140467|NCT02003222|64263831|FG002|Intensification|Alternative therapy|0|||
23140468|NCT02003222|64263832|FG003|Intensification|Alternative therapy|0|||
23432234|NCT01423916|65327583|FG001|Overall Study|Protocol Deviation|0|||
23432235|NCT01423916|65327584|FG002|Overall Study|Protocol Deviation|0|||
23432236|NCT02066129|65327590|FG000|Overall Study|Lost to Follow-up|13|||
23432237|NCT02066129|65327591|FG001|Overall Study|Lost to Follow-up|12|||
23622117|NCT01644188|66004833|FG000|Overall Study|Last visit outside protocol visit window|14|||
23622118|NCT01644188|66004834|FG001|Overall Study|Last visit outside protocol visit window|16|||
23622119|NCT01644188|66004833|FG000|Overall Study|Site closure|1|||
23622120|NCT01644188|66004834|FG001|Overall Study|Site closure|1|||
23622121|NCT01644188|66004833|FG000|Overall Study|Other than specified above|6|||
23622122|NCT01644188|66004834|FG001|Overall Study|Other than specified above|7|||
23622123|NCT00468130|66004835|FG000|Overall Study|Adverse Event|2|||
23622124|NCT00468130|66004836|FG001|Overall Study|Adverse Event|1|||
23622125|NCT00468130|66004835|FG000|Overall Study|Withdrawal by Subject|0|||
23622126|NCT00468130|66004836|FG001|Overall Study|Withdrawal by Subject|1|||
23432238|NCT02066129|65327590|FG000|Overall Study|Withdrawal by Subject|7|||
23432239|NCT02066129|65327591|FG001|Overall Study|Withdrawal by Subject|10|||
23432240|NCT02066129|65327590|FG000|Overall Study|Lack of Efficacy|8|||
23432241|NCT02066129|65327591|FG001|Overall Study|Lack of Efficacy|10|||
23432242|NCT02066129|65327590|FG000|Overall Study|Physician Decision|1|||
23432243|NCT02066129|65327591|FG001|Overall Study|Physician Decision|1|||
23432244|NCT04566692|65327592|FG000|Overall Study|Adverse Event|2|||
23432245|NCT04566692|65327593|FG001|Overall Study|Adverse Event|0|||
23432246|NCT04566692|65327592|FG000|Overall Study|Withdrawal by Subject|1|||
23432247|NCT04566692|65327593|FG001|Overall Study|Withdrawal by Subject|1|||
23432248|NCT04896593|65327594|FG000|Overall Study|Withdrawal by Subject|2|||
23432249|NCT04896593|65327594|FG000|Overall Study|Lost to Follow-up|1|||
23432250|NCT04896593|65327594|FG000|Overall Study|Did not complete onboarding|2|||
23432251|NCT00098306|65327596|FG000|Double Blind|Randomized, not treated|9|||
23432252|NCT00098306|65327597|FG001|Double Blind|Randomized, not treated|5|||
23432253|NCT00098306|65327598|FG002|Double Blind|Randomized, not treated|2|||
23432254|NCT00098306|65327599|FG003|Double Blind|Randomized, not treated|0|||
23432255|NCT00098306|65327600|FG004|Double Blind|Randomized, not treated|0|||
23432256|NCT00098306|65327601|FG005|Double Blind|Randomized, not treated|0|||
23432257|NCT00098306|65327602|FG006|Double Blind|Randomized, not treated|0|||
23432258|NCT00098306|65327596|FG000|Double Blind|Ongoing at cut-off date|151|||
23432259|NCT00098306|65327597|FG001|Double Blind|Ongoing at cut-off date|166|||
23432260|NCT00098306|65327598|FG002|Double Blind|Ongoing at cut-off date|72|||
23432261|NCT00098306|65327599|FG003|Double Blind|Ongoing at cut-off date|0|||
23432262|NCT00098306|65327600|FG004|Double Blind|Ongoing at cut-off date|0|||
23432263|NCT00098306|65327601|FG005|Double Blind|Ongoing at cut-off date|0|||
23432264|NCT00098306|65327602|FG006|Double Blind|Ongoing at cut-off date|0|||
23432265|NCT00098306|65327596|FG000|Double Blind|Adverse Event|11|||
23432266|NCT00098306|65327597|FG001|Double Blind|Adverse Event|10|||
23432267|NCT00098306|65327598|FG002|Double Blind|Adverse Event|6|||
23432268|NCT00098306|65327599|FG003|Double Blind|Adverse Event|0|||
23432269|NCT00098306|65327600|FG004|Double Blind|Adverse Event|0|||
23432270|NCT00098306|65327601|FG005|Double Blind|Adverse Event|0|||
23432271|NCT00098306|65327602|FG006|Double Blind|Adverse Event|0|||
23432272|NCT00098306|65327596|FG000|Double Blind|Lack of Efficacy|43|||
23432273|NCT00098306|65327597|FG001|Double Blind|Lack of Efficacy|34|||
23432274|NCT00098306|65327598|FG002|Double Blind|Lack of Efficacy|17|||
23432275|NCT00098306|65327599|FG003|Double Blind|Lack of Efficacy|0|||
23432276|NCT00098306|65327600|FG004|Double Blind|Lack of Efficacy|0|||
23432277|NCT00098306|65327601|FG005|Double Blind|Lack of Efficacy|0|||
23622127|NCT03842436|66004840|FG000|Overall Study|Lost to Follow-up|1|||
23622128|NCT00236184|66004841|FG000|Overall Study|Adverse Event|5|||
23140469|NCT02003222|64263833|FG004|Intensification|Alternative therapy|8|||
23140470|NCT02003222|64263829|FG000|Intensification|Disease progression|0|||
23140471|NCT02003222|64263830|FG001|Intensification|Disease progression|0|||
23622129|NCT00236184|66004842|FG001|Overall Study|Adverse Event|2|||
23622130|NCT00236184|66004841|FG000|Overall Study|Lack of Efficacy|0|||
23140472|NCT02003222|64263831|FG002|Intensification|Disease progression|0|||
23140473|NCT02003222|64263832|FG003|Intensification|Disease progression|0|||
23140474|NCT02003222|64263833|FG004|Intensification|Disease progression|18|||
23432278|NCT00098306|65327602|FG006|Double Blind|Lack of Efficacy|0|||
23432279|NCT00098306|65327596|FG000|Double Blind|Death|1|||
23432280|NCT00098306|65327597|FG001|Double Blind|Death|4|||
23432281|NCT00098306|65327598|FG002|Double Blind|Death|1|||
23432282|NCT00098306|65327599|FG003|Double Blind|Death|0|||
23432283|NCT00098306|65327600|FG004|Double Blind|Death|0|||
23432284|NCT00098306|65327601|FG005|Double Blind|Death|0|||
23432285|NCT00098306|65327602|FG006|Double Blind|Death|0|||
23432286|NCT00098306|65327596|FG000|Double Blind|Participant defaulted|19|||
23432287|NCT00098306|65327597|FG001|Double Blind|Participant defaulted|18|||
23432288|NCT00098306|65327598|FG002|Double Blind|Participant defaulted|11|||
23432289|NCT00098306|65327599|FG003|Double Blind|Participant defaulted|0|||
23432290|NCT00098306|65327600|FG004|Double Blind|Participant defaulted|0|||
23432291|NCT00098306|65327601|FG005|Double Blind|Participant defaulted|0|||
23432292|NCT00098306|65327602|FG006|Double Blind|Participant defaulted|0|||
23432293|NCT00098306|65327596|FG000|Double Blind|Un-specified|7|||
23432294|NCT00098306|65327597|FG001|Double Blind|Un-specified|3|||
23432295|NCT00098306|65327598|FG002|Double Blind|Un-specified|11|||
23432296|NCT00098306|65327599|FG003|Double Blind|Un-specified|0|||
23432297|NCT00098306|65327600|FG004|Double Blind|Un-specified|0|||
23432298|NCT00098306|65327601|FG005|Double Blind|Un-specified|0|||
23432299|NCT00098306|65327602|FG006|Double Blind|Un-specified|0|||
23432300|NCT00098306|65327596|FG000|Open Label|Lack of Efficacy|0|||
23432301|NCT00098306|65327597|FG001|Open Label|Lack of Efficacy|0|||
23432302|NCT00098306|65327598|FG002|Open Label|Lack of Efficacy|0|||
23432303|NCT00098306|65327599|FG003|Open Label|Lack of Efficacy|13|||
23432304|NCT00098306|65327600|FG004|Open Label|Lack of Efficacy|0|||
23432305|NCT00098306|65327601|FG005|Open Label|Lack of Efficacy|0|||
23432306|NCT00098306|65327602|FG006|Open Label|Lack of Efficacy|0|||
23432307|NCT00098306|65327596|FG000|Open Label|Adverse Event|0|||
23432308|NCT00098306|65327597|FG001|Open Label|Adverse Event|0|||
23432309|NCT00098306|65327598|FG002|Open Label|Adverse Event|0|||
23432310|NCT00098306|65327599|FG003|Open Label|Adverse Event|2|||
23432311|NCT00098306|65327600|FG004|Open Label|Adverse Event|0|||
23432312|NCT00098306|65327601|FG005|Open Label|Adverse Event|0|||
23432313|NCT00098306|65327602|FG006|Open Label|Adverse Event|0|||
23432314|NCT00098306|65327596|FG000|Open Label|Death|0|||
23432315|NCT00098306|65327597|FG001|Open Label|Death|0|||
23432316|NCT00098306|65327598|FG002|Open Label|Death|0|||
23432317|NCT00098306|65327599|FG003|Open Label|Death|4|||
23432318|NCT00098306|65327600|FG004|Open Label|Death|0|||
23432319|NCT00098306|65327601|FG005|Open Label|Death|0|||
23432320|NCT00098306|65327602|FG006|Open Label|Death|0|||
23140475|NCT02003222|64263829|FG000|Intensification|Withdrawal by Subject|0|||
23432321|NCT00098306|65327596|FG000|Open Label|Participant defaulted|0|||
23432322|NCT00098306|65327597|FG001|Open Label|Participant defaulted|0|||
23432323|NCT00098306|65327598|FG002|Open Label|Participant defaulted|0|||
23432324|NCT00098306|65327599|FG003|Open Label|Participant defaulted|24|||
23432325|NCT00098306|65327600|FG004|Open Label|Participant defaulted|0|||
23432326|NCT00098306|65327601|FG005|Open Label|Participant defaulted|0|||
23432327|NCT00098306|65327602|FG006|Open Label|Participant defaulted|0|||
23432328|NCT00098306|65327596|FG000|Open Label|Un-specified|0|||
23432329|NCT00098306|65327597|FG001|Open Label|Un-specified|0|||
23432330|NCT00098306|65327598|FG002|Open Label|Un-specified|0|||
23432331|NCT00098306|65327599|FG003|Open Label|Un-specified|15|||
23432332|NCT00098306|65327600|FG004|Open Label|Un-specified|0|||
23432333|NCT00098306|65327601|FG005|Open Label|Un-specified|0|||
23432334|NCT00098306|65327602|FG006|Open Label|Un-specified|0|||
23432335|NCT00098306|65327596|FG000|Open Label|Ongoing at cut-off date|0|||
23432336|NCT00098306|65327597|FG001|Open Label|Ongoing at cut-off date|0|||
23432337|NCT00098306|65327598|FG002|Open Label|Ongoing at cut-off date|0|||
23432338|NCT00098306|65327599|FG003|Open Label|Ongoing at cut-off date|269|||
23432339|NCT00098306|65327600|FG004|Open Label|Ongoing at cut-off date|62|||
23432340|NCT00098306|65327601|FG005|Open Label|Ongoing at cut-off date|0|||
23432341|NCT00098306|65327602|FG006|Open Label|Ongoing at cut-off date|0|||
23432342|NCT00098306|65327596|FG000|Observational Phase|Death|0|||
23432343|NCT00098306|65327597|FG001|Observational Phase|Death|0|||
23432344|NCT00098306|65327598|FG002|Observational Phase|Death|0|||
23432345|NCT00098306|65327599|FG003|Observational Phase|Death|0|||
23432346|NCT00098306|65327600|FG004|Observational Phase|Death|0|||
23432347|NCT00098306|65327601|FG005|Observational Phase|Death|5|||
23432348|NCT00098306|65327602|FG006|Observational Phase|Death|4|||
23432349|NCT00098306|65327596|FG000|Observational Phase|Participant defaulted|0|||
23432350|NCT00098306|65327597|FG001|Observational Phase|Participant defaulted|0|||
23432351|NCT00098306|65327598|FG002|Observational Phase|Participant defaulted|0|||
23432352|NCT00098306|65327599|FG003|Observational Phase|Participant defaulted|0|||
23140476|NCT02003222|64263830|FG001|Intensification|Withdrawal by Subject|0|||
23432353|NCT00098306|65327600|FG004|Observational Phase|Participant defaulted|0|||
23432354|NCT00098306|65327601|FG005|Observational Phase|Participant defaulted|34|||
23432355|NCT00098306|65327602|FG006|Observational Phase|Participant defaulted|18|||
23432356|NCT00098306|65327596|FG000|Observational Phase|Un-specified|0|||
23432357|NCT00098306|65327597|FG001|Observational Phase|Un-specified|0|||
23432358|NCT00098306|65327598|FG002|Observational Phase|Un-specified|0|||
23432359|NCT00098306|65327599|FG003|Observational Phase|Un-specified|0|||
23432360|NCT00098306|65327600|FG004|Observational Phase|Un-specified|0|||
23432361|NCT00098306|65327601|FG005|Observational Phase|Un-specified|7|||
23432362|NCT00098306|65327602|FG006|Observational Phase|Un-specified|4|||
23432363|NCT03443427|65327605|FG000|Overall Study|Adverse Event|2|||
23432364|NCT03443427|65327606|FG001|Overall Study|Adverse Event|3|||
23432365|NCT03443427|65327605|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
23432366|NCT03443427|65327606|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
23432367|NCT03443427|65327605|FG000|Overall Study|Other|4|||
23432368|NCT03443427|65327606|FG001|Overall Study|Other|6|||
23432369|NCT01422824|65327607|FG000|Overall Study|Case record form not evaluated|1|||
23432370|NCT01422824|65327607|FG000|Overall Study|Lost to Follow-up|37|||
23432371|NCT02014584|65327610|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432372|NCT02014584|65327611|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
23432373|NCT02014584|65327612|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432374|NCT02014584|65327613|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432375|NCT02014584|65327614|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432376|NCT02014584|65327615|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
23432377|NCT02014584|65327610|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
23432378|NCT02014584|65327611|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
23432379|NCT02014584|65327612|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
23432380|NCT02014584|65327613|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
23432381|NCT02014584|65327614|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
23432382|NCT02014584|65327615|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
23432383|NCT02014584|65327610|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432384|NCT02014584|65327611|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432385|NCT02014584|65327612|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
23432386|NCT02014584|65327613|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432387|NCT02014584|65327614|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432388|NCT02014584|65327615|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
23432389|NCT02014584|65327610|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
23432390|NCT02014584|65327611|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
23432391|NCT02014584|65327612|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
23432392|NCT02014584|65327613|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
23622131|NCT00236184|66004842|FG001|Overall Study|Lack of Efficacy|1|||
23622132|NCT00236184|66004841|FG000|Overall Study|Lost to Follow-up|3|||
23622133|NCT00236184|66004842|FG001|Overall Study|Lost to Follow-up|4|||
23622134|NCT00236184|66004841|FG000|Overall Study|Physician Decision|1|||
23622135|NCT00236184|66004842|FG001|Overall Study|Physician Decision|1|||
23622136|NCT00236184|66004841|FG000|Overall Study|Withdrawal by Subject|3|||
23140477|NCT02003222|64263831|FG002|Intensification|Withdrawal by Subject|0|||
23140478|NCT02003222|64263832|FG003|Intensification|Withdrawal by Subject|0|||
23140479|NCT02003222|64263833|FG004|Intensification|Withdrawal by Subject|5|||
23140480|NCT02003222|64263829|FG000|Intensification|Other reasons|0|||
23140481|NCT02003222|64263830|FG001|Intensification|Other reasons|0|||
23140482|NCT02003222|64263831|FG002|Intensification|Other reasons|0|||
23140483|NCT02003222|64263832|FG003|Intensification|Other reasons|0|||
23140484|NCT02003222|64263833|FG004|Intensification|Other reasons|8|||
23140485|NCT02656823|64263837|FG000|Overall Study|Adverse Event|3|||
23140486|NCT02656823|64263837|FG000|Overall Study|Lost to Follow-up|2|||
23140487|NCT01015560|64263838|FG000|Overall Study|Adverse Event|1|||
23140488|NCT01015560|64263838|FG000|Overall Study|Not protocol specified|1|||
23140489|NCT01015560|64263838|FG000|Overall Study|Withdrawal by Subject|1|||
23140490|NCT03562247|64263839|FG000|Overall Study|Lost to Follow-up|3|||
23140491|NCT03562247|64263840|FG001|Overall Study|Lost to Follow-up|1|||
23216146|NCT03024255|64531415|FG003|Overall Study|Withdrawal by Subject|3|||
23216147|NCT03024255|64531412|FG000|Overall Study|Protocol Violation|0|||
23216148|NCT03024255|64531413|FG001|Overall Study|Protocol Violation|0|||
23216149|NCT03024255|64531414|FG002|Overall Study|Protocol Violation|2|||
23216150|NCT03024255|64531415|FG003|Overall Study|Protocol Violation|0|||
23216151|NCT03024255|64531412|FG000|Overall Study|Lost to Follow-up|1|||
23216152|NCT03024255|64531413|FG001|Overall Study|Lost to Follow-up|2|||
23216153|NCT03024255|64531414|FG002|Overall Study|Lost to Follow-up|1|||
23216154|NCT03024255|64531415|FG003|Overall Study|Lost to Follow-up|1|||
23216155|NCT03024255|64531412|FG000|Overall Study|Lack of Efficacy|1|||
23216156|NCT03024255|64531413|FG001|Overall Study|Lack of Efficacy|0|||
23216157|NCT03024255|64531414|FG002|Overall Study|Lack of Efficacy|0|||
23216158|NCT03024255|64531415|FG003|Overall Study|Lack of Efficacy|0|||
23216159|NCT03024255|64531412|FG000|Overall Study|Protocol Noncompliance|1|||
23216160|NCT03024255|64531413|FG001|Overall Study|Protocol Noncompliance|1|||
23216161|NCT03024255|64531414|FG002|Overall Study|Protocol Noncompliance|0|||
23432393|NCT02014584|65327614|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
23432394|NCT02014584|65327615|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
23622137|NCT00236184|66004842|FG001|Overall Study|Withdrawal by Subject|0|||
23140492|NCT03562247|64263841|FG002|Overall Study|Lost to Follow-up|1|||
23622138|NCT00236184|66004841|FG000|Overall Study|Protocol Violation|3|||
23140493|NCT03426605|64263842|FG000|Overall Study|AML relapse or progression|2|||
23140494|NCT03426605|64263843|FG001|Overall Study|AML relapse or progression|1|||
23140495|NCT03426605|64263844|FG002|Overall Study|AML relapse or progression|2|||
23216162|NCT03024255|64531415|FG003|Overall Study|Protocol Noncompliance|1|||
23216163|NCT00438464|64531418|FG000|Overall Study|Terminated Early|14|||
23216164|NCT00438464|64531419|FG001|Overall Study|Terminated Early|5|||
23216165|NCT00438464|64531418|FG000|Overall Study|Incomplete data submission|0|||
23216166|NCT00438464|64531419|FG001|Overall Study|Incomplete data submission|2|||
23216167|NCT05441540|64531422|FG000|Overall Study|Withdrawal by Subject|2|||
23216168|NCT03371251|64531427|FG000|Overall Study|Withdrawal by Subject|1|||
23216169|NCT03371251|64531428|FG001|Overall Study|Withdrawal by Subject|0|||
23216170|NCT03371251|64531429|FG002|Overall Study|Withdrawal by Subject|1|||
23216171|NCT03371251|64531430|FG003|Overall Study|Withdrawal by Subject|0|||
23216172|NCT03371251|64531431|FG004|Overall Study|Withdrawal by Subject|2|||
23216173|NCT03371251|64531432|FG005|Overall Study|Withdrawal by Subject|2|||
23216174|NCT03371251|64531427|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
23216175|NCT03371251|64531428|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
23216176|NCT03371251|64531429|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
23216177|NCT03371251|64531430|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
23216178|NCT03371251|64531431|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
23216179|NCT03371251|64531432|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
23216180|NCT03371251|64531427|FG000|Overall Study|Adverse Event|0|||
23216181|NCT03371251|64531428|FG001|Overall Study|Adverse Event|0|||
23216182|NCT03371251|64531429|FG002|Overall Study|Adverse Event|0|||
23216183|NCT03371251|64531430|FG003|Overall Study|Adverse Event|0|||
23216184|NCT03371251|64531431|FG004|Overall Study|Adverse Event|1|||
23216185|NCT03371251|64531432|FG005|Overall Study|Adverse Event|0|||
23216186|NCT03371251|64531427|FG000|Overall Study|Decision by Sponsor|0|||
23216187|NCT03371251|64531428|FG001|Overall Study|Decision by Sponsor|0|||
23216188|NCT03371251|64531429|FG002|Overall Study|Decision by Sponsor|0|||
23216189|NCT03371251|64531430|FG003|Overall Study|Decision by Sponsor|0|||
23216190|NCT03371251|64531431|FG004|Overall Study|Decision by Sponsor|2|||
23216191|NCT03371251|64531432|FG005|Overall Study|Decision by Sponsor|0|||
23216192|NCT03094611|64531433|FG000|Overall Study|Lack of Efficacy|1|||
23216193|NCT03094611|64531433|FG000|Overall Study|Stem Cell Transplant|1|||
23216194|NCT00994162|64531434|FG000|Overall Study|Withdrawal by Subject|1|||
23216195|NCT00994162|64531434|FG000|Overall Study|Lost to Follow-up|2|||
23216196|NCT00994162|64531434|FG000|Overall Study|Product Complaint|1|||
23216197|NCT00994162|64531434|FG000|Overall Study|Poor Compliance|5|||
23216198|NCT00994162|64531434|FG000|Overall Study|Lack of Response|3|||
23216199|NCT00994162|64531434|FG000|Overall Study|Discharged from Hospital|4|||
23216200|NCT00994162|64531434|FG000|Overall Study|Death|2|||
23554655|NCT03494166|65757883|FG003|Overall Study|Withdrawal by Subject|5|||
23554656|NCT03494166|65757884|FG004|Overall Study|Withdrawal by Subject|3|||
23554657|NCT03494166|65757885|FG005|Overall Study|Withdrawal by Subject|17|||
23554658|NCT03494166|65757880|FG000|Overall Study|Screen failure|1|||
23554659|NCT03494166|65757881|FG001|Overall Study|Screen failure|0|||
23140496|NCT03426605|64263845|FG003|Overall Study|AML relapse or progression|2|||
23140497|NCT03426605|64263842|FG000|Overall Study|Treatment failure|3|||
23554660|NCT03494166|65757882|FG002|Overall Study|Screen failure|0|||
23554661|NCT03494166|65757883|FG003|Overall Study|Screen failure|0|||
23554662|NCT03494166|65757884|FG004|Overall Study|Screen failure|1|||
23554663|NCT03494166|65757885|FG005|Overall Study|Screen failure|0|||
23554664|NCT03151005|65757889|FG000|Overall Study|Lost to Follow-up|5|||
23554665|NCT03151005|65757890|FG001|Overall Study|Lost to Follow-up|5|||
23554666|NCT02450331|65757899|FG000|Overall Study|Death|162|||
23554667|NCT02450331|65757900|FG001|Overall Study|Death|171|||
23554668|NCT02450331|65757899|FG000|Overall Study|Lost to Follow-up|14|||
23554669|NCT02450331|65757900|FG001|Overall Study|Lost to Follow-up|12|||
23140498|NCT03426605|64263843|FG001|Overall Study|Treatment failure|2|||
23140499|NCT03426605|64263844|FG002|Overall Study|Treatment failure|0|||
23140500|NCT03426605|64263845|FG003|Overall Study|Treatment failure|0|||
23140501|NCT03426605|64263842|FG000|Overall Study|Adverse Event|1|||
23140502|NCT03426605|64263843|FG001|Overall Study|Adverse Event|0|||
23140503|NCT03426605|64263844|FG002|Overall Study|Adverse Event|1|||
23140504|NCT03426605|64263845|FG003|Overall Study|Adverse Event|1|||
23140505|NCT03426605|64263842|FG000|Overall Study|Withdrawal by Subject|0|||
23140506|NCT03426605|64263843|FG001|Overall Study|Withdrawal by Subject|0|||
23140507|NCT03426605|64263844|FG002|Overall Study|Withdrawal by Subject|1|||
23216201|NCT00994162|64531434|FG000|Overall Study|Care Transferred to Another Physician|2|||
23216202|NCT00994162|64531434|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
23216203|NCT00994162|64531434|FG000|Overall Study|Physician Decision|2|||
23216204|NCT00994162|64531434|FG000|Overall Study|Surrounding Wound Erythematous|1|||
23318046|NCT01098474|64908235|FG005|Follow Up Phase|Travelled out of study area|0|||
23318047|NCT01098474|64908230|FG000|Follow Up Phase|Other|0|||
23554670|NCT02450331|65757899|FG000|Overall Study|Withdrawal by Subject|55|||
23554671|NCT02450331|65757900|FG001|Overall Study|Withdrawal by Subject|44|||
23554672|NCT02450331|65757899|FG000|Overall Study|Non-specified other|1|||
23554673|NCT02450331|65757900|FG001|Overall Study|Non-specified other|1|||
23554674|NCT04252742|65757902|FG000|Overall Study|Decision by sponsor|0|||
23554675|NCT04252742|65757903|FG001|Overall Study|Decision by sponsor|2|||
23140508|NCT03426605|64263845|FG003|Overall Study|Withdrawal by Subject|1|||
23140509|NCT01920854|64263846|FG000|Overall Study|Withdrawal by Subject|1|||
23140510|NCT01920854|64263847|FG001|Overall Study|Withdrawal by Subject|0|||
23140511|NCT01920854|64263848|FG002|Overall Study|Withdrawal by Subject|0|||
23140512|NCT01920854|64263849|FG003|Overall Study|Withdrawal by Subject|0|||
23140513|NCT01920854|64263850|FG004|Overall Study|Withdrawal by Subject|1|||
23140514|NCT01920854|64263851|FG005|Overall Study|Withdrawal by Subject|0|||
23140515|NCT01920854|64263852|FG006|Overall Study|Withdrawal by Subject|1|||
23140516|NCT02656329|64263853|FG000|Overall Study|Lost to Follow-up|2|||
23140517|NCT02656329|64263854|FG001|Overall Study|Lost to Follow-up|3|||
23140518|NCT02656329|64263853|FG000|Overall Study|Withdrawal by Subject|7|||
23140519|NCT02656329|64263854|FG001|Overall Study|Withdrawal by Subject|6|||
23140520|NCT02656329|64263853|FG000|Overall Study|Study termination by Sponsor|150|||
23140521|NCT02656329|64263854|FG001|Overall Study|Study termination by Sponsor|142|||
23140522|NCT02656329|64263853|FG000|Overall Study|Other than specified above|5|||
23140523|NCT02656329|64263854|FG001|Overall Study|Other than specified above|6|||
23140524|NCT00969709|64263858|FG000|Overall Study|Adverse Event|3|||
23140525|NCT00969709|64263859|FG001|Overall Study|Adverse Event|13|||
23140526|NCT00969709|64263860|FG002|Overall Study|Adverse Event|26|||
23216205|NCT00994162|64531434|FG000|Overall Study|Machine Losing Vaccum|1|||
23216206|NCT00994162|64531434|FG000|Overall Study|Patient Lived Too Far Away|1|||
23216207|NCT00994162|64531434|FG000|Overall Study|Above Knee Amputation|1|||
23216208|NCT00994162|64531434|FG000|Overall Study|Reason Not Reported By Site|1|||
23216209|NCT00646113|64531437|FG000|Overall Study|Lost to Follow-up|5|||
23216210|NCT00646113|64531437|FG000|Overall Study|Adverse Event|3|||
23216211|NCT02186561|64531441|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
23216212|NCT02186561|64531441|FG000|Enrollment|Enrollment Cap Reached|5|||
23216213|NCT02186561|64531441|FG000|Enrollment|Insurance Denial|2|||
23216214|NCT02186561|64531441|FG000|Enrollment|Withdrawal by Subject|2|||
23216215|NCT02186561|64531441|FG000|Enrollment|Investigator Withdrew Consent|1|||
23216216|NCT02186561|64531441|FG000|30-Day Post Index Procedure Visit|Death|1|||
23216217|NCT02186561|64531441|FG000|1- Year Post Index Procedure Visit|Death|1|||
23216218|NCT02186561|64531441|FG000|1- Year Post Index Procedure Visit|Missed|1|||
23216219|NCT00249795|64534424|FG000|Overall Study|Not treated|16|||
23216220|NCT00249795|64534425|FG001|Overall Study|Not treated|14|||
23216221|NCT00249795|64534424|FG000|Overall Study|Symptomatic hypotension|127|||
23216222|NCT00249795|64534425|FG001|Overall Study|Symptomatic hypotension|64|||
23216223|NCT00249795|64534424|FG000|Overall Study|Other Serious Adverse Event|84|||
23216224|NCT00249795|64534425|FG001|Overall Study|Other Serious Adverse Event|93|||
23216225|NCT00249795|64534424|FG000|Overall Study|Qualifying condition not present|26|||
23216226|NCT00249795|64534425|FG001|Overall Study|Qualifying condition not present|29|||
23216227|NCT00249795|64534424|FG000|Overall Study|Withdrawal by Subject|678|||
23216228|NCT00249795|64534425|FG001|Overall Study|Withdrawal by Subject|742|||
23216229|NCT00249795|64534424|FG000|Overall Study|Thromboembolic / outcome event|39|||
23216230|NCT00249795|64534425|FG001|Overall Study|Thromboembolic / outcome event|45|||
23216231|NCT00249795|64534424|FG000|Overall Study|Oral anticoagulant required|2|||
23216232|NCT00249795|64534425|FG001|Overall Study|Oral anticoagulant required|0|||
23216233|NCT00249795|64534424|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
23216234|NCT00249795|64534425|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
23318048|NCT01098474|64908231|FG001|Follow Up Phase|Other|0|||
23216235|NCT00249795|64534424|FG000|Overall Study|Non-compliance|71|||
23216236|NCT00249795|64534425|FG001|Overall Study|Non-compliance|69|||
23216237|NCT00249795|64534424|FG000|Overall Study|Study drug intolerance|3|||
23216238|NCT00249795|64534425|FG001|Overall Study|Study drug intolerance|3|||
23216239|NCT00249795|64534424|FG000|Overall Study|Other adverse events (non-serious)|188|||
23216240|NCT00249795|64534425|FG001|Overall Study|Other adverse events (non-serious)|159|||
23216241|NCT00249795|64534424|FG000|Overall Study|Physician withdrew consent|71|||
23216242|NCT00249795|64534425|FG001|Overall Study|Physician withdrew consent|63|||
23216243|NCT00249795|64534424|FG000|Overall Study|Surgery / procedure|4|||
23216244|NCT00249795|64534425|FG001|Overall Study|Surgery / procedure|5|||
23216245|NCT00249795|64534424|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
23216246|NCT00249795|64534425|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
23216247|NCT00249795|64534424|FG000|Overall Study|Lightheadedness / dizziness|15|||
23216248|NCT00249795|64534425|FG001|Overall Study|Lightheadedness / dizziness|11|||
23216249|NCT00249795|64534424|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
23216250|NCT00249795|64534425|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
23216251|NCT00249795|64534424|FG000|Overall Study|Other contraindicated medication|1|||
23216252|NCT00249795|64534425|FG001|Overall Study|Other contraindicated medication|1|||
23140527|NCT00969709|64263861|FG003|Overall Study|Adverse Event|12|||
23140528|NCT00969709|64263858|FG000|Overall Study|Lack of Efficacy|7|||
23318049|NCT01098474|64908232|FG002|Follow Up Phase|Other|0|||
23140529|NCT00969709|64263859|FG001|Overall Study|Lack of Efficacy|4|||
23140530|NCT00969709|64263860|FG002|Overall Study|Lack of Efficacy|1|||
23140531|NCT00969709|64263861|FG003|Overall Study|Lack of Efficacy|3|||
23140532|NCT00969709|64263858|FG000|Overall Study|Protocol Violation|9|||
23216253|NCT00249795|64534424|FG000|Overall Study|Event related to cardiac condition|17|||
23216254|NCT00249795|64534425|FG001|Overall Study|Event related to cardiac condition|16|||
23318050|NCT01098474|64908233|FG003|Follow Up Phase|Other|0|||
23216255|NCT00249795|64534424|FG000|Overall Study|Patient not wish to continue after May08|4|||
23622139|NCT00236184|66004842|FG001|Overall Study|Protocol Violation|0|||
23554676|NCT04252742|65757902|FG000|Overall Study|Withdrawal by Subject|15|||
23554677|NCT04252742|65757903|FG001|Overall Study|Withdrawal by Subject|9|||
23554678|NCT04252742|65757902|FG000|Overall Study|Lost to Follow-up|0|||
23554679|NCT04252742|65757903|FG001|Overall Study|Lost to Follow-up|1|||
23554680|NCT00736645|65757904|FG000|Overall Study|Adverse Event|0|||
23554681|NCT00736645|65757905|FG001|Overall Study|Adverse Event|2|||
23554682|NCT00736645|65757906|FG002|Overall Study|Adverse Event|0|||
23554683|NCT00736645|65757907|FG003|Overall Study|Adverse Event|0|||
23554684|NCT01936857|65757908|FG000|Overall Study|Sent to prison or 06 center|11|||
23554685|NCT01936857|65757909|FG001|Overall Study|Sent to prison or 06 center|12|||
23554686|NCT01936857|65757908|FG000|Overall Study|Lost to Follow-up|10|||
23554687|NCT01936857|65757909|FG001|Overall Study|Lost to Follow-up|7|||
23554688|NCT01936857|65757908|FG000|Overall Study|Death|7|||
23554689|NCT01936857|65757909|FG001|Overall Study|Death|3|||
23554690|NCT01936857|65757908|FG000|Overall Study|Moved|2|||
23554691|NCT01936857|65757909|FG001|Overall Study|Moved|1|||
23554692|NCT01936857|65757908|FG000|Overall Study|Withdrawal by Subject|1|||
23554693|NCT01936857|65757909|FG001|Overall Study|Withdrawal by Subject|0|||
23554694|NCT01936857|65757908|FG000|Overall Study|Side effect of medication|1|||
23554695|NCT01936857|65757909|FG001|Overall Study|Side effect of medication|0|||
23554696|NCT01936857|65757908|FG000|Overall Study|Other|2|||
23554697|NCT01936857|65757909|FG001|Overall Study|Other|2|||
23554698|NCT01235546|65757910|FG000|Overall Study|Staff error, medication not administered|1|||
23554699|NCT01235546|65757911|FG001|Overall Study|Staff error, medication not administered|0|||
23554700|NCT01235546|65757910|FG000|Overall Study|Protocol Violation|1|||
23554701|NCT01235546|65757911|FG001|Overall Study|Protocol Violation|1|||
23554702|NCT01569438|65757912|FG000|Overall Study|Lack of Efficacy|1|||
23554703|NCT01569438|65757913|FG001|Overall Study|Lack of Efficacy|2|||
23554704|NCT01569438|65757912|FG000|Overall Study|Withdrawal by Subject|0|||
23554705|NCT01569438|65757913|FG001|Overall Study|Withdrawal by Subject|3|||
23554706|NCT01569438|65757912|FG000|Overall Study|Adverse Event|2|||
23554707|NCT01569438|65757913|FG001|Overall Study|Adverse Event|15|||
23554708|NCT01569438|65757912|FG000|Overall Study|Protocol Violation|2|||
23554709|NCT01569438|65757913|FG001|Overall Study|Protocol Violation|0|||
23554710|NCT01569438|65757912|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
23554711|NCT01569438|65757913|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
23554712|NCT01569438|65757912|FG000|Overall Study|Sponsor/Physician decision|1|||
23554713|NCT01569438|65757913|FG001|Overall Study|Sponsor/Physician decision|1|||
23554714|NCT01569438|65757912|FG000|Overall Study|Unable to adhere to study schedule|0|||
23554715|NCT01569438|65757913|FG001|Overall Study|Unable to adhere to study schedule|1|||
23554716|NCT02047045|65757915|FG000|Baseline|Withdrawal by Subject|3|||
23554717|NCT02047045|65757916|FG001|Baseline|Withdrawal by Subject|2|||
23554718|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
23554719|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
23554720|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
23554721|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
23554722|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
23554723|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
23554724|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
23554725|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
23554726|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
23554727|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
23622140|NCT00236184|66004841|FG000|Overall Study|non-compliance with study drug|2|||
23622141|NCT00236184|66004842|FG001|Overall Study|non-compliance with study drug|1|||
23216256|NCT00249795|64534425|FG001|Overall Study|Patient not wish to continue after May08|6|||
23216257|NCT00249795|64534424|FG000|Overall Study|Site not agree to continue after May08|1|||
23216258|NCT00249795|64534425|FG001|Overall Study|Site not agree to continue after May08|1|||
23216259|NCT00249795|64534424|FG000|Overall Study|Lost to Follow-up|0|||
23216260|NCT00249795|64534425|FG001|Overall Study|Lost to Follow-up|2|||
23216261|NCT00249795|64534424|FG000|Overall Study|Missing|0|||
23216262|NCT00249795|64534425|FG001|Overall Study|Missing|1|||
23216263|NCT02759562|64534428|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
23216264|NCT02759562|64534429|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
23216265|NCT02759562|64534428|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
23554728|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
23554729|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
23554730|NCT02047045|65757915|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
23554731|NCT02047045|65757916|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
23554732|NCT02047045|65757915|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
23554733|NCT02047045|65757916|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
23554734|NCT00541450|65757917|FG000|Phase A|Adverse Event|3|||
23554735|NCT00541450|65757918|FG001|Phase A|Adverse Event|0|||
23554736|NCT00541450|65757917|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
23140533|NCT00969709|64263859|FG001|Overall Study|Protocol Violation|5|||
23140534|NCT00969709|64263860|FG002|Overall Study|Protocol Violation|9|||
23140535|NCT00969709|64263861|FG003|Overall Study|Protocol Violation|10|||
23140536|NCT00969709|64263858|FG000|Overall Study|Withdrawal by Subject|9|||
23140537|NCT00969709|64263859|FG001|Overall Study|Withdrawal by Subject|12|||
23140538|NCT00969709|64263860|FG002|Overall Study|Withdrawal by Subject|11|||
23140539|NCT00969709|64263861|FG003|Overall Study|Withdrawal by Subject|23|||
23140540|NCT00969709|64263858|FG000|Overall Study|Lost to Follow-up|10|||
23140541|NCT00969709|64263859|FG001|Overall Study|Lost to Follow-up|14|||
23140542|NCT00969709|64263860|FG002|Overall Study|Lost to Follow-up|8|||
23140543|NCT00969709|64263861|FG003|Overall Study|Lost to Follow-up|15|||
23140544|NCT00969709|64263858|FG000|Overall Study|Other reasons|0|||
23140545|NCT00969709|64263859|FG001|Overall Study|Other reasons|0|||
23140546|NCT00969709|64263860|FG002|Overall Study|Other reasons|3|||
23140547|NCT00969709|64263861|FG003|Overall Study|Other reasons|0|||
23140548|NCT02595073|64263862|FG000|Overall Study|Progressive Disease|0|||
23140549|NCT02595073|64263863|FG001|Overall Study|Progressive Disease|1|||
23140550|NCT02595073|64263862|FG000|Overall Study|Protocol Violation|2|||
23140551|NCT02595073|64263863|FG001|Overall Study|Protocol Violation|0|||
23140552|NCT02029846|64263868|FG000|Overall Study|n=1 each arm|1|||
23140553|NCT02029846|64263869|FG001|Overall Study|n=1 each arm|1|||
23140554|NCT01236365|64263870|FG000|Overall Study|Lost to Follow-up|0|||
23140555|NCT01236365|64263871|FG001|Overall Study|Lost to Follow-up|2|||
23140556|NCT01236365|64263870|FG000|Overall Study|Moved Out of State|1|||
23140557|NCT01236365|64263871|FG001|Overall Study|Moved Out of State|0|||
23140558|NCT01236365|64263870|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
23140559|NCT01236365|64263871|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
23140560|NCT00600886|64263872|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
23140561|NCT00600886|64263873|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
23140562|NCT00600886|64263872|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
23140563|NCT00600886|64263873|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
23140564|NCT00600886|64263872|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
23140565|NCT00600886|64263873|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
23140566|NCT00600886|64263872|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
23140567|NCT00600886|64263873|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
23140568|NCT00600886|64263872|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
23140569|NCT00600886|64263873|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
23140570|NCT00600886|64263872|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
23140571|NCT00600886|64263873|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
23140572|NCT00600886|64263872|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
23140573|NCT00600886|64263873|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
23140574|NCT00600886|64263872|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
23140575|NCT00600886|64263873|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
23140576|NCT00600886|64263872|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
23140577|NCT00600886|64263873|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
23140578|NCT00600886|64263872|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
23140579|NCT00600886|64263873|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
23140580|NCT00600886|64263872|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
23140581|NCT00600886|64263873|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
23140582|NCT00600886|64263872|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
23140583|NCT00600886|64263873|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
23140584|NCT00600886|64263872|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
23140585|NCT00600886|64263873|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
23140586|NCT00600886|64263872|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
23140587|NCT00600886|64263873|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
23140588|NCT00600886|64263872|FG000|Extension - Same Treatment (FAS)|Death|1|||
23140589|NCT00600886|64263873|FG001|Extension - Same Treatment (FAS)|Death|1|||
23140590|NCT00600886|64263872|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
23140591|NCT00600886|64263873|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
23140592|NCT00600886|64263872|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
23140593|NCT00600886|64263873|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
23140594|NCT00600886|64263872|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
23140595|NCT00600886|64263873|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
23140596|NCT00600886|64263872|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
23318051|NCT01098474|64908234|FG004|Follow Up Phase|Other|0|||
23318052|NCT01098474|64908235|FG005|Follow Up Phase|Other|4|||
23140597|NCT00600886|64263873|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
23140598|NCT00600886|64263872|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
23140599|NCT00600886|64263873|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
23140600|NCT00600886|64263872|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
23318053|NCT01098474|64908230|FG000|Follow Up Phase|Withdrawal by Subject|0|||
23216266|NCT02759562|64534429|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
23216267|NCT05552859|64534430|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
23216268|NCT05552859|64534431|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
23216269|NCT00967226|64534432|FG000|Overall Study|Adverse Event|0|||
23216270|NCT00967226|64534433|FG001|Overall Study|Adverse Event|5|||
23216271|NCT00967226|64534432|FG000|Overall Study|Protocol Violation|2|||
23216272|NCT00967226|64534433|FG001|Overall Study|Protocol Violation|0|||
23216273|NCT00967226|64534432|FG000|Overall Study|Physician Decision|0|||
23216274|NCT00967226|64534433|FG001|Overall Study|Physician Decision|1|||
23216275|NCT00656084|64534434|FG000|Overall Study|Adverse Event|4|||
23216276|NCT00656084|64534434|FG000|Overall Study|Withdrawal by Subject|1|||
23216277|NCT00656084|64534434|FG000|Overall Study|Patient Request|1|||
23216278|NCT00656084|64534434|FG000|Overall Study|Investigator Request|1|||
23216279|NCT01742091|64534435|FG000|Overall Study|Adverse Event|0|||
23216280|NCT01742091|64534436|FG001|Overall Study|Adverse Event|0|||
23216281|NCT01742091|64534437|FG002|Overall Study|Adverse Event|0|||
23216282|NCT01742091|64534438|FG003|Overall Study|Adverse Event|0|||
23216283|NCT01742091|64534439|FG004|Overall Study|Adverse Event|1|||
23216284|NCT01742091|64534440|FG005|Overall Study|Adverse Event|0|||
23216285|NCT01742091|64534435|FG000|Overall Study|Physician Decision|0|||
23216286|NCT01742091|64534436|FG001|Overall Study|Physician Decision|0|||
23216287|NCT01742091|64534437|FG002|Overall Study|Physician Decision|0|||
23216288|NCT01742091|64534438|FG003|Overall Study|Physician Decision|0|||
23216289|NCT01742091|64534439|FG004|Overall Study|Physician Decision|0|||
23216290|NCT01742091|64534440|FG005|Overall Study|Physician Decision|1|||
23216291|NCT01742091|64534435|FG000|Overall Study|Withdrawal by Subject|0|||
23216292|NCT01742091|64534436|FG001|Overall Study|Withdrawal by Subject|0|||
23216293|NCT01742091|64534437|FG002|Overall Study|Withdrawal by Subject|0|||
23216294|NCT01742091|64534438|FG003|Overall Study|Withdrawal by Subject|1|||
23216295|NCT01742091|64534439|FG004|Overall Study|Withdrawal by Subject|0|||
23216296|NCT01742091|64534440|FG005|Overall Study|Withdrawal by Subject|0|||
23216297|NCT01742091|64534435|FG000|Overall Study|Lost to Follow-up|0|||
23216298|NCT01742091|64534436|FG001|Overall Study|Lost to Follow-up|0|||
23216299|NCT01742091|64534437|FG002|Overall Study|Lost to Follow-up|0|||
23216300|NCT01742091|64534438|FG003|Overall Study|Lost to Follow-up|0|||
23216301|NCT01742091|64534439|FG004|Overall Study|Lost to Follow-up|0|||
23216302|NCT01742091|64534440|FG005|Overall Study|Lost to Follow-up|1|||
23216303|NCT00557323|64534441|FG000|Overall Study|Death|3|||
23216304|NCT00557323|64534441|FG000|Overall Study|Withdrawal by Subject|2|||
23216305|NCT00557323|64534441|FG000|Overall Study|Administrative change|2|||
23216306|NCT00606177|64534443|FG000|Overall Study|Adverse Event|9|||
23216307|NCT00606177|64534444|FG001|Overall Study|Adverse Event|5|||
23216308|NCT00606177|64534443|FG000|Overall Study|Lack of Efficacy|3|||
23216309|NCT00606177|64534444|FG001|Overall Study|Lack of Efficacy|7|||
23216310|NCT00606177|64534443|FG000|Overall Study|Physician Decision|1|||
23216311|NCT00606177|64534444|FG001|Overall Study|Physician Decision|0|||
23216312|NCT00606177|64534443|FG000|Overall Study|Protocol Violation|1|||
23216313|NCT00606177|64534444|FG001|Overall Study|Protocol Violation|4|||
23216314|NCT00606177|64534443|FG000|Overall Study|Withdrawal by Subject|5|||
23216315|NCT00606177|64534444|FG001|Overall Study|Withdrawal by Subject|6|||
23216316|NCT00606177|64534443|FG000|Overall Study|Progression to depressive phase|6|||
23216317|NCT00606177|64534444|FG001|Overall Study|Progression to depressive phase|1|||
23216318|NCT00606177|64534443|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
23216319|NCT00606177|64534444|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
23216320|NCT00606177|64534443|FG000|Overall Study|Change of residence or other commitments|1|||
23216321|NCT00606177|64534444|FG001|Overall Study|Change of residence or other commitments|1|||
23216322|NCT04397796|64534447|FG000|Overall Study|Death|3|||
23216323|NCT04397796|64534448|FG001|Overall Study|Death|1|||
23216324|NCT01000025|64534449|FG000|Overall Study|Adverse Event|43|||
23216325|NCT01000025|64534450|FG001|Overall Study|Adverse Event|2|||
23216326|NCT01000025|64534449|FG000|Overall Study|Withdrawal by Subject|13|||
23216327|NCT01000025|64534450|FG001|Overall Study|Withdrawal by Subject|8|||
23622142|NCT00236184|66004841|FG000|Overall Study|other|1|||
23622143|NCT00236184|66004842|FG001|Overall Study|other|2|||
23216328|NCT01000025|64534449|FG000|Overall Study|Death|23|||
23216329|NCT01000025|64534450|FG001|Overall Study|Death|13|||
23216330|NCT01000025|64534449|FG000|Overall Study|Lack of Efficacy|363|||
23216331|NCT01000025|64534450|FG001|Overall Study|Lack of Efficacy|208|||
23216332|NCT01000025|64534449|FG000|Overall Study|Intercurrent Illness|26|||
23216333|NCT01000025|64534450|FG001|Overall Study|Intercurrent Illness|7|||
23216334|NCT00064077|64534451|FG000|Overall Study|Improper prior treatment|1|||
23216335|NCT00064077|64534452|FG001|Overall Study|Improper prior treatment|0|||
23432395|NCT02014584|65327610|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23216336|NCT00064077|64534453|FG002|Overall Study|Improper prior treatment|0|||
23216337|NCT00064077|64534454|FG003|Overall Study|Improper prior treatment|0|||
23216338|NCT00064077|64534451|FG000|Overall Study|Poor risk|2|||
23216339|NCT00064077|64534452|FG001|Overall Study|Poor risk|0|||
23216340|NCT00064077|64534453|FG002|Overall Study|Poor risk|1|||
23216341|NCT00064077|64534454|FG003|Overall Study|Poor risk|1|||
23216342|NCT00064077|64534451|FG000|Overall Study|Pathology|10|||
23216343|NCT00064077|64534452|FG001|Overall Study|Pathology|7|||
23216344|NCT00064077|64534453|FG002|Overall Study|Pathology|3|||
23216345|NCT00064077|64534454|FG003|Overall Study|Pathology|4|||
23216346|NCT00064077|64534451|FG000|Overall Study|No surgery|0|||
23216347|NCT00064077|64534452|FG001|Overall Study|No surgery|0|||
23216348|NCT00064077|64534453|FG002|Overall Study|No surgery|1|||
23216349|NCT00064077|64534454|FG003|Overall Study|No surgery|0|||
23216350|NCT00064077|64534451|FG000|Overall Study|No tumor|0|||
23216351|NCT00064077|64534452|FG001|Overall Study|No tumor|0|||
23216352|NCT00064077|64534453|FG002|Overall Study|No tumor|1|||
23216353|NCT00064077|64534454|FG003|Overall Study|No tumor|0|||
23216354|NCT00064077|64534451|FG000|Overall Study|Other reasons|2|||
23216355|NCT00064077|64534452|FG001|Overall Study|Other reasons|2|||
23216356|NCT00064077|64534453|FG002|Overall Study|Other reasons|1|||
23622144|NCT00505414|66004843|FG000|Titration Phase|Adverse Event|0|||
23622145|NCT00505414|66004844|FG001|Titration Phase|Adverse Event|0|||
23622146|NCT00505414|66004845|FG002|Titration Phase|Adverse Event|0|||
23622147|NCT00505414|66004846|FG003|Titration Phase|Adverse Event|8|||
23622148|NCT00505414|66004847|FG004|Titration Phase|Adverse Event|3|||
23622149|NCT00505414|66004843|FG000|Titration Phase|Death|0|||
23622150|NCT00505414|66004844|FG001|Titration Phase|Death|0|||
23622151|NCT00505414|66004845|FG002|Titration Phase|Death|0|||
23622152|NCT00505414|66004846|FG003|Titration Phase|Death|2|||
23622153|NCT00505414|66004847|FG004|Titration Phase|Death|0|||
23622154|NCT00505414|66004843|FG000|Titration Phase|Lack of Efficacy|0|||
23622155|NCT00505414|66004844|FG001|Titration Phase|Lack of Efficacy|0|||
23140601|NCT00600886|64263873|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
23216357|NCT00064077|64534454|FG003|Overall Study|Other reasons|2|||
23622156|NCT00505414|66004845|FG002|Titration Phase|Lack of Efficacy|0|||
23622157|NCT00505414|66004846|FG003|Titration Phase|Lack of Efficacy|10|||
23140602|NCT00600886|64263872|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
23140603|NCT00600886|64263873|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
23140604|NCT00600886|64263872|FG000|Extension - After Crossover (CAS)|Death|1|||
23140605|NCT00600886|64263873|FG001|Extension - After Crossover (CAS)|Death|0|||
23140606|NCT02706899|64263874|FG000|Overall Study|Withdrawal by Subject|1|||
23140607|NCT02706899|64263875|FG001|Overall Study|Withdrawal by Subject|0|||
23140608|NCT02706899|64263874|FG000|Overall Study|Death|8|||
23140609|NCT02706899|64263875|FG001|Overall Study|Death|0|||
23140610|NCT02706899|64263874|FG000|Overall Study|Study Termination by Sponsor|4|||
23140611|NCT02706899|64263875|FG001|Overall Study|Study Termination by Sponsor|6|||
23140612|NCT01942785|64263876|FG000|Overall Study|Adverse Event|2|||
23140613|NCT01942785|64263876|FG000|Overall Study|Withdrawal by Subject|1|||
23140614|NCT01942785|64263876|FG000|Overall Study|Protocol Violation|1|||
23140615|NCT03484273|64263877|FG000|Overall Study|Equipment Malfunction|1|||
23140616|NCT03484273|64263877|FG000|Overall Study|Data excluded from analysis|1|||
23140617|NCT00069108|64263880|FG000|Overall Study|Withdrawal by Subject|5|||
23140618|NCT00069108|64263881|FG001|Overall Study|Withdrawal by Subject|9|||
23140619|NCT00069108|64263880|FG000|Overall Study|Adverse Event|64|||
23140620|NCT00069108|64263881|FG001|Overall Study|Adverse Event|42|||
23140621|NCT00069108|64263880|FG000|Overall Study|Death|6|||
23140622|NCT00069108|64263881|FG001|Overall Study|Death|6|||
23140623|NCT00069108|64263880|FG000|Overall Study|Administration|15|||
23140624|NCT00069108|64263881|FG001|Overall Study|Administration|4|||
23140625|NCT00069108|64263880|FG000|Overall Study|Insufficient therapy|117|||
23140626|NCT00069108|64263881|FG001|Overall Study|Insufficient therapy|144|||
23140627|NCT00069108|64263880|FG000|Overall Study|Violation criteria|1|||
23140628|NCT00069108|64263881|FG001|Overall Study|Violation criteria|4|||
23140629|NCT00069108|64263880|FG000|Overall Study|Refused treatment|5|||
23140630|NCT00069108|64263881|FG001|Overall Study|Refused treatment|10|||
23140631|NCT00190749|64263883|FG000|Overall Study|Lost to Follow-up|8|||
23140632|NCT00190749|64263884|FG001|Overall Study|Lost to Follow-up|11|||
23140633|NCT00190749|64263883|FG000|Overall Study|Withdrawal by Subject|10|||
23140634|NCT00190749|64263884|FG001|Overall Study|Withdrawal by Subject|6|||
23140635|NCT00190749|64263883|FG000|Overall Study|Protocol Violation|5|||
23140636|NCT00190749|64263884|FG001|Overall Study|Protocol Violation|4|||
23140637|NCT00190749|64263883|FG000|Overall Study|Adverse Event|0|||
23216358|NCT00291499|64534455|FG000|Overall Study|Adverse Event|3|||
23140638|NCT00190749|64263884|FG001|Overall Study|Adverse Event|5|||
23140639|NCT00190749|64263883|FG000|Overall Study|Lack of Efficacy|2|||
23140640|NCT00190749|64263884|FG001|Overall Study|Lack of Efficacy|3|||
23140641|NCT00190749|64263883|FG000|Overall Study|Reason Not Specified|0|||
23140642|NCT00190749|64263884|FG001|Overall Study|Reason Not Specified|2|||
23140643|NCT00190749|64263883|FG000|Overall Study|Sponsor Decision|1|||
23216359|NCT00291499|64534456|FG001|Overall Study|Adverse Event|8|||
23216360|NCT00291499|64534455|FG000|Overall Study|Change to other therapy|2|||
23622158|NCT00505414|66004847|FG004|Titration Phase|Lack of Efficacy|1|||
23216361|NCT00291499|64534456|FG001|Overall Study|Change to other therapy|1|||
23622159|NCT00505414|66004843|FG000|Titration Phase|Protocol Violation|0|||
23622160|NCT00505414|66004844|FG001|Titration Phase|Protocol Violation|0|||
23622161|NCT00505414|66004845|FG002|Titration Phase|Protocol Violation|0|||
23622162|NCT00505414|66004846|FG003|Titration Phase|Protocol Violation|0|||
23622163|NCT00505414|66004847|FG004|Titration Phase|Protocol Violation|1|||
23622164|NCT00505414|66004843|FG000|Titration Phase|Withdrawal by Subject|0|||
23140644|NCT00190749|64263884|FG001|Overall Study|Sponsor Decision|0|||
23140645|NCT05718466|64263885|FG000|Overall Study|Withdrawal by Subject|1|||
23140646|NCT05718466|64263886|FG001|Overall Study|Withdrawal by Subject|2|||
23432396|NCT02014584|65327611|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23432397|NCT02014584|65327612|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23432398|NCT02014584|65327613|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23432399|NCT02014584|65327614|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
23432400|NCT02014584|65327615|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
23432401|NCT02648217|65327616|FG000|Overall Study|Adverse Event|0|||
23140647|NCT05718466|64263885|FG000|Overall Study|Death|0|||
23140648|NCT05718466|64263886|FG001|Overall Study|Death|1|||
23140649|NCT00468104|64263887|FG000|First Intervention|Protocol Violation|2|||
23140650|NCT00468104|64263888|FG001|First Intervention|Protocol Violation|1|||
23554737|NCT00541450|65757918|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
23554738|NCT00541450|65757917|FG000|Phase A|Hyperglycemia|0|||
23554739|NCT00541450|65757918|FG001|Phase A|Hyperglycemia|1|||
23554740|NCT00541450|65757917|FG000|Phase A|Lost to Follow-up|6|||
23554741|NCT00541450|65757918|FG001|Phase A|Lost to Follow-up|4|||
23554742|NCT00541450|65757917|FG000|Phase A|Physician Decision|2|||
23554743|NCT00541450|65757918|FG001|Phase A|Physician Decision|0|||
23554744|NCT00541450|65757917|FG000|Phase A|Protocol Violation|2|||
23554745|NCT00541450|65757918|FG001|Phase A|Protocol Violation|3|||
23554746|NCT00541450|65757917|FG000|Phase A|Withdrawal by Subject|7|||
23554747|NCT00541450|65757918|FG001|Phase A|Withdrawal by Subject|7|||
23554748|NCT00541450|65757917|FG000|Phase B|Adverse Event|6|||
23554749|NCT00541450|65757918|FG001|Phase B|Adverse Event|6|||
23140651|NCT00468104|64263887|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
23140652|NCT00468104|64263888|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
23140653|NCT00468104|64263887|FG000|First Intervention|died within 3 weeks|1|||
23140654|NCT00468104|64263888|FG001|First Intervention|died within 3 weeks|0|||
23140655|NCT00468104|64263887|FG000|First Intervention|malposition/blocked chest tube tube|2|||
23140656|NCT00468104|64263888|FG001|First Intervention|malposition/blocked chest tube tube|0|||
23432402|NCT02648217|65327617|FG001|Overall Study|Adverse Event|1|||
23140657|NCT00468104|64263887|FG000|First Intervention|large lung mass with minimal effusion|1|||
23140658|NCT00468104|64263888|FG001|First Intervention|large lung mass with minimal effusion|0|||
23140659|NCT00468104|64263887|FG000|First Intervention|associated prolonged pneumothorax|1|||
23140660|NCT00468104|64263888|FG001|First Intervention|associated prolonged pneumothorax|0|||
23140661|NCT00468104|64263887|FG000|First Intervention|trapped lung|1|||
23140662|NCT00468104|64263888|FG001|First Intervention|trapped lung|0|||
23140663|NCT00468104|64263887|FG000|Second Intervention|Withdrawal by Subject|5|||
23140664|NCT00468104|64263888|FG001|Second Intervention|Withdrawal by Subject|2|||
23140665|NCT00468104|64263887|FG000|Second Intervention|discarded for malposition of chest tube|0|||
23140666|NCT00468104|64263888|FG001|Second Intervention|discarded for malposition of chest tube|2|||
23140667|NCT00467285|64263893|FG000|Overall Study|Lost to Follow-up|4|||
23140668|NCT00467285|64263894|FG001|Overall Study|Lost to Follow-up|4|||
23140669|NCT02128542|64263899|FG000|Overall Study|Lost to Follow-up|3|||
23140670|NCT02128542|64263900|FG001|Overall Study|Lost to Follow-up|0|||
23140671|NCT02128542|64263899|FG000|Overall Study|Withdrew Consent|1|||
23140672|NCT02128542|64263900|FG001|Overall Study|Withdrew Consent|0|||
23140673|NCT00790751|64263901|FG000|Overall Study|Protocol non-compliance|16|||
23140674|NCT00790751|64263902|FG001|Overall Study|Protocol non-compliance|16|||
23140675|NCT00790751|64263903|FG002|Overall Study|Protocol non-compliance|10|||
23140676|NCT00790751|64263904|FG003|Overall Study|Protocol non-compliance|11|||
23140677|NCT00790751|64263901|FG000|Overall Study|Lost to Follow-up|4|||
23140678|NCT00790751|64263902|FG001|Overall Study|Lost to Follow-up|9|||
23432403|NCT02648217|65327616|FG000|Overall Study|Lost to Follow-up|1|||
23622165|NCT00505414|66004844|FG001|Titration Phase|Withdrawal by Subject|0|||
23622166|NCT00505414|66004845|FG002|Titration Phase|Withdrawal by Subject|0|||
23622167|NCT00505414|66004846|FG003|Titration Phase|Withdrawal by Subject|3|||
23140679|NCT00790751|64263903|FG002|Overall Study|Lost to Follow-up|4|||
23140680|NCT00790751|64263904|FG003|Overall Study|Lost to Follow-up|5|||
23140681|NCT00790751|64263901|FG000|Overall Study|Adverse Event|5|||
23140682|NCT00790751|64263902|FG001|Overall Study|Adverse Event|3|||
23140683|NCT00790751|64263903|FG002|Overall Study|Adverse Event|5|||
23140684|NCT00790751|64263904|FG003|Overall Study|Adverse Event|4|||
23432404|NCT02648217|65327617|FG001|Overall Study|Lost to Follow-up|1|||
23554750|NCT00541450|65757917|FG000|Phase B|Hyperglycemia|10|||
23554751|NCT00541450|65757918|FG001|Phase B|Hyperglycemia|9|||
23554752|NCT00541450|65757917|FG000|Phase B|Lost to Follow-up|6|||
23554753|NCT00541450|65757918|FG001|Phase B|Lost to Follow-up|4|||
23216362|NCT00291499|64534455|FG000|Overall Study|Intercurrent illness|1|||
23216363|NCT00291499|64534456|FG001|Overall Study|Intercurrent illness|0|||
23216364|NCT00291499|64534455|FG000|Overall Study|Protocol Violation|2|||
23216365|NCT00291499|64534456|FG001|Overall Study|Protocol Violation|2|||
23216366|NCT00291499|64534455|FG000|Overall Study|Other reasons|1|||
23216367|NCT00291499|64534456|FG001|Overall Study|Other reasons|4|||
23216368|NCT00696436|64534459|FG000|Overall Study|Adverse Event|7|||
23216369|NCT00696436|64534460|FG001|Overall Study|Adverse Event|9|||
23216370|NCT00696436|64534461|FG002|Overall Study|Adverse Event|8|||
23216371|NCT00696436|64534462|FG003|Overall Study|Adverse Event|6|||
23216372|NCT00696436|64534463|FG004|Overall Study|Adverse Event|4|||
23216373|NCT00696436|64534459|FG000|Overall Study|Protocol Violation|3|||
23216374|NCT00696436|64534460|FG001|Overall Study|Protocol Violation|2|||
23216375|NCT00696436|64534461|FG002|Overall Study|Protocol Violation|2|||
23140685|NCT00790751|64263901|FG000|Overall Study|Requirement for restricted medication|0|||
23140686|NCT00790751|64263902|FG001|Overall Study|Requirement for restricted medication|2|||
23140687|NCT00790751|64263903|FG002|Overall Study|Requirement for restricted medication|0|||
23140688|NCT00790751|64263904|FG003|Overall Study|Requirement for restricted medication|0|||
23140689|NCT00790751|64263901|FG000|Overall Study|Death|0|||
23140690|NCT00790751|64263902|FG001|Overall Study|Death|0|||
23140691|NCT00790751|64263903|FG002|Overall Study|Death|1|||
23140692|NCT00790751|64263904|FG003|Overall Study|Death|0|||
23140693|NCT00790751|64263901|FG000|Overall Study|Physician Decision|0|||
23140694|NCT00790751|64263902|FG001|Overall Study|Physician Decision|0|||
23140695|NCT00790751|64263903|FG002|Overall Study|Physician Decision|0|||
23140696|NCT00790751|64263904|FG003|Overall Study|Physician Decision|1|||
23140697|NCT02545933|64263905|FG000|Overall Study|Adverse Event|3|||
23140698|NCT02545933|64263906|FG001|Overall Study|Adverse Event|0|||
23140699|NCT02545933|64263907|FG002|Overall Study|Adverse Event|0|||
23140700|NCT02545933|64263905|FG000|Overall Study|Withdrawal by Subject|2|||
23140701|NCT02545933|64263906|FG001|Overall Study|Withdrawal by Subject|3|||
23140702|NCT02545933|64263907|FG002|Overall Study|Withdrawal by Subject|3|||
23140703|NCT02545933|64263905|FG000|Overall Study|Protocol Violation|1|||
23140704|NCT02545933|64263906|FG001|Overall Study|Protocol Violation|0|||
23140705|NCT02545933|64263907|FG002|Overall Study|Protocol Violation|1|||
23140706|NCT00768079|64267538|FG000|Overall Study|Lost to Follow-up|2|||
23140707|NCT00768079|64267539|FG001|Overall Study|Lost to Follow-up|0|||
23140708|NCT00768079|64267540|FG002|Overall Study|Lost to Follow-up|4|||
23140709|NCT00768079|64267538|FG000|Overall Study|Participant incarcerated|0|||
23140710|NCT00768079|64267539|FG001|Overall Study|Participant incarcerated|1|||
23140711|NCT00768079|64267540|FG002|Overall Study|Participant incarcerated|0|||
23140712|NCT02257567|64267548|FG000|Overall Study|Adverse Event|0|||
23140713|NCT02257567|64267549|FG001|Overall Study|Adverse Event|0|||
23140714|NCT02257567|64267550|FG002|Overall Study|Adverse Event|0|||
23140715|NCT02257567|64267551|FG003|Overall Study|Adverse Event|1|||
23140716|NCT02257567|64267552|FG004|Overall Study|Adverse Event|1|||
23140717|NCT02257567|64267553|FG005|Overall Study|Adverse Event|0|||
23140718|NCT02257567|64267554|FG006|Overall Study|Adverse Event|0|||
23140719|NCT02257567|64267555|FG007|Overall Study|Adverse Event|0|||
23140720|NCT02257567|64267556|FG008|Overall Study|Adverse Event|1|||
23140721|NCT02257567|64267557|FG009|Overall Study|Adverse Event|0|||
23140722|NCT02257567|64267558|FG010|Overall Study|Adverse Event|0|||
23140723|NCT02257567|64267548|FG000|Overall Study|Death|2|||
23140724|NCT02257567|64267549|FG001|Overall Study|Death|2|||
23140725|NCT02257567|64267550|FG002|Overall Study|Death|2|||
23140726|NCT02257567|64267551|FG003|Overall Study|Death|4|||
23140727|NCT02257567|64267552|FG004|Overall Study|Death|15|||
23140728|NCT02257567|64267553|FG005|Overall Study|Death|11|||
23140729|NCT02257567|64267554|FG006|Overall Study|Death|26|||
23140730|NCT02257567|64267555|FG007|Overall Study|Death|30|||
23140731|NCT02257567|64267556|FG008|Overall Study|Death|2|||
23140732|NCT02257567|64267557|FG009|Overall Study|Death|18|||
23140733|NCT02257567|64267558|FG010|Overall Study|Death|65|||
23140734|NCT02257567|64267548|FG000|Overall Study|Lost to Follow-up|0|||
23140735|NCT02257567|64267549|FG001|Overall Study|Lost to Follow-up|0|||
23140736|NCT02257567|64267550|FG002|Overall Study|Lost to Follow-up|0|||
23140737|NCT02257567|64267551|FG003|Overall Study|Lost to Follow-up|0|||
23140738|NCT02257567|64267552|FG004|Overall Study|Lost to Follow-up|2|||
23140739|NCT02257567|64267553|FG005|Overall Study|Lost to Follow-up|2|||
23216376|NCT00696436|64534462|FG003|Overall Study|Protocol Violation|0|||
23216377|NCT00696436|64534463|FG004|Overall Study|Protocol Violation|1|||
23140740|NCT02257567|64267554|FG006|Overall Study|Lost to Follow-up|0|||
23140741|NCT02257567|64267555|FG007|Overall Study|Lost to Follow-up|0|||
23140742|NCT02257567|64267556|FG008|Overall Study|Lost to Follow-up|0|||
23140743|NCT02257567|64267557|FG009|Overall Study|Lost to Follow-up|1|||
23140744|NCT02257567|64267558|FG010|Overall Study|Lost to Follow-up|1|||
23140745|NCT02257567|64267548|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23140746|NCT02257567|64267549|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23175844|NCT01554579|64386589|FG001|Overall Study|Withdrawal by Subject|1|||
23216378|NCT00696436|64534459|FG000|Overall Study|Lost to Follow-up|1|||
23216379|NCT00696436|64534460|FG001|Overall Study|Lost to Follow-up|6|||
23216380|NCT00696436|64534461|FG002|Overall Study|Lost to Follow-up|2|||
23216381|NCT00696436|64534462|FG003|Overall Study|Lost to Follow-up|4|||
23216382|NCT00696436|64534463|FG004|Overall Study|Lost to Follow-up|3|||
23216383|NCT00696436|64534459|FG000|Overall Study|Withdrawal by Subject|4|||
23216384|NCT00696436|64534460|FG001|Overall Study|Withdrawal by Subject|11|||
23216385|NCT00696436|64534461|FG002|Overall Study|Withdrawal by Subject|5|||
23216386|NCT00696436|64534462|FG003|Overall Study|Withdrawal by Subject|7|||
23216387|NCT00696436|64534463|FG004|Overall Study|Withdrawal by Subject|1|||
23216388|NCT00696436|64534459|FG000|Overall Study|Lack of Efficacy|3|||
23432405|NCT02648217|65327616|FG000|Overall Study|Withdrawal by Subject|4|||
23432406|NCT02648217|65327617|FG001|Overall Study|Withdrawal by Subject|3|||
23432407|NCT02648217|65327616|FG000|Overall Study|Unclassified|5|||
23140747|NCT02257567|64267550|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23140748|NCT02257567|64267551|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23140749|NCT02257567|64267552|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
23140750|NCT02257567|64267553|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23140751|NCT02257567|64267554|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
23140752|NCT02257567|64267555|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23140753|NCT02257567|64267556|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23140754|NCT02257567|64267557|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23140755|NCT02257567|64267558|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
23140756|NCT02257567|64267548|FG000|Overall Study|Physician Decision|0|||
23140757|NCT02257567|64267549|FG001|Overall Study|Physician Decision|0|||
23140758|NCT02257567|64267550|FG002|Overall Study|Physician Decision|0|||
23140759|NCT02257567|64267551|FG003|Overall Study|Physician Decision|0|||
23140760|NCT02257567|64267552|FG004|Overall Study|Physician Decision|0|||
23140761|NCT02257567|64267553|FG005|Overall Study|Physician Decision|0|||
23140762|NCT02257567|64267554|FG006|Overall Study|Physician Decision|0|||
23140763|NCT02257567|64267555|FG007|Overall Study|Physician Decision|2|||
23140764|NCT02257567|64267556|FG008|Overall Study|Physician Decision|0|||
23140765|NCT02257567|64267557|FG009|Overall Study|Physician Decision|1|||
23140766|NCT02257567|64267558|FG010|Overall Study|Physician Decision|0|||
23140767|NCT02257567|64267548|FG000|Overall Study|Withdrawal by Subject|0|||
23140768|NCT02257567|64267549|FG001|Overall Study|Withdrawal by Subject|0|||
23140769|NCT02257567|64267550|FG002|Overall Study|Withdrawal by Subject|2|||
23140770|NCT02257567|64267551|FG003|Overall Study|Withdrawal by Subject|0|||
23140771|NCT02257567|64267552|FG004|Overall Study|Withdrawal by Subject|0|||
23140772|NCT02257567|64267553|FG005|Overall Study|Withdrawal by Subject|6|||
23140773|NCT02257567|64267554|FG006|Overall Study|Withdrawal by Subject|6|||
23140774|NCT02257567|64267555|FG007|Overall Study|Withdrawal by Subject|6|||
23140775|NCT02257567|64267556|FG008|Overall Study|Withdrawal by Subject|1|||
23140776|NCT02257567|64267557|FG009|Overall Study|Withdrawal by Subject|1|||
23140777|NCT02257567|64267558|FG010|Overall Study|Withdrawal by Subject|10|||
23140778|NCT03607422|64267559|FG000|Overall Study|Adverse Event|7|||
23216389|NCT00696436|64534460|FG001|Overall Study|Lack of Efficacy|1|||
23216390|NCT00696436|64534461|FG002|Overall Study|Lack of Efficacy|5|||
23216391|NCT00696436|64534462|FG003|Overall Study|Lack of Efficacy|2|||
23216392|NCT00696436|64534463|FG004|Overall Study|Lack of Efficacy|4|||
23216393|NCT00696436|64534459|FG000|Overall Study|Participant Unavailability|2|||
23216394|NCT00696436|64534460|FG001|Overall Study|Participant Unavailability|0|||
23216395|NCT00696436|64534461|FG002|Overall Study|Participant Unavailability|2|||
23216396|NCT00696436|64534462|FG003|Overall Study|Participant Unavailability|1|||
23216397|NCT00696436|64534463|FG004|Overall Study|Participant Unavailability|0|||
23216398|NCT00696436|64534459|FG000|Overall Study|Administrative Error|2|||
23216399|NCT00696436|64534460|FG001|Overall Study|Administrative Error|0|||
23216400|NCT00696436|64534461|FG002|Overall Study|Administrative Error|2|||
23216401|NCT00696436|64534462|FG003|Overall Study|Administrative Error|0|||
23432408|NCT02648217|65327617|FG001|Overall Study|Unclassified|0|||
23216402|NCT00696436|64534463|FG004|Overall Study|Administrative Error|0|||
23216403|NCT00696436|64534459|FG000|Overall Study|Participant Non-compliance|0|||
23216404|NCT00696436|64534460|FG001|Overall Study|Participant Non-compliance|0|||
23216405|NCT00696436|64534461|FG002|Overall Study|Participant Non-compliance|1|||
23216406|NCT00696436|64534462|FG003|Overall Study|Participant Non-compliance|2|||
23216407|NCT00696436|64534463|FG004|Overall Study|Participant Non-compliance|0|||
23432409|NCT02345330|65327618|FG000|Overall Study|Death|1|||
23140779|NCT03607422|64267560|FG001|Overall Study|Adverse Event|3|||
23216408|NCT00696436|64534459|FG000|Overall Study|Administrative Decision|1|||
23432410|NCT02345330|65327618|FG000|Overall Study|Progressive Disease|2|||
23140780|NCT03607422|64267561|FG002|Overall Study|Adverse Event|2|||
23140781|NCT03607422|64267562|FG003|Overall Study|Adverse Event|0|||
23140782|NCT03607422|64267563|FG004|Overall Study|Adverse Event|2|||
23140783|NCT03607422|64267564|FG005|Overall Study|Adverse Event|0|||
23140784|NCT03607422|64267559|FG000|Overall Study|Withdrawal by Subject|11|||
23140785|NCT03607422|64267560|FG001|Overall Study|Withdrawal by Subject|3|||
23140786|NCT03607422|64267561|FG002|Overall Study|Withdrawal by Subject|6|||
23554754|NCT00541450|65757917|FG000|Phase B|Physician Decision|4|||
23318054|NCT01098474|64908231|FG001|Follow Up Phase|Withdrawal by Subject|0|||
23318055|NCT01098474|64908232|FG002|Follow Up Phase|Withdrawal by Subject|0|||
23554755|NCT00541450|65757918|FG001|Phase B|Physician Decision|2|||
23554756|NCT00541450|65757917|FG000|Phase B|Pregnancy|0|||
23554757|NCT00541450|65757918|FG001|Phase B|Pregnancy|1|||
23140787|NCT03607422|64267562|FG003|Overall Study|Withdrawal by Subject|2|||
23554758|NCT00541450|65757917|FG000|Phase B|Protocol Violation|3|||
23554759|NCT00541450|65757918|FG001|Phase B|Protocol Violation|3|||
23554760|NCT00541450|65757917|FG000|Phase B|Withdrawal by Subject|8|||
23554761|NCT00541450|65757918|FG001|Phase B|Withdrawal by Subject|6|||
23554762|NCT03266770|65757928|FG000|Overall Study|Physician Decision|3|||
23554763|NCT03266770|65757928|FG000|Overall Study|Insufficient study supplies|1|||
23554764|NCT03266770|65757928|FG000|Overall Study|Adverse Event|1|||
23554765|NCT01274182|65757929|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
23318056|NCT01098474|64908233|FG003|Follow Up Phase|Withdrawal by Subject|2|||
23318057|NCT01098474|64908234|FG004|Follow Up Phase|Withdrawal by Subject|0|||
23318058|NCT01098474|64908235|FG005|Follow Up Phase|Withdrawal by Subject|1|||
23318059|NCT01098474|64908230|FG000|Follow Up Phase|Lost to Follow-up|0|||
23318060|NCT01098474|64908231|FG001|Follow Up Phase|Lost to Follow-up|0|||
23318061|NCT01098474|64908232|FG002|Follow Up Phase|Lost to Follow-up|0|||
23318062|NCT01098474|64908233|FG003|Follow Up Phase|Lost to Follow-up|0|||
23318063|NCT01098474|64908234|FG004|Follow Up Phase|Lost to Follow-up|1|||
23318064|NCT01098474|64908235|FG005|Follow Up Phase|Lost to Follow-up|0|||
23318065|NCT03447743|64908236|FG000|Overall Study|Withdrawal by Subject|2|||
23318066|NCT03447743|64908236|FG000|Overall Study|Lost to Follow-up|3|||
23318067|NCT03447743|64908236|FG000|Overall Study|Adverse Event|1|||
23318068|NCT03447743|64908236|FG000|Overall Study|Did not meet criteria to continue|1|||
23318069|NCT00306995|64908237|FG000|Study Part I|Withdrawal by Subject|0|||
23318070|NCT00306995|64908238|FG001|Study Part I|Withdrawal by Subject|0|||
23318071|NCT00306995|64908239|FG002|Study Part I|Withdrawal by Subject|0|||
23318072|NCT00306995|64908240|FG003|Study Part I|Withdrawal by Subject|0|||
23318073|NCT00306995|64908241|FG004|Study Part I|Withdrawal by Subject|0|||
23318074|NCT00306995|64908242|FG005|Study Part I|Withdrawal by Subject|0|||
23318075|NCT00306995|64908243|FG006|Study Part I|Withdrawal by Subject|1|||
23318076|NCT00306995|64908237|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
23318077|NCT00306995|64908238|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
23318078|NCT00306995|64908239|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
23318079|NCT00306995|64908240|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
23318080|NCT00306995|64908241|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
23318081|NCT00306995|64908242|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
23318082|NCT00306995|64908243|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
23318083|NCT01420965|64908248|FG000|Overall Study|Withdrawal by Subject|1|||
23318084|NCT01420965|64908249|FG001|Overall Study|Withdrawal by Subject|0|||
23318085|NCT01420965|64908250|FG002|Overall Study|Withdrawal by Subject|0|||
23318086|NCT01420965|64908248|FG000|Overall Study|Adverse Event|0|||
23318087|NCT01420965|64908249|FG001|Overall Study|Adverse Event|1|||
23554766|NCT01274182|65757930|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23140788|NCT03607422|64267563|FG004|Overall Study|Withdrawal by Subject|0|||
23140789|NCT03607422|64267564|FG005|Overall Study|Withdrawal by Subject|0|||
23140790|NCT03607422|64267559|FG000|Overall Study|Lost to Follow-up|0|||
23140791|NCT03607422|64267560|FG001|Overall Study|Lost to Follow-up|0|||
23216409|NCT00696436|64534460|FG001|Overall Study|Administrative Decision|0|||
23216410|NCT00696436|64534461|FG002|Overall Study|Administrative Decision|0|||
23216411|NCT00696436|64534462|FG003|Overall Study|Administrative Decision|0|||
23216412|NCT00696436|64534463|FG004|Overall Study|Administrative Decision|0|||
23216413|NCT00696436|64534459|FG000|Overall Study|Missing|0|||
23216414|NCT00696436|64534460|FG001|Overall Study|Missing|1|||
23216415|NCT00696436|64534461|FG002|Overall Study|Missing|1|||
23216416|NCT00696436|64534462|FG003|Overall Study|Missing|0|||
23216417|NCT00696436|64534463|FG004|Overall Study|Missing|0|||
23318088|NCT01420965|64908250|FG002|Overall Study|Adverse Event|0|||
23554767|NCT01274182|65757931|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
23554768|NCT01274182|65757929|FG000|Overall Study|Adverse Event|4|||
23554769|NCT01274182|65757930|FG001|Overall Study|Adverse Event|5|||
23554770|NCT01274182|65757931|FG002|Overall Study|Adverse Event|3|||
23140792|NCT03607422|64267561|FG002|Overall Study|Lost to Follow-up|1|||
23554771|NCT01274182|65757929|FG000|Overall Study|Withdrawal by Subject|5|||
23140793|NCT03607422|64267562|FG003|Overall Study|Lost to Follow-up|0|||
23140794|NCT03607422|64267563|FG004|Overall Study|Lost to Follow-up|0|||
23216418|NCT03276572|64534464|FG000|Overall Study|In follow-up|0|||
23140795|NCT03607422|64267564|FG005|Overall Study|Lost to Follow-up|0|||
23140796|NCT03607422|64267559|FG000|Overall Study|Other|12|||
23140797|NCT03607422|64267560|FG001|Overall Study|Other|4|||
23140798|NCT03607422|64267561|FG002|Overall Study|Other|1|||
23140799|NCT03607422|64267562|FG003|Overall Study|Other|2|||
23140800|NCT03607422|64267563|FG004|Overall Study|Other|0|||
23140801|NCT03607422|64267564|FG005|Overall Study|Other|2|||
23140802|NCT03607422|64267559|FG000|Overall Study|Ongoing at Time of Analysis|8|||
23140803|NCT03607422|64267560|FG001|Overall Study|Ongoing at Time of Analysis|0|||
23140804|NCT03607422|64267561|FG002|Overall Study|Ongoing at Time of Analysis|2|||
23140805|NCT03607422|64267562|FG003|Overall Study|Ongoing at Time of Analysis|1|||
23140806|NCT03607422|64267563|FG004|Overall Study|Ongoing at Time of Analysis|1|||
23140807|NCT03607422|64267564|FG005|Overall Study|Ongoing at Time of Analysis|1|||
23140808|NCT03170349|64267565|FG000|At 30 Days Follow-up|Death|1|||
23140809|NCT03170349|64267565|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
23140810|NCT03170349|64267565|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
23140811|NCT03170349|64267565|FG000|At 6 Months Follow-up|Death|3|||
23140812|NCT03170349|64267565|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
23140813|NCT03170349|64267565|FG000|At 1 Year Follow-up|Death|6|||
23140814|NCT03170349|64267565|FG000|At 2 Year Follow-up|Missed Visit|4|||
23140815|NCT03170349|64267565|FG000|At 2 Year Follow-up|Death|13|||
23140816|NCT03170349|64267565|FG000|At 2 Year Follow-up|Withdrawal by Subject|1|||
23140817|NCT01210118|64267566|FG000|Overall Study|Lost to Follow-up|1|||
23140818|NCT01210118|64267567|FG001|Overall Study|Lost to Follow-up|1|||
23140819|NCT01210118|64267566|FG000|Overall Study|Protocol Violation|1|||
23140820|NCT01210118|64267567|FG001|Overall Study|Protocol Violation|1|||
23140821|NCT01210118|64267566|FG000|Overall Study|Spontaneous abortion|1|||
23140822|NCT01210118|64267567|FG001|Overall Study|Spontaneous abortion|3|||
23140823|NCT02319759|64267570|FG000|Week 0 - 16|Lack of Efficacy|1|||
23140824|NCT02319759|64267571|FG001|Week 0 - 16|Lack of Efficacy|0|||
23140825|NCT02319759|64267572|FG002|Week 0 - 16|Lack of Efficacy|0|||
23140826|NCT02319759|64267573|FG003|Week 0 - 16|Lack of Efficacy|0|||
23140827|NCT02319759|64267574|FG004|Week 0 - 16|Lack of Efficacy|0|||
23140828|NCT02319759|64267570|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
23140829|NCT02319759|64267571|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
23140830|NCT02319759|64267572|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
23140831|NCT02319759|64267573|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
23140832|NCT02319759|64267574|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
23140833|NCT02319759|64267570|FG000|Week 16 - 24|Lack of Efficacy|1|||
23140834|NCT02319759|64267571|FG001|Week 16 - 24|Lack of Efficacy|0|||
23140835|NCT02319759|64267572|FG002|Week 16 - 24|Lack of Efficacy|1|||
23140836|NCT02319759|64267573|FG003|Week 16 - 24|Lack of Efficacy|0|||
23140837|NCT02319759|64267574|FG004|Week 16 - 24|Lack of Efficacy|0|||
23140838|NCT02319759|64267570|FG000|Week 16 - 24|Lost to Follow-up|1|||
23140839|NCT02319759|64267571|FG001|Week 16 - 24|Lost to Follow-up|0|||
23140840|NCT02319759|64267572|FG002|Week 16 - 24|Lost to Follow-up|0|||
23140841|NCT02319759|64267573|FG003|Week 16 - 24|Lost to Follow-up|0|||
23140842|NCT02319759|64267574|FG004|Week 16 - 24|Lost to Follow-up|0|||
23140843|NCT02319759|64267570|FG000|Week 16 - 24|Withdrawal by Subject|0|||
23140844|NCT02319759|64267571|FG001|Week 16 - 24|Withdrawal by Subject|0|||
23140845|NCT02319759|64267572|FG002|Week 16 - 24|Withdrawal by Subject|2|||
23140846|NCT02319759|64267573|FG003|Week 16 - 24|Withdrawal by Subject|0|||
23140847|NCT02319759|64267574|FG004|Week 16 - 24|Withdrawal by Subject|0|||
23140848|NCT02319759|64267570|FG000|Week 24 - 56|Adverse Event|0|||
23140849|NCT02319759|64267571|FG001|Week 24 - 56|Adverse Event|0|||
23140850|NCT02319759|64267572|FG002|Week 24 - 56|Adverse Event|2|||
23140851|NCT02319759|64267573|FG003|Week 24 - 56|Adverse Event|0|||
23140852|NCT02319759|64267574|FG004|Week 24 - 56|Adverse Event|0|||
23140853|NCT02319759|64267570|FG000|Week 24 - 56|Lack of Efficacy|0|||
23140854|NCT02319759|64267571|FG001|Week 24 - 56|Lack of Efficacy|0|||
23140855|NCT02319759|64267572|FG002|Week 24 - 56|Lack of Efficacy|0|||
23140856|NCT02319759|64267573|FG003|Week 24 - 56|Lack of Efficacy|2|||
23140857|NCT02319759|64267574|FG004|Week 24 - 56|Lack of Efficacy|1|||
23140858|NCT02319759|64267570|FG000|Week 24 - 56|Withdrawal by Subject|0|||
23140859|NCT02319759|64267571|FG001|Week 24 - 56|Withdrawal by Subject|1|||
23140860|NCT02319759|64267572|FG002|Week 24 - 56|Withdrawal by Subject|0|||
23140861|NCT02319759|64267573|FG003|Week 24 - 56|Withdrawal by Subject|0|||
23140862|NCT02319759|64267574|FG004|Week 24 - 56|Withdrawal by Subject|0|||
23140863|NCT02319759|64267570|FG000|Week 24 - 56|Lost to Follow-up|0|||
23140864|NCT02319759|64267571|FG001|Week 24 - 56|Lost to Follow-up|0|||
23140865|NCT02319759|64267572|FG002|Week 24 - 56|Lost to Follow-up|0|||
23140866|NCT02319759|64267573|FG003|Week 24 - 56|Lost to Follow-up|0|||
23140867|NCT02319759|64267574|FG004|Week 24 - 56|Lost to Follow-up|1|||
23140868|NCT02962960|64267577|FG000|Overall Study|Withdrawal by Subject|1|||
23140869|NCT02962960|64267578|FG001|Overall Study|Withdrawal by Subject|1|||
23140870|NCT02962960|64267579|FG002|Overall Study|Withdrawal by Subject|0|||
23140871|NCT02962960|64267577|FG000|Overall Study|Adverse Event|1|||
23140872|NCT02962960|64267578|FG001|Overall Study|Adverse Event|1|||
23140873|NCT02962960|64267579|FG002|Overall Study|Adverse Event|0|||
23140874|NCT02962960|64267577|FG000|Overall Study|Protocol Violation|1|||
23140875|NCT02962960|64267578|FG001|Overall Study|Protocol Violation|0|||
23140876|NCT02962960|64267579|FG002|Overall Study|Protocol Violation|0|||
23140877|NCT01237587|64267586|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
23140878|NCT01237587|64267587|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
23140879|NCT01237587|64267586|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
23140880|NCT01237587|64267587|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
23140881|NCT01237587|64267586|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
23140882|NCT01237587|64267587|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
23140883|NCT01237587|64267586|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
23140884|NCT01237587|64267587|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
23140885|NCT01237587|64267586|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
23140886|NCT01237587|64267587|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
23140887|NCT01237587|64267586|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
23140888|NCT01237587|64267587|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
23140889|NCT01237587|64267586|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
23140890|NCT01237587|64267587|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
23140891|NCT01237587|64267586|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
23140892|NCT01237587|64267587|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
23140893|NCT01237587|64267586|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
23140894|NCT01237587|64267587|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
23140895|NCT01237587|64267586|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
23140896|NCT01237587|64267587|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
23140897|NCT01237587|64267586|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
23140898|NCT01237587|64267587|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
23216419|NCT03276572|64534465|FG001|Overall Study|In follow-up|0|||
23318089|NCT02729909|64908251|FG000|Overall Study|Lost to Follow-up|0|||
23318090|NCT02729909|64908252|FG001|Overall Study|Lost to Follow-up|1|||
23318091|NCT02729909|64908251|FG000|Overall Study|Lack of Efficacy|0|||
23318092|NCT02729909|64908252|FG001|Overall Study|Lack of Efficacy|2|||
23318093|NCT02729909|64908251|FG000|Overall Study|Significant Protocol Deviation|0|||
23318094|NCT02729909|64908252|FG001|Overall Study|Significant Protocol Deviation|2|||
23318095|NCT02729909|64908251|FG000|Overall Study|Voluntary Withdrawal|1|||
23318096|NCT02729909|64908252|FG001|Overall Study|Voluntary Withdrawal|0|||
23318097|NCT01699815|64908255|FG000|Overall Study|Protocol Violation|4|||
23432411|NCT00734071|65327619|FG000|Overall Study|Adverse Event|4|||
23432412|NCT00734071|65327620|FG001|Overall Study|Adverse Event|3|||
23432413|NCT00734071|65327619|FG000|Overall Study|Lack of Efficacy|3|||
23432414|NCT00734071|65327620|FG001|Overall Study|Lack of Efficacy|1|||
23432415|NCT00734071|65327619|FG000|Overall Study|Noncompliance|2|||
23432416|NCT00734071|65327620|FG001|Overall Study|Noncompliance|2|||
23432417|NCT00734071|65327619|FG000|Overall Study|Protocol Deviations|3|||
23432418|NCT00734071|65327620|FG001|Overall Study|Protocol Deviations|4|||
23432419|NCT00734071|65327619|FG000|Overall Study|Voluntary Withdrawal|9|||
23432420|NCT00734071|65327620|FG001|Overall Study|Voluntary Withdrawal|7|||
23432421|NCT00734071|65327619|FG000|Overall Study|Lost to Follow-up|16|||
23432422|NCT00734071|65327620|FG001|Overall Study|Lost to Follow-up|8|||
23432423|NCT00734071|65327619|FG000|Overall Study|Other|1|||
23432424|NCT00734071|65327620|FG001|Overall Study|Other|2|||
23432425|NCT01291277|65327621|FG000|Overall Study|Death|2|||
23432426|NCT01291277|65327622|FG001|Overall Study|Death|2|||
23432427|NCT01291277|65327621|FG000|Overall Study|Lost to Follow-up|3|||
23554772|NCT01274182|65757930|FG001|Overall Study|Withdrawal by Subject|5|||
23554773|NCT01274182|65757931|FG002|Overall Study|Withdrawal by Subject|3|||
23554774|NCT01274182|65757929|FG000|Overall Study|Lost to Follow-up|2|||
23554775|NCT01274182|65757930|FG001|Overall Study|Lost to Follow-up|3|||
23554776|NCT01274182|65757931|FG002|Overall Study|Lost to Follow-up|1|||
23554777|NCT01274182|65757929|FG000|Overall Study|Protocol Violation|3|||
23554778|NCT01274182|65757930|FG001|Overall Study|Protocol Violation|2|||
23554779|NCT01274182|65757931|FG002|Overall Study|Protocol Violation|0|||
23554780|NCT01274182|65757929|FG000|Overall Study|Death|1|||
23554781|NCT01274182|65757930|FG001|Overall Study|Death|0|||
23554782|NCT01274182|65757931|FG002|Overall Study|Death|1|||
23554783|NCT00377403|65757932|FG000|Overall Study|Unable to contact for telephone intervie|4|||
23554784|NCT00377403|65757933|FG001|Overall Study|Unable to contact for telephone intervie|7|||
23554785|NCT00803452|65757935|FG000|Overall Study|Adverse Event|0|||
23140899|NCT01237587|64267586|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
23140900|NCT01237587|64267587|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
23140901|NCT01237587|64267586|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
23140902|NCT01237587|64267587|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
23140903|NCT01237587|64267586|FG000|Taper Phase|Adverse Event|0|||
23140904|NCT01237587|64267587|FG001|Taper Phase|Adverse Event|2|||
23140905|NCT01237587|64267586|FG000|Taper Phase|Protocol Violation|2|||
23432428|NCT01291277|65327622|FG001|Overall Study|Lost to Follow-up|1|||
23622168|NCT00505414|66004847|FG004|Titration Phase|Withdrawal by Subject|4|||
23622169|NCT00505414|66004843|FG000|Titration Phase|Underlying disease and therapy required|0|||
23622170|NCT00505414|66004844|FG001|Titration Phase|Underlying disease and therapy required|0|||
23622171|NCT00505414|66004845|FG002|Titration Phase|Underlying disease and therapy required|0|||
23622172|NCT00505414|66004846|FG003|Titration Phase|Underlying disease and therapy required|7|||
23622173|NCT00505414|66004847|FG004|Titration Phase|Underlying disease and therapy required|3|||
23622174|NCT00505414|66004843|FG000|Maintenance Phase|Adverse Event|2|||
23622175|NCT00505414|66004844|FG001|Maintenance Phase|Adverse Event|2|||
23622176|NCT00505414|66004845|FG002|Maintenance Phase|Adverse Event|3|||
23622177|NCT00505414|66004846|FG003|Maintenance Phase|Adverse Event|0|||
23622178|NCT00505414|66004847|FG004|Maintenance Phase|Adverse Event|0|||
23622179|NCT00505414|66004843|FG000|Maintenance Phase|Death|2|||
23622180|NCT00505414|66004844|FG001|Maintenance Phase|Death|0|||
23622181|NCT00505414|66004845|FG002|Maintenance Phase|Death|1|||
23622182|NCT00505414|66004846|FG003|Maintenance Phase|Death|0|||
23140906|NCT01237587|64267587|FG001|Taper Phase|Protocol Violation|0|||
23140907|NCT01237587|64267586|FG000|Taper Phase|Lack of Efficacy|2|||
23140908|NCT01237587|64267587|FG001|Taper Phase|Lack of Efficacy|5|||
23622183|NCT00505414|66004847|FG004|Maintenance Phase|Death|0|||
23622184|NCT00505414|66004843|FG000|Maintenance Phase|Lack of Efficacy|2|||
23622185|NCT00505414|66004844|FG001|Maintenance Phase|Lack of Efficacy|1|||
23622186|NCT00505414|66004845|FG002|Maintenance Phase|Lack of Efficacy|1|||
23140909|NCT01237587|64267586|FG000|Taper Phase|Parent/Guardian Decision|0|||
23140910|NCT01237587|64267587|FG001|Taper Phase|Parent/Guardian Decision|2|||
23140911|NCT01237587|64267586|FG000|Taper Phase|Sponsor Decision|1|||
23554786|NCT00803452|65757936|FG001|Overall Study|Adverse Event|2|||
23554787|NCT00803452|65757935|FG000|Overall Study|Lost to Follow-up|0|||
23554788|NCT00803452|65757936|FG001|Overall Study|Lost to Follow-up|3|||
23554789|NCT01515748|65757938|FG000|Overall Study|Withdrawal by Subject|32|||
23554790|NCT01515748|65757939|FG001|Overall Study|Withdrawal by Subject|41|||
23554791|NCT01515748|65757938|FG000|Overall Study|Lost to Follow-up|2|||
23554792|NCT01515748|65757939|FG001|Overall Study|Lost to Follow-up|4|||
23554793|NCT01515748|65757938|FG000|Overall Study|Other than specified above|5|||
23554794|NCT01515748|65757939|FG001|Overall Study|Other than specified above|10|||
23554795|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
23554796|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
23554797|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
23554798|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
23554799|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
23554800|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
23554801|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
23554802|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
23554803|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
23554804|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
23554805|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
23554806|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
23554807|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
23554808|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
23554809|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
23554810|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
23554811|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
23554812|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
23554813|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
23554814|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
23554815|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
23554816|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
23554817|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
23554818|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
23554819|NCT01256411|65757945|FG000|Extension by Maximum Treatment|Adverse Event|4|||
23554820|NCT01256411|65757946|FG001|Extension by Maximum Treatment|Adverse Event|2|||
23554821|NCT01256411|65757947|FG002|Extension by Maximum Treatment|Adverse Event|1|||
23622187|NCT00505414|66004846|FG003|Maintenance Phase|Lack of Efficacy|0|||
23140912|NCT01237587|64267587|FG001|Taper Phase|Sponsor Decision|0|||
23140913|NCT01237587|64267586|FG000|Taper Phase|Withdrawal by Subject|0|||
23140914|NCT01237587|64267587|FG001|Taper Phase|Withdrawal by Subject|1|||
23140915|NCT04684394|64267592|FG000|Overall Study|Death|1|||
23216420|NCT03276572|64534466|FG002|Overall Study|In follow-up|0|||
23216421|NCT03276572|64534467|FG003|Overall Study|In follow-up|0|||
23554822|NCT01256411|65757948|FG003|Extension by Maximum Treatment|Adverse Event|0|||
23554823|NCT01256411|65757949|FG004|Extension by Maximum Treatment|Adverse Event|0|||
23622188|NCT00505414|66004847|FG004|Maintenance Phase|Lack of Efficacy|0|||
23622189|NCT00505414|66004843|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23140916|NCT04684394|64267593|FG001|Overall Study|Death|2|||
23140917|NCT04684394|64267592|FG000|Overall Study|Lost to Follow-up|1|||
23622190|NCT00505414|66004844|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23622191|NCT00505414|66004845|FG002|Maintenance Phase|Withdrawal by Subject|1|||
23622192|NCT00505414|66004846|FG003|Maintenance Phase|Withdrawal by Subject|0|||
23622193|NCT00505414|66004847|FG004|Maintenance Phase|Withdrawal by Subject|0|||
23622194|NCT00505414|66004843|FG000|Maintenance Phase|underlying disease and therapy required|0|||
23622195|NCT00505414|66004844|FG001|Maintenance Phase|underlying disease and therapy required|2|||
23622196|NCT00505414|66004845|FG002|Maintenance Phase|underlying disease and therapy required|2|||
23622197|NCT00505414|66004846|FG003|Maintenance Phase|underlying disease and therapy required|0|||
23622198|NCT00505414|66004847|FG004|Maintenance Phase|underlying disease and therapy required|0|||
23622199|NCT00792259|66004848|FG000|Overall Study|Poor Quality Scans|1|||
23622200|NCT00792259|66004849|FG001|Overall Study|Poor Quality Scans|0|||
23432429|NCT04405245|65327623|FG000|Overall Study|Adverse Event|0|||
23432430|NCT04405245|65327624|FG001|Overall Study|Adverse Event|1|||
23432431|NCT04405245|65327625|FG002|Overall Study|Adverse Event|0|||
23432432|NCT00852241|65327627|FG000|Overall Study|Physician Decision|18|||
23432433|NCT01554514|65327630|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
23432434|NCT01554514|65327630|FG000|Overall Study|Physician Decision|1|||
23432435|NCT00109577|65327631|FG000|Overall Study|Withdrawal by Subject|3|||
23432436|NCT00109577|65327632|FG001|Overall Study|Withdrawal by Subject|3|||
23432437|NCT01424228|65327634|FG000|Overall Study|Withdrawal by Subject|27|||
23432438|NCT01424228|65327635|FG001|Overall Study|Withdrawal by Subject|11|||
23432439|NCT01424228|65327634|FG000|Overall Study|Adverse Event|10|||
23432440|NCT01424228|65327635|FG001|Overall Study|Adverse Event|14|||
23432441|NCT01424228|65327634|FG000|Overall Study|Sponsor's decision|9|||
23432442|NCT01424228|65327635|FG001|Overall Study|Sponsor's decision|12|||
23432443|NCT01424228|65327634|FG000|Overall Study|Lack of Efficacy|5|||
23432444|NCT01424228|65327635|FG001|Overall Study|Lack of Efficacy|7|||
23432445|NCT01424228|65327634|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
23432446|NCT01424228|65327635|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
23432447|NCT01424228|65327634|FG000|Overall Study|Non-compliance|2|||
23432448|NCT01424228|65327635|FG001|Overall Study|Non-compliance|0|||
23432449|NCT01424228|65327634|FG000|Overall Study|Worsening of symptoms|1|||
23432450|NCT01424228|65327635|FG001|Overall Study|Worsening of symptoms|0|||
23432451|NCT01424228|65327634|FG000|Overall Study|Unplanned journey|0|||
23432452|NCT01424228|65327635|FG001|Overall Study|Unplanned journey|1|||
23432453|NCT00565136|65327636|FG000|Overall Study|Lost to Follow-up|1|||
23432454|NCT00565136|65327636|FG000|Overall Study|Withdrawal by Subject|1|||
23432455|NCT00565136|65327636|FG000|Overall Study|Protocol Violation|1|||
23432456|NCT00588094|65327641|FG000|Overall Study|Adverse Event|3|||
23432457|NCT00588094|65327641|FG000|Overall Study|Progression of Disease|2|||
23432458|NCT03966885|65327642|FG000|Overall Study|Death|1|||
23432459|NCT03966885|65327643|FG001|Overall Study|Death|0|||
23432460|NCT03966885|65327642|FG000|Overall Study|Lost to Follow-up|1|||
23432461|NCT03966885|65327643|FG001|Overall Study|Lost to Follow-up|2|||
23432462|NCT03966885|65327642|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
23432463|NCT03966885|65327643|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
23432464|NCT03966885|65327642|FG000|Overall Study|Moved from study area.|0|||
23432465|NCT03966885|65327643|FG001|Overall Study|Moved from study area.|2|||
23432466|NCT01424566|65327647|FG000|Single-blind Treatment|Adverse Event|71|||
23432467|NCT01424566|65327648|FG001|Single-blind Treatment|Adverse Event|0|||
23432468|NCT01424566|65327649|FG002|Single-blind Treatment|Adverse Event|0|||
23432469|NCT01424566|65327647|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
23432470|NCT01424566|65327648|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
23432471|NCT01424566|65327649|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
23432472|NCT01424566|65327647|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
23432473|NCT01424566|65327648|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
23432474|NCT01424566|65327649|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
23432475|NCT01424566|65327647|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
23432476|NCT01424566|65327648|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
23432477|NCT01424566|65327649|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
23432478|NCT01424566|65327647|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
23622201|NCT00792259|66004850|FG002|Overall Study|Poor Quality Scans|0|||
23622202|NCT01951378|66004851|FG000|Overall Study|Study Terminated-Not completed|23|||
23622203|NCT01951378|66004852|FG001|Overall Study|Study Terminated-Not completed|17|||
23432479|NCT01424566|65327648|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
23432480|NCT01424566|65327649|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
23432481|NCT01424566|65327647|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
23432482|NCT01424566|65327648|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
23432483|NCT01424566|65327649|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
23432484|NCT01424566|65327647|FG000|Double-blind Treatment|Adverse Event|0|||
23432485|NCT01424566|65327648|FG001|Double-blind Treatment|Adverse Event|21|||
23432486|NCT01424566|65327649|FG002|Double-blind Treatment|Adverse Event|13|||
23432487|NCT01424566|65327647|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
23622204|NCT01253447|66004853|FG000|Overall Study|Adverse Event|2|||
23554824|NCT01256411|65757950|FG005|Extension by Maximum Treatment|Adverse Event|0|||
23554825|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
23554826|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
23554827|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
23554828|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
23554829|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
23554830|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
23554831|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554832|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554833|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554834|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554835|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
23554836|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
23554837|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23140918|NCT04684394|64267593|FG001|Overall Study|Lost to Follow-up|0|||
23140919|NCT04684394|64267592|FG000|Overall Study|Withdrawal by Subject|2|||
23140920|NCT04684394|64267593|FG001|Overall Study|Withdrawal by Subject|0|||
23140921|NCT04684394|64267592|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
23554838|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23554839|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23554840|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23554841|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
23554842|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
23554843|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
23554844|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
23554845|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
23554846|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
23554847|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
23554848|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
23554849|NCT01256411|65757945|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
23554850|NCT01256411|65757946|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
23554851|NCT01256411|65757947|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
23554852|NCT01256411|65757948|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
23554853|NCT01256411|65757949|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
23554854|NCT01256411|65757950|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
23554855|NCT00857207|65757952|FG000|Overall Study|Withdrawal by Subject|13|||
23554856|NCT00857207|65757953|FG001|Overall Study|Withdrawal by Subject|0|||
23554857|NCT00857207|65757952|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
23554858|NCT00857207|65757953|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
23554859|NCT00857207|65757952|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
23554860|NCT00857207|65757953|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
23554861|NCT03574597|65757954|FG000|Overall Study|Withdrawal by Subject|67|||
23554862|NCT03574597|65757955|FG001|Overall Study|Withdrawal by Subject|96|||
23554863|NCT03574597|65757954|FG000|Overall Study|Lost to Follow-up|192|||
23554864|NCT03574597|65757955|FG001|Overall Study|Lost to Follow-up|188|||
23622205|NCT04016805|66004854|FG000|Overall Study|Sponsor's Discretion|30|||
23140922|NCT04684394|64267593|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
23432488|NCT01424566|65327648|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
23140923|NCT01076192|64267594|FG000|Overall Study|Other|197|||
23140924|NCT02041520|64267595|FG000|Overall Study|Adverse Event|2|||
23432489|NCT01424566|65327649|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
23432490|NCT01424566|65327647|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
23432491|NCT01424566|65327648|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
23432492|NCT01424566|65327649|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
23432493|NCT01424566|65327647|FG000|Double-blind Treatment|Lack of Efficacy|0|||
23432494|NCT01424566|65327648|FG001|Double-blind Treatment|Lack of Efficacy|1|||
23432495|NCT01424566|65327649|FG002|Double-blind Treatment|Lack of Efficacy|1|||
23432496|NCT01704456|65327650|FG000|Overall Study|Lost to Follow-up|8|||
23432497|NCT01704456|65327651|FG001|Overall Study|Lost to Follow-up|14|||
23432498|NCT00952614|65327652|FG000|Overall Study|Death|3|||
23432499|NCT00952614|65327652|FG000|Overall Study|Lost to Follow-up|3|||
23318098|NCT01699815|64908256|FG001|Overall Study|Protocol Violation|7|||
23432500|NCT00952614|65327652|FG000|Overall Study|other reason|1|||
23554865|NCT01843374|65757956|FG000|Overall Study|Death|155|||
23554866|NCT01843374|65757957|FG001|Overall Study|Death|313|||
23554867|NCT01843374|65757956|FG000|Overall Study|Withdrawal by Subject|14|||
23140925|NCT02041520|64267596|FG001|Overall Study|Adverse Event|1|||
23216422|NCT03276572|64534468|FG004|Overall Study|In follow-up|0|||
23432501|NCT01283542|65327653|FG000|Main Phase|Acute or progressive vision loss|1|||
23432502|NCT01283542|65327653|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
23432503|NCT01283542|65327653|FG000|Main Phase|abnormal laboratory values|5|||
23432504|NCT01283542|65327653|FG000|Extension Phase|Physician Decision|1|||
23432505|NCT01283542|65327653|FG000|Extension Phase|Adverse Event|1|||
23318099|NCT01699815|64908255|FG000|Overall Study|record could not be located|1|||
23318100|NCT01699815|64908256|FG001|Overall Study|record could not be located|0|||
23318101|NCT01699815|64908255|FG000|Overall Study|Adverse Event|0|||
23318102|NCT01699815|64908256|FG001|Overall Study|Adverse Event|1|||
23318103|NCT00171951|64908260|FG000|Overall Study|Adverse Event|1|||
23318104|NCT00171951|64908260|FG000|Overall Study|Abnormal Laboratory Values|2|||
23318105|NCT00171951|64908260|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23318106|NCT00171951|64908260|FG000|Overall Study|Participants Withdrew Consent|3|||
23318107|NCT00171951|64908260|FG000|Overall Study|New Cancer Therapy|5|||
23318108|NCT00171951|64908260|FG000|Overall Study|Reason not Specified|2|||
23318109|NCT01625988|64908263|FG000|Overall Study|Lost to Follow-up|5|||
23318110|NCT01625988|64908264|FG001|Overall Study|Lost to Follow-up|6|||
23318111|NCT01625988|64908263|FG000|Overall Study|Withdrawal by Subject|8|||
23318112|NCT01625988|64908264|FG001|Overall Study|Withdrawal by Subject|3|||
23318113|NCT01625988|64908263|FG000|Overall Study|Adverse Event|0|||
23140926|NCT02041520|64267595|FG000|Overall Study|Withdrawal by Subject|3|||
23140927|NCT02041520|64267596|FG001|Overall Study|Withdrawal by Subject|4|||
23140928|NCT02041520|64267595|FG000|Overall Study|Protocol Violation|1|||
23140929|NCT02041520|64267596|FG001|Overall Study|Protocol Violation|0|||
23140930|NCT02041520|64267595|FG000|Overall Study|Lost to Follow-up|0|||
23140931|NCT02041520|64267596|FG001|Overall Study|Lost to Follow-up|1|||
23140932|NCT02041520|64267595|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
23140933|NCT02041520|64267596|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
23140934|NCT00883051|64267601|FG000|Overall Study|Lost to Follow-up|0|||
23140935|NCT00883051|64267602|FG001|Overall Study|Lost to Follow-up|0|||
23140936|NCT00883051|64267603|FG002|Overall Study|Lost to Follow-up|0|||
23140937|NCT00883051|64267604|FG003|Overall Study|Lost to Follow-up|0|||
23140938|NCT00883051|64267605|FG004|Overall Study|Lost to Follow-up|1|||
23140939|NCT00883051|64267601|FG000|Overall Study|Did not use study medication|24|||
23140940|NCT00883051|64267602|FG001|Overall Study|Did not use study medication|22|||
23140941|NCT00883051|64267603|FG002|Overall Study|Did not use study medication|29|||
23140942|NCT00883051|64267604|FG003|Overall Study|Did not use study medication|29|||
23140943|NCT00883051|64267605|FG004|Overall Study|Did not use study medication|17|||
23140944|NCT03733899|64267606|FG000|Period 1|Protocol Violation|0|||
23140945|NCT03733899|64267607|FG001|Period 1|Protocol Violation|0|||
23140946|NCT03733899|64267608|FG002|Period 1|Protocol Violation|0|||
23140947|NCT03733899|64267609|FG003|Period 1|Protocol Violation|0|||
23140948|NCT03733899|64267610|FG004|Period 1|Protocol Violation|0|||
23140949|NCT03733899|64267611|FG005|Period 1|Protocol Violation|1|||
23140950|NCT03733899|64267606|FG000|Period 2|Unscuccessful Treatment|0|||
23140951|NCT03733899|64267607|FG001|Period 2|Unscuccessful Treatment|1|||
23140952|NCT03733899|64267608|FG002|Period 2|Unscuccessful Treatment|0|||
23140953|NCT03733899|64267609|FG003|Period 2|Unscuccessful Treatment|0|||
23140954|NCT03733899|64267610|FG004|Period 2|Unscuccessful Treatment|0|||
23140955|NCT03733899|64267611|FG005|Period 2|Unscuccessful Treatment|0|||
23140956|NCT03733899|64267606|FG000|Period 3|Withdrawal by Subject|1|||
23140957|NCT03733899|64267607|FG001|Period 3|Withdrawal by Subject|0|||
23140958|NCT03733899|64267608|FG002|Period 3|Withdrawal by Subject|0|||
23140959|NCT03733899|64267609|FG003|Period 3|Withdrawal by Subject|0|||
23140960|NCT03733899|64267610|FG004|Period 3|Withdrawal by Subject|0|||
23140961|NCT03733899|64267611|FG005|Period 3|Withdrawal by Subject|0|||
23140962|NCT01007448|64267614|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
23140963|NCT01007448|64267615|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
23140964|NCT01007448|64267614|FG000|Overall Study|Staph Skin Infection Flare|1|||
23432506|NCT01283542|65327653|FG000|Extension Phase|Administrative problems|1|||
23140965|NCT01007448|64267615|FG001|Overall Study|Staph Skin Infection Flare|0|||
23140966|NCT01007448|64267614|FG000|Overall Study|Participant Leaving the Country|1|||
23140967|NCT01007448|64267615|FG001|Overall Study|Participant Leaving the Country|0|||
23140968|NCT01007448|64267614|FG000|Overall Study|Participant Given Prohibited Medication|1|||
23318114|NCT01625988|64908264|FG001|Overall Study|Adverse Event|1|||
23318115|NCT01625988|64908263|FG000|Overall Study|Lack of Efficacy|0|||
23318116|NCT01625988|64908264|FG001|Overall Study|Lack of Efficacy|1|||
23318117|NCT01625988|64908263|FG000|Overall Study|Randomized Inappropriately|1|||
23318118|NCT01625988|64908264|FG001|Overall Study|Randomized Inappropriately|0|||
23140969|NCT01007448|64267615|FG001|Overall Study|Participant Given Prohibited Medication|0|||
23140970|NCT01007448|64267614|FG000|Overall Study|Progressive Disease|1|||
23140971|NCT01007448|64267615|FG001|Overall Study|Progressive Disease|2|||
23140972|NCT01007448|64267614|FG000|Overall Study|Lack of Efficacy|2|||
23140973|NCT01007448|64267615|FG001|Overall Study|Lack of Efficacy|0|||
23140974|NCT01007448|64267614|FG000|Overall Study|Withdrawal by Subject|2|||
23140975|NCT01007448|64267615|FG001|Overall Study|Withdrawal by Subject|3|||
23140976|NCT01007448|64267614|FG000|Overall Study|Adverse Event|1|||
23318119|NCT01625988|64908263|FG000|Overall Study|Protocol Violation|0|||
23318120|NCT01625988|64908264|FG001|Overall Study|Protocol Violation|2|||
23318121|NCT00477633|64908265|FG000|Overall Study|Did not receive treatment|23|||
23318122|NCT00477633|64908265|FG000|Overall Study|Adverse Event|143|||
23318123|NCT00477633|64908265|FG000|Overall Study|Pregnancy|23|||
23318124|NCT00477633|64908265|FG000|Overall Study|Lost to Follow-up|271|||
23318125|NCT00477633|64908265|FG000|Overall Study|Withdrawal by Subject|149|||
23318126|NCT00477633|64908265|FG000|Overall Study|Protocol Violation|25|||
23318127|NCT00477633|64908265|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
23318128|NCT00398866|64908266|FG000|Overall Study|Adverse Event|1|||
23318129|NCT00398866|64908267|FG001|Overall Study|Adverse Event|0|||
23318130|NCT00398866|64908268|FG002|Overall Study|Adverse Event|0|||
23318131|NCT00398866|64908266|FG000|Overall Study|Lack of Efficacy|0|||
23318132|NCT00398866|64908267|FG001|Overall Study|Lack of Efficacy|0|||
23318133|NCT00398866|64908268|FG002|Overall Study|Lack of Efficacy|1|||
23318134|NCT00398866|64908266|FG000|Overall Study|Lost to Follow-up|7|||
23318135|NCT00398866|64908267|FG001|Overall Study|Lost to Follow-up|6|||
23318136|NCT00398866|64908268|FG002|Overall Study|Lost to Follow-up|4|||
23318137|NCT00398866|64908266|FG000|Overall Study|Withdrawal by Subject|5|||
23216423|NCT03276572|64534469|FG005|Overall Study|In follow-up|1|||
23216424|NCT03276572|64534470|FG006|Overall Study|In follow-up|1|||
23216425|NCT03276572|64534464|FG000|Overall Study|Lost to Follow-up|0|||
23216426|NCT03276572|64534465|FG001|Overall Study|Lost to Follow-up|0|||
23216427|NCT03276572|64534466|FG002|Overall Study|Lost to Follow-up|0|||
23216428|NCT03276572|64534467|FG003|Overall Study|Lost to Follow-up|0|||
23216429|NCT03276572|64534468|FG004|Overall Study|Lost to Follow-up|0|||
23216430|NCT03276572|64534469|FG005|Overall Study|Lost to Follow-up|0|||
23622206|NCT04016805|66004855|FG001|Overall Study|Sponsor's Discretion|6|||
23216431|NCT03276572|64534470|FG006|Overall Study|Lost to Follow-up|1|||
23216432|NCT02150213|64534480|FG000|Overall Study|Lost to Follow-up|1|||
23216433|NCT02150213|64534480|FG000|Overall Study|Withdrawal by Subject|1|||
23216434|NCT00239356|64534482|FG000|Overall Study|Lack of Efficacy|1|||
23216435|NCT00239356|64534483|FG001|Overall Study|Lack of Efficacy|0|||
23216436|NCT00239356|64534482|FG000|Overall Study|Adverse Event|6|||
23216437|NCT00239356|64534483|FG001|Overall Study|Adverse Event|0|||
23216438|NCT00239356|64534482|FG000|Overall Study|Withdrawal by Subject|15|||
23216439|NCT00239356|64534483|FG001|Overall Study|Withdrawal by Subject|6|||
23216440|NCT00239356|64534482|FG000|Overall Study|Lost to Follow-up|3|||
23216441|NCT00239356|64534483|FG001|Overall Study|Lost to Follow-up|0|||
23216442|NCT00239356|64534482|FG000|Overall Study|poor/non-compliance|2|||
23216443|NCT00239356|64534483|FG001|Overall Study|poor/non-compliance|0|||
23216444|NCT00239356|64534482|FG000|Overall Study|Pregnancy|1|||
23216445|NCT00239356|64534483|FG001|Overall Study|Pregnancy|0|||
23216446|NCT00239356|64534482|FG000|Overall Study|Administrative reason|0|||
23216447|NCT00239356|64534483|FG001|Overall Study|Administrative reason|1|||
23216448|NCT00239356|64534482|FG000|Overall Study|Drug available on market|11|||
23216449|NCT00239356|64534483|FG001|Overall Study|Drug available on market|2|||
23216450|NCT03549117|64534485|FG000|Overall Study|Withdrawal by Subject|1|||
23216451|NCT03549117|64534486|FG001|Overall Study|Withdrawal by Subject|0|||
23216452|NCT02574481|64534487|FG000|Overall Study|Withdrawal by Subject|29|||
23216453|NCT02574481|64534488|FG001|Overall Study|Withdrawal by Subject|15|||
23216454|NCT02574481|64534489|FG002|Overall Study|Withdrawal by Subject|4|||
23216455|NCT02574481|64534490|FG003|Overall Study|Withdrawal by Subject|1|||
23622207|NCT04016805|66004856|FG002|Overall Study|Sponsor's Discretion|5|||
23622208|NCT04680637|66004860|FG000|Overall Study|Lost to Follow-up|0|||
23622209|NCT04680637|66004861|FG001|Overall Study|Lost to Follow-up|1|||
23216456|NCT02574481|64534487|FG000|Overall Study|Adverse Event|5|||
23216457|NCT02574481|64534488|FG001|Overall Study|Adverse Event|1|||
23216458|NCT02574481|64534489|FG002|Overall Study|Adverse Event|1|||
23216459|NCT02574481|64534490|FG003|Overall Study|Adverse Event|0|||
23216460|NCT02574481|64534487|FG000|Overall Study|Visit Missed|15|||
23216461|NCT02574481|64534488|FG001|Overall Study|Visit Missed|7|||
23216462|NCT02574481|64534489|FG002|Overall Study|Visit Missed|5|||
23216463|NCT02574481|64534490|FG003|Overall Study|Visit Missed|0|||
23216464|NCT02574481|64534487|FG000|Overall Study|Other|7|||
23216465|NCT02574481|64534488|FG001|Overall Study|Other|2|||
23216466|NCT02574481|64534489|FG002|Overall Study|Other|0|||
23216467|NCT02574481|64534490|FG003|Overall Study|Other|0|||
23216468|NCT02574481|64534487|FG000|Overall Study|Death|48|||
23318138|NCT00398866|64908267|FG001|Overall Study|Withdrawal by Subject|1|||
23318139|NCT00398866|64908268|FG002|Overall Study|Withdrawal by Subject|2|||
23622210|NCT04680637|66004862|FG002|Overall Study|Lost to Follow-up|0|||
23318140|NCT00398866|64908266|FG000|Overall Study|Unable to complete requirements of study|1|||
23318141|NCT00398866|64908267|FG001|Overall Study|Unable to complete requirements of study|1|||
23318142|NCT00398866|64908268|FG002|Overall Study|Unable to complete requirements of study|1|||
23622211|NCT04680637|66004863|FG003|Overall Study|Lost to Follow-up|1|||
23216469|NCT02574481|64534488|FG001|Overall Study|Death|26|||
23216470|NCT02574481|64534489|FG002|Overall Study|Death|12|||
23216471|NCT02574481|64534490|FG003|Overall Study|Death|4|||
23216472|NCT02574481|64534487|FG000|Overall Study|Physician Decision|5|||
23432507|NCT01896271|65327654|FG000|Overall Study|Physician Decision|10|||
23432508|NCT00989781|65327661|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
23432509|NCT00989781|65327662|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
23140977|NCT01007448|64267615|FG001|Overall Study|Adverse Event|4|||
23140978|NCT03801915|64267616|FG000|Overall Study|Screen failure|0|||
23432510|NCT03022981|65327663|FG000|Overall Study|Adverse Event|0|||
23432511|NCT03022981|65327664|FG001|Overall Study|Adverse Event|1|||
23140979|NCT03801915|64267617|FG001|Overall Study|Screen failure|0|||
23432512|NCT03022981|65327665|FG002|Overall Study|Adverse Event|0|||
23432513|NCT03022981|65327663|FG000|Overall Study|Investigator's Discretion|0|||
23432514|NCT03022981|65327664|FG001|Overall Study|Investigator's Discretion|1|||
23432515|NCT03022981|65327665|FG002|Overall Study|Investigator's Discretion|2|||
23432516|NCT03022981|65327663|FG000|Overall Study|Lost to Follow-up|6|||
23432517|NCT03022981|65327664|FG001|Overall Study|Lost to Follow-up|2|||
23432518|NCT03022981|65327665|FG002|Overall Study|Lost to Follow-up|1|||
23432519|NCT03022981|65327663|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23432520|NCT03022981|65327664|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23432521|NCT03022981|65327665|FG002|Overall Study|Non-Compliance With Study Drug|2|||
23432522|NCT03022981|65327663|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
23432523|NCT03022981|65327664|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
23432524|NCT03022981|65327665|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
23432525|NCT02477553|65327670|FG000|Overall Study|Screening up-to-date|12|||
23432526|NCT02477553|65327671|FG001|Overall Study|Screening up-to-date|13|||
23432527|NCT02477553|65327670|FG000|Overall Study|No MD visit|1|||
23432528|NCT02477553|65327671|FG001|Overall Study|No MD visit|1|||
23140980|NCT03801915|64267618|FG002|Overall Study|Screen failure|1|||
23140981|NCT03801915|64267616|FG000|Overall Study|Ineligible|1|||
23140982|NCT03801915|64267617|FG001|Overall Study|Ineligible|0|||
23140983|NCT03801915|64267618|FG002|Overall Study|Ineligible|0|||
23140984|NCT03801915|64267616|FG000|Overall Study|Physician Decision|2|||
23140985|NCT03801915|64267617|FG001|Overall Study|Physician Decision|1|||
23140986|NCT03801915|64267618|FG002|Overall Study|Physician Decision|0|||
23140987|NCT02679508|64267619|FG000|Healing Phase|Protocol Violation|1|||
23140988|NCT02679508|64267620|FG001|Healing Phase|Protocol Violation|1|||
23140989|NCT02679508|64267619|FG000|Healing Phase|Lost to Follow-up|1|||
23140990|NCT02679508|64267620|FG001|Healing Phase|Lost to Follow-up|0|||
23140991|NCT02679508|64267619|FG000|Maintenance Phase|Adverse Event|12|||
23140992|NCT02679508|64267620|FG001|Maintenance Phase|Adverse Event|2|||
23140993|NCT02679508|64267619|FG000|Maintenance Phase|Lost to Follow-up|0|||
23140994|NCT02679508|64267620|FG001|Maintenance Phase|Lost to Follow-up|1|||
23140995|NCT02679508|64267619|FG000|Maintenance Phase|Withdrawal by Subject|15|||
23140996|NCT02679508|64267620|FG001|Maintenance Phase|Withdrawal by Subject|8|||
23140997|NCT02679508|64267619|FG000|Maintenance Phase|Other|5|||
23140998|NCT02679508|64267620|FG001|Maintenance Phase|Other|4|||
23140999|NCT02481947|64267624|FG000|Overall Study|Withdrawal by Subject|24|||
23141000|NCT02481947|64267625|FG001|Overall Study|Withdrawal by Subject|10|||
23141001|NCT02481947|64267624|FG000|Overall Study|Lost to Follow-up|11|||
23141002|NCT02481947|64267625|FG001|Overall Study|Lost to Follow-up|5|||
23141003|NCT02481947|64267624|FG000|Overall Study|Adverse Event|6|||
23141004|NCT02481947|64267625|FG001|Overall Study|Adverse Event|11|||
23141005|NCT02481947|64267624|FG000|Overall Study|Physician Decision|4|||
23141006|NCT02481947|64267625|FG001|Overall Study|Physician Decision|5|||
23141007|NCT02481947|64267624|FG000|Overall Study|Protocol Violation|1|||
23141008|NCT02481947|64267625|FG001|Overall Study|Protocol Violation|5|||
23141009|NCT01028027|64267633|FG000|Overall Study|Lost to Follow-up|4|||
23141010|NCT01028027|64267634|FG001|Overall Study|Lost to Follow-up|1|||
23141011|NCT01028027|64267633|FG000|Overall Study|Withdrawal by Subject|5|||
23141012|NCT01028027|64267634|FG001|Overall Study|Withdrawal by Subject|3|||
23141013|NCT01028027|64267633|FG000|Overall Study|Adverse Event|4|||
23141014|NCT01028027|64267634|FG001|Overall Study|Adverse Event|7|||
23141015|NCT01028027|64267633|FG000|Overall Study|Protocol Violation|3|||
23432529|NCT02477553|65327670|FG000|Overall Study|Workup consistent w/CRC|1|||
23432530|NCT02477553|65327671|FG001|Overall Study|Workup consistent w/CRC|1|||
23432531|NCT02477553|65327670|FG000|Overall Study|Technical issues with intervention|2|||
23432532|NCT02477553|65327671|FG001|Overall Study|Technical issues with intervention|0|||
23432533|NCT02477553|65327670|FG000|Overall Study|Elevated risk for CRC|2|||
23141016|NCT01028027|64267634|FG001|Overall Study|Protocol Violation|1|||
23141017|NCT01028027|64267633|FG000|Overall Study|Lack of Efficacy|0|||
23141018|NCT01028027|64267634|FG001|Overall Study|Lack of Efficacy|1|||
23141019|NCT01941719|64267635|FG000|Overall Study|Lost to Follow-up|20|||
23141020|NCT01941719|64267636|FG001|Overall Study|Lost to Follow-up|19|||
23141021|NCT02729831|64267637|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
23141022|NCT02729831|64267638|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
23318143|NCT00741338|64908270|FG000|Overall Study|Adverse Event|0|||
23318144|NCT00741338|64908271|FG001|Overall Study|Adverse Event|1|||
23318145|NCT02899195|64908272|FG000|Concurrent Durvalumab|Adverse Event|4|||
23318146|NCT02899195|64908272|FG000|Concurrent Durvalumab|Physician Decision|1|||
23141023|NCT02729831|64267639|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
23216473|NCT02574481|64534488|FG001|Overall Study|Physician Decision|2|||
23216474|NCT02574481|64534489|FG002|Overall Study|Physician Decision|0|||
23216475|NCT02574481|64534490|FG003|Overall Study|Physician Decision|0|||
23216476|NCT02574481|64534487|FG000|Overall Study|Lost to Follow-up|5|||
23216477|NCT02574481|64534488|FG001|Overall Study|Lost to Follow-up|1|||
23216478|NCT02574481|64534489|FG002|Overall Study|Lost to Follow-up|3|||
23216479|NCT02574481|64534490|FG003|Overall Study|Lost to Follow-up|0|||
23318147|NCT02899195|64908272|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
23318148|NCT02899195|64908272|FG000|Concurrent Durvalumab|Progressive Disease|5|||
23318149|NCT02899195|64908272|FG000|Maintenance Durvalumab|Adverse Event|1|||
23318150|NCT02899195|64908272|FG000|Maintenance Durvalumab|Physician Decision|1|||
23318151|NCT02899195|64908272|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
23318152|NCT02899195|64908272|FG000|Maintenance Durvalumab|Progressive Disease|31|||
23318153|NCT01560416|64908274|FG000|Randomized Phase|Crossover Participants|7|||
23318154|NCT01560416|64908275|FG001|Randomized Phase|Crossover Participants|0|||
23318155|NCT01333397|64908276|FG000|Overall Study|Lost to Follow-up|1|||
23318156|NCT01333397|64908277|FG001|Overall Study|Lost to Follow-up|0|||
23318157|NCT01333397|64908278|FG002|Overall Study|Lost to Follow-up|0|||
23318158|NCT01333397|64908279|FG003|Overall Study|Lost to Follow-up|1|||
23318159|NCT01333397|64908280|FG004|Overall Study|Lost to Follow-up|0|||
23318160|NCT00461253|64908288|FG000|Overall Study|Death|985|||
23318161|NCT00461253|64908289|FG001|Overall Study|Death|0|||
23318162|NCT00461253|64908288|FG000|Overall Study|Protocol Violation|613|||
23318163|NCT00461253|64908289|FG001|Overall Study|Protocol Violation|236|||
23318164|NCT00461253|64908288|FG000|Overall Study|no response|2609|||
23216480|NCT00617591|64534493|FG000|Overall Study|Withdrew consent during Induction|4|||
23216481|NCT00617591|64534493|FG000|Overall Study|Withdrew consent during Maintenance|6|||
23216482|NCT02306161|64534494|FG000|Overall Study|Death|1|||
23216483|NCT02306161|64534495|FG001|Overall Study|Death|3|||
23216484|NCT02306161|64534494|FG000|Overall Study|Lack of Efficacy|20|||
23216485|NCT02306161|64534495|FG001|Overall Study|Lack of Efficacy|43|||
23216486|NCT02306161|64534494|FG000|Overall Study|Physician Decision|30|||
23216487|NCT02306161|64534495|FG001|Overall Study|Physician Decision|18|||
23216488|NCT02306161|64534494|FG000|Overall Study|Withdrawal by Subject|4|||
23216489|NCT02306161|64534495|FG001|Overall Study|Withdrawal by Subject|0|||
23216490|NCT02306161|64534494|FG000|Overall Study|Ineligible|9|||
23216491|NCT02306161|64534495|FG001|Overall Study|Ineligible|5|||
23216492|NCT00435994|64534499|FG000|Overall Study|Lost to Follow-up|7|||
23216493|NCT00435994|64534500|FG001|Overall Study|Lost to Follow-up|0|||
23216494|NCT00435994|64534501|FG002|Overall Study|Lost to Follow-up|0|||
23216495|NCT02905825|64534504|FG000|Overall Study|Protocol Violation|11|||
23432534|NCT02477553|65327671|FG001|Overall Study|Elevated risk for CRC|2|||
23432535|NCT02477553|65327670|FG000|Overall Study|MD advised against screening|1|||
23432536|NCT02477553|65327671|FG001|Overall Study|MD advised against screening|3|||
23432537|NCT02477553|65327670|FG000|Overall Study|patient deceased|1|||
23432538|NCT02477553|65327671|FG001|Overall Study|patient deceased|0|||
23432539|NCT01274429|65327672|FG000|Overall Study|Study closed do to lack of funding|5|||
23432540|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
23432541|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
23432542|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
23432543|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
23432544|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
23216496|NCT02905825|64534504|FG000|Overall Study|Device Malfunction|1|||
23318165|NCT00461253|64908289|FG001|Overall Study|no response|11789|||
23318166|NCT00461253|64908288|FG000|Overall Study|administrative|773|||
23318167|NCT00461253|64908289|FG001|Overall Study|administrative|7773|||
23318168|NCT00704132|64908296|FG000|Overall Study|Clinical Adverse Experience|1|||
23318169|NCT00704132|64908297|FG001|Overall Study|Clinical Adverse Experience|0|||
23318170|NCT00704132|64908296|FG000|Overall Study|Lack of Efficacy|0|||
23318171|NCT00704132|64908297|FG001|Overall Study|Lack of Efficacy|1|||
23318172|NCT00704132|64908296|FG000|Overall Study|Withdrawal by Subject|0|||
23216497|NCT00701103|64534508|FG000|Overall Study|Adverse Event|0|||
23216498|NCT00701103|64534509|FG001|Overall Study|Adverse Event|0|||
23216499|NCT00701103|64534510|FG002|Overall Study|Adverse Event|1|||
23216500|NCT00701103|64534511|FG003|Overall Study|Adverse Event|1|||
23432545|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
23432546|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
23216501|NCT00701103|64534512|FG004|Overall Study|Adverse Event|0|||
23318173|NCT00704132|64908297|FG001|Overall Study|Withdrawal by Subject|1|||
23318174|NCT01130493|64908298|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
23216502|NCT00701103|64534513|FG005|Overall Study|Adverse Event|1|||
23216503|NCT00701103|64534514|FG006|Overall Study|Adverse Event|1|||
23216504|NCT00701103|64534515|FG007|Overall Study|Adverse Event|0|||
23216505|NCT00701103|64534516|FG008|Overall Study|Adverse Event|0|||
23318175|NCT01130493|64908299|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
23318176|NCT01130493|64908300|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
23318177|NCT01130493|64908298|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
23432547|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
23432548|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
23432549|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
23432550|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
23432551|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
23432552|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
23432553|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
23141024|NCT02729831|64267640|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
23141025|NCT02729831|64267637|FG000|1 Week Post-visit|Lost to Follow-up|43|||
23141026|NCT02729831|64267638|FG001|1 Week Post-visit|Lost to Follow-up|40|||
23141027|NCT02729831|64267639|FG002|1 Week Post-visit|Lost to Follow-up|38|||
23141028|NCT02729831|64267640|FG003|1 Week Post-visit|Lost to Follow-up|36|||
23141029|NCT02729831|64267637|FG000|6 Month Follow-up|Lost to Follow-up|54|||
23141030|NCT02729831|64267638|FG001|6 Month Follow-up|Lost to Follow-up|51|||
23141031|NCT02729831|64267639|FG002|6 Month Follow-up|Lost to Follow-up|48|||
23141032|NCT02729831|64267640|FG003|6 Month Follow-up|Lost to Follow-up|42|||
23141033|NCT02729831|64267637|FG000|6 Month Follow-up|Death|1|||
23141034|NCT02729831|64267638|FG001|6 Month Follow-up|Death|3|||
23141035|NCT02729831|64267639|FG002|6 Month Follow-up|Death|0|||
23141036|NCT02729831|64267640|FG003|6 Month Follow-up|Death|1|||
23141037|NCT02963610|64267641|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
23141038|NCT03110185|64267642|FG000|Overall Study|Death|0|||
23216506|NCT00701103|64534517|FG009|Overall Study|Adverse Event|2|||
23216507|NCT00701103|64534518|FG010|Overall Study|Adverse Event|0|||
23216508|NCT00701103|64534508|FG000|Overall Study|Progressive Disease|5|||
23216509|NCT00701103|64534509|FG001|Overall Study|Progressive Disease|2|||
23216510|NCT00701103|64534510|FG002|Overall Study|Progressive Disease|6|||
23216511|NCT00701103|64534511|FG003|Overall Study|Progressive Disease|5|||
23216512|NCT00701103|64534512|FG004|Overall Study|Progressive Disease|6|||
23216513|NCT00701103|64534513|FG005|Overall Study|Progressive Disease|5|||
23216514|NCT00701103|64534514|FG006|Overall Study|Progressive Disease|7|||
23216515|NCT00701103|64534515|FG007|Overall Study|Progressive Disease|7|||
23216516|NCT00701103|64534516|FG008|Overall Study|Progressive Disease|8|||
23216517|NCT00701103|64534517|FG009|Overall Study|Progressive Disease|8|||
23216518|NCT00701103|64534518|FG010|Overall Study|Progressive Disease|11|||
23216519|NCT00701103|64534508|FG000|Overall Study|Withdrawal by Subject|0|||
23216520|NCT00701103|64534509|FG001|Overall Study|Withdrawal by Subject|1|||
23216521|NCT00701103|64534510|FG002|Overall Study|Withdrawal by Subject|1|||
23216522|NCT00701103|64534511|FG003|Overall Study|Withdrawal by Subject|0|||
23216523|NCT00701103|64534512|FG004|Overall Study|Withdrawal by Subject|0|||
23216524|NCT00701103|64534513|FG005|Overall Study|Withdrawal by Subject|0|||
23432554|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
23432555|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
23432556|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
23432557|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
23432558|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
23432559|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
23432560|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
23432561|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
23432562|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
23432563|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
23432564|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
23432565|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
23432566|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
23432567|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
23432568|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
23432569|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
23432570|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
23432571|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
23622212|NCT04680637|66004860|FG000|Overall Study|Death|1|||
23141039|NCT03110185|64267643|FG001|Overall Study|Death|1|||
23141040|NCT03110185|64267642|FG000|Overall Study|Withdrawal by Subject|2|||
23141041|NCT03110185|64267643|FG001|Overall Study|Withdrawal by Subject|7|||
23216525|NCT00701103|64534514|FG006|Overall Study|Withdrawal by Subject|0|||
23216526|NCT00701103|64534515|FG007|Overall Study|Withdrawal by Subject|0|||
23216527|NCT00701103|64534516|FG008|Overall Study|Withdrawal by Subject|0|||
23318178|NCT01130493|64908299|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
23216528|NCT00701103|64534517|FG009|Overall Study|Withdrawal by Subject|0|||
23216529|NCT00701103|64534518|FG010|Overall Study|Withdrawal by Subject|0|||
23432572|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
23432573|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
23432574|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
23432575|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
23432576|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
23432577|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
23432578|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
23432579|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
23432580|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
23432581|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
23432582|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
23432583|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
23432584|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
23432585|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
23432586|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
23432587|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
23141042|NCT03110185|64267642|FG000|Overall Study|Time Constraints|0|||
23318179|NCT01130493|64908300|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
23318180|NCT01130493|64908298|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
23318181|NCT01130493|64908299|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
23318182|NCT01130493|64908300|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
23318183|NCT01130493|64908298|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
23318184|NCT01130493|64908299|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
23318185|NCT01130493|64908300|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
23318186|NCT01130493|64908298|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
23318187|NCT01130493|64908299|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
23318188|NCT01130493|64908300|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
23141043|NCT03110185|64267643|FG001|Overall Study|Time Constraints|6|||
23141044|NCT03110185|64267642|FG000|Overall Study|Conflict with care|5|||
23141045|NCT03110185|64267643|FG001|Overall Study|Conflict with care|12|||
23141046|NCT03110185|64267642|FG000|Overall Study|Protocol Violation|1|||
23141047|NCT03110185|64267643|FG001|Overall Study|Protocol Violation|4|||
23141048|NCT03110185|64267642|FG000|Overall Study|MRI Incompatible|2|||
23141049|NCT03110185|64267643|FG001|Overall Study|MRI Incompatible|0|||
23141050|NCT03110185|64267642|FG000|Overall Study|Patient Refusal|0|||
23141051|NCT03110185|64267643|FG001|Overall Study|Patient Refusal|1|||
23141052|NCT00690443|64267644|FG000|Overall Study|Adverse Event|1|||
23141053|NCT00690443|64267645|FG001|Overall Study|Adverse Event|2|||
23141054|NCT03695237|64267648|FG000|Overall Study|Withdrawal by Subject|1|||
23141055|NCT03695237|64267649|FG001|Overall Study|Withdrawal by Subject|3|||
23141056|NCT03695237|64267648|FG000|Overall Study|Lost to Follow-up|1|||
23141057|NCT03695237|64267649|FG001|Overall Study|Lost to Follow-up|2|||
23141058|NCT03695237|64267648|FG000|Overall Study|Other, Not Specified|8|||
23318189|NCT01130493|64908298|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
23318190|NCT01130493|64908299|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
23318191|NCT01130493|64908300|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
23318192|NCT01130493|64908298|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
23318193|NCT01130493|64908299|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
23318194|NCT01130493|64908300|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
23318195|NCT01130493|64908298|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
23318196|NCT01130493|64908299|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
23141059|NCT03695237|64267649|FG001|Overall Study|Other, Not Specified|2|||
23141060|NCT00321373|64267650|FG000|Overall Study|Adverse Event|0|||
23141061|NCT00321373|64267651|FG001|Overall Study|Adverse Event|0|||
23141062|NCT00321373|64267652|FG002|Overall Study|Adverse Event|1|||
23141063|NCT00321373|64267650|FG000|Overall Study|Lost to Follow-up|1|||
23141064|NCT00321373|64267651|FG001|Overall Study|Lost to Follow-up|0|||
23141065|NCT00321373|64267652|FG002|Overall Study|Lost to Follow-up|1|||
23141066|NCT00321373|64267650|FG000|Overall Study|Withdrawal by Subject|1|||
23141067|NCT00321373|64267651|FG001|Overall Study|Withdrawal by Subject|0|||
23141068|NCT00321373|64267652|FG002|Overall Study|Withdrawal by Subject|0|||
23318197|NCT01130493|64908300|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
23318198|NCT01130493|64908298|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
23318199|NCT01130493|64908299|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
23141069|NCT00321373|64267650|FG000|Overall Study|Other|0|||
23141070|NCT00321373|64267651|FG001|Overall Study|Other|0|||
23141071|NCT00321373|64267652|FG002|Overall Study|Other|1|||
23141072|NCT04097301|64267653|FG000|Overall Study|Death|1|||
23432588|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
23432589|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
23432590|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
23432591|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
23432592|NCT02008357|65327673|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
23432593|NCT02008357|65327674|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
23432594|NCT02008357|65327673|FG000|Open-label Extension Period|Adverse Event|8|||
23432595|NCT02008357|65327674|FG001|Open-label Extension Period|Adverse Event|7|||
23432596|NCT02008357|65327673|FG000|Open-label Extension Period|Death|7|||
23432597|NCT02008357|65327674|FG001|Open-label Extension Period|Death|4|||
23432598|NCT02008357|65327673|FG000|Open-label Extension Period|Lack of Efficacy|9|||
23432599|NCT02008357|65327674|FG001|Open-label Extension Period|Lack of Efficacy|5|||
23432600|NCT02008357|65327673|FG000|Open-label Extension Period|Lost to Follow-up|2|||
23432601|NCT02008357|65327674|FG001|Open-label Extension Period|Lost to Follow-up|2|||
23432602|NCT02008357|65327673|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
23216530|NCT00701103|64534508|FG000|Overall Study|Other|0|||
23216531|NCT00701103|64534509|FG001|Overall Study|Other|0|||
23216532|NCT00701103|64534510|FG002|Overall Study|Other|0|||
23432603|NCT02008357|65327674|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
23432604|NCT02008357|65327673|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
23432605|NCT02008357|65327674|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
23432606|NCT02008357|65327673|FG000|Open-label Extension Period|Safety Risk|2|||
23622213|NCT04680637|66004861|FG001|Overall Study|Death|0|||
23622214|NCT04680637|66004862|FG002|Overall Study|Death|0|||
23622215|NCT04680637|66004863|FG003|Overall Study|Death|0|||
23622216|NCT04680637|66004860|FG000|Overall Study|Withdrawal by Subject|7|||
23622217|NCT04680637|66004861|FG001|Overall Study|Withdrawal by Subject|10|||
23622218|NCT04680637|66004862|FG002|Overall Study|Withdrawal by Subject|17|||
23622219|NCT04680637|66004863|FG003|Overall Study|Withdrawal by Subject|15|||
23622220|NCT04680637|66004860|FG000|Overall Study|Decision by Sponsor|21|||
23622221|NCT04680637|66004861|FG001|Overall Study|Decision by Sponsor|15|||
23622222|NCT04680637|66004862|FG002|Overall Study|Decision by Sponsor|7|||
23622223|NCT04680637|66004863|FG003|Overall Study|Decision by Sponsor|32|||
23622224|NCT00661713|66004864|FG000|Overall Study|Death|1|||
23622225|NCT00661713|66004865|FG001|Overall Study|Death|0|||
23622226|NCT00661713|66004866|FG002|Overall Study|Death|0|||
23622227|NCT00661713|66004867|FG003|Overall Study|Death|0|||
23622228|NCT00661713|66004868|FG004|Overall Study|Death|1|||
23622229|NCT00661713|66004869|FG005|Overall Study|Death|0|||
23622230|NCT00661713|66004870|FG006|Overall Study|Death|0|||
23622231|NCT00661713|66004871|FG007|Overall Study|Death|0|||
23622232|NCT00661713|66004864|FG000|Overall Study|Unable to Classify|1|||
23622233|NCT00661713|66004865|FG001|Overall Study|Unable to Classify|0|||
23622234|NCT00661713|66004866|FG002|Overall Study|Unable to Classify|0|||
23622235|NCT00661713|66004867|FG003|Overall Study|Unable to Classify|0|||
23622236|NCT00661713|66004868|FG004|Overall Study|Unable to Classify|0|||
23622237|NCT00661713|66004869|FG005|Overall Study|Unable to Classify|0|||
23622238|NCT00661713|66004870|FG006|Overall Study|Unable to Classify|0|||
23622239|NCT00661713|66004871|FG007|Overall Study|Unable to Classify|0|||
23622240|NCT00661713|66004864|FG000|Overall Study|Protocol Violation|1|||
23622241|NCT00661713|66004865|FG001|Overall Study|Protocol Violation|6|||
23318200|NCT01130493|64908300|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
23318201|NCT01130493|64908298|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
23318202|NCT01130493|64908299|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
23318203|NCT01130493|64908300|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
23318204|NCT01130493|64908298|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
23432607|NCT02008357|65327674|FG001|Open-label Extension Period|Safety Risk|1|||
23622242|NCT00661713|66004866|FG002|Overall Study|Protocol Violation|3|||
23622243|NCT00661713|66004867|FG003|Overall Study|Protocol Violation|3|||
23622244|NCT00661713|66004868|FG004|Overall Study|Protocol Violation|0|||
23622245|NCT00661713|66004869|FG005|Overall Study|Protocol Violation|2|||
23622246|NCT00661713|66004870|FG006|Overall Study|Protocol Violation|2|||
23622247|NCT00661713|66004871|FG007|Overall Study|Protocol Violation|1|||
23622248|NCT00661713|66004864|FG000|Overall Study|Withdrawal by Subject|11|||
23622249|NCT00661713|66004865|FG001|Overall Study|Withdrawal by Subject|25|||
23622250|NCT00661713|66004866|FG002|Overall Study|Withdrawal by Subject|12|||
23432608|NCT02008357|65327673|FG000|Open-label Extension Period|Non-Compliance|0|||
23432609|NCT02008357|65327674|FG001|Open-label Extension Period|Non-Compliance|1|||
23622251|NCT00661713|66004867|FG003|Overall Study|Withdrawal by Subject|21|||
23622252|NCT00661713|66004868|FG004|Overall Study|Withdrawal by Subject|12|||
23622253|NCT00661713|66004869|FG005|Overall Study|Withdrawal by Subject|26|||
23622254|NCT00661713|66004870|FG006|Overall Study|Withdrawal by Subject|45|||
23432610|NCT02008357|65327673|FG000|Open-label Extension Period|Investigator Recommendation|0|||
23622255|NCT00661713|66004871|FG007|Overall Study|Withdrawal by Subject|9|||
23318205|NCT01130493|64908299|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
23318206|NCT01130493|64908300|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
23318207|NCT01130493|64908298|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
23318208|NCT01130493|64908299|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
23318209|NCT01130493|64908300|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
23318210|NCT01130493|64908298|FG000|Part 2: OLE|Adverse Event|0|||
23318211|NCT01130493|64908299|FG001|Part 2: OLE|Adverse Event|2|||
23318212|NCT01130493|64908300|FG002|Part 2: OLE|Adverse Event|1|||
23318213|NCT01130493|64908298|FG000|Part 2: OLE|Withdrawal by Subject|0|||
23318214|NCT01130493|64908299|FG001|Part 2: OLE|Withdrawal by Subject|1|||
23318215|NCT01130493|64908300|FG002|Part 2: OLE|Withdrawal by Subject|4|||
23318216|NCT02463357|64908303|FG000|Overall Study|Withdrawal by Subject|1|||
23318217|NCT02463357|64908304|FG001|Overall Study|Withdrawal by Subject|0|||
23432611|NCT02008357|65327674|FG001|Open-label Extension Period|Investigator Recommendation|1|||
23432612|NCT02008357|65327673|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
23432613|NCT02008357|65327674|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
23432614|NCT02008357|65327673|FG000|Open-label Extension Period|Coordinating Center Request|2|||
23432615|NCT02008357|65327674|FG001|Open-label Extension Period|Coordinating Center Request|4|||
23432616|NCT02008357|65327673|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
23318218|NCT02463357|64908305|FG002|Overall Study|Withdrawal by Subject|0|||
23318219|NCT02463357|64908306|FG003|Overall Study|Withdrawal by Subject|0|||
23318220|NCT02463357|64908307|FG004|Overall Study|Withdrawal by Subject|0|||
23318221|NCT02463357|64908303|FG000|Overall Study|Withdrawal by Subject|0|||
23318222|NCT02463357|64908304|FG001|Overall Study|Withdrawal by Subject|0|||
23318223|NCT02463357|64908305|FG002|Overall Study|Withdrawal by Subject|0|||
23318224|NCT02463357|64908306|FG003|Overall Study|Withdrawal by Subject|0|||
23318225|NCT02463357|64908307|FG004|Overall Study|Withdrawal by Subject|1|||
23318226|NCT00799058|64908310|FG000|Overall Study|Withdrawal by Subject|2|||
23318227|NCT00799058|64908311|FG001|Overall Study|Withdrawal by Subject|2|||
23318228|NCT00799058|64908312|FG002|Overall Study|Withdrawal by Subject|2|||
23432617|NCT02008357|65327674|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
23432618|NCT02008357|65327673|FG000|Open-label Extension Period|Study Ended|20|||
23432619|NCT02008357|65327674|FG001|Open-label Extension Period|Study Ended|25|||
23432620|NCT02008357|65327673|FG000|Open-label Extension Period|Personal Reasons|0|||
23432621|NCT02008357|65327674|FG001|Open-label Extension Period|Personal Reasons|1|||
23432622|NCT02008357|65327673|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
23432623|NCT02008357|65327674|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
23432624|NCT02008357|65327673|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
23554868|NCT01843374|65757957|FG001|Overall Study|Withdrawal by Subject|20|||
23554869|NCT01843374|65757956|FG000|Overall Study|Withdrawing due to Other reason|20|||
23554870|NCT01843374|65757957|FG001|Overall Study|Withdrawing due to Other reason|46|||
23554871|NCT02723864|65757958|FG000|Overall Study|Refused further treatment|1|||
23554872|NCT02723864|65757959|FG001|Overall Study|Refused further treatment|0|||
23554873|NCT02723864|65757960|FG002|Overall Study|Refused further treatment|0|||
23554874|NCT02723864|65757961|FG003|Overall Study|Refused further treatment|0|||
23554875|NCT02723864|65757962|FG004|Overall Study|Refused further treatment|1|||
23554876|NCT02723864|65757963|FG005|Overall Study|Refused further treatment|2|||
23554877|NCT02723864|65757964|FG006|Overall Study|Refused further treatment|0|||
23554878|NCT02723864|65757958|FG000|Overall Study|Exceed treatment hold time|0|||
23554879|NCT02723864|65757959|FG001|Overall Study|Exceed treatment hold time|1|||
23554880|NCT02723864|65757960|FG002|Overall Study|Exceed treatment hold time|0|||
23554881|NCT02723864|65757961|FG003|Overall Study|Exceed treatment hold time|0|||
23554882|NCT02723864|65757962|FG004|Overall Study|Exceed treatment hold time|0|||
23554883|NCT02723864|65757963|FG005|Overall Study|Exceed treatment hold time|0|||
23554884|NCT02723864|65757964|FG006|Overall Study|Exceed treatment hold time|0|||
23554885|NCT02723864|65757958|FG000|Overall Study|Clinical progression|0|||
23554886|NCT02723864|65757959|FG001|Overall Study|Clinical progression|0|||
23554887|NCT02723864|65757960|FG002|Overall Study|Clinical progression|1|||
23554888|NCT02723864|65757961|FG003|Overall Study|Clinical progression|0|||
23554889|NCT02723864|65757962|FG004|Overall Study|Clinical progression|0|||
23554890|NCT02723864|65757963|FG005|Overall Study|Clinical progression|3|||
23554891|NCT02723864|65757964|FG006|Overall Study|Clinical progression|1|||
23554892|NCT02723864|65757958|FG000|Overall Study|Physician Decision|0|||
23554893|NCT02723864|65757959|FG001|Overall Study|Physician Decision|0|||
23554894|NCT02723864|65757960|FG002|Overall Study|Physician Decision|0|||
23554895|NCT02723864|65757961|FG003|Overall Study|Physician Decision|0|||
23554896|NCT02723864|65757962|FG004|Overall Study|Physician Decision|0|||
23554897|NCT02723864|65757963|FG005|Overall Study|Physician Decision|0|||
23554898|NCT02723864|65757964|FG006|Overall Study|Physician Decision|1|||
23554899|NCT02723864|65757958|FG000|Overall Study|Changes in patient condition|0|||
23554900|NCT02723864|65757959|FG001|Overall Study|Changes in patient condition|0|||
23554901|NCT02723864|65757960|FG002|Overall Study|Changes in patient condition|0|||
23554902|NCT02723864|65757961|FG003|Overall Study|Changes in patient condition|0|||
23432625|NCT02008357|65327674|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
23432626|NCT02008357|65327673|FG000|Open-label Extension Period|Other|2|||
23622256|NCT00661713|66004864|FG000|Overall Study|Lost to Follow-up|2|||
23622257|NCT00661713|66004865|FG001|Overall Study|Lost to Follow-up|7|||
23622258|NCT00661713|66004866|FG002|Overall Study|Lost to Follow-up|2|||
23622259|NCT00661713|66004867|FG003|Overall Study|Lost to Follow-up|2|||
23622260|NCT00661713|66004868|FG004|Overall Study|Lost to Follow-up|5|||
23622261|NCT00661713|66004869|FG005|Overall Study|Lost to Follow-up|7|||
23622262|NCT00661713|66004870|FG006|Overall Study|Lost to Follow-up|14|||
23622263|NCT00661713|66004871|FG007|Overall Study|Lost to Follow-up|1|||
23216533|NCT00701103|64534511|FG003|Overall Study|Other|0|||
23318229|NCT00799058|64908310|FG000|Overall Study|Lost to Follow-up|1|||
23318230|NCT00799058|64908311|FG001|Overall Study|Lost to Follow-up|2|||
23318231|NCT00799058|64908312|FG002|Overall Study|Lost to Follow-up|1|||
23318232|NCT00799058|64908310|FG000|Overall Study|Adverse Event|0|||
23318233|NCT00799058|64908311|FG001|Overall Study|Adverse Event|2|||
23318234|NCT00799058|64908312|FG002|Overall Study|Adverse Event|0|||
23318235|NCT00799058|64908310|FG000|Overall Study|Pregnancy|1|||
23318236|NCT00799058|64908311|FG001|Overall Study|Pregnancy|0|||
23318237|NCT00799058|64908312|FG002|Overall Study|Pregnancy|0|||
23318238|NCT00799058|64908310|FG000|Overall Study|Not adherent|3|||
23216534|NCT00701103|64534512|FG004|Overall Study|Other|0|||
23216535|NCT00701103|64534513|FG005|Overall Study|Other|0|||
23216536|NCT00701103|64534514|FG006|Overall Study|Other|0|||
23216537|NCT00701103|64534515|FG007|Overall Study|Other|0|||
23216538|NCT00701103|64534516|FG008|Overall Study|Other|1|||
23432627|NCT02008357|65327674|FG001|Open-label Extension Period|Other|0|||
23318239|NCT00799058|64908311|FG001|Overall Study|Not adherent|2|||
23622264|NCT00661713|66004864|FG000|Overall Study|Administrative Reason|0|||
23622265|NCT00661713|66004865|FG001|Overall Study|Administrative Reason|1|||
23141073|NCT04097301|64267653|FG000|Overall Study|Withdrawal by Subject|1|||
23141074|NCT04097301|64267653|FG000|Overall Study|Screening Failure|5|||
23141075|NCT00985153|64267654|FG000|Overall Study|Lost to Follow-up|16|||
23141076|NCT00985153|64267655|FG001|Overall Study|Lost to Follow-up|19|||
23432628|NCT01375608|65327678|FG000|Overall Study|Withdrawal by Subject|2|||
23432629|NCT01948063|65327679|FG000|Overall Study|Boston MCI halted research protocol|0|||
23432630|NCT01948063|65327680|FG001|Overall Study|Boston MCI halted research protocol|1|||
23432631|NCT01948063|65327679|FG000|Overall Study|Discovered an enrollment in other study|0|||
23432632|NCT01948063|65327680|FG001|Overall Study|Discovered an enrollment in other study|1|||
23432633|NCT01948063|65327679|FG000|Overall Study|Blood samples were accidentally thawed|1|||
23141077|NCT00985153|64267656|FG002|Overall Study|Lost to Follow-up|17|||
23141078|NCT00985153|64267657|FG003|Overall Study|Lost to Follow-up|20|||
23141079|NCT00985153|64267654|FG000|Overall Study|Protocol Violation|3|||
23432634|NCT01948063|65327680|FG001|Overall Study|Blood samples were accidentally thawed|0|||
23432635|NCT01353911|65327687|FG000|Overall Study|Lost to Follow-up|2|||
23432636|NCT01353911|65327688|FG001|Overall Study|Lost to Follow-up|6|||
23432637|NCT01353911|65327689|FG002|Overall Study|Lost to Follow-up|4|||
23432638|NCT01353911|65327690|FG003|Overall Study|Lost to Follow-up|0|||
23432639|NCT01353911|65327691|FG004|Overall Study|Lost to Follow-up|4|||
23432640|NCT01353911|65327692|FG005|Overall Study|Lost to Follow-up|4|||
23318240|NCT00799058|64908312|FG002|Overall Study|Not adherent|1|||
23318241|NCT00799058|64908310|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
23318242|NCT00799058|64908311|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
23318243|NCT00799058|64908312|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
23318244|NCT00799058|64908310|FG000|Overall Study|IP dispensing error|1|||
23318245|NCT00799058|64908311|FG001|Overall Study|IP dispensing error|0|||
23318246|NCT00799058|64908312|FG002|Overall Study|IP dispensing error|0|||
23318247|NCT00799058|64908310|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
23622266|NCT00661713|66004866|FG002|Overall Study|Administrative Reason|0|||
23141080|NCT00985153|64267655|FG001|Overall Study|Protocol Violation|2|||
23141081|NCT00985153|64267656|FG002|Overall Study|Protocol Violation|4|||
23141082|NCT00985153|64267657|FG003|Overall Study|Protocol Violation|3|||
23216539|NCT00701103|64534517|FG009|Overall Study|Other|1|||
23216540|NCT00701103|64534518|FG010|Overall Study|Other|0|||
23216541|NCT00651313|64534519|FG000|Overall Study|Adverse Event|0|||
23318248|NCT00799058|64908311|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
23141083|NCT00985153|64267654|FG000|Overall Study|Withdrawal by Subject|6|||
23141084|NCT00985153|64267655|FG001|Overall Study|Withdrawal by Subject|11|||
23318249|NCT00799058|64908312|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
23318250|NCT00799058|64908310|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
23432641|NCT01353911|65327693|FG006|Overall Study|Lost to Follow-up|3|||
23432642|NCT01353911|65327694|FG007|Overall Study|Lost to Follow-up|6|||
23216542|NCT00651313|64534520|FG001|Overall Study|Adverse Event|1|||
23216543|NCT00651313|64534519|FG000|Overall Study|Withdrawal by Subject|3|||
23432643|NCT01353911|65327687|FG000|Overall Study|Withdrawal by Subject|2|||
23432644|NCT01353911|65327688|FG001|Overall Study|Withdrawal by Subject|3|||
23622267|NCT00661713|66004867|FG003|Overall Study|Administrative Reason|2|||
23432645|NCT01353911|65327689|FG002|Overall Study|Withdrawal by Subject|4|||
23432646|NCT01353911|65327690|FG003|Overall Study|Withdrawal by Subject|2|||
23432647|NCT01353911|65327691|FG004|Overall Study|Withdrawal by Subject|2|||
23432648|NCT01353911|65327692|FG005|Overall Study|Withdrawal by Subject|3|||
23432649|NCT01353911|65327693|FG006|Overall Study|Withdrawal by Subject|3|||
23432650|NCT01353911|65327694|FG007|Overall Study|Withdrawal by Subject|9|||
23432651|NCT01353911|65327687|FG000|Overall Study|Status Not Recorded|4|||
23432652|NCT01353911|65327688|FG001|Overall Study|Status Not Recorded|0|||
23318251|NCT00799058|64908311|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
23318252|NCT00799058|64908312|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
23318253|NCT00799058|64908310|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
23318254|NCT00799058|64908311|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
23318255|NCT00799058|64908312|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
23318256|NCT00799058|64908310|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
23340857|NCT01936181|64992870|FG000|Randomised, Double-blind|Pregnancy|0|||
23141085|NCT00985153|64267656|FG002|Overall Study|Withdrawal by Subject|11|||
23141086|NCT00985153|64267657|FG003|Overall Study|Withdrawal by Subject|10|||
23141087|NCT00985153|64267654|FG000|Overall Study|Missed One or More Bleeds|7|||
23141088|NCT00985153|64267655|FG001|Overall Study|Missed One or More Bleeds|7|||
23141089|NCT00985153|64267656|FG002|Overall Study|Missed One or More Bleeds|8|||
23141090|NCT00985153|64267657|FG003|Overall Study|Missed One or More Bleeds|10|||
23141091|NCT00985153|64267654|FG000|Overall Study|Incomplete Safety Follow-up|3|||
23141092|NCT00985153|64267655|FG001|Overall Study|Incomplete Safety Follow-up|5|||
23141093|NCT00985153|64267656|FG002|Overall Study|Incomplete Safety Follow-up|4|||
23141094|NCT00985153|64267657|FG003|Overall Study|Incomplete Safety Follow-up|4|||
23141095|NCT01183260|64267658|FG000|Overall Study|Intraop screen failure|2|||
23141096|NCT01183260|64267659|FG001|Overall Study|Intraop screen failure|0|||
23141097|NCT01183260|64267658|FG000|Overall Study|Withdrawal by Subject|1|||
23141098|NCT01183260|64267659|FG001|Overall Study|Withdrawal by Subject|1|||
23141099|NCT01183260|64267658|FG000|Overall Study|Revised within 30 days|0|||
23141100|NCT01183260|64267659|FG001|Overall Study|Revised within 30 days|1|||
23141101|NCT01183260|64267658|FG000|Overall Study|Death|1|||
23141102|NCT01183260|64267659|FG001|Overall Study|Death|0|||
23141103|NCT02673515|64267660|FG000|Overall Study|Lack of motivation|2|||
23141104|NCT02673515|64267661|FG001|Overall Study|Lack of motivation|1|||
23141105|NCT04256629|64267662|FG000|Overall Study|Adverse Event|0|||
23141106|NCT04256629|64267663|FG001|Overall Study|Adverse Event|0|||
23141107|NCT04256629|64267664|FG002|Overall Study|Adverse Event|0|||
23141108|NCT04256629|64267665|FG003|Overall Study|Adverse Event|0|||
23141109|NCT04256629|64267666|FG004|Overall Study|Adverse Event|0|||
23141110|NCT04256629|64267667|FG005|Overall Study|Adverse Event|1|||
23141111|NCT04256629|64267662|FG000|Overall Study|Protocol Violation|0|||
23141112|NCT04256629|64267663|FG001|Overall Study|Protocol Violation|1|||
23141113|NCT04256629|64267664|FG002|Overall Study|Protocol Violation|0|||
23141114|NCT04256629|64267665|FG003|Overall Study|Protocol Violation|0|||
23141115|NCT04256629|64267666|FG004|Overall Study|Protocol Violation|0|||
23141116|NCT04256629|64267667|FG005|Overall Study|Protocol Violation|0|||
23141117|NCT00178126|64267668|FG000|Overall Study|Lost to Follow-up|21|||
23141118|NCT00178126|64267669|FG001|Overall Study|Lost to Follow-up|21|||
23141119|NCT00178126|64267668|FG000|Overall Study|did not receive intervention|4|||
23141120|NCT00178126|64267669|FG001|Overall Study|did not receive intervention|6|||
23141121|NCT04002401|64267670|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
23141122|NCT04002401|64267670|FG000|Overall Study|Death|10|||
23141123|NCT04002401|64267670|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
23141124|NCT04002401|64267670|FG000|Overall Study|Enrolled but Never Treated|1|||
23141125|NCT04002401|64267670|FG000|Overall Study|Lost to Follow-up|1|||
23141126|NCT03737474|64267671|FG000|Overall Study|Adverse Event|18|||
23141127|NCT03737474|64267672|FG001|Overall Study|Adverse Event|48|||
23141128|NCT03737474|64267671|FG000|Overall Study|Lack of Efficacy|1|||
23141129|NCT03737474|64267672|FG001|Overall Study|Lack of Efficacy|3|||
23141130|NCT03737474|64267671|FG000|Overall Study|Protocol Violation|0|||
23141131|NCT03737474|64267672|FG001|Overall Study|Protocol Violation|8|||
23141132|NCT03737474|64267671|FG000|Overall Study|Withdrawal by Subject|5|||
23141133|NCT03737474|64267672|FG001|Overall Study|Withdrawal by Subject|20|||
23141134|NCT03737474|64267671|FG000|Overall Study|Non-compliance With Study Drug|0|||
23141135|NCT03737474|64267672|FG001|Overall Study|Non-compliance With Study Drug|1|||
23141136|NCT03737474|64267671|FG000|Overall Study|Physician Decision|1|||
23432653|NCT01353911|65327689|FG002|Overall Study|Status Not Recorded|1|||
23432654|NCT01353911|65327690|FG003|Overall Study|Status Not Recorded|0|||
23141137|NCT03737474|64267672|FG001|Overall Study|Physician Decision|4|||
23141138|NCT05249829|64267678|FG000|Overall Study|Participant Relocation|0|||
23141139|NCT05249829|64267679|FG001|Overall Study|Participant Relocation|1|||
23216544|NCT00651313|64534520|FG001|Overall Study|Withdrawal by Subject|1|||
23432655|NCT01353911|65327691|FG004|Overall Study|Status Not Recorded|0|||
23432656|NCT01353911|65327692|FG005|Overall Study|Status Not Recorded|0|||
23141140|NCT05249829|64267680|FG002|Overall Study|Participant Relocation|2|||
23141141|NCT05249829|64267681|FG003|Overall Study|Participant Relocation|2|||
23141142|NCT05249829|64267678|FG000|Overall Study|Withdrawal by Subject|9|||
23141143|NCT05249829|64267679|FG001|Overall Study|Withdrawal by Subject|17|||
23141144|NCT05249829|64267680|FG002|Overall Study|Withdrawal by Subject|40|||
23141145|NCT05249829|64267681|FG003|Overall Study|Withdrawal by Subject|35|||
23141146|NCT05249829|64267678|FG000|Overall Study|Physician Decision|1|||
23141147|NCT05249829|64267679|FG001|Overall Study|Physician Decision|0|||
23141148|NCT05249829|64267680|FG002|Overall Study|Physician Decision|0|||
23141149|NCT05249829|64267681|FG003|Overall Study|Physician Decision|0|||
23141150|NCT05249829|64267678|FG000|Overall Study|Lost to Follow-up|16|||
23318257|NCT00799058|64908311|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
23318258|NCT00799058|64908312|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
23432657|NCT01353911|65327693|FG006|Overall Study|Status Not Recorded|0|||
23432658|NCT01353911|65327694|FG007|Overall Study|Status Not Recorded|0|||
23432659|NCT01264419|65327695|FG000|Overall Study|Lost to Follow-up|3|||
23318259|NCT04778904|64908313|FG000|Overall Study|Protocol Violation|1|||
23318260|NCT04778904|64908314|FG001|Overall Study|Protocol Violation|0|||
23318261|NCT04778904|64908315|FG002|Overall Study|Protocol Violation|0|||
23318262|NCT04778904|64908316|FG003|Overall Study|Protocol Violation|0|||
23318263|NCT04778904|64908313|FG000|Overall Study|Withdrawal by Subject|0|||
23318264|NCT04778904|64908314|FG001|Overall Study|Withdrawal by Subject|0|||
23318265|NCT04778904|64908315|FG002|Overall Study|Withdrawal by Subject|1|||
23318266|NCT04778904|64908316|FG003|Overall Study|Withdrawal by Subject|0|||
23318267|NCT01611857|64908317|FG000|Overall Study|Withdrawal by Subject|0|||
23318268|NCT01611857|64908318|FG001|Overall Study|Withdrawal by Subject|2|||
23318269|NCT00233402|64908323|FG000|Overall Study|No pathology data|12|||
23318270|NCT00233402|64908324|FG001|Overall Study|No pathology data|9|||
23318271|NCT00233402|64908323|FG000|Overall Study|No Ta/T1|89|||
23318272|NCT00233402|64908324|FG001|Overall Study|No Ta/T1|94|||
23318273|NCT00233402|64908323|FG000|Overall Study|Lost to follow up etc|3|||
23318274|NCT00233402|64908324|FG001|Overall Study|Lost to follow up etc|21|||
23318275|NCT03323398|64908325|FG000|Overall Study|Other than Specified|0|||
23318276|NCT03323398|64908326|FG001|Overall Study|Other than Specified|1|||
23318277|NCT03323398|64908327|FG002|Overall Study|Other than Specified|2|||
23318278|NCT03323398|64908328|FG003|Overall Study|Other than Specified|0|||
23318279|NCT03323398|64908329|FG004|Overall Study|Other than Specified|0|||
23318280|NCT03323398|64908330|FG005|Overall Study|Other than Specified|0|||
23318281|NCT03323398|64908331|FG006|Overall Study|Other than Specified|1|||
23432660|NCT03131596|65327696|FG000|Overall Study|Protocol Violation|3|||
23554903|NCT02723864|65757962|FG004|Overall Study|Changes in patient condition|0|||
23554904|NCT02723864|65757963|FG005|Overall Study|Changes in patient condition|1|||
23554905|NCT02723864|65757964|FG006|Overall Study|Changes in patient condition|0|||
23554906|NCT02723864|65757958|FG000|Overall Study|Patient choice|0|||
23554907|NCT02723864|65757959|FG001|Overall Study|Patient choice|0|||
23554908|NCT02723864|65757960|FG002|Overall Study|Patient choice|0|||
23554909|NCT02723864|65757961|FG003|Overall Study|Patient choice|0|||
23554910|NCT02723864|65757962|FG004|Overall Study|Patient choice|0|||
23554911|NCT02723864|65757963|FG005|Overall Study|Patient choice|1|||
23554912|NCT02723864|65757964|FG006|Overall Study|Patient choice|0|||
23554913|NCT02723864|65757958|FG000|Overall Study|Adverse Event|0|||
23554914|NCT02723864|65757959|FG001|Overall Study|Adverse Event|0|||
23554915|NCT02723864|65757960|FG002|Overall Study|Adverse Event|0|||
23554916|NCT02723864|65757961|FG003|Overall Study|Adverse Event|0|||
23554917|NCT02723864|65757962|FG004|Overall Study|Adverse Event|0|||
23554918|NCT02723864|65757963|FG005|Overall Study|Adverse Event|1|||
23554919|NCT02723864|65757964|FG006|Overall Study|Adverse Event|0|||
23554920|NCT02723864|65757958|FG000|Overall Study|Started new treatment|0|||
23554921|NCT02723864|65757959|FG001|Overall Study|Started new treatment|0|||
23554922|NCT02723864|65757960|FG002|Overall Study|Started new treatment|0|||
23554923|NCT02723864|65757961|FG003|Overall Study|Started new treatment|0|||
23554924|NCT02723864|65757962|FG004|Overall Study|Started new treatment|0|||
23554925|NCT02723864|65757963|FG005|Overall Study|Started new treatment|1|||
23141151|NCT05249829|64267679|FG001|Overall Study|Lost to Follow-up|16|||
23318282|NCT03323398|64908332|FG007|Overall Study|Other than Specified|0|||
23318283|NCT03323398|64908333|FG008|Overall Study|Other than Specified|2|||
23554926|NCT02723864|65757964|FG006|Overall Study|Started new treatment|0|||
23141152|NCT05249829|64267680|FG002|Overall Study|Lost to Follow-up|57|||
23318284|NCT03323398|64908325|FG000|Overall Study|Lost to Follow-up|1|||
23318285|NCT03323398|64908326|FG001|Overall Study|Lost to Follow-up|2|||
23318286|NCT03323398|64908327|FG002|Overall Study|Lost to Follow-up|1|||
23432661|NCT03131596|65327697|FG001|Overall Study|Protocol Violation|3|||
23216545|NCT00651313|64534519|FG000|Overall Study|Lost to Follow-up|1|||
23432662|NCT03131596|65327696|FG000|Overall Study|Lost to Follow-up|3|||
23554927|NCT02723864|65757958|FG000|Overall Study|Switched to alternative treatment|0|||
23141153|NCT05249829|64267681|FG003|Overall Study|Lost to Follow-up|60|||
23216546|NCT00651313|64534520|FG001|Overall Study|Lost to Follow-up|1|||
23141154|NCT05249829|64267678|FG000|Overall Study|Adverse Event|2|||
23141155|NCT05249829|64267679|FG001|Overall Study|Adverse Event|2|||
23141156|NCT05249829|64267680|FG002|Overall Study|Adverse Event|2|||
23141157|NCT05249829|64267681|FG003|Overall Study|Adverse Event|2|||
23141158|NCT05249829|64267678|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
23141159|NCT05249829|64267679|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
23141160|NCT05249829|64267680|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
23141161|NCT05249829|64267681|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
23141162|NCT05249829|64267678|FG000|Overall Study|Protocol Violation|2|||
23141163|NCT05249829|64267679|FG001|Overall Study|Protocol Violation|0|||
23141164|NCT05249829|64267680|FG002|Overall Study|Protocol Violation|5|||
23141165|NCT05249829|64267681|FG003|Overall Study|Protocol Violation|3|||
23141166|NCT05249829|64267678|FG000|Overall Study|Death|0|||
23141167|NCT05249829|64267679|FG001|Overall Study|Death|1|||
23141168|NCT05249829|64267680|FG002|Overall Study|Death|2|||
23141169|NCT05249829|64267681|FG003|Overall Study|Death|4|||
23141170|NCT00842985|64267682|FG000|Screening|Did not meet entrance requirements|27|||
23141171|NCT00842985|64267682|FG000|First Intervention|Withdrawal by Subject|3|||
23141172|NCT00842985|64267682|FG000|First Intervention|Protocol Violation|3|||
23141173|NCT00842985|64267682|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
23141174|NCT00842985|64267682|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
23141175|NCT01048671|64267691|FG000|Overall Study|Protocol Violation|0|||
23141176|NCT01048671|64267692|FG001|Overall Study|Protocol Violation|1|||
23141177|NCT01048671|64267693|FG002|Overall Study|Protocol Violation|1|||
23141178|NCT01313689|64267696|FG000|24-Week Randomization 1|Adverse Event|10|||
23141179|NCT01313689|64267697|FG001|24-Week Randomization 1|Adverse Event|5|||
23141180|NCT01313689|64267698|FG002|24-Week Randomization 1|Adverse Event|0|||
23141181|NCT01313689|64267699|FG003|24-Week Randomization 1|Adverse Event|0|||
23141182|NCT01313689|64267700|FG004|24-Week Randomization 1|Adverse Event|0|||
23141183|NCT01313689|64267696|FG000|24-Week Randomization 1|Physician Decision|4|||
23318287|NCT03323398|64908328|FG003|Overall Study|Lost to Follow-up|0|||
23318288|NCT03323398|64908329|FG004|Overall Study|Lost to Follow-up|0|||
23318289|NCT03323398|64908330|FG005|Overall Study|Lost to Follow-up|0|||
23318290|NCT03323398|64908331|FG006|Overall Study|Lost to Follow-up|0|||
23141184|NCT01313689|64267697|FG001|24-Week Randomization 1|Physician Decision|5|||
23141185|NCT01313689|64267698|FG002|24-Week Randomization 1|Physician Decision|0|||
23141186|NCT01313689|64267699|FG003|24-Week Randomization 1|Physician Decision|0|||
23141187|NCT01313689|64267700|FG004|24-Week Randomization 1|Physician Decision|0|||
23141188|NCT01313689|64267696|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
23141189|NCT01313689|64267697|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
23141190|NCT01313689|64267698|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
23141191|NCT01313689|64267699|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
23141192|NCT01313689|64267700|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
23141193|NCT01313689|64267696|FG000|24-Week Randomization 2|Adverse Event|0|||
23141194|NCT01313689|64267697|FG001|24-Week Randomization 2|Adverse Event|0|||
23141195|NCT01313689|64267698|FG002|24-Week Randomization 2|Adverse Event|2|||
23141196|NCT01313689|64267699|FG003|24-Week Randomization 2|Adverse Event|0|||
23141197|NCT01313689|64267700|FG004|24-Week Randomization 2|Adverse Event|8|||
23141198|NCT01313689|64267696|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
23141199|NCT01313689|64267697|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
23141200|NCT01313689|64267698|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
23141201|NCT01313689|64267699|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
23141202|NCT01313689|64267700|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
23141203|NCT01313689|64267696|FG000|24-Week Randomization 2|Physician Decision|0|||
23141204|NCT01313689|64267697|FG001|24-Week Randomization 2|Physician Decision|0|||
23141205|NCT01313689|64267698|FG002|24-Week Randomization 2|Physician Decision|0|||
23141206|NCT01313689|64267699|FG003|24-Week Randomization 2|Physician Decision|0|||
23141207|NCT01313689|64267700|FG004|24-Week Randomization 2|Physician Decision|4|||
23141208|NCT03541174|64267701|FG000|Part 1 Double-Blind|Adverse Event|6|||
23141209|NCT03541174|64267702|FG001|Part 1 Double-Blind|Adverse Event|5|||
23141210|NCT03541174|64267703|FG002|Part 1 Double-Blind|Adverse Event|2|||
23141211|NCT03541174|64267704|FG003|Part 1 Double-Blind|Adverse Event|0|||
23141212|NCT03541174|64267705|FG004|Part 1 Double-Blind|Adverse Event|0|||
23141213|NCT03541174|64267706|FG005|Part 1 Double-Blind|Adverse Event|0|||
23141214|NCT03541174|64267701|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
23141215|NCT03541174|64267702|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
23141216|NCT03541174|64267703|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
23141217|NCT03541174|64267704|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
23141218|NCT03541174|64267705|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
23141219|NCT03541174|64267706|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
23141220|NCT03541174|64267701|FG000|Part 1 Double-Blind|Other reasons|3|||
23141221|NCT03541174|64267702|FG001|Part 1 Double-Blind|Other reasons|2|||
23141222|NCT03541174|64267703|FG002|Part 1 Double-Blind|Other reasons|3|||
23141223|NCT03541174|64267704|FG003|Part 1 Double-Blind|Other reasons|0|||
23318291|NCT03323398|64908332|FG007|Overall Study|Lost to Follow-up|0|||
23141224|NCT03541174|64267705|FG004|Part 1 Double-Blind|Other reasons|0|||
23141225|NCT03541174|64267706|FG005|Part 1 Double-Blind|Other reasons|0|||
23141226|NCT03541174|64267701|FG000|Part 2 Single-Blind|Adverse Event|0|||
23141227|NCT03541174|64267702|FG001|Part 2 Single-Blind|Adverse Event|0|||
23141228|NCT03541174|64267703|FG002|Part 2 Single-Blind|Adverse Event|0|||
23141229|NCT03541174|64267704|FG003|Part 2 Single-Blind|Adverse Event|25|||
23141230|NCT03541174|64267705|FG004|Part 2 Single-Blind|Adverse Event|0|||
23141231|NCT03541174|64267706|FG005|Part 2 Single-Blind|Adverse Event|0|||
23141232|NCT03541174|64267701|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
23141233|NCT03541174|64267702|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
23141234|NCT03541174|64267703|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
23141235|NCT03541174|64267704|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
23141236|NCT03541174|64267705|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
23141237|NCT03541174|64267706|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
23141238|NCT03541174|64267701|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
23141239|NCT03541174|64267702|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
23141240|NCT03541174|64267703|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
23141241|NCT03541174|64267704|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
23141242|NCT03541174|64267705|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
23141243|NCT03541174|64267706|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
23141244|NCT03541174|64267701|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
23141245|NCT03541174|64267702|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
23141246|NCT03541174|64267703|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
23141247|NCT03541174|64267704|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
23141248|NCT03541174|64267705|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
23141249|NCT03541174|64267706|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
23141250|NCT03541174|64267701|FG000|Part 2 Single-Blind|Death|0|||
23141251|NCT03541174|64267702|FG001|Part 2 Single-Blind|Death|0|||
23141252|NCT03541174|64267703|FG002|Part 2 Single-Blind|Death|0|||
23141253|NCT03541174|64267704|FG003|Part 2 Single-Blind|Death|5|||
23141254|NCT03541174|64267705|FG004|Part 2 Single-Blind|Death|0|||
23141255|NCT03541174|64267706|FG005|Part 2 Single-Blind|Death|0|||
23141256|NCT03541174|64267701|FG000|Part 2 Single-Blind|Pregnancy|0|||
23141257|NCT03541174|64267702|FG001|Part 2 Single-Blind|Pregnancy|0|||
23141258|NCT03541174|64267703|FG002|Part 2 Single-Blind|Pregnancy|0|||
23141259|NCT03541174|64267704|FG003|Part 2 Single-Blind|Pregnancy|1|||
23141260|NCT03541174|64267705|FG004|Part 2 Single-Blind|Pregnancy|0|||
23141261|NCT03541174|64267706|FG005|Part 2 Single-Blind|Pregnancy|0|||
23141262|NCT03541174|64267701|FG000|Part 2 Single-Blind|Other reasons|0|||
23141263|NCT03541174|64267702|FG001|Part 2 Single-Blind|Other reasons|0|||
23141264|NCT03541174|64267703|FG002|Part 2 Single-Blind|Other reasons|0|||
23432663|NCT03131596|65327697|FG001|Overall Study|Lost to Follow-up|0|||
23432664|NCT00558272|65327701|FG000|Overall Study|Adverse Event|10|||
23432665|NCT00558272|65327702|FG001|Overall Study|Adverse Event|0|||
23432666|NCT00558272|65327701|FG000|Overall Study|Death|1|||
23432667|NCT00558272|65327702|FG001|Overall Study|Death|0|||
23432668|NCT00558272|65327701|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
23432669|NCT00558272|65327702|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
23432670|NCT00558272|65327701|FG000|Overall Study|AZ study team decision|0|||
23432671|NCT00558272|65327702|FG001|Overall Study|AZ study team decision|1|||
23432672|NCT00558272|65327701|FG000|Overall Study|Incorrectly enrolled|1|||
23432673|NCT00558272|65327702|FG001|Overall Study|Incorrectly enrolled|0|||
23432674|NCT00558272|65327701|FG000|Overall Study|Withdrawal by Subject|0|||
23432675|NCT00558272|65327702|FG001|Overall Study|Withdrawal by Subject|1|||
23432676|NCT01220180|65327703|FG000|Overall Study|Lost to Follow-up|76|||
23432677|NCT01220180|65327703|FG000|Overall Study|Other|72|||
23432678|NCT01220180|65327703|FG000|Overall Study|Adverse Event|35|||
23432679|NCT01220180|65327703|FG000|Overall Study|Lack of Efficacy|22|||
23554928|NCT02723864|65757959|FG001|Overall Study|Switched to alternative treatment|0|||
23554929|NCT02723864|65757960|FG002|Overall Study|Switched to alternative treatment|0|||
23554930|NCT02723864|65757961|FG003|Overall Study|Switched to alternative treatment|0|||
23554931|NCT02723864|65757962|FG004|Overall Study|Switched to alternative treatment|0|||
23554932|NCT02723864|65757963|FG005|Overall Study|Switched to alternative treatment|1|||
23554933|NCT02723864|65757964|FG006|Overall Study|Switched to alternative treatment|0|||
23554934|NCT02723864|65757958|FG000|Overall Study|Late determination of ineligibility|0|||
23554935|NCT02723864|65757959|FG001|Overall Study|Late determination of ineligibility|0|||
23141265|NCT03541174|64267704|FG003|Part 2 Single-Blind|Other reasons|32|||
23141266|NCT03541174|64267705|FG004|Part 2 Single-Blind|Other reasons|0|||
23432680|NCT01220180|65327703|FG000|Overall Study|Death|1|||
23432681|NCT01220180|65327703|FG000|Overall Study|Randomized but not treated|1|||
23432682|NCT00483002|65327708|FG000|Overall Study|Adverse Event|68|||
23432683|NCT00483002|65327708|FG000|Overall Study|Lack of Efficacy|555|||
23141267|NCT03541174|64267706|FG005|Part 2 Single-Blind|Other reasons|0|||
23141268|NCT03541174|64267701|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
23432684|NCT00483002|65327708|FG000|Overall Study|Lost to Follow-up|962|||
23141269|NCT03541174|64267702|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
23141270|NCT03541174|64267703|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
23141271|NCT03541174|64267704|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
23554936|NCT02723864|65757960|FG002|Overall Study|Late determination of ineligibility|0|||
23554937|NCT02723864|65757961|FG003|Overall Study|Late determination of ineligibility|0|||
23554938|NCT02723864|65757962|FG004|Overall Study|Late determination of ineligibility|0|||
23554939|NCT02723864|65757963|FG005|Overall Study|Late determination of ineligibility|1|||
23554940|NCT02723864|65757964|FG006|Overall Study|Late determination of ineligibility|0|||
23554941|NCT00428090|65757967|FG000|Overall Study|Adverse Event|10|||
23554942|NCT00428090|65757968|FG001|Overall Study|Adverse Event|8|||
23554943|NCT00428090|65757969|FG002|Overall Study|Adverse Event|10|||
23554944|NCT00428090|65757970|FG003|Overall Study|Adverse Event|11|||
23554945|NCT00428090|65757967|FG000|Overall Study|Lost to Follow-up|3|||
23554946|NCT00428090|65757968|FG001|Overall Study|Lost to Follow-up|6|||
23554947|NCT00428090|65757969|FG002|Overall Study|Lost to Follow-up|1|||
23554948|NCT00428090|65757970|FG003|Overall Study|Lost to Follow-up|4|||
23554949|NCT00428090|65757967|FG000|Overall Study|Protocol Violation|3|||
23554950|NCT00428090|65757968|FG001|Overall Study|Protocol Violation|1|||
23554951|NCT00428090|65757969|FG002|Overall Study|Protocol Violation|3|||
23554952|NCT00428090|65757970|FG003|Overall Study|Protocol Violation|3|||
23554953|NCT00428090|65757967|FG000|Overall Study|Withdrawal by Subject|10|||
23554954|NCT00428090|65757968|FG001|Overall Study|Withdrawal by Subject|12|||
23554955|NCT00428090|65757969|FG002|Overall Study|Withdrawal by Subject|15|||
23554956|NCT00428090|65757970|FG003|Overall Study|Withdrawal by Subject|5|||
23554957|NCT00428090|65757967|FG000|Overall Study|Sponsor terminated study|0|||
23554958|NCT00428090|65757968|FG001|Overall Study|Sponsor terminated study|1|||
23554959|NCT00428090|65757969|FG002|Overall Study|Sponsor terminated study|0|||
23554960|NCT00428090|65757970|FG003|Overall Study|Sponsor terminated study|0|||
23554961|NCT00428090|65757967|FG000|Overall Study|Non-compliance|4|||
23554962|NCT00428090|65757968|FG001|Overall Study|Non-compliance|0|||
23554963|NCT00428090|65757969|FG002|Overall Study|Non-compliance|1|||
23554964|NCT00428090|65757970|FG003|Overall Study|Non-compliance|3|||
23141272|NCT03541174|64267705|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
23141273|NCT03541174|64267706|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
23141274|NCT03541174|64267701|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
23141275|NCT03541174|64267702|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
23141276|NCT03541174|64267703|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
23141277|NCT03541174|64267704|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
23554965|NCT00428090|65757967|FG000|Overall Study|Par. did not returned to visit|1|||
23554966|NCT00428090|65757968|FG001|Overall Study|Par. did not returned to visit|0|||
23554967|NCT00428090|65757969|FG002|Overall Study|Par. did not returned to visit|0|||
23554968|NCT00428090|65757970|FG003|Overall Study|Par. did not returned to visit|1|||
23554969|NCT00428090|65757967|FG000|Overall Study|Follow-Up visit not possible|1|||
23554970|NCT00428090|65757968|FG001|Overall Study|Follow-Up visit not possible|0|||
23554971|NCT00428090|65757969|FG002|Overall Study|Follow-Up visit not possible|0|||
23554972|NCT00428090|65757970|FG003|Overall Study|Follow-Up visit not possible|0|||
23554973|NCT00428090|65757967|FG000|Overall Study|Prohibited medication used for SAE|1|||
23554974|NCT00428090|65757968|FG001|Overall Study|Prohibited medication used for SAE|0|||
23554975|NCT00428090|65757969|FG002|Overall Study|Prohibited medication used for SAE|0|||
23622268|NCT00661713|66004868|FG004|Overall Study|Administrative Reason|2|||
23622269|NCT00661713|66004869|FG005|Overall Study|Administrative Reason|2|||
23622270|NCT00661713|66004870|FG006|Overall Study|Administrative Reason|1|||
23622271|NCT00661713|66004871|FG007|Overall Study|Administrative Reason|0|||
23622272|NCT00661713|66004864|FG000|Overall Study|Adverse Event|0|||
23622273|NCT00661713|66004865|FG001|Overall Study|Adverse Event|0|||
23622274|NCT00661713|66004866|FG002|Overall Study|Adverse Event|0|||
23622275|NCT00661713|66004867|FG003|Overall Study|Adverse Event|0|||
23622276|NCT00661713|66004868|FG004|Overall Study|Adverse Event|0|||
23622277|NCT00661713|66004869|FG005|Overall Study|Adverse Event|0|||
23622278|NCT00661713|66004870|FG006|Overall Study|Adverse Event|1|||
23622279|NCT00661713|66004871|FG007|Overall Study|Adverse Event|0|||
23622280|NCT00661713|66004864|FG000|Overall Study|Inappropriate Enrollment|0|||
23622281|NCT00661713|66004865|FG001|Overall Study|Inappropriate Enrollment|0|||
23622282|NCT00661713|66004866|FG002|Overall Study|Inappropriate Enrollment|0|||
23622283|NCT00661713|66004867|FG003|Overall Study|Inappropriate Enrollment|0|||
23622284|NCT00661713|66004868|FG004|Overall Study|Inappropriate Enrollment|0|||
23622285|NCT00661713|66004869|FG005|Overall Study|Inappropriate Enrollment|0|||
23622286|NCT00661713|66004870|FG006|Overall Study|Inappropriate Enrollment|1|||
23622287|NCT00661713|66004871|FG007|Overall Study|Inappropriate Enrollment|0|||
23622288|NCT02049515|66004872|FG000|Overall Study|Adverse Event|46|||
23141278|NCT03541174|64267705|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
23622289|NCT02049515|66004873|FG001|Overall Study|Adverse Event|2|||
23622290|NCT02049515|66004872|FG000|Overall Study|Protocol-specified Disease Progression|23|||
23216547|NCT00651313|64534519|FG000|Overall Study|Adminstrative Discontinuation|2|||
23622291|NCT02049515|66004873|FG001|Overall Study|Protocol-specified Disease Progression|2|||
23554976|NCT00428090|65757970|FG003|Overall Study|Prohibited medication used for SAE|0|||
23622292|NCT02049515|66004872|FG000|Overall Study|Death|6|||
23554977|NCT00428090|65757967|FG000|Overall Study|Death of par.|1|||
23432685|NCT00483002|65327708|FG000|Overall Study|Other|2|||
23432686|NCT00483002|65327708|FG000|Overall Study|Other|967|||
23432687|NCT00527319|65327709|FG000|Overall Study|Withdrawal by Subject|5|||
23432688|NCT00527319|65327710|FG001|Overall Study|Withdrawal by Subject|0|||
23432689|NCT00527319|65327711|FG002|Overall Study|Withdrawal by Subject|1|||
23432690|NCT00527319|65327709|FG000|Overall Study|Lost to Follow-up|1|||
23432691|NCT00527319|65327710|FG001|Overall Study|Lost to Follow-up|0|||
23432692|NCT00527319|65327711|FG002|Overall Study|Lost to Follow-up|0|||
23432693|NCT00527319|65327709|FG000|Overall Study|Death|0|||
23432694|NCT00527319|65327710|FG001|Overall Study|Death|3|||
23432695|NCT00527319|65327711|FG002|Overall Study|Death|1|||
23432696|NCT00527319|65327709|FG000|Overall Study|Intercurrent Medical Illness|0|||
23432697|NCT00527319|65327710|FG001|Overall Study|Intercurrent Medical Illness|1|||
23432698|NCT00527319|65327711|FG002|Overall Study|Intercurrent Medical Illness|3|||
23432699|NCT00527319|65327709|FG000|Overall Study|Adverse Event|0|||
23432700|NCT00527319|65327710|FG001|Overall Study|Adverse Event|0|||
23432701|NCT00527319|65327711|FG002|Overall Study|Adverse Event|1|||
23432702|NCT01753401|65327712|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
23432703|NCT01753401|65327713|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
23432704|NCT01753401|65327714|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
23432705|NCT01753401|65327715|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
23432706|NCT01753401|65327712|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
23432707|NCT01753401|65327713|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
23432708|NCT01753401|65327714|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
23432709|NCT01753401|65327715|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
23432710|NCT01753401|65327712|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
23432711|NCT01753401|65327713|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
23432712|NCT01753401|65327714|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
23432713|NCT01753401|65327715|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
23432714|NCT01753401|65327712|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
23432715|NCT01753401|65327713|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
23432716|NCT01753401|65327714|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
23432717|NCT01753401|65327715|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
23432718|NCT01753401|65327712|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
23432719|NCT01753401|65327713|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
23432720|NCT01753401|65327714|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
23432721|NCT01753401|65327715|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
23432722|NCT01753401|65327712|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
23432723|NCT01753401|65327713|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
23432724|NCT01753401|65327714|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
23432725|NCT01753401|65327715|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
23432726|NCT01753401|65327712|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
23432727|NCT01753401|65327713|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
23432728|NCT01753401|65327714|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
23432729|NCT01753401|65327715|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
23432730|NCT00576472|65327716|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432731|NCT00576472|65327717|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432732|NCT00576472|65327718|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432733|NCT00576472|65327719|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
23432734|NCT00576472|65327720|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432735|NCT00576472|65327721|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432736|NCT00576472|65327722|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432737|NCT00576472|65327723|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432738|NCT00576472|65327724|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432739|NCT00576472|65327725|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432740|NCT00576472|65327726|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432741|NCT00576472|65327727|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432742|NCT00576472|65327728|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432743|NCT00576472|65327729|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
23141279|NCT03541174|64267706|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
23141280|NCT03541174|64267701|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23141281|NCT03541174|64267702|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23141282|NCT03541174|64267703|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23141283|NCT03541174|64267704|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23141284|NCT03541174|64267705|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
23141285|NCT03541174|64267706|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
23216548|NCT00651313|64534520|FG001|Overall Study|Adminstrative Discontinuation|3|||
23432744|NCT00576472|65327730|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
23432745|NCT00576472|65327716|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
23216549|NCT01015820|64534521|FG000|Overall Study|Suboptimal measurements|1|||
23432746|NCT00576472|65327717|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
23432747|NCT00576472|65327718|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
23432748|NCT00576472|65327719|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
23432749|NCT00576472|65327720|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
23432750|NCT00576472|65327721|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
23432751|NCT00576472|65327722|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
23432752|NCT00576472|65327723|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
23432753|NCT00576472|65327724|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
23432754|NCT00576472|65327725|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
23432755|NCT00576472|65327726|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
23432756|NCT00576472|65327727|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
23432757|NCT00576472|65327728|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
23432758|NCT00576472|65327729|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
23432759|NCT00576472|65327730|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
23432760|NCT00576472|65327716|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432761|NCT00576472|65327717|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432762|NCT00576472|65327718|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432763|NCT00576472|65327719|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
23432764|NCT00576472|65327720|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432765|NCT00576472|65327721|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432766|NCT00576472|65327722|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432767|NCT00576472|65327723|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432768|NCT00576472|65327724|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432769|NCT00576472|65327725|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432770|NCT00576472|65327726|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432771|NCT00576472|65327727|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432772|NCT00576472|65327728|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432773|NCT00576472|65327729|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432774|NCT00576472|65327730|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
23432775|NCT00576472|65327716|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
23432776|NCT00576472|65327717|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
23432777|NCT00576472|65327718|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
23432778|NCT00576472|65327719|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
23432779|NCT00576472|65327720|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
23432780|NCT00576472|65327721|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
23432781|NCT00576472|65327722|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
23432782|NCT00576472|65327723|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
23432783|NCT00576472|65327724|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
23432784|NCT00576472|65327725|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
23432785|NCT00576472|65327726|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
23432786|NCT00576472|65327727|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
23432787|NCT00576472|65327728|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
23432788|NCT00576472|65327729|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
23432789|NCT00576472|65327730|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
23432790|NCT00576472|65327716|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432791|NCT00576472|65327717|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432792|NCT00576472|65327718|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432793|NCT00576472|65327719|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
23432794|NCT00576472|65327720|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432795|NCT00576472|65327721|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432796|NCT00576472|65327722|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432797|NCT00576472|65327723|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432798|NCT00576472|65327724|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432799|NCT00576472|65327725|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432800|NCT00576472|65327726|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432801|NCT00576472|65327727|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432802|NCT00576472|65327728|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432803|NCT00576472|65327729|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432804|NCT00576472|65327730|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
23432805|NCT00576472|65327716|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432806|NCT00576472|65327717|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432807|NCT00576472|65327718|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432808|NCT00576472|65327719|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432809|NCT00576472|65327720|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432810|NCT00576472|65327721|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432811|NCT00576472|65327722|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
23432812|NCT00576472|65327723|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432813|NCT00576472|65327724|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432814|NCT00576472|65327725|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432815|NCT00576472|65327726|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432816|NCT00576472|65327727|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432817|NCT00576472|65327728|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432818|NCT00576472|65327729|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432819|NCT00576472|65327730|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
23432820|NCT00576472|65327716|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
23432821|NCT00576472|65327717|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
23432822|NCT00576472|65327718|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
23432823|NCT00576472|65327719|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
23432824|NCT00576472|65327720|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
23432825|NCT00576472|65327721|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
23432826|NCT00576472|65327722|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
23141286|NCT03541174|64267701|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
23141287|NCT03541174|64267702|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
23141288|NCT03541174|64267703|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
23432827|NCT00576472|65327723|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
23432828|NCT00576472|65327724|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
23432829|NCT00576472|65327725|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
23432830|NCT00576472|65327726|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
23432831|NCT00576472|65327727|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
23432832|NCT00576472|65327728|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
23432833|NCT00576472|65327729|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
23432834|NCT00576472|65327730|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
23432835|NCT00576472|65327716|FG000|MPH Cross Over Phase|Physician Decision|0|||
23432836|NCT00576472|65327717|FG001|MPH Cross Over Phase|Physician Decision|0|||
23432837|NCT00576472|65327718|FG002|MPH Cross Over Phase|Physician Decision|0|||
23432838|NCT00576472|65327719|FG003|MPH Cross Over Phase|Physician Decision|0|||
23432839|NCT00576472|65327720|FG004|MPH Cross Over Phase|Physician Decision|0|||
23432840|NCT00576472|65327721|FG005|MPH Cross Over Phase|Physician Decision|0|||
23432841|NCT00576472|65327722|FG006|MPH Cross Over Phase|Physician Decision|4|||
23432842|NCT00576472|65327723|FG007|MPH Cross Over Phase|Physician Decision|0|||
23432843|NCT00576472|65327724|FG008|MPH Cross Over Phase|Physician Decision|0|||
23432844|NCT00576472|65327725|FG009|MPH Cross Over Phase|Physician Decision|0|||
23432845|NCT00576472|65327726|FG010|MPH Cross Over Phase|Physician Decision|0|||
23432846|NCT00576472|65327727|FG011|MPH Cross Over Phase|Physician Decision|0|||
23432847|NCT00576472|65327728|FG012|MPH Cross Over Phase|Physician Decision|0|||
23432848|NCT00576472|65327729|FG013|MPH Cross Over Phase|Physician Decision|0|||
23432849|NCT00576472|65327730|FG014|MPH Cross Over Phase|Physician Decision|0|||
23432850|NCT00576472|65327716|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432851|NCT00576472|65327717|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
23554978|NCT00428090|65757968|FG001|Overall Study|Death of par.|0|||
23554979|NCT00428090|65757969|FG002|Overall Study|Death of par.|1|||
23554980|NCT00428090|65757970|FG003|Overall Study|Death of par.|0|||
23554981|NCT00428090|65757967|FG000|Overall Study|Visit 7 exceed the visit window|0|||
23318292|NCT03323398|64908333|FG008|Overall Study|Lost to Follow-up|0|||
23318293|NCT03323398|64908325|FG000|Overall Study|Death|4|||
23318294|NCT03323398|64908326|FG001|Overall Study|Death|6|||
23318295|NCT03323398|64908327|FG002|Overall Study|Death|2|||
23318296|NCT03323398|64908328|FG003|Overall Study|Death|2|||
23318297|NCT03323398|64908329|FG004|Overall Study|Death|1|||
23318298|NCT03323398|64908330|FG005|Overall Study|Death|2|||
23318299|NCT03323398|64908331|FG006|Overall Study|Death|0|||
23318300|NCT03323398|64908332|FG007|Overall Study|Death|0|||
23318301|NCT03323398|64908333|FG008|Overall Study|Death|6|||
23318302|NCT03323398|64908325|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
23318303|NCT03323398|64908326|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
23318304|NCT03323398|64908327|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
23318305|NCT03323398|64908328|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
23318306|NCT03323398|64908329|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
23318307|NCT03323398|64908330|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
23318308|NCT03323398|64908331|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
23318309|NCT03323398|64908332|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
23318310|NCT03323398|64908333|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
23318311|NCT03323398|64908325|FG000|Overall Study|Withdrawal by Subject|2|||
23318312|NCT03323398|64908326|FG001|Overall Study|Withdrawal by Subject|1|||
23318313|NCT03323398|64908327|FG002|Overall Study|Withdrawal by Subject|3|||
23318314|NCT03323398|64908328|FG003|Overall Study|Withdrawal by Subject|0|||
23318315|NCT03323398|64908329|FG004|Overall Study|Withdrawal by Subject|0|||
23318316|NCT03323398|64908330|FG005|Overall Study|Withdrawal by Subject|1|||
23432852|NCT00576472|65327718|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432853|NCT00576472|65327719|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432854|NCT00576472|65327720|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
23554982|NCT00428090|65757968|FG001|Overall Study|Visit 7 exceed the visit window|1|||
23318317|NCT03323398|64908331|FG006|Overall Study|Withdrawal by Subject|0|||
23141289|NCT03541174|64267704|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
23141290|NCT03541174|64267705|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
23318318|NCT03323398|64908332|FG007|Overall Study|Withdrawal by Subject|0|||
23318319|NCT03323398|64908333|FG008|Overall Study|Withdrawal by Subject|0|||
23318320|NCT03323398|64908325|FG000|Overall Study|Participant was Put on Hospice|0|||
23318321|NCT03323398|64908326|FG001|Overall Study|Participant was Put on Hospice|0|||
23318322|NCT03323398|64908327|FG002|Overall Study|Participant was Put on Hospice|0|||
23141291|NCT03541174|64267706|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
23141292|NCT03541174|64267701|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23141293|NCT03541174|64267702|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23141294|NCT03541174|64267703|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23141295|NCT03541174|64267704|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23141296|NCT03541174|64267705|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
23141297|NCT03541174|64267706|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
23141298|NCT00324675|64267707|FG000|Overall Study|Adverse Event|1|||
23141299|NCT00324675|64267708|FG001|Overall Study|Adverse Event|0|||
23141300|NCT01209143|64267709|FG000|Overall Study|Adverse Event|2|||
23141301|NCT01209143|64267710|FG001|Overall Study|Adverse Event|1|||
23141302|NCT01209143|64267709|FG000|Overall Study|Death|0|||
23141303|NCT01209143|64267710|FG001|Overall Study|Death|1|||
23141304|NCT01209143|64267709|FG000|Overall Study|Physician Decision|3|||
23141305|NCT01209143|64267710|FG001|Overall Study|Physician Decision|1|||
23141306|NCT01209143|64267709|FG000|Overall Study|Lost to Follow-up|1|||
23141307|NCT01209143|64267710|FG001|Overall Study|Lost to Follow-up|0|||
23141308|NCT01209143|64267709|FG000|Overall Study|Withdrawal by Subject|2|||
23141309|NCT01209143|64267710|FG001|Overall Study|Withdrawal by Subject|1|||
23141310|NCT01209143|64267709|FG000|Overall Study|Disease progression|11|||
23141311|NCT01209143|64267710|FG001|Overall Study|Disease progression|16|||
23141312|NCT02679573|64267711|FG000|Overall Study|Adverse Event|13|||
23141313|NCT02679573|64267712|FG001|Overall Study|Adverse Event|6|||
23141314|NCT02679573|64267711|FG000|Overall Study|Lack of Efficacy|12|||
23141315|NCT02679573|64267712|FG001|Overall Study|Lack of Efficacy|15|||
23141316|NCT02679573|64267711|FG000|Overall Study|Could not complete required study visits|6|||
23141317|NCT02679573|64267712|FG001|Overall Study|Could not complete required study visits|2|||
23141318|NCT02679573|64267711|FG000|Overall Study|Withdrawal by Subject|2|||
23216550|NCT01015820|64534522|FG001|Overall Study|Suboptimal measurements|0|||
23216551|NCT01153893|64534523|FG000|Overall Study|Adverse Event|1|||
23216552|NCT01153893|64534524|FG001|Overall Study|Adverse Event|0|||
23216553|NCT00050622|64534525|FG000|Overall Study|Adverse Event|1|||
23216554|NCT03673956|64534526|FG000|Overall Study|Lost to Follow-up|1|||
23216555|NCT03673956|64534527|FG001|Overall Study|Lost to Follow-up|0|||
23216556|NCT03673956|64534528|FG002|Overall Study|Lost to Follow-up|0|||
23216557|NCT03673956|64534529|FG003|Overall Study|Lost to Follow-up|0|||
23318323|NCT03323398|64908328|FG003|Overall Study|Participant was Put on Hospice|0|||
23318324|NCT03323398|64908329|FG004|Overall Study|Participant was Put on Hospice|0|||
23318325|NCT03323398|64908330|FG005|Overall Study|Participant was Put on Hospice|0|||
23318326|NCT03323398|64908331|FG006|Overall Study|Participant was Put on Hospice|1|||
23318327|NCT03323398|64908332|FG007|Overall Study|Participant was Put on Hospice|0|||
23318328|NCT03323398|64908333|FG008|Overall Study|Participant was Put on Hospice|0|||
23318329|NCT03323398|64908325|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
23318330|NCT03323398|64908326|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
23318331|NCT03323398|64908327|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
23318332|NCT03323398|64908328|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
23318333|NCT03323398|64908329|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
23318334|NCT03323398|64908330|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
23318335|NCT03323398|64908331|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
23318336|NCT03323398|64908332|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
23141319|NCT02679573|64267712|FG001|Overall Study|Withdrawal by Subject|9|||
23141320|NCT02679573|64267711|FG000|Overall Study|Death|2|||
23141321|NCT02679573|64267712|FG001|Overall Study|Death|0|||
23141322|NCT02679573|64267711|FG000|Overall Study|Physician Decision|2|||
23141323|NCT02679573|64267712|FG001|Overall Study|Physician Decision|4|||
23318337|NCT03323398|64908333|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
23318338|NCT00582010|64908334|FG000|Overall Study|Death|0|||
23318339|NCT00582010|64908335|FG001|Overall Study|Death|1|||
23318340|NCT04194645|64908338|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23141324|NCT02679573|64267711|FG000|Overall Study|Lost to Follow-up|0|||
23141325|NCT02679573|64267712|FG001|Overall Study|Lost to Follow-up|3|||
23141326|NCT01759368|64267713|FG000|Overall Study|Lost to Follow-up|1|||
23141327|NCT01759368|64267714|FG001|Overall Study|Lost to Follow-up|0|||
23141328|NCT00986674|64267723|FG000|Overall Study|Lack of Efficacy|28|||
23141329|NCT00986674|64267724|FG001|Overall Study|Lack of Efficacy|25|||
23216558|NCT03673956|64534526|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
23318341|NCT04194645|64908339|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318342|NCT04194645|64908340|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318343|NCT04194645|64908341|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318344|NCT04194645|64908342|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318345|NCT04194645|64908343|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318346|NCT04194645|64908344|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318347|NCT04194645|64908345|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318348|NCT04194645|64908346|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318349|NCT04194645|64908347|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
23318350|NCT04194645|64908348|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318351|NCT04194645|64908349|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318352|NCT04194645|64908350|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318353|NCT04194645|64908351|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318354|NCT04194645|64908352|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
23318355|NCT01851330|64908353|FG000|Overall Study|Lack of Efficacy|10|||
23318356|NCT01851330|64908354|FG001|Overall Study|Lack of Efficacy|9|||
23318357|NCT01851330|64908355|FG002|Overall Study|Lack of Efficacy|2|||
23318358|NCT01851330|64908353|FG000|Overall Study|Lost to Follow-up|1|||
23318359|NCT01851330|64908354|FG001|Overall Study|Lost to Follow-up|6|||
23318360|NCT01851330|64908355|FG002|Overall Study|Lost to Follow-up|9|||
23318361|NCT01851330|64908353|FG000|Overall Study|Withdrew Consent|2|||
23318362|NCT01851330|64908354|FG001|Overall Study|Withdrew Consent|1|||
23318363|NCT01851330|64908355|FG002|Overall Study|Withdrew Consent|0|||
23318364|NCT01851330|64908353|FG000|Overall Study|Investigator's Discretion|0|||
23318365|NCT01851330|64908354|FG001|Overall Study|Investigator's Discretion|0|||
23318366|NCT01851330|64908355|FG002|Overall Study|Investigator's Discretion|1|||
23318367|NCT00261950|64908358|FG000|Overall Study|Lost to Follow-up|2|||
23318368|NCT00261950|64908358|FG000|Overall Study|Death|6|||
23318369|NCT00261950|64908358|FG000|Overall Study|Withdrawal by Subject|5|||
23318370|NCT00261950|64908358|FG000|Overall Study|Other|1|||
23318371|NCT00261950|64908358|FG000|Overall Study|Physician Decision|1|||
23318372|NCT00261950|64908358|FG000|Overall Study|Protocol specified Criteria|11|||
23318373|NCT00796757|64908359|FG000|Overall Study|Withdrawal by Subject|14|||
23318374|NCT00796757|64908359|FG000|Overall Study|Death|61|||
23318375|NCT00796757|64908359|FG000|Overall Study|Protocol Violation|1|||
23318376|NCT00796757|64908359|FG000|Overall Study|Participant noncompliance|1|||
23318377|NCT00796757|64908359|FG000|Overall Study|Investigator's decision|2|||
23318378|NCT00796757|64908359|FG000|Overall Study|Other|7|||
23318379|NCT00442962|64908360|FG000|Overall Study|Pregnancy|1|||
23318380|NCT00442962|64908360|FG000|Overall Study|Lost to Follow-up|7|||
23318381|NCT01442688|64908364|FG000|First Intervention|Withdrawal by Subject|1|||
23318382|NCT01442688|64908365|FG001|First Intervention|Withdrawal by Subject|0|||
23318383|NCT01442688|64908364|FG000|First Intervention|subject incarcerated|1|||
23318384|NCT01442688|64908365|FG001|First Intervention|subject incarcerated|0|||
23318385|NCT01442688|64908364|FG000|Second Intervention|Adverse Event|1|||
23318386|NCT01442688|64908365|FG001|Second Intervention|Adverse Event|0|||
23318387|NCT03316547|64908370|FG000|Overall Study|Death|3|||
23318388|NCT03316547|64908371|FG001|Overall Study|Death|1|||
23554983|NCT00428090|65757969|FG002|Overall Study|Visit 7 exceed the visit window|0|||
23554984|NCT00428090|65757970|FG003|Overall Study|Visit 7 exceed the visit window|0|||
23554985|NCT00428090|65757967|FG000|Overall Study|Medical monitor terminated par.|0|||
23554986|NCT00428090|65757968|FG001|Overall Study|Medical monitor terminated par.|1|||
23554987|NCT00428090|65757969|FG002|Overall Study|Medical monitor terminated par.|0|||
23554988|NCT00428090|65757970|FG003|Overall Study|Medical monitor terminated par.|0|||
23554989|NCT00428090|65757967|FG000|Overall Study|Mental status of par. was|0|||
23554990|NCT00428090|65757968|FG001|Overall Study|Mental status of par. was|1|||
23554991|NCT00428090|65757969|FG002|Overall Study|Mental status of par. was|0|||
23622293|NCT02049515|66004873|FG001|Overall Study|Death|0|||
23622294|NCT02049515|66004872|FG000|Overall Study|Physician Decision|5|||
23216559|NCT03673956|64534527|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
23216560|NCT03673956|64534528|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
23216561|NCT03673956|64534529|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
23216562|NCT03332303|64534532|FG000|Overall Study|Participant did not dose|1|||
23216563|NCT03332303|64534533|FG001|Overall Study|Participant did not dose|2|||
23216564|NCT03332303|64534534|FG002|Overall Study|Participant did not dose|0|||
23216565|NCT03332303|64534532|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
23216566|NCT03332303|64534533|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
23216567|NCT03332303|64534534|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
23216568|NCT03332303|64534532|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
23216569|NCT03332303|64534533|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
23216570|NCT03332303|64534534|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
23216571|NCT03332303|64534532|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
23318389|NCT03316547|64908370|FG000|Overall Study|Lost to Follow-up|6|||
23554992|NCT00428090|65757970|FG003|Overall Study|Mental status of par. was|0|||
23554993|NCT00428090|65757967|FG000|Overall Study|Worsening of AD|0|||
23554994|NCT00428090|65757968|FG001|Overall Study|Worsening of AD|0|||
23554995|NCT00428090|65757969|FG002|Overall Study|Worsening of AD|1|||
23554996|NCT00428090|65757970|FG003|Overall Study|Worsening of AD|0|||
23554997|NCT00428090|65757967|FG000|Overall Study|Excluded for concerning QTc value|0|||
23554998|NCT00428090|65757968|FG001|Overall Study|Excluded for concerning QTc value|0|||
23554999|NCT00428090|65757969|FG002|Overall Study|Excluded for concerning QTc value|1|||
23555000|NCT00428090|65757970|FG003|Overall Study|Excluded for concerning QTc value|0|||
23555001|NCT00428090|65757967|FG000|Overall Study|Insufficient AD documentation|0|||
23555002|NCT00428090|65757968|FG001|Overall Study|Insufficient AD documentation|0|||
23555003|NCT00428090|65757969|FG002|Overall Study|Insufficient AD documentation|1|||
23555004|NCT00428090|65757970|FG003|Overall Study|Insufficient AD documentation|0|||
23555005|NCT00428090|65757967|FG000|Overall Study|High MMSE scores|0|||
23555006|NCT00428090|65757968|FG001|Overall Study|High MMSE scores|0|||
23555007|NCT00428090|65757969|FG002|Overall Study|High MMSE scores|1|||
23555008|NCT00428090|65757970|FG003|Overall Study|High MMSE scores|0|||
23555009|NCT00428090|65757967|FG000|Overall Study|Deterioration of cognitive status|0|||
23555010|NCT00428090|65757968|FG001|Overall Study|Deterioration of cognitive status|0|||
23555011|NCT00428090|65757969|FG002|Overall Study|Deterioration of cognitive status|1|||
23318390|NCT03316547|64908371|FG001|Overall Study|Lost to Follow-up|6|||
23318391|NCT03316547|64908370|FG000|Overall Study|Withdrawal by Subject|3|||
23318392|NCT03316547|64908371|FG001|Overall Study|Withdrawal by Subject|2|||
23318393|NCT03316547|64908370|FG000|Overall Study|Transfer to another hospital|6|||
23318394|NCT03316547|64908371|FG001|Overall Study|Transfer to another hospital|4|||
23318395|NCT00402116|64908374|FG000|Overall Study|Jaw infection after surgery-other|1|||
23318396|NCT00402116|64908375|FG001|Overall Study|Jaw infection after surgery-other|0|||
23318397|NCT00402116|64908376|FG002|Overall Study|Jaw infection after surgery-other|0|||
23318398|NCT00402116|64908374|FG000|Overall Study|Withdrawal by Subject|1|||
23318399|NCT00402116|64908375|FG001|Overall Study|Withdrawal by Subject|0|||
23318400|NCT00402116|64908376|FG002|Overall Study|Withdrawal by Subject|5|||
23318401|NCT00402116|64908374|FG000|Overall Study|Treatment completed per protocol|1|||
23555012|NCT00428090|65757970|FG003|Overall Study|Deterioration of cognitive status|0|||
23555013|NCT00428090|65757967|FG000|Overall Study|Serious adverse event|0|||
23555014|NCT00428090|65757968|FG001|Overall Study|Serious adverse event|0|||
23555015|NCT00428090|65757969|FG002|Overall Study|Serious adverse event|1|||
23555016|NCT00428090|65757970|FG003|Overall Study|Serious adverse event|0|||
23555017|NCT00428090|65757967|FG000|Overall Study|Excluded for heart insufficiency|0|||
23555018|NCT00428090|65757968|FG001|Overall Study|Excluded for heart insufficiency|0|||
23555019|NCT00428090|65757969|FG002|Overall Study|Excluded for heart insufficiency|1|||
23555020|NCT00428090|65757970|FG003|Overall Study|Excluded for heart insufficiency|0|||
23555021|NCT00428090|65757967|FG000|Overall Study|Raised Creatinine Value|0|||
23555022|NCT00428090|65757968|FG001|Overall Study|Raised Creatinine Value|0|||
23555023|NCT00428090|65757969|FG002|Overall Study|Raised Creatinine Value|0|||
23555024|NCT00428090|65757970|FG003|Overall Study|Raised Creatinine Value|1|||
23318402|NCT00402116|64908375|FG001|Overall Study|Treatment completed per protocol|1|||
23216572|NCT03332303|64534533|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
23318403|NCT00402116|64908376|FG002|Overall Study|Treatment completed per protocol|2|||
23318404|NCT00402116|64908374|FG000|Overall Study|other complicating disease|0|||
23318405|NCT00402116|64908375|FG001|Overall Study|other complicating disease|0|||
23318406|NCT00402116|64908376|FG002|Overall Study|other complicating disease|2|||
23318407|NCT00402116|64908374|FG000|Overall Study|Disease Progression|0|||
23318408|NCT00402116|64908375|FG001|Overall Study|Disease Progression|4|||
23318409|NCT00402116|64908376|FG002|Overall Study|Disease Progression|38|||
23318410|NCT00402116|64908374|FG000|Overall Study|mistaken thrombocytopenia|0|||
23318411|NCT00402116|64908375|FG001|Overall Study|mistaken thrombocytopenia|0|||
23555025|NCT01024608|65757973|FG000|Overall Study|Adverse Event|1|||
23555026|NCT01024608|65757974|FG001|Overall Study|Adverse Event|0|||
23555027|NCT01024608|65757973|FG000|Overall Study|Withdrawal by Subject|1|||
23555028|NCT01024608|65757974|FG001|Overall Study|Withdrawal by Subject|0|||
23555029|NCT01024608|65757973|FG000|Overall Study|Lost to Follow-up|0|||
23555030|NCT01024608|65757974|FG001|Overall Study|Lost to Follow-up|1|||
23555031|NCT01024608|65757973|FG000|Overall Study|Protocol Violation|0|||
23216573|NCT03332303|64534534|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
23216574|NCT03332303|64534532|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
23318412|NCT00402116|64908376|FG002|Overall Study|mistaken thrombocytopenia|1|||
23318413|NCT00402116|64908374|FG000|Overall Study|decline related hyponatremia/tumor|0|||
23318414|NCT00402116|64908375|FG001|Overall Study|decline related hyponatremia/tumor|0|||
23318415|NCT00402116|64908376|FG002|Overall Study|decline related hyponatremia/tumor|1|||
23318416|NCT00402116|64908374|FG000|Overall Study|Adverse Event|0|||
23555032|NCT01024608|65757974|FG001|Overall Study|Protocol Violation|3|||
23555033|NCT01024608|65757973|FG000|Overall Study|Never received study treatment|2|||
23555034|NCT01024608|65757974|FG001|Overall Study|Never received study treatment|0|||
23318417|NCT00402116|64908375|FG001|Overall Study|Adverse Event|1|||
23318418|NCT00402116|64908376|FG002|Overall Study|Adverse Event|6|||
23318419|NCT03281876|64908377|FG000|Overall Study|Adverse Event|4|||
23318420|NCT03281876|64908378|FG001|Overall Study|Adverse Event|15|||
23318421|NCT03281876|64908377|FG000|Overall Study|Lost to Follow-up|1|||
23318422|NCT03281876|64908378|FG001|Overall Study|Lost to Follow-up|4|||
23318423|NCT03281876|64908377|FG000|Overall Study|Withdrawal by Subject|11|||
23318424|NCT03281876|64908378|FG001|Overall Study|Withdrawal by Subject|15|||
23318425|NCT03281876|64908377|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23318426|NCT03281876|64908378|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23555035|NCT02925676|65757975|FG000|Overall Study|Withdrawal by Subject|1|||
23555036|NCT02626780|65757979|FG000|Overall Study|Withdrawal by Subject|3|||
23555037|NCT00166296|65757980|FG000|Overall Study|Withdrawal by Subject|1|||
23555038|NCT00166296|65757981|FG001|Overall Study|Withdrawal by Subject|3|||
23555039|NCT00166296|65757980|FG000|Overall Study|Adverse Event|2|||
23555040|NCT00166296|65757981|FG001|Overall Study|Adverse Event|4|||
23555041|NCT00166296|65757980|FG000|Overall Study|Lost to Follow-up|4|||
23555042|NCT00166296|65757981|FG001|Overall Study|Lost to Follow-up|2|||
23555043|NCT04512066|65757984|FG000|Double-blind Treatment Period|Adverse Event|6|||
23555044|NCT04512066|65757985|FG001|Double-blind Treatment Period|Adverse Event|4|||
23555045|NCT04512066|65757986|FG002|Double-blind Treatment Period|Adverse Event|5|||
23555046|NCT04512066|65757987|FG003|Double-blind Treatment Period|Adverse Event|1|||
23555047|NCT04512066|65757988|FG004|Double-blind Treatment Period|Adverse Event|0|||
23555048|NCT04512066|65757989|FG005|Double-blind Treatment Period|Adverse Event|0|||
23555049|NCT04512066|65757984|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
23555050|NCT04512066|65757985|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
23555051|NCT04512066|65757986|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
23555052|NCT04512066|65757987|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
23555053|NCT04512066|65757988|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
23555054|NCT04512066|65757989|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
23555055|NCT04512066|65757984|FG000|Double-blind Treatment Period|Physician Decision|1|||
23555056|NCT04512066|65757985|FG001|Double-blind Treatment Period|Physician Decision|0|||
23555057|NCT04512066|65757986|FG002|Double-blind Treatment Period|Physician Decision|1|||
23555058|NCT04512066|65757987|FG003|Double-blind Treatment Period|Physician Decision|0|||
23555059|NCT04512066|65757988|FG004|Double-blind Treatment Period|Physician Decision|0|||
23555060|NCT04512066|65757989|FG005|Double-blind Treatment Period|Physician Decision|0|||
23555061|NCT04512066|65757984|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
23555062|NCT04512066|65757985|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
23555063|NCT04512066|65757986|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
23555064|NCT04512066|65757987|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
23555065|NCT04512066|65757988|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
23555066|NCT04512066|65757989|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
23555067|NCT04512066|65757984|FG000|Extension Period|Adverse Event|0|||
23555068|NCT04512066|65757985|FG001|Extension Period|Adverse Event|1|||
23555069|NCT04512066|65757986|FG002|Extension Period|Adverse Event|4|||
23555070|NCT04512066|65757987|FG003|Extension Period|Adverse Event|3|||
23555071|NCT04512066|65757988|FG004|Extension Period|Adverse Event|1|||
23555072|NCT04512066|65757989|FG005|Extension Period|Adverse Event|3|||
23555073|NCT04512066|65757984|FG000|Extension Period|Death|0|||
23555074|NCT04512066|65757985|FG001|Extension Period|Death|0|||
23555075|NCT04512066|65757986|FG002|Extension Period|Death|0|||
23555076|NCT04512066|65757987|FG003|Extension Period|Death|0|||
23555077|NCT04512066|65757988|FG004|Extension Period|Death|0|||
23555078|NCT04512066|65757989|FG005|Extension Period|Death|1|||
23555079|NCT04512066|65757984|FG000|Extension Period|Lack of Efficacy|0|||
23555080|NCT04512066|65757985|FG001|Extension Period|Lack of Efficacy|4|||
23555081|NCT04512066|65757986|FG002|Extension Period|Lack of Efficacy|4|||
23555082|NCT04512066|65757987|FG003|Extension Period|Lack of Efficacy|1|||
23216575|NCT03332303|64534533|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
23318427|NCT03281876|64908377|FG000|Overall Study|OTHER|5|||
23555083|NCT04512066|65757988|FG004|Extension Period|Lack of Efficacy|3|||
23555084|NCT04512066|65757989|FG005|Extension Period|Lack of Efficacy|3|||
23555085|NCT04512066|65757984|FG000|Extension Period|Lost to Follow-up|0|||
23555086|NCT04512066|65757985|FG001|Extension Period|Lost to Follow-up|1|||
23555087|NCT04512066|65757986|FG002|Extension Period|Lost to Follow-up|5|||
23555088|NCT04512066|65757987|FG003|Extension Period|Lost to Follow-up|2|||
23555089|NCT04512066|65757988|FG004|Extension Period|Lost to Follow-up|3|||
23555090|NCT04512066|65757989|FG005|Extension Period|Lost to Follow-up|2|||
23622295|NCT02049515|66004873|FG001|Overall Study|Physician Decision|1|||
23622296|NCT02049515|66004872|FG000|Overall Study|Withdrawal by Subject|3|||
23622297|NCT02049515|66004873|FG001|Overall Study|Withdrawal by Subject|0|||
23622298|NCT02049515|66004872|FG000|Overall Study|Termination of the Study by Sponsor|2|||
23318428|NCT03281876|64908378|FG001|Overall Study|OTHER|5|||
23318429|NCT00324987|64908379|FG000|Overall Study|Adverse Event|2|||
23318430|NCT00324987|64908380|FG001|Overall Study|Adverse Event|1|||
23432855|NCT00576472|65327721|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432856|NCT00576472|65327722|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432857|NCT00576472|65327723|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432858|NCT00576472|65327724|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
23432859|NCT00576472|65327725|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432860|NCT00576472|65327726|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
23432861|NCT00576472|65327727|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
23432862|NCT00576472|65327728|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
23432863|NCT00576472|65327729|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
23622299|NCT02049515|66004873|FG001|Overall Study|Termination of the Study by Sponsor|0|||
23622300|NCT02049515|66004872|FG000|Overall Study|Protocol Violation|1|||
23622301|NCT02049515|66004873|FG001|Overall Study|Protocol Violation|1|||
23622302|NCT02049515|66004872|FG000|Overall Study|Clinical Deterioration|1|||
23622303|NCT02049515|66004873|FG001|Overall Study|Clinical Deterioration|0|||
23622304|NCT02049515|66004872|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
23622305|NCT02049515|66004873|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
23622306|NCT02049515|66004872|FG000|Overall Study|Treatment Interruption >42 Days|1|||
23622307|NCT02049515|66004873|FG001|Overall Study|Treatment Interruption >42 Days|0|||
23432864|NCT00576472|65327730|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
23622308|NCT02049515|66004872|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
23622309|NCT02049515|66004873|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
23622310|NCT00570921|66004877|FG000|Overall Study|Protocol Violation|1|||
23622311|NCT00570921|66004877|FG000|Overall Study|Physician Decision|1|||
23622312|NCT02507687|66004878|FG000|Overall Study|Adverse Event|3|||
23622313|NCT02507687|66004879|FG001|Overall Study|Adverse Event|2|||
23622314|NCT02507687|66004880|FG002|Overall Study|Adverse Event|2|||
23622315|NCT02507687|66004881|FG003|Overall Study|Adverse Event|2|||
23622316|NCT02507687|66004878|FG000|Overall Study|Withdrawal by Subject|1|||
23622317|NCT02507687|66004879|FG001|Overall Study|Withdrawal by Subject|4|||
23622318|NCT02507687|66004880|FG002|Overall Study|Withdrawal by Subject|6|||
23622319|NCT02507687|66004881|FG003|Overall Study|Withdrawal by Subject|6|||
23622320|NCT02507687|66004878|FG000|Overall Study|Protocol Violation|1|||
23622321|NCT02507687|66004879|FG001|Overall Study|Protocol Violation|0|||
23622322|NCT02507687|66004880|FG002|Overall Study|Protocol Violation|2|||
23622323|NCT02507687|66004881|FG003|Overall Study|Protocol Violation|0|||
23555091|NCT04512066|65757984|FG000|Extension Period|Non-compliance with study drug|0|||
23555092|NCT04512066|65757985|FG001|Extension Period|Non-compliance with study drug|1|||
23555093|NCT04512066|65757986|FG002|Extension Period|Non-compliance with study drug|0|||
23555094|NCT04512066|65757987|FG003|Extension Period|Non-compliance with study drug|0|||
23555095|NCT04512066|65757988|FG004|Extension Period|Non-compliance with study drug|0|||
23555096|NCT04512066|65757989|FG005|Extension Period|Non-compliance with study drug|1|||
23555097|NCT04512066|65757984|FG000|Extension Period|Other|0|||
23555098|NCT04512066|65757985|FG001|Extension Period|Other|2|||
23555099|NCT04512066|65757986|FG002|Extension Period|Other|0|||
23555100|NCT04512066|65757987|FG003|Extension Period|Other|0|||
23555101|NCT04512066|65757988|FG004|Extension Period|Other|0|||
23555102|NCT04512066|65757989|FG005|Extension Period|Other|0|||
23555103|NCT04512066|65757984|FG000|Extension Period|Physician Decision|0|||
23555104|NCT04512066|65757985|FG001|Extension Period|Physician Decision|2|||
23555105|NCT04512066|65757986|FG002|Extension Period|Physician Decision|0|||
23555106|NCT04512066|65757987|FG003|Extension Period|Physician Decision|1|||
23555107|NCT04512066|65757988|FG004|Extension Period|Physician Decision|1|||
23555108|NCT04512066|65757989|FG005|Extension Period|Physician Decision|0|||
23555109|NCT04512066|65757984|FG000|Extension Period|Withdrawal by Subject|0|||
23555110|NCT04512066|65757985|FG001|Extension Period|Withdrawal by Subject|3|||
23555111|NCT04512066|65757986|FG002|Extension Period|Withdrawal by Subject|7|||
23555112|NCT04512066|65757987|FG003|Extension Period|Withdrawal by Subject|11|||
23555113|NCT04512066|65757988|FG004|Extension Period|Withdrawal by Subject|8|||
23622324|NCT02507687|66004878|FG000|Overall Study|Lost to Follow-up|0|||
23622325|NCT02507687|66004879|FG001|Overall Study|Lost to Follow-up|0|||
23622326|NCT02507687|66004880|FG002|Overall Study|Lost to Follow-up|2|||
23622327|NCT02507687|66004881|FG003|Overall Study|Lost to Follow-up|1|||
23432865|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23555114|NCT04512066|65757989|FG005|Extension Period|Withdrawal by Subject|4|||
23555115|NCT02178566|65757990|FG000|Overall Study|patient did not complete due to noncompliance|0|||
23555116|NCT02178566|65757991|FG001|Overall Study|patient did not complete due to noncompliance|1|||
23555117|NCT00645164|65757992|FG000|Overall Study|Lost to Follow-up|2|||
23555118|NCT00645164|65757992|FG000|Overall Study|Withdrawal by Subject|4|||
23622328|NCT02507687|66004878|FG000|Overall Study|Screen Failure|0|||
23622329|NCT02507687|66004879|FG001|Overall Study|Screen Failure|0|||
23555119|NCT00645164|65757992|FG000|Overall Study|Protocol Violation|1|||
23555120|NCT03489304|65757995|FG000|Overall Study|Lost to Follow-up|4|||
23622330|NCT02507687|66004880|FG002|Overall Study|Screen Failure|1|||
23622331|NCT02507687|66004881|FG003|Overall Study|Screen Failure|0|||
23622332|NCT02507687|66004878|FG000|Overall Study|Other, Not Specified|0|||
23622333|NCT02507687|66004879|FG001|Overall Study|Other, Not Specified|0|||
23622334|NCT02507687|66004880|FG002|Overall Study|Other, Not Specified|2|||
23622335|NCT02507687|66004881|FG003|Overall Study|Other, Not Specified|4|||
23622336|NCT03371485|66004882|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
23216576|NCT03332303|64534534|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
23216577|NCT03332303|64534532|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
23555121|NCT00952367|65757996|FG000|Overall Study|Withdrawal by Subject|2|||
23555122|NCT00952367|65757996|FG000|Overall Study|Noncoordination|1|||
23555123|NCT00952367|65757996|FG000|Overall Study|Protocol Violation|3|||
23555124|NCT00886340|65757999|FG000|Overall Study|Withdrawal by Subject|0|||
23555125|NCT00886340|65758000|FG001|Overall Study|Withdrawal by Subject|7|||
23555126|NCT02181803|65758004|FG000|Overall Study|Withdrawal by Subject|0|||
23555127|NCT02181803|65758005|FG001|Overall Study|Withdrawal by Subject|2|||
23555128|NCT02181803|65758006|FG002|Overall Study|Withdrawal by Subject|0|||
23318431|NCT00324987|64908379|FG000|Overall Study|Withdrawal by Subject|1|||
23318432|NCT00324987|64908380|FG001|Overall Study|Withdrawal by Subject|1|||
23318433|NCT00324987|64908379|FG000|Overall Study|Progression|1|||
23318434|NCT00324987|64908380|FG001|Overall Study|Progression|1|||
23318435|NCT00324987|64908379|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
23318436|NCT00324987|64908380|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
23318437|NCT01756079|64908389|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
23318438|NCT01756079|64908389|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
23318439|NCT01756079|64908389|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
23216578|NCT03332303|64534533|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
23216579|NCT03332303|64534534|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
23216580|NCT03332303|64534532|FG000|Overall Study|Participant had a significant protocol deviation|0|||
23555129|NCT02181803|65758007|FG003|Overall Study|Withdrawal by Subject|0|||
23216581|NCT03332303|64534533|FG001|Overall Study|Participant had a significant protocol deviation|1|||
23216582|NCT03332303|64534534|FG002|Overall Study|Participant had a significant protocol deviation|0|||
23216583|NCT01590212|64534535|FG000|Overall Study|Withdrawal by Subject|2|||
23216584|NCT01590212|64534536|FG001|Overall Study|Withdrawal by Subject|2|||
23216585|NCT01590212|64534537|FG002|Overall Study|Withdrawal by Subject|2|||
23216586|NCT01590212|64534535|FG000|Overall Study|Lost to Follow-up|1|||
23216587|NCT01590212|64534536|FG001|Overall Study|Lost to Follow-up|2|||
23216588|NCT01590212|64534537|FG002|Overall Study|Lost to Follow-up|3|||
23216589|NCT01803711|64534538|FG000|Overall Study|Adverse Event|1|||
23216590|NCT01803711|64534539|FG001|Overall Study|Adverse Event|1|||
23216591|NCT02067533|64534540|FG000|Overall Study|Lost to Follow-up|4|||
23216592|NCT02067533|64534541|FG001|Overall Study|Lost to Follow-up|2|||
23216593|NCT01827319|64534542|FG000|Overall Study|Lost to Follow-up|3|||
23216594|NCT03228394|64534543|FG000|Overall Study|Lost to Follow-up|0|||
23216595|NCT03228394|64534544|FG001|Overall Study|Lost to Follow-up|0|||
23216596|NCT03228394|64534545|FG002|Overall Study|Lost to Follow-up|1|||
23216597|NCT03228394|64534546|FG003|Overall Study|Lost to Follow-up|1|||
23216598|NCT03228394|64534547|FG004|Overall Study|Lost to Follow-up|0|||
23555130|NCT02181803|65758008|FG004|Overall Study|Withdrawal by Subject|0|||
23555131|NCT02181803|65758009|FG005|Overall Study|Withdrawal by Subject|0|||
23622337|NCT03371485|66004882|FG000|2-year Follow-up|Death|5|||
23622338|NCT03022578|66004884|FG000|Overall Study|Adverse Event|1|||
23622339|NCT03022578|66004884|FG000|Overall Study|Lack of Efficacy|2|||
23622340|NCT03022578|66004884|FG000|Overall Study|Withdrawal by Subject|1|||
23622341|NCT01004185|66004887|FG000|Overall Study|Adverse Event|1|||
23622342|NCT01004185|66004888|FG001|Overall Study|Adverse Event|1|||
23622343|NCT01004185|66004887|FG000|Overall Study|Lost to Follow-up|0|||
23622344|NCT01004185|66004888|FG001|Overall Study|Lost to Follow-up|1|||
23622345|NCT01004185|66004887|FG000|Overall Study|Lack of Efficacy|2|||
23622346|NCT01004185|66004888|FG001|Overall Study|Lack of Efficacy|1|||
23622347|NCT01004185|66004887|FG000|Overall Study|Sponsor Terminated Study|4|||
23622348|NCT01004185|66004888|FG001|Overall Study|Sponsor Terminated Study|5|||
23555132|NCT02181803|65758010|FG006|Overall Study|Withdrawal by Subject|0|||
23555133|NCT02181803|65758011|FG007|Overall Study|Withdrawal by Subject|0|||
23555134|NCT02181803|65758012|FG008|Overall Study|Withdrawal by Subject|0|||
23622349|NCT01004185|66004887|FG000|Overall Study|Withdrawal by Subject|2|||
23622350|NCT01004185|66004888|FG001|Overall Study|Withdrawal by Subject|1|||
23216599|NCT03228394|64534548|FG005|Overall Study|Lost to Follow-up|0|||
23216600|NCT03228394|64534549|FG006|Overall Study|Lost to Follow-up|2|||
23216601|NCT03228394|64534550|FG007|Overall Study|Lost to Follow-up|0|||
23216602|NCT03228394|64534543|FG000|Overall Study|Withdrawal by Subject|0|||
23216603|NCT03228394|64534544|FG001|Overall Study|Withdrawal by Subject|0|||
23216604|NCT03228394|64534545|FG002|Overall Study|Withdrawal by Subject|1|||
23216605|NCT03228394|64534546|FG003|Overall Study|Withdrawal by Subject|0|||
23555135|NCT02181803|65758004|FG000|Overall Study|Physician Decision|0|||
23555136|NCT02181803|65758005|FG001|Overall Study|Physician Decision|0|||
23318440|NCT01756079|64908389|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
23318441|NCT01756079|64908389|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
23318442|NCT02792699|64908390|FG000|Overall Study|Adverse Event|1|||
23318443|NCT02792699|64908391|FG001|Overall Study|Adverse Event|2|||
23318444|NCT02792699|64908392|FG002|Overall Study|Adverse Event|4|||
23432866|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432867|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23622351|NCT01101061|66004891|FG000|Overall Study|Adverse Event|0|||
23555137|NCT02181803|65758006|FG002|Overall Study|Physician Decision|0|||
23555138|NCT02181803|65758007|FG003|Overall Study|Physician Decision|1|||
23141330|NCT00986674|64267725|FG002|Overall Study|Lack of Efficacy|23|||
23141331|NCT00986674|64267723|FG000|Overall Study|Adverse Event|4|||
23141332|NCT00986674|64267724|FG001|Overall Study|Adverse Event|8|||
23141333|NCT00986674|64267725|FG002|Overall Study|Adverse Event|9|||
23141334|NCT00986674|64267723|FG000|Overall Study|Death|5|||
23141335|NCT00986674|64267724|FG001|Overall Study|Death|0|||
23141336|NCT00986674|64267725|FG002|Overall Study|Death|4|||
23141337|NCT00986674|64267723|FG000|Overall Study|Withdrawal by Subject|6|||
23432868|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432869|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432870|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432871|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432872|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432873|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432874|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432875|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432876|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432877|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432878|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
23432879|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
23432880|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
23555139|NCT02181803|65758008|FG004|Overall Study|Physician Decision|0|||
23555140|NCT02181803|65758009|FG005|Overall Study|Physician Decision|0|||
23555141|NCT02181803|65758010|FG006|Overall Study|Physician Decision|0|||
23555142|NCT02181803|65758011|FG007|Overall Study|Physician Decision|1|||
23555143|NCT02181803|65758012|FG008|Overall Study|Physician Decision|0|||
23141338|NCT00986674|64267724|FG001|Overall Study|Withdrawal by Subject|2|||
23141339|NCT00986674|64267725|FG002|Overall Study|Withdrawal by Subject|1|||
23141340|NCT00986674|64267723|FG000|Overall Study|alternative therapy|0|||
23141341|NCT00986674|64267724|FG001|Overall Study|alternative therapy|0|||
23141342|NCT00986674|64267725|FG002|Overall Study|alternative therapy|1|||
23555144|NCT02181803|65758004|FG000|Overall Study|Adverse Event|0|||
23141343|NCT00986674|64267723|FG000|Overall Study|not start protocol therapy|4|||
23141344|NCT00986674|64267724|FG001|Overall Study|not start protocol therapy|3|||
23141345|NCT00986674|64267725|FG002|Overall Study|not start protocol therapy|1|||
23141346|NCT00986674|64267723|FG000|Overall Study|unknown/not specify|0|||
23555145|NCT02181803|65758005|FG001|Overall Study|Adverse Event|2|||
23555146|NCT02181803|65758006|FG002|Overall Study|Adverse Event|0|||
23555147|NCT02181803|65758007|FG003|Overall Study|Adverse Event|1|||
23555148|NCT02181803|65758008|FG004|Overall Study|Adverse Event|0|||
23555149|NCT02181803|65758009|FG005|Overall Study|Adverse Event|0|||
23555150|NCT02181803|65758010|FG006|Overall Study|Adverse Event|1|||
23555151|NCT02181803|65758011|FG007|Overall Study|Adverse Event|0|||
23555152|NCT02181803|65758012|FG008|Overall Study|Adverse Event|0|||
23555153|NCT02487810|65758014|FG000|Overall Study|Withdrawal by Subject|1|||
23555154|NCT02487810|65758015|FG001|Overall Study|Withdrawal by Subject|0|||
23555155|NCT02732938|65758019|FG000|Overall Study|Death|0|||
23622352|NCT01101061|66004892|FG001|Overall Study|Adverse Event|0|||
23141347|NCT00986674|64267724|FG001|Overall Study|unknown/not specify|7|||
23141348|NCT00986674|64267725|FG002|Overall Study|unknown/not specify|9|||
23141349|NCT02533570|64267726|FG000|Overall Study|Adverse Event|0|||
23141350|NCT02533570|64267727|FG001|Overall Study|Adverse Event|1|||
23141351|NCT02533570|64267728|FG002|Overall Study|Adverse Event|1|||
23141352|NCT01201265|64267729|FG000|Overall Study|Death|14|||
23141353|NCT01201265|64267729|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23141354|NCT01201265|64267729|FG000|Overall Study|Lost to Follow-up|10|||
23141355|NCT01201265|64267729|FG000|Overall Study|Withdrawal by Subject|7|||
23141356|NCT01201265|64267729|FG000|Overall Study|Disease Progression|4|||
23141357|NCT01065844|64267730|FG000|Overall Study|Adverse Event|5|||
23141358|NCT01776541|64267731|FG000|Overall Study|Administrative Reason|6|||
23141359|NCT01776541|64267732|FG001|Overall Study|Administrative Reason|2|||
23141360|NCT01776541|64267731|FG000|Overall Study|Death|4|||
23141361|NCT01776541|64267732|FG001|Overall Study|Death|0|||
23141362|NCT01776541|64267731|FG000|Overall Study|Lost to Follow-up|27|||
23141363|NCT01776541|64267732|FG001|Overall Study|Lost to Follow-up|48|||
23318445|NCT02792699|64908390|FG000|Overall Study|Withdrawal by Subject|4|||
23318446|NCT02792699|64908391|FG001|Overall Study|Withdrawal by Subject|4|||
23318447|NCT02792699|64908392|FG002|Overall Study|Withdrawal by Subject|3|||
23318448|NCT02792699|64908390|FG000|Overall Study|Lost to Follow-up|0|||
23318449|NCT02792699|64908391|FG001|Overall Study|Lost to Follow-up|1|||
23318450|NCT02792699|64908392|FG002|Overall Study|Lost to Follow-up|2|||
23318451|NCT02792699|64908390|FG000|Overall Study|Physician Decision|2|||
23141364|NCT01776541|64267731|FG000|Overall Study|Unclassified|5|||
23141365|NCT01776541|64267732|FG001|Overall Study|Unclassified|4|||
23141366|NCT01776541|64267731|FG000|Overall Study|Protocol Violation|2|||
23141367|NCT01776541|64267732|FG001|Overall Study|Protocol Violation|1|||
23432881|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
23318452|NCT02792699|64908391|FG001|Overall Study|Physician Decision|0|||
23318453|NCT02792699|64908392|FG002|Overall Study|Physician Decision|0|||
23141368|NCT01776541|64267731|FG000|Overall Study|Withdrawal by Subject|12|||
23141369|NCT01776541|64267732|FG001|Overall Study|Withdrawal by Subject|20|||
23141370|NCT01877837|64267733|FG000|Overall Study|Lost to Follow-up|1|||
23141371|NCT01877837|64267733|FG000|Overall Study|Ineligible|4|||
23141372|NCT01011387|64267734|FG000|Overall Study|Withdrawal by Subject|3|||
23141373|NCT01011387|64267734|FG000|Overall Study|Adverse Event|2|||
23141374|NCT01011387|64267734|FG000|Overall Study|Protocol Violation|1|||
23141375|NCT02842827|64267735|FG000|Overall Study|Adverse Event|0|||
23141376|NCT02842827|64267736|FG001|Overall Study|Adverse Event|1|||
23141377|NCT02842827|64267737|FG002|Overall Study|Adverse Event|0|||
23141378|NCT02842827|64267738|FG003|Overall Study|Adverse Event|1|||
23141379|NCT02842827|64267739|FG004|Overall Study|Adverse Event|0|||
23216606|NCT03228394|64534547|FG004|Overall Study|Withdrawal by Subject|0|||
23216607|NCT03228394|64534548|FG005|Overall Study|Withdrawal by Subject|0|||
23216608|NCT03228394|64534549|FG006|Overall Study|Withdrawal by Subject|1|||
23432882|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
23432883|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
23432884|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
23432885|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
23432886|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
23216609|NCT03228394|64534550|FG007|Overall Study|Withdrawal by Subject|3|||
23216610|NCT03228394|64534543|FG000|Overall Study|Protocol Violation|0|||
23216611|NCT03228394|64534544|FG001|Overall Study|Protocol Violation|0|||
23216612|NCT03228394|64534545|FG002|Overall Study|Protocol Violation|0|||
23216613|NCT03228394|64534546|FG003|Overall Study|Protocol Violation|1|||
23216614|NCT03228394|64534547|FG004|Overall Study|Protocol Violation|0|||
23216615|NCT03228394|64534548|FG005|Overall Study|Protocol Violation|0|||
23216616|NCT03228394|64534549|FG006|Overall Study|Protocol Violation|0|||
23216617|NCT03228394|64534550|FG007|Overall Study|Protocol Violation|0|||
23216618|NCT03228394|64534543|FG000|Overall Study|Physician Decision|0|||
23216619|NCT03228394|64534544|FG001|Overall Study|Physician Decision|0|||
23216620|NCT03228394|64534545|FG002|Overall Study|Physician Decision|0|||
23216621|NCT03228394|64534546|FG003|Overall Study|Physician Decision|0|||
23216622|NCT03228394|64534547|FG004|Overall Study|Physician Decision|0|||
23216623|NCT03228394|64534548|FG005|Overall Study|Physician Decision|0|||
23216624|NCT03228394|64534549|FG006|Overall Study|Physician Decision|1|||
23216625|NCT03228394|64534550|FG007|Overall Study|Physician Decision|0|||
23216626|NCT03228394|64534543|FG000|Overall Study|Noncompliance|0|||
23216627|NCT03228394|64534544|FG001|Overall Study|Noncompliance|0|||
23216628|NCT03228394|64534545|FG002|Overall Study|Noncompliance|0|||
23216629|NCT03228394|64534546|FG003|Overall Study|Noncompliance|0|||
23216630|NCT03228394|64534547|FG004|Overall Study|Noncompliance|0|||
23216631|NCT03228394|64534548|FG005|Overall Study|Noncompliance|0|||
23216632|NCT03228394|64534549|FG006|Overall Study|Noncompliance|1|||
23216633|NCT03228394|64534550|FG007|Overall Study|Noncompliance|0|||
23216634|NCT01602549|64534553|FG000|Overall Study|Protocol Violation|0|||
23216635|NCT01602549|64534554|FG001|Overall Study|Protocol Violation|1|||
23216636|NCT01602549|64534553|FG000|Overall Study|Withdrawal by Subject|1|||
23216637|NCT01602549|64534554|FG001|Overall Study|Withdrawal by Subject|0|||
23318454|NCT02792699|64908390|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
23318455|NCT02792699|64908391|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
23318456|NCT02792699|64908392|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
23141380|NCT02842827|64267740|FG005|Overall Study|Adverse Event|1|||
23141381|NCT02842827|64267741|FG006|Overall Study|Adverse Event|0|||
23141382|NCT02842827|64267742|FG007|Overall Study|Adverse Event|0|||
23141383|NCT02842827|64267735|FG000|Overall Study|Death|1|||
23216638|NCT01263093|64534555|FG000|Washout|Physician Decision|1|||
23216639|NCT01263093|64534556|FG001|Washout|Physician Decision|0|||
23216640|NCT01263093|64534555|FG000|Period 2|Adverse Event|1|||
23216641|NCT01263093|64534556|FG001|Period 2|Adverse Event|0|||
23141384|NCT02842827|64267736|FG001|Overall Study|Death|0|||
23216642|NCT03170258|64534559|FG000|Overall Study|Physician Decision|4|||
23216643|NCT03170258|64534560|FG001|Overall Study|Physician Decision|0|||
23318457|NCT02792699|64908390|FG000|Overall Study|Other|1|||
23318458|NCT02792699|64908391|FG001|Overall Study|Other|0|||
23318459|NCT02792699|64908392|FG002|Overall Study|Other|0|||
23318460|NCT03278626|64908393|FG000|Overall Study|Death|2|||
23141385|NCT02842827|64267737|FG002|Overall Study|Death|2|||
23141386|NCT02842827|64267738|FG003|Overall Study|Death|3|||
23318461|NCT03278626|64908393|FG000|Overall Study|Toxicity|1|||
23141387|NCT02842827|64267739|FG004|Overall Study|Death|2|||
23141388|NCT02842827|64267740|FG005|Overall Study|Death|1|||
23141389|NCT02842827|64267741|FG006|Overall Study|Death|0|||
23141390|NCT02842827|64267742|FG007|Overall Study|Death|4|||
23141391|NCT02842827|64267735|FG000|Overall Study|Physician Decision|1|||
23141392|NCT02842827|64267736|FG001|Overall Study|Physician Decision|3|||
23141393|NCT02842827|64267737|FG002|Overall Study|Physician Decision|0|||
23141394|NCT02842827|64267738|FG003|Overall Study|Physician Decision|0|||
23141395|NCT02842827|64267739|FG004|Overall Study|Physician Decision|1|||
23141396|NCT02842827|64267740|FG005|Overall Study|Physician Decision|4|||
23141397|NCT02842827|64267741|FG006|Overall Study|Physician Decision|2|||
23141398|NCT02842827|64267742|FG007|Overall Study|Physician Decision|1|||
23141399|NCT02842827|64267735|FG000|Overall Study|Protocol Defined Disease Progression|0|||
23141400|NCT02842827|64267736|FG001|Overall Study|Protocol Defined Disease Progression|0|||
23141401|NCT02842827|64267737|FG002|Overall Study|Protocol Defined Disease Progression|0|||
23141402|NCT02842827|64267738|FG003|Overall Study|Protocol Defined Disease Progression|0|||
23141403|NCT02842827|64267739|FG004|Overall Study|Protocol Defined Disease Progression|0|||
23141404|NCT02842827|64267740|FG005|Overall Study|Protocol Defined Disease Progression|1|||
23141405|NCT02842827|64267741|FG006|Overall Study|Protocol Defined Disease Progression|0|||
23141406|NCT02842827|64267742|FG007|Overall Study|Protocol Defined Disease Progression|0|||
23141407|NCT02842827|64267735|FG000|Overall Study|Participant Withdrawal of Consent|1|||
23141408|NCT02842827|64267736|FG001|Overall Study|Participant Withdrawal of Consent|2|||
23141409|NCT02842827|64267737|FG002|Overall Study|Participant Withdrawal of Consent|2|||
23141410|NCT02842827|64267738|FG003|Overall Study|Participant Withdrawal of Consent|2|||
23141411|NCT02842827|64267739|FG004|Overall Study|Participant Withdrawal of Consent|2|||
23141412|NCT02842827|64267740|FG005|Overall Study|Participant Withdrawal of Consent|1|||
23318462|NCT03278626|64908393|FG000|Overall Study|Disease Progression|2|||
23141413|NCT02842827|64267741|FG006|Overall Study|Participant Withdrawal of Consent|2|||
23141414|NCT02842827|64267742|FG007|Overall Study|Participant Withdrawal of Consent|1|||
23141415|NCT01257425|64267743|FG000|Overall Study|Lack of Efficacy|3|||
23141416|NCT01257425|64267744|FG001|Overall Study|Lack of Efficacy|3|||
23141417|NCT01257425|64267743|FG000|Overall Study|Adverse Event|1|||
23141418|NCT01257425|64267744|FG001|Overall Study|Adverse Event|1|||
23141419|NCT01257425|64267743|FG000|Overall Study|Protocol Violation|1|||
23141420|NCT01257425|64267744|FG001|Overall Study|Protocol Violation|1|||
23141421|NCT01257425|64267743|FG000|Overall Study|Withdrawal by Subject|0|||
23141422|NCT01257425|64267744|FG001|Overall Study|Withdrawal by Subject|1|||
23141423|NCT01257425|64267743|FG000|Overall Study|Death|1|||
23141424|NCT01257425|64267744|FG001|Overall Study|Death|0|||
23141425|NCT00484289|64267754|FG000|Long Term Phase|Adverse Event|1|||
23141426|NCT00484289|64267755|FG001|Long Term Phase|Adverse Event|17|||
23141427|NCT00484289|64267756|FG002|Long Term Phase|Adverse Event|5|||
23141428|NCT00484289|64267754|FG000|Long Term Phase|Withdrawal by Subject|0|||
23141429|NCT00484289|64267755|FG001|Long Term Phase|Withdrawal by Subject|7|||
23141430|NCT00484289|64267756|FG002|Long Term Phase|Withdrawal by Subject|6|||
23141431|NCT00484289|64267754|FG000|Long Term Phase|Inadequate response|2|||
23141432|NCT00484289|64267755|FG001|Long Term Phase|Inadequate response|7|||
23141433|NCT00484289|64267756|FG002|Long Term Phase|Inadequate response|4|||
23141434|NCT00484289|64267754|FG000|Long Term Phase|Other Reason|0|||
23141435|NCT00484289|64267755|FG001|Long Term Phase|Other Reason|5|||
23141436|NCT00484289|64267756|FG002|Long Term Phase|Other Reason|1|||
23141437|NCT00484289|64267754|FG000|Post Marketing Phase|Adverse Event|0|||
23141438|NCT00484289|64267755|FG001|Post Marketing Phase|Adverse Event|1|||
23141439|NCT00484289|64267756|FG002|Post Marketing Phase|Adverse Event|0|||
23141440|NCT02447172|64267758|FG000|Overall Study|Adverse Event|11|||
23141441|NCT02447172|64267759|FG001|Overall Study|Adverse Event|8|||
23141442|NCT02447172|64267760|FG002|Overall Study|Adverse Event|7|||
23141443|NCT02447172|64267758|FG000|Overall Study|Death|3|||
23141444|NCT02447172|64267759|FG001|Overall Study|Death|1|||
23141445|NCT02447172|64267760|FG002|Overall Study|Death|0|||
23141446|NCT02447172|64267758|FG000|Overall Study|Protocol Violation|2|||
23141447|NCT02447172|64267759|FG001|Overall Study|Protocol Violation|1|||
23141448|NCT02447172|64267760|FG002|Overall Study|Protocol Violation|2|||
23141449|NCT02447172|64267758|FG000|Overall Study|Lost to Follow-up|7|||
23141450|NCT02447172|64267759|FG001|Overall Study|Lost to Follow-up|4|||
23141451|NCT02447172|64267760|FG002|Overall Study|Lost to Follow-up|4|||
23141452|NCT02447172|64267758|FG000|Overall Study|Withdrawal by Subject|5|||
23141453|NCT02447172|64267759|FG001|Overall Study|Withdrawal by Subject|1|||
23141454|NCT02447172|64267760|FG002|Overall Study|Withdrawal by Subject|3|||
23141455|NCT02447172|64267758|FG000|Overall Study|protocol specific treatment unrelated|3|||
23141456|NCT02447172|64267759|FG001|Overall Study|protocol specific treatment unrelated|0|||
23141457|NCT02447172|64267760|FG002|Overall Study|protocol specific treatment unrelated|2|||
23318463|NCT01653912|64908396|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23141458|NCT00336895|64267761|FG000|Overall Study|diarrhea|1|||
23141459|NCT00336895|64267761|FG000|Overall Study|nausea and upset stomach|1|||
23141460|NCT00336895|64267761|FG000|Overall Study|Physician Decision|1|||
23141461|NCT00336895|64267761|FG000|Overall Study|screen failed|1|||
23141462|NCT00156819|64267762|FG000|Overall Study|Lost to Follow-up|1|||
23141463|NCT00156819|64267763|FG001|Overall Study|Lost to Follow-up|1|||
23141464|NCT00156819|64267764|FG002|Overall Study|Lost to Follow-up|3|||
23141465|NCT02292927|64267776|FG000|Overall Study|Protocol Violation|13|||
23141466|NCT02292927|64267777|FG001|Overall Study|Protocol Violation|7|||
23141467|NCT01411215|64267779|FG000|Overall Study|Adverse Event|1|||
23141468|NCT01411215|64267780|FG001|Overall Study|Adverse Event|2|||
23141469|NCT01411215|64267779|FG000|Overall Study|Lack of Efficacy|2|||
23141470|NCT01411215|64267780|FG001|Overall Study|Lack of Efficacy|4|||
23141471|NCT01411215|64267779|FG000|Overall Study|Lost to Follow-up|12|||
23141472|NCT01411215|64267780|FG001|Overall Study|Lost to Follow-up|18|||
23141473|NCT01411215|64267779|FG000|Overall Study|Did not meet entrance criteria|0|||
23141474|NCT01411215|64267780|FG001|Overall Study|Did not meet entrance criteria|1|||
23141475|NCT01411215|64267779|FG000|Overall Study|Study terminated by sponsor|2|||
23141476|NCT01411215|64267780|FG001|Overall Study|Study terminated by sponsor|15|||
23141477|NCT01411215|64267779|FG000|Overall Study|Protocol Violation|3|||
23141478|NCT01411215|64267780|FG001|Overall Study|Protocol Violation|5|||
23141479|NCT01411215|64267779|FG000|Overall Study|Withdrawal by Subject|34|||
23141480|NCT01411215|64267780|FG001|Overall Study|Withdrawal by Subject|21|||
23141481|NCT01411215|64267779|FG000|Overall Study|Other|12|||
23141482|NCT01411215|64267780|FG001|Overall Study|Other|17|||
23141483|NCT01411215|64267779|FG000|Overall Study|Screen failure|0|||
23141484|NCT01411215|64267780|FG001|Overall Study|Screen failure|1|||
23141485|NCT01585987|64267781|FG000|Randomized|Withdrawal by Subject|0|||
23141486|NCT01585987|64267782|FG001|Randomized|Withdrawal by Subject|4|||
23141487|NCT01585987|64267781|FG000|Randomized|No longer met criteria|0|||
23141488|NCT01585987|64267782|FG001|Randomized|No longer met criteria|2|||
23141489|NCT01585987|64267781|FG000|Treated|Disease Progression|39|||
23141490|NCT01585987|64267782|FG001|Treated|Disease Progression|36|||
23141491|NCT01585987|64267781|FG000|Treated|Study Drug Toxicity|9|||
23141492|NCT01585987|64267782|FG001|Treated|Study Drug Toxicity|5|||
23141493|NCT01585987|64267781|FG000|Treated|Adverse Event|3|||
23141494|NCT01585987|64267782|FG001|Treated|Adverse Event|0|||
23141495|NCT01585987|64267781|FG000|Treated|Withdrawal by Subject|1|||
23141496|NCT01585987|64267782|FG001|Treated|Withdrawal by Subject|2|||
23141497|NCT01585987|64267781|FG000|Treated|Death|1|||
23141498|NCT01585987|64267782|FG001|Treated|Death|0|||
23141499|NCT01585987|64267781|FG000|Treated|Lost to Follow-up|0|||
23141500|NCT01585987|64267782|FG001|Treated|Lost to Follow-up|1|||
23141501|NCT01585987|64267781|FG000|Treated|Maximum Clinical Benefit|0|||
23141502|NCT01585987|64267782|FG001|Treated|Maximum Clinical Benefit|1|||
23141503|NCT01585987|64267781|FG000|Treated|Non-Specified|1|||
23141504|NCT01585987|64267782|FG001|Treated|Non-Specified|2|||
23141505|NCT01585987|64267781|FG000|Treated|Subject Request|0|||
23141506|NCT01585987|64267782|FG001|Treated|Subject Request|1|||
23141507|NCT01585987|64267781|FG000|Treated|Poor/Non-Compliance|0|||
23141508|NCT01585987|64267782|FG001|Treated|Poor/Non-Compliance|1|||
23141509|NCT02783768|64267783|FG000|Overall Study|Lost to Follow-up|1|||
23141510|NCT02783768|64267784|FG001|Overall Study|Lost to Follow-up|0|||
23141511|NCT02288247|64267785|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
23141512|NCT02288247|64267786|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
23141513|NCT02288247|64267785|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
23141514|NCT02288247|64267786|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
23141515|NCT02288247|64267785|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
23141516|NCT02288247|64267786|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
23141517|NCT02288247|64267785|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
23141518|NCT02288247|64267786|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
23141519|NCT02288247|64267785|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
23141520|NCT02288247|64267786|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
23141521|NCT02288247|64267785|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
23141522|NCT02288247|64267786|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
23141523|NCT02288247|64267785|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
23318464|NCT01653912|64908397|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
23622353|NCT01101061|66004893|FG002|Overall Study|Adverse Event|1|||
23141524|NCT02288247|64267786|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
23141525|NCT02288247|64267785|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
23141526|NCT02288247|64267786|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
23141527|NCT02288247|64267785|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
23141528|NCT02288247|64267786|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
23141529|NCT02288247|64267785|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
23141530|NCT02288247|64267786|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
23141531|NCT02288247|64267785|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
23141532|NCT02288247|64267786|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
23141533|NCT02288247|64267785|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
23141534|NCT02288247|64267786|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
23141535|NCT02288247|64267785|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
23141536|NCT02288247|64267786|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
23141537|NCT02288247|64267785|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
23141538|NCT02288247|64267786|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
23141539|NCT02288247|64267785|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
23141540|NCT02288247|64267786|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
23141541|NCT01598311|64267787|FG000|Overall Study|Physician Decision|4|||
23141542|NCT01598311|64267788|FG001|Overall Study|Physician Decision|5|||
23141543|NCT01598311|64267787|FG000|Overall Study|Adverse Event|9|||
23141544|NCT01598311|64267788|FG001|Overall Study|Adverse Event|13|||
23141545|NCT01598311|64267787|FG000|Overall Study|Lost to Follow-up|7|||
23141546|NCT01598311|64267788|FG001|Overall Study|Lost to Follow-up|12|||
23141547|NCT01598311|64267787|FG000|Overall Study|Withdrawal by Subject|9|||
23141548|NCT01598311|64267788|FG001|Overall Study|Withdrawal by Subject|13|||
23141549|NCT01598311|64267787|FG000|Overall Study|No reason provided.|0|||
23141550|NCT01598311|64267788|FG001|Overall Study|No reason provided.|5|||
23141551|NCT01598311|64267787|FG000|Overall Study|Randomized but never treated|8|||
23141552|NCT01598311|64267788|FG001|Overall Study|Randomized but never treated|5|||
23141553|NCT01598311|64267787|FG000|Overall Study|Treated but no confirmed CDAD|9|||
23141554|NCT01598311|64267788|FG001|Overall Study|Treated but no confirmed CDAD|8|||
23141555|NCT01598311|64267787|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
23141556|NCT01598311|64267788|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
23141557|NCT00903682|64267789|FG000|Overall Study|Adverse Event|6|||
23141558|NCT00903682|64267790|FG001|Overall Study|Adverse Event|13|||
23141559|NCT00903682|64267789|FG000|Overall Study|Lost to Follow-up|1|||
23141560|NCT00903682|64267790|FG001|Overall Study|Lost to Follow-up|0|||
23141561|NCT00903682|64267789|FG000|Overall Study|Withdrawal by Subject|5|||
23141562|NCT00903682|64267790|FG001|Overall Study|Withdrawal by Subject|0|||
23141563|NCT00903682|64267789|FG000|Overall Study|Pregnancy|0|||
23141564|NCT00903682|64267790|FG001|Overall Study|Pregnancy|1|||
23141565|NCT00903682|64267789|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
23141566|NCT00903682|64267790|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
23141567|NCT00903682|64267789|FG000|Overall Study|Subject Non-Compliant|1|||
23141568|NCT00903682|64267790|FG001|Overall Study|Subject Non-Compliant|0|||
23141569|NCT00903682|64267789|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
23141570|NCT00903682|64267790|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
23141571|NCT00903682|64267789|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
23141572|NCT00903682|64267790|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
23141573|NCT00591721|64267791|FG000|Overall Study|Withdrawal by Subject|10|||
23141574|NCT00591721|64267792|FG001|Overall Study|Withdrawal by Subject|10|||
23141575|NCT00591721|64267791|FG000|Overall Study|Lost to Follow-up|1|||
23141576|NCT00591721|64267792|FG001|Overall Study|Lost to Follow-up|4|||
23141577|NCT00591721|64267791|FG000|Overall Study|Intervention not received|10|||
23141578|NCT00591721|64267792|FG001|Overall Study|Intervention not received|8|||
23141579|NCT00825825|64267793|FG000|First Medication Period (14 Days)|Adverse Event|1|||
23141580|NCT00825825|64267794|FG001|First Medication Period (14 Days)|Adverse Event|0|||
23141581|NCT00825825|64267795|FG002|First Medication Period (14 Days)|Adverse Event|0|||
23141582|NCT00825825|64267796|FG003|First Medication Period (14 Days)|Adverse Event|0|||
23141583|NCT00825825|64267797|FG004|First Medication Period (14 Days)|Adverse Event|0|||
23141584|NCT00825825|64267798|FG005|First Medication Period (14 Days)|Adverse Event|1|||
23141585|NCT00825825|64267793|FG000|First Medication Period (14 Days)|Physician Decision|2|||
23141586|NCT00825825|64267794|FG001|First Medication Period (14 Days)|Physician Decision|0|||
23141587|NCT00825825|64267795|FG002|First Medication Period (14 Days)|Physician Decision|1|||
23141588|NCT00825825|64267796|FG003|First Medication Period (14 Days)|Physician Decision|0|||
23141589|NCT00825825|64267797|FG004|First Medication Period (14 Days)|Physician Decision|0|||
23141590|NCT00825825|64267798|FG005|First Medication Period (14 Days)|Physician Decision|1|||
23141591|NCT00825825|64267793|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
23141592|NCT00825825|64267794|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
23141593|NCT00825825|64267795|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
23141594|NCT00825825|64267796|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
23141595|NCT00825825|64267797|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
23141596|NCT00825825|64267798|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
23141597|NCT00825825|64267793|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
23141598|NCT00825825|64267794|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
23141599|NCT00825825|64267795|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
23141600|NCT00825825|64267796|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
23141601|NCT00825825|64267797|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
23141602|NCT00825825|64267798|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
23141603|NCT00825825|64267793|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
23216644|NCT03170258|64534559|FG000|Overall Study|Equipment issues|1|||
23216645|NCT03170258|64534560|FG001|Overall Study|Equipment issues|0|||
23141604|NCT00825825|64267794|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
23141605|NCT00825825|64267795|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
23141606|NCT00825825|64267796|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
23141607|NCT00825825|64267797|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
23141608|NCT00825825|64267798|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
23141609|NCT00825825|64267793|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
23141610|NCT00825825|64267794|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
23141611|NCT00825825|64267795|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
23141612|NCT00825825|64267796|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
23141613|NCT00825825|64267797|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
23141614|NCT00825825|64267798|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
23141615|NCT00825825|64267793|FG000|Third Medication Period (14 Days)|poor data quality|0|||
23141616|NCT00825825|64267794|FG001|Third Medication Period (14 Days)|poor data quality|1|||
23141617|NCT00825825|64267795|FG002|Third Medication Period (14 Days)|poor data quality|0|||
23141618|NCT00825825|64267796|FG003|Third Medication Period (14 Days)|poor data quality|0|||
23141619|NCT00825825|64267797|FG004|Third Medication Period (14 Days)|poor data quality|0|||
23141620|NCT00825825|64267798|FG005|Third Medication Period (14 Days)|poor data quality|0|||
23141621|NCT01323634|64267804|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
23141622|NCT01323634|64267805|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
23141623|NCT01323634|64267806|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
23141624|NCT01323634|64267804|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
23141625|NCT01323634|64267805|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
23141626|NCT01323634|64267806|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
23141627|NCT01323634|64267804|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
23141628|NCT01323634|64267805|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23141629|NCT01323634|64267806|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23141630|NCT01323634|64267804|FG000|2-week Run-in Period|Physician Decision|5|||
23141631|NCT01323634|64267805|FG001|2-week Run-in Period|Physician Decision|0|||
23141632|NCT01323634|64267806|FG002|2-week Run-in Period|Physician Decision|0|||
23141633|NCT01323634|64267804|FG000|2-week Run-in Period|Protocol Violation|1|||
23141634|NCT01323634|64267805|FG001|2-week Run-in Period|Protocol Violation|0|||
23141635|NCT01323634|64267806|FG002|2-week Run-in Period|Protocol Violation|0|||
23141636|NCT01323634|64267804|FG000|2-week Run-in Period|Adverse Event|1|||
23141637|NCT01323634|64267805|FG001|2-week Run-in Period|Adverse Event|0|||
23141638|NCT01323634|64267806|FG002|2-week Run-in Period|Adverse Event|0|||
23141639|NCT01323634|64267804|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23141640|NCT01323634|64267805|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
23141641|NCT01323634|64267806|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
23141642|NCT01323634|64267804|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23141643|NCT01323634|64267805|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23141644|NCT01323634|64267806|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
23141645|NCT01323634|64267804|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23141646|NCT01323634|64267805|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
23141647|NCT01323634|64267806|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
23141648|NCT01323634|64267804|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23141649|NCT01323634|64267805|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
23141650|NCT01323634|64267806|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
23141651|NCT01323634|64267804|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
23141652|NCT01323634|64267805|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
23141653|NCT01323634|64267806|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
23141654|NCT01323634|64267804|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23141655|NCT01323634|64267805|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
23141656|NCT01323634|64267806|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
23141657|NCT01323634|64267804|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
23141658|NCT01323634|64267805|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
23141659|NCT01323634|64267806|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
23141660|NCT02730598|64267807|FG000|Overall Study|Withdrawal by Subject|3|||
23216646|NCT03170258|64534559|FG000|Overall Study|Medication|1|||
23216647|NCT03170258|64534560|FG001|Overall Study|Medication|0|||
23141661|NCT02730598|64267808|FG001|Overall Study|Withdrawal by Subject|3|||
23141662|NCT02730598|64267807|FG000|Overall Study|Protocol Violation|0|||
23141663|NCT02730598|64267808|FG001|Overall Study|Protocol Violation|1|||
23141664|NCT02730598|64267807|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
23216648|NCT03170258|64534559|FG000|Overall Study|Sleep issues|1|||
23216649|NCT03170258|64534560|FG001|Overall Study|Sleep issues|0|||
23432887|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
23432888|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
23432889|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
23432890|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
23432891|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
23432892|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
23432893|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
23432894|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
23432895|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
23432896|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
23432897|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
23432898|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
23432899|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
23432900|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
23622354|NCT01101061|66004894|FG003|Overall Study|Adverse Event|0|||
23622355|NCT01101061|66004895|FG004|Overall Study|Adverse Event|0|||
23141665|NCT02730598|64267808|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
23318465|NCT01653912|64908398|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23432901|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
23432902|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
23432903|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
23432904|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
23432905|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
23432906|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
23432907|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
23432908|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
23432909|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
23318466|NCT01653912|64908399|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23318467|NCT01653912|64908400|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23318468|NCT01653912|64908401|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
23318469|NCT01653912|64908396|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23318470|NCT01653912|64908397|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23318471|NCT01653912|64908398|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
23318472|NCT01653912|64908399|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23318473|NCT01653912|64908400|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23318474|NCT01653912|64908401|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
23318475|NCT01653912|64908396|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23318476|NCT01653912|64908397|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23318477|NCT01653912|64908398|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23318478|NCT01653912|64908399|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
23318479|NCT01653912|64908400|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23318480|NCT01653912|64908401|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
23318481|NCT01653912|64908396|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23318482|NCT01653912|64908397|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23318483|NCT01653912|64908398|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23318484|NCT01653912|64908399|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
23318485|NCT01653912|64908400|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23318486|NCT01653912|64908401|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
23318487|NCT01653912|64908396|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23318488|NCT01653912|64908397|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23318489|NCT01653912|64908398|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23318490|NCT01653912|64908399|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23318491|NCT01653912|64908400|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
23318492|NCT01653912|64908401|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
23318493|NCT01653912|64908396|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23318494|NCT01653912|64908397|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23318495|NCT01653912|64908398|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23318496|NCT01653912|64908399|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23318497|NCT01653912|64908400|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
23318498|NCT01653912|64908401|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
23318499|NCT01653912|64908396|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23318500|NCT01653912|64908397|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23318501|NCT01653912|64908398|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23432910|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Side effects|0|||
23432911|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Side effects|0|||
23432912|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Side effects|0|||
23141666|NCT01183234|64267809|FG000|First Intervention|Adverse Event|1|||
23318502|NCT01653912|64908399|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23318503|NCT01653912|64908400|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
23622356|NCT01101061|66004896|FG005|Overall Study|Adverse Event|0|||
23622357|NCT00469859|66004897|FG000|Overall Study|Inevaluable|0|||
23622358|NCT00469859|66004898|FG001|Overall Study|Inevaluable|2|||
23318504|NCT01653912|64908401|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
23318505|NCT00359801|64908404|FG000|Overall Study|Lost to Follow-up|72|||
23318506|NCT00359801|64908405|FG001|Overall Study|Lost to Follow-up|58|||
23318507|NCT00359801|64908404|FG000|Overall Study|Withdrawal by Subject|143|||
23318508|NCT00359801|64908405|FG001|Overall Study|Withdrawal by Subject|96|||
23622359|NCT03481556|66004899|FG000|Overall Study|Adverse Event|1|||
23622360|NCT03481556|66004900|FG001|Overall Study|Adverse Event|0|||
23622361|NCT03481556|66004901|FG002|Overall Study|Adverse Event|0|||
23622362|NCT03481556|66004902|FG003|Overall Study|Adverse Event|0|||
23622363|NCT03481556|66004899|FG000|Overall Study|Death|4|||
23622364|NCT03481556|66004900|FG001|Overall Study|Death|2|||
23622365|NCT03481556|66004901|FG002|Overall Study|Death|3|||
23622366|NCT03481556|66004902|FG003|Overall Study|Death|16|||
23622367|NCT03481556|66004899|FG000|Overall Study|Study Terminated by Sponsor|10|||
23622368|NCT03481556|66004900|FG001|Overall Study|Study Terminated by Sponsor|5|||
23622369|NCT03481556|66004901|FG002|Overall Study|Study Terminated by Sponsor|2|||
23622370|NCT03481556|66004902|FG003|Overall Study|Study Terminated by Sponsor|9|||
23318509|NCT00359801|64908404|FG000|Overall Study|Other|66|||
23318510|NCT00359801|64908405|FG001|Overall Study|Other|46|||
23318511|NCT00359801|64908404|FG000|Overall Study|Final Status Unknown: missing data|7|||
23318512|NCT00359801|64908405|FG001|Overall Study|Final Status Unknown: missing data|4|||
23318513|NCT00359801|64908404|FG000|Overall Study|Sponsor Decision|17|||
23318514|NCT00359801|64908405|FG001|Overall Study|Sponsor Decision|16|||
23318515|NCT01757275|64908417|FG000|Overall Study|Lost to Follow-up|1|||
23432913|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Side effects|0|||
23141667|NCT01183234|64267810|FG001|First Intervention|Adverse Event|0|||
23141668|NCT01103362|64267811|FG000|Overall Study|study terminated|596|||
23141669|NCT01054170|64267814|FG000|Overall Study|Protocol Violation|1|||
23141670|NCT01054170|64267815|FG001|Overall Study|Protocol Violation|0|||
23141671|NCT01054170|64267814|FG000|Overall Study|Withdrawal by Subject|3|||
23141672|NCT01054170|64267815|FG001|Overall Study|Withdrawal by Subject|2|||
23141673|NCT01054170|64267814|FG000|Overall Study|Adverse Event|0|||
23141674|NCT01054170|64267815|FG001|Overall Study|Adverse Event|4|||
23141675|NCT01313117|64267816|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
23141676|NCT01313117|64267816|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
23141677|NCT01079663|64267819|FG000|Overall Study|Adverse Event|0|||
23141678|NCT01079663|64267820|FG001|Overall Study|Adverse Event|2|||
23141679|NCT01079663|64267819|FG000|Overall Study|Protocol Violation|0|||
23141680|NCT01079663|64267820|FG001|Overall Study|Protocol Violation|2|||
23141681|NCT03265938|64267821|FG000|Overall Study|Withdrawal by Subject|1|||
23141682|NCT03265938|64267821|FG000|Overall Study|Physician Decision|1|||
23141683|NCT03265938|64267821|FG000|Overall Study|friable mass|6|||
23141684|NCT00423943|64267822|FG000|Overall Study|Withdrawal by Subject|3|||
23141685|NCT00423943|64267823|FG001|Overall Study|Withdrawal by Subject|1|||
23141686|NCT02649946|64267824|FG000|Overall Study|Withdrawal by Subject|1|||
23141687|NCT02649946|64267825|FG001|Overall Study|Withdrawal by Subject|1|||
23141688|NCT02649946|64267824|FG000|Overall Study|Death|7|||
23141689|NCT02649946|64267825|FG001|Overall Study|Death|9|||
23141690|NCT02649946|64267824|FG000|Overall Study|Physician Decision|1|||
23141691|NCT02649946|64267825|FG001|Overall Study|Physician Decision|0|||
23141692|NCT02649946|64267824|FG000|Overall Study|Lost to Follow-up|2|||
23141693|NCT02649946|64267825|FG001|Overall Study|Lost to Follow-up|1|||
23141694|NCT02649946|64267824|FG000|Overall Study|Erroneously enrolled|1|||
23141695|NCT02649946|64267825|FG001|Overall Study|Erroneously enrolled|0|||
23141696|NCT02649946|64267824|FG000|Overall Study|Missed 6-month follow-up visit|0|||
23141697|NCT02649946|64267825|FG001|Overall Study|Missed 6-month follow-up visit|4|||
23141698|NCT00122460|64267831|FG000|Overall Study|investigational study phase ongoing|7|||
23141699|NCT00122460|64267832|FG001|Overall Study|investigational study phase ongoing|1|||
23555156|NCT02732938|65758020|FG001|Overall Study|Death|11|||
23141700|NCT00901186|64267833|FG000|Overall Study|Lack of Efficacy|0|||
23141701|NCT00901186|64267834|FG001|Overall Study|Lack of Efficacy|1|||
23141702|NCT00901186|64267833|FG000|Overall Study|Abnormal laboratory values|0|||
23141703|NCT00901186|64267834|FG001|Overall Study|Abnormal laboratory values|1|||
23141704|NCT00901186|64267833|FG000|Overall Study|Lost to Follow-up|2|||
23141705|NCT00901186|64267834|FG001|Overall Study|Lost to Follow-up|0|||
23318516|NCT01757275|64908418|FG001|Overall Study|Lost to Follow-up|2|||
23318517|NCT01757275|64908417|FG000|Overall Study|Adverse Event|3|||
23555157|NCT02732938|65758021|FG002|Overall Study|Death|0|||
23555158|NCT02732938|65758019|FG000|Overall Study|Randomized but did not receive treatment|0|||
23555159|NCT02732938|65758020|FG001|Overall Study|Randomized but did not receive treatment|1|||
23555160|NCT02732938|65758021|FG002|Overall Study|Randomized but did not receive treatment|0|||
23555161|NCT02732938|65758019|FG000|Overall Study|Refused further follow-up|1|||
23555162|NCT02732938|65758020|FG001|Overall Study|Refused further follow-up|0|||
23555163|NCT02732938|65758021|FG002|Overall Study|Refused further follow-up|0|||
23555164|NCT02732938|65758019|FG000|Overall Study|Study terminated by sponsor|3|||
23318518|NCT01757275|64908418|FG001|Overall Study|Adverse Event|3|||
23318519|NCT01757275|64908417|FG000|Overall Study|Withdrawal by Subject|2|||
23318520|NCT01757275|64908418|FG001|Overall Study|Withdrawal by Subject|4|||
23318521|NCT01757275|64908417|FG000|Overall Study|Not treated|3|||
23318522|NCT01757275|64908418|FG001|Overall Study|Not treated|4|||
23318523|NCT02586155|64908419|FG000|Overall Study|Adverse Event|2|||
23318524|NCT02586155|64908420|FG001|Overall Study|Adverse Event|3|||
23318525|NCT02586155|64908419|FG000|Overall Study|Withdrawal by Subject|31|||
23318526|NCT02586155|64908420|FG001|Overall Study|Withdrawal by Subject|24|||
23318527|NCT02586155|64908419|FG000|Overall Study|Lost to Follow-up|7|||
23318528|NCT02586155|64908420|FG001|Overall Study|Lost to Follow-up|13|||
23318529|NCT02586155|64908419|FG000|Overall Study|Death|61|||
23318530|NCT02586155|64908420|FG001|Overall Study|Death|72|||
23318531|NCT02586155|64908419|FG000|Overall Study|Other reasons|26|||
23318532|NCT02586155|64908420|FG001|Overall Study|Other reasons|15|||
23318533|NCT03280381|64908424|FG000|Overall Study|Physician Decision|0|||
23318534|NCT03280381|64908425|FG001|Overall Study|Physician Decision|2|||
23318535|NCT01371539|64908426|FG000|Period One: One Week|Lost to Follow-up|0|||
23318536|NCT01371539|64908427|FG001|Period One: One Week|Lost to Follow-up|1|||
23318537|NCT01371539|64908426|FG000|Period Two: One Week|Lost to Follow-up|0|||
23318538|NCT01371539|64908427|FG001|Period Two: One Week|Lost to Follow-up|1|||
23318539|NCT01371539|64908426|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
23318540|NCT01371539|64908427|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
23318541|NCT01371539|64908426|FG000|Period Two: One Week|Time/job conflict|0|||
23318542|NCT01371539|64908427|FG001|Period Two: One Week|Time/job conflict|1|||
23318543|NCT00958893|64908430|FG000|Overall Study|Study prematurely terminated|4|||
23318544|NCT02862730|64908431|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23318545|NCT02862730|64908432|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23318546|NCT02862730|64908433|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
23318547|NCT02862730|64908434|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23318548|NCT02862730|64908435|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23318549|NCT02862730|64908436|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23318550|NCT02862730|64908437|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
23318551|NCT02862730|64908431|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
23318552|NCT02862730|64908432|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23318553|NCT02862730|64908433|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23318554|NCT02862730|64908434|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23318555|NCT02862730|64908435|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23318556|NCT02862730|64908436|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23318557|NCT02862730|64908437|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
23318558|NCT02862730|64908431|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23318559|NCT02862730|64908432|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23318560|NCT02862730|64908433|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
23318561|NCT02862730|64908434|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23318562|NCT02862730|64908435|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
23318563|NCT02862730|64908436|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23318564|NCT02862730|64908437|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
23318565|NCT02862730|64908431|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23318566|NCT02862730|64908432|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23318567|NCT02862730|64908433|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23318568|NCT02862730|64908434|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
23318569|NCT02862730|64908435|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23318570|NCT02862730|64908436|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23318571|NCT02862730|64908437|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
23318572|NCT00425373|64908438|FG000|Overall Study|Adverse Event|2|||
23318573|NCT00425373|64908439|FG001|Overall Study|Adverse Event|2|||
23318574|NCT00425373|64908440|FG002|Overall Study|Adverse Event|0|||
23318575|NCT00425373|64908441|FG003|Overall Study|Adverse Event|1|||
23318576|NCT00425373|64908442|FG004|Overall Study|Adverse Event|4|||
23318577|NCT00425373|64908443|FG005|Overall Study|Adverse Event|6|||
23318578|NCT00425373|64908444|FG006|Overall Study|Adverse Event|2|||
23318579|NCT00425373|64908445|FG007|Overall Study|Adverse Event|3|||
23318580|NCT00425373|64908446|FG008|Overall Study|Adverse Event|8|||
23318581|NCT00425373|64908438|FG000|Overall Study|Lost to Follow-up|0|||
23318582|NCT00425373|64908439|FG001|Overall Study|Lost to Follow-up|1|||
23318583|NCT00425373|64908440|FG002|Overall Study|Lost to Follow-up|0|||
23318584|NCT00425373|64908441|FG003|Overall Study|Lost to Follow-up|0|||
23318585|NCT00425373|64908442|FG004|Overall Study|Lost to Follow-up|1|||
23318586|NCT00425373|64908443|FG005|Overall Study|Lost to Follow-up|0|||
23318587|NCT00425373|64908444|FG006|Overall Study|Lost to Follow-up|0|||
23318588|NCT00425373|64908445|FG007|Overall Study|Lost to Follow-up|0|||
23318589|NCT00425373|64908446|FG008|Overall Study|Lost to Follow-up|0|||
23318590|NCT00425373|64908438|FG000|Overall Study|Protocol Violation|1|||
23622371|NCT00552513|66004903|FG000|Overall Study|Lost to Follow-up|5|||
23622372|NCT00552513|66004904|FG001|Overall Study|Lost to Follow-up|1|||
23622373|NCT03864341|66004905|FG000|Overall Study|Withdrawal by Subject|1|||
23622374|NCT02204319|66004909|FG000|Overall Study|Pregnancy|1|||
23622375|NCT02204319|66004909|FG000|Overall Study|Withdrawal by Subject|2|||
23622376|NCT02853305|66004910|FG000|Overall Study|Death|287|||
23622377|NCT02853305|66004911|FG001|Overall Study|Death|249|||
23622378|NCT02853305|66004912|FG002|Overall Study|Death|300|||
23622379|NCT02853305|66004910|FG000|Overall Study|Withdrawal by Subject|2|||
23622380|NCT02853305|66004911|FG001|Overall Study|Withdrawal by Subject|8|||
23318591|NCT00425373|64908439|FG001|Overall Study|Protocol Violation|0|||
23318592|NCT00425373|64908440|FG002|Overall Study|Protocol Violation|1|||
23318593|NCT00425373|64908441|FG003|Overall Study|Protocol Violation|0|||
23318594|NCT00425373|64908442|FG004|Overall Study|Protocol Violation|0|||
23318595|NCT00425373|64908443|FG005|Overall Study|Protocol Violation|0|||
23318596|NCT00425373|64908444|FG006|Overall Study|Protocol Violation|0|||
23318597|NCT00425373|64908445|FG007|Overall Study|Protocol Violation|5|||
23318598|NCT00425373|64908446|FG008|Overall Study|Protocol Violation|3|||
23318599|NCT00425373|64908438|FG000|Overall Study|Withdrawal by Subject|2|||
23622381|NCT02853305|66004912|FG002|Overall Study|Withdrawal by Subject|3|||
23622382|NCT02853305|66004910|FG000|Overall Study|Transferred to Extension Study|46|||
23622383|NCT02853305|66004911|FG001|Overall Study|Transferred to Extension Study|30|||
23622384|NCT02853305|66004912|FG002|Overall Study|Transferred to Extension Study|25|||
23622385|NCT02853305|66004910|FG000|Overall Study|Did Not Continue on Extension Study|16|||
23622386|NCT02853305|66004911|FG001|Overall Study|Did Not Continue on Extension Study|20|||
23622387|NCT02853305|66004912|FG002|Overall Study|Did Not Continue on Extension Study|24|||
23622388|NCT00848393|66004915|FG000|Overall Study|Protocol Violation|0|||
23622389|NCT00848393|66004916|FG001|Overall Study|Protocol Violation|0|||
23622390|NCT00848393|66004917|FG002|Overall Study|Protocol Violation|1|||
23622391|NCT00848393|66004915|FG000|Overall Study|surgical complications unrelated to stud|0|||
23622392|NCT00848393|66004916|FG001|Overall Study|surgical complications unrelated to stud|0|||
23622393|NCT00848393|66004917|FG002|Overall Study|surgical complications unrelated to stud|2|||
23622394|NCT02972242|66004920|FG000|Overall Study|Withdrawal by Subject|1|||
23622395|NCT02972242|66004921|FG001|Overall Study|Withdrawal by Subject|0|||
23622396|NCT01281917|66004922|FG000|Overall Study|Withdrawal by Subject|1|||
23622397|NCT02633397|66004926|FG000|Overall Study|Adverse Event|8|||
23622398|NCT02633397|66004927|FG001|Overall Study|Adverse Event|8|||
23622399|NCT02633397|66004926|FG000|Overall Study|Study Burden|4|||
23622400|NCT02633397|66004927|FG001|Overall Study|Study Burden|1|||
23622401|NCT02633397|66004926|FG000|Overall Study|Treatment interruption|2|||
23622402|NCT02633397|66004927|FG001|Overall Study|Treatment interruption|5|||
23622403|NCT02633397|66004926|FG000|Overall Study|Death|2|||
23622404|NCT02633397|66004927|FG001|Overall Study|Death|2|||
23622405|NCT02633397|66004926|FG000|Overall Study|Physician Decision|0|||
23622406|NCT02633397|66004927|FG001|Overall Study|Physician Decision|1|||
23622407|NCT04353817|66004928|FG000|Overall Study|Adverse Event|0|||
23622408|NCT04353817|66004929|FG001|Overall Study|Adverse Event|1|||
23622409|NCT01222533|66004930|FG000|Overall Study|Adverse Event|5|||
23622410|NCT01222533|66004930|FG000|Overall Study|Withdrawal by Subject|5|||
23622411|NCT01222533|66004930|FG000|Overall Study|Other|4|||
23622412|NCT00519285|66004931|FG000|Overall Study|Adverse Event|127|||
23622413|NCT00519285|66004932|FG001|Overall Study|Adverse Event|266|||
23622414|NCT00519285|66004931|FG000|Overall Study|Disease progression|334|||
23622415|NCT00519285|66004932|FG001|Overall Study|Disease progression|186|||
23622416|NCT00519285|66004931|FG000|Overall Study|Physician Decision|75|||
23622417|NCT00519285|66004932|FG001|Overall Study|Physician Decision|47|||
23622418|NCT00519285|66004931|FG000|Overall Study|Participant's request|53|||
23622419|NCT00519285|66004932|FG001|Overall Study|Participant's request|84|||
23622420|NCT00519285|66004931|FG000|Overall Study|Consent withdrawn|4|||
23622421|NCT00519285|66004932|FG001|Overall Study|Consent withdrawn|5|||
23141706|NCT00901186|64267833|FG000|Overall Study|Adverse Event|2|||
23318600|NCT00425373|64908439|FG001|Overall Study|Withdrawal by Subject|0|||
23318601|NCT00425373|64908440|FG002|Overall Study|Withdrawal by Subject|2|||
23318602|NCT00425373|64908441|FG003|Overall Study|Withdrawal by Subject|1|||
23622422|NCT00519285|66004931|FG000|Overall Study|Poor compliance to protocol|5|||
23622423|NCT00519285|66004932|FG001|Overall Study|Poor compliance to protocol|7|||
23622424|NCT00519285|66004931|FG000|Overall Study|Reason unspecified|5|||
23622425|NCT00519285|66004932|FG001|Overall Study|Reason unspecified|8|||
23622426|NCT00519285|66004931|FG000|Overall Study|Not treated|8|||
23622427|NCT00519285|66004932|FG001|Overall Study|Not treated|7|||
23622428|NCT00519285|66004931|FG000|Overall Study|Treatment ongoing|1|||
23622429|NCT00519285|66004932|FG001|Overall Study|Treatment ongoing|2|||
23622430|NCT03269695|66004933|FG000|Overall Study|Adverse Event|2|||
23622431|NCT03269695|66004934|FG001|Overall Study|Adverse Event|1|||
23622432|NCT03269695|66004933|FG000|Overall Study|Lack of Efficacy|0|||
23622433|NCT03269695|66004934|FG001|Overall Study|Lack of Efficacy|1|||
23622434|NCT03269695|66004933|FG000|Overall Study|Withdrawal by Subject|0|||
23622435|NCT03269695|66004934|FG001|Overall Study|Withdrawal by Subject|1|||
23622436|NCT02246218|66004935|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23622437|NCT02246218|66004936|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23622438|NCT02246218|66004935|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
23622439|NCT02246218|66004936|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
23622440|NCT02246218|66004935|FG000|Overall Study|Adverse Event|1|||
23622441|NCT02246218|66004936|FG001|Overall Study|Adverse Event|1|||
23622442|NCT02246218|66004935|FG000|Overall Study|Lost to Follow-up|1|||
23622443|NCT02246218|66004936|FG001|Overall Study|Lost to Follow-up|0|||
23622444|NCT01880437|66004937|FG000|Overall Study|Death|12|||
23622445|NCT01880437|66004938|FG001|Overall Study|Death|4|||
23622446|NCT01880437|66004939|FG002|Overall Study|Death|17|||
23622447|NCT01880437|66004937|FG000|Overall Study|Study terminated by Sponsor|3|||
23622448|NCT01880437|66004938|FG001|Overall Study|Study terminated by Sponsor|0|||
23622449|NCT01880437|66004939|FG002|Overall Study|Study terminated by Sponsor|2|||
23622450|NCT00591409|66004940|FG000|Overall Study|Not Treated|0|||
23622451|NCT00591409|66004941|FG001|Overall Study|Not Treated|0|||
23622452|NCT00591409|66004942|FG002|Overall Study|Not Treated|0|||
23622453|NCT00591409|66004943|FG003|Overall Study|Not Treated|0|||
23622454|NCT00591409|66004944|FG004|Overall Study|Not Treated|1|||
23622455|NCT00591409|66004945|FG005|Overall Study|Not Treated|0|||
23622456|NCT00591409|66004946|FG006|Overall Study|Not Treated|0|||
23622457|NCT00591409|66004947|FG007|Overall Study|Not Treated|0|||
23622458|NCT00591409|66004948|FG008|Overall Study|Not Treated|0|||
23318603|NCT00425373|64908442|FG004|Overall Study|Withdrawal by Subject|4|||
23318604|NCT00425373|64908443|FG005|Overall Study|Withdrawal by Subject|0|||
23318605|NCT00425373|64908444|FG006|Overall Study|Withdrawal by Subject|2|||
23318606|NCT00425373|64908445|FG007|Overall Study|Withdrawal by Subject|2|||
23318607|NCT00425373|64908446|FG008|Overall Study|Withdrawal by Subject|2|||
23318608|NCT00425373|64908438|FG000|Overall Study|Lack of Efficacy|0|||
23318609|NCT00425373|64908439|FG001|Overall Study|Lack of Efficacy|0|||
23622459|NCT00591409|66004949|FG009|Overall Study|Not Treated|1|||
23622460|NCT00349622|66004952|FG000|Overall Study|Death|168|||
23622461|NCT00349622|66004953|FG001|Overall Study|Death|86|||
23622462|NCT00349622|66004952|FG000|Overall Study|Lost to Follow-up|5|||
23622463|NCT00349622|66004953|FG001|Overall Study|Lost to Follow-up|1|||
23622464|NCT00349622|66004952|FG000|Overall Study|Withdrawal by Subject|5|||
23622465|NCT00349622|66004953|FG001|Overall Study|Withdrawal by Subject|9|||
23622466|NCT02482935|66004956|FG000|Period 1|Withdrawal by Subject|1|||
23622467|NCT02482935|66004957|FG001|Period 1|Withdrawal by Subject|0|||
23622468|NCT01388478|66004962|FG000|Overall Study|Adverse Event|4|||
23622469|NCT01388478|66004962|FG000|Overall Study|Withdrawal by Subject|1|||
23622470|NCT01874665|66004963|FG000|Overall Study|Adverse Event|6|||
23622471|NCT01874665|66004964|FG001|Overall Study|Adverse Event|2|||
23622472|NCT01874665|66004963|FG000|Overall Study|Withdrawal by Subject|4|||
23622473|NCT01874665|66004964|FG001|Overall Study|Withdrawal by Subject|1|||
23622474|NCT01874665|66004963|FG000|Overall Study|Physician Decision|3|||
23622475|NCT01874665|66004964|FG001|Overall Study|Physician Decision|0|||
23622476|NCT01874665|66004963|FG000|Overall Study|Clinical Progressive Disease|4|||
23622477|NCT01874665|66004964|FG001|Overall Study|Clinical Progressive Disease|3|||
23622478|NCT01874665|66004963|FG000|Overall Study|Study Terminated by Sponsor|0|||
23622479|NCT01874665|66004964|FG001|Overall Study|Study Terminated by Sponsor|2|||
23141707|NCT00901186|64267834|FG001|Overall Study|Adverse Event|4|||
23141708|NCT00901186|64267833|FG000|Overall Study|Administration problems|0|||
23622480|NCT01874665|66004963|FG000|Overall Study|Documented Progressive Disease|11|||
23141709|NCT00901186|64267834|FG001|Overall Study|Administration problems|1|||
23141710|NCT00901186|64267833|FG000|Overall Study|Protocol deviations|5|||
23141711|NCT00901186|64267834|FG001|Overall Study|Protocol deviations|4|||
23141712|NCT03536754|64267835|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
23141713|NCT03536754|64267836|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
23141714|NCT03536754|64267837|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
23141715|NCT03536754|64267838|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
23141716|NCT03536754|64267839|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
23141717|NCT03536754|64267835|FG000|Open Label Extension|Other|0|||
23141718|NCT03536754|64267836|FG001|Open Label Extension|Other|0|||
23141719|NCT03536754|64267837|FG002|Open Label Extension|Other|0|||
23141720|NCT03536754|64267838|FG003|Open Label Extension|Other|0|||
23141721|NCT03536754|64267839|FG004|Open Label Extension|Other|1|||
23141722|NCT03730480|64267841|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
23141723|NCT02667587|64267850|FG000|Pre-Treatment|Not reported|1|||
23141724|NCT02667587|64267851|FG001|Pre-Treatment|Not reported|0|||
23141725|NCT02667587|64267850|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
23141726|NCT02667587|64267851|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
23141727|NCT02667587|64267850|FG000|Pre-Treatment|Participant withdrew consent|0|||
23141728|NCT02667587|64267851|FG001|Pre-Treatment|Participant withdrew consent|1|||
23141729|NCT02667587|64267850|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
23141730|NCT02667587|64267851|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
23141731|NCT02667587|64267850|FG000|End of Treatment|Other reasons|11|||
23216650|NCT01601704|64534563|FG000|Overall Study|Randomized but not dispensed study med|1|||
23216651|NCT01601704|64534564|FG001|Overall Study|Randomized but not dispensed study med|4|||
23216652|NCT00418717|64534565|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
23216653|NCT00418717|64534565|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
23216654|NCT00810810|64534566|FG000|Overall Study|Withdrawal by Subject|0|||
23216655|NCT00810810|64534567|FG001|Overall Study|Withdrawal by Subject|8|||
23216656|NCT00810810|64534568|FG002|Overall Study|Withdrawal by Subject|10|||
23216657|NCT00810810|64534569|FG003|Overall Study|Withdrawal by Subject|8|||
23216658|NCT00810810|64534566|FG000|Overall Study|Physician Decision|0|||
23216659|NCT00810810|64534567|FG001|Overall Study|Physician Decision|3|||
23216660|NCT00810810|64534568|FG002|Overall Study|Physician Decision|1|||
23216661|NCT00810810|64534569|FG003|Overall Study|Physician Decision|5|||
23216662|NCT02290340|64534570|FG000|Overall Study|Lost to Follow-up|0|||
23216663|NCT02290340|64534571|FG001|Overall Study|Lost to Follow-up|0|||
23216664|NCT02290340|64534572|FG002|Overall Study|Lost to Follow-up|0|||
23216665|NCT02290340|64534573|FG003|Overall Study|Lost to Follow-up|1|||
23216666|NCT02290340|64534570|FG000|Overall Study|Withdrawal by Subject|1|||
23216667|NCT02290340|64534571|FG001|Overall Study|Withdrawal by Subject|0|||
23216668|NCT02290340|64534572|FG002|Overall Study|Withdrawal by Subject|0|||
23216669|NCT02290340|64534573|FG003|Overall Study|Withdrawal by Subject|0|||
23216670|NCT02290340|64534570|FG000|Overall Study|Other|1|||
23216671|NCT02290340|64534571|FG001|Overall Study|Other|0|||
23216672|NCT02290340|64534572|FG002|Overall Study|Other|0|||
23216673|NCT02290340|64534573|FG003|Overall Study|Other|1|||
23318610|NCT00425373|64908440|FG002|Overall Study|Lack of Efficacy|0|||
23318611|NCT00425373|64908441|FG003|Overall Study|Lack of Efficacy|0|||
23318612|NCT00425373|64908442|FG004|Overall Study|Lack of Efficacy|1|||
23318613|NCT00425373|64908443|FG005|Overall Study|Lack of Efficacy|3|||
23318614|NCT00425373|64908444|FG006|Overall Study|Lack of Efficacy|3|||
23318615|NCT00425373|64908445|FG007|Overall Study|Lack of Efficacy|0|||
23318616|NCT00425373|64908446|FG008|Overall Study|Lack of Efficacy|5|||
23318617|NCT00805675|64908453|FG000|Overall Study|Adverse Event|0|||
23318618|NCT00805675|64908454|FG001|Overall Study|Adverse Event|0|||
23318619|NCT00805675|64908455|FG002|Overall Study|Adverse Event|1|||
23318620|NCT04172597|64908463|FG000|Overall Study|Disease Progression|0|||
23318621|NCT04172597|64908464|FG001|Overall Study|Disease Progression|0|||
23318622|NCT04172597|64908465|FG002|Overall Study|Disease Progression|0|||
23318623|NCT04172597|64908466|FG003|Overall Study|Disease Progression|0|||
23318624|NCT04172597|64908467|FG004|Overall Study|Disease Progression|1|||
23318625|NCT02842073|64908468|FG000|Overall Study|Withdrawal by Subject|1|||
23318626|NCT02445963|64908469|FG000|Overall Study|Lost to Follow-up|1|||
23318627|NCT02445963|64908470|FG001|Overall Study|Lost to Follow-up|0|||
23318628|NCT02445963|64908471|FG002|Overall Study|Lost to Follow-up|0|||
23318629|NCT02445963|64908472|FG003|Overall Study|Lost to Follow-up|0|||
23318630|NCT02445963|64908469|FG000|Overall Study|Change in employment|1|||
23318631|NCT02445963|64908470|FG001|Overall Study|Change in employment|0|||
23318632|NCT02445963|64908471|FG002|Overall Study|Change in employment|0|||
23141732|NCT02667587|64267851|FG001|End of Treatment|Other reasons|8|||
23141733|NCT02667587|64267850|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
23141734|NCT02667587|64267851|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
23141735|NCT02667587|64267850|FG000|End of Treatment|Poor/Non-Compliance|0|||
23141736|NCT02667587|64267851|FG001|End of Treatment|Poor/Non-Compliance|1|||
23141737|NCT02667587|64267850|FG000|End of Treatment|Maximum Clinical Benefit|3|||
23141738|NCT02667587|64267851|FG001|End of Treatment|Maximum Clinical Benefit|3|||
23141739|NCT02667587|64267850|FG000|End of Treatment|Participant Withdrew Consent|5|||
23141740|NCT02667587|64267851|FG001|End of Treatment|Participant Withdrew Consent|6|||
23318633|NCT02445963|64908472|FG003|Overall Study|Change in employment|0|||
23318634|NCT02445963|64908469|FG000|Overall Study|Symptoms post-vaccination|0|||
23318635|NCT02445963|64908470|FG001|Overall Study|Symptoms post-vaccination|0|||
23216674|NCT04114539|64534574|FG000|Overall Study|Adverse Event|14|||
23318636|NCT02445963|64908471|FG002|Overall Study|Symptoms post-vaccination|1|||
23318637|NCT02445963|64908472|FG003|Overall Study|Symptoms post-vaccination|0|||
23318638|NCT04152863|64908473|FG000|Overall Study|Death|13|||
23318639|NCT04152863|64908474|FG001|Overall Study|Death|12|||
23318640|NCT04152863|64908475|FG002|Overall Study|Death|7|||
23318641|NCT04152863|64908473|FG000|Overall Study|Physician Decision|1|||
23318642|NCT04152863|64908474|FG001|Overall Study|Physician Decision|1|||
23318643|NCT04152863|64908475|FG002|Overall Study|Physician Decision|1|||
23318644|NCT04152863|64908473|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
23318645|NCT04152863|64908474|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
23318646|NCT04152863|64908475|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
23318647|NCT04152863|64908473|FG000|Overall Study|Withdrawal by Subject|2|||
23432914|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Side effects|0|||
23216675|NCT04114539|64534574|FG000|Overall Study|Lost to Follow-up|2|||
23216676|NCT04114539|64534574|FG000|Overall Study|Non-compliance with Protocol|2|||
23318648|NCT04152863|64908474|FG001|Overall Study|Withdrawal by Subject|1|||
23318649|NCT04152863|64908475|FG002|Overall Study|Withdrawal by Subject|3|||
23318650|NCT00141778|64912161|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
23318651|NCT00141778|64912162|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
23318652|NCT00141778|64912163|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
23318653|NCT00141778|64912161|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
23318654|NCT00141778|64912162|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
23318655|NCT00141778|64912163|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
23318656|NCT00141778|64912161|FG000|Started Study Medication|Withdrawal by Subject|0|||
23318657|NCT00141778|64912162|FG001|Started Study Medication|Withdrawal by Subject|2|||
23318658|NCT00141778|64912163|FG002|Started Study Medication|Withdrawal by Subject|0|||
23318659|NCT00141778|64912161|FG000|Started Study Medication|Difficulty Swallowing|0|||
23318660|NCT00141778|64912162|FG001|Started Study Medication|Difficulty Swallowing|1|||
23318661|NCT00141778|64912163|FG002|Started Study Medication|Difficulty Swallowing|0|||
23318662|NCT00141778|64912161|FG000|Started Study Medication|Chest Discomfort|0|||
23318663|NCT00141778|64912162|FG001|Started Study Medication|Chest Discomfort|0|||
23318664|NCT00141778|64912163|FG002|Started Study Medication|Chest Discomfort|1|||
23318665|NCT00134901|64912164|FG000|Overall Study|Lost to Follow-up|5|||
23318666|NCT00134901|64912165|FG001|Overall Study|Lost to Follow-up|5|||
23318667|NCT00134901|64912164|FG000|Overall Study|discontinued intervention|12|||
23318668|NCT00134901|64912165|FG001|Overall Study|discontinued intervention|10|||
23318669|NCT00715624|64912166|FG000|Overall Study|Adverse Event|12|||
23318670|NCT00715624|64912167|FG001|Overall Study|Adverse Event|37|||
23318671|NCT00715624|64912166|FG000|Overall Study|Lack of Efficacy|11|||
23318672|NCT00715624|64912167|FG001|Overall Study|Lack of Efficacy|11|||
23318673|NCT00715624|64912166|FG000|Overall Study|Lost to Follow-up|1|||
23318674|NCT00715624|64912167|FG001|Overall Study|Lost to Follow-up|2|||
23318675|NCT00715624|64912166|FG000|Overall Study|Protocol Violation|1|||
23318676|NCT00715624|64912167|FG001|Overall Study|Protocol Violation|0|||
23318677|NCT00715624|64912166|FG000|Overall Study|Withdrawal by Subject|11|||
23318678|NCT00715624|64912167|FG001|Overall Study|Withdrawal by Subject|25|||
23318679|NCT00715624|64912166|FG000|Overall Study|Familial and personal reasons|10|||
23318680|NCT00715624|64912167|FG001|Overall Study|Familial and personal reasons|22|||
23318681|NCT00715624|64912166|FG000|Overall Study|Poor compliance|6|||
23318682|NCT00715624|64912167|FG001|Overall Study|Poor compliance|13|||
23318683|NCT00715624|64912166|FG000|Overall Study|Sponsor decision|0|||
23318684|NCT00715624|64912167|FG001|Overall Study|Sponsor decision|4|||
23318685|NCT00715624|64912166|FG000|Overall Study|Incorrect randomization (not treated)|0|||
23318686|NCT00715624|64912167|FG001|Overall Study|Incorrect randomization (not treated)|1|||
23318687|NCT00715624|64912166|FG000|Overall Study|Other|0|||
23318688|NCT00715624|64912167|FG001|Overall Study|Other|1|||
23318689|NCT02925403|64912168|FG000|Overall Study|Lost to Follow-up|0|||
23318690|NCT02925403|64912169|FG001|Overall Study|Lost to Follow-up|1|||
23318691|NCT04564092|64912178|FG000|Overall Study|Withdrawal by Subject|1|||
23141741|NCT02667587|64267850|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
23141742|NCT02667587|64267851|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
23141743|NCT02667587|64267850|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
23141744|NCT02667587|64267851|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
23141745|NCT02667587|64267850|FG000|End of Treatment|Death|2|||
23141746|NCT02667587|64267851|FG001|End of Treatment|Death|1|||
23141747|NCT02667587|64267850|FG000|End of Treatment|Study Drug Toxicity|74|||
23141748|NCT02667587|64267851|FG001|End of Treatment|Study Drug Toxicity|18|||
23141749|NCT02667587|64267850|FG000|End of Treatment|Disease progression|177|||
23141750|NCT02667587|64267851|FG001|End of Treatment|Disease progression|222|||
23141751|NCT02667587|64267850|FG000|End of Treatment|Lost to Follow-up|1|||
23141752|NCT02667587|64267851|FG001|End of Treatment|Lost to Follow-up|3|||
23141753|NCT02476279|64267852|FG000|Overall Study|Lost to Follow-up|1|||
23141754|NCT02476279|64267853|FG001|Overall Study|Lost to Follow-up|1|||
23141755|NCT02704754|64267854|FG000|Overall Study|Lost to Follow-up|1|||
23141756|NCT02704754|64267855|FG001|Overall Study|Lost to Follow-up|1|||
23141757|NCT02704754|64267854|FG000|Overall Study|Lack of Efficacy|1|||
23141758|NCT02704754|64267855|FG001|Overall Study|Lack of Efficacy|0|||
23318692|NCT02006732|64912181|FG000|Overall Study|Adverse Event|10|||
23318693|NCT02006732|64912182|FG001|Overall Study|Adverse Event|7|||
23318694|NCT02006732|64912183|FG002|Overall Study|Adverse Event|4|||
23318695|NCT02006732|64912184|FG003|Overall Study|Adverse Event|2|||
23318696|NCT02006732|64912181|FG000|Overall Study|Lack of Efficacy|6|||
23318697|NCT02006732|64912182|FG001|Overall Study|Lack of Efficacy|3|||
23318698|NCT02006732|64912183|FG002|Overall Study|Lack of Efficacy|1|||
23318699|NCT02006732|64912184|FG003|Overall Study|Lack of Efficacy|1|||
23318700|NCT02006732|64912181|FG000|Overall Study|Protocol Violation|1|||
23318701|NCT02006732|64912182|FG001|Overall Study|Protocol Violation|1|||
23318702|NCT02006732|64912183|FG002|Overall Study|Protocol Violation|0|||
23318703|NCT02006732|64912184|FG003|Overall Study|Protocol Violation|0|||
23141759|NCT02704754|64267854|FG000|Overall Study|Withdrawal by Subject|1|||
23141760|NCT02704754|64267855|FG001|Overall Study|Withdrawal by Subject|0|||
23318704|NCT02006732|64912181|FG000|Overall Study|Lost to Follow-up|0|||
23216677|NCT04114539|64534574|FG000|Overall Study|Non-compliance with Study Drug|1|||
23216678|NCT04114539|64534574|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
23216679|NCT04114539|64534574|FG000|Overall Study|Withdrew consent|10|||
23216680|NCT04114539|64534574|FG000|Overall Study|Others not specified|5|||
23216681|NCT04114539|64534574|FG000|Overall Study|Investigator Decision|2|||
23216682|NCT02988219|64534575|FG000|Overall Study|Lack of Efficacy|1|||
23216683|NCT02988219|64534576|FG001|Overall Study|Lack of Efficacy|1|||
23216684|NCT02988219|64534575|FG000|Overall Study|Withdrawal by Subject|0|||
23216685|NCT02988219|64534576|FG001|Overall Study|Withdrawal by Subject|2|||
23216686|NCT02460978|64534577|FG000|Overall Study|Adverse Event|17|||
23216687|NCT02460978|64534578|FG001|Overall Study|Adverse Event|11|||
23318705|NCT02006732|64912182|FG001|Overall Study|Lost to Follow-up|1|||
23318706|NCT02006732|64912183|FG002|Overall Study|Lost to Follow-up|0|||
23318707|NCT02006732|64912184|FG003|Overall Study|Lost to Follow-up|0|||
23318708|NCT02006732|64912181|FG000|Overall Study|Withdrawal by Subject|3|||
23318709|NCT02006732|64912182|FG001|Overall Study|Withdrawal by Subject|0|||
23318710|NCT02006732|64912183|FG002|Overall Study|Withdrawal by Subject|4|||
23318711|NCT02006732|64912184|FG003|Overall Study|Withdrawal by Subject|1|||
23318712|NCT00761657|64912185|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
23318713|NCT00761657|64912186|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
23318714|NCT00761657|64912187|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
23216688|NCT02460978|64534579|FG002|Overall Study|Adverse Event|11|||
23216689|NCT02460978|64534577|FG000|Overall Study|Withdrawal by Subject|5|||
23216690|NCT02460978|64534578|FG001|Overall Study|Withdrawal by Subject|5|||
23216691|NCT02460978|64534579|FG002|Overall Study|Withdrawal by Subject|14|||
23216692|NCT02460978|64534577|FG000|Overall Study|Lost to Follow-up|2|||
23216693|NCT02460978|64534578|FG001|Overall Study|Lost to Follow-up|3|||
23216694|NCT02460978|64534579|FG002|Overall Study|Lost to Follow-up|1|||
23216695|NCT02460978|64534577|FG000|Overall Study|Protocol Violation|1|||
23216696|NCT02460978|64534578|FG001|Overall Study|Protocol Violation|1|||
23216697|NCT02460978|64534579|FG002|Overall Study|Protocol Violation|1|||
23216698|NCT02460978|64534577|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
23216699|NCT02460978|64534578|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
23216700|NCT02460978|64534579|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
23216701|NCT02460978|64534577|FG000|Overall Study|Pregnancy|0|||
23216702|NCT02460978|64534578|FG001|Overall Study|Pregnancy|0|||
23216703|NCT02460978|64534579|FG002|Overall Study|Pregnancy|2|||
23216704|NCT01467661|64534580|FG000|Overall Study|Adverse Event|16|||
23216705|NCT01467661|64534580|FG000|Overall Study|Withdrawal by Subject|1|||
23216706|NCT01467661|64534580|FG000|Overall Study|Lack of Efficacy|3|||
23216707|NCT01467661|64534580|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
23216708|NCT01437267|64534581|FG000|Overall Study|Withdrawal by Subject|0|||
23432915|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Side effects|0|||
23432916|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Side effects|0|||
23432917|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Side effects|0|||
23432918|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Side effects|0|||
23432919|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Side effects|0|||
23432920|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Side effects|0|||
23432921|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Side effects|0|||
23432922|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Side effects|0|||
23318715|NCT00761657|64912188|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
23318716|NCT00761657|64912189|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
23141761|NCT01844687|64267856|FG000|Visit 1|Protocol Violation|3|||
23141762|NCT01844687|64267856|FG000|Visit 1|Lost to Follow-up|5|||
23141763|NCT01844687|64267856|FG000|Visit 2|Withdrawal by Subject|1|||
23141764|NCT01844687|64267856|FG000|Visit 2|Protocol Violation|1|||
23141765|NCT01844687|64267856|FG000|Visit 3|Lost to Follow-up|1|||
23141766|NCT01844687|64267856|FG000|Visit 3|Withdrawal by Subject|3|||
23141767|NCT01844687|64267856|FG000|Visit 3|child care problems|1|||
23141768|NCT01844687|64267856|FG000|Visit 4|Pregnancy|1|||
23141769|NCT01844687|64267856|FG000|Visit 4|Lost to Follow-up|1|||
23141770|NCT01844687|64267856|FG000|Visit 4|Withdrawal by Subject|2|||
23141771|NCT02407990|64267857|FG000|Overall Study|Death|2|||
23216709|NCT01437267|64534582|FG001|Overall Study|Withdrawal by Subject|0|||
23216710|NCT01437267|64534583|FG002|Overall Study|Withdrawal by Subject|0|||
23318717|NCT00761657|64912190|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
23318718|NCT00761657|64912191|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
23318719|NCT00761657|64912192|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
23141772|NCT02407990|64267858|FG001|Overall Study|Death|22|||
23318720|NCT00761657|64912193|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
23318721|NCT00761657|64912185|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23141773|NCT02407990|64267859|FG002|Overall Study|Death|23|||
23141774|NCT02407990|64267860|FG003|Overall Study|Death|7|||
23141775|NCT02407990|64267861|FG004|Overall Study|Death|17|||
23141776|NCT02407990|64267862|FG005|Overall Study|Death|16|||
23141777|NCT02407990|64267863|FG006|Overall Study|Death|10|||
23216711|NCT01437267|64534584|FG003|Overall Study|Withdrawal by Subject|1|||
23216712|NCT01437267|64534585|FG004|Overall Study|Withdrawal by Subject|0|||
23318722|NCT00761657|64912186|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23318723|NCT00761657|64912187|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
23318724|NCT00761657|64912188|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
23318725|NCT00761657|64912189|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23318726|NCT00761657|64912190|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23318727|NCT00761657|64912191|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23318728|NCT00761657|64912192|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23318729|NCT00761657|64912193|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
23318730|NCT00761657|64912185|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
23318731|NCT00761657|64912186|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
23318732|NCT00761657|64912187|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
23318733|NCT00761657|64912188|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
23318734|NCT00761657|64912189|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
23318735|NCT00761657|64912190|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
23318736|NCT00761657|64912191|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
23318737|NCT00761657|64912192|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
23318738|NCT00761657|64912193|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
23318739|NCT00761657|64912185|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
23318740|NCT00761657|64912186|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
23318741|NCT00761657|64912187|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
23318742|NCT00761657|64912188|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
23318743|NCT00761657|64912189|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
23318744|NCT00761657|64912190|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
23141778|NCT02407990|64267864|FG007|Overall Study|Death|248|||
23141779|NCT02407990|64267857|FG000|Overall Study|Lost to Follow-up|0|||
23141780|NCT02407990|64267858|FG001|Overall Study|Lost to Follow-up|1|||
23141781|NCT02407990|64267859|FG002|Overall Study|Lost to Follow-up|0|||
23141782|NCT02407990|64267860|FG003|Overall Study|Lost to Follow-up|0|||
23141783|NCT02407990|64267861|FG004|Overall Study|Lost to Follow-up|0|||
23141784|NCT02407990|64267862|FG005|Overall Study|Lost to Follow-up|0|||
23318745|NCT00761657|64912191|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
23318746|NCT00761657|64912192|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
23318747|NCT00761657|64912193|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
23318748|NCT02215967|64912194|FG000|Overall Study|Patient became ineligible for treatment|0|||
23318749|NCT02215967|64912195|FG001|Overall Study|Patient became ineligible for treatment|0|||
23318750|NCT02215967|64912196|FG002|Overall Study|Patient became ineligible for treatment|0|||
23318751|NCT02215967|64912197|FG003|Overall Study|Patient became ineligible for treatment|3|||
23318752|NCT02215967|64912194|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
23318753|NCT02215967|64912195|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
23318754|NCT02215967|64912196|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
23318755|NCT02215967|64912197|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
23318756|NCT01023035|64912210|FG000|Treatment Period|Adverse Event|27|||
23318757|NCT01023035|64912211|FG001|Treatment Period|Adverse Event|32|||
23318758|NCT01023035|64912212|FG002|Treatment Period|Adverse Event|50|||
23318759|NCT01023035|64912210|FG000|Treatment Period|Non-Medical Reasons|19|||
23318760|NCT01023035|64912211|FG001|Treatment Period|Non-Medical Reasons|22|||
23318761|NCT01023035|64912212|FG002|Treatment Period|Non-Medical Reasons|44|||
23318762|NCT01023035|64912210|FG000|Treatment Period|Treatment Failure|26|||
23318763|NCT01023035|64912211|FG001|Treatment Period|Treatment Failure|31|||
23318764|NCT01023035|64912212|FG002|Treatment Period|Treatment Failure|24|||
23318765|NCT01023035|64912210|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
23318766|NCT01023035|64912211|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
23318767|NCT01023035|64912212|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
23318768|NCT01023035|64912210|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
23318769|NCT01023035|64912211|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
23318770|NCT01023035|64912212|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
23318771|NCT00111241|64912213|FG000|Overall Study|Lost to Follow-up|1|||
23318772|NCT00111241|64912214|FG001|Overall Study|Lost to Follow-up|0|||
23555165|NCT02732938|65758020|FG001|Overall Study|Study terminated by sponsor|6|||
23141785|NCT02407990|64267863|FG006|Overall Study|Lost to Follow-up|0|||
23141786|NCT02407990|64267864|FG007|Overall Study|Lost to Follow-up|17|||
23141787|NCT02407990|64267857|FG000|Overall Study|Progressive Disease|0|||
23141788|NCT02407990|64267858|FG001|Overall Study|Progressive Disease|0|||
23318773|NCT00111241|64912213|FG000|Overall Study|Withdrawal by Subject|4|||
23318774|NCT00111241|64912214|FG001|Overall Study|Withdrawal by Subject|0|||
23141789|NCT02407990|64267859|FG002|Overall Study|Progressive Disease|0|||
23216713|NCT01437267|64534586|FG005|Overall Study|Withdrawal by Subject|0|||
23318775|NCT00111241|64912213|FG000|Overall Study|Protocol Violation|9|||
23318776|NCT00111241|64912214|FG001|Overall Study|Protocol Violation|8|||
23555166|NCT02732938|65758021|FG002|Overall Study|Study terminated by sponsor|0|||
23318777|NCT00111241|64912213|FG000|Overall Study|Adverse Event|1|||
23318778|NCT00111241|64912214|FG001|Overall Study|Adverse Event|0|||
23318779|NCT03180645|64912215|FG000|Overall Study|Adverse Event|0|||
23141790|NCT02407990|64267860|FG003|Overall Study|Progressive Disease|0|||
23141791|NCT02407990|64267861|FG004|Overall Study|Progressive Disease|0|||
23318780|NCT03180645|64912216|FG001|Overall Study|Adverse Event|1|||
23318781|NCT03180645|64912217|FG002|Overall Study|Adverse Event|2|||
23318782|NCT02290405|64912218|FG000|Overall Study|Withdrawal by Subject|1|||
23318783|NCT02290405|64912219|FG001|Overall Study|Withdrawal by Subject|0|||
23318784|NCT01645787|64912221|FG000|Washout (2 Weeks)|Adverse Event|1|||
23318785|NCT01645787|64912222|FG001|Washout (2 Weeks)|Adverse Event|0|||
23318786|NCT03629184|64912223|FG000|Overall Study|Withdrawal by Subject|2|||
23318787|NCT03629184|64912224|FG001|Overall Study|Withdrawal by Subject|1|||
23318788|NCT03629184|64912223|FG000|Overall Study|Physician Decision|1|||
23318789|NCT03629184|64912224|FG001|Overall Study|Physician Decision|0|||
23318790|NCT01399658|64912225|FG000|Overall Study|Ineligible|1|||
23318791|NCT01399658|64912225|FG000|Overall Study|Machine Technical Issue|3|||
23318792|NCT01399658|64912225|FG000|Overall Study|Alternative therapy|1|||
23318793|NCT01399658|64912225|FG000|Overall Study|No reason given|1|||
23318794|NCT03845296|64912226|FG000|Overall Study|On Treatment|2|||
23318795|NCT03845296|64912227|FG001|Overall Study|On Treatment|1|||
23318796|NCT03845296|64912226|FG000|Overall Study|Adverse Event|4|||
23318797|NCT03845296|64912227|FG001|Overall Study|Adverse Event|11|||
23318798|NCT03845296|64912226|FG000|Overall Study|Refusal unrelated to adverse event|0|||
23318799|NCT03845296|64912227|FG001|Overall Study|Refusal unrelated to adverse event|1|||
23318800|NCT03845296|64912226|FG000|Overall Study|Progression/relapse|14|||
23318801|NCT03845296|64912227|FG001|Overall Study|Progression/relapse|18|||
23318802|NCT03845296|64912226|FG000|Overall Study|Death|4|||
23318803|NCT03845296|64912227|FG001|Overall Study|Death|0|||
23318804|NCT03845296|64912226|FG000|Overall Study|Other - not protocol specified|1|||
23318805|NCT03845296|64912227|FG001|Overall Study|Other - not protocol specified|3|||
23318806|NCT04439201|64912231|FG000|Overall Study|Ineligible|2|||
23318807|NCT04439201|64912231|FG000|Overall Study|Never start protocol therapy|1|||
23318808|NCT04439201|64912231|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
23318809|NCT04439201|64912231|FG000|Overall Study|Mutation status not confirmed|4|||
23318810|NCT04439201|64912231|FG000|Overall Study|Adverse Event|1|||
23318811|NCT04439201|64912231|FG000|Overall Study|Death|7|||
23318812|NCT04439201|64912231|FG000|Overall Study|Withdrawal by Subject|2|||
23318813|NCT04439201|64912231|FG000|Overall Study|Disease progression|20|||
23318814|NCT04439201|64912231|FG000|Overall Study|Alternative therapy|1|||
23318815|NCT04439201|64912231|FG000|Overall Study|Physician Decision|1|||
23318816|NCT03519087|64912232|FG000|Clinic Evaluation|Physician Decision|15|||
23318817|NCT03519087|64912233|FG001|Clinic Evaluation|Physician Decision|18|||
23318818|NCT03519087|64912234|FG002|Clinic Evaluation|Physician Decision|0|||
23318819|NCT03519087|64912235|FG003|Clinic Evaluation|Physician Decision|0|||
23318820|NCT03519087|64912236|FG004|Clinic Evaluation|Physician Decision|0|||
23318821|NCT03519087|64912232|FG000|Clinic Evaluation|Protocol Violation|1|||
23318822|NCT03519087|64912233|FG001|Clinic Evaluation|Protocol Violation|0|||
23318823|NCT03519087|64912234|FG002|Clinic Evaluation|Protocol Violation|0|||
23318824|NCT03519087|64912235|FG003|Clinic Evaluation|Protocol Violation|0|||
23318825|NCT03519087|64912236|FG004|Clinic Evaluation|Protocol Violation|0|||
23318826|NCT03519087|64912232|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
23318827|NCT03519087|64912233|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
23318828|NCT03519087|64912234|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
23318829|NCT03519087|64912235|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
23318830|NCT03519087|64912236|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
23318831|NCT03519087|64912232|FG000|Re-randomization for Treatment|Not appropriate|2|||
23318832|NCT03519087|64912233|FG001|Re-randomization for Treatment|Not appropriate|3|||
23318833|NCT03519087|64912234|FG002|Re-randomization for Treatment|Not appropriate|0|||
23318834|NCT03519087|64912235|FG003|Re-randomization for Treatment|Not appropriate|0|||
23318835|NCT03519087|64912236|FG004|Re-randomization for Treatment|Not appropriate|0|||
23318836|NCT03519087|64912232|FG000|Laboratory Testing|Lost to Follow-up|0|||
23318837|NCT03519087|64912233|FG001|Laboratory Testing|Lost to Follow-up|0|||
23318838|NCT03519087|64912234|FG002|Laboratory Testing|Lost to Follow-up|2|||
23318839|NCT03519087|64912235|FG003|Laboratory Testing|Lost to Follow-up|3|||
23318840|NCT03519087|64912236|FG004|Laboratory Testing|Lost to Follow-up|6|||
23555167|NCT05159622|65758022|FG000|Overall Study|Lost to Follow-up|4|||
23318841|NCT03519087|64912232|FG000|Laboratory Testing|Protocol Violation|0|||
23318842|NCT03519087|64912233|FG001|Laboratory Testing|Protocol Violation|0|||
23318843|NCT03519087|64912234|FG002|Laboratory Testing|Protocol Violation|0|||
23318844|NCT03519087|64912235|FG003|Laboratory Testing|Protocol Violation|1|||
23318845|NCT03519087|64912236|FG004|Laboratory Testing|Protocol Violation|0|||
23318846|NCT00396812|64912242|FG000|Overall Study|Physician Decision|1|||
23318847|NCT00739063|64912243|FG000|Overall Study|Screen failures|8|||
23318848|NCT02856555|64912244|FG000|Overall Study|Adverse Event|1|||
23318849|NCT02856555|64912245|FG001|Overall Study|Adverse Event|0|||
23318850|NCT02856555|64912246|FG002|Overall Study|Adverse Event|0|||
23318851|NCT02856555|64912244|FG000|Overall Study|Lost to Follow-up|1|||
23318852|NCT02856555|64912245|FG001|Overall Study|Lost to Follow-up|3|||
23318853|NCT02856555|64912246|FG002|Overall Study|Lost to Follow-up|0|||
23555168|NCT05159622|65758023|FG001|Overall Study|Lost to Follow-up|5|||
23216714|NCT01437267|64534581|FG000|Overall Study|Protocol Violation|0|||
23216715|NCT01437267|64534582|FG001|Overall Study|Protocol Violation|1|||
23216716|NCT01437267|64534583|FG002|Overall Study|Protocol Violation|0|||
23318854|NCT02856555|64912244|FG000|Overall Study|Withdrawal by Subject|3|||
23318855|NCT02856555|64912245|FG001|Overall Study|Withdrawal by Subject|0|||
23318856|NCT02856555|64912246|FG002|Overall Study|Withdrawal by Subject|0|||
23318857|NCT02856555|64912244|FG000|Overall Study|Randomized but Never Treated|0|||
23318858|NCT02856555|64912245|FG001|Overall Study|Randomized but Never Treated|1|||
23318859|NCT02856555|64912246|FG002|Overall Study|Randomized but Never Treated|0|||
23318860|NCT00270855|64912249|FG000|Overall Study|Withdrawal by Subject|8|||
23318861|NCT00270855|64912250|FG001|Overall Study|Withdrawal by Subject|8|||
23318862|NCT01256502|64912253|FG000|Overall Study|Had scaffold removed|4|||
23318863|NCT01256502|64912253|FG000|Overall Study|Personal reasons|5|||
23318864|NCT01256502|64912253|FG000|Overall Study|Protocol deviation|1|||
23318865|NCT02565511|64912255|FG000|Overall Study|Study terminated by Sponsor|35|||
23318866|NCT02565511|64912256|FG001|Overall Study|Study terminated by Sponsor|22|||
23318867|NCT02565511|64912257|FG002|Overall Study|Study terminated by Sponsor|235|||
23622481|NCT01874665|66004964|FG001|Overall Study|Documented Progressive Disease|7|||
23622482|NCT01874665|66004963|FG000|Overall Study|Other|2|||
23141792|NCT02407990|64267862|FG005|Overall Study|Progressive Disease|0|||
23141793|NCT02407990|64267863|FG006|Overall Study|Progressive Disease|0|||
23141794|NCT02407990|64267864|FG007|Overall Study|Progressive Disease|1|||
23141795|NCT02407990|64267857|FG000|Overall Study|Withdrawal by Subject|0|||
23141796|NCT02407990|64267858|FG001|Overall Study|Withdrawal by Subject|0|||
23141797|NCT02407990|64267859|FG002|Overall Study|Withdrawal by Subject|0|||
23141798|NCT02407990|64267860|FG003|Overall Study|Withdrawal by Subject|0|||
23216717|NCT01437267|64534584|FG003|Overall Study|Protocol Violation|0|||
23216718|NCT01437267|64534585|FG004|Overall Study|Protocol Violation|0|||
23141799|NCT02407990|64267861|FG004|Overall Study|Withdrawal by Subject|1|||
23141800|NCT02407990|64267862|FG005|Overall Study|Withdrawal by Subject|0|||
23141801|NCT02407990|64267863|FG006|Overall Study|Withdrawal by Subject|0|||
23141802|NCT02407990|64267864|FG007|Overall Study|Withdrawal by Subject|30|||
23141803|NCT02407990|64267857|FG000|Overall Study|Study Terminated by Sponsor|1|||
23141804|NCT02407990|64267858|FG001|Overall Study|Study Terminated by Sponsor|3|||
23141805|NCT02407990|64267859|FG002|Overall Study|Study Terminated by Sponsor|3|||
23141806|NCT02407990|64267860|FG003|Overall Study|Study Terminated by Sponsor|0|||
23141807|NCT02407990|64267861|FG004|Overall Study|Study Terminated by Sponsor|3|||
23141808|NCT02407990|64267862|FG005|Overall Study|Study Terminated by Sponsor|4|||
23141809|NCT02407990|64267863|FG006|Overall Study|Study Terminated by Sponsor|3|||
23216719|NCT01437267|64534586|FG005|Overall Study|Protocol Violation|0|||
23216720|NCT01149343|64534587|FG000|Overall Study|Withdrawal by Subject|1|||
23216721|NCT01149343|64534588|FG001|Overall Study|Withdrawal by Subject|1|||
23216722|NCT01149343|64534589|FG002|Overall Study|Withdrawal by Subject|1|||
23216723|NCT01149343|64534590|FG003|Overall Study|Withdrawal by Subject|5|||
23622483|NCT01874665|66004964|FG001|Overall Study|Other|0|||
23622484|NCT02971228|66004965|FG000|Overall Study|Withdrawal by Subject|1|||
23622485|NCT02971228|66004966|FG001|Overall Study|Withdrawal by Subject|1|||
23622486|NCT02971228|66004967|FG002|Overall Study|Withdrawal by Subject|0|||
23141810|NCT02407990|64267864|FG007|Overall Study|Study Terminated by Sponsor|37|||
23141811|NCT02407990|64267857|FG000|Overall Study|Logistics|0|||
23141812|NCT02407990|64267858|FG001|Overall Study|Logistics|0|||
23141813|NCT02407990|64267859|FG002|Overall Study|Logistics|0|||
23141814|NCT02407990|64267860|FG003|Overall Study|Logistics|0|||
23141815|NCT02407990|64267861|FG004|Overall Study|Logistics|0|||
23141816|NCT02407990|64267862|FG005|Overall Study|Logistics|0|||
23141817|NCT02407990|64267863|FG006|Overall Study|Logistics|0|||
23141818|NCT02407990|64267864|FG007|Overall Study|Logistics|1|||
23141819|NCT02407990|64267857|FG000|Overall Study|Rolled into long-term extension study|0|||
23141820|NCT02407990|64267858|FG001|Overall Study|Rolled into long-term extension study|0|||
23141821|NCT02407990|64267859|FG002|Overall Study|Rolled into long-term extension study|0|||
23141822|NCT02407990|64267860|FG003|Overall Study|Rolled into long-term extension study|0|||
23141823|NCT02407990|64267861|FG004|Overall Study|Rolled into long-term extension study|0|||
23141824|NCT02407990|64267862|FG005|Overall Study|Rolled into long-term extension study|0|||
23216724|NCT01149343|64534587|FG000|Overall Study|Death|10|||
23216725|NCT01149343|64534588|FG001|Overall Study|Death|13|||
23216726|NCT01149343|64534589|FG002|Overall Study|Death|18|||
23318868|NCT02565511|64912258|FG003|Overall Study|Study terminated by Sponsor|156|||
23318869|NCT02565511|64912255|FG000|Overall Study|Withdrawal by Subject|3|||
23622487|NCT02971228|66004968|FG003|Overall Study|Withdrawal by Subject|0|||
23141825|NCT02407990|64267863|FG006|Overall Study|Rolled into long-term extension study|0|||
23141826|NCT02407990|64267864|FG007|Overall Study|Rolled into long-term extension study|1|||
23141827|NCT00687973|64267865|FG000|Overall Study|Adverse Event|18|||
23141828|NCT00687973|64267866|FG001|Overall Study|Adverse Event|28|||
23216727|NCT01149343|64534590|FG003|Overall Study|Death|18|||
23216728|NCT01149343|64534587|FG000|Overall Study|Lost to Follow-up|1|||
23318870|NCT02565511|64912256|FG001|Overall Study|Withdrawal by Subject|0|||
23622488|NCT02971228|66004969|FG004|Overall Study|Withdrawal by Subject|0|||
23318871|NCT02565511|64912257|FG002|Overall Study|Withdrawal by Subject|12|||
23318872|NCT02565511|64912258|FG003|Overall Study|Withdrawal by Subject|5|||
23318873|NCT02565511|64912255|FG000|Overall Study|Adverse Event|0|||
23318874|NCT02565511|64912256|FG001|Overall Study|Adverse Event|0|||
23318875|NCT02565511|64912257|FG002|Overall Study|Adverse Event|1|||
23318876|NCT02565511|64912258|FG003|Overall Study|Adverse Event|1|||
23318877|NCT02565511|64912255|FG000|Overall Study|Lost to Follow-up|4|||
23318878|NCT02565511|64912256|FG001|Overall Study|Lost to Follow-up|1|||
23318879|NCT02565511|64912257|FG002|Overall Study|Lost to Follow-up|0|||
23318880|NCT02565511|64912258|FG003|Overall Study|Lost to Follow-up|1|||
23318881|NCT02565511|64912255|FG000|Overall Study|Physician Decision|0|||
23318882|NCT02565511|64912256|FG001|Overall Study|Physician Decision|0|||
23318883|NCT02565511|64912257|FG002|Overall Study|Physician Decision|0|||
23318884|NCT02565511|64912258|FG003|Overall Study|Physician Decision|1|||
23318885|NCT02565511|64912255|FG000|Overall Study|Protocol deviation|0|||
23318886|NCT02565511|64912256|FG001|Overall Study|Protocol deviation|0|||
23318887|NCT02565511|64912257|FG002|Overall Study|Protocol deviation|3|||
23318888|NCT02565511|64912258|FG003|Overall Study|Protocol deviation|0|||
23318889|NCT01198132|64912259|FG000|Overall Study|Withdrawal by Subject|4|||
23318890|NCT01198132|64912260|FG001|Overall Study|Withdrawal by Subject|5|||
23318891|NCT01198132|64912259|FG000|Overall Study|Physician Decision|5|||
23318892|NCT01198132|64912260|FG001|Overall Study|Physician Decision|4|||
23318893|NCT01198132|64912259|FG000|Overall Study|Other Unspecified|3|||
23318894|NCT01198132|64912260|FG001|Overall Study|Other Unspecified|6|||
23318895|NCT01198132|64912259|FG000|Overall Study|Lack of Efficacy|2|||
23318896|NCT01198132|64912260|FG001|Overall Study|Lack of Efficacy|3|||
23141829|NCT00687973|64267865|FG000|Overall Study|Lack of Efficacy|2|||
23141830|NCT00687973|64267866|FG001|Overall Study|Lack of Efficacy|3|||
23141831|NCT00687973|64267865|FG000|Overall Study|Protocol Violation|1|||
23141832|NCT00687973|64267866|FG001|Overall Study|Protocol Violation|2|||
23141833|NCT00687973|64267865|FG000|Overall Study|Administrative Reasons|0|||
23141834|NCT00687973|64267866|FG001|Overall Study|Administrative Reasons|2|||
23141835|NCT00687973|64267865|FG000|Overall Study|Withdrawal by Subject|3|||
23318897|NCT01198132|64912259|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
23318898|NCT01198132|64912260|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
23432923|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Side effects|0|||
23318899|NCT01198132|64912259|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
23432924|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Side effects|8|||
23555169|NCT03076970|65758024|FG000|Washout Period 2|Adverse Event|0|||
23555170|NCT03076970|65758025|FG001|Washout Period 2|Adverse Event|0|||
23555171|NCT03076970|65758026|FG002|Washout Period 2|Adverse Event|0|||
23141836|NCT00687973|64267866|FG001|Overall Study|Withdrawal by Subject|3|||
23141837|NCT01290315|64267867|FG000|Overall Study|Adverse Event|0|||
23141838|NCT01290315|64267868|FG001|Overall Study|Adverse Event|0|||
23141839|NCT01290315|64267869|FG002|Overall Study|Adverse Event|0|||
23555172|NCT03076970|65758027|FG003|Washout Period 2|Adverse Event|0|||
23555173|NCT03076970|65758028|FG004|Washout Period 2|Adverse Event|1|||
23555174|NCT03076970|65758029|FG005|Washout Period 2|Adverse Event|0|||
23555175|NCT03076970|65758024|FG000|Period 3|Withdrawal by Subject|0|||
23555176|NCT03076970|65758025|FG001|Period 3|Withdrawal by Subject|0|||
23555177|NCT03076970|65758026|FG002|Period 3|Withdrawal by Subject|0|||
23555178|NCT03076970|65758027|FG003|Period 3|Withdrawal by Subject|0|||
23555179|NCT03076970|65758028|FG004|Period 3|Withdrawal by Subject|0|||
23555180|NCT03076970|65758029|FG005|Period 3|Withdrawal by Subject|1|||
23555181|NCT03076970|65758024|FG000|Period 3|Failure to meet I/E criteria|0|||
23555182|NCT03076970|65758025|FG001|Period 3|Failure to meet I/E criteria|0|||
23555183|NCT03076970|65758026|FG002|Period 3|Failure to meet I/E criteria|0|||
23555184|NCT03076970|65758027|FG003|Period 3|Failure to meet I/E criteria|0|||
23555185|NCT03076970|65758028|FG004|Period 3|Failure to meet I/E criteria|1|||
23555186|NCT03076970|65758029|FG005|Period 3|Failure to meet I/E criteria|0|||
23555187|NCT00511875|65758030|FG000|Overall Study|Lost to Follow-up|4|||
23555188|NCT00511875|65758031|FG001|Overall Study|Lost to Follow-up|0|||
23555189|NCT00511875|65758030|FG000|Overall Study|Missing variables|1|||
23555190|NCT00511875|65758031|FG001|Overall Study|Missing variables|0|||
23555191|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
23555192|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
23555193|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
23555194|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
23555195|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Other|13|||
23555196|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
23555197|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
23555198|NCT02497287|65758032|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
23555199|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
23555200|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
23555201|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
23555202|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
23141840|NCT01290315|64267870|FG003|Overall Study|Adverse Event|3|||
23141841|NCT01290315|64267867|FG000|Overall Study|Selection criteria/compliance|2|||
23141842|NCT01290315|64267868|FG001|Overall Study|Selection criteria/compliance|1|||
23141843|NCT01290315|64267869|FG002|Overall Study|Selection criteria/compliance|0|||
23141844|NCT01290315|64267870|FG003|Overall Study|Selection criteria/compliance|2|||
23141845|NCT01290315|64267867|FG000|Overall Study|Lost to Follow-up|0|||
23141846|NCT01290315|64267868|FG001|Overall Study|Lost to Follow-up|1|||
23141847|NCT01290315|64267869|FG002|Overall Study|Lost to Follow-up|0|||
23141848|NCT01290315|64267870|FG003|Overall Study|Lost to Follow-up|0|||
23141849|NCT01290315|64267867|FG000|Overall Study|Withdrawal by Subject|1|||
23141850|NCT01290315|64267868|FG001|Overall Study|Withdrawal by Subject|1|||
23141851|NCT01290315|64267869|FG002|Overall Study|Withdrawal by Subject|0|||
23141852|NCT01290315|64267870|FG003|Overall Study|Withdrawal by Subject|0|||
23141853|NCT00848926|64267871|FG000|Treatment Period|Progressive disease|45|||
23141854|NCT00848926|64267871|FG000|Treatment Period|Adverse Event|20|||
23141855|NCT00848926|64267871|FG000|Treatment Period|Physician Decision|12|||
23141856|NCT00848926|64267871|FG000|Treatment Period|Withdrawal by Subject|7|||
23141857|NCT00848926|64267871|FG000|Follow-up Period|Lost to Follow-up|7|||
23141858|NCT00848926|64267871|FG000|Follow-up Period|Withdrawal by Subject|3|||
23141859|NCT00848926|64267871|FG000|Follow-up Period|Other|2|||
23141860|NCT05056987|64267876|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
23141861|NCT05056987|64267877|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
23141862|NCT05056987|64267876|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
23141863|NCT05056987|64267877|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
23141864|NCT02915302|64267878|FG000|Overall Study|Adverse Event|3|||
23141865|NCT02915302|64267879|FG001|Overall Study|Adverse Event|0|||
23141866|NCT02915302|64267878|FG000|Overall Study|Protocol Violation|20|||
23141867|NCT02915302|64267879|FG001|Overall Study|Protocol Violation|27|||
23141868|NCT02915302|64267878|FG000|Overall Study|Lost to Follow-up|19|||
23141869|NCT02915302|64267879|FG001|Overall Study|Lost to Follow-up|22|||
23141870|NCT02915302|64267878|FG000|Overall Study|Withdrawal by Subject|22|||
23141871|NCT02915302|64267879|FG001|Overall Study|Withdrawal by Subject|29|||
23141872|NCT02915302|64267878|FG000|Overall Study|Other|1|||
23141873|NCT02915302|64267879|FG001|Overall Study|Other|0|||
23141874|NCT02372136|64270500|FG000|Overall Study|Death|3|||
23141875|NCT02372136|64270501|FG001|Overall Study|Death|1|||
23141876|NCT00427895|64270502|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23141877|NCT00427895|64270503|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23141878|NCT00427895|64270504|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23141879|NCT00427895|64270505|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
23141880|NCT00427895|64270506|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23141881|NCT00427895|64270507|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23141882|NCT00427895|64270508|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23141883|NCT00427895|64270509|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
23141884|NCT00427895|64270502|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23141885|NCT00427895|64270503|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23141886|NCT00427895|64270504|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23141887|NCT00427895|64270505|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23141888|NCT00427895|64270506|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23141889|NCT00427895|64270507|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23141890|NCT00427895|64270508|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
23141891|NCT00427895|64270509|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
23141892|NCT00427895|64270502|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
23141893|NCT00427895|64270503|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
23141894|NCT00427895|64270504|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
23141895|NCT00427895|64270505|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
23141896|NCT00427895|64270506|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
23141897|NCT00427895|64270507|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
23141898|NCT00427895|64270508|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
23141899|NCT00427895|64270509|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
23141900|NCT00427895|64270502|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
23141901|NCT00427895|64270503|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
23141902|NCT00427895|64270504|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
23141903|NCT00427895|64270505|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
23141904|NCT00427895|64270506|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
23141905|NCT00427895|64270507|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
23141906|NCT00427895|64270508|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
23141907|NCT00427895|64270509|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
23141908|NCT00427895|64270502|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23141909|NCT00427895|64270503|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
23141910|NCT00427895|64270504|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
23141911|NCT00427895|64270505|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
23141912|NCT00427895|64270506|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23141913|NCT00427895|64270507|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23141914|NCT00427895|64270508|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23141915|NCT00427895|64270509|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
23141916|NCT00427895|64270502|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
23141917|NCT00427895|64270503|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23141918|NCT00427895|64270504|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
23141919|NCT00427895|64270505|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
23141920|NCT00427895|64270506|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23141921|NCT00427895|64270507|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23141922|NCT00427895|64270508|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23141923|NCT00427895|64270509|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
23141924|NCT00427895|64270502|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
23141925|NCT00427895|64270503|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
23141926|NCT00427895|64270504|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23141927|NCT00427895|64270505|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23141928|NCT00427895|64270506|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23141929|NCT00427895|64270507|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23141930|NCT00427895|64270508|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23141931|NCT00427895|64270509|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
23141932|NCT00427895|64270502|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
23141933|NCT00427895|64270503|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
23141934|NCT00427895|64270504|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
23141935|NCT00427895|64270505|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
23141936|NCT00427895|64270506|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
23141937|NCT00427895|64270507|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
23141938|NCT00427895|64270508|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
23141939|NCT00427895|64270509|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
23141940|NCT00427895|64270502|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23141941|NCT00427895|64270503|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23141942|NCT00427895|64270504|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23141943|NCT00427895|64270505|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
23141944|NCT00427895|64270506|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23141945|NCT00427895|64270507|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23141946|NCT00427895|64270508|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23141947|NCT00427895|64270509|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
23141948|NCT00427895|64270502|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
23141949|NCT00427895|64270503|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
23141950|NCT00427895|64270504|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
23141951|NCT00427895|64270505|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
23141952|NCT00427895|64270506|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
23141953|NCT00427895|64270507|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
23141954|NCT00427895|64270508|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
23141955|NCT00427895|64270509|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
23141956|NCT00427895|64270502|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23141957|NCT00427895|64270503|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23141958|NCT00427895|64270504|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
23141959|NCT00427895|64270505|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
23141960|NCT00427895|64270506|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23141961|NCT00427895|64270507|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23141962|NCT00427895|64270508|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23141963|NCT00427895|64270509|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
23141964|NCT00427895|64270502|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23141965|NCT00427895|64270503|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
23141966|NCT00427895|64270504|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
23141967|NCT00427895|64270505|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
23141968|NCT00427895|64270506|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23141969|NCT00427895|64270507|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23141970|NCT00427895|64270508|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23141971|NCT00427895|64270509|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
23141972|NCT00427895|64270502|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
23141973|NCT00427895|64270503|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
23141974|NCT00427895|64270504|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23141975|NCT00427895|64270505|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
23141976|NCT00427895|64270506|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23141977|NCT00427895|64270507|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23141978|NCT00427895|64270508|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23141979|NCT00427895|64270509|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
23141980|NCT00427895|64270502|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
23141981|NCT00427895|64270503|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
23216729|NCT01149343|64534588|FG001|Overall Study|Lost to Follow-up|0|||
23216730|NCT01149343|64534589|FG002|Overall Study|Lost to Follow-up|0|||
23216731|NCT01149343|64534590|FG003|Overall Study|Lost to Follow-up|1|||
23216732|NCT01149343|64534587|FG000|Overall Study|Other|8|||
23216733|NCT01149343|64534588|FG001|Overall Study|Other|10|||
23216734|NCT01149343|64534589|FG002|Overall Study|Other|2|||
23216735|NCT01149343|64534590|FG003|Overall Study|Other|14|||
23216736|NCT01149343|64534587|FG000|Overall Study|Sponsor study termination|0|||
23216737|NCT01149343|64534588|FG001|Overall Study|Sponsor study termination|0|||
23216738|NCT01149343|64534589|FG002|Overall Study|Sponsor study termination|0|||
23216739|NCT01149343|64534590|FG003|Overall Study|Sponsor study termination|2|||
23216740|NCT01149343|64534587|FG000|Overall Study|Recurrence / Progressive disease|0|||
23216741|NCT01149343|64534588|FG001|Overall Study|Recurrence / Progressive disease|0|||
23216742|NCT01149343|64534589|FG002|Overall Study|Recurrence / Progressive disease|1|||
23216743|NCT01149343|64534590|FG003|Overall Study|Recurrence / Progressive disease|0|||
23216744|NCT00510484|64534593|FG000|Wash-out Period|Adverse Event|0|||
23216745|NCT00510484|64534594|FG001|Wash-out Period|Adverse Event|1|||
23216746|NCT01306032|64534595|FG000|First Intervention|Adverse Event|1|||
23216747|NCT01306032|64534596|FG001|First Intervention|Adverse Event|0|||
23216748|NCT01306032|64534597|FG002|First Intervention|Adverse Event|1|||
23216749|NCT01306032|64534598|FG003|First Intervention|Adverse Event|0|||
23216750|NCT01306032|64534599|FG004|First Intervention|Adverse Event|0|||
23216751|NCT01306032|64534600|FG005|First Intervention|Adverse Event|1|||
23216752|NCT01306032|64534595|FG000|First Intervention|Withdrawal by Subject|0|||
23216753|NCT01306032|64534596|FG001|First Intervention|Withdrawal by Subject|2|||
23216754|NCT01306032|64534597|FG002|First Intervention|Withdrawal by Subject|0|||
23216755|NCT01306032|64534598|FG003|First Intervention|Withdrawal by Subject|1|||
23216756|NCT01306032|64534599|FG004|First Intervention|Withdrawal by Subject|0|||
23216757|NCT01306032|64534600|FG005|First Intervention|Withdrawal by Subject|0|||
23216758|NCT01306032|64534595|FG000|First Intervention|Death|0|||
23216759|NCT01306032|64534596|FG001|First Intervention|Death|0|||
23216760|NCT01306032|64534597|FG002|First Intervention|Death|1|||
23216761|NCT01306032|64534598|FG003|First Intervention|Death|0|||
23216762|NCT01306032|64534599|FG004|First Intervention|Death|0|||
23216763|NCT01306032|64534600|FG005|First Intervention|Death|0|||
23216764|NCT01306032|64534595|FG000|First Intervention|Ineligible|0|||
23216765|NCT01306032|64534596|FG001|First Intervention|Ineligible|0|||
23216766|NCT01306032|64534597|FG002|First Intervention|Ineligible|0|||
23216767|NCT01306032|64534598|FG003|First Intervention|Ineligible|0|||
23216768|NCT01306032|64534599|FG004|First Intervention|Ineligible|0|||
23216769|NCT01306032|64534600|FG005|First Intervention|Ineligible|1|||
23216770|NCT01306032|64534595|FG000|First Intervention|Progressive disease|0|||
23216771|NCT01306032|64534596|FG001|First Intervention|Progressive disease|0|||
23216772|NCT01306032|64534597|FG002|First Intervention|Progressive disease|0|||
23216773|NCT01306032|64534598|FG003|First Intervention|Progressive disease|0|||
23216774|NCT01306032|64534599|FG004|First Intervention|Progressive disease|2|||
23216775|NCT01306032|64534600|FG005|First Intervention|Progressive disease|0|||
23216776|NCT01306032|64534595|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
23216777|NCT01306032|64534596|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
23216778|NCT01306032|64534597|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
23216779|NCT01306032|64534598|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
23216780|NCT01306032|64534599|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
23216781|NCT01306032|64534600|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
23216782|NCT01306032|64534595|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
23216783|NCT01306032|64534596|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
23216784|NCT01306032|64534597|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
23216785|NCT01306032|64534598|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
23216786|NCT01306032|64534599|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
23216787|NCT01306032|64534600|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
23216788|NCT01927068|64534602|FG000|Overall Study|Death|37|||
23216789|NCT01927068|64534603|FG001|Overall Study|Death|3|||
23432925|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432926|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23216790|NCT01927068|64534602|FG000|Overall Study|Withdrawal by Subject|50|||
23216791|NCT01927068|64534603|FG001|Overall Study|Withdrawal by Subject|3|||
23216792|NCT01927068|64534602|FG000|Overall Study|Lost to Follow-up|10|||
23216793|NCT01927068|64534603|FG001|Overall Study|Lost to Follow-up|2|||
23216794|NCT01927068|64534602|FG000|Overall Study|Physician Decision|9|||
23216795|NCT01927068|64534603|FG001|Overall Study|Physician Decision|0|||
23216796|NCT01927068|64534602|FG000|Overall Study|Missed last follow-up visit|2|||
23216797|NCT01927068|64534603|FG001|Overall Study|Missed last follow-up visit|0|||
23216798|NCT03587584|64534612|FG000|Overall Study|SOC deviations|4|||
23216799|NCT03587584|64534613|FG001|Overall Study|SOC deviations|6|||
23216800|NCT03587584|64534612|FG000|Overall Study|Incomplete data|0|||
23216801|NCT03587584|64534613|FG001|Overall Study|Incomplete data|3|||
23216802|NCT00510068|64534615|FG000|Double-blind Period|Disease progression|98|||
23432927|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432928|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432929|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432930|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432931|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432932|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23318900|NCT01198132|64912260|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
23318901|NCT01198132|64912259|FG000|Overall Study|Adverse Event|0|||
23318902|NCT01198132|64912260|FG001|Overall Study|Adverse Event|1|||
23318903|NCT01198132|64912259|FG000|Overall Study|Protocol Violation|1|||
23432933|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432934|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432935|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432936|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432937|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432938|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
23432939|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
23432940|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
23432941|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
23432942|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
23432943|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
23432944|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
23432945|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
23432946|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
23432947|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
23432948|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
23432949|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
23432950|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
23432951|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
23432952|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
23432953|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
23432954|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
23432955|NCT00576472|65327716|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432956|NCT00576472|65327717|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432957|NCT00576472|65327718|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432958|NCT00576472|65327719|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432959|NCT00576472|65327720|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432960|NCT00576472|65327721|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432961|NCT00576472|65327722|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432962|NCT00576472|65327723|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432963|NCT00576472|65327724|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432964|NCT00576472|65327725|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432965|NCT00576472|65327726|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432966|NCT00576472|65327727|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432967|NCT00576472|65327728|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432968|NCT00576472|65327729|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
23432969|NCT00576472|65327730|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
23432970|NCT00940485|65327733|FG000|Overall Study|HBeAb positive at Baseline|3|||
23432971|NCT00940485|65327734|FG001|Overall Study|HBeAb positive at Baseline|2|||
23318904|NCT01198132|64912260|FG001|Overall Study|Protocol Violation|0|||
23318905|NCT03685344|64912262|FG000|Overall Study|Withdrawal by Subject|1|||
23318906|NCT03685344|64912263|FG001|Overall Study|Withdrawal by Subject|1|||
23432972|NCT00940485|65327733|FG000|Overall Study|Lost to Follow-up|2|||
23432973|NCT00940485|65327734|FG001|Overall Study|Lost to Follow-up|3|||
23432974|NCT00940485|65327733|FG000|Overall Study|Adverse Event|8|||
23432975|NCT00940485|65327734|FG001|Overall Study|Adverse Event|0|||
23432976|NCT00940485|65327733|FG000|Overall Study|Withdrawal by Subject|1|||
23555203|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
23141982|NCT00427895|64270504|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
23318907|NCT03685344|64912264|FG002|Overall Study|Withdrawal by Subject|2|||
23555204|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
23555205|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
23555206|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
23555207|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
23555208|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
23555209|NCT02497287|65758032|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
23555210|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
23555211|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
23555212|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
23555213|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
23555214|NCT02497287|65758032|FG000|Follow-up Phase (4 Week)|Other|1|||
23318908|NCT03685344|64912265|FG003|Overall Study|Withdrawal by Subject|0|||
23318909|NCT03685344|64912262|FG000|Overall Study|Physician Decision|1|||
23318910|NCT03685344|64912263|FG001|Overall Study|Physician Decision|1|||
23318911|NCT03685344|64912264|FG002|Overall Study|Physician Decision|5|||
23318912|NCT03685344|64912265|FG003|Overall Study|Physician Decision|0|||
23318913|NCT03685344|64912262|FG000|Overall Study|Death|1|||
23318914|NCT03685344|64912263|FG001|Overall Study|Death|1|||
23318915|NCT03685344|64912264|FG002|Overall Study|Death|0|||
23318916|NCT03685344|64912265|FG003|Overall Study|Death|0|||
23318917|NCT01301729|64912266|FG000|Overall Study|Withdrawal by Subject|2|||
23318918|NCT01301729|64912266|FG000|Overall Study|Participant did not Return for Treatment|1|||
23318919|NCT01301729|64912266|FG000|Overall Study|Violated Selection Criteria|1|||
23318920|NCT01478373|64912267|FG000|Treatment Phase|Protocol Violation|1|||
23318921|NCT01478373|64912267|FG000|Survival Phase|Adverse Event|8|||
23318922|NCT01478373|64912267|FG000|Survival Phase|Protocol Violation|1|||
23318923|NCT01478373|64912267|FG000|Survival Phase|crossover to another study|2|||
23318924|NCT01478373|64912267|FG000|Survival Phase|Progressive Disease|27|||
23318925|NCT02756611|64912268|FG000|Overall Study|Death|70|||
23216803|NCT00510068|64534616|FG001|Double-blind Period|Disease progression|169|||
23216804|NCT00510068|64534615|FG000|Double-blind Period|Final primary analysis|52|||
23216805|NCT00510068|64534616|FG001|Double-blind Period|Final primary analysis|18|||
23318926|NCT02756611|64912268|FG000|Overall Study|Withdrawal by Subject|2|||
23318927|NCT02756611|64912268|FG000|Overall Study|Lost to Follow-up|3|||
23141983|NCT00427895|64270505|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
23216806|NCT00510068|64534615|FG000|Double-blind Period|Adverse Event|37|||
23216807|NCT00510068|64534616|FG001|Double-blind Period|Adverse Event|7|||
23216808|NCT00510068|64534615|FG000|Double-blind Period|Withdrawal by Subject|8|||
23216809|NCT00510068|64534616|FG001|Double-blind Period|Withdrawal by Subject|6|||
23216810|NCT00510068|64534615|FG000|Double-blind Period|Death|4|||
23216811|NCT00510068|64534616|FG001|Double-blind Period|Death|3|||
23318928|NCT02756611|64912268|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
23318929|NCT02756611|64912268|FG000|Overall Study|Other|10|||
23318930|NCT02481869|64912269|FG000|Overall Study|Lost to Follow-up|3|||
23318931|NCT02481869|64912270|FG001|Overall Study|Lost to Follow-up|4|||
23141984|NCT00427895|64270506|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
23141985|NCT00427895|64270507|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
23141986|NCT00427895|64270508|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
23141987|NCT00427895|64270509|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
23141988|NCT00427895|64270502|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23141989|NCT00427895|64270503|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
23141990|NCT00427895|64270504|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23141991|NCT00427895|64270505|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23141992|NCT00427895|64270506|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23141993|NCT00427895|64270507|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23141994|NCT00427895|64270508|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23141995|NCT00427895|64270509|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
23141996|NCT00427895|64270502|FG000|Vax 1/Year 1 Follow-up|Death|1|||
23141997|NCT00427895|64270503|FG001|Vax 1/Year 1 Follow-up|Death|0|||
23141998|NCT00427895|64270504|FG002|Vax 1/Year 1 Follow-up|Death|0|||
23141999|NCT00427895|64270505|FG003|Vax 1/Year 1 Follow-up|Death|0|||
23142000|NCT00427895|64270506|FG004|Vax 1/Year 1 Follow-up|Death|0|||
23142001|NCT00427895|64270507|FG005|Vax 1/Year 1 Follow-up|Death|0|||
23142002|NCT00427895|64270508|FG006|Vax 1/Year 1 Follow-up|Death|0|||
23142003|NCT00427895|64270509|FG007|Vax 1/Year 1 Follow-up|Death|0|||
23142004|NCT00427895|64270502|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23142005|NCT00427895|64270503|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23142006|NCT00427895|64270504|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
23142007|NCT00427895|64270505|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
23142008|NCT00427895|64270506|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23142009|NCT00427895|64270507|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23142010|NCT00427895|64270508|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23142011|NCT00427895|64270509|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
23142012|NCT00427895|64270502|FG000|Vax 1/Year 1 Follow-up|Other|0|||
23142013|NCT00427895|64270503|FG001|Vax 1/Year 1 Follow-up|Other|0|||
23142014|NCT00427895|64270504|FG002|Vax 1/Year 1 Follow-up|Other|0|||
23142015|NCT00427895|64270505|FG003|Vax 1/Year 1 Follow-up|Other|2|||
23142016|NCT00427895|64270506|FG004|Vax 1/Year 1 Follow-up|Other|0|||
23142017|NCT00427895|64270507|FG005|Vax 1/Year 1 Follow-up|Other|0|||
23142018|NCT00427895|64270508|FG006|Vax 1/Year 1 Follow-up|Other|0|||
23142019|NCT00427895|64270509|FG007|Vax 1/Year 1 Follow-up|Other|0|||
23318932|NCT02481869|64912269|FG000|Overall Study|Withdrawal by Subject|2|||
23318933|NCT02481869|64912270|FG001|Overall Study|Withdrawal by Subject|0|||
23318934|NCT01755091|64912273|FG000|Overall Study|Withdrawal by Subject|6|||
23318935|NCT01755091|64912274|FG001|Overall Study|Withdrawal by Subject|1|||
23318936|NCT01755091|64912275|FG002|Overall Study|Withdrawal by Subject|3|||
23142020|NCT00427895|64270502|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
23216812|NCT00510068|64534615|FG000|Double-blind Period|Abnormal test result (s)|1|||
23216813|NCT00510068|64534616|FG001|Double-blind Period|Abnormal test result (s)|0|||
23216814|NCT00510068|64534615|FG000|Double-blind Period|Lost to Follow-up|1|||
23216815|NCT00510068|64534616|FG001|Double-blind Period|Lost to Follow-up|0|||
23216816|NCT00510068|64534615|FG000|Double-blind Period|Protocol Violation|6|||
23216817|NCT00510068|64534616|FG001|Double-blind Period|Protocol Violation|0|||
23216818|NCT00510068|64534615|FG000|Open-label Period|Disease Progression|124|||
23216819|NCT00510068|64534616|FG001|Open-label Period|Disease Progression|0|||
23216820|NCT00510068|64534615|FG000|Open-label Period|Adverse Event|46|||
23216821|NCT00510068|64534616|FG001|Open-label Period|Adverse Event|0|||
23216822|NCT00510068|64534615|FG000|Open-label Period|Withdrawal by Subject|21|||
23216823|NCT00510068|64534616|FG001|Open-label Period|Withdrawal by Subject|0|||
23216824|NCT00510068|64534615|FG000|Open-label Period|Administrative problems|17|||
23216825|NCT00510068|64534616|FG001|Open-label Period|Administrative problems|0|||
23216826|NCT00510068|64534615|FG000|Open-label Period|Death|7|||
23216827|NCT00510068|64534616|FG001|Open-label Period|Death|0|||
23216828|NCT00510068|64534615|FG000|Open-label Period|New cancer therapy|7|||
23216829|NCT00510068|64534616|FG001|Open-label Period|New cancer therapy|0|||
23216830|NCT00510068|64534615|FG000|Open-label Period|Protocol Violation|2|||
23216831|NCT00510068|64534616|FG001|Open-label Period|Protocol Violation|0|||
23216832|NCT00510068|64534615|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
23216833|NCT00510068|64534616|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
23622489|NCT02971228|66004965|FG000|Overall Study|Logistical challenges|0|||
23622490|NCT02971228|66004966|FG001|Overall Study|Logistical challenges|1|||
23622491|NCT02971228|66004967|FG002|Overall Study|Logistical challenges|0|||
23622492|NCT02971228|66004968|FG003|Overall Study|Logistical challenges|0|||
23622493|NCT02971228|66004969|FG004|Overall Study|Logistical challenges|0|||
23622494|NCT01732588|66004970|FG000|First Intervention (7 Days)|Adverse Event|0|||
23622495|NCT01732588|66004971|FG001|First Intervention (7 Days)|Adverse Event|1|||
23622496|NCT01732588|66004972|FG002|First Intervention (7 Days)|Adverse Event|0|||
23622497|NCT00526097|66004975|FG000|Overall Study|Adverse Event|6|||
23622498|NCT00526097|66004976|FG001|Overall Study|Adverse Event|44|||
23622499|NCT00526097|66004975|FG000|Overall Study|Protocol Violation|4|||
23622500|NCT00526097|66004976|FG001|Overall Study|Protocol Violation|10|||
23622501|NCT00526097|66004975|FG000|Overall Study|Withdrawal by Subject|3|||
23622502|NCT00526097|66004976|FG001|Overall Study|Withdrawal by Subject|1|||
23622503|NCT00526097|66004975|FG000|Overall Study|Other|2|||
23622504|NCT00526097|66004976|FG001|Overall Study|Other|1|||
23622505|NCT01665599|66004977|FG000|Overall Study|Adverse Event|1|||
23622506|NCT01665599|66004977|FG000|Overall Study|Consent Withdrawn|1|||
23622507|NCT01665599|66004977|FG000|Overall Study|Investigator/Sponsor decision|1|||
23622508|NCT01665599|66004977|FG000|Overall Study|Death|1|||
23622509|NCT01665599|66004977|FG000|Overall Study|Lost to Follow-up|2|||
23622510|NCT01665599|66004977|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
23622511|NCT01665599|66004977|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
23622512|NCT04522778|66004978|FG000|Overall Study|Patient did not want to wear the device|1|||
23622513|NCT04522778|66004979|FG001|Overall Study|Patient did not want to wear the device|0|||
23622514|NCT04522778|66004978|FG000|Overall Study|Lost to Follow-up|0|||
23622515|NCT04522778|66004979|FG001|Overall Study|Lost to Follow-up|1|||
23622516|NCT02138253|66004982|FG000|Overall Study|Adverse Event|3|||
23622517|NCT02138253|66004983|FG001|Overall Study|Adverse Event|3|||
23622518|NCT02138253|66004982|FG000|Overall Study|Lost to Follow-up|2|||
23622519|NCT02138253|66004983|FG001|Overall Study|Lost to Follow-up|1|||
23622520|NCT02138253|66004982|FG000|Overall Study|Physician Decision|2|||
23622521|NCT02138253|66004983|FG001|Overall Study|Physician Decision|0|||
23216834|NCT01938001|64534617|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
23216835|NCT01938001|64534618|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
23216836|NCT01938001|64534617|FG000|Pre-Treatment|Death|1|||
23216837|NCT01938001|64534618|FG001|Pre-Treatment|Death|0|||
23216838|NCT01938001|64534617|FG000|Treatment|Death|2|||
23216839|NCT01938001|64534618|FG001|Treatment|Death|0|||
23216840|NCT01938001|64534617|FG000|Treatment|Adverse Event|14|||
23216841|NCT01938001|64534618|FG001|Treatment|Adverse Event|8|||
23216842|NCT01938001|64534617|FG000|Treatment|Progressive Disease|21|||
23318937|NCT01755091|64912273|FG000|Overall Study|Adverse Event|1|||
23318938|NCT01755091|64912274|FG001|Overall Study|Adverse Event|1|||
23216843|NCT01938001|64534618|FG001|Treatment|Progressive Disease|54|||
23216844|NCT01938001|64534617|FG000|Treatment|Withdrawal by Subject|13|||
23216845|NCT01938001|64534618|FG001|Treatment|Withdrawal by Subject|7|||
23318939|NCT01755091|64912275|FG002|Overall Study|Adverse Event|1|||
23622522|NCT02138253|66004982|FG000|Overall Study|Non compliance|1|||
23622523|NCT02138253|66004983|FG001|Overall Study|Non compliance|0|||
23216846|NCT01938001|64534617|FG000|Treatment|Other reasons|2|||
23216847|NCT01938001|64534618|FG001|Treatment|Other reasons|1|||
23216848|NCT01373918|64534621|FG000|Overall Study|Physician Decision|0|||
23216849|NCT01373918|64534622|FG001|Overall Study|Physician Decision|1|||
23216850|NCT04186663|64534626|FG000|Overall Study|Lost to Follow-up|1|||
23622524|NCT02138253|66004982|FG000|Overall Study|Withdrawal by Subject|1|||
23622525|NCT02138253|66004983|FG001|Overall Study|Withdrawal by Subject|0|||
23216851|NCT04186663|64534626|FG000|Overall Study|Unable to complete blood draw|3|||
23216852|NCT00807014|64534631|FG000|Overall Study|Participant Considered Disease Cured|13|||
23216853|NCT00807014|64534632|FG001|Overall Study|Participant Considered Disease Cured|2|||
23216854|NCT00807014|64534631|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
23216855|NCT00807014|64534632|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
23216856|NCT00807014|64534631|FG000|Overall Study|Protocol Violation|2|||
23216857|NCT00807014|64534632|FG001|Overall Study|Protocol Violation|8|||
23216858|NCT00807014|64534631|FG000|Overall Study|Adverse Event|0|||
23216859|NCT00807014|64534632|FG001|Overall Study|Adverse Event|2|||
23216860|NCT00807014|64534631|FG000|Overall Study|Lost to Follow-up|9|||
23216861|NCT00807014|64534632|FG001|Overall Study|Lost to Follow-up|7|||
23216862|NCT00807014|64534631|FG000|Overall Study|Recovery|1|||
23216863|NCT00807014|64534632|FG001|Overall Study|Recovery|0|||
23216864|NCT00807014|64534631|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
23318940|NCT01755091|64912273|FG000|Overall Study|Lost to Follow-up|1|||
23318941|NCT01755091|64912274|FG001|Overall Study|Lost to Follow-up|0|||
23318942|NCT01755091|64912275|FG002|Overall Study|Lost to Follow-up|1|||
23318943|NCT01755091|64912273|FG000|Overall Study|Physician Decision|1|||
23318944|NCT01755091|64912274|FG001|Overall Study|Physician Decision|1|||
23318945|NCT01755091|64912275|FG002|Overall Study|Physician Decision|2|||
23432977|NCT00940485|65327734|FG001|Overall Study|Withdrawal by Subject|1|||
23432978|NCT00940485|65327733|FG000|Overall Study|Others|1|||
23432979|NCT00940485|65327734|FG001|Overall Study|Others|1|||
23432980|NCT03517566|65327735|FG000|Overall Study|Adverse Event|5|||
23432981|NCT03517566|65327736|FG001|Overall Study|Adverse Event|2|||
23432982|NCT03517566|65327737|FG002|Overall Study|Adverse Event|2|||
23432983|NCT03517566|65327738|FG003|Overall Study|Adverse Event|8|||
23432984|NCT03517566|65327739|FG004|Overall Study|Adverse Event|7|||
23432985|NCT03517566|65327735|FG000|Overall Study|Lack of Efficacy|3|||
23432986|NCT03517566|65327736|FG001|Overall Study|Lack of Efficacy|2|||
23432987|NCT03517566|65327737|FG002|Overall Study|Lack of Efficacy|1|||
23432988|NCT03517566|65327738|FG003|Overall Study|Lack of Efficacy|1|||
23432989|NCT03517566|65327739|FG004|Overall Study|Lack of Efficacy|4|||
23432990|NCT03517566|65327735|FG000|Overall Study|Lost to Follow-up|3|||
23432991|NCT03517566|65327736|FG001|Overall Study|Lost to Follow-up|1|||
23432992|NCT03517566|65327737|FG002|Overall Study|Lost to Follow-up|1|||
23432993|NCT03517566|65327738|FG003|Overall Study|Lost to Follow-up|1|||
23432994|NCT03517566|65327739|FG004|Overall Study|Lost to Follow-up|0|||
23432995|NCT03517566|65327735|FG000|Overall Study|Physician Decision|1|||
23432996|NCT03517566|65327736|FG001|Overall Study|Physician Decision|1|||
23432997|NCT03517566|65327737|FG002|Overall Study|Physician Decision|0|||
23432998|NCT03517566|65327738|FG003|Overall Study|Physician Decision|1|||
23432999|NCT03517566|65327739|FG004|Overall Study|Physician Decision|0|||
23433000|NCT03517566|65327735|FG000|Overall Study|Pregnancy|0|||
23433001|NCT03517566|65327736|FG001|Overall Study|Pregnancy|1|||
23433002|NCT03517566|65327737|FG002|Overall Study|Pregnancy|0|||
23433003|NCT03517566|65327738|FG003|Overall Study|Pregnancy|0|||
23433004|NCT03517566|65327739|FG004|Overall Study|Pregnancy|0|||
23433005|NCT03517566|65327735|FG000|Overall Study|Protocol Deviation|0|||
23433006|NCT03517566|65327736|FG001|Overall Study|Protocol Deviation|1|||
23433007|NCT03517566|65327737|FG002|Overall Study|Protocol Deviation|0|||
23433008|NCT03517566|65327738|FG003|Overall Study|Protocol Deviation|1|||
23433009|NCT03517566|65327739|FG004|Overall Study|Protocol Deviation|1|||
23433010|NCT03517566|65327735|FG000|Overall Study|Study terminated by Sponsor|11|||
23433011|NCT03517566|65327736|FG001|Overall Study|Study terminated by Sponsor|5|||
23433012|NCT03517566|65327737|FG002|Overall Study|Study terminated by Sponsor|6|||
23433013|NCT03517566|65327738|FG003|Overall Study|Study terminated by Sponsor|14|||
23433014|NCT03517566|65327739|FG004|Overall Study|Study terminated by Sponsor|12|||
23433015|NCT03517566|65327735|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
23142021|NCT00427895|64270503|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
23142022|NCT00427895|64270504|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
23142023|NCT00427895|64270505|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
23142024|NCT00427895|64270506|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
23142025|NCT00427895|64270507|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
23142026|NCT00427895|64270508|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
23142027|NCT00427895|64270509|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
23142028|NCT03038438|64270510|FG000|Overall Study|Death|3|||
23142029|NCT03038438|64270510|FG000|Overall Study|Lost to Follow-up|8|||
23142030|NCT03038438|64270510|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
23142031|NCT03038438|64270510|FG000|Overall Study|Withdrawal by Subject|5|||
23142032|NCT03038438|64270510|FG000|Overall Study|No 36-Month Follow-Up|18|||
23142033|NCT03616977|64270511|FG000|Period 1|Physician Decision|0|||
23142034|NCT03616977|64270512|FG001|Period 1|Physician Decision|1|||
23142035|NCT03616977|64270511|FG000|Period 3|Adverse Event|1|||
23142036|NCT03616977|64270512|FG001|Period 3|Adverse Event|1|||
23142037|NCT01210664|64270513|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
23433016|NCT03517566|65327736|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
23433017|NCT03517566|65327737|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
23433018|NCT03517566|65327738|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
23433019|NCT03517566|65327739|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
23433020|NCT03157037|65327740|FG000|Overall Study|Death|1|||
23433021|NCT03688555|65327746|FG000|Treatment Period|Adverse Event|0|||
23433022|NCT03688555|65327747|FG001|Treatment Period|Adverse Event|0|||
23433023|NCT03688555|65327748|FG002|Treatment Period|Adverse Event|1|||
23433024|NCT00324233|65327751|FG000|First Period|unable to insert catheter|1|||
23433025|NCT00324233|65327752|FG001|First Period|unable to insert catheter|0|||
23433026|NCT00324233|65327751|FG000|Second Period|unable to insert catheter|1|||
23433027|NCT00324233|65327752|FG001|Second Period|unable to insert catheter|1|||
23433028|NCT00324233|65327751|FG000|Second Period|Protocol Violation|4|||
23433029|NCT00324233|65327752|FG001|Second Period|Protocol Violation|6|||
23433030|NCT01581619|65327753|FG000|Overall Study|Withdrawal by Subject|1|||
23433031|NCT01581619|65327753|FG000|Overall Study|Lost to Follow-up|1|||
23433032|NCT00820222|65327754|FG000|Overall Study|Lost to Follow-up|10|||
23433033|NCT00820222|65327755|FG001|Overall Study|Lost to Follow-up|9|||
23433034|NCT00820222|65327754|FG000|Overall Study|Withdrawal by Subject|19|||
23433035|NCT00820222|65327755|FG001|Overall Study|Withdrawal by Subject|21|||
23433036|NCT00820222|65327754|FG000|Overall Study|Physician Decision|93|||
23433037|NCT00820222|65327755|FG001|Overall Study|Physician Decision|88|||
23433038|NCT00820222|65327754|FG000|Overall Study|Sponsor Terminated Study|43|||
23433039|NCT00820222|65327755|FG001|Overall Study|Sponsor Terminated Study|65|||
23433040|NCT00820222|65327754|FG000|Overall Study|Unkown|11|||
23433041|NCT00820222|65327755|FG001|Overall Study|Unkown|7|||
23433042|NCT00896649|65327758|FG000|Overall Study|Physician Decision|1|||
23433043|NCT00896649|65327758|FG000|Overall Study|Pregnancy|1|||
23433044|NCT00896649|65327758|FG000|Overall Study|missing documentation|1|||
23433045|NCT00896649|65327758|FG000|Overall Study|technical difficulties|2|||
23433046|NCT02831933|65327761|FG000|Overall Study|Physician Decision|11|||
23433047|NCT04598269|65327762|FG000|Overall Study|Adverse Event|0|||
23433048|NCT04598269|65327763|FG001|Overall Study|Adverse Event|3|||
23433049|NCT04598269|65327762|FG000|Overall Study|Withdrawal by Subject|1|||
23433050|NCT04598269|65327763|FG001|Overall Study|Withdrawal by Subject|4|||
23433051|NCT04598269|65327762|FG000|Overall Study|Lost to Follow-up|1|||
23433052|NCT04598269|65327763|FG001|Overall Study|Lost to Follow-up|0|||
23433053|NCT04598269|65327762|FG000|Overall Study|Not Treated|2|||
23433054|NCT04598269|65327763|FG001|Overall Study|Not Treated|0|||
23433055|NCT01751139|65327764|FG000|Overall Study|Other|135|||
23433056|NCT01751139|65327764|FG000|Overall Study|Sponsor study termination|1609|||
23433057|NCT01751139|65327764|FG000|Overall Study|Lost to Follow-up|240|||
23433058|NCT01751139|65327764|FG000|Overall Study|Withdrawal by Subject|251|||
23433059|NCT01751139|65327764|FG000|Overall Study|Adverse Event|1|||
23433060|NCT01751139|65327764|FG000|Overall Study|Death|31|||
23433061|NCT00958217|65327768|FG000|Overall Study|Death|2|||
23433062|NCT00958217|65327769|FG001|Overall Study|Death|1|||
23433063|NCT00958217|65327768|FG000|Overall Study|Withdrawal by Subject|4|||
23433064|NCT00958217|65327769|FG001|Overall Study|Withdrawal by Subject|3|||
23433065|NCT00958217|65327768|FG000|Overall Study|Lost to Follow-up|17|||
23433066|NCT00958217|65327769|FG001|Overall Study|Lost to Follow-up|19|||
23433067|NCT00958217|65327768|FG000|Overall Study|Moved out of area|1|||
23433068|NCT00958217|65327769|FG001|Overall Study|Moved out of area|1|||
23433069|NCT00958217|65327768|FG000|Overall Study|Inpatient hospitalization|0|||
23433070|NCT00958217|65327769|FG001|Overall Study|Inpatient hospitalization|1|||
23433071|NCT01943552|65327770|FG000|Overall Study|Adverse Event|3|||
23433072|NCT01943552|65327771|FG001|Overall Study|Adverse Event|2|||
23433073|NCT01943552|65327770|FG000|Overall Study|Withdrawal by Subject|6|||
23433074|NCT01943552|65327771|FG001|Overall Study|Withdrawal by Subject|6|||
23433075|NCT01943552|65327770|FG000|Overall Study|Other Reasons|16|||
23433076|NCT01943552|65327771|FG001|Overall Study|Other Reasons|17|||
23433077|NCT01272869|65327774|FG000|Period 2 (14 Days)|Adverse Event|1|||
23433078|NCT01272869|65327775|FG001|Period 2 (14 Days)|Adverse Event|0|||
23433079|NCT00086411|65327776|FG000|Overall Study|Lost to Follow-up|11|||
23433080|NCT00086411|65327777|FG001|Overall Study|Lost to Follow-up|11|||
23433081|NCT00086411|65327778|FG002|Overall Study|Lost to Follow-up|13|||
23433082|NCT00086411|65327779|FG003|Overall Study|Lost to Follow-up|12|||
23433083|NCT02440789|65327781|FG000|Overall Study|Withdrawal by Subject|3|||
23433084|NCT02440789|65327781|FG000|Overall Study|Not willing to adhere to reqs|1|||
23433085|NCT03149029|65327782|FG000|Overall Study|Adverse Event|2|||
23433086|NCT03149029|65327783|FG001|Overall Study|Adverse Event|0|||
23433087|NCT01732913|65327784|FG000|Overall Study|Study Terminated by Sponsor|105|||
23433088|NCT01732913|65327785|FG001|Overall Study|Study Terminated by Sponsor|55|||
23433089|NCT01732913|65327784|FG000|Overall Study|Withdrawal by Subject|27|||
23433090|NCT01732913|65327785|FG001|Overall Study|Withdrawal by Subject|4|||
23433091|NCT01732913|65327784|FG000|Overall Study|Physician Decision|14|||
23433092|NCT01732913|65327785|FG001|Overall Study|Physician Decision|7|||
23433093|NCT01732913|65327784|FG000|Overall Study|Other|7|||
23433094|NCT01732913|65327785|FG001|Overall Study|Other|1|||
23142038|NCT01210664|64270514|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
23216865|NCT00807014|64534632|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
23216866|NCT00571688|64534633|FG000|Overall Study|Lost to Follow-up|3|||
23216867|NCT00571688|64534634|FG001|Overall Study|Lost to Follow-up|6|||
23216868|NCT00571688|64534633|FG000|Overall Study|subject did not tolerate Consta|1|||
23216869|NCT00571688|64534634|FG001|Overall Study|subject did not tolerate Consta|0|||
23216870|NCT00571688|64534633|FG000|Overall Study|subject moved out of the area|1|||
23216871|NCT00571688|64534634|FG001|Overall Study|subject moved out of the area|0|||
23216872|NCT03136484|64534635|FG000|Overall Study|Withdrawal by Subject|19|||
23216873|NCT03136484|64534636|FG001|Overall Study|Withdrawal by Subject|14|||
23216874|NCT03136484|64534635|FG000|Overall Study|Lost to Follow-up|7|||
23216875|NCT03136484|64534636|FG001|Overall Study|Lost to Follow-up|8|||
23216876|NCT03136484|64534635|FG000|Overall Study|Death|1|||
23216877|NCT03136484|64534636|FG001|Overall Study|Death|0|||
23216878|NCT01998399|64534637|FG000|Overall Study|Lost to Follow-up|1|||
23216879|NCT01998399|64534638|FG001|Overall Study|Lost to Follow-up|3|||
23216880|NCT01998399|64534637|FG000|Overall Study|Death|4|||
23216881|NCT01998399|64534638|FG001|Overall Study|Death|2|||
23216882|NCT01998399|64534637|FG000|Overall Study|Study stopped before dosing completed|3|||
23216883|NCT01998399|64534638|FG001|Overall Study|Study stopped before dosing completed|3|||
23216884|NCT01998399|64534637|FG000|Overall Study|Withdrawal by Subject|0|||
23216885|NCT01998399|64534638|FG001|Overall Study|Withdrawal by Subject|1|||
23216886|NCT00323310|64534639|FG000|Overall Study|Withdrawal by Subject|1|||
23216887|NCT00323310|64534639|FG000|Overall Study|a parent refused blood draw|1|||
23216888|NCT00323310|64534639|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
23216889|NCT00801892|64534642|FG000|Main Study Period|Withdrawal by Subject|0|||
23216890|NCT00801892|64534643|FG001|Main Study Period|Withdrawal by Subject|1|||
23216891|NCT00801892|64534642|FG000|Sham Crossover Period|Lost to Follow-up|0|||
23216892|NCT00801892|64534643|FG001|Sham Crossover Period|Lost to Follow-up|2|||
23622526|NCT03599622|66004988|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
23142039|NCT01210664|64270515|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
23142040|NCT01210664|64270516|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
23142041|NCT01210664|64270513|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
23142042|NCT01210664|64270514|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
23142043|NCT01210664|64270515|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
23142044|NCT01210664|64270516|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
23142045|NCT01210664|64270513|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
23142046|NCT01210664|64270514|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
23142047|NCT01210664|64270515|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
23142048|NCT01210664|64270516|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
23142049|NCT02571049|64270517|FG000|Screening|Did not meet entry criteria|2|||
23142050|NCT02571049|64270518|FG001|Screening|Did not meet entry criteria|2|||
23142051|NCT02571049|64270517|FG000|Randomization|No migraine attack|0|||
23142052|NCT02571049|64270518|FG001|Randomization|No migraine attack|1|||
23142053|NCT02571049|64270517|FG000|Randomization|Adverse Event|0|||
23142054|NCT02571049|64270518|FG001|Randomization|Adverse Event|1|||
23142055|NCT00591370|64270521|FG000|Overall Study|Not Treated|2|||
23142056|NCT01227577|64270522|FG000|Overall Study|Protocol deviation|3|||
23142057|NCT01227577|64270522|FG000|Overall Study|Death|3|||
23142058|NCT01227577|64270522|FG000|Overall Study|Administrative problems|2|||
23142059|NCT01227577|64270522|FG000|Overall Study|Lost to Follow-up|1|||
23142060|NCT01227577|64270522|FG000|Overall Study|Withdrawal by Subject|4|||
23142061|NCT01227577|64270522|FG000|Overall Study|Lack of Efficacy|5|||
23142062|NCT01227577|64270522|FG000|Overall Study|Adverse Event|17|||
23142063|NCT01853137|64270525|FG000|Overall Study|Lost to Follow-up|4|||
23142064|NCT01853137|64270526|FG001|Overall Study|Lost to Follow-up|1|||
23142065|NCT02054741|64270527|FG000|Overall Study|Protocol Violation|13|||
23142066|NCT02054741|64270528|FG001|Overall Study|Protocol Violation|2|||
23142067|NCT02054741|64270527|FG000|Overall Study|Withdrawal by Subject|10|||
23142068|NCT02054741|64270528|FG001|Overall Study|Withdrawal by Subject|5|||
23142069|NCT02054741|64270527|FG000|Overall Study|Death|94|||
23142070|NCT02054741|64270528|FG001|Overall Study|Death|90|||
23142071|NCT02054741|64270527|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
23142072|NCT02054741|64270528|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
23142073|NCT03305731|64270529|FG000|Overall Study|Protocol Violation|1|||
23142074|NCT03426267|64270530|FG000|Overall Study|Physician Decision|1|||
23142075|NCT03426267|64270531|FG001|Overall Study|Physician Decision|4|||
23142076|NCT03426267|64270530|FG000|Overall Study|Lost to Follow-up|1|||
23142077|NCT03426267|64270531|FG001|Overall Study|Lost to Follow-up|0|||
23216893|NCT00659126|64534644|FG000|Overall Study|Adverse Event|2|||
23216894|NCT00659126|64534645|FG001|Overall Study|Adverse Event|2|||
23216895|NCT00659126|64534644|FG000|Overall Study|Screen failure|1|||
23216896|NCT00659126|64534645|FG001|Overall Study|Screen failure|1|||
23216897|NCT00659126|64534644|FG000|Overall Study|Technical problems with MRI|0|||
23142078|NCT03426267|64270530|FG000|Overall Study|Withdrawal by Subject|4|||
23142079|NCT03426267|64270531|FG001|Overall Study|Withdrawal by Subject|10|||
23142080|NCT03426267|64270530|FG000|Overall Study|Protocol Violation|1|||
23142081|NCT03426267|64270531|FG001|Overall Study|Protocol Violation|3|||
23216898|NCT00659126|64534645|FG001|Overall Study|Technical problems with MRI|1|||
23216899|NCT01400139|64534647|FG000|HYD Core Study|Adverse Event|210|||
23216900|NCT01400139|64534647|FG000|HYD Core Study|Lack of Efficacy|59|||
23216901|NCT01400139|64534647|FG000|HYD Core Study|Withdrawal by Subject|114|||
23433095|NCT01732913|65327784|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
23433096|NCT01732913|65327785|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
23142082|NCT03426267|64270530|FG000|Overall Study|Adverse Event|9|||
23142083|NCT03426267|64270531|FG001|Overall Study|Adverse Event|27|||
23142084|NCT03426267|64270530|FG000|Overall Study|Prohibited Treatment Intake|2|||
23142085|NCT03426267|64270531|FG001|Overall Study|Prohibited Treatment Intake|3|||
23142086|NCT03426267|64270530|FG000|Overall Study|Lack of Efficacy|0|||
23216902|NCT01400139|64534647|FG000|HYD Core Study|Lost to Follow-up|39|||
23216903|NCT01400139|64534647|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
23318946|NCT03567980|64912276|FG000|Overall Study|Adverse Event|1|||
23318947|NCT00129545|64912277|FG000|Overall Study|Death|5|||
23318948|NCT00129545|64912278|FG001|Overall Study|Death|60|||
23318949|NCT00129545|64912279|FG002|Overall Study|Death|44|||
23318950|NCT00129545|64912277|FG000|Overall Study|Withdrawal by Subject|3|||
23318951|NCT00129545|64912278|FG001|Overall Study|Withdrawal by Subject|18|||
23318952|NCT00129545|64912279|FG002|Overall Study|Withdrawal by Subject|44|||
23318953|NCT00129545|64912277|FG000|Overall Study|Lost to Follow-up|2|||
23318954|NCT00129545|64912278|FG001|Overall Study|Lost to Follow-up|22|||
23318955|NCT00129545|64912279|FG002|Overall Study|Lost to Follow-up|13|||
23318956|NCT00129545|64912277|FG000|Overall Study|Physician Decision|0|||
23433097|NCT01814670|65330360|FG000|Overall Study|Protocol Violation|12|||
23433098|NCT00042666|65330362|FG000|Overall Study|Adverse Event|2|||
23433099|NCT00042666|65330362|FG000|Overall Study|Death|4|||
23433100|NCT00042666|65330362|FG000|Overall Study|Protocol Violation|1|||
23433101|NCT00042666|65330362|FG000|Overall Study|Participant/Physician Perception|1|||
23433102|NCT00042666|65330362|FG000|Overall Study|Progressive Disease|41|||
23318957|NCT00129545|64912278|FG001|Overall Study|Physician Decision|3|||
23318958|NCT00129545|64912279|FG002|Overall Study|Physician Decision|10|||
23318959|NCT00129545|64912277|FG000|Overall Study|Device not implanted|16|||
23318960|NCT00129545|64912278|FG001|Overall Study|Device not implanted|61|||
23318961|NCT00129545|64912279|FG002|Overall Study|Device not implanted|0|||
23318962|NCT00490841|64912280|FG000|Overall Study|Death|5|||
23318963|NCT00490841|64912280|FG000|Overall Study|Withdrawal by Subject|4|||
23318964|NCT00490841|64912280|FG000|Overall Study|Lost to Follow-up|1|||
23318965|NCT00490841|64912280|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
23318966|NCT04411914|64912283|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
23318967|NCT04411914|64912284|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
23318968|NCT01433055|64912287|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
23433103|NCT00042666|65330362|FG000|Overall Study|Other|1|||
23433104|NCT00042666|65330362|FG000|Overall Study|Other|4|||
23433105|NCT02943915|65330363|FG000|Overall Study|Withdrawal by Subject|2|||
23318969|NCT01433055|64912288|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
23318970|NCT01433055|64912287|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
23318971|NCT01433055|64912288|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
23318972|NCT01597778|64912289|FG000|Overall Study|Death|7|||
23142087|NCT03426267|64270531|FG001|Overall Study|Lack of Efficacy|25|||
23216904|NCT01400139|64534647|FG000|HYD Core Study|Administrative|56|||
23216905|NCT01400139|64534647|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
23318973|NCT01597778|64912290|FG001|Overall Study|Death|10|||
23318974|NCT01597778|64912289|FG000|Overall Study|Withdrawal by Subject|3|||
23318975|NCT01597778|64912290|FG001|Overall Study|Withdrawal by Subject|4|||
23318976|NCT01597778|64912289|FG000|Overall Study|Adverse Event|1|||
23318977|NCT01597778|64912290|FG001|Overall Study|Adverse Event|1|||
23318978|NCT01597778|64912289|FG000|Overall Study|Protocol Violation|1|||
23318979|NCT01597778|64912290|FG001|Overall Study|Protocol Violation|11|||
23318980|NCT01597778|64912289|FG000|Overall Study|Transplanted off protocol|2|||
23433106|NCT02943915|65330364|FG001|Overall Study|Withdrawal by Subject|1|||
23433107|NCT02943915|65330365|FG002|Overall Study|Withdrawal by Subject|0|||
23433108|NCT02943915|65330366|FG003|Overall Study|Withdrawal by Subject|0|||
23433109|NCT02943915|65330363|FG000|Overall Study|Lost to Follow-up|3|||
23318981|NCT01597778|64912290|FG001|Overall Study|Transplanted off protocol|3|||
23433110|NCT02943915|65330364|FG001|Overall Study|Lost to Follow-up|1|||
23433111|NCT02943915|65330365|FG002|Overall Study|Lost to Follow-up|0|||
23142088|NCT03426267|64270530|FG000|Overall Study|other|3|||
23318982|NCT02536846|64912291|FG000|Overall Study|Withdrawal by Subject|1|||
23433112|NCT02943915|65330366|FG003|Overall Study|Lost to Follow-up|0|||
23142089|NCT03426267|64270531|FG001|Overall Study|other|0|||
23142090|NCT03254485|64270535|FG000|Overall Study|Adverse Event|3|||
23216906|NCT01400139|64534647|FG000|HYD Extension Period|Adverse Event|8|||
23216907|NCT01400139|64534647|FG000|HYD Extension Period|Withdrawal by Subject|5|||
23318983|NCT00996489|64912294|FG000|Overall Study|Device failure|45|||
23318984|NCT00996489|64912294|FG000|Overall Study|Discontinued|116|||
23318985|NCT04043455|64912297|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
23318986|NCT04043455|64912298|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
23318987|NCT04043455|64912299|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
23318988|NCT04043455|64912300|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
23318989|NCT04043455|64912301|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
23318990|NCT04043455|64912302|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
23318991|NCT04043455|64912297|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
23318992|NCT04043455|64912298|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
23318993|NCT04043455|64912299|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
23318994|NCT04043455|64912300|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
23318995|NCT04043455|64912301|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
23318996|NCT04043455|64912302|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
23318997|NCT04043455|64912297|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
23318998|NCT04043455|64912298|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
23318999|NCT04043455|64912299|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
23319000|NCT04043455|64912300|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
23319001|NCT04043455|64912301|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
23319002|NCT04043455|64912302|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
23319003|NCT04043455|64912297|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
23319004|NCT04043455|64912298|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
23319005|NCT04043455|64912299|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
23319006|NCT04043455|64912300|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
23319007|NCT04043455|64912301|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
23319008|NCT04043455|64912302|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
23319009|NCT04043455|64912297|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23319010|NCT04043455|64912298|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
23319011|NCT04043455|64912299|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23319012|NCT04043455|64912300|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23319013|NCT04043455|64912301|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23319014|NCT04043455|64912302|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
23319015|NCT04043455|64912297|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
23319016|NCT04043455|64912298|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23319017|NCT04043455|64912299|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23319018|NCT04043455|64912300|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23319019|NCT04043455|64912301|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23319020|NCT04043455|64912302|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
23319021|NCT04043455|64912297|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23319022|NCT04043455|64912298|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
23319023|NCT04043455|64912299|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23433113|NCT02943915|65330363|FG000|Overall Study|excluded|0|||
23433114|NCT02943915|65330364|FG001|Overall Study|excluded|1|||
23433115|NCT02943915|65330365|FG002|Overall Study|excluded|0|||
23433116|NCT02943915|65330366|FG003|Overall Study|excluded|0|||
23433117|NCT01825941|65330367|FG000|Overall Study|Lost to Follow-up|4|||
23433118|NCT01825941|65330368|FG001|Overall Study|Lost to Follow-up|1|||
23433119|NCT03006887|65330369|FG000|Overall Study|Adverse Event|1|||
23142091|NCT03254485|64270536|FG001|Overall Study|Adverse Event|0|||
23142092|NCT03254485|64270537|FG002|Overall Study|Adverse Event|0|||
23142093|NCT03254485|64270538|FG003|Overall Study|Adverse Event|6|||
23142094|NCT03254485|64270535|FG000|Overall Study|Protocol Violation|6|||
23142095|NCT03254485|64270536|FG001|Overall Study|Protocol Violation|0|||
23142096|NCT03254485|64270537|FG002|Overall Study|Protocol Violation|0|||
23142097|NCT03254485|64270538|FG003|Overall Study|Protocol Violation|2|||
23142098|NCT03254485|64270535|FG000|Overall Study|Withdrawal by Subject|1|||
23142099|NCT03254485|64270536|FG001|Overall Study|Withdrawal by Subject|0|||
23142100|NCT03254485|64270537|FG002|Overall Study|Withdrawal by Subject|0|||
23142101|NCT03254485|64270538|FG003|Overall Study|Withdrawal by Subject|4|||
23142102|NCT03254485|64270535|FG000|Overall Study|Death|0|||
23142103|NCT03254485|64270536|FG001|Overall Study|Death|0|||
23142104|NCT03254485|64270537|FG002|Overall Study|Death|0|||
23142105|NCT03254485|64270538|FG003|Overall Study|Death|1|||
23142106|NCT03254485|64270535|FG000|Overall Study|Lost to Follow-up|1|||
23142107|NCT03254485|64270536|FG001|Overall Study|Lost to Follow-up|0|||
23142108|NCT03254485|64270537|FG002|Overall Study|Lost to Follow-up|0|||
23142109|NCT03254485|64270538|FG003|Overall Study|Lost to Follow-up|0|||
23319024|NCT04043455|64912300|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23319025|NCT04043455|64912301|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23319026|NCT04043455|64912302|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
23319027|NCT04043455|64912297|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
23319028|NCT04043455|64912298|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
23319029|NCT04043455|64912299|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
23319030|NCT04043455|64912300|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
23319031|NCT04043455|64912301|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
23319032|NCT04043455|64912302|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
23319033|NCT04043455|64912297|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
23319034|NCT04043455|64912298|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
23319035|NCT04043455|64912299|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
23622527|NCT03599622|66004989|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
23622528|NCT03599622|66004990|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
23622529|NCT03599622|66004991|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
23622530|NCT03599622|66004988|FG000|Pre-Treatment Period|Other reasons|1|||
23622531|NCT03599622|66004989|FG001|Pre-Treatment Period|Other reasons|1|||
23622532|NCT03599622|66004990|FG002|Pre-Treatment Period|Other reasons|1|||
23622533|NCT03599622|66004991|FG003|Pre-Treatment Period|Other reasons|0|||
23622534|NCT03599622|66004988|FG000|Treatment Period|Adverse Event|11|||
23622535|NCT03599622|66004989|FG001|Treatment Period|Adverse Event|20|||
23622536|NCT03599622|66004990|FG002|Treatment Period|Adverse Event|18|||
23622537|NCT03599622|66004991|FG003|Treatment Period|Adverse Event|2|||
23622538|NCT03599622|66004988|FG000|Treatment Period|Lack of Efficacy|18|||
23622539|NCT03599622|66004989|FG001|Treatment Period|Lack of Efficacy|12|||
23622540|NCT03599622|66004990|FG002|Treatment Period|Lack of Efficacy|13|||
23622541|NCT03599622|66004991|FG003|Treatment Period|Lack of Efficacy|2|||
23622542|NCT03599622|66004988|FG000|Treatment Period|Withdrawal by Subject|5|||
23622543|NCT03599622|66004989|FG001|Treatment Period|Withdrawal by Subject|11|||
23319036|NCT04043455|64912300|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
23319037|NCT04043455|64912301|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
23319038|NCT04043455|64912302|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
23319039|NCT04043455|64912297|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23319040|NCT04043455|64912298|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23319041|NCT04043455|64912299|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23319042|NCT04043455|64912300|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23622544|NCT03599622|66004990|FG002|Treatment Period|Withdrawal by Subject|16|||
23622545|NCT03599622|66004991|FG003|Treatment Period|Withdrawal by Subject|1|||
23622546|NCT03599622|66004988|FG000|Treatment Period|Other reasons|4|||
23622547|NCT03599622|66004989|FG001|Treatment Period|Other reasons|6|||
23622548|NCT03599622|66004990|FG002|Treatment Period|Other reasons|7|||
23622549|NCT03599622|66004991|FG003|Treatment Period|Other reasons|0|||
23622550|NCT03599622|66004988|FG000|Treatment Period|Lost to Follow-up|1|||
23622551|NCT03599622|66004989|FG001|Treatment Period|Lost to Follow-up|0|||
23622552|NCT03599622|66004990|FG002|Treatment Period|Lost to Follow-up|0|||
23622553|NCT03599622|66004991|FG003|Treatment Period|Lost to Follow-up|0|||
23622554|NCT03599622|66004988|FG000|Treatment Period|Study terminated by sponsor|7|||
23622555|NCT03599622|66004989|FG001|Treatment Period|Study terminated by sponsor|20|||
23319043|NCT04043455|64912301|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
23319044|NCT04043455|64912302|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
23319045|NCT04043455|64912297|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
23319046|NCT04043455|64912298|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
23319047|NCT04043455|64912299|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
23319048|NCT04043455|64912300|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
23319049|NCT04043455|64912301|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
23319050|NCT04043455|64912302|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
23319051|NCT01911273|64912312|FG000|Overall Study|Progression of Disease|1|||
23319052|NCT01911273|64912313|FG001|Overall Study|Progression of Disease|0|||
23319053|NCT01911273|64912312|FG000|Overall Study|Withdrawal by Subject|0|||
23319054|NCT01911273|64912313|FG001|Overall Study|Withdrawal by Subject|2|||
23319055|NCT00041132|64912320|FG000|Overall Study|Adverse Event|19|||
23319056|NCT00041132|64912320|FG000|Overall Study|Death|1|||
23319057|NCT00041132|64912320|FG000|Overall Study|Not Eligible|7|||
23319058|NCT00041132|64912320|FG000|Overall Study|Withdrawal by Subject|1|||
23319059|NCT00041132|64912320|FG000|Overall Study|Physician Decision|2|||
23622556|NCT03599622|66004990|FG002|Treatment Period|Study terminated by sponsor|15|||
23622557|NCT03599622|66004991|FG003|Treatment Period|Study terminated by sponsor|0|||
23622558|NCT03599622|66004988|FG000|Treatment Period|Site terminated by sponsor|0|||
23622559|NCT03599622|66004989|FG001|Treatment Period|Site terminated by sponsor|1|||
23622560|NCT03599622|66004990|FG002|Treatment Period|Site terminated by sponsor|0|||
23622561|NCT03599622|66004991|FG003|Treatment Period|Site terminated by sponsor|0|||
23319060|NCT00887289|64912321|FG000|Overall Study|Lack of Efficacy|14|||
23319061|NCT00887289|64912321|FG000|Overall Study|Adverse Event|27|||
23319062|NCT00887289|64912321|FG000|Overall Study|Withdrawal by Subject|26|||
23319063|NCT00887289|64912321|FG000|Overall Study|Lost to Follow-up|8|||
23319064|NCT00887289|64912321|FG000|Overall Study|Other|20|||
23319065|NCT02905032|64912322|FG000|Overall Study|Withdrawal by Subject|2|||
23319066|NCT02905032|64912323|FG001|Overall Study|Withdrawal by Subject|0|||
23319067|NCT02905032|64912324|FG002|Overall Study|Withdrawal by Subject|0|||
23319068|NCT02905032|64912322|FG000|Overall Study|Protocol Violation|6|||
23319069|NCT02905032|64912323|FG001|Overall Study|Protocol Violation|12|||
23319070|NCT02905032|64912324|FG002|Overall Study|Protocol Violation|0|||
23319071|NCT01173120|64912325|FG000|Overall Study|Lack of Efficacy|2|||
23319072|NCT01173120|64912325|FG000|Overall Study|Lost to Follow-up|1|||
23319073|NCT01173120|64912325|FG000|Overall Study|Participant Decision|2|||
23319074|NCT01173120|64912325|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
23319075|NCT01173120|64912325|FG000|Overall Study|Switch-Participant Decision|12|||
23319076|NCT01173120|64912325|FG000|Overall Study|Switch-Difficulty With Device|12|||
23319077|NCT03971474|64912328|FG000|Overall Study|Adverse Event|11|||
23622562|NCT00107978|66004993|FG000|Overall Study|Adverse Event|1|||
23622563|NCT00107978|66004994|FG001|Overall Study|Adverse Event|5|||
23622564|NCT00107978|66004993|FG000|Overall Study|Death|3|||
23622565|NCT00107978|66004994|FG001|Overall Study|Death|3|||
23622566|NCT00107978|66004993|FG000|Overall Study|Lost to Follow-up|20|||
23622567|NCT00107978|66004994|FG001|Overall Study|Lost to Follow-up|28|||
23622568|NCT00107978|66004993|FG000|Overall Study|Withdrawal by Subject|4|||
23622569|NCT00107978|66004994|FG001|Overall Study|Withdrawal by Subject|9|||
23622570|NCT00107978|66004993|FG000|Overall Study|Protocol Violation|0|||
23622571|NCT00107978|66004994|FG001|Overall Study|Protocol Violation|1|||
23216908|NCT01400139|64534647|FG000|HYD Extension Period|Administrative|10|||
23216909|NCT02843178|64534650|FG000|Overall Study|Lost to Follow-up|8|||
23216910|NCT02843178|64534651|FG001|Overall Study|Lost to Follow-up|8|||
23216911|NCT02843178|64534652|FG002|Overall Study|Lost to Follow-up|6|||
23216912|NCT02843178|64534653|FG003|Overall Study|Lost to Follow-up|3|||
23319078|NCT03971474|64912329|FG001|Overall Study|Adverse Event|7|||
23319079|NCT03971474|64912328|FG000|Overall Study|Refusal unrelated to adverse event|5|||
23622572|NCT00107978|66004993|FG000|Overall Study|Other|5|||
23622573|NCT00107978|66004994|FG001|Overall Study|Other|4|||
23622574|NCT00436956|66004995|FG000|Overall Study|Not evaluable|1|||
23622575|NCT00436956|66004996|FG001|Overall Study|Not evaluable|0|||
23622576|NCT03796208|66004997|FG000|Overall Study|Withdrawal by Subject|3|||
23622577|NCT03796208|66004998|FG001|Overall Study|Withdrawal by Subject|0|||
23622578|NCT03796208|66004997|FG000|Overall Study|Loss of pregnancy|1|||
23622579|NCT03796208|66004998|FG001|Overall Study|Loss of pregnancy|1|||
23622580|NCT03796208|66004997|FG000|Overall Study|Changed prenatal clinics|0|||
23622581|NCT03796208|66004998|FG001|Overall Study|Changed prenatal clinics|5|||
23622582|NCT03796208|66004997|FG000|Overall Study|Lost to Follow-up|20|||
23622583|NCT03796208|66004998|FG001|Overall Study|Lost to Follow-up|16|||
23622584|NCT00337285|66004999|FG000|Overall Study|Withdrawal by Subject|42|||
23622585|NCT00337285|66004999|FG000|Overall Study|Lost to Follow-up|41|||
23622586|NCT00337285|66004999|FG000|Overall Study|Adverse Event|28|||
23622587|NCT00337285|66004999|FG000|Overall Study|Protocol Violation|27|||
23622588|NCT00337285|66004999|FG000|Overall Study|Lack of Efficacy|11|||
23622589|NCT00337285|66004999|FG000|Overall Study|Death|1|||
23142110|NCT03254485|64270535|FG000|Overall Study|Other|1|||
23142111|NCT03254485|64270536|FG001|Overall Study|Other|0|||
23142112|NCT03254485|64270537|FG002|Overall Study|Other|0|||
23142113|NCT03254485|64270538|FG003|Overall Study|Other|2|||
23142114|NCT02175004|64270545|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
23142115|NCT02175004|64270546|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
23142116|NCT02175004|64270545|FG000|Overall Study|Investigator Judgment|1|||
23142117|NCT02175004|64270546|FG001|Overall Study|Investigator Judgment|4|||
23142118|NCT02175004|64270545|FG000|Overall Study|Voluntary Withdrawal|6|||
23142119|NCT02175004|64270546|FG001|Overall Study|Voluntary Withdrawal|19|||
23142120|NCT02175004|64270545|FG000|Overall Study|Liver Transplant|1|||
23142121|NCT02175004|64270546|FG001|Overall Study|Liver Transplant|0|||
23142122|NCT02175004|64270545|FG000|Overall Study|Disease Progression|1|||
23622590|NCT00337285|66004999|FG000|Overall Study|Physician Decision|1|||
23622591|NCT00337285|66004999|FG000|Overall Study|Lack of protocol compliance|7|||
23622592|NCT01101334|66005000|FG000|Overall Study|Adverse Event|9|||
23216913|NCT02843178|64534650|FG000|Overall Study|Withdrawal by Subject|0|||
23319080|NCT03971474|64912329|FG001|Overall Study|Refusal unrelated to adverse event|1|||
23319081|NCT03971474|64912328|FG000|Overall Study|Progression/relapse|40|||
23622593|NCT01101334|66005001|FG001|Overall Study|Adverse Event|4|||
23622594|NCT01101334|66005000|FG000|Overall Study|Death|7|||
23142123|NCT02175004|64270546|FG001|Overall Study|Disease Progression|0|||
23622595|NCT01101334|66005001|FG001|Overall Study|Death|1|||
23622596|NCT01101334|66005000|FG000|Overall Study|Withdrawal by Subject|4|||
23622597|NCT01101334|66005001|FG001|Overall Study|Withdrawal by Subject|3|||
23622598|NCT01101334|66005000|FG000|Overall Study|Withdrawal by Sponsor|1|||
23142124|NCT02175004|64270545|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
23142125|NCT02175004|64270546|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
23319082|NCT03971474|64912329|FG001|Overall Study|Progression/relapse|47|||
23319083|NCT03971474|64912328|FG000|Overall Study|Death|6|||
23319084|NCT03971474|64912329|FG001|Overall Study|Death|3|||
23319085|NCT03971474|64912328|FG000|Overall Study|Other - not protocol specified|5|||
23433120|NCT01183065|65330372|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
23433121|NCT02713867|65330376|FG000|Randomization|Other Reason|2|||
23433122|NCT02713867|65330377|FG001|Randomization|Other Reason|1|||
23433123|NCT02713867|65330376|FG000|Randomization|Participant Withdrew consent|0|||
23433124|NCT02713867|65330377|FG001|Randomization|Participant Withdrew consent|2|||
23433125|NCT02713867|65330376|FG000|Treatment Period|Other Reasons|22|||
23433126|NCT02713867|65330377|FG001|Treatment Period|Other Reasons|28|||
23433127|NCT02713867|65330376|FG000|Treatment Period|Administrative reason by sponsor|21|||
23433128|NCT02713867|65330377|FG001|Treatment Period|Administrative reason by sponsor|16|||
23433129|NCT02713867|65330376|FG000|Treatment Period|No longer meets study criteria|2|||
23433130|NCT02713867|65330377|FG001|Treatment Period|No longer meets study criteria|1|||
23433131|NCT02713867|65330376|FG000|Treatment Period|Poor/Non Compliance|1|||
23433132|NCT02713867|65330377|FG001|Treatment Period|Poor/Non Compliance|0|||
23433133|NCT02713867|65330376|FG000|Treatment Period|Maximum Clinical Benefit|5|||
23319086|NCT03971474|64912329|FG001|Overall Study|Other - not protocol specified|4|||
23319087|NCT03971474|64912328|FG000|Overall Study|On treatment|0|||
23319088|NCT03971474|64912329|FG001|Overall Study|On treatment|7|||
23319089|NCT01295320|64912330|FG000|Overall Study|Adverse Event|2|||
23319090|NCT01295320|64912330|FG000|Overall Study|Lost to Follow-up|4|||
23319091|NCT01295320|64912330|FG000|Overall Study|Withdrawal by Subject|2|||
23319092|NCT01295320|64912330|FG000|Overall Study|Subject was bedridden|1|||
23319093|NCT01295320|64912330|FG000|Overall Study|Unable to travel|1|||
23319094|NCT03142191|64912332|FG000|Placebo Controlled Period|Death|0|||
23319095|NCT03142191|64912333|FG001|Placebo Controlled Period|Death|1|||
23319096|NCT03142191|64912334|FG002|Placebo Controlled Period|Death|1|||
23319097|NCT03142191|64912335|FG003|Placebo Controlled Period|Death|0|||
23319098|NCT03142191|64912336|FG004|Placebo Controlled Period|Death|0|||
23319099|NCT03142191|64912332|FG000|Placebo Controlled Period|Adverse Event|4|||
23319100|NCT03142191|64912333|FG001|Placebo Controlled Period|Adverse Event|5|||
23433134|NCT02713867|65330377|FG001|Treatment Period|Maximum Clinical Benefit|6|||
23433135|NCT02713867|65330376|FG000|Treatment Period|Withdrew consent|3|||
23433136|NCT02713867|65330377|FG001|Treatment Period|Withdrew consent|6|||
23433137|NCT02713867|65330376|FG000|Treatment Period|Requested to Discontinue|8|||
23433138|NCT02713867|65330377|FG001|Treatment Period|Requested to Discontinue|8|||
23433139|NCT02713867|65330376|FG000|Treatment Period|AE unrelated to Study Drug|11|||
23433140|NCT02713867|65330377|FG001|Treatment Period|AE unrelated to Study Drug|10|||
23433141|NCT02713867|65330376|FG000|Treatment Period|Death|7|||
23433142|NCT02713867|65330377|FG001|Treatment Period|Death|3|||
23433143|NCT02713867|65330376|FG000|Treatment Period|Study Drug Toxicity|16|||
23433144|NCT02713867|65330377|FG001|Treatment Period|Study Drug Toxicity|19|||
23433145|NCT02713867|65330376|FG000|Treatment Period|Disease Progression|82|||
23433146|NCT02713867|65330377|FG001|Treatment Period|Disease Progression|83|||
23433147|NCT00924443|65330380|FG000|Overall Study|Physician Decision|2|||
23433148|NCT00924443|65330380|FG000|Overall Study|Protocol Violation|1|||
23433149|NCT00082381|65330381|FG000|Overall Study|Adverse Event|27|||
23433150|NCT00082381|65330382|FG001|Overall Study|Adverse Event|2|||
23433151|NCT00082381|65330381|FG000|Overall Study|Lost to Follow-up|5|||
23433152|NCT00082381|65330382|FG001|Overall Study|Lost to Follow-up|7|||
23433153|NCT00082381|65330381|FG000|Overall Study|Patient Decision|8|||
23433154|NCT00082381|65330382|FG001|Overall Study|Patient Decision|4|||
23433155|NCT00082381|65330381|FG000|Overall Study|Physician Decision|1|||
23433156|NCT00082381|65330382|FG001|Overall Study|Physician Decision|2|||
23433157|NCT00082381|65330381|FG000|Overall Study|Protocol Violation|10|||
23433158|NCT00082381|65330382|FG001|Overall Study|Protocol Violation|11|||
23433159|NCT00082381|65330381|FG000|Overall Study|Loss of Glucose Control|4|||
23433160|NCT00082381|65330382|FG001|Overall Study|Loss of Glucose Control|0|||
23433161|NCT02553538|65330385|FG000|Overall Study|Could Not Reach by Telephone|133|||
23433162|NCT02553538|65330386|FG001|Overall Study|Could Not Reach by Telephone|0|||
23433163|NCT02553538|65330385|FG000|Overall Study|Died or Left Network|54|||
23433164|NCT02553538|65330386|FG001|Overall Study|Died or Left Network|56|||
23319101|NCT03142191|64912334|FG002|Placebo Controlled Period|Adverse Event|1|||
23433165|NCT00094107|65330387|FG000|Overall Study|Lack of Efficacy|23|||
23433166|NCT00094107|65330387|FG000|Overall Study|Death|5|||
23433167|NCT00094107|65330387|FG000|Overall Study|Adverse Event|3|||
23142126|NCT00757783|64270547|FG000|Overall Study|Adverse Event|0|||
23433168|NCT00094107|65330387|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
23319102|NCT03142191|64912335|FG003|Placebo Controlled Period|Adverse Event|0|||
23433169|NCT00599638|65330390|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
23433170|NCT00599638|65330391|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
23433171|NCT00599638|65330392|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
23216914|NCT02843178|64534651|FG001|Overall Study|Withdrawal by Subject|0|||
23216915|NCT02843178|64534652|FG002|Overall Study|Withdrawal by Subject|1|||
23216916|NCT02843178|64534653|FG003|Overall Study|Withdrawal by Subject|1|||
23319103|NCT03142191|64912336|FG004|Placebo Controlled Period|Adverse Event|0|||
23319104|NCT03142191|64912332|FG000|Placebo Controlled Period|Progressive Disease|1|||
23319105|NCT03142191|64912333|FG001|Placebo Controlled Period|Progressive Disease|0|||
23319106|NCT03142191|64912334|FG002|Placebo Controlled Period|Progressive Disease|1|||
23555215|NCT04791761|65758038|FG000|Overall Study|Lost to Follow-up|8|||
23142127|NCT00757783|64270548|FG001|Overall Study|Adverse Event|2|||
23142128|NCT00757783|64270547|FG000|Overall Study|Lost to Follow-up|1|||
23142129|NCT00757783|64270548|FG001|Overall Study|Lost to Follow-up|1|||
23142130|NCT00757783|64270547|FG000|Overall Study|Protocol Violation|1|||
23142131|NCT00757783|64270548|FG001|Overall Study|Protocol Violation|0|||
23142132|NCT00757783|64270547|FG000|Overall Study|Withdrawal by Subject|2|||
23142133|NCT00757783|64270548|FG001|Overall Study|Withdrawal by Subject|1|||
23142134|NCT00757783|64270547|FG000|Overall Study|Other|1|||
23142135|NCT00757783|64270548|FG001|Overall Study|Other|2|||
23142136|NCT01874431|64270549|FG000|Overall Study|Physician Decision|0|||
23142137|NCT01874431|64270550|FG001|Overall Study|Physician Decision|0|||
23142138|NCT01874431|64270551|FG002|Overall Study|Physician Decision|1|||
23142139|NCT01874431|64270552|FG003|Overall Study|Physician Decision|0|||
23142140|NCT01874431|64270553|FG004|Overall Study|Physician Decision|0|||
23142141|NCT01874431|64270554|FG005|Overall Study|Physician Decision|0|||
23142142|NCT01874431|64270555|FG006|Overall Study|Physician Decision|0|||
23142143|NCT01874431|64270556|FG007|Overall Study|Physician Decision|0|||
23142144|NCT01874431|64270549|FG000|Overall Study|Adverse Event|5|||
23142145|NCT01874431|64270550|FG001|Overall Study|Adverse Event|4|||
23142146|NCT01874431|64270551|FG002|Overall Study|Adverse Event|6|||
23142147|NCT01874431|64270552|FG003|Overall Study|Adverse Event|5|||
23142148|NCT01874431|64270553|FG004|Overall Study|Adverse Event|2|||
23142149|NCT01874431|64270554|FG005|Overall Study|Adverse Event|8|||
23142150|NCT01874431|64270555|FG006|Overall Study|Adverse Event|2|||
23142151|NCT01874431|64270556|FG007|Overall Study|Adverse Event|3|||
23142152|NCT01874431|64270549|FG000|Overall Study|Protocol Violation|1|||
23142153|NCT01874431|64270550|FG001|Overall Study|Protocol Violation|1|||
23142154|NCT01874431|64270551|FG002|Overall Study|Protocol Violation|1|||
23142155|NCT01874431|64270552|FG003|Overall Study|Protocol Violation|0|||
23142156|NCT01874431|64270553|FG004|Overall Study|Protocol Violation|3|||
23142157|NCT01874431|64270554|FG005|Overall Study|Protocol Violation|2|||
23142158|NCT01874431|64270555|FG006|Overall Study|Protocol Violation|1|||
23142159|NCT01874431|64270556|FG007|Overall Study|Protocol Violation|1|||
23142160|NCT01874431|64270549|FG000|Overall Study|Non-compliance|0|||
23142161|NCT01874431|64270550|FG001|Overall Study|Non-compliance|0|||
23142162|NCT01874431|64270551|FG002|Overall Study|Non-compliance|0|||
23142163|NCT01874431|64270552|FG003|Overall Study|Non-compliance|0|||
23142164|NCT01874431|64270553|FG004|Overall Study|Non-compliance|1|||
23142165|NCT01874431|64270554|FG005|Overall Study|Non-compliance|0|||
23142166|NCT01874431|64270555|FG006|Overall Study|Non-compliance|1|||
23142167|NCT01874431|64270556|FG007|Overall Study|Non-compliance|0|||
23142168|NCT01874431|64270549|FG000|Overall Study|Logistical difficulties|0|||
23142169|NCT01874431|64270550|FG001|Overall Study|Logistical difficulties|0|||
23142170|NCT01874431|64270551|FG002|Overall Study|Logistical difficulties|0|||
23142171|NCT01874431|64270552|FG003|Overall Study|Logistical difficulties|0|||
23142172|NCT01874431|64270553|FG004|Overall Study|Logistical difficulties|0|||
23555216|NCT04791761|65758039|FG001|Overall Study|Lost to Follow-up|6|||
23555217|NCT04791761|65758040|FG002|Overall Study|Lost to Follow-up|10|||
23555218|NCT04791761|65758038|FG000|Overall Study|Withdrawal by Subject|0|||
23555219|NCT04791761|65758039|FG001|Overall Study|Withdrawal by Subject|1|||
23555220|NCT04791761|65758040|FG002|Overall Study|Withdrawal by Subject|1|||
23555221|NCT04791761|65758038|FG000|Overall Study|Protocol Violation|0|||
23555222|NCT04791761|65758039|FG001|Overall Study|Protocol Violation|1|||
23555223|NCT04791761|65758040|FG002|Overall Study|Protocol Violation|1|||
23555224|NCT04020341|65758041|FG000|Overall Study|Adverse Event|8|||
23555225|NCT04020341|65758042|FG001|Overall Study|Adverse Event|6|||
23555226|NCT04020341|65758041|FG000|Overall Study|Lost to Follow-up|8|||
23555227|NCT04020341|65758042|FG001|Overall Study|Lost to Follow-up|2|||
23555228|NCT04020341|65758041|FG000|Overall Study|Withdrawal by Subject|16|||
23555229|NCT04020341|65758042|FG001|Overall Study|Withdrawal by Subject|16|||
23555230|NCT04020341|65758041|FG000|Overall Study|Participant not able to swallow the tablet|1|||
23555231|NCT04020341|65758042|FG001|Overall Study|Participant not able to swallow the tablet|0|||
23555232|NCT04020341|65758041|FG000|Overall Study|Physician Decision|0|||
23555233|NCT04020341|65758042|FG001|Overall Study|Physician Decision|2|||
23555234|NCT04020341|65758041|FG000|Overall Study|Protocol Deviation|0|||
23555235|NCT04020341|65758042|FG001|Overall Study|Protocol Deviation|2|||
23555236|NCT04987762|65758045|FG000|Overall Study|Study was Terminated by Sponsor|103|||
23555237|NCT01970462|65758046|FG000|Overall Study|Lost to Follow-up|0|||
23555238|NCT01970462|65758047|FG001|Overall Study|Lost to Follow-up|2|||
23555239|NCT00440531|65758054|FG000|Overall Study|Adverse Event|1|||
23216917|NCT03725293|64534657|FG000|Overall Study|Physician Decision|9|||
23216918|NCT03725293|64534658|FG001|Overall Study|Physician Decision|6|||
23216919|NCT03725293|64534657|FG000|Overall Study|alternative vascular access needs|1|||
23216920|NCT03725293|64534658|FG001|Overall Study|alternative vascular access needs|2|||
23319107|NCT03142191|64912335|FG003|Placebo Controlled Period|Progressive Disease|0|||
23319108|NCT03142191|64912336|FG004|Placebo Controlled Period|Progressive Disease|0|||
23319109|NCT03142191|64912332|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
23216921|NCT03725293|64534657|FG000|Overall Study|venous anatomy screen failures|2|||
23216922|NCT03725293|64534658|FG001|Overall Study|venous anatomy screen failures|1|||
23216923|NCT00443846|64534662|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
23216924|NCT00443846|64534663|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
23216925|NCT00443846|64534662|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
23216926|NCT00443846|64534663|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
23216927|NCT00443846|64534662|FG000|Overall Study|Adverse Event|0|||
23216928|NCT00443846|64534663|FG001|Overall Study|Adverse Event|1|||
23216929|NCT00443846|64534662|FG000|Overall Study|Personal reason|8|||
23216930|NCT00443846|64534663|FG001|Overall Study|Personal reason|3|||
23216931|NCT00443846|64534662|FG000|Overall Study|Lost to Follow-up|1|||
23216932|NCT00443846|64534663|FG001|Overall Study|Lost to Follow-up|2|||
23216933|NCT00555568|64534664|FG000|Overall Study|Lost to Follow-up|26|||
23216934|NCT00555568|64534665|FG001|Overall Study|Lost to Follow-up|16|||
23216935|NCT00555568|64534666|FG002|Overall Study|Lost to Follow-up|16|||
23216936|NCT00718523|64534667|FG000|Overall Study|Withdrawal by Subject|5|||
23216937|NCT00718523|64534668|FG001|Overall Study|Withdrawal by Subject|7|||
23216938|NCT00718523|64534667|FG000|Overall Study|Death|13|||
23216939|NCT00718523|64534668|FG001|Overall Study|Death|17|||
23216940|NCT00517413|64534669|FG000|Overall Study|Adverse Event|7|||
23216941|NCT00517413|64534669|FG000|Overall Study|Death|13|||
23216942|NCT00517413|64534669|FG000|Overall Study|Protocol Violation|15|||
23216943|NCT00517413|64534669|FG000|Overall Study|Withdrawal by Subject|2|||
23216944|NCT00517413|64534669|FG000|Overall Study|Failure to return|1|||
23216945|NCT00517413|64534669|FG000|Overall Study|Other-Reasons|23|||
23216946|NCT05159362|64534670|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
23216947|NCT05159362|64534671|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
23216948|NCT05159362|64534672|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
23216949|NCT02873208|64534673|FG000|Overall Study|Withdrawal by Subject|36|||
23216950|NCT02873208|64534673|FG000|Overall Study|Lost to Follow-up|22|||
23216951|NCT02873208|64534673|FG000|Overall Study|Adverse Event|15|||
23216952|NCT02873208|64534673|FG000|Overall Study|Non-compliance with study drug|12|||
23216953|NCT02873208|64534673|FG000|Overall Study|Protocol Violation|8|||
23216954|NCT02873208|64534673|FG000|Overall Study|Pregnancy|2|||
23216955|NCT02873208|64534673|FG000|Overall Study|Incarceration|1|||
23216956|NCT02873208|64534673|FG000|Overall Study|Lack of Efficacy|1|||
23216957|NCT02873208|64534673|FG000|Overall Study|Physician Decision|1|||
23216958|NCT00728936|64534675|FG000|Overall Study|Withdrawal by Subject|0|||
23216959|NCT00728936|64534676|FG001|Overall Study|Withdrawal by Subject|0|||
23216960|NCT00728936|64534677|FG002|Overall Study|Withdrawal by Subject|0|||
23216961|NCT00728936|64534678|FG003|Overall Study|Withdrawal by Subject|0|||
23216962|NCT00728936|64534679|FG004|Overall Study|Withdrawal by Subject|0|||
23216963|NCT00728936|64534680|FG005|Overall Study|Withdrawal by Subject|1|||
23216964|NCT00728936|64534681|FG006|Overall Study|Withdrawal by Subject|0|||
23319110|NCT03142191|64912333|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
23319111|NCT03142191|64912334|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
23319112|NCT03142191|64912335|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
23319113|NCT03142191|64912336|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
23319114|NCT03142191|64912332|FG000|Placebo Controlled Period|Other Reasons|1|||
23319115|NCT03142191|64912333|FG001|Placebo Controlled Period|Other Reasons|0|||
23319116|NCT03142191|64912334|FG002|Placebo Controlled Period|Other Reasons|0|||
23319117|NCT03142191|64912335|FG003|Placebo Controlled Period|Other Reasons|0|||
23319118|NCT03142191|64912336|FG004|Placebo Controlled Period|Other Reasons|0|||
23319119|NCT03142191|64912332|FG000|Active Treatment Extension Period|Death|2|||
23319120|NCT03142191|64912333|FG001|Active Treatment Extension Period|Death|1|||
23216965|NCT03148756|64534682|FG000|Overall Study|Study Terminated|0|||
23216966|NCT03148756|64534683|FG001|Overall Study|Study Terminated|1|||
23216967|NCT02062398|64534684|FG000|Overall Study|Implant removal|1|||
23216968|NCT03210220|64534685|FG000|Overall Study|Physician Decision|1|||
23216969|NCT03210220|64534686|FG001|Overall Study|Physician Decision|0|||
23216970|NCT01522443|64534687|FG000|Overall Study|No longer receiving clinical benefit|36|||
23319121|NCT03142191|64912334|FG002|Active Treatment Extension Period|Death|1|||
23319122|NCT03142191|64912335|FG003|Active Treatment Extension Period|Death|1|||
23319123|NCT03142191|64912336|FG004|Active Treatment Extension Period|Death|0|||
23319124|NCT03142191|64912332|FG000|Active Treatment Extension Period|Adverse Event|6|||
23216971|NCT01522443|64534688|FG001|Overall Study|No longer receiving clinical benefit|28|||
23216972|NCT01522443|64534687|FG000|Overall Study|Adverse Event|10|||
23216973|NCT01522443|64534688|FG001|Overall Study|Adverse Event|15|||
23216974|NCT01522443|64534687|FG000|Overall Study|Withdrawal by Subject|5|||
23216975|NCT01522443|64534688|FG001|Overall Study|Withdrawal by Subject|8|||
23216976|NCT01522443|64534687|FG000|Overall Study|No study treatment given|1|||
23216977|NCT01522443|64534688|FG001|Overall Study|No study treatment given|1|||
23216978|NCT01522443|64534687|FG000|Overall Study|Other|1|||
23216979|NCT01522443|64534688|FG001|Overall Study|Other|3|||
23216980|NCT03168555|64534689|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
23216981|NCT03168555|64534689|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
23216982|NCT03168555|64534689|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
23216983|NCT03168555|64534689|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
23216984|NCT02064205|64534690|FG000|Overall Study|Withdrawal by Subject|1|||
23216985|NCT01438307|64534691|FG000|Overall Study|Death|1|||
23216986|NCT01438307|64534692|FG001|Overall Study|Death|1|||
23216987|NCT01142193|64534703|FG000|Overall Study|Adverse Event|12|||
23216988|NCT01142193|64534704|FG001|Overall Study|Adverse Event|4|||
23216989|NCT01142193|64534703|FG000|Overall Study|Lack of Efficacy|2|||
23216990|NCT01142193|64534704|FG001|Overall Study|Lack of Efficacy|1|||
23216991|NCT01142193|64534703|FG000|Overall Study|Physician Decision|1|||
23216992|NCT01142193|64534704|FG001|Overall Study|Physician Decision|1|||
23216993|NCT01142193|64534703|FG000|Overall Study|Withdrawal by Subject|4|||
23216994|NCT01142193|64534704|FG001|Overall Study|Withdrawal by Subject|3|||
23216995|NCT01142193|64534703|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
23216996|NCT01142193|64534704|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
23216997|NCT01142193|64534703|FG000|Overall Study|Other|1|||
23216998|NCT01142193|64534704|FG001|Overall Study|Other|2|||
23216999|NCT02091921|64534705|FG000|Overall Study|Adverse Event|3|||
23217000|NCT01998880|64534708|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
23555240|NCT00440531|65758055|FG001|Overall Study|Adverse Event|0|||
23217001|NCT01998880|64534709|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
23217002|NCT01998880|64534708|FG000|Overall Study|Disease Progression|1|||
23217003|NCT01998880|64534709|FG001|Overall Study|Disease Progression|8|||
23217004|NCT01998880|64534708|FG000|Overall Study|Withdrew Consent|2|||
23217005|NCT01998880|64534709|FG001|Overall Study|Withdrew Consent|1|||
23217006|NCT01998880|64534708|FG000|Overall Study|Death|3|||
23217007|NCT01998880|64534709|FG001|Overall Study|Death|6|||
23555241|NCT00440531|65758056|FG002|Overall Study|Adverse Event|2|||
23555242|NCT00440531|65758054|FG000|Overall Study|Withdrawal by Subject|2|||
23555243|NCT00440531|65758055|FG001|Overall Study|Withdrawal by Subject|0|||
23555244|NCT00440531|65758056|FG002|Overall Study|Withdrawal by Subject|0|||
23555245|NCT00440531|65758054|FG000|Overall Study|Protocol Violation|1|||
23555246|NCT00440531|65758055|FG001|Overall Study|Protocol Violation|2|||
23555247|NCT00440531|65758056|FG002|Overall Study|Protocol Violation|0|||
23555248|NCT00440531|65758054|FG000|Overall Study|Lost to Follow-up|4|||
23555249|NCT00440531|65758055|FG001|Overall Study|Lost to Follow-up|3|||
23555250|NCT00440531|65758056|FG002|Overall Study|Lost to Follow-up|5|||
23555251|NCT00440531|65758054|FG000|Overall Study|see pre-assignment details|2|||
23555252|NCT00440531|65758055|FG001|Overall Study|see pre-assignment details|0|||
23555253|NCT00440531|65758056|FG002|Overall Study|see pre-assignment details|0|||
23555254|NCT01773070|65758057|FG000|Overall Study|Withdrawal by Subject|24|||
23555255|NCT01773070|65758057|FG000|Overall Study|Lost to Follow-up|39|||
23555256|NCT01773070|65758057|FG000|Overall Study|Other|15|||
23555257|NCT01773070|65758057|FG000|Overall Study|Death (unrelated to study procedures)|3|||
23555258|NCT02355743|65758058|FG000|Overall Study|Withdrawal by Subject|1|||
23555259|NCT02355743|65758058|FG000|Overall Study|Lost to Follow-up|1|||
23555260|NCT03927950|65758059|FG000|Overall Study|Adverse Event|9|||
23555261|NCT01693068|65758060|FG000|Randomization Period|On-study|2|||
23555262|NCT01693068|65758061|FG001|Randomization Period|On-study|5|||
23555263|NCT01693068|65758062|FG002|Randomization Period|On-study|0|||
23555264|NCT01693068|65758060|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
23555265|NCT01693068|65758061|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
23555266|NCT01693068|65758062|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
23555267|NCT04385368|65758063|FG000|Overall Study|Death|5|||
23555268|NCT04385368|65758064|FG001|Overall Study|Death|5|||
23555269|NCT04385368|65758063|FG000|Overall Study|Physician Decision|3|||
23555270|NCT04385368|65758064|FG001|Overall Study|Physician Decision|0|||
23555271|NCT04385368|65758063|FG000|Overall Study|Withdrawal by Subject|4|||
23555272|NCT04385368|65758064|FG001|Overall Study|Withdrawal by Subject|3|||
23555273|NCT02970318|65758065|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
23555274|NCT02970318|65758066|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
23555275|NCT02970318|65758067|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
23555276|NCT02970318|65758068|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
23555277|NCT02970318|65758065|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
23555278|NCT02970318|65758066|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
23555279|NCT02970318|65758067|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
23555280|NCT02970318|65758068|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
23622599|NCT01101334|66005001|FG001|Overall Study|Withdrawal by Sponsor|1|||
23622600|NCT01101334|66005000|FG000|Overall Study|Progressive Disease|22|||
23622601|NCT01101334|66005001|FG001|Overall Study|Progressive Disease|35|||
23622602|NCT01101334|66005000|FG000|Overall Study|Other|2|||
23622603|NCT01101334|66005001|FG001|Overall Study|Other|1|||
23622604|NCT01066936|66005002|FG000|Overall Study|Death|2|||
23622605|NCT01066936|66005002|FG000|Overall Study|Device revised/removed|1|||
23622606|NCT01066936|66005002|FG000|Overall Study|Lost to Follow-up|3|||
23622607|NCT01066936|66005002|FG000|Overall Study|Withdrawal by Subject|4|||
23622608|NCT04969276|66005003|FG000|Overall Study|Protocol Deviation|0|||
23622609|NCT04969276|66005004|FG001|Overall Study|Protocol Deviation|1|||
23622610|NCT04969276|66005005|FG002|Overall Study|Protocol Deviation|0|||
23622611|NCT04969276|66005003|FG000|Overall Study|Withdrawal by Subject|1|||
23622612|NCT04969276|66005004|FG001|Overall Study|Withdrawal by Subject|10|||
23622613|NCT04969276|66005005|FG002|Overall Study|Withdrawal by Subject|0|||
23622614|NCT04969276|66005003|FG000|Overall Study|Lost to Follow-up|0|||
23622615|NCT04969276|66005004|FG001|Overall Study|Lost to Follow-up|1|||
23622616|NCT04969276|66005005|FG002|Overall Study|Lost to Follow-up|0|||
23622617|NCT00604188|66005006|FG000|Overall Study|Adverse Event|1|||
23622618|NCT00604188|66005007|FG001|Overall Study|Adverse Event|4|||
23622619|NCT00604188|66005006|FG000|Overall Study|Lost to Follow-up|17|||
23217008|NCT01998880|64534708|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23217009|NCT01998880|64534709|FG001|Overall Study|Insufficient Therapeutic Response|5|||
23217010|NCT01998880|64534708|FG000|Overall Study|Administrative/Other|1|||
23217011|NCT01998880|64534709|FG001|Overall Study|Administrative/Other|1|||
23217012|NCT01998880|64534708|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
23217013|NCT01998880|64534709|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
23319125|NCT03142191|64912333|FG001|Active Treatment Extension Period|Adverse Event|5|||
23319126|NCT03142191|64912334|FG002|Active Treatment Extension Period|Adverse Event|4|||
23319127|NCT03142191|64912335|FG003|Active Treatment Extension Period|Adverse Event|1|||
23319128|NCT03142191|64912336|FG004|Active Treatment Extension Period|Adverse Event|0|||
23319129|NCT03142191|64912332|FG000|Active Treatment Extension Period|Progressive Disease|10|||
23319130|NCT03142191|64912333|FG001|Active Treatment Extension Period|Progressive Disease|5|||
23319131|NCT03142191|64912334|FG002|Active Treatment Extension Period|Progressive Disease|4|||
23319132|NCT03142191|64912335|FG003|Active Treatment Extension Period|Progressive Disease|1|||
23319133|NCT03142191|64912336|FG004|Active Treatment Extension Period|Progressive Disease|2|||
23319134|NCT03142191|64912332|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
23319135|NCT03142191|64912333|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
23622620|NCT00604188|66005007|FG001|Overall Study|Lost to Follow-up|15|||
23622621|NCT00604188|66005006|FG000|Overall Study|Withdrawal by Subject|5|||
23622622|NCT00604188|66005007|FG001|Overall Study|Withdrawal by Subject|1|||
23622623|NCT00604188|66005006|FG000|Overall Study|Non-compliance with protocol|4|||
23622624|NCT00604188|66005007|FG001|Overall Study|Non-compliance with protocol|4|||
23217014|NCT01998880|64534708|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
23217015|NCT01998880|64534709|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23217016|NCT01998880|64534708|FG000|Overall Study|Did Not Receive Treatment|3|||
23217017|NCT01998880|64534709|FG001|Overall Study|Did Not Receive Treatment|2|||
23217018|NCT03339401|64534715|FG000|Overall Study|Death|2|||
23217019|NCT03339401|64534716|FG001|Overall Study|Death|1|||
23217020|NCT03339401|64534715|FG000|Overall Study|Withdrawal by Subject|2|||
23217021|NCT03339401|64534716|FG001|Overall Study|Withdrawal by Subject|0|||
23217022|NCT03339401|64534715|FG000|Overall Study|Study terminated|4|||
23217023|NCT03339401|64534716|FG001|Overall Study|Study terminated|3|||
23217024|NCT03339401|64534715|FG000|Overall Study|Investigator Decision|1|||
23217025|NCT03339401|64534716|FG001|Overall Study|Investigator Decision|0|||
23217026|NCT01742078|64534723|FG000|Overall Study|Withdrawal by Subject|0|||
23217027|NCT01742078|64534724|FG001|Overall Study|Withdrawal by Subject|0|||
23217028|NCT01742078|64534725|FG002|Overall Study|Withdrawal by Subject|0|||
23217029|NCT01742078|64534726|FG003|Overall Study|Withdrawal by Subject|1|||
23217030|NCT01742078|64534727|FG004|Overall Study|Withdrawal by Subject|0|||
23217031|NCT01742078|64534728|FG005|Overall Study|Withdrawal by Subject|0|||
23217032|NCT01742078|64534729|FG006|Overall Study|Withdrawal by Subject|0|||
23217033|NCT01742078|64534730|FG007|Overall Study|Withdrawal by Subject|0|||
23217034|NCT01742078|64534731|FG008|Overall Study|Withdrawal by Subject|0|||
23217035|NCT01732107|64534733|FG000|Overall Study|Adverse Event|2|||
23217036|NCT01732107|64534733|FG000|Overall Study|Disease Progression|8|||
23217037|NCT01732107|64534733|FG000|Overall Study|Physician Decision|1|||
23217038|NCT01732107|64534733|FG000|Overall Study|Withdrawal by Subject|2|||
23217039|NCT00709124|64534736|FG000|Overall Study|Death|3|||
23217040|NCT00709124|64534737|FG001|Overall Study|Death|1|||
23622625|NCT00604188|66005006|FG000|Overall Study|Did not receive study drug|0|||
23622626|NCT00604188|66005007|FG001|Overall Study|Did not receive study drug|1|||
23622627|NCT01193218|66005008|FG000|0-12 Weeks|Adverse Event|6|||
23217041|NCT00709124|64534736|FG000|Overall Study|encephalopathy; can't do assessment|1|||
23217042|NCT00709124|64534737|FG001|Overall Study|encephalopathy; can't do assessment|0|||
23622628|NCT01193218|66005009|FG001|0-12 Weeks|Adverse Event|0|||
23622629|NCT01193218|66005010|FG002|0-12 Weeks|Adverse Event|1|||
23622630|NCT01193218|66005011|FG003|0-12 Weeks|Adverse Event|0|||
23622631|NCT01193218|66005012|FG004|0-12 Weeks|Adverse Event|0|||
23622632|NCT01193218|66005013|FG005|0-12 Weeks|Adverse Event|2|||
23622633|NCT01193218|66005014|FG006|0-12 Weeks|Adverse Event|2|||
23622634|NCT01193218|66005015|FG007|0-12 Weeks|Adverse Event|0|||
23622635|NCT01193218|66005008|FG000|0-12 Weeks|Protocol Violation|0|||
23622636|NCT01193218|66005009|FG001|0-12 Weeks|Protocol Violation|0|||
23622637|NCT01193218|66005010|FG002|0-12 Weeks|Protocol Violation|0|||
23622638|NCT01193218|66005011|FG003|0-12 Weeks|Protocol Violation|0|||
23622639|NCT01193218|66005012|FG004|0-12 Weeks|Protocol Violation|1|||
23319136|NCT03142191|64912334|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
23622640|NCT01193218|66005013|FG005|0-12 Weeks|Protocol Violation|1|||
23622641|NCT01193218|66005014|FG006|0-12 Weeks|Protocol Violation|0|||
23622642|NCT01193218|66005015|FG007|0-12 Weeks|Protocol Violation|0|||
23319137|NCT03142191|64912335|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
23319138|NCT03142191|64912336|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
23319139|NCT03142191|64912332|FG000|Active Treatment Extension Period|Physician Decision|2|||
23319140|NCT03142191|64912333|FG001|Active Treatment Extension Period|Physician Decision|0|||
23319141|NCT03142191|64912334|FG002|Active Treatment Extension Period|Physician Decision|0|||
23319142|NCT03142191|64912335|FG003|Active Treatment Extension Period|Physician Decision|0|||
23319143|NCT03142191|64912336|FG004|Active Treatment Extension Period|Physician Decision|0|||
23319144|NCT03142191|64912332|FG000|Active Treatment Extension Period|Other Reasons|3|||
23319145|NCT03142191|64912333|FG001|Active Treatment Extension Period|Other Reasons|3|||
23319146|NCT03142191|64912334|FG002|Active Treatment Extension Period|Other Reasons|3|||
23319147|NCT03142191|64912335|FG003|Active Treatment Extension Period|Other Reasons|8|||
23319148|NCT03142191|64912336|FG004|Active Treatment Extension Period|Other Reasons|3|||
23319149|NCT03142191|64912332|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
23319150|NCT03142191|64912333|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
23319151|NCT03142191|64912334|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
23319152|NCT03142191|64912335|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
23319153|NCT03142191|64912336|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
23319154|NCT03296527|64912337|FG000|Overall Study|Adverse Event|15|||
23319155|NCT03296527|64912338|FG001|Overall Study|Adverse Event|33|||
23319156|NCT03296527|64912337|FG000|Overall Study|Protocol Deviation|4|||
23319157|NCT03296527|64912338|FG001|Overall Study|Protocol Deviation|0|||
23319158|NCT03296527|64912337|FG000|Overall Study|Participant withdrew consent|3|||
23319159|NCT03296527|64912338|FG001|Overall Study|Participant withdrew consent|1|||
23319160|NCT03296527|64912337|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
23319161|NCT03296527|64912338|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
23319162|NCT03296527|64912337|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
23319163|NCT03296527|64912338|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
23319164|NCT03296527|64912337|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
23319165|NCT03296527|64912338|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
23319166|NCT03296527|64912337|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
23622643|NCT01193218|66005008|FG000|0-12 Weeks|Withdrawal by Subject|3|||
23622644|NCT01193218|66005009|FG001|0-12 Weeks|Withdrawal by Subject|0|||
23622645|NCT01193218|66005010|FG002|0-12 Weeks|Withdrawal by Subject|2|||
23622646|NCT01193218|66005011|FG003|0-12 Weeks|Withdrawal by Subject|0|||
23622647|NCT01193218|66005012|FG004|0-12 Weeks|Withdrawal by Subject|0|||
23622648|NCT01193218|66005013|FG005|0-12 Weeks|Withdrawal by Subject|0|||
23622649|NCT01193218|66005014|FG006|0-12 Weeks|Withdrawal by Subject|1|||
23622650|NCT01193218|66005015|FG007|0-12 Weeks|Withdrawal by Subject|0|||
23622651|NCT01193218|66005008|FG000|12-52 Weeks|Adverse Event|1|||
23217043|NCT00033371|64534738|FG000|Overall Study|Adverse Event|1|||
23217044|NCT00033371|64534739|FG001|Overall Study|Adverse Event|5|||
23217045|NCT00033371|64534738|FG000|Overall Study|Lost to Follow-up|2|||
23217046|NCT00033371|64534739|FG001|Overall Study|Lost to Follow-up|1|||
23217047|NCT00033371|64534738|FG000|Overall Study|Withdrawal by Subject|3|||
23217048|NCT00033371|64534739|FG001|Overall Study|Withdrawal by Subject|3|||
23217049|NCT00033371|64534738|FG000|Overall Study|Disease Progression|0|||
23217050|NCT00033371|64534739|FG001|Overall Study|Disease Progression|1|||
23217051|NCT04839393|64534740|FG000|Overall Study|Adverse Event|0|||
23217052|NCT04839393|64534741|FG001|Overall Study|Adverse Event|0|||
23217053|NCT04839393|64534742|FG002|Overall Study|Adverse Event|2|||
23217054|NCT04839393|64534740|FG000|Overall Study|Withdrawal by participant|0|||
23217055|NCT04839393|64534741|FG001|Overall Study|Withdrawal by participant|0|||
23622652|NCT01193218|66005009|FG001|12-52 Weeks|Adverse Event|0|||
23622653|NCT01193218|66005010|FG002|12-52 Weeks|Adverse Event|1|||
23622654|NCT01193218|66005011|FG003|12-52 Weeks|Adverse Event|2|||
23217056|NCT04839393|64534742|FG002|Overall Study|Withdrawal by participant|1|||
23217057|NCT00094835|64534743|FG000|Overall Study|Physician Decision|1|||
23217058|NCT00094835|64534744|FG001|Overall Study|Physician Decision|0|||
23319167|NCT03296527|64912338|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
23319168|NCT03296527|64912337|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
23319169|NCT03296527|64912338|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
23319170|NCT03284723|64912339|FG000|Overall Study|Death|0|||
23319171|NCT03284723|64912340|FG001|Overall Study|Death|0|||
23319172|NCT03284723|64912341|FG002|Overall Study|Death|0|||
23319173|NCT03284723|64912342|FG003|Overall Study|Death|1|||
23319174|NCT03284723|64912343|FG004|Overall Study|Death|0|||
23319175|NCT03284723|64912344|FG005|Overall Study|Death|0|||
23319176|NCT03284723|64912345|FG006|Overall Study|Death|1|||
23319177|NCT03284723|64912346|FG007|Overall Study|Death|0|||
23319178|NCT03284723|64912347|FG008|Overall Study|Death|0|||
23319179|NCT03284723|64912348|FG009|Overall Study|Death|2|||
23319180|NCT03284723|64912349|FG010|Overall Study|Death|1|||
23319181|NCT03284723|64912350|FG011|Overall Study|Death|0|||
23319182|NCT03284723|64912339|FG000|Overall Study|Lost to Follow-up|0|||
23319183|NCT03284723|64912340|FG001|Overall Study|Lost to Follow-up|0|||
23319184|NCT03284723|64912341|FG002|Overall Study|Lost to Follow-up|0|||
23319185|NCT03284723|64912342|FG003|Overall Study|Lost to Follow-up|0|||
23319186|NCT03284723|64912343|FG004|Overall Study|Lost to Follow-up|0|||
23319187|NCT03284723|64912344|FG005|Overall Study|Lost to Follow-up|2|||
23319188|NCT03284723|64912345|FG006|Overall Study|Lost to Follow-up|1|||
23319189|NCT03284723|64912346|FG007|Overall Study|Lost to Follow-up|0|||
23319190|NCT03284723|64912347|FG008|Overall Study|Lost to Follow-up|0|||
23319191|NCT03284723|64912348|FG009|Overall Study|Lost to Follow-up|2|||
23319192|NCT03284723|64912349|FG010|Overall Study|Lost to Follow-up|0|||
23319193|NCT03284723|64912350|FG011|Overall Study|Lost to Follow-up|0|||
23319194|NCT03284723|64912339|FG000|Overall Study|Study Terminated By Sponsor|0|||
23319195|NCT03284723|64912340|FG001|Overall Study|Study Terminated By Sponsor|0|||
23319196|NCT03284723|64912341|FG002|Overall Study|Study Terminated By Sponsor|0|||
23319197|NCT03284723|64912342|FG003|Overall Study|Study Terminated By Sponsor|0|||
23319198|NCT03284723|64912343|FG004|Overall Study|Study Terminated By Sponsor|1|||
23319199|NCT03284723|64912344|FG005|Overall Study|Study Terminated By Sponsor|0|||
23319200|NCT03284723|64912345|FG006|Overall Study|Study Terminated By Sponsor|0|||
23319201|NCT03284723|64912346|FG007|Overall Study|Study Terminated By Sponsor|0|||
23319202|NCT03284723|64912347|FG008|Overall Study|Study Terminated By Sponsor|1|||
23319203|NCT03284723|64912348|FG009|Overall Study|Study Terminated By Sponsor|1|||
23319204|NCT03284723|64912349|FG010|Overall Study|Study Terminated By Sponsor|1|||
23319205|NCT03284723|64912350|FG011|Overall Study|Study Terminated By Sponsor|1|||
23319206|NCT03284723|64912339|FG000|Overall Study|Withdrawal by Subject|0|||
23319207|NCT03284723|64912340|FG001|Overall Study|Withdrawal by Subject|0|||
23319208|NCT03284723|64912341|FG002|Overall Study|Withdrawal by Subject|0|||
23319209|NCT03284723|64912342|FG003|Overall Study|Withdrawal by Subject|0|||
23142173|NCT01874431|64270554|FG005|Overall Study|Logistical difficulties|0|||
23142174|NCT01874431|64270555|FG006|Overall Study|Logistical difficulties|1|||
23142175|NCT01874431|64270556|FG007|Overall Study|Logistical difficulties|0|||
23142176|NCT01874431|64270549|FG000|Overall Study|Withdrawal by Subject|0|||
23142177|NCT01874431|64270550|FG001|Overall Study|Withdrawal by Subject|0|||
23142178|NCT01874431|64270551|FG002|Overall Study|Withdrawal by Subject|1|||
23142179|NCT01874431|64270552|FG003|Overall Study|Withdrawal by Subject|2|||
23142180|NCT01874431|64270553|FG004|Overall Study|Withdrawal by Subject|1|||
23142181|NCT01874431|64270554|FG005|Overall Study|Withdrawal by Subject|1|||
23142182|NCT01874431|64270555|FG006|Overall Study|Withdrawal by Subject|3|||
23142183|NCT01874431|64270556|FG007|Overall Study|Withdrawal by Subject|0|||
23142184|NCT01874431|64270549|FG000|Overall Study|Sponsor decision|0|||
23142185|NCT01874431|64270550|FG001|Overall Study|Sponsor decision|0|||
23142186|NCT01874431|64270551|FG002|Overall Study|Sponsor decision|0|||
23142187|NCT01874431|64270552|FG003|Overall Study|Sponsor decision|0|||
23142188|NCT01874431|64270553|FG004|Overall Study|Sponsor decision|1|||
23142189|NCT01874431|64270554|FG005|Overall Study|Sponsor decision|0|||
23142190|NCT01874431|64270555|FG006|Overall Study|Sponsor decision|0|||
23142191|NCT01874431|64270556|FG007|Overall Study|Sponsor decision|0|||
23142192|NCT01874431|64270549|FG000|Overall Study|Lost to Follow-up|0|||
23142193|NCT01874431|64270550|FG001|Overall Study|Lost to Follow-up|0|||
23142194|NCT01874431|64270551|FG002|Overall Study|Lost to Follow-up|1|||
23142195|NCT01874431|64270552|FG003|Overall Study|Lost to Follow-up|0|||
23142196|NCT01874431|64270553|FG004|Overall Study|Lost to Follow-up|0|||
23142197|NCT01874431|64270554|FG005|Overall Study|Lost to Follow-up|0|||
23142198|NCT01874431|64270555|FG006|Overall Study|Lost to Follow-up|0|||
23142199|NCT01874431|64270556|FG007|Overall Study|Lost to Follow-up|0|||
23142200|NCT03010176|64270559|FG000|Overall Study|Death|21|||
23142201|NCT03010176|64270560|FG001|Overall Study|Death|35|||
23142202|NCT03010176|64270561|FG002|Overall Study|Death|19|||
23319210|NCT03284723|64912343|FG004|Overall Study|Withdrawal by Subject|5|||
23319211|NCT03284723|64912344|FG005|Overall Study|Withdrawal by Subject|3|||
23319212|NCT03284723|64912345|FG006|Overall Study|Withdrawal by Subject|1|||
23319213|NCT03284723|64912346|FG007|Overall Study|Withdrawal by Subject|0|||
23319214|NCT03284723|64912347|FG008|Overall Study|Withdrawal by Subject|6|||
23319215|NCT03284723|64912348|FG009|Overall Study|Withdrawal by Subject|0|||
23319216|NCT03284723|64912349|FG010|Overall Study|Withdrawal by Subject|3|||
23622655|NCT01193218|66005012|FG004|12-52 Weeks|Adverse Event|3|||
23622656|NCT01193218|66005013|FG005|12-52 Weeks|Adverse Event|3|||
23622657|NCT01193218|66005014|FG006|12-52 Weeks|Adverse Event|1|||
23622658|NCT01193218|66005015|FG007|12-52 Weeks|Adverse Event|2|||
23217059|NCT00094835|64534745|FG002|Overall Study|Physician Decision|0|||
23217060|NCT00094835|64534746|FG003|Overall Study|Physician Decision|0|||
23217061|NCT00094835|64534747|FG004|Overall Study|Physician Decision|0|||
23217062|NCT00094835|64534748|FG005|Overall Study|Physician Decision|1|||
23217063|NCT00094835|64534749|FG006|Overall Study|Physician Decision|0|||
23217064|NCT00094835|64534743|FG000|Overall Study|Withdrawal by Subject|0|||
23217065|NCT00094835|64534744|FG001|Overall Study|Withdrawal by Subject|0|||
23217066|NCT00094835|64534745|FG002|Overall Study|Withdrawal by Subject|0|||
23217067|NCT00094835|64534746|FG003|Overall Study|Withdrawal by Subject|0|||
23217068|NCT00094835|64534747|FG004|Overall Study|Withdrawal by Subject|0|||
23217069|NCT00094835|64534748|FG005|Overall Study|Withdrawal by Subject|0|||
23217070|NCT00094835|64534749|FG006|Overall Study|Withdrawal by Subject|1|||
23217071|NCT00094835|64534743|FG000|Overall Study|Lost to Follow-up|0|||
23217072|NCT00094835|64534744|FG001|Overall Study|Lost to Follow-up|0|||
23217073|NCT00094835|64534745|FG002|Overall Study|Lost to Follow-up|0|||
23217074|NCT00094835|64534746|FG003|Overall Study|Lost to Follow-up|0|||
23217075|NCT00094835|64534747|FG004|Overall Study|Lost to Follow-up|1|||
23217076|NCT00094835|64534748|FG005|Overall Study|Lost to Follow-up|0|||
23217077|NCT00094835|64534749|FG006|Overall Study|Lost to Follow-up|0|||
23217078|NCT00094835|64534743|FG000|Overall Study|Death|1|||
23217079|NCT00094835|64534744|FG001|Overall Study|Death|0|||
23217080|NCT00094835|64534745|FG002|Overall Study|Death|0|||
23217081|NCT00094835|64534746|FG003|Overall Study|Death|0|||
23217082|NCT00094835|64534747|FG004|Overall Study|Death|1|||
23217083|NCT00094835|64534748|FG005|Overall Study|Death|0|||
23217084|NCT00094835|64534749|FG006|Overall Study|Death|0|||
23217085|NCT00094835|64534743|FG000|Overall Study|Non-compliance|1|||
23217086|NCT00094835|64534744|FG001|Overall Study|Non-compliance|2|||
23217087|NCT00094835|64534745|FG002|Overall Study|Non-compliance|2|||
23217088|NCT00094835|64534746|FG003|Overall Study|Non-compliance|0|||
23217089|NCT00094835|64534747|FG004|Overall Study|Non-compliance|2|||
23319217|NCT03284723|64912350|FG011|Overall Study|Withdrawal by Subject|1|||
23217090|NCT00094835|64534748|FG005|Overall Study|Non-compliance|2|||
23217091|NCT00094835|64534749|FG006|Overall Study|Non-compliance|1|||
23217092|NCT00094835|64534743|FG000|Overall Study|Other|1|||
23217093|NCT00094835|64534744|FG001|Overall Study|Other|1|||
23217094|NCT00094835|64534745|FG002|Overall Study|Other|1|||
23217095|NCT00094835|64534746|FG003|Overall Study|Other|1|||
23217096|NCT00094835|64534747|FG004|Overall Study|Other|0|||
23217097|NCT00094835|64534748|FG005|Overall Study|Other|0|||
23217098|NCT00094835|64534749|FG006|Overall Study|Other|0|||
23217099|NCT01297309|64538196|FG000|Overall Study|Eligibility failure|2|||
23217100|NCT01297309|64538196|FG000|Overall Study|Screen failure|2|||
23217101|NCT01297309|64538196|FG000|Overall Study|Withdrawal by Subject|5|||
23319218|NCT03284723|64912339|FG000|Overall Study|Other|1|||
23142203|NCT03010176|64270562|FG003|Overall Study|Death|19|||
23142204|NCT03010176|64270563|FG004|Overall Study|Death|14|||
23142205|NCT03010176|64270564|FG005|Overall Study|Death|0|||
23142206|NCT03010176|64270559|FG000|Overall Study|Lost to Follow-up|0|||
23142207|NCT03010176|64270560|FG001|Overall Study|Lost to Follow-up|0|||
23142208|NCT03010176|64270561|FG002|Overall Study|Lost to Follow-up|0|||
23142209|NCT03010176|64270562|FG003|Overall Study|Lost to Follow-up|0|||
23142210|NCT03010176|64270563|FG004|Overall Study|Lost to Follow-up|1|||
23142211|NCT03010176|64270564|FG005|Overall Study|Lost to Follow-up|0|||
23142212|NCT03010176|64270559|FG000|Overall Study|Physician Decision|0|||
23142213|NCT03010176|64270560|FG001|Overall Study|Physician Decision|4|||
23142214|NCT03010176|64270561|FG002|Overall Study|Physician Decision|0|||
23142215|NCT03010176|64270562|FG003|Overall Study|Physician Decision|1|||
23142216|NCT03010176|64270563|FG004|Overall Study|Physician Decision|0|||
23142217|NCT03010176|64270564|FG005|Overall Study|Physician Decision|0|||
23217102|NCT01297309|64538196|FG000|Overall Study|Adverse Event|1|||
23217103|NCT01297309|64538196|FG000|Overall Study|Investigator Decision|2|||
23217104|NCT01297309|64538196|FG000|Overall Study|Death|1|||
23319219|NCT03284723|64912340|FG001|Overall Study|Other|0|||
23142218|NCT03010176|64270559|FG000|Overall Study|Sponsor Decision|0|||
23142219|NCT03010176|64270560|FG001|Overall Study|Sponsor Decision|4|||
23217105|NCT01297309|64538196|FG000|Overall Study|Participant not entering extensionperiod|1|||
23217106|NCT04702984|64538199|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
23217107|NCT01357889|64538200|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
23217108|NCT01357889|64538201|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
23142220|NCT03010176|64270561|FG002|Overall Study|Sponsor Decision|4|||
23142221|NCT03010176|64270562|FG003|Overall Study|Sponsor Decision|1|||
23217109|NCT01357889|64538200|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
23319220|NCT03284723|64912341|FG002|Overall Study|Other|1|||
23319221|NCT03284723|64912342|FG003|Overall Study|Other|0|||
23622659|NCT01193218|66005008|FG000|12-52 Weeks|Lack of Efficacy|0|||
23142222|NCT03010176|64270563|FG004|Overall Study|Sponsor Decision|6|||
23142223|NCT03010176|64270564|FG005|Overall Study|Sponsor Decision|0|||
23142224|NCT03010176|64270559|FG000|Overall Study|Withdrawal by Subject|11|||
23142225|NCT03010176|64270560|FG001|Overall Study|Withdrawal by Subject|9|||
23142226|NCT03010176|64270561|FG002|Overall Study|Withdrawal by Subject|3|||
23142227|NCT03010176|64270562|FG003|Overall Study|Withdrawal by Subject|0|||
23142228|NCT03010176|64270563|FG004|Overall Study|Withdrawal by Subject|4|||
23142229|NCT03010176|64270564|FG005|Overall Study|Withdrawal by Subject|0|||
23433172|NCT00599638|65330393|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
23433173|NCT00599638|65330390|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
23433174|NCT00599638|65330391|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
23433175|NCT00599638|65330392|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
23433176|NCT00599638|65330393|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
23433177|NCT00599638|65330390|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
23433178|NCT00599638|65330391|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
23433179|NCT00599638|65330392|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
23142230|NCT00682890|64270565|FG000|Overall Study|Lost to Follow-up|1|||
23142231|NCT00682890|64270566|FG001|Overall Study|Lost to Follow-up|1|||
23142232|NCT00682890|64270565|FG000|Overall Study|subject moved away|0|||
23142233|NCT00682890|64270566|FG001|Overall Study|subject moved away|1|||
23142234|NCT00682890|64270565|FG000|Overall Study|heavy menstrual bleeding|1|||
23142235|NCT00682890|64270566|FG001|Overall Study|heavy menstrual bleeding|0|||
23142236|NCT03401229|64270568|FG000|Overall Study|Lost to Follow-up|2|||
23142237|NCT03401229|64270569|FG001|Overall Study|Lost to Follow-up|1|||
23142238|NCT03401229|64270568|FG000|Overall Study|Other|1|||
23142239|NCT03401229|64270569|FG001|Overall Study|Other|3|||
23142240|NCT03401229|64270568|FG000|Overall Study|Adverse Event|8|||
23142241|NCT03401229|64270569|FG001|Overall Study|Adverse Event|6|||
23142242|NCT03401229|64270568|FG000|Overall Study|Withdrawal by Subject|29|||
23142243|NCT03401229|64270569|FG001|Overall Study|Withdrawal by Subject|26|||
23142244|NCT03401229|64270568|FG000|Overall Study|COVID-19|0|||
23142245|NCT03401229|64270569|FG001|Overall Study|COVID-19|1|||
23142246|NCT02502799|64270570|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
23142247|NCT02502799|64270571|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
23142248|NCT02502799|64270572|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
23142249|NCT02502799|64270573|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
23142250|NCT02502799|64270570|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
23142251|NCT02502799|64270571|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
23142252|NCT02502799|64270572|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
23142253|NCT02502799|64270573|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
23142254|NCT02502799|64270570|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
23142255|NCT02502799|64270571|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
23142256|NCT02502799|64270572|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
23142257|NCT02502799|64270573|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
23142258|NCT02502799|64270570|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
23142259|NCT02502799|64270571|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
23142260|NCT02502799|64270572|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
23142261|NCT02502799|64270573|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
23433180|NCT00599638|65330393|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
23319222|NCT03284723|64912343|FG004|Overall Study|Other|1|||
23142262|NCT02502799|64270570|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
23142263|NCT02502799|64270571|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
23142264|NCT02502799|64270572|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
23142265|NCT02502799|64270573|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
23142266|NCT00717067|64270574|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
23142267|NCT00717067|64270575|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
23142268|NCT00717067|64270576|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
23142269|NCT00717067|64270577|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
23142270|NCT00717067|64270578|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
23142271|NCT01012713|64270579|FG000|Overall Study|Lack of Efficacy|3|||
23142272|NCT02831387|64270580|FG000|Overall Study|Withdrawal by Subject|1|||
23142273|NCT02831387|64270581|FG001|Overall Study|Withdrawal by Subject|1|||
23217110|NCT01357889|64538201|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
23319223|NCT03284723|64912344|FG005|Overall Study|Other|0|||
23433181|NCT00599638|65330390|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
23622660|NCT01193218|66005009|FG001|12-52 Weeks|Lack of Efficacy|0|||
23142274|NCT02831387|64270580|FG000|Overall Study|Discontinued due to stock recovery|0|||
23142275|NCT02831387|64270581|FG001|Overall Study|Discontinued due to stock recovery|1|||
23142276|NCT03169101|64270584|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
23142277|NCT03169101|64270585|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
23142278|NCT03169101|64270586|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
23319224|NCT03284723|64912345|FG006|Overall Study|Other|0|||
23319225|NCT03284723|64912346|FG007|Overall Study|Other|0|||
23319226|NCT03284723|64912347|FG008|Overall Study|Other|0|||
23319227|NCT03284723|64912348|FG009|Overall Study|Other|0|||
23319228|NCT03284723|64912349|FG010|Overall Study|Other|1|||
23319229|NCT03284723|64912350|FG011|Overall Study|Other|0|||
23319230|NCT03284723|64912339|FG000|Overall Study|Adverse Event|0|||
23319231|NCT03284723|64912340|FG001|Overall Study|Adverse Event|0|||
23319232|NCT03284723|64912341|FG002|Overall Study|Adverse Event|0|||
23319233|NCT03284723|64912342|FG003|Overall Study|Adverse Event|0|||
23319234|NCT03284723|64912343|FG004|Overall Study|Adverse Event|0|||
23319235|NCT03284723|64912344|FG005|Overall Study|Adverse Event|0|||
23319236|NCT03284723|64912345|FG006|Overall Study|Adverse Event|0|||
23319237|NCT03284723|64912346|FG007|Overall Study|Adverse Event|0|||
23319238|NCT03284723|64912347|FG008|Overall Study|Adverse Event|1|||
23319239|NCT03284723|64912348|FG009|Overall Study|Adverse Event|0|||
23319240|NCT03284723|64912349|FG010|Overall Study|Adverse Event|0|||
23319241|NCT03284723|64912350|FG011|Overall Study|Adverse Event|0|||
23319242|NCT04071405|64912351|FG000|Overall Study|Protocol Violation|3|||
23319243|NCT04779879|64912352|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23319244|NCT04779879|64912353|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23319245|NCT04779879|64912354|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23319246|NCT04779879|64912355|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
23319247|NCT04779879|64912356|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23319248|NCT04779879|64912357|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
23319249|NCT04779879|64912352|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
23319250|NCT04779879|64912353|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
23319251|NCT04779879|64912354|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
23319252|NCT04779879|64912355|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
23319253|NCT04779879|64912356|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
23319254|NCT04779879|64912357|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
23622661|NCT01193218|66005010|FG002|12-52 Weeks|Lack of Efficacy|0|||
23622662|NCT01193218|66005011|FG003|12-52 Weeks|Lack of Efficacy|0|||
23622663|NCT01193218|66005012|FG004|12-52 Weeks|Lack of Efficacy|0|||
23622664|NCT01193218|66005013|FG005|12-52 Weeks|Lack of Efficacy|0|||
23622665|NCT01193218|66005014|FG006|12-52 Weeks|Lack of Efficacy|1|||
23622666|NCT01193218|66005015|FG007|12-52 Weeks|Lack of Efficacy|0|||
23217111|NCT01357889|64538200|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
23217112|NCT01357889|64538201|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
23217113|NCT01357889|64538200|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
23217114|NCT01357889|64538201|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
23217115|NCT01357889|64538200|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
23217116|NCT01357889|64538201|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
23217117|NCT01357889|64538200|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
23217118|NCT01357889|64538201|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
23217119|NCT01357889|64538200|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
23217120|NCT01357889|64538201|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
23217121|NCT01357889|64538200|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
23217122|NCT01357889|64538201|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
23217123|NCT01357889|64538200|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
23217124|NCT01357889|64538201|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
23217125|NCT01357889|64538200|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
23217126|NCT01357889|64538201|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
23217127|NCT01357889|64538200|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
23217128|NCT01357889|64538201|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
23217129|NCT01357889|64538200|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
23217130|NCT01357889|64538201|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
23217131|NCT01357889|64538200|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
23217132|NCT01357889|64538201|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
23217133|NCT00814307|64538207|FG000|Overall Study|Randomized but not treated|1|||
23217134|NCT00814307|64538208|FG001|Overall Study|Randomized but not treated|0|||
23217135|NCT00814307|64538209|FG002|Overall Study|Randomized but not treated|0|||
23217136|NCT00814307|64538210|FG003|Overall Study|Randomized but not treated|0|||
23217137|NCT00814307|64538207|FG000|Overall Study|Adverse Event|3|||
23217138|NCT00814307|64538208|FG001|Overall Study|Adverse Event|9|||
23217139|NCT00814307|64538209|FG002|Overall Study|Adverse Event|3|||
23217140|NCT00814307|64538210|FG003|Overall Study|Adverse Event|2|||
23319255|NCT04779879|64912352|FG000|Part C: Up to Week 36|Death|0|||
23319256|NCT04779879|64912353|FG001|Part C: Up to Week 36|Death|0|||
23319257|NCT04779879|64912354|FG002|Part C: Up to Week 36|Death|0|||
23319258|NCT04779879|64912355|FG003|Part C: Up to Week 36|Death|0|||
23217141|NCT00814307|64538207|FG000|Overall Study|Lack of Efficacy|1|||
23217142|NCT00814307|64538208|FG001|Overall Study|Lack of Efficacy|1|||
23319259|NCT04779879|64912356|FG004|Part C: Up to Week 36|Death|0|||
23622667|NCT01193218|66005008|FG000|12-52 Weeks|Withdrawal by Subject|3|||
23142279|NCT03169101|64270587|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
23142280|NCT02910739|64270588|FG000|Overall Study|Adverse Event|1|||
23142281|NCT02910739|64270589|FG001|Overall Study|Adverse Event|0|||
23142282|NCT02910739|64270590|FG002|Overall Study|Adverse Event|0|||
23142283|NCT02910739|64270591|FG003|Overall Study|Adverse Event|0|||
23142284|NCT00055601|64270592|FG000|Overall Study|Protocol Violation|1|||
23142285|NCT00055601|64270593|FG001|Overall Study|Protocol Violation|1|||
23142286|NCT00055601|64270592|FG000|Overall Study|No protocol treatment received|1|||
23142287|NCT00055601|64270593|FG001|Overall Study|No protocol treatment received|1|||
23142288|NCT00552240|64270597|FG000|Overall Study|Adverse Event|9|||
23142289|NCT00552240|64270598|FG001|Overall Study|Adverse Event|9|||
23142290|NCT00552240|64270597|FG000|Overall Study|Protocol Violation|1|||
23142291|NCT00552240|64270598|FG001|Overall Study|Protocol Violation|1|||
23142292|NCT00552240|64270597|FG000|Overall Study|Lost to Follow-up|5|||
23142293|NCT00552240|64270598|FG001|Overall Study|Lost to Follow-up|6|||
23142294|NCT00552240|64270597|FG000|Overall Study|Withdrawal by Subject|2|||
23142295|NCT00552240|64270598|FG001|Overall Study|Withdrawal by Subject|2|||
23142296|NCT00552240|64270597|FG000|Overall Study|Lack of Efficacy|6|||
23217143|NCT00814307|64538209|FG002|Overall Study|Lack of Efficacy|3|||
23319260|NCT04779879|64912357|FG005|Part C: Up to Week 36|Death|1|||
23319261|NCT04779879|64912352|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
23319262|NCT04779879|64912353|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
23319263|NCT04779879|64912354|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
23319264|NCT04779879|64912355|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
23319265|NCT04779879|64912356|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
23319266|NCT04779879|64912357|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
23319267|NCT01277211|64912358|FG000|Overall Study|Adverse Event|60|||
23319268|NCT01277211|64912359|FG001|Overall Study|Adverse Event|22|||
23319269|NCT01277211|64912358|FG000|Overall Study|Pregnancy|9|||
23319270|NCT01277211|64912359|FG001|Overall Study|Pregnancy|4|||
23319271|NCT01277211|64912358|FG000|Overall Study|Lost to Follow-up|14|||
23319272|NCT01277211|64912359|FG001|Overall Study|Lost to Follow-up|9|||
23319273|NCT01277211|64912358|FG000|Overall Study|Did not wish to continue|17|||
23319274|NCT01277211|64912359|FG001|Overall Study|Did not wish to continue|0|||
23319275|NCT01277211|64912358|FG000|Overall Study|Withdrew Consent|9|||
23319276|NCT01277211|64912359|FG001|Overall Study|Withdrew Consent|9|||
23319277|NCT01277211|64912358|FG000|Overall Study|Non-compliance with protocol|13|||
23319278|NCT01277211|64912359|FG001|Overall Study|Non-compliance with protocol|4|||
23319279|NCT01277211|64912358|FG000|Overall Study|Did not meet protocol eligibility|1|||
23319280|NCT01277211|64912359|FG001|Overall Study|Did not meet protocol eligibility|0|||
23319281|NCT01277211|64912358|FG000|Overall Study|Administrative|3|||
23319282|NCT01277211|64912359|FG001|Overall Study|Administrative|0|||
23319283|NCT01277211|64912358|FG000|Overall Study|Pregnancy wish|0|||
23319284|NCT01277211|64912359|FG001|Overall Study|Pregnancy wish|2|||
23319285|NCT01277211|64912358|FG000|Overall Study|Discontinued prior to treatment|24|||
23319286|NCT01277211|64912359|FG001|Overall Study|Discontinued prior to treatment|13|||
23319287|NCT02181790|64912361|FG000|Overall Study|study terminated|2|||
23319288|NCT02181790|64912362|FG001|Overall Study|study terminated|0|||
23319289|NCT00474266|64912368|FG000|Overall Study|Withdrawal by Subject|7|||
23319290|NCT00474266|64912369|FG001|Overall Study|Withdrawal by Subject|20|||
23319291|NCT00474266|64912370|FG002|Overall Study|Withdrawal by Subject|4|||
23319292|NCT00474266|64912371|FG003|Overall Study|Withdrawal by Subject|7|||
23319293|NCT02368314|64912372|FG000|Overall Study|Withdrawal by Subject|2|||
23319294|NCT02368314|64912373|FG001|Overall Study|Withdrawal by Subject|1|||
23319295|NCT02368314|64912372|FG000|Overall Study|Adverse Event|1|||
23319296|NCT02368314|64912373|FG001|Overall Study|Adverse Event|2|||
23319297|NCT03624192|64912374|FG000|Overall Study|Lost to Follow-up|1|||
23319298|NCT03624192|64912375|FG001|Overall Study|Lost to Follow-up|1|||
23319299|NCT00591773|64912378|FG000|Overall Study|Adverse Event|9|||
23319300|NCT00591773|64912379|FG001|Overall Study|Adverse Event|9|||
23319301|NCT00591773|64912380|FG002|Overall Study|Adverse Event|6|||
23319302|NCT00591773|64912378|FG000|Overall Study|Protocol Violation|2|||
23319303|NCT00591773|64912379|FG001|Overall Study|Protocol Violation|3|||
23319304|NCT00591773|64912380|FG002|Overall Study|Protocol Violation|0|||
23319305|NCT00591773|64912378|FG000|Overall Study|Lost to Follow-up|1|||
23319306|NCT00591773|64912379|FG001|Overall Study|Lost to Follow-up|4|||
23319307|NCT00591773|64912380|FG002|Overall Study|Lost to Follow-up|1|||
23319308|NCT00591773|64912378|FG000|Overall Study|Withdrawal by Subject|2|||
23319309|NCT00591773|64912379|FG001|Overall Study|Withdrawal by Subject|5|||
23319310|NCT00591773|64912380|FG002|Overall Study|Withdrawal by Subject|3|||
23319311|NCT00591773|64912378|FG000|Overall Study|Lack of Efficacy|1|||
23142297|NCT00552240|64270598|FG001|Overall Study|Lack of Efficacy|0|||
23142298|NCT00552240|64270597|FG000|Overall Study|Other|1|||
23142299|NCT00552240|64270598|FG001|Overall Study|Other|0|||
23142300|NCT03271021|64270600|FG000|Overall Study|Adverse Event|3|||
23319312|NCT00591773|64912379|FG001|Overall Study|Lack of Efficacy|2|||
23319313|NCT00591773|64912380|FG002|Overall Study|Lack of Efficacy|2|||
23319314|NCT00591773|64912378|FG000|Overall Study|Other|1|||
23319315|NCT00591773|64912379|FG001|Overall Study|Other|1|||
23319316|NCT00591773|64912380|FG002|Overall Study|Other|4|||
23319317|NCT02620579|64912381|FG000|Overall Study|Physician Decision|0|||
23319318|NCT02620579|64912382|FG001|Overall Study|Physician Decision|0|||
23319319|NCT02620579|64912383|FG002|Overall Study|Physician Decision|0|||
23142301|NCT03271021|64270601|FG001|Overall Study|Adverse Event|2|||
23142302|NCT03271021|64270600|FG000|Overall Study|Withdrawal by Subject|36|||
23142303|NCT03271021|64270601|FG001|Overall Study|Withdrawal by Subject|53|||
23142304|NCT03271021|64270600|FG000|Overall Study|Lost to Follow-up|34|||
23142305|NCT03271021|64270601|FG001|Overall Study|Lost to Follow-up|39|||
23142306|NCT03271021|64270600|FG000|Overall Study|Protocol Violation|6|||
23142307|NCT03271021|64270601|FG001|Overall Study|Protocol Violation|4|||
23142308|NCT03271021|64270600|FG000|Overall Study|Abnormal Lab Results|1|||
23142309|NCT03271021|64270601|FG001|Overall Study|Abnormal Lab Results|0|||
23142310|NCT03271021|64270600|FG000|Overall Study|Miscellaneous|9|||
23142311|NCT03271021|64270601|FG001|Overall Study|Miscellaneous|8|||
23142312|NCT01074216|64270602|FG000|Overall Study|Physician Decision|1|||
23142313|NCT01074216|64270602|FG000|Overall Study|Not Treated|12|||
23142314|NCT01226095|64270603|FG000|Overall Study|Poor compliance|1|||
23142315|NCT01853644|64270604|FG000|Registration and Treatment Start|Did not start treatment|1|||
23142316|NCT01853644|64270604|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
23142317|NCT01853644|64270604|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
23142318|NCT01853644|64270604|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
23142319|NCT01853644|64270604|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
23142320|NCT01853644|64270604|FG000|Continued Treatment After First Response|Adverse Event|2|||
23142321|NCT01853644|64270604|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
23142322|NCT02009761|64270605|FG000|Overall Study|Adverse Event|4|||
23142323|NCT02134977|64270606|FG000|Overall Study|Protocol Deviation|102|||
23142324|NCT04375761|64270609|FG000|Overall Study|Death|1|||
23142325|NCT04375761|64270610|FG001|Overall Study|Death|2|||
23142326|NCT04375761|64270609|FG000|Overall Study|Lost to Follow-up|203|||
23142327|NCT04375761|64270610|FG001|Overall Study|Lost to Follow-up|380|||
23142328|NCT04375761|64270609|FG000|Overall Study|Withdrawal by Subject|47|||
23142329|NCT04375761|64270610|FG001|Overall Study|Withdrawal by Subject|98|||
23142330|NCT04375761|64270609|FG000|Overall Study|Noncompliance with study procedure|121|||
23142331|NCT04375761|64270610|FG001|Overall Study|Noncompliance with study procedure|251|||
23142332|NCT04375761|64270609|FG000|Overall Study|Reimbursement not enough|1|||
23142333|NCT04375761|64270610|FG001|Overall Study|Reimbursement not enough|2|||
23142334|NCT04375761|64270609|FG000|Overall Study|Unforeseen family circumstances|1|||
23217144|NCT00814307|64538210|FG003|Overall Study|Lack of Efficacy|4|||
23217145|NCT00814307|64538207|FG000|Overall Study|Other|1|||
23217146|NCT00814307|64538208|FG001|Overall Study|Other|2|||
23217147|NCT00814307|64538209|FG002|Overall Study|Other|0|||
23217148|NCT00814307|64538210|FG003|Overall Study|Other|1|||
23217149|NCT00814307|64538207|FG000|Overall Study|Protocol Violation|2|||
23622668|NCT01193218|66005009|FG001|12-52 Weeks|Withdrawal by Subject|0|||
23217150|NCT00814307|64538208|FG001|Overall Study|Protocol Violation|8|||
23217151|NCT00814307|64538209|FG002|Overall Study|Protocol Violation|1|||
23319320|NCT02620579|64912384|FG003|Overall Study|Physician Decision|1|||
23319321|NCT02620579|64912381|FG000|Overall Study|Withdrawal by Subject|0|||
23319322|NCT02620579|64912382|FG001|Overall Study|Withdrawal by Subject|1|||
23319323|NCT02620579|64912383|FG002|Overall Study|Withdrawal by Subject|1|||
23319324|NCT02620579|64912384|FG003|Overall Study|Withdrawal by Subject|0|||
23319325|NCT02652949|64912386|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
23319326|NCT02652949|64912386|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
23319327|NCT02652949|64912386|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
23319328|NCT02652949|64912386|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
23319329|NCT02652949|64912386|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
23319330|NCT02652949|64912386|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
23319331|NCT02652949|64912386|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
23319332|NCT02652949|64912386|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
23319333|NCT02652949|64912386|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
23319334|NCT02652949|64912386|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
23319335|NCT02652949|64912386|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
23319336|NCT02652949|64912386|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
23319337|NCT02652949|64912386|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
23622669|NCT01193218|66005010|FG002|12-52 Weeks|Withdrawal by Subject|3|||
23622670|NCT01193218|66005011|FG003|12-52 Weeks|Withdrawal by Subject|0|||
23142335|NCT04375761|64270610|FG001|Overall Study|Unforeseen family circumstances|3|||
23142336|NCT04375761|64270609|FG000|Overall Study|Test too painful|1|||
23142337|NCT04375761|64270610|FG001|Overall Study|Test too painful|1|||
23142338|NCT04375761|64270609|FG000|Overall Study|Moved|0|||
23217152|NCT00814307|64538210|FG003|Overall Study|Protocol Violation|1|||
23217153|NCT00814307|64538207|FG000|Overall Study|Withdrawal by Subject|4|||
23217154|NCT00814307|64538208|FG001|Overall Study|Withdrawal by Subject|6|||
23217155|NCT00814307|64538209|FG002|Overall Study|Withdrawal by Subject|0|||
23622671|NCT01193218|66005012|FG004|12-52 Weeks|Withdrawal by Subject|0|||
23622672|NCT01193218|66005013|FG005|12-52 Weeks|Withdrawal by Subject|2|||
23622673|NCT01193218|66005014|FG006|12-52 Weeks|Withdrawal by Subject|1|||
23622674|NCT01193218|66005015|FG007|12-52 Weeks|Withdrawal by Subject|2|||
23622675|NCT01193218|66005008|FG000|12-52 Weeks|Other reason than above|1|||
23622676|NCT01193218|66005009|FG001|12-52 Weeks|Other reason than above|0|||
23622677|NCT01193218|66005010|FG002|12-52 Weeks|Other reason than above|0|||
23622678|NCT01193218|66005011|FG003|12-52 Weeks|Other reason than above|1|||
23622679|NCT01193218|66005012|FG004|12-52 Weeks|Other reason than above|1|||
23622680|NCT01193218|66005013|FG005|12-52 Weeks|Other reason than above|0|||
23622681|NCT01193218|66005014|FG006|12-52 Weeks|Other reason than above|0|||
23622682|NCT01193218|66005015|FG007|12-52 Weeks|Other reason than above|0|||
23319338|NCT02652949|64912386|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
23319339|NCT02652949|64912386|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
23319340|NCT02652949|64912386|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
23319341|NCT02652949|64912386|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
23433182|NCT00599638|65330391|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
23433183|NCT00599638|65330392|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
23433184|NCT00599638|65330393|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
23433185|NCT00599638|65330390|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
23433186|NCT00599638|65330391|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
23433187|NCT00599638|65330392|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
23433188|NCT00599638|65330393|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
23433189|NCT00599638|65330390|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
23433190|NCT00599638|65330391|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
23433191|NCT00599638|65330392|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
23319342|NCT02498392|64912389|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
23319343|NCT02498392|64912390|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
23319344|NCT02498392|64912389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
23433192|NCT00599638|65330393|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
23433193|NCT00599638|65330390|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
23433194|NCT00599638|65330391|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
23433195|NCT00599638|65330392|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
23142339|NCT04375761|64270610|FG001|Overall Study|Moved|2|||
23142340|NCT04375761|64270609|FG000|Overall Study|Nonresponsive|0|||
23142341|NCT04375761|64270610|FG001|Overall Study|Nonresponsive|5|||
23142342|NCT02951767|64270611|FG000|Overall Study|Study Terminated By Sponsor|9|||
23142343|NCT02951767|64270611|FG000|Overall Study|Withdrawal by Subject|11|||
23142344|NCT02951767|64270611|FG000|Overall Study|Death|96|||
23142345|NCT02951767|64270611|FG000|Overall Study|Lost to Follow-up|2|||
23142346|NCT02951767|64270611|FG000|Overall Study|Physician Decision|1|||
23142347|NCT00775463|64270612|FG000|Overall Study|Withdrawal by Subject|0|||
23142348|NCT00775463|64270613|FG001|Overall Study|Withdrawal by Subject|1|||
23142349|NCT00775463|64270612|FG000|Overall Study|Adverse Event|7|||
23142350|NCT00775463|64270613|FG001|Overall Study|Adverse Event|9|||
23142351|NCT00775463|64270612|FG000|Overall Study|Protocol Violation|2|||
23142352|NCT00775463|64270613|FG001|Overall Study|Protocol Violation|2|||
23142353|NCT00775463|64270612|FG000|Overall Study|Lost to Follow-up|1|||
23142354|NCT00775463|64270613|FG001|Overall Study|Lost to Follow-up|0|||
23142355|NCT00775463|64270612|FG000|Overall Study|Lack of Efficacy|1|||
23142356|NCT00775463|64270613|FG001|Overall Study|Lack of Efficacy|1|||
23142357|NCT01773291|64270614|FG000|Overall Study|Protocol Violation|1|||
23142358|NCT01773291|64270615|FG001|Overall Study|Protocol Violation|0|||
23142359|NCT01773291|64270616|FG002|Overall Study|Protocol Violation|0|||
23142360|NCT01773291|64270614|FG000|Overall Study|Withdrawal by Subject|0|||
23142361|NCT01773291|64270615|FG001|Overall Study|Withdrawal by Subject|0|||
23142362|NCT01773291|64270616|FG002|Overall Study|Withdrawal by Subject|1|||
23433196|NCT00599638|65330393|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
23433197|NCT00599638|65330390|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
23433198|NCT00599638|65330391|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
23622683|NCT02561078|66005016|FG000|Overall Study|Adverse Event|5|||
23622684|NCT02561078|66005017|FG001|Overall Study|Adverse Event|2|||
23622685|NCT02561078|66005016|FG000|Overall Study|Death|2|||
23622686|NCT02561078|66005017|FG001|Overall Study|Death|1|||
23622687|NCT02561078|66005016|FG000|Overall Study|Lost to Follow-up|2|||
23622688|NCT02561078|66005017|FG001|Overall Study|Lost to Follow-up|6|||
23622689|NCT02561078|66005016|FG000|Overall Study|Non-Compliance with Study Drug|6|||
23622690|NCT02561078|66005017|FG001|Overall Study|Non-Compliance with Study Drug|3|||
23622691|NCT02561078|66005016|FG000|Overall Study|Physician Decision|2|||
23622692|NCT02561078|66005017|FG001|Overall Study|Physician Decision|3|||
23622693|NCT02561078|66005016|FG000|Overall Study|Withdrawal by Subject|13|||
23142363|NCT04882995|64270617|FG000|Overall Study|Withdrawal by Subject|1|||
23142364|NCT04882995|64270618|FG001|Overall Study|Withdrawal by Subject|2|||
23622694|NCT02561078|66005017|FG001|Overall Study|Withdrawal by Subject|10|||
23319345|NCT02498392|64912390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
23319346|NCT02498392|64912389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
23319347|NCT02498392|64912390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
23142365|NCT04882995|64270617|FG000|Overall Study|Protocol Violation|4|||
23142366|NCT04882995|64270618|FG001|Overall Study|Protocol Violation|4|||
23142367|NCT04882995|64270617|FG000|Overall Study|Surgery postponed due to COVID|1|||
23142368|NCT04882995|64270618|FG001|Overall Study|Surgery postponed due to COVID|1|||
23142369|NCT02924428|64270619|FG000|Overall Study|Adverse Event|1|||
23142370|NCT02924428|64270620|FG001|Overall Study|Adverse Event|0|||
23142371|NCT02924428|64270619|FG000|Overall Study|Physician Decision|1|||
23142372|NCT02924428|64270620|FG001|Overall Study|Physician Decision|0|||
23142373|NCT02924428|64270619|FG000|Overall Study|Lost to Follow-up|2|||
23622695|NCT01227928|66005018|FG000|Overall Study|Lost to Follow-up|4|||
23622696|NCT01227928|66005019|FG001|Overall Study|Lost to Follow-up|2|||
23622697|NCT01227928|66005018|FG000|Overall Study|Withdrawal by Subject|4|||
23319348|NCT02498392|64912389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
23319349|NCT02498392|64912390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
23622698|NCT01227928|66005019|FG001|Overall Study|Withdrawal by Subject|3|||
23622699|NCT01227928|66005018|FG000|Overall Study|Death|14|||
23622700|NCT01227928|66005019|FG001|Overall Study|Death|12|||
23622701|NCT00713206|66005020|FG000|Overall Study|Lost to Follow-up|4|||
23622702|NCT00713206|66005021|FG001|Overall Study|Lost to Follow-up|4|||
23622703|NCT00713206|66005020|FG000|Overall Study|Death|1|||
23622704|NCT00713206|66005021|FG001|Overall Study|Death|0|||
23622705|NCT03082612|66005022|FG000|Overall Study|Lost to Follow-up|2|||
23622706|NCT03082612|66005023|FG001|Overall Study|Lost to Follow-up|0|||
23622707|NCT01845649|66005024|FG000|Overall Study|Adverse Event|7|||
23622708|NCT01845649|66005025|FG001|Overall Study|Adverse Event|10|||
23622709|NCT01845649|66005024|FG000|Overall Study|Lack of Efficacy|1|||
23622710|NCT01845649|66005025|FG001|Overall Study|Lack of Efficacy|1|||
23622711|NCT01845649|66005024|FG000|Overall Study|Lost to Follow-up|2|||
23622712|NCT01845649|66005025|FG001|Overall Study|Lost to Follow-up|2|||
23622713|NCT01845649|66005024|FG000|Overall Study|Withdrew Consent|12|||
23622714|NCT01845649|66005025|FG001|Overall Study|Withdrew Consent|4|||
23622715|NCT01845649|66005024|FG000|Overall Study|Protocol Deviation|7|||
23622716|NCT01845649|66005025|FG001|Overall Study|Protocol Deviation|4|||
23622717|NCT01845649|66005024|FG000|Overall Study|Reason not Specified|2|||
23622718|NCT01845649|66005025|FG001|Overall Study|Reason not Specified|1|||
23622719|NCT02037256|66005026|FG000|Overall Study|Protocol Violation|0|||
23622720|NCT02037256|66005027|FG001|Overall Study|Protocol Violation|1|||
23622721|NCT02037256|66005026|FG000|Overall Study|Withdrawn prior to Velcade|0|||
23622722|NCT02037256|66005027|FG001|Overall Study|Withdrawn prior to Velcade|2|||
23622723|NCT03305809|66005028|FG000|Overall Study|Adverse Event|2|||
23622724|NCT03305809|66005029|FG001|Overall Study|Adverse Event|2|||
23622725|NCT03305809|66005030|FG002|Overall Study|Adverse Event|6|||
23622726|NCT03305809|66005031|FG003|Overall Study|Adverse Event|6|||
23622727|NCT03305809|66005028|FG000|Overall Study|Death|0|||
23622728|NCT03305809|66005029|FG001|Overall Study|Death|0|||
23622729|NCT03305809|66005030|FG002|Overall Study|Death|1|||
23622730|NCT03305809|66005031|FG003|Overall Study|Death|1|||
23622731|NCT03305809|66005028|FG000|Overall Study|Lost to Follow-up|1|||
23622732|NCT03305809|66005029|FG001|Overall Study|Lost to Follow-up|2|||
23319350|NCT02498392|64912389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
23319351|NCT02498392|64912390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
23622733|NCT03305809|66005030|FG002|Overall Study|Lost to Follow-up|0|||
23622734|NCT03305809|66005031|FG003|Overall Study|Lost to Follow-up|0|||
23622735|NCT03305809|66005028|FG000|Overall Study|Sponsor Decision|1|||
23622736|NCT03305809|66005029|FG001|Overall Study|Sponsor Decision|0|||
23622737|NCT03305809|66005030|FG002|Overall Study|Sponsor Decision|1|||
23622738|NCT03305809|66005031|FG003|Overall Study|Sponsor Decision|8|||
23622739|NCT03305809|66005028|FG000|Overall Study|Physician Decision|0|||
23622740|NCT03305809|66005029|FG001|Overall Study|Physician Decision|0|||
23622741|NCT03305809|66005030|FG002|Overall Study|Physician Decision|2|||
23622742|NCT03305809|66005031|FG003|Overall Study|Physician Decision|4|||
23622743|NCT03305809|66005028|FG000|Overall Study|Progressive Disease|0|||
23622744|NCT03305809|66005029|FG001|Overall Study|Progressive Disease|0|||
23622745|NCT03305809|66005030|FG002|Overall Study|Progressive Disease|1|||
23142374|NCT02924428|64270620|FG001|Overall Study|Lost to Follow-up|4|||
23622746|NCT03305809|66005031|FG003|Overall Study|Progressive Disease|0|||
23142375|NCT02924428|64270619|FG000|Overall Study|Pregnancy|0|||
23142376|NCT02924428|64270620|FG001|Overall Study|Pregnancy|1|||
23622747|NCT03305809|66005028|FG000|Overall Study|Protocol Violation|1|||
23622748|NCT03305809|66005029|FG001|Overall Study|Protocol Violation|0|||
23622749|NCT03305809|66005030|FG002|Overall Study|Protocol Violation|2|||
23622750|NCT03305809|66005031|FG003|Overall Study|Protocol Violation|3|||
23622751|NCT03305809|66005028|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
23622752|NCT03305809|66005029|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
23622753|NCT03305809|66005030|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
23622754|NCT03305809|66005031|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
23622755|NCT03305809|66005028|FG000|Overall Study|Withdrawal by Subject|2|||
23622756|NCT03305809|66005029|FG001|Overall Study|Withdrawal by Subject|4|||
23622757|NCT03305809|66005030|FG002|Overall Study|Withdrawal by Subject|5|||
23622758|NCT03305809|66005031|FG003|Overall Study|Withdrawal by Subject|2|||
23622759|NCT03305809|66005028|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
23622760|NCT03305809|66005029|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
23622761|NCT03305809|66005030|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
23622762|NCT03305809|66005031|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
23622763|NCT01316887|66005032|FG000|Overall Study|Adverse Event|13|||
23622764|NCT01316887|66005033|FG001|Overall Study|Adverse Event|21|||
23622765|NCT01316887|66005034|FG002|Overall Study|Adverse Event|17|||
23622766|NCT01316887|66005032|FG000|Overall Study|Lack of Efficacy|9|||
23622767|NCT01316887|66005033|FG001|Overall Study|Lack of Efficacy|3|||
23622768|NCT01316887|66005034|FG002|Overall Study|Lack of Efficacy|1|||
23622769|NCT01316887|66005032|FG000|Overall Study|Protocol Violation|2|||
23622770|NCT01316887|66005033|FG001|Overall Study|Protocol Violation|6|||
23622771|NCT01316887|66005034|FG002|Overall Study|Protocol Violation|6|||
23622772|NCT01316887|66005032|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
23622773|NCT01316887|66005033|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
23622774|NCT01316887|66005034|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
23622775|NCT01316887|66005032|FG000|Overall Study|Study Closed/Terminated|2|||
23622776|NCT01316887|66005033|FG001|Overall Study|Study Closed/Terminated|4|||
23622777|NCT01316887|66005034|FG002|Overall Study|Study Closed/Terminated|3|||
23622778|NCT01316887|66005032|FG000|Overall Study|Lost to Follow-up|1|||
23622779|NCT01316887|66005033|FG001|Overall Study|Lost to Follow-up|7|||
23622780|NCT01316887|66005034|FG002|Overall Study|Lost to Follow-up|5|||
23622781|NCT01316887|66005032|FG000|Overall Study|Withdrawal by Subject|8|||
23622782|NCT01316887|66005033|FG001|Overall Study|Withdrawal by Subject|16|||
23622783|NCT01316887|66005034|FG002|Overall Study|Withdrawal by Subject|15|||
23622784|NCT02175745|66005036|FG000|Overall Study|Not Eligible|1|||
23622785|NCT05043883|66005037|FG000|Overall Study|Minimum required measurements could not be taken|4|||
23622786|NCT00043186|66005040|FG000|Overall Study|Physician Decision|0|||
23622787|NCT00043186|66005041|FG001|Overall Study|Physician Decision|0|||
23622788|NCT00043186|66005042|FG002|Overall Study|Physician Decision|3|||
23622789|NCT00043186|66005043|FG003|Overall Study|Physician Decision|0|||
23622790|NCT00043186|66005044|FG004|Overall Study|Physician Decision|1|||
23622791|NCT00043186|66005045|FG005|Overall Study|Physician Decision|0|||
23622792|NCT00043186|66005046|FG006|Overall Study|Physician Decision|0|||
23622793|NCT00043186|66005047|FG007|Overall Study|Physician Decision|1|||
23622794|NCT00043186|66005048|FG008|Overall Study|Physician Decision|1|||
23622795|NCT00043186|66005040|FG000|Overall Study|Adverse Event|2|||
23622796|NCT00043186|66005041|FG001|Overall Study|Adverse Event|2|||
23622797|NCT00043186|66005042|FG002|Overall Study|Adverse Event|2|||
23622798|NCT00043186|66005043|FG003|Overall Study|Adverse Event|3|||
23622799|NCT00043186|66005044|FG004|Overall Study|Adverse Event|2|||
23622800|NCT00043186|66005045|FG005|Overall Study|Adverse Event|1|||
23622801|NCT00043186|66005046|FG006|Overall Study|Adverse Event|2|||
23622802|NCT00043186|66005047|FG007|Overall Study|Adverse Event|1|||
23622803|NCT00043186|66005048|FG008|Overall Study|Adverse Event|3|||
23622804|NCT00043186|66005040|FG000|Overall Study|Withdrawal by Subject|11|||
23622805|NCT00043186|66005041|FG001|Overall Study|Withdrawal by Subject|8|||
23622806|NCT00043186|66005042|FG002|Overall Study|Withdrawal by Subject|11|||
23622807|NCT00043186|66005043|FG003|Overall Study|Withdrawal by Subject|13|||
23622808|NCT00043186|66005044|FG004|Overall Study|Withdrawal by Subject|14|||
23622809|NCT00043186|66005045|FG005|Overall Study|Withdrawal by Subject|6|||
23622810|NCT00043186|66005046|FG006|Overall Study|Withdrawal by Subject|12|||
23622811|NCT00043186|66005047|FG007|Overall Study|Withdrawal by Subject|9|||
23622812|NCT00043186|66005048|FG008|Overall Study|Withdrawal by Subject|10|||
23622813|NCT00043186|66005040|FG000|Overall Study|Death|0|||
23622814|NCT00043186|66005041|FG001|Overall Study|Death|0|||
23622815|NCT00043186|66005042|FG002|Overall Study|Death|1|||
23622816|NCT00043186|66005043|FG003|Overall Study|Death|0|||
23622817|NCT00043186|66005044|FG004|Overall Study|Death|0|||
23622818|NCT00043186|66005045|FG005|Overall Study|Death|0|||
23622819|NCT00043186|66005046|FG006|Overall Study|Death|2|||
23622820|NCT00043186|66005047|FG007|Overall Study|Death|0|||
23622821|NCT00043186|66005048|FG008|Overall Study|Death|0|||
23622822|NCT00043186|66005040|FG000|Overall Study|Disease progression|1|||
23622823|NCT00043186|66005041|FG001|Overall Study|Disease progression|0|||
23622824|NCT00043186|66005042|FG002|Overall Study|Disease progression|0|||
23622825|NCT00043186|66005043|FG003|Overall Study|Disease progression|3|||
23622826|NCT00043186|66005044|FG004|Overall Study|Disease progression|0|||
23622827|NCT00043186|66005045|FG005|Overall Study|Disease progression|0|||
23622828|NCT00043186|66005046|FG006|Overall Study|Disease progression|0|||
23622829|NCT00043186|66005047|FG007|Overall Study|Disease progression|4|||
23622830|NCT00043186|66005048|FG008|Overall Study|Disease progression|0|||
23622831|NCT00043186|66005040|FG000|Overall Study|Ineligibility determined|0|||
23433199|NCT00599638|65330392|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
23433200|NCT00599638|65330393|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
23433201|NCT00599638|65330390|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
23319352|NCT02498392|64912389|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
23622832|NCT00043186|66005041|FG001|Overall Study|Ineligibility determined|0|||
23622833|NCT00043186|66005042|FG002|Overall Study|Ineligibility determined|0|||
23622834|NCT00043186|66005043|FG003|Overall Study|Ineligibility determined|0|||
23622835|NCT00043186|66005044|FG004|Overall Study|Ineligibility determined|0|||
23319353|NCT02498392|64912390|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
23319354|NCT02430480|64912391|FG000|Overall Study|Death|1|||
23319355|NCT02430480|64912391|FG000|Overall Study|Anesthesia concerns|1|||
23319356|NCT02430480|64912391|FG000|Overall Study|Progressed on treatment|1|||
23319357|NCT02503787|64912392|FG000|Enrollment|Withdrawal by Subject|6|||
23319358|NCT02503787|64912392|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
23319359|NCT02503787|64912392|FG000|Enrollment|Physician Decision|2|||
23319360|NCT02503787|64912392|FG000|Enrollment|Insurance issue|2|||
23319361|NCT02503787|64912392|FG000|Enrollment|Lost to Follow-up|1|||
23319362|NCT02503787|64912392|FG000|Enrollment|Study closure|1|||
23319363|NCT02503787|64912392|FG000|Enrollment|Adverse Event|1|||
23319364|NCT02503787|64912392|FG000|Enrollment|Protocol Violation|1|||
23622836|NCT00043186|66005045|FG005|Overall Study|Ineligibility determined|0|||
23622837|NCT00043186|66005046|FG006|Overall Study|Ineligibility determined|0|||
23622838|NCT00043186|66005047|FG007|Overall Study|Ineligibility determined|0|||
23622839|NCT00043186|66005048|FG008|Overall Study|Ineligibility determined|1|||
23142377|NCT00812331|64270621|FG000|Overall Study|Adverse Event|1|||
23319365|NCT02503787|64912392|FG000|Enrollment|Inability to implant system|1|||
23319366|NCT02503787|64912392|FG000|Enrollment|Unable to be programmed|1|||
23319367|NCT02503787|64912392|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
23319368|NCT02503787|64912392|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
23319369|NCT02503787|64912392|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
23319370|NCT02503787|64912392|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
23319371|NCT02503787|64912392|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
23319372|NCT02503787|64912392|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
23319373|NCT00524420|64912393|FG000|Overall Study|Lack of Efficacy|1|||
23319374|NCT00524420|64912394|FG001|Overall Study|Lack of Efficacy|0|||
23319375|NCT00104572|64912403|FG000|Overall Study|Withdrawal by Subject|3|||
23319376|NCT00104572|64912404|FG001|Overall Study|Withdrawal by Subject|3|||
23319377|NCT00104572|64912405|FG002|Overall Study|Withdrawal by Subject|0|||
23319378|NCT00314951|64912406|FG000|Treatment|Didn't meet criteria for mITT population|16|||
23319379|NCT00314951|64912407|FG001|Treatment|Didn't meet criteria for mITT population|11|||
23319380|NCT00314951|64912406|FG000|Follow-up|mITT failure|44|||
23319381|NCT00314951|64912407|FG001|Follow-up|mITT failure|34|||
23319382|NCT00193050|64912409|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
23319383|NCT00193050|64912409|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
23319384|NCT00193050|64912409|FG000|Neoadjuvant Treatment|Physician Decision|2|||
23319385|NCT00193050|64912409|FG000|Neoadjuvant Treatment|Adverse Event|2|||
23319386|NCT00193050|64912409|FG000|Adjuvant|Physician Decision|5|||
23319387|NCT00193050|64912409|FG000|Adjuvant|Intercurrent Hospitalization|3|||
23319388|NCT00193050|64912409|FG000|Adjuvant|Lack of Efficacy|2|||
23319389|NCT02288312|64912410|FG000|Overall Study|Pregnancy|1|||
23319390|NCT02288312|64912411|FG001|Overall Study|Pregnancy|0|||
23319391|NCT02288312|64912412|FG002|Overall Study|Pregnancy|0|||
23319392|NCT02929056|64912413|FG000|Overall Study|Lost to Follow-up|0|||
23319393|NCT02929056|64912414|FG001|Overall Study|Lost to Follow-up|1|||
23319394|NCT00998309|64912416|FG000|Overall Study|Protocol Violation|4|||
23319395|NCT04238650|64912419|FG000|Overall Study|Withdrawal by Subject|0|||
23319396|NCT04238650|64912420|FG001|Overall Study|Withdrawal by Subject|1|||
23319397|NCT02633787|64912421|FG000|Overall Study|Withdrawal by Subject|1|||
23319398|NCT01108718|64912422|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
23319399|NCT01108718|64912423|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
23319400|NCT00339144|64912431|FG000|Overall Study|Disease progression|5|||
23319401|NCT00339144|64912432|FG001|Overall Study|Disease progression|2|||
23433202|NCT00599638|65330391|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
23622840|NCT00043186|66005040|FG000|Overall Study|Lost to Follow-up|3|||
23142378|NCT00812331|64270622|FG001|Overall Study|Adverse Event|0|||
23142379|NCT00812331|64270623|FG002|Overall Study|Adverse Event|0|||
23142380|NCT00812331|64270624|FG003|Overall Study|Adverse Event|0|||
23622841|NCT00043186|66005041|FG001|Overall Study|Lost to Follow-up|5|||
23142381|NCT00812331|64270625|FG004|Overall Study|Adverse Event|0|||
23319402|NCT00339144|64912433|FG002|Overall Study|Disease progression|2|||
23319403|NCT00339144|64912431|FG000|Overall Study|Study drug toxicity|3|||
23319404|NCT00339144|64912432|FG001|Overall Study|Study drug toxicity|1|||
23319405|NCT00339144|64912433|FG002|Overall Study|Study drug toxicity|1|||
23319406|NCT00339144|64912431|FG000|Overall Study|Participant's request to discontinuation|1|||
23319407|NCT00339144|64912432|FG001|Overall Study|Participant's request to discontinuation|0|||
23622842|NCT00043186|66005042|FG002|Overall Study|Lost to Follow-up|1|||
23622843|NCT00043186|66005043|FG003|Overall Study|Lost to Follow-up|1|||
23622844|NCT00043186|66005044|FG004|Overall Study|Lost to Follow-up|1|||
23622845|NCT00043186|66005045|FG005|Overall Study|Lost to Follow-up|1|||
23622846|NCT00043186|66005046|FG006|Overall Study|Lost to Follow-up|1|||
23622847|NCT00043186|66005047|FG007|Overall Study|Lost to Follow-up|1|||
23622848|NCT00043186|66005048|FG008|Overall Study|Lost to Follow-up|2|||
23622849|NCT00043186|66005040|FG000|Overall Study|Noncompliance|0|||
23622850|NCT00043186|66005041|FG001|Overall Study|Noncompliance|0|||
23622851|NCT00043186|66005042|FG002|Overall Study|Noncompliance|1|||
23142382|NCT00946101|64270629|FG000|Overall Study|Lost to Follow-up|2|||
23622852|NCT00043186|66005043|FG003|Overall Study|Noncompliance|1|||
23622853|NCT00043186|66005044|FG004|Overall Study|Noncompliance|0|||
23622854|NCT00043186|66005045|FG005|Overall Study|Noncompliance|0|||
23622855|NCT00043186|66005046|FG006|Overall Study|Noncompliance|0|||
23622856|NCT00043186|66005047|FG007|Overall Study|Noncompliance|0|||
23622857|NCT00043186|66005048|FG008|Overall Study|Noncompliance|0|||
23622858|NCT00043186|66005040|FG000|Overall Study|Other|0|||
23622859|NCT00043186|66005041|FG001|Overall Study|Other|0|||
23622860|NCT00043186|66005042|FG002|Overall Study|Other|1|||
23142383|NCT00946101|64270630|FG001|Overall Study|Lost to Follow-up|1|||
23142384|NCT00946101|64270629|FG000|Overall Study|Withdrawal of consent|2|||
23142385|NCT00946101|64270630|FG001|Overall Study|Withdrawal of consent|0|||
23142386|NCT00946101|64270629|FG000|Overall Study|Physician Decision|0|||
23142387|NCT00946101|64270630|FG001|Overall Study|Physician Decision|1|||
23142388|NCT01078454|64270631|FG000|Overall Study|Adverse Event|1|||
23142389|NCT01078454|64270632|FG001|Overall Study|Adverse Event|1|||
23142390|NCT01078454|64270631|FG000|Overall Study|Death|0|||
23142391|NCT01078454|64270632|FG001|Overall Study|Death|1|||
23142392|NCT00825916|64270634|FG000|Overall Study|Lost to Follow-up|4|||
23142393|NCT00825916|64270635|FG001|Overall Study|Lost to Follow-up|2|||
23142394|NCT00825916|64270636|FG002|Overall Study|Lost to Follow-up|1|||
23142395|NCT01948908|64270640|FG000|Overall Study|Protocol Violation|1|||
23142396|NCT01948908|64270641|FG001|Overall Study|Protocol Violation|0|||
23142397|NCT01948908|64270642|FG002|Overall Study|Protocol Violation|2|||
23142398|NCT01178385|64270643|FG000|Overall Study|Withdrawal by Subject|2|||
23142399|NCT01178385|64270644|FG001|Overall Study|Withdrawal by Subject|0|||
23142400|NCT00645801|64270645|FG000|Overall Study|unclear if patient took all the medication.|1|||
23142401|NCT00645801|64270646|FG001|Overall Study|unclear if patient took all the medication.|0|||
23142402|NCT00645801|64270645|FG000|Overall Study|Lost to Follow-up|19|||
23142403|NCT00645801|64270646|FG001|Overall Study|Lost to Follow-up|15|||
23142404|NCT02572882|64270647|FG000|Overall Study|Withdrawal by Subject|1|||
23142405|NCT02572882|64270647|FG000|Overall Study|Participant received kidney transplant|1|||
23142406|NCT00551460|64270650|FG000|Overall Study|Adverse Event|1|||
23142407|NCT00551460|64270650|FG000|Overall Study|Withdrawal by Subject|1|||
23142408|NCT00551460|64270650|FG000|Overall Study|Physician Decision|1|||
23142409|NCT00551460|64270650|FG000|Overall Study|Death|7|||
23142410|NCT00551460|64270650|FG000|Overall Study|Ineligible|4|||
23142411|NCT00551460|64270650|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
23142412|NCT02630693|64270652|FG000|Overall Study|No receive treatment|0|||
23142413|NCT02630693|64270653|FG001|Overall Study|No receive treatment|1|||
23142414|NCT01491672|64270656|FG000|Overall Study|Lost to Follow-up|0|||
23142415|NCT01491672|64270657|FG001|Overall Study|Lost to Follow-up|4|||
23142416|NCT01491672|64270658|FG002|Overall Study|Lost to Follow-up|1|||
23142417|NCT01491672|64270656|FG000|Overall Study|Withdrawal by Subject|6|||
23142418|NCT01491672|64270657|FG001|Overall Study|Withdrawal by Subject|7|||
23142419|NCT01491672|64270658|FG002|Overall Study|Withdrawal by Subject|0|||
23142420|NCT01491672|64270656|FG000|Overall Study|Adverse Event|8|||
23622861|NCT00043186|66005043|FG003|Overall Study|Other|1|||
23622862|NCT00043186|66005044|FG004|Overall Study|Other|0|||
23622863|NCT00043186|66005045|FG005|Overall Study|Other|0|||
23319408|NCT00339144|64912433|FG002|Overall Study|Participant's request to discontinuation|1|||
23319409|NCT00535405|64912440|FG000|Overall Study|Adverse Event|6|||
23319410|NCT00535405|64912441|FG001|Overall Study|Adverse Event|8|||
23319411|NCT00535405|64912442|FG002|Overall Study|Adverse Event|3|||
23142421|NCT01491672|64270657|FG001|Overall Study|Adverse Event|10|||
23319412|NCT00535405|64912443|FG003|Overall Study|Adverse Event|8|||
23319413|NCT00535405|64912444|FG004|Overall Study|Adverse Event|6|||
23319414|NCT00535405|64912440|FG000|Overall Study|Lost to Follow-up|1|||
23142422|NCT01491672|64270658|FG002|Overall Study|Adverse Event|4|||
23142423|NCT01491672|64270656|FG000|Overall Study|Disease progression|42|||
23142424|NCT01491672|64270657|FG001|Overall Study|Disease progression|34|||
23142425|NCT01491672|64270658|FG002|Overall Study|Disease progression|6|||
23142426|NCT01491672|64270656|FG000|Overall Study|Protocol deviation|0|||
23142427|NCT01491672|64270657|FG001|Overall Study|Protocol deviation|1|||
23142428|NCT01491672|64270658|FG002|Overall Study|Protocol deviation|0|||
23622864|NCT00043186|66005046|FG006|Overall Study|Other|0|||
23622865|NCT00043186|66005047|FG007|Overall Study|Other|0|||
23319415|NCT00535405|64912441|FG001|Overall Study|Lost to Follow-up|3|||
23622866|NCT00043186|66005048|FG008|Overall Study|Other|0|||
23622867|NCT00197106|66005049|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
23319416|NCT00535405|64912442|FG002|Overall Study|Lost to Follow-up|3|||
23319417|NCT00535405|64912443|FG003|Overall Study|Lost to Follow-up|2|||
23319418|NCT00535405|64912444|FG004|Overall Study|Lost to Follow-up|1|||
23319419|NCT00535405|64912440|FG000|Overall Study|Physician Decision|3|||
23319420|NCT00535405|64912441|FG001|Overall Study|Physician Decision|2|||
23319421|NCT00535405|64912442|FG002|Overall Study|Physician Decision|0|||
23319422|NCT00535405|64912443|FG003|Overall Study|Physician Decision|1|||
23319423|NCT00535405|64912444|FG004|Overall Study|Physician Decision|1|||
23319424|NCT00535405|64912440|FG000|Overall Study|Protocol Violation|2|||
23319425|NCT00535405|64912441|FG001|Overall Study|Protocol Violation|2|||
23319426|NCT00535405|64912442|FG002|Overall Study|Protocol Violation|2|||
23319427|NCT00535405|64912443|FG003|Overall Study|Protocol Violation|1|||
23319428|NCT00535405|64912444|FG004|Overall Study|Protocol Violation|0|||
23319429|NCT00535405|64912440|FG000|Overall Study|Withdrawal by Subject|5|||
23319430|NCT00535405|64912441|FG001|Overall Study|Withdrawal by Subject|11|||
23319431|NCT00535405|64912442|FG002|Overall Study|Withdrawal by Subject|10|||
23319432|NCT00535405|64912443|FG003|Overall Study|Withdrawal by Subject|10|||
23319433|NCT00535405|64912444|FG004|Overall Study|Withdrawal by Subject|8|||
23319434|NCT03257865|64912445|FG000|Overall Study|Adverse Event|4|||
23319435|NCT03257865|64912446|FG001|Overall Study|Adverse Event|8|||
23319436|NCT03257865|64912445|FG000|Overall Study|Lack of Efficacy|1|||
23319437|NCT03257865|64912446|FG001|Overall Study|Lack of Efficacy|2|||
23319438|NCT03257865|64912445|FG000|Overall Study|Non-compliance with Study Drug|0|||
23319439|NCT03257865|64912446|FG001|Overall Study|Non-compliance with Study Drug|2|||
23319440|NCT03257865|64912445|FG000|Overall Study|Withdrawal by Subject|23|||
23319441|NCT03257865|64912446|FG001|Overall Study|Withdrawal by Subject|17|||
23319442|NCT03257865|64912445|FG000|Overall Study|Physician Decision|3|||
23319443|NCT03257865|64912446|FG001|Overall Study|Physician Decision|1|||
23319444|NCT03257865|64912445|FG000|Overall Study|Other|0|||
23319445|NCT03257865|64912446|FG001|Overall Study|Other|1|||
23319446|NCT03257865|64912445|FG000|Overall Study|Lost to Follow-up|4|||
23319447|NCT03257865|64912446|FG001|Overall Study|Lost to Follow-up|4|||
23319448|NCT01807065|64915496|FG000|Overall Study|Receive no sip-T due to IV access|1|||
23319449|NCT01807065|64915497|FG001|Overall Study|Receive no sip-T due to IV access|1|||
23319450|NCT02443740|64915511|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319451|NCT02443740|64915512|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319452|NCT02443740|64915513|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319453|NCT02443740|64915514|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319454|NCT02443740|64915515|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319455|NCT02443740|64915516|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
23319456|NCT02443740|64915517|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319457|NCT02443740|64915518|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319458|NCT02443740|64915519|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319459|NCT02443740|64915520|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319460|NCT02443740|64915521|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
23319461|NCT02443740|64915511|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
23319462|NCT02443740|64915512|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23319463|NCT02443740|64915513|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23319464|NCT02443740|64915514|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23319465|NCT02443740|64915515|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23319466|NCT02443740|64915516|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23319467|NCT02443740|64915517|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
23319468|NCT02443740|64915518|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23319469|NCT02443740|64915519|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23319470|NCT02443740|64915520|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23319471|NCT02443740|64915521|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
23319472|NCT02443740|64915511|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23319473|NCT02443740|64915512|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23319474|NCT02443740|64915513|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23319475|NCT02443740|64915514|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23319476|NCT02443740|64915515|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23319477|NCT02443740|64915516|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
23319478|NCT02443740|64915517|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23622868|NCT00197106|66005050|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
23622869|NCT00197106|66005051|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
23622870|NCT00197106|66005049|FG000|Overall Treatment Period|Lack of Efficacy|0|||
23142429|NCT01491672|64270656|FG000|Overall Study|Death|0|||
23319479|NCT02443740|64915518|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23319480|NCT02443740|64915519|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23319481|NCT02443740|64915520|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23319482|NCT02443740|64915521|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
23319483|NCT02575833|64915522|FG000|Overall Study|Withdrawal by Subject|0|||
23622871|NCT00197106|66005050|FG001|Overall Treatment Period|Lack of Efficacy|1|||
23622872|NCT00197106|66005051|FG002|Overall Treatment Period|Lack of Efficacy|0|||
23622873|NCT00197106|66005049|FG000|Overall Treatment Period|Lost to Follow-up|0|||
23622874|NCT00197106|66005050|FG001|Overall Treatment Period|Lost to Follow-up|0|||
23622875|NCT00197106|66005051|FG002|Overall Treatment Period|Lost to Follow-up|2|||
23622876|NCT00197106|66005049|FG000|Overall Treatment Period|Protocol Violation|0|||
23622877|NCT00197106|66005050|FG001|Overall Treatment Period|Protocol Violation|0|||
23622878|NCT00197106|66005051|FG002|Overall Treatment Period|Protocol Violation|2|||
23319484|NCT02575833|64915523|FG001|Overall Study|Withdrawal by Subject|1|||
23319485|NCT02575833|64915522|FG000|Overall Study|Lost to Follow-up|1|||
23319486|NCT02575833|64915523|FG001|Overall Study|Lost to Follow-up|0|||
23319487|NCT04315506|64915524|FG000|Overall Study|Lost to Follow-up|74|||
23319488|NCT04315506|64915525|FG001|Overall Study|Lost to Follow-up|82|||
23319489|NCT04315506|64915524|FG000|Overall Study|Withdrawal by Subject|8|||
23319490|NCT04315506|64915525|FG001|Overall Study|Withdrawal by Subject|8|||
23319491|NCT04315506|64915524|FG000|Overall Study|Physician Decision|0|||
23319492|NCT04315506|64915525|FG001|Overall Study|Physician Decision|1|||
23319493|NCT01406574|64915526|FG000|Overall Study|Adverse Event|0|||
23319494|NCT01406574|64915527|FG001|Overall Study|Adverse Event|0|||
23319495|NCT01406574|64915528|FG002|Overall Study|Adverse Event|1|||
23319496|NCT01406574|64915529|FG003|Overall Study|Adverse Event|3|||
23319497|NCT01406574|64915526|FG000|Overall Study|Physician Decision|0|||
23319498|NCT01406574|64915527|FG001|Overall Study|Physician Decision|0|||
23555281|NCT02970318|65758065|FG000|Overall for Arm A & Main for Arm B|Death|41|||
23555282|NCT02970318|65758066|FG001|Overall for Arm A & Main for Arm B|Death|33|||
23555283|NCT02970318|65758067|FG002|Overall for Arm A & Main for Arm B|Death|0|||
23555284|NCT02970318|65758068|FG003|Overall for Arm A & Main for Arm B|Death|0|||
23555285|NCT02970318|65758065|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
23555286|NCT02970318|65758066|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
23319499|NCT01406574|64915528|FG002|Overall Study|Physician Decision|0|||
23319500|NCT01406574|64915529|FG003|Overall Study|Physician Decision|1|||
23217156|NCT00814307|64538210|FG003|Overall Study|Withdrawal by Subject|2|||
23217157|NCT00814307|64538207|FG000|Overall Study|Death|0|||
23217158|NCT00814307|64538208|FG001|Overall Study|Death|1|||
23319501|NCT01406574|64915526|FG000|Overall Study|Withdrawal by Subject|0|||
23319502|NCT01406574|64915527|FG001|Overall Study|Withdrawal by Subject|1|||
23319503|NCT01406574|64915528|FG002|Overall Study|Withdrawal by Subject|0|||
23319504|NCT01406574|64915529|FG003|Overall Study|Withdrawal by Subject|0|||
23319505|NCT01406574|64915526|FG000|Overall Study|Definite progression of primary disease|1|||
23319506|NCT01406574|64915527|FG001|Overall Study|Definite progression of primary disease|0|||
23555287|NCT02970318|65758067|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
23319507|NCT01406574|64915528|FG002|Overall Study|Definite progression of primary disease|0|||
23319508|NCT01406574|64915529|FG003|Overall Study|Definite progression of primary disease|0|||
23319509|NCT01570686|64915530|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23319510|NCT01570686|64915531|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23319511|NCT01570686|64915530|FG000|Overall Study|Administrative problems|0|||
23319512|NCT01570686|64915531|FG001|Overall Study|Administrative problems|1|||
23217159|NCT00814307|64538209|FG002|Overall Study|Death|0|||
23555288|NCT02970318|65758068|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
23555289|NCT02970318|65758065|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
23555290|NCT02970318|65758066|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
23555291|NCT02970318|65758067|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
23555292|NCT02970318|65758068|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
23555293|NCT02970318|65758065|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
23555294|NCT02970318|65758066|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
23555295|NCT02970318|65758067|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
23555296|NCT02970318|65758068|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
23555297|NCT02970318|65758065|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
23555298|NCT02970318|65758066|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
23555299|NCT02970318|65758067|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
23555300|NCT02970318|65758068|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
23555301|NCT00386022|65758074|FG000|Plus Estrogen|Lost to Follow-up|2|||
23555302|NCT00386022|65758075|FG001|Plus Estrogen|Lost to Follow-up|0|||
23555303|NCT00386022|65758074|FG000|Plus Estrogen|Adverse Event|0|||
23555304|NCT00386022|65758075|FG001|Plus Estrogen|Adverse Event|1|||
23555305|NCT01441102|65758076|FG000|Overall Study|Adverse Event|1|||
23555306|NCT01441102|65758076|FG000|Overall Study|Withdrawal by Subject|2|||
23555307|NCT03371940|65758077|FG000|Overall Study|Withdrawal by Subject|8|||
23555308|NCT03371940|65758078|FG001|Overall Study|Withdrawal by Subject|1|||
23555309|NCT03371940|65758079|FG002|Overall Study|Withdrawal by Subject|3|||
23555310|NCT03371940|65758080|FG003|Overall Study|Withdrawal by Subject|4|||
23555311|NCT00689026|65758081|FG000|Overall Study|Withdrawal by Subject|13|||
23319513|NCT01570686|64915530|FG000|Overall Study|Adverse Event|8|||
23319514|NCT01570686|64915531|FG001|Overall Study|Adverse Event|6|||
23319515|NCT01570686|64915530|FG000|Overall Study|Lost to Follow-up|4|||
23319516|NCT01570686|64915531|FG001|Overall Study|Lost to Follow-up|3|||
23319517|NCT01570686|64915530|FG000|Overall Study|Protocol Deviation|3|||
23319518|NCT01570686|64915531|FG001|Overall Study|Protocol Deviation|0|||
23319519|NCT01570686|64915530|FG000|Overall Study|Withdrawal by Subject|4|||
23319520|NCT01570686|64915531|FG001|Overall Study|Withdrawal by Subject|4|||
23319521|NCT01570686|64915530|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23319522|NCT01570686|64915531|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23433203|NCT00599638|65330392|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
23433204|NCT00599638|65330393|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
23217160|NCT00814307|64538210|FG003|Overall Study|Death|0|||
23217161|NCT00367432|64538211|FG000|First Period (16 Weeks)|Adverse Event|6|||
23217162|NCT00367432|64538212|FG001|First Period (16 Weeks)|Adverse Event|0|||
23217163|NCT00367432|64538211|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
23217164|NCT00367432|64538212|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
23217165|NCT00367432|64538211|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
23217166|NCT00367432|64538212|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
23217167|NCT00367432|64538211|FG000|First Period (16 Weeks)|Other Reason|2|||
23217168|NCT00367432|64538212|FG001|First Period (16 Weeks)|Other Reason|0|||
23217169|NCT00367432|64538211|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
23217170|NCT00367432|64538212|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
23217171|NCT00367432|64538211|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
23217172|NCT00367432|64538212|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
23217173|NCT00367432|64538211|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
23217174|NCT00367432|64538212|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
23217175|NCT00367432|64538211|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
23217176|NCT00367432|64538212|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
23217177|NCT00367432|64538211|FG000|Second Period (up to 54 Months)|Other Reason|6|||
23217178|NCT00367432|64538212|FG001|Second Period (up to 54 Months)|Other Reason|2|||
23217179|NCT03287869|64538213|FG000|Overall Study|Adverse Event|14|||
23217180|NCT03287869|64538214|FG001|Overall Study|Adverse Event|12|||
23217181|NCT03287869|64538213|FG000|Overall Study|Lack of Efficacy|1|||
23217182|NCT03287869|64538214|FG001|Overall Study|Lack of Efficacy|0|||
23217183|NCT03287869|64538213|FG000|Overall Study|Lost to Follow-up|13|||
23217184|NCT03287869|64538214|FG001|Overall Study|Lost to Follow-up|19|||
23217185|NCT03287869|64538213|FG000|Overall Study|Non-Compliance With Study Drug|5|||
23217186|NCT03287869|64538214|FG001|Overall Study|Non-Compliance With Study Drug|9|||
23217187|NCT03287869|64538213|FG000|Overall Study|Progressive Disease|1|||
23217188|NCT03287869|64538214|FG001|Overall Study|Progressive Disease|0|||
23217189|NCT03287869|64538213|FG000|Overall Study|Protocol Deviation|2|||
23217190|NCT03287869|64538214|FG001|Overall Study|Protocol Deviation|1|||
23217191|NCT03287869|64538213|FG000|Overall Study|Withdrawal by Subject|36|||
23217192|NCT03287869|64538214|FG001|Overall Study|Withdrawal by Subject|43|||
23217193|NCT03287869|64538213|FG000|Overall Study|Early Closure of the Site|0|||
23217194|NCT03287869|64538214|FG001|Overall Study|Early Closure of the Site|1|||
23217195|NCT03287869|64538213|FG000|Overall Study|Physician Decision|5|||
23217196|NCT03287869|64538214|FG001|Overall Study|Physician Decision|5|||
23217197|NCT03287869|64538213|FG000|Overall Study|Reason not Specified|6|||
23217198|NCT03287869|64538214|FG001|Overall Study|Reason not Specified|3|||
23217199|NCT03407170|64538215|FG000|Overall Study|Adverse Event|1|||
23217200|NCT00209170|64538220|FG000|Overall Study|Adverse Event|0|||
23217201|NCT00209170|64538221|FG001|Overall Study|Adverse Event|1|||
23217202|NCT00209170|64538220|FG000|Overall Study|Withdrawal by Subject|2|||
23217203|NCT00209170|64538221|FG001|Overall Study|Withdrawal by Subject|1|||
23217204|NCT00209170|64538220|FG000|Overall Study|Lack of Efficacy|0|||
23217205|NCT00209170|64538221|FG001|Overall Study|Lack of Efficacy|1|||
23217206|NCT04583969|64538225|FG000|Overall Study|Death|31|||
23217207|NCT04583969|64538226|FG001|Overall Study|Death|38|||
23217208|NCT04583969|64538225|FG000|Overall Study|Lost to Follow-up|16|||
23217209|NCT04583969|64538226|FG001|Overall Study|Lost to Follow-up|13|||
23217210|NCT04583969|64538225|FG000|Overall Study|Protocol Violation|1|||
23217211|NCT04583969|64538226|FG001|Overall Study|Protocol Violation|0|||
23217212|NCT04583969|64538225|FG000|Overall Study|Withdrawal by Subject|3|||
23217213|NCT04583969|64538226|FG001|Overall Study|Withdrawal by Subject|3|||
23217214|NCT04583969|64538225|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
23217215|NCT04583969|64538226|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
23319523|NCT02189837|64915532|FG000|Overall Study|Withdrawal by Subject|2|||
23433205|NCT04232215|65330394|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
23433206|NCT04232215|65330395|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23217216|NCT04583969|64538225|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
23217217|NCT04583969|64538226|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
23217218|NCT04583969|64538225|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
23217219|NCT04583969|64538226|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
23319524|NCT02189837|64915533|FG001|Overall Study|Withdrawal by Subject|1|||
23319525|NCT02189837|64915534|FG002|Overall Study|Withdrawal by Subject|3|||
23319526|NCT02189837|64915535|FG003|Overall Study|Withdrawal by Subject|1|||
23319527|NCT02189837|64915532|FG000|Overall Study|Sponsor Decision|0|||
23319528|NCT02189837|64915533|FG001|Overall Study|Sponsor Decision|0|||
23319529|NCT02189837|64915534|FG002|Overall Study|Sponsor Decision|0|||
23319530|NCT02189837|64915535|FG003|Overall Study|Sponsor Decision|1|||
23319531|NCT02211417|64915536|FG000|Overall Study|Withdrawal by Subject|11|||
23319532|NCT02211417|64915537|FG001|Overall Study|Withdrawal by Subject|8|||
23319533|NCT02211417|64915536|FG000|Overall Study|Protocol Violation|1|||
23319534|NCT02211417|64915537|FG001|Overall Study|Protocol Violation|0|||
23319535|NCT02211417|64915536|FG000|Overall Study|Pregnancy|0|||
23319536|NCT02211417|64915537|FG001|Overall Study|Pregnancy|1|||
23319537|NCT02211417|64915536|FG000|Overall Study|Lost to Follow-up|2|||
23319538|NCT02211417|64915537|FG001|Overall Study|Lost to Follow-up|3|||
23319539|NCT02211417|64915536|FG000|Overall Study|Adverse Event|1|||
23319540|NCT02211417|64915537|FG001|Overall Study|Adverse Event|4|||
23319541|NCT02964312|64915539|FG000|Overall Study|Lost to Follow-up|28|||
23319542|NCT02964312|64915539|FG000|Overall Study|Withdrawal by Subject|11|||
23319543|NCT02964312|64915539|FG000|Overall Study|Lack of Efficacy|10|||
23319544|NCT02964312|64915539|FG000|Overall Study|Did not consent to long-term FU|14|||
23319545|NCT02964312|64915539|FG000|Overall Study|Death|1|||
23319546|NCT02016183|64915543|FG000|Overall Study|Case Report Forms Uncollected|13|||
23319547|NCT02016183|64915543|FG000|Overall Study|Protocol Violation|52|||
23319548|NCT00191191|64915544|FG000|Overall Study|Entry Criteria Exclusion|2|||
23319549|NCT00191191|64915545|FG001|Overall Study|Entry Criteria Exclusion|0|||
23319550|NCT00191191|64915544|FG000|Overall Study|Treated with Another Systemic Agent|1|||
23319551|NCT00191191|64915545|FG001|Overall Study|Treated with Another Systemic Agent|1|||
23319552|NCT00191191|64915544|FG000|Overall Study|Adverse Event|11|||
23319553|NCT00191191|64915545|FG001|Overall Study|Adverse Event|21|||
23319554|NCT00191191|64915544|FG000|Overall Study|Progressive Disease|84|||
23319555|NCT00191191|64915545|FG001|Overall Study|Progressive Disease|72|||
23319556|NCT00191191|64915544|FG000|Overall Study|Toxicity After Dose Reduction|7|||
23319557|NCT00191191|64915545|FG001|Overall Study|Toxicity After Dose Reduction|8|||
23319558|NCT00191191|64915544|FG000|Overall Study|Family/Caregiver Decision|5|||
23319559|NCT00191191|64915545|FG001|Overall Study|Family/Caregiver Decision|7|||
23319560|NCT00191191|64915544|FG000|Overall Study|Lost to Follow-up|1|||
23319561|NCT00191191|64915545|FG001|Overall Study|Lost to Follow-up|0|||
23319562|NCT00191191|64915544|FG000|Overall Study|Physician Decision|3|||
23319563|NCT00191191|64915545|FG001|Overall Study|Physician Decision|2|||
23319564|NCT00191191|64915544|FG000|Overall Study|Good Clinical Practice Violation|0|||
23319565|NCT00191191|64915545|FG001|Overall Study|Good Clinical Practice Violation|1|||
23319566|NCT00307086|64915553|FG000|Overall Study|ineligible|5|||
23319567|NCT02135614|64915556|FG000|Overall Study|Randomized but Not Treated|2|||
23319568|NCT02135614|64915557|FG001|Overall Study|Randomized but Not Treated|1|||
23319569|NCT02135614|64915556|FG000|Overall Study|Adverse Event|0|||
23319570|NCT02135614|64915557|FG001|Overall Study|Adverse Event|1|||
23319571|NCT02135614|64915556|FG000|Overall Study|Death|1|||
23319572|NCT02135614|64915557|FG001|Overall Study|Death|0|||
23319573|NCT02135614|64915556|FG000|Overall Study|Investigator's Discretion|0|||
23319574|NCT02135614|64915557|FG001|Overall Study|Investigator's Discretion|1|||
23319575|NCT02135614|64915556|FG000|Overall Study|Withdrew Consent|2|||
23319576|NCT02135614|64915557|FG001|Overall Study|Withdrew Consent|2|||
23319577|NCT02135614|64915556|FG000|Overall Study|Lost to Follow-up|3|||
23319578|NCT02135614|64915557|FG001|Overall Study|Lost to Follow-up|0|||
23319579|NCT02165735|64915559|FG000|Overall Study|Lost to Follow-up|12|||
23319580|NCT02165735|64915560|FG001|Overall Study|Lost to Follow-up|10|||
23319581|NCT02165735|64915559|FG000|Overall Study|Withdrawal by Subject|3|||
23319582|NCT02165735|64915560|FG001|Overall Study|Withdrawal by Subject|0|||
23319583|NCT02165735|64915559|FG000|Overall Study|Participant indicated lack of time|1|||
23319584|NCT02165735|64915560|FG001|Overall Study|Participant indicated lack of time|3|||
23319585|NCT02165735|64915559|FG000|Overall Study|Protocol Violation|0|||
23319586|NCT02165735|64915560|FG001|Overall Study|Protocol Violation|1|||
23319587|NCT00064987|64915561|FG000|Overall Study|Physician Decision|3|||
23319588|NCT00064987|64915562|FG001|Overall Study|Physician Decision|0|||
23319589|NCT05445492|64915564|FG000|Overall Study|Physician Decision|1|||
23319590|NCT01659151|64915565|FG000|Overall Study|Inadequate TIL growth|1|||
23319591|NCT01232452|64915567|FG000|Overall Study|Adverse Event|17|||
23319592|NCT01232452|64915568|FG001|Overall Study|Adverse Event|15|||
23319593|NCT01232452|64915567|FG000|Overall Study|Withdrawal by Subject|11|||
23319594|NCT01232452|64915568|FG001|Overall Study|Withdrawal by Subject|8|||
23319595|NCT01232452|64915567|FG000|Overall Study|Physician Decision|8|||
23319596|NCT01232452|64915568|FG001|Overall Study|Physician Decision|12|||
23319597|NCT01232452|64915567|FG000|Overall Study|Protocol entry criterion not met|0|||
23319598|NCT01232452|64915568|FG001|Overall Study|Protocol entry criterion not met|2|||
23319599|NCT01232452|64915567|FG000|Overall Study|Sponsor Decision|3|||
23319600|NCT01232452|64915568|FG001|Overall Study|Sponsor Decision|1|||
23319601|NCT01232452|64915567|FG000|Overall Study|Protocol Violation|0|||
23555312|NCT00689026|65758082|FG001|Overall Study|Withdrawal by Subject|6|||
23555313|NCT02459262|65758083|FG000|Overall Study|Withdrawal by Subject|0|||
23555314|NCT02459262|65758084|FG001|Overall Study|Withdrawal by Subject|0|||
23555315|NCT02459262|65758085|FG002|Overall Study|Withdrawal by Subject|0|||
23555316|NCT02459262|65758086|FG003|Overall Study|Withdrawal by Subject|0|||
23217220|NCT04583969|64538225|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
23217221|NCT04583969|64538226|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
23319602|NCT01232452|64915568|FG001|Overall Study|Protocol Violation|1|||
23319603|NCT04146012|64915569|FG000|Overall Study|Study Terminated|30|||
23319604|NCT04146012|64915570|FG001|Overall Study|Study Terminated|15|||
23319605|NCT01200069|64915577|FG000|Overall Study|Withdrawal by Subject|0|||
23319606|NCT01200069|64915578|FG001|Overall Study|Withdrawal by Subject|1|||
23319607|NCT01924754|64915579|FG000|Overall Study|Lost to Follow-up|1|||
23319608|NCT01924754|64915580|FG001|Overall Study|Lost to Follow-up|2|||
23319609|NCT01924754|64915581|FG002|Overall Study|Lost to Follow-up|1|||
23319610|NCT01924754|64915579|FG000|Overall Study|Pregnancy|0|||
23319611|NCT01924754|64915580|FG001|Overall Study|Pregnancy|1|||
23319612|NCT01924754|64915581|FG002|Overall Study|Pregnancy|2|||
23319613|NCT00489827|64915582|FG000|Overall Study|Intraoperative exclusion criteria|1|||
23217222|NCT04583969|64538225|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
23217223|NCT04583969|64538226|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
23217224|NCT00132314|64538227|FG000|Overall Study|Lost to Follow-up|70|||
23217225|NCT00132314|64538228|FG001|Overall Study|Lost to Follow-up|62|||
23217226|NCT00132314|64538227|FG000|Overall Study|Lacked SSN|1|||
23217227|NCT00132314|64538228|FG001|Overall Study|Lacked SSN|3|||
23217228|NCT00132314|64538227|FG000|Overall Study|Refused intervention at baseline|2|||
23217229|NCT00132314|64538228|FG001|Overall Study|Refused intervention at baseline|7|||
23217230|NCT00379236|64538229|FG000|Double-blind|Adverse Event|11|||
23217231|NCT00379236|64538230|FG001|Double-blind|Adverse Event|6|||
23217232|NCT00379236|64538231|FG002|Double-blind|Adverse Event|0|||
23217233|NCT00379236|64538229|FG000|Double-blind|Protocol Violation|3|||
23217234|NCT00379236|64538230|FG001|Double-blind|Protocol Violation|3|||
23217235|NCT00379236|64538231|FG002|Double-blind|Protocol Violation|0|||
23217236|NCT00379236|64538229|FG000|Double-blind|Withdrawal by Subject|12|||
23319614|NCT00489827|64915583|FG001|Overall Study|Intraoperative exclusion criteria|1|||
23319615|NCT00489827|64915582|FG000|Overall Study|Intraoperative exclusion criteria|1|||
23319616|NCT00489827|64915583|FG001|Overall Study|Intraoperative exclusion criteria|1|||
23319617|NCT01107197|64915584|FG000|Overall Study|Death|12|||
23319618|NCT01107197|64915585|FG001|Overall Study|Death|10|||
23319619|NCT01107197|64915584|FG000|Overall Study|Lost to Follow-up|5|||
23319620|NCT01107197|64915585|FG001|Overall Study|Lost to Follow-up|8|||
23319621|NCT01107197|64915584|FG000|Overall Study|Withdrawal by Subject|3|||
23319622|NCT01107197|64915585|FG001|Overall Study|Withdrawal by Subject|5|||
23319623|NCT00362336|64915588|FG000|Overall Study|Serious Adverse Event|1|||
23319624|NCT00362336|64915589|FG001|Overall Study|Serious Adverse Event|0|||
23319625|NCT00362336|64915590|FG002|Overall Study|Serious Adverse Event|1|||
23319626|NCT00362336|64915588|FG000|Overall Study|Protocol Violation|0|||
23319627|NCT00362336|64915589|FG001|Overall Study|Protocol Violation|0|||
23319628|NCT00362336|64915590|FG002|Overall Study|Protocol Violation|1|||
23319629|NCT00362336|64915588|FG000|Overall Study|Lost to Follow-up|6|||
23319630|NCT00362336|64915589|FG001|Overall Study|Lost to Follow-up|4|||
23319631|NCT00362336|64915590|FG002|Overall Study|Lost to Follow-up|0|||
23319632|NCT00362336|64915588|FG000|Overall Study|Withdrawal by Subject|3|||
23319633|NCT00362336|64915589|FG001|Overall Study|Withdrawal by Subject|3|||
23319634|NCT00362336|64915590|FG002|Overall Study|Withdrawal by Subject|1|||
23319635|NCT02717455|64915592|FG000|Overall Study|Adverse Event|1|||
23319636|NCT02717455|64915593|FG001|Overall Study|Adverse Event|0|||
23319637|NCT02717455|64915594|FG002|Overall Study|Adverse Event|0|||
23319638|NCT02717455|64915595|FG003|Overall Study|Adverse Event|2|||
23319639|NCT02717455|64915596|FG004|Overall Study|Adverse Event|2|||
23319640|NCT02717455|64915597|FG005|Overall Study|Adverse Event|2|||
23319641|NCT02717455|64915592|FG000|Overall Study|Withdrawal by Subject|1|||
23555317|NCT02459262|65758087|FG004|Overall Study|Withdrawal by Subject|0|||
23217237|NCT00379236|64538230|FG001|Double-blind|Withdrawal by Subject|13|||
23217238|NCT00379236|64538231|FG002|Double-blind|Withdrawal by Subject|0|||
23217239|NCT00379236|64538229|FG000|Double-blind|Lost to Follow-up|4|||
23217240|NCT00379236|64538230|FG001|Double-blind|Lost to Follow-up|3|||
23217241|NCT00379236|64538231|FG002|Double-blind|Lost to Follow-up|0|||
23217242|NCT00379236|64538229|FG000|Double-blind|Use of exclusionary medication|1|||
23217243|NCT00379236|64538230|FG001|Double-blind|Use of exclusionary medication|2|||
23217244|NCT00379236|64538231|FG002|Double-blind|Use of exclusionary medication|0|||
23217245|NCT00379236|64538229|FG000|Double-blind|Other|3|||
23319642|NCT02717455|64915593|FG001|Overall Study|Withdrawal by Subject|1|||
23319643|NCT02717455|64915594|FG002|Overall Study|Withdrawal by Subject|0|||
23319644|NCT02717455|64915595|FG003|Overall Study|Withdrawal by Subject|2|||
23319645|NCT02717455|64915596|FG004|Overall Study|Withdrawal by Subject|2|||
23319646|NCT02717455|64915597|FG005|Overall Study|Withdrawal by Subject|1|||
23319647|NCT02717455|64915592|FG000|Overall Study|Death|1|||
23319648|NCT02717455|64915593|FG001|Overall Study|Death|0|||
23319649|NCT02717455|64915594|FG002|Overall Study|Death|0|||
23142430|NCT01491672|64270657|FG001|Overall Study|Death|4|||
23142431|NCT01491672|64270658|FG002|Overall Study|Death|0|||
23142432|NCT03725085|64270659|FG000|Overall Study|Lost to Follow-up|2|||
23142433|NCT00618982|64270660|FG000|Overall Study|Adverse Event|23|||
23142434|NCT00618982|64270660|FG000|Overall Study|Withdrawal by Subject|1|||
23142435|NCT00618982|64270660|FG000|Overall Study|Protocol Violation|1|||
23142436|NCT00618982|64270660|FG000|Overall Study|ongoing, still treated with study med.|25|||
23142437|NCT04822597|64270661|FG000|Overall Study|Withdrawal by Subject|0|||
23142438|NCT04822597|64270662|FG001|Overall Study|Withdrawal by Subject|1|||
23142439|NCT04822597|64270663|FG002|Overall Study|Withdrawal by Subject|1|||
23142440|NCT04822597|64270664|FG003|Overall Study|Withdrawal by Subject|0|||
23142441|NCT04822597|64270661|FG000|Overall Study|Physician Decision|0|||
23142442|NCT04822597|64270662|FG001|Overall Study|Physician Decision|0|||
23142443|NCT04822597|64270663|FG002|Overall Study|Physician Decision|1|||
23142444|NCT04822597|64270664|FG003|Overall Study|Physician Decision|1|||
23142445|NCT04822597|64270661|FG000|Overall Study|Subject withdrawn after enrollment|0|||
23142446|NCT04822597|64270662|FG001|Overall Study|Subject withdrawn after enrollment|1|||
23142447|NCT04822597|64270663|FG002|Overall Study|Subject withdrawn after enrollment|0|||
23142448|NCT04822597|64270664|FG003|Overall Study|Subject withdrawn after enrollment|1|||
23142449|NCT04822597|64270661|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
23142450|NCT04822597|64270662|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
23142451|NCT04822597|64270663|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
23142452|NCT04822597|64270664|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
23142453|NCT01577745|64270665|FG000|Overall Study|Withdrawal by Subject|0|||
23142454|NCT01577745|64270666|FG001|Overall Study|Withdrawal by Subject|1|||
23142455|NCT01577745|64270667|FG002|Overall Study|Withdrawal by Subject|0|||
23142456|NCT01577745|64270668|FG003|Overall Study|Withdrawal by Subject|3|||
23142457|NCT01577745|64270669|FG004|Overall Study|Withdrawal by Subject|2|||
23142458|NCT01577745|64270670|FG005|Overall Study|Withdrawal by Subject|0|||
23142459|NCT01577745|64270665|FG000|Overall Study|Death|3|||
23142460|NCT01577745|64270666|FG001|Overall Study|Death|2|||
23142461|NCT01577745|64270667|FG002|Overall Study|Death|2|||
23142462|NCT01577745|64270668|FG003|Overall Study|Death|1|||
23142463|NCT01577745|64270669|FG004|Overall Study|Death|1|||
23142464|NCT01577745|64270670|FG005|Overall Study|Death|3|||
23142465|NCT01577745|64270665|FG000|Overall Study|Physician Decision|0|||
23142466|NCT01577745|64270666|FG001|Overall Study|Physician Decision|0|||
23142467|NCT01577745|64270667|FG002|Overall Study|Physician Decision|0|||
23142468|NCT01577745|64270668|FG003|Overall Study|Physician Decision|1|||
23142469|NCT01577745|64270669|FG004|Overall Study|Physician Decision|1|||
23142470|NCT01577745|64270670|FG005|Overall Study|Physician Decision|0|||
23142471|NCT01577745|64270665|FG000|Overall Study|Lost to Follow-up|0|||
23142472|NCT01577745|64270666|FG001|Overall Study|Lost to Follow-up|0|||
23142473|NCT01577745|64270667|FG002|Overall Study|Lost to Follow-up|0|||
23142474|NCT01577745|64270668|FG003|Overall Study|Lost to Follow-up|0|||
23142475|NCT01577745|64270669|FG004|Overall Study|Lost to Follow-up|0|||
23142476|NCT01577745|64270670|FG005|Overall Study|Lost to Follow-up|1|||
23142477|NCT01577745|64270665|FG000|Overall Study|Alternative Therapy|0|||
23319650|NCT02717455|64915595|FG003|Overall Study|Death|0|||
23319651|NCT02717455|64915596|FG004|Overall Study|Death|1|||
23319652|NCT02717455|64915597|FG005|Overall Study|Death|0|||
23319653|NCT02717455|64915592|FG000|Overall Study|Did not receive study drug|0|||
23319654|NCT02717455|64915593|FG001|Overall Study|Did not receive study drug|0|||
23319655|NCT02717455|64915594|FG002|Overall Study|Did not receive study drug|0|||
23319656|NCT02717455|64915595|FG003|Overall Study|Did not receive study drug|1|||
23319657|NCT02717455|64915596|FG004|Overall Study|Did not receive study drug|0|||
23319658|NCT02717455|64915597|FG005|Overall Study|Did not receive study drug|1|||
23319659|NCT02717455|64915592|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23319660|NCT02717455|64915593|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23319661|NCT02717455|64915594|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23319662|NCT02717455|64915595|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23142478|NCT01577745|64270666|FG001|Overall Study|Alternative Therapy|0|||
23142479|NCT01577745|64270667|FG002|Overall Study|Alternative Therapy|0|||
23142480|NCT01577745|64270668|FG003|Overall Study|Alternative Therapy|1|||
23142481|NCT01577745|64270669|FG004|Overall Study|Alternative Therapy|1|||
23142482|NCT01577745|64270670|FG005|Overall Study|Alternative Therapy|0|||
23142483|NCT02383056|64270675|FG000|Overall Study|Adverse Event|1|||
23433207|NCT00129961|65330396|FG000|Overall Study|Adverse Event|1|||
23142484|NCT02383056|64270676|FG001|Overall Study|Adverse Event|0|||
23142485|NCT02383056|64270675|FG000|Overall Study|Lost to Follow-up|0|||
23142486|NCT02383056|64270676|FG001|Overall Study|Lost to Follow-up|2|||
23142487|NCT00424385|64270682|FG000|Cohort 0|Withdrawal by Subject|5|||
23142488|NCT00424385|64270682|FG000|Cohort 0|Physician Decision|1|||
23142489|NCT00424385|64270682|FG000|Cohort 1|Withdrawal by Subject|1|||
23142490|NCT02709096|64270687|FG000|Overall Study|non-compliance|1|||
23142491|NCT02709096|64270688|FG001|Overall Study|non-compliance|1|||
23142492|NCT01696942|64270698|FG000|Overall Study|Withdrawal by Subject|1|||
23142493|NCT01696942|64270699|FG001|Overall Study|Withdrawal by Subject|0|||
23142494|NCT01696942|64270698|FG000|Overall Study|Protocol Violation|1|||
23142495|NCT01696942|64270699|FG001|Overall Study|Protocol Violation|2|||
23142496|NCT01696942|64270698|FG000|Overall Study|screen failure|0|||
23142497|NCT01696942|64270699|FG001|Overall Study|screen failure|1|||
23142498|NCT00642772|64270700|FG000|Overall Study|Lost to Follow-up|3|||
23142499|NCT00642772|64270700|FG000|Overall Study|Withdrawal by Subject|7|||
23142500|NCT00421707|64270701|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
23142501|NCT00421707|64270702|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
23142502|NCT00421707|64270701|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
23142503|NCT00421707|64270702|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
23142504|NCT00421707|64270701|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
23142505|NCT00421707|64270702|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
23142506|NCT00421707|64270701|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
23142507|NCT00421707|64270702|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
23142508|NCT00421707|64270701|FG000|Period 2: Washout|Adverse Event|1|||
23142509|NCT00421707|64270702|FG001|Period 2: Washout|Adverse Event|1|||
23142510|NCT00421707|64270701|FG000|Period 2: Washout|Withdrawal by Subject|0|||
23142511|NCT00421707|64270702|FG001|Period 2: Washout|Withdrawal by Subject|1|||
23142512|NCT00421707|64270701|FG000|Period 2: Washout|Lost to Follow-up|0|||
23142513|NCT00421707|64270702|FG001|Period 2: Washout|Lost to Follow-up|1|||
23142514|NCT00421707|64270701|FG000|Period 2: Washout|Other: Pregnancy|0|||
23142515|NCT00421707|64270702|FG001|Period 2: Washout|Other: Pregnancy|1|||
23142516|NCT00421707|64270701|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
23142517|NCT00421707|64270702|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
23142518|NCT00421707|64270701|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
23142519|NCT00421707|64270702|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
23142520|NCT00421707|64270701|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
23142521|NCT00421707|64270702|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
23142522|NCT00252577|64270707|FG000|Overall Study|Lost to Follow-up|20|||
23142523|NCT01878214|64270708|FG000|Overall Study|Withdrawal by Subject|18|||
23142524|NCT01878214|64270709|FG001|Overall Study|Withdrawal by Subject|7|||
23142525|NCT01878214|64270708|FG000|Overall Study|Death|0|||
23142526|NCT01878214|64270709|FG001|Overall Study|Death|1|||
23142527|NCT01878214|64270708|FG000|Overall Study|Lost to Follow-up|35|||
23142528|NCT01878214|64270709|FG001|Overall Study|Lost to Follow-up|36|||
23142529|NCT01248780|64270712|FG000|Overall Study|Lack of Efficacy|2|||
23142530|NCT01248780|64270713|FG001|Overall Study|Lack of Efficacy|0|||
23142531|NCT01248780|64270712|FG000|Overall Study|Lost to Follow-up|0|||
23142532|NCT01248780|64270713|FG001|Overall Study|Lost to Follow-up|1|||
23142533|NCT01248780|64270712|FG000|Overall Study|Death|0|||
23142534|NCT01248780|64270713|FG001|Overall Study|Death|1|||
23142535|NCT01248780|64270712|FG000|Overall Study|Adverse Event|2|||
23142536|NCT01248780|64270713|FG001|Overall Study|Adverse Event|7|||
23142537|NCT01248780|64270712|FG000|Overall Study|Protocol Violation|1|||
23142538|NCT01248780|64270713|FG001|Overall Study|Protocol Violation|1|||
23142539|NCT01248780|64270712|FG000|Overall Study|Withdrawal by Subject|4|||
23142540|NCT01248780|64270713|FG001|Overall Study|Withdrawal by Subject|4|||
23319663|NCT02717455|64915596|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
23319664|NCT02717455|64915597|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
23319665|NCT02717455|64915592|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
23319666|NCT02717455|64915593|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
23319667|NCT02717455|64915594|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
23319668|NCT02717455|64915595|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
23319669|NCT02717455|64915596|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
23319670|NCT02717455|64915597|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
23319671|NCT01625091|64915598|FG000|Intervention|Death|1|||
23319672|NCT01625091|64915599|FG001|Intervention|Death|1|||
23319673|NCT01625091|64915598|FG000|Intervention|Withdrawal by Subject|4|||
23319674|NCT01625091|64915599|FG001|Intervention|Withdrawal by Subject|1|||
23319675|NCT01625091|64915598|FG000|Intervention|Adverse Event|0|||
23319676|NCT01625091|64915599|FG001|Intervention|Adverse Event|2|||
23142541|NCT01248780|64270712|FG000|Overall Study|Not treated|0|||
23142542|NCT01248780|64270713|FG001|Overall Study|Not treated|1|||
23142543|NCT01012739|64270718|FG000|Treatment Period 1|Adverse Event|0|||
23142544|NCT01012739|64270719|FG001|Treatment Period 1|Adverse Event|0|||
23142545|NCT01012739|64270720|FG002|Treatment Period 1|Adverse Event|0|||
23142546|NCT01012739|64270721|FG003|Treatment Period 1|Adverse Event|1|||
23142547|NCT01012739|64270718|FG000|Treatment Period 2|Abnormal test procedure results|0|||
23142548|NCT01012739|64270719|FG001|Treatment Period 2|Abnormal test procedure results|0|||
23142549|NCT01012739|64270720|FG002|Treatment Period 2|Abnormal test procedure results|0|||
23319677|NCT01625091|64915598|FG000|Intervention|Lost to Follow-up|4|||
23319678|NCT01625091|64915599|FG001|Intervention|Lost to Follow-up|4|||
23319679|NCT01625091|64915598|FG000|Intervention|Study termination|2|||
23319680|NCT01625091|64915599|FG001|Intervention|Study termination|3|||
23319681|NCT01625091|64915598|FG000|Post-intervention|Death|0|||
23319682|NCT01625091|64915599|FG001|Post-intervention|Death|1|||
23319683|NCT01625091|64915598|FG000|Post-intervention|Lost to Follow-up|2|||
23319684|NCT01625091|64915599|FG001|Post-intervention|Lost to Follow-up|0|||
23319685|NCT01625091|64915598|FG000|Post-intervention|Study termination|2|||
23319686|NCT01625091|64915599|FG001|Post-intervention|Study termination|1|||
23319687|NCT00805467|64915600|FG000|Overall Study|Lack of Efficacy|0|||
23319688|NCT00805467|64915601|FG001|Overall Study|Lack of Efficacy|8|||
23319689|NCT00805467|64915602|FG002|Overall Study|Lack of Efficacy|13|||
23142550|NCT01012739|64270721|FG003|Treatment Period 2|Abnormal test procedure results|1|||
23142551|NCT04161495|64270722|FG000|Overall Study|Withdrawal by Subject|3|||
23142552|NCT04161495|64270723|FG001|Overall Study|Withdrawal by Subject|0|||
23142553|NCT04161495|64270722|FG000|Overall Study|Protocol Violation|1|||
23142554|NCT04161495|64270723|FG001|Overall Study|Protocol Violation|0|||
23142555|NCT04161495|64270722|FG000|Overall Study|Prohibited concomitant medication|3|||
23142556|NCT04161495|64270723|FG001|Overall Study|Prohibited concomitant medication|0|||
23142557|NCT04161495|64270722|FG000|Overall Study|Adverse Event|1|||
23142558|NCT04161495|64270723|FG001|Overall Study|Adverse Event|0|||
23142559|NCT04161495|64270722|FG000|Overall Study|Other - Unspecified|1|||
23142560|NCT04161495|64270723|FG001|Overall Study|Other - Unspecified|0|||
23142561|NCT04161495|64270722|FG000|Overall Study|Death|0|||
23142562|NCT04161495|64270723|FG001|Overall Study|Death|1|||
23142563|NCT00153062|64270732|FG000|Overall Study|Death|360|||
23142564|NCT00153062|64270733|FG001|Overall Study|Death|352|||
23142565|NCT00153062|64270734|FG002|Overall Study|Death|369|||
23142566|NCT00153062|64270735|FG003|Overall Study|Death|365|||
23142567|NCT00153062|64270732|FG000|Overall Study|Withdrawal by Subject|14|||
23142568|NCT00153062|64270733|FG001|Overall Study|Withdrawal by Subject|30|||
23142569|NCT00153062|64270734|FG002|Overall Study|Withdrawal by Subject|27|||
23142570|NCT00153062|64270735|FG003|Overall Study|Withdrawal by Subject|28|||
23142571|NCT00153062|64270732|FG000|Overall Study|Lost to Follow-up|12|||
23142572|NCT00153062|64270733|FG001|Overall Study|Lost to Follow-up|20|||
23142573|NCT00153062|64270734|FG002|Overall Study|Lost to Follow-up|15|||
23142574|NCT00153062|64270735|FG003|Overall Study|Lost to Follow-up|16|||
23142575|NCT00153062|64270732|FG000|Overall Study|Adverse Event|0|||
23142576|NCT00153062|64270733|FG001|Overall Study|Adverse Event|1|||
23142577|NCT00153062|64270734|FG002|Overall Study|Adverse Event|1|||
23142578|NCT00153062|64270735|FG003|Overall Study|Adverse Event|0|||
23142579|NCT00153062|64270732|FG000|Overall Study|Protocol Violation|0|||
23142580|NCT00153062|64270733|FG001|Overall Study|Protocol Violation|2|||
23142581|NCT00153062|64270734|FG002|Overall Study|Protocol Violation|1|||
23142582|NCT00153062|64270735|FG003|Overall Study|Protocol Violation|1|||
23142583|NCT00153062|64270732|FG000|Overall Study|No disposition data available|1|||
23142584|NCT00153062|64270733|FG001|Overall Study|No disposition data available|1|||
23142585|NCT00153062|64270734|FG002|Overall Study|No disposition data available|1|||
23142586|NCT00153062|64270735|FG003|Overall Study|No disposition data available|1|||
23142587|NCT00153062|64270732|FG000|Overall Study|Other|0|||
23142588|NCT00153062|64270733|FG001|Overall Study|Other|0|||
23142589|NCT00153062|64270734|FG002|Overall Study|Other|1|||
23142590|NCT00153062|64270735|FG003|Overall Study|Other|0|||
23142591|NCT00705679|64270738|FG000|Overall Study|Adverse Event|1|||
23142592|NCT00705679|64270739|FG001|Overall Study|Adverse Event|1|||
23142593|NCT00705679|64270740|FG002|Overall Study|Adverse Event|0|||
23142594|NCT00705679|64270741|FG003|Overall Study|Adverse Event|0|||
23142595|NCT00705679|64270742|FG004|Overall Study|Adverse Event|0|||
23142596|NCT00705679|64270738|FG000|Overall Study|Death|0|||
23142597|NCT00705679|64270739|FG001|Overall Study|Death|0|||
23142598|NCT00705679|64270740|FG002|Overall Study|Death|3|||
23142599|NCT00705679|64270741|FG003|Overall Study|Death|2|||
23142600|NCT00705679|64270742|FG004|Overall Study|Death|1|||
23142601|NCT00705679|64270738|FG000|Overall Study|Lost to Follow-up|32|||
23142602|NCT00705679|64270739|FG001|Overall Study|Lost to Follow-up|60|||
23142603|NCT00705679|64270740|FG002|Overall Study|Lost to Follow-up|44|||
23142604|NCT00705679|64270741|FG003|Overall Study|Lost to Follow-up|30|||
23142605|NCT00705679|64270742|FG004|Overall Study|Lost to Follow-up|35|||
23142606|NCT00705679|64270738|FG000|Overall Study|Physician Decision|0|||
23319690|NCT00805467|64915603|FG003|Overall Study|Lack of Efficacy|86|||
23319691|NCT00805467|64915600|FG000|Overall Study|Lost to Follow-up|0|||
23319692|NCT00805467|64915601|FG001|Overall Study|Lost to Follow-up|1|||
23433208|NCT00129961|65330397|FG001|Overall Study|Adverse Event|0|||
23142607|NCT00705679|64270739|FG001|Overall Study|Physician Decision|1|||
23142608|NCT00705679|64270740|FG002|Overall Study|Physician Decision|0|||
23142609|NCT00705679|64270741|FG003|Overall Study|Physician Decision|1|||
23142610|NCT00705679|64270742|FG004|Overall Study|Physician Decision|0|||
23142611|NCT00705679|64270738|FG000|Overall Study|Withdrawal by Subject|32|||
23142612|NCT00705679|64270739|FG001|Overall Study|Withdrawal by Subject|77|||
23142613|NCT00705679|64270740|FG002|Overall Study|Withdrawal by Subject|68|||
23142614|NCT00705679|64270741|FG003|Overall Study|Withdrawal by Subject|47|||
23319693|NCT00805467|64915602|FG002|Overall Study|Lost to Follow-up|7|||
23319694|NCT00805467|64915603|FG003|Overall Study|Lost to Follow-up|21|||
23319695|NCT00805467|64915600|FG000|Overall Study|Withdrawal by Subject|0|||
23319696|NCT00805467|64915601|FG001|Overall Study|Withdrawal by Subject|6|||
23319697|NCT00805467|64915602|FG002|Overall Study|Withdrawal by Subject|45|||
23319698|NCT00805467|64915603|FG003|Overall Study|Withdrawal by Subject|50|||
23319699|NCT00805467|64915600|FG000|Overall Study|Protocol Violation|0|||
23142615|NCT00705679|64270742|FG004|Overall Study|Withdrawal by Subject|33|||
23142616|NCT00323856|64270747|FG000|Overall Study|Withdrawal by Subject|1|||
23142617|NCT00323856|64270747|FG000|Overall Study|Was uncooperative and noncompliant|1|||
23142618|NCT00323856|64270747|FG000|Overall Study|Reason not specified|1|||
23142619|NCT00323856|64270747|FG000|Overall Study|Missing|2|||
23142620|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
23142621|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
23142622|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
23142623|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
23142624|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
23142625|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
23142626|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
23142627|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23142628|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23142629|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23142630|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23142631|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
23142632|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Death|1|||
23142633|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Death|2|||
23142634|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Death|2|||
23142635|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Death|0|||
23142636|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Death|0|||
23142637|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Death|0|||
23142638|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
23142639|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
23142640|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
23142641|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
23142642|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
23142643|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
23142644|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
23142645|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23142646|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23142647|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23142648|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23142649|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
23142650|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
23142651|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23142652|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23142653|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23142654|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23142655|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
23142656|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
23142657|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23142658|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23142659|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23142660|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23142661|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
23142662|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23142663|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
23142664|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23142665|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23142666|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23319700|NCT00805467|64915601|FG001|Overall Study|Protocol Violation|3|||
23622879|NCT00197106|66005049|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
23319701|NCT00805467|64915602|FG002|Overall Study|Protocol Violation|0|||
23142667|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
23142668|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
23142669|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
23142670|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
23142671|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
23142672|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
23142673|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
23142674|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23142675|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23142676|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
23142677|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23142678|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23142679|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
23142680|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Site closure|0|||
23142681|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Site closure|0|||
23142682|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Site closure|1|||
23142683|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Site closure|0|||
23142684|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Site closure|0|||
23142685|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Site closure|0|||
23142686|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
23142687|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
23142688|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
23142689|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
23142690|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
23142691|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
23142692|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
23142693|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
23142694|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
23142695|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
23142696|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
23142697|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
23142698|NCT03439254|64270750|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
23142699|NCT03439254|64270751|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
23142700|NCT03439254|64270752|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
23142701|NCT03439254|64270753|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
23142702|NCT03439254|64270754|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
23142703|NCT03439254|64270755|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
23142704|NCT03439254|64270750|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
23142705|NCT03439254|64270751|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
23142706|NCT03439254|64270752|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
23142707|NCT03439254|64270753|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
23142708|NCT03439254|64270754|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
23142709|NCT03439254|64270755|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
23142710|NCT03439254|64270750|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
23142711|NCT03439254|64270751|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
23142712|NCT03439254|64270752|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
23142713|NCT03439254|64270753|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
23142714|NCT03439254|64270754|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
23142715|NCT03439254|64270755|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
23142716|NCT03439254|64270750|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23142717|NCT03439254|64270751|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23142718|NCT03439254|64270752|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23142719|NCT03439254|64270753|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23142720|NCT03439254|64270754|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
23142721|NCT03439254|64270755|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
23555318|NCT02459262|65758088|FG005|Overall Study|Withdrawal by Subject|0|||
23555319|NCT02459262|65758089|FG006|Overall Study|Withdrawal by Subject|0|||
23555320|NCT02459262|65758090|FG007|Overall Study|Withdrawal by Subject|0|||
23555321|NCT02459262|65758091|FG008|Overall Study|Withdrawal by Subject|0|||
23555322|NCT02459262|65758092|FG009|Overall Study|Withdrawal by Subject|1|||
23555323|NCT02459262|65758093|FG010|Overall Study|Withdrawal by Subject|0|||
23555324|NCT02355002|65758094|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
23555325|NCT02355002|65758095|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
23555326|NCT02355002|65758094|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
23319702|NCT00805467|64915603|FG003|Overall Study|Protocol Violation|5|||
23319703|NCT00805467|64915600|FG000|Overall Study|Adverse Event|0|||
23319704|NCT00805467|64915601|FG001|Overall Study|Adverse Event|13|||
23319705|NCT00805467|64915602|FG002|Overall Study|Adverse Event|26|||
23319706|NCT00805467|64915603|FG003|Overall Study|Adverse Event|57|||
23319707|NCT00805467|64915600|FG000|Overall Study|Death|0|||
23319708|NCT00805467|64915601|FG001|Overall Study|Death|2|||
23319709|NCT00805467|64915602|FG002|Overall Study|Death|7|||
23319710|NCT00805467|64915603|FG003|Overall Study|Death|5|||
23319711|NCT00805467|64915600|FG000|Overall Study|Physician Decision|0|||
23319712|NCT00805467|64915601|FG001|Overall Study|Physician Decision|1|||
23319713|NCT00805467|64915602|FG002|Overall Study|Physician Decision|2|||
23319714|NCT00805467|64915603|FG003|Overall Study|Physician Decision|6|||
23319715|NCT00805467|64915600|FG000|Overall Study|Not reported|0|||
23319716|NCT00805467|64915601|FG001|Overall Study|Not reported|0|||
23319717|NCT00805467|64915602|FG002|Overall Study|Not reported|3|||
23319718|NCT00805467|64915603|FG003|Overall Study|Not reported|7|||
23319719|NCT00613171|64915604|FG000|Overall Study|Adverse Event|7|||
23319720|NCT00613171|64915604|FG000|Overall Study|Withdrawal by Subject|3|||
23319721|NCT00613171|64915604|FG000|Overall Study|Reason not Specified|4|||
23319722|NCT02676765|64915605|FG000|Overall Study|Lost to Follow-up|0|||
23319723|NCT02676765|64915606|FG001|Overall Study|Lost to Follow-up|1|||
23319724|NCT01056289|64915609|FG000|Open-label Phase|Adverse Event|29|||
23319725|NCT01056289|64915610|FG001|Open-label Phase|Adverse Event|0|||
23319726|NCT01056289|64915611|FG002|Open-label Phase|Adverse Event|0|||
23319727|NCT01056289|64915612|FG003|Open-label Phase|Adverse Event|0|||
23319728|NCT01056289|64915609|FG000|Open-label Phase|Lost to Follow-up|30|||
23319729|NCT01056289|64915610|FG001|Open-label Phase|Lost to Follow-up|0|||
23319730|NCT01056289|64915611|FG002|Open-label Phase|Lost to Follow-up|0|||
23319731|NCT01056289|64915612|FG003|Open-label Phase|Lost to Follow-up|0|||
23319732|NCT01056289|64915609|FG000|Open-label Phase|Other|9|||
23319733|NCT01056289|64915610|FG001|Open-label Phase|Other|0|||
23319734|NCT01056289|64915611|FG002|Open-label Phase|Other|0|||
23319735|NCT01056289|64915612|FG003|Open-label Phase|Other|0|||
23319736|NCT01056289|64915609|FG000|Open-label Phase|Protocol Violation|6|||
23319737|NCT01056289|64915610|FG001|Open-label Phase|Protocol Violation|0|||
23319738|NCT01056289|64915611|FG002|Open-label Phase|Protocol Violation|0|||
23319739|NCT01056289|64915612|FG003|Open-label Phase|Protocol Violation|0|||
23319740|NCT01056289|64915609|FG000|Open-label Phase|Withdrawal by Subject|26|||
23319741|NCT01056289|64915610|FG001|Open-label Phase|Withdrawal by Subject|0|||
23319742|NCT01056289|64915611|FG002|Open-label Phase|Withdrawal by Subject|0|||
23319743|NCT01056289|64915612|FG003|Open-label Phase|Withdrawal by Subject|0|||
23319744|NCT01056289|64915609|FG000|Open-label Phase|Lack of Efficacy|18|||
23319745|NCT01056289|64915610|FG001|Open-label Phase|Lack of Efficacy|0|||
23319746|NCT01056289|64915611|FG002|Open-label Phase|Lack of Efficacy|0|||
23319747|NCT01056289|64915612|FG003|Open-label Phase|Lack of Efficacy|0|||
23319748|NCT01056289|64915609|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
23319749|NCT01056289|64915610|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
23319750|NCT01056289|64915611|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
23319751|NCT01056289|64915612|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
23319752|NCT01056289|64915609|FG000|Double-blind Phase|Adverse Event|0|||
23319753|NCT01056289|64915610|FG001|Double-blind Phase|Adverse Event|1|||
23319754|NCT01056289|64915611|FG002|Double-blind Phase|Adverse Event|2|||
23319755|NCT01056289|64915612|FG003|Double-blind Phase|Adverse Event|1|||
23319756|NCT01056289|64915609|FG000|Double-blind Phase|Lost to Follow-up|0|||
23319757|NCT01056289|64915610|FG001|Double-blind Phase|Lost to Follow-up|2|||
23319758|NCT01056289|64915611|FG002|Double-blind Phase|Lost to Follow-up|2|||
23319759|NCT01056289|64915612|FG003|Double-blind Phase|Lost to Follow-up|2|||
23319760|NCT01056289|64915609|FG000|Double-blind Phase|Other|0|||
23319761|NCT01056289|64915610|FG001|Double-blind Phase|Other|0|||
23319762|NCT01056289|64915611|FG002|Double-blind Phase|Other|1|||
23319763|NCT01056289|64915612|FG003|Double-blind Phase|Other|2|||
23319764|NCT01056289|64915609|FG000|Double-blind Phase|Protocol Violation|0|||
23319765|NCT01056289|64915610|FG001|Double-blind Phase|Protocol Violation|0|||
23622880|NCT00197106|66005050|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
23622881|NCT00197106|66005051|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
23217246|NCT00379236|64538230|FG001|Double-blind|Other|7|||
23319766|NCT01056289|64915611|FG002|Double-blind Phase|Protocol Violation|1|||
23319767|NCT01056289|64915612|FG003|Double-blind Phase|Protocol Violation|1|||
23319768|NCT01056289|64915609|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23319769|NCT01056289|64915610|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23319770|NCT01056289|64915611|FG002|Double-blind Phase|Withdrawal by Subject|4|||
23319771|NCT01056289|64915612|FG003|Double-blind Phase|Withdrawal by Subject|2|||
23319772|NCT01056289|64915609|FG000|Double-blind Phase|Discontinuation symptom|0|||
23319773|NCT01056289|64915610|FG001|Double-blind Phase|Discontinuation symptom|1|||
23319774|NCT01056289|64915611|FG002|Double-blind Phase|Discontinuation symptom|2|||
23319775|NCT01056289|64915612|FG003|Double-blind Phase|Discontinuation symptom|2|||
23319776|NCT01056289|64915609|FG000|Double-blind Phase|Physician Decision|0|||
23319777|NCT01056289|64915610|FG001|Double-blind Phase|Physician Decision|0|||
23319778|NCT01056289|64915611|FG002|Double-blind Phase|Physician Decision|1|||
23319779|NCT01056289|64915612|FG003|Double-blind Phase|Physician Decision|0|||
23319780|NCT02892149|64915613|FG000|Overall Study|Death|262|||
23319781|NCT02892149|64915614|FG001|Overall Study|Death|278|||
23319782|NCT02892149|64915613|FG000|Overall Study|Withdrawal by Subject|53|||
23433209|NCT00129961|65330396|FG000|Overall Study|Death|1|||
23555327|NCT02355002|65758095|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
23555328|NCT02355002|65758094|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
23555329|NCT02355002|65758095|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
23555330|NCT02355002|65758094|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
23555331|NCT02355002|65758095|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
23555332|NCT02355002|65758094|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
23555333|NCT02355002|65758095|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
23555334|NCT02355002|65758094|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
23555335|NCT02355002|65758095|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
23555336|NCT02355002|65758094|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
23555337|NCT02355002|65758095|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
23555338|NCT03014674|65758096|FG000|Overall Study|Withdrawal by Subject|1|||
23555339|NCT03014674|65758097|FG001|Overall Study|Withdrawal by Subject|0|||
23555340|NCT03014674|65758098|FG002|Overall Study|Withdrawal by Subject|0|||
23555341|NCT02481310|65758103|FG000|Follow up|Still in follow up|0|||
23555342|NCT02481310|65758104|FG001|Follow up|Still in follow up|3|||
23555343|NCT02481310|65758105|FG002|Follow up|Still in follow up|0|||
23555344|NCT00156065|65758106|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
23555345|NCT00156065|65758107|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
23555346|NCT00156065|65758108|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
23555347|NCT00156065|65758106|FG000|Overall Study|Adverse Event|8|||
23555348|NCT00156065|65758107|FG001|Overall Study|Adverse Event|11|||
23555349|NCT00156065|65758108|FG002|Overall Study|Adverse Event|4|||
23555350|NCT00156065|65758106|FG000|Overall Study|Lack of Efficacy|2|||
23555351|NCT00156065|65758107|FG001|Overall Study|Lack of Efficacy|9|||
23555352|NCT00156065|65758108|FG002|Overall Study|Lack of Efficacy|3|||
23555353|NCT00156065|65758106|FG000|Overall Study|Withdrawal by Subject|13|||
23555354|NCT00156065|65758107|FG001|Overall Study|Withdrawal by Subject|26|||
23555355|NCT00156065|65758108|FG002|Overall Study|Withdrawal by Subject|16|||
23555356|NCT00156065|65758106|FG000|Overall Study|Lost to Follow-up|5|||
23555357|NCT00156065|65758107|FG001|Overall Study|Lost to Follow-up|7|||
23555358|NCT00156065|65758108|FG002|Overall Study|Lost to Follow-up|1|||
23555359|NCT00156065|65758106|FG000|Overall Study|Other|2|||
23555360|NCT00156065|65758107|FG001|Overall Study|Other|9|||
23555361|NCT00156065|65758108|FG002|Overall Study|Other|3|||
23555362|NCT04198805|65758109|FG000|Overall Study|Death|0|||
23555363|NCT04198805|65758110|FG001|Overall Study|Death|0|||
23555364|NCT04198805|65758111|FG002|Overall Study|Death|0|||
23555365|NCT04198805|65758112|FG003|Overall Study|Death|1|||
23555366|NCT04198805|65758109|FG000|Overall Study|Early Termination|8|||
23555367|NCT04198805|65758110|FG001|Overall Study|Early Termination|4|||
23555368|NCT04198805|65758111|FG002|Overall Study|Early Termination|6|||
23555369|NCT04198805|65758112|FG003|Overall Study|Early Termination|9|||
23555370|NCT05338333|65758113|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
23555371|NCT05338333|65758114|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
23555372|NCT02747238|65758135|FG000|Overall Study|Lack of Efficacy|0|||
23555373|NCT02747238|65758136|FG001|Overall Study|Lack of Efficacy|1|||
23555374|NCT02747238|65758135|FG000|Overall Study|Data lost|3|||
23555375|NCT02747238|65758136|FG001|Overall Study|Data lost|5|||
23555376|NCT01688466|65758137|FG000|Overall Study|Withdrawal by Subject|2|||
23555377|NCT01688466|65758138|FG001|Overall Study|Withdrawal by Subject|1|||
23555378|NCT01688466|65758137|FG000|Overall Study|Death|0|||
23555379|NCT01688466|65758138|FG001|Overall Study|Death|1|||
23555380|NCT01688466|65758137|FG000|Overall Study|Adverse Event|0|||
23555381|NCT01688466|65758138|FG001|Overall Study|Adverse Event|4|||
23555382|NCT01688466|65758137|FG000|Overall Study|Not evaluable|0|||
23622882|NCT01589523|66005052|FG000|Overall Study|Withdrawal by Subject|1|||
23622883|NCT00576823|66005053|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
23433210|NCT00129961|65330397|FG001|Overall Study|Death|1|||
23555383|NCT01688466|65758138|FG001|Overall Study|Not evaluable|1|||
23555384|NCT01181726|65758140|FG000|First Intervention|Adverse Event|1|||
23555385|NCT01181726|65758141|FG001|First Intervention|Adverse Event|0|||
23555386|NCT02332720|65758142|FG000|Part A and Part B|Lost to Follow-up|1|||
23555387|NCT02332720|65758143|FG001|Part A and Part B|Lost to Follow-up|0|||
23555388|NCT02332720|65758144|FG002|Part A and Part B|Lost to Follow-up|0|||
23555389|NCT02332720|65758145|FG003|Part A and Part B|Lost to Follow-up|0|||
23555390|NCT02332720|65758146|FG004|Part A and Part B|Lost to Follow-up|0|||
23555391|NCT02332720|65758147|FG005|Part A and Part B|Lost to Follow-up|2|||
23555392|NCT02332720|65758148|FG006|Part A and Part B|Lost to Follow-up|1|||
23555393|NCT02332720|65758149|FG007|Part A and Part B|Lost to Follow-up|1|||
23555394|NCT02332720|65758150|FG008|Part A and Part B|Lost to Follow-up|0|||
23555395|NCT02332720|65758151|FG009|Part A and Part B|Lost to Follow-up|0|||
23555396|NCT02332720|65758152|FG010|Part A and Part B|Lost to Follow-up|0|||
23555397|NCT02332720|65758153|FG011|Part A and Part B|Lost to Follow-up|0|||
23555398|NCT02332720|65758154|FG012|Part A and Part B|Lost to Follow-up|0|||
23555399|NCT02332720|65758155|FG013|Part A and Part B|Lost to Follow-up|0|||
23555400|NCT02332720|65758156|FG014|Part A and Part B|Lost to Follow-up|0|||
23555401|NCT02332720|65758157|FG015|Part A and Part B|Lost to Follow-up|1|||
23555402|NCT02332720|65758158|FG016|Part A and Part B|Lost to Follow-up|0|||
23555403|NCT02332720|65758159|FG017|Part A and Part B|Lost to Follow-up|0|||
23555404|NCT02332720|65758160|FG018|Part A and Part B|Lost to Follow-up|0|||
23555405|NCT02332720|65758161|FG019|Part A and Part B|Lost to Follow-up|0|||
23555406|NCT02332720|65758162|FG020|Part A and Part B|Lost to Follow-up|0|||
23555407|NCT02332720|65758163|FG021|Part A and Part B|Lost to Follow-up|0|||
23555408|NCT02332720|65758164|FG022|Part A and Part B|Lost to Follow-up|0|||
23555409|NCT02332720|65758142|FG000|Part A and Part B|Adverse Event|0|||
23555410|NCT02332720|65758143|FG001|Part A and Part B|Adverse Event|0|||
23555411|NCT02332720|65758144|FG002|Part A and Part B|Adverse Event|0|||
23555412|NCT02332720|65758145|FG003|Part A and Part B|Adverse Event|0|||
23555413|NCT02332720|65758146|FG004|Part A and Part B|Adverse Event|0|||
23555414|NCT02332720|65758147|FG005|Part A and Part B|Adverse Event|0|||
23555415|NCT02332720|65758148|FG006|Part A and Part B|Adverse Event|0|||
23555416|NCT02332720|65758149|FG007|Part A and Part B|Adverse Event|0|||
23555417|NCT02332720|65758150|FG008|Part A and Part B|Adverse Event|0|||
23555418|NCT02332720|65758151|FG009|Part A and Part B|Adverse Event|0|||
23555419|NCT02332720|65758152|FG010|Part A and Part B|Adverse Event|0|||
23555420|NCT02332720|65758153|FG011|Part A and Part B|Adverse Event|0|||
23555421|NCT02332720|65758154|FG012|Part A and Part B|Adverse Event|0|||
23555422|NCT02332720|65758155|FG013|Part A and Part B|Adverse Event|0|||
23555423|NCT02332720|65758156|FG014|Part A and Part B|Adverse Event|0|||
23555424|NCT02332720|65758157|FG015|Part A and Part B|Adverse Event|0|||
23555425|NCT02332720|65758158|FG016|Part A and Part B|Adverse Event|0|||
23555426|NCT02332720|65758159|FG017|Part A and Part B|Adverse Event|1|||
23555427|NCT02332720|65758160|FG018|Part A and Part B|Adverse Event|0|||
23555428|NCT02332720|65758161|FG019|Part A and Part B|Adverse Event|0|||
23555429|NCT02332720|65758162|FG020|Part A and Part B|Adverse Event|0|||
23555430|NCT02332720|65758163|FG021|Part A and Part B|Adverse Event|0|||
23555431|NCT02332720|65758164|FG022|Part A and Part B|Adverse Event|0|||
23555432|NCT02332720|65758142|FG000|Part A and Part B|Physician Decision|0|||
23555433|NCT02332720|65758143|FG001|Part A and Part B|Physician Decision|0|||
23555434|NCT02332720|65758144|FG002|Part A and Part B|Physician Decision|0|||
23555435|NCT02332720|65758145|FG003|Part A and Part B|Physician Decision|0|||
23555436|NCT02332720|65758146|FG004|Part A and Part B|Physician Decision|0|||
23555437|NCT02332720|65758147|FG005|Part A and Part B|Physician Decision|0|||
23555438|NCT02332720|65758148|FG006|Part A and Part B|Physician Decision|0|||
23555439|NCT02332720|65758149|FG007|Part A and Part B|Physician Decision|0|||
23555440|NCT02332720|65758150|FG008|Part A and Part B|Physician Decision|0|||
23555441|NCT02332720|65758151|FG009|Part A and Part B|Physician Decision|0|||
23555442|NCT02332720|65758152|FG010|Part A and Part B|Physician Decision|0|||
23622884|NCT00576823|66005054|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
23622885|NCT00576823|66005055|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
23622886|NCT00576823|66005053|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
23622887|NCT00576823|66005054|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
23622888|NCT00576823|66005055|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
23622889|NCT00733226|66005060|FG000|Overall Study|Withdrawal by Subject|1|||
23622890|NCT00733226|66005061|FG001|Overall Study|Withdrawal by Subject|0|||
23622891|NCT00733226|66005060|FG000|Overall Study|Lost to Follow-up|2|||
23622892|NCT00733226|66005061|FG001|Overall Study|Lost to Follow-up|0|||
23622893|NCT00733226|66005060|FG000|Overall Study|moved to another place|2|||
23622894|NCT00733226|66005061|FG001|Overall Study|moved to another place|0|||
23622895|NCT03544229|66005062|FG000|Overall Study|Adverse Event|1|||
23622896|NCT03544229|66005063|FG001|Overall Study|Adverse Event|0|||
23622897|NCT03544229|66005064|FG002|Overall Study|Adverse Event|1|||
23217247|NCT00379236|64538231|FG002|Double-blind|Other|0|||
23555443|NCT02332720|65758153|FG011|Part A and Part B|Physician Decision|0|||
23555444|NCT02332720|65758154|FG012|Part A and Part B|Physician Decision|0|||
23555445|NCT02332720|65758155|FG013|Part A and Part B|Physician Decision|0|||
23555446|NCT02332720|65758156|FG014|Part A and Part B|Physician Decision|0|||
23555447|NCT02332720|65758157|FG015|Part A and Part B|Physician Decision|0|||
23555448|NCT02332720|65758158|FG016|Part A and Part B|Physician Decision|0|||
23555449|NCT02332720|65758159|FG017|Part A and Part B|Physician Decision|0|||
23555450|NCT02332720|65758160|FG018|Part A and Part B|Physician Decision|1|||
23555451|NCT02332720|65758161|FG019|Part A and Part B|Physician Decision|0|||
23555452|NCT02332720|65758162|FG020|Part A and Part B|Physician Decision|0|||
23622898|NCT03544229|66005065|FG003|Overall Study|Adverse Event|0|||
23622899|NCT03544229|66005062|FG000|Overall Study|Protocol Deviation|0|||
23622900|NCT03544229|66005063|FG001|Overall Study|Protocol Deviation|0|||
23622901|NCT03544229|66005064|FG002|Overall Study|Protocol Deviation|1|||
23555453|NCT02332720|65758163|FG021|Part A and Part B|Physician Decision|0|||
23555454|NCT02332720|65758164|FG022|Part A and Part B|Physician Decision|0|||
23555455|NCT02332720|65758142|FG000|Part A and Part B|Withdrawal by Subject|0|||
23555456|NCT02332720|65758143|FG001|Part A and Part B|Withdrawal by Subject|0|||
23622902|NCT03544229|66005065|FG003|Overall Study|Protocol Deviation|0|||
23622903|NCT03544229|66005062|FG000|Overall Study|Lost to Follow-up|3|||
23622904|NCT03544229|66005063|FG001|Overall Study|Lost to Follow-up|0|||
23622905|NCT03544229|66005064|FG002|Overall Study|Lost to Follow-up|0|||
23555457|NCT02332720|65758144|FG002|Part A and Part B|Withdrawal by Subject|0|||
23555458|NCT02332720|65758145|FG003|Part A and Part B|Withdrawal by Subject|0|||
23555459|NCT02332720|65758146|FG004|Part A and Part B|Withdrawal by Subject|0|||
23555460|NCT02332720|65758147|FG005|Part A and Part B|Withdrawal by Subject|1|||
23555461|NCT02332720|65758148|FG006|Part A and Part B|Withdrawal by Subject|0|||
23555462|NCT02332720|65758149|FG007|Part A and Part B|Withdrawal by Subject|0|||
23555463|NCT02332720|65758150|FG008|Part A and Part B|Withdrawal by Subject|0|||
23555464|NCT02332720|65758151|FG009|Part A and Part B|Withdrawal by Subject|0|||
23555465|NCT02332720|65758152|FG010|Part A and Part B|Withdrawal by Subject|0|||
23555466|NCT02332720|65758153|FG011|Part A and Part B|Withdrawal by Subject|0|||
23555467|NCT02332720|65758154|FG012|Part A and Part B|Withdrawal by Subject|0|||
23555468|NCT02332720|65758155|FG013|Part A and Part B|Withdrawal by Subject|0|||
23555469|NCT02332720|65758156|FG014|Part A and Part B|Withdrawal by Subject|0|||
23555470|NCT02332720|65758157|FG015|Part A and Part B|Withdrawal by Subject|0|||
23555471|NCT02332720|65758158|FG016|Part A and Part B|Withdrawal by Subject|0|||
23555472|NCT02332720|65758159|FG017|Part A and Part B|Withdrawal by Subject|0|||
23555473|NCT02332720|65758160|FG018|Part A and Part B|Withdrawal by Subject|0|||
23555474|NCT02332720|65758161|FG019|Part A and Part B|Withdrawal by Subject|1|||
23319783|NCT02892149|64915614|FG001|Overall Study|Withdrawal by Subject|47|||
23319784|NCT02892149|64915613|FG000|Overall Study|Lost to Follow-up|37|||
23319785|NCT02892149|64915614|FG001|Overall Study|Lost to Follow-up|31|||
23319786|NCT03092219|64915615|FG000|Overall Study|Protocol Violation|7|||
23319787|NCT03092219|64915616|FG001|Overall Study|Protocol Violation|4|||
23319788|NCT01320293|64915631|FG000|Overall Study|Lack of Efficacy|1|||
23622906|NCT03544229|66005065|FG003|Overall Study|Lost to Follow-up|2|||
23622907|NCT03544229|66005062|FG000|Overall Study|Voluntary Withdrawal|2|||
23622908|NCT03544229|66005063|FG001|Overall Study|Voluntary Withdrawal|1|||
23142722|NCT03439254|64270750|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23142723|NCT03439254|64270751|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23142724|NCT03439254|64270752|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23142725|NCT03439254|64270753|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23142726|NCT03439254|64270754|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
23142727|NCT03439254|64270755|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
23142728|NCT03439254|64270750|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23142729|NCT03439254|64270751|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23142730|NCT03439254|64270752|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23142731|NCT03439254|64270753|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23142732|NCT03439254|64270754|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
23142733|NCT03439254|64270755|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
23142734|NCT03439254|64270750|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23142735|NCT03439254|64270751|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23142736|NCT03439254|64270752|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23319789|NCT01320293|64915631|FG000|Overall Study|Adverse Event|1|||
23319790|NCT04578535|64915637|FG000|Overall Study|Lost to Follow-up|1|||
23555475|NCT02332720|65758162|FG020|Part A and Part B|Withdrawal by Subject|0|||
23555476|NCT02332720|65758163|FG021|Part A and Part B|Withdrawal by Subject|0|||
23555477|NCT02332720|65758164|FG022|Part A and Part B|Withdrawal by Subject|0|||
23622909|NCT03544229|66005064|FG002|Overall Study|Voluntary Withdrawal|3|||
23142737|NCT03439254|64270753|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23142738|NCT03439254|64270754|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
23319791|NCT04578535|64915638|FG001|Overall Study|Lost to Follow-up|0|||
23319792|NCT04578535|64915639|FG002|Overall Study|Lost to Follow-up|0|||
23319793|NCT04578535|64915640|FG003|Overall Study|Lost to Follow-up|1|||
23319794|NCT04578535|64915641|FG004|Overall Study|Lost to Follow-up|0|||
23142739|NCT03439254|64270755|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
23142740|NCT03439254|64270750|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23319795|NCT04578535|64915642|FG005|Overall Study|Lost to Follow-up|2|||
23319796|NCT04578535|64915637|FG000|Overall Study|Pregnancy|1|||
23555478|NCT01410474|65758165|FG000|Overall Study|Withdrawal by Subject|0|||
23319797|NCT04578535|64915638|FG001|Overall Study|Pregnancy|0|||
23555479|NCT01410474|65758166|FG001|Overall Study|Withdrawal by Subject|1|||
23555480|NCT03945188|65758167|FG000|Overall Study|Protocol Violation|1|||
23319798|NCT04578535|64915639|FG002|Overall Study|Pregnancy|0|||
23319799|NCT04578535|64915640|FG003|Overall Study|Pregnancy|0|||
23319800|NCT04578535|64915641|FG004|Overall Study|Pregnancy|0|||
23142741|NCT03439254|64270751|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23142742|NCT03439254|64270752|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23142743|NCT03439254|64270753|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
23142744|NCT03439254|64270754|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23142745|NCT03439254|64270755|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
23142746|NCT03439254|64270750|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
23142747|NCT03439254|64270751|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
23319801|NCT04578535|64915642|FG005|Overall Study|Pregnancy|0|||
23319802|NCT04578535|64915637|FG000|Overall Study|Withdrawal by Subject|0|||
23319803|NCT04578535|64915638|FG001|Overall Study|Withdrawal by Subject|0|||
23319804|NCT04578535|64915639|FG002|Overall Study|Withdrawal by Subject|0|||
23319805|NCT04578535|64915640|FG003|Overall Study|Withdrawal by Subject|1|||
23319806|NCT04578535|64915641|FG004|Overall Study|Withdrawal by Subject|1|||
23319807|NCT04578535|64915642|FG005|Overall Study|Withdrawal by Subject|5|||
23319808|NCT04578535|64915637|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
23319809|NCT04578535|64915638|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
23319810|NCT04578535|64915639|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
23319811|NCT04578535|64915640|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
23319812|NCT04578535|64915641|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
23319813|NCT04578535|64915642|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
23319814|NCT00754650|64915648|FG000|Overall Study|Disease Progression|2|||
23319815|NCT01937871|64915649|FG000|Overall Study|Adverse Event|6|||
23319816|NCT01937871|64915650|FG001|Overall Study|Adverse Event|6|||
23142748|NCT03439254|64270752|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
23142749|NCT03439254|64270753|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
23142750|NCT03439254|64270754|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
23142751|NCT03439254|64270755|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
23142752|NCT03439254|64270750|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
23142753|NCT03439254|64270751|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
23142754|NCT03439254|64270752|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
23142755|NCT03439254|64270753|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
23142756|NCT03439254|64270754|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
23142757|NCT03439254|64270755|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
23142758|NCT02240693|64273683|FG000|Overall Study|Adverse Event|0|||
23319817|NCT01937871|64915651|FG002|Overall Study|Adverse Event|2|||
23319818|NCT01937871|64915649|FG000|Overall Study|Lost to Follow-up|8|||
23319819|NCT01937871|64915650|FG001|Overall Study|Lost to Follow-up|2|||
23319820|NCT01937871|64915651|FG002|Overall Study|Lost to Follow-up|4|||
23319821|NCT01937871|64915649|FG000|Overall Study|Withdrawal by Subject|9|||
23319822|NCT01937871|64915650|FG001|Overall Study|Withdrawal by Subject|6|||
23555481|NCT03945188|65758168|FG001|Overall Study|Protocol Violation|0|||
23555482|NCT03945188|65758167|FG000|Overall Study|Disease worsening|79|||
23555483|NCT03945188|65758168|FG001|Overall Study|Disease worsening|73|||
23555484|NCT03945188|65758167|FG000|Overall Study|Physician Decision|2|||
23555485|NCT03945188|65758168|FG001|Overall Study|Physician Decision|2|||
23555486|NCT03945188|65758167|FG000|Overall Study|Lack of Efficacy|7|||
23555487|NCT03945188|65758168|FG001|Overall Study|Lack of Efficacy|4|||
23555488|NCT03945188|65758167|FG000|Overall Study|Pregnancy|2|||
23555489|NCT03945188|65758168|FG001|Overall Study|Pregnancy|0|||
23555490|NCT03945188|65758167|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
23555491|NCT03945188|65758168|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
23555492|NCT03945188|65758167|FG000|Overall Study|Adverse Event|10|||
23555493|NCT03945188|65758168|FG001|Overall Study|Adverse Event|5|||
23555494|NCT03945188|65758167|FG000|Overall Study|Other|2|||
23555495|NCT03945188|65758168|FG001|Overall Study|Other|2|||
23555496|NCT03945188|65758167|FG000|Overall Study|Lost to Follow-up|1|||
23555497|NCT03945188|65758168|FG001|Overall Study|Lost to Follow-up|2|||
23555498|NCT02163733|65758176|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
23142759|NCT02240693|64273684|FG001|Overall Study|Adverse Event|0|||
23142760|NCT02240693|64273685|FG002|Overall Study|Adverse Event|0|||
23142761|NCT02240693|64273686|FG003|Overall Study|Adverse Event|0|||
23142762|NCT02240693|64273687|FG004|Overall Study|Adverse Event|1|||
23142763|NCT02240693|64273683|FG000|Overall Study|Withdrawal by Subject|0|||
23319823|NCT01937871|64915651|FG002|Overall Study|Withdrawal by Subject|4|||
23319824|NCT01937871|64915649|FG000|Overall Study|Physician Decision|0|||
23319825|NCT01937871|64915650|FG001|Overall Study|Physician Decision|1|||
23319826|NCT01937871|64915651|FG002|Overall Study|Physician Decision|0|||
23555499|NCT02163733|65758177|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
23319827|NCT01937871|64915649|FG000|Overall Study|Entry Criteria Not Met|1|||
23555500|NCT02163733|65758178|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
23217248|NCT00379236|64538229|FG000|Double-blind|Data could not be retrieved|2|||
23217249|NCT00379236|64538230|FG001|Double-blind|Data could not be retrieved|2|||
23217250|NCT00379236|64538231|FG002|Double-blind|Data could not be retrieved|0|||
23217251|NCT00379236|64538229|FG000|Open-label Extension|Adverse Event|0|||
23555501|NCT02163733|65758176|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
23555502|NCT02163733|65758177|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
23555503|NCT02163733|65758178|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
23555504|NCT00504426|65758183|FG000|Overall Study|Adverse Event|0|||
23555505|NCT00504426|65758184|FG001|Overall Study|Adverse Event|0|||
23555506|NCT00504426|65758185|FG002|Overall Study|Adverse Event|2|||
23555507|NCT00504426|65758186|FG003|Overall Study|Adverse Event|0|||
23555508|NCT00504426|65758183|FG000|Overall Study|Protocol Violation|1|||
23555509|NCT00504426|65758184|FG001|Overall Study|Protocol Violation|1|||
23555510|NCT00504426|65758185|FG002|Overall Study|Protocol Violation|2|||
23555511|NCT00504426|65758186|FG003|Overall Study|Protocol Violation|0|||
23555512|NCT00504426|65758183|FG000|Overall Study|Withdrawal by Subject|2|||
23555513|NCT00504426|65758184|FG001|Overall Study|Withdrawal by Subject|0|||
23555514|NCT00504426|65758185|FG002|Overall Study|Withdrawal by Subject|0|||
23555515|NCT00504426|65758186|FG003|Overall Study|Withdrawal by Subject|0|||
23555516|NCT01922076|65762256|FG000|Overall Study|Adverse Event|0|||
23555517|NCT01922076|65762257|FG001|Overall Study|Adverse Event|0|||
23555518|NCT01922076|65762258|FG002|Overall Study|Adverse Event|0|||
23555519|NCT01922076|65762259|FG003|Overall Study|Adverse Event|0|||
23555520|NCT01922076|65762260|FG004|Overall Study|Adverse Event|1|||
23555521|NCT01922076|65762261|FG005|Overall Study|Adverse Event|0|||
23555522|NCT01922076|65762262|FG006|Overall Study|Adverse Event|0|||
23555523|NCT01922076|65762256|FG000|Overall Study|Physician Decision|0|||
23555524|NCT01922076|65762257|FG001|Overall Study|Physician Decision|0|||
23555525|NCT01922076|65762258|FG002|Overall Study|Physician Decision|1|||
23555526|NCT01922076|65762259|FG003|Overall Study|Physician Decision|0|||
23555527|NCT01922076|65762260|FG004|Overall Study|Physician Decision|0|||
23555528|NCT01922076|65762261|FG005|Overall Study|Physician Decision|0|||
23555529|NCT01922076|65762262|FG006|Overall Study|Physician Decision|0|||
23555530|NCT01922076|65762256|FG000|Overall Study|Withdrawal by Subject|0|||
23555531|NCT01922076|65762257|FG001|Overall Study|Withdrawal by Subject|0|||
23555532|NCT01922076|65762258|FG002|Overall Study|Withdrawal by Subject|0|||
23555533|NCT01922076|65762259|FG003|Overall Study|Withdrawal by Subject|1|||
23555534|NCT01922076|65762260|FG004|Overall Study|Withdrawal by Subject|0|||
23555535|NCT01922076|65762261|FG005|Overall Study|Withdrawal by Subject|1|||
23555536|NCT01922076|65762262|FG006|Overall Study|Withdrawal by Subject|1|||
23555537|NCT00453986|65762263|FG000|Overall Study|Lost to Follow-up|6|||
23555538|NCT00453986|65762264|FG001|Overall Study|Lost to Follow-up|5|||
23555539|NCT00453986|65762265|FG002|Overall Study|Lost to Follow-up|6|||
23555540|NCT00453986|65762266|FG003|Overall Study|Lost to Follow-up|2|||
23555541|NCT00453986|65762267|FG004|Overall Study|Lost to Follow-up|0|||
23555542|NCT00689221|65762268|FG000|Overall Study|Ongoing at cut-off date|39|||
23555543|NCT00689221|65762269|FG001|Overall Study|Ongoing at cut-off date|36|||
23555544|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
23555545|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
23555546|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
23555547|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
23555548|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
23555549|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
23555550|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
23555551|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
23555552|NCT00117676|65762270|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
23555553|NCT00117676|65762271|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
23555554|NCT00117676|65762270|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
23555555|NCT00117676|65762271|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
23555556|NCT00117676|65762270|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
23555557|NCT00117676|65762271|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
23555558|NCT00117676|65762270|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
23217252|NCT00379236|64538230|FG001|Open-label Extension|Adverse Event|0|||
23555559|NCT00117676|65762271|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
23555560|NCT00117676|65762270|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
23555561|NCT00117676|65762271|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
23622910|NCT03544229|66005065|FG003|Overall Study|Voluntary Withdrawal|0|||
23217253|NCT00379236|64538231|FG002|Open-label Extension|Adverse Event|13|||
23217254|NCT00379236|64538229|FG000|Open-label Extension|Protocol Violation|0|||
23555562|NCT00117676|65762270|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
23555563|NCT00117676|65762271|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
23555564|NCT00117676|65762270|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
23555565|NCT00117676|65762271|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
23555566|NCT00117676|65762270|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
23555567|NCT00117676|65762271|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
23555568|NCT00117676|65762270|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
23555569|NCT00117676|65762271|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
23555570|NCT00117676|65762270|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
23319828|NCT01937871|64915650|FG001|Overall Study|Entry Criteria Not Met|2|||
23319829|NCT01937871|64915651|FG002|Overall Study|Entry Criteria Not Met|1|||
23319830|NCT03071276|64915652|FG000|Overall Study|Adverse Event|1|||
23319831|NCT03071276|64915652|FG000|Overall Study|Lack of Efficacy|14|||
23319832|NCT01262872|64915653|FG000|Step 2|Death|0|||
23319833|NCT01262872|64915654|FG001|Step 2|Death|0|||
23319834|NCT01262872|64915655|FG002|Step 2|Death|0|||
23319835|NCT01262872|64915656|FG003|Step 2|Death|1|||
23319836|NCT01262872|64915657|FG004|Step 2|Death|0|||
23622911|NCT03544229|66005062|FG000|Overall Study|Lack of Efficacy|0|||
23622912|NCT03544229|66005063|FG001|Overall Study|Lack of Efficacy|1|||
23622913|NCT03544229|66005064|FG002|Overall Study|Lack of Efficacy|0|||
23622914|NCT03544229|66005065|FG003|Overall Study|Lack of Efficacy|0|||
23622915|NCT01726517|66005068|FG000|Overall Study|Withdrawal by Subject|0|||
23433211|NCT00129961|65330396|FG000|Overall Study|Withdrawal by Sponsor|14|||
23433212|NCT00129961|65330397|FG001|Overall Study|Withdrawal by Sponsor|20|||
23433213|NCT00129961|65330396|FG000|Overall Study|Physician Decision|1|||
23433214|NCT00129961|65330397|FG001|Overall Study|Physician Decision|0|||
23555571|NCT00117676|65762271|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
23319837|NCT01262872|64915658|FG005|Step 2|Death|2|||
23319838|NCT01262872|64915659|FG006|Step 2|Death|2|||
23319839|NCT01262872|64915660|FG007|Step 2|Death|1|||
23555572|NCT00117676|65762270|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
23555573|NCT00117676|65762271|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
23555574|NCT00117676|65762270|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
23142764|NCT02240693|64273684|FG001|Overall Study|Withdrawal by Subject|0|||
23142765|NCT02240693|64273685|FG002|Overall Study|Withdrawal by Subject|2|||
23142766|NCT02240693|64273686|FG003|Overall Study|Withdrawal by Subject|1|||
23142767|NCT02240693|64273687|FG004|Overall Study|Withdrawal by Subject|0|||
23142768|NCT02240693|64273683|FG000|Overall Study|Other than specified|0|||
23142769|NCT02240693|64273684|FG001|Overall Study|Other than specified|0|||
23142770|NCT02240693|64273685|FG002|Overall Study|Other than specified|2|||
23142771|NCT02240693|64273686|FG003|Overall Study|Other than specified|0|||
23142772|NCT02240693|64273687|FG004|Overall Study|Other than specified|0|||
23142773|NCT00423930|64273688|FG000|Overall Study|Withdrawal by Subject|2|||
23142774|NCT01047293|64273691|FG000|Overall Study|DLT criteria not fulfilled|1|||
23142775|NCT01047293|64273692|FG001|Overall Study|DLT criteria not fulfilled|1|||
23142776|NCT01047293|64273693|FG002|Overall Study|DLT criteria not fulfilled|0|||
23142777|NCT01047293|64273694|FG003|Overall Study|DLT criteria not fulfilled|0|||
23142778|NCT03343301|64273695|FG000|Overall Study|Withdrawal by Subject|1|||
23142779|NCT03343301|64273696|FG001|Overall Study|Withdrawal by Subject|1|||
23142780|NCT03343301|64273695|FG000|Overall Study|Death|0|||
23142781|NCT03343301|64273696|FG001|Overall Study|Death|2|||
23142782|NCT03343301|64273695|FG000|Overall Study|Other|0|||
23142783|NCT03343301|64273696|FG001|Overall Study|Other|6|||
23142784|NCT03343301|64273695|FG000|Overall Study|Missing|2|||
23142785|NCT03343301|64273696|FG001|Overall Study|Missing|0|||
23142786|NCT01201317|64273699|FG000|Overall Study|Withdrawal by Subject|5|||
23142787|NCT01201317|64273700|FG001|Overall Study|Withdrawal by Subject|0|||
23142788|NCT01201317|64273701|FG002|Overall Study|Withdrawal by Subject|3|||
23142789|NCT01201317|64273699|FG000|Overall Study|Adverse Event|2|||
23142790|NCT01201317|64273700|FG001|Overall Study|Adverse Event|2|||
23142791|NCT01201317|64273701|FG002|Overall Study|Adverse Event|2|||
23142792|NCT01201317|64273699|FG000|Overall Study|Screen failure|1|||
23142793|NCT01201317|64273700|FG001|Overall Study|Screen failure|1|||
23142794|NCT01201317|64273701|FG002|Overall Study|Screen failure|0|||
23142795|NCT01201317|64273699|FG000|Overall Study|Protocol Violation|0|||
23142796|NCT01201317|64273700|FG001|Overall Study|Protocol Violation|1|||
23142797|NCT01201317|64273701|FG002|Overall Study|Protocol Violation|1|||
23142798|NCT01201317|64273699|FG000|Overall Study|Death|0|||
23142799|NCT01201317|64273700|FG001|Overall Study|Death|1|||
23142800|NCT01201317|64273701|FG002|Overall Study|Death|0|||
23142801|NCT01201317|64273699|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23142802|NCT01201317|64273700|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23142803|NCT01201317|64273701|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23142804|NCT01201317|64273699|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
23142805|NCT01201317|64273700|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
23319840|NCT01262872|64915653|FG000|Step 2|Protocol Violation|0|||
23142806|NCT01201317|64273701|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
23142807|NCT01201317|64273699|FG000|Overall Study|Decrease in renal function|0|||
23319841|NCT01262872|64915654|FG001|Step 2|Protocol Violation|0|||
23142808|NCT01201317|64273700|FG001|Overall Study|Decrease in renal function|1|||
23142809|NCT01201317|64273701|FG002|Overall Study|Decrease in renal function|0|||
23142810|NCT01201317|64273699|FG000|Overall Study|Lack of Efficacy|1|||
23142811|NCT01201317|64273700|FG001|Overall Study|Lack of Efficacy|0|||
23142812|NCT01201317|64273701|FG002|Overall Study|Lack of Efficacy|0|||
23142813|NCT01201317|64273699|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
23319842|NCT01262872|64915655|FG002|Step 2|Protocol Violation|1|||
23319843|NCT01262872|64915656|FG003|Step 2|Protocol Violation|0|||
23319844|NCT01262872|64915657|FG004|Step 2|Protocol Violation|0|||
23319845|NCT01262872|64915658|FG005|Step 2|Protocol Violation|0|||
23319846|NCT01262872|64915659|FG006|Step 2|Protocol Violation|3|||
23319847|NCT01262872|64915660|FG007|Step 2|Protocol Violation|1|||
23319848|NCT01262872|64915653|FG000|Step 2|Withdrawal by Subject|0|||
23319849|NCT01262872|64915654|FG001|Step 2|Withdrawal by Subject|0|||
23319850|NCT01262872|64915655|FG002|Step 2|Withdrawal by Subject|4|||
23319851|NCT01262872|64915656|FG003|Step 2|Withdrawal by Subject|6|||
23319852|NCT01262872|64915657|FG004|Step 2|Withdrawal by Subject|3|||
23319853|NCT01262872|64915658|FG005|Step 2|Withdrawal by Subject|1|||
23319854|NCT01262872|64915659|FG006|Step 2|Withdrawal by Subject|2|||
23319855|NCT01262872|64915660|FG007|Step 2|Withdrawal by Subject|1|||
23319856|NCT01262872|64915653|FG000|Step 2|Migrated/moved from study area|0|||
23319857|NCT01262872|64915654|FG001|Step 2|Migrated/moved from study area|0|||
23319858|NCT01262872|64915655|FG002|Step 2|Migrated/moved from study area|4|||
23319859|NCT01262872|64915656|FG003|Step 2|Migrated/moved from study area|3|||
23319860|NCT01262872|64915657|FG004|Step 2|Migrated/moved from study area|2|||
23319861|NCT01262872|64915658|FG005|Step 2|Migrated/moved from study area|6|||
23433215|NCT00129961|65330396|FG000|Overall Study|Withdrawal by Subject|2|||
23433216|NCT00129961|65330397|FG001|Overall Study|Withdrawal by Subject|1|||
23433217|NCT00129961|65330396|FG000|Overall Study|Missing Record|0|||
23433218|NCT00129961|65330397|FG001|Overall Study|Missing Record|1|||
23433219|NCT02925741|65330398|FG000|Overall Study|Withdrawal by Subject|11|||
23433220|NCT02925741|65330399|FG001|Overall Study|Withdrawal by Subject|0|||
23319862|NCT01262872|64915659|FG006|Step 2|Migrated/moved from study area|2|||
23319863|NCT01262872|64915660|FG007|Step 2|Migrated/moved from study area|3|||
23319864|NCT02861014|64915661|FG000|Primary Analysis|Adverse Event|7|||
23319865|NCT02861014|64915661|FG000|Primary Analysis|Death|1|||
23319866|NCT02861014|64915661|FG000|Primary Analysis|Lack of Efficacy|3|||
23319867|NCT02861014|64915661|FG000|Primary Analysis|Physician Decision|2|||
23319868|NCT02861014|64915661|FG000|Primary Analysis|Pregnancy|4|||
23319869|NCT02861014|64915661|FG000|Primary Analysis|Protocol Violation|2|||
23319870|NCT02861014|64915661|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
23319871|NCT02861014|64915661|FG000|Primary Analysis|Withdrawal by Subject|14|||
23319872|NCT02861014|64915661|FG000|Primary Analysis|Commercial ocrelizumab|3|||
23319873|NCT02861014|64915661|FG000|Safety Follow-up|Adverse Event|1|||
23319874|NCT02861014|64915661|FG000|Safety Follow-up|Pregnancy|1|||
23319875|NCT02861014|64915661|FG000|Safety Follow-up|Withdrawal by Subject|9|||
23319876|NCT02861014|64915661|FG000|Safety Follow-up|Study terminated by sponsor|1|||
23319877|NCT02861014|64915661|FG000|Safety Follow-up|Physician Decision|1|||
23319878|NCT02861014|64915661|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
23319879|NCT02861014|64915661|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
23319880|NCT01526057|64915662|FG000|Overall Study|Withdrawal by Subject|3|||
23319881|NCT01526057|64915663|FG001|Overall Study|Withdrawal by Subject|2|||
23319882|NCT01526057|64915664|FG002|Overall Study|Withdrawal by Subject|2|||
23319883|NCT01526057|64915662|FG000|Overall Study|Adverse Event|3|||
23319884|NCT01526057|64915663|FG001|Overall Study|Adverse Event|1|||
23319885|NCT01526057|64915664|FG002|Overall Study|Adverse Event|1|||
23319886|NCT01526057|64915662|FG000|Overall Study|Death|1|||
23319887|NCT01526057|64915663|FG001|Overall Study|Death|0|||
23319888|NCT01526057|64915664|FG002|Overall Study|Death|0|||
23433221|NCT00395850|65330400|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
23555575|NCT00117676|65762271|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
23555576|NCT00117676|65762270|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
23555577|NCT00117676|65762271|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
23555578|NCT00117676|65762270|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
23555579|NCT00117676|65762271|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
23555580|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
23555581|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
23555582|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
23555583|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
23555584|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
23142814|NCT01201317|64273700|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
23142815|NCT01201317|64273701|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
23142816|NCT01639495|64273702|FG000|Overall Study|Lost to Follow-up|6|||
23319889|NCT01526057|64915662|FG000|Overall Study|Lost to Follow-up|1|||
23319890|NCT01526057|64915663|FG001|Overall Study|Lost to Follow-up|0|||
23622916|NCT01726517|66005069|FG001|Overall Study|Withdrawal by Subject|0|||
23142817|NCT01639495|64273702|FG000|Overall Study|Consented but didn't have study catheter|4|||
23217255|NCT00379236|64538230|FG001|Open-label Extension|Protocol Violation|0|||
23217256|NCT00379236|64538231|FG002|Open-label Extension|Protocol Violation|7|||
23217257|NCT00379236|64538229|FG000|Open-label Extension|Withdrawal by Subject|0|||
23217258|NCT00379236|64538230|FG001|Open-label Extension|Withdrawal by Subject|0|||
23217259|NCT00379236|64538231|FG002|Open-label Extension|Withdrawal by Subject|13|||
23217260|NCT00379236|64538229|FG000|Open-label Extension|Lost to Follow-up|0|||
23217261|NCT00379236|64538230|FG001|Open-label Extension|Lost to Follow-up|0|||
23217262|NCT00379236|64538231|FG002|Open-label Extension|Lost to Follow-up|12|||
23217263|NCT00379236|64538229|FG000|Open-label Extension|Use of exclusionary medication|0|||
23217264|NCT00379236|64538230|FG001|Open-label Extension|Use of exclusionary medication|0|||
23217265|NCT00379236|64538231|FG002|Open-label Extension|Use of exclusionary medication|3|||
23217266|NCT00379236|64538229|FG000|Open-label Extension|Other|0|||
23217267|NCT00379236|64538230|FG001|Open-label Extension|Other|0|||
23217268|NCT00379236|64538231|FG002|Open-label Extension|Other|7|||
23217269|NCT02254551|64538236|FG000|Dose Escalation|Physician Decision|1|||
23217270|NCT02254551|64538236|FG000|Dose Escalation|Dose-limiting toxicity|2|||
23319891|NCT01526057|64915664|FG002|Overall Study|Lost to Follow-up|1|||
23319892|NCT01526057|64915662|FG000|Overall Study|Other|1|||
23319893|NCT01526057|64915663|FG001|Overall Study|Other|0|||
23319894|NCT01526057|64915664|FG002|Overall Study|Other|1|||
23319895|NCT01526057|64915662|FG000|Overall Study|Protocol Violation|0|||
23319896|NCT01526057|64915663|FG001|Overall Study|Protocol Violation|0|||
23319897|NCT01526057|64915664|FG002|Overall Study|Protocol Violation|1|||
23319898|NCT03536884|64915665|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
23319899|NCT03536884|64915666|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
23319900|NCT03536884|64915667|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319901|NCT03536884|64915668|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319902|NCT03536884|64915669|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319903|NCT03536884|64915670|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319904|NCT03536884|64915671|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319905|NCT03536884|64915672|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319906|NCT03536884|64915673|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319907|NCT03536884|64915674|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319908|NCT03536884|64915675|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319909|NCT03536884|64915676|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
23319910|NCT03536884|64915665|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319911|NCT03536884|64915666|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
23319912|NCT03536884|64915667|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319913|NCT03536884|64915668|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319914|NCT03536884|64915669|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319915|NCT03536884|64915670|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319916|NCT03536884|64915671|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319917|NCT03536884|64915672|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319918|NCT03536884|64915673|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319919|NCT03536884|64915674|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23622917|NCT01726517|66005070|FG002|Overall Study|Withdrawal by Subject|1|||
23142818|NCT01639495|64273702|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
23142819|NCT01639495|64273702|FG000|Overall Study|No radiofrequency energy applied|2|||
23142820|NCT02208999|64273705|FG000|Overall Study|Lost to Follow-up|1|||
23142821|NCT02121834|64273706|FG000|Overall Study|Protocol Violation|0|||
23142822|NCT02121834|64273707|FG001|Overall Study|Protocol Violation|1|||
23142823|NCT02121834|64273708|FG002|Overall Study|Protocol Violation|0|||
23142824|NCT02121834|64273709|FG003|Overall Study|Protocol Violation|0|||
23142825|NCT02121834|64273710|FG004|Overall Study|Protocol Violation|0|||
23142826|NCT02121834|64273711|FG005|Overall Study|Protocol Violation|0|||
23142827|NCT02121834|64273712|FG006|Overall Study|Protocol Violation|0|||
23142828|NCT02121834|64273706|FG000|Overall Study|Withdrawal by Subject|0|||
23142829|NCT02121834|64273707|FG001|Overall Study|Withdrawal by Subject|1|||
23217271|NCT01851863|64538237|FG000|Overall Study|Did not receive study medication|2|||
23217272|NCT01851863|64538238|FG001|Overall Study|Did not receive study medication|5|||
23217273|NCT01851863|64538239|FG002|Overall Study|Did not receive study medication|3|||
23319920|NCT03536884|64915675|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319921|NCT03536884|64915676|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
23319922|NCT03536884|64915665|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
23622918|NCT01726517|66005071|FG003|Overall Study|Withdrawal by Subject|0|||
23142830|NCT02121834|64273708|FG002|Overall Study|Withdrawal by Subject|1|||
23142831|NCT02121834|64273709|FG003|Overall Study|Withdrawal by Subject|0|||
23217274|NCT01851863|64538240|FG003|Overall Study|Did not receive study medication|0|||
23142832|NCT02121834|64273710|FG004|Overall Study|Withdrawal by Subject|0|||
23142833|NCT02121834|64273711|FG005|Overall Study|Withdrawal by Subject|0|||
23142834|NCT02121834|64273712|FG006|Overall Study|Withdrawal by Subject|0|||
23142835|NCT02121834|64273706|FG000|Overall Study|Lost to Follow-up|0|||
23142836|NCT02121834|64273707|FG001|Overall Study|Lost to Follow-up|0|||
23142837|NCT02121834|64273708|FG002|Overall Study|Lost to Follow-up|1|||
23142838|NCT02121834|64273709|FG003|Overall Study|Lost to Follow-up|0|||
23142839|NCT02121834|64273710|FG004|Overall Study|Lost to Follow-up|0|||
23142840|NCT02121834|64273711|FG005|Overall Study|Lost to Follow-up|0|||
23142841|NCT02121834|64273712|FG006|Overall Study|Lost to Follow-up|0|||
23142842|NCT02634346|64273713|FG000|Overall Study|Withdrawal by Subject|8|||
23142843|NCT02634346|64273714|FG001|Overall Study|Withdrawal by Subject|9|||
23142844|NCT02634346|64273715|FG002|Overall Study|Withdrawal by Subject|8|||
23142845|NCT02634346|64273713|FG000|Overall Study|Adverse Event|2|||
23142846|NCT02634346|64273714|FG001|Overall Study|Adverse Event|2|||
23142847|NCT02634346|64273715|FG002|Overall Study|Adverse Event|7|||
23142848|NCT02634346|64273713|FG000|Overall Study|Lack of Efficacy|1|||
23142849|NCT02634346|64273714|FG001|Overall Study|Lack of Efficacy|2|||
23142850|NCT02634346|64273715|FG002|Overall Study|Lack of Efficacy|8|||
23142851|NCT02634346|64273713|FG000|Overall Study|Lost to Follow-up|1|||
23142852|NCT02634346|64273714|FG001|Overall Study|Lost to Follow-up|0|||
23142853|NCT02634346|64273715|FG002|Overall Study|Lost to Follow-up|0|||
23142854|NCT02634346|64273713|FG000|Overall Study|Protocol Violation|0|||
23142855|NCT02634346|64273714|FG001|Overall Study|Protocol Violation|1|||
23142856|NCT02634346|64273715|FG002|Overall Study|Protocol Violation|0|||
23142857|NCT00709852|64273716|FG000|Period 1|Adverse Event|2|||
23142858|NCT00709852|64273717|FG001|Period 1|Adverse Event|0|||
23142859|NCT00709852|64273716|FG000|Period 1|Withdrawal by Subject|4|||
23142860|NCT00709852|64273717|FG001|Period 1|Withdrawal by Subject|2|||
23142861|NCT00709852|64273716|FG000|Period 1|Protocol Violation|1|||
23142862|NCT00709852|64273717|FG001|Period 1|Protocol Violation|0|||
23319923|NCT03536884|64915666|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
23319924|NCT03536884|64915667|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23319925|NCT03536884|64915668|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23319926|NCT03536884|64915669|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23319927|NCT03536884|64915670|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23433222|NCT00395850|65330401|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
23433223|NCT00395850|65330402|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
23433224|NCT00395850|65330403|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
23433225|NCT00395850|65330400|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
23433226|NCT00395850|65330401|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
23433227|NCT00395850|65330402|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
23433228|NCT00395850|65330403|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
23433229|NCT00395850|65330400|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
23433230|NCT00395850|65330401|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
23433231|NCT00395850|65330402|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
23433232|NCT00395850|65330403|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
23433233|NCT00395850|65330400|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
23433234|NCT00395850|65330401|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
23433235|NCT00395850|65330402|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
23433236|NCT00395850|65330403|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
23433237|NCT00395850|65330400|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
23433238|NCT00395850|65330401|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
23433239|NCT00395850|65330402|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
23433240|NCT00395850|65330403|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
23433241|NCT00395850|65330400|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
23433242|NCT00395850|65330401|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
23142863|NCT00709852|64273716|FG000|Period 1|Defective scanner|0|||
23142864|NCT00709852|64273717|FG001|Period 1|Defective scanner|1|||
23142865|NCT00709852|64273716|FG000|Period 1|Lost to Follow-up|1|||
23142866|NCT00709852|64273717|FG001|Period 1|Lost to Follow-up|0|||
23142867|NCT00709852|64273716|FG000|Period 2|Protocol Violation|4|||
23142868|NCT00709852|64273717|FG001|Period 2|Protocol Violation|1|||
23142869|NCT00709852|64273716|FG000|Period 2|Adverse Event|1|||
23142870|NCT00709852|64273717|FG001|Period 2|Adverse Event|1|||
23142871|NCT00709852|64273716|FG000|Period 2|Lost to Follow-up|1|||
23142872|NCT00709852|64273717|FG001|Period 2|Lost to Follow-up|0|||
23142873|NCT00709852|64273716|FG000|Period 2|No 72-hour follow-up|3|||
23142874|NCT00709852|64273717|FG001|Period 2|No 72-hour follow-up|0|||
23142875|NCT03278106|64273718|FG000|Overall Study|No protocol treatment|1|||
23142876|NCT02668185|64273719|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
23142877|NCT02668185|64273720|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
23142878|NCT02668185|64273719|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
23142879|NCT02668185|64273720|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
23142880|NCT02668185|64273719|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
23142881|NCT02668185|64273720|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
23319928|NCT03536884|64915671|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23319929|NCT03536884|64915672|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23319930|NCT03536884|64915673|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23319931|NCT03536884|64915674|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23319932|NCT03536884|64915675|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23319933|NCT03536884|64915676|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
23319934|NCT03536884|64915665|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319935|NCT03536884|64915666|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
23319936|NCT03536884|64915667|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319937|NCT03536884|64915668|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319938|NCT03536884|64915669|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319939|NCT03536884|64915670|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319940|NCT03536884|64915671|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319941|NCT03536884|64915672|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319942|NCT03536884|64915673|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319943|NCT03536884|64915674|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319944|NCT03536884|64915675|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319945|NCT03536884|64915676|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
23319946|NCT03536884|64915665|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319947|NCT03536884|64915666|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
23319948|NCT03536884|64915667|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319949|NCT03536884|64915668|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319950|NCT03536884|64915669|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319951|NCT03536884|64915670|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319952|NCT03536884|64915671|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319953|NCT03536884|64915672|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319954|NCT03536884|64915673|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319955|NCT03536884|64915674|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319956|NCT03536884|64915675|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319957|NCT03536884|64915676|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
23319958|NCT03536884|64915665|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319959|NCT03536884|64915666|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
23319960|NCT03536884|64915667|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319961|NCT03536884|64915668|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319962|NCT03536884|64915669|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319963|NCT03536884|64915670|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319964|NCT03536884|64915671|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319965|NCT03536884|64915672|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319966|NCT03536884|64915673|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319967|NCT03536884|64915674|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319968|NCT03536884|64915675|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319969|NCT03536884|64915676|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
23319970|NCT03536884|64915665|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319971|NCT03536884|64915666|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319972|NCT03536884|64915667|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
23319973|NCT03536884|64915668|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319974|NCT03536884|64915669|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
23319975|NCT03536884|64915670|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319976|NCT03536884|64915671|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319977|NCT03536884|64915672|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319978|NCT03536884|64915673|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319979|NCT03536884|64915674|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319980|NCT03536884|64915675|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319981|NCT03536884|64915676|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
23319982|NCT03536884|64915665|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23142882|NCT02668185|64273719|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
23142883|NCT02668185|64273720|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
23142884|NCT02483585|64273721|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
23142885|NCT02483585|64273722|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
23142886|NCT02483585|64273721|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
23142887|NCT02483585|64273722|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
23142888|NCT02483585|64273721|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
23142889|NCT02483585|64273722|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
23217275|NCT01851863|64538237|FG000|Overall Study|Lost to Follow-up|3|||
23217276|NCT01851863|64538238|FG001|Overall Study|Lost to Follow-up|4|||
23217277|NCT01851863|64538239|FG002|Overall Study|Lost to Follow-up|2|||
23217278|NCT01851863|64538240|FG003|Overall Study|Lost to Follow-up|3|||
23217279|NCT00469209|64538241|FG000|Overall Study|Adverse Event|1|||
23217280|NCT00469209|64538242|FG001|Overall Study|Adverse Event|0|||
23217281|NCT00469209|64538243|FG002|Overall Study|Adverse Event|1|||
23142890|NCT02483585|64273721|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
23142891|NCT02483585|64273722|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
23142892|NCT02483585|64273721|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
23142893|NCT02483585|64273722|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
23142894|NCT02483585|64273721|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
23142895|NCT02483585|64273722|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
23142896|NCT02483585|64273721|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
23142897|NCT02483585|64273722|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
23142898|NCT00368992|64273723|FG000|Overall Study|Ineligible|5|||
23142899|NCT00368992|64273723|FG000|Overall Study|Refused treatment|3|||
23142900|NCT00368992|64273723|FG000|Overall Study|Lack of Efficacy|63|||
23217282|NCT03934203|64538245|FG000|Overall Study|Adverse Event|0|||
23217283|NCT03934203|64538246|FG001|Overall Study|Adverse Event|0|||
23217284|NCT03934203|64538247|FG002|Overall Study|Adverse Event|1|||
23319983|NCT03536884|64915666|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23319984|NCT03536884|64915667|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
23319985|NCT03536884|64915668|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
23319986|NCT03536884|64915669|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
23319987|NCT03536884|64915670|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23433243|NCT00395850|65330402|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
23433244|NCT00395850|65330403|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
23217285|NCT03934203|64538248|FG003|Overall Study|Adverse Event|0|||
23217286|NCT03934203|64538249|FG004|Overall Study|Adverse Event|1|||
23217287|NCT03934203|64538250|FG005|Overall Study|Adverse Event|0|||
23217288|NCT03934203|64538251|FG006|Overall Study|Adverse Event|2|||
23217289|NCT03934203|64538252|FG007|Overall Study|Adverse Event|0|||
23217290|NCT03934203|64538253|FG008|Overall Study|Adverse Event|0|||
23217291|NCT03934203|64538254|FG009|Overall Study|Adverse Event|0|||
23217292|NCT03934203|64538255|FG010|Overall Study|Adverse Event|0|||
23217293|NCT03934203|64538256|FG011|Overall Study|Adverse Event|0|||
23217294|NCT03934203|64538257|FG012|Overall Study|Adverse Event|0|||
23217295|NCT03934203|64538258|FG013|Overall Study|Adverse Event|1|||
23217296|NCT03934203|64538259|FG014|Overall Study|Adverse Event|0|||
23217297|NCT01042938|64538260|FG000|Overall Study|Withdrawal by Subject|1|||
23217298|NCT01042938|64538261|FG001|Overall Study|Withdrawal by Subject|1|||
23217299|NCT01042938|64538260|FG000|Overall Study|Protocol Violation|1|||
23622919|NCT01726517|66005072|FG004|Overall Study|Withdrawal by Subject|0|||
23622920|NCT01482429|66005073|FG000|Care Usual|Protocol Violation|0|||
23622921|NCT01482429|66005074|FG001|Care Usual|Protocol Violation|172|||
23622922|NCT01482429|66005073|FG000|Care Usual|Lost to Follow-up|0|||
23622923|NCT01482429|66005074|FG001|Care Usual|Lost to Follow-up|1|||
23622924|NCT01482429|66005073|FG000|Protocol|Protocol Violation|275|||
23622925|NCT01482429|66005074|FG001|Protocol|Protocol Violation|0|||
23622926|NCT03279978|66005076|FG000|Overall Study|Withdrawal by Subject|0|||
23622927|NCT03279978|66005077|FG001|Overall Study|Withdrawal by Subject|1|||
23622928|NCT03279978|66005078|FG002|Overall Study|Withdrawal by Subject|0|||
23622929|NCT03279978|66005079|FG003|Overall Study|Withdrawal by Subject|0|||
23622930|NCT03279978|66005080|FG004|Overall Study|Withdrawal by Subject|0|||
23622931|NCT03279978|66005081|FG005|Overall Study|Withdrawal by Subject|0|||
23622932|NCT03279978|66005082|FG006|Overall Study|Withdrawal by Subject|0|||
23622933|NCT03279978|66005083|FG007|Overall Study|Withdrawal by Subject|0|||
23622934|NCT03279978|66005084|FG008|Overall Study|Withdrawal by Subject|0|||
23622935|NCT03279978|66005085|FG009|Overall Study|Withdrawal by Subject|1|||
23622936|NCT03279978|66005076|FG000|Overall Study|Lost to Follow-up|1|||
23142901|NCT00368992|64273723|FG000|Overall Study|Adverse Event|26|||
23217300|NCT01042938|64538261|FG001|Overall Study|Protocol Violation|1|||
23217301|NCT01042938|64538260|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
23217302|NCT01042938|64538261|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
23433245|NCT00395850|65330400|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
23433246|NCT00395850|65330401|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
23622937|NCT03279978|66005077|FG001|Overall Study|Lost to Follow-up|0|||
23217303|NCT02650895|64538265|FG000|Overall Study|Withdrawal by Subject|0|||
23217304|NCT02650895|64538266|FG001|Overall Study|Withdrawal by Subject|1|||
23433247|NCT00395850|65330402|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
23433248|NCT00395850|65330403|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
23433249|NCT04583956|65330404|FG000|Overall Study|Death|9|||
23433250|NCT04583956|65330405|FG001|Overall Study|Death|11|||
23433251|NCT04583956|65330404|FG000|Overall Study|Lost to Follow-up|7|||
23433252|NCT04583956|65330405|FG001|Overall Study|Lost to Follow-up|9|||
23433253|NCT04583956|65330404|FG000|Overall Study|Protocol Violation|2|||
23433254|NCT04583956|65330405|FG001|Overall Study|Protocol Violation|0|||
23433255|NCT04583956|65330404|FG000|Overall Study|Withdrawal by Subject|0|||
23622938|NCT03279978|66005078|FG002|Overall Study|Lost to Follow-up|1|||
23622939|NCT03279978|66005079|FG003|Overall Study|Lost to Follow-up|0|||
23622940|NCT03279978|66005080|FG004|Overall Study|Lost to Follow-up|0|||
23622941|NCT03279978|66005081|FG005|Overall Study|Lost to Follow-up|0|||
23622942|NCT03279978|66005082|FG006|Overall Study|Lost to Follow-up|0|||
23622943|NCT03279978|66005083|FG007|Overall Study|Lost to Follow-up|0|||
23622944|NCT03279978|66005084|FG008|Overall Study|Lost to Follow-up|0|||
23622945|NCT03279978|66005085|FG009|Overall Study|Lost to Follow-up|0|||
23622946|NCT03279978|66005076|FG000|Overall Study|Other than stated above|0|||
23622947|NCT03279978|66005077|FG001|Overall Study|Other than stated above|0|||
23622948|NCT03279978|66005078|FG002|Overall Study|Other than stated above|0|||
23622949|NCT03279978|66005079|FG003|Overall Study|Other than stated above|0|||
23622950|NCT03279978|66005080|FG004|Overall Study|Other than stated above|0|||
23622951|NCT03279978|66005081|FG005|Overall Study|Other than stated above|0|||
23622952|NCT03279978|66005082|FG006|Overall Study|Other than stated above|1|||
23622953|NCT03279978|66005083|FG007|Overall Study|Other than stated above|0|||
23622954|NCT03279978|66005084|FG008|Overall Study|Other than stated above|0|||
23622955|NCT03279978|66005085|FG009|Overall Study|Other than stated above|0|||
23622956|NCT03245619|66005090|FG000|Part A (Up to Day 22)|Physician Decision|4|||
23622957|NCT03245619|66005091|FG001|Part A (Up to Day 22)|Physician Decision|6|||
23622958|NCT03245619|66005092|FG002|Part A (Up to Day 22)|Physician Decision|6|||
23622959|NCT03245619|66005093|FG003|Part A (Up to Day 22)|Physician Decision|0|||
23622960|NCT03245619|66005094|FG004|Part A (Up to Day 22)|Physician Decision|0|||
23622961|NCT03245619|66005095|FG005|Part A (Up to Day 22)|Physician Decision|0|||
23622962|NCT03245619|66005096|FG006|Part A (Up to Day 22)|Physician Decision|0|||
23622963|NCT03245619|66005097|FG007|Part A (Up to Day 22)|Physician Decision|0|||
23622964|NCT03245619|66005098|FG008|Part A (Up to Day 22)|Physician Decision|0|||
23622965|NCT03245619|66005099|FG009|Part A (Up to Day 22)|Physician Decision|0|||
23217305|NCT02650895|64538267|FG002|Overall Study|Withdrawal by Subject|0|||
23217306|NCT02650895|64538268|FG003|Overall Study|Withdrawal by Subject|0|||
23217307|NCT02650895|64538269|FG004|Overall Study|Withdrawal by Subject|0|||
23217308|NCT02650895|64538270|FG005|Overall Study|Withdrawal by Subject|0|||
23433256|NCT04583956|65330405|FG001|Overall Study|Withdrawal by Subject|2|||
23433257|NCT04583956|65330404|FG000|Overall Study|Randomized but not dosed|2|||
23217309|NCT01170221|64538275|FG000|Overall Study|Lost to Follow-up|22|||
23217310|NCT01170221|64538276|FG001|Overall Study|Lost to Follow-up|21|||
23433258|NCT04583956|65330405|FG001|Overall Study|Randomized but not dosed|3|||
23433259|NCT04583956|65330404|FG000|Overall Study|Withdrawal of consent before product administration|1|||
23622966|NCT03245619|66005100|FG010|Part A (Up to Day 22)|Physician Decision|0|||
23319988|NCT03536884|64915671|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23319989|NCT03536884|64915672|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23319990|NCT03536884|64915673|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23319991|NCT03536884|64915674|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23319992|NCT03536884|64915675|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23319993|NCT03536884|64915676|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
23319994|NCT03536884|64915665|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23319995|NCT03536884|64915666|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23319996|NCT03536884|64915667|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23319997|NCT03536884|64915668|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
23319998|NCT03536884|64915669|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
23319999|NCT03536884|64915670|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23320000|NCT03536884|64915671|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23320001|NCT03536884|64915672|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23320002|NCT03536884|64915673|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23320003|NCT03536884|64915674|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23622967|NCT03245619|66005101|FG011|Part A (Up to Day 22)|Physician Decision|0|||
23622968|NCT03245619|66005102|FG012|Part A (Up to Day 22)|Physician Decision|0|||
23217311|NCT01170221|64538275|FG000|Overall Study|Withdrawal by Subject|9|||
23622969|NCT03245619|66005103|FG013|Part A (Up to Day 22)|Physician Decision|0|||
23622970|NCT03245619|66005104|FG014|Part A (Up to Day 22)|Physician Decision|0|||
23217312|NCT01170221|64538276|FG001|Overall Study|Withdrawal by Subject|7|||
23433260|NCT04583956|65330405|FG001|Overall Study|Withdrawal of consent before product administration|0|||
23433261|NCT01504204|65330408|FG000|Overall Study|Lost to Follow-up|1|||
23433262|NCT01504204|65330409|FG001|Overall Study|Lost to Follow-up|1|||
23433263|NCT05098509|65330413|FG000|Overall Study|Withdrawal by Subject|0|||
23320004|NCT03536884|64915675|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23320005|NCT03536884|64915676|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
23320006|NCT03536884|64915665|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23320007|NCT03536884|64915666|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23320008|NCT03536884|64915667|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
23320009|NCT03536884|64915668|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
23320010|NCT03536884|64915669|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
23320011|NCT03536884|64915670|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23320012|NCT03536884|64915671|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23320013|NCT03536884|64915672|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23320014|NCT03536884|64915673|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23320015|NCT03536884|64915674|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23320016|NCT03536884|64915675|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23320017|NCT03536884|64915676|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
23320018|NCT03536884|64915665|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23320019|NCT03536884|64915666|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23320020|NCT03536884|64915667|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
23320021|NCT03536884|64915668|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
23320022|NCT03536884|64915669|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
23320023|NCT03536884|64915670|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23320024|NCT03536884|64915671|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23320025|NCT03536884|64915672|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23320026|NCT03536884|64915673|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23320027|NCT03536884|64915674|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23320028|NCT03536884|64915675|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23433264|NCT05098509|65330414|FG001|Overall Study|Withdrawal by Subject|0|||
23433265|NCT05098509|65330415|FG002|Overall Study|Withdrawal by Subject|1|||
23433266|NCT05098509|65330416|FG003|Overall Study|Withdrawal by Subject|0|||
23433267|NCT05098509|65330413|FG000|Overall Study|Early study termination|1|||
23320029|NCT03536884|64915676|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
23320030|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
23320031|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
23320032|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
23320033|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
23320034|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
23320035|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
23433268|NCT05098509|65330414|FG001|Overall Study|Early study termination|1|||
23433269|NCT05098509|65330415|FG002|Overall Study|Early study termination|1|||
23433270|NCT05098509|65330416|FG003|Overall Study|Early study termination|0|||
23433271|NCT01600053|65330417|FG000|Overall Study|Adverse Event|2|||
23433272|NCT01600053|65330417|FG000|Overall Study|trial will not meet the interim endpoint|9|||
23433273|NCT01176565|65330418|FG000|Overall Study|Lost to Follow-up|12|||
23433274|NCT01176565|65330419|FG001|Overall Study|Lost to Follow-up|16|||
23433275|NCT01176565|65330418|FG000|Overall Study|Withdrawal by Subject|7|||
23555585|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
23555586|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
23555587|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
23555588|NCT00117676|65762270|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
23555589|NCT00117676|65762271|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
23555590|NCT00117676|65762270|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
23555591|NCT00117676|65762271|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
23555592|NCT00117676|65762270|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
23555593|NCT00117676|65762271|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
23555594|NCT00117676|65762270|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
23555595|NCT00117676|65762271|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
23555596|NCT00117676|65762270|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
23555597|NCT00117676|65762271|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
23555598|NCT00117676|65762270|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
23555599|NCT00117676|65762271|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
23555600|NCT00117676|65762270|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
23555601|NCT00117676|65762271|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
23555602|NCT00117676|65762270|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
23555603|NCT00117676|65762271|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
23555604|NCT00117676|65762270|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
23433276|NCT01176565|65330419|FG001|Overall Study|Withdrawal by Subject|1|||
23433277|NCT01176565|65330418|FG000|Overall Study|Not Analyzed (any other reason)|1|||
23433278|NCT01176565|65330419|FG001|Overall Study|Not Analyzed (any other reason)|2|||
23433279|NCT03344172|65330420|FG000|Overall Study|Received <1 dose of treatment|1|||
23433280|NCT03344172|65330421|FG001|Overall Study|Received <1 dose of treatment|0|||
23433281|NCT01455220|65330422|FG000|Overall Study|screen fail|30|||
23433282|NCT02392403|65330424|FG000|Overall Study|Adverse Event|1|||
23433283|NCT02392403|65330424|FG000|Overall Study|Death|1|||
23433284|NCT02392403|65330424|FG000|Overall Study|Withdrawal by Subject|1|||
23433285|NCT01147900|65330425|FG000|At Year 10|Lost to Follow-up|0|||
23433286|NCT01147900|65330426|FG001|At Year 10|Lost to Follow-up|1|||
23433287|NCT01147900|65330427|FG002|At Year 10|Lost to Follow-up|0|||
23433288|NCT00694304|65330428|FG000|Overall Study|Adverse Event|42|||
23433289|NCT00694304|65330428|FG000|Overall Study|Lack of Efficacy|35|||
23433290|NCT00694304|65330428|FG000|Overall Study|Non-compliance With Study Product|16|||
23433291|NCT00694304|65330428|FG000|Overall Study|Protocol Violation|6|||
23433292|NCT00694304|65330428|FG000|Overall Study|Withdrawal of Consent|61|||
23433293|NCT00694304|65330428|FG000|Overall Study|Lost to Follow-up|15|||
23433294|NCT00694304|65330428|FG000|Overall Study|Administrative or Other Reasons|32|||
23433295|NCT02540265|65330429|FG000|Overall Study|Lost to Follow-up|0|||
23433296|NCT02540265|65330430|FG001|Overall Study|Lost to Follow-up|0|||
23433297|NCT02540265|65330431|FG002|Overall Study|Lost to Follow-up|1|||
23433298|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
23433299|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
23433300|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
23142902|NCT00368992|64273723|FG000|Overall Study|Death|4|||
23142903|NCT00368992|64273723|FG000|Overall Study|Other|9|||
23142904|NCT03241225|64273727|FG000|Overall Study|Lost to Follow-up|2|||
23320036|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
23320037|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
23320038|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
23320039|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
23320040|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
23320041|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
23142905|NCT03241225|64273728|FG001|Overall Study|Lost to Follow-up|1|||
23142906|NCT03241225|64273727|FG000|Overall Study|Protocol Violation|4|||
23142907|NCT03241225|64273728|FG001|Overall Study|Protocol Violation|1|||
23142908|NCT03241225|64273727|FG000|Overall Study|Withdrawal by Subject|1|||
23142909|NCT03241225|64273728|FG001|Overall Study|Withdrawal by Subject|0|||
23142910|NCT02354508|64273736|FG000|Period 1: Core Phase|Adverse Event|1|||
23142911|NCT02354508|64273737|FG001|Period 1: Core Phase|Adverse Event|1|||
23142912|NCT02354508|64273738|FG002|Period 1: Core Phase|Adverse Event|2|||
23142913|NCT02354508|64273736|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
23142914|NCT02354508|64273737|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
23142915|NCT02354508|64273738|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
23142916|NCT02354508|64273736|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
23142917|NCT02354508|64273737|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
23217313|NCT01170221|64538275|FG000|Overall Study|Subject completed only screening and LFU|1|||
23217314|NCT01170221|64538276|FG001|Overall Study|Subject completed only screening and LFU|0|||
23217315|NCT01170221|64538275|FG000|Overall Study|Randomized but not treated|1|||
23217316|NCT01170221|64538276|FG001|Overall Study|Randomized but not treated|0|||
23320042|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23320043|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23320044|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23320045|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23320046|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23320047|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
23320048|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
23320049|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
23320050|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
23320051|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23320052|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23320053|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
23320054|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23433301|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
23433302|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
23433303|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
23433304|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
23433305|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
23433306|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
23433307|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
23433308|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
23433309|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
23433310|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
23433311|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
23433312|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
23142918|NCT02354508|64273738|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
23142919|NCT02354508|64273736|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
23142920|NCT02354508|64273737|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
23142921|NCT02354508|64273738|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
23142922|NCT02354508|64273736|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
23142923|NCT02354508|64273737|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
23142924|NCT02354508|64273738|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
23142925|NCT02354508|64273736|FG000|Period 2: Extension Phase|Physician Decision|5|||
23142926|NCT02354508|64273737|FG001|Period 2: Extension Phase|Physician Decision|0|||
23142927|NCT02354508|64273738|FG002|Period 2: Extension Phase|Physician Decision|1|||
23142928|NCT02354508|64273736|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
23142929|NCT02354508|64273737|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
23142930|NCT02354508|64273738|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
23142931|NCT02354508|64273736|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
23433313|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
23433314|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
23433315|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
23433316|NCT01302054|65330435|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
23433317|NCT01302054|65330436|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
23433318|NCT01302054|65330437|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
23622971|NCT03245619|66005105|FG015|Part A (Up to Day 22)|Physician Decision|0|||
23142932|NCT02354508|64273737|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
23142933|NCT02354508|64273738|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
23142934|NCT02354508|64273736|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
23142935|NCT02354508|64273737|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
23142936|NCT02354508|64273738|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
23142937|NCT01813929|64273743|FG000|Overall Study|Withdrawal by Subject|0|||
23142938|NCT01813929|64273744|FG001|Overall Study|Withdrawal by Subject|1|||
23142939|NCT01079130|64273745|FG000|Overall Study|Adverse Event|1|||
23142940|NCT01079130|64273746|FG001|Overall Study|Adverse Event|1|||
23142941|NCT01079130|64273747|FG002|Overall Study|Adverse Event|0|||
23142942|NCT01079130|64273748|FG003|Overall Study|Adverse Event|1|||
23142943|NCT01079130|64273749|FG004|Overall Study|Adverse Event|5|||
23142944|NCT01079130|64273750|FG005|Overall Study|Adverse Event|1|||
23142945|NCT01079130|64273745|FG000|Overall Study|Administrative problems|1|||
23142946|NCT01079130|64273746|FG001|Overall Study|Administrative problems|3|||
23142947|NCT01079130|64273747|FG002|Overall Study|Administrative problems|0|||
23142948|NCT01079130|64273748|FG003|Overall Study|Administrative problems|0|||
23142949|NCT01079130|64273749|FG004|Overall Study|Administrative problems|0|||
23142950|NCT01079130|64273750|FG005|Overall Study|Administrative problems|1|||
23142951|NCT01079130|64273745|FG000|Overall Study|Withdrawal by Subject|0|||
23142952|NCT01079130|64273746|FG001|Overall Study|Withdrawal by Subject|1|||
23142953|NCT01079130|64273747|FG002|Overall Study|Withdrawal by Subject|0|||
23142954|NCT01079130|64273748|FG003|Overall Study|Withdrawal by Subject|0|||
23142955|NCT01079130|64273749|FG004|Overall Study|Withdrawal by Subject|1|||
23142956|NCT01079130|64273750|FG005|Overall Study|Withdrawal by Subject|3|||
23142957|NCT01079130|64273745|FG000|Overall Study|Protocol deviation|0|||
23142958|NCT01079130|64273746|FG001|Overall Study|Protocol deviation|2|||
23142959|NCT01079130|64273747|FG002|Overall Study|Protocol deviation|1|||
23142960|NCT01079130|64273748|FG003|Overall Study|Protocol deviation|2|||
23142961|NCT01079130|64273749|FG004|Overall Study|Protocol deviation|0|||
23142962|NCT01079130|64273750|FG005|Overall Study|Protocol deviation|0|||
23142963|NCT01079130|64273745|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23142964|NCT01079130|64273746|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23142965|NCT01079130|64273747|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23142966|NCT01079130|64273748|FG003|Overall Study|Abnormal test procedure result(s)|0|||
23217317|NCT03057951|64538279|FG000|Overall Study|Adverse Event|553|||
23217318|NCT03057951|64538280|FG001|Overall Study|Adverse Event|575|||
23217319|NCT03057951|64538279|FG000|Overall Study|Protocol Violation|30|||
23217320|NCT03057951|64538280|FG001|Overall Study|Protocol Violation|24|||
23217321|NCT03057951|64538279|FG000|Overall Study|Lost to Follow-up|6|||
23142967|NCT01079130|64273749|FG004|Overall Study|Abnormal test procedure result(s)|1|||
23142968|NCT01079130|64273750|FG005|Overall Study|Abnormal test procedure result(s)|0|||
23217322|NCT03057951|64538280|FG001|Overall Study|Lost to Follow-up|16|||
23217323|NCT03057951|64538279|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
23217324|NCT03057951|64538280|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
23217325|NCT03057951|64538279|FG000|Overall Study|Study drug stopped, reason missing|6|||
23433319|NCT01302054|65330435|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
23433320|NCT01302054|65330436|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
23433321|NCT01302054|65330437|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
23320055|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23320056|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23320057|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23320058|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23433322|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23433323|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
23433324|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
23433325|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23433326|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
23433327|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23433328|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23433329|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
23433330|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
23433331|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
23433332|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
23433333|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
23433334|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23433335|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
23433336|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
23433337|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
23433338|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
23433339|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
23433340|NCT01302054|65330435|FG000|Double-Blind Treatment Phase|Other|0|||
23433341|NCT01302054|65330436|FG001|Double-Blind Treatment Phase|Other|4|||
23433342|NCT01302054|65330437|FG002|Double-Blind Treatment Phase|Other|9|||
23433343|NCT01452919|65330438|FG000|Open-Label Treatment|Adverse Event|5|||
23433344|NCT01452919|65330439|FG001|Open-Label Treatment|Adverse Event|0|||
23433345|NCT01452919|65330440|FG002|Open-Label Treatment|Adverse Event|0|||
23433346|NCT01452919|65330438|FG000|Open-Label Treatment|Lost to Follow-up|4|||
23433347|NCT01452919|65330439|FG001|Open-Label Treatment|Lost to Follow-up|0|||
23433348|NCT01452919|65330440|FG002|Open-Label Treatment|Lost to Follow-up|0|||
23433349|NCT01452919|65330438|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
23433350|NCT01452919|65330439|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
23433351|NCT01452919|65330440|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
23433352|NCT01452919|65330438|FG000|Open-Label Treatment|Protocol Violation|4|||
23433353|NCT01452919|65330439|FG001|Open-Label Treatment|Protocol Violation|0|||
23433354|NCT01452919|65330440|FG002|Open-Label Treatment|Protocol Violation|0|||
23433355|NCT01452919|65330438|FG000|Open-Label Treatment|Sponsor Decision|1|||
23142969|NCT01079130|64273745|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23142970|NCT01079130|64273746|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23142971|NCT01079130|64273747|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23142972|NCT01079130|64273748|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
23142973|NCT01079130|64273749|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
23142974|NCT01079130|64273750|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
23142975|NCT01079130|64273745|FG000|Overall Study|Lost to Follow-up|0|||
23142976|NCT01079130|64273746|FG001|Overall Study|Lost to Follow-up|0|||
23142977|NCT01079130|64273747|FG002|Overall Study|Lost to Follow-up|0|||
23142978|NCT01079130|64273748|FG003|Overall Study|Lost to Follow-up|0|||
23142979|NCT01079130|64273749|FG004|Overall Study|Lost to Follow-up|1|||
23142980|NCT01079130|64273750|FG005|Overall Study|Lost to Follow-up|0|||
23142981|NCT01777269|64273753|FG000|Overall Study|Adverse Event|24|||
23142982|NCT01777269|64273754|FG001|Overall Study|Adverse Event|33|||
23142983|NCT01777269|64273753|FG000|Overall Study|Lack of Efficacy|8|||
23142984|NCT01777269|64273754|FG001|Overall Study|Lack of Efficacy|10|||
23142985|NCT01777269|64273753|FG000|Overall Study|Protocol Violation|4|||
23142986|NCT01777269|64273754|FG001|Overall Study|Protocol Violation|4|||
23142987|NCT01777269|64273753|FG000|Overall Study|Participants reached stopping criteria|1|||
23142988|NCT01777269|64273754|FG001|Overall Study|Participants reached stopping criteria|1|||
23142989|NCT01777269|64273753|FG000|Overall Study|Lost to Follow-up|4|||
23142990|NCT01777269|64273754|FG001|Overall Study|Lost to Follow-up|0|||
23142991|NCT01777269|64273753|FG000|Overall Study|Physician Decision|5|||
23142992|NCT01777269|64273754|FG001|Overall Study|Physician Decision|2|||
23142993|NCT01777269|64273753|FG000|Overall Study|Withdrawal by Subject|9|||
23142994|NCT01777269|64273754|FG001|Overall Study|Withdrawal by Subject|9|||
23142995|NCT01337115|64273755|FG000|Overall Study|Protocol Violation|2|||
23142996|NCT01337115|64273756|FG001|Overall Study|Protocol Violation|0|||
23142997|NCT02217332|64273757|FG000|Overall Study|Adverse Event|3|||
23142998|NCT02217332|64273757|FG000|Overall Study|Dose interruption >1 month|1|||
23142999|NCT02217332|64273757|FG000|Overall Study|Protocol Violation (eligibility)|1|||
23320059|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
23433356|NCT01452919|65330439|FG001|Open-Label Treatment|Sponsor Decision|0|||
23433357|NCT01452919|65330440|FG002|Open-Label Treatment|Sponsor Decision|0|||
23433358|NCT01452919|65330438|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
23433359|NCT01452919|65330439|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
23433360|NCT01452919|65330440|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
23433361|NCT01452919|65330438|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
23433362|NCT01452919|65330439|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
23433363|NCT01452919|65330440|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
23433364|NCT01452919|65330438|FG000|Randomization Treatment|Adverse Event|0|||
23433365|NCT01452919|65330439|FG001|Randomization Treatment|Adverse Event|0|||
23433366|NCT01452919|65330440|FG002|Randomization Treatment|Adverse Event|2|||
23433367|NCT01452919|65330438|FG000|Randomization Treatment|Sponsor Decision|0|||
23433368|NCT01452919|65330439|FG001|Randomization Treatment|Sponsor Decision|1|||
23433369|NCT01452919|65330440|FG002|Randomization Treatment|Sponsor Decision|0|||
23433370|NCT01452919|65330438|FG000|Randomization Treatment|Withdrawal by Subject|0|||
23433371|NCT01452919|65330439|FG001|Randomization Treatment|Withdrawal by Subject|1|||
23433372|NCT01452919|65330440|FG002|Randomization Treatment|Withdrawal by Subject|0|||
23433373|NCT01452919|65330438|FG000|Randomization Treatment|Subject is moving or has moved|0|||
23433374|NCT01452919|65330439|FG001|Randomization Treatment|Subject is moving or has moved|1|||
23433375|NCT01452919|65330440|FG002|Randomization Treatment|Subject is moving or has moved|0|||
23433376|NCT03908476|65330443|FG000|Overall Study|Death|3|||
23433377|NCT03908476|65330444|FG001|Overall Study|Death|0|||
23433378|NCT03908476|65330443|FG000|Overall Study|Lost to Follow-up|3|||
23433379|NCT03908476|65330444|FG001|Overall Study|Lost to Follow-up|1|||
23622972|NCT03245619|66005106|FG016|Part A (Up to Day 22)|Physician Decision|0|||
23622973|NCT02143063|66005109|FG000|Overall Study|Lost to Follow-up|16|||
23622974|NCT02143063|66005110|FG001|Overall Study|Lost to Follow-up|28|||
23622975|NCT02143063|66005111|FG002|Overall Study|Lost to Follow-up|29|||
23622976|NCT02143063|66005109|FG000|Overall Study|Withdrawal by Subject|0|||
23622977|NCT02143063|66005110|FG001|Overall Study|Withdrawal by Subject|1|||
23622978|NCT02143063|66005111|FG002|Overall Study|Withdrawal by Subject|0|||
23622979|NCT02143063|66005109|FG000|Overall Study|Death|0|||
23622980|NCT02143063|66005110|FG001|Overall Study|Death|1|||
23622981|NCT02143063|66005111|FG002|Overall Study|Death|1|||
23143000|NCT02217332|64273757|FG000|Overall Study|Withdrawal by Subject|1|||
23143001|NCT02217332|64273757|FG000|Overall Study|Lost to Follow-up|1|||
23143002|NCT01411839|64273758|FG000|Overall Study|Lost to Follow-up|4|||
23143003|NCT01411839|64273759|FG001|Overall Study|Lost to Follow-up|3|||
23143004|NCT00560066|64273760|FG000|Overall Study|Death|2|||
23143005|NCT00560066|64273761|FG001|Overall Study|Death|1|||
23143006|NCT00560066|64273760|FG000|Overall Study|Withdrawal by Subject|0|||
23143007|NCT00560066|64273761|FG001|Overall Study|Withdrawal by Subject|3|||
23143008|NCT00560066|64273760|FG000|Overall Study|Lost to Follow-up|4|||
23143009|NCT00560066|64273761|FG001|Overall Study|Lost to Follow-up|10|||
23143010|NCT00560066|64273760|FG000|Overall Study|Protocol Violation|0|||
23143011|NCT00560066|64273761|FG001|Overall Study|Protocol Violation|1|||
23143012|NCT00560066|64273760|FG000|Overall Study|Administrative reason|0|||
23143013|NCT00560066|64273761|FG001|Overall Study|Administrative reason|5|||
23143014|NCT00560066|64273760|FG000|Overall Study|Missing primary reason|0|||
23143015|NCT00560066|64273761|FG001|Overall Study|Missing primary reason|2|||
23143016|NCT00158860|64273762|FG000|Overall Study|Adverse Event|3|||
23143017|NCT00158860|64273763|FG001|Overall Study|Adverse Event|6|||
23143018|NCT00158860|64273762|FG000|Overall Study|Lost to Follow-up|11|||
23143019|NCT00158860|64273763|FG001|Overall Study|Lost to Follow-up|17|||
23143020|NCT00158860|64273762|FG000|Overall Study|Protocol Violation|8|||
23143021|NCT00158860|64273763|FG001|Overall Study|Protocol Violation|23|||
23143022|NCT00158860|64273762|FG000|Overall Study|Withdrawal by Subject|7|||
23143023|NCT00158860|64273763|FG001|Overall Study|Withdrawal by Subject|17|||
23143024|NCT00158860|64273762|FG000|Overall Study|MOVING OUT OF STATE|1|||
23143025|NCT00158860|64273763|FG001|Overall Study|MOVING OUT OF STATE|0|||
23143026|NCT00158860|64273762|FG000|Overall Study|Pregnancy|3|||
23143027|NCT00158860|64273763|FG001|Overall Study|Pregnancy|3|||
23143028|NCT00158860|64273762|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
23143029|NCT00158860|64273763|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
23143030|NCT00158860|64273762|FG000|Overall Study|SPONSOR REQUEST|0|||
23143031|NCT00158860|64273763|FG001|Overall Study|SPONSOR REQUEST|1|||
23143032|NCT00158860|64273762|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
23143033|NCT00158860|64273763|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
23143034|NCT00158860|64273762|FG000|Overall Study|Closed per sponsor|0|||
23143035|NCT00158860|64273763|FG001|Overall Study|Closed per sponsor|1|||
23143036|NCT01122862|64273764|FG000|Period 1|Protocol Violation|0|||
23143037|NCT01122862|64273765|FG001|Period 1|Protocol Violation|1|||
23143038|NCT01122862|64273766|FG002|Period 1|Protocol Violation|0|||
23143039|NCT01122862|64273764|FG000|Period 2|Adverse Event|0|||
23143040|NCT01122862|64273765|FG001|Period 2|Adverse Event|0|||
23143041|NCT01122862|64273766|FG002|Period 2|Adverse Event|1|||
23143042|NCT01116882|64273769|FG000|30-day|Lost to Follow-up|50|||
23143043|NCT01116882|64273770|FG001|30-day|Lost to Follow-up|21|||
23143044|NCT01116882|64273769|FG000|30-day|Withdrawal by Subject|2|||
23143045|NCT01116882|64273770|FG001|30-day|Withdrawal by Subject|4|||
23143046|NCT01116882|64273769|FG000|30-day|Other Reasons|16|||
23143047|NCT01116882|64273770|FG001|30-day|Other Reasons|6|||
23143048|NCT01116882|64273769|FG000|12-month|Lost to Follow-up|111|||
23143049|NCT01116882|64273770|FG001|12-month|Lost to Follow-up|42|||
23143050|NCT01116882|64273769|FG000|12-month|Other Reasons|151|||
23143051|NCT01116882|64273770|FG001|12-month|Other Reasons|49|||
23143052|NCT01116882|64273769|FG000|12-month|Withdrawal by Subject|5|||
23143053|NCT01116882|64273770|FG001|12-month|Withdrawal by Subject|8|||
23143054|NCT00448279|64273771|FG000|Overall Study|Lost to Follow-up|2|||
23143055|NCT00448279|64273772|FG001|Overall Study|Lost to Follow-up|2|||
23143056|NCT00448279|64273771|FG000|Overall Study|Adverse Event|1|||
23143057|NCT00448279|64273772|FG001|Overall Study|Adverse Event|1|||
23143058|NCT00448279|64273771|FG000|Overall Study|Disease progression|16|||
23143059|NCT00448279|64273772|FG001|Overall Study|Disease progression|18|||
23143060|NCT00448279|64273771|FG000|Overall Study|Withdrawal by Subject|4|||
23143061|NCT00448279|64273772|FG001|Overall Study|Withdrawal by Subject|3|||
23143062|NCT00448279|64273771|FG000|Overall Study|Other|6|||
23143063|NCT00448279|64273772|FG001|Overall Study|Other|4|||
23143064|NCT00448279|64273771|FG000|Overall Study|Protocol Violation|0|||
23143065|NCT00448279|64273772|FG001|Overall Study|Protocol Violation|1|||
23143066|NCT00932113|64273777|FG000|Overall Study|Lost to Follow-up|1|||
23143067|NCT00932113|64273778|FG001|Overall Study|Lost to Follow-up|0|||
23143068|NCT02480153|64273781|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
23143069|NCT02480153|64273782|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
23143070|NCT02480153|64273783|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
23143071|NCT02480153|64273781|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
23143072|NCT02480153|64273782|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
23143073|NCT02480153|64273783|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
23143074|NCT02480153|64273781|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
23143075|NCT02480153|64273782|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
23143076|NCT02480153|64273783|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
23143077|NCT02480153|64273781|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
23143078|NCT02480153|64273782|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
23143079|NCT02480153|64273783|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
23143080|NCT02480153|64273781|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
23143081|NCT02480153|64273782|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
23143082|NCT02480153|64273783|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
23143083|NCT02480153|64273781|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
23143084|NCT02480153|64273782|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
23143085|NCT02480153|64273783|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
23143086|NCT02480153|64273781|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
23143087|NCT02480153|64273782|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
23143088|NCT02480153|64273783|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
23143089|NCT02480153|64273781|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
23143090|NCT02480153|64273782|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
23143091|NCT02480153|64273783|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
23143092|NCT02480153|64273781|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
23143093|NCT02480153|64273782|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
23143094|NCT02480153|64273783|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
23143095|NCT02480153|64273781|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
23143096|NCT02480153|64273782|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
23143097|NCT02480153|64273783|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
23143098|NCT02480153|64273781|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
23143099|NCT02480153|64273782|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
23143100|NCT02480153|64273783|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
23143101|NCT02480153|64273781|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
23143102|NCT02480153|64273782|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
23143103|NCT02480153|64273783|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
23143104|NCT02480153|64273781|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
23143105|NCT02480153|64273782|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
23143106|NCT02480153|64273783|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
23143107|NCT02480153|64273781|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
23143108|NCT02480153|64273782|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
23143109|NCT02480153|64273783|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
23143110|NCT02480153|64273781|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
23143111|NCT02480153|64273782|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
23143112|NCT02480153|64273783|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
23217326|NCT03057951|64538280|FG001|Overall Study|Study drug stopped, reason missing|1|||
23217327|NCT03057951|64538279|FG000|Overall Study|Medical advice|6|||
23217328|NCT03057951|64538280|FG001|Overall Study|Medical advice|2|||
23217329|NCT03057951|64538279|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
23217330|NCT03057951|64538280|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
23217331|NCT03057951|64538279|FG000|Overall Study|Investigator decision|2|||
23217332|NCT03057951|64538280|FG001|Overall Study|Investigator decision|0|||
23217333|NCT03057951|64538279|FG000|Overall Study|Patient decision|5|||
23217334|NCT03057951|64538280|FG001|Overall Study|Patient decision|2|||
23217335|NCT03057951|64538279|FG000|Overall Study|Not attending study visits|3|||
23217336|NCT03057951|64538280|FG001|Overall Study|Not attending study visits|0|||
23217337|NCT03057951|64538279|FG000|Overall Study|Patient moved away|3|||
23217338|NCT03057951|64538280|FG001|Overall Study|Patient moved away|4|||
23217339|NCT03057951|64538279|FG000|Overall Study|Other reason than stated above|23|||
23320060|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23320061|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
23143113|NCT02480153|64273781|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
23143114|NCT02480153|64273782|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
23143115|NCT02480153|64273783|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
23143116|NCT02480153|64273781|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
23143117|NCT02480153|64273782|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
23143118|NCT02480153|64273783|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
23143119|NCT02480153|64273781|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
23143120|NCT02480153|64273782|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
23143121|NCT02480153|64273783|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
23143122|NCT03929757|64273784|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
23143123|NCT03929757|64273785|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
23143124|NCT03929757|64273786|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
23143125|NCT03929757|64273784|FG000|Main Study: Up to Day 365|Other|1|||
23143126|NCT03929757|64273785|FG001|Main Study: Up to Day 365|Other|0|||
23143127|NCT03929757|64273786|FG002|Main Study: Up to Day 365|Other|0|||
23143128|NCT03929757|64273784|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
23143129|NCT03929757|64273785|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
23143130|NCT03929757|64273786|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
23143131|NCT01340651|64273787|FG000|Overall Study|Adverse Event|3|||
23143132|NCT01340651|64273787|FG000|Overall Study|Consent Withdrawn|2|||
23143133|NCT01340651|64273787|FG000|Overall Study|Commercial Supply per Sponsor|12|||
23143134|NCT00896051|64273789|FG000|Overall Study|Adverse Event|2|||
23143135|NCT00896051|64273790|FG001|Overall Study|Adverse Event|1|||
23143136|NCT00896051|64273789|FG000|Overall Study|Lost to Follow-up|3|||
23143137|NCT00896051|64273790|FG001|Overall Study|Lost to Follow-up|2|||
23143138|NCT00896051|64273789|FG000|Overall Study|Withdrawal by Subject|3|||
23143139|NCT00896051|64273790|FG001|Overall Study|Withdrawal by Subject|2|||
23143140|NCT00896051|64273789|FG000|Overall Study|Subject noncompliant|1|||
23143141|NCT00896051|64273790|FG001|Overall Study|Subject noncompliant|3|||
23143142|NCT00896051|64273789|FG000|Overall Study|Other|1|||
23143143|NCT00896051|64273790|FG001|Overall Study|Other|1|||
23143144|NCT02678247|64273792|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
23143145|NCT02678247|64273793|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
23143146|NCT02678247|64273792|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
23143147|NCT02678247|64273793|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
23143148|NCT02678247|64273792|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
23143149|NCT02678247|64273793|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
23143150|NCT02678247|64273792|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
23143151|NCT02678247|64273793|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
23143152|NCT02678247|64273792|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
23143153|NCT02678247|64273793|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
23320062|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23622982|NCT01121913|66005112|FG000|First Intervention Period|Adverse Event|0|||
23622983|NCT01121913|66005113|FG001|First Intervention Period|Adverse Event|0|||
23143154|NCT02678247|64273792|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
23143155|NCT02678247|64273793|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
23217340|NCT03057951|64538280|FG001|Overall Study|Other reason than stated above|29|||
23217341|NCT03057951|64538279|FG000|Overall Study|Not treated|2|||
23217342|NCT03057951|64538280|FG001|Overall Study|Not treated|1|||
23217343|NCT04581863|64538281|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
23217344|NCT04581863|64538282|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
23217345|NCT00389441|64538283|FG000|Overall Study|Adverse Event|7|||
23217346|NCT00389441|64538283|FG000|Overall Study|Death|4|||
23217347|NCT00389441|64538283|FG000|Overall Study|Lost to Follow-up|2|||
23143156|NCT01575028|64273794|FG000|Overall Study|Physician Decision|0|||
23143157|NCT01575028|64273795|FG001|Overall Study|Physician Decision|1|||
23143158|NCT03037931|64273796|FG000|Overall Study|Death|354|||
23143159|NCT03037931|64273797|FG001|Overall Study|Death|367|||
23143160|NCT03037931|64273796|FG000|Overall Study|Lost to Follow-up|7|||
23143161|NCT03037931|64273797|FG001|Overall Study|Lost to Follow-up|4|||
23143162|NCT03037931|64273796|FG000|Overall Study|Withdrawal by Subject|48|||
23143163|NCT03037931|64273797|FG001|Overall Study|Withdrawal by Subject|41|||
23143164|NCT00081770|64273798|FG000|Overall Study|Adverse Event|130|||
23143165|NCT00081770|64273799|FG001|Overall Study|Adverse Event|98|||
23143166|NCT00081770|64273800|FG002|Overall Study|Adverse Event|136|||
23143167|NCT00081770|64273798|FG000|Overall Study|Lack of Efficacy|262|||
23143168|NCT00081770|64273799|FG001|Overall Study|Lack of Efficacy|357|||
23143169|NCT00081770|64273800|FG002|Overall Study|Lack of Efficacy|211|||
23143170|NCT00081770|64273798|FG000|Overall Study|Lost to Follow-up|45|||
23143171|NCT00081770|64273799|FG001|Overall Study|Lost to Follow-up|34|||
23143172|NCT00081770|64273800|FG002|Overall Study|Lost to Follow-up|45|||
23143173|NCT00081770|64273798|FG000|Overall Study|Protocol Violation|15|||
23143174|NCT00081770|64273799|FG001|Overall Study|Protocol Violation|10|||
23143175|NCT00081770|64273800|FG002|Overall Study|Protocol Violation|10|||
23143176|NCT00081770|64273798|FG000|Overall Study|Withdrawal by Subject|45|||
23143177|NCT00081770|64273799|FG001|Overall Study|Withdrawal by Subject|40|||
23143178|NCT00081770|64273800|FG002|Overall Study|Withdrawal by Subject|42|||
23143179|NCT00081770|64273798|FG000|Overall Study|Did not meet protocol eligibility|2|||
23143180|NCT00081770|64273799|FG001|Overall Study|Did not meet protocol eligibility|0|||
23143181|NCT00081770|64273800|FG002|Overall Study|Did not meet protocol eligibility|3|||
23143182|NCT00081770|64273798|FG000|Overall Study|Administrative|1|||
23143183|NCT00081770|64273799|FG001|Overall Study|Administrative|0|||
23143184|NCT00081770|64273800|FG002|Overall Study|Administrative|1|||
23143185|NCT00081770|64273798|FG000|Overall Study|Other|2|||
23143186|NCT00081770|64273799|FG001|Overall Study|Other|7|||
23143187|NCT00081770|64273800|FG002|Overall Study|Other|8|||
23143188|NCT02090959|64273801|FG000|Overall Study|Withdrawal by Subject|10|||
23143189|NCT02090959|64273801|FG000|Overall Study|Adverse Event|1|||
23143190|NCT02090959|64273801|FG000|Overall Study|Investigator decision|2|||
23143191|NCT02090959|64273801|FG000|Overall Study|Study termination|6|||
23143192|NCT02090959|64273801|FG000|Overall Study|Enrolled but not treated|1|||
23143193|NCT02090959|64273801|FG000|Overall Study|Transfer for compassionate use medicine|4|||
23143194|NCT02090959|64273801|FG000|Overall Study|Move to medical need program|3|||
23143195|NCT02090959|64273801|FG000|Overall Study|Entered in to other study|34|||
23143196|NCT02090959|64273801|FG000|Overall Study|Switched to commercial supply|88|||
23143197|NCT02090959|64273801|FG000|Overall Study|Other than specified|2|||
23143198|NCT02294227|64273803|FG000|Overall Study|Death|0|||
23143199|NCT02294227|64273804|FG001|Overall Study|Death|0|||
23143200|NCT02294227|64273805|FG002|Overall Study|Death|1|||
23143201|NCT02294227|64273803|FG000|Overall Study|Subject/Guardian Decision|6|||
23143202|NCT02294227|64273804|FG001|Overall Study|Subject/Guardian Decision|3|||
23143203|NCT02294227|64273805|FG002|Overall Study|Subject/Guardian Decision|7|||
23143204|NCT02294227|64273803|FG000|Overall Study|Physician Decision|1|||
23143205|NCT02294227|64273804|FG001|Overall Study|Physician Decision|2|||
23143206|NCT02294227|64273805|FG002|Overall Study|Physician Decision|1|||
23143207|NCT02294227|64273803|FG000|Overall Study|Lost to Follow-up|1|||
23143208|NCT02294227|64273804|FG001|Overall Study|Lost to Follow-up|0|||
23143209|NCT02294227|64273805|FG002|Overall Study|Lost to Follow-up|0|||
23143210|NCT02294227|64273803|FG000|Overall Study|Lack of Efficacy|11|||
23143211|NCT02294227|64273804|FG001|Overall Study|Lack of Efficacy|12|||
23143212|NCT02294227|64273805|FG002|Overall Study|Lack of Efficacy|8|||
23143213|NCT02294227|64273803|FG000|Overall Study|Adverse Event|6|||
23143214|NCT02294227|64273804|FG001|Overall Study|Adverse Event|8|||
23143215|NCT02294227|64273805|FG002|Overall Study|Adverse Event|2|||
23143216|NCT01498679|64273811|FG000|Overall Study|Adverse Event|1|||
23143217|NCT01498679|64273812|FG001|Overall Study|Adverse Event|4|||
23143218|NCT01498679|64273811|FG000|Overall Study|Lack of Efficacy|72|||
23143219|NCT01498679|64273812|FG001|Overall Study|Lack of Efficacy|12|||
23143220|NCT01498679|64273811|FG000|Overall Study|Protocol Violation|4|||
23143221|NCT01498679|64273812|FG001|Overall Study|Protocol Violation|0|||
23143222|NCT01498679|64273811|FG000|Overall Study|Physician Decision|0|||
23433380|NCT03908476|65330443|FG000|Overall Study|Withdrawal by Subject|7|||
23143223|NCT01498679|64273812|FG001|Overall Study|Physician Decision|2|||
23143224|NCT01498679|64273811|FG000|Overall Study|Withdrawal by Subject|12|||
23143225|NCT01498679|64273812|FG001|Overall Study|Withdrawal by Subject|4|||
23143226|NCT00983931|64273813|FG000|14 Day Washout Period|Physician Decision|1|||
23143227|NCT01945060|64273820|FG000|Overall Study|Lost to follow up|1|||
23143228|NCT01945060|64273821|FG001|Overall Study|Lost to follow up|0|||
23143229|NCT01945060|64273820|FG000|Overall Study|Distress related to IV access|0|||
23143230|NCT01945060|64273821|FG001|Overall Study|Distress related to IV access|1|||
23143231|NCT02578862|64273822|FG000|Overall Study|Withdrawal by Subject|0|||
23143232|NCT02578862|64273823|FG001|Overall Study|Withdrawal by Subject|1|||
23143233|NCT02578862|64273822|FG000|Overall Study|Unplanned unilateral procedure|0|||
23143234|NCT02578862|64273823|FG001|Overall Study|Unplanned unilateral procedure|1|||
23143235|NCT03945825|64273824|FG000|Overall Study|Enrolled but treatment not administered|0|||
23143236|NCT03945825|64273825|FG001|Overall Study|Enrolled but treatment not administered|0|||
23143237|NCT03945825|64273826|FG002|Overall Study|Enrolled but treatment not administered|0|||
23143238|NCT03945825|64273827|FG003|Overall Study|Enrolled but treatment not administered|0|||
23143239|NCT03945825|64273828|FG004|Overall Study|Enrolled but treatment not administered|1|||
23143240|NCT03945825|64273829|FG005|Overall Study|Enrolled but treatment not administered|0|||
23143241|NCT03945825|64273824|FG000|Overall Study|Lost to Follow-up|1|||
23143242|NCT03945825|64273825|FG001|Overall Study|Lost to Follow-up|5|||
23143243|NCT03945825|64273826|FG002|Overall Study|Lost to Follow-up|0|||
23143244|NCT03945825|64273827|FG003|Overall Study|Lost to Follow-up|1|||
23320063|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23320064|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23320065|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
23320066|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23217348|NCT00389441|64538283|FG000|Overall Study|Withdrawal by Subject|4|||
23217349|NCT00389441|64538283|FG000|Overall Study|Physician Decision|1|||
23217350|NCT00389441|64538283|FG000|Overall Study|Protocol Violation|1|||
23217351|NCT00389441|64538283|FG000|Overall Study|Global deterioration of health status|4|||
23217352|NCT00389441|64538283|FG000|Overall Study|Objective progression or relapse|26|||
23217353|NCT00389441|64538283|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
23217354|NCT00389441|64538283|FG000|Overall Study|Clinical progression|1|||
23143245|NCT03945825|64273828|FG004|Overall Study|Lost to Follow-up|2|||
23320067|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23320068|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23320069|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23320070|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23320071|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
23320072|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23320073|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
23320074|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
23320075|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23320076|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23320077|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
23320078|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23320079|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23320080|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23320081|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23320082|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23320083|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
23320084|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
23320085|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
23320086|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
23320087|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23320088|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23320089|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
23320090|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320091|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320092|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320093|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320094|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23217355|NCT03628599|64538284|FG000|Overall Study|Adverse Event|0|||
23217356|NCT03628599|64538285|FG001|Overall Study|Adverse Event|1|||
23320095|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
23320096|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320097|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320098|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320099|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320100|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320101|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
23320102|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320103|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320104|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320105|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320106|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320107|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320108|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
23217357|NCT02120352|64538286|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
23217358|NCT02120352|64538287|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
23217359|NCT02120352|64538288|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
23143246|NCT03945825|64273829|FG005|Overall Study|Lost to Follow-up|2|||
23143247|NCT03945825|64273824|FG000|Overall Study|Withdrawal by Subject|1|||
23143248|NCT03945825|64273825|FG001|Overall Study|Withdrawal by Subject|0|||
23143249|NCT03945825|64273826|FG002|Overall Study|Withdrawal by Subject|1|||
23320109|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320110|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320111|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320112|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320113|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
23320114|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320115|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320116|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320117|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320118|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320119|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320120|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
23143250|NCT03945825|64273827|FG003|Overall Study|Withdrawal by Subject|1|||
23143251|NCT03945825|64273828|FG004|Overall Study|Withdrawal by Subject|0|||
23143252|NCT03945825|64273829|FG005|Overall Study|Withdrawal by Subject|1|||
23143253|NCT00784693|64273832|FG000|Overall Study|Lost to Follow-up|0|||
23143254|NCT00784693|64273833|FG001|Overall Study|Lost to Follow-up|1|||
23143255|NCT00784693|64273832|FG000|Overall Study|Lack of Efficacy|1|||
23143256|NCT00784693|64273833|FG001|Overall Study|Lack of Efficacy|1|||
23143257|NCT00784693|64273832|FG000|Overall Study|Withdrawal by Subject|0|||
23143258|NCT00784693|64273833|FG001|Overall Study|Withdrawal by Subject|4|||
23143259|NCT00784693|64273832|FG000|Overall Study|Randomized but not Treated|1|||
23143260|NCT00784693|64273833|FG001|Overall Study|Randomized but not Treated|0|||
23143261|NCT00784693|64273832|FG000|Overall Study|Other|1|||
23143262|NCT00784693|64273833|FG001|Overall Study|Other|0|||
23143263|NCT00824161|64273834|FG000|Overall Study|Withdrawal by Subject|1|||
23143264|NCT00824161|64273834|FG000|Overall Study|Screen Failure|1|||
23143265|NCT02875977|64273835|FG000|Overall Study|Lost to Follow-up|42|||
23143266|NCT02875977|64273836|FG001|Overall Study|Lost to Follow-up|29|||
23320121|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320122|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320123|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320124|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320125|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
23320126|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320127|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320128|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320129|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320130|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320131|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
23320132|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320133|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320134|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320135|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320136|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320137|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
23320138|NCT03536884|64915665|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320139|NCT03536884|64915666|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320140|NCT03536884|64915667|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320141|NCT03536884|64915668|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320142|NCT03536884|64915669|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320143|NCT03536884|64915670|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320144|NCT03536884|64915671|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320145|NCT03536884|64915672|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23433381|NCT03908476|65330444|FG001|Overall Study|Withdrawal by Subject|1|||
23433382|NCT03908476|65330443|FG000|Overall Study|Physician Decision|2|||
23433383|NCT03908476|65330444|FG001|Overall Study|Physician Decision|0|||
23433384|NCT03908476|65330443|FG000|Overall Study|System Explanted and not Replaced|4|||
23433385|NCT03908476|65330444|FG001|Overall Study|System Explanted and not Replaced|0|||
23433386|NCT03908476|65330443|FG000|Overall Study|Intrathecal Pump|1|||
23143267|NCT01296347|64273837|FG000|Allocation|Withdrawal by Subject|1|||
23143268|NCT01296347|64273838|FG001|Allocation|Withdrawal by Subject|2|||
23143269|NCT01296347|64273837|FG000|Allocation|Lack of Efficacy|1|||
23143270|NCT01296347|64273838|FG001|Allocation|Lack of Efficacy|2|||
23143271|NCT01296347|64273837|FG000|Allocation|not received infusion|1|||
23143272|NCT01296347|64273838|FG001|Allocation|not received infusion|0|||
23143273|NCT01296347|64273837|FG000|6 Week Follow up|Death|0|||
23143274|NCT01296347|64273838|FG001|6 Week Follow up|Death|1|||
23143275|NCT01296347|64273837|FG000|3 Month Follow up|Death|1|||
23143276|NCT01296347|64273838|FG001|3 Month Follow up|Death|0|||
23143277|NCT01296347|64273837|FG000|3 Month Follow up|Lost to Follow-up|0|||
23143278|NCT01296347|64273838|FG001|3 Month Follow up|Lost to Follow-up|1|||
23143279|NCT01296347|64273837|FG000|6 Month Follow up|Death|2|||
23143280|NCT01296347|64273838|FG001|6 Month Follow up|Death|1|||
23143281|NCT01296347|64273837|FG000|6 Month Follow up|Lost to Follow-up|0|||
23143282|NCT01296347|64273838|FG001|6 Month Follow up|Lost to Follow-up|1|||
23143283|NCT01296347|64273837|FG000|12 Month Follow up|Lost to Follow-up|3|||
23143284|NCT01296347|64273838|FG001|12 Month Follow up|Lost to Follow-up|1|||
23143285|NCT01296347|64273837|FG000|12 Month Follow up|Death|1|||
23143286|NCT01296347|64273838|FG001|12 Month Follow up|Death|1|||
23143287|NCT01296347|64273837|FG000|12 Month Follow up|Withdrawal by Subject|0|||
23143288|NCT01296347|64273838|FG001|12 Month Follow up|Withdrawal by Subject|1|||
23143289|NCT01828073|64273839|FG000|Overall Study|Lost to Follow-up|1|||
23320146|NCT03536884|64915673|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
23320147|NCT03536884|64915674|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320148|NCT03536884|64915675|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320149|NCT03536884|64915676|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
23320150|NCT03536884|64915665|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23320151|NCT03536884|64915666|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23320152|NCT03536884|64915667|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23320153|NCT03536884|64915668|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23320154|NCT03536884|64915669|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23320155|NCT03536884|64915670|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23320156|NCT03536884|64915671|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23320157|NCT03536884|64915672|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23320158|NCT03536884|64915673|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
23320159|NCT03536884|64915674|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
23320160|NCT03536884|64915675|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
23320161|NCT03536884|64915676|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
23143290|NCT01828073|64273840|FG001|Overall Study|Lost to Follow-up|2|||
23143291|NCT01590017|64273843|FG000|Overall Study|Adverse Event|1|||
23143292|NCT01590017|64273843|FG000|Overall Study|Withdrawal by Subject|1|||
23143293|NCT01590017|64273843|FG000|Overall Study|Lack of Efficacy|1|||
23143294|NCT01590017|64273843|FG000|Overall Study|Physician Decision|1|||
23143295|NCT00640133|64273844|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
23143296|NCT00640133|64273845|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
23143297|NCT00640133|64273844|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
23143298|NCT00640133|64273845|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
23143299|NCT00640133|64273844|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
23143300|NCT00640133|64273845|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
23143301|NCT00959647|64273846|FG000|Overall Study|Adverse Event|2|||
23143302|NCT00959647|64273846|FG000|Overall Study|Progressive disease|6|||
23143303|NCT00959647|64273846|FG000|Overall Study|Study terminated by sponsor|4|||
23143304|NCT00959647|64273846|FG000|Overall Study|Withdrawal by Subject|7|||
23143305|NCT00744523|64273847|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
23143306|NCT00744523|64273848|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
23143307|NCT00394082|64273849|FG000|Overall Study|Unacceptable toxicity|15|||
23143308|NCT00394082|64273849|FG000|Overall Study|Adverse Event|4|||
23217360|NCT02120352|64538289|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
23217361|NCT02120352|64538290|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
23217362|NCT02120352|64538291|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
23143309|NCT00394082|64273849|FG000|Overall Study|Physician Decision|4|||
23143310|NCT00394082|64273849|FG000|Overall Study|Withdrawal by Subject|2|||
23143311|NCT00394082|64273849|FG000|Overall Study|Other|1|||
23143312|NCT03536143|64273857|FG000|Overall Study|Early termination, Sponsor decision|1|||
23143313|NCT03527173|64273859|FG000|Overall Study|Lost to Follow-up|4|||
23143314|NCT03527173|64273860|FG001|Overall Study|Lost to Follow-up|2|||
23143315|NCT03527173|64273859|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
23217363|NCT02120352|64538292|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
23217364|NCT02120352|64538286|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
23217365|NCT02120352|64538287|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23320162|NCT03536884|64915665|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23320163|NCT03536884|64915666|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23433387|NCT03908476|65330444|FG001|Overall Study|Intrathecal Pump|0|||
23143316|NCT03527173|64273860|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
23143317|NCT03527173|64273859|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
23143318|NCT03527173|64273860|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
23143319|NCT03527173|64273859|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
23143320|NCT03527173|64273860|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23143321|NCT00757588|64273861|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
23217366|NCT02120352|64538288|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23217367|NCT02120352|64538289|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23217368|NCT02120352|64538290|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23217369|NCT02120352|64538291|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23217370|NCT02120352|64538292|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
23217371|NCT02120352|64538286|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
23217372|NCT02120352|64538287|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
23217373|NCT02120352|64538288|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
23217374|NCT02120352|64538289|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
23217375|NCT02120352|64538290|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
23217376|NCT02120352|64538291|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
23217377|NCT02120352|64538292|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
23217378|NCT02120352|64538286|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
23217379|NCT02120352|64538287|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23217380|NCT02120352|64538288|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23217381|NCT02120352|64538289|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23622984|NCT01121913|66005114|FG002|First Intervention Period|Adverse Event|1|||
23217382|NCT02120352|64538290|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23217383|NCT02120352|64538291|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23217384|NCT02120352|64538292|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
23217385|NCT02120352|64538286|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
23217386|NCT02120352|64538287|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23217387|NCT02120352|64538288|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23217388|NCT02120352|64538289|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23217389|NCT02120352|64538290|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23217390|NCT02120352|64538291|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23217391|NCT02120352|64538292|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
23217392|NCT02120352|64538286|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
23217393|NCT02120352|64538287|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23217394|NCT02120352|64538288|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23622985|NCT01121913|66005115|FG003|First Intervention Period|Adverse Event|0|||
23622986|NCT01121913|66005112|FG000|First Washout Period|Withdrawal by Subject|1|||
23622987|NCT01121913|66005113|FG001|First Washout Period|Withdrawal by Subject|0|||
23622988|NCT01121913|66005114|FG002|First Washout Period|Withdrawal by Subject|0|||
23622989|NCT01121913|66005115|FG003|First Washout Period|Withdrawal by Subject|0|||
23622990|NCT01121913|66005112|FG000|Second Intervention Period|Adverse Event|0|||
23622991|NCT01121913|66005113|FG001|Second Intervention Period|Adverse Event|0|||
23622992|NCT01121913|66005114|FG002|Second Intervention Period|Adverse Event|1|||
23622993|NCT01121913|66005115|FG003|Second Intervention Period|Adverse Event|0|||
23622994|NCT01121913|66005112|FG000|Second Washout Period|Withdrawal by Subject|0|||
23622995|NCT01121913|66005113|FG001|Second Washout Period|Withdrawal by Subject|0|||
23622996|NCT01121913|66005114|FG002|Second Washout Period|Withdrawal by Subject|1|||
23622997|NCT01121913|66005115|FG003|Second Washout Period|Withdrawal by Subject|0|||
23622998|NCT01121913|66005112|FG000|Third Washout Period|Adverse Event|1|||
23622999|NCT01121913|66005113|FG001|Third Washout Period|Adverse Event|0|||
23623000|NCT01121913|66005114|FG002|Third Washout Period|Adverse Event|0|||
23623001|NCT01121913|66005115|FG003|Third Washout Period|Adverse Event|0|||
23623002|NCT01192776|66005116|FG000|Overall Study|Death|8|||
23623003|NCT01192776|66005117|FG001|Overall Study|Death|15|||
23623004|NCT01192776|66005118|FG002|Overall Study|Death|18|||
23623005|NCT01192776|66005119|FG003|Overall Study|Death|15|||
23623006|NCT01192776|66005116|FG000|Overall Study|Lost to Follow-up|3|||
23623007|NCT01192776|66005117|FG001|Overall Study|Lost to Follow-up|6|||
23623008|NCT01192776|66005118|FG002|Overall Study|Lost to Follow-up|3|||
23623009|NCT01192776|66005119|FG003|Overall Study|Lost to Follow-up|5|||
23623010|NCT02560389|66005120|FG000|Overall Study|Lost to Follow-up|1|||
23623011|NCT02560389|66005121|FG001|Overall Study|Lost to Follow-up|2|||
23623012|NCT02560389|66005122|FG002|Overall Study|Lost to Follow-up|2|||
23623013|NCT02560389|66005120|FG000|Overall Study|Tested positive for illicit substance|0|||
23217395|NCT02120352|64538289|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23217396|NCT02120352|64538290|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23217397|NCT02120352|64538291|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23217398|NCT02120352|64538292|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
23217399|NCT02120352|64538286|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
23217400|NCT02120352|64538287|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
23217401|NCT02120352|64538288|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
23623014|NCT02560389|66005121|FG001|Overall Study|Tested positive for illicit substance|1|||
23623015|NCT02560389|66005122|FG002|Overall Study|Tested positive for illicit substance|0|||
23623016|NCT00363649|66005124|FG000|Overall Study|Withdrawal by Subject|1|||
23623017|NCT00363649|66005125|FG001|Overall Study|Withdrawal by Subject|1|||
23623018|NCT00363649|66005124|FG000|Overall Study|Adverse Event|6|||
23217402|NCT02120352|64538289|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
23217403|NCT02120352|64538290|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
23217404|NCT02120352|64538291|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
23217405|NCT02120352|64538292|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
23217406|NCT02120352|64538286|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
23623019|NCT00363649|66005125|FG001|Overall Study|Adverse Event|0|||
23623020|NCT02396953|66005133|FG000|Overall Study|Withdrawal by Subject|0|||
23623021|NCT02396953|66005134|FG001|Overall Study|Withdrawal by Subject|0|||
23623022|NCT02396953|66005135|FG002|Overall Study|Withdrawal by Subject|1|||
23623023|NCT02396953|66005133|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
23623024|NCT02396953|66005134|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
23217407|NCT02120352|64538287|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
23217408|NCT02120352|64538288|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
23217409|NCT02120352|64538289|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
23217410|NCT02120352|64538290|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
23217411|NCT02120352|64538291|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
23217412|NCT02120352|64538292|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
23217413|NCT02120352|64538286|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23217414|NCT02120352|64538287|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
23217415|NCT02120352|64538288|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23217416|NCT02120352|64538289|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
23217417|NCT02120352|64538290|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23217418|NCT02120352|64538291|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23217419|NCT02120352|64538292|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
23217420|NCT02120352|64538286|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23217421|NCT02120352|64538287|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
23217422|NCT02120352|64538288|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
23217423|NCT02120352|64538289|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23433388|NCT03908476|65330443|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
23555605|NCT00117676|65762271|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
23623025|NCT02396953|66005135|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
23623026|NCT02396953|66005133|FG000|Overall Study|Personal Reasons|1|||
23623027|NCT02396953|66005134|FG001|Overall Study|Personal Reasons|1|||
23623028|NCT02396953|66005135|FG002|Overall Study|Personal Reasons|0|||
23623029|NCT00405912|66005136|FG000|Overall Study|Withdrawal by Subject|12|||
23623030|NCT00405912|66005137|FG001|Overall Study|Withdrawal by Subject|11|||
23623031|NCT00405912|66005138|FG002|Overall Study|Withdrawal by Subject|12|||
23623032|NCT00405912|66005136|FG000|Overall Study|Lost to Follow-up|4|||
23623033|NCT00405912|66005137|FG001|Overall Study|Lost to Follow-up|8|||
23623034|NCT00405912|66005138|FG002|Overall Study|Lost to Follow-up|4|||
23623035|NCT01020747|66005139|FG000|Overall Study|Withdrawal by Subject|1|||
23623036|NCT02151643|66005140|FG000|Overall Study|Adverse Event|2|||
23623037|NCT02151643|66005141|FG001|Overall Study|Adverse Event|0|||
23623038|NCT02151643|66005142|FG002|Overall Study|Adverse Event|1|||
23623039|NCT02151643|66005143|FG003|Overall Study|Adverse Event|4|||
23623040|NCT02151643|66005144|FG004|Overall Study|Adverse Event|0|||
23623041|NCT02151643|66005140|FG000|Overall Study|Withdrawal by Subject|0|||
23623042|NCT02151643|66005141|FG001|Overall Study|Withdrawal by Subject|1|||
23623043|NCT02151643|66005142|FG002|Overall Study|Withdrawal by Subject|1|||
23623044|NCT02151643|66005143|FG003|Overall Study|Withdrawal by Subject|1|||
23623045|NCT02151643|66005144|FG004|Overall Study|Withdrawal by Subject|1|||
23623046|NCT02151643|66005140|FG000|Overall Study|Hyperphosphataemia|1|||
23623047|NCT02151643|66005141|FG001|Overall Study|Hyperphosphataemia|0|||
23623048|NCT02151643|66005142|FG002|Overall Study|Hyperphosphataemia|0|||
23623049|NCT02151643|66005143|FG003|Overall Study|Hyperphosphataemia|0|||
23623050|NCT02151643|66005144|FG004|Overall Study|Hyperphosphataemia|1|||
23555606|NCT00117676|65762270|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
23555607|NCT00117676|65762271|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
23555608|NCT00117676|65762270|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
23555609|NCT00117676|65762271|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
23555610|NCT00117676|65762270|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
23623051|NCT02151643|66005140|FG000|Overall Study|High Ferritin levels|3|||
23623052|NCT02151643|66005141|FG001|Overall Study|High Ferritin levels|3|||
23623053|NCT02151643|66005142|FG002|Overall Study|High Ferritin levels|2|||
23623054|NCT02151643|66005143|FG003|Overall Study|High Ferritin levels|2|||
23217424|NCT02120352|64538290|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23217425|NCT02120352|64538291|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23217426|NCT02120352|64538292|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
23623055|NCT02151643|66005144|FG004|Overall Study|High Ferritin levels|1|||
23217427|NCT02120352|64538286|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23217428|NCT02120352|64538287|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23623056|NCT02016690|66005145|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
23623057|NCT02016690|66005145|FG000|Overall Study|Excluded from SAS: Duplication|2|||
23623058|NCT02016690|66005145|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
23623059|NCT02016690|66005145|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
23623060|NCT02016690|66005145|FG000|Overall Study|Did not meet inclusion criteria|13|||
23623061|NCT02016690|66005145|FG000|Overall Study|Hospitalized for RSV at study start|3|||
23623062|NCT03440047|66005150|FG000|Overall Study|Withdrawal by Subject|2|||
23623063|NCT00833898|66005151|FG000|Overall Study|Withdrawal by Subject|33|||
23623064|NCT00833898|66005152|FG001|Overall Study|Withdrawal by Subject|27|||
23623065|NCT00833898|66005151|FG000|Overall Study|Lost to Follow-up|7|||
23623066|NCT00833898|66005152|FG001|Overall Study|Lost to Follow-up|7|||
23623067|NCT00833898|66005151|FG000|Overall Study|Patient did not receive transplant|0|||
23623068|NCT00833898|66005152|FG001|Overall Study|Patient did not receive transplant|2|||
23623069|NCT04696146|66005153|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
23623070|NCT04696146|66005154|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
23623071|NCT04696146|66005153|FG000|Overall Study|Off hours issue with product|1|||
23623072|NCT04696146|66005154|FG001|Overall Study|Off hours issue with product|0|||
23623073|NCT02381652|66005157|FG000|Overall Study|Withdrawal by Subject|0|||
23623074|NCT02381652|66005158|FG001|Overall Study|Withdrawal by Subject|0|||
23623075|NCT02381652|66005159|FG002|Overall Study|Withdrawal by Subject|1|||
23623076|NCT00460564|66005165|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
23623077|NCT00460564|66005166|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
23623078|NCT00460564|66005167|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623079|NCT00460564|66005168|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623080|NCT00460564|66005169|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623081|NCT00460564|66005170|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623082|NCT00460564|66005171|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623083|NCT00460564|66005172|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
23623084|NCT00460564|66005165|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
23143322|NCT00757588|64273862|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
23143323|NCT00757588|64273861|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
23143324|NCT00757588|64273862|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
23143325|NCT00757588|64273861|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
23623085|NCT00460564|66005166|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623086|NCT00460564|66005167|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623087|NCT00460564|66005168|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623088|NCT00460564|66005169|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623089|NCT00460564|66005170|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623090|NCT00460564|66005171|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623091|NCT00460564|66005172|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
23623092|NCT00460564|66005165|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623093|NCT00460564|66005166|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623094|NCT00460564|66005167|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623095|NCT00460564|66005168|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623096|NCT00460564|66005169|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
23623097|NCT00460564|66005170|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
23623098|NCT00460564|66005171|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
23623099|NCT00460564|66005172|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
23623100|NCT00460564|66005165|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23623101|NCT00460564|66005166|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23623102|NCT00460564|66005167|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23143326|NCT00757588|64273862|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
23143327|NCT00757588|64273861|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
23143328|NCT00757588|64273862|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
23143329|NCT00757588|64273861|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
23143330|NCT00757588|64273862|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
23143331|NCT00757588|64273861|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
23143332|NCT00757588|64273862|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
23217429|NCT02120352|64538288|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
23217430|NCT02120352|64538289|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
23217431|NCT02120352|64538290|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23217432|NCT02120352|64538291|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23623103|NCT00460564|66005168|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23623104|NCT00460564|66005169|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
23623105|NCT00460564|66005170|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
23623106|NCT00460564|66005171|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23217433|NCT02120352|64538292|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
23623107|NCT00460564|66005172|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
23143333|NCT00757588|64273861|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
23143334|NCT00757588|64273862|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
23143335|NCT00757588|64273861|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
23143336|NCT00757588|64273862|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
23143337|NCT00757588|64273861|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
23143338|NCT00757588|64273862|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
23143339|NCT00757588|64273861|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
23143340|NCT00757588|64273862|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
23143341|NCT00757588|64273861|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
23143342|NCT00757588|64273862|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
23143343|NCT00757588|64273861|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
23143344|NCT00757588|64273862|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
23143345|NCT00757588|64273861|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
23143346|NCT00757588|64273862|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
23143347|NCT00757588|64273861|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
23143348|NCT00757588|64273862|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
23143349|NCT00757588|64273861|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
23143350|NCT00757588|64273862|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
23143351|NCT00757588|64273861|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
23143352|NCT00757588|64273862|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
23555611|NCT00117676|65762271|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
23555612|NCT00117676|65762270|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
23555613|NCT00117676|65762271|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
23555614|NCT04120233|65762274|FG000|Overall Study|Adverse Event|0|||
23555615|NCT04120233|65762275|FG001|Overall Study|Adverse Event|0|||
23555616|NCT04120233|65762276|FG002|Overall Study|Adverse Event|0|||
23555617|NCT04120233|65762277|FG003|Overall Study|Adverse Event|0|||
23555618|NCT04120233|65762278|FG004|Overall Study|Adverse Event|1|||
23555619|NCT04120233|65762279|FG005|Overall Study|Adverse Event|0|||
23555620|NCT00677833|65762280|FG000|Overall Study|Withdrawal by Subject|4|||
23555621|NCT00677833|65762281|FG001|Overall Study|Withdrawal by Subject|0|||
23555622|NCT00677833|65762282|FG002|Overall Study|Withdrawal by Subject|1|||
23143365|NCT00679627|64273880|FG000|Overall Study|Death|41|||
23143366|NCT00679627|64273881|FG001|Overall Study|Death|29|||
23143367|NCT00679627|64273880|FG000|Overall Study|Adverse Event|43|||
23217434|NCT02120352|64538286|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23217435|NCT02120352|64538287|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23320164|NCT03536884|64915667|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23623108|NCT00460564|66005165|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623109|NCT00460564|66005166|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623110|NCT00460564|66005167|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623111|NCT00460564|66005168|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623112|NCT00460564|66005169|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
23623113|NCT00460564|66005170|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623114|NCT00460564|66005171|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623115|NCT00460564|66005172|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
23623116|NCT00537329|66008309|FG000|Overall Study|Death|10|||
23623117|NCT00537329|66008309|FG000|Overall Study|Adverse Event|3|||
23623118|NCT00537329|66008309|FG000|Overall Study|Lack of Efficacy|2|||
23623119|NCT00537329|66008309|FG000|Overall Study|Lost to Follow-up|6|||
23623120|NCT00537329|66008309|FG000|Overall Study|Withdrawal by Subject|4|||
23623121|NCT00537329|66008309|FG000|Overall Study|Other|1|||
23623122|NCT03772041|66008314|FG000|Overall Study|Adverse Event|8|||
23623123|NCT03772041|66008315|FG001|Overall Study|Adverse Event|3|||
23623124|NCT03772041|66008314|FG000|Overall Study|Withdrawal by Subject|0|||
23623125|NCT03772041|66008315|FG001|Overall Study|Withdrawal by Subject|2|||
23623126|NCT03772041|66008314|FG000|Overall Study|Protocol Violation|4|||
23623127|NCT03772041|66008315|FG001|Overall Study|Protocol Violation|2|||
23623128|NCT03772041|66008314|FG000|Overall Study|Physician Decision|2|||
23623129|NCT03772041|66008315|FG001|Overall Study|Physician Decision|3|||
23623130|NCT01161446|66008319|FG000|Overall Study|Lost to Follow-up|18|||
23623131|NCT01161446|66008320|FG001|Overall Study|Lost to Follow-up|14|||
23623132|NCT01161446|66008319|FG000|Overall Study|Withdrawal by Subject|0|||
23623133|NCT01161446|66008320|FG001|Overall Study|Withdrawal by Subject|1|||
23143368|NCT00679627|64273881|FG001|Overall Study|Adverse Event|53|||
23143369|NCT00679627|64273880|FG000|Overall Study|Withdrawal by Subject|168|||
23143370|NCT00679627|64273881|FG001|Overall Study|Withdrawal by Subject|172|||
23143371|NCT00679627|64273880|FG000|Overall Study|Lost to Follow-up|22|||
23143372|NCT00679627|64273881|FG001|Overall Study|Lost to Follow-up|26|||
23143373|NCT00679627|64273880|FG000|Overall Study|Early Study Closure|425|||
23143374|NCT00679627|64273881|FG001|Overall Study|Early Study Closure|405|||
23623134|NCT01313624|66008321|FG000|Double-Blind Phase|Adverse Event|27|||
23623135|NCT01313624|66008322|FG001|Double-Blind Phase|Adverse Event|4|||
23623136|NCT01313624|66008321|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
23623137|NCT01313624|66008322|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
23623138|NCT01313624|66008321|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23623139|NCT01313624|66008322|FG001|Double-Blind Phase|Lost to Follow-up|2|||
23623140|NCT01313624|66008321|FG000|Double-Blind Phase|Physician Decision|1|||
23623141|NCT01313624|66008322|FG001|Double-Blind Phase|Physician Decision|0|||
23623142|NCT01313624|66008321|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23623143|NCT01313624|66008322|FG001|Double-Blind Phase|Lack of Efficacy|0|||
23623144|NCT01313624|66008321|FG000|Open-Label Phase|Adverse Event|1|||
23623145|NCT01313624|66008322|FG001|Open-Label Phase|Adverse Event|10|||
23623146|NCT01313624|66008321|FG000|Open-Label Phase|Withdrawal by Subject|2|||
23623147|NCT01313624|66008322|FG001|Open-Label Phase|Withdrawal by Subject|2|||
23623148|NCT01313624|66008321|FG000|Open-Label Phase|Lost to Follow-up|1|||
23217436|NCT02120352|64538288|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23217437|NCT02120352|64538289|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
23217438|NCT02120352|64538290|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23217439|NCT02120352|64538291|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23217440|NCT02120352|64538292|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
23217441|NCT02120352|64538286|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
23217442|NCT02120352|64538287|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
23217443|NCT02120352|64538288|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
23217444|NCT02120352|64538289|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
23217445|NCT02120352|64538290|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
23217446|NCT02120352|64538291|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
23217447|NCT02120352|64538292|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
23217448|NCT02120352|64538286|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23217449|NCT02120352|64538287|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
23217450|NCT02120352|64538288|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23217451|NCT02120352|64538289|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23217452|NCT02120352|64538290|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23217453|NCT02120352|64538291|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23217454|NCT02120352|64538292|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
23217455|NCT02120352|64538286|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
23217456|NCT02120352|64538287|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
23217457|NCT02120352|64538288|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
23217458|NCT02120352|64538289|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
23217459|NCT02120352|64538290|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
23217460|NCT02120352|64538291|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
23217461|NCT02120352|64538292|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
23217462|NCT02120352|64538286|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23217463|NCT02120352|64538287|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23217464|NCT02120352|64538288|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23217465|NCT02120352|64538289|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23217466|NCT02120352|64538290|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
23217467|NCT02120352|64538291|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23217468|NCT02120352|64538292|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
23217469|NCT02120352|64538286|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
23217470|NCT02120352|64538287|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
23217471|NCT02120352|64538288|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
23217472|NCT02120352|64538289|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
23320165|NCT03536884|64915668|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23320166|NCT03536884|64915669|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23320167|NCT03536884|64915670|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23320168|NCT03536884|64915671|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23320169|NCT03536884|64915672|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23320170|NCT03536884|64915673|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
23320171|NCT03536884|64915674|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
23217473|NCT02120352|64538290|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
23217474|NCT02120352|64538291|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
23217475|NCT02120352|64538292|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
23320172|NCT03536884|64915675|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
23320173|NCT03536884|64915676|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
23623149|NCT01313624|66008322|FG001|Open-Label Phase|Lost to Follow-up|1|||
23623150|NCT01114139|66008323|FG000|Overall Study|Adverse Event|3|||
23623151|NCT01114139|66008324|FG001|Overall Study|Adverse Event|2|||
23217476|NCT02120352|64538286|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
23623152|NCT01114139|66008323|FG000|Overall Study|Lost to Follow-up|15|||
23217477|NCT02120352|64538287|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
23217478|NCT02120352|64538288|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
23217479|NCT02120352|64538289|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
23623153|NCT01114139|66008324|FG001|Overall Study|Lost to Follow-up|3|||
23623154|NCT01114139|66008323|FG000|Overall Study|Withdrawal by Subject|17|||
23623155|NCT01114139|66008324|FG001|Overall Study|Withdrawal by Subject|6|||
23623156|NCT01114139|66008323|FG000|Overall Study|Other-Missed 1 visit|1|||
23623157|NCT01114139|66008324|FG001|Overall Study|Other-Missed 1 visit|0|||
23623158|NCT01114139|66008323|FG000|Overall Study|Other-Protocol Violation|1|||
23623159|NCT01114139|66008324|FG001|Overall Study|Other-Protocol Violation|0|||
23623160|NCT01114139|66008323|FG000|Overall Study|Other-Out of window for study drug dose|1|||
23623161|NCT01114139|66008324|FG001|Overall Study|Other-Out of window for study drug dose|0|||
23623162|NCT01114139|66008323|FG000|Overall Study|Other-Participant falsified records|0|||
23623163|NCT01114139|66008324|FG001|Overall Study|Other-Participant falsified records|1|||
23623164|NCT01114139|66008323|FG000|Overall Study|Other-Participant went on hospice|0|||
23623165|NCT01114139|66008324|FG001|Overall Study|Other-Participant went on hospice|1|||
23623166|NCT01114139|66008323|FG000|Overall Study|Other-Physician changed treatment|1|||
23623167|NCT01114139|66008324|FG001|Overall Study|Other-Physician changed treatment|0|||
23623168|NCT01114139|66008323|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
23623169|NCT01114139|66008324|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
23623170|NCT02760485|66008325|FG000|Phase 1|Death|3|||
23623171|NCT02760485|66008326|FG001|Phase 1|Death|6|||
23623172|NCT02760485|66008327|FG002|Phase 1|Death|0|||
23623173|NCT02760485|66008325|FG000|Phase 1|Withdrawal by Subject|2|||
23623174|NCT02760485|66008326|FG001|Phase 1|Withdrawal by Subject|0|||
23623175|NCT02760485|66008327|FG002|Phase 1|Withdrawal by Subject|0|||
23623176|NCT02760485|66008325|FG000|Phase 1|Progressive Disease|1|||
23623177|NCT02760485|66008326|FG001|Phase 1|Progressive Disease|0|||
23623178|NCT02760485|66008327|FG002|Phase 1|Progressive Disease|0|||
23623179|NCT02760485|66008325|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
23623180|NCT02760485|66008326|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
23623181|NCT02760485|66008327|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
23623182|NCT02760485|66008325|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
23623183|NCT02760485|66008326|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
23623184|NCT02760485|66008327|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
23623185|NCT02760485|66008325|FG000|Phase 2|Death|0|||
23623186|NCT02760485|66008326|FG001|Phase 2|Death|0|||
23623187|NCT02760485|66008327|FG002|Phase 2|Death|12|||
23623188|NCT02760485|66008325|FG000|Phase 2|Withdrawal by Subject|0|||
23623189|NCT02760485|66008326|FG001|Phase 2|Withdrawal by Subject|0|||
23623190|NCT02760485|66008327|FG002|Phase 2|Withdrawal by Subject|3|||
23623191|NCT02760485|66008325|FG000|Phase 2|Progressive Disease|0|||
23623192|NCT02760485|66008326|FG001|Phase 2|Progressive Disease|0|||
23623193|NCT02760485|66008327|FG002|Phase 2|Progressive Disease|1|||
23623194|NCT02760485|66008325|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
23623195|NCT02760485|66008326|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
23623196|NCT02760485|66008327|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
23623197|NCT01278615|66008328|FG000|Overall Study|Withdrawal by Subject|2|||
23623198|NCT03475056|66008329|FG000|Overall Study|Lost to Follow-up|0|||
23623199|NCT03475056|66008330|FG001|Overall Study|Lost to Follow-up|1|||
23623200|NCT03475056|66008329|FG000|Overall Study|Moved from Area|0|||
23623201|NCT03475056|66008330|FG001|Overall Study|Moved from Area|2|||
23623202|NCT00677092|66008331|FG000|Overall Study|Adverse Event|1|||
23623203|NCT00677092|66008331|FG000|Overall Study|Lost to Follow-up|1|||
23623204|NCT00677092|66008331|FG000|Overall Study|Withdrawal by Subject|3|||
23623205|NCT00677092|66008331|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
23623206|NCT01243411|66008332|FG000|Overall Study|Withdrawal by Subject|18|||
23623207|NCT01243411|66008332|FG000|Overall Study|Lost to Follow-up|10|||
23623208|NCT01243411|66008332|FG000|Overall Study|Adverse Event|5|||
23623209|NCT01243411|66008332|FG000|Overall Study|Other|8|||
23623210|NCT01264887|66008333|FG000|Overall Study|Adverse Event|5|||
23623211|NCT01264887|66008333|FG000|Overall Study|Death|7|||
23623212|NCT01264887|66008333|FG000|Overall Study|Lack of Efficacy|5|||
23217480|NCT02120352|64538290|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
23623213|NCT01264887|66008333|FG000|Overall Study|Physician Decision|4|||
23623214|NCT01264887|66008333|FG000|Overall Study|Withdrawal by Subject|6|||
23623215|NCT01264887|66008333|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
23623216|NCT01264887|66008333|FG000|Overall Study|Other|2|||
23623217|NCT00409409|66008337|FG000|Overall Study|Adverse Event|7|||
23623218|NCT00409409|66008338|FG001|Overall Study|Adverse Event|2|||
23623219|NCT00409409|66008337|FG000|Overall Study|Withdrawal by Subject|1|||
23623220|NCT00409409|66008338|FG001|Overall Study|Withdrawal by Subject|1|||
23623221|NCT00409409|66008337|FG000|Overall Study|Any other reason not above-mentioned|0|||
23623222|NCT00409409|66008338|FG001|Overall Study|Any other reason not above-mentioned|1|||
23623223|NCT01722045|66008339|FG000|Overall Study|Adverse Event|8|||
23623224|NCT01722045|66008339|FG000|Overall Study|Death|3|||
23217481|NCT02120352|64538291|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
23217482|NCT02120352|64538292|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
23217483|NCT02120352|64538286|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
23217484|NCT02120352|64538287|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
23217485|NCT02120352|64538288|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
23217486|NCT02120352|64538289|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
23217487|NCT02120352|64538290|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
23320174|NCT03536884|64915665|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320175|NCT03536884|64915666|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320176|NCT03536884|64915667|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320177|NCT03536884|64915668|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320178|NCT03536884|64915669|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320179|NCT03536884|64915670|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320180|NCT03536884|64915671|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320181|NCT03536884|64915672|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320182|NCT03536884|64915673|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320183|NCT03536884|64915674|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320184|NCT03536884|64915675|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
23320185|NCT03536884|64915676|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
23320186|NCT03536884|64915665|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23320187|NCT03536884|64915666|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23555623|NCT00677833|65762283|FG003|Overall Study|Withdrawal by Subject|3|||
23555624|NCT00677833|65762280|FG000|Overall Study|Lost to Follow-up|0|||
23555625|NCT00677833|65762281|FG001|Overall Study|Lost to Follow-up|0|||
23555626|NCT00677833|65762282|FG002|Overall Study|Lost to Follow-up|1|||
23555627|NCT00677833|65762283|FG003|Overall Study|Lost to Follow-up|0|||
23555628|NCT02657031|65762287|FG000|Overall Study|Adverse Event|1|||
23555629|NCT02657031|65762288|FG001|Overall Study|Adverse Event|2|||
23555630|NCT02355028|65762289|FG000|Overall Study|Adverse Event|2|||
23555631|NCT02355028|65762290|FG001|Overall Study|Adverse Event|0|||
23320188|NCT03536884|64915667|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23320189|NCT03536884|64915668|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23320190|NCT03536884|64915669|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23320191|NCT03536884|64915670|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23320192|NCT03536884|64915671|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23555632|NCT02355028|65762289|FG000|Overall Study|Withdrawal by Subject|1|||
23555633|NCT02355028|65762290|FG001|Overall Study|Withdrawal by Subject|1|||
23555634|NCT02355028|65762289|FG000|Overall Study|Deemed ineligible after randomization|8|||
23555635|NCT02355028|65762290|FG001|Overall Study|Deemed ineligible after randomization|4|||
23555636|NCT01111123|65762291|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
23555637|NCT01111123|65762292|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
23555638|NCT01111123|65762291|FG000|Maintenance Phase|Lost to Follow-up|0|||
23555639|NCT01111123|65762292|FG001|Maintenance Phase|Lost to Follow-up|2|||
23555640|NCT01791725|65762296|FG000|Overall Study|Withdrawal by Subject|0|||
23555641|NCT01791725|65762297|FG001|Overall Study|Withdrawal by Subject|1|||
23555642|NCT01791725|65762298|FG002|Overall Study|Withdrawal by Subject|0|||
23555643|NCT02314624|65762299|FG000|Overall Study|No participating patient|16|||
23555644|NCT02314624|65762300|FG001|Overall Study|No participating patient|13|||
23555645|NCT02314624|65762299|FG000|Overall Study|Participant withdrew|7|||
23555646|NCT02314624|65762300|FG001|Overall Study|Participant withdrew|2|||
23555647|NCT02314624|65762299|FG000|Overall Study|Lost to Follow-up|2|||
23555648|NCT02314624|65762300|FG001|Overall Study|Lost to Follow-up|5|||
23555649|NCT02314624|65762299|FG000|Overall Study|Dropped/Excluded by PI|6|||
23555650|NCT02314624|65762300|FG001|Overall Study|Dropped/Excluded by PI|6|||
23555651|NCT02822222|65762301|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
23555652|NCT02822222|65762302|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
23555653|NCT02291679|65762303|FG000|Overall Study|Adverse Event|2|||
23555654|NCT02291679|65762304|FG001|Overall Study|Adverse Event|12|||
23555655|NCT02291679|65762305|FG002|Overall Study|Adverse Event|19|||
23555656|NCT02291679|65762303|FG000|Overall Study|Protocol Violation|5|||
23555657|NCT02291679|65762304|FG001|Overall Study|Protocol Violation|1|||
23555658|NCT02291679|65762305|FG002|Overall Study|Protocol Violation|7|||
23555659|NCT02291679|65762303|FG000|Overall Study|Withdrew Consent|18|||
23555660|NCT02291679|65762304|FG001|Overall Study|Withdrew Consent|10|||
23555661|NCT02291679|65762305|FG002|Overall Study|Withdrew Consent|15|||
23555662|NCT02291679|65762303|FG000|Overall Study|Lost to Follow-up|12|||
23555663|NCT02291679|65762304|FG001|Overall Study|Lost to Follow-up|10|||
23555664|NCT02291679|65762305|FG002|Overall Study|Lost to Follow-up|9|||
23320193|NCT03536884|64915672|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23320194|NCT03536884|64915673|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23320195|NCT03536884|64915674|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23320196|NCT03536884|64915675|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
23320197|NCT03536884|64915676|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
23320198|NCT03536884|64915665|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320199|NCT03536884|64915666|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320200|NCT03536884|64915667|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320201|NCT03536884|64915668|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320202|NCT03536884|64915669|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320203|NCT03536884|64915670|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320204|NCT03536884|64915671|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320205|NCT03536884|64915672|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320206|NCT03536884|64915673|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320207|NCT03536884|64915674|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320208|NCT03536884|64915675|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
23320209|NCT03536884|64915676|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
23320210|NCT01495000|64915677|FG000|Overall Study|Lost to Follow-up|2|||
23320211|NCT01495000|64915678|FG001|Overall Study|Lost to Follow-up|2|||
23320212|NCT01495000|64915677|FG000|Overall Study|Protocol Violation|1|||
23320213|NCT01495000|64915678|FG001|Overall Study|Protocol Violation|0|||
23320214|NCT01495000|64915677|FG000|Overall Study|Withdrawal by Subject|10|||
23320215|NCT01495000|64915678|FG001|Overall Study|Withdrawal by Subject|10|||
23320216|NCT01597973|64915684|FG000|Overall Study|Found ineligible before study medication started|4|||
23320217|NCT01597973|64915685|FG001|Overall Study|Found ineligible before study medication started|2|||
23320218|NCT01597973|64915684|FG000|Overall Study|Eligible pathogen not confirmed|14|||
23320219|NCT01597973|64915685|FG001|Overall Study|Eligible pathogen not confirmed|15|||
23320220|NCT01597973|64915684|FG000|Overall Study|LAR not authorized to consent|0|||
23320221|NCT01597973|64915685|FG001|Overall Study|LAR not authorized to consent|1|||
23320222|NCT01597973|64915684|FG000|Overall Study|Ineligible due to early seizures|1|||
23320223|NCT01597973|64915685|FG001|Overall Study|Ineligible due to early seizures|0|||
23320224|NCT01597973|64915684|FG000|Overall Study|Ineligible due to non-target infection|1|||
23320225|NCT01597973|64915685|FG001|Overall Study|Ineligible due to non-target infection|1|||
23320226|NCT00616421|64915690|FG000|Overall Study|Withdrawal by Subject|9|||
23143375|NCT00585195|64273882|FG000|Overall Study|Adverse Event|0|||
23143376|NCT00585195|64273883|FG001|Overall Study|Adverse Event|0|||
23143377|NCT00585195|64273884|FG002|Overall Study|Adverse Event|0|||
23143378|NCT00585195|64273885|FG003|Overall Study|Adverse Event|0|||
23143379|NCT00585195|64273886|FG004|Overall Study|Adverse Event|2|||
23143380|NCT00585195|64273887|FG005|Overall Study|Adverse Event|1|||
23143381|NCT00585195|64273888|FG006|Overall Study|Adverse Event|0|||
23143382|NCT00585195|64273889|FG007|Overall Study|Adverse Event|1|||
23143383|NCT00585195|64273890|FG008|Overall Study|Adverse Event|0|||
23320227|NCT00616421|64915691|FG001|Overall Study|Withdrawal by Subject|11|||
23320228|NCT00616421|64915692|FG002|Overall Study|Withdrawal by Subject|8|||
23320229|NCT00616421|64915690|FG000|Overall Study|Lost to Follow-up|12|||
23320230|NCT00616421|64915691|FG001|Overall Study|Lost to Follow-up|26|||
23320231|NCT00616421|64915692|FG002|Overall Study|Lost to Follow-up|30|||
23320232|NCT00616421|64915690|FG000|Overall Study|Inappropriate enrollment|3|||
23320233|NCT00616421|64915691|FG001|Overall Study|Inappropriate enrollment|0|||
23320234|NCT00616421|64915692|FG002|Overall Study|Inappropriate enrollment|1|||
23320235|NCT00616421|64915690|FG000|Overall Study|Administrative reason|1|||
23320236|NCT00616421|64915691|FG001|Overall Study|Administrative reason|0|||
23320237|NCT00616421|64915692|FG002|Overall Study|Administrative reason|0|||
23320238|NCT00616421|64915690|FG000|Overall Study|Protocol Violation|0|||
23320239|NCT00616421|64915691|FG001|Overall Study|Protocol Violation|1|||
23320240|NCT00616421|64915692|FG002|Overall Study|Protocol Violation|2|||
23320241|NCT00616421|64915690|FG000|Overall Study|Unable to classify|1|||
23320242|NCT00616421|64915691|FG001|Overall Study|Unable to classify|0|||
23320243|NCT00616421|64915692|FG002|Overall Study|Unable to classify|0|||
23320244|NCT02766335|64915697|FG000|Initial Registration|Adverse Event|6|||
23320245|NCT02766335|64915698|FG001|Initial Registration|Adverse Event|3|||
23320246|NCT02766335|64915699|FG002|Initial Registration|Adverse Event|0|||
23320247|NCT02766335|64915697|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
23320248|NCT02766335|64915698|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
23320249|NCT02766335|64915699|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
23320250|NCT02766335|64915697|FG000|Initial Registration|Progression/relapse|49|||
23143384|NCT00585195|64273891|FG009|Overall Study|Adverse Event|0|||
23143385|NCT00585195|64273892|FG010|Overall Study|Adverse Event|3|||
23623225|NCT01722045|66008339|FG000|Overall Study|Withdrawal by Subject|8|||
23623226|NCT01722045|66008339|FG000|Overall Study|Lost to Follow-up|4|||
23623227|NCT01722045|66008339|FG000|Overall Study|Protocol Deviation|1|||
23623228|NCT01722045|66008339|FG000|Overall Study|Physician Decision|3|||
23623229|NCT01722045|66008339|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
23623230|NCT02344173|66008340|FG000|Procedure|Ablation Procedure Not Performed|7|||
23623231|NCT02344173|66008340|FG000|12-month Visit|Death|8|||
23623232|NCT02344173|66008340|FG000|12-month Visit|Withdrawal by Subject|30|||
23623233|NCT02344173|66008340|FG000|12-month Visit|Lost to Follow-up|58|||
23623234|NCT03016598|66008341|FG000|Overall Study|Lost to Follow-up|0|||
23623235|NCT03016598|66008342|FG001|Overall Study|Lost to Follow-up|2|||
23623236|NCT00104637|66008343|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
23623237|NCT00104637|66008344|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
23623238|NCT01255761|66008349|FG000|Overall Study|Adverse Event|29|||
23623239|NCT01255761|66008350|FG001|Overall Study|Adverse Event|43|||
23623240|NCT01255761|66008349|FG000|Overall Study|Lack of Efficacy|86|||
23623241|NCT01255761|66008350|FG001|Overall Study|Lack of Efficacy|74|||
23623242|NCT01255761|66008349|FG000|Overall Study|Protocol Violation|9|||
23623243|NCT01255761|66008350|FG001|Overall Study|Protocol Violation|5|||
23623244|NCT01255761|66008349|FG000|Overall Study|Lost to Follow-up|10|||
23623245|NCT01255761|66008350|FG001|Overall Study|Lost to Follow-up|8|||
23623246|NCT01255761|66008349|FG000|Overall Study|Withdrawal by Subject|11|||
23623247|NCT01255761|66008350|FG001|Overall Study|Withdrawal by Subject|27|||
23623248|NCT01255761|66008349|FG000|Overall Study|Other Reasons|37|||
23623249|NCT01255761|66008350|FG001|Overall Study|Other Reasons|18|||
23623250|NCT00263575|66008354|FG000|Titration Period|Adverse Event|14|||
23623251|NCT00263575|66008354|FG000|Titration Period|Withdrawal by Subject|10|||
23623252|NCT00263575|66008354|FG000|Titration Period|Protocol Violation|9|||
23623253|NCT00263575|66008354|FG000|Titration Period|Sponsor Decision|2|||
23623254|NCT00263575|66008354|FG000|Titration Period|Other|2|||
23623255|NCT00263575|66008354|FG000|Titration Period|Lack of Efficacy|6|||
23623256|NCT00263575|66008354|FG000|Maintence Period|Adverse Event|23|||
23623257|NCT00263575|66008354|FG000|Maintence Period|Withdrawal by Subject|8|||
23623258|NCT00263575|66008354|FG000|Maintence Period|Protocol Violation|4|||
23623259|NCT00263575|66008354|FG000|Maintence Period|Lack of Efficacy|4|||
23623260|NCT00263575|66008354|FG000|Maintence Period|Physician Decision|6|||
23623261|NCT00263575|66008354|FG000|Maintence Period|Lost to Follow-up|1|||
23623262|NCT00263575|66008354|FG000|Maintence Period|Sponsor Decision|24|||
23623263|NCT00263575|66008354|FG000|Maintence Period|Other|7|||
23623264|NCT02980705|66008357|FG000|Overall Study|Adverse Event|0|||
23623265|NCT02980705|66008358|FG001|Overall Study|Adverse Event|1|||
23623266|NCT02980705|66008357|FG000|Overall Study|Withdrawal by Subject|6|||
23623267|NCT02980705|66008358|FG001|Overall Study|Withdrawal by Subject|9|||
23623268|NCT02980705|66008357|FG000|Overall Study|withdrew participation|0|||
23623269|NCT02980705|66008358|FG001|Overall Study|withdrew participation|1|||
23623270|NCT02980705|66008357|FG000|Overall Study|Lost to Follow-up|2|||
23623271|NCT02980705|66008358|FG001|Overall Study|Lost to Follow-up|0|||
23623272|NCT01850823|66008363|FG000|Overall Study|Early Visit Window|0|||
23623273|NCT01850823|66008364|FG001|Overall Study|Early Visit Window|1|||
23623274|NCT01850823|66008365|FG002|Overall Study|Early Visit Window|4|||
23623275|NCT01850823|66008363|FG000|Overall Study|Enrolled in Error|0|||
23623276|NCT01850823|66008364|FG001|Overall Study|Enrolled in Error|1|||
23623277|NCT01850823|66008365|FG002|Overall Study|Enrolled in Error|2|||
23623278|NCT01850823|66008363|FG000|Overall Study|Lack of Efficacy|1|||
23623279|NCT01850823|66008364|FG001|Overall Study|Lack of Efficacy|0|||
23623280|NCT01850823|66008365|FG002|Overall Study|Lack of Efficacy|0|||
23623281|NCT01850823|66008363|FG000|Overall Study|Lost to Follow-up|0|||
23143386|NCT00585195|64273893|FG011|Overall Study|Adverse Event|0|||
23143387|NCT00585195|64273894|FG012|Overall Study|Adverse Event|8|||
23143388|NCT00585195|64273895|FG013|Overall Study|Adverse Event|6|||
23623282|NCT01850823|66008364|FG001|Overall Study|Lost to Follow-up|0|||
23623283|NCT01850823|66008365|FG002|Overall Study|Lost to Follow-up|1|||
23623284|NCT01850823|66008363|FG000|Overall Study|Restricted Medication|0|||
23623285|NCT01850823|66008364|FG001|Overall Study|Restricted Medication|0|||
23623286|NCT01850823|66008365|FG002|Overall Study|Restricted Medication|2|||
23623287|NCT01850823|66008363|FG000|Overall Study|Significant worstening of SAR|0|||
23623288|NCT01850823|66008364|FG001|Overall Study|Significant worstening of SAR|1|||
23623289|NCT01850823|66008365|FG002|Overall Study|Significant worstening of SAR|0|||
23623290|NCT01850823|66008363|FG000|Overall Study|Withdrawal by Subject|2|||
23623291|NCT01850823|66008364|FG001|Overall Study|Withdrawal by Subject|0|||
23623292|NCT01850823|66008365|FG002|Overall Study|Withdrawal by Subject|1|||
23623293|NCT04811339|66008369|FG000|Overall Study|lack of transportation not wanting to return|4|||
23623294|NCT04811339|66008370|FG001|Overall Study|lack of transportation not wanting to return|8|||
23623295|NCT04811339|66008371|FG002|Overall Study|lack of transportation not wanting to return|0|||
23623296|NCT04811339|66008369|FG000|Overall Study|Adverse Event|3|||
23623297|NCT04811339|66008370|FG001|Overall Study|Adverse Event|0|||
23623298|NCT04811339|66008371|FG002|Overall Study|Adverse Event|0|||
23623299|NCT04811339|66008369|FG000|Overall Study|Lost to Follow-up|1|||
23623300|NCT04811339|66008370|FG001|Overall Study|Lost to Follow-up|0|||
23623301|NCT04811339|66008371|FG002|Overall Study|Lost to Follow-up|0|||
23623302|NCT04811339|66008369|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
23623303|NCT04811339|66008370|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
23623304|NCT04811339|66008371|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
23623305|NCT04811339|66008369|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
23623306|NCT04811339|66008370|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
23623307|NCT04811339|66008371|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
23623308|NCT04811339|66008369|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
23623309|NCT04811339|66008370|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
23623310|NCT04811339|66008371|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
23623311|NCT04811339|66008369|FG000|Overall Study|Withdrawal by Subject|0|||
23623312|NCT04811339|66008370|FG001|Overall Study|Withdrawal by Subject|3|||
23623313|NCT04811339|66008371|FG002|Overall Study|Withdrawal by Subject|0|||
23623314|NCT04811339|66008369|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
23143389|NCT00585195|64273896|FG014|Overall Study|Adverse Event|4|||
23143390|NCT00585195|64273897|FG015|Overall Study|Adverse Event|1|||
23143391|NCT00585195|64273898|FG016|Overall Study|Adverse Event|14|||
23143392|NCT00585195|64273899|FG017|Overall Study|Adverse Event|9|||
23143393|NCT00585195|64273900|FG018|Overall Study|Adverse Event|2|||
23143394|NCT00585195|64273901|FG019|Overall Study|Adverse Event|3|||
23143395|NCT00585195|64273902|FG020|Overall Study|Adverse Event|1|||
23143396|NCT00585195|64273882|FG000|Overall Study|Progressive Disease|2|||
23143397|NCT00585195|64273883|FG001|Overall Study|Progressive Disease|2|||
23143398|NCT00585195|64273884|FG002|Overall Study|Progressive Disease|5|||
23143399|NCT00585195|64273885|FG003|Overall Study|Progressive Disease|4|||
23143400|NCT00585195|64273886|FG004|Overall Study|Progressive Disease|6|||
23143401|NCT00585195|64273887|FG005|Overall Study|Progressive Disease|4|||
23320251|NCT02766335|64915698|FG001|Initial Registration|Progression/relapse|15|||
23320252|NCT02766335|64915699|FG002|Initial Registration|Progression/relapse|0|||
23320253|NCT02766335|64915697|FG000|Initial Registration|Death|1|||
23320254|NCT02766335|64915698|FG001|Initial Registration|Death|3|||
23143402|NCT00585195|64273888|FG006|Overall Study|Progressive Disease|6|||
23143403|NCT00585195|64273889|FG007|Overall Study|Progressive Disease|3|||
23143404|NCT00585195|64273890|FG008|Overall Study|Progressive Disease|0|||
23143405|NCT00585195|64273891|FG009|Overall Study|Progressive Disease|5|||
23143406|NCT00585195|64273892|FG010|Overall Study|Progressive Disease|2|||
23143407|NCT00585195|64273893|FG011|Overall Study|Progressive Disease|25|||
23143408|NCT00585195|64273894|FG012|Overall Study|Progressive Disease|29|||
23143409|NCT00585195|64273895|FG013|Overall Study|Progressive Disease|26|||
23143410|NCT00585195|64273896|FG014|Overall Study|Progressive Disease|21|||
23143411|NCT00585195|64273897|FG015|Overall Study|Progressive Disease|12|||
23143412|NCT00585195|64273898|FG016|Overall Study|Progressive Disease|94|||
23320255|NCT02766335|64915699|FG002|Initial Registration|Death|0|||
23320256|NCT02766335|64915697|FG000|Initial Registration|not protocol specified|1|||
23555665|NCT02291679|65762303|FG000|Overall Study|Insufficient Therapeutic Response|5|||
23555666|NCT02291679|65762304|FG001|Overall Study|Insufficient Therapeutic Response|5|||
23555667|NCT02291679|65762305|FG002|Overall Study|Insufficient Therapeutic Response|7|||
23555668|NCT02291679|65762303|FG000|Overall Study|Other|2|||
23555669|NCT02291679|65762304|FG001|Overall Study|Other|4|||
23555670|NCT02291679|65762305|FG002|Overall Study|Other|2|||
23555671|NCT00981084|65762306|FG000|Post Intervention (Data Analysis)|poor effort|1|||
23555672|NCT00981084|65762307|FG001|Post Intervention (Data Analysis)|poor effort|1|||
23555673|NCT00981084|65762306|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
23555674|NCT00981084|65762307|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
23555675|NCT03318523|65762310|FG000|PC Period: Up to Year 1|Adverse Event|1|||
23555676|NCT03318523|65762311|FG001|PC Period: Up to Year 1|Adverse Event|0|||
23555677|NCT03318523|65762312|FG002|PC Period: Up to Year 1|Adverse Event|2|||
23555678|NCT03318523|65762313|FG003|PC Period: Up to Year 1|Adverse Event|0|||
23555679|NCT03318523|65762314|FG004|PC Period: Up to Year 1|Adverse Event|0|||
23555680|NCT03318523|65762315|FG005|PC Period: Up to Year 1|Adverse Event|0|||
23555681|NCT03318523|65762316|FG006|PC Period: Up to Year 1|Adverse Event|0|||
23555682|NCT03318523|65762317|FG007|PC Period: Up to Year 1|Adverse Event|0|||
23555683|NCT03318523|65762318|FG008|PC Period: Up to Year 1|Adverse Event|0|||
23555684|NCT03318523|65762319|FG009|PC Period: Up to Year 1|Adverse Event|0|||
23555685|NCT03318523|65762310|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
23555686|NCT03318523|65762311|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
23555687|NCT03318523|65762312|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555688|NCT03318523|65762313|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
23555689|NCT03318523|65762314|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
23143413|NCT00585195|64273899|FG017|Overall Study|Progressive Disease|42|||
23143414|NCT00585195|64273900|FG018|Overall Study|Progressive Disease|4|||
23143415|NCT00585195|64273901|FG019|Overall Study|Progressive Disease|9|||
23143416|NCT00585195|64273902|FG020|Overall Study|Progressive Disease|8|||
23143417|NCT00585195|64273882|FG000|Overall Study|Withdrawal by Subject|1|||
23143418|NCT00585195|64273883|FG001|Overall Study|Withdrawal by Subject|1|||
23320257|NCT02766335|64915698|FG001|Initial Registration|not protocol specified|9|||
23320258|NCT02766335|64915699|FG002|Initial Registration|not protocol specified|0|||
23320259|NCT02766335|64915697|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
23320260|NCT02766335|64915698|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
23320261|NCT02766335|64915699|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
23320262|NCT02766335|64915697|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
23320263|NCT02766335|64915698|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
23320264|NCT02766335|64915699|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
23320265|NCT02439216|64915708|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
23320266|NCT02439216|64915709|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23320267|NCT02439216|64915710|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23320268|NCT02439216|64915711|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23320269|NCT02439216|64915712|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23320270|NCT02439216|64915713|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23143419|NCT00585195|64273884|FG002|Overall Study|Withdrawal by Subject|2|||
23143420|NCT00585195|64273885|FG003|Overall Study|Withdrawal by Subject|2|||
23143421|NCT00585195|64273886|FG004|Overall Study|Withdrawal by Subject|0|||
23143422|NCT00585195|64273887|FG005|Overall Study|Withdrawal by Subject|0|||
23143423|NCT00585195|64273888|FG006|Overall Study|Withdrawal by Subject|0|||
23143424|NCT00585195|64273889|FG007|Overall Study|Withdrawal by Subject|1|||
23143425|NCT00585195|64273890|FG008|Overall Study|Withdrawal by Subject|0|||
23143426|NCT00585195|64273891|FG009|Overall Study|Withdrawal by Subject|0|||
23143427|NCT00585195|64273892|FG010|Overall Study|Withdrawal by Subject|3|||
23143428|NCT00585195|64273893|FG011|Overall Study|Withdrawal by Subject|8|||
23143429|NCT00585195|64273894|FG012|Overall Study|Withdrawal by Subject|15|||
23143430|NCT00585195|64273895|FG013|Overall Study|Withdrawal by Subject|0|||
23143431|NCT00585195|64273896|FG014|Overall Study|Withdrawal by Subject|3|||
23143432|NCT00585195|64273897|FG015|Overall Study|Withdrawal by Subject|0|||
23143433|NCT00585195|64273898|FG016|Overall Study|Withdrawal by Subject|7|||
23143434|NCT00585195|64273899|FG017|Overall Study|Withdrawal by Subject|1|||
23143435|NCT00585195|64273900|FG018|Overall Study|Withdrawal by Subject|2|||
23143436|NCT00585195|64273901|FG019|Overall Study|Withdrawal by Subject|2|||
23143437|NCT00585195|64273902|FG020|Overall Study|Withdrawal by Subject|0|||
23143438|NCT00585195|64273882|FG000|Overall Study|Other|0|||
23143439|NCT00585195|64273883|FG001|Overall Study|Other|1|||
23143440|NCT00585195|64273884|FG002|Overall Study|Other|1|||
23143441|NCT00585195|64273885|FG003|Overall Study|Other|1|||
23320271|NCT02439216|64915714|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23320272|NCT02439216|64915715|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23320273|NCT02439216|64915716|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
23320274|NCT02439216|64915708|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23143442|NCT00585195|64273886|FG004|Overall Study|Other|0|||
23143443|NCT00585195|64273887|FG005|Overall Study|Other|1|||
23143444|NCT00585195|64273888|FG006|Overall Study|Other|0|||
23143445|NCT00585195|64273889|FG007|Overall Study|Other|0|||
23143446|NCT00585195|64273890|FG008|Overall Study|Other|2|||
23143447|NCT00585195|64273891|FG009|Overall Study|Other|1|||
23143448|NCT00585195|64273892|FG010|Overall Study|Other|0|||
23143449|NCT00585195|64273893|FG011|Overall Study|Other|19|||
23143450|NCT00585195|64273894|FG012|Overall Study|Other|24|||
23143451|NCT00585195|64273895|FG013|Overall Study|Other|7|||
23143452|NCT00585195|64273896|FG014|Overall Study|Other|11|||
23143453|NCT00585195|64273897|FG015|Overall Study|Other|3|||
23143454|NCT00585195|64273898|FG016|Overall Study|Other|28|||
23143455|NCT00585195|64273899|FG017|Overall Study|Other|12|||
23143456|NCT00585195|64273900|FG018|Overall Study|Other|10|||
23217488|NCT02120352|64538291|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
23320275|NCT02439216|64915709|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23320276|NCT02439216|64915710|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23320277|NCT02439216|64915711|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23143457|NCT00585195|64273901|FG019|Overall Study|Other|4|||
23143458|NCT00585195|64273902|FG020|Overall Study|Other|2|||
23143459|NCT00585195|64273882|FG000|Overall Study|Randomized not treated|0|||
23143460|NCT00585195|64273883|FG001|Overall Study|Randomized not treated|0|||
23143461|NCT00585195|64273884|FG002|Overall Study|Randomized not treated|1|||
23143462|NCT00585195|64273885|FG003|Overall Study|Randomized not treated|0|||
23143463|NCT00585195|64273886|FG004|Overall Study|Randomized not treated|1|||
23143464|NCT00585195|64273887|FG005|Overall Study|Randomized not treated|0|||
23143465|NCT00585195|64273888|FG006|Overall Study|Randomized not treated|1|||
23143466|NCT00585195|64273889|FG007|Overall Study|Randomized not treated|0|||
23143467|NCT00585195|64273890|FG008|Overall Study|Randomized not treated|0|||
23143468|NCT00585195|64273891|FG009|Overall Study|Randomized not treated|0|||
23217489|NCT02120352|64538292|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
23555690|NCT03318523|65762315|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555691|NCT03318523|65762316|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555692|NCT03318523|65762317|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555693|NCT03318523|65762318|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555694|NCT03318523|65762319|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
23555695|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555696|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555697|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555698|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555699|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
23555700|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555701|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555702|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
23555703|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
23555704|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
23555705|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555706|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555707|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555708|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23623315|NCT04811339|66008370|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
23623316|NCT04811339|66008371|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
23623317|NCT04811339|66008369|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
23623318|NCT04811339|66008370|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
23623319|NCT04811339|66008371|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
23623320|NCT02210208|66008372|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
23623321|NCT02210208|66008372|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
23623322|NCT02210208|66008372|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
23623323|NCT02514577|66008373|FG000|Overall Study|Lost to Follow-up|6|||
23623324|NCT02514577|66008374|FG001|Overall Study|Lost to Follow-up|6|||
23623325|NCT02514577|66008373|FG000|Overall Study|Protocol Violation|1|||
23623326|NCT02514577|66008374|FG001|Overall Study|Protocol Violation|0|||
23623327|NCT02514577|66008373|FG000|Overall Study|Withdrawal by Subject|6|||
23623328|NCT02514577|66008374|FG001|Overall Study|Withdrawal by Subject|6|||
23623329|NCT02514577|66008373|FG000|Overall Study|Adverse Event|1|||
23623330|NCT02514577|66008374|FG001|Overall Study|Adverse Event|1|||
23623331|NCT01836198|66008375|FG000|Part A, Period 2|Protocol Violation|0|||
23623332|NCT01836198|66008376|FG001|Part A, Period 2|Protocol Violation|1|||
23143469|NCT00585195|64273892|FG010|Overall Study|Randomized not treated|2|||
23217490|NCT02120352|64538286|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23217491|NCT02120352|64538287|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
23217492|NCT02120352|64538288|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
23217493|NCT02120352|64538289|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23217494|NCT02120352|64538290|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23217495|NCT02120352|64538291|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23217496|NCT02120352|64538292|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
23217497|NCT02120352|64538286|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
23555709|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
23555710|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555711|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
23555712|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
23555713|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
23555714|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
23623333|NCT01836198|66008377|FG002|Part A, Period 2|Protocol Violation|0|||
23143470|NCT00585195|64273893|FG011|Overall Study|Randomized not treated|0|||
23143471|NCT00585195|64273894|FG012|Overall Study|Randomized not treated|0|||
23143472|NCT00585195|64273895|FG013|Overall Study|Randomized not treated|0|||
23143473|NCT00585195|64273896|FG014|Overall Study|Randomized not treated|0|||
23143474|NCT00585195|64273897|FG015|Overall Study|Randomized not treated|1|||
23143475|NCT00585195|64273898|FG016|Overall Study|Randomized not treated|0|||
23143476|NCT00585195|64273899|FG017|Overall Study|Randomized not treated|1|||
23143477|NCT00585195|64273900|FG018|Overall Study|Randomized not treated|3|||
23143478|NCT00585195|64273901|FG019|Overall Study|Randomized not treated|0|||
23143479|NCT00585195|64273902|FG020|Overall Study|Randomized not treated|2|||
23143480|NCT00585195|64273882|FG000|Overall Study|Death|0|||
23217498|NCT02120352|64538287|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
23143481|NCT00585195|64273883|FG001|Overall Study|Death|0|||
23143482|NCT00585195|64273884|FG002|Overall Study|Death|0|||
23143483|NCT00585195|64273885|FG003|Overall Study|Death|0|||
23320278|NCT02439216|64915712|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23320279|NCT02439216|64915713|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23320280|NCT02439216|64915714|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23555715|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23217499|NCT02120352|64538288|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
23217500|NCT02120352|64538289|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
23217501|NCT02120352|64538290|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
23217502|NCT02120352|64538291|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
23217503|NCT02120352|64538292|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
23217504|NCT02120352|64538286|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23217505|NCT02120352|64538287|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23217506|NCT02120352|64538288|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23217507|NCT02120352|64538289|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23217508|NCT02120352|64538290|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23217509|NCT02120352|64538291|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
23217510|NCT02120352|64538292|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
23217511|NCT00361218|64538295|FG000|Overall Study|Lost to Follow-up|11|||
23217512|NCT00361218|64538295|FG000|Overall Study|Personal Reasons|7|||
23217513|NCT00361218|64538295|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
23217514|NCT01599806|64538296|FG000|Overall Study|Lost to Follow-up|20|||
23217515|NCT01599806|64538297|FG001|Overall Study|Lost to Follow-up|20|||
23217516|NCT01599806|64538296|FG000|Overall Study|Withdrawal by Subject|12|||
23217517|NCT01599806|64538297|FG001|Overall Study|Withdrawal by Subject|12|||
23217518|NCT01599806|64538296|FG000|Overall Study|Other Eligibility criteria|11|||
23217519|NCT01599806|64538297|FG001|Overall Study|Other Eligibility criteria|9|||
23217520|NCT01855945|64538304|FG000|Overall Study|Adverse Event|0|||
23217521|NCT01855945|64538305|FG001|Overall Study|Adverse Event|0|||
23217522|NCT01855945|64538306|FG002|Overall Study|Adverse Event|0|||
23217523|NCT01855945|64538307|FG003|Overall Study|Adverse Event|0|||
23217524|NCT01855945|64538308|FG004|Overall Study|Adverse Event|0|||
23217525|NCT01855945|64538309|FG005|Overall Study|Adverse Event|0|||
23217526|NCT01855945|64538310|FG006|Overall Study|Adverse Event|1|||
23320281|NCT02439216|64915715|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
23143484|NCT00585195|64273886|FG004|Overall Study|Death|0|||
23143485|NCT00585195|64273887|FG005|Overall Study|Death|0|||
23143486|NCT00585195|64273888|FG006|Overall Study|Death|0|||
23143487|NCT00585195|64273889|FG007|Overall Study|Death|0|||
23143488|NCT00585195|64273890|FG008|Overall Study|Death|1|||
23143489|NCT00585195|64273891|FG009|Overall Study|Death|0|||
23143490|NCT00585195|64273892|FG010|Overall Study|Death|1|||
23143491|NCT00585195|64273893|FG011|Overall Study|Death|1|||
23143492|NCT00585195|64273894|FG012|Overall Study|Death|7|||
23143493|NCT00585195|64273895|FG013|Overall Study|Death|2|||
23143494|NCT00585195|64273896|FG014|Overall Study|Death|8|||
23143495|NCT00585195|64273897|FG015|Overall Study|Death|2|||
23143496|NCT00585195|64273898|FG016|Overall Study|Death|11|||
23143497|NCT00585195|64273899|FG017|Overall Study|Death|0|||
23143498|NCT00585195|64273900|FG018|Overall Study|Death|0|||
23143499|NCT00585195|64273901|FG019|Overall Study|Death|0|||
23143500|NCT00585195|64273902|FG020|Overall Study|Death|1|||
23143501|NCT00585195|64273882|FG000|Overall Study|Lost to Follow-up|0|||
23143502|NCT00585195|64273883|FG001|Overall Study|Lost to Follow-up|0|||
23143503|NCT00585195|64273884|FG002|Overall Study|Lost to Follow-up|0|||
23143504|NCT00585195|64273885|FG003|Overall Study|Lost to Follow-up|0|||
23143505|NCT00585195|64273886|FG004|Overall Study|Lost to Follow-up|0|||
23143506|NCT00585195|64273887|FG005|Overall Study|Lost to Follow-up|0|||
23143507|NCT00585195|64273888|FG006|Overall Study|Lost to Follow-up|0|||
23143508|NCT00585195|64273889|FG007|Overall Study|Lost to Follow-up|0|||
23143509|NCT00585195|64273890|FG008|Overall Study|Lost to Follow-up|0|||
23143510|NCT00585195|64273891|FG009|Overall Study|Lost to Follow-up|0|||
23143511|NCT00585195|64273892|FG010|Overall Study|Lost to Follow-up|0|||
23143512|NCT00585195|64273893|FG011|Overall Study|Lost to Follow-up|0|||
23143513|NCT00585195|64273894|FG012|Overall Study|Lost to Follow-up|1|||
23143514|NCT00585195|64273895|FG013|Overall Study|Lost to Follow-up|0|||
23143515|NCT00585195|64273896|FG014|Overall Study|Lost to Follow-up|0|||
23217527|NCT01855945|64538311|FG007|Overall Study|Adverse Event|0|||
23217528|NCT01855945|64538312|FG008|Overall Study|Adverse Event|0|||
23217529|NCT01855945|64538313|FG009|Overall Study|Adverse Event|0|||
23217530|NCT01855945|64538314|FG010|Overall Study|Adverse Event|0|||
23217531|NCT01855945|64538315|FG011|Overall Study|Adverse Event|0|||
23217532|NCT01855945|64538304|FG000|Overall Study|Death|0|||
23555716|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555717|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555718|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23143516|NCT00585195|64273897|FG015|Overall Study|Lost to Follow-up|0|||
23143517|NCT00585195|64273898|FG016|Overall Study|Lost to Follow-up|0|||
23143518|NCT00585195|64273899|FG017|Overall Study|Lost to Follow-up|2|||
23217533|NCT01855945|64538305|FG001|Overall Study|Death|0|||
23217534|NCT01855945|64538306|FG002|Overall Study|Death|0|||
23217535|NCT01855945|64538307|FG003|Overall Study|Death|0|||
23217536|NCT01855945|64538308|FG004|Overall Study|Death|0|||
23217537|NCT01855945|64538309|FG005|Overall Study|Death|0|||
23217538|NCT01855945|64538310|FG006|Overall Study|Death|2|||
23217539|NCT01855945|64538311|FG007|Overall Study|Death|0|||
23217540|NCT01855945|64538312|FG008|Overall Study|Death|0|||
23217541|NCT01855945|64538313|FG009|Overall Study|Death|0|||
23217542|NCT01855945|64538314|FG010|Overall Study|Death|0|||
23143519|NCT00585195|64273900|FG018|Overall Study|Lost to Follow-up|0|||
23143520|NCT00585195|64273901|FG019|Overall Study|Lost to Follow-up|0|||
23555719|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555720|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
23555721|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555722|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555723|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555724|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
23555725|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23143521|NCT00585195|64273902|FG020|Overall Study|Lost to Follow-up|0|||
23217543|NCT01855945|64538315|FG011|Overall Study|Death|0|||
23217544|NCT01855945|64538304|FG000|Overall Study|Lost to Follow-up|11|||
23320282|NCT02439216|64915716|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
23320283|NCT02439216|64915708|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23320284|NCT02439216|64915709|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23320285|NCT02439216|64915710|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23320286|NCT02439216|64915711|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23320287|NCT02439216|64915712|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23320288|NCT02439216|64915713|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23320289|NCT02439216|64915714|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
23320290|NCT02439216|64915715|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
23320291|NCT02439216|64915716|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
23143522|NCT00585195|64273882|FG000|Overall Study|Site Terminated by Sponsor|0|||
23320292|NCT02439216|64915708|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23320293|NCT02439216|64915709|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23320294|NCT02439216|64915710|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23320295|NCT02439216|64915711|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23320296|NCT02439216|64915712|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23320297|NCT02439216|64915713|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23320298|NCT02439216|64915714|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23320299|NCT02439216|64915715|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
23320300|NCT02439216|64915716|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
23320301|NCT02439216|64915708|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23320302|NCT02439216|64915709|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23320303|NCT02439216|64915710|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23320304|NCT02439216|64915711|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23320305|NCT02439216|64915712|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23320306|NCT02439216|64915713|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23433389|NCT03908476|65330444|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
23623334|NCT01580995|66008378|FG000|Overall Study|Lost to Follow-up|2|||
23623335|NCT01580995|66008379|FG001|Overall Study|Lost to Follow-up|2|||
23623336|NCT00217022|66008380|FG000|Overall Study|Withdrawal by Subject|1|||
23143523|NCT00585195|64273883|FG001|Overall Study|Site Terminated by Sponsor|0|||
23143524|NCT00585195|64273884|FG002|Overall Study|Site Terminated by Sponsor|0|||
23143525|NCT00585195|64273885|FG003|Overall Study|Site Terminated by Sponsor|0|||
23143526|NCT00585195|64273886|FG004|Overall Study|Site Terminated by Sponsor|0|||
23143527|NCT00585195|64273887|FG005|Overall Study|Site Terminated by Sponsor|0|||
23143528|NCT00585195|64273888|FG006|Overall Study|Site Terminated by Sponsor|0|||
23143529|NCT00585195|64273889|FG007|Overall Study|Site Terminated by Sponsor|0|||
23143530|NCT00585195|64273890|FG008|Overall Study|Site Terminated by Sponsor|0|||
23143531|NCT00585195|64273891|FG009|Overall Study|Site Terminated by Sponsor|0|||
23143532|NCT00585195|64273892|FG010|Overall Study|Site Terminated by Sponsor|0|||
23217545|NCT01855945|64538305|FG001|Overall Study|Lost to Follow-up|10|||
23217546|NCT01855945|64538306|FG002|Overall Study|Lost to Follow-up|7|||
23217547|NCT01855945|64538307|FG003|Overall Study|Lost to Follow-up|3|||
23217548|NCT01855945|64538308|FG004|Overall Study|Lost to Follow-up|0|||
23217549|NCT01855945|64538309|FG005|Overall Study|Lost to Follow-up|3|||
23217550|NCT01855945|64538310|FG006|Overall Study|Lost to Follow-up|4|||
23217551|NCT01855945|64538311|FG007|Overall Study|Lost to Follow-up|7|||
23143533|NCT00585195|64273893|FG011|Overall Study|Site Terminated by Sponsor|0|||
23217552|NCT01855945|64538312|FG008|Overall Study|Lost to Follow-up|2|||
23555726|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555727|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555728|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555729|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555730|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555731|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555732|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555733|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
23555734|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
23555735|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
23555736|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
23555737|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
23555738|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
23555739|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
23555740|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
23555741|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
23555742|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
23555743|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
23555744|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
23555745|NCT03318523|65762310|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555746|NCT03318523|65762311|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555747|NCT03318523|65762312|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555748|NCT03318523|65762313|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555749|NCT03318523|65762314|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
23555750|NCT03318523|65762315|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555751|NCT03318523|65762316|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555752|NCT03318523|65762317|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
23555753|NCT03318523|65762318|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
23555754|NCT03318523|65762319|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
23555755|NCT00734630|65762320|FG000|Overall Study|Lack of Efficacy|4|||
23555756|NCT00734630|65762321|FG001|Overall Study|Lack of Efficacy|4|||
23555757|NCT00734630|65762320|FG000|Overall Study|Withdrawal by Subject|7|||
23555758|NCT00734630|65762321|FG001|Overall Study|Withdrawal by Subject|9|||
23320307|NCT02439216|64915714|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
23320308|NCT02439216|64915715|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
23320309|NCT02439216|64915716|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
23320310|NCT03156504|64915717|FG000|Overall Study|Withdrawal by Subject|1|||
23320311|NCT01514461|64915718|FG000|Overall Study|Adverse Event|2|||
23320312|NCT01514461|64915719|FG001|Overall Study|Adverse Event|1|||
23320313|NCT01514461|64915720|FG002|Overall Study|Adverse Event|3|||
23320314|NCT01514461|64915718|FG000|Overall Study|Physician Decision|1|||
23320315|NCT01514461|64915719|FG001|Overall Study|Physician Decision|1|||
23320316|NCT01514461|64915720|FG002|Overall Study|Physician Decision|0|||
23320317|NCT01514461|64915718|FG000|Overall Study|Patient/guardian decision|1|||
23320318|NCT01514461|64915719|FG001|Overall Study|Patient/guardian decision|1|||
23320319|NCT01514461|64915720|FG002|Overall Study|Patient/guardian decision|1|||
23320320|NCT01514461|64915718|FG000|Overall Study|Death|1|||
23320321|NCT01514461|64915719|FG001|Overall Study|Death|0|||
23320322|NCT01514461|64915720|FG002|Overall Study|Death|0|||
23320323|NCT00699998|64915721|FG000|Overall Study|Withdrawal by Subject|194|||
23320324|NCT00699998|64915722|FG001|Overall Study|Withdrawal by Subject|83|||
23320325|NCT00699998|64915723|FG002|Overall Study|Withdrawal by Subject|202|||
23320326|NCT00699998|64915724|FG003|Overall Study|Withdrawal by Subject|80|||
23320327|NCT00699998|64915721|FG000|Overall Study|Physician Decision|3|||
23320328|NCT00699998|64915722|FG001|Overall Study|Physician Decision|2|||
23320329|NCT00699998|64915723|FG002|Overall Study|Physician Decision|1|||
23320330|NCT00699998|64915724|FG003|Overall Study|Physician Decision|1|||
23320331|NCT00699998|64915721|FG000|Overall Study|Lost to Follow-up|2|||
23320332|NCT00699998|64915722|FG001|Overall Study|Lost to Follow-up|1|||
23143534|NCT00585195|64273894|FG012|Overall Study|Site Terminated by Sponsor|1|||
23143535|NCT00585195|64273895|FG013|Overall Study|Site Terminated by Sponsor|0|||
23320333|NCT00699998|64915723|FG002|Overall Study|Lost to Follow-up|3|||
23320334|NCT00699998|64915724|FG003|Overall Study|Lost to Follow-up|1|||
23320335|NCT01439802|64915725|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
23143536|NCT00585195|64273896|FG014|Overall Study|Site Terminated by Sponsor|0|||
23320336|NCT01439802|64915725|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
23320337|NCT00853099|64915726|FG000|Double-blind Period|Adverse Event|7|||
23320338|NCT00853099|64915727|FG001|Double-blind Period|Adverse Event|9|||
23320339|NCT00853099|64915728|FG002|Double-blind Period|Adverse Event|13|||
23143537|NCT00585195|64273897|FG015|Overall Study|Site Terminated by Sponsor|0|||
23320340|NCT00853099|64915729|FG003|Double-blind Period|Adverse Event|0|||
23555759|NCT00734630|65762320|FG000|Overall Study|Lost to Follow-up|13|||
23555760|NCT00734630|65762321|FG001|Overall Study|Lost to Follow-up|7|||
23555761|NCT00734630|65762320|FG000|Overall Study|Protocol Violation|0|||
23555762|NCT00734630|65762321|FG001|Overall Study|Protocol Violation|3|||
23555763|NCT00734630|65762320|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
23555764|NCT00734630|65762321|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
23555765|NCT00734630|65762320|FG000|Overall Study|Adverse Event|3|||
23555766|NCT00734630|65762321|FG001|Overall Study|Adverse Event|6|||
23555767|NCT00734630|65762320|FG000|Overall Study|Randomized in Error|0|||
23555768|NCT00734630|65762321|FG001|Overall Study|Randomized in Error|1|||
23555769|NCT00734630|65762320|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
23555770|NCT00734630|65762321|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
23555771|NCT00734630|65762320|FG000|Overall Study|Poor Compliance|1|||
23555772|NCT00734630|65762321|FG001|Overall Study|Poor Compliance|1|||
23555773|NCT01338025|65762322|FG000|Overall Study|Unexpected closure of study|10|||
23555774|NCT01338025|65762323|FG001|Overall Study|Unexpected closure of study|9|||
23555775|NCT01338025|65762322|FG000|Overall Study|Withdrawal by Subject|0|||
23555776|NCT01338025|65762323|FG001|Overall Study|Withdrawal by Subject|2|||
23555777|NCT01338025|65762322|FG000|Overall Study|Found ineligible after starting|1|||
23555778|NCT01338025|65762323|FG001|Overall Study|Found ineligible after starting|0|||
23555779|NCT01313286|65762328|FG000|Period 1|Withdrawal by Subject|2|||
23555780|NCT01313286|65762329|FG001|Period 1|Withdrawal by Subject|0|||
23555781|NCT00952822|65762330|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
23555782|NCT00952822|65762331|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
23555783|NCT00952822|65762332|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
23555784|NCT00952822|65762333|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
23555785|NCT00952822|65762330|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
23555786|NCT00952822|65762331|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
23555787|NCT00952822|65762332|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
23320341|NCT00853099|64915726|FG000|Double-blind Period|Withdrawal by Subject|2|||
23555788|NCT00952822|65762333|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
23555789|NCT04495179|65762336|FG000|Overall Study|Lost to Follow-up|0|||
23555790|NCT04495179|65762337|FG001|Overall Study|Lost to Follow-up|1|||
23555791|NCT04495179|65762336|FG000|Overall Study|Withdrawal by Subject|2|||
23555792|NCT04495179|65762337|FG001|Overall Study|Withdrawal by Subject|4|||
23555793|NCT04495179|65762336|FG000|Overall Study|Study terminated by sponsor|0|||
23555794|NCT04495179|65762337|FG001|Overall Study|Study terminated by sponsor|18|||
23555795|NCT04495179|65762336|FG000|Overall Study|Death|0|||
23555796|NCT04495179|65762337|FG001|Overall Study|Death|4|||
23555797|NCT04495179|65762336|FG000|Overall Study|Adverse Event|0|||
23555798|NCT04495179|65762337|FG001|Overall Study|Adverse Event|1|||
23555799|NCT02192502|65762338|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
23555800|NCT02192502|65762339|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
23555801|NCT02192502|65762338|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
23555802|NCT02192502|65762339|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
23555803|NCT02192502|65762338|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
23555804|NCT02192502|65762339|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
23555805|NCT01944631|65762340|FG000|Overall Study|Adverse Event|1|||
23555806|NCT01944631|65762341|FG001|Overall Study|Adverse Event|0|||
23320342|NCT00853099|64915727|FG001|Double-blind Period|Withdrawal by Subject|3|||
23320343|NCT00853099|64915728|FG002|Double-blind Period|Withdrawal by Subject|0|||
23555807|NCT01944631|65762340|FG000|Overall Study|Lost to Follow-up|3|||
23555808|NCT01944631|65762341|FG001|Overall Study|Lost to Follow-up|1|||
23555809|NCT01944631|65762340|FG000|Overall Study|Withdrawal by Subject|0|||
23555810|NCT01944631|65762341|FG001|Overall Study|Withdrawal by Subject|1|||
23555811|NCT01685138|65762345|FG000|Overall Study|Lost to Follow-up|1|||
23555812|NCT01685138|65762345|FG000|Overall Study|Protocol Violation|1|||
23555813|NCT01685138|65762345|FG000|Overall Study|No longer requires treatment|1|||
23555814|NCT01685138|65762345|FG000|Overall Study|Subject/guardian decision|2|||
23555815|NCT01685138|65762345|FG000|Overall Study|Physician Decision|6|||
23555816|NCT01685138|65762345|FG000|Overall Study|Death|10|||
23555817|NCT01685138|65762345|FG000|Overall Study|Adverse Event|18|||
23433390|NCT01966445|65330445|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23555818|NCT01685138|65762345|FG000|Overall Study|Progressive disease|53|||
23555819|NCT00999466|65762346|FG000|Main Part|Withdrawal by Subject|0|||
23555820|NCT00999466|65762347|FG001|Main Part|Withdrawal by Subject|0|||
23555821|NCT00999466|65762348|FG002|Main Part|Withdrawal by Subject|2|||
23555822|NCT00999466|65762346|FG000|Main Part|Adverse Event|0|||
23555823|NCT00999466|65762347|FG001|Main Part|Adverse Event|4|||
23555824|NCT00999466|65762348|FG002|Main Part|Adverse Event|2|||
23555825|NCT03432364|65762349|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
23433391|NCT01966445|65330446|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23555826|NCT01040260|65762350|FG000|Overall Study|Withdrawal by Subject|12|||
23555827|NCT01040260|65762351|FG001|Overall Study|Withdrawal by Subject|6|||
23555828|NCT01040260|65762350|FG000|Overall Study|Lost to Follow-up|3|||
23555829|NCT01040260|65762351|FG001|Overall Study|Lost to Follow-up|5|||
23555830|NCT02384759|65762356|FG000|Overall Study|Patients not treated|3|||
23555831|NCT02384759|65762357|FG001|Overall Study|Patients not treated|2|||
23555832|NCT02633137|65762361|FG000|Overall Study|Adverse Event|1|||
23555833|NCT02633137|65762361|FG000|Overall Study|Lack of Efficacy|2|||
23555834|NCT02633137|65762361|FG000|Overall Study|Withdrawal by Subject|1|||
23555835|NCT01050816|65762362|FG000|Overall Study|Lost to Follow-up|2|||
23555836|NCT01050816|65762362|FG000|Overall Study|patient's refusal|2|||
23555837|NCT00045305|65762366|FG000|Overall Study|Lack of Efficacy|6|||
23555838|NCT00045305|65762366|FG000|Overall Study|Adverse Event|3|||
23555839|NCT00045305|65762366|FG000|Overall Study|Death|3|||
23555840|NCT00045305|65762366|FG000|Overall Study|site error|2|||
23555841|NCT00746590|65762367|FG000|Overall Study|Death|1|||
23555842|NCT00569582|65762368|FG000|Overall Study|Withdrawal by Subject|5|||
23555843|NCT00569582|65762368|FG000|Overall Study|Death|2|||
23555844|NCT00569582|65762368|FG000|Overall Study|Adverse Event|7|||
23555845|NCT00569582|65762368|FG000|Overall Study|Subject was too ill to travel.|1|||
23143538|NCT00585195|64273898|FG016|Overall Study|Site Terminated by Sponsor|0|||
23143539|NCT00585195|64273899|FG017|Overall Study|Site Terminated by Sponsor|0|||
23143540|NCT00585195|64273900|FG018|Overall Study|Site Terminated by Sponsor|0|||
23143541|NCT00585195|64273901|FG019|Overall Study|Site Terminated by Sponsor|0|||
23143542|NCT00585195|64273902|FG020|Overall Study|Site Terminated by Sponsor|0|||
23143543|NCT00585195|64273882|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
23143544|NCT00585195|64273883|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
23143545|NCT00585195|64273884|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
23143546|NCT00585195|64273885|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
23320344|NCT00853099|64915729|FG003|Double-blind Period|Withdrawal by Subject|0|||
23320345|NCT00853099|64915726|FG000|Double-blind Period|Lack of Efficacy|14|||
23320346|NCT00853099|64915727|FG001|Double-blind Period|Lack of Efficacy|17|||
23320347|NCT00853099|64915728|FG002|Double-blind Period|Lack of Efficacy|16|||
23320348|NCT00853099|64915729|FG003|Double-blind Period|Lack of Efficacy|0|||
23320349|NCT00853099|64915726|FG000|Double-blind Period|Other|0|||
23433392|NCT01966445|65330447|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23433393|NCT01966445|65330448|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
23433394|NCT01966445|65330449|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23433395|NCT01966445|65330450|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
23433396|NCT01966445|65330451|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
23433397|NCT01966445|65330445|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
23433398|NCT01966445|65330446|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
23433399|NCT01966445|65330447|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
23433400|NCT01966445|65330448|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
23433401|NCT01966445|65330449|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
23433402|NCT01966445|65330450|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
23433403|NCT01966445|65330451|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
23433404|NCT01966445|65330445|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
23555846|NCT00569582|65762368|FG000|Overall Study|Subject was non-compliant.|1|||
23555847|NCT01756352|65762369|FG000|Overall Study|moved away and lost to followup|1|||
23555848|NCT01615328|65762370|FG000|Overall Study|Lost to Follow-up|3|||
23555849|NCT01615328|65762371|FG001|Overall Study|Lost to Follow-up|5|||
23555850|NCT00708916|65762372|FG000|Overall Study|Subject Noncompliance|2|||
23555851|NCT00708916|65762372|FG000|Overall Study|Adverse Event|2|||
23555852|NCT04279314|65762381|FG000|Overall Study|Adverse Event|55|||
23143547|NCT00585195|64273886|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
23143548|NCT00585195|64273887|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
23143549|NCT00585195|64273888|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
23555853|NCT04279314|65762381|FG000|Overall Study|Withdrawal by Subject|5|||
23143550|NCT00585195|64273889|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
23143551|NCT00585195|64273890|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
23217553|NCT01855945|64538313|FG009|Overall Study|Lost to Follow-up|0|||
23217554|NCT01855945|64538314|FG010|Overall Study|Lost to Follow-up|0|||
23217555|NCT01855945|64538315|FG011|Overall Study|Lost to Follow-up|2|||
23217556|NCT01855945|64538304|FG000|Overall Study|Other - Unclassified|1|||
23217557|NCT01855945|64538305|FG001|Overall Study|Other - Unclassified|1|||
23217558|NCT01855945|64538306|FG002|Overall Study|Other - Unclassified|1|||
23217559|NCT01855945|64538307|FG003|Overall Study|Other - Unclassified|0|||
23217560|NCT01855945|64538308|FG004|Overall Study|Other - Unclassified|0|||
23217561|NCT01855945|64538309|FG005|Overall Study|Other - Unclassified|0|||
23217562|NCT01855945|64538310|FG006|Overall Study|Other - Unclassified|2|||
23217563|NCT01855945|64538311|FG007|Overall Study|Other - Unclassified|1|||
23217564|NCT01855945|64538312|FG008|Overall Study|Other - Unclassified|0|||
23217565|NCT01855945|64538313|FG009|Overall Study|Other - Unclassified|0|||
23217566|NCT01855945|64538314|FG010|Overall Study|Other - Unclassified|1|||
23433405|NCT01966445|65330446|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
23555854|NCT04279314|65762381|FG000|Overall Study|Lack of Efficacy|5|||
23433406|NCT01966445|65330447|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
23433407|NCT01966445|65330448|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
23433408|NCT01966445|65330449|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
23433409|NCT01966445|65330450|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
23433410|NCT01966445|65330451|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
23433411|NCT01966445|65330445|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433412|NCT01966445|65330446|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433413|NCT01966445|65330447|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433414|NCT01966445|65330448|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433415|NCT01966445|65330449|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433416|NCT01966445|65330450|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
23433417|NCT01966445|65330451|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
23433418|NCT01966445|65330445|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433419|NCT01966445|65330446|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433420|NCT01966445|65330447|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433421|NCT01966445|65330448|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433422|NCT01966445|65330449|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433423|NCT01966445|65330450|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
23433424|NCT01966445|65330451|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
23433425|NCT02273960|65330452|FG000|Short Term Period|Lost to Follow-up|1|||
23433426|NCT02273960|65330453|FG001|Short Term Period|Lost to Follow-up|0|||
23433427|NCT02273960|65330454|FG002|Short Term Period|Lost to Follow-up|0|||
23433428|NCT02273960|65330455|FG003|Short Term Period|Lost to Follow-up|0|||
23433429|NCT02273960|65330452|FG000|Short Term Period|Lack of Efficacy|0|||
23433430|NCT02273960|65330453|FG001|Short Term Period|Lack of Efficacy|0|||
23433431|NCT02273960|65330454|FG002|Short Term Period|Lack of Efficacy|0|||
23433432|NCT02273960|65330455|FG003|Short Term Period|Lack of Efficacy|1|||
23433433|NCT02273960|65330452|FG000|Short Term Period|ST complete, not entering LTE|4|||
23433434|NCT02273960|65330453|FG001|Short Term Period|ST complete, not entering LTE|6|||
23433435|NCT02273960|65330454|FG002|Short Term Period|ST complete, not entering LTE|4|||
23433436|NCT02273960|65330455|FG003|Short Term Period|ST complete, not entering LTE|5|||
23433437|NCT02273960|65330452|FG000|Long Term Extension|Death|0|||
23433438|NCT02273960|65330453|FG001|Long Term Extension|Death|0|||
23433439|NCT02273960|65330454|FG002|Long Term Extension|Death|0|||
23433440|NCT02273960|65330455|FG003|Long Term Extension|Death|1|||
23433441|NCT02032407|65330457|FG000|Overall Study|Lost to Follow-up|2|||
23433442|NCT02032407|65330457|FG000|Overall Study|Pregnancy|1|||
23433443|NCT02032407|65330457|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23433444|NCT00619099|65330458|FG000|Overall Study|Progressive Disease|7|||
23433445|NCT00619099|65330459|FG001|Overall Study|Progressive Disease|5|||
23433446|NCT00619099|65330458|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
23433447|NCT00619099|65330459|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
23433448|NCT00619099|65330458|FG000|Overall Study|Adverse Event|4|||
23433449|NCT00619099|65330459|FG001|Overall Study|Adverse Event|3|||
23433450|NCT00619099|65330458|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
23433451|NCT00619099|65330459|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
23433452|NCT00619099|65330458|FG000|Overall Study|Withdrawal by Subject|10|||
23433453|NCT00619099|65330459|FG001|Overall Study|Withdrawal by Subject|2|||
23433454|NCT00619099|65330458|FG000|Overall Study|Physician Decision|9|||
23433455|NCT00619099|65330459|FG001|Overall Study|Physician Decision|6|||
23433456|NCT00500760|65330460|FG000|Overall Study|Death|32|||
23433457|NCT00500760|65330461|FG001|Overall Study|Death|15|||
23433458|NCT00500760|65330460|FG000|Overall Study|Withdrawal by Subject|5|||
23433459|NCT00500760|65330461|FG001|Overall Study|Withdrawal by Subject|7|||
23433460|NCT00500760|65330460|FG000|Overall Study|Administrative decision|2|||
23433461|NCT00500760|65330461|FG001|Overall Study|Administrative decision|0|||
23433462|NCT00500760|65330460|FG000|Overall Study|Lost to Follow-up|3|||
23433463|NCT00500760|65330461|FG001|Overall Study|Lost to Follow-up|0|||
23433464|NCT00500760|65330460|FG000|Overall Study|Other|1|||
23433465|NCT00500760|65330461|FG001|Overall Study|Other|2|||
23433466|NCT01309269|65330464|FG000|Overall Study|Adverse Event|56|||
23143552|NCT00585195|64273891|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
23143553|NCT00585195|64273892|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
23143554|NCT00585195|64273893|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
23143555|NCT00585195|64273894|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
23143556|NCT00585195|64273895|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
23143557|NCT00585195|64273896|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
23143558|NCT00585195|64273897|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
23320350|NCT00853099|64915727|FG001|Double-blind Period|Other|0|||
23433467|NCT01309269|65330464|FG000|Overall Study|Withdrawal by Subject|25|||
23433468|NCT01309269|65330464|FG000|Overall Study|Lack of Acceptance|15|||
23555855|NCT04279314|65762381|FG000|Overall Study|Protocol Violation|3|||
23143559|NCT00585195|64273898|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
23320351|NCT00853099|64915728|FG002|Double-blind Period|Other|1|||
23320352|NCT00853099|64915729|FG003|Double-blind Period|Other|0|||
23320353|NCT00853099|64915726|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
23320354|NCT00853099|64915727|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
23320355|NCT00853099|64915728|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
23320356|NCT00853099|64915729|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
23320357|NCT00853099|64915726|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
23320358|NCT00853099|64915727|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
23320359|NCT00853099|64915728|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
23320360|NCT00853099|64915729|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
23433469|NCT01309269|65330464|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
23433470|NCT01309269|65330464|FG000|Overall Study|Kidney Transplant|25|||
23433471|NCT01309269|65330464|FG000|Overall Study|Administrative Problems|141|||
23433472|NCT01309269|65330464|FG000|Overall Study|Other|256|||
23433473|NCT01309269|65330464|FG000|Overall Study|Other|1|||
23433474|NCT01309269|65330464|FG000|Overall Study|Study Completion Data Not Recorded|95|||
23433475|NCT01309269|65330464|FG000|Overall Study|Enrolled but not Treated|107|||
23433476|NCT04268173|65330471|FG000|Overall Study|Lost to Follow-up|75|||
23433477|NCT04268173|65330472|FG001|Overall Study|Lost to Follow-up|108|||
23433478|NCT01306656|65330473|FG000|Overall Study|Lost to Follow-up|1|||
23433479|NCT01306656|65330474|FG001|Overall Study|Lost to Follow-up|0|||
23433480|NCT02690649|65330475|FG000|Overall Study|Withdrawal by Subject|1|||
23433481|NCT02690649|65330476|FG001|Overall Study|Withdrawal by Subject|1|||
23433482|NCT02690649|65330475|FG000|Overall Study|Protocol Violation|0|||
23433483|NCT02690649|65330476|FG001|Overall Study|Protocol Violation|3|||
23433484|NCT01012323|65330477|FG000|Overall Study|Investigator Judgment|1|||
23433485|NCT03320330|65330478|FG000|Overall Study|Lack of Efficacy|5|||
23433486|NCT03320330|65330479|FG001|Overall Study|Lack of Efficacy|5|||
23433487|NCT03320330|65330480|FG002|Overall Study|Lack of Efficacy|14|||
23433488|NCT03320330|65330478|FG000|Overall Study|Physician Decision|1|||
23433489|NCT03320330|65330479|FG001|Overall Study|Physician Decision|0|||
23433490|NCT03320330|65330480|FG002|Overall Study|Physician Decision|0|||
23433491|NCT02891382|65330481|FG000|Overall Study|Lost to Follow-up|3|||
23433492|NCT02891382|65330482|FG001|Overall Study|Lost to Follow-up|4|||
23433493|NCT02891382|65330483|FG002|Overall Study|Lost to Follow-up|5|||
23433494|NCT02891382|65330484|FG003|Overall Study|Lost to Follow-up|3|||
23433495|NCT02891382|65330485|FG004|Overall Study|Lost to Follow-up|4|||
23433496|NCT03203291|65330486|FG000|Overall Study|Withdrawal by Subject|1|||
23433497|NCT02658656|65330489|FG000|Screening|Failed eligibility criteria|0|||
23433498|NCT02658656|65330490|FG001|Screening|Failed eligibility criteria|0|||
23433499|NCT02658656|65330491|FG002|Screening|Failed eligibility criteria|263|||
23433500|NCT02658656|65330489|FG000|Randomization|Withdrawal by Subject|8|||
23433501|NCT02658656|65330490|FG001|Randomization|Withdrawal by Subject|7|||
23433502|NCT02658656|65330491|FG002|Randomization|Withdrawal by Subject|0|||
23433503|NCT02658656|65330489|FG000|Randomization|Lost to Follow-up|1|||
23433504|NCT02658656|65330490|FG001|Randomization|Lost to Follow-up|3|||
23433505|NCT02658656|65330491|FG002|Randomization|Lost to Follow-up|0|||
23433506|NCT02658656|65330489|FG000|Randomization|Adverse Event|4|||
23433507|NCT02658656|65330490|FG001|Randomization|Adverse Event|0|||
23433508|NCT02658656|65330491|FG002|Randomization|Adverse Event|0|||
23433509|NCT02658656|65330489|FG000|Randomization|Administrative Termination|3|||
23433510|NCT02658656|65330490|FG001|Randomization|Administrative Termination|1|||
23433511|NCT02658656|65330491|FG002|Randomization|Administrative Termination|0|||
23433512|NCT02658656|65330489|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
23433513|NCT02658656|65330490|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
23433514|NCT02658656|65330491|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
23433515|NCT02658656|65330489|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
23433516|NCT02658656|65330490|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
23433517|NCT02658656|65330491|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
23623337|NCT00217022|66008381|FG001|Overall Study|Withdrawal by Subject|1|||
23320361|NCT00853099|64915726|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
23433518|NCT02658656|65330489|FG000|Randomization|Not eligible for Randomization|1|||
23433519|NCT02658656|65330490|FG001|Randomization|Not eligible for Randomization|0|||
23433520|NCT02658656|65330491|FG002|Randomization|Not eligible for Randomization|0|||
23433521|NCT02658656|65330489|FG000|Randomization|Protocol Violation|1|||
23433522|NCT02658656|65330490|FG001|Randomization|Protocol Violation|0|||
23433523|NCT02658656|65330491|FG002|Randomization|Protocol Violation|0|||
23433524|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
23433525|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
23433526|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
23433527|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
23433528|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
23433529|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
23623338|NCT01013740|66008385|FG000|Overall Study|Lost to Follow-up|3|||
23433530|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
23433531|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
23433532|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Death|0|||
23433533|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Death|1|||
23433534|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
23433535|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
23433536|NCT03281304|65330496|FG000|Treatment Phase (up to 42 Months)|Other|0|||
23433537|NCT03281304|65330497|FG001|Treatment Phase (up to 42 Months)|Other|2|||
23433538|NCT03281304|65330496|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
23433539|NCT03281304|65330497|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
23433540|NCT03773107|65330499|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
23433541|NCT03773107|65330500|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
23433542|NCT03773107|65330501|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
23433543|NCT03773107|65330502|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
23433544|NCT00590577|65330503|FG000|Overall Study|Lack of Efficacy|31|||
23433545|NCT00590577|65330504|FG001|Overall Study|Lack of Efficacy|28|||
23433546|NCT00590577|65330505|FG002|Overall Study|Lack of Efficacy|23|||
23433547|NCT00590577|65330506|FG003|Overall Study|Lack of Efficacy|45|||
23433548|NCT00590577|65330503|FG000|Overall Study|Withdrawal by Subject|23|||
23433549|NCT00590577|65330504|FG001|Overall Study|Withdrawal by Subject|28|||
23433550|NCT00590577|65330505|FG002|Overall Study|Withdrawal by Subject|30|||
23433551|NCT00590577|65330506|FG003|Overall Study|Withdrawal by Subject|26|||
23433552|NCT00590577|65330503|FG000|Overall Study|Adverse Event|10|||
23433553|NCT00590577|65330504|FG001|Overall Study|Adverse Event|10|||
23433554|NCT00590577|65330505|FG002|Overall Study|Adverse Event|13|||
23433555|NCT00590577|65330506|FG003|Overall Study|Adverse Event|11|||
23433556|NCT00590577|65330503|FG000|Overall Study|Lost to Follow-up|12|||
23433557|NCT00590577|65330504|FG001|Overall Study|Lost to Follow-up|6|||
23433558|NCT00590577|65330505|FG002|Overall Study|Lost to Follow-up|6|||
23433559|NCT00590577|65330506|FG003|Overall Study|Lost to Follow-up|9|||
23433560|NCT00590577|65330503|FG000|Overall Study|Pregnancy|0|||
23433561|NCT00590577|65330504|FG001|Overall Study|Pregnancy|1|||
23433562|NCT00590577|65330505|FG002|Overall Study|Pregnancy|0|||
23433563|NCT00590577|65330506|FG003|Overall Study|Pregnancy|0|||
23433564|NCT00590577|65330503|FG000|Overall Study|Various reasons|1|||
23433565|NCT00590577|65330504|FG001|Overall Study|Various reasons|3|||
23433566|NCT00590577|65330505|FG002|Overall Study|Various reasons|1|||
23433567|NCT00590577|65330506|FG003|Overall Study|Various reasons|2|||
23433568|NCT01406015|65330510|FG000|Overall Study|Withdrawal by Subject|3|||
23433569|NCT01406015|65330511|FG001|Overall Study|Withdrawal by Subject|3|||
23433570|NCT04030247|65330514|FG000|Overall Study|Withdrawal by Subject|4|||
23433571|NCT04030247|65330514|FG000|Overall Study|Lost to Follow-up|13|||
23433572|NCT01805037|65330516|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
23433573|NCT01805037|65330517|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
23433574|NCT01805037|65330516|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
23433575|NCT01805037|65330517|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
23433576|NCT01805037|65330516|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
23433577|NCT01805037|65330517|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
23433578|NCT01805037|65330516|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
23433579|NCT01805037|65330517|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
23433580|NCT01805037|65330516|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
23433581|NCT01805037|65330517|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
23433582|NCT01805037|65330516|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
23433583|NCT01805037|65330517|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
23433584|NCT01805037|65330516|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
23433585|NCT01805037|65330517|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
23433586|NCT01805037|65330516|FG000|Follow Up (up to 3 Years)|Death|0|||
23433587|NCT01805037|65330517|FG001|Follow Up (up to 3 Years)|Death|2|||
23433588|NCT01805037|65330516|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
23143560|NCT00585195|64273899|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
23143561|NCT00585195|64273900|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
23320362|NCT00853099|64915727|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
23433589|NCT01805037|65330517|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
23433590|NCT01805037|65330516|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
23433591|NCT01805037|65330517|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
23433592|NCT02102399|65330518|FG000|Overall Study|Withdrawal by Subject|6|||
23433593|NCT02102399|65330519|FG001|Overall Study|Withdrawal by Subject|4|||
23433594|NCT01641822|65330522|FG000|Run-in Phase|Noncompliance with study drug|1|||
23433595|NCT01641822|65330523|FG001|Run-in Phase|Noncompliance with study drug|0|||
23433596|NCT01641822|65330524|FG002|Run-in Phase|Noncompliance with study drug|0|||
23433597|NCT01641822|65330522|FG000|Run-in Phase|Adverse Event|3|||
23433598|NCT01641822|65330523|FG001|Run-in Phase|Adverse Event|0|||
23143562|NCT00585195|64273901|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
23143563|NCT00585195|64273902|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
23143564|NCT00738582|64273908|FG000|Combination Therapy|Completed Combination Therapy|1|||
23143565|NCT00738582|64273909|FG001|Combination Therapy|Completed Combination Therapy|0|||
23143566|NCT00738582|64273908|FG000|Combination Therapy|Physician Decision|1|||
23143567|NCT00738582|64273909|FG001|Combination Therapy|Physician Decision|0|||
23143568|NCT00738582|64273908|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
23143569|NCT00738582|64273909|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
23143570|NCT00738582|64273908|FG000|Combination Therapy|Other|5|||
23143571|NCT00738582|64273909|FG001|Combination Therapy|Other|0|||
23143572|NCT00738582|64273908|FG000|Combination Therapy|Adverse Event|16|||
23433599|NCT01641822|65330524|FG002|Run-in Phase|Adverse Event|0|||
23433600|NCT01641822|65330522|FG000|Run-in Phase|Withdrew consent|1|||
23217567|NCT01855945|64538315|FG011|Overall Study|Other - Unclassified|0|||
23217568|NCT01855945|64538304|FG000|Overall Study|Withdrawal by Subject|4|||
23217569|NCT01855945|64538305|FG001|Overall Study|Withdrawal by Subject|0|||
23217570|NCT01855945|64538306|FG002|Overall Study|Withdrawal by Subject|4|||
23217571|NCT01855945|64538307|FG003|Overall Study|Withdrawal by Subject|1|||
23217572|NCT01855945|64538308|FG004|Overall Study|Withdrawal by Subject|1|||
23433601|NCT01641822|65330523|FG001|Run-in Phase|Withdrew consent|0|||
23433602|NCT01641822|65330524|FG002|Run-in Phase|Withdrew consent|0|||
23433603|NCT01641822|65330522|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
23433604|NCT01641822|65330523|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
23433605|NCT01641822|65330524|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
23433606|NCT01641822|65330522|FG000|Comparative Phase|Noncompliance with study drug|0|||
23433607|NCT01641822|65330523|FG001|Comparative Phase|Noncompliance with study drug|1|||
23433608|NCT01641822|65330524|FG002|Comparative Phase|Noncompliance with study drug|0|||
23433609|NCT01641822|65330522|FG000|Comparative Phase|Investigator's discretion|0|||
23433610|NCT01641822|65330523|FG001|Comparative Phase|Investigator's discretion|0|||
23433611|NCT01641822|65330524|FG002|Comparative Phase|Investigator's discretion|1|||
23433612|NCT01641822|65330522|FG000|Comparative Phase|Pregnancy|0|||
23433613|NCT01641822|65330523|FG001|Comparative Phase|Pregnancy|0|||
23433614|NCT01641822|65330524|FG002|Comparative Phase|Pregnancy|1|||
23433615|NCT01641822|65330522|FG000|Comparative Phase|Adverse event, serious fatal|0|||
23433616|NCT01641822|65330523|FG001|Comparative Phase|Adverse event, serious fatal|1|||
23433617|NCT01641822|65330524|FG002|Comparative Phase|Adverse event, serious fatal|0|||
23433618|NCT01641822|65330522|FG000|Comparative Phase|Withdrew consent|0|||
23433619|NCT01641822|65330523|FG001|Comparative Phase|Withdrew consent|3|||
23433620|NCT01641822|65330524|FG002|Comparative Phase|Withdrew consent|7|||
23433621|NCT01641822|65330522|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
23433622|NCT01641822|65330523|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
23433623|NCT01641822|65330524|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
23433624|NCT02271945|65330525|FG000|Overall Study|Death|3|||
23433625|NCT02271945|65330526|FG001|Overall Study|Death|3|||
23433626|NCT02271945|65330525|FG000|Overall Study|Withdrawal by Subject|1|||
23433627|NCT02271945|65330526|FG001|Overall Study|Withdrawal by Subject|1|||
23143573|NCT00738582|64273909|FG001|Combination Therapy|Adverse Event|0|||
23143574|NCT00738582|64273908|FG000|Combination Therapy|Progressive Disease|9|||
23143575|NCT00738582|64273909|FG001|Combination Therapy|Progressive Disease|0|||
23143576|NCT00738582|64273908|FG000|Maintenance Therapy|Other|0|||
23143577|NCT00738582|64273909|FG001|Maintenance Therapy|Other|2|||
23217573|NCT01855945|64538309|FG005|Overall Study|Withdrawal by Subject|0|||
23217574|NCT01855945|64538310|FG006|Overall Study|Withdrawal by Subject|1|||
23217575|NCT01855945|64538311|FG007|Overall Study|Withdrawal by Subject|0|||
23217576|NCT01855945|64538312|FG008|Overall Study|Withdrawal by Subject|0|||
23217577|NCT01855945|64538313|FG009|Overall Study|Withdrawal by Subject|2|||
23217578|NCT01855945|64538314|FG010|Overall Study|Withdrawal by Subject|4|||
23217579|NCT01855945|64538315|FG011|Overall Study|Withdrawal by Subject|1|||
23217580|NCT03446612|64538316|FG000|Overall Study|Protocol defined stopping criteria|0|||
23217581|NCT03446612|64538317|FG001|Overall Study|Protocol defined stopping criteria|1|||
23217582|NCT00981747|64538320|FG000|Losartan|Withdrawal by Subject|1|||
23433628|NCT02271945|65330525|FG000|Overall Study|Other|1|||
23433629|NCT02271945|65330526|FG001|Overall Study|Other|1|||
23433630|NCT00710385|65330529|FG000|Overall Study|Did not qualify|1|||
23433631|NCT00710385|65330529|FG000|Overall Study|Withdrawal by Subject|1|||
23143578|NCT00738582|64273908|FG000|Maintenance Therapy|Adverse Event|0|||
23143579|NCT00738582|64273909|FG001|Maintenance Therapy|Adverse Event|6|||
23143580|NCT00738582|64273908|FG000|Maintenance Therapy|Progressive Disease|0|||
23217583|NCT00981747|64538320|FG000|Losartan|Death|1|||
23217584|NCT00981747|64538320|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
23217585|NCT00415519|64538321|FG000|Overall Study|Adverse Event|1|||
23217586|NCT00415519|64538322|FG001|Overall Study|Adverse Event|0|||
23217587|NCT00415519|64538321|FG000|Overall Study|Withdrawal by Subject|2|||
23217588|NCT00415519|64538322|FG001|Overall Study|Withdrawal by Subject|0|||
23143581|NCT00738582|64273909|FG001|Maintenance Therapy|Progressive Disease|47|||
23143582|NCT00738582|64273908|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
23320363|NCT00853099|64915728|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
23320364|NCT00853099|64915729|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
23320365|NCT00853099|64915726|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
23320366|NCT00853099|64915727|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
23320367|NCT00853099|64915728|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
23320368|NCT00853099|64915729|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
23320369|NCT00853099|64915726|FG000|Double-blind + Open-label Periods|Other|0|||
23320370|NCT00853099|64915727|FG001|Double-blind + Open-label Periods|Other|0|||
23320371|NCT00853099|64915728|FG002|Double-blind + Open-label Periods|Other|0|||
23320372|NCT00853099|64915729|FG003|Double-blind + Open-label Periods|Other|6|||
23320373|NCT01260701|64915730|FG000|Overall Study|Adverse Event|9|||
23320374|NCT01260701|64915730|FG000|Overall Study|Withdrawal by Subject|2|||
23320375|NCT01260701|64915730|FG000|Overall Study|Progression|53|||
23320376|NCT01260701|64915730|FG000|Overall Study|Death|2|||
23320377|NCT01260701|64915730|FG000|Overall Study|Not protocol specified|3|||
23320378|NCT01260701|64915730|FG000|Overall Study|Under review|1|||
23320379|NCT01260701|64915730|FG000|Overall Study|Ineligible|4|||
23320380|NCT01260701|64915730|FG000|Overall Study|Did not begin protocol therapy|1|||
23320381|NCT00185588|64915733|FG000|Overall Study|Adverse Event|3|||
23320382|NCT00185588|64915734|FG001|Overall Study|Adverse Event|1|||
23320383|NCT00185588|64915735|FG002|Overall Study|Adverse Event|4|||
23320384|NCT00185588|64915736|FG003|Overall Study|Adverse Event|2|||
23320385|NCT00185588|64915733|FG000|Overall Study|Lost to Follow-up|0|||
23320386|NCT00185588|64915734|FG001|Overall Study|Lost to Follow-up|0|||
23320387|NCT00185588|64915735|FG002|Overall Study|Lost to Follow-up|1|||
23320388|NCT00185588|64915736|FG003|Overall Study|Lost to Follow-up|2|||
23320389|NCT00185588|64915733|FG000|Overall Study|Withdrawal by Subject|0|||
23320390|NCT00185588|64915734|FG001|Overall Study|Withdrawal by Subject|1|||
23320391|NCT00185588|64915735|FG002|Overall Study|Withdrawal by Subject|0|||
23320392|NCT00185588|64915736|FG003|Overall Study|Withdrawal by Subject|0|||
23320393|NCT00185588|64915733|FG000|Overall Study|Physician Decision|0|||
23320394|NCT00185588|64915734|FG001|Overall Study|Physician Decision|0|||
23320395|NCT00185588|64915735|FG002|Overall Study|Physician Decision|1|||
23320396|NCT00185588|64915736|FG003|Overall Study|Physician Decision|0|||
23320397|NCT01750190|64915737|FG000|Overall Study|Adverse Event|47|||
23320398|NCT01750190|64915738|FG001|Overall Study|Adverse Event|19|||
23217589|NCT00415519|64538321|FG000|Overall Study|Patient's convenience|1|||
23217590|NCT00415519|64538322|FG001|Overall Study|Patient's convenience|0|||
23217591|NCT03934541|64538326|FG000|Overall Study|Study Terminated by Sponsor|0|||
23320399|NCT01750190|64915737|FG000|Overall Study|Death|38|||
23555856|NCT04279314|65762381|FG000|Overall Study|Other (not COVID-19 related)|2|||
23555857|NCT01368900|65762382|FG000|Overall Study|Lost to Follow-up|7|||
23555858|NCT00335452|65762383|FG000|Overall Study|Death|156|||
23555859|NCT00335452|65762384|FG001|Overall Study|Death|144|||
23555860|NCT00335452|65762385|FG002|Overall Study|Death|158|||
23555861|NCT00335452|65762386|FG003|Overall Study|Death|129|||
23555862|NCT00335452|65762383|FG000|Overall Study|Lost to Follow-up|2|||
23555863|NCT00335452|65762384|FG001|Overall Study|Lost to Follow-up|3|||
23555864|NCT00335452|65762385|FG002|Overall Study|Lost to Follow-up|1|||
23217592|NCT03934541|64538327|FG001|Overall Study|Study Terminated by Sponsor|1|||
23217593|NCT03934541|64538328|FG002|Overall Study|Study Terminated by Sponsor|0|||
23217594|NCT03934541|64538329|FG003|Overall Study|Study Terminated by Sponsor|0|||
23217595|NCT04285853|64538330|FG000|Overall Study|Withdrawal by Subject|1|||
23217596|NCT04285853|64538331|FG001|Overall Study|Withdrawal by Subject|0|||
23555865|NCT00335452|65762386|FG003|Overall Study|Lost to Follow-up|2|||
23555866|NCT01221948|65762389|FG000|Overall Study|Physician Decision|5|||
23555867|NCT01221948|65762389|FG000|Overall Study|Withdrawal by Subject|2|||
23217597|NCT04285853|64538330|FG000|Overall Study|Lost to Follow-up|9|||
23217598|NCT04285853|64538331|FG001|Overall Study|Lost to Follow-up|5|||
23217599|NCT01313039|64538345|FG000|Overall Study|Physician Decision|1|||
23217600|NCT01313039|64538345|FG000|Overall Study|Adverse Event|1|||
23217601|NCT02670928|64538346|FG000|Overall Study|Adverse Event|3|||
23217602|NCT02670928|64538347|FG001|Overall Study|Adverse Event|1|||
23217603|NCT02670928|64538346|FG000|Overall Study|Withdrawal by Subject|4|||
23217604|NCT02670928|64538347|FG001|Overall Study|Withdrawal by Subject|0|||
23320400|NCT01750190|64915738|FG001|Overall Study|Death|11|||
23320401|NCT01750190|64915737|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
23320402|NCT01750190|64915738|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
23320403|NCT01750190|64915737|FG000|Overall Study|Lost to Follow-up|28|||
23320404|NCT01750190|64915738|FG001|Overall Study|Lost to Follow-up|7|||
23320405|NCT01750190|64915737|FG000|Overall Study|Physician Decision|16|||
23217605|NCT02670928|64538346|FG000|Overall Study|Lost to Follow-up|1|||
23217606|NCT02670928|64538347|FG001|Overall Study|Lost to Follow-up|0|||
23217607|NCT02670928|64538346|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
23217608|NCT02670928|64538347|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
23320406|NCT01750190|64915738|FG001|Overall Study|Physician Decision|17|||
23555868|NCT01221948|65762389|FG000|Overall Study|not disclosed|2|||
23217609|NCT01711541|64538350|FG000|Overall Study|Cancel prior to treatment|0|||
23217610|NCT01711541|64538351|FG001|Overall Study|Cancel prior to treatment|0|||
23217611|NCT01711541|64538352|FG002|Overall Study|Cancel prior to treatment|0|||
23217612|NCT01711541|64538353|FG003|Overall Study|Cancel prior to treatment|1|||
23217613|NCT01711541|64538354|FG004|Overall Study|Cancel prior to treatment|0|||
23320407|NCT01750190|64915737|FG000|Overall Study|Protocol Violation|6|||
23320408|NCT01750190|64915738|FG001|Overall Study|Protocol Violation|5|||
23320409|NCT01750190|64915737|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
23320410|NCT01750190|64915738|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
23217614|NCT01711541|64538350|FG000|Overall Study|Ineligible|0|||
23217615|NCT01711541|64538351|FG001|Overall Study|Ineligible|1|||
23217616|NCT01711541|64538352|FG002|Overall Study|Ineligible|0|||
23217617|NCT01711541|64538353|FG003|Overall Study|Ineligible|0|||
23217618|NCT01711541|64538354|FG004|Overall Study|Ineligible|0|||
23217619|NCT01369225|64538355|FG000|Overall Study|Withdrawal by Subject|1|||
23217620|NCT01369225|64538356|FG001|Overall Study|Withdrawal by Subject|0|||
23217621|NCT01369225|64538357|FG002|Overall Study|Withdrawal by Subject|2|||
23217622|NCT01369225|64538358|FG003|Overall Study|Withdrawal by Subject|1|||
23217623|NCT01369225|64538359|FG004|Overall Study|Withdrawal by Subject|0|||
23217624|NCT01369225|64538360|FG005|Overall Study|Withdrawal by Subject|0|||
23217625|NCT01369225|64538355|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
23217626|NCT01369225|64538356|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
23217627|NCT01369225|64538357|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
23217628|NCT01369225|64538358|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
23217629|NCT01369225|64538359|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
23217630|NCT01369225|64538360|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
23217631|NCT01369225|64538355|FG000|Overall Study|Other|1|||
23217632|NCT01369225|64538356|FG001|Overall Study|Other|0|||
23217633|NCT01369225|64538357|FG002|Overall Study|Other|0|||
23217634|NCT01369225|64538358|FG003|Overall Study|Other|0|||
23217635|NCT01369225|64538359|FG004|Overall Study|Other|1|||
23217636|NCT01369225|64538360|FG005|Overall Study|Other|0|||
23217637|NCT01369225|64538355|FG000|Overall Study|Adverse Event|0|||
23217638|NCT01369225|64538356|FG001|Overall Study|Adverse Event|0|||
23217639|NCT01369225|64538357|FG002|Overall Study|Adverse Event|0|||
23217640|NCT01369225|64538358|FG003|Overall Study|Adverse Event|1|||
23217641|NCT01369225|64538359|FG004|Overall Study|Adverse Event|1|||
23217642|NCT01369225|64538360|FG005|Overall Study|Adverse Event|0|||
23217643|NCT04038385|64538361|FG000|Overall Study|Completed baseline assessment only|7|||
23217644|NCT04038385|64538362|FG001|Overall Study|Completed baseline assessment only|4|||
23217645|NCT04038385|64538361|FG000|Overall Study|Moved out of area|4|||
23217646|NCT04038385|64538362|FG001|Overall Study|Moved out of area|2|||
23320411|NCT01750190|64915737|FG000|Overall Study|Withdrawal by Subject|83|||
23320412|NCT01750190|64915738|FG001|Overall Study|Withdrawal by Subject|89|||
23320413|NCT01750190|64915737|FG000|Overall Study|Kidney Transplant|8|||
23320414|NCT01750190|64915738|FG001|Overall Study|Kidney Transplant|4|||
23320415|NCT01750190|64915737|FG000|Overall Study|Dialysis|22|||
23320416|NCT01750190|64915738|FG001|Overall Study|Dialysis|8|||
23320417|NCT01750190|64915737|FG000|Overall Study|Other than Specified|13|||
23320418|NCT01750190|64915738|FG001|Overall Study|Other than Specified|4|||
23320419|NCT00789035|64915751|FG000|Overall Study|Adverse Event|0|||
23320420|NCT00789035|64915752|FG001|Overall Study|Adverse Event|2|||
23320421|NCT00789035|64915753|FG002|Overall Study|Adverse Event|0|||
23320422|NCT00789035|64915754|FG003|Overall Study|Adverse Event|1|||
23320423|NCT00789035|64915755|FG004|Overall Study|Adverse Event|3|||
23320424|NCT00789035|64915751|FG000|Overall Study|Lack of Efficacy|3|||
23320425|NCT00789035|64915752|FG001|Overall Study|Lack of Efficacy|0|||
23320426|NCT00789035|64915753|FG002|Overall Study|Lack of Efficacy|0|||
23320427|NCT00789035|64915754|FG003|Overall Study|Lack of Efficacy|0|||
23217647|NCT04038385|64538361|FG000|Overall Study|Discontinued study involvement|6|||
23217648|NCT04038385|64538362|FG001|Overall Study|Discontinued study involvement|1|||
23217649|NCT01655069|64538363|FG000|Overall Study|Physician Decision|0|||
23217650|NCT01655069|64538364|FG001|Overall Study|Physician Decision|0|||
23217651|NCT01655069|64538365|FG002|Overall Study|Physician Decision|0|||
23217652|NCT01655069|64538366|FG003|Overall Study|Physician Decision|1|||
23217653|NCT01655069|64538363|FG000|Overall Study|Adverse Event|6|||
23217654|NCT01655069|64538364|FG001|Overall Study|Adverse Event|7|||
23217655|NCT01655069|64538365|FG002|Overall Study|Adverse Event|2|||
23217656|NCT01655069|64538366|FG003|Overall Study|Adverse Event|3|||
23217657|NCT01655069|64538363|FG000|Overall Study|Lack of Efficacy|0|||
23217658|NCT01655069|64538364|FG001|Overall Study|Lack of Efficacy|1|||
23217659|NCT01655069|64538365|FG002|Overall Study|Lack of Efficacy|0|||
23217660|NCT01655069|64538366|FG003|Overall Study|Lack of Efficacy|0|||
23217661|NCT01655069|64538363|FG000|Overall Study|No Treatment Needed|0|||
23320428|NCT00789035|64915755|FG004|Overall Study|Lack of Efficacy|2|||
23320429|NCT00789035|64915751|FG000|Overall Study|Protocol Violation|1|||
23320430|NCT00789035|64915752|FG001|Overall Study|Protocol Violation|0|||
23217662|NCT01655069|64538364|FG001|Overall Study|No Treatment Needed|1|||
23217663|NCT01655069|64538365|FG002|Overall Study|No Treatment Needed|0|||
23320431|NCT00789035|64915753|FG002|Overall Study|Protocol Violation|0|||
23320432|NCT00789035|64915754|FG003|Overall Study|Protocol Violation|0|||
23320433|NCT00789035|64915755|FG004|Overall Study|Protocol Violation|0|||
23320434|NCT00789035|64915751|FG000|Overall Study|Withdrawal by Subject|0|||
23320435|NCT00789035|64915752|FG001|Overall Study|Withdrawal by Subject|2|||
23320436|NCT00789035|64915753|FG002|Overall Study|Withdrawal by Subject|0|||
23320437|NCT00789035|64915754|FG003|Overall Study|Withdrawal by Subject|0|||
23320438|NCT00789035|64915755|FG004|Overall Study|Withdrawal by Subject|0|||
23320439|NCT00789035|64915751|FG000|Overall Study|Other reason not defined above|2|||
23320440|NCT00789035|64915752|FG001|Overall Study|Other reason not defined above|3|||
23320441|NCT00789035|64915753|FG002|Overall Study|Other reason not defined above|1|||
23320442|NCT00789035|64915754|FG003|Overall Study|Other reason not defined above|0|||
23320443|NCT00789035|64915755|FG004|Overall Study|Other reason not defined above|1|||
23320444|NCT01982955|64915757|FG000|Overall Study|Randomized but not treated|0|||
23623339|NCT01013740|66008386|FG001|Overall Study|Lost to Follow-up|5|||
23623340|NCT01013740|66008385|FG000|Overall Study|Physician Decision|2|||
23623341|NCT01013740|66008386|FG001|Overall Study|Physician Decision|0|||
23623342|NCT01013740|66008385|FG000|Overall Study|Withdrawal by Subject|2|||
23623343|NCT01013740|66008386|FG001|Overall Study|Withdrawal by Subject|10|||
23623344|NCT01013740|66008385|FG000|Overall Study|study close / terminated : done in error|2|||
23623345|NCT01013740|66008386|FG001|Overall Study|study close / terminated : done in error|1|||
23623346|NCT01013740|66008385|FG000|Overall Study|Missing|2|||
23623347|NCT01013740|66008386|FG001|Overall Study|Missing|1|||
23623348|NCT01013740|66008385|FG000|Overall Study|Ongoing: Study records not completed|0|||
23623349|NCT01013740|66008386|FG001|Overall Study|Ongoing: Study records not completed|2|||
23623350|NCT01657877|66008389|FG000|Overall Study|Withdrawal by Subject|4|||
23623351|NCT01657877|66008389|FG000|Overall Study|Protocol Violation|6|||
23623352|NCT01657877|66008389|FG000|Overall Study|Adverse Event|2|||
23623353|NCT01657877|66008389|FG000|Overall Study|Other Reason|2|||
23623354|NCT02670122|66008390|FG000|Overall Study|Lost to Follow-up|4|||
23143583|NCT00738582|64273909|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
23143584|NCT03143166|64273910|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
23143585|NCT01689337|64273912|FG000|Overall Study|Study Discontinuation|1|||
23143586|NCT01650246|64273913|FG000|Overall Study|Adverse Event|23|||
23143587|NCT01650246|64273913|FG000|Overall Study|Protocol Violation|5|||
23143588|NCT01650246|64273913|FG000|Overall Study|Sponsor terminated study|53|||
23143589|NCT01650246|64273913|FG000|Overall Study|Lost to Follow-up|5|||
23143590|NCT01650246|64273913|FG000|Overall Study|Withdrawal by Subject|26|||
23143591|NCT01650246|64273913|FG000|Overall Study|Death|1|||
23143592|NCT01650246|64273913|FG000|Overall Study|Lack of Efficacy|30|||
23143593|NCT02768870|64273914|FG000|Overall Study|Death|1|||
23143594|NCT02768870|64273914|FG000|Overall Study|Reoperation|6|||
23143595|NCT02768870|64273914|FG000|Overall Study|Lost to Follow-up|1|||
23143596|NCT02768870|64273914|FG000|Overall Study|Exit|4|||
23143597|NCT01347762|64273922|FG000|Overall Study|Lost to Follow-up|0|||
23217664|NCT01655069|64538366|FG003|Overall Study|No Treatment Needed|0|||
23217665|NCT01655069|64538363|FG000|Overall Study|Withdrawal by Subject|2|||
23217666|NCT01655069|64538364|FG001|Overall Study|Withdrawal by Subject|3|||
23217667|NCT01655069|64538365|FG002|Overall Study|Withdrawal by Subject|0|||
23217668|NCT01655069|64538366|FG003|Overall Study|Withdrawal by Subject|0|||
23217669|NCT01810380|64538367|FG000|Overall Study|Randomised not treated|2|||
23217670|NCT01810380|64538368|FG001|Overall Study|Randomised not treated|1|||
23217671|NCT01810380|64538369|FG002|Overall Study|Randomised not treated|1|||
23217672|NCT01810380|64538367|FG000|Overall Study|Adverse Event|11|||
23217673|NCT01810380|64538368|FG001|Overall Study|Adverse Event|14|||
23217674|NCT01810380|64538369|FG002|Overall Study|Adverse Event|4|||
23217675|NCT01810380|64538367|FG000|Overall Study|Lack of Efficacy|24|||
23217676|NCT01810380|64538368|FG001|Overall Study|Lack of Efficacy|10|||
23217677|NCT01810380|64538369|FG002|Overall Study|Lack of Efficacy|11|||
23217678|NCT01810380|64538367|FG000|Overall Study|Protocol Violation|1|||
23217679|NCT01810380|64538368|FG001|Overall Study|Protocol Violation|0|||
23217680|NCT01810380|64538369|FG002|Overall Study|Protocol Violation|1|||
23217681|NCT01810380|64538367|FG000|Overall Study|Withdrawal by Subject|6|||
23217682|NCT01810380|64538368|FG001|Overall Study|Withdrawal by Subject|0|||
23217683|NCT01810380|64538369|FG002|Overall Study|Withdrawal by Subject|6|||
23217684|NCT01810380|64538367|FG000|Overall Study|Administrative or other reasons|11|||
23217685|NCT01810380|64538368|FG001|Overall Study|Administrative or other reasons|13|||
23217686|NCT01810380|64538369|FG002|Overall Study|Administrative or other reasons|9|||
23217687|NCT00045630|64538370|FG000|Overall Study|Adverse Event|1|||
23217688|NCT00045630|64538370|FG000|Overall Study|Refusal unrelated to adverse event|1|||
23217689|NCT00045630|64538370|FG000|Overall Study|Progression/relapse|1|||
23217690|NCT00045630|64538370|FG000|Overall Study|Death|1|||
23217691|NCT00045630|64538370|FG000|Overall Study|Ineligible|2|||
23217692|NCT03488238|64538376|FG000|Overall Study|Equipment malfunction|1|||
23320445|NCT01982955|64915758|FG001|Overall Study|Randomized but not treated|0|||
23320446|NCT01982955|64915759|FG002|Overall Study|Randomized but not treated|0|||
23143598|NCT01347762|64273923|FG001|Overall Study|Lost to Follow-up|1|||
23143599|NCT01347762|64273924|FG002|Overall Study|Lost to Follow-up|6|||
23143600|NCT01347762|64273925|FG003|Overall Study|Lost to Follow-up|5|||
23143601|NCT01347762|64273922|FG000|Overall Study|Withdrawal by Subject|4|||
23143602|NCT01347762|64273923|FG001|Overall Study|Withdrawal by Subject|1|||
23143603|NCT01347762|64273924|FG002|Overall Study|Withdrawal by Subject|3|||
23143604|NCT01347762|64273925|FG003|Overall Study|Withdrawal by Subject|3|||
23143605|NCT01801735|64273929|FG000|Overall Study|Adverse Event|79|||
23143606|NCT01801735|64273929|FG000|Overall Study|Lack of Efficacy|28|||
23143607|NCT01801735|64273929|FG000|Overall Study|Withdrawal by Subject|27|||
23217693|NCT03488238|64538376|FG000|Overall Study|Adverse Event|1|||
23217694|NCT02983799|64538383|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
23217695|NCT02983799|64538384|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
23217696|NCT02983799|64538385|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
23217697|NCT02983799|64538386|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
23217698|NCT02983799|64538387|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
23217699|NCT02983799|64538383|FG000|Overall Study|Death|20|||
23217700|NCT02983799|64538384|FG001|Overall Study|Death|5|||
23217701|NCT02983799|64538385|FG002|Overall Study|Death|23|||
23217702|NCT02983799|64538386|FG003|Overall Study|Death|47|||
23217703|NCT02983799|64538387|FG004|Overall Study|Death|7|||
23217704|NCT02983799|64538383|FG000|Overall Study|Withdrawal by Subject|1|||
23217705|NCT02983799|64538384|FG001|Overall Study|Withdrawal by Subject|0|||
23217706|NCT02983799|64538385|FG002|Overall Study|Withdrawal by Subject|3|||
23217707|NCT02983799|64538386|FG003|Overall Study|Withdrawal by Subject|4|||
23320447|NCT01982955|64915760|FG003|Overall Study|Randomized but not treated|1|||
23320448|NCT01982955|64915761|FG004|Overall Study|Randomized but not treated|0|||
23320449|NCT02681510|64915762|FG000|Overall Study|Withdrawal by Subject|1|||
23320450|NCT02681510|64915762|FG000|Overall Study|Lost to Follow-up|9|||
23320451|NCT00451204|64915766|FG000|Overall Study|Adverse Event|4|||
23320452|NCT00451204|64915767|FG001|Overall Study|Adverse Event|6|||
23320453|NCT00451204|64915766|FG000|Overall Study|Lack of Efficacy|4|||
23320454|NCT00451204|64915767|FG001|Overall Study|Lack of Efficacy|4|||
23320455|NCT00451204|64915766|FG000|Overall Study|Lost to Follow-up|4|||
23320456|NCT00451204|64915767|FG001|Overall Study|Lost to Follow-up|4|||
23320457|NCT00451204|64915766|FG000|Overall Study|Protocol Violation|1|||
23320458|NCT00451204|64915767|FG001|Overall Study|Protocol Violation|0|||
23320459|NCT00451204|64915766|FG000|Overall Study|Patient refusal|8|||
23320460|NCT00451204|64915767|FG001|Overall Study|Patient refusal|4|||
23320461|NCT00451204|64915766|FG000|Overall Study|Other|1|||
23320462|NCT00451204|64915767|FG001|Overall Study|Other|2|||
23320463|NCT00369486|64915775|FG000|4-Week Visit|Missed visit|2|||
23320464|NCT00369486|64915776|FG001|4-Week Visit|Missed visit|2|||
23320465|NCT00369486|64915777|FG002|4-Week Visit|Missed visit|0|||
23320466|NCT00369486|64915778|FG003|4-Week Visit|Missed visit|2|||
23320467|NCT00369486|64915779|FG004|4-Week Visit|Missed visit|1|||
23320468|NCT00369486|64915775|FG000|4-Week Visit|Dropped|0|||
23320469|NCT00369486|64915776|FG001|4-Week Visit|Dropped|0|||
23320470|NCT00369486|64915777|FG002|4-Week Visit|Dropped|1|||
23320471|NCT00369486|64915778|FG003|4-Week Visit|Dropped|0|||
23320472|NCT00369486|64915779|FG004|4-Week Visit|Dropped|0|||
23320473|NCT00369486|64915775|FG000|8-Week Visit|Missed visit|0|||
23320474|NCT00369486|64915776|FG001|8-Week Visit|Missed visit|1|||
23555869|NCT01221948|65762389|FG000|Overall Study|Death|1|||
23217708|NCT02983799|64538387|FG004|Overall Study|Withdrawal by Subject|1|||
23217709|NCT02983799|64538383|FG000|Overall Study|Protocol Violation|0|||
23217710|NCT02983799|64538384|FG001|Overall Study|Protocol Violation|1|||
23217711|NCT02983799|64538385|FG002|Overall Study|Protocol Violation|0|||
23217712|NCT02983799|64538386|FG003|Overall Study|Protocol Violation|0|||
23320475|NCT00369486|64915777|FG002|8-Week Visit|Missed visit|0|||
23320476|NCT00369486|64915778|FG003|8-Week Visit|Missed visit|0|||
23320477|NCT00369486|64915779|FG004|8-Week Visit|Missed visit|1|||
23143608|NCT01801735|64273929|FG000|Overall Study|Protocol Violation|25|||
23320478|NCT00369486|64915775|FG000|8-Week Visit|Dropped|0|||
23320479|NCT00369486|64915776|FG001|8-Week Visit|Dropped|0|||
23320480|NCT00369486|64915777|FG002|8-Week Visit|Dropped|0|||
23555870|NCT01221948|65762389|FG000|Overall Study|Protocol Violation|4|||
23555871|NCT01951638|65762393|FG000|Treatment Period|Protocol Violation|0|||
23555872|NCT01951638|65762394|FG001|Treatment Period|Protocol Violation|0|||
23555873|NCT01951638|65762395|FG002|Treatment Period|Protocol Violation|0|||
23555874|NCT01951638|65762396|FG003|Treatment Period|Protocol Violation|2|||
23555875|NCT01951638|65762397|FG004|Treatment Period|Protocol Violation|0|||
23555876|NCT01951638|65762393|FG000|Treatment Period|Protocol-driven decision point|1|||
23555877|NCT01951638|65762394|FG001|Treatment Period|Protocol-driven decision point|3|||
23555878|NCT01951638|65762395|FG002|Treatment Period|Protocol-driven decision point|0|||
23555879|NCT01951638|65762396|FG003|Treatment Period|Protocol-driven decision point|0|||
23555880|NCT01951638|65762397|FG004|Treatment Period|Protocol-driven decision point|0|||
23555881|NCT01951638|65762393|FG000|Treatment Period|Logistical difficulties|0|||
23555882|NCT01951638|65762394|FG001|Treatment Period|Logistical difficulties|1|||
23555883|NCT01951638|65762395|FG002|Treatment Period|Logistical difficulties|1|||
23320481|NCT00369486|64915778|FG003|8-Week Visit|Dropped|1|||
23320482|NCT00369486|64915779|FG004|8-Week Visit|Dropped|0|||
23320483|NCT00369486|64915775|FG000|17-Week Visit|Missed visit|0|||
23320484|NCT00369486|64915776|FG001|17-Week Visit|Missed visit|0|||
23320485|NCT00369486|64915777|FG002|17-Week Visit|Missed visit|1|||
23320486|NCT00369486|64915778|FG003|17-Week Visit|Missed visit|1|||
23320487|NCT00369486|64915779|FG004|17-Week Visit|Missed visit|1|||
23320488|NCT00369486|64915775|FG000|34-Week Visit|Dropped|0|||
23320489|NCT00369486|64915776|FG001|34-Week Visit|Dropped|1|||
23320490|NCT00369486|64915777|FG002|34-Week Visit|Dropped|1|||
23320491|NCT00369486|64915778|FG003|34-Week Visit|Dropped|3|||
23320492|NCT00369486|64915779|FG004|34-Week Visit|Dropped|3|||
23320493|NCT03541317|64915780|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
23320494|NCT03541317|64915781|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23320495|NCT03541317|64915782|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23320496|NCT03541317|64915783|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23320497|NCT03541317|64915784|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23320498|NCT03541317|64915785|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
23320499|NCT03200717|64915786|FG000|Overall Study|Progressive disease|24|||
23320500|NCT03200717|64915787|FG001|Overall Study|Progressive disease|5|||
23320501|NCT03200717|64915786|FG000|Overall Study|Adverse Event|11|||
23320502|NCT03200717|64915787|FG001|Overall Study|Adverse Event|8|||
23320503|NCT03200717|64915786|FG000|Overall Study|Physician Decision|3|||
23320504|NCT03200717|64915787|FG001|Overall Study|Physician Decision|2|||
23320505|NCT03200717|64915786|FG000|Overall Study|Death|2|||
23320506|NCT03200717|64915787|FG001|Overall Study|Death|0|||
23320507|NCT03200717|64915786|FG000|Overall Study|Subject/Guardian Decision|1|||
23320508|NCT03200717|64915787|FG001|Overall Study|Subject/Guardian Decision|0|||
23320509|NCT02064296|64915788|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
23320510|NCT02064296|64915789|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
23143609|NCT01801735|64273929|FG000|Overall Study|Lost to Follow-up|15|||
23143610|NCT01801735|64273929|FG000|Overall Study|Non-compliance with Trial Drug|13|||
23143611|NCT01801735|64273929|FG000|Overall Study|Physician Decision|3|||
23143612|NCT01801735|64273929|FG000|Overall Study|Death|1|||
23143613|NCT01801735|64273929|FG000|Overall Study|Other, including site closure|19|||
23143614|NCT00495586|64273932|FG000|Overall Study|Withdrawal by Subject|4|||
23143615|NCT00495586|64273933|FG001|Overall Study|Withdrawal by Subject|4|||
23143616|NCT01506609|64273934|FG000|Overall Study|Adverse Event Related to Progression|0|||
23143617|NCT01506609|64273935|FG001|Overall Study|Adverse Event Related to Progression|0|||
23143618|NCT01506609|64273936|FG002|Overall Study|Adverse Event Related to Progression|0|||
23143619|NCT01506609|64273937|FG003|Overall Study|Adverse Event Related to Progression|3|||
23143620|NCT01506609|64273938|FG004|Overall Study|Adverse Event Related to Progression|7|||
23143621|NCT01506609|64273939|FG005|Overall Study|Adverse Event Related to Progression|3|||
23143622|NCT01506609|64273934|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
23143623|NCT01506609|64273935|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
23143624|NCT01506609|64273936|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
23143625|NCT01506609|64273937|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
23143626|NCT01506609|64273938|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
23143627|NCT01506609|64273939|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
23143628|NCT01506609|64273934|FG000|Overall Study|Withdrawal by Subject|0|||
23143629|NCT01506609|64273935|FG001|Overall Study|Withdrawal by Subject|0|||
23143630|NCT01506609|64273936|FG002|Overall Study|Withdrawal by Subject|0|||
23143631|NCT01506609|64273937|FG003|Overall Study|Withdrawal by Subject|9|||
23143632|NCT01506609|64273938|FG004|Overall Study|Withdrawal by Subject|7|||
23143633|NCT01506609|64273939|FG005|Overall Study|Withdrawal by Subject|7|||
23143634|NCT01506609|64273934|FG000|Overall Study|Lost to Follow-up|0|||
23143635|NCT01506609|64273935|FG001|Overall Study|Lost to Follow-up|0|||
23143636|NCT01506609|64273936|FG002|Overall Study|Lost to Follow-up|0|||
23143637|NCT01506609|64273937|FG003|Overall Study|Lost to Follow-up|1|||
23143638|NCT01506609|64273938|FG004|Overall Study|Lost to Follow-up|2|||
23143639|NCT01506609|64273939|FG005|Overall Study|Lost to Follow-up|0|||
23143640|NCT01506609|64273934|FG000|Overall Study|Sponsor Discontinued Study|0|||
23143641|NCT01506609|64273935|FG001|Overall Study|Sponsor Discontinued Study|0|||
23143642|NCT01506609|64273936|FG002|Overall Study|Sponsor Discontinued Study|0|||
23143643|NCT01506609|64273937|FG003|Overall Study|Sponsor Discontinued Study|2|||
23143644|NCT01506609|64273938|FG004|Overall Study|Sponsor Discontinued Study|2|||
23143645|NCT01506609|64273939|FG005|Overall Study|Sponsor Discontinued Study|0|||
23143646|NCT01506609|64273934|FG000|Overall Study|Progressive Disease per Protocol|1|||
23320511|NCT02064296|64915790|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
23320512|NCT02064296|64915788|FG000|Intervention|Withdrawal by Subject|0|||
23320513|NCT02064296|64915789|FG001|Intervention|Withdrawal by Subject|1|||
23320514|NCT02064296|64915790|FG002|Intervention|Withdrawal by Subject|2|||
23320515|NCT02952586|64915791|FG000|Lead-In Phase (7 Days)|Death|0|||
23320516|NCT02952586|64915792|FG001|Lead-In Phase (7 Days)|Death|1|||
23320517|NCT02952586|64915791|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
23320518|NCT02952586|64915792|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
23320519|NCT02952586|64915791|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
23320520|NCT02952586|64915792|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
23320521|NCT02952586|64915791|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
23320522|NCT02952586|64915792|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
23320523|NCT02952586|64915791|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
23320524|NCT02952586|64915792|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
23320525|NCT02952586|64915791|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
23320526|NCT02952586|64915792|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
23320527|NCT02952586|64915791|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
23320528|NCT02952586|64915792|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
23143647|NCT01506609|64273935|FG001|Overall Study|Progressive Disease per Protocol|0|||
23143648|NCT01506609|64273936|FG002|Overall Study|Progressive Disease per Protocol|0|||
23320529|NCT02952586|64915791|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
23320530|NCT02952586|64915792|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
23143649|NCT01506609|64273937|FG003|Overall Study|Progressive Disease per Protocol|64|||
23143650|NCT01506609|64273938|FG004|Overall Study|Progressive Disease per Protocol|57|||
23143651|NCT01506609|64273939|FG005|Overall Study|Progressive Disease per Protocol|74|||
23143652|NCT01506609|64273934|FG000|Overall Study|Other, Not Specified|0|||
23320531|NCT02952586|64915791|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
23320532|NCT02952586|64915792|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
23320533|NCT02952586|64915791|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
23320534|NCT02952586|64915792|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
23320535|NCT02952586|64915791|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
23320536|NCT02952586|64915792|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
23320537|NCT02952586|64915791|FG000|CRT for Cisplatin (63 Days)|Death|3|||
23320538|NCT02952586|64915792|FG001|CRT for Cisplatin (63 Days)|Death|8|||
23320539|NCT02952586|64915791|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
23320540|NCT02952586|64915792|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
23320541|NCT02952586|64915791|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
23433632|NCT00710385|65330529|FG000|Overall Study|Undisclosed back pain|1|||
23143653|NCT01506609|64273935|FG001|Overall Study|Other, Not Specified|0|||
23143654|NCT01506609|64273936|FG002|Overall Study|Other, Not Specified|0|||
23143655|NCT01506609|64273937|FG003|Overall Study|Other, Not Specified|10|||
23143656|NCT01506609|64273938|FG004|Overall Study|Other, Not Specified|7|||
23143657|NCT01506609|64273939|FG005|Overall Study|Other, Not Specified|3|||
23143658|NCT01506609|64273934|FG000|Overall Study|Missing / Unknown Reason|1|||
23143659|NCT01506609|64273935|FG001|Overall Study|Missing / Unknown Reason|0|||
23217713|NCT02983799|64538387|FG004|Overall Study|Protocol Violation|1|||
23217714|NCT02983799|64538383|FG000|Overall Study|Lost to Follow-up|1|||
23217715|NCT02983799|64538384|FG001|Overall Study|Lost to Follow-up|0|||
23217716|NCT02983799|64538385|FG002|Overall Study|Lost to Follow-up|1|||
23217717|NCT02983799|64538386|FG003|Overall Study|Lost to Follow-up|0|||
23217718|NCT02983799|64538387|FG004|Overall Study|Lost to Follow-up|0|||
23217719|NCT02517268|64538390|FG000|Overall Study|Withdrawal by Subject|1|||
23217720|NCT02517268|64538391|FG001|Overall Study|Withdrawal by Subject|0|||
23217721|NCT01809197|64538392|FG000|Overall Study|Lost to Follow-up|4|||
23217722|NCT01809197|64538393|FG001|Overall Study|Lost to Follow-up|2|||
23217723|NCT01809197|64538392|FG000|Overall Study|Adverse Event|2|||
23217724|NCT01809197|64538393|FG001|Overall Study|Adverse Event|3|||
23217725|NCT01809197|64538392|FG000|Overall Study|Failed slit lamp exam|1|||
23217726|NCT01809197|64538393|FG001|Overall Study|Failed slit lamp exam|0|||
23217727|NCT01809197|64538392|FG000|Overall Study|Non-Compliance|1|||
23217728|NCT01809197|64538393|FG001|Overall Study|Non-Compliance|1|||
23217729|NCT01809197|64538392|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
23217730|NCT01809197|64538393|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
23217731|NCT01809197|64538392|FG000|Overall Study|Withdrawal by Subject|1|||
23217732|NCT01809197|64538393|FG001|Overall Study|Withdrawal by Subject|1|||
23217733|NCT01809197|64538392|FG000|Overall Study|Product not available|0|||
23433633|NCT00710385|65330529|FG000|Overall Study|Physician Decision|1|||
23555884|NCT01951638|65762396|FG003|Treatment Period|Logistical difficulties|0|||
23555885|NCT01951638|65762397|FG004|Treatment Period|Logistical difficulties|0|||
23143660|NCT01506609|64273936|FG002|Overall Study|Missing / Unknown Reason|1|||
23143661|NCT01506609|64273937|FG003|Overall Study|Missing / Unknown Reason|4|||
23217734|NCT01809197|64538393|FG001|Overall Study|Product not available|1|||
23217735|NCT02384993|64538397|FG000|Overall Study|Adverse Event|0|||
23217736|NCT02384993|64538398|FG001|Overall Study|Adverse Event|1|||
23217737|NCT03175562|64538400|FG000|Overall Study|Adverse Event|1|||
23320542|NCT02952586|64915792|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
23320543|NCT02952586|64915791|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
23217738|NCT03175562|64538400|FG000|Overall Study|Lost to Follow-up|3|||
23433634|NCT00710385|65330529|FG000|Overall Study|Undisclosed excessive methadone use|1|||
23143662|NCT01506609|64273938|FG004|Overall Study|Missing / Unknown Reason|4|||
23143663|NCT01506609|64273939|FG005|Overall Study|Missing / Unknown Reason|2|||
23143664|NCT01952054|64273942|FG000|Overall Study|Physician Decision|1|||
23143665|NCT01209780|64277378|FG000|Overall Study|Adverse Event|0|||
23143666|NCT01209780|64277379|FG001|Overall Study|Adverse Event|1|||
23143667|NCT01209780|64277380|FG002|Overall Study|Adverse Event|0|||
23143668|NCT01209780|64277381|FG003|Overall Study|Adverse Event|0|||
23143669|NCT01209780|64277382|FG004|Overall Study|Adverse Event|0|||
23143670|NCT01209780|64277378|FG000|Overall Study|Withdrawal by Subject|9|||
23320544|NCT02952586|64915792|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
23320545|NCT02952586|64915791|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
23320546|NCT02952586|64915792|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
23320547|NCT02952586|64915791|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
23320548|NCT02952586|64915792|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
23320549|NCT02952586|64915791|FG000|CRT for Cisplatin (63 Days)|Other|1|||
23320550|NCT02952586|64915792|FG001|CRT for Cisplatin (63 Days)|Other|1|||
23320551|NCT02952586|64915791|FG000|CRT for IMRT (63 Days)|Death|5|||
23320552|NCT02952586|64915792|FG001|CRT for IMRT (63 Days)|Death|8|||
23320553|NCT02952586|64915791|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
23320554|NCT02952586|64915792|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
23320555|NCT02952586|64915791|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
23320556|NCT02952586|64915792|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
23320557|NCT02952586|64915791|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
23320558|NCT02952586|64915792|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
23320559|NCT02952586|64915791|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
23320560|NCT02952586|64915792|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
23320561|NCT02952586|64915791|FG000|CRT for IMRT (63 Days)|Other|1|||
23320562|NCT02952586|64915792|FG001|CRT for IMRT (63 Days)|Other|0|||
23320563|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Death|17|||
23320564|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Death|11|||
23320565|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
23320566|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
23320567|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
23320568|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
23320569|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
23320570|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
23320571|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
23320572|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
23320573|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
23320574|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
23320575|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
23320576|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
23320577|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
23320578|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
23320579|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Other|2|||
23320580|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Other|1|||
23320581|NCT02952586|64915791|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
23320582|NCT02952586|64915792|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
23320583|NCT02952586|64915791|FG000|Follow-Up Phase (90 Days)|Death|12|||
23320584|NCT02952586|64915792|FG001|Follow-Up Phase (90 Days)|Death|10|||
23320585|NCT02952586|64915791|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
23320586|NCT02952586|64915792|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
23320587|NCT02952586|64915791|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
23320588|NCT02952586|64915792|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
23320589|NCT02952586|64915791|FG000|Follow-Up Phase (90 Days)|Other|7|||
23320590|NCT02952586|64915792|FG001|Follow-Up Phase (90 Days)|Other|5|||
23320591|NCT02952586|64915791|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
23320592|NCT02952586|64915792|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
23320593|NCT02952586|64915791|FG000|LT Follow-up (up to 45 Months)|Death|51|||
23320594|NCT02952586|64915792|FG001|LT Follow-up (up to 45 Months)|Death|31|||
23320595|NCT02952586|64915791|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
23320596|NCT02952586|64915792|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
23143671|NCT01209780|64277379|FG001|Overall Study|Withdrawal by Subject|2|||
23143672|NCT01209780|64277380|FG002|Overall Study|Withdrawal by Subject|1|||
23320597|NCT02952586|64915791|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
23320598|NCT02952586|64915792|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
23320599|NCT02952586|64915791|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
23433635|NCT01278407|65330530|FG000|Confirmatory Phase|Adverse Event|5|||
23143673|NCT01209780|64277381|FG003|Overall Study|Withdrawal by Subject|1|||
23143674|NCT01209780|64277382|FG004|Overall Study|Withdrawal by Subject|0|||
23320600|NCT02952586|64915792|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
23433636|NCT01278407|65330531|FG001|Confirmatory Phase|Adverse Event|10|||
23555886|NCT01951638|65762393|FG000|Treatment Period|Withdrawal by Subject|9|||
23555887|NCT01951638|65762394|FG001|Treatment Period|Withdrawal by Subject|6|||
23555888|NCT01951638|65762395|FG002|Treatment Period|Withdrawal by Subject|4|||
23143675|NCT01209780|64277378|FG000|Overall Study|Lost to Follow-up|17|||
23143676|NCT01209780|64277379|FG001|Overall Study|Lost to Follow-up|12|||
23143677|NCT01209780|64277380|FG002|Overall Study|Lost to Follow-up|3|||
23555889|NCT01951638|65762396|FG003|Treatment Period|Withdrawal by Subject|5|||
23555890|NCT01951638|65762397|FG004|Treatment Period|Withdrawal by Subject|4|||
23555891|NCT01951638|65762393|FG000|Treatment Period|Death|0|||
23555892|NCT01951638|65762394|FG001|Treatment Period|Death|0|||
23555893|NCT01951638|65762395|FG002|Treatment Period|Death|0|||
23555894|NCT01951638|65762396|FG003|Treatment Period|Death|3|||
23555895|NCT01951638|65762397|FG004|Treatment Period|Death|1|||
23555896|NCT01951638|65762393|FG000|Treatment Period|Adverse Event|3|||
23555897|NCT01951638|65762394|FG001|Treatment Period|Adverse Event|4|||
23555898|NCT01951638|65762395|FG002|Treatment Period|Adverse Event|8|||
23555899|NCT01951638|65762396|FG003|Treatment Period|Adverse Event|6|||
23555900|NCT01951638|65762397|FG004|Treatment Period|Adverse Event|5|||
23555901|NCT01951638|65762393|FG000|Follow-up Period|Protocol Violation|0|||
23555902|NCT01951638|65762394|FG001|Follow-up Period|Protocol Violation|0|||
23555903|NCT01951638|65762395|FG002|Follow-up Period|Protocol Violation|0|||
23555904|NCT01951638|65762396|FG003|Follow-up Period|Protocol Violation|1|||
23555905|NCT01951638|65762397|FG004|Follow-up Period|Protocol Violation|0|||
23555906|NCT01951638|65762393|FG000|Follow-up Period|Logistical difficulties|0|||
23555907|NCT01951638|65762394|FG001|Follow-up Period|Logistical difficulties|2|||
23555908|NCT01951638|65762395|FG002|Follow-up Period|Logistical difficulties|0|||
23555909|NCT01951638|65762396|FG003|Follow-up Period|Logistical difficulties|0|||
23555910|NCT01951638|65762397|FG004|Follow-up Period|Logistical difficulties|1|||
23555911|NCT01951638|65762393|FG000|Follow-up Period|Withdrawal by Subject|1|||
23555912|NCT01951638|65762394|FG001|Follow-up Period|Withdrawal by Subject|5|||
23555913|NCT01951638|65762395|FG002|Follow-up Period|Withdrawal by Subject|2|||
23555914|NCT01951638|65762396|FG003|Follow-up Period|Withdrawal by Subject|1|||
23555915|NCT01951638|65762397|FG004|Follow-up Period|Withdrawal by Subject|2|||
23555916|NCT01951638|65762393|FG000|Follow-up Period|Lost to Follow-up|0|||
23555917|NCT01951638|65762394|FG001|Follow-up Period|Lost to Follow-up|1|||
23555918|NCT01951638|65762395|FG002|Follow-up Period|Lost to Follow-up|0|||
23555919|NCT01951638|65762396|FG003|Follow-up Period|Lost to Follow-up|1|||
23555920|NCT01951638|65762397|FG004|Follow-up Period|Lost to Follow-up|0|||
23555921|NCT01951638|65762393|FG000|Follow-up Period|Death|1|||
23555922|NCT01951638|65762394|FG001|Follow-up Period|Death|0|||
23143678|NCT01209780|64277381|FG003|Overall Study|Lost to Follow-up|9|||
23143679|NCT01209780|64277382|FG004|Overall Study|Lost to Follow-up|4|||
23143680|NCT01209780|64277378|FG000|Overall Study|Protocol Violation|0|||
23143681|NCT01209780|64277379|FG001|Overall Study|Protocol Violation|1|||
23143682|NCT01209780|64277380|FG002|Overall Study|Protocol Violation|0|||
23143683|NCT01209780|64277381|FG003|Overall Study|Protocol Violation|0|||
23143684|NCT01209780|64277382|FG004|Overall Study|Protocol Violation|0|||
23143685|NCT01209780|64277378|FG000|Overall Study|Inappropriate enrollment|0|||
23143686|NCT01209780|64277379|FG001|Overall Study|Inappropriate enrollment|2|||
23143687|NCT01209780|64277380|FG002|Overall Study|Inappropriate enrollment|0|||
23143688|NCT01209780|64277381|FG003|Overall Study|Inappropriate enrollment|0|||
23143689|NCT01209780|64277382|FG004|Overall Study|Inappropriate enrollment|1|||
23143690|NCT00320541|64277383|FG000|Overall Study|Adverse Event|21|||
23143691|NCT00320541|64277384|FG001|Overall Study|Adverse Event|19|||
23217739|NCT03175562|64538400|FG000|Overall Study|Withdrawal by Subject|7|||
23555923|NCT01951638|65762395|FG002|Follow-up Period|Death|1|||
23555924|NCT01951638|65762396|FG003|Follow-up Period|Death|4|||
23555925|NCT01951638|65762397|FG004|Follow-up Period|Death|1|||
23555926|NCT01951638|65762393|FG000|Follow-up Period|Adverse Event|0|||
23555927|NCT01951638|65762394|FG001|Follow-up Period|Adverse Event|1|||
23555928|NCT01951638|65762395|FG002|Follow-up Period|Adverse Event|2|||
23555929|NCT01951638|65762396|FG003|Follow-up Period|Adverse Event|1|||
23555930|NCT01951638|65762397|FG004|Follow-up Period|Adverse Event|1|||
23555931|NCT05099926|65762398|FG000|Overall Study|Lost to Follow-up|1|||
23555932|NCT04517864|65762401|FG000|Placebo-Controlled Phase|Adverse Event|1|||
23555933|NCT04517864|65762402|FG001|Placebo-Controlled Phase|Adverse Event|0|||
23555934|NCT04517864|65762401|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
23555935|NCT04517864|65762402|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
23555936|NCT04517864|65762401|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
23555937|NCT04517864|65762402|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
23143692|NCT00320541|64277383|FG000|Overall Study|Protocol Violation|0|||
23143693|NCT00320541|64277384|FG001|Overall Study|Protocol Violation|1|||
23555938|NCT04517864|65762401|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
23555939|NCT04517864|65762402|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
23555940|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Adverse Event|1|||
23555941|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Adverse Event|0|||
23143694|NCT00320541|64277383|FG000|Overall Study|Withdrawal by Subject|12|||
23555942|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
23143695|NCT00320541|64277384|FG001|Overall Study|Withdrawal by Subject|16|||
23555943|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
23555944|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
23143696|NCT00320541|64277383|FG000|Overall Study|Physician Decision|9|||
23555945|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
23555946|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Physician Decision|1|||
23555947|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Physician Decision|0|||
23555948|NCT04517864|65762401|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
23555949|NCT04517864|65762402|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
23555950|NCT04517864|65762401|FG000|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|20|||
23555951|NCT04517864|65762402|FG001|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|24|||
23555952|NCT01297959|65762403|FG000|Overall Study|Adverse Event|0|||
23555953|NCT01297959|65762404|FG001|Overall Study|Adverse Event|1|||
23555954|NCT01297959|65762403|FG000|Overall Study|Protocol Violation|2|||
23555955|NCT01297959|65762404|FG001|Overall Study|Protocol Violation|1|||
23623355|NCT05006417|66008391|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
23143697|NCT00320541|64277384|FG001|Overall Study|Physician Decision|13|||
23143698|NCT00320541|64277383|FG000|Overall Study|Other|3|||
23143699|NCT00320541|64277384|FG001|Overall Study|Other|4|||
23143700|NCT00320541|64277383|FG000|Overall Study|Sponsor Decision|2|||
23143701|NCT00320541|64277384|FG001|Overall Study|Sponsor Decision|1|||
23143702|NCT00320541|64277383|FG000|Overall Study|Death due to Study Disease|1|||
23143703|NCT00320541|64277384|FG001|Overall Study|Death due to Study Disease|3|||
23143704|NCT00320541|64277383|FG000|Overall Study|Death due to Adverse Event(s)|1|||
23143705|NCT00320541|64277384|FG001|Overall Study|Death due to Adverse Event(s)|0|||
23143706|NCT00320541|64277383|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
23143707|NCT00320541|64277384|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
23143708|NCT00413972|64277385|FG000|Overall Study|Adverse Event|2|||
23143709|NCT00413972|64277386|FG001|Overall Study|Adverse Event|1|||
23143710|NCT00413972|64277387|FG002|Overall Study|Adverse Event|0|||
23143711|NCT00413972|64277388|FG003|Overall Study|Adverse Event|0|||
23143712|NCT00413972|64277385|FG000|Overall Study|Lost to Follow-up|1|||
23143713|NCT00413972|64277386|FG001|Overall Study|Lost to Follow-up|2|||
23143714|NCT00413972|64277387|FG002|Overall Study|Lost to Follow-up|1|||
23143715|NCT00413972|64277388|FG003|Overall Study|Lost to Follow-up|0|||
23143716|NCT00413972|64277385|FG000|Overall Study|Withdrawal by Subject|4|||
23143717|NCT00413972|64277386|FG001|Overall Study|Withdrawal by Subject|5|||
23143718|NCT00413972|64277387|FG002|Overall Study|Withdrawal by Subject|7|||
23143719|NCT00413972|64277388|FG003|Overall Study|Withdrawal by Subject|2|||
23143720|NCT00413972|64277385|FG000|Overall Study|Protocol Violation|0|||
23143721|NCT00413972|64277386|FG001|Overall Study|Protocol Violation|0|||
23143722|NCT00413972|64277387|FG002|Overall Study|Protocol Violation|2|||
23143723|NCT00413972|64277388|FG003|Overall Study|Protocol Violation|0|||
23143724|NCT00413972|64277385|FG000|Overall Study|Other|0|||
23143725|NCT00413972|64277386|FG001|Overall Study|Other|0|||
23143726|NCT00413972|64277387|FG002|Overall Study|Other|0|||
23143727|NCT00413972|64277388|FG003|Overall Study|Other|1|||
23143728|NCT02409368|64277389|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
23143729|NCT02409368|64277390|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
23143730|NCT02409368|64277391|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
23143731|NCT02409368|64277392|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
23143732|NCT02409368|64277389|FG000|ECOG Reclassification|Death|1|||
23143733|NCT02409368|64277390|FG001|ECOG Reclassification|Death|5|||
23143734|NCT02409368|64277391|FG002|ECOG Reclassification|Death|0|||
23143735|NCT02409368|64277392|FG003|ECOG Reclassification|Death|0|||
23143736|NCT02409368|64277389|FG000|ECOG Reclassification|Disease Progression|113|||
23143737|NCT02409368|64277390|FG001|ECOG Reclassification|Disease Progression|382|||
23143738|NCT02409368|64277391|FG002|ECOG Reclassification|Disease Progression|70|||
23143739|NCT02409368|64277392|FG003|ECOG Reclassification|Disease Progression|1|||
23143740|NCT02409368|64277389|FG000|ECOG Reclassification|Lost to Follow-up|1|||
23143741|NCT02409368|64277390|FG001|ECOG Reclassification|Lost to Follow-up|5|||
23143742|NCT02409368|64277391|FG002|ECOG Reclassification|Lost to Follow-up|0|||
23143743|NCT02409368|64277392|FG003|ECOG Reclassification|Lost to Follow-up|0|||
23143744|NCT02409368|64277389|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
23143745|NCT02409368|64277390|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
23143746|NCT02409368|64277391|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
23143747|NCT02409368|64277392|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
23143748|NCT02409368|64277389|FG000|ECOG Reclassification|Poor/non-compliance|0|||
23143749|NCT02409368|64277390|FG001|ECOG Reclassification|Poor/non-compliance|3|||
23143750|NCT02409368|64277391|FG002|ECOG Reclassification|Poor/non-compliance|2|||
23143751|NCT02409368|64277392|FG003|ECOG Reclassification|Poor/non-compliance|0|||
23555956|NCT01297959|65762403|FG000|Overall Study|Withdrawal by Subject|5|||
23143752|NCT02409368|64277389|FG000|ECOG Reclassification|Study drug toxicity|17|||
23143753|NCT02409368|64277390|FG001|ECOG Reclassification|Study drug toxicity|42|||
23143754|NCT02409368|64277391|FG002|ECOG Reclassification|Study drug toxicity|7|||
23143755|NCT02409368|64277392|FG003|ECOG Reclassification|Study drug toxicity|0|||
23143756|NCT02409368|64277389|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
23217740|NCT03175562|64538400|FG000|Overall Study|Other (Not Specified)|5|||
23433637|NCT01278407|65330532|FG002|Confirmatory Phase|Adverse Event|1|||
23433638|NCT01278407|65330533|FG003|Confirmatory Phase|Adverse Event|0|||
23433639|NCT01278407|65330534|FG004|Confirmatory Phase|Adverse Event|0|||
23433640|NCT01278407|65330530|FG000|Confirmatory Phase|Participant's Choice|3|||
23433641|NCT01278407|65330531|FG001|Confirmatory Phase|Participant's Choice|5|||
23433642|NCT01278407|65330532|FG002|Confirmatory Phase|Participant's Choice|3|||
23433643|NCT01278407|65330533|FG003|Confirmatory Phase|Participant's Choice|0|||
23433644|NCT01278407|65330534|FG004|Confirmatory Phase|Participant's Choice|0|||
23433645|NCT01278407|65330530|FG000|Confirmatory Phase|Other|1|||
23217741|NCT02910219|64538402|FG000|Overall Study|Withdrawal by Subject|1|||
23433646|NCT01278407|65330531|FG001|Confirmatory Phase|Other|1|||
23433647|NCT01278407|65330532|FG002|Confirmatory Phase|Other|2|||
23433648|NCT01278407|65330533|FG003|Confirmatory Phase|Other|0|||
23433649|NCT01278407|65330534|FG004|Confirmatory Phase|Other|0|||
23623356|NCT02194829|66008398|FG000|Overall Study|Adverse Event|2|||
23623357|NCT02194829|66008399|FG001|Overall Study|Adverse Event|2|||
23623358|NCT02194829|66008398|FG000|Overall Study|Death|0|||
23623359|NCT02194829|66008399|FG001|Overall Study|Death|1|||
23623360|NCT02194829|66008398|FG000|Overall Study|Disease progression|0|||
23623361|NCT02194829|66008399|FG001|Overall Study|Disease progression|1|||
23623362|NCT02194829|66008398|FG000|Overall Study|Withdrawal by Subject|0|||
23623363|NCT02194829|66008399|FG001|Overall Study|Withdrawal by Subject|1|||
23623364|NCT02194829|66008398|FG000|Overall Study|Never started protocol therapy|0|||
23623365|NCT02194829|66008399|FG001|Overall Study|Never started protocol therapy|1|||
23623366|NCT00813098|66008400|FG000|Overall Study|Adverse Event|2|||
23623367|NCT00813098|66008401|FG001|Overall Study|Adverse Event|4|||
23623368|NCT00813098|66008402|FG002|Overall Study|Adverse Event|1|||
23623369|NCT00813098|66008400|FG000|Overall Study|Withdrawal by Subject|0|||
23623370|NCT00813098|66008401|FG001|Overall Study|Withdrawal by Subject|1|||
23623371|NCT00813098|66008402|FG002|Overall Study|Withdrawal by Subject|0|||
23623372|NCT00813098|66008400|FG000|Overall Study|Inability to complete study procedures|1|||
23623373|NCT00813098|66008401|FG001|Overall Study|Inability to complete study procedures|0|||
23623374|NCT00813098|66008402|FG002|Overall Study|Inability to complete study procedures|0|||
23623375|NCT00813098|66008400|FG000|Overall Study|Lost to Follow-up|0|||
23623376|NCT00813098|66008401|FG001|Overall Study|Lost to Follow-up|1|||
23623377|NCT00813098|66008402|FG002|Overall Study|Lost to Follow-up|0|||
23623378|NCT00813098|66008400|FG000|Overall Study|Protocol Violation|0|||
23623379|NCT00813098|66008401|FG001|Overall Study|Protocol Violation|0|||
23623380|NCT00813098|66008402|FG002|Overall Study|Protocol Violation|1|||
23623381|NCT00813098|66008400|FG000|Overall Study|Principal Investigator decision|0|||
23623382|NCT00813098|66008401|FG001|Overall Study|Principal Investigator decision|1|||
23623383|NCT00813098|66008402|FG002|Overall Study|Principal Investigator decision|0|||
23623384|NCT00813098|66008400|FG000|Overall Study|Withdrew Consent|0|||
23623385|NCT00813098|66008401|FG001|Overall Study|Withdrew Consent|1|||
23623386|NCT00813098|66008402|FG002|Overall Study|Withdrew Consent|0|||
23623387|NCT01263925|66008403|FG000|Overall Study|Protocol Violation|1|||
23623388|NCT01263925|66008404|FG001|Overall Study|Protocol Violation|0|||
23623389|NCT01263925|66008403|FG000|Overall Study|Lack of Efficacy|0|||
23623390|NCT01263925|66008404|FG001|Overall Study|Lack of Efficacy|1|||
23143757|NCT02409368|64277390|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
23143758|NCT02409368|64277391|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
23143759|NCT02409368|64277392|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
23143760|NCT02409368|64277389|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
23143761|NCT02409368|64277390|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
23143762|NCT02409368|64277391|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
23143763|NCT02409368|64277392|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
23217742|NCT02910219|64538403|FG001|Overall Study|Withdrawal by Subject|1|||
23217743|NCT00880607|64538411|FG000|Overall Study|Physician Decision|2|||
23217744|NCT00880607|64538412|FG001|Overall Study|Physician Decision|2|||
23217745|NCT00880607|64538411|FG000|Overall Study|Protocol Violation|2|||
23623391|NCT01263925|66008403|FG000|Overall Study|Adverse Event|23|||
23623392|NCT01263925|66008404|FG001|Overall Study|Adverse Event|22|||
23623393|NCT01263925|66008403|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
23623394|NCT01263925|66008404|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
23623395|NCT01263925|66008403|FG000|Overall Study|Withdrawal by Subject|6|||
23623396|NCT01263925|66008404|FG001|Overall Study|Withdrawal by Subject|8|||
23623397|NCT01263925|66008403|FG000|Overall Study|Other|4|||
23623398|NCT01263925|66008404|FG001|Overall Study|Other|4|||
23433650|NCT01278407|65330530|FG000|Extension Phase|Adverse Event|0|||
23433651|NCT01278407|65330531|FG001|Extension Phase|Adverse Event|0|||
23433652|NCT01278407|65330532|FG002|Extension Phase|Adverse Event|0|||
23433653|NCT01278407|65330533|FG003|Extension Phase|Adverse Event|7|||
23433654|NCT01278407|65330534|FG004|Extension Phase|Adverse Event|16|||
23433655|NCT01278407|65330530|FG000|Extension Phase|Participant's Choice|0|||
23433656|NCT01278407|65330531|FG001|Extension Phase|Participant's Choice|0|||
23433657|NCT01278407|65330532|FG002|Extension Phase|Participant's Choice|0|||
23433658|NCT01278407|65330533|FG003|Extension Phase|Participant's Choice|4|||
23433659|NCT01278407|65330534|FG004|Extension Phase|Participant's Choice|11|||
23433660|NCT01278407|65330530|FG000|Extension Phase|Other|0|||
23433661|NCT01278407|65330531|FG001|Extension Phase|Other|0|||
23433662|NCT01278407|65330532|FG002|Extension Phase|Other|0|||
23433663|NCT01278407|65330533|FG003|Extension Phase|Other|1|||
23433664|NCT01278407|65330534|FG004|Extension Phase|Other|3|||
23433665|NCT05392803|65330538|FG000|Overall Study|Lost to Follow-up|0|||
23433666|NCT05392803|65330539|FG001|Overall Study|Lost to Follow-up|2|||
23433667|NCT02690714|65330544|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
23433668|NCT02690714|65330544|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
23433669|NCT04732949|65330545|FG000|Overall Study|Withdrawal by Subject|23|||
23433670|NCT04732949|65330546|FG001|Overall Study|Withdrawal by Subject|27|||
23433671|NCT04732949|65330545|FG000|Overall Study|Protocol Violation|0|||
23433672|NCT04732949|65330546|FG001|Overall Study|Protocol Violation|1|||
23433673|NCT04732949|65330545|FG000|Overall Study|Non-compliance|0|||
23433674|NCT04732949|65330546|FG001|Overall Study|Non-compliance|2|||
23433675|NCT04732949|65330545|FG000|Overall Study|Physician Decision|2|||
23433676|NCT04732949|65330546|FG001|Overall Study|Physician Decision|1|||
23433677|NCT04732949|65330545|FG000|Overall Study|Serious adverse event (Fatal)|16|||
23433678|NCT04732949|65330546|FG001|Overall Study|Serious adverse event (Fatal)|18|||
23555957|NCT01297959|65762404|FG001|Overall Study|Withdrawal by Subject|4|||
23143764|NCT02409368|64277389|FG000|ECOG Reclassification|Participant withdrew consent|2|||
23143765|NCT02409368|64277390|FG001|ECOG Reclassification|Participant withdrew consent|3|||
23143766|NCT02409368|64277391|FG002|ECOG Reclassification|Participant withdrew consent|4|||
23143767|NCT02409368|64277392|FG003|ECOG Reclassification|Participant withdrew consent|0|||
23320601|NCT03775486|64915793|FG000|Initial Therapy Phase|Other reason provided|0|||
23320602|NCT03775486|64915794|FG001|Initial Therapy Phase|Other reason provided|15|||
23320603|NCT03775486|64915793|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
23320604|NCT03775486|64915794|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
23320605|NCT03775486|64915793|FG000|Initial Therapy Phase|Protocol Violation|0|||
23320606|NCT03775486|64915794|FG001|Initial Therapy Phase|Protocol Violation|2|||
23320607|NCT03775486|64915793|FG000|Initial Therapy Phase|Adverse Event|0|||
23320608|NCT03775486|64915794|FG001|Initial Therapy Phase|Adverse Event|34|||
23320609|NCT03775486|64915793|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
23320610|NCT03775486|64915794|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
23320611|NCT03775486|64915793|FG000|Maintenance Phase|Withdrawal by Subject|13|||
23320612|NCT03775486|64915794|FG001|Maintenance Phase|Withdrawal by Subject|12|||
23320613|NCT03775486|64915793|FG000|Maintenance Phase|Death|44|||
23320614|NCT03775486|64915794|FG001|Maintenance Phase|Death|45|||
23143768|NCT02409368|64277389|FG000|ECOG Reclassification|Other Reasons|5|||
23143769|NCT02409368|64277390|FG001|ECOG Reclassification|Other Reasons|26|||
23143770|NCT02409368|64277391|FG002|ECOG Reclassification|Other Reasons|2|||
23143771|NCT02409368|64277392|FG003|ECOG Reclassification|Other Reasons|0|||
23143772|NCT02409368|64277389|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
23143773|NCT02409368|64277390|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
23143774|NCT02409368|64277391|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
23320615|NCT02452476|64915805|FG000|Overall Study|Death|4|||
23320616|NCT02452476|64915806|FG001|Overall Study|Death|7|||
23320617|NCT02452476|64915805|FG000|Overall Study|Lost to Follow-up|1|||
23320618|NCT02452476|64915806|FG001|Overall Study|Lost to Follow-up|1|||
23320619|NCT02452476|64915805|FG000|Overall Study|Physician Decision|1|||
23320620|NCT02452476|64915806|FG001|Overall Study|Physician Decision|1|||
23320621|NCT02452476|64915805|FG000|Overall Study|Not treated|5|||
23320622|NCT02452476|64915806|FG001|Overall Study|Not treated|1|||
23320623|NCT01284361|64915811|FG000|Overall Study|Withdrawal by Subject|1|||
23320624|NCT01284361|64915811|FG000|Overall Study|Protocol Violation|5|||
23320625|NCT01284361|64915811|FG000|Overall Study|Adverse Event|1|||
23320626|NCT01284361|64915811|FG000|Overall Study|Lost to Follow-up|2|||
23320627|NCT02723344|64915821|FG000|Overall Study|Lost to Follow-up|0|||
23320628|NCT02723344|64915822|FG001|Overall Study|Lost to Follow-up|4|||
23433679|NCT04732949|65330545|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
23433680|NCT04732949|65330546|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
23143775|NCT02409368|64277392|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
23320629|NCT02755649|64919225|FG000|Overall Study|Transitioned into OLE study|99|||
23320630|NCT02755649|64919226|FG001|Overall Study|Transitioned into OLE study|98|||
23433681|NCT04732949|65330545|FG000|Overall Study|Non-serious adverse event|1|||
23433682|NCT04732949|65330546|FG001|Overall Study|Non-serious adverse event|3|||
23433683|NCT04732949|65330545|FG000|Overall Study|Lost to Follow-up|26|||
23320631|NCT02755649|64919227|FG002|Overall Study|Transitioned into OLE study|100|||
23320632|NCT02755649|64919225|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
23320633|NCT02755649|64919226|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
23320634|NCT02755649|64919227|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
23320635|NCT02755649|64919225|FG000|Overall Study|Physician Decision|0|||
23320636|NCT02755649|64919226|FG001|Overall Study|Physician Decision|0|||
23320637|NCT02755649|64919227|FG002|Overall Study|Physician Decision|2|||
23320638|NCT02755649|64919225|FG000|Overall Study|Withdrawal by Subject|0|||
23320639|NCT02755649|64919226|FG001|Overall Study|Withdrawal by Subject|1|||
23320640|NCT02755649|64919227|FG002|Overall Study|Withdrawal by Subject|0|||
23320641|NCT02755649|64919225|FG000|Overall Study|Undecided|1|||
23320642|NCT02755649|64919226|FG001|Overall Study|Undecided|0|||
23320643|NCT02755649|64919227|FG002|Overall Study|Undecided|0|||
23320644|NCT00378573|64919228|FG000|Treatment Period|Adverse Event|9|||
23320645|NCT00378573|64919228|FG000|Treatment Period|Physician Decision|1|||
23320646|NCT00378573|64919228|FG000|Treatment Period|Withdrawal by Subject|2|||
23320647|NCT00378573|64919228|FG000|Treatment Period|Disease Progression|4|||
23320648|NCT00378573|64919228|FG000|Treatment Period|Sponsor decision to close study|1|||
23320649|NCT00378573|64919228|FG000|Follow-up|Death|12|||
23320650|NCT00378573|64919228|FG000|Follow-up|Lost to Follow-up|1|||
23320651|NCT00378573|64919228|FG000|Follow-up|Withdrawal by Subject|1|||
23320652|NCT04542057|64919229|FG000|Overall Study|Death|3|||
23320653|NCT04542057|64919230|FG001|Overall Study|Death|1|||
23320654|NCT04542057|64919229|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
23320655|NCT04542057|64919230|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
23320656|NCT04542057|64919229|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
23320657|NCT04542057|64919230|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
23320658|NCT04542057|64919229|FG000|Overall Study|Adverse Event|15|||
23320659|NCT04542057|64919230|FG001|Overall Study|Adverse Event|6|||
23320660|NCT04542057|64919229|FG000|Overall Study|COVID-19 adverse event|6|||
23320661|NCT04542057|64919230|FG001|Overall Study|COVID-19 adverse event|4|||
23320662|NCT04542057|64919229|FG000|Overall Study|Lack of Efficacy|2|||
23320663|NCT04542057|64919230|FG001|Overall Study|Lack of Efficacy|5|||
23320664|NCT04542057|64919229|FG000|Overall Study|Study terminated by sponsor|1|||
23320665|NCT04542057|64919230|FG001|Overall Study|Study terminated by sponsor|0|||
23320666|NCT04542057|64919229|FG000|Overall Study|Investigator discretion|2|||
23320667|NCT04542057|64919230|FG001|Overall Study|Investigator discretion|1|||
23320668|NCT04542057|64919229|FG000|Overall Study|Withdrawal by Subject|52|||
23320669|NCT04542057|64919230|FG001|Overall Study|Withdrawal by Subject|30|||
23320670|NCT04542057|64919229|FG000|Overall Study|Lost to Follow-up|8|||
23320671|NCT04542057|64919230|FG001|Overall Study|Lost to Follow-up|11|||
23320672|NCT04542057|64919229|FG000|Overall Study|Other|2|||
23320673|NCT04542057|64919230|FG001|Overall Study|Other|2|||
23320674|NCT03908437|64919232|FG000|Overall Study|Death|0|||
23555958|NCT01297959|65762403|FG000|Overall Study|Physician Decision|0|||
23555959|NCT01297959|65762404|FG001|Overall Study|Physician Decision|1|||
23555960|NCT01297959|65762403|FG000|Overall Study|Unrelated medical illness / complication|0|||
23555961|NCT01297959|65762404|FG001|Overall Study|Unrelated medical illness / complication|2|||
23555962|NCT01297959|65762403|FG000|Overall Study|Other|13|||
23555963|NCT01297959|65762404|FG001|Overall Study|Other|7|||
23555964|NCT02618616|65762405|FG000|Overall Study|Lack of Efficacy|4|||
23623399|NCT01263925|66008403|FG000|Overall Study|Lost to Follow-up|3|||
23623400|NCT01263925|66008404|FG001|Overall Study|Lost to Follow-up|1|||
23623401|NCT01263925|66008403|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
23623402|NCT01263925|66008404|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
23623403|NCT01263925|66008403|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
23623404|NCT01263925|66008404|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
23623405|NCT01263925|66008403|FG000|Overall Study|AE/ Withdrawal|1|||
23623406|NCT01263925|66008404|FG001|Overall Study|AE/ Withdrawal|4|||
23623407|NCT01263925|66008403|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
23623408|NCT01263925|66008404|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
23623409|NCT01263925|66008403|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
23320675|NCT03908437|64919233|FG001|Overall Study|Death|1|||
23320676|NCT03908437|64919232|FG000|Overall Study|Lost to Follow-up|31|||
23320677|NCT03908437|64919233|FG001|Overall Study|Lost to Follow-up|24|||
23320678|NCT00711880|64919234|FG000|Overall Study|Adverse Event|11|||
23320679|NCT00711880|64919235|FG001|Overall Study|Adverse Event|2|||
23320680|NCT00711880|64919234|FG000|Overall Study|Patient non-compliance|1|||
23320681|NCT00711880|64919235|FG001|Overall Study|Patient non-compliance|0|||
23320682|NCT00711880|64919234|FG000|Overall Study|Lack of Efficacy|1|||
23320683|NCT00711880|64919235|FG001|Overall Study|Lack of Efficacy|5|||
23320684|NCT01821807|64919238|FG000|Overall Study|Lost to Follow-up|3|||
23320685|NCT01821807|64919239|FG001|Overall Study|Lost to Follow-up|1|||
23555965|NCT02618616|65762406|FG001|Overall Study|Lack of Efficacy|0|||
23623410|NCT01263925|66008404|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
23320686|NCT01626690|64919240|FG000|Overall Study|Protocol Violation|1|||
23320687|NCT01626690|64919241|FG001|Overall Study|Protocol Violation|0|||
23320688|NCT01626690|64919240|FG000|Overall Study|Adverse Event|1|||
23320689|NCT01626690|64919241|FG001|Overall Study|Adverse Event|0|||
23320690|NCT02245412|64919242|FG000|Treatment Period|Death|1|||
23320691|NCT02245412|64919243|FG001|Treatment Period|Death|1|||
23320692|NCT02245412|64919244|FG002|Treatment Period|Death|0|||
23320693|NCT02245412|64919242|FG000|Treatment Period|Physician Decision|1|||
23320694|NCT02245412|64919243|FG001|Treatment Period|Physician Decision|1|||
23320695|NCT02245412|64919244|FG002|Treatment Period|Physician Decision|0|||
23320696|NCT02245412|64919242|FG000|Treatment Period|Withdrawal by Subject|2|||
23320697|NCT02245412|64919243|FG001|Treatment Period|Withdrawal by Subject|1|||
23320698|NCT02245412|64919244|FG002|Treatment Period|Withdrawal by Subject|0|||
23320699|NCT02245412|64919242|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
23320700|NCT02245412|64919243|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
23320701|NCT02245412|64919244|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
23320702|NCT02245412|64919242|FG000|Follow-Up Period|Death|4|||
23320703|NCT02245412|64919243|FG001|Follow-Up Period|Death|2|||
23320704|NCT02245412|64919244|FG002|Follow-Up Period|Death|1|||
23433684|NCT04732949|65330546|FG001|Overall Study|Lost to Follow-up|27|||
23433685|NCT04732949|65330545|FG000|Overall Study|Other|6|||
23143776|NCT00796120|64277398|FG000|Overall Study|Death|3|||
23143777|NCT00796120|64277399|FG001|Overall Study|Death|0|||
23143778|NCT00796120|64277398|FG000|Overall Study|Adverse Event|11|||
23143779|NCT00796120|64277399|FG001|Overall Study|Adverse Event|6|||
23143780|NCT00796120|64277398|FG000|Overall Study|Progressive disease|22|||
23143781|NCT00796120|64277399|FG001|Overall Study|Progressive disease|13|||
23143782|NCT00796120|64277398|FG000|Overall Study|Participant refusal|3|||
23143783|NCT00796120|64277399|FG001|Overall Study|Participant refusal|4|||
23143784|NCT00796120|64277398|FG000|Overall Study|Other|6|||
23143785|NCT00796120|64277399|FG001|Overall Study|Other|17|||
23143786|NCT00796120|64277398|FG000|Overall Study|Physician Decision|16|||
23143787|NCT00796120|64277399|FG001|Overall Study|Physician Decision|17|||
23143788|NCT00796120|64277398|FG000|Overall Study|Randomized but not treated|0|||
23143789|NCT00796120|64277399|FG001|Overall Study|Randomized but not treated|3|||
23143790|NCT01272804|64277400|FG000|Overall Study|Adverse Event|1|||
23143791|NCT01272804|64277401|FG001|Overall Study|Adverse Event|0|||
23433686|NCT04732949|65330546|FG001|Overall Study|Other|3|||
23433687|NCT02202538|65330549|FG000|Overall Study|Withdrawal by Subject|5|||
23143792|NCT01272804|64277402|FG002|Overall Study|Adverse Event|0|||
23143793|NCT01272804|64277403|FG003|Overall Study|Adverse Event|0|||
23217746|NCT00880607|64538412|FG001|Overall Study|Protocol Violation|1|||
23217747|NCT00880607|64538411|FG000|Overall Study|surgery did not extend past L1 level|3|||
23217748|NCT00880607|64538412|FG001|Overall Study|surgery did not extend past L1 level|0|||
23217749|NCT01313078|64538413|FG000|Overall Study|Death|1|||
23217750|NCT01313078|64538413|FG000|Overall Study|Discontinued study drug|1|||
23217751|NCT01313078|64538413|FG000|Overall Study|Withdrawal by Subject|1|||
23217752|NCT02057068|64538418|FG000|Overall Study|Withdrawal by Subject|2|||
23217753|NCT02057068|64538419|FG001|Overall Study|Withdrawal by Subject|2|||
23217754|NCT02057068|64538418|FG000|Overall Study|Caregiver (CG) Health|0|||
23217755|NCT02057068|64538419|FG001|Overall Study|Caregiver (CG) Health|2|||
23217756|NCT02057068|64538418|FG000|Overall Study|Carepartner (CP) Health|4|||
23217757|NCT02057068|64538419|FG001|Overall Study|Carepartner (CP) Health|2|||
23217758|NCT02057068|64538418|FG000|Overall Study|Lost to Follow-up|2|||
23217759|NCT02057068|64538419|FG001|Overall Study|Lost to Follow-up|2|||
23217760|NCT01376245|64538420|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
23217761|NCT01376245|64538421|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
23217762|NCT01376245|64538422|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
23217763|NCT01376245|64538423|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
23143794|NCT01272804|64277404|FG004|Overall Study|Adverse Event|2|||
23143795|NCT01272804|64277405|FG005|Overall Study|Adverse Event|1|||
23143796|NCT04214600|64277408|FG000|Overall Study|Lost to Follow-up|9|||
23143797|NCT04214600|64277409|FG001|Overall Study|Lost to Follow-up|14|||
23143798|NCT01249274|64277417|FG000|Overall Study|Lost to Follow-up|3|||
23143799|NCT01249274|64277418|FG001|Overall Study|Lost to Follow-up|4|||
23143800|NCT01249274|64277417|FG000|Overall Study|Received inpatient substance treatment|1|||
23217764|NCT01376245|64538424|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
23217765|NCT01376245|64538420|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
23320705|NCT02245412|64919242|FG000|Follow-Up Period|Physician Decision|1|||
23217766|NCT01376245|64538421|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
23217767|NCT01376245|64538422|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
23217768|NCT01376245|64538423|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
23217769|NCT01376245|64538424|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
23433688|NCT02202538|65330549|FG000|Overall Study|Did not meet all inclusion criteria|2|||
23143801|NCT01249274|64277418|FG001|Overall Study|Received inpatient substance treatment|2|||
23143802|NCT01271803|64277419|FG000|Overall Study|Progressive disease|0|||
23143803|NCT01271803|64277420|FG001|Overall Study|Progressive disease|0|||
23143804|NCT01271803|64277421|FG002|Overall Study|Progressive disease|2|||
23143805|NCT01271803|64277419|FG000|Overall Study|Death|53|||
23143806|NCT01271803|64277420|FG001|Overall Study|Death|34|||
23143807|NCT01271803|64277421|FG002|Overall Study|Death|0|||
23143808|NCT01271803|64277419|FG000|Overall Study|Withdrawal by Subject|1|||
23143809|NCT01271803|64277420|FG001|Overall Study|Withdrawal by Subject|5|||
23143810|NCT01271803|64277421|FG002|Overall Study|Withdrawal by Subject|0|||
23143811|NCT01271803|64277419|FG000|Overall Study|Lost to Follow-up|1|||
23623411|NCT01263925|66008403|FG000|Overall Study|Withdrawal/ Not specified|0|||
23623412|NCT01263925|66008404|FG001|Overall Study|Withdrawal/ Not specified|1|||
23623413|NCT00746785|66008407|FG000|Overall Study|Lost to Follow-up|29|||
23623414|NCT00746785|66008408|FG001|Overall Study|Lost to Follow-up|25|||
23623415|NCT00746785|66008409|FG002|Overall Study|Lost to Follow-up|27|||
23623416|NCT02019641|66008412|FG000|10-Week Follow up|Withdrawal by investigator|2|||
23623417|NCT02019641|66008413|FG001|10-Week Follow up|Withdrawal by investigator|0|||
23623418|NCT02019641|66008414|FG002|10-Week Follow up|Withdrawal by investigator|0|||
23143812|NCT01271803|64277420|FG001|Overall Study|Lost to Follow-up|0|||
23143813|NCT01271803|64277421|FG002|Overall Study|Lost to Follow-up|0|||
23143814|NCT04975438|64277422|FG000|Overall Study|Lost to Follow-up|1|||
23623419|NCT02019641|66008412|FG000|10-Week Follow up|Withdrawal by Subject|1|||
23623420|NCT02019641|66008413|FG001|10-Week Follow up|Withdrawal by Subject|1|||
23623421|NCT02019641|66008414|FG002|10-Week Follow up|Withdrawal by Subject|0|||
23623422|NCT02019641|66008412|FG000|20-Week Follow up|Withdrawal by investigator|0|||
23143815|NCT04975438|64277423|FG001|Overall Study|Lost to Follow-up|0|||
23143816|NCT04975438|64277424|FG002|Overall Study|Lost to Follow-up|1|||
23217770|NCT01376245|64538420|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
23217771|NCT01376245|64538421|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
23217772|NCT01376245|64538422|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
23217773|NCT01376245|64538423|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
23217774|NCT01376245|64538424|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
23217775|NCT01376245|64538420|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
23217776|NCT01376245|64538421|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
23217777|NCT01376245|64538422|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
23217778|NCT01376245|64538423|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
23217779|NCT01376245|64538424|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
23217780|NCT01376245|64538420|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
23217781|NCT01376245|64538421|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
23217782|NCT01376245|64538422|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
23217783|NCT01376245|64538423|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
23217784|NCT01376245|64538424|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
23217785|NCT01376245|64538420|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
23217786|NCT01376245|64538421|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
23217787|NCT01376245|64538422|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
23217788|NCT01376245|64538423|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
23217789|NCT01376245|64538424|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
23217790|NCT01376245|64538420|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
23217791|NCT01376245|64538421|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
23217792|NCT01376245|64538422|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
23217793|NCT01376245|64538423|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
23217794|NCT01376245|64538424|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
23217795|NCT01376245|64538420|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23217796|NCT01376245|64538421|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
23217797|NCT01376245|64538422|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23217798|NCT01376245|64538423|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
23217799|NCT01376245|64538424|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
23217800|NCT01376245|64538420|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23217801|NCT01376245|64538421|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
23217802|NCT01376245|64538422|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
23217803|NCT01376245|64538423|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
23217804|NCT01376245|64538424|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23433689|NCT02202538|65330549|FG000|Overall Study|Investigator Decision|1|||
23433690|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
23433691|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
23433692|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
23433693|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
23623423|NCT02019641|66008413|FG001|20-Week Follow up|Withdrawal by investigator|0|||
23143817|NCT04975438|64277425|FG003|Overall Study|Lost to Follow-up|0|||
23143818|NCT04975438|64277422|FG000|Overall Study|Withdrawal by Subject|1|||
23143819|NCT04975438|64277423|FG001|Overall Study|Withdrawal by Subject|0|||
23143820|NCT04975438|64277424|FG002|Overall Study|Withdrawal by Subject|0|||
23143821|NCT04975438|64277425|FG003|Overall Study|Withdrawal by Subject|0|||
23555966|NCT02618616|65762405|FG000|Overall Study|Pregnancy|0|||
23555967|NCT02618616|65762406|FG001|Overall Study|Pregnancy|1|||
23555968|NCT02618616|65762405|FG000|Overall Study|Adverse Event|8|||
23555969|NCT02618616|65762406|FG001|Overall Study|Adverse Event|0|||
23555970|NCT02618616|65762405|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
23555971|NCT02618616|65762406|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
23143822|NCT02075541|64277428|FG000|Overall Study|Serious Adverse Event|1|||
23217805|NCT01376245|64538420|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23217806|NCT01376245|64538421|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
23217807|NCT01376245|64538422|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23217808|NCT01376245|64538423|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23217809|NCT01376245|64538424|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23217810|NCT01376245|64538420|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
23217811|NCT01376245|64538421|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
23217812|NCT01376245|64538422|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
23217813|NCT01376245|64538423|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
23217814|NCT01376245|64538424|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
23217815|NCT01376245|64538420|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23217816|NCT01376245|64538421|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
23217817|NCT01376245|64538422|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23217818|NCT01376245|64538423|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
23217819|NCT01376245|64538424|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
23217820|NCT01335698|64538430|FG000|Treatment Stage 1|Lack of Efficacy|3|||
23217821|NCT01335698|64538431|FG001|Treatment Stage 1|Lack of Efficacy|1|||
23217822|NCT01335698|64538432|FG002|Treatment Stage 1|Lack of Efficacy|3|||
23217823|NCT01335698|64538433|FG003|Treatment Stage 1|Lack of Efficacy|3|||
23555972|NCT02618616|65762405|FG000|Overall Study|Consent withdrawn by subject|8|||
23143823|NCT02075541|64277429|FG001|Overall Study|Serious Adverse Event|4|||
23143824|NCT02075541|64277428|FG000|Overall Study|Protocol Violation|1|||
23143825|NCT02075541|64277429|FG001|Overall Study|Protocol Violation|0|||
23143826|NCT02075541|64277428|FG000|Overall Study|Withdrawal by Subject|1|||
23143827|NCT02075541|64277429|FG001|Overall Study|Withdrawal by Subject|3|||
23143828|NCT02075541|64277428|FG000|Overall Study|Sponsor study termination|0|||
23217824|NCT01335698|64538434|FG004|Treatment Stage 1|Lack of Efficacy|1|||
23217825|NCT01335698|64538430|FG000|Treatment Stage 1|Adverse Event|1|||
23217826|NCT01335698|64538431|FG001|Treatment Stage 1|Adverse Event|2|||
23217827|NCT01335698|64538432|FG002|Treatment Stage 1|Adverse Event|2|||
23217828|NCT01335698|64538433|FG003|Treatment Stage 1|Adverse Event|1|||
23217829|NCT01335698|64538434|FG004|Treatment Stage 1|Adverse Event|1|||
23217830|NCT01335698|64538430|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
23217831|NCT01335698|64538431|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
23217832|NCT01335698|64538432|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
23217833|NCT01335698|64538433|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
23217834|NCT01335698|64538434|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
23217835|NCT01335698|64538430|FG000|Treatment Stage 1|Lost to Follow-up|1|||
23217836|NCT01335698|64538431|FG001|Treatment Stage 1|Lost to Follow-up|1|||
23217837|NCT01335698|64538432|FG002|Treatment Stage 1|Lost to Follow-up|0|||
23217838|NCT01335698|64538433|FG003|Treatment Stage 1|Lost to Follow-up|0|||
23217839|NCT01335698|64538434|FG004|Treatment Stage 1|Lost to Follow-up|0|||
23217840|NCT01335698|64538430|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
23217841|NCT01335698|64538431|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
23217842|NCT01335698|64538432|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
23217843|NCT01335698|64538433|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
23217844|NCT01335698|64538434|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
23217845|NCT01335698|64538430|FG000|Treatment Stage 1|No longer meets study criteria|1|||
23217846|NCT01335698|64538431|FG001|Treatment Stage 1|No longer meets study criteria|1|||
23217847|NCT01335698|64538432|FG002|Treatment Stage 1|No longer meets study criteria|0|||
23217848|NCT01335698|64538433|FG003|Treatment Stage 1|No longer meets study criteria|1|||
23217849|NCT01335698|64538434|FG004|Treatment Stage 1|No longer meets study criteria|0|||
23217850|NCT01335698|64538430|FG000|Treatment Stage 1|Other|1|||
23555973|NCT02618616|65762406|FG001|Overall Study|Consent withdrawn by subject|5|||
23555974|NCT02618616|65762405|FG000|Overall Study|Lost to Follow-up|0|||
23555975|NCT02618616|65762406|FG001|Overall Study|Lost to Follow-up|1|||
23555976|NCT02953938|65762407|FG000|Overall Study|Adverse Event|0|||
23555977|NCT02953938|65762408|FG001|Overall Study|Adverse Event|1|||
23217851|NCT01335698|64538431|FG001|Treatment Stage 1|Other|0|||
23555978|NCT02953938|65762407|FG000|Overall Study|Withdrawal by Subject|1|||
23555979|NCT02953938|65762408|FG001|Overall Study|Withdrawal by Subject|1|||
23217852|NCT01335698|64538432|FG002|Treatment Stage 1|Other|0|||
23555980|NCT01345630|65762409|FG000|Overall Study|Adverse Event|22|||
23555981|NCT01345630|65762410|FG001|Overall Study|Adverse Event|23|||
23143829|NCT02075541|64277429|FG001|Overall Study|Sponsor study termination|1|||
23555982|NCT01345630|65762409|FG000|Overall Study|Lost to Follow-up|17|||
23555983|NCT01345630|65762410|FG001|Overall Study|Lost to Follow-up|16|||
23555984|NCT01345630|65762409|FG000|Overall Study|Protocol Violation|4|||
23555985|NCT01345630|65762410|FG001|Overall Study|Protocol Violation|1|||
23555986|NCT01345630|65762409|FG000|Overall Study|Medication error without associated AE|0|||
23143830|NCT02075541|64277428|FG000|Overall Study|Other- unable to perform study procedure|1|||
23143831|NCT02075541|64277429|FG001|Overall Study|Other- unable to perform study procedure|0|||
23143832|NCT04335812|64277430|FG000|Overall Study|Withdrawal by Subject|1|||
23143833|NCT04335812|64277431|FG001|Overall Study|Withdrawal by Subject|3|||
23143834|NCT04335812|64277430|FG000|Overall Study|Lost to Follow-up|12|||
23143835|NCT04335812|64277431|FG001|Overall Study|Lost to Follow-up|12|||
23143836|NCT04335812|64277430|FG000|Overall Study|Did not engage in the intervention|22|||
23143837|NCT04335812|64277431|FG001|Overall Study|Did not engage in the intervention|18|||
23143838|NCT01898923|64277432|FG000|Overall Study|Lack of Efficacy|5|||
23143839|NCT01898923|64277433|FG001|Overall Study|Lack of Efficacy|6|||
23143840|NCT01898923|64277432|FG000|Overall Study|Adverse Event|3|||
23143841|NCT01898923|64277433|FG001|Overall Study|Adverse Event|1|||
23143842|NCT01898923|64277432|FG000|Overall Study|Lost to Follow-up|0|||
23143843|NCT01898923|64277433|FG001|Overall Study|Lost to Follow-up|1|||
23143844|NCT01898923|64277432|FG000|Overall Study|Withdrawal by Subject|4|||
23143845|NCT01898923|64277433|FG001|Overall Study|Withdrawal by Subject|7|||
23143846|NCT01898923|64277432|FG000|Overall Study|Physician Decision|3|||
23143847|NCT01898923|64277433|FG001|Overall Study|Physician Decision|4|||
23143848|NCT01898923|64277432|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
23143849|NCT01898923|64277433|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
23433694|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
23433695|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
23433696|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
23433697|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
23433698|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
23433699|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
23433700|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
23433701|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
23433702|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
23143850|NCT01127139|64277434|FG000|Overall Study|Adverse Event|40|||
23217853|NCT01335698|64538433|FG003|Treatment Stage 1|Other|1|||
23217854|NCT01335698|64538434|FG004|Treatment Stage 1|Other|0|||
23217855|NCT01335698|64538430|FG000|Treatment Stage 2|Lack of Efficacy|2|||
23217856|NCT01335698|64538431|FG001|Treatment Stage 2|Lack of Efficacy|1|||
23217857|NCT01335698|64538432|FG002|Treatment Stage 2|Lack of Efficacy|3|||
23217858|NCT01335698|64538433|FG003|Treatment Stage 2|Lack of Efficacy|1|||
23217859|NCT01335698|64538434|FG004|Treatment Stage 2|Lack of Efficacy|0|||
23555987|NCT01345630|65762410|FG001|Overall Study|Medication error without associated AE|1|||
23555988|NCT01345630|65762409|FG000|Overall Study|Study terminated by sponsor|254|||
23555989|NCT01345630|65762410|FG001|Overall Study|Study terminated by sponsor|285|||
23217860|NCT01335698|64538430|FG000|Treatment Stage 2|Adverse Event|2|||
23320706|NCT02245412|64919243|FG001|Follow-Up Period|Physician Decision|0|||
23320707|NCT02245412|64919244|FG002|Follow-Up Period|Physician Decision|0|||
23320708|NCT02245412|64919242|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
23320709|NCT02245412|64919243|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
23320710|NCT02245412|64919244|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
23320711|NCT02431364|64919249|FG000|Overall Study|Adverse Event|0|||
23217861|NCT01335698|64538431|FG001|Treatment Stage 2|Adverse Event|0|||
23217862|NCT01335698|64538432|FG002|Treatment Stage 2|Adverse Event|0|||
23217863|NCT01335698|64538433|FG003|Treatment Stage 2|Adverse Event|3|||
23217864|NCT01335698|64538434|FG004|Treatment Stage 2|Adverse Event|0|||
23217865|NCT01335698|64538430|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
23217866|NCT01335698|64538431|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
23217867|NCT01335698|64538432|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
23217868|NCT01335698|64538433|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
23217869|NCT01335698|64538434|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
23320712|NCT02431364|64919250|FG001|Overall Study|Adverse Event|1|||
23320713|NCT02431364|64919251|FG002|Overall Study|Adverse Event|0|||
23433703|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
23433704|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
23555990|NCT01345630|65762409|FG000|Overall Study|Other reasons|6|||
23143851|NCT01127139|64277434|FG000|Overall Study|Incompliance|12|||
23555991|NCT01345630|65762410|FG001|Overall Study|Other reasons|8|||
23217870|NCT01335698|64538430|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
23217871|NCT01335698|64538431|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
23217872|NCT01335698|64538432|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
23217873|NCT01335698|64538433|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
23143852|NCT01127139|64277434|FG000|Overall Study|Lack of Efficacy|4|||
23320714|NCT02431364|64919252|FG003|Overall Study|Adverse Event|0|||
23320715|NCT02431364|64919253|FG004|Overall Study|Adverse Event|0|||
23320716|NCT02431364|64919249|FG000|Overall Study|Randomized but never treated|0|||
23320717|NCT02431364|64919250|FG001|Overall Study|Randomized but never treated|0|||
23320718|NCT02431364|64919251|FG002|Overall Study|Randomized but never treated|0|||
23320719|NCT02431364|64919252|FG003|Overall Study|Randomized but never treated|1|||
23320720|NCT02431364|64919253|FG004|Overall Study|Randomized but never treated|0|||
23320721|NCT00606632|64919254|FG000|Overall Study|Withdrawal by Subject|13|||
23320722|NCT00606632|64919254|FG000|Overall Study|Miscellaneous reasons|9|||
23320723|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #1|24|||
23320724|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #1|0|||
23320725|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
23320726|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
23320727|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23320728|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320729|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
23320730|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
23320731|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
23320732|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
23320733|NCT03888066|64919256|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23320734|NCT03888066|64919257|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320735|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23320736|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320737|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
23143853|NCT01127139|64277434|FG000|Overall Study|Reason not specified|1|||
23143854|NCT00777946|64277435|FG000|Overall Study|Adverse Event|11|||
23143855|NCT00777946|64277436|FG001|Overall Study|Adverse Event|1|||
23143856|NCT00777946|64277437|FG002|Overall Study|Adverse Event|3|||
23143857|NCT00777946|64277435|FG000|Overall Study|Lack of Efficacy|0|||
23143858|NCT00777946|64277436|FG001|Overall Study|Lack of Efficacy|0|||
23143859|NCT00777946|64277437|FG002|Overall Study|Lack of Efficacy|9|||
23320738|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
23320739|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23320740|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320741|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
23320742|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320743|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #2|5|||
23320744|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #2|0|||
23320745|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
23320746|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
23320747|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
23320748|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
23320749|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
23320750|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
23320751|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #3|11|||
23320752|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #3|0|||
23320753|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
23320754|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
23320755|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
23320756|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23320757|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23320758|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320759|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #4|3|||
23320760|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #4|0|||
23320761|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
23320762|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
23320763|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
23320764|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
23320765|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
23320766|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23143860|NCT00777946|64277435|FG000|Overall Study|Condition no longer required study drug|1|||
23143861|NCT00777946|64277436|FG001|Overall Study|Condition no longer required study drug|0|||
23143862|NCT00777946|64277437|FG002|Overall Study|Condition no longer required study drug|0|||
23320767|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
23320768|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
23320769|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
23320770|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320771|NCT03888066|64919256|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
23320772|NCT03888066|64919257|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23320773|NCT03888066|64919256|FG000|Run-in Phase|AE (Adverse Event)|17|||
23320774|NCT03888066|64919257|FG001|Run-in Phase|AE (Adverse Event)|0|||
23320775|NCT03888066|64919256|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
23320776|NCT03888066|64919257|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
23320777|NCT03888066|64919256|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23320778|NCT03888066|64919257|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320779|NCT03888066|64919256|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
23320780|NCT03888066|64919257|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320781|NCT03888066|64919256|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
23320782|NCT03888066|64919257|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23320783|NCT03888066|64919256|FG000|Run-in Phase|Withdrawal by Subject|43|||
23320784|NCT03888066|64919257|FG001|Run-in Phase|Withdrawal by Subject|0|||
23320785|NCT03888066|64919256|FG000|Run-in Phase|AE; Physician Decision|1|||
23320786|NCT03888066|64919257|FG001|Run-in Phase|AE; Physician Decision|0|||
23320787|NCT03888066|64919256|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
23320788|NCT03888066|64919257|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
23320789|NCT03888066|64919256|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
23320790|NCT03888066|64919257|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
23320791|NCT03888066|64919256|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
23320792|NCT03888066|64919257|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
23320793|NCT03888066|64919256|FG000|Run-in Phase|Death|1|||
23320794|NCT03888066|64919257|FG001|Run-in Phase|Death|0|||
23320795|NCT03888066|64919256|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
23320796|NCT03888066|64919257|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
23320797|NCT03888066|64919256|FG000|Run-in Phase|Physician Decision|1|||
23320798|NCT03888066|64919257|FG001|Run-in Phase|Physician Decision|0|||
23320799|NCT03888066|64919256|FG000|Run-in Phase|Protocol Violation|13|||
23320800|NCT03888066|64919257|FG001|Run-in Phase|Protocol Violation|0|||
23320801|NCT03888066|64919256|FG000|Run-in Phase|Sponsor Request|34|||
23320802|NCT03888066|64919257|FG001|Run-in Phase|Sponsor Request|0|||
23320803|NCT03888066|64919256|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
23320804|NCT03888066|64919257|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
23320805|NCT03888066|64919256|FG000|Run-in Phase|Withdrawal Of Consent|1|||
23320806|NCT03888066|64919257|FG001|Run-in Phase|Withdrawal Of Consent|0|||
23320807|NCT03888066|64919256|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
23320808|NCT03888066|64919257|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
23320809|NCT03888066|64919256|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
23320810|NCT03888066|64919257|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
23320811|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
23320812|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
23320813|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
23320814|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
23433705|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
23555992|NCT01345630|65762409|FG000|Overall Study|Withdrawn due to pregnancy|1|||
23320815|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
23320816|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
23433706|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
23555993|NCT01345630|65762410|FG001|Overall Study|Withdrawn due to pregnancy|2|||
23555994|NCT01345630|65762409|FG000|Overall Study|No longer willing to participate|9|||
23143863|NCT00777946|64277435|FG000|Overall Study|Patient withdrew consent|3|||
23143864|NCT00777946|64277436|FG001|Overall Study|Patient withdrew consent|2|||
23143865|NCT00777946|64277437|FG002|Overall Study|Patient withdrew consent|3|||
23143866|NCT00777946|64277435|FG000|Overall Study|Lost to Follow-up|3|||
23143867|NCT00777946|64277436|FG001|Overall Study|Lost to Follow-up|1|||
23143868|NCT00777946|64277437|FG002|Overall Study|Lost to Follow-up|0|||
23143869|NCT00777946|64277435|FG000|Overall Study|Protocol deviation|2|||
23143870|NCT00777946|64277436|FG001|Overall Study|Protocol deviation|1|||
23143871|NCT00777946|64277437|FG002|Overall Study|Protocol deviation|1|||
23143872|NCT00777946|64277435|FG000|Overall Study|Randomized in error|1|||
23143873|NCT00777946|64277436|FG001|Overall Study|Randomized in error|1|||
23320817|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
23555995|NCT01345630|65762410|FG001|Overall Study|No longer willing to participate|12|||
23143874|NCT00777946|64277437|FG002|Overall Study|Randomized in error|0|||
23433707|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
23433708|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
23433709|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
23433710|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
23433711|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
23433712|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
23143875|NCT03603028|64277438|FG000|Overall Study|Withdrawal by Subject|1|||
23143876|NCT02054520|64277440|FG000|Overall Study|Adverse Event|1|||
23143877|NCT02054520|64277441|FG001|Overall Study|Adverse Event|4|||
23143878|NCT02054520|64277442|FG002|Overall Study|Adverse Event|2|||
23143879|NCT02054520|64277443|FG003|Overall Study|Adverse Event|1|||
23143880|NCT02054520|64277444|FG004|Overall Study|Adverse Event|1|||
23143881|NCT02054520|64277445|FG005|Overall Study|Adverse Event|0|||
23143882|NCT02054520|64277440|FG000|Overall Study|Lack of Efficacy|7|||
23143883|NCT02054520|64277441|FG001|Overall Study|Lack of Efficacy|0|||
23143884|NCT02054520|64277442|FG002|Overall Study|Lack of Efficacy|2|||
23143885|NCT02054520|64277443|FG003|Overall Study|Lack of Efficacy|1|||
23143886|NCT02054520|64277444|FG004|Overall Study|Lack of Efficacy|3|||
23143887|NCT02054520|64277445|FG005|Overall Study|Lack of Efficacy|2|||
23143888|NCT02054520|64277440|FG000|Overall Study|Withdrawal by Subject|1|||
23143889|NCT02054520|64277441|FG001|Overall Study|Withdrawal by Subject|0|||
23143890|NCT02054520|64277442|FG002|Overall Study|Withdrawal by Subject|0|||
23143891|NCT02054520|64277443|FG003|Overall Study|Withdrawal by Subject|2|||
23143892|NCT02054520|64277444|FG004|Overall Study|Withdrawal by Subject|1|||
23143893|NCT02054520|64277445|FG005|Overall Study|Withdrawal by Subject|0|||
23143894|NCT02054520|64277440|FG000|Overall Study|Physician Decision|0|||
23143895|NCT02054520|64277441|FG001|Overall Study|Physician Decision|1|||
23143896|NCT02054520|64277442|FG002|Overall Study|Physician Decision|0|||
23143897|NCT02054520|64277443|FG003|Overall Study|Physician Decision|1|||
23143898|NCT02054520|64277444|FG004|Overall Study|Physician Decision|0|||
23143899|NCT02054520|64277445|FG005|Overall Study|Physician Decision|1|||
23143900|NCT02054520|64277440|FG000|Overall Study|Study terminated by Sponsor|0|||
23143901|NCT02054520|64277441|FG001|Overall Study|Study terminated by Sponsor|0|||
23143902|NCT02054520|64277442|FG002|Overall Study|Study terminated by Sponsor|2|||
23143903|NCT02054520|64277443|FG003|Overall Study|Study terminated by Sponsor|1|||
23143904|NCT02054520|64277444|FG004|Overall Study|Study terminated by Sponsor|0|||
23143905|NCT02054520|64277445|FG005|Overall Study|Study terminated by Sponsor|0|||
23143906|NCT02647320|64277446|FG000|Overall Study|Adverse Event|0|||
23143907|NCT02647320|64277447|FG001|Overall Study|Adverse Event|1|||
23143908|NCT02647320|64277448|FG002|Overall Study|Adverse Event|3|||
23143909|NCT02647320|64277449|FG003|Overall Study|Adverse Event|2|||
23143910|NCT02647320|64277450|FG004|Overall Study|Adverse Event|1|||
23143911|NCT02647320|64277446|FG000|Overall Study|Protocol Violation|0|||
23143912|NCT02647320|64277447|FG001|Overall Study|Protocol Violation|0|||
23143913|NCT02647320|64277448|FG002|Overall Study|Protocol Violation|3|||
23143914|NCT02647320|64277449|FG003|Overall Study|Protocol Violation|0|||
23143915|NCT02647320|64277450|FG004|Overall Study|Protocol Violation|0|||
23143916|NCT02647320|64277446|FG000|Overall Study|Withdrawal by Subject|7|||
23143917|NCT02647320|64277447|FG001|Overall Study|Withdrawal by Subject|4|||
23143918|NCT02647320|64277448|FG002|Overall Study|Withdrawal by Subject|2|||
23143919|NCT02647320|64277449|FG003|Overall Study|Withdrawal by Subject|2|||
23143920|NCT02647320|64277450|FG004|Overall Study|Withdrawal by Subject|7|||
23143921|NCT02647320|64277446|FG000|Overall Study|Persistent hyperglycemia|0|||
23143922|NCT02647320|64277447|FG001|Overall Study|Persistent hyperglycemia|1|||
23143923|NCT02647320|64277448|FG002|Overall Study|Persistent hyperglycemia|1|||
23143924|NCT02647320|64277449|FG003|Overall Study|Persistent hyperglycemia|1|||
23143925|NCT02647320|64277450|FG004|Overall Study|Persistent hyperglycemia|1|||
23143926|NCT02647320|64277446|FG000|Overall Study|Study terminated by sponsor|1|||
23143927|NCT02647320|64277447|FG001|Overall Study|Study terminated by sponsor|1|||
23143928|NCT02647320|64277448|FG002|Overall Study|Study terminated by sponsor|1|||
23433713|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
23433714|NCT01532869|65330550|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
23143929|NCT02647320|64277449|FG003|Overall Study|Study terminated by sponsor|1|||
23143930|NCT02647320|64277450|FG004|Overall Study|Study terminated by sponsor|2|||
23143931|NCT02647320|64277446|FG000|Overall Study|Reason not provided|0|||
23143932|NCT02647320|64277447|FG001|Overall Study|Reason not provided|0|||
23143933|NCT02647320|64277448|FG002|Overall Study|Reason not provided|1|||
23143934|NCT02647320|64277449|FG003|Overall Study|Reason not provided|0|||
23143935|NCT02647320|64277450|FG004|Overall Study|Reason not provided|2|||
23143936|NCT02647320|64277446|FG000|Overall Study|Lost to Follow-up|1|||
23143937|NCT02647320|64277447|FG001|Overall Study|Lost to Follow-up|1|||
23143938|NCT02647320|64277448|FG002|Overall Study|Lost to Follow-up|0|||
23143939|NCT02647320|64277449|FG003|Overall Study|Lost to Follow-up|0|||
23143940|NCT02647320|64277450|FG004|Overall Study|Lost to Follow-up|0|||
23143941|NCT02647320|64277446|FG000|Overall Study|Develop anemia|1|||
23143942|NCT02647320|64277447|FG001|Overall Study|Develop anemia|0|||
23143943|NCT02647320|64277448|FG002|Overall Study|Develop anemia|0|||
23320818|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
23433715|NCT01532869|65330551|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
23433716|NCT01532869|65330550|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
23555996|NCT01345630|65762409|FG000|Overall Study|Insufficient clinical response|48|||
23555997|NCT01345630|65762410|FG001|Overall Study|Insufficient clinical response|11|||
23555998|NCT00654901|65762411|FG000|Overall Study|Lost to Follow-up|1|||
23555999|NCT00654901|65762412|FG001|Overall Study|Lost to Follow-up|0|||
23556000|NCT00654901|65762413|FG002|Overall Study|Lost to Follow-up|1|||
23556001|NCT00654901|65762414|FG003|Overall Study|Lost to Follow-up|0|||
23556002|NCT00654901|65762411|FG000|Overall Study|Withdrawal by Subject|3|||
23556003|NCT00654901|65762412|FG001|Overall Study|Withdrawal by Subject|0|||
23556004|NCT00654901|65762413|FG002|Overall Study|Withdrawal by Subject|1|||
23556005|NCT00654901|65762414|FG003|Overall Study|Withdrawal by Subject|0|||
23556006|NCT02184611|65762415|FG000|Overall Study|Lack of Efficacy|11|||
23556007|NCT02184611|65762416|FG001|Overall Study|Lack of Efficacy|15|||
23556008|NCT02184611|65762415|FG000|Overall Study|Withdrawal by Subject|5|||
23556009|NCT02184611|65762416|FG001|Overall Study|Withdrawal by Subject|6|||
23556010|NCT02184611|65762415|FG000|Overall Study|Adverse Event|4|||
23556011|NCT02184611|65762416|FG001|Overall Study|Adverse Event|5|||
23556012|NCT02184611|65762415|FG000|Overall Study|Protocol Violation|1|||
23556013|NCT02184611|65762416|FG001|Overall Study|Protocol Violation|1|||
23556014|NCT02184611|65762415|FG000|Overall Study|Protocol defined stopping criteria|0|||
23556015|NCT02184611|65762416|FG001|Overall Study|Protocol defined stopping criteria|1|||
23556016|NCT03403426|65762417|FG000|Overall Study|Death|1|||
23556017|NCT03403426|65762417|FG000|Overall Study|Lost to Follow-up|2|||
23143944|NCT02647320|64277449|FG003|Overall Study|Develop anemia|0|||
23143945|NCT02647320|64277450|FG004|Overall Study|Develop anemia|0|||
23143946|NCT02647320|64277446|FG000|Overall Study|Lack of Efficacy|0|||
23143947|NCT02647320|64277447|FG001|Overall Study|Lack of Efficacy|0|||
23143948|NCT02647320|64277448|FG002|Overall Study|Lack of Efficacy|0|||
23143949|NCT02647320|64277449|FG003|Overall Study|Lack of Efficacy|1|||
23143950|NCT02647320|64277450|FG004|Overall Study|Lack of Efficacy|0|||
23143951|NCT02647320|64277446|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
23143952|NCT02647320|64277447|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
23143953|NCT02647320|64277448|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
23143954|NCT02647320|64277449|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
23143955|NCT02647320|64277450|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
23143956|NCT00390910|64277451|FG000|Overall Study|Adverse Event|1|||
23143957|NCT00390910|64277452|FG001|Overall Study|Adverse Event|0|||
23143958|NCT00390910|64277453|FG002|Overall Study|Adverse Event|0|||
23143959|NCT00390910|64277451|FG000|Overall Study|Lost to Follow-up|0|||
23143960|NCT00390910|64277452|FG001|Overall Study|Lost to Follow-up|1|||
23143961|NCT00390910|64277453|FG002|Overall Study|Lost to Follow-up|5|||
23143962|NCT00390910|64277451|FG000|Overall Study|Withdrawal by Subject|1|||
23143963|NCT00390910|64277452|FG001|Overall Study|Withdrawal by Subject|3|||
23143964|NCT00390910|64277453|FG002|Overall Study|Withdrawal by Subject|2|||
23143965|NCT00390910|64277451|FG000|Overall Study|Migrated/moved from study area|0|||
23143966|NCT00390910|64277452|FG001|Overall Study|Migrated/moved from study area|0|||
23143967|NCT00390910|64277453|FG002|Overall Study|Migrated/moved from study area|3|||
23143968|NCT01635920|64277454|FG000|Overall Study|Adverse Event|1|||
23143969|NCT01635920|64277455|FG001|Overall Study|Adverse Event|0|||
23143970|NCT01635920|64277454|FG000|Overall Study|Lost to Follow-up|0|||
23143971|NCT01635920|64277455|FG001|Overall Study|Lost to Follow-up|1|||
23143972|NCT01635920|64277454|FG000|Overall Study|Subject decision|2|||
23143973|NCT01635920|64277455|FG001|Overall Study|Subject decision|0|||
23143974|NCT00903630|64277458|FG000|Phase 2|Adverse Event|0|||
23143975|NCT00903630|64277459|FG001|Phase 2|Adverse Event|0|||
23143976|NCT00903630|64277460|FG002|Phase 2|Adverse Event|1|||
23143977|NCT00561951|64277461|FG000|Overall Study|Adverse Event|11|||
23433717|NCT01532869|65330551|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
23556018|NCT03338894|65762418|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
23556019|NCT00671931|65762419|FG000|Overall Study|Physician Decision|1|||
23556020|NCT00671931|65762420|FG001|Overall Study|Physician Decision|0|||
23556021|NCT00671931|65762421|FG002|Overall Study|Physician Decision|0|||
23623424|NCT02019641|66008414|FG002|20-Week Follow up|Withdrawal by investigator|1|||
23623425|NCT02353871|66008415|FG000|Overall Study|Protocol deviation|0|||
23143978|NCT00561951|64277462|FG001|Overall Study|Adverse Event|14|||
23143979|NCT00561951|64277463|FG002|Overall Study|Adverse Event|14|||
23143980|NCT00561951|64277461|FG000|Overall Study|Lack of Efficacy|5|||
23556022|NCT00671931|65762422|FG003|Overall Study|Physician Decision|2|||
23556023|NCT00671931|65762423|FG004|Overall Study|Physician Decision|1|||
23556024|NCT03382782|65762424|FG000|Cohort 1|Withdrawal by Subject|11|||
23143981|NCT00561951|64277462|FG001|Overall Study|Lack of Efficacy|3|||
23143982|NCT00561951|64277463|FG002|Overall Study|Lack of Efficacy|2|||
23143983|NCT00561951|64277461|FG000|Overall Study|Lost to Follow-up|1|||
23143984|NCT00561951|64277462|FG001|Overall Study|Lost to Follow-up|1|||
23623426|NCT02353871|66008416|FG001|Overall Study|Protocol deviation|1|||
23433718|NCT01532869|65330550|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
23556025|NCT03382782|65762425|FG001|Cohort 1|Withdrawal by Subject|5|||
23556026|NCT03382782|65762426|FG002|Cohort 1|Withdrawal by Subject|0|||
23556027|NCT03382782|65762424|FG000|Cohort 2|Withdrawal by Subject|1|||
23556028|NCT03382782|65762425|FG001|Cohort 2|Withdrawal by Subject|1|||
23556029|NCT03382782|65762426|FG002|Cohort 2|Withdrawal by Subject|0|||
23556030|NCT03382782|65762424|FG000|Cohort 3|Withdrawal by Subject|1|||
23556031|NCT03382782|65762425|FG001|Cohort 3|Withdrawal by Subject|2|||
23556032|NCT03382782|65762426|FG002|Cohort 3|Withdrawal by Subject|0|||
23556033|NCT04870710|65762429|FG000|Overall Study|Lost to Follow-up|3|||
23556034|NCT04040751|65762430|FG000|Overall Study|Withdrawal by Subject|2|||
23556035|NCT04040751|65762431|FG001|Overall Study|Withdrawal by Subject|0|||
23556036|NCT04040751|65762432|FG002|Overall Study|Withdrawal by Subject|2|||
23556037|NCT04040751|65762433|FG003|Overall Study|Withdrawal by Subject|0|||
23556038|NCT03685591|65762434|FG000|Overall Study|Global Deterioration of Health Status|0|||
23556039|NCT03685591|65762435|FG001|Overall Study|Global Deterioration of Health Status|0|||
23556040|NCT03685591|65762436|FG002|Overall Study|Global Deterioration of Health Status|0|||
23556041|NCT03685591|65762437|FG003|Overall Study|Global Deterioration of Health Status|1|||
23556042|NCT03685591|65762438|FG004|Overall Study|Global Deterioration of Health Status|2|||
23556043|NCT03685591|65762439|FG005|Overall Study|Global Deterioration of Health Status|4|||
23556044|NCT03685591|65762440|FG006|Overall Study|Global Deterioration of Health Status|1|||
23556045|NCT03685591|65762441|FG007|Overall Study|Global Deterioration of Health Status|1|||
23556046|NCT03685591|65762442|FG008|Overall Study|Global Deterioration of Health Status|0|||
23556047|NCT03685591|65762434|FG000|Overall Study|Progressive Disease|1|||
23556048|NCT03685591|65762435|FG001|Overall Study|Progressive Disease|1|||
23556049|NCT03685591|65762436|FG002|Overall Study|Progressive Disease|0|||
23556050|NCT03685591|65762437|FG003|Overall Study|Progressive Disease|3|||
23143985|NCT00561951|64277463|FG002|Overall Study|Lost to Follow-up|0|||
23143986|NCT00561951|64277461|FG000|Overall Study|Withdrawal by Subject|10|||
23143987|NCT00561951|64277462|FG001|Overall Study|Withdrawal by Subject|9|||
23143988|NCT00561951|64277463|FG002|Overall Study|Withdrawal by Subject|10|||
23143989|NCT00561951|64277461|FG000|Overall Study|Protocol Violation|4|||
23143990|NCT00561951|64277462|FG001|Overall Study|Protocol Violation|3|||
23143991|NCT00561951|64277463|FG002|Overall Study|Protocol Violation|4|||
23143992|NCT00561951|64277461|FG000|Overall Study|Physician Decision|1|||
23143993|NCT00561951|64277462|FG001|Overall Study|Physician Decision|0|||
23143994|NCT00561951|64277463|FG002|Overall Study|Physician Decision|0|||
23143995|NCT00561951|64277461|FG000|Overall Study|Pregnancy|0|||
23143996|NCT00561951|64277462|FG001|Overall Study|Pregnancy|1|||
23143997|NCT00561951|64277463|FG002|Overall Study|Pregnancy|0|||
23143998|NCT00561951|64277461|FG000|Overall Study|Meet Withdrawal Criterion|0|||
23143999|NCT00561951|64277462|FG001|Overall Study|Meet Withdrawal Criterion|1|||
23144000|NCT00561951|64277463|FG002|Overall Study|Meet Withdrawal Criterion|1|||
23144001|NCT00561951|64277461|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
23144002|NCT00561951|64277462|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
23144003|NCT00561951|64277463|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
23144004|NCT01324440|64277464|FG000|Overall Study|Subject moved|0|||
23144005|NCT01324440|64277465|FG001|Overall Study|Subject moved|1|||
23144006|NCT00262951|64277466|FG000|Overall Study|Progressive disease/relapse|3|||
23144007|NCT00262951|64277466|FG000|Overall Study|Adverse Event|7|||
23144008|NCT00262951|64277466|FG000|Overall Study|Death|1|||
23144009|NCT00262951|64277466|FG000|Overall Study|Withdrawal by Subject|1|||
23144010|NCT00262951|64277466|FG000|Overall Study|Alternative treatment|3|||
23144011|NCT00262951|64277466|FG000|Overall Study|Off treatment for other disease|1|||
23144012|NCT00596427|64277470|FG000|Overall Study|Withdrawal by Subject|2|||
23144013|NCT00596427|64277471|FG001|Overall Study|Withdrawal by Subject|2|||
23144014|NCT00596427|64277470|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
23144015|NCT00596427|64277471|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
23144016|NCT00596427|64277470|FG000|Overall Study|Protocol Violation|1|||
23144017|NCT00596427|64277471|FG001|Overall Study|Protocol Violation|0|||
23144018|NCT02680002|64277472|FG000|Overall Study|Lost to Follow-up|5|||
23144019|NCT02680002|64277473|FG001|Overall Study|Lost to Follow-up|1|||
23144020|NCT02680002|64277474|FG002|Overall Study|Lost to Follow-up|4|||
23320819|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
23320820|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
23433719|NCT01532869|65330551|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
23144021|NCT02680002|64277475|FG003|Overall Study|Lost to Follow-up|2|||
23144022|NCT02680002|64277476|FG004|Overall Study|Lost to Follow-up|0|||
23144023|NCT02680002|64277477|FG005|Overall Study|Lost to Follow-up|2|||
23144024|NCT02680002|64277472|FG000|Overall Study|Physician Decision|5|||
23144025|NCT02680002|64277473|FG001|Overall Study|Physician Decision|1|||
23556051|NCT03685591|65762438|FG004|Overall Study|Progressive Disease|5|||
23556052|NCT03685591|65762439|FG005|Overall Study|Progressive Disease|4|||
23556053|NCT03685591|65762440|FG006|Overall Study|Progressive Disease|3|||
23556054|NCT03685591|65762441|FG007|Overall Study|Progressive Disease|2|||
23144026|NCT02680002|64277474|FG002|Overall Study|Physician Decision|1|||
23217874|NCT01335698|64538434|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
23217875|NCT01335698|64538430|FG000|Treatment Stage 2|Lost to Follow-up|1|||
23217876|NCT01335698|64538431|FG001|Treatment Stage 2|Lost to Follow-up|0|||
23217877|NCT01335698|64538432|FG002|Treatment Stage 2|Lost to Follow-up|0|||
23217878|NCT01335698|64538433|FG003|Treatment Stage 2|Lost to Follow-up|0|||
23217879|NCT01335698|64538434|FG004|Treatment Stage 2|Lost to Follow-up|0|||
23217880|NCT01335698|64538430|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
23217881|NCT01335698|64538431|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
23217882|NCT01335698|64538432|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
23217883|NCT01335698|64538433|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
23217884|NCT01335698|64538434|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
23217885|NCT01335698|64538430|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
23217886|NCT01335698|64538431|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
23217887|NCT01335698|64538432|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
23217888|NCT01335698|64538433|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
23217889|NCT01335698|64538434|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
23217890|NCT01335698|64538430|FG000|Treatment Stage 2|Switched to another formulation|1|||
23320821|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
23320822|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
23320823|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
23320824|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
23320825|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
23320826|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
23320827|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
23320828|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
23556055|NCT03685591|65762442|FG008|Overall Study|Progressive Disease|1|||
23556056|NCT03685591|65762434|FG000|Overall Study|Other|0|||
23556057|NCT03685591|65762435|FG001|Overall Study|Other|0|||
23556058|NCT03685591|65762436|FG002|Overall Study|Other|1|||
23556059|NCT03685591|65762437|FG003|Overall Study|Other|0|||
23556060|NCT03685591|65762438|FG004|Overall Study|Other|2|||
23556061|NCT03685591|65762439|FG005|Overall Study|Other|3|||
23556062|NCT03685591|65762440|FG006|Overall Study|Other|0|||
23556063|NCT03685591|65762441|FG007|Overall Study|Other|0|||
23556064|NCT03685591|65762442|FG008|Overall Study|Other|0|||
23556065|NCT03685591|65762434|FG000|Overall Study|Withdrawal by Subject|0|||
23556066|NCT03685591|65762435|FG001|Overall Study|Withdrawal by Subject|0|||
23556067|NCT03685591|65762436|FG002|Overall Study|Withdrawal by Subject|0|||
23556068|NCT03685591|65762437|FG003|Overall Study|Withdrawal by Subject|0|||
23556069|NCT03685591|65762438|FG004|Overall Study|Withdrawal by Subject|3|||
23556070|NCT03685591|65762439|FG005|Overall Study|Withdrawal by Subject|2|||
23556071|NCT03685591|65762440|FG006|Overall Study|Withdrawal by Subject|0|||
23556072|NCT03685591|65762441|FG007|Overall Study|Withdrawal by Subject|0|||
23556073|NCT03685591|65762442|FG008|Overall Study|Withdrawal by Subject|1|||
23556074|NCT03685591|65762434|FG000|Overall Study|Adverse Event|0|||
23556075|NCT03685591|65762435|FG001|Overall Study|Adverse Event|0|||
23556076|NCT03685591|65762436|FG002|Overall Study|Adverse Event|0|||
23556077|NCT03685591|65762437|FG003|Overall Study|Adverse Event|1|||
23556078|NCT03685591|65762438|FG004|Overall Study|Adverse Event|1|||
23556079|NCT03685591|65762439|FG005|Overall Study|Adverse Event|4|||
23556080|NCT03685591|65762440|FG006|Overall Study|Adverse Event|0|||
23556081|NCT03685591|65762441|FG007|Overall Study|Adverse Event|1|||
23556082|NCT03685591|65762442|FG008|Overall Study|Adverse Event|1|||
23556083|NCT02889133|65762443|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
23556084|NCT02889133|65762444|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
23556085|NCT02889133|65762443|FG000|Completed Primary Outcome|Manufacturing error|3|||
23556086|NCT02889133|65762444|FG001|Completed Primary Outcome|Manufacturing error|8|||
23556087|NCT02889133|65762443|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
23556088|NCT02889133|65762444|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
23556089|NCT02889133|65762443|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
23556090|NCT02889133|65762444|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
23556091|NCT02889133|65762443|FG000|Completed Primary Outcome|Protocol Violation|1|||
23556092|NCT02889133|65762444|FG001|Completed Primary Outcome|Protocol Violation|0|||
23556093|NCT02889133|65762443|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
23217891|NCT01335698|64538431|FG001|Treatment Stage 2|Switched to another formulation|1|||
23217892|NCT01335698|64538432|FG002|Treatment Stage 2|Switched to another formulation|0|||
23556094|NCT02889133|65762444|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
23556095|NCT02889133|65762443|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
23556096|NCT02889133|65762444|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
23556097|NCT02889133|65762443|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
23556098|NCT02889133|65762444|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
23217893|NCT01335698|64538433|FG003|Treatment Stage 2|Switched to another formulation|0|||
23144027|NCT02680002|64277475|FG003|Overall Study|Physician Decision|1|||
23144028|NCT02680002|64277476|FG004|Overall Study|Physician Decision|1|||
23144029|NCT02680002|64277477|FG005|Overall Study|Physician Decision|1|||
23144030|NCT02680002|64277472|FG000|Overall Study|Protocol Violation|1|||
23144031|NCT02680002|64277473|FG001|Overall Study|Protocol Violation|0|||
23144032|NCT02680002|64277474|FG002|Overall Study|Protocol Violation|1|||
23144033|NCT02680002|64277475|FG003|Overall Study|Protocol Violation|0|||
23144034|NCT02680002|64277476|FG004|Overall Study|Protocol Violation|1|||
23144035|NCT02680002|64277477|FG005|Overall Study|Protocol Violation|2|||
23144036|NCT02680002|64277472|FG000|Overall Study|Withdrawal by Subject|0|||
23144037|NCT02680002|64277473|FG001|Overall Study|Withdrawal by Subject|0|||
23144038|NCT02680002|64277474|FG002|Overall Study|Withdrawal by Subject|1|||
23144039|NCT02680002|64277475|FG003|Overall Study|Withdrawal by Subject|0|||
23144040|NCT02680002|64277476|FG004|Overall Study|Withdrawal by Subject|2|||
23144041|NCT02680002|64277477|FG005|Overall Study|Withdrawal by Subject|2|||
23144042|NCT02680002|64277472|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
23144043|NCT02680002|64277473|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
23144044|NCT02680002|64277474|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
23144045|NCT02680002|64277475|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
23144046|NCT02680002|64277476|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
23144047|NCT02680002|64277477|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
23144048|NCT02680002|64277472|FG000|Overall Study|Other|0|||
23144049|NCT02680002|64277473|FG001|Overall Study|Other|1|||
23144050|NCT02680002|64277474|FG002|Overall Study|Other|0|||
23144051|NCT02680002|64277475|FG003|Overall Study|Other|0|||
23144052|NCT02680002|64277476|FG004|Overall Study|Other|1|||
23144053|NCT02680002|64277477|FG005|Overall Study|Other|0|||
23144054|NCT02680002|64277472|FG000|Overall Study|Adverse Event|0|||
23144055|NCT02680002|64277473|FG001|Overall Study|Adverse Event|0|||
23144056|NCT02680002|64277474|FG002|Overall Study|Adverse Event|0|||
23144057|NCT02680002|64277475|FG003|Overall Study|Adverse Event|0|||
23144058|NCT02680002|64277476|FG004|Overall Study|Adverse Event|1|||
23144059|NCT02680002|64277477|FG005|Overall Study|Adverse Event|2|||
23320829|NCT03888066|64919256|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
23320830|NCT03888066|64919257|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
23320831|NCT01401452|64919258|FG000|Overall Study|Adverse reaction|9|||
23320832|NCT01401452|64919258|FG000|Overall Study|Lost to Follow-up|12|||
23320833|NCT01401452|64919258|FG000|Overall Study|Lack of Efficacy|30|||
23320834|NCT01401452|64919258|FG000|Overall Study|Participant developed breast cancer|1|||
23320835|NCT01401452|64919258|FG000|Overall Study|Tx stopped due to financial reasons|1|||
23320836|NCT01401452|64919258|FG000|Overall Study|Tx stopped by psychiatrist|1|||
23320837|NCT01401452|64919258|FG000|Overall Study|No more visits within the 36 wk followup|4|||
23320838|NCT01401452|64919258|FG000|Overall Study|Subject did not come to follow up visits|2|||
23320839|NCT01401452|64919258|FG000|Overall Study|Subject didn't return for routine visits|1|||
23320840|NCT01401452|64919258|FG000|Overall Study|Subject moved to another city|1|||
23556099|NCT02889133|65762443|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
23556100|NCT02889133|65762444|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
23556101|NCT02889133|65762443|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
23556102|NCT02889133|65762444|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
23556103|NCT00948974|65762452|FG000|Overall Study|Lost to Follow-up|23|||
23556104|NCT00948974|65762453|FG001|Overall Study|Lost to Follow-up|20|||
23556105|NCT00330174|65762454|FG000|Overall Study|Withdrawal by Subject|7|||
23556106|NCT00330174|65762455|FG001|Overall Study|Withdrawal by Subject|7|||
23556107|NCT00330174|65762454|FG000|Overall Study|Lost to Follow-up|4|||
23556108|NCT00330174|65762455|FG001|Overall Study|Lost to Follow-up|1|||
23556109|NCT00330174|65762454|FG000|Overall Study|Clinical deterioration|1|||
23556110|NCT00330174|65762455|FG001|Overall Study|Clinical deterioration|2|||
23556111|NCT00330174|65762454|FG000|Overall Study|Excessive missed visits|3|||
23556112|NCT00330174|65762455|FG001|Overall Study|Excessive missed visits|8|||
23556113|NCT00330174|65762454|FG000|Overall Study|Miscellaneous reasons|7|||
23556114|NCT00330174|65762455|FG001|Overall Study|Miscellaneous reasons|1|||
23556115|NCT01514448|65762456|FG000|Overall Study|Death|7|||
23556116|NCT01514448|65762457|FG001|Overall Study|Death|8|||
23623427|NCT02353871|66008415|FG000|Overall Study|Consent withdrawn|1|||
23144060|NCT00609765|64277478|FG000|Overall Study|Study ended prior to 12 months|1|||
23144061|NCT04875676|64277479|FG000|Overall Study|Lost to Follow-up|1|||
23144062|NCT04875676|64277480|FG001|Overall Study|Lost to Follow-up|0|||
23144063|NCT04875676|64277481|FG002|Overall Study|Lost to Follow-up|0|||
23144064|NCT01139021|64277483|FG000|Overall Study|Adverse Event|0|||
23144065|NCT01139021|64277484|FG001|Overall Study|Adverse Event|0|||
23144066|NCT01139021|64277485|FG002|Overall Study|Adverse Event|0|||
23320841|NCT01401452|64919258|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
23320842|NCT01401452|64919258|FG000|Overall Study|Psoriatic arthritis|1|||
23556117|NCT01514448|65762456|FG000|Overall Study|Withdrawal by Subject|2|||
23623428|NCT02353871|66008416|FG001|Overall Study|Consent withdrawn|8|||
23144067|NCT01139021|64277486|FG003|Overall Study|Adverse Event|0|||
23144068|NCT01139021|64277487|FG004|Overall Study|Adverse Event|1|||
23556118|NCT01514448|65762457|FG001|Overall Study|Withdrawal by Subject|0|||
23556119|NCT01514448|65762456|FG000|Overall Study|Lost to Follow-up|2|||
23556120|NCT01514448|65762457|FG001|Overall Study|Lost to Follow-up|0|||
23556121|NCT01514448|65762456|FG000|Overall Study|New Cancer Therapy|1|||
23556122|NCT01514448|65762457|FG001|Overall Study|New Cancer Therapy|0|||
23556123|NCT03750006|65762461|FG000|Overall Study|Withdrawal by Subject|8|||
23556124|NCT03750006|65762461|FG000|Overall Study|COVID PANDEMIC|11|||
23320843|NCT01401452|64919258|FG000|Overall Study|Participant stopped Tx|2|||
23320844|NCT01401452|64919258|FG000|Overall Study|Discontinuation for personal reasons|1|||
23320845|NCT01401452|64919258|FG000|Overall Study|Treatment failure|1|||
23320846|NCT01401452|64919258|FG000|Overall Study|Unsatisfactory output|1|||
23556125|NCT03238300|65762463|FG000|Baseline (Before Intervention)|Physician Decision|0|||
23556126|NCT03238300|65762464|FG001|Baseline (Before Intervention)|Physician Decision|1|||
23556127|NCT03238300|65762463|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
23556128|NCT03238300|65762464|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
23556129|NCT03238300|65762463|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
23556130|NCT03238300|65762464|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
23556131|NCT03238300|65762463|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
23556132|NCT03238300|65762464|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
23556133|NCT03848403|65762470|FG000|Period 2 (Day 8)|Adverse Event|1|||
23556134|NCT03848403|65762471|FG001|Period 2 (Day 8)|Adverse Event|2|||
23144069|NCT01139021|64277488|FG005|Overall Study|Adverse Event|0|||
23144070|NCT01139021|64277483|FG000|Overall Study|Lost to Follow-up|0|||
23144071|NCT01139021|64277484|FG001|Overall Study|Lost to Follow-up|0|||
23144072|NCT01139021|64277485|FG002|Overall Study|Lost to Follow-up|0|||
23144073|NCT01139021|64277486|FG003|Overall Study|Lost to Follow-up|0|||
23144074|NCT01139021|64277487|FG004|Overall Study|Lost to Follow-up|2|||
23144075|NCT01139021|64277488|FG005|Overall Study|Lost to Follow-up|0|||
23144076|NCT01139021|64277483|FG000|Overall Study|Protocol Violation|1|||
23144077|NCT01139021|64277484|FG001|Overall Study|Protocol Violation|0|||
23144078|NCT01139021|64277485|FG002|Overall Study|Protocol Violation|0|||
23144079|NCT01139021|64277486|FG003|Overall Study|Protocol Violation|0|||
23144080|NCT01139021|64277487|FG004|Overall Study|Protocol Violation|2|||
23144081|NCT01139021|64277488|FG005|Overall Study|Protocol Violation|0|||
23144082|NCT01139021|64277483|FG000|Overall Study|Withdrawal by Subject|0|||
23144083|NCT01139021|64277484|FG001|Overall Study|Withdrawal by Subject|0|||
23144084|NCT01139021|64277485|FG002|Overall Study|Withdrawal by Subject|0|||
23144085|NCT01139021|64277486|FG003|Overall Study|Withdrawal by Subject|1|||
23144086|NCT01139021|64277487|FG004|Overall Study|Withdrawal by Subject|4|||
23144087|NCT01139021|64277488|FG005|Overall Study|Withdrawal by Subject|0|||
23144088|NCT01966471|64277489|FG000|Overall Study|Death|44|||
23144089|NCT01966471|64277490|FG001|Overall Study|Death|56|||
23144090|NCT01966471|64277489|FG000|Overall Study|Lost to Follow-up|46|||
23144091|NCT01966471|64277490|FG001|Overall Study|Lost to Follow-up|39|||
23144092|NCT01966471|64277489|FG000|Overall Study|Various reasons|4|||
23144093|NCT01966471|64277490|FG001|Overall Study|Various reasons|4|||
23144094|NCT01966471|64277489|FG000|Overall Study|Physician Decision|7|||
23144095|NCT01966471|64277490|FG001|Overall Study|Physician Decision|5|||
23144096|NCT01966471|64277489|FG000|Overall Study|Study Terminated By Sponsor|758|||
23144097|NCT01966471|64277490|FG001|Overall Study|Study Terminated By Sponsor|773|||
23144098|NCT01966471|64277489|FG000|Overall Study|Withdrawal by Subject|59|||
23144099|NCT01966471|64277490|FG001|Overall Study|Withdrawal by Subject|51|||
23144100|NCT00690820|64277491|FG000|Period 1|Withdrawal by Subject|0|||
23144101|NCT00690820|64277492|FG001|Period 1|Withdrawal by Subject|1|||
23144102|NCT00031551|64277493|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
23144103|NCT00031551|64277494|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
23144104|NCT02520284|64277503|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
23144105|NCT02520284|64277504|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
23144106|NCT02520284|64277505|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
23144107|NCT02520284|64277503|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
23144108|NCT02520284|64277504|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
23144109|NCT02520284|64277505|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
23144110|NCT02520284|64277503|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
23320847|NCT01401452|64919258|FG000|Overall Study|Subject withdrew because of Tx success|1|||
23320848|NCT01401452|64919258|FG000|Overall Study|Subject chose to discontinue treatment|1|||
23320849|NCT01401452|64919258|FG000|Overall Study|Participant withdrew consent|1|||
23144111|NCT02520284|64277504|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
23144112|NCT02520284|64277505|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
23144113|NCT02520284|64277503|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
23144114|NCT02520284|64277504|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
23556135|NCT03848403|65762472|FG002|Period 2 (Day 8)|Adverse Event|2|||
23556136|NCT03848403|65762470|FG000|Period 2 (Day 8)|Physician Decision|0|||
23556137|NCT03848403|65762471|FG001|Period 2 (Day 8)|Physician Decision|1|||
23144115|NCT02520284|64277505|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
23320850|NCT00946920|64919259|FG000|Overall Study|Withdrawal by Subject|28|||
23320851|NCT00946920|64919260|FG001|Overall Study|Withdrawal by Subject|15|||
23433720|NCT01532869|65330550|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
23433721|NCT01532869|65330551|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
23433722|NCT01532869|65330550|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
23433723|NCT01532869|65330551|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
23433724|NCT00772109|65330552|FG000|Overall Study|Serious adverse event|1|||
23556138|NCT03848403|65762472|FG002|Period 2 (Day 8)|Physician Decision|0|||
23320852|NCT00946920|64919259|FG000|Overall Study|Lost to Follow-up|2|||
23320853|NCT00946920|64919260|FG001|Overall Study|Lost to Follow-up|2|||
23320854|NCT00946920|64919259|FG000|Overall Study|Physician Decision|5|||
23320855|NCT00946920|64919260|FG001|Overall Study|Physician Decision|2|||
23320856|NCT00946920|64919259|FG000|Overall Study|Adverse Event|41|||
23320857|NCT00946920|64919260|FG001|Overall Study|Adverse Event|14|||
23320858|NCT00946920|64919259|FG000|Overall Study|Protocol Violation|16|||
23320859|NCT00946920|64919260|FG001|Overall Study|Protocol Violation|8|||
23320860|NCT00946920|64919259|FG000|Overall Study|Miscellaneous reasons|18|||
23320861|NCT00946920|64919260|FG001|Overall Study|Miscellaneous reasons|3|||
23320862|NCT01245283|64919261|FG000|Overall Study|Lost to Follow-up|14|||
23320863|NCT01245283|64919262|FG001|Overall Study|Lost to Follow-up|11|||
23320864|NCT01245283|64919263|FG002|Overall Study|Lost to Follow-up|11|||
23320865|NCT02422797|64919264|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
23320866|NCT02422797|64919265|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
23320867|NCT02422797|64919264|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
23320868|NCT02422797|64919265|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
23320869|NCT02422797|64919264|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
23320870|NCT02422797|64919265|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
23320871|NCT02422797|64919264|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
23320872|NCT02422797|64919265|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
23320873|NCT02422797|64919264|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
23320874|NCT02422797|64919265|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
23320875|NCT02422797|64919264|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
23320876|NCT02422797|64919265|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
23320877|NCT02422797|64919264|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
23320878|NCT02422797|64919265|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
23320879|NCT02422797|64919264|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
23320880|NCT02422797|64919265|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
23320881|NCT02422797|64919264|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
23320882|NCT02422797|64919265|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
23320883|NCT02422797|64919264|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
23320884|NCT02422797|64919265|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
23320885|NCT02422797|64919264|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
23320886|NCT02422797|64919265|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
23320887|NCT02422797|64919264|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
23320888|NCT02422797|64919265|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
23320889|NCT02422797|64919264|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
23320890|NCT02422797|64919265|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
23320891|NCT02422797|64919264|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
23320892|NCT02422797|64919265|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
23320893|NCT02422797|64919264|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
23320894|NCT02422797|64919265|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
23320895|NCT02422797|64919264|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
23320896|NCT02422797|64919265|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
23320897|NCT02422797|64919264|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
23320898|NCT02422797|64919265|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
23320899|NCT02422797|64919264|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
23320900|NCT02422797|64919265|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
23320901|NCT02422797|64919264|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
23320902|NCT02422797|64919265|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
23320903|NCT02422797|64919264|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
23320904|NCT02422797|64919265|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
23320905|NCT02422797|64919264|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
23320906|NCT02422797|64919265|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
23320907|NCT03905694|64919266|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
23320908|NCT02269098|64919268|FG000|Overall Study|Lost to Follow-up|14|||
23320909|NCT02269098|64919269|FG001|Overall Study|Lost to Follow-up|9|||
23433725|NCT00772109|65330553|FG001|Overall Study|Serious adverse event|0|||
23556139|NCT03848403|65762470|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
23556140|NCT03848403|65762471|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
23556141|NCT03848403|65762472|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
23556142|NCT00540124|65762483|FG000|Overall Study|Adverse Event|0|||
23556143|NCT00540124|65762484|FG001|Overall Study|Adverse Event|2|||
23556144|NCT00540124|65762485|FG002|Overall Study|Adverse Event|1|||
23556145|NCT00540124|65762483|FG000|Overall Study|Entry Criteria Not Met|2|||
23556146|NCT00540124|65762484|FG001|Overall Study|Entry Criteria Not Met|0|||
23556147|NCT00540124|65762485|FG002|Overall Study|Entry Criteria Not Met|0|||
23556148|NCT00540124|65762483|FG000|Overall Study|Lack of Efficacy|1|||
23556149|NCT00540124|65762484|FG001|Overall Study|Lack of Efficacy|0|||
23556150|NCT00540124|65762485|FG002|Overall Study|Lack of Efficacy|0|||
23556151|NCT00540124|65762483|FG000|Overall Study|Withdrawal by Subject|1|||
23556152|NCT00540124|65762484|FG001|Overall Study|Withdrawal by Subject|1|||
23556153|NCT00540124|65762485|FG002|Overall Study|Withdrawal by Subject|0|||
23556154|NCT00833560|65762486|FG000|Overall Study|Toxicity|13|||
23556155|NCT00833560|65762486|FG000|Overall Study|Adverse Event|11|||
23556156|NCT00833560|65762486|FG000|Overall Study|Protocol Violation|6|||
23556157|NCT00833560|65762486|FG000|Overall Study|Lack of Efficacy|4|||
23556158|NCT00833560|65762486|FG000|Overall Study|Death|2|||
23556159|NCT00833560|65762486|FG000|Overall Study|Pregression of other disease|1|||
23556160|NCT00833560|65762486|FG000|Overall Study|Other|5|||
23556161|NCT01137474|65762487|FG000|Overall Study|Adverse Event|3|||
23556162|NCT01137474|65762488|FG001|Overall Study|Adverse Event|5|||
23556163|NCT01137474|65762489|FG002|Overall Study|Adverse Event|1|||
23556164|NCT01137474|65762490|FG003|Overall Study|Adverse Event|3|||
23556165|NCT01137474|65762487|FG000|Overall Study|Withdrawal by Subject|7|||
23556166|NCT01137474|65762488|FG001|Overall Study|Withdrawal by Subject|2|||
23556167|NCT01137474|65762489|FG002|Overall Study|Withdrawal by Subject|6|||
23556168|NCT01137474|65762490|FG003|Overall Study|Withdrawal by Subject|9|||
23556169|NCT01137474|65762487|FG000|Overall Study|No longer met study criteria|6|||
23556170|NCT01137474|65762488|FG001|Overall Study|No longer met study criteria|1|||
23556171|NCT01137474|65762489|FG002|Overall Study|No longer met study criteria|0|||
23556172|NCT01137474|65762490|FG003|Overall Study|No longer met study criteria|5|||
23556173|NCT01137474|65762487|FG000|Overall Study|Lost to Follow-up|5|||
23556174|NCT01137474|65762488|FG001|Overall Study|Lost to Follow-up|1|||
23623429|NCT02353871|66008415|FG000|Overall Study|Lost to Follow-up|2|||
23144116|NCT02520284|64277503|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
23144117|NCT02520284|64277504|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
23144118|NCT02520284|64277505|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
23144119|NCT02520284|64277503|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
23144120|NCT02520284|64277504|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
23144121|NCT02520284|64277505|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
23144122|NCT02520284|64277503|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
23144123|NCT02520284|64277504|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
23144124|NCT02520284|64277505|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
23144125|NCT02520284|64277503|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
23144126|NCT02520284|64277504|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
23144127|NCT02520284|64277505|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
23144128|NCT02520284|64277503|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
23144129|NCT02520284|64277504|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
23144130|NCT02520284|64277505|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
23144131|NCT02520284|64277503|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
23144132|NCT02520284|64277504|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
23144133|NCT02520284|64277505|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
23144134|NCT02520284|64277503|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
23144135|NCT02520284|64277504|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
23144136|NCT02520284|64277505|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
23320910|NCT00770328|64919270|FG000|Overall Study|Adverse Event|11|||
23320911|NCT00770328|64919271|FG001|Overall Study|Adverse Event|2|||
23320912|NCT00770328|64919270|FG000|Overall Study|Lost to Follow-up|2|||
23320913|NCT00770328|64919271|FG001|Overall Study|Lost to Follow-up|2|||
23320914|NCT02301390|64919272|FG000|Overall Study|Withdrawal by Subject|3|||
23320915|NCT02301390|64919273|FG001|Overall Study|Withdrawal by Subject|5|||
23556175|NCT01137474|65762489|FG002|Overall Study|Lost to Follow-up|0|||
23556176|NCT01137474|65762490|FG003|Overall Study|Lost to Follow-up|2|||
23556177|NCT01137474|65762487|FG000|Overall Study|Lack of Efficacy|0|||
23556178|NCT01137474|65762488|FG001|Overall Study|Lack of Efficacy|0|||
23556179|NCT01137474|65762489|FG002|Overall Study|Lack of Efficacy|0|||
23556180|NCT01137474|65762490|FG003|Overall Study|Lack of Efficacy|2|||
23556181|NCT01137474|65762487|FG000|Overall Study|Other|3|||
23556182|NCT01137474|65762488|FG001|Overall Study|Other|1|||
23556183|NCT01137474|65762489|FG002|Overall Study|Other|0|||
23217894|NCT01335698|64538434|FG004|Treatment Stage 2|Switched to another formulation|0|||
23217895|NCT01449955|64538438|FG000|Overall Study|Withdrawal by Subject|1|||
23217896|NCT01449955|64538439|FG001|Overall Study|Withdrawal by Subject|2|||
23217897|NCT03862495|64538440|FG000|Overall Study|Lost to Follow-up|37|||
23144137|NCT01506453|64277506|FG000|Overall Study|Withdrawal prior to treatment|0|||
23144138|NCT01506453|64277507|FG001|Overall Study|Withdrawal prior to treatment|2|||
23144139|NCT00409773|64277508|FG000|Overall Study|Adverse Event|3|||
23144140|NCT00409773|64277509|FG001|Overall Study|Adverse Event|4|||
23144141|NCT00409773|64277510|FG002|Overall Study|Adverse Event|4|||
23144142|NCT00409773|64277511|FG003|Overall Study|Adverse Event|2|||
23556184|NCT01137474|65762490|FG003|Overall Study|Other|0|||
23623430|NCT02353871|66008416|FG001|Overall Study|Lost to Follow-up|0|||
23144143|NCT00409773|64277512|FG004|Overall Study|Adverse Event|6|||
23144144|NCT00409773|64277508|FG000|Overall Study|Lost to Follow-up|6|||
23144145|NCT00409773|64277509|FG001|Overall Study|Lost to Follow-up|1|||
23144146|NCT00409773|64277510|FG002|Overall Study|Lost to Follow-up|2|||
23144147|NCT00409773|64277511|FG003|Overall Study|Lost to Follow-up|3|||
23556185|NCT01137474|65762487|FG000|Overall Study|Pregnancy|0|||
23144148|NCT00409773|64277512|FG004|Overall Study|Lost to Follow-up|1|||
23144149|NCT00409773|64277508|FG000|Overall Study|Physician Decision|0|||
23144150|NCT00409773|64277509|FG001|Overall Study|Physician Decision|0|||
23144151|NCT00409773|64277510|FG002|Overall Study|Physician Decision|0|||
23144152|NCT00409773|64277511|FG003|Overall Study|Physician Decision|2|||
23144153|NCT00409773|64277512|FG004|Overall Study|Physician Decision|0|||
23217898|NCT03862495|64538441|FG001|Overall Study|Lost to Follow-up|35|||
23217899|NCT03943446|64538443|FG000|Overall Study|Lost to Follow-up|0|||
23217900|NCT03943446|64538444|FG001|Overall Study|Lost to Follow-up|0|||
23217901|NCT03943446|64538445|FG002|Overall Study|Lost to Follow-up|1|||
23217902|NCT03943446|64538443|FG000|Overall Study|Withdrawal by Subject|1|||
23217903|NCT03943446|64538444|FG001|Overall Study|Withdrawal by Subject|1|||
23217904|NCT03943446|64538445|FG002|Overall Study|Withdrawal by Subject|2|||
23217905|NCT03943446|64538443|FG000|Overall Study|Study Terminated by Sponsor|1|||
23217906|NCT03943446|64538444|FG001|Overall Study|Study Terminated by Sponsor|2|||
23217907|NCT03943446|64538445|FG002|Overall Study|Study Terminated by Sponsor|1|||
23217908|NCT03943446|64538443|FG000|Overall Study|Reason not Specified|5|||
23217909|NCT03943446|64538444|FG001|Overall Study|Reason not Specified|1|||
23217910|NCT03943446|64538445|FG002|Overall Study|Reason not Specified|3|||
23556186|NCT01137474|65762488|FG001|Overall Study|Pregnancy|1|||
23556187|NCT01137474|65762489|FG002|Overall Study|Pregnancy|0|||
23556188|NCT01137474|65762490|FG003|Overall Study|Pregnancy|0|||
23556189|NCT01137474|65762487|FG000|Overall Study|Administrative reason by sponsor|0|||
23556190|NCT01137474|65762488|FG001|Overall Study|Administrative reason by sponsor|1|||
23144154|NCT00409773|64277508|FG000|Overall Study|Protocol Violation|0|||
23144155|NCT00409773|64277509|FG001|Overall Study|Protocol Violation|2|||
23556191|NCT01137474|65762489|FG002|Overall Study|Administrative reason by sponsor|0|||
23556192|NCT01137474|65762490|FG003|Overall Study|Administrative reason by sponsor|0|||
23556193|NCT02390531|65762491|FG000|Overall Study|Death|0|||
23556194|NCT02390531|65762492|FG001|Overall Study|Death|2|||
23556195|NCT02390531|65762493|FG002|Overall Study|Death|0|||
23556196|NCT02390531|65762494|FG003|Overall Study|Death|1|||
23556197|NCT02390531|65762495|FG004|Overall Study|Death|0|||
23556198|NCT02390531|65762496|FG005|Overall Study|Death|0|||
23556199|NCT02390531|65762497|FG006|Overall Study|Death|0|||
23556200|NCT02390531|65762498|FG007|Overall Study|Death|1|||
23556201|NCT02390531|65762491|FG000|Overall Study|Protocol Violation|0|||
23556202|NCT02390531|65762492|FG001|Overall Study|Protocol Violation|0|||
23556203|NCT02390531|65762493|FG002|Overall Study|Protocol Violation|0|||
23623431|NCT01231464|66008423|FG000|Overall Study|Adverse Event|0|||
23623432|NCT01231464|66008424|FG001|Overall Study|Adverse Event|1|||
23623433|NCT01231464|66008423|FG000|Overall Study|Protocol Violation|1|||
23623434|NCT01231464|66008424|FG001|Overall Study|Protocol Violation|2|||
23623435|NCT01231464|66008423|FG000|Overall Study|Lost to Follow-up|1|||
23144156|NCT00409773|64277510|FG002|Overall Study|Protocol Violation|3|||
23144157|NCT00409773|64277511|FG003|Overall Study|Protocol Violation|3|||
23144158|NCT00409773|64277512|FG004|Overall Study|Protocol Violation|1|||
23144159|NCT00409773|64277508|FG000|Overall Study|Withdrawal by Subject|0|||
23217911|NCT02944513|64538447|FG000|Overall Study|Withdrawal by Subject|4|||
23556204|NCT02390531|65762494|FG003|Overall Study|Protocol Violation|0|||
23556205|NCT02390531|65762495|FG004|Overall Study|Protocol Violation|1|||
23217912|NCT02944513|64538448|FG001|Overall Study|Withdrawal by Subject|1|||
23217913|NCT01981109|64538449|FG000|Overall Study|Death|36|||
23217914|NCT01981109|64538449|FG000|Overall Study|Withdrawal by Subject|40|||
23556206|NCT02390531|65762496|FG005|Overall Study|Protocol Violation|0|||
23556207|NCT02390531|65762497|FG006|Overall Study|Protocol Violation|2|||
23623436|NCT01231464|66008424|FG001|Overall Study|Lost to Follow-up|2|||
23623437|NCT01231464|66008423|FG000|Overall Study|Withdrawal by Subject|3|||
23144160|NCT00409773|64277509|FG001|Overall Study|Withdrawal by Subject|0|||
23144161|NCT00409773|64277510|FG002|Overall Study|Withdrawal by Subject|0|||
23144162|NCT00409773|64277511|FG003|Overall Study|Withdrawal by Subject|2|||
23623438|NCT01231464|66008424|FG001|Overall Study|Withdrawal by Subject|2|||
23144163|NCT00409773|64277512|FG004|Overall Study|Withdrawal by Subject|1|||
23144164|NCT00409773|64277508|FG000|Overall Study|Lack of Eligibility|0|||
23144165|NCT00409773|64277509|FG001|Overall Study|Lack of Eligibility|0|||
23144166|NCT00409773|64277510|FG002|Overall Study|Lack of Eligibility|0|||
23144167|NCT00409773|64277511|FG003|Overall Study|Lack of Eligibility|0|||
23144168|NCT00409773|64277512|FG004|Overall Study|Lack of Eligibility|1|||
23144169|NCT00731120|64277514|FG000|Overall Study|Adverse Event|7|||
23144170|NCT00731120|64277515|FG001|Overall Study|Adverse Event|6|||
23144171|NCT00731120|64277516|FG002|Overall Study|Adverse Event|8|||
23144172|NCT00731120|64277514|FG000|Overall Study|Lack of Efficacy|4|||
23144173|NCT00731120|64277515|FG001|Overall Study|Lack of Efficacy|5|||
23144174|NCT00731120|64277516|FG002|Overall Study|Lack of Efficacy|4|||
23144175|NCT00731120|64277514|FG000|Overall Study|Noncompliance with Study Drug|3|||
23144176|NCT00731120|64277515|FG001|Overall Study|Noncompliance with Study Drug|3|||
23144177|NCT00731120|64277516|FG002|Overall Study|Noncompliance with Study Drug|1|||
23144178|NCT00731120|64277514|FG000|Overall Study|Protocol Deviations|1|||
23144179|NCT00731120|64277515|FG001|Overall Study|Protocol Deviations|6|||
23144180|NCT00731120|64277516|FG002|Overall Study|Protocol Deviations|1|||
23144181|NCT00731120|64277514|FG000|Overall Study|Withdrawal of Consent|13|||
23144182|NCT00731120|64277515|FG001|Overall Study|Withdrawal of Consent|8|||
23144183|NCT00731120|64277516|FG002|Overall Study|Withdrawal of Consent|4|||
23144184|NCT00731120|64277514|FG000|Overall Study|Lost to Follow-up|10|||
23144185|NCT00731120|64277515|FG001|Overall Study|Lost to Follow-up|15|||
23144186|NCT00731120|64277516|FG002|Overall Study|Lost to Follow-up|17|||
23144187|NCT00731120|64277514|FG000|Overall Study|Other|4|||
23144188|NCT00731120|64277515|FG001|Overall Study|Other|0|||
23433726|NCT00772109|65330554|FG002|Overall Study|Serious adverse event|1|||
23433727|NCT00772109|65330555|FG003|Overall Study|Serious adverse event|0|||
23433728|NCT00772109|65330552|FG000|Overall Study|Protocol Violation|5|||
23433729|NCT00772109|65330553|FG001|Overall Study|Protocol Violation|8|||
23433730|NCT00772109|65330554|FG002|Overall Study|Protocol Violation|7|||
23433731|NCT00772109|65330555|FG003|Overall Study|Protocol Violation|6|||
23433732|NCT00772109|65330552|FG000|Overall Study|Lost to Follow-up|7|||
23433733|NCT00772109|65330553|FG001|Overall Study|Lost to Follow-up|3|||
23433734|NCT00772109|65330554|FG002|Overall Study|Lost to Follow-up|5|||
23433735|NCT00772109|65330555|FG003|Overall Study|Lost to Follow-up|9|||
23433736|NCT00772109|65330552|FG000|Overall Study|Withdrawal by Subject|8|||
23433737|NCT00772109|65330553|FG001|Overall Study|Withdrawal by Subject|8|||
23433738|NCT00772109|65330554|FG002|Overall Study|Withdrawal by Subject|6|||
23433739|NCT00772109|65330555|FG003|Overall Study|Withdrawal by Subject|16|||
23433740|NCT01075984|65330556|FG000|Treatment Phase|Adverse Event|0|||
23433741|NCT01075984|65330557|FG001|Treatment Phase|Adverse Event|1|||
23433742|NCT01075984|65330558|FG002|Treatment Phase|Adverse Event|3|||
23433743|NCT01075984|65330559|FG003|Treatment Phase|Adverse Event|7|||
23433744|NCT01075984|65330560|FG004|Treatment Phase|Adverse Event|35|||
23433745|NCT01075984|65330556|FG000|Treatment Phase|Protocol Violation|0|||
23433746|NCT01075984|65330557|FG001|Treatment Phase|Protocol Violation|0|||
23433747|NCT01075984|65330558|FG002|Treatment Phase|Protocol Violation|1|||
23433748|NCT01075984|65330559|FG003|Treatment Phase|Protocol Violation|0|||
23433749|NCT01075984|65330560|FG004|Treatment Phase|Protocol Violation|3|||
23433750|NCT01075984|65330556|FG000|Treatment Phase|Withdrawal by Subject|0|||
23556208|NCT02390531|65762498|FG007|Overall Study|Protocol Violation|0|||
23556209|NCT00542880|65762499|FG000|Period 1|Eligibility criteria not fulfilled|2|||
23556210|NCT00542880|65762500|FG001|Period 1|Eligibility criteria not fulfilled|6|||
23556211|NCT00542880|65762499|FG000|Period 1|Adverse Event|2|||
23556212|NCT00542880|65762500|FG001|Period 1|Adverse Event|2|||
23556213|NCT00542880|65762499|FG000|Period 1|Development of study-specific criteria|1|||
23144189|NCT00731120|64277516|FG002|Overall Study|Other|1|||
23433751|NCT01075984|65330557|FG001|Treatment Phase|Withdrawal by Subject|0|||
23433752|NCT01075984|65330558|FG002|Treatment Phase|Withdrawal by Subject|2|||
23433753|NCT01075984|65330559|FG003|Treatment Phase|Withdrawal by Subject|0|||
23433754|NCT01075984|65330560|FG004|Treatment Phase|Withdrawal by Subject|15|||
23433755|NCT01075984|65330556|FG000|Treatment Phase|Treatment Failure|0|||
23556214|NCT00542880|65762500|FG001|Period 1|Development of study-specific criteria|2|||
23144190|NCT02699983|64277517|FG000|Overall Study|Withdrawal by Subject|1|||
23144191|NCT02699983|64277518|FG001|Overall Study|Withdrawal by Subject|0|||
23144192|NCT00899548|64277519|FG000|Overall Study|Physician Decision|3|||
23144193|NCT03291587|64277520|FG000|Overall Study|Lost to Follow-up|62|||
23144194|NCT03291587|64277521|FG001|Overall Study|Lost to Follow-up|43|||
23144195|NCT03291587|64277520|FG000|Overall Study|Refused to Answer|5|||
23144196|NCT03291587|64277521|FG001|Overall Study|Refused to Answer|2|||
23144197|NCT03291587|64277520|FG000|Overall Study|Death|2|||
23144198|NCT03291587|64277521|FG001|Overall Study|Death|4|||
23433756|NCT01075984|65330557|FG001|Treatment Phase|Treatment Failure|0|||
23433757|NCT01075984|65330558|FG002|Treatment Phase|Treatment Failure|1|||
23433758|NCT01075984|65330559|FG003|Treatment Phase|Treatment Failure|0|||
23433759|NCT01075984|65330560|FG004|Treatment Phase|Treatment Failure|5|||
23144199|NCT03291587|64277520|FG000|Overall Study|Not interested in participating|8|||
23433760|NCT01075984|65330556|FG000|Treatment Phase|Progression of disease|0|||
23144200|NCT03291587|64277521|FG001|Overall Study|Not interested in participating|6|||
23144201|NCT03291587|64277520|FG000|Overall Study|Too busy to participate|4|||
23144202|NCT03291587|64277521|FG001|Overall Study|Too busy to participate|2|||
23144203|NCT04025580|64277522|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
23144204|NCT04025580|64277523|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
23144205|NCT04025580|64277524|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
23144206|NCT01236339|64277525|FG000|Overall Study|Termination of study by sponsor|11|||
23144207|NCT01236339|64277526|FG001|Overall Study|Termination of study by sponsor|13|||
23144208|NCT01222507|64277527|FG000|Overall Study|Physician Decision|1|||
23144209|NCT01222507|64277527|FG000|Overall Study|Withdrawal by Subject|1|||
23144210|NCT02325557|64277530|FG000|Overall Study|Progressive disease|1|||
23144211|NCT02325557|64277531|FG001|Overall Study|Progressive disease|0|||
23144212|NCT02325557|64277532|FG002|Overall Study|Progressive disease|0|||
23144213|NCT02325557|64277533|FG003|Overall Study|Progressive disease|0|||
23144214|NCT02325557|64277530|FG000|Overall Study|Withdrawal by Subject|4|||
23144215|NCT02325557|64277531|FG001|Overall Study|Withdrawal by Subject|0|||
23144216|NCT02325557|64277532|FG002|Overall Study|Withdrawal by Subject|0|||
23144217|NCT02325557|64277533|FG003|Overall Study|Withdrawal by Subject|15|||
23144218|NCT02325557|64277530|FG000|Overall Study|Death|5|||
23144219|NCT02325557|64277531|FG001|Overall Study|Death|1|||
23144220|NCT02325557|64277532|FG002|Overall Study|Death|1|||
23144221|NCT02325557|64277533|FG003|Overall Study|Death|16|||
23144222|NCT02325557|64277530|FG000|Overall Study|Lost to Follow-up|0|||
23144223|NCT02325557|64277531|FG001|Overall Study|Lost to Follow-up|0|||
23144224|NCT02325557|64277532|FG002|Overall Study|Lost to Follow-up|1|||
23144225|NCT02325557|64277533|FG003|Overall Study|Lost to Follow-up|1|||
23144226|NCT02325557|64277530|FG000|Overall Study|Other|0|||
23144227|NCT02325557|64277531|FG001|Overall Study|Other|0|||
23144228|NCT02325557|64277532|FG002|Overall Study|Other|0|||
23144229|NCT02325557|64277533|FG003|Overall Study|Other|5|||
23144230|NCT00723021|64277536|FG000|Intervention Period 4|Adverse Event|0|||
23144231|NCT00723021|64277537|FG001|Intervention Period 4|Adverse Event|0|||
23144232|NCT00723021|64277538|FG002|Intervention Period 4|Adverse Event|0|||
23144233|NCT00723021|64277539|FG003|Intervention Period 4|Adverse Event|0|||
23144234|NCT00723021|64277540|FG004|Intervention Period 4|Adverse Event|1|||
23144235|NCT01435616|64277541|FG000|Overall Study|Adverse Event|39|||
23144236|NCT01435616|64277542|FG001|Overall Study|Adverse Event|21|||
23144237|NCT01435616|64277541|FG000|Overall Study|Death|7|||
23144238|NCT01435616|64277542|FG001|Overall Study|Death|2|||
23144239|NCT01435616|64277541|FG000|Overall Study|Lost to Follow-up|22|||
23144240|NCT01435616|64277542|FG001|Overall Study|Lost to Follow-up|13|||
23144241|NCT01435616|64277541|FG000|Overall Study|Protocol Violation|16|||
23144242|NCT01435616|64277542|FG001|Overall Study|Protocol Violation|13|||
23217915|NCT01981109|64538449|FG000|Overall Study|Lost to Follow-up|9|||
23217916|NCT01981109|64538449|FG000|Overall Study|No Discontinuation Documentation|37|||
23217917|NCT01981109|64538449|FG000|Overall Study|Study Termination|100|||
23217918|NCT01981109|64538449|FG000|Overall Study|No data available|2|||
23217919|NCT01281189|64538450|FG000|Overall Study|Adverse Event|7|||
23217920|NCT01281189|64538451|FG001|Overall Study|Adverse Event|9|||
23217921|NCT01281189|64538450|FG000|Overall Study|Lost to Follow-up|6|||
23217922|NCT01281189|64538451|FG001|Overall Study|Lost to Follow-up|4|||
23217923|NCT01281189|64538450|FG000|Overall Study|Withdrawal by Subject|21|||
23217924|NCT01281189|64538451|FG001|Overall Study|Withdrawal by Subject|24|||
23217925|NCT01281189|64538450|FG000|Overall Study|Physician Decision|2|||
23320916|NCT02301390|64919272|FG000|Overall Study|Protocol Violation|1|||
23320917|NCT02301390|64919273|FG001|Overall Study|Protocol Violation|0|||
23320918|NCT02301390|64919272|FG000|Overall Study|Physician Decision|1|||
23320919|NCT02301390|64919273|FG001|Overall Study|Physician Decision|0|||
23320920|NCT02301390|64919272|FG000|Overall Study|Lost to Follow-up|0|||
23320921|NCT02301390|64919273|FG001|Overall Study|Lost to Follow-up|1|||
23320922|NCT02301390|64919272|FG000|Overall Study|Death|2|||
23320923|NCT02301390|64919273|FG001|Overall Study|Death|2|||
23320924|NCT02301390|64919272|FG000|Overall Study|Procedure not completed|0|||
23144243|NCT01435616|64277541|FG000|Overall Study|Withdrawal by Subject|66|||
23144244|NCT01435616|64277542|FG001|Overall Study|Withdrawal by Subject|24|||
23144245|NCT01435616|64277541|FG000|Overall Study|Physician Decision|20|||
23144246|NCT01435616|64277542|FG001|Overall Study|Physician Decision|7|||
23144247|NCT01435616|64277541|FG000|Overall Study|Sponsor Decision|1|||
23217926|NCT01281189|64538451|FG001|Overall Study|Physician Decision|3|||
23217927|NCT01281189|64538450|FG000|Overall Study|Death|103|||
23217928|NCT01281189|64538451|FG001|Overall Study|Death|91|||
23217929|NCT01281189|64538450|FG000|Overall Study|Other|8|||
23217930|NCT01281189|64538451|FG001|Overall Study|Other|12|||
23320925|NCT02301390|64919273|FG001|Overall Study|Procedure not completed|4|||
23144248|NCT01435616|64277542|FG001|Overall Study|Sponsor Decision|0|||
23217931|NCT01143714|64538452|FG000|Overall Study|Adverse Event|4|||
23217932|NCT01143714|64538453|FG001|Overall Study|Adverse Event|2|||
23217933|NCT01143714|64538452|FG000|Overall Study|Withdrawal by Subject|1|||
23320926|NCT02301390|64919272|FG000|Overall Study|Missed multiple visits|1|||
23556215|NCT00542880|65762499|FG000|Period 1|Withdrawal by Subject|1|||
23144249|NCT01912456|64277543|FG000|Period 1|Physician Decision|0|||
23144250|NCT01912456|64277544|FG001|Period 1|Physician Decision|0|||
23144251|NCT01912456|64277545|FG002|Period 1|Physician Decision|1|||
23144252|NCT01912456|64277546|FG003|Period 1|Physician Decision|0|||
23144253|NCT01912456|64277543|FG000|Period 1|non-compliance|1|||
23144254|NCT01912456|64277544|FG001|Period 1|non-compliance|0|||
23144255|NCT01912456|64277545|FG002|Period 1|non-compliance|0|||
23144256|NCT01912456|64277546|FG003|Period 1|non-compliance|1|||
23144257|NCT01912456|64277543|FG000|Period 1|Adverse Event|1|||
23144258|NCT01912456|64277544|FG001|Period 1|Adverse Event|0|||
23144259|NCT01912456|64277545|FG002|Period 1|Adverse Event|0|||
23144260|NCT01912456|64277546|FG003|Period 1|Adverse Event|1|||
23144261|NCT01912456|64277543|FG000|Period 1|Withdrawal by Subject|0|||
23144262|NCT01912456|64277544|FG001|Period 1|Withdrawal by Subject|1|||
23144263|NCT01912456|64277545|FG002|Period 1|Withdrawal by Subject|1|||
23144264|NCT01912456|64277546|FG003|Period 1|Withdrawal by Subject|1|||
23320927|NCT02301390|64919273|FG001|Overall Study|Missed multiple visits|1|||
23433761|NCT01075984|65330557|FG001|Treatment Phase|Progression of disease|0|||
23433762|NCT01075984|65330558|FG002|Treatment Phase|Progression of disease|0|||
23433763|NCT01075984|65330559|FG003|Treatment Phase|Progression of disease|0|||
23433764|NCT01075984|65330560|FG004|Treatment Phase|Progression of disease|2|||
23433765|NCT01075984|65330556|FG000|Follow-up Phase|Protocol Violation|0|||
23433766|NCT01075984|65330557|FG001|Follow-up Phase|Protocol Violation|0|||
23144265|NCT01912456|64277543|FG000|Period 2|Lack of Efficacy|0|||
23144266|NCT01912456|64277544|FG001|Period 2|Lack of Efficacy|2|||
23144267|NCT01912456|64277545|FG002|Period 2|Lack of Efficacy|0|||
23144268|NCT01912456|64277546|FG003|Period 2|Lack of Efficacy|0|||
23320928|NCT02301390|64919272|FG000|Overall Study|study terminated|2|||
23320929|NCT02301390|64919273|FG001|Overall Study|study terminated|0|||
23320930|NCT00280735|64919274|FG000|Overall Study|Adverse Event|5|||
23320931|NCT00280735|64919274|FG000|Overall Study|Lack of Efficacy|3|||
23320932|NCT00280735|64919274|FG000|Overall Study|Withdrawal by Subject|8|||
23320933|NCT00280735|64919274|FG000|Overall Study|Intercurrent Illness|2|||
23320934|NCT04841577|64919275|FG000|Overall Study|Adverse Event|5|||
23217934|NCT01143714|64538453|FG001|Overall Study|Withdrawal by Subject|0|||
23320935|NCT04841577|64919276|FG001|Overall Study|Adverse Event|10|||
23144269|NCT01912456|64277543|FG000|Period 2|Adverse Event|0|||
23144270|NCT01912456|64277544|FG001|Period 2|Adverse Event|0|||
23217935|NCT01143714|64538452|FG000|Overall Study|Subject non-compliance|0|||
23217936|NCT01143714|64538453|FG001|Overall Study|Subject non-compliance|1|||
23217937|NCT01143714|64538452|FG000|Overall Study|wound closed = deemed healed|1|||
23217938|NCT01143714|64538453|FG001|Overall Study|wound closed = deemed healed|0|||
23217939|NCT01143714|64538452|FG000|Overall Study|wound size increased|1|||
23320936|NCT04841577|64919275|FG000|Overall Study|Lost to Follow-up|8|||
23320937|NCT04841577|64919276|FG001|Overall Study|Lost to Follow-up|7|||
23217940|NCT01143714|64538453|FG001|Overall Study|wound size increased|0|||
23217941|NCT03947255|64538454|FG000|Overall Study|Study Closure by Sponsor|2|||
23217942|NCT03947255|64538455|FG001|Overall Study|Study Closure by Sponsor|2|||
23217943|NCT03947255|64538454|FG000|Overall Study|Withdrawal by Subject|2|||
23217944|NCT03947255|64538455|FG001|Overall Study|Withdrawal by Subject|2|||
23217945|NCT03947255|64538454|FG000|Overall Study|Lost to Follow-up|2|||
23217946|NCT03947255|64538455|FG001|Overall Study|Lost to Follow-up|0|||
23217947|NCT03947255|64538454|FG000|Overall Study|Death|0|||
23217948|NCT03947255|64538455|FG001|Overall Study|Death|2|||
23217949|NCT04362813|64538457|FG000|Overall Study|Death|12|||
23217950|NCT04362813|64538458|FG001|Overall Study|Death|16|||
23217951|NCT04362813|64538457|FG000|Overall Study|Withdrawal by Subject|3|||
23217952|NCT04362813|64538458|FG001|Overall Study|Withdrawal by Subject|1|||
23320938|NCT04841577|64919275|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
23320939|NCT04841577|64919276|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
23320940|NCT04841577|64919275|FG000|Overall Study|Other|0|||
23433767|NCT01075984|65330558|FG002|Follow-up Phase|Protocol Violation|1|||
23433768|NCT01075984|65330559|FG003|Follow-up Phase|Protocol Violation|0|||
23144271|NCT01912456|64277545|FG002|Period 2|Adverse Event|0|||
23144272|NCT01912456|64277546|FG003|Period 2|Adverse Event|1|||
23144273|NCT02164383|64277547|FG000|Overall Study|Lost to Follow-up|1|||
23144274|NCT02164383|64277548|FG001|Overall Study|Lost to Follow-up|0|||
23144275|NCT01439360|64277551|FG000|Overall Study|Adverse Event|4|||
23217953|NCT04362813|64538457|FG000|Overall Study|Protocol Violation|0|||
23217954|NCT04362813|64538458|FG001|Overall Study|Protocol Violation|3|||
23217955|NCT04362813|64538457|FG000|Overall Study|Lost to Follow-up|1|||
23217956|NCT04362813|64538458|FG001|Overall Study|Lost to Follow-up|1|||
23217957|NCT04362813|64538457|FG000|Overall Study|Enrolled but did not receive treatment|2|||
23320941|NCT04841577|64919276|FG001|Overall Study|Other|1|||
23320942|NCT02508935|64919277|FG000|Overall Study|Withdrawal by Subject|1|||
23433769|NCT01075984|65330560|FG004|Follow-up Phase|Protocol Violation|3|||
23433770|NCT01075984|65330556|FG000|Follow-up Phase|Adverse Event|0|||
23144276|NCT01439360|64277552|FG001|Overall Study|Adverse Event|16|||
23144277|NCT01439360|64277551|FG000|Overall Study|Lost to Follow-up|43|||
23144278|NCT01439360|64277552|FG001|Overall Study|Lost to Follow-up|58|||
23320943|NCT02508935|64919277|FG000|Overall Study|Withdrawal by Caregiver|8|||
23320944|NCT02508935|64919277|FG000|Overall Study|Pain Score <4|1|||
23320945|NCT02508935|64919277|FG000|Overall Study|Emesis|3|||
23320946|NCT02508935|64919277|FG000|Overall Study|Adverse Event|3|||
23320947|NCT02508935|64919277|FG000|Overall Study|Protocol Violation|1|||
23320948|NCT02508935|64919277|FG000|Overall Study|Physician Decision|1|||
23320949|NCT02508935|64919277|FG000|Overall Study|Trial terminated by sponsor|5|||
23320950|NCT00595309|64919278|FG000|Overall Study|Lost to Follow-up|1|||
23320951|NCT00595309|64919278|FG000|Overall Study|planned vaccination against yellow fever|1|||
23320952|NCT00595309|64919278|FG000|Overall Study|acute infection after V0|1|||
23320953|NCT00595309|64919278|FG000|Overall Study|personal reason|1|||
23320954|NCT01042093|64919279|FG000|Overall Study|Protocol Violation|2|||
23320955|NCT01042093|64919280|FG001|Overall Study|Protocol Violation|2|||
23320956|NCT01042093|64919281|FG002|Overall Study|Protocol Violation|2|||
23320957|NCT01042093|64919282|FG003|Overall Study|Protocol Violation|3|||
23320958|NCT01042093|64919279|FG000|Overall Study|Withdrawal by Subject|0|||
23320959|NCT01042093|64919280|FG001|Overall Study|Withdrawal by Subject|0|||
23320960|NCT01042093|64919281|FG002|Overall Study|Withdrawal by Subject|0|||
23320961|NCT01042093|64919282|FG003|Overall Study|Withdrawal by Subject|1|||
23320962|NCT02413229|64919288|FG000|Overall Study|Adverse Event|0|||
23320963|NCT02413229|64919289|FG001|Overall Study|Adverse Event|0|||
23320964|NCT02413229|64919290|FG002|Overall Study|Adverse Event|0|||
23320965|NCT02413229|64919291|FG003|Overall Study|Adverse Event|1|||
23320966|NCT02413229|64919292|FG004|Overall Study|Adverse Event|0|||
23320967|NCT02413229|64919293|FG005|Overall Study|Adverse Event|0|||
23320968|NCT02413229|64919294|FG006|Overall Study|Adverse Event|0|||
23320969|NCT02413229|64919295|FG007|Overall Study|Adverse Event|1|||
23320970|NCT02413229|64919288|FG000|Overall Study|Lost to Follow-up|0|||
23320971|NCT02413229|64919289|FG001|Overall Study|Lost to Follow-up|0|||
23320972|NCT02413229|64919290|FG002|Overall Study|Lost to Follow-up|1|||
23320973|NCT02413229|64919291|FG003|Overall Study|Lost to Follow-up|0|||
23320974|NCT02413229|64919292|FG004|Overall Study|Lost to Follow-up|2|||
23320975|NCT02413229|64919293|FG005|Overall Study|Lost to Follow-up|0|||
23320976|NCT02413229|64919294|FG006|Overall Study|Lost to Follow-up|0|||
23320977|NCT02413229|64919295|FG007|Overall Study|Lost to Follow-up|0|||
23320978|NCT02413229|64919288|FG000|Overall Study|Withdrawal by Subject|1|||
23320979|NCT02413229|64919289|FG001|Overall Study|Withdrawal by Subject|1|||
23320980|NCT02413229|64919290|FG002|Overall Study|Withdrawal by Subject|0|||
23320981|NCT02413229|64919291|FG003|Overall Study|Withdrawal by Subject|0|||
23320982|NCT02413229|64919292|FG004|Overall Study|Withdrawal by Subject|1|||
23320983|NCT02413229|64919293|FG005|Overall Study|Withdrawal by Subject|0|||
23320984|NCT02413229|64919294|FG006|Overall Study|Withdrawal by Subject|0|||
23320985|NCT02413229|64919295|FG007|Overall Study|Withdrawal by Subject|2|||
23320986|NCT02413229|64919288|FG000|Overall Study|Progressive Disease|0|||
23320987|NCT02413229|64919289|FG001|Overall Study|Progressive Disease|0|||
23320988|NCT02413229|64919290|FG002|Overall Study|Progressive Disease|0|||
23320989|NCT02413229|64919291|FG003|Overall Study|Progressive Disease|0|||
23320990|NCT02413229|64919292|FG004|Overall Study|Progressive Disease|0|||
23320991|NCT02413229|64919293|FG005|Overall Study|Progressive Disease|0|||
23320992|NCT02413229|64919294|FG006|Overall Study|Progressive Disease|0|||
23320993|NCT02413229|64919295|FG007|Overall Study|Progressive Disease|1|||
23320994|NCT02201784|64919300|FG000|Overall Study|Failure to achieve adequate block|2|||
23320995|NCT02201784|64919301|FG001|Overall Study|Failure to achieve adequate block|0|||
23320996|NCT04342819|64919302|FG000|Overall Study|Declined|4|||
23320997|NCT04342819|64919302|FG000|Overall Study|Not meeeting selection criteria|1|||
23144279|NCT01439360|64277551|FG000|Overall Study|Others|10|||
23144280|NCT01439360|64277552|FG001|Overall Study|Others|5|||
23144281|NCT01439360|64277551|FG000|Overall Study|Protocol Violation|1|||
23144282|NCT01439360|64277552|FG001|Overall Study|Protocol Violation|0|||
23144283|NCT01439360|64277551|FG000|Overall Study|Withdrawal by Subject|140|||
23320998|NCT03122886|64919303|FG000|Overall Study|Withdrawal by Subject|1|||
23320999|NCT03122886|64919304|FG001|Overall Study|Withdrawal by Subject|2|||
23321000|NCT03594071|64919305|FG000|Overall Study|Re-operation|3|||
23321001|NCT03594071|64919305|FG000|Overall Study|Missed visit|2|||
23321002|NCT00451178|64919306|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
23321003|NCT00451178|64919307|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
23321004|NCT00451178|64919306|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
23321005|NCT00451178|64919307|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
23321006|NCT00451178|64919306|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
23321007|NCT00451178|64919307|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
23321008|NCT00451178|64919306|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
23321009|NCT00451178|64919307|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
23321010|NCT00451178|64919306|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
23321011|NCT00451178|64919307|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
23321012|NCT00451178|64919306|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
23433771|NCT01075984|65330557|FG001|Follow-up Phase|Adverse Event|0|||
23144284|NCT01439360|64277552|FG001|Overall Study|Withdrawal by Subject|129|||
23321013|NCT00451178|64919307|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
23321014|NCT00451178|64919306|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
23321015|NCT00451178|64919307|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
23321016|NCT00451178|64919306|FG000|Prior to Maintenance Therapy|PD|2|||
23321017|NCT00451178|64919307|FG001|Prior to Maintenance Therapy|PD|0|||
23321018|NCT00451178|64919306|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
23144285|NCT02893930|64277553|FG000|Overall Study|Adverse Event|3|||
23144286|NCT02893930|64277553|FG000|Overall Study|Death|1|||
23321019|NCT00451178|64919307|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
23321020|NCT00451178|64919306|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
23321021|NCT00451178|64919307|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
23321022|NCT00451178|64919306|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
23321023|NCT00451178|64919307|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
23321024|NCT00451178|64919306|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
23321025|NCT00451178|64919307|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
23321026|NCT00451178|64919306|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
23321027|NCT00451178|64919307|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
23321028|NCT00451178|64919306|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
23321029|NCT00451178|64919307|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
23321030|NCT00451178|64919306|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
23321031|NCT00451178|64919307|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
23321032|NCT02308124|64919318|FG000|Overall Study|Lost to Follow-up|6|||
23321033|NCT02308124|64919319|FG001|Overall Study|Lost to Follow-up|6|||
23321034|NCT02308124|64919320|FG002|Overall Study|Lost to Follow-up|6|||
23321035|NCT02308124|64919318|FG000|Overall Study|Adverse Event|0|||
23321036|NCT02308124|64919319|FG001|Overall Study|Adverse Event|2|||
23321037|NCT02308124|64919320|FG002|Overall Study|Adverse Event|2|||
23321038|NCT03380429|64919322|FG000|Overall Study|Physician Decision|0|||
23321039|NCT03380429|64919323|FG001|Overall Study|Physician Decision|1|||
23321040|NCT03380429|64919324|FG002|Overall Study|Physician Decision|0|||
23321041|NCT03380429|64919325|FG003|Overall Study|Physician Decision|1|||
23321042|NCT03380429|64919326|FG004|Overall Study|Physician Decision|1|||
23321043|NCT03380429|64919322|FG000|Overall Study|Withdrawal by Subject|3|||
23321044|NCT03380429|64919323|FG001|Overall Study|Withdrawal by Subject|3|||
23321045|NCT03380429|64919324|FG002|Overall Study|Withdrawal by Subject|5|||
23321046|NCT03380429|64919325|FG003|Overall Study|Withdrawal by Subject|2|||
23321047|NCT03380429|64919326|FG004|Overall Study|Withdrawal by Subject|1|||
23321048|NCT03380429|64919322|FG000|Overall Study|Lost to Follow-up|0|||
23321049|NCT03380429|64919323|FG001|Overall Study|Lost to Follow-up|2|||
23321050|NCT03380429|64919324|FG002|Overall Study|Lost to Follow-up|4|||
23321051|NCT03380429|64919325|FG003|Overall Study|Lost to Follow-up|3|||
23321052|NCT03380429|64919326|FG004|Overall Study|Lost to Follow-up|1|||
23321053|NCT03380429|64919322|FG000|Overall Study|Protocol Violation|1|||
23321054|NCT03380429|64919323|FG001|Overall Study|Protocol Violation|0|||
23321055|NCT03380429|64919324|FG002|Overall Study|Protocol Violation|1|||
23321056|NCT03380429|64919325|FG003|Overall Study|Protocol Violation|0|||
23321057|NCT03380429|64919326|FG004|Overall Study|Protocol Violation|1|||
23321058|NCT03380429|64919322|FG000|Overall Study|Lack of Efficacy|0|||
23321059|NCT03380429|64919323|FG001|Overall Study|Lack of Efficacy|0|||
23321060|NCT03380429|64919324|FG002|Overall Study|Lack of Efficacy|0|||
23321061|NCT03380429|64919325|FG003|Overall Study|Lack of Efficacy|2|||
23321062|NCT03380429|64919326|FG004|Overall Study|Lack of Efficacy|1|||
23321063|NCT03380429|64919322|FG000|Overall Study|Adverse Event|1|||
23144287|NCT02893930|64277553|FG000|Overall Study|Disease progression|5|||
23321064|NCT03380429|64919323|FG001|Overall Study|Adverse Event|1|||
23321065|NCT03380429|64919324|FG002|Overall Study|Adverse Event|1|||
23321066|NCT03380429|64919325|FG003|Overall Study|Adverse Event|2|||
23321067|NCT03380429|64919326|FG004|Overall Study|Adverse Event|0|||
23321068|NCT00261443|64919328|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
23321069|NCT00261443|64919329|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
23321070|NCT00261443|64919330|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
23321071|NCT00261443|64919328|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
23321072|NCT00261443|64919329|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
23321073|NCT00261443|64919330|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
23321074|NCT00261443|64919328|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
23321075|NCT00261443|64919329|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
23321076|NCT00261443|64919330|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
23321077|NCT00261443|64919328|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
23321078|NCT00261443|64919329|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
23321079|NCT00261443|64919330|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
23321080|NCT00261443|64919328|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
23144288|NCT02893930|64277553|FG000|Overall Study|Withdrawal by Subject|2|||
23144289|NCT02893930|64277553|FG000|Overall Study|Physician Decision|1|||
23321081|NCT00261443|64919329|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
23321082|NCT00261443|64919330|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
23321083|NCT00261443|64919328|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
23433772|NCT01075984|65330558|FG002|Follow-up Phase|Adverse Event|0|||
23433773|NCT01075984|65330559|FG003|Follow-up Phase|Adverse Event|2|||
23433774|NCT01075984|65330560|FG004|Follow-up Phase|Adverse Event|27|||
23433775|NCT01075984|65330556|FG000|Follow-up Phase|Administrative|0|||
23433776|NCT01075984|65330557|FG001|Follow-up Phase|Administrative|0|||
23433777|NCT01075984|65330558|FG002|Follow-up Phase|Administrative|0|||
23433778|NCT01075984|65330559|FG003|Follow-up Phase|Administrative|0|||
23433779|NCT01075984|65330560|FG004|Follow-up Phase|Administrative|1|||
23433780|NCT01075984|65330556|FG000|Follow-up Phase|Withdrawal by Subject|0|||
23433781|NCT01075984|65330557|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23433782|NCT01075984|65330558|FG002|Follow-up Phase|Withdrawal by Subject|0|||
23433783|NCT01075984|65330559|FG003|Follow-up Phase|Withdrawal by Subject|0|||
23433784|NCT01075984|65330560|FG004|Follow-up Phase|Withdrawal by Subject|10|||
23433785|NCT01075984|65330556|FG000|Follow-up Phase|Progression of disease|0|||
23433786|NCT01075984|65330557|FG001|Follow-up Phase|Progression of disease|0|||
23433787|NCT01075984|65330558|FG002|Follow-up Phase|Progression of disease|0|||
23433788|NCT01075984|65330559|FG003|Follow-up Phase|Progression of disease|0|||
23433789|NCT01075984|65330560|FG004|Follow-up Phase|Progression of disease|2|||
23433790|NCT01075984|65330556|FG000|Follow-up Phase|Treatment failure|0|||
23433791|NCT01075984|65330557|FG001|Follow-up Phase|Treatment failure|0|||
23433792|NCT01075984|65330558|FG002|Follow-up Phase|Treatment failure|0|||
23433793|NCT01075984|65330559|FG003|Follow-up Phase|Treatment failure|0|||
23433794|NCT01075984|65330560|FG004|Follow-up Phase|Treatment failure|4|||
23433795|NCT04699461|65330561|FG000|Overall Study|Withdrawal by Subject|1|||
23556216|NCT00542880|65762500|FG001|Period 1|Withdrawal by Subject|1|||
23556217|NCT00542880|65762499|FG000|Period 1|Protocol Violation|0|||
23556218|NCT00542880|65762500|FG001|Period 1|Protocol Violation|1|||
23556219|NCT00542880|65762499|FG000|Period 2|Adverse Event|5|||
23556220|NCT00542880|65762500|FG001|Period 2|Adverse Event|7|||
23556221|NCT00542880|65762499|FG000|Period 2|Eligibility not fulfilled|0|||
23556222|NCT00542880|65762500|FG001|Period 2|Eligibility not fulfilled|1|||
23556223|NCT00542880|65762499|FG000|Period 2|Discontinuation criteria|2|||
23433796|NCT04699461|65330562|FG001|Overall Study|Withdrawal by Subject|0|||
23433797|NCT04699461|65330561|FG000|Overall Study|Study termination by sponsor|2|||
23433798|NCT04699461|65330562|FG001|Overall Study|Study termination by sponsor|1|||
23433799|NCT04699461|65330561|FG000|Overall Study|Death|1|||
23556224|NCT00542880|65762500|FG001|Period 2|Discontinuation criteria|0|||
23144290|NCT02893930|64277553|FG000|Overall Study|Ineligible|1|||
23144291|NCT01154010|64277554|FG000|Overall Study|Lost to Follow-up|0|||
23144292|NCT01154010|64277555|FG001|Overall Study|Lost to Follow-up|1|||
23144293|NCT01688830|64277556|FG000|Overall Study|Lost to Follow-up|0|||
23144294|NCT01688830|64277557|FG001|Overall Study|Lost to Follow-up|0|||
23144295|NCT01688830|64277558|FG002|Overall Study|Lost to Follow-up|0|||
23144296|NCT01688830|64277559|FG003|Overall Study|Lost to Follow-up|0|||
23144297|NCT01688830|64277560|FG004|Overall Study|Lost to Follow-up|0|||
23144298|NCT01688830|64277561|FG005|Overall Study|Lost to Follow-up|0|||
23144299|NCT01688830|64277562|FG006|Overall Study|Lost to Follow-up|0|||
23144300|NCT01688830|64277563|FG007|Overall Study|Lost to Follow-up|0|||
23144301|NCT01688830|64277564|FG008|Overall Study|Lost to Follow-up|0|||
23144302|NCT01688830|64277565|FG009|Overall Study|Lost to Follow-up|0|||
23144303|NCT01688830|64277566|FG010|Overall Study|Lost to Follow-up|1|||
23144304|NCT01688830|64277567|FG011|Overall Study|Lost to Follow-up|0|||
23144305|NCT01688830|64277568|FG012|Overall Study|Lost to Follow-up|0|||
23144306|NCT01688830|64277569|FG013|Overall Study|Lost to Follow-up|0|||
23144307|NCT01688830|64277570|FG014|Overall Study|Lost to Follow-up|0|||
23144308|NCT01688830|64277571|FG015|Overall Study|Lost to Follow-up|0|||
23144309|NCT01688830|64277572|FG016|Overall Study|Lost to Follow-up|0|||
23144310|NCT01688830|64277573|FG017|Overall Study|Lost to Follow-up|0|||
23144311|NCT01688830|64277574|FG018|Overall Study|Lost to Follow-up|0|||
23144312|NCT01688830|64277575|FG019|Overall Study|Lost to Follow-up|0|||
23217958|NCT04362813|64538458|FG001|Overall Study|Enrolled but did not receive treatment|4|||
23433800|NCT04699461|65330562|FG001|Overall Study|Death|0|||
23433801|NCT04699461|65330561|FG000|Overall Study|Radiographic progression|0|||
23433802|NCT04699461|65330562|FG001|Overall Study|Radiographic progression|1|||
23433803|NCT00428844|65330568|FG000|Completed Study Drug Treatment|Adverse Event|2|||
23556225|NCT00542880|65762499|FG000|Period 2|Severe non-compliance|0|||
23556226|NCT00542880|65762500|FG001|Period 2|Severe non-compliance|1|||
23144313|NCT01688830|64277576|FG020|Overall Study|Lost to Follow-up|0|||
23144314|NCT00370331|64277577|FG000|Overall Study|Adverse Event|4|||
23433804|NCT00428844|65330569|FG001|Completed Study Drug Treatment|Adverse Event|4|||
23144315|NCT00370331|64277578|FG001|Overall Study|Adverse Event|13|||
23144316|NCT00370331|64277577|FG000|Overall Study|Withdrawal by Subject|2|||
23433805|NCT00428844|65330570|FG002|Completed Study Drug Treatment|Adverse Event|4|||
23433806|NCT00428844|65330568|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
23433807|NCT00428844|65330569|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
23433808|NCT00428844|65330570|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
23433809|NCT00428844|65330568|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
23433810|NCT00428844|65330569|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
23433811|NCT00428844|65330570|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
23433812|NCT00428844|65330568|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
23433813|NCT00428844|65330569|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
23433814|NCT00428844|65330570|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
23433815|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
23433816|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
23623439|NCT00927901|66008426|FG000|Treatment Period 1|Subject withdrew consent|0|||
23623440|NCT00927901|66008427|FG001|Treatment Period 1|Subject withdrew consent|0|||
23623441|NCT00927901|66008428|FG002|Treatment Period 1|Subject withdrew consent|1|||
23433817|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
23433818|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
23433819|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
23433820|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
23433821|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
23433822|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
23433823|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
23433824|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
23433825|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
23433826|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
23433827|NCT00428844|65330568|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
23433828|NCT00428844|65330569|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
23433829|NCT00428844|65330570|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
23433830|NCT01455194|65330571|FG000|Overall Study|Screen Failure|20|||
23433831|NCT01455194|65330572|FG001|Overall Study|Screen Failure|0|||
23433832|NCT01455194|65330573|FG002|Overall Study|Screen Failure|0|||
23144317|NCT00370331|64277578|FG001|Overall Study|Withdrawal by Subject|4|||
23144318|NCT00370331|64277577|FG000|Overall Study|Lost to Follow-up|0|||
23144319|NCT00370331|64277578|FG001|Overall Study|Lost to Follow-up|3|||
23144320|NCT00370331|64277577|FG000|Overall Study|Lack of Efficacy|0|||
23144321|NCT00370331|64277578|FG001|Overall Study|Lack of Efficacy|1|||
23144322|NCT00370331|64277577|FG000|Overall Study|Non-compliance|0|||
23144323|NCT00370331|64277578|FG001|Overall Study|Non-compliance|1|||
23144324|NCT00370331|64277577|FG000|Overall Study|Protocol Violation|1|||
23144325|NCT00370331|64277578|FG001|Overall Study|Protocol Violation|1|||
23144326|NCT01745848|64277579|FG000|Overall Study|Adverse Event|6|||
23144327|NCT01853982|64277582|FG000|Overall Study|Withdrawal by Subject|1|||
23144328|NCT01853982|64277583|FG001|Overall Study|Withdrawal by Subject|0|||
23144329|NCT01853982|64277582|FG000|Overall Study|Death|1|||
23623442|NCT00927901|66008429|FG003|Treatment Period 1|Subject withdrew consent|0|||
23623443|NCT00927901|66008426|FG000|Treatment Period 4|Adverse Event|0|||
23623444|NCT00927901|66008427|FG001|Treatment Period 4|Adverse Event|0|||
23623445|NCT00927901|66008428|FG002|Treatment Period 4|Adverse Event|0|||
23623446|NCT00927901|66008429|FG003|Treatment Period 4|Adverse Event|1|||
23623447|NCT00927901|66008426|FG000|Treatment Period 4|Subject withdrew consent|0|||
23623448|NCT00927901|66008427|FG001|Treatment Period 4|Subject withdrew consent|0|||
23623449|NCT00927901|66008428|FG002|Treatment Period 4|Subject withdrew consent|1|||
23623450|NCT00927901|66008429|FG003|Treatment Period 4|Subject withdrew consent|0|||
23623451|NCT01841697|66008430|FG000|Overall Study|Death|0|||
23623452|NCT01841697|66008431|FG001|Overall Study|Death|1|||
23623453|NCT01841697|66008430|FG000|Overall Study|Lost to Follow-up|4|||
23144330|NCT01853982|64277583|FG001|Overall Study|Death|0|||
23144331|NCT01853982|64277582|FG000|Overall Study|Lost to Follow-up|0|||
23433833|NCT01455194|65330574|FG003|Overall Study|Screen Failure|0|||
23433834|NCT01455194|65330571|FG000|Overall Study|Randomisation Failure|90|||
23433835|NCT01455194|65330572|FG001|Overall Study|Randomisation Failure|0|||
23433836|NCT01455194|65330573|FG002|Overall Study|Randomisation Failure|0|||
23433837|NCT01455194|65330574|FG003|Overall Study|Randomisation Failure|0|||
23433838|NCT01455194|65330571|FG000|Overall Study|Deterioration in asthma|12|||
23433839|NCT01455194|65330572|FG001|Overall Study|Deterioration in asthma|6|||
23433840|NCT01455194|65330573|FG002|Overall Study|Deterioration in asthma|14|||
23433841|NCT01455194|65330574|FG003|Overall Study|Deterioration in asthma|9|||
23623454|NCT01841697|66008431|FG001|Overall Study|Lost to Follow-up|1|||
23623455|NCT01841697|66008430|FG000|Overall Study|Withdrawal by Subject|16|||
23433842|NCT01455194|65330571|FG000|Overall Study|Adverse Event|1|||
23433843|NCT01455194|65330572|FG001|Overall Study|Adverse Event|1|||
23623456|NCT01841697|66008431|FG001|Overall Study|Withdrawal by Subject|16|||
23623457|NCT01006889|66008432|FG000|Overall Study|Withdrawal by Subject|3|||
23623458|NCT00365547|66008433|FG000|Overall Study|Insurance did not cover Avastin|1|||
23144332|NCT01853982|64277583|FG001|Overall Study|Lost to Follow-up|1|||
23144333|NCT02683876|64277584|FG000|Overall Study|samples damaged during shipping|2|||
23623459|NCT00365547|66008433|FG000|Overall Study|Screen failure|1|||
23623460|NCT00365547|66008433|FG000|Overall Study|Withdrawal by Subject|1|||
23433844|NCT01455194|65330573|FG002|Overall Study|Adverse Event|1|||
23433845|NCT01455194|65330574|FG003|Overall Study|Adverse Event|3|||
23556227|NCT00542880|65762499|FG000|Period 2|Other|0|||
23623461|NCT00644878|66008434|FG000|Overall Study|Adverse Event|2|||
23623462|NCT00644878|66008434|FG000|Overall Study|Abnormal laboratory value|3|||
23623463|NCT00644878|66008434|FG000|Overall Study|Protocol deviation|2|||
23623464|NCT00644878|66008434|FG000|Overall Study|Treatment duration completed as per protocol|11|||
23623465|NCT03765164|66008437|FG000|Pre-intervention|Withdrawal by Subject|5|||
23623466|NCT03765164|66008438|FG001|Pre-intervention|Withdrawal by Subject|6|||
23623467|NCT04599907|66008439|FG000|Overall Study|Withdrawal by Subject|1|||
23556228|NCT00542880|65762500|FG001|Period 2|Other|1|||
23556229|NCT00542880|65762499|FG000|Period 3|Adverse Event|0|||
23556230|NCT00542880|65762500|FG001|Period 3|Adverse Event|2|||
23556231|NCT01833143|65762501|FG000|Overall Study|Not Treated|1|||
23556232|NCT02612064|65762502|FG000|Overall Study|Withdrawal by Subject|1|||
23556233|NCT02612064|65762503|FG001|Overall Study|Withdrawal by Subject|1|||
23556234|NCT02612064|65762502|FG000|Overall Study|Other|0|||
23556235|NCT02612064|65762503|FG001|Overall Study|Other|2|||
23556236|NCT00633464|65762506|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
23556237|NCT00633464|65762507|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
23556238|NCT00633464|65762506|FG000|Overall Study|Never Treated (Randomized in error)|0|||
23556239|NCT00633464|65762507|FG001|Overall Study|Never Treated (Randomized in error)|1|||
23556240|NCT01266850|65762508|FG000|Overall Study|Lost to Follow-up|19|||
23556241|NCT01266850|65762509|FG001|Overall Study|Lost to Follow-up|19|||
23556242|NCT01266850|65762510|FG002|Overall Study|Lost to Follow-up|13|||
23556243|NCT01266850|65762511|FG003|Overall Study|Lost to Follow-up|13|||
23556244|NCT01266850|65762512|FG004|Overall Study|Lost to Follow-up|12|||
23556245|NCT01266850|65762508|FG000|Overall Study|Withdrawal by Subject|8|||
23556246|NCT01266850|65762509|FG001|Overall Study|Withdrawal by Subject|9|||
23556247|NCT01266850|65762510|FG002|Overall Study|Withdrawal by Subject|6|||
23556248|NCT01266850|65762511|FG003|Overall Study|Withdrawal by Subject|9|||
23556249|NCT01266850|65762512|FG004|Overall Study|Withdrawal by Subject|12|||
23556250|NCT01266850|65762508|FG000|Overall Study|Physician Decision|3|||
23556251|NCT01266850|65762509|FG001|Overall Study|Physician Decision|6|||
23556252|NCT01266850|65762510|FG002|Overall Study|Physician Decision|4|||
23556253|NCT01266850|65762511|FG003|Overall Study|Physician Decision|4|||
23556254|NCT01266850|65762512|FG004|Overall Study|Physician Decision|3|||
23556255|NCT01266850|65762508|FG000|Overall Study|Protocol Violation|0|||
23556256|NCT01266850|65762509|FG001|Overall Study|Protocol Violation|1|||
23556257|NCT01266850|65762510|FG002|Overall Study|Protocol Violation|0|||
23556258|NCT01266850|65762511|FG003|Overall Study|Protocol Violation|1|||
23556259|NCT01266850|65762512|FG004|Overall Study|Protocol Violation|2|||
23556260|NCT01266850|65762508|FG000|Overall Study|Adverse Event|0|||
23556261|NCT01266850|65762509|FG001|Overall Study|Adverse Event|0|||
23623468|NCT04599907|66008440|FG001|Overall Study|Withdrawal by Subject|7|||
23623469|NCT04599907|66008441|FG002|Overall Study|Withdrawal by Subject|6|||
23556262|NCT01266850|65762510|FG002|Overall Study|Adverse Event|0|||
23556263|NCT01266850|65762511|FG003|Overall Study|Adverse Event|0|||
23556264|NCT01266850|65762512|FG004|Overall Study|Adverse Event|1|||
23556265|NCT01266850|65762508|FG000|Overall Study|Site Closure|0|||
23556266|NCT01266850|65762509|FG001|Overall Study|Site Closure|1|||
23556267|NCT01266850|65762510|FG002|Overall Study|Site Closure|1|||
23556268|NCT01266850|65762511|FG003|Overall Study|Site Closure|1|||
23556269|NCT01266850|65762512|FG004|Overall Study|Site Closure|0|||
23556270|NCT00553696|65762515|FG000|Overall Study|Adverse Event|2|||
23556271|NCT00553696|65762516|FG001|Overall Study|Adverse Event|4|||
23556272|NCT00553696|65762517|FG002|Overall Study|Adverse Event|0|||
23556273|NCT00553696|65762518|FG003|Overall Study|Adverse Event|1|||
23556274|NCT00553696|65762515|FG000|Overall Study|Global deterioration of health status|0|||
23556275|NCT00553696|65762516|FG001|Overall Study|Global deterioration of health status|2|||
23556276|NCT00553696|65762517|FG002|Overall Study|Global deterioration of health status|0|||
23556277|NCT00553696|65762518|FG003|Overall Study|Global deterioration of health status|0|||
23144334|NCT02683876|64277585|FG001|Overall Study|samples damaged during shipping|0|||
23433846|NCT01455194|65330571|FG000|Overall Study|Withdrawal by Subject|21|||
23433847|NCT01455194|65330572|FG001|Overall Study|Withdrawal by Subject|16|||
23556278|NCT00553696|65762515|FG000|Overall Study|Objective progression or relapse|2|||
23556279|NCT00553696|65762516|FG001|Overall Study|Objective progression or relapse|9|||
23556280|NCT00553696|65762517|FG002|Overall Study|Objective progression or relapse|6|||
23556281|NCT00553696|65762518|FG003|Overall Study|Objective progression or relapse|0|||
23556282|NCT00553696|65762515|FG000|Overall Study|Withdrawal by Subject|0|||
23556283|NCT00553696|65762516|FG001|Overall Study|Withdrawal by Subject|1|||
23556284|NCT00553696|65762517|FG002|Overall Study|Withdrawal by Subject|0|||
23556285|NCT00553696|65762518|FG003|Overall Study|Withdrawal by Subject|0|||
23623470|NCT04599907|66008439|FG000|Overall Study|Lost to Follow-up|0|||
23623471|NCT04599907|66008440|FG001|Overall Study|Lost to Follow-up|1|||
23556286|NCT00238433|65762519|FG000|Overall Study|Screen failure|1|||
23623472|NCT04599907|66008441|FG002|Overall Study|Lost to Follow-up|0|||
23623473|NCT01426113|66008442|FG000|Overall Study|Study Discontinued|1|||
23556287|NCT00238433|65762519|FG000|Overall Study|Lost to Follow-up|1|||
23556288|NCT00238433|65762519|FG000|Overall Study|Death|1|||
23556289|NCT02657317|65762521|FG000|Overall Study|Withdrawal by Subject|2|||
23556290|NCT02657317|65762522|FG001|Overall Study|Withdrawal by Subject|0|||
23556291|NCT02657317|65762521|FG000|Overall Study|Lost to Follow-up|3|||
23556292|NCT02657317|65762522|FG001|Overall Study|Lost to Follow-up|3|||
23556293|NCT02216773|65762524|FG000|Overall Study|Disease progression|4|||
23556294|NCT02216773|65762525|FG001|Overall Study|Disease progression|2|||
23556295|NCT02216773|65762524|FG000|Overall Study|Insufficient FLRV|4|||
23623474|NCT01426113|66008443|FG001|Overall Study|Study Discontinued|1|||
23623475|NCT01426113|66008442|FG000|Overall Study|Adverse Event|0|||
23623476|NCT01426113|66008443|FG001|Overall Study|Adverse Event|1|||
23144335|NCT00770341|64277586|FG000|Overall Study|Did not meet eligibility criteria|1|||
23321084|NCT00261443|64919329|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
23321085|NCT00261443|64919330|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
23321086|NCT00261443|64919328|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
23321087|NCT00261443|64919329|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
23321088|NCT00261443|64919330|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
23321089|NCT00261443|64919328|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
23321090|NCT00261443|64919329|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
23321091|NCT00261443|64919330|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
23321092|NCT00261443|64919328|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
23321093|NCT00261443|64919329|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
23321094|NCT00261443|64919330|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
23144336|NCT00770341|64277587|FG001|Overall Study|Did not meet eligibility criteria|0|||
23144337|NCT00770341|64277588|FG002|Overall Study|Did not meet eligibility criteria|0|||
23144338|NCT00770341|64277586|FG000|Overall Study|Withdrawal by Subject|0|||
23144339|NCT00770341|64277587|FG001|Overall Study|Withdrawal by Subject|1|||
23321095|NCT00261443|64919328|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
23321096|NCT00261443|64919329|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
23321097|NCT00261443|64919330|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
23321098|NCT00261443|64919328|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
23321099|NCT00261443|64919329|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
23321100|NCT00261443|64919330|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
23321101|NCT00261443|64919328|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
23321102|NCT00261443|64919329|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
23321103|NCT00261443|64919330|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
23321104|NCT00261443|64919328|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
23321105|NCT00261443|64919329|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
23321106|NCT00261443|64919330|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
23321107|NCT00261443|64919328|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
23321108|NCT00261443|64919329|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
23321109|NCT00261443|64919330|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
23144340|NCT00770341|64277588|FG002|Overall Study|Withdrawal by Subject|0|||
23321110|NCT00261443|64919328|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
23321111|NCT00261443|64919329|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
23321112|NCT00261443|64919330|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
23321113|NCT00261443|64919328|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
23321114|NCT00261443|64919329|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
23321115|NCT00261443|64919330|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
23321116|NCT00261443|64919328|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
23321117|NCT00261443|64919329|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
23321118|NCT00261443|64919330|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
23321119|NCT00261443|64919328|FG000|3: Assessment of Relapse|Adverse Event|0|||
23321120|NCT00261443|64919329|FG001|3: Assessment of Relapse|Adverse Event|15|||
23321121|NCT00261443|64919330|FG002|3: Assessment of Relapse|Adverse Event|19|||
23321122|NCT00261443|64919328|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
23321123|NCT00261443|64919329|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
23321124|NCT00261443|64919330|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
23321125|NCT00261443|64919328|FG000|3: Assessment of Relapse|Death|0|||
23556296|NCT02216773|65762525|FG001|Overall Study|Insufficient FLRV|0|||
23623477|NCT00809341|66008444|FG000|Overall Study|Physician Decision|0|||
23321126|NCT00261443|64919329|FG001|3: Assessment of Relapse|Death|0|||
23321127|NCT00261443|64919330|FG002|3: Assessment of Relapse|Death|1|||
23321128|NCT00261443|64919328|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
23321129|NCT00261443|64919329|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
23321130|NCT00261443|64919330|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
23321131|NCT00261443|64919328|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
23623478|NCT00809341|66008445|FG001|Overall Study|Physician Decision|1|||
23321132|NCT00261443|64919329|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
23321133|NCT00261443|64919330|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
23144341|NCT00770341|64277586|FG000|Overall Study|Clinical Adverse Event|3|||
23144342|NCT00770341|64277587|FG001|Overall Study|Clinical Adverse Event|1|||
23144343|NCT00770341|64277588|FG002|Overall Study|Clinical Adverse Event|2|||
23144344|NCT00770341|64277586|FG000|Overall Study|Laboratory adverse event|3|||
23144345|NCT00770341|64277587|FG001|Overall Study|Laboratory adverse event|3|||
23144346|NCT00770341|64277588|FG002|Overall Study|Laboratory adverse event|0|||
23144347|NCT00770341|64277586|FG000|Overall Study|Lack of Efficacy|3|||
23144348|NCT00770341|64277587|FG001|Overall Study|Lack of Efficacy|0|||
23144349|NCT00770341|64277588|FG002|Overall Study|Lack of Efficacy|1|||
23144350|NCT00770341|64277586|FG000|Overall Study|Other|1|||
23321134|NCT00261443|64919328|FG000|3: Assessment of Relapse|Pregnancy|0|||
23321135|NCT00261443|64919329|FG001|3: Assessment of Relapse|Pregnancy|2|||
23321136|NCT00261443|64919330|FG002|3: Assessment of Relapse|Pregnancy|1|||
23321137|NCT00261443|64919328|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
23321138|NCT00261443|64919329|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
23321139|NCT00261443|64919330|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
23321140|NCT00261443|64919328|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
23321141|NCT00261443|64919329|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
23321142|NCT00261443|64919330|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
23321143|NCT00261443|64919328|FG000|3: Assessment of Relapse|Other Reasons|0|||
23321144|NCT00261443|64919329|FG001|3: Assessment of Relapse|Other Reasons|4|||
23321145|NCT00261443|64919330|FG002|3: Assessment of Relapse|Other Reasons|3|||
23321146|NCT00261443|64919328|FG000|4: Extension Phase|Adverse Event|0|||
23321147|NCT00261443|64919329|FG001|4: Extension Phase|Adverse Event|1|||
23321148|NCT00261443|64919330|FG002|4: Extension Phase|Adverse Event|0|||
23321149|NCT00261443|64919328|FG000|4: Extension Phase|Withdrawal by Subject|0|||
23321150|NCT00261443|64919329|FG001|4: Extension Phase|Withdrawal by Subject|1|||
23321151|NCT00261443|64919330|FG002|4: Extension Phase|Withdrawal by Subject|2|||
23321152|NCT00261443|64919328|FG000|4: Extension Phase|Lost to Follow-up|0|||
23321153|NCT00261443|64919329|FG001|4: Extension Phase|Lost to Follow-up|1|||
23321154|NCT00261443|64919330|FG002|4: Extension Phase|Lost to Follow-up|0|||
23321155|NCT04289363|64919331|FG000|Overall Study|Lost to Follow-up|14|||
23321156|NCT04289363|64919332|FG001|Overall Study|Lost to Follow-up|0|||
23321157|NCT03345420|64919333|FG000|Overall Study|Withdrawal by Subject|1|||
23321158|NCT03410056|64919334|FG000|Overall Study|Decision by Sponsor|0|||
23321159|NCT03410056|64919335|FG001|Overall Study|Decision by Sponsor|0|||
23321160|NCT03410056|64919336|FG002|Overall Study|Decision by Sponsor|3|||
23321161|NCT03410056|64919337|FG003|Overall Study|Decision by Sponsor|0|||
23321162|NCT03410056|64919338|FG004|Overall Study|Decision by Sponsor|0|||
23321163|NCT03410056|64919339|FG005|Overall Study|Decision by Sponsor|0|||
23144351|NCT00770341|64277587|FG001|Overall Study|Other|0|||
23144352|NCT00770341|64277588|FG002|Overall Study|Other|0|||
23144353|NCT00770341|64277586|FG000|Overall Study|Not treated|1|||
23144354|NCT00770341|64277587|FG001|Overall Study|Not treated|0|||
23144355|NCT00770341|64277588|FG002|Overall Study|Not treated|0|||
23217959|NCT01250756|64538459|FG000|Infant Series|Withdrawal by Subject|4|||
23321164|NCT03410056|64919340|FG006|Overall Study|Decision by Sponsor|0|||
23321165|NCT03410056|64919334|FG000|Overall Study|Withdrawal by Subject|0|||
23321166|NCT03410056|64919335|FG001|Overall Study|Withdrawal by Subject|2|||
23321167|NCT03410056|64919336|FG002|Overall Study|Withdrawal by Subject|5|||
23321168|NCT03410056|64919337|FG003|Overall Study|Withdrawal by Subject|5|||
23321169|NCT03410056|64919338|FG004|Overall Study|Withdrawal by Subject|0|||
23321170|NCT03410056|64919339|FG005|Overall Study|Withdrawal by Subject|0|||
23321171|NCT03410056|64919340|FG006|Overall Study|Withdrawal by Subject|0|||
23321172|NCT00444587|64919343|FG000|Overall Study|Death|2|||
23321173|NCT00444587|64919344|FG001|Overall Study|Death|1|||
23321174|NCT00444587|64919343|FG000|Overall Study|Progression of the disease|73|||
23321175|NCT00444587|64919344|FG001|Overall Study|Progression of the disease|8|||
23321176|NCT00444587|64919343|FG000|Overall Study|Refused treatment/did not cooperate|4|||
23321177|NCT00444587|64919344|FG001|Overall Study|Refused treatment/did not cooperate|1|||
23321178|NCT00444587|64919343|FG000|Overall Study|Investigator decision|3|||
23321179|NCT00444587|64919344|FG001|Overall Study|Investigator decision|0|||
23321180|NCT00444587|64919343|FG000|Overall Study|Protocol Violation|1|||
23321181|NCT00444587|64919344|FG001|Overall Study|Protocol Violation|0|||
23321182|NCT00444587|64919343|FG000|Overall Study|Missing|0|||
23321183|NCT00444587|64919344|FG001|Overall Study|Missing|5|||
23144356|NCT01442779|64277589|FG000|Overall Study|Withdrawal by Subject|3|||
23321184|NCT03126435|64919345|FG000|Overall Study|Death|90|||
23321185|NCT03126435|64919346|FG001|Overall Study|Death|84|||
23321186|NCT03126435|64919345|FG000|Overall Study|Lost to Follow-up|4|||
23321187|NCT03126435|64919346|FG001|Overall Study|Lost to Follow-up|3|||
23321188|NCT03126435|64919345|FG000|Overall Study|Physician Decision|0|||
23144357|NCT01442779|64277589|FG000|Overall Study|Death|3|||
23144358|NCT01442779|64277589|FG000|Overall Study|Non-compliance|1|||
23321189|NCT03126435|64919346|FG001|Overall Study|Physician Decision|1|||
23321190|NCT03126435|64919345|FG000|Overall Study|Withdrawal by Subject|6|||
23623479|NCT00329550|66008446|FG000|Overall Study|Adverse Event|3|||
23623480|NCT00329550|66008447|FG001|Overall Study|Adverse Event|4|||
23623481|NCT00329550|66008448|FG002|Overall Study|Adverse Event|2|||
23144359|NCT01211288|64277590|FG000|Overall Study|Lost to Follow-up|1|||
23144360|NCT01211288|64277591|FG001|Overall Study|Lost to Follow-up|1|||
23144361|NCT03587974|64277592|FG000|Overall Study|caregiver demented, care recipient died|3|||
23144362|NCT03587974|64277593|FG001|Overall Study|caregiver demented, care recipient died|3|||
23144363|NCT03587974|64277592|FG000|Overall Study|Withdrawal by Subject|2|||
23144364|NCT03587974|64277593|FG001|Overall Study|Withdrawal by Subject|1|||
23144365|NCT00372229|64277594|FG000|Study Phase|Graft loss|0|||
23144366|NCT00372229|64277595|FG001|Study Phase|Graft loss|3|||
23144367|NCT00372229|64277594|FG000|Study Phase|Protocol Violation|3|||
23144368|NCT00372229|64277595|FG001|Study Phase|Protocol Violation|4|||
23144369|NCT00372229|64277594|FG000|Study Phase|Consent withdrawn|16|||
23144370|NCT00372229|64277595|FG001|Study Phase|Consent withdrawn|14|||
23144371|NCT00372229|64277594|FG000|Study Phase|Refused treatment/did not cooperate|3|||
23433848|NCT01455194|65330573|FG002|Overall Study|Withdrawal by Subject|12|||
23321191|NCT03126435|64919346|FG001|Overall Study|Withdrawal by Subject|12|||
23321192|NCT03126435|64919345|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
23321193|NCT03126435|64919346|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
23321194|NCT02635984|64919347|FG000|Overall Study|Lost to Follow-up|2|||
23321195|NCT02635984|64919348|FG001|Overall Study|Lost to Follow-up|4|||
23321196|NCT02635984|64919347|FG000|Overall Study|Study Arm Closed|1|||
23321197|NCT02635984|64919348|FG001|Overall Study|Study Arm Closed|0|||
23321198|NCT01565707|64919349|FG000|Overall Study|Adverse Event|1|||
23321199|NCT01565707|64919350|FG001|Overall Study|Adverse Event|6|||
23321200|NCT01565707|64919351|FG002|Overall Study|Adverse Event|2|||
23321201|NCT01565707|64919352|FG003|Overall Study|Adverse Event|1|||
23321202|NCT01565707|64919349|FG000|Overall Study|Lost to Follow-up|1|||
23321203|NCT01565707|64919350|FG001|Overall Study|Lost to Follow-up|0|||
23556297|NCT02216773|65762524|FG000|Overall Study|Abandoned|4|||
23556298|NCT02216773|65762525|FG001|Overall Study|Abandoned|3|||
23556299|NCT02173548|65762533|FG000|Overall Study|Lost to Follow-up|0|||
23556300|NCT02173548|65762534|FG001|Overall Study|Lost to Follow-up|2|||
23144372|NCT00372229|64277595|FG001|Study Phase|Refused treatment/did not cooperate|1|||
23144373|NCT00372229|64277594|FG000|Study Phase|Death|3|||
23144374|NCT00372229|64277595|FG001|Study Phase|Death|2|||
23144375|NCT00372229|64277594|FG000|Study Phase|Reason not specified|3|||
23144376|NCT00372229|64277595|FG001|Study Phase|Reason not specified|2|||
23144377|NCT00372229|64277594|FG000|Study Phase|Lost to Follow-up|3|||
23144378|NCT00372229|64277595|FG001|Study Phase|Lost to Follow-up|3|||
23144379|NCT00372229|64277594|FG000|Follow-Up Phase|Graft loss|8|||
23144380|NCT00372229|64277595|FG001|Follow-Up Phase|Graft loss|7|||
23144381|NCT00372229|64277594|FG000|Follow-Up Phase|Consent withdrawn|13|||
23144382|NCT00372229|64277595|FG001|Follow-Up Phase|Consent withdrawn|19|||
23144383|NCT00372229|64277594|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
23144384|NCT00372229|64277595|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
23321204|NCT01565707|64919351|FG002|Overall Study|Lost to Follow-up|0|||
23556301|NCT02173548|65762533|FG000|Overall Study|Withdrawal by Subject|1|||
23556302|NCT02173548|65762534|FG001|Overall Study|Withdrawal by Subject|0|||
23556303|NCT00785291|65762535|FG000|Overall Study|Never began treatment|8|||
23556304|NCT00785291|65762536|FG001|Overall Study|Never began treatment|4|||
23556305|NCT00785291|65762537|FG002|Overall Study|Never began treatment|4|||
23556306|NCT00785291|65762535|FG000|Overall Study|Adverse Event|39|||
23556307|NCT00785291|65762536|FG001|Overall Study|Adverse Event|70|||
23556308|NCT00785291|65762537|FG002|Overall Study|Adverse Event|56|||
23556309|NCT00785291|65762535|FG000|Overall Study|Death|7|||
23556310|NCT00785291|65762536|FG001|Overall Study|Death|4|||
23556311|NCT00785291|65762537|FG002|Overall Study|Death|3|||
23556312|NCT00785291|65762535|FG000|Overall Study|Withdrawal by Subject|35|||
23556313|NCT00785291|65762536|FG001|Overall Study|Withdrawal by Subject|36|||
23556314|NCT00785291|65762537|FG002|Overall Study|Withdrawal by Subject|17|||
23556315|NCT00785291|65762535|FG000|Overall Study|Alternative Therapy|12|||
23556316|NCT00785291|65762536|FG001|Overall Study|Alternative Therapy|6|||
23556317|NCT00785291|65762537|FG002|Overall Study|Alternative Therapy|7|||
23556318|NCT00785291|65762535|FG000|Overall Study|Complicating illness|6|||
23623482|NCT00329550|66008446|FG000|Overall Study|Withdrawal of Consent|1|||
23623483|NCT00329550|66008447|FG001|Overall Study|Withdrawal of Consent|0|||
23144385|NCT00372229|64277594|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
23144386|NCT00372229|64277595|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
23144387|NCT00372229|64277594|FG000|Follow-Up Phase|Death|9|||
23321205|NCT01565707|64919352|FG003|Overall Study|Lost to Follow-up|0|||
23321206|NCT01565707|64919349|FG000|Overall Study|Protocol Violation|1|||
23321207|NCT01565707|64919350|FG001|Overall Study|Protocol Violation|0|||
23556319|NCT00785291|65762536|FG001|Overall Study|Complicating illness|4|||
23556320|NCT00785291|65762537|FG002|Overall Study|Complicating illness|4|||
23556321|NCT00785291|65762535|FG000|Overall Study|Other Medical Reasons|29|||
23623484|NCT00329550|66008448|FG002|Overall Study|Withdrawal of Consent|1|||
23433849|NCT01455194|65330574|FG003|Overall Study|Withdrawal by Subject|9|||
23433850|NCT01455194|65330571|FG000|Overall Study|Lost to Follow-up|2|||
23623485|NCT00329550|66008446|FG000|Overall Study|Due to Relocation|0|||
23623486|NCT00329550|66008447|FG001|Overall Study|Due to Relocation|0|||
23623487|NCT00329550|66008448|FG002|Overall Study|Due to Relocation|1|||
23623488|NCT02669407|66008449|FG000|Overall Study|Physician Decision|3|||
23623489|NCT02918292|66008450|FG000|Study Enrollment Prior to Transplant|Death|1|||
23623490|NCT02918292|66008450|FG000|Study Follow up After Transplant|Death|6|||
23623491|NCT02835092|66008451|FG000|Overall Study|Withdrawal by Subject|3|||
23623492|NCT02835092|66008452|FG001|Overall Study|Withdrawal by Subject|6|||
23623493|NCT02835092|66008453|FG002|Overall Study|Withdrawal by Subject|3|||
23623494|NCT02835092|66008451|FG000|Overall Study|Lost to Follow-up|0|||
23623495|NCT02835092|66008452|FG001|Overall Study|Lost to Follow-up|2|||
23623496|NCT02835092|66008453|FG002|Overall Study|Lost to Follow-up|0|||
23623497|NCT00350298|66008462|FG000|Overall Study|Death|7|||
23623498|NCT00350298|66008463|FG001|Overall Study|Death|8|||
23623499|NCT00350298|66008462|FG000|Overall Study|Lost to Follow-up|1|||
23623500|NCT00350298|66008463|FG001|Overall Study|Lost to Follow-up|2|||
23623501|NCT00350298|66008462|FG000|Overall Study|Withdrawal by Subject|1|||
23623502|NCT00350298|66008463|FG001|Overall Study|Withdrawal by Subject|3|||
23321208|NCT01565707|64919351|FG002|Overall Study|Protocol Violation|0|||
23433851|NCT01455194|65330572|FG001|Overall Study|Lost to Follow-up|0|||
23433852|NCT01455194|65330573|FG002|Overall Study|Lost to Follow-up|1|||
23433853|NCT01455194|65330574|FG003|Overall Study|Lost to Follow-up|1|||
23433854|NCT01455194|65330571|FG000|Overall Study|Pregnancy|0|||
23433855|NCT01455194|65330572|FG001|Overall Study|Pregnancy|1|||
23433856|NCT01455194|65330573|FG002|Overall Study|Pregnancy|1|||
23144388|NCT00372229|64277595|FG001|Follow-Up Phase|Death|12|||
23144389|NCT00372229|64277594|FG000|Follow-Up Phase|Administrative|1|||
23144390|NCT00372229|64277595|FG001|Follow-Up Phase|Administrative|0|||
23144391|NCT00372229|64277594|FG000|Follow-Up Phase|Reason not specified|2|||
23144392|NCT00372229|64277595|FG001|Follow-Up Phase|Reason not specified|3|||
23144393|NCT00372229|64277594|FG000|Follow-Up Phase|Lost to Follow-up|12|||
23144394|NCT00372229|64277595|FG001|Follow-Up Phase|Lost to Follow-up|10|||
23433857|NCT01455194|65330574|FG003|Overall Study|Pregnancy|0|||
23433858|NCT01455194|65330571|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
23623503|NCT00684203|66008468|FG000|Overall Study|Adverse Event|6|||
23144395|NCT00343252|64277596|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
23144396|NCT00343252|64277597|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
23144397|NCT00343252|64277596|FG000|6 Months (All Treated Participants)|Death|0|||
23217960|NCT01250756|64538460|FG001|Infant Series|Withdrawal by Subject|5|||
23217961|NCT01250756|64538459|FG000|Infant Series|Randomized, Not Vaccinated|2|||
23217962|NCT01250756|64538460|FG001|Infant Series|Randomized, Not Vaccinated|2|||
23217963|NCT01250756|64538459|FG000|Infant Series|Other|22|||
23217964|NCT01250756|64538460|FG001|Infant Series|Other|0|||
23217965|NCT01250756|64538459|FG000|After Infant Series|Adverse Event|5|||
23217966|NCT01250756|64538460|FG001|After Infant Series|Adverse Event|2|||
23144398|NCT00343252|64277597|FG001|6 Months (All Treated Participants)|Death|2|||
23144399|NCT00343252|64277596|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
23144400|NCT00343252|64277597|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
23144401|NCT00343252|64277596|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
23144402|NCT00343252|64277597|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
23144403|NCT00343252|64277596|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
23144404|NCT00343252|64277597|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
23144405|NCT00343252|64277596|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
23144406|NCT00343252|64277597|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
23144407|NCT00343252|64277596|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
23217967|NCT01250756|64538459|FG000|After Infant Series|Withdrawal by Subject|4|||
23217968|NCT01250756|64538460|FG001|After Infant Series|Withdrawal by Subject|1|||
23217969|NCT01250756|64538459|FG000|After Infant Series|Other|2|||
23217970|NCT01250756|64538460|FG001|After Infant Series|Other|1|||
23217971|NCT01250756|64538459|FG000|Toddler Dose|Adverse Event|0|||
23217972|NCT01250756|64538460|FG001|Toddler Dose|Adverse Event|1|||
23321209|NCT01565707|64919352|FG003|Overall Study|Protocol Violation|1|||
23321210|NCT01565707|64919349|FG000|Overall Study|Withdrawal by Subject|3|||
23321211|NCT01565707|64919350|FG001|Overall Study|Withdrawal by Subject|1|||
23433859|NCT01455194|65330572|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
23433860|NCT01455194|65330573|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
23623504|NCT00684203|66008469|FG001|Overall Study|Adverse Event|4|||
23623505|NCT00684203|66008470|FG002|Overall Study|Adverse Event|8|||
23623506|NCT00684203|66008471|FG003|Overall Study|Adverse Event|0|||
23623507|NCT00684203|66008472|FG004|Overall Study|Adverse Event|0|||
23144408|NCT00343252|64277597|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
23217973|NCT01250756|64538459|FG000|After Toddler Dose|Adverse Event|0|||
23433861|NCT01455194|65330574|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
23623508|NCT00684203|66008473|FG005|Overall Study|Adverse Event|0|||
23217974|NCT01250756|64538460|FG001|After Toddler Dose|Adverse Event|1|||
23217975|NCT00927758|64538467|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
23217976|NCT00927758|64538468|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
23217977|NCT00927758|64538469|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
23217978|NCT00927758|64538470|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
23217979|NCT00927758|64538471|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
23217980|NCT00927758|64538472|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
23217981|NCT00927758|64538467|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
23217982|NCT00927758|64538468|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
23217983|NCT00927758|64538469|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
23217984|NCT00927758|64538470|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
23217985|NCT00927758|64538471|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
23217986|NCT00927758|64538472|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
23217987|NCT03209362|64538475|FG000|Overall Study|Adverse Event|0|||
23217988|NCT03209362|64538476|FG001|Overall Study|Adverse Event|1|||
23217989|NCT03209362|64538475|FG000|Overall Study|Lost to Follow-up|0|||
23217990|NCT03209362|64538476|FG001|Overall Study|Lost to Follow-up|1|||
23217991|NCT03209362|64538475|FG000|Overall Study|Withdrawal by Subject|2|||
23217992|NCT03209362|64538476|FG001|Overall Study|Withdrawal by Subject|0|||
23217993|NCT03209362|64538475|FG000|Overall Study|Other|0|||
23217994|NCT03209362|64538476|FG001|Overall Study|Other|1|||
23217995|NCT00830804|64538478|FG000|Overall Study|Lost to Follow-up|4|||
23217996|NCT00830804|64538478|FG000|Overall Study|Death|1|||
23144409|NCT00343252|64277596|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
23144410|NCT00343252|64277597|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
23144411|NCT00343252|64277596|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
23144412|NCT00343252|64277597|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
23321212|NCT01565707|64919351|FG002|Overall Study|Withdrawal by Subject|1|||
23321213|NCT01565707|64919352|FG003|Overall Study|Withdrawal by Subject|1|||
23321214|NCT01565707|64919349|FG000|Overall Study|Randomized but not evaluable|2|||
23321215|NCT01565707|64919350|FG001|Overall Study|Randomized but not evaluable|0|||
23321216|NCT01565707|64919351|FG002|Overall Study|Randomized but not evaluable|0|||
23321217|NCT01565707|64919352|FG003|Overall Study|Randomized but not evaluable|0|||
23321218|NCT01565707|64919349|FG000|Overall Study|Miscellaneous|1|||
23321219|NCT01565707|64919350|FG001|Overall Study|Miscellaneous|1|||
23144413|NCT00343252|64277596|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
23144414|NCT00343252|64277597|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
23144415|NCT00343252|64277596|FG000|12 Months (All Treated Participants)|Death|3|||
23144416|NCT00343252|64277597|FG001|12 Months (All Treated Participants)|Death|3|||
23144417|NCT00343252|64277596|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
23144418|NCT00343252|64277597|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
23144419|NCT00343252|64277596|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
23144420|NCT00343252|64277597|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
23144421|NCT00343252|64277596|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
23144422|NCT00343252|64277597|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
23144423|NCT00343252|64277596|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
23144424|NCT00343252|64277597|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
23144425|NCT00343252|64277596|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
23144426|NCT00343252|64277597|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
23144427|NCT00343252|64277596|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
23144428|NCT00343252|64277597|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
23144429|NCT00343252|64277596|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
23144430|NCT00343252|64277597|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
23144431|NCT00343252|64277596|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
23144432|NCT00343252|64277597|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
23144433|NCT00343252|64277596|FG000|18 Months (All Treated Participants)|Death|4|||
23144434|NCT00343252|64277597|FG001|18 Months (All Treated Participants)|Death|5|||
23217997|NCT00830804|64538478|FG000|Overall Study|Unable to get to clinic|7|||
23217998|NCT00830804|64538478|FG000|Overall Study|Consent withdrawn|2|||
23217999|NCT00830804|64538478|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
23218000|NCT01457924|64538479|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
23218001|NCT01457924|64538480|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
23218002|NCT01457924|64538481|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
23218003|NCT01457924|64538482|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
23218004|NCT01457924|64538483|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
23321220|NCT01565707|64919351|FG002|Overall Study|Miscellaneous|0|||
23321221|NCT01565707|64919352|FG003|Overall Study|Miscellaneous|2|||
23433862|NCT01455194|65330571|FG000|Overall Study|Miscellaneous|4|||
23144435|NCT00343252|64277596|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
23144436|NCT00343252|64277597|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
23144437|NCT00343252|64277596|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
23144438|NCT00343252|64277597|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
23144439|NCT00343252|64277596|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
23144440|NCT00343252|64277597|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
23144441|NCT00343252|64277596|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
23144442|NCT00343252|64277597|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
23144443|NCT00343252|64277596|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
23144444|NCT00343252|64277597|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
23321222|NCT03066258|64919353|FG000|Overall Study|Death|1|||
23321223|NCT03066258|64919354|FG001|Overall Study|Death|0|||
23321224|NCT03066258|64919355|FG002|Overall Study|Death|0|||
23321225|NCT03066258|64919356|FG003|Overall Study|Death|0|||
23321226|NCT03066258|64919357|FG004|Overall Study|Death|1|||
23321227|NCT02286843|64919358|FG000|Overall Study|Not Treated|4|||
23321228|NCT02286843|64919358|FG000|Overall Study|Protocol Violation|1|||
23321229|NCT02286843|64919358|FG000|Overall Study|Withdrawal by Subject|1|||
23321230|NCT02910011|64919359|FG000|Overall Study|Physician Decision|2|||
23321231|NCT01228019|64919360|FG000|Overall Study|Dose Violation|70|||
23321232|NCT01228019|64919360|FG000|Overall Study|Duplicate enrollment|1|||
23321233|NCT01228019|64919360|FG000|Overall Study|Missing pre-treatment data|72|||
23321234|NCT01228019|64919360|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
23433863|NCT01455194|65330572|FG001|Overall Study|Miscellaneous|5|||
23433864|NCT01455194|65330573|FG002|Overall Study|Miscellaneous|1|||
23433865|NCT01455194|65330574|FG003|Overall Study|Miscellaneous|4|||
23433866|NCT00267150|65330575|FG000|Overall Study|Adverse Event|1|||
23433867|NCT02951429|65330576|FG000|Overall Study|Adverse Event|3|||
23433868|NCT02951429|65330577|FG001|Overall Study|Adverse Event|7|||
23433869|NCT02951429|65330576|FG000|Overall Study|Death|28|||
23433870|NCT02951429|65330577|FG001|Overall Study|Death|36|||
23144445|NCT00343252|64277596|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
23144446|NCT00343252|64277597|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
23144447|NCT00343252|64277596|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
23433871|NCT02951429|65330576|FG000|Overall Study|Lack of Efficacy|0|||
23144448|NCT00343252|64277597|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
23144449|NCT02019927|64277598|FG000|Overall Study|Lost to Follow-up|2|||
23144450|NCT02019927|64277599|FG001|Overall Study|Lost to Follow-up|4|||
23144451|NCT02019927|64277600|FG002|Overall Study|Lost to Follow-up|1|||
23144452|NCT02019927|64277601|FG003|Overall Study|Lost to Follow-up|2|||
23433872|NCT02951429|65330577|FG001|Overall Study|Lack of Efficacy|1|||
23433873|NCT02951429|65330576|FG000|Overall Study|Lost to Follow-up|0|||
23433874|NCT02951429|65330577|FG001|Overall Study|Lost to Follow-up|1|||
23433875|NCT02951429|65330576|FG000|Overall Study|Lung Transplantation|9|||
23433876|NCT02951429|65330577|FG001|Overall Study|Lung Transplantation|6|||
23433877|NCT02951429|65330576|FG000|Overall Study|Other|1|||
23433878|NCT02951429|65330577|FG001|Overall Study|Other|3|||
23433879|NCT02951429|65330576|FG000|Overall Study|Progressive Disease|1|||
23433880|NCT02951429|65330577|FG001|Overall Study|Progressive Disease|1|||
23433881|NCT02951429|65330576|FG000|Overall Study|Withdrawal by Subject|7|||
23433882|NCT02951429|65330577|FG001|Overall Study|Withdrawal by Subject|11|||
23433883|NCT02951429|65330576|FG000|Overall Study|Participant ongoing in the study|23|||
23433884|NCT02951429|65330577|FG001|Overall Study|Participant ongoing in the study|17|||
23433885|NCT00931801|65330578|FG000|Overall Study|Adverse Event|0|||
23433886|NCT00931801|65330579|FG001|Overall Study|Adverse Event|0|||
23433887|NCT00931801|65330580|FG002|Overall Study|Adverse Event|1|||
23433888|NCT00931801|65330578|FG000|Overall Study|Lost to Follow-up|0|||
23433889|NCT00931801|65330579|FG001|Overall Study|Lost to Follow-up|1|||
23433890|NCT00931801|65330580|FG002|Overall Study|Lost to Follow-up|0|||
23433891|NCT00931801|65330578|FG000|Overall Study|Withdrawal by Subject|1|||
23433892|NCT00931801|65330579|FG001|Overall Study|Withdrawal by Subject|0|||
23556322|NCT00785291|65762536|FG001|Overall Study|Other Medical Reasons|25|||
23144453|NCT02019927|64277602|FG004|Overall Study|Lost to Follow-up|3|||
23144454|NCT02019927|64277603|FG005|Overall Study|Lost to Follow-up|1|||
23144455|NCT01589237|64277604|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
23321235|NCT01228019|64919360|FG000|Overall Study|Violation of Entry Criterion|9|||
23321236|NCT00098774|64919361|FG000|Overall Study|Adverse Event|2|||
23321237|NCT00098774|64919361|FG000|Overall Study|Disease Progression|9|||
23321238|NCT00098774|64919361|FG000|Overall Study|Withdrawal by Subject|1|||
23321239|NCT00098774|64919361|FG000|Overall Study|Failed (to respond) during induction|4|||
23321240|NCT00098774|64919361|FG000|Overall Study|Physician Decision|2|||
23321241|NCT01197911|64919362|FG000|Overall Study|Adverse Event|0|||
23433893|NCT00931801|65330580|FG002|Overall Study|Withdrawal by Subject|0|||
23433894|NCT00931801|65330578|FG000|Overall Study|Confirmed Virologic Failure|0|||
23433895|NCT00931801|65330579|FG001|Overall Study|Confirmed Virologic Failure|0|||
23433896|NCT00931801|65330580|FG002|Overall Study|Confirmed Virologic Failure|3|||
23433897|NCT01090063|65330582|FG000|Screen|Screen Failed|4|||
23433898|NCT01090063|65330582|FG000|Treatment|Withdrawal by Subject|4|||
23433899|NCT02925728|65330583|FG000|Overall Study|Death|3|||
23433900|NCT02925728|65330584|FG001|Overall Study|Death|5|||
23433901|NCT02925728|65330583|FG000|Overall Study|Physician Decision|1|||
23433902|NCT02925728|65330584|FG001|Overall Study|Physician Decision|0|||
23433903|NCT02925728|65330583|FG000|Overall Study|Withdrawal by Subject|1|||
23433904|NCT02925728|65330584|FG001|Overall Study|Withdrawal by Subject|0|||
23433905|NCT01266317|65330585|FG000|Overall Study|Withdrawal by Subject|2|||
23144456|NCT01589237|64277605|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
23433906|NCT04356040|65330610|FG000|Overall Study|Death|2|||
23433907|NCT04356040|65330611|FG001|Overall Study|Death|0|||
23433908|NCT04356040|65330610|FG000|Overall Study|Lost to Follow-up|1|||
23433909|NCT04356040|65330611|FG001|Overall Study|Lost to Follow-up|0|||
23433910|NCT04356040|65330610|FG000|Overall Study|Physician Decision|0|||
23433911|NCT04356040|65330611|FG001|Overall Study|Physician Decision|1|||
23433912|NCT04356040|65330610|FG000|Overall Study|Withdrawal by Subject|13|||
23433913|NCT04356040|65330611|FG001|Overall Study|Withdrawal by Subject|1|||
23433914|NCT04356040|65330610|FG000|Overall Study|Enrollment Pause|10|||
23433915|NCT04356040|65330611|FG001|Overall Study|Enrollment Pause|0|||
23433916|NCT04356040|65330610|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
23433917|NCT04356040|65330611|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
23433918|NCT04356040|65330610|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
23433919|NCT04356040|65330611|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
23433920|NCT04356040|65330610|FG000|Overall Study|PI left institution|3|||
23433921|NCT04356040|65330611|FG001|Overall Study|PI left institution|0|||
23433922|NCT00566254|65330612|FG000|Overall Study|Adverse Event|3|||
23433923|NCT00566254|65330613|FG001|Overall Study|Adverse Event|1|||
23433924|NCT00566254|65330612|FG000|Overall Study|Protocol Violation|1|||
23433925|NCT00566254|65330613|FG001|Overall Study|Protocol Violation|3|||
23433926|NCT00566254|65330612|FG000|Overall Study|Withdrawal by Subject|1|||
23433927|NCT00566254|65330613|FG001|Overall Study|Withdrawal by Subject|2|||
23433928|NCT00566254|65330612|FG000|Overall Study|Lack of Efficacy|5|||
23433929|NCT00566254|65330613|FG001|Overall Study|Lack of Efficacy|6|||
23433930|NCT00566254|65330612|FG000|Overall Study|Other|0|||
23433931|NCT00566254|65330613|FG001|Overall Study|Other|2|||
23433932|NCT01818284|65330615|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
23433933|NCT01818284|65330616|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
23433934|NCT01818284|65330615|FG000|Overall Study|Death|0|||
23433935|NCT01818284|65330616|FG001|Overall Study|Death|2|||
23433936|NCT03755661|65330619|FG000|Overall Study|Lost to Follow-up|1|||
23433937|NCT03755661|65330620|FG001|Overall Study|Lost to Follow-up|0|||
23433938|NCT01620944|65330621|FG000|Overall Study|Early termination of Study|2|||
23433939|NCT01620944|65330622|FG001|Overall Study|Early termination of Study|1|||
23433940|NCT01746173|65330623|FG000|Overall Study|Disease Progression|2|||
23433941|NCT02974842|65330624|FG000|Overall Study|Withdrawal by Subject|4|||
23433942|NCT02974842|65330624|FG000|Overall Study|Screen failures|4|||
23433943|NCT01939366|65330625|FG000|Overall Study|Adverse Event|8|||
23433944|NCT01939366|65330626|FG001|Overall Study|Adverse Event|17|||
23433945|NCT01939366|65330627|FG002|Overall Study|Adverse Event|30|||
23433946|NCT01939366|65330628|FG003|Overall Study|Adverse Event|8|||
23433947|NCT01939366|65330629|FG004|Overall Study|Adverse Event|5|||
23144457|NCT01589237|64277606|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
23144458|NCT01589237|64277607|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
23144459|NCT01589237|64277604|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
23433948|NCT01939366|65330625|FG000|Overall Study|Lack of Efficacy|2|||
23433949|NCT01939366|65330626|FG001|Overall Study|Lack of Efficacy|1|||
23433950|NCT01939366|65330627|FG002|Overall Study|Lack of Efficacy|1|||
23433951|NCT01939366|65330628|FG003|Overall Study|Lack of Efficacy|1|||
23433952|NCT01939366|65330629|FG004|Overall Study|Lack of Efficacy|3|||
23433953|NCT01939366|65330625|FG000|Overall Study|Lost to Follow-up|1|||
23433954|NCT01939366|65330626|FG001|Overall Study|Lost to Follow-up|1|||
23433955|NCT01939366|65330627|FG002|Overall Study|Lost to Follow-up|0|||
23433956|NCT01939366|65330628|FG003|Overall Study|Lost to Follow-up|0|||
23433957|NCT01939366|65330629|FG004|Overall Study|Lost to Follow-up|0|||
23433958|NCT01939366|65330625|FG000|Overall Study|Withdrawal by Subject|1|||
23433959|NCT01939366|65330626|FG001|Overall Study|Withdrawal by Subject|0|||
23433960|NCT01939366|65330627|FG002|Overall Study|Withdrawal by Subject|2|||
23433961|NCT01939366|65330628|FG003|Overall Study|Withdrawal by Subject|2|||
23433962|NCT01939366|65330629|FG004|Overall Study|Withdrawal by Subject|3|||
23556323|NCT00785291|65762537|FG002|Overall Study|Other Medical Reasons|15|||
23433963|NCT01939366|65330625|FG000|Overall Study|Inclusion criteria not met|0|||
23433964|NCT01939366|65330626|FG001|Overall Study|Inclusion criteria not met|1|||
23433965|NCT01939366|65330627|FG002|Overall Study|Inclusion criteria not met|1|||
23556324|NCT01059630|65762538|FG000|Overall Study|Death|100|||
23556325|NCT01059630|65762539|FG001|Overall Study|Death|84|||
23433966|NCT01939366|65330628|FG003|Overall Study|Inclusion criteria not met|0|||
23433967|NCT01939366|65330629|FG004|Overall Study|Inclusion criteria not met|1|||
23556326|NCT01059630|65762538|FG000|Overall Study|Lost to Follow-up|4|||
23144460|NCT01589237|64277605|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
23144461|NCT01589237|64277606|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
23144462|NCT01589237|64277607|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
23144463|NCT01589237|64277604|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
23144464|NCT01589237|64277605|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
23144465|NCT01589237|64277606|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
23144466|NCT01589237|64277607|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
23144467|NCT01589237|64277604|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
23144468|NCT01589237|64277605|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
23144469|NCT01589237|64277606|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
23144470|NCT01589237|64277607|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
23556327|NCT01059630|65762539|FG001|Overall Study|Lost to Follow-up|1|||
23556328|NCT01059630|65762538|FG000|Overall Study|Physician Decision|2|||
23556329|NCT01059630|65762539|FG001|Overall Study|Physician Decision|4|||
23144471|NCT01275131|64277611|FG000|Period 1|Withdrawal by Subject|1|||
23144472|NCT01275131|64277612|FG001|Period 1|Withdrawal by Subject|0|||
23556330|NCT01059630|65762538|FG000|Overall Study|Withdrawal by Subject|21|||
23321242|NCT01197911|64919363|FG001|Overall Study|Adverse Event|0|||
23321243|NCT01197911|64919364|FG002|Overall Study|Adverse Event|1|||
23556331|NCT01059630|65762539|FG001|Overall Study|Withdrawal by Subject|14|||
23556332|NCT01843192|65762543|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
23556333|NCT01843192|65762544|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
23144473|NCT01275131|64277613|FG002|Period 1|Withdrawal by Subject|3|||
23144474|NCT01275131|64277614|FG003|Period 1|Withdrawal by Subject|2|||
23144475|NCT01275131|64277611|FG000|Period 1|Physician Decision|1|||
23144476|NCT01275131|64277612|FG001|Period 1|Physician Decision|0|||
23144477|NCT01275131|64277613|FG002|Period 1|Physician Decision|0|||
23144478|NCT01275131|64277614|FG003|Period 1|Physician Decision|0|||
23144479|NCT01275131|64277611|FG000|Period 2 (Crossover)|Adverse Event|0|||
23144480|NCT01275131|64277612|FG001|Period 2 (Crossover)|Adverse Event|1|||
23144481|NCT01275131|64277613|FG002|Period 2 (Crossover)|Adverse Event|0|||
23144482|NCT01275131|64277614|FG003|Period 2 (Crossover)|Adverse Event|0|||
23144483|NCT01275131|64277611|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
23144484|NCT01275131|64277612|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
23144485|NCT01275131|64277613|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
23321244|NCT00065156|64919367|FG000|Overall Study|Adverse Event|37|||
23321245|NCT00065156|64919367|FG000|Overall Study|Lack of Efficacy|52|||
23623509|NCT00684203|66008468|FG000|Overall Study|Protocol-defined clinical event|3|||
23556334|NCT01843192|65762545|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
23556335|NCT01123382|65762548|FG000|Overall Study|Withdrawal by Subject|1|||
23556336|NCT01123382|65762549|FG001|Overall Study|Withdrawal by Subject|4|||
23556337|NCT01123382|65762548|FG000|Overall Study|Lost to Follow-up|1|||
23556338|NCT01123382|65762549|FG001|Overall Study|Lost to Follow-up|2|||
23556339|NCT02114151|65762552|FG000|Overall Study|Death|1|||
23556340|NCT02114151|65762552|FG000|Overall Study|Lost to Follow-up|1|||
23556341|NCT02114151|65762552|FG000|Overall Study|Withdrawal by Subject|5|||
23556342|NCT01844284|65762553|FG000|Overall Study|Lost to Follow-up|12|||
23623510|NCT00684203|66008469|FG001|Overall Study|Protocol-defined clinical event|1|||
23623511|NCT00684203|66008470|FG002|Overall Study|Protocol-defined clinical event|0|||
23623512|NCT00684203|66008471|FG003|Overall Study|Protocol-defined clinical event|0|||
23623513|NCT00684203|66008472|FG004|Overall Study|Protocol-defined clinical event|0|||
23623514|NCT00684203|66008473|FG005|Overall Study|Protocol-defined clinical event|0|||
23433968|NCT01939366|65330625|FG000|Overall Study|Other|0|||
23623515|NCT00684203|66008468|FG000|Overall Study|Withdrawal by Subject|0|||
23321246|NCT00065156|64919367|FG000|Overall Study|Withdrawal by Subject|8|||
23321247|NCT00065156|64919367|FG000|Overall Study|Lost to Follow-up|1|||
23321248|NCT00065156|64919367|FG000|Overall Study|Death|11|||
23321249|NCT00065156|64919367|FG000|Overall Study|Study Closed by Sponsor|2|||
23321250|NCT00065156|64919367|FG000|Overall Study|Disease Progression|7|||
23433969|NCT01939366|65330626|FG001|Overall Study|Other|0|||
23433970|NCT01939366|65330627|FG002|Overall Study|Other|2|||
23556343|NCT01844284|65762554|FG001|Overall Study|Lost to Follow-up|7|||
23556344|NCT01687257|65762555|FG000|Overall Study|Efficacy Failure|6|||
23556345|NCT01687257|65762556|FG001|Overall Study|Efficacy Failure|0|||
23623516|NCT00684203|66008469|FG001|Overall Study|Withdrawal by Subject|2|||
23623517|NCT00684203|66008470|FG002|Overall Study|Withdrawal by Subject|1|||
23144486|NCT01275131|64277614|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
23144487|NCT00759915|64277615|FG000|Overall Study|Withdrawal by Subject|1|||
23321251|NCT00065156|64919367|FG000|Overall Study|Investigator Decision|2|||
23321252|NCT00065156|64919367|FG000|Overall Study|Non-Compliance|2|||
23321253|NCT00065156|64919367|FG000|Overall Study|Loss of Response|1|||
23321254|NCT00065156|64919367|FG000|Overall Study|Secondary Malign Disease|1|||
23556346|NCT01687257|65762557|FG002|Overall Study|Efficacy Failure|5|||
23556347|NCT01687257|65762555|FG000|Overall Study|Subject Withdrew Consent|1|||
23321255|NCT04113018|64919368|FG000|Overall Study|Death|2|||
23321256|NCT04113018|64919368|FG000|Overall Study|Lost to Follow-up|1|||
23321257|NCT04113018|64919368|FG000|Overall Study|Still On Study (on study treatment)|24|||
23321258|NCT04113018|64919368|FG000|Overall Study|Still On Study (in follow up)|12|||
23321259|NCT00100828|64919369|FG000|Overall Study|Physician Decision|6|||
23321260|NCT00356525|64919371|FG000|Overall Study|Progressive Disease|8|||
23321261|NCT00356525|64919372|FG001|Overall Study|Progressive Disease|5|||
23321262|NCT00356525|64919373|FG002|Overall Study|Progressive Disease|4|||
23321263|NCT00356525|64919374|FG003|Overall Study|Progressive Disease|2|||
23321264|NCT00356525|64919371|FG000|Overall Study|Adverse Event|1|||
23321265|NCT00356525|64919372|FG001|Overall Study|Adverse Event|3|||
23321266|NCT00356525|64919373|FG002|Overall Study|Adverse Event|1|||
23321267|NCT00356525|64919374|FG003|Overall Study|Adverse Event|1|||
23321268|NCT00356525|64919371|FG000|Overall Study|Lost to Follow-up|1|||
23321269|NCT00356525|64919372|FG001|Overall Study|Lost to Follow-up|0|||
23321270|NCT00356525|64919373|FG002|Overall Study|Lost to Follow-up|0|||
23321271|NCT00356525|64919374|FG003|Overall Study|Lost to Follow-up|0|||
23321272|NCT00356525|64919371|FG000|Overall Study|Physician Decision|2|||
23433971|NCT01939366|65330628|FG003|Overall Study|Other|2|||
23433972|NCT01939366|65330629|FG004|Overall Study|Other|1|||
23433973|NCT01939366|65330625|FG000|Overall Study|Protocol Violation|0|||
23433974|NCT01939366|65330626|FG001|Overall Study|Protocol Violation|0|||
23144488|NCT00759915|64277616|FG001|Overall Study|Withdrawal by Subject|0|||
23144489|NCT00759915|64277615|FG000|Overall Study|Adverse Event|0|||
23144490|NCT00759915|64277616|FG001|Overall Study|Adverse Event|1|||
23144491|NCT02401867|64277617|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
23144492|NCT02401867|64277617|FG000|Analysis|Cervical assay could not be conducted|9|||
23433975|NCT01939366|65330627|FG002|Overall Study|Protocol Violation|0|||
23556348|NCT01687257|65762556|FG001|Overall Study|Subject Withdrew Consent|1|||
23556349|NCT01687257|65762557|FG002|Overall Study|Subject Withdrew Consent|1|||
23556350|NCT01687257|65762555|FG000|Overall Study|Adverse Event|1|||
23556351|NCT01687257|65762556|FG001|Overall Study|Adverse Event|0|||
23321273|NCT00356525|64919372|FG001|Overall Study|Physician Decision|2|||
23321274|NCT00356525|64919373|FG002|Overall Study|Physician Decision|2|||
23321275|NCT00356525|64919374|FG003|Overall Study|Physician Decision|1|||
23321276|NCT00356525|64919371|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
23321277|NCT00356525|64919372|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
23433976|NCT01939366|65330628|FG003|Overall Study|Protocol Violation|1|||
23144493|NCT01919814|64277618|FG000|Overall Study|Adverse Event|1|||
23218005|NCT01457924|64538479|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
23218006|NCT01457924|64538480|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
23218007|NCT01457924|64538481|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
23218008|NCT01457924|64538482|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
23144494|NCT01919814|64277619|FG001|Overall Study|Adverse Event|0|||
23144495|NCT01919814|64277618|FG000|Overall Study|Protocol Violation|1|||
23144496|NCT01919814|64277619|FG001|Overall Study|Protocol Violation|0|||
23144497|NCT01919814|64277618|FG000|Overall Study|Withdrawal by Subject|1|||
23433977|NCT01939366|65330629|FG004|Overall Study|Protocol Violation|0|||
23433978|NCT01939366|65330625|FG000|Overall Study|Sponsor decision|0|||
23144498|NCT01919814|64277619|FG001|Overall Study|Withdrawal by Subject|0|||
23144499|NCT02499770|64277620|FG000|Overall Study|Death|17|||
23433979|NCT01939366|65330626|FG001|Overall Study|Sponsor decision|0|||
23433980|NCT01939366|65330627|FG002|Overall Study|Sponsor decision|0|||
23556352|NCT01687257|65762557|FG002|Overall Study|Adverse Event|0|||
23556353|NCT01687257|65762555|FG000|Overall Study|Investigator's Discretion|0|||
23556354|NCT01687257|65762556|FG001|Overall Study|Investigator's Discretion|3|||
23556355|NCT01687257|65762557|FG002|Overall Study|Investigator's Discretion|0|||
23556356|NCT00500903|65762558|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
23556357|NCT00500903|65762559|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
23144500|NCT02499770|64277621|FG001|Overall Study|Death|56|||
23144501|NCT02499770|64277620|FG000|Overall Study|Study completion|1|||
23144502|NCT02499770|64277621|FG001|Overall Study|Study completion|10|||
23144503|NCT02499770|64277620|FG000|Overall Study|Withdrawal by Subject|0|||
23144504|NCT02499770|64277621|FG001|Overall Study|Withdrawal by Subject|7|||
23144505|NCT02499770|64277620|FG000|Overall Study|Lost to Follow-up|0|||
23321278|NCT00356525|64919373|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
23321279|NCT00356525|64919374|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
23321280|NCT00356525|64919371|FG000|Overall Study|Withdrawal by Subject|1|||
23321281|NCT00356525|64919372|FG001|Overall Study|Withdrawal by Subject|1|||
23433981|NCT01939366|65330628|FG003|Overall Study|Sponsor decision|0|||
23433982|NCT01939366|65330629|FG004|Overall Study|Sponsor decision|2|||
23321282|NCT00356525|64919373|FG002|Overall Study|Withdrawal by Subject|0|||
23321283|NCT00356525|64919374|FG003|Overall Study|Withdrawal by Subject|3|||
23321284|NCT00356525|64919371|FG000|Overall Study|Death|0|||
23321285|NCT00356525|64919372|FG001|Overall Study|Death|0|||
23321286|NCT00356525|64919373|FG002|Overall Study|Death|0|||
23321287|NCT00356525|64919374|FG003|Overall Study|Death|1|||
23556358|NCT00500903|65762560|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
23144506|NCT02499770|64277621|FG001|Overall Study|Lost to Follow-up|2|||
23144507|NCT02499770|64277620|FG000|Overall Study|Subject declined further treatment|1|||
23144508|NCT02499770|64277621|FG001|Overall Study|Subject declined further treatment|0|||
23144509|NCT02499770|64277620|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
23144510|NCT02499770|64277621|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
23144511|NCT02499770|64277620|FG000|Overall Study|Randomized but not enrolled|0|||
23144512|NCT02499770|64277621|FG001|Overall Study|Randomized but not enrolled|1|||
23144513|NCT00319839|64277624|FG000|Overall Study|Adverse Event|5|||
23144514|NCT00319839|64277624|FG000|Overall Study|Withdrawal by Subject|1|||
23144515|NCT00887432|64277627|FG000|Overall Study|Start Excluded Therapy|3|||
23144516|NCT00887432|64277628|FG001|Overall Study|Start Excluded Therapy|0|||
23144517|NCT00887432|64277627|FG000|Overall Study|Did not complete treatment|6|||
23144518|NCT00887432|64277628|FG001|Overall Study|Did not complete treatment|8|||
23144519|NCT00887432|64277627|FG000|Overall Study|Protocol Violation|2|||
23144520|NCT00887432|64277628|FG001|Overall Study|Protocol Violation|3|||
23144521|NCT00887432|64277627|FG000|Overall Study|Withdrawal by Subject|3|||
23144522|NCT00887432|64277628|FG001|Overall Study|Withdrawal by Subject|2|||
23144523|NCT00887432|64277627|FG000|Overall Study|Lost to Follow-up|1|||
23144524|NCT00887432|64277628|FG001|Overall Study|Lost to Follow-up|0|||
23144525|NCT00887432|64277627|FG000|Overall Study|No reason provided|0|||
23144526|NCT00887432|64277628|FG001|Overall Study|No reason provided|1|||
23144527|NCT01036763|64277629|FG000|Overall Study|Adverse Event|25|||
23144528|NCT01036763|64277629|FG000|Overall Study|Lost to Follow-up|28|||
23433983|NCT01939366|65330625|FG000|Overall Study|GCP non-compliance at site|2|||
23433984|NCT01939366|65330626|FG001|Overall Study|GCP non-compliance at site|3|||
23433985|NCT01939366|65330627|FG002|Overall Study|GCP non-compliance at site|2|||
23433986|NCT01939366|65330628|FG003|Overall Study|GCP non-compliance at site|3|||
23433987|NCT01939366|65330629|FG004|Overall Study|GCP non-compliance at site|3|||
23433988|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
23433989|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
23433990|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
23433991|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
23433992|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
23433993|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
23433994|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
23433995|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
23433996|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
23433997|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
23433998|NCT01263015|65330630|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
23433999|NCT01263015|65330631|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
23434000|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
23434001|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
23434002|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
23434003|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
23434004|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
23434005|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
23434006|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
23434007|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
23434008|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
23434009|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
23434010|NCT01263015|65330630|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
23434011|NCT01263015|65330631|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
23434012|NCT01972789|65330632|FG000|Overall Study|Adverse Event|11|||
23434013|NCT01972789|65330633|FG001|Overall Study|Adverse Event|4|||
23434014|NCT01972789|65330632|FG000|Overall Study|Subject withdrew consent|14|||
23434015|NCT01972789|65330633|FG001|Overall Study|Subject withdrew consent|12|||
23434016|NCT01972789|65330632|FG000|Overall Study|Lost to Follow-up|4|||
23434017|NCT01972789|65330633|FG001|Overall Study|Lost to Follow-up|7|||
23434018|NCT01972789|65330632|FG000|Overall Study|Death|7|||
23434019|NCT01972789|65330633|FG001|Overall Study|Death|5|||
23434020|NCT01972789|65330632|FG000|Overall Study|Protocol deviation|1|||
23434021|NCT01972789|65330633|FG001|Overall Study|Protocol deviation|0|||
23434022|NCT01972789|65330632|FG000|Overall Study|Physician Decision|3|||
23144529|NCT01036763|64277629|FG000|Overall Study|Other reason (not specified)|40|||
23144530|NCT00372385|64277630|FG000|Overall Study|Adverse Event|6|||
23144531|NCT00372385|64277631|FG001|Overall Study|Adverse Event|11|||
23434023|NCT01972789|65330633|FG001|Overall Study|Physician Decision|2|||
23434024|NCT02708485|65330634|FG000|Overall Study|Withdrawal by Subject|3|||
23434025|NCT02708485|65330635|FG001|Overall Study|Withdrawal by Subject|2|||
23623518|NCT00684203|66008471|FG003|Overall Study|Withdrawal by Subject|0|||
23623519|NCT00684203|66008472|FG004|Overall Study|Withdrawal by Subject|0|||
23144532|NCT00372385|64277632|FG002|Overall Study|Adverse Event|9|||
23144533|NCT00372385|64277633|FG003|Overall Study|Adverse Event|7|||
23434026|NCT02301624|65330636|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
23434027|NCT02301624|65330637|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
23144534|NCT00372385|64277630|FG000|Overall Study|Noncompliance|0|||
23144535|NCT00372385|64277631|FG001|Overall Study|Noncompliance|1|||
23144536|NCT00372385|64277632|FG002|Overall Study|Noncompliance|1|||
23144537|NCT00372385|64277633|FG003|Overall Study|Noncompliance|1|||
23144538|NCT00372385|64277630|FG000|Overall Study|Physician Decision|1|||
23144539|NCT00372385|64277631|FG001|Overall Study|Physician Decision|0|||
23144540|NCT00372385|64277632|FG002|Overall Study|Physician Decision|0|||
23434028|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
23434029|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
23434030|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Adverse Event|2|||
23434031|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Adverse Event|5|||
23434032|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Physician Decision|3|||
23434033|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Physician Decision|3|||
23434034|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Death|2|||
23434035|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Death|1|||
23434036|NCT02301624|65330636|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
23434037|NCT02301624|65330637|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
23434038|NCT00279812|65330638|FG000|Overall Study|Protocol Violation|1|||
23434039|NCT00279812|65330639|FG001|Overall Study|Protocol Violation|1|||
23434040|NCT00279812|65330640|FG002|Overall Study|Protocol Violation|0|||
23434041|NCT00279812|65330641|FG003|Overall Study|Protocol Violation|0|||
23434042|NCT00279812|65330642|FG004|Overall Study|Protocol Violation|1|||
23434043|NCT00279812|65330643|FG005|Overall Study|Protocol Violation|0|||
23434044|NCT00279812|65330638|FG000|Overall Study|Withdrawal by Subject|0|||
23434045|NCT00279812|65330639|FG001|Overall Study|Withdrawal by Subject|4|||
23434046|NCT00279812|65330640|FG002|Overall Study|Withdrawal by Subject|2|||
23434047|NCT00279812|65330641|FG003|Overall Study|Withdrawal by Subject|0|||
23434048|NCT00279812|65330642|FG004|Overall Study|Withdrawal by Subject|0|||
23434049|NCT00279812|65330643|FG005|Overall Study|Withdrawal by Subject|0|||
23434050|NCT00279812|65330638|FG000|Overall Study|Adverse Event|0|||
23434051|NCT00279812|65330639|FG001|Overall Study|Adverse Event|1|||
23434052|NCT00279812|65330640|FG002|Overall Study|Adverse Event|1|||
23434053|NCT00279812|65330641|FG003|Overall Study|Adverse Event|0|||
23434054|NCT00279812|65330642|FG004|Overall Study|Adverse Event|2|||
23434055|NCT00279812|65330643|FG005|Overall Study|Adverse Event|1|||
23434056|NCT01895309|65330645|FG000|Overall Study|Adverse Event|13|||
23434057|NCT01895309|65330646|FG001|Overall Study|Adverse Event|17|||
23434058|NCT01895309|65330645|FG000|Overall Study|Protocol Violation|1|||
23434059|NCT01895309|65330646|FG001|Overall Study|Protocol Violation|0|||
23434060|NCT01895309|65330645|FG000|Overall Study|Lack of Efficacy|1|||
23434061|NCT01895309|65330646|FG001|Overall Study|Lack of Efficacy|3|||
23434062|NCT01895309|65330645|FG000|Overall Study|Lost to Follow-up|1|||
23434063|NCT01895309|65330646|FG001|Overall Study|Lost to Follow-up|3|||
23434064|NCT01895309|65330645|FG000|Overall Study|Physician Decision|15|||
23434065|NCT01895309|65330646|FG001|Overall Study|Physician Decision|10|||
23434066|NCT01895309|65330645|FG000|Overall Study|Withdrawal by Subject|9|||
23434067|NCT01895309|65330646|FG001|Overall Study|Withdrawal by Subject|18|||
23434068|NCT03263780|65330654|FG000|Overall Study|Withdrawal by Subject|3|||
23434069|NCT03263780|65330654|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
23434070|NCT02678923|65330657|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
23434071|NCT02678923|65330658|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
23434072|NCT02678923|65330657|FG000|Overall Study|Withdrawal by Subject|3|||
23434073|NCT02678923|65330658|FG001|Overall Study|Withdrawal by Subject|2|||
23434074|NCT02678923|65330657|FG000|Overall Study|Lost to Follow-up|1|||
23434075|NCT02678923|65330658|FG001|Overall Study|Lost to Follow-up|0|||
23434076|NCT02678923|65330657|FG000|Overall Study|Did Not Return for Study Visits|1|||
23434077|NCT02678923|65330658|FG001|Overall Study|Did Not Return for Study Visits|0|||
23434078|NCT03597061|65330659|FG000|Overall Study|Lost to Follow-up|1|||
23434079|NCT03597061|65330660|FG001|Overall Study|Lost to Follow-up|0|||
23434080|NCT03597061|65330659|FG000|Overall Study|Protocol Violation|0|||
23434081|NCT03597061|65330660|FG001|Overall Study|Protocol Violation|1|||
23434082|NCT00849108|65330662|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
23556359|NCT00500903|65762558|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
23144541|NCT00372385|64277633|FG003|Overall Study|Physician Decision|0|||
23144542|NCT00372385|64277630|FG000|Overall Study|Lost to Follow-up|2|||
23218009|NCT01457924|64538483|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
23434083|NCT00849108|65330663|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
23434084|NCT00849108|65330662|FG000|Cohort 2 Efficacy|Adverse Event|0|||
23434085|NCT00849108|65330663|FG001|Cohort 2 Efficacy|Adverse Event|1|||
23434086|NCT00849108|65330662|FG000|Cohort 2 Efficacy|Other|0|||
23144543|NCT00372385|64277631|FG001|Overall Study|Lost to Follow-up|0|||
23434087|NCT00849108|65330663|FG001|Cohort 2 Efficacy|Other|9|||
23434088|NCT04046250|65333987|FG000|Overall Study|Death|0|||
23434089|NCT04046250|65333988|FG001|Overall Study|Death|1|||
23434090|NCT04046250|65333987|FG000|Overall Study|Withdrawal by Subject|3|||
23434091|NCT04046250|65333988|FG001|Overall Study|Withdrawal by Subject|3|||
23434092|NCT02708355|65333989|FG000|Overall Study|Adverse Event|1|||
23434093|NCT02708355|65333990|FG001|Overall Study|Adverse Event|0|||
23434094|NCT02708355|65333991|FG002|Overall Study|Adverse Event|0|||
23434095|NCT00902174|65333992|FG000|Overall Study|Adverse Event|27|||
23434096|NCT00902174|65333993|FG001|Overall Study|Adverse Event|7|||
23434097|NCT00902174|65333992|FG000|Overall Study|Lack of Efficacy|1|||
23434098|NCT00902174|65333993|FG001|Overall Study|Lack of Efficacy|5|||
23434099|NCT00902174|65333992|FG000|Overall Study|Death|2|||
23434100|NCT00902174|65333993|FG001|Overall Study|Death|2|||
23434101|NCT00902174|65333992|FG000|Overall Study|Withdrawal by Subject|2|||
23434102|NCT00902174|65333993|FG001|Overall Study|Withdrawal by Subject|1|||
23434103|NCT00902174|65333992|FG000|Overall Study|Abnormal labs|1|||
23434104|NCT00902174|65333993|FG001|Overall Study|Abnormal labs|1|||
23434105|NCT00902174|65333992|FG000|Overall Study|Protocol Violation|1|||
23434106|NCT00902174|65333993|FG001|Overall Study|Protocol Violation|1|||
23434107|NCT00902174|65333992|FG000|Overall Study|Administration problem|0|||
23434108|NCT00902174|65333993|FG001|Overall Study|Administration problem|1|||
23434109|NCT01639755|65333999|FG000|Overall Study|Study Ongoing|15|||
23434110|NCT01639755|65333999|FG000|Overall Study|Patient had device explantation|4|||
23434111|NCT02262754|65334000|FG000|Overall Study|Adverse Event|3|||
23434112|NCT02262754|65334001|FG001|Overall Study|Adverse Event|4|||
23434113|NCT02262754|65334002|FG002|Overall Study|Adverse Event|0|||
23434114|NCT02262754|65334000|FG000|Overall Study|Lack of Efficacy|2|||
23434115|NCT02262754|65334001|FG001|Overall Study|Lack of Efficacy|0|||
23434116|NCT02262754|65334002|FG002|Overall Study|Lack of Efficacy|1|||
23434117|NCT02262754|65334000|FG000|Overall Study|Lost to Follow-up|0|||
23434118|NCT02262754|65334001|FG001|Overall Study|Lost to Follow-up|0|||
23434119|NCT02262754|65334002|FG002|Overall Study|Lost to Follow-up|1|||
23434120|NCT02262754|65334000|FG000|Overall Study|No longer meets eligibility criteria|0|||
23434121|NCT02262754|65334001|FG001|Overall Study|No longer meets eligibility criteria|1|||
23434122|NCT02262754|65334002|FG002|Overall Study|No longer meets eligibility criteria|0|||
23434123|NCT02262754|65334000|FG000|Overall Study|Study terminated by sponsor|5|||
23434124|NCT02262754|65334001|FG001|Overall Study|Study terminated by sponsor|4|||
23434125|NCT02262754|65334002|FG002|Overall Study|Study terminated by sponsor|4|||
23434126|NCT02262754|65334000|FG000|Overall Study|Protocol Violation|1|||
23434127|NCT02262754|65334001|FG001|Overall Study|Protocol Violation|0|||
23434128|NCT02262754|65334002|FG002|Overall Study|Protocol Violation|0|||
23434129|NCT02262754|65334000|FG000|Overall Study|Withdrawal by Subject|1|||
23434130|NCT02262754|65334001|FG001|Overall Study|Withdrawal by Subject|0|||
23434131|NCT02262754|65334002|FG002|Overall Study|Withdrawal by Subject|1|||
23434132|NCT02262754|65334000|FG000|Overall Study|Other|4|||
23434133|NCT02262754|65334001|FG001|Overall Study|Other|0|||
23434134|NCT02262754|65334002|FG002|Overall Study|Other|2|||
23434135|NCT01990859|65334005|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
23434136|NCT01990859|65334005|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
23434137|NCT01299116|65334006|FG000|Overall Study|Lost to Follow-up|65|||
23434138|NCT01299116|65334007|FG001|Overall Study|Lost to Follow-up|9|||
23434139|NCT01299116|65334008|FG002|Overall Study|Lost to Follow-up|11|||
23434140|NCT03664765|65334009|FG000|Overall Study|Withdrawal by Subject|4|||
23434141|NCT03664765|65334010|FG001|Overall Study|Withdrawal by Subject|1|||
23434142|NCT03664765|65334009|FG000|Overall Study|Lost to Follow-up|0|||
23434143|NCT03664765|65334010|FG001|Overall Study|Lost to Follow-up|1|||
23434144|NCT00545103|65334015|FG000|Overall Study|Lack of Efficacy|48|||
23434145|NCT00545103|65334016|FG001|Overall Study|Lack of Efficacy|45|||
23434146|NCT00545103|65334017|FG002|Overall Study|Lack of Efficacy|31|||
23434147|NCT00545103|65334018|FG003|Overall Study|Lack of Efficacy|27|||
23434148|NCT00545103|65334015|FG000|Overall Study|Withdrawal by Subject|6|||
23434149|NCT00545103|65334016|FG001|Overall Study|Withdrawal by Subject|10|||
23434150|NCT00545103|65334017|FG002|Overall Study|Withdrawal by Subject|18|||
23434151|NCT00545103|65334018|FG003|Overall Study|Withdrawal by Subject|22|||
23434152|NCT00545103|65334015|FG000|Overall Study|Adverse Event|11|||
23434153|NCT00545103|65334016|FG001|Overall Study|Adverse Event|12|||
23434154|NCT00545103|65334017|FG002|Overall Study|Adverse Event|17|||
23434155|NCT00545103|65334018|FG003|Overall Study|Adverse Event|10|||
23434156|NCT00545103|65334015|FG000|Overall Study|Lost to Follow-up|4|||
23434157|NCT00545103|65334016|FG001|Overall Study|Lost to Follow-up|6|||
23434158|NCT00545103|65334017|FG002|Overall Study|Lost to Follow-up|3|||
23434159|NCT00545103|65334018|FG003|Overall Study|Lost to Follow-up|4|||
23434160|NCT00545103|65334015|FG000|Overall Study|Protocol Violation|1|||
23434161|NCT00545103|65334016|FG001|Overall Study|Protocol Violation|2|||
23321288|NCT00356525|64919371|FG000|Overall Study|Sponsor Decision|0|||
23434162|NCT00545103|65334017|FG002|Overall Study|Protocol Violation|3|||
23434163|NCT00545103|65334018|FG003|Overall Study|Protocol Violation|0|||
23434164|NCT00545103|65334015|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
23434165|NCT00545103|65334016|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
23434166|NCT00545103|65334017|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
23434167|NCT00545103|65334018|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
23434168|NCT00545103|65334015|FG000|Overall Study|Difficult to open package|0|||
23434169|NCT00545103|65334016|FG001|Overall Study|Difficult to open package|0|||
23434170|NCT00545103|65334017|FG002|Overall Study|Difficult to open package|0|||
23434171|NCT00545103|65334018|FG003|Overall Study|Difficult to open package|1|||
23434172|NCT00545103|65334015|FG000|Overall Study|Investigational product not taken|1|||
23434173|NCT00545103|65334016|FG001|Overall Study|Investigational product not taken|0|||
23434174|NCT00545103|65334017|FG002|Overall Study|Investigational product not taken|0|||
23434175|NCT00545103|65334018|FG003|Overall Study|Investigational product not taken|1|||
23434176|NCT00545103|65334015|FG000|Overall Study|Wish to start a family|0|||
23434177|NCT00545103|65334016|FG001|Overall Study|Wish to start a family|0|||
23434178|NCT00545103|65334017|FG002|Overall Study|Wish to start a family|0|||
23434179|NCT00545103|65334018|FG003|Overall Study|Wish to start a family|1|||
23434180|NCT00545103|65334015|FG000|Overall Study|Diverticulitis crisis|0|||
23434181|NCT00545103|65334016|FG001|Overall Study|Diverticulitis crisis|0|||
23434182|NCT00545103|65334017|FG002|Overall Study|Diverticulitis crisis|0|||
23434183|NCT00545103|65334018|FG003|Overall Study|Diverticulitis crisis|1|||
23434184|NCT00545103|65334015|FG000|Overall Study|Personal reasons|1|||
23434185|NCT00545103|65334016|FG001|Overall Study|Personal reasons|0|||
23434186|NCT00545103|65334017|FG002|Overall Study|Personal reasons|0|||
23556360|NCT00500903|65762559|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
23556361|NCT00500903|65762560|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23556362|NCT00500903|65762558|FG000|Overall Study|Progressive Disease|41|||
23556363|NCT00500903|65762559|FG001|Overall Study|Progressive Disease|2|||
23556364|NCT00500903|65762560|FG002|Overall Study|Progressive Disease|15|||
23321289|NCT00356525|64919372|FG001|Overall Study|Sponsor Decision|0|||
23321290|NCT00356525|64919373|FG002|Overall Study|Sponsor Decision|0|||
23321291|NCT00356525|64919374|FG003|Overall Study|Sponsor Decision|1|||
23321292|NCT01610492|64919375|FG000|Overall Study|Adverse Event|1|||
23321293|NCT01610492|64919375|FG000|Overall Study|Lack of Efficacy|3|||
23321294|NCT01610492|64919375|FG000|Overall Study|Other: Reached stopping criteria|1|||
23321295|NCT01610492|64919375|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
23321296|NCT03830333|64919378|FG000|Overall Study|Death|0|||
23321297|NCT03830333|64919379|FG001|Overall Study|Death|1|||
23321298|NCT03830333|64919378|FG000|Overall Study|Withdrawal by Subject|5|||
23321299|NCT03830333|64919379|FG001|Overall Study|Withdrawal by Subject|1|||
23321300|NCT03830333|64919378|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
23321301|NCT03830333|64919379|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
23321302|NCT01090414|64919380|FG000|Study 101-99|Progressive Disease|28|||
23321303|NCT01090414|64919381|FG001|Study 101-99|Progressive Disease|48|||
23321304|NCT01090414|64919382|FG002|Study 101-99|Progressive Disease|10|||
23321305|NCT01090414|64919383|FG003|Study 101-99|Progressive Disease|4|||
23321306|NCT01090414|64919380|FG000|Study 101-99|Adverse Event|10|||
23321307|NCT01090414|64919381|FG001|Study 101-99|Adverse Event|28|||
23321308|NCT01090414|64919382|FG002|Study 101-99|Adverse Event|18|||
23321309|NCT01090414|64919383|FG003|Study 101-99|Adverse Event|0|||
23321310|NCT01090414|64919380|FG000|Study 101-99|Investigator Request|1|||
23321311|NCT01090414|64919381|FG001|Study 101-99|Investigator Request|11|||
23321312|NCT01090414|64919382|FG002|Study 101-99|Investigator Request|4|||
23321313|NCT01090414|64919383|FG003|Study 101-99|Investigator Request|0|||
23321314|NCT01090414|64919380|FG000|Study 101-99|Death|3|||
23321315|NCT01090414|64919381|FG001|Study 101-99|Death|8|||
23321316|NCT01090414|64919382|FG002|Study 101-99|Death|1|||
23321317|NCT01090414|64919383|FG003|Study 101-99|Death|0|||
23321318|NCT01090414|64919380|FG000|Study 101-99|Sponsor Discontinued Study|0|||
23321319|NCT01090414|64919381|FG001|Study 101-99|Sponsor Discontinued Study|7|||
23321320|NCT01090414|64919382|FG002|Study 101-99|Sponsor Discontinued Study|5|||
23321321|NCT01090414|64919383|FG003|Study 101-99|Sponsor Discontinued Study|0|||
23321322|NCT01090414|64919380|FG000|Study 101-99|Other (Unknown Reasons)|3|||
23321323|NCT01090414|64919381|FG001|Study 101-99|Other (Unknown Reasons)|3|||
23321324|NCT01090414|64919382|FG002|Study 101-99|Other (Unknown Reasons)|0|||
23321325|NCT01090414|64919383|FG003|Study 101-99|Other (Unknown Reasons)|0|||
23321326|NCT01090414|64919380|FG000|Study 101-99|Withdrew Consent|0|||
23321327|NCT01090414|64919381|FG001|Study 101-99|Withdrew Consent|2|||
23321328|NCT01090414|64919382|FG002|Study 101-99|Withdrew Consent|3|||
23321329|NCT01090414|64919383|FG003|Study 101-99|Withdrew Consent|1|||
23321330|NCT01090414|64919380|FG000|Study 101-99|Participant Request|3|||
23321331|NCT01090414|64919381|FG001|Study 101-99|Participant Request|1|||
23321332|NCT01090414|64919382|FG002|Study 101-99|Participant Request|0|||
23321333|NCT01090414|64919383|FG003|Study 101-99|Participant Request|0|||
23321334|NCT02493660|64919384|FG000|Overall Study|Physician Decision|0|||
23321335|NCT02493660|64919385|FG001|Overall Study|Physician Decision|1|||
23321336|NCT02493660|64919384|FG000|Overall Study|Adverse Event|4|||
23321337|NCT02493660|64919385|FG001|Overall Study|Adverse Event|2|||
23321338|NCT02493660|64919384|FG000|Overall Study|Withdrawal by Subject|2|||
23321339|NCT02493660|64919385|FG001|Overall Study|Withdrawal by Subject|3|||
23434187|NCT00545103|65334018|FG003|Overall Study|Personal reasons|0|||
23434188|NCT00545103|65334015|FG000|Overall Study|Subject's decision|1|||
23434189|NCT00545103|65334016|FG001|Overall Study|Subject's decision|0|||
23434190|NCT00545103|65334017|FG002|Overall Study|Subject's decision|0|||
23434191|NCT00545103|65334018|FG003|Overall Study|Subject's decision|0|||
23434192|NCT00545103|65334015|FG000|Overall Study|Noncompliance|0|||
23434193|NCT00545103|65334016|FG001|Overall Study|Noncompliance|1|||
23434194|NCT00545103|65334017|FG002|Overall Study|Noncompliance|0|||
23434195|NCT00545103|65334018|FG003|Overall Study|Noncompliance|0|||
23434196|NCT00545103|65334015|FG000|Overall Study|Investigator decision|0|||
23434197|NCT00545103|65334016|FG001|Overall Study|Investigator decision|0|||
23434198|NCT00545103|65334017|FG002|Overall Study|Investigator decision|1|||
23434199|NCT00545103|65334018|FG003|Overall Study|Investigator decision|0|||
23434200|NCT00545103|65334015|FG000|Overall Study|Subject moved|0|||
23434201|NCT00545103|65334016|FG001|Overall Study|Subject moved|1|||
23434202|NCT00545103|65334017|FG002|Overall Study|Subject moved|0|||
23434203|NCT00545103|65334018|FG003|Overall Study|Subject moved|0|||
23434204|NCT00545103|65334015|FG000|Overall Study|Use of prohibited medication|0|||
23434205|NCT00545103|65334016|FG001|Overall Study|Use of prohibited medication|0|||
23434206|NCT00545103|65334017|FG002|Overall Study|Use of prohibited medication|1|||
23434207|NCT00545103|65334018|FG003|Overall Study|Use of prohibited medication|0|||
23434208|NCT00545103|65334015|FG000|Overall Study|Does not want to take study drug anymore|1|||
23434209|NCT00545103|65334016|FG001|Overall Study|Does not want to take study drug anymore|0|||
23434210|NCT00545103|65334017|FG002|Overall Study|Does not want to take study drug anymore|1|||
23434211|NCT00545103|65334018|FG003|Overall Study|Does not want to take study drug anymore|0|||
23434212|NCT00545103|65334015|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
23434213|NCT00545103|65334016|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
23434214|NCT00545103|65334017|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
23434215|NCT00545103|65334018|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
23434216|NCT00545103|65334015|FG000|Overall Study|Death|0|||
23434217|NCT00545103|65334016|FG001|Overall Study|Death|1|||
23144544|NCT00372385|64277632|FG002|Overall Study|Lost to Follow-up|0|||
23144545|NCT00372385|64277633|FG003|Overall Study|Lost to Follow-up|0|||
23144546|NCT00372385|64277630|FG000|Overall Study|Withdrawal by Subject|2|||
23144547|NCT00372385|64277631|FG001|Overall Study|Withdrawal by Subject|1|||
23144548|NCT00372385|64277632|FG002|Overall Study|Withdrawal by Subject|0|||
23144549|NCT00372385|64277633|FG003|Overall Study|Withdrawal by Subject|0|||
23144550|NCT00372385|64277630|FG000|Overall Study|Refusal of Treatment|3|||
23144551|NCT00372385|64277631|FG001|Overall Study|Refusal of Treatment|6|||
23144552|NCT00372385|64277632|FG002|Overall Study|Refusal of Treatment|0|||
23144553|NCT00372385|64277633|FG003|Overall Study|Refusal of Treatment|0|||
23144554|NCT00372385|64277630|FG000|Overall Study|No Response|1|||
23144555|NCT00372385|64277631|FG001|Overall Study|No Response|1|||
23144556|NCT00372385|64277632|FG002|Overall Study|No Response|0|||
23144557|NCT00372385|64277633|FG003|Overall Study|No Response|0|||
23144558|NCT00372385|64277630|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
23144559|NCT00372385|64277631|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
23144560|NCT00372385|64277632|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
23144561|NCT00372385|64277633|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
23144562|NCT00372385|64277630|FG000|Overall Study|Virologic Stopping Rule|17|||
23144563|NCT00372385|64277631|FG001|Overall Study|Virologic Stopping Rule|0|||
23144564|NCT00372385|64277632|FG002|Overall Study|Virologic Stopping Rule|0|||
23144565|NCT00372385|64277633|FG003|Overall Study|Virologic Stopping Rule|0|||
23144566|NCT00799513|64277634|FG000|Overall Study|Physician Decision|1|||
23144567|NCT00799513|64277634|FG000|Overall Study|Adverse Event|1|||
23144568|NCT00505284|64277635|FG000|Overall Study|Adverse Event|3|||
23144569|NCT00505284|64277636|FG001|Overall Study|Adverse Event|7|||
23144570|NCT00505284|64277637|FG002|Overall Study|Adverse Event|9|||
23434218|NCT00545103|65334017|FG002|Overall Study|Death|0|||
23434219|NCT00545103|65334018|FG003|Overall Study|Death|0|||
23434220|NCT04268745|65334020|FG000|Overall Study|Lost to Follow-up|2|||
23434221|NCT04268745|65334021|FG001|Overall Study|Lost to Follow-up|3|||
23434222|NCT04268745|65334020|FG000|Overall Study|Withdrawal by Subject|4|||
23434223|NCT04268745|65334021|FG001|Overall Study|Withdrawal by Subject|2|||
23434224|NCT04268745|65334020|FG000|Overall Study|Death in the family|1|||
23434225|NCT04268745|65334021|FG001|Overall Study|Death in the family|0|||
23434226|NCT03688100|65334022|FG000|Overall Study|Lost to Follow-up|21|||
23434227|NCT03688100|65334023|FG001|Overall Study|Lost to Follow-up|15|||
23434228|NCT03688100|65334024|FG002|Overall Study|Lost to Follow-up|15|||
23434229|NCT03688100|65334025|FG003|Overall Study|Lost to Follow-up|18|||
23434230|NCT03688100|65334022|FG000|Overall Study|Withdrawal by Subject|19|||
23144571|NCT00505284|64277638|FG003|Overall Study|Adverse Event|14|||
23144572|NCT00505284|64277639|FG004|Overall Study|Adverse Event|22|||
23144573|NCT00505284|64277635|FG000|Overall Study|Protocol Violation|0|||
23144574|NCT00505284|64277636|FG001|Overall Study|Protocol Violation|1|||
23434231|NCT03688100|65334023|FG001|Overall Study|Withdrawal by Subject|16|||
23434232|NCT03688100|65334024|FG002|Overall Study|Withdrawal by Subject|0|||
23434233|NCT03688100|65334025|FG003|Overall Study|Withdrawal by Subject|0|||
23434234|NCT03688100|65334022|FG000|Overall Study|Death|36|||
23434235|NCT03688100|65334023|FG001|Overall Study|Death|27|||
23434236|NCT03688100|65334024|FG002|Overall Study|Death|0|||
23434237|NCT03688100|65334025|FG003|Overall Study|Death|0|||
23434238|NCT01270256|65334031|FG000|Overall Study|Withdrawal by Subject|1|||
23434239|NCT01270256|65334032|FG001|Overall Study|Withdrawal by Subject|0|||
23434240|NCT02607228|65334033|FG000|Overall Study|Progressive Disease|4|||
23434241|NCT02607228|65334034|FG001|Overall Study|Progressive Disease|3|||
23321340|NCT02493660|64919384|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
23321341|NCT02493660|64919385|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
23321342|NCT02493660|64919384|FG000|Overall Study|Protocol Violation|0|||
23321343|NCT02493660|64919385|FG001|Overall Study|Protocol Violation|1|||
23321344|NCT02493660|64919384|FG000|Overall Study|Death|0|||
23321345|NCT02493660|64919385|FG001|Overall Study|Death|1|||
23321346|NCT02493660|64919384|FG000|Overall Study|Lost to Follow-up|2|||
23321347|NCT02493660|64919385|FG001|Overall Study|Lost to Follow-up|4|||
23321348|NCT03052751|64919389|FG000|Dosing Period 1|Adverse Event|0|||
23321349|NCT03052751|64919390|FG001|Dosing Period 1|Adverse Event|1|||
23321350|NCT03052751|64919391|FG002|Dosing Period 1|Adverse Event|0|||
23321351|NCT03052751|64919392|FG003|Dosing Period 1|Adverse Event|0|||
23321352|NCT03052751|64919393|FG004|Dosing Period 1|Adverse Event|0|||
23321353|NCT03052751|64919394|FG005|Dosing Period 1|Adverse Event|0|||
23321354|NCT03052751|64919389|FG000|Dosing Period 2|Adverse Event|0|||
23321355|NCT03052751|64919390|FG001|Dosing Period 2|Adverse Event|0|||
23321356|NCT03052751|64919391|FG002|Dosing Period 2|Adverse Event|3|||
23321357|NCT03052751|64919392|FG003|Dosing Period 2|Adverse Event|0|||
23321358|NCT03052751|64919393|FG004|Dosing Period 2|Adverse Event|0|||
23321359|NCT03052751|64919394|FG005|Dosing Period 2|Adverse Event|0|||
23321360|NCT03052751|64919389|FG000|Observation Period|Adverse Event|0|||
23321361|NCT03052751|64919390|FG001|Observation Period|Adverse Event|0|||
23321362|NCT03052751|64919391|FG002|Observation Period|Adverse Event|0|||
23321363|NCT03052751|64919392|FG003|Observation Period|Adverse Event|0|||
23321364|NCT03052751|64919393|FG004|Observation Period|Adverse Event|1|||
23321365|NCT03052751|64919394|FG005|Observation Period|Adverse Event|0|||
23321366|NCT01762800|64919395|FG000|Overall Study|Adverse Event|8|||
23321367|NCT01762800|64919396|FG001|Overall Study|Adverse Event|13|||
23321368|NCT01762800|64919395|FG000|Overall Study|Lack of Efficacy|3|||
23321369|NCT01762800|64919396|FG001|Overall Study|Lack of Efficacy|2|||
23321370|NCT01762800|64919395|FG000|Overall Study|Study Closed/Terminated|0|||
23321371|NCT01762800|64919396|FG001|Overall Study|Study Closed/Terminated|1|||
23321372|NCT01762800|64919395|FG000|Overall Study|Physician Decision|1|||
23321373|NCT01762800|64919396|FG001|Overall Study|Physician Decision|1|||
23321374|NCT01762800|64919395|FG000|Overall Study|Withdrawal by Subject|7|||
23321375|NCT01762800|64919396|FG001|Overall Study|Withdrawal by Subject|4|||
23321376|NCT03875508|64919397|FG000|Overall Study|Adverse Event|1|||
23321377|NCT03875508|64919397|FG000|Overall Study|Lost to Follow-up|8|||
23321378|NCT03875508|64919397|FG000|Overall Study|Lack of Efficacy|1|||
23321379|NCT03875508|64919397|FG000|Overall Study|Other, not specified|2|||
23321380|NCT03953612|64919398|FG000|Overall Study|Randomized but did not start|1|||
23321381|NCT03953612|64919399|FG001|Overall Study|Randomized but did not start|1|||
23321382|NCT03953612|64919400|FG002|Overall Study|Randomized but did not start|1|||
23321383|NCT03953612|64919398|FG000|Overall Study|Withdrawal by Subject|2|||
23321384|NCT03953612|64919399|FG001|Overall Study|Withdrawal by Subject|1|||
23321385|NCT03953612|64919400|FG002|Overall Study|Withdrawal by Subject|0|||
23321386|NCT03910673|64919401|FG000|Overall Study|Adverse Event|0|||
23321387|NCT03910673|64919402|FG001|Overall Study|Adverse Event|0|||
23321388|NCT03910673|64919403|FG002|Overall Study|Adverse Event|0|||
23321389|NCT03910673|64919404|FG003|Overall Study|Adverse Event|2|||
23321390|NCT03910673|64919405|FG004|Overall Study|Adverse Event|0|||
23321391|NCT03717012|64919409|FG000|Overall Study|Due to trial termination|1|||
23321392|NCT03717012|64919410|FG001|Overall Study|Due to trial termination|2|||
23321393|NCT03717012|64919409|FG000|Overall Study|Protocol Violation|0|||
23321394|NCT03717012|64919410|FG001|Overall Study|Protocol Violation|2|||
23321395|NCT03717012|64919409|FG000|Overall Study|Adverse Event|0|||
23321396|NCT03717012|64919410|FG001|Overall Study|Adverse Event|1|||
23321397|NCT03717012|64919409|FG000|Overall Study|Lung transplant|0|||
23321398|NCT03717012|64919410|FG001|Overall Study|Lung transplant|1|||
23321399|NCT01870778|64919411|FG000|Overall Study|Withdrawal by Subject|8|||
23321400|NCT01870778|64919412|FG001|Overall Study|Withdrawal by Subject|7|||
23321401|NCT01870778|64919411|FG000|Overall Study|Lost to Follow-up|0|||
23434242|NCT02607228|65334035|FG002|Overall Study|Progressive Disease|1|||
23321402|NCT01870778|64919412|FG001|Overall Study|Lost to Follow-up|2|||
23321403|NCT02864992|64919413|FG000|Overall Study|still on treatment|15|||
23321404|NCT02864992|64919414|FG001|Overall Study|still on treatment|1|||
23321405|NCT02864992|64919415|FG002|Overall Study|still on treatment|33|||
23321406|NCT03267212|64919416|FG000|First Intervention|Lost to Follow-up|0|||
23321407|NCT03267212|64919417|FG001|First Intervention|Lost to Follow-up|2|||
23321408|NCT03267212|64919416|FG000|First Intervention|Withdrawal by Subject|1|||
23434243|NCT02607228|65334036|FG003|Overall Study|Progressive Disease|5|||
23434244|NCT02607228|65334037|FG004|Overall Study|Progressive Disease|4|||
23434245|NCT02607228|65334038|FG005|Overall Study|Progressive Disease|3|||
23434246|NCT02607228|65334039|FG006|Overall Study|Progressive Disease|1|||
23434247|NCT02607228|65334033|FG000|Overall Study|Adverse Event|1|||
23434248|NCT02607228|65334034|FG001|Overall Study|Adverse Event|0|||
23434249|NCT02607228|65334035|FG002|Overall Study|Adverse Event|1|||
23434250|NCT02607228|65334036|FG003|Overall Study|Adverse Event|0|||
23434251|NCT02607228|65334037|FG004|Overall Study|Adverse Event|1|||
23434252|NCT02607228|65334038|FG005|Overall Study|Adverse Event|1|||
23434253|NCT02607228|65334039|FG006|Overall Study|Adverse Event|1|||
23434254|NCT02607228|65334033|FG000|Overall Study|Investigator's Discretion|0|||
23434255|NCT02607228|65334034|FG001|Overall Study|Investigator's Discretion|0|||
23434256|NCT02607228|65334035|FG002|Overall Study|Investigator's Discretion|1|||
23434257|NCT02607228|65334036|FG003|Overall Study|Investigator's Discretion|0|||
23434258|NCT02607228|65334037|FG004|Overall Study|Investigator's Discretion|0|||
23434259|NCT02607228|65334038|FG005|Overall Study|Investigator's Discretion|1|||
23434260|NCT02607228|65334039|FG006|Overall Study|Investigator's Discretion|0|||
23434261|NCT02607228|65334033|FG000|Overall Study|Withdrew Consent|0|||
23434262|NCT02607228|65334034|FG001|Overall Study|Withdrew Consent|1|||
23144575|NCT00505284|64277637|FG002|Overall Study|Protocol Violation|1|||
23144576|NCT00505284|64277638|FG003|Overall Study|Protocol Violation|0|||
23144577|NCT00505284|64277639|FG004|Overall Study|Protocol Violation|0|||
23434263|NCT02607228|65334035|FG002|Overall Study|Withdrew Consent|0|||
23434264|NCT02607228|65334036|FG003|Overall Study|Withdrew Consent|0|||
23434265|NCT02607228|65334037|FG004|Overall Study|Withdrew Consent|0|||
23434266|NCT02607228|65334038|FG005|Overall Study|Withdrew Consent|1|||
23434267|NCT02607228|65334039|FG006|Overall Study|Withdrew Consent|0|||
23434268|NCT02607228|65334033|FG000|Overall Study|Study Terminated by Sponsor|0|||
23434269|NCT02607228|65334034|FG001|Overall Study|Study Terminated by Sponsor|0|||
23434270|NCT02607228|65334035|FG002|Overall Study|Study Terminated by Sponsor|0|||
23434271|NCT02607228|65334036|FG003|Overall Study|Study Terminated by Sponsor|1|||
23434272|NCT02607228|65334037|FG004|Overall Study|Study Terminated by Sponsor|0|||
23434273|NCT02607228|65334038|FG005|Overall Study|Study Terminated by Sponsor|0|||
23434274|NCT02607228|65334039|FG006|Overall Study|Study Terminated by Sponsor|0|||
23434275|NCT01729208|65334047|FG000|Baseline|Physician Decision|5|||
23434276|NCT01729208|65334048|FG001|Baseline|Physician Decision|4|||
23434277|NCT01729208|65334047|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
23434278|NCT01729208|65334048|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
23434279|NCT01729208|65334047|FG000|12 Months Follow-up|Lost to Follow-up|3|||
23434280|NCT01729208|65334048|FG001|12 Months Follow-up|Lost to Follow-up|3|||
23434281|NCT01729208|65334047|FG000|24 Months Follow-up|Lost to Follow-up|3|||
23434282|NCT01729208|65334048|FG001|24 Months Follow-up|Lost to Follow-up|0|||
23434283|NCT01729208|65334047|FG000|36 Months Follow-up|Physician Decision|1|||
23434284|NCT01729208|65334048|FG001|36 Months Follow-up|Physician Decision|0|||
23434285|NCT01729208|65334047|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
23434286|NCT01729208|65334048|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
23434287|NCT00908037|65334049|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434288|NCT00908037|65334050|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434289|NCT00908037|65334051|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434290|NCT00908037|65334052|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434291|NCT00908037|65334053|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
23434292|NCT00908037|65334054|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434293|NCT00908037|65334055|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
23434294|NCT00908037|65334056|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434295|NCT00908037|65334057|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
23434296|NCT00908037|65334058|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434297|NCT00908037|65334059|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434298|NCT00908037|65334060|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
23434299|NCT00908037|65334049|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434300|NCT00908037|65334050|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434301|NCT00908037|65334051|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434302|NCT00908037|65334052|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434303|NCT00908037|65334053|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
23556365|NCT00500903|65762558|FG000|Overall Study|Patient Declined Further Treatment|0|||
23144578|NCT00505284|64277635|FG000|Overall Study|Withdrawal by Subject|2|||
23434304|NCT00908037|65334054|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434305|NCT00908037|65334055|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434306|NCT00908037|65334056|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434307|NCT00908037|65334057|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
23434308|NCT00908037|65334058|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434309|NCT00908037|65334059|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23434310|NCT00908037|65334060|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
23556366|NCT00500903|65762559|FG001|Overall Study|Patient Declined Further Treatment|0|||
23434311|NCT00908037|65334049|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434312|NCT00908037|65334050|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434313|NCT00908037|65334051|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434314|NCT00908037|65334052|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
23434315|NCT00908037|65334053|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434316|NCT00908037|65334054|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434317|NCT00908037|65334055|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
23434318|NCT00908037|65334056|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434319|NCT00908037|65334057|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434320|NCT00908037|65334058|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434321|NCT00908037|65334059|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434322|NCT00908037|65334060|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
23434323|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434324|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434325|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434326|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434327|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434328|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434329|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434330|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434331|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434332|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434333|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
23434334|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
23434335|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434336|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434337|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434338|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434339|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434340|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434341|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434342|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434343|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434344|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
23434345|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
23434346|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
23434347|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434348|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434349|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434350|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434351|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434352|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434353|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434354|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434355|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434356|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
23434357|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434358|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
23434359|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434360|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434361|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434362|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434363|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23144579|NCT00505284|64277636|FG001|Overall Study|Withdrawal by Subject|6|||
23144580|NCT00505284|64277637|FG002|Overall Study|Withdrawal by Subject|1|||
23144581|NCT00505284|64277638|FG003|Overall Study|Withdrawal by Subject|0|||
23144582|NCT00505284|64277639|FG004|Overall Study|Withdrawal by Subject|6|||
23321409|NCT03267212|64919417|FG001|First Intervention|Withdrawal by Subject|1|||
23434364|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434365|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434366|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434367|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23623520|NCT00684203|66008473|FG005|Overall Study|Withdrawal by Subject|0|||
23623521|NCT00684203|66008468|FG000|Overall Study|Did not meet protocol eligibility|0|||
23434368|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434369|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
23434370|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
23434371|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434372|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434373|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434374|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434375|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434376|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23556367|NCT00500903|65762560|FG002|Overall Study|Patient Declined Further Treatment|3|||
23556368|NCT00500903|65762558|FG000|Overall Study|Symptomatic Deterioration|2|||
23556369|NCT00500903|65762559|FG001|Overall Study|Symptomatic Deterioration|0|||
23556370|NCT00500903|65762560|FG002|Overall Study|Symptomatic Deterioration|0|||
23144583|NCT00505284|64277635|FG000|Overall Study|Lack of Efficacy|0|||
23144584|NCT00505284|64277636|FG001|Overall Study|Lack of Efficacy|1|||
23144585|NCT00505284|64277637|FG002|Overall Study|Lack of Efficacy|1|||
23218010|NCT01457924|64538479|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
23321410|NCT03267212|64919416|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
23321411|NCT03267212|64919417|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
23556371|NCT00500903|65762558|FG000|Overall Study|Reason Not Specified|10|||
23556372|NCT00500903|65762559|FG001|Overall Study|Reason Not Specified|0|||
23556373|NCT00500903|65762560|FG002|Overall Study|Reason Not Specified|2|||
23556374|NCT03802123|65762568|FG000|Overall Study|Withdrawal by Subject|3|||
23556375|NCT03802123|65762568|FG000|Overall Study|Physician Decision|1|||
23556376|NCT03802123|65762568|FG000|Overall Study|Subject moved to hospice care|1|||
23556377|NCT03802123|65762568|FG000|Overall Study|technician error|1|||
23556378|NCT03802123|65762568|FG000|Overall Study|Death|3|||
23623522|NCT00684203|66008469|FG001|Overall Study|Did not meet protocol eligibility|1|||
23144586|NCT00505284|64277638|FG003|Overall Study|Lack of Efficacy|1|||
23144587|NCT00505284|64277639|FG004|Overall Study|Lack of Efficacy|1|||
23144588|NCT00505284|64277635|FG000|Overall Study|Physician Decision|0|||
23144589|NCT00505284|64277636|FG001|Overall Study|Physician Decision|1|||
23144590|NCT00505284|64277637|FG002|Overall Study|Physician Decision|0|||
23144591|NCT00505284|64277638|FG003|Overall Study|Physician Decision|0|||
23144592|NCT00505284|64277639|FG004|Overall Study|Physician Decision|0|||
23144593|NCT00505284|64277635|FG000|Overall Study|Other|5|||
23144594|NCT00505284|64277636|FG001|Overall Study|Other|0|||
23144595|NCT00505284|64277637|FG002|Overall Study|Other|0|||
23144596|NCT00505284|64277638|FG003|Overall Study|Other|4|||
23144597|NCT00505284|64277639|FG004|Overall Study|Other|4|||
23144598|NCT00966277|64277642|FG000|Overall Study|Withdrawal by Subject|3|||
23144599|NCT00966277|64277643|FG001|Overall Study|Withdrawal by Subject|0|||
23144600|NCT00966277|64277642|FG000|Overall Study|Ineligible|1|||
23144601|NCT00966277|64277643|FG001|Overall Study|Ineligible|3|||
23144602|NCT00966277|64277642|FG000|Overall Study|Treatment Plan Changed|0|||
23144603|NCT00966277|64277643|FG001|Overall Study|Treatment Plan Changed|1|||
23144604|NCT00511901|64277644|FG000|Overall Study|Withdrawal by Subject|1|||
23144605|NCT00511901|64277645|FG001|Overall Study|Withdrawal by Subject|3|||
23144606|NCT01403610|64277646|FG000|Overall Study|Withdrawal by Subject|2|||
23144607|NCT01403610|64277647|FG001|Overall Study|Withdrawal by Subject|0|||
23144608|NCT01403610|64277648|FG002|Overall Study|Withdrawal by Subject|0|||
23144609|NCT01403610|64277649|FG003|Overall Study|Withdrawal by Subject|0|||
23144610|NCT01403610|64277646|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
23144611|NCT01403610|64277647|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
23144612|NCT01403610|64277648|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
23144613|NCT01403610|64277649|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
23144614|NCT01768117|64277650|FG000|Overall Study|Lost to Follow-up|1|||
23144615|NCT01768117|64277650|FG000|Overall Study|Withdrawal by Subject|2|||
23144616|NCT01768117|64277650|FG000|Overall Study|Protocol Violation|3|||
23144617|NCT04634825|64277651|FG000|Overall Study|Death|10|||
23144618|NCT04634825|64277652|FG001|Overall Study|Death|3|||
23144619|NCT04634825|64277651|FG000|Overall Study|Lost to Follow-up|1|||
23144620|NCT04634825|64277652|FG001|Overall Study|Lost to Follow-up|0|||
23144621|NCT04634825|64277651|FG000|Overall Study|Study terminated by sponsor|35|||
23144622|NCT04634825|64277652|FG001|Overall Study|Study terminated by sponsor|11|||
23144623|NCT04634825|64277651|FG000|Overall Study|Withdrawal by Subject|2|||
23144624|NCT04634825|64277652|FG001|Overall Study|Withdrawal by Subject|0|||
23144625|NCT01217957|64277656|FG000|Phase 1|Withdrawal by Patient|1|||
23144626|NCT01217957|64277657|FG001|Phase 1|Withdrawal by Patient|0|||
23144627|NCT01217957|64277658|FG002|Phase 1|Withdrawal by Patient|1|||
23144628|NCT01217957|64277659|FG003|Phase 1|Withdrawal by Patient|1|||
23144629|NCT01217957|64277660|FG004|Phase 1|Withdrawal by Patient|0|||
23144630|NCT01217957|64277656|FG000|Phase 2|Withdrawal by Patient|0|||
23144631|NCT01217957|64277657|FG001|Phase 2|Withdrawal by Patient|0|||
23144632|NCT01217957|64277658|FG002|Phase 2|Withdrawal by Patient|0|||
23144633|NCT01217957|64277659|FG003|Phase 2|Withdrawal by Patient|0|||
23144634|NCT01217957|64277660|FG004|Phase 2|Withdrawal by Patient|1|||
23144635|NCT00938860|64277662|FG000|Overall Study|Adverse Event|2|||
23434377|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434378|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434379|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434380|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
23434381|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434382|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
23434383|NCT00908037|65334049|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434384|NCT00908037|65334050|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434385|NCT00908037|65334051|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434386|NCT00908037|65334052|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434387|NCT00908037|65334053|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434388|NCT00908037|65334054|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434389|NCT00908037|65334055|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434390|NCT00908037|65334056|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434391|NCT00908037|65334057|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434392|NCT00908037|65334058|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23218011|NCT01457924|64538480|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
23218012|NCT01457924|64538481|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
23218013|NCT01457924|64538482|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
23218014|NCT01457924|64538483|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
23218015|NCT01457924|64538479|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
23218016|NCT01457924|64538480|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
23218017|NCT01457924|64538481|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
23218018|NCT01457924|64538482|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
23218019|NCT01457924|64538483|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
23218020|NCT01457924|64538479|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
23218021|NCT01457924|64538480|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
23218022|NCT01457924|64538481|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
23434393|NCT00908037|65334059|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
23434394|NCT00908037|65334060|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
23434395|NCT01113580|65334061|FG000|Overall Study|Protocol Violation|1|||
23434396|NCT01113580|65334062|FG001|Overall Study|Protocol Violation|0|||
23434397|NCT01624090|65334065|FG000|Overall Study|DLT, taken off therapy|0|||
23434398|NCT01624090|65334066|FG001|Overall Study|DLT, taken off therapy|1|||
23434399|NCT01624090|65334067|FG002|Overall Study|DLT, taken off therapy|0|||
23434400|NCT01624090|65334068|FG003|Overall Study|DLT, taken off therapy|0|||
23434401|NCT01624090|65334065|FG000|Overall Study|Withdrew prior to treatment|0|||
23434402|NCT01624090|65334066|FG001|Overall Study|Withdrew prior to treatment|1|||
23434403|NCT01624090|65334067|FG002|Overall Study|Withdrew prior to treatment|0|||
23434404|NCT01624090|65334068|FG003|Overall Study|Withdrew prior to treatment|0|||
23434405|NCT01624090|65334065|FG000|Overall Study|Died on study|0|||
23434406|NCT01624090|65334066|FG001|Overall Study|Died on study|0|||
23434407|NCT01624090|65334067|FG002|Overall Study|Died on study|2|||
23218023|NCT01457924|64538482|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
23218024|NCT01457924|64538483|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
23218025|NCT01457924|64538479|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
23218026|NCT01457924|64538480|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
23434408|NCT01624090|65334068|FG003|Overall Study|Died on study|0|||
23434409|NCT01624090|65334065|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
23556379|NCT00082173|65762569|FG000|Overall Study|Withdrawal by Subject|3|||
23144636|NCT00938860|64277663|FG001|Overall Study|Adverse Event|1|||
23144637|NCT00938860|64277662|FG000|Overall Study|Abnormal laboratory values|2|||
23144638|NCT00938860|64277663|FG001|Overall Study|Abnormal laboratory values|2|||
23144639|NCT00938860|64277662|FG000|Overall Study|Withdrawal by Subject|11|||
23144640|NCT00938860|64277663|FG001|Overall Study|Withdrawal by Subject|8|||
23144641|NCT00938860|64277662|FG000|Overall Study|Lost to Follow-up|4|||
23144642|NCT00938860|64277663|FG001|Overall Study|Lost to Follow-up|4|||
23144643|NCT00938860|64277662|FG000|Overall Study|Administration problems|2|||
23218027|NCT01457924|64538481|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
23144644|NCT00938860|64277663|FG001|Overall Study|Administration problems|0|||
23144645|NCT00938860|64277662|FG000|Overall Study|Death|1|||
23144646|NCT00938860|64277663|FG001|Overall Study|Death|1|||
23218028|NCT01457924|64538482|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
23218029|NCT01457924|64538483|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
23434410|NCT01624090|65334066|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
23434411|NCT01624090|65334067|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
23434412|NCT01624090|65334068|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
23434413|NCT01624090|65334065|FG000|Overall Study|Dose escalated|0|||
23434414|NCT01624090|65334066|FG001|Overall Study|Dose escalated|0|||
23434415|NCT01624090|65334067|FG002|Overall Study|Dose escalated|3|||
23434416|NCT01624090|65334068|FG003|Overall Study|Dose escalated|0|||
23434417|NCT02212678|65334069|FG000|Overall Study|Adverse Event|1|||
23434418|NCT00454181|65334072|FG000|Overall Study|Adverse Event|1|||
23144647|NCT00938860|64277662|FG000|Overall Study|Protocol Violation|3|||
23144648|NCT00938860|64277663|FG001|Overall Study|Protocol Violation|1|||
23434419|NCT00454181|65334073|FG001|Overall Study|Adverse Event|1|||
23434420|NCT00454181|65334072|FG000|Overall Study|Lost to Follow-up|11|||
23434421|NCT00454181|65334073|FG001|Overall Study|Lost to Follow-up|1|||
23434422|NCT00454181|65334072|FG000|Overall Study|Protocol Violation|1|||
23434423|NCT00454181|65334073|FG001|Overall Study|Protocol Violation|1|||
23434424|NCT00454181|65334072|FG000|Overall Study|Withdrawal by Subject|2|||
23434425|NCT00454181|65334073|FG001|Overall Study|Withdrawal by Subject|0|||
23434426|NCT01026220|65334075|FG000|Induction|Death|1|||
23434427|NCT01026220|65334076|FG001|Induction|Death|0|||
23434428|NCT01026220|65334077|FG002|Induction|Death|0|||
23434429|NCT01026220|65334075|FG000|Induction|Lack of Efficacy|2|||
23434430|NCT01026220|65334076|FG001|Induction|Lack of Efficacy|0|||
23434431|NCT01026220|65334077|FG002|Induction|Lack of Efficacy|0|||
23434432|NCT01026220|65334075|FG000|Induction|Physician Decision|12|||
23434433|NCT01026220|65334076|FG001|Induction|Physician Decision|0|||
23434434|NCT01026220|65334077|FG002|Induction|Physician Decision|0|||
23434435|NCT01026220|65334075|FG000|Induction|Withdrawal by Subject|9|||
23434436|NCT01026220|65334076|FG001|Induction|Withdrawal by Subject|0|||
23434437|NCT01026220|65334077|FG002|Induction|Withdrawal by Subject|0|||
23434438|NCT01026220|65334075|FG000|Induction|Ineligible|1|||
23434439|NCT01026220|65334076|FG001|Induction|Ineligible|0|||
23434440|NCT01026220|65334077|FG002|Induction|Ineligible|0|||
23434441|NCT01026220|65334075|FG000|Consolidation Maintenance|Death|0|||
23144649|NCT00753272|64277664|FG000|Overall Study|Adverse Event|878|||
23144650|NCT00753272|64277665|FG001|Overall Study|Adverse Event|869|||
23144651|NCT00753272|64277664|FG000|Overall Study|Protocol Violation|28|||
23144652|NCT00753272|64277665|FG001|Overall Study|Protocol Violation|46|||
23144653|NCT00753272|64277664|FG000|Overall Study|Withdrawal by Subject|2481|||
23144654|NCT00753272|64277665|FG001|Overall Study|Withdrawal by Subject|2407|||
23144655|NCT00753272|64277664|FG000|Overall Study|Lost to Follow-up|491|||
23144656|NCT00753272|64277665|FG001|Overall Study|Lost to Follow-up|497|||
23144657|NCT00753272|64277664|FG000|Overall Study|Other|1104|||
23144658|NCT00753272|64277665|FG001|Overall Study|Other|1088|||
23144659|NCT01174160|64277666|FG000|Overall Study|Adverse Event|1|||
23144660|NCT01174160|64277667|FG001|Overall Study|Adverse Event|0|||
23144661|NCT01174160|64277666|FG000|Overall Study|Lost to Follow-up|1|||
23144662|NCT01174160|64277667|FG001|Overall Study|Lost to Follow-up|0|||
23144663|NCT01174160|64277666|FG000|Overall Study|Physician Decision|1|||
23144664|NCT01174160|64277667|FG001|Overall Study|Physician Decision|0|||
23144665|NCT01174160|64277666|FG000|Overall Study|Protocol Violation|4|||
23434442|NCT01026220|65334076|FG001|Consolidation Maintenance|Death|1|||
23434443|NCT01026220|65334077|FG002|Consolidation Maintenance|Death|0|||
23434444|NCT01026220|65334075|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
23434445|NCT01026220|65334076|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
23434446|NCT01026220|65334077|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
23556380|NCT00082173|65762570|FG001|Overall Study|Withdrawal by Subject|5|||
23556381|NCT00082173|65762569|FG000|Overall Study|Lost to Follow-up|1|||
23556382|NCT00082173|65762570|FG001|Overall Study|Lost to Follow-up|0|||
23144666|NCT01174160|64277667|FG001|Overall Study|Protocol Violation|6|||
23144667|NCT01174160|64277666|FG000|Overall Study|Withdrawal by Subject|1|||
23556383|NCT00082173|65762569|FG000|Overall Study|Adverse Event|1|||
23218030|NCT01457924|64538479|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
23434447|NCT01026220|65334075|FG000|Consolidation Maintenance|Physician Decision|0|||
23556384|NCT00082173|65762570|FG001|Overall Study|Adverse Event|0|||
23556385|NCT00082173|65762569|FG000|Overall Study|Culture negative or resistant at baselin|5|||
23556386|NCT00082173|65762570|FG001|Overall Study|Culture negative or resistant at baselin|6|||
23556387|NCT04259450|65762574|FG000|Overall Study|Adverse event/ Toxicity|0|||
23556388|NCT04259450|65762575|FG001|Overall Study|Adverse event/ Toxicity|3|||
23556389|NCT04259450|65762576|FG002|Overall Study|Adverse event/ Toxicity|0|||
23556390|NCT04259450|65762577|FG003|Overall Study|Adverse event/ Toxicity|1|||
23556391|NCT04259450|65762578|FG004|Overall Study|Adverse event/ Toxicity|0|||
23556392|NCT04259450|65762579|FG005|Overall Study|Adverse event/ Toxicity|0|||
23144668|NCT01174160|64277667|FG001|Overall Study|Withdrawal by Subject|0|||
23434448|NCT01026220|65334076|FG001|Consolidation Maintenance|Physician Decision|2|||
23434449|NCT01026220|65334077|FG002|Consolidation Maintenance|Physician Decision|7|||
23434450|NCT01026220|65334075|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
23144669|NCT00346268|64277671|FG000|Overall Study|Adverse Event|1|||
23556393|NCT04259450|65762580|FG006|Overall Study|Adverse event/ Toxicity|0|||
23434451|NCT01026220|65334076|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
23434452|NCT01026220|65334077|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
23556394|NCT04259450|65762581|FG007|Overall Study|Adverse event/ Toxicity|1|||
23556395|NCT04259450|65762582|FG008|Overall Study|Adverse event/ Toxicity|0|||
23556396|NCT04259450|65762583|FG009|Overall Study|Adverse event/ Toxicity|3|||
23556397|NCT04259450|65762574|FG000|Overall Study|Disease progression|2|||
23434453|NCT01196416|65334078|FG000|Overall Study|Withdrawal by Subject|2|||
23434454|NCT01079936|65334079|FG000|Phase I: MTD|First Remission Status|2|||
23434455|NCT01079936|65334080|FG001|Phase I: MTD|First Remission Status|0|||
23434456|NCT01079936|65334081|FG002|Phase I: MTD|First Remission Status|0|||
23434457|NCT01079936|65334082|FG003|Phase I: MTD|First Remission Status|0|||
23434458|NCT01079936|65334083|FG004|Phase I: MTD|First Remission Status|0|||
23434459|NCT01079936|65334079|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
23434460|NCT01079936|65334080|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
23434461|NCT01079936|65334081|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
23434462|NCT01079936|65334082|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
23434463|NCT01079936|65334083|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
23434464|NCT01079936|65334079|FG000|Phase II|Adverse Event|0|||
23434465|NCT01079936|65334080|FG001|Phase II|Adverse Event|0|||
23556398|NCT04259450|65762575|FG001|Overall Study|Disease progression|3|||
23556399|NCT04259450|65762576|FG002|Overall Study|Disease progression|4|||
23556400|NCT04259450|65762577|FG003|Overall Study|Disease progression|4|||
23623523|NCT00684203|66008470|FG002|Overall Study|Did not meet protocol eligibility|0|||
23623524|NCT00684203|66008471|FG003|Overall Study|Did not meet protocol eligibility|0|||
23556401|NCT04259450|65762578|FG004|Overall Study|Disease progression|6|||
23556402|NCT04259450|65762579|FG005|Overall Study|Disease progression|6|||
23556403|NCT04259450|65762580|FG006|Overall Study|Disease progression|5|||
23556404|NCT04259450|65762581|FG007|Overall Study|Disease progression|15|||
23556405|NCT04259450|65762582|FG008|Overall Study|Disease progression|6|||
23556406|NCT04259450|65762583|FG009|Overall Study|Disease progression|17|||
23556407|NCT04259450|65762574|FG000|Overall Study|Death|0|||
23556408|NCT04259450|65762575|FG001|Overall Study|Death|0|||
23556409|NCT04259450|65762576|FG002|Overall Study|Death|0|||
23556410|NCT04259450|65762577|FG003|Overall Study|Death|0|||
23556411|NCT04259450|65762578|FG004|Overall Study|Death|0|||
23556412|NCT04259450|65762579|FG005|Overall Study|Death|0|||
23556413|NCT04259450|65762580|FG006|Overall Study|Death|0|||
23556414|NCT04259450|65762581|FG007|Overall Study|Death|1|||
23556415|NCT04259450|65762582|FG008|Overall Study|Death|1|||
23556416|NCT04259450|65762583|FG009|Overall Study|Death|0|||
23556417|NCT04259450|65762574|FG000|Overall Study|Withdrawal by Subject|0|||
23556418|NCT04259450|65762575|FG001|Overall Study|Withdrawal by Subject|0|||
23556419|NCT04259450|65762576|FG002|Overall Study|Withdrawal by Subject|0|||
23556420|NCT04259450|65762577|FG003|Overall Study|Withdrawal by Subject|0|||
23556421|NCT04259450|65762578|FG004|Overall Study|Withdrawal by Subject|0|||
23556422|NCT04259450|65762579|FG005|Overall Study|Withdrawal by Subject|0|||
23556423|NCT04259450|65762580|FG006|Overall Study|Withdrawal by Subject|0|||
23556424|NCT04259450|65762581|FG007|Overall Study|Withdrawal by Subject|1|||
23556425|NCT04259450|65762582|FG008|Overall Study|Withdrawal by Subject|0|||
23556426|NCT04259450|65762583|FG009|Overall Study|Withdrawal by Subject|0|||
23556427|NCT04259450|65762574|FG000|Overall Study|Long Term Adverse Event|0|||
23556428|NCT04259450|65762575|FG001|Overall Study|Long Term Adverse Event|0|||
23556429|NCT04259450|65762576|FG002|Overall Study|Long Term Adverse Event|0|||
23556430|NCT04259450|65762577|FG003|Overall Study|Long Term Adverse Event|0|||
23556431|NCT04259450|65762578|FG004|Overall Study|Long Term Adverse Event|0|||
23556432|NCT04259450|65762579|FG005|Overall Study|Long Term Adverse Event|0|||
23556433|NCT04259450|65762580|FG006|Overall Study|Long Term Adverse Event|0|||
23623525|NCT00684203|66008472|FG004|Overall Study|Did not meet protocol eligibility|0|||
23144670|NCT00346268|64277672|FG001|Overall Study|Adverse Event|0|||
23144671|NCT00346268|64277671|FG000|Overall Study|Protocol Violation|1|||
23144672|NCT00346268|64277672|FG001|Overall Study|Protocol Violation|0|||
23144673|NCT00346268|64277671|FG000|Overall Study|Participant refused|0|||
23144674|NCT00346268|64277672|FG001|Overall Study|Participant refused|3|||
23144675|NCT00577473|64277673|FG000|Overall Study|Protocol Violation|1|||
23144676|NCT00577473|64277674|FG001|Overall Study|Protocol Violation|4|||
23144677|NCT00577473|64277673|FG000|Overall Study|Adverse Event|8|||
23144678|NCT00577473|64277674|FG001|Overall Study|Adverse Event|5|||
23144679|NCT00577473|64277673|FG000|Overall Study|Withdrawal by Subject|2|||
23144680|NCT00577473|64277674|FG001|Overall Study|Withdrawal by Subject|6|||
23144681|NCT00577473|64277673|FG000|Overall Study|Physician Decision|2|||
23144682|NCT00577473|64277674|FG001|Overall Study|Physician Decision|2|||
23144683|NCT00577473|64277673|FG000|Overall Study|Lack of Efficacy|8|||
23144684|NCT00577473|64277674|FG001|Overall Study|Lack of Efficacy|7|||
23144685|NCT03658668|64277679|FG000|Overall Study|Time Commitment|1|||
23144686|NCT03658668|64277680|FG001|Overall Study|Time Commitment|1|||
23144687|NCT00406653|64277681|FG000|Induction Period|Adverse Event|1|||
23144688|NCT00406653|64277682|FG001|Induction Period|Adverse Event|10|||
23144689|NCT00406653|64277683|FG002|Induction Period|Adverse Event|4|||
23556434|NCT04259450|65762581|FG007|Overall Study|Long Term Adverse Event|0|||
23556435|NCT04259450|65762582|FG008|Overall Study|Long Term Adverse Event|0|||
23556436|NCT04259450|65762583|FG009|Overall Study|Long Term Adverse Event|1|||
23556437|NCT03280121|65762586|FG000|Overall Study|Physician Decision|1|||
23556438|NCT03280121|65762586|FG000|Overall Study|Lost to Follow-up|1|||
23556439|NCT03280121|65762586|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
23556440|NCT01559454|65765894|FG000|Overall Study|Lost to Follow-up|3|||
23556441|NCT01559454|65765895|FG001|Overall Study|Lost to Follow-up|2|||
23556442|NCT01559454|65765894|FG000|Overall Study|Withdrawal by Subject|0|||
23556443|NCT01559454|65765895|FG001|Overall Study|Withdrawal by Subject|1|||
23144690|NCT00406653|64277684|FG003|Induction Period|Adverse Event|11|||
23144691|NCT00406653|64277685|FG004|Induction Period|Adverse Event|0|||
23144692|NCT00406653|64277686|FG005|Induction Period|Adverse Event|0|||
23144693|NCT00406653|64277687|FG006|Induction Period|Adverse Event|0|||
23144694|NCT00406653|64277681|FG000|Induction Period|Lack of Efficacy|11|||
23144695|NCT00406653|64277682|FG001|Induction Period|Lack of Efficacy|14|||
23144696|NCT00406653|64277683|FG002|Induction Period|Lack of Efficacy|8|||
23144697|NCT00406653|64277684|FG003|Induction Period|Lack of Efficacy|10|||
23144698|NCT00406653|64277685|FG004|Induction Period|Lack of Efficacy|0|||
23144699|NCT00406653|64277686|FG005|Induction Period|Lack of Efficacy|0|||
23434466|NCT01079936|65334081|FG002|Phase II|Adverse Event|1|||
23434467|NCT01079936|65334082|FG003|Phase II|Adverse Event|0|||
23434468|NCT01079936|65334083|FG004|Phase II|Adverse Event|0|||
23434469|NCT01079936|65334079|FG000|Phase II|Insurance Issue|0|||
23434470|NCT01079936|65334080|FG001|Phase II|Insurance Issue|0|||
23144700|NCT00406653|64277687|FG006|Induction Period|Lack of Efficacy|0|||
23144701|NCT00406653|64277681|FG000|Induction Period|Lost to Follow-up|0|||
23144702|NCT00406653|64277682|FG001|Induction Period|Lost to Follow-up|2|||
23144703|NCT00406653|64277683|FG002|Induction Period|Lost to Follow-up|0|||
23144704|NCT00406653|64277684|FG003|Induction Period|Lost to Follow-up|0|||
23144705|NCT00406653|64277685|FG004|Induction Period|Lost to Follow-up|0|||
23144706|NCT00406653|64277686|FG005|Induction Period|Lost to Follow-up|0|||
23144707|NCT00406653|64277687|FG006|Induction Period|Lost to Follow-up|0|||
23144708|NCT00406653|64277681|FG000|Induction Period|Withdrawal of Consent|2|||
23144709|NCT00406653|64277682|FG001|Induction Period|Withdrawal of Consent|5|||
23144710|NCT00406653|64277683|FG002|Induction Period|Withdrawal of Consent|1|||
23218031|NCT01457924|64538480|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
23321412|NCT00633243|64919418|FG000|Overall Study|Withdrawal by Subject|0|||
23321413|NCT00633243|64919419|FG001|Overall Study|Withdrawal by Subject|1|||
23321414|NCT00633243|64919418|FG000|Overall Study|incarceration|0|||
23321415|NCT00633243|64919419|FG001|Overall Study|incarceration|2|||
23321416|NCT00633243|64919418|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
23556444|NCT01559454|65765894|FG000|Overall Study|Physician Decision|0|||
23556445|NCT01559454|65765895|FG001|Overall Study|Physician Decision|1|||
23556446|NCT01559454|65765894|FG000|Overall Study|Protocol Violation|0|||
23556447|NCT01559454|65765895|FG001|Overall Study|Protocol Violation|1|||
23556448|NCT01559454|65765894|FG000|Overall Study|Lack of Efficacy|0|||
23144711|NCT00406653|64277684|FG003|Induction Period|Withdrawal of Consent|2|||
23321417|NCT00633243|64919419|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
23321418|NCT00633243|64919418|FG000|Overall Study|Not comfortable with self-injecting|0|||
23321419|NCT00633243|64919419|FG001|Overall Study|Not comfortable with self-injecting|1|||
23321420|NCT00633243|64919418|FG000|Overall Study|Mental Health--Depression|0|||
23321421|NCT00633243|64919419|FG001|Overall Study|Mental Health--Depression|1|||
23434471|NCT01079936|65334081|FG002|Phase II|Insurance Issue|0|||
23434472|NCT01079936|65334082|FG003|Phase II|Insurance Issue|0|||
23434473|NCT01079936|65334083|FG004|Phase II|Insurance Issue|1|||
23434474|NCT03667690|65334086|FG000|Overall Study|Adverse Event|0|||
23321422|NCT00633243|64919418|FG000|Overall Study|Couldn't tolerate side-effects|1|||
23321423|NCT00633243|64919419|FG001|Overall Study|Couldn't tolerate side-effects|1|||
23321424|NCT02797171|64919420|FG000|Overall Study|Lost to Follow-up|2|||
23321425|NCT02797171|64919421|FG001|Overall Study|Lost to Follow-up|0|||
23321426|NCT02797171|64919422|FG002|Overall Study|Lost to Follow-up|2|||
23321427|NCT02797171|64919423|FG003|Overall Study|Lost to Follow-up|1|||
23321428|NCT02797171|64919424|FG004|Overall Study|Lost to Follow-up|2|||
23434475|NCT03667690|65334087|FG001|Overall Study|Adverse Event|3|||
23321429|NCT02797171|64919425|FG005|Overall Study|Lost to Follow-up|0|||
23321430|NCT02797171|64919420|FG000|Overall Study|Withdrawal by Subject|1|||
23434476|NCT03667690|65334086|FG000|Overall Study|Death|22|||
23434477|NCT03667690|65334087|FG001|Overall Study|Death|21|||
23556449|NCT01559454|65765895|FG001|Overall Study|Lack of Efficacy|1|||
23144712|NCT00406653|64277685|FG004|Induction Period|Withdrawal of Consent|0|||
23144713|NCT00406653|64277686|FG005|Induction Period|Withdrawal of Consent|0|||
23144714|NCT00406653|64277687|FG006|Induction Period|Withdrawal of Consent|0|||
23144715|NCT00406653|64277681|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
23434478|NCT03667690|65334086|FG000|Overall Study|Lost to Follow-up|4|||
23434479|NCT03667690|65334087|FG001|Overall Study|Lost to Follow-up|5|||
23434480|NCT03667690|65334086|FG000|Overall Study|Withdrawal by Subject|7|||
23556450|NCT00733499|65765896|FG000|Pre-operative|Protocol Violation|0|||
23321431|NCT02797171|64919421|FG001|Overall Study|Withdrawal by Subject|1|||
23321432|NCT02797171|64919422|FG002|Overall Study|Withdrawal by Subject|0|||
23321433|NCT02797171|64919423|FG003|Overall Study|Withdrawal by Subject|0|||
23321434|NCT02797171|64919424|FG004|Overall Study|Withdrawal by Subject|0|||
23321435|NCT02797171|64919425|FG005|Overall Study|Withdrawal by Subject|0|||
23321436|NCT02797171|64919420|FG000|Overall Study|Protocol Violation|1|||
23321437|NCT02797171|64919421|FG001|Overall Study|Protocol Violation|0|||
23321438|NCT02797171|64919422|FG002|Overall Study|Protocol Violation|0|||
23321439|NCT02797171|64919423|FG003|Overall Study|Protocol Violation|0|||
23321440|NCT02797171|64919424|FG004|Overall Study|Protocol Violation|0|||
23321441|NCT02797171|64919425|FG005|Overall Study|Protocol Violation|0|||
23321442|NCT02797171|64919420|FG000|Overall Study|Participant unable to adhere|0|||
23321443|NCT02797171|64919421|FG001|Overall Study|Participant unable to adhere|1|||
23321444|NCT02797171|64919422|FG002|Overall Study|Participant unable to adhere|0|||
23321445|NCT02797171|64919423|FG003|Overall Study|Participant unable to adhere|0|||
23321446|NCT02797171|64919424|FG004|Overall Study|Participant unable to adhere|0|||
23321447|NCT02797171|64919425|FG005|Overall Study|Participant unable to adhere|0|||
23321448|NCT02797171|64919420|FG000|Overall Study|Not Randomized|0|||
23321449|NCT02797171|64919421|FG001|Overall Study|Not Randomized|0|||
23321450|NCT02797171|64919422|FG002|Overall Study|Not Randomized|0|||
23321451|NCT02797171|64919423|FG003|Overall Study|Not Randomized|0|||
23321452|NCT02797171|64919424|FG004|Overall Study|Not Randomized|0|||
23321453|NCT02797171|64919425|FG005|Overall Study|Not Randomized|1|||
23321454|NCT00299130|64919426|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
23321455|NCT00299130|64919427|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
23321456|NCT00299130|64919428|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
23321457|NCT00299130|64919426|FG000|Treatment Period (up to 5 Years)|Death|1|||
23321458|NCT00299130|64919427|FG001|Treatment Period (up to 5 Years)|Death|3|||
23321459|NCT00299130|64919428|FG002|Treatment Period (up to 5 Years)|Death|1|||
23321460|NCT00299130|64919426|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
23321461|NCT00299130|64919427|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
23321462|NCT00299130|64919428|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
23321463|NCT00299130|64919426|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
23321464|NCT00299130|64919427|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
23321465|NCT00299130|64919428|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
23321466|NCT00299130|64919426|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
23321467|NCT00299130|64919427|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
23321468|NCT00299130|64919428|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
23321469|NCT00299130|64919426|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
23321470|NCT00299130|64919427|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
23321471|NCT00299130|64919428|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
23321472|NCT00299130|64919426|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
23321473|NCT00299130|64919427|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
23321474|NCT00299130|64919428|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
23321475|NCT00299130|64919426|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
23321476|NCT00299130|64919427|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
23321477|NCT00299130|64919428|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
23321478|NCT00299130|64919426|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
23321479|NCT00299130|64919427|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
23321480|NCT00299130|64919428|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
23321481|NCT00299130|64919426|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
23321482|NCT00299130|64919427|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
23321483|NCT00299130|64919428|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
23321484|NCT00299130|64919426|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
23321485|NCT00299130|64919427|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
23321486|NCT00299130|64919428|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
23321487|NCT00299130|64919426|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
23321488|NCT00299130|64919427|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
23321489|NCT00299130|64919428|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
23321490|NCT00299130|64919426|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
23321491|NCT00299130|64919427|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
23321492|NCT00299130|64919428|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
23321493|NCT00299130|64919426|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
23321494|NCT00299130|64919427|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
23321495|NCT00299130|64919428|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
23321496|NCT00299130|64919426|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
23321497|NCT00299130|64919427|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
23321498|NCT00299130|64919428|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
23321499|NCT00299130|64919426|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
23556451|NCT00733499|65765897|FG001|Pre-operative|Protocol Violation|1|||
23321500|NCT00299130|64919427|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
23321501|NCT00299130|64919428|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
23321502|NCT00299130|64919426|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
23321503|NCT00299130|64919427|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
23321504|NCT00299130|64919428|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
23321505|NCT00545714|64919429|FG000|Induction Phase (6 Months)|Physician Decision|3|||
23321506|NCT00545714|64919429|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
23321507|NCT00545714|64919429|FG000|Induction Phase (6 Months)|Disease Progression|1|||
23321508|NCT00545714|64919429|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
23321509|NCT00545714|64919429|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
23218032|NCT01457924|64538481|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
23218033|NCT01457924|64538482|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
23218034|NCT01457924|64538483|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
23218035|NCT01457924|64538479|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
23218036|NCT01457924|64538480|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
23218037|NCT01457924|64538481|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
23218038|NCT01457924|64538482|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
23218039|NCT01457924|64538483|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
23218040|NCT01457924|64538479|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
23218041|NCT01457924|64538480|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
23321510|NCT00545714|64919429|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
23321511|NCT00545714|64919429|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
23321512|NCT00545714|64919429|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
23321513|NCT00545714|64919429|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
23321514|NCT00545714|64919429|FG000|Maintenance Phase (36 Months)|Death|2|||
23321515|NCT00584454|64919432|FG000|Overall Study|Adverse Event|1|||
23321516|NCT00584454|64919432|FG000|Overall Study|Relocation|1|||
23321517|NCT00584454|64919432|FG000|Overall Study|Clinical Hold|2|||
23321518|NCT02174627|64919436|FG000|Overall Study|Missing|0|||
23321519|NCT02174627|64919437|FG001|Overall Study|Missing|1|||
23321520|NCT02174627|64919436|FG000|Overall Study|Incorrect enrolment before randomization|0|||
23321521|NCT02174627|64919437|FG001|Overall Study|Incorrect enrolment before randomization|1|||
23321522|NCT02174627|64919436|FG000|Overall Study|Participant decision|84|||
23321523|NCT02174627|64919437|FG001|Overall Study|Participant decision|128|||
23321524|NCT01811472|64919439|FG000|Overall Study|Adverse Event|1|||
23218042|NCT01457924|64538481|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
23434481|NCT03667690|65334087|FG001|Overall Study|Withdrawal by Subject|8|||
23321525|NCT01811472|64919440|FG001|Overall Study|Adverse Event|0|||
23218043|NCT01457924|64538482|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
23218044|NCT01457924|64538483|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
23218045|NCT01457924|64538479|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
23218046|NCT01457924|64538480|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
23218047|NCT01457924|64538481|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
23218048|NCT01457924|64538482|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
23218049|NCT01457924|64538483|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
23218050|NCT01457924|64538479|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
23218051|NCT01457924|64538480|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
23218052|NCT01457924|64538481|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
23218053|NCT01457924|64538482|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
23218054|NCT01457924|64538483|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
23218055|NCT01457924|64538479|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
23218056|NCT01457924|64538480|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
23218057|NCT01457924|64538481|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
23218058|NCT01457924|64538482|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
23218059|NCT01457924|64538483|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
23218060|NCT01457924|64538479|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
23218061|NCT01457924|64538480|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
23218062|NCT01457924|64538481|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
23218063|NCT01457924|64538482|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
23218064|NCT01457924|64538483|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
23218065|NCT00520299|64538488|FG000|Overall Study|Withdrawal by Subject|0|||
23218066|NCT00520299|64538489|FG001|Overall Study|Withdrawal by Subject|0|||
23218067|NCT00520299|64538490|FG002|Overall Study|Withdrawal by Subject|2|||
23218068|NCT00520299|64538488|FG000|Overall Study|Progressive disease|0|||
23218069|NCT00520299|64538489|FG001|Overall Study|Progressive disease|3|||
23218070|NCT00520299|64538490|FG002|Overall Study|Progressive disease|4|||
23218071|NCT01563107|64538491|FG000|Overall Study|Physician Decision|0|||
23218072|NCT01563107|64538492|FG001|Overall Study|Physician Decision|1|||
23321526|NCT01811472|64919441|FG002|Overall Study|Adverse Event|4|||
23434482|NCT03667690|65334086|FG000|Overall Study|Subject could not return for additional investigational product|1|||
23321527|NCT01811472|64919439|FG000|Overall Study|Lost to Follow-up|0|||
23321528|NCT01811472|64919440|FG001|Overall Study|Lost to Follow-up|0|||
23321529|NCT01811472|64919441|FG002|Overall Study|Lost to Follow-up|1|||
23321530|NCT01811472|64919439|FG000|Overall Study|Subject/guardian decision|1|||
23321531|NCT01811472|64919440|FG001|Overall Study|Subject/guardian decision|0|||
23434483|NCT03667690|65334087|FG001|Overall Study|Subject could not return for additional investigational product|0|||
23434484|NCT03667690|65334086|FG000|Overall Study|Subject discharged to hospice care|2|||
23434485|NCT03667690|65334087|FG001|Overall Study|Subject discharged to hospice care|0|||
23321532|NCT01811472|64919441|FG002|Overall Study|Subject/guardian decision|0|||
23321533|NCT01060072|64919442|FG000|Overall Study|Adverse Event|1|||
23321534|NCT01060072|64919443|FG001|Overall Study|Adverse Event|1|||
23321535|NCT01060072|64919442|FG000|Overall Study|Physician Decision|0|||
23321536|NCT01060072|64919443|FG001|Overall Study|Physician Decision|2|||
23321537|NCT01060072|64919442|FG000|Overall Study|Protocol Violation|0|||
23321538|NCT01060072|64919443|FG001|Overall Study|Protocol Violation|1|||
23321539|NCT01060072|64919442|FG000|Overall Study|Acute cholecystitis|1|||
23321540|NCT01060072|64919443|FG001|Overall Study|Acute cholecystitis|0|||
23321541|NCT01060072|64919442|FG000|Overall Study|Excluded Medications|0|||
23321542|NCT01060072|64919443|FG001|Overall Study|Excluded Medications|1|||
23321543|NCT03404674|64919455|FG000|Overall Study|Inability to Attend Future Visits|0|||
23321544|NCT03404674|64919456|FG001|Overall Study|Inability to Attend Future Visits|1|||
23321545|NCT03404674|64919457|FG002|Overall Study|Inability to Attend Future Visits|1|||
23321546|NCT03404674|64919458|FG003|Overall Study|Inability to Attend Future Visits|0|||
23321547|NCT03404674|64919459|FG004|Overall Study|Inability to Attend Future Visits|0|||
23321548|NCT03404674|64919460|FG005|Overall Study|Inability to Attend Future Visits|0|||
23321549|NCT03404674|64919455|FG000|Overall Study|Behavioral Problems|0|||
23321550|NCT03404674|64919456|FG001|Overall Study|Behavioral Problems|0|||
23321551|NCT03404674|64919457|FG002|Overall Study|Behavioral Problems|1|||
23321552|NCT03404674|64919458|FG003|Overall Study|Behavioral Problems|0|||
23321553|NCT03404674|64919459|FG004|Overall Study|Behavioral Problems|0|||
23321554|NCT03404674|64919460|FG005|Overall Study|Behavioral Problems|0|||
23321555|NCT03404674|64919455|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
23321556|NCT03404674|64919456|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
23321557|NCT03404674|64919457|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
23321558|NCT03404674|64919458|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
23321559|NCT03404674|64919459|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
23321560|NCT03404674|64919460|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
23321561|NCT02698163|64919463|FG000|Overall Study|Lost to Follow-up|0|||
23321562|NCT02698163|64919464|FG001|Overall Study|Lost to Follow-up|1|||
23321563|NCT01659125|64919465|FG000|Overall Study|Withdrawal by Subject|2|||
23321564|NCT01659125|64919465|FG000|Overall Study|Lost to Follow-up|7|||
23321565|NCT01659125|64919465|FG000|Overall Study|Technical Problem|1|||
23321566|NCT01659125|64919465|FG000|Overall Study|Time Constraints|2|||
23321567|NCT01659125|64919465|FG000|Overall Study|Failed to Start Treatment|2|||
23321568|NCT04782076|64919468|FG000|Overall Study|Family Emergency|1|||
23321569|NCT03348163|64919469|FG000|Overall Study|Withdrawal by Subject|2|||
23434486|NCT03667690|65334086|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
23434487|NCT03667690|65334087|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
23434488|NCT03667690|65334086|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
23434489|NCT03667690|65334087|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
23434490|NCT03667690|65334086|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
23321570|NCT03348163|64919470|FG001|Overall Study|Withdrawal by Subject|0|||
23321571|NCT02094417|64919477|FG000|Overall Study|Adverse Event|0|||
23321572|NCT02094417|64919478|FG001|Overall Study|Adverse Event|0|||
23321573|NCT02094417|64919479|FG002|Overall Study|Adverse Event|0|||
23321574|NCT02094417|64919480|FG003|Overall Study|Adverse Event|1|||
23321575|NCT02094417|64919477|FG000|Overall Study|Eligibility criteria|0|||
23321576|NCT02094417|64919478|FG001|Overall Study|Eligibility criteria|1|||
23321577|NCT02094417|64919479|FG002|Overall Study|Eligibility criteria|0|||
23321578|NCT02094417|64919480|FG003|Overall Study|Eligibility criteria|0|||
23321579|NCT02094417|64919477|FG000|Overall Study|No responder|4|||
23321580|NCT02094417|64919478|FG001|Overall Study|No responder|4|||
23556452|NCT00733499|65765896|FG000|3 Months Follow-up|Death|1|||
23321581|NCT02094417|64919479|FG002|Overall Study|No responder|4|||
23321582|NCT02094417|64919480|FG003|Overall Study|No responder|3|||
23321583|NCT02094417|64919477|FG000|Overall Study|Unable to conduct observations or assess|0|||
23321584|NCT02094417|64919478|FG001|Overall Study|Unable to conduct observations or assess|1|||
23321585|NCT02094417|64919479|FG002|Overall Study|Unable to conduct observations or assess|0|||
23321586|NCT02094417|64919480|FG003|Overall Study|Unable to conduct observations or assess|0|||
23321587|NCT02094417|64919477|FG000|Overall Study|Withdrawal by Subject|1|||
23321588|NCT02094417|64919478|FG001|Overall Study|Withdrawal by Subject|2|||
23321589|NCT02094417|64919479|FG002|Overall Study|Withdrawal by Subject|1|||
23321590|NCT02094417|64919480|FG003|Overall Study|Withdrawal by Subject|3|||
23321591|NCT01957397|64919489|FG000|Test Period 1|sudden leakage/small bag|1|||
23321592|NCT01957397|64919490|FG001|Test Period 1|sudden leakage/small bag|1|||
23321593|NCT01957397|64919489|FG000|Test Period 1|Withdrawal by Subject|1|||
23321594|NCT01957397|64919490|FG001|Test Period 1|Withdrawal by Subject|0|||
23321595|NCT01957397|64919489|FG000|Test Period 2|Adverse Event|0|||
23434491|NCT03667690|65334087|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
23321596|NCT01957397|64919490|FG001|Test Period 2|Adverse Event|1|||
23321597|NCT01957397|64919489|FG000|Test Period 3|Adverse Event|1|||
23434492|NCT03667690|65334086|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
23434493|NCT03667690|65334087|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
23434494|NCT03667690|65334086|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
23434495|NCT03667690|65334087|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
23321598|NCT01957397|64919490|FG001|Test Period 3|Adverse Event|2|||
23321599|NCT01957397|64919489|FG000|Test Period 3|the adhesive did not work|1|||
23321600|NCT01957397|64919490|FG001|Test Period 3|the adhesive did not work|0|||
23321601|NCT02756208|64919491|FG000|Overall Study|Withdrawal by Subject|1|||
23321602|NCT02756208|64919492|FG001|Overall Study|Withdrawal by Subject|0|||
23321603|NCT02756208|64919493|FG002|Overall Study|Withdrawal by Subject|1|||
23321604|NCT02756208|64919494|FG003|Overall Study|Withdrawal by Subject|3|||
23321605|NCT02756208|64919491|FG000|Overall Study|Lost to Follow-up|3|||
23321606|NCT02756208|64919492|FG001|Overall Study|Lost to Follow-up|1|||
23321607|NCT02756208|64919493|FG002|Overall Study|Lost to Follow-up|1|||
23321608|NCT02756208|64919494|FG003|Overall Study|Lost to Follow-up|1|||
23321609|NCT02756208|64919491|FG000|Overall Study|Physician Decision|1|||
23321610|NCT02756208|64919492|FG001|Overall Study|Physician Decision|0|||
23321611|NCT02756208|64919493|FG002|Overall Study|Physician Decision|0|||
23321612|NCT02756208|64919494|FG003|Overall Study|Physician Decision|0|||
23321613|NCT02756208|64919491|FG000|Overall Study|Protocol Violation|0|||
23321614|NCT02756208|64919492|FG001|Overall Study|Protocol Violation|1|||
23321615|NCT02756208|64919493|FG002|Overall Study|Protocol Violation|0|||
23321616|NCT02756208|64919494|FG003|Overall Study|Protocol Violation|0|||
23321617|NCT01168427|64919498|FG000|Overall Study|Patient exited prior to implant|1|||
23321618|NCT03682107|64919499|FG000|Overall Study|Withdrawal by Subject|0|||
23321619|NCT03682107|64919500|FG001|Overall Study|Withdrawal by Subject|1|||
23321620|NCT03682107|64919501|FG002|Overall Study|Withdrawal by Subject|0|||
23321621|NCT03682107|64919502|FG003|Overall Study|Withdrawal by Subject|0|||
23321622|NCT03682107|64919503|FG004|Overall Study|Withdrawal by Subject|0|||
23321623|NCT04583735|64919504|FG000|Double-masked Treatment Period|Adverse Event|0|||
23434496|NCT03761810|65334094|FG000|Overall Study|Adverse Event|12|||
23434497|NCT03761810|65334095|FG001|Overall Study|Adverse Event|0|||
23434498|NCT03761810|65334094|FG000|Overall Study|Lost to Follow-up|15|||
23434499|NCT03761810|65334095|FG001|Overall Study|Lost to Follow-up|7|||
23321624|NCT04583735|64919505|FG001|Double-masked Treatment Period|Adverse Event|1|||
23321625|NCT04583735|64919504|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
23321626|NCT04583735|64919505|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
23321627|NCT04583735|64919504|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
23321628|NCT04583735|64919505|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
23321629|NCT04583735|64919504|FG000|Open-label Treatment Period|Adverse Event|1|||
23434500|NCT03761810|65334094|FG000|Overall Study|Pregnancy|1|||
23434501|NCT03761810|65334095|FG001|Overall Study|Pregnancy|0|||
23434502|NCT03761810|65334094|FG000|Overall Study|Withdrawal by Subject|14|||
23434503|NCT03761810|65334095|FG001|Overall Study|Withdrawal by Subject|5|||
23434504|NCT03761810|65334094|FG000|Overall Study|Physician Decision|1|||
23434505|NCT03761810|65334095|FG001|Overall Study|Physician Decision|0|||
23434506|NCT03761810|65334094|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
23434507|NCT03761810|65334095|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23434508|NCT03761810|65334094|FG000|Overall Study|Other Than Specified|1|||
23434509|NCT03761810|65334095|FG001|Overall Study|Other Than Specified|0|||
23434510|NCT03160885|65334096|FG000|Initial Treatment Period|Not dosed|2|||
23434511|NCT03160885|65334097|FG001|Initial Treatment Period|Not dosed|0|||
23434512|NCT03160885|65334098|FG002|Initial Treatment Period|Not dosed|0|||
23434513|NCT03160885|65334099|FG003|Initial Treatment Period|Not dosed|0|||
23434514|NCT03160885|65334100|FG004|Initial Treatment Period|Not dosed|0|||
23434515|NCT03160885|65334101|FG005|Initial Treatment Period|Not dosed|0|||
23556453|NCT00733499|65765897|FG001|3 Months Follow-up|Death|2|||
23321630|NCT04583735|64919505|FG001|Open-label Treatment Period|Adverse Event|1|||
23321631|NCT04583735|64919504|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
23434516|NCT03160885|65334102|FG006|Initial Treatment Period|Not dosed|0|||
23434517|NCT03160885|65334096|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
23556454|NCT00733499|65765896|FG000|6 Months Follow-up|Death|0|||
23144716|NCT00406653|64277682|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
23321632|NCT04583735|64919505|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23321633|NCT04583735|64919504|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23321634|NCT04583735|64919505|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
23321635|NCT02348112|64919506|FG000|Overall Study|Withdrawal by Subject|32|||
23321636|NCT02348112|64919507|FG001|Overall Study|Withdrawal by Subject|29|||
23321637|NCT02348112|64919506|FG000|Overall Study|Lost to Follow-up|24|||
23321638|NCT02348112|64919507|FG001|Overall Study|Lost to Follow-up|20|||
23321639|NCT02348112|64919506|FG000|Overall Study|Physician Decision|17|||
23321640|NCT02348112|64919507|FG001|Overall Study|Physician Decision|15|||
23321641|NCT02348112|64919506|FG000|Overall Study|Site closed due to PI leaving|0|||
23321642|NCT02348112|64919507|FG001|Overall Study|Site closed due to PI leaving|30|||
23321643|NCT02348112|64919506|FG000|Overall Study|Sponsor withdrawal|0|||
23321644|NCT02348112|64919507|FG001|Overall Study|Sponsor withdrawal|7|||
23321645|NCT02348112|64919506|FG000|Overall Study|Death|0|||
23321646|NCT02348112|64919507|FG001|Overall Study|Death|1|||
23321647|NCT01275729|64919508|FG000|Overall Study|Death|3|||
23321648|NCT01275729|64919508|FG000|Overall Study|Withdrawal by Subject|1|||
23321649|NCT02548832|64919511|FG000|Overall Study|Lost to Follow-up|2|||
23321650|NCT02548832|64919512|FG001|Overall Study|Lost to Follow-up|2|||
23321651|NCT02548832|64919513|FG002|Overall Study|Lost to Follow-up|2|||
23321652|NCT02533180|64919516|FG000|Overall Study|Death|0|||
23321653|NCT02533180|64919517|FG001|Overall Study|Death|2|||
23321654|NCT02533180|64919516|FG000|Overall Study|Lost to Follow-up|0|||
23321655|NCT02533180|64919517|FG001|Overall Study|Lost to Follow-up|1|||
23321656|NCT02533180|64919516|FG000|Overall Study|Physician Decision|0|||
23321657|NCT02533180|64919517|FG001|Overall Study|Physician Decision|1|||
23321658|NCT02533180|64919516|FG000|Overall Study|Withdrawal by Subject|2|||
23321659|NCT02533180|64919517|FG001|Overall Study|Withdrawal by Subject|5|||
23321660|NCT02533180|64919516|FG000|Overall Study|Screen Failure|37|||
23321661|NCT02533180|64919517|FG001|Overall Study|Screen Failure|0|||
23321662|NCT02533180|64919516|FG000|Overall Study|Protocol Deviation|0|||
23321663|NCT02533180|64919517|FG001|Overall Study|Protocol Deviation|1|||
23321664|NCT02533180|64919516|FG000|Overall Study|Non-compliance|0|||
23321665|NCT02533180|64919517|FG001|Overall Study|Non-compliance|1|||
23321666|NCT03203473|64919518|FG000|Induction Phase|Never started primary treatment|2|||
23321667|NCT03203473|64919519|FG001|Induction Phase|Never started primary treatment|0|||
23321668|NCT03203473|64919520|FG002|Induction Phase|Never started primary treatment|0|||
23321669|NCT03203473|64919518|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
23321670|NCT03203473|64919519|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
23321671|NCT03203473|64919520|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
23321672|NCT03203473|64919518|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
23321673|NCT03203473|64919519|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
23321674|NCT03203473|64919520|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
23144717|NCT00406653|64277683|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
23144718|NCT00406653|64277684|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
23321675|NCT03203473|64919518|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
23321676|NCT03203473|64919519|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
23321677|NCT03203473|64919520|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
23321678|NCT03203473|64919518|FG000|Arm Allocation Phase|started salvage therapy|0|||
23321679|NCT03203473|64919519|FG001|Arm Allocation Phase|started salvage therapy|5|||
23321680|NCT03203473|64919520|FG002|Arm Allocation Phase|started salvage therapy|0|||
23321681|NCT03203473|64919518|FG000|Arm Allocation Phase|Disease progression|0|||
23321682|NCT03203473|64919519|FG001|Arm Allocation Phase|Disease progression|0|||
23321683|NCT03203473|64919520|FG002|Arm Allocation Phase|Disease progression|37|||
23321684|NCT03203473|64919518|FG000|Arm Allocation Phase|Adverse Event|0|||
23321685|NCT03203473|64919519|FG001|Arm Allocation Phase|Adverse Event|0|||
23321686|NCT03203473|64919520|FG002|Arm Allocation Phase|Adverse Event|11|||
23321687|NCT03203473|64919518|FG000|Arm Allocation Phase|Physician Decision|0|||
23321688|NCT03203473|64919519|FG001|Arm Allocation Phase|Physician Decision|0|||
23321689|NCT03203473|64919520|FG002|Arm Allocation Phase|Physician Decision|3|||
23321690|NCT03203473|64919518|FG000|Arm Allocation Phase|Death|0|||
23321691|NCT03203473|64919519|FG001|Arm Allocation Phase|Death|0|||
23321692|NCT03203473|64919520|FG002|Arm Allocation Phase|Death|1|||
23321693|NCT03203473|64919518|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
23321694|NCT03203473|64919519|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
23321695|NCT03203473|64919520|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
23321696|NCT03203473|64919518|FG000|Arm Allocation Phase|Intercurrent illness|0|||
23321697|NCT03203473|64919519|FG001|Arm Allocation Phase|Intercurrent illness|0|||
23321698|NCT03203473|64919520|FG002|Arm Allocation Phase|Intercurrent illness|1|||
23321699|NCT03203473|64919518|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
23321700|NCT03203473|64919519|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
23321701|NCT03203473|64919520|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
23144719|NCT00406653|64277685|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
23321702|NCT03772717|64919521|FG000|Overall Study|Withdrawal by Subject|2|||
23321703|NCT01133067|64919522|FG000|Overall Study|Death|136|||
23321704|NCT01133067|64919522|FG000|Overall Study|Lost to Follow-up|3|||
23321705|NCT04607135|64922842|FG000|Overall Study|Physician Decision|1|||
23321706|NCT04607135|64922842|FG000|Overall Study|Withdrawal by Subject|1|||
23321707|NCT04607135|64922842|FG000|Overall Study|Equipment not working|3|||
23321708|NCT03334435|64922849|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
23321709|NCT03334435|64922850|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
23321710|NCT03334435|64922851|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
23321711|NCT03334435|64922852|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
23321712|NCT03334435|64922853|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
23321713|NCT03334435|64922854|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321714|NCT03334435|64922855|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321715|NCT03334435|64922856|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321716|NCT03334435|64922857|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321717|NCT03334435|64922858|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321718|NCT03334435|64922859|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321719|NCT03334435|64922860|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321720|NCT03334435|64922861|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321721|NCT03334435|64922862|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321722|NCT03334435|64922863|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
23321723|NCT03334435|64922849|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
23321724|NCT03334435|64922850|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
23321725|NCT03334435|64922851|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
23321726|NCT03334435|64922852|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
23321727|NCT03334435|64922853|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
23321728|NCT03334435|64922854|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321729|NCT03334435|64922855|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321730|NCT03334435|64922856|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321731|NCT03334435|64922857|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321732|NCT03334435|64922858|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321733|NCT03334435|64922859|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321734|NCT03334435|64922860|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321735|NCT03334435|64922861|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321736|NCT03334435|64922862|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321737|NCT03334435|64922863|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
23321738|NCT03334435|64922849|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
23321739|NCT03334435|64922850|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
23321740|NCT03334435|64922851|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
23321741|NCT03334435|64922852|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
23321742|NCT03334435|64922853|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
23321743|NCT03334435|64922854|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321744|NCT03334435|64922855|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321745|NCT03334435|64922856|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321746|NCT03334435|64922857|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321747|NCT03334435|64922858|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321748|NCT03334435|64922859|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321749|NCT03334435|64922860|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321750|NCT03334435|64922861|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321751|NCT03334435|64922862|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321752|NCT03334435|64922863|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
23321753|NCT03334435|64922849|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
23321754|NCT03334435|64922850|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
23321755|NCT03334435|64922851|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
23321756|NCT03334435|64922852|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
23321757|NCT03334435|64922853|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
23218073|NCT01563107|64538493|FG002|Overall Study|Physician Decision|1|||
23218074|NCT01563107|64538494|FG003|Overall Study|Physician Decision|3|||
23218075|NCT01563107|64538491|FG000|Overall Study|Withdrawal by Subject|1|||
23218076|NCT01563107|64538492|FG001|Overall Study|Withdrawal by Subject|2|||
23218077|NCT01563107|64538493|FG002|Overall Study|Withdrawal by Subject|1|||
23321758|NCT03334435|64922854|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321759|NCT03334435|64922855|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321760|NCT03334435|64922856|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321761|NCT03334435|64922857|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321762|NCT03334435|64922858|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321763|NCT03334435|64922859|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321764|NCT03334435|64922860|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321765|NCT03334435|64922861|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321766|NCT03334435|64922862|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321767|NCT03334435|64922863|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
23321768|NCT03334435|64922849|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
23321769|NCT03334435|64922850|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321770|NCT03334435|64922851|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
23321771|NCT03334435|64922852|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
23321772|NCT03334435|64922853|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
23321773|NCT03334435|64922854|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321774|NCT03334435|64922855|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321775|NCT03334435|64922856|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321776|NCT03334435|64922857|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321777|NCT03334435|64922858|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321778|NCT03334435|64922859|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321779|NCT03334435|64922860|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321780|NCT03334435|64922861|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321781|NCT03334435|64922862|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321782|NCT03334435|64922863|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
23321783|NCT03334435|64922849|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321784|NCT03334435|64922850|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321785|NCT03334435|64922851|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321786|NCT03334435|64922852|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
23321787|NCT03334435|64922853|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321788|NCT03334435|64922854|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321789|NCT03334435|64922855|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321790|NCT03334435|64922856|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321791|NCT03334435|64922857|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321792|NCT03334435|64922858|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321793|NCT03334435|64922859|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321794|NCT03334435|64922860|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321795|NCT03334435|64922861|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321796|NCT03334435|64922862|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321797|NCT03334435|64922863|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
23321798|NCT03334435|64922849|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
23321799|NCT03334435|64922850|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
23321800|NCT03334435|64922851|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
23321801|NCT03334435|64922852|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
23321802|NCT03334435|64922853|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
23321803|NCT03334435|64922854|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
23218078|NCT01563107|64538494|FG003|Overall Study|Withdrawal by Subject|2|||
23218079|NCT01040845|64538495|FG000|Overall Study|Withdrawal by Subject|1|||
23218080|NCT01040845|64538496|FG001|Overall Study|Withdrawal by Subject|1|||
23556455|NCT00733499|65765897|FG001|6 Months Follow-up|Death|2|||
23556456|NCT00733499|65765896|FG000|6 Months Follow-up|Adverse Event|0|||
23556457|NCT00733499|65765897|FG001|6 Months Follow-up|Adverse Event|1|||
23556458|NCT00733499|65765896|FG000|12 Months Follow-up|Death|2|||
23556459|NCT00733499|65765897|FG001|12 Months Follow-up|Death|1|||
23556460|NCT00733499|65765896|FG000|24 Months Follow-up|Death|0|||
23556461|NCT00733499|65765897|FG001|24 Months Follow-up|Death|1|||
23556462|NCT00733499|65765896|FG000|5 Year Followup|Adverse Event|2|||
23556463|NCT00733499|65765897|FG001|5 Year Followup|Adverse Event|2|||
23556464|NCT00733499|65765896|FG000|5 Year Followup|Non device related AE|0|||
23556465|NCT00733499|65765897|FG001|5 Year Followup|Non device related AE|1|||
23321804|NCT03334435|64922855|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
23321805|NCT03334435|64922856|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
23321806|NCT03334435|64922857|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
23321807|NCT03334435|64922858|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
23321808|NCT03334435|64922859|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
23321809|NCT03334435|64922860|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
23321810|NCT03334435|64922861|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
23556466|NCT00733499|65765896|FG000|5 Year Followup|Revision of Study Implant|0|||
23556467|NCT00733499|65765897|FG001|5 Year Followup|Revision of Study Implant|1|||
23556468|NCT00733499|65765896|FG000|5 Year Followup|Lost to Follow-up|2|||
23556469|NCT00733499|65765897|FG001|5 Year Followup|Lost to Follow-up|0|||
23556470|NCT00733499|65765896|FG000|5 Year Followup|Death|13|||
23556471|NCT00733499|65765897|FG001|5 Year Followup|Death|19|||
23556472|NCT00733499|65765896|FG000|5 Year Followup|missing, unable to locate|0|||
23556473|NCT00733499|65765897|FG001|5 Year Followup|missing, unable to locate|1|||
23556474|NCT00733499|65765896|FG000|5 Year Followup|Withdrawal by Subject|4|||
23556475|NCT00733499|65765897|FG001|5 Year Followup|Withdrawal by Subject|1|||
23556476|NCT00733499|65765896|FG000|10 Year Followup|Death|9|||
23556477|NCT00733499|65765897|FG001|10 Year Followup|Death|7|||
23556478|NCT00733499|65765896|FG000|10 Year Followup|Adverse Event|3|||
23218081|NCT01040845|64538495|FG000|Overall Study|Physician Decision|1|||
23218082|NCT01040845|64538496|FG001|Overall Study|Physician Decision|0|||
23218083|NCT00562640|64538500|FG000|Overall Study|Death|0|||
23218084|NCT00562640|64538501|FG001|Overall Study|Death|1|||
23218085|NCT00562640|64538502|FG002|Overall Study|Death|1|||
23218086|NCT00562640|64538503|FG003|Overall Study|Death|0|||
23218087|NCT01194869|64538504|FG000|Overall Study|Disease Progression|2|||
23218088|NCT01194869|64538504|FG000|Overall Study|Toxicity|2|||
23218089|NCT01878097|64538505|FG000|Baseline|Surveys not fully completed|2497|||
23218090|NCT01878097|64538506|FG001|Baseline|Surveys not fully completed|1800|||
23218091|NCT01878097|64538505|FG000|Implementation Year 1|Surveys not fully completed|3202|||
23218092|NCT01878097|64538506|FG001|Implementation Year 1|Surveys not fully completed|2549|||
23218093|NCT01878097|64538505|FG000|Implementation Year 2|Surveys not fully completed|3281|||
23218094|NCT01878097|64538506|FG001|Implementation Year 2|Surveys not fully completed|2841|||
23218095|NCT01878097|64538505|FG000|Implementation Year 3|Surveys not fully completed|3494|||
23218096|NCT01878097|64538506|FG001|Implementation Year 3|Surveys not fully completed|2980|||
23218097|NCT01878097|64538505|FG000|Implementation Year 4|Surveys not fully completed|3604|||
23218098|NCT01878097|64538506|FG001|Implementation Year 4|Surveys not fully completed|3007|||
23218099|NCT00431496|64538509|FG000|Overall Study|Adverse Event|3|||
23218100|NCT00431496|64538509|FG000|Overall Study|Lost to Follow-up|1|||
23218101|NCT00431496|64538509|FG000|Overall Study|Withdrawal by Subject|2|||
23218102|NCT00431496|64538509|FG000|Overall Study|Protocol-specified criteria|5|||
23218103|NCT01002742|64538515|FG000|Overall Study|Determined to be ineligible|0|||
23218104|NCT01002742|64538516|FG001|Overall Study|Determined to be ineligible|1|||
23218105|NCT00425100|64538517|FG000|Overall Study|Adverse Event|36|||
23218106|NCT00425100|64538517|FG000|Overall Study|Lack of Efficacy|4|||
23218107|NCT00425100|64538517|FG000|Overall Study|Lost to Follow-up|2|||
23218108|NCT00425100|64538517|FG000|Overall Study|Protocol Violation|4|||
23218109|NCT00425100|64538517|FG000|Overall Study|Withdrawal by Subject|7|||
23218110|NCT05263921|64541454|FG000|Overall Study|Other: family emergency.|0|||
23218111|NCT05263921|64541455|FG001|Overall Study|Other: family emergency.|0|||
23218112|NCT05263921|64541456|FG002|Overall Study|Other: family emergency.|1|||
23218113|NCT05263921|64541457|FG003|Overall Study|Other: family emergency.|0|||
23218114|NCT02725268|64541458|FG000|Overall Study|Death|58|||
23218115|NCT02725268|64541459|FG001|Overall Study|Death|59|||
23218116|NCT02725268|64541460|FG002|Overall Study|Death|30|||
23218117|NCT02725268|64541461|FG003|Overall Study|Death|16|||
23218118|NCT02725268|64541458|FG000|Overall Study|Lost to Follow-up|4|||
23218119|NCT02725268|64541459|FG001|Overall Study|Lost to Follow-up|3|||
23218120|NCT02725268|64541460|FG002|Overall Study|Lost to Follow-up|0|||
23218121|NCT02725268|64541461|FG003|Overall Study|Lost to Follow-up|1|||
23218122|NCT02725268|64541458|FG000|Overall Study|Site Terminated by Sponsor|0|||
23218123|NCT02725268|64541459|FG001|Overall Study|Site Terminated by Sponsor|1|||
23218124|NCT02725268|64541460|FG002|Overall Study|Site Terminated by Sponsor|0|||
23218125|NCT02725268|64541461|FG003|Overall Study|Site Terminated by Sponsor|0|||
23218126|NCT02725268|64541458|FG000|Overall Study|Withdrawal by Subject|8|||
23218127|NCT02725268|64541459|FG001|Overall Study|Withdrawal by Subject|6|||
23218128|NCT02725268|64541460|FG002|Overall Study|Withdrawal by Subject|8|||
23218129|NCT02725268|64541461|FG003|Overall Study|Withdrawal by Subject|1|||
23218130|NCT02725268|64541458|FG000|Overall Study|Reason not Specified|2|||
23218131|NCT02725268|64541459|FG001|Overall Study|Reason not Specified|1|||
23218132|NCT02725268|64541460|FG002|Overall Study|Reason not Specified|0|||
23218133|NCT02725268|64541461|FG003|Overall Study|Reason not Specified|0|||
23218134|NCT04685538|64541462|FG000|Overall Study|Adverse Event|0|||
23218135|NCT04685538|64541463|FG001|Overall Study|Adverse Event|1|||
23556479|NCT00733499|65765897|FG001|10 Year Followup|Adverse Event|3|||
23218136|NCT04685538|64541462|FG000|Overall Study|Lost to Follow-up|0|||
23218137|NCT04685538|64541463|FG001|Overall Study|Lost to Follow-up|2|||
23218138|NCT01102140|64541464|FG000|Overall Study|Lost to Follow-up|1|||
23556480|NCT00733499|65765896|FG000|10 Year Followup|Lost to Follow-up|3|||
23218139|NCT01102140|64541465|FG001|Overall Study|Lost to Follow-up|0|||
23556481|NCT00733499|65765897|FG001|10 Year Followup|Lost to Follow-up|2|||
23218140|NCT01102140|64541464|FG000|Overall Study|Investigator terminated study|2|||
23218141|NCT01102140|64541465|FG001|Overall Study|Investigator terminated study|2|||
23218142|NCT00499460|64541468|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
23218143|NCT00499460|64541469|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
23218144|NCT00499460|64541468|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
23556482|NCT00733499|65765896|FG000|10 Year Followup|Withdrawal by Subject|5|||
23321811|NCT03334435|64922862|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
23321812|NCT03334435|64922863|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
23321813|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23321814|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23321815|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23321816|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23321817|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
23321818|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
23321819|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
23321820|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
23321821|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
23321822|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
23321823|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
23321824|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
23321825|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
23321826|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
23321827|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
23321828|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23321829|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23321830|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23321831|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23321832|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
23321833|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
23321834|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
23321835|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
23321836|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
23321837|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
23321838|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
23321839|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
23321840|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
23144720|NCT00406653|64277686|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
23144721|NCT00406653|64277687|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
23321841|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
23144722|NCT00406653|64277681|FG000|Induction Period|Pregnancy|1|||
23144723|NCT00406653|64277682|FG001|Induction Period|Pregnancy|0|||
23144724|NCT00406653|64277683|FG002|Induction Period|Pregnancy|0|||
23144725|NCT00406653|64277684|FG003|Induction Period|Pregnancy|0|||
23144726|NCT00406653|64277685|FG004|Induction Period|Pregnancy|0|||
23144727|NCT00406653|64277686|FG005|Induction Period|Pregnancy|0|||
23144728|NCT00406653|64277687|FG006|Induction Period|Pregnancy|0|||
23144729|NCT00406653|64277681|FG000|Induction Period|Declined participation but followup done|0|||
23144730|NCT00406653|64277682|FG001|Induction Period|Declined participation but followup done|2|||
23144731|NCT00406653|64277683|FG002|Induction Period|Declined participation but followup done|1|||
23144732|NCT00406653|64277684|FG003|Induction Period|Declined participation but followup done|1|||
23144733|NCT00406653|64277685|FG004|Induction Period|Declined participation but followup done|0|||
23144734|NCT00406653|64277686|FG005|Induction Period|Declined participation but followup done|0|||
23144735|NCT00406653|64277687|FG006|Induction Period|Declined participation but followup done|0|||
23144736|NCT00406653|64277681|FG000|Induction Period|Given prohibited drug|0|||
23144737|NCT00406653|64277682|FG001|Induction Period|Given prohibited drug|1|||
23144738|NCT00406653|64277683|FG002|Induction Period|Given prohibited drug|2|||
23144739|NCT00406653|64277684|FG003|Induction Period|Given prohibited drug|0|||
23144740|NCT00406653|64277685|FG004|Induction Period|Given prohibited drug|0|||
23144741|NCT00406653|64277686|FG005|Induction Period|Given prohibited drug|0|||
23144742|NCT00406653|64277687|FG006|Induction Period|Given prohibited drug|0|||
23144743|NCT00406653|64277681|FG000|Induction Period|Incarcerated|0|||
23144744|NCT00406653|64277682|FG001|Induction Period|Incarcerated|0|||
23144745|NCT00406653|64277683|FG002|Induction Period|Incarcerated|1|||
23144746|NCT00406653|64277684|FG003|Induction Period|Incarcerated|0|||
23144747|NCT00406653|64277685|FG004|Induction Period|Incarcerated|0|||
23144748|NCT00406653|64277686|FG005|Induction Period|Incarcerated|0|||
23144749|NCT00406653|64277687|FG006|Induction Period|Incarcerated|0|||
23321842|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
23144750|NCT00406653|64277681|FG000|Induction Period|Patient relocated|0|||
23144751|NCT00406653|64277682|FG001|Induction Period|Patient relocated|0|||
23218145|NCT00499460|64541469|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
23144752|NCT00406653|64277683|FG002|Induction Period|Patient relocated|1|||
23144753|NCT00406653|64277684|FG003|Induction Period|Patient relocated|0|||
23144754|NCT00406653|64277685|FG004|Induction Period|Patient relocated|0|||
23434518|NCT03160885|65334097|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
23434519|NCT03160885|65334098|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23623526|NCT00684203|66008473|FG005|Overall Study|Did not meet protocol eligibility|0|||
23623527|NCT01157351|66008474|FG000|Overall Study|Adverse Event|5|||
23623528|NCT01157351|66008475|FG001|Overall Study|Adverse Event|4|||
23218146|NCT00499460|64541468|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
23218147|NCT00499460|64541469|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
23218148|NCT00412113|64541470|FG000|Overall Study|Adverse Event|11|||
23434520|NCT03160885|65334099|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23434521|NCT03160885|65334100|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23434522|NCT03160885|65334101|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23623529|NCT01157351|66008474|FG000|Overall Study|Death|1|||
23623530|NCT01157351|66008475|FG001|Overall Study|Death|0|||
23623531|NCT01157351|66008474|FG000|Overall Study|Lost to Follow-up|53|||
23623532|NCT01157351|66008475|FG001|Overall Study|Lost to Follow-up|55|||
23623533|NCT01157351|66008474|FG000|Overall Study|Withdrawal by Subject|37|||
23623534|NCT01157351|66008475|FG001|Overall Study|Withdrawal by Subject|27|||
23623535|NCT01157351|66008474|FG000|Overall Study|Physician Decision|5|||
23623536|NCT01157351|66008475|FG001|Overall Study|Physician Decision|4|||
23623537|NCT01157351|66008474|FG000|Overall Study|Protocol Violation|0|||
23623538|NCT01157351|66008475|FG001|Overall Study|Protocol Violation|1|||
23623539|NCT01157351|66008474|FG000|Overall Study|Other|32|||
23144755|NCT00406653|64277686|FG005|Induction Period|Patient relocated|0|||
23144756|NCT00406653|64277687|FG006|Induction Period|Patient relocated|0|||
23144757|NCT00406653|64277681|FG000|Maintenance Period|Adverse Event|0|||
23144758|NCT00406653|64277682|FG001|Maintenance Period|Adverse Event|0|||
23434523|NCT03160885|65334102|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
23434524|NCT03160885|65334096|FG000|Open-label Treatment|Not dosed|0|||
23434525|NCT03160885|65334097|FG001|Open-label Treatment|Not dosed|0|||
23434526|NCT03160885|65334098|FG002|Open-label Treatment|Not dosed|0|||
23434527|NCT03160885|65334099|FG003|Open-label Treatment|Not dosed|0|||
23434528|NCT03160885|65334100|FG004|Open-label Treatment|Not dosed|0|||
23434529|NCT03160885|65334101|FG005|Open-label Treatment|Not dosed|0|||
23434530|NCT03160885|65334102|FG006|Open-label Treatment|Not dosed|2|||
23434531|NCT03160885|65334096|FG000|Open-label Treatment|Discontinued IMP|0|||
23434532|NCT03160885|65334097|FG001|Open-label Treatment|Discontinued IMP|0|||
23144759|NCT00406653|64277683|FG002|Maintenance Period|Adverse Event|0|||
23144760|NCT00406653|64277684|FG003|Maintenance Period|Adverse Event|0|||
23144761|NCT00406653|64277685|FG004|Maintenance Period|Adverse Event|1|||
23144762|NCT00406653|64277686|FG005|Maintenance Period|Adverse Event|1|||
23144763|NCT00406653|64277687|FG006|Maintenance Period|Adverse Event|0|||
23144764|NCT00406653|64277681|FG000|Maintenance Period|Lack of Efficacy|0|||
23144765|NCT00406653|64277682|FG001|Maintenance Period|Lack of Efficacy|0|||
23144766|NCT00406653|64277683|FG002|Maintenance Period|Lack of Efficacy|0|||
23144767|NCT00406653|64277684|FG003|Maintenance Period|Lack of Efficacy|0|||
23144768|NCT00406653|64277685|FG004|Maintenance Period|Lack of Efficacy|20|||
23144769|NCT00406653|64277686|FG005|Maintenance Period|Lack of Efficacy|26|||
23144770|NCT00406653|64277687|FG006|Maintenance Period|Lack of Efficacy|0|||
23144771|NCT00406653|64277681|FG000|Maintenance Period|Lost to Follow-up|0|||
23144772|NCT00406653|64277682|FG001|Maintenance Period|Lost to Follow-up|0|||
23144773|NCT00406653|64277683|FG002|Maintenance Period|Lost to Follow-up|0|||
23144774|NCT00406653|64277684|FG003|Maintenance Period|Lost to Follow-up|0|||
23144775|NCT00406653|64277685|FG004|Maintenance Period|Lost to Follow-up|2|||
23144776|NCT00406653|64277686|FG005|Maintenance Period|Lost to Follow-up|1|||
23144777|NCT00406653|64277687|FG006|Maintenance Period|Lost to Follow-up|0|||
23144778|NCT00406653|64277681|FG000|Maintenance Period|Withdrawal of Consent|0|||
23144779|NCT00406653|64277682|FG001|Maintenance Period|Withdrawal of Consent|0|||
23144780|NCT00406653|64277683|FG002|Maintenance Period|Withdrawal of Consent|0|||
23144781|NCT00406653|64277684|FG003|Maintenance Period|Withdrawal of Consent|0|||
23144782|NCT00406653|64277685|FG004|Maintenance Period|Withdrawal of Consent|2|||
23144783|NCT00406653|64277686|FG005|Maintenance Period|Withdrawal of Consent|0|||
23144784|NCT00406653|64277687|FG006|Maintenance Period|Withdrawal of Consent|0|||
23144785|NCT00406653|64277681|FG000|Maintenance Period|Pregnancy|0|||
23144786|NCT00406653|64277682|FG001|Maintenance Period|Pregnancy|0|||
23144787|NCT00406653|64277683|FG002|Maintenance Period|Pregnancy|0|||
23144788|NCT00406653|64277684|FG003|Maintenance Period|Pregnancy|0|||
23144789|NCT00406653|64277685|FG004|Maintenance Period|Pregnancy|0|||
23144790|NCT00406653|64277686|FG005|Maintenance Period|Pregnancy|1|||
23434533|NCT03160885|65334098|FG002|Open-label Treatment|Discontinued IMP|0|||
23623540|NCT01157351|66008475|FG001|Overall Study|Other|36|||
23623541|NCT01157351|66008474|FG000|Overall Study|Noncompliance with Study Drug|0|||
23623542|NCT01157351|66008475|FG001|Overall Study|Noncompliance with Study Drug|3|||
23623543|NCT01157351|66008474|FG000|Overall Study|Randomized but not Treated|4|||
23144791|NCT00406653|64277687|FG006|Maintenance Period|Pregnancy|0|||
23144792|NCT00406653|64277681|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
23144793|NCT00406653|64277682|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
23434534|NCT03160885|65334099|FG003|Open-label Treatment|Discontinued IMP|0|||
23434535|NCT03160885|65334100|FG004|Open-label Treatment|Discontinued IMP|0|||
23434536|NCT03160885|65334101|FG005|Open-label Treatment|Discontinued IMP|0|||
23434537|NCT03160885|65334102|FG006|Open-label Treatment|Discontinued IMP|131|||
23434538|NCT03160885|65334096|FG000|Open-label Treatment|Completed Week 50|0|||
23144794|NCT00406653|64277683|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
23144795|NCT00406653|64277684|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
23144796|NCT00406653|64277685|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
23321843|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23434539|NCT03160885|65334097|FG001|Open-label Treatment|Completed Week 50|0|||
23434540|NCT03160885|65334098|FG002|Open-label Treatment|Completed Week 50|0|||
23434541|NCT03160885|65334099|FG003|Open-label Treatment|Completed Week 50|0|||
23434542|NCT03160885|65334100|FG004|Open-label Treatment|Completed Week 50|0|||
23434543|NCT03160885|65334101|FG005|Open-label Treatment|Completed Week 50|0|||
23434544|NCT03160885|65334102|FG006|Open-label Treatment|Completed Week 50|4|||
23434545|NCT03160885|65334096|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434546|NCT03160885|65334097|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434547|NCT03160885|65334098|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434548|NCT03160885|65334099|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
23434549|NCT03160885|65334100|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434550|NCT03160885|65334101|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434551|NCT03160885|65334102|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
23434552|NCT03160885|65334096|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
23434553|NCT03160885|65334097|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
23434554|NCT03160885|65334098|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
23434555|NCT03160885|65334099|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
23434556|NCT03160885|65334100|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
23434557|NCT03160885|65334101|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
23434558|NCT03160885|65334102|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
23434559|NCT03160885|65334096|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23434560|NCT03160885|65334097|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23434561|NCT03160885|65334098|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
23434562|NCT03160885|65334099|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
23434563|NCT03160885|65334100|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
23434564|NCT03160885|65334101|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
23434565|NCT03160885|65334102|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
23434566|NCT03160885|65334096|FG000|Maintenance Treatment Period|Completed Week 50|0|||
23434567|NCT03160885|65334097|FG001|Maintenance Treatment Period|Completed Week 50|0|||
23434568|NCT03160885|65334098|FG002|Maintenance Treatment Period|Completed Week 50|1|||
23434569|NCT03160885|65334099|FG003|Maintenance Treatment Period|Completed Week 50|0|||
23434570|NCT03160885|65334100|FG004|Maintenance Treatment Period|Completed Week 50|0|||
23434571|NCT03160885|65334101|FG005|Maintenance Treatment Period|Completed Week 50|0|||
23434572|NCT03160885|65334102|FG006|Maintenance Treatment Period|Completed Week 50|0|||
23434573|NCT00084487|65334103|FG000|Overall Study|Death|1|||
23434574|NCT01229449|65334107|FG000|Overall Study|Withdrawal by Subject|0|||
23434575|NCT01229449|65334108|FG001|Overall Study|Withdrawal by Subject|3|||
23434576|NCT01229449|65334109|FG002|Overall Study|Withdrawal by Subject|0|||
23434577|NCT01229449|65334110|FG003|Overall Study|Withdrawal by Subject|1|||
23434578|NCT01229449|65334111|FG004|Overall Study|Withdrawal by Subject|1|||
23434579|NCT01229449|65334107|FG000|Overall Study|Lost to Follow-up|1|||
23434580|NCT01229449|65334108|FG001|Overall Study|Lost to Follow-up|1|||
23434581|NCT01229449|65334109|FG002|Overall Study|Lost to Follow-up|1|||
23434582|NCT01229449|65334110|FG003|Overall Study|Lost to Follow-up|0|||
23434583|NCT01229449|65334111|FG004|Overall Study|Lost to Follow-up|0|||
23434584|NCT01229449|65334107|FG000|Overall Study|Physician Decision|0|||
23434585|NCT01229449|65334108|FG001|Overall Study|Physician Decision|0|||
23434586|NCT01229449|65334109|FG002|Overall Study|Physician Decision|1|||
23434587|NCT01229449|65334110|FG003|Overall Study|Physician Decision|0|||
23434588|NCT01229449|65334111|FG004|Overall Study|Physician Decision|0|||
23434589|NCT01953913|65334114|FG000|Overall Study|Disease Progression|349|||
23434590|NCT01953913|65334114|FG000|Overall Study|Worsening of underlying cancer|22|||
23434591|NCT01953913|65334114|FG000|Overall Study|Adverse Event|20|||
23434592|NCT01953913|65334114|FG000|Overall Study|Protocol Violation|6|||
23321844|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23434593|NCT01953913|65334114|FG000|Overall Study|Lost to Follow-up|4|||
23434594|NCT01953913|65334114|FG000|Overall Study|Withdrawal by Subject|32|||
23434595|NCT01953913|65334114|FG000|Overall Study|Other than listed|108|||
23434596|NCT01953913|65334114|FG000|Overall Study|Not Treated|1|||
23434597|NCT00847015|65334115|FG000|Overall Study|Withdrawal by Subject|1|||
23434598|NCT00847015|65334115|FG000|Overall Study|declined any surgery|1|||
23218149|NCT00412113|64541471|FG001|Overall Study|Adverse Event|15|||
23434599|NCT00847015|65334115|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
23434600|NCT02175368|65334118|FG000|Overall Study|Lost to Follow-up|1|||
23434601|NCT01571453|65334120|FG000|Overall Study|Adverse Event|14|||
23434602|NCT01571453|65334121|FG001|Overall Study|Adverse Event|32|||
23434603|NCT01571453|65334120|FG000|Overall Study|Lack of Efficacy|8|||
23434604|NCT01571453|65334121|FG001|Overall Study|Lack of Efficacy|3|||
23434605|NCT01571453|65334120|FG000|Overall Study|Non-compliance|2|||
23434606|NCT01571453|65334121|FG001|Overall Study|Non-compliance|4|||
23434607|NCT01571453|65334120|FG000|Overall Study|Protocol Violation|1|||
23434608|NCT01571453|65334121|FG001|Overall Study|Protocol Violation|5|||
23434609|NCT01571453|65334120|FG000|Overall Study|Withdrawal of consent|5|||
23434610|NCT01571453|65334121|FG001|Overall Study|Withdrawal of consent|13|||
23434611|NCT01571453|65334120|FG000|Overall Study|Lost to Follow-up|4|||
23434612|NCT01571453|65334121|FG001|Overall Study|Lost to Follow-up|2|||
23434613|NCT01571453|65334120|FG000|Overall Study|Administrative or other reason(s)|4|||
23434614|NCT01571453|65334121|FG001|Overall Study|Administrative or other reason(s)|3|||
23434615|NCT00504894|65334122|FG000|Overall Study|fMRI technical problems|1|||
23434616|NCT00504894|65334123|FG001|Overall Study|fMRI technical problems|1|||
23434617|NCT00504894|65334124|FG002|Overall Study|fMRI technical problems|0|||
23434618|NCT00504894|65334122|FG000|Overall Study|Withdrawal by Subject|0|||
23434619|NCT00504894|65334123|FG001|Overall Study|Withdrawal by Subject|1|||
23434620|NCT00504894|65334124|FG002|Overall Study|Withdrawal by Subject|0|||
23434621|NCT00504894|65334122|FG000|Overall Study|Infusion technical problems|0|||
23434622|NCT00504894|65334123|FG001|Overall Study|Infusion technical problems|1|||
23434623|NCT00504894|65334124|FG002|Overall Study|Infusion technical problems|0|||
23434624|NCT00504894|65334122|FG000|Overall Study|poor subject data|2|||
23434625|NCT00504894|65334123|FG001|Overall Study|poor subject data|0|||
23434626|NCT00504894|65334124|FG002|Overall Study|poor subject data|0|||
23434627|NCT02905006|65334125|FG000|Overall Study|Adverse Event|1|||
23434628|NCT02905006|65334126|FG001|Overall Study|Adverse Event|1|||
23434629|NCT02905006|65334127|FG002|Overall Study|Adverse Event|1|||
23434630|NCT02905006|65334128|FG003|Overall Study|Adverse Event|1|||
23434631|NCT02905006|65334129|FG004|Overall Study|Adverse Event|0|||
23434632|NCT02905006|65334130|FG005|Overall Study|Adverse Event|1|||
23434633|NCT02905006|65334125|FG000|Overall Study|Lack of Efficacy|1|||
23434634|NCT02905006|65334126|FG001|Overall Study|Lack of Efficacy|0|||
23434635|NCT02905006|65334127|FG002|Overall Study|Lack of Efficacy|0|||
23434636|NCT02905006|65334128|FG003|Overall Study|Lack of Efficacy|0|||
23434637|NCT02905006|65334129|FG004|Overall Study|Lack of Efficacy|0|||
23434638|NCT02905006|65334130|FG005|Overall Study|Lack of Efficacy|0|||
23434639|NCT02905006|65334125|FG000|Overall Study|Protocol Violation|2|||
23434640|NCT02905006|65334126|FG001|Overall Study|Protocol Violation|0|||
23434641|NCT02905006|65334127|FG002|Overall Study|Protocol Violation|0|||
23434642|NCT02905006|65334128|FG003|Overall Study|Protocol Violation|0|||
23434643|NCT02905006|65334129|FG004|Overall Study|Protocol Violation|0|||
23434644|NCT02905006|65334130|FG005|Overall Study|Protocol Violation|0|||
23434645|NCT02905006|65334125|FG000|Overall Study|Lost to Follow-up|0|||
23434646|NCT02905006|65334126|FG001|Overall Study|Lost to Follow-up|0|||
23434647|NCT02905006|65334127|FG002|Overall Study|Lost to Follow-up|0|||
23434648|NCT02905006|65334128|FG003|Overall Study|Lost to Follow-up|1|||
23434649|NCT02905006|65334129|FG004|Overall Study|Lost to Follow-up|1|||
23434650|NCT02905006|65334130|FG005|Overall Study|Lost to Follow-up|0|||
23434651|NCT02905006|65334125|FG000|Overall Study|Withdrawal by Subject|0|||
23434652|NCT02905006|65334126|FG001|Overall Study|Withdrawal by Subject|0|||
23434653|NCT02905006|65334127|FG002|Overall Study|Withdrawal by Subject|1|||
23434654|NCT02905006|65334128|FG003|Overall Study|Withdrawal by Subject|1|||
23556483|NCT00733499|65765897|FG001|10 Year Followup|Withdrawal by Subject|5|||
23556484|NCT00733499|65765896|FG000|10 Year Followup|missing, unable to locate|0|||
23556485|NCT00733499|65765897|FG001|10 Year Followup|missing, unable to locate|2|||
23556486|NCT00567190|65765898|FG000|Overall Study|Death|235|||
23556487|NCT00567190|65765899|FG001|Overall Study|Death|280|||
23556488|NCT00567190|65765898|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
23556489|NCT00567190|65765899|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
23556490|NCT03751631|65765900|FG000|Overall Study|Withdrawal by Subject|0|||
23321845|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23434655|NCT02905006|65334129|FG004|Overall Study|Withdrawal by Subject|0|||
23434656|NCT02905006|65334130|FG005|Overall Study|Withdrawal by Subject|1|||
23434657|NCT02905006|65334125|FG000|Overall Study|Screening exclusion criteria met|1|||
23434658|NCT02905006|65334126|FG001|Overall Study|Screening exclusion criteria met|0|||
23434659|NCT02905006|65334127|FG002|Overall Study|Screening exclusion criteria met|0|||
23434660|NCT02905006|65334128|FG003|Overall Study|Screening exclusion criteria met|0|||
23434661|NCT02905006|65334129|FG004|Overall Study|Screening exclusion criteria met|0|||
23434662|NCT02905006|65334130|FG005|Overall Study|Screening exclusion criteria met|0|||
23556491|NCT03751631|65765901|FG001|Overall Study|Withdrawal by Subject|0|||
23623544|NCT01157351|66008475|FG001|Overall Study|Randomized but not Treated|2|||
23434663|NCT02905006|65334125|FG000|Overall Study|Lab withdrawal criterion met|0|||
23556492|NCT03751631|65765902|FG002|Overall Study|Withdrawal by Subject|1|||
23434664|NCT02905006|65334126|FG001|Overall Study|Lab withdrawal criterion met|1|||
23434665|NCT02905006|65334127|FG002|Overall Study|Lab withdrawal criterion met|2|||
23434666|NCT02905006|65334128|FG003|Overall Study|Lab withdrawal criterion met|2|||
23434667|NCT02905006|65334129|FG004|Overall Study|Lab withdrawal criterion met|2|||
23434668|NCT02905006|65334130|FG005|Overall Study|Lab withdrawal criterion met|1|||
23434669|NCT02905006|65334125|FG000|Overall Study|Positive for Tuberculosis|0|||
23556493|NCT03751631|65765903|FG003|Overall Study|Withdrawal by Subject|1|||
23434670|NCT02905006|65334126|FG001|Overall Study|Positive for Tuberculosis|1|||
23434671|NCT02905006|65334127|FG002|Overall Study|Positive for Tuberculosis|0|||
23434672|NCT02905006|65334128|FG003|Overall Study|Positive for Tuberculosis|0|||
23434673|NCT02905006|65334129|FG004|Overall Study|Positive for Tuberculosis|0|||
23434674|NCT02905006|65334130|FG005|Overall Study|Positive for Tuberculosis|0|||
23434675|NCT02905006|65334125|FG000|Overall Study|Subject positive for Hep B|0|||
23434676|NCT02905006|65334126|FG001|Overall Study|Subject positive for Hep B|0|||
23434677|NCT02905006|65334127|FG002|Overall Study|Subject positive for Hep B|1|||
23434678|NCT02905006|65334128|FG003|Overall Study|Subject positive for Hep B|0|||
23434679|NCT02905006|65334129|FG004|Overall Study|Subject positive for Hep B|0|||
23434680|NCT02905006|65334130|FG005|Overall Study|Subject positive for Hep B|0|||
23434681|NCT02905006|65334125|FG000|Overall Study|Patient moved abroad|0|||
23434682|NCT02905006|65334126|FG001|Overall Study|Patient moved abroad|0|||
23434683|NCT02905006|65334127|FG002|Overall Study|Patient moved abroad|0|||
23434684|NCT02905006|65334128|FG003|Overall Study|Patient moved abroad|1|||
23434685|NCT02905006|65334129|FG004|Overall Study|Patient moved abroad|0|||
23434686|NCT02905006|65334130|FG005|Overall Study|Patient moved abroad|0|||
23434687|NCT02905006|65334125|FG000|Overall Study|Patient randomized by mistake|0|||
23434688|NCT02905006|65334126|FG001|Overall Study|Patient randomized by mistake|0|||
23434689|NCT02905006|65334127|FG002|Overall Study|Patient randomized by mistake|0|||
23434690|NCT02905006|65334128|FG003|Overall Study|Patient randomized by mistake|0|||
23434691|NCT02905006|65334129|FG004|Overall Study|Patient randomized by mistake|0|||
23434692|NCT02905006|65334130|FG005|Overall Study|Patient randomized by mistake|1|||
23434693|NCT02409719|65334135|FG000|Overall Study|Lost to Follow-up|3|||
23434694|NCT02409719|65334136|FG001|Overall Study|Lost to Follow-up|3|||
23434695|NCT00737633|65334137|FG000|Overall Study|Study terminated by sponsor|44|||
23434696|NCT00737633|65334138|FG001|Overall Study|Study terminated by sponsor|55|||
23434697|NCT00737633|65334137|FG000|Overall Study|Lost to Follow-up|0|||
23434698|NCT00737633|65334138|FG001|Overall Study|Lost to Follow-up|1|||
23434699|NCT00737633|65334137|FG000|Overall Study|protocol non-compliance|0|||
23434700|NCT00737633|65334138|FG001|Overall Study|protocol non-compliance|1|||
23434701|NCT03316950|65334141|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
23434702|NCT03316950|65334142|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
23434703|NCT03316950|65334143|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
23434704|NCT03316950|65334144|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
23434705|NCT03316950|65334141|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
23434706|NCT03316950|65334142|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
23434707|NCT03316950|65334143|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
23434708|NCT03316950|65334144|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
23434709|NCT03316950|65334141|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
23434710|NCT03316950|65334142|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
23144797|NCT00406653|64277686|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
23434711|NCT03316950|65334143|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
23434712|NCT03316950|65334144|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
23556494|NCT03751631|65765904|FG004|Overall Study|Withdrawal by Subject|0|||
23556495|NCT03751631|65765905|FG005|Overall Study|Withdrawal by Subject|0|||
23556496|NCT02856113|65765906|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23556497|NCT02856113|65765907|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23556498|NCT02856113|65765906|FG000|Overall Study|Significant Protocol Deviation|1|||
23556499|NCT02856113|65765907|FG001|Overall Study|Significant Protocol Deviation|0|||
23556500|NCT02856113|65765906|FG000|Overall Study|Lost to Follow-up|3|||
23623545|NCT00591591|66008482|FG000|Overall Study|Withdrawal by Subject|1|||
23434713|NCT00330681|65334145|FG000|Overall Study|Adverse Event|3|||
23434714|NCT00330681|65334146|FG001|Overall Study|Adverse Event|6|||
23434715|NCT00330681|65334145|FG000|Overall Study|Protocol Violation|0|||
23434716|NCT00330681|65334146|FG001|Overall Study|Protocol Violation|1|||
23434717|NCT00330681|65334145|FG000|Overall Study|Withdrawal by Subject|5|||
23434718|NCT00330681|65334146|FG001|Overall Study|Withdrawal by Subject|5|||
23144798|NCT00406653|64277687|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
23321846|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23434719|NCT00330681|65334145|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
23434720|NCT00330681|65334146|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
23434721|NCT02322190|65334150|FG000|Overall Study|Death on study|1|||
23434722|NCT02322190|65334151|FG001|Overall Study|Death on study|0|||
23434723|NCT00629798|65334160|FG000|Overall Study|Not Treated|4|||
23434724|NCT02453555|65334161|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
23434725|NCT02453555|65334162|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
23434726|NCT02453555|65334163|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
23434727|NCT02453555|65334164|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
23434728|NCT02453555|65334165|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
23434729|NCT02453555|65334166|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
23434730|NCT02453555|65334161|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
23434731|NCT02453555|65334162|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434732|NCT02453555|65334163|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434733|NCT02453555|65334164|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434734|NCT02453555|65334165|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434735|NCT02453555|65334166|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
23434736|NCT02453555|65334161|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
23434737|NCT02453555|65334162|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
23434738|NCT02453555|65334163|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23434739|NCT02453555|65334164|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23434740|NCT02453555|65334165|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23434741|NCT02453555|65334166|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23434742|NCT02453555|65334161|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
23434743|NCT02453555|65334162|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
23434744|NCT02453555|65334163|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
23434745|NCT02453555|65334164|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
23434746|NCT02453555|65334165|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
23434747|NCT02453555|65334166|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
23434748|NCT02453555|65334161|FG000|Extension Period|Adverse Event|0|||
23434749|NCT02453555|65334162|FG001|Extension Period|Adverse Event|0|||
23434750|NCT02453555|65334163|FG002|Extension Period|Adverse Event|1|||
23434751|NCT02453555|65334164|FG003|Extension Period|Adverse Event|2|||
23434752|NCT02453555|65334165|FG004|Extension Period|Adverse Event|1|||
23434753|NCT02453555|65334166|FG005|Extension Period|Adverse Event|1|||
23434754|NCT02453555|65334161|FG000|Extension Period|Protocol Violation|0|||
23434755|NCT02453555|65334162|FG001|Extension Period|Protocol Violation|0|||
23434756|NCT02453555|65334163|FG002|Extension Period|Protocol Violation|1|||
23434757|NCT02453555|65334164|FG003|Extension Period|Protocol Violation|0|||
23434758|NCT02453555|65334165|FG004|Extension Period|Protocol Violation|0|||
23434759|NCT02453555|65334166|FG005|Extension Period|Protocol Violation|0|||
23434760|NCT02453555|65334161|FG000|Extension Period|Withdrawal by Subject|0|||
23434761|NCT02453555|65334162|FG001|Extension Period|Withdrawal by Subject|0|||
23434762|NCT02453555|65334163|FG002|Extension Period|Withdrawal by Subject|1|||
23434763|NCT02453555|65334164|FG003|Extension Period|Withdrawal by Subject|0|||
23556501|NCT02856113|65765907|FG001|Overall Study|Lost to Follow-up|5|||
23556502|NCT02856113|65765906|FG000|Overall Study|Voluntary Withdrawal|3|||
23556503|NCT02856113|65765907|FG001|Overall Study|Voluntary Withdrawal|5|||
23556504|NCT02856113|65765906|FG000|Overall Study|Pregnancy|0|||
23556505|NCT02856113|65765907|FG001|Overall Study|Pregnancy|1|||
23556506|NCT02856113|65765906|FG000|Overall Study|Principal Investigator Discretion|2|||
23556507|NCT02856113|65765907|FG001|Overall Study|Principal Investigator Discretion|1|||
23556508|NCT02856113|65765906|FG000|Overall Study|Randomized but not Treated|1|||
23556509|NCT02856113|65765907|FG001|Overall Study|Randomized but not Treated|0|||
23556510|NCT02856113|65765906|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
23144799|NCT00406653|64277681|FG000|Maintenance Period|Error in disease score evaluation|0|||
23144800|NCT00406653|64277682|FG001|Maintenance Period|Error in disease score evaluation|0|||
23144801|NCT00406653|64277683|FG002|Maintenance Period|Error in disease score evaluation|0|||
23144802|NCT00406653|64277684|FG003|Maintenance Period|Error in disease score evaluation|0|||
23144803|NCT00406653|64277685|FG004|Maintenance Period|Error in disease score evaluation|1|||
23144804|NCT00406653|64277686|FG005|Maintenance Period|Error in disease score evaluation|0|||
23144805|NCT00406653|64277687|FG006|Maintenance Period|Error in disease score evaluation|0|||
23144806|NCT00406653|64277681|FG000|Open-Label Period|Death|0|||
23144807|NCT00406653|64277682|FG001|Open-Label Period|Death|0|||
23144808|NCT00406653|64277683|FG002|Open-Label Period|Death|0|||
23144809|NCT00406653|64277684|FG003|Open-Label Period|Death|0|||
23218150|NCT00412113|64541470|FG000|Overall Study|did not receive treatment|1|||
23218151|NCT00412113|64541471|FG001|Overall Study|did not receive treatment|0|||
23556511|NCT02856113|65765907|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
23623546|NCT00591591|66008483|FG001|Overall Study|Withdrawal by Subject|37|||
23144810|NCT00406653|64277685|FG004|Open-Label Period|Death|0|||
23144811|NCT00406653|64277686|FG005|Open-Label Period|Death|0|||
23144812|NCT00406653|64277687|FG006|Open-Label Period|Death|1|||
23144813|NCT00406653|64277681|FG000|Open-Label Period|Adverse Event|0|||
23144814|NCT00406653|64277682|FG001|Open-Label Period|Adverse Event|0|||
23321847|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23434764|NCT02453555|65334165|FG004|Extension Period|Withdrawal by Subject|0|||
23434765|NCT02453555|65334166|FG005|Extension Period|Withdrawal by Subject|0|||
23434766|NCT04349033|65334167|FG000|Overall Study|Lost to Follow-up|3|||
23434767|NCT04349033|65334168|FG001|Overall Study|Lost to Follow-up|1|||
23434768|NCT04349033|65334169|FG002|Overall Study|Lost to Follow-up|1|||
23434769|NCT01563185|65334170|FG000|Overall Study|Withdrawal by Subject|1|||
23434770|NCT01563185|65334170|FG000|Overall Study|Non-Compliance with study drug|1|||
23434771|NCT00471887|65334171|FG000|Overall Study|Adverse Event|9|||
23434772|NCT01792518|65334172|FG000|Overall Study|Adverse Event|3|||
23434773|NCT01792518|65334173|FG001|Overall Study|Adverse Event|4|||
23434774|NCT01792518|65334172|FG000|Overall Study|Protocol Violation|0|||
23434775|NCT01792518|65334173|FG001|Overall Study|Protocol Violation|1|||
23434776|NCT01792518|65334172|FG000|Overall Study|Lost to Follow-up|3|||
23434777|NCT01792518|65334173|FG001|Overall Study|Lost to Follow-up|1|||
23434778|NCT01792518|65334172|FG000|Overall Study|Withdrawal by Subject|2|||
23434779|NCT01792518|65334173|FG001|Overall Study|Withdrawal by Subject|0|||
23434780|NCT01792518|65334172|FG000|Overall Study|Other Reason|0|||
23434781|NCT01792518|65334173|FG001|Overall Study|Other Reason|1|||
23434782|NCT00932165|65334174|FG000|Overall Study|Lost to Follow-up|1|||
23434783|NCT03657095|65334175|FG000|Overall Study|Withdrawal by Subject|1|||
23434784|NCT03657095|65334176|FG001|Overall Study|Withdrawal by Subject|1|||
23434785|NCT03657095|65334175|FG000|Overall Study|Adverse Event|0|||
23434786|NCT03657095|65334176|FG001|Overall Study|Adverse Event|3|||
23434787|NCT03657095|65334175|FG000|Overall Study|Study Terminated by Sponsor|58|||
23434788|NCT03657095|65334176|FG001|Overall Study|Study Terminated by Sponsor|49|||
23434789|NCT03180307|65334178|FG000|Overall Study|Lost to Follow-up|2|||
23434790|NCT03180307|65334179|FG001|Overall Study|Lost to Follow-up|0|||
23434791|NCT03180307|65334178|FG000|Overall Study|Death|1|||
23434792|NCT03180307|65334179|FG001|Overall Study|Death|0|||
23434793|NCT03180307|65334178|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
23434794|NCT03180307|65334179|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
23434795|NCT05079477|65334180|FG000|Overall Study|Lost to Follow-up|2|||
23434796|NCT05079477|65334181|FG001|Overall Study|Lost to Follow-up|0|||
23434797|NCT05079477|65334180|FG000|Overall Study|Withdrawal by Subject|1|||
23434798|NCT05079477|65334181|FG001|Overall Study|Withdrawal by Subject|0|||
23434799|NCT05079477|65334180|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
23434800|NCT05079477|65334181|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
23434801|NCT05079477|65334180|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
23434802|NCT05079477|65334181|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
23434803|NCT01772576|65334182|FG000|Overall Study|Death|15|||
23434804|NCT01772576|65334182|FG000|Overall Study|Protocol Violation|1|||
23434805|NCT01772576|65334182|FG000|Overall Study|Lost to Follow-up|3|||
23434806|NCT01772576|65334182|FG000|Overall Study|Study device not used|3|||
23434807|NCT01772576|65334182|FG000|Overall Study|Adverse Event|6|||
23434808|NCT01772576|65334182|FG000|Overall Study|Withdrawal by Subject|6|||
23434809|NCT03684694|65334183|FG000|Phase 1|Withdrawal by Subject|1|||
23434810|NCT03684694|65334184|FG001|Phase 1|Withdrawal by Subject|0|||
23434811|NCT03684694|65334185|FG002|Phase 1|Withdrawal by Subject|0|||
23434812|NCT03684694|65334186|FG003|Phase 1|Withdrawal by Subject|0|||
23434813|NCT03684694|65334187|FG004|Phase 1|Withdrawal by Subject|0|||
23144815|NCT00406653|64277683|FG002|Open-Label Period|Adverse Event|0|||
23144816|NCT00406653|64277684|FG003|Open-Label Period|Adverse Event|0|||
23144817|NCT00406653|64277685|FG004|Open-Label Period|Adverse Event|0|||
23144818|NCT00406653|64277686|FG005|Open-Label Period|Adverse Event|0|||
23144819|NCT00406653|64277687|FG006|Open-Label Period|Adverse Event|18|||
23144820|NCT00406653|64277681|FG000|Open-Label Period|Lack of Efficacy|0|||
23144821|NCT00406653|64277682|FG001|Open-Label Period|Lack of Efficacy|0|||
23144822|NCT00406653|64277683|FG002|Open-Label Period|Lack of Efficacy|0|||
23144823|NCT00406653|64277684|FG003|Open-Label Period|Lack of Efficacy|0|||
23144824|NCT00406653|64277685|FG004|Open-Label Period|Lack of Efficacy|0|||
23144825|NCT00406653|64277686|FG005|Open-Label Period|Lack of Efficacy|0|||
23144826|NCT00406653|64277687|FG006|Open-Label Period|Lack of Efficacy|160|||
23434814|NCT03684694|65334188|FG005|Phase 1|Withdrawal by Subject|0|||
23434815|NCT03684694|65334183|FG000|Phase 1|Investigator/Sponsor Decision|12|||
23434816|NCT03684694|65334184|FG001|Phase 1|Investigator/Sponsor Decision|2|||
23434817|NCT03684694|65334185|FG002|Phase 1|Investigator/Sponsor Decision|1|||
23434818|NCT03684694|65334186|FG003|Phase 1|Investigator/Sponsor Decision|0|||
23434819|NCT03684694|65334187|FG004|Phase 1|Investigator/Sponsor Decision|0|||
23434820|NCT03684694|65334188|FG005|Phase 1|Investigator/Sponsor Decision|0|||
23434821|NCT03684694|65334183|FG000|Phase 1|Death|24|||
23144827|NCT00406653|64277681|FG000|Open-Label Period|Lost to Follow-up|0|||
23144828|NCT00406653|64277682|FG001|Open-Label Period|Lost to Follow-up|0|||
23144829|NCT00406653|64277683|FG002|Open-Label Period|Lost to Follow-up|0|||
23434822|NCT03684694|65334184|FG001|Phase 1|Death|0|||
23434823|NCT03684694|65334185|FG002|Phase 1|Death|3|||
23434824|NCT03684694|65334186|FG003|Phase 1|Death|0|||
23434825|NCT03684694|65334187|FG004|Phase 1|Death|0|||
23434826|NCT03684694|65334188|FG005|Phase 1|Death|0|||
23434827|NCT03684694|65334183|FG000|Phase 1|Lost to Follow-up|0|||
23434828|NCT03684694|65334184|FG001|Phase 1|Lost to Follow-up|0|||
23434829|NCT03684694|65334185|FG002|Phase 1|Lost to Follow-up|1|||
23434830|NCT03684694|65334186|FG003|Phase 1|Lost to Follow-up|0|||
23434831|NCT03684694|65334187|FG004|Phase 1|Lost to Follow-up|0|||
23434832|NCT03684694|65334188|FG005|Phase 1|Lost to Follow-up|0|||
23434833|NCT03684694|65334183|FG000|Phase 1|Miscellaneous|0|||
23434834|NCT03684694|65334184|FG001|Phase 1|Miscellaneous|1|||
23434835|NCT03684694|65334185|FG002|Phase 1|Miscellaneous|0|||
23434836|NCT03684694|65334186|FG003|Phase 1|Miscellaneous|0|||
23434837|NCT03684694|65334187|FG004|Phase 1|Miscellaneous|0|||
23434838|NCT03684694|65334188|FG005|Phase 1|Miscellaneous|0|||
23434839|NCT03684694|65334183|FG000|Phase 2|Withdrawal by Subject|0|||
23434840|NCT03684694|65334184|FG001|Phase 2|Withdrawal by Subject|0|||
23434841|NCT03684694|65334185|FG002|Phase 2|Withdrawal by Subject|0|||
23434842|NCT03684694|65334186|FG003|Phase 2|Withdrawal by Subject|0|||
23434843|NCT03684694|65334187|FG004|Phase 2|Withdrawal by Subject|0|||
23434844|NCT03684694|65334188|FG005|Phase 2|Withdrawal by Subject|1|||
23434845|NCT03684694|65334183|FG000|Phase 2|Investigator/Sponsor Decision|0|||
23434846|NCT03684694|65334184|FG001|Phase 2|Investigator/Sponsor Decision|0|||
23434847|NCT03684694|65334185|FG002|Phase 2|Investigator/Sponsor Decision|0|||
23434848|NCT03684694|65334186|FG003|Phase 2|Investigator/Sponsor Decision|17|||
23434849|NCT03684694|65334187|FG004|Phase 2|Investigator/Sponsor Decision|16|||
23434850|NCT03684694|65334188|FG005|Phase 2|Investigator/Sponsor Decision|6|||
23434851|NCT03684694|65334183|FG000|Phase 2|Death|0|||
23434852|NCT03684694|65334184|FG001|Phase 2|Death|0|||
23434853|NCT03684694|65334185|FG002|Phase 2|Death|0|||
23434854|NCT03684694|65334186|FG003|Phase 2|Death|28|||
23434855|NCT03684694|65334187|FG004|Phase 2|Death|14|||
23434856|NCT03684694|65334188|FG005|Phase 2|Death|3|||
23434857|NCT03684694|65334183|FG000|Phase 2|Lost to Follow-up|0|||
23434858|NCT03684694|65334184|FG001|Phase 2|Lost to Follow-up|0|||
23434859|NCT03684694|65334185|FG002|Phase 2|Lost to Follow-up|0|||
23434860|NCT03684694|65334186|FG003|Phase 2|Lost to Follow-up|1|||
23434861|NCT03684694|65334187|FG004|Phase 2|Lost to Follow-up|0|||
23434862|NCT03684694|65334188|FG005|Phase 2|Lost to Follow-up|0|||
23434863|NCT03684694|65334183|FG000|Phase 2|Miscellaneous|0|||
23434864|NCT03684694|65334184|FG001|Phase 2|Miscellaneous|0|||
23434865|NCT03684694|65334185|FG002|Phase 2|Miscellaneous|0|||
23434866|NCT03684694|65334186|FG003|Phase 2|Miscellaneous|3|||
23434867|NCT03684694|65334187|FG004|Phase 2|Miscellaneous|0|||
23434868|NCT03684694|65334188|FG005|Phase 2|Miscellaneous|0|||
23434869|NCT01717326|65334189|FG000|Overall Study|Death|0|||
23434870|NCT01717326|65334190|FG001|Overall Study|Death|0|||
23434871|NCT01717326|65334191|FG002|Overall Study|Death|0|||
23434872|NCT01717326|65334192|FG003|Overall Study|Death|0|||
23434873|NCT01717326|65334193|FG004|Overall Study|Death|0|||
23434874|NCT01717326|65334194|FG005|Overall Study|Death|0|||
23434875|NCT01717326|65334195|FG006|Overall Study|Death|0|||
23434876|NCT01717326|65334196|FG007|Overall Study|Death|0|||
23434877|NCT01717326|65334197|FG008|Overall Study|Death|0|||
23434878|NCT01717326|65334198|FG009|Overall Study|Death|0|||
23434879|NCT01717326|65334199|FG010|Overall Study|Death|1|||
23434880|NCT01717326|65334200|FG011|Overall Study|Death|0|||
23434881|NCT01717326|65334201|FG012|Overall Study|Death|0|||
23434882|NCT01717326|65334202|FG013|Overall Study|Death|0|||
23434883|NCT01717326|65334203|FG014|Overall Study|Death|0|||
23434884|NCT01717326|65334204|FG015|Overall Study|Death|0|||
23434885|NCT01717326|65334205|FG016|Overall Study|Death|0|||
23434886|NCT01717326|65334206|FG017|Overall Study|Death|0|||
23434887|NCT01717326|65334207|FG018|Overall Study|Death|0|||
23434888|NCT01717326|65334208|FG019|Overall Study|Death|0|||
23434889|NCT01717326|65334189|FG000|Overall Study|Lost to Follow-up|3|||
23434890|NCT01717326|65334190|FG001|Overall Study|Lost to Follow-up|0|||
23434891|NCT01717326|65334191|FG002|Overall Study|Lost to Follow-up|0|||
23434892|NCT01717326|65334192|FG003|Overall Study|Lost to Follow-up|2|||
23623547|NCT00591591|66008482|FG000|Overall Study|Lack of Efficacy|10|||
23434893|NCT01717326|65334193|FG004|Overall Study|Lost to Follow-up|1|||
23434894|NCT01717326|65334194|FG005|Overall Study|Lost to Follow-up|0|||
23434895|NCT01717326|65334195|FG006|Overall Study|Lost to Follow-up|1|||
23144830|NCT00406653|64277684|FG003|Open-Label Period|Lost to Follow-up|0|||
23434896|NCT01717326|65334196|FG007|Overall Study|Lost to Follow-up|0|||
23434897|NCT01717326|65334197|FG008|Overall Study|Lost to Follow-up|0|||
23434898|NCT01717326|65334198|FG009|Overall Study|Lost to Follow-up|0|||
23434899|NCT01717326|65334199|FG010|Overall Study|Lost to Follow-up|1|||
23434900|NCT01717326|65334200|FG011|Overall Study|Lost to Follow-up|0|||
23434901|NCT01717326|65334201|FG012|Overall Study|Lost to Follow-up|0|||
23434902|NCT01717326|65334202|FG013|Overall Study|Lost to Follow-up|0|||
23434903|NCT01717326|65334203|FG014|Overall Study|Lost to Follow-up|0|||
23434904|NCT01717326|65334204|FG015|Overall Study|Lost to Follow-up|2|||
23434905|NCT01717326|65334205|FG016|Overall Study|Lost to Follow-up|1|||
23434906|NCT01717326|65334206|FG017|Overall Study|Lost to Follow-up|0|||
23434907|NCT01717326|65334207|FG018|Overall Study|Lost to Follow-up|2|||
23434908|NCT01717326|65334208|FG019|Overall Study|Lost to Follow-up|3|||
23434909|NCT01717326|65334189|FG000|Overall Study|Physician Decision|0|||
23434910|NCT01717326|65334190|FG001|Overall Study|Physician Decision|0|||
23434911|NCT01717326|65334191|FG002|Overall Study|Physician Decision|0|||
23434912|NCT01717326|65334192|FG003|Overall Study|Physician Decision|0|||
23434913|NCT01717326|65334193|FG004|Overall Study|Physician Decision|0|||
23434914|NCT01717326|65334194|FG005|Overall Study|Physician Decision|0|||
23434915|NCT01717326|65334195|FG006|Overall Study|Physician Decision|0|||
23434916|NCT01717326|65334196|FG007|Overall Study|Physician Decision|0|||
23434917|NCT01717326|65334197|FG008|Overall Study|Physician Decision|0|||
23434918|NCT01717326|65334198|FG009|Overall Study|Physician Decision|1|||
23434919|NCT01717326|65334199|FG010|Overall Study|Physician Decision|0|||
23434920|NCT01717326|65334200|FG011|Overall Study|Physician Decision|0|||
23434921|NCT01717326|65334201|FG012|Overall Study|Physician Decision|0|||
23321848|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
23321849|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
23321850|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
23321851|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
23321852|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
23434922|NCT01717326|65334202|FG013|Overall Study|Physician Decision|0|||
23434923|NCT01717326|65334203|FG014|Overall Study|Physician Decision|0|||
23434924|NCT01717326|65334204|FG015|Overall Study|Physician Decision|0|||
23434925|NCT01717326|65334205|FG016|Overall Study|Physician Decision|0|||
23434926|NCT01717326|65334206|FG017|Overall Study|Physician Decision|0|||
23434927|NCT01717326|65334207|FG018|Overall Study|Physician Decision|0|||
23434928|NCT01717326|65334208|FG019|Overall Study|Physician Decision|0|||
23434929|NCT01717326|65334189|FG000|Overall Study|Protocol Violation|0|||
23434930|NCT01717326|65334190|FG001|Overall Study|Protocol Violation|0|||
23434931|NCT01717326|65334191|FG002|Overall Study|Protocol Violation|0|||
23434932|NCT01717326|65334192|FG003|Overall Study|Protocol Violation|0|||
23434933|NCT01717326|65334193|FG004|Overall Study|Protocol Violation|1|||
23434934|NCT01717326|65334194|FG005|Overall Study|Protocol Violation|0|||
23434935|NCT01717326|65334195|FG006|Overall Study|Protocol Violation|0|||
23434936|NCT01717326|65334196|FG007|Overall Study|Protocol Violation|0|||
23434937|NCT01717326|65334197|FG008|Overall Study|Protocol Violation|0|||
23434938|NCT01717326|65334198|FG009|Overall Study|Protocol Violation|0|||
23434939|NCT01717326|65334199|FG010|Overall Study|Protocol Violation|0|||
23556512|NCT01949311|65765914|FG000|Overall Study|Lost to Follow-up|73|||
23556513|NCT01949311|65765914|FG000|Overall Study|Terminated by Sponsor|708|||
23556514|NCT01949311|65765914|FG000|Overall Study|Withdrawal by Subject|375|||
23556515|NCT01949311|65765914|FG000|Overall Study|Lack of Efficacy|50|||
23556516|NCT01949311|65765914|FG000|Overall Study|Protocol Deviation|34|||
23556517|NCT01949311|65765914|FG000|Overall Study|Pregnancy|20|||
23556518|NCT01949311|65765914|FG000|Overall Study|Physician Decision|9|||
23556519|NCT01949311|65765914|FG000|Overall Study|Other|4|||
23556520|NCT01949311|65765914|FG000|Overall Study|Adverse Event|107|||
23556521|NCT02151266|65765915|FG000|Overall Study|Lost to Follow-up|1|||
23556522|NCT02151266|65765916|FG001|Overall Study|Lost to Follow-up|4|||
23556523|NCT02151266|65765917|FG002|Overall Study|Lost to Follow-up|1|||
23556524|NCT02151266|65765915|FG000|Overall Study|Did NOT receive intervention|3|||
23556525|NCT02151266|65765916|FG001|Overall Study|Did NOT receive intervention|6|||
23556526|NCT02151266|65765917|FG002|Overall Study|Did NOT receive intervention|2|||
23556527|NCT02151266|65765915|FG000|Overall Study|Not able to exercise|4|||
23556528|NCT02151266|65765916|FG001|Overall Study|Not able to exercise|5|||
23556529|NCT02151266|65765917|FG002|Overall Study|Not able to exercise|4|||
23556530|NCT02338154|65765921|FG000|Overall Study|Death|46|||
23556531|NCT02338154|65765921|FG000|Overall Study|Valve Implant Failure|17|||
23556532|NCT02338154|65765921|FG000|Overall Study|Valve Explant|11|||
23556533|NCT02338154|65765921|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
23556534|NCT02338154|65765921|FG000|Overall Study|Lost to Follow-up|8|||
23556535|NCT02338154|65765921|FG000|Overall Study|Other Reason|3|||
23623548|NCT00591591|66008483|FG001|Overall Study|Lack of Efficacy|2|||
23623549|NCT02970305|66008484|FG000|Overall Study|Adverse Event|10|||
23434940|NCT01717326|65334200|FG011|Overall Study|Protocol Violation|0|||
23434941|NCT01717326|65334201|FG012|Overall Study|Protocol Violation|0|||
23434942|NCT01717326|65334202|FG013|Overall Study|Protocol Violation|0|||
23434943|NCT01717326|65334203|FG014|Overall Study|Protocol Violation|0|||
23434944|NCT01717326|65334204|FG015|Overall Study|Protocol Violation|0|||
23434945|NCT01717326|65334205|FG016|Overall Study|Protocol Violation|0|||
23434946|NCT01717326|65334206|FG017|Overall Study|Protocol Violation|0|||
23434947|NCT01717326|65334207|FG018|Overall Study|Protocol Violation|0|||
23434948|NCT01717326|65334208|FG019|Overall Study|Protocol Violation|0|||
23556536|NCT02338154|65765921|FG000|Overall Study|Patients Without Exit Form|47|||
23556537|NCT02338154|65765921|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
23556538|NCT00316082|65765924|FG000|Overall Study|Lack of Efficacy|2|||
23556539|NCT00316082|65765925|FG001|Overall Study|Lack of Efficacy|3|||
23556540|NCT00316082|65765926|FG002|Overall Study|Lack of Efficacy|3|||
23556541|NCT00316082|65765927|FG003|Overall Study|Lack of Efficacy|4|||
23434949|NCT01717326|65334189|FG000|Overall Study|Withdrawal by Subject|0|||
23434950|NCT01717326|65334190|FG001|Overall Study|Withdrawal by Subject|1|||
23434951|NCT01717326|65334191|FG002|Overall Study|Withdrawal by Subject|0|||
23434952|NCT01717326|65334192|FG003|Overall Study|Withdrawal by Subject|0|||
23434953|NCT01717326|65334193|FG004|Overall Study|Withdrawal by Subject|0|||
23434954|NCT01717326|65334194|FG005|Overall Study|Withdrawal by Subject|0|||
23434955|NCT01717326|65334195|FG006|Overall Study|Withdrawal by Subject|0|||
23434956|NCT01717326|65334196|FG007|Overall Study|Withdrawal by Subject|0|||
23434957|NCT01717326|65334197|FG008|Overall Study|Withdrawal by Subject|0|||
23434958|NCT01717326|65334198|FG009|Overall Study|Withdrawal by Subject|1|||
23434959|NCT01717326|65334199|FG010|Overall Study|Withdrawal by Subject|0|||
23434960|NCT01717326|65334200|FG011|Overall Study|Withdrawal by Subject|0|||
23434961|NCT01717326|65334201|FG012|Overall Study|Withdrawal by Subject|1|||
23434962|NCT01717326|65334202|FG013|Overall Study|Withdrawal by Subject|0|||
23434963|NCT01717326|65334203|FG014|Overall Study|Withdrawal by Subject|0|||
23434964|NCT01717326|65334204|FG015|Overall Study|Withdrawal by Subject|1|||
23434965|NCT01717326|65334205|FG016|Overall Study|Withdrawal by Subject|0|||
23434966|NCT01717326|65334206|FG017|Overall Study|Withdrawal by Subject|0|||
23434967|NCT01717326|65334207|FG018|Overall Study|Withdrawal by Subject|2|||
23556542|NCT00316082|65765928|FG004|Overall Study|Lack of Efficacy|6|||
23556543|NCT00316082|65765924|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
23556544|NCT00316082|65765925|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
23556545|NCT00316082|65765926|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
23556546|NCT00316082|65765927|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
23623550|NCT02970305|66008485|FG001|Overall Study|Adverse Event|6|||
23623551|NCT02970305|66008484|FG000|Overall Study|Lack of Efficacy|1|||
23556547|NCT00316082|65765928|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
23556548|NCT00316082|65765924|FG000|Overall Study|Lost to Follow-up|7|||
23556549|NCT00316082|65765925|FG001|Overall Study|Lost to Follow-up|6|||
23556550|NCT00316082|65765926|FG002|Overall Study|Lost to Follow-up|7|||
23556551|NCT00316082|65765927|FG003|Overall Study|Lost to Follow-up|8|||
23556552|NCT00316082|65765928|FG004|Overall Study|Lost to Follow-up|6|||
23556553|NCT00316082|65765924|FG000|Overall Study|Poor/noncompliance|6|||
23556554|NCT00316082|65765925|FG001|Overall Study|Poor/noncompliance|1|||
23556555|NCT00316082|65765926|FG002|Overall Study|Poor/noncompliance|4|||
23556556|NCT00316082|65765927|FG003|Overall Study|Poor/noncompliance|1|||
23556557|NCT00316082|65765928|FG004|Overall Study|Poor/noncompliance|4|||
23556558|NCT00316082|65765924|FG000|Overall Study|Adverse Event|4|||
23556559|NCT00316082|65765925|FG001|Overall Study|Adverse Event|2|||
23556560|NCT00316082|65765926|FG002|Overall Study|Adverse Event|5|||
23556561|NCT00316082|65765927|FG003|Overall Study|Adverse Event|1|||
23556562|NCT00316082|65765928|FG004|Overall Study|Adverse Event|3|||
23556563|NCT00316082|65765924|FG000|Overall Study|Subject no longer meets study criteria|3|||
23556564|NCT00316082|65765925|FG001|Overall Study|Subject no longer meets study criteria|1|||
23556565|NCT00316082|65765926|FG002|Overall Study|Subject no longer meets study criteria|2|||
23556566|NCT00316082|65765927|FG003|Overall Study|Subject no longer meets study criteria|2|||
23556567|NCT00316082|65765928|FG004|Overall Study|Subject no longer meets study criteria|1|||
23556568|NCT00316082|65765924|FG000|Overall Study|Physician Decision|1|||
23556569|NCT00316082|65765925|FG001|Overall Study|Physician Decision|1|||
23556570|NCT00316082|65765926|FG002|Overall Study|Physician Decision|2|||
23556571|NCT00316082|65765927|FG003|Overall Study|Physician Decision|1|||
23556572|NCT00316082|65765928|FG004|Overall Study|Physician Decision|1|||
23556573|NCT00316082|65765924|FG000|Overall Study|Death|0|||
23556574|NCT00316082|65765925|FG001|Overall Study|Death|0|||
23556575|NCT00316082|65765926|FG002|Overall Study|Death|1|||
23556576|NCT00316082|65765927|FG003|Overall Study|Death|0|||
23623552|NCT02970305|66008485|FG001|Overall Study|Lack of Efficacy|1|||
23623553|NCT02970305|66008484|FG000|Overall Study|Noncompliance with study drug|2|||
23623554|NCT02970305|66008485|FG001|Overall Study|Noncompliance with study drug|4|||
23623555|NCT02970305|66008484|FG000|Overall Study|Protocol Violation|2|||
23623556|NCT02970305|66008485|FG001|Overall Study|Protocol Violation|2|||
23434968|NCT01717326|65334208|FG019|Overall Study|Withdrawal by Subject|3|||
23434969|NCT01092663|65334211|FG000|Overall Study|Withdrawal by Subject|3|||
23434970|NCT01092663|65334212|FG001|Overall Study|Withdrawal by Subject|2|||
23434971|NCT01092663|65334211|FG000|Overall Study|Glucose >300mg/dL|1|||
23434972|NCT01092663|65334212|FG001|Overall Study|Glucose >300mg/dL|0|||
23434973|NCT01092663|65334211|FG000|Overall Study|High fasting triglyceride|2|||
23556577|NCT00316082|65765928|FG004|Overall Study|Death|0|||
23556578|NCT00316082|65765924|FG000|Overall Study|Administrative reason by sponsor|0|||
23556579|NCT00316082|65765925|FG001|Overall Study|Administrative reason by sponsor|0|||
23556580|NCT00316082|65765926|FG002|Overall Study|Administrative reason by sponsor|1|||
23556581|NCT00316082|65765927|FG003|Overall Study|Administrative reason by sponsor|0|||
23556582|NCT00316082|65765928|FG004|Overall Study|Administrative reason by sponsor|0|||
23556583|NCT00031486|65765929|FG000|Overall Study|Adverse Event|1|||
23556584|NCT00031486|65765930|FG001|Overall Study|Adverse Event|0|||
23556585|NCT00031486|65765929|FG000|Overall Study|Lost to Follow-up|0|||
23556586|NCT00031486|65765930|FG001|Overall Study|Lost to Follow-up|1|||
23321853|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
23321854|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
23321855|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
23321856|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
23321857|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
23434974|NCT01092663|65334212|FG001|Overall Study|High fasting triglyceride|0|||
23434975|NCT01092663|65334211|FG000|Overall Study|Adverse Event|1|||
23556587|NCT00031486|65765929|FG000|Overall Study|Withdrawal by Subject|3|||
23556588|NCT00031486|65765930|FG001|Overall Study|Withdrawal by Subject|2|||
23556589|NCT00031486|65765929|FG000|Overall Study|Death|0|||
23556590|NCT00031486|65765930|FG001|Overall Study|Death|3|||
23556591|NCT00031486|65765929|FG000|Overall Study|Non-compliant|0|||
23556592|NCT00031486|65765930|FG001|Overall Study|Non-compliant|4|||
23556593|NCT00031486|65765929|FG000|Overall Study|Did not meet eligibility requirement|2|||
23556594|NCT00031486|65765930|FG001|Overall Study|Did not meet eligibility requirement|1|||
23556595|NCT00031486|65765929|FG000|Overall Study|Other|1|||
23556596|NCT00031486|65765930|FG001|Overall Study|Other|1|||
23556597|NCT01972529|65765937|FG000|Overall Study|Adverse Event|0|||
23556598|NCT01972529|65765938|FG001|Overall Study|Adverse Event|1|||
23218152|NCT02260388|64541478|FG000|Overall Study|Lost to Follow-up|2|||
23218153|NCT02260388|64541479|FG001|Overall Study|Lost to Follow-up|8|||
23218154|NCT02260388|64541480|FG002|Overall Study|Lost to Follow-up|3|||
23218155|NCT02260388|64541481|FG003|Overall Study|Lost to Follow-up|4|||
23218156|NCT03970824|64541489|FG000|Overall Study|Withdrawal by Subject|1|||
23218157|NCT03970824|64541490|FG001|Overall Study|Withdrawal by Subject|1|||
23218158|NCT03970824|64541491|FG002|Overall Study|Withdrawal by Subject|3|||
23218159|NCT03970824|64541489|FG000|Overall Study|Lost to Follow-up|0|||
23218160|NCT03970824|64541490|FG001|Overall Study|Lost to Follow-up|2|||
23218161|NCT03970824|64541491|FG002|Overall Study|Lost to Follow-up|1|||
23218162|NCT03970824|64541489|FG000|Overall Study|Adverse Event|1|||
23218163|NCT03970824|64541490|FG001|Overall Study|Adverse Event|0|||
23218164|NCT03970824|64541491|FG002|Overall Study|Adverse Event|0|||
23218165|NCT01024920|64541492|FG000|Overall Study|Progressive disease|47|||
23218166|NCT01024920|64541493|FG001|Overall Study|Progressive disease|25|||
23218167|NCT01024920|64541492|FG000|Overall Study|Adverse Event|8|||
23218168|NCT01024920|64541493|FG001|Overall Study|Adverse Event|4|||
23218169|NCT01024920|64541492|FG000|Overall Study|Lost to Follow-up|0|||
23218170|NCT01024920|64541493|FG001|Overall Study|Lost to Follow-up|1|||
23218171|NCT01024920|64541492|FG000|Overall Study|Patient refusal to continue|4|||
23218172|NCT01024920|64541493|FG001|Overall Study|Patient refusal to continue|0|||
23218173|NCT01024920|64541492|FG000|Overall Study|Other than listed|5|||
23218174|NCT01024920|64541493|FG001|Overall Study|Other than listed|1|||
23218175|NCT01024920|64541492|FG000|Overall Study|Not treated|3|||
23218176|NCT01024920|64541493|FG001|Overall Study|Not treated|0|||
23218177|NCT01024920|64541492|FG000|Overall Study|Protocol Violation|0|||
23218178|NCT01024920|64541493|FG001|Overall Study|Protocol Violation|1|||
23218179|NCT01634113|64541494|FG000|Overall Study|Not treated|0|||
23218180|NCT01634113|64541495|FG001|Overall Study|Not treated|0|||
23218181|NCT01634113|64541496|FG002|Overall Study|Not treated|1|||
23218182|NCT01302691|64541503|FG000|Overall Study|Adverse Event|2|||
23218183|NCT01302691|64541504|FG001|Overall Study|Adverse Event|0|||
23218184|NCT01302691|64541503|FG000|Overall Study|Death|0|||
23218185|NCT01302691|64541504|FG001|Overall Study|Death|1|||
23218186|NCT01302691|64541503|FG000|Overall Study|Lost to Follow-up|1|||
23218187|NCT01302691|64541504|FG001|Overall Study|Lost to Follow-up|0|||
23218188|NCT01302691|64541503|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
23218189|NCT01302691|64541504|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
23218190|NCT01302691|64541503|FG000|Overall Study|Physician Decision|0|||
23218191|NCT01302691|64541504|FG001|Overall Study|Physician Decision|1|||
23218192|NCT01302691|64541503|FG000|Overall Study|Protocol Violation|1|||
23218193|NCT01302691|64541504|FG001|Overall Study|Protocol Violation|0|||
23218194|NCT04968353|64541512|FG000|Overall Study|Non-compliance|1|||
23218195|NCT04968353|64541513|FG001|Overall Study|Non-compliance|0|||
23218196|NCT04968353|64541514|FG002|Overall Study|Non-compliance|2|||
23218197|NCT04968353|64541515|FG003|Overall Study|Non-compliance|0|||
23218198|NCT00968708|64541523|FG000|Overall Study|Adverse Event|169|||
23218199|NCT00968708|64541524|FG001|Overall Study|Adverse Event|150|||
23434976|NCT01092663|65334212|FG001|Overall Study|Adverse Event|1|||
23556599|NCT01972529|65765939|FG002|Overall Study|Adverse Event|0|||
23218200|NCT00968708|64541523|FG000|Overall Study|Major Protocol Deviation|0|||
23218201|NCT00968708|64541524|FG001|Overall Study|Major Protocol Deviation|1|||
23218202|NCT00968708|64541523|FG000|Overall Study|Lost to Follow-up|19|||
23218203|NCT00968708|64541524|FG001|Overall Study|Lost to Follow-up|11|||
23218204|NCT00968708|64541523|FG000|Overall Study|Voluntary Withdrawal|104|||
23218205|NCT00968708|64541524|FG001|Overall Study|Voluntary Withdrawal|101|||
23218206|NCT00968708|64541523|FG000|Overall Study|Investigator Discretion|0|||
23218207|NCT00968708|64541524|FG001|Overall Study|Investigator Discretion|1|||
23556600|NCT01972529|65765940|FG003|Overall Study|Adverse Event|0|||
23434977|NCT01092663|65334211|FG000|Overall Study|Protocol Violation|0|||
23144831|NCT00406653|64277685|FG004|Open-Label Period|Lost to Follow-up|0|||
23144832|NCT00406653|64277686|FG005|Open-Label Period|Lost to Follow-up|0|||
23144833|NCT00406653|64277687|FG006|Open-Label Period|Lost to Follow-up|6|||
23144834|NCT00406653|64277681|FG000|Open-Label Period|Withdrawal of Consent|0|||
23144835|NCT00406653|64277682|FG001|Open-Label Period|Withdrawal of Consent|0|||
23321858|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23321859|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23321860|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23321861|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23321862|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
23144836|NCT00406653|64277683|FG002|Open-Label Period|Withdrawal of Consent|0|||
23144837|NCT00406653|64277684|FG003|Open-Label Period|Withdrawal of Consent|0|||
23144838|NCT00406653|64277685|FG004|Open-Label Period|Withdrawal of Consent|0|||
23144839|NCT00406653|64277686|FG005|Open-Label Period|Withdrawal of Consent|0|||
23144840|NCT00406653|64277687|FG006|Open-Label Period|Withdrawal of Consent|11|||
23144841|NCT00406653|64277681|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23144842|NCT00406653|64277682|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23144843|NCT00406653|64277683|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23144844|NCT00406653|64277684|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23144845|NCT00406653|64277685|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23144846|NCT00406653|64277686|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
23144847|NCT00406653|64277687|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
23144848|NCT00406653|64277681|FG000|Open-Label Period|Pregnancy|0|||
23144849|NCT00406653|64277682|FG001|Open-Label Period|Pregnancy|0|||
23144850|NCT00406653|64277683|FG002|Open-Label Period|Pregnancy|0|||
23144851|NCT00406653|64277684|FG003|Open-Label Period|Pregnancy|0|||
23144852|NCT00406653|64277685|FG004|Open-Label Period|Pregnancy|0|||
23144853|NCT00406653|64277686|FG005|Open-Label Period|Pregnancy|0|||
23144854|NCT00406653|64277687|FG006|Open-Label Period|Pregnancy|2|||
23144855|NCT00406653|64277681|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
23144856|NCT00406653|64277682|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
23144857|NCT00406653|64277683|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
23144858|NCT00406653|64277684|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
23144859|NCT00406653|64277685|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
23144860|NCT00406653|64277686|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
23144861|NCT00406653|64277687|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
23144862|NCT00406653|64277681|FG000|Open-Label Period|Declined participation but followup done|0|||
23144863|NCT00406653|64277682|FG001|Open-Label Period|Declined participation but followup done|0|||
23144864|NCT00406653|64277683|FG002|Open-Label Period|Declined participation but followup done|0|||
23144865|NCT00406653|64277684|FG003|Open-Label Period|Declined participation but followup done|0|||
23144866|NCT00406653|64277685|FG004|Open-Label Period|Declined participation but followup done|0|||
23144867|NCT00406653|64277686|FG005|Open-Label Period|Declined participation but followup done|0|||
23144868|NCT00406653|64277687|FG006|Open-Label Period|Declined participation but followup done|8|||
23144869|NCT00406653|64277681|FG000|Open-Label Period|Discontinued by Sponsor|0|||
23144870|NCT00406653|64277682|FG001|Open-Label Period|Discontinued by Sponsor|0|||
23144871|NCT00406653|64277683|FG002|Open-Label Period|Discontinued by Sponsor|0|||
23144872|NCT00406653|64277684|FG003|Open-Label Period|Discontinued by Sponsor|0|||
23144873|NCT00406653|64277685|FG004|Open-Label Period|Discontinued by Sponsor|0|||
23144874|NCT00406653|64277686|FG005|Open-Label Period|Discontinued by Sponsor|0|||
23144875|NCT00406653|64277687|FG006|Open-Label Period|Discontinued by Sponsor|1|||
23144876|NCT00406653|64277681|FG000|Open-Label Period|Refused followup|0|||
23144877|NCT00406653|64277682|FG001|Open-Label Period|Refused followup|0|||
23144878|NCT00406653|64277683|FG002|Open-Label Period|Refused followup|0|||
23144879|NCT00406653|64277684|FG003|Open-Label Period|Refused followup|0|||
23144880|NCT00406653|64277685|FG004|Open-Label Period|Refused followup|0|||
23144881|NCT00406653|64277686|FG005|Open-Label Period|Refused followup|0|||
23144882|NCT00406653|64277687|FG006|Open-Label Period|Refused followup|1|||
23144883|NCT02344004|64277688|FG000|Overall Study|Adverse Event|11|||
23144884|NCT02344004|64277689|FG001|Overall Study|Adverse Event|1|||
23144885|NCT02344004|64277688|FG000|Overall Study|Death|9|||
23144886|NCT02344004|64277689|FG001|Overall Study|Death|7|||
23144887|NCT02344004|64277688|FG000|Overall Study|Physician Decision|4|||
23144888|NCT02344004|64277689|FG001|Overall Study|Physician Decision|1|||
23144889|NCT02344004|64277688|FG000|Overall Study|Withdrawal by Subject|22|||
23144890|NCT02344004|64277689|FG001|Overall Study|Withdrawal by Subject|5|||
23144891|NCT02344004|64277688|FG000|Overall Study|Rescue Medication|2|||
23144892|NCT02344004|64277689|FG001|Overall Study|Rescue Medication|0|||
23144893|NCT02344004|64277688|FG000|Overall Study|Other Not Specified|12|||
23321863|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
23321864|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
23434978|NCT01092663|65334212|FG001|Overall Study|Protocol Violation|1|||
23623557|NCT02970305|66008484|FG000|Overall Study|Withdrawal by Subject|12|||
23623558|NCT02970305|66008485|FG001|Overall Study|Withdrawal by Subject|11|||
23623559|NCT02970305|66008484|FG000|Overall Study|Not further specified|1|||
23623560|NCT02970305|66008485|FG001|Overall Study|Not further specified|2|||
23623561|NCT02970305|66008484|FG000|Overall Study|Lost to Follow-up|1|||
23623562|NCT02970305|66008485|FG001|Overall Study|Lost to Follow-up|2|||
23623563|NCT00816556|66008486|FG000|Overall Study|Adverse Event|1|||
23623564|NCT00816556|66008487|FG001|Overall Study|Adverse Event|1|||
23623565|NCT00816556|66008488|FG002|Overall Study|Adverse Event|1|||
23623566|NCT00816556|66008486|FG000|Overall Study|Withdrawal by Subject|1|||
23556601|NCT01972529|65765937|FG000|Overall Study|Lost to Follow-up|1|||
23556602|NCT01972529|65765938|FG001|Overall Study|Lost to Follow-up|0|||
23556603|NCT01972529|65765939|FG002|Overall Study|Lost to Follow-up|0|||
23556604|NCT01972529|65765940|FG003|Overall Study|Lost to Follow-up|0|||
23556605|NCT01972529|65765937|FG000|Overall Study|Participant Choice|0|||
23556606|NCT01972529|65765938|FG001|Overall Study|Participant Choice|1|||
23556607|NCT01972529|65765939|FG002|Overall Study|Participant Choice|0|||
23556608|NCT01972529|65765940|FG003|Overall Study|Participant Choice|0|||
23556609|NCT01972529|65765937|FG000|Overall Study|Withdrawl of Consent|1|||
23556610|NCT01972529|65765938|FG001|Overall Study|Withdrawl of Consent|2|||
23556611|NCT01972529|65765939|FG002|Overall Study|Withdrawl of Consent|0|||
23556612|NCT01972529|65765940|FG003|Overall Study|Withdrawl of Consent|1|||
23144894|NCT02344004|64277689|FG001|Overall Study|Other Not Specified|0|||
23556613|NCT01972529|65765937|FG000|Overall Study|Other|0|||
23556614|NCT01972529|65765938|FG001|Overall Study|Other|0|||
23556615|NCT01972529|65765939|FG002|Overall Study|Other|0|||
23556616|NCT01972529|65765940|FG003|Overall Study|Other|2|||
23556617|NCT01972529|65765937|FG000|Overall Study|Not treated|0|||
23556618|NCT01972529|65765938|FG001|Overall Study|Not treated|1|||
23556619|NCT01972529|65765939|FG002|Overall Study|Not treated|2|||
23556620|NCT01972529|65765940|FG003|Overall Study|Not treated|1|||
23556621|NCT03260868|65765941|FG000|Overall Study|Poor Compliance to Protocol|0|||
23556622|NCT03260868|65765942|FG001|Overall Study|Poor Compliance to Protocol|2|||
23556623|NCT03260868|65765941|FG000|Overall Study|Study Terminated By Sponsor|2|||
23556624|NCT03260868|65765942|FG001|Overall Study|Study Terminated By Sponsor|1|||
23556625|NCT03260868|65765941|FG000|Overall Study|Other than specified above|1|||
23556626|NCT03260868|65765942|FG001|Overall Study|Other than specified above|0|||
23144895|NCT02344004|64277688|FG000|Overall Study|Protocol Violation|1|||
23144896|NCT02344004|64277689|FG001|Overall Study|Protocol Violation|0|||
23144897|NCT03235284|64277690|FG000|Overall Study|Adverse Event|1|||
23144898|NCT03235284|64277691|FG001|Overall Study|Adverse Event|2|||
23144899|NCT03235284|64277692|FG002|Overall Study|Adverse Event|1|||
23144900|NCT01098097|64277703|FG000|Overall Study|Adverse Event|17|||
23144901|NCT01098097|64277703|FG000|Overall Study|Lost to Follow-up|18|||
23144902|NCT01098097|64277703|FG000|Overall Study|Status unknown|16|||
23144903|NCT01098097|64277703|FG000|Overall Study|No reason reported|31|||
23144904|NCT04788511|64280752|FG000|Overall Study|Withdrawal by Subject|2|||
23144905|NCT04788511|64280753|FG001|Overall Study|Withdrawal by Subject|1|||
23144906|NCT04788511|64280752|FG000|Overall Study|Lost to Follow-up|2|||
23144907|NCT04788511|64280753|FG001|Overall Study|Lost to Follow-up|7|||
23144908|NCT04788511|64280752|FG000|Overall Study|Death|3|||
23144909|NCT04788511|64280753|FG001|Overall Study|Death|4|||
23144910|NCT01485354|64280758|FG000|Overall Study|Withdrawal by Subject|5|||
23144911|NCT01636960|64280759|FG000|Induction Phase|Adverse Event|2|||
23144912|NCT01636960|64280759|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
23144913|NCT01636960|64280759|FG000|Maintenance Phase|Adverse Event|3|||
23144914|NCT01636960|64280759|FG000|Maintenance Phase|Progressive disease|1|||
23144915|NCT02640157|64280760|FG000|Overall Study|Adverse Event|2|||
23144916|NCT02640157|64280761|FG001|Overall Study|Adverse Event|2|||
23144917|NCT02640157|64280762|FG002|Overall Study|Adverse Event|1|||
23144918|NCT02640157|64280760|FG000|Overall Study|Withdrew consent|2|||
23144919|NCT02640157|64280761|FG001|Overall Study|Withdrew consent|0|||
23556627|NCT04721925|65765943|FG000|2-Month Assessment|Lost to Follow-up|5|||
23556628|NCT04721925|65765944|FG001|2-Month Assessment|Lost to Follow-up|3|||
23556629|NCT04721925|65765943|FG000|4-Month Assessment|Lost to Follow-up|3|||
23623567|NCT00816556|66008487|FG001|Overall Study|Withdrawal by Subject|1|||
23623568|NCT00816556|66008488|FG002|Overall Study|Withdrawal by Subject|1|||
23623569|NCT00816556|66008486|FG000|Overall Study|Lost to Follow-up|0|||
23623570|NCT00816556|66008487|FG001|Overall Study|Lost to Follow-up|0|||
23623571|NCT00816556|66008488|FG002|Overall Study|Lost to Follow-up|1|||
23623572|NCT00488319|66008489|FG000|Overall Study|Adverse Event|1|||
23144920|NCT02640157|64280762|FG002|Overall Study|Withdrew consent|2|||
23144921|NCT02640157|64280760|FG000|Overall Study|Lost to Follow-up|9|||
23144922|NCT02640157|64280761|FG001|Overall Study|Lost to Follow-up|2|||
23556630|NCT04721925|65765944|FG001|4-Month Assessment|Lost to Follow-up|6|||
23556631|NCT03232983|65765945|FG000|Period 1|Physician Decision|0|||
23556632|NCT03232983|65765946|FG001|Period 1|Physician Decision|0|||
23556633|NCT03232983|65765947|FG002|Period 1|Physician Decision|1|||
23556634|NCT03232983|65765948|FG003|Period 1|Physician Decision|0|||
23556635|NCT03232983|65765945|FG000|Washout Period 2|Physician Decision|0|||
23321865|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
23321866|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
23321867|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
23321868|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
23434979|NCT03688620|65334213|FG000|Overall Study|Other|0|||
23556636|NCT03232983|65765946|FG001|Washout Period 2|Physician Decision|0|||
23556637|NCT03232983|65765947|FG002|Washout Period 2|Physician Decision|1|||
23556638|NCT03232983|65765948|FG003|Washout Period 2|Physician Decision|0|||
23556639|NCT03232983|65765945|FG000|Washout Period 2|Withdrawal by Subject|0|||
23556640|NCT03232983|65765946|FG001|Washout Period 2|Withdrawal by Subject|0|||
23556641|NCT03232983|65765947|FG002|Washout Period 2|Withdrawal by Subject|0|||
23556642|NCT03232983|65765948|FG003|Washout Period 2|Withdrawal by Subject|1|||
23556643|NCT03232983|65765945|FG000|Period 4|Withdrawal by Subject|1|||
23556644|NCT03232983|65765946|FG001|Period 4|Withdrawal by Subject|0|||
23556645|NCT03232983|65765947|FG002|Period 4|Withdrawal by Subject|0|||
23556646|NCT03232983|65765948|FG003|Period 4|Withdrawal by Subject|0|||
23556647|NCT01169675|65765949|FG000|Overall Study|Progressive disease|13|||
23556648|NCT01169675|65765950|FG001|Overall Study|Progressive disease|2|||
23556649|NCT01169675|65765951|FG002|Overall Study|Progressive disease|5|||
23556650|NCT01169675|65765952|FG003|Overall Study|Progressive disease|15|||
23556651|NCT01169675|65765953|FG004|Overall Study|Progressive disease|1|||
23556652|NCT01169675|65765949|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23556653|NCT01169675|65765950|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23556654|NCT01169675|65765951|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23556655|NCT01169675|65765952|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23556656|NCT01169675|65765953|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23556657|NCT01169675|65765949|FG000|Overall Study|Adverse Event|5|||
23556658|NCT01169675|65765950|FG001|Overall Study|Adverse Event|1|||
23556659|NCT01169675|65765951|FG002|Overall Study|Adverse Event|2|||
23556660|NCT01169675|65765952|FG003|Overall Study|Adverse Event|0|||
23556661|NCT01169675|65765953|FG004|Overall Study|Adverse Event|0|||
23556662|NCT01169675|65765949|FG000|Overall Study|Withdrawal by Subject|1|||
23144923|NCT02640157|64280762|FG002|Overall Study|Lost to Follow-up|7|||
23144924|NCT02640157|64280760|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
23144925|NCT02640157|64280761|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
23144926|NCT02640157|64280762|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
23144927|NCT00950950|64280763|FG000|Overall Study|Adverse Event|1|||
23144928|NCT00950950|64280764|FG001|Overall Study|Adverse Event|0|||
23144929|NCT00950950|64280763|FG000|Overall Study|Withdrawal by Subject|0|||
23144930|NCT00950950|64280764|FG001|Overall Study|Withdrawal by Subject|1|||
23144931|NCT01759407|64280765|FG000|Overall Study|Protocol Violation|0|||
23144932|NCT01759407|64280766|FG001|Overall Study|Protocol Violation|2|||
23144933|NCT03333837|64280767|FG000|Overall Study|Adverse Event|2|||
23144934|NCT03333837|64280768|FG001|Overall Study|Adverse Event|1|||
23144935|NCT03333837|64280769|FG002|Overall Study|Adverse Event|1|||
23144936|NCT03333837|64280770|FG003|Overall Study|Adverse Event|1|||
23144937|NCT03333837|64280771|FG004|Overall Study|Adverse Event|0|||
23144938|NCT03333837|64280767|FG000|Overall Study|Caregiver withdrew|0|||
23144939|NCT03333837|64280768|FG001|Overall Study|Caregiver withdrew|2|||
23144940|NCT03333837|64280769|FG002|Overall Study|Caregiver withdrew|1|||
23144941|NCT03333837|64280770|FG003|Overall Study|Caregiver withdrew|0|||
23144942|NCT03333837|64280771|FG004|Overall Study|Caregiver withdrew|0|||
23144943|NCT03333837|64280767|FG000|Overall Study|Withdrawal by Subject|0|||
23144944|NCT03333837|64280768|FG001|Overall Study|Withdrawal by Subject|0|||
23144945|NCT03333837|64280769|FG002|Overall Study|Withdrawal by Subject|1|||
23144946|NCT03333837|64280770|FG003|Overall Study|Withdrawal by Subject|1|||
23144947|NCT03333837|64280771|FG004|Overall Study|Withdrawal by Subject|3|||
23144948|NCT03333837|64280767|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
23144949|NCT03333837|64280768|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
23144950|NCT03333837|64280769|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
23144951|NCT03333837|64280770|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
23434980|NCT03688620|65334214|FG001|Overall Study|Other|0|||
23144952|NCT03333837|64280771|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
23144953|NCT03809429|64280772|FG000|Overall Study|Withdrawal by Subject|7|||
23144954|NCT03809429|64280773|FG001|Overall Study|Withdrawal by Subject|3|||
23144955|NCT03809429|64280772|FG000|Overall Study|Adverse Event|6|||
23434981|NCT03688620|65334215|FG002|Overall Study|Other|1|||
23556663|NCT01169675|65765950|FG001|Overall Study|Withdrawal by Subject|0|||
23556664|NCT01169675|65765951|FG002|Overall Study|Withdrawal by Subject|0|||
23556665|NCT01169675|65765952|FG003|Overall Study|Withdrawal by Subject|1|||
23556666|NCT01169675|65765953|FG004|Overall Study|Withdrawal by Subject|2|||
23556667|NCT01169675|65765949|FG000|Overall Study|Other Reason Not Defined Above|0|||
23556668|NCT01169675|65765950|FG001|Overall Study|Other Reason Not Defined Above|0|||
23556669|NCT01169675|65765951|FG002|Overall Study|Other Reason Not Defined Above|0|||
23321869|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
23623573|NCT00488319|66008490|FG001|Overall Study|Adverse Event|2|||
23321870|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
23321871|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
23321872|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
23434982|NCT03688620|65334213|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
23434983|NCT03688620|65334214|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
23556670|NCT01169675|65765952|FG003|Overall Study|Other Reason Not Defined Above|1|||
23556671|NCT01169675|65765953|FG004|Overall Study|Other Reason Not Defined Above|1|||
23556672|NCT00515502|65765954|FG000|Treatment Period 1|Adverse Event|0|||
23556673|NCT00515502|65765955|FG001|Treatment Period 1|Adverse Event|0|||
23556674|NCT00515502|65765956|FG002|Treatment Period 1|Adverse Event|0|||
23556675|NCT00515502|65765957|FG003|Treatment Period 1|Adverse Event|0|||
23556676|NCT00515502|65765958|FG004|Treatment Period 1|Adverse Event|0|||
23556677|NCT00515502|65765959|FG005|Treatment Period 1|Adverse Event|0|||
23556678|NCT00515502|65765960|FG006|Treatment Period 1|Adverse Event|1|||
23556679|NCT00515502|65765961|FG007|Treatment Period 1|Adverse Event|0|||
23556680|NCT00515502|65765962|FG008|Treatment Period 1|Adverse Event|1|||
23623574|NCT00488319|66008491|FG002|Overall Study|Adverse Event|23|||
23623575|NCT00488319|66008489|FG000|Overall Study|Lack of Efficacy|6|||
23321873|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23321874|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23321875|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23321876|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23321877|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23321878|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23321879|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
23321880|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
23321881|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
23321882|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
23321883|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
23321884|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
23321885|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
23321886|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
23321887|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
23321888|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321889|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321890|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321891|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321892|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321893|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321894|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321895|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321896|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321897|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321898|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321899|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
23321900|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321901|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
23321902|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
23321903|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321904|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321905|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321906|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321907|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321908|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
23321909|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321910|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321911|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321912|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
23434984|NCT03688620|65334215|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
23556681|NCT00515502|65765963|FG009|Treatment Period 1|Adverse Event|0|||
23556682|NCT00515502|65765964|FG010|Treatment Period 1|Adverse Event|0|||
23556683|NCT00515502|65765965|FG011|Treatment Period 1|Adverse Event|1|||
23556684|NCT00515502|65765954|FG000|Treatment Period 2|Adverse Event|0|||
23623576|NCT00488319|66008490|FG001|Overall Study|Lack of Efficacy|12|||
23623577|NCT00488319|66008491|FG002|Overall Study|Lack of Efficacy|27|||
23321913|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321914|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321915|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321916|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
23321917|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
23321918|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23321919|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23321920|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23321921|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23321922|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23321923|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23321924|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23321925|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23321926|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23144956|NCT03809429|64280773|FG001|Overall Study|Adverse Event|9|||
23144957|NCT03809429|64280772|FG000|Overall Study|COVID-19|3|||
23321927|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
23321928|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23321929|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
23321930|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23321931|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23321932|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
23321933|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23321934|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23321935|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23321936|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23321937|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23321938|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
23321939|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
23321940|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23321941|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23321942|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23321943|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
23321944|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
23321945|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
23321946|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
23321947|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
23321948|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321949|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321950|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321951|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321952|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23144958|NCT03809429|64280773|FG001|Overall Study|COVID-19|1|||
23144959|NCT03809429|64280772|FG000|Overall Study|Participant was discontinued by investigator|12|||
23144960|NCT03809429|64280773|FG001|Overall Study|Participant was discontinued by investigator|7|||
23144961|NCT02935452|64280774|FG000|Overall Study|work and life commintment|3|||
23144962|NCT02935452|64280775|FG001|Overall Study|work and life commintment|1|||
23144963|NCT03384654|64280776|FG000|Overall Study|Withdrawal by Subject|0|||
23144964|NCT03384654|64280777|FG001|Overall Study|Withdrawal by Subject|0|||
23321953|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
23321954|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321955|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321956|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321957|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321958|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
23321959|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321960|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321961|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
23321962|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
23321963|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23434985|NCT03688620|65334213|FG000|Overall Study|Lost to Follow-up|16|||
23144965|NCT03384654|64280778|FG002|Overall Study|Withdrawal by Subject|1|||
23144966|NCT03384654|64280779|FG003|Overall Study|Withdrawal by Subject|0|||
23144967|NCT02318797|64280790|FG000|Overall Study|Death|3|||
23144968|NCT02318797|64280791|FG001|Overall Study|Death|6|||
23556685|NCT00515502|65765955|FG001|Treatment Period 2|Adverse Event|1|||
23556686|NCT00515502|65765956|FG002|Treatment Period 2|Adverse Event|0|||
23556687|NCT00515502|65765957|FG003|Treatment Period 2|Adverse Event|0|||
23144969|NCT02318797|64280790|FG000|Overall Study|Lost to Follow-up|85|||
23144970|NCT02318797|64280791|FG001|Overall Study|Lost to Follow-up|96|||
23556688|NCT00515502|65765958|FG004|Treatment Period 2|Adverse Event|0|||
23556689|NCT00515502|65765959|FG005|Treatment Period 2|Adverse Event|0|||
23556690|NCT00515502|65765960|FG006|Treatment Period 2|Adverse Event|0|||
23556691|NCT00515502|65765961|FG007|Treatment Period 2|Adverse Event|0|||
23556692|NCT00515502|65765962|FG008|Treatment Period 2|Adverse Event|0|||
23556693|NCT00515502|65765963|FG009|Treatment Period 2|Adverse Event|0|||
23556694|NCT00515502|65765964|FG010|Treatment Period 2|Adverse Event|0|||
23556695|NCT00515502|65765965|FG011|Treatment Period 2|Adverse Event|0|||
23556696|NCT00338884|65765966|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
23556697|NCT00338884|65765966|FG000|Overall Study|Adverse Event|14|||
23556698|NCT00338884|65765966|FG000|Overall Study|Death|8|||
23556699|NCT00338884|65765966|FG000|Overall Study|Other|4|||
23556700|NCT00338884|65765966|FG000|Overall Study|Global Deterioration of Health Status|3|||
23556701|NCT00338884|65765966|FG000|Overall Study|Withdrawal by Subject|3|||
23556702|NCT00338884|65765966|FG000|Overall Study|Lost to Follow-up|1|||
23556703|NCT00338884|65765966|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
23556704|NCT00316173|65765968|FG000|Run-in Phase|Adverse Event|1|||
23556705|NCT00316173|65765969|FG001|Run-in Phase|Adverse Event|0|||
23556706|NCT00316173|65765968|FG000|Run-in Phase|Protocol Violation|1|||
23556707|NCT00316173|65765969|FG001|Run-in Phase|Protocol Violation|0|||
23556708|NCT00316173|65765968|FG000|Run-in Phase|Study Follow-up Stopped|5|||
23556709|NCT00316173|65765969|FG001|Run-in Phase|Study Follow-up Stopped|0|||
23144971|NCT01190514|64280792|FG000|First Intervention (Period 1)|Adverse Event|1|||
23144972|NCT01190514|64280793|FG001|First Intervention (Period 1)|Adverse Event|0|||
23144973|NCT01190514|64280794|FG002|First Intervention (Period 1)|Adverse Event|0|||
23144974|NCT01190514|64280795|FG003|First Intervention (Period 1)|Adverse Event|0|||
23144975|NCT01190514|64280792|FG000|Third Intervention (Period 3)|Adverse Event|1|||
23144976|NCT01190514|64280793|FG001|Third Intervention (Period 3)|Adverse Event|0|||
23144977|NCT01190514|64280794|FG002|Third Intervention (Period 3)|Adverse Event|0|||
23144978|NCT01190514|64280795|FG003|Third Intervention (Period 3)|Adverse Event|0|||
23144979|NCT00810394|64280796|FG000|Overall Study|Withdrawal by Subject|3|||
23144980|NCT01658826|64280799|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
23144981|NCT01658826|64280800|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
23144982|NCT01658826|64280799|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
23144983|NCT01658826|64280800|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
23144984|NCT01658826|64280799|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
23144985|NCT01658826|64280800|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
23144986|NCT01658826|64280799|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
23144987|NCT01658826|64280800|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
23144988|NCT01658826|64280799|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
23144989|NCT01658826|64280800|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
23144990|NCT01658826|64280799|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
23144991|NCT01658826|64280800|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
23218208|NCT00968708|64541523|FG000|Overall Study|Other|26|||
23218209|NCT00968708|64541524|FG001|Overall Study|Other|34|||
23218210|NCT00416312|64541525|FG000|Overall Study|tumors not visible on imaging|2|||
23218211|NCT01390038|64541526|FG000|Overall Study|Death|1|||
23218212|NCT01390038|64541526|FG000|Overall Study|Lost to Follow-up|1|||
23218213|NCT01390038|64541526|FG000|Overall Study|Withdrawal by Subject|4|||
23218214|NCT01390038|64541526|FG000|Overall Study|Simpliciti System Removal|2|||
23218215|NCT00608842|64541527|FG000|Overall Study|Participant's Request|0|||
23218216|NCT00608842|64541528|FG001|Overall Study|Participant's Request|1|||
23218217|NCT00608842|64541529|FG002|Overall Study|Participant's Request|2|||
23218218|NCT00608842|64541530|FG003|Overall Study|Participant's Request|1|||
23218219|NCT00608842|64541527|FG000|Overall Study|Lost to Follow-up|1|||
23218220|NCT00608842|64541528|FG001|Overall Study|Lost to Follow-up|0|||
23218221|NCT00608842|64541529|FG002|Overall Study|Lost to Follow-up|0|||
23218222|NCT00608842|64541530|FG003|Overall Study|Lost to Follow-up|0|||
23321964|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23556710|NCT00316173|65765968|FG000|Treatment Phase|Adverse Event|0|||
23623578|NCT00488319|66008489|FG000|Overall Study|Lost to Follow-up|3|||
23556711|NCT00316173|65765969|FG001|Treatment Phase|Adverse Event|1|||
23556712|NCT00316173|65765968|FG000|Treatment Phase|Lack of Efficacy|0|||
23556713|NCT00316173|65765969|FG001|Treatment Phase|Lack of Efficacy|3|||
23556714|NCT00316173|65765968|FG000|Treatment Phase|Lost to Follow-up|0|||
23556715|NCT00316173|65765969|FG001|Treatment Phase|Lost to Follow-up|3|||
23556716|NCT00316173|65765968|FG000|Treatment Phase|Withdrawal by Subject|0|||
23556717|NCT00316173|65765969|FG001|Treatment Phase|Withdrawal by Subject|1|||
23556718|NCT00316173|65765968|FG000|Treatment Phase|Study Follow-up Stopped|0|||
23556719|NCT00316173|65765969|FG001|Treatment Phase|Study Follow-up Stopped|34|||
23556720|NCT00765843|65765971|FG000|Overall Study|Lost to Follow-up|1|||
23556721|NCT00765843|65765972|FG001|Overall Study|Lost to Follow-up|3|||
23556722|NCT00765843|65765973|FG002|Overall Study|Lost to Follow-up|2|||
23556723|NCT00765843|65765971|FG000|Overall Study|did not return to receive intervention|0|||
23556724|NCT00765843|65765972|FG001|Overall Study|did not return to receive intervention|1|||
23556725|NCT00765843|65765973|FG002|Overall Study|did not return to receive intervention|0|||
23556726|NCT00765843|65765971|FG000|Overall Study|Adverse Event|0|||
23556727|NCT00765843|65765972|FG001|Overall Study|Adverse Event|0|||
23556728|NCT00765843|65765973|FG002|Overall Study|Adverse Event|1|||
23556729|NCT04102579|65765974|FG000|Overall Study|Withdrawal by Subject|3|||
23556730|NCT04102579|65765975|FG001|Overall Study|Withdrawal by Subject|4|||
23556731|NCT04102579|65765974|FG000|Overall Study|Lost to Follow-up|0|||
23556732|NCT04102579|65765975|FG001|Overall Study|Lost to Follow-up|1|||
23556733|NCT04102579|65765974|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
23556734|NCT04102579|65765975|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
23556735|NCT04102579|65765974|FG000|Overall Study|Other than Specified|1|||
23556736|NCT04102579|65765975|FG001|Overall Study|Other than Specified|0|||
23556737|NCT04102579|65765974|FG000|Overall Study|Not Dosed with Study Drug|0|||
23556738|NCT04102579|65765975|FG001|Overall Study|Not Dosed with Study Drug|1|||
23556739|NCT02701985|65765976|FG000|Overall Study|Withdrawal by Subject|1|||
23556740|NCT02701985|65765977|FG001|Overall Study|Withdrawal by Subject|1|||
23556741|NCT02701985|65765976|FG000|Overall Study|Lost to Follow-up|1|||
23556742|NCT02701985|65765977|FG001|Overall Study|Lost to Follow-up|0|||
23556743|NCT02701985|65765976|FG000|Overall Study|Death|1|||
23556744|NCT02701985|65765977|FG001|Overall Study|Death|0|||
23144992|NCT01658826|64280799|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
23144993|NCT01658826|64280800|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
23144994|NCT01658826|64280799|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
23144995|NCT01658826|64280800|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
23144996|NCT01658826|64280799|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
23144997|NCT01658826|64280800|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
23144998|NCT03513588|64280809|FG000|Overall Study|Lost to Follow-up|0|||
23144999|NCT03513588|64280810|FG001|Overall Study|Lost to Follow-up|1|||
23145000|NCT03513588|64280811|FG002|Overall Study|Lost to Follow-up|1|||
23145001|NCT03513588|64280809|FG000|Overall Study|Study dosing paused by sponsor|1|||
23145002|NCT03513588|64280810|FG001|Overall Study|Study dosing paused by sponsor|1|||
23145003|NCT03513588|64280811|FG002|Overall Study|Study dosing paused by sponsor|0|||
23145004|NCT03513588|64280809|FG000|Overall Study|Death|0|||
23145005|NCT03513588|64280810|FG001|Overall Study|Death|0|||
23145006|NCT03513588|64280811|FG002|Overall Study|Death|1|||
23145007|NCT04751656|64280812|FG000|Overall Study|Lost to Follow-up|1|||
23145008|NCT01839487|64280813|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
23145009|NCT01839487|64280814|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23145010|NCT01839487|64280815|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23145011|NCT01839487|64280816|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23145012|NCT01839487|64280817|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23145013|NCT01839487|64280818|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
23145014|NCT01839487|64280813|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
23145015|NCT01839487|64280814|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
23145016|NCT01839487|64280815|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
23145017|NCT01839487|64280816|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
23145018|NCT01839487|64280817|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
23145019|NCT01839487|64280818|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
23145020|NCT01839487|64280813|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23145021|NCT01839487|64280814|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
23145022|NCT01839487|64280815|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23145023|NCT01839487|64280816|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23145024|NCT01839487|64280817|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23145025|NCT01839487|64280818|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
23145026|NCT01839487|64280813|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
23556745|NCT02701985|65765976|FG000|Overall Study|Adverse Event|0|||
23556746|NCT02701985|65765977|FG001|Overall Study|Adverse Event|5|||
23556747|NCT02001194|65765980|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
23556748|NCT02001194|65765981|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
23556749|NCT02001194|65765982|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
23556750|NCT02001194|65765983|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
23556751|NCT02001194|65765980|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
23321965|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23321966|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23321967|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23321968|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23321969|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23321970|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
23321971|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
23321972|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23321973|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
23321974|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
23321975|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
23145027|NCT01839487|64280814|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23321976|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23321977|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
23321978|NCT03334435|64922849|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321979|NCT03334435|64922850|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321980|NCT03334435|64922851|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321981|NCT03334435|64922852|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321982|NCT03334435|64922853|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23218223|NCT01989572|64541531|FG000|Overall Study|Lack of Efficacy|35|||
23218224|NCT01989572|64541532|FG001|Overall Study|Lack of Efficacy|48|||
23218225|NCT01989572|64541533|FG002|Overall Study|Lack of Efficacy|48|||
23218226|NCT01989572|64541534|FG003|Overall Study|Lack of Efficacy|43|||
23321983|NCT03334435|64922854|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23434986|NCT03688620|65334214|FG001|Overall Study|Lost to Follow-up|0|||
23556752|NCT02001194|65765981|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
23556753|NCT02001194|65765982|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
23556754|NCT02001194|65765983|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
23556755|NCT01132326|65765985|FG000|Overall Study|Lack of Efficacy|25|||
23556756|NCT01132326|65765985|FG000|Overall Study|Adverse Event|37|||
23556757|NCT01132326|65765985|FG000|Overall Study|Protocol Violation|1|||
23145028|NCT01839487|64280815|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23145029|NCT01839487|64280816|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23145030|NCT01839487|64280817|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23145031|NCT01839487|64280818|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
23556758|NCT01132326|65765985|FG000|Overall Study|Lost to Follow-up|16|||
23556759|NCT01132326|65765985|FG000|Overall Study|Withdrawal by Subject|40|||
23556760|NCT01132326|65765985|FG000|Overall Study|Physician Decision|10|||
23556761|NCT01132326|65765985|FG000|Overall Study|Study Termination|80|||
23556762|NCT01132326|65765985|FG000|Overall Study|Declining Health|1|||
23556763|NCT01132326|65765985|FG000|Overall Study|Pregnancy|1|||
23556764|NCT01132326|65765985|FG000|Overall Study|Caregiver Withdrew Consent|1|||
23556765|NCT01132326|65765985|FG000|Overall Study|Death|5|||
23556766|NCT01132326|65765985|FG000|Overall Study|Subject Unable to Come To Visits|1|||
23556767|NCT01111838|65765986|FG000|Overall Study|Patient Ineligible|2|||
23556768|NCT01111838|65765986|FG000|Overall Study|Not Treated|3|||
23556769|NCT01111838|65765986|FG000|Overall Study|Clinical deterioration|1|||
23556770|NCT01111838|65765986|FG000|Overall Study|Other Complicating Disease|1|||
23556771|NCT00716092|65765987|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
23556772|NCT00716092|65765988|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
23556773|NCT00716092|65765989|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
23556774|NCT00168038|65765990|FG000|Overall Study|Adverse Event|1|||
23623579|NCT00488319|66008490|FG001|Overall Study|Lost to Follow-up|5|||
23145032|NCT01839487|64280813|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
23145033|NCT01839487|64280814|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
23145034|NCT01839487|64280815|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
23145035|NCT01839487|64280816|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
23145036|NCT01839487|64280817|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
23145037|NCT01839487|64280818|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
23145038|NCT01839487|64280813|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
23145039|NCT01839487|64280814|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
23145040|NCT01839487|64280815|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
23145041|NCT01839487|64280816|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
23145042|NCT01839487|64280817|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
23145043|NCT01839487|64280818|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
23218227|NCT01989572|64541535|FG004|Overall Study|Lack of Efficacy|71|||
23218228|NCT01989572|64541536|FG005|Overall Study|Lack of Efficacy|79|||
23218229|NCT01989572|64541531|FG000|Overall Study|Adverse Event|2|||
23556775|NCT00168038|65765990|FG000|Overall Study|Therapy failure|1|||
23556776|NCT00387894|65765991|FG000|Overall Study|Withdrawal by Subject|1|||
23556777|NCT04839965|65765992|FG000|Overall Study|Death|6|||
23556778|NCT04839965|65765993|FG001|Overall Study|Death|6|||
23556779|NCT04839965|65765992|FG000|Overall Study|Lost to Follow-up|1|||
23145044|NCT01839487|64280813|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
23145045|NCT01839487|64280814|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
23145046|NCT01839487|64280815|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
23145047|NCT01839487|64280816|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
23145048|NCT01839487|64280817|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
23145049|NCT01839487|64280818|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
23145050|NCT01839487|64280813|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
23145051|NCT01839487|64280814|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
23145052|NCT01839487|64280815|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
23145053|NCT01839487|64280816|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
23145054|NCT01839487|64280817|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
23145055|NCT01839487|64280818|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
23145056|NCT01839487|64280813|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
23145057|NCT01839487|64280814|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
23145058|NCT01839487|64280815|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
23145059|NCT01839487|64280816|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
23145060|NCT01839487|64280817|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
23145061|NCT01839487|64280818|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
23145062|NCT02186223|64280819|FG000|Overall Study|Not eligible for device placement|6|||
23145063|NCT02186223|64280819|FG000|Overall Study|Unable to obtain femoral access|3|||
23145064|NCT02186223|64280819|FG000|Overall Study|Death|3|||
23145065|NCT02186223|64280819|FG000|Overall Study|Device in place less than 48 hours|9|||
23145066|NCT02043678|64280820|FG000|Overall Study|Never treated|11|||
23145067|NCT02043678|64280821|FG001|Overall Study|Never treated|9|||
23145068|NCT02043678|64280820|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
23145069|NCT02043678|64280821|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
23145070|NCT02043678|64280820|FG000|Overall Study|AE without clinical PD|51|||
23145071|NCT02043678|64280821|FG001|Overall Study|AE without clinical PD|34|||
23145072|NCT02043678|64280820|FG000|Overall Study|Lost to Follow-up|1|||
23145073|NCT02043678|64280821|FG001|Overall Study|Lost to Follow-up|1|||
23145074|NCT02043678|64280820|FG000|Overall Study|Other|19|||
23145075|NCT02043678|64280821|FG001|Overall Study|Other|16|||
23145076|NCT02043678|64280820|FG000|Overall Study|Clinical PD|108|||
23145077|NCT02043678|64280821|FG001|Overall Study|Clinical PD|138|||
23145078|NCT02043678|64280820|FG000|Overall Study|Radiological PD|91|||
23145079|NCT02043678|64280821|FG001|Overall Study|Radiological PD|80|||
23145080|NCT02043678|64280820|FG000|Overall Study|Protocol-driven decision point|56|||
23145081|NCT02043678|64280821|FG001|Overall Study|Protocol-driven decision point|56|||
23145082|NCT02043678|64280820|FG000|Overall Study|Withdrawal by Subject|12|||
23145083|NCT02043678|64280821|FG001|Overall Study|Withdrawal by Subject|15|||
23145084|NCT02043678|64280820|FG000|Overall Study|Ongoing with treatment|34|||
23145085|NCT02043678|64280821|FG001|Overall Study|Ongoing with treatment|38|||
23145086|NCT01350336|64280822|FG000|Overall Study|Lost to Follow-up|31|||
23145087|NCT01350336|64280822|FG000|Overall Study|Withdrawal by Subject|14|||
23145088|NCT01350336|64280822|FG000|Overall Study|Physician Decision|8|||
23145089|NCT01350336|64280822|FG000|Overall Study|Death|4|||
23145090|NCT01259284|64280823|FG000|Overall Study|Study Termination|2|||
23145091|NCT01259284|64280824|FG001|Overall Study|Study Termination|0|||
23145092|NCT01259284|64280825|FG002|Overall Study|Study Termination|0|||
23145093|NCT01163916|64280830|FG000|Overall Study|Withdrawal by Subject|2|||
23145094|NCT01163916|64280831|FG001|Overall Study|Withdrawal by Subject|0|||
23145095|NCT01163916|64280832|FG002|Overall Study|Withdrawal by Subject|2|||
23145096|NCT01163916|64280830|FG000|Overall Study|Adverse Event|2|||
23145097|NCT01163916|64280831|FG001|Overall Study|Adverse Event|0|||
23145098|NCT01163916|64280832|FG002|Overall Study|Adverse Event|1|||
23145099|NCT01163916|64280830|FG000|Overall Study|Lack of Efficacy|2|||
23218230|NCT01989572|64541532|FG001|Overall Study|Adverse Event|1|||
23145100|NCT01163916|64280831|FG001|Overall Study|Lack of Efficacy|0|||
23145101|NCT01163916|64280832|FG002|Overall Study|Lack of Efficacy|1|||
23145102|NCT01163916|64280830|FG000|Overall Study|Other|24|||
23145103|NCT01163916|64280831|FG001|Overall Study|Other|4|||
23145104|NCT01163916|64280832|FG002|Overall Study|Other|16|||
23218231|NCT01989572|64541533|FG002|Overall Study|Adverse Event|3|||
23145105|NCT00511472|64280833|FG000|Overall Study|Clinical Adverse Event|1|||
23145106|NCT00511472|64280834|FG001|Overall Study|Clinical Adverse Event|2|||
23145107|NCT00511472|64280833|FG000|Overall Study|Laboratory Adverse Event|0|||
23145108|NCT00511472|64280834|FG001|Overall Study|Laboratory Adverse Event|2|||
23145109|NCT00511472|64280833|FG000|Overall Study|Not reported|2|||
23145110|NCT00511472|64280834|FG001|Overall Study|Not reported|2|||
23145111|NCT01588496|64280838|FG000|Overall Study|Withdrawal by Subject|0|||
23145112|NCT01588496|64280839|FG001|Overall Study|Withdrawal by Subject|1|||
23145113|NCT01588496|64280840|FG002|Overall Study|Withdrawal by Subject|0|||
23556780|NCT04839965|65765993|FG001|Overall Study|Lost to Follow-up|0|||
23145114|NCT01136811|64280841|FG000|Overall Study|Physician Decision|11|||
23145115|NCT01502631|64280842|FG000|Overall Study|Adverse Event|5|||
23145116|NCT01502631|64280843|FG001|Overall Study|Adverse Event|8|||
23145117|NCT01502631|64280842|FG000|Overall Study|Lost to Follow-up|2|||
23145118|NCT01502631|64280843|FG001|Overall Study|Lost to Follow-up|2|||
23145119|NCT01502631|64280842|FG000|Overall Study|Participant withdrew consent|2|||
23145120|NCT01502631|64280843|FG001|Overall Study|Participant withdrew consent|4|||
23145121|NCT01502631|64280842|FG000|Overall Study|Participant non-compliant|1|||
23145122|NCT01502631|64280843|FG001|Overall Study|Participant non-compliant|0|||
23145123|NCT01502631|64280842|FG000|Overall Study|Investigator's decision|0|||
23145124|NCT01502631|64280843|FG001|Overall Study|Investigator's decision|1|||
23145125|NCT01502631|64280842|FG000|Overall Study|Other|10|||
23145126|NCT01502631|64280843|FG001|Overall Study|Other|5|||
23145127|NCT01285609|64280844|FG000|Randomized|Progressive Disease|41|||
23145128|NCT01285609|64280845|FG001|Randomized|Progressive Disease|61|||
23145129|NCT01285609|64280844|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
23145130|NCT01285609|64280845|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
23145131|NCT01285609|64280844|FG000|Randomized|Study Drug Toxicity|13|||
23145132|NCT01285609|64280845|FG001|Randomized|Study Drug Toxicity|14|||
23145133|NCT01285609|64280844|FG000|Randomized|Death|5|||
23145134|NCT01285609|64280845|FG001|Randomized|Death|7|||
23145135|NCT01285609|64280844|FG000|Randomized|Withdrawal by Subject|8|||
23145136|NCT01285609|64280845|FG001|Randomized|Withdrawal by Subject|11|||
23145137|NCT01285609|64280844|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
23145138|NCT01285609|64280845|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
23145139|NCT01285609|64280844|FG000|Randomized|Undisclosed Reasons|1|||
23145140|NCT01285609|64280845|FG001|Randomized|Undisclosed Reasons|0|||
23145141|NCT01285609|64280844|FG000|Randomized|Randomized but not Treated|4|||
23145142|NCT01285609|64280845|FG001|Randomized|Randomized but not Treated|4|||
23145143|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
23145144|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
23145145|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
23145146|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
23145147|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
23145148|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
23145149|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
23145150|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
23145151|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Death|11|||
23145152|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Death|3|||
23145153|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
23145154|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
23145155|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Not Reported|0|||
23145156|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Not Reported|2|||
23145157|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
23145158|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
23145159|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
23145160|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
23145161|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
23145162|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
23145163|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
23145164|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
23145165|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
23145166|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
23145167|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
23145168|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
23145169|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
23145170|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
23145171|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
23145172|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
23145173|NCT01285609|64280844|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
23145174|NCT01285609|64280845|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
23145175|NCT01285609|64280844|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
23145176|NCT01285609|64280845|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
23145177|NCT03213457|64280849|FG000|Overall Study|Not Treated|1|||
23145178|NCT03213457|64280850|FG001|Overall Study|Not Treated|1|||
23145179|NCT03213457|64280851|FG002|Overall Study|Not Treated|0|||
23145180|NCT03213457|64280849|FG000|Overall Study|Adverse Event|16|||
23145181|NCT03213457|64280850|FG001|Overall Study|Adverse Event|9|||
23145182|NCT03213457|64280851|FG002|Overall Study|Adverse Event|41|||
23145183|NCT03213457|64280849|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23145184|NCT03213457|64280850|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23145185|NCT03213457|64280851|FG002|Overall Study|Non-Compliance With Study Drug|7|||
23145186|NCT03213457|64280849|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
23145187|NCT03213457|64280850|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
23145188|NCT03213457|64280851|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
23145189|NCT03213457|64280849|FG000|Overall Study|Withdrawal by Subject|18|||
23145190|NCT03213457|64280850|FG001|Overall Study|Withdrawal by Subject|7|||
23145191|NCT03213457|64280851|FG002|Overall Study|Withdrawal by Subject|35|||
23145192|NCT03213457|64280849|FG000|Overall Study|Lost to Follow-up|12|||
23145193|NCT03213457|64280850|FG001|Overall Study|Lost to Follow-up|12|||
23145194|NCT03213457|64280851|FG002|Overall Study|Lost to Follow-up|33|||
23145195|NCT03213457|64280849|FG000|Overall Study|Pregnancy|11|||
23145196|NCT03213457|64280850|FG001|Overall Study|Pregnancy|0|||
23145197|NCT03213457|64280851|FG002|Overall Study|Pregnancy|7|||
23145198|NCT03213457|64280849|FG000|Overall Study|Protocol Violation|1|||
23145199|NCT03213457|64280850|FG001|Overall Study|Protocol Violation|1|||
23145200|NCT03213457|64280851|FG002|Overall Study|Protocol Violation|6|||
23145201|NCT03213457|64280849|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
23145202|NCT03213457|64280850|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
23145203|NCT03213457|64280851|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
23145204|NCT03213457|64280849|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
23145205|NCT03213457|64280850|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
23145206|NCT03213457|64280851|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
23145207|NCT03213457|64280849|FG000|Overall Study|Lack of Efficacy|12|||
23218232|NCT01989572|64541534|FG003|Overall Study|Adverse Event|0|||
23218233|NCT01989572|64541535|FG004|Overall Study|Adverse Event|3|||
23218234|NCT01989572|64541536|FG005|Overall Study|Adverse Event|0|||
23218235|NCT01989572|64541531|FG000|Overall Study|Death|0|||
23218236|NCT01989572|64541532|FG001|Overall Study|Death|0|||
23218237|NCT01989572|64541533|FG002|Overall Study|Death|0|||
23218238|NCT01989572|64541534|FG003|Overall Study|Death|0|||
23218239|NCT01989572|64541535|FG004|Overall Study|Death|1|||
23218240|NCT01989572|64541536|FG005|Overall Study|Death|0|||
23218241|NCT01989572|64541531|FG000|Overall Study|Withdrawal by Subject|4|||
23218242|NCT01989572|64541532|FG001|Overall Study|Withdrawal by Subject|1|||
23218243|NCT01989572|64541533|FG002|Overall Study|Withdrawal by Subject|5|||
23218244|NCT01989572|64541534|FG003|Overall Study|Withdrawal by Subject|1|||
23218245|NCT01989572|64541535|FG004|Overall Study|Withdrawal by Subject|12|||
23218246|NCT01989572|64541536|FG005|Overall Study|Withdrawal by Subject|4|||
23218247|NCT01989572|64541531|FG000|Overall Study|complicating disease|1|||
23218248|NCT01989572|64541532|FG001|Overall Study|complicating disease|1|||
23218249|NCT01989572|64541533|FG002|Overall Study|complicating disease|2|||
23218250|NCT01989572|64541534|FG003|Overall Study|complicating disease|0|||
23218251|NCT01989572|64541535|FG004|Overall Study|complicating disease|1|||
23218252|NCT01989572|64541536|FG005|Overall Study|complicating disease|0|||
23218253|NCT01989572|64541531|FG000|Overall Study|error|2|||
23218254|NCT01989572|64541532|FG001|Overall Study|error|1|||
23218255|NCT01989572|64541533|FG002|Overall Study|error|1|||
23218256|NCT01989572|64541534|FG003|Overall Study|error|1|||
23218257|NCT01989572|64541535|FG004|Overall Study|error|1|||
23218258|NCT01989572|64541536|FG005|Overall Study|error|1|||
23218259|NCT01989572|64541531|FG000|Overall Study|maximum dose reached|0|||
23218260|NCT01989572|64541532|FG001|Overall Study|maximum dose reached|1|||
23218261|NCT01989572|64541533|FG002|Overall Study|maximum dose reached|0|||
23218262|NCT01989572|64541534|FG003|Overall Study|maximum dose reached|0|||
23218263|NCT01989572|64541535|FG004|Overall Study|maximum dose reached|1|||
23434987|NCT03688620|65334215|FG002|Overall Study|Lost to Follow-up|1|||
23434988|NCT03688620|65334213|FG000|Overall Study|Withdrawal by Subject|0|||
23434989|NCT03688620|65334214|FG001|Overall Study|Withdrawal by Subject|0|||
23434990|NCT03688620|65334215|FG002|Overall Study|Withdrawal by Subject|6|||
23434991|NCT00895453|65334216|FG000|Overall Study|Lost to Follow-up|25|||
23434992|NCT00895453|65334217|FG001|Overall Study|Lost to Follow-up|25|||
23434993|NCT00895453|65334218|FG002|Overall Study|Lost to Follow-up|23|||
23434994|NCT04891107|65334221|FG000|Overall Study|Physician Decision|1|||
23623580|NCT00488319|66008491|FG002|Overall Study|Lost to Follow-up|16|||
23145208|NCT03213457|64280850|FG001|Overall Study|Lack of Efficacy|2|||
23218264|NCT01989572|64541536|FG005|Overall Study|maximum dose reached|0|||
23434995|NCT04891107|65334221|FG000|Overall Study|Withdrawal by Subject|1|||
23434996|NCT04891107|65334221|FG000|Overall Study|Screen failure after consent|1|||
23145209|NCT03213457|64280851|FG002|Overall Study|Lack of Efficacy|9|||
23145210|NCT03213457|64280849|FG000|Overall Study|Other, Not Specified|11|||
23218265|NCT01989572|64541531|FG000|Overall Study|unknown/not specify|3|||
23218266|NCT01989572|64541532|FG001|Overall Study|unknown/not specify|4|||
23218267|NCT01989572|64541533|FG002|Overall Study|unknown/not specify|1|||
23218268|NCT01989572|64541534|FG003|Overall Study|unknown/not specify|3|||
23218269|NCT01989572|64541535|FG004|Overall Study|unknown/not specify|3|||
23218270|NCT01989572|64541536|FG005|Overall Study|unknown/not specify|5|||
23434997|NCT02900170|65334223|FG000|Overall Study|Lost to Follow-up|8|||
23434998|NCT00551291|65334224|FG000|Overall Study|Physician Decision|1|||
23145211|NCT03213457|64280850|FG001|Overall Study|Other, Not Specified|3|||
23145212|NCT03213457|64280851|FG002|Overall Study|Other, Not Specified|26|||
23145213|NCT00400985|64280853|FG000|Overall Study|Withdrawal by Subject|5|||
23145214|NCT00400985|64280853|FG000|Overall Study|system modification|8|||
23145215|NCT00400985|64280853|FG000|Overall Study|Death|30|||
23145216|NCT00400985|64280853|FG000|Overall Study|Lost to Follow-up|9|||
23145217|NCT01580969|64280854|FG000|Overall Study|Physician Decision|3|||
23145218|NCT01580969|64280855|FG001|Overall Study|Physician Decision|0|||
23145219|NCT01580969|64280856|FG002|Overall Study|Physician Decision|0|||
23145220|NCT00953407|64280857|FG000|Overall Study|Failed inclusion criteria|1|||
23145221|NCT00953407|64280858|FG001|Overall Study|Failed inclusion criteria|1|||
23145222|NCT00953407|64280859|FG002|Overall Study|Failed inclusion criteria|1|||
23145223|NCT00953407|64280860|FG003|Overall Study|Failed inclusion criteria|1|||
23145224|NCT00953407|64280861|FG004|Overall Study|Failed inclusion criteria|1|||
23145225|NCT00953407|64280857|FG000|Overall Study|Lost to Follow-up|0|||
23145226|NCT00953407|64280858|FG001|Overall Study|Lost to Follow-up|0|||
23145227|NCT00953407|64280859|FG002|Overall Study|Lost to Follow-up|0|||
23145228|NCT00953407|64280860|FG003|Overall Study|Lost to Follow-up|1|||
23145229|NCT00953407|64280861|FG004|Overall Study|Lost to Follow-up|0|||
23145230|NCT00995020|64280871|FG000|Overall Study|margin analysis not performed|2|||
23145231|NCT00995020|64280872|FG001|Overall Study|margin analysis not performed|5|||
23145232|NCT00995020|64280871|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
23145233|NCT00995020|64280872|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
23145234|NCT04187989|64280875|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
23145235|NCT04187989|64280876|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
23145236|NCT04187989|64280875|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
23145237|NCT04187989|64280876|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
23145238|NCT04526197|64280879|FG000|Period 1|Adverse Event|0|||
23145239|NCT04526197|64280880|FG001|Period 1|Adverse Event|1|||
23145240|NCT04526197|64280879|FG000|Period 1|Withdrawal by Subject|1|||
23145241|NCT04526197|64280880|FG001|Period 1|Withdrawal by Subject|0|||
23145242|NCT04526197|64280879|FG000|Period 2|Adverse Event|0|||
23145243|NCT04526197|64280880|FG001|Period 2|Adverse Event|1|||
23145244|NCT04526197|64280879|FG000|Period 2|Withdrawal by Subject|0|||
23145245|NCT04526197|64280880|FG001|Period 2|Withdrawal by Subject|1|||
23145246|NCT03214094|64280881|FG000|Overall Study|Case Report Forms Uncollected|14|||
23145247|NCT03214094|64280881|FG000|Overall Study|Protocol Deviation|46|||
23145248|NCT03435497|64280882|FG000|Overall Study|Lost to Follow-up|1|||
23145249|NCT03435497|64280883|FG001|Overall Study|Lost to Follow-up|0|||
23145250|NCT03435497|64280882|FG000|Overall Study|Death|1|||
23145251|NCT03435497|64280883|FG001|Overall Study|Death|0|||
23145252|NCT03435497|64280882|FG000|Overall Study|Withdrawal by Subject|0|||
23145253|NCT03435497|64280883|FG001|Overall Study|Withdrawal by Subject|4|||
23145254|NCT03435497|64280882|FG000|Overall Study|Wrong survey administered|0|||
23145255|NCT03435497|64280883|FG001|Overall Study|Wrong survey administered|2|||
23145256|NCT02084056|64280884|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
23145257|NCT02084056|64280885|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23145258|NCT02084056|64280886|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23145259|NCT02084056|64280887|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23145260|NCT02084056|64280884|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
23145261|NCT02084056|64280885|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23145262|NCT02084056|64280886|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23145263|NCT02084056|64280887|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23145264|NCT01718353|64280890|FG000|Overall Study|Lost to Follow-up|0|||
23145265|NCT01718353|64280891|FG001|Overall Study|Lost to Follow-up|1|||
23145266|NCT01718353|64280890|FG000|Overall Study|Principal Investigator's Decision|10|||
23145267|NCT01718353|64280891|FG001|Overall Study|Principal Investigator's Decision|4|||
23145268|NCT01718353|64280890|FG000|Overall Study|Randomized but not treated|2|||
23145269|NCT01718353|64280891|FG001|Overall Study|Randomized but not treated|0|||
23145270|NCT02342743|64280892|FG000|Baseline Period|Withdrawal by Subject|3|||
23145271|NCT02342743|64280892|FG000|Baseline Period|Lost to Follow-up|2|||
23145272|NCT02342743|64280892|FG000|Baseline Period|Change in prophylactic medication|3|||
23145273|NCT02342743|64280892|FG000|Baseline Period|Screening failure regarding baseline|7|||
23623581|NCT00488319|66008489|FG000|Overall Study|Withdrawal by Subject|5|||
23145274|NCT02342743|64280892|FG000|Treatment Period|Withdrawal by Subject|2|||
23145275|NCT02342743|64280892|FG000|Treatment Period|Lost to Follow-up|8|||
23145276|NCT02342743|64280892|FG000|Treatment Period|Change in prophylactic medication|1|||
23145277|NCT00871780|64280895|FG000|Overall Study|Enrolled But Not Treated|6|||
23145278|NCT00871780|64280895|FG000|Overall Study|Withdrawal by Subject|9|||
23145279|NCT00871780|64280895|FG000|Overall Study|Adverse Event|6|||
23145280|NCT00871780|64280895|FG000|Overall Study|Voluntary Discontinuation|4|||
23145281|NCT00871780|64280895|FG000|Overall Study|Death|1|||
23145282|NCT00871780|64280895|FG000|Overall Study|Physician Decision|1|||
23145283|NCT02958267|64280898|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
23145284|NCT02958267|64280899|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
23145285|NCT02958267|64280898|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
23145286|NCT02958267|64280899|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
23145287|NCT02958267|64280898|FG000|Follow-up Visits|Additional treatment pursued|2|||
23145288|NCT02958267|64280899|FG001|Follow-up Visits|Additional treatment pursued|1|||
23145289|NCT04754477|64280900|FG000|Overall Study|Withdrawal by Subject|1|||
23145290|NCT02513745|64280902|FG000|Overall Study|Criteria at time of surgery not met.|3|||
23145291|NCT02513745|64280903|FG001|Overall Study|Criteria at time of surgery not met.|3|||
23145292|NCT01270971|64280904|FG000|Overall Study|Withdrawal by Subject|24|||
23145293|NCT01270971|64280905|FG001|Overall Study|Withdrawal by Subject|11|||
23145294|NCT01270971|64280904|FG000|Overall Study|Lost to Follow-up|18|||
23145295|NCT01270971|64280905|FG001|Overall Study|Lost to Follow-up|5|||
23145296|NCT01270971|64280904|FG000|Overall Study|Adverse Event|1|||
23145297|NCT01270971|64280905|FG001|Overall Study|Adverse Event|2|||
23145298|NCT01270971|64280904|FG000|Overall Study|Non compliance|2|||
23145299|NCT01270971|64280905|FG001|Overall Study|Non compliance|2|||
23145300|NCT01270971|64280904|FG000|Overall Study|Non-specific|7|||
23145301|NCT01270971|64280905|FG001|Overall Study|Non-specific|3|||
23145302|NCT01013597|64280906|FG000|Overall Study|Withdrawal by Subject|1|||
23145303|NCT01145755|64280907|FG000|Overall Study|Adverse Event|2|||
23145304|NCT01145755|64280908|FG001|Overall Study|Adverse Event|4|||
23145305|NCT01145755|64280909|FG002|Overall Study|Adverse Event|2|||
23145306|NCT01145755|64280907|FG000|Overall Study|Withdrawal by Subject|2|||
23145307|NCT01145755|64280908|FG001|Overall Study|Withdrawal by Subject|2|||
23145308|NCT01145755|64280909|FG002|Overall Study|Withdrawal by Subject|2|||
23145309|NCT01145755|64280907|FG000|Overall Study|Lost to Follow-up|2|||
23145310|NCT01145755|64280908|FG001|Overall Study|Lost to Follow-up|3|||
23145311|NCT01145755|64280909|FG002|Overall Study|Lost to Follow-up|1|||
23145312|NCT01145755|64280907|FG000|Overall Study|Protocol Violation|0|||
23145313|NCT01145755|64280908|FG001|Overall Study|Protocol Violation|3|||
23556781|NCT02158884|65765996|FG000|Baseline Assessment|Missed performance assessment|3|||
23556782|NCT02158884|65765996|FG000|Baseline Assessment|Missed SMFA|1|||
23556783|NCT02158884|65765996|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
23556784|NCT02158884|65765996|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
23556785|NCT02158884|65765996|FG000|6 Month Assessment|Missed SMFA|20|||
23145314|NCT01145755|64280909|FG002|Overall Study|Protocol Violation|1|||
23434999|NCT01067469|65334225|FG000|Overall Study|Withdrawal by Subject|0|||
23435000|NCT01067469|65334226|FG001|Overall Study|Withdrawal by Subject|1|||
23435001|NCT01067469|65334225|FG000|Overall Study|Disease Progression|0|||
23435002|NCT01067469|65334226|FG001|Overall Study|Disease Progression|1|||
23435003|NCT00950742|65334230|FG000|Overall Study|Other Adverse Event|1|||
23435004|NCT00950742|65334231|FG001|Overall Study|Other Adverse Event|0|||
23435005|NCT00950742|65334230|FG000|Overall Study|Withdrawal by Subject|3|||
23435006|NCT00950742|65334231|FG001|Overall Study|Withdrawal by Subject|0|||
23435007|NCT00950742|65334230|FG000|Overall Study|Progressive Disease|6|||
23435008|NCT00950742|65334231|FG001|Overall Study|Progressive Disease|2|||
23435009|NCT00950742|65334230|FG000|Overall Study|Dose limiting toxicity|6|||
23435010|NCT00950742|65334231|FG001|Overall Study|Dose limiting toxicity|0|||
23435011|NCT04038567|65334232|FG000|Overall Study|Lost to Follow-up|6|||
23435012|NCT04038567|65334233|FG001|Overall Study|Lost to Follow-up|4|||
23435013|NCT04038567|65334234|FG002|Overall Study|Lost to Follow-up|5|||
23435014|NCT04038567|65334235|FG003|Overall Study|Lost to Follow-up|4|||
23435015|NCT04038567|65334236|FG004|Overall Study|Lost to Follow-up|6|||
23435016|NCT04038567|65334237|FG005|Overall Study|Lost to Follow-up|4|||
23435017|NCT04038567|65334238|FG006|Overall Study|Lost to Follow-up|4|||
23435018|NCT04038567|65334239|FG007|Overall Study|Lost to Follow-up|1|||
23435019|NCT04038567|65334232|FG000|Overall Study|Withdrawal by Subject|2|||
23435020|NCT04038567|65334233|FG001|Overall Study|Withdrawal by Subject|1|||
23435021|NCT04038567|65334234|FG002|Overall Study|Withdrawal by Subject|1|||
23435022|NCT04038567|65334235|FG003|Overall Study|Withdrawal by Subject|1|||
23435023|NCT04038567|65334236|FG004|Overall Study|Withdrawal by Subject|4|||
23435024|NCT04038567|65334237|FG005|Overall Study|Withdrawal by Subject|1|||
23435025|NCT04038567|65334238|FG006|Overall Study|Withdrawal by Subject|1|||
23556786|NCT02158884|65765996|FG000|12 Month Assessment|Missed SMFA|17|||
23145315|NCT01145755|64280907|FG000|Overall Study|Study Closure|14|||
23145316|NCT01145755|64280908|FG001|Overall Study|Study Closure|14|||
23435026|NCT04038567|65334239|FG007|Overall Study|Withdrawal by Subject|1|||
23435027|NCT04038567|65334232|FG000|Overall Study|missed survey window|1|||
23435028|NCT04038567|65334233|FG001|Overall Study|missed survey window|2|||
23435029|NCT04038567|65334234|FG002|Overall Study|missed survey window|0|||
23435030|NCT04038567|65334235|FG003|Overall Study|missed survey window|0|||
23435031|NCT04038567|65334236|FG004|Overall Study|missed survey window|1|||
23145317|NCT01145755|64280909|FG002|Overall Study|Study Closure|17|||
23145318|NCT01145755|64280907|FG000|Overall Study|Lack of Efficacy|0|||
23145319|NCT01145755|64280908|FG001|Overall Study|Lack of Efficacy|1|||
23435032|NCT04038567|65334237|FG005|Overall Study|missed survey window|1|||
23435033|NCT04038567|65334238|FG006|Overall Study|missed survey window|2|||
23556787|NCT01281202|65765997|FG000|Overall Study|Adverse Event|2|||
23321984|NCT03334435|64922855|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321985|NCT03334435|64922856|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321986|NCT03334435|64922857|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321987|NCT03334435|64922858|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321988|NCT03334435|64922859|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321989|NCT03334435|64922860|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
23321990|NCT03334435|64922861|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
23321991|NCT03334435|64922862|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
23321992|NCT03334435|64922863|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
23321993|NCT02964247|64922867|FG000|Overall Study|Lost to Follow-up|2|||
23321994|NCT02964247|64922868|FG001|Overall Study|Lost to Follow-up|0|||
23321995|NCT02964247|64922867|FG000|Overall Study|Withdrawal by Subject|1|||
23321996|NCT02964247|64922868|FG001|Overall Study|Withdrawal by Subject|2|||
23321997|NCT02860546|64922869|FG000|Overall Study|Clinical Progression|6|||
23321998|NCT02860546|64922869|FG000|Overall Study|Radiological Progression|12|||
23321999|NCT03889886|64922870|FG000|Overall Study|Other|0|||
23322000|NCT03889886|64922871|FG001|Overall Study|Other|1|||
23322001|NCT03889886|64922872|FG002|Overall Study|Other|0|||
23322002|NCT03889886|64922873|FG003|Overall Study|Other|1|||
23322003|NCT03889886|64922870|FG000|Overall Study|Withdrawal by Subject|0|||
23322004|NCT03889886|64922871|FG001|Overall Study|Withdrawal by Subject|0|||
23322005|NCT03889886|64922872|FG002|Overall Study|Withdrawal by Subject|1|||
23322006|NCT03889886|64922873|FG003|Overall Study|Withdrawal by Subject|0|||
23322007|NCT03889886|64922870|FG000|Overall Study|Adverse Event|0|||
23322008|NCT03889886|64922871|FG001|Overall Study|Adverse Event|0|||
23322009|NCT03889886|64922872|FG002|Overall Study|Adverse Event|0|||
23322010|NCT03889886|64922873|FG003|Overall Study|Adverse Event|6|||
23623582|NCT00488319|66008490|FG001|Overall Study|Withdrawal by Subject|20|||
23145320|NCT01145755|64280909|FG002|Overall Study|Lack of Efficacy|0|||
23145321|NCT01145755|64280907|FG000|Overall Study|Patient could not swollow medication|0|||
23145322|NCT01145755|64280908|FG001|Overall Study|Patient could not swollow medication|0|||
23145323|NCT01145755|64280909|FG002|Overall Study|Patient could not swollow medication|1|||
23145324|NCT01145755|64280907|FG000|Overall Study|Withdrawal by Subject|0|||
23145325|NCT01145755|64280908|FG001|Overall Study|Withdrawal by Subject|0|||
23145326|NCT01145755|64280909|FG002|Overall Study|Withdrawal by Subject|1|||
23145327|NCT01145755|64280907|FG000|Overall Study|Positive urine ethanol|0|||
23145328|NCT01145755|64280908|FG001|Overall Study|Positive urine ethanol|1|||
23145329|NCT01145755|64280909|FG002|Overall Study|Positive urine ethanol|0|||
23145330|NCT02937454|64280912|FG000|Overall Study|Adverse Event|0|||
23145331|NCT02937454|64280913|FG001|Overall Study|Adverse Event|1|||
23145332|NCT02937454|64280912|FG000|Overall Study|Death|98|||
23145333|NCT02937454|64280913|FG001|Overall Study|Death|95|||
23145334|NCT02937454|64280912|FG000|Overall Study|Lost to Follow-up|1|||
23145335|NCT02937454|64280913|FG001|Overall Study|Lost to Follow-up|1|||
23145336|NCT02937454|64280912|FG000|Overall Study|Physician Decision|0|||
23145337|NCT02937454|64280913|FG001|Overall Study|Physician Decision|1|||
23145338|NCT02937454|64280912|FG000|Overall Study|Protocol Violation|6|||
23145339|NCT02937454|64280913|FG001|Overall Study|Protocol Violation|10|||
23145340|NCT02937454|64280912|FG000|Overall Study|Withdrawal by Subject|27|||
23145341|NCT02937454|64280913|FG001|Overall Study|Withdrawal by Subject|15|||
23145342|NCT02937454|64280912|FG000|Overall Study|Other|8|||
23145343|NCT02937454|64280913|FG001|Overall Study|Other|5|||
23145344|NCT02216357|64280914|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
23145345|NCT02216357|64280915|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
23145346|NCT03057977|64280918|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
23145347|NCT03057977|64280919|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
23145348|NCT03057977|64280918|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
23145349|NCT03057977|64280919|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
23145350|NCT03057977|64280918|FG000|Discontinuation From Treatment|Protocol Violation|6|||
23145351|NCT03057977|64280919|FG001|Discontinuation From Treatment|Protocol Violation|5|||
23145352|NCT03057977|64280918|FG000|Discontinuation From Treatment|Not treated|4|||
23145353|NCT03057977|64280919|FG001|Discontinuation From Treatment|Not treated|0|||
23145354|NCT03057977|64280918|FG000|Discontinuation From Treatment|Adverse Event|343|||
23145355|NCT03057977|64280919|FG001|Discontinuation From Treatment|Adverse Event|337|||
23145356|NCT03057977|64280918|FG000|Discontinuation From Treatment|Reason Unknown|0|||
23322011|NCT02163057|64922874|FG000|Overall Study|Participant Refusal to Continue|2|||
23322012|NCT02163057|64922875|FG001|Overall Study|Participant Refusal to Continue|2|||
23322013|NCT02163057|64922874|FG000|Overall Study|Participant Significant Noncompliance|0|||
23435034|NCT04038567|65334239|FG007|Overall Study|missed survey window|2|||
23145357|NCT03057977|64280919|FG001|Discontinuation From Treatment|Reason Unknown|1|||
23145358|NCT03057977|64280918|FG000|Discontinuation From Treatment|Personal Reasons|1|||
23145359|NCT03057977|64280919|FG001|Discontinuation From Treatment|Personal Reasons|1|||
23145360|NCT03057977|64280918|FG000|Discontinuation From Treatment|Unblinded medication|1|||
23145361|NCT03057977|64280919|FG001|Discontinuation From Treatment|Unblinded medication|0|||
23435035|NCT04038567|65334232|FG000|Overall Study|technical issues|0|||
23435036|NCT04038567|65334233|FG001|Overall Study|technical issues|0|||
23435037|NCT04038567|65334234|FG002|Overall Study|technical issues|0|||
23435038|NCT04038567|65334235|FG003|Overall Study|technical issues|0|||
23435039|NCT04038567|65334236|FG004|Overall Study|technical issues|0|||
23435040|NCT04038567|65334237|FG005|Overall Study|technical issues|0|||
23435041|NCT04038567|65334238|FG006|Overall Study|technical issues|1|||
23435042|NCT04038567|65334239|FG007|Overall Study|technical issues|0|||
23435043|NCT04038567|65334232|FG000|Overall Study|Medical issues (i.e., illness)|0|||
23435044|NCT04038567|65334233|FG001|Overall Study|Medical issues (i.e., illness)|1|||
23435045|NCT04038567|65334234|FG002|Overall Study|Medical issues (i.e., illness)|2|||
23435046|NCT04038567|65334235|FG003|Overall Study|Medical issues (i.e., illness)|1|||
23435047|NCT04038567|65334236|FG004|Overall Study|Medical issues (i.e., illness)|1|||
23435048|NCT04038567|65334237|FG005|Overall Study|Medical issues (i.e., illness)|1|||
23435049|NCT04038567|65334238|FG006|Overall Study|Medical issues (i.e., illness)|0|||
23435050|NCT04038567|65334239|FG007|Overall Study|Medical issues (i.e., illness)|0|||
23435051|NCT04038567|65334232|FG000|Overall Study|Death|0|||
23435052|NCT04038567|65334233|FG001|Overall Study|Death|0|||
23435053|NCT04038567|65334234|FG002|Overall Study|Death|0|||
23435054|NCT04038567|65334235|FG003|Overall Study|Death|1|||
23435055|NCT04038567|65334236|FG004|Overall Study|Death|1|||
23435056|NCT04038567|65334237|FG005|Overall Study|Death|0|||
23435057|NCT04038567|65334238|FG006|Overall Study|Death|0|||
23435058|NCT04038567|65334239|FG007|Overall Study|Death|1|||
23435059|NCT01555125|65334240|FG000|Induction Period|Lost to Follow-up|0|||
23435060|NCT01555125|65334241|FG001|Induction Period|Lost to Follow-up|2|||
23435061|NCT01555125|65334242|FG002|Induction Period|Lost to Follow-up|0|||
23435062|NCT01555125|65334243|FG003|Induction Period|Lost to Follow-up|0|||
23435063|NCT01555125|65334244|FG004|Induction Period|Lost to Follow-up|0|||
23435064|NCT01555125|65334240|FG000|Induction Period|Adverse Event|0|||
23435065|NCT01555125|65334241|FG001|Induction Period|Adverse Event|1|||
23435066|NCT01555125|65334242|FG002|Induction Period|Adverse Event|0|||
23435067|NCT01555125|65334243|FG003|Induction Period|Adverse Event|0|||
23435068|NCT01555125|65334244|FG004|Induction Period|Adverse Event|1|||
23435069|NCT01555125|65334240|FG000|Induction Period|Subject / guardian decision|0|||
23435070|NCT01555125|65334241|FG001|Induction Period|Subject / guardian decision|0|||
23435071|NCT01555125|65334242|FG002|Induction Period|Subject / guardian decision|0|||
23435072|NCT01555125|65334243|FG003|Induction Period|Subject / guardian decision|0|||
23435073|NCT01555125|65334244|FG004|Induction Period|Subject / guardian decision|2|||
23435074|NCT01555125|65334240|FG000|Induction Period|Death|1|||
23435075|NCT01555125|65334241|FG001|Induction Period|Death|0|||
23435076|NCT01555125|65334242|FG002|Induction Period|Death|0|||
23435077|NCT01555125|65334243|FG003|Induction Period|Death|0|||
23435078|NCT01555125|65334244|FG004|Induction Period|Death|0|||
23435079|NCT01555125|65334240|FG000|Maintenance Period|Adverse Event|1|||
23435080|NCT01555125|65334241|FG001|Maintenance Period|Adverse Event|1|||
23435081|NCT01555125|65334242|FG002|Maintenance Period|Adverse Event|0|||
23435082|NCT01555125|65334243|FG003|Maintenance Period|Adverse Event|0|||
23435083|NCT01555125|65334244|FG004|Maintenance Period|Adverse Event|0|||
23435084|NCT01555125|65334240|FG000|Maintenance Period|Subject / guardian decision|1|||
23435085|NCT01555125|65334241|FG001|Maintenance Period|Subject / guardian decision|2|||
23435086|NCT01555125|65334242|FG002|Maintenance Period|Subject / guardian decision|0|||
23435087|NCT01555125|65334243|FG003|Maintenance Period|Subject / guardian decision|0|||
23435088|NCT01555125|65334244|FG004|Maintenance Period|Subject / guardian decision|0|||
23435089|NCT01555125|65334240|FG000|Maintenance Period|Lost to Follow-up|2|||
23435090|NCT01555125|65334241|FG001|Maintenance Period|Lost to Follow-up|0|||
23435091|NCT01555125|65334242|FG002|Maintenance Period|Lost to Follow-up|0|||
23435092|NCT01555125|65334243|FG003|Maintenance Period|Lost to Follow-up|1|||
23435093|NCT01555125|65334244|FG004|Maintenance Period|Lost to Follow-up|0|||
23435094|NCT01555125|65334240|FG000|Maintenance Period|Lack of Efficacy|6|||
23435095|NCT01555125|65334241|FG001|Maintenance Period|Lack of Efficacy|1|||
23435096|NCT01555125|65334242|FG002|Maintenance Period|Lack of Efficacy|3|||
23435097|NCT01555125|65334243|FG003|Maintenance Period|Lack of Efficacy|0|||
23435098|NCT01555125|65334244|FG004|Maintenance Period|Lack of Efficacy|0|||
23435099|NCT01555125|65334240|FG000|Maintenance Period|Physician Decision|0|||
23435100|NCT01555125|65334241|FG001|Maintenance Period|Physician Decision|0|||
23435101|NCT01555125|65334242|FG002|Maintenance Period|Physician Decision|1|||
23435102|NCT01555125|65334243|FG003|Maintenance Period|Physician Decision|0|||
23435103|NCT01555125|65334244|FG004|Maintenance Period|Physician Decision|0|||
23435104|NCT01555125|65334240|FG000|Maintenance Period|Death|0|||
23435105|NCT01555125|65334241|FG001|Maintenance Period|Death|0|||
23435106|NCT01555125|65334242|FG002|Maintenance Period|Death|0|||
23435107|NCT01555125|65334243|FG003|Maintenance Period|Death|1|||
23322014|NCT02163057|64922875|FG001|Overall Study|Participant Significant Noncompliance|1|||
23435108|NCT01555125|65334244|FG004|Maintenance Period|Death|0|||
23435109|NCT01555125|65334240|FG000|Extension|Adverse Event|1|||
23435110|NCT01555125|65334241|FG001|Extension|Adverse Event|2|||
23435111|NCT01555125|65334242|FG002|Extension|Adverse Event|1|||
23435112|NCT01555125|65334243|FG003|Extension|Adverse Event|1|||
23435113|NCT01555125|65334244|FG004|Extension|Adverse Event|0|||
23435114|NCT01555125|65334240|FG000|Extension|Protocol deviation|1|||
23435115|NCT01555125|65334241|FG001|Extension|Protocol deviation|0|||
23435116|NCT01555125|65334242|FG002|Extension|Protocol deviation|0|||
23435117|NCT01555125|65334243|FG003|Extension|Protocol deviation|0|||
23435118|NCT01555125|65334244|FG004|Extension|Protocol deviation|0|||
23435119|NCT01555125|65334240|FG000|Extension|Lack of Efficacy|7|||
23435120|NCT01555125|65334241|FG001|Extension|Lack of Efficacy|6|||
23435121|NCT01555125|65334242|FG002|Extension|Lack of Efficacy|3|||
23435122|NCT01555125|65334243|FG003|Extension|Lack of Efficacy|0|||
23145362|NCT03057977|64280918|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
23145363|NCT03057977|64280919|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
23145364|NCT03057977|64280918|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
23145365|NCT03057977|64280919|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
23145366|NCT03057977|64280918|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
23145367|NCT03057977|64280919|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
23435123|NCT01555125|65334244|FG004|Extension|Lack of Efficacy|0|||
23435124|NCT01555125|65334240|FG000|Extension|Lost to Follow-up|2|||
23435125|NCT01555125|65334241|FG001|Extension|Lost to Follow-up|1|||
23435126|NCT01555125|65334242|FG002|Extension|Lost to Follow-up|2|||
23435127|NCT01555125|65334243|FG003|Extension|Lost to Follow-up|0|||
23435128|NCT01555125|65334244|FG004|Extension|Lost to Follow-up|0|||
23435129|NCT01555125|65334240|FG000|Extension|Study terminated by sponsor|32|||
23435130|NCT01555125|65334241|FG001|Extension|Study terminated by sponsor|33|||
23435131|NCT01555125|65334242|FG002|Extension|Study terminated by sponsor|16|||
23435132|NCT01555125|65334243|FG003|Extension|Study terminated by sponsor|20|||
23435133|NCT01555125|65334244|FG004|Extension|Study terminated by sponsor|0|||
23435134|NCT01555125|65334240|FG000|Extension|Subject/guardian decision|1|||
23435135|NCT01555125|65334241|FG001|Extension|Subject/guardian decision|9|||
23435136|NCT01555125|65334242|FG002|Extension|Subject/guardian decision|1|||
23435137|NCT01555125|65334243|FG003|Extension|Subject/guardian decision|0|||
23435138|NCT01555125|65334244|FG004|Extension|Subject/guardian decision|0|||
23435139|NCT01555125|65334240|FG000|Extension|Technical Problems|1|||
23435140|NCT01555125|65334241|FG001|Extension|Technical Problems|0|||
23435141|NCT01555125|65334242|FG002|Extension|Technical Problems|0|||
23435142|NCT01555125|65334243|FG003|Extension|Technical Problems|1|||
23435143|NCT01555125|65334244|FG004|Extension|Technical Problems|0|||
23435144|NCT01555125|65334240|FG000|Follow-Up Period|Lost to Follow-up|1|||
23435145|NCT01555125|65334241|FG001|Follow-Up Period|Lost to Follow-up|0|||
23435146|NCT01555125|65334242|FG002|Follow-Up Period|Lost to Follow-up|0|||
23435147|NCT01555125|65334243|FG003|Follow-Up Period|Lost to Follow-up|0|||
23435148|NCT01555125|65334244|FG004|Follow-Up Period|Lost to Follow-up|0|||
23435149|NCT01555125|65334240|FG000|Follow-Up Period|Subject / guardian decision|3|||
23435150|NCT01555125|65334241|FG001|Follow-Up Period|Subject / guardian decision|1|||
23435151|NCT01555125|65334242|FG002|Follow-Up Period|Subject / guardian decision|1|||
23435152|NCT01555125|65334243|FG003|Follow-Up Period|Subject / guardian decision|1|||
23435153|NCT01555125|65334244|FG004|Follow-Up Period|Subject / guardian decision|0|||
23435154|NCT01457846|65334245|FG000|Overall Study|Death before treatment|1|||
23435155|NCT01457846|65334246|FG001|Overall Study|Death before treatment|2|||
23435156|NCT01457846|65334245|FG000|Overall Study|Did not receive treatment|0|||
23435157|NCT01457846|65334246|FG001|Overall Study|Did not receive treatment|1|||
23435158|NCT01457846|65334245|FG000|Overall Study|Death|27|||
23435159|NCT01457846|65334246|FG001|Overall Study|Death|16|||
23435160|NCT01457846|65334245|FG000|Overall Study|Unclassified reason for not completed|11|||
23435161|NCT01457846|65334246|FG001|Overall Study|Unclassified reason for not completed|10|||
23435162|NCT01457846|65334245|FG000|Overall Study|Withdrawal by Subject|1|||
23435163|NCT01457846|65334246|FG001|Overall Study|Withdrawal by Subject|1|||
23435164|NCT01457846|65334245|FG000|Overall Study|Lost to Follow-up|1|||
23435165|NCT01457846|65334246|FG001|Overall Study|Lost to Follow-up|0|||
23322015|NCT02163057|64922874|FG000|Overall Study|Progression of Disease|1|||
23435166|NCT03629912|65334247|FG000|Overall Study|Lost to Follow-up|19|||
23435167|NCT03629912|65334248|FG001|Overall Study|Lost to Follow-up|7|||
23435168|NCT03629912|65334249|FG002|Overall Study|Lost to Follow-up|5|||
23435169|NCT03629912|65334250|FG003|Overall Study|Lost to Follow-up|1|||
23435170|NCT03629912|65334247|FG000|Overall Study|Withdrawal by Subject|6|||
23435171|NCT03629912|65334248|FG001|Overall Study|Withdrawal by Subject|0|||
23435172|NCT03629912|65334249|FG002|Overall Study|Withdrawal by Subject|1|||
23435173|NCT03629912|65334250|FG003|Overall Study|Withdrawal by Subject|2|||
23435174|NCT03629912|65334247|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
23435175|NCT03629912|65334248|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
23435176|NCT03629912|65334249|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
23435177|NCT03629912|65334250|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
23435178|NCT03629912|65334247|FG000|Overall Study|Death|1|||
23435179|NCT03629912|65334248|FG001|Overall Study|Death|0|||
23435180|NCT03629912|65334249|FG002|Overall Study|Death|0|||
23435181|NCT03629912|65334250|FG003|Overall Study|Death|0|||
23435182|NCT02895945|65334252|FG000|Overall Study|Physician Decision|2|||
23435183|NCT02895945|65334253|FG001|Overall Study|Physician Decision|1|||
23435184|NCT02540291|65336991|FG000|Overall Study|Death|7|||
23435185|NCT02540291|65336992|FG001|Overall Study|Death|7|||
23435186|NCT02540291|65336993|FG002|Overall Study|Death|5|||
23435187|NCT02540291|65336994|FG003|Overall Study|Death|7|||
23435188|NCT02540291|65336991|FG000|Overall Study|Lost to Follow-up|0|||
23435189|NCT02540291|65336992|FG001|Overall Study|Lost to Follow-up|0|||
23435190|NCT02540291|65336993|FG002|Overall Study|Lost to Follow-up|1|||
23435191|NCT02540291|65336994|FG003|Overall Study|Lost to Follow-up|0|||
23435192|NCT02540291|65336991|FG000|Overall Study|Withdrawal Of Consent|0|||
23435193|NCT02540291|65336992|FG001|Overall Study|Withdrawal Of Consent|1|||
23435194|NCT02540291|65336993|FG002|Overall Study|Withdrawal Of Consent|0|||
23435195|NCT02540291|65336994|FG003|Overall Study|Withdrawal Of Consent|0|||
23435196|NCT02540291|65336991|FG000|Overall Study|Study Terminated By Sponsor|1|||
23435197|NCT02540291|65336992|FG001|Overall Study|Study Terminated By Sponsor|0|||
23435198|NCT02540291|65336993|FG002|Overall Study|Study Terminated By Sponsor|0|||
23435199|NCT02540291|65336994|FG003|Overall Study|Study Terminated By Sponsor|0|||
23435200|NCT02540291|65336991|FG000|Overall Study|Other|0|||
23435201|NCT02540291|65336992|FG001|Overall Study|Other|0|||
23435202|NCT02540291|65336993|FG002|Overall Study|Other|1|||
23435203|NCT02540291|65336994|FG003|Overall Study|Other|0|||
23435204|NCT01147848|65336995|FG000|Run-in Period|Screen Failure|623|||
23145368|NCT03057977|64280918|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
23145369|NCT03057977|64280919|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
23435205|NCT01147848|65336996|FG001|Run-in Period|Screen Failure|0|||
23435206|NCT01147848|65336997|FG002|Run-in Period|Screen Failure|0|||
23435207|NCT01147848|65336995|FG000|Run-in Period|Run-in Failure|135|||
23435208|NCT01147848|65336996|FG001|Run-in Period|Run-in Failure|0|||
23435209|NCT01147848|65336997|FG002|Run-in Period|Run-in Failure|0|||
23435210|NCT01147848|65336995|FG000|Randomized Phase|Adverse Event|0|||
23435211|NCT01147848|65336996|FG001|Randomized Phase|Adverse Event|6|||
23435212|NCT01147848|65336997|FG002|Randomized Phase|Adverse Event|8|||
23435213|NCT01147848|65336995|FG000|Randomized Phase|Lack of Efficacy|0|||
23435214|NCT01147848|65336996|FG001|Randomized Phase|Lack of Efficacy|20|||
23435215|NCT01147848|65336997|FG002|Randomized Phase|Lack of Efficacy|11|||
23435216|NCT01147848|65336995|FG000|Randomized Phase|Protocol Violation|0|||
23435217|NCT01147848|65336996|FG001|Randomized Phase|Protocol Violation|7|||
23435218|NCT01147848|65336997|FG002|Randomized Phase|Protocol Violation|10|||
23435219|NCT01147848|65336995|FG000|Randomized Phase|Lost to Follow-up|0|||
23145370|NCT03057977|64280918|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
23145371|NCT03057977|64280919|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
23145372|NCT03057977|64280918|FG000|Discontinuation From Treatment|Not attending study visit|3|||
23145373|NCT03057977|64280919|FG001|Discontinuation From Treatment|Not attending study visit|10|||
23145374|NCT03057977|64280918|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
23145375|NCT03057977|64280919|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
23145376|NCT03057977|64280918|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
23145377|NCT03057977|64280919|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
23145378|NCT03057977|64280918|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
23145379|NCT03057977|64280919|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
23145380|NCT03057977|64280918|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
23145381|NCT03057977|64280919|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
23145382|NCT03057977|64280918|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
23145383|NCT03057977|64280919|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
23145384|NCT00063154|64280923|FG000|Overall Study|Disease progression|27|||
23145385|NCT00063154|64280923|FG000|Overall Study|Adverse Event|2|||
23145386|NCT00063154|64280923|FG000|Overall Study|Physician Decision|10|||
23145387|NCT00063154|64280923|FG000|Overall Study|Death|3|||
23145388|NCT00063154|64280923|FG000|Overall Study|Reason unspecified|1|||
23145389|NCT00063154|64280923|FG000|Overall Study|Did not receive treatment|8|||
23145390|NCT00701779|64280930|FG000|Overall Study|Adverse Event|6|||
23145391|NCT00701779|64280930|FG000|Overall Study|Lost to Follow-up|1|||
23145392|NCT00701779|64280930|FG000|Overall Study|Withdrawal by Subject|2|||
23145393|NCT04058366|64280931|FG000|Overall Study|Adverse Event|14|||
23145394|NCT04058366|64280931|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
23435220|NCT01147848|65336996|FG001|Randomized Phase|Lost to Follow-up|5|||
23435221|NCT01147848|65336997|FG002|Randomized Phase|Lost to Follow-up|7|||
23435222|NCT01147848|65336995|FG000|Randomized Phase|Physician Decision|0|||
23145395|NCT04058366|64280931|FG000|Overall Study|Commercial drug is available for participants|6|||
23145396|NCT04058366|64280931|FG000|Overall Study|Death|1|||
23435223|NCT01147848|65336996|FG001|Randomized Phase|Physician Decision|0|||
23435224|NCT01147848|65336997|FG002|Randomized Phase|Physician Decision|1|||
23435225|NCT01147848|65336995|FG000|Randomized Phase|Withdrawal by Subject|0|||
23145397|NCT04058366|64280931|FG000|Overall Study|Other non-compliance|2|||
23145398|NCT04058366|64280931|FG000|Overall Study|Other|6|||
23145399|NCT02092220|64280932|FG000|Period 1|Unrelated Illness|0|||
23145400|NCT02092220|64280933|FG001|Period 1|Unrelated Illness|2|||
23145401|NCT02092220|64280932|FG000|Period 2|Severe Hypoglycaemia|1|||
23145402|NCT02092220|64280933|FG001|Period 2|Severe Hypoglycaemia|0|||
23145403|NCT02092220|64280932|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
23145404|NCT02092220|64280933|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
23145405|NCT02076178|64280936|FG000|Oral Phase|Adverse Event|0|||
23145406|NCT02076178|64280937|FG001|Oral Phase|Adverse Event|7|||
23145407|NCT02076178|64280936|FG000|Oral Phase|Withdrawal by Subject|0|||
23145408|NCT02076178|64280937|FG001|Oral Phase|Withdrawal by Subject|4|||
23145409|NCT02076178|64280936|FG000|Oral Phase|Physician Decision|0|||
23145410|NCT02076178|64280937|FG001|Oral Phase|Physician Decision|1|||
23145411|NCT02076178|64280936|FG000|Injection Phase|Protocol defined stopping criteria|1|||
23145412|NCT02076178|64280937|FG001|Injection Phase|Protocol defined stopping criteria|0|||
23145413|NCT02076178|64280936|FG000|Injection Phase|Withdrawal by Subject|0|||
23145414|NCT02076178|64280937|FG001|Injection Phase|Withdrawal by Subject|3|||
23145415|NCT02076178|64280936|FG000|Injection Phase|Physician Decision|0|||
23145416|NCT02076178|64280937|FG001|Injection Phase|Physician Decision|3|||
23145417|NCT02076178|64280936|FG000|Injection Phase|Lost to Follow-up|0|||
23145418|NCT02076178|64280937|FG001|Injection Phase|Lost to Follow-up|1|||
23145419|NCT03718533|64280943|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
23435226|NCT01147848|65336996|FG001|Randomized Phase|Withdrawal by Subject|7|||
23435227|NCT01147848|65336997|FG002|Randomized Phase|Withdrawal by Subject|9|||
23435228|NCT02479139|65336998|FG000|Overall Study|Lost to Follow-up|2|||
23435229|NCT02479139|65336999|FG001|Overall Study|Lost to Follow-up|4|||
23435230|NCT02479139|65337000|FG002|Overall Study|Lost to Follow-up|4|||
23435231|NCT02479139|65337001|FG003|Overall Study|Lost to Follow-up|2|||
23435232|NCT02479139|65337002|FG004|Overall Study|Lost to Follow-up|3|||
23435233|NCT02479139|65337003|FG005|Overall Study|Lost to Follow-up|5|||
23145420|NCT03718533|64280943|FG000|Overall Study|Protocol deviation|1|||
23435234|NCT02479139|65336998|FG000|Overall Study|Withdrew Consent|5|||
23435235|NCT02479139|65336999|FG001|Overall Study|Withdrew Consent|6|||
23435236|NCT02479139|65337000|FG002|Overall Study|Withdrew Consent|1|||
23435237|NCT02479139|65337001|FG003|Overall Study|Withdrew Consent|4|||
23435238|NCT02479139|65337002|FG004|Overall Study|Withdrew Consent|1|||
23435239|NCT02479139|65337003|FG005|Overall Study|Withdrew Consent|1|||
23435240|NCT02479139|65336998|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435241|NCT02479139|65336999|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435242|NCT02479139|65337000|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
23435243|NCT02479139|65337001|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435244|NCT02479139|65337002|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435245|NCT02479139|65337003|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
23435246|NCT02479139|65336998|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23435247|NCT02479139|65336999|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23435248|NCT02479139|65337000|FG002|Overall Study|Other Miscellaneous Reasons|1|||
23435249|NCT02479139|65337001|FG003|Overall Study|Other Miscellaneous Reasons|1|||
23435250|NCT02479139|65337002|FG004|Overall Study|Other Miscellaneous Reasons|1|||
23435251|NCT02479139|65337003|FG005|Overall Study|Other Miscellaneous Reasons|0|||
23435252|NCT03995355|65337004|FG000|Overall Study|Adverse Event|1|||
23435253|NCT03995355|65337005|FG001|Overall Study|Adverse Event|0|||
23435254|NCT03995355|65337004|FG000|Overall Study|Withdrawal by Subject|1|||
23435255|NCT03995355|65337005|FG001|Overall Study|Withdrawal by Subject|0|||
23145421|NCT03718533|64280943|FG000|Overall Study|Disease progression|1|||
23145422|NCT03718533|64280943|FG000|Overall Study|Relapse|1|||
23145423|NCT03718533|64280943|FG000|Overall Study|Physician Decision|2|||
23145424|NCT03718533|64280943|FG000|Overall Study|Physician Decision and Adverse Event|1|||
23145425|NCT00866723|64280945|FG000|Overall Study|Withdrawal by Subject|1|||
23145426|NCT00866723|64280945|FG000|Overall Study|Disease Progression|4|||
23145427|NCT00252733|64280946|FG000|Overall Study|Withdrawal by Subject|73|||
23145428|NCT00252733|64280947|FG001|Overall Study|Withdrawal by Subject|67|||
23145429|NCT00252733|64280946|FG000|Overall Study|Death|7|||
23145430|NCT00252733|64280947|FG001|Overall Study|Death|5|||
23145431|NCT00252733|64280946|FG000|Overall Study|Lost to Follow-up|12|||
23145432|NCT00252733|64280947|FG001|Overall Study|Lost to Follow-up|6|||
23435256|NCT03995355|65337004|FG000|Overall Study|Scheduling Issues|0|||
23556788|NCT01281202|65765998|FG001|Overall Study|Adverse Event|0|||
23145433|NCT00252733|64280946|FG000|Overall Study|Multiple Reasons|14|||
23145434|NCT00252733|64280947|FG001|Overall Study|Multiple Reasons|14|||
23145435|NCT02966301|64280951|FG000|Overall Study|Death|2|||
23145436|NCT02966301|64280951|FG000|Overall Study|Withdrawal by Subject|1|||
23145437|NCT03170154|64280952|FG000|Overall Study|Lost to Follow-up|4|||
23145438|NCT03170154|64280952|FG000|Overall Study|Death|2|||
23145439|NCT03170154|64280952|FG000|Overall Study|Withdrawal by Subject|2|||
23435257|NCT03995355|65337005|FG001|Overall Study|Scheduling Issues|1|||
23435258|NCT01174173|65337006|FG000|Overall Study|drug-drug interaction|1|||
23435259|NCT01918332|65337009|FG000|Overall Study|Adverse Event|0|||
23145440|NCT03240874|64280953|FG000|Overall Study|Lost to Follow-up|0|||
23145441|NCT03240874|64280954|FG001|Overall Study|Lost to Follow-up|2|||
23145442|NCT03240874|64280955|FG002|Overall Study|Lost to Follow-up|4|||
23145443|NCT03240874|64280956|FG003|Overall Study|Lost to Follow-up|1|||
23145444|NCT00985946|64280958|FG000|Overall Study|Lost to Follow-up|6|||
23145445|NCT00985946|64280958|FG000|Overall Study|Withdrawal by Subject|1|||
23145446|NCT00601419|64280960|FG000|Overall Study|Lost to Follow-up|3|||
23145447|NCT00601419|64280960|FG000|Overall Study|Missed Visits|1|||
23145448|NCT03628898|64280961|FG000|Overall Study|Device deficiency|1|||
23145449|NCT00960531|64280962|FG000|Overall Study|Lack of Efficacy|1|||
23145450|NCT00960531|64280963|FG001|Overall Study|Lack of Efficacy|0|||
23145451|NCT00960531|64280964|FG002|Overall Study|Lack of Efficacy|0|||
23145452|NCT00960531|64280965|FG003|Overall Study|Lack of Efficacy|0|||
23145453|NCT00960531|64280966|FG004|Overall Study|Lack of Efficacy|0|||
23145454|NCT00960531|64280967|FG005|Overall Study|Lack of Efficacy|0|||
23145455|NCT00960531|64280968|FG006|Overall Study|Lack of Efficacy|0|||
23145456|NCT00960531|64280969|FG007|Overall Study|Lack of Efficacy|0|||
23145457|NCT00960531|64280970|FG008|Overall Study|Lack of Efficacy|0|||
23145458|NCT00960531|64280971|FG009|Overall Study|Lack of Efficacy|0|||
23145459|NCT00960531|64280962|FG000|Overall Study|Withdrawal by Subject|1|||
23145460|NCT00960531|64280963|FG001|Overall Study|Withdrawal by Subject|0|||
23145461|NCT00960531|64280964|FG002|Overall Study|Withdrawal by Subject|5|||
23145462|NCT00960531|64280965|FG003|Overall Study|Withdrawal by Subject|2|||
23145463|NCT00960531|64280966|FG004|Overall Study|Withdrawal by Subject|0|||
23145464|NCT00960531|64280967|FG005|Overall Study|Withdrawal by Subject|0|||
23145465|NCT00960531|64280968|FG006|Overall Study|Withdrawal by Subject|2|||
23145466|NCT00960531|64280969|FG007|Overall Study|Withdrawal by Subject|0|||
23145467|NCT00960531|64280970|FG008|Overall Study|Withdrawal by Subject|1|||
23145468|NCT00960531|64280971|FG009|Overall Study|Withdrawal by Subject|0|||
23145469|NCT00960531|64280962|FG000|Overall Study|Caregiver Request|2|||
23145470|NCT00960531|64280963|FG001|Overall Study|Caregiver Request|0|||
23145471|NCT00960531|64280964|FG002|Overall Study|Caregiver Request|6|||
23322016|NCT02163057|64922875|FG001|Overall Study|Progression of Disease|2|||
23435260|NCT01918332|65337010|FG001|Overall Study|Adverse Event|0|||
23435261|NCT01918332|65337011|FG002|Overall Study|Adverse Event|0|||
23435262|NCT01918332|65337012|FG003|Overall Study|Adverse Event|1|||
23435263|NCT01918332|65337009|FG000|Overall Study|Withdrawal by Subject|2|||
23435264|NCT01918332|65337010|FG001|Overall Study|Withdrawal by Subject|3|||
23435265|NCT01918332|65337011|FG002|Overall Study|Withdrawal by Subject|2|||
23435266|NCT01918332|65337012|FG003|Overall Study|Withdrawal by Subject|3|||
23435267|NCT01918332|65337009|FG000|Overall Study|Protocol Violation|6|||
23435268|NCT01918332|65337010|FG001|Overall Study|Protocol Violation|2|||
23435269|NCT01918332|65337011|FG002|Overall Study|Protocol Violation|6|||
23435270|NCT01918332|65337012|FG003|Overall Study|Protocol Violation|3|||
23435271|NCT01918332|65337009|FG000|Overall Study|lipid result by central lab did not meet|0|||
23435272|NCT01918332|65337010|FG001|Overall Study|lipid result by central lab did not meet|0|||
23435273|NCT01918332|65337011|FG002|Overall Study|lipid result by central lab did not meet|1|||
23435274|NCT01918332|65337012|FG003|Overall Study|lipid result by central lab did not meet|0|||
23435275|NCT00498355|65337013|FG000|Overall Study|Lost to Follow-up|1|||
23435276|NCT00991406|65337014|FG000|Overall Study|One participant did not respond to FES.|1|||
23435277|NCT00718770|65337015|FG000|Overall Study|Adverse Event|1|||
23435278|NCT00718770|65337015|FG000|Overall Study|Lack of Efficacy|1|||
23435279|NCT00718770|65337015|FG000|Overall Study|Lack of Efficacy|1|||
23435280|NCT00718770|65337015|FG000|Overall Study|Adverse Event|1|||
23435281|NCT00718770|65337015|FG000|Overall Study|Lack of Efficacy|1|||
23435282|NCT00718770|65337015|FG000|Overall Study|Adverse Event|1|||
23435283|NCT00718770|65337015|FG000|Overall Study|Lack of Efficacy|1|||
23435284|NCT00718770|65337015|FG000|Overall Study|Adverse Event|1|||
23435285|NCT03615066|65337016|FG000|Main Study|Withdrew Consent|0|||
23435286|NCT03615066|65337017|FG001|Main Study|Withdrew Consent|1|||
23435287|NCT03615066|65337018|FG002|Main Study|Withdrew Consent|1|||
23435288|NCT03615066|65337016|FG000|Main Study|Lost to Follow-up|0|||
23435289|NCT03615066|65337017|FG001|Main Study|Lost to Follow-up|0|||
23556789|NCT01281202|65765997|FG000|Overall Study|Withdrawal by Subject|2|||
23556790|NCT01281202|65765998|FG001|Overall Study|Withdrawal by Subject|2|||
23322017|NCT00711243|64922878|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
23435290|NCT03615066|65337018|FG002|Main Study|Lost to Follow-up|1|||
23145472|NCT00960531|64280965|FG003|Overall Study|Caregiver Request|5|||
23145473|NCT00960531|64280966|FG004|Overall Study|Caregiver Request|0|||
23145474|NCT00960531|64280967|FG005|Overall Study|Caregiver Request|2|||
23145475|NCT00960531|64280968|FG006|Overall Study|Caregiver Request|3|||
23145476|NCT00960531|64280969|FG007|Overall Study|Caregiver Request|1|||
23145477|NCT00960531|64280970|FG008|Overall Study|Caregiver Request|3|||
23145478|NCT00960531|64280971|FG009|Overall Study|Caregiver Request|0|||
23435291|NCT03615066|65337016|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
23435292|NCT03615066|65337017|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
23435293|NCT03615066|65337018|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
23556791|NCT01281202|65765997|FG000|Overall Study|Protocol Violation|11|||
23435294|NCT03615066|65337016|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
23435295|NCT03615066|65337017|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
23435296|NCT03615066|65337018|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
23435297|NCT03615066|65337016|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
23435298|NCT03615066|65337017|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
23435299|NCT03615066|65337018|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
23435300|NCT00095173|65337027|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
23435301|NCT00095173|65337028|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435302|NCT00095173|65337029|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435303|NCT00095173|65337030|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435304|NCT00095173|65337031|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435305|NCT00095173|65337032|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
23435306|NCT00095173|65337027|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
23435307|NCT00095173|65337028|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435308|NCT00095173|65337029|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435309|NCT00095173|65337030|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435310|NCT00095173|65337031|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435311|NCT00095173|65337032|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
23435312|NCT00095173|65337027|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
23435313|NCT00095173|65337028|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435314|NCT00095173|65337029|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435315|NCT00095173|65337030|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435316|NCT00095173|65337031|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435317|NCT00095173|65337032|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
23435318|NCT00095173|65337027|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
23435319|NCT00095173|65337028|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
23435320|NCT00095173|65337029|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
23435321|NCT00095173|65337030|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
23435322|NCT00095173|65337031|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
23435323|NCT00095173|65337032|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
23435324|NCT00095173|65337027|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
23435325|NCT00095173|65337028|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
23435326|NCT00095173|65337029|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
23435327|NCT00095173|65337030|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
23435328|NCT00095173|65337031|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
23435329|NCT00095173|65337032|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
23435330|NCT00095173|65337027|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435331|NCT00095173|65337028|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
23435332|NCT00095173|65337029|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435333|NCT00095173|65337030|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435334|NCT00095173|65337031|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435335|NCT00095173|65337032|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
23435336|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Death|0|||
23435337|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Death|0|||
23435338|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Death|0|||
23435339|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Death|0|||
23435340|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Death|0|||
23435341|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Death|1|||
23435342|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
23435343|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
23435344|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
23435345|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
23435346|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
23435347|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
23435348|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
23435349|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
23435350|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
23435351|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
23435352|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
23435353|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
23435354|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
23435355|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
23435356|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
23435357|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
23435358|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
23435359|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
23435360|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
23435361|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
23435362|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
23435363|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
23435364|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
23435365|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
23435366|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
23435367|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
23435368|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
23435369|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
23435370|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
23435371|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
23435372|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
23435373|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
23435374|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
23435375|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
23435376|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
23435377|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
23435378|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
23435379|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
23435380|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
23435381|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
23435382|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
23435383|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
23435384|NCT00095173|65337027|FG000|Open-Label Extension Phase (Period C)|Other|0|||
23435385|NCT00095173|65337028|FG001|Open-Label Extension Phase (Period C)|Other|0|||
23435386|NCT00095173|65337029|FG002|Open-Label Extension Phase (Period C)|Other|0|||
23435387|NCT00095173|65337030|FG003|Open-Label Extension Phase (Period C)|Other|4|||
23435388|NCT00095173|65337031|FG004|Open-Label Extension Phase (Period C)|Other|6|||
23435389|NCT00095173|65337032|FG005|Open-Label Extension Phase (Period C)|Other|8|||
23435390|NCT03216746|65337035|FG000|Overall Study|Lost to Follow-up|6|||
23435391|NCT03216746|65337036|FG001|Overall Study|Lost to Follow-up|8|||
23435392|NCT03216746|65337037|FG002|Overall Study|Lost to Follow-up|5|||
23435393|NCT03216746|65337038|FG003|Overall Study|Lost to Follow-up|6|||
23435394|NCT00764673|65337039|FG000|Overall Study|Death|1|||
23435395|NCT00764673|65337039|FG000|Overall Study|Lost to Follow-up|3|||
23435396|NCT00764673|65337039|FG000|Overall Study|Withdrawal by Subject|6|||
23435397|NCT00764673|65337039|FG000|Overall Study|Revision of Device|2|||
23435398|NCT00391625|65337040|FG000|Month 14|Withdrawal by Subject|1|||
23435399|NCT00391625|65337040|FG000|Month 50|Physician Decision|1|||
23435400|NCT04167137|65337042|FG000|Overall Study|Disease progression|1|||
23435401|NCT04167137|65337043|FG001|Overall Study|Disease progression|1|||
23435402|NCT04167137|65337044|FG002|Overall Study|Disease progression|3|||
23435403|NCT04167137|65337045|FG003|Overall Study|Disease progression|3|||
23435404|NCT04167137|65337046|FG004|Overall Study|Disease progression|2|||
23435405|NCT04167137|65337047|FG005|Overall Study|Disease progression|3|||
23435406|NCT04167137|65337048|FG006|Overall Study|Disease progression|2|||
23435407|NCT04167137|65337049|FG007|Overall Study|Disease progression|2|||
23435408|NCT04167137|65337042|FG000|Overall Study|Withdrawal by Subject|1|||
23435409|NCT04167137|65337043|FG001|Overall Study|Withdrawal by Subject|0|||
23435410|NCT04167137|65337044|FG002|Overall Study|Withdrawal by Subject|0|||
23435411|NCT04167137|65337045|FG003|Overall Study|Withdrawal by Subject|1|||
23435412|NCT04167137|65337046|FG004|Overall Study|Withdrawal by Subject|0|||
23435413|NCT04167137|65337047|FG005|Overall Study|Withdrawal by Subject|2|||
23435414|NCT04167137|65337048|FG006|Overall Study|Withdrawal by Subject|1|||
23435415|NCT04167137|65337049|FG007|Overall Study|Withdrawal by Subject|0|||
23435416|NCT04167137|65337042|FG000|Overall Study|Adverse Event|0|||
23435417|NCT04167137|65337043|FG001|Overall Study|Adverse Event|0|||
23435418|NCT04167137|65337044|FG002|Overall Study|Adverse Event|0|||
23435419|NCT04167137|65337045|FG003|Overall Study|Adverse Event|0|||
23435420|NCT04167137|65337046|FG004|Overall Study|Adverse Event|0|||
23435421|NCT04167137|65337047|FG005|Overall Study|Adverse Event|1|||
23435422|NCT04167137|65337048|FG006|Overall Study|Adverse Event|0|||
23435423|NCT04167137|65337049|FG007|Overall Study|Adverse Event|1|||
23435424|NCT04167137|65337042|FG000|Overall Study|Physician Decision|0|||
23435425|NCT04167137|65337043|FG001|Overall Study|Physician Decision|0|||
23435426|NCT04167137|65337044|FG002|Overall Study|Physician Decision|0|||
23435427|NCT04167137|65337045|FG003|Overall Study|Physician Decision|1|||
23435428|NCT04167137|65337046|FG004|Overall Study|Physician Decision|0|||
23435429|NCT04167137|65337047|FG005|Overall Study|Physician Decision|0|||
23435430|NCT04167137|65337048|FG006|Overall Study|Physician Decision|1|||
23435431|NCT04167137|65337049|FG007|Overall Study|Physician Decision|0|||
23435432|NCT04167137|65337042|FG000|Overall Study|Death|0|||
23435433|NCT04167137|65337043|FG001|Overall Study|Death|1|||
23435434|NCT04167137|65337044|FG002|Overall Study|Death|0|||
23435435|NCT04167137|65337045|FG003|Overall Study|Death|0|||
23435436|NCT04167137|65337046|FG004|Overall Study|Death|0|||
23435437|NCT04167137|65337047|FG005|Overall Study|Death|0|||
23435438|NCT04167137|65337048|FG006|Overall Study|Death|0|||
23435439|NCT04167137|65337049|FG007|Overall Study|Death|0|||
23435440|NCT04167137|65337042|FG000|Overall Study|Study terminated by Sponsor|0|||
23435441|NCT04167137|65337043|FG001|Overall Study|Study terminated by Sponsor|0|||
23435442|NCT04167137|65337044|FG002|Overall Study|Study terminated by Sponsor|0|||
23435443|NCT04167137|65337045|FG003|Overall Study|Study terminated by Sponsor|0|||
23435444|NCT04167137|65337046|FG004|Overall Study|Study terminated by Sponsor|0|||
23435445|NCT04167137|65337047|FG005|Overall Study|Study terminated by Sponsor|0|||
23435446|NCT04167137|65337048|FG006|Overall Study|Study terminated by Sponsor|0|||
23435447|NCT04167137|65337049|FG007|Overall Study|Study terminated by Sponsor|1|||
23435448|NCT00866814|65337052|FG000|Overall Study|Lost to Follow-up|12|||
23435449|NCT00866814|65337052|FG000|Overall Study|Adverse Event|2|||
23435450|NCT00866814|65337052|FG000|Overall Study|Physician Decision|1|||
23435451|NCT00866814|65337052|FG000|Overall Study|Death|1|||
23435452|NCT00866814|65337052|FG000|Overall Study|No longer wished to participate|1|||
23435453|NCT00866814|65337052|FG000|Overall Study|Unable to meet follow-up requirements|2|||
23435454|NCT00866814|65337052|FG000|Overall Study|Moved to area without study site|1|||
23435455|NCT00559988|65337058|FG000|Overall Study|Death|147|||
23435456|NCT00559988|65337059|FG001|Overall Study|Death|140|||
23435457|NCT00559988|65337058|FG000|Overall Study|Withdrawal by Subject|152|||
23435458|NCT00559988|65337059|FG001|Overall Study|Withdrawal by Subject|139|||
23435459|NCT00559988|65337058|FG000|Overall Study|Lost to Follow-up|42|||
23435460|NCT00559988|65337059|FG001|Overall Study|Lost to Follow-up|56|||
23435461|NCT00559988|65337058|FG000|Overall Study|ICD device explanted|10|||
23435462|NCT00559988|65337059|FG001|Overall Study|ICD device explanted|17|||
23435463|NCT01008449|65337060|FG000|Overall Study|Lost to Follow-up|29|||
23435464|NCT01008449|65337061|FG001|Overall Study|Lost to Follow-up|19|||
23435465|NCT00470418|65337062|FG000|Overall Study|Withdrawal by Subject|1|||
23435466|NCT00470418|65337063|FG001|Overall Study|Withdrawal by Subject|0|||
23435467|NCT03576716|65337064|FG000|Overall Study|Withdrawal by Subject|0|||
23435468|NCT03576716|65337065|FG001|Overall Study|Withdrawal by Subject|1|||
23435469|NCT00727558|65337066|FG000|Overall Study|Lens issue|0|||
23435470|NCT00727558|65337067|FG001|Overall Study|Lens issue|1|||
23435471|NCT00727558|65337066|FG000|Overall Study|Adverse Event|0|||
23435472|NCT00727558|65337067|FG001|Overall Study|Adverse Event|1|||
23435473|NCT00727558|65337066|FG000|Overall Study|Subject unable to return for follow-up|1|||
23435474|NCT00727558|65337067|FG001|Overall Study|Subject unable to return for follow-up|1|||
23435475|NCT00727558|65337066|FG000|Overall Study|Lost to Follow-up|1|||
23145479|NCT00960531|64280962|FG000|Overall Study|Investigator Request|0|||
23145480|NCT00960531|64280963|FG001|Overall Study|Investigator Request|0|||
23145481|NCT00960531|64280964|FG002|Overall Study|Investigator Request|1|||
23145482|NCT00960531|64280965|FG003|Overall Study|Investigator Request|0|||
23145483|NCT00960531|64280966|FG004|Overall Study|Investigator Request|0|||
23145484|NCT00960531|64280967|FG005|Overall Study|Investigator Request|0|||
23145485|NCT00960531|64280968|FG006|Overall Study|Investigator Request|0|||
23435476|NCT00727558|65337067|FG001|Overall Study|Lost to Follow-up|0|||
23435477|NCT01959243|65337068|FG000|Overall Study|Investigator Decision|3|||
23435478|NCT01959243|65337069|FG001|Overall Study|Investigator Decision|0|||
23435479|NCT01959243|65337068|FG000|Overall Study|Adverse Event|5|||
23435480|NCT01959243|65337069|FG001|Overall Study|Adverse Event|2|||
23435481|NCT01959243|65337068|FG000|Overall Study|Administrative reasons|2|||
23435482|NCT01959243|65337069|FG001|Overall Study|Administrative reasons|1|||
23435483|NCT01959243|65337068|FG000|Overall Study|Lost to Follow-up|3|||
23435484|NCT01959243|65337069|FG001|Overall Study|Lost to Follow-up|1|||
23435485|NCT03652675|65337070|FG000|Overall Study|Lost to Follow-up|4|||
23435486|NCT03652675|65337071|FG001|Overall Study|Lost to Follow-up|4|||
23435487|NCT04544683|65337074|FG000|Overall Study|Lost to Follow-up|2|||
23435488|NCT04544683|65337074|FG000|Overall Study|Underwent cervical spine surgery|6|||
23435489|NCT03848949|65337075|FG000|Overall Study|Lost to Follow-up|5|||
23435490|NCT03848949|65337076|FG001|Overall Study|Lost to Follow-up|7|||
23435491|NCT00527982|65337078|FG000|Overall Study|Physician Decision|1|||
23435492|NCT00527982|65337079|FG001|Overall Study|Physician Decision|0|||
23435493|NCT02516228|65337084|FG000|Overall Study|Lost to Follow-up|1|||
23435494|NCT02516228|65337084|FG000|Overall Study|Withdrawal by Subject|1|||
23435495|NCT02516228|65337084|FG000|Overall Study|Physician Decision|1|||
23435496|NCT02666105|65337085|FG000|Overall Study|Death|1|||
23435497|NCT03565237|65337086|FG000|Overall Study|Non-compliance of Investigational Product|1|||
23435498|NCT03565237|65337086|FG000|Overall Study|Physician Decision|1|||
23145486|NCT00960531|64280969|FG007|Overall Study|Investigator Request|0|||
23145487|NCT00960531|64280970|FG008|Overall Study|Investigator Request|0|||
23145488|NCT00960531|64280971|FG009|Overall Study|Investigator Request|0|||
23145489|NCT00960531|64280962|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
23145490|NCT00960531|64280963|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23145491|NCT00960531|64280964|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
23435499|NCT02726022|65337087|FG000|Overall Study|Adverse Event|14|||
23435500|NCT02726022|65337087|FG000|Overall Study|Treatment Failure|8|||
23435501|NCT02726022|65337087|FG000|Overall Study|Poor Compliance|13|||
23435502|NCT02726022|65337087|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
23435503|NCT03824587|65337088|FG000|Run-in Period|Screen Failure|0|||
23435504|NCT03824587|65337089|FG001|Run-in Period|Screen Failure|275|||
23435505|NCT03824587|65337088|FG000|Treatment Period|Adverse Event|4|||
23435506|NCT03824587|65337089|FG001|Treatment Period|Adverse Event|1|||
23435507|NCT03824587|65337088|FG000|Treatment Period|Withdrawal by Subject|0|||
23435508|NCT03824587|65337089|FG001|Treatment Period|Withdrawal by Subject|1|||
23435509|NCT03824587|65337088|FG000|Treatment Period|Kidney Transplant|1|||
23435510|NCT03824587|65337089|FG001|Treatment Period|Kidney Transplant|1|||
23435511|NCT00812565|65337092|FG000|Overall Study|Did Not Receive Study Medication|1|||
23435512|NCT00812565|65337093|FG001|Overall Study|Did Not Receive Study Medication|1|||
23435513|NCT00812565|65337094|FG002|Overall Study|Did Not Receive Study Medication|0|||
23435514|NCT00812565|65337095|FG003|Overall Study|Did Not Receive Study Medication|0|||
23435515|NCT00812565|65337096|FG004|Overall Study|Did Not Receive Study Medication|0|||
23435516|NCT00812565|65337097|FG005|Overall Study|Did Not Receive Study Medication|0|||
23435517|NCT00812565|65337098|FG006|Overall Study|Did Not Receive Study Medication|0|||
23435518|NCT00812565|65337099|FG007|Overall Study|Did Not Receive Study Medication|0|||
23435519|NCT00812565|65337092|FG000|Overall Study|Adverse Event|0|||
23435520|NCT00812565|65337093|FG001|Overall Study|Adverse Event|0|||
23435521|NCT00812565|65337094|FG002|Overall Study|Adverse Event|0|||
23435522|NCT00812565|65337095|FG003|Overall Study|Adverse Event|2|||
23435523|NCT00812565|65337096|FG004|Overall Study|Adverse Event|0|||
23435524|NCT00812565|65337097|FG005|Overall Study|Adverse Event|0|||
23435525|NCT00812565|65337098|FG006|Overall Study|Adverse Event|0|||
23435526|NCT00812565|65337099|FG007|Overall Study|Adverse Event|1|||
23435527|NCT00812565|65337092|FG000|Overall Study|Did Not Come to Study Visit|1|||
23435528|NCT00812565|65337093|FG001|Overall Study|Did Not Come to Study Visit|0|||
23435529|NCT00812565|65337094|FG002|Overall Study|Did Not Come to Study Visit|0|||
23435530|NCT00812565|65337095|FG003|Overall Study|Did Not Come to Study Visit|0|||
23435531|NCT00812565|65337096|FG004|Overall Study|Did Not Come to Study Visit|0|||
23435532|NCT00812565|65337097|FG005|Overall Study|Did Not Come to Study Visit|0|||
23435533|NCT00812565|65337098|FG006|Overall Study|Did Not Come to Study Visit|0|||
23435534|NCT00812565|65337099|FG007|Overall Study|Did Not Come to Study Visit|0|||
23435535|NCT00812565|65337092|FG000|Overall Study|Withdrawal of Consent|1|||
23435536|NCT00812565|65337093|FG001|Overall Study|Withdrawal of Consent|0|||
23435537|NCT00812565|65337094|FG002|Overall Study|Withdrawal of Consent|0|||
23435538|NCT00812565|65337095|FG003|Overall Study|Withdrawal of Consent|0|||
23435539|NCT00812565|65337096|FG004|Overall Study|Withdrawal of Consent|1|||
23435540|NCT00812565|65337097|FG005|Overall Study|Withdrawal of Consent|0|||
23435541|NCT00812565|65337098|FG006|Overall Study|Withdrawal of Consent|0|||
23435542|NCT00812565|65337099|FG007|Overall Study|Withdrawal of Consent|0|||
23435543|NCT00812565|65337092|FG000|Overall Study|Reason Not Specified|0|||
23218271|NCT01989572|64541531|FG000|Overall Study|not start protocol therapy|5|||
23218272|NCT01989572|64541532|FG001|Overall Study|not start protocol therapy|1|||
23218273|NCT01989572|64541533|FG002|Overall Study|not start protocol therapy|2|||
23218274|NCT01989572|64541534|FG003|Overall Study|not start protocol therapy|3|||
23218275|NCT01989572|64541535|FG004|Overall Study|not start protocol therapy|4|||
23218276|NCT01989572|64541536|FG005|Overall Study|not start protocol therapy|18|||
23218277|NCT01989572|64541531|FG000|Overall Study|alternative therapy|3|||
23218278|NCT01989572|64541532|FG001|Overall Study|alternative therapy|0|||
23218279|NCT01989572|64541533|FG002|Overall Study|alternative therapy|0|||
23218280|NCT01989572|64541534|FG003|Overall Study|alternative therapy|0|||
23218281|NCT01989572|64541535|FG004|Overall Study|alternative therapy|1|||
23218282|NCT01989572|64541536|FG005|Overall Study|alternative therapy|3|||
23435544|NCT00812565|65337093|FG001|Overall Study|Reason Not Specified|0|||
23435545|NCT00812565|65337094|FG002|Overall Study|Reason Not Specified|0|||
23435546|NCT00812565|65337095|FG003|Overall Study|Reason Not Specified|0|||
23435547|NCT00812565|65337096|FG004|Overall Study|Reason Not Specified|0|||
23435548|NCT00812565|65337097|FG005|Overall Study|Reason Not Specified|1|||
23435549|NCT00812565|65337098|FG006|Overall Study|Reason Not Specified|0|||
23218283|NCT00439725|64541537|FG000|Treatment Period|Withdrawal by Subject|22|||
23322018|NCT00711243|64922879|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
23435550|NCT00812565|65337099|FG007|Overall Study|Reason Not Specified|0|||
23435551|NCT03244826|65337100|FG000|Overall Study|Withdrawal by Subject|2|||
23435552|NCT03244826|65337101|FG001|Overall Study|Withdrawal by Subject|0|||
23435553|NCT03244826|65337100|FG000|Overall Study|Transplant delayed or withdrawn|12|||
23435554|NCT03244826|65337101|FG001|Overall Study|Transplant delayed or withdrawn|10|||
23435555|NCT00186901|65337102|FG000|Overall Study|Pregnancy|6|||
23435556|NCT00186901|65337103|FG001|Overall Study|Pregnancy|3|||
23435557|NCT00186901|65337104|FG002|Overall Study|Pregnancy|0|||
23435558|NCT00186901|65337102|FG000|Overall Study|Lost to Follow-up|6|||
23435559|NCT00186901|65337103|FG001|Overall Study|Lost to Follow-up|3|||
23218284|NCT00439725|64541538|FG001|Treatment Period|Withdrawal by Subject|19|||
23435560|NCT00186901|65337104|FG002|Overall Study|Lost to Follow-up|0|||
23435561|NCT00186901|65337102|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
23435562|NCT00186901|65337103|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
23435563|NCT00186901|65337104|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
23435564|NCT00186901|65337102|FG000|Overall Study|ALL relapse or second malignancy|1|||
23435565|NCT00186901|65337103|FG001|Overall Study|ALL relapse or second malignancy|2|||
23435566|NCT00186901|65337104|FG002|Overall Study|ALL relapse or second malignancy|0|||
23435567|NCT00186901|65337102|FG000|Overall Study|Withdrawal by Subject|4|||
23435568|NCT00186901|65337103|FG001|Overall Study|Withdrawal by Subject|5|||
23435569|NCT00186901|65337104|FG002|Overall Study|Withdrawal by Subject|0|||
23435570|NCT00186901|65337102|FG000|Overall Study|Open label|3|||
23435571|NCT00186901|65337103|FG001|Overall Study|Open label|2|||
23435572|NCT00186901|65337104|FG002|Overall Study|Open label|0|||
23435573|NCT00186901|65337102|FG000|Overall Study|Limited adherence to study requirements|20|||
23435574|NCT00186901|65337103|FG001|Overall Study|Limited adherence to study requirements|23|||
23556792|NCT01281202|65765998|FG001|Overall Study|Protocol Violation|10|||
23435575|NCT00186901|65337104|FG002|Overall Study|Limited adherence to study requirements|0|||
23435576|NCT00186901|65337102|FG000|Overall Study|Bone Mineral Density > 0|0|||
23435577|NCT00186901|65337103|FG001|Overall Study|Bone Mineral Density > 0|0|||
23435578|NCT00186901|65337104|FG002|Overall Study|Bone Mineral Density > 0|149|||
23435579|NCT02554981|65337105|FG000|Overall Study|Adverse Event|1|||
23435580|NCT02554981|65337105|FG000|Overall Study|Administrative Reasons|1|||
23435581|NCT02554981|65337105|FG000|Overall Study|Other Miscellaneous Reasons|3|||
23435582|NCT03459365|65337106|FG000|Overall Study|Withdrawal by Subject|6|||
23435583|NCT03459365|65337106|FG000|Overall Study|Protocol Violation|8|||
23435584|NCT00528996|65337107|FG000|Overall Study|Other reasons than listing|6|||
23435585|NCT00528996|65337108|FG001|Overall Study|Other reasons than listing|7|||
23435586|NCT00528996|65337109|FG002|Overall Study|Other reasons than listing|14|||
23435587|NCT00528996|65337110|FG003|Overall Study|Other reasons than listing|11|||
23435588|NCT00528996|65337111|FG004|Overall Study|Other reasons than listing|5|||
23435589|NCT00528996|65337107|FG000|Overall Study|Refused continue medication|16|||
23435590|NCT00528996|65337108|FG001|Overall Study|Refused continue medication|0|||
23435591|NCT00528996|65337109|FG002|Overall Study|Refused continue medication|3|||
23435592|NCT00528996|65337110|FG003|Overall Study|Refused continue medication|3|||
23435593|NCT00528996|65337111|FG004|Overall Study|Refused continue medication|6|||
23435594|NCT00528996|65337107|FG000|Overall Study|Lost to Follow-up|2|||
23435595|NCT00528996|65337108|FG001|Overall Study|Lost to Follow-up|0|||
23556793|NCT01281202|65765997|FG000|Overall Study|Administrative|2|||
23556794|NCT01281202|65765998|FG001|Overall Study|Administrative|8|||
23556795|NCT01281202|65765997|FG000|Overall Study|Lost to Follow-up|11|||
23556796|NCT01281202|65765998|FG001|Overall Study|Lost to Follow-up|13|||
23556797|NCT01281202|65765997|FG000|Overall Study|Incarceration|0|||
23556798|NCT01281202|65765998|FG001|Overall Study|Incarceration|3|||
23556799|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
23556800|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
23556801|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
23623583|NCT00488319|66008491|FG002|Overall Study|Withdrawal by Subject|44|||
23322019|NCT00711243|64922880|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
23322020|NCT00711243|64922881|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
23322021|NCT00711243|64922882|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
23322022|NCT00711243|64922883|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
23322023|NCT00711243|64922878|FG000|Reached First Response/4 Cycles|Death|0|||
23322024|NCT00711243|64922879|FG001|Reached First Response/4 Cycles|Death|0|||
23322025|NCT00711243|64922880|FG002|Reached First Response/4 Cycles|Death|0|||
23322026|NCT00711243|64922881|FG003|Reached First Response/4 Cycles|Death|0|||
23322027|NCT00711243|64922882|FG004|Reached First Response/4 Cycles|Death|0|||
23322028|NCT00711243|64922883|FG005|Reached First Response/4 Cycles|Death|2|||
23322029|NCT00711243|64922878|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
23322030|NCT00711243|64922879|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
23322031|NCT00711243|64922880|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
23322032|NCT00711243|64922881|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
23322033|NCT00711243|64922882|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
23322034|NCT00711243|64922883|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
23322035|NCT00711243|64922878|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
23322036|NCT00711243|64922879|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
23435596|NCT00528996|65337109|FG002|Overall Study|Lost to Follow-up|4|||
23435597|NCT00528996|65337110|FG003|Overall Study|Lost to Follow-up|1|||
23435598|NCT00528996|65337111|FG004|Overall Study|Lost to Follow-up|3|||
23435599|NCT00528996|65337107|FG000|Overall Study|Protocol Violation|1|||
23435600|NCT00528996|65337108|FG001|Overall Study|Protocol Violation|2|||
23435601|NCT00528996|65337109|FG002|Overall Study|Protocol Violation|3|||
23435602|NCT00528996|65337110|FG003|Overall Study|Protocol Violation|3|||
23556802|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
23556803|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
23435603|NCT00528996|65337111|FG004|Overall Study|Protocol Violation|2|||
23435604|NCT00528996|65337107|FG000|Overall Study|Lack of Efficacy|7|||
23435605|NCT00528996|65337108|FG001|Overall Study|Lack of Efficacy|2|||
23435606|NCT00528996|65337109|FG002|Overall Study|Lack of Efficacy|1|||
23435607|NCT00528996|65337110|FG003|Overall Study|Lack of Efficacy|3|||
23435608|NCT00528996|65337111|FG004|Overall Study|Lack of Efficacy|3|||
23435609|NCT00528996|65337107|FG000|Overall Study|Adverse Event|32|||
23145492|NCT00960531|64280965|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
23145493|NCT00960531|64280966|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
23218285|NCT00439725|64541537|FG000|Treatment Period|Study terminated by sponsor|156|||
23218286|NCT00439725|64541538|FG001|Treatment Period|Study terminated by sponsor|148|||
23218287|NCT00439725|64541537|FG000|Treatment Period|Site closed by investigator|1|||
23218288|NCT00439725|64541538|FG001|Treatment Period|Site closed by investigator|2|||
23218289|NCT00439725|64541537|FG000|Treatment Period|Adverse Event|39|||
23218290|NCT00439725|64541538|FG001|Treatment Period|Adverse Event|18|||
23435610|NCT00528996|65337108|FG001|Overall Study|Adverse Event|13|||
23145494|NCT00960531|64280967|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
23145495|NCT00960531|64280968|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
23145496|NCT00960531|64280969|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
23145497|NCT00960531|64280970|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
23145498|NCT00960531|64280971|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
23145499|NCT00960531|64280962|FG000|Overall Study|Lost to Follow-up|0|||
23145500|NCT00960531|64280963|FG001|Overall Study|Lost to Follow-up|0|||
23145501|NCT00960531|64280964|FG002|Overall Study|Lost to Follow-up|1|||
23145502|NCT00960531|64280965|FG003|Overall Study|Lost to Follow-up|0|||
23145503|NCT00960531|64280966|FG004|Overall Study|Lost to Follow-up|0|||
23145504|NCT00960531|64280967|FG005|Overall Study|Lost to Follow-up|0|||
23145505|NCT00960531|64280968|FG006|Overall Study|Lost to Follow-up|1|||
23145506|NCT00960531|64280969|FG007|Overall Study|Lost to Follow-up|0|||
23145507|NCT00960531|64280970|FG008|Overall Study|Lost to Follow-up|0|||
23145508|NCT00960531|64280971|FG009|Overall Study|Lost to Follow-up|0|||
23145509|NCT00960531|64280962|FG000|Overall Study|Failed to Return|2|||
23145510|NCT00960531|64280963|FG001|Overall Study|Failed to Return|0|||
23145511|NCT00960531|64280964|FG002|Overall Study|Failed to Return|0|||
23145512|NCT00960531|64280965|FG003|Overall Study|Failed to Return|0|||
23145513|NCT00960531|64280966|FG004|Overall Study|Failed to Return|0|||
23145514|NCT00960531|64280967|FG005|Overall Study|Failed to Return|0|||
23145515|NCT00960531|64280968|FG006|Overall Study|Failed to Return|0|||
23145516|NCT00960531|64280969|FG007|Overall Study|Failed to Return|2|||
23145517|NCT00960531|64280970|FG008|Overall Study|Failed to Return|0|||
23145518|NCT00960531|64280971|FG009|Overall Study|Failed to Return|0|||
23145519|NCT00960531|64280962|FG000|Overall Study|Adverse Event (AE)|2|||
23145520|NCT00960531|64280963|FG001|Overall Study|Adverse Event (AE)|0|||
23145521|NCT00960531|64280964|FG002|Overall Study|Adverse Event (AE)|0|||
23145522|NCT00960531|64280965|FG003|Overall Study|Adverse Event (AE)|0|||
23145523|NCT00960531|64280966|FG004|Overall Study|Adverse Event (AE)|0|||
23145524|NCT00960531|64280967|FG005|Overall Study|Adverse Event (AE)|1|||
23145525|NCT00960531|64280968|FG006|Overall Study|Adverse Event (AE)|2|||
23145526|NCT00960531|64280969|FG007|Overall Study|Adverse Event (AE)|0|||
23145527|NCT00960531|64280970|FG008|Overall Study|Adverse Event (AE)|2|||
23145528|NCT00960531|64280971|FG009|Overall Study|Adverse Event (AE)|0|||
23145529|NCT00960531|64280962|FG000|Overall Study|Reason not Specified|2|||
23145530|NCT00960531|64280963|FG001|Overall Study|Reason not Specified|1|||
23145531|NCT00960531|64280964|FG002|Overall Study|Reason not Specified|13|||
23145532|NCT00960531|64280965|FG003|Overall Study|Reason not Specified|1|||
23145533|NCT00960531|64280966|FG004|Overall Study|Reason not Specified|2|||
23145534|NCT00960531|64280967|FG005|Overall Study|Reason not Specified|0|||
23145535|NCT00960531|64280968|FG006|Overall Study|Reason not Specified|16|||
23145536|NCT00960531|64280969|FG007|Overall Study|Reason not Specified|0|||
23145537|NCT00960531|64280970|FG008|Overall Study|Reason not Specified|8|||
23145538|NCT00960531|64280971|FG009|Overall Study|Reason not Specified|1|||
23145539|NCT03118674|64280977|FG000|Overall Study|Lost to Follow-up|2|||
23145540|NCT03118674|64280977|FG000|Overall Study|Screen Faliure|8|||
23145541|NCT03118674|64280977|FG000|Overall Study|Withdrawal by Subject|5|||
23145542|NCT00711529|64280981|FG000|Overall Study|Protocol Violation|2|||
23145543|NCT00711529|64280982|FG001|Overall Study|Protocol Violation|0|||
23145544|NCT00711529|64280981|FG000|Overall Study|Withdrawal by Subject|2|||
23145545|NCT00711529|64280982|FG001|Overall Study|Withdrawal by Subject|6|||
23435611|NCT00528996|65337109|FG002|Overall Study|Adverse Event|18|||
23435612|NCT00528996|65337110|FG003|Overall Study|Adverse Event|29|||
23145546|NCT00928447|64280985|FG000|Overall Study|Withdrawal by Subject|1|||
23145547|NCT00928447|64280985|FG000|Overall Study|Investigator's decision|1|||
23145548|NCT02027623|64280989|FG000|Overall Study|Lost to Follow-up|3|||
23145549|NCT02027623|64280990|FG001|Overall Study|Lost to Follow-up|3|||
23145550|NCT02027623|64280989|FG000|Overall Study|Withdrawal by Subject|6|||
23145551|NCT02027623|64280990|FG001|Overall Study|Withdrawal by Subject|9|||
23145552|NCT04281004|64280991|FG000|Overall Study|Physician Decision|1|||
23145553|NCT04281004|64280992|FG001|Overall Study|Physician Decision|0|||
23435613|NCT00528996|65337111|FG004|Overall Study|Adverse Event|18|||
23435614|NCT03908970|65337112|FG000|Overall Study|Adverse Event|7|||
23435615|NCT03908970|65337113|FG001|Overall Study|Adverse Event|21|||
23435616|NCT03908970|65337112|FG000|Overall Study|Physician Decision|1|||
23435617|NCT03908970|65337113|FG001|Overall Study|Physician Decision|4|||
23435618|NCT03908970|65337112|FG000|Overall Study|Withdrawal by Subject|9|||
23435619|NCT03908970|65337113|FG001|Overall Study|Withdrawal by Subject|22|||
23435620|NCT00400569|65337114|FG000|Overall Study|Death|1|||
23435621|NCT03235089|65337116|FG000|Overall Study|Lost to Follow-up|1|||
23435622|NCT03235089|65337117|FG001|Overall Study|Lost to Follow-up|1|||
23435623|NCT03235089|65337116|FG000|Overall Study|Physician Decision|2|||
23435624|NCT03235089|65337117|FG001|Overall Study|Physician Decision|2|||
23435625|NCT02540993|65337121|FG000|Overall Study|Lost to Follow-up|5|||
23435626|NCT02540993|65337122|FG001|Overall Study|Lost to Follow-up|3|||
23435627|NCT02540993|65337121|FG000|Overall Study|Withdrawal by Subject|4|||
23435628|NCT02540993|65337122|FG001|Overall Study|Withdrawal by Subject|6|||
23435629|NCT02540993|65337121|FG000|Overall Study|GCP violations|33|||
23435630|NCT02540993|65337122|FG001|Overall Study|GCP violations|27|||
23435631|NCT04356352|65337123|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
23435632|NCT04356352|65337124|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
23435633|NCT04356352|65337125|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
23435634|NCT04356352|65337123|FG000|Overall Study|Protocol Violation|0|||
23435635|NCT04356352|65337124|FG001|Overall Study|Protocol Violation|3|||
23435636|NCT04356352|65337125|FG002|Overall Study|Protocol Violation|1|||
23145554|NCT00537485|64280993|FG000|Overall Study|Adverse Event|10|||
23145555|NCT00537485|64280994|FG001|Overall Study|Adverse Event|5|||
23145556|NCT00537485|64280993|FG000|Overall Study|Withdrawal by Subject|3|||
23145557|NCT00537485|64280994|FG001|Overall Study|Withdrawal by Subject|2|||
23145558|NCT00537485|64280993|FG000|Overall Study|Withdrawal by Subject|1|||
23145559|NCT00537485|64280994|FG001|Overall Study|Withdrawal by Subject|3|||
23145560|NCT00537485|64280993|FG000|Overall Study|Physician Decision|1|||
23145561|NCT00537485|64280994|FG001|Overall Study|Physician Decision|0|||
23145562|NCT03215810|64280995|FG000|Overall Study|Still responding to nivolumab|1|||
23145563|NCT03215810|64280995|FG000|Overall Study|Insufficient TIL growth|1|||
23145564|NCT03215810|64280995|FG000|Overall Study|Decline in performance status|1|||
23145565|NCT03215810|64280995|FG000|Overall Study|Withdrawal by Subject|1|||
23145566|NCT00323297|64280996|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
23145567|NCT00323297|64280997|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
23145568|NCT00323297|64280996|FG000|Part A (Double Blind Randomized)|Death|0|||
23145569|NCT00323297|64280997|FG001|Part A (Double Blind Randomized)|Death|1|||
23145570|NCT00323297|64280996|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
23145571|NCT00323297|64280997|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
23145572|NCT00323297|64280996|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
23145573|NCT00323297|64280997|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
23145574|NCT00323297|64280996|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
23145575|NCT00323297|64280997|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
23145576|NCT00323297|64280996|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
23145577|NCT00323297|64280997|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
23145578|NCT00323297|64280996|FG000|Part B (Open-label)|Death|0|||
23145579|NCT00323297|64280997|FG001|Part B (Open-label)|Death|1|||
23145580|NCT00323297|64280996|FG000|Part B (Open-label)|Reason unspecified|0|||
23145581|NCT00323297|64280997|FG001|Part B (Open-label)|Reason unspecified|1|||
23218291|NCT00439725|64541537|FG000|Treatment Period|Physician Decision|1|||
23218292|NCT00439725|64541538|FG001|Treatment Period|Physician Decision|1|||
23218293|NCT00439725|64541537|FG000|Treatment Period|Protocol Violation|2|||
23218294|NCT00439725|64541538|FG001|Treatment Period|Protocol Violation|1|||
23218295|NCT00439725|64541537|FG000|Treatment Period|Clinical endpoint reached|6|||
23218296|NCT00439725|64541538|FG001|Treatment Period|Clinical endpoint reached|50|||
23218297|NCT00439725|64541537|FG000|Treatment Period|Technical problems|1|||
23218298|NCT00439725|64541538|FG001|Treatment Period|Technical problems|0|||
23218299|NCT00439725|64541537|FG000|Treatment Period|Lost to Follow-up|1|||
23218300|NCT00439725|64541538|FG001|Treatment Period|Lost to Follow-up|1|||
23218301|NCT00439725|64541537|FG000|Treatment Period|Participant convenience|1|||
23218302|NCT00439725|64541538|FG001|Treatment Period|Participant convenience|0|||
23218303|NCT00439725|64541537|FG000|Treatment Period|Protocol driven decision point|1|||
23218304|NCT00439725|64541538|FG001|Treatment Period|Protocol driven decision point|1|||
23435637|NCT01549873|65337128|FG000|Overall Study|Physician Decision|0|||
23435638|NCT01549873|65337129|FG001|Overall Study|Physician Decision|1|||
23435639|NCT03040986|65337132|FG000|Overall Study|Hospice|1|||
23435640|NCT03040986|65337133|FG001|Overall Study|Hospice|0|||
23435641|NCT03040986|65337132|FG000|Overall Study|Adverse Event|2|||
23435642|NCT03040986|65337133|FG001|Overall Study|Adverse Event|1|||
23145582|NCT00323297|64280996|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
23145583|NCT00323297|64280997|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
23145584|NCT00323297|64280996|FG000|Part B (Open-label)|Lack of Efficacy|3|||
23145585|NCT00323297|64280997|FG001|Part B (Open-label)|Lack of Efficacy|1|||
23145586|NCT00323297|64280996|FG000|Part B (Open-label)|Adverse Event|5|||
23145587|NCT00323297|64280997|FG001|Part B (Open-label)|Adverse Event|5|||
23145588|NCT00323297|64280996|FG000|Part B (Open-label)|Protocol Violation|0|||
23145589|NCT00323297|64280997|FG001|Part B (Open-label)|Protocol Violation|1|||
23322037|NCT00711243|64922880|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
23322038|NCT00711243|64922881|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
23322039|NCT00711243|64922882|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
23322040|NCT00711243|64922883|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
23322041|NCT00711243|64922878|FG000|Treated Cycle 5 After First Response|Death|0|||
23322042|NCT00711243|64922879|FG001|Treated Cycle 5 After First Response|Death|0|||
23435643|NCT03040986|65337132|FG000|Overall Study|Disease progression on study|3|||
23435644|NCT03040986|65337133|FG001|Overall Study|Disease progression on study|1|||
23556804|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
23556805|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
23556806|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
23556807|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
23556808|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
23556809|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
23145590|NCT02973048|64280998|FG000|Overall Study|Epidural catheter insertion failure|1|||
23145591|NCT02973048|64280999|FG001|Overall Study|Epidural catheter insertion failure|0|||
23145592|NCT02973048|64280998|FG000|Overall Study|Withdrawal by Subject|0|||
23145593|NCT02973048|64280999|FG001|Overall Study|Withdrawal by Subject|3|||
23145594|NCT00686725|64281002|FG000|Overall Study|Adverse Event|1|||
23145595|NCT00686725|64281003|FG001|Overall Study|Adverse Event|1|||
23145596|NCT00686725|64281002|FG000|Overall Study|Progressive Disease|17|||
23145597|NCT00686725|64281003|FG001|Overall Study|Progressive Disease|23|||
23145598|NCT00686725|64281002|FG000|Overall Study|Lost to Follow-up|7|||
23145599|NCT00686725|64281003|FG001|Overall Study|Lost to Follow-up|5|||
23145600|NCT00686725|64281002|FG000|Overall Study|Death|6|||
23145601|NCT00686725|64281003|FG001|Overall Study|Death|3|||
23145602|NCT00686725|64281002|FG000|Overall Study|Withdrawal by Subject|13|||
23145603|NCT00686725|64281003|FG001|Overall Study|Withdrawal by Subject|4|||
23145604|NCT00686725|64281002|FG000|Overall Study|Protocol Violation|1|||
23145605|NCT00686725|64281003|FG001|Overall Study|Protocol Violation|3|||
23145606|NCT00686725|64281002|FG000|Overall Study|Other|1|||
23145607|NCT00686725|64281003|FG001|Overall Study|Other|3|||
23145608|NCT03451162|64281006|FG000|Overall Study|Lost to Follow-up|1|||
23145609|NCT03451162|64281007|FG001|Overall Study|Lost to Follow-up|0|||
23145610|NCT03451162|64281008|FG002|Overall Study|Lost to Follow-up|0|||
23145611|NCT03451162|64281009|FG003|Overall Study|Lost to Follow-up|0|||
23145612|NCT03451162|64281010|FG004|Overall Study|Lost to Follow-up|0|||
23145613|NCT03451162|64281006|FG000|Overall Study|Physician Decision|0|||
23145614|NCT03451162|64281007|FG001|Overall Study|Physician Decision|1|||
23145615|NCT03451162|64281008|FG002|Overall Study|Physician Decision|0|||
23145616|NCT03451162|64281009|FG003|Overall Study|Physician Decision|0|||
23145617|NCT03451162|64281010|FG004|Overall Study|Physician Decision|0|||
23145618|NCT03451162|64281006|FG000|Overall Study|Withdrawal by Subject|1|||
23145619|NCT03451162|64281007|FG001|Overall Study|Withdrawal by Subject|1|||
23145620|NCT03451162|64281008|FG002|Overall Study|Withdrawal by Subject|0|||
23145621|NCT03451162|64281009|FG003|Overall Study|Withdrawal by Subject|0|||
23145622|NCT03451162|64281010|FG004|Overall Study|Withdrawal by Subject|0|||
23145623|NCT02752074|64281015|FG000|Overall Study|Lost to Follow-up|1|||
23145624|NCT02752074|64281016|FG001|Overall Study|Lost to Follow-up|4|||
23145625|NCT02752074|64281015|FG000|Overall Study|Death|146|||
23145626|NCT02752074|64281016|FG001|Overall Study|Death|129|||
23145627|NCT02752074|64281015|FG000|Overall Study|Withdrawal by Subject|9|||
23145628|NCT02752074|64281016|FG001|Overall Study|Withdrawal by Subject|10|||
23145629|NCT01614197|64281019|FG000|Overall Study|Withdrawal by Subject|0|||
23145630|NCT01614197|64281020|FG001|Overall Study|Withdrawal by Subject|1|||
23145631|NCT01614197|64281021|FG002|Overall Study|Withdrawal by Subject|0|||
23145632|NCT01614197|64281022|FG003|Overall Study|Withdrawal by Subject|0|||
23145633|NCT04507126|64281023|FG000|Overall Study|Withdrawal by Subject|1|||
23145634|NCT04507126|64281023|FG000|Overall Study|Protocol Violation|2|||
23145635|NCT04507126|64281023|FG000|Overall Study|Physician Decision|1|||
23145636|NCT00504881|64281028|FG000|Overall Study|Lack of Efficacy|1|||
23435645|NCT01844778|65337134|FG000|Overall Study|Protocol deviation|0|||
23145637|NCT00504881|64281029|FG001|Overall Study|Lack of Efficacy|5|||
23145638|NCT00504881|64281028|FG000|Overall Study|Lost to Follow-up|0|||
23145639|NCT00504881|64281029|FG001|Overall Study|Lost to Follow-up|2|||
23145640|NCT00504881|64281028|FG000|Overall Study|Withdrawal by Subject|1|||
23145641|NCT00504881|64281029|FG001|Overall Study|Withdrawal by Subject|4|||
23145642|NCT00504881|64281028|FG000|Overall Study|Non-Compliance|1|||
23322043|NCT00711243|64922880|FG002|Treated Cycle 5 After First Response|Death|0|||
23322044|NCT00711243|64922881|FG003|Treated Cycle 5 After First Response|Death|0|||
23556810|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
23556811|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
23556812|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
23556813|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
23556814|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
23556815|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
23556816|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
23556817|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
23556818|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
23556819|NCT04162769|65765999|FG000|Double-blind Treatment (12-Week)|Other|0|||
23556820|NCT04162769|65766000|FG001|Double-blind Treatment (12-Week)|Other|1|||
23556821|NCT04162769|65766001|FG002|Double-blind Treatment (12-Week)|Other|1|||
23556822|NCT04162769|65766002|FG003|Double-blind Treatment (12-Week)|Other|0|||
23556823|NCT04162769|65765999|FG000|OLE Period (52-Week)|Adverse Event|0|||
23556824|NCT04162769|65766000|FG001|OLE Period (52-Week)|Adverse Event|0|||
23556825|NCT04162769|65766001|FG002|OLE Period (52-Week)|Adverse Event|0|||
23556826|NCT04162769|65766002|FG003|OLE Period (52-Week)|Adverse Event|5|||
23556827|NCT04162769|65765999|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
23556828|NCT04162769|65766000|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
23556829|NCT04162769|65766001|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
23556830|NCT04162769|65766002|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
23556831|NCT04162769|65765999|FG000|OLE Period (52-Week)|Physician Decision|0|||
23556832|NCT04162769|65766000|FG001|OLE Period (52-Week)|Physician Decision|0|||
23556833|NCT04162769|65766001|FG002|OLE Period (52-Week)|Physician Decision|0|||
23556834|NCT04162769|65766002|FG003|OLE Period (52-Week)|Physician Decision|1|||
23556835|NCT04162769|65765999|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
23556836|NCT04162769|65766000|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
23556837|NCT04162769|65766001|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
23556838|NCT04162769|65766002|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
23556839|NCT04162769|65765999|FG000|OLE Period (52-Week)|Protocol deviation|0|||
23556840|NCT04162769|65766000|FG001|OLE Period (52-Week)|Protocol deviation|0|||
23556841|NCT04162769|65766001|FG002|OLE Period (52-Week)|Protocol deviation|0|||
23556842|NCT04162769|65766002|FG003|OLE Period (52-Week)|Protocol deviation|2|||
23623584|NCT00488319|66008489|FG000|Overall Study|Other reasons for withdrawal|0|||
23623585|NCT00488319|66008490|FG001|Overall Study|Other reasons for withdrawal|4|||
23623586|NCT00488319|66008491|FG002|Overall Study|Other reasons for withdrawal|12|||
23623587|NCT00944229|66008492|FG000|Overall Study|Withdrawal by Subject|11|||
23623588|NCT00944229|66008492|FG000|Overall Study|Physician Decision|14|||
23623589|NCT02959177|66008493|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
23145643|NCT00504881|64281029|FG001|Overall Study|Non-Compliance|0|||
23145644|NCT00504881|64281028|FG000|Overall Study|No Birth Control|0|||
23145645|NCT00504881|64281029|FG001|Overall Study|No Birth Control|1|||
23145646|NCT00504881|64281028|FG000|Overall Study|Safety Visit not performed|0|||
23145647|NCT00504881|64281029|FG001|Overall Study|Safety Visit not performed|1|||
23145648|NCT00504881|64281028|FG000|Overall Study|AE, serious fatal|0|||
23145649|NCT00504881|64281029|FG001|Overall Study|AE, serious fatal|1|||
23145650|NCT00504881|64281028|FG000|Overall Study|SAE, non-fatal|2|||
23145651|NCT00504881|64281029|FG001|Overall Study|SAE, non-fatal|6|||
23145652|NCT00504881|64281028|FG000|Overall Study|AE, non-serious non-fatal|4|||
23145653|NCT00504881|64281029|FG001|Overall Study|AE, non-serious non-fatal|14|||
23145654|NCT00504881|64281028|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23145655|NCT00504881|64281029|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
23145656|NCT00504881|64281028|FG000|Overall Study|AE of unknown type|1|||
23145657|NCT00504881|64281029|FG001|Overall Study|AE of unknown type|0|||
23145658|NCT02527343|64281030|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
23145659|NCT02527343|64281031|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23145660|NCT02527343|64281032|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23145661|NCT02527343|64281033|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23145662|NCT02527343|64281034|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23145663|NCT02527343|64281035|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
23145664|NCT02527343|64281030|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
23145665|NCT02527343|64281031|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23145666|NCT02527343|64281032|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23556843|NCT04530448|65766003|FG000|Overall Study|Physician Decision|3|||
23145667|NCT02527343|64281033|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23145668|NCT02527343|64281034|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23145669|NCT02527343|64281035|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
23435646|NCT01844778|65337135|FG001|Overall Study|Protocol deviation|1|||
23435647|NCT01844778|65337136|FG002|Overall Study|Protocol deviation|2|||
23556844|NCT04530448|65766004|FG001|Overall Study|Physician Decision|0|||
23556845|NCT03496662|65766007|FG000|Overall Study|Adverse Event|1|||
23556846|NCT03496662|65766008|FG001|Overall Study|Adverse Event|0|||
23623590|NCT02959177|66008494|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
23623591|NCT02959177|66008495|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
23623592|NCT02959177|66008493|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
23623593|NCT02959177|66008494|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
23623594|NCT02959177|66008495|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
23623595|NCT02959177|66008493|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
23623596|NCT02959177|66008494|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
23623597|NCT02959177|66008495|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
23623598|NCT02959177|66008493|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
23623599|NCT02959177|66008494|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23623600|NCT02959177|66008495|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
23623601|NCT02959177|66008493|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
23623602|NCT02959177|66008494|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
23556847|NCT03496662|65766009|FG002|Overall Study|Adverse Event|1|||
23556848|NCT03496662|65766007|FG000|Overall Study|Physician Decision|1|||
23556849|NCT03496662|65766008|FG001|Overall Study|Physician Decision|0|||
23556850|NCT03496662|65766009|FG002|Overall Study|Physician Decision|3|||
23556851|NCT03496662|65766007|FG000|Overall Study|Withdrawal by Subject|0|||
23556852|NCT03496662|65766008|FG001|Overall Study|Withdrawal by Subject|0|||
23556853|NCT03496662|65766009|FG002|Overall Study|Withdrawal by Subject|2|||
23556854|NCT03496662|65766007|FG000|Overall Study|Death|0|||
23556855|NCT03496662|65766008|FG001|Overall Study|Death|0|||
23556856|NCT03496662|65766009|FG002|Overall Study|Death|2|||
23556857|NCT03496662|65766007|FG000|Overall Study|Noncompliance|0|||
23556858|NCT03496662|65766008|FG001|Overall Study|Noncompliance|0|||
23556859|NCT03496662|65766009|FG002|Overall Study|Noncompliance|1|||
23556860|NCT04398537|65766010|FG000|Overall Study|Physician Decision|10|||
23556861|NCT04398537|65766011|FG001|Overall Study|Physician Decision|15|||
23556862|NCT04843930|65766017|FG000|Randomization|Withdrawal by Subject|6|||
23556863|NCT04843930|65766018|FG001|Randomization|Withdrawal by Subject|6|||
23556864|NCT04843930|65766019|FG002|Randomization|Withdrawal by Subject|0|||
23556865|NCT04843930|65766020|FG003|Randomization|Withdrawal by Subject|0|||
23556866|NCT04843930|65766017|FG000|Week 6 Assessment|Adverse Event|3|||
23556867|NCT04843930|65766018|FG001|Week 6 Assessment|Adverse Event|0|||
23556868|NCT04843930|65766019|FG002|Week 6 Assessment|Adverse Event|0|||
23556869|NCT04843930|65766020|FG003|Week 6 Assessment|Adverse Event|0|||
23556870|NCT04843930|65766017|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
23556871|NCT04843930|65766018|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
23556872|NCT04843930|65766019|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
23556873|NCT04843930|65766020|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
23556874|NCT04843930|65766017|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
23556875|NCT04843930|65766018|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
23556876|NCT04843930|65766019|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
23556877|NCT04843930|65766020|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
23556878|NCT03879408|65766021|FG000|Overall Study|Lost to Follow-up|0|||
23556879|NCT03879408|65766022|FG001|Overall Study|Lost to Follow-up|3|||
23556880|NCT03879408|65766023|FG002|Overall Study|Lost to Follow-up|2|||
23556881|NCT03879408|65766024|FG003|Overall Study|Lost to Follow-up|1|||
23556882|NCT03879408|65766025|FG004|Overall Study|Lost to Follow-up|0|||
23556883|NCT03879408|65766021|FG000|Overall Study|Withdrawal by Subject|2|||
23556884|NCT03879408|65766022|FG001|Overall Study|Withdrawal by Subject|1|||
23556885|NCT03879408|65766023|FG002|Overall Study|Withdrawal by Subject|1|||
23556886|NCT03879408|65766024|FG003|Overall Study|Withdrawal by Subject|0|||
23556887|NCT03879408|65766025|FG004|Overall Study|Withdrawal by Subject|1|||
23556888|NCT00089141|65766028|FG000|Overall Study|Termination of trial|18|||
23556889|NCT00089141|65766029|FG001|Overall Study|Termination of trial|24|||
23623603|NCT02959177|66008495|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
23623604|NCT02959177|66008493|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
23556890|NCT04535947|65766036|FG000|Overall Study|Adverse Event|1|||
23556891|NCT04535947|65766037|FG001|Overall Study|Adverse Event|4|||
23556892|NCT04535947|65766036|FG000|Overall Study|Other reasons not specified|2|||
23556893|NCT04535947|65766037|FG001|Overall Study|Other reasons not specified|0|||
23556894|NCT04535947|65766036|FG000|Overall Study|Withdrawal by Subject|1|||
23556895|NCT04535947|65766037|FG001|Overall Study|Withdrawal by Subject|1|||
23556896|NCT01357616|65766038|FG000|Overall Study|Adverse Event|1|||
23556897|NCT01357616|65766039|FG001|Overall Study|Adverse Event|1|||
23623605|NCT02959177|66008494|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
23623606|NCT02959177|66008495|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
23623607|NCT02959177|66008493|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
23556898|NCT01357616|65766038|FG000|Overall Study|Lost to Follow-up|4|||
23556899|NCT01357616|65766039|FG001|Overall Study|Lost to Follow-up|3|||
23556900|NCT01357616|65766038|FG000|Overall Study|Protocol Violation|0|||
23556901|NCT01357616|65766039|FG001|Overall Study|Protocol Violation|2|||
23556902|NCT01357616|65766038|FG000|Overall Study|Inadequate Control of IOP|1|||
23556903|NCT01357616|65766039|FG001|Overall Study|Inadequate Control of IOP|2|||
23556904|NCT01357616|65766038|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
23556905|NCT01357616|65766039|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
23218305|NCT00439725|64541537|FG000|Treatment Period|Death|1|||
23218306|NCT00439725|64541538|FG001|Treatment Period|Death|1|||
23556906|NCT01357616|65766038|FG000|Overall Study|Withdrawal by Subject|1|||
23556907|NCT01357616|65766039|FG001|Overall Study|Withdrawal by Subject|0|||
23145670|NCT02527343|64281030|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23145671|NCT02527343|64281031|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
23145672|NCT02527343|64281032|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23623608|NCT02959177|66008494|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
23556908|NCT00558064|65766040|FG000|Overall Study|Adverse Event|3|||
23556909|NCT00558064|65766041|FG001|Overall Study|Adverse Event|2|||
23556910|NCT00558064|65766040|FG000|Overall Study|Lack of Efficacy|0|||
23556911|NCT00558064|65766041|FG001|Overall Study|Lack of Efficacy|1|||
23556912|NCT00558064|65766040|FG000|Overall Study|Protocol Violation|1|||
23556913|NCT00558064|65766041|FG001|Overall Study|Protocol Violation|0|||
23556914|NCT00558064|65766040|FG000|Overall Study|Lost to Follow-up|0|||
23556915|NCT00558064|65766041|FG001|Overall Study|Lost to Follow-up|1|||
23556916|NCT00558064|65766040|FG000|Overall Study|Withdrawal by Subject|0|||
23556917|NCT00558064|65766041|FG001|Overall Study|Withdrawal by Subject|1|||
23556918|NCT00558064|65766040|FG000|Overall Study|No visit within allowance period|1|||
23556919|NCT00558064|65766041|FG001|Overall Study|No visit within allowance period|0|||
23556920|NCT00119405|65766048|FG000|Overall Study|Withdrawal by Subject|1|||
23556921|NCT02658630|65766049|FG000|Overall Study|Withdrawal by Subject|4|||
23556922|NCT01433354|65766072|FG000|Overall Study|Adverse Event|6|||
23556923|NCT01433354|65766072|FG000|Overall Study|Lost to Follow-up|1|||
23556924|NCT01433354|65766072|FG000|Overall Study|Administrative problems|90|||
23623609|NCT02959177|66008495|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
23623610|NCT02647645|66008503|FG000|Overall Study|Lost to Follow-up|2|||
23623611|NCT02647645|66008504|FG001|Overall Study|Lost to Follow-up|1|||
23623612|NCT00611715|66008505|FG000|Overall Study|Disease Progression|24|||
23623613|NCT00611715|66008506|FG001|Overall Study|Disease Progression|4|||
23623614|NCT00611715|66008505|FG000|Overall Study|Withdrawal by Subject|5|||
23623615|NCT00611715|66008506|FG001|Overall Study|Withdrawal by Subject|1|||
23623616|NCT00611715|66008505|FG000|Overall Study|Adverse Event|9|||
23623617|NCT00611715|66008506|FG001|Overall Study|Adverse Event|1|||
23623618|NCT00611715|66008505|FG000|Overall Study|Death|1|||
23145673|NCT02527343|64281033|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23145674|NCT02527343|64281034|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23145675|NCT02527343|64281035|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23145676|NCT02527343|64281030|FG000|RT Period: Weeks 1 to 52|Other|4|||
23145677|NCT02527343|64281031|FG001|RT Period: Weeks 1 to 52|Other|3|||
23145678|NCT02527343|64281032|FG002|RT Period: Weeks 1 to 52|Other|0|||
23145679|NCT02527343|64281033|FG003|RT Period: Weeks 1 to 52|Other|0|||
23145680|NCT02527343|64281034|FG004|RT Period: Weeks 1 to 52|Other|0|||
23145681|NCT02527343|64281035|FG005|RT Period: Weeks 1 to 52|Other|0|||
23145682|NCT02527343|64281030|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23145683|NCT02527343|64281031|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23145684|NCT02527343|64281032|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
23145685|NCT02527343|64281033|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23145686|NCT02527343|64281034|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23145687|NCT02527343|64281035|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
23145688|NCT02527343|64281030|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23145689|NCT02527343|64281031|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23145690|NCT02527343|64281032|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23145691|NCT02527343|64281033|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
23145692|NCT02527343|64281034|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23145693|NCT02527343|64281035|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
23145694|NCT02527343|64281030|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23145695|NCT02527343|64281031|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23145696|NCT02527343|64281032|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23145697|NCT02527343|64281033|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23556925|NCT01433354|65766072|FG000|Overall Study|Protocol Violation|2|||
23556926|NCT01433354|65766072|FG000|Overall Study|Lack of Efficacy|17|||
23556927|NCT01433354|65766072|FG000|Overall Study|Subject Withdrew Consent|3|||
23623619|NCT00611715|66008506|FG001|Overall Study|Death|0|||
23623620|NCT00611715|66008505|FG000|Overall Study|two patients are still on treatment|2|||
23145698|NCT02527343|64281034|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
23145699|NCT02527343|64281035|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
23218307|NCT00439725|64541537|FG000|Treatment Period|Participant did not receive treatment|4|||
23556928|NCT02089230|65766080|FG000|Overall Study|Death|0|||
23556929|NCT02089230|65766081|FG001|Overall Study|Death|0|||
23556930|NCT02089230|65766082|FG002|Overall Study|Death|2|||
23556931|NCT02089230|65766080|FG000|Overall Study|Seeking Alternative Therapy|0|||
23556932|NCT02089230|65766081|FG001|Overall Study|Seeking Alternative Therapy|0|||
23556933|NCT02089230|65766082|FG002|Overall Study|Seeking Alternative Therapy|4|||
23556934|NCT04465357|65766083|FG000|Overall Study|Adverse Event|2|||
23556935|NCT04465357|65766083|FG000|Overall Study|Lack of Efficacy|1|||
23556936|NCT04465357|65766083|FG000|Overall Study|Lost to Follow-up|2|||
23556937|NCT04465357|65766083|FG000|Overall Study|Withdrawal by Subject|6|||
23556938|NCT04465357|65766083|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
23556939|NCT00441701|65766084|FG000|Overall Study|Adverse Event|3|||
23556940|NCT00441701|65766085|FG001|Overall Study|Adverse Event|2|||
23556941|NCT00441701|65766086|FG002|Overall Study|Adverse Event|1|||
23556942|NCT00441701|65766087|FG003|Overall Study|Adverse Event|0|||
23556943|NCT00441701|65766088|FG004|Overall Study|Adverse Event|2|||
23556944|NCT00441701|65766089|FG005|Overall Study|Adverse Event|2|||
23556945|NCT00441701|65766090|FG006|Overall Study|Adverse Event|0|||
23556946|NCT00441701|65766091|FG007|Overall Study|Adverse Event|0|||
23556947|NCT00441701|65766092|FG008|Overall Study|Adverse Event|0|||
23556948|NCT00441701|65766093|FG009|Overall Study|Adverse Event|0|||
23556949|NCT00441701|65766084|FG000|Overall Study|Lack of Efficacy|2|||
23556950|NCT00441701|65766085|FG001|Overall Study|Lack of Efficacy|0|||
23556951|NCT00441701|65766086|FG002|Overall Study|Lack of Efficacy|2|||
23556952|NCT00441701|65766087|FG003|Overall Study|Lack of Efficacy|2|||
23556953|NCT00441701|65766088|FG004|Overall Study|Lack of Efficacy|0|||
23556954|NCT00441701|65766089|FG005|Overall Study|Lack of Efficacy|1|||
23556955|NCT00441701|65766090|FG006|Overall Study|Lack of Efficacy|0|||
23556956|NCT00441701|65766091|FG007|Overall Study|Lack of Efficacy|0|||
23556957|NCT00441701|65766092|FG008|Overall Study|Lack of Efficacy|0|||
23556958|NCT00441701|65766093|FG009|Overall Study|Lack of Efficacy|0|||
23556959|NCT00441701|65766084|FG000|Overall Study|Withdrawal by Subject|0|||
23556960|NCT00441701|65766085|FG001|Overall Study|Withdrawal by Subject|2|||
23556961|NCT00441701|65766086|FG002|Overall Study|Withdrawal by Subject|1|||
23556962|NCT00441701|65766087|FG003|Overall Study|Withdrawal by Subject|1|||
23623621|NCT00611715|66008506|FG001|Overall Study|two patients are still on treatment|0|||
23623622|NCT01841112|66008507|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
23623623|NCT01841112|66008508|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
23623624|NCT01841112|66008509|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
23623625|NCT01841112|66008510|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
23623626|NCT01841112|66008511|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
23623627|NCT03561597|66008512|FG000|Overall Study|Lost to Follow-up|20|||
23623628|NCT02250534|66008513|FG000|Overall Study|Lost to Follow-up|18|||
23623629|NCT02250534|66008514|FG001|Overall Study|Lost to Follow-up|28|||
23623630|NCT02250534|66008515|FG002|Overall Study|Lost to Follow-up|33|||
23623631|NCT02250534|66008513|FG000|Overall Study|Personal reasons|7|||
23623632|NCT02250534|66008514|FG001|Overall Study|Personal reasons|8|||
23623633|NCT02250534|66008515|FG002|Overall Study|Personal reasons|14|||
23623634|NCT02250534|66008513|FG000|Overall Study|Adverse Event|6|||
23623635|NCT02250534|66008514|FG001|Overall Study|Adverse Event|3|||
23623636|NCT02250534|66008515|FG002|Overall Study|Adverse Event|8|||
23623637|NCT02250534|66008513|FG000|Overall Study|incarcerated|2|||
23623638|NCT02250534|66008514|FG001|Overall Study|incarcerated|1|||
23623639|NCT02250534|66008515|FG002|Overall Study|incarcerated|2|||
23623640|NCT02250534|66008513|FG000|Overall Study|Withdrawal by Subject|0|||
23623641|NCT02250534|66008514|FG001|Overall Study|Withdrawal by Subject|1|||
23623642|NCT02250534|66008515|FG002|Overall Study|Withdrawal by Subject|2|||
23623643|NCT02250534|66008513|FG000|Overall Study|Death|0|||
23623644|NCT02250534|66008514|FG001|Overall Study|Death|1|||
23623645|NCT02250534|66008515|FG002|Overall Study|Death|1|||
23623646|NCT02250534|66008513|FG000|Overall Study|Physician Decision|1|||
23623647|NCT02250534|66008514|FG001|Overall Study|Physician Decision|3|||
23623648|NCT02250534|66008515|FG002|Overall Study|Physician Decision|1|||
23623649|NCT02250534|66008513|FG000|Overall Study|Protocol Violation|1|||
23218308|NCT00439725|64541538|FG001|Treatment Period|Participant did not receive treatment|4|||
23218309|NCT00439725|64541537|FG000|Observational Period|Withdrawal by Subject|2|||
23218310|NCT00439725|64541538|FG001|Observational Period|Withdrawal by Subject|2|||
23218311|NCT00439725|64541537|FG000|Observational Period|Lost to Follow-up|0|||
23218312|NCT00439725|64541538|FG001|Observational Period|Lost to Follow-up|1|||
23218313|NCT00439725|64541537|FG000|Observational Period|Death|0|||
23218314|NCT00439725|64541538|FG001|Observational Period|Death|2|||
23623650|NCT02250534|66008514|FG001|Overall Study|Protocol Violation|0|||
23623651|NCT02250534|66008515|FG002|Overall Study|Protocol Violation|1|||
23623652|NCT02250534|66008513|FG000|Overall Study|Reason unknown|1|||
23218315|NCT00439725|64541537|FG000|Observational Period|Study termination by sponsor|1|||
23556963|NCT00441701|65766088|FG004|Overall Study|Withdrawal by Subject|0|||
23556964|NCT00441701|65766089|FG005|Overall Study|Withdrawal by Subject|0|||
23556965|NCT00441701|65766090|FG006|Overall Study|Withdrawal by Subject|0|||
23556966|NCT00441701|65766091|FG007|Overall Study|Withdrawal by Subject|0|||
23556967|NCT00441701|65766092|FG008|Overall Study|Withdrawal by Subject|0|||
23556968|NCT00441701|65766093|FG009|Overall Study|Withdrawal by Subject|0|||
23556969|NCT02279043|65766094|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
23556970|NCT02279043|65766095|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
23218316|NCT00439725|64541538|FG001|Observational Period|Study termination by sponsor|1|||
23218317|NCT00439725|64541537|FG000|Observational Period|Clinical endpoint reached|3|||
23218318|NCT00439725|64541538|FG001|Observational Period|Clinical endpoint reached|1|||
23218319|NCT00439725|64541537|FG000|Observational Period|Technical problems|1|||
23218320|NCT00439725|64541538|FG001|Observational Period|Technical problems|0|||
23218321|NCT00439725|64541537|FG000|Observational Period|Participant convenience|1|||
23218322|NCT00439725|64541538|FG001|Observational Period|Participant convenience|0|||
23218323|NCT00254163|64541539|FG000|Overall Study|Adverse Event|29|||
23218324|NCT00254163|64541540|FG001|Overall Study|Adverse Event|26|||
23218325|NCT00254163|64541539|FG000|Overall Study|Patient request/withdrew consent|6|||
23218326|NCT00254163|64541540|FG001|Overall Study|Patient request/withdrew consent|4|||
23218327|NCT00254163|64541539|FG000|Overall Study|Investigator request|1|||
23218328|NCT00254163|64541540|FG001|Overall Study|Investigator request|3|||
23218329|NCT00254163|64541539|FG000|Overall Study|Failed entry|1|||
23218330|NCT00254163|64541540|FG001|Overall Study|Failed entry|3|||
23218331|NCT00254163|64541539|FG000|Overall Study|Progressive disease|0|||
23218332|NCT00254163|64541540|FG001|Overall Study|Progressive disease|1|||
23218333|NCT00254163|64541539|FG000|Overall Study|Death|0|||
23218334|NCT00254163|64541540|FG001|Overall Study|Death|1|||
23218335|NCT00254163|64541539|FG000|Overall Study|Other|8|||
23218336|NCT00254163|64541540|FG001|Overall Study|Other|8|||
23218337|NCT00724815|64541545|FG000|Overall Study|Randomized, not treated|31|||
23218338|NCT00724815|64541546|FG001|Overall Study|Randomized, not treated|30|||
23218339|NCT00724815|64541545|FG000|Overall Study|Adverse Event|5|||
23218340|NCT00724815|64541546|FG001|Overall Study|Adverse Event|3|||
23218341|NCT00724815|64541545|FG000|Overall Study|Lost to Follow-up|4|||
23218342|NCT00724815|64541546|FG001|Overall Study|Lost to Follow-up|1|||
23218343|NCT00724815|64541545|FG000|Overall Study|Other Various|3|||
23218344|NCT00724815|64541546|FG001|Overall Study|Other Various|5|||
23218345|NCT00268463|64541547|FG000|Overall Study|study terminated due to low accrual|10|||
23218346|NCT00268463|64541548|FG001|Overall Study|study terminated due to low accrual|12|||
23218347|NCT02427100|64541549|FG000|Overall Study|Lost to Follow-up|0|||
23218348|NCT02427100|64541550|FG001|Overall Study|Lost to Follow-up|2|||
23218349|NCT01146951|64541553|FG000|Overall Study|Adverse Event|4|||
23218350|NCT01146951|64541554|FG001|Overall Study|Adverse Event|1|||
23218351|NCT01906476|64541556|FG000|Overall Study|Lost to Follow-up|17|||
23218352|NCT01906476|64541557|FG001|Overall Study|Lost to Follow-up|16|||
23218353|NCT01316939|64541561|FG000|Overall Study|Study closed/terminated|26|||
23218354|NCT01316939|64541562|FG001|Overall Study|Study closed/terminated|25|||
23218355|NCT01316939|64541563|FG002|Overall Study|Study closed/terminated|23|||
23218356|NCT01316939|64541561|FG000|Overall Study|Lack of Efficacy|24|||
23218357|NCT01316939|64541562|FG001|Overall Study|Lack of Efficacy|25|||
23218358|NCT01316939|64541563|FG002|Overall Study|Lack of Efficacy|25|||
23218359|NCT01316939|64541561|FG000|Overall Study|Adverse Event|9|||
23218360|NCT01316939|64541562|FG001|Overall Study|Adverse Event|12|||
23218361|NCT01316939|64541563|FG002|Overall Study|Adverse Event|11|||
23218362|NCT01316939|64541561|FG000|Overall Study|Withdrawal by Subject|1|||
23218363|NCT01316939|64541562|FG001|Overall Study|Withdrawal by Subject|3|||
23218364|NCT01316939|64541563|FG002|Overall Study|Withdrawal by Subject|6|||
23218365|NCT01316939|64541561|FG000|Overall Study|Physician Decision|2|||
23218366|NCT01316939|64541562|FG001|Overall Study|Physician Decision|2|||
23218367|NCT01316939|64541563|FG002|Overall Study|Physician Decision|1|||
23218368|NCT01316939|64541561|FG000|Overall Study|Lost to Follow-up|0|||
23218369|NCT01316939|64541562|FG001|Overall Study|Lost to Follow-up|0|||
23218370|NCT01316939|64541563|FG002|Overall Study|Lost to Follow-up|2|||
23218371|NCT01316939|64541561|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
23218372|NCT01316939|64541562|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
23218373|NCT01316939|64541563|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
23218374|NCT01316939|64541561|FG000|Overall Study|Protocol Violation|0|||
23218375|NCT01316939|64541562|FG001|Overall Study|Protocol Violation|1|||
23218376|NCT01316939|64541563|FG002|Overall Study|Protocol Violation|0|||
23218377|NCT00565812|64541567|FG000|Overall Study|Death|2|||
23218378|NCT00565812|64541568|FG001|Overall Study|Death|1|||
23218379|NCT00565812|64541569|FG002|Overall Study|Death|3|||
23218380|NCT00565812|64541567|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
23218381|NCT00565812|64541568|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
23218382|NCT00565812|64541569|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
23218383|NCT00565812|64541567|FG000|Overall Study|Lost to Follow-up|10|||
23218384|NCT00565812|64541568|FG001|Overall Study|Lost to Follow-up|8|||
23218385|NCT00565812|64541569|FG002|Overall Study|Lost to Follow-up|8|||
23218386|NCT00565812|64541567|FG000|Overall Study|Withdrawal by Subject|58|||
23218387|NCT00565812|64541568|FG001|Overall Study|Withdrawal by Subject|47|||
23218388|NCT00565812|64541569|FG002|Overall Study|Withdrawal by Subject|48|||
23218389|NCT00565812|64541567|FG000|Overall Study|Work Schedule|5|||
23218390|NCT00565812|64541568|FG001|Overall Study|Work Schedule|3|||
23218391|NCT00565812|64541569|FG002|Overall Study|Work Schedule|1|||
23218392|NCT00565812|64541567|FG000|Overall Study|Protocol Violation|2|||
23218393|NCT00565812|64541568|FG001|Overall Study|Protocol Violation|6|||
23435648|NCT01844778|65337134|FG000|Overall Study|Withdrawal by Subject|2|||
23435649|NCT01844778|65337135|FG001|Overall Study|Withdrawal by Subject|0|||
23556971|NCT02279043|65766096|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
23556972|NCT02279043|65766094|FG000|Overall Study|Lost to Follow-up|46|||
23556973|NCT02279043|65766095|FG001|Overall Study|Lost to Follow-up|88|||
23556974|NCT02279043|65766096|FG002|Overall Study|Lost to Follow-up|0|||
23556975|NCT00003508|65766097|FG000|Overall Study|Not evaluable|5|||
23556976|NCT05899686|65766098|FG000|Overall Study|Protocol Violation|1|||
23556977|NCT02709005|65766099|FG000|Overall Study|Lost to Follow-up|1|||
23556978|NCT02709005|65766100|FG001|Overall Study|Lost to Follow-up|1|||
23556979|NCT02709005|65766099|FG000|Overall Study|Withdrawal by Subject|3|||
23556980|NCT02709005|65766100|FG001|Overall Study|Withdrawal by Subject|0|||
23556981|NCT04477187|65766101|FG000|Overall Study|Lost to Follow-up|2|||
23556982|NCT00445679|65766104|FG000|Overall Study|Adverse Event|22|||
23623653|NCT02250534|66008514|FG001|Overall Study|Reason unknown|0|||
23623654|NCT02250534|66008515|FG002|Overall Study|Reason unknown|0|||
23145700|NCT02527343|64281030|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
23145701|NCT02527343|64281031|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
23145702|NCT02527343|64281032|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
23145703|NCT02527343|64281033|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
23145704|NCT02527343|64281034|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
23145705|NCT02527343|64281035|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
23145706|NCT02527343|64281030|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
23145707|NCT02527343|64281031|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
23145708|NCT02527343|64281032|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
23145709|NCT02527343|64281033|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
23145710|NCT02527343|64281034|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
23145711|NCT02527343|64281035|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
23145712|NCT02527343|64281030|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
23145713|NCT02527343|64281031|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
23145714|NCT02527343|64281032|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
23145715|NCT02527343|64281033|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
23145716|NCT02527343|64281034|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
23145717|NCT02527343|64281035|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
23145718|NCT02527343|64281030|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
23145719|NCT02527343|64281031|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
23145720|NCT02527343|64281032|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
23145721|NCT02527343|64281033|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
23145722|NCT02527343|64281034|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
23145723|NCT02527343|64281035|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
23145724|NCT02527343|64281030|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23145725|NCT02527343|64281031|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23145726|NCT02527343|64281032|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23145727|NCT02527343|64281033|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23145728|NCT02527343|64281034|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
23145729|NCT02527343|64281035|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
23145730|NCT02527343|64281030|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
23145731|NCT02527343|64281031|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
23145732|NCT02527343|64281032|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
23145733|NCT02527343|64281033|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
23145734|NCT02527343|64281034|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
23145735|NCT02527343|64281035|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
23145736|NCT01602562|64281037|FG000|Overall Study|Adverse Event|3|||
23145737|NCT01602562|64281038|FG001|Overall Study|Adverse Event|1|||
23145738|NCT01602562|64281037|FG000|Overall Study|Physician Decision|1|||
23145739|NCT01602562|64281038|FG001|Overall Study|Physician Decision|1|||
23145740|NCT01602562|64281037|FG000|Overall Study|Withdrawal by Subject|1|||
23145741|NCT01602562|64281038|FG001|Overall Study|Withdrawal by Subject|1|||
23145742|NCT00835120|64281039|FG000|Overall Study|Lack of Efficacy|1|||
23145743|NCT00835120|64281039|FG000|Overall Study|Lost to Follow-up|3|||
23145744|NCT00835120|64281039|FG000|Overall Study|Adverse Event|2|||
23145745|NCT00835120|64281039|FG000|Overall Study|Withdrawal by Subject|2|||
23145746|NCT01193920|64281045|FG000|Overall Study|Withdrawal by Subject|1|||
23145747|NCT01193920|64281046|FG001|Overall Study|Withdrawal by Subject|0|||
23145748|NCT01193920|64281047|FG002|Overall Study|Withdrawal by Subject|5|||
23145749|NCT01193920|64281048|FG003|Overall Study|Withdrawal by Subject|1|||
23145750|NCT01193920|64281049|FG004|Overall Study|Withdrawal by Subject|3|||
23145751|NCT01193920|64281050|FG005|Overall Study|Withdrawal by Subject|1|||
23145752|NCT01193920|64281051|FG006|Overall Study|Withdrawal by Subject|3|||
23145753|NCT01193920|64281052|FG007|Overall Study|Withdrawal by Subject|0|||
23218394|NCT00565812|64541569|FG002|Overall Study|Protocol Violation|4|||
23556983|NCT00445679|65766105|FG001|Overall Study|Adverse Event|12|||
23556984|NCT00445679|65766106|FG002|Overall Study|Adverse Event|30|||
23556985|NCT00445679|65766107|FG003|Overall Study|Adverse Event|19|||
23556986|NCT00445679|65766104|FG000|Overall Study|Failed to return|1|||
23556987|NCT00445679|65766105|FG001|Overall Study|Failed to return|3|||
23322045|NCT00711243|64922882|FG004|Treated Cycle 5 After First Response|Death|0|||
23435650|NCT01844778|65337136|FG002|Overall Study|Withdrawal by Subject|0|||
23556988|NCT00445679|65766106|FG002|Overall Study|Failed to return|2|||
23556989|NCT00445679|65766107|FG003|Overall Study|Failed to return|2|||
23556990|NCT00445679|65766104|FG000|Overall Study|Physician Decision|0|||
23556991|NCT00445679|65766105|FG001|Overall Study|Physician Decision|0|||
23145754|NCT01193920|64281053|FG008|Overall Study|Withdrawal by Subject|1|||
23145755|NCT01193920|64281054|FG009|Overall Study|Withdrawal by Subject|0|||
23145756|NCT01193920|64281045|FG000|Overall Study|Lost to Follow-up|1|||
23145757|NCT01193920|64281046|FG001|Overall Study|Lost to Follow-up|0|||
23145758|NCT01193920|64281047|FG002|Overall Study|Lost to Follow-up|1|||
23145759|NCT01193920|64281048|FG003|Overall Study|Lost to Follow-up|1|||
23145760|NCT01193920|64281049|FG004|Overall Study|Lost to Follow-up|3|||
23145761|NCT01193920|64281050|FG005|Overall Study|Lost to Follow-up|3|||
23145762|NCT01193920|64281051|FG006|Overall Study|Lost to Follow-up|1|||
23145763|NCT01193920|64281052|FG007|Overall Study|Lost to Follow-up|0|||
23145764|NCT01193920|64281053|FG008|Overall Study|Lost to Follow-up|2|||
23145765|NCT01193920|64281054|FG009|Overall Study|Lost to Follow-up|3|||
23218395|NCT00565812|64541567|FG000|Overall Study|Adverse Event|41|||
23218396|NCT00565812|64541568|FG001|Overall Study|Adverse Event|54|||
23218397|NCT00565812|64541569|FG002|Overall Study|Adverse Event|40|||
23218398|NCT00565812|64541567|FG000|Overall Study|Jury Duty|1|||
23218399|NCT00565812|64541568|FG001|Overall Study|Jury Duty|0|||
23218400|NCT00565812|64541569|FG002|Overall Study|Jury Duty|0|||
23218401|NCT00565812|64541567|FG000|Overall Study|Relocated Out of Area|5|||
23218402|NCT00565812|64541568|FG001|Overall Study|Relocated Out of Area|8|||
23218403|NCT00565812|64541569|FG002|Overall Study|Relocated Out of Area|9|||
23218404|NCT00565812|64541567|FG000|Overall Study|Sponsor Decision|1|||
23218405|NCT00565812|64541568|FG001|Overall Study|Sponsor Decision|5|||
23218406|NCT00565812|64541569|FG002|Overall Study|Sponsor Decision|1|||
23218407|NCT00565812|64541567|FG000|Overall Study|Domestic Reasons|7|||
23218408|NCT00565812|64541568|FG001|Overall Study|Domestic Reasons|1|||
23218409|NCT00565812|64541569|FG002|Overall Study|Domestic Reasons|3|||
23218410|NCT00565812|64541567|FG000|Overall Study|Research Site Closure|6|||
23218411|NCT00565812|64541568|FG001|Overall Study|Research Site Closure|1|||
23218412|NCT00565812|64541569|FG002|Overall Study|Research Site Closure|8|||
23218413|NCT00565812|64541567|FG000|Overall Study|Surgical Intervention|0|||
23218414|NCT00565812|64541568|FG001|Overall Study|Surgical Intervention|1|||
23218415|NCT00565812|64541569|FG002|Overall Study|Surgical Intervention|2|||
23218416|NCT00565812|64541567|FG000|Overall Study|Low Compliance|1|||
23218417|NCT00565812|64541568|FG001|Overall Study|Low Compliance|0|||
23218418|NCT00565812|64541569|FG002|Overall Study|Low Compliance|1|||
23218419|NCT00565812|64541567|FG000|Overall Study|Follow-up Visit Not Completed|2|||
23218420|NCT00565812|64541568|FG001|Overall Study|Follow-up Visit Not Completed|0|||
23218421|NCT00565812|64541569|FG002|Overall Study|Follow-up Visit Not Completed|1|||
23218422|NCT00565812|64541567|FG000|Overall Study|Physician Decision|2|||
23218423|NCT00565812|64541568|FG001|Overall Study|Physician Decision|0|||
23218424|NCT00565812|64541569|FG002|Overall Study|Physician Decision|0|||
23218425|NCT02768103|64541575|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
23218426|NCT01517412|64541581|FG000|Overall Study|Adverse Event|10|||
23435651|NCT01844778|65337134|FG000|Overall Study|Adverse Event|0|||
23435652|NCT01844778|65337135|FG001|Overall Study|Adverse Event|2|||
23218427|NCT01517412|64541582|FG001|Overall Study|Adverse Event|11|||
23218428|NCT01517412|64541581|FG000|Overall Study|Lack of Efficacy|10|||
23435653|NCT01844778|65337136|FG002|Overall Study|Adverse Event|2|||
23145766|NCT01193920|64281045|FG000|Overall Study|Protocol Violation|1|||
23218429|NCT01517412|64541582|FG001|Overall Study|Lack of Efficacy|5|||
23218430|NCT01517412|64541581|FG000|Overall Study|Poor compliance to protocol|8|||
23218431|NCT01517412|64541582|FG001|Overall Study|Poor compliance to protocol|3|||
23218432|NCT01517412|64541581|FG000|Overall Study|Other than specified above|8|||
23218433|NCT01517412|64541582|FG001|Overall Study|Other than specified above|5|||
23322046|NCT00711243|64922883|FG005|Treated Cycle 5 After First Response|Death|2|||
23145767|NCT01193920|64281046|FG001|Overall Study|Protocol Violation|0|||
23556992|NCT00445679|65766106|FG002|Overall Study|Physician Decision|1|||
23556993|NCT00445679|65766107|FG003|Overall Study|Physician Decision|0|||
23556994|NCT00445679|65766104|FG000|Overall Study|Lost to Follow-up|10|||
23556995|NCT00445679|65766105|FG001|Overall Study|Lost to Follow-up|6|||
23556996|NCT00445679|65766106|FG002|Overall Study|Lost to Follow-up|6|||
23556997|NCT00445679|65766107|FG003|Overall Study|Lost to Follow-up|5|||
23556998|NCT00445679|65766104|FG000|Overall Study|Compliance|3|||
23556999|NCT00445679|65766105|FG001|Overall Study|Compliance|2|||
23557000|NCT00445679|65766106|FG002|Overall Study|Compliance|1|||
23557001|NCT00445679|65766107|FG003|Overall Study|Compliance|2|||
23557002|NCT00445679|65766104|FG000|Overall Study|Withdrawal of Informed Consent|0|||
23557003|NCT00445679|65766105|FG001|Overall Study|Withdrawal of Informed Consent|0|||
23557004|NCT00445679|65766106|FG002|Overall Study|Withdrawal of Informed Consent|1|||
23218434|NCT04018612|64541583|FG000|Overall Study|Withdrawal by Subject|1|||
23218435|NCT04018612|64541584|FG001|Overall Study|Withdrawal by Subject|0|||
23218436|NCT04018612|64541585|FG002|Overall Study|Withdrawal by Subject|1|||
23218437|NCT01432457|64541586|FG000|Overall Study|Adverse Event|7|||
23145768|NCT01193920|64281047|FG002|Overall Study|Protocol Violation|0|||
23145769|NCT01193920|64281048|FG003|Overall Study|Protocol Violation|0|||
23145770|NCT01193920|64281049|FG004|Overall Study|Protocol Violation|0|||
23145771|NCT01193920|64281050|FG005|Overall Study|Protocol Violation|0|||
23145772|NCT01193920|64281051|FG006|Overall Study|Protocol Violation|0|||
23145773|NCT01193920|64281052|FG007|Overall Study|Protocol Violation|0|||
23145774|NCT01193920|64281053|FG008|Overall Study|Protocol Violation|0|||
23145775|NCT01193920|64281054|FG009|Overall Study|Protocol Violation|0|||
23145776|NCT01193920|64281045|FG000|Overall Study|Death|0|||
23145777|NCT01193920|64281046|FG001|Overall Study|Death|0|||
23145778|NCT01193920|64281047|FG002|Overall Study|Death|0|||
23145779|NCT01193920|64281048|FG003|Overall Study|Death|1|||
23145780|NCT01193920|64281049|FG004|Overall Study|Death|0|||
23145781|NCT01193920|64281050|FG005|Overall Study|Death|0|||
23145782|NCT01193920|64281051|FG006|Overall Study|Death|2|||
23145783|NCT01193920|64281052|FG007|Overall Study|Death|3|||
23145784|NCT01193920|64281053|FG008|Overall Study|Death|2|||
23218438|NCT01432457|64541587|FG001|Overall Study|Adverse Event|10|||
23218439|NCT01432457|64541588|FG002|Overall Study|Adverse Event|16|||
23145785|NCT01193920|64281054|FG009|Overall Study|Death|4|||
23145786|NCT01193920|64281045|FG000|Overall Study|Unable to classify|0|||
23145787|NCT01193920|64281046|FG001|Overall Study|Unable to classify|0|||
23145788|NCT01193920|64281047|FG002|Overall Study|Unable to classify|0|||
23145789|NCT01193920|64281048|FG003|Overall Study|Unable to classify|1|||
23145790|NCT01193920|64281049|FG004|Overall Study|Unable to classify|0|||
23218440|NCT01432457|64541586|FG000|Overall Study|Lack of Efficacy|2|||
23218441|NCT01432457|64541587|FG001|Overall Study|Lack of Efficacy|1|||
23218442|NCT01432457|64541588|FG002|Overall Study|Lack of Efficacy|1|||
23218443|NCT01432457|64541586|FG000|Overall Study|Lost to Follow-up|11|||
23218444|NCT01432457|64541587|FG001|Overall Study|Lost to Follow-up|15|||
23218445|NCT01432457|64541588|FG002|Overall Study|Lost to Follow-up|20|||
23218446|NCT01432457|64541586|FG000|Overall Study|Protocol Violation|3|||
23218447|NCT01432457|64541587|FG001|Overall Study|Protocol Violation|2|||
23218448|NCT01432457|64541588|FG002|Overall Study|Protocol Violation|6|||
23218449|NCT01432457|64541586|FG000|Overall Study|Withdrawal by Subject|6|||
23218450|NCT01432457|64541587|FG001|Overall Study|Withdrawal by Subject|11|||
23557005|NCT00445679|65766107|FG003|Overall Study|Withdrawal of Informed Consent|0|||
23623655|NCT02506881|66008517|FG000|First Intervention (Day 1)|Protocol Violation|0|||
23623656|NCT02506881|66008518|FG001|First Intervention (Day 1)|Protocol Violation|0|||
23623657|NCT02506881|66008519|FG002|First Intervention (Day 1)|Protocol Violation|1|||
23623658|NCT02506881|66008520|FG003|First Intervention (Day 1)|Protocol Violation|0|||
23623659|NCT02506881|66008517|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
23623660|NCT02506881|66008518|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
23623661|NCT02506881|66008519|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23623662|NCT02506881|66008520|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
23623663|NCT02506881|66008517|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
23623664|NCT02506881|66008518|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
23145791|NCT01193920|64281050|FG005|Overall Study|Unable to classify|0|||
23145792|NCT01193920|64281051|FG006|Overall Study|Unable to classify|0|||
23145793|NCT01193920|64281052|FG007|Overall Study|Unable to classify|1|||
23218451|NCT01432457|64541588|FG002|Overall Study|Withdrawal by Subject|9|||
23218452|NCT01432457|64541586|FG000|Overall Study|Reasons not defined|2|||
23557006|NCT00445679|65766104|FG000|Overall Study|Protocol Violation|2|||
23557007|NCT00445679|65766105|FG001|Overall Study|Protocol Violation|3|||
23557008|NCT00445679|65766106|FG002|Overall Study|Protocol Violation|3|||
23557009|NCT00445679|65766107|FG003|Overall Study|Protocol Violation|1|||
23557010|NCT00445679|65766104|FG000|Overall Study|Withdrawal by Subject|8|||
23557011|NCT00445679|65766105|FG001|Overall Study|Withdrawal by Subject|14|||
23557012|NCT00445679|65766106|FG002|Overall Study|Withdrawal by Subject|20|||
23557013|NCT00445679|65766107|FG003|Overall Study|Withdrawal by Subject|18|||
23623665|NCT02506881|66008519|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
23218453|NCT01432457|64541587|FG001|Overall Study|Reasons not defined|3|||
23218454|NCT01432457|64541588|FG002|Overall Study|Reasons not defined|4|||
23218455|NCT01432457|64541586|FG000|Overall Study|Did not take study drug|6|||
23218456|NCT01432457|64541587|FG001|Overall Study|Did not take study drug|6|||
23623666|NCT02506881|66008520|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
23145794|NCT01193920|64281053|FG008|Overall Study|Unable to classify|0|||
23218457|NCT01432457|64541588|FG002|Overall Study|Did not take study drug|3|||
23145795|NCT01193920|64281054|FG009|Overall Study|Unable to classify|0|||
23145796|NCT01100034|64283579|FG000|Overall Study|Lost to Follow-up|11|||
23145797|NCT01100034|64283579|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
23218458|NCT00762268|64541590|FG000|Overall Study|Withdrawal by Subject|3|||
23557014|NCT00445679|65766104|FG000|Overall Study|Lack of Efficacy|2|||
23557015|NCT00445679|65766105|FG001|Overall Study|Lack of Efficacy|6|||
23145798|NCT01100034|64283579|FG000|Overall Study|Withdrawal by Subject|4|||
23145799|NCT01100034|64283579|FG000|Overall Study|Sponsor decision|21|||
23145800|NCT01100034|64283579|FG000|Overall Study|Participated in another clinical trial|1|||
23145801|NCT01100034|64283579|FG000|Overall Study|Participants moved to another hospital|4|||
23145802|NCT01100034|64283579|FG000|Overall Study|Site closed due to non-responsiveness|1|||
23145803|NCT00093808|64283587|FG000|Overall Study|Cancel participation before receiving tx|1|||
23145804|NCT00093808|64283587|FG000|Overall Study|Protocol Violation|1|||
23145805|NCT00221195|64283588|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
23145806|NCT00221195|64283589|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
23145807|NCT00221195|64283588|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
23145808|NCT00221195|64283589|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
23145809|NCT00221195|64283588|FG000|Washout Period (Months 7-9)|Death|0|||
23145810|NCT00221195|64283589|FG001|Washout Period (Months 7-9)|Death|1|||
23145811|NCT00221195|64283588|FG000|Therapy 2 (Months 10-15)|Death|1|||
23145812|NCT00221195|64283589|FG001|Therapy 2 (Months 10-15)|Death|0|||
23145813|NCT00221195|64283588|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
23145814|NCT00221195|64283589|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
23145815|NCT00838929|64283590|FG000|Overall Study|Protocol Violation|0|||
23145816|NCT00838929|64283591|FG001|Overall Study|Protocol Violation|1|||
23145817|NCT00838929|64283592|FG002|Overall Study|Protocol Violation|0|||
23145818|NCT00838929|64283590|FG000|Overall Study|Disease progression|0|||
23145819|NCT00838929|64283591|FG001|Overall Study|Disease progression|2|||
23145820|NCT00838929|64283592|FG002|Overall Study|Disease progression|1|||
23322047|NCT00711243|64922878|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
23322048|NCT00711243|64922879|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
23322049|NCT00711243|64922880|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
23322050|NCT00711243|64922881|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
23322051|NCT00711243|64922882|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
23322052|NCT00711243|64922883|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
23322053|NCT00711243|64922878|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23322054|NCT00711243|64922879|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23322055|NCT00711243|64922880|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23322056|NCT00711243|64922881|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23322057|NCT00711243|64922882|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
23322058|NCT00711243|64922883|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
23322059|NCT02566889|64922884|FG000|Overall Study|Withdrawal by Subject|3|||
23322060|NCT02566889|64922885|FG001|Overall Study|Withdrawal by Subject|1|||
23322061|NCT02566889|64922884|FG000|Overall Study|Adverse Event|4|||
23322062|NCT02566889|64922885|FG001|Overall Study|Adverse Event|2|||
23322063|NCT02566889|64922884|FG000|Overall Study|Other|6|||
23322064|NCT02566889|64922885|FG001|Overall Study|Other|2|||
23322065|NCT05219448|64922888|FG000|Overall Study|Lost to Follow-up|9|||
23322066|NCT05219448|64922889|FG001|Overall Study|Lost to Follow-up|0|||
23322067|NCT02107131|64922890|FG000|Overall Study|Lost to Follow-up|4|||
23557016|NCT00445679|65766106|FG002|Overall Study|Lack of Efficacy|2|||
23557017|NCT00445679|65766107|FG003|Overall Study|Lack of Efficacy|0|||
23557018|NCT01984697|65766108|FG000|Overall Study|Adverse Event|0|||
23557019|NCT01984697|65766109|FG001|Overall Study|Adverse Event|0|||
23557020|NCT01984697|65766110|FG002|Overall Study|Adverse Event|2|||
23557021|NCT01984697|65766111|FG003|Overall Study|Adverse Event|0|||
23557022|NCT01984697|65766112|FG004|Overall Study|Adverse Event|0|||
23557023|NCT01984697|65766108|FG000|Overall Study|Lost to Follow-up|14|||
23557024|NCT01984697|65766109|FG001|Overall Study|Lost to Follow-up|5|||
23557025|NCT01984697|65766110|FG002|Overall Study|Lost to Follow-up|10|||
23557026|NCT01984697|65766111|FG003|Overall Study|Lost to Follow-up|6|||
23557027|NCT01984697|65766112|FG004|Overall Study|Lost to Follow-up|21|||
23557028|NCT01984697|65766108|FG000|Overall Study|Physician Decision|3|||
23557029|NCT01984697|65766109|FG001|Overall Study|Physician Decision|0|||
23557030|NCT01984697|65766110|FG002|Overall Study|Physician Decision|0|||
23557031|NCT01984697|65766111|FG003|Overall Study|Physician Decision|1|||
23557032|NCT01984697|65766112|FG004|Overall Study|Physician Decision|0|||
23557033|NCT01984697|65766108|FG000|Overall Study|Protocol Violation|8|||
23145821|NCT01658150|64283593|FG000|Overall Study|Withdrawal by Subject|1|||
23145822|NCT03646656|64283594|FG000|Overall Study|Lost to Follow-up|1|||
23145823|NCT03646656|64283595|FG001|Overall Study|Lost to Follow-up|0|||
23145824|NCT03646656|64283594|FG000|Overall Study|Withdrawal by Subject|2|||
23322068|NCT02107131|64922891|FG001|Overall Study|Lost to Follow-up|4|||
23322069|NCT02107131|64922890|FG000|Overall Study|Physician Decision|1|||
23322070|NCT02107131|64922891|FG001|Overall Study|Physician Decision|0|||
23322071|NCT02107131|64922890|FG000|Overall Study|Withdrawal by Subject|2|||
23557034|NCT01984697|65766109|FG001|Overall Study|Protocol Violation|5|||
23557035|NCT01984697|65766110|FG002|Overall Study|Protocol Violation|3|||
23557036|NCT01984697|65766111|FG003|Overall Study|Protocol Violation|2|||
23557037|NCT01984697|65766112|FG004|Overall Study|Protocol Violation|0|||
23557038|NCT01984697|65766108|FG000|Overall Study|Withdrawal by Subject|15|||
23435654|NCT00915551|65337142|FG000|Overall Study|Withdrawal by Subject|0|||
23435655|NCT00915551|65337143|FG001|Overall Study|Withdrawal by Subject|1|||
23435656|NCT02437084|65337146|FG000|Overall Study|Withdrawal by Subject|2|||
23435657|NCT02437084|65337146|FG000|Overall Study|Physician Decision|1|||
23435658|NCT01276223|65337147|FG000|Overall Study|Adverse Event|7|||
23435659|NCT01276223|65337148|FG001|Overall Study|Adverse Event|4|||
23435660|NCT01276223|65337149|FG002|Overall Study|Adverse Event|1|||
23435661|NCT01276223|65337147|FG000|Overall Study|Lost to Follow-up|0|||
23435662|NCT01276223|65337148|FG001|Overall Study|Lost to Follow-up|0|||
23435663|NCT01276223|65337149|FG002|Overall Study|Lost to Follow-up|1|||
23435664|NCT01276223|65337147|FG000|Overall Study|Other|0|||
23435665|NCT01276223|65337148|FG001|Overall Study|Other|0|||
23435666|NCT01276223|65337149|FG002|Overall Study|Other|1|||
23435667|NCT01276223|65337147|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
23435668|NCT01276223|65337148|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
23435669|NCT01276223|65337149|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
23435670|NCT01276223|65337147|FG000|Overall Study|Protocol Violation|1|||
23435671|NCT01276223|65337148|FG001|Overall Study|Protocol Violation|0|||
23435672|NCT01276223|65337149|FG002|Overall Study|Protocol Violation|0|||
23435673|NCT01600092|65337150|FG000|Overall Study|Adverse Event|2|||
23435674|NCT01600092|65337151|FG001|Overall Study|Adverse Event|0|||
23435675|NCT01600092|65337150|FG000|Overall Study|Lost to Follow-up|4|||
23435676|NCT01600092|65337151|FG001|Overall Study|Lost to Follow-up|6|||
23435677|NCT01600092|65337150|FG000|Overall Study|Withdrawal by parent/guardian|8|||
23435678|NCT01600092|65337151|FG001|Overall Study|Withdrawal by parent/guardian|6|||
23435679|NCT01600092|65337150|FG000|Overall Study|Physician Decision|1|||
23435680|NCT01600092|65337151|FG001|Overall Study|Physician Decision|1|||
23435681|NCT01600092|65337150|FG000|Overall Study|Randomized but not vaccinated|3|||
23435682|NCT01600092|65337151|FG001|Overall Study|Randomized but not vaccinated|3|||
23435683|NCT00490776|65337153|FG000|Overall Study|Withdrawal by Subject|1|||
23435684|NCT00490776|65337153|FG000|Overall Study|Administrative Problems|1|||
23435685|NCT00490776|65337153|FG000|Overall Study|Death|1|||
23435686|NCT00490776|65337153|FG000|Overall Study|New Cancer Therapy|1|||
23435687|NCT00490776|65337153|FG000|Overall Study|Disease Progression|5|||
23435688|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
23435689|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
23435690|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
23435691|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435692|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435693|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435694|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435695|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435696|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
23435697|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Physician Decision|1|||
23435698|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Physician Decision|2|||
23435699|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Physician Decision|0|||
23435700|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Physician Decision|0|||
23435701|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Physician Decision|0|||
23435702|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Physician Decision|0|||
23435703|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Physician Decision|0|||
23435704|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Physician Decision|0|||
23435705|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Physician Decision|0|||
23435706|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
23435707|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
23435708|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
23435709|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
23435710|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
23435711|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
23435712|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
23435713|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
23435714|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
23435715|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
23435716|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435717|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435718|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435719|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435720|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435721|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435722|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435723|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
23435724|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
23435725|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
23435726|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435727|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435728|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435729|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435730|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435731|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435732|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
23435733|NCT04405076|65337156|FG000|Part A (Blinded Phase)|Other than Specified|0|||
23435734|NCT04405076|65337157|FG001|Part A (Blinded Phase)|Other than Specified|0|||
23435735|NCT04405076|65337158|FG002|Part A (Blinded Phase)|Other than Specified|3|||
23435736|NCT04405076|65337159|FG003|Part A (Blinded Phase)|Other than Specified|0|||
23435737|NCT04405076|65337160|FG004|Part A (Blinded Phase)|Other than Specified|0|||
23557039|NCT01984697|65766109|FG001|Overall Study|Withdrawal by Subject|21|||
23557040|NCT01984697|65766110|FG002|Overall Study|Withdrawal by Subject|13|||
23435738|NCT04405076|65337161|FG005|Part A (Blinded Phase)|Other than Specified|0|||
23435739|NCT04405076|65337162|FG006|Part A (Blinded Phase)|Other than Specified|0|||
23435740|NCT04405076|65337163|FG007|Part A (Blinded Phase)|Other than Specified|0|||
23435741|NCT04405076|65337164|FG008|Part A (Blinded Phase)|Other than Specified|0|||
23435742|NCT04405076|65337156|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435743|NCT04405076|65337157|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435744|NCT04405076|65337158|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435745|NCT04405076|65337159|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
23435746|NCT04405076|65337160|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
23435747|NCT04405076|65337161|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
23435748|NCT04405076|65337162|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435749|NCT04405076|65337163|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435750|NCT04405076|65337164|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
23435751|NCT04405076|65337156|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435752|NCT04405076|65337157|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435753|NCT04405076|65337158|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435754|NCT04405076|65337159|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435755|NCT04405076|65337160|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
23435756|NCT04405076|65337161|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435757|NCT04405076|65337162|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435758|NCT04405076|65337163|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435759|NCT04405076|65337164|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
23435760|NCT04405076|65337156|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435761|NCT04405076|65337157|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435762|NCT04405076|65337158|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435763|NCT04405076|65337159|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
23435764|NCT04405076|65337160|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
23435765|NCT04405076|65337161|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
23435766|NCT04405076|65337162|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435767|NCT04405076|65337163|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435768|NCT04405076|65337164|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
23435769|NCT04405076|65337156|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435770|NCT04405076|65337157|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435771|NCT04405076|65337158|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435772|NCT04405076|65337159|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435773|NCT04405076|65337160|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435774|NCT04405076|65337161|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23435775|NCT04405076|65337162|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
23557041|NCT01984697|65766111|FG003|Overall Study|Withdrawal by Subject|11|||
23557042|NCT01984697|65766112|FG004|Overall Study|Withdrawal by Subject|13|||
23557043|NCT01984697|65766108|FG000|Overall Study|Missed last follow-up visit|1|||
23557044|NCT01984697|65766109|FG001|Overall Study|Missed last follow-up visit|0|||
23557045|NCT01984697|65766110|FG002|Overall Study|Missed last follow-up visit|0|||
23557046|NCT01984697|65766111|FG003|Overall Study|Missed last follow-up visit|0|||
23557047|NCT01984697|65766112|FG004|Overall Study|Missed last follow-up visit|0|||
23557048|NCT01984697|65766108|FG000|Overall Study|Death|0|||
23557049|NCT01984697|65766109|FG001|Overall Study|Death|0|||
23557050|NCT01984697|65766110|FG002|Overall Study|Death|0|||
23435776|NCT04405076|65337163|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
23557051|NCT01984697|65766111|FG003|Overall Study|Death|1|||
23557052|NCT01984697|65766112|FG004|Overall Study|Death|0|||
23557053|NCT01984697|65766108|FG000|Overall Study|Pregnancy|2|||
23557054|NCT01984697|65766109|FG001|Overall Study|Pregnancy|0|||
23557055|NCT01984697|65766110|FG002|Overall Study|Pregnancy|1|||
23435777|NCT04405076|65337164|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
23435778|NCT04405076|65337156|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435779|NCT04405076|65337157|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435780|NCT04405076|65337158|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435781|NCT04405076|65337159|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435782|NCT04405076|65337160|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435783|NCT04405076|65337161|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435784|NCT04405076|65337162|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
23435785|NCT04405076|65337163|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435786|NCT04405076|65337164|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
23435787|NCT04856904|65337166|FG000|Overall Study|Physician Decision|1|||
23435788|NCT04856904|65337167|FG001|Overall Study|Physician Decision|1|||
23435789|NCT04856904|65337166|FG000|Overall Study|Withdrawal by Subject|13|||
23435790|NCT04856904|65337167|FG001|Overall Study|Withdrawal by Subject|13|||
23435791|NCT04856904|65337166|FG000|Overall Study|Adverse Event|1|||
23435792|NCT04856904|65337167|FG001|Overall Study|Adverse Event|1|||
23435793|NCT04856904|65337166|FG000|Overall Study|Non-compliance with study drug|1|||
23435794|NCT04856904|65337167|FG001|Overall Study|Non-compliance with study drug|1|||
23435795|NCT04856904|65337166|FG000|Overall Study|Lost to Follow-up|4|||
23435796|NCT04856904|65337167|FG001|Overall Study|Lost to Follow-up|4|||
23435797|NCT04856904|65337166|FG000|Overall Study|Withdrawal by Subject|1|||
23435798|NCT04856904|65337167|FG001|Overall Study|Withdrawal by Subject|1|||
23435799|NCT04856904|65337166|FG000|Overall Study|Protocol Violation|1|||
23435800|NCT04856904|65337167|FG001|Overall Study|Protocol Violation|1|||
23435801|NCT01438177|65337168|FG000|Overall Study|Withdrawal by Subject|1|||
23435802|NCT01438177|65337168|FG000|Overall Study|Initiation of new therapy|1|||
23435803|NCT05327361|65337172|FG000|Overall Study|Lost to Follow-up|4|||
23435804|NCT02305238|65337176|FG000|Overall Study|Death|2|||
23435805|NCT02305238|65337177|FG001|Overall Study|Death|1|||
23435806|NCT02305238|65337178|FG002|Overall Study|Death|0|||
23435807|NCT02305238|65337176|FG000|Overall Study|Progressive disease|4|||
23435808|NCT02305238|65337177|FG001|Overall Study|Progressive disease|4|||
23435809|NCT02305238|65337178|FG002|Overall Study|Progressive disease|0|||
23435810|NCT02305238|65337176|FG000|Overall Study|Logistical difficulties|1|||
23435811|NCT02305238|65337177|FG001|Overall Study|Logistical difficulties|3|||
23435812|NCT02305238|65337178|FG002|Overall Study|Logistical difficulties|0|||
23435813|NCT02305238|65337176|FG000|Overall Study|Protocol Violation|0|||
23435814|NCT02305238|65337177|FG001|Overall Study|Protocol Violation|3|||
23435815|NCT02305238|65337178|FG002|Overall Study|Protocol Violation|0|||
23435816|NCT02305238|65337176|FG000|Overall Study|Physician Decision|2|||
23435817|NCT02305238|65337177|FG001|Overall Study|Physician Decision|1|||
23435818|NCT02305238|65337178|FG002|Overall Study|Physician Decision|0|||
23435819|NCT02305238|65337176|FG000|Overall Study|Adverse Event|4|||
23435820|NCT02305238|65337177|FG001|Overall Study|Adverse Event|2|||
23435821|NCT02305238|65337178|FG002|Overall Study|Adverse Event|0|||
23435822|NCT02305238|65337176|FG000|Overall Study|Withdrawal by Subject|3|||
23435823|NCT02305238|65337177|FG001|Overall Study|Withdrawal by Subject|4|||
23435824|NCT02305238|65337178|FG002|Overall Study|Withdrawal by Subject|0|||
23435825|NCT02305238|65337176|FG000|Overall Study|Randomized failure|0|||
23435826|NCT02305238|65337177|FG001|Overall Study|Randomized failure|0|||
23435827|NCT02305238|65337178|FG002|Overall Study|Randomized failure|8|||
23145825|NCT03646656|64283595|FG001|Overall Study|Withdrawal by Subject|0|||
23145826|NCT00743275|64283596|FG000|Overall Study|Protocol Violation|0|||
23145827|NCT00743275|64283597|FG001|Overall Study|Protocol Violation|1|||
23145828|NCT00547365|64283598|FG000|Overall Study|Physician Decision|1|||
23145829|NCT00547365|64283598|FG000|Overall Study|Lost to Follow-up|1|||
23145830|NCT00547365|64283598|FG000|Overall Study|Protocol Violation|2|||
23145831|NCT00547365|64283598|FG000|Overall Study|death (not related to study)|4|||
23145832|NCT02074553|64283600|FG000|Intervention Period 1|Family Emergency|0|||
23145833|NCT02074553|64283601|FG001|Intervention Period 1|Family Emergency|0|||
23145834|NCT02074553|64283602|FG002|Intervention Period 1|Family Emergency|0|||
23145835|NCT02074553|64283603|FG003|Intervention Period 1|Family Emergency|1|||
23145836|NCT02074553|64283604|FG004|Intervention Period 1|Family Emergency|0|||
23145837|NCT02074553|64283605|FG005|Intervention Period 1|Family Emergency|0|||
23145838|NCT02074553|64283606|FG006|Intervention Period 1|Family Emergency|0|||
23145839|NCT02074553|64283607|FG007|Intervention Period 1|Family Emergency|0|||
23145840|NCT02074553|64283600|FG000|Washout Period 1|Adverse Event|1|||
23145841|NCT02074553|64283601|FG001|Washout Period 1|Adverse Event|0|||
23435828|NCT02305238|65337176|FG000|Overall Study|Required procedure failed|0|||
23435829|NCT02305238|65337177|FG001|Overall Study|Required procedure failed|1|||
23435830|NCT02305238|65337178|FG002|Overall Study|Required procedure failed|0|||
23435831|NCT02540668|65337179|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
23435832|NCT02540668|65337180|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
23435833|NCT00293020|65337187|FG000|Overall Study|Withdrawal by Subject|34|||
23435834|NCT00293020|65337187|FG000|Overall Study|Adverse Event|30|||
23435835|NCT00293020|65337187|FG000|Overall Study|Death|32|||
23145842|NCT02074553|64283602|FG002|Washout Period 1|Adverse Event|0|||
23145843|NCT02074553|64283603|FG003|Washout Period 1|Adverse Event|0|||
23145844|NCT02074553|64283604|FG004|Washout Period 1|Adverse Event|0|||
23145845|NCT02074553|64283605|FG005|Washout Period 1|Adverse Event|0|||
23145846|NCT02074553|64283606|FG006|Washout Period 1|Adverse Event|0|||
23145847|NCT02074553|64283607|FG007|Washout Period 1|Adverse Event|0|||
23145848|NCT02074553|64283600|FG000|Washout Period 1|Physician Decision|0|||
23145849|NCT02074553|64283601|FG001|Washout Period 1|Physician Decision|0|||
23145850|NCT02074553|64283602|FG002|Washout Period 1|Physician Decision|0|||
23145851|NCT02074553|64283603|FG003|Washout Period 1|Physician Decision|1|||
23145852|NCT02074553|64283604|FG004|Washout Period 1|Physician Decision|0|||
23145853|NCT02074553|64283605|FG005|Washout Period 1|Physician Decision|0|||
23145854|NCT02074553|64283606|FG006|Washout Period 1|Physician Decision|0|||
23145855|NCT02074553|64283607|FG007|Washout Period 1|Physician Decision|0|||
23145856|NCT02074553|64283600|FG000|Washout Period 1|Other|0|||
23145857|NCT02074553|64283601|FG001|Washout Period 1|Other|0|||
23145858|NCT02074553|64283602|FG002|Washout Period 1|Other|0|||
23145859|NCT02074553|64283603|FG003|Washout Period 1|Other|0|||
23145860|NCT02074553|64283604|FG004|Washout Period 1|Other|0|||
23145861|NCT02074553|64283605|FG005|Washout Period 1|Other|1|||
23145862|NCT02074553|64283606|FG006|Washout Period 1|Other|0|||
23145863|NCT02074553|64283607|FG007|Washout Period 1|Other|0|||
23145864|NCT02074553|64283600|FG000|Washout Period 2|Adverse Event|0|||
23145865|NCT02074553|64283601|FG001|Washout Period 2|Adverse Event|0|||
23145866|NCT02074553|64283602|FG002|Washout Period 2|Adverse Event|0|||
23145867|NCT02074553|64283603|FG003|Washout Period 2|Adverse Event|0|||
23435836|NCT00293020|65337187|FG000|Overall Study|Lack of Efficacy|12|||
23435837|NCT00293020|65337187|FG000|Overall Study|Lost to Follow-up|4|||
23435838|NCT00293020|65337187|FG000|Overall Study|Protocol Violation|6|||
23435839|NCT00293020|65337187|FG000|Overall Study|Physician Decision|21|||
23435840|NCT00293020|65337187|FG000|Overall Study|Other Reason|22|||
23435841|NCT00293020|65337187|FG000|Overall Study|No dose taken|1|||
23435842|NCT01264770|65337189|FG000|Overall Study|Not reported|0|||
23435843|NCT01264770|65337190|FG001|Overall Study|Not reported|0|||
23435844|NCT01264770|65337191|FG002|Overall Study|Not reported|1|||
23145868|NCT02074553|64283604|FG004|Washout Period 2|Adverse Event|0|||
23145869|NCT02074553|64283605|FG005|Washout Period 2|Adverse Event|0|||
23435845|NCT01264770|65337192|FG003|Overall Study|Not reported|0|||
23435846|NCT01264770|65337193|FG004|Overall Study|Not reported|0|||
23435847|NCT01264770|65337194|FG005|Overall Study|Not reported|0|||
23435848|NCT01264770|65337189|FG000|Overall Study|e.g., change in circumstances|8|||
23435849|NCT01264770|65337190|FG001|Overall Study|e.g., change in circumstances|3|||
23435850|NCT01264770|65337191|FG002|Overall Study|e.g., change in circumstances|3|||
23435851|NCT01264770|65337192|FG003|Overall Study|e.g., change in circumstances|3|||
23435852|NCT01264770|65337193|FG004|Overall Study|e.g., change in circumstances|4|||
23435853|NCT01264770|65337194|FG005|Overall Study|e.g., change in circumstances|4|||
23435854|NCT01264770|65337189|FG000|Overall Study|Severe non-compliance to protocol|0|||
23435855|NCT01264770|65337190|FG001|Overall Study|Severe non-compliance to protocol|0|||
23435856|NCT01264770|65337191|FG002|Overall Study|Severe non-compliance to protocol|1|||
23435857|NCT01264770|65337192|FG003|Overall Study|Severe non-compliance to protocol|1|||
23435858|NCT01264770|65337193|FG004|Overall Study|Severe non-compliance to protocol|0|||
23145870|NCT02074553|64283606|FG006|Washout Period 2|Adverse Event|1|||
23145871|NCT02074553|64283607|FG007|Washout Period 2|Adverse Event|0|||
23145872|NCT02074553|64283600|FG000|Washout Period 2|Physician Decision|0|||
23145873|NCT02074553|64283601|FG001|Washout Period 2|Physician Decision|0|||
23145874|NCT02074553|64283602|FG002|Washout Period 2|Physician Decision|0|||
23145875|NCT02074553|64283603|FG003|Washout Period 2|Physician Decision|0|||
23435859|NCT01264770|65337194|FG005|Overall Study|Severe non-compliance to protocol|0|||
23435860|NCT01264770|65337189|FG000|Overall Study|Lack of therapeutic response|1|||
23435861|NCT01264770|65337190|FG001|Overall Study|Lack of therapeutic response|0|||
23435862|NCT01264770|65337191|FG002|Overall Study|Lack of therapeutic response|2|||
23435863|NCT01264770|65337192|FG003|Overall Study|Lack of therapeutic response|1|||
23435864|NCT01264770|65337193|FG004|Overall Study|Lack of therapeutic response|1|||
23435865|NCT01264770|65337194|FG005|Overall Study|Lack of therapeutic response|0|||
23435866|NCT01264770|65337189|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
23435867|NCT01264770|65337190|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
23557056|NCT01984697|65766111|FG003|Overall Study|Pregnancy|0|||
23557057|NCT01984697|65766112|FG004|Overall Study|Pregnancy|1|||
23145876|NCT02074553|64283604|FG004|Washout Period 2|Physician Decision|0|||
23145877|NCT02074553|64283605|FG005|Washout Period 2|Physician Decision|1|||
23145878|NCT02074553|64283606|FG006|Washout Period 2|Physician Decision|0|||
23557058|NCT00855062|65766114|FG000|Step1|Early Study Closure|5|||
23435868|NCT01264770|65337191|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
23435869|NCT01264770|65337192|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
23145879|NCT02074553|64283607|FG007|Washout Period 2|Physician Decision|0|||
23435870|NCT01264770|65337193|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
23557059|NCT00855062|65766115|FG001|Step1|Early Study Closure|7|||
23435871|NCT01264770|65337194|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
23435872|NCT01264770|65337189|FG000|Overall Study|Lost to Follow-up|0|||
23435873|NCT01264770|65337190|FG001|Overall Study|Lost to Follow-up|0|||
23435874|NCT01264770|65337191|FG002|Overall Study|Lost to Follow-up|1|||
23435875|NCT01264770|65337192|FG003|Overall Study|Lost to Follow-up|1|||
23435876|NCT01264770|65337193|FG004|Overall Study|Lost to Follow-up|0|||
23435877|NCT01264770|65337194|FG005|Overall Study|Lost to Follow-up|0|||
23435878|NCT01264770|65337189|FG000|Overall Study|Adverse Event|7|||
23435879|NCT01264770|65337190|FG001|Overall Study|Adverse Event|7|||
23435880|NCT01264770|65337191|FG002|Overall Study|Adverse Event|8|||
23435881|NCT01264770|65337192|FG003|Overall Study|Adverse Event|0|||
23435882|NCT01264770|65337193|FG004|Overall Study|Adverse Event|2|||
23435883|NCT01264770|65337194|FG005|Overall Study|Adverse Event|1|||
23435884|NCT00377364|65337195|FG000|Overall Study|Lost to Follow-up|1|||
23435885|NCT00377364|65337196|FG001|Overall Study|Lost to Follow-up|0|||
23435886|NCT00377364|65337195|FG000|Overall Study|Withdrawal by Subject|1|||
23435887|NCT00377364|65337196|FG001|Overall Study|Withdrawal by Subject|0|||
23435888|NCT01439373|65337200|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
23435889|NCT01439373|65337201|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
23435890|NCT01439373|65337200|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
23435891|NCT01439373|65337201|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
23435892|NCT01008904|65337213|FG000|Overall Study|Lost to Follow-up|1|||
23435893|NCT01008904|65337213|FG000|Overall Study|Adverse Event|2|||
23435894|NCT01008904|65337213|FG000|Overall Study|unexpected unrelated surgery|1|||
23435895|NCT03508609|65337215|FG000|Overall Study|Withdrawal by Subject|1|||
23435896|NCT00837759|65337216|FG000|Overall Study|Protocol Violation|3|||
23435897|NCT00837759|65337216|FG000|Overall Study|Lost to Follow-up|1|||
23435898|NCT02277119|65337219|FG000|Overall Study|Lack of Efficacy|1|||
23435899|NCT02277119|65337220|FG001|Overall Study|Lack of Efficacy|1|||
23435900|NCT02277119|65337221|FG002|Overall Study|Lack of Efficacy|1|||
23435901|NCT02277119|65337219|FG000|Overall Study|Protocol Violation|2|||
23435902|NCT02277119|65337220|FG001|Overall Study|Protocol Violation|3|||
23435903|NCT02277119|65337221|FG002|Overall Study|Protocol Violation|7|||
23435904|NCT02353728|65337222|FG000|Overall Study|Subject non-compliance|1|||
23435905|NCT02428205|65337227|FG000|Overall Study|Lack of Efficacy|1|||
23435906|NCT02428205|65337228|FG001|Overall Study|Lack of Efficacy|0|||
23435907|NCT02428205|65337227|FG000|Overall Study|Lost to Follow-up|1|||
23435908|NCT02428205|65337228|FG001|Overall Study|Lost to Follow-up|1|||
23435909|NCT02428205|65337227|FG000|Overall Study|Worse behavior|0|||
23435910|NCT02428205|65337228|FG001|Overall Study|Worse behavior|1|||
23435911|NCT03369236|65337231|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
23435912|NCT03369236|65337232|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
23435913|NCT03369236|65337231|FG000|Open-label Extension Period|Lack of Efficacy|2|||
23435914|NCT03369236|65337232|FG001|Open-label Extension Period|Lack of Efficacy|1|||
23435915|NCT03369236|65337231|FG000|Open-label Extension Period|Adverse Event|0|||
23435916|NCT03369236|65337232|FG001|Open-label Extension Period|Adverse Event|1|||
23435917|NCT03369236|65337231|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
23435918|NCT03369236|65337232|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
23435919|NCT02252965|65337235|FG000|Overall Study|Adverse Event|9|||
23435920|NCT02252965|65337236|FG001|Overall Study|Adverse Event|14|||
23435921|NCT02252965|65337235|FG000|Overall Study|Lost to Follow-up|16|||
23435922|NCT02252965|65337236|FG001|Overall Study|Lost to Follow-up|8|||
23435923|NCT02252965|65337235|FG000|Overall Study|Protocol Violation|4|||
23435924|NCT02252965|65337236|FG001|Overall Study|Protocol Violation|5|||
23435925|NCT02252965|65337235|FG000|Overall Study|Lack of Efficacy|0|||
23435926|NCT02252965|65337236|FG001|Overall Study|Lack of Efficacy|2|||
23435927|NCT02252965|65337235|FG000|Overall Study|Withdrawal by Subject|7|||
23435928|NCT02252965|65337236|FG001|Overall Study|Withdrawal by Subject|9|||
23435929|NCT02252965|65337235|FG000|Overall Study|Other|4|||
23435930|NCT02252965|65337236|FG001|Overall Study|Other|5|||
23435931|NCT01403116|65337237|FG000|Overall Study|Adverse Event|7|||
23435932|NCT01403116|65337238|FG001|Overall Study|Adverse Event|4|||
23435933|NCT01403116|65337237|FG000|Overall Study|Lost to Follow-up|7|||
23435934|NCT01403116|65337238|FG001|Overall Study|Lost to Follow-up|5|||
23557060|NCT00855062|65766114|FG000|Step1|Adverse Event|1|||
23435935|NCT01403116|65337237|FG000|Overall Study|Withdrawal by Subject|12|||
23435936|NCT01403116|65337238|FG001|Overall Study|Withdrawal by Subject|15|||
23435937|NCT01403116|65337237|FG000|Overall Study|Non-compliance of study drug|3|||
23557061|NCT00855062|65766115|FG001|Step1|Adverse Event|1|||
23557062|NCT00855062|65766114|FG000|Step1|Protocol Violation|1|||
23435938|NCT01403116|65337238|FG001|Overall Study|Non-compliance of study drug|0|||
23435939|NCT01403116|65337237|FG000|Overall Study|Protocol Violation|0|||
23435940|NCT01403116|65337238|FG001|Overall Study|Protocol Violation|1|||
23435941|NCT01403116|65337237|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
23435942|NCT01403116|65337238|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
23435943|NCT01403116|65337237|FG000|Overall Study|Hct >54%|2|||
23435944|NCT01403116|65337238|FG001|Overall Study|Hct >54%|0|||
23435945|NCT01403116|65337237|FG000|Overall Study|unable to keep appointments|0|||
23435946|NCT01403116|65337238|FG001|Overall Study|unable to keep appointments|2|||
23435947|NCT01620528|65337242|FG000|Treatment Period|Did Not Receive Study Drug|0|||
23435948|NCT01620528|65337243|FG001|Treatment Period|Did Not Receive Study Drug|0|||
23435949|NCT01620528|65337244|FG002|Treatment Period|Did Not Receive Study Drug|1|||
23435950|NCT01620528|65337242|FG000|Treatment Period|Withdrawal by Subject|35|||
23435951|NCT01620528|65337243|FG001|Treatment Period|Withdrawal by Subject|21|||
23435952|NCT01620528|65337244|FG002|Treatment Period|Withdrawal by Subject|16|||
23435953|NCT01620528|65337242|FG000|Treatment Period|Adverse Event|17|||
23435954|NCT01620528|65337243|FG001|Treatment Period|Adverse Event|13|||
23435955|NCT01620528|65337244|FG002|Treatment Period|Adverse Event|21|||
23435956|NCT01620528|65337242|FG000|Treatment Period|Lost to Follow-up|16|||
23435957|NCT01620528|65337243|FG001|Treatment Period|Lost to Follow-up|8|||
23435958|NCT01620528|65337244|FG002|Treatment Period|Lost to Follow-up|14|||
23435959|NCT01620528|65337242|FG000|Treatment Period|Other|9|||
23435960|NCT01620528|65337243|FG001|Treatment Period|Other|5|||
23435961|NCT01620528|65337244|FG002|Treatment Period|Other|7|||
23435962|NCT01620528|65337242|FG000|Treatment Period|Subject Noncompliant|11|||
23435963|NCT01620528|65337243|FG001|Treatment Period|Subject Noncompliant|2|||
23435964|NCT01620528|65337244|FG002|Treatment Period|Subject Noncompliant|2|||
23435965|NCT01620528|65337242|FG000|Treatment Period|Pregnancy|7|||
23435966|NCT01620528|65337243|FG001|Treatment Period|Pregnancy|2|||
23435967|NCT01620528|65337244|FG002|Treatment Period|Pregnancy|2|||
23435968|NCT01620528|65337242|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
23435969|NCT01620528|65337243|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
23435970|NCT01620528|65337244|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
23435971|NCT01620528|65337242|FG000|Treatment Period|Exclusionary Medication Received|0|||
23435972|NCT01620528|65337243|FG001|Treatment Period|Exclusionary Medication Received|1|||
23435973|NCT01620528|65337244|FG002|Treatment Period|Exclusionary Medication Received|0|||
23435974|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
23435975|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
23435976|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
23435977|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
23435978|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23435979|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
23435980|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
23435981|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
23435982|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
23435983|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
23435984|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
23435985|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
23435986|NCT01620528|65337242|FG000|Post-Treatment Follow-Up Period|Other|6|||
23435987|NCT01620528|65337243|FG001|Post-Treatment Follow-Up Period|Other|4|||
23435988|NCT01620528|65337244|FG002|Post-Treatment Follow-Up Period|Other|2|||
23435989|NCT00527332|65337245|FG000|Overall Study|Protocol Violation|4|||
23435990|NCT00527332|65337246|FG001|Overall Study|Protocol Violation|8|||
23435991|NCT00527332|65337245|FG000|Overall Study|Withdrew consent|5|||
23435992|NCT00527332|65337246|FG001|Overall Study|Withdrew consent|1|||
23435993|NCT02936284|65337252|FG000|Overall Study|Withdrawal by Subject|3|||
23623667|NCT00275301|66008532|FG000|Overall Study|Adverse Event|5|||
23623668|NCT02171130|66008534|FG000|Overall Study|Death|1|||
23623669|NCT02171130|66008534|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
23623670|NCT02171130|66008534|FG000|Overall Study|Discontinued; Site Termination|5|||
23145880|NCT02074553|64283600|FG000|Washout Period 2|Lost to Follow-up|0|||
23145881|NCT02074553|64283601|FG001|Washout Period 2|Lost to Follow-up|0|||
23435994|NCT02936284|65337253|FG001|Overall Study|Withdrawal by Subject|1|||
23435995|NCT02936284|65337252|FG000|Overall Study|Lost to Follow-up|7|||
23435996|NCT02936284|65337253|FG001|Overall Study|Lost to Follow-up|8|||
23435997|NCT02999633|65337254|FG000|Overall Study|Adverse Event|2|||
23557063|NCT00855062|65766115|FG001|Step1|Protocol Violation|0|||
23557064|NCT00855062|65766114|FG000|Step1|Pregnancy|1|||
23557065|NCT00855062|65766115|FG001|Step1|Pregnancy|0|||
23557066|NCT00855062|65766114|FG000|Step1|Withdrawal by Subject|2|||
23557067|NCT00855062|65766115|FG001|Step1|Withdrawal by Subject|3|||
23557068|NCT00855062|65766114|FG000|Step2|Early Study Closure|6|||
23557069|NCT00855062|65766115|FG001|Step2|Early Study Closure|2|||
23557070|NCT00855062|65766114|FG000|Step2|Adverse Event|0|||
23557071|NCT00855062|65766115|FG001|Step2|Adverse Event|3|||
23557072|NCT00855062|65766114|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
23557073|NCT00855062|65766115|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
23557074|NCT02120027|65766119|FG000|Overall Study|Adverse Event|4|||
23322072|NCT02107131|64922891|FG001|Overall Study|Withdrawal by Subject|0|||
23435998|NCT02999633|65337254|FG000|Overall Study|Progressive disease|12|||
23557075|NCT02120027|65766120|FG001|Overall Study|Adverse Event|5|||
23557076|NCT02120027|65766119|FG000|Overall Study|Lack of Efficacy|3|||
23435999|NCT00705146|65337257|FG000|Overall Study|Lost to Follow-up|1|||
23436000|NCT00705146|65337258|FG001|Overall Study|Lost to Follow-up|1|||
23436001|NCT03689855|65337267|FG000|Overall Study|Adverse Event|3|||
23436002|NCT03689855|65337267|FG000|Overall Study|Withdrawal by Subject|1|||
23436003|NCT03922620|65340559|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
23436004|NCT03922620|65340560|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
23436005|NCT02873338|65340561|FG000|Overall Study|Adverse Event|0|||
23436006|NCT02873338|65340562|FG001|Overall Study|Adverse Event|2|||
23436007|NCT02873338|65340563|FG002|Overall Study|Adverse Event|1|||
23436008|NCT02873338|65340561|FG000|Overall Study|Death|2|||
23436009|NCT02873338|65340562|FG001|Overall Study|Death|1|||
23436010|NCT02873338|65340563|FG002|Overall Study|Death|1|||
23436011|NCT02873338|65340561|FG000|Overall Study|Withdrawal by Subject|2|||
23436012|NCT02873338|65340562|FG001|Overall Study|Withdrawal by Subject|1|||
23436013|NCT02873338|65340563|FG002|Overall Study|Withdrawal by Subject|3|||
23436014|NCT02873338|65340561|FG000|Overall Study|Lack of Efficacy|0|||
23436015|NCT02873338|65340562|FG001|Overall Study|Lack of Efficacy|2|||
23436016|NCT02873338|65340563|FG002|Overall Study|Lack of Efficacy|0|||
23436017|NCT02873338|65340561|FG000|Overall Study|Other or Missing|14|||
23436018|NCT02873338|65340562|FG001|Overall Study|Other or Missing|15|||
23436019|NCT02873338|65340563|FG002|Overall Study|Other or Missing|13|||
23436020|NCT00428389|65340571|FG000|Core Phase|Adverse Event|6|||
23436021|NCT00428389|65340572|FG001|Core Phase|Adverse Event|4|||
23436022|NCT00428389|65340571|FG000|Core Phase|Lack of Efficacy|2|||
23436023|NCT00428389|65340572|FG001|Core Phase|Lack of Efficacy|0|||
23436024|NCT00428389|65340571|FG000|Core Phase|Abnormal test procedure result(s)|0|||
23436025|NCT00428389|65340572|FG001|Core Phase|Abnormal test procedure result(s)|1|||
23436026|NCT00428389|65340571|FG000|Core Phase|Withdrawal by Subject|3|||
23436027|NCT00428389|65340572|FG001|Core Phase|Withdrawal by Subject|4|||
23436028|NCT00428389|65340571|FG000|Core Phase|Protocol deviation|0|||
23436029|NCT00428389|65340572|FG001|Core Phase|Protocol deviation|2|||
23436030|NCT00428389|65340571|FG000|Extension Phase|Adverse Event|17|||
23436031|NCT00428389|65340572|FG001|Extension Phase|Adverse Event|11|||
23436032|NCT00428389|65340571|FG000|Extension Phase|Lack of Efficacy|4|||
23436033|NCT00428389|65340572|FG001|Extension Phase|Lack of Efficacy|3|||
23436034|NCT00428389|65340571|FG000|Extension Phase|Withdrawal by Subject|6|||
23436035|NCT00428389|65340572|FG001|Extension Phase|Withdrawal by Subject|6|||
23436036|NCT00428389|65340571|FG000|Extension Phase|Lost to Follow-up|0|||
23436037|NCT00428389|65340572|FG001|Extension Phase|Lost to Follow-up|3|||
23436038|NCT00428389|65340571|FG000|Extension Phase|Death|1|||
23436039|NCT00428389|65340572|FG001|Extension Phase|Death|0|||
23436040|NCT00428389|65340571|FG000|Extension Phase|Protocol Violation|3|||
23436041|NCT00428389|65340572|FG001|Extension Phase|Protocol Violation|2|||
23436042|NCT00428389|65340571|FG000|Extension Phase|Administrative problems|1|||
23436043|NCT00428389|65340572|FG001|Extension Phase|Administrative problems|1|||
23436044|NCT01870726|65340573|FG000|Overall Study|Withdrawal of informed consent|0|||
23436045|NCT01870726|65340574|FG001|Overall Study|Withdrawal of informed consent|0|||
23436046|NCT01870726|65340575|FG002|Overall Study|Withdrawal of informed consent|0|||
23436047|NCT01870726|65340576|FG003|Overall Study|Withdrawal of informed consent|1|||
23436048|NCT01870726|65340577|FG004|Overall Study|Withdrawal of informed consent|0|||
23436049|NCT01870726|65340578|FG005|Overall Study|Withdrawal of informed consent|0|||
23436050|NCT01870726|65340579|FG006|Overall Study|Withdrawal of informed consent|0|||
23436051|NCT01870726|65340573|FG000|Overall Study|Withdrawal by Subject|0|||
23436052|NCT01870726|65340574|FG001|Overall Study|Withdrawal by Subject|1|||
23436053|NCT01870726|65340575|FG002|Overall Study|Withdrawal by Subject|0|||
23436054|NCT01870726|65340576|FG003|Overall Study|Withdrawal by Subject|0|||
23145882|NCT02074553|64283602|FG002|Washout Period 2|Lost to Follow-up|1|||
23145883|NCT02074553|64283603|FG003|Washout Period 2|Lost to Follow-up|0|||
23145884|NCT02074553|64283604|FG004|Washout Period 2|Lost to Follow-up|0|||
23145885|NCT02074553|64283605|FG005|Washout Period 2|Lost to Follow-up|0|||
23145886|NCT02074553|64283606|FG006|Washout Period 2|Lost to Follow-up|0|||
23145887|NCT02074553|64283607|FG007|Washout Period 2|Lost to Follow-up|0|||
23145888|NCT02074553|64283600|FG000|Washout Period 3|Physician Decision|0|||
23145889|NCT02074553|64283601|FG001|Washout Period 3|Physician Decision|0|||
23145890|NCT02074553|64283602|FG002|Washout Period 3|Physician Decision|0|||
23145891|NCT02074553|64283603|FG003|Washout Period 3|Physician Decision|0|||
23145892|NCT02074553|64283604|FG004|Washout Period 3|Physician Decision|0|||
23436055|NCT01870726|65340577|FG004|Overall Study|Withdrawal by Subject|0|||
23557077|NCT02120027|65766120|FG001|Overall Study|Lack of Efficacy|5|||
23145893|NCT02074553|64283605|FG005|Washout Period 3|Physician Decision|0|||
23145894|NCT02074553|64283606|FG006|Washout Period 3|Physician Decision|0|||
23436056|NCT01870726|65340578|FG005|Overall Study|Withdrawal by Subject|0|||
23436057|NCT01870726|65340579|FG006|Overall Study|Withdrawal by Subject|0|||
23436058|NCT01870726|65340573|FG000|Overall Study|Adverse Event|0|||
23436059|NCT01870726|65340574|FG001|Overall Study|Adverse Event|0|||
23436060|NCT01870726|65340575|FG002|Overall Study|Adverse Event|0|||
23436061|NCT01870726|65340576|FG003|Overall Study|Adverse Event|0|||
23145895|NCT02074553|64283607|FG007|Washout Period 3|Physician Decision|1|||
23145896|NCT00756470|64283608|FG000|Overall Study|Withdrawal by Subject|1|||
23145897|NCT00756470|64283608|FG000|Overall Study|Adverse Event|4|||
23145898|NCT01640054|64283616|FG000|Overall Study|Study-specific disc criteria|1|||
23145899|NCT01640054|64283616|FG000|Overall Study|Lack of Efficacy|3|||
23145900|NCT01640054|64283616|FG000|Overall Study|Adverse Event|2|||
23145901|NCT01139658|64283617|FG000|Overall Study|Adverse Event|10|||
23145902|NCT01139658|64283618|FG001|Overall Study|Adverse Event|27|||
23145903|NCT01139658|64283617|FG000|Overall Study|Lack of Efficacy|15|||
23145904|NCT01139658|64283618|FG001|Overall Study|Lack of Efficacy|7|||
23436062|NCT01870726|65340577|FG004|Overall Study|Adverse Event|1|||
23436063|NCT01870726|65340578|FG005|Overall Study|Adverse Event|1|||
23436064|NCT01870726|65340579|FG006|Overall Study|Adverse Event|0|||
23436065|NCT01870726|65340573|FG000|Overall Study|Progressive disease|5|||
23436066|NCT01870726|65340574|FG001|Overall Study|Progressive disease|5|||
23436067|NCT01870726|65340575|FG002|Overall Study|Progressive disease|4|||
23436068|NCT01870726|65340576|FG003|Overall Study|Progressive disease|5|||
23436069|NCT01870726|65340577|FG004|Overall Study|Progressive disease|6|||
23436070|NCT01870726|65340578|FG005|Overall Study|Progressive disease|4|||
23436071|NCT01870726|65340579|FG006|Overall Study|Progressive disease|10|||
23436072|NCT03178669|65340580|FG000|Overall Study|Adverse Event|4|||
23436073|NCT03178669|65340581|FG001|Overall Study|Adverse Event|1|||
23436074|NCT03178669|65340582|FG002|Overall Study|Adverse Event|4|||
23436075|NCT03178669|65340583|FG003|Overall Study|Adverse Event|2|||
23436076|NCT03178669|65340584|FG004|Overall Study|Adverse Event|2|||
23436077|NCT03178669|65340580|FG000|Overall Study|Lack of Efficacy|0|||
23436078|NCT03178669|65340581|FG001|Overall Study|Lack of Efficacy|0|||
23436079|NCT03178669|65340582|FG002|Overall Study|Lack of Efficacy|2|||
23436080|NCT03178669|65340583|FG003|Overall Study|Lack of Efficacy|0|||
23436081|NCT03178669|65340584|FG004|Overall Study|Lack of Efficacy|1|||
23436082|NCT03178669|65340580|FG000|Overall Study|Physician Decision|0|||
23436083|NCT03178669|65340581|FG001|Overall Study|Physician Decision|0|||
23436084|NCT03178669|65340582|FG002|Overall Study|Physician Decision|0|||
23436085|NCT03178669|65340583|FG003|Overall Study|Physician Decision|0|||
23436086|NCT03178669|65340584|FG004|Overall Study|Physician Decision|1|||
23436087|NCT03178669|65340580|FG000|Overall Study|Withdrawal by Subject|1|||
23436088|NCT03178669|65340581|FG001|Overall Study|Withdrawal by Subject|0|||
23436089|NCT03178669|65340582|FG002|Overall Study|Withdrawal by Subject|1|||
23557078|NCT02120027|65766119|FG000|Overall Study|Lost to Follow-up|5|||
23557079|NCT02120027|65766120|FG001|Overall Study|Lost to Follow-up|13|||
23557080|NCT02120027|65766119|FG000|Overall Study|Other|4|||
23557081|NCT02120027|65766120|FG001|Overall Study|Other|0|||
23557082|NCT02120027|65766119|FG000|Overall Study|Physician Decision|4|||
23145905|NCT01139658|64283617|FG000|Overall Study|Withdrawal by Subject|2|||
23145906|NCT01139658|64283618|FG001|Overall Study|Withdrawal by Subject|4|||
23145907|NCT01139658|64283617|FG000|Overall Study|No documentation of treatment|1|||
23145908|NCT01139658|64283618|FG001|Overall Study|No documentation of treatment|0|||
23145909|NCT01139658|64283617|FG000|Overall Study|Other|28|||
23145910|NCT01139658|64283618|FG001|Overall Study|Other|75|||
23145911|NCT03588728|64283621|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
23145912|NCT03588728|64283622|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
23145913|NCT03588728|64283623|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
23145914|NCT03588728|64283624|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
23145915|NCT03588728|64283621|FG000|Overall Study|Lab shut down due to COVID-19|0|||
23145916|NCT03588728|64283622|FG001|Overall Study|Lab shut down due to COVID-19|0|||
23145917|NCT03588728|64283623|FG002|Overall Study|Lab shut down due to COVID-19|0|||
23145918|NCT03588728|64283624|FG003|Overall Study|Lab shut down due to COVID-19|1|||
23145919|NCT03588728|64283621|FG000|Overall Study|multiple technical issues|1|||
23557083|NCT02120027|65766120|FG001|Overall Study|Physician Decision|3|||
23557084|NCT02120027|65766119|FG000|Overall Study|Protocol Violation|18|||
23557085|NCT02120027|65766120|FG001|Overall Study|Protocol Violation|21|||
23557086|NCT02120027|65766119|FG000|Overall Study|Study terminated by Sponsor|45|||
23145920|NCT03588728|64283622|FG001|Overall Study|multiple technical issues|0|||
23145921|NCT03588728|64283623|FG002|Overall Study|multiple technical issues|0|||
23218459|NCT00762268|64541591|FG001|Overall Study|Withdrawal by Subject|3|||
23436090|NCT03178669|65340583|FG003|Overall Study|Withdrawal by Subject|1|||
23436091|NCT03178669|65340584|FG004|Overall Study|Withdrawal by Subject|0|||
23436092|NCT03178669|65340580|FG000|Overall Study|Lost to Follow-up|0|||
23436093|NCT03178669|65340581|FG001|Overall Study|Lost to Follow-up|0|||
23436094|NCT03178669|65340582|FG002|Overall Study|Lost to Follow-up|0|||
23436095|NCT03178669|65340583|FG003|Overall Study|Lost to Follow-up|1|||
23436096|NCT03178669|65340584|FG004|Overall Study|Lost to Follow-up|0|||
23145922|NCT03588728|64283624|FG003|Overall Study|multiple technical issues|0|||
23145923|NCT03588728|64283621|FG000|Overall Study|Hospitalized for COVID|1|||
23145924|NCT03588728|64283622|FG001|Overall Study|Hospitalized for COVID|0|||
23145925|NCT03588728|64283623|FG002|Overall Study|Hospitalized for COVID|0|||
23436097|NCT02798471|65340585|FG000|Overall Study|Adverse Event|7|||
23557087|NCT02120027|65766120|FG001|Overall Study|Study terminated by Sponsor|47|||
23557088|NCT02120027|65766119|FG000|Overall Study|Withdrawal by Subject|33|||
23557089|NCT02120027|65766120|FG001|Overall Study|Withdrawal by Subject|25|||
23557090|NCT01559844|65766121|FG000|Overall Study|Consent Withdrawn|7|||
23557091|NCT01559844|65766121|FG000|Overall Study|Death|5|||
23557092|NCT01559844|65766121|FG000|Overall Study|Efficacy Failure|10|||
23557093|NCT01559844|65766121|FG000|Overall Study|No Longer A Transplant Candidate|3|||
23557094|NCT01951625|65766122|FG000|Treatment Period|Protocol Violation|2|||
23557095|NCT01951625|65766123|FG001|Treatment Period|Protocol Violation|0|||
23557096|NCT01951625|65766124|FG002|Treatment Period|Protocol Violation|1|||
23557097|NCT01951625|65766125|FG003|Treatment Period|Protocol Violation|3|||
23623671|NCT02171130|66008534|FG000|Overall Study|Withdrawal by Subject|3|||
23623672|NCT02171130|66008534|FG000|Overall Study|Physician Decision|1|||
23623673|NCT02171130|66008534|FG000|Overall Study|Lost to Follow-up|1|||
23623674|NCT02171130|66008534|FG000|Overall Study|Met Exclusion Criteria|1|||
23623675|NCT02517528|66008535|FG000|Overall Study|Withdrawal by Subject|1|||
23623676|NCT00951171|66008536|FG000|Overall Study|Adverse Event|2|||
23623677|NCT00951171|66008537|FG001|Overall Study|Adverse Event|0|||
23623678|NCT01503164|66008540|FG000|Overall Study|Withdrawal by Subject|2|||
23623679|NCT01503164|66008541|FG001|Overall Study|Withdrawal by Subject|1|||
23623680|NCT02859064|66008547|FG000|Overall Study|Progressive Disease|3|||
23623681|NCT02859064|66008547|FG000|Overall Study|Physician Decision|1|||
23623682|NCT02859064|66008547|FG000|Overall Study|Withdrawal by Subject|1|||
23623683|NCT02859064|66008547|FG000|Overall Study|Death|1|||
23623684|NCT01751165|66008553|FG000|Overall Study|Adverse event, serious fatal|1|||
23623685|NCT01751165|66008554|FG001|Overall Study|Adverse event, serious fatal|0|||
23623686|NCT01751165|66008555|FG002|Overall Study|Adverse event, serious fatal|1|||
23623687|NCT01751165|66008553|FG000|Overall Study|Withdrawal by Subject|0|||
23623688|NCT01751165|66008554|FG001|Overall Study|Withdrawal by Subject|0|||
23623689|NCT01751165|66008555|FG002|Overall Study|Withdrawal by Subject|1|||
23623690|NCT01751165|66008553|FG000|Overall Study|Serious adverse event|0|||
23623691|NCT01751165|66008554|FG001|Overall Study|Serious adverse event|2|||
23623692|NCT01751165|66008555|FG002|Overall Study|Serious adverse event|0|||
23623693|NCT01751165|66008553|FG000|Overall Study|Lost to Follow-up|1|||
23623694|NCT01751165|66008554|FG001|Overall Study|Lost to Follow-up|1|||
23623695|NCT01751165|66008555|FG002|Overall Study|Lost to Follow-up|1|||
23623696|NCT01721746|66008556|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
23623697|NCT01721746|66008557|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
23623698|NCT01721746|66008556|FG000|Pre-Treatment|Withdrawal by Subject|1|||
23623699|NCT01721746|66008557|FG001|Pre-Treatment|Withdrawal by Subject|16|||
23623700|NCT01721746|66008556|FG000|Pre-Treatment|Poor/Non-compliance|1|||
23623701|NCT01721746|66008557|FG001|Pre-Treatment|Poor/Non-compliance|0|||
23623702|NCT01721746|66008556|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
23623703|NCT01721746|66008557|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
23623704|NCT01721746|66008556|FG000|Treatment|Disease Progression|192|||
23623705|NCT01721746|66008557|FG001|Treatment|Disease Progression|74|||
23623706|NCT01721746|66008556|FG000|Treatment|Study Drug Toxicity|19|||
23623707|NCT01721746|66008557|FG001|Treatment|Study Drug Toxicity|11|||
23623708|NCT01721746|66008556|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
23623709|NCT01721746|66008557|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
23623710|NCT01721746|66008556|FG000|Treatment|Participant request to discontinue Study treatment|26|||
23623711|NCT01721746|66008557|FG001|Treatment|Participant request to discontinue Study treatment|7|||
23623712|NCT01721746|66008556|FG000|Treatment|Participant withdrew consent|4|||
23623713|NCT01721746|66008557|FG001|Treatment|Participant withdrew consent|2|||
23623714|NCT01721746|66008556|FG000|Treatment|Maximum Clinical Benefit|9|||
23623715|NCT01721746|66008557|FG001|Treatment|Maximum Clinical Benefit|3|||
23623716|NCT01721746|66008556|FG000|Treatment|Poor/Non-compliance|2|||
23623717|NCT01721746|66008557|FG001|Treatment|Poor/Non-compliance|0|||
23623718|NCT01721746|66008556|FG000|Treatment|Participant no longer met Study criteria|4|||
23623719|NCT01721746|66008557|FG001|Treatment|Participant no longer met Study criteria|0|||
23623720|NCT01721746|66008556|FG000|Treatment|Other reasons|6|||
23623721|NCT01721746|66008557|FG001|Treatment|Other reasons|2|||
23145926|NCT03588728|64283624|FG003|Overall Study|Hospitalized for COVID|0|||
23623722|NCT03517111|66008561|FG000|Enrolled|Withdrawal by Subject|0|||
23623723|NCT03517111|66008562|FG001|Enrolled|Withdrawal by Subject|1|||
23623724|NCT03517111|66008563|FG002|Enrolled|Withdrawal by Subject|0|||
23623725|NCT03517111|66008561|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
23623726|NCT03517111|66008562|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
23623727|NCT03517111|66008563|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
23145927|NCT03588728|64283621|FG000|Overall Study|Schedule change unable to attend sessions|1|||
23322073|NCT02107131|64922890|FG000|Overall Study|mental instability|1|||
23557098|NCT01951625|65766126|FG004|Treatment Period|Protocol Violation|2|||
23557099|NCT01951625|65766122|FG000|Treatment Period|Physician Decision|0|||
23557100|NCT01951625|65766123|FG001|Treatment Period|Physician Decision|0|||
23623728|NCT03517111|66008561|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
23623729|NCT03517111|66008562|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
23623730|NCT03517111|66008563|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
23623731|NCT03517111|66008561|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
23623732|NCT03517111|66008562|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
23623733|NCT03517111|66008563|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
23623734|NCT03517111|66008561|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
23145928|NCT03588728|64283622|FG001|Overall Study|Schedule change unable to attend sessions|0|||
23145929|NCT03588728|64283623|FG002|Overall Study|Schedule change unable to attend sessions|0|||
23436098|NCT02798471|65340586|FG001|Overall Study|Adverse Event|2|||
23436099|NCT02798471|65340585|FG000|Overall Study|Physician Decision|3|||
23436100|NCT02798471|65340586|FG001|Overall Study|Physician Decision|7|||
23436101|NCT02798471|65340585|FG000|Overall Study|Death|2|||
23436102|NCT02798471|65340586|FG001|Overall Study|Death|3|||
23436103|NCT02798471|65340585|FG000|Overall Study|Lost to Follow-up|0|||
23436104|NCT02798471|65340586|FG001|Overall Study|Lost to Follow-up|1|||
23436105|NCT02798471|65340585|FG000|Overall Study|Other|5|||
23145930|NCT03588728|64283624|FG003|Overall Study|Schedule change unable to attend sessions|0|||
23218460|NCT00212758|64541592|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
23218461|NCT00212758|64541593|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
23218462|NCT00212758|64541592|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
23557101|NCT01951625|65766124|FG002|Treatment Period|Physician Decision|0|||
23557102|NCT01951625|65766125|FG003|Treatment Period|Physician Decision|0|||
23557103|NCT01951625|65766126|FG004|Treatment Period|Physician Decision|1|||
23557104|NCT01951625|65766122|FG000|Treatment Period|Protocol driven decision point|0|||
23557105|NCT01951625|65766123|FG001|Treatment Period|Protocol driven decision point|5|||
23557106|NCT01951625|65766124|FG002|Treatment Period|Protocol driven decision point|0|||
23557107|NCT01951625|65766125|FG003|Treatment Period|Protocol driven decision point|2|||
23623735|NCT03517111|66008562|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
23623736|NCT03517111|66008563|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
23218463|NCT00212758|64541593|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
23145931|NCT01340196|64283625|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
23145932|NCT00836095|64283626|FG000|Overall Study|Physician Decision|0|||
23145933|NCT00836095|64283627|FG001|Overall Study|Physician Decision|3|||
23145934|NCT00332189|64283628|FG000|Overall Study|Adverse Event|3|||
23145935|NCT00332189|64283628|FG000|Overall Study|Uncooperative/Noncompliant|3|||
23145936|NCT00332189|64283628|FG000|Overall Study|Withdrawal by Subject|9|||
23145937|NCT00332189|64283628|FG000|Overall Study|Lack of Efficacy|4|||
23145938|NCT00332189|64283628|FG000|Overall Study|Moved out of country|2|||
23145939|NCT01030198|64283629|FG000|Overall Study|Could not measure efficacy accurately|0|||
23145940|NCT01030198|64283630|FG001|Overall Study|Could not measure efficacy accurately|7|||
23145941|NCT00971932|64283631|FG000|Overall Study|Withdrawal by Subject|1|||
23145942|NCT00971932|64283631|FG000|Overall Study|Investigator's decision|2|||
23145943|NCT00971932|64283631|FG000|Overall Study|Ongoing|4|||
23145944|NCT03226275|64283637|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
23145945|NCT03226275|64283638|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
23145946|NCT03226275|64283639|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
23145947|NCT03226275|64283640|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
23145948|NCT03226275|64283637|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
23145949|NCT03226275|64283638|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
23145950|NCT03226275|64283639|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
23145951|NCT03226275|64283640|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
23145952|NCT01001832|64283641|FG000|Short-term Period|Adverse Event|2|||
23145953|NCT01001832|64283642|FG001|Short-term Period|Adverse Event|3|||
23145954|NCT01001832|64283641|FG000|Long-term Period|Adverse Event|2|||
23145955|NCT01001832|64283642|FG001|Long-term Period|Adverse Event|1|||
23218464|NCT01001234|64541596|FG000|Overall Study|Withdrawal by Subject|2|||
23218465|NCT01001234|64541597|FG001|Overall Study|Withdrawal by Subject|0|||
23218466|NCT01001234|64541598|FG002|Overall Study|Withdrawal by Subject|3|||
23218467|NCT01001234|64541599|FG003|Overall Study|Withdrawal by Subject|0|||
23218468|NCT01001234|64541600|FG004|Overall Study|Withdrawal by Subject|0|||
23218469|NCT01001234|64541596|FG000|Overall Study|Protocol Violation|34|||
23218470|NCT01001234|64541597|FG001|Overall Study|Protocol Violation|3|||
23623737|NCT00695136|66008564|FG000|Overall Study|Withdrawal by Subject|1|||
23623738|NCT00695136|66008564|FG000|Overall Study|unrelated adverse event|1|||
23436106|NCT02798471|65340586|FG001|Overall Study|Other|3|||
23436107|NCT02798471|65340585|FG000|Overall Study|Subject withdrew consent|0|||
23436108|NCT02798471|65340586|FG001|Overall Study|Subject withdrew consent|6|||
23436109|NCT02798471|65340585|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
23557108|NCT01951625|65766126|FG004|Treatment Period|Protocol driven decision point|1|||
23145956|NCT01001832|64283641|FG000|Long-term Period|Withdrawal by Subject|1|||
23145957|NCT01001832|64283642|FG001|Long-term Period|Withdrawal by Subject|0|||
23436110|NCT02798471|65340586|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
23145958|NCT01001832|64283641|FG000|Long-term Period|Lack of Efficacy|0|||
23145959|NCT01001832|64283642|FG001|Long-term Period|Lack of Efficacy|2|||
23145960|NCT01001832|64283641|FG000|Long-term Period|Other|1|||
23145961|NCT01001832|64283642|FG001|Long-term Period|Other|2|||
23145962|NCT01001832|64283641|FG000|Follow-up Period|Withdrawal by Subject|1|||
23145963|NCT01001832|64283642|FG001|Follow-up Period|Withdrawal by Subject|0|||
23145964|NCT01001832|64283641|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
23145965|NCT01001832|64283642|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
23145966|NCT01001832|64283641|FG000|Follow-up Period|Other|2|||
23145967|NCT01001832|64283642|FG001|Follow-up Period|Other|1|||
23145968|NCT02684357|64283643|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
23145969|NCT02684357|64283644|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
23145970|NCT02684357|64283645|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
23436111|NCT02798471|65340585|FG000|Overall Study|Randomized, but not treated|0|||
23436112|NCT02798471|65340586|FG001|Overall Study|Randomized, but not treated|2|||
23436113|NCT01673620|65340587|FG000|Overall Study|Adverse Event|1|||
23436114|NCT01673620|65340588|FG001|Overall Study|Adverse Event|0|||
23557109|NCT01951625|65766122|FG000|Treatment Period|Non compliance with study drug|1|||
23557110|NCT01951625|65766123|FG001|Treatment Period|Non compliance with study drug|2|||
23557111|NCT01951625|65766124|FG002|Treatment Period|Non compliance with study drug|2|||
23557112|NCT01951625|65766125|FG003|Treatment Period|Non compliance with study drug|0|||
23557113|NCT01951625|65766126|FG004|Treatment Period|Non compliance with study drug|0|||
23557114|NCT01951625|65766122|FG000|Treatment Period|Death|3|||
23557115|NCT01951625|65766123|FG001|Treatment Period|Death|2|||
23557116|NCT01951625|65766124|FG002|Treatment Period|Death|2|||
23557117|NCT01951625|65766125|FG003|Treatment Period|Death|1|||
23557118|NCT01951625|65766126|FG004|Treatment Period|Death|2|||
23557119|NCT01951625|65766122|FG000|Treatment Period|Adverse Event|7|||
23557120|NCT01951625|65766123|FG001|Treatment Period|Adverse Event|10|||
23557121|NCT01951625|65766124|FG002|Treatment Period|Adverse Event|9|||
23557122|NCT01951625|65766125|FG003|Treatment Period|Adverse Event|8|||
23557123|NCT01951625|65766126|FG004|Treatment Period|Adverse Event|8|||
23557124|NCT01951625|65766122|FG000|Treatment Period|Withdrawal by Subject|5|||
23557125|NCT01951625|65766123|FG001|Treatment Period|Withdrawal by Subject|2|||
23557126|NCT01951625|65766124|FG002|Treatment Period|Withdrawal by Subject|1|||
23557127|NCT01951625|65766125|FG003|Treatment Period|Withdrawal by Subject|7|||
23557128|NCT01951625|65766126|FG004|Treatment Period|Withdrawal by Subject|3|||
23557129|NCT01951625|65766122|FG000|Treatment Period|Lost to Follow-up|1|||
23557130|NCT01951625|65766123|FG001|Treatment Period|Lost to Follow-up|0|||
23557131|NCT01951625|65766124|FG002|Treatment Period|Lost to Follow-up|0|||
23557132|NCT01951625|65766125|FG003|Treatment Period|Lost to Follow-up|1|||
23557133|NCT01951625|65766126|FG004|Treatment Period|Lost to Follow-up|0|||
23557134|NCT01951625|65766122|FG000|Follow Up Period|Non-compliance with study drug|1|||
23557135|NCT01951625|65766123|FG001|Follow Up Period|Non-compliance with study drug|0|||
23557136|NCT01951625|65766124|FG002|Follow Up Period|Non-compliance with study drug|0|||
23557137|NCT01951625|65766125|FG003|Follow Up Period|Non-compliance with study drug|0|||
23557138|NCT01951625|65766126|FG004|Follow Up Period|Non-compliance with study drug|0|||
23557139|NCT01951625|65766122|FG000|Follow Up Period|Death|1|||
23557140|NCT01951625|65766123|FG001|Follow Up Period|Death|3|||
23557141|NCT01951625|65766124|FG002|Follow Up Period|Death|2|||
23557142|NCT01951625|65766125|FG003|Follow Up Period|Death|2|||
23557143|NCT01951625|65766126|FG004|Follow Up Period|Death|1|||
23557144|NCT01951625|65766122|FG000|Follow Up Period|Logistical difficulties|1|||
23557145|NCT01951625|65766123|FG001|Follow Up Period|Logistical difficulties|2|||
23623739|NCT02916706|66008565|FG000|Overall Study|Adverse Event|0|||
23623740|NCT02916706|66008566|FG001|Overall Study|Adverse Event|1|||
23623741|NCT02916706|66008565|FG000|Overall Study|Lost to Follow-up|0|||
23623742|NCT02916706|66008566|FG001|Overall Study|Lost to Follow-up|1|||
23436115|NCT00994643|65340589|FG000|Overall Study|Withdrawal by Subject|1|||
23436116|NCT02123576|65340592|FG000|Overall Study|Adverse Event|1|||
23436117|NCT02123576|65340593|FG001|Overall Study|Adverse Event|0|||
23145971|NCT02684357|64283646|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
23145972|NCT02684357|64283647|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
23145973|NCT02684357|64283648|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
23145974|NCT02684357|64283643|FG000|Part A|Lost to Follow-up|0|||
23436118|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
23557146|NCT01951625|65766124|FG002|Follow Up Period|Logistical difficulties|0|||
23557147|NCT01951625|65766125|FG003|Follow Up Period|Logistical difficulties|0|||
23557148|NCT01951625|65766126|FG004|Follow Up Period|Logistical difficulties|0|||
23557149|NCT01951625|65766122|FG000|Follow Up Period|Adverse Event|0|||
23557150|NCT01951625|65766123|FG001|Follow Up Period|Adverse Event|3|||
23557151|NCT01951625|65766124|FG002|Follow Up Period|Adverse Event|2|||
23557152|NCT01951625|65766125|FG003|Follow Up Period|Adverse Event|3|||
23557153|NCT01951625|65766126|FG004|Follow Up Period|Adverse Event|5|||
23557154|NCT01951625|65766122|FG000|Follow Up Period|Withdrawal by Subject|4|||
23557155|NCT01951625|65766123|FG001|Follow Up Period|Withdrawal by Subject|1|||
23557156|NCT01951625|65766124|FG002|Follow Up Period|Withdrawal by Subject|0|||
23557157|NCT01951625|65766125|FG003|Follow Up Period|Withdrawal by Subject|5|||
23557158|NCT01951625|65766126|FG004|Follow Up Period|Withdrawal by Subject|3|||
23557159|NCT01951625|65766122|FG000|Follow Up Period|Lost to Follow-up|1|||
23557160|NCT01951625|65766123|FG001|Follow Up Period|Lost to Follow-up|0|||
23557161|NCT01951625|65766124|FG002|Follow Up Period|Lost to Follow-up|0|||
23557162|NCT01951625|65766125|FG003|Follow Up Period|Lost to Follow-up|1|||
23557163|NCT01951625|65766126|FG004|Follow Up Period|Lost to Follow-up|1|||
23557164|NCT01281644|65766127|FG000|Overall Study|Lost to Follow-up|3|||
23557165|NCT01281644|65766127|FG000|Overall Study|Withdrawal by Subject|2|||
23557166|NCT00409682|65766128|FG000|Open-label Induction Period|Adverse Event|1|||
23557167|NCT00409682|65766129|FG001|Open-label Induction Period|Adverse Event|0|||
23557168|NCT00409682|65766130|FG002|Open-label Induction Period|Adverse Event|0|||
23557169|NCT00409682|65766128|FG000|Open-label Induction Period|Lack of Efficacy|1|||
23557170|NCT00409682|65766129|FG001|Open-label Induction Period|Lack of Efficacy|0|||
23557171|NCT00409682|65766130|FG002|Open-label Induction Period|Lack of Efficacy|0|||
23557172|NCT00409682|65766128|FG000|Open-label Induction Period|Protocol Violation|1|||
23557173|NCT00409682|65766129|FG001|Open-label Induction Period|Protocol Violation|0|||
23557174|NCT00409682|65766130|FG002|Open-label Induction Period|Protocol Violation|0|||
23557175|NCT00409682|65766128|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
23557176|NCT00409682|65766129|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
23557177|NCT00409682|65766130|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
23557178|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
23557179|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
23557180|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
23557181|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
23557182|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
23557183|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
23557184|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
23557185|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
23557186|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
23557187|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
23557188|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
23557189|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
23557190|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
23557191|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
23557192|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
23557193|NCT00409682|65766128|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
23557194|NCT00409682|65766129|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
23557195|NCT00409682|65766130|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
23557196|NCT05232864|65766131|FG000|Overall Study|Adverse Event|0|||
23557197|NCT05232864|65766132|FG001|Overall Study|Adverse Event|1|||
23145975|NCT02684357|64283644|FG001|Part A|Lost to Follow-up|2|||
23145976|NCT02684357|64283645|FG002|Part A|Lost to Follow-up|2|||
23145977|NCT02684357|64283646|FG003|Part A|Lost to Follow-up|0|||
23145978|NCT02684357|64283647|FG004|Part A|Lost to Follow-up|0|||
23557198|NCT05232864|65766131|FG000|Overall Study|Study terminated by sponsor|16|||
23557199|NCT05232864|65766132|FG001|Overall Study|Study terminated by sponsor|14|||
23557200|NCT02365519|65766133|FG000|Randomized and Treated|Adverse Event|0|||
23623743|NCT02916706|66008565|FG000|Overall Study|Physician Decision|1|||
23322074|NCT02107131|64922891|FG001|Overall Study|mental instability|0|||
23322075|NCT02107131|64922890|FG000|Overall Study|Death|0|||
23623744|NCT02916706|66008566|FG001|Overall Study|Physician Decision|0|||
23623745|NCT02916706|66008565|FG000|Overall Study|Protocol Violation|3|||
23145979|NCT02684357|64283648|FG005|Part A|Lost to Follow-up|0|||
23145980|NCT02684357|64283643|FG000|Part A|Withdrawal by Subject|3|||
23145981|NCT02684357|64283644|FG001|Part A|Withdrawal by Subject|0|||
23145982|NCT02684357|64283645|FG002|Part A|Withdrawal by Subject|0|||
23145983|NCT02684357|64283646|FG003|Part A|Withdrawal by Subject|0|||
23145984|NCT02684357|64283647|FG004|Part A|Withdrawal by Subject|0|||
23145985|NCT02684357|64283648|FG005|Part A|Withdrawal by Subject|0|||
23145986|NCT02684357|64283643|FG000|Part A|Other|0|||
23145987|NCT02684357|64283644|FG001|Part A|Other|1|||
23145988|NCT02684357|64283645|FG002|Part A|Other|0|||
23145989|NCT02684357|64283646|FG003|Part A|Other|0|||
23145990|NCT02684357|64283647|FG004|Part A|Other|0|||
23145991|NCT02684357|64283648|FG005|Part A|Other|0|||
23145992|NCT02684357|64283643|FG000|Part B|Adverse Event (Other)|0|||
23145993|NCT02684357|64283644|FG001|Part B|Adverse Event (Other)|0|||
23145994|NCT02684357|64283645|FG002|Part B|Adverse Event (Other)|0|||
23322076|NCT02107131|64922891|FG001|Overall Study|Death|1|||
23145995|NCT02684357|64283646|FG003|Part B|Adverse Event (Other)|1|||
23145996|NCT02684357|64283647|FG004|Part B|Adverse Event (Other)|1|||
23145997|NCT02684357|64283648|FG005|Part B|Adverse Event (Other)|1|||
23145998|NCT02684357|64283643|FG000|Part B|Lost to Follow-up|0|||
23145999|NCT02684357|64283644|FG001|Part B|Lost to Follow-up|0|||
23557201|NCT02365519|65766134|FG001|Randomized and Treated|Adverse Event|1|||
23557202|NCT02365519|65766135|FG002|Randomized and Treated|Adverse Event|0|||
23557203|NCT02365519|65766133|FG000|Randomized and Treated|Withdrawal by Subject|0|||
23557204|NCT02365519|65766134|FG001|Randomized and Treated|Withdrawal by Subject|1|||
23557205|NCT02365519|65766135|FG002|Randomized and Treated|Withdrawal by Subject|1|||
23557206|NCT00337272|65766136|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
23557207|NCT00337272|65766137|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
23557208|NCT00337272|65766136|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
23557209|NCT00337272|65766137|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
23557210|NCT00337272|65766136|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
23557211|NCT00337272|65766137|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
23557212|NCT00337272|65766136|FG000|Treatment Period|Non-compliance|1|||
23557213|NCT00337272|65766137|FG001|Treatment Period|Non-compliance|1|||
23557214|NCT00337272|65766136|FG000|Treatment Period|Withdrawal by Subject|0|||
23557215|NCT00337272|65766137|FG001|Treatment Period|Withdrawal by Subject|1|||
23557216|NCT00337272|65766136|FG000|Withdrawal Period|Non-compliance|0|||
23557217|NCT00337272|65766137|FG001|Withdrawal Period|Non-compliance|1|||
23557218|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
23557219|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
23557220|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
23557221|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
23557222|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
23557223|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
23557224|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Death|1|||
23557225|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Death|0|||
23557226|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Adverse Event|1|||
23557227|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Adverse Event|0|||
23557228|NCT02586025|65766138|FG000|Neoadjuvant Treatment|Physician Decision|2|||
23557229|NCT02586025|65766139|FG001|Neoadjuvant Treatment|Physician Decision|1|||
23557230|NCT02586025|65766138|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
23557231|NCT02586025|65766139|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
23557232|NCT02586025|65766138|FG000|Adjuvant Treatment|Recurrent Disease|4|||
23557233|NCT02586025|65766139|FG001|Adjuvant Treatment|Recurrent Disease|5|||
23557234|NCT02586025|65766138|FG000|Adjuvant Treatment|Physician Decision|0|||
23557235|NCT02586025|65766139|FG001|Adjuvant Treatment|Physician Decision|1|||
23557236|NCT02586025|65766138|FG000|Adjuvant Treatment|Pregnancy|1|||
23557237|NCT02586025|65766139|FG001|Adjuvant Treatment|Pregnancy|0|||
23557238|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Death|11|||
23557239|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Death|11|||
23557240|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
23557241|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
23557242|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
23557243|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
23557244|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
23557245|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
23557246|NCT02586025|65766138|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
23557247|NCT02586025|65766139|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
23557248|NCT01877408|65766141|FG000|Overall Study|Lost to Follow-up|0|||
23557249|NCT01877408|65766142|FG001|Overall Study|Lost to Follow-up|2|||
23557250|NCT01552954|65766143|FG000|Overall Study|Adverse Event|1|||
23557251|NCT01552954|65766144|FG001|Overall Study|Adverse Event|2|||
23557252|NCT01552954|65766143|FG000|Overall Study|Lost to Follow-up|1|||
23557253|NCT01552954|65766144|FG001|Overall Study|Lost to Follow-up|1|||
23557254|NCT01552954|65766143|FG000|Overall Study|Withdrawal by Subject|1|||
23557255|NCT01552954|65766144|FG001|Overall Study|Withdrawal by Subject|1|||
23557256|NCT01552954|65766143|FG000|Overall Study|Protocol Violation|1|||
23557257|NCT01552954|65766144|FG001|Overall Study|Protocol Violation|2|||
23557258|NCT01552954|65766143|FG000|Overall Study|diagnosed DM|1|||
23557259|NCT01552954|65766144|FG001|Overall Study|diagnosed DM|0|||
23557260|NCT01362439|65766145|FG000|Overall Study|Adverse Event|1|||
23557261|NCT01362439|65766145|FG000|Overall Study|Lack of Efficacy|3|||
23557262|NCT01362439|65766145|FG000|Overall Study|Lost to Follow-up|2|||
23557263|NCT01362439|65766145|FG000|Overall Study|Study medication non-compliant|1|||
23146000|NCT02684357|64283645|FG002|Part B|Lost to Follow-up|0|||
23146001|NCT02684357|64283646|FG003|Part B|Lost to Follow-up|1|||
23146002|NCT02684357|64283647|FG004|Part B|Lost to Follow-up|1|||
23557264|NCT01362439|65766145|FG000|Overall Study|Participant who withdrew consent|8|||
23146003|NCT02684357|64283648|FG005|Part B|Lost to Follow-up|7|||
23557265|NCT01648348|65766154|FG000|Overall Study|Cancel|1|||
23557266|NCT01648348|65766155|FG001|Overall Study|Cancel|0|||
23557267|NCT01648348|65766156|FG002|Overall Study|Cancel|0|||
23557268|NCT01648348|65766157|FG003|Overall Study|Cancel|0|||
23557269|NCT01648348|65766158|FG004|Overall Study|Cancel|3|||
23557270|NCT01648348|65766159|FG005|Overall Study|Cancel|6|||
23557271|NCT01648348|65766154|FG000|Overall Study|Replaced for MTD analysis|1|||
23557272|NCT01648348|65766155|FG001|Overall Study|Replaced for MTD analysis|0|||
23557273|NCT01648348|65766156|FG002|Overall Study|Replaced for MTD analysis|1|||
23557274|NCT01648348|65766157|FG003|Overall Study|Replaced for MTD analysis|0|||
23557275|NCT01648348|65766158|FG004|Overall Study|Replaced for MTD analysis|0|||
23557276|NCT01648348|65766159|FG005|Overall Study|Replaced for MTD analysis|0|||
23557277|NCT02690974|65766168|FG000|Overall Study|Adverse Event|16|||
23557278|NCT02690974|65766168|FG000|Overall Study|Death|9|||
23557279|NCT02690974|65766168|FG000|Overall Study|Subject/guardian decision|4|||
23557280|NCT02690974|65766168|FG000|Overall Study|Lost to Follow-up|3|||
23557281|NCT02690974|65766168|FG000|Overall Study|Withdrawal of Informed Consent|3|||
23557282|NCT02690974|65766168|FG000|Overall Study|Physician Decision|2|||
23557283|NCT02690974|65766168|FG000|Overall Study|Non-compliance with study treatment|1|||
23557284|NCT02690974|65766168|FG000|Overall Study|Protocol-defined stopping criteria|1|||
23557285|NCT02690974|65766168|FG000|Overall Study|Protocol Deviation|1|||
23557286|NCT01875185|65766169|FG000|Overall Study|study was terminated|52|||
23557287|NCT01875185|65766170|FG001|Overall Study|study was terminated|48|||
23557288|NCT02048072|65766171|FG000|Overall Study|Adverse Event|3|||
23557289|NCT02048072|65766171|FG000|Overall Study|Lost to Follow-up|1|||
23557290|NCT00526630|65766174|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
23557291|NCT00526630|65766175|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
23557292|NCT00526630|65766174|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
23557293|NCT00526630|65766175|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
23557294|NCT02219048|65766176|FG000|Overall Study|Adverse Event|2|||
23557295|NCT02219048|65766177|FG001|Overall Study|Adverse Event|5|||
23557296|NCT02219048|65766176|FG000|Overall Study|No longer meets eligibility criteria|1|||
23557297|NCT02219048|65766177|FG001|Overall Study|No longer meets eligibility criteria|0|||
23557298|NCT02219048|65766176|FG000|Overall Study|Study terminated by sponsor|16|||
23557299|NCT02219048|65766177|FG001|Overall Study|Study terminated by sponsor|15|||
23557300|NCT02219048|65766176|FG000|Overall Study|Withdrawal by Subject|2|||
23557301|NCT02219048|65766177|FG001|Overall Study|Withdrawal by Subject|0|||
23557302|NCT02219048|65766176|FG000|Overall Study|Other|0|||
23557303|NCT02219048|65766177|FG001|Overall Study|Other|1|||
23557304|NCT02623322|65766181|FG000|Overall Study|Lost to Follow-up|2|||
23557305|NCT02623322|65766182|FG001|Overall Study|Lost to Follow-up|1|||
23557306|NCT02623322|65766183|FG002|Overall Study|Lost to Follow-up|0|||
23557307|NCT04918784|65766184|FG000|Overall Study|Amputation - no longer eligible|1|||
23557308|NCT04918784|65766185|FG001|Overall Study|Amputation - no longer eligible|2|||
23557309|NCT04918784|65766184|FG000|Overall Study|Death|1|||
23557310|NCT04918784|65766185|FG001|Overall Study|Death|0|||
23557311|NCT04918784|65766184|FG000|Overall Study|patient non-compliance|3|||
23557312|NCT04918784|65766185|FG001|Overall Study|patient non-compliance|1|||
23557313|NCT04918784|65766184|FG000|Overall Study|Adverse Event|1|||
23557314|NCT04918784|65766185|FG001|Overall Study|Adverse Event|0|||
23557315|NCT02276222|65766186|FG000|Overall Study|Adverse Event|62|||
23557316|NCT02276222|65766187|FG001|Overall Study|Adverse Event|11|||
23557317|NCT02276222|65766186|FG000|Overall Study|Death|3|||
23557318|NCT02276222|65766187|FG001|Overall Study|Death|4|||
23557319|NCT02276222|65766186|FG000|Overall Study|Lack of Efficacy|13|||
23557320|NCT02276222|65766187|FG001|Overall Study|Lack of Efficacy|3|||
23557321|NCT02276222|65766186|FG000|Overall Study|Protocol Violation|3|||
23557322|NCT02276222|65766187|FG001|Overall Study|Protocol Violation|2|||
23557323|NCT02276222|65766186|FG000|Overall Study|Withdrawal by Subject|79|||
23557324|NCT02276222|65766187|FG001|Overall Study|Withdrawal by Subject|33|||
23557325|NCT02276222|65766186|FG000|Overall Study|non compliance with study medication|6|||
23557326|NCT02276222|65766187|FG001|Overall Study|non compliance with study medication|2|||
23557327|NCT02276222|65766186|FG000|Overall Study|sponsor decision|0|||
23557328|NCT02276222|65766187|FG001|Overall Study|sponsor decision|3|||
23146004|NCT02684357|64283643|FG000|Part B|Withdrawal by Subject|0|||
23146005|NCT02684357|64283644|FG001|Part B|Withdrawal by Subject|0|||
23146006|NCT02684357|64283645|FG002|Part B|Withdrawal by Subject|0|||
23146007|NCT02684357|64283646|FG003|Part B|Withdrawal by Subject|0|||
23146008|NCT02684357|64283647|FG004|Part B|Withdrawal by Subject|2|||
23146009|NCT02684357|64283648|FG005|Part B|Withdrawal by Subject|4|||
23146010|NCT02684357|64283643|FG000|Part B|Other|0|||
23146011|NCT02684357|64283644|FG001|Part B|Other|0|||
23146012|NCT02684357|64283645|FG002|Part B|Other|0|||
23146013|NCT02684357|64283646|FG003|Part B|Other|1|||
23146014|NCT02684357|64283647|FG004|Part B|Other|0|||
23557329|NCT02276222|65766186|FG000|Overall Study|Lost to Follow-up|15|||
23557330|NCT02276222|65766187|FG001|Overall Study|Lost to Follow-up|5|||
23557331|NCT02276222|65766186|FG000|Overall Study|Physician Decision|2|||
23557332|NCT02276222|65766187|FG001|Overall Study|Physician Decision|1|||
23557333|NCT02276222|65766186|FG000|Overall Study|sheduling conflict|1|||
23557334|NCT02276222|65766187|FG001|Overall Study|sheduling conflict|0|||
23557335|NCT02276222|65766186|FG000|Overall Study|subject withdrew after randomization|1|||
23557336|NCT02276222|65766187|FG001|Overall Study|subject withdrew after randomization|0|||
23146015|NCT02684357|64283648|FG005|Part B|Other|1|||
23146016|NCT01026454|64283651|FG000|Second Intervention|Pregnancy|1|||
23146017|NCT01026454|64283652|FG001|Second Intervention|Pregnancy|1|||
23623746|NCT02916706|66008566|FG001|Overall Study|Protocol Violation|1|||
23146018|NCT01230788|64283661|FG000|Overall Study|Prescribed exclusion drug|1|||
23146019|NCT02070588|64283662|FG000|Overall Study|Withdrawal by Subject|29|||
23146020|NCT02070588|64283663|FG001|Overall Study|Withdrawal by Subject|1|||
23146021|NCT02070588|64283664|FG002|Overall Study|Withdrawal by Subject|0|||
23146022|NCT02070588|64283662|FG000|Overall Study|Writhdrawal due to early termination|9|||
23146023|NCT02070588|64283663|FG001|Overall Study|Writhdrawal due to early termination|0|||
23146024|NCT02070588|64283664|FG002|Overall Study|Writhdrawal due to early termination|0|||
23146025|NCT02070588|64283662|FG000|Overall Study|Adverse Event|1|||
23146026|NCT02070588|64283663|FG001|Overall Study|Adverse Event|0|||
23146027|NCT02070588|64283664|FG002|Overall Study|Adverse Event|0|||
23146028|NCT01037244|64283665|FG000|Overall Study|Adverse Event|3|||
23436119|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
23557337|NCT04493931|65766188|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
23557338|NCT04493931|65766189|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557339|NCT04493931|65766190|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557340|NCT04493931|65766191|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557341|NCT04493931|65766192|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557342|NCT04493931|65766193|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557343|NCT04493931|65766194|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
23557344|NCT04493931|65766188|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557345|NCT04493931|65766189|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
23557346|NCT04493931|65766190|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557347|NCT04493931|65766191|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557348|NCT04493931|65766192|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557349|NCT04493931|65766193|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557350|NCT04493931|65766194|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
23557351|NCT04493931|65766188|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557352|NCT04493931|65766189|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
23557353|NCT04493931|65766190|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557354|NCT04493931|65766191|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557355|NCT04493931|65766192|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557356|NCT04493931|65766193|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557357|NCT04493931|65766194|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
23557358|NCT04493931|65766188|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557359|NCT04493931|65766189|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557360|NCT04493931|65766190|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
23557361|NCT04493931|65766191|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557362|NCT04493931|65766192|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557363|NCT04493931|65766193|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557364|NCT04493931|65766194|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
23557365|NCT01533493|65766195|FG000|Overall Study|Adverse Event|2|||
23557366|NCT01533493|65766196|FG001|Overall Study|Adverse Event|1|||
23557367|NCT01533493|65766195|FG000|Overall Study|Withdrawal by Subject|1|||
23557368|NCT01533493|65766196|FG001|Overall Study|Withdrawal by Subject|2|||
23557369|NCT01533493|65766195|FG000|Overall Study|Lost to Follow-up|2|||
23557370|NCT01533493|65766196|FG001|Overall Study|Lost to Follow-up|0|||
23557371|NCT00266825|65766197|FG000|Completed Follow-Up|Lost to Follow-up|14|||
23557372|NCT00266825|65766198|FG001|Completed Follow-Up|Lost to Follow-up|19|||
23557373|NCT00266825|65766197|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
23557374|NCT00266825|65766198|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
23557375|NCT02543658|65766202|FG000|Overall Study|Lack of Efficacy|0|||
23557376|NCT02543658|65766203|FG001|Overall Study|Lack of Efficacy|4|||
23557377|NCT01621126|65766206|FG000|Overall Study|Physician Decision|6|||
23557378|NCT04241094|65766207|FG000|Overall Study|Dropped out of treatment|4|||
23557379|NCT04241094|65766207|FG000|Overall Study|Ineligible after clinical assessment|2|||
23557380|NCT04241094|65766207|FG000|Overall Study|Lost to Follow-up|2|||
23557381|NCT00766675|65769304|FG000|Overall Study|Adverse Event|16|||
23557382|NCT00766675|65769304|FG000|Overall Study|Lost to Follow-up|2|||
23557383|NCT00766675|65769304|FG000|Overall Study|Withdrawal by Subject|11|||
23557384|NCT00766675|65769304|FG000|Overall Study|Protocol Violation|8|||
23557385|NCT00766675|65769304|FG000|Overall Study|Participant took prohibited medication|1|||
23557386|NCT00766675|65769304|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
23557387|NCT00766675|65769304|FG000|Overall Study|Insufficient therapy|1|||
23146029|NCT01037244|64283666|FG001|Overall Study|Adverse Event|2|||
23436120|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
23557388|NCT00522301|65769305|FG000|Overall Study|Withdrawal by Subject|1|||
23557389|NCT00522301|65769305|FG000|Overall Study|Adverse Event|5|||
23557390|NCT03466086|65769306|FG000|Period 1|Sponsor decision due to study timeline|1|||
23146030|NCT01037244|64283667|FG002|Overall Study|Adverse Event|6|||
23623747|NCT02916706|66008565|FG000|Overall Study|Withdrawal by Subject|6|||
23623748|NCT02916706|66008566|FG001|Overall Study|Withdrawal by Subject|9|||
23623749|NCT02916706|66008565|FG000|Overall Study|Other|5|||
23623750|NCT02916706|66008566|FG001|Overall Study|Other|19|||
23623751|NCT00719212|66008567|FG000|Overall Study|Death|41|||
23146031|NCT01037244|64283668|FG003|Overall Study|Adverse Event|3|||
23146032|NCT01037244|64283665|FG000|Overall Study|Lack of Efficacy|1|||
23146033|NCT01037244|64283666|FG001|Overall Study|Lack of Efficacy|1|||
23146034|NCT01037244|64283667|FG002|Overall Study|Lack of Efficacy|0|||
23146035|NCT01037244|64283668|FG003|Overall Study|Lack of Efficacy|1|||
23146036|NCT01037244|64283665|FG000|Overall Study|Lost to Follow-up|3|||
23218471|NCT01001234|64541598|FG002|Overall Study|Protocol Violation|19|||
23218472|NCT01001234|64541599|FG003|Overall Study|Protocol Violation|18|||
23146037|NCT01037244|64283666|FG001|Overall Study|Lost to Follow-up|3|||
23146038|NCT01037244|64283667|FG002|Overall Study|Lost to Follow-up|4|||
23146039|NCT01037244|64283668|FG003|Overall Study|Lost to Follow-up|4|||
23146040|NCT01037244|64283665|FG000|Overall Study|Withdrawal by Subject|1|||
23146041|NCT01037244|64283666|FG001|Overall Study|Withdrawal by Subject|5|||
23146042|NCT01037244|64283667|FG002|Overall Study|Withdrawal by Subject|3|||
23146043|NCT01037244|64283668|FG003|Overall Study|Withdrawal by Subject|5|||
23146044|NCT01037244|64283665|FG000|Overall Study|Partner Withdrew Consent|2|||
23146045|NCT01037244|64283666|FG001|Overall Study|Partner Withdrew Consent|1|||
23146046|NCT01037244|64283667|FG002|Overall Study|Partner Withdrew Consent|0|||
23146047|NCT01037244|64283668|FG003|Overall Study|Partner Withdrew Consent|0|||
23146048|NCT01037244|64283665|FG000|Overall Study|Various|3|||
23146049|NCT01037244|64283666|FG001|Overall Study|Various|2|||
23146050|NCT01037244|64283667|FG002|Overall Study|Various|1|||
23146051|NCT01037244|64283668|FG003|Overall Study|Various|1|||
23146052|NCT02960854|64283675|FG000|Overall Study|Not Disclosed|2|||
23146053|NCT02960854|64283676|FG001|Overall Study|Not Disclosed|2|||
23146054|NCT02960854|64283675|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
23146055|NCT02960854|64283676|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
23146056|NCT02960854|64283675|FG000|Overall Study|Subject Withdrew Consent|0|||
23146057|NCT02960854|64283676|FG001|Overall Study|Subject Withdrew Consent|1|||
23146058|NCT02960854|64283675|FG000|Overall Study|Death|4|||
23146059|NCT02960854|64283676|FG001|Overall Study|Death|6|||
23146060|NCT03740997|64283683|FG000|Overall Study|Withdrawal by Subject|1|||
23146061|NCT03740997|64283684|FG001|Overall Study|Withdrawal by Subject|0|||
23146062|NCT03740997|64283683|FG000|Overall Study|Participant was unable to complete study procedures|1|||
23146063|NCT03740997|64283684|FG001|Overall Study|Participant was unable to complete study procedures|0|||
23146064|NCT02435966|64283685|FG000|Overall Study|Withdrawal by Subject|0|||
23146065|NCT02435966|64283686|FG001|Overall Study|Withdrawal by Subject|1|||
23146066|NCT02435966|64283687|FG002|Overall Study|Withdrawal by Subject|0|||
23146067|NCT04433585|64283688|FG000|Overall Study|Withdrawal by Subject|15|||
23146068|NCT04433585|64283689|FG001|Overall Study|Withdrawal by Subject|3|||
23146069|NCT04433585|64283690|FG002|Overall Study|Withdrawal by Subject|15|||
23146070|NCT04433585|64283691|FG003|Overall Study|Withdrawal by Subject|6|||
23146071|NCT04433585|64283688|FG000|Overall Study|Adverse Event|10|||
23146072|NCT04433585|64283689|FG001|Overall Study|Adverse Event|4|||
23146073|NCT04433585|64283690|FG002|Overall Study|Adverse Event|1|||
23146074|NCT04433585|64283691|FG003|Overall Study|Adverse Event|0|||
23146075|NCT04433585|64283688|FG000|Overall Study|Due to the conflict in Ukraine|2|||
23146076|NCT04433585|64283689|FG001|Overall Study|Due to the conflict in Ukraine|1|||
23146077|NCT04433585|64283690|FG002|Overall Study|Due to the conflict in Ukraine|1|||
23146078|NCT04433585|64283691|FG003|Overall Study|Due to the conflict in Ukraine|2|||
23146079|NCT04433585|64283688|FG000|Overall Study|Physician Decision|1|||
23146080|NCT04433585|64283689|FG001|Overall Study|Physician Decision|2|||
23146081|NCT04433585|64283690|FG002|Overall Study|Physician Decision|0|||
23218473|NCT01001234|64541600|FG004|Overall Study|Protocol Violation|0|||
23218474|NCT01001234|64541596|FG000|Overall Study|Lost to Follow-up|0|||
23218475|NCT01001234|64541597|FG001|Overall Study|Lost to Follow-up|0|||
23218476|NCT01001234|64541598|FG002|Overall Study|Lost to Follow-up|1|||
23218477|NCT01001234|64541599|FG003|Overall Study|Lost to Follow-up|2|||
23146082|NCT04433585|64283691|FG003|Overall Study|Physician Decision|0|||
23146083|NCT04433585|64283688|FG000|Overall Study|Lost to Follow-up|1|||
23146084|NCT04433585|64283689|FG001|Overall Study|Lost to Follow-up|1|||
23146085|NCT04433585|64283690|FG002|Overall Study|Lost to Follow-up|1|||
23146086|NCT04433585|64283691|FG003|Overall Study|Lost to Follow-up|0|||
23146087|NCT04433585|64283688|FG000|Overall Study|Lack of Efficacy|0|||
23218478|NCT01001234|64541600|FG004|Overall Study|Lost to Follow-up|0|||
23146088|NCT04433585|64283689|FG001|Overall Study|Lack of Efficacy|1|||
23146089|NCT04433585|64283690|FG002|Overall Study|Lack of Efficacy|1|||
23146090|NCT04433585|64283691|FG003|Overall Study|Lack of Efficacy|1|||
23146091|NCT04433585|64283688|FG000|Overall Study|Death|0|||
23146092|NCT04433585|64283689|FG001|Overall Study|Death|1|||
23146093|NCT04433585|64283690|FG002|Overall Study|Death|0|||
23146094|NCT04433585|64283691|FG003|Overall Study|Death|0|||
23218479|NCT01001234|64541596|FG000|Overall Study|Physician Decision|1|||
23623752|NCT00719212|66008567|FG000|Overall Study|Lost to Follow-up|2|||
23557391|NCT03466086|65769307|FG001|Period 1|Sponsor decision due to study timeline|0|||
23557392|NCT03466086|65769306|FG000|Period 1|Withdrawal by Subject|1|||
23557393|NCT03466086|65769307|FG001|Period 1|Withdrawal by Subject|0|||
23557394|NCT03576768|65769308|FG000|Overall Study|Lost to Follow-up|3|||
23557395|NCT03576768|65769309|FG001|Overall Study|Lost to Follow-up|3|||
23557396|NCT03576768|65769310|FG002|Overall Study|Lost to Follow-up|0|||
23557397|NCT03576768|65769311|FG003|Overall Study|Lost to Follow-up|0|||
23557398|NCT04123067|65769312|FG000|Overall Study|Lost to Follow-up|0|||
23557399|NCT04123067|65769313|FG001|Overall Study|Lost to Follow-up|1|||
23557400|NCT01806584|65769314|FG000|Overall Study|Adverse Event|2|||
23557401|NCT01806584|65769315|FG001|Overall Study|Adverse Event|1|||
23557402|NCT01806584|65769314|FG000|Overall Study|Death|1|||
23557403|NCT01806584|65769315|FG001|Overall Study|Death|0|||
23557404|NCT01806584|65769314|FG000|Overall Study|Lost to Follow-up|0|||
23557405|NCT01806584|65769315|FG001|Overall Study|Lost to Follow-up|2|||
23557406|NCT01806584|65769314|FG000|Overall Study|Study terminated by sponsor|9|||
23557407|NCT01806584|65769315|FG001|Overall Study|Study terminated by sponsor|14|||
23557408|NCT01806584|65769314|FG000|Overall Study|Withdrawal by Subject|1|||
23557409|NCT01806584|65769315|FG001|Overall Study|Withdrawal by Subject|1|||
23557410|NCT01806584|65769314|FG000|Overall Study|Other unspecified|1|||
23557411|NCT01806584|65769315|FG001|Overall Study|Other unspecified|0|||
23557412|NCT01235403|65769316|FG000|Overall Study|Adverse Event|14|||
23557413|NCT01235403|65769316|FG000|Overall Study|Lost to Follow-up|2|||
23557414|NCT01235403|65769316|FG000|Overall Study|Withdrawal by Subject|4|||
23557415|NCT01235403|65769316|FG000|Overall Study|Lack of Efficacy|2|||
23146095|NCT04615247|64283692|FG000|Overall Study|Adverse Event|0|||
23146096|NCT04615247|64283693|FG001|Overall Study|Adverse Event|2|||
23146097|NCT04615247|64283692|FG000|Overall Study|Withdrawal by Subject|1|||
23146098|NCT04615247|64283693|FG001|Overall Study|Withdrawal by Subject|1|||
23146099|NCT00593957|64283697|FG000|Overall Study|Physician Decision|0|||
23146100|NCT00593957|64283698|FG001|Overall Study|Physician Decision|1|||
23146101|NCT00593957|64283699|FG002|Overall Study|Physician Decision|2|||
23146102|NCT00203476|64283704|FG000|Overall Study|Lost to Follow-up|1|||
23146103|NCT00203476|64283705|FG001|Overall Study|Lost to Follow-up|0|||
23146104|NCT00203476|64283706|FG002|Overall Study|Lost to Follow-up|0|||
23146105|NCT00203476|64283704|FG000|Overall Study|Withdrawal by Subject|0|||
23146106|NCT00203476|64283705|FG001|Overall Study|Withdrawal by Subject|1|||
23146107|NCT00203476|64283706|FG002|Overall Study|Withdrawal by Subject|0|||
23146108|NCT01440374|64283707|FG000|Part 1: Open-label Phase|Adverse Event|5|||
23146109|NCT01440374|64283708|FG001|Part 1: Open-label Phase|Adverse Event|0|||
23146110|NCT01440374|64283709|FG002|Part 1: Open-label Phase|Adverse Event|0|||
23146111|NCT01440374|64283710|FG003|Part 1: Open-label Phase|Adverse Event|0|||
23146112|NCT01440374|64283707|FG000|Part 1: Open-label Phase|Physician Decision|1|||
23146113|NCT01440374|64283708|FG001|Part 1: Open-label Phase|Physician Decision|0|||
23146114|NCT01440374|64283709|FG002|Part 1: Open-label Phase|Physician Decision|0|||
23146115|NCT01440374|64283710|FG003|Part 1: Open-label Phase|Physician Decision|0|||
23146116|NCT01440374|64283707|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
23146117|NCT01440374|64283708|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
23146118|NCT01440374|64283709|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
23146119|NCT01440374|64283710|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
23146120|NCT01440374|64283707|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
23146121|NCT01440374|64283708|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
23146122|NCT01440374|64283709|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
23146123|NCT01440374|64283710|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
23146124|NCT01440374|64283707|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
23146125|NCT01440374|64283708|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
23146126|NCT01440374|64283709|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
23146127|NCT01440374|64283710|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
23146128|NCT01440374|64283707|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
23146129|NCT01440374|64283708|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
23146130|NCT01440374|64283709|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
23146131|NCT01440374|64283710|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
23146132|NCT01440374|64283707|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
23146133|NCT01440374|64283708|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
23146134|NCT01440374|64283709|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
23146135|NCT01440374|64283710|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
23146136|NCT01440374|64283707|FG000|Part 2; Double-blind Phase|Not treated|0|||
23146137|NCT01440374|64283708|FG001|Part 2; Double-blind Phase|Not treated|0|||
23146138|NCT01440374|64283709|FG002|Part 2; Double-blind Phase|Not treated|1|||
23557416|NCT01235403|65769316|FG000|Overall Study|Other reasons for premature termination|4|||
23557417|NCT01678131|65769323|FG000|Overall Study|Adverse Event|0|||
23557418|NCT01678131|65769324|FG001|Overall Study|Adverse Event|1|||
23557419|NCT01678131|65769325|FG002|Overall Study|Adverse Event|0|||
23557420|NCT01678131|65769323|FG000|Overall Study|Withdrawal by Subject|0|||
23146139|NCT01440374|64283710|FG003|Part 2; Double-blind Phase|Not treated|0|||
23218480|NCT01001234|64541597|FG001|Overall Study|Physician Decision|0|||
23146140|NCT01440374|64283707|FG000|Part 3: Extension|Withdrawal by Subject|0|||
23146141|NCT01440374|64283708|FG001|Part 3: Extension|Withdrawal by Subject|0|||
23146142|NCT01440374|64283709|FG002|Part 3: Extension|Withdrawal by Subject|0|||
23146143|NCT01440374|64283710|FG003|Part 3: Extension|Withdrawal by Subject|5|||
23146144|NCT01440374|64283707|FG000|Part 3: Extension|Adverse Event|0|||
23146145|NCT01440374|64283708|FG001|Part 3: Extension|Adverse Event|0|||
23146146|NCT01440374|64283709|FG002|Part 3: Extension|Adverse Event|0|||
23146147|NCT01440374|64283710|FG003|Part 3: Extension|Adverse Event|13|||
23146148|NCT01440374|64283707|FG000|Part 3: Extension|Physician Decision|0|||
23146149|NCT01440374|64283708|FG001|Part 3: Extension|Physician Decision|0|||
23146150|NCT01440374|64283709|FG002|Part 3: Extension|Physician Decision|0|||
23146151|NCT01440374|64283710|FG003|Part 3: Extension|Physician Decision|14|||
23146152|NCT00705523|64283711|FG000|Overall Study|Lost to Follow-up|2|||
23146153|NCT00705523|64283712|FG001|Overall Study|Lost to Follow-up|3|||
23146154|NCT01672723|64283720|FG000|First Intervention|Adverse Event|3|||
23146155|NCT01672723|64283721|FG001|First Intervention|Adverse Event|0|||
23146156|NCT01146054|64283722|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
23146157|NCT01146054|64283722|FG000|Overall Study|Rapid tumor progression|2|||
23146158|NCT01146054|64283722|FG000|Overall Study|Other illness precluded treatment|2|||
23146159|NCT01146054|64283722|FG000|Overall Study|Lost to Follow-up|1|||
23146160|NCT05105789|64283723|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
23146161|NCT03486457|64283724|FG000|Up to Month 3|Adverse Event|2|||
23146162|NCT03486457|64283725|FG001|Up to Month 3|Adverse Event|5|||
23146163|NCT03486457|64283724|FG000|Up to Month 3|Lack of Efficacy|1|||
23146164|NCT03486457|64283725|FG001|Up to Month 3|Lack of Efficacy|0|||
23146165|NCT03486457|64283724|FG000|Up to Month 3|Withdrawal by Subject|1|||
23146166|NCT03486457|64283725|FG001|Up to Month 3|Withdrawal by Subject|0|||
23146167|NCT03486457|64283724|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
23146168|NCT03486457|64283725|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
23146169|NCT03486457|64283724|FG000|Up to Month 3|Other|1|||
23146170|NCT03486457|64283725|FG001|Up to Month 3|Other|0|||
23146171|NCT03486457|64283724|FG000|Month 3 to Month 6|Adverse Event|2|||
23146172|NCT03486457|64283725|FG001|Month 3 to Month 6|Adverse Event|0|||
23146173|NCT03486457|64283724|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
23146174|NCT03486457|64283725|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
23322077|NCT02107131|64922890|FG000|Overall Study|Protocol Violation|0|||
23557421|NCT01678131|65769324|FG001|Overall Study|Withdrawal by Subject|0|||
23557422|NCT01678131|65769325|FG002|Overall Study|Withdrawal by Subject|2|||
23557423|NCT00676130|65769326|FG000|Overall Study|Lost to Follow-up|0|||
23557424|NCT00676130|65769327|FG001|Overall Study|Lost to Follow-up|1|||
23557425|NCT00676130|65769326|FG000|Overall Study|Found ineligible|3|||
23557426|NCT00676130|65769327|FG001|Overall Study|Found ineligible|2|||
23557427|NCT00676130|65769326|FG000|Overall Study|Withdrawal by Subject|0|||
23557428|NCT00676130|65769327|FG001|Overall Study|Withdrawal by Subject|1|||
23557429|NCT00077064|65769328|FG000|Overall Study|Adverse Event|0|||
23557430|NCT00077064|65769329|FG001|Overall Study|Adverse Event|4|||
23557431|NCT00077064|65769328|FG000|Overall Study|Patient refusal|0|||
23557432|NCT00077064|65769329|FG001|Overall Study|Patient refusal|2|||
23557433|NCT01959425|65769331|FG000|Overall Study|Withdrawal by Subject|5|||
23557434|NCT01959425|65769332|FG001|Overall Study|Withdrawal by Subject|4|||
23557435|NCT01959425|65769331|FG000|Overall Study|Lost to Follow-up|1|||
23557436|NCT01959425|65769332|FG001|Overall Study|Lost to Follow-up|0|||
23557437|NCT01959425|65769331|FG000|Overall Study|Discontinued Subjects|6|||
23557438|NCT01959425|65769332|FG001|Overall Study|Discontinued Subjects|4|||
23557439|NCT02807636|65769335|FG000|Overall Study|Lost to Follow-up|9|||
23557440|NCT02807636|65769336|FG001|Overall Study|Lost to Follow-up|12|||
23557441|NCT02807636|65769337|FG002|Overall Study|Lost to Follow-up|6|||
23557442|NCT02807636|65769335|FG000|Overall Study|Protocol Deviation|2|||
23557443|NCT02807636|65769336|FG001|Overall Study|Protocol Deviation|0|||
23557444|NCT02807636|65769337|FG002|Overall Study|Protocol Deviation|0|||
23557445|NCT02807636|65769335|FG000|Overall Study|Symptomatic Deterioration|0|||
23557446|NCT02807636|65769336|FG001|Overall Study|Symptomatic Deterioration|1|||
23557447|NCT02807636|65769337|FG002|Overall Study|Symptomatic Deterioration|0|||
23557448|NCT02807636|65769335|FG000|Overall Study|Withdrawal by Subject|39|||
23557449|NCT02807636|65769336|FG001|Overall Study|Withdrawal by Subject|27|||
23557450|NCT02807636|65769337|FG002|Overall Study|Withdrawal by Subject|23|||
23557451|NCT02807636|65769335|FG000|Overall Study|Death|298|||
23146175|NCT03486457|64283724|FG000|Month 3 to Month 6|Pregnancy|0|||
23146176|NCT03486457|64283725|FG001|Month 3 to Month 6|Pregnancy|1|||
23146177|NCT03486457|64283724|FG000|Month 3 to Month 6|Other|1|||
23146178|NCT03486457|64283725|FG001|Month 3 to Month 6|Other|0|||
23146179|NCT00448123|64283730|FG000|Overall Study|Lost to Follow-up|9|||
23557452|NCT02807636|65769336|FG001|Overall Study|Death|327|||
23322078|NCT02107131|64922891|FG001|Overall Study|Protocol Violation|4|||
23557453|NCT02807636|65769337|FG002|Overall Study|Death|266|||
23146180|NCT00448123|64283731|FG001|Overall Study|Lost to Follow-up|6|||
23146181|NCT00448123|64283730|FG000|Overall Study|Physician Decision|6|||
23146182|NCT00448123|64283731|FG001|Overall Study|Physician Decision|6|||
23557454|NCT02807636|65769335|FG000|Overall Study|Ongoing in Study|52|||
23557455|NCT02807636|65769336|FG001|Overall Study|Ongoing in Study|84|||
23557456|NCT02807636|65769337|FG002|Overall Study|Ongoing in Study|67|||
23557457|NCT03703466|65769338|FG000|Overall Study|Death|2|||
23557458|NCT03703466|65769339|FG001|Overall Study|Death|1|||
23557459|NCT03703466|65769340|FG002|Overall Study|Death|0|||
23557460|NCT03703466|65769338|FG000|Overall Study|Withdrawal by Subject|0|||
23557461|NCT03703466|65769339|FG001|Overall Study|Withdrawal by Subject|3|||
23557462|NCT03703466|65769340|FG002|Overall Study|Withdrawal by Subject|0|||
23557463|NCT03703466|65769338|FG000|Overall Study|Completed < 3 Cycles|2|||
23557464|NCT03703466|65769339|FG001|Overall Study|Completed < 3 Cycles|2|||
23557465|NCT03703466|65769340|FG002|Overall Study|Completed < 3 Cycles|2|||
23557466|NCT00677235|65769343|FG000|Overall Study|Withdrawal by Subject|1|||
23557467|NCT00677235|65769344|FG001|Overall Study|Withdrawal by Subject|1|||
23557468|NCT00677235|65769343|FG000|Overall Study|Lost to Follow-up|2|||
23557469|NCT00677235|65769344|FG001|Overall Study|Lost to Follow-up|1|||
23557470|NCT00677235|65769343|FG000|Overall Study|Death|37|||
23557471|NCT00677235|65769344|FG001|Overall Study|Death|36|||
23557472|NCT00677235|65769343|FG000|Overall Study|Adverse Experience|1|||
23557473|NCT00677235|65769344|FG001|Overall Study|Adverse Experience|0|||
23557474|NCT00827541|65769349|FG000|Overall Study|Exitus|1|||
23557475|NCT00827541|65769350|FG001|Overall Study|Exitus|8|||
23557476|NCT00827541|65769349|FG000|Overall Study|Other|1|||
23557477|NCT00827541|65769350|FG001|Overall Study|Other|3|||
23557478|NCT00827541|65769349|FG000|Overall Study|Pathogen not susceptible|1|||
23557479|NCT00827541|65769350|FG001|Overall Study|Pathogen not susceptible|0|||
23557480|NCT00827541|65769349|FG000|Overall Study|Lack of effectiveness|1|||
23557481|NCT00827541|65769350|FG001|Overall Study|Lack of effectiveness|0|||
23557482|NCT03248375|65769351|FG000|Overall Study|Lost to Follow-up|5|||
23557483|NCT03520400|65769356|FG000|Overall Study|Physician Decision|15|||
23557484|NCT03520400|65769357|FG001|Overall Study|Physician Decision|7|||
23557485|NCT02191267|65769358|FG000|Overall Study|Withdrawal by Subject|1|||
23557486|NCT02191267|65769359|FG001|Overall Study|Withdrawal by Subject|0|||
23557487|NCT02191267|65769360|FG002|Overall Study|Withdrawal by Subject|0|||
23557488|NCT01693692|65769367|FG000|Overall Study|Withdrawal by Subject|12|||
23557489|NCT01693692|65769368|FG001|Overall Study|Withdrawal by Subject|10|||
23557490|NCT01693692|65769369|FG002|Overall Study|Withdrawal by Subject|11|||
23557491|NCT01693692|65769367|FG000|Overall Study|Adverse Event|7|||
23557492|NCT01693692|65769368|FG001|Overall Study|Adverse Event|14|||
23557493|NCT01693692|65769369|FG002|Overall Study|Adverse Event|9|||
23557494|NCT01693692|65769367|FG000|Overall Study|Physician Decision|0|||
23146183|NCT03353350|64283734|FG000|30-week Core Treatment Period|Protocol Violation|1|||
23146184|NCT03353350|64283735|FG001|30-week Core Treatment Period|Protocol Violation|1|||
23146185|NCT03353350|64283736|FG002|30-week Core Treatment Period|Protocol Violation|1|||
23146186|NCT03353350|64283737|FG003|30-week Core Treatment Period|Protocol Violation|0|||
23146187|NCT03353350|64283734|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
23146188|NCT03353350|64283735|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
23146189|NCT03353350|64283736|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
23146190|NCT03353350|64283737|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
23146191|NCT03353350|64283734|FG000|30-week Core Treatment Period|Adverse Event|0|||
23146192|NCT03353350|64283735|FG001|30-week Core Treatment Period|Adverse Event|4|||
23146193|NCT03353350|64283736|FG002|30-week Core Treatment Period|Adverse Event|2|||
23146194|NCT03353350|64283737|FG003|30-week Core Treatment Period|Adverse Event|3|||
23146195|NCT03353350|64283734|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
23146196|NCT03353350|64283735|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
23146197|NCT03353350|64283736|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
23146198|NCT03353350|64283737|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
23146199|NCT03353350|64283734|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
23146200|NCT03353350|64283735|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
23146201|NCT03353350|64283736|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
23146202|NCT03353350|64283737|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
23146203|NCT03353350|64283734|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
23146204|NCT03353350|64283735|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
23146205|NCT03353350|64283736|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
23146206|NCT03353350|64283737|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
23146207|NCT03353350|64283734|FG000|26-week Treatment Extension Period|Adverse Event|1|||
23557495|NCT01693692|65769368|FG001|Overall Study|Physician Decision|0|||
23557496|NCT01693692|65769369|FG002|Overall Study|Physician Decision|1|||
23557497|NCT01693692|65769367|FG000|Overall Study|Protocol Violation|5|||
23557498|NCT01693692|65769368|FG001|Overall Study|Protocol Violation|4|||
23557499|NCT01693692|65769369|FG002|Overall Study|Protocol Violation|6|||
23557500|NCT01693692|65769367|FG000|Overall Study|Lost to Follow-up|2|||
23557501|NCT01693692|65769368|FG001|Overall Study|Lost to Follow-up|2|||
23557502|NCT01693692|65769369|FG002|Overall Study|Lost to Follow-up|3|||
23557503|NCT01693692|65769367|FG000|Overall Study|Other|4|||
23146208|NCT03353350|64283735|FG001|26-week Treatment Extension Period|Adverse Event|0|||
23146209|NCT03353350|64283736|FG002|26-week Treatment Extension Period|Adverse Event|0|||
23146210|NCT03353350|64283737|FG003|26-week Treatment Extension Period|Adverse Event|1|||
23146211|NCT03353350|64283734|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
23146212|NCT03353350|64283735|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
23146213|NCT03353350|64283736|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
23146214|NCT03353350|64283737|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
23146215|NCT01003990|64283740|FG000|Overall Study|Adverse Event|8|||
23146216|NCT01003990|64283741|FG001|Overall Study|Adverse Event|5|||
23146217|NCT01003990|64283742|FG002|Overall Study|Adverse Event|11|||
23146218|NCT01003990|64283740|FG000|Overall Study|Death|0|||
23146219|NCT01003990|64283741|FG001|Overall Study|Death|8|||
23146220|NCT01003990|64283742|FG002|Overall Study|Death|1|||
23146221|NCT01003990|64283740|FG000|Overall Study|Lack of Efficacy|10|||
23146222|NCT01003990|64283741|FG001|Overall Study|Lack of Efficacy|2|||
23146223|NCT01003990|64283742|FG002|Overall Study|Lack of Efficacy|3|||
23146224|NCT01003990|64283740|FG000|Overall Study|Lost to Follow-up|30|||
23146225|NCT01003990|64283741|FG001|Overall Study|Lost to Follow-up|12|||
23146226|NCT01003990|64283742|FG002|Overall Study|Lost to Follow-up|7|||
23146227|NCT01003990|64283740|FG000|Overall Study|Reasons Not Identified|14|||
23146228|NCT01003990|64283741|FG001|Overall Study|Reasons Not Identified|13|||
23146229|NCT01003990|64283742|FG002|Overall Study|Reasons Not Identified|8|||
23146230|NCT01003990|64283740|FG000|Overall Study|Poor/Non-compliance|4|||
23146231|NCT01003990|64283741|FG001|Overall Study|Poor/Non-compliance|3|||
23146232|NCT01003990|64283742|FG002|Overall Study|Poor/Non-compliance|2|||
23146233|NCT01003990|64283740|FG000|Overall Study|Pregnancy|10|||
23146234|NCT01003990|64283741|FG001|Overall Study|Pregnancy|2|||
23146235|NCT01003990|64283742|FG002|Overall Study|Pregnancy|4|||
23146236|NCT01003990|64283740|FG000|Overall Study|No Longer Met Study Criteria|4|||
23146237|NCT01003990|64283741|FG001|Overall Study|No Longer Met Study Criteria|1|||
23146238|NCT01003990|64283742|FG002|Overall Study|No Longer Met Study Criteria|0|||
23146239|NCT01003990|64283740|FG000|Overall Study|Subject Withdrew Consent|12|||
23146240|NCT01003990|64283741|FG001|Overall Study|Subject Withdrew Consent|5|||
23146241|NCT01003990|64283742|FG002|Overall Study|Subject Withdrew Consent|7|||
23146242|NCT01155375|64283747|FG000|Overall Study|Adverse Event|1|||
23146243|NCT01155375|64283748|FG001|Overall Study|Adverse Event|0|||
23146244|NCT00381303|64283749|FG000|Overall Study|Lost to Follow-up|25|||
23146245|NCT00381303|64283750|FG001|Overall Study|Lost to Follow-up|9|||
23146246|NCT00381303|64283749|FG000|Overall Study|AE/HIV-related event|22|||
23146247|NCT00381303|64283750|FG001|Overall Study|AE/HIV-related event|6|||
23146248|NCT00381303|64283749|FG000|Overall Study|Non-Adherence|13|||
23146249|NCT00381303|64283750|FG001|Overall Study|Non-Adherence|6|||
23146250|NCT00381303|64283749|FG000|Overall Study|Withdrawal by Subject|13|||
23146251|NCT00381303|64283750|FG001|Overall Study|Withdrawal by Subject|6|||
23146252|NCT00381303|64283749|FG000|Overall Study|Virologic failure|6|||
23146253|NCT00381303|64283750|FG001|Overall Study|Virologic failure|4|||
23146254|NCT00381303|64283749|FG000|Overall Study|Ineligible to continue the trial|2|||
23146255|NCT00381303|64283750|FG001|Overall Study|Ineligible to continue the trial|1|||
23146256|NCT00381303|64283749|FG000|Overall Study|Pregnancy|2|||
23146257|NCT00381303|64283750|FG001|Overall Study|Pregnancy|0|||
23146258|NCT00381303|64283749|FG000|Overall Study|Physician Decision|1|||
23146259|NCT00381303|64283750|FG001|Overall Study|Physician Decision|0|||
23146260|NCT00381303|64283749|FG000|Overall Study|Physician's decision to close the site|3|||
23146261|NCT00381303|64283750|FG001|Overall Study|Physician's decision to close the site|1|||
23146262|NCT00381303|64283749|FG000|Overall Study|Subject moved out of state|2|||
23146263|NCT00381303|64283750|FG001|Overall Study|Subject moved out of state|0|||
23146264|NCT00381303|64283749|FG000|Overall Study|Subject taking too many different meds|1|||
23146265|NCT00381303|64283750|FG001|Overall Study|Subject taking too many different meds|0|||
23146266|NCT00381303|64283749|FG000|Overall Study|No virologic response by week 12|1|||
23146267|NCT00381303|64283750|FG001|Overall Study|No virologic response by week 12|0|||
23146268|NCT00381303|64283749|FG000|Overall Study|Subject was too busy for appointments|1|||
23146269|NCT00381303|64283750|FG001|Overall Study|Subject was too busy for appointments|0|||
23146270|NCT00381303|64283749|FG000|Overall Study|Subject did not continue visits|1|||
23146271|NCT00381303|64283750|FG001|Overall Study|Subject did not continue visits|0|||
23146272|NCT00381303|64283749|FG000|Overall Study|Subject primary physician's decision|1|||
23146273|NCT00381303|64283750|FG001|Overall Study|Subject primary physician's decision|0|||
23146274|NCT01551212|64283755|FG000|Overall Study|Graft loss/Retransplantation|0|||
23146275|NCT01551212|64283756|FG001|Overall Study|Graft loss/Retransplantation|1|||
23146276|NCT01551212|64283755|FG000|Overall Study|Administrative problems|1|||
23146277|NCT01551212|64283756|FG001|Overall Study|Administrative problems|2|||
23146278|NCT01551212|64283755|FG000|Overall Study|Lost to Follow-up|0|||
23146279|NCT01551212|64283756|FG001|Overall Study|Lost to Follow-up|1|||
23146280|NCT01551212|64283755|FG000|Overall Study|Protocol Violation|0|||
23146281|NCT01551212|64283756|FG001|Overall Study|Protocol Violation|1|||
23146282|NCT01551212|64283755|FG000|Overall Study|Withdrawal by Subject|0|||
23146283|NCT01551212|64283756|FG001|Overall Study|Withdrawal by Subject|7|||
23146284|NCT01551212|64283755|FG000|Overall Study|Death|2|||
23146285|NCT01551212|64283756|FG001|Overall Study|Death|4|||
23146286|NCT01551212|64283755|FG000|Overall Study|Never Received Study Treatment|2|||
23146287|NCT01551212|64283756|FG001|Overall Study|Never Received Study Treatment|4|||
23146288|NCT00846391|64283757|FG000|Overall Study|Physician Decision|0|||
23146289|NCT00846391|64283758|FG001|Overall Study|Physician Decision|0|||
23146290|NCT00846391|64283759|FG002|Overall Study|Physician Decision|1|||
23146291|NCT00846391|64283757|FG000|Overall Study|Study Terminated by Sponsor|1|||
23146292|NCT00846391|64283758|FG001|Overall Study|Study Terminated by Sponsor|2|||
23146293|NCT00846391|64283759|FG002|Overall Study|Study Terminated by Sponsor|2|||
23146294|NCT00666679|64283762|FG000|First Intervention|Lost to Follow-up|1|||
23146295|NCT00666679|64283763|FG001|First Intervention|Lost to Follow-up|0|||
23623753|NCT00719212|66008567|FG000|Overall Study|Withdrawal by Subject|1|||
23623754|NCT03023423|66008568|FG000|Overall Study|Death|5|||
23623755|NCT03023423|66008569|FG001|Overall Study|Death|12|||
23623756|NCT03023423|66008570|FG002|Overall Study|Death|20|||
23623757|NCT03023423|66008568|FG000|Overall Study|Other|0|||
23623758|NCT03023423|66008569|FG001|Overall Study|Other|2|||
23623759|NCT03023423|66008570|FG002|Overall Study|Other|2|||
23623760|NCT03023423|66008568|FG000|Overall Study|Ongoing|2|||
23623761|NCT03023423|66008569|FG001|Overall Study|Ongoing|32|||
23623762|NCT03023423|66008570|FG002|Overall Study|Ongoing|24|||
23623763|NCT03991988|66008571|FG000|Overall Study|Withdrawal by Subject|2|||
23623764|NCT03991988|66008572|FG001|Overall Study|Withdrawal by Subject|2|||
23623765|NCT02196077|66008573|FG000|Overall Study|Adverse Event|4|||
23623766|NCT02196077|66008573|FG000|Overall Study|Lack of Efficacy|1|||
23623767|NCT02196077|66008573|FG000|Overall Study|Withdrawal by Subject|14|||
23623768|NCT02196077|66008573|FG000|Overall Study|Physician Decision|1|||
23623769|NCT02196077|66008573|FG000|Overall Study|Lost to Follow-up|3|||
23623770|NCT02196077|66008573|FG000|Overall Study|Protocol Violation|24|||
23623771|NCT00371462|66008574|FG000|Overall Study|Withdrawal by Subject|1|||
23623772|NCT00371462|66008575|FG001|Overall Study|Withdrawal by Subject|0|||
23623773|NCT00371462|66008574|FG000|Overall Study|Other|7|||
23623774|NCT00371462|66008575|FG001|Overall Study|Other|8|||
23623775|NCT01776008|66008576|FG000|Overall Study|ineligible|2|||
23623776|NCT02447432|66008577|FG000|Epoch 001|Adverse Event|1|||
23623777|NCT02447432|66008578|FG001|Epoch 001|Adverse Event|1|||
23623778|NCT02447432|66008577|FG000|Epoch 001|Withdrawal by Subject|0|||
23623779|NCT02447432|66008578|FG001|Epoch 001|Withdrawal by Subject|4|||
23623780|NCT02447432|66008577|FG000|Epoch 001|Migrated/moved from study area|3|||
23623781|NCT02447432|66008578|FG001|Epoch 001|Migrated/moved from study area|5|||
23623782|NCT02447432|66008577|FG000|Epoch 001|Lost to Follow-up|1|||
23623783|NCT02447432|66008578|FG001|Epoch 001|Lost to Follow-up|3|||
23623784|NCT00510146|66008581|FG000|Double-Blind Treatment|Adverse Event|30|||
23623785|NCT00510146|66008582|FG001|Double-Blind Treatment|Adverse Event|13|||
23623786|NCT00510146|66008581|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
23623787|NCT00510146|66008582|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
23623788|NCT00510146|66008581|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
23623789|NCT00510146|66008582|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
23623790|NCT00510146|66008581|FG000|Double-Blind Treatment|Physician Decision|6|||
23623791|NCT00510146|66008582|FG001|Double-Blind Treatment|Physician Decision|0|||
23623792|NCT00510146|66008581|FG000|Double-Blind Treatment|Protocol Violation|1|||
23623793|NCT00510146|66008582|FG001|Double-Blind Treatment|Protocol Violation|2|||
23623794|NCT00510146|66008581|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
23623795|NCT00510146|66008582|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
23623796|NCT00510146|66008581|FG000|Double-Blind Treatment|Clinical Relapse|0|||
23623797|NCT00510146|66008582|FG001|Double-Blind Treatment|Clinical Relapse|1|||
23623798|NCT00510146|66008581|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
23623799|NCT00510146|66008582|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
23623800|NCT00510146|66008581|FG000|Open-Label Treatment|Adverse Event|22|||
23623801|NCT00510146|66008582|FG001|Open-Label Treatment|Adverse Event|8|||
23623802|NCT00510146|66008581|FG000|Open-Label Treatment|Death|1|||
23623803|NCT00510146|66008582|FG001|Open-Label Treatment|Death|1|||
23623804|NCT00510146|66008581|FG000|Open-Label Treatment|Lack of Efficacy|4|||
23146296|NCT00666679|64283762|FG000|First Intervention|Protocol Violation|1|||
23146297|NCT00666679|64283763|FG001|First Intervention|Protocol Violation|0|||
23146298|NCT00666679|64283762|FG000|First Intervention|Withdrawal by Subject|1|||
23623805|NCT00510146|66008582|FG001|Open-Label Treatment|Lack of Efficacy|0|||
23623806|NCT00510146|66008581|FG000|Open-Label Treatment|Lost to Follow-up|10|||
23623807|NCT00510146|66008582|FG001|Open-Label Treatment|Lost to Follow-up|1|||
23623808|NCT00510146|66008581|FG000|Open-Label Treatment|Physician Decision|3|||
23623809|NCT00510146|66008582|FG001|Open-Label Treatment|Physician Decision|1|||
23623810|NCT00510146|66008581|FG000|Open-Label Treatment|Protocol Violation|4|||
23623811|NCT00510146|66008582|FG001|Open-Label Treatment|Protocol Violation|2|||
23623812|NCT00510146|66008581|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
23623813|NCT00510146|66008582|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
23623814|NCT00510146|66008581|FG000|Open-Label Treatment|Clinical Relapse|1|||
23146299|NCT00666679|64283763|FG001|First Intervention|Withdrawal by Subject|0|||
23146300|NCT00666679|64283762|FG000|First Intervention|Randomized did not start treatment|1|||
23146301|NCT00666679|64283763|FG001|First Intervention|Randomized did not start treatment|1|||
23146302|NCT00666679|64283762|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
23146303|NCT00666679|64283763|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
23146304|NCT00666679|64283762|FG000|Washout Period of 1 Week|Protocol Violation|0|||
23146305|NCT00666679|64283763|FG001|Washout Period of 1 Week|Protocol Violation|1|||
23146306|NCT00666679|64283762|FG000|Second Intervention|Adverse Event|1|||
23146307|NCT00666679|64283763|FG001|Second Intervention|Adverse Event|0|||
23146308|NCT00666679|64283762|FG000|Second Intervention|Death|0|||
23146309|NCT00666679|64283763|FG001|Second Intervention|Death|1|||
23146310|NCT04964414|64283764|FG000|Overall Study|Lost to Follow-up|10|||
23146311|NCT04964414|64283765|FG001|Overall Study|Lost to Follow-up|8|||
23146312|NCT04964414|64283764|FG000|Overall Study|Withdrawal by Subject|1|||
23146313|NCT04964414|64283765|FG001|Overall Study|Withdrawal by Subject|1|||
23146314|NCT01388790|64283768|FG000|Overall Study|Ongoing at data cut-off date|8|||
23146315|NCT03357952|64283769|FG000|Overall Study|Withdrawal by Subject|0|||
23146316|NCT03357952|64283770|FG001|Overall Study|Withdrawal by Subject|1|||
23146317|NCT03357952|64283769|FG000|Overall Study|Sponsor Decision|9|||
23146318|NCT03357952|64283770|FG001|Overall Study|Sponsor Decision|0|||
23146319|NCT01664598|64283771|FG000|Overall Study|Sponsor Decision|1|||
23146320|NCT01664598|64283771|FG000|Overall Study|Withdrawal of Informed Consent|4|||
23146321|NCT01664598|64283771|FG000|Overall Study|Adverse Event|1|||
23146322|NCT01211522|64283772|FG000|Overall Study|Withdrawal by Subject|3|||
23146323|NCT01211522|64283773|FG001|Overall Study|Withdrawal by Subject|7|||
23146324|NCT01211522|64283774|FG002|Overall Study|Withdrawal by Subject|5|||
23146325|NCT00007345|64283775|FG000|Overall Study|Refused further treatment|0|||
23146326|NCT00007345|64283776|FG001|Overall Study|Refused further treatment|7|||
23146327|NCT00007345|64283775|FG000|Overall Study|Switched to alternative treatment|0|||
23146328|NCT00007345|64283776|FG001|Overall Study|Switched to alternative treatment|3|||
23146329|NCT00007345|64283775|FG000|Overall Study|Intercurrent illness|1|||
23146330|NCT00007345|64283776|FG001|Overall Study|Intercurrent illness|0|||
23146331|NCT00007345|64283775|FG000|Overall Study|Death on study|1|||
23146332|NCT00007345|64283776|FG001|Overall Study|Death on study|1|||
23146333|NCT01959516|64283777|FG000|Epoch 1|Adverse Event|4|||
23146334|NCT01959516|64283778|FG001|Epoch 1|Adverse Event|1|||
23146335|NCT01959516|64283777|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
23146336|NCT01959516|64283778|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
23146337|NCT01959516|64283777|FG000|Epoch 1|Subject withdrew consent|3|||
23146338|NCT01959516|64283778|FG001|Epoch 1|Subject withdrew consent|2|||
23146339|NCT01959516|64283777|FG000|Epoch 1|Administrative problems|1|||
23146340|NCT01959516|64283778|FG001|Epoch 1|Administrative problems|0|||
23146341|NCT01959516|64283777|FG000|Epoch 1|Use of prohibited treatment|1|||
23146342|NCT01959516|64283778|FG001|Epoch 1|Use of prohibited treatment|0|||
23146343|NCT01959516|64283777|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
23146344|NCT01959516|64283778|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
23146345|NCT01959516|64283777|FG000|Epoch 1|Protocol deviation|0|||
23146346|NCT01959516|64283778|FG001|Epoch 1|Protocol deviation|1|||
23146347|NCT01959516|64283777|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
23146348|NCT01959516|64283778|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
23146349|NCT01959516|64283777|FG000|Epoch 2|Subject withdrew consent|1|||
23146350|NCT01959516|64283778|FG001|Epoch 2|Subject withdrew consent|0|||
23146351|NCT01959516|64283777|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
23146352|NCT01959516|64283778|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
23146353|NCT00852540|64283779|FG000|Overall Study|Adverse Event|10|||
23146354|NCT00852540|64283780|FG001|Overall Study|Adverse Event|3|||
23146355|NCT00852540|64283779|FG000|Overall Study|Lack of Efficacy|15|||
23146356|NCT00852540|64283780|FG001|Overall Study|Lack of Efficacy|3|||
23146357|NCT00852540|64283779|FG000|Overall Study|Protocol Violation|1|||
23146358|NCT00852540|64283780|FG001|Overall Study|Protocol Violation|2|||
23146359|NCT00852540|64283779|FG000|Overall Study|Lost to Follow-up|2|||
23557504|NCT01693692|65769368|FG001|Overall Study|Other|4|||
23146360|NCT00852540|64283780|FG001|Overall Study|Lost to Follow-up|3|||
23146361|NCT00852540|64283779|FG000|Overall Study|Investigator Discretion|2|||
23146362|NCT00852540|64283780|FG001|Overall Study|Investigator Discretion|3|||
23146363|NCT00852540|64283779|FG000|Overall Study|Withdrawal by Subject|3|||
23146364|NCT00852540|64283780|FG001|Overall Study|Withdrawal by Subject|1|||
23146365|NCT00852540|64283779|FG000|Overall Study|Did Not Receive Study Drug|3|||
23146366|NCT00852540|64283780|FG001|Overall Study|Did Not Receive Study Drug|3|||
23146367|NCT00141726|64283784|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
23146368|NCT00701220|64283785|FG000|Overall Study|Withdrawal by Subject|0|||
23146369|NCT00701220|64283786|FG001|Overall Study|Withdrawal by Subject|2|||
23146370|NCT00701220|64283785|FG000|Overall Study|Protocol Violation|2|||
23146371|NCT00701220|64283786|FG001|Overall Study|Protocol Violation|0|||
23146372|NCT01802567|64283787|FG000|Overall Study|Withdrawal by Subject|2|||
23146373|NCT01802567|64283787|FG000|Overall Study|Physician Decision|1|||
23146374|NCT01802567|64283787|FG000|Overall Study|Lack of Efficacy|7|||
23436121|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
23436122|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
23436123|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
23436124|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
23436125|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
23322079|NCT03817190|64922892|FG000|Overall Study|Early Termination|13|||
23322080|NCT03817190|64922893|FG001|Overall Study|Early Termination|20|||
23322081|NCT03817190|64922892|FG000|Overall Study|Adverse Event|10|||
23322082|NCT03817190|64922893|FG001|Overall Study|Adverse Event|17|||
23436126|NCT00383162|65340603|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
23436127|NCT00383162|65340604|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
23436128|NCT00383162|65340603|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
23436129|NCT00383162|65340604|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
23436130|NCT00383162|65340603|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
23436131|NCT00383162|65340604|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
23436132|NCT00383162|65340603|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
23436133|NCT00383162|65340604|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
23218481|NCT01001234|64541598|FG002|Overall Study|Physician Decision|0|||
23218482|NCT01001234|64541599|FG003|Overall Study|Physician Decision|0|||
23218483|NCT01001234|64541600|FG004|Overall Study|Physician Decision|0|||
23218484|NCT01001234|64541596|FG000|Overall Study|Not Treated: Adverse Event|1|||
23218485|NCT01001234|64541597|FG001|Overall Study|Not Treated: Adverse Event|0|||
23218486|NCT01001234|64541598|FG002|Overall Study|Not Treated: Adverse Event|0|||
23218487|NCT01001234|64541599|FG003|Overall Study|Not Treated: Adverse Event|0|||
23322083|NCT03817190|64922892|FG000|Overall Study|Withdrawal by Subject|12|||
23322084|NCT03817190|64922893|FG001|Overall Study|Withdrawal by Subject|8|||
23322085|NCT03817190|64922892|FG000|Overall Study|Lost to Follow-up|11|||
23322086|NCT03817190|64922893|FG001|Overall Study|Lost to Follow-up|7|||
23322087|NCT03817190|64922892|FG000|Overall Study|Lack of Efficacy|7|||
23322088|NCT03817190|64922893|FG001|Overall Study|Lack of Efficacy|5|||
23322089|NCT03817190|64922892|FG000|Overall Study|Investigator Decision|5|||
23322090|NCT03817190|64922893|FG001|Overall Study|Investigator Decision|1|||
23322091|NCT03817190|64922892|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
23322092|NCT03817190|64922893|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
23322093|NCT03817190|64922892|FG000|Overall Study|Lack of Contact|1|||
23322094|NCT03817190|64922893|FG001|Overall Study|Lack of Contact|0|||
23322095|NCT03817190|64922892|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
23322096|NCT03817190|64922893|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
23218488|NCT01001234|64541600|FG004|Overall Study|Not Treated: Adverse Event|0|||
23218489|NCT01001234|64541596|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
23218490|NCT01001234|64541597|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
23218491|NCT01001234|64541598|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
23218492|NCT01001234|64541599|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
23218493|NCT01001234|64541600|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
23218494|NCT01001234|64541596|FG000|Overall Study|Not Treated: Protocol Violation|3|||
23218495|NCT01001234|64541597|FG001|Overall Study|Not Treated: Protocol Violation|0|||
23218496|NCT01001234|64541598|FG002|Overall Study|Not Treated: Protocol Violation|0|||
23218497|NCT01001234|64541599|FG003|Overall Study|Not Treated: Protocol Violation|0|||
23218498|NCT01001234|64541600|FG004|Overall Study|Not Treated: Protocol Violation|0|||
23322097|NCT01495702|64922894|FG000|Randomized Phase|Randomized But Not Treated|1|||
23322098|NCT01495702|64922895|FG001|Randomized Phase|Randomized But Not Treated|4|||
23322099|NCT01495702|64922894|FG000|Randomized Phase|Adverse Event|2|||
23322100|NCT01495702|64922895|FG001|Randomized Phase|Adverse Event|2|||
23322101|NCT01495702|64922894|FG000|Randomized Phase|Death|1|||
23322102|NCT01495702|64922895|FG001|Randomized Phase|Death|0|||
23322103|NCT01495702|64922894|FG000|Randomized Phase|Lack of Efficacy|2|||
23322104|NCT01495702|64922895|FG001|Randomized Phase|Lack of Efficacy|0|||
23322105|NCT01495702|64922894|FG000|Randomized Phase|Investigators Discretion|2|||
23322106|NCT01495702|64922895|FG001|Randomized Phase|Investigators Discretion|0|||
23322107|NCT01495702|64922894|FG000|Randomized Phase|Withdrew Consent|10|||
23322108|NCT01495702|64922895|FG001|Randomized Phase|Withdrew Consent|18|||
23322109|NCT01495702|64922894|FG000|Randomized Phase|Lost to Follow-up|4|||
23436134|NCT00383162|65340603|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
23218499|NCT01001234|64541596|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
23218500|NCT01001234|64541597|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
23322110|NCT01495702|64922895|FG001|Randomized Phase|Lost to Follow-up|3|||
23322111|NCT01495702|64922894|FG000|Randomized Phase|Participant Noncompliance|1|||
23322112|NCT01495702|64922895|FG001|Randomized Phase|Participant Noncompliance|0|||
23322113|NCT01495702|64922894|FG000|Randomized Phase|Protocol Violation|3|||
23322114|NCT01495702|64922895|FG001|Randomized Phase|Protocol Violation|1|||
23322115|NCT02115607|64922896|FG000|Overall Study|Withdrawal by Subject|1|||
23322116|NCT05373108|64922897|FG000|Overall Study|Withdrawal by Subject|2|||
23436135|NCT00383162|65340604|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
23436136|NCT04079114|65340605|FG000|Overall Study|Study prematuely terminated.|166|||
23436137|NCT00488826|65340608|FG000|Overall Study|Withdrawal by Subject|40|||
23436138|NCT00488826|65340609|FG001|Overall Study|Withdrawal by Subject|35|||
23436139|NCT00488826|65340610|FG002|Overall Study|Withdrawal by Subject|19|||
23436140|NCT00488826|65340608|FG000|Overall Study|Protocol Violation|0|||
23436141|NCT00488826|65340609|FG001|Overall Study|Protocol Violation|0|||
23436142|NCT00488826|65340610|FG002|Overall Study|Protocol Violation|2|||
23436143|NCT00488826|65340608|FG000|Overall Study|Adverse Event|9|||
23436144|NCT00488826|65340609|FG001|Overall Study|Adverse Event|15|||
23146375|NCT01802567|64283787|FG000|Overall Study|Consented but did not start therapy|7|||
23146376|NCT01802567|64283787|FG000|Overall Study|Protocol Violation|1|||
23146377|NCT00494481|64283788|FG000|Overall Study|Condition under investigation worsened|11|||
23146378|NCT00494481|64283789|FG001|Overall Study|Condition under investigation worsened|13|||
23146379|NCT00494481|64283788|FG000|Overall Study|Adverse Event|15|||
23146380|NCT00494481|64283789|FG001|Overall Study|Adverse Event|11|||
23436145|NCT00488826|65340610|FG002|Overall Study|Adverse Event|4|||
23436146|NCT00488826|65340608|FG000|Overall Study|Lost to Follow-up|5|||
23436147|NCT00488826|65340609|FG001|Overall Study|Lost to Follow-up|1|||
23436148|NCT00488826|65340610|FG002|Overall Study|Lost to Follow-up|0|||
23436149|NCT00488826|65340608|FG000|Overall Study|Protocol Deviations|2|||
23436150|NCT00488826|65340609|FG001|Overall Study|Protocol Deviations|1|||
23436151|NCT00488826|65340610|FG002|Overall Study|Protocol Deviations|1|||
23436152|NCT00118430|65340613|FG000|Overall Study|Withdrawal by Subject|6|||
23436153|NCT00118430|65340614|FG001|Overall Study|Withdrawal by Subject|2|||
23436154|NCT00118430|65340615|FG002|Overall Study|Withdrawal by Subject|0|||
23436155|NCT00118430|65340613|FG000|Overall Study|Lost to Follow-up|15|||
23436156|NCT00118430|65340614|FG001|Overall Study|Lost to Follow-up|22|||
23436157|NCT00118430|65340615|FG002|Overall Study|Lost to Follow-up|28|||
23436158|NCT02508428|65340616|FG000|Overall Study|Death|32|||
23436159|NCT02508428|65340617|FG001|Overall Study|Death|33|||
23436160|NCT02508428|65340616|FG000|Overall Study|Liner revised|3|||
23436161|NCT02508428|65340617|FG001|Overall Study|Liner revised|19|||
23436162|NCT02508428|65340616|FG000|Overall Study|Incomplete follow-up|17|||
23436163|NCT02508428|65340617|FG001|Overall Study|Incomplete follow-up|15|||
23436164|NCT02478255|65340618|FG000|Overall Study|Physician Decision|6|||
23436165|NCT02478255|65340619|FG001|Overall Study|Physician Decision|0|||
23436166|NCT02478255|65340618|FG000|Overall Study|Withdrawal by Subject|2|||
23436167|NCT02478255|65340619|FG001|Overall Study|Withdrawal by Subject|0|||
23436168|NCT00398320|65340620|FG000|Overall Study|Death|1|||
23436169|NCT00398320|65340620|FG000|Overall Study|Adverse Event|4|||
23436170|NCT00398320|65340620|FG000|Overall Study|Physician Decision|1|||
23436171|NCT02828020|65340623|FG000|Treatment Period|Adverse Event|3|||
23436172|NCT02828020|65340624|FG001|Treatment Period|Adverse Event|1|||
23436173|NCT02828020|65340625|FG002|Treatment Period|Adverse Event|1|||
23436174|NCT02828020|65340623|FG000|Treatment Period|Withdrawal of Consent|10|||
23322117|NCT02932462|64922898|FG000|Overall Study|Adverse Event|1|||
23322118|NCT02932462|64922899|FG001|Overall Study|Adverse Event|2|||
23322119|NCT02932462|64922898|FG000|Overall Study|Lost to Follow-up|4|||
23436175|NCT02828020|65340624|FG001|Treatment Period|Withdrawal of Consent|14|||
23436176|NCT02828020|65340625|FG002|Treatment Period|Withdrawal of Consent|9|||
23436177|NCT02828020|65340623|FG000|Treatment Period|Lost to Follow-up|21|||
23436178|NCT02828020|65340624|FG001|Treatment Period|Lost to Follow-up|24|||
23436179|NCT02828020|65340625|FG002|Treatment Period|Lost to Follow-up|18|||
23146381|NCT00494481|64283788|FG000|Overall Study|Other|1|||
23146382|NCT00494481|64283789|FG001|Overall Study|Other|0|||
23146383|NCT00494481|64283788|FG000|Overall Study|Never received IP|2|||
23146384|NCT00494481|64283789|FG001|Overall Study|Never received IP|0|||
23146385|NCT01313637|64283793|FG000|Overall Study|Adverse Event|17|||
23146386|NCT01313637|64283794|FG001|Overall Study|Adverse Event|24|||
23146387|NCT01313637|64283795|FG002|Overall Study|Adverse Event|25|||
23146388|NCT01313637|64283796|FG003|Overall Study|Adverse Event|18|||
23146389|NCT01313637|64283793|FG000|Overall Study|Lack of Efficacy|44|||
23146390|NCT01313637|64283794|FG001|Overall Study|Lack of Efficacy|38|||
23146391|NCT01313637|64283795|FG002|Overall Study|Lack of Efficacy|37|||
23146392|NCT01313637|64283796|FG003|Overall Study|Lack of Efficacy|24|||
23146393|NCT01313637|64283793|FG000|Overall Study|Protocol Violation|4|||
23436180|NCT02828020|65340623|FG000|Treatment Period|Lack of Qualifying Event|44|||
23436181|NCT02828020|65340624|FG001|Treatment Period|Lack of Qualifying Event|53|||
23436182|NCT02828020|65340625|FG002|Treatment Period|Lack of Qualifying Event|43|||
23436183|NCT02828020|65340623|FG000|Treatment Period|Pregnancy|0|||
23436184|NCT02828020|65340624|FG001|Treatment Period|Pregnancy|2|||
23436185|NCT02828020|65340625|FG002|Treatment Period|Pregnancy|0|||
23436186|NCT02828020|65340623|FG000|Treatment Period|Protocol Violation|2|||
23436187|NCT02828020|65340624|FG001|Treatment Period|Protocol Violation|4|||
23436188|NCT02828020|65340625|FG002|Treatment Period|Protocol Violation|7|||
23436189|NCT02828020|65340623|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
23146394|NCT01313637|64283794|FG001|Overall Study|Protocol Violation|3|||
23322120|NCT02932462|64922899|FG001|Overall Study|Lost to Follow-up|1|||
23436190|NCT02828020|65340624|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
23436191|NCT02828020|65340625|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
23436192|NCT02828020|65340623|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
23436193|NCT02828020|65340624|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
23436194|NCT02828020|65340625|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
23436195|NCT02828020|65340623|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
23436196|NCT02828020|65340624|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
23436197|NCT02828020|65340625|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
23436198|NCT02828020|65340623|FG000|Safety Follow-up Period|Protocol Violation|0|||
23436199|NCT02828020|65340624|FG001|Safety Follow-up Period|Protocol Violation|2|||
23436200|NCT02828020|65340625|FG002|Safety Follow-up Period|Protocol Violation|1|||
23436201|NCT02828020|65340623|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
23436202|NCT02828020|65340624|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
23436203|NCT02828020|65340625|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
23436204|NCT00679172|65340627|FG000|Overall Study|Non-compliance|1|||
23436205|NCT00679172|65340628|FG001|Overall Study|Non-compliance|1|||
23436206|NCT00679172|65340629|FG002|Overall Study|Non-compliance|0|||
23436207|NCT00679172|65340630|FG003|Overall Study|Non-compliance|1|||
23436208|NCT00679172|65340631|FG004|Overall Study|Non-compliance|0|||
23436209|NCT00679172|65340627|FG000|Overall Study|Other not specified|0|||
23436210|NCT00679172|65340628|FG001|Overall Study|Other not specified|0|||
23436211|NCT00679172|65340629|FG002|Overall Study|Other not specified|1|||
23436212|NCT00679172|65340630|FG003|Overall Study|Other not specified|0|||
23436213|NCT00679172|65340631|FG004|Overall Study|Other not specified|0|||
23436214|NCT01789606|65340633|FG000|Overall Study|Participant not Purchased the Product|0|||
23436215|NCT01789606|65340634|FG001|Overall Study|Participant not Purchased the Product|20|||
23436216|NCT01789606|65340633|FG000|Overall Study|Withdrawal by Subject|0|||
23436217|NCT01789606|65340634|FG001|Overall Study|Withdrawal by Subject|1|||
23436218|NCT01789606|65340633|FG000|Overall Study|Ineligible|6|||
23436219|NCT01789606|65340634|FG001|Overall Study|Ineligible|2|||
23436220|NCT01789606|65340633|FG000|Overall Study|Administrative Reasons|17|||
23436221|NCT01789606|65340634|FG001|Overall Study|Administrative Reasons|6|||
23436222|NCT01789606|65340633|FG000|Overall Study|No Study Medication Taken|0|||
23436223|NCT01789606|65340634|FG001|Overall Study|No Study Medication Taken|1|||
23436224|NCT01789606|65340633|FG000|Overall Study|Protocol Violation|0|||
23436225|NCT01789606|65340634|FG001|Overall Study|Protocol Violation|55|||
23436226|NCT01789606|65340633|FG000|Overall Study|Adverse Event|0|||
23436227|NCT01789606|65340634|FG001|Overall Study|Adverse Event|3|||
23436228|NCT01789606|65340633|FG000|Overall Study|Lost to Follow-up|0|||
23436229|NCT01789606|65340634|FG001|Overall Study|Lost to Follow-up|14|||
23436230|NCT01789606|65340633|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
23436231|NCT01789606|65340634|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
23146395|NCT01313637|64283795|FG002|Overall Study|Protocol Violation|11|||
23146396|NCT01313637|64283796|FG003|Overall Study|Protocol Violation|5|||
23146397|NCT01313637|64283793|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
23146398|NCT01313637|64283794|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
23146399|NCT01313637|64283795|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
23146400|NCT01313637|64283796|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
23146401|NCT01313637|64283793|FG000|Overall Study|Lost to Follow-up|0|||
23146402|NCT01313637|64283794|FG001|Overall Study|Lost to Follow-up|2|||
23146403|NCT01313637|64283795|FG002|Overall Study|Lost to Follow-up|1|||
23146404|NCT01313637|64283796|FG003|Overall Study|Lost to Follow-up|3|||
23146405|NCT01313637|64283793|FG000|Overall Study|Withdrawal by Subject|11|||
23146406|NCT01313637|64283794|FG001|Overall Study|Withdrawal by Subject|13|||
23146407|NCT01313637|64283795|FG002|Overall Study|Withdrawal by Subject|18|||
23146408|NCT01313637|64283796|FG003|Overall Study|Withdrawal by Subject|15|||
23146409|NCT03371381|64283797|FG000|Overall Study|Death|5|||
23146410|NCT03371381|64283797|FG000|Overall Study|Study terminated by sponsor|3|||
23146411|NCT03371381|64283797|FG000|Overall Study|Other|4|||
23146412|NCT02434939|64283798|FG000|Overall Study|Lack of Efficacy|34|||
23146413|NCT02434939|64283799|FG001|Overall Study|Lack of Efficacy|48|||
23146414|NCT02434939|64283798|FG000|Overall Study|Withdrawal by Subject|3|||
23146415|NCT02434939|64283799|FG001|Overall Study|Withdrawal by Subject|0|||
23146416|NCT02434939|64283798|FG000|Overall Study|Adverse Event|0|||
23146417|NCT02434939|64283799|FG001|Overall Study|Adverse Event|1|||
23146418|NCT00069238|64283801|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
23146419|NCT00069238|64283802|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
23146420|NCT00069238|64283803|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
23146421|NCT00069238|64283801|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
23436232|NCT02039856|65340635|FG000|Overall Study|Death|5|||
23146422|NCT00069238|64283802|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
23146423|NCT00069238|64283803|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
23436233|NCT02039856|65340636|FG001|Overall Study|Death|3|||
23436234|NCT02039856|65340635|FG000|Overall Study|Partial survey completion|61|||
23436235|NCT02039856|65340636|FG001|Overall Study|Partial survey completion|26|||
23322121|NCT02932462|64922898|FG000|Overall Study|Protocol Violation|0|||
23322122|NCT02932462|64922899|FG001|Overall Study|Protocol Violation|5|||
23322123|NCT02932462|64922898|FG000|Overall Study|Withdrawal by Subject|1|||
23322124|NCT02932462|64922899|FG001|Overall Study|Withdrawal by Subject|4|||
23322125|NCT02932462|64922898|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23322126|NCT02932462|64922899|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23322127|NCT02932462|64922898|FG000|Overall Study|Progressive Disease|1|||
23322128|NCT02932462|64922899|FG001|Overall Study|Progressive Disease|0|||
23322129|NCT02370238|64922909|FG000|Overall Study|Death|42|||
23322130|NCT02370238|64922910|FG001|Overall Study|Death|35|||
23322131|NCT02370238|64922909|FG000|Overall Study|Lost to Follow-up|1|||
23322132|NCT02370238|64922910|FG001|Overall Study|Lost to Follow-up|3|||
23322133|NCT02370238|64922909|FG000|Overall Study|Withdrawal by Subject|2|||
23322134|NCT02370238|64922910|FG001|Overall Study|Withdrawal by Subject|6|||
23322135|NCT02370238|64922909|FG000|Overall Study|Other|2|||
23322136|NCT02370238|64922910|FG001|Overall Study|Other|1|||
23322137|NCT03022370|64922912|FG000|Overall Study|Death|6|||
23322138|NCT03022370|64922913|FG001|Overall Study|Death|12|||
23322139|NCT03022370|64922912|FG000|Overall Study|Lost to Follow-up|174|||
23557505|NCT01693692|65769369|FG002|Overall Study|Other|6|||
23557506|NCT02272725|65769372|FG000|Overall Study|equipment malfunction|2|||
23557507|NCT02272725|65769373|FG001|Overall Study|equipment malfunction|0|||
23557508|NCT00696410|65769374|FG000|Overall Study|Lost to Follow-up|2|||
23557509|NCT00696410|65769375|FG001|Overall Study|Lost to Follow-up|0|||
23146424|NCT00069238|64283801|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
23146425|NCT00069238|64283802|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
23146426|NCT00069238|64283803|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
23146427|NCT02057523|64283811|FG000|Overall Study|Withdrawal by Subject|1|||
23146428|NCT02057523|64283811|FG000|Overall Study|Lack of Efficacy|1|||
23146429|NCT02647866|64283812|FG000|Overall Study|Adverse Event|0|||
23146430|NCT02647866|64283813|FG001|Overall Study|Adverse Event|0|||
23146431|NCT02647866|64283814|FG002|Overall Study|Adverse Event|2|||
23146432|NCT02647866|64283815|FG003|Overall Study|Adverse Event|2|||
23146433|NCT02647866|64283816|FG004|Overall Study|Adverse Event|1|||
23146434|NCT02647866|64283812|FG000|Overall Study|Disease Worsening|3|||
23146435|NCT02647866|64283813|FG001|Overall Study|Disease Worsening|1|||
23146436|NCT02647866|64283814|FG002|Overall Study|Disease Worsening|0|||
23146437|NCT02647866|64283815|FG003|Overall Study|Disease Worsening|0|||
23218501|NCT01001234|64541598|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
23218502|NCT01001234|64541599|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
23218503|NCT01001234|64541600|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
23218504|NCT01001234|64541596|FG000|Overall Study|Not Treated: Pregnancy|3|||
23218505|NCT01001234|64541597|FG001|Overall Study|Not Treated: Pregnancy|0|||
23218506|NCT01001234|64541598|FG002|Overall Study|Not Treated: Pregnancy|0|||
23218507|NCT01001234|64541599|FG003|Overall Study|Not Treated: Pregnancy|0|||
23218508|NCT01001234|64541600|FG004|Overall Study|Not Treated: Pregnancy|0|||
23218509|NCT01001234|64541596|FG000|Overall Study|Not Treated: Physician Decision|37|||
23218510|NCT01001234|64541597|FG001|Overall Study|Not Treated: Physician Decision|4|||
23218511|NCT01001234|64541598|FG002|Overall Study|Not Treated: Physician Decision|0|||
23218512|NCT01001234|64541599|FG003|Overall Study|Not Treated: Physician Decision|0|||
23322140|NCT03022370|64922913|FG001|Overall Study|Lost to Follow-up|109|||
23557510|NCT00696410|65769374|FG000|Overall Study|Withdrawal by Subject|8|||
23146438|NCT02647866|64283816|FG004|Overall Study|Disease Worsening|1|||
23146439|NCT02647866|64283812|FG000|Overall Study|Withdrawal by Subject|1|||
23146440|NCT02647866|64283813|FG001|Overall Study|Withdrawal by Subject|1|||
23557511|NCT00696410|65769375|FG001|Overall Study|Withdrawal by Subject|0|||
23557512|NCT00696410|65769374|FG000|Overall Study|Physician Decision|3|||
23557513|NCT00696410|65769375|FG001|Overall Study|Physician Decision|0|||
23623815|NCT00510146|66008582|FG001|Open-Label Treatment|Clinical Relapse|1|||
23623816|NCT00510146|66008581|FG000|Open-Label Treatment|Sponsor Decision|2|||
23146441|NCT02647866|64283814|FG002|Overall Study|Withdrawal by Subject|2|||
23146442|NCT02647866|64283815|FG003|Overall Study|Withdrawal by Subject|4|||
23146443|NCT02647866|64283816|FG004|Overall Study|Withdrawal by Subject|4|||
23146444|NCT02647866|64283812|FG000|Overall Study|Physician Decision|0|||
23146445|NCT02647866|64283813|FG001|Overall Study|Physician Decision|1|||
23146446|NCT02647866|64283814|FG002|Overall Study|Physician Decision|1|||
23146447|NCT02647866|64283815|FG003|Overall Study|Physician Decision|0|||
23146448|NCT02647866|64283816|FG004|Overall Study|Physician Decision|2|||
23322141|NCT05024747|64922914|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
23322142|NCT05024747|64922915|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
23322143|NCT05024747|64922914|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
23322144|NCT05024747|64922915|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
23322145|NCT05024747|64922914|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
23322146|NCT05024747|64922915|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
23322147|NCT01197534|64922916|FG000|Overall Study|Not reported|16|||
23322148|NCT01197534|64922917|FG001|Overall Study|Not reported|10|||
23322149|NCT01197534|64922918|FG002|Overall Study|Not reported|16|||
23146449|NCT02647866|64283812|FG000|Overall Study|Death|0|||
23146450|NCT02647866|64283813|FG001|Overall Study|Death|1|||
23146451|NCT02647866|64283814|FG002|Overall Study|Death|0|||
23146452|NCT02647866|64283815|FG003|Overall Study|Death|0|||
23436236|NCT02039856|65340635|FG000|Overall Study|Lost to Follow-up|388|||
23436237|NCT02039856|65340636|FG001|Overall Study|Lost to Follow-up|206|||
23436238|NCT02039856|65340635|FG000|Overall Study|Withdrawal by Subject|1573|||
23436239|NCT02039856|65340636|FG001|Overall Study|Withdrawal by Subject|618|||
23436240|NCT03675737|65340637|FG000|Overall Study|Death|593|||
23436241|NCT03675737|65340638|FG001|Overall Study|Death|660|||
23436242|NCT03675737|65340637|FG000|Overall Study|Lost to Follow-up|1|||
23436243|NCT03675737|65340638|FG001|Overall Study|Lost to Follow-up|5|||
23436244|NCT03675737|65340637|FG000|Overall Study|Physician Decision|1|||
23436245|NCT03675737|65340638|FG001|Overall Study|Physician Decision|0|||
23436246|NCT03675737|65340637|FG000|Overall Study|Withdrawal by Subject|14|||
23436247|NCT03675737|65340638|FG001|Overall Study|Withdrawal by Subject|12|||
23436248|NCT03675737|65340637|FG000|Overall Study|Ongoing in Study|181|||
23436249|NCT03675737|65340638|FG001|Overall Study|Ongoing in Study|112|||
23436250|NCT01374178|65340645|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
23436251|NCT01374178|65340646|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
23436252|NCT01374178|65340645|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
23436253|NCT01374178|65340646|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
23436254|NCT01736618|65340649|FG000|Overall Study|Death|294|||
23436255|NCT01736618|65340649|FG000|Overall Study|Lost to Follow-up|193|||
23436256|NCT01736618|65340649|FG000|Overall Study|Withdrawal by Subject|54|||
23436257|NCT01736618|65340649|FG000|Overall Study|Subject unable to be followed at study location|223|||
23436258|NCT01736618|65340649|FG000|Overall Study|Physician Decision|33|||
23436259|NCT01736618|65340649|FG000|Overall Study|Transplant or removal of target organ|19|||
23436260|NCT01736618|65340649|FG000|Overall Study|Change in indication or condition|78|||
23436261|NCT01736618|65340649|FG000|Overall Study|Study device explant|103|||
23436262|NCT01736618|65340649|FG000|Overall Study|Unable to complete implant|2|||
23436263|NCT03101085|65340651|FG000|Overall Study|Lost to Follow-up|0|||
23146453|NCT02647866|64283816|FG004|Overall Study|Death|0|||
23146454|NCT02647866|64283812|FG000|Overall Study|Subject moved to different country|1|||
23146455|NCT02647866|64283813|FG001|Overall Study|Subject moved to different country|0|||
23146456|NCT02647866|64283814|FG002|Overall Study|Subject moved to different country|0|||
23146457|NCT02647866|64283815|FG003|Overall Study|Subject moved to different country|0|||
23146458|NCT02647866|64283816|FG004|Overall Study|Subject moved to different country|0|||
23146459|NCT02319525|64283822|FG000|Overall Study|Withdrawal by Subject|2|||
23146460|NCT02319525|64283823|FG001|Overall Study|Withdrawal by Subject|1|||
23146461|NCT01177787|64287177|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
23146462|NCT01177787|64287177|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
23146463|NCT01177787|64287177|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
23146464|NCT01778023|64287178|FG000|Overall Study|Withdrawal by Subject|0|||
23146465|NCT01778023|64287179|FG001|Overall Study|Withdrawal by Subject|3|||
23146466|NCT02569957|64287180|FG000|Overall Study|Withdrawal by Subject|0|||
23146467|NCT02569957|64287181|FG001|Overall Study|Withdrawal by Subject|1|||
23146468|NCT00512317|64287183|FG000|Overall Study|Insufficient clinical response|36|||
23146469|NCT00512317|64287183|FG000|Overall Study|Withdrawal by Subject|23|||
23146470|NCT00512317|64287183|FG000|Overall Study|Sponsor closure of study|21|||
23146471|NCT00512317|64287183|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
23146472|NCT00512317|64287183|FG000|Overall Study|Adverse Event|13|||
23146473|NCT00512317|64287183|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
23146474|NCT00512317|64287183|FG000|Overall Study|Lost to Follow-up|2|||
23146475|NCT00512317|64287183|FG000|Overall Study|Other|2|||
23146476|NCT02795429|64287184|FG000|Overall Study|Adverse Event|1|||
23146477|NCT02795429|64287185|FG001|Overall Study|Adverse Event|2|||
23146478|NCT02795429|64287186|FG002|Overall Study|Adverse Event|1|||
23146479|NCT02795429|64287187|FG003|Overall Study|Adverse Event|2|||
23146480|NCT02795429|64287188|FG004|Overall Study|Adverse Event|1|||
23146481|NCT02795429|64287184|FG000|Overall Study|Death|1|||
23146482|NCT02795429|64287185|FG001|Overall Study|Death|0|||
23146483|NCT02795429|64287186|FG002|Overall Study|Death|1|||
23146484|NCT02795429|64287187|FG003|Overall Study|Death|2|||
23146485|NCT02795429|64287188|FG004|Overall Study|Death|1|||
23146486|NCT02795429|64287184|FG000|Overall Study|Physician Decision|0|||
23436264|NCT03101085|65340652|FG001|Overall Study|Lost to Follow-up|1|||
23436265|NCT02986854|65340654|FG000|Overall Study|Withdrawal by Subject|0|||
23146487|NCT02795429|64287185|FG001|Overall Study|Physician Decision|0|||
23146488|NCT02795429|64287186|FG002|Overall Study|Physician Decision|2|||
23146489|NCT02795429|64287187|FG003|Overall Study|Physician Decision|1|||
23146490|NCT02795429|64287188|FG004|Overall Study|Physician Decision|5|||
23146491|NCT02795429|64287184|FG000|Overall Study|Progressive disease|3|||
23146492|NCT02795429|64287185|FG001|Overall Study|Progressive disease|7|||
23146493|NCT02795429|64287186|FG002|Overall Study|Progressive disease|6|||
23146494|NCT02795429|64287187|FG003|Overall Study|Progressive disease|26|||
23436266|NCT02986854|65340655|FG001|Overall Study|Withdrawal by Subject|1|||
23146495|NCT02795429|64287188|FG004|Overall Study|Progressive disease|20|||
23146496|NCT02795429|64287184|FG000|Overall Study|Subject/guardian decision|1|||
23146497|NCT02795429|64287185|FG001|Overall Study|Subject/guardian decision|1|||
23146498|NCT02795429|64287186|FG002|Overall Study|Subject/guardian decision|1|||
23146499|NCT02795429|64287187|FG003|Overall Study|Subject/guardian decision|1|||
23146500|NCT02795429|64287188|FG004|Overall Study|Subject/guardian decision|3|||
23146501|NCT03442985|64287189|FG000|Overall Study|Sponsor Request|55|||
23146502|NCT03442985|64287190|FG001|Overall Study|Sponsor Request|60|||
23146503|NCT03442985|64287191|FG002|Overall Study|Sponsor Request|54|||
23146504|NCT03442985|64287189|FG000|Overall Study|Lost to Follow-up|5|||
23146505|NCT03442985|64287190|FG001|Overall Study|Lost to Follow-up|2|||
23146506|NCT03442985|64287191|FG002|Overall Study|Lost to Follow-up|7|||
23146507|NCT03442985|64287189|FG000|Overall Study|Withdrawal by Subject|2|||
23146508|NCT03442985|64287190|FG001|Overall Study|Withdrawal by Subject|3|||
23146509|NCT03442985|64287191|FG002|Overall Study|Withdrawal by Subject|4|||
23146510|NCT03442985|64287189|FG000|Overall Study|Adverse Event|0|||
23146511|NCT03442985|64287190|FG001|Overall Study|Adverse Event|1|||
23146512|NCT03442985|64287191|FG002|Overall Study|Adverse Event|0|||
23146513|NCT00926211|64287192|FG000|Overall Study|Lost to Follow-up|1|||
23146514|NCT02796560|64287193|FG000|Overall Study|Adverse Event|2|||
23146515|NCT02796560|64287194|FG001|Overall Study|Adverse Event|0|||
23146516|NCT02796560|64287193|FG000|Overall Study|Withdrawal by Subject|2|||
23146517|NCT02796560|64287194|FG001|Overall Study|Withdrawal by Subject|2|||
23146518|NCT02720536|64287195|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
23146519|NCT02720536|64287195|FG000|Overall Study|PR - pregnancy|2|||
23146520|NCT02720536|64287195|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
23146521|NCT02720536|64287195|FG000|Overall Study|PR - death|1|||
23146522|NCT02720536|64287195|FG000|Overall Study|PR - adverse event|1|||
23436267|NCT02986854|65340656|FG002|Overall Study|Withdrawal by Subject|1|||
23436268|NCT02986854|65340654|FG000|Overall Study|Lost to Follow-up|3|||
23436269|NCT02986854|65340655|FG001|Overall Study|Lost to Follow-up|11|||
23436270|NCT02986854|65340656|FG002|Overall Study|Lost to Follow-up|2|||
23436271|NCT01078168|65340666|FG000|Overall Study|Physician Decision|0|||
23557514|NCT00512148|65769379|FG000|Primay Study Period|Withdrawal by Subject|1|||
23557515|NCT00136955|65769381|FG000|Overall Study|Adverse Event|8|||
23557516|NCT00136955|65769381|FG000|Overall Study|Lost to Follow-up|1|||
23557517|NCT00136955|65769381|FG000|Overall Study|Withdrawal by Subject|2|||
23146523|NCT02720536|64287195|FG000|Overall Study|PR - abnormal lab value(s)|1|||
23146524|NCT02720536|64287195|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
23557518|NCT00136955|65769381|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
23557519|NCT00522626|65769382|FG000|Overall Study|Lost to Follow-up|7|||
23557520|NCT03409666|65769390|FG000|Overall Study|Physician Decision|0|||
23557521|NCT03409666|65769391|FG001|Overall Study|Physician Decision|1|||
23557522|NCT03409666|65769390|FG000|Overall Study|Protocol Violation|0|||
23557523|NCT03409666|65769391|FG001|Overall Study|Protocol Violation|3|||
23557524|NCT00295022|65769392|FG000|Overall Study|Adverse Event|1|||
23557525|NCT00295022|65769393|FG001|Overall Study|Adverse Event|1|||
23557526|NCT00295022|65769394|FG002|Overall Study|Adverse Event|2|||
23557527|NCT00295022|65769392|FG000|Overall Study|Lost to Follow-up|0|||
23557528|NCT00295022|65769393|FG001|Overall Study|Lost to Follow-up|0|||
23557529|NCT00295022|65769394|FG002|Overall Study|Lost to Follow-up|1|||
23557530|NCT00295022|65769392|FG000|Overall Study|Withdrawal by Subject|0|||
23623817|NCT00510146|66008582|FG001|Open-Label Treatment|Sponsor Decision|0|||
23146525|NCT01369511|64287205|FG000|Overall Study|Adverse Event|1|||
23146526|NCT01369511|64287206|FG001|Overall Study|Adverse Event|1|||
23146527|NCT01369511|64287207|FG002|Overall Study|Adverse Event|5|||
23146528|NCT01369511|64287208|FG003|Overall Study|Adverse Event|0|||
23146529|NCT01369511|64287205|FG000|Overall Study|Entry criteria not met|2|||
23146530|NCT01369511|64287206|FG001|Overall Study|Entry criteria not met|0|||
23146531|NCT01369511|64287207|FG002|Overall Study|Entry criteria not met|0|||
23146532|NCT01369511|64287208|FG003|Overall Study|Entry criteria not met|1|||
23146533|NCT01369511|64287205|FG000|Overall Study|Lost to Follow-up|0|||
23146534|NCT01369511|64287206|FG001|Overall Study|Lost to Follow-up|1|||
23146535|NCT01369511|64287207|FG002|Overall Study|Lost to Follow-up|1|||
23146536|NCT01369511|64287208|FG003|Overall Study|Lost to Follow-up|2|||
23146537|NCT01369511|64287205|FG000|Overall Study|Protocol Violation|0|||
23557531|NCT00295022|65769393|FG001|Overall Study|Withdrawal by Subject|0|||
23623818|NCT01703845|66008583|FG000|Overall Study|Adverse Event|1|||
23146538|NCT01369511|64287206|FG001|Overall Study|Protocol Violation|1|||
23146539|NCT01369511|64287207|FG002|Overall Study|Protocol Violation|0|||
23322150|NCT01197534|64922916|FG000|Overall Study|Enrolment in long term extension|57|||
23146540|NCT01369511|64287208|FG003|Overall Study|Protocol Violation|2|||
23322151|NCT01197534|64922917|FG001|Overall Study|Enrolment in long term extension|66|||
23557532|NCT00295022|65769394|FG002|Overall Study|Withdrawal by Subject|2|||
23557533|NCT01113502|65769405|FG000|Overall Study|Withdrawal by Subject|1|||
23623819|NCT01703845|66008584|FG001|Overall Study|Adverse Event|0|||
23146541|NCT01369511|64287205|FG000|Overall Study|Physician Decision|3|||
23436272|NCT01078168|65340667|FG001|Overall Study|Physician Decision|1|||
23557534|NCT01113502|65769406|FG001|Overall Study|Withdrawal by Subject|0|||
23557535|NCT01113502|65769407|FG002|Overall Study|Withdrawal by Subject|1|||
23557536|NCT01113502|65769408|FG003|Overall Study|Withdrawal by Subject|1|||
23557537|NCT01113502|65769409|FG004|Overall Study|Withdrawal by Subject|0|||
23557538|NCT01113502|65769405|FG000|Overall Study|Adverse Event|0|||
23557539|NCT01113502|65769406|FG001|Overall Study|Adverse Event|0|||
23557540|NCT01113502|65769407|FG002|Overall Study|Adverse Event|3|||
23146542|NCT01369511|64287206|FG001|Overall Study|Physician Decision|4|||
23146543|NCT01369511|64287207|FG002|Overall Study|Physician Decision|0|||
23218513|NCT01001234|64541600|FG004|Overall Study|Not Treated: Physician Decision|0|||
23218514|NCT01001234|64541596|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
23218515|NCT01001234|64541597|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
23218516|NCT01001234|64541598|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
23218517|NCT01001234|64541599|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
23218518|NCT01001234|64541600|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
23218519|NCT01570309|64541607|FG000|Overall Study|Withdrawal by Subject|3|||
23218520|NCT01570309|64541608|FG001|Overall Study|Withdrawal by Subject|3|||
23218521|NCT02773368|64541614|FG000|Overall Study|Lost to Follow-up|4|||
23218522|NCT02773368|64541615|FG001|Overall Study|Lost to Follow-up|1|||
23218523|NCT02773368|64541614|FG000|Overall Study|Withdrawal by Subject|5|||
23218524|NCT02773368|64541615|FG001|Overall Study|Withdrawal by Subject|1|||
23218525|NCT02773368|64541614|FG000|Overall Study|Unclassified|1|||
23218526|NCT02773368|64541615|FG001|Overall Study|Unclassified|1|||
23218527|NCT02773368|64541614|FG000|Overall Study|Missing|0|||
23218528|NCT02773368|64541615|FG001|Overall Study|Missing|1|||
23218529|NCT02142504|64541616|FG000|Overall Study|Protocol Violation|2|||
23218530|NCT02142504|64541617|FG001|Overall Study|Protocol Violation|1|||
23218531|NCT02142504|64541618|FG002|Overall Study|Protocol Violation|2|||
23218532|NCT02142504|64541616|FG000|Overall Study|Adverse Event|2|||
23218533|NCT02142504|64541617|FG001|Overall Study|Adverse Event|3|||
23218534|NCT02142504|64541618|FG002|Overall Study|Adverse Event|4|||
23218535|NCT02142504|64541616|FG000|Overall Study|Lost to Follow-up|12|||
23218536|NCT02142504|64541617|FG001|Overall Study|Lost to Follow-up|19|||
23218537|NCT02142504|64541618|FG002|Overall Study|Lost to Follow-up|17|||
23218538|NCT02142504|64541616|FG000|Overall Study|Withdrawal by Subject|7|||
23218539|NCT02142504|64541617|FG001|Overall Study|Withdrawal by Subject|9|||
23218540|NCT02142504|64541618|FG002|Overall Study|Withdrawal by Subject|11|||
23218541|NCT02142504|64541616|FG000|Overall Study|Pregnancy|4|||
23218542|NCT02142504|64541617|FG001|Overall Study|Pregnancy|4|||
23218543|NCT02142504|64541618|FG002|Overall Study|Pregnancy|2|||
23218544|NCT02142504|64541616|FG000|Overall Study|Physician Decision|0|||
23218545|NCT02142504|64541617|FG001|Overall Study|Physician Decision|1|||
23322152|NCT01197534|64922918|FG002|Overall Study|Enrolment in long term extension|119|||
23322153|NCT01197534|64922916|FG000|Overall Study|Severe non-compliance to protocol|3|||
23436273|NCT01730586|65340669|FG000|Overall Study|Progressive Disease|2|||
23557541|NCT01113502|65769408|FG003|Overall Study|Adverse Event|2|||
23557542|NCT01113502|65769409|FG004|Overall Study|Adverse Event|0|||
23557543|NCT00662857|65769410|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
23557544|NCT00662857|65769411|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
23557545|NCT00662857|65769410|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
23557546|NCT00662857|65769411|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
23557547|NCT00662857|65769410|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
23557548|NCT00662857|65769411|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
23557549|NCT02432105|65769412|FG000|Overall Study|Lost to Follow-up|1|||
23146544|NCT01369511|64287208|FG003|Overall Study|Physician Decision|0|||
23146545|NCT01369511|64287205|FG000|Overall Study|Sponsor decision|2|||
23146546|NCT01369511|64287206|FG001|Overall Study|Sponsor decision|0|||
23146547|NCT01369511|64287207|FG002|Overall Study|Sponsor decision|1|||
23146548|NCT01369511|64287208|FG003|Overall Study|Sponsor decision|0|||
23146549|NCT01369511|64287205|FG000|Overall Study|Withdrawal by Subject|5|||
23146550|NCT01369511|64287206|FG001|Overall Study|Withdrawal by Subject|6|||
23146551|NCT01369511|64287207|FG002|Overall Study|Withdrawal by Subject|4|||
23146552|NCT01369511|64287208|FG003|Overall Study|Withdrawal by Subject|6|||
23146553|NCT00764751|64287209|FG000|Overall Study|Adverse Event|1|||
23146554|NCT00764751|64287210|FG001|Overall Study|Adverse Event|1|||
23146555|NCT00764751|64287209|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
23146556|NCT00764751|64287210|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
23146557|NCT00171704|64287211|FG000|Overall Study|Adverse Event|24|||
23146558|NCT00171704|64287212|FG001|Overall Study|Adverse Event|33|||
23146559|NCT00171704|64287211|FG000|Overall Study|Disease Progression|14|||
23146560|NCT00171704|64287212|FG001|Overall Study|Disease Progression|9|||
23146561|NCT00171704|64287211|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
23218546|NCT02142504|64541618|FG002|Overall Study|Physician Decision|3|||
23218547|NCT02142504|64541616|FG000|Overall Study|Reason Not Specified|4|||
23322154|NCT01197534|64922917|FG001|Overall Study|Severe non-compliance to protocol|4|||
23557550|NCT02432105|65769413|FG001|Overall Study|Lost to Follow-up|1|||
23557551|NCT02432105|65769414|FG002|Overall Study|Lost to Follow-up|0|||
23146562|NCT00171704|64287212|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
23146563|NCT00171704|64287211|FG000|Overall Study|Administrative Problems|2|||
23146564|NCT00171704|64287212|FG001|Overall Study|Administrative Problems|1|||
23146565|NCT00171704|64287211|FG000|Overall Study|Death|2|||
23146566|NCT00171704|64287212|FG001|Overall Study|Death|2|||
23146567|NCT00171704|64287211|FG000|Overall Study|Withdrawal by Subject|1|||
23146568|NCT00171704|64287212|FG001|Overall Study|Withdrawal by Subject|3|||
23146569|NCT00171704|64287211|FG000|Overall Study|Protocol Violation|0|||
23146570|NCT00171704|64287212|FG001|Overall Study|Protocol Violation|1|||
23146571|NCT00975507|64287214|FG000|Overall Study|Adverse Event|1|||
23146572|NCT00975507|64287215|FG001|Overall Study|Adverse Event|0|||
23146573|NCT00975507|64287214|FG000|Overall Study|Lost to Follow-up|7|||
23146574|NCT00975507|64287215|FG001|Overall Study|Lost to Follow-up|1|||
23146575|NCT00975507|64287214|FG000|Overall Study|Protocol Violation|2|||
23146576|NCT00975507|64287215|FG001|Overall Study|Protocol Violation|0|||
23146577|NCT00975507|64287214|FG000|Overall Study|Withdrawal by Subject|10|||
23146578|NCT00975507|64287215|FG001|Overall Study|Withdrawal by Subject|3|||
23146579|NCT03602066|64287216|FG000|Overall Study|Withdrawal by Subject|2|||
23146580|NCT03602066|64287217|FG001|Overall Study|Withdrawal by Subject|0|||
23146581|NCT03602066|64287216|FG000|Overall Study|Physician Decision|1|||
23218548|NCT02142504|64541617|FG001|Overall Study|Reason Not Specified|5|||
23218549|NCT02142504|64541618|FG002|Overall Study|Reason Not Specified|4|||
23218550|NCT01192204|64541625|FG000|Overall Study|could not keep recall appointments|1|||
23218551|NCT01192204|64541626|FG001|Overall Study|could not keep recall appointments|0|||
23218552|NCT01202760|64541627|FG000|Overall Study|Entry Criteria Not Met|0|||
23218553|NCT01202760|64541628|FG001|Overall Study|Entry Criteria Not Met|3|||
23436274|NCT01730586|65340669|FG000|Overall Study|Inadequate Trial|8|||
23218554|NCT01202760|64541629|FG002|Overall Study|Entry Criteria Not Met|1|||
23218555|NCT01202760|64541627|FG000|Overall Study|Adverse Event|11|||
23218556|NCT01202760|64541628|FG001|Overall Study|Adverse Event|9|||
23218557|NCT01202760|64541629|FG002|Overall Study|Adverse Event|10|||
23436275|NCT01730586|65340669|FG000|Overall Study|Adverse Event|2|||
23436276|NCT01730586|65340669|FG000|Overall Study|Hospice|1|||
23436277|NCT00830180|65340670|FG000|Overall Study|Adverse Event|6|||
23436278|NCT00830180|65340670|FG000|Overall Study|Death|11|||
23436279|NCT00830180|65340670|FG000|Overall Study|Insufficient clinical response|1|||
23436280|NCT00830180|65340670|FG000|Overall Study|Withdrawal by Subject|5|||
23436281|NCT00830180|65340670|FG000|Overall Study|Progressive disease|2|||
23436282|NCT00830180|65340670|FG000|Overall Study|Other - Unspecified|1|||
23436283|NCT03916484|65340671|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
23436284|NCT03916484|65340672|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
23436285|NCT03916484|65340673|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
23436286|NCT03916484|65340674|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
23436287|NCT03916484|65340671|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
23557552|NCT02432105|65769412|FG000|Overall Study|Withdrawal by Subject|1|||
23557553|NCT02432105|65769413|FG001|Overall Study|Withdrawal by Subject|0|||
23218558|NCT01202760|64541627|FG000|Overall Study|Death|2|||
23218559|NCT01202760|64541628|FG001|Overall Study|Death|1|||
23218560|NCT01202760|64541629|FG002|Overall Study|Death|0|||
23218561|NCT01202760|64541627|FG000|Overall Study|Lack of Efficacy|6|||
23218562|NCT01202760|64541628|FG001|Overall Study|Lack of Efficacy|8|||
23218563|NCT01202760|64541629|FG002|Overall Study|Lack of Efficacy|7|||
23218564|NCT01202760|64541627|FG000|Overall Study|Lost to Follow-up|0|||
23218565|NCT01202760|64541628|FG001|Overall Study|Lost to Follow-up|2|||
23218566|NCT01202760|64541629|FG002|Overall Study|Lost to Follow-up|1|||
23218567|NCT01202760|64541627|FG000|Overall Study|Parent / Caregiver Decision|0|||
23218568|NCT01202760|64541628|FG001|Overall Study|Parent / Caregiver Decision|1|||
23218569|NCT01202760|64541629|FG002|Overall Study|Parent / Caregiver Decision|0|||
23218570|NCT01202760|64541627|FG000|Overall Study|Withdrawal by Subject|17|||
23218571|NCT01202760|64541628|FG001|Overall Study|Withdrawal by Subject|18|||
23218572|NCT01202760|64541629|FG002|Overall Study|Withdrawal by Subject|14|||
23557554|NCT02432105|65769414|FG002|Overall Study|Withdrawal by Subject|1|||
23557555|NCT02432105|65769412|FG000|Overall Study|Culture positive for yeast|0|||
23557556|NCT02432105|65769413|FG001|Overall Study|Culture positive for yeast|1|||
23557557|NCT02432105|65769414|FG002|Overall Study|Culture positive for yeast|0|||
23557558|NCT02432105|65769412|FG000|Overall Study|Randomized in error|0|||
23557559|NCT02432105|65769413|FG001|Overall Study|Randomized in error|0|||
23557560|NCT02432105|65769414|FG002|Overall Study|Randomized in error|2|||
23218573|NCT01202760|64541627|FG000|Overall Study|Physician Decision|0|||
23218574|NCT01202760|64541628|FG001|Overall Study|Physician Decision|1|||
23218575|NCT01202760|64541629|FG002|Overall Study|Physician Decision|0|||
23436288|NCT03916484|65340672|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
23557561|NCT00621543|65769415|FG000|Overall Study|Lost to Follow-up|23|||
23557562|NCT02274857|65769420|FG000|Overall Study|Adverse Event|1|||
23557563|NCT02274857|65769421|FG001|Overall Study|Adverse Event|0|||
23146582|NCT03602066|64287217|FG001|Overall Study|Physician Decision|0|||
23146583|NCT05220254|64287218|FG000|Overall Study|Withdrawal by Subject|4|||
23218576|NCT01202760|64541627|FG000|Overall Study|Protocol Violation|7|||
23218577|NCT01202760|64541628|FG001|Overall Study|Protocol Violation|5|||
23218578|NCT01202760|64541629|FG002|Overall Study|Protocol Violation|2|||
23218579|NCT01202760|64541627|FG000|Overall Study|Sponsor Decision|4|||
23218580|NCT01202760|64541628|FG001|Overall Study|Sponsor Decision|4|||
23218581|NCT01202760|64541629|FG002|Overall Study|Sponsor Decision|0|||
23218582|NCT03146403|64541630|FG000|Overall Study|Withdrawal by Subject|0|||
23218583|NCT03146403|64541631|FG001|Overall Study|Withdrawal by Subject|3|||
23218584|NCT03146403|64541630|FG000|Overall Study|Lost to Follow-up|2|||
23218585|NCT03146403|64541631|FG001|Overall Study|Lost to Follow-up|0|||
23218586|NCT02197897|64541636|FG000|Overall Study|not eligible|1|||
23218587|NCT03000686|64541644|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
23218588|NCT03000686|64541645|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
23218589|NCT03000686|64541646|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
23218590|NCT03000686|64541647|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
23218591|NCT01293084|64541649|FG000|Overall Study|Physician Decision|3|||
23218592|NCT01293084|64541649|FG000|Overall Study|Withdrawal by Subject|2|||
23218593|NCT02709109|64541650|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
23218594|NCT02709109|64541651|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
23218595|NCT02709109|64541652|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
23436289|NCT03916484|65340673|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
23436290|NCT03916484|65340674|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
23436291|NCT02777827|65340675|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
23436292|NCT02777827|65340676|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
23146584|NCT05220254|64287218|FG000|Overall Study|Removed due to ineligibility|1|||
23436293|NCT02777827|65340677|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
23557564|NCT02274857|65769420|FG000|Overall Study|Death|1|||
23557565|NCT02274857|65769421|FG001|Overall Study|Death|2|||
23557566|NCT02274857|65769420|FG000|Overall Study|Lost to Follow-up|3|||
23557567|NCT02274857|65769421|FG001|Overall Study|Lost to Follow-up|0|||
23557568|NCT02274857|65769420|FG000|Overall Study|Physician Decision|2|||
23557569|NCT02274857|65769421|FG001|Overall Study|Physician Decision|0|||
23557570|NCT02274857|65769420|FG000|Overall Study|Trial screen failure|0|||
23557571|NCT02274857|65769421|FG001|Overall Study|Trial screen failure|2|||
23557572|NCT02274857|65769420|FG000|Overall Study|Withdrawal by Subject|11|||
23557573|NCT02274857|65769421|FG001|Overall Study|Withdrawal by Subject|2|||
23557574|NCT02274857|65769420|FG000|Overall Study|Other|2|||
23557575|NCT02274857|65769421|FG001|Overall Study|Other|0|||
23557576|NCT03284788|65769428|FG000|Overall Study|Withdrawal by Subject|2|||
23557577|NCT03017079|65769429|FG000|Overall Study|Physician Decision|1|||
23557578|NCT03017079|65769430|FG001|Overall Study|Physician Decision|1|||
23557579|NCT03017079|65769429|FG000|Overall Study|Death|3|||
23557580|NCT03017079|65769430|FG001|Overall Study|Death|2|||
23557581|NCT03017079|65769429|FG000|Overall Study|Lack of Efficacy|2|||
23557582|NCT03017079|65769430|FG001|Overall Study|Lack of Efficacy|2|||
23146585|NCT05220254|64287218|FG000|Overall Study|Lost to Follow-up|7|||
23557583|NCT03017079|65769429|FG000|Overall Study|Protocol Violation|0|||
23146586|NCT02502097|64287219|FG000|Period 1|Adverse Event|0|||
23146587|NCT02502097|64287220|FG001|Period 1|Adverse Event|0|||
23146588|NCT02502097|64287221|FG002|Period 1|Adverse Event|1|||
23146589|NCT02502097|64287222|FG003|Period 1|Adverse Event|0|||
23146590|NCT02502097|64287219|FG000|Wash Out Period|Adverse Event|0|||
23146591|NCT02502097|64287220|FG001|Wash Out Period|Adverse Event|1|||
23146592|NCT02502097|64287221|FG002|Wash Out Period|Adverse Event|1|||
23146593|NCT02502097|64287222|FG003|Wash Out Period|Adverse Event|1|||
23146594|NCT02502097|64287219|FG000|Period 2|Adverse Event|0|||
23146595|NCT02502097|64287220|FG001|Period 2|Adverse Event|0|||
23146596|NCT02502097|64287221|FG002|Period 2|Adverse Event|1|||
23146597|NCT02502097|64287222|FG003|Period 2|Adverse Event|0|||
23146598|NCT00881608|64287223|FG000|Overall Study|Study prematurely terminated|11|||
23146599|NCT01298518|64287224|FG000|Overall Study|Withdrawal by Subject|0|||
23146600|NCT01298518|64287225|FG001|Overall Study|Withdrawal by Subject|0|||
23146601|NCT01298518|64287226|FG002|Overall Study|Withdrawal by Subject|1|||
23218596|NCT02709109|64541653|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
23218597|NCT02709109|64541650|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
23218598|NCT02709109|64541651|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
23218599|NCT02709109|64541652|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
23436294|NCT02777827|65340678|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
23436295|NCT02777827|65340679|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
23218600|NCT02709109|64541653|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
23557584|NCT03017079|65769430|FG001|Overall Study|Protocol Violation|1|||
23218601|NCT02709109|64541650|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
23557585|NCT04082884|65769432|FG000|Overall Study|Withdrawal by Subject|1|||
23146602|NCT01480284|64287227|FG000|Overall Study|Withdrawal by Subject|2|||
23557586|NCT00789815|65769433|FG000|Overall Study|Protocol Violation|6|||
23557587|NCT00789815|65769434|FG001|Overall Study|Protocol Violation|1|||
23557588|NCT00789815|65769433|FG000|Overall Study|Intubation due to massive bleeding|1|||
23146603|NCT01480284|64287228|FG001|Overall Study|Withdrawal by Subject|0|||
23146604|NCT01480284|64287227|FG000|Overall Study|Adverse Event|1|||
23146605|NCT01480284|64287228|FG001|Overall Study|Adverse Event|0|||
23146606|NCT01480284|64287227|FG000|Overall Study|Study closed/terminated|3|||
23146607|NCT01480284|64287228|FG001|Overall Study|Study closed/terminated|0|||
23146608|NCT01480284|64287227|FG000|Overall Study|Lost to Follow-up|1|||
23146609|NCT01480284|64287228|FG001|Overall Study|Lost to Follow-up|0|||
23436296|NCT02777827|65340680|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
23436297|NCT01183468|65340684|FG000|Overall Study|Lost to Follow-up|2|||
23436298|NCT01183468|65340685|FG001|Overall Study|Lost to Follow-up|1|||
23436299|NCT01183468|65340686|FG002|Overall Study|Lost to Follow-up|0|||
23436300|NCT01183468|65340687|FG003|Overall Study|Lost to Follow-up|0|||
23436301|NCT01183468|65340684|FG000|Overall Study|Physician Decision|1|||
23557589|NCT00789815|65769434|FG001|Overall Study|Intubation due to massive bleeding|0|||
23557590|NCT00490282|65769439|FG000|Overall Study|Withdrawal by Subject|3|||
23557591|NCT00539279|65769440|FG000|Treatment|Withdrawal by Subject|10|||
23146610|NCT01480284|64287227|FG000|Overall Study|Physician Decision|1|||
23557592|NCT00539279|65769441|FG001|Treatment|Withdrawal by Subject|8|||
23218602|NCT02709109|64541651|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
23218603|NCT02709109|64541652|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
23218604|NCT02709109|64541653|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
23218605|NCT02709109|64541650|FG000|Washout Period (28 Days)|Other|2|||
23218606|NCT02709109|64541651|FG001|Washout Period (28 Days)|Other|2|||
23218607|NCT02709109|64541652|FG002|Washout Period (28 Days)|Other|3|||
23322155|NCT01197534|64922918|FG002|Overall Study|Severe non-compliance to protocol|1|||
23322156|NCT01197534|64922916|FG000|Overall Study|Lack of therapeutic response|9|||
23322157|NCT01197534|64922917|FG001|Overall Study|Lack of therapeutic response|4|||
23218608|NCT02709109|64541653|FG003|Washout Period (28 Days)|Other|0|||
23218609|NCT02709109|64541650|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
23218610|NCT02709109|64541651|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
23557593|NCT00539279|65769440|FG000|Treatment|Death|1|||
23218611|NCT02709109|64541652|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
23218612|NCT02709109|64541653|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
23218613|NCT02709109|64541650|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
23218614|NCT02709109|64541651|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
23218615|NCT02709109|64541652|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
23218616|NCT02709109|64541653|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
23218617|NCT02709109|64541650|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
23218618|NCT02709109|64541651|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
23218619|NCT02709109|64541652|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
23218620|NCT02709109|64541653|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
23218621|NCT02709109|64541650|FG000|Treatment Period 2 (28 Days)|Other|0|||
23218622|NCT02709109|64541651|FG001|Treatment Period 2 (28 Days)|Other|0|||
23218623|NCT02709109|64541652|FG002|Treatment Period 2 (28 Days)|Other|1|||
23218624|NCT02709109|64541653|FG003|Treatment Period 2 (28 Days)|Other|0|||
23218625|NCT00719537|64541655|FG000|Overall Study|Withdrawal by Subject|1|||
23322158|NCT01197534|64922918|FG002|Overall Study|Lack of therapeutic response|9|||
23436302|NCT01183468|65340685|FG001|Overall Study|Physician Decision|0|||
23557594|NCT00539279|65769441|FG001|Treatment|Death|0|||
23557595|NCT00539279|65769440|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
23557596|NCT00539279|65769441|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
23557597|NCT00539279|65769440|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
23146611|NCT01480284|64287228|FG001|Overall Study|Physician Decision|0|||
23146612|NCT01607554|64287229|FG000|Overall Study|Disease progression|2|||
23557598|NCT00539279|65769441|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
23557599|NCT01120249|65769442|FG000|Overall Study|No protocol treatment received|21|||
23557600|NCT01120249|65769443|FG001|Overall Study|No protocol treatment received|15|||
23557601|NCT01120249|65769442|FG000|Overall Study|Disease recurrence|107|||
23557602|NCT01120249|65769443|FG001|Overall Study|Disease recurrence|57|||
23557603|NCT01120249|65769442|FG000|Overall Study|Death|1|||
23557604|NCT01120249|65769443|FG001|Overall Study|Death|0|||
23623820|NCT01703845|66008583|FG000|Overall Study|Protocol Violation|1|||
23623821|NCT01703845|66008584|FG001|Overall Study|Protocol Violation|0|||
23146613|NCT01740323|64287230|FG000|Overall Study|Adverse Event|1|||
23146614|NCT01740323|64287231|FG001|Overall Study|Adverse Event|0|||
23146615|NCT01740323|64287230|FG000|Overall Study|Randomized but did not take study drug|1|||
23218626|NCT00719537|64541656|FG001|Overall Study|Withdrawal by Subject|0|||
23218627|NCT00719537|64541655|FG000|Overall Study|Lost to Follow-up|0|||
23436303|NCT01183468|65340686|FG002|Overall Study|Physician Decision|0|||
23436304|NCT01183468|65340687|FG003|Overall Study|Physician Decision|0|||
23146616|NCT01740323|64287231|FG001|Overall Study|Randomized but did not take study drug|0|||
23557605|NCT01120249|65769442|FG000|Overall Study|Adverse Event|40|||
23557606|NCT01120249|65769443|FG001|Overall Study|Adverse Event|276|||
23557607|NCT01120249|65769442|FG000|Overall Study|Participant refusal|34|||
23623822|NCT01703845|66008583|FG000|Overall Study|other than stated above|1|||
23146617|NCT02079610|64287234|FG000|Overall Study|Withdrawal by Subject|1|||
23322159|NCT01197534|64922916|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
23322160|NCT01197534|64922917|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
23322161|NCT01197534|64922918|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
23146618|NCT02079610|64287235|FG001|Overall Study|Withdrawal by Subject|1|||
23146619|NCT01376349|64287236|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
23146620|NCT01376349|64287237|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
23146621|NCT01376349|64287238|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
23146622|NCT01376349|64287236|FG000|Raondomized Treatment|Adverse Event|13|||
23146623|NCT01376349|64287237|FG001|Raondomized Treatment|Adverse Event|17|||
23322162|NCT01197534|64922916|FG000|Overall Study|Lost to Follow-up|1|||
23322163|NCT01197534|64922917|FG001|Overall Study|Lost to Follow-up|4|||
23322164|NCT01197534|64922918|FG002|Overall Study|Lost to Follow-up|2|||
23322165|NCT01197534|64922916|FG000|Overall Study|Adverse Event|35|||
23322166|NCT01197534|64922917|FG001|Overall Study|Adverse Event|36|||
23322167|NCT01197534|64922918|FG002|Overall Study|Adverse Event|24|||
23322168|NCT02524847|64922919|FG000|Overall Study|Adverse Event|4|||
23322169|NCT02524847|64922919|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
23322170|NCT02524847|64922919|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
23322171|NCT02524847|64922919|FG000|Overall Study|Death|1|||
23146624|NCT01376349|64287238|FG002|Raondomized Treatment|Adverse Event|14|||
23146625|NCT01376349|64287236|FG000|Raondomized Treatment|Unkown|1|||
23146626|NCT01376349|64287237|FG001|Raondomized Treatment|Unkown|2|||
23218628|NCT00719537|64541656|FG001|Overall Study|Lost to Follow-up|1|||
23218629|NCT00813917|64541664|FG000|Overall Study|Adverse Event|0|||
23322172|NCT02524847|64922919|FG000|Overall Study|Reason not Specified|1|||
23322173|NCT04728802|64922921|FG000|Overall Study|Withdrawal by Subject|4|||
23322174|NCT04728802|64922922|FG001|Overall Study|Withdrawal by Subject|20|||
23322175|NCT04728802|64922921|FG000|Overall Study|Physician Decision|7|||
23322176|NCT04728802|64922922|FG001|Overall Study|Physician Decision|7|||
23322177|NCT04728802|64922921|FG000|Overall Study|Protocol Violation|10|||
23322178|NCT04728802|64922922|FG001|Overall Study|Protocol Violation|4|||
23322179|NCT04728802|64922921|FG000|Overall Study|Transfer|1|||
23322180|NCT04728802|64922922|FG001|Overall Study|Transfer|0|||
23322181|NCT04728802|64922921|FG000|Overall Study|Death|4|||
23322182|NCT04728802|64922922|FG001|Overall Study|Death|5|||
23322183|NCT04728802|64922921|FG000|Overall Study|Other|3|||
23322184|NCT04728802|64922922|FG001|Overall Study|Other|0|||
23322185|NCT01810302|64922929|FG000|Overall Study|Death|1|||
23322186|NCT01810302|64922930|FG001|Overall Study|Death|0|||
23322187|NCT01810302|64922929|FG000|Overall Study|Physician Decision|0|||
23322188|NCT01810302|64922930|FG001|Overall Study|Physician Decision|1|||
23322189|NCT01443728|64922935|FG000|Overall Study|Lost to Follow-up|2|||
23322190|NCT01443728|64922936|FG001|Overall Study|Lost to Follow-up|0|||
23322191|NCT01443728|64922935|FG000|Overall Study|Withdrawal by Subject|1|||
23322192|NCT01443728|64922936|FG001|Overall Study|Withdrawal by Subject|1|||
23322193|NCT01443728|64922935|FG000|Overall Study|Adverse Event|0|||
23322194|NCT01443728|64922936|FG001|Overall Study|Adverse Event|2|||
23322195|NCT00625820|64922937|FG000|Overall Study|Withdrawal by Subject|1|||
23322196|NCT00246324|64922942|FG000|Overall Study|Withdrawal by Subject|1|||
23322197|NCT01924689|64922943|FG000|Overall Study|Death|0|||
23322198|NCT01924689|64922944|FG001|Overall Study|Death|1|||
23322199|NCT01924689|64922945|FG002|Overall Study|Death|0|||
23322200|NCT01924689|64922946|FG003|Overall Study|Death|1|||
23322201|NCT01924689|64922947|FG004|Overall Study|Death|0|||
23322202|NCT01924689|64922948|FG005|Overall Study|Death|0|||
23146627|NCT01376349|64287238|FG002|Raondomized Treatment|Unkown|1|||
23146628|NCT01376349|64287236|FG000|Raondomized Treatment|Alternative Treatment|0|||
23218630|NCT00813917|64541665|FG001|Overall Study|Adverse Event|1|||
23218631|NCT00813917|64541664|FG000|Overall Study|Withdrawal by Subject|3|||
23218632|NCT00813917|64541665|FG001|Overall Study|Withdrawal by Subject|4|||
23218633|NCT00813917|64541664|FG000|Overall Study|Lost to Follow-up|3|||
23218634|NCT00813917|64541665|FG001|Overall Study|Lost to Follow-up|1|||
23146629|NCT01376349|64287237|FG001|Raondomized Treatment|Alternative Treatment|0|||
23218635|NCT02693691|64541666|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
23322203|NCT01924689|64922943|FG000|Overall Study|Disease progression|0|||
23322204|NCT01924689|64922944|FG001|Overall Study|Disease progression|0|||
23146630|NCT01376349|64287238|FG002|Raondomized Treatment|Alternative Treatment|1|||
23218636|NCT02693691|64541666|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
23322205|NCT01924689|64922945|FG002|Overall Study|Disease progression|2|||
23322206|NCT01924689|64922946|FG003|Overall Study|Disease progression|0|||
23322207|NCT01924689|64922947|FG004|Overall Study|Disease progression|3|||
23322208|NCT01924689|64922948|FG005|Overall Study|Disease progression|2|||
23322209|NCT01924689|64922943|FG000|Overall Study|New therapy or study|3|||
23322210|NCT01924689|64922944|FG001|Overall Study|New therapy or study|2|||
23322211|NCT01924689|64922945|FG002|Overall Study|New therapy or study|1|||
23322212|NCT01924689|64922946|FG003|Overall Study|New therapy or study|4|||
23322213|NCT01924689|64922947|FG004|Overall Study|New therapy or study|2|||
23436305|NCT01183468|65340684|FG000|Overall Study|Withdrawal by Subject|0|||
23436306|NCT01183468|65340685|FG001|Overall Study|Withdrawal by Subject|1|||
23436307|NCT01183468|65340686|FG002|Overall Study|Withdrawal by Subject|0|||
23436308|NCT01183468|65340687|FG003|Overall Study|Withdrawal by Subject|0|||
23436309|NCT02915978|65340688|FG000|Overall Study|Adverse Event|2|||
23436310|NCT02915978|65340689|FG001|Overall Study|Adverse Event|1|||
23436311|NCT02915978|65340690|FG002|Overall Study|Adverse Event|0|||
23436312|NCT01153698|65340691|FG000|Overall Study|Adverse Event|12|||
23436313|NCT01153698|65340691|FG000|Overall Study|Lost to Follow-up|4|||
23436314|NCT01153698|65340691|FG000|Overall Study|Withdrawal by Subject|2|||
23436315|NCT01153698|65340691|FG000|Overall Study|Switch to other anticoagulants|4|||
23436316|NCT01153698|65340691|FG000|Overall Study|Other|2|||
23436317|NCT01153698|65340691|FG000|Overall Study|Not treated with Pradaxa|5|||
23436318|NCT03129360|65340692|FG000|Overall Study|Did not meet entry criteria|0|||
23436319|NCT03129360|65340693|FG001|Overall Study|Did not meet entry criteria|2|||
23436320|NCT03129360|65340694|FG002|Overall Study|Did not meet entry criteria|1|||
23436321|NCT03129360|65340692|FG000|Overall Study|Excluded due to motion in scanner|1|||
23436322|NCT03129360|65340693|FG001|Overall Study|Excluded due to motion in scanner|0|||
23557608|NCT01120249|65769443|FG001|Overall Study|Participant refusal|42|||
23557609|NCT01120249|65769442|FG000|Overall Study|Other reasons, not protocol specified|29|||
23557610|NCT01120249|65769443|FG001|Overall Study|Other reasons, not protocol specified|22|||
23557611|NCT01089374|65769451|FG000|Overall Study|Lost to Follow-up|3|||
23557612|NCT01089374|65769452|FG001|Overall Study|Lost to Follow-up|0|||
23557613|NCT01089374|65769451|FG000|Overall Study|Withdrawal by Subject|1|||
23557614|NCT01089374|65769452|FG001|Overall Study|Withdrawal by Subject|0|||
23557615|NCT01089374|65769451|FG000|Overall Study|Study closed early - low accrual|6|||
23557616|NCT01089374|65769452|FG001|Overall Study|Study closed early - low accrual|0|||
23557617|NCT01696981|65769459|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
23557618|NCT01696981|65769460|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
23557619|NCT01696981|65769459|FG000|Overall Study|Died Before Randomization|3|||
23557620|NCT01696981|65769460|FG001|Overall Study|Died Before Randomization|8|||
23557621|NCT01696981|65769459|FG000|Overall Study|Died Before ASU (Control)|278|||
23557622|NCT01696981|65769460|FG001|Overall Study|Died Before ASU (Control)|0|||
23557623|NCT01696981|65769459|FG000|Overall Study|Refused ASU (Control)|920|||
23557624|NCT01696981|65769460|FG001|Overall Study|Refused ASU (Control)|0|||
23557625|NCT01696981|65769459|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
23557626|NCT01696981|65769460|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
23557627|NCT03298451|65769461|FG000|Overall Study|Death|275|||
23557628|NCT03298451|65769462|FG001|Overall Study|Death|260|||
23557629|NCT03298451|65769463|FG002|Overall Study|Death|122|||
23557630|NCT03298451|65769464|FG003|Overall Study|Death|280|||
23557631|NCT03298451|65769461|FG000|Overall Study|Lost to Follow-up|1|||
23557632|NCT03298451|65769462|FG001|Overall Study|Lost to Follow-up|1|||
23557633|NCT03298451|65769463|FG002|Overall Study|Lost to Follow-up|0|||
23557634|NCT03298451|65769464|FG003|Overall Study|Lost to Follow-up|7|||
23557635|NCT03298451|65769461|FG000|Overall Study|Withdrawal by Subject|9|||
23557636|NCT03298451|65769462|FG001|Overall Study|Withdrawal by Subject|7|||
23557637|NCT03298451|65769463|FG002|Overall Study|Withdrawal by Subject|1|||
23557638|NCT03298451|65769464|FG003|Overall Study|Withdrawal by Subject|20|||
23557639|NCT00620750|65769465|FG000|Overall Study|Lost to Follow-up|25|||
23557640|NCT02057874|65769472|FG000|Overall Study|participant did not return for scan|1|||
23557641|NCT00180479|65769473|FG000|Overall Study|Death|4|||
23557642|NCT00180479|65769474|FG001|Overall Study|Death|2|||
23557643|NCT00180479|65769473|FG000|Overall Study|Lost to Follow-up|9|||
23557644|NCT00180479|65769474|FG001|Overall Study|Lost to Follow-up|7|||
23557645|NCT00180479|65769473|FG000|Overall Study|Withdrawal by Subject|3|||
23557646|NCT00180479|65769474|FG001|Overall Study|Withdrawal by Subject|3|||
23557647|NCT00180479|65769473|FG000|Overall Study|Informed consent not signed|0|||
23557648|NCT00180479|65769474|FG001|Overall Study|Informed consent not signed|1|||
23557649|NCT02954354|65769475|FG000|Overall Study|Adverse Event|2|||
23557650|NCT02954354|65769476|FG001|Overall Study|Adverse Event|2|||
23557651|NCT02954354|65769477|FG002|Overall Study|Adverse Event|4|||
23557652|NCT02954354|65769475|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
23557653|NCT02954354|65769476|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
23557654|NCT02954354|65769477|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
23436323|NCT03129360|65340694|FG002|Overall Study|Excluded due to motion in scanner|0|||
23557655|NCT02954354|65769475|FG000|Overall Study|Lack of Efficacy|0|||
23557656|NCT02954354|65769476|FG001|Overall Study|Lack of Efficacy|2|||
23146631|NCT01211197|64287240|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23436324|NCT04576897|65340695|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
23436325|NCT03197376|65340696|FG000|Primary and Booster Phase|Adverse Event|0|||
23557657|NCT02954354|65769477|FG002|Overall Study|Lack of Efficacy|0|||
23557658|NCT02954354|65769475|FG000|Overall Study|Withdrawal by Subject|17|||
23557659|NCT02954354|65769476|FG001|Overall Study|Withdrawal by Subject|9|||
23557660|NCT02954354|65769477|FG002|Overall Study|Withdrawal by Subject|11|||
23557661|NCT02954354|65769475|FG000|Overall Study|Lost to Follow-up|12|||
23436326|NCT03197376|65340697|FG001|Primary and Booster Phase|Adverse Event|0|||
23436327|NCT03197376|65340698|FG002|Primary and Booster Phase|Adverse Event|0|||
23436328|NCT03197376|65340699|FG003|Primary and Booster Phase|Adverse Event|1|||
23436329|NCT03197376|65340696|FG000|Primary and Booster Phase|Death|1|||
23436330|NCT03197376|65340697|FG001|Primary and Booster Phase|Death|0|||
23436331|NCT03197376|65340698|FG002|Primary and Booster Phase|Death|0|||
23436332|NCT03197376|65340699|FG003|Primary and Booster Phase|Death|2|||
23436333|NCT03197376|65340696|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
23436334|NCT03197376|65340697|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
23436335|NCT03197376|65340698|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
23436336|NCT03197376|65340699|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
23436337|NCT03197376|65340696|FG000|Primary and Booster Phase|Physician Decision|1|||
23436338|NCT03197376|65340697|FG001|Primary and Booster Phase|Physician Decision|0|||
23436339|NCT03197376|65340698|FG002|Primary and Booster Phase|Physician Decision|1|||
23146632|NCT01211197|64287241|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23146633|NCT01211197|64287242|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23146634|NCT01211197|64287243|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23146635|NCT01211197|64287244|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23146636|NCT01211197|64287245|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23146637|NCT01211197|64287240|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
23146638|NCT01211197|64287241|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
23146639|NCT01211197|64287242|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
23146640|NCT01211197|64287243|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
23146641|NCT01211197|64287244|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
23146642|NCT01211197|64287245|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
23146643|NCT02359877|64287246|FG000|Overall Study|Withdrawal by Subject|1|||
23146644|NCT02359877|64287247|FG001|Overall Study|Withdrawal by Subject|0|||
23146645|NCT02359877|64287248|FG002|Overall Study|Withdrawal by Subject|0|||
23146646|NCT02359877|64287249|FG003|Overall Study|Withdrawal by Subject|2|||
23146647|NCT02359877|64287246|FG000|Overall Study|Adverse Event|0|||
23146648|NCT02359877|64287247|FG001|Overall Study|Adverse Event|0|||
23146649|NCT02359877|64287248|FG002|Overall Study|Adverse Event|0|||
23146650|NCT02359877|64287249|FG003|Overall Study|Adverse Event|1|||
23146651|NCT01794923|64287250|FG000|Overall Study|Adverse Event|0|||
23436340|NCT03197376|65340699|FG003|Primary and Booster Phase|Physician Decision|3|||
23436341|NCT03197376|65340696|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
23436342|NCT03197376|65340697|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
23436343|NCT03197376|65340698|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
23436344|NCT03197376|65340699|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
23436345|NCT03197376|65340696|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
23436346|NCT03197376|65340697|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
23436347|NCT03197376|65340698|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
23436348|NCT03197376|65340699|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
23436349|NCT03197376|65340696|FG000|Primary and Booster Phase|Not vaccine related|1|||
23436350|NCT03197376|65340697|FG001|Primary and Booster Phase|Not vaccine related|2|||
23436351|NCT03197376|65340698|FG002|Primary and Booster Phase|Not vaccine related|0|||
23436352|NCT03197376|65340699|FG003|Primary and Booster Phase|Not vaccine related|6|||
23436353|NCT03197376|65340696|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
23436354|NCT03197376|65340697|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
23436355|NCT03197376|65340698|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
23436356|NCT03197376|65340699|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
23436357|NCT03197376|65340696|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
23436358|NCT03197376|65340697|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
23436359|NCT03197376|65340698|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
23436360|NCT03197376|65340699|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
23436361|NCT03197376|65340696|FG000|Immune Persistence Phase|Not vaccine related|1|||
23436362|NCT03197376|65340697|FG001|Immune Persistence Phase|Not vaccine related|0|||
23436363|NCT03197376|65340698|FG002|Immune Persistence Phase|Not vaccine related|1|||
23436364|NCT03197376|65340699|FG003|Immune Persistence Phase|Not vaccine related|1|||
23436365|NCT05096312|65340700|FG000|Overall Study|Lost to Follow-up|2|||
23436366|NCT05096312|65340701|FG001|Overall Study|Lost to Follow-up|4|||
23436367|NCT05096312|65340700|FG000|Overall Study|Adverse Event|1|||
23436368|NCT05096312|65340701|FG001|Overall Study|Adverse Event|0|||
23436369|NCT02104947|65340707|FG000|Overall Study|Withdrawal by Subject|10|||
23436370|NCT02104947|65340708|FG001|Overall Study|Withdrawal by Subject|3|||
23146652|NCT01794923|64287251|FG001|Overall Study|Adverse Event|0|||
23146653|NCT01794923|64287252|FG002|Overall Study|Adverse Event|1|||
23146654|NCT01862640|64287253|FG000|Overall Study|Adverse Event|4|||
23146655|NCT01862640|64287254|FG001|Overall Study|Adverse Event|10|||
23436371|NCT02104947|65340707|FG000|Overall Study|Lost to Follow-up|4|||
23436372|NCT02104947|65340708|FG001|Overall Study|Lost to Follow-up|4|||
23146656|NCT01862640|64287255|FG002|Overall Study|Adverse Event|6|||
23146657|NCT01862640|64287256|FG003|Overall Study|Adverse Event|8|||
23322214|NCT01924689|64922948|FG005|Overall Study|New therapy or study|0|||
23322215|NCT01924689|64922943|FG000|Overall Study|Withdrawal of consent|0|||
23322216|NCT01924689|64922944|FG001|Overall Study|Withdrawal of consent|0|||
23322217|NCT01924689|64922945|FG002|Overall Study|Withdrawal of consent|1|||
23322218|NCT01924689|64922946|FG003|Overall Study|Withdrawal of consent|1|||
23322219|NCT01924689|64922947|FG004|Overall Study|Withdrawal of consent|0|||
23322220|NCT01924689|64922948|FG005|Overall Study|Withdrawal of consent|0|||
23322221|NCT01924689|64922943|FG000|Overall Study|Other|0|||
23322222|NCT01924689|64922944|FG001|Overall Study|Other|0|||
23322223|NCT01924689|64922945|FG002|Overall Study|Other|0|||
23322224|NCT01924689|64922946|FG003|Overall Study|Other|0|||
23322225|NCT01924689|64922947|FG004|Overall Study|Other|1|||
23322226|NCT01924689|64922948|FG005|Overall Study|Other|0|||
23322227|NCT01994850|64922950|FG000|Overall Study|Physician Decision|1|||
23322228|NCT01994850|64922950|FG000|Overall Study|Withdrawal by Subject|1|||
23322229|NCT04428034|64922954|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
23322230|NCT01027702|64922960|FG000|Overall Study|Received subsequent therapy|1|||
23322231|NCT01027702|64922961|FG001|Overall Study|Received subsequent therapy|2|||
23322232|NCT01027702|64922962|FG002|Overall Study|Received subsequent therapy|0|||
23322233|NCT01027702|64922963|FG003|Overall Study|Received subsequent therapy|4|||
23322234|NCT01027702|64922964|FG004|Overall Study|Received subsequent therapy|1|||
23322235|NCT01027702|64922965|FG005|Overall Study|Received subsequent therapy|0|||
23322236|NCT01027702|64922966|FG006|Overall Study|Received subsequent therapy|1|||
23322237|NCT01027702|64922960|FG000|Overall Study|Death|0|||
23322238|NCT01027702|64922961|FG001|Overall Study|Death|0|||
23322239|NCT01027702|64922962|FG002|Overall Study|Death|1|||
23322240|NCT01027702|64922963|FG003|Overall Study|Death|0|||
23322241|NCT01027702|64922964|FG004|Overall Study|Death|0|||
23322242|NCT01027702|64922965|FG005|Overall Study|Death|0|||
23322243|NCT01027702|64922966|FG006|Overall Study|Death|0|||
23322244|NCT01286753|64922967|FG000|Overall Study|Adverse Event|7|||
23322245|NCT01286753|64922968|FG001|Overall Study|Adverse Event|6|||
23322246|NCT01286753|64922967|FG000|Overall Study|Progression|11|||
23322247|NCT01286753|64922968|FG001|Overall Study|Progression|13|||
23322248|NCT01286753|64922967|FG000|Overall Study|Refused Treatment|1|||
23322249|NCT01286753|64922968|FG001|Overall Study|Refused Treatment|0|||
23322250|NCT01286753|64922967|FG000|Overall Study|Withdrawal of Consent|0|||
23322251|NCT01286753|64922968|FG001|Overall Study|Withdrawal of Consent|2|||
23322252|NCT01286753|64922967|FG000|Overall Study|Discontinued to Join Extension Study|6|||
23322253|NCT01286753|64922968|FG001|Overall Study|Discontinued to Join Extension Study|4|||
23322254|NCT01286753|64922967|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
23322255|NCT01286753|64922968|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
23322256|NCT02955212|64922977|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
23322257|NCT02955212|64922978|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
23322258|NCT02955212|64922977|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
23322259|NCT02955212|64922978|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
23322260|NCT02955212|64922977|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
23322261|NCT02955212|64922978|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
23322262|NCT02955212|64922977|FG000|Period 1: Double-blind Treatment Period|Other|3|||
23322263|NCT02955212|64922978|FG001|Period 1: Double-blind Treatment Period|Other|2|||
23322264|NCT02955212|64922977|FG000|Period 2: Open-label Extension|Adverse Event|11|||
23322265|NCT02955212|64922978|FG001|Period 2: Open-label Extension|Adverse Event|7|||
23322266|NCT02955212|64922977|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
23322267|NCT02955212|64922978|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
23322268|NCT02955212|64922977|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
23322269|NCT02955212|64922978|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
23322270|NCT02955212|64922977|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
23322271|NCT02955212|64922978|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
23322272|NCT02955212|64922977|FG000|Period 2: Open-label Extension|Other|2|||
23322273|NCT02955212|64922978|FG001|Period 2: Open-label Extension|Other|4|||
23557662|NCT02954354|65769476|FG001|Overall Study|Lost to Follow-up|5|||
23218637|NCT02693691|64541666|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
23322274|NCT00262028|64922979|FG000|Overall Study|Withdrawal by Subject|6|||
23322275|NCT00262028|64922980|FG001|Overall Study|Withdrawal by Subject|3|||
23322276|NCT00262028|64922981|FG002|Overall Study|Withdrawal by Subject|6|||
23322277|NCT00262028|64922982|FG003|Overall Study|Withdrawal by Subject|5|||
23322278|NCT00262028|64922983|FG004|Overall Study|Withdrawal by Subject|2|||
23322279|NCT00262028|64922984|FG005|Overall Study|Withdrawal by Subject|3|||
23322280|NCT00262028|64922985|FG006|Overall Study|Withdrawal by Subject|5|||
23322281|NCT00262028|64922986|FG007|Overall Study|Withdrawal by Subject|7|||
23322282|NCT00262028|64922987|FG008|Overall Study|Withdrawal by Subject|2|||
23322283|NCT00262028|64922979|FG000|Overall Study|Lost to Follow-up|7|||
23322284|NCT00262028|64922980|FG001|Overall Study|Lost to Follow-up|7|||
23322285|NCT00262028|64922981|FG002|Overall Study|Lost to Follow-up|5|||
23322286|NCT00262028|64922982|FG003|Overall Study|Lost to Follow-up|5|||
23436373|NCT02104947|65340707|FG000|Overall Study|Protocol Violation|6|||
23436374|NCT02104947|65340708|FG001|Overall Study|Protocol Violation|8|||
23436375|NCT02104947|65340707|FG000|Overall Study|Adverse Event|57|||
23436376|NCT02104947|65340708|FG001|Overall Study|Adverse Event|38|||
23436377|NCT02104947|65340707|FG000|Overall Study|Other than stated above|2|||
23436378|NCT02104947|65340708|FG001|Overall Study|Other than stated above|3|||
23436379|NCT02220712|65340709|FG000|Overall Study|Adverse Event|1|||
23436380|NCT02220712|65340709|FG000|Overall Study|Withdrawal by Subject|2|||
23436381|NCT02220712|65340709|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
23436382|NCT04023682|65340710|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
23436383|NCT03624127|65340711|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
23436384|NCT03624127|65340712|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
23436385|NCT03624127|65340713|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
23436386|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
23436387|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
23436388|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
23436389|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Death|0|||
23436390|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Death|1|||
23436391|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Death|0|||
23436392|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
23436393|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
23436394|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
23436395|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
23436396|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
23436397|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
23436398|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
23436399|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
23436400|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
23436401|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
23436402|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
23436403|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
23436404|NCT03624127|65340711|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
23436405|NCT03624127|65340712|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
23436406|NCT03624127|65340713|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
23436407|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
23436408|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
23436409|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
23436410|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
23436411|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
23436412|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
23436413|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
23436414|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
23436415|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
23436416|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
23436417|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
23436418|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
23436419|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
23436420|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
23436421|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
23436422|NCT03624127|65340711|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
23436423|NCT03624127|65340712|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
23436424|NCT03624127|65340713|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
23436425|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
23436426|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
23436427|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
23436428|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
23436429|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
23436430|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
23436431|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
23436432|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
23436433|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
23436434|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
23436435|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
23436436|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
23436437|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
23436438|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
23436439|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
23436440|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
23436441|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
23436442|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
23436443|NCT03624127|65340711|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
23146658|NCT01862640|64287253|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
23146659|NCT01862640|64287254|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
23146660|NCT01862640|64287255|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
23146661|NCT01862640|64287256|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
23146662|NCT01862640|64287253|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
23218638|NCT02693691|64541666|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
23218639|NCT02693691|64541666|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
23218640|NCT02693691|64541666|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
23218641|NCT02693691|64541666|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
23218642|NCT00571519|64541673|FG000|Overall Study|Subject withdrew consent|0|||
23218643|NCT00571519|64541674|FG001|Overall Study|Subject withdrew consent|1|||
23218644|NCT00571519|64541675|FG002|Overall Study|Subject withdrew consent|0|||
23218645|NCT00571519|64541676|FG003|Overall Study|Subject withdrew consent|2|||
23218646|NCT00571519|64541677|FG004|Overall Study|Subject withdrew consent|1|||
23218647|NCT00571519|64541678|FG005|Overall Study|Subject withdrew consent|1|||
23218648|NCT00571519|64541679|FG006|Overall Study|Subject withdrew consent|2|||
23218649|NCT00571519|64541673|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
23322287|NCT00262028|64922983|FG004|Overall Study|Lost to Follow-up|4|||
23322288|NCT00262028|64922984|FG005|Overall Study|Lost to Follow-up|3|||
23146663|NCT01862640|64287254|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
23146664|NCT01862640|64287255|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
23146665|NCT01862640|64287256|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
23146666|NCT01862640|64287253|FG000|Overall Study|Withdrawal by Subject|2|||
23146667|NCT01862640|64287254|FG001|Overall Study|Withdrawal by Subject|4|||
23146668|NCT01862640|64287255|FG002|Overall Study|Withdrawal by Subject|8|||
23146669|NCT01862640|64287256|FG003|Overall Study|Withdrawal by Subject|5|||
23322289|NCT00262028|64922985|FG006|Overall Study|Lost to Follow-up|3|||
23322290|NCT00262028|64922986|FG007|Overall Study|Lost to Follow-up|5|||
23322291|NCT00262028|64922987|FG008|Overall Study|Lost to Follow-up|6|||
23322292|NCT00262028|64922979|FG000|Overall Study|Administrative Reason|11|||
23322293|NCT00262028|64922980|FG001|Overall Study|Administrative Reason|14|||
23322294|NCT00262028|64922981|FG002|Overall Study|Administrative Reason|9|||
23322295|NCT00262028|64922982|FG003|Overall Study|Administrative Reason|12|||
23322296|NCT00262028|64922983|FG004|Overall Study|Administrative Reason|6|||
23322297|NCT00262028|64922984|FG005|Overall Study|Administrative Reason|7|||
23322298|NCT00262028|64922985|FG006|Overall Study|Administrative Reason|4|||
23322299|NCT00262028|64922986|FG007|Overall Study|Administrative Reason|6|||
23322300|NCT00262028|64922987|FG008|Overall Study|Administrative Reason|10|||
23322301|NCT00262028|64922979|FG000|Overall Study|Protocol Violation|0|||
23322302|NCT00262028|64922980|FG001|Overall Study|Protocol Violation|0|||
23436444|NCT03624127|65340712|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
23436445|NCT03624127|65340713|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
23436446|NCT02294734|65340714|FG000|Overall Study|Adverse Event|5|||
23146670|NCT01862640|64287253|FG000|Overall Study|Protocol Deviation|0|||
23146671|NCT01862640|64287254|FG001|Overall Study|Protocol Deviation|0|||
23146672|NCT01862640|64287255|FG002|Overall Study|Protocol Deviation|1|||
23146673|NCT01862640|64287256|FG003|Overall Study|Protocol Deviation|0|||
23146674|NCT02027701|64287261|FG000|Overall Study|Adverse Event|3|||
23146675|NCT02027701|64287261|FG000|Overall Study|Lack of Efficacy|8|||
23146676|NCT02027701|64287261|FG000|Overall Study|Physician Decision|2|||
23146677|NCT02027701|64287261|FG000|Overall Study|Withdrawal by Subject|3|||
23146678|NCT02446886|64287262|FG000|Overall Study|Adverse Event|1|||
23146679|NCT02446886|64287263|FG001|Overall Study|Adverse Event|3|||
23146680|NCT02446886|64287262|FG000|Overall Study|Withdrawal by Subject|1|||
23146681|NCT02446886|64287263|FG001|Overall Study|Withdrawal by Subject|1|||
23146682|NCT01699789|64287266|FG000|Overall Study|Withdrawal by Subject|18|||
23218650|NCT00571519|64541674|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
23218651|NCT00571519|64541675|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
23218652|NCT00571519|64541676|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
23322303|NCT00262028|64922981|FG002|Overall Study|Protocol Violation|0|||
23322304|NCT00262028|64922982|FG003|Overall Study|Protocol Violation|1|||
23436447|NCT02294734|65340715|FG001|Overall Study|Adverse Event|5|||
23436448|NCT02294734|65340714|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
23436449|NCT02294734|65340715|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
23146683|NCT01699789|64287267|FG001|Overall Study|Withdrawal by Subject|23|||
23146684|NCT01699789|64287266|FG000|Overall Study|Death|1|||
23322305|NCT00262028|64922983|FG004|Overall Study|Protocol Violation|0|||
23322306|NCT00262028|64922984|FG005|Overall Study|Protocol Violation|0|||
23322307|NCT00262028|64922985|FG006|Overall Study|Protocol Violation|0|||
23322308|NCT00262028|64922986|FG007|Overall Study|Protocol Violation|0|||
23436450|NCT02294734|65340714|FG000|Overall Study|Lost to Follow-up|2|||
23146685|NCT01699789|64287267|FG001|Overall Study|Death|2|||
23322309|NCT00262028|64922987|FG008|Overall Study|Protocol Violation|0|||
23322310|NCT00262028|64922979|FG000|Overall Study|Unable to classify|0|||
23436451|NCT02294734|65340715|FG001|Overall Study|Lost to Follow-up|0|||
23436452|NCT02294734|65340714|FG000|Overall Study|Physician Decision|2|||
23436453|NCT02294734|65340715|FG001|Overall Study|Physician Decision|1|||
23436454|NCT02294734|65340714|FG000|Overall Study|Withdrawal by Subject|4|||
23436455|NCT02294734|65340715|FG001|Overall Study|Withdrawal by Subject|2|||
23436456|NCT03052816|65340716|FG000|Overall Study|Withdrawal by Subject|1|||
23436457|NCT03052816|65340717|FG001|Overall Study|Withdrawal by Subject|0|||
23436458|NCT03052816|65340716|FG000|Overall Study|Desired opioids|2|||
23436459|NCT03052816|65340717|FG001|Overall Study|Desired opioids|0|||
23146686|NCT01699789|64287266|FG000|Overall Study|Lost to Follow-up|83|||
23146687|NCT01699789|64287267|FG001|Overall Study|Lost to Follow-up|101|||
23146688|NCT00395460|64287270|FG000|Overall Study|Withdrawal by Subject|1|||
23146689|NCT00395460|64287271|FG001|Overall Study|Withdrawal by Subject|0|||
23146690|NCT02349360|64287272|FG000|Overall Study|Withdrawal by Subject|0|||
23146691|NCT02349360|64287273|FG001|Overall Study|Withdrawal by Subject|1|||
23146692|NCT00940108|64287274|FG000|Overall Study|Adverse Event|2|||
23146693|NCT00940108|64287275|FG001|Overall Study|Adverse Event|4|||
23146694|NCT00940108|64287276|FG002|Overall Study|Adverse Event|0|||
23436460|NCT01630889|65340718|FG000|Overall Study|Death|2|||
23436461|NCT01630889|65340718|FG000|Overall Study|Withdrawal by Subject|1|||
23436462|NCT01630889|65340718|FG000|Overall Study|Other than Specified|2|||
23436463|NCT01630889|65340718|FG000|Overall Study|Lost to Follow-up|4|||
23436464|NCT01630889|65340718|FG000|Overall Study|Other|1|||
23436465|NCT02669121|65340719|FG000|Overall Study|Adverse Event|4|||
23436466|NCT02669121|65340720|FG001|Overall Study|Adverse Event|5|||
23436467|NCT02669121|65340719|FG000|Overall Study|Lost to Follow-up|15|||
23436468|NCT02669121|65340720|FG001|Overall Study|Lost to Follow-up|27|||
23436469|NCT02669121|65340719|FG000|Overall Study|Withdrawal by Subject|132|||
23436470|NCT02669121|65340720|FG001|Overall Study|Withdrawal by Subject|140|||
23436471|NCT02669121|65340719|FG000|Overall Study|Pregnancy|0|||
23436472|NCT02669121|65340720|FG001|Overall Study|Pregnancy|1|||
23436473|NCT02669121|65340719|FG000|Overall Study|Discharged from US Military Active Service|117|||
23436474|NCT02669121|65340720|FG001|Overall Study|Discharged from US Military Active Service|91|||
23436475|NCT02669121|65340719|FG000|Overall Study|Reason not Specified|22|||
23436476|NCT02669121|65340720|FG001|Overall Study|Reason not Specified|18|||
23436477|NCT01300572|65340721|FG000|Overall Study|HAMA + post dosimetry|1|||
23436478|NCT03834220|65340722|FG000|Overall Study|Adverse Event|1|||
23436479|NCT03834220|65340723|FG001|Overall Study|Adverse Event|0|||
23436480|NCT03834220|65340724|FG002|Overall Study|Adverse Event|0|||
23436481|NCT03834220|65340722|FG000|Overall Study|Death|8|||
23436482|NCT03834220|65340723|FG001|Overall Study|Death|1|||
23436483|NCT03834220|65340724|FG002|Overall Study|Death|17|||
23436484|NCT03834220|65340722|FG000|Overall Study|Reason not Specified|9|||
23436485|NCT03834220|65340723|FG001|Overall Study|Reason not Specified|0|||
23436486|NCT03834220|65340724|FG002|Overall Study|Reason not Specified|6|||
23436487|NCT03834220|65340722|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
23436488|NCT03834220|65340723|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
23436489|NCT03834220|65340724|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
23436490|NCT03834220|65340722|FG000|Overall Study|Withdrawal of Consent|2|||
23436491|NCT03834220|65340723|FG001|Overall Study|Withdrawal of Consent|2|||
23436492|NCT03834220|65340724|FG002|Overall Study|Withdrawal of Consent|2|||
23436493|NCT01192412|65340725|FG000|Overall Study|Lost to Follow-up|2|||
23436494|NCT01192412|65340726|FG001|Overall Study|Lost to Follow-up|1|||
23436495|NCT01192412|65340725|FG000|Overall Study|Withdrawal by Subject|2|||
23436496|NCT01192412|65340726|FG001|Overall Study|Withdrawal by Subject|1|||
23436497|NCT01019369|65340727|FG000|Overall Study|Lost to Follow-up|10|||
23436498|NCT01019369|65340728|FG001|Overall Study|Lost to Follow-up|6|||
23436499|NCT01019369|65340727|FG000|Overall Study|Withdrawal by Subject|0|||
23436500|NCT01019369|65340728|FG001|Overall Study|Withdrawal by Subject|1|||
23436501|NCT02337634|65340735|FG000|Overall Study|Protocol Violation|3|||
23436502|NCT02337634|65340736|FG001|Overall Study|Protocol Violation|1|||
23436503|NCT02337634|65340735|FG000|Overall Study|Lost to Follow-up|1|||
23436504|NCT02337634|65340736|FG001|Overall Study|Lost to Follow-up|0|||
23436505|NCT01329939|65340737|FG000|Overall Study|Lost to Follow-up|3|||
23436506|NCT01329939|65340738|FG001|Overall Study|Lost to Follow-up|0|||
23436507|NCT01329939|65340739|FG002|Overall Study|Lost to Follow-up|1|||
23436508|NCT01329939|65340740|FG003|Overall Study|Lost to Follow-up|2|||
23436509|NCT01329939|65340737|FG000|Overall Study|Withdrawal by Subject|0|||
23436510|NCT01329939|65340738|FG001|Overall Study|Withdrawal by Subject|1|||
23146695|NCT00940108|64287277|FG003|Overall Study|Adverse Event|2|||
23146696|NCT00940108|64287274|FG000|Overall Study|Withdrew Consent|2|||
23146697|NCT00940108|64287275|FG001|Overall Study|Withdrew Consent|1|||
23146698|NCT00940108|64287276|FG002|Overall Study|Withdrew Consent|0|||
23436511|NCT01329939|65340739|FG002|Overall Study|Withdrawal by Subject|0|||
23436512|NCT01329939|65340740|FG003|Overall Study|Withdrawal by Subject|0|||
23146699|NCT00940108|64287277|FG003|Overall Study|Withdrew Consent|1|||
23322311|NCT00262028|64922980|FG001|Overall Study|Unable to classify|3|||
23436513|NCT01329939|65340737|FG000|Overall Study|Adverse Event|0|||
23436514|NCT01329939|65340738|FG001|Overall Study|Adverse Event|0|||
23436515|NCT01329939|65340739|FG002|Overall Study|Adverse Event|0|||
23436516|NCT01329939|65340740|FG003|Overall Study|Adverse Event|3|||
23436517|NCT02879578|65340743|FG000|Overall Study|Adverse Event|1|||
23218653|NCT00571519|64541677|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
23218654|NCT00571519|64541678|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
23218655|NCT00571519|64541679|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
23146700|NCT00940108|64287274|FG000|Overall Study|Dose 2 contraindicated|1|||
23146701|NCT00940108|64287275|FG001|Overall Study|Dose 2 contraindicated|1|||
23146702|NCT00940108|64287276|FG002|Overall Study|Dose 2 contraindicated|0|||
23146703|NCT00940108|64287277|FG003|Overall Study|Dose 2 contraindicated|1|||
23146704|NCT00940108|64287274|FG000|Overall Study|Declined further vaccination|0|||
23146705|NCT00940108|64287275|FG001|Overall Study|Declined further vaccination|1|||
23146706|NCT00940108|64287276|FG002|Overall Study|Declined further vaccination|3|||
23146707|NCT00940108|64287277|FG003|Overall Study|Declined further vaccination|0|||
23146708|NCT00940108|64287274|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
23146709|NCT00940108|64287275|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
23146710|NCT00940108|64287276|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
23146711|NCT00940108|64287277|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
23557663|NCT02954354|65769477|FG002|Overall Study|Lost to Follow-up|0|||
23557664|NCT02954354|65769475|FG000|Overall Study|Miscellaneous|2|||
23146712|NCT00940108|64287274|FG000|Overall Study|Viral illness after Dose 1|0|||
23146713|NCT00940108|64287275|FG001|Overall Study|Viral illness after Dose 1|1|||
23146714|NCT00940108|64287276|FG002|Overall Study|Viral illness after Dose 1|0|||
23218656|NCT00571519|64541673|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
23218657|NCT00571519|64541674|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
23218658|NCT00571519|64541675|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
23436518|NCT02879578|65340744|FG001|Overall Study|Adverse Event|2|||
23436519|NCT02879578|65340745|FG002|Overall Study|Adverse Event|14|||
23436520|NCT02879578|65340743|FG000|Overall Study|Protocol Violation|0|||
23436521|NCT02879578|65340744|FG001|Overall Study|Protocol Violation|1|||
23436522|NCT02879578|65340745|FG002|Overall Study|Protocol Violation|1|||
23436523|NCT02879578|65340743|FG000|Overall Study|Withdrawal by Subject|8|||
23436524|NCT02879578|65340744|FG001|Overall Study|Withdrawal by Subject|6|||
23436525|NCT02879578|65340745|FG002|Overall Study|Withdrawal by Subject|9|||
23436526|NCT02879578|65340743|FG000|Overall Study|Lost to Follow-up|1|||
23436527|NCT02879578|65340744|FG001|Overall Study|Lost to Follow-up|0|||
23436528|NCT02879578|65340745|FG002|Overall Study|Lost to Follow-up|4|||
23436529|NCT02879578|65340743|FG000|Overall Study|Physician Decision|0|||
23436530|NCT02879578|65340744|FG001|Overall Study|Physician Decision|0|||
23436531|NCT02879578|65340745|FG002|Overall Study|Physician Decision|4|||
23436532|NCT00167310|65340749|FG000|Overall Study|Protocol Violation|5|||
23436533|NCT00167310|65340750|FG001|Overall Study|Protocol Violation|3|||
23436534|NCT00167310|65340749|FG000|Overall Study|Withdrawal by Subject|3|||
23436535|NCT00167310|65340750|FG001|Overall Study|Withdrawal by Subject|7|||
23436536|NCT01431963|65340751|FG000|Overall Study|Adverse Event|18|||
23436537|NCT01431963|65340751|FG000|Overall Study|Lack of Efficacy|7|||
23436538|NCT01431963|65340751|FG000|Overall Study|Protocol Violation|1|||
23436539|NCT01431963|65340751|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
23436540|NCT01431963|65340751|FG000|Overall Study|Physician Decision|4|||
23218659|NCT00571519|64541676|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
23218660|NCT00571519|64541677|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
23218661|NCT00571519|64541678|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
23218662|NCT00571519|64541679|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
23218663|NCT00571519|64541673|FG000|Overall Study|Termination of study by Sponsor|2|||
23218664|NCT00571519|64541674|FG001|Overall Study|Termination of study by Sponsor|7|||
23218665|NCT00571519|64541675|FG002|Overall Study|Termination of study by Sponsor|10|||
23218666|NCT00571519|64541676|FG003|Overall Study|Termination of study by Sponsor|24|||
23218667|NCT00571519|64541677|FG004|Overall Study|Termination of study by Sponsor|8|||
23218668|NCT00571519|64541678|FG005|Overall Study|Termination of study by Sponsor|9|||
23218669|NCT00571519|64541679|FG006|Overall Study|Termination of study by Sponsor|22|||
23436541|NCT01431963|65340751|FG000|Overall Study|Withdrawal by Subject|3|||
23436542|NCT00148941|65340759|FG000|Overall Study|Lost to Follow-up|17|||
23436543|NCT00148941|65340760|FG001|Overall Study|Lost to Follow-up|24|||
23436544|NCT00148941|65340761|FG002|Overall Study|Lost to Follow-up|18|||
23218670|NCT00571519|64541673|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23436545|NCT00148941|65340762|FG003|Overall Study|Lost to Follow-up|22|||
23436546|NCT00148941|65340759|FG000|Overall Study|Withdrawal by Subject|1|||
23436547|NCT00148941|65340760|FG001|Overall Study|Withdrawal by Subject|0|||
23436548|NCT00148941|65340761|FG002|Overall Study|Withdrawal by Subject|1|||
23436549|NCT00148941|65340762|FG003|Overall Study|Withdrawal by Subject|0|||
23322312|NCT00262028|64922981|FG002|Overall Study|Unable to classify|0|||
23436550|NCT00148941|65340759|FG000|Overall Study|Other|0|||
23436551|NCT00148941|65340760|FG001|Overall Study|Other|0|||
23218671|NCT00571519|64541674|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23218672|NCT00571519|64541675|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
23218673|NCT00571519|64541676|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23218674|NCT00571519|64541677|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23218675|NCT00571519|64541678|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23218676|NCT00571519|64541679|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
23218677|NCT03039569|64541680|FG000|Overall Study|Lost to Follow-up|5|||
23218678|NCT03039569|64541681|FG001|Overall Study|Lost to Follow-up|4|||
23218679|NCT02911519|64541682|FG000|Overall Study|Lost to Follow-up|2|||
23218680|NCT02911519|64541683|FG001|Overall Study|Lost to Follow-up|2|||
23218681|NCT02911519|64541682|FG000|Overall Study|Death|0|||
23218682|NCT02911519|64541683|FG001|Overall Study|Death|2|||
23218683|NCT03379376|64541686|FG000|Overall Study|Lost to Follow-up|2|||
23218684|NCT03379376|64541686|FG000|Overall Study|Did not wish to complete follow up|1|||
23218685|NCT03379376|64541686|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
23218686|NCT03379376|64541686|FG000|Overall Study|Death|1|||
23218687|NCT00937326|64541687|FG000|Overall Study|Adverse Event|0|||
23218688|NCT00937326|64541688|FG001|Overall Study|Adverse Event|3|||
23218689|NCT00937326|64541689|FG002|Overall Study|Adverse Event|1|||
23218690|NCT00937326|64541690|FG003|Overall Study|Adverse Event|1|||
23218691|NCT00937326|64541691|FG004|Overall Study|Adverse Event|2|||
23218692|NCT00937326|64541687|FG000|Overall Study|Death|0|||
23218693|NCT00937326|64541688|FG001|Overall Study|Death|0|||
23218694|NCT00937326|64541689|FG002|Overall Study|Death|1|||
23436552|NCT00148941|65340761|FG002|Overall Study|Other|1|||
23436553|NCT00148941|65340762|FG003|Overall Study|Other|2|||
23436554|NCT01073930|65340765|FG000|Overall Study|Withdrawal by Subject|3|||
23436555|NCT01073930|65340766|FG001|Overall Study|Withdrawal by Subject|2|||
23557665|NCT02954354|65769476|FG001|Overall Study|Miscellaneous|2|||
23557666|NCT02954354|65769477|FG002|Overall Study|Miscellaneous|1|||
23146715|NCT00940108|64287277|FG003|Overall Study|Viral illness after Dose 1|0|||
23146716|NCT00940108|64287274|FG000|Overall Study|Diagnosed with H1N1|0|||
23436556|NCT01073930|65340765|FG000|Overall Study|Lost to Follow-up|0|||
23436557|NCT01073930|65340766|FG001|Overall Study|Lost to Follow-up|1|||
23436558|NCT01073930|65340765|FG000|Overall Study|Adverse Event|0|||
23436559|NCT01073930|65340766|FG001|Overall Study|Adverse Event|1|||
23436560|NCT01073930|65340765|FG000|Overall Study|Noncompliance with study drug|0|||
23436561|NCT01073930|65340766|FG001|Overall Study|Noncompliance with study drug|1|||
23557667|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
23557668|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
23557669|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
23557670|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
23557671|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
23146717|NCT00940108|64287275|FG001|Overall Study|Diagnosed with H1N1|0|||
23146718|NCT00940108|64287276|FG002|Overall Study|Diagnosed with H1N1|0|||
23218695|NCT00937326|64541690|FG003|Overall Study|Death|0|||
23218696|NCT00937326|64541691|FG004|Overall Study|Death|0|||
23218697|NCT00937326|64541687|FG000|Overall Study|Withdrawal by Subject|3|||
23218698|NCT00937326|64541688|FG001|Overall Study|Withdrawal by Subject|4|||
23218699|NCT00937326|64541689|FG002|Overall Study|Withdrawal by Subject|1|||
23218700|NCT00937326|64541690|FG003|Overall Study|Withdrawal by Subject|4|||
23218701|NCT00937326|64541691|FG004|Overall Study|Withdrawal by Subject|3|||
23146719|NCT00940108|64287277|FG003|Overall Study|Diagnosed with H1N1|1|||
23146720|NCT00807235|64287278|FG000|Overall Study|Adverse Event|1|||
23146721|NCT00807235|64287279|FG001|Overall Study|Adverse Event|0|||
23146722|NCT03040622|64287280|FG000|Overall Study|unable to implant device|3|||
23146723|NCT03707925|64287282|FG000|Overall Study|Inevaluable|1|||
23146724|NCT01313650|64287283|FG000|Overall Study|Adverse Event|9|||
23146725|NCT01313650|64287284|FG001|Overall Study|Adverse Event|34|||
23146726|NCT01313650|64287285|FG002|Overall Study|Adverse Event|24|||
23436562|NCT01073930|65340765|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
23436563|NCT01073930|65340766|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
23436564|NCT02651220|65340767|FG000|Overall Study|Adverse Event|1|||
23557672|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
23146727|NCT01313650|64287286|FG003|Overall Study|Adverse Event|23|||
23218702|NCT00937326|64541687|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
23436565|NCT02651220|65340768|FG001|Overall Study|Adverse Event|5|||
23436566|NCT02651220|65340769|FG002|Overall Study|Adverse Event|1|||
23557673|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
23557674|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
23146728|NCT01313650|64287283|FG000|Overall Study|Lack of Efficacy|37|||
23146729|NCT01313650|64287284|FG001|Overall Study|Lack of Efficacy|20|||
23218703|NCT00937326|64541688|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
23218704|NCT00937326|64541689|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
23322313|NCT00262028|64922982|FG003|Overall Study|Unable to classify|0|||
23218705|NCT00937326|64541690|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
23218706|NCT00937326|64541691|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
23218707|NCT03619837|64541692|FG000|Screening|received organs from HCV-negative donors|47|||
23218708|NCT03619837|64541692|FG000|Screening|died on the wait-list|2|||
23218709|NCT03619837|64541692|FG000|Screening|remained on the wait list|40|||
23218710|NCT03619837|64541692|FG000|Screening|didn't meet eligibility criteria|3|||
23218711|NCT03619837|64541692|FG000|Screening|withdrew consent|2|||
23218712|NCT03619837|64541692|FG000|Screening|never listed for HCV-viremic donor|1|||
23218713|NCT03619837|64541692|FG000|Screening|developed exclusion criteria|2|||
23218714|NCT03619837|64541692|FG000|Screening|excluded by the investigator due to non-compliance|1|||
23218715|NCT02096042|64541695|FG000|Overall Study|Disease Progression|1|||
23218716|NCT02096042|64541696|FG001|Overall Study|Disease Progression|0|||
23218717|NCT02096042|64541697|FG002|Overall Study|Disease Progression|0|||
23557675|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
23557676|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
23557677|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
23557678|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
23557679|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
23557680|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
23557681|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
23557682|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
23557683|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
23557684|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
23557685|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
23557686|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
23557687|NCT04003155|65769478|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
23557688|NCT04003155|65769479|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
23557689|NCT04003155|65769480|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
23557690|NCT04003155|65769481|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
23557691|NCT04003155|65769482|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
23557692|NCT04003155|65769478|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
23557693|NCT04003155|65769479|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
23557694|NCT04003155|65769480|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
23557695|NCT04003155|65769481|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
23557696|NCT04003155|65769482|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
23557697|NCT04003155|65769478|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
23557698|NCT04003155|65769479|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
23557699|NCT04003155|65769480|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
23557700|NCT04003155|65769481|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
23557701|NCT04003155|65769482|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
23557702|NCT04003155|65769478|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
23146730|NCT01313650|64287285|FG002|Overall Study|Lack of Efficacy|32|||
23218718|NCT05406440|64541707|FG000|Overall Study|Lost to Follow-up|0|||
23218719|NCT05406440|64541708|FG001|Overall Study|Lost to Follow-up|0|||
23218720|NCT05406440|64541709|FG002|Overall Study|Lost to Follow-up|0|||
23146731|NCT01313650|64287286|FG003|Overall Study|Lack of Efficacy|20|||
23146732|NCT01313650|64287283|FG000|Overall Study|Lost to Follow-up|1|||
23146733|NCT01313650|64287284|FG001|Overall Study|Lost to Follow-up|0|||
23146734|NCT01313650|64287285|FG002|Overall Study|Lost to Follow-up|3|||
23146735|NCT01313650|64287286|FG003|Overall Study|Lost to Follow-up|2|||
23146736|NCT01313650|64287283|FG000|Overall Study|Withdrawal by Subject|16|||
23146737|NCT01313650|64287284|FG001|Overall Study|Withdrawal by Subject|20|||
23146738|NCT01313650|64287285|FG002|Overall Study|Withdrawal by Subject|15|||
23146739|NCT01313650|64287286|FG003|Overall Study|Withdrawal by Subject|15|||
23146740|NCT01313650|64287283|FG000|Overall Study|Protocol Violation|4|||
23146741|NCT01313650|64287284|FG001|Overall Study|Protocol Violation|7|||
23218721|NCT05406440|64541710|FG003|Overall Study|Lost to Follow-up|0|||
23218722|NCT05406440|64541711|FG004|Overall Study|Lost to Follow-up|2|||
23218723|NCT05406440|64541712|FG005|Overall Study|Lost to Follow-up|0|||
23218724|NCT05406440|64541713|FG006|Overall Study|Lost to Follow-up|0|||
23218725|NCT05406440|64541707|FG000|Overall Study|Physician Decision|0|||
23218726|NCT05406440|64541708|FG001|Overall Study|Physician Decision|0|||
23218727|NCT05406440|64541709|FG002|Overall Study|Physician Decision|0|||
23218728|NCT05406440|64541710|FG003|Overall Study|Physician Decision|0|||
23218729|NCT05406440|64541711|FG004|Overall Study|Physician Decision|1|||
23218730|NCT05406440|64541712|FG005|Overall Study|Physician Decision|0|||
23146742|NCT01313650|64287285|FG002|Overall Study|Protocol Violation|5|||
23146743|NCT01313650|64287286|FG003|Overall Study|Protocol Violation|6|||
23146744|NCT01313650|64287283|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
23146745|NCT01313650|64287284|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
23436567|NCT02651220|65340767|FG000|Overall Study|Lost to Follow-up|8|||
23218731|NCT05406440|64541713|FG006|Overall Study|Physician Decision|0|||
23218732|NCT05406440|64541707|FG000|Overall Study|Withdrawal by Subject|0|||
23218733|NCT05406440|64541708|FG001|Overall Study|Withdrawal by Subject|0|||
23218734|NCT05406440|64541709|FG002|Overall Study|Withdrawal by Subject|0|||
23436568|NCT02651220|65340768|FG001|Overall Study|Lost to Follow-up|14|||
23436569|NCT02651220|65340769|FG002|Overall Study|Lost to Follow-up|14|||
23436570|NCT02651220|65340767|FG000|Overall Study|Non-Compliance with Study Drug|4|||
23436571|NCT02651220|65340768|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23436572|NCT02651220|65340769|FG002|Overall Study|Non-Compliance with Study Drug|1|||
23436573|NCT02651220|65340767|FG000|Overall Study|Pregnancy|1|||
23218735|NCT05406440|64541710|FG003|Overall Study|Withdrawal by Subject|0|||
23218736|NCT05406440|64541711|FG004|Overall Study|Withdrawal by Subject|0|||
23218737|NCT05406440|64541712|FG005|Overall Study|Withdrawal by Subject|2|||
23218738|NCT05406440|64541713|FG006|Overall Study|Withdrawal by Subject|0|||
23436574|NCT02651220|65340768|FG001|Overall Study|Pregnancy|0|||
23436575|NCT02651220|65340769|FG002|Overall Study|Pregnancy|1|||
23436576|NCT02651220|65340767|FG000|Overall Study|Protocol Violation|0|||
23436577|NCT02651220|65340768|FG001|Overall Study|Protocol Violation|0|||
23436578|NCT02651220|65340769|FG002|Overall Study|Protocol Violation|1|||
23436579|NCT02651220|65340767|FG000|Overall Study|Withdrawal by Subject|5|||
23436580|NCT02651220|65340768|FG001|Overall Study|Withdrawal by Subject|6|||
23436581|NCT02651220|65340769|FG002|Overall Study|Withdrawal by Subject|8|||
23436582|NCT02651220|65340767|FG000|Overall Study|Miscellaneous|4|||
23436583|NCT02651220|65340768|FG001|Overall Study|Miscellaneous|1|||
23436584|NCT02651220|65340769|FG002|Overall Study|Miscellaneous|2|||
23436585|NCT02651220|65340767|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23436586|NCT02651220|65340768|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23436587|NCT02651220|65340769|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
23436588|NCT00494507|65340772|FG000|Double-Blind Phase|Adverse Event|2|||
23436589|NCT00494507|65340773|FG001|Double-Blind Phase|Adverse Event|0|||
23436590|NCT00494507|65340774|FG002|Double-Blind Phase|Adverse Event|1|||
23436591|NCT00494507|65340775|FG003|Double-Blind Phase|Adverse Event|0|||
23436592|NCT00494507|65340772|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
23436593|NCT00494507|65340773|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
23436594|NCT00494507|65340774|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23436595|NCT00494507|65340775|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23436596|NCT00494507|65340772|FG000|Double-Blind Phase|Subject Non-compliance|0|||
23436597|NCT00494507|65340773|FG001|Double-Blind Phase|Subject Non-compliance|0|||
23436598|NCT00494507|65340774|FG002|Double-Blind Phase|Subject Non-compliance|1|||
23436599|NCT00494507|65340775|FG003|Double-Blind Phase|Subject Non-compliance|0|||
23146746|NCT01313650|64287285|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
23146747|NCT01313650|64287286|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
23146748|NCT02196714|64287289|FG000|Overall Study|Protocol Violation|0|||
23146749|NCT02196714|64287290|FG001|Overall Study|Protocol Violation|0|||
23146750|NCT02196714|64287291|FG002|Overall Study|Protocol Violation|1|||
23146751|NCT02196714|64287292|FG003|Overall Study|Protocol Violation|0|||
23146752|NCT00232141|64287302|FG000|Overall Study|Adverse Event|9|||
23146753|NCT00232141|64287303|FG001|Overall Study|Adverse Event|4|||
23146754|NCT00232141|64287302|FG000|Overall Study|Lack of Efficacy|0|||
23146755|NCT00232141|64287303|FG001|Overall Study|Lack of Efficacy|3|||
23146756|NCT00232141|64287302|FG000|Overall Study|Lost to Follow-up|9|||
23146757|NCT00232141|64287303|FG001|Overall Study|Lost to Follow-up|6|||
23146758|NCT00232141|64287302|FG000|Overall Study|Other|8|||
23146759|NCT00232141|64287303|FG001|Overall Study|Other|10|||
23146760|NCT00232141|64287302|FG000|Overall Study|Withdrawal by Subject|5|||
23146761|NCT00232141|64287303|FG001|Overall Study|Withdrawal by Subject|3|||
23146762|NCT00971243|64287304|FG000|Double Blind Period|Adverse Event|2|||
23146763|NCT00971243|64287305|FG001|Double Blind Period|Adverse Event|3|||
23146764|NCT00971243|64287306|FG002|Double Blind Period|Adverse Event|2|||
23146765|NCT00971243|64287307|FG003|Double Blind Period|Adverse Event|2|||
23146766|NCT00971243|64287308|FG004|Double Blind Period|Adverse Event|3|||
23146767|NCT00971243|64287304|FG000|Double Blind Period|Lost to Follow-up|0|||
23146768|NCT00971243|64287305|FG001|Double Blind Period|Lost to Follow-up|1|||
23146769|NCT00971243|64287306|FG002|Double Blind Period|Lost to Follow-up|1|||
23146770|NCT00971243|64287307|FG003|Double Blind Period|Lost to Follow-up|0|||
23146771|NCT00971243|64287308|FG004|Double Blind Period|Lost to Follow-up|1|||
23146772|NCT00971243|64287304|FG000|Double Blind Period|Physician Decision|10|||
23218739|NCT01484561|64541714|FG000|Overall Study|Lack of Efficacy|3|||
23436600|NCT00494507|65340772|FG000|Double-Blind Phase|Negative DNA test|0|||
23436601|NCT00494507|65340773|FG001|Double-Blind Phase|Negative DNA test|0|||
23436602|NCT00494507|65340774|FG002|Double-Blind Phase|Negative DNA test|0|||
23436603|NCT00494507|65340775|FG003|Double-Blind Phase|Negative DNA test|1|||
23436604|NCT00494507|65340772|FG000|Open-Label Phase|Adverse Event|0|||
23436605|NCT00494507|65340773|FG001|Open-Label Phase|Adverse Event|1|||
23146773|NCT00971243|64287305|FG001|Double Blind Period|Physician Decision|6|||
23146774|NCT00971243|64287306|FG002|Double Blind Period|Physician Decision|7|||
23218740|NCT01484561|64541715|FG001|Overall Study|Lack of Efficacy|1|||
23436606|NCT00494507|65340774|FG002|Open-Label Phase|Adverse Event|5|||
23436607|NCT00494507|65340775|FG003|Open-Label Phase|Adverse Event|3|||
23218741|NCT01484561|64541714|FG000|Overall Study|Lost to Follow-up|1|||
23436608|NCT00494507|65340772|FG000|Open-Label Phase|Worsening Disease|0|||
23436609|NCT00494507|65340773|FG001|Open-Label Phase|Worsening Disease|0|||
23436610|NCT00494507|65340774|FG002|Open-Label Phase|Worsening Disease|0|||
23436611|NCT00494507|65340775|FG003|Open-Label Phase|Worsening Disease|2|||
23436612|NCT00172042|65340776|FG000|Overall Study|Adverse Event|27|||
23436613|NCT00172042|65340777|FG001|Overall Study|Adverse Event|13|||
23436614|NCT00172042|65340776|FG000|Overall Study|Abnormal laboratory value(s)|5|||
23436615|NCT00172042|65340777|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23557703|NCT04003155|65769479|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
23557704|NCT04003155|65769480|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
23623823|NCT01703845|66008584|FG001|Overall Study|other than stated above|0|||
23623824|NCT01427738|66008585|FG000|Overall Study|Death|12|||
23623825|NCT01427738|66008586|FG001|Overall Study|Death|9|||
23322314|NCT00262028|64922983|FG004|Overall Study|Unable to classify|0|||
23322315|NCT00262028|64922984|FG005|Overall Study|Unable to classify|0|||
23322316|NCT00262028|64922985|FG006|Overall Study|Unable to classify|0|||
23322317|NCT00262028|64922986|FG007|Overall Study|Unable to classify|0|||
23623826|NCT01427738|66008585|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23623827|NCT01427738|66008586|FG001|Overall Study|Severe debilitation, unable to continue|1|||
23322318|NCT00262028|64922987|FG008|Overall Study|Unable to classify|1|||
23322319|NCT01074944|64922988|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
23322320|NCT01074944|64922989|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
23322321|NCT01074944|64922990|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
23322322|NCT01074944|64922991|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
23322323|NCT01074944|64922992|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
23322324|NCT01074944|64922988|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
23322325|NCT01074944|64922989|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
23322326|NCT01074944|64922990|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
23322327|NCT01074944|64922991|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
23322328|NCT01074944|64922992|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
23557705|NCT04003155|65769481|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
23557706|NCT04003155|65769482|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
23623828|NCT01427738|66008585|FG000|Overall Study|Subject unable to get to clinic|5|||
23146775|NCT00971243|64287307|FG003|Double Blind Period|Physician Decision|6|||
23146776|NCT00971243|64287308|FG004|Double Blind Period|Physician Decision|7|||
23146777|NCT00971243|64287304|FG000|Double Blind Period|Protocol Violation|2|||
23146778|NCT00971243|64287305|FG001|Double Blind Period|Protocol Violation|0|||
23146779|NCT00971243|64287306|FG002|Double Blind Period|Protocol Violation|3|||
23557707|NCT04003155|65769478|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
23557708|NCT04003155|65769479|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
23557709|NCT04003155|65769480|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
23146780|NCT00971243|64287307|FG003|Double Blind Period|Protocol Violation|2|||
23146781|NCT00971243|64287308|FG004|Double Blind Period|Protocol Violation|2|||
23146782|NCT00971243|64287304|FG000|Double Blind Period|Withdrawal by Subject|4|||
23146783|NCT00971243|64287305|FG001|Double Blind Period|Withdrawal by Subject|1|||
23146784|NCT00971243|64287306|FG002|Double Blind Period|Withdrawal by Subject|4|||
23146785|NCT00971243|64287307|FG003|Double Blind Period|Withdrawal by Subject|4|||
23146786|NCT00971243|64287308|FG004|Double Blind Period|Withdrawal by Subject|4|||
23146787|NCT00971243|64287304|FG000|Double Blind Period|Other reasons|1|||
23146788|NCT00971243|64287305|FG001|Double Blind Period|Other reasons|0|||
23146789|NCT00971243|64287306|FG002|Double Blind Period|Other reasons|2|||
23146790|NCT00971243|64287307|FG003|Double Blind Period|Other reasons|0|||
23146791|NCT00971243|64287308|FG004|Double Blind Period|Other reasons|1|||
23146792|NCT00971243|64287304|FG000|Open-label Period|Adverse Event|1|||
23146793|NCT00971243|64287305|FG001|Open-label Period|Adverse Event|0|||
23146794|NCT00971243|64287306|FG002|Open-label Period|Adverse Event|1|||
23146795|NCT00971243|64287307|FG003|Open-label Period|Adverse Event|1|||
23146796|NCT00971243|64287308|FG004|Open-label Period|Adverse Event|0|||
23146797|NCT00971243|64287304|FG000|Open-label Period|Physician Decision|5|||
23322329|NCT01074944|64922988|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
23322330|NCT01074944|64922989|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
23322331|NCT01074944|64922990|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
23436616|NCT00172042|65340776|FG000|Overall Study|Abnormal test procedure(s)|0|||
23557710|NCT04003155|65769481|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
23623829|NCT01427738|66008586|FG001|Overall Study|Subject unable to get to clinic|2|||
23623830|NCT01427738|66008585|FG000|Overall Study|Withdrawal by Subject|0|||
23436617|NCT00172042|65340777|FG001|Overall Study|Abnormal test procedure(s)|3|||
23623831|NCT01427738|66008586|FG001|Overall Study|Withdrawal by Subject|2|||
23146798|NCT00971243|64287305|FG001|Open-label Period|Physician Decision|9|||
23146799|NCT00971243|64287306|FG002|Open-label Period|Physician Decision|3|||
23146800|NCT00971243|64287307|FG003|Open-label Period|Physician Decision|7|||
23436618|NCT00172042|65340776|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
23146801|NCT00971243|64287308|FG004|Open-label Period|Physician Decision|2|||
23623832|NCT01427738|66008585|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
23322332|NCT01074944|64922991|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
23322333|NCT01074944|64922992|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
23322334|NCT01074944|64922988|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
23557711|NCT04003155|65769482|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
23557712|NCT02070484|65769483|FG000|Overall Study|Withdrawal by Subject|1|||
23322335|NCT01074944|64922989|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
23322336|NCT01074944|64922990|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
23322337|NCT01074944|64922991|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
23557713|NCT02070484|65769484|FG001|Overall Study|Withdrawal by Subject|0|||
23557714|NCT02044848|65769492|FG000|Overall Study|Administrative Problems|2|||
23557715|NCT02044848|65769493|FG001|Overall Study|Administrative Problems|3|||
23557716|NCT02969525|65769494|FG000|Double-Blind Period|Adverse Event|0|||
23146802|NCT00971243|64287304|FG000|Open-label Period|Protocol Violation|1|||
23146803|NCT00971243|64287305|FG001|Open-label Period|Protocol Violation|1|||
23146804|NCT00971243|64287306|FG002|Open-label Period|Protocol Violation|1|||
23146805|NCT00971243|64287307|FG003|Open-label Period|Protocol Violation|0|||
23146806|NCT00971243|64287308|FG004|Open-label Period|Protocol Violation|1|||
23146807|NCT00971243|64287304|FG000|Open-label Period|Withdrawal by Subject|1|||
23146808|NCT00971243|64287305|FG001|Open-label Period|Withdrawal by Subject|0|||
23146809|NCT00971243|64287306|FG002|Open-label Period|Withdrawal by Subject|0|||
23146810|NCT00971243|64287307|FG003|Open-label Period|Withdrawal by Subject|2|||
23146811|NCT00971243|64287308|FG004|Open-label Period|Withdrawal by Subject|1|||
23146812|NCT00971243|64287304|FG000|Open-label Period|Other reason|0|||
23146813|NCT00971243|64287305|FG001|Open-label Period|Other reason|0|||
23146814|NCT00971243|64287306|FG002|Open-label Period|Other reason|0|||
23146815|NCT00971243|64287307|FG003|Open-label Period|Other reason|0|||
23146816|NCT00971243|64287308|FG004|Open-label Period|Other reason|2|||
23146817|NCT00762970|64287311|FG000|Overall Study|Withdrawal by Subject|7|||
23146818|NCT00762970|64287312|FG001|Overall Study|Withdrawal by Subject|4|||
23146819|NCT00762970|64287313|FG002|Overall Study|Withdrawal by Subject|0|||
23146820|NCT00762970|64287311|FG000|Overall Study|Protocol Violation|3|||
23146821|NCT00762970|64287312|FG001|Overall Study|Protocol Violation|1|||
23146822|NCT00762970|64287313|FG002|Overall Study|Protocol Violation|1|||
23146823|NCT00762970|64287311|FG000|Overall Study|Lost to Follow-up|1|||
23146824|NCT00762970|64287312|FG001|Overall Study|Lost to Follow-up|2|||
23146825|NCT00762970|64287313|FG002|Overall Study|Lost to Follow-up|0|||
23146826|NCT00762970|64287311|FG000|Overall Study|Difficulty of handling lens|1|||
23146827|NCT00762970|64287312|FG001|Overall Study|Difficulty of handling lens|2|||
23146828|NCT00762970|64287313|FG002|Overall Study|Difficulty of handling lens|0|||
23146829|NCT03021954|64287314|FG000|Overall Study|Lost to Follow-up|10|||
23146830|NCT03021954|64287315|FG001|Overall Study|Lost to Follow-up|43|||
23146831|NCT03021954|64287314|FG000|Overall Study|Subjects had avulsion trauma|4|||
23146832|NCT03021954|64287315|FG001|Overall Study|Subjects had avulsion trauma|1|||
23146833|NCT00402363|64287316|FG000|Overall Study|Adverse Event|9|||
23146834|NCT00402363|64287317|FG001|Overall Study|Adverse Event|14|||
23146835|NCT00402363|64287318|FG002|Overall Study|Adverse Event|2|||
23146836|NCT00402363|64287319|FG003|Overall Study|Adverse Event|2|||
23146837|NCT00402363|64287316|FG000|Overall Study|Withdrew Consent|10|||
23146838|NCT00402363|64287317|FG001|Overall Study|Withdrew Consent|5|||
23146839|NCT00402363|64287318|FG002|Overall Study|Withdrew Consent|2|||
23146840|NCT00402363|64287319|FG003|Overall Study|Withdrew Consent|1|||
23146841|NCT00402363|64287316|FG000|Overall Study|Protocol Violation|3|||
23146842|NCT00402363|64287317|FG001|Overall Study|Protocol Violation|5|||
23146843|NCT00402363|64287318|FG002|Overall Study|Protocol Violation|0|||
23146844|NCT00402363|64287319|FG003|Overall Study|Protocol Violation|3|||
23146845|NCT00402363|64287316|FG000|Overall Study|Lost to Follow-up|5|||
23146846|NCT00402363|64287317|FG001|Overall Study|Lost to Follow-up|4|||
23146847|NCT00402363|64287318|FG002|Overall Study|Lost to Follow-up|0|||
23146848|NCT00402363|64287319|FG003|Overall Study|Lost to Follow-up|2|||
23146849|NCT00402363|64287316|FG000|Overall Study|"Captured as Other"|6|||
23146850|NCT00402363|64287317|FG001|Overall Study|"Captured as Other"|2|||
23146851|NCT00402363|64287318|FG002|Overall Study|"Captured as Other"|2|||
23146852|NCT00402363|64287319|FG003|Overall Study|"Captured as Other"|2|||
23322338|NCT01074944|64922992|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
23436619|NCT00172042|65340777|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
23557717|NCT02969525|65769495|FG001|Double-Blind Period|Adverse Event|0|||
23557718|NCT02969525|65769496|FG002|Double-Blind Period|Adverse Event|1|||
23146853|NCT02038543|64287320|FG000|Overall Study|Screen Failure|0|||
23146854|NCT02038543|64287321|FG001|Overall Study|Screen Failure|0|||
23146855|NCT02038543|64287322|FG002|Overall Study|Screen Failure|0|||
23146856|NCT02038543|64287323|FG003|Overall Study|Screen Failure|1|||
23146857|NCT02038543|64287320|FG000|Overall Study|Withdrawal by Subject|0|||
23146858|NCT02038543|64287321|FG001|Overall Study|Withdrawal by Subject|0|||
23146859|NCT02038543|64287322|FG002|Overall Study|Withdrawal by Subject|0|||
23146860|NCT02038543|64287323|FG003|Overall Study|Withdrawal by Subject|1|||
23146861|NCT02170389|64287324|FG000|Overall Study|Study terminated prior to start of treat|1|||
23146862|NCT02245672|64287328|FG000|Overall Study|Adverse Event|4|||
23146863|NCT02245672|64287329|FG001|Overall Study|Adverse Event|4|||
23146864|NCT02245672|64287330|FG002|Overall Study|Adverse Event|4|||
23146865|NCT02245672|64287328|FG000|Overall Study|Lost to Follow-up|3|||
23146866|NCT02245672|64287329|FG001|Overall Study|Lost to Follow-up|5|||
23146867|NCT02245672|64287330|FG002|Overall Study|Lost to Follow-up|1|||
23146868|NCT02245672|64287328|FG000|Overall Study|Withdrawal by Subject|6|||
23557719|NCT02969525|65769497|FG003|Double-Blind Period|Adverse Event|1|||
23557720|NCT02969525|65769498|FG004|Double-Blind Period|Adverse Event|0|||
23557721|NCT02969525|65769499|FG005|Double-Blind Period|Adverse Event|0|||
23557722|NCT02969525|65769500|FG006|Double-Blind Period|Adverse Event|0|||
23557723|NCT02969525|65769501|FG007|Double-Blind Period|Adverse Event|0|||
23557724|NCT02969525|65769502|FG008|Double-Blind Period|Adverse Event|0|||
23146869|NCT02245672|64287329|FG001|Overall Study|Withdrawal by Subject|3|||
23146870|NCT02245672|64287330|FG002|Overall Study|Withdrawal by Subject|0|||
23146871|NCT02245672|64287328|FG000|Overall Study|Randomized in error (not treated)|0|||
23146872|NCT02245672|64287329|FG001|Overall Study|Randomized in error (not treated)|1|||
23146873|NCT02245672|64287330|FG002|Overall Study|Randomized in error (not treated)|0|||
23146874|NCT03153137|64287337|FG000|Overall Study|Lost to Follow-up|1|||
23146875|NCT03153137|64287338|FG001|Overall Study|Lost to Follow-up|0|||
23146876|NCT03153137|64287337|FG000|Overall Study|Withdrawal by Subject|2|||
23146877|NCT03153137|64287338|FG001|Overall Study|Withdrawal by Subject|1|||
23146878|NCT03153137|64287337|FG000|Overall Study|Physician Decision|0|||
23146879|NCT03153137|64287338|FG001|Overall Study|Physician Decision|3|||
23146880|NCT02471833|64287341|FG000|Overall Study|Lost to Follow-up|1|||
23146881|NCT02471833|64287342|FG001|Overall Study|Lost to Follow-up|0|||
23146882|NCT02471833|64287343|FG002|Overall Study|Lost to Follow-up|0|||
23146883|NCT02471833|64287341|FG000|Overall Study|Withdrawal by Subject|2|||
23146884|NCT02471833|64287342|FG001|Overall Study|Withdrawal by Subject|1|||
23146885|NCT02471833|64287343|FG002|Overall Study|Withdrawal by Subject|5|||
23146886|NCT01890148|64287344|FG000|Overall Study|Adverse Event|1|||
23146887|NCT01175356|64287347|FG000|Overall Study|Death|1|||
23146888|NCT01175356|64287347|FG000|Overall Study|Lack of Efficacy|12|||
23146889|NCT01175356|64287347|FG000|Overall Study|Lost to Follow-up|1|||
23146890|NCT01175356|64287347|FG000|Overall Study|Physician Decision|23|||
23146891|NCT01175356|64287347|FG000|Overall Study|Ineligible|1|||
23146892|NCT01175356|64287347|FG000|Overall Study|Treatment Slot Not Available|18|||
23146893|NCT01175356|64287347|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
23146894|NCT01175356|64287347|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
23146895|NCT01175356|64287347|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
23146896|NCT01175356|64287347|FG000|Overall Study|Inadequate stem cell for transplant|1|||
23146897|NCT01175356|64287347|FG000|Overall Study|Initiation other tx prior to completion|9|||
23146898|NCT02808143|64287348|FG000|Maintenance Phase|Disease recurrence|1|||
23146899|NCT02808143|64287349|FG001|Maintenance Phase|Disease recurrence|3|||
23146900|NCT02808143|64287348|FG000|Maintenance Phase|Disease progression|1|||
23146901|NCT02808143|64287349|FG001|Maintenance Phase|Disease progression|2|||
23146902|NCT02808143|64287348|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
23322339|NCT01074944|64922988|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
23322340|NCT01074944|64922989|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
23322341|NCT01074944|64922990|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
23322342|NCT01074944|64922991|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
23322343|NCT01074944|64922992|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
23322344|NCT01074944|64922988|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
23322345|NCT01074944|64922989|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
23322346|NCT01074944|64922990|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
23322347|NCT01074944|64922991|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
23322348|NCT01074944|64922992|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
23322349|NCT01074944|64922988|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
23322350|NCT01074944|64922989|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
23322351|NCT01074944|64922990|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
23322352|NCT01074944|64922991|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
23322353|NCT01074944|64922992|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
23322354|NCT01074944|64922988|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
23322355|NCT01074944|64922989|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
23322356|NCT01074944|64922990|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
23322357|NCT01074944|64922991|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
23557725|NCT02969525|65769503|FG009|Double-Blind Period|Adverse Event|0|||
23146903|NCT02808143|64287349|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
23146904|NCT02808143|64287348|FG000|Survival Follow-Up|Disease recurrence|0|||
23146905|NCT02808143|64287349|FG001|Survival Follow-Up|Disease recurrence|2|||
23557726|NCT02969525|65769504|FG010|Double-Blind Period|Adverse Event|0|||
23557727|NCT02969525|65769505|FG011|Double-Blind Period|Adverse Event|0|||
23146906|NCT02808143|64287348|FG000|Survival Follow-Up|Adverse Event|0|||
23146907|NCT02808143|64287349|FG001|Survival Follow-Up|Adverse Event|1|||
23322358|NCT01074944|64922992|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
23322359|NCT01074944|64922988|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
23322360|NCT01074944|64922989|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
23322361|NCT01074944|64922990|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
23322362|NCT01074944|64922991|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
23322363|NCT01074944|64922992|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
23322364|NCT01074944|64922988|FG000|Long Term Treatment|Adverse Event|0|||
23322365|NCT01074944|64922989|FG001|Long Term Treatment|Adverse Event|0|||
23322366|NCT01074944|64922990|FG002|Long Term Treatment|Adverse Event|0|||
23322367|NCT01074944|64922991|FG003|Long Term Treatment|Adverse Event|3|||
23322368|NCT01074944|64922992|FG004|Long Term Treatment|Adverse Event|0|||
23322369|NCT01074944|64922988|FG000|Long Term Treatment|Lost to Follow-up|0|||
23322370|NCT01074944|64922989|FG001|Long Term Treatment|Lost to Follow-up|0|||
23322371|NCT01074944|64922990|FG002|Long Term Treatment|Lost to Follow-up|0|||
23322372|NCT01074944|64922991|FG003|Long Term Treatment|Lost to Follow-up|2|||
23322373|NCT01074944|64922992|FG004|Long Term Treatment|Lost to Follow-up|0|||
23322374|NCT01074944|64922988|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
23322375|NCT01074944|64922989|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
23322376|NCT01074944|64922990|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
23322377|NCT01074944|64922991|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
23322378|NCT01074944|64922992|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
23322379|NCT01074944|64922988|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
23322380|NCT01074944|64922989|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
23322381|NCT01074944|64922990|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
23322382|NCT01074944|64922991|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
23322383|NCT01074944|64922992|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
23322384|NCT01074944|64922988|FG000|Long Term Treatment|Withdrawal by Subject|0|||
23322385|NCT01074944|64922989|FG001|Long Term Treatment|Withdrawal by Subject|0|||
23322386|NCT01074944|64922990|FG002|Long Term Treatment|Withdrawal by Subject|0|||
23322387|NCT01074944|64922991|FG003|Long Term Treatment|Withdrawal by Subject|2|||
23322388|NCT01074944|64922992|FG004|Long Term Treatment|Withdrawal by Subject|0|||
23322389|NCT01074944|64922988|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
23322390|NCT01074944|64922989|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
23322391|NCT01074944|64922990|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
23322392|NCT01074944|64922991|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
23322393|NCT01074944|64922992|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
23322394|NCT01074944|64922988|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
23322395|NCT01074944|64922989|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
23322396|NCT01074944|64922990|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
23322397|NCT01074944|64922991|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
23322398|NCT01074944|64922992|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
23322399|NCT00742209|64922993|FG000|Overall Study|Adverse Event|11|||
23322400|NCT00742209|64922994|FG001|Overall Study|Adverse Event|4|||
23322401|NCT00742209|64922995|FG002|Overall Study|Adverse Event|17|||
23322402|NCT00742209|64922996|FG003|Overall Study|Adverse Event|16|||
23322403|NCT00742209|64922997|FG004|Overall Study|Adverse Event|13|||
23322404|NCT00742209|64922993|FG000|Overall Study|Participant Withdrew Consent|8|||
23322405|NCT00742209|64922994|FG001|Overall Study|Participant Withdrew Consent|4|||
23322406|NCT00742209|64922995|FG002|Overall Study|Participant Withdrew Consent|14|||
23322407|NCT00742209|64922996|FG003|Overall Study|Participant Withdrew Consent|7|||
23322408|NCT00742209|64922997|FG004|Overall Study|Participant Withdrew Consent|4|||
23322409|NCT00742209|64922993|FG000|Overall Study|Protocol Violation|6|||
23322410|NCT00742209|64922994|FG001|Overall Study|Protocol Violation|5|||
23322411|NCT00742209|64922995|FG002|Overall Study|Protocol Violation|4|||
23322412|NCT00742209|64922996|FG003|Overall Study|Protocol Violation|5|||
23322413|NCT00742209|64922997|FG004|Overall Study|Protocol Violation|3|||
23322414|NCT00742209|64922993|FG000|Overall Study|Lost to Follow-up|3|||
23322415|NCT00742209|64922994|FG001|Overall Study|Lost to Follow-up|4|||
23322416|NCT00742209|64922995|FG002|Overall Study|Lost to Follow-up|5|||
23146908|NCT02808143|64287348|FG000|Survival Follow-Up|Death|1|||
23322417|NCT00742209|64922996|FG003|Overall Study|Lost to Follow-up|5|||
23322418|NCT00742209|64922997|FG004|Overall Study|Lost to Follow-up|3|||
23322419|NCT00742209|64922993|FG000|Overall Study|Lack of Efficacy|6|||
23322420|NCT00742209|64922994|FG001|Overall Study|Lack of Efficacy|1|||
23146909|NCT02808143|64287349|FG001|Survival Follow-Up|Death|0|||
23322421|NCT00742209|64922995|FG002|Overall Study|Lack of Efficacy|1|||
23322422|NCT00742209|64922996|FG003|Overall Study|Lack of Efficacy|3|||
23322423|NCT00742209|64922997|FG004|Overall Study|Lack of Efficacy|1|||
23322424|NCT00742209|64922993|FG000|Overall Study|Investigator Discretion|0|||
23322425|NCT00742209|64922994|FG001|Overall Study|Investigator Discretion|0|||
23322426|NCT00742209|64922995|FG002|Overall Study|Investigator Discretion|5|||
23322427|NCT00742209|64922996|FG003|Overall Study|Investigator Discretion|1|||
23436620|NCT00172042|65340776|FG000|Overall Study|Patient no longer requires study drug|10|||
23436621|NCT00172042|65340777|FG001|Overall Study|Patient no longer requires study drug|8|||
23436622|NCT00172042|65340776|FG000|Overall Study|Protocol Violation|8|||
23436623|NCT00172042|65340777|FG001|Overall Study|Protocol Violation|7|||
23436624|NCT00172042|65340776|FG000|Overall Study|Withdrawal by Subject|37|||
23436625|NCT00172042|65340777|FG001|Overall Study|Withdrawal by Subject|25|||
23557728|NCT02969525|65769494|FG000|Double-Blind Period|LOW EGFR|0|||
23436626|NCT00172042|65340776|FG000|Overall Study|Lost to Follow-up|3|||
23436627|NCT00172042|65340777|FG001|Overall Study|Lost to Follow-up|5|||
23436628|NCT00172042|65340776|FG000|Overall Study|Administrative problems|13|||
23436629|NCT00172042|65340777|FG001|Overall Study|Administrative problems|10|||
23436630|NCT00172042|65340776|FG000|Overall Study|Death|42|||
23436631|NCT00172042|65340777|FG001|Overall Study|Death|42|||
23436632|NCT03188510|65340779|FG000|Overall Study|Inappropriate behavior with site staff|0|||
23436633|NCT03188510|65340780|FG001|Overall Study|Inappropriate behavior with site staff|1|||
23436634|NCT03188510|65340781|FG002|Overall Study|Inappropriate behavior with site staff|0|||
23436635|NCT02461745|65340782|FG000|Overall Study|Lack of Efficacy|9|||
23436636|NCT02461745|65340783|FG001|Overall Study|Lack of Efficacy|1|||
23436637|NCT02461745|65340782|FG000|Overall Study|Lost to Follow-up|2|||
23436638|NCT02461745|65340783|FG001|Overall Study|Lost to Follow-up|2|||
23436639|NCT02461745|65340782|FG000|Overall Study|Withdrawal by Subject|3|||
23436640|NCT02461745|65340783|FG001|Overall Study|Withdrawal by Subject|1|||
23436641|NCT00367835|65340784|FG000|Overall Study|Adverse Event|14|||
23436642|NCT00367835|65340785|FG001|Overall Study|Adverse Event|1|||
23218742|NCT01484561|64541715|FG001|Overall Study|Lost to Follow-up|0|||
23218743|NCT01484561|64541714|FG000|Overall Study|Withdrawal by Subject|3|||
23436643|NCT00367835|65340784|FG000|Overall Study|Protocol Violation|1|||
23436644|NCT00367835|65340785|FG001|Overall Study|Protocol Violation|7|||
23436645|NCT00367835|65340784|FG000|Overall Study|Withdrawal by Subject|7|||
23436646|NCT00367835|65340785|FG001|Overall Study|Withdrawal by Subject|6|||
23436647|NCT00367835|65340784|FG000|Overall Study|Lost to Follow-up|1|||
23436648|NCT00367835|65340785|FG001|Overall Study|Lost to Follow-up|4|||
23436649|NCT00367835|65340784|FG000|Overall Study|Lack of Efficacy|3|||
23436650|NCT00367835|65340785|FG001|Overall Study|Lack of Efficacy|12|||
23436651|NCT00367835|65340784|FG000|Overall Study|Subject in juvenile detention center|1|||
23436652|NCT00367835|65340785|FG001|Overall Study|Subject in juvenile detention center|0|||
23436653|NCT00367835|65340784|FG000|Overall Study|refused blood collection|1|||
23436654|NCT00367835|65340785|FG001|Overall Study|refused blood collection|0|||
23436655|NCT00367835|65340784|FG000|Overall Study|Did not respond to calls|1|||
23436656|NCT00367835|65340785|FG001|Overall Study|Did not respond to calls|0|||
23436657|NCT00367835|65340784|FG000|Overall Study|History of lead poisoning|0|||
23436658|NCT00367835|65340785|FG001|Overall Study|History of lead poisoning|1|||
23436659|NCT00079677|65340790|FG000|Overall Study|Adverse Event|5|||
23436660|NCT00079677|65340791|FG001|Overall Study|Adverse Event|6|||
23436661|NCT00079677|65340790|FG000|Overall Study|Lack of Efficacy|1|||
23436662|NCT00079677|65340791|FG001|Overall Study|Lack of Efficacy|0|||
23436663|NCT00079677|65340790|FG000|Overall Study|Lost to Follow-up|2|||
23436664|NCT00079677|65340791|FG001|Overall Study|Lost to Follow-up|2|||
23436665|NCT00079677|65340790|FG000|Overall Study|Physician Decision|3|||
23436666|NCT00079677|65340791|FG001|Overall Study|Physician Decision|0|||
23436667|NCT00079677|65340790|FG000|Overall Study|Protocol Violation|2|||
23436668|NCT00079677|65340791|FG001|Overall Study|Protocol Violation|3|||
23436669|NCT00079677|65340790|FG000|Overall Study|Withdrawal by Subject|5|||
23436670|NCT00079677|65340791|FG001|Overall Study|Withdrawal by Subject|3|||
23436671|NCT00079677|65340790|FG000|Overall Study|Miscellaneous|2|||
23436672|NCT00079677|65340791|FG001|Overall Study|Miscellaneous|0|||
23436673|NCT01563172|65340796|FG000|Overall Study|Adverse Event|5|||
23436674|NCT01563172|65340796|FG000|Overall Study|Lost to Follow-up|2|||
23436675|NCT01563172|65340796|FG000|Overall Study|Other (Protocol deviation)|5|||
23436676|NCT01563172|65340796|FG000|Overall Study|Other (Not specified)|1|||
23436677|NCT00447122|65340797|FG000|Overall Study|worsening medical condition -came off|0|||
23436678|NCT00447122|65340798|FG001|Overall Study|worsening medical condition -came off|1|||
23436679|NCT00447122|65340799|FG002|Overall Study|worsening medical condition -came off|0|||
23436680|NCT00447122|65340800|FG003|Overall Study|worsening medical condition -came off|0|||
23436681|NCT01371305|65340801|FG000|Overall Study|Adverse Event|0|||
23436682|NCT01371305|65340802|FG001|Overall Study|Adverse Event|0|||
23436683|NCT01371305|65340803|FG002|Overall Study|Adverse Event|0|||
23436684|NCT01371305|65340804|FG003|Overall Study|Adverse Event|2|||
23436685|NCT01371305|65340805|FG004|Overall Study|Adverse Event|1|||
23436686|NCT01371305|65340806|FG005|Overall Study|Adverse Event|0|||
23436687|NCT01371305|65340801|FG000|Overall Study|Study terminated by sponsor|0|||
23218744|NCT01484561|64541715|FG001|Overall Study|Withdrawal by Subject|0|||
23436688|NCT01371305|65340802|FG001|Overall Study|Study terminated by sponsor|0|||
23436689|NCT01371305|65340803|FG002|Overall Study|Study terminated by sponsor|0|||
23557729|NCT02969525|65769495|FG001|Double-Blind Period|LOW EGFR|0|||
23557730|NCT02969525|65769496|FG002|Double-Blind Period|LOW EGFR|0|||
23557731|NCT02969525|65769497|FG003|Double-Blind Period|LOW EGFR|1|||
23436690|NCT01371305|65340804|FG003|Overall Study|Study terminated by sponsor|0|||
23436691|NCT01371305|65340805|FG004|Overall Study|Study terminated by sponsor|3|||
23436692|NCT01371305|65340806|FG005|Overall Study|Study terminated by sponsor|1|||
23436693|NCT01371305|65340801|FG000|Overall Study|Subject request|0|||
23436694|NCT01371305|65340802|FG001|Overall Study|Subject request|0|||
23436695|NCT01371305|65340803|FG002|Overall Study|Subject request|0|||
23436696|NCT01371305|65340804|FG003|Overall Study|Subject request|0|||
23436697|NCT01371305|65340805|FG004|Overall Study|Subject request|0|||
23436698|NCT01371305|65340806|FG005|Overall Study|Subject request|1|||
23436699|NCT01793883|65340807|FG000|Overall Study|Withdrawal by Subject|3|||
23436700|NCT01793883|65340808|FG001|Overall Study|Withdrawal by Subject|7|||
23436701|NCT01793883|65340809|FG002|Overall Study|Withdrawal by Subject|3|||
23436702|NCT01793883|65340807|FG000|Overall Study|Subject noncompliance|0|||
23436703|NCT01793883|65340808|FG001|Overall Study|Subject noncompliance|1|||
23436704|NCT01793883|65340809|FG002|Overall Study|Subject noncompliance|1|||
23436705|NCT01793883|65340807|FG000|Overall Study|Lost to Follow-up|5|||
23436706|NCT01793883|65340808|FG001|Overall Study|Lost to Follow-up|1|||
23436707|NCT01793883|65340809|FG002|Overall Study|Lost to Follow-up|3|||
23436708|NCT01793883|65340807|FG000|Overall Study|Randomized in error|1|||
23436709|NCT01793883|65340808|FG001|Overall Study|Randomized in error|0|||
23436710|NCT01793883|65340809|FG002|Overall Study|Randomized in error|0|||
23436711|NCT01793883|65340807|FG000|Overall Study|Unable to complete spriometry|1|||
23436712|NCT01793883|65340808|FG001|Overall Study|Unable to complete spriometry|0|||
23436713|NCT01793883|65340809|FG002|Overall Study|Unable to complete spriometry|0|||
23436714|NCT01793883|65340807|FG000|Overall Study|Unable to complete measurements|1|||
23436715|NCT01793883|65340808|FG001|Overall Study|Unable to complete measurements|0|||
23436716|NCT01793883|65340809|FG002|Overall Study|Unable to complete measurements|0|||
23436717|NCT01793883|65340807|FG000|Overall Study|Met exclusion criteria|1|||
23436718|NCT01793883|65340808|FG001|Overall Study|Met exclusion criteria|0|||
23436719|NCT01793883|65340809|FG002|Overall Study|Met exclusion criteria|0|||
23436720|NCT01793883|65340807|FG000|Overall Study|Dosing error|0|||
23436721|NCT01793883|65340808|FG001|Overall Study|Dosing error|1|||
23436722|NCT01793883|65340809|FG002|Overall Study|Dosing error|0|||
23436723|NCT01793883|65340807|FG000|Overall Study|Respiratory distress during spirometry|0|||
23436724|NCT01793883|65340808|FG001|Overall Study|Respiratory distress during spirometry|0|||
23436725|NCT01793883|65340809|FG002|Overall Study|Respiratory distress during spirometry|1|||
23436726|NCT03262441|65340810|FG000|Overall Study|Withdrawal by Subject|1|||
23436727|NCT01846741|65340811|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
23436728|NCT01052077|65340816|FG000|Phase A|Lost to Follow-up|22|||
23436729|NCT01052077|65340817|FG001|Phase A|Lost to Follow-up|0|||
23436730|NCT01052077|65340818|FG002|Phase A|Lost to Follow-up|0|||
23436731|NCT01052077|65340819|FG003|Phase A|Lost to Follow-up|0|||
23436732|NCT01052077|65340816|FG000|Phase A|Adverse Event|32|||
23436733|NCT01052077|65340817|FG001|Phase A|Adverse Event|0|||
23436734|NCT01052077|65340818|FG002|Phase A|Adverse Event|0|||
23436735|NCT01052077|65340819|FG003|Phase A|Adverse Event|0|||
23436736|NCT01052077|65340816|FG000|Phase A|Met Withdrawal Criteria|26|||
23436737|NCT01052077|65340817|FG001|Phase A|Met Withdrawal Criteria|0|||
23436738|NCT01052077|65340818|FG002|Phase A|Met Withdrawal Criteria|0|||
23436739|NCT01052077|65340819|FG003|Phase A|Met Withdrawal Criteria|0|||
23436740|NCT01052077|65340816|FG000|Phase A|Physician Decision|10|||
23436741|NCT01052077|65340817|FG001|Phase A|Physician Decision|0|||
23436742|NCT01052077|65340818|FG002|Phase A|Physician Decision|0|||
23436743|NCT01052077|65340819|FG003|Phase A|Physician Decision|0|||
23436744|NCT01052077|65340816|FG000|Phase A|Withdrawal by Subject|29|||
23436745|NCT01052077|65340817|FG001|Phase A|Withdrawal by Subject|0|||
23436746|NCT01052077|65340818|FG002|Phase A|Withdrawal by Subject|0|||
23436747|NCT01052077|65340819|FG003|Phase A|Withdrawal by Subject|0|||
23436748|NCT01052077|65340816|FG000|Phase A|Protocol Deviation|27|||
23557732|NCT02969525|65769498|FG004|Double-Blind Period|LOW EGFR|0|||
23557733|NCT02969525|65769499|FG005|Double-Blind Period|LOW EGFR|0|||
23557734|NCT02969525|65769500|FG006|Double-Blind Period|LOW EGFR|0|||
23557735|NCT02969525|65769501|FG007|Double-Blind Period|LOW EGFR|0|||
23218745|NCT01484561|64541714|FG000|Overall Study|Other|1|||
23218746|NCT01484561|64541715|FG001|Overall Study|Other|1|||
23436749|NCT01052077|65340817|FG001|Phase A|Protocol Deviation|0|||
23436750|NCT01052077|65340818|FG002|Phase A|Protocol Deviation|0|||
23436751|NCT01052077|65340819|FG003|Phase A|Protocol Deviation|0|||
23436752|NCT01052077|65340816|FG000|Phase B|Lost to Follow-up|0|||
23436753|NCT01052077|65340817|FG001|Phase B|Lost to Follow-up|2|||
23436754|NCT01052077|65340818|FG002|Phase B|Lost to Follow-up|3|||
23436755|NCT01052077|65340819|FG003|Phase B|Lost to Follow-up|0|||
23436756|NCT01052077|65340816|FG000|Phase B|Adverse Event|0|||
23436757|NCT01052077|65340817|FG001|Phase B|Adverse Event|9|||
23436758|NCT01052077|65340818|FG002|Phase B|Adverse Event|2|||
23218747|NCT01484561|64541714|FG000|Overall Study|Adverse Event|1|||
23436759|NCT01052077|65340819|FG003|Phase B|Adverse Event|0|||
23436760|NCT01052077|65340816|FG000|Phase B|Met Withdrawal Criteria|0|||
23436761|NCT01052077|65340817|FG001|Phase B|Met Withdrawal Criteria|2|||
23557736|NCT02969525|65769502|FG008|Double-Blind Period|LOW EGFR|0|||
23146910|NCT01444456|64287350|FG000|Overall Study|Withdrawal by Subject|21|||
23146911|NCT01444456|64287350|FG000|Overall Study|Physician Decision|9|||
23146912|NCT01444456|64287350|FG000|Overall Study|Lost to Follow-up|37|||
23146913|NCT01444456|64287350|FG000|Overall Study|Death|73|||
23146914|NCT01444456|64287350|FG000|Overall Study|Ineligibility determined|23|||
23146915|NCT01444456|64287350|FG000|Overall Study|Other|18|||
23146916|NCT01444456|64287350|FG000|Overall Study|Not treated|104|||
23146917|NCT03604523|64287351|FG000|Overall Study|Physician Decision|1|||
23146918|NCT03604523|64287352|FG001|Overall Study|Physician Decision|0|||
23146919|NCT02095951|64287353|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
23146920|NCT02095951|64287354|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
23146921|NCT00820027|64287355|FG000|Overall Study|Adverse Event|15|||
23146922|NCT00820027|64287356|FG001|Overall Study|Adverse Event|8|||
23146923|NCT00820027|64287357|FG002|Overall Study|Adverse Event|10|||
23146924|NCT00820027|64287358|FG003|Overall Study|Adverse Event|5|||
23146925|NCT00820027|64287355|FG000|Overall Study|Lack of Efficacy|2|||
23146926|NCT00820027|64287356|FG001|Overall Study|Lack of Efficacy|1|||
23146927|NCT00820027|64287357|FG002|Overall Study|Lack of Efficacy|2|||
23146928|NCT00820027|64287358|FG003|Overall Study|Lack of Efficacy|2|||
23146929|NCT00820027|64287355|FG000|Overall Study|Physician Decision|0|||
23146930|NCT00820027|64287356|FG001|Overall Study|Physician Decision|1|||
23146931|NCT00820027|64287357|FG002|Overall Study|Physician Decision|1|||
23146932|NCT00820027|64287358|FG003|Overall Study|Physician Decision|0|||
23557737|NCT02969525|65769503|FG009|Double-Blind Period|LOW EGFR|0|||
23557738|NCT02969525|65769504|FG010|Double-Blind Period|LOW EGFR|0|||
23557739|NCT02969525|65769505|FG011|Double-Blind Period|LOW EGFR|0|||
23557740|NCT02969525|65769494|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
23557741|NCT02969525|65769495|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557742|NCT02969525|65769496|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557743|NCT02969525|65769497|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
23557744|NCT02969525|65769498|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557745|NCT02969525|65769499|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23146933|NCT00820027|64287355|FG000|Overall Study|Protocol Violation|3|||
23146934|NCT00820027|64287356|FG001|Overall Study|Protocol Violation|0|||
23146935|NCT00820027|64287357|FG002|Overall Study|Protocol Violation|4|||
23146936|NCT00820027|64287358|FG003|Overall Study|Protocol Violation|0|||
23146937|NCT00820027|64287355|FG000|Overall Study|Withdrawal by Subject|6|||
23146938|NCT00820027|64287356|FG001|Overall Study|Withdrawal by Subject|4|||
23146939|NCT00820027|64287357|FG002|Overall Study|Withdrawal by Subject|4|||
23146940|NCT00820027|64287358|FG003|Overall Study|Withdrawal by Subject|6|||
23146941|NCT01054846|64287359|FG000|Overall Study|Lost to Follow-up|76|||
23146942|NCT01054846|64287360|FG001|Overall Study|Lost to Follow-up|17|||
23146943|NCT03739437|64287365|FG000|Overall Study|Lost to Follow-up|2|||
23146944|NCT03739437|64287366|FG001|Overall Study|Lost to Follow-up|5|||
23146945|NCT01079741|64287367|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
23146946|NCT01079741|64287368|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
23146947|NCT01079741|64287369|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
23146948|NCT01079741|64287370|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
23146949|NCT01079741|64287371|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
23146950|NCT01079741|64287367|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
23146951|NCT01079741|64287368|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
23146952|NCT01079741|64287369|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
23146953|NCT01079741|64287370|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
23218748|NCT01484561|64541715|FG001|Overall Study|Adverse Event|4|||
23218749|NCT01922739|64541716|FG000|Titration/Adjustment Period|Adverse Event|3|||
23218750|NCT01922739|64541716|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
23557746|NCT02969525|65769500|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557747|NCT02969525|65769501|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557748|NCT02969525|65769502|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557749|NCT02969525|65769503|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557750|NCT02969525|65769504|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557751|NCT02969525|65769505|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
23557752|NCT02969525|65769494|FG000|Dose-Blind Period|Adverse Event|0|||
23557753|NCT02969525|65769495|FG001|Dose-Blind Period|Adverse Event|0|||
23557754|NCT02969525|65769496|FG002|Dose-Blind Period|Adverse Event|0|||
23557755|NCT02969525|65769497|FG003|Dose-Blind Period|Adverse Event|0|||
23557756|NCT02969525|65769498|FG004|Dose-Blind Period|Adverse Event|0|||
23557757|NCT02969525|65769499|FG005|Dose-Blind Period|Adverse Event|0|||
23557758|NCT02969525|65769500|FG006|Dose-Blind Period|Adverse Event|0|||
23557759|NCT02969525|65769501|FG007|Dose-Blind Period|Adverse Event|0|||
23557760|NCT02969525|65769502|FG008|Dose-Blind Period|Adverse Event|0|||
23146954|NCT01079741|64287371|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
23146955|NCT01596621|64287372|FG000|Overall Study|Death|4|||
23146956|NCT01596621|64287372|FG000|Overall Study|Withdrawal by Subject|9|||
23557761|NCT02969525|65769503|FG009|Dose-Blind Period|Adverse Event|1|||
23322428|NCT00742209|64922997|FG004|Overall Study|Investigator Discretion|1|||
23322429|NCT01289678|64922998|FG000|Overall Study|Physician Decision|6|||
23322430|NCT02207634|64923001|FG000|Overall Study|Withdrawal by Subject|21|||
23322431|NCT02207634|64923002|FG001|Overall Study|Withdrawal by Subject|31|||
23322432|NCT02207634|64923001|FG000|Overall Study|Lost to Follow-up|1|||
23322433|NCT02207634|64923002|FG001|Overall Study|Lost to Follow-up|0|||
23322434|NCT04747470|64923003|FG000|Overall Study|Death|0|||
23322435|NCT04747470|64923004|FG001|Overall Study|Death|3|||
23322436|NCT04747470|64923005|FG002|Overall Study|Death|2|||
23322437|NCT04747470|64923006|FG003|Overall Study|Death|2|||
23322438|NCT04747470|64923007|FG004|Overall Study|Death|2|||
23322439|NCT04747470|64923008|FG005|Overall Study|Death|0|||
23322440|NCT04747470|64923009|FG006|Overall Study|Death|0|||
23322441|NCT04747470|64923010|FG007|Overall Study|Death|0|||
23322442|NCT04747470|64923011|FG008|Overall Study|Death|0|||
23322443|NCT04747470|64923012|FG009|Overall Study|Death|0|||
23322444|NCT04747470|64923013|FG010|Overall Study|Death|0|||
23322445|NCT04747470|64923003|FG000|Overall Study|Withdrew Consent|0|||
23322446|NCT04747470|64923004|FG001|Overall Study|Withdrew Consent|0|||
23322447|NCT04747470|64923005|FG002|Overall Study|Withdrew Consent|0|||
23322448|NCT04747470|64923006|FG003|Overall Study|Withdrew Consent|1|||
23322449|NCT04747470|64923007|FG004|Overall Study|Withdrew Consent|0|||
23322450|NCT04747470|64923008|FG005|Overall Study|Withdrew Consent|0|||
23322451|NCT04747470|64923009|FG006|Overall Study|Withdrew Consent|0|||
23322452|NCT04747470|64923010|FG007|Overall Study|Withdrew Consent|0|||
23322453|NCT04747470|64923011|FG008|Overall Study|Withdrew Consent|0|||
23322454|NCT04747470|64923012|FG009|Overall Study|Withdrew Consent|0|||
23322455|NCT04747470|64923013|FG010|Overall Study|Withdrew Consent|0|||
23322456|NCT04747470|64923003|FG000|Overall Study|Study Terminated by Sponsor|0|||
23322457|NCT04747470|64923004|FG001|Overall Study|Study Terminated by Sponsor|0|||
23322458|NCT04747470|64923005|FG002|Overall Study|Study Terminated by Sponsor|1|||
23322459|NCT04747470|64923006|FG003|Overall Study|Study Terminated by Sponsor|0|||
23557762|NCT02969525|65769504|FG010|Dose-Blind Period|Adverse Event|1|||
23557763|NCT02969525|65769505|FG011|Dose-Blind Period|Adverse Event|1|||
23557764|NCT02969525|65769494|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
23557765|NCT02969525|65769495|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
23557766|NCT02969525|65769496|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
23557767|NCT02969525|65769497|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
23557768|NCT02969525|65769498|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
23557769|NCT02969525|65769499|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
23557770|NCT02969525|65769500|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
23557771|NCT02969525|65769501|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
23557772|NCT02969525|65769502|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
23557773|NCT02969525|65769503|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
23557774|NCT02969525|65769504|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
23557775|NCT02969525|65769505|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
23557776|NCT02969525|65769494|FG000|Dose-Blind Period|Non-cooperating patient|0|||
23557777|NCT02969525|65769495|FG001|Dose-Blind Period|Non-cooperating patient|0|||
23557778|NCT02969525|65769496|FG002|Dose-Blind Period|Non-cooperating patient|0|||
23557779|NCT02969525|65769497|FG003|Dose-Blind Period|Non-cooperating patient|0|||
23557780|NCT02969525|65769498|FG004|Dose-Blind Period|Non-cooperating patient|0|||
23557781|NCT02969525|65769499|FG005|Dose-Blind Period|Non-cooperating patient|0|||
23557782|NCT02969525|65769500|FG006|Dose-Blind Period|Non-cooperating patient|0|||
23557783|NCT02969525|65769501|FG007|Dose-Blind Period|Non-cooperating patient|0|||
23557784|NCT02969525|65769502|FG008|Dose-Blind Period|Non-cooperating patient|0|||
23557785|NCT02969525|65769503|FG009|Dose-Blind Period|Non-cooperating patient|0|||
23557786|NCT02969525|65769504|FG010|Dose-Blind Period|Non-cooperating patient|0|||
23557787|NCT02969525|65769505|FG011|Dose-Blind Period|Non-cooperating patient|1|||
23557788|NCT02969525|65769494|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557789|NCT02969525|65769495|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557790|NCT02969525|65769496|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557791|NCT02969525|65769497|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557792|NCT02969525|65769498|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557793|NCT02969525|65769499|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23146957|NCT01596621|64287372|FG000|Overall Study|Disease Progression|49|||
23146958|NCT01596621|64287372|FG000|Overall Study|Lost to Follow-up|3|||
23322460|NCT04747470|64923007|FG004|Overall Study|Study Terminated by Sponsor|2|||
23322461|NCT04747470|64923008|FG005|Overall Study|Study Terminated by Sponsor|0|||
23322462|NCT04747470|64923009|FG006|Overall Study|Study Terminated by Sponsor|0|||
23322463|NCT04747470|64923010|FG007|Overall Study|Study Terminated by Sponsor|0|||
23322464|NCT04747470|64923011|FG008|Overall Study|Study Terminated by Sponsor|0|||
23322465|NCT04747470|64923012|FG009|Overall Study|Study Terminated by Sponsor|0|||
23322466|NCT04747470|64923013|FG010|Overall Study|Study Terminated by Sponsor|0|||
23322467|NCT01276041|64923017|FG000|Overall Study|Adverse Event|2|||
23557794|NCT02969525|65769500|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557795|NCT02969525|65769501|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557796|NCT02969525|65769502|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23436762|NCT01052077|65340818|FG002|Phase B|Met Withdrawal Criteria|1|||
23436763|NCT01052077|65340819|FG003|Phase B|Met Withdrawal Criteria|0|||
23436764|NCT01052077|65340816|FG000|Phase B|Physician Decision|0|||
23436765|NCT01052077|65340817|FG001|Phase B|Physician Decision|1|||
23436766|NCT01052077|65340818|FG002|Phase B|Physician Decision|1|||
23436767|NCT01052077|65340819|FG003|Phase B|Physician Decision|0|||
23436768|NCT01052077|65340816|FG000|Phase B|Withdrawal by Subject|0|||
23436769|NCT01052077|65340817|FG001|Phase B|Withdrawal by Subject|0|||
23436770|NCT01052077|65340818|FG002|Phase B|Withdrawal by Subject|5|||
23436771|NCT01052077|65340819|FG003|Phase B|Withdrawal by Subject|0|||
23436772|NCT01052077|65340816|FG000|Phase B|Protocol Deviation|0|||
23436773|NCT01052077|65340817|FG001|Phase B|Protocol Deviation|3|||
23436774|NCT01052077|65340818|FG002|Phase B|Protocol Deviation|4|||
23436775|NCT01052077|65340819|FG003|Phase B|Protocol Deviation|0|||
23436776|NCT01052077|65340816|FG000|Phase B|Lack of Efficacy|0|||
23436777|NCT01052077|65340817|FG001|Phase B|Lack of Efficacy|1|||
23436778|NCT01052077|65340818|FG002|Phase B|Lack of Efficacy|0|||
23436779|NCT01052077|65340819|FG003|Phase B|Lack of Efficacy|0|||
23436780|NCT01052077|65340816|FG000|Phase A+|Lost to Follow-up|0|||
23436781|NCT01052077|65340817|FG001|Phase A+|Lost to Follow-up|0|||
23436782|NCT01052077|65340818|FG002|Phase A+|Lost to Follow-up|0|||
23436783|NCT01052077|65340819|FG003|Phase A+|Lost to Follow-up|8|||
23436784|NCT01052077|65340816|FG000|Phase A+|Adverse Event|0|||
23436785|NCT01052077|65340817|FG001|Phase A+|Adverse Event|0|||
23436786|NCT01052077|65340818|FG002|Phase A+|Adverse Event|0|||
23436787|NCT01052077|65340819|FG003|Phase A+|Adverse Event|4|||
23436788|NCT01052077|65340816|FG000|Phase A+|Met Withdrawal Criteria|0|||
23436789|NCT01052077|65340817|FG001|Phase A+|Met Withdrawal Criteria|0|||
23436790|NCT01052077|65340818|FG002|Phase A+|Met Withdrawal Criteria|0|||
23436791|NCT01052077|65340819|FG003|Phase A+|Met Withdrawal Criteria|2|||
23436792|NCT01052077|65340816|FG000|Phase A+|Withdrawal by Subject|0|||
23436793|NCT01052077|65340817|FG001|Phase A+|Withdrawal by Subject|0|||
23436794|NCT01052077|65340818|FG002|Phase A+|Withdrawal by Subject|0|||
23436795|NCT01052077|65340819|FG003|Phase A+|Withdrawal by Subject|7|||
23436796|NCT01368081|65340820|FG000|Overall Study|Adverse Event|4|||
23436797|NCT01368081|65340821|FG001|Overall Study|Adverse Event|4|||
23557797|NCT02969525|65769503|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557798|NCT02969525|65769504|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
23557799|NCT02969525|65769505|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
23557800|NCT01649232|65769506|FG000|Overall Study|Physician Decision|2|||
23557801|NCT01649232|65769507|FG001|Overall Study|Physician Decision|0|||
23557802|NCT00415610|65769510|FG000|Overall Study|Death|3|||
23557803|NCT00415610|65769511|FG001|Overall Study|Death|2|||
23557804|NCT00415610|65769512|FG002|Overall Study|Death|5|||
23436798|NCT01368081|65340822|FG002|Overall Study|Adverse Event|3|||
23436799|NCT01368081|65340823|FG003|Overall Study|Adverse Event|2|||
23436800|NCT01368081|65340824|FG004|Overall Study|Adverse Event|2|||
23436801|NCT01368081|65340825|FG005|Overall Study|Adverse Event|5|||
23436802|NCT01368081|65340826|FG006|Overall Study|Adverse Event|6|||
23436803|NCT01368081|65340827|FG007|Overall Study|Adverse Event|2|||
23436804|NCT01368081|65340828|FG008|Overall Study|Adverse Event|3|||
23436805|NCT01368081|65340829|FG009|Overall Study|Adverse Event|5|||
23436806|NCT01368081|65340830|FG010|Overall Study|Adverse Event|6|||
23436807|NCT01368081|65340831|FG011|Overall Study|Adverse Event|1|||
23436808|NCT01368081|65340832|FG012|Overall Study|Adverse Event|3|||
23436809|NCT01368081|65340820|FG000|Overall Study|Lack of Efficacy|0|||
23436810|NCT01368081|65340821|FG001|Overall Study|Lack of Efficacy|1|||
23436811|NCT01368081|65340822|FG002|Overall Study|Lack of Efficacy|0|||
23436812|NCT01368081|65340823|FG003|Overall Study|Lack of Efficacy|1|||
23436813|NCT01368081|65340824|FG004|Overall Study|Lack of Efficacy|0|||
23436814|NCT01368081|65340825|FG005|Overall Study|Lack of Efficacy|0|||
23436815|NCT01368081|65340826|FG006|Overall Study|Lack of Efficacy|0|||
23436816|NCT01368081|65340827|FG007|Overall Study|Lack of Efficacy|2|||
23436817|NCT01368081|65340828|FG008|Overall Study|Lack of Efficacy|0|||
23436818|NCT01368081|65340829|FG009|Overall Study|Lack of Efficacy|0|||
23436819|NCT01368081|65340830|FG010|Overall Study|Lack of Efficacy|0|||
23436820|NCT01368081|65340831|FG011|Overall Study|Lack of Efficacy|0|||
23436821|NCT01368081|65340832|FG012|Overall Study|Lack of Efficacy|0|||
23436822|NCT01368081|65340820|FG000|Overall Study|Protocol Violation|0|||
23436823|NCT01368081|65340821|FG001|Overall Study|Protocol Violation|0|||
23436824|NCT01368081|65340822|FG002|Overall Study|Protocol Violation|0|||
23436825|NCT01368081|65340823|FG003|Overall Study|Protocol Violation|0|||
23436826|NCT01368081|65340824|FG004|Overall Study|Protocol Violation|0|||
23436827|NCT01368081|65340825|FG005|Overall Study|Protocol Violation|1|||
23436828|NCT01368081|65340826|FG006|Overall Study|Protocol Violation|0|||
23436829|NCT01368081|65340827|FG007|Overall Study|Protocol Violation|1|||
23436830|NCT01368081|65340828|FG008|Overall Study|Protocol Violation|0|||
23436831|NCT01368081|65340829|FG009|Overall Study|Protocol Violation|0|||
23436832|NCT01368081|65340830|FG010|Overall Study|Protocol Violation|0|||
23557805|NCT00394355|65769516|FG000|Overall Study|Adverse Event|10|||
23557806|NCT00394355|65769517|FG001|Overall Study|Adverse Event|6|||
23436833|NCT01368081|65340831|FG011|Overall Study|Protocol Violation|0|||
23436834|NCT01368081|65340832|FG012|Overall Study|Protocol Violation|0|||
23436835|NCT01368081|65340820|FG000|Overall Study|Lost to Follow-up|0|||
23436836|NCT01368081|65340821|FG001|Overall Study|Lost to Follow-up|0|||
23436837|NCT01368081|65340822|FG002|Overall Study|Lost to Follow-up|0|||
23436838|NCT01368081|65340823|FG003|Overall Study|Lost to Follow-up|0|||
23436839|NCT01368081|65340824|FG004|Overall Study|Lost to Follow-up|0|||
23436840|NCT01368081|65340825|FG005|Overall Study|Lost to Follow-up|0|||
23436841|NCT01368081|65340826|FG006|Overall Study|Lost to Follow-up|0|||
23436842|NCT01368081|65340827|FG007|Overall Study|Lost to Follow-up|0|||
23436843|NCT01368081|65340828|FG008|Overall Study|Lost to Follow-up|0|||
23436844|NCT01368081|65340829|FG009|Overall Study|Lost to Follow-up|0|||
23436845|NCT01368081|65340830|FG010|Overall Study|Lost to Follow-up|0|||
23436846|NCT01368081|65340831|FG011|Overall Study|Lost to Follow-up|0|||
23436847|NCT01368081|65340832|FG012|Overall Study|Lost to Follow-up|1|||
23436848|NCT01368081|65340820|FG000|Overall Study|Withdrawal by Subject|4|||
23436849|NCT01368081|65340821|FG001|Overall Study|Withdrawal by Subject|4|||
23436850|NCT01368081|65340822|FG002|Overall Study|Withdrawal by Subject|1|||
23436851|NCT01368081|65340823|FG003|Overall Study|Withdrawal by Subject|1|||
23436852|NCT01368081|65340824|FG004|Overall Study|Withdrawal by Subject|0|||
23436853|NCT01368081|65340825|FG005|Overall Study|Withdrawal by Subject|3|||
23436854|NCT01368081|65340826|FG006|Overall Study|Withdrawal by Subject|4|||
23436855|NCT01368081|65340827|FG007|Overall Study|Withdrawal by Subject|2|||
23436856|NCT01368081|65340828|FG008|Overall Study|Withdrawal by Subject|5|||
23436857|NCT01368081|65340829|FG009|Overall Study|Withdrawal by Subject|4|||
23436858|NCT01368081|65340830|FG010|Overall Study|Withdrawal by Subject|3|||
23436859|NCT01368081|65340831|FG011|Overall Study|Withdrawal by Subject|2|||
23436860|NCT01368081|65340832|FG012|Overall Study|Withdrawal by Subject|0|||
23436861|NCT01368081|65340820|FG000|Overall Study|Other reason not defined above|2|||
23436862|NCT01368081|65340821|FG001|Overall Study|Other reason not defined above|0|||
23436863|NCT01368081|65340822|FG002|Overall Study|Other reason not defined above|0|||
23436864|NCT01368081|65340823|FG003|Overall Study|Other reason not defined above|1|||
23436865|NCT01368081|65340824|FG004|Overall Study|Other reason not defined above|0|||
23436866|NCT01368081|65340825|FG005|Overall Study|Other reason not defined above|1|||
23436867|NCT01368081|65340826|FG006|Overall Study|Other reason not defined above|2|||
23436868|NCT01368081|65340827|FG007|Overall Study|Other reason not defined above|0|||
23436869|NCT01368081|65340828|FG008|Overall Study|Other reason not defined above|0|||
23436870|NCT01368081|65340829|FG009|Overall Study|Other reason not defined above|1|||
23436871|NCT01368081|65340830|FG010|Overall Study|Other reason not defined above|0|||
23436872|NCT01368081|65340831|FG011|Overall Study|Other reason not defined above|0|||
23436873|NCT01368081|65340832|FG012|Overall Study|Other reason not defined above|3|||
23436874|NCT02476006|65340833|FG000|Overall Study|Death|4|||
23436875|NCT02476006|65340833|FG000|Overall Study|Lack of treatment efficacy|2|||
23436876|NCT02476006|65340833|FG000|Overall Study|Pregnancy|1|||
23436877|NCT02476006|65340833|FG000|Overall Study|Participant did not wish to continue|39|||
23436878|NCT02476006|65340833|FG000|Overall Study|Adverse Event|41|||
23436879|NCT02476006|65340833|FG000|Overall Study|Poor compliance to study protocol|3|||
23436880|NCT02476006|65340833|FG000|Overall Study|Sponsor decision|6|||
23436881|NCT02476006|65340833|FG000|Overall Study|Lost to Follow-up|5|||
23436882|NCT02476006|65340833|FG000|Overall Study|Physician Decision|5|||
23436883|NCT02476006|65340833|FG000|Overall Study|Study ended treatment not available|4|||
23436884|NCT02476006|65340833|FG000|Overall Study|Switched to commercial drug|4|||
23436885|NCT02476006|65340833|FG000|Overall Study|Excluded from study|1|||
23436886|NCT02476006|65340833|FG000|Overall Study|Protocol Violation|1|||
23436887|NCT02476006|65340833|FG000|Overall Study|Enrolled but not treated|4|||
23436888|NCT00410605|65340835|FG000|Overall Study|Adverse Event|12|||
23436889|NCT00410605|65340835|FG000|Overall Study|Physician Decision|3|||
23436890|NCT00410605|65340835|FG000|Overall Study|Withdrawal by Subject|5|||
23436891|NCT00410605|65340835|FG000|Overall Study|Started Non-Protocol Therapy|3|||
23436892|NCT00410605|65340835|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
23436893|NCT00410605|65340835|FG000|Overall Study|Transferred to another Institution|1|||
23436894|NCT03890367|65340836|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23436895|NCT03890367|65340837|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23557807|NCT00394355|65769518|FG002|Overall Study|Adverse Event|7|||
23218751|NCT01922739|64541716|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
23436896|NCT03890367|65340838|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23436897|NCT03890367|65340836|FG000|Overall Study|Protocol deviation|2|||
23436898|NCT03890367|65340837|FG001|Overall Study|Protocol deviation|2|||
23436899|NCT03890367|65340838|FG002|Overall Study|Protocol deviation|1|||
23557808|NCT00394355|65769519|FG003|Overall Study|Adverse Event|8|||
23436900|NCT03890367|65340836|FG000|Overall Study|Lost to Follow-up|1|||
23436901|NCT03890367|65340837|FG001|Overall Study|Lost to Follow-up|1|||
23436902|NCT03890367|65340838|FG002|Overall Study|Lost to Follow-up|0|||
23436903|NCT00626405|65340839|FG000|Overall Study|Deemed Ineligible|1|||
23436904|NCT00626405|65340840|FG001|Overall Study|Deemed Ineligible|0|||
23436905|NCT00626405|65340839|FG000|Overall Study|Withdrawal by Subject|0|||
23436906|NCT00626405|65340840|FG001|Overall Study|Withdrawal by Subject|1|||
23436907|NCT00699335|65340843|FG000|Overall Study|Combination of multiple reasons|176|||
23436908|NCT00699335|65340843|FG000|Overall Study|Missing data|52|||
23436909|NCT02421588|65340846|FG000|Overall Study|Non-treatment-related AE|8|||
23218752|NCT01922739|64541716|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
23322468|NCT01276041|64923017|FG000|Overall Study|Protocol Violation|1|||
23322469|NCT00916383|64923018|FG000|Overall Study|Adverse Event|1|||
23322470|NCT00916383|64923018|FG000|Overall Study|Death|1|||
23322471|NCT00916383|64923018|FG000|Overall Study|Protocol Violation|1|||
23322472|NCT00729937|64923019|FG000|Overall Study|Lost to Follow-up|49|||
23322473|NCT00729937|64923020|FG001|Overall Study|Lost to Follow-up|58|||
23322474|NCT00729937|64923021|FG002|Overall Study|Lost to Follow-up|18|||
23322475|NCT00729937|64923022|FG003|Overall Study|Lost to Follow-up|33|||
23322476|NCT00729937|64923023|FG004|Overall Study|Lost to Follow-up|18|||
23322477|NCT00729937|64923024|FG005|Overall Study|Lost to Follow-up|23|||
23322478|NCT00729937|64923019|FG000|Overall Study|Physician Decision|7|||
23322479|NCT00729937|64923020|FG001|Overall Study|Physician Decision|16|||
23322480|NCT00729937|64923021|FG002|Overall Study|Physician Decision|2|||
23322481|NCT00729937|64923022|FG003|Overall Study|Physician Decision|0|||
23322482|NCT00729937|64923023|FG004|Overall Study|Physician Decision|5|||
23322483|NCT00729937|64923024|FG005|Overall Study|Physician Decision|8|||
23322484|NCT00729937|64923019|FG000|Overall Study|Death|1|||
23322485|NCT00729937|64923020|FG001|Overall Study|Death|0|||
23322486|NCT00729937|64923021|FG002|Overall Study|Death|1|||
23322487|NCT00729937|64923022|FG003|Overall Study|Death|0|||
23322488|NCT00729937|64923023|FG004|Overall Study|Death|0|||
23322489|NCT00729937|64923024|FG005|Overall Study|Death|1|||
23322490|NCT00729937|64923019|FG000|Overall Study|Withdrawal by Subject|3|||
23322491|NCT00729937|64923020|FG001|Overall Study|Withdrawal by Subject|5|||
23322492|NCT00729937|64923021|FG002|Overall Study|Withdrawal by Subject|6|||
23322493|NCT00729937|64923022|FG003|Overall Study|Withdrawal by Subject|0|||
23322494|NCT00729937|64923023|FG004|Overall Study|Withdrawal by Subject|4|||
23322495|NCT00729937|64923024|FG005|Overall Study|Withdrawal by Subject|2|||
23322496|NCT00729937|64923019|FG000|Overall Study|Randomized but not treated|12|||
23322497|NCT00729937|64923020|FG001|Overall Study|Randomized but not treated|6|||
23322498|NCT00729937|64923021|FG002|Overall Study|Randomized but not treated|1|||
23322499|NCT00729937|64923022|FG003|Overall Study|Randomized but not treated|0|||
23322500|NCT00729937|64923023|FG004|Overall Study|Randomized but not treated|1|||
23322501|NCT00729937|64923024|FG005|Overall Study|Randomized but not treated|3|||
23322502|NCT00729937|64923019|FG000|Overall Study|Did not meet eligibility criteria|2|||
23322503|NCT00729937|64923020|FG001|Overall Study|Did not meet eligibility criteria|1|||
23322504|NCT00729937|64923021|FG002|Overall Study|Did not meet eligibility criteria|0|||
23322505|NCT00729937|64923022|FG003|Overall Study|Did not meet eligibility criteria|0|||
23322506|NCT00729937|64923023|FG004|Overall Study|Did not meet eligibility criteria|0|||
23322507|NCT00729937|64923024|FG005|Overall Study|Did not meet eligibility criteria|0|||
23322508|NCT00729937|64923019|FG000|Overall Study|Incarcerated|0|||
23322509|NCT00729937|64923020|FG001|Overall Study|Incarcerated|2|||
23322510|NCT00729937|64923021|FG002|Overall Study|Incarcerated|1|||
23322511|NCT00729937|64923022|FG003|Overall Study|Incarcerated|1|||
23322512|NCT00729937|64923023|FG004|Overall Study|Incarcerated|0|||
23322513|NCT00729937|64923024|FG005|Overall Study|Incarcerated|0|||
23322514|NCT00866359|64923027|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
23322515|NCT00866359|64923028|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
23322516|NCT00866359|64923029|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
23322517|NCT00866359|64923030|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
23322518|NCT00866359|64923027|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
23322519|NCT00866359|64923028|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
23322520|NCT00866359|64923029|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
23322521|NCT00866359|64923030|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
23322522|NCT00866359|64923027|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
23322523|NCT00866359|64923028|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
23322524|NCT00866359|64923029|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
23322525|NCT00866359|64923030|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
23322526|NCT00866359|64923027|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
23322527|NCT00866359|64923028|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
23322528|NCT00866359|64923029|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
23322529|NCT00866359|64923030|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
23322530|NCT00866359|64923027|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
23322531|NCT00866359|64923028|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
23436910|NCT02421588|65340847|FG001|Overall Study|Non-treatment-related AE|8|||
23436911|NCT02421588|65340846|FG000|Overall Study|Progressive disease|152|||
23322532|NCT00866359|64923029|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
23322533|NCT00866359|64923030|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
23322534|NCT00866359|64923027|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
23322535|NCT00866359|64923028|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
23436912|NCT02421588|65340847|FG001|Overall Study|Progressive disease|135|||
23146959|NCT01596621|64287372|FG000|Overall Study|Other than specified|13|||
23146960|NCT00250679|64287373|FG000|Overall Study|Adverse Event|12|||
23146961|NCT00250679|64287374|FG001|Overall Study|Adverse Event|15|||
23146962|NCT00250679|64287375|FG002|Overall Study|Adverse Event|16|||
23146963|NCT00250679|64287373|FG000|Overall Study|Protocol Violation|2|||
23146964|NCT00250679|64287374|FG001|Overall Study|Protocol Violation|4|||
23146965|NCT00250679|64287375|FG002|Overall Study|Protocol Violation|3|||
23146966|NCT00250679|64287373|FG000|Overall Study|Withdrawal by Subject|15|||
23146967|NCT00250679|64287374|FG001|Overall Study|Withdrawal by Subject|18|||
23146968|NCT00250679|64287375|FG002|Overall Study|Withdrawal by Subject|15|||
23146969|NCT00250679|64287373|FG000|Overall Study|Lost to Follow-up|3|||
23146970|NCT00250679|64287374|FG001|Overall Study|Lost to Follow-up|4|||
23146971|NCT00250679|64287375|FG002|Overall Study|Lost to Follow-up|2|||
23146972|NCT00250679|64287373|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
23146973|NCT00250679|64287374|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
23146974|NCT00250679|64287375|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
23146975|NCT00250679|64287373|FG000|Overall Study|Lack of Efficacy|0|||
23146976|NCT00250679|64287374|FG001|Overall Study|Lack of Efficacy|1|||
23146977|NCT00250679|64287375|FG002|Overall Study|Lack of Efficacy|3|||
23146978|NCT00250679|64287373|FG000|Overall Study|Technical Holter issues|1|||
23146979|NCT00250679|64287374|FG001|Overall Study|Technical Holter issues|0|||
23146980|NCT00250679|64287375|FG002|Overall Study|Technical Holter issues|2|||
23146981|NCT00250679|64287373|FG000|Overall Study|Moved|1|||
23146982|NCT00250679|64287374|FG001|Overall Study|Moved|1|||
23146983|NCT00250679|64287375|FG002|Overall Study|Moved|0|||
23146984|NCT00250679|64287373|FG000|Overall Study|Non-compliance|1|||
23146985|NCT00250679|64287374|FG001|Overall Study|Non-compliance|1|||
23146986|NCT00250679|64287375|FG002|Overall Study|Non-compliance|0|||
23146987|NCT00250679|64287373|FG000|Overall Study|various single events: hip surgery,diary|3|||
23146988|NCT00250679|64287374|FG001|Overall Study|various single events: hip surgery,diary|1|||
23146989|NCT00250679|64287375|FG002|Overall Study|various single events: hip surgery,diary|1|||
23146990|NCT00985166|64287378|FG000|Overall Study|Lost to Follow-up|3|||
23146991|NCT00985166|64287379|FG001|Overall Study|Lost to Follow-up|2|||
23146992|NCT00985166|64287380|FG002|Overall Study|Lost to Follow-up|2|||
23146993|NCT00985166|64287378|FG000|Overall Study|Withdrawal by Subject|3|||
23146994|NCT00985166|64287379|FG001|Overall Study|Withdrawal by Subject|2|||
23557809|NCT00394355|65769516|FG000|Overall Study|Did not meet protocol eligibility|1|||
23146995|NCT00985166|64287380|FG002|Overall Study|Withdrawal by Subject|0|||
23146996|NCT00985166|64287378|FG000|Overall Study|Test not done|2|||
23146997|NCT00985166|64287379|FG001|Overall Study|Test not done|0|||
23146998|NCT00985166|64287380|FG002|Overall Study|Test not done|4|||
23146999|NCT00985166|64287378|FG000|Overall Study|Other|1|||
23147000|NCT00985166|64287379|FG001|Overall Study|Other|0|||
23557810|NCT00394355|65769517|FG001|Overall Study|Did not meet protocol eligibility|5|||
23557811|NCT00394355|65769518|FG002|Overall Study|Did not meet protocol eligibility|4|||
23557812|NCT00394355|65769519|FG003|Overall Study|Did not meet protocol eligibility|2|||
23557813|NCT00394355|65769516|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
23557814|NCT00394355|65769517|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
23557815|NCT00394355|65769518|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
23557816|NCT00394355|65769519|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
23557817|NCT00394355|65769516|FG000|Overall Study|Subject withdrawal - related to drug|1|||
23557818|NCT00394355|65769517|FG001|Overall Study|Subject withdrawal - related to drug|0|||
23557819|NCT00394355|65769518|FG002|Overall Study|Subject withdrawal - related to drug|0|||
23557820|NCT00394355|65769519|FG003|Overall Study|Subject withdrawal - related to drug|0|||
23557821|NCT00394355|65769516|FG000|Overall Study|Lost to Follow-up|7|||
23147001|NCT00985166|64287380|FG002|Overall Study|Other|1|||
23147002|NCT01136772|64287384|FG000|Overall Study|Adverse Event|15|||
23147003|NCT01136772|64287385|FG001|Overall Study|Adverse Event|14|||
23147004|NCT01136772|64287384|FG000|Overall Study|Lack of Efficacy|42|||
23147005|NCT01136772|64287385|FG001|Overall Study|Lack of Efficacy|39|||
23147006|NCT01136772|64287384|FG000|Overall Study|Administrative|14|||
23557822|NCT00394355|65769517|FG001|Overall Study|Lost to Follow-up|5|||
23557823|NCT00394355|65769518|FG002|Overall Study|Lost to Follow-up|4|||
23557824|NCT00394355|65769519|FG003|Overall Study|Lost to Follow-up|3|||
23557825|NCT00394355|65769516|FG000|Overall Study|Noncompliance with protocol|4|||
23147007|NCT01136772|64287385|FG001|Overall Study|Administrative|12|||
23147008|NCT01136772|64287384|FG000|Overall Study|Withdrawal by Subject|33|||
23147009|NCT01136772|64287385|FG001|Overall Study|Withdrawal by Subject|36|||
23147010|NCT01136772|64287384|FG000|Overall Study|Did not receive injection|10|||
23147011|NCT01136772|64287385|FG001|Overall Study|Did not receive injection|7|||
23147012|NCT01136772|64287384|FG000|Overall Study|Did not follow up after first injection|2|||
23147013|NCT01136772|64287385|FG001|Overall Study|Did not follow up after first injection|2|||
23147014|NCT03681951|64287393|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
23147015|NCT03681951|64287394|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23147016|NCT03681951|64287395|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23436913|NCT02421588|65340846|FG000|Overall Study|Death|11|||
23436914|NCT02421588|65340847|FG001|Overall Study|Death|3|||
23436915|NCT02421588|65340846|FG000|Overall Study|Physician Decision|8|||
23436916|NCT02421588|65340847|FG001|Overall Study|Physician Decision|17|||
23557826|NCT00394355|65769517|FG001|Overall Study|Noncompliance with protocol|3|||
23557827|NCT00394355|65769518|FG002|Overall Study|Noncompliance with protocol|10|||
23557828|NCT00394355|65769519|FG003|Overall Study|Noncompliance with protocol|8|||
23557829|NCT00394355|65769516|FG000|Overall Study|Administrative|0|||
23557830|NCT00394355|65769517|FG001|Overall Study|Administrative|1|||
23557831|NCT00394355|65769518|FG002|Overall Study|Administrative|1|||
23557832|NCT00394355|65769519|FG003|Overall Study|Administrative|1|||
23557833|NCT00394355|65769516|FG000|Overall Study|Lack of Efficacy|0|||
23147017|NCT03681951|64287396|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23147018|NCT03681951|64287397|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23147019|NCT03681951|64287398|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23147020|NCT03681951|64287399|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23147021|NCT03681951|64287400|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
23147022|NCT03681951|64287393|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
23147023|NCT03681951|64287394|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23147024|NCT03681951|64287395|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23147025|NCT03681951|64287396|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23147026|NCT03681951|64287397|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23557834|NCT00394355|65769517|FG001|Overall Study|Lack of Efficacy|0|||
23557835|NCT00394355|65769518|FG002|Overall Study|Lack of Efficacy|2|||
23557836|NCT00394355|65769519|FG003|Overall Study|Lack of Efficacy|3|||
23557837|NCT02548455|65769521|FG000|Overall Study|Withdrawal by Subject|27|||
23557838|NCT02548455|65769521|FG000|Overall Study|Death|26|||
23557839|NCT02548455|65769521|FG000|Overall Study|Lost to Follow-up|14|||
23557840|NCT02548455|65769521|FG000|Overall Study|Visit not completed|173|||
23557841|NCT00508261|65769522|FG000|Overall Study|Other|0|||
23557842|NCT00508261|65769523|FG001|Overall Study|Other|1|||
23557843|NCT00508261|65769524|FG002|Overall Study|Other|1|||
23557844|NCT00508261|65769525|FG003|Overall Study|Other|0|||
23557845|NCT00508261|65769522|FG000|Overall Study|Serious Adverse Event|0|||
23557846|NCT00508261|65769523|FG001|Overall Study|Serious Adverse Event|1|||
23557847|NCT00508261|65769524|FG002|Overall Study|Serious Adverse Event|0|||
23557848|NCT00508261|65769525|FG003|Overall Study|Serious Adverse Event|0|||
23557849|NCT00508261|65769522|FG000|Overall Study|Withdrawal by Subject|3|||
23557850|NCT00508261|65769523|FG001|Overall Study|Withdrawal by Subject|4|||
23557851|NCT00508261|65769524|FG002|Overall Study|Withdrawal by Subject|4|||
23557852|NCT00508261|65769525|FG003|Overall Study|Withdrawal by Subject|0|||
23436917|NCT02421588|65340846|FG000|Overall Study|Other reason not specified|3|||
23557853|NCT00508261|65769522|FG000|Overall Study|Migrated/ moved from study area|0|||
23557854|NCT00508261|65769523|FG001|Overall Study|Migrated/ moved from study area|1|||
23557855|NCT00508261|65769524|FG002|Overall Study|Migrated/ moved from study area|0|||
23147027|NCT03681951|64287398|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23147028|NCT03681951|64287399|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23147029|NCT03681951|64287400|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
23147030|NCT03681951|64287393|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
23147031|NCT03681951|64287394|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23147032|NCT03681951|64287395|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23147033|NCT03681951|64287396|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23147034|NCT03681951|64287397|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23147035|NCT03681951|64287398|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23147036|NCT03681951|64287399|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23147037|NCT03681951|64287400|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
23147038|NCT02313233|64287401|FG000|Overall Study|Withdrawal by Subject|1|||
23147039|NCT02313233|64287402|FG001|Overall Study|Withdrawal by Subject|2|||
23147040|NCT02313233|64287401|FG000|Overall Study|Administrative reason|1|||
23147041|NCT02313233|64287402|FG001|Overall Study|Administrative reason|1|||
23147042|NCT01971203|64287403|FG000|Overall Study|Protocol Violation|3|||
23557856|NCT00508261|65769525|FG003|Overall Study|Migrated/ moved from study area|0|||
23557857|NCT00508261|65769522|FG000|Overall Study|Lost to Follow-up|0|||
23557858|NCT00508261|65769523|FG001|Overall Study|Lost to Follow-up|1|||
23557859|NCT00508261|65769524|FG002|Overall Study|Lost to Follow-up|1|||
23557860|NCT00508261|65769525|FG003|Overall Study|Lost to Follow-up|1|||
23557861|NCT01505387|65769526|FG000|Overall Study|Protocol Violation|1|||
23147043|NCT01971203|64287404|FG001|Overall Study|Protocol Violation|2|||
23147044|NCT01971203|64287403|FG000|Overall Study|Withdrawal by Subject|5|||
23218753|NCT01922739|64541716|FG000|Open-label Treatment Period|Adverse Event|6|||
23436918|NCT02421588|65340847|FG001|Overall Study|Other reason not specified|1|||
23557862|NCT01505387|65769527|FG001|Overall Study|Protocol Violation|0|||
23557863|NCT01505387|65769526|FG000|Overall Study|Withdrawal by Subject|1|||
23557864|NCT01505387|65769527|FG001|Overall Study|Withdrawal by Subject|1|||
23557865|NCT00710606|65769528|FG000|Overall Study|Adverse Event|0|||
23557866|NCT00710606|65769529|FG001|Overall Study|Adverse Event|2|||
23557867|NCT03395405|65769530|FG000|Overall Study|Death|0|||
23557868|NCT03395405|65769531|FG001|Overall Study|Death|2|||
23557869|NCT03395405|65769530|FG000|Overall Study|Lost to Follow-up|0|||
23557870|NCT03395405|65769531|FG001|Overall Study|Lost to Follow-up|1|||
23557871|NCT03395405|65769530|FG000|Overall Study|Protocol Violation|0|||
23557872|NCT03395405|65769531|FG001|Overall Study|Protocol Violation|1|||
23557873|NCT03395405|65769530|FG000|Overall Study|Withdrawal by Subject|3|||
23557874|NCT03395405|65769531|FG001|Overall Study|Withdrawal by Subject|1|||
23557875|NCT03395405|65769530|FG000|Overall Study|COVID-19 Pandemic|1|||
23557876|NCT03395405|65769531|FG001|Overall Study|COVID-19 Pandemic|0|||
23557877|NCT02007434|65769532|FG000|Overall Study|Lost to Follow-up|0|||
23557878|NCT02007434|65769533|FG001|Overall Study|Lost to Follow-up|1|||
23557879|NCT02007434|65769534|FG002|Overall Study|Lost to Follow-up|0|||
23557880|NCT02007434|65769535|FG003|Overall Study|Lost to Follow-up|0|||
23557881|NCT02007434|65769536|FG004|Overall Study|Lost to Follow-up|0|||
23557882|NCT02007434|65769537|FG005|Overall Study|Lost to Follow-up|0|||
23557883|NCT02007434|65769538|FG006|Overall Study|Lost to Follow-up|0|||
23557884|NCT02007434|65769539|FG007|Overall Study|Lost to Follow-up|0|||
23557885|NCT02007434|65769532|FG000|Overall Study|Non-compliance|1|||
23557886|NCT02007434|65769533|FG001|Overall Study|Non-compliance|0|||
23557887|NCT02007434|65769534|FG002|Overall Study|Non-compliance|1|||
23557888|NCT02007434|65769535|FG003|Overall Study|Non-compliance|0|||
23557889|NCT02007434|65769536|FG004|Overall Study|Non-compliance|0|||
23557890|NCT02007434|65769537|FG005|Overall Study|Non-compliance|0|||
23557891|NCT02007434|65769538|FG006|Overall Study|Non-compliance|0|||
23557892|NCT02007434|65769539|FG007|Overall Study|Non-compliance|0|||
23557893|NCT01287611|65769540|FG000|Overall Study|Lost to Follow-up|29|||
23557894|NCT01287611|65769541|FG001|Overall Study|Lost to Follow-up|16|||
23557895|NCT01287611|65769540|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
23557896|NCT01287611|65769541|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
23557897|NCT02857426|65769557|FG000|Overall Study|Disease progression|34|||
23557898|NCT02857426|65769558|FG001|Overall Study|Disease progression|13|||
23147045|NCT01971203|64287404|FG001|Overall Study|Withdrawal by Subject|6|||
23147046|NCT01971203|64287403|FG000|Overall Study|Adverse Event|1|||
23147047|NCT01971203|64287404|FG001|Overall Study|Adverse Event|0|||
23557899|NCT02857426|65769557|FG000|Overall Study|Study drug toxicity|4|||
23557900|NCT02857426|65769558|FG001|Overall Study|Study drug toxicity|1|||
23147048|NCT00634010|64287405|FG000|Overall Study|Adverse Event|2|||
23147049|NCT00634010|64287406|FG001|Overall Study|Adverse Event|5|||
23147050|NCT00634010|64287405|FG000|Overall Study|Withdrawal by Subject|5|||
23147051|NCT00634010|64287406|FG001|Overall Study|Withdrawal by Subject|6|||
23147052|NCT00634010|64287405|FG000|Overall Study|Physician Decision|1|||
23147053|NCT00634010|64287406|FG001|Overall Study|Physician Decision|1|||
23147054|NCT00634010|64287405|FG000|Overall Study|Disease Progression|1|||
23147055|NCT00634010|64287406|FG001|Overall Study|Disease Progression|1|||
23557901|NCT02857426|65769557|FG000|Overall Study|Death|1|||
23147056|NCT00634010|64287405|FG000|Overall Study|Non-Compliant|1|||
23147057|NCT00634010|64287406|FG001|Overall Study|Non-Compliant|1|||
23147058|NCT02147353|64287409|FG000|Overall Study|Lost to Follow-up|2|||
23147059|NCT02147353|64287410|FG001|Overall Study|Lost to Follow-up|0|||
23147060|NCT02147353|64287409|FG000|Overall Study|unable to make visits|4|||
23147061|NCT02147353|64287410|FG001|Overall Study|unable to make visits|0|||
23147062|NCT02147353|64287409|FG000|Overall Study|medication noncompliance|3|||
23147063|NCT02147353|64287410|FG001|Overall Study|medication noncompliance|0|||
23147064|NCT00440700|64287411|FG000|Overall Study|Withdrawal by Subject|8|||
23147065|NCT00440700|64287412|FG001|Overall Study|Withdrawal by Subject|8|||
23147066|NCT00440700|64287413|FG002|Overall Study|Withdrawal by Subject|4|||
23147067|NCT01111474|64287414|FG000|Overall Study|Lost to Follow-up|12|||
23147068|NCT02370043|64287417|FG000|Overall Study|Withdrawal by Subject|0|||
23147069|NCT02370043|64287418|FG001|Overall Study|Withdrawal by Subject|0|||
23147070|NCT02370043|64287419|FG002|Overall Study|Withdrawal by Subject|0|||
23147071|NCT02370043|64287420|FG003|Overall Study|Withdrawal by Subject|0|||
23147072|NCT02370043|64287421|FG004|Overall Study|Withdrawal by Subject|1|||
23557902|NCT02857426|65769558|FG001|Overall Study|Death|0|||
23147073|NCT02370043|64287422|FG005|Overall Study|Withdrawal by Subject|1|||
23147074|NCT00688181|64287429|FG000|Overall Study|Lost to Follow-up|17|||
23147075|NCT00688181|64287429|FG000|Overall Study|Unknown Reason|4|||
23147076|NCT00688181|64287429|FG000|Overall Study|Non-clinical Reason|2|||
23147077|NCT00104676|64287430|FG000|Overall Study|Death|3|||
23147078|NCT00104676|64287431|FG001|Overall Study|Death|2|||
23147079|NCT00104676|64287430|FG000|Overall Study|Withdrawal by Subject|0|||
23557903|NCT02857426|65769557|FG000|Overall Study|Adverse event unrelated to study drug|6|||
23557904|NCT02857426|65769558|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23557905|NCT02857426|65769557|FG000|Overall Study|Participant withdrew consent|1|||
23557906|NCT02857426|65769558|FG001|Overall Study|Participant withdrew consent|1|||
23557907|NCT02857426|65769557|FG000|Overall Study|Maximum clinical benefit|1|||
23557908|NCT02857426|65769558|FG001|Overall Study|Maximum clinical benefit|0|||
23557909|NCT02857426|65769557|FG000|Overall Study|Completed treatment|0|||
23557910|NCT02857426|65769558|FG001|Overall Study|Completed treatment|2|||
23557911|NCT02719990|65769559|FG000|Overall Study|Physician Decision|2|||
23557912|NCT02719990|65769559|FG000|Overall Study|Withdrawal by Subject|2|||
23557913|NCT02719990|65769559|FG000|Overall Study|Study Terminated By Sponsor|32|||
23557914|NCT02740049|65769560|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
23557915|NCT01060553|65769561|FG000|Overall Study|Lost to Follow-up|3|||
23557916|NCT01060553|65769562|FG001|Overall Study|Lost to Follow-up|5|||
23557917|NCT01060553|65769561|FG000|Overall Study|Withdrawal by Subject|5|||
23557918|NCT01060553|65769562|FG001|Overall Study|Withdrawal by Subject|5|||
23557919|NCT01060553|65769561|FG000|Overall Study|Lack of Efficacy|1|||
23557920|NCT01060553|65769562|FG001|Overall Study|Lack of Efficacy|0|||
23557921|NCT01078155|65769563|FG000|Overall Study|Adverse Event|7|||
23557922|NCT01078155|65769563|FG000|Overall Study|Lack of Efficacy|16|||
23557923|NCT01078155|65769563|FG000|Overall Study|Participant's Decision|6|||
23557924|NCT01078155|65769563|FG000|Overall Study|Lost to Follow-up|15|||
23557925|NCT00441090|65769564|FG000|Overall Study|Adverse Event|0|||
23557926|NCT00441090|65769565|FG001|Overall Study|Adverse Event|1|||
23557927|NCT00441090|65769566|FG002|Overall Study|Adverse Event|1|||
23557928|NCT00441090|65769567|FG003|Overall Study|Adverse Event|0|||
23557929|NCT00441090|65769568|FG004|Overall Study|Adverse Event|0|||
23557930|NCT00441090|65769564|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
23557931|NCT00441090|65769565|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
23557932|NCT00441090|65769566|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
23557933|NCT00441090|65769567|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
23557934|NCT00441090|65769568|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
23557935|NCT00441090|65769564|FG000|Overall Study|Withdrawal by Subject|1|||
23557936|NCT00441090|65769565|FG001|Overall Study|Withdrawal by Subject|0|||
23557937|NCT00441090|65769566|FG002|Overall Study|Withdrawal by Subject|1|||
23557938|NCT00441090|65769567|FG003|Overall Study|Withdrawal by Subject|0|||
23557939|NCT00441090|65769568|FG004|Overall Study|Withdrawal by Subject|0|||
23557940|NCT00441090|65769564|FG000|Overall Study|Lack of Efficacy|1|||
23557941|NCT00441090|65769565|FG001|Overall Study|Lack of Efficacy|0|||
23557942|NCT00441090|65769566|FG002|Overall Study|Lack of Efficacy|0|||
23557943|NCT00441090|65769567|FG003|Overall Study|Lack of Efficacy|0|||
23147080|NCT00104676|64287431|FG001|Overall Study|Withdrawal by Subject|2|||
23147081|NCT00104676|64287430|FG000|Overall Study|treatment interruption|4|||
23147082|NCT00104676|64287431|FG001|Overall Study|treatment interruption|10|||
23147083|NCT01259726|64287432|FG000|Overall Study|Death|1|||
23147084|NCT01259726|64287433|FG001|Overall Study|Death|0|||
23147085|NCT01259726|64287434|FG002|Overall Study|Death|0|||
23147086|NCT01259726|64287435|FG003|Overall Study|Death|0|||
23147087|NCT01259726|64287432|FG000|Overall Study|Physician Decision|2|||
23147088|NCT01259726|64287433|FG001|Overall Study|Physician Decision|0|||
23147089|NCT01259726|64287434|FG002|Overall Study|Physician Decision|1|||
23147090|NCT01259726|64287435|FG003|Overall Study|Physician Decision|1|||
23147091|NCT01259726|64287432|FG000|Overall Study|Withdrawal by Subject|1|||
23147092|NCT01259726|64287433|FG001|Overall Study|Withdrawal by Subject|3|||
23147093|NCT01259726|64287434|FG002|Overall Study|Withdrawal by Subject|2|||
23147094|NCT01259726|64287435|FG003|Overall Study|Withdrawal by Subject|1|||
23147095|NCT01259726|64287432|FG000|Overall Study|Lost to Follow-up|1|||
23147096|NCT01259726|64287433|FG001|Overall Study|Lost to Follow-up|1|||
23147097|NCT01259726|64287434|FG002|Overall Study|Lost to Follow-up|1|||
23147098|NCT01259726|64287435|FG003|Overall Study|Lost to Follow-up|3|||
23147099|NCT00607022|64287438|FG000|Overall Study|Withdrawal by Subject|1|||
23147100|NCT00607022|64287439|FG001|Overall Study|Withdrawal by Subject|0|||
23147101|NCT00607022|64287440|FG002|Overall Study|Withdrawal by Subject|0|||
23147102|NCT00876694|64287441|FG000|Overall Study|Adverse Event|10|||
23147103|NCT00876694|64287442|FG001|Overall Study|Adverse Event|7|||
23147104|NCT00876694|64287441|FG000|Overall Study|Subject withdrew consent|6|||
23147105|NCT00876694|64287442|FG001|Overall Study|Subject withdrew consent|4|||
23147106|NCT00876694|64287441|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23147107|NCT00876694|64287442|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23557944|NCT00441090|65769568|FG004|Overall Study|Lack of Efficacy|0|||
23557945|NCT02347657|65769569|FG000|Overall Study|Physician Decision|0|||
23557946|NCT02347657|65769570|FG001|Overall Study|Physician Decision|1|||
23557947|NCT02347657|65769569|FG000|Overall Study|Adverse Event|8|||
23557948|NCT02347657|65769570|FG001|Overall Study|Adverse Event|4|||
23557949|NCT02347657|65769569|FG000|Overall Study|Withdrawal by Subject|6|||
23557950|NCT02347657|65769570|FG001|Overall Study|Withdrawal by Subject|7|||
23147108|NCT00876694|64287441|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23147109|NCT00876694|64287442|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23147110|NCT00876694|64287441|FG000|Overall Study|Administrative problems|1|||
23147111|NCT00876694|64287442|FG001|Overall Study|Administrative problems|1|||
23147112|NCT00876694|64287441|FG000|Overall Study|Death|1|||
23147113|NCT00876694|64287442|FG001|Overall Study|Death|0|||
23557951|NCT02347657|65769569|FG000|Overall Study|Randomized but not treated|1|||
23557952|NCT02347657|65769570|FG001|Overall Study|Randomized but not treated|0|||
23557953|NCT02347657|65769569|FG000|Overall Study|Other|3|||
23557954|NCT02347657|65769570|FG001|Overall Study|Other|3|||
23557955|NCT00404495|65769571|FG000|Overall Study|Death|37|||
23557956|NCT00404495|65769572|FG001|Overall Study|Death|11|||
23557957|NCT00404495|65769571|FG000|Overall Study|Lost to Follow-up|5|||
23557958|NCT00404495|65769572|FG001|Overall Study|Lost to Follow-up|0|||
23557959|NCT00404495|65769571|FG000|Overall Study|Other|1|||
23557960|NCT00404495|65769572|FG001|Overall Study|Other|0|||
23557961|NCT00404495|65769571|FG000|Overall Study|Withdrawal by Subject|1|||
23147114|NCT01498653|64287443|FG000|Overall Study|Adverse Event|2|||
23147115|NCT01498653|64287444|FG001|Overall Study|Adverse Event|2|||
23147116|NCT01498653|64287443|FG000|Overall Study|Lack of Efficacy|12|||
23147117|NCT01498653|64287444|FG001|Overall Study|Lack of Efficacy|26|||
23557962|NCT00404495|65769572|FG001|Overall Study|Withdrawal by Subject|0|||
23557963|NCT00725452|65769575|FG000|Overall Study|Adverse Event|3|||
23147118|NCT01498653|64287443|FG000|Overall Study|Protocol Violation|0|||
23147119|NCT01498653|64287444|FG001|Overall Study|Protocol Violation|4|||
23147120|NCT01498653|64287443|FG000|Overall Study|Lost to Follow-up|1|||
23147121|NCT01498653|64287444|FG001|Overall Study|Lost to Follow-up|0|||
23147122|NCT01498653|64287443|FG000|Overall Study|Physician Decision|2|||
23147123|NCT01498653|64287444|FG001|Overall Study|Physician Decision|0|||
23147124|NCT01498653|64287443|FG000|Overall Study|Withdrawal by Subject|2|||
23147125|NCT01498653|64287444|FG001|Overall Study|Withdrawal by Subject|3|||
23147126|NCT01142596|64287445|FG000|Overall Study|Withdrawal by Subject|9|||
23147127|NCT01142596|64287446|FG001|Overall Study|Withdrawal by Subject|35|||
23147128|NCT01142596|64287445|FG000|Overall Study|Adverse Event|8|||
23147129|NCT01142596|64287446|FG001|Overall Study|Adverse Event|35|||
23147130|NCT01142596|64287445|FG000|Overall Study|Lack of Efficacy|5|||
23147131|NCT01142596|64287446|FG001|Overall Study|Lack of Efficacy|9|||
23147132|NCT01142596|64287445|FG000|Overall Study|Lost to Follow-up|2|||
23147133|NCT01142596|64287446|FG001|Overall Study|Lost to Follow-up|3|||
23147134|NCT01142596|64287445|FG000|Overall Study|Other reason (not specified)|5|||
23147135|NCT01142596|64287446|FG001|Overall Study|Other reason (not specified)|4|||
23147136|NCT00091169|64287447|FG000|Overall Study|Disease progression|3|||
23147137|NCT00091169|64287448|FG001|Overall Study|Disease progression|1|||
23147138|NCT00091169|64287447|FG000|Overall Study|Adverse Event|11|||
23147139|NCT00091169|64287448|FG001|Overall Study|Adverse Event|17|||
23147140|NCT00091169|64287447|FG000|Overall Study|Death|4|||
23147141|NCT00091169|64287448|FG001|Overall Study|Death|1|||
23147142|NCT00091169|64287447|FG000|Overall Study|Withdrawal by Subject|10|||
23147143|NCT00091169|64287448|FG001|Overall Study|Withdrawal by Subject|13|||
23147144|NCT00091169|64287447|FG000|Overall Study|Other|3|||
23147145|NCT00091169|64287448|FG001|Overall Study|Other|4|||
23147146|NCT00091169|64287447|FG000|Overall Study|Not start protocol therapy|26|||
23147147|NCT00091169|64287448|FG001|Overall Study|Not start protocol therapy|17|||
23147148|NCT01906346|64287449|FG000|Overall Study|AEs|1|||
23147149|NCT01620255|64287454|FG000|Overall Study|Withdrawal by Subject|4|||
23147150|NCT01620255|64287455|FG001|Overall Study|Withdrawal by Subject|1|||
23147151|NCT01620255|64287456|FG002|Overall Study|Withdrawal by Subject|1|||
23147152|NCT01620255|64287457|FG003|Overall Study|Withdrawal by Subject|2|||
23147153|NCT01620255|64287458|FG004|Overall Study|Withdrawal by Subject|4|||
23147154|NCT01620255|64287454|FG000|Overall Study|Participant underwent fecal transplant|0|||
23147155|NCT01620255|64287455|FG001|Overall Study|Participant underwent fecal transplant|0|||
23147156|NCT01620255|64287456|FG002|Overall Study|Participant underwent fecal transplant|1|||
23147157|NCT01620255|64287457|FG003|Overall Study|Participant underwent fecal transplant|0|||
23147158|NCT01620255|64287458|FG004|Overall Study|Participant underwent fecal transplant|0|||
23557964|NCT00725452|65769575|FG000|Overall Study|Lack of Efficacy|2|||
23557965|NCT00725452|65769575|FG000|Overall Study|Reason not specified|1|||
23557966|NCT00725452|65769575|FG000|Overall Study|Physician Decision|1|||
23557967|NCT00725452|65769575|FG000|Overall Study|Withdrawal by Subject|3|||
23557968|NCT00725452|65769575|FG000|Overall Study|Lost to Follow-up|1|||
23557969|NCT01323530|65769577|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
23557970|NCT01323530|65769578|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23557971|NCT01323530|65769579|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23147159|NCT01620255|64287454|FG000|Overall Study|Non-compliance|0|||
23147160|NCT01620255|64287455|FG001|Overall Study|Non-compliance|1|||
23147161|NCT01620255|64287456|FG002|Overall Study|Non-compliance|0|||
23147162|NCT01620255|64287457|FG003|Overall Study|Non-compliance|0|||
23147163|NCT01620255|64287458|FG004|Overall Study|Non-compliance|0|||
23147164|NCT01620255|64287454|FG000|Overall Study|Adverse Event|0|||
23147165|NCT01620255|64287455|FG001|Overall Study|Adverse Event|4|||
23147166|NCT01620255|64287456|FG002|Overall Study|Adverse Event|0|||
23147167|NCT01620255|64287457|FG003|Overall Study|Adverse Event|1|||
23147168|NCT01620255|64287458|FG004|Overall Study|Adverse Event|1|||
23147169|NCT01620255|64287454|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
23147170|NCT01620255|64287455|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
23557972|NCT01323530|65769580|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23322536|NCT00866359|64923029|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
23557973|NCT01323530|65769581|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23557974|NCT01323530|65769582|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
23557975|NCT01323530|65769583|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23557976|NCT01323530|65769577|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
23557977|NCT01323530|65769578|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
23557978|NCT01323530|65769579|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
23557979|NCT01323530|65769580|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23147171|NCT01620255|64287456|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
23147172|NCT01620255|64287457|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
23147173|NCT01620255|64287458|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
23147174|NCT00718640|64287468|FG000|Overall Study|Adverse Event|4|||
23147175|NCT00718640|64287468|FG000|Overall Study|Death|1|||
23147176|NCT00718640|64287468|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
23147177|NCT00447382|64287469|FG000|Overall Study|Adverse Event|1|||
23557980|NCT01323530|65769581|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
23147178|NCT00447382|64287470|FG001|Overall Study|Adverse Event|1|||
23147179|NCT00447382|64287469|FG000|Overall Study|Lack of Efficacy|1|||
23147180|NCT00447382|64287470|FG001|Overall Study|Lack of Efficacy|0|||
23147181|NCT00447382|64287469|FG000|Overall Study|Protocol Violation|2|||
23147182|NCT00447382|64287470|FG001|Overall Study|Protocol Violation|0|||
23147183|NCT00447382|64287469|FG000|Overall Study|Unclassified|2|||
23147184|NCT00447382|64287470|FG001|Overall Study|Unclassified|5|||
23147185|NCT00639223|64287471|FG000|Overall Study|Lost to Follow-up|0|||
23147186|NCT00639223|64287472|FG001|Overall Study|Lost to Follow-up|2|||
23147187|NCT03019185|64287476|FG000|Overall Study|Lost to Follow-up|3|||
23147188|NCT03019185|64287477|FG001|Overall Study|Lost to Follow-up|0|||
23147189|NCT03019185|64287478|FG002|Overall Study|Lost to Follow-up|2|||
23147190|NCT03019185|64287476|FG000|Overall Study|Withdrawal by Subject|1|||
23147191|NCT03019185|64287477|FG001|Overall Study|Withdrawal by Subject|1|||
23147192|NCT03019185|64287478|FG002|Overall Study|Withdrawal by Subject|0|||
23147193|NCT03019185|64287476|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
23147194|NCT03019185|64287477|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
23147195|NCT03019185|64287478|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
23147196|NCT03019185|64287476|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
23147197|NCT03019185|64287477|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
23147198|NCT03019185|64287478|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
23147199|NCT01029652|64287481|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
23147200|NCT01029652|64287482|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
23147201|NCT01029652|64287481|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
23147202|NCT01029652|64287482|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
23147203|NCT01029652|64287481|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
23147204|NCT01029652|64287482|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
23147205|NCT01029652|64287481|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
23147206|NCT01029652|64287482|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
23147207|NCT01029652|64287481|FG000|Core Study (0-12 Weeks)|Death|0|||
23147208|NCT01029652|64287482|FG001|Core Study (0-12 Weeks)|Death|1|||
23147209|NCT01029652|64287481|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
23147210|NCT01029652|64287482|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
23147211|NCT01029652|64287481|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
23147212|NCT01029652|64287482|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
23147213|NCT01029652|64287481|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
23147214|NCT01029652|64287482|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
23147215|NCT01029652|64287481|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
23147216|NCT01029652|64287482|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
23147217|NCT01029652|64287481|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
23147218|NCT01029652|64287482|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
23147219|NCT01029652|64287481|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
23147220|NCT01029652|64287482|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
23147221|NCT01029652|64287481|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
23147222|NCT01029652|64287482|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
23147223|NCT04508023|64287490|FG000|Overall Study|Withdrawal by Subject|1|||
23147224|NCT04508023|64287491|FG001|Overall Study|Withdrawal by Subject|2|||
23147225|NCT03610165|64287495|FG000|Overall Study|Device didn't work|0|||
23322537|NCT00866359|64923030|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
23557981|NCT01323530|65769582|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23147226|NCT03610165|64287496|FG001|Overall Study|Device didn't work|1|||
23175845|NCT04640766|64386590|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
23175846|NCT01506882|64386591|FG000|Overall Study|Lack of Efficacy|4|||
23175847|NCT01506882|64386592|FG001|Overall Study|Lack of Efficacy|3|||
23175848|NCT01506882|64386591|FG000|Overall Study|Lost to Follow-up|1|||
23436919|NCT02421588|65340846|FG000|Overall Study|Symptomatic deterioration|13|||
23147227|NCT01020448|64290815|FG000|Pre-assignment|Adverse Event|6|||
23147228|NCT01020448|64290815|FG000|Pre-assignment|Withdrawal by Subject|5|||
23147229|NCT01020448|64290815|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
23557982|NCT01323530|65769583|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23557983|NCT01323530|65769577|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
23557984|NCT01323530|65769578|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
23557985|NCT01323530|65769579|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
23557986|NCT01323530|65769580|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
23557987|NCT01323530|65769581|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
23557988|NCT01323530|65769582|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
23557989|NCT01323530|65769583|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
23557990|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557991|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557992|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557993|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557994|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557995|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
23557996|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
23557997|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23557998|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23557999|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23558000|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23558001|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23558002|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
23558003|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
23558004|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558005|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558006|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558007|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558008|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558009|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
23558010|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
23558011|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558012|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558013|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558014|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558015|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558016|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
23558017|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
23558018|NCT01323530|65769577|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23147230|NCT01020448|64290815|FG000|Treatment|Adverse Event|11|||
23147231|NCT01020448|64290815|FG000|Treatment|Consent Withdrawn|3|||
23147232|NCT01020448|64290815|FG000|Treatment|Disease Progression|2|||
23147233|NCT01020448|64290815|FG000|Treatment|Lack of Efficacy|8|||
23147234|NCT01020448|64290815|FG000|Treatment|Lost to Follow-up|2|||
23147235|NCT02054325|64290816|FG000|Overall Study|Lost to Follow-up|8|||
23147236|NCT02054325|64290817|FG001|Overall Study|Lost to Follow-up|5|||
23147237|NCT01016964|64290818|FG000|Overall Study|Lost to Follow-up|3|||
23147238|NCT01016964|64290819|FG001|Overall Study|Lost to Follow-up|3|||
23147239|NCT01215175|64290820|FG000|Overall Study|Lost to Follow-up|0|||
23147240|NCT01215175|64290821|FG001|Overall Study|Lost to Follow-up|1|||
23147241|NCT01215175|64290822|FG002|Overall Study|Lost to Follow-up|0|||
23147242|NCT01215175|64290823|FG003|Overall Study|Lost to Follow-up|1|||
23147243|NCT01215175|64290824|FG004|Overall Study|Lost to Follow-up|0|||
23147244|NCT05208866|64290825|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
23147245|NCT01557283|64290834|FG000|Overall Study|Lost to Follow-up|7|||
23147246|NCT01557283|64290834|FG000|Overall Study|Non-responder|19|||
23147247|NCT01557283|64290834|FG000|Overall Study|Adverse Event|7|||
23147248|NCT01557283|64290834|FG000|Overall Study|Lack of Efficacy|1|||
23147249|NCT01557283|64290834|FG000|Overall Study|Non-compliance|1|||
23147250|NCT01557283|64290834|FG000|Overall Study|Withdrawal by Subject|1|||
23147251|NCT01557283|64290834|FG000|Overall Study|Participant's weight too high for dose|1|||
23147252|NCT01557283|64290834|FG000|Overall Study|Worsening of psoriasis|1|||
23147253|NCT01557283|64290834|FG000|Overall Study|Other|6|||
23147254|NCT03645057|64290837|FG000|Randomization to Baseline|Lost to Follow-up|1|||
23147255|NCT03645057|64290838|FG001|Randomization to Baseline|Lost to Follow-up|0|||
23147256|NCT03645057|64290839|FG002|Randomization to Baseline|Lost to Follow-up|1|||
23147257|NCT03645057|64290840|FG003|Randomization to Baseline|Lost to Follow-up|0|||
23147258|NCT03645057|64290837|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
23175849|NCT01506882|64386592|FG001|Overall Study|Lost to Follow-up|0|||
23558019|NCT01323530|65769578|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558020|NCT01323530|65769579|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558021|NCT01323530|65769580|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558022|NCT01323530|65769581|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558023|NCT01323530|65769582|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
23558024|NCT01323530|65769583|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
23147259|NCT03645057|64290838|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
23147260|NCT03645057|64290839|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
23558025|NCT04274894|65769584|FG000|Overall Study|Adverse Event|7|||
23558026|NCT04274894|65769584|FG000|Overall Study|Withdrew consent|5|||
23558027|NCT04274894|65769584|FG000|Overall Study|Lost to Follow-up|9|||
23558028|NCT04274894|65769584|FG000|Overall Study|COVID-19 infection|1|||
23558029|NCT04274894|65769584|FG000|Overall Study|Other, not specified|20|||
23558030|NCT01065350|65769591|FG000|Overall Study|Received incorrect drug allocation|0|||
23558031|NCT01065350|65769592|FG001|Overall Study|Received incorrect drug allocation|1|||
23558032|NCT01735201|65769593|FG000|Overall Study|Adverse Event|1|||
23558033|NCT01735201|65769594|FG001|Overall Study|Adverse Event|1|||
23558034|NCT01735201|65769595|FG002|Overall Study|Adverse Event|0|||
23558035|NCT01735201|65769596|FG003|Overall Study|Adverse Event|1|||
23147261|NCT03645057|64290840|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
23147262|NCT03645057|64290837|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
23147263|NCT03645057|64290838|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
23147264|NCT03645057|64290839|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
23147265|NCT03645057|64290840|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
23147266|NCT03645057|64290837|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
23147267|NCT03645057|64290838|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
23147268|NCT03645057|64290839|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
23147269|NCT03645057|64290840|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
23147270|NCT01072877|64290841|FG000|Overall Study|Lost to Follow-up|1|||
23147271|NCT01072877|64290842|FG001|Overall Study|Lost to Follow-up|1|||
23147272|NCT01072877|64290843|FG002|Overall Study|Lost to Follow-up|0|||
23147273|NCT01072877|64290844|FG003|Overall Study|Lost to Follow-up|2|||
23147274|NCT01072877|64290845|FG004|Overall Study|Lost to Follow-up|0|||
23147275|NCT02901041|64290848|FG000|Overall Study|Withdrawal by PI|4|||
23147276|NCT02901041|64290849|FG001|Overall Study|Withdrawal by PI|8|||
23147277|NCT02901041|64290848|FG000|Overall Study|Withdrawal by Subject|7|||
23147278|NCT02901041|64290849|FG001|Overall Study|Withdrawal by Subject|3|||
23147279|NCT00876928|64290850|FG000|Overall Study|Lost to Follow-up|2|||
23147280|NCT00876928|64290851|FG001|Overall Study|Lost to Follow-up|5|||
23147281|NCT00876928|64290850|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
23147282|NCT00876928|64290851|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
23147283|NCT02308020|64290854|FG000|Overall Study|Lost to Follow-up|1|||
23147284|NCT02308020|64290855|FG001|Overall Study|Lost to Follow-up|7|||
23147285|NCT02308020|64290856|FG002|Overall Study|Lost to Follow-up|0|||
23147286|NCT02308020|64290857|FG003|Overall Study|Lost to Follow-up|0|||
23147287|NCT02308020|64290858|FG004|Overall Study|Lost to Follow-up|1|||
23147288|NCT02308020|64290859|FG005|Overall Study|Lost to Follow-up|2|||
23147289|NCT02308020|64290854|FG000|Overall Study|Sponsor Decision|0|||
23147290|NCT02308020|64290855|FG001|Overall Study|Sponsor Decision|8|||
23147291|NCT02308020|64290856|FG002|Overall Study|Sponsor Decision|0|||
23147292|NCT02308020|64290857|FG003|Overall Study|Sponsor Decision|2|||
23147293|NCT02308020|64290858|FG004|Overall Study|Sponsor Decision|2|||
23147294|NCT02308020|64290859|FG005|Overall Study|Sponsor Decision|1|||
23558036|NCT01735201|65769597|FG004|Overall Study|Adverse Event|1|||
23558037|NCT01735201|65769598|FG005|Overall Study|Adverse Event|3|||
23558038|NCT01735201|65769599|FG006|Overall Study|Adverse Event|2|||
23558039|NCT01735201|65769600|FG007|Overall Study|Adverse Event|1|||
23558040|NCT01735201|65769593|FG000|Overall Study|Personal Reasons|1|||
23558041|NCT01735201|65769594|FG001|Overall Study|Personal Reasons|0|||
23558042|NCT01735201|65769595|FG002|Overall Study|Personal Reasons|0|||
23558043|NCT01735201|65769596|FG003|Overall Study|Personal Reasons|0|||
23558044|NCT01735201|65769597|FG004|Overall Study|Personal Reasons|0|||
23558045|NCT01735201|65769598|FG005|Overall Study|Personal Reasons|0|||
23558046|NCT01735201|65769599|FG006|Overall Study|Personal Reasons|0|||
23558047|NCT01735201|65769600|FG007|Overall Study|Personal Reasons|0|||
23322538|NCT01127256|64923031|FG000|Overall Study|Adverse Event|13|||
23558048|NCT01735201|65769593|FG000|Overall Study|Protocol Violation|1|||
23558049|NCT01735201|65769594|FG001|Overall Study|Protocol Violation|0|||
23147295|NCT02308020|64290854|FG000|Overall Study|Withdrawal by Subject|3|||
23147296|NCT02308020|64290855|FG001|Overall Study|Withdrawal by Subject|5|||
23147297|NCT02308020|64290856|FG002|Overall Study|Withdrawal by Subject|3|||
23147298|NCT02308020|64290857|FG003|Overall Study|Withdrawal by Subject|2|||
23558050|NCT01735201|65769595|FG002|Overall Study|Protocol Violation|0|||
23558051|NCT01735201|65769596|FG003|Overall Study|Protocol Violation|0|||
23558052|NCT01735201|65769597|FG004|Overall Study|Protocol Violation|0|||
23147299|NCT02308020|64290858|FG004|Overall Study|Withdrawal by Subject|1|||
23147300|NCT02308020|64290859|FG005|Overall Study|Withdrawal by Subject|2|||
23436920|NCT02421588|65340847|FG001|Overall Study|Symptomatic deterioration|19|||
23436921|NCT02421588|65340846|FG000|Overall Study|Treatment-related AE|10|||
23436922|NCT02421588|65340847|FG001|Overall Study|Treatment-related AE|14|||
23436923|NCT02421588|65340846|FG000|Overall Study|Withdrawal by Subject|14|||
23436924|NCT02421588|65340847|FG001|Overall Study|Withdrawal by Subject|16|||
23436925|NCT02421588|65340846|FG000|Overall Study|Not treated|2|||
23436926|NCT02421588|65340847|FG001|Overall Study|Not treated|8|||
23436927|NCT02725866|65340848|FG000|Overall Study|Failure to return|6|||
23436928|NCT02725866|65340848|FG000|Overall Study|Withdrew consent|3|||
23436929|NCT02725866|65340848|FG000|Overall Study|Insufficient virological response|1|||
23436930|NCT02725866|65340848|FG000|Overall Study|Other, not specified|4|||
23436931|NCT01123707|65340849|FG000|Overall Study|Lost to Follow-up|3|||
23436932|NCT01123707|65340850|FG001|Overall Study|Lost to Follow-up|1|||
23436933|NCT01123707|65340851|FG002|Overall Study|Lost to Follow-up|3|||
23436934|NCT01123707|65340852|FG003|Overall Study|Lost to Follow-up|2|||
23436935|NCT01123707|65340849|FG000|Overall Study|Adverse Event|5|||
23436936|NCT01123707|65340850|FG001|Overall Study|Adverse Event|7|||
23436937|NCT01123707|65340851|FG002|Overall Study|Adverse Event|5|||
23436938|NCT01123707|65340852|FG003|Overall Study|Adverse Event|3|||
23436939|NCT01123707|65340849|FG000|Overall Study|Sponsor Discontinued Study|30|||
23436940|NCT01123707|65340850|FG001|Overall Study|Sponsor Discontinued Study|24|||
23436941|NCT01123707|65340851|FG002|Overall Study|Sponsor Discontinued Study|25|||
23436942|NCT01123707|65340852|FG003|Overall Study|Sponsor Discontinued Study|40|||
23436943|NCT01123707|65340849|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
23436944|NCT01123707|65340850|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
23436945|NCT01123707|65340851|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
23436946|NCT01123707|65340852|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
23436947|NCT01123707|65340849|FG000|Overall Study|Investigator Withdrew Participant|0|||
23436948|NCT01123707|65340850|FG001|Overall Study|Investigator Withdrew Participant|1|||
23436949|NCT01123707|65340851|FG002|Overall Study|Investigator Withdrew Participant|1|||
23436950|NCT01123707|65340852|FG003|Overall Study|Investigator Withdrew Participant|1|||
23436951|NCT01123707|65340849|FG000|Overall Study|Subject Withdrew Consent|4|||
23436952|NCT01123707|65340850|FG001|Overall Study|Subject Withdrew Consent|5|||
23436953|NCT01123707|65340851|FG002|Overall Study|Subject Withdrew Consent|1|||
23436954|NCT01123707|65340852|FG003|Overall Study|Subject Withdrew Consent|2|||
23436955|NCT01123707|65340849|FG000|Overall Study|Lack of Efficacy|1|||
23436956|NCT01123707|65340850|FG001|Overall Study|Lack of Efficacy|2|||
23436957|NCT01123707|65340851|FG002|Overall Study|Lack of Efficacy|1|||
23436958|NCT01123707|65340852|FG003|Overall Study|Lack of Efficacy|0|||
23436959|NCT01123707|65340849|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
23436960|NCT01123707|65340850|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
23436961|NCT01123707|65340851|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
23436962|NCT01123707|65340852|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
23436963|NCT04058886|65340853|FG000|Overall Study|Withdrawal by Subject|4|||
23436964|NCT04058886|65340853|FG000|Overall Study|Inadequate deafness interpreter service|1|||
23436965|NCT03194438|65340856|FG000|Overall Study|Withdrawal by Subject|2|||
23436966|NCT03722524|65340857|FG000|Overall Study|Protocol Violation|86|||
23436967|NCT03722524|65340857|FG000|Overall Study|Adverse Event|7|||
23436968|NCT03722524|65340857|FG000|Overall Study|Lost to Follow-up|1|||
23436969|NCT03722524|65340857|FG000|Overall Study|Reason is not stated|1|||
23436970|NCT03722524|65340857|FG000|Overall Study|Physician Decision|1|||
23436971|NCT03722524|65340857|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
23436972|NCT05320393|65340864|FG000|Overall Study|Withdrawal by Subject|1|||
23436973|NCT05320393|65340865|FG001|Overall Study|Withdrawal by Subject|0|||
23436974|NCT05320393|65340866|FG002|Overall Study|Withdrawal by Subject|2|||
23436975|NCT05320393|65340864|FG000|Overall Study|Lost to Follow-up|1|||
23436976|NCT05320393|65340865|FG001|Overall Study|Lost to Follow-up|2|||
23436977|NCT05320393|65340866|FG002|Overall Study|Lost to Follow-up|1|||
23436978|NCT05320393|65340864|FG000|Overall Study|Moved; too much driving|0|||
23436979|NCT05320393|65340865|FG001|Overall Study|Moved; too much driving|0|||
23436980|NCT05320393|65340866|FG002|Overall Study|Moved; too much driving|2|||
23436981|NCT05320393|65340864|FG000|Overall Study|Did not receive treatment|0|||
23436982|NCT05320393|65340865|FG001|Overall Study|Did not receive treatment|0|||
23436983|NCT05320393|65340866|FG002|Overall Study|Did not receive treatment|1|||
23436984|NCT02332291|65340867|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
23436985|NCT02332291|65340868|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
23436986|NCT02332291|65340867|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
23436987|NCT02332291|65340868|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
23436988|NCT02332291|65340867|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
23436989|NCT02332291|65340868|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
23623833|NCT01427738|66008586|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
23623834|NCT01427738|66008585|FG000|Overall Study|Lost to Follow-up|1|||
23436990|NCT02332291|65340867|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
23218754|NCT01922739|64541716|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
23147301|NCT00402597|64290860|FG000|Overall Study|Death|15|||
23147302|NCT00402597|64290861|FG001|Overall Study|Death|7|||
23147303|NCT00402597|64290862|FG002|Overall Study|Death|6|||
23147304|NCT00402597|64290863|FG003|Overall Study|Death|4|||
23147305|NCT00402597|64290864|FG004|Overall Study|Death|6|||
23147306|NCT00402597|64290860|FG000|Overall Study|Adverse Event|81|||
23147307|NCT00402597|64290861|FG001|Overall Study|Adverse Event|18|||
23147308|NCT00402597|64290862|FG002|Overall Study|Adverse Event|106|||
23147309|NCT00402597|64290863|FG003|Overall Study|Adverse Event|39|||
23147310|NCT00402597|64290864|FG004|Overall Study|Adverse Event|71|||
23147311|NCT00402597|64290860|FG000|Overall Study|Lost to Follow-up|8|||
23147312|NCT00402597|64290861|FG001|Overall Study|Lost to Follow-up|1|||
23147313|NCT00402597|64290862|FG002|Overall Study|Lost to Follow-up|8|||
23147314|NCT00402597|64290863|FG003|Overall Study|Lost to Follow-up|2|||
23147315|NCT00402597|64290864|FG004|Overall Study|Lost to Follow-up|3|||
23147316|NCT00402597|64290860|FG000|Overall Study|Withdrawal by Subject|57|||
23147317|NCT00402597|64290861|FG001|Overall Study|Withdrawal by Subject|16|||
23558053|NCT01735201|65769598|FG005|Overall Study|Protocol Violation|0|||
23558054|NCT01735201|65769599|FG006|Overall Study|Protocol Violation|0|||
23558055|NCT01735201|65769600|FG007|Overall Study|Protocol Violation|0|||
23147318|NCT00402597|64290862|FG002|Overall Study|Withdrawal by Subject|65|||
23147319|NCT00402597|64290863|FG003|Overall Study|Withdrawal by Subject|15|||
23147320|NCT00402597|64290864|FG004|Overall Study|Withdrawal by Subject|24|||
23147321|NCT00402597|64290860|FG000|Overall Study|reason not specified|30|||
23147322|NCT00402597|64290861|FG001|Overall Study|reason not specified|4|||
23147323|NCT00402597|64290862|FG002|Overall Study|reason not specified|27|||
23147324|NCT00402597|64290863|FG003|Overall Study|reason not specified|14|||
23147325|NCT00402597|64290864|FG004|Overall Study|reason not specified|20|||
23147326|NCT01013285|64290870|FG000|Overall Study|Death|48|||
23147327|NCT01013285|64290871|FG001|Overall Study|Death|89|||
23147328|NCT00628251|64290872|FG000|Randomised Part|Withdrawal by Subject|0|||
23436991|NCT02332291|65340868|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
23436992|NCT02332291|65340867|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
23436993|NCT02332291|65340868|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
23436994|NCT02332291|65340867|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
23436995|NCT02332291|65340868|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
23436996|NCT00238238|65340869|FG000|Overall Study|Withdrawal by Subject|0|||
23436997|NCT00238238|65340870|FG001|Overall Study|Withdrawal by Subject|3|||
23436998|NCT00238238|65340871|FG002|Overall Study|Withdrawal by Subject|0|||
23436999|NCT01620762|65340872|FG000|Overall Study|Protocol Violation|1|||
23437000|NCT01620762|65340873|FG001|Overall Study|Protocol Violation|1|||
23437001|NCT01620762|65340874|FG002|Overall Study|Protocol Violation|1|||
23437002|NCT01620762|65340872|FG000|Overall Study|Adverse Event|9|||
23437003|NCT01620762|65340873|FG001|Overall Study|Adverse Event|5|||
23437004|NCT01620762|65340874|FG002|Overall Study|Adverse Event|2|||
23437005|NCT01620762|65340872|FG000|Overall Study|Withdrawal by Subject|23|||
23437006|NCT01620762|65340873|FG001|Overall Study|Withdrawal by Subject|26|||
23437007|NCT01620762|65340874|FG002|Overall Study|Withdrawal by Subject|27|||
23437008|NCT01620762|65340872|FG000|Overall Study|Lost to Follow-up|11|||
23437009|NCT01620762|65340873|FG001|Overall Study|Lost to Follow-up|17|||
23437010|NCT01620762|65340874|FG002|Overall Study|Lost to Follow-up|10|||
23437011|NCT01620762|65340872|FG000|Overall Study|Protocol deviation|1|||
23437012|NCT01620762|65340873|FG001|Overall Study|Protocol deviation|1|||
23558056|NCT01735201|65769593|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23558057|NCT01735201|65769594|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23558058|NCT01735201|65769595|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23558059|NCT01735201|65769596|FG003|Overall Study|Other Miscellaneous Reasons|1|||
23558060|NCT01735201|65769597|FG004|Overall Study|Other Miscellaneous Reasons|0|||
23558061|NCT01735201|65769598|FG005|Overall Study|Other Miscellaneous Reasons|2|||
23623835|NCT01427738|66008586|FG001|Overall Study|Lost to Follow-up|5|||
23623836|NCT00632931|66008589|FG000|Part 1, Period 1|Protocol Violation|1|||
23147329|NCT00628251|64290873|FG001|Randomised Part|Withdrawal by Subject|0|||
23147330|NCT00628251|64290874|FG002|Randomised Part|Withdrawal by Subject|1|||
23147331|NCT00628251|64290872|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
23437013|NCT01620762|65340874|FG002|Overall Study|Protocol deviation|6|||
23437014|NCT01620762|65340872|FG000|Overall Study|Subject deterioration|0|||
23437015|NCT01620762|65340873|FG001|Overall Study|Subject deterioration|1|||
23437016|NCT01620762|65340874|FG002|Overall Study|Subject deterioration|1|||
23147332|NCT00628251|64290873|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
23147333|NCT00628251|64290874|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
23147334|NCT00628251|64290872|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
23147335|NCT00628251|64290873|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
23437017|NCT01620762|65340872|FG000|Overall Study|Non-specified|3|||
23437018|NCT01620762|65340873|FG001|Overall Study|Non-specified|6|||
23558062|NCT01735201|65769599|FG006|Overall Study|Other Miscellaneous Reasons|1|||
23558063|NCT01735201|65769600|FG007|Overall Study|Other Miscellaneous Reasons|1|||
23623837|NCT00632931|66008590|FG001|Part 1, Period 1|Protocol Violation|0|||
23437019|NCT01620762|65340874|FG002|Overall Study|Non-specified|5|||
23437020|NCT01620762|65340872|FG000|Overall Study|Use of prohibted therapies|0|||
23437021|NCT01620762|65340873|FG001|Overall Study|Use of prohibted therapies|1|||
23437022|NCT01620762|65340874|FG002|Overall Study|Use of prohibted therapies|1|||
23437023|NCT00695864|65340875|FG000|Placebo|Withdrawal by Subject|1|||
23558064|NCT00696384|65769601|FG000|Open Label Phase|Adverse Event|27|||
23558065|NCT00696384|65769602|FG001|Open Label Phase|Adverse Event|0|||
23558066|NCT00696384|65769603|FG002|Open Label Phase|Adverse Event|0|||
23558067|NCT00696384|65769601|FG000|Open Label Phase|Protocol Violation|18|||
23437024|NCT00695864|65340875|FG000|Placebo|Physician Decision|4|||
23437025|NCT02161757|65340878|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
23437026|NCT02161757|65340879|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
23437027|NCT02161757|65340880|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
23437028|NCT02161757|65340878|FG000|Treatment Through Study Completion|Adverse Event|1|||
23437029|NCT02161757|65340879|FG001|Treatment Through Study Completion|Adverse Event|1|||
23437030|NCT02161757|65340880|FG002|Treatment Through Study Completion|Adverse Event|0|||
23437031|NCT02161757|65340878|FG000|Treatment Through Study Completion|Protocol Violation|0|||
23437032|NCT02161757|65340879|FG001|Treatment Through Study Completion|Protocol Violation|1|||
23437033|NCT02161757|65340880|FG002|Treatment Through Study Completion|Protocol Violation|2|||
23437034|NCT02161757|65340878|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
23437035|NCT02161757|65340879|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
23437036|NCT02161757|65340880|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
23437037|NCT02161757|65340878|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
23437038|NCT02161757|65340879|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
23437039|NCT02161757|65340880|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
23437040|NCT02161757|65340878|FG000|Treatment Through Study Completion|Other|20|||
23437041|NCT02161757|65340879|FG001|Treatment Through Study Completion|Other|19|||
23437042|NCT02161757|65340880|FG002|Treatment Through Study Completion|Other|12|||
23437043|NCT02161757|65340878|FG000|Treatment Through Study Completion|Death|2|||
23437044|NCT02161757|65340879|FG001|Treatment Through Study Completion|Death|1|||
23437045|NCT02161757|65340880|FG002|Treatment Through Study Completion|Death|1|||
23437046|NCT04384523|65340881|FG000|Overall Study|Lost to Follow-up|0|||
23437047|NCT04384523|65340882|FG001|Overall Study|Lost to Follow-up|0|||
23437048|NCT04384523|65340883|FG002|Overall Study|Lost to Follow-up|0|||
23147336|NCT00628251|64290874|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
23147337|NCT00628251|64290872|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
23147338|NCT00628251|64290873|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
23147339|NCT00628251|64290874|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
23147340|NCT00628251|64290872|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
23147341|NCT00628251|64290873|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
23147342|NCT00628251|64290874|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
23147343|NCT00628251|64290872|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
23558068|NCT00696384|65769602|FG001|Open Label Phase|Protocol Violation|0|||
23558069|NCT00696384|65769603|FG002|Open Label Phase|Protocol Violation|0|||
23558070|NCT00696384|65769601|FG000|Open Label Phase|Lost to Follow-up|24|||
23558071|NCT00696384|65769602|FG001|Open Label Phase|Lost to Follow-up|0|||
23558072|NCT00696384|65769603|FG002|Open Label Phase|Lost to Follow-up|0|||
23147344|NCT00628251|64290873|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
23147345|NCT00628251|64290874|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
23147346|NCT03421431|64290883|FG000|Overall Study|Adverse Event|2|||
23558073|NCT00696384|65769601|FG000|Open Label Phase|Withdrawal by Subject|37|||
23558074|NCT00696384|65769602|FG001|Open Label Phase|Withdrawal by Subject|0|||
23558075|NCT00696384|65769603|FG002|Open Label Phase|Withdrawal by Subject|0|||
23558076|NCT00696384|65769601|FG000|Open Label Phase|Other|6|||
23558077|NCT00696384|65769602|FG001|Open Label Phase|Other|0|||
23558078|NCT00696384|65769603|FG002|Open Label Phase|Other|0|||
23558079|NCT00696384|65769601|FG000|Open Label Phase|Lack of Efficacy|3|||
23558080|NCT00696384|65769602|FG001|Open Label Phase|Lack of Efficacy|0|||
23558081|NCT00696384|65769603|FG002|Open Label Phase|Lack of Efficacy|0|||
23558082|NCT00696384|65769601|FG000|Open Label Phase|Physician Decision|4|||
23558083|NCT00696384|65769602|FG001|Open Label Phase|Physician Decision|0|||
23558084|NCT00696384|65769603|FG002|Open Label Phase|Physician Decision|0|||
23558085|NCT00696384|65769601|FG000|Double Blind Phase|Adverse Event|0|||
23558086|NCT00696384|65769602|FG001|Double Blind Phase|Adverse Event|2|||
23558087|NCT00696384|65769603|FG002|Double Blind Phase|Adverse Event|2|||
23147347|NCT03421431|64290884|FG001|Overall Study|Adverse Event|1|||
23437049|NCT04384523|65340884|FG003|Overall Study|Lost to Follow-up|0|||
23437050|NCT04384523|65340885|FG004|Overall Study|Lost to Follow-up|0|||
23437051|NCT04384523|65340886|FG005|Overall Study|Lost to Follow-up|1|||
23437052|NCT04384523|65340881|FG000|Overall Study|Protocol Violation|0|||
23437053|NCT04384523|65340882|FG001|Overall Study|Protocol Violation|1|||
23437054|NCT04384523|65340883|FG002|Overall Study|Protocol Violation|0|||
23437055|NCT04384523|65340884|FG003|Overall Study|Protocol Violation|0|||
23437056|NCT04384523|65340885|FG004|Overall Study|Protocol Violation|0|||
23437057|NCT04384523|65340886|FG005|Overall Study|Protocol Violation|0|||
23437058|NCT04384523|65340881|FG000|Overall Study|Withdrawal by Subject|1|||
23437059|NCT04384523|65340882|FG001|Overall Study|Withdrawal by Subject|0|||
23437060|NCT04384523|65340883|FG002|Overall Study|Withdrawal by Subject|0|||
23437061|NCT04384523|65340884|FG003|Overall Study|Withdrawal by Subject|0|||
23437062|NCT04384523|65340885|FG004|Overall Study|Withdrawal by Subject|0|||
23437063|NCT04384523|65340886|FG005|Overall Study|Withdrawal by Subject|0|||
23437064|NCT03659136|65340887|FG000|Overall Study|Not treated|2|||
23437065|NCT03659136|65340888|FG001|Overall Study|Not treated|0|||
23437066|NCT03659136|65340887|FG000|Overall Study|Covid-19 related|1|||
23437067|NCT03659136|65340888|FG001|Overall Study|Covid-19 related|1|||
23147348|NCT03421431|64290885|FG002|Overall Study|Adverse Event|12|||
23147349|NCT03421431|64290883|FG000|Overall Study|Lost to Follow-up|1|||
23147350|NCT03421431|64290884|FG001|Overall Study|Lost to Follow-up|1|||
23147351|NCT03421431|64290885|FG002|Overall Study|Lost to Follow-up|1|||
23147352|NCT03421431|64290883|FG000|Overall Study|Withdrawal by Subject|3|||
23147353|NCT03421431|64290884|FG001|Overall Study|Withdrawal by Subject|2|||
23147354|NCT03421431|64290885|FG002|Overall Study|Withdrawal by Subject|1|||
23147355|NCT03421431|64290883|FG000|Overall Study|Protocol Violation|0|||
23147356|NCT03421431|64290884|FG001|Overall Study|Protocol Violation|1|||
23437068|NCT03659136|65340887|FG000|Overall Study|Withdrawal by Subject|1|||
23437069|NCT03659136|65340888|FG001|Overall Study|Withdrawal by Subject|6|||
23437070|NCT03659136|65340887|FG000|Overall Study|Adverse Event|4|||
23437071|NCT03659136|65340888|FG001|Overall Study|Adverse Event|6|||
23437072|NCT03659136|65340887|FG000|Overall Study|Progressive disease|37|||
23437073|NCT03659136|65340888|FG001|Overall Study|Progressive disease|31|||
23437074|NCT03659136|65340887|FG000|Overall Study|Study closure|2|||
23437075|NCT03659136|65340888|FG001|Overall Study|Study closure|2|||
23437076|NCT03659136|65340887|FG000|Overall Study|Sponsor decision/recommendation|3|||
23623838|NCT00632931|66008591|FG002|Part 1, Period 1|Protocol Violation|0|||
23623839|NCT00632931|66008589|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
23623840|NCT00632931|66008590|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
23623841|NCT00632931|66008591|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
23623842|NCT00632931|66008589|FG000|Part 2|Adverse Event|0|||
23437077|NCT03659136|65340888|FG001|Overall Study|Sponsor decision/recommendation|2|||
23437078|NCT03659136|65340887|FG000|Overall Study|Switched to other drug/therapy|2|||
23437079|NCT03659136|65340888|FG001|Overall Study|Switched to other drug/therapy|2|||
23437080|NCT03659136|65340887|FG000|Overall Study|Lack of clinical benefit|0|||
23437081|NCT03659136|65340888|FG001|Overall Study|Lack of clinical benefit|1|||
23437082|NCT03078855|65340892|FG000|Overall Study|Lack of Efficacy|62|||
23437083|NCT03078855|65340893|FG001|Overall Study|Lack of Efficacy|31|||
23437084|NCT03078855|65340892|FG000|Overall Study|Death|1|||
23437085|NCT03078855|65340893|FG001|Overall Study|Death|0|||
23437086|NCT03078855|65340892|FG000|Overall Study|Withdrawal by Subject|12|||
23437087|NCT03078855|65340893|FG001|Overall Study|Withdrawal by Subject|6|||
23437088|NCT03078855|65340892|FG000|Overall Study|Physician Decision|3|||
23437089|NCT03078855|65340893|FG001|Overall Study|Physician Decision|2|||
23437090|NCT03078855|65340892|FG000|Overall Study|Second Malignancy|4|||
23437091|NCT03078855|65340893|FG001|Overall Study|Second Malignancy|0|||
23437092|NCT03078855|65340892|FG000|Overall Study|Ineligible|2|||
23437093|NCT03078855|65340893|FG001|Overall Study|Ineligible|0|||
23437094|NCT03078855|65340892|FG000|Overall Study|Withdrew before day 1 treatment|2|||
23437095|NCT03078855|65340893|FG001|Overall Study|Withdrew before day 1 treatment|1|||
23437096|NCT00923845|65340894|FG000|Induction Therapy|Poor performance status|0|||
23437097|NCT00923845|65340895|FG001|Induction Therapy|Poor performance status|2|||
23437098|NCT02249182|65340896|FG000|Treatment Phase|Lost to Follow-up|4|||
23437099|NCT02249182|65340897|FG001|Treatment Phase|Lost to Follow-up|0|||
23437100|NCT02249182|65340898|FG002|Treatment Phase|Lost to Follow-up|0|||
23437101|NCT02249182|65340899|FG003|Treatment Phase|Lost to Follow-up|0|||
23437102|NCT02249182|65340900|FG004|Treatment Phase|Lost to Follow-up|0|||
23437103|NCT04039217|65343986|FG000|Overall Study|Lost to Follow-up|1|||
23437104|NCT01298765|65343987|FG000|Titration Period|Adverse Event|26|||
23437105|NCT01298765|65343987|FG000|Titration Period|Death|1|||
23437106|NCT01298765|65343987|FG000|Titration Period|Lack of Efficacy|21|||
23437107|NCT01298765|65343987|FG000|Titration Period|Lost to Follow-up|9|||
23147357|NCT03421431|64290885|FG002|Overall Study|Protocol Violation|0|||
23147358|NCT03421431|64290883|FG000|Overall Study|Participant met Stopping Rules|0|||
23147359|NCT03421431|64290884|FG001|Overall Study|Participant met Stopping Rules|1|||
23147360|NCT03421431|64290885|FG002|Overall Study|Participant met Stopping Rules|0|||
23147361|NCT00394953|64290888|FG000|First Treatment Period|Adverse Event|1|||
23437108|NCT01298765|65343987|FG000|Titration Period|Physician Decision|1|||
23437109|NCT01298765|65343987|FG000|Titration Period|Withdrawal by Subject|10|||
23437110|NCT01298765|65343987|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
23437111|NCT01298765|65343987|FG000|Long-Term Treatment Period|Adverse Event|19|||
23437112|NCT01298765|65343987|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
23437113|NCT01298765|65343987|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
23623843|NCT00632931|66008590|FG001|Part 2|Adverse Event|0|||
23437114|NCT01298765|65343987|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
23437115|NCT01298765|65343987|FG000|Long-Term Treatment Period|Physician Decision|1|||
23437116|NCT01298765|65343987|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
23437117|NCT03916081|65343988|FG000|Overall Study|Adverse Event|1|||
23437118|NCT03916081|65343989|FG001|Overall Study|Adverse Event|0|||
23437119|NCT03916081|65343990|FG002|Overall Study|Adverse Event|0|||
23437120|NCT03916081|65343988|FG000|Overall Study|Physician Decision|0|||
23437121|NCT03916081|65343989|FG001|Overall Study|Physician Decision|0|||
23437122|NCT03916081|65343990|FG002|Overall Study|Physician Decision|1|||
23437123|NCT03916081|65343988|FG000|Overall Study|Lost to Follow-up|0|||
23437124|NCT03916081|65343989|FG001|Overall Study|Lost to Follow-up|1|||
23437125|NCT03916081|65343990|FG002|Overall Study|Lost to Follow-up|0|||
23437126|NCT03916081|65343988|FG000|Overall Study|Withdrawal by Subject|3|||
23437127|NCT03916081|65343989|FG001|Overall Study|Withdrawal by Subject|0|||
23437128|NCT03916081|65343990|FG002|Overall Study|Withdrawal by Subject|1|||
23437129|NCT03916081|65343988|FG000|Overall Study|Worsening of AD|0|||
23437130|NCT03916081|65343989|FG001|Overall Study|Worsening of AD|0|||
23437131|NCT03916081|65343990|FG002|Overall Study|Worsening of AD|1|||
23437132|NCT01088399|65343997|FG000|Overall Study|Adverse Event|211|||
23437133|NCT01088399|65343998|FG001|Overall Study|Adverse Event|16|||
23437134|NCT01088399|65343999|FG002|Overall Study|Adverse Event|0|||
23437135|NCT01088399|65343997|FG000|Overall Study|Death|204|||
23437136|NCT01088399|65343998|FG001|Overall Study|Death|45|||
23437137|NCT01088399|65343999|FG002|Overall Study|Death|0|||
23437138|NCT01088399|65343997|FG000|Overall Study|Lack of Efficacy|298|||
23437139|NCT01088399|65343998|FG001|Overall Study|Lack of Efficacy|7|||
23437140|NCT01088399|65343999|FG002|Overall Study|Lack of Efficacy|5|||
23437141|NCT01088399|65343997|FG000|Overall Study|Lost to Follow-up|1070|||
23437142|NCT01088399|65343998|FG001|Overall Study|Lost to Follow-up|278|||
23437143|NCT01088399|65343999|FG002|Overall Study|Lost to Follow-up|58|||
23437144|NCT01088399|65343997|FG000|Overall Study|Physician Decision|531|||
23437145|NCT01088399|65343998|FG001|Overall Study|Physician Decision|88|||
23437146|NCT01088399|65343999|FG002|Overall Study|Physician Decision|16|||
23437147|NCT01088399|65343997|FG000|Overall Study|Withdrawal by Subject|544|||
23437148|NCT01088399|65343998|FG001|Overall Study|Withdrawal by Subject|195|||
23437149|NCT01088399|65343999|FG002|Overall Study|Withdrawal by Subject|33|||
23437150|NCT01088399|65343997|FG000|Overall Study|Change to or start of somatropin therapy|234|||
23437151|NCT01088399|65343998|FG001|Overall Study|Change to or start of somatropin therapy|17|||
23437152|NCT01088399|65343999|FG002|Overall Study|Change to or start of somatropin therapy|12|||
23437153|NCT01088399|65343997|FG000|Overall Study|Sponsor decision|1573|||
23437154|NCT01088399|65343998|FG001|Overall Study|Sponsor decision|298|||
23437155|NCT01088399|65343999|FG002|Overall Study|Sponsor decision|7|||
23437156|NCT01088399|65343997|FG000|Overall Study|Protocol Violation|10|||
23437157|NCT01088399|65343998|FG001|Overall Study|Protocol Violation|1|||
23437158|NCT01088399|65343999|FG002|Overall Study|Protocol Violation|0|||
23437159|NCT01088399|65343997|FG000|Overall Study|Enrollment criteria not met|48|||
23437160|NCT01088399|65343998|FG001|Overall Study|Enrollment criteria not met|119|||
23437161|NCT01088399|65343999|FG002|Overall Study|Enrollment criteria not met|70|||
23437162|NCT01088399|65343997|FG000|Overall Study|Study summary visit not completed|2398|||
23437163|NCT01088399|65343998|FG001|Overall Study|Study summary visit not completed|283|||
23437164|NCT01088399|65343999|FG002|Overall Study|Study summary visit not completed|80|||
23437165|NCT03405818|65344013|FG000|Overall Study|Withdrawal by Subject|4|||
23437166|NCT03405818|65344013|FG000|Overall Study|Lost to Follow-up|4|||
23437167|NCT01894022|65344017|FG000|Overall Study|Death|1|||
23437168|NCT01894022|65344018|FG001|Overall Study|Death|0|||
23437169|NCT01894022|65344017|FG000|Overall Study|Adverse Event, non-fatal|1|||
23437170|NCT01894022|65344018|FG001|Overall Study|Adverse Event, non-fatal|0|||
23558088|NCT00696384|65769601|FG000|Double Blind Phase|Lost to Follow-up|0|||
23558089|NCT00696384|65769602|FG001|Double Blind Phase|Lost to Follow-up|2|||
23558090|NCT00696384|65769603|FG002|Double Blind Phase|Lost to Follow-up|1|||
23437171|NCT01894022|65344017|FG000|Overall Study|Study Closed/terminated|7|||
23437172|NCT01894022|65344018|FG001|Overall Study|Study Closed/terminated|10|||
23558091|NCT00696384|65769601|FG000|Double Blind Phase|Withdrawal by Subject|0|||
23437173|NCT01853878|65344020|FG000|Overall Study|Recurrence|2|||
23437174|NCT01853878|65344021|FG001|Overall Study|Recurrence|0|||
23437175|NCT01853878|65344020|FG000|Overall Study|Adverse Event|2|||
23437176|NCT01853878|65344021|FG001|Overall Study|Adverse Event|0|||
23437177|NCT01853878|65344020|FG000|Overall Study|Withdrawal by Subject|3|||
23437178|NCT01853878|65344021|FG001|Overall Study|Withdrawal by Subject|1|||
23437179|NCT01853878|65344020|FG000|Overall Study|Migrated/moved from the study area|1|||
23437180|NCT01853878|65344021|FG001|Overall Study|Migrated/moved from the study area|0|||
23437181|NCT01853878|65344020|FG000|Overall Study|Other|55|||
23437182|NCT01853878|65344021|FG001|Overall Study|Other|43|||
23437183|NCT01105377|65344022|FG000|Overall Study|Withdrawal by Subject|0|||
23437184|NCT01105377|65344023|FG001|Overall Study|Withdrawal by Subject|1|||
23558092|NCT00696384|65769602|FG001|Double Blind Phase|Withdrawal by Subject|4|||
23437185|NCT01068158|65344024|FG000|Overall Study|Withdrawal by Subject|1|||
23437186|NCT01068158|65344025|FG001|Overall Study|Withdrawal by Subject|2|||
23147362|NCT00394953|64290889|FG001|First Treatment Period|Adverse Event|2|||
23147363|NCT00394953|64290888|FG000|First Treatment Period|Death|6|||
23147364|NCT00394953|64290889|FG001|First Treatment Period|Death|7|||
23147365|NCT00394953|64290888|FG000|First Treatment Period|Lack of Efficacy|1|||
23147366|NCT00394953|64290889|FG001|First Treatment Period|Lack of Efficacy|1|||
23147367|NCT00394953|64290888|FG000|First Treatment Period|Withdrawal by Subject|6|||
23147368|NCT00394953|64290889|FG001|First Treatment Period|Withdrawal by Subject|3|||
23147369|NCT00394953|64290888|FG000|First Treatment Period|Lost to Follow-up|0|||
23147370|NCT00394953|64290889|FG001|First Treatment Period|Lost to Follow-up|1|||
23437187|NCT01068158|65344024|FG000|Overall Study|Lost to Follow-up|7|||
23437188|NCT01068158|65344025|FG001|Overall Study|Lost to Follow-up|0|||
23437189|NCT01068158|65344024|FG000|Overall Study|Protocol Violation|0|||
23437190|NCT01068158|65344025|FG001|Overall Study|Protocol Violation|2|||
23437191|NCT00687531|65344026|FG000|Overall Study|Did not meet protocol eligibility|104|||
23437192|NCT00687531|65344026|FG000|Overall Study|Adverse Event|5|||
23437193|NCT00687531|65344026|FG000|Overall Study|Lost to Follow-up|26|||
23437194|NCT01336023|65344030|FG000|Week 0 to Week 26|Adverse Event|8|||
23437195|NCT01336023|65344031|FG001|Week 0 to Week 26|Adverse Event|10|||
23437196|NCT01336023|65344032|FG002|Week 0 to Week 26|Adverse Event|24|||
23437197|NCT01336023|65344030|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
23437198|NCT01336023|65344031|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
23437199|NCT01336023|65344032|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
23437200|NCT01336023|65344030|FG000|Week 0 to Week 26|Protocol Violation|1|||
23437201|NCT01336023|65344031|FG001|Week 0 to Week 26|Protocol Violation|2|||
23437202|NCT01336023|65344032|FG002|Week 0 to Week 26|Protocol Violation|0|||
23437203|NCT01336023|65344030|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
23437204|NCT01336023|65344031|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
23437205|NCT01336023|65344032|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
23437206|NCT01336023|65344030|FG000|Week 0 to Week 26|Unclassified|5|||
23437207|NCT01336023|65344031|FG001|Week 0 to Week 26|Unclassified|16|||
23437208|NCT01336023|65344032|FG002|Week 0 to Week 26|Unclassified|9|||
23437209|NCT01336023|65344030|FG000|Week 27 to 52|Adverse Event|1|||
23147371|NCT00394953|64290888|FG000|First Treatment Period|Renal transplant|11|||
23147372|NCT00394953|64290889|FG001|First Treatment Period|Renal transplant|7|||
23147373|NCT00394953|64290888|FG000|First Treatment Period|Not defined|4|||
23147374|NCT00394953|64290889|FG001|First Treatment Period|Not defined|1|||
23147375|NCT00394953|64290888|FG000|Second Treatment Period|Adverse Event|2|||
23147376|NCT00394953|64290889|FG001|Second Treatment Period|Adverse Event|5|||
23147377|NCT00394953|64290888|FG000|Second Treatment Period|Death|8|||
23147378|NCT00394953|64290889|FG001|Second Treatment Period|Death|4|||
23147379|NCT00394953|64290888|FG000|Second Treatment Period|Lack of Efficacy|9|||
23147380|NCT00394953|64290889|FG001|Second Treatment Period|Lack of Efficacy|47|||
23147381|NCT00394953|64290888|FG000|Second Treatment Period|Withdrawal by Subject|3|||
23147382|NCT00394953|64290889|FG001|Second Treatment Period|Withdrawal by Subject|3|||
23147383|NCT00394953|64290888|FG000|Second Treatment Period|Lost to Follow-up|0|||
23147384|NCT00394953|64290889|FG001|Second Treatment Period|Lost to Follow-up|1|||
23147385|NCT00394953|64290888|FG000|Second Treatment Period|Renal transplant|4|||
23437210|NCT01336023|65344031|FG001|Week 27 to 52|Adverse Event|5|||
23437211|NCT01336023|65344032|FG002|Week 27 to 52|Adverse Event|2|||
23437212|NCT01336023|65344030|FG000|Week 27 to 52|Protocol Violation|0|||
23437213|NCT01336023|65344031|FG001|Week 27 to 52|Protocol Violation|2|||
23437214|NCT01336023|65344032|FG002|Week 27 to 52|Protocol Violation|1|||
23437215|NCT01336023|65344030|FG000|Week 27 to 52|Withdrawal Criteria|14|||
23437216|NCT01336023|65344031|FG001|Week 27 to 52|Withdrawal Criteria|19|||
23437217|NCT01336023|65344032|FG002|Week 27 to 52|Withdrawal Criteria|16|||
23437218|NCT01336023|65344030|FG000|Week 27 to 52|Unclassified|13|||
23437219|NCT01336023|65344031|FG001|Week 27 to 52|Unclassified|18|||
23437220|NCT01336023|65344032|FG002|Week 27 to 52|Unclassified|9|||
23437221|NCT02596945|65344038|FG000|Overall Study|No documentation of study drug dosing|3|||
23437222|NCT02596945|65344038|FG000|Overall Study|Other|32|||
23437223|NCT02596945|65344038|FG000|Overall Study|Change to hemodialysis|15|||
23437224|NCT02596945|65344038|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
23437225|NCT02596945|65344038|FG000|Overall Study|Withdrawal by Subject|1|||
23437226|NCT02596945|65344038|FG000|Overall Study|Missing|1|||
23437227|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Adverse Event|33|||
23437228|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
23437229|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
23437230|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
23437231|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Physician Decision|6|||
23147386|NCT00394953|64290889|FG001|Second Treatment Period|Renal transplant|6|||
23147387|NCT00394953|64290888|FG000|Second Treatment Period|Not defined|3|||
23147388|NCT00394953|64290889|FG001|Second Treatment Period|Not defined|8|||
23437232|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
23437233|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
23437234|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
23623844|NCT00632931|66008591|FG002|Part 2|Adverse Event|3|||
23437235|NCT00965419|65344039|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
23437236|NCT00965419|65344039|FG000|Follow-up Phase|Adverse Event|9|||
23437237|NCT00965419|65344039|FG000|Follow-up Phase|Protocol Violation|4|||
23437238|NCT00965419|65344039|FG000|Follow-up Phase|Withdrawal by Subject|8|||
23437239|NCT00965419|65344039|FG000|Follow-up Phase|Physician Decision|4|||
23437240|NCT00965419|65344039|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
23437241|NCT00965419|65344039|FG000|Follow-up Phase|Lack of Efficacy|28|||
23437242|NCT04186871|65344040|FG000|Overall Study|Lack of Efficacy|0|||
23437243|NCT04186871|65344041|FG001|Overall Study|Lack of Efficacy|1|||
23437244|NCT04186871|65344042|FG002|Overall Study|Lack of Efficacy|0|||
23437245|NCT04186871|65344043|FG003|Overall Study|Lack of Efficacy|0|||
23437246|NCT04186871|65344044|FG004|Overall Study|Lack of Efficacy|1|||
23437247|NCT04186871|65344045|FG005|Overall Study|Lack of Efficacy|1|||
23437248|NCT04186871|65344040|FG000|Overall Study|Adverse Event|1|||
23437249|NCT04186871|65344041|FG001|Overall Study|Adverse Event|1|||
23437250|NCT04186871|65344042|FG002|Overall Study|Adverse Event|0|||
23437251|NCT04186871|65344043|FG003|Overall Study|Adverse Event|0|||
23147389|NCT00706433|64290890|FG000|Overall Study|Lost to Follow-up|3|||
23147390|NCT00706433|64290891|FG001|Overall Study|Lost to Follow-up|1|||
23437252|NCT04186871|65344044|FG004|Overall Study|Adverse Event|0|||
23437253|NCT04186871|65344045|FG005|Overall Study|Adverse Event|2|||
23437254|NCT04186871|65344040|FG000|Overall Study|Study terminated by sponsor|1|||
23437255|NCT04186871|65344041|FG001|Overall Study|Study terminated by sponsor|2|||
23437256|NCT04186871|65344042|FG002|Overall Study|Study terminated by sponsor|0|||
23437257|NCT04186871|65344043|FG003|Overall Study|Study terminated by sponsor|1|||
23437258|NCT04186871|65344044|FG004|Overall Study|Study terminated by sponsor|0|||
23437259|NCT04186871|65344045|FG005|Overall Study|Study terminated by sponsor|0|||
23437260|NCT04186871|65344040|FG000|Overall Study|Other reasons|0|||
23437261|NCT04186871|65344041|FG001|Overall Study|Other reasons|0|||
23437262|NCT04186871|65344042|FG002|Overall Study|Other reasons|0|||
23437263|NCT04186871|65344043|FG003|Overall Study|Other reasons|0|||
23437264|NCT04186871|65344044|FG004|Overall Study|Other reasons|0|||
23437265|NCT04186871|65344045|FG005|Overall Study|Other reasons|1|||
23437266|NCT04186871|65344040|FG000|Overall Study|Withdrawal by Subject|0|||
23437267|NCT04186871|65344041|FG001|Overall Study|Withdrawal by Subject|0|||
23437268|NCT04186871|65344042|FG002|Overall Study|Withdrawal by Subject|0|||
23437269|NCT04186871|65344043|FG003|Overall Study|Withdrawal by Subject|0|||
23437270|NCT04186871|65344044|FG004|Overall Study|Withdrawal by Subject|0|||
23147391|NCT00706433|64290892|FG002|Overall Study|Lost to Follow-up|6|||
23147392|NCT00706433|64290893|FG003|Overall Study|Lost to Follow-up|0|||
23147393|NCT00706433|64290890|FG000|Overall Study|Withdrawal by Subject|1|||
23147394|NCT00706433|64290891|FG001|Overall Study|Withdrawal by Subject|2|||
23147395|NCT00706433|64290892|FG002|Overall Study|Withdrawal by Subject|3|||
23147396|NCT00706433|64290893|FG003|Overall Study|Withdrawal by Subject|1|||
23147397|NCT00706433|64290890|FG000|Overall Study|Adverse Event|0|||
23147398|NCT00706433|64290891|FG001|Overall Study|Adverse Event|0|||
23147399|NCT00706433|64290892|FG002|Overall Study|Adverse Event|1|||
23147400|NCT00706433|64290893|FG003|Overall Study|Adverse Event|0|||
23147401|NCT00706433|64290890|FG000|Overall Study|Protocol Violation|1|||
23147402|NCT00706433|64290891|FG001|Overall Study|Protocol Violation|0|||
23147403|NCT00706433|64290892|FG002|Overall Study|Protocol Violation|0|||
23147404|NCT00706433|64290893|FG003|Overall Study|Protocol Violation|0|||
23147405|NCT00706433|64290890|FG000|Overall Study|new job|0|||
23147406|NCT00706433|64290891|FG001|Overall Study|new job|0|||
23322539|NCT01127256|64923032|FG001|Overall Study|Adverse Event|13|||
23147407|NCT00706433|64290892|FG002|Overall Study|new job|0|||
23147408|NCT00706433|64290893|FG003|Overall Study|new job|1|||
23147409|NCT00728481|64290894|FG000|Overall Study|Withdrawal by Subject|0|||
23147410|NCT00728481|64290895|FG001|Overall Study|Withdrawal by Subject|1|||
23558093|NCT00696384|65769603|FG002|Double Blind Phase|Withdrawal by Subject|3|||
23322540|NCT01127256|64923031|FG000|Overall Study|Lack of Efficacy|4|||
23322541|NCT01127256|64923032|FG001|Overall Study|Lack of Efficacy|0|||
23322542|NCT01127256|64923031|FG000|Overall Study|Lost to Follow-up|16|||
23437271|NCT04186871|65344045|FG005|Overall Study|Withdrawal by Subject|1|||
23437272|NCT04186871|65344040|FG000|Overall Study|Lost to Follow-up|0|||
23437273|NCT04186871|65344041|FG001|Overall Study|Lost to Follow-up|0|||
23437274|NCT04186871|65344042|FG002|Overall Study|Lost to Follow-up|0|||
23558094|NCT00696384|65769601|FG000|Double Blind Phase|Lack of Efficacy|0|||
23147411|NCT00728481|64290894|FG000|Overall Study|Adverse Event|0|||
23147412|NCT00728481|64290895|FG001|Overall Study|Adverse Event|1|||
23147413|NCT00728481|64290894|FG000|Overall Study|Study medication non-compliance|0|||
23147414|NCT00728481|64290895|FG001|Overall Study|Study medication non-compliance|2|||
23437275|NCT04186871|65344043|FG003|Overall Study|Lost to Follow-up|0|||
23437276|NCT04186871|65344044|FG004|Overall Study|Lost to Follow-up|0|||
23437277|NCT04186871|65344045|FG005|Overall Study|Lost to Follow-up|1|||
23147415|NCT00728481|64290894|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
23147416|NCT00728481|64290895|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
23322543|NCT01127256|64923032|FG001|Overall Study|Lost to Follow-up|17|||
23437278|NCT02292706|65344046|FG000|Overall Study|Lost to Follow-up|20|||
23322544|NCT01127256|64923031|FG000|Overall Study|Withdrawal by Subject|5|||
23322545|NCT01127256|64923032|FG001|Overall Study|Withdrawal by Subject|9|||
23558095|NCT00696384|65769602|FG001|Double Blind Phase|Lack of Efficacy|1|||
23558096|NCT00696384|65769603|FG002|Double Blind Phase|Lack of Efficacy|0|||
23558097|NCT00696384|65769601|FG000|Double Blind Phase|Physician Decision|0|||
23322546|NCT01127256|64923031|FG000|Overall Study|Protocol Violation|1|||
23322547|NCT01127256|64923032|FG001|Overall Study|Protocol Violation|0|||
23322548|NCT00580788|64923033|FG000|Overall Study|Adverse Event|0|||
23322549|NCT00580788|64923034|FG001|Overall Study|Adverse Event|0|||
23322550|NCT00580788|64923035|FG002|Overall Study|Adverse Event|0|||
23322551|NCT00580788|64923036|FG003|Overall Study|Adverse Event|1|||
23322552|NCT00124748|64923037|FG000|Overall Study|Adverse Event|8|||
23322553|NCT00124748|64923038|FG001|Overall Study|Adverse Event|39|||
23322554|NCT00124748|64923037|FG000|Overall Study|Abnormal laboratory Value|2|||
23322555|NCT00124748|64923038|FG001|Overall Study|Abnormal laboratory Value|2|||
23322556|NCT00124748|64923037|FG000|Overall Study|Abnormal Procedure|0|||
23322557|NCT00124748|64923038|FG001|Overall Study|Abnormal Procedure|1|||
23322558|NCT00124748|64923037|FG000|Overall Study|Lack of Efficacy|20|||
23322559|NCT00124748|64923038|FG001|Overall Study|Lack of Efficacy|41|||
23322560|NCT00124748|64923037|FG000|Overall Study|No longer requires study drug|1|||
23322561|NCT00124748|64923038|FG001|Overall Study|No longer requires study drug|1|||
23322562|NCT00124748|64923037|FG000|Overall Study|Protocol Violation|3|||
23322563|NCT00124748|64923038|FG001|Overall Study|Protocol Violation|1|||
23322564|NCT00124748|64923037|FG000|Overall Study|Withdrawal by Subject|5|||
23322565|NCT00124748|64923038|FG001|Overall Study|Withdrawal by Subject|15|||
23322566|NCT00124748|64923037|FG000|Overall Study|Lost to Follow-up|2|||
23322567|NCT00124748|64923038|FG001|Overall Study|Lost to Follow-up|7|||
23322568|NCT00124748|64923037|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
23322569|NCT00124748|64923038|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
23322570|NCT00124748|64923037|FG000|Overall Study|Death|1|||
23322571|NCT00124748|64923038|FG001|Overall Study|Death|3|||
23322572|NCT00908544|64923039|FG000|Overall Study|Withdrawal by Subject|2|||
23322573|NCT00908544|64923040|FG001|Overall Study|Withdrawal by Subject|4|||
23322574|NCT00908544|64923039|FG000|Overall Study|Lack of Efficacy|0|||
23322575|NCT00908544|64923040|FG001|Overall Study|Lack of Efficacy|1|||
23322576|NCT00908544|64923039|FG000|Overall Study|Pregnancy|1|||
23322577|NCT00908544|64923040|FG001|Overall Study|Pregnancy|0|||
23322578|NCT00908544|64923039|FG000|Overall Study|Relocation abroad|1|||
23322579|NCT00908544|64923040|FG001|Overall Study|Relocation abroad|1|||
23322580|NCT00908544|64923039|FG000|Overall Study|Unable to visit sutdy center|1|||
23322581|NCT00908544|64923040|FG001|Overall Study|Unable to visit sutdy center|0|||
23322582|NCT00344448|64923043|FG000|Screening|Withdrawal by Subject|0|||
23322583|NCT00344448|64923044|FG001|Screening|Withdrawal by Subject|1|||
23322584|NCT00344448|64923043|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
23322585|NCT00344448|64923044|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
23322586|NCT00344448|64923043|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
23322587|NCT00344448|64923044|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
23322588|NCT00344448|64923043|FG000|Open Label|Withdrawal by Subject|1|||
23322589|NCT00344448|64923044|FG001|Open Label|Withdrawal by Subject|1|||
23322590|NCT00344448|64923043|FG000|Open Label|Study terminated|1|||
23322591|NCT00344448|64923044|FG001|Open Label|Study terminated|0|||
23322592|NCT01153425|64923045|FG000|Overall Study|Withdrawal by Subject|3|||
23322593|NCT01153425|64923046|FG001|Overall Study|Withdrawal by Subject|3|||
23558098|NCT00696384|65769602|FG001|Double Blind Phase|Physician Decision|2|||
23558099|NCT00696384|65769603|FG002|Double Blind Phase|Physician Decision|0|||
23558100|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
23558101|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
23558102|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
23558103|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
23558104|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
23558105|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
23322594|NCT01459783|64923055|FG000|Baseline to 6 Months|Death|1|||
23322595|NCT01459783|64923056|FG001|Baseline to 6 Months|Death|0|||
23322596|NCT01459783|64923055|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
23322597|NCT01459783|64923056|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
23322598|NCT01459783|64923055|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
23322599|NCT01459783|64923056|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
23322600|NCT01459783|64923055|FG000|6 Months to 12 Months|Death|0|||
23322601|NCT01459783|64923056|FG001|6 Months to 12 Months|Death|1|||
23322602|NCT01459783|64923055|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
23558106|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
23558107|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
23558108|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
23558109|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
23558110|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
23322603|NCT01459783|64923056|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
23437279|NCT02292706|65344047|FG001|Overall Study|Lost to Follow-up|44|||
23437280|NCT02292706|65344048|FG002|Overall Study|Lost to Follow-up|24|||
23437281|NCT02292706|65344049|FG003|Overall Study|Lost to Follow-up|61|||
23437282|NCT02292706|65344050|FG004|Overall Study|Lost to Follow-up|21|||
23147417|NCT04051827|64290896|FG000|Overall Study|Death|1|||
23147418|NCT04051827|64290896|FG000|Overall Study|Withdrawal by Subject|4|||
23147419|NCT04051827|64290896|FG000|Overall Study|Progressive disease|16|||
23147420|NCT04051827|64290896|FG000|Overall Study|Physician Decision|1|||
23147421|NCT04051827|64290896|FG000|Overall Study|Other|4|||
23147422|NCT02101034|64290899|FG000|Overall Study|Enrolled but did not start treatment|0|||
23147423|NCT02101034|64290900|FG001|Overall Study|Enrolled but did not start treatment|0|||
23147424|NCT02101034|64290901|FG002|Overall Study|Enrolled but did not start treatment|1|||
23147425|NCT02101034|64290902|FG003|Overall Study|Enrolled but did not start treatment|0|||
23147426|NCT02101034|64290903|FG004|Overall Study|Enrolled but did not start treatment|0|||
23147427|NCT01214187|64290904|FG000|Overall Study|Adverse Event|6|||
23147428|NCT01214187|64290905|FG001|Overall Study|Adverse Event|2|||
23147429|NCT01214187|64290904|FG000|Overall Study|Death|1|||
23147430|NCT01214187|64290905|FG001|Overall Study|Death|1|||
23147431|NCT01214187|64290904|FG000|Overall Study|Withdrawal by Subject|0|||
23147432|NCT01214187|64290905|FG001|Overall Study|Withdrawal by Subject|3|||
23147433|NCT01592864|64290909|FG000|Overall Study|Withdrawal by Subject|0|||
23147434|NCT01592864|64290910|FG001|Overall Study|Withdrawal by Subject|1|||
23147435|NCT01480674|64290911|FG000|Overall Study|Death|23|||
23147436|NCT01480674|64290911|FG000|Overall Study|Lost to Follow-up|2|||
23147437|NCT01480674|64290911|FG000|Overall Study|visit not done|10|||
23147438|NCT01422850|64290912|FG000|Overall Study|Physician Decision|3|||
23147439|NCT00138671|64290914|FG000|Overall Study|Death|0|||
23558111|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
23558112|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23558113|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23558114|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23558115|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
23558116|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
23558117|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23558118|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23558119|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23558120|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Death|2|||
23623845|NCT00632931|66008589|FG000|Part 2|Death|0|||
23623846|NCT00632931|66008590|FG001|Part 2|Death|0|||
23147440|NCT00138671|64290915|FG001|Overall Study|Death|3|||
23437283|NCT02292706|65344051|FG005|Overall Study|Lost to Follow-up|52|||
23558121|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Death|2|||
23558122|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Death|0|||
23437284|NCT02292706|65344052|FG006|Overall Study|Lost to Follow-up|25|||
23437285|NCT02292706|65344053|FG007|Overall Study|Lost to Follow-up|0|||
23437286|NCT02292706|65344046|FG000|Overall Study|Withdrew consent|15|||
23437287|NCT02292706|65344047|FG001|Overall Study|Withdrew consent|56|||
23437288|NCT02292706|65344048|FG002|Overall Study|Withdrew consent|43|||
23437289|NCT02292706|65344049|FG003|Overall Study|Withdrew consent|36|||
23437290|NCT02292706|65344050|FG004|Overall Study|Withdrew consent|13|||
23437291|NCT02292706|65344051|FG005|Overall Study|Withdrew consent|51|||
23147441|NCT00138671|64290914|FG000|Overall Study|Adverse Event|6|||
23437292|NCT02292706|65344052|FG006|Overall Study|Withdrew consent|20|||
23437293|NCT02292706|65344053|FG007|Overall Study|Withdrew consent|0|||
23437294|NCT02292706|65344046|FG000|Overall Study|Death|3|||
23437295|NCT02292706|65344047|FG001|Overall Study|Death|11|||
23437296|NCT02292706|65344048|FG002|Overall Study|Death|16|||
23437297|NCT02292706|65344049|FG003|Overall Study|Death|22|||
23437298|NCT02292706|65344050|FG004|Overall Study|Death|8|||
23437299|NCT02292706|65344051|FG005|Overall Study|Death|17|||
23437300|NCT02292706|65344052|FG006|Overall Study|Death|3|||
23437301|NCT02292706|65344053|FG007|Overall Study|Death|0|||
23437302|NCT02292706|65344046|FG000|Overall Study|Study terminated by sponsor|0|||
23437303|NCT02292706|65344047|FG001|Overall Study|Study terminated by sponsor|9|||
23147442|NCT00138671|64290915|FG001|Overall Study|Adverse Event|3|||
23147443|NCT00138671|64290914|FG000|Overall Study|Lost to Follow-up|1|||
23147444|NCT00138671|64290915|FG001|Overall Study|Lost to Follow-up|2|||
23147445|NCT00138671|64290914|FG000|Overall Study|Withdrawal by Subject|3|||
23437304|NCT02292706|65344048|FG002|Overall Study|Study terminated by sponsor|4|||
23437305|NCT02292706|65344049|FG003|Overall Study|Study terminated by sponsor|21|||
23437306|NCT02292706|65344050|FG004|Overall Study|Study terminated by sponsor|11|||
23437307|NCT02292706|65344051|FG005|Overall Study|Study terminated by sponsor|13|||
23437308|NCT02292706|65344052|FG006|Overall Study|Study terminated by sponsor|3|||
23437309|NCT02292706|65344053|FG007|Overall Study|Study terminated by sponsor|0|||
23437310|NCT02292706|65344046|FG000|Overall Study|Investigator's discretion|4|||
23558123|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Death|0|||
23558124|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Death|0|||
23623847|NCT00632931|66008591|FG002|Part 2|Death|1|||
23623848|NCT00632931|66008589|FG000|Part 2|Lack of Efficacy|0|||
23147446|NCT00138671|64290915|FG001|Overall Study|Withdrawal by Subject|5|||
23147447|NCT00138671|64290914|FG000|Overall Study|Other|3|||
23147448|NCT00138671|64290915|FG001|Overall Study|Other|3|||
23147449|NCT01295034|64290916|FG000|Overall Study|Lost to Follow-up|5|||
23147450|NCT01295034|64290917|FG001|Overall Study|Lost to Follow-up|5|||
23147451|NCT03231943|64290920|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147452|NCT03231943|64290921|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
23147453|NCT03231943|64290922|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
23147454|NCT03231943|64290923|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147455|NCT03231943|64290924|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147456|NCT03231943|64290925|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147457|NCT03231943|64290926|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147458|NCT03231943|64290927|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147459|NCT03231943|64290928|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147460|NCT03231943|64290929|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147461|NCT03231943|64290930|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147462|NCT03231943|64290931|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147463|NCT03231943|64290932|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
23147464|NCT03231943|64290920|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147465|NCT03231943|64290921|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
23147466|NCT03231943|64290922|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147467|NCT03231943|64290923|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147468|NCT03231943|64290924|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147469|NCT03231943|64290925|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147470|NCT03231943|64290926|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147471|NCT03231943|64290927|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147472|NCT03231943|64290928|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147473|NCT03231943|64290929|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147474|NCT03231943|64290930|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147475|NCT03231943|64290931|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147476|NCT03231943|64290932|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
23147477|NCT03231943|64290920|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
23147478|NCT03231943|64290921|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147479|NCT03231943|64290922|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147480|NCT03231943|64290923|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147481|NCT03231943|64290924|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147482|NCT03231943|64290925|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147483|NCT03231943|64290926|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147484|NCT03231943|64290927|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147485|NCT03231943|64290928|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147486|NCT03231943|64290929|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147487|NCT03231943|64290930|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147488|NCT03231943|64290931|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147489|NCT03231943|64290932|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
23147490|NCT03231943|64290920|FG000|Part 2|Adverse Event|0|||
23147491|NCT03231943|64290921|FG001|Part 2|Adverse Event|0|||
23147492|NCT03231943|64290922|FG002|Part 2|Adverse Event|0|||
23147493|NCT03231943|64290923|FG003|Part 2|Adverse Event|0|||
23147494|NCT03231943|64290924|FG004|Part 2|Adverse Event|0|||
23147495|NCT03231943|64290925|FG005|Part 2|Adverse Event|0|||
23147496|NCT03231943|64290926|FG006|Part 2|Adverse Event|0|||
23147497|NCT03231943|64290927|FG007|Part 2|Adverse Event|0|||
23147498|NCT03231943|64290928|FG008|Part 2|Adverse Event|0|||
23147499|NCT03231943|64290929|FG009|Part 2|Adverse Event|0|||
23147500|NCT03231943|64290930|FG010|Part 2|Adverse Event|1|||
23147501|NCT03231943|64290931|FG011|Part 2|Adverse Event|0|||
23147502|NCT03231943|64290932|FG012|Part 2|Adverse Event|0|||
23147503|NCT03231943|64290920|FG000|Part 2|Withdrawal by Subject|0|||
23147504|NCT03231943|64290921|FG001|Part 2|Withdrawal by Subject|0|||
23147505|NCT03231943|64290922|FG002|Part 2|Withdrawal by Subject|0|||
23147506|NCT03231943|64290923|FG003|Part 2|Withdrawal by Subject|0|||
23147507|NCT03231943|64290924|FG004|Part 2|Withdrawal by Subject|0|||
23147508|NCT03231943|64290925|FG005|Part 2|Withdrawal by Subject|0|||
23147509|NCT03231943|64290926|FG006|Part 2|Withdrawal by Subject|0|||
23147510|NCT03231943|64290927|FG007|Part 2|Withdrawal by Subject|0|||
23147511|NCT03231943|64290928|FG008|Part 2|Withdrawal by Subject|0|||
23147512|NCT03231943|64290929|FG009|Part 2|Withdrawal by Subject|0|||
23147513|NCT03231943|64290930|FG010|Part 2|Withdrawal by Subject|0|||
23147514|NCT03231943|64290931|FG011|Part 2|Withdrawal by Subject|1|||
23147515|NCT03231943|64290932|FG012|Part 2|Withdrawal by Subject|0|||
23147516|NCT01078675|64290941|FG000|Overall Study|Withdrawal by Subject|7|||
23147517|NCT01078675|64290942|FG001|Overall Study|Withdrawal by Subject|3|||
23147518|NCT01078675|64290941|FG000|Overall Study|Protocol Violation|56|||
23558125|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
23147519|NCT01078675|64290942|FG001|Overall Study|Protocol Violation|0|||
23437311|NCT02292706|65344047|FG001|Overall Study|Investigator's discretion|9|||
23437312|NCT02292706|65344048|FG002|Overall Study|Investigator's discretion|7|||
23437313|NCT02292706|65344049|FG003|Overall Study|Investigator's discretion|11|||
23437314|NCT02292706|65344050|FG004|Overall Study|Investigator's discretion|4|||
23437315|NCT02292706|65344051|FG005|Overall Study|Investigator's discretion|10|||
23437316|NCT02292706|65344052|FG006|Overall Study|Investigator's discretion|1|||
23437317|NCT02292706|65344053|FG007|Overall Study|Investigator's discretion|0|||
23437318|NCT02292706|65344046|FG000|Overall Study|Liver transplant|1|||
23437319|NCT02292706|65344047|FG001|Overall Study|Liver transplant|1|||
23437320|NCT02292706|65344048|FG002|Overall Study|Liver transplant|11|||
23437321|NCT02292706|65344049|FG003|Overall Study|Liver transplant|16|||
23437322|NCT02292706|65344050|FG004|Overall Study|Liver transplant|5|||
23437323|NCT02292706|65344051|FG005|Overall Study|Liver transplant|6|||
23437324|NCT02292706|65344052|FG006|Overall Study|Liver transplant|5|||
23437325|NCT02292706|65344053|FG007|Overall Study|Liver transplant|0|||
23437326|NCT02292706|65344046|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
23437327|NCT02292706|65344047|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
23437328|NCT02292706|65344048|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
23437329|NCT02292706|65344049|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
23437330|NCT02292706|65344050|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
23437331|NCT02292706|65344051|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
23437332|NCT02292706|65344052|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
23437333|NCT02292706|65344053|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
23437334|NCT02292706|65344046|FG000|Overall Study|Subject terminated by sponsor|1|||
23558126|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
23558127|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
23558128|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
23558129|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
23558130|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
23558131|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
23558132|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
23147520|NCT01078675|64290941|FG000|Overall Study|Provided in CRF for specific reasons|2|||
23147521|NCT01078675|64290942|FG001|Overall Study|Provided in CRF for specific reasons|3|||
23147522|NCT01078675|64290941|FG000|Overall Study|Adverse Event|3|||
23147523|NCT01078675|64290942|FG001|Overall Study|Adverse Event|0|||
23558133|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
23558134|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
23558135|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
23558136|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
23558137|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
23147524|NCT01448213|64290943|FG000|Overall Study|Lost to Follow-up|12|||
23147525|NCT01448213|64290944|FG001|Overall Study|Lost to Follow-up|10|||
23147526|NCT01448213|64290943|FG000|Overall Study|Adverse Event|4|||
23147527|NCT01448213|64290944|FG001|Overall Study|Adverse Event|10|||
23147528|NCT01448213|64290943|FG000|Overall Study|Protocol Violation|1|||
23147529|NCT01448213|64290944|FG001|Overall Study|Protocol Violation|2|||
23147530|NCT01324323|64290945|FG000|Overall Study|Withdrawal by Subject|1|||
23147531|NCT00412971|64290947|FG000|Overall Study|Lost to Follow-up|17|||
23147532|NCT00412971|64290948|FG001|Overall Study|Lost to Follow-up|9|||
23147533|NCT00412971|64290947|FG000|Overall Study|Protocol Violation|13|||
23147534|NCT00412971|64290948|FG001|Overall Study|Protocol Violation|1|||
23147535|NCT00275262|64290949|FG000|Overall Study|Adverse Event|2|||
23147536|NCT00275262|64290950|FG001|Overall Study|Adverse Event|0|||
23147537|NCT00275262|64290949|FG000|Overall Study|Disease progression|2|||
23558138|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
23558139|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
23558140|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
23558141|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
23147538|NCT00275262|64290950|FG001|Overall Study|Disease progression|5|||
23147539|NCT00275262|64290949|FG000|Overall Study|Lost to Follow-up|0|||
23147540|NCT00275262|64290950|FG001|Overall Study|Lost to Follow-up|2|||
23147541|NCT00275262|64290949|FG000|Overall Study|Protocol Violation|0|||
23147542|NCT00275262|64290950|FG001|Overall Study|Protocol Violation|2|||
23147543|NCT00275262|64290949|FG000|Overall Study|Death|1|||
23322604|NCT01459783|64923055|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
23437335|NCT02292706|65344047|FG001|Overall Study|Subject terminated by sponsor|0|||
23322605|NCT01459783|64923056|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
23437336|NCT02292706|65344048|FG002|Overall Study|Subject terminated by sponsor|0|||
23558142|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
23558143|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
23558144|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
23558145|NCT03420781|65769610|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
23558146|NCT03420781|65769611|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
23558147|NCT03420781|65769612|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
23558148|NCT03420781|65769613|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
23147544|NCT00275262|64290950|FG001|Overall Study|Death|0|||
23147545|NCT00275262|64290949|FG000|Overall Study|Started Chemotherapy|1|||
23147546|NCT00275262|64290950|FG001|Overall Study|Started Chemotherapy|0|||
23147547|NCT00455325|64290951|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
23147548|NCT00455325|64290952|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
23147549|NCT00455325|64290953|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
23147550|NCT00455325|64290954|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
23147551|NCT00455325|64290951|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
23147552|NCT00455325|64290952|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
23147553|NCT00455325|64290953|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
23147554|NCT00455325|64290954|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
23147555|NCT00455325|64290951|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
23147556|NCT00455325|64290952|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
23147557|NCT00455325|64290953|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
23147558|NCT00455325|64290954|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
23147559|NCT00455325|64290951|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
23147560|NCT00455325|64290952|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
23147561|NCT00455325|64290953|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
23147562|NCT00455325|64290954|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
23147563|NCT00455325|64290951|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
23147564|NCT00455325|64290952|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
23147565|NCT00455325|64290953|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
23147566|NCT00455325|64290954|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
23147567|NCT00455325|64290951|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
23147568|NCT00455325|64290952|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
23147569|NCT00455325|64290953|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
23147570|NCT00455325|64290954|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
23147571|NCT00455325|64290951|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
23558149|NCT03420781|65769614|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
23558150|NCT03420781|65769610|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
23558151|NCT03420781|65769611|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
23558152|NCT03420781|65769612|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
23558153|NCT03420781|65769613|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
23558154|NCT03420781|65769614|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
23558155|NCT03420781|65769610|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
23558156|NCT03420781|65769611|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
23558157|NCT03420781|65769612|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
23558158|NCT03420781|65769613|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
23558159|NCT03420781|65769614|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
23558160|NCT03420781|65769610|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
23558161|NCT03420781|65769611|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
23558162|NCT03420781|65769612|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
23558163|NCT03420781|65769613|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
23558164|NCT03420781|65769614|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
23558165|NCT01964326|65769615|FG000|Overall Study|Adverse Event|48|||
23558166|NCT01964326|65769615|FG000|Overall Study|Death|2|||
23558167|NCT01964326|65769615|FG000|Overall Study|Protocol Violation|4|||
23558168|NCT01964326|65769615|FG000|Overall Study|Lost to Follow-up|88|||
23558169|NCT01964326|65769615|FG000|Overall Study|Withdrawal by Subject|87|||
23558170|NCT01964326|65769615|FG000|Overall Study|Pregnancy|1|||
23558171|NCT01964326|65769615|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
23558172|NCT01964326|65769615|FG000|Overall Study|Physician Decision|55|||
23558173|NCT01964326|65769615|FG000|Overall Study|Investigator Discretion|1|||
23558174|NCT01964326|65769615|FG000|Overall Study|Other|9|||
23558175|NCT01964326|65769615|FG000|Overall Study|Did not meet eligibility criteria|1|||
23558176|NCT02686034|65769616|FG000|Run-In Period 1|Eligibility|12|||
23558177|NCT02686034|65769617|FG001|Run-In Period 1|Eligibility|10|||
23558178|NCT02686034|65769616|FG000|Run-In Period 1|Withdrawal by Subject|4|||
23558179|NCT02686034|65769617|FG001|Run-In Period 1|Withdrawal by Subject|3|||
23147572|NCT00455325|64290952|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
23147573|NCT00455325|64290953|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
23147574|NCT00455325|64290954|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
23558180|NCT02686034|65769616|FG000|Run-In Period 1|Lost to Follow-up|4|||
23147575|NCT01933113|64290955|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
23558181|NCT02686034|65769617|FG001|Run-In Period 1|Lost to Follow-up|4|||
23558182|NCT02686034|65769616|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
23558183|NCT02686034|65769617|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
23558184|NCT02686034|65769616|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
23558185|NCT02686034|65769617|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
23218755|NCT01922739|64541716|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
23218756|NCT01922739|64541716|FG000|Open-label Treatment Period|Protocol Violation|5|||
23218757|NCT01922739|64541716|FG000|Open-label Treatment Period|Pregnancy|1|||
23218758|NCT01922739|64541716|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
23218759|NCT01922739|64541716|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
23218760|NCT01922739|64541716|FG000|Open-label Treatment Period|Physician Decision|1|||
23218761|NCT01922739|64541716|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
23218762|NCT01181141|64541717|FG000|Overall Study|Adverse Event|2|||
23218763|NCT01181141|64541718|FG001|Overall Study|Adverse Event|1|||
23218764|NCT01181141|64541717|FG000|Overall Study|Lack of Efficacy|1|||
23218765|NCT01181141|64541718|FG001|Overall Study|Lack of Efficacy|0|||
23218766|NCT01181141|64541717|FG000|Overall Study|Lost to Follow-up|1|||
23218767|NCT01181141|64541718|FG001|Overall Study|Lost to Follow-up|1|||
23218768|NCT01181141|64541717|FG000|Overall Study|Physician Decision|2|||
23218769|NCT01181141|64541718|FG001|Overall Study|Physician Decision|0|||
23218770|NCT01181141|64541717|FG000|Overall Study|Protocol Violation|3|||
23218771|NCT01181141|64541718|FG001|Overall Study|Protocol Violation|1|||
23218772|NCT01181141|64541717|FG000|Overall Study|Withdrawal by Subject|3|||
23218773|NCT01181141|64541718|FG001|Overall Study|Withdrawal by Subject|1|||
23218774|NCT01176240|64541719|FG000|Study 306A|Lack of Efficacy|2|||
23218775|NCT01176240|64541720|FG001|Study 306A|Lack of Efficacy|1|||
23218776|NCT01176240|64541719|FG000|Study 306A|Protocol Violation|0|||
23218777|NCT01176240|64541720|FG001|Study 306A|Protocol Violation|1|||
23218778|NCT01176240|64541719|FG000|Study 306A|Withdrawal by Subject|0|||
23218779|NCT01176240|64541720|FG001|Study 306A|Withdrawal by Subject|1|||
23218780|NCT01176240|64541719|FG000|Study 306A|Stop due to diverse problems|1|||
23218781|NCT01176240|64541720|FG001|Study 306A|Stop due to diverse problems|0|||
23218782|NCT01176240|64541719|FG000|Study 306B|Lack of Efficacy|5|||
23218783|NCT01176240|64541720|FG001|Study 306B|Lack of Efficacy|3|||
23218784|NCT01176240|64541719|FG000|Study 306B|Adverse Event|10|||
23218785|NCT01176240|64541720|FG001|Study 306B|Adverse Event|5|||
23218786|NCT01176240|64541719|FG000|Study 306B|Protocol Violation|2|||
23218787|NCT01176240|64541720|FG001|Study 306B|Protocol Violation|3|||
23218788|NCT01176240|64541719|FG000|Study 306B|Withdrawal by Subject|4|||
23218789|NCT01176240|64541720|FG001|Study 306B|Withdrawal by Subject|1|||
23218790|NCT01176240|64541719|FG000|Study 306B|Physician Decision|2|||
23218791|NCT01176240|64541720|FG001|Study 306B|Physician Decision|1|||
23218792|NCT01176240|64541719|FG000|Study 306B|Supine Hypertension|1|||
23218793|NCT01176240|64541720|FG001|Study 306B|Supine Hypertension|2|||
23218794|NCT01176240|64541719|FG000|Study 306B|Lost to Follow-up|0|||
23218795|NCT01176240|64541720|FG001|Study 306B|Lost to Follow-up|1|||
23218796|NCT01176240|64541719|FG000|Study 306B|withdrew prior to dosing|2|||
23218797|NCT01176240|64541720|FG001|Study 306B|withdrew prior to dosing|1|||
23218798|NCT00092677|64541721|FG000|Overall Study|Lost to Follow-up|0|||
23218799|NCT00092677|64541722|FG001|Overall Study|Lost to Follow-up|2|||
23218800|NCT00092677|64541721|FG000|Overall Study|Adminstrative|5|||
23218801|NCT00092677|64541722|FG001|Overall Study|Adminstrative|9|||
23218802|NCT01587274|64541725|FG000|Overall Study|Lost to Follow-up|4|||
23218803|NCT01587274|64541726|FG001|Overall Study|Lost to Follow-up|5|||
23218804|NCT01587274|64541727|FG002|Overall Study|Lost to Follow-up|3|||
23218805|NCT02563925|64541728|FG000|Overall Study|Withdrawal by Subject|2|||
23218806|NCT00640146|64541729|FG000|Overall Study|Adverse Event|2|||
23218807|NCT00640146|64541730|FG001|Overall Study|Adverse Event|0|||
23218808|NCT00640146|64541729|FG000|Overall Study|Lost to Follow-up|0|||
23218809|NCT00640146|64541730|FG001|Overall Study|Lost to Follow-up|1|||
23218810|NCT00640146|64541729|FG000|Overall Study|Lack of Efficacy|0|||
23218811|NCT00640146|64541730|FG001|Overall Study|Lack of Efficacy|1|||
23218812|NCT00640146|64541729|FG000|Overall Study|Withdrawal by Subject|1|||
23218813|NCT00640146|64541730|FG001|Overall Study|Withdrawal by Subject|1|||
23218814|NCT00640146|64541729|FG000|Overall Study|Randomized but not treated|1|||
23218815|NCT00640146|64541730|FG001|Overall Study|Randomized but not treated|3|||
23218816|NCT03004976|64544659|FG000|Overall Study|Lost to Follow-up|7|||
23218817|NCT03004976|64544660|FG001|Overall Study|Lost to Follow-up|5|||
23218818|NCT03004976|64544659|FG000|Overall Study|Physician Decision|1|||
23218819|NCT03004976|64544660|FG001|Overall Study|Physician Decision|0|||
23218820|NCT03004976|64544659|FG000|Overall Study|Withdrawal by Subject|1|||
23218821|NCT03004976|64544660|FG001|Overall Study|Withdrawal by Subject|0|||
23218822|NCT03004976|64544659|FG000|Overall Study|Death|4|||
23218823|NCT03004976|64544660|FG001|Overall Study|Death|1|||
23218824|NCT03363165|64544662|FG000|3-month Follow-up|Death|0|||
23218825|NCT03363165|64544663|FG001|3-month Follow-up|Death|1|||
23218826|NCT03363165|64544662|FG000|6-month Follow-up|Death|0|||
23218827|NCT03363165|64544663|FG001|6-month Follow-up|Death|1|||
23218828|NCT03363165|64544662|FG000|6-month Follow-up|Withdrawal by Subject|1|||
23218829|NCT03363165|64544663|FG001|6-month Follow-up|Withdrawal by Subject|1|||
23218830|NCT03363165|64544662|FG000|12-month Follow-up|Death|1|||
23218831|NCT03363165|64544663|FG001|12-month Follow-up|Death|1|||
23218832|NCT03363165|64544662|FG000|12-month Follow-up|Withdrawal by Subject|1|||
23558186|NCT02686034|65769616|FG000|Randomized Controlled Period 2|Adverse Event|0|||
23558187|NCT02686034|65769617|FG001|Randomized Controlled Period 2|Adverse Event|2|||
23558188|NCT02686034|65769616|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
23558189|NCT02686034|65769617|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
23558190|NCT02686034|65769616|FG000|Open Label Period 3|Lost to Follow-up|0|||
23558191|NCT02686034|65769617|FG001|Open Label Period 3|Lost to Follow-up|1|||
23558192|NCT00590902|65769623|FG000|Overall Study|Death|1|||
23558193|NCT02090634|65769626|FG000|Overall Study|Lost to Follow-up|0|||
23558194|NCT02090634|65769627|FG001|Overall Study|Lost to Follow-up|1|||
23558195|NCT02090634|65769626|FG000|Overall Study|Death|0|||
23558196|NCT02090634|65769627|FG001|Overall Study|Death|1|||
23558197|NCT02090634|65769626|FG000|Overall Study|Protocol Violation|3|||
23558198|NCT02090634|65769627|FG001|Overall Study|Protocol Violation|1|||
23558199|NCT02090634|65769626|FG000|Overall Study|Adverse Event|2|||
23558200|NCT02090634|65769627|FG001|Overall Study|Adverse Event|0|||
23558201|NCT01471054|65769628|FG000|Overall Study|Study terminated prematurely|4|||
23558202|NCT01471054|65769629|FG001|Overall Study|Study terminated prematurely|0|||
23558203|NCT02831257|65769630|FG000|Overall Study|Lack of Efficacy|3|||
23558204|NCT02831257|65769630|FG000|Overall Study|Adverse Event|2|||
23558205|NCT02831257|65769630|FG000|Overall Study|Physician Decision|1|||
23558206|NCT02831257|65769630|FG000|Overall Study|Withdrawal by Subject|6|||
23558207|NCT00742079|65769631|FG000|Overall Study|Lost to Follow-up|0|||
23558208|NCT00742079|65769632|FG001|Overall Study|Lost to Follow-up|1|||
23558209|NCT00977665|65769633|FG000|Overall Study|Withdrawal by Subject|1|||
23558210|NCT00977665|65769634|FG001|Overall Study|Withdrawal by Subject|3|||
23558211|NCT00977665|65769633|FG000|Overall Study|Physician Decision|2|||
23558212|NCT00977665|65769634|FG001|Overall Study|Physician Decision|1|||
23558213|NCT00977665|65769633|FG000|Overall Study|Sponsor requested withdrawal|0|||
23558214|NCT00977665|65769634|FG001|Overall Study|Sponsor requested withdrawal|1|||
23558215|NCT00977665|65769633|FG000|Overall Study|Lost to Follow-up|1|||
23558216|NCT00977665|65769634|FG001|Overall Study|Lost to Follow-up|0|||
23558217|NCT00977665|65769633|FG000|Overall Study|Death|3|||
23558218|NCT00977665|65769634|FG001|Overall Study|Death|2|||
23558219|NCT00977665|65769633|FG000|Overall Study|Adverse Event|14|||
23558220|NCT00977665|65769634|FG001|Overall Study|Adverse Event|7|||
23558221|NCT00977665|65769633|FG000|Overall Study|Treatment failure|0|||
23558222|NCT00977665|65769634|FG001|Overall Study|Treatment failure|1|||
23558223|NCT02027402|65769635|FG000|Overall Study|Withdrawal by Subject|4|||
23558224|NCT02027402|65769636|FG001|Overall Study|Withdrawal by Subject|1|||
23558225|NCT03315143|65769639|FG000|Overall Study|Death|240|||
23558226|NCT03315143|65769640|FG001|Overall Study|Death|246|||
23558227|NCT03315143|65769639|FG000|Overall Study|Withdrawal by Subject|57|||
23558228|NCT03315143|65769640|FG001|Overall Study|Withdrawal by Subject|68|||
23558229|NCT03315143|65769639|FG000|Overall Study|Site Terminated by Sponsor|256|||
23558230|NCT03315143|65769640|FG001|Overall Study|Site Terminated by Sponsor|282|||
23558231|NCT03315143|65769639|FG000|Overall Study|Study Terminated by Sponsor|4723|||
23558232|NCT03315143|65769640|FG001|Overall Study|Study Terminated by Sponsor|4664|||
23558233|NCT03315143|65769639|FG000|Overall Study|Reason not Specified|16|||
23558234|NCT03315143|65769640|FG001|Overall Study|Reason not Specified|32|||
23558235|NCT01666951|65769647|FG000|Overall Study|Not dosed|1|||
23558236|NCT01666951|65769648|FG001|Overall Study|Not dosed|1|||
23558237|NCT00985725|65769649|FG000|Overall Study|Adverse Event|4|||
23558238|NCT00985725|65769650|FG001|Overall Study|Adverse Event|1|||
23558239|NCT00985725|65769649|FG000|Overall Study|Protocol Violation|1|||
23558240|NCT00985725|65769650|FG001|Overall Study|Protocol Violation|3|||
23558241|NCT00985725|65769649|FG000|Overall Study|Withdrawal by Subject|4|||
23558242|NCT00985725|65769650|FG001|Overall Study|Withdrawal by Subject|4|||
23147576|NCT01201343|64290956|FG000|Overall Study|Adverse Event|6|||
23147577|NCT01201343|64290956|FG000|Overall Study|Withdrawal by Subject|5|||
23147578|NCT01201343|64290956|FG000|Overall Study|Lost to Follow-up|2|||
23147579|NCT01201343|64290956|FG000|Overall Study|Lack of Efficacy|2|||
23147580|NCT01201343|64290956|FG000|Overall Study|Participant wrongly included in trial|1|||
23147581|NCT01201343|64290956|FG000|Overall Study|Randomized, not treated|3|||
23147582|NCT00001962|64290957|FG000|Overall Study|Lack of Efficacy|18|||
23147583|NCT00001962|64290957|FG000|Overall Study|Lack of Accrual|6|||
23218833|NCT03363165|64544663|FG001|12-month Follow-up|Withdrawal by Subject|1|||
23558243|NCT00985725|65769649|FG000|Overall Study|Lost to Follow-up|1|||
23558244|NCT00985725|65769650|FG001|Overall Study|Lost to Follow-up|1|||
23558245|NCT00985725|65769649|FG000|Overall Study|Lack of Efficacy|0|||
23558246|NCT00985725|65769650|FG001|Overall Study|Lack of Efficacy|1|||
23558247|NCT00985725|65769649|FG000|Overall Study|Non-compliance|1|||
23558248|NCT00985725|65769650|FG001|Overall Study|Non-compliance|2|||
23218834|NCT02699125|64544664|FG000|Placebo|Lost to Follow-up|2|||
23558249|NCT00985725|65769649|FG000|Overall Study|Out-of-window visits|0|||
23558250|NCT00985725|65769650|FG001|Overall Study|Out-of-window visits|1|||
23558251|NCT02487472|65769652|FG000|Overall Study|Did not complete telephonic interviews|9|||
23558252|NCT02487472|65769652|FG000|Overall Study|Other|2|||
23558253|NCT02240108|65772421|FG000|Overall Study|Other than specified|8|||
23437337|NCT02292706|65344049|FG003|Overall Study|Subject terminated by sponsor|2|||
23558254|NCT02240108|65772422|FG001|Overall Study|Other than specified|6|||
23558255|NCT02240108|65772421|FG000|Overall Study|Adverse Event|1|||
23558256|NCT02240108|65772422|FG001|Overall Study|Adverse Event|9|||
23558257|NCT02240108|65772421|FG000|Overall Study|Pregnancy|1|||
23147584|NCT00001962|64290957|FG000|Overall Study|Death|1|||
23558258|NCT02240108|65772422|FG001|Overall Study|Pregnancy|0|||
23558259|NCT02240108|65772421|FG000|Overall Study|Withdrawal by Subject|4|||
23558260|NCT02240108|65772422|FG001|Overall Study|Withdrawal by Subject|9|||
23558261|NCT02240108|65772421|FG000|Overall Study|StudyTerminated by Sponsor|0|||
23147585|NCT00001962|64290957|FG000|Overall Study|Lost to Follow-up|2|||
23147586|NCT00001962|64290957|FG000|Overall Study|Adverse Event|1|||
23147587|NCT03406260|64290958|FG000|Period 1|Adverse Event|0|||
23147588|NCT03406260|64290959|FG001|Period 1|Adverse Event|0|||
23147589|NCT03406260|64290960|FG002|Period 1|Adverse Event|0|||
23147590|NCT03406260|64290961|FG003|Period 1|Adverse Event|0|||
23147591|NCT03406260|64290962|FG004|Period 1|Adverse Event|1|||
23147592|NCT03406260|64290963|FG005|Period 1|Adverse Event|0|||
23147593|NCT01000636|64290964|FG000|Overall Study|Withdrawal by Subject|1|||
23147594|NCT01000636|64290964|FG000|Overall Study|Adverse Event|1|||
23147595|NCT04484831|64290965|FG000|Overall Study|Withdrawal by Subject|1|||
23147596|NCT04484831|64290966|FG001|Overall Study|Withdrawal by Subject|0|||
23147597|NCT02739360|64290969|FG000|Overall Study|Adverse Event|1|||
23147598|NCT02739360|64290969|FG000|Overall Study|Study terminated by Sponsor|2|||
23147599|NCT03575143|64290974|FG000|Overall Study|Lost to Follow-up|0|||
23147600|NCT03575143|64290975|FG001|Overall Study|Lost to Follow-up|0|||
23147601|NCT03575143|64290976|FG002|Overall Study|Lost to Follow-up|4|||
23147602|NCT03575143|64290974|FG000|Overall Study|Withdrawal by Subject|0|||
23147603|NCT03575143|64290975|FG001|Overall Study|Withdrawal by Subject|0|||
23147604|NCT03575143|64290976|FG002|Overall Study|Withdrawal by Subject|5|||
23147605|NCT03575143|64290974|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
23147606|NCT03575143|64290975|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
23147607|NCT03575143|64290976|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
23147608|NCT00760669|64290977|FG000|Overall Study|Not assessed for overall improvement|18|||
23147609|NCT00760669|64290977|FG000|Overall Study|Participants missing efficacy assessment|6|||
23147610|NCT00760669|64290977|FG000|Overall Study|Participants with overlapping cases|1|||
23147611|NCT00760669|64290977|FG000|Overall Study|Took drug before entering in contract|5|||
23147612|NCT02824263|64290978|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
23147613|NCT02824263|64290979|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
23147614|NCT02824263|64290978|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
23147615|NCT02824263|64290979|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
23147616|NCT01774110|64290982|FG000|Overall Study|Lost to Follow-up|7|||
23147617|NCT01929980|64290983|FG000|Overall Study|Physician Decision|1|||
23147618|NCT01272947|64290986|FG000|Overall Study|Abnormal Laboratory Value|2|||
23147619|NCT01272947|64290987|FG001|Overall Study|Abnormal Laboratory Value|2|||
23147620|NCT01716117|64290988|FG000|Overall Study|Death|5|||
23147621|NCT01716117|64290989|FG001|Overall Study|Death|2|||
23437338|NCT02292706|65344050|FG004|Overall Study|Subject terminated by sponsor|1|||
23558262|NCT02240108|65772422|FG001|Overall Study|StudyTerminated by Sponsor|1|||
23558263|NCT02130284|65772423|FG000|Overall Study|Withdrawal by Subject|3|||
23147622|NCT01716117|64290988|FG000|Overall Study|Withdrawal by Subject|2|||
23147623|NCT01716117|64290989|FG001|Overall Study|Withdrawal by Subject|0|||
23147624|NCT02141074|64290993|FG000|Pre-prophylaxis|Adverse Event|3|||
23147625|NCT02141074|64290994|FG001|Pre-prophylaxis|Adverse Event|0|||
23147626|NCT02141074|64290993|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
23147627|NCT02141074|64290994|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
23147628|NCT02141074|64290993|FG000|Prophylaxis|Adverse Event|0|||
23147629|NCT02141074|64290994|FG001|Prophylaxis|Adverse Event|4|||
23147630|NCT02141074|64290993|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
23147631|NCT02141074|64290994|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
23147632|NCT02141074|64290993|FG000|Prophylaxis|Withdrawal by Subject|0|||
23147633|NCT02141074|64290994|FG001|Prophylaxis|Withdrawal by Subject|1|||
23147634|NCT01603082|64290996|FG000|Overall Study|Adverse Event|0|||
23147635|NCT01603082|64290997|FG001|Overall Study|Adverse Event|1|||
23147636|NCT01603082|64290996|FG000|Overall Study|Withdrawal by Subject|1|||
23437339|NCT02292706|65344051|FG005|Overall Study|Subject terminated by sponsor|0|||
23558264|NCT02130284|65772423|FG000|Overall Study|Subject Withdrew Consent|1|||
23558265|NCT02130284|65772423|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
23147637|NCT01603082|64290997|FG001|Overall Study|Withdrawal by Subject|0|||
23147638|NCT01603082|64290996|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
23147639|NCT01603082|64290997|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
23147640|NCT01016977|64290999|FG000|Overall Study|Lost to Follow-up|1|||
23147641|NCT01016977|64291000|FG001|Overall Study|Lost to Follow-up|0|||
23147642|NCT01016977|64290999|FG000|Overall Study|Withdrawal by Subject|2|||
23147643|NCT01016977|64291000|FG001|Overall Study|Withdrawal by Subject|2|||
23218835|NCT02699125|64544665|FG001|Placebo|Lost to Follow-up|0|||
23218836|NCT02699125|64544664|FG000|Placebo|Protocol Violation|1|||
23218837|NCT02699125|64544665|FG001|Placebo|Protocol Violation|0|||
23218838|NCT02699125|64544664|FG000|Placebo|Withdrawal by Subject|0|||
23218839|NCT02699125|64544665|FG001|Placebo|Withdrawal by Subject|4|||
23218840|NCT02699125|64544664|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
23218841|NCT02699125|64544665|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
23218842|NCT00845845|64544666|FG000|Overall Study|Lost to Follow-up|0|||
23218843|NCT00845845|64544667|FG001|Overall Study|Lost to Follow-up|4|||
23218844|NCT00251589|64544669|FG000|Overall Study|Adverse Event|5|||
23218845|NCT00251589|64544670|FG001|Overall Study|Adverse Event|1|||
23218846|NCT00251589|64544671|FG002|Overall Study|Adverse Event|2|||
23218847|NCT00251589|64544672|FG003|Overall Study|Adverse Event|1|||
23218848|NCT00251589|64544669|FG000|Overall Study|Withdrawal by Subject|1|||
23218849|NCT00251589|64544670|FG001|Overall Study|Withdrawal by Subject|1|||
23218850|NCT00251589|64544671|FG002|Overall Study|Withdrawal by Subject|0|||
23218851|NCT00251589|64544672|FG003|Overall Study|Withdrawal by Subject|0|||
23218852|NCT00251589|64544669|FG000|Overall Study|Discontinued due to progressive disease|9|||
23218853|NCT00251589|64544670|FG001|Overall Study|Discontinued due to progressive disease|1|||
23218854|NCT00251589|64544671|FG002|Overall Study|Discontinued due to progressive disease|0|||
23218855|NCT00251589|64544672|FG003|Overall Study|Discontinued due to progressive disease|1|||
23218856|NCT00318370|64544682|FG000|Period 1|Lack of Efficacy|5|||
23218857|NCT00318370|64544683|FG001|Period 1|Lack of Efficacy|0|||
23218858|NCT00318370|64544684|FG002|Period 1|Lack of Efficacy|0|||
23218859|NCT00318370|64544682|FG000|Period 1|Physician Decision|1|||
23218860|NCT00318370|64544683|FG001|Period 1|Physician Decision|0|||
23218861|NCT00318370|64544684|FG002|Period 1|Physician Decision|0|||
23218862|NCT00318370|64544682|FG000|Period 1|Withdrawal by Subject|1|||
23218863|NCT00318370|64544683|FG001|Period 1|Withdrawal by Subject|0|||
23218864|NCT00318370|64544684|FG002|Period 1|Withdrawal by Subject|0|||
23218865|NCT00318370|64544682|FG000|Period 2|Adverse Event|0|||
23218866|NCT00318370|64544683|FG001|Period 2|Adverse Event|3|||
23218867|NCT00318370|64544684|FG002|Period 2|Adverse Event|0|||
23218868|NCT00318370|64544682|FG000|Period 2|Lack of Efficacy|0|||
23558266|NCT02130284|65772423|FG000|Overall Study|Subject was screened as backup for study|3|||
23558267|NCT02130284|65772423|FG000|Overall Study|Screen Failure|1|||
23558268|NCT02636270|65772424|FG000|Overall Study|Adverse Event|1|||
23558269|NCT02636270|65772425|FG001|Overall Study|Adverse Event|0|||
23558270|NCT02636270|65772426|FG002|Overall Study|Adverse Event|0|||
23558271|NCT02636270|65772424|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
23558272|NCT02636270|65772425|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
23558273|NCT02636270|65772426|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
23558274|NCT04225988|65772427|FG000|Overall Study|Withdrawal by Subject|2|||
23558275|NCT04225988|65772428|FG001|Overall Study|Withdrawal by Subject|0|||
23558276|NCT02569710|65772429|FG000|Overall Study|Adverse Event|1|||
23558277|NCT02569710|65772430|FG001|Overall Study|Adverse Event|0|||
23558278|NCT02569710|65772431|FG002|Overall Study|Adverse Event|0|||
23558279|NCT02569710|65772432|FG003|Overall Study|Adverse Event|0|||
23558280|NCT02569710|65772433|FG004|Overall Study|Adverse Event|0|||
23558281|NCT02569710|65772434|FG005|Overall Study|Adverse Event|0|||
23558282|NCT02569710|65772435|FG006|Overall Study|Adverse Event|0|||
23558283|NCT02569710|65772436|FG007|Overall Study|Adverse Event|0|||
23558284|NCT02569710|65772437|FG008|Overall Study|Adverse Event|0|||
23558285|NCT02569710|65772438|FG009|Overall Study|Adverse Event|0|||
23558286|NCT02569710|65772429|FG000|Overall Study|Lost to Follow-up|0|||
23558287|NCT02569710|65772430|FG001|Overall Study|Lost to Follow-up|0|||
23558288|NCT02569710|65772431|FG002|Overall Study|Lost to Follow-up|0|||
23558289|NCT02569710|65772432|FG003|Overall Study|Lost to Follow-up|0|||
23558290|NCT02569710|65772433|FG004|Overall Study|Lost to Follow-up|0|||
23558291|NCT02569710|65772434|FG005|Overall Study|Lost to Follow-up|0|||
23558292|NCT02569710|65772435|FG006|Overall Study|Lost to Follow-up|1|||
23558293|NCT02569710|65772436|FG007|Overall Study|Lost to Follow-up|0|||
23558294|NCT02569710|65772437|FG008|Overall Study|Lost to Follow-up|1|||
23558295|NCT02569710|65772438|FG009|Overall Study|Lost to Follow-up|0|||
23558296|NCT02569710|65772429|FG000|Overall Study|Virologic failure|0|||
23558297|NCT02569710|65772430|FG001|Overall Study|Virologic failure|0|||
23558298|NCT02569710|65772431|FG002|Overall Study|Virologic failure|0|||
23558299|NCT02569710|65772432|FG003|Overall Study|Virologic failure|0|||
23558300|NCT02569710|65772433|FG004|Overall Study|Virologic failure|1|||
23558301|NCT02569710|65772434|FG005|Overall Study|Virologic failure|0|||
23558302|NCT02569710|65772435|FG006|Overall Study|Virologic failure|1|||
23218869|NCT00318370|64544683|FG001|Period 2|Lack of Efficacy|5|||
23218870|NCT00318370|64544684|FG002|Period 2|Lack of Efficacy|0|||
23218871|NCT00318370|64544682|FG000|Period 2|Physician Decision|0|||
23218872|NCT00318370|64544683|FG001|Period 2|Physician Decision|1|||
23218873|NCT00318370|64544684|FG002|Period 2|Physician Decision|0|||
23218874|NCT00318370|64544682|FG000|Period 2|Withdrawal by Subject|0|||
23558303|NCT02569710|65772436|FG007|Overall Study|Virologic failure|0|||
23623849|NCT00632931|66008590|FG001|Part 2|Lack of Efficacy|0|||
23623850|NCT00632931|66008591|FG002|Part 2|Lack of Efficacy|17|||
23623851|NCT00632931|66008589|FG000|Part 2|Withdrawal by Subject|0|||
23623852|NCT00632931|66008590|FG001|Part 2|Withdrawal by Subject|0|||
23623853|NCT00632931|66008591|FG002|Part 2|Withdrawal by Subject|3|||
23623854|NCT02826798|66008592|FG000|Overall Study|Withdrawal by Subject|0|||
23623855|NCT02826798|66008593|FG001|Overall Study|Withdrawal by Subject|1|||
23623856|NCT02826798|66008594|FG002|Overall Study|Withdrawal by Subject|0|||
23623857|NCT02826798|66008595|FG003|Overall Study|Withdrawal by Subject|1|||
23623858|NCT02826798|66008596|FG004|Overall Study|Withdrawal by Subject|0|||
23623859|NCT00506922|66011464|FG000|Overall Study|Physician Decision|0|||
23623860|NCT00506922|66011465|FG001|Overall Study|Physician Decision|0|||
23623861|NCT00506922|66011466|FG002|Overall Study|Physician Decision|0|||
23623862|NCT00506922|66011467|FG003|Overall Study|Physician Decision|2|||
23623863|NCT00506922|66011468|FG004|Overall Study|Physician Decision|0|||
23623864|NCT00506922|66011464|FG000|Overall Study|Withdrawal by Subject|0|||
23623865|NCT00506922|66011465|FG001|Overall Study|Withdrawal by Subject|0|||
23623866|NCT00506922|66011466|FG002|Overall Study|Withdrawal by Subject|0|||
23623867|NCT00506922|66011467|FG003|Overall Study|Withdrawal by Subject|0|||
23623868|NCT00506922|66011468|FG004|Overall Study|Withdrawal by Subject|1|||
23623869|NCT01268098|66011476|FG000|Overall Study|Adverse Event|1|||
23623870|NCT01268098|66011477|FG001|Overall Study|Adverse Event|0|||
23623871|NCT02741713|66011478|FG000|Overall Study|Surgery type changed intra-operatively|2|||
23623872|NCT02741713|66011479|FG001|Overall Study|Surgery type changed intra-operatively|1|||
23623873|NCT00887198|66011481|FG000|Randomized Period|Ongoing|42|||
23558304|NCT02569710|65772437|FG008|Overall Study|Virologic failure|0|||
23558305|NCT02569710|65772438|FG009|Overall Study|Virologic failure|0|||
23558306|NCT02569710|65772429|FG000|Overall Study|Withdrawal by Subject|0|||
23558307|NCT02569710|65772430|FG001|Overall Study|Withdrawal by Subject|0|||
23558308|NCT02569710|65772431|FG002|Overall Study|Withdrawal by Subject|0|||
23558309|NCT02569710|65772432|FG003|Overall Study|Withdrawal by Subject|0|||
23623874|NCT00887198|66011482|FG001|Randomized Period|Ongoing|0|||
23623875|NCT00887198|66011483|FG002|Randomized Period|Ongoing|0|||
23147644|NCT01786174|64291001|FG000|Overall Study|Discontinued Study Drug|2|||
23147645|NCT01786174|64291002|FG001|Overall Study|Discontinued Study Drug|0|||
23147646|NCT00084266|64291003|FG000|Overall Study|Death|42|||
23147647|NCT00084266|64291004|FG001|Overall Study|Death|39|||
23147648|NCT00084266|64291003|FG000|Overall Study|Adverse Event|8|||
23147649|NCT00084266|64291004|FG001|Overall Study|Adverse Event|5|||
23147650|NCT00084266|64291003|FG000|Overall Study|Lack of Efficacy|2|||
23147651|NCT00084266|64291004|FG001|Overall Study|Lack of Efficacy|4|||
23147652|NCT00084266|64291003|FG000|Overall Study|Lost to Follow-up|5|||
23147653|NCT00084266|64291004|FG001|Overall Study|Lost to Follow-up|3|||
23147654|NCT00084266|64291003|FG000|Overall Study|Participant not willing to participate|3|||
23147655|NCT00084266|64291004|FG001|Overall Study|Participant not willing to participate|8|||
23147656|NCT00084266|64291003|FG000|Overall Study|Other|360|||
23558310|NCT02569710|65772433|FG004|Overall Study|Withdrawal by Subject|0|||
23623876|NCT00887198|66011481|FG000|Randomized Period|Adverse Event|50|||
23623877|NCT00887198|66011482|FG001|Randomized Period|Adverse Event|33|||
23623878|NCT00887198|66011483|FG002|Randomized Period|Adverse Event|0|||
23623879|NCT00887198|66011481|FG000|Randomized Period|Lost to Follow-up|1|||
23623880|NCT00887198|66011482|FG001|Randomized Period|Lost to Follow-up|0|||
23147657|NCT00084266|64291004|FG001|Overall Study|Other|344|||
23147658|NCT00084266|64291003|FG000|Overall Study|Randomized not treated|21|||
23147659|NCT00084266|64291004|FG001|Overall Study|Randomized not treated|20|||
23147660|NCT01256658|64291005|FG000|Period 1|Lost to Follow-up|837|||
23147661|NCT01256658|64291006|FG001|Period 1|Lost to Follow-up|661|||
23147662|NCT01256658|64291005|FG000|Period 1|Withdrawal by Subject|35|||
23147663|NCT01256658|64291006|FG001|Period 1|Withdrawal by Subject|43|||
23147664|NCT01256658|64291005|FG000|Period 1|Death|48|||
23147665|NCT01256658|64291006|FG001|Period 1|Death|44|||
23558311|NCT02569710|65772434|FG005|Overall Study|Withdrawal by Subject|1|||
23558312|NCT02569710|65772435|FG006|Overall Study|Withdrawal by Subject|0|||
23558313|NCT02569710|65772436|FG007|Overall Study|Withdrawal by Subject|0|||
23558314|NCT02569710|65772437|FG008|Overall Study|Withdrawal by Subject|0|||
23558315|NCT02569710|65772438|FG009|Overall Study|Withdrawal by Subject|0|||
23558316|NCT01971723|65772439|FG000|Overall Study|Withdrawal by Subject|1|||
23558317|NCT01971723|65772440|FG001|Overall Study|Withdrawal by Subject|1|||
23558318|NCT01971723|65772439|FG000|Overall Study|Protocol Violation|1|||
23558319|NCT01971723|65772440|FG001|Overall Study|Protocol Violation|2|||
23623881|NCT00887198|66011483|FG002|Randomized Period|Lost to Follow-up|0|||
23623882|NCT00887198|66011481|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
23623883|NCT00887198|66011482|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
23623884|NCT00887198|66011483|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
23623885|NCT00887198|66011481|FG000|Randomized Period|Withdrawal by Subject|41|||
23623886|NCT00887198|66011482|FG001|Randomized Period|Withdrawal by Subject|56|||
23147666|NCT03437278|64291007|FG000|Overall Study|Adverse Event|0|||
23623887|NCT00887198|66011483|FG002|Randomized Period|Withdrawal by Subject|0|||
23322606|NCT01459783|64923055|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
23322607|NCT01459783|64923056|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
23322608|NCT00709995|64923057|FG000|Overall Study|Adverse Event|4|||
23322609|NCT00709995|64923058|FG001|Overall Study|Adverse Event|2|||
23322610|NCT00709995|64923057|FG000|Overall Study|Withdrawal by Subject|1|||
23322611|NCT00709995|64923058|FG001|Overall Study|Withdrawal by Subject|3|||
23322612|NCT04700137|64923059|FG000|Overall Study|Lost to Follow-up|1|||
23322613|NCT04700137|64923060|FG001|Overall Study|Lost to Follow-up|6|||
23322614|NCT04700137|64923061|FG002|Overall Study|Lost to Follow-up|1|||
23322615|NCT04700137|64923062|FG003|Overall Study|Lost to Follow-up|1|||
23322616|NCT04700137|64923059|FG000|Overall Study|Withdrawal by Subject|0|||
23322617|NCT04700137|64923060|FG001|Overall Study|Withdrawal by Subject|0|||
23322618|NCT04700137|64923061|FG002|Overall Study|Withdrawal by Subject|1|||
23322619|NCT04700137|64923062|FG003|Overall Study|Withdrawal by Subject|0|||
23322620|NCT04700137|64923059|FG000|Overall Study|Death|0|||
23558320|NCT00593567|65772443|FG000|Overall Study|Adverse Event|2|||
23558321|NCT00593567|65772444|FG001|Overall Study|Adverse Event|0|||
23558322|NCT00593567|65772443|FG000|Overall Study|Physician Decision|2|||
23558323|NCT00593567|65772444|FG001|Overall Study|Physician Decision|0|||
23558324|NCT00593567|65772443|FG000|Overall Study|Protocol Violation|13|||
23558325|NCT00593567|65772444|FG001|Overall Study|Protocol Violation|7|||
23558326|NCT00593567|65772443|FG000|Overall Study|Lack of Efficacy|2|||
23558327|NCT00593567|65772444|FG001|Overall Study|Lack of Efficacy|1|||
23558328|NCT00593567|65772443|FG000|Overall Study|Withdrawal by Subject|1|||
23558329|NCT00593567|65772444|FG001|Overall Study|Withdrawal by Subject|2|||
23558330|NCT02220894|65772445|FG000|Overall Study|Adverse Event|127|||
23558331|NCT02220894|65772446|FG001|Overall Study|Adverse Event|74|||
23558332|NCT02220894|65772445|FG000|Overall Study|Death|418|||
23558333|NCT02220894|65772446|FG001|Overall Study|Death|508|||
23558334|NCT02220894|65772445|FG000|Overall Study|Lost to Follow-up|0|||
23558335|NCT02220894|65772446|FG001|Overall Study|Lost to Follow-up|4|||
23558336|NCT02220894|65772445|FG000|Overall Study|Site Terminated by Sponsor|2|||
23558337|NCT02220894|65772446|FG001|Overall Study|Site Terminated by Sponsor|0|||
23558338|NCT02220894|65772445|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
23558339|NCT02220894|65772446|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
23558340|NCT02220894|65772445|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23558341|NCT02220894|65772446|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23558342|NCT02220894|65772445|FG000|Overall Study|Withdrawal by Subject|10|||
23558343|NCT02220894|65772446|FG001|Overall Study|Withdrawal by Subject|9|||
23558344|NCT00538590|65772448|FG000|Overall Study|Death|1|||
23558345|NCT00538590|65772449|FG001|Overall Study|Death|0|||
23147667|NCT03437278|64291008|FG001|Overall Study|Adverse Event|0|||
23147668|NCT03437278|64291009|FG002|Overall Study|Adverse Event|1|||
23147669|NCT03437278|64291007|FG000|Overall Study|Progressive disease|1|||
23147670|NCT03437278|64291008|FG001|Overall Study|Progressive disease|0|||
23147671|NCT03437278|64291009|FG002|Overall Study|Progressive disease|0|||
23147672|NCT03437278|64291007|FG000|Overall Study|Physician Decision|1|||
23558346|NCT00844857|65772453|FG000|Overall Study|Adverse Event|24|||
23558347|NCT00844857|65772454|FG001|Overall Study|Adverse Event|5|||
23558348|NCT00844857|65772453|FG000|Overall Study|Sponsor Decision|1|||
23558349|NCT00844857|65772454|FG001|Overall Study|Sponsor Decision|1|||
23147673|NCT03437278|64291008|FG001|Overall Study|Physician Decision|0|||
23147674|NCT03437278|64291009|FG002|Overall Study|Physician Decision|1|||
23147675|NCT01488487|64291010|FG000|Overall Study|Adverse Event|6|||
23147676|NCT01488487|64291010|FG000|Overall Study|Death|1|||
23147677|NCT01488487|64291010|FG000|Overall Study|Withdrawal by Subject|2|||
23322621|NCT04700137|64923060|FG001|Overall Study|Death|0|||
23322622|NCT04700137|64923061|FG002|Overall Study|Death|1|||
23322623|NCT04700137|64923062|FG003|Overall Study|Death|0|||
23558350|NCT00844857|65772453|FG000|Overall Study|Physician Decision|2|||
23558351|NCT00844857|65772454|FG001|Overall Study|Physician Decision|0|||
23147678|NCT02683941|64291011|FG000|Double-blind Phase|Adverse Event|0|||
23147679|NCT02683941|64291012|FG001|Double-blind Phase|Adverse Event|1|||
23147680|NCT02683941|64291011|FG000|Double-blind Phase|Withdrawal by Subject|4|||
23147681|NCT02683941|64291012|FG001|Double-blind Phase|Withdrawal by Subject|2|||
23147682|NCT02683941|64291011|FG000|Double-blind Phase|Lost to Follow-up|1|||
23147683|NCT02683941|64291012|FG001|Double-blind Phase|Lost to Follow-up|0|||
23147684|NCT02683941|64291011|FG000|Double-blind Phase|Disease Progression|5|||
23147685|NCT02683941|64291012|FG001|Double-blind Phase|Disease Progression|2|||
23147686|NCT02683941|64291011|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
23558352|NCT00844857|65772453|FG000|Overall Study|Parent/Caregiver Decision|6|||
23558353|NCT00844857|65772454|FG001|Overall Study|Parent/Caregiver Decision|2|||
23147687|NCT02683941|64291012|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
23322624|NCT04981717|64923063|FG000|Overall Study|Protocol Violation|0|||
23558354|NCT00844857|65772453|FG000|Overall Study|Withdrawal by Subject|8|||
23558355|NCT00844857|65772454|FG001|Overall Study|Withdrawal by Subject|7|||
23558356|NCT00844857|65772453|FG000|Overall Study|Protocol Violation|6|||
23558357|NCT00844857|65772454|FG001|Overall Study|Protocol Violation|0|||
23623888|NCT00887198|66011481|FG000|Randomized Period|Progressive disease|366|||
23623889|NCT00887198|66011482|FG001|Randomized Period|Progressive disease|370|||
23623890|NCT00887198|66011483|FG002|Randomized Period|Progressive disease|0|||
23623891|NCT00887198|66011481|FG000|Randomized Period|Other|42|||
23623892|NCT00887198|66011482|FG001|Randomized Period|Other|30|||
23623893|NCT00887198|66011483|FG002|Randomized Period|Other|0|||
23623894|NCT00887198|66011481|FG000|Randomized Period|Randomized, Not treated|4|||
23623895|NCT00887198|66011482|FG001|Randomized Period|Randomized, Not treated|2|||
23623896|NCT00887198|66011483|FG002|Randomized Period|Randomized, Not treated|0|||
23623897|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
23623898|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
23623899|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
23623900|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
23623901|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
23623902|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
23623903|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
23623904|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
23623905|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
23623906|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
23623907|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
23623908|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
23623909|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
23623910|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
23623911|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
23623912|NCT00887198|66011481|FG000|Cross Over (Placebo to AA)|Other|0|||
23623913|NCT00887198|66011482|FG001|Cross Over (Placebo to AA)|Other|0|||
23623914|NCT00887198|66011483|FG002|Cross Over (Placebo to AA)|Other|19|||
23558358|NCT00844857|65772453|FG000|Overall Study|Lack of Efficacy|5|||
23623915|NCT01588366|66011490|FG000|Overall Study|Adverse Event|0|||
23623916|NCT01588366|66011491|FG001|Overall Study|Adverse Event|1|||
23558359|NCT00844857|65772454|FG001|Overall Study|Lack of Efficacy|5|||
23558360|NCT00844857|65772453|FG000|Overall Study|Clinical Relapse|0|||
23558361|NCT00844857|65772454|FG001|Overall Study|Clinical Relapse|1|||
23558362|NCT00844857|65772453|FG000|Overall Study|Entry Criteria Not Met|0|||
23558363|NCT00844857|65772454|FG001|Overall Study|Entry Criteria Not Met|1|||
23558364|NCT00844857|65772453|FG000|Overall Study|Lost to Follow-up|2|||
23558365|NCT00844857|65772454|FG001|Overall Study|Lost to Follow-up|3|||
23558366|NCT00844857|65772453|FG000|Overall Study|Did Not Take Study Drug|3|||
23558367|NCT00844857|65772454|FG001|Overall Study|Did Not Take Study Drug|1|||
23558368|NCT00844857|65772453|FG000|Overall Study|Good Clinical Practice Violations|21|||
23558369|NCT00844857|65772454|FG001|Overall Study|Good Clinical Practice Violations|11|||
23558370|NCT02403180|65772455|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
23558371|NCT02403180|65772456|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
23558372|NCT02403180|65772455|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
23558373|NCT02403180|65772456|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
23558374|NCT00105235|65772459|FG000|Overall Study|Death|4|||
23558375|NCT00105235|65772459|FG000|Overall Study|Physician Decision|1|||
23558376|NCT00105235|65772459|FG000|Overall Study|Withdrawal by Subject|2|||
23558377|NCT03224182|65772468|FG000|Overall Study|Study Drug Not Instilled|6|||
23558378|NCT03224182|65772469|FG001|Overall Study|Study Drug Not Instilled|1|||
23558379|NCT03224182|65772468|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
23558380|NCT03224182|65772469|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
23558381|NCT03224182|65772468|FG000|Overall Study|Withdrew of Consent|4|||
23558382|NCT03224182|65772469|FG001|Overall Study|Withdrew of Consent|2|||
23558383|NCT03224182|65772468|FG000|Overall Study|Investigator Decision|3|||
23558384|NCT03224182|65772469|FG001|Overall Study|Investigator Decision|1|||
23558385|NCT03224182|65772468|FG000|Overall Study|Sponsor Decision|26|||
23558386|NCT03224182|65772469|FG001|Overall Study|Sponsor Decision|12|||
23623917|NCT01588366|66011492|FG002|Overall Study|Adverse Event|0|||
23623918|NCT01588366|66011493|FG003|Overall Study|Adverse Event|1|||
23623919|NCT01588366|66011494|FG004|Overall Study|Adverse Event|0|||
23322625|NCT04981717|64923064|FG001|Overall Study|Protocol Violation|3|||
23558387|NCT03224182|65772468|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
23558388|NCT03224182|65772469|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
23558389|NCT03224182|65772468|FG000|Overall Study|Lost to Follow-up|1|||
23558390|NCT03224182|65772469|FG001|Overall Study|Lost to Follow-up|0|||
23558391|NCT03224182|65772468|FG000|Overall Study|Participant Had Recurrence|11|||
23623920|NCT01588366|66011495|FG005|Overall Study|Adverse Event|2|||
23623921|NCT02104505|66011498|FG000|First Intervention (14 Days)|Adverse Event|2|||
23623922|NCT02104505|66011499|FG001|First Intervention (14 Days)|Adverse Event|0|||
23623923|NCT02104505|66011498|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
23623924|NCT02104505|66011499|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
23623925|NCT02104505|66011498|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
23218875|NCT00318370|64544683|FG001|Period 2|Withdrawal by Subject|1|||
23147688|NCT02683941|64291011|FG000|Open-label Treatment Phase|Disease Progression|1|||
23147689|NCT02683941|64291012|FG001|Open-label Treatment Phase|Disease Progression|2|||
23147690|NCT02683941|64291011|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
23147691|NCT02683941|64291012|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
23147692|NCT02683941|64291011|FG000|Open-label Treatment Phase|Other|1|||
23147693|NCT02683941|64291012|FG001|Open-label Treatment Phase|Other|0|||
23147694|NCT02683941|64291011|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
23147695|NCT02683941|64291012|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
23147696|NCT02683941|64291011|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
23147697|NCT02683941|64291012|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
23147698|NCT02683941|64291011|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
23147699|NCT02683941|64291012|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
23147700|NCT02683941|64291011|FG000|Open-label Follow-up Phase|Other|8|||
23147701|NCT02683941|64291012|FG001|Open-label Follow-up Phase|Other|1|||
23147702|NCT03346057|64291013|FG000|Overall Study|Death|1|||
23147703|NCT03346057|64291014|FG001|Overall Study|Death|2|||
23147704|NCT03346057|64291015|FG002|Overall Study|Death|0|||
23147705|NCT03346057|64291016|FG003|Overall Study|Death|0|||
23147706|NCT03346057|64291013|FG000|Overall Study|Lost to Follow-up|0|||
23147707|NCT03346057|64291014|FG001|Overall Study|Lost to Follow-up|2|||
23147708|NCT03346057|64291015|FG002|Overall Study|Lost to Follow-up|1|||
23147709|NCT03346057|64291016|FG003|Overall Study|Lost to Follow-up|0|||
23147710|NCT03346057|64291013|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
23147711|NCT03346057|64291014|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
23147712|NCT03346057|64291015|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
23147713|NCT03346057|64291016|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
23147714|NCT03346057|64291013|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
23147715|NCT03346057|64291014|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
23147716|NCT03346057|64291015|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
23147717|NCT03346057|64291016|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
23147718|NCT03346057|64291013|FG000|Overall Study|Physician Decision|3|||
23147719|NCT03346057|64291014|FG001|Overall Study|Physician Decision|2|||
23147720|NCT03346057|64291015|FG002|Overall Study|Physician Decision|0|||
23147721|NCT03346057|64291016|FG003|Overall Study|Physician Decision|2|||
23147722|NCT03346057|64291013|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
23147723|NCT03346057|64291014|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
23147724|NCT03346057|64291015|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
23147725|NCT03346057|64291016|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
23147726|NCT03346057|64291013|FG000|Overall Study|Withdrawal by Subject|1|||
23147727|NCT03346057|64291014|FG001|Overall Study|Withdrawal by Subject|0|||
23147728|NCT03346057|64291015|FG002|Overall Study|Withdrawal by Subject|0|||
23147729|NCT03346057|64291016|FG003|Overall Study|Withdrawal by Subject|0|||
23147730|NCT00655863|64291017|FG000|Overall Study|Lost to Follow-up|0|||
23147731|NCT00655863|64291018|FG001|Overall Study|Lost to Follow-up|0|||
23147732|NCT00655863|64291019|FG002|Overall Study|Lost to Follow-up|1|||
23147733|NCT00640016|64291020|FG000|Overall Study|Withdrawal by Subject|0|||
23147734|NCT00640016|64291021|FG001|Overall Study|Withdrawal by Subject|1|||
23147735|NCT00640016|64291022|FG002|Overall Study|Withdrawal by Subject|0|||
23147736|NCT00640016|64291023|FG003|Overall Study|Withdrawal by Subject|0|||
23147737|NCT00640016|64291020|FG000|Overall Study|Study termination|2|||
23322626|NCT04981717|64923063|FG000|Overall Study|Adverse Event|1|||
23322627|NCT04981717|64923064|FG001|Overall Study|Adverse Event|3|||
23558392|NCT03224182|65772469|FG001|Overall Study|Participant Had Recurrence|5|||
23558393|NCT03224182|65772468|FG000|Overall Study|Death|0|||
23558394|NCT03224182|65772469|FG001|Overall Study|Death|1|||
23558395|NCT03224182|65772468|FG000|Overall Study|Reason not Specified|3|||
23558396|NCT03224182|65772469|FG001|Overall Study|Reason not Specified|3|||
23558397|NCT03224182|65772468|FG000|Overall Study|Other|1|||
23558398|NCT03224182|65772469|FG001|Overall Study|Other|0|||
23558399|NCT03021668|65772470|FG000|Overall Study|Physician Decision|0|||
23558400|NCT03021668|65772471|FG001|Overall Study|Physician Decision|1|||
23558401|NCT02054806|65772474|FG000|Overall Study|Sponsor Decision|31|||
23558402|NCT02054806|65772474|FG000|Overall Study|Withdrawal by Subject|43|||
23623926|NCT02104505|66011499|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
23623927|NCT02104505|66011498|FG000|First Intervention (14 Days)|exclusionary condition|0|||
23147738|NCT00640016|64291021|FG001|Overall Study|Study termination|1|||
23147739|NCT00640016|64291022|FG002|Overall Study|Study termination|3|||
23147740|NCT00640016|64291023|FG003|Overall Study|Study termination|2|||
23147741|NCT00640016|64291020|FG000|Overall Study|Adverse Event|0|||
23147742|NCT00640016|64291021|FG001|Overall Study|Adverse Event|0|||
23147743|NCT00640016|64291022|FG002|Overall Study|Adverse Event|0|||
23147744|NCT00640016|64291023|FG003|Overall Study|Adverse Event|1|||
23558403|NCT02054806|65772474|FG000|Overall Study|Protocol Violation|2|||
23147745|NCT02187809|64291024|FG000|Overall Study|The study was terminated|3|||
23147746|NCT00107120|64291025|FG000|Overall Study|Adverse Event|4|||
23322628|NCT04981717|64923063|FG000|Overall Study|Pregnancy|1|||
23558404|NCT02054806|65772474|FG000|Overall Study|Lost to Follow-up|10|||
23558405|NCT02054806|65772474|FG000|Overall Study|Death|391|||
23558406|NCT01114204|65772475|FG000|Overall Study|Adverse Event|3|||
23558407|NCT01114204|65772476|FG001|Overall Study|Adverse Event|2|||
23558408|NCT01114204|65772475|FG000|Overall Study|Lost to Follow-up|1|||
23558409|NCT01114204|65772476|FG001|Overall Study|Lost to Follow-up|0|||
23558410|NCT01114204|65772475|FG000|Overall Study|Withdrawal by Subject|10|||
23558411|NCT01114204|65772476|FG001|Overall Study|Withdrawal by Subject|6|||
23558412|NCT01114204|65772475|FG000|Overall Study|Death|1|||
23558413|NCT01114204|65772476|FG001|Overall Study|Death|0|||
23558414|NCT01114204|65772475|FG000|Overall Study|Other-Personal reasons|2|||
23558415|NCT01114204|65772476|FG001|Overall Study|Other-Personal reasons|0|||
23558416|NCT01114204|65772475|FG000|Overall Study|Other-Medical monitor request|1|||
23558417|NCT01114204|65772476|FG001|Overall Study|Other-Medical monitor request|0|||
23558418|NCT01114204|65772475|FG000|Overall Study|Other-Participant request|2|||
23558419|NCT01114204|65772476|FG001|Overall Study|Other-Participant request|0|||
23558420|NCT01114204|65772475|FG000|Overall Study|Other-Protocol Violation|1|||
23558421|NCT01114204|65772476|FG001|Overall Study|Other-Protocol Violation|0|||
23558422|NCT01445652|65772477|FG000|Overall Study|Not comfortable in lenses|5|||
23558423|NCT01445652|65772478|FG001|Overall Study|Not comfortable in lenses|0|||
23558424|NCT01445652|65772477|FG000|Overall Study|Failed to attend scheduled visit|2|||
23558425|NCT01445652|65772478|FG001|Overall Study|Failed to attend scheduled visit|3|||
23558426|NCT01445652|65772477|FG000|Overall Study|Failed teach session|2|||
23558427|NCT01445652|65772478|FG001|Overall Study|Failed teach session|0|||
23558428|NCT01445652|65772477|FG000|Overall Study|Adverse Event|1|||
23558429|NCT01445652|65772478|FG001|Overall Study|Adverse Event|0|||
23558430|NCT03286751|65772480|FG000|Washout Period 1|Withdrawal by Subject|0|||
23558431|NCT03286751|65772481|FG001|Washout Period 1|Withdrawal by Subject|0|||
23558432|NCT03286751|65772482|FG002|Washout Period 1|Withdrawal by Subject|0|||
23558433|NCT03286751|65772483|FG003|Washout Period 1|Withdrawal by Subject|0|||
23558434|NCT03286751|65772484|FG004|Washout Period 1|Withdrawal by Subject|1|||
23558435|NCT03286751|65772485|FG005|Washout Period 1|Withdrawal by Subject|0|||
23558436|NCT03286751|65772480|FG000|Washout Period 2|Personal Reasons|0|||
23558437|NCT03286751|65772481|FG001|Washout Period 2|Personal Reasons|1|||
23558438|NCT03286751|65772482|FG002|Washout Period 2|Personal Reasons|0|||
23558439|NCT03286751|65772483|FG003|Washout Period 2|Personal Reasons|0|||
23558440|NCT03286751|65772484|FG004|Washout Period 2|Personal Reasons|0|||
23558441|NCT03286751|65772485|FG005|Washout Period 2|Personal Reasons|0|||
23558442|NCT03286751|65772480|FG000|Washout Period 5|Adverse Event|0|||
23558443|NCT03286751|65772481|FG001|Washout Period 5|Adverse Event|0|||
23558444|NCT03286751|65772482|FG002|Washout Period 5|Adverse Event|0|||
23558445|NCT03286751|65772483|FG003|Washout Period 5|Adverse Event|0|||
23558446|NCT03286751|65772484|FG004|Washout Period 5|Adverse Event|1|||
23558447|NCT03286751|65772485|FG005|Washout Period 5|Adverse Event|0|||
23558448|NCT01591382|65772495|FG000|Overall Study|Discharged Prior to Study Completion|2|||
23322629|NCT04981717|64923064|FG001|Overall Study|Pregnancy|0|||
23322630|NCT04981717|64923063|FG000|Overall Study|Physician Decision|1|||
23322631|NCT04981717|64923064|FG001|Overall Study|Physician Decision|0|||
23322632|NCT04981717|64923063|FG000|Overall Study|Sponsor Request|157|||
23322633|NCT04981717|64923064|FG001|Overall Study|Sponsor Request|172|||
23322634|NCT04981717|64923063|FG000|Overall Study|Lost to Follow-up|4|||
23322635|NCT04981717|64923064|FG001|Overall Study|Lost to Follow-up|5|||
23322636|NCT04981717|64923063|FG000|Overall Study|Withdrawal by Subject|50|||
23322637|NCT04981717|64923064|FG001|Overall Study|Withdrawal by Subject|37|||
23322638|NCT04352101|64923065|FG000|Overall Study|Physician Decision|2|||
23322639|NCT04352101|64923066|FG001|Overall Study|Physician Decision|1|||
23322640|NCT02002221|64923070|FG000|Overall Study|Adverse Event|2|||
23322641|NCT02002221|64923071|FG001|Overall Study|Adverse Event|1|||
23322642|NCT02002221|64923070|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23322643|NCT02002221|64923071|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23322644|NCT02002221|64923070|FG000|Overall Study|Patient withdrew consent|0|||
23322645|NCT02002221|64923071|FG001|Overall Study|Patient withdrew consent|1|||
23322646|NCT00289848|64923072|FG000|Overall Study|Adverse Event|6|||
23558449|NCT01591382|65772496|FG001|Overall Study|Discharged Prior to Study Completion|1|||
23558450|NCT01591382|65772495|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
23558451|NCT01591382|65772496|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
23558452|NCT01982435|65772497|FG000|Overall Study|Adverse Event|1|||
23558453|NCT01982435|65772498|FG001|Overall Study|Adverse Event|0|||
23558454|NCT01654601|65772499|FG000|1st Administration|Withdrawal by Subject|2|||
23558455|NCT01654601|65772500|FG001|1st Administration|Withdrawal by Subject|0|||
23558456|NCT01654601|65772499|FG000|1st Administration|Protocol Violation|0|||
23147747|NCT00107120|64291026|FG001|Overall Study|Adverse Event|1|||
23558457|NCT01654601|65772500|FG001|1st Administration|Protocol Violation|2|||
23558458|NCT01654601|65772499|FG000|2nd Administration|Adverse Event|1|||
23558459|NCT01654601|65772500|FG001|2nd Administration|Adverse Event|0|||
23558460|NCT01654601|65772499|FG000|2nd Administration|Protocol Violation|0|||
23147748|NCT00107120|64291025|FG000|Overall Study|Lack of Efficacy|5|||
23322647|NCT00289848|64923073|FG001|Overall Study|Adverse Event|4|||
23623928|NCT02104505|66011499|FG001|First Intervention (14 Days)|exclusionary condition|1|||
23623929|NCT02104505|66011498|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
23623930|NCT02104505|66011499|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
23623931|NCT02104505|66011498|FG000|Second Intervention (14 Days)|Adverse Event|2|||
23623932|NCT02104505|66011499|FG001|Second Intervention (14 Days)|Adverse Event|0|||
23558461|NCT01654601|65772500|FG001|2nd Administration|Protocol Violation|1|||
23558462|NCT03419364|65772501|FG000|Overall Study|Delivery due to maternal condition|2|||
23558463|NCT03419364|65772502|FG001|Overall Study|Delivery due to maternal condition|0|||
23558464|NCT03419364|65772503|FG002|Overall Study|Delivery due to maternal condition|0|||
23558465|NCT00587964|65772505|FG000|Overall Study|Withdrawal by Subject|1|||
23558466|NCT00587964|65772505|FG000|Overall Study|Lost to Follow-up|1|||
23558467|NCT00587964|65772505|FG000|Overall Study|Patient found to be ineligible|1|||
23558468|NCT00587964|65772505|FG000|Overall Study|Patient did not receive intervention|5|||
23558469|NCT00587964|65772505|FG000|Overall Study|Progression of Disease|4|||
23558470|NCT03295318|65772506|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
23558471|NCT03295318|65772507|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
23558472|NCT03295318|65772508|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
23558473|NCT03295318|65772506|FG000|Overall Study|Death|1|||
23558474|NCT03295318|65772507|FG001|Overall Study|Death|1|||
23558475|NCT03295318|65772508|FG002|Overall Study|Death|1|||
23558476|NCT03295318|65772506|FG000|Overall Study|Protocol Violation|4|||
23558477|NCT03295318|65772507|FG001|Overall Study|Protocol Violation|3|||
23558478|NCT03295318|65772508|FG002|Overall Study|Protocol Violation|3|||
23558479|NCT03295318|65772506|FG000|Overall Study|Withdrawal by Subject|0|||
23558480|NCT03295318|65772507|FG001|Overall Study|Withdrawal by Subject|0|||
23558481|NCT03295318|65772508|FG002|Overall Study|Withdrawal by Subject|1|||
23623933|NCT01797562|66011502|FG000|Overall Study|Protocol Violation|5|||
23623934|NCT00469456|66011503|FG000|Overall Study|Adverse Event|4|||
23623935|NCT00469456|66011504|FG001|Overall Study|Adverse Event|3|||
23623936|NCT00469456|66011503|FG000|Overall Study|Protocol Violation|1|||
23623937|NCT00469456|66011504|FG001|Overall Study|Protocol Violation|0|||
23623938|NCT00469456|66011503|FG000|Overall Study|Withdrawal by Subject|4|||
23623939|NCT00469456|66011504|FG001|Overall Study|Withdrawal by Subject|1|||
23623940|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
23623941|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
23623942|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
23623943|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
23623944|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
23623945|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
23623946|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
23147749|NCT00107120|64291026|FG001|Overall Study|Lack of Efficacy|5|||
23147750|NCT00107120|64291025|FG000|Overall Study|Protocol Violation|3|||
23147751|NCT00107120|64291026|FG001|Overall Study|Protocol Violation|0|||
23147752|NCT00107120|64291025|FG000|Overall Study|Withdrawal by Subject|8|||
23147753|NCT00107120|64291026|FG001|Overall Study|Withdrawal by Subject|9|||
23147754|NCT00107120|64291025|FG000|Overall Study|Lost to Follow-up|8|||
23147755|NCT00107120|64291026|FG001|Overall Study|Lost to Follow-up|6|||
23437340|NCT02292706|65344052|FG006|Overall Study|Subject terminated by sponsor|0|||
23437341|NCT02292706|65344053|FG007|Overall Study|Subject terminated by sponsor|0|||
23437342|NCT02292706|65344046|FG000|Overall Study|Missing|0|||
23437343|NCT02292706|65344047|FG001|Overall Study|Missing|0|||
23558482|NCT03295318|65772506|FG000|Overall Study|Subject discontinued due to travel|0|||
23623947|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
23623948|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
23623949|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
23623950|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
23147756|NCT00107120|64291025|FG000|Overall Study|Pregnancy|0|||
23147757|NCT00107120|64291026|FG001|Overall Study|Pregnancy|1|||
23147758|NCT00107120|64291025|FG000|Overall Study|moving away from site|1|||
23147759|NCT00107120|64291026|FG001|Overall Study|moving away from site|1|||
23558483|NCT03295318|65772507|FG001|Overall Study|Subject discontinued due to travel|1|||
23558484|NCT03295318|65772508|FG002|Overall Study|Subject discontinued due to travel|0|||
23558485|NCT00118716|65772514|FG000|Overall Study|Adverse Event|2|||
23558486|NCT00118716|65772515|FG001|Overall Study|Adverse Event|7|||
23558487|NCT00118716|65772514|FG000|Overall Study|Protocol Violation|5|||
23558488|NCT00118716|65772515|FG001|Overall Study|Protocol Violation|4|||
23558489|NCT00118716|65772514|FG000|Overall Study|Withdrawal by Subject|0|||
23558490|NCT00118716|65772515|FG001|Overall Study|Withdrawal by Subject|1|||
23437344|NCT02292706|65344048|FG002|Overall Study|Missing|1|||
23437345|NCT02292706|65344049|FG003|Overall Study|Missing|1|||
23558491|NCT00118716|65772514|FG000|Overall Study|Exacerbation|2|||
23558492|NCT00118716|65772515|FG001|Overall Study|Exacerbation|2|||
23623951|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
23437346|NCT02292706|65344050|FG004|Overall Study|Missing|0|||
23322648|NCT00289848|64923072|FG000|Overall Study|Death|1|||
23322649|NCT00289848|64923073|FG001|Overall Study|Death|0|||
23322650|NCT00289848|64923072|FG000|Overall Study|Lack of Efficacy|20|||
23322651|NCT00289848|64923073|FG001|Overall Study|Lack of Efficacy|24|||
23322652|NCT00289848|64923072|FG000|Overall Study|Lost to Follow-up|3|||
23322653|NCT00289848|64923073|FG001|Overall Study|Lost to Follow-up|1|||
23322654|NCT00289848|64923072|FG000|Overall Study|Protocol Violation|5|||
23322655|NCT00289848|64923073|FG001|Overall Study|Protocol Violation|2|||
23322656|NCT00289848|64923072|FG000|Overall Study|Withdrawal by Subject|5|||
23322657|NCT00289848|64923073|FG001|Overall Study|Withdrawal by Subject|11|||
23322658|NCT00289848|64923072|FG000|Overall Study|Patient Moved|6|||
23322659|NCT00289848|64923073|FG001|Overall Study|Patient Moved|2|||
23322660|NCT00289848|64923072|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
23322661|NCT00289848|64923073|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
23322662|NCT04324021|64923076|FG000|Overall Study|Adverse Event|1|||
23322663|NCT04324021|64923077|FG001|Overall Study|Adverse Event|0|||
23322664|NCT04324021|64923078|FG002|Overall Study|Adverse Event|0|||
23322665|NCT04324021|64923076|FG000|Overall Study|Lack of Efficacy|0|||
23322666|NCT04324021|64923077|FG001|Overall Study|Lack of Efficacy|0|||
23322667|NCT04324021|64923078|FG002|Overall Study|Lack of Efficacy|1|||
23322668|NCT04324021|64923076|FG000|Overall Study|Death|1|||
23322669|NCT04324021|64923077|FG001|Overall Study|Death|1|||
23322670|NCT04324021|64923078|FG002|Overall Study|Death|0|||
23322671|NCT01176513|64923079|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
23322672|NCT02454933|64923080|FG000|Overall Study|Progressive disease|10|||
23322673|NCT02454933|64923081|FG001|Overall Study|Progressive disease|7|||
23322674|NCT02454933|64923080|FG000|Overall Study|Adverse Event|1|||
23322675|NCT02454933|64923081|FG001|Overall Study|Adverse Event|1|||
23322676|NCT02454933|64923080|FG000|Overall Study|Withdrawal by Subject|0|||
23322677|NCT02454933|64923081|FG001|Overall Study|Withdrawal by Subject|3|||
23322678|NCT02454933|64923080|FG000|Overall Study|Lost to Follow-up|1|||
23322679|NCT02454933|64923081|FG001|Overall Study|Lost to Follow-up|0|||
23322680|NCT02121652|64923086|FG000|Overall Study|Lost to Follow-up|2|||
23322681|NCT02121652|64923087|FG001|Overall Study|Lost to Follow-up|1|||
23322682|NCT02121652|64923086|FG000|Overall Study|Death|1|||
23322683|NCT02121652|64923087|FG001|Overall Study|Death|0|||
23147760|NCT00107120|64291025|FG000|Overall Study|death of parent|0|||
23147761|NCT00107120|64291026|FG001|Overall Study|death of parent|1|||
23147762|NCT02349451|64291030|FG000|Overall Study|Withdrawal by Subject|0|||
23147763|NCT02349451|64291031|FG001|Overall Study|Withdrawal by Subject|1|||
23147764|NCT02349451|64291032|FG002|Overall Study|Withdrawal by Subject|2|||
23147765|NCT02349451|64291033|FG003|Overall Study|Withdrawal by Subject|1|||
23147766|NCT01067326|64291034|FG000|Overall Study|Adverse Event|0|||
23147767|NCT01067326|64291035|FG001|Overall Study|Adverse Event|2|||
23147768|NCT01067326|64291034|FG000|Overall Study|Withdrawal by Subject|1|||
23322684|NCT02121652|64923086|FG000|Overall Study|Withdrawal by Subject|3|||
23322685|NCT02121652|64923087|FG001|Overall Study|Withdrawal by Subject|3|||
23322686|NCT01524978|64923088|FG000|Overall Study|Other|16|||
23322687|NCT01524978|64923089|FG001|Overall Study|Other|2|||
23322688|NCT01524978|64923090|FG002|Overall Study|Other|1|||
23322689|NCT01524978|64923091|FG003|Overall Study|Other|2|||
23322690|NCT01524978|64923092|FG004|Overall Study|Other|1|||
23322691|NCT01524978|64923093|FG005|Overall Study|Other|3|||
23322692|NCT01524978|64923094|FG006|Overall Study|Other|17|||
23322693|NCT01524978|64923095|FG007|Overall Study|Other|1|||
23322694|NCT01524978|64923096|FG008|Overall Study|Other|2|||
23322695|NCT01524978|64923097|FG009|Overall Study|Other|2|||
23322696|NCT01524978|64923098|FG010|Overall Study|Other|5|||
23322697|NCT01524978|64923088|FG000|Overall Study|Withdrawal by Subject|12|||
23558493|NCT00118716|65772514|FG000|Overall Study|Discontinued by sponsor|1|||
23558494|NCT00118716|65772515|FG001|Overall Study|Discontinued by sponsor|1|||
23558495|NCT00118716|65772514|FG000|Overall Study|Non-compliance|1|||
23558496|NCT00118716|65772515|FG001|Overall Study|Non-compliance|3|||
23558497|NCT00118716|65772514|FG000|Overall Study|misrandomized|1|||
23558498|NCT00118716|65772515|FG001|Overall Study|misrandomized|1|||
23558499|NCT00118716|65772514|FG000|Overall Study|Expired drug use|1|||
23558500|NCT00118716|65772515|FG001|Overall Study|Expired drug use|2|||
23558501|NCT00118716|65772514|FG000|Overall Study|Investigator discretion|0|||
23623952|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
23147769|NCT01067326|64291035|FG001|Overall Study|Withdrawal by Subject|0|||
23147770|NCT01067326|64291034|FG000|Overall Study|Early Study Termination|1|||
23322698|NCT01524978|64923089|FG001|Overall Study|Withdrawal by Subject|0|||
23322699|NCT01524978|64923090|FG002|Overall Study|Withdrawal by Subject|1|||
23147771|NCT01067326|64291035|FG001|Overall Study|Early Study Termination|1|||
23147772|NCT03618823|64291038|FG000|Overall Study|Lost to Follow-up|63|||
23322700|NCT01524978|64923091|FG003|Overall Study|Withdrawal by Subject|1|||
23322701|NCT01524978|64923092|FG004|Overall Study|Withdrawal by Subject|3|||
23322702|NCT01524978|64923093|FG005|Overall Study|Withdrawal by Subject|1|||
23322703|NCT01524978|64923094|FG006|Overall Study|Withdrawal by Subject|6|||
23437347|NCT02292706|65344051|FG005|Overall Study|Missing|1|||
23218876|NCT00318370|64544684|FG002|Period 2|Withdrawal by Subject|0|||
23218877|NCT00318370|64544682|FG000|Period 2|Other|0|||
23437348|NCT02292706|65344052|FG006|Overall Study|Missing|0|||
23437349|NCT02292706|65344053|FG007|Overall Study|Missing|0|||
23558502|NCT00118716|65772515|FG001|Overall Study|Investigator discretion|1|||
23558503|NCT01324271|65772516|FG000|Overall Study|Lost to Follow-up|3|||
23558504|NCT01324271|65772517|FG001|Overall Study|Lost to Follow-up|0|||
23558505|NCT01324271|65772516|FG000|Overall Study|Physician Decision|1|||
23558506|NCT01324271|65772517|FG001|Overall Study|Physician Decision|0|||
23558507|NCT02173054|65772536|FG000|Overall Study|lack of compliance|1|||
23558508|NCT02173054|65772537|FG001|Overall Study|lack of compliance|0|||
23558509|NCT02173054|65772538|FG002|Overall Study|lack of compliance|0|||
23558510|NCT02173054|65772536|FG000|Overall Study|Withdrawal by Subject|0|||
23558511|NCT02173054|65772537|FG001|Overall Study|Withdrawal by Subject|0|||
23558512|NCT02173054|65772538|FG002|Overall Study|Withdrawal by Subject|1|||
23558513|NCT00430248|65772539|FG000|Overall Study|Adverse Event|49|||
23558514|NCT00430248|65772540|FG001|Overall Study|Adverse Event|61|||
23558515|NCT00430248|65772541|FG002|Overall Study|Adverse Event|64|||
23558516|NCT00430248|65772539|FG000|Overall Study|Protocol Violation|10|||
23558517|NCT00430248|65772540|FG001|Overall Study|Protocol Violation|2|||
23558518|NCT00430248|65772541|FG002|Overall Study|Protocol Violation|4|||
23558519|NCT00430248|65772539|FG000|Overall Study|Personal Reasons|12|||
23558520|NCT00430248|65772540|FG001|Overall Study|Personal Reasons|24|||
23558521|NCT00430248|65772541|FG002|Overall Study|Personal Reasons|9|||
23558522|NCT00430248|65772539|FG000|Overall Study|Lost to Follow-up|28|||
23558523|NCT00430248|65772540|FG001|Overall Study|Lost to Follow-up|33|||
23558524|NCT00430248|65772541|FG002|Overall Study|Lost to Follow-up|28|||
23558525|NCT00430248|65772539|FG000|Overall Study|Therapeutic Failure|1|||
23558526|NCT00430248|65772540|FG001|Overall Study|Therapeutic Failure|1|||
23558527|NCT00430248|65772541|FG002|Overall Study|Therapeutic Failure|1|||
23623953|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
23147773|NCT03618823|64291039|FG001|Overall Study|Lost to Follow-up|61|||
23147774|NCT03678103|64291041|FG000|Overall Study|Withdrawn prior to completion|4|||
23147775|NCT03103763|64291042|FG000|Overall Study|Death|15|||
23147776|NCT03103763|64291043|FG001|Overall Study|Death|5|||
23147777|NCT03103763|64291044|FG002|Overall Study|Death|5|||
23147778|NCT03103763|64291042|FG000|Overall Study|Withdrawal by Subject|0|||
23147779|NCT03103763|64291043|FG001|Overall Study|Withdrawal by Subject|3|||
23147780|NCT03103763|64291044|FG002|Overall Study|Withdrawal by Subject|2|||
23147781|NCT01390181|64291045|FG000|Overall Study|Lost to Follow-up|1|||
23147782|NCT01390181|64291045|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
23147783|NCT04079803|64291049|FG000|Overall Study|Withdrawal by Subject|0|||
23147784|NCT04079803|64291050|FG001|Overall Study|Withdrawal by Subject|0|||
23147785|NCT04079803|64291051|FG002|Overall Study|Withdrawal by Subject|1|||
23147786|NCT01280812|64291052|FG000|Overall Study|Withdrawal by Subject|2|||
23147787|NCT01280812|64291053|FG001|Overall Study|Withdrawal by Subject|1|||
23147788|NCT01280812|64291054|FG002|Overall Study|Withdrawal by Subject|0|||
23147789|NCT01280812|64291052|FG000|Overall Study|Lost to Follow-up|1|||
23147790|NCT01280812|64291053|FG001|Overall Study|Lost to Follow-up|1|||
23147791|NCT01280812|64291054|FG002|Overall Study|Lost to Follow-up|1|||
23147792|NCT02080221|64291063|FG000|Overall Study|Withdrawal by Subject|1|||
23147793|NCT02080221|64291063|FG000|Overall Study|Clinical Progression of Disease|1|||
23147794|NCT01637623|64291073|FG000|Overall Study|Lost to Follow-up|0|||
23147795|NCT01637623|64291074|FG001|Overall Study|Lost to Follow-up|0|||
23147796|NCT01637623|64291075|FG002|Overall Study|Lost to Follow-up|2|||
23147797|NCT01637623|64291073|FG000|Overall Study|Physician Decision|1|||
23147798|NCT01637623|64291074|FG001|Overall Study|Physician Decision|0|||
23147799|NCT01637623|64291075|FG002|Overall Study|Physician Decision|1|||
23147800|NCT00300781|64291078|FG000|Overall Study|Disease Progression|55|||
23147801|NCT00300781|64291079|FG001|Overall Study|Disease Progression|52|||
23147802|NCT00300781|64291078|FG000|Overall Study|Adverse Event|5|||
23147803|NCT00300781|64291079|FG001|Overall Study|Adverse Event|6|||
23147804|NCT00300781|64291078|FG000|Overall Study|Withdrawal by Subject|1|||
23147805|NCT00300781|64291079|FG001|Overall Study|Withdrawal by Subject|2|||
23147806|NCT00300781|64291078|FG000|Overall Study|Physician Decision|1|||
23147807|NCT00300781|64291079|FG001|Overall Study|Physician Decision|0|||
23437350|NCT02292706|65344046|FG000|Overall Study|Virologic relapse or reinfection|1|||
23437351|NCT02292706|65344047|FG001|Overall Study|Virologic relapse or reinfection|0|||
23558528|NCT00430248|65772539|FG000|Overall Study|Withdrawal by Subject|14|||
23558529|NCT00430248|65772540|FG001|Overall Study|Withdrawal by Subject|20|||
23623954|NCT01664923|66011505|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
23558530|NCT00430248|65772541|FG002|Overall Study|Withdrawal by Subject|16|||
23558531|NCT00430248|65772539|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23623955|NCT01664923|66011506|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
23147808|NCT00300781|64291078|FG000|Overall Study|Not Recorded|0|||
23147809|NCT00300781|64291079|FG001|Overall Study|Not Recorded|1|||
23147810|NCT00300781|64291078|FG000|Overall Study|Symptomatic Deterioration|1|||
23218878|NCT00318370|64544683|FG001|Period 2|Other|1|||
23147811|NCT00300781|64291079|FG001|Overall Study|Symptomatic Deterioration|0|||
23147812|NCT00300781|64291078|FG000|Overall Study|Lost to Follow-up|0|||
23147813|NCT00300781|64291079|FG001|Overall Study|Lost to Follow-up|1|||
23147814|NCT04744285|64291080|FG000|Overall Study|Withdrawal by Subject|1|||
23147815|NCT04744285|64291081|FG001|Overall Study|Withdrawal by Subject|1|||
23147816|NCT04744285|64291082|FG002|Overall Study|Withdrawal by Subject|2|||
23147817|NCT04744285|64291083|FG003|Overall Study|Withdrawal by Subject|1|||
23147818|NCT01386788|64291084|FG000|Overall Study|Lost to Follow-up|2|||
23147819|NCT01231516|64291091|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
23147820|NCT01231516|64291092|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
23147821|NCT01231516|64291091|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
23147822|NCT01231516|64291092|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
23147823|NCT01231516|64291091|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
23218879|NCT00318370|64544684|FG002|Period 2|Other|0|||
23218880|NCT00318370|64544682|FG000|Period 3|Adverse Event|0|||
23218881|NCT00318370|64544683|FG001|Period 3|Adverse Event|0|||
23218882|NCT00318370|64544684|FG002|Period 3|Adverse Event|1|||
23147824|NCT01231516|64291092|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
23147825|NCT01231516|64291091|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
23147826|NCT01231516|64291092|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
23147827|NCT01231516|64291091|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
23147828|NCT01231516|64291092|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
23147829|NCT01231516|64291091|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
23147830|NCT01231516|64291092|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
23147831|NCT01231516|64291091|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
23147832|NCT01231516|64291092|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
23147833|NCT01231516|64291091|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
23147834|NCT01231516|64291092|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
23147835|NCT01231516|64291091|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
23147836|NCT01231516|64291092|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
23147837|NCT01231516|64291091|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
23218883|NCT00318370|64544682|FG000|Period 3|Lack of Efficacy|0|||
23218884|NCT00318370|64544683|FG001|Period 3|Lack of Efficacy|0|||
23218885|NCT00318370|64544684|FG002|Period 3|Lack of Efficacy|24|||
23218886|NCT00318370|64544682|FG000|Period 3|Death|0|||
23218887|NCT00318370|64544683|FG001|Period 3|Death|0|||
23437352|NCT02292706|65344048|FG002|Overall Study|Virologic relapse or reinfection|0|||
23147838|NCT01231516|64291092|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
23147839|NCT01231516|64291091|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
23147840|NCT01231516|64291092|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
23147841|NCT01231516|64291091|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
23147842|NCT01231516|64291092|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
23147843|NCT01231516|64291091|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
23147844|NCT01231516|64291092|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
23147845|NCT01231516|64291091|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
23147846|NCT01231516|64291092|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
23147847|NCT01231516|64291091|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
23147848|NCT01231516|64291092|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
23147849|NCT01231516|64291091|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
23437353|NCT02292706|65344049|FG003|Overall Study|Virologic relapse or reinfection|1|||
23437354|NCT02292706|65344050|FG004|Overall Study|Virologic relapse or reinfection|0|||
23558532|NCT00430248|65772540|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
23558533|NCT00430248|65772541|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23558534|NCT00430248|65772539|FG000|Overall Study|Gout Flare|3|||
23558535|NCT00430248|65772540|FG001|Overall Study|Gout Flare|7|||
23558536|NCT00430248|65772541|FG002|Overall Study|Gout Flare|2|||
23558537|NCT00430248|65772539|FG000|Overall Study|Reason Not Specified|8|||
23558538|NCT00430248|65772540|FG001|Overall Study|Reason Not Specified|8|||
23558539|NCT00430248|65772541|FG002|Overall Study|Reason Not Specified|11|||
23558540|NCT03508843|65772542|FG000|Overall Study|Withdrawal by Subject|1|||
23558541|NCT03508843|65772542|FG000|Overall Study|technical difficulties|2|||
23558542|NCT04044456|65772547|FG000|Overall Study|Lost to Follow-up|4|||
23558543|NCT04044456|65772548|FG001|Overall Study|Lost to Follow-up|1|||
23558544|NCT04044456|65772547|FG000|Overall Study|Withdrawal by Subject|1|||
23558545|NCT04044456|65772548|FG001|Overall Study|Withdrawal by Subject|0|||
23147850|NCT01231516|64291092|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
23218888|NCT00318370|64544684|FG002|Period 3|Death|1|||
23218889|NCT00318370|64544682|FG000|Period 3|Physician Decision|0|||
23558546|NCT01330316|65772549|FG000|Overall Study|Adverse Event|2|||
23558547|NCT01330316|65772550|FG001|Overall Study|Adverse Event|2|||
23437355|NCT02292706|65344051|FG005|Overall Study|Virologic relapse or reinfection|1|||
23437356|NCT02292706|65344052|FG006|Overall Study|Virologic relapse or reinfection|0|||
23437357|NCT02292706|65344053|FG007|Overall Study|Virologic relapse or reinfection|0|||
23147851|NCT00475033|64291096|FG000|Infant Series|Failed to return|3|||
23147852|NCT00475033|64291097|FG001|Infant Series|Failed to return|4|||
23147853|NCT00475033|64291096|FG000|Infant Series|Parent or legal guardian request|1|||
23322704|NCT01524978|64923095|FG007|Overall Study|Withdrawal by Subject|2|||
23322705|NCT01524978|64923096|FG008|Overall Study|Withdrawal by Subject|4|||
23322706|NCT01524978|64923097|FG009|Overall Study|Withdrawal by Subject|0|||
23322707|NCT01524978|64923098|FG010|Overall Study|Withdrawal by Subject|5|||
23322708|NCT01524978|64923088|FG000|Overall Study|Lost to Follow-up|0|||
23322709|NCT01524978|64923089|FG001|Overall Study|Lost to Follow-up|0|||
23322710|NCT01524978|64923090|FG002|Overall Study|Lost to Follow-up|3|||
23322711|NCT01524978|64923091|FG003|Overall Study|Lost to Follow-up|0|||
23322712|NCT01524978|64923092|FG004|Overall Study|Lost to Follow-up|1|||
23322713|NCT01524978|64923093|FG005|Overall Study|Lost to Follow-up|1|||
23322714|NCT01524978|64923094|FG006|Overall Study|Lost to Follow-up|2|||
23322715|NCT01524978|64923095|FG007|Overall Study|Lost to Follow-up|0|||
23322716|NCT01524978|64923096|FG008|Overall Study|Lost to Follow-up|1|||
23322717|NCT01524978|64923097|FG009|Overall Study|Lost to Follow-up|1|||
23322718|NCT01524978|64923098|FG010|Overall Study|Lost to Follow-up|1|||
23322719|NCT01524978|64923088|FG000|Overall Study|Death|34|||
23322720|NCT01524978|64923089|FG001|Overall Study|Death|2|||
23322721|NCT01524978|64923090|FG002|Overall Study|Death|5|||
23322722|NCT01524978|64923091|FG003|Overall Study|Death|24|||
23322723|NCT01524978|64923092|FG004|Overall Study|Death|4|||
23322724|NCT01524978|64923093|FG005|Overall Study|Death|4|||
23322725|NCT01524978|64923094|FG006|Overall Study|Death|1|||
23322726|NCT01524978|64923095|FG007|Overall Study|Death|9|||
23322727|NCT01524978|64923096|FG008|Overall Study|Death|5|||
23322728|NCT01524978|64923097|FG009|Overall Study|Death|6|||
23322729|NCT01524978|64923098|FG010|Overall Study|Death|17|||
23322730|NCT00417170|64923102|FG000|Overall Study|Adverse Event|1|||
23322731|NCT00417170|64923103|FG001|Overall Study|Adverse Event|1|||
23322732|NCT00417170|64923102|FG000|Overall Study|Withdrawal by Subject|1|||
23322733|NCT00417170|64923103|FG001|Overall Study|Withdrawal by Subject|1|||
23322734|NCT00417170|64923102|FG000|Overall Study|Lost to Follow-up|0|||
23322735|NCT00417170|64923103|FG001|Overall Study|Lost to Follow-up|1|||
23322736|NCT03736031|64923105|FG000|Overall Study|Death|2|||
23322737|NCT03736031|64923106|FG001|Overall Study|Death|4|||
23322738|NCT03736031|64923105|FG000|Overall Study|Lost to Follow-up|21|||
23322739|NCT03736031|64923106|FG001|Overall Study|Lost to Follow-up|2|||
23322740|NCT03736031|64923105|FG000|Overall Study|Withdrawal by Subject|9|||
23322741|NCT03736031|64923106|FG001|Overall Study|Withdrawal by Subject|0|||
23322742|NCT03280264|64923110|FG000|Overall Study|Adverse Event|1|||
23322743|NCT03280264|64923110|FG000|Overall Study|Physician Decision|1|||
23322744|NCT03280264|64923110|FG000|Overall Study|Withdrawal by Subject|1|||
23322745|NCT01154231|64923113|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
23322746|NCT01154231|64923113|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
23322747|NCT01564537|64923114|FG000|Overall Study|Site Terminated by Sponsor|1|||
23322748|NCT01564537|64923115|FG001|Overall Study|Site Terminated by Sponsor|0|||
23322749|NCT01564537|64923114|FG000|Overall Study|Withdrawal by Subject|12|||
23322750|NCT01564537|64923115|FG001|Overall Study|Withdrawal by Subject|14|||
23322751|NCT01564537|64923114|FG000|Overall Study|Lost to Follow-up|7|||
23322752|NCT01564537|64923115|FG001|Overall Study|Lost to Follow-up|3|||
23322753|NCT01564537|64923114|FG000|Overall Study|Reason not specified|81|||
23322754|NCT01564537|64923115|FG001|Overall Study|Reason not specified|82|||
23322755|NCT02553772|64923121|FG000|Overall Study|Adverse Event|2|||
23623956|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
23218890|NCT00318370|64544683|FG001|Period 3|Physician Decision|0|||
23322756|NCT02553772|64923122|FG001|Overall Study|Adverse Event|3|||
23322757|NCT02553772|64923121|FG000|Overall Study|Lost to Follow-up|2|||
23322758|NCT02553772|64923122|FG001|Overall Study|Lost to Follow-up|1|||
23322759|NCT02553772|64923121|FG000|Overall Study|Withdrawal of Consent|1|||
23322760|NCT02553772|64923122|FG001|Overall Study|Withdrawal of Consent|1|||
23322761|NCT02553772|64923121|FG000|Overall Study|Lack of Efficacy|1|||
23322762|NCT02553772|64923122|FG001|Overall Study|Lack of Efficacy|0|||
23322763|NCT02553772|64923121|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23322764|NCT02553772|64923122|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23623957|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
23623958|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
23322765|NCT03154125|64923130|FG000|Overall Study|Lost to Follow-up|11|||
23322766|NCT03154125|64923131|FG001|Overall Study|Lost to Follow-up|11|||
23322767|NCT03154125|64923132|FG002|Overall Study|Lost to Follow-up|0|||
23322768|NCT03154125|64923130|FG000|Overall Study|Withdrawal by Subject|49|||
23322769|NCT03154125|64923131|FG001|Overall Study|Withdrawal by Subject|55|||
23322770|NCT03154125|64923132|FG002|Overall Study|Withdrawal by Subject|8|||
23322771|NCT03154125|64923130|FG000|Overall Study|Physician Decision|13|||
23322772|NCT03154125|64923131|FG001|Overall Study|Physician Decision|6|||
23147854|NCT00475033|64291097|FG001|Infant Series|Parent or legal guardian request|5|||
23147855|NCT00475033|64291096|FG000|Infant Series|Protocol Violation|1|||
23147856|NCT00475033|64291097|FG001|Infant Series|Protocol Violation|2|||
23147857|NCT00475033|64291096|FG000|Infant Series|Lost to Follow-up|2|||
23147858|NCT00475033|64291097|FG001|Infant Series|Lost to Follow-up|0|||
23147859|NCT00475033|64291096|FG000|Infant Series|Adverse Event|0|||
23147860|NCT00475033|64291097|FG001|Infant Series|Adverse Event|2|||
23147861|NCT00475033|64291096|FG000|After the Infant Series|Adverse Event|0|||
23147862|NCT00475033|64291097|FG001|After the Infant Series|Adverse Event|4|||
23147863|NCT00475033|64291096|FG000|After the Infant Series|Parent or legal guardian request|2|||
23147864|NCT00475033|64291097|FG001|After the Infant Series|Parent or legal guardian request|2|||
23147865|NCT00475033|64291096|FG000|After the Infant Series|Failed to return|2|||
23147866|NCT00475033|64291097|FG001|After the Infant Series|Failed to return|1|||
23147867|NCT00475033|64291096|FG000|After the Infant Series|Protocol Violation|1|||
23147868|NCT00475033|64291097|FG001|After the Infant Series|Protocol Violation|0|||
23147869|NCT00475033|64291096|FG000|After the Infant Series|Lost to Follow-up|1|||
23558548|NCT01330316|65772549|FG000|Overall Study|Lack of Efficacy|0|||
23558549|NCT01330316|65772550|FG001|Overall Study|Lack of Efficacy|10|||
23558550|NCT01330316|65772549|FG000|Overall Study|Lost to Follow-up|0|||
23558551|NCT01330316|65772550|FG001|Overall Study|Lost to Follow-up|1|||
23558552|NCT01330316|65772549|FG000|Overall Study|Withdrawal by Subject|0|||
23558553|NCT01330316|65772550|FG001|Overall Study|Withdrawal by Subject|1|||
23558554|NCT01330316|65772549|FG000|Overall Study|other than above|0|||
23558555|NCT01330316|65772550|FG001|Overall Study|other than above|1|||
23558556|NCT01320943|65772553|FG000|Overall Study|Lost to Follow-up|1|||
23558557|NCT01320943|65772554|FG001|Overall Study|Lost to Follow-up|0|||
23558558|NCT01320943|65772553|FG000|Overall Study|Physician Decision|0|||
23558559|NCT01320943|65772554|FG001|Overall Study|Physician Decision|1|||
23558560|NCT01320943|65772553|FG000|Overall Study|Randomized but not Treated|0|||
23558561|NCT01320943|65772554|FG001|Overall Study|Randomized but not Treated|1|||
23558562|NCT03988166|65772559|FG000|Overall Study|Lost to Follow-up|2|||
23558563|NCT03988166|65772559|FG000|Overall Study|Death|1|||
23147870|NCT00475033|64291097|FG001|After the Infant Series|Lost to Follow-up|0|||
23147871|NCT00475033|64291096|FG000|After the Infant Series|Other|0|||
23147872|NCT00475033|64291097|FG001|After the Infant Series|Other|1|||
23147873|NCT00475033|64291096|FG000|Toddler Dose|Parent or legal guardian request|2|||
23147874|NCT00475033|64291097|FG001|Toddler Dose|Parent or legal guardian request|0|||
23147875|NCT00475033|64291096|FG000|Toddler Dose|Failed to return|1|||
23147876|NCT00475033|64291097|FG001|Toddler Dose|Failed to return|0|||
23147877|NCT00475033|64291096|FG000|Toddler Dose|Lost to Follow-up|1|||
23147878|NCT00475033|64291097|FG001|Toddler Dose|Lost to Follow-up|0|||
23147879|NCT00912964|64291098|FG000|Overall Study|Eligibility criterion not met|1|||
23147880|NCT00912964|64291099|FG001|Overall Study|Eligibility criterion not met|1|||
23147881|NCT00912964|64291100|FG002|Overall Study|Eligibility criterion not met|0|||
23558564|NCT03954743|65772564|FG000|Overall Study|Adverse Event|1|||
23558565|NCT03954743|65772565|FG001|Overall Study|Adverse Event|0|||
23558566|NCT03954743|65772564|FG000|Overall Study|Lost to Follow-up|6|||
23558567|NCT03954743|65772565|FG001|Overall Study|Lost to Follow-up|4|||
23558568|NCT03954743|65772564|FG000|Overall Study|Protocol Violation|1|||
23623959|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
23147882|NCT00912964|64291098|FG000|Overall Study|Adverse Event|15|||
23147883|NCT00912964|64291099|FG001|Overall Study|Adverse Event|18|||
23147884|NCT00912964|64291100|FG002|Overall Study|Adverse Event|12|||
23147885|NCT00912964|64291098|FG000|Overall Study|Lack of Efficacy|11|||
23147886|NCT00912964|64291099|FG001|Overall Study|Lack of Efficacy|4|||
23147887|NCT00912964|64291100|FG002|Overall Study|Lack of Efficacy|3|||
23147888|NCT00912964|64291098|FG000|Overall Study|Withdrawal by Subject|20|||
23147889|NCT00912964|64291099|FG001|Overall Study|Withdrawal by Subject|12|||
23147890|NCT00912964|64291100|FG002|Overall Study|Withdrawal by Subject|18|||
23147891|NCT00912964|64291098|FG000|Overall Study|Lost to Follow-up|4|||
23147892|NCT00912964|64291099|FG001|Overall Study|Lost to Follow-up|3|||
23147893|NCT00912964|64291100|FG002|Overall Study|Lost to Follow-up|3|||
23558569|NCT03954743|65772565|FG001|Overall Study|Protocol Violation|0|||
23558570|NCT03954743|65772564|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
23558571|NCT03954743|65772565|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
23147894|NCT00912964|64291098|FG000|Overall Study|Protocol Violation|5|||
23147895|NCT00912964|64291099|FG001|Overall Study|Protocol Violation|3|||
23147896|NCT00912964|64291100|FG002|Overall Study|Protocol Violation|8|||
23147897|NCT00912964|64291098|FG000|Overall Study|Taking exclusionary medications|7|||
23558572|NCT03954743|65772564|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
23558573|NCT03954743|65772565|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23558574|NCT01337674|65772566|FG000|Treatment Period 1|Adverse Event|0|||
23558575|NCT01337674|65772567|FG001|Treatment Period 1|Adverse Event|1|||
23558576|NCT01337674|65772568|FG002|Treatment Period 1|Adverse Event|0|||
23147898|NCT00912964|64291099|FG001|Overall Study|Taking exclusionary medications|4|||
23147899|NCT00912964|64291100|FG002|Overall Study|Taking exclusionary medications|8|||
23147900|NCT00912964|64291098|FG000|Overall Study|Medical History|1|||
23218891|NCT00318370|64544684|FG002|Period 3|Physician Decision|1|||
23218892|NCT00318370|64544682|FG000|Period 3|Withdrawal by Subject|0|||
23218893|NCT00318370|64544683|FG001|Period 3|Withdrawal by Subject|0|||
23218894|NCT00318370|64544684|FG002|Period 3|Withdrawal by Subject|3|||
23218895|NCT00318370|64544682|FG000|Period 3|Other|0|||
23218896|NCT00318370|64544683|FG001|Period 3|Other|0|||
23218897|NCT00318370|64544684|FG002|Period 3|Other|3|||
23218898|NCT01248364|64544685|FG000|Overall Study|Adverse Event|0|||
23218899|NCT01248364|64544686|FG001|Overall Study|Adverse Event|1|||
23218900|NCT01248364|64544687|FG002|Overall Study|Adverse Event|0|||
23218901|NCT01248364|64544688|FG003|Overall Study|Adverse Event|0|||
23218902|NCT03235726|64544689|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23218903|NCT03235726|64544690|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23218904|NCT03235726|64544691|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23218905|NCT03235726|64544692|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23218906|NCT03235726|64544693|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
23218907|NCT03235726|64544694|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23218908|NCT03235726|64544695|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23218909|NCT03235726|64544696|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23218910|NCT03235726|64544697|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23218911|NCT03235726|64544698|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
23218912|NCT03235726|64544689|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23218913|NCT03235726|64544690|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23218914|NCT03235726|64544691|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23218915|NCT03235726|64544692|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23218916|NCT03235726|64544693|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
23218917|NCT03235726|64544694|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23218918|NCT03235726|64544695|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23218919|NCT03235726|64544696|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23218920|NCT03235726|64544697|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23218921|NCT03235726|64544698|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
23218922|NCT02255760|64544699|FG000|Overall Study|Lost to Follow-up|0|||
23218923|NCT02255760|64544700|FG001|Overall Study|Lost to Follow-up|1|||
23218924|NCT02255760|64544701|FG002|Overall Study|Lost to Follow-up|0|||
23218925|NCT02255760|64544702|FG003|Overall Study|Lost to Follow-up|0|||
23218926|NCT02255760|64544703|FG004|Overall Study|Lost to Follow-up|0|||
23218927|NCT01997281|64544706|FG000|Overall Study|Withdrawal by Subject|1|||
23218928|NCT01997281|64544707|FG001|Overall Study|Withdrawal by Subject|0|||
23218929|NCT01112982|64544708|FG000|Overall Study|Withdrawal by Subject|1|||
23218930|NCT01112982|64544708|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
23218931|NCT00607919|64544710|FG000|Acute Phase|Adverse Event|9|||
23218932|NCT00607919|64544711|FG001|Acute Phase|Adverse Event|2|||
23218933|NCT00607919|64544710|FG000|Acute Phase|Entry Criteria Not Met|1|||
23218934|NCT00607919|64544711|FG001|Acute Phase|Entry Criteria Not Met|1|||
23218935|NCT00607919|64544710|FG000|Acute Phase|Lack of Efficacy|1|||
23218936|NCT00607919|64544711|FG001|Acute Phase|Lack of Efficacy|2|||
23218937|NCT00607919|64544710|FG000|Acute Phase|Lost to Follow-up|9|||
23218938|NCT00607919|64544711|FG001|Acute Phase|Lost to Follow-up|3|||
23218939|NCT00607919|64544710|FG000|Acute Phase|Parent/Caregiver Decision|6|||
23218940|NCT00607919|64544711|FG001|Acute Phase|Parent/Caregiver Decision|4|||
23218941|NCT00607919|64544710|FG000|Acute Phase|Protocol Violation|5|||
23218942|NCT00607919|64544711|FG001|Acute Phase|Protocol Violation|1|||
23218943|NCT00607919|64544710|FG000|Acute Phase|Withdrawal by Subject|3|||
23218944|NCT00607919|64544711|FG001|Acute Phase|Withdrawal by Subject|3|||
23218945|NCT00607919|64544710|FG000|Open-Label Phase|Adverse Event|1|||
23558577|NCT01337674|65772569|FG003|Treatment Period 1|Adverse Event|0|||
23558578|NCT01337674|65772566|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
23558579|NCT01337674|65772567|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
23558580|NCT01337674|65772568|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
23558581|NCT01337674|65772569|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
23558582|NCT01337674|65772566|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23558583|NCT01337674|65772567|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23558584|NCT01337674|65772568|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23558585|NCT01337674|65772569|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23558586|NCT02641392|65772572|FG000|Overall Study|Lost to Follow-up|0|||
23558587|NCT02641392|65772573|FG001|Overall Study|Lost to Follow-up|0|||
23218946|NCT00607919|64544711|FG001|Open-Label Phase|Adverse Event|5|||
23218947|NCT00607919|64544710|FG000|Open-Label Phase|Lost to Follow-up|4|||
23218948|NCT00607919|64544711|FG001|Open-Label Phase|Lost to Follow-up|1|||
23218949|NCT00607919|64544710|FG000|Open-Label Phase|Protocol Violation|2|||
23218950|NCT00607919|64544711|FG001|Open-Label Phase|Protocol Violation|2|||
23218951|NCT00607919|64544710|FG000|Open-Label Phase|Withdrawal by Subject|2|||
23218952|NCT00607919|64544711|FG001|Open-Label Phase|Withdrawal by Subject|2|||
23218953|NCT00607919|64544710|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
23218954|NCT00607919|64544711|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
23218955|NCT00606294|64544712|FG000|Overall Study|Withdrawal by Subject|36|||
23218956|NCT00606294|64544713|FG001|Overall Study|Withdrawal by Subject|0|||
23218957|NCT02116361|64544718|FG000|Overall Study|Pregnancy|0|||
23218958|NCT02116361|64544719|FG001|Overall Study|Pregnancy|0|||
23147901|NCT00912964|64291099|FG001|Overall Study|Medical History|0|||
23147902|NCT00912964|64291100|FG002|Overall Study|Medical History|0|||
23147903|NCT00912964|64291098|FG000|Overall Study|Non-compliance with study procedures|2|||
23147904|NCT00912964|64291099|FG001|Overall Study|Non-compliance with study procedures|0|||
23147905|NCT00912964|64291100|FG002|Overall Study|Non-compliance with study procedures|0|||
23147906|NCT00912964|64291098|FG000|Overall Study|Violation of exclusion criterion|0|||
23147907|NCT00912964|64291099|FG001|Overall Study|Violation of exclusion criterion|0|||
23147908|NCT00912964|64291100|FG002|Overall Study|Violation of exclusion criterion|2|||
23147909|NCT00912964|64291098|FG000|Overall Study|Randomized but never received study drug|0|||
23147910|NCT00912964|64291099|FG001|Overall Study|Randomized but never received study drug|1|||
23147911|NCT00912964|64291100|FG002|Overall Study|Randomized but never received study drug|0|||
23147912|NCT03097133|64291102|FG000|Overall Study|Lost to Follow-up|3|||
23147913|NCT03097133|64291103|FG001|Overall Study|Lost to Follow-up|2|||
23147914|NCT03097133|64291102|FG000|Overall Study|Withdrawal by Subject|2|||
23147915|NCT03097133|64291103|FG001|Overall Study|Withdrawal by Subject|5|||
23147916|NCT03097133|64291102|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
23147917|NCT03097133|64291103|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
23147918|NCT03097133|64291102|FG000|Overall Study|Other|3|||
23147919|NCT03097133|64291103|FG001|Overall Study|Other|2|||
23147920|NCT03097133|64291102|FG000|Overall Study|Adverse Event|1|||
23147921|NCT03097133|64291103|FG001|Overall Study|Adverse Event|0|||
23147922|NCT01498289|64291104|FG000|Overall Study|Adverse Event|16|||
23147923|NCT01498289|64291105|FG001|Overall Study|Adverse Event|18|||
23147924|NCT01498289|64291104|FG000|Overall Study|Death|6|||
23147925|NCT01498289|64291105|FG001|Overall Study|Death|8|||
23147926|NCT01498289|64291104|FG000|Overall Study|Withdrawal unrelated to AE|16|||
23147927|NCT01498289|64291105|FG001|Overall Study|Withdrawal unrelated to AE|16|||
23147928|NCT01498289|64291104|FG000|Overall Study|Progression/relapse|53|||
23147929|NCT01498289|64291105|FG001|Overall Study|Progression/relapse|59|||
23147930|NCT01498289|64291104|FG000|Overall Study|Not protocol specified|7|||
23147931|NCT01498289|64291105|FG001|Overall Study|Not protocol specified|2|||
23147932|NCT01498289|64291104|FG000|Overall Study|Reason under review|0|||
23147933|NCT01498289|64291105|FG001|Overall Study|Reason under review|1|||
23147934|NCT03756350|64293795|FG000|Overall Study|Lost to Follow-up|1|||
23147935|NCT00795951|64293798|FG000|Overall Study|Lost to Follow-up|1|||
23218959|NCT02116361|64544720|FG002|Overall Study|Pregnancy|0|||
23218960|NCT02116361|64544721|FG003|Overall Study|Pregnancy|1|||
23218961|NCT02116361|64544718|FG000|Overall Study|Protocol Violation|1|||
23218962|NCT02116361|64544719|FG001|Overall Study|Protocol Violation|0|||
23218963|NCT02116361|64544720|FG002|Overall Study|Protocol Violation|0|||
23218964|NCT02116361|64544721|FG003|Overall Study|Protocol Violation|2|||
23218965|NCT02116361|64544718|FG000|Overall Study|Physician Decision|2|||
23437358|NCT00360568|65344055|FG000|Overall Study|Adverse Event|1|||
23437359|NCT00360568|65344056|FG001|Overall Study|Adverse Event|2|||
23437360|NCT00360568|65344055|FG000|Overall Study|Lack of Efficacy|1|||
23437361|NCT00360568|65344056|FG001|Overall Study|Lack of Efficacy|0|||
23437362|NCT00360568|65344055|FG000|Overall Study|Withdrawal by Subject|0|||
23437363|NCT00360568|65344056|FG001|Overall Study|Withdrawal by Subject|3|||
23437364|NCT01879072|65344057|FG000|Overall Study|Withdrawal by Subject|121|||
23437365|NCT01879072|65344057|FG000|Overall Study|Not Transplanted|30|||
23437366|NCT00622388|65344058|FG000|Overall Study|Disease Progression|47|||
23437367|NCT00622388|65344058|FG000|Overall Study|Adverse Event|6|||
23147936|NCT00795951|64293798|FG000|Overall Study|Withdrawal by Subject|1|||
23218966|NCT02116361|64544719|FG001|Overall Study|Physician Decision|3|||
23218967|NCT02116361|64544720|FG002|Overall Study|Physician Decision|0|||
23437368|NCT00622388|65344058|FG000|Overall Study|Protocol Violation|3|||
23558588|NCT02641392|65772574|FG002|Overall Study|Lost to Follow-up|2|||
23558589|NCT02641392|65772572|FG000|Overall Study|Withdrawal by Subject|0|||
23218968|NCT02116361|64544721|FG003|Overall Study|Physician Decision|0|||
23218969|NCT02116361|64544718|FG000|Overall Study|Adverse Event|1|||
23218970|NCT02116361|64544719|FG001|Overall Study|Adverse Event|0|||
23218971|NCT02116361|64544720|FG002|Overall Study|Adverse Event|0|||
23218972|NCT02116361|64544721|FG003|Overall Study|Adverse Event|3|||
23218973|NCT02116361|64544718|FG000|Overall Study|Other Reasons|3|||
23218974|NCT02116361|64544719|FG001|Overall Study|Other Reasons|3|||
23322773|NCT03154125|64923132|FG002|Overall Study|Physician Decision|0|||
23437369|NCT00622388|65344058|FG000|Overall Study|Participant Refusal|1|||
23437370|NCT00622388|65344058|FG000|Overall Study|Death|3|||
23558590|NCT02641392|65772573|FG001|Overall Study|Withdrawal by Subject|0|||
23558591|NCT02641392|65772574|FG002|Overall Study|Withdrawal by Subject|17|||
23558592|NCT02641392|65772572|FG000|Overall Study|Adverse Event|0|||
23218975|NCT02116361|64544720|FG002|Overall Study|Other Reasons|3|||
23218976|NCT02116361|64544721|FG003|Overall Study|Other Reasons|3|||
23218977|NCT02116361|64544718|FG000|Overall Study|Lack of Efficacy|5|||
23558593|NCT02641392|65772573|FG001|Overall Study|Adverse Event|1|||
23147937|NCT00051363|64293799|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
23218978|NCT02116361|64544719|FG001|Overall Study|Lack of Efficacy|7|||
23218979|NCT02116361|64544720|FG002|Overall Study|Lack of Efficacy|4|||
23147938|NCT00051363|64293800|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
23147939|NCT00051363|64293799|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
23147940|NCT00051363|64293800|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
23147941|NCT00051363|64293799|FG000|Overall Study|Death|2|||
23147942|NCT00051363|64293800|FG001|Overall Study|Death|2|||
23147943|NCT00051363|64293799|FG000|Overall Study|Excluded Pre-Randomization|2|||
23147944|NCT00051363|64293800|FG001|Overall Study|Excluded Pre-Randomization|5|||
23147945|NCT01978262|64293801|FG000|Overall Study|Withdrawal by Subject|9|||
23147946|NCT01978262|64293801|FG000|Overall Study|Lost to Follow-up|2|||
23147947|NCT00195507|64293802|FG000|Overall Study|Adverse Event|24|||
23147948|NCT00195507|64293803|FG001|Overall Study|Adverse Event|13|||
23147949|NCT00195507|64293802|FG000|Overall Study|Death|0|||
23147950|NCT00195507|64293803|FG001|Overall Study|Death|1|||
23147951|NCT00195507|64293802|FG000|Overall Study|Failed to Return|4|||
23147952|NCT00195507|64293803|FG001|Overall Study|Failed to Return|3|||
23147953|NCT00195507|64293802|FG000|Overall Study|Physician Decision|1|||
23558594|NCT02641392|65772574|FG002|Overall Study|Adverse Event|25|||
23558595|NCT02641392|65772572|FG000|Overall Study|Study Terminated by Sponsor|4|||
23558596|NCT02641392|65772573|FG001|Overall Study|Study Terminated by Sponsor|12|||
23558597|NCT02641392|65772574|FG002|Overall Study|Study Terminated by Sponsor|144|||
23558598|NCT02641392|65772572|FG000|Overall Study|Lack of Efficacy|0|||
23558599|NCT02641392|65772573|FG001|Overall Study|Lack of Efficacy|0|||
23558600|NCT02641392|65772574|FG002|Overall Study|Lack of Efficacy|101|||
23558601|NCT02641392|65772572|FG000|Overall Study|Miscellaneous|0|||
23558602|NCT02641392|65772573|FG001|Overall Study|Miscellaneous|0|||
23558603|NCT02641392|65772574|FG002|Overall Study|Miscellaneous|3|||
23558604|NCT02641392|65772572|FG000|Overall Study|Death|0|||
23558605|NCT02641392|65772573|FG001|Overall Study|Death|0|||
23558606|NCT02641392|65772574|FG002|Overall Study|Death|1|||
23558607|NCT00331344|65772575|FG000|Phase I|Adverse Event|0|||
23558608|NCT00331344|65772576|FG001|Phase I|Adverse Event|0|||
23558609|NCT00331344|65772577|FG002|Phase I|Adverse Event|0|||
23558610|NCT00331344|65772578|FG003|Phase I|Adverse Event|1|||
23558611|NCT00331344|65772579|FG004|Phase I|Adverse Event|2|||
23558612|NCT00331344|65772580|FG005|Phase I|Adverse Event|2|||
23558613|NCT00331344|65772581|FG006|Phase I|Adverse Event|0|||
23558614|NCT00331344|65772582|FG007|Phase I|Adverse Event|1|||
23558615|NCT00331344|65772583|FG008|Phase I|Adverse Event|0|||
23558616|NCT00331344|65772575|FG000|Phase II|Death|0|||
23558617|NCT00331344|65772576|FG001|Phase II|Death|0|||
23558618|NCT00331344|65772577|FG002|Phase II|Death|0|||
23558619|NCT00331344|65772578|FG003|Phase II|Death|0|||
23558620|NCT00331344|65772579|FG004|Phase II|Death|0|||
23558621|NCT00331344|65772580|FG005|Phase II|Death|0|||
23558622|NCT00331344|65772581|FG006|Phase II|Death|0|||
23558623|NCT00331344|65772582|FG007|Phase II|Death|0|||
23558624|NCT00331344|65772583|FG008|Phase II|Death|4|||
23558625|NCT02068495|65772584|FG000|Overall Study|Case Report Forms Uncollected|60|||
23558626|NCT02068495|65772584|FG000|Overall Study|Protocol Deviation|49|||
23558627|NCT01119898|65772585|FG000|Overall Study|Adverse Event|4|||
23558628|NCT01119898|65772586|FG001|Overall Study|Adverse Event|5|||
23558629|NCT01119898|65772585|FG000|Overall Study|Withdrawal by Subject|1|||
23558630|NCT01119898|65772586|FG001|Overall Study|Withdrawal by Subject|4|||
23558631|NCT01119898|65772585|FG000|Overall Study|Lack of Efficacy|0|||
23558632|NCT01119898|65772586|FG001|Overall Study|Lack of Efficacy|2|||
23558633|NCT01119898|65772585|FG000|Overall Study|Protocol Violation|1|||
23558634|NCT01119898|65772586|FG001|Overall Study|Protocol Violation|1|||
23558635|NCT01119898|65772585|FG000|Overall Study|Medical procedure|1|||
23623960|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
23147954|NCT00195507|64293803|FG001|Overall Study|Physician Decision|2|||
23147955|NCT00195507|64293802|FG000|Overall Study|Lost to Follow-up|3|||
23147956|NCT00195507|64293803|FG001|Overall Study|Lost to Follow-up|2|||
23147957|NCT00195507|64293802|FG000|Overall Study|Protocol Violation|5|||
23147958|NCT00195507|64293803|FG001|Overall Study|Protocol Violation|4|||
23218980|NCT02116361|64544721|FG003|Overall Study|Lack of Efficacy|3|||
23218981|NCT02116361|64544718|FG000|Overall Study|Lost to Follow-up|4|||
23558636|NCT01119898|65772586|FG001|Overall Study|Medical procedure|0|||
23558637|NCT01119898|65772585|FG000|Overall Study|Randomized in error did not participate|1|||
23558638|NCT01119898|65772586|FG001|Overall Study|Randomized in error did not participate|0|||
23558639|NCT02342886|65772587|FG000|Overall Study|Treatment non-compliance|1|||
23558640|NCT02342886|65772588|FG001|Overall Study|Treatment non-compliance|0|||
23558641|NCT02342886|65772589|FG002|Overall Study|Treatment non-compliance|0|||
23558642|NCT02342886|65772590|FG003|Overall Study|Treatment non-compliance|1|||
23558643|NCT02342886|65772591|FG004|Overall Study|Treatment non-compliance|0|||
23437371|NCT00622388|65344058|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
23437372|NCT00622388|65344058|FG000|Overall Study|Took Prohibited Medication|2|||
23437373|NCT00622388|65344058|FG000|Overall Study|Withdrew Consent|1|||
23437374|NCT00622388|65344058|FG000|Overall Study|Insurance Expired|1|||
23437375|NCT00802893|65344059|FG000|Overall Study|study terminated|3|||
23147959|NCT00195507|64293802|FG000|Overall Study|Lack of Efficacy|40|||
23147960|NCT00195507|64293803|FG001|Overall Study|Lack of Efficacy|67|||
23558644|NCT02342886|65772587|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
23558645|NCT02342886|65772588|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
23437376|NCT01983774|65344060|FG000|Overall Study|Lung Transplant|0|||
23437377|NCT01983774|65344061|FG001|Overall Study|Lung Transplant|1|||
23437378|NCT01983774|65344060|FG000|Overall Study|Lost to Follow-up|1|||
23437379|NCT01983774|65344061|FG001|Overall Study|Lost to Follow-up|0|||
23437380|NCT00408434|65344062|FG000|Overall Study|Adverse Event|0|||
23437381|NCT00408434|65344063|FG001|Overall Study|Adverse Event|0|||
23437382|NCT00408434|65344064|FG002|Overall Study|Adverse Event|1|||
23437383|NCT00408434|65344065|FG003|Overall Study|Adverse Event|0|||
23437384|NCT00408434|65344066|FG004|Overall Study|Adverse Event|0|||
23558646|NCT02342886|65772589|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
23558647|NCT02342886|65772590|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
23558648|NCT02342886|65772591|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
23558649|NCT02342886|65772587|FG000|Overall Study|Adverse event/specific toxicity|4|||
23437385|NCT00408434|65344067|FG005|Overall Study|Adverse Event|0|||
23437386|NCT00408434|65344068|FG006|Overall Study|Adverse Event|0|||
23437387|NCT00408434|65344062|FG000|Overall Study|Progressive disease|6|||
23437388|NCT00408434|65344063|FG001|Overall Study|Progressive disease|3|||
23437389|NCT00408434|65344064|FG002|Overall Study|Progressive disease|4|||
23437390|NCT00408434|65344065|FG003|Overall Study|Progressive disease|3|||
23437391|NCT00408434|65344066|FG004|Overall Study|Progressive disease|3|||
23437392|NCT00408434|65344067|FG005|Overall Study|Progressive disease|1|||
23437393|NCT00408434|65344068|FG006|Overall Study|Progressive disease|4|||
23437394|NCT00408434|65344062|FG000|Overall Study|Other|0|||
23437395|NCT00408434|65344063|FG001|Overall Study|Other|0|||
23558650|NCT02342886|65772588|FG001|Overall Study|Adverse event/specific toxicity|3|||
23558651|NCT02342886|65772589|FG002|Overall Study|Adverse event/specific toxicity|11|||
23558652|NCT02342886|65772590|FG003|Overall Study|Adverse event/specific toxicity|2|||
23558653|NCT02342886|65772591|FG004|Overall Study|Adverse event/specific toxicity|1|||
23558654|NCT02342886|65772587|FG000|Overall Study|Lost to Follow-up|1|||
23558655|NCT02342886|65772588|FG001|Overall Study|Lost to Follow-up|0|||
23558656|NCT02342886|65772589|FG002|Overall Study|Lost to Follow-up|0|||
23558657|NCT02342886|65772590|FG003|Overall Study|Lost to Follow-up|0|||
23558658|NCT02342886|65772591|FG004|Overall Study|Lost to Follow-up|0|||
23558659|NCT02342886|65772587|FG000|Overall Study|Death|1|||
23558660|NCT02342886|65772588|FG001|Overall Study|Death|2|||
23558661|NCT02342886|65772589|FG002|Overall Study|Death|1|||
23558662|NCT02342886|65772590|FG003|Overall Study|Death|0|||
23558663|NCT02342886|65772591|FG004|Overall Study|Death|1|||
23558664|NCT02342886|65772587|FG000|Overall Study|Withdrawal by Subject|0|||
23147961|NCT00195507|64293802|FG000|Overall Study|Withdrawal by Subject|16|||
23147962|NCT00195507|64293803|FG001|Overall Study|Withdrawal by Subject|23|||
23147963|NCT00195507|64293802|FG000|Overall Study|Protocol Deviation|6|||
23147964|NCT00195507|64293803|FG001|Overall Study|Protocol Deviation|3|||
23147965|NCT00568321|64293811|FG000|Overall Study|Adverse Event|1|||
23147966|NCT00568321|64293812|FG001|Overall Study|Adverse Event|0|||
23147967|NCT00568321|64293813|FG002|Overall Study|Adverse Event|0|||
23147968|NCT00568321|64293811|FG000|Overall Study|Lack of Efficacy|8|||
23147969|NCT00568321|64293812|FG001|Overall Study|Lack of Efficacy|5|||
23147970|NCT00568321|64293813|FG002|Overall Study|Lack of Efficacy|6|||
23437396|NCT00408434|65344064|FG002|Overall Study|Other|1|||
23437397|NCT00408434|65344065|FG003|Overall Study|Other|0|||
23437398|NCT00408434|65344066|FG004|Overall Study|Other|2|||
23437399|NCT00408434|65344067|FG005|Overall Study|Other|1|||
23437400|NCT00408434|65344068|FG006|Overall Study|Other|0|||
23437401|NCT00408434|65344062|FG000|Overall Study|Terminated by Investigator|0|||
23437402|NCT00408434|65344063|FG001|Overall Study|Terminated by Investigator|0|||
23437403|NCT00408434|65344064|FG002|Overall Study|Terminated by Investigator|0|||
23437404|NCT00408434|65344065|FG003|Overall Study|Terminated by Investigator|0|||
23437405|NCT00408434|65344066|FG004|Overall Study|Terminated by Investigator|1|||
23147971|NCT00568321|64293811|FG000|Overall Study|Lost to Follow-up|0|||
23437406|NCT00408434|65344067|FG005|Overall Study|Terminated by Investigator|1|||
23437407|NCT00408434|65344068|FG006|Overall Study|Terminated by Investigator|0|||
23437408|NCT02335424|65344069|FG000|Overall Study|Withdrawal by Subject|19|||
23558665|NCT02342886|65772588|FG001|Overall Study|Withdrawal by Subject|1|||
23147972|NCT00568321|64293812|FG001|Overall Study|Lost to Follow-up|0|||
23437409|NCT02335424|65344069|FG000|Overall Study|Adverse Event|25|||
23437410|NCT02335424|65344069|FG000|Overall Study|Death|273|||
23437411|NCT02335424|65344069|FG000|Overall Study|Lost to Follow-up|3|||
23437412|NCT02335424|65344069|FG000|Overall Study|Physician Decision|13|||
23437413|NCT02335424|65344069|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
23437414|NCT02335424|65344069|FG000|Overall Study|Protocol Violation|1|||
23437415|NCT02335424|65344069|FG000|Overall Study|Screen failure|1|||
23437416|NCT02092025|65344070|FG000|Overall Study|Case Report Forms Uncollected|44|||
23437417|NCT02092025|65344070|FG000|Overall Study|Protocol Deviation|24|||
23623961|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
23623962|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
23437418|NCT03228212|65344074|FG000|Period 1|Adverse Event|1|||
23437419|NCT03228212|65344075|FG001|Period 1|Adverse Event|0|||
23437420|NCT03228212|65344074|FG000|Period 1|no longer meets eligibility criteria|0|||
23147973|NCT00568321|64293813|FG002|Overall Study|Lost to Follow-up|1|||
23147974|NCT00568321|64293811|FG000|Overall Study|Withdrawal by Subject|2|||
23147975|NCT00568321|64293812|FG001|Overall Study|Withdrawal by Subject|0|||
23147976|NCT00568321|64293813|FG002|Overall Study|Withdrawal by Subject|0|||
23147977|NCT00568321|64293811|FG000|Overall Study|Protocol Violation|0|||
23147978|NCT00568321|64293812|FG001|Overall Study|Protocol Violation|0|||
23147979|NCT00568321|64293813|FG002|Overall Study|Protocol Violation|1|||
23147980|NCT00568321|64293811|FG000|Overall Study|Randomized, not treated|2|||
23147981|NCT00568321|64293812|FG001|Overall Study|Randomized, not treated|0|||
23147982|NCT00568321|64293813|FG002|Overall Study|Randomized, not treated|1|||
23147983|NCT04936841|64293814|FG000|Overall Study|Death|1|||
23147984|NCT01143038|64293815|FG000|Overall Study|Withdrawal by Subject|4|||
23147985|NCT01143038|64293815|FG000|Overall Study|Requirement for alternative therapy|5|||
23147986|NCT01143038|64293815|FG000|Overall Study|Adverse Event|3|||
23147987|NCT01143038|64293815|FG000|Overall Study|Lost to Follow-up|2|||
23147988|NCT01143038|64293815|FG000|Overall Study|Protocol Deviation|1|||
23147989|NCT01143038|64293815|FG000|Overall Study|Death|1|||
23147990|NCT00823901|64293824|FG000|Overall Study|Adverse Event|1|||
23147991|NCT00823901|64293825|FG001|Overall Study|Adverse Event|1|||
23147992|NCT00823901|64293824|FG000|Overall Study|Lack of Efficacy|1|||
23322774|NCT03154125|64923130|FG000|Overall Study|Protocol Violation|3|||
23322775|NCT03154125|64923131|FG001|Overall Study|Protocol Violation|5|||
23322776|NCT03154125|64923132|FG002|Overall Study|Protocol Violation|0|||
23322777|NCT02126826|64923133|FG000|Overall Study|Withdrawal by Subject|0|||
23322778|NCT02126826|64923134|FG001|Overall Study|Withdrawal by Subject|0|||
23322779|NCT02126826|64923135|FG002|Overall Study|Withdrawal by Subject|0|||
23322780|NCT02126826|64923136|FG003|Overall Study|Withdrawal by Subject|1|||
23322781|NCT02126826|64923137|FG004|Overall Study|Withdrawal by Subject|0|||
23322782|NCT02126826|64923138|FG005|Overall Study|Withdrawal by Subject|0|||
23322783|NCT02126826|64923139|FG006|Overall Study|Withdrawal by Subject|0|||
23437421|NCT03228212|65344075|FG001|Period 1|no longer meets eligibility criteria|1|||
23437422|NCT03228212|65344074|FG000|Period 2|Lost to Follow-up|1|||
23437423|NCT03228212|65344075|FG001|Period 2|Lost to Follow-up|0|||
23437424|NCT01496846|65344076|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
23437425|NCT01496846|65344077|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
23437426|NCT01496846|65344078|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
23623963|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
23623964|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
23623965|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
23623966|NCT01664923|66011505|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
23623967|NCT01664923|66011506|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
23322784|NCT03452943|64923142|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
23623968|NCT04486313|66011507|FG000|Overall Study|Lost to Follow-up|7|||
23623969|NCT04486313|66011508|FG001|Overall Study|Lost to Follow-up|9|||
23623970|NCT04486313|66011507|FG000|Overall Study|Withdrawal by Subject|8|||
23623971|NCT04486313|66011508|FG001|Overall Study|Withdrawal by Subject|6|||
23623972|NCT04486313|66011507|FG000|Overall Study|Physician Decision|1|||
23623973|NCT04486313|66011508|FG001|Overall Study|Physician Decision|1|||
23623974|NCT04486313|66011507|FG000|Overall Study|Death|2|||
23623975|NCT04486313|66011508|FG001|Overall Study|Death|0|||
23623976|NCT04486313|66011507|FG000|Overall Study|Protocol Violation|1|||
23322785|NCT03452943|64923143|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
23322786|NCT03452943|64923142|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
23322787|NCT03452943|64923143|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
23322788|NCT03452943|64923142|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
23623977|NCT04486313|66011508|FG001|Overall Study|Protocol Violation|1|||
23147993|NCT00823901|64293825|FG001|Overall Study|Lack of Efficacy|0|||
23147994|NCT00823901|64293824|FG000|Overall Study|Lost to Follow-up|2|||
23147995|NCT00823901|64293825|FG001|Overall Study|Lost to Follow-up|1|||
23147996|NCT02604433|64293827|FG000|Overall Study|Withdrawal by Subject|37|||
23147997|NCT02604433|64293828|FG001|Overall Study|Withdrawal by Subject|16|||
23322789|NCT03452943|64923143|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
23322790|NCT03452943|64923142|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
23322791|NCT03452943|64923143|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
23147998|NCT02604433|64293827|FG000|Overall Study|Adverse Event|4|||
23147999|NCT02604433|64293828|FG001|Overall Study|Adverse Event|0|||
23437427|NCT01496846|65344079|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
23437428|NCT01496846|65344080|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
23437429|NCT01496846|65344081|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
23437430|NCT03208088|65344082|FG000|Period 2|Withdrawal by Subject|0|||
23437431|NCT03208088|65344083|FG001|Period 2|Withdrawal by Subject|0|||
23437432|NCT03208088|65344084|FG002|Period 2|Withdrawal by Subject|0|||
23437433|NCT03208088|65344085|FG003|Period 2|Withdrawal by Subject|0|||
23437434|NCT03208088|65344086|FG004|Period 2|Withdrawal by Subject|0|||
23437435|NCT03208088|65344087|FG005|Period 2|Withdrawal by Subject|0|||
23437436|NCT03208088|65344088|FG006|Period 2|Withdrawal by Subject|0|||
23437437|NCT03208088|65344089|FG007|Period 2|Withdrawal by Subject|0|||
23437438|NCT03208088|65344090|FG008|Period 2|Withdrawal by Subject|1|||
23437439|NCT03208088|65344091|FG009|Period 2|Withdrawal by Subject|0|||
23437440|NCT03208088|65344082|FG000|Period 3|Unsatisfactory Test Article|0|||
23437441|NCT03208088|65344083|FG001|Period 3|Unsatisfactory Test Article|0|||
23437442|NCT03208088|65344084|FG002|Period 3|Unsatisfactory Test Article|0|||
23437443|NCT03208088|65344085|FG003|Period 3|Unsatisfactory Test Article|1|||
23437444|NCT03208088|65344086|FG004|Period 3|Unsatisfactory Test Article|0|||
23437445|NCT03208088|65344087|FG005|Period 3|Unsatisfactory Test Article|0|||
23437446|NCT03208088|65344088|FG006|Period 3|Unsatisfactory Test Article|0|||
23437447|NCT03208088|65344089|FG007|Period 3|Unsatisfactory Test Article|0|||
23437448|NCT03208088|65344090|FG008|Period 3|Unsatisfactory Test Article|0|||
23437449|NCT03208088|65344091|FG009|Period 3|Unsatisfactory Test Article|0|||
23437450|NCT03208088|65344082|FG000|Period 4|Unsatisfactory Test Article|0|||
23437451|NCT03208088|65344083|FG001|Period 4|Unsatisfactory Test Article|0|||
23437452|NCT03208088|65344084|FG002|Period 4|Unsatisfactory Test Article|0|||
23437453|NCT03208088|65344085|FG003|Period 4|Unsatisfactory Test Article|1|||
23437454|NCT03208088|65344086|FG004|Period 4|Unsatisfactory Test Article|0|||
23437455|NCT03208088|65344087|FG005|Period 4|Unsatisfactory Test Article|0|||
23437456|NCT03208088|65344088|FG006|Period 4|Unsatisfactory Test Article|0|||
23437457|NCT03208088|65344089|FG007|Period 4|Unsatisfactory Test Article|0|||
23437458|NCT03208088|65344090|FG008|Period 4|Unsatisfactory Test Article|0|||
23437459|NCT03208088|65344091|FG009|Period 4|Unsatisfactory Test Article|0|||
23437460|NCT00835341|65344092|FG000|Overall Study|Lost to Follow-up|3|||
23437461|NCT00835341|65344093|FG001|Overall Study|Lost to Follow-up|12|||
23437462|NCT04006392|65344094|FG000|Overall Study|Lost to Follow-up|0|||
23437463|NCT04006392|65344095|FG001|Overall Study|Lost to Follow-up|1|||
23437464|NCT04078152|65344096|FG000|Overall Study|Other|83|||
23437465|NCT04078152|65344097|FG001|Overall Study|Other|22|||
23437466|NCT04078152|65344098|FG002|Overall Study|Other|25|||
23437467|NCT04078152|65344096|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
23437468|NCT04078152|65344097|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
23437469|NCT04078152|65344098|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
23437470|NCT04078152|65344096|FG000|Overall Study|Withdrawal by Subject|5|||
23437471|NCT04078152|65344097|FG001|Overall Study|Withdrawal by Subject|0|||
23437472|NCT04078152|65344098|FG002|Overall Study|Withdrawal by Subject|1|||
23437473|NCT04078152|65344096|FG000|Overall Study|Death|10|||
23437474|NCT04078152|65344097|FG001|Overall Study|Death|2|||
23437475|NCT04078152|65344098|FG002|Overall Study|Death|12|||
23437476|NCT04078152|65344096|FG000|Overall Study|Adverse Event|1|||
23437477|NCT04078152|65344097|FG001|Overall Study|Adverse Event|0|||
23437478|NCT04078152|65344098|FG002|Overall Study|Adverse Event|0|||
23437479|NCT01811186|65344099|FG000|Overall Study|Adverse Event|54|||
23437480|NCT01811186|65344100|FG001|Overall Study|Adverse Event|38|||
23437481|NCT01811186|65344099|FG000|Overall Study|Protocol Violation|5|||
23437482|NCT01811186|65344100|FG001|Overall Study|Protocol Violation|6|||
23437483|NCT01811186|65344099|FG000|Overall Study|Withdrawal by Subject|5|||
23437484|NCT01811186|65344100|FG001|Overall Study|Withdrawal by Subject|10|||
23437485|NCT01811186|65344099|FG000|Overall Study|Lack of Efficacy|3|||
23437486|NCT01811186|65344100|FG001|Overall Study|Lack of Efficacy|6|||
23437487|NCT01811186|65344099|FG000|Overall Study|Lost to Follow-up|4|||
23437488|NCT01811186|65344100|FG001|Overall Study|Lost to Follow-up|2|||
23437489|NCT03270891|65344101|FG000|Overall Study|Lost to Follow-up|3|||
23437490|NCT03270891|65344102|FG001|Overall Study|Lost to Follow-up|6|||
23437491|NCT03270891|65344103|FG002|Overall Study|Lost to Follow-up|0|||
23437492|NCT03270891|65344101|FG000|Overall Study|Withdrawal by Subject|1|||
23437493|NCT03270891|65344102|FG001|Overall Study|Withdrawal by Subject|0|||
23437494|NCT03270891|65344103|FG002|Overall Study|Withdrawal by Subject|0|||
23437495|NCT03270891|65344101|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
23437496|NCT03270891|65344102|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
23437497|NCT03270891|65344103|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
23148000|NCT02604433|64293827|FG000|Overall Study|Other reasons|3|||
23437498|NCT01727336|65344105|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
23437499|NCT01727336|65344106|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
23437500|NCT01727336|65344107|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
23437501|NCT01727336|65344108|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
23437502|NCT01727336|65344109|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
23437503|NCT01727336|65344110|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
23437504|NCT01727336|65344105|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
23437505|NCT01727336|65344106|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
23437506|NCT01727336|65344107|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
23437507|NCT01727336|65344108|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
23437508|NCT01727336|65344109|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
23437509|NCT01727336|65344110|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
23437510|NCT01727336|65344105|FG000|Part 2 Blinded|Death|0|||
23437511|NCT01727336|65344106|FG001|Part 2 Blinded|Death|0|||
23437512|NCT01727336|65344107|FG002|Part 2 Blinded|Death|0|||
23437513|NCT01727336|65344108|FG003|Part 2 Blinded|Death|0|||
23437514|NCT01727336|65344109|FG004|Part 2 Blinded|Death|20|||
23437515|NCT01727336|65344110|FG005|Part 2 Blinded|Death|16|||
23437516|NCT01727336|65344105|FG000|Part 2 Blinded|Lack of Efficacy|0|||
23437517|NCT01727336|65344106|FG001|Part 2 Blinded|Lack of Efficacy|0|||
23437518|NCT01727336|65344107|FG002|Part 2 Blinded|Lack of Efficacy|0|||
23437519|NCT01727336|65344108|FG003|Part 2 Blinded|Lack of Efficacy|0|||
23437520|NCT01727336|65344109|FG004|Part 2 Blinded|Lack of Efficacy|42|||
23437521|NCT01727336|65344110|FG005|Part 2 Blinded|Lack of Efficacy|44|||
23437522|NCT01727336|65344105|FG000|Part 2 Blinded|Lost to Follow-up|0|||
23437523|NCT01727336|65344106|FG001|Part 2 Blinded|Lost to Follow-up|0|||
23437524|NCT01727336|65344107|FG002|Part 2 Blinded|Lost to Follow-up|0|||
23437525|NCT01727336|65344108|FG003|Part 2 Blinded|Lost to Follow-up|0|||
23437526|NCT01727336|65344109|FG004|Part 2 Blinded|Lost to Follow-up|0|||
23437527|NCT01727336|65344110|FG005|Part 2 Blinded|Lost to Follow-up|1|||
23437528|NCT01727336|65344105|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
23437529|NCT01727336|65344106|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
23437530|NCT01727336|65344107|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
23437531|NCT01727336|65344108|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
23437532|NCT01727336|65344109|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
23437533|NCT01727336|65344110|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
23437534|NCT01727336|65344105|FG000|Part 2 Blinded|use of prohibited medications|0|||
23437535|NCT01727336|65344106|FG001|Part 2 Blinded|use of prohibited medications|0|||
23437536|NCT01727336|65344107|FG002|Part 2 Blinded|use of prohibited medications|0|||
23437537|NCT01727336|65344108|FG003|Part 2 Blinded|use of prohibited medications|0|||
23437538|NCT01727336|65344109|FG004|Part 2 Blinded|use of prohibited medications|1|||
23437539|NCT01727336|65344110|FG005|Part 2 Blinded|use of prohibited medications|3|||
23437540|NCT02126839|65344111|FG000|Overall Study|Adverse Event|0|||
23437541|NCT02126839|65344112|FG001|Overall Study|Adverse Event|1|||
23437542|NCT02126839|65344111|FG000|Overall Study|Withdrawal by Subject|1|||
23437543|NCT02126839|65344112|FG001|Overall Study|Withdrawal by Subject|0|||
23437544|NCT02126839|65344111|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23437545|NCT02126839|65344112|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23437546|NCT02126839|65344111|FG000|Overall Study|Protocol Violation|2|||
23437547|NCT02126839|65344112|FG001|Overall Study|Protocol Violation|3|||
23437548|NCT02126839|65344111|FG000|Overall Study|Sponsor request|0|||
23437549|NCT02126839|65344112|FG001|Overall Study|Sponsor request|1|||
23437550|NCT02126839|65344111|FG000|Overall Study|Lost to Follow-up|1|||
23437551|NCT02126839|65344112|FG001|Overall Study|Lost to Follow-up|4|||
23437552|NCT02126839|65344111|FG000|Overall Study|Other|5|||
23437553|NCT02126839|65344112|FG001|Overall Study|Other|5|||
23437554|NCT01534195|65344118|FG000|Overall Study|Withdrawal by Subject|1|||
23437555|NCT01534195|65344119|FG001|Overall Study|Withdrawal by Subject|1|||
23437556|NCT00445770|65344121|FG000|Overall Study|Adverse Event|9|||
23437557|NCT00445770|65344122|FG001|Overall Study|Adverse Event|15|||
23437558|NCT00445770|65344123|FG002|Overall Study|Adverse Event|19|||
23437559|NCT00445770|65344121|FG000|Overall Study|Lack of Efficacy|38|||
23437560|NCT00445770|65344122|FG001|Overall Study|Lack of Efficacy|13|||
23437561|NCT00445770|65344123|FG002|Overall Study|Lack of Efficacy|6|||
23623978|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
23437562|NCT00445770|65344121|FG000|Overall Study|Lost to Follow-up|0|||
23437563|NCT00445770|65344122|FG001|Overall Study|Lost to Follow-up|2|||
23437564|NCT00445770|65344123|FG002|Overall Study|Lost to Follow-up|0|||
23437565|NCT00445770|65344121|FG000|Overall Study|Other|6|||
23437566|NCT00445770|65344122|FG001|Overall Study|Other|5|||
23437567|NCT00445770|65344123|FG002|Overall Study|Other|6|||
23437568|NCT02921087|65344139|FG000|Overall Study|Withdrawal by Subject|0|||
23437569|NCT02921087|65344140|FG001|Overall Study|Withdrawal by Subject|1|||
23437570|NCT01140061|65344143|FG000|Part I|Adverse Event|1|||
23437571|NCT01140061|65344144|FG001|Part I|Adverse Event|0|||
23437572|NCT01140061|65344145|FG002|Part I|Adverse Event|0|||
23437573|NCT01140061|65344146|FG003|Part I|Adverse Event|0|||
23437574|NCT01140061|65344147|FG004|Part I|Adverse Event|0|||
23437575|NCT01140061|65344148|FG005|Part I|Adverse Event|0|||
23437576|NCT01140061|65344149|FG006|Part I|Adverse Event|0|||
23437577|NCT01140061|65344150|FG007|Part I|Adverse Event|0|||
23623979|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
23623980|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
23623981|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
23623982|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
23623983|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
23623984|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
23623985|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
23623986|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Death|6|||
23623987|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Death|2|||
23623988|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Death|2|||
23623989|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Death|9|||
23623990|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
23623991|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
23623992|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
23623993|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
23623994|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
23623995|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
23623996|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
23623997|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
23623998|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
23148001|NCT02604433|64293828|FG001|Overall Study|Other reasons|5|||
23148002|NCT02604433|64293827|FG000|Overall Study|Death|4|||
23148003|NCT02604433|64293828|FG001|Overall Study|Death|1|||
23148004|NCT02604433|64293827|FG000|Overall Study|Transition to Rollover Protocol|169|||
23148005|NCT02604433|64293828|FG001|Overall Study|Transition to Rollover Protocol|82|||
23148006|NCT02604433|64293827|FG000|Overall Study|Physician Decision|1|||
23148007|NCT02604433|64293828|FG001|Overall Study|Physician Decision|1|||
23148008|NCT02604433|64293827|FG000|Overall Study|Lack of Efficacy|0|||
23148009|NCT02604433|64293828|FG001|Overall Study|Lack of Efficacy|1|||
23148010|NCT05211739|64293830|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
23148011|NCT05211739|64293831|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
23148012|NCT05211739|64293830|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
23322792|NCT03452943|64923142|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
23322793|NCT03452943|64923143|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
23322794|NCT03452943|64923142|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
23322795|NCT03452943|64923143|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
23322796|NCT03993379|64923144|FG000|Overall Study|The study was terminated early due to business decision.|0|||
23322797|NCT03993379|64923145|FG001|Overall Study|The study was terminated early due to business decision.|2|||
23322798|NCT03993379|64923146|FG002|Overall Study|The study was terminated early due to business decision.|0|||
23322799|NCT03993379|64923147|FG003|Overall Study|The study was terminated early due to business decision.|0|||
23322800|NCT03993379|64923144|FG000|Overall Study|Withdrawal by Subject|0|||
23322801|NCT03993379|64923145|FG001|Overall Study|Withdrawal by Subject|1|||
23322802|NCT03993379|64923146|FG002|Overall Study|Withdrawal by Subject|0|||
23322803|NCT03993379|64923147|FG003|Overall Study|Withdrawal by Subject|0|||
23322804|NCT02618759|64923148|FG000|Overall Study|Lost to Follow-up|0|||
23322805|NCT02618759|64923149|FG001|Overall Study|Lost to Follow-up|1|||
23322806|NCT02618759|64923148|FG000|Overall Study|Withdrawal by Subject|1|||
23322807|NCT02618759|64923149|FG001|Overall Study|Withdrawal by Subject|0|||
23322808|NCT02618759|64923148|FG000|Overall Study|Other Reasons|1|||
23322809|NCT02618759|64923149|FG001|Overall Study|Other Reasons|4|||
23322810|NCT00577863|64923152|FG000|Overall Study|Adverse Event|4|||
23322811|NCT00577863|64923153|FG001|Overall Study|Adverse Event|2|||
23322812|NCT00577863|64923152|FG000|Overall Study|Death|1|||
23322813|NCT00577863|64923153|FG001|Overall Study|Death|0|||
23322814|NCT00577863|64923152|FG000|Overall Study|Lost to Follow-up|2|||
23322815|NCT00577863|64923153|FG001|Overall Study|Lost to Follow-up|2|||
23322816|NCT00577863|64923152|FG000|Overall Study|Entry Criteria Exclusion|1|||
23322817|NCT00577863|64923153|FG001|Overall Study|Entry Criteria Exclusion|0|||
23322818|NCT00577863|64923152|FG000|Overall Study|Withdrawal by Subject|0|||
23322819|NCT00577863|64923153|FG001|Overall Study|Withdrawal by Subject|2|||
23322820|NCT00577863|64923152|FG000|Overall Study|Sponsor Decision|2|||
23322821|NCT00577863|64923153|FG001|Overall Study|Sponsor Decision|7|||
23148013|NCT05211739|64293831|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
23148014|NCT05211739|64293830|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
23148015|NCT05211739|64293831|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
23322822|NCT00577863|64923152|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
23322823|NCT00577863|64923153|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
23322824|NCT01569295|64923154|FG000|Overall Study|Progressive Disease|75|||
23322825|NCT01569295|64923155|FG001|Overall Study|Progressive Disease|139|||
23322826|NCT01569295|64923154|FG000|Overall Study|Adverse Event|39|||
23623999|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
23624000|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
23624001|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
23148016|NCT05211739|64293830|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
23148017|NCT05211739|64293831|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
23148018|NCT02986334|64293832|FG000|Overall Study|Withdrawal by Subject|0|||
23148019|NCT02986334|64293833|FG001|Overall Study|Withdrawal by Subject|1|||
23148020|NCT02986334|64293834|FG002|Overall Study|Withdrawal by Subject|2|||
23148021|NCT02986334|64293832|FG000|Overall Study|Lost to Follow-up|1|||
23148022|NCT02986334|64293833|FG001|Overall Study|Lost to Follow-up|2|||
23148023|NCT02986334|64293834|FG002|Overall Study|Lost to Follow-up|1|||
23148024|NCT02986334|64293832|FG000|Overall Study|Adverse Event|0|||
23148025|NCT02986334|64293833|FG001|Overall Study|Adverse Event|2|||
23148026|NCT02986334|64293834|FG002|Overall Study|Adverse Event|1|||
23148027|NCT02986334|64293832|FG000|Overall Study|non compliance in phone ratings|2|||
23148028|NCT02986334|64293833|FG001|Overall Study|non compliance in phone ratings|1|||
23148029|NCT02986334|64293834|FG002|Overall Study|non compliance in phone ratings|2|||
23148030|NCT02986334|64293832|FG000|Overall Study|undisclosed comorbidities|0|||
23148031|NCT02986334|64293833|FG001|Overall Study|undisclosed comorbidities|1|||
23148032|NCT02986334|64293834|FG002|Overall Study|undisclosed comorbidities|1|||
23148033|NCT05266586|64293835|FG000|Overall Study|Adverse Event|2|||
23148034|NCT05266586|64293836|FG001|Overall Study|Adverse Event|2|||
23148035|NCT05266586|64293837|FG002|Overall Study|Adverse Event|1|||
23148036|NCT05266586|64293835|FG000|Overall Study|Withdrawal by Subject|1|||
23148037|NCT05266586|64293836|FG001|Overall Study|Withdrawal by Subject|0|||
23148038|NCT05266586|64293837|FG002|Overall Study|Withdrawal by Subject|1|||
23148039|NCT05266586|64293835|FG000|Overall Study|Non-compliance with study drug|0|||
23148040|NCT05266586|64293836|FG001|Overall Study|Non-compliance with study drug|1|||
23148041|NCT05266586|64293837|FG002|Overall Study|Non-compliance with study drug|0|||
23148042|NCT05266586|64293835|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
23148043|NCT05266586|64293836|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
23148044|NCT05266586|64293837|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
23148045|NCT04217590|64293838|FG000|Overall Study|Other|1|||
23148046|NCT04217590|64293839|FG001|Overall Study|Other|1|||
23148047|NCT04217590|64293838|FG000|Overall Study|Withdrawal by Subject|3|||
23148048|NCT04217590|64293839|FG001|Overall Study|Withdrawal by Subject|1|||
23148049|NCT04217590|64293838|FG000|Overall Study|Death|0|||
23148050|NCT04217590|64293839|FG001|Overall Study|Death|1|||
23148051|NCT01920594|64293840|FG000|Overall Study|Adverse Event|4|||
23148052|NCT01920594|64293841|FG001|Overall Study|Adverse Event|2|||
23148053|NCT01920594|64293840|FG000|Overall Study|Lost to Follow-up|1|||
23148054|NCT01920594|64293841|FG001|Overall Study|Lost to Follow-up|0|||
23148055|NCT01920594|64293840|FG000|Overall Study|Recovery|2|||
23148056|NCT01920594|64293841|FG001|Overall Study|Recovery|0|||
23148057|NCT01920594|64293840|FG000|Overall Study|Investigator discretion|0|||
23148058|NCT01920594|64293841|FG001|Overall Study|Investigator discretion|1|||
23148059|NCT03907410|64293842|FG000|Overall Study|Lost to Follow-up|4|||
23148060|NCT03907410|64293843|FG001|Overall Study|Lost to Follow-up|1|||
23218982|NCT02116361|64544719|FG001|Overall Study|Lost to Follow-up|5|||
23218983|NCT02116361|64544720|FG002|Overall Study|Lost to Follow-up|7|||
23322827|NCT01569295|64923155|FG001|Overall Study|Adverse Event|14|||
23322828|NCT01569295|64923154|FG000|Overall Study|Withdrawal by Subject|25|||
23322829|NCT01569295|64923155|FG001|Overall Study|Withdrawal by Subject|12|||
23322830|NCT01569295|64923154|FG000|Overall Study|Death|19|||
23322831|NCT01569295|64923155|FG001|Overall Study|Death|15|||
23322832|NCT01569295|64923154|FG000|Overall Study|Physician Decision|13|||
23322833|NCT01569295|64923155|FG001|Overall Study|Physician Decision|18|||
23322834|NCT01569295|64923154|FG000|Overall Study|Study Terminated by Sponsor|24|||
23322835|NCT01569295|64923155|FG001|Overall Study|Study Terminated by Sponsor|2|||
23558666|NCT02342886|65772589|FG002|Overall Study|Withdrawal by Subject|0|||
23148061|NCT03907410|64293844|FG002|Overall Study|Lost to Follow-up|1|||
23218984|NCT02116361|64544721|FG003|Overall Study|Lost to Follow-up|5|||
23218985|NCT02116361|64544718|FG000|Overall Study|Personal Reasons|6|||
23218986|NCT02116361|64544719|FG001|Overall Study|Personal Reasons|6|||
23218987|NCT02116361|64544720|FG002|Overall Study|Personal Reasons|4|||
23218988|NCT02116361|64544721|FG003|Overall Study|Personal Reasons|9|||
23218989|NCT02116361|64544718|FG000|Overall Study|Investigator Decision - Relapse|9|||
23218990|NCT02116361|64544719|FG001|Overall Study|Investigator Decision - Relapse|7|||
23218991|NCT02116361|64544720|FG002|Overall Study|Investigator Decision - Relapse|8|||
23218992|NCT02116361|64544721|FG003|Overall Study|Investigator Decision - Relapse|5|||
23218993|NCT00804986|64544725|FG000|Overall Study|Adverse Event|0|||
23218994|NCT00804986|64544726|FG001|Overall Study|Adverse Event|1|||
23322836|NCT01569295|64923154|FG000|Overall Study|Other Reason not Specified|3|||
23322837|NCT01569295|64923155|FG001|Overall Study|Other Reason not Specified|5|||
23322838|NCT01569295|64923154|FG000|Overall Study|Non-Compliance with Study Drug|6|||
23322839|NCT01569295|64923155|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23148062|NCT03907410|64293842|FG000|Overall Study|Lost to follow-up and research burden|0|||
23218995|NCT00804986|64544727|FG002|Overall Study|Adverse Event|2|||
23558667|NCT02342886|65772590|FG003|Overall Study|Withdrawal by Subject|1|||
23437578|NCT01140061|65344151|FG008|Part I|Adverse Event|0|||
23437579|NCT01140061|65344152|FG009|Part I|Adverse Event|0|||
23437580|NCT01140061|65344143|FG000|Extension|Laboratory Adverse Event|0|||
23437581|NCT01140061|65344144|FG001|Extension|Laboratory Adverse Event|0|||
23437582|NCT01140061|65344145|FG002|Extension|Laboratory Adverse Event|0|||
23437583|NCT01140061|65344146|FG003|Extension|Laboratory Adverse Event|0|||
23437584|NCT01140061|65344147|FG004|Extension|Laboratory Adverse Event|0|||
23437585|NCT01140061|65344148|FG005|Extension|Laboratory Adverse Event|0|||
23148063|NCT03907410|64293843|FG001|Overall Study|Lost to follow-up and research burden|0|||
23148064|NCT03907410|64293844|FG002|Overall Study|Lost to follow-up and research burden|1|||
23437586|NCT01140061|65344149|FG006|Extension|Laboratory Adverse Event|0|||
23437587|NCT01140061|65344150|FG007|Extension|Laboratory Adverse Event|0|||
23437588|NCT01140061|65344151|FG008|Extension|Laboratory Adverse Event|0|||
23437589|NCT01140061|65344152|FG009|Extension|Laboratory Adverse Event|1|||
23437590|NCT00320424|65344153|FG000|Overall Study|Adverse Event|3|||
23148065|NCT02260882|64293845|FG000|Overall Study|Protocol Violation|0|||
23437591|NCT00320424|65344153|FG000|Overall Study|Other|3|||
23437592|NCT00547521|65344154|FG000|Short Term Study (4 Months)|Adverse Event|1|||
23437593|NCT00547521|65344155|FG001|Short Term Study (4 Months)|Adverse Event|0|||
23218996|NCT00804986|64544728|FG003|Overall Study|Adverse Event|1|||
23218997|NCT00804986|64544729|FG004|Overall Study|Adverse Event|3|||
23218998|NCT00804986|64544730|FG005|Overall Study|Adverse Event|0|||
23218999|NCT00804986|64544725|FG000|Overall Study|Lack of Efficacy|0|||
23219000|NCT00804986|64544726|FG001|Overall Study|Lack of Efficacy|0|||
23219001|NCT00804986|64544727|FG002|Overall Study|Lack of Efficacy|0|||
23219002|NCT00804986|64544728|FG003|Overall Study|Lack of Efficacy|1|||
23219003|NCT00804986|64544729|FG004|Overall Study|Lack of Efficacy|0|||
23219004|NCT00804986|64544730|FG005|Overall Study|Lack of Efficacy|3|||
23219005|NCT00804986|64544725|FG000|Overall Study|Lost to Follow-up|0|||
23219006|NCT00804986|64544726|FG001|Overall Study|Lost to Follow-up|0|||
23219007|NCT00804986|64544727|FG002|Overall Study|Lost to Follow-up|0|||
23437594|NCT00547521|65344154|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
23437595|NCT00547521|65344155|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
23437596|NCT00547521|65344154|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
23437597|NCT00547521|65344155|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
23437598|NCT00547521|65344154|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
23437599|NCT00547521|65344155|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
23437600|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
23437601|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
23148066|NCT02260882|64293846|FG001|Overall Study|Protocol Violation|1|||
23148067|NCT00041067|64293847|FG000|Overall Study|Adverse Event|20|||
23148068|NCT00041067|64293847|FG000|Overall Study|Progression|19|||
23148069|NCT00041067|64293847|FG000|Overall Study|Patient refusal|12|||
23148070|NCT00041067|64293847|FG000|Overall Study|Other reasons|23|||
23148071|NCT00041067|64293847|FG000|Overall Study|Ineligible|2|||
23148072|NCT00888433|64293848|FG000|Overall Study|Withdrawal by Subject|1|||
23148073|NCT00888433|64293849|FG001|Overall Study|Withdrawal by Subject|2|||
23148074|NCT00888433|64293848|FG000|Overall Study|Missed Visit|2|||
23148075|NCT00888433|64293849|FG001|Overall Study|Missed Visit|1|||
23219008|NCT00804986|64544728|FG003|Overall Study|Lost to Follow-up|1|||
23437602|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
23437603|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
23437604|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
23437605|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
23437606|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
23437607|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
23437608|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Other|0|||
23437609|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Other|2|||
23437610|NCT00547521|65344154|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
23437611|NCT00547521|65344155|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
23437612|NCT01868477|65344162|FG000|Overall Study|Adverse Event|2|||
23437613|NCT01868477|65344163|FG001|Overall Study|Adverse Event|4|||
23437614|NCT01868477|65344162|FG000|Overall Study|Disease progression|1|||
23437615|NCT01868477|65344163|FG001|Overall Study|Disease progression|1|||
23219009|NCT00804986|64544729|FG004|Overall Study|Lost to Follow-up|1|||
23219010|NCT00804986|64544730|FG005|Overall Study|Lost to Follow-up|3|||
23219011|NCT00804986|64544725|FG000|Overall Study|Protocol Violation|0|||
23322840|NCT01569295|64923154|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
23437616|NCT01868477|65344162|FG000|Overall Study|Withdrawal by Subject|1|||
23437617|NCT01868477|65344163|FG001|Overall Study|Withdrawal by Subject|0|||
23437618|NCT02409342|65344164|FG000|Overall Study|Death|211|||
23148076|NCT01233869|64293852|FG000|Initial Treatment Period (24 Months)|Death|1|||
23148077|NCT01233869|64293853|FG001|Initial Treatment Period (24 Months)|Death|0|||
23219012|NCT00804986|64544726|FG001|Overall Study|Protocol Violation|1|||
23437619|NCT02409342|65344165|FG001|Overall Study|Death|201|||
23437620|NCT02409342|65344164|FG000|Overall Study|Withdrawal by Subject|24|||
23148078|NCT01233869|64293854|FG002|Initial Treatment Period (24 Months)|Death|0|||
23148079|NCT01233869|64293855|FG003|Initial Treatment Period (24 Months)|Death|0|||
23148080|NCT01233869|64293852|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
23148081|NCT01233869|64293853|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
23148082|NCT01233869|64293854|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
23148083|NCT01233869|64293855|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
23148084|NCT01233869|64293852|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
23148085|NCT01233869|64293853|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
23148086|NCT01233869|64293854|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
23148087|NCT01233869|64293855|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
23148088|NCT01233869|64293852|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
23148089|NCT01233869|64293853|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
23148090|NCT01233869|64293854|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
23148091|NCT01233869|64293855|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
23148092|NCT01233869|64293852|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
23148093|NCT01233869|64293853|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
23148094|NCT01233869|64293854|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
23148095|NCT01233869|64293855|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
23148096|NCT01233869|64293852|FG000|Extended Treatment Period (46 Months)|Other|3|||
23148097|NCT01233869|64293853|FG001|Extended Treatment Period (46 Months)|Other|0|||
23148098|NCT01233869|64293854|FG002|Extended Treatment Period (46 Months)|Other|0|||
23148099|NCT01233869|64293855|FG003|Extended Treatment Period (46 Months)|Other|3|||
23148100|NCT01233869|64293852|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
23148101|NCT01233869|64293853|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
23148102|NCT01233869|64293854|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
23148103|NCT01233869|64293855|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
23148104|NCT02982187|64293857|FG000|Overall Study|Withdrawal by Subject|0|||
23148105|NCT02982187|64293858|FG001|Overall Study|Withdrawal by Subject|0|||
23148106|NCT02982187|64293859|FG002|Overall Study|Withdrawal by Subject|0|||
23148107|NCT02982187|64293860|FG003|Overall Study|Withdrawal by Subject|0|||
23148108|NCT02982187|64293861|FG004|Overall Study|Withdrawal by Subject|0|||
23148109|NCT02982187|64293862|FG005|Overall Study|Withdrawal by Subject|0|||
23148110|NCT02982187|64293863|FG006|Overall Study|Withdrawal by Subject|1|||
23148111|NCT02982187|64293864|FG007|Overall Study|Withdrawal by Subject|0|||
23148112|NCT01940354|64293869|FG000|Overall Study|Withdrawal by Subject|4|||
23148113|NCT01940354|64293870|FG001|Overall Study|Withdrawal by Subject|2|||
23148114|NCT00583024|64293876|FG000|Overall Study|Lost to Follow-up|4|||
23148115|NCT02178553|64293877|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
23148116|NCT02178553|64293878|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
23148117|NCT02178553|64293877|FG000|Overall Study|Physician Decision|0|||
23148118|NCT02178553|64293878|FG001|Overall Study|Physician Decision|4|||
23148119|NCT02178553|64293877|FG000|Overall Study|Technical problem with injection|1|||
23148120|NCT02178553|64293878|FG001|Overall Study|Technical problem with injection|3|||
23148121|NCT00528567|64293879|FG000|Overall Study|Death|4|||
23148122|NCT00528567|64293880|FG001|Overall Study|Death|5|||
23148123|NCT00528567|64293879|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
23148124|NCT00528567|64293880|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
23148125|NCT00528567|64293879|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
23148126|NCT00528567|64293880|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
23148127|NCT00528567|64293879|FG000|Overall Study|Violation Criteria at Entry|3|||
23148128|NCT00528567|64293880|FG001|Overall Study|Violation Criteria at Entry|17|||
23148129|NCT00528567|64293879|FG000|Overall Study|Withdrew Consent|59|||
23148130|NCT00528567|64293880|FG001|Overall Study|Withdrew Consent|55|||
23148131|NCT00528567|64293879|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
23148132|NCT00528567|64293880|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
23148133|NCT00528567|64293879|FG000|Overall Study|Failure to Return|1|||
23148134|NCT00528567|64293880|FG001|Overall Study|Failure to Return|4|||
23148135|NCT00528567|64293879|FG000|Overall Study|Other Protocol Violation|5|||
23148136|NCT00528567|64293880|FG001|Overall Study|Other Protocol Violation|21|||
23148137|NCT00528567|64293879|FG000|Overall Study|Administrative/Other|22|||
23148138|NCT00528567|64293880|FG001|Overall Study|Administrative/Other|75|||
23148139|NCT01326533|64293881|FG000|Overall Study|Lost to Follow-up|2|||
23148140|NCT01326533|64293882|FG001|Overall Study|Lost to Follow-up|0|||
23148141|NCT01326533|64293881|FG000|Overall Study|Withdrawal by Subject|1|||
23148142|NCT01326533|64293882|FG001|Overall Study|Withdrawal by Subject|0|||
23148143|NCT01326533|64293881|FG000|Overall Study|Adverse Event|1|||
23148144|NCT01326533|64293882|FG001|Overall Study|Adverse Event|0|||
23148145|NCT01765192|64293887|FG000|Treatment Period 1|Adverse Event|0|||
23148146|NCT01765192|64293888|FG001|Treatment Period 1|Adverse Event|1|||
23219013|NCT00804986|64544727|FG002|Overall Study|Protocol Violation|0|||
23219014|NCT00804986|64544728|FG003|Overall Study|Protocol Violation|1|||
23219015|NCT00804986|64544729|FG004|Overall Study|Protocol Violation|0|||
23148147|NCT01765192|64293887|FG000|Washout Period|Voluntary Withdrawal|1|||
23148148|NCT01765192|64293888|FG001|Washout Period|Voluntary Withdrawal|1|||
23148149|NCT01765192|64293887|FG000|Washout Period|Reason not specified|1|||
23148150|NCT01765192|64293888|FG001|Washout Period|Reason not specified|0|||
23148151|NCT01765192|64293887|FG000|Treatment Period 2|Reason not specified|0|||
23148152|NCT01765192|64293888|FG001|Treatment Period 2|Reason not specified|2|||
23148153|NCT01765192|64293887|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
23148154|NCT01765192|64293888|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
23148155|NCT01206777|64293900|FG000|Overall Study|Death|1|||
23148156|NCT01206777|64293900|FG000|Overall Study|Adverse Event|1|||
23148157|NCT03334409|64293901|FG000|Overall Study|Did not meet inclusion criteria|1|||
23148158|NCT03334409|64293902|FG001|Overall Study|Did not meet inclusion criteria|0|||
23148159|NCT03294109|64293903|FG000|Overall Study|Withdrawal by Subject|6|||
23148160|NCT03294109|64293904|FG001|Overall Study|Withdrawal by Subject|5|||
23148161|NCT00769860|64293905|FG000|Overall Study|Withdrawal by Subject|2|||
23148162|NCT00769860|64293906|FG001|Overall Study|Withdrawal by Subject|0|||
23148163|NCT01723774|64293907|FG000|Neoadjuvant|Ki67 > 10%|4|||
23148164|NCT01723774|64293908|FG001|Neoadjuvant|Ki67 > 10%|0|||
23148165|NCT01723774|64293909|FG002|Neoadjuvant|Ki67 > 10%|10|||
23148166|NCT01723774|64293910|FG003|Neoadjuvant|Ki67 > 10%|0|||
23148167|NCT01723774|64293907|FG000|Neoadjuvant|Withdrawal by Subject|3|||
23148168|NCT01723774|64293908|FG001|Neoadjuvant|Withdrawal by Subject|1|||
23148169|NCT01723774|64293909|FG002|Neoadjuvant|Withdrawal by Subject|0|||
23148170|NCT01723774|64293910|FG003|Neoadjuvant|Withdrawal by Subject|0|||
23148171|NCT01723774|64293907|FG000|Neoadjuvant|Disease progression|0|||
23148172|NCT01723774|64293908|FG001|Neoadjuvant|Disease progression|1|||
23148173|NCT01723774|64293909|FG002|Neoadjuvant|Disease progression|1|||
23148174|NCT01723774|64293910|FG003|Neoadjuvant|Disease progression|0|||
23148175|NCT01723774|64293907|FG000|Neoadjuvant|Adverse Event|0|||
23148176|NCT01723774|64293908|FG001|Neoadjuvant|Adverse Event|1|||
23148177|NCT01723774|64293909|FG002|Neoadjuvant|Adverse Event|2|||
23148178|NCT01723774|64293910|FG003|Neoadjuvant|Adverse Event|0|||
23148179|NCT01723774|64293907|FG000|Neoadjuvant|High estradiol|0|||
23148180|NCT01723774|64293908|FG001|Neoadjuvant|High estradiol|1|||
23148181|NCT01723774|64293909|FG002|Neoadjuvant|High estradiol|0|||
23148182|NCT01723774|64293910|FG003|Neoadjuvant|High estradiol|0|||
23148183|NCT04201821|64293911|FG000|Overall Study|Withdrawal by Subject|2|||
23624002|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
23624003|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
23624004|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
23624005|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
23624006|NCT03730662|66011510|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
23624007|NCT03730662|66011511|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
23624008|NCT03730662|66011512|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
23624009|NCT03730662|66011513|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
23624010|NCT03730662|66011510|FG000|Variable Treatment Period|Adverse Event|1|||
23624011|NCT03730662|66011511|FG001|Variable Treatment Period|Adverse Event|2|||
23624012|NCT03730662|66011512|FG002|Variable Treatment Period|Adverse Event|0|||
23624013|NCT03730662|66011513|FG003|Variable Treatment Period|Adverse Event|7|||
23624014|NCT03730662|66011510|FG000|Variable Treatment Period|Death|9|||
23624015|NCT03730662|66011511|FG001|Variable Treatment Period|Death|0|||
23624016|NCT03730662|66011512|FG002|Variable Treatment Period|Death|6|||
23624017|NCT03730662|66011513|FG003|Variable Treatment Period|Death|26|||
23624018|NCT03730662|66011510|FG000|Variable Treatment Period|Lost to Follow-up|2|||
23624019|NCT03730662|66011511|FG001|Variable Treatment Period|Lost to Follow-up|1|||
23624020|NCT03730662|66011512|FG002|Variable Treatment Period|Lost to Follow-up|4|||
23624021|NCT03730662|66011513|FG003|Variable Treatment Period|Lost to Follow-up|11|||
23624022|NCT03730662|66011510|FG000|Variable Treatment Period|Personal Reason|0|||
23624023|NCT03730662|66011511|FG001|Variable Treatment Period|Personal Reason|2|||
23624024|NCT03730662|66011512|FG002|Variable Treatment Period|Personal Reason|1|||
23624025|NCT03730662|66011513|FG003|Variable Treatment Period|Personal Reason|6|||
23624026|NCT03730662|66011510|FG000|Variable Treatment Period|Physician Decision|0|||
23624027|NCT03730662|66011511|FG001|Variable Treatment Period|Physician Decision|0|||
23148184|NCT00162032|64293912|FG000|Overall Study|Lost to Follow-up|4|||
23148185|NCT00162032|64293913|FG001|Overall Study|Lost to Follow-up|2|||
23148186|NCT00162032|64293912|FG000|Overall Study|Reason not specified|1|||
23148187|NCT00162032|64293913|FG001|Overall Study|Reason not specified|0|||
23148188|NCT03566810|64293914|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
23624028|NCT03730662|66011512|FG002|Variable Treatment Period|Physician Decision|0|||
23148189|NCT03566810|64293915|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
23148190|NCT03566810|64293916|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
23148191|NCT03566810|64293917|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
23624029|NCT03730662|66011513|FG003|Variable Treatment Period|Physician Decision|3|||
23624030|NCT03730662|66011510|FG000|Variable Treatment Period|Protocol Violation|0|||
23624031|NCT03730662|66011511|FG001|Variable Treatment Period|Protocol Violation|1|||
23148192|NCT00803270|64293918|FG000|Overall Study|Lost to Follow-up|1|||
23148193|NCT00803270|64293919|FG001|Overall Study|Lost to Follow-up|2|||
23148194|NCT00536809|64293920|FG000|Phase II|Adverse Event|1|||
23148195|NCT00536809|64293920|FG000|Phase II|Referred for surgical resection|1|||
23624032|NCT03730662|66011512|FG002|Variable Treatment Period|Protocol Violation|1|||
23624033|NCT03730662|66011513|FG003|Variable Treatment Period|Protocol Violation|1|||
23624034|NCT03730662|66011510|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
23624035|NCT03730662|66011511|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
23624036|NCT03730662|66011512|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
23624037|NCT03730662|66011513|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
23624038|NCT01167192|66011515|FG000|Overall Study|Adverse Event|1|||
23624039|NCT01167192|66011515|FG000|Overall Study|Death|1|||
23624040|NCT01167192|66011515|FG000|Overall Study|Withdrawal by Subject|1|||
23624041|NCT01167192|66011515|FG000|Overall Study|Insurance denial|1|||
23624042|NCT01086384|66011516|FG000|2-week Run-in Period|Adverse Event|1|||
23624043|NCT01086384|66011517|FG001|2-week Run-in Period|Adverse Event|0|||
23624044|NCT01086384|66011518|FG002|2-week Run-in Period|Adverse Event|0|||
23624045|NCT01086384|66011516|FG000|2-week Run-in Period|Protocol Violation|1|||
23624046|NCT01086384|66011517|FG001|2-week Run-in Period|Protocol Violation|0|||
23624047|NCT01086384|66011518|FG002|2-week Run-in Period|Protocol Violation|0|||
23624048|NCT01086384|66011516|FG000|2-week Run-in Period|Lost to Follow-up|1|||
23624049|NCT01086384|66011517|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23624050|NCT01086384|66011518|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23624051|NCT01086384|66011516|FG000|2-week Run-in Period|Physician Decision|6|||
23624052|NCT01086384|66011517|FG001|2-week Run-in Period|Physician Decision|0|||
23624053|NCT01086384|66011518|FG002|2-week Run-in Period|Physician Decision|0|||
23624054|NCT01086384|66011516|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
23624055|NCT01086384|66011517|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23624056|NCT01086384|66011518|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23624057|NCT01086384|66011516|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
23624058|NCT01086384|66011517|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
23624059|NCT01086384|66011518|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
23624060|NCT01086384|66011516|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
23624061|NCT01086384|66011517|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
23148196|NCT01395316|64293927|FG000|Overall Study|Lost to Follow-up|2|||
23148197|NCT01395316|64293927|FG000|Overall Study|poor MRI quality|1|||
23148198|NCT01294683|64293928|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
23148199|NCT01294683|64293929|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
23148200|NCT01294683|64293928|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
23148201|NCT01294683|64293929|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
23148202|NCT01294683|64293928|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
23148203|NCT01294683|64293929|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
23148204|NCT01294683|64293928|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
23148205|NCT01294683|64293929|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
23148206|NCT01294683|64293928|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
23148207|NCT01294683|64293929|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
23148208|NCT01294683|64293928|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
23148209|NCT01294683|64293929|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
23148210|NCT01294683|64293928|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
23148211|NCT01294683|64293929|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
23148212|NCT01294683|64293928|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
23148213|NCT01294683|64293929|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
23148214|NCT01294683|64293928|FG000|Post Crossover (Period III)|Adverse Event|6|||
23148215|NCT01294683|64293929|FG001|Post Crossover (Period III)|Adverse Event|6|||
23148216|NCT01294683|64293928|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
23148217|NCT01294683|64293929|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
23148218|NCT01294683|64293928|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
23148219|NCT01294683|64293929|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
23148220|NCT01294683|64293928|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
23148221|NCT01294683|64293929|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
23148222|NCT00564018|64293930|FG000|Overall Study|Withdrawal by Subject|2|||
23148223|NCT00564018|64293931|FG001|Overall Study|Withdrawal by Subject|3|||
23148224|NCT00564018|64293932|FG002|Overall Study|Withdrawal by Subject|1|||
23148225|NCT02411578|64293937|FG000|Crossover Trial Phase|Pregnancy|0|||
23148226|NCT02411578|64293938|FG001|Crossover Trial Phase|Pregnancy|1|||
23148227|NCT00352885|64293939|FG000|Overall Study|Withdrawal by Subject|0|||
23437621|NCT02409342|65344165|FG001|Overall Study|Withdrawal by Subject|17|||
23437622|NCT02409342|65344164|FG000|Overall Study|Study Terminated By Sponsor|48|||
23624062|NCT01086384|66011518|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
23624063|NCT01086384|66011516|FG000|2-week Run-in Period|Randomized in Error|1|||
23624064|NCT01086384|66011517|FG001|2-week Run-in Period|Randomized in Error|0|||
23624065|NCT01086384|66011518|FG002|2-week Run-in Period|Randomized in Error|0|||
23624066|NCT01086384|66011516|FG000|Treatment Period|Withdrawal by Subject|0|||
23148228|NCT00352885|64293940|FG001|Overall Study|Withdrawal by Subject|3|||
23148229|NCT00352885|64293939|FG000|Overall Study|Development of major depression|0|||
23148230|NCT00352885|64293940|FG001|Overall Study|Development of major depression|1|||
23148231|NCT00352885|64293939|FG000|Overall Study|Progression of metastatic melanoma|5|||
23148232|NCT00352885|64293940|FG001|Overall Study|Progression of metastatic melanoma|3|||
23148233|NCT00352885|64293939|FG000|Overall Study|Side effects of IL-2 administration|1|||
23148234|NCT00352885|64293940|FG001|Overall Study|Side effects of IL-2 administration|0|||
23148235|NCT00528866|64293941|FG000|Overall Study|Protocol Violation|6|||
23148236|NCT00147823|64293942|FG000|Overall Study|Lost to Follow-up|6|||
23148237|NCT00147823|64293943|FG001|Overall Study|Lost to Follow-up|12|||
23148238|NCT00147823|64293942|FG000|Overall Study|Physician Decision|1|||
23148239|NCT00147823|64293943|FG001|Overall Study|Physician Decision|0|||
23148240|NCT00147823|64293942|FG000|Overall Study|Withdrawal by Subject|0|||
23148241|NCT00147823|64293943|FG001|Overall Study|Withdrawal by Subject|1|||
23624067|NCT01086384|66011517|FG001|Treatment Period|Withdrawal by Subject|53|||
23148242|NCT00147823|64293942|FG000|Overall Study|Did not receive vitoss due to infection|6|||
23148243|NCT00147823|64293943|FG001|Overall Study|Did not receive vitoss due to infection|2|||
23148244|NCT00892723|64293944|FG000|Overall Study|Lost to Follow-up|1|||
23148245|NCT00892723|64293945|FG001|Overall Study|Lost to Follow-up|3|||
23148246|NCT00892723|64293946|FG002|Overall Study|Lost to Follow-up|1|||
23148247|NCT00892723|64293944|FG000|Overall Study|Withdrawal by Subject|1|||
23148248|NCT00892723|64293945|FG001|Overall Study|Withdrawal by Subject|1|||
23148249|NCT00892723|64293946|FG002|Overall Study|Withdrawal by Subject|1|||
23148250|NCT00655486|64293947|FG000|Overall Study|Adverse Event|10|||
23148251|NCT00655486|64293947|FG000|Overall Study|Lack of Efficacy|8|||
23148252|NCT00655486|64293947|FG000|Overall Study|Withdrawal by Subject|4|||
23148253|NCT00655486|64293947|FG000|Overall Study|Protocol Violation|1|||
23148254|NCT00655486|64293947|FG000|Overall Study|Unsatisfactory compliance|2|||
23148255|NCT00655486|64293947|FG000|Overall Study|Other: Pregnancy|1|||
23148256|NCT00655486|64293947|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
23148257|NCT00655486|64293947|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
23219016|NCT00804986|64544730|FG005|Overall Study|Protocol Violation|0|||
23148258|NCT04427501|64293948|FG000|Overall Study|Death|0|||
23148259|NCT04427501|64293949|FG001|Overall Study|Death|0|||
23148260|NCT04427501|64293950|FG002|Overall Study|Death|0|||
23148261|NCT04427501|64293951|FG003|Overall Study|Death|0|||
23148262|NCT04427501|64293952|FG004|Overall Study|Death|0|||
23219017|NCT00804986|64544725|FG000|Overall Study|Withdrawal by Subject|0|||
23219018|NCT00804986|64544726|FG001|Overall Study|Withdrawal by Subject|3|||
23219019|NCT00804986|64544727|FG002|Overall Study|Withdrawal by Subject|0|||
23219020|NCT00804986|64544728|FG003|Overall Study|Withdrawal by Subject|3|||
23219021|NCT00804986|64544729|FG004|Overall Study|Withdrawal by Subject|5|||
23219022|NCT00804986|64544730|FG005|Overall Study|Withdrawal by Subject|3|||
23219023|NCT00804986|64544725|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
23219024|NCT00804986|64544726|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
23219025|NCT00804986|64544727|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
23437623|NCT02409342|65344165|FG001|Overall Study|Study Terminated By Sponsor|59|||
23437624|NCT02409342|65344164|FG000|Overall Study|Lost to Follow-up|3|||
23148263|NCT04427501|64293953|FG005|Overall Study|Death|15|||
23148264|NCT04427501|64293954|FG006|Overall Study|Death|0|||
23148265|NCT04427501|64293955|FG007|Overall Study|Death|0|||
23148266|NCT04427501|64293956|FG008|Overall Study|Death|0|||
23558668|NCT02342886|65772591|FG004|Overall Study|Withdrawal by Subject|0|||
23148267|NCT04427501|64293957|FG009|Overall Study|Death|0|||
23219026|NCT00804986|64544728|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
23437625|NCT02409342|65344165|FG001|Overall Study|Lost to Follow-up|5|||
23558669|NCT02342886|65772587|FG000|Overall Study|Investigator/sponsor decision|0|||
23558670|NCT02342886|65772588|FG001|Overall Study|Investigator/sponsor decision|2|||
23558671|NCT02342886|65772589|FG002|Overall Study|Investigator/sponsor decision|0|||
23558672|NCT02342886|65772590|FG003|Overall Study|Investigator/sponsor decision|3|||
23558673|NCT02342886|65772591|FG004|Overall Study|Investigator/sponsor decision|1|||
23558674|NCT02342886|65772587|FG000|Overall Study|Pregnancy|0|||
23558675|NCT02342886|65772588|FG001|Overall Study|Pregnancy|0|||
23558676|NCT02342886|65772589|FG002|Overall Study|Pregnancy|2|||
23558677|NCT02342886|65772590|FG003|Overall Study|Pregnancy|0|||
23558678|NCT02342886|65772591|FG004|Overall Study|Pregnancy|0|||
23558679|NCT02342886|65772587|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
23558680|NCT02342886|65772588|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
23558681|NCT02342886|65772589|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
23558682|NCT02342886|65772590|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
23558683|NCT02342886|65772591|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
23558684|NCT02342886|65772587|FG000|Overall Study|Protocol Violation|0|||
23558685|NCT02342886|65772588|FG001|Overall Study|Protocol Violation|0|||
23558686|NCT02342886|65772589|FG002|Overall Study|Protocol Violation|0|||
23558687|NCT02342886|65772590|FG003|Overall Study|Protocol Violation|2|||
23558688|NCT02342886|65772591|FG004|Overall Study|Protocol Violation|0|||
23322841|NCT01569295|64923155|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
23148268|NCT04427501|64293958|FG010|Overall Study|Death|0|||
23148269|NCT04427501|64293959|FG011|Overall Study|Death|0|||
23148270|NCT04427501|64293948|FG000|Overall Study|Lost to Follow-up|5|||
23148271|NCT04427501|64293949|FG001|Overall Study|Lost to Follow-up|1|||
23148272|NCT04427501|64293950|FG002|Overall Study|Lost to Follow-up|2|||
23148273|NCT04427501|64293951|FG003|Overall Study|Lost to Follow-up|0|||
23148274|NCT04427501|64293952|FG004|Overall Study|Lost to Follow-up|2|||
23322842|NCT01569295|64923154|FG000|Overall Study|Lost to Follow-up|1|||
23322843|NCT01569295|64923155|FG001|Overall Study|Lost to Follow-up|1|||
23322844|NCT00972595|64923156|FG000|Period 1|Adverse Event|1|||
23322845|NCT00972595|64923157|FG001|Period 1|Adverse Event|0|||
23322846|NCT04108299|64923158|FG000|Overall Study|Not interested in participating|2|||
23322847|NCT04108299|64923159|FG001|Overall Study|Not interested in participating|1|||
23322848|NCT04108299|64923160|FG002|Overall Study|Not interested in participating|2|||
23322849|NCT04108299|64923161|FG003|Overall Study|Not interested in participating|1|||
23322850|NCT03668808|64923162|FG000|First Intervention|Withdrawal by Subject|2|||
23322851|NCT03668808|64923163|FG001|First Intervention|Withdrawal by Subject|2|||
23322852|NCT03499067|64923164|FG000|First Intervention|Physician Decision|2|||
23322853|NCT03499067|64923165|FG001|First Intervention|Physician Decision|1|||
23322854|NCT03499067|64923164|FG000|First Intervention|Withdrawal by Subject|3|||
23322855|NCT03499067|64923165|FG001|First Intervention|Withdrawal by Subject|6|||
23322856|NCT01372748|64923166|FG000|Overall Study|Lost to Follow-up|16|||
23322857|NCT01372748|64923167|FG001|Overall Study|Lost to Follow-up|34|||
23322858|NCT01372748|64923166|FG000|Overall Study|Withdrawal by Subject|7|||
23322859|NCT01372748|64923167|FG001|Overall Study|Withdrawal by Subject|5|||
23322860|NCT02661217|64923168|FG000|Overall Study|Physician Decision|12|||
23322861|NCT02661217|64923169|FG001|Overall Study|Physician Decision|15|||
23322862|NCT02661217|64923168|FG000|Overall Study|Lost to Follow-up|1|||
23322863|NCT02661217|64923169|FG001|Overall Study|Lost to Follow-up|4|||
23148275|NCT04427501|64293953|FG005|Overall Study|Lost to Follow-up|11|||
23148276|NCT04427501|64293954|FG006|Overall Study|Lost to Follow-up|10|||
23148277|NCT04427501|64293955|FG007|Overall Study|Lost to Follow-up|10|||
23148278|NCT04427501|64293956|FG008|Overall Study|Lost to Follow-up|2|||
23148279|NCT04427501|64293957|FG009|Overall Study|Lost to Follow-up|5|||
23148280|NCT04427501|64293958|FG010|Overall Study|Lost to Follow-up|2|||
23148281|NCT04427501|64293959|FG011|Overall Study|Lost to Follow-up|0|||
23148282|NCT04427501|64293948|FG000|Overall Study|Physician Decision|0|||
23148283|NCT04427501|64293949|FG001|Overall Study|Physician Decision|3|||
23148284|NCT04427501|64293950|FG002|Overall Study|Physician Decision|0|||
23148285|NCT04427501|64293951|FG003|Overall Study|Physician Decision|0|||
23322864|NCT02661217|64923168|FG000|Overall Study|Protocol Deviation|0|||
23322865|NCT02661217|64923169|FG001|Overall Study|Protocol Deviation|4|||
23437626|NCT02409342|65344164|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
23558689|NCT04027348|65772592|FG000|Overall Study|Adverse Event|2|||
23558690|NCT03764072|65772598|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558691|NCT03764072|65772599|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558692|NCT03764072|65772600|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
23558693|NCT03764072|65772601|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558694|NCT03764072|65772602|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558695|NCT03764072|65772603|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
23558696|NCT03764072|65772598|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
23558697|NCT03764072|65772599|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
23558698|NCT03764072|65772600|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
23558699|NCT03764072|65772601|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
23558700|NCT03764072|65772602|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
23558701|NCT03764072|65772603|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
23558702|NCT03764072|65772598|FG000|Overall Study|Lost to Follow-up|0|||
23558703|NCT03764072|65772599|FG001|Overall Study|Lost to Follow-up|0|||
23558704|NCT03764072|65772600|FG002|Overall Study|Lost to Follow-up|0|||
23558705|NCT03764072|65772601|FG003|Overall Study|Lost to Follow-up|0|||
23558706|NCT03764072|65772602|FG004|Overall Study|Lost to Follow-up|1|||
23558707|NCT03764072|65772603|FG005|Overall Study|Lost to Follow-up|0|||
23558708|NCT02034708|65772608|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
23558709|NCT02034708|65772609|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
23148286|NCT04427501|64293952|FG004|Overall Study|Physician Decision|0|||
23148287|NCT04427501|64293953|FG005|Overall Study|Physician Decision|0|||
23219027|NCT00804986|64544729|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
23322866|NCT02661217|64923168|FG000|Overall Study|Non-compliance with study treatment|5|||
23148288|NCT04427501|64293954|FG006|Overall Study|Physician Decision|2|||
23148289|NCT04427501|64293955|FG007|Overall Study|Physician Decision|0|||
23148290|NCT04427501|64293956|FG008|Overall Study|Physician Decision|0|||
23322867|NCT02661217|64923169|FG001|Overall Study|Non-compliance with study treatment|5|||
23148291|NCT04427501|64293957|FG009|Overall Study|Physician Decision|0|||
23624068|NCT01086384|66011518|FG002|Treatment Period|Withdrawal by Subject|55|||
23624069|NCT01086384|66011516|FG000|Treatment Period|Protocol Violation|0|||
23624070|NCT01086384|66011517|FG001|Treatment Period|Protocol Violation|26|||
23624071|NCT01086384|66011518|FG002|Treatment Period|Protocol Violation|17|||
23624072|NCT01086384|66011516|FG000|Treatment Period|Lack of Efficacy|0|||
23624073|NCT01086384|66011517|FG001|Treatment Period|Lack of Efficacy|22|||
23624074|NCT01086384|66011518|FG002|Treatment Period|Lack of Efficacy|13|||
23624075|NCT01086384|66011516|FG000|Treatment Period|Adverse Event|0|||
23624076|NCT01086384|66011517|FG001|Treatment Period|Adverse Event|19|||
23624077|NCT01086384|66011518|FG002|Treatment Period|Adverse Event|15|||
23558710|NCT02034708|65772608|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
23624078|NCT01086384|66011516|FG000|Treatment Period|Lost to Follow-up|0|||
23624079|NCT01086384|66011517|FG001|Treatment Period|Lost to Follow-up|11|||
23624080|NCT01086384|66011518|FG002|Treatment Period|Lost to Follow-up|9|||
23624081|NCT01086384|66011516|FG000|Treatment Period|Physician Decision|0|||
23624082|NCT01086384|66011517|FG001|Treatment Period|Physician Decision|9|||
23624083|NCT01086384|66011518|FG002|Treatment Period|Physician Decision|6|||
23624084|NCT01086384|66011516|FG000|Treatment Period|Study Closed/Terminated|0|||
23624085|NCT01086384|66011517|FG001|Treatment Period|Study Closed/Terminated|7|||
23624086|NCT01086384|66011518|FG002|Treatment Period|Study Closed/Terminated|8|||
23558711|NCT02034708|65772609|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
23558712|NCT02034708|65772608|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
23558713|NCT02034708|65772609|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
23558714|NCT02034708|65772608|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
23558715|NCT02034708|65772609|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
23558716|NCT01572389|65772610|FG000|Overall Study|Death|1|||
23558717|NCT01572389|65772611|FG001|Overall Study|Death|3|||
23558718|NCT01572389|65772610|FG000|Overall Study|Withdrawal by Subject|14|||
23558719|NCT01572389|65772611|FG001|Overall Study|Withdrawal by Subject|2|||
23624087|NCT01086384|66011516|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
23624088|NCT01086384|66011517|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
23624089|NCT01086384|66011518|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
23624090|NCT01086384|66011516|FG000|Treatment Period|Received Treatment in Error|0|||
23624091|NCT01086384|66011517|FG001|Treatment Period|Received Treatment in Error|1|||
23624092|NCT01086384|66011518|FG002|Treatment Period|Received Treatment in Error|0|||
23624093|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
23624094|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
23624095|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
23624096|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
23624097|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
23624098|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
23624099|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
23624100|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
23624101|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
23624102|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
23624103|NCT03774875|66011523|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
23624104|NCT03774875|66011524|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
23624105|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
23624106|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
23624107|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
23624108|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
23624109|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
23624110|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
23624111|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
23624112|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
23624113|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
23148292|NCT04427501|64293958|FG010|Overall Study|Physician Decision|0|||
23148293|NCT04427501|64293959|FG011|Overall Study|Physician Decision|0|||
23148294|NCT04427501|64293948|FG000|Overall Study|Withdrawal by Subject|9|||
23148295|NCT04427501|64293949|FG001|Overall Study|Withdrawal by Subject|2|||
23148296|NCT04427501|64293950|FG002|Overall Study|Withdrawal by Subject|2|||
23148297|NCT04427501|64293951|FG003|Overall Study|Withdrawal by Subject|3|||
23148298|NCT04427501|64293952|FG004|Overall Study|Withdrawal by Subject|7|||
23558720|NCT01572389|65772610|FG000|Overall Study|Lost to Follow-up|25|||
23624114|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
23624115|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
23624116|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
23624117|NCT03774875|66011523|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
23624118|NCT03774875|66011524|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
23148299|NCT04427501|64293953|FG005|Overall Study|Withdrawal by Subject|25|||
23322868|NCT02661217|64923168|FG000|Overall Study|Death|21|||
23322869|NCT02661217|64923169|FG001|Overall Study|Death|15|||
23322870|NCT02661217|64923168|FG000|Overall Study|Adverse Event|10|||
23322871|NCT02661217|64923169|FG001|Overall Study|Adverse Event|8|||
23322872|NCT02661217|64923168|FG000|Overall Study|Withdrawal by Subject|15|||
23322873|NCT02661217|64923169|FG001|Overall Study|Withdrawal by Subject|19|||
23322874|NCT02661217|64923168|FG000|Overall Study|Did not enter follow-up epoch|7|||
23322875|NCT02661217|64923169|FG001|Overall Study|Did not enter follow-up epoch|10|||
23322876|NCT02661217|64923168|FG000|Overall Study|Death - no study drug received|1|||
23322877|NCT02661217|64923169|FG001|Overall Study|Death - no study drug received|2|||
23322878|NCT02661217|64923168|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
23322879|NCT02661217|64923169|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
23322880|NCT00879086|64923170|FG000|Overall Study|Adverse Event|3|||
23322881|NCT00879086|64923171|FG001|Overall Study|Adverse Event|15|||
23322882|NCT00879086|64923170|FG000|Overall Study|Participant choice|2|||
23322883|NCT00879086|64923171|FG001|Overall Study|Participant choice|2|||
23322884|NCT00879086|64923170|FG000|Overall Study|Progression of disease|40|||
23322885|NCT00879086|64923171|FG001|Overall Study|Progression of disease|26|||
23322886|NCT00879086|64923170|FG000|Overall Study|Withdrawal of consent|2|||
23322887|NCT00879086|64923171|FG001|Overall Study|Withdrawal of consent|1|||
23624119|NCT01726049|66011525|FG000|Overall Study|Death|1|||
23624120|NCT01726049|66011526|FG001|Overall Study|Death|1|||
23624121|NCT01726049|66011525|FG000|Overall Study|Adverse Event|4|||
23624122|NCT01726049|66011526|FG001|Overall Study|Adverse Event|1|||
23624123|NCT01726049|66011525|FG000|Overall Study|refused second HC|0|||
23624124|NCT01726049|66011526|FG001|Overall Study|refused second HC|2|||
23624125|NCT00478647|66011528|FG000|Overall Study|Adverse Event|1|||
23624126|NCT00478647|66011528|FG000|Overall Study|Withdrawal by Subject|1|||
23624127|NCT00727415|66011529|FG000|Phase I|Dose Limiting Toxicity|2|||
23624128|NCT03856047|66011532|FG000|Overall Study|Withdrawal by Subject|0|||
23624129|NCT03856047|66011533|FG001|Overall Study|Withdrawal by Subject|1|||
23624130|NCT03856047|66011534|FG002|Overall Study|Withdrawal by Subject|1|||
23624131|NCT03856047|66011535|FG003|Overall Study|Withdrawal by Subject|0|||
23624132|NCT03856047|66011536|FG004|Overall Study|Withdrawal by Subject|3|||
23624133|NCT03856047|66011537|FG005|Overall Study|Withdrawal by Subject|0|||
23624134|NCT03856047|66011538|FG006|Overall Study|Withdrawal by Subject|2|||
23624135|NCT03856047|66011532|FG000|Overall Study|Lost to Follow-up|4|||
23624136|NCT03856047|66011533|FG001|Overall Study|Lost to Follow-up|2|||
23624137|NCT03856047|66011534|FG002|Overall Study|Lost to Follow-up|3|||
23624138|NCT03856047|66011535|FG003|Overall Study|Lost to Follow-up|1|||
23624139|NCT03856047|66011536|FG004|Overall Study|Lost to Follow-up|4|||
23624140|NCT03856047|66011537|FG005|Overall Study|Lost to Follow-up|4|||
23624141|NCT03856047|66011538|FG006|Overall Study|Lost to Follow-up|4|||
23624142|NCT00585975|66011539|FG000|Overall Study|Withdrawal by Subject|3|||
23624143|NCT00585975|66011540|FG001|Overall Study|Withdrawal by Subject|3|||
23624144|NCT00585975|66011539|FG000|Overall Study|Lost to Follow-up|2|||
23624145|NCT00585975|66011540|FG001|Overall Study|Lost to Follow-up|1|||
23624146|NCT00585975|66011539|FG000|Overall Study|Enrollment met/over-enrolled|10|||
23624147|NCT00585975|66011540|FG001|Overall Study|Enrollment met/over-enrolled|9|||
23624148|NCT00607997|66011542|FG000|Overall Study|Lack of Efficacy|6|||
23148300|NCT04427501|64293954|FG006|Overall Study|Withdrawal by Subject|15|||
23148301|NCT04427501|64293955|FG007|Overall Study|Withdrawal by Subject|7|||
23148302|NCT04427501|64293956|FG008|Overall Study|Withdrawal by Subject|4|||
23148303|NCT04427501|64293957|FG009|Overall Study|Withdrawal by Subject|1|||
23148304|NCT04427501|64293958|FG010|Overall Study|Withdrawal by Subject|4|||
23148305|NCT04427501|64293959|FG011|Overall Study|Withdrawal by Subject|0|||
23148306|NCT04427501|64293948|FG000|Overall Study|Other - as reported by the investigator|1|||
23148307|NCT04427501|64293949|FG001|Overall Study|Other - as reported by the investigator|0|||
23148308|NCT04427501|64293950|FG002|Overall Study|Other - as reported by the investigator|0|||
23148309|NCT04427501|64293951|FG003|Overall Study|Other - as reported by the investigator|0|||
23148310|NCT04427501|64293952|FG004|Overall Study|Other - as reported by the investigator|0|||
23322888|NCT00879086|64923170|FG000|Overall Study|Other|4|||
23322889|NCT00879086|64923171|FG001|Overall Study|Other|6|||
23322890|NCT00879086|64923170|FG000|Overall Study|Death|1|||
23322891|NCT00879086|64923171|FG001|Overall Study|Death|2|||
23322892|NCT03125798|64926555|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
23624149|NCT00607997|66011543|FG001|Overall Study|Lack of Efficacy|20|||
23624150|NCT00607997|66011544|FG002|Overall Study|Lack of Efficacy|14|||
23624151|NCT00607997|66011545|FG003|Overall Study|Lack of Efficacy|10|||
23624152|NCT00607997|66011542|FG000|Overall Study|Death|8|||
23624153|NCT00607997|66011543|FG001|Overall Study|Death|5|||
23624154|NCT00607997|66011544|FG002|Overall Study|Death|2|||
23624155|NCT00607997|66011545|FG003|Overall Study|Death|5|||
23624156|NCT00607997|66011542|FG000|Overall Study|Adverse Event|3|||
23624157|NCT00607997|66011543|FG001|Overall Study|Adverse Event|1|||
23624158|NCT00607997|66011544|FG002|Overall Study|Adverse Event|2|||
23624159|NCT00607997|66011545|FG003|Overall Study|Adverse Event|0|||
23322893|NCT03125798|64926556|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
23322894|NCT03125798|64926555|FG000|Overall Study|Conversion to thoracotomy|7|||
23322895|NCT03125798|64926556|FG001|Overall Study|Conversion to thoracotomy|7|||
23322896|NCT02585778|64926560|FG000|Overall Study|Adverse Event|17|||
23322897|NCT02585778|64926561|FG001|Overall Study|Adverse Event|4|||
23322898|NCT02585778|64926560|FG000|Overall Study|Participant did not wish to continue|9|||
23322899|NCT02585778|64926561|FG001|Overall Study|Participant did not wish to continue|4|||
23322900|NCT02585778|64926560|FG000|Overall Study|Poor compliance to study protocol|0|||
23322901|NCT02585778|64926561|FG001|Overall Study|Poor compliance to study protocol|2|||
23322902|NCT02585778|64926560|FG000|Overall Study|Death|0|||
23322903|NCT02585778|64926561|FG001|Overall Study|Death|1|||
23322904|NCT02585778|64926560|FG000|Overall Study|Randomized but not treated|1|||
23322905|NCT02585778|64926561|FG001|Overall Study|Randomized but not treated|2|||
23322906|NCT02585778|64926560|FG000|Overall Study|Other than specified above|6|||
23322907|NCT02585778|64926561|FG001|Overall Study|Other than specified above|2|||
23322908|NCT02854527|64926563|FG000|Overall Study|Adverse Event|0|||
23322909|NCT02854527|64926564|FG001|Overall Study|Adverse Event|0|||
23322910|NCT02854527|64926565|FG002|Overall Study|Adverse Event|0|||
23322911|NCT02854527|64926566|FG003|Overall Study|Adverse Event|0|||
23322912|NCT02854527|64926567|FG004|Overall Study|Adverse Event|1|||
23322913|NCT02854527|64926568|FG005|Overall Study|Adverse Event|0|||
23322914|NCT02854527|64926569|FG006|Overall Study|Adverse Event|0|||
23322915|NCT02854527|64926570|FG007|Overall Study|Adverse Event|0|||
23322916|NCT02854527|64926571|FG008|Overall Study|Adverse Event|0|||
23322917|NCT02854527|64926572|FG009|Overall Study|Adverse Event|0|||
23322918|NCT02854527|64926563|FG000|Overall Study|Lost to Follow-up|0|||
23322919|NCT02854527|64926564|FG001|Overall Study|Lost to Follow-up|0|||
23322920|NCT02854527|64926565|FG002|Overall Study|Lost to Follow-up|0|||
23322921|NCT02854527|64926566|FG003|Overall Study|Lost to Follow-up|1|||
23322922|NCT02854527|64926567|FG004|Overall Study|Lost to Follow-up|0|||
23322923|NCT02854527|64926568|FG005|Overall Study|Lost to Follow-up|0|||
23322924|NCT02854527|64926569|FG006|Overall Study|Lost to Follow-up|0|||
23322925|NCT02854527|64926570|FG007|Overall Study|Lost to Follow-up|0|||
23322926|NCT02854527|64926571|FG008|Overall Study|Lost to Follow-up|0|||
23322927|NCT02854527|64926572|FG009|Overall Study|Lost to Follow-up|0|||
23322928|NCT02387840|64926578|FG000|Overall Study|Death|0|||
23322929|NCT02387840|64926579|FG001|Overall Study|Death|0|||
23322930|NCT02387840|64926580|FG002|Overall Study|Death|0|||
23322931|NCT02387840|64926581|FG003|Overall Study|Death|0|||
23322932|NCT02387840|64926582|FG004|Overall Study|Death|0|||
23322933|NCT02387840|64926583|FG005|Overall Study|Death|1|||
23322934|NCT02392481|64926584|FG000|Overall Study|Adverse Event|0|||
23322935|NCT02392481|64926585|FG001|Overall Study|Adverse Event|0|||
23322936|NCT02392481|64926586|FG002|Overall Study|Adverse Event|1|||
23322937|NCT02392481|64926587|FG003|Overall Study|Adverse Event|2|||
23322938|NCT02392481|64926584|FG000|Overall Study|Withdrawal by Subject|0|||
23322939|NCT02392481|64926585|FG001|Overall Study|Withdrawal by Subject|0|||
23322940|NCT02392481|64926586|FG002|Overall Study|Withdrawal by Subject|1|||
23322941|NCT02392481|64926587|FG003|Overall Study|Withdrawal by Subject|0|||
23322942|NCT01112059|64926588|FG000|Overall Study|Withdrawal by Subject|1|||
23322943|NCT01112059|64926589|FG001|Overall Study|Withdrawal by Subject|0|||
23322944|NCT00615199|64926596|FG000|Overall Study|Adverse Event|3|||
23322945|NCT00615199|64926597|FG001|Overall Study|Adverse Event|1|||
23322946|NCT00615199|64926598|FG002|Overall Study|Adverse Event|1|||
23322947|NCT00615199|64926599|FG003|Overall Study|Adverse Event|0|||
23322948|NCT00615199|64926596|FG000|Overall Study|Lack of Efficacy|2|||
23322949|NCT00615199|64926597|FG001|Overall Study|Lack of Efficacy|0|||
23322950|NCT00615199|64926598|FG002|Overall Study|Lack of Efficacy|0|||
23322951|NCT00615199|64926599|FG003|Overall Study|Lack of Efficacy|1|||
23322952|NCT00615199|64926596|FG000|Overall Study|Lost to Follow-up|1|||
23322953|NCT00615199|64926597|FG001|Overall Study|Lost to Follow-up|0|||
23322954|NCT00615199|64926598|FG002|Overall Study|Lost to Follow-up|0|||
23322955|NCT00615199|64926599|FG003|Overall Study|Lost to Follow-up|0|||
23322956|NCT00615199|64926596|FG000|Overall Study|Other|0|||
23322957|NCT00615199|64926597|FG001|Overall Study|Other|0|||
23219028|NCT00804986|64544730|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
23219029|NCT00804986|64544725|FG000|Overall Study|Sponsor Decision|0|||
23322958|NCT00615199|64926598|FG002|Overall Study|Other|0|||
23322959|NCT00615199|64926599|FG003|Overall Study|Other|1|||
23322960|NCT00615199|64926596|FG000|Overall Study|Withdrawal by Subject|2|||
23219030|NCT00804986|64544726|FG001|Overall Study|Sponsor Decision|1|||
23322961|NCT00615199|64926597|FG001|Overall Study|Withdrawal by Subject|1|||
23322962|NCT00615199|64926598|FG002|Overall Study|Withdrawal by Subject|0|||
23322963|NCT00615199|64926599|FG003|Overall Study|Withdrawal by Subject|0|||
23322964|NCT00445432|64926605|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
23219031|NCT00804986|64544727|FG002|Overall Study|Sponsor Decision|0|||
23322965|NCT00445432|64926606|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
23322966|NCT00445432|64926607|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
23558721|NCT01572389|65772611|FG001|Overall Study|Lost to Follow-up|14|||
23322967|NCT00445432|64926608|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
23322968|NCT00445432|64926605|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
23322969|NCT00445432|64926606|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
23322970|NCT00445432|64926607|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
23322971|NCT00445432|64926608|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
23322972|NCT00445432|64926605|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
23322973|NCT00445432|64926606|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
23322974|NCT00445432|64926607|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
23322975|NCT00445432|64926608|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
23322976|NCT00445432|64926605|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
23322977|NCT00445432|64926606|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
23322978|NCT00445432|64926607|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
23322979|NCT00445432|64926608|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
23322980|NCT00445432|64926605|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
23322981|NCT00445432|64926606|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
23322982|NCT00445432|64926607|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
23322983|NCT00445432|64926608|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
23322984|NCT00445432|64926605|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
23322985|NCT00445432|64926606|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
23322986|NCT00445432|64926607|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
23322987|NCT00445432|64926608|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
23322988|NCT00445432|64926605|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
23322989|NCT00445432|64926606|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
23322990|NCT00445432|64926607|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
23322991|NCT00445432|64926608|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
23322992|NCT00369941|64926612|FG000|Overall Study|Never Treated|1|||
23322993|NCT00369941|64926613|FG001|Overall Study|Never Treated|2|||
23322994|NCT00369941|64926612|FG000|Overall Study|Adverse Event|14|||
23322995|NCT00369941|64926613|FG001|Overall Study|Adverse Event|28|||
23322996|NCT00369941|64926612|FG000|Overall Study|Lack of Efficacy|6|||
23322997|NCT00369941|64926613|FG001|Overall Study|Lack of Efficacy|10|||
23322998|NCT00369941|64926612|FG000|Overall Study|Lost to Follow-up|12|||
23322999|NCT00369941|64926613|FG001|Overall Study|Lost to Follow-up|22|||
23323000|NCT00369941|64926612|FG000|Overall Study|Protocol Violation|5|||
23323001|NCT00369941|64926613|FG001|Overall Study|Protocol Violation|3|||
23323002|NCT00369941|64926612|FG000|Overall Study|Withdrawal by Subject|5|||
23323003|NCT00369941|64926613|FG001|Overall Study|Withdrawal by Subject|18|||
23323004|NCT00369941|64926612|FG000|Overall Study|Pregnancy|4|||
23323005|NCT00369941|64926613|FG001|Overall Study|Pregnancy|2|||
23323006|NCT00369941|64926612|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
23323007|NCT00369941|64926613|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
23323008|NCT00369941|64926612|FG000|Overall Study|Moved|11|||
23323009|NCT00369941|64926613|FG001|Overall Study|Moved|5|||
23323010|NCT00369941|64926612|FG000|Overall Study|Treatment with Prohibited Medication|3|||
23323011|NCT00369941|64926613|FG001|Overall Study|Treatment with Prohibited Medication|1|||
23323012|NCT00369941|64926612|FG000|Overall Study|Employment Interfered with Study Visits|1|||
23323013|NCT00369941|64926613|FG001|Overall Study|Employment Interfered with Study Visits|0|||
23148311|NCT04427501|64293953|FG005|Overall Study|Other - as reported by the investigator|6|||
23148312|NCT04427501|64293954|FG006|Overall Study|Other - as reported by the investigator|6|||
23148313|NCT04427501|64293955|FG007|Overall Study|Other - as reported by the investigator|0|||
23148314|NCT04427501|64293956|FG008|Overall Study|Other - as reported by the investigator|0|||
23148315|NCT04427501|64293957|FG009|Overall Study|Other - as reported by the investigator|0|||
23148316|NCT04427501|64293958|FG010|Overall Study|Other - as reported by the investigator|0|||
23148317|NCT04427501|64293959|FG011|Overall Study|Other - as reported by the investigator|0|||
23148318|NCT04427501|64293948|FG000|Overall Study|Other|0|||
23148319|NCT04427501|64293949|FG001|Overall Study|Other|0|||
23148320|NCT04427501|64293950|FG002|Overall Study|Other|0|||
23148321|NCT04427501|64293951|FG003|Overall Study|Other|0|||
23148322|NCT04427501|64293952|FG004|Overall Study|Other|0|||
23148323|NCT04427501|64293953|FG005|Overall Study|Other|0|||
23148324|NCT04427501|64293954|FG006|Overall Study|Other|0|||
23148325|NCT04427501|64293955|FG007|Overall Study|Other|0|||
23148326|NCT04427501|64293956|FG008|Overall Study|Other|0|||
23148327|NCT04427501|64293957|FG009|Overall Study|Other|0|||
23323014|NCT00369941|64926612|FG000|Overall Study|Study Site Terminated|2|||
23323015|NCT00369941|64926613|FG001|Overall Study|Study Site Terminated|0|||
23323016|NCT00369941|64926612|FG000|Overall Study|Miscellaneous|3|||
23323017|NCT00369941|64926613|FG001|Overall Study|Miscellaneous|3|||
23148328|NCT04427501|64293958|FG010|Overall Study|Other|0|||
23148329|NCT04427501|64293959|FG011|Overall Study|Other|1|||
23148330|NCT01019317|64293960|FG000|Overall Study|Not Eligible|4|||
23323018|NCT00196326|64926616|FG000|Overall Study|Did not meet protocol requirements|64|||
23323019|NCT00196326|64926616|FG000|Overall Study|Non-compliance with the protocol|81|||
23323020|NCT00196326|64926616|FG000|Overall Study|Physician Decision|3|||
23148331|NCT00066742|64293961|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
23148332|NCT00066742|64293961|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
23148333|NCT00066742|64293961|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
23148334|NCT00066742|64293961|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
23148335|NCT00066742|64293961|FG000|Induction Chemoradiotherapy|Ineligible|3|||
23148336|NCT00066742|64293961|FG000|Consolidation Chemotherapy|not protocol specified|1|||
23148337|NCT00066742|64293961|FG000|Consolidation Chemotherapy|Ineligible|2|||
23148338|NCT01176773|64293963|FG000|Overall Study|Screen Failure|2|||
23148339|NCT01176773|64293963|FG000|Overall Study|Withdrew consent|1|||
23148340|NCT01176968|64293964|FG000|Overall Study|Adverse Event|10|||
23148341|NCT01176968|64293965|FG001|Overall Study|Adverse Event|11|||
23148342|NCT01176968|64293964|FG000|Overall Study|Death|2|||
23148343|NCT01176968|64293965|FG001|Overall Study|Death|3|||
23148344|NCT01176968|64293964|FG000|Overall Study|Lack of Efficacy|0|||
23148345|NCT01176968|64293965|FG001|Overall Study|Lack of Efficacy|1|||
23148346|NCT01176968|64293964|FG000|Overall Study|Lost to Follow-up|16|||
23148347|NCT01176968|64293965|FG001|Overall Study|Lost to Follow-up|14|||
23148348|NCT01176968|64293964|FG000|Overall Study|Withdrawal by Subject|48|||
23323021|NCT00196326|64926616|FG000|Overall Study|Withdrawal by Subject|225|||
23323022|NCT00196326|64926616|FG000|Overall Study|Adverse Event|253|||
23323023|NCT00196326|64926616|FG000|Overall Study|Pregnancy|34|||
23323024|NCT00196326|64926616|FG000|Overall Study|Lost to Follow-up|304|||
23323025|NCT00196326|64926616|FG000|Overall Study|Other|22|||
23323026|NCT00618371|64926619|FG000|Overall Study|Withdrawal by Subject|2|||
23323027|NCT03639779|64926625|FG000|Overall Study|Lost to Follow-up|1|||
23323028|NCT00322712|64926626|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
23323029|NCT01720225|64926627|FG000|Overall Study|Withdrawal by Subject|0|||
23323030|NCT01720225|64926628|FG001|Overall Study|Withdrawal by Subject|1|||
23323031|NCT01720225|64926627|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
23323032|NCT01720225|64926628|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
23323033|NCT02404805|64926639|FG000|Overall Study|Withdrawal by Subject|1|||
23323034|NCT02404805|64926640|FG001|Overall Study|Withdrawal by Subject|0|||
23323035|NCT02404805|64926641|FG002|Overall Study|Withdrawal by Subject|0|||
23323036|NCT02404805|64926642|FG003|Overall Study|Withdrawal by Subject|0|||
23323037|NCT02404805|64926643|FG004|Overall Study|Withdrawal by Subject|0|||
23558722|NCT01572389|65772610|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
23558723|NCT01572389|65772611|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
23558724|NCT01412801|65772612|FG000|Overall Study|Death|0|||
23558725|NCT01412801|65772613|FG001|Overall Study|Death|1|||
23558726|NCT01412801|65772614|FG002|Overall Study|Death|0|||
23558727|NCT01412801|65772615|FG003|Overall Study|Death|4|||
23558728|NCT01412801|65772616|FG004|Overall Study|Death|2|||
23558729|NCT01412801|65772617|FG005|Overall Study|Death|2|||
23558730|NCT01412801|65772612|FG000|Overall Study|Lost to Follow-up|1|||
23148349|NCT01176968|64293965|FG001|Overall Study|Withdrawal by Subject|48|||
23148350|NCT01176968|64293964|FG000|Overall Study|Protocol Violation|2|||
23148351|NCT01176968|64293965|FG001|Overall Study|Protocol Violation|1|||
23148352|NCT01176968|64293964|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23148353|NCT01176968|64293965|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
23148354|NCT01176968|64293964|FG000|Overall Study|Study terminated by sponsor|0|||
23148355|NCT01176968|64293965|FG001|Overall Study|Study terminated by sponsor|1|||
23148356|NCT01176968|64293964|FG000|Overall Study|Reason not defined|5|||
23148357|NCT01176968|64293965|FG001|Overall Study|Reason not defined|3|||
23148358|NCT00288509|64293968|FG000|Treatment Cycle 1|Adverse Event|1|||
23148359|NCT00288509|64293968|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
23148360|NCT00288509|64293968|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
23148361|NCT00288509|64293968|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
23148362|NCT00288509|64293968|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
23148363|NCT00288509|64293968|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
23148364|NCT00288509|64293968|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
23148365|NCT00288509|64293968|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
23148366|NCT00288509|64293968|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
23148367|NCT00288509|64293968|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
23148368|NCT00288509|64293968|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
23558731|NCT01412801|65772613|FG001|Overall Study|Lost to Follow-up|2|||
23558732|NCT01412801|65772614|FG002|Overall Study|Lost to Follow-up|4|||
23148369|NCT00288509|64293968|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
23148370|NCT00288509|64293968|FG000|Treatment Cycle 4|Physician Decision|4|||
23148371|NCT00288509|64293968|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
23148372|NCT00293722|64293969|FG000|Overall Study|Other|427|||
23148373|NCT01128738|64293972|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
23148374|NCT01128738|64293973|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
23323038|NCT02404805|64926644|FG005|Overall Study|Withdrawal by Subject|0|||
23323039|NCT01326845|64926645|FG000|Overall Study|Administrative Problems|5|||
23558733|NCT01412801|65772615|FG003|Overall Study|Lost to Follow-up|0|||
23558734|NCT01412801|65772616|FG004|Overall Study|Lost to Follow-up|1|||
23558735|NCT01412801|65772617|FG005|Overall Study|Lost to Follow-up|1|||
23558736|NCT01412801|65772612|FG000|Overall Study|Withdrawal by Subject|3|||
23558737|NCT01412801|65772613|FG001|Overall Study|Withdrawal by Subject|2|||
23558738|NCT01412801|65772614|FG002|Overall Study|Withdrawal by Subject|1|||
23558739|NCT01412801|65772615|FG003|Overall Study|Withdrawal by Subject|0|||
23558740|NCT01412801|65772616|FG004|Overall Study|Withdrawal by Subject|0|||
23558741|NCT01412801|65772617|FG005|Overall Study|Withdrawal by Subject|0|||
23558742|NCT01412801|65772612|FG000|Overall Study|Relocated to another area|0|||
23558743|NCT01412801|65772613|FG001|Overall Study|Relocated to another area|0|||
23624160|NCT00607997|66011542|FG000|Overall Study|Physician Decision|4|||
23624161|NCT00607997|66011543|FG001|Overall Study|Physician Decision|1|||
23624162|NCT00607997|66011544|FG002|Overall Study|Physician Decision|0|||
23624163|NCT00607997|66011545|FG003|Overall Study|Physician Decision|0|||
23624164|NCT00607997|66011542|FG000|Overall Study|Relapse, recurrent illness|4|||
23624165|NCT00607997|66011543|FG001|Overall Study|Relapse, recurrent illness|0|||
23624166|NCT00607997|66011544|FG002|Overall Study|Relapse, recurrent illness|2|||
23624167|NCT00607997|66011545|FG003|Overall Study|Relapse, recurrent illness|0|||
23624168|NCT00607997|66011542|FG000|Overall Study|Other without explanation|2|||
23624169|NCT00607997|66011543|FG001|Overall Study|Other without explanation|0|||
23624170|NCT00607997|66011544|FG002|Overall Study|Other without explanation|4|||
23624171|NCT00607997|66011545|FG003|Overall Study|Other without explanation|1|||
23148375|NCT01128738|64293972|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
23148376|NCT01128738|64293973|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
23624172|NCT00494026|66011546|FG000|Overall Study|Sponsor Decision|4|||
23624173|NCT02781311|66011551|FG000|Overall Study|Adverse Event|2|||
23624174|NCT02781311|66011552|FG001|Overall Study|Adverse Event|6|||
23624175|NCT02781311|66011553|FG002|Overall Study|Adverse Event|1|||
23624176|NCT02781311|66011551|FG000|Overall Study|Withdrawal of Consent|11|||
23624177|NCT02781311|66011552|FG001|Overall Study|Withdrawal of Consent|12|||
23624178|NCT02781311|66011553|FG002|Overall Study|Withdrawal of Consent|2|||
23624179|NCT02781311|66011551|FG000|Overall Study|Lost to Follow-up|11|||
23624180|NCT02781311|66011552|FG001|Overall Study|Lost to Follow-up|8|||
23624181|NCT02781311|66011553|FG002|Overall Study|Lost to Follow-up|1|||
23624182|NCT02781311|66011551|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23624183|NCT02781311|66011552|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23624184|NCT02781311|66011553|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23624185|NCT01813305|66011554|FG000|Overall Study|Withdrawal by Subject|12|||
23624186|NCT01813305|66011555|FG001|Overall Study|Withdrawal by Subject|5|||
23624187|NCT01813305|66011554|FG000|Overall Study|Safety Concern|4|||
23624188|NCT01813305|66011555|FG001|Overall Study|Safety Concern|0|||
23624189|NCT01813305|66011554|FG000|Overall Study|Ulcer became worse|4|||
23624190|NCT01813305|66011555|FG001|Overall Study|Ulcer became worse|0|||
23624191|NCT01813305|66011554|FG000|Overall Study|Physician Decision|4|||
23624192|NCT01813305|66011555|FG001|Overall Study|Physician Decision|0|||
23148377|NCT01128738|64293972|FG000|Second TP|Lost to Follow-up|0|||
23148378|NCT01128738|64293973|FG001|Second TP|Lost to Follow-up|1|||
23148379|NCT01128738|64293972|FG000|Second TP|Withdrawal by Subject|0|||
23148380|NCT01128738|64293973|FG001|Second TP|Withdrawal by Subject|2|||
23148381|NCT01831856|64293975|FG000|Overall Study|Adverse Event|5|||
23148382|NCT01831856|64293976|FG001|Overall Study|Adverse Event|8|||
23148383|NCT01831856|64293975|FG000|Overall Study|Lack of Efficacy|13|||
23148384|NCT01831856|64293976|FG001|Overall Study|Lack of Efficacy|11|||
23148385|NCT01831856|64293975|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
23148386|NCT01831856|64293976|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
23148387|NCT00601250|64293981|FG000|Overall Study|Adverse Event|3|||
23148388|NCT00601250|64293982|FG001|Overall Study|Adverse Event|9|||
23148389|NCT00601250|64293981|FG000|Overall Study|Protocol Violation|3|||
23148390|NCT00601250|64293982|FG001|Overall Study|Protocol Violation|2|||
23148391|NCT00601250|64293981|FG000|Overall Study|Lost to Follow-up|2|||
23148392|NCT00601250|64293982|FG001|Overall Study|Lost to Follow-up|6|||
23148393|NCT00601250|64293981|FG000|Overall Study|Withdrawal by Subject|4|||
23148394|NCT00601250|64293982|FG001|Overall Study|Withdrawal by Subject|13|||
23148395|NCT00601250|64293981|FG000|Overall Study|Other incl. lack of efficacy|2|||
23323040|NCT01326845|64926646|FG001|Overall Study|Administrative Problems|2|||
23624193|NCT01813305|66011554|FG000|Overall Study|Lost to Follow-up|3|||
23148396|NCT00601250|64293982|FG001|Overall Study|Other incl. lack of efficacy|9|||
23323041|NCT01326845|64926645|FG000|Overall Study|Adverse Event|1|||
23624194|NCT01813305|66011555|FG001|Overall Study|Lost to Follow-up|1|||
23624195|NCT01813305|66011554|FG000|Overall Study|Protocol Violation|1|||
23624196|NCT01813305|66011555|FG001|Overall Study|Protocol Violation|0|||
23624197|NCT01813305|66011554|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
23624198|NCT01813305|66011555|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
23148397|NCT00938470|64293986|FG000|Overall Study|Disease Progression|3|||
23148398|NCT00938470|64293987|FG001|Overall Study|Disease Progression|0|||
23148399|NCT00938470|64293986|FG000|Overall Study|Alternate Treatment|1|||
23558744|NCT01412801|65772614|FG002|Overall Study|Relocated to another area|2|||
23624199|NCT00195442|66011558|FG000|Overall Study|Less than expected therapeutic effect|38|||
23558745|NCT01412801|65772615|FG003|Overall Study|Relocated to another area|0|||
23558746|NCT01412801|65772616|FG004|Overall Study|Relocated to another area|0|||
23558747|NCT01412801|65772617|FG005|Overall Study|Relocated to another area|0|||
23558748|NCT02428296|65772618|FG000|Overall Study|Adverse Event|7|||
23558749|NCT02428296|65772618|FG000|Overall Study|Withdrawal by Subject|2|||
23558750|NCT02110901|65772621|FG000|Overall Study|Death|6|||
23148400|NCT00938470|64293987|FG001|Overall Study|Alternate Treatment|0|||
23148401|NCT00938470|64293986|FG000|Overall Study|Death|3|||
23148402|NCT00938470|64293987|FG001|Overall Study|Death|2|||
23148403|NCT00938470|64293986|FG000|Overall Study|Other Reason|0|||
23148404|NCT00938470|64293987|FG001|Overall Study|Other Reason|1|||
23148405|NCT00026208|64293988|FG000|Overall Study|Complications of auto accident|1|||
23148406|NCT00026208|64293989|FG001|Overall Study|Complications of auto accident|0|||
23148407|NCT00821431|64293990|FG000|Overall Study|Adverse Event|6|||
23148408|NCT00821431|64293991|FG001|Overall Study|Adverse Event|3|||
23148409|NCT00821431|64293990|FG000|Overall Study|Withdrawal by Subject|5|||
23148410|NCT00821431|64293991|FG001|Overall Study|Withdrawal by Subject|0|||
23148411|NCT00821431|64293990|FG000|Overall Study|Lost to Follow-up|1|||
23148412|NCT00821431|64293991|FG001|Overall Study|Lost to Follow-up|0|||
23148413|NCT00821431|64293990|FG000|Overall Study|Protocol Violation|3|||
23148414|NCT00821431|64293991|FG001|Overall Study|Protocol Violation|1|||
23148415|NCT00821431|64293990|FG000|Overall Study|Physician Decision|0|||
23148416|NCT00821431|64293991|FG001|Overall Study|Physician Decision|1|||
23148417|NCT02301936|64293994|FG000|Overall Study|Lost to Follow-up|1|||
23148418|NCT02301936|64293995|FG001|Overall Study|Lost to Follow-up|0|||
23148419|NCT01477333|64293996|FG000|Overall Study|Adverse Event|1|||
23148420|NCT01477333|64293996|FG000|Overall Study|Withdrawal by Subject|1|||
23148421|NCT01477333|64293996|FG000|Overall Study|Clinical Deterioration|1|||
23148422|NCT00705432|64293998|FG000|Treatment Period|Adverse Event|45|||
23148423|NCT00705432|64293999|FG001|Treatment Period|Adverse Event|37|||
23148424|NCT00705432|64294000|FG002|Treatment Period|Adverse Event|51|||
23148425|NCT00705432|64294001|FG003|Treatment Period|Adverse Event|12|||
23148426|NCT00705432|64294002|FG004|Treatment Period|Adverse Event|8|||
23148427|NCT00705432|64294003|FG005|Treatment Period|Adverse Event|9|||
23148428|NCT00705432|64293998|FG000|Treatment Period|Treatment failure|92|||
23148429|NCT00705432|64293999|FG001|Treatment Period|Treatment failure|42|||
23148430|NCT00705432|64294000|FG002|Treatment Period|Treatment failure|33|||
23148431|NCT00705432|64294001|FG003|Treatment Period|Treatment failure|25|||
23148432|NCT00705432|64294002|FG004|Treatment Period|Treatment failure|13|||
23148433|NCT00705432|64294003|FG005|Treatment Period|Treatment failure|14|||
23148434|NCT00705432|64293998|FG000|Treatment Period|Non medical reason|26|||
23148435|NCT00705432|64293999|FG001|Treatment Period|Non medical reason|32|||
23148436|NCT00705432|64294000|FG002|Treatment Period|Non medical reason|37|||
23148437|NCT00705432|64294001|FG003|Treatment Period|Non medical reason|4|||
23148438|NCT00705432|64294002|FG004|Treatment Period|Non medical reason|7|||
23148439|NCT00705432|64294003|FG005|Treatment Period|Non medical reason|7|||
23148440|NCT00705432|64293998|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
23148441|NCT00705432|64293999|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
23148442|NCT00705432|64294000|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
23148443|NCT00705432|64294001|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
23148444|NCT00705432|64294002|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
23148445|NCT00705432|64294003|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
23148446|NCT00705432|64293998|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
23148447|NCT00705432|64293999|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
23148448|NCT00705432|64294000|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
23148449|NCT00705432|64294001|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
23148450|NCT00705432|64294002|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
23148451|NCT00705432|64294003|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
23148452|NCT02273726|64294004|FG000|Overall Study|Death|70|||
23148453|NCT02273726|64294005|FG001|Overall Study|Death|62|||
23148454|NCT02273726|64294004|FG000|Overall Study|Withdrawal by Subject|41|||
23148455|NCT02273726|64294005|FG001|Overall Study|Withdrawal by Subject|29|||
23323042|NCT01326845|64926646|FG001|Overall Study|Adverse Event|0|||
23148456|NCT02273726|64294004|FG000|Overall Study|Kidney transplant|31|||
23148457|NCT02273726|64294005|FG001|Overall Study|Kidney transplant|39|||
23148458|NCT02273726|64294004|FG000|Overall Study|Physician Decision|30|||
23148459|NCT02273726|64294005|FG001|Overall Study|Physician Decision|15|||
23148460|NCT02273726|64294004|FG000|Overall Study|Adverse Event|27|||
23148461|NCT02273726|64294005|FG001|Overall Study|Adverse Event|9|||
23148462|NCT02273726|64294004|FG000|Overall Study|Lost to Follow-up|6|||
23148463|NCT02273726|64294005|FG001|Overall Study|Lost to Follow-up|3|||
23148464|NCT02273726|64294004|FG000|Overall Study|Lack of Efficacy|6|||
23148465|NCT02273726|64294005|FG001|Overall Study|Lack of Efficacy|1|||
23148466|NCT02273726|64294004|FG000|Overall Study|Protocol Violation|4|||
23558751|NCT02110901|65772622|FG001|Overall Study|Death|3|||
23558752|NCT02110901|65772621|FG000|Overall Study|Lost to Follow-up|12|||
23558753|NCT02110901|65772622|FG001|Overall Study|Lost to Follow-up|8|||
23558754|NCT02110901|65772621|FG000|Overall Study|Withdrawal by Subject|7|||
23558755|NCT02110901|65772622|FG001|Overall Study|Withdrawal by Subject|3|||
23219032|NCT00804986|64544728|FG003|Overall Study|Sponsor Decision|0|||
23437627|NCT02409342|65344165|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
23558756|NCT02110901|65772621|FG000|Overall Study|received a kidney transplant|5|||
23558757|NCT02110901|65772622|FG001|Overall Study|received a kidney transplant|0|||
23558758|NCT00118898|65772626|FG000|Overall Study|Death|6|||
23558759|NCT00118898|65772627|FG001|Overall Study|Death|11|||
23558760|NCT00118898|65772628|FG002|Overall Study|Death|6|||
23558761|NCT00118898|65772629|FG003|Overall Study|Death|8|||
23558762|NCT00118898|65772626|FG000|Overall Study|Lost to Follow-up|26|||
23558763|NCT00118898|65772627|FG001|Overall Study|Lost to Follow-up|34|||
23558764|NCT00118898|65772628|FG002|Overall Study|Lost to Follow-up|33|||
23558765|NCT00118898|65772629|FG003|Overall Study|Lost to Follow-up|33|||
23558766|NCT00118898|65772626|FG000|Overall Study|Withdrawal by Subject|10|||
23558767|NCT00118898|65772627|FG001|Overall Study|Withdrawal by Subject|5|||
23558768|NCT00118898|65772628|FG002|Overall Study|Withdrawal by Subject|8|||
23558769|NCT00118898|65772629|FG003|Overall Study|Withdrawal by Subject|8|||
23558770|NCT00118898|65772626|FG000|Overall Study|Site Closure|33|||
23558771|NCT00118898|65772627|FG001|Overall Study|Site Closure|31|||
23558772|NCT00118898|65772628|FG002|Overall Study|Site Closure|28|||
23558773|NCT00118898|65772629|FG003|Overall Study|Site Closure|37|||
23558774|NCT00118898|65772626|FG000|Overall Study|Severe debilitation|1|||
23558775|NCT00118898|65772627|FG001|Overall Study|Severe debilitation|4|||
23558776|NCT00118898|65772628|FG002|Overall Study|Severe debilitation|6|||
23558777|NCT00118898|65772629|FG003|Overall Study|Severe debilitation|4|||
23558778|NCT00118898|65772626|FG000|Overall Study|Not compliant with requirements|11|||
23558779|NCT00118898|65772627|FG001|Overall Study|Not compliant with requirements|13|||
23558780|NCT00118898|65772628|FG002|Overall Study|Not compliant with requirements|11|||
23558781|NCT00118898|65772629|FG003|Overall Study|Not compliant with requirements|11|||
23558782|NCT00118898|65772626|FG000|Overall Study|Not able to get to clinic|34|||
23558783|NCT00118898|65772627|FG001|Overall Study|Not able to get to clinic|43|||
23558784|NCT00118898|65772628|FG002|Overall Study|Not able to get to clinic|31|||
23558785|NCT00118898|65772629|FG003|Overall Study|Not able to get to clinic|40|||
23558786|NCT00989092|65772633|FG000|Overall Study|Physician Decision|9|||
23558787|NCT00989092|65772634|FG001|Overall Study|Physician Decision|6|||
23558788|NCT00989092|65772633|FG000|Overall Study|Adverse Event|20|||
23558789|NCT00989092|65772634|FG001|Overall Study|Adverse Event|1|||
23558790|NCT00989092|65772633|FG000|Overall Study|Chemotherapy initiated|12|||
23558791|NCT00989092|65772634|FG001|Overall Study|Chemotherapy initiated|4|||
23558792|NCT00989092|65772633|FG000|Overall Study|Withdrawal by Subject|17|||
23558793|NCT00989092|65772634|FG001|Overall Study|Withdrawal by Subject|9|||
23558794|NCT00989092|65772633|FG000|Overall Study|Death|14|||
23558795|NCT00989092|65772634|FG001|Overall Study|Death|2|||
23558796|NCT00989092|65772633|FG000|Overall Study|Ineligibility determined|3|||
23558797|NCT00989092|65772634|FG001|Overall Study|Ineligibility determined|3|||
23558798|NCT00989092|65772633|FG000|Overall Study|Lost to Follow-up|6|||
23558799|NCT00989092|65772634|FG001|Overall Study|Lost to Follow-up|2|||
23558800|NCT00989092|65772633|FG000|Overall Study|Other|3|||
23558801|NCT00989092|65772634|FG001|Overall Study|Other|1|||
23558802|NCT00989092|65772633|FG000|Overall Study|Protocol deviation|2|||
23558803|NCT00989092|65772634|FG001|Overall Study|Protocol deviation|0|||
23558804|NCT00989092|65772633|FG000|Overall Study|Erythropoietin therapy initiated|2|||
23558805|NCT00989092|65772634|FG001|Overall Study|Erythropoietin therapy initiated|0|||
23558806|NCT00989092|65772633|FG000|Overall Study|Did not receive study drug|2|||
23558807|NCT00989092|65772634|FG001|Overall Study|Did not receive study drug|0|||
23558808|NCT00941798|65772635|FG000|Overall Study|Withdrawal by Subject|72|||
23558809|NCT00941798|65772636|FG001|Overall Study|Withdrawal by Subject|74|||
23558810|NCT00941798|65772635|FG000|Overall Study|Adverse Event|43|||
23558811|NCT00941798|65772636|FG001|Overall Study|Adverse Event|23|||
23558812|NCT00941798|65772635|FG000|Overall Study|Lost to Follow-up|29|||
23558813|NCT00941798|65772636|FG001|Overall Study|Lost to Follow-up|23|||
23558814|NCT00941798|65772635|FG000|Overall Study|Protocol Violation|17|||
23558815|NCT00941798|65772636|FG001|Overall Study|Protocol Violation|20|||
23558816|NCT00941798|65772635|FG000|Overall Study|Administrative problems|13|||
23558817|NCT00941798|65772636|FG001|Overall Study|Administrative problems|23|||
23558818|NCT00941798|65772635|FG000|Overall Study|Lack of Efficacy|10|||
23558819|NCT00941798|65772636|FG001|Overall Study|Lack of Efficacy|17|||
23558820|NCT00941798|65772635|FG000|Overall Study|Patient's inability to use device|6|||
23558821|NCT00941798|65772636|FG001|Overall Study|Patient's inability to use device|1|||
23558822|NCT00941798|65772635|FG000|Overall Study|Abnormal test procedure results|3|||
23624200|NCT00195442|66011558|FG000|Overall Study|Lost to Follow-up|27|||
23558823|NCT00941798|65772636|FG001|Overall Study|Abnormal test procedure results|1|||
23558824|NCT00941798|65772635|FG000|Overall Study|Abnormal laboratory values|1|||
23558825|NCT00941798|65772636|FG001|Overall Study|Abnormal laboratory values|2|||
23558826|NCT00941798|65772635|FG000|Overall Study|Death|0|||
23558827|NCT00941798|65772636|FG001|Overall Study|Death|1|||
23148467|NCT02273726|64294005|FG001|Overall Study|Protocol Violation|0|||
23148468|NCT02273726|64294004|FG000|Overall Study|Other than specified|28|||
23148469|NCT02273726|64294005|FG001|Overall Study|Other than specified|30|||
23148470|NCT04824521|64294010|FG000|Overall Study|Lost to Follow-up|1|||
23148471|NCT00908232|64294013|FG000|Cycle 1 to 4|Death|5|||
23148472|NCT00908232|64294014|FG001|Cycle 1 to 4|Death|0|||
23558828|NCT01648270|65772638|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
23558829|NCT02055157|65772644|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
23558830|NCT02055157|65772645|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
23558831|NCT02055157|65772646|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
23558832|NCT02055157|65772647|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
23558833|NCT02055157|65772644|FG000|Initial 6 Months|Adverse Event|0|||
23558834|NCT02055157|65772645|FG001|Initial 6 Months|Adverse Event|0|||
23558835|NCT02055157|65772646|FG002|Initial 6 Months|Adverse Event|0|||
23558836|NCT02055157|65772647|FG003|Initial 6 Months|Adverse Event|1|||
23558837|NCT02055157|65772644|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
23558838|NCT02055157|65772645|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
23558839|NCT02055157|65772646|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
23558840|NCT02055157|65772647|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
23558841|NCT02055157|65772644|FG000|18-month Extension|Investigator decision|0|||
23558842|NCT02055157|65772645|FG001|18-month Extension|Investigator decision|1|||
23558843|NCT02055157|65772646|FG002|18-month Extension|Investigator decision|0|||
23558844|NCT02055157|65772647|FG003|18-month Extension|Investigator decision|0|||
23558845|NCT02055157|65772644|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
23558846|NCT02055157|65772645|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
23558847|NCT02055157|65772646|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
23558848|NCT02055157|65772647|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
23558849|NCT00982930|65772649|FG000|Overall Study|Adverse Event|1|||
23148473|NCT00908232|64294015|FG002|Cycle 1 to 4|Death|0|||
23148474|NCT00908232|64294016|FG003|Cycle 1 to 4|Death|0|||
23148475|NCT00908232|64294013|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
23148476|NCT00908232|64294014|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
23148477|NCT00908232|64294015|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
23148478|NCT00908232|64294016|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
23148479|NCT00908232|64294013|FG000|Cycle 1 to 4|Progressive Disease|6|||
23148480|NCT00908232|64294014|FG001|Cycle 1 to 4|Progressive Disease|0|||
23148481|NCT00908232|64294015|FG002|Cycle 1 to 4|Progressive Disease|0|||
23148482|NCT00908232|64294016|FG003|Cycle 1 to 4|Progressive Disease|0|||
23148483|NCT00908232|64294013|FG000|Cycle 1 to 4|Adverse Event|12|||
23148484|NCT00908232|64294014|FG001|Cycle 1 to 4|Adverse Event|0|||
23148485|NCT00908232|64294015|FG002|Cycle 1 to 4|Adverse Event|0|||
23148486|NCT00908232|64294016|FG003|Cycle 1 to 4|Adverse Event|0|||
23148487|NCT00908232|64294013|FG000|Cycle 1 to 4|Other|1|||
23148488|NCT00908232|64294014|FG001|Cycle 1 to 4|Other|0|||
23148489|NCT00908232|64294015|FG002|Cycle 1 to 4|Other|0|||
23148490|NCT00908232|64294016|FG003|Cycle 1 to 4|Other|0|||
23148491|NCT00908232|64294013|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
23148492|NCT00908232|64294014|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
23148493|NCT00908232|64294015|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
23148494|NCT00908232|64294016|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
23148495|NCT00908232|64294013|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
23148496|NCT00908232|64294014|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
23148497|NCT00908232|64294015|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
23148498|NCT00908232|64294016|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
23148499|NCT00908232|64294013|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
23148500|NCT00908232|64294014|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
23148501|NCT00908232|64294015|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
23148502|NCT00908232|64294016|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
23148503|NCT00908232|64294013|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
23148504|NCT00908232|64294014|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
23558850|NCT00982930|65772649|FG000|Overall Study|Withdrawal by Subject|1|||
23558851|NCT00982930|65772649|FG000|Overall Study|Administrative Problems|2|||
23558852|NCT01733732|65772663|FG000|Overall Study|Adverse Event|1|||
23558853|NCT01733732|65772664|FG001|Overall Study|Adverse Event|0|||
23558854|NCT01733732|65772663|FG000|Overall Study|Did not attend all study visits|1|||
23558855|NCT01733732|65772664|FG001|Overall Study|Did not attend all study visits|0|||
23148505|NCT00908232|64294015|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
23148506|NCT00908232|64294016|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
23148507|NCT00908232|64294013|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
23148508|NCT00908232|64294014|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
23148509|NCT00908232|64294015|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
23148510|NCT00908232|64294016|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
23148511|NCT00908232|64294013|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
23558856|NCT01194570|65772665|FG000|Overall Study|Adverse Event|22|||
23558857|NCT01194570|65772666|FG001|Overall Study|Adverse Event|40|||
23558858|NCT01194570|65772665|FG000|Overall Study|Death|6|||
23558859|NCT01194570|65772666|FG001|Overall Study|Death|20|||
23558860|NCT01194570|65772665|FG000|Overall Study|Lack of Efficacy|32|||
23558861|NCT01194570|65772666|FG001|Overall Study|Lack of Efficacy|33|||
23558862|NCT01194570|65772665|FG000|Overall Study|Lost to Follow-up|4|||
23558863|NCT01194570|65772666|FG001|Overall Study|Lost to Follow-up|15|||
23558864|NCT01194570|65772665|FG000|Overall Study|Non-Compliance|2|||
23558865|NCT01194570|65772666|FG001|Overall Study|Non-Compliance|2|||
23558866|NCT01194570|65772665|FG000|Overall Study|Non-Compliance With Study Drug|2|||
23558867|NCT01194570|65772666|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23558868|NCT01194570|65772665|FG000|Overall Study|Other|18|||
23323043|NCT01326845|64926645|FG000|Overall Study|Misisng|1|||
23323044|NCT01326845|64926646|FG001|Overall Study|Misisng|3|||
23323045|NCT00711087|64926647|FG000|Overall Study|Lost to Follow-up|1|||
23323046|NCT00711087|64926648|FG001|Overall Study|Lost to Follow-up|0|||
23323047|NCT00638508|64926649|FG000|Overall Study|Physician Decision|5|||
23558869|NCT01194570|65772666|FG001|Overall Study|Other|47|||
23558870|NCT01194570|65772665|FG000|Overall Study|Physician Decision|10|||
23558871|NCT01194570|65772666|FG001|Overall Study|Physician Decision|25|||
23558872|NCT01194570|65772665|FG000|Overall Study|Protocol Violation|1|||
23558873|NCT01194570|65772666|FG001|Overall Study|Protocol Violation|2|||
23558874|NCT01194570|65772665|FG000|Overall Study|Study Terminated By Sponsor|0|||
23558875|NCT01194570|65772666|FG001|Overall Study|Study Terminated By Sponsor|1|||
23558876|NCT01194570|65772665|FG000|Overall Study|Withdrawal by Subject|57|||
23558877|NCT01194570|65772666|FG001|Overall Study|Withdrawal by Subject|82|||
23558878|NCT01194570|65772665|FG000|Overall Study|Pregnancy|1|||
23558879|NCT01194570|65772666|FG001|Overall Study|Pregnancy|1|||
23558880|NCT02124265|65772667|FG000|Overall Study|Adverse Event|1|||
23558881|NCT01242748|65772670|FG000|Overall Study|Adverse Event|10|||
23558882|NCT01242748|65772671|FG001|Overall Study|Adverse Event|5|||
23558883|NCT01242748|65772670|FG000|Overall Study|Lost to Follow-up|6|||
23558884|NCT01242748|65772671|FG001|Overall Study|Lost to Follow-up|2|||
23558885|NCT01242748|65772670|FG000|Overall Study|Physician Decision|3|||
23558886|NCT01242748|65772671|FG001|Overall Study|Physician Decision|2|||
23558887|NCT01242748|65772670|FG000|Overall Study|Protocol Violation|1|||
23558888|NCT01242748|65772671|FG001|Overall Study|Protocol Violation|0|||
23219033|NCT00804986|64544729|FG004|Overall Study|Sponsor Decision|0|||
23219034|NCT00804986|64544730|FG005|Overall Study|Sponsor Decision|0|||
23558889|NCT01242748|65772670|FG000|Overall Study|Withdrawal by Subject|10|||
23558890|NCT01242748|65772671|FG001|Overall Study|Withdrawal by Subject|2|||
23558891|NCT01242748|65772670|FG000|Overall Study|Miscellaneous reasons|8|||
23558892|NCT01242748|65772671|FG001|Overall Study|Miscellaneous reasons|3|||
23558893|NCT00659490|65772675|FG000|Overall Study|Lost to Follow-up|2|||
23558894|NCT00659490|65772676|FG001|Overall Study|Lost to Follow-up|0|||
23558895|NCT00659490|65772677|FG002|Overall Study|Lost to Follow-up|1|||
23558896|NCT02172625|65772678|FG000|Overall Study|Adverse Event|0|||
23558897|NCT02172625|65772679|FG001|Overall Study|Adverse Event|1|||
23558898|NCT02172625|65772678|FG000|Overall Study|Pregnancy|0|||
23558899|NCT02172625|65772679|FG001|Overall Study|Pregnancy|1|||
23558900|NCT02172625|65772678|FG000|Overall Study|car accident|0|||
23558901|NCT02172625|65772679|FG001|Overall Study|car accident|1|||
23558902|NCT02839343|65772680|FG000|Overall Study|Withdrawal by Subject|3|||
23219035|NCT00804986|64544725|FG000|Overall Study|Physician Decision|1|||
23219036|NCT00804986|64544726|FG001|Overall Study|Physician Decision|0|||
23219037|NCT00804986|64544727|FG002|Overall Study|Physician Decision|0|||
23219038|NCT00804986|64544728|FG003|Overall Study|Physician Decision|0|||
23219039|NCT00804986|64544729|FG004|Overall Study|Physician Decision|0|||
23219040|NCT00804986|64544730|FG005|Overall Study|Physician Decision|0|||
23219041|NCT00614991|64544731|FG000|Overall Study|Adverse Event|3|||
23219042|NCT00614991|64544732|FG001|Overall Study|Adverse Event|3|||
23219043|NCT00614991|64544733|FG002|Overall Study|Adverse Event|0|||
23219044|NCT00614991|64544734|FG003|Overall Study|Adverse Event|0|||
23558903|NCT02839343|65772681|FG001|Overall Study|Withdrawal by Subject|1|||
23558904|NCT02839343|65772680|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
23558905|NCT02839343|65772681|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
23558906|NCT02839343|65772680|FG000|Overall Study|Adverse Event|1|||
23558907|NCT02839343|65772681|FG001|Overall Study|Adverse Event|0|||
23558908|NCT03929562|65772682|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
23219045|NCT00614991|64544735|FG004|Overall Study|Adverse Event|1|||
23219046|NCT00614991|64544736|FG005|Overall Study|Adverse Event|0|||
23558909|NCT03929562|65772683|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
23558910|NCT03929562|65772682|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
23558911|NCT03929562|65772683|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
23558912|NCT03929562|65772682|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
23558913|NCT03929562|65772683|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
23219047|NCT00105183|64544739|FG000|Overall Study|Death|19|||
23323048|NCT00638508|64926650|FG001|Overall Study|Physician Decision|2|||
23558914|NCT03988634|65772684|FG000|Double-Blind|Adverse Event|4|||
23558915|NCT03988634|65772685|FG001|Double-Blind|Adverse Event|0|||
23558916|NCT03988634|65772686|FG002|Double-Blind|Adverse Event|0|||
23558917|NCT03988634|65772684|FG000|Double-Blind|Death|18|||
23558918|NCT03988634|65772685|FG001|Double-Blind|Death|26|||
23558919|NCT03988634|65772686|FG002|Double-Blind|Death|0|||
23558920|NCT03988634|65772684|FG000|Double-Blind|Lost to Follow-up|6|||
23558921|NCT03988634|65772685|FG001|Double-Blind|Lost to Follow-up|7|||
23558922|NCT03988634|65772686|FG002|Double-Blind|Lost to Follow-up|0|||
23558923|NCT03988634|65772684|FG000|Double-Blind|Physician Decision|9|||
23558924|NCT03988634|65772685|FG001|Double-Blind|Physician Decision|5|||
23558925|NCT03988634|65772686|FG002|Double-Blind|Physician Decision|0|||
23558926|NCT03988634|65772684|FG000|Double-Blind|Subject decision|24|||
23558927|NCT03988634|65772685|FG001|Double-Blind|Subject decision|13|||
23558928|NCT03988634|65772686|FG002|Double-Blind|Subject decision|0|||
23558929|NCT03988634|65772684|FG000|Open-Label|Adverse Event|0|||
23558930|NCT03988634|65772685|FG001|Open-Label|Adverse Event|0|||
23558931|NCT03988634|65772686|FG002|Open-Label|Adverse Event|7|||
23558932|NCT03988634|65772684|FG000|Open-Label|Physician Decision|0|||
23558933|NCT03988634|65772685|FG001|Open-Label|Physician Decision|0|||
23558934|NCT03988634|65772686|FG002|Open-Label|Physician Decision|1|||
23558935|NCT03988634|65772684|FG000|Open-Label|Technical problems|0|||
23558936|NCT03988634|65772685|FG001|Open-Label|Technical problems|0|||
23558937|NCT03988634|65772686|FG002|Open-Label|Technical problems|1|||
23558938|NCT00779779|65772693|FG000|Overall Study|Adverse Event|1|||
23558939|NCT00779779|65772693|FG000|Overall Study|Protocol Violation|14|||
23558940|NCT00779779|65772693|FG000|Overall Study|Withdrawal by Subject|4|||
23558941|NCT00779779|65772693|FG000|Overall Study|Lost to Follow-up|5|||
23558942|NCT02119260|65772694|FG000|Overall Study|Adverse Event|1|||
23558943|NCT02119260|65772695|FG001|Overall Study|Adverse Event|0|||
23558944|NCT02119260|65772696|FG002|Overall Study|Adverse Event|0|||
23558945|NCT02119260|65772697|FG003|Overall Study|Adverse Event|0|||
23558946|NCT02119260|65772698|FG004|Overall Study|Adverse Event|0|||
23558947|NCT02119260|65772699|FG005|Overall Study|Adverse Event|0|||
23558948|NCT02119260|65772700|FG006|Overall Study|Adverse Event|0|||
23558949|NCT02119260|65772694|FG000|Overall Study|Withdrew consent|0|||
23558950|NCT02119260|65772695|FG001|Overall Study|Withdrew consent|1|||
23558951|NCT02119260|65772696|FG002|Overall Study|Withdrew consent|1|||
23558952|NCT02119260|65772697|FG003|Overall Study|Withdrew consent|0|||
23558953|NCT02119260|65772698|FG004|Overall Study|Withdrew consent|0|||
23558954|NCT02119260|65772699|FG005|Overall Study|Withdrew consent|0|||
23558955|NCT02119260|65772700|FG006|Overall Study|Withdrew consent|0|||
23558956|NCT00116844|65776117|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
23558957|NCT00116844|65776118|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
23558958|NCT00116844|65776117|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
23558959|NCT00116844|65776118|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
23558960|NCT00116844|65776117|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
23558961|NCT00116844|65776118|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
23558962|NCT00116844|65776117|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
23558963|NCT00116844|65776118|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
23558964|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
23558965|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
23558966|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
23148512|NCT00908232|64294014|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
23148513|NCT00908232|64294015|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
23148514|NCT00908232|64294016|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
23148515|NCT00908232|64294013|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
23148516|NCT00908232|64294014|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
23148517|NCT00908232|64294015|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
23148518|NCT00908232|64294016|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
23148519|NCT00908232|64294013|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
23148520|NCT00908232|64294014|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
23148521|NCT00908232|64294015|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
23148522|NCT00908232|64294016|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
23148523|NCT02279862|64294020|FG000|Overall Study|Study drug toxicity|3|||
23148524|NCT02279862|64294021|FG001|Overall Study|Study drug toxicity|6|||
23148525|NCT02279862|64294020|FG000|Overall Study|No longer meets criteria|0|||
23148526|NCT02279862|64294021|FG001|Overall Study|No longer meets criteria|1|||
23148527|NCT02279862|64294020|FG000|Overall Study|Administrative reason by sponsor|0|||
23148528|NCT02279862|64294021|FG001|Overall Study|Administrative reason by sponsor|1|||
23148529|NCT02279862|64294020|FG000|Overall Study|Disease progression|5|||
23148530|NCT02279862|64294021|FG001|Overall Study|Disease progression|2|||
23558967|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
23558968|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
23558969|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
23558970|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
23558971|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
23558972|NCT00116844|65776117|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
23558973|NCT00116844|65776118|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
23558974|NCT03040713|65776120|FG000|Overall Study|Positive amyloid scan|3|||
23558975|NCT02979639|65776121|FG000|Overall Study|Withdrawal based on medical judgement|1|||
23558976|NCT02979639|65776121|FG000|Overall Study|Lost to Follow-up|8|||
23558977|NCT02979639|65776121|FG000|Overall Study|Withdrawal by Subject|3|||
23558978|NCT02979639|65776121|FG000|Overall Study|Adverse Event|2|||
23558979|NCT00939484|65776122|FG000|Overall Study|Progression/Relapse|8|||
23558980|NCT00939484|65776123|FG001|Overall Study|Progression/Relapse|20|||
23558981|NCT00939484|65776124|FG002|Overall Study|Progression/Relapse|3|||
23558982|NCT02243280|65776127|FG000|Treated|Adverse Event|1|||
23558983|NCT02243280|65776128|FG001|Treated|Adverse Event|0|||
23558984|NCT02243280|65776129|FG002|Treated|Adverse Event|0|||
23558985|NCT02243280|65776130|FG003|Treated|Adverse Event|0|||
23558986|NCT02243280|65776131|FG004|Treated|Adverse Event|0|||
23558987|NCT02243280|65776132|FG005|Treated|Adverse Event|0|||
23558988|NCT02243280|65776133|FG006|Treated|Adverse Event|0|||
23323049|NCT01207583|64926651|FG000|Overall Study|Withdrawal by Subject|0|||
23323050|NCT01207583|64926652|FG001|Overall Study|Withdrawal by Subject|3|||
23323051|NCT01207583|64926653|FG002|Overall Study|Withdrawal by Subject|1|||
23323052|NCT01207583|64926651|FG000|Overall Study|Participant failed to return|1|||
23323053|NCT01207583|64926652|FG001|Overall Study|Participant failed to return|0|||
23323054|NCT01207583|64926653|FG002|Overall Study|Participant failed to return|0|||
23323055|NCT01207583|64926651|FG000|Overall Study|Lost to Follow-up|0|||
23323056|NCT01207583|64926652|FG001|Overall Study|Lost to Follow-up|2|||
23323057|NCT01207583|64926653|FG002|Overall Study|Lost to Follow-up|0|||
23323058|NCT01392963|64926656|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
23323059|NCT01392963|64926657|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
23323060|NCT01392963|64926656|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
23323061|NCT01392963|64926657|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
23323062|NCT01392963|64926656|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
23323063|NCT01392963|64926657|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
23323064|NCT03805412|64926658|FG000|Overall Study|Lost to Follow-up|0|||
23323065|NCT03805412|64926659|FG001|Overall Study|Lost to Follow-up|1|||
23323066|NCT00124917|64926660|FG000|Overall Study|Physician Decision|3|||
23323067|NCT03593395|64926670|FG000|Overall Study|Lost to Follow-up|48|||
23323068|NCT03593395|64926671|FG001|Overall Study|Lost to Follow-up|3|||
23323069|NCT03593395|64926670|FG000|Overall Study|Withdrawal by Subject|5|||
23323070|NCT03593395|64926671|FG001|Overall Study|Withdrawal by Subject|24|||
23323071|NCT03593395|64926670|FG000|Overall Study|Death|2|||
23323072|NCT03593395|64926671|FG001|Overall Study|Death|3|||
23323073|NCT03593395|64926670|FG000|Overall Study|Physician Decision|0|||
23323074|NCT03593395|64926671|FG001|Overall Study|Physician Decision|6|||
23323075|NCT03593395|64926670|FG000|Overall Study|Participant Relocated|19|||
23323076|NCT03593395|64926671|FG001|Overall Study|Participant Relocated|3|||
23323077|NCT03593395|64926670|FG000|Overall Study|No Information|1|||
23323078|NCT03593395|64926671|FG001|Overall Study|No Information|7|||
23323079|NCT02899962|64926678|FG000|Open-label Phase|Adverse Event|2|||
23323080|NCT02899962|64926679|FG001|Open-label Phase|Adverse Event|0|||
23323081|NCT02899962|64926680|FG002|Open-label Phase|Adverse Event|0|||
23323082|NCT02899962|64926678|FG000|Open-label Phase|Lost to Follow-up|9|||
23323083|NCT02899962|64926679|FG001|Open-label Phase|Lost to Follow-up|0|||
23323084|NCT02899962|64926680|FG002|Open-label Phase|Lost to Follow-up|0|||
23323085|NCT02899962|64926678|FG000|Open-label Phase|Other reasons|9|||
23323086|NCT02899962|64926679|FG001|Open-label Phase|Other reasons|0|||
23323087|NCT02899962|64926680|FG002|Open-label Phase|Other reasons|0|||
23323088|NCT02899962|64926678|FG000|Open-label Phase|Withdrawal by Subject|7|||
23323089|NCT02899962|64926679|FG001|Open-label Phase|Withdrawal by Subject|0|||
23323090|NCT02899962|64926680|FG002|Open-label Phase|Withdrawal by Subject|0|||
23323091|NCT02899962|64926678|FG000|Maintenance Phase|Adverse Event|0|||
23323092|NCT02899962|64926679|FG001|Maintenance Phase|Adverse Event|2|||
23323093|NCT02899962|64926680|FG002|Maintenance Phase|Adverse Event|1|||
23323094|NCT02899962|64926678|FG000|Maintenance Phase|Death|0|||
23148531|NCT02279862|64294020|FG000|Overall Study|Study closed by sponsor|16|||
23323095|NCT02899962|64926679|FG001|Maintenance Phase|Death|0|||
23558989|NCT02243280|65776134|FG007|Treated|Adverse Event|0|||
23558990|NCT02243280|65776135|FG008|Treated|Adverse Event|0|||
23624201|NCT00195442|66011558|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
23323096|NCT02899962|64926680|FG002|Maintenance Phase|Death|1|||
23323097|NCT02899962|64926678|FG000|Maintenance Phase|Lack of Efficacy|0|||
23323098|NCT02899962|64926679|FG001|Maintenance Phase|Lack of Efficacy|20|||
23323099|NCT02899962|64926680|FG002|Maintenance Phase|Lack of Efficacy|16|||
23323100|NCT02899962|64926678|FG000|Maintenance Phase|Lost to Follow-up|0|||
23323101|NCT02899962|64926679|FG001|Maintenance Phase|Lost to Follow-up|12|||
23323102|NCT02899962|64926680|FG002|Maintenance Phase|Lost to Follow-up|14|||
23323103|NCT02899962|64926678|FG000|Maintenance Phase|Other reasons|0|||
23558991|NCT02243280|65776136|FG009|Treated|Adverse Event|0|||
23558992|NCT02243280|65776137|FG010|Treated|Adverse Event|1|||
23558993|NCT02243280|65776127|FG000|Treated|Lost to Follow-up|0|||
23558994|NCT02243280|65776128|FG001|Treated|Lost to Follow-up|0|||
23558995|NCT02243280|65776129|FG002|Treated|Lost to Follow-up|0|||
23558996|NCT02243280|65776130|FG003|Treated|Lost to Follow-up|0|||
23558997|NCT02243280|65776131|FG004|Treated|Lost to Follow-up|0|||
23558998|NCT02243280|65776132|FG005|Treated|Lost to Follow-up|0|||
23558999|NCT02243280|65776133|FG006|Treated|Lost to Follow-up|0|||
23559000|NCT02243280|65776134|FG007|Treated|Lost to Follow-up|0|||
23148532|NCT02279862|64294021|FG001|Overall Study|Study closed by sponsor|13|||
23148533|NCT02279862|64294020|FG000|Overall Study|Other|1|||
23148534|NCT02279862|64294021|FG001|Overall Study|Other|2|||
23148535|NCT02279862|64294020|FG000|Overall Study|Withdrawal by Subject|1|||
23148536|NCT02279862|64294021|FG001|Overall Study|Withdrawal by Subject|0|||
23148537|NCT01295281|64294022|FG000|First Intervention (7 Days)|Death|0|||
23148538|NCT01295281|64294023|FG001|First Intervention (7 Days)|Death|1|||
23148539|NCT02038920|64294026|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
23148540|NCT02038920|64294027|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
23148541|NCT02038920|64294028|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
23148542|NCT02038920|64294029|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
23148543|NCT02038920|64294030|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
23148544|NCT02038920|64294031|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
23148545|NCT02038920|64294026|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
23148546|NCT02038920|64294027|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23148547|NCT02038920|64294028|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23148548|NCT02038920|64294029|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23148549|NCT02038920|64294030|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23148550|NCT02038920|64294031|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
23148551|NCT02038920|64294026|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
23148552|NCT02038920|64294027|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
23148553|NCT02038920|64294028|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
23148554|NCT02038920|64294029|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
23148555|NCT02038920|64294030|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
23148556|NCT02038920|64294031|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
23148557|NCT02038920|64294026|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
23148558|NCT02038920|64294027|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
23148559|NCT02038920|64294028|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
23148560|NCT02038920|64294029|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
23148561|NCT02038920|64294030|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
23148562|NCT02038920|64294031|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
23148563|NCT02038920|64294026|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23148564|NCT02038920|64294027|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23148565|NCT02038920|64294028|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
23148566|NCT02038920|64294029|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23148567|NCT02038920|64294030|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23148568|NCT02038920|64294031|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
23148569|NCT02038920|64294026|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
23148570|NCT02038920|64294027|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
23148571|NCT02038920|64294028|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
23148572|NCT02038920|64294029|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
23148573|NCT02038920|64294030|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
23148574|NCT02038920|64294031|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
23148575|NCT02038920|64294026|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23148576|NCT02038920|64294027|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23148577|NCT02038920|64294028|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23148578|NCT02038920|64294029|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23148579|NCT02038920|64294030|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
23148580|NCT02038920|64294031|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
23148581|NCT02038920|64294026|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23148582|NCT02038920|64294027|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23148583|NCT02038920|64294028|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23559001|NCT02243280|65776135|FG008|Treated|Lost to Follow-up|1|||
23559002|NCT02243280|65776136|FG009|Treated|Lost to Follow-up|0|||
23559003|NCT02243280|65776137|FG010|Treated|Lost to Follow-up|2|||
23148584|NCT02038920|64294029|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23148585|NCT02038920|64294030|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
23559004|NCT01830595|65776138|FG000|First Period|Withdrawal by Subject|1|||
23559005|NCT01830595|65776139|FG001|First Period|Withdrawal by Subject|3|||
23559006|NCT01830595|65776138|FG000|Washout|Withdrawal by Subject|2|||
23323104|NCT02899962|64926679|FG001|Maintenance Phase|Other reasons|9|||
23323105|NCT02899962|64926680|FG002|Maintenance Phase|Other reasons|13|||
23323106|NCT02899962|64926678|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
23323107|NCT02899962|64926679|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
23323108|NCT02899962|64926680|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
23323109|NCT02899962|64926678|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
23323110|NCT02899962|64926679|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
23323111|NCT02899962|64926680|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
23559007|NCT01830595|65776139|FG001|Washout|Withdrawal by Subject|2|||
23559008|NCT00641719|65776142|FG000|Overall Study|Lack of Efficacy|1|||
23559009|NCT00641719|65776143|FG001|Overall Study|Lack of Efficacy|2|||
23559010|NCT00641719|65776142|FG000|Overall Study|Adverse Event|24|||
23559011|NCT00641719|65776143|FG001|Overall Study|Adverse Event|29|||
23559012|NCT00641719|65776142|FG000|Overall Study|Withdrawal by Subject|4|||
23559013|NCT00641719|65776143|FG001|Overall Study|Withdrawal by Subject|4|||
23559014|NCT00641719|65776142|FG000|Overall Study|Reason Not Specified|1|||
23559015|NCT00641719|65776143|FG001|Overall Study|Reason Not Specified|2|||
23559016|NCT00045708|65776144|FG000|Phase 1|early progressive disease|0|||
23219048|NCT00105183|64544740|FG001|Overall Study|Death|13|||
23219049|NCT00105183|64544741|FG002|Overall Study|Death|15|||
23219050|NCT00105183|64544739|FG000|Overall Study|Withdrawal by Subject|1|||
23219051|NCT00105183|64544740|FG001|Overall Study|Withdrawal by Subject|1|||
23219052|NCT00105183|64544741|FG002|Overall Study|Withdrawal by Subject|4|||
23219053|NCT00105183|64544739|FG000|Overall Study|Physician Decision|1|||
23219054|NCT00105183|64544740|FG001|Overall Study|Physician Decision|2|||
23219055|NCT00105183|64544741|FG002|Overall Study|Physician Decision|3|||
23219056|NCT00105183|64544739|FG000|Overall Study|Lost to Follow-up|0|||
23219057|NCT00105183|64544740|FG001|Overall Study|Lost to Follow-up|1|||
23219058|NCT00105183|64544741|FG002|Overall Study|Lost to Follow-up|1|||
23219059|NCT00105183|64544739|FG000|Overall Study|Other reason|1|||
23219060|NCT00105183|64544740|FG001|Overall Study|Other reason|2|||
23219061|NCT00105183|64544741|FG002|Overall Study|Other reason|0|||
23219062|NCT03077243|64544742|FG000|Overall Study|Death|1|||
23219063|NCT03077243|64544743|FG001|Overall Study|Death|2|||
23219064|NCT03077243|64544744|FG002|Overall Study|Death|0|||
23219065|NCT03077243|64544745|FG003|Overall Study|Death|0|||
23219066|NCT03077243|64544742|FG000|Overall Study|Withdrawal by Subject|1|||
23219067|NCT03077243|64544743|FG001|Overall Study|Withdrawal by Subject|3|||
23323112|NCT02899962|64926678|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23323113|NCT02899962|64926679|FG001|Maintenance Phase|Withdrawal by Subject|30|||
23559017|NCT00045708|65776145|FG001|Phase 1|early progressive disease|1|||
23624202|NCT00195442|66011558|FG000|Overall Study|Intermittent product shortage|21|||
23148586|NCT02038920|64294031|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
23148587|NCT02038920|64294026|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23148588|NCT02038920|64294027|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23148589|NCT02038920|64294028|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23148590|NCT02038920|64294029|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23148591|NCT02038920|64294030|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
23148592|NCT02038920|64294031|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
23148593|NCT02038920|64294026|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23148594|NCT02038920|64294027|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23148595|NCT02038920|64294028|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23148596|NCT02038920|64294029|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23148597|NCT02038920|64294030|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
23148598|NCT02038920|64294031|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
23148599|NCT02038920|64294026|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23148600|NCT02038920|64294027|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23148601|NCT02038920|64294028|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23148602|NCT02038920|64294029|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23148603|NCT02038920|64294030|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
23148604|NCT02038920|64294031|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
23148605|NCT02038920|64294026|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23148606|NCT02038920|64294027|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23148607|NCT02038920|64294028|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23148608|NCT02038920|64294029|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23148609|NCT02038920|64294030|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
23148610|NCT02038920|64294031|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
23148611|NCT01184053|64294032|FG000|Overall Study|progression while on treatment|3|||
23148612|NCT01174238|64294035|FG000|Overall Study|Lost to Follow-up|2|||
23148613|NCT01840605|64294036|FG000|Overall Study|Adverse Event|0|||
23148614|NCT01840605|64294037|FG001|Overall Study|Adverse Event|1|||
23148615|NCT01840605|64294036|FG000|Overall Study|Physician Decision|2|||
23559018|NCT00045708|65776146|FG002|Phase 1|early progressive disease|0|||
23559019|NCT02157779|65776147|FG000|Overall Study|Logistical|9|||
23559020|NCT02157779|65776148|FG001|Overall Study|Logistical|3|||
23559021|NCT02157779|65776147|FG000|Overall Study|Stopped attending, reason unknown|11|||
23559022|NCT02157779|65776148|FG001|Overall Study|Stopped attending, reason unknown|7|||
23559023|NCT02157779|65776147|FG000|Overall Study|No response to outreach after Baseline|1|||
23559024|NCT02157779|65776148|FG001|Overall Study|No response to outreach after Baseline|1|||
23559025|NCT02157779|65776147|FG000|Overall Study|Moved|1|||
23559026|NCT02157779|65776148|FG001|Overall Study|Moved|0|||
23559027|NCT02157779|65776147|FG000|Overall Study|Medical|1|||
23559028|NCT02157779|65776148|FG001|Overall Study|Medical|0|||
23559029|NCT02157779|65776147|FG000|Overall Study|Legal issue|1|||
23559030|NCT02157779|65776148|FG001|Overall Study|Legal issue|0|||
23559031|NCT01059643|65776153|FG000|Overall Study|Adverse Event|3|||
23559032|NCT01059643|65776153|FG000|Overall Study|Withdrawal by Subject|2|||
23559033|NCT01059643|65776153|FG000|Overall Study|Physician Decision|1|||
23559034|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
23559035|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
23559036|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
23559037|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
23148616|NCT01840605|64294037|FG001|Overall Study|Physician Decision|1|||
23148617|NCT01251120|64294038|FG000|Overall Study|Lack of Efficacy|0|||
23148618|NCT01251120|64294039|FG001|Overall Study|Lack of Efficacy|1|||
23148619|NCT01387230|64294040|FG000|Overall Study|Adverse Event|0|||
23148620|NCT01387230|64294041|FG001|Overall Study|Adverse Event|1|||
23148621|NCT01387230|64294042|FG002|Overall Study|Adverse Event|3|||
23148622|NCT01387230|64294040|FG000|Overall Study|Lack of Efficacy|8|||
23148623|NCT01387230|64294041|FG001|Overall Study|Lack of Efficacy|5|||
23148624|NCT01387230|64294042|FG002|Overall Study|Lack of Efficacy|4|||
23148625|NCT01387230|64294040|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
23148626|NCT01387230|64294041|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
23148627|NCT01387230|64294042|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
23148628|NCT01387230|64294040|FG000|Overall Study|Lost to Follow-up|0|||
23148629|NCT01387230|64294041|FG001|Overall Study|Lost to Follow-up|0|||
23148630|NCT01387230|64294042|FG002|Overall Study|Lost to Follow-up|1|||
23148631|NCT01387230|64294040|FG000|Overall Study|Withdrawal by Subject|4|||
23148632|NCT01387230|64294041|FG001|Overall Study|Withdrawal by Subject|1|||
23148633|NCT01387230|64294042|FG002|Overall Study|Withdrawal by Subject|0|||
23148634|NCT04014361|64294045|FG000|Period 2|Physician Decision|0|||
23148635|NCT04014361|64294046|FG001|Period 2|Physician Decision|0|||
23219068|NCT03077243|64544744|FG002|Overall Study|Withdrawal by Subject|0|||
23219069|NCT03077243|64544745|FG003|Overall Study|Withdrawal by Subject|0|||
23219070|NCT03077243|64544742|FG000|Overall Study|Physician Decision|1|||
23219071|NCT03077243|64544743|FG001|Overall Study|Physician Decision|0|||
23219072|NCT03077243|64544744|FG002|Overall Study|Physician Decision|0|||
23219073|NCT03077243|64544745|FG003|Overall Study|Physician Decision|0|||
23219074|NCT03077243|64544742|FG000|Overall Study|Research at two study sites terminated early|0|||
23219075|NCT03077243|64544743|FG001|Overall Study|Research at two study sites terminated early|0|||
23219076|NCT03077243|64544744|FG002|Overall Study|Research at two study sites terminated early|0|||
23219077|NCT03077243|64544745|FG003|Overall Study|Research at two study sites terminated early|69|||
23219078|NCT00441480|64544746|FG000|Overall Study|Protocol Violation|1|||
23219079|NCT00441480|64544747|FG001|Overall Study|Protocol Violation|1|||
23219080|NCT00441480|64544746|FG000|Overall Study|Withdrawal by Subject|2|||
23219081|NCT00441480|64544747|FG001|Overall Study|Withdrawal by Subject|3|||
23219082|NCT02925312|64544751|FG000|Overall Study|Lost to Follow-up|25|||
23219083|NCT02925312|64544752|FG001|Overall Study|Lost to Follow-up|0|||
23219084|NCT02925312|64544751|FG000|Overall Study|Adverse Event|2|||
23219085|NCT02925312|64544752|FG001|Overall Study|Adverse Event|0|||
23219086|NCT01119963|64544755|FG000|Overall Study|Lost to Follow-up|1|||
23148636|NCT04014361|64294047|FG002|Period 2|Physician Decision|0|||
23148637|NCT04014361|64294048|FG003|Period 2|Physician Decision|1|||
23148638|NCT04014361|64294049|FG004|Period 2|Physician Decision|0|||
23219087|NCT01119963|64544756|FG001|Overall Study|Lost to Follow-up|1|||
23559038|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
23559039|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
23559040|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
23559041|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
23148639|NCT04014361|64294050|FG005|Period 2|Physician Decision|0|||
23148640|NCT04014361|64294051|FG006|Period 2|Physician Decision|0|||
23148641|NCT04014361|64294052|FG007|Period 2|Physician Decision|0|||
23148642|NCT02594163|64294053|FG000|Treatment Period|Progressive disease|2|||
23148643|NCT02594163|64294054|FG001|Treatment Period|Progressive disease|3|||
23148644|NCT02594163|64294053|FG000|Treatment Period|Adverse Event|1|||
23148645|NCT02594163|64294054|FG001|Treatment Period|Adverse Event|5|||
23148646|NCT02594163|64294053|FG000|Treatment Period|Physician Decision|1|||
23148647|NCT02594163|64294054|FG001|Treatment Period|Physician Decision|3|||
23559042|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
23323114|NCT02899962|64926680|FG002|Maintenance Phase|Withdrawal by Subject|36|||
23323115|NCT00517881|64926681|FG000|Overall Study|Protocol Violation|2|||
23323116|NCT00517881|64926681|FG000|Overall Study|Adverse Event|1|||
23323117|NCT00517881|64926681|FG000|Overall Study|Renal transplantation|2|||
23323118|NCT02601014|64926682|FG000|Overall Study|Adverse Event|3|||
23323119|NCT02601014|64926683|FG001|Overall Study|Adverse Event|3|||
23323120|NCT02601014|64926682|FG000|Overall Study|Death|3|||
23323121|NCT02601014|64926683|FG001|Overall Study|Death|1|||
23323122|NCT02601014|64926682|FG000|Overall Study|Disease progression|4|||
23323123|NCT02601014|64926683|FG001|Overall Study|Disease progression|8|||
23323124|NCT00682786|64926684|FG000|Overall Study|Withdrawal by Subject|2|||
23323125|NCT00682786|64926685|FG001|Overall Study|Withdrawal by Subject|2|||
23323126|NCT00682786|64926684|FG000|Overall Study|Did not receive irinotecan|0|||
23323127|NCT00682786|64926685|FG001|Overall Study|Did not receive irinotecan|1|||
23323128|NCT02792517|64926686|FG000|Overall Study|Withdrawal by Subject|10|||
23323129|NCT02792517|64926686|FG000|Overall Study|Decision by Sponsor|7|||
23323130|NCT02792517|64926686|FG000|Overall Study|Lost to Follow-up|3|||
23323131|NCT02040805|64926687|FG000|Overall Study|Lost to Follow-up|14|||
23323132|NCT02040805|64926688|FG001|Overall Study|Lost to Follow-up|9|||
23323133|NCT02040805|64926687|FG000|Overall Study|Withdrawal by Subject|28|||
23323134|NCT02040805|64926688|FG001|Overall Study|Withdrawal by Subject|41|||
23323135|NCT01396512|64926689|FG000|Overall Study|Withdrawal by Subject|0|||
23323136|NCT01396512|64926690|FG001|Overall Study|Withdrawal by Subject|1|||
23323137|NCT02847260|64926691|FG000|Overall Study|Adverse Event|3|||
23323138|NCT02847260|64926691|FG000|Overall Study|Withdrawal by Subject|2|||
23323139|NCT02847260|64926691|FG000|Overall Study|Clinical Deterioration|1|||
23323140|NCT02847260|64926691|FG000|Overall Study|Physician Decision|1|||
23323141|NCT00470535|64926693|FG000|Overall Study|Disease Progression|13|||
23323142|NCT00470535|64926693|FG000|Overall Study|Withdrawal by Subject|1|||
23323143|NCT00470535|64926693|FG000|Overall Study|Adverse Event|1|||
23323144|NCT00470535|64926693|FG000|Overall Study|Death|1|||
23323145|NCT00470535|64926693|FG000|Overall Study|Other|2|||
23323146|NCT02906670|64926694|FG000|Cohort 1, QW|Radiological Progression|1|||
23323147|NCT02906670|64926695|FG001|Cohort 1, QW|Radiological Progression|0|||
23323148|NCT02906670|64926696|FG002|Cohort 1, QW|Radiological Progression|0|||
23323149|NCT02906670|64926697|FG003|Cohort 1, QW|Radiological Progression|0|||
23323150|NCT02906670|64926698|FG004|Cohort 1, QW|Radiological Progression|0|||
23323151|NCT02906670|64926699|FG005|Cohort 1, QW|Radiological Progression|0|||
23323152|NCT02906670|64926700|FG006|Cohort 1, QW|Radiological Progression|0|||
23323153|NCT02906670|64926701|FG007|Cohort 1, QW|Radiological Progression|0|||
23323154|NCT02906670|64926702|FG008|Cohort 1, QW|Radiological Progression|0|||
23148648|NCT02594163|64294053|FG000|Treatment Period|Study termination by sponsor|2|||
23148649|NCT02594163|64294054|FG001|Treatment Period|Study termination by sponsor|1|||
23148650|NCT02594163|64294053|FG000|Treatment Period|Other, Non-AE|1|||
23148651|NCT02594163|64294054|FG001|Treatment Period|Other, Non-AE|0|||
23148652|NCT02594163|64294053|FG000|Follow-up Period|Withdrawal by Subject|0|||
23148653|NCT02594163|64294054|FG001|Follow-up Period|Withdrawal by Subject|1|||
23148654|NCT02594163|64294053|FG000|Follow-up Period|Study Termination by Sponsor|6|||
23148655|NCT02594163|64294054|FG001|Follow-up Period|Study Termination by Sponsor|4|||
23148656|NCT02594163|64294053|FG000|Follow-up Period|Lost to Follow-up|1|||
23219088|NCT03382262|64544758|FG000|Overall Study|Physician Decision|0|||
23323155|NCT02906670|64926703|FG009|Cohort 1, QW|Radiological Progression|0|||
23148657|NCT02594163|64294054|FG001|Follow-up Period|Lost to Follow-up|0|||
23148658|NCT02594163|64294053|FG000|Follow-up Period|Death|2|||
23219089|NCT03382262|64544759|FG001|Overall Study|Physician Decision|0|||
23219090|NCT03382262|64544760|FG002|Overall Study|Physician Decision|1|||
23219091|NCT03382262|64544761|FG003|Overall Study|Physician Decision|0|||
23219092|NCT03382262|64544758|FG000|Overall Study|Withdrawal by Subject|0|||
23219093|NCT03382262|64544759|FG001|Overall Study|Withdrawal by Subject|0|||
23219094|NCT03382262|64544760|FG002|Overall Study|Withdrawal by Subject|0|||
23219095|NCT03382262|64544761|FG003|Overall Study|Withdrawal by Subject|1|||
23323156|NCT02906670|64926694|FG000|Cohort 2, QW|Radiological Progression|0|||
23323157|NCT02906670|64926695|FG001|Cohort 2, QW|Radiological Progression|1|||
23323158|NCT02906670|64926696|FG002|Cohort 2, QW|Radiological Progression|0|||
23323159|NCT02906670|64926697|FG003|Cohort 2, QW|Radiological Progression|0|||
23323160|NCT02906670|64926698|FG004|Cohort 2, QW|Radiological Progression|0|||
23323161|NCT02906670|64926699|FG005|Cohort 2, QW|Radiological Progression|0|||
23323162|NCT02906670|64926700|FG006|Cohort 2, QW|Radiological Progression|0|||
23323163|NCT02906670|64926701|FG007|Cohort 2, QW|Radiological Progression|0|||
23323164|NCT02906670|64926702|FG008|Cohort 2, QW|Radiological Progression|0|||
23148659|NCT02594163|64294054|FG001|Follow-up Period|Death|5|||
23148660|NCT02594163|64294053|FG000|Follow-up Period|Adverse Event|0|||
23148661|NCT02594163|64294054|FG001|Follow-up Period|Adverse Event|1|||
23148662|NCT02594163|64294053|FG000|Follow-up Period|Progressive Disease|2|||
23219096|NCT01263444|64544762|FG000|Overall Study|Adverse Event|8|||
23219097|NCT01263444|64544762|FG000|Overall Study|Withdrawal by Subject|1|||
23323165|NCT02906670|64926703|FG009|Cohort 2, QW|Radiological Progression|0|||
23624203|NCT00195442|66011558|FG000|Overall Study|Death|7|||
23148663|NCT02594163|64294054|FG001|Follow-up Period|Progressive Disease|0|||
23148664|NCT02594163|64294053|FG000|Follow-up Period|Physician Decision|0|||
23148665|NCT02594163|64294054|FG001|Follow-up Period|Physician Decision|1|||
23148666|NCT02244996|64294057|FG000|Overall Study|Lack of Efficacy|2|||
23148667|NCT02244996|64294058|FG001|Overall Study|Lack of Efficacy|6|||
23148668|NCT04209621|64294059|FG000|Overall Study|Death|1|||
23148669|NCT04209621|64294059|FG000|Overall Study|Study Terminated Early|2|||
23148670|NCT00822172|64294060|FG000|Overall Study|Adverse Event|10|||
23148671|NCT00822172|64294061|FG001|Overall Study|Adverse Event|12|||
23148672|NCT00822172|64294060|FG000|Overall Study|Death|1|||
23148673|NCT00822172|64294061|FG001|Overall Study|Death|0|||
23148674|NCT00822172|64294060|FG000|Overall Study|Lost to Follow-up|3|||
23148675|NCT00822172|64294061|FG001|Overall Study|Lost to Follow-up|1|||
23148676|NCT00822172|64294060|FG000|Overall Study|Withdrawal by Subject|1|||
23148677|NCT00822172|64294061|FG001|Overall Study|Withdrawal by Subject|4|||
23148678|NCT00822172|64294060|FG000|Overall Study|site closed|0|||
23148679|NCT00822172|64294061|FG001|Overall Study|site closed|1|||
23148680|NCT00822172|64294060|FG000|Overall Study|Other|0|||
23148681|NCT00822172|64294061|FG001|Overall Study|Other|1|||
23148682|NCT01372410|64294062|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
23219098|NCT01263444|64544762|FG000|Overall Study|Protocol Violation|1|||
23219099|NCT00423592|64544763|FG000|Overall Study|Adverse Event (through Week 12)|2|||
23219100|NCT00423592|64544763|FG000|Overall Study|Adverse Event (post Week 12)|5|||
23219101|NCT00383708|64544764|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
23219102|NCT00383708|64544764|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
23219103|NCT00383708|64544764|FG000|Run-in Period|Protocol Violation|4|||
23219104|NCT00383708|64544764|FG000|Run-in Period|Adverse Event|2|||
23219105|NCT00383708|64544764|FG000|Run-in Period|Claustrophobia|1|||
23219106|NCT00383708|64544764|FG000|Co-administration Period|Adverse Event|5|||
23219107|NCT01001572|64544768|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
23219108|NCT01001572|64544769|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
23219109|NCT01001572|64544770|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
23219110|NCT01001572|64544768|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
23219111|NCT01001572|64544769|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
23219112|NCT01001572|64544770|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
23219113|NCT01001572|64544768|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
23219114|NCT01001572|64544769|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
23219115|NCT01001572|64544770|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
23219116|NCT01001572|64544768|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
23219117|NCT01001572|64544769|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
23219118|NCT01001572|64544770|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
23219119|NCT01001572|64544768|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
23219120|NCT01001572|64544769|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
23219121|NCT01001572|64544770|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
23219122|NCT01001572|64544768|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
23219123|NCT01001572|64544769|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
23219124|NCT01001572|64544770|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
23219125|NCT01001572|64544768|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
23219126|NCT01001572|64544769|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
23219127|NCT01001572|64544770|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
23219128|NCT01001572|64544768|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
23219129|NCT01001572|64544769|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
23219130|NCT01001572|64544770|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
23219131|NCT01001572|64544768|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23219132|NCT01001572|64544769|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
23219133|NCT01001572|64544770|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
23219134|NCT01001572|64544768|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23219135|NCT01001572|64544769|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
23624204|NCT00195442|66011558|FG000|Overall Study|No reason specified|4|||
23148683|NCT01372410|64294063|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
23148684|NCT01372410|64294064|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23148685|NCT01372410|64294065|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23148686|NCT01372410|64294066|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
23219136|NCT01001572|64544770|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
23219137|NCT01001572|64544768|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
23219138|NCT01001572|64544769|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
23148687|NCT01372410|64294067|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23148688|NCT01372410|64294068|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23148689|NCT01372410|64294069|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
23148690|NCT01372410|64294062|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
23148691|NCT01372410|64294063|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
23148692|NCT01372410|64294064|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
23148693|NCT01372410|64294065|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
23148694|NCT01372410|64294066|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
23148695|NCT01372410|64294067|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
23148696|NCT01372410|64294068|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
23148697|NCT01372410|64294069|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
23148698|NCT01372410|64294062|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23148699|NCT01372410|64294063|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23148700|NCT01372410|64294064|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23148701|NCT01372410|64294065|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23148702|NCT01372410|64294066|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
23148703|NCT01372410|64294067|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23148704|NCT01372410|64294068|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23148705|NCT01372410|64294069|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
23559043|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
23559044|NCT00261495|65776154|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
23148706|NCT01372410|64294062|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23148707|NCT01372410|64294063|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23148708|NCT01372410|64294064|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23148709|NCT01372410|64294065|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23148710|NCT01372410|64294066|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23148711|NCT01372410|64294067|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23148712|NCT01372410|64294068|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
23148713|NCT01372410|64294069|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
23148714|NCT01372410|64294062|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
23148715|NCT01372410|64294063|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23148716|NCT01372410|64294064|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23148717|NCT01372410|64294065|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23148718|NCT01372410|64294066|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23148719|NCT01372410|64294067|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23148720|NCT01372410|64294068|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
23148721|NCT01372410|64294069|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
23148722|NCT01372410|64294062|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23148723|NCT01372410|64294063|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23148724|NCT01372410|64294064|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23148725|NCT01372410|64294065|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23148726|NCT01372410|64294066|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
23148727|NCT01372410|64294067|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23148728|NCT01372410|64294068|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23148729|NCT01372410|64294069|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
23148730|NCT01372410|64294062|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23148731|NCT01372410|64294063|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23148732|NCT01372410|64294064|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23148733|NCT01372410|64294065|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23148734|NCT01372410|64294066|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
23148735|NCT01372410|64294067|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
23148736|NCT01372410|64294068|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
23148737|NCT01372410|64294069|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
23148738|NCT01372410|64294062|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23148739|NCT01372410|64294063|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23148740|NCT01372410|64294064|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23148741|NCT01372410|64294065|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23148742|NCT01372410|64294066|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23148743|NCT01372410|64294067|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23559045|NCT00261495|65776155|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
23559046|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
23559047|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
23559048|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
23559049|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
23559050|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
23559051|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
23559052|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
23624205|NCT00195442|66011558|FG000|Overall Study|Poor cooperation|2|||
23148744|NCT01372410|64294068|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
23148745|NCT01372410|64294069|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
23148746|NCT01372410|64294062|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
23148747|NCT01372410|64294063|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
23148748|NCT01372410|64294064|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
23148749|NCT01372410|64294065|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
23559053|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
23559054|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
23559055|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
23559056|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
23559057|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
23559058|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
23559059|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
23559060|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
23559061|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
23559062|NCT00261495|65776154|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
23559063|NCT00261495|65776155|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
23559064|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
23559065|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
23559066|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
23148750|NCT01372410|64294066|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
23148751|NCT01372410|64294067|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
23148752|NCT01372410|64294068|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
23148753|NCT01372410|64294069|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
23148754|NCT01372410|64294062|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23148755|NCT01372410|64294063|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23148756|NCT01372410|64294064|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23148757|NCT01372410|64294065|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23148758|NCT01372410|64294066|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23148759|NCT01372410|64294067|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
23148760|NCT01372410|64294068|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23148761|NCT01372410|64294069|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
23148762|NCT00719563|64297397|FG000|Overall Study|Adverse Event|16|||
23148763|NCT00719563|64297398|FG001|Overall Study|Adverse Event|13|||
23148764|NCT00719563|64297397|FG000|Overall Study|Medical condition changed|3|||
23148765|NCT00719563|64297398|FG001|Overall Study|Medical condition changed|5|||
23148766|NCT00719563|64297397|FG000|Overall Study|Lack of Efficacy|3|||
23148767|NCT00719563|64297398|FG001|Overall Study|Lack of Efficacy|7|||
23148768|NCT00719563|64297397|FG000|Overall Study|Personal reasons|6|||
23148769|NCT00719563|64297398|FG001|Overall Study|Personal reasons|7|||
23148770|NCT00719563|64297397|FG000|Overall Study|Unknown reasons|4|||
23148771|NCT00719563|64297398|FG001|Overall Study|Unknown reasons|6|||
23148772|NCT00719563|64297397|FG000|Overall Study|Noncompliant|1|||
23148773|NCT00719563|64297398|FG001|Overall Study|Noncompliant|1|||
23148774|NCT00719563|64297397|FG000|Overall Study|Lost to Follow-up|5|||
23148775|NCT00719563|64297398|FG001|Overall Study|Lost to Follow-up|3|||
23148776|NCT00523718|64297399|FG000|Overall Study|Withdrawal by Subject|1|||
23148777|NCT00523718|64297400|FG001|Overall Study|Withdrawal by Subject|0|||
23148778|NCT00523718|64297399|FG000|Overall Study|Protocol Violation|2|||
23148779|NCT00523718|64297400|FG001|Overall Study|Protocol Violation|0|||
23148780|NCT00887250|64297402|FG000|Overall Study|Adverse Event|3|||
23148781|NCT00887250|64297403|FG001|Overall Study|Adverse Event|0|||
23148782|NCT00887250|64297404|FG002|Overall Study|Adverse Event|7|||
23148783|NCT00887250|64297402|FG000|Overall Study|Lack of Efficacy|9|||
23148784|NCT00887250|64297403|FG001|Overall Study|Lack of Efficacy|6|||
23148785|NCT00887250|64297404|FG002|Overall Study|Lack of Efficacy|1|||
23148786|NCT00887250|64297402|FG000|Overall Study|Lost to Follow-up|2|||
23148787|NCT00887250|64297403|FG001|Overall Study|Lost to Follow-up|3|||
23148788|NCT00887250|64297404|FG002|Overall Study|Lost to Follow-up|1|||
23148789|NCT00887250|64297402|FG000|Overall Study|Protocol Violation|2|||
23148790|NCT00887250|64297403|FG001|Overall Study|Protocol Violation|2|||
23148791|NCT00887250|64297404|FG002|Overall Study|Protocol Violation|1|||
23148792|NCT00887250|64297402|FG000|Overall Study|Withdrawal by Subject|2|||
23148793|NCT00887250|64297403|FG001|Overall Study|Withdrawal by Subject|1|||
23148794|NCT00887250|64297404|FG002|Overall Study|Withdrawal by Subject|2|||
23323166|NCT02906670|64926694|FG000|Cohort 3, QW|Radiological Progression|0|||
23559067|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23559068|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
23148795|NCT00887250|64297402|FG000|Overall Study|Patient uncooperative|0|||
23148796|NCT00887250|64297403|FG001|Overall Study|Patient uncooperative|0|||
23148797|NCT00887250|64297404|FG002|Overall Study|Patient uncooperative|1|||
23148798|NCT01572922|64297405|FG000|Overall Study|Adverse Event|1|||
23148799|NCT01572922|64297405|FG000|Overall Study|Protocol Violation|1|||
23148800|NCT01572922|64297405|FG000|Overall Study|Death|1|||
23148801|NCT00117845|64297407|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
23148802|NCT03431857|64297408|FG000|Overall Study|Death|6|||
23559069|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
23148803|NCT03431857|64297408|FG000|Overall Study|Lost to Follow-up|41|||
23148804|NCT03431857|64297408|FG000|Overall Study|Adverse Event|6|||
23148805|NCT03431857|64297408|FG000|Overall Study|Withdrawal by Subject|1|||
23148806|NCT02941926|64297410|FG000|Core Phase|Progressive disease|1109|||
23148807|NCT02941926|64297410|FG000|Core Phase|Adverse Event|504|||
23148808|NCT02941926|64297410|FG000|Core Phase|Subject/guardian decision|127|||
23148809|NCT02941926|64297410|FG000|Core Phase|Physician Decision|112|||
23148810|NCT02941926|64297410|FG000|Core Phase|Death|46|||
23148811|NCT02941926|64297410|FG000|Core Phase|Protocol deviation|34|||
23148812|NCT02941926|64297410|FG000|Core Phase|Lost to Follow-up|8|||
23148813|NCT02941926|64297410|FG000|Core Phase|Technical problems|5|||
23148814|NCT02941926|64297410|FG000|Extension Phase|Physician Decision|155|||
23148815|NCT02941926|64297410|FG000|Extension Phase|Progressive disease|115|||
23148816|NCT02941926|64297410|FG000|Extension Phase|Adverse Event|13|||
23148817|NCT02941926|64297410|FG000|Extension Phase|Subject/Guardian decision|12|||
23148818|NCT02941926|64297410|FG000|Extension Phase|Death|6|||
23148819|NCT02141984|64297411|FG000|Overall Study|Lack of Efficacy|2|||
23148820|NCT00307125|64297414|FG000|Screening Phase|Adverse Event|1|||
23148821|NCT00307125|64297415|FG001|Screening Phase|Adverse Event|0|||
23148822|NCT00307125|64297416|FG002|Screening Phase|Adverse Event|0|||
23148823|NCT00307125|64297414|FG000|Screening Phase|Protocol Violation|27|||
23148824|NCT00307125|64297415|FG001|Screening Phase|Protocol Violation|0|||
23148825|NCT00307125|64297416|FG002|Screening Phase|Protocol Violation|0|||
23148826|NCT00307125|64297414|FG000|Screening Phase|Lost to Follow-up|87|||
23148827|NCT00307125|64297415|FG001|Screening Phase|Lost to Follow-up|0|||
23437628|NCT02409342|65344164|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
23437629|NCT02409342|65344165|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
23437630|NCT02409342|65344164|FG000|Overall Study|Sponsor Decision|1|||
23437631|NCT02409342|65344165|FG001|Overall Study|Sponsor Decision|0|||
23437632|NCT04667104|65344166|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
23437633|NCT04667104|65344167|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
23437634|NCT04667104|65344168|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
23437635|NCT01192568|65344174|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
23437636|NCT01192568|65344175|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
23437637|NCT01192568|65344176|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
23437638|NCT01192568|65344177|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
23437639|NCT01192568|65344174|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
23437640|NCT01192568|65344175|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
23437641|NCT01192568|65344176|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
23437642|NCT01192568|65344177|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
23437643|NCT01114438|65344178|FG000|Overall Study|Adverse Event|10|||
23437644|NCT01114438|65344178|FG000|Overall Study|concomitant medication|1|||
23437645|NCT01114438|65344178|FG000|Overall Study|Physician Decision|1|||
23437646|NCT01114438|65344178|FG000|Overall Study|Withdrawal by Subject|2|||
23437647|NCT01209078|65344179|FG000|Overall Study|Adverse Event|5|||
23437648|NCT01209078|65344180|FG001|Overall Study|Adverse Event|0|||
23437649|NCT01209078|65344179|FG000|Overall Study|Lost to Follow-up|4|||
23437650|NCT01209078|65344180|FG001|Overall Study|Lost to Follow-up|0|||
23437651|NCT01209078|65344179|FG000|Overall Study|Physician Decision|5|||
23559070|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23559071|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
23559072|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
23559073|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
23559074|NCT00261495|65776154|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
23559075|NCT00261495|65776155|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23559076|NCT00674570|65776161|FG000|Overall Study|Withdrawal by Subject|0|||
23148828|NCT00307125|64297416|FG002|Screening Phase|Lost to Follow-up|0|||
23437652|NCT01209078|65344180|FG001|Overall Study|Physician Decision|2|||
23437653|NCT01209078|65344179|FG000|Overall Study|Withdrawal by Subject|2|||
23559077|NCT00674570|65776162|FG001|Overall Study|Withdrawal by Subject|2|||
23148829|NCT00307125|64297414|FG000|Screening Phase|Death|10|||
23148830|NCT00307125|64297415|FG001|Screening Phase|Death|0|||
23148831|NCT00307125|64297416|FG002|Screening Phase|Death|0|||
23148832|NCT00307125|64297414|FG000|Screening Phase|Withdrawal by Subject|77|||
23148833|NCT00307125|64297415|FG001|Screening Phase|Withdrawal by Subject|0|||
23148834|NCT00307125|64297416|FG002|Screening Phase|Withdrawal by Subject|0|||
23148835|NCT00307125|64297414|FG000|Screening Phase|Physician Decision|26|||
23148836|NCT00307125|64297415|FG001|Screening Phase|Physician Decision|0|||
23559078|NCT00674570|65776163|FG002|Overall Study|Withdrawal by Subject|0|||
23559079|NCT01424930|65776164|FG000|Overall Study|Adverse Event|0|||
23559080|NCT01424930|65776165|FG001|Overall Study|Adverse Event|1|||
23559081|NCT01424930|65776164|FG000|Overall Study|Death|1|||
23559082|NCT01424930|65776165|FG001|Overall Study|Death|0|||
23559083|NCT01424930|65776164|FG000|Overall Study|Progressive Disease|3|||
23559084|NCT01424930|65776165|FG001|Overall Study|Progressive Disease|6|||
23559085|NCT01424930|65776164|FG000|Overall Study|Screen Failure|0|||
23559086|NCT01424930|65776165|FG001|Overall Study|Screen Failure|1|||
23559087|NCT01424930|65776164|FG000|Overall Study|Reason not specified|0|||
23559088|NCT01424930|65776165|FG001|Overall Study|Reason not specified|6|||
23559089|NCT00464815|65776166|FG000|Overall Study|Withdrawal by Subject|6|||
23559090|NCT00464815|65776167|FG001|Overall Study|Withdrawal by Subject|3|||
23559091|NCT03172702|65776170|FG000|Overall Study|Adverse Event|9|||
23559092|NCT03172702|65776170|FG000|Overall Study|Death|2|||
23559093|NCT03172702|65776170|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
23559094|NCT03172702|65776170|FG000|Overall Study|Withdrawal by Subject|5|||
23559095|NCT03172702|65776170|FG000|Overall Study|Other|2|||
23559096|NCT00420199|65776171|FG000|Overall Study|Participant no longer met study criteria|1|||
23559097|NCT00420199|65776172|FG001|Overall Study|Participant no longer met study criteria|0|||
23559098|NCT02436811|65776173|FG000|Overall Study|Lost to Follow-up|2|||
23559099|NCT02436811|65776174|FG001|Overall Study|Lost to Follow-up|9|||
23559100|NCT02436811|65776175|FG002|Overall Study|Lost to Follow-up|7|||
23559101|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
23559102|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
23559103|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
23559104|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
23559105|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
23559106|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
23559107|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
23624206|NCT00195442|66011558|FG000|Overall Study|Other|14|||
23624207|NCT00975676|66011559|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
23624208|NCT00975676|66011560|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
23624209|NCT01185171|66011566|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
23624210|NCT01185171|66011566|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
23624211|NCT01185171|66011566|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
23624212|NCT01185171|66011566|FG000|Maintenance|Elevated liver transaminases|3|||
23148837|NCT00307125|64297416|FG002|Screening Phase|Physician Decision|0|||
23148838|NCT00307125|64297414|FG000|Screening Phase|Sponsor Decision|4|||
23148839|NCT00307125|64297415|FG001|Screening Phase|Sponsor Decision|0|||
23148840|NCT00307125|64297416|FG002|Screening Phase|Sponsor Decision|0|||
23148841|NCT00307125|64297414|FG000|Screening Phase|Study Terminated|17|||
23148842|NCT00307125|64297415|FG001|Screening Phase|Study Terminated|0|||
23148843|NCT00307125|64297416|FG002|Screening Phase|Study Terminated|0|||
23148844|NCT00307125|64297414|FG000|Screening Phase|Graft Loss|3|||
23148845|NCT00307125|64297415|FG001|Screening Phase|Graft Loss|0|||
23148846|NCT00307125|64297416|FG002|Screening Phase|Graft Loss|0|||
23148847|NCT00307125|64297414|FG000|Screening Phase|Graft Failure|8|||
23148848|NCT00307125|64297415|FG001|Screening Phase|Graft Failure|0|||
23148849|NCT00307125|64297416|FG002|Screening Phase|Graft Failure|0|||
23148850|NCT00307125|64297414|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
23148851|NCT00307125|64297415|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
23148852|NCT00307125|64297416|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
23148853|NCT00307125|64297414|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
23148854|NCT00307125|64297415|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
23148855|NCT00307125|64297416|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
23148856|NCT00307125|64297414|FG000|Screening Phase|Moved or transferred facilities|34|||
23148857|NCT00307125|64297415|FG001|Screening Phase|Moved or transferred facilities|0|||
23148858|NCT00307125|64297416|FG002|Screening Phase|Moved or transferred facilities|0|||
23148859|NCT00307125|64297414|FG000|Screening Phase|Received Pancreas Transplant|8|||
23148860|NCT00307125|64297415|FG001|Screening Phase|Received Pancreas Transplant|0|||
23148861|NCT00307125|64297416|FG002|Screening Phase|Received Pancreas Transplant|0|||
23148862|NCT00307125|64297414|FG000|Screening Phase|Ineligible for pilot|4|||
23148863|NCT00307125|64297415|FG001|Screening Phase|Ineligible for pilot|0|||
23148864|NCT00307125|64297416|FG002|Screening Phase|Ineligible for pilot|0|||
23148865|NCT00307125|64297414|FG000|Screening Phase|Try to get pregnant|1|||
23323167|NCT02906670|64926695|FG001|Cohort 3, QW|Radiological Progression|0|||
23559108|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
23559109|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
23559110|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
23559111|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
23559112|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
23559113|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
23559114|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
23559115|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
23559116|NCT02417064|65776176|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
23624213|NCT01185171|66011566|FG000|Maintenance|Rush|2|||
23624214|NCT01185171|66011566|FG000|Maintenance|Diarrhea|1|||
23148866|NCT00307125|64297415|FG001|Screening Phase|Try to get pregnant|0|||
23148867|NCT00307125|64297416|FG002|Screening Phase|Try to get pregnant|0|||
23148868|NCT00307125|64297414|FG000|Screening Phase|Developed acute leukemia|1|||
23148869|NCT00307125|64297415|FG001|Screening Phase|Developed acute leukemia|0|||
23148870|NCT00307125|64297416|FG002|Screening Phase|Developed acute leukemia|0|||
23148871|NCT00307125|64297414|FG000|Screening Phase|Metastatic colon cancer|1|||
23437654|NCT01209078|65344180|FG001|Overall Study|Withdrawal by Subject|1|||
23148872|NCT00307125|64297415|FG001|Screening Phase|Metastatic colon cancer|0|||
23148873|NCT00307125|64297416|FG002|Screening Phase|Metastatic colon cancer|0|||
23148874|NCT00307125|64297414|FG000|Screening Phase|Malignancy|1|||
23148875|NCT00307125|64297415|FG001|Screening Phase|Malignancy|0|||
23437655|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Death|113|||
23437656|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Death|189|||
23437657|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
23437658|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
23437659|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
23437660|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
23437661|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
23437662|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
23437663|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
23437664|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
23437665|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
23437666|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
23437667|NCT02677896|65344181|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
23437668|NCT02677896|65344182|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
23437669|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
23437670|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
23437671|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
23437672|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
23437673|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
23437674|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
23437675|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
23437676|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
23437677|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
23437678|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
23437679|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
23437680|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
23437681|NCT02677896|65344181|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
23437682|NCT02677896|65344182|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
23437683|NCT04230213|65344188|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
23437684|NCT04230213|65344189|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
23437685|NCT04230213|65344190|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
23437686|NCT04230213|65344188|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
23437687|NCT04230213|65344189|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
23559117|NCT02417064|65776177|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
23559118|NCT02417064|65776178|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
23559119|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
23559120|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
23148876|NCT00307125|64297416|FG002|Screening Phase|Malignancy|0|||
23148877|NCT00307125|64297414|FG000|Screening Phase|PAK|1|||
23559121|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
23559122|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
23559123|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
23559124|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
23559125|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
23559126|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
23559127|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
23559128|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
23559129|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
23559130|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
23559131|NCT02417064|65776176|FG000|Follow-up Phase (24 Weeks)|Other|2|||
23559132|NCT02417064|65776177|FG001|Follow-up Phase (24 Weeks)|Other|2|||
23148878|NCT00307125|64297415|FG001|Screening Phase|PAK|0|||
23148879|NCT00307125|64297416|FG002|Screening Phase|PAK|0|||
23148880|NCT00307125|64297414|FG000|Screening Phase|Ineligible|1|||
23148881|NCT00307125|64297415|FG001|Screening Phase|Ineligible|0|||
23148882|NCT00307125|64297416|FG002|Screening Phase|Ineligible|0|||
23148883|NCT00307125|64297414|FG000|Screening Phase|Screen Error|1|||
23148884|NCT00307125|64297415|FG001|Screening Phase|Screen Error|0|||
23148885|NCT00307125|64297416|FG002|Screening Phase|Screen Error|0|||
23148886|NCT00307125|64297414|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
23148887|NCT00307125|64297415|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
23148888|NCT00307125|64297416|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
23148889|NCT00307125|64297414|FG000|Screening Phase|AMR and treated with rituximab|1|||
23148890|NCT00307125|64297415|FG001|Screening Phase|AMR and treated with rituximab|0|||
23148891|NCT00307125|64297416|FG002|Screening Phase|AMR and treated with rituximab|0|||
23559133|NCT02417064|65776178|FG002|Follow-up Phase (24 Weeks)|Other|3|||
23559134|NCT03255824|65776185|FG000|Overall Study|Under-sedation|2|||
23559135|NCT03255824|65776186|FG001|Overall Study|Under-sedation|1|||
23559136|NCT01256567|65776191|FG000|Overall Study|Withdrawal by Subject|1|||
23559137|NCT03214367|65776193|FG000|Lead-in Period|Withdrawal by Subject|50|||
23559138|NCT03214367|65776194|FG001|Lead-in Period|Withdrawal by Subject|0|||
23148892|NCT00307125|64297414|FG000|Screening Phase|Coronary artery bypass|1|||
23148893|NCT00307125|64297415|FG001|Screening Phase|Coronary artery bypass|0|||
23219139|NCT01001572|64544770|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
23219140|NCT01001572|64544768|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
23219141|NCT01001572|64544769|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
23219142|NCT01001572|64544770|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
23219143|NCT01001572|64544768|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
23219144|NCT01001572|64544769|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
23219145|NCT01001572|64544770|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
23219146|NCT01001572|64544768|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23219147|NCT01001572|64544769|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23219148|NCT01001572|64544770|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23219149|NCT01843205|64544775|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
23219150|NCT01843205|64544776|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
23219151|NCT00953225|64544782|FG000|Overall Study|Withdrawal by Subject|2|||
23219152|NCT00953225|64544783|FG001|Overall Study|Withdrawal by Subject|0|||
23219153|NCT02266004|64544786|FG000|Overall Study|unrelated adverse event|1|||
23219154|NCT02266004|64544786|FG000|Overall Study|Physician Decision|1|||
23219155|NCT02920450|64544787|FG000|Overall Study|Death|1|||
23219156|NCT02920450|64544788|FG001|Overall Study|Death|0|||
23219157|NCT02920450|64544789|FG002|Overall Study|Death|0|||
23219158|NCT02920450|64544790|FG003|Overall Study|Death|0|||
23219159|NCT02920450|64544787|FG000|Overall Study|Withdrawal by Subject|1|||
23323168|NCT02906670|64926696|FG002|Cohort 3, QW|Radiological Progression|2|||
23323169|NCT02906670|64926697|FG003|Cohort 3, QW|Radiological Progression|0|||
23323170|NCT02906670|64926698|FG004|Cohort 3, QW|Radiological Progression|0|||
23148894|NCT00307125|64297416|FG002|Screening Phase|Coronary artery bypass|0|||
23148895|NCT00307125|64297414|FG000|Pilot Phase|Lost to Follow-up|0|||
23148896|NCT00307125|64297415|FG001|Pilot Phase|Lost to Follow-up|1|||
23148897|NCT00307125|64297416|FG002|Pilot Phase|Lost to Follow-up|0|||
23148898|NCT00307125|64297414|FG000|Pilot Phase|Withdrawal by Subject|0|||
23148899|NCT00307125|64297415|FG001|Pilot Phase|Withdrawal by Subject|1|||
23148900|NCT00307125|64297416|FG002|Pilot Phase|Withdrawal by Subject|1|||
23148901|NCT01118325|64297420|FG000|Overall Study|Adverse Event|1|||
23148902|NCT01118325|64297421|FG001|Overall Study|Adverse Event|0|||
23148903|NCT01118325|64297422|FG002|Overall Study|Adverse Event|1|||
23323171|NCT02906670|64926699|FG005|Cohort 3, QW|Radiological Progression|0|||
23323172|NCT02906670|64926700|FG006|Cohort 3, QW|Radiological Progression|0|||
23323173|NCT02906670|64926701|FG007|Cohort 3, QW|Radiological Progression|0|||
23323174|NCT02906670|64926702|FG008|Cohort 3, QW|Radiological Progression|0|||
23323175|NCT02906670|64926703|FG009|Cohort 3, QW|Radiological Progression|0|||
23323176|NCT02906670|64926694|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
23323177|NCT02906670|64926695|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
23323178|NCT02906670|64926696|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
23323179|NCT02906670|64926697|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
23323180|NCT02906670|64926698|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
23323181|NCT02906670|64926699|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
23323182|NCT02906670|64926700|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
23323183|NCT02906670|64926701|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
23323184|NCT02906670|64926702|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
23323185|NCT02906670|64926703|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
23323186|NCT02906670|64926694|FG000|Cohort 4, Q2W|Radiological Progression|0|||
23559139|NCT03214367|65776195|FG002|Lead-in Period|Withdrawal by Subject|0|||
23559140|NCT03214367|65776196|FG003|Lead-in Period|Withdrawal by Subject|0|||
23559141|NCT03214367|65776197|FG004|Lead-in Period|Withdrawal by Subject|2|||
23148904|NCT00462865|64297423|FG000|Overall Study|Adverse Event|1|||
23148905|NCT01436071|64297424|FG000|Overall Study|Adverse Event|1|||
23148906|NCT01436071|64297425|FG001|Overall Study|Adverse Event|0|||
23148907|NCT01436071|64297424|FG000|Overall Study|Lack of Efficacy|16|||
23219160|NCT02920450|64544788|FG001|Overall Study|Withdrawal by Subject|0|||
23219161|NCT02920450|64544789|FG002|Overall Study|Withdrawal by Subject|0|||
23219162|NCT02920450|64544790|FG003|Overall Study|Withdrawal by Subject|0|||
23219163|NCT00424346|64544794|FG000|Core Study|Adverse Event|5|||
23219164|NCT00424346|64544795|FG001|Core Study|Adverse Event|3|||
23219165|NCT00424346|64544796|FG002|Core Study|Adverse Event|1|||
23219166|NCT00424346|64544797|FG003|Core Study|Adverse Event|1|||
23323187|NCT02906670|64926695|FG001|Cohort 4, Q2W|Radiological Progression|0|||
23323188|NCT02906670|64926696|FG002|Cohort 4, Q2W|Radiological Progression|0|||
23323189|NCT02906670|64926697|FG003|Cohort 4, Q2W|Radiological Progression|0|||
23323190|NCT02906670|64926698|FG004|Cohort 4, Q2W|Radiological Progression|0|||
23323191|NCT02906670|64926699|FG005|Cohort 4, Q2W|Radiological Progression|1|||
23323192|NCT02906670|64926700|FG006|Cohort 4, Q2W|Radiological Progression|0|||
23323193|NCT02906670|64926701|FG007|Cohort 4, Q2W|Radiological Progression|0|||
23323194|NCT02906670|64926702|FG008|Cohort 4, Q2W|Radiological Progression|0|||
23323195|NCT02906670|64926703|FG009|Cohort 4, Q2W|Radiological Progression|0|||
23323196|NCT02906670|64926694|FG000|Cohort 4, Q2W|Clinical Progression|0|||
23323197|NCT02906670|64926695|FG001|Cohort 4, Q2W|Clinical Progression|0|||
23323198|NCT02906670|64926696|FG002|Cohort 4, Q2W|Clinical Progression|0|||
23323199|NCT02906670|64926697|FG003|Cohort 4, Q2W|Clinical Progression|0|||
23323200|NCT02906670|64926698|FG004|Cohort 4, Q2W|Clinical Progression|0|||
23323201|NCT02906670|64926699|FG005|Cohort 4, Q2W|Clinical Progression|2|||
23323202|NCT02906670|64926700|FG006|Cohort 4, Q2W|Clinical Progression|0|||
23323203|NCT02906670|64926701|FG007|Cohort 4, Q2W|Clinical Progression|0|||
23323204|NCT02906670|64926702|FG008|Cohort 4, Q2W|Clinical Progression|0|||
23323205|NCT02906670|64926703|FG009|Cohort 4, Q2W|Clinical Progression|0|||
23323206|NCT02906670|64926694|FG000|Cohort 5, Q2W|Radiological Progression|0|||
23323207|NCT02906670|64926695|FG001|Cohort 5, Q2W|Radiological Progression|0|||
23323208|NCT02906670|64926696|FG002|Cohort 5, Q2W|Radiological Progression|0|||
23323209|NCT02906670|64926697|FG003|Cohort 5, Q2W|Radiological Progression|0|||
23323210|NCT02906670|64926698|FG004|Cohort 5, Q2W|Radiological Progression|0|||
23323211|NCT02906670|64926699|FG005|Cohort 5, Q2W|Radiological Progression|0|||
23323212|NCT02906670|64926700|FG006|Cohort 5, Q2W|Radiological Progression|4|||
23323213|NCT02906670|64926701|FG007|Cohort 5, Q2W|Radiological Progression|0|||
23323214|NCT02906670|64926702|FG008|Cohort 5, Q2W|Radiological Progression|0|||
23323215|NCT02906670|64926703|FG009|Cohort 5, Q2W|Radiological Progression|0|||
23323216|NCT02906670|64926694|FG000|Cohort 5, Q2W|Clinical Progression|0|||
23323217|NCT02906670|64926695|FG001|Cohort 5, Q2W|Clinical Progression|0|||
23323218|NCT02906670|64926696|FG002|Cohort 5, Q2W|Clinical Progression|0|||
23323219|NCT02906670|64926697|FG003|Cohort 5, Q2W|Clinical Progression|0|||
23323220|NCT02906670|64926698|FG004|Cohort 5, Q2W|Clinical Progression|0|||
23323221|NCT02906670|64926699|FG005|Cohort 5, Q2W|Clinical Progression|0|||
23323222|NCT02906670|64926700|FG006|Cohort 5, Q2W|Clinical Progression|1|||
23323223|NCT02906670|64926701|FG007|Cohort 5, Q2W|Clinical Progression|0|||
23323224|NCT02906670|64926702|FG008|Cohort 5, Q2W|Clinical Progression|0|||
23323225|NCT02906670|64926703|FG009|Cohort 5, Q2W|Clinical Progression|0|||
23323226|NCT02906670|64926694|FG000|Cohort 5, Q2W|Adverse Event|0|||
23323227|NCT02906670|64926695|FG001|Cohort 5, Q2W|Adverse Event|0|||
23323228|NCT02906670|64926696|FG002|Cohort 5, Q2W|Adverse Event|0|||
23323229|NCT02906670|64926697|FG003|Cohort 5, Q2W|Adverse Event|0|||
23323230|NCT02906670|64926698|FG004|Cohort 5, Q2W|Adverse Event|0|||
23323231|NCT02906670|64926699|FG005|Cohort 5, Q2W|Adverse Event|0|||
23323232|NCT02906670|64926700|FG006|Cohort 5, Q2W|Adverse Event|1|||
23323233|NCT02906670|64926701|FG007|Cohort 5, Q2W|Adverse Event|0|||
23323234|NCT02906670|64926702|FG008|Cohort 5, Q2W|Adverse Event|0|||
23323235|NCT02906670|64926703|FG009|Cohort 5, Q2W|Adverse Event|0|||
23323236|NCT02906670|64926694|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23323237|NCT02906670|64926695|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23323238|NCT02906670|64926696|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23323239|NCT02906670|64926697|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23323240|NCT02906670|64926698|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23323241|NCT02906670|64926699|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23323242|NCT02906670|64926700|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
23323243|NCT02906670|64926701|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23323244|NCT02906670|64926702|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23323245|NCT02906670|64926703|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
23323246|NCT02906670|64926694|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
23323247|NCT02906670|64926695|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
23323248|NCT02906670|64926696|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
23323249|NCT02906670|64926697|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
23323250|NCT02906670|64926698|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
23323251|NCT02906670|64926699|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
23323252|NCT02906670|64926700|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
23323253|NCT02906670|64926701|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
23323254|NCT02906670|64926702|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
23323255|NCT02906670|64926703|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
23323256|NCT02906670|64926694|FG000|Cohort 5P, Q2W|Adverse Event|0|||
23323257|NCT02906670|64926695|FG001|Cohort 5P, Q2W|Adverse Event|0|||
23323258|NCT02906670|64926696|FG002|Cohort 5P, Q2W|Adverse Event|0|||
23323259|NCT02906670|64926697|FG003|Cohort 5P, Q2W|Adverse Event|0|||
23323260|NCT02906670|64926698|FG004|Cohort 5P, Q2W|Adverse Event|0|||
23148908|NCT01436071|64297425|FG001|Overall Study|Lack of Efficacy|7|||
23148909|NCT01436071|64297424|FG000|Overall Study|Protocol Violation|0|||
23323261|NCT02906670|64926699|FG005|Cohort 5P, Q2W|Adverse Event|0|||
23323262|NCT02906670|64926700|FG006|Cohort 5P, Q2W|Adverse Event|0|||
23323263|NCT02906670|64926701|FG007|Cohort 5P, Q2W|Adverse Event|1|||
23323264|NCT02906670|64926702|FG008|Cohort 5P, Q2W|Adverse Event|0|||
23323265|NCT02906670|64926703|FG009|Cohort 5P, Q2W|Adverse Event|0|||
23323266|NCT02906670|64926694|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
23323267|NCT02906670|64926695|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
23323268|NCT02906670|64926696|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
23148910|NCT01436071|64297425|FG001|Overall Study|Protocol Violation|1|||
23148911|NCT01436071|64297424|FG000|Overall Study|Lost to Follow-up|3|||
23148912|NCT01436071|64297425|FG001|Overall Study|Lost to Follow-up|1|||
23148913|NCT01436071|64297424|FG000|Overall Study|Physician Decision|1|||
23148914|NCT01436071|64297425|FG001|Overall Study|Physician Decision|0|||
23148915|NCT01436071|64297424|FG000|Overall Study|Withdrawal by Subject|2|||
23148916|NCT01436071|64297425|FG001|Overall Study|Withdrawal by Subject|2|||
23148917|NCT01436071|64297424|FG000|Overall Study|Did Not Receive Trial Medication|3|||
23148918|NCT01436071|64297425|FG001|Overall Study|Did Not Receive Trial Medication|3|||
23148919|NCT04464265|64297426|FG000|Overall Study|Physician Decision|2|||
23148920|NCT03873493|64297432|FG000|Overall Study|Withdrawal by Subject|1|||
23148921|NCT03873493|64297432|FG000|Overall Study|Death|9|||
23148922|NCT03873493|64297432|FG000|Overall Study|Lost to Follow-up|1|||
23148923|NCT03873493|64297432|FG000|Overall Study|Study Terminated by Sponsor|1|||
23323269|NCT02906670|64926697|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
23323270|NCT02906670|64926698|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
23323271|NCT02906670|64926699|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
23323272|NCT02906670|64926700|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
23323273|NCT02906670|64926701|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
23323274|NCT02906670|64926702|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
23323275|NCT02906670|64926703|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
23559142|NCT03214367|65776198|FG005|Lead-in Period|Withdrawal by Subject|0|||
23559143|NCT03214367|65776199|FG006|Lead-in Period|Withdrawal by Subject|0|||
23148924|NCT03873493|64297432|FG000|Overall Study|Other|2|||
23148925|NCT00999713|64297433|FG000|Overall Study|Physician Decision|2|||
23148926|NCT00999713|64297434|FG001|Overall Study|Physician Decision|0|||
23148927|NCT01774084|64297435|FG000|Overall Study|Personal reasons|1|||
23148928|NCT01774084|64297436|FG001|Overall Study|Personal reasons|0|||
23148929|NCT03872453|64297437|FG000|Overall Study|Adverse Event|1|||
23148930|NCT03872453|64297438|FG001|Overall Study|Adverse Event|1|||
23148931|NCT03872453|64297439|FG002|Overall Study|Adverse Event|0|||
23148932|NCT03872453|64297440|FG003|Overall Study|Adverse Event|0|||
23148933|NCT03872453|64297437|FG000|Overall Study|Lost to Follow-up|8|||
23148934|NCT03872453|64297438|FG001|Overall Study|Lost to Follow-up|7|||
23148935|NCT03872453|64297439|FG002|Overall Study|Lost to Follow-up|4|||
23148936|NCT03872453|64297440|FG003|Overall Study|Lost to Follow-up|4|||
23148937|NCT03872453|64297437|FG000|Overall Study|Never Treated Migraine|19|||
23148938|NCT03872453|64297438|FG001|Overall Study|Never Treated Migraine|17|||
23148939|NCT03872453|64297439|FG002|Overall Study|Never Treated Migraine|13|||
23148940|NCT03872453|64297440|FG003|Overall Study|Never Treated Migraine|12|||
23148941|NCT03872453|64297437|FG000|Overall Study|Pregnancy|1|||
23148942|NCT03872453|64297438|FG001|Overall Study|Pregnancy|0|||
23148943|NCT03872453|64297439|FG002|Overall Study|Pregnancy|0|||
23148944|NCT03872453|64297440|FG003|Overall Study|Pregnancy|0|||
23148945|NCT03872453|64297437|FG000|Overall Study|Protocol Deviation|2|||
23148946|NCT03872453|64297438|FG001|Overall Study|Protocol Deviation|0|||
23148947|NCT03872453|64297439|FG002|Overall Study|Protocol Deviation|0|||
23148948|NCT03872453|64297440|FG003|Overall Study|Protocol Deviation|2|||
23148949|NCT03872453|64297437|FG000|Overall Study|Withdrawal by Subject|0|||
23559144|NCT03214367|65776200|FG007|Lead-in Period|Withdrawal by Subject|0|||
23559145|NCT03214367|65776193|FG000|Lead-in Period|Adverse Event|3|||
23559146|NCT03214367|65776194|FG001|Lead-in Period|Adverse Event|0|||
23559147|NCT03214367|65776195|FG002|Lead-in Period|Adverse Event|0|||
23148950|NCT03872453|64297438|FG001|Overall Study|Withdrawal by Subject|1|||
23148951|NCT03872453|64297439|FG002|Overall Study|Withdrawal by Subject|2|||
23148952|NCT03872453|64297440|FG003|Overall Study|Withdrawal by Subject|0|||
23148953|NCT03872453|64297437|FG000|Overall Study|Other Than Specified|1|||
23559148|NCT03214367|65776196|FG003|Lead-in Period|Adverse Event|0|||
23559149|NCT03214367|65776197|FG004|Lead-in Period|Adverse Event|0|||
23148954|NCT03872453|64297438|FG001|Overall Study|Other Than Specified|0|||
23559150|NCT03214367|65776198|FG005|Lead-in Period|Adverse Event|0|||
23559151|NCT03214367|65776199|FG006|Lead-in Period|Adverse Event|0|||
23559152|NCT03214367|65776200|FG007|Lead-in Period|Adverse Event|0|||
23559153|NCT03214367|65776193|FG000|Lead-in Period|Lost to Follow-up|12|||
23148955|NCT03872453|64297439|FG002|Overall Study|Other Than Specified|0|||
23323276|NCT02906670|64926694|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
23148956|NCT03872453|64297440|FG003|Overall Study|Other Than Specified|0|||
23148957|NCT02168842|64297449|FG000|Overall Study|Withdrawal by Subject|5|||
23148958|NCT02168842|64297450|FG001|Overall Study|Withdrawal by Subject|3|||
23148959|NCT02168842|64297449|FG000|Overall Study|Lost to Follow-up|0|||
23148960|NCT02168842|64297450|FG001|Overall Study|Lost to Follow-up|2|||
23148961|NCT02168842|64297449|FG000|Overall Study|Death|2|||
23148962|NCT02168842|64297450|FG001|Overall Study|Death|1|||
23148963|NCT02168842|64297449|FG000|Overall Study|Physician Decision|1|||
23148964|NCT02168842|64297450|FG001|Overall Study|Physician Decision|2|||
23559154|NCT03214367|65776194|FG001|Lead-in Period|Lost to Follow-up|0|||
23148965|NCT01351623|64297453|FG000|Overall Study|Protocol Violation|2|||
23148966|NCT01351623|64297453|FG000|Overall Study|Adverse Event|4|||
23148967|NCT01351623|64297453|FG000|Overall Study|Withdrawal by Subject|1|||
23148968|NCT01351623|64297453|FG000|Overall Study|Death|2|||
23148969|NCT00567268|64297454|FG000|Overall Study|Protocol Violation|7|||
23148970|NCT00567268|64297454|FG000|Overall Study|Lost to Follow-up|36|||
23148971|NCT00567268|64297454|FG000|Overall Study|No Visit After First Day of Treatment|2|||
23148972|NCT00567268|64297454|FG000|Overall Study|No Drug Administration|4|||
23148973|NCT00567268|64297454|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
23148974|NCT02374021|64297456|FG000|Overall Study|Adverse Event|1|||
23148975|NCT02374021|64297457|FG001|Overall Study|Adverse Event|0|||
23148976|NCT02374021|64297456|FG000|Overall Study|Lost to Follow-up|3|||
23219167|NCT00424346|64544794|FG000|Core Study|Abnormal Laboratory Values|0|||
23219168|NCT00424346|64544795|FG001|Core Study|Abnormal Laboratory Values|1|||
23219169|NCT00424346|64544796|FG002|Core Study|Abnormal Laboratory Values|0|||
23219170|NCT00424346|64544797|FG003|Core Study|Abnormal Laboratory Values|0|||
23437688|NCT04230213|65344190|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
23559155|NCT03214367|65776195|FG002|Lead-in Period|Lost to Follow-up|0|||
23559156|NCT03214367|65776196|FG003|Lead-in Period|Lost to Follow-up|0|||
23437689|NCT04230213|65344188|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
23437690|NCT04230213|65344189|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
23437691|NCT04230213|65344190|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
23437692|NCT04230213|65344188|FG000|TP2: Week 10 to Week 16|Other|0|||
23148977|NCT02374021|64297457|FG001|Overall Study|Lost to Follow-up|2|||
23148978|NCT02374021|64297456|FG000|Overall Study|Physician Decision|0|||
23148979|NCT02374021|64297457|FG001|Overall Study|Physician Decision|3|||
23148980|NCT02374021|64297456|FG000|Overall Study|Withdrawal by Subject|6|||
23148981|NCT02374021|64297457|FG001|Overall Study|Withdrawal by Subject|5|||
23148982|NCT02374021|64297456|FG000|Overall Study|Poor Adherence|0|||
23148983|NCT02374021|64297457|FG001|Overall Study|Poor Adherence|1|||
23148984|NCT02374021|64297456|FG000|Overall Study|Scan protocol not followed|0|||
23148985|NCT02374021|64297457|FG001|Overall Study|Scan protocol not followed|1|||
23148986|NCT02374021|64297456|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
23148987|NCT02374021|64297457|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
23148988|NCT04540133|64297458|FG000|Overall Study|Lost to Follow-up|1|||
23437693|NCT04230213|65344189|FG001|TP2: Week 10 to Week 16|Other|2|||
23437694|NCT04230213|65344190|FG002|TP2: Week 10 to Week 16|Other|1|||
23437695|NCT04230213|65344188|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
23437696|NCT04230213|65344189|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
23437697|NCT04230213|65344190|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
23437698|NCT04230213|65344188|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
23437699|NCT04230213|65344189|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
23437700|NCT04230213|65344190|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
23437701|NCT04230213|65344188|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
23437702|NCT04230213|65344189|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
23437703|NCT04230213|65344190|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
23437704|NCT04230213|65344188|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
23437705|NCT04230213|65344189|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
23437706|NCT04230213|65344190|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
23559157|NCT03214367|65776197|FG004|Lead-in Period|Lost to Follow-up|0|||
23559158|NCT03214367|65776198|FG005|Lead-in Period|Lost to Follow-up|0|||
23559159|NCT03214367|65776199|FG006|Lead-in Period|Lost to Follow-up|0|||
23559160|NCT03214367|65776200|FG007|Lead-in Period|Lost to Follow-up|0|||
23148989|NCT04540133|64297459|FG001|Overall Study|Lost to Follow-up|0|||
23148990|NCT01101477|64297460|FG000|Overall Study|Protocol Violation|5|||
23148991|NCT01101477|64297461|FG001|Overall Study|Protocol Violation|3|||
23148992|NCT01101477|64297462|FG002|Overall Study|Protocol Violation|1|||
23148993|NCT00261846|64297463|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
23148994|NCT00261846|64297464|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
23148995|NCT00261846|64297465|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
23148996|NCT00261846|64297466|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23148997|NCT00261846|64297467|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23148998|NCT00261846|64297468|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23148999|NCT00261846|64297469|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23219171|NCT00424346|64544794|FG000|Core Study|Lack of Efficacy|1|||
23437707|NCT04230213|65344188|FG000|TP3: Week 16 to Week 22|Other|0|||
23559161|NCT03214367|65776193|FG000|Lead-in Period|Sponsor Decision|11|||
23437708|NCT04230213|65344189|FG001|TP3: Week 16 to Week 22|Other|1|||
23559162|NCT03214367|65776194|FG001|Lead-in Period|Sponsor Decision|0|||
23149000|NCT00261846|64297470|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23149001|NCT00261846|64297471|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23149002|NCT00261846|64297472|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23149003|NCT00261846|64297473|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23219172|NCT00424346|64544795|FG001|Core Study|Lack of Efficacy|3|||
23149004|NCT00261846|64297474|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
23149005|NCT00261846|64297463|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149006|NCT00261846|64297464|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149007|NCT00261846|64297465|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149008|NCT00261846|64297466|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
23149009|NCT00261846|64297467|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149010|NCT00261846|64297468|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149011|NCT00261846|64297469|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149012|NCT00261846|64297470|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149013|NCT00261846|64297471|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
23149014|NCT00261846|64297472|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149015|NCT00261846|64297473|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149016|NCT00261846|64297474|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
23149017|NCT00261846|64297463|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23149018|NCT00261846|64297464|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23149019|NCT00261846|64297465|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23149020|NCT00261846|64297466|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
23149021|NCT00261846|64297467|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
23149022|NCT00261846|64297468|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
23149023|NCT00261846|64297469|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
23149024|NCT00261846|64297470|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
23149025|NCT00261846|64297471|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23149026|NCT00261846|64297472|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
23149027|NCT00261846|64297473|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23149028|NCT00261846|64297474|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
23149029|NCT00261846|64297463|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23149030|NCT00261846|64297464|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23149031|NCT00261846|64297465|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23149032|NCT00261846|64297466|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
23149033|NCT00261846|64297467|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
23149034|NCT00261846|64297468|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23149035|NCT00261846|64297469|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
23437709|NCT04230213|65344190|FG002|TP3: Week 16 to Week 22|Other|3|||
23437710|NCT04230213|65344188|FG000|TP4: Week 22 to Week 32|Other|0|||
23437711|NCT04230213|65344189|FG001|TP4: Week 22 to Week 32|Other|5|||
23437712|NCT04230213|65344190|FG002|TP4: Week 22 to Week 32|Other|5|||
23437713|NCT04230213|65344188|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
23437714|NCT04230213|65344189|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
23437715|NCT04230213|65344190|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
23437716|NCT04230213|65344188|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
23437717|NCT04230213|65344189|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
23437718|NCT04230213|65344190|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
23437719|NCT04230213|65344188|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
23437720|NCT04230213|65344189|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
23437721|NCT04230213|65344190|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
23149036|NCT00261846|64297470|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23437722|NCT04230213|65344188|FG000|Follow up: Week 32 to Week 36|Other|0|||
23437723|NCT04230213|65344189|FG001|Follow up: Week 32 to Week 36|Other|1|||
23149037|NCT00261846|64297471|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
23437724|NCT04230213|65344190|FG002|Follow up: Week 32 to Week 36|Other|1|||
23437725|NCT00788710|65344191|FG000|Overall Study|Adverse Event|1|||
23437726|NCT00788710|65344192|FG001|Overall Study|Adverse Event|3|||
23437727|NCT00788710|65344193|FG002|Overall Study|Adverse Event|4|||
23437728|NCT00788710|65344191|FG000|Overall Study|Lack of Efficacy|0|||
23437729|NCT00788710|65344192|FG001|Overall Study|Lack of Efficacy|0|||
23437730|NCT00788710|65344193|FG002|Overall Study|Lack of Efficacy|1|||
23437731|NCT00788710|65344191|FG000|Overall Study|Lost to Follow-up|0|||
23437732|NCT00788710|65344192|FG001|Overall Study|Lost to Follow-up|1|||
23437733|NCT00788710|65344193|FG002|Overall Study|Lost to Follow-up|0|||
23437734|NCT00788710|65344191|FG000|Overall Study|Physician Decision|2|||
23437735|NCT00788710|65344192|FG001|Overall Study|Physician Decision|1|||
23437736|NCT00788710|65344193|FG002|Overall Study|Physician Decision|0|||
23437737|NCT00788710|65344191|FG000|Overall Study|Protocol Violation|0|||
23559163|NCT03214367|65776195|FG002|Lead-in Period|Sponsor Decision|0|||
23559164|NCT03214367|65776196|FG003|Lead-in Period|Sponsor Decision|0|||
23149038|NCT00261846|64297472|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
23437738|NCT00788710|65344192|FG001|Overall Study|Protocol Violation|1|||
23437739|NCT00788710|65344193|FG002|Overall Study|Protocol Violation|1|||
23559165|NCT03214367|65776197|FG004|Lead-in Period|Sponsor Decision|0|||
23559166|NCT03214367|65776198|FG005|Lead-in Period|Sponsor Decision|0|||
23559167|NCT03214367|65776199|FG006|Lead-in Period|Sponsor Decision|0|||
23559168|NCT03214367|65776200|FG007|Lead-in Period|Sponsor Decision|0|||
23437740|NCT00788710|65344191|FG000|Overall Study|Withdrawal by Subject|2|||
23437741|NCT00788710|65344192|FG001|Overall Study|Withdrawal by Subject|2|||
23437742|NCT00788710|65344193|FG002|Overall Study|Withdrawal by Subject|0|||
23437743|NCT02487030|65344194|FG000|Overall Study|Lack of Efficacy|2|||
23219173|NCT00424346|64544796|FG002|Core Study|Lack of Efficacy|0|||
23219174|NCT00424346|64544797|FG003|Core Study|Lack of Efficacy|4|||
23437744|NCT02487030|65344195|FG001|Overall Study|Lack of Efficacy|4|||
23437745|NCT02487030|65344196|FG002|Overall Study|Lack of Efficacy|1|||
23437746|NCT02487030|65344197|FG003|Overall Study|Lack of Efficacy|0|||
23437747|NCT02487030|65344198|FG004|Overall Study|Lack of Efficacy|1|||
23437748|NCT02487030|65344199|FG005|Overall Study|Lack of Efficacy|0|||
23437749|NCT02487030|65344200|FG006|Overall Study|Lack of Efficacy|0|||
23437750|NCT02487030|65344194|FG000|Overall Study|Lost to Follow-up|0|||
23437751|NCT02487030|65344195|FG001|Overall Study|Lost to Follow-up|0|||
23437752|NCT02487030|65344196|FG002|Overall Study|Lost to Follow-up|1|||
23437753|NCT02487030|65344197|FG003|Overall Study|Lost to Follow-up|1|||
23437754|NCT02487030|65344198|FG004|Overall Study|Lost to Follow-up|0|||
23437755|NCT02487030|65344199|FG005|Overall Study|Lost to Follow-up|1|||
23437756|NCT02487030|65344200|FG006|Overall Study|Lost to Follow-up|0|||
23437757|NCT02487030|65344194|FG000|Overall Study|Adverse Event|0|||
23559169|NCT03214367|65776193|FG000|Lead-in Period|Physician Decision|12|||
23559170|NCT03214367|65776194|FG001|Lead-in Period|Physician Decision|0|||
23559171|NCT03214367|65776195|FG002|Lead-in Period|Physician Decision|0|||
23559172|NCT03214367|65776196|FG003|Lead-in Period|Physician Decision|0|||
23559173|NCT03214367|65776197|FG004|Lead-in Period|Physician Decision|0|||
23219175|NCT00424346|64544794|FG000|Core Study|Withdrawal by Subject|1|||
23219176|NCT00424346|64544795|FG001|Core Study|Withdrawal by Subject|0|||
23219177|NCT00424346|64544796|FG002|Core Study|Withdrawal by Subject|0|||
23219178|NCT00424346|64544797|FG003|Core Study|Withdrawal by Subject|2|||
23219179|NCT00424346|64544794|FG000|Core Study|Lost to Follow-up|1|||
23219180|NCT00424346|64544795|FG001|Core Study|Lost to Follow-up|1|||
23219181|NCT00424346|64544796|FG002|Core Study|Lost to Follow-up|0|||
23219182|NCT00424346|64544797|FG003|Core Study|Lost to Follow-up|0|||
23219183|NCT00424346|64544794|FG000|Core Study|Administrative Problems|1|||
23219184|NCT00424346|64544795|FG001|Core Study|Administrative Problems|0|||
23219185|NCT00424346|64544796|FG002|Core Study|Administrative Problems|1|||
23219186|NCT00424346|64544797|FG003|Core Study|Administrative Problems|0|||
23219187|NCT00424346|64544794|FG000|Core Study|Protocol Violation|0|||
23219188|NCT00424346|64544795|FG001|Core Study|Protocol Violation|0|||
23219189|NCT00424346|64544796|FG002|Core Study|Protocol Violation|2|||
23219190|NCT00424346|64544797|FG003|Core Study|Protocol Violation|0|||
23219191|NCT00424346|64544794|FG000|Extension Phase|Adverse Event|0|||
23219192|NCT00424346|64544795|FG001|Extension Phase|Adverse Event|9|||
23219193|NCT00424346|64544796|FG002|Extension Phase|Adverse Event|5|||
23219194|NCT00424346|64544797|FG003|Extension Phase|Adverse Event|4|||
23219195|NCT00424346|64544794|FG000|Extension Phase|Lack of Efficacy|0|||
23219196|NCT00424346|64544795|FG001|Extension Phase|Lack of Efficacy|16|||
23219197|NCT00424346|64544796|FG002|Extension Phase|Lack of Efficacy|14|||
23219198|NCT00424346|64544797|FG003|Extension Phase|Lack of Efficacy|11|||
23219199|NCT00424346|64544794|FG000|Extension Phase|Withdrawal by Subject|0|||
23219200|NCT00424346|64544795|FG001|Extension Phase|Withdrawal by Subject|5|||
23219201|NCT00424346|64544796|FG002|Extension Phase|Withdrawal by Subject|3|||
23219202|NCT00424346|64544797|FG003|Extension Phase|Withdrawal by Subject|4|||
23323277|NCT02906670|64926695|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
23437758|NCT02487030|65344195|FG001|Overall Study|Adverse Event|0|||
23559174|NCT03214367|65776198|FG005|Lead-in Period|Physician Decision|0|||
23559175|NCT03214367|65776199|FG006|Lead-in Period|Physician Decision|0|||
23559176|NCT03214367|65776200|FG007|Lead-in Period|Physician Decision|0|||
23559177|NCT03214367|65776193|FG000|Lead-in Period|Protocol Violation|5|||
23559178|NCT03214367|65776194|FG001|Lead-in Period|Protocol Violation|0|||
23559179|NCT03214367|65776195|FG002|Lead-in Period|Protocol Violation|0|||
23559180|NCT03214367|65776196|FG003|Lead-in Period|Protocol Violation|0|||
23559181|NCT03214367|65776197|FG004|Lead-in Period|Protocol Violation|0|||
23559182|NCT03214367|65776198|FG005|Lead-in Period|Protocol Violation|0|||
23559183|NCT03214367|65776199|FG006|Lead-in Period|Protocol Violation|0|||
23559184|NCT03214367|65776200|FG007|Lead-in Period|Protocol Violation|0|||
23559185|NCT03214367|65776193|FG000|Lead-in Period|Treatment Interruption|1|||
23219203|NCT00424346|64544794|FG000|Extension Phase|Lost to Follow-up|0|||
23219204|NCT00424346|64544795|FG001|Extension Phase|Lost to Follow-up|2|||
23219205|NCT00424346|64544796|FG002|Extension Phase|Lost to Follow-up|0|||
23219206|NCT00424346|64544797|FG003|Extension Phase|Lost to Follow-up|0|||
23219207|NCT00424346|64544794|FG000|Extension Phase|Administrative Problems|0|||
23437759|NCT02487030|65344196|FG002|Overall Study|Adverse Event|0|||
23437760|NCT02487030|65344197|FG003|Overall Study|Adverse Event|1|||
23437761|NCT02487030|65344198|FG004|Overall Study|Adverse Event|0|||
23219208|NCT00424346|64544795|FG001|Extension Phase|Administrative Problems|69|||
23219209|NCT00424346|64544796|FG002|Extension Phase|Administrative Problems|32|||
23219210|NCT00424346|64544797|FG003|Extension Phase|Administrative Problems|35|||
23559186|NCT03214367|65776194|FG001|Lead-in Period|Treatment Interruption|0|||
23559187|NCT03214367|65776195|FG002|Lead-in Period|Treatment Interruption|0|||
23559188|NCT03214367|65776196|FG003|Lead-in Period|Treatment Interruption|0|||
23559189|NCT03214367|65776197|FG004|Lead-in Period|Treatment Interruption|0|||
23559190|NCT03214367|65776198|FG005|Lead-in Period|Treatment Interruption|0|||
23559191|NCT03214367|65776199|FG006|Lead-in Period|Treatment Interruption|0|||
23323278|NCT02906670|64926696|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
23323279|NCT02906670|64926697|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
23323280|NCT02906670|64926698|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
23323281|NCT02906670|64926699|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
23323282|NCT02906670|64926700|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
23323283|NCT02906670|64926701|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
23323284|NCT02906670|64926702|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
23323285|NCT02906670|64926703|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
23323286|NCT02906670|64926694|FG000|Cohort 4P, QW|Radiological Progression|0|||
23323287|NCT02906670|64926695|FG001|Cohort 4P, QW|Radiological Progression|0|||
23323288|NCT02906670|64926696|FG002|Cohort 4P, QW|Radiological Progression|0|||
23323289|NCT02906670|64926697|FG003|Cohort 4P, QW|Radiological Progression|3|||
23323290|NCT02906670|64926698|FG004|Cohort 4P, QW|Radiological Progression|0|||
23323291|NCT02906670|64926699|FG005|Cohort 4P, QW|Radiological Progression|0|||
23323292|NCT02906670|64926700|FG006|Cohort 4P, QW|Radiological Progression|0|||
23323293|NCT02906670|64926701|FG007|Cohort 4P, QW|Radiological Progression|0|||
23323294|NCT02906670|64926702|FG008|Cohort 4P, QW|Radiological Progression|0|||
23323295|NCT02906670|64926703|FG009|Cohort 4P, QW|Radiological Progression|0|||
23559192|NCT03214367|65776200|FG007|Lead-in Period|Treatment Interruption|0|||
23559193|NCT03214367|65776193|FG000|Treatment Period|Adverse Event|0|||
23323296|NCT02906670|64926694|FG000|Cohort 7P, Q2W|Adverse Event|0|||
23323297|NCT02906670|64926695|FG001|Cohort 7P, Q2W|Adverse Event|0|||
23323298|NCT02906670|64926696|FG002|Cohort 7P, Q2W|Adverse Event|0|||
23323299|NCT02906670|64926697|FG003|Cohort 7P, Q2W|Adverse Event|0|||
23323300|NCT02906670|64926698|FG004|Cohort 7P, Q2W|Adverse Event|0|||
23323301|NCT02906670|64926699|FG005|Cohort 7P, Q2W|Adverse Event|0|||
23323302|NCT02906670|64926700|FG006|Cohort 7P, Q2W|Adverse Event|0|||
23323303|NCT02906670|64926701|FG007|Cohort 7P, Q2W|Adverse Event|0|||
23323304|NCT02906670|64926702|FG008|Cohort 7P, Q2W|Adverse Event|0|||
23323305|NCT02906670|64926703|FG009|Cohort 7P, Q2W|Adverse Event|1|||
23323306|NCT02906670|64926694|FG000|Cohort 7P, Q2W|Physician Decision|0|||
23323307|NCT02906670|64926695|FG001|Cohort 7P, Q2W|Physician Decision|0|||
23323308|NCT02906670|64926696|FG002|Cohort 7P, Q2W|Physician Decision|0|||
23323309|NCT02906670|64926697|FG003|Cohort 7P, Q2W|Physician Decision|0|||
23323310|NCT02906670|64926698|FG004|Cohort 7P, Q2W|Physician Decision|0|||
23323311|NCT02906670|64926699|FG005|Cohort 7P, Q2W|Physician Decision|0|||
23323312|NCT02906670|64926700|FG006|Cohort 7P, Q2W|Physician Decision|0|||
23323313|NCT02906670|64926701|FG007|Cohort 7P, Q2W|Physician Decision|0|||
23323314|NCT02906670|64926702|FG008|Cohort 7P, Q2W|Physician Decision|0|||
23323315|NCT02906670|64926703|FG009|Cohort 7P, Q2W|Physician Decision|1|||
23323316|NCT02906670|64926694|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23323317|NCT02906670|64926695|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23323318|NCT02906670|64926696|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23323319|NCT02906670|64926697|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23323320|NCT02906670|64926698|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23323321|NCT02906670|64926699|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23323322|NCT02906670|64926700|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23323323|NCT02906670|64926701|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23323324|NCT02906670|64926702|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
23559194|NCT03214367|65776194|FG001|Treatment Period|Adverse Event|1|||
23559195|NCT03214367|65776195|FG002|Treatment Period|Adverse Event|4|||
23559196|NCT03214367|65776196|FG003|Treatment Period|Adverse Event|2|||
23559197|NCT03214367|65776197|FG004|Treatment Period|Adverse Event|0|||
23559198|NCT03214367|65776198|FG005|Treatment Period|Adverse Event|0|||
23559199|NCT03214367|65776199|FG006|Treatment Period|Adverse Event|0|||
23559200|NCT03214367|65776200|FG007|Treatment Period|Adverse Event|0|||
23559201|NCT03214367|65776193|FG000|Treatment Period|Death|0|||
23149039|NCT00261846|64297473|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
23559202|NCT03214367|65776194|FG001|Treatment Period|Death|1|||
23559203|NCT03214367|65776195|FG002|Treatment Period|Death|1|||
23559204|NCT03214367|65776196|FG003|Treatment Period|Death|1|||
23559205|NCT03214367|65776197|FG004|Treatment Period|Death|0|||
23559206|NCT03214367|65776198|FG005|Treatment Period|Death|0|||
23149040|NCT00261846|64297474|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
23323325|NCT02906670|64926703|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
23323326|NCT02906670|64926694|FG000|Cohort 5P, QW|Radiological Progression|0|||
23323327|NCT02906670|64926695|FG001|Cohort 5P, QW|Radiological Progression|0|||
23323328|NCT02906670|64926696|FG002|Cohort 5P, QW|Radiological Progression|0|||
23323329|NCT02906670|64926697|FG003|Cohort 5P, QW|Radiological Progression|0|||
23323330|NCT02906670|64926698|FG004|Cohort 5P, QW|Radiological Progression|3|||
23323331|NCT02906670|64926699|FG005|Cohort 5P, QW|Radiological Progression|0|||
23559207|NCT03214367|65776199|FG006|Treatment Period|Death|0|||
23559208|NCT03214367|65776200|FG007|Treatment Period|Death|0|||
23559209|NCT03214367|65776193|FG000|Treatment Period|Lost to Follow-up|0|||
23559210|NCT03214367|65776194|FG001|Treatment Period|Lost to Follow-up|5|||
23559211|NCT03214367|65776195|FG002|Treatment Period|Lost to Follow-up|3|||
23559212|NCT03214367|65776196|FG003|Treatment Period|Lost to Follow-up|2|||
23559213|NCT03214367|65776197|FG004|Treatment Period|Lost to Follow-up|0|||
23624215|NCT01185171|66011566|FG000|Maintenance|Xerostomia|1|||
23624216|NCT01185171|66011566|FG000|Maintenance|Nausea|1|||
23624217|NCT01185171|66011566|FG000|Maintenance|Comorbid Illness|2|||
23624218|NCT01185171|66011566|FG000|Maintenance|Withdrawal by Subject|1|||
23624219|NCT01185171|66011566|FG000|Maintenance|Disease Recurrence|1|||
23624220|NCT00511836|66011572|FG000|Double-blind Period|Lost to Follow-up|1|||
23624221|NCT00511836|66011573|FG001|Double-blind Period|Lost to Follow-up|0|||
23624222|NCT00908349|66011589|FG000|Overall Study|Adverse Event|10|||
23624223|NCT00908349|66011589|FG000|Overall Study|Withdrawal by Subject|9|||
23624224|NCT00908349|66011589|FG000|Overall Study|Physician Decision|5|||
23624225|NCT00908349|66011589|FG000|Overall Study|Lost to Follow-up|5|||
23624226|NCT00908349|66011589|FG000|Overall Study|Various|6|||
23624227|NCT01434680|66011592|FG000|Overall Study|Withdrawal by Subject|1|||
23624228|NCT01434680|66011593|FG001|Overall Study|Withdrawal by Subject|0|||
23624229|NCT01434680|66011594|FG002|Overall Study|Withdrawal by Subject|2|||
23624230|NCT01434680|66011595|FG003|Overall Study|Withdrawal by Subject|0|||
23624231|NCT01434680|66011592|FG000|Overall Study|Lost to Follow-up|1|||
23624232|NCT01434680|66011593|FG001|Overall Study|Lost to Follow-up|1|||
23624233|NCT01434680|66011594|FG002|Overall Study|Lost to Follow-up|0|||
23624234|NCT01434680|66011595|FG003|Overall Study|Lost to Follow-up|0|||
23624235|NCT01434680|66011592|FG000|Overall Study|Protocol Violation|1|||
23624236|NCT01434680|66011593|FG001|Overall Study|Protocol Violation|1|||
23624237|NCT01434680|66011594|FG002|Overall Study|Protocol Violation|0|||
23624238|NCT01434680|66011595|FG003|Overall Study|Protocol Violation|0|||
23624239|NCT02635386|66011599|FG000|Overall Study|Pregnancy|2|||
23624240|NCT02635386|66011600|FG001|Overall Study|Pregnancy|0|||
23624241|NCT02635386|66011601|FG002|Overall Study|Pregnancy|0|||
23624242|NCT02635386|66011602|FG003|Overall Study|Pregnancy|0|||
23624243|NCT02635386|66011603|FG004|Overall Study|Pregnancy|2|||
23624244|NCT02635386|66011599|FG000|Overall Study|Withdrawal by Subject|1|||
23624245|NCT02635386|66011600|FG001|Overall Study|Withdrawal by Subject|1|||
23624246|NCT02635386|66011601|FG002|Overall Study|Withdrawal by Subject|0|||
23624247|NCT02635386|66011602|FG003|Overall Study|Withdrawal by Subject|1|||
23624248|NCT02635386|66011603|FG004|Overall Study|Withdrawal by Subject|0|||
23624249|NCT02635386|66011599|FG000|Overall Study|Physician Decision|0|||
23624250|NCT02635386|66011600|FG001|Overall Study|Physician Decision|1|||
23624251|NCT02635386|66011601|FG002|Overall Study|Physician Decision|0|||
23624252|NCT02635386|66011602|FG003|Overall Study|Physician Decision|0|||
23624253|NCT02635386|66011603|FG004|Overall Study|Physician Decision|0|||
23624254|NCT02635386|66011599|FG000|Overall Study|Moved Out of State|0|||
23624255|NCT02635386|66011600|FG001|Overall Study|Moved Out of State|1|||
23149041|NCT00261846|64297463|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
23149042|NCT00261846|64297464|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
23437762|NCT02487030|65344199|FG005|Overall Study|Adverse Event|0|||
23437763|NCT02487030|65344200|FG006|Overall Study|Adverse Event|0|||
23437764|NCT02487030|65344194|FG000|Overall Study|Death|0|||
23437765|NCT02487030|65344195|FG001|Overall Study|Death|0|||
23559214|NCT03214367|65776198|FG005|Treatment Period|Lost to Follow-up|2|||
23559215|NCT03214367|65776199|FG006|Treatment Period|Lost to Follow-up|1|||
23559216|NCT03214367|65776200|FG007|Treatment Period|Lost to Follow-up|0|||
23149043|NCT00261846|64297465|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
23149044|NCT00261846|64297466|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
23149045|NCT00261846|64297467|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
23149046|NCT00261846|64297468|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
23149047|NCT00261846|64297469|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
23437766|NCT02487030|65344196|FG002|Overall Study|Death|0|||
23624256|NCT02635386|66011601|FG002|Overall Study|Moved Out of State|0|||
23624257|NCT02635386|66011602|FG003|Overall Study|Moved Out of State|0|||
23559217|NCT03214367|65776193|FG000|Treatment Period|Sponsor Decision|0|||
23624258|NCT02635386|66011603|FG004|Overall Study|Moved Out of State|0|||
23624259|NCT02635386|66011599|FG000|Overall Study|Noncompliant|0|||
23149048|NCT00261846|64297470|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
23437767|NCT02487030|65344197|FG003|Overall Study|Death|0|||
23559218|NCT03214367|65776194|FG001|Treatment Period|Sponsor Decision|3|||
23624260|NCT02635386|66011600|FG001|Overall Study|Noncompliant|2|||
23624261|NCT02635386|66011601|FG002|Overall Study|Noncompliant|1|||
23624262|NCT02635386|66011602|FG003|Overall Study|Noncompliant|1|||
23149049|NCT00261846|64297471|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
23149050|NCT00261846|64297472|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
23149051|NCT00261846|64297473|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
23559219|NCT03214367|65776195|FG002|Treatment Period|Sponsor Decision|0|||
23559220|NCT03214367|65776196|FG003|Treatment Period|Sponsor Decision|0|||
23624263|NCT02635386|66011603|FG004|Overall Study|Noncompliant|1|||
23624264|NCT02635386|66011599|FG000|Overall Study|side effects|0|||
23624265|NCT02635386|66011600|FG001|Overall Study|side effects|0|||
23624266|NCT02635386|66011601|FG002|Overall Study|side effects|1|||
23559221|NCT03214367|65776197|FG004|Treatment Period|Sponsor Decision|0|||
23559222|NCT03214367|65776198|FG005|Treatment Period|Sponsor Decision|0|||
23559223|NCT03214367|65776199|FG006|Treatment Period|Sponsor Decision|0|||
23559224|NCT03214367|65776200|FG007|Treatment Period|Sponsor Decision|0|||
23559225|NCT03214367|65776193|FG000|Treatment Period|Physician Decision|0|||
23559226|NCT03214367|65776194|FG001|Treatment Period|Physician Decision|1|||
23559227|NCT03214367|65776195|FG002|Treatment Period|Physician Decision|2|||
23559228|NCT03214367|65776196|FG003|Treatment Period|Physician Decision|0|||
23559229|NCT03214367|65776197|FG004|Treatment Period|Physician Decision|0|||
23559230|NCT03214367|65776198|FG005|Treatment Period|Physician Decision|0|||
23559231|NCT03214367|65776199|FG006|Treatment Period|Physician Decision|0|||
23559232|NCT03214367|65776200|FG007|Treatment Period|Physician Decision|0|||
23559233|NCT03214367|65776193|FG000|Treatment Period|Protocol Violation|0|||
23559234|NCT03214367|65776194|FG001|Treatment Period|Protocol Violation|3|||
23559235|NCT03214367|65776195|FG002|Treatment Period|Protocol Violation|0|||
23559236|NCT03214367|65776196|FG003|Treatment Period|Protocol Violation|0|||
23559237|NCT03214367|65776197|FG004|Treatment Period|Protocol Violation|0|||
23559238|NCT03214367|65776198|FG005|Treatment Period|Protocol Violation|0|||
23559239|NCT03214367|65776199|FG006|Treatment Period|Protocol Violation|0|||
23559240|NCT03214367|65776200|FG007|Treatment Period|Protocol Violation|0|||
23559241|NCT03214367|65776193|FG000|Treatment Period|Withdrawal by Subject|0|||
23624267|NCT02635386|66011602|FG003|Overall Study|side effects|4|||
23624268|NCT02635386|66011603|FG004|Overall Study|side effects|6|||
23624269|NCT02635386|66011599|FG000|Overall Study|needed other major surgery|0|||
23624270|NCT02635386|66011600|FG001|Overall Study|needed other major surgery|1|||
23624271|NCT02635386|66011601|FG002|Overall Study|needed other major surgery|0|||
23624272|NCT02635386|66011602|FG003|Overall Study|needed other major surgery|0|||
23624273|NCT02635386|66011603|FG004|Overall Study|needed other major surgery|0|||
23624274|NCT02635386|66011599|FG000|Overall Study|Other medical problems not drug related|0|||
23624275|NCT02635386|66011600|FG001|Overall Study|Other medical problems not drug related|0|||
23624276|NCT02635386|66011601|FG002|Overall Study|Other medical problems not drug related|0|||
23624277|NCT02635386|66011602|FG003|Overall Study|Other medical problems not drug related|1|||
23624278|NCT02635386|66011603|FG004|Overall Study|Other medical problems not drug related|0|||
23624279|NCT00808899|66011606|FG000|Overall Study|Death|1|||
23624280|NCT00808899|66011606|FG000|Overall Study|Physician Decision|3|||
23624281|NCT02654132|66011611|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
23624282|NCT02654132|66011612|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
23624283|NCT02654132|66011611|FG000|Treatment Period|Disease progression|43|||
23624284|NCT02654132|66011612|FG001|Treatment Period|Disease progression|38|||
23624285|NCT02654132|66011611|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
23149052|NCT00261846|64297474|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
23559242|NCT03214367|65776194|FG001|Treatment Period|Withdrawal by Subject|20|||
23559243|NCT03214367|65776195|FG002|Treatment Period|Withdrawal by Subject|23|||
23559244|NCT03214367|65776196|FG003|Treatment Period|Withdrawal by Subject|14|||
23559245|NCT03214367|65776197|FG004|Treatment Period|Withdrawal by Subject|0|||
23559246|NCT03214367|65776198|FG005|Treatment Period|Withdrawal by Subject|1|||
23559247|NCT03214367|65776199|FG006|Treatment Period|Withdrawal by Subject|1|||
23149053|NCT00261846|64297463|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
23559248|NCT03214367|65776200|FG007|Treatment Period|Withdrawal by Subject|1|||
23559249|NCT04124926|65776201|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
23559250|NCT04124926|65776202|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
23559251|NCT04124926|65776203|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
23559252|NCT04124926|65776204|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
23559253|NCT04124926|65776205|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
23559254|NCT04124926|65776201|FG000|Healing Phase|Protocol Violation|0|||
23559255|NCT04124926|65776202|FG001|Healing Phase|Protocol Violation|1|||
23149054|NCT00261846|64297464|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
23437768|NCT02487030|65344198|FG004|Overall Study|Death|1|||
23437769|NCT02487030|65344199|FG005|Overall Study|Death|0|||
23437770|NCT02487030|65344200|FG006|Overall Study|Death|0|||
23437771|NCT01099397|65344201|FG000|Overall Study|Lost to Follow-up|4|||
23437772|NCT01099397|65344201|FG000|Overall Study|Protocol Violation|4|||
23559256|NCT04124926|65776203|FG002|Healing Phase|Protocol Violation|0|||
23559257|NCT04124926|65776204|FG003|Healing Phase|Protocol Violation|0|||
23559258|NCT04124926|65776205|FG004|Healing Phase|Protocol Violation|0|||
23559259|NCT04124926|65776201|FG000|Healing Phase|Lost to Follow-up|5|||
23624286|NCT02654132|66011612|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
23624287|NCT02654132|66011611|FG000|Treatment Period|Other reasons|4|||
23624288|NCT02654132|66011612|FG001|Treatment Period|Other reasons|2|||
23149055|NCT00261846|64297465|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
23437773|NCT01099397|65344201|FG000|Overall Study|Withdrawal by Subject|5|||
23437774|NCT02927938|65344202|FG000|Overall Study|Death|0|||
23559260|NCT04124926|65776202|FG001|Healing Phase|Lost to Follow-up|4|||
23559261|NCT04124926|65776203|FG002|Healing Phase|Lost to Follow-up|0|||
23559262|NCT04124926|65776204|FG003|Healing Phase|Lost to Follow-up|0|||
23559263|NCT04124926|65776205|FG004|Healing Phase|Lost to Follow-up|0|||
23559264|NCT04124926|65776201|FG000|Healing Phase|Voluntary Withdrawal|10|||
23559265|NCT04124926|65776202|FG001|Healing Phase|Voluntary Withdrawal|7|||
23559266|NCT04124926|65776203|FG002|Healing Phase|Voluntary Withdrawal|0|||
23559267|NCT04124926|65776204|FG003|Healing Phase|Voluntary Withdrawal|0|||
23559268|NCT04124926|65776205|FG004|Healing Phase|Voluntary Withdrawal|0|||
23559269|NCT04124926|65776201|FG000|Healing Phase|Withdrawal of Consent|5|||
23559270|NCT04124926|65776202|FG001|Healing Phase|Withdrawal of Consent|3|||
23559271|NCT04124926|65776203|FG002|Healing Phase|Withdrawal of Consent|0|||
23559272|NCT04124926|65776204|FG003|Healing Phase|Withdrawal of Consent|0|||
23559273|NCT04124926|65776205|FG004|Healing Phase|Withdrawal of Consent|0|||
23559274|NCT04124926|65776201|FG000|Healing Phase|Miscellaneous|8|||
23559275|NCT04124926|65776202|FG001|Healing Phase|Miscellaneous|7|||
23559276|NCT04124926|65776203|FG002|Healing Phase|Miscellaneous|0|||
23559277|NCT04124926|65776204|FG003|Healing Phase|Miscellaneous|0|||
23559278|NCT04124926|65776205|FG004|Healing Phase|Miscellaneous|0|||
23559279|NCT04124926|65776201|FG000|Healing Phase|Randomized but not Treated|0|||
23559280|NCT04124926|65776202|FG001|Healing Phase|Randomized but not Treated|3|||
23559281|NCT04124926|65776203|FG002|Healing Phase|Randomized but not Treated|0|||
23559282|NCT04124926|65776204|FG003|Healing Phase|Randomized but not Treated|0|||
23559283|NCT04124926|65776205|FG004|Healing Phase|Randomized but not Treated|0|||
23559284|NCT04124926|65776201|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
23559285|NCT04124926|65776202|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
23323332|NCT02906670|64926700|FG006|Cohort 5P, QW|Radiological Progression|0|||
23559286|NCT04124926|65776203|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
23559287|NCT04124926|65776204|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
23559288|NCT04124926|65776205|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
23559289|NCT04124926|65776201|FG000|Maintenance Phase|Protocol Violation|0|||
23559290|NCT04124926|65776202|FG001|Maintenance Phase|Protocol Violation|0|||
23559291|NCT04124926|65776203|FG002|Maintenance Phase|Protocol Violation|3|||
23559292|NCT04124926|65776204|FG003|Maintenance Phase|Protocol Violation|0|||
23559293|NCT04124926|65776205|FG004|Maintenance Phase|Protocol Violation|0|||
23624289|NCT02654132|66011611|FG000|Treatment Period|Study drug toxicity|2|||
23624290|NCT02654132|66011612|FG001|Treatment Period|Study drug toxicity|2|||
23624291|NCT02654132|66011611|FG000|Treatment Period|Withdrawal by Subject|2|||
23624292|NCT02654132|66011612|FG001|Treatment Period|Withdrawal by Subject|1|||
23624293|NCT02654132|66011611|FG000|Treatment Period|Maximum Clinical Benefit|0|||
23624294|NCT02654132|66011612|FG001|Treatment Period|Maximum Clinical Benefit|2|||
23624295|NCT02654132|66011611|FG000|Treatment Period|Participant request to discontinue|2|||
23624296|NCT02654132|66011612|FG001|Treatment Period|Participant request to discontinue|0|||
23624297|NCT02654132|66011611|FG000|Treatment Period|Administrative reasons by sponsor|0|||
23624298|NCT02654132|66011612|FG001|Treatment Period|Administrative reasons by sponsor|1|||
23624299|NCT02654132|66011611|FG000|Treatment Period|Death|1|||
23624300|NCT02654132|66011612|FG001|Treatment Period|Death|0|||
23323333|NCT02906670|64926701|FG007|Cohort 5P, QW|Radiological Progression|0|||
23323334|NCT02906670|64926702|FG008|Cohort 5P, QW|Radiological Progression|0|||
23323335|NCT02906670|64926703|FG009|Cohort 5P, QW|Radiological Progression|0|||
23323336|NCT01662492|64926704|FG000|Overall Study|Other miscellaneous reasons.|1|||
23624301|NCT03296566|66011615|FG000|Overall Study|Lost to Follow-up|19|||
23624302|NCT03296566|66011616|FG001|Overall Study|Lost to Follow-up|46|||
23624303|NCT03296566|66011615|FG000|Overall Study|Withdrawal by Subject|0|||
23624304|NCT03296566|66011616|FG001|Overall Study|Withdrawal by Subject|3|||
23624305|NCT01036165|66011617|FG000|Overall Study|Adverse Event|6|||
23624306|NCT01036165|66011617|FG000|Overall Study|Lost to Follow-up|2|||
23624307|NCT01036165|66011617|FG000|Overall Study|Withdrawal by Subject|3|||
23624308|NCT01036165|66011617|FG000|Overall Study|Device Related Issues|3|||
23624309|NCT01036165|66011617|FG000|Overall Study|Problems finding proper area to inject|1|||
23624310|NCT03927690|66011618|FG000|Overall Study|Withdrawal by Subject|3|||
23624311|NCT03927690|66011619|FG001|Overall Study|Withdrawal by Subject|1|||
23624312|NCT03927690|66011620|FG002|Overall Study|Withdrawal by Subject|1|||
23624313|NCT03927690|66011618|FG000|Overall Study|Adverse Event|1|||
23149056|NCT00261846|64297466|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
23323337|NCT01662492|64926705|FG001|Overall Study|Other miscellaneous reasons.|0|||
23559294|NCT04124926|65776201|FG000|Maintenance Phase|Lost to Follow-up|0|||
23323338|NCT01662492|64926706|FG002|Overall Study|Other miscellaneous reasons.|1|||
23559295|NCT04124926|65776202|FG001|Maintenance Phase|Lost to Follow-up|0|||
23559296|NCT04124926|65776203|FG002|Maintenance Phase|Lost to Follow-up|7|||
23559297|NCT04124926|65776204|FG003|Maintenance Phase|Lost to Follow-up|8|||
23624314|NCT03927690|66011619|FG001|Overall Study|Adverse Event|0|||
23624315|NCT03927690|66011620|FG002|Overall Study|Adverse Event|0|||
23149057|NCT00261846|64297467|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
23624316|NCT03927690|66011618|FG000|Overall Study|Death|1|||
23624317|NCT03927690|66011619|FG001|Overall Study|Death|0|||
23624318|NCT03927690|66011620|FG002|Overall Study|Death|0|||
23624319|NCT03927690|66011618|FG000|Overall Study|Lost to Follow-up|2|||
23624320|NCT03927690|66011619|FG001|Overall Study|Lost to Follow-up|2|||
23323339|NCT01662492|64926704|FG000|Overall Study|Withdrawal by Subject|0|||
23323340|NCT01662492|64926705|FG001|Overall Study|Withdrawal by Subject|0|||
23323341|NCT01662492|64926706|FG002|Overall Study|Withdrawal by Subject|1|||
23323342|NCT01662492|64926704|FG000|Overall Study|Protocol Violation|1|||
23323343|NCT01662492|64926705|FG001|Overall Study|Protocol Violation|0|||
23323344|NCT01662492|64926706|FG002|Overall Study|Protocol Violation|0|||
23323345|NCT01662492|64926704|FG000|Overall Study|Lost to Follow-up|0|||
23323346|NCT01662492|64926705|FG001|Overall Study|Lost to Follow-up|0|||
23323347|NCT01662492|64926706|FG002|Overall Study|Lost to Follow-up|2|||
23323348|NCT01662492|64926704|FG000|Overall Study|Lack of Efficacy|1|||
23323349|NCT01662492|64926705|FG001|Overall Study|Lack of Efficacy|1|||
23323350|NCT01662492|64926706|FG002|Overall Study|Lack of Efficacy|2|||
23323351|NCT02676882|64926707|FG000|Overall Study|Adverse Event|1|||
23323352|NCT02676882|64926708|FG001|Overall Study|Adverse Event|0|||
23323353|NCT02676882|64926707|FG000|Overall Study|Lost to Follow-up|1|||
23323354|NCT02676882|64926708|FG001|Overall Study|Lost to Follow-up|0|||
23323355|NCT02676882|64926707|FG000|Overall Study|Withdrawal by Subject|1|||
23323356|NCT02676882|64926708|FG001|Overall Study|Withdrawal by Subject|2|||
23323357|NCT03288714|64926710|FG000|Overall Study|Lost to Follow-up|2|||
23323358|NCT03288714|64926711|FG001|Overall Study|Lost to Follow-up|1|||
23323359|NCT03288714|64926710|FG000|Overall Study|Non-compliance with study schedule|2|||
23323360|NCT03288714|64926711|FG001|Overall Study|Non-compliance with study schedule|0|||
23323361|NCT03288714|64926710|FG000|Overall Study|Withdrawal by Subject|3|||
23323362|NCT03288714|64926711|FG001|Overall Study|Withdrawal by Subject|1|||
23323363|NCT03288714|64926710|FG000|Overall Study|Clinical Worsening|2|||
23323364|NCT03288714|64926711|FG001|Overall Study|Clinical Worsening|1|||
23323365|NCT03288714|64926710|FG000|Overall Study|Adverse Event|1|||
23323366|NCT03288714|64926711|FG001|Overall Study|Adverse Event|0|||
23323367|NCT01125917|64926720|FG000|Overall Study|Adverse Event|43|||
23323368|NCT01125917|64926720|FG000|Overall Study|Lost to Follow-up|23|||
23323369|NCT01125917|64926720|FG000|Overall Study|Withdrawal by Subject|31|||
23323370|NCT01125917|64926720|FG000|Overall Study|Administrative|223|||
23323371|NCT01125917|64926720|FG000|Overall Study|Lack of Efficacy|19|||
23323372|NCT00276484|64926721|FG000|Overall Study|Adverse Event|4|||
23323373|NCT00276484|64926722|FG001|Overall Study|Adverse Event|7|||
23323374|NCT00276484|64926721|FG000|Overall Study|Lost to Follow-up|1|||
23323375|NCT00276484|64926722|FG001|Overall Study|Lost to Follow-up|1|||
23323376|NCT00276484|64926721|FG000|Overall Study|Protocol Violation|0|||
23323377|NCT00276484|64926722|FG001|Overall Study|Protocol Violation|1|||
23323378|NCT00276484|64926721|FG000|Overall Study|Withdrawal by Subject|4|||
23323379|NCT00276484|64926722|FG001|Overall Study|Withdrawal by Subject|3|||
23323380|NCT00276484|64926721|FG000|Overall Study|Could not take time off work|0|||
23323381|NCT00276484|64926722|FG001|Overall Study|Could not take time off work|1|||
23323382|NCT01547390|64926723|FG000|Overall Study|Withdrawal by Subject|10|||
23323383|NCT01547390|64926724|FG001|Overall Study|Withdrawal by Subject|7|||
23323384|NCT01547390|64926723|FG000|Overall Study|termination of pregnancy|0|||
23323385|NCT01547390|64926724|FG001|Overall Study|termination of pregnancy|1|||
23559298|NCT04124926|65776205|FG004|Maintenance Phase|Lost to Follow-up|9|||
23559299|NCT04124926|65776201|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
23559300|NCT04124926|65776202|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
23559301|NCT04124926|65776203|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
23559302|NCT04124926|65776204|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
23559303|NCT04124926|65776205|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
23559304|NCT04124926|65776201|FG000|Maintenance Phase|Pregnancy|0|||
23559305|NCT04124926|65776202|FG001|Maintenance Phase|Pregnancy|0|||
23559306|NCT04124926|65776203|FG002|Maintenance Phase|Pregnancy|0|||
23559307|NCT04124926|65776204|FG003|Maintenance Phase|Pregnancy|1|||
23559308|NCT04124926|65776205|FG004|Maintenance Phase|Pregnancy|0|||
23559309|NCT04124926|65776201|FG000|Maintenance Phase|Lack of Efficacy|0|||
23559310|NCT04124926|65776202|FG001|Maintenance Phase|Lack of Efficacy|0|||
23559311|NCT04124926|65776203|FG002|Maintenance Phase|Lack of Efficacy|0|||
23559312|NCT04124926|65776204|FG003|Maintenance Phase|Lack of Efficacy|0|||
23559313|NCT04124926|65776205|FG004|Maintenance Phase|Lack of Efficacy|1|||
23559314|NCT04124926|65776201|FG000|Maintenance Phase|Withdrawal of Consent|0|||
23559315|NCT04124926|65776202|FG001|Maintenance Phase|Withdrawal of Consent|0|||
23559316|NCT04124926|65776203|FG002|Maintenance Phase|Withdrawal of Consent|5|||
23323386|NCT01547390|64926723|FG000|Overall Study|Lost to Follow-up|0|||
23559317|NCT04124926|65776204|FG003|Maintenance Phase|Withdrawal of Consent|5|||
23559318|NCT04124926|65776205|FG004|Maintenance Phase|Withdrawal of Consent|5|||
23559319|NCT04124926|65776201|FG000|Maintenance Phase|Miscellaneous|0|||
23559320|NCT04124926|65776202|FG001|Maintenance Phase|Miscellaneous|0|||
23437775|NCT02927938|65344203|FG001|Overall Study|Death|1|||
23323387|NCT01547390|64926724|FG001|Overall Study|Lost to Follow-up|2|||
23323388|NCT01547390|64926723|FG000|Overall Study|Adverse Event|3|||
23323389|NCT01547390|64926724|FG001|Overall Study|Adverse Event|0|||
23323390|NCT01522456|64926735|FG000|Overall Study|Adverse Event|2|||
23323391|NCT01522456|64926735|FG000|Overall Study|Lost to Follow-up|2|||
23323392|NCT01522456|64926735|FG000|Overall Study|Withdrawal by Subject|2|||
23323393|NCT01522456|64926735|FG000|Overall Study|Pregnancy|1|||
23323394|NCT01522456|64926735|FG000|Overall Study|Tolerability Assessment|1|||
23323395|NCT01753999|64926736|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
23323396|NCT01753999|64926737|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
23323397|NCT01753999|64926736|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
23323398|NCT01753999|64926737|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
23323399|NCT01753999|64926736|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
23323400|NCT01753999|64926737|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
23323401|NCT01753999|64926736|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
23323402|NCT01753999|64926737|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
23323403|NCT01753999|64926736|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
23323404|NCT01753999|64926737|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
23323405|NCT01753999|64926736|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
23323406|NCT01753999|64926737|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
23323407|NCT01371747|64926738|FG000|Overall Study|Adverse Event|4|||
23323408|NCT01371747|64926739|FG001|Overall Study|Adverse Event|2|||
23323409|NCT01371747|64926740|FG002|Overall Study|Adverse Event|7|||
23323410|NCT01371747|64926741|FG003|Overall Study|Adverse Event|2|||
23323411|NCT01371747|64926742|FG004|Overall Study|Adverse Event|2|||
23323412|NCT01371747|64926743|FG005|Overall Study|Adverse Event|2|||
23323413|NCT01371747|64926738|FG000|Overall Study|Death|1|||
23323414|NCT01371747|64926739|FG001|Overall Study|Death|0|||
23323415|NCT01371747|64926740|FG002|Overall Study|Death|4|||
23323416|NCT01371747|64926741|FG003|Overall Study|Death|1|||
23323417|NCT01371747|64926742|FG004|Overall Study|Death|2|||
23323418|NCT01371747|64926743|FG005|Overall Study|Death|0|||
23323419|NCT01371747|64926738|FG000|Overall Study|Abnormal Renal Function|0|||
23323420|NCT01371747|64926739|FG001|Overall Study|Abnormal Renal Function|2|||
23323421|NCT01371747|64926740|FG002|Overall Study|Abnormal Renal Function|0|||
23323422|NCT01371747|64926741|FG003|Overall Study|Abnormal Renal Function|1|||
23323423|NCT01371747|64926742|FG004|Overall Study|Abnormal Renal Function|0|||
23323424|NCT01371747|64926743|FG005|Overall Study|Abnormal Renal Function|1|||
23323425|NCT01371747|64926738|FG000|Overall Study|High Serum Potassium Results|1|||
23323426|NCT01371747|64926739|FG001|Overall Study|High Serum Potassium Results|1|||
23323427|NCT01371747|64926740|FG002|Overall Study|High Serum Potassium Results|1|||
23323428|NCT01371747|64926741|FG003|Overall Study|High Serum Potassium Results|2|||
23323429|NCT01371747|64926742|FG004|Overall Study|High Serum Potassium Results|0|||
23323430|NCT01371747|64926743|FG005|Overall Study|High Serum Potassium Results|2|||
23323431|NCT01371747|64926738|FG000|Overall Study|Low Serum Potassium Results|1|||
23323432|NCT01371747|64926739|FG001|Overall Study|Low Serum Potassium Results|1|||
23323433|NCT01371747|64926740|FG002|Overall Study|Low Serum Potassium Results|1|||
23323434|NCT01371747|64926741|FG003|Overall Study|Low Serum Potassium Results|1|||
23323435|NCT01371747|64926742|FG004|Overall Study|Low Serum Potassium Results|0|||
23323436|NCT01371747|64926743|FG005|Overall Study|Low Serum Potassium Results|3|||
23323437|NCT01371747|64926738|FG000|Overall Study|Protocol Violation|0|||
23323438|NCT01371747|64926739|FG001|Overall Study|Protocol Violation|0|||
23323439|NCT01371747|64926740|FG002|Overall Study|Protocol Violation|1|||
23323440|NCT01371747|64926741|FG003|Overall Study|Protocol Violation|0|||
23323441|NCT01371747|64926742|FG004|Overall Study|Protocol Violation|0|||
23323442|NCT01371747|64926743|FG005|Overall Study|Protocol Violation|0|||
23323443|NCT01371747|64926738|FG000|Overall Study|Non-Compliance|3|||
23323444|NCT01371747|64926739|FG001|Overall Study|Non-Compliance|4|||
23323445|NCT01371747|64926740|FG002|Overall Study|Non-Compliance|3|||
23323446|NCT01371747|64926741|FG003|Overall Study|Non-Compliance|0|||
23323447|NCT01371747|64926742|FG004|Overall Study|Non-Compliance|0|||
23323448|NCT01371747|64926743|FG005|Overall Study|Non-Compliance|1|||
23323449|NCT01371747|64926738|FG000|Overall Study|Physician Decision|0|||
23323450|NCT01371747|64926739|FG001|Overall Study|Physician Decision|0|||
23323451|NCT01371747|64926740|FG002|Overall Study|Physician Decision|0|||
23323452|NCT01371747|64926741|FG003|Overall Study|Physician Decision|0|||
23323453|NCT01371747|64926742|FG004|Overall Study|Physician Decision|1|||
23323454|NCT01371747|64926743|FG005|Overall Study|Physician Decision|0|||
23323455|NCT01371747|64926738|FG000|Overall Study|Withdrawal by Subject|6|||
23323456|NCT01371747|64926739|FG001|Overall Study|Withdrawal by Subject|12|||
23323457|NCT01371747|64926740|FG002|Overall Study|Withdrawal by Subject|5|||
23323458|NCT01371747|64926741|FG003|Overall Study|Withdrawal by Subject|2|||
23323459|NCT01371747|64926742|FG004|Overall Study|Withdrawal by Subject|2|||
23323460|NCT01371747|64926743|FG005|Overall Study|Withdrawal by Subject|4|||
23323461|NCT01371747|64926738|FG000|Overall Study|Other Reasons|2|||
23323462|NCT01371747|64926739|FG001|Overall Study|Other Reasons|1|||
23323463|NCT01371747|64926740|FG002|Overall Study|Other Reasons|2|||
23323464|NCT01371747|64926741|FG003|Overall Study|Other Reasons|0|||
23323465|NCT01371747|64926742|FG004|Overall Study|Other Reasons|0|||
23323466|NCT01371747|64926743|FG005|Overall Study|Other Reasons|1|||
23323467|NCT00838526|64926744|FG000|Overall Study|Adverse Event|3|||
23323468|NCT00838526|64926745|FG001|Overall Study|Adverse Event|12|||
23323469|NCT00838526|64926744|FG000|Overall Study|Lost to Follow-up|4|||
23323470|NCT00838526|64926745|FG001|Overall Study|Lost to Follow-up|12|||
23323471|NCT00838526|64926744|FG000|Overall Study|Withdrawal by Subject|4|||
23323472|NCT00838526|64926745|FG001|Overall Study|Withdrawal by Subject|5|||
23323473|NCT00838526|64926744|FG000|Overall Study|Lack of Efficacy|2|||
23323474|NCT00838526|64926745|FG001|Overall Study|Lack of Efficacy|3|||
23323475|NCT00838526|64926744|FG000|Overall Study|Other|11|||
23323476|NCT00838526|64926745|FG001|Overall Study|Other|7|||
23323477|NCT02492867|64926746|FG000|Overall Study|Alternate therapy|1|||
23323478|NCT02492867|64926746|FG000|Overall Study|Withdrawal by Subject|2|||
23323479|NCT02492867|64926746|FG000|Overall Study|Disease progression after treatment started|1|||
23323480|NCT02492867|64926746|FG000|Overall Study|Death|1|||
23323481|NCT00925704|64926747|FG000|First Intervention|Withdrew consent|0|||
23323482|NCT00925704|64926748|FG001|First Intervention|Withdrew consent|0|||
23323483|NCT00925704|64926749|FG002|First Intervention|Withdrew consent|0|||
23323484|NCT00925704|64926750|FG003|First Intervention|Withdrew consent|1|||
23323485|NCT00925704|64926751|FG004|First Intervention|Withdrew consent|1|||
23323486|NCT00925704|64926752|FG005|First Intervention|Withdrew consent|0|||
23323487|NCT00925704|64926747|FG000|Second Intervention|Withdrawal by Subject|1|||
23323488|NCT00925704|64926748|FG001|Second Intervention|Withdrawal by Subject|0|||
23323489|NCT00925704|64926749|FG002|Second Intervention|Withdrawal by Subject|0|||
23323490|NCT00925704|64926750|FG003|Second Intervention|Withdrawal by Subject|0|||
23323491|NCT00925704|64926751|FG004|Second Intervention|Withdrawal by Subject|1|||
23323492|NCT00925704|64926752|FG005|Second Intervention|Withdrawal by Subject|0|||
23323493|NCT00925704|64926747|FG000|Third Intervention|Withdrew consent|0|||
23323494|NCT00925704|64926748|FG001|Third Intervention|Withdrew consent|0|||
23323495|NCT00925704|64926749|FG002|Third Intervention|Withdrew consent|0|||
23323496|NCT00925704|64926750|FG003|Third Intervention|Withdrew consent|0|||
23323497|NCT00925704|64926751|FG004|Third Intervention|Withdrew consent|0|||
23323498|NCT00925704|64926752|FG005|Third Intervention|Withdrew consent|1|||
23323499|NCT00768248|64926753|FG000|Overall Study|Research coordinator didn't collect data|1|||
23323500|NCT00768248|64926754|FG001|Overall Study|Research coordinator didn't collect data|1|||
23559321|NCT04124926|65776203|FG002|Maintenance Phase|Miscellaneous|1|||
23624321|NCT03927690|66011620|FG002|Overall Study|Lost to Follow-up|1|||
23624322|NCT00719043|66011621|FG000|Overall Study|Adverse Event|5|||
23624323|NCT00719043|66011622|FG001|Overall Study|Adverse Event|1|||
23624324|NCT00719043|66011623|FG002|Overall Study|Adverse Event|2|||
23624325|NCT00719043|66011624|FG003|Overall Study|Adverse Event|2|||
23624326|NCT00719043|66011625|FG004|Overall Study|Adverse Event|1|||
23624327|NCT00719043|66011626|FG005|Overall Study|Adverse Event|4|||
23624328|NCT00719043|66011627|FG006|Overall Study|Adverse Event|4|||
23624329|NCT00719043|66011621|FG000|Overall Study|Lost to Follow-up|14|||
23323501|NCT02763046|64926755|FG000|Overall Study|Adverse Event|5|||
23559322|NCT04124926|65776204|FG003|Maintenance Phase|Miscellaneous|2|||
23559323|NCT04124926|65776205|FG004|Maintenance Phase|Miscellaneous|4|||
23559324|NCT04124926|65776201|FG000|Maintenance Phase|Randomized but not Treated|0|||
23559325|NCT04124926|65776202|FG001|Maintenance Phase|Randomized but not Treated|0|||
23559326|NCT04124926|65776203|FG002|Maintenance Phase|Randomized but not Treated|2|||
23559327|NCT04124926|65776204|FG003|Maintenance Phase|Randomized but not Treated|2|||
23559328|NCT04124926|65776205|FG004|Maintenance Phase|Randomized but not Treated|0|||
23559329|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
23559330|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
23559331|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
23559332|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
23559333|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
23323502|NCT02763046|64926756|FG001|Overall Study|Adverse Event|4|||
23323503|NCT02763046|64926757|FG002|Overall Study|Adverse Event|0|||
23323504|NCT02763046|64926755|FG000|Overall Study|Lack of Efficacy|1|||
23323505|NCT02763046|64926756|FG001|Overall Study|Lack of Efficacy|1|||
23323506|NCT02763046|64926757|FG002|Overall Study|Lack of Efficacy|3|||
23323507|NCT02763046|64926755|FG000|Overall Study|Physician Decision|1|||
23323508|NCT02763046|64926756|FG001|Overall Study|Physician Decision|0|||
23323509|NCT02763046|64926757|FG002|Overall Study|Physician Decision|1|||
23323510|NCT02763046|64926755|FG000|Overall Study|Subject/guardian decision|2|||
23323511|NCT02763046|64926756|FG001|Overall Study|Subject/guardian decision|0|||
23323512|NCT02763046|64926757|FG002|Overall Study|Subject/guardian decision|4|||
23624330|NCT00719043|66011622|FG001|Overall Study|Lost to Follow-up|10|||
23624331|NCT00719043|66011623|FG002|Overall Study|Lost to Follow-up|8|||
23323513|NCT01288079|64926758|FG000|Overall Study|Withdrawal by Subject|2|||
23323514|NCT01288079|64926759|FG001|Overall Study|Withdrawal by Subject|4|||
23323515|NCT01288079|64926760|FG002|Overall Study|Withdrawal by Subject|1|||
23323516|NCT01288079|64926761|FG003|Overall Study|Withdrawal by Subject|0|||
23323517|NCT01288079|64926758|FG000|Overall Study|Adverse Event|2|||
23624332|NCT00719043|66011624|FG003|Overall Study|Lost to Follow-up|9|||
23624333|NCT00719043|66011625|FG004|Overall Study|Lost to Follow-up|10|||
23624334|NCT00719043|66011626|FG005|Overall Study|Lost to Follow-up|9|||
23323518|NCT01288079|64926759|FG001|Overall Study|Adverse Event|1|||
23323519|NCT01288079|64926760|FG002|Overall Study|Adverse Event|2|||
23323520|NCT01288079|64926761|FG003|Overall Study|Adverse Event|3|||
23323521|NCT01288079|64926758|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
23323522|NCT01288079|64926759|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
23323523|NCT01288079|64926760|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
23323524|NCT01288079|64926761|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
23323525|NCT01288079|64926758|FG000|Overall Study|Condition under Investigation Worsened|0|||
23149058|NCT00261846|64297468|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
23149059|NCT00261846|64297469|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
23559334|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
23559335|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
23559336|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
23559337|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
23559338|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
23559339|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
23559340|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
23559341|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
23559342|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
23559343|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
23559344|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
23559345|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
23559346|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
23559347|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
23559348|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
23559349|NCT00549757|65776206|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
23559350|NCT00549757|65776207|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
23559351|NCT00549757|65776206|FG000|Extension Period (in Average 9 Months)|Death|143|||
23559352|NCT00549757|65776207|FG001|Extension Period (in Average 9 Months)|Death|136|||
23559353|NCT00549757|65776206|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
23559354|NCT00549757|65776207|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
23559355|NCT00549757|65776206|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
23559356|NCT00549757|65776207|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
23559357|NCT00549757|65776206|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
23559358|NCT00549757|65776207|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
23559359|NCT00863655|65776208|FG000|Overall Study|Protocol Violation|4|||
23559360|NCT00863655|65776209|FG001|Overall Study|Protocol Violation|0|||
23559361|NCT00863655|65776208|FG000|Overall Study|Adverse Event|52|||
23559362|NCT00863655|65776209|FG001|Overall Study|Adverse Event|8|||
23559363|NCT00863655|65776208|FG000|Overall Study|Withdrawal by Subject|47|||
23559364|NCT00863655|65776209|FG001|Overall Study|Withdrawal by Subject|7|||
23559365|NCT00863655|65776208|FG000|Overall Study|Administrative problems|1|||
23559366|NCT00863655|65776209|FG001|Overall Study|Administrative problems|0|||
23559367|NCT00863655|65776208|FG000|Overall Study|Death|7|||
23559368|NCT00863655|65776209|FG001|Overall Study|Death|1|||
23559369|NCT00863655|65776208|FG000|Overall Study|New cancer therapy|5|||
23559370|NCT00863655|65776209|FG001|Overall Study|New cancer therapy|1|||
23559371|NCT00863655|65776208|FG000|Overall Study|Disease progression|364|||
23559372|NCT00863655|65776209|FG001|Overall Study|Disease progression|221|||
23559373|NCT00863655|65776208|FG000|Overall Study|Treatment completed as per protocol|5|||
23559374|NCT00863655|65776209|FG001|Overall Study|Treatment completed as per protocol|1|||
23559375|NCT00572195|65776210|FG000|Overall Study|Withdrawal by Subject|50|||
23559376|NCT00572195|65776210|FG000|Overall Study|Death|9|||
23559377|NCT00572195|65776210|FG000|Overall Study|Adverse Event|4|||
23559378|NCT00572195|65776210|FG000|Overall Study|Lost to Follow-up|5|||
23559379|NCT02170025|65776211|FG000|Overall Study|Adverse Event|2|||
23149060|NCT00261846|64297470|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
23149061|NCT00261846|64297471|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
23323526|NCT01288079|64926759|FG001|Overall Study|Condition under Investigation Worsened|0|||
23559380|NCT02170025|65776212|FG001|Overall Study|Adverse Event|0|||
23559381|NCT00002558|65776213|FG000|Overall Study|Withdrawal by Subject|0|||
23559382|NCT00002558|65776214|FG001|Overall Study|Withdrawal by Subject|1|||
23559383|NCT03595332|65776215|FG000|Overall Study|Lost to Follow-up|16|||
23559384|NCT03595332|65776216|FG001|Overall Study|Lost to Follow-up|22|||
23559385|NCT03595332|65776215|FG000|Overall Study|Unable to retrieve ID from school|0|||
23559386|NCT03595332|65776216|FG001|Overall Study|Unable to retrieve ID from school|2|||
23559387|NCT03445065|65776219|FG000|Overall Study|Withdrawal by Subject|3|||
23149062|NCT00261846|64297472|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
23149063|NCT00261846|64297473|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
23149064|NCT00261846|64297474|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
23323527|NCT01288079|64926760|FG002|Overall Study|Condition under Investigation Worsened|0|||
23559388|NCT03445065|65776220|FG001|Overall Study|Withdrawal by Subject|6|||
23149065|NCT00261846|64297463|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
23559389|NCT03445065|65776221|FG002|Overall Study|Withdrawal by Subject|2|||
23559390|NCT03445065|65776222|FG003|Overall Study|Withdrawal by Subject|2|||
23559391|NCT03445065|65776219|FG000|Overall Study|Other|4|||
23559392|NCT03445065|65776220|FG001|Overall Study|Other|3|||
23559393|NCT03445065|65776221|FG002|Overall Study|Other|3|||
23559394|NCT03445065|65776222|FG003|Overall Study|Other|1|||
23559395|NCT01122381|65776225|FG000|Overall Study|study terminated early|0|||
23559396|NCT01122381|65776226|FG001|Overall Study|study terminated early|1|||
23624335|NCT00719043|66011627|FG006|Overall Study|Lost to Follow-up|9|||
23624336|NCT00719043|66011621|FG000|Overall Study|Protocol Violation|0|||
23624337|NCT00719043|66011622|FG001|Overall Study|Protocol Violation|0|||
23624338|NCT00719043|66011623|FG002|Overall Study|Protocol Violation|0|||
23624339|NCT00719043|66011624|FG003|Overall Study|Protocol Violation|0|||
23219211|NCT00424346|64544794|FG000|Extension Phase|Death|0|||
23624340|NCT00719043|66011625|FG004|Overall Study|Protocol Violation|0|||
23624341|NCT00719043|66011626|FG005|Overall Study|Protocol Violation|1|||
23624342|NCT00719043|66011627|FG006|Overall Study|Protocol Violation|0|||
23624343|NCT00719043|66011621|FG000|Overall Study|Other|1|||
23624344|NCT00719043|66011622|FG001|Overall Study|Other|0|||
23624345|NCT00719043|66011623|FG002|Overall Study|Other|1|||
23624346|NCT00719043|66011624|FG003|Overall Study|Other|2|||
23624347|NCT00719043|66011625|FG004|Overall Study|Other|0|||
23624348|NCT00719043|66011626|FG005|Overall Study|Other|2|||
23624349|NCT00719043|66011627|FG006|Overall Study|Other|1|||
23624350|NCT00719043|66011621|FG000|Overall Study|Withdrawal by Subject|12|||
23624351|NCT00719043|66011622|FG001|Overall Study|Withdrawal by Subject|14|||
23624352|NCT00719043|66011623|FG002|Overall Study|Withdrawal by Subject|9|||
23624353|NCT00719043|66011624|FG003|Overall Study|Withdrawal by Subject|10|||
23219212|NCT00424346|64544795|FG001|Extension Phase|Death|0|||
23219213|NCT00424346|64544796|FG002|Extension Phase|Death|0|||
23219214|NCT00424346|64544797|FG003|Extension Phase|Death|1|||
23219215|NCT00424346|64544794|FG000|Extension Phase|Protocol Violation|0|||
23219216|NCT00424346|64544795|FG001|Extension Phase|Protocol Violation|1|||
23219217|NCT00424346|64544796|FG002|Extension Phase|Protocol Violation|1|||
23219218|NCT00424346|64544797|FG003|Extension Phase|Protocol Violation|0|||
23219219|NCT02420795|64544798|FG000|Overall Study|Withdrawal by Subject|1|||
23219220|NCT02420795|64544799|FG001|Overall Study|Withdrawal by Subject|0|||
23219221|NCT02420795|64544800|FG002|Overall Study|Withdrawal by Subject|0|||
23219222|NCT02420795|64544798|FG000|Overall Study|Adverse Event|1|||
23219223|NCT02420795|64544799|FG001|Overall Study|Adverse Event|0|||
23219224|NCT02420795|64544800|FG002|Overall Study|Adverse Event|0|||
23219225|NCT02420795|64544798|FG000|Overall Study|Progressive disease|2|||
23219226|NCT02420795|64544799|FG001|Overall Study|Progressive disease|2|||
23149066|NCT00261846|64297464|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
23149067|NCT00261846|64297465|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
23149068|NCT00261846|64297466|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
23149069|NCT00261846|64297467|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
23149070|NCT00261846|64297468|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
23149071|NCT00261846|64297469|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
23149072|NCT00261846|64297470|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
23149073|NCT00261846|64297471|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
23149074|NCT00261846|64297472|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
23149075|NCT00261846|64297473|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
23149076|NCT00261846|64297474|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
23149077|NCT03181451|64297476|FG000|Overall Study|Adverse Event|0|||
23149078|NCT03181451|64297477|FG001|Overall Study|Adverse Event|1|||
23219227|NCT02420795|64544800|FG002|Overall Study|Progressive disease|4|||
23219228|NCT02420795|64544798|FG000|Overall Study|Death|0|||
23219229|NCT02420795|64544799|FG001|Overall Study|Death|0|||
23219230|NCT02420795|64544800|FG002|Overall Study|Death|1|||
23219231|NCT04423757|64544803|FG000|Overall Study|Adverse Event|2|||
23219232|NCT04423757|64544804|FG001|Overall Study|Adverse Event|0|||
23219233|NCT04423757|64544803|FG000|Overall Study|Not treated|1|||
23559397|NCT04605978|65776227|FG000|Overall Study|Adverse Event|2|||
23559398|NCT04605978|65776228|FG001|Overall Study|Adverse Event|1|||
23624354|NCT00719043|66011625|FG004|Overall Study|Withdrawal by Subject|16|||
23219234|NCT04423757|64544804|FG001|Overall Study|Not treated|1|||
23219235|NCT00712933|64544805|FG000|Overall Study|Adverse Event|69|||
23219236|NCT00712933|64544805|FG000|Overall Study|Lack of Efficacy|6|||
23559399|NCT04605978|65776227|FG000|Overall Study|Withdrawal nonmedical reason|1|||
23624355|NCT00719043|66011626|FG005|Overall Study|Withdrawal by Subject|18|||
23149079|NCT03181451|64297478|FG002|Overall Study|Adverse Event|0|||
23149080|NCT03181451|64297476|FG000|Overall Study|Withdrawal by Subject|0|||
23219237|NCT00712933|64544805|FG000|Overall Study|Lost to Follow-up|22|||
23624356|NCT00719043|66011627|FG006|Overall Study|Withdrawal by Subject|14|||
23624357|NCT00878553|66011629|FG000|Sleep Study|Withdrawal by Subject|2|||
23624358|NCT00878553|66011630|FG001|Sleep Study|Withdrawal by Subject|0|||
23219238|NCT00712933|64544805|FG000|Overall Study|Non-compliance with study drug|13|||
23219239|NCT00712933|64544805|FG000|Overall Study|Other Pregnancy|37|||
23149081|NCT03181451|64297477|FG001|Overall Study|Withdrawal by Subject|1|||
23149082|NCT03181451|64297478|FG002|Overall Study|Withdrawal by Subject|0|||
23624359|NCT00878553|66011631|FG002|Sleep Study|Withdrawal by Subject|0|||
23624360|NCT00878553|66011632|FG003|Sleep Study|Withdrawal by Subject|0|||
23624361|NCT00878553|66011633|FG004|Sleep Study|Withdrawal by Subject|0|||
23624362|NCT00878553|66011629|FG000|Sleep Study|Lost to Follow-up|1|||
23624363|NCT00878553|66011630|FG001|Sleep Study|Lost to Follow-up|0|||
23624364|NCT00878553|66011631|FG002|Sleep Study|Lost to Follow-up|0|||
23624365|NCT00878553|66011632|FG003|Sleep Study|Lost to Follow-up|0|||
23624366|NCT00878553|66011633|FG004|Sleep Study|Lost to Follow-up|0|||
23559400|NCT04605978|65776228|FG001|Overall Study|Withdrawal nonmedical reason|1|||
23559401|NCT00733980|65776229|FG000|Overall Study|Adverse Event|5|||
23559402|NCT00733980|65776230|FG001|Overall Study|Adverse Event|2|||
23559403|NCT00733980|65776229|FG000|Overall Study|Lack of Efficacy|0|||
23559404|NCT00733980|65776230|FG001|Overall Study|Lack of Efficacy|1|||
23559405|NCT00733980|65776229|FG000|Overall Study|Protocol Violation|2|||
23559406|NCT00733980|65776230|FG001|Overall Study|Protocol Violation|1|||
23559407|NCT00733980|65776229|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
23559408|NCT00733980|65776230|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
23559409|NCT00733980|65776229|FG000|Overall Study|Lost to Follow-up|6|||
23559410|NCT00733980|65776230|FG001|Overall Study|Lost to Follow-up|11|||
23559411|NCT00733980|65776229|FG000|Overall Study|Physician Decision|2|||
23559412|NCT00733980|65776230|FG001|Overall Study|Physician Decision|3|||
23559413|NCT00733980|65776229|FG000|Overall Study|Withdrawal by Subject|6|||
23559414|NCT00733980|65776230|FG001|Overall Study|Withdrawal by Subject|2|||
23559415|NCT02230956|65776231|FG000|Overall Study|Adverse Event|1|||
23559416|NCT02230956|65776232|FG001|Overall Study|Adverse Event|1|||
23559417|NCT02230956|65776233|FG002|Overall Study|Adverse Event|0|||
23559418|NCT02230956|65776231|FG000|Overall Study|Lack of Efficacy|1|||
23559419|NCT02230956|65776232|FG001|Overall Study|Lack of Efficacy|1|||
23559420|NCT02230956|65776233|FG002|Overall Study|Lack of Efficacy|1|||
23559421|NCT02230956|65776231|FG000|Overall Study|Lost to Follow-up|1|||
23559422|NCT02230956|65776232|FG001|Overall Study|Lost to Follow-up|1|||
23559423|NCT02230956|65776233|FG002|Overall Study|Lost to Follow-up|2|||
23559424|NCT02230956|65776231|FG000|Overall Study|Personal Reasons|2|||
23559425|NCT02230956|65776232|FG001|Overall Study|Personal Reasons|1|||
23559426|NCT02230956|65776233|FG002|Overall Study|Personal Reasons|1|||
23559427|NCT02230956|65776231|FG000|Overall Study|Protocol Violation|0|||
23559428|NCT02230956|65776232|FG001|Overall Study|Protocol Violation|1|||
23559429|NCT02230956|65776233|FG002|Overall Study|Protocol Violation|1|||
23624367|NCT00878553|66011629|FG000|Sleep Study|car accident|1|||
23624368|NCT00878553|66011630|FG001|Sleep Study|car accident|0|||
23149083|NCT00388154|64297479|FG000|Overall Study|Withdrawal by Subject|1|||
23149084|NCT01601847|64297480|FG000|Overall Study|Death|1|||
23149085|NCT01601847|64297481|FG001|Overall Study|Death|0|||
23149086|NCT01601847|64297480|FG000|Overall Study|Withdrawal by Subject|11|||
23149087|NCT01601847|64297481|FG001|Overall Study|Withdrawal by Subject|7|||
23149088|NCT01601847|64297480|FG000|Overall Study|Lost to Follow-up|1|||
23149089|NCT01601847|64297481|FG001|Overall Study|Lost to Follow-up|3|||
23149090|NCT04620811|64297482|FG000|Overall Study|Withdrawal by Subject|18|||
23149091|NCT04620811|64297483|FG001|Overall Study|Withdrawal by Subject|15|||
23219240|NCT00712933|64544805|FG000|Overall Study|Sponsor decision|14|||
23219241|NCT00712933|64544805|FG000|Overall Study|Withdrew consent|4|||
23149092|NCT04620811|64297482|FG000|Overall Study|Adverse Event|6|||
23149093|NCT04620811|64297483|FG001|Overall Study|Adverse Event|11|||
23149094|NCT04620811|64297482|FG000|Overall Study|Lost to Follow-up|4|||
23149095|NCT04620811|64297483|FG001|Overall Study|Lost to Follow-up|8|||
23149096|NCT04620811|64297482|FG000|Overall Study|Physician Decision|1|||
23219242|NCT00712933|64544805|FG000|Overall Study|Hip replacement surgery|1|||
23219243|NCT00712933|64544805|FG000|Overall Study|Involved in Clinical research|3|||
23219244|NCT00712933|64544805|FG000|Overall Study|Participant hospitalized|1|||
23219245|NCT00712933|64544805|FG000|Overall Study|Participant travelled overseas|2|||
23219246|NCT00712933|64544805|FG000|Overall Study|Death of patient|1|||
23559430|NCT02230956|65776231|FG000|Overall Study|Other Miscellaneous Reason|0|||
23559431|NCT02230956|65776232|FG001|Overall Study|Other Miscellaneous Reason|1|||
23559432|NCT02230956|65776233|FG002|Overall Study|Other Miscellaneous Reason|2|||
23624369|NCT00878553|66011631|FG002|Sleep Study|car accident|0|||
23624370|NCT00878553|66011632|FG003|Sleep Study|car accident|0|||
23149097|NCT04620811|64297483|FG001|Overall Study|Physician Decision|4|||
23323528|NCT01288079|64926761|FG003|Overall Study|Condition under Investigation Worsened|1|||
23323529|NCT01288079|64926758|FG000|Overall Study|Lack of Efficacy|2|||
23624371|NCT00878553|66011633|FG004|Sleep Study|car accident|0|||
23624372|NCT00878553|66011629|FG000|Sleep Study|family emergency|1|||
23149098|NCT04620811|64297482|FG000|Overall Study|Sponsor Decision|0|||
23149099|NCT04620811|64297483|FG001|Overall Study|Sponsor Decision|1|||
23149100|NCT04620811|64297482|FG000|Overall Study|Elevation of ALT or AST|1|||
23559433|NCT04247282|65776243|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
23559434|NCT04247282|65776244|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
23149101|NCT04620811|64297483|FG001|Overall Study|Elevation of ALT or AST|0|||
23149102|NCT04620811|64297482|FG000|Overall Study|Other|3|||
23624373|NCT00878553|66011630|FG001|Sleep Study|family emergency|0|||
23624374|NCT00878553|66011631|FG002|Sleep Study|family emergency|0|||
23624375|NCT00878553|66011632|FG003|Sleep Study|family emergency|0|||
23624376|NCT00878553|66011633|FG004|Sleep Study|family emergency|0|||
23624377|NCT00878553|66011629|FG000|PK Study|Withdrawal by Subject|0|||
23624378|NCT00878553|66011630|FG001|PK Study|Withdrawal by Subject|0|||
23624379|NCT00878553|66011631|FG002|PK Study|Withdrawal by Subject|0|||
23624380|NCT00878553|66011632|FG003|PK Study|Withdrawal by Subject|1|||
23624381|NCT00878553|66011633|FG004|PK Study|Withdrawal by Subject|0|||
23624382|NCT00598871|66011634|FG000|Overall Study|Adverse Event|0|||
23624383|NCT00598871|66011635|FG001|Overall Study|Adverse Event|1|||
23624384|NCT03834623|66011636|FG000|Overall Study|Progression|0|||
23624385|NCT03834623|66011637|FG001|Overall Study|Progression|1|||
23559435|NCT04247282|65776245|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
23559436|NCT04247282|65776246|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
23559437|NCT04247282|65776243|FG000|Overall Study|Refused further treatment|0|||
23559438|NCT04247282|65776244|FG001|Overall Study|Refused further treatment|1|||
23624386|NCT00776659|66011638|FG000|Overall Study|Lost to Follow-up|15|||
23624387|NCT00776659|66011638|FG000|Overall Study|Withdrawal by Subject|10|||
23624388|NCT00776659|66011638|FG000|Overall Study|Study Terminated by Sponsor|1|||
23624389|NCT04081389|66011639|FG000|Overall Study|Withdrawal by Subject|0|||
23624390|NCT04081389|66011640|FG001|Overall Study|Withdrawal by Subject|0|||
23624391|NCT04081389|66011641|FG002|Overall Study|Withdrawal by Subject|1|||
23624392|NCT04081389|66011642|FG003|Overall Study|Withdrawal by Subject|0|||
23149103|NCT04620811|64297483|FG001|Overall Study|Other|5|||
23149104|NCT03881553|64297489|FG000|Overall Study|Discharged prior to participation|1|||
23149105|NCT03881553|64297490|FG001|Overall Study|Discharged prior to participation|1|||
23149106|NCT03881553|64297491|FG002|Overall Study|Discharged prior to participation|0|||
23149107|NCT03881553|64297489|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
23149108|NCT03881553|64297490|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
23149109|NCT03881553|64297491|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
23149110|NCT01106404|64297492|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
23149111|NCT01106404|64297493|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
23149112|NCT01106404|64297492|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
23149113|NCT01106404|64297493|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
23149114|NCT01106404|64297492|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
23149115|NCT01106404|64297493|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
23149116|NCT01106404|64297492|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
23559439|NCT04247282|65776245|FG002|Overall Study|Refused further treatment|0|||
23559440|NCT04247282|65776246|FG003|Overall Study|Refused further treatment|0|||
23559441|NCT03300570|65776253|FG000|Overall Study|Adverse Event|0|||
23559442|NCT03300570|65776254|FG001|Overall Study|Adverse Event|1|||
23559443|NCT03300570|65776253|FG000|Overall Study|Withdrawal by Subject|1|||
23559444|NCT03300570|65776254|FG001|Overall Study|Withdrawal by Subject|0|||
23559445|NCT03300570|65776253|FG000|Overall Study|Inadequate bowel prep|1|||
23559446|NCT03300570|65776254|FG001|Overall Study|Inadequate bowel prep|0|||
23559447|NCT00658567|65776258|FG000|Overall Study|Adverse Event|5|||
23559448|NCT00658567|65776259|FG001|Overall Study|Adverse Event|2|||
23559449|NCT00658567|65776260|FG002|Overall Study|Adverse Event|3|||
23559450|NCT00658567|65776258|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
23559451|NCT00658567|65776259|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
23559452|NCT00658567|65776260|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
23559453|NCT00658567|65776258|FG000|Overall Study|Physician Decision|0|||
23559454|NCT00658567|65776259|FG001|Overall Study|Physician Decision|1|||
23559455|NCT00658567|65776260|FG002|Overall Study|Physician Decision|0|||
23559456|NCT00658567|65776258|FG000|Overall Study|At Discretion of Sponsor|1|||
23559457|NCT00658567|65776259|FG001|Overall Study|At Discretion of Sponsor|1|||
23559458|NCT00658567|65776260|FG002|Overall Study|At Discretion of Sponsor|1|||
23559459|NCT00685945|65776269|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
23559460|NCT01553318|65776270|FG000|Overall Study|Protocol Violation|3|||
23149117|NCT01106404|64297493|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
23559461|NCT01553318|65776271|FG001|Overall Study|Protocol Violation|2|||
23559462|NCT01435655|65776272|FG000|Overall Study|Death|2|||
23559463|NCT01435655|65776272|FG000|Overall Study|Other|1|||
23624393|NCT01124838|66011646|FG000|Overall Study|Miscellaneous|4|||
23624394|NCT01124838|66011647|FG001|Overall Study|Miscellaneous|2|||
23624395|NCT01124838|66011646|FG000|Overall Study|Adverse Event|7|||
23624396|NCT01124838|66011647|FG001|Overall Study|Adverse Event|11|||
23624397|NCT01124838|66011646|FG000|Overall Study|Lack of Efficacy|2|||
23624398|NCT01124838|66011647|FG001|Overall Study|Lack of Efficacy|0|||
23624399|NCT01124838|66011646|FG000|Overall Study|Withdrawal by Subject|3|||
23624400|NCT01124838|66011647|FG001|Overall Study|Withdrawal by Subject|2|||
23149118|NCT02745392|64297494|FG000|Overall Study|Lost to Follow-up|0|||
23149119|NCT02745392|64297495|FG001|Overall Study|Lost to Follow-up|1|||
23149120|NCT02745392|64297496|FG002|Overall Study|Lost to Follow-up|0|||
23149121|NCT02745392|64297497|FG003|Overall Study|Lost to Follow-up|0|||
23149122|NCT00730171|64297501|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
23149123|NCT00730171|64297501|FG000|Overall Study|Adverse Event|193|||
23149124|NCT00730171|64297501|FG000|Overall Study|Protocol Violation|48|||
23149125|NCT00730171|64297501|FG000|Overall Study|Withdrawal by Subject|202|||
23149126|NCT00730171|64297501|FG000|Overall Study|Lost to Follow-up|121|||
23149127|NCT00730171|64297501|FG000|Overall Study|Insufficient Therapeutic Response|141|||
23149128|NCT00730171|64297501|FG000|Overall Study|Other|61|||
23149129|NCT01810016|64297502|FG000|Overall Study|Progressive disease|1|||
23149130|NCT01810016|64297503|FG001|Overall Study|Progressive disease|1|||
23149131|NCT01810016|64297504|FG002|Overall Study|Progressive disease|0|||
23149132|NCT01810016|64297502|FG000|Overall Study|Death|0|||
23149133|NCT01810016|64297503|FG001|Overall Study|Death|0|||
23149134|NCT01810016|64297504|FG002|Overall Study|Death|1|||
23149135|NCT01133379|64297505|FG000|Overall Study|Withdrawal by Subject|0|||
23149136|NCT01133379|64297506|FG001|Overall Study|Withdrawal by Subject|1|||
23149137|NCT01133379|64297507|FG002|Overall Study|Withdrawal by Subject|1|||
23149138|NCT01133379|64297505|FG000|Overall Study|Lost to Follow-up|1|||
23149139|NCT01133379|64297506|FG001|Overall Study|Lost to Follow-up|1|||
23149140|NCT01133379|64297507|FG002|Overall Study|Lost to Follow-up|1|||
23149141|NCT01478360|64297510|FG000|Overall Study|Lost to Follow-up|1|||
23149142|NCT01478360|64297511|FG001|Overall Study|Lost to Follow-up|0|||
23149143|NCT01478360|64297510|FG000|Overall Study|Adverse Event|0|||
23149144|NCT01478360|64297511|FG001|Overall Study|Adverse Event|1|||
23149145|NCT01478360|64297510|FG000|Overall Study|Administrative problems|1|||
23149146|NCT01478360|64297511|FG001|Overall Study|Administrative problems|2|||
23149147|NCT00056862|64297512|FG000|Overall Study|Protocol Violation|1|||
23149148|NCT00056862|64297513|FG001|Overall Study|Protocol Violation|0|||
23149149|NCT00887679|64297514|FG000|Overall Study|Withdrawal by Subject|1|||
23149150|NCT00887679|64297514|FG000|Overall Study|Lost to Follow-up|4|||
23149151|NCT00887679|64297514|FG000|Overall Study|Physician Decision|5|||
23149152|NCT03093350|64297515|FG000|Overall Study|Death|1|||
23149153|NCT03093350|64297515|FG000|Overall Study|Signed consent, never began treartment|1|||
23149154|NCT00235326|64297524|FG000|Overall Study|Lost to Follow-up|746|||
23149155|NCT00235326|64297525|FG001|Overall Study|Lost to Follow-up|1400|||
23149156|NCT00909792|64297526|FG000|Period 1|Did not meet inclusion criteria|0|||
23149157|NCT00909792|64297527|FG001|Period 1|Did not meet inclusion criteria|1|||
23149158|NCT00909792|64297526|FG000|Period 2|Biomicroscopy|1|||
23149159|NCT00909792|64297527|FG001|Period 2|Biomicroscopy|0|||
23149160|NCT00909792|64297526|FG000|Period 2|Lost to Follow-up|0|||
23149161|NCT00909792|64297527|FG001|Period 2|Lost to Follow-up|1|||
23149162|NCT02547233|64297528|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
23149163|NCT02547233|64297529|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
23323530|NCT01288079|64926759|FG001|Overall Study|Lack of Efficacy|2|||
23323531|NCT01288079|64926760|FG002|Overall Study|Lack of Efficacy|0|||
23323532|NCT01288079|64926761|FG003|Overall Study|Lack of Efficacy|2|||
23323533|NCT01288079|64926758|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
23323534|NCT01288079|64926759|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
23323535|NCT01288079|64926760|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
23323536|NCT01288079|64926761|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
23624401|NCT01124838|66011646|FG000|Overall Study|Lost to Follow-up|2|||
23624402|NCT01124838|66011647|FG001|Overall Study|Lost to Follow-up|0|||
23624403|NCT00004445|66011648|FG000|Overall Study|Physician Decision|2|||
23624404|NCT00004445|66011648|FG000|Overall Study|Withdrawal by Subject|1|||
23624405|NCT00548847|66011649|FG000|Overall Study|Disease progression|7|||
23624406|NCT00761956|66011650|FG000|Overall Study|Lost to Follow-up|6|||
23624407|NCT00761956|66011651|FG001|Overall Study|Lost to Follow-up|11|||
23624408|NCT00761956|66011650|FG000|Overall Study|Withdrawal by Subject|3|||
23624409|NCT00761956|66011651|FG001|Overall Study|Withdrawal by Subject|8|||
23149164|NCT02547233|64297528|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
23149165|NCT02547233|64297529|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
23149166|NCT02547233|64297528|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
23149167|NCT02547233|64297529|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
23149168|NCT02547233|64297528|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
23149169|NCT02547233|64297529|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
23149170|NCT02547233|64297528|FG000|12-month Follow-up|Withdrawal by Subject|10|||
23323537|NCT01288079|64926758|FG000|Overall Study|Lost to Follow-up|1|||
23149171|NCT02547233|64297529|FG001|12-month Follow-up|Withdrawal by Subject|10|||
23149172|NCT02547233|64297528|FG000|12-month Follow-up|Lost to Follow-up|3|||
23149173|NCT02547233|64297529|FG001|12-month Follow-up|Lost to Follow-up|3|||
23624410|NCT00761956|66011650|FG000|Overall Study|Death|0|||
23149174|NCT02547233|64297528|FG000|12-month Follow-up|Lack of Efficacy|1|||
23624411|NCT00761956|66011651|FG001|Overall Study|Death|1|||
23624412|NCT00761956|66011650|FG000|Overall Study|Adverse Event|26|||
23624413|NCT00761956|66011651|FG001|Overall Study|Adverse Event|34|||
23149175|NCT02547233|64297529|FG001|12-month Follow-up|Lack of Efficacy|2|||
23149176|NCT02547233|64297528|FG000|12-month Follow-up|Protocol Violation|0|||
23149177|NCT02547233|64297529|FG001|12-month Follow-up|Protocol Violation|1|||
23149178|NCT02547233|64297528|FG000|12-month Follow-up|Other|0|||
23559464|NCT01499082|65776275|FG000|Overall Study|Randomized but not Treated|0|||
23559465|NCT01499082|65776276|FG001|Overall Study|Randomized but not Treated|1|||
23559466|NCT01499082|65776275|FG000|Overall Study|Adverse Event|12|||
23559467|NCT01499082|65776276|FG001|Overall Study|Adverse Event|16|||
23559468|NCT01499082|65776275|FG000|Overall Study|Lack of Efficacy|1|||
23559469|NCT01499082|65776276|FG001|Overall Study|Lack of Efficacy|1|||
23559470|NCT01499082|65776275|FG000|Overall Study|Protocol Violation|6|||
23559471|NCT01499082|65776276|FG001|Overall Study|Protocol Violation|8|||
23559472|NCT01499082|65776275|FG000|Overall Study|Diverse Reasons|18|||
23559473|NCT01499082|65776276|FG001|Overall Study|Diverse Reasons|14|||
23559474|NCT01499082|65776275|FG000|Overall Study|Site Closure for Noncompliance|5|||
23559475|NCT01499082|65776276|FG001|Overall Study|Site Closure for Noncompliance|2|||
23559476|NCT01499082|65776275|FG000|Overall Study|Hypoglycemia|2|||
23559477|NCT01499082|65776276|FG001|Overall Study|Hypoglycemia|3|||
23149179|NCT02547233|64297529|FG001|12-month Follow-up|Other|1|||
23149180|NCT02225353|64297530|FG000|Overall Study|Lost to Follow-up|0|||
23149181|NCT02225353|64297531|FG001|Overall Study|Lost to Follow-up|1|||
23149182|NCT02225353|64297532|FG002|Overall Study|Lost to Follow-up|3|||
23559478|NCT01499082|65776275|FG000|Overall Study|Lost to Follow-up|1|||
23559479|NCT01499082|65776276|FG001|Overall Study|Lost to Follow-up|3|||
23559480|NCT00790452|65776277|FG000|Overall Study|Drug supply issue|1|||
23559481|NCT00790452|65776278|FG001|Overall Study|Drug supply issue|0|||
23559482|NCT03649230|65776279|FG000|Overall Study|Adverse Event|12|||
23559483|NCT03649230|65776279|FG000|Overall Study|Death|8|||
23559484|NCT03649230|65776279|FG000|Overall Study|Withdrawal by Subject|6|||
23559485|NCT03649230|65776279|FG000|Overall Study|Physician Decision|5|||
23559486|NCT03649230|65776279|FG000|Overall Study|Disease progression|5|||
23559487|NCT03649230|65776279|FG000|Overall Study|Switched to non-HEC|5|||
23559488|NCT03649230|65776279|FG000|Overall Study|Chemotherapy discontinued|4|||
23559489|NCT03649230|65776279|FG000|Overall Study|Received only 3 HEC cycles|4|||
23559490|NCT03649230|65776279|FG000|Overall Study|Screen Failure|3|||
23559491|NCT03649230|65776279|FG000|Overall Study|Patient stopped treatment|2|||
23559492|NCT03649230|65776279|FG000|Overall Study|Protocol Violation|1|||
23559493|NCT03649230|65776279|FG000|Overall Study|Non-compliance|1|||
23559494|NCT03649230|65776279|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
23559495|NCT01490125|65776280|FG000|Period I|Adverse Event|4|||
23559496|NCT01490125|65776281|FG001|Period I|Adverse Event|1|||
23559497|NCT01490125|65776282|FG002|Period I|Adverse Event|1|||
23559498|NCT01490125|65776283|FG003|Period I|Adverse Event|3|||
23559499|NCT01490125|65776284|FG004|Period I|Adverse Event|2|||
23559500|NCT01490125|65776285|FG005|Period I|Adverse Event|4|||
23559501|NCT01490125|65776280|FG000|Period I|Protocol Violation|1|||
23559502|NCT01490125|65776281|FG001|Period I|Protocol Violation|1|||
23559503|NCT01490125|65776282|FG002|Period I|Protocol Violation|1|||
23559504|NCT01490125|65776283|FG003|Period I|Protocol Violation|1|||
23559505|NCT01490125|65776284|FG004|Period I|Protocol Violation|0|||
23559506|NCT01490125|65776285|FG005|Period I|Protocol Violation|0|||
23559507|NCT01490125|65776280|FG000|Period I|Withdrawal by Subject|1|||
23559508|NCT01490125|65776281|FG001|Period I|Withdrawal by Subject|3|||
23559509|NCT01490125|65776282|FG002|Period I|Withdrawal by Subject|2|||
23559510|NCT01490125|65776283|FG003|Period I|Withdrawal by Subject|1|||
23559511|NCT01490125|65776284|FG004|Period I|Withdrawal by Subject|2|||
23149183|NCT02225353|64297530|FG000|Overall Study|Protocol Violation|4|||
23149184|NCT02225353|64297531|FG001|Overall Study|Protocol Violation|5|||
23219247|NCT00712933|64544805|FG000|Overall Study|Other Physician decision|1|||
23219248|NCT00712933|64544805|FG000|Overall Study|Not committed to contraception|1|||
23559512|NCT01490125|65776285|FG005|Period I|Withdrawal by Subject|1|||
23149185|NCT02225353|64297532|FG002|Overall Study|Protocol Violation|12|||
23149186|NCT01119001|64297533|FG000|Overall Study|Withdrawal by Subject|2|||
23149187|NCT01019980|64297534|FG000|Overall Study|Drug not available.|2|||
23149188|NCT01019980|64297535|FG001|Overall Study|Drug not available.|0|||
23323538|NCT01288079|64926759|FG001|Overall Study|Lost to Follow-up|1|||
23323539|NCT01288079|64926760|FG002|Overall Study|Lost to Follow-up|1|||
23559513|NCT01490125|65776280|FG000|Period II|Adverse Event|2|||
23559514|NCT01490125|65776281|FG001|Period II|Adverse Event|3|||
23559515|NCT01490125|65776282|FG002|Period II|Adverse Event|2|||
23559516|NCT01490125|65776283|FG003|Period II|Adverse Event|2|||
23559517|NCT01490125|65776284|FG004|Period II|Adverse Event|4|||
23559518|NCT01490125|65776285|FG005|Period II|Adverse Event|2|||
23559519|NCT01490125|65776280|FG000|Period II|Protocol Violation|0|||
23559520|NCT01490125|65776281|FG001|Period II|Protocol Violation|0|||
23559521|NCT01490125|65776282|FG002|Period II|Protocol Violation|1|||
23559522|NCT01490125|65776283|FG003|Period II|Protocol Violation|1|||
23559523|NCT01490125|65776284|FG004|Period II|Protocol Violation|0|||
23559524|NCT01490125|65776285|FG005|Period II|Protocol Violation|0|||
23559525|NCT01490125|65776280|FG000|Period II|Lost to Follow-up|0|||
23559526|NCT01490125|65776281|FG001|Period II|Lost to Follow-up|1|||
23149189|NCT01383161|64297536|FG000|Overall Study|Adverse Event|5|||
23323540|NCT01288079|64926761|FG003|Overall Study|Lost to Follow-up|0|||
23323541|NCT01288079|64926758|FG000|Overall Study|Other or Study Termination|11|||
23323542|NCT01288079|64926759|FG001|Overall Study|Other or Study Termination|15|||
23323543|NCT01288079|64926760|FG002|Overall Study|Other or Study Termination|14|||
23323544|NCT01288079|64926761|FG003|Overall Study|Other or Study Termination|8|||
23323545|NCT01526655|64926766|FG000|Overall Study|Withdrawal by Subject|0|||
23323546|NCT01526655|64926767|FG001|Overall Study|Withdrawal by Subject|1|||
23323547|NCT00856492|64926768|FG000|Overall Study|Ineligible or withdrew consent|1|||
23323548|NCT00856492|64926769|FG001|Overall Study|Ineligible or withdrew consent|1|||
23323549|NCT00856492|64926770|FG002|Overall Study|Ineligible or withdrew consent|2|||
23323550|NCT03305848|64926771|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
23323551|NCT03305848|64926771|FG000|Overall Study|Physician Decision|2|||
23149190|NCT01383161|64297537|FG001|Overall Study|Adverse Event|1|||
23559527|NCT01490125|65776282|FG002|Period II|Lost to Follow-up|0|||
23559528|NCT01490125|65776283|FG003|Period II|Lost to Follow-up|0|||
23559529|NCT01490125|65776284|FG004|Period II|Lost to Follow-up|0|||
23559530|NCT01490125|65776285|FG005|Period II|Lost to Follow-up|0|||
23559531|NCT01490125|65776280|FG000|Period II|Withdrawal by Subject|1|||
23559532|NCT01490125|65776281|FG001|Period II|Withdrawal by Subject|0|||
23559533|NCT01490125|65776282|FG002|Period II|Withdrawal by Subject|0|||
23559534|NCT01490125|65776283|FG003|Period II|Withdrawal by Subject|0|||
23559535|NCT01490125|65776284|FG004|Period II|Withdrawal by Subject|0|||
23559536|NCT01490125|65776285|FG005|Period II|Withdrawal by Subject|0|||
23559537|NCT01490125|65776280|FG000|Period III|Adverse Event|3|||
23559538|NCT01490125|65776281|FG001|Period III|Adverse Event|1|||
23559539|NCT01490125|65776282|FG002|Period III|Adverse Event|0|||
23559540|NCT01490125|65776283|FG003|Period III|Adverse Event|1|||
23559541|NCT01490125|65776284|FG004|Period III|Adverse Event|0|||
23559542|NCT01490125|65776285|FG005|Period III|Adverse Event|0|||
23559543|NCT01490125|65776280|FG000|Period III|Death|0|||
23559544|NCT01490125|65776281|FG001|Period III|Death|0|||
23559545|NCT01490125|65776282|FG002|Period III|Death|0|||
23559546|NCT01490125|65776283|FG003|Period III|Death|1|||
23559547|NCT01490125|65776284|FG004|Period III|Death|0|||
23559548|NCT01490125|65776285|FG005|Period III|Death|0|||
23559549|NCT01490125|65776280|FG000|Period III|Lack of Efficacy|0|||
23559550|NCT01490125|65776281|FG001|Period III|Lack of Efficacy|0|||
23559551|NCT01490125|65776282|FG002|Period III|Lack of Efficacy|0|||
23559552|NCT01490125|65776283|FG003|Period III|Lack of Efficacy|0|||
23559553|NCT01490125|65776284|FG004|Period III|Lack of Efficacy|1|||
23559554|NCT01490125|65776285|FG005|Period III|Lack of Efficacy|0|||
23559555|NCT04179721|65776286|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
23559556|NCT04179721|65776287|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
23559557|NCT04179721|65776286|FG000|Overall Study|Lost to Follow-up|0|||
23559558|NCT04179721|65776287|FG001|Overall Study|Lost to Follow-up|1|||
23559559|NCT01061333|65776289|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
23559560|NCT01061333|65776290|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
23559561|NCT04425902|65776291|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
23559562|NCT01353222|65776297|FG000|Overall Study|Death|30|||
23559563|NCT01353222|65776298|FG001|Overall Study|Death|30|||
23559564|NCT01353222|65776297|FG000|Overall Study|Withdrawal by Subject|8|||
23559565|NCT01353222|65776298|FG001|Overall Study|Withdrawal by Subject|5|||
23559566|NCT01353222|65776297|FG000|Overall Study|Study Terminated|31|||
23559567|NCT01353222|65776298|FG001|Overall Study|Study Terminated|37|||
23559568|NCT01353222|65776297|FG000|Overall Study|Site closed research department|1|||
23559569|NCT01353222|65776298|FG001|Overall Study|Site closed research department|0|||
23559570|NCT00570674|65776300|FG000|Overall Study|Withdrawal by Subject|0|||
23149191|NCT01383161|64297536|FG000|Overall Study|Withdrawal by Subject|0|||
23149192|NCT01383161|64297537|FG001|Overall Study|Withdrawal by Subject|2|||
23149193|NCT01383161|64297536|FG000|Overall Study|Lack of Efficacy|0|||
23149194|NCT01383161|64297537|FG001|Overall Study|Lack of Efficacy|1|||
23323552|NCT01368497|64926774|FG000|Overall Study|Lost to Follow-up|2|||
23559571|NCT00570674|65776301|FG001|Overall Study|Withdrawal by Subject|0|||
23559572|NCT00570674|65776302|FG002|Overall Study|Withdrawal by Subject|1|||
23559573|NCT00570674|65776303|FG003|Overall Study|Withdrawal by Subject|0|||
23149195|NCT03359590|64297538|FG000|First Intervention|Withdrawal by Subject|1|||
23149196|NCT03359590|64297539|FG001|First Intervention|Withdrawal by Subject|1|||
23559574|NCT00570674|65776304|FG004|Overall Study|Withdrawal by Subject|0|||
23149197|NCT03359590|64297538|FG000|First Intervention|Protocol Violation|0|||
23323553|NCT02789137|64926775|FG000|Overall Study|Dropped out/Died|58|||
23323554|NCT02790437|64926776|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
23559575|NCT00570674|65776305|FG005|Overall Study|Withdrawal by Subject|0|||
23149198|NCT03359590|64297539|FG001|First Intervention|Protocol Violation|1|||
23559576|NCT00570674|65776306|FG006|Overall Study|Withdrawal by Subject|0|||
23559577|NCT05168579|65776307|FG000|Overall Study|Lack of Consent|1|||
23559578|NCT05168579|65776308|FG001|Overall Study|Lack of Consent|0|||
23559579|NCT05168579|65776307|FG000|Overall Study|Conflicts with time|2|||
23559580|NCT05168579|65776308|FG001|Overall Study|Conflicts with time|0|||
23149199|NCT03267940|64297543|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
23149200|NCT03267940|64297544|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
23149201|NCT03267940|64297545|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
23149202|NCT03267940|64297546|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
23149203|NCT03267940|64297547|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
23149204|NCT03267940|64297548|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
23149205|NCT03267940|64297543|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23149206|NCT03267940|64297544|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
23559581|NCT05168579|65776307|FG000|Overall Study|Time slots were full|3|||
23559582|NCT05168579|65776308|FG001|Overall Study|Time slots were full|0|||
23559583|NCT05168579|65776307|FG000|Overall Study|Lost to Follow-up|0|||
23559584|NCT05168579|65776308|FG001|Overall Study|Lost to Follow-up|15|||
23559585|NCT02606279|65776309|FG000|Overall Study|Lost to Follow-up|0|||
23559586|NCT02606279|65776310|FG001|Overall Study|Lost to Follow-up|1|||
23559587|NCT04710927|65776311|FG000|Overall Study|Lost to Follow-up|7|||
23559588|NCT04710927|65776312|FG001|Overall Study|Lost to Follow-up|6|||
23559589|NCT04710927|65776313|FG002|Overall Study|Lost to Follow-up|5|||
23559590|NCT03320018|65776314|FG000|Treatment Period|Withdrawal by Subject|1|||
23559591|NCT03320018|65776315|FG001|Treatment Period|Withdrawal by Subject|0|||
23559592|NCT03320018|65776314|FG000|Day 90 Follow up|Death|0|||
23559593|NCT03320018|65776315|FG001|Day 90 Follow up|Death|1|||
23559594|NCT00943306|65776317|FG000|Overall Study|Physician Decision|1|||
23559595|NCT00943306|65776317|FG000|Overall Study|Death|1|||
23559596|NCT00943306|65776317|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
23559597|NCT02691182|65776319|FG000|Overall Study|Withdrawal by Subject|4|||
23559598|NCT02691182|65776320|FG001|Overall Study|Withdrawal by Subject|7|||
23559599|NCT02691182|65776321|FG002|Overall Study|Withdrawal by Subject|6|||
23559600|NCT02691182|65776322|FG003|Overall Study|Withdrawal by Subject|8|||
23559601|NCT02691182|65776319|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
23559602|NCT02691182|65776320|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
23559603|NCT02691182|65776321|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
23559604|NCT02691182|65776322|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
23559605|NCT02691182|65776319|FG000|Overall Study|Lost to Follow-up|8|||
23559606|NCT02691182|65776320|FG001|Overall Study|Lost to Follow-up|33|||
23559607|NCT02691182|65776321|FG002|Overall Study|Lost to Follow-up|19|||
23559608|NCT02691182|65776322|FG003|Overall Study|Lost to Follow-up|22|||
23559609|NCT02691182|65776319|FG000|Overall Study|Adverse Event|3|||
23559610|NCT02691182|65776320|FG001|Overall Study|Adverse Event|10|||
23559611|NCT02691182|65776321|FG002|Overall Study|Adverse Event|10|||
23559612|NCT02691182|65776322|FG003|Overall Study|Adverse Event|11|||
23149207|NCT03267940|64297545|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23149208|NCT03267940|64297546|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23149209|NCT03267940|64297547|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23149210|NCT03267940|64297548|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
23149211|NCT03267940|64297543|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23149212|NCT03267940|64297544|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
23149213|NCT03267940|64297545|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23149214|NCT03267940|64297546|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23149215|NCT03267940|64297547|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23149216|NCT03267940|64297548|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
23149217|NCT03267940|64297543|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
23149218|NCT03267940|64297544|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
23149219|NCT03267940|64297545|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
23437776|NCT02927938|65344204|FG002|Overall Study|Death|0|||
23559613|NCT02691182|65776319|FG000|Overall Study|Physician Decision|3|||
23559614|NCT02691182|65776320|FG001|Overall Study|Physician Decision|7|||
23559615|NCT02691182|65776321|FG002|Overall Study|Physician Decision|14|||
23559616|NCT02691182|65776322|FG003|Overall Study|Physician Decision|8|||
23559617|NCT02691182|65776319|FG000|Overall Study|Lack of Efficacy|0|||
23149220|NCT03267940|64297546|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
23149221|NCT03267940|64297547|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
23149222|NCT03267940|64297548|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
23149223|NCT03267940|64297543|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
23149224|NCT03267940|64297544|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
23437777|NCT02927938|65344205|FG003|Overall Study|Death|4|||
23559618|NCT02691182|65776320|FG001|Overall Study|Lack of Efficacy|0|||
23559619|NCT02691182|65776321|FG002|Overall Study|Lack of Efficacy|0|||
23559620|NCT02691182|65776322|FG003|Overall Study|Lack of Efficacy|4|||
23559621|NCT02691182|65776319|FG000|Overall Study|Protocol Violation|2|||
23559622|NCT02691182|65776320|FG001|Overall Study|Protocol Violation|6|||
23559623|NCT02691182|65776321|FG002|Overall Study|Protocol Violation|6|||
23559624|NCT02691182|65776322|FG003|Overall Study|Protocol Violation|8|||
23559625|NCT02691182|65776319|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
23559626|NCT02691182|65776320|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
23559627|NCT02691182|65776321|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
23559628|NCT02691182|65776322|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
23559629|NCT02691182|65776319|FG000|Overall Study|Missing|0|||
23559630|NCT02691182|65776320|FG001|Overall Study|Missing|5|||
23559631|NCT02691182|65776321|FG002|Overall Study|Missing|1|||
23559632|NCT02691182|65776322|FG003|Overall Study|Missing|5|||
23559633|NCT01807650|65776323|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
23559634|NCT01807650|65776323|FG000|Overall Study|Adverse Event|5|||
23559635|NCT01807650|65776323|FG000|Overall Study|Other|2|||
23559636|NCT00691938|65776328|FG000|Overall Study|QTc prolongation|1|||
23559637|NCT00691938|65776329|FG001|Overall Study|QTc prolongation|0|||
23559638|NCT00691938|65776330|FG002|Overall Study|QTc prolongation|0|||
23149225|NCT03267940|64297545|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
23149226|NCT03267940|64297546|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
23149227|NCT03267940|64297547|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
23149228|NCT03267940|64297548|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
23149229|NCT03267940|64297543|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
23149230|NCT03267940|64297544|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
23149231|NCT03267940|64297545|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
23149232|NCT03267940|64297546|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
23149233|NCT03267940|64297547|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
23149234|NCT03267940|64297548|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
23149235|NCT03267940|64297543|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
23149236|NCT03267940|64297544|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
23149237|NCT03267940|64297545|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
23149238|NCT03267940|64297546|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
23149239|NCT03267940|64297547|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
23149240|NCT03267940|64297548|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
23149241|NCT03267940|64297543|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
23149242|NCT03267940|64297544|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
23149243|NCT03267940|64297545|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
23149244|NCT03267940|64297546|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
23149245|NCT03267940|64297547|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
23149246|NCT03267940|64297548|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
23559639|NCT00691938|65776331|FG003|Overall Study|QTc prolongation|0|||
23559640|NCT00691938|65776332|FG004|Overall Study|QTc prolongation|0|||
23559641|NCT00691938|65776333|FG005|Overall Study|QTc prolongation|0|||
23559642|NCT00691938|65776334|FG006|Overall Study|QTc prolongation|0|||
23149247|NCT03267940|64297543|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
23149248|NCT03267940|64297544|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
23149249|NCT03267940|64297545|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
23149250|NCT03267940|64297546|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
23149251|NCT03267940|64297547|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
23149252|NCT03267940|64297548|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
23149253|NCT02742766|64297549|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149254|NCT02742766|64297550|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23219249|NCT00712933|64544805|FG000|Overall Study|Participant received medication|1|||
23559643|NCT04080752|65776335|FG000|Overall Study|Adverse Event|2|||
23559644|NCT04080752|65776336|FG001|Overall Study|Adverse Event|3|||
23559645|NCT04080752|65776335|FG000|Overall Study|Lack of Efficacy|1|||
23559646|NCT04080752|65776336|FG001|Overall Study|Lack of Efficacy|0|||
23559647|NCT04080752|65776335|FG000|Overall Study|Lost to Follow-up|1|||
23559648|NCT04080752|65776336|FG001|Overall Study|Lost to Follow-up|0|||
23559649|NCT04080752|65776335|FG000|Overall Study|Pregnancy|0|||
23559650|NCT04080752|65776336|FG001|Overall Study|Pregnancy|1|||
23559651|NCT04080752|65776335|FG000|Overall Study|Withdrawal by Subject|7|||
23559652|NCT04080752|65776336|FG001|Overall Study|Withdrawal by Subject|0|||
23559653|NCT04080752|65776335|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23149255|NCT02742766|64297551|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149256|NCT02742766|64297552|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23219250|NCT00712933|64544805|FG000|Overall Study|Physician Decision|36|||
23219251|NCT00712933|64544805|FG000|Overall Study|Protocol Violation|4|||
23559654|NCT04080752|65776336|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23559655|NCT04080752|65776335|FG000|Overall Study|Other|2|||
23624414|NCT01181609|66011652|FG000|Overall Study|Adverse Event|1|||
23559656|NCT04080752|65776336|FG001|Overall Study|Other|1|||
23559657|NCT01657266|65776337|FG000|Overall Study|Lost to Follow-up|2|||
23559658|NCT01657266|65776338|FG001|Overall Study|Lost to Follow-up|2|||
23149257|NCT02742766|64297553|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23559659|NCT01657266|65776337|FG000|Overall Study|Adverse Event|2|||
23559660|NCT01657266|65776338|FG001|Overall Study|Adverse Event|3|||
23559661|NCT04098406|65776339|FG000|Overall Study|Adverse Event|2|||
23559662|NCT04098406|65776340|FG001|Overall Study|Adverse Event|1|||
23559663|NCT04098406|65776339|FG000|Overall Study|Withdrawal by Subject|1|||
23559664|NCT04098406|65776340|FG001|Overall Study|Withdrawal by Subject|0|||
23559665|NCT00985985|65776344|FG000|Overall Study|Adverse Event|4|||
23559666|NCT00985985|65776345|FG001|Overall Study|Adverse Event|2|||
23559667|NCT00985985|65776346|FG002|Overall Study|Adverse Event|2|||
23559668|NCT00985985|65776347|FG003|Overall Study|Adverse Event|2|||
23559669|NCT00985985|65776344|FG000|Overall Study|Lost to Follow-up|4|||
23559670|NCT00985985|65776345|FG001|Overall Study|Lost to Follow-up|11|||
23559671|NCT00985985|65776346|FG002|Overall Study|Lost to Follow-up|2|||
23559672|NCT00985985|65776347|FG003|Overall Study|Lost to Follow-up|3|||
23559673|NCT00985985|65776344|FG000|Overall Study|Protocol Violation|1|||
23559674|NCT00985985|65776345|FG001|Overall Study|Protocol Violation|2|||
23559675|NCT00985985|65776346|FG002|Overall Study|Protocol Violation|0|||
23559676|NCT00985985|65776347|FG003|Overall Study|Protocol Violation|1|||
23559677|NCT00985985|65776344|FG000|Overall Study|Lack of Efficacy|5|||
23559678|NCT00985985|65776345|FG001|Overall Study|Lack of Efficacy|6|||
23559679|NCT00985985|65776346|FG002|Overall Study|Lack of Efficacy|1|||
23559680|NCT00985985|65776347|FG003|Overall Study|Lack of Efficacy|3|||
23559681|NCT00985985|65776344|FG000|Overall Study|Withdrawal by Subject|4|||
23559682|NCT00985985|65776345|FG001|Overall Study|Withdrawal by Subject|2|||
23559683|NCT00985985|65776346|FG002|Overall Study|Withdrawal by Subject|2|||
23149258|NCT02742766|64297554|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23219252|NCT00712933|64544805|FG000|Overall Study|Withdrawal by Subject|151|||
23219253|NCT01527110|64544806|FG000|Overall Study|Adverse Event|1|||
23219254|NCT02999191|64544807|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
23219255|NCT02999191|64544808|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
23219256|NCT02999191|64544809|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
23437778|NCT02927938|65344202|FG000|Overall Study|Early Study Termination|1|||
23149259|NCT02742766|64297555|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149260|NCT02742766|64297556|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149261|NCT02742766|64297557|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149262|NCT02742766|64297558|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149263|NCT02742766|64297559|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149264|NCT02742766|64297560|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149265|NCT02742766|64297561|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149266|NCT02742766|64297562|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
23149267|NCT02742766|64297563|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149268|NCT02742766|64297564|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149269|NCT02742766|64297565|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149270|NCT02742766|64297566|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149271|NCT02742766|64297567|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
23149272|NCT02742766|64297549|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149273|NCT02742766|64297550|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149274|NCT02742766|64297551|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149275|NCT02742766|64297552|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149276|NCT02742766|64297553|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149277|NCT02742766|64297554|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
23219257|NCT01709708|64544813|FG000|Overall Study|Protocol Violation|1|||
23437779|NCT02927938|65344203|FG001|Overall Study|Early Study Termination|5|||
23437780|NCT02927938|65344204|FG002|Overall Study|Early Study Termination|4|||
23437781|NCT02927938|65344205|FG003|Overall Study|Early Study Termination|3|||
23437782|NCT01380834|65344206|FG000|Overall Study|Physician Decision|1|||
23437783|NCT01380834|65344207|FG001|Overall Study|Physician Decision|0|||
23437784|NCT00455143|65344212|FG000|Overall Study|Physician Decision|1|||
23437785|NCT00455143|65344212|FG000|Overall Study|Withdrawal by Subject|1|||
23437786|NCT00455143|65344212|FG000|Overall Study|Staff was not avail to follow patient|2|||
23437787|NCT00455143|65344212|FG000|Overall Study|No longer met Inclusion Criteria|1|||
23437788|NCT00455143|65344212|FG000|Overall Study|Surgical time, staff not available|1|||
23559684|NCT00985985|65776347|FG003|Overall Study|Withdrawal by Subject|2|||
23437789|NCT01543776|65344215|FG000|Overall Study|Withdrawal by Subject|2|||
23559685|NCT00985985|65776344|FG000|Overall Study|Other Reason|6|||
23559686|NCT00985985|65776345|FG001|Overall Study|Other Reason|1|||
23559687|NCT00985985|65776346|FG002|Overall Study|Other Reason|4|||
23559688|NCT00985985|65776347|FG003|Overall Study|Other Reason|2|||
23559689|NCT01750879|65776350|FG000|Overall Study|Adverse Event|8|||
23559690|NCT01750879|65776351|FG001|Overall Study|Adverse Event|0|||
23559691|NCT01750879|65776350|FG000|Overall Study|Lack of Efficacy|1|||
23149278|NCT02742766|64297555|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149279|NCT02742766|64297556|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149280|NCT02742766|64297557|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
23437790|NCT01543776|65344216|FG001|Overall Study|Withdrawal by Subject|2|||
23437791|NCT00392990|65344217|FG000|Treatment on Study|Adverse Event|3|||
23437792|NCT00392990|65344218|FG001|Treatment on Study|Adverse Event|1|||
23437793|NCT00392990|65344217|FG000|Follow up for 2 Years|Death|4|||
23624415|NCT01181609|66011652|FG000|Overall Study|Withdrawal by Subject|1|||
23624416|NCT01181609|66011652|FG000|Overall Study|Lost to Follow-up|1|||
23624417|NCT01181609|66011652|FG000|Overall Study|Death|50|||
23624418|NCT00344032|66011653|FG000|Overall Study|Adverse Event|0|||
23624419|NCT00344032|66011654|FG001|Overall Study|Adverse Event|1|||
23624420|NCT00344032|66011653|FG000|Overall Study|Withdrawal by Subject|6|||
23624421|NCT00344032|66011654|FG001|Overall Study|Withdrawal by Subject|2|||
23624422|NCT00344032|66011653|FG000|Overall Study|Lost to Follow-up|4|||
23624423|NCT00344032|66011654|FG001|Overall Study|Lost to Follow-up|6|||
23624424|NCT00344032|66011653|FG000|Overall Study|Physician Decision|4|||
23624425|NCT00344032|66011654|FG001|Overall Study|Physician Decision|1|||
23624426|NCT03246347|66011657|FG000|Overall Study|On Study|23|||
23624427|NCT01340014|66011658|FG000|Period 1, First 7 Days|Adverse Event|1|||
23624428|NCT01340014|66011659|FG001|Period 1, First 7 Days|Adverse Event|0|||
23624429|NCT01340014|66011658|FG000|Period 1, First 7 Days|Personal Reasons|1|||
23624430|NCT01340014|66011659|FG001|Period 1, First 7 Days|Personal Reasons|0|||
23624431|NCT01340014|66011658|FG000|Period 2, Second 7 Days|Adverse Event|0|||
23624432|NCT01340014|66011659|FG001|Period 2, Second 7 Days|Adverse Event|1|||
23624433|NCT00320398|66011667|FG000|Overall Study|Adverse Event|1|||
23624434|NCT00320398|66011668|FG001|Overall Study|Adverse Event|4|||
23624435|NCT00320398|66011667|FG000|Overall Study|Other|1|||
23624436|NCT00320398|66011668|FG001|Overall Study|Other|0|||
23624437|NCT01777490|66011669|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
23624438|NCT01777490|66011670|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
23624439|NCT01777490|66011671|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
23624440|NCT01777490|66011672|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
23624441|NCT00983905|66011676|FG000|Theophylline Alone|Adverse Event|1|||
23624442|NCT00983905|66011676|FG000|Colchicine Alone|Adverse Event|2|||
23624443|NCT00846768|66011686|FG000|Overall Study|Adverse Event|0|||
23624444|NCT00846768|66011687|FG001|Overall Study|Adverse Event|1|||
23624445|NCT00846768|66011688|FG002|Overall Study|Adverse Event|0|||
23624446|NCT00846768|66011689|FG003|Overall Study|Adverse Event|0|||
23624447|NCT01375114|66011690|FG000|Overall Study|Lost to Follow-up|1|||
23624448|NCT01375114|66011691|FG001|Overall Study|Lost to Follow-up|0|||
23624449|NCT01375114|66011692|FG002|Overall Study|Lost to Follow-up|1|||
23624450|NCT01375114|66011690|FG000|Overall Study|Disease Progression|3|||
23624451|NCT01375114|66011691|FG001|Overall Study|Disease Progression|2|||
23624452|NCT01375114|66011692|FG002|Overall Study|Disease Progression|2|||
23624453|NCT01375114|66011690|FG000|Overall Study|Patient Changed Mind|0|||
23624454|NCT01375114|66011691|FG001|Overall Study|Patient Changed Mind|0|||
23624455|NCT01375114|66011692|FG002|Overall Study|Patient Changed Mind|2|||
23624456|NCT01375114|66011690|FG000|Overall Study|Pruritus|0|||
23624457|NCT01375114|66011691|FG001|Overall Study|Pruritus|0|||
23624458|NCT01375114|66011692|FG002|Overall Study|Pruritus|1|||
23624459|NCT01375114|66011690|FG000|Overall Study|Restlessness|0|||
23624460|NCT01375114|66011691|FG001|Overall Study|Restlessness|0|||
23624461|NCT01375114|66011692|FG002|Overall Study|Restlessness|1|||
23437794|NCT00392990|65344218|FG001|Follow up for 2 Years|Death|0|||
23437795|NCT00666965|65344219|FG000|Overall Study|Adverse Event|0|||
23437796|NCT00666965|65344220|FG001|Overall Study|Adverse Event|2|||
23437797|NCT00666965|65344221|FG002|Overall Study|Adverse Event|1|||
23437798|NCT00666965|65344222|FG003|Overall Study|Adverse Event|9|||
23437799|NCT00666965|65344219|FG000|Overall Study|Lack of Efficacy|1|||
23437800|NCT00666965|65344220|FG001|Overall Study|Lack of Efficacy|1|||
23624462|NCT01375114|66011690|FG000|Overall Study|Diarrhea|0|||
23624463|NCT01375114|66011691|FG001|Overall Study|Diarrhea|0|||
23624464|NCT01375114|66011692|FG002|Overall Study|Diarrhea|1|||
23624465|NCT01375114|66011690|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
23624466|NCT01375114|66011691|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
23624467|NCT01375114|66011692|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
23624468|NCT01375114|66011690|FG000|Overall Study|Nausea|0|||
23624469|NCT01375114|66011691|FG001|Overall Study|Nausea|1|||
23149281|NCT02742766|64297558|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149282|NCT02742766|64297559|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149283|NCT02742766|64297560|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149284|NCT02742766|64297561|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
23149285|NCT02742766|64297562|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
23149286|NCT02742766|64297563|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149287|NCT02742766|64297564|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
23149288|NCT02742766|64297565|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149289|NCT02742766|64297566|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149290|NCT02742766|64297567|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
23149291|NCT04178967|64297570|FG000|Induction Period|Adverse Event|4|||
23149292|NCT04178967|64297571|FG001|Induction Period|Adverse Event|6|||
23219258|NCT01709708|64544814|FG001|Overall Study|Protocol Violation|2|||
23219259|NCT00407550|64544815|FG000|Overall Study|Adverse Event|0|||
23219260|NCT00407550|64544816|FG001|Overall Study|Adverse Event|1|||
23219261|NCT00407550|64544815|FG000|Overall Study|Withdrawal by Subject|0|||
23219262|NCT00407550|64544816|FG001|Overall Study|Withdrawal by Subject|2|||
23219263|NCT00407550|64544815|FG000|Overall Study|Death|1|||
23219264|NCT00407550|64544816|FG001|Overall Study|Death|0|||
23219265|NCT00407550|64544815|FG000|Overall Study|Insurance or Other medical condition|2|||
23219266|NCT00407550|64544816|FG001|Overall Study|Insurance or Other medical condition|1|||
23219267|NCT00355134|64544822|FG000|Core Phase|Withdrawal by Subject|35|||
23219268|NCT00355134|64544823|FG001|Core Phase|Withdrawal by Subject|24|||
23219269|NCT00355134|64544824|FG002|Core Phase|Withdrawal by Subject|35|||
23219270|NCT00355134|64544825|FG003|Core Phase|Withdrawal by Subject|0|||
23219271|NCT00355134|64544826|FG004|Core Phase|Withdrawal by Subject|0|||
23219272|NCT00355134|64544822|FG000|Core Phase|Adverse Event|28|||
23219273|NCT00355134|64544823|FG001|Core Phase|Adverse Event|22|||
23219274|NCT00355134|64544824|FG002|Core Phase|Adverse Event|16|||
23219275|NCT00355134|64544825|FG003|Core Phase|Adverse Event|0|||
23219276|NCT00355134|64544826|FG004|Core Phase|Adverse Event|0|||
23219277|NCT00355134|64544822|FG000|Core Phase|Lost to Follow-up|17|||
23219278|NCT00355134|64544823|FG001|Core Phase|Lost to Follow-up|13|||
23219279|NCT00355134|64544824|FG002|Core Phase|Lost to Follow-up|21|||
23219280|NCT00355134|64544825|FG003|Core Phase|Lost to Follow-up|0|||
23219281|NCT00355134|64544826|FG004|Core Phase|Lost to Follow-up|0|||
23219282|NCT00355134|64544822|FG000|Core Phase|Abnormal laboratory value(s)|19|||
23219283|NCT00355134|64544823|FG001|Core Phase|Abnormal laboratory value(s)|14|||
23219284|NCT00355134|64544824|FG002|Core Phase|Abnormal laboratory value(s)|2|||
23219285|NCT00355134|64544825|FG003|Core Phase|Abnormal laboratory value(s)|0|||
23219286|NCT00355134|64544826|FG004|Core Phase|Abnormal laboratory value(s)|0|||
23219287|NCT00355134|64544822|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
23219288|NCT00355134|64544823|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
23624470|NCT01375114|66011692|FG002|Overall Study|Nausea|0|||
23624471|NCT01375114|66011690|FG000|Overall Study|Increased AST/ALT|0|||
23624472|NCT01375114|66011691|FG001|Overall Study|Increased AST/ALT|1|||
23624473|NCT01375114|66011692|FG002|Overall Study|Increased AST/ALT|0|||
23624474|NCT01375114|66011690|FG000|Overall Study|Vaginal Hemorrhage|0|||
23219289|NCT00355134|64544824|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
23219290|NCT00355134|64544825|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
23219291|NCT00355134|64544826|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
23219292|NCT00355134|64544822|FG000|Core Phase|Administrative problems|5|||
23219293|NCT00355134|64544823|FG001|Core Phase|Administrative problems|3|||
23219294|NCT00355134|64544824|FG002|Core Phase|Administrative problems|5|||
23219295|NCT00355134|64544825|FG003|Core Phase|Administrative problems|0|||
23219296|NCT00355134|64544826|FG004|Core Phase|Administrative problems|0|||
23219297|NCT00355134|64544822|FG000|Core Phase|Protocol Violation|3|||
23219298|NCT00355134|64544823|FG001|Core Phase|Protocol Violation|2|||
23437801|NCT00666965|65344221|FG002|Overall Study|Lack of Efficacy|0|||
23437802|NCT00666965|65344222|FG003|Overall Study|Lack of Efficacy|0|||
23437803|NCT00666965|65344219|FG000|Overall Study|Protocol Violation|0|||
23437804|NCT00666965|65344220|FG001|Overall Study|Protocol Violation|0|||
23437805|NCT00666965|65344221|FG002|Overall Study|Protocol Violation|0|||
23437806|NCT00666965|65344222|FG003|Overall Study|Protocol Violation|2|||
23437807|NCT00666965|65344219|FG000|Overall Study|Discontinuation criteria|2|||
23437808|NCT00666965|65344220|FG001|Overall Study|Discontinuation criteria|1|||
23437809|NCT00666965|65344221|FG002|Overall Study|Discontinuation criteria|1|||
23437810|NCT00666965|65344222|FG003|Overall Study|Discontinuation criteria|2|||
23437811|NCT00666965|65344219|FG000|Overall Study|Withdrawal by Subject|0|||
23437812|NCT00666965|65344220|FG001|Overall Study|Withdrawal by Subject|0|||
23437813|NCT00666965|65344221|FG002|Overall Study|Withdrawal by Subject|0|||
23437814|NCT00666965|65344222|FG003|Overall Study|Withdrawal by Subject|2|||
23437815|NCT02516592|65344223|FG000|Overall Study|Patient withdrew consent|5|||
23437816|NCT02516592|65344224|FG001|Overall Study|Patient withdrew consent|2|||
23437817|NCT02516592|65344223|FG000|Overall Study|Protocol deviation|4|||
23437818|NCT02516592|65344224|FG001|Overall Study|Protocol deviation|4|||
23437819|NCT02516592|65344223|FG000|Overall Study|Lost to Follow-up|2|||
23437820|NCT02516592|65344224|FG001|Overall Study|Lost to Follow-up|3|||
23624475|NCT01375114|66011691|FG001|Overall Study|Vaginal Hemorrhage|1|||
23219299|NCT00355134|64544824|FG002|Core Phase|Protocol Violation|2|||
23219300|NCT00355134|64544825|FG003|Core Phase|Protocol Violation|0|||
23437821|NCT02516592|65344223|FG000|Overall Study|Patient/guardian decision|2|||
23219301|NCT00355134|64544826|FG004|Core Phase|Protocol Violation|0|||
23219302|NCT00355134|64544822|FG000|Core Phase|Abnormal test procedure result(s)|1|||
23219303|NCT00355134|64544823|FG001|Core Phase|Abnormal test procedure result(s)|2|||
23219304|NCT00355134|64544824|FG002|Core Phase|Abnormal test procedure result(s)|1|||
23219305|NCT00355134|64544825|FG003|Core Phase|Abnormal test procedure result(s)|0|||
23219306|NCT00355134|64544826|FG004|Core Phase|Abnormal test procedure result(s)|0|||
23624476|NCT01375114|66011692|FG002|Overall Study|Vaginal Hemorrhage|0|||
23624477|NCT01375114|66011690|FG000|Overall Study|Family problem|0|||
23219307|NCT00355134|64544822|FG000|Core Phase|Condition no longer requires study drug|1|||
23219308|NCT00355134|64544823|FG001|Core Phase|Condition no longer requires study drug|0|||
23219309|NCT00355134|64544824|FG002|Core Phase|Condition no longer requires study drug|1|||
23219310|NCT00355134|64544825|FG003|Core Phase|Condition no longer requires study drug|0|||
23559692|NCT01750879|65776351|FG001|Overall Study|Lack of Efficacy|0|||
23559693|NCT01750879|65776350|FG000|Overall Study|Withdrawal by Subject|1|||
23559694|NCT01750879|65776351|FG001|Overall Study|Withdrawal by Subject|0|||
23559695|NCT01750879|65776350|FG000|Overall Study|Did not complete per protocol|0|||
23559696|NCT01750879|65776351|FG001|Overall Study|Did not complete per protocol|3|||
23559697|NCT03813238|65776369|FG000|Overall Study|Adverse Event|0|||
23559698|NCT03813238|65776370|FG001|Overall Study|Adverse Event|6|||
23559699|NCT03813238|65776369|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23559700|NCT03813238|65776370|FG001|Overall Study|Withdrawal by parent/guardian|2|||
23559701|NCT03813238|65776369|FG000|Overall Study|Lost to Follow-up|0|||
23559702|NCT03813238|65776370|FG001|Overall Study|Lost to Follow-up|1|||
23559703|NCT03813238|65776369|FG000|Overall Study|Other than specified|1|||
23559704|NCT03813238|65776370|FG001|Overall Study|Other than specified|2|||
23559705|NCT01201811|65776371|FG000|Overall Study|Adverse Event|6|||
23559706|NCT01201811|65776371|FG000|Overall Study|Disease progression|3|||
23559707|NCT01201811|65776371|FG000|Overall Study|Withdrawal by Subject|3|||
23559708|NCT01201811|65776371|FG000|Overall Study|Death|4|||
23559709|NCT01201811|65776371|FG000|Overall Study|Treatment Failure|2|||
23559710|NCT01201811|65776371|FG000|Overall Study|Physician Decision|1|||
23559711|NCT02277743|65776372|FG000|Overall Study|Protocol Violation|1|||
23559712|NCT02277743|65776373|FG001|Overall Study|Protocol Violation|1|||
23559713|NCT02277743|65776374|FG002|Overall Study|Protocol Violation|1|||
23559714|NCT02277743|65776372|FG000|Overall Study|Adverse Event|10|||
23559715|NCT02277743|65776373|FG001|Overall Study|Adverse Event|6|||
23559716|NCT02277743|65776374|FG002|Overall Study|Adverse Event|6|||
23559717|NCT02277743|65776372|FG000|Overall Study|Lack of Efficacy|11|||
23559718|NCT02277743|65776373|FG001|Overall Study|Lack of Efficacy|4|||
23559719|NCT02277743|65776374|FG002|Overall Study|Lack of Efficacy|3|||
23559720|NCT02277743|65776372|FG000|Overall Study|Other than specified above|18|||
23559721|NCT02277743|65776373|FG001|Overall Study|Other than specified above|5|||
23219311|NCT00355134|64544826|FG004|Core Phase|Condition no longer requires study drug|0|||
23219312|NCT00355134|64544822|FG000|Extension Phase|Withdrawal by Subject|7|||
23559722|NCT02277743|65776374|FG002|Overall Study|Other than specified above|16|||
23559723|NCT02634788|65776375|FG000|Overall Study|Adverse Event|0|||
23559724|NCT02634788|65776376|FG001|Overall Study|Adverse Event|8|||
23559725|NCT02634788|65776377|FG002|Overall Study|Adverse Event|3|||
23559726|NCT02634788|65776378|FG003|Overall Study|Adverse Event|1|||
23559727|NCT02634788|65776375|FG000|Overall Study|Lack of Efficacy|4|||
23559728|NCT02634788|65776376|FG001|Overall Study|Lack of Efficacy|0|||
23559729|NCT02634788|65776377|FG002|Overall Study|Lack of Efficacy|1|||
23559730|NCT02634788|65776378|FG003|Overall Study|Lack of Efficacy|4|||
23559731|NCT02634788|65776375|FG000|Overall Study|Lost to Follow-up|0|||
23559732|NCT02634788|65776376|FG001|Overall Study|Lost to Follow-up|1|||
23559733|NCT02634788|65776377|FG002|Overall Study|Lost to Follow-up|0|||
23559734|NCT02634788|65776378|FG003|Overall Study|Lost to Follow-up|0|||
23559735|NCT02634788|65776375|FG000|Overall Study|Withdrawal by Subject|0|||
23559736|NCT02634788|65776376|FG001|Overall Study|Withdrawal by Subject|1|||
23559737|NCT02634788|65776377|FG002|Overall Study|Withdrawal by Subject|1|||
23559738|NCT02634788|65776378|FG003|Overall Study|Withdrawal by Subject|0|||
23559739|NCT00754338|65776379|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
23559740|NCT00754338|65776380|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
23559741|NCT00754338|65776381|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
23559742|NCT00754338|65776382|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
23559743|NCT00754338|65776379|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
23559744|NCT00754338|65776380|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
23559745|NCT00754338|65776381|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
23559746|NCT00754338|65776382|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
23559747|NCT00755222|65776383|FG000|Overall Study|Withdrawal by Subject|4|||
23219313|NCT00355134|64544823|FG001|Extension Phase|Withdrawal by Subject|11|||
23219314|NCT00355134|64544824|FG002|Extension Phase|Withdrawal by Subject|0|||
23559748|NCT00755222|65776384|FG001|Overall Study|Withdrawal by Subject|2|||
23219315|NCT00355134|64544825|FG003|Extension Phase|Withdrawal by Subject|7|||
23219316|NCT00355134|64544826|FG004|Extension Phase|Withdrawal by Subject|5|||
23219317|NCT00355134|64544822|FG000|Extension Phase|Adverse Event|13|||
23219318|NCT00355134|64544823|FG001|Extension Phase|Adverse Event|9|||
23559749|NCT00755222|65776383|FG000|Overall Study|Adverse Event|2|||
23559750|NCT00755222|65776384|FG001|Overall Study|Adverse Event|0|||
23559751|NCT00755222|65776383|FG000|Overall Study|Protocol Violation|2|||
23559752|NCT00755222|65776384|FG001|Overall Study|Protocol Violation|0|||
23559753|NCT04349280|65776386|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
23559754|NCT04349280|65776387|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
23219319|NCT00355134|64544824|FG002|Extension Phase|Adverse Event|0|||
23219320|NCT00355134|64544825|FG003|Extension Phase|Adverse Event|3|||
23219321|NCT00355134|64544826|FG004|Extension Phase|Adverse Event|5|||
23219322|NCT00355134|64544822|FG000|Extension Phase|Lost to Follow-up|2|||
23219323|NCT00355134|64544823|FG001|Extension Phase|Lost to Follow-up|6|||
23219324|NCT00355134|64544824|FG002|Extension Phase|Lost to Follow-up|0|||
23219325|NCT00355134|64544825|FG003|Extension Phase|Lost to Follow-up|2|||
23437822|NCT02516592|65344224|FG001|Overall Study|Patient/guardian decision|1|||
23437823|NCT02516592|65344223|FG000|Overall Study|Adverse Event|1|||
23437824|NCT02516592|65344224|FG001|Overall Study|Adverse Event|2|||
23437825|NCT02516592|65344223|FG000|Overall Study|Abnormal test procedure result|1|||
23437826|NCT02516592|65344224|FG001|Overall Study|Abnormal test procedure result|0|||
23437827|NCT02516592|65344223|FG000|Overall Study|Death|1|||
23437828|NCT02516592|65344224|FG001|Overall Study|Death|1|||
23437829|NCT01320202|65344225|FG000|Overall Study|Adverse Event|5|||
23437830|NCT01320202|65344226|FG001|Overall Study|Adverse Event|5|||
23437831|NCT01320202|65344225|FG000|Overall Study|Death|5|||
23437832|NCT01320202|65344226|FG001|Overall Study|Death|3|||
23437833|NCT01320202|65344225|FG000|Overall Study|Lost to Follow-up|1|||
23437834|NCT01320202|65344226|FG001|Overall Study|Lost to Follow-up|0|||
23437835|NCT01320202|65344225|FG000|Overall Study|Physician Decision|3|||
23437836|NCT01320202|65344226|FG001|Overall Study|Physician Decision|1|||
23559755|NCT04349280|65776386|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
23559756|NCT04349280|65776387|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
23559757|NCT04349280|65776386|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
23559758|NCT04349280|65776387|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
23559759|NCT02052310|65776391|FG000|Overall Study|Death|64|||
23559760|NCT02052310|65776392|FG001|Overall Study|Death|54|||
23559761|NCT02052310|65776391|FG000|Overall Study|Withdrawal by Subject|37|||
23559762|NCT02052310|65776392|FG001|Overall Study|Withdrawal by Subject|49|||
23559763|NCT02052310|65776391|FG000|Overall Study|Other than specified|32|||
23559764|NCT02052310|65776392|FG001|Overall Study|Other than specified|29|||
23559765|NCT02052310|65776391|FG000|Overall Study|Adverse Event|29|||
23149293|NCT04178967|64297572|FG002|Induction Period|Adverse Event|0|||
23149294|NCT04178967|64297573|FG003|Induction Period|Adverse Event|0|||
23149295|NCT04178967|64297574|FG004|Induction Period|Adverse Event|0|||
23149296|NCT04178967|64297575|FG005|Induction Period|Adverse Event|0|||
23149297|NCT04178967|64297576|FG006|Induction Period|Adverse Event|0|||
23149298|NCT04178967|64297577|FG007|Induction Period|Adverse Event|0|||
23149299|NCT04178967|64297578|FG008|Induction Period|Adverse Event|0|||
23149300|NCT04178967|64297579|FG009|Induction Period|Adverse Event|0|||
23149301|NCT04178967|64297580|FG010|Induction Period|Adverse Event|0|||
23149302|NCT04178967|64297570|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
23149303|NCT04178967|64297571|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
23149304|NCT04178967|64297572|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
23149305|NCT04178967|64297573|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
23149306|NCT04178967|64297574|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
23149307|NCT04178967|64297575|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
23149308|NCT04178967|64297576|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
23149309|NCT04178967|64297577|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
23149310|NCT04178967|64297578|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
23149311|NCT04178967|64297579|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
23149312|NCT04178967|64297580|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
23149313|NCT04178967|64297570|FG000|Induction Period|Lack of Efficacy|4|||
23149314|NCT04178967|64297571|FG001|Induction Period|Lack of Efficacy|1|||
23149315|NCT04178967|64297572|FG002|Induction Period|Lack of Efficacy|0|||
23149316|NCT04178967|64297573|FG003|Induction Period|Lack of Efficacy|0|||
23149317|NCT04178967|64297574|FG004|Induction Period|Lack of Efficacy|0|||
23149318|NCT04178967|64297575|FG005|Induction Period|Lack of Efficacy|0|||
23149319|NCT04178967|64297576|FG006|Induction Period|Lack of Efficacy|0|||
23149320|NCT04178967|64297577|FG007|Induction Period|Lack of Efficacy|0|||
23149321|NCT04178967|64297578|FG008|Induction Period|Lack of Efficacy|0|||
23149322|NCT04178967|64297579|FG009|Induction Period|Lack of Efficacy|0|||
23149323|NCT04178967|64297580|FG010|Induction Period|Lack of Efficacy|0|||
23149324|NCT04178967|64297570|FG000|Induction Period|Protocol Violation|0|||
23149325|NCT04178967|64297571|FG001|Induction Period|Protocol Violation|6|||
23149326|NCT04178967|64297572|FG002|Induction Period|Protocol Violation|0|||
23149327|NCT04178967|64297573|FG003|Induction Period|Protocol Violation|0|||
23149328|NCT04178967|64297574|FG004|Induction Period|Protocol Violation|0|||
23149329|NCT04178967|64297575|FG005|Induction Period|Protocol Violation|0|||
23149330|NCT04178967|64297576|FG006|Induction Period|Protocol Violation|0|||
23149331|NCT04178967|64297577|FG007|Induction Period|Protocol Violation|0|||
23149332|NCT04178967|64297578|FG008|Induction Period|Protocol Violation|0|||
23149333|NCT04178967|64297579|FG009|Induction Period|Protocol Violation|0|||
23149334|NCT04178967|64297580|FG010|Induction Period|Protocol Violation|0|||
23149335|NCT04178967|64297570|FG000|Induction Period|Withdrawal by Subject|6|||
23149336|NCT04178967|64297571|FG001|Induction Period|Withdrawal by Subject|4|||
23624478|NCT01375114|66011691|FG001|Overall Study|Family problem|1|||
23624479|NCT01375114|66011692|FG002|Overall Study|Family problem|0|||
23624480|NCT01375114|66011690|FG000|Overall Study|Protocol Violation|2|||
23559766|NCT02052310|65776392|FG001|Overall Study|Adverse Event|22|||
23559767|NCT02052310|65776391|FG000|Overall Study|Kidney Transplant|23|||
23559768|NCT02052310|65776392|FG001|Overall Study|Kidney Transplant|29|||
23559769|NCT02052310|65776391|FG000|Overall Study|Physician Decision|14|||
23559770|NCT02052310|65776392|FG001|Overall Study|Physician Decision|7|||
23323555|NCT02790437|64926777|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
23323556|NCT02790437|64926776|FG000|Overall Study|Adverse Event|1|||
23323557|NCT02790437|64926777|FG001|Overall Study|Adverse Event|0|||
23323558|NCT02790437|64926776|FG000|Overall Study|Withdrawal by Subject|1|||
23323559|NCT02790437|64926777|FG001|Overall Study|Withdrawal by Subject|0|||
23323560|NCT02456740|64926780|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
23323561|NCT02456740|64926781|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
23323562|NCT02456740|64926782|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
23323563|NCT02456740|64926783|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23323564|NCT02456740|64926784|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23559771|NCT02052310|65776391|FG000|Overall Study|Lack of Efficacy|6|||
23559772|NCT02052310|65776392|FG001|Overall Study|Lack of Efficacy|1|||
23559773|NCT02052310|65776391|FG000|Overall Study|Site Terminated by Sponsor|5|||
23323565|NCT02456740|64926785|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23323566|NCT02456740|64926786|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23323567|NCT02456740|64926787|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23323568|NCT02456740|64926788|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
23323569|NCT02456740|64926780|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
23323570|NCT02456740|64926781|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
23323571|NCT02456740|64926782|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
23323572|NCT02456740|64926783|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23323573|NCT02456740|64926784|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23323574|NCT02456740|64926785|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23323575|NCT02456740|64926786|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23323576|NCT02456740|64926787|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23323577|NCT02456740|64926788|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
23323578|NCT02456740|64926780|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
23323579|NCT02456740|64926781|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
23323580|NCT02456740|64926782|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
23323581|NCT02456740|64926783|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23323582|NCT02456740|64926784|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23323583|NCT02456740|64926785|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23323584|NCT02456740|64926786|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23323585|NCT02456740|64926787|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23323586|NCT02456740|64926788|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
23323587|NCT02456740|64926780|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23323588|NCT02456740|64926781|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23323589|NCT02456740|64926782|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23323590|NCT02456740|64926783|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
23323591|NCT02456740|64926784|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
23323592|NCT02456740|64926785|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23323593|NCT02456740|64926786|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23323594|NCT02456740|64926787|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
23323595|NCT02456740|64926788|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
23323596|NCT02456740|64926780|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23323597|NCT02456740|64926781|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23559774|NCT02052310|65776392|FG001|Overall Study|Site Terminated by Sponsor|13|||
23559775|NCT02052310|65776391|FG000|Overall Study|Lost to Follow-up|4|||
23559776|NCT02052310|65776392|FG001|Overall Study|Lost to Follow-up|2|||
23559777|NCT02052310|65776391|FG000|Overall Study|Protocol Violation|1|||
23559778|NCT02052310|65776392|FG001|Overall Study|Protocol Violation|6|||
23559779|NCT01301391|65776393|FG000|Overall Study|Death|13|||
23559780|NCT01301391|65776393|FG000|Overall Study|Lost to Follow-up|3|||
23559781|NCT01301391|65776393|FG000|Overall Study|Physician Decision|2|||
23559782|NCT01301391|65776393|FG000|Overall Study|Sponsor's decision|8|||
23559783|NCT01666808|65776394|FG000|Overall Study|Lost to Follow-up|9|||
23323598|NCT02456740|64926782|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23437837|NCT01320202|65344225|FG000|Overall Study|Protocol Violation|2|||
23559784|NCT01666808|65776395|FG001|Overall Study|Lost to Follow-up|15|||
23559785|NCT01666808|65776394|FG000|Overall Study|Withdrawal by Subject|3|||
23437838|NCT01320202|65344226|FG001|Overall Study|Protocol Violation|1|||
23559786|NCT01666808|65776395|FG001|Overall Study|Withdrawal by Subject|1|||
23559787|NCT01666808|65776394|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
23559788|NCT01666808|65776395|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
23559789|NCT01995539|65776398|FG000|Overall Study|Screening Failure|1|||
23559790|NCT01995539|65776398|FG000|Overall Study|Withdrawal by Investigator|15|||
23559791|NCT01995539|65776398|FG000|Overall Study|Withdrawal by Subject|11|||
23559792|NCT01995539|65776398|FG000|Overall Study|Lost to Follow-up|5|||
23559793|NCT01995539|65776398|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
23559794|NCT04493216|65776402|FG000|Overall Study|Study terminated by sponsor|30|||
23559795|NCT04493216|65776403|FG001|Overall Study|Study terminated by sponsor|33|||
23559796|NCT04493216|65776404|FG002|Overall Study|Study terminated by sponsor|28|||
23559797|NCT04493216|65776405|FG003|Overall Study|Study terminated by sponsor|27|||
23559798|NCT04493216|65776402|FG000|Overall Study|Withdrawal by Subject|2|||
23559799|NCT04493216|65776403|FG001|Overall Study|Withdrawal by Subject|1|||
23559800|NCT04493216|65776404|FG002|Overall Study|Withdrawal by Subject|1|||
23559801|NCT04493216|65776405|FG003|Overall Study|Withdrawal by Subject|2|||
23559802|NCT04493216|65776402|FG000|Overall Study|Protocol Violation|1|||
23559803|NCT04493216|65776403|FG001|Overall Study|Protocol Violation|2|||
23559804|NCT04493216|65776404|FG002|Overall Study|Protocol Violation|0|||
23559805|NCT04493216|65776405|FG003|Overall Study|Protocol Violation|2|||
23559806|NCT04493216|65776402|FG000|Overall Study|Physician Decision|0|||
23559807|NCT04493216|65776403|FG001|Overall Study|Physician Decision|0|||
23559808|NCT04493216|65776404|FG002|Overall Study|Physician Decision|1|||
23559809|NCT04493216|65776405|FG003|Overall Study|Physician Decision|0|||
23559810|NCT04493216|65776402|FG000|Overall Study|Lost to Follow-up|2|||
23559811|NCT04493216|65776403|FG001|Overall Study|Lost to Follow-up|1|||
23559812|NCT04493216|65776404|FG002|Overall Study|Lost to Follow-up|0|||
23559813|NCT04493216|65776405|FG003|Overall Study|Lost to Follow-up|1|||
23559814|NCT04493216|65776402|FG000|Overall Study|Adverse Event|1|||
23559815|NCT04493216|65776403|FG001|Overall Study|Adverse Event|4|||
23559816|NCT04493216|65776404|FG002|Overall Study|Adverse Event|5|||
23559817|NCT04493216|65776405|FG003|Overall Study|Adverse Event|2|||
23559818|NCT04493216|65776402|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
23559819|NCT04493216|65776403|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
23559820|NCT04493216|65776404|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
23559821|NCT04493216|65776405|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
23559822|NCT00682643|65776406|FG000|Overall Study|Adverse Event|12|||
23559823|NCT00682643|65776407|FG001|Overall Study|Adverse Event|23|||
23559824|NCT00682643|65776406|FG000|Overall Study|Lack of Efficacy|2|||
23559825|NCT00682643|65776407|FG001|Overall Study|Lack of Efficacy|0|||
23559826|NCT00682643|65776406|FG000|Overall Study|Protocol Violation|38|||
23559827|NCT00682643|65776407|FG001|Overall Study|Protocol Violation|76|||
23559828|NCT00682643|65776406|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
23559829|NCT00682643|65776407|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
23559830|NCT00682643|65776406|FG000|Overall Study|Lost to Follow-up|1|||
23559831|NCT00682643|65776407|FG001|Overall Study|Lost to Follow-up|6|||
23559832|NCT00682643|65776406|FG000|Overall Study|Physician Decision|2|||
23559833|NCT00682643|65776407|FG001|Overall Study|Physician Decision|6|||
23559834|NCT00682643|65776406|FG000|Overall Study|Withdrawal by Subject|19|||
23559835|NCT00682643|65776407|FG001|Overall Study|Withdrawal by Subject|53|||
23559836|NCT00682643|65776406|FG000|Overall Study|Did Not Receive Study Drug|1|||
23559837|NCT00682643|65776407|FG001|Overall Study|Did Not Receive Study Drug|1|||
23559838|NCT00949715|65776412|FG000|Overall Study|Physician Decision|1|||
23559839|NCT00949715|65776413|FG001|Overall Study|Physician Decision|0|||
23559840|NCT00949715|65776412|FG000|Overall Study|Lost to Follow-up|1|||
23559841|NCT00949715|65776413|FG001|Overall Study|Lost to Follow-up|0|||
23559842|NCT00949715|65776412|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
23559843|NCT00949715|65776413|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
23149337|NCT04178967|64297572|FG002|Induction Period|Withdrawal by Subject|0|||
23149338|NCT04178967|64297573|FG003|Induction Period|Withdrawal by Subject|0|||
23149339|NCT04178967|64297574|FG004|Induction Period|Withdrawal by Subject|0|||
23149340|NCT04178967|64297575|FG005|Induction Period|Withdrawal by Subject|0|||
23149341|NCT04178967|64297576|FG006|Induction Period|Withdrawal by Subject|0|||
23149342|NCT04178967|64297577|FG007|Induction Period|Withdrawal by Subject|0|||
23149343|NCT04178967|64297578|FG008|Induction Period|Withdrawal by Subject|0|||
23149344|NCT04178967|64297579|FG009|Induction Period|Withdrawal by Subject|0|||
23149345|NCT04178967|64297580|FG010|Induction Period|Withdrawal by Subject|0|||
23149346|NCT04178967|64297570|FG000|Induction Period|Lost to Follow-up|2|||
23149347|NCT04178967|64297571|FG001|Induction Period|Lost to Follow-up|0|||
23149348|NCT04178967|64297572|FG002|Induction Period|Lost to Follow-up|0|||
23149349|NCT04178967|64297573|FG003|Induction Period|Lost to Follow-up|0|||
23559844|NCT01453348|65779471|FG000|Overall Study|Death|0|||
23559845|NCT01453348|65779472|FG001|Overall Study|Death|0|||
23559846|NCT01453348|65779473|FG002|Overall Study|Death|1|||
23559847|NCT01453348|65779471|FG000|Overall Study|Withdrawal by Subject|0|||
23323599|NCT02456740|64926783|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
23323600|NCT02456740|64926784|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
23323601|NCT02456740|64926785|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
23323602|NCT02456740|64926786|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
23323603|NCT02456740|64926787|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
23323604|NCT02456740|64926788|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
23323605|NCT02456740|64926780|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23323606|NCT02456740|64926781|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23323607|NCT02456740|64926782|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23323608|NCT02456740|64926783|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23323609|NCT02456740|64926784|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23323610|NCT02456740|64926785|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23323611|NCT02456740|64926786|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23323612|NCT02456740|64926787|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
23323613|NCT02456740|64926788|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
23323614|NCT02456740|64926780|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23323615|NCT02456740|64926781|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23323616|NCT02456740|64926782|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23323617|NCT02456740|64926783|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
23323618|NCT02456740|64926784|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
23323619|NCT02456740|64926785|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
23323620|NCT02456740|64926786|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
23323621|NCT02456740|64926787|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
23323622|NCT02456740|64926788|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
23323623|NCT02009722|64926789|FG000|Overall Study|Protocol Violation|1|||
23323624|NCT02009722|64926790|FG001|Overall Study|Protocol Violation|2|||
23559848|NCT01453348|65779472|FG001|Overall Study|Withdrawal by Subject|1|||
23559849|NCT01453348|65779473|FG002|Overall Study|Withdrawal by Subject|0|||
23559850|NCT01453348|65779471|FG000|Overall Study|Protocol Violation|1|||
23559851|NCT01453348|65779472|FG001|Overall Study|Protocol Violation|0|||
23559852|NCT01453348|65779473|FG002|Overall Study|Protocol Violation|0|||
23559853|NCT01224158|65779474|FG000|Overall Study|Withdrawal by Subject|1|||
23559854|NCT01224158|65779475|FG001|Overall Study|Withdrawal by Subject|0|||
23559855|NCT01494584|65779478|FG000|Overall Study|Study Closed/Terminated|1|||
23559856|NCT03010462|65779484|FG000|Overall Study|Withdrawal by Subject|3|||
23559857|NCT03010462|65779485|FG001|Overall Study|Withdrawal by Subject|1|||
23624481|NCT01375114|66011691|FG001|Overall Study|Protocol Violation|0|||
23323625|NCT02009722|64926789|FG000|Overall Study|Did not receive intervention|0|||
23559858|NCT00524030|65779488|FG000|Overall Study|Lack of Efficacy|10|||
23559859|NCT00524030|65779489|FG001|Overall Study|Lack of Efficacy|24|||
23559860|NCT00524030|65779488|FG000|Overall Study|Lost to Follow-up|0|||
23559861|NCT00524030|65779489|FG001|Overall Study|Lost to Follow-up|2|||
23559862|NCT00524030|65779488|FG000|Overall Study|Withdrawal by Subject|3|||
23559863|NCT00524030|65779489|FG001|Overall Study|Withdrawal by Subject|8|||
23559864|NCT00524030|65779488|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
23559865|NCT00524030|65779489|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
23559866|NCT00524030|65779488|FG000|Overall Study|Protocol Violation|0|||
23559867|NCT00524030|65779489|FG001|Overall Study|Protocol Violation|1|||
23559868|NCT00524030|65779488|FG000|Overall Study|Pregnancy|1|||
23559869|NCT00524030|65779489|FG001|Overall Study|Pregnancy|0|||
23559870|NCT00524030|65779488|FG000|Overall Study|Adverse Event|3|||
23559871|NCT00524030|65779489|FG001|Overall Study|Adverse Event|21|||
23559872|NCT00524030|65779488|FG000|Overall Study|Death|0|||
23559873|NCT00524030|65779489|FG001|Overall Study|Death|1|||
23559874|NCT02472652|65779490|FG000|Overall Study|Lost to Follow-up|1|||
23559875|NCT02192970|65779498|FG000|Overall Study|Lost to Follow-up|6|||
23559876|NCT02192970|65779499|FG001|Overall Study|Lost to Follow-up|0|||
23559877|NCT03587142|65779500|FG000|Overall Study|Lost to Follow-up|5|||
23559878|NCT03587142|65779501|FG001|Overall Study|Lost to Follow-up|3|||
23624482|NCT01375114|66011692|FG002|Overall Study|Protocol Violation|0|||
23323626|NCT02009722|64926790|FG001|Overall Study|Did not receive intervention|1|||
23323627|NCT01622673|64926791|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23323628|NCT01622673|64926792|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23323629|NCT01622673|64926793|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23323630|NCT01622673|64926794|FG003|Treatment Period 1|Withdrawal by Subject|1|||
23323631|NCT01622673|64926795|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23437839|NCT01320202|65344225|FG000|Overall Study|Withdrawal by Subject|10|||
23437840|NCT01320202|65344226|FG001|Overall Study|Withdrawal by Subject|3|||
23559879|NCT03587142|65779500|FG000|Overall Study|Did not complete the f4 visit|3|||
23323632|NCT01622673|64926796|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23323633|NCT01622673|64926791|FG000|Treatment Period 1|Protocol Violation|0|||
23559880|NCT03587142|65779501|FG001|Overall Study|Did not complete the f4 visit|7|||
23559881|NCT01337986|65779502|FG000|Overall Study|Adverse Event|2|||
23559882|NCT01337986|65779503|FG001|Overall Study|Adverse Event|2|||
23149350|NCT04178967|64297574|FG004|Induction Period|Lost to Follow-up|0|||
23149351|NCT04178967|64297575|FG005|Induction Period|Lost to Follow-up|0|||
23149352|NCT04178967|64297576|FG006|Induction Period|Lost to Follow-up|0|||
23149353|NCT04178967|64297577|FG007|Induction Period|Lost to Follow-up|0|||
23149354|NCT04178967|64297578|FG008|Induction Period|Lost to Follow-up|0|||
23149355|NCT04178967|64297579|FG009|Induction Period|Lost to Follow-up|0|||
23149356|NCT04178967|64297580|FG010|Induction Period|Lost to Follow-up|0|||
23149357|NCT04178967|64297570|FG000|Induction Period|Participant Missed Study Visits|0|||
23149358|NCT04178967|64297571|FG001|Induction Period|Participant Missed Study Visits|1|||
23149359|NCT04178967|64297572|FG002|Induction Period|Participant Missed Study Visits|0|||
23149360|NCT04178967|64297573|FG003|Induction Period|Participant Missed Study Visits|0|||
23149361|NCT04178967|64297574|FG004|Induction Period|Participant Missed Study Visits|0|||
23149362|NCT04178967|64297575|FG005|Induction Period|Participant Missed Study Visits|0|||
23149363|NCT04178967|64297576|FG006|Induction Period|Participant Missed Study Visits|0|||
23149364|NCT04178967|64297577|FG007|Induction Period|Participant Missed Study Visits|0|||
23149365|NCT04178967|64297578|FG008|Induction Period|Participant Missed Study Visits|0|||
23149366|NCT04178967|64297579|FG009|Induction Period|Participant Missed Study Visits|0|||
23149367|NCT04178967|64297580|FG010|Induction Period|Participant Missed Study Visits|0|||
23323634|NCT01622673|64926792|FG001|Treatment Period 1|Protocol Violation|1|||
23149368|NCT04178967|64297570|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
23149369|NCT04178967|64297571|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
23149370|NCT04178967|64297572|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
23149371|NCT04178967|64297573|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
23149372|NCT04178967|64297574|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
23149373|NCT04178967|64297575|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
23149374|NCT04178967|64297576|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
23149375|NCT04178967|64297577|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
23149376|NCT04178967|64297578|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
23149377|NCT04178967|64297579|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
23149378|NCT04178967|64297580|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
23149379|NCT04178967|64297570|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23149380|NCT04178967|64297571|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23149381|NCT04178967|64297572|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23149382|NCT04178967|64297573|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23149383|NCT04178967|64297574|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23323635|NCT01622673|64926793|FG002|Treatment Period 1|Protocol Violation|0|||
23559883|NCT01337986|65779502|FG000|Overall Study|Lost to Follow-up|1|||
23559884|NCT01337986|65779503|FG001|Overall Study|Lost to Follow-up|0|||
23559885|NCT01337986|65779502|FG000|Overall Study|Protocol Violation|0|||
23559886|NCT01337986|65779503|FG001|Overall Study|Protocol Violation|3|||
23559887|NCT02487498|65779509|FG000|Period: Period 1|Adverse Event|2|||
23559888|NCT02487498|65779510|FG001|Period: Period 1|Adverse Event|4|||
23559889|NCT02487498|65779509|FG000|Period: Period 1|Subject/guardian decision|2|||
23559890|NCT02487498|65779510|FG001|Period: Period 1|Subject/guardian decision|4|||
23559891|NCT02487498|65779509|FG000|Period: Period 1|Lost to Follow-up|0|||
23559892|NCT02487498|65779510|FG001|Period: Period 1|Lost to Follow-up|2|||
23559893|NCT02487498|65779509|FG000|Period: Period 1|Lack of Efficacy|1|||
23559894|NCT02487498|65779510|FG001|Period: Period 1|Lack of Efficacy|0|||
23559895|NCT02487498|65779509|FG000|Period: Period 1|Physician Decision|0|||
23559896|NCT02487498|65779510|FG001|Period: Period 1|Physician Decision|1|||
23559897|NCT02487498|65779509|FG000|Period: Period 1|Protocol deviation|1|||
23559898|NCT02487498|65779510|FG001|Period: Period 1|Protocol deviation|0|||
23559899|NCT02487498|65779509|FG000|Period: Washout|Subject/guardian decision|0|||
23559900|NCT02487498|65779510|FG001|Period: Washout|Subject/guardian decision|5|||
23559901|NCT02487498|65779509|FG000|Period: Washout|Lack of Efficacy|1|||
23559902|NCT02487498|65779510|FG001|Period: Washout|Lack of Efficacy|1|||
23559903|NCT02487498|65779509|FG000|Period: Washout|Physician Decision|1|||
23559904|NCT02487498|65779510|FG001|Period: Washout|Physician Decision|0|||
23559905|NCT02487498|65779509|FG000|Period: Washout|Non-compliance with study treatment|0|||
23559906|NCT02487498|65779510|FG001|Period: Washout|Non-compliance with study treatment|1|||
23559907|NCT02487498|65779509|FG000|Period: Period 2|Adverse Event|2|||
23559908|NCT02487498|65779510|FG001|Period: Period 2|Adverse Event|2|||
23559909|NCT02487498|65779509|FG000|Period: Period 2|Subject/guardian decision|2|||
23149384|NCT04178967|64297575|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
23559910|NCT02487498|65779510|FG001|Period: Period 2|Subject/guardian decision|1|||
23559911|NCT02487498|65779509|FG000|Period: Period 2|Lost to Follow-up|1|||
23149385|NCT04178967|64297576|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23149386|NCT04178967|64297577|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23323636|NCT01622673|64926794|FG003|Treatment Period 1|Protocol Violation|0|||
23559912|NCT02487498|65779510|FG001|Period: Period 2|Lost to Follow-up|1|||
23559913|NCT02487498|65779509|FG000|Period: Period 2|Death|0|||
23149387|NCT04178967|64297578|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23149388|NCT04178967|64297579|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23149389|NCT04178967|64297580|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23149390|NCT04178967|64297570|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149391|NCT04178967|64297571|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149392|NCT04178967|64297572|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149393|NCT04178967|64297573|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
23149394|NCT04178967|64297574|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149395|NCT04178967|64297575|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149396|NCT04178967|64297576|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149397|NCT04178967|64297577|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149398|NCT04178967|64297578|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149399|NCT04178967|64297579|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149400|NCT04178967|64297580|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23149401|NCT04178967|64297570|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149402|NCT04178967|64297571|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149403|NCT04178967|64297572|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149404|NCT04178967|64297573|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149405|NCT04178967|64297574|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149406|NCT04178967|64297575|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149407|NCT04178967|64297576|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
23149408|NCT04178967|64297577|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149409|NCT04178967|64297578|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149410|NCT04178967|64297579|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149411|NCT04178967|64297580|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
23149412|NCT04178967|64297570|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23149413|NCT04178967|64297571|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23149414|NCT04178967|64297572|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23149415|NCT04178967|64297573|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23149416|NCT04178967|64297574|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
23149417|NCT04178967|64297575|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
23149418|NCT04178967|64297576|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23149419|NCT04178967|64297577|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
23149420|NCT04178967|64297578|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23323637|NCT01622673|64926795|FG004|Treatment Period 1|Protocol Violation|0|||
23323638|NCT01622673|64926796|FG005|Treatment Period 1|Protocol Violation|0|||
23323639|NCT01622673|64926791|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23323640|NCT01622673|64926792|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23559914|NCT02487498|65779510|FG001|Period: Period 2|Death|1|||
23559915|NCT02487498|65779509|FG000|Period: Period 2|Physician Decision|1|||
23559916|NCT02487498|65779510|FG001|Period: Period 2|Physician Decision|0|||
23559917|NCT02238379|65779511|FG000|Overall Study|Lost to Follow-up|1|||
23559918|NCT02238379|65779512|FG001|Overall Study|Lost to Follow-up|0|||
23559919|NCT03645759|65779513|FG000|Overall Study|Lost to Follow-up|3|||
23559920|NCT03645759|65779514|FG001|Overall Study|Lost to Follow-up|2|||
23559921|NCT01127646|65779517|FG000|Overall Study|Entry Criteria Not Met|1|||
23559922|NCT01127646|65779518|FG001|Overall Study|Entry Criteria Not Met|0|||
23559923|NCT01127646|65779517|FG000|Overall Study|Protocol Violation|0|||
23559924|NCT01127646|65779518|FG001|Overall Study|Protocol Violation|1|||
23559925|NCT01564368|65779524|FG000|Overall Study|Ineligible|18|||
23559926|NCT01564368|65779524|FG000|Overall Study|Not Randomized in Parent study|116|||
23559927|NCT01564368|65779524|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
23559928|NCT01564368|65779524|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
23559929|NCT03145766|65779525|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
23559930|NCT03145766|65779526|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
23559931|NCT03145766|65779527|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
23559932|NCT03145766|65779528|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
23559933|NCT03145766|65779529|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
23559934|NCT03145766|65779525|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
23559935|NCT03145766|65779526|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
23559936|NCT03145766|65779527|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
23559937|NCT03145766|65779528|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
23559938|NCT03145766|65779529|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
23559939|NCT03145766|65779525|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
23559940|NCT03145766|65779526|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
23559941|NCT03145766|65779527|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
23323641|NCT01622673|64926793|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23559942|NCT03145766|65779528|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
23559943|NCT03145766|65779529|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
23559944|NCT03145766|65779525|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
23559945|NCT03145766|65779526|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
23559946|NCT03145766|65779527|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
23559947|NCT03145766|65779528|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
23559948|NCT03145766|65779529|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
23559949|NCT03145766|65779525|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
23559950|NCT03145766|65779526|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
23559951|NCT03145766|65779527|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
23559952|NCT03145766|65779528|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
23559953|NCT03145766|65779529|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
23559954|NCT03145766|65779525|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
23559955|NCT03145766|65779526|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
23559956|NCT03145766|65779527|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
23559957|NCT03145766|65779528|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
23559958|NCT03145766|65779529|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
23559959|NCT03145766|65779525|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
23559960|NCT03145766|65779526|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
23559961|NCT03145766|65779527|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
23559962|NCT03145766|65779528|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
23559963|NCT03145766|65779529|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
23559964|NCT03002610|65779538|FG000|Overall Study|Withdrawal by Subject|6|||
23559965|NCT03002610|65779539|FG001|Overall Study|Withdrawal by Subject|25|||
23559966|NCT03002610|65779540|FG002|Overall Study|Withdrawal by Subject|13|||
23559967|NCT02160314|65779544|FG000|Overall Study|Adverse Event|0|||
23559968|NCT02160314|65779545|FG001|Overall Study|Adverse Event|6|||
23559969|NCT02160314|65779544|FG000|Overall Study|Protocol Violation|0|||
23559970|NCT02160314|65779545|FG001|Overall Study|Protocol Violation|4|||
23559971|NCT02160314|65779544|FG000|Overall Study|Withdrawal by Subject|1|||
23559972|NCT02160314|65779545|FG001|Overall Study|Withdrawal by Subject|2|||
23559973|NCT02160314|65779544|FG000|Overall Study|Lost to Follow-up|0|||
23559974|NCT02160314|65779545|FG001|Overall Study|Lost to Follow-up|1|||
23559975|NCT01820559|65779546|FG000|Overall Study|Adverse Event|4|||
23559976|NCT01820559|65779547|FG001|Overall Study|Adverse Event|6|||
23559977|NCT01820559|65779548|FG002|Overall Study|Adverse Event|13|||
23559978|NCT01820559|65779546|FG000|Overall Study|Withdrawal by Subject|1|||
23559979|NCT01820559|65779547|FG001|Overall Study|Withdrawal by Subject|2|||
23559980|NCT01820559|65779548|FG002|Overall Study|Withdrawal by Subject|5|||
23559981|NCT01820559|65779546|FG000|Overall Study|Protocol Violation|2|||
23559982|NCT01820559|65779547|FG001|Overall Study|Protocol Violation|1|||
23559983|NCT01820559|65779548|FG002|Overall Study|Protocol Violation|3|||
23559984|NCT01820559|65779546|FG000|Overall Study|Subject's non-compliance|1|||
23559985|NCT01820559|65779547|FG001|Overall Study|Subject's non-compliance|0|||
23559986|NCT01820559|65779548|FG002|Overall Study|Subject's non-compliance|2|||
23624483|NCT00983892|66011694|FG000|Overall Study|Withdrawal by Subject|10|||
23624484|NCT00983892|66011695|FG001|Overall Study|Withdrawal by Subject|12|||
23624485|NCT00934700|66011696|FG000|Overall Study|missing scan|5|||
23624486|NCT00934700|66011697|FG001|Overall Study|missing scan|9|||
23149421|NCT04178967|64297579|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23149422|NCT04178967|64297580|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23149423|NCT04178967|64297570|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23149424|NCT04178967|64297571|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23149425|NCT04178967|64297572|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
23149426|NCT04178967|64297573|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
23149427|NCT04178967|64297574|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
23149428|NCT04178967|64297575|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
23149429|NCT04178967|64297576|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
23149430|NCT04178967|64297577|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
23149431|NCT04178967|64297578|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23149432|NCT04178967|64297579|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23149433|NCT04178967|64297580|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
23219326|NCT00355134|64544826|FG004|Extension Phase|Lost to Follow-up|4|||
23219327|NCT00355134|64544822|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
23219328|NCT00355134|64544823|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
23219329|NCT00355134|64544824|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
23219330|NCT00355134|64544825|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
23624487|NCT00934700|66011696|FG000|Overall Study|Death|8|||
23624488|NCT00934700|66011697|FG001|Overall Study|Death|3|||
23323642|NCT01622673|64926794|FG003|Treatment Period 2|Withdrawal by Subject|1|||
23323643|NCT01622673|64926795|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23323644|NCT01622673|64926796|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23323645|NCT01622673|64926791|FG000|Treatment Period 3|Protocol Violation|0|||
23323646|NCT01622673|64926792|FG001|Treatment Period 3|Protocol Violation|1|||
23559987|NCT01820559|65779546|FG000|Overall Study|Lost to Follow-up|3|||
23559988|NCT01820559|65779547|FG001|Overall Study|Lost to Follow-up|2|||
23559989|NCT01820559|65779548|FG002|Overall Study|Lost to Follow-up|2|||
23559990|NCT01820559|65779546|FG000|Overall Study|At sponsor request|0|||
23559991|NCT01820559|65779547|FG001|Overall Study|At sponsor request|0|||
23559992|NCT01820559|65779548|FG002|Overall Study|At sponsor request|1|||
23559993|NCT01820559|65779546|FG000|Overall Study|Lack of Efficacy|3|||
23559994|NCT01820559|65779547|FG001|Overall Study|Lack of Efficacy|2|||
23559995|NCT01820559|65779548|FG002|Overall Study|Lack of Efficacy|3|||
23323647|NCT01622673|64926793|FG002|Treatment Period 3|Protocol Violation|0|||
23323648|NCT01622673|64926794|FG003|Treatment Period 3|Protocol Violation|0|||
23323649|NCT01622673|64926795|FG004|Treatment Period 3|Protocol Violation|0|||
23323650|NCT01622673|64926796|FG005|Treatment Period 3|Protocol Violation|0|||
23323651|NCT00462904|64926797|FG000|Overall Study|Lost to Follow-up|1|||
23559996|NCT00437645|65779551|FG000|Overall Study|Adverse Event|15|||
23559997|NCT00437645|65779552|FG001|Overall Study|Adverse Event|84|||
23559998|NCT00437645|65779551|FG000|Overall Study|Withdrawal by Subject|10|||
23559999|NCT00437645|65779552|FG001|Overall Study|Withdrawal by Subject|22|||
23219331|NCT00355134|64544826|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
23560000|NCT00437645|65779551|FG000|Overall Study|Protocol Violation|3|||
23560001|NCT00437645|65779552|FG001|Overall Study|Protocol Violation|3|||
23560002|NCT00437645|65779551|FG000|Overall Study|Lost to Follow-up|2|||
23560003|NCT00437645|65779552|FG001|Overall Study|Lost to Follow-up|3|||
23560004|NCT00437645|65779551|FG000|Overall Study|Administrative problems|2|||
23560005|NCT00437645|65779552|FG001|Overall Study|Administrative problems|1|||
23560006|NCT00437645|65779551|FG000|Overall Study|Lack of Efficacy|2|||
23560007|NCT00437645|65779552|FG001|Overall Study|Lack of Efficacy|1|||
23560008|NCT00437645|65779551|FG000|Overall Study|Condition no longer requires study drug|1|||
23219332|NCT00355134|64544822|FG000|Extension Phase|Administrative problems|2|||
23219333|NCT00355134|64544823|FG001|Extension Phase|Administrative problems|4|||
23219334|NCT00355134|64544824|FG002|Extension Phase|Administrative problems|0|||
23219335|NCT00355134|64544825|FG003|Extension Phase|Administrative problems|1|||
23219336|NCT00355134|64544826|FG004|Extension Phase|Administrative problems|1|||
23219337|NCT00355134|64544822|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
23219338|NCT00355134|64544823|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
23219339|NCT00355134|64544824|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
23219340|NCT00355134|64544825|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
23219341|NCT00355134|64544826|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
23219342|NCT00355134|64544822|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
23219343|NCT00355134|64544823|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
23219344|NCT00355134|64544824|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
23219345|NCT00355134|64544825|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
23219346|NCT00355134|64544826|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
23219347|NCT00355134|64544822|FG000|Extension Phase|Protocol Violation|0|||
23219348|NCT00355134|64544823|FG001|Extension Phase|Protocol Violation|0|||
23219349|NCT00355134|64544824|FG002|Extension Phase|Protocol Violation|0|||
23219350|NCT00355134|64544825|FG003|Extension Phase|Protocol Violation|1|||
23219351|NCT00355134|64544826|FG004|Extension Phase|Protocol Violation|0|||
23219352|NCT01749800|64544827|FG000|Overall Study|not meeting inclusion criteria|3|||
23219353|NCT01749800|64544828|FG001|Overall Study|not meeting inclusion criteria|0|||
23219354|NCT01749800|64544829|FG002|Overall Study|not meeting inclusion criteria|0|||
23219355|NCT01749800|64544827|FG000|Overall Study|Withdrawal by Subject|0|||
23219356|NCT01749800|64544828|FG001|Overall Study|Withdrawal by Subject|1|||
23219357|NCT01749800|64544829|FG002|Overall Study|Withdrawal by Subject|0|||
23219358|NCT00910728|64544832|FG000|Overall Study|Lack of Efficacy|2|||
23219359|NCT00910728|64544833|FG001|Overall Study|Lack of Efficacy|3|||
23219360|NCT00910728|64544834|FG002|Overall Study|Lack of Efficacy|1|||
23219361|NCT00910728|64544835|FG003|Overall Study|Lack of Efficacy|2|||
23219362|NCT00910728|64544836|FG004|Overall Study|Lack of Efficacy|1|||
23560009|NCT00437645|65779552|FG001|Overall Study|Condition no longer requires study drug|1|||
23560010|NCT00508404|65779555|FG000|Overall Study|Ongoing at Data Cut-off|12|||
23560011|NCT00508404|65779555|FG000|Overall Study|Adverse Event|2|||
23219363|NCT00910728|64544837|FG005|Overall Study|Lack of Efficacy|0|||
23219364|NCT00910728|64544838|FG006|Overall Study|Lack of Efficacy|2|||
23219365|NCT00910728|64544839|FG007|Overall Study|Lack of Efficacy|2|||
23323652|NCT03055624|64926799|FG000|Overall Study|Study closed|9|||
23323653|NCT01050530|64926800|FG000|Overall Study|Adverse Event|6|||
23323654|NCT01050530|64926801|FG001|Overall Study|Adverse Event|3|||
23323655|NCT01050530|64926800|FG000|Overall Study|Lack of Efficacy|1|||
23560012|NCT00508404|65779555|FG000|Overall Study|Death|16|||
23219366|NCT00910728|64544840|FG008|Overall Study|Lack of Efficacy|2|||
23219367|NCT00910728|64544832|FG000|Overall Study|Withdrawal by Subject|0|||
23219368|NCT00910728|64544833|FG001|Overall Study|Withdrawal by Subject|0|||
23219369|NCT00910728|64544834|FG002|Overall Study|Withdrawal by Subject|0|||
23219370|NCT00910728|64544835|FG003|Overall Study|Withdrawal by Subject|0|||
23219371|NCT00910728|64544836|FG004|Overall Study|Withdrawal by Subject|3|||
23219372|NCT00910728|64544837|FG005|Overall Study|Withdrawal by Subject|1|||
23219373|NCT00910728|64544838|FG006|Overall Study|Withdrawal by Subject|2|||
23219374|NCT00910728|64544839|FG007|Overall Study|Withdrawal by Subject|0|||
23219375|NCT00910728|64544840|FG008|Overall Study|Withdrawal by Subject|0|||
23219376|NCT00910728|64544832|FG000|Overall Study|(not specified)|2|||
23219377|NCT00910728|64544833|FG001|Overall Study|(not specified)|0|||
23219378|NCT00910728|64544834|FG002|Overall Study|(not specified)|1|||
23219379|NCT00910728|64544835|FG003|Overall Study|(not specified)|0|||
23219380|NCT00910728|64544836|FG004|Overall Study|(not specified)|1|||
23219381|NCT00910728|64544837|FG005|Overall Study|(not specified)|0|||
23219382|NCT00910728|64544838|FG006|Overall Study|(not specified)|0|||
23219383|NCT00910728|64544839|FG007|Overall Study|(not specified)|0|||
23219384|NCT00910728|64544840|FG008|Overall Study|(not specified)|0|||
23219385|NCT00910728|64544832|FG000|Overall Study|Adverse Event|2|||
23219386|NCT00910728|64544833|FG001|Overall Study|Adverse Event|0|||
23219387|NCT00910728|64544834|FG002|Overall Study|Adverse Event|1|||
23219388|NCT00910728|64544835|FG003|Overall Study|Adverse Event|1|||
23560013|NCT00508404|65779555|FG000|Overall Study|Physician Decision|2|||
23560014|NCT00508404|65779555|FG000|Overall Study|Withdrawal by Subject|3|||
23560015|NCT00508404|65779555|FG000|Overall Study|Protocol-specified Criteria|2|||
23560016|NCT00508404|65779555|FG000|Overall Study|Lost to Follow-up|2|||
23560017|NCT00508404|65779555|FG000|Overall Study|Other - Not Specified|3|||
23560018|NCT00840801|65779556|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
23560019|NCT00840801|65779557|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
23560020|NCT00840801|65779558|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
23219389|NCT00910728|64544836|FG004|Overall Study|Adverse Event|0|||
23560021|NCT00840801|65779556|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
23219390|NCT00910728|64544837|FG005|Overall Study|Adverse Event|0|||
23219391|NCT00910728|64544838|FG006|Overall Study|Adverse Event|2|||
23219392|NCT00910728|64544839|FG007|Overall Study|Adverse Event|1|||
23219393|NCT00910728|64544840|FG008|Overall Study|Adverse Event|1|||
23219394|NCT02455388|64544843|FG000|Overall Study|Protocol Violation|1|||
23219395|NCT02455388|64544844|FG001|Overall Study|Protocol Violation|0|||
23219396|NCT02455388|64544845|FG002|Overall Study|Protocol Violation|4|||
23219397|NCT02455388|64544843|FG000|Overall Study|Withdrawal by Subject|0|||
23219398|NCT02455388|64544844|FG001|Overall Study|Withdrawal by Subject|0|||
23219399|NCT02455388|64544845|FG002|Overall Study|Withdrawal by Subject|7|||
23219400|NCT00044213|64544846|FG000|Overall Study|Withdrawal by Subject|50|||
23219401|NCT00044213|64544847|FG001|Overall Study|Withdrawal by Subject|65|||
23219402|NCT00044213|64544848|FG002|Overall Study|Withdrawal by Subject|91|||
23219403|NCT00044213|64544849|FG003|Overall Study|Withdrawal by Subject|83|||
23219404|NCT00044213|64544846|FG000|Overall Study|Death|42|||
23219405|NCT00044213|64544847|FG001|Overall Study|Death|42|||
23219406|NCT00044213|64544848|FG002|Overall Study|Death|42|||
23219407|NCT00044213|64544849|FG003|Overall Study|Death|49|||
23219408|NCT00044213|64544846|FG000|Overall Study|Lost to Follow-up|8|||
23219409|NCT00044213|64544847|FG001|Overall Study|Lost to Follow-up|5|||
23219410|NCT00044213|64544848|FG002|Overall Study|Lost to Follow-up|5|||
23219411|NCT00044213|64544849|FG003|Overall Study|Lost to Follow-up|4|||
23219412|NCT00425945|64544850|FG000|Overall Study|Concern about Supplement|2|||
23219413|NCT00425945|64544851|FG001|Overall Study|Concern about Supplement|0|||
23219414|NCT00425945|64544850|FG000|Overall Study|Inconvenience|0|||
23219415|NCT00425945|64544851|FG001|Overall Study|Inconvenience|2|||
23560022|NCT00840801|65779557|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
23624489|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
23624490|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
23219416|NCT00425945|64544850|FG000|Overall Study|Lost to Follow-up|0|||
23219417|NCT00425945|64544851|FG001|Overall Study|Lost to Follow-up|2|||
23219418|NCT00425945|64544850|FG000|Overall Study|Began hypertension medication|1|||
23219419|NCT00425945|64544851|FG001|Overall Study|Began hypertension medication|0|||
23219420|NCT00425945|64544850|FG000|Overall Study|Began cancer treatments|1|||
23219421|NCT00425945|64544851|FG001|Overall Study|Began cancer treatments|0|||
23219422|NCT00425945|64544850|FG000|Overall Study|Moved from area|0|||
23219423|NCT00425945|64544851|FG001|Overall Study|Moved from area|1|||
23219424|NCT02820038|64544852|FG000|Overall Study|Lost to Follow-up|7|||
23219425|NCT02820038|64544853|FG001|Overall Study|Lost to Follow-up|11|||
23219426|NCT02820038|64544854|FG002|Overall Study|Lost to Follow-up|2|||
23219427|NCT02820038|64544855|FG003|Overall Study|Lost to Follow-up|9|||
23219428|NCT02820038|64544852|FG000|Overall Study|Withdrawal by Subject|3|||
23219429|NCT02820038|64544853|FG001|Overall Study|Withdrawal by Subject|14|||
23219430|NCT02820038|64544854|FG002|Overall Study|Withdrawal by Subject|3|||
23219431|NCT02820038|64544855|FG003|Overall Study|Withdrawal by Subject|13|||
23323656|NCT01050530|64926801|FG001|Overall Study|Lack of Efficacy|4|||
23323657|NCT01050530|64926800|FG000|Overall Study|Withdrawal by Subject|0|||
23323658|NCT01050530|64926801|FG001|Overall Study|Withdrawal by Subject|3|||
23323659|NCT01050530|64926800|FG000|Overall Study|Protocol Violation|1|||
23323660|NCT01050530|64926801|FG001|Overall Study|Protocol Violation|0|||
23323661|NCT02687451|64926802|FG000|Overall Study|Withdrawal by Subject|1|||
23323662|NCT02687451|64926803|FG001|Overall Study|Withdrawal by Subject|0|||
23323663|NCT02687451|64926804|FG002|Overall Study|Withdrawal by Subject|0|||
23323664|NCT02687451|64926805|FG003|Overall Study|Withdrawal by Subject|0|||
23323665|NCT02687451|64926806|FG004|Overall Study|Withdrawal by Subject|0|||
23323666|NCT02687451|64926807|FG005|Overall Study|Withdrawal by Subject|1|||
23323667|NCT01640249|64926808|FG000|Period 1|Withdrawal by Subject|1|||
23323668|NCT01640249|64926809|FG001|Period 1|Withdrawal by Subject|0|||
23323669|NCT01640249|64926810|FG002|Period 1|Withdrawal by Subject|0|||
23323670|NCT01640249|64926811|FG003|Period 1|Withdrawal by Subject|0|||
23323671|NCT01640249|64926812|FG004|Period 1|Withdrawal by Subject|0|||
23323672|NCT01640249|64926813|FG005|Period 1|Withdrawal by Subject|1|||
23323673|NCT01640249|64926814|FG006|Period 1|Withdrawal by Subject|0|||
23323674|NCT03644342|64926815|FG000|Overall Study|Adverse Event|2|||
23323675|NCT03644342|64926816|FG001|Overall Study|Adverse Event|0|||
23323676|NCT03644342|64926815|FG000|Overall Study|Protocol Violation|0|||
23323677|NCT03644342|64926816|FG001|Overall Study|Protocol Violation|1|||
23323678|NCT01256879|64926826|FG000|Overall Study|Withdrawal by Subject|1|||
23323679|NCT03301649|64926827|FG000|Overall Study|Need alternate therapy due to live lice|17|||
23323680|NCT03301649|64926828|FG001|Overall Study|Need alternate therapy due to live lice|25|||
23323681|NCT03301649|64926829|FG002|Overall Study|Need alternate therapy due to live lice|81|||
23323682|NCT03301649|64926827|FG000|Overall Study|Lost to Follow-up|11|||
23323683|NCT03301649|64926828|FG001|Overall Study|Lost to Follow-up|11|||
23323684|NCT03301649|64926829|FG002|Overall Study|Lost to Follow-up|3|||
23323685|NCT03301649|64926827|FG000|Overall Study|Protocol Violation|0|||
23323686|NCT03301649|64926828|FG001|Overall Study|Protocol Violation|1|||
23323687|NCT03301649|64926829|FG002|Overall Study|Protocol Violation|1|||
23323688|NCT03301649|64926827|FG000|Overall Study|Withdrawal by Subject|10|||
23323689|NCT03301649|64926828|FG001|Overall Study|Withdrawal by Subject|4|||
23323690|NCT03301649|64926829|FG002|Overall Study|Withdrawal by Subject|0|||
23323691|NCT03301649|64926827|FG000|Overall Study|Other than specified|5|||
23323692|NCT03301649|64926828|FG001|Overall Study|Other than specified|3|||
23323693|NCT03301649|64926829|FG002|Overall Study|Other than specified|0|||
23323694|NCT01071915|64926830|FG000|Overall Study|Adverse Event|3|||
23323695|NCT01071915|64926830|FG000|Overall Study|Physician Decision|2|||
23323696|NCT01071915|64926830|FG000|Overall Study|Withdrawal by Subject|2|||
23323697|NCT01071915|64926830|FG000|Overall Study|Miscellaneous Reasons|2|||
23323698|NCT02500043|64926831|FG000|Overall Study|Randomized, but not Treated|2|||
23323699|NCT02500043|64926832|FG001|Overall Study|Randomized, but not Treated|2|||
23323700|NCT02500043|64926831|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
23323701|NCT02500043|64926832|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
23323702|NCT02500043|64926831|FG000|Overall Study|Adverse Event|33|||
23323703|NCT02500043|64926832|FG001|Overall Study|Adverse Event|11|||
23323704|NCT02500043|64926831|FG000|Overall Study|Clinical Progression|54|||
23323705|NCT02500043|64926832|FG001|Overall Study|Clinical Progression|35|||
23323706|NCT02500043|64926831|FG000|Overall Study|Radiological Progression|192|||
23323707|NCT02500043|64926832|FG001|Overall Study|Radiological Progression|110|||
23219432|NCT00524043|64544856|FG000|Overall Study|Lack of Efficacy|15|||
23219433|NCT00524043|64544857|FG001|Overall Study|Lack of Efficacy|13|||
23219434|NCT00524043|64544858|FG002|Overall Study|Lack of Efficacy|14|||
23219435|NCT00524043|64544856|FG000|Overall Study|Withdrawal by Subject|5|||
23219436|NCT00524043|64544857|FG001|Overall Study|Withdrawal by Subject|7|||
23219437|NCT00524043|64544858|FG002|Overall Study|Withdrawal by Subject|7|||
23219438|NCT00524043|64544856|FG000|Overall Study|Adverse Event|5|||
23219439|NCT00524043|64544857|FG001|Overall Study|Adverse Event|2|||
23219440|NCT00524043|64544858|FG002|Overall Study|Adverse Event|7|||
23219441|NCT00524043|64544856|FG000|Overall Study|Lost to Follow-up|3|||
23219442|NCT00524043|64544857|FG001|Overall Study|Lost to Follow-up|5|||
23323708|NCT02500043|64926831|FG000|Overall Study|Physician's Decision|11|||
23323709|NCT02500043|64926832|FG001|Overall Study|Physician's Decision|3|||
23219443|NCT00524043|64544858|FG002|Overall Study|Lost to Follow-up|3|||
23219444|NCT00524043|64544856|FG000|Overall Study|Various (eg, incarceration)|2|||
23219445|NCT00524043|64544857|FG001|Overall Study|Various (eg, incarceration)|1|||
23219446|NCT00524043|64544858|FG002|Overall Study|Various (eg, incarceration)|0|||
23219447|NCT01156532|64544859|FG000|Overall Study|Family Reasons|1|||
23323710|NCT02500043|64926831|FG000|Overall Study|Withdrawal by Subject|14|||
23323711|NCT02500043|64926832|FG001|Overall Study|Withdrawal by Subject|4|||
23323712|NCT02500043|64926831|FG000|Overall Study|Death|11|||
23219448|NCT01156532|64544859|FG000|Overall Study|Lost to Follow-up|1|||
23323713|NCT02500043|64926832|FG001|Overall Study|Death|2|||
23323714|NCT02500043|64926831|FG000|Overall Study|Protocol Deviation|1|||
23323715|NCT02500043|64926832|FG001|Overall Study|Protocol Deviation|0|||
23323716|NCT00153179|64926835|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
23149434|NCT04178967|64297570|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23149435|NCT04178967|64297571|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23149436|NCT04178967|64297572|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23149437|NCT04178967|64297573|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
23149438|NCT04178967|64297574|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23149439|NCT04178967|64297575|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
23149440|NCT04178967|64297576|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
23149441|NCT04178967|64297577|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
23149442|NCT04178967|64297578|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23149443|NCT04178967|64297579|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23149444|NCT04178967|64297580|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23149445|NCT04178967|64297570|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
23149446|NCT04178967|64297571|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
23149447|NCT04178967|64297572|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
23149448|NCT04178967|64297573|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
23149449|NCT04178967|64297574|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
23149450|NCT04178967|64297575|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
23149451|NCT04178967|64297576|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
23149452|NCT04178967|64297577|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
23149453|NCT04178967|64297578|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
23149454|NCT04178967|64297579|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
23149455|NCT04178967|64297580|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
23149456|NCT04178967|64297570|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23149457|NCT04178967|64297571|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23149458|NCT04178967|64297572|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23149459|NCT04178967|64297573|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23149460|NCT04178967|64297574|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23149461|NCT04178967|64297575|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23149462|NCT04178967|64297576|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23149463|NCT04178967|64297577|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23149464|NCT04178967|64297578|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
23149465|NCT04178967|64297579|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
23149466|NCT04178967|64297580|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
23560023|NCT00840801|65779558|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
23560024|NCT00840801|65779556|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
23560025|NCT00840801|65779557|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
23560026|NCT00840801|65779558|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
23560027|NCT00840801|65779556|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
23560028|NCT00840801|65779557|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
23560029|NCT00840801|65779558|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
23560030|NCT05056870|65779559|FG000|Period 1|Site COVID-19 Related|3|||
23560031|NCT05056870|65779560|FG001|Period 1|Site COVID-19 Related|3|||
23560032|NCT05056870|65779559|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
23560033|NCT05056870|65779560|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
23560034|NCT05056870|65779559|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
23560035|NCT05056870|65779560|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
23560036|NCT05056870|65779559|FG000|Period 2|COVID-19 Related|1|||
23560037|NCT05056870|65779560|FG001|Period 2|COVID-19 Related|0|||
23560038|NCT05056870|65779559|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
23560039|NCT05056870|65779560|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
23560040|NCT01699022|65779561|FG000|Overall Study|Early discontinuation from the study|3|||
23560041|NCT00736489|65779562|FG000|Period 1|Lost to Follow-up|1|||
23560042|NCT00736489|65779563|FG001|Period 1|Lost to Follow-up|0|||
23560043|NCT00736489|65779564|FG002|Period 1|Lost to Follow-up|0|||
23560044|NCT00736489|65779565|FG003|Period 1|Lost to Follow-up|0|||
23560045|NCT00736489|65779566|FG004|Period 1|Lost to Follow-up|0|||
23560046|NCT00736489|65779567|FG005|Period 1|Lost to Follow-up|0|||
23560047|NCT00736489|65779562|FG000|Period 1|Withdrawal by Subject|0|||
23560048|NCT00736489|65779563|FG001|Period 1|Withdrawal by Subject|0|||
23560049|NCT00736489|65779564|FG002|Period 1|Withdrawal by Subject|0|||
23560050|NCT00736489|65779565|FG003|Period 1|Withdrawal by Subject|0|||
23560051|NCT00736489|65779566|FG004|Period 1|Withdrawal by Subject|0|||
23560052|NCT00736489|65779567|FG005|Period 1|Withdrawal by Subject|1|||
23560053|NCT00509236|65779568|FG000|Overall Study|Adverse Event|7|||
23560054|NCT00509236|65779569|FG001|Overall Study|Adverse Event|9|||
23560055|NCT00509236|65779568|FG000|Overall Study|Withdrawal by Subject|5|||
23560056|NCT00509236|65779569|FG001|Overall Study|Withdrawal by Subject|10|||
23560057|NCT00509236|65779568|FG000|Overall Study|Protocol Violation|3|||
23560058|NCT00509236|65779569|FG001|Overall Study|Protocol Violation|0|||
23149467|NCT04178967|64297570|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23560059|NCT00509236|65779568|FG000|Overall Study|Excluded Medication|1|||
23560060|NCT00509236|65779569|FG001|Overall Study|Excluded Medication|1|||
23560061|NCT00509236|65779568|FG000|Overall Study|Scheduled Kidney Transplant|1|||
23560062|NCT00509236|65779569|FG001|Overall Study|Scheduled Kidney Transplant|0|||
23560063|NCT01778556|65779570|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
23560064|NCT01778556|65779571|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
23560065|NCT01778556|65779570|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
23560066|NCT01778556|65779571|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
23560067|NCT01778556|65779570|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
23560068|NCT01778556|65779571|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
23560069|NCT01778556|65779570|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
23560070|NCT01778556|65779571|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
23560071|NCT03108157|65779572|FG000|Overall Study|Protocol Violation|15|||
23149468|NCT04178967|64297571|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23149469|NCT04178967|64297572|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23149470|NCT04178967|64297573|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23149471|NCT04178967|64297574|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23219449|NCT01448707|64544861|FG000|Overall Study|Adverse Event|3|||
23219450|NCT01448707|64544862|FG001|Overall Study|Adverse Event|1|||
23219451|NCT01448707|64544861|FG000|Overall Study|Lost to Follow-up|2|||
23219452|NCT01448707|64544862|FG001|Overall Study|Lost to Follow-up|6|||
23219453|NCT01448707|64544861|FG000|Overall Study|Withdrawal by Subject|6|||
23219454|NCT01448707|64544862|FG001|Overall Study|Withdrawal by Subject|7|||
23219455|NCT01448707|64544861|FG000|Overall Study|Other|7|||
23219456|NCT01448707|64544862|FG001|Overall Study|Other|4|||
23219457|NCT00224003|64544864|FG000|Overall Study|Adverse Event|1|||
23219458|NCT00224003|64544864|FG000|Overall Study|Protocol Violation|2|||
23149472|NCT04178967|64297575|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23149473|NCT04178967|64297576|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23149474|NCT04178967|64297577|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23149475|NCT04178967|64297578|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23149476|NCT04178967|64297579|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
23149477|NCT04178967|64297580|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23560072|NCT03108157|65779573|FG001|Overall Study|Protocol Violation|4|||
23219459|NCT00224003|64544864|FG000|Overall Study|Withdrawal by Subject|1|||
23560073|NCT01965938|65779587|FG000|Overall Study|Withdrawal by Subject|1|||
23560074|NCT01965938|65779588|FG001|Overall Study|Withdrawal by Subject|0|||
23560075|NCT05050578|65779590|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
23560076|NCT05050578|65779591|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
23149478|NCT04178967|64297570|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23149479|NCT04178967|64297571|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23149480|NCT04178967|64297572|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23149481|NCT04178967|64297573|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23149482|NCT04178967|64297574|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23149483|NCT04178967|64297575|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23149484|NCT04178967|64297576|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23149485|NCT04178967|64297577|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23149486|NCT04178967|64297578|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
23149487|NCT04178967|64297579|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
23219460|NCT00224003|64544864|FG000|Overall Study|unk|3|||
23219461|NCT00114218|64544865|FG000|Overall Study|Wrong Cell Type|2|||
23560077|NCT05050578|65779590|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
23560078|NCT05050578|65779591|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
23560079|NCT05050578|65779590|FG000|Period 2, 30 Days|Protocol Violation|0|||
23560080|NCT05050578|65779591|FG001|Period 2, 30 Days|Protocol Violation|1|||
23219462|NCT00114218|64544865|FG000|Overall Study|Wrong Primary|1|||
23219463|NCT00114218|64544865|FG000|Overall Study|Never Treated|1|||
23560081|NCT00800202|65779592|FG000|Overall Study|Adverse Event|7|||
23560082|NCT00800202|65779593|FG001|Overall Study|Adverse Event|6|||
23560083|NCT00800202|65779592|FG000|Overall Study|Death|1|||
23560084|NCT00800202|65779593|FG001|Overall Study|Death|0|||
23560085|NCT00800202|65779592|FG000|Overall Study|Other|5|||
23560086|NCT00800202|65779593|FG001|Overall Study|Other|0|||
23560087|NCT00800202|65779592|FG000|Overall Study|Disease Progression|54|||
23219464|NCT01105936|64544866|FG000|Period 1|Adverse Event|0|||
23219465|NCT01105936|64544867|FG001|Period 1|Adverse Event|0|||
23219466|NCT01105936|64544868|FG002|Period 1|Adverse Event|0|||
23219467|NCT01105936|64544869|FG003|Period 1|Adverse Event|1|||
23219468|NCT01105936|64544866|FG000|Period 2|Adverse Event|1|||
23219469|NCT01105936|64544867|FG001|Period 2|Adverse Event|0|||
23219470|NCT01105936|64544868|FG002|Period 2|Adverse Event|0|||
23219471|NCT01105936|64544869|FG003|Period 2|Adverse Event|0|||
23437841|NCT01320202|65344225|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
23560088|NCT00800202|65779593|FG001|Overall Study|Disease Progression|18|||
23219472|NCT01105936|64544866|FG000|Period 3|Protocol Violation|0|||
23149488|NCT04178967|64297580|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
23437842|NCT01320202|65344226|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
23437843|NCT01320202|65344225|FG000|Overall Study|kidney transplant|1|||
23437844|NCT01320202|65344226|FG001|Overall Study|kidney transplant|2|||
23437845|NCT01320202|65344225|FG000|Overall Study|blood transfusion|1|||
23437846|NCT01320202|65344226|FG001|Overall Study|blood transfusion|7|||
23437847|NCT01320202|65344225|FG000|Overall Study|moved/changed dialysis|5|||
23437848|NCT01320202|65344226|FG001|Overall Study|moved/changed dialysis|2|||
23437849|NCT01320202|65344225|FG000|Overall Study|sponsor request|2|||
23437850|NCT01320202|65344226|FG001|Overall Study|sponsor request|0|||
23437851|NCT01320202|65344225|FG000|Overall Study|ineligible|3|||
23437852|NCT01320202|65344226|FG001|Overall Study|ineligible|0|||
23437853|NCT01320202|65344225|FG000|Overall Study|regained renal function|1|||
23437854|NCT01320202|65344226|FG001|Overall Study|regained renal function|0|||
23560089|NCT00991341|65779597|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
23560090|NCT00991341|65779598|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
23560091|NCT00991341|65779597|FG000|Overall Study|Death|3|||
23560092|NCT00991341|65779598|FG001|Overall Study|Death|0|||
23560093|NCT00991341|65779597|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
23560094|NCT00991341|65779598|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
23560095|NCT00991341|65779597|FG000|Overall Study|Physician Decision|1|||
23149489|NCT04178967|64297570|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149490|NCT04178967|64297571|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149491|NCT04178967|64297572|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149492|NCT04178967|64297573|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149493|NCT04178967|64297574|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149494|NCT04178967|64297575|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149495|NCT04178967|64297576|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149496|NCT04178967|64297577|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149497|NCT04178967|64297578|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149498|NCT04178967|64297579|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
23149499|NCT04178967|64297580|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
23149500|NCT04178967|64297570|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149501|NCT04178967|64297571|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149502|NCT04178967|64297572|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149503|NCT04178967|64297573|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149504|NCT04178967|64297574|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149505|NCT04178967|64297575|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149506|NCT04178967|64297576|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149507|NCT04178967|64297577|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149508|NCT04178967|64297578|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149509|NCT04178967|64297579|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
23149510|NCT04178967|64297580|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
23149511|NCT00972777|64297582|FG000|Overall Study|Adverse Event|3|||
23149512|NCT00972777|64297583|FG001|Overall Study|Adverse Event|2|||
23149513|NCT00972777|64297582|FG000|Overall Study|Lost to Follow-up|0|||
23149514|NCT00972777|64297583|FG001|Overall Study|Lost to Follow-up|4|||
23219473|NCT01105936|64544867|FG001|Period 3|Protocol Violation|2|||
23437855|NCT03088813|65344232|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
23437856|NCT03088813|65344233|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
23437857|NCT03088813|65344234|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
23437858|NCT03088813|65344235|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
23437859|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
23437860|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
23437861|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
23437862|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
23560096|NCT00991341|65779598|FG001|Overall Study|Physician Decision|2|||
23560097|NCT00991341|65779597|FG000|Overall Study|Withdrawal by Subject|3|||
23560098|NCT00991341|65779598|FG001|Overall Study|Withdrawal by Subject|4|||
23560099|NCT00514683|65779599|FG000|Overall Study|Not treated|2|||
23560100|NCT00514683|65779600|FG001|Overall Study|Not treated|1|||
23560101|NCT00514683|65779601|FG002|Overall Study|Not treated|0|||
23560102|NCT00514683|65779602|FG003|Overall Study|Not treated|0|||
23437863|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
23560103|NCT00514683|65779603|FG004|Overall Study|Not treated|1|||
23149515|NCT00972777|64297582|FG000|Overall Study|Withdrawal by Subject|4|||
23437864|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
23560104|NCT00514683|65779599|FG000|Overall Study|Adverse Event|21|||
23560105|NCT00514683|65779600|FG001|Overall Study|Adverse Event|20|||
23560106|NCT00514683|65779601|FG002|Overall Study|Adverse Event|15|||
23437865|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
23437866|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
23437867|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
23437868|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
23149516|NCT00972777|64297583|FG001|Overall Study|Withdrawal by Subject|5|||
23149517|NCT00972777|64297582|FG000|Overall Study|Physician Decision|4|||
23149518|NCT00972777|64297583|FG001|Overall Study|Physician Decision|0|||
23149519|NCT00972777|64297582|FG000|Overall Study|Protocol Violation|0|||
23149520|NCT00972777|64297583|FG001|Overall Study|Protocol Violation|2|||
23149521|NCT00972777|64297582|FG000|Overall Study|Screening Failure|2|||
23149522|NCT00972777|64297583|FG001|Overall Study|Screening Failure|1|||
23149523|NCT00972777|64297582|FG000|Overall Study|Missed visit|1|||
23437869|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
23437870|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
23437871|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
23437872|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
23437873|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
23437874|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
23437875|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
23437876|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
23149524|NCT00972777|64297583|FG001|Overall Study|Missed visit|0|||
23149525|NCT03085758|64297584|FG000|Overall Study|Death|26|||
23149526|NCT03085758|64297585|FG001|Overall Study|Death|24|||
23149527|NCT03085758|64297586|FG002|Overall Study|Death|53|||
23149528|NCT03085758|64297584|FG000|Overall Study|Lost to Follow-up|1|||
23149529|NCT03085758|64297585|FG001|Overall Study|Lost to Follow-up|1|||
23149530|NCT03085758|64297586|FG002|Overall Study|Lost to Follow-up|1|||
23149531|NCT03085758|64297584|FG000|Overall Study|Withdrawal by Subject|2|||
23149532|NCT03085758|64297585|FG001|Overall Study|Withdrawal by Subject|2|||
23149533|NCT03085758|64297586|FG002|Overall Study|Withdrawal by Subject|1|||
23149534|NCT03085758|64297584|FG000|Overall Study|Refusal to recall it up to day 90|0|||
23149535|NCT03085758|64297585|FG001|Overall Study|Refusal to recall it up to day 90|0|||
23149536|NCT03085758|64297586|FG002|Overall Study|Refusal to recall it up to day 90|1|||
23149537|NCT03085758|64297584|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
23149538|NCT03085758|64297585|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
23149539|NCT03085758|64297586|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
23149540|NCT01117857|64297587|FG000|Overall Study|Lost to Follow-up|4|||
23149541|NCT01117857|64297587|FG000|Overall Study|Withdrawal by Subject|4|||
23437877|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
23437878|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
23437879|NCT03088813|65344232|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
23437880|NCT03088813|65344233|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
23437881|NCT03088813|65344234|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
23437882|NCT03088813|65344235|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
23437883|NCT03172130|65344238|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
23437884|NCT03172130|65344239|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
23437885|NCT03997825|65344241|FG000|Overall Study|Death|3|||
23437886|NCT03997825|65344241|FG000|Overall Study|Lost to Follow-up|10|||
23437887|NCT03997825|65344241|FG000|Overall Study|Withdrawal by Subject|3|||
23437888|NCT03997825|65344241|FG000|Overall Study|Refused participation|1|||
23437889|NCT01123395|65344242|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
23437890|NCT01123395|65344243|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
23437891|NCT04407234|65344244|FG000|Overall Study|Adverse Event|3|||
23437892|NCT04407234|65344245|FG001|Overall Study|Adverse Event|3|||
23437893|NCT00861471|65344249|FG000|Overall Study|Withdrawal by Subject|1|||
23437894|NCT00861471|65344249|FG000|Overall Study|Adverse Event|2|||
23437895|NCT00861471|65344249|FG000|Overall Study|Lack of Efficacy|3|||
23437896|NCT00861471|65344249|FG000|Overall Study|treatment for lumbar laminectomy|1|||
23437897|NCT00861471|65344249|FG000|Overall Study|Physician Decision|2|||
23437898|NCT00828750|65344250|FG000|Overall Study|Lack of Efficacy|3|||
23437899|NCT00828750|65344250|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
23437900|NCT00064792|65344251|FG000|Overall Study|Withdrawal by Subject|2|||
23437901|NCT00064792|65344252|FG001|Overall Study|Withdrawal by Subject|0|||
23560107|NCT00514683|65779602|FG003|Overall Study|Adverse Event|13|||
23149542|NCT01117857|64297587|FG000|Overall Study|Physician Decision|1|||
23437902|NCT00064792|65344251|FG000|Overall Study|Adverse Event|3|||
23149543|NCT02460497|64297588|FG000|Overall Study|Participant Requested Withdrawal|4|||
23149544|NCT02460497|64297588|FG000|Overall Study|Non-Compliance|1|||
23149545|NCT02460497|64297588|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
23149546|NCT02460497|64297588|FG000|Overall Study|Lost to Follow-up|2|||
23149547|NCT02460497|64297588|FG000|Overall Study|Investigator Decision|1|||
23437903|NCT00064792|65344252|FG001|Overall Study|Adverse Event|0|||
23437904|NCT00250276|65344253|FG000|Overall Study|Serious Adverse Event|0|||
23149548|NCT02469896|64297589|FG000|Overall Study|Withdrawal by Subject|2|||
23437905|NCT00250276|65344254|FG001|Overall Study|Serious Adverse Event|0|||
23437906|NCT00250276|65344255|FG002|Overall Study|Serious Adverse Event|1|||
23437907|NCT00250276|65344256|FG003|Overall Study|Serious Adverse Event|0|||
23437908|NCT00250276|65344253|FG000|Overall Study|Non-serious Adverse Event|2|||
23437909|NCT00250276|65344254|FG001|Overall Study|Non-serious Adverse Event|0|||
23437910|NCT00250276|65344255|FG002|Overall Study|Non-serious Adverse Event|0|||
23437911|NCT00250276|65344256|FG003|Overall Study|Non-serious Adverse Event|2|||
23437912|NCT00250276|65344253|FG000|Overall Study|Protocol Violation|0|||
23437913|NCT00250276|65344254|FG001|Overall Study|Protocol Violation|1|||
23437914|NCT00250276|65344255|FG002|Overall Study|Protocol Violation|0|||
23437915|NCT00250276|65344256|FG003|Overall Study|Protocol Violation|0|||
23437916|NCT00250276|65344253|FG000|Overall Study|Withdrawal by Subject|1|||
23437917|NCT00250276|65344254|FG001|Overall Study|Withdrawal by Subject|2|||
23437918|NCT00250276|65344255|FG002|Overall Study|Withdrawal by Subject|3|||
23437919|NCT00250276|65344256|FG003|Overall Study|Withdrawal by Subject|2|||
23437920|NCT00250276|65344253|FG000|Overall Study|Migrated/moved from study area|3|||
23437921|NCT00250276|65344254|FG001|Overall Study|Migrated/moved from study area|0|||
23437922|NCT00250276|65344255|FG002|Overall Study|Migrated/moved from study area|2|||
23437923|NCT00250276|65344256|FG003|Overall Study|Migrated/moved from study area|7|||
23437924|NCT00250276|65344253|FG000|Overall Study|Lost to Follow-up|11|||
23437925|NCT00250276|65344254|FG001|Overall Study|Lost to Follow-up|18|||
23437926|NCT00250276|65344255|FG002|Overall Study|Lost to Follow-up|13|||
23437927|NCT00250276|65344256|FG003|Overall Study|Lost to Follow-up|8|||
23437928|NCT01832532|65344258|FG000|Overall Study|Withdrawal by Subject|5|||
23437929|NCT01832532|65344259|FG001|Overall Study|Withdrawal by Subject|2|||
23437930|NCT00999518|65344265|FG000|Overall Study|Adverse Event|1|||
23437931|NCT00999518|65344266|FG001|Overall Study|Adverse Event|6|||
23437932|NCT00999518|65344267|FG002|Overall Study|Adverse Event|3|||
23437933|NCT00999518|65344268|FG003|Overall Study|Adverse Event|1|||
23437934|NCT00999518|65344269|FG004|Overall Study|Adverse Event|2|||
23437935|NCT00999518|65344265|FG000|Overall Study|Lack of Efficacy|2|||
23437936|NCT00999518|65344266|FG001|Overall Study|Lack of Efficacy|0|||
23437937|NCT00999518|65344267|FG002|Overall Study|Lack of Efficacy|0|||
23437938|NCT00999518|65344268|FG003|Overall Study|Lack of Efficacy|2|||
23437939|NCT00999518|65344269|FG004|Overall Study|Lack of Efficacy|2|||
23437940|NCT00999518|65344265|FG000|Overall Study|Lost to Follow-up|0|||
23437941|NCT00999518|65344266|FG001|Overall Study|Lost to Follow-up|0|||
23437942|NCT00999518|65344267|FG002|Overall Study|Lost to Follow-up|0|||
23437943|NCT00999518|65344268|FG003|Overall Study|Lost to Follow-up|4|||
23437944|NCT00999518|65344269|FG004|Overall Study|Lost to Follow-up|1|||
23437945|NCT00999518|65344265|FG000|Overall Study|Did not meet entrance criteria|0|||
23437946|NCT00999518|65344266|FG001|Overall Study|Did not meet entrance criteria|0|||
23560108|NCT00514683|65779603|FG004|Overall Study|Adverse Event|27|||
23560109|NCT00514683|65779599|FG000|Overall Study|Protocol Violation|1|||
23560110|NCT00514683|65779600|FG001|Overall Study|Protocol Violation|1|||
23560111|NCT00514683|65779601|FG002|Overall Study|Protocol Violation|0|||
23149549|NCT02469896|64297590|FG001|Overall Study|Withdrawal by Subject|0|||
23149550|NCT01791803|64297596|FG000|Overall Study|Withdrawal by Subject|0|||
23149551|NCT01791803|64297597|FG001|Overall Study|Withdrawal by Subject|0|||
23149552|NCT01791803|64297598|FG002|Overall Study|Withdrawal by Subject|0|||
23437947|NCT00999518|65344267|FG002|Overall Study|Did not meet entrance criteria|0|||
23437948|NCT00999518|65344268|FG003|Overall Study|Did not meet entrance criteria|0|||
23437949|NCT00999518|65344269|FG004|Overall Study|Did not meet entrance criteria|1|||
23437950|NCT00999518|65344265|FG000|Overall Study|Study terminated by sponsor|10|||
23560112|NCT00514683|65779602|FG003|Overall Study|Protocol Violation|1|||
23560113|NCT00514683|65779603|FG004|Overall Study|Protocol Violation|0|||
23560114|NCT00514683|65779599|FG000|Overall Study|Withdrawal by Subject|2|||
23560115|NCT00514683|65779600|FG001|Overall Study|Withdrawal by Subject|2|||
23560116|NCT00514683|65779601|FG002|Overall Study|Withdrawal by Subject|1|||
23560117|NCT00514683|65779602|FG003|Overall Study|Withdrawal by Subject|0|||
23560118|NCT00514683|65779603|FG004|Overall Study|Withdrawal by Subject|4|||
23560119|NCT00514683|65779599|FG000|Overall Study|Reason other than listed above|0|||
23560120|NCT00514683|65779600|FG001|Overall Study|Reason other than listed above|1|||
23560121|NCT00514683|65779601|FG002|Overall Study|Reason other than listed above|2|||
23560122|NCT00514683|65779602|FG003|Overall Study|Reason other than listed above|0|||
23560123|NCT00514683|65779603|FG004|Overall Study|Reason other than listed above|1|||
23560124|NCT04382924|65779604|FG000|Overall Study|Death|2|||
23437951|NCT00999518|65344266|FG001|Overall Study|Study terminated by sponsor|6|||
23437952|NCT00999518|65344267|FG002|Overall Study|Study terminated by sponsor|5|||
23437953|NCT00999518|65344268|FG003|Overall Study|Study terminated by sponsor|5|||
23149553|NCT01791803|64297599|FG003|Overall Study|Withdrawal by Subject|2|||
23437954|NCT00999518|65344269|FG004|Overall Study|Study terminated by sponsor|9|||
23560125|NCT04382924|65779605|FG001|Overall Study|Death|5|||
23560126|NCT04382924|65779606|FG002|Overall Study|Death|4|||
23560127|NCT04382924|65779604|FG000|Overall Study|Protocol Violation|0|||
23560128|NCT04382924|65779605|FG001|Overall Study|Protocol Violation|1|||
23219474|NCT01105936|64544868|FG002|Period 3|Protocol Violation|0|||
23219475|NCT01105936|64544869|FG003|Period 3|Protocol Violation|0|||
23219476|NCT01855425|64544870|FG000|Overall Study|Physician Decision|20|||
23219477|NCT02204410|64544871|FG000|Overall Study|Lost to Follow-up|5|||
23437955|NCT00999518|65344265|FG000|Overall Study|Pregnancy|0|||
23437956|NCT00999518|65344266|FG001|Overall Study|Pregnancy|0|||
23437957|NCT00999518|65344267|FG002|Overall Study|Pregnancy|1|||
23624491|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
23624492|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
23624493|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Death|0|||
23624494|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Death|1|||
23624495|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
23624496|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
23624497|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
23624498|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
23624499|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
23624500|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
23624501|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
23624502|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
23624503|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
23624504|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
23624505|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
23624506|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
23624507|NCT01309243|66011701|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
23624508|NCT01309243|66011702|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
23624509|NCT01309243|66011701|FG000|Extension Phase|Lost to Follow-up|6|||
23624510|NCT01309243|66011702|FG001|Extension Phase|Lost to Follow-up|0|||
23624511|NCT02215954|66011703|FG000|Overall Study|Adverse Event|0|||
23624512|NCT02215954|66011704|FG001|Overall Study|Adverse Event|0|||
23437958|NCT00999518|65344268|FG003|Overall Study|Pregnancy|0|||
23437959|NCT00999518|65344269|FG004|Overall Study|Pregnancy|0|||
23437960|NCT00999518|65344265|FG000|Overall Study|Protocol Violation|0|||
23437961|NCT00999518|65344266|FG001|Overall Study|Protocol Violation|1|||
23437962|NCT00999518|65344267|FG002|Overall Study|Protocol Violation|0|||
23437963|NCT00999518|65344268|FG003|Overall Study|Protocol Violation|0|||
23437964|NCT00999518|65344269|FG004|Overall Study|Protocol Violation|2|||
23437965|NCT00999518|65344265|FG000|Overall Study|Withdrawal by Subject|5|||
23437966|NCT00999518|65344266|FG001|Overall Study|Withdrawal by Subject|4|||
23437967|NCT00999518|65344267|FG002|Overall Study|Withdrawal by Subject|10|||
23624513|NCT02215954|66011705|FG002|Overall Study|Adverse Event|1|||
23624514|NCT02215954|66011703|FG000|Overall Study|Withdrawal by Subject|0|||
23624515|NCT02215954|66011704|FG001|Overall Study|Withdrawal by Subject|0|||
23437968|NCT00999518|65344268|FG003|Overall Study|Withdrawal by Subject|6|||
23437969|NCT00999518|65344269|FG004|Overall Study|Withdrawal by Subject|1|||
23437970|NCT00999518|65344265|FG000|Overall Study|Other|5|||
23560129|NCT04382924|65779606|FG002|Overall Study|Protocol Violation|1|||
23560130|NCT04382924|65779604|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
23560131|NCT04382924|65779605|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
23560132|NCT04382924|65779606|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
23560133|NCT04382924|65779604|FG000|Overall Study|Withdrawal by Subject|6|||
23560134|NCT04382924|65779605|FG001|Overall Study|Withdrawal by Subject|3|||
23560135|NCT04382924|65779606|FG002|Overall Study|Withdrawal by Subject|6|||
23560136|NCT05292534|65779607|FG000|Overall Study|Protocol Violation|3|||
23560137|NCT05292534|65779608|FG001|Overall Study|Protocol Violation|4|||
23560138|NCT05292534|65779607|FG000|Overall Study|Withdrawal by Subject|0|||
23560139|NCT05292534|65779608|FG001|Overall Study|Withdrawal by Subject|1|||
23560140|NCT03633929|65779609|FG000|Overall Study|Lost to Follow-up|1|||
23624516|NCT02215954|66011705|FG002|Overall Study|Withdrawal by Subject|2|||
23624517|NCT02215954|66011703|FG000|Overall Study|Not exposed|1|||
23437971|NCT00999518|65344266|FG001|Overall Study|Other|7|||
23437972|NCT00999518|65344267|FG002|Overall Study|Other|1|||
23437973|NCT00999518|65344268|FG003|Overall Study|Other|4|||
23560141|NCT03633929|65779609|FG000|Overall Study|Did not login to software. Did not participate|3|||
23560142|NCT01125722|65779620|FG000|Overall Study|Withdrawal by Subject|2|||
23560143|NCT01125722|65779621|FG001|Overall Study|Withdrawal by Subject|1|||
23624518|NCT02215954|66011704|FG001|Overall Study|Not exposed|1|||
23624519|NCT02215954|66011705|FG002|Overall Study|Not exposed|3|||
23219478|NCT02204410|64544871|FG000|Overall Study|Physician Decision|2|||
23437974|NCT00999518|65344269|FG004|Overall Study|Other|5|||
23437975|NCT00999518|65344265|FG000|Overall Study|Randomized but not Treated|1|||
23437976|NCT00999518|65344266|FG001|Overall Study|Randomized but not Treated|1|||
23437977|NCT00999518|65344267|FG002|Overall Study|Randomized but not Treated|2|||
23437978|NCT00999518|65344268|FG003|Overall Study|Randomized but not Treated|0|||
23560144|NCT01125722|65779620|FG000|Overall Study|Lost to Follow-up|1|||
23560145|NCT01125722|65779621|FG001|Overall Study|Lost to Follow-up|0|||
23437979|NCT00999518|65344269|FG004|Overall Study|Randomized but not Treated|1|||
23437980|NCT02396589|65344272|FG000|Intervention|Lost to Follow-up|1|||
23437981|NCT02396589|65344273|FG001|Intervention|Lost to Follow-up|0|||
23437982|NCT02396589|65344272|FG000|6 Month Follow-up|change in health status|0|||
23560146|NCT01690130|65779625|FG000|Overall Study|Subject have cancelled visit.|1|||
23560147|NCT01690130|65779626|FG001|Overall Study|Subject have cancelled visit.|0|||
23560148|NCT04510675|65779627|FG000|Overall Study|Withdrawal by Subject|5|||
23560149|NCT00552084|65779630|FG000|Overall Study|Adverse Event|2|||
23560150|NCT00552084|65779631|FG001|Overall Study|Adverse Event|3|||
23560151|NCT00552084|65779630|FG000|Overall Study|Withdrawal by Subject|4|||
23560152|NCT00552084|65779631|FG001|Overall Study|Withdrawal by Subject|5|||
23560153|NCT00552084|65779630|FG000|Overall Study|Protocol Violation|1|||
23560154|NCT00552084|65779631|FG001|Overall Study|Protocol Violation|0|||
23560155|NCT00552084|65779630|FG000|Overall Study|change in anti-arrythmic drug|1|||
23560156|NCT00552084|65779631|FG001|Overall Study|change in anti-arrythmic drug|1|||
23560157|NCT00321048|65779632|FG000|Overall Study|Withdrawal by Subject|6|||
23560158|NCT00321048|65779633|FG001|Overall Study|Withdrawal by Subject|8|||
23560159|NCT01197508|65779634|FG000|Overall Study|Withdrawal by Subject|8|||
23560160|NCT01197508|65779635|FG001|Overall Study|Withdrawal by Subject|7|||
23560161|NCT01197508|65779636|FG002|Overall Study|Withdrawal by Subject|15|||
23560162|NCT01197508|65779637|FG003|Overall Study|Withdrawal by Subject|4|||
23560163|NCT01197508|65779634|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
23149554|NCT01791803|64297596|FG000|Overall Study|Physician Decision|0|||
23149555|NCT01791803|64297597|FG001|Overall Study|Physician Decision|2|||
23149556|NCT01791803|64297598|FG002|Overall Study|Physician Decision|0|||
23149557|NCT01791803|64297599|FG003|Overall Study|Physician Decision|1|||
23149558|NCT01791803|64297596|FG000|Overall Study|Death|0|||
23149559|NCT01791803|64297597|FG001|Overall Study|Death|0|||
23149560|NCT01791803|64297598|FG002|Overall Study|Death|2|||
23149561|NCT01791803|64297599|FG003|Overall Study|Death|2|||
23219479|NCT02204410|64544871|FG000|Overall Study|Protocol Violation|1|||
23437983|NCT02396589|65344273|FG001|6 Month Follow-up|change in health status|1|||
23437984|NCT02396589|65344272|FG000|9 Month Follow-up|Death|0|||
23437985|NCT02396589|65344273|FG001|9 Month Follow-up|Death|1|||
23560164|NCT01197508|65779635|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
23560165|NCT01197508|65779636|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
23560166|NCT01197508|65779637|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
23219480|NCT02204410|64544871|FG000|Overall Study|Withdrawal by Subject|3|||
23219481|NCT03693404|64544872|FG000|Overall Study|Withdrawal by Subject|1|||
23219482|NCT03693404|64544873|FG001|Overall Study|Withdrawal by Subject|0|||
23219483|NCT03693404|64544872|FG000|Overall Study|Lost to Follow-up|0|||
23219484|NCT03693404|64544873|FG001|Overall Study|Lost to Follow-up|5|||
23219485|NCT03693404|64544872|FG000|Overall Study|Excluded from Analysis|0|||
23219486|NCT03693404|64544873|FG001|Overall Study|Excluded from Analysis|1|||
23219487|NCT00841672|64544894|FG000|Overall Study|Adverse Event|7|||
23219488|NCT00841672|64544895|FG001|Overall Study|Adverse Event|16|||
23219489|NCT00841672|64544894|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23219490|NCT00841672|64544895|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23219491|NCT00841672|64544894|FG000|Overall Study|Subject withdrew consent|2|||
23219492|NCT00841672|64544895|FG001|Overall Study|Subject withdrew consent|4|||
23219493|NCT00841672|64544894|FG000|Overall Study|Lost to Follow-up|1|||
23560167|NCT01197508|65779634|FG000|Overall Study|Adverse Event|10|||
23560168|NCT01197508|65779635|FG001|Overall Study|Adverse Event|13|||
23560169|NCT01197508|65779636|FG002|Overall Study|Adverse Event|23|||
23560170|NCT01197508|65779637|FG003|Overall Study|Adverse Event|3|||
23560171|NCT01197508|65779634|FG000|Overall Study|Severe non-compliance to protocol|0|||
23560172|NCT01197508|65779635|FG001|Overall Study|Severe non-compliance to protocol|3|||
23560173|NCT01197508|65779636|FG002|Overall Study|Severe non-compliance to protocol|1|||
23219494|NCT00841672|64544895|FG001|Overall Study|Lost to Follow-up|1|||
23560174|NCT01197508|65779637|FG003|Overall Study|Severe non-compliance to protocol|3|||
23560175|NCT01197508|65779634|FG000|Overall Study|Condition under investigation worsened|1|||
23560176|NCT01197508|65779635|FG001|Overall Study|Condition under investigation worsened|1|||
23560177|NCT01197508|65779636|FG002|Overall Study|Condition under investigation worsened|1|||
23560178|NCT01197508|65779637|FG003|Overall Study|Condition under investigation worsened|1|||
23560179|NCT01197508|65779634|FG000|Overall Study|Lack of Efficacy|1|||
23560180|NCT01197508|65779635|FG001|Overall Study|Lack of Efficacy|2|||
23560181|NCT01197508|65779636|FG002|Overall Study|Lack of Efficacy|2|||
23560182|NCT01197508|65779637|FG003|Overall Study|Lack of Efficacy|1|||
23624520|NCT01200485|66011706|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
23149562|NCT01330914|64297600|FG000|Overall Study|Withdrawal by Subject|4|||
23219495|NCT00841672|64544894|FG000|Overall Study|Administrative problems|9|||
23219496|NCT00841672|64544895|FG001|Overall Study|Administrative problems|9|||
23219497|NCT00841672|64544894|FG000|Overall Study|Misrandomized|1|||
23437986|NCT02396589|65344272|FG000|12 Month Follow up|Lost to Follow-up|0|||
23437987|NCT02396589|65344273|FG001|12 Month Follow up|Lost to Follow-up|2|||
23149563|NCT01330914|64297600|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
23437988|NCT01041287|65344274|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
23437989|NCT01041287|65344275|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
23437990|NCT01041287|65344274|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
23437991|NCT01041287|65344275|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
23437992|NCT00659230|65344276|FG000|Overall Study|Lost to Follow-up|2|||
23437993|NCT00659230|65344277|FG001|Overall Study|Lost to Follow-up|5|||
23437994|NCT00659230|65344276|FG000|Overall Study|Lost source documentation|5|||
23437995|NCT00659230|65344277|FG001|Overall Study|Lost source documentation|4|||
23624521|NCT01200485|66011707|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
23624522|NCT01200485|66011708|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
23437996|NCT00659230|65344276|FG000|Overall Study|Did not return post-randomization|2|||
23560183|NCT01197508|65779634|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23624523|NCT01200485|66011706|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
23624524|NCT01200485|66011707|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
23624525|NCT01200485|66011708|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
23624526|NCT03187353|66011712|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
23624527|NCT03187353|66011713|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
23624528|NCT03187353|66011712|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
23624529|NCT03187353|66011713|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
23624530|NCT03187353|66011712|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
23624531|NCT03187353|66011713|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
23624532|NCT03187353|66011712|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
23624533|NCT03187353|66011713|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
23624534|NCT03187353|66011712|FG000|Washout (2 Weeks)|Adverse Event|2|||
23624535|NCT03187353|66011713|FG001|Washout (2 Weeks)|Adverse Event|0|||
23560184|NCT01197508|65779635|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23560185|NCT01197508|65779636|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23560186|NCT01197508|65779637|FG003|Overall Study|Study-specific withdrawal criteria|2|||
23560187|NCT01197508|65779634|FG000|Overall Study|Lost to Follow-up|1|||
23560188|NCT01197508|65779635|FG001|Overall Study|Lost to Follow-up|1|||
23560189|NCT01197508|65779636|FG002|Overall Study|Lost to Follow-up|2|||
23560190|NCT01197508|65779637|FG003|Overall Study|Lost to Follow-up|0|||
23560191|NCT01197508|65779634|FG000|Overall Study|Other|2|||
23560192|NCT01197508|65779635|FG001|Overall Study|Other|3|||
23560193|NCT01197508|65779636|FG002|Overall Study|Other|2|||
23560194|NCT01197508|65779637|FG003|Overall Study|Other|2|||
23560195|NCT01712009|65779638|FG000|Overall Study|Withdrawal by Subject|24|||
23560196|NCT01712009|65779639|FG001|Overall Study|Withdrawal by Subject|15|||
23560197|NCT01712009|65779640|FG002|Overall Study|Withdrawal by Subject|8|||
23560198|NCT01712009|65779638|FG000|Overall Study|Lost to Follow-up|2|||
23560199|NCT01712009|65779639|FG001|Overall Study|Lost to Follow-up|0|||
23560200|NCT01712009|65779640|FG002|Overall Study|Lost to Follow-up|1|||
23560201|NCT01712009|65779638|FG000|Overall Study|Decision by Sponsor|12|||
23560202|NCT01712009|65779639|FG001|Overall Study|Decision by Sponsor|14|||
23560203|NCT01712009|65779640|FG002|Overall Study|Decision by Sponsor|12|||
23560204|NCT02901626|65779646|FG000|Overall Study|Lost to Follow-up|1|||
23560205|NCT02901626|65779647|FG001|Overall Study|Lost to Follow-up|1|||
23560206|NCT04524598|65779648|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
23560207|NCT04524598|65779649|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
23560208|NCT04524598|65779650|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
23560209|NCT04524598|65779651|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
23560210|NCT04524598|65779652|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
23560211|NCT04524598|65779648|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
23560212|NCT04524598|65779649|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
23560213|NCT04524598|65779650|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560214|NCT04524598|65779651|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560215|NCT04524598|65779652|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560216|NCT04524598|65779648|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
23560217|NCT04524598|65779649|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
23560218|NCT04524598|65779650|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
23560219|NCT04524598|65779651|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
23560220|NCT04524598|65779652|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
23560221|NCT04524598|65779648|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
23560222|NCT04524598|65779649|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
23560223|NCT04524598|65779650|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
23560224|NCT04524598|65779651|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
23560225|NCT04524598|65779652|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
23560226|NCT04524598|65779648|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560227|NCT04524598|65779649|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560228|NCT04524598|65779650|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
23560229|NCT04524598|65779651|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
23560230|NCT04524598|65779652|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560231|NCT04524598|65779648|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
23560232|NCT04524598|65779649|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
23560233|NCT04524598|65779650|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
23560234|NCT04524598|65779651|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
23560235|NCT04524598|65779652|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
23560236|NCT04524598|65779648|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560237|NCT04524598|65779649|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560238|NCT04524598|65779650|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560239|NCT04524598|65779651|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
23560240|NCT04524598|65779652|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
23560241|NCT00454571|65779653|FG000|Overall Study|Adverse Event|2|||
23560242|NCT00454571|65779654|FG001|Overall Study|Adverse Event|0|||
23560243|NCT00454571|65779653|FG000|Overall Study|Physician Decision|0|||
23560244|NCT00454571|65779654|FG001|Overall Study|Physician Decision|1|||
23560245|NCT00454571|65779653|FG000|Overall Study|Protocol Violation|1|||
23560246|NCT00454571|65779654|FG001|Overall Study|Protocol Violation|0|||
23149564|NCT01446016|64297601|FG000|Overall Study|Lost to Follow-up|3|||
23149565|NCT01446016|64297601|FG000|Overall Study|Withdrawal by Subject|1|||
23149566|NCT01446016|64297601|FG000|Overall Study|Toxicity|3|||
23149567|NCT00833911|64297605|FG000|Titration|Adverse Event|18|||
23149568|NCT00833911|64297605|FG000|Titration|Withdrawal by Subject|3|||
23149569|NCT00833911|64297605|FG000|Maintenance Phase I|Adverse Event|73|||
23149570|NCT00833911|64297605|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
23149571|NCT00833911|64297605|FG000|Maintenance Phase I|Physician Decision|10|||
23149572|NCT00833911|64297605|FG000|Maintenance Phase I|Lack of Efficacy|4|||
23149573|NCT00833911|64297605|FG000|Maintenance Phase II|Adverse Event|6|||
23149574|NCT00833911|64297605|FG000|Maintenance Phase II|Physician Decision|2|||
23149575|NCT00833911|64297605|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
23149576|NCT00833911|64297605|FG000|Maintenance Phase II|Lack of Efficacy|1|||
23149577|NCT03285178|64297606|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
23149578|NCT03285178|64297607|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23149579|NCT03285178|64297608|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23149580|NCT03285178|64297609|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23149581|NCT03285178|64297610|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23149582|NCT03285178|64297611|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23149583|NCT03285178|64297612|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
23149584|NCT03285178|64297606|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
23149585|NCT03285178|64297607|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23149586|NCT03285178|64297608|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23149587|NCT03285178|64297609|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23149588|NCT03285178|64297610|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23149589|NCT03285178|64297611|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23149590|NCT03285178|64297612|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
23149591|NCT03285178|64297606|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
23149592|NCT03285178|64297607|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
23149593|NCT03285178|64297608|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
23149594|NCT03285178|64297609|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
23149595|NCT03285178|64297610|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
23149596|NCT03285178|64297611|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
23149597|NCT03285178|64297612|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
23149598|NCT03285178|64297606|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
23219498|NCT00841672|64544895|FG001|Overall Study|Misrandomized|0|||
23219499|NCT00841672|64544894|FG000|Overall Study|Protocol Deviation|0|||
23219500|NCT00841672|64544895|FG001|Overall Study|Protocol Deviation|1|||
23219501|NCT03457636|64544896|FG000|Overall Study|Lost to Follow-up|2|||
23219502|NCT02023268|64544897|FG000|Overall Study|Lack of Efficacy|0|||
23219503|NCT02023268|64544898|FG001|Overall Study|Lack of Efficacy|1|||
23219504|NCT02023268|64544897|FG000|Overall Study|Adverse Event|0|||
23219505|NCT02023268|64544898|FG001|Overall Study|Adverse Event|2|||
23219506|NCT02023268|64544897|FG000|Overall Study|Withdrawal by Subject|0|||
23219507|NCT02023268|64544898|FG001|Overall Study|Withdrawal by Subject|1|||
23560247|NCT00454571|65779653|FG000|Overall Study|Withdrawal by Subject|10|||
23624536|NCT03187353|66011712|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
23560248|NCT00454571|65779654|FG001|Overall Study|Withdrawal by Subject|5|||
23560249|NCT04934722|65779655|FG000|Overall Study|Death|4|||
23149599|NCT03285178|64297607|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23149600|NCT03285178|64297608|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23149601|NCT03285178|64297609|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23149602|NCT03285178|64297610|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23149603|NCT03285178|64297611|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23149604|NCT03285178|64297612|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
23149605|NCT03285178|64297606|FG000|Single-Blind Run-In Period|Physician Decision|2|||
23149606|NCT03285178|64297607|FG001|Single-Blind Run-In Period|Physician Decision|0|||
23149607|NCT03285178|64297608|FG002|Single-Blind Run-In Period|Physician Decision|0|||
23149608|NCT03285178|64297609|FG003|Single-Blind Run-In Period|Physician Decision|0|||
23149609|NCT03285178|64297610|FG004|Single-Blind Run-In Period|Physician Decision|0|||
23560250|NCT04934722|65779656|FG001|Overall Study|Death|3|||
23560251|NCT04934722|65779655|FG000|Overall Study|Participants Ongoing|88|||
23560252|NCT04934722|65779656|FG001|Overall Study|Participants Ongoing|91|||
23323717|NCT00153179|64926836|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
23323718|NCT00153179|64926837|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
23323719|NCT00153179|64926838|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
23323720|NCT01742897|64926839|FG000|Overall Study|Adverse Event|3|||
23323721|NCT01742897|64926839|FG000|Overall Study|Withdrawal by Subject|1|||
23323722|NCT01742897|64926839|FG000|Overall Study|Other|1|||
23323723|NCT02072980|64926840|FG000|Period 2, Second Wear|Adverse Event|0|||
23323724|NCT02072980|64926841|FG001|Period 2, Second Wear|Adverse Event|1|||
23323725|NCT02685735|64926847|FG000|Overall Study|Missing construct or pain data|23|||
23323726|NCT02685735|64926848|FG001|Overall Study|Missing construct or pain data|22|||
23323727|NCT03565900|64926853|FG000|Overall Study|Disposition Unknown|4|||
23323728|NCT03565900|64926854|FG001|Overall Study|Disposition Unknown|1|||
23323729|NCT03565900|64926853|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23323730|NCT03565900|64926854|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
23323731|NCT03565900|64926853|FG000|Overall Study|Withdrawal by Subject|4|||
23323732|NCT03565900|64926854|FG001|Overall Study|Withdrawal by Subject|5|||
23323733|NCT03565900|64926853|FG000|Overall Study|Randomized By Mistake|0|||
23323734|NCT03565900|64926854|FG001|Overall Study|Randomized By Mistake|2|||
23323735|NCT03565900|64926853|FG000|Overall Study|Physician Decision|7|||
23323736|NCT03565900|64926854|FG001|Overall Study|Physician Decision|11|||
23323737|NCT03565900|64926853|FG000|Overall Study|Death|9|||
23323738|NCT03565900|64926854|FG001|Overall Study|Death|7|||
23323739|NCT00214383|64926855|FG000|Overall Study|Lost to Follow-up|16|||
23323740|NCT00214383|64926856|FG001|Overall Study|Lost to Follow-up|26|||
23323741|NCT00927589|64926857|FG000|Overall Study|Death|1|||
23437997|NCT00659230|65344277|FG001|Overall Study|Did not return post-randomization|3|||
23437998|NCT00859937|65344278|FG000|Overall Study|Protocol Violation|1|||
23437999|NCT00859937|65344279|FG001|Overall Study|Protocol Violation|0|||
23438000|NCT00620113|65344280|FG000|Overall Study|Adverse Event|3|||
23438001|NCT00620113|65344281|FG001|Overall Study|Adverse Event|2|||
23438002|NCT00620113|65344282|FG002|Overall Study|Adverse Event|2|||
23438003|NCT00620113|65344283|FG003|Overall Study|Adverse Event|1|||
23438004|NCT00620113|65344280|FG000|Overall Study|Lack of Efficacy|2|||
23438005|NCT00620113|65344281|FG001|Overall Study|Lack of Efficacy|3|||
23438006|NCT00620113|65344282|FG002|Overall Study|Lack of Efficacy|0|||
23438007|NCT00620113|65344283|FG003|Overall Study|Lack of Efficacy|2|||
23560253|NCT01786330|65779659|FG000|Overall Study|Withdrawal by Subject|0|||
23560254|NCT01786330|65779660|FG001|Overall Study|Withdrawal by Subject|1|||
23560255|NCT01786330|65779659|FG000|Overall Study|Lost to Follow-up|0|||
23560256|NCT01786330|65779660|FG001|Overall Study|Lost to Follow-up|1|||
23560257|NCT01786330|65779659|FG000|Overall Study|Excluded intraoperatively|0|||
23560258|NCT01786330|65779660|FG001|Overall Study|Excluded intraoperatively|1|||
23149610|NCT03285178|64297611|FG005|Single-Blind Run-In Period|Physician Decision|0|||
23560259|NCT01786330|65779659|FG000|Overall Study|Protocol Violation|1|||
23560260|NCT01786330|65779660|FG001|Overall Study|Protocol Violation|0|||
23219518|NCT00701441|64544906|FG000|Overall Study|failure in cpap compliance|0|||
23219519|NCT00701441|64544907|FG001|Overall Study|failure in cpap compliance|4|||
23219520|NCT02578992|64544908|FG000|Overall Study|equipment not available or malfunction|3|||
23219521|NCT02578992|64544909|FG001|Overall Study|equipment not available or malfunction|3|||
23219522|NCT00527072|64544910|FG000|Overall Study|Adverse Event|13|||
23219523|NCT00527072|64544910|FG000|Overall Study|Lack of Efficacy|11|||
23219524|NCT00527072|64544910|FG000|Overall Study|Lost to Follow-up|3|||
23323742|NCT00927589|64926857|FG000|Overall Study|Physician Decision|1|||
23323743|NCT00927589|64926857|FG000|Overall Study|Withdrawal by Subject|3|||
23323744|NCT00927589|64926857|FG000|Overall Study|Adverse Event|2|||
23438008|NCT00620113|65344280|FG000|Overall Study|Physician Decision|1|||
23323745|NCT00927589|64926857|FG000|Overall Study|Disease Progression|8|||
23323746|NCT00927589|64926857|FG000|Overall Study|Non-compliance|1|||
23323747|NCT00808210|64926858|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
23438009|NCT00620113|65344281|FG001|Overall Study|Physician Decision|0|||
23438010|NCT00620113|65344282|FG002|Overall Study|Physician Decision|0|||
23560261|NCT00615264|65779668|FG000|Overall Study|Withdrawal by Subject|17|||
23323748|NCT00808210|64926859|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
23323749|NCT00808210|64926858|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
23323750|NCT00808210|64926859|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
23323751|NCT00808210|64926858|FG000|Double-Blind TX Period|Adverse Event|0|||
23323752|NCT00808210|64926859|FG001|Double-Blind TX Period|Adverse Event|1|||
23323753|NCT00808210|64926858|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
23323754|NCT00808210|64926859|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
23323755|NCT00808210|64926858|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
23323756|NCT00808210|64926859|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
23323757|NCT00808210|64926858|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
23323758|NCT00808210|64926859|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
23323759|NCT01866826|64926864|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
23323760|NCT01866826|64926865|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
23323761|NCT01866826|64926864|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
23323762|NCT01866826|64926865|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
23323763|NCT01866826|64926864|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
23323764|NCT01866826|64926865|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
23323765|NCT03552380|64926867|FG000|Study Treatment|Disease Progression|3|||
23323766|NCT03552380|64926868|FG001|Study Treatment|Disease Progression|4|||
23323767|NCT03552380|64926867|FG000|Study Treatment|Adverse Event|2|||
23323768|NCT03552380|64926868|FG001|Study Treatment|Adverse Event|2|||
23560262|NCT00615264|65779669|FG001|Overall Study|Withdrawal by Subject|19|||
23560263|NCT00615264|65779668|FG000|Overall Study|Lost to Follow-up|6|||
23560264|NCT00615264|65779669|FG001|Overall Study|Lost to Follow-up|13|||
23438011|NCT00620113|65344283|FG003|Overall Study|Physician Decision|2|||
23438012|NCT00620113|65344280|FG000|Overall Study|Protocol Violation|2|||
23438013|NCT00620113|65344281|FG001|Overall Study|Protocol Violation|1|||
23438014|NCT00620113|65344282|FG002|Overall Study|Protocol Violation|0|||
23438015|NCT00620113|65344283|FG003|Overall Study|Protocol Violation|0|||
23560265|NCT00615264|65779668|FG000|Overall Study|Adverse Event|8|||
23560266|NCT00615264|65779669|FG001|Overall Study|Adverse Event|5|||
23624537|NCT03187353|66011713|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
23560267|NCT00615264|65779668|FG000|Overall Study|Death|1|||
23560268|NCT00615264|65779669|FG001|Overall Study|Death|1|||
23560269|NCT00615264|65779668|FG000|Overall Study|Protocol Violation|11|||
23560270|NCT00615264|65779669|FG001|Overall Study|Protocol Violation|7|||
23560271|NCT00615264|65779668|FG000|Overall Study|Not defined|7|||
23560272|NCT00615264|65779669|FG001|Overall Study|Not defined|4|||
23560273|NCT00615264|65779668|FG000|Overall Study|Dermal Hypersensitivity|0|||
23560274|NCT00615264|65779669|FG001|Overall Study|Dermal Hypersensitivity|3|||
23560275|NCT01984684|65779671|FG000|Overall Study|Lost to Follow-up|25|||
23560276|NCT01984684|65779672|FG001|Overall Study|Lost to Follow-up|24|||
23560277|NCT01984684|65779671|FG000|Overall Study|Adverse Event|8|||
23560278|NCT01984684|65779672|FG001|Overall Study|Adverse Event|12|||
23560279|NCT01984684|65779671|FG000|Overall Study|Withdrawal by Subject|9|||
23624538|NCT04014790|66011714|FG000|Overall Study|Death|4|||
23624539|NCT04014790|66011714|FG000|Overall Study|Adverse Event|1|||
23624540|NCT04014790|66011714|FG000|Overall Study|Withdrawal by Subject|1|||
23624541|NCT03128671|66011717|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
23624542|NCT03128671|66011718|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
23624543|NCT03128671|66011717|FG000|Allocation|Death|1|||
23624544|NCT03128671|66011718|FG001|Allocation|Death|0|||
23624545|NCT03128671|66011717|FG000|Allocation|Withdrawal by Subject|4|||
23624546|NCT03128671|66011718|FG001|Allocation|Withdrawal by Subject|0|||
23624547|NCT03128671|66011717|FG000|Intervention|Withdrawal by Subject|11|||
23624548|NCT03128671|66011718|FG001|Intervention|Withdrawal by Subject|10|||
23624549|NCT03128671|66011717|FG000|Intervention|Palliative/hospice care initiated|9|||
23624550|NCT03128671|66011718|FG001|Intervention|Palliative/hospice care initiated|10|||
23624551|NCT03128671|66011717|FG000|Intervention|Death|13|||
23624552|NCT03128671|66011718|FG001|Intervention|Death|11|||
23624553|NCT03128671|66011717|FG000|Intervention|Interrupted by hurricane|1|||
23624554|NCT03128671|66011718|FG001|Intervention|Interrupted by hurricane|0|||
23624555|NCT03128671|66011717|FG000|Intervention|Physician Decision|2|||
23624556|NCT03128671|66011718|FG001|Intervention|Physician Decision|3|||
23560280|NCT01984684|65779672|FG001|Overall Study|Withdrawal by Subject|9|||
23624557|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
23438016|NCT00620113|65344280|FG000|Overall Study|Withdrawal by Subject|5|||
23438017|NCT00620113|65344281|FG001|Overall Study|Withdrawal by Subject|1|||
23624558|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
23560281|NCT01984684|65779671|FG000|Overall Study|Lack of Efficacy|3|||
23560282|NCT01984684|65779672|FG001|Overall Study|Lack of Efficacy|6|||
23560283|NCT01984684|65779671|FG000|Overall Study|Physician Decision|4|||
23624559|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
23624560|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
23323769|NCT03552380|64926867|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
23323770|NCT03552380|64926868|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
23323771|NCT03552380|64926867|FG000|Follow up|Death|3|||
23323772|NCT03552380|64926868|FG001|Follow up|Death|4|||
23323773|NCT03552380|64926867|FG000|Follow up|Site IRB terminated|0|||
23323774|NCT03552380|64926868|FG001|Follow up|Site IRB terminated|1|||
23323775|NCT01349192|64926869|FG000|Overall Study|Protocol Violation|0|||
23323776|NCT01349192|64926870|FG001|Overall Study|Protocol Violation|1|||
23323777|NCT01349192|64926869|FG000|Overall Study|Withdrawal by Subject|0|||
23323778|NCT01349192|64926870|FG001|Overall Study|Withdrawal by Subject|2|||
23323779|NCT01349192|64926869|FG000|Overall Study|Lost to Follow-up|1|||
23323780|NCT01349192|64926870|FG001|Overall Study|Lost to Follow-up|3|||
23323781|NCT01349192|64926869|FG000|Overall Study|Failure to adhere to Protocol|2|||
23323782|NCT01349192|64926870|FG001|Overall Study|Failure to adhere to Protocol|0|||
23323783|NCT01786993|64926871|FG000|Overall Study|Death|6|||
23323784|NCT01786993|64926872|FG001|Overall Study|Death|7|||
23323785|NCT01786993|64926871|FG000|Overall Study|Withdrawal by Subject|3|||
23323786|NCT01786993|64926872|FG001|Overall Study|Withdrawal by Subject|2|||
23323787|NCT01786993|64926871|FG000|Overall Study|Lost to Follow-up|0|||
23323788|NCT01786993|64926872|FG001|Overall Study|Lost to Follow-up|1|||
23323789|NCT01786993|64926871|FG000|Overall Study|Subject Non-Compliance|1|||
23323790|NCT01786993|64926872|FG001|Overall Study|Subject Non-Compliance|0|||
23323791|NCT01786993|64926871|FG000|Overall Study|System Explant|1|||
23323792|NCT01786993|64926872|FG001|Overall Study|System Explant|0|||
23323793|NCT01786993|64926871|FG000|Overall Study|Hospice Admission|1|||
23323794|NCT01786993|64926872|FG001|Overall Study|Hospice Admission|0|||
23323795|NCT00652340|64926873|FG000|Overall Study|Had not progressed.|4|||
23323796|NCT00652340|64926874|FG001|Overall Study|Had not progressed.|3|||
23323797|NCT04720053|64926875|FG000|Overall Study|Lost to Follow-up|12|||
23323798|NCT01026194|64926878|FG000|Period 1：Double Blind Period|Adverse Event|2|||
23323799|NCT01026194|64926879|FG001|Period 1：Double Blind Period|Adverse Event|1|||
23323800|NCT01026194|64926878|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
23323801|NCT01026194|64926879|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
23323802|NCT01026194|64926878|FG000|Period 1：Double Blind Period|Physician Decision|0|||
23323803|NCT01026194|64926879|FG001|Period 1：Double Blind Period|Physician Decision|4|||
23323804|NCT01026194|64926878|FG000|Period 2：Open-label Period|Adverse Event|4|||
23323805|NCT01026194|64926879|FG001|Period 2：Open-label Period|Adverse Event|5|||
23323806|NCT01026194|64926878|FG000|Period 2：Open-label Period|Physician Decision|3|||
23323807|NCT01026194|64926879|FG001|Period 2：Open-label Period|Physician Decision|1|||
23323808|NCT01026194|64926878|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
23323809|NCT01026194|64926879|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
23323810|NCT00247676|64926882|FG000|Overall Study|Death|5|||
23323811|NCT00247676|64926882|FG000|Overall Study|Adverse Event|11|||
23323812|NCT00247676|64926882|FG000|Overall Study|Lack of Efficacy|15|||
23323813|NCT00247676|64926882|FG000|Overall Study|Other|3|||
23323814|NCT00247676|64926882|FG000|Overall Study|Withdrawal by Subject|2|||
23560284|NCT01984684|65779672|FG001|Overall Study|Physician Decision|2|||
23560285|NCT01984684|65779671|FG000|Overall Study|Protocol Violation|4|||
23560286|NCT01984684|65779672|FG001|Overall Study|Protocol Violation|2|||
23560287|NCT01984684|65779671|FG000|Overall Study|Death|0|||
23560288|NCT01984684|65779672|FG001|Overall Study|Death|1|||
23560289|NCT01984684|65779671|FG000|Overall Study|Noncompliance with study drug|2|||
23560290|NCT01984684|65779672|FG001|Overall Study|Noncompliance with study drug|1|||
23560291|NCT01984684|65779671|FG000|Overall Study|Subject incarcerated|1|||
23560292|NCT01984684|65779672|FG001|Overall Study|Subject incarcerated|0|||
23560293|NCT01984684|65779671|FG000|Overall Study|Study drug not available at site|1|||
23560294|NCT01984684|65779672|FG001|Overall Study|Study drug not available at site|1|||
23560295|NCT01984684|65779671|FG000|Overall Study|Subject had inadequate IV access|0|||
23624561|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
23624562|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
23624563|NCT03201900|66011719|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
23323815|NCT02556801|64926886|FG000|Overall Study|Lost to Follow-up|1|||
23323816|NCT02556801|64926887|FG001|Overall Study|Lost to Follow-up|0|||
23323817|NCT02556801|64926888|FG002|Overall Study|Lost to Follow-up|2|||
23438018|NCT00620113|65344282|FG002|Overall Study|Withdrawal by Subject|3|||
23438019|NCT00620113|65344283|FG003|Overall Study|Withdrawal by Subject|5|||
23560296|NCT01984684|65779672|FG001|Overall Study|Subject had inadequate IV access|1|||
23560297|NCT00855595|65779674|FG000|Overall Study|Withdrawal by Subject|1|||
23323818|NCT02556801|64926889|FG003|Overall Study|Lost to Follow-up|0|||
23323819|NCT02556801|64926886|FG000|Overall Study|Withdrawal by Subject|1|||
23323820|NCT02556801|64926887|FG001|Overall Study|Withdrawal by Subject|1|||
23323821|NCT02556801|64926888|FG002|Overall Study|Withdrawal by Subject|1|||
23323822|NCT02556801|64926889|FG003|Overall Study|Withdrawal by Subject|0|||
23323823|NCT02556801|64926886|FG000|Overall Study|Protocol Violation|0|||
23323824|NCT02556801|64926887|FG001|Overall Study|Protocol Violation|3|||
23323825|NCT02556801|64926888|FG002|Overall Study|Protocol Violation|1|||
23323826|NCT02556801|64926889|FG003|Overall Study|Protocol Violation|1|||
23323827|NCT02556801|64926886|FG000|Overall Study|Adverse Event|0|||
23323828|NCT02556801|64926887|FG001|Overall Study|Adverse Event|2|||
23323829|NCT02556801|64926888|FG002|Overall Study|Adverse Event|0|||
23323830|NCT02556801|64926889|FG003|Overall Study|Adverse Event|3|||
23323831|NCT02556801|64926886|FG000|Overall Study|Pregnancy|0|||
23323832|NCT02556801|64926887|FG001|Overall Study|Pregnancy|1|||
23323833|NCT02556801|64926888|FG002|Overall Study|Pregnancy|0|||
23323834|NCT02556801|64926889|FG003|Overall Study|Pregnancy|0|||
23323835|NCT02556801|64926886|FG000|Overall Study|Personal reasons patient|0|||
23323836|NCT02556801|64926887|FG001|Overall Study|Personal reasons patient|0|||
23323837|NCT02556801|64926888|FG002|Overall Study|Personal reasons patient|0|||
23323838|NCT02556801|64926889|FG003|Overall Study|Personal reasons patient|1|||
23323839|NCT02719184|64926890|FG000|Overall Study|Other than listed|1|||
23323840|NCT02719184|64926891|FG001|Overall Study|Other than listed|12|||
23323841|NCT02719184|64926892|FG002|Overall Study|Other than listed|13|||
23323842|NCT02719184|64926893|FG003|Overall Study|Other than listed|22|||
23323843|NCT02719184|64926894|FG004|Overall Study|Other than listed|9|||
23323844|NCT02719184|64926890|FG000|Overall Study|Withdrawal by Subject|5|||
23323845|NCT02719184|64926891|FG001|Overall Study|Withdrawal by Subject|3|||
23323846|NCT02719184|64926892|FG002|Overall Study|Withdrawal by Subject|6|||
23323847|NCT02719184|64926893|FG003|Overall Study|Withdrawal by Subject|6|||
23323848|NCT02719184|64926894|FG004|Overall Study|Withdrawal by Subject|0|||
23323849|NCT02719184|64926890|FG000|Overall Study|Lost to Follow-up|0|||
23323850|NCT02719184|64926891|FG001|Overall Study|Lost to Follow-up|4|||
23323851|NCT02719184|64926892|FG002|Overall Study|Lost to Follow-up|1|||
23323852|NCT02719184|64926893|FG003|Overall Study|Lost to Follow-up|3|||
23323853|NCT02719184|64926894|FG004|Overall Study|Lost to Follow-up|0|||
23323854|NCT02719184|64926890|FG000|Overall Study|Protocol Violation|0|||
23323855|NCT02719184|64926891|FG001|Overall Study|Protocol Violation|3|||
23323856|NCT02719184|64926892|FG002|Overall Study|Protocol Violation|0|||
23149611|NCT03285178|64297612|FG006|Single-Blind Run-In Period|Physician Decision|0|||
23149612|NCT03285178|64297606|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23149613|NCT03285178|64297607|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
23149614|NCT03285178|64297608|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
23149615|NCT03285178|64297609|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23149616|NCT03285178|64297610|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23149617|NCT03285178|64297611|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23149618|NCT03285178|64297612|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
23149619|NCT03285178|64297606|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23149620|NCT03285178|64297607|FG001|Double-Blind Treatment Period|Adverse Event|0|||
23149621|NCT03285178|64297608|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23149622|NCT03285178|64297609|FG003|Double-Blind Treatment Period|Adverse Event|0|||
23149623|NCT03285178|64297610|FG004|Double-Blind Treatment Period|Adverse Event|0|||
23149624|NCT03285178|64297611|FG005|Double-Blind Treatment Period|Adverse Event|0|||
23149625|NCT03285178|64297612|FG006|Double-Blind Treatment Period|Adverse Event|2|||
23149626|NCT03285178|64297606|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23149627|NCT03285178|64297607|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23149628|NCT03285178|64297608|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
23149629|NCT03285178|64297609|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
23323857|NCT02719184|64926893|FG003|Overall Study|Protocol Violation|2|||
23323858|NCT02719184|64926894|FG004|Overall Study|Protocol Violation|0|||
23323859|NCT02719184|64926890|FG000|Overall Study|Adverse Event|0|||
23323860|NCT02719184|64926891|FG001|Overall Study|Adverse Event|0|||
23323861|NCT02719184|64926892|FG002|Overall Study|Adverse Event|0|||
23323862|NCT02719184|64926893|FG003|Overall Study|Adverse Event|3|||
23323863|NCT02719184|64926894|FG004|Overall Study|Adverse Event|0|||
23323864|NCT04067050|64926895|FG000|One Month|Lost to Follow-up|4|||
23323865|NCT04067050|64926896|FG001|One Month|Lost to Follow-up|0|||
23323866|NCT04067050|64926895|FG000|Two Month|Lost to Follow-up|1|||
23323867|NCT04067050|64926896|FG001|Two Month|Lost to Follow-up|0|||
23323868|NCT04067050|64926895|FG000|Two Month|Adverse Event|1|||
23323869|NCT04067050|64926896|FG001|Two Month|Adverse Event|0|||
23323870|NCT02208089|64926899|FG000|Overall Study|Withdrawal by Subject|1|||
23323871|NCT02208089|64926900|FG001|Overall Study|Withdrawal by Subject|0|||
23323872|NCT02208089|64926899|FG000|Overall Study|Lost to Follow-up|6|||
23323873|NCT02208089|64926900|FG001|Overall Study|Lost to Follow-up|0|||
23149630|NCT03285178|64297610|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
23323874|NCT04447040|64926901|FG000|Overall Study|Lost to Follow-up|2|||
23323875|NCT04447040|64926902|FG001|Overall Study|Lost to Follow-up|1|||
23323876|NCT04447040|64926903|FG002|Overall Study|Lost to Follow-up|3|||
23323877|NCT04447040|64926904|FG003|Overall Study|Lost to Follow-up|3|||
23323878|NCT04447040|64926905|FG004|Overall Study|Lost to Follow-up|1|||
23323879|NCT04447040|64926906|FG005|Overall Study|Lost to Follow-up|3|||
23323880|NCT04447040|64926901|FG000|Overall Study|Withdrawal by Subject|0|||
23323881|NCT04447040|64926902|FG001|Overall Study|Withdrawal by Subject|1|||
23323882|NCT04447040|64926903|FG002|Overall Study|Withdrawal by Subject|1|||
23323883|NCT04447040|64926904|FG003|Overall Study|Withdrawal by Subject|1|||
23323884|NCT04447040|64926905|FG004|Overall Study|Withdrawal by Subject|0|||
23323885|NCT04447040|64926906|FG005|Overall Study|Withdrawal by Subject|0|||
23323886|NCT02500589|64926908|FG000|Overall Study|Withdrawal by Subject|11|||
23323887|NCT02500589|64926909|FG001|Overall Study|Withdrawal by Subject|14|||
23323888|NCT02500589|64926908|FG000|Overall Study|Lost to Follow-up|10|||
23323889|NCT02500589|64926909|FG001|Overall Study|Lost to Follow-up|12|||
23323890|NCT02500589|64926908|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
23323891|NCT02500589|64926909|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
23323892|NCT02500589|64926908|FG000|Overall Study|Death|7|||
23323893|NCT02500589|64926909|FG001|Overall Study|Death|5|||
23323894|NCT01147068|64926911|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
23323895|NCT01147068|64926912|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23323896|NCT01147068|64926913|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23323897|NCT01147068|64926914|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23323898|NCT01147068|64926915|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23323899|NCT01147068|64926916|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
23323900|NCT01147068|64926917|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
23323901|NCT01147068|64926911|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
23323902|NCT01147068|64926912|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
23323903|NCT01147068|64926913|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
23323904|NCT01147068|64926914|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
23323905|NCT01147068|64926915|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
23323906|NCT01147068|64926916|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
23323907|NCT01147068|64926917|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
23323908|NCT01147068|64926911|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
23323909|NCT01147068|64926912|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
23323910|NCT01147068|64926913|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
23323911|NCT01147068|64926914|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
23323912|NCT01147068|64926915|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
23323913|NCT01147068|64926916|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
23323914|NCT01147068|64926917|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
23323915|NCT01147068|64926911|FG000|Subjects That Received 2nd Dose|Other|0|||
23323916|NCT01147068|64926912|FG001|Subjects That Received 2nd Dose|Other|3|||
23323917|NCT01147068|64926913|FG002|Subjects That Received 2nd Dose|Other|3|||
23624564|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
23624565|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
23624566|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
23624567|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
23624568|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
23624569|NCT03201900|66011719|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
23624570|NCT01214421|66011720|FG000|Overall Study|Lost to Follow-up|7|||
23624571|NCT01214421|66011721|FG001|Overall Study|Lost to Follow-up|3|||
23624572|NCT01214421|66011722|FG002|Overall Study|Lost to Follow-up|7|||
23624573|NCT01214421|66011723|FG003|Overall Study|Lost to Follow-up|3|||
23624574|NCT01214421|66011720|FG000|Overall Study|Adverse Event|16|||
23624575|NCT01214421|66011721|FG001|Overall Study|Adverse Event|35|||
23624576|NCT01214421|66011722|FG002|Overall Study|Adverse Event|14|||
23624577|NCT01214421|66011723|FG003|Overall Study|Adverse Event|3|||
23624578|NCT01214421|66011720|FG000|Overall Study|Sponsor Discontinued Site|1|||
23624579|NCT01214421|66011721|FG001|Overall Study|Sponsor Discontinued Site|2|||
23624580|NCT01214421|66011722|FG002|Overall Study|Sponsor Discontinued Site|0|||
23624581|NCT01214421|66011723|FG003|Overall Study|Sponsor Discontinued Site|0|||
23624582|NCT01214421|66011720|FG000|Overall Study|Withdrawal Criteria Met|3|||
23624583|NCT01214421|66011721|FG001|Overall Study|Withdrawal Criteria Met|0|||
23624584|NCT01214421|66011722|FG002|Overall Study|Withdrawal Criteria Met|2|||
23624585|NCT01214421|66011723|FG003|Overall Study|Withdrawal Criteria Met|1|||
23624586|NCT01214421|66011720|FG000|Overall Study|Physician Decision|2|||
23624587|NCT01214421|66011721|FG001|Overall Study|Physician Decision|0|||
23624588|NCT01214421|66011722|FG002|Overall Study|Physician Decision|4|||
23624589|NCT01214421|66011723|FG003|Overall Study|Physician Decision|0|||
23624590|NCT01214421|66011720|FG000|Overall Study|Withdrawal by Subject|21|||
23624591|NCT01214421|66011721|FG001|Overall Study|Withdrawal by Subject|18|||
23323918|NCT01147068|64926914|FG003|Subjects That Received 2nd Dose|Other|0|||
23323919|NCT01147068|64926915|FG004|Subjects That Received 2nd Dose|Other|1|||
23323920|NCT01147068|64926916|FG005|Subjects That Received 2nd Dose|Other|0|||
23323921|NCT01147068|64926917|FG006|Subjects That Received 2nd Dose|Other|0|||
23323922|NCT01147068|64926911|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
23624592|NCT01214421|66011722|FG002|Overall Study|Withdrawal by Subject|11|||
23323923|NCT01147068|64926912|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
23323924|NCT01147068|64926913|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
23323925|NCT01147068|64926914|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
23323926|NCT01147068|64926915|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
23323927|NCT01147068|64926916|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
23323928|NCT01147068|64926917|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
23560298|NCT00855595|65779675|FG001|Overall Study|Withdrawal by Subject|2|||
23149631|NCT03285178|64297611|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
23149632|NCT03285178|64297612|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
23149633|NCT03285178|64297606|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23149634|NCT03285178|64297607|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23149635|NCT03285178|64297608|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23149636|NCT03285178|64297609|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23149637|NCT03285178|64297610|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23149638|NCT03285178|64297611|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23149639|NCT03285178|64297612|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23149640|NCT03285178|64297606|FG000|Double-Blind Treatment Period|COVID-19|0|||
23149641|NCT03285178|64297607|FG001|Double-Blind Treatment Period|COVID-19|0|||
23149642|NCT03285178|64297608|FG002|Double-Blind Treatment Period|COVID-19|1|||
23149643|NCT03285178|64297609|FG003|Double-Blind Treatment Period|COVID-19|0|||
23149644|NCT03285178|64297610|FG004|Double-Blind Treatment Period|COVID-19|0|||
23149645|NCT03285178|64297611|FG005|Double-Blind Treatment Period|COVID-19|0|||
23149646|NCT03285178|64297612|FG006|Double-Blind Treatment Period|COVID-19|0|||
23149647|NCT01287065|64297613|FG000|Treatment Period 1|Adverse Event|0|||
23149648|NCT01287065|64297614|FG001|Treatment Period 1|Adverse Event|0|||
23149649|NCT01287065|64297615|FG002|Treatment Period 1|Adverse Event|0|||
23149650|NCT01287065|64297616|FG003|Treatment Period 1|Adverse Event|0|||
23149651|NCT01287065|64297617|FG004|Treatment Period 1|Adverse Event|1|||
23149652|NCT01287065|64297618|FG005|Treatment Period 1|Adverse Event|0|||
23149653|NCT01287065|64297613|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23149654|NCT01287065|64297614|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23149655|NCT01287065|64297615|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23149656|NCT01287065|64297616|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23149657|NCT01287065|64297617|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23149658|NCT01287065|64297618|FG005|Treatment Period 1|Withdrawal by Subject|1|||
23149659|NCT00174265|64297625|FG000|Overall Study|Adverse Event|7|||
23149660|NCT00174265|64297626|FG001|Overall Study|Adverse Event|4|||
23149661|NCT00174265|64297625|FG000|Overall Study|Lack of Efficacy|2|||
23149662|NCT00174265|64297626|FG001|Overall Study|Lack of Efficacy|2|||
23149663|NCT00174265|64297625|FG000|Overall Study|Withdrawal by Subject|3|||
23149664|NCT00174265|64297626|FG001|Overall Study|Withdrawal by Subject|5|||
23149665|NCT00174265|64297625|FG000|Overall Study|Lost to Follow-up|1|||
23149666|NCT00174265|64297626|FG001|Overall Study|Lost to Follow-up|0|||
23149667|NCT00174265|64297625|FG000|Overall Study|Other (Not specified)|16|||
23149668|NCT00174265|64297626|FG001|Overall Study|Other (Not specified)|10|||
23149669|NCT04399122|64297636|FG000|Overall Study|Lost to Follow-up|2|||
23149670|NCT04399122|64297637|FG001|Overall Study|Lost to Follow-up|0|||
23149671|NCT04399122|64297636|FG000|Overall Study|Withdrawal by Subject|1|||
23149672|NCT04399122|64297637|FG001|Overall Study|Withdrawal by Subject|0|||
23149673|NCT04226833|64297653|FG000|Overall Study|Death|0|||
23149674|NCT04226833|64297654|FG001|Overall Study|Death|0|||
23149675|NCT04226833|64297655|FG002|Overall Study|Death|1|||
23560299|NCT00855595|65779674|FG000|Overall Study|Lost to Follow-up|3|||
23560300|NCT00855595|65779675|FG001|Overall Study|Lost to Follow-up|3|||
23560301|NCT00855595|65779674|FG000|Overall Study|Adverse Event|1|||
23560302|NCT00855595|65779675|FG001|Overall Study|Adverse Event|1|||
23560303|NCT00855595|65779674|FG000|Overall Study|patient moved out of state|1|||
23560304|NCT00855595|65779675|FG001|Overall Study|patient moved out of state|0|||
23560305|NCT00855595|65779674|FG000|Overall Study|patient left country|0|||
23560306|NCT00855595|65779675|FG001|Overall Study|patient left country|1|||
23560307|NCT02940574|65779676|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
23560308|NCT02940574|65779677|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
23560309|NCT02940574|65779676|FG000|1-year Follow-up|Lost to Follow-up|3|||
23560310|NCT02940574|65779677|FG001|1-year Follow-up|Lost to Follow-up|4|||
23560311|NCT00152464|65779678|FG000|Overall Study|Adverse Event|3|||
23149676|NCT04226833|64297656|FG003|Overall Study|Death|0|||
23149677|NCT01526551|64297657|FG000|Overall Study|Lack of returned parental consent form|424|||
23149678|NCT01822522|64297658|FG000|Overall Study|Adverse Event|1|||
23149679|NCT01822522|64297659|FG001|Overall Study|Adverse Event|1|||
23149680|NCT01822522|64297660|FG002|Overall Study|Adverse Event|1|||
23149681|NCT01822522|64297661|FG003|Overall Study|Adverse Event|0|||
23149682|NCT01822522|64297662|FG004|Overall Study|Adverse Event|0|||
23149683|NCT01822522|64297663|FG005|Overall Study|Adverse Event|1|||
23149684|NCT01822522|64297658|FG000|Overall Study|Death|3|||
23149685|NCT01822522|64297659|FG001|Overall Study|Death|0|||
23560312|NCT00152464|65779679|FG001|Overall Study|Adverse Event|6|||
23560313|NCT00152464|65779678|FG000|Overall Study|Lost to Follow-up|8|||
23560314|NCT00152464|65779679|FG001|Overall Study|Lost to Follow-up|4|||
23560315|NCT00152464|65779678|FG000|Overall Study|Protocol Violation|3|||
23560316|NCT00152464|65779679|FG001|Overall Study|Protocol Violation|1|||
23560317|NCT00152464|65779678|FG000|Overall Study|Withdrawal by Subject|21|||
23560318|NCT00152464|65779679|FG001|Overall Study|Withdrawal by Subject|22|||
23560319|NCT00152464|65779678|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
23624593|NCT01214421|66011723|FG003|Overall Study|Withdrawal by Subject|2|||
23624594|NCT00732992|66011724|FG000|Overall Study|Adverse Event|1|||
23624595|NCT00732992|66011725|FG001|Overall Study|Adverse Event|1|||
23624596|NCT00732992|66011724|FG000|Overall Study|Objective Progression or Relapse|3|||
23624597|NCT00732992|66011725|FG001|Overall Study|Objective Progression or Relapse|5|||
23624598|NCT00732992|66011724|FG000|Overall Study|Global Deterioration of Health Status|1|||
23624599|NCT00732992|66011725|FG001|Overall Study|Global Deterioration of Health Status|0|||
23624600|NCT00732992|66011724|FG000|Overall Study|Withdrawal by Subject|1|||
23624601|NCT00732992|66011725|FG001|Overall Study|Withdrawal by Subject|0|||
23624602|NCT02202109|66011727|FG000|Overall Study|Lost to Follow-up|88|||
23624603|NCT02202109|66011728|FG001|Overall Study|Lost to Follow-up|87|||
23624604|NCT02202109|66011727|FG000|Overall Study|Withdrawal by Subject|2|||
23624605|NCT02202109|66011728|FG001|Overall Study|Withdrawal by Subject|0|||
23624606|NCT03635086|66011729|FG000|Overall Study|Withdrawal of consent|0|||
23624607|NCT03635086|66011730|FG001|Overall Study|Withdrawal of consent|0|||
23624608|NCT03635086|66011731|FG002|Overall Study|Withdrawal of consent|1|||
23624609|NCT03635086|66011732|FG003|Overall Study|Withdrawal of consent|0|||
23624610|NCT03635086|66011733|FG004|Overall Study|Withdrawal of consent|0|||
23624611|NCT03635086|66011729|FG000|Overall Study|Adverse Event|0|||
23624612|NCT03635086|66011730|FG001|Overall Study|Adverse Event|1|||
23624613|NCT03635086|66011731|FG002|Overall Study|Adverse Event|0|||
23624614|NCT03635086|66011732|FG003|Overall Study|Adverse Event|0|||
23624615|NCT03635086|66011733|FG004|Overall Study|Adverse Event|0|||
23624616|NCT03635086|66011729|FG000|Overall Study|Lost to Follow-up|1|||
23624617|NCT03635086|66011730|FG001|Overall Study|Lost to Follow-up|0|||
23624618|NCT03635086|66011731|FG002|Overall Study|Lost to Follow-up|0|||
23624619|NCT03635086|66011732|FG003|Overall Study|Lost to Follow-up|0|||
23624620|NCT03635086|66011733|FG004|Overall Study|Lost to Follow-up|0|||
23624621|NCT03188536|66011734|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
23624622|NCT03188536|66011734|FG000|Overall Study|Not participated/met inclusion criteria|1|||
23624623|NCT04245345|66011735|FG000|Overall Study|Death|1|||
23624624|NCT04245345|66011735|FG000|Overall Study|Exited prior to implant|5|||
23560320|NCT00152464|65779679|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
23560321|NCT00152464|65779678|FG000|Overall Study|Eczema deterioration|0|||
23560322|NCT00152464|65779679|FG001|Overall Study|Eczema deterioration|1|||
23624625|NCT04245345|66011735|FG000|Overall Study|Exited prior to 1-month|9|||
23624626|NCT04245345|66011735|FG000|Overall Study|Missed 1-month visit|3|||
23624627|NCT04245345|66011735|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
23624628|NCT04245345|66011735|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
23624629|NCT02872311|66011736|FG000|Overall Study|Death|2|||
23560323|NCT00152464|65779678|FG000|Overall Study|Parent decision|1|||
23560324|NCT00152464|65779679|FG001|Overall Study|Parent decision|1|||
23560325|NCT00152464|65779678|FG000|Overall Study|Investigator decision|1|||
23560326|NCT00152464|65779679|FG001|Overall Study|Investigator decision|0|||
23560327|NCT00152464|65779678|FG000|Overall Study|Lack of Efficacy|1|||
23560328|NCT00152464|65779679|FG001|Overall Study|Lack of Efficacy|0|||
23560329|NCT00152464|65779678|FG000|Overall Study|Eczema poorly controlled|1|||
23560330|NCT00152464|65779679|FG001|Overall Study|Eczema poorly controlled|0|||
23560331|NCT00152464|65779678|FG000|Overall Study|Patient relocated|1|||
23560332|NCT00152464|65779679|FG001|Overall Study|Patient relocated|0|||
23560333|NCT00499863|65779680|FG000|Overall Study|Lack of Efficacy|21|||
23560334|NCT00499863|65779681|FG001|Overall Study|Lack of Efficacy|27|||
23560335|NCT00499863|65779680|FG000|Overall Study|Protocol Violation|12|||
23560336|NCT00499863|65779681|FG001|Overall Study|Protocol Violation|7|||
23560337|NCT00499863|65779680|FG000|Overall Study|Withdrawal by Subject|6|||
23624630|NCT02872311|66011737|FG001|Overall Study|Death|0|||
23624631|NCT02872311|66011738|FG002|Overall Study|Death|0|||
23624632|NCT02872311|66011739|FG003|Overall Study|Death|0|||
23624633|NCT02872311|66011740|FG004|Overall Study|Death|0|||
23560338|NCT00499863|65779681|FG001|Overall Study|Withdrawal by Subject|4|||
23560339|NCT00499863|65779680|FG000|Overall Study|Adverse Event|8|||
23560340|NCT00499863|65779681|FG001|Overall Study|Adverse Event|2|||
23560341|NCT00499863|65779680|FG000|Overall Study|Sponsor decision|2|||
23560342|NCT00499863|65779681|FG001|Overall Study|Sponsor decision|2|||
23624634|NCT02872311|66011736|FG000|Overall Study|Lost to Follow-up|2|||
23624635|NCT02872311|66011737|FG001|Overall Study|Lost to Follow-up|0|||
23560343|NCT00499863|65779680|FG000|Overall Study|Lost to Follow-up|1|||
23560344|NCT00499863|65779681|FG001|Overall Study|Lost to Follow-up|1|||
23624636|NCT02872311|66011738|FG002|Overall Study|Lost to Follow-up|0|||
23624637|NCT02872311|66011739|FG003|Overall Study|Lost to Follow-up|0|||
23624638|NCT02872311|66011740|FG004|Overall Study|Lost to Follow-up|0|||
23149686|NCT01822522|64297660|FG002|Overall Study|Death|2|||
23149687|NCT01822522|64297661|FG003|Overall Study|Death|0|||
23149688|NCT01822522|64297662|FG004|Overall Study|Death|0|||
23149689|NCT01822522|64297663|FG005|Overall Study|Death|0|||
23149690|NCT01822522|64297658|FG000|Overall Study|Lost to Follow-up|0|||
23149691|NCT01822522|64297659|FG001|Overall Study|Lost to Follow-up|0|||
23149692|NCT01822522|64297660|FG002|Overall Study|Lost to Follow-up|1|||
23149693|NCT01822522|64297661|FG003|Overall Study|Lost to Follow-up|1|||
23149694|NCT01822522|64297662|FG004|Overall Study|Lost to Follow-up|0|||
23149695|NCT01822522|64297663|FG005|Overall Study|Lost to Follow-up|1|||
23149696|NCT01822522|64297658|FG000|Overall Study|Withdrawal by Subject|0|||
23149697|NCT01822522|64297659|FG001|Overall Study|Withdrawal by Subject|0|||
23149698|NCT01822522|64297660|FG002|Overall Study|Withdrawal by Subject|0|||
23149699|NCT01822522|64297661|FG003|Overall Study|Withdrawal by Subject|1|||
23149700|NCT01822522|64297662|FG004|Overall Study|Withdrawal by Subject|0|||
23149701|NCT01822522|64297663|FG005|Overall Study|Withdrawal by Subject|0|||
23149702|NCT01822522|64297658|FG000|Overall Study|Lack of Efficacy|0|||
23149703|NCT01822522|64297659|FG001|Overall Study|Lack of Efficacy|0|||
23149704|NCT01822522|64297660|FG002|Overall Study|Lack of Efficacy|0|||
23149705|NCT01822522|64297661|FG003|Overall Study|Lack of Efficacy|0|||
23149706|NCT01822522|64297662|FG004|Overall Study|Lack of Efficacy|0|||
23149707|NCT01822522|64297663|FG005|Overall Study|Lack of Efficacy|2|||
23149708|NCT02336178|64297664|FG000|Overall Study|Lost to Follow-up|1|||
23149709|NCT02336178|64297664|FG000|Overall Study|Protocol Violation|1|||
23149710|NCT02336178|64297664|FG000|Overall Study|Withdrawal by Subject|1|||
23149711|NCT02336178|64297664|FG000|Overall Study|Other|1|||
23149712|NCT01163721|64297667|FG000|Overall Study|Adverse Event|5|||
23149713|NCT01163721|64297668|FG001|Overall Study|Adverse Event|6|||
23149714|NCT01163721|64297667|FG000|Overall Study|Withdrawal by Subject|3|||
23149715|NCT01163721|64297668|FG001|Overall Study|Withdrawal by Subject|4|||
23149716|NCT01163721|64297667|FG000|Overall Study|Lost to Follow-up|0|||
23149717|NCT01163721|64297668|FG001|Overall Study|Lost to Follow-up|1|||
23149718|NCT01163721|64297667|FG000|Overall Study|Physician Decision|0|||
23149719|NCT01163721|64297668|FG001|Overall Study|Physician Decision|1|||
23149720|NCT00092495|64297672|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
23149721|NCT00092495|64297673|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
23149722|NCT00092495|64297674|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23149723|NCT00092495|64297675|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
23149724|NCT00092495|64297676|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23149725|NCT00092495|64297672|FG000|Base Study Vaccination Period|Extended|0|||
23149726|NCT00092495|64297673|FG001|Base Study Vaccination Period|Extended|0|||
23149727|NCT00092495|64297674|FG002|Base Study Vaccination Period|Extended|0|||
23149728|NCT00092495|64297675|FG003|Base Study Vaccination Period|Extended|1|||
23149729|NCT00092495|64297676|FG004|Base Study Vaccination Period|Extended|0|||
23149730|NCT00092495|64297672|FG000|Base Study Vaccination Period|*Clinical AE|1|||
23149731|NCT00092495|64297673|FG001|Base Study Vaccination Period|*Clinical AE|0|||
23149732|NCT00092495|64297674|FG002|Base Study Vaccination Period|*Clinical AE|1|||
23149733|NCT00092495|64297675|FG003|Base Study Vaccination Period|*Clinical AE|2|||
23149734|NCT00092495|64297676|FG004|Base Study Vaccination Period|*Clinical AE|0|||
23149735|NCT00092495|64297672|FG000|Base Study Vaccination Period|*Other reasons|1|||
23149736|NCT00092495|64297673|FG001|Base Study Vaccination Period|*Other reasons|0|||
23149737|NCT00092495|64297674|FG002|Base Study Vaccination Period|*Other reasons|0|||
23149738|NCT00092495|64297675|FG003|Base Study Vaccination Period|*Other reasons|1|||
23149739|NCT00092495|64297676|FG004|Base Study Vaccination Period|*Other reasons|0|||
23149740|NCT00092495|64297672|FG000|Base Study Vaccination Period|*Pregnancy|0|||
23149741|NCT00092495|64297673|FG001|Base Study Vaccination Period|*Pregnancy|2|||
23149742|NCT00092495|64297674|FG002|Base Study Vaccination Period|*Pregnancy|5|||
23149743|NCT00092495|64297675|FG003|Base Study Vaccination Period|*Pregnancy|7|||
23149744|NCT00092495|64297676|FG004|Base Study Vaccination Period|*Pregnancy|0|||
23149745|NCT00092495|64297672|FG000|Base Study Vaccination Period|Adverse Event|1|||
23149746|NCT00092495|64297673|FG001|Base Study Vaccination Period|Adverse Event|0|||
23149747|NCT00092495|64297674|FG002|Base Study Vaccination Period|Adverse Event|0|||
23149748|NCT00092495|64297675|FG003|Base Study Vaccination Period|Adverse Event|3|||
23149749|NCT00092495|64297676|FG004|Base Study Vaccination Period|Adverse Event|0|||
23323929|NCT01147068|64926911|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23624639|NCT02872311|66011736|FG000|Overall Study|Protocol Violation|0|||
23149750|NCT00092495|64297672|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
23149751|NCT00092495|64297673|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
23149752|NCT00092495|64297674|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
23149753|NCT00092495|64297675|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
23149754|NCT00092495|64297676|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
23149755|NCT00092495|64297672|FG000|Base Study Vaccination Period|Moved|3|||
23149756|NCT00092495|64297673|FG001|Base Study Vaccination Period|Moved|1|||
23149757|NCT00092495|64297674|FG002|Base Study Vaccination Period|Moved|2|||
23149758|NCT00092495|64297675|FG003|Base Study Vaccination Period|Moved|2|||
23149759|NCT00092495|64297676|FG004|Base Study Vaccination Period|Moved|0|||
23149760|NCT00092495|64297672|FG000|Base Study Vaccination Period|Other|1|||
23149761|NCT00092495|64297673|FG001|Base Study Vaccination Period|Other|1|||
23149762|NCT00092495|64297674|FG002|Base Study Vaccination Period|Other|0|||
23149763|NCT00092495|64297675|FG003|Base Study Vaccination Period|Other|2|||
23149764|NCT00092495|64297676|FG004|Base Study Vaccination Period|Other|0|||
23149765|NCT00092495|64297672|FG000|Base Study Vaccination Period|Pregnancy|2|||
23149766|NCT00092495|64297673|FG001|Base Study Vaccination Period|Pregnancy|0|||
23149767|NCT00092495|64297674|FG002|Base Study Vaccination Period|Pregnancy|0|||
23149768|NCT00092495|64297675|FG003|Base Study Vaccination Period|Pregnancy|0|||
23149769|NCT00092495|64297676|FG004|Base Study Vaccination Period|Pregnancy|0|||
23149770|NCT00092495|64297672|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
23149771|NCT00092495|64297673|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
23149772|NCT00092495|64297674|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
23149773|NCT00092495|64297675|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
23149774|NCT00092495|64297676|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
23149775|NCT00092495|64297672|FG000|Base Study Vaccination Period|Protocol Violation|1|||
23149776|NCT00092495|64297673|FG001|Base Study Vaccination Period|Protocol Violation|0|||
23149777|NCT00092495|64297674|FG002|Base Study Vaccination Period|Protocol Violation|0|||
23149778|NCT00092495|64297675|FG003|Base Study Vaccination Period|Protocol Violation|0|||
23149779|NCT00092495|64297676|FG004|Base Study Vaccination Period|Protocol Violation|0|||
23149780|NCT00092495|64297672|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
23149781|NCT00092495|64297673|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
23149782|NCT00092495|64297674|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
23149783|NCT00092495|64297675|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
23149784|NCT00092495|64297676|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
23149785|NCT00092495|64297672|FG000|Base Study Follow-up Period|Extended|0|||
23149786|NCT00092495|64297673|FG001|Base Study Follow-up Period|Extended|0|||
23149787|NCT00092495|64297674|FG002|Base Study Follow-up Period|Extended|1|||
23149788|NCT00092495|64297675|FG003|Base Study Follow-up Period|Extended|2|||
23149789|NCT00092495|64297676|FG004|Base Study Follow-up Period|Extended|0|||
23149790|NCT00092495|64297672|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
23149791|NCT00092495|64297673|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
23149792|NCT00092495|64297674|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
23149793|NCT00092495|64297675|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
23149794|NCT00092495|64297676|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
23149795|NCT00092495|64297672|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
23149796|NCT00092495|64297673|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
23149797|NCT00092495|64297674|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
23149798|NCT00092495|64297675|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
23149799|NCT00092495|64297676|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
23149800|NCT01106027|64297677|FG000|Overall Study|Lost graft early, discontinued|1|||
23149801|NCT01009034|64297681|FG000|Overall Study|Lost to Follow-up|2|||
23149802|NCT01009034|64297681|FG000|Overall Study|Withdrawal by Subject|2|||
23149803|NCT01178671|64297682|FG000|Overall Study|Adverse Event|4|||
23149804|NCT01178671|64297683|FG001|Overall Study|Adverse Event|6|||
23149805|NCT01178671|64297682|FG000|Overall Study|Protocol Violation|1|||
23149806|NCT01178671|64297683|FG001|Overall Study|Protocol Violation|1|||
23560345|NCT02710292|65779682|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
23149807|NCT01178671|64297682|FG000|Overall Study|Lack of Efficacy|0|||
23149808|NCT01178671|64297683|FG001|Overall Study|Lack of Efficacy|1|||
23149809|NCT01178671|64297682|FG000|Overall Study|Lost to Follow-up|3|||
23149810|NCT01178671|64297683|FG001|Overall Study|Lost to Follow-up|1|||
23149811|NCT01178671|64297682|FG000|Overall Study|Physician Decision|4|||
23149812|NCT01178671|64297683|FG001|Overall Study|Physician Decision|6|||
23149813|NCT03064035|64297684|FG000|Overall Study|Did not receive allocated intervention|4|||
23149814|NCT03064035|64297685|FG001|Overall Study|Did not receive allocated intervention|2|||
23149815|NCT03064035|64297684|FG000|Overall Study|Lost to Follow-up|1|||
23149816|NCT03064035|64297685|FG001|Overall Study|Lost to Follow-up|1|||
23149817|NCT02234323|64297688|FG000|All Enrolled|Not Treated: Completed study in database|2|||
23149818|NCT02234323|64297688|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
23149819|NCT02234323|64297688|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
23149820|NCT02234323|64297688|FG000|All Treated|Death|1|||
23560346|NCT02710292|65779683|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
23560347|NCT02710292|65779682|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
23149821|NCT02234323|64297688|FG000|All Treated|Physician Decision|5|||
23149822|NCT02234323|64297688|FG000|All Treated|Lack of Efficacy|3|||
23149823|NCT02234323|64297688|FG000|All Treated|Exceeded lab value limit|2|||
23149824|NCT02234323|64297688|FG000|All Treated|Other|7|||
23149825|NCT04448756|64297691|FG000|Overall Study|Adverse Event|0|||
23149826|NCT04448756|64297692|FG001|Overall Study|Adverse Event|1|||
23149827|NCT04448756|64297693|FG002|Overall Study|Adverse Event|0|||
23560348|NCT02710292|65779683|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
23560349|NCT01373931|65779686|FG000|Lead-in Period|Adverse Event|2|||
23560350|NCT01373931|65779687|FG001|Lead-in Period|Adverse Event|0|||
23560351|NCT01373931|65779686|FG000|Period 1|Adverse Event|2|||
23560352|NCT01373931|65779687|FG001|Period 1|Adverse Event|0|||
23560353|NCT01373931|65779686|FG000|Period 1|Withdrawal by Subject|0|||
23560354|NCT01373931|65779687|FG001|Period 1|Withdrawal by Subject|2|||
23560355|NCT03324880|65779688|FG000|Overall Study|Adverse Event|0|||
23560356|NCT03324880|65779689|FG001|Overall Study|Adverse Event|2|||
23560357|NCT03324880|65779688|FG000|Overall Study|Withdrawal by Subject|2|||
23560358|NCT03324880|65779689|FG001|Overall Study|Withdrawal by Subject|2|||
23560359|NCT03324880|65779688|FG000|Overall Study|Lost to Follow-up|0|||
23560360|NCT03324880|65779689|FG001|Overall Study|Lost to Follow-up|1|||
23560361|NCT03324880|65779688|FG000|Overall Study|Product Recall|0|||
23560362|NCT03324880|65779689|FG001|Overall Study|Product Recall|1|||
23560363|NCT04209725|65779690|FG000|Overall Study|Adverse Event|1|||
23560364|NCT01538472|65779701|FG000|Overall Study|Disease Progression|3|||
23560365|NCT01538472|65779701|FG000|Overall Study|Death|1|||
23560366|NCT01489189|65779702|FG000|Overall Study|Withdrawal by Subject|20|||
23560367|NCT01489189|65779703|FG001|Overall Study|Withdrawal by Subject|23|||
23560368|NCT01489189|65779702|FG000|Overall Study|Death|10|||
23560369|NCT01489189|65779703|FG001|Overall Study|Death|8|||
23560370|NCT01489189|65779702|FG000|Overall Study|Missed Visit|1|||
23560371|NCT01489189|65779703|FG001|Overall Study|Missed Visit|4|||
23560372|NCT03308825|65779705|FG000|Overall Study|Lost to Follow-up|2|||
23560373|NCT03308825|65779706|FG001|Overall Study|Lost to Follow-up|2|||
23560374|NCT03308825|65779707|FG002|Overall Study|Lost to Follow-up|1|||
23560375|NCT03308825|65779708|FG003|Overall Study|Lost to Follow-up|0|||
23560376|NCT03308825|65779705|FG000|Overall Study|Protocol Violation|0|||
23560377|NCT03308825|65779706|FG001|Overall Study|Protocol Violation|2|||
23624640|NCT02872311|66011737|FG001|Overall Study|Protocol Violation|2|||
23624641|NCT02872311|66011738|FG002|Overall Study|Protocol Violation|1|||
23624642|NCT02872311|66011739|FG003|Overall Study|Protocol Violation|0|||
23624643|NCT02872311|66011740|FG004|Overall Study|Protocol Violation|0|||
23624644|NCT04706793|66011741|FG000|Treatment|Disease worsening|10|||
23624645|NCT04706793|66011742|FG001|Treatment|Disease worsening|10|||
23624646|NCT04706793|66011741|FG000|Follow-up|Lack of Efficacy|1|||
23624647|NCT04706793|66011742|FG001|Follow-up|Lack of Efficacy|0|||
23624648|NCT04706793|66011741|FG000|Follow-up|Disease worsening|8|||
23624649|NCT04706793|66011742|FG001|Follow-up|Disease worsening|10|||
23624650|NCT04706793|66011741|FG000|Follow-up|Adverse Event|1|||
23624651|NCT04706793|66011742|FG001|Follow-up|Adverse Event|0|||
23624652|NCT00917462|66011743|FG000|Overall Study|Clinical Deterioration|1|||
23624653|NCT00805285|66011746|FG000|Overall Study|Lack of Efficacy|1|||
23624654|NCT03458728|66011747|FG000|Overall Study|Adverse Event|1|||
23624655|NCT03458728|66011748|FG001|Overall Study|Adverse Event|0|||
23624656|NCT03458728|66011747|FG000|Overall Study|Physician Decision|1|||
23624657|NCT03458728|66011748|FG001|Overall Study|Physician Decision|0|||
23624658|NCT03458728|66011747|FG000|Overall Study|Progressive disease - clinical assessment|1|||
23624659|NCT03458728|66011748|FG001|Overall Study|Progressive disease - clinical assessment|0|||
23624660|NCT03458728|66011747|FG000|Overall Study|Progressive disease - radiological progression|21|||
23624661|NCT03458728|66011748|FG001|Overall Study|Progressive disease - radiological progression|6|||
23624662|NCT03458728|66011747|FG000|Overall Study|Withdrawal by Subject|0|||
23624663|NCT03458728|66011748|FG001|Overall Study|Withdrawal by Subject|1|||
23624664|NCT01461005|66011753|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
23624665|NCT00704171|66011754|FG000|Overall Study|Withdrawal by Subject|1|||
23624666|NCT00704171|66011755|FG001|Overall Study|Withdrawal by Subject|0|||
23149828|NCT04448756|64297691|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
23149829|NCT04448756|64297692|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
23560378|NCT03308825|65779707|FG002|Overall Study|Protocol Violation|0|||
23560379|NCT03308825|65779708|FG003|Overall Study|Protocol Violation|0|||
23624667|NCT01919398|66011756|FG000|Overall Study|Progressive Disease|0|||
23624668|NCT01919398|66011757|FG001|Overall Study|Progressive Disease|0|||
23624669|NCT01919398|66011758|FG002|Overall Study|Progressive Disease|4|||
23624670|NCT01710800|66011759|FG000|Overall Study|Withdrawal by Subject|21|||
23624671|NCT01710800|66011759|FG000|Overall Study|Protocol Violation|1|||
23560380|NCT03573908|65779709|FG000|Treatment Period|Adverse Event|4|||
23624672|NCT01801982|66011760|FG000|Overall Study|Lost to Follow-up|1|||
23624673|NCT00745498|66011761|FG000|Overall Study|Lost to Follow-up|1|||
23624674|NCT00745498|66011762|FG001|Overall Study|Lost to Follow-up|1|||
23560381|NCT03573908|65779710|FG001|Treatment Period|Adverse Event|9|||
23560382|NCT03573908|65779711|FG002|Treatment Period|Adverse Event|0|||
23560383|NCT03573908|65779712|FG003|Treatment Period|Adverse Event|0|||
23560384|NCT03573908|65779713|FG004|Treatment Period|Adverse Event|0|||
23624675|NCT00745498|66011763|FG002|Overall Study|Lost to Follow-up|3|||
23624676|NCT00745498|66011761|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
23560385|NCT03573908|65779709|FG000|Treatment Period|Protocol Violation|1|||
23560386|NCT03573908|65779710|FG001|Treatment Period|Protocol Violation|0|||
23149830|NCT04448756|64297693|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
23149831|NCT04448756|64297691|FG000|Overall Study|Withdrawal by Subject|0|||
23149832|NCT04448756|64297692|FG001|Overall Study|Withdrawal by Subject|3|||
23149833|NCT04448756|64297693|FG002|Overall Study|Withdrawal by Subject|1|||
23149834|NCT04448756|64297691|FG000|Overall Study|Death|2|||
23149835|NCT04448756|64297692|FG001|Overall Study|Death|1|||
23149836|NCT04448756|64297693|FG002|Overall Study|Death|0|||
23149837|NCT02804178|64297696|FG000|Overall Study|Adverse Event|1|||
23149838|NCT00937833|64297700|FG000|Overall Study|Protocol Violation|1|||
23149839|NCT00937833|64297701|FG001|Overall Study|Protocol Violation|2|||
23149840|NCT00937833|64297700|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
23149841|NCT00937833|64297701|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
23149842|NCT00937833|64297700|FG000|Overall Study|Lost to Follow-up|10|||
23149843|NCT00937833|64297701|FG001|Overall Study|Lost to Follow-up|8|||
23149844|NCT00937833|64297700|FG000|Overall Study|Withdrawal by Subject|4|||
23149845|NCT00937833|64297701|FG001|Overall Study|Withdrawal by Subject|6|||
23323930|NCT01147068|64926912|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23323931|NCT01147068|64926913|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23323932|NCT01147068|64926914|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
23323933|NCT01147068|64926915|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23323934|NCT01147068|64926916|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23323935|NCT01147068|64926917|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
23323936|NCT01147068|64926911|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
23323937|NCT01147068|64926912|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
23323938|NCT01147068|64926913|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
23323939|NCT01147068|64926914|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
23323940|NCT01147068|64926915|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
23323941|NCT01147068|64926916|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
23323942|NCT01147068|64926917|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
23323943|NCT01070953|64926920|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
23323944|NCT01070953|64926920|FG000|Participants for Safety Evaluation|Off-label use|283|||
23323945|NCT01070953|64926920|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
23323946|NCT01070953|64926920|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
23323947|NCT01070953|64926920|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
23323948|NCT01070953|64926920|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
23323949|NCT01070953|64926920|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
23323950|NCT01070953|64926920|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
23323951|NCT01070953|64926920|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
23323952|NCT01070953|64926920|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
23323953|NCT02501928|64926921|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23323954|NCT02501928|64926922|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
23323955|NCT02501928|64926923|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
23323956|NCT02501928|64926924|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
23323957|NCT02501928|64926925|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
23323958|NCT02501928|64926926|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
23323959|NCT01651117|64926927|FG000|Overall Study|Death|2|||
23323960|NCT01651117|64926928|FG001|Overall Study|Death|3|||
23323961|NCT01651117|64926929|FG002|Overall Study|Death|2|||
23323962|NCT01651117|64926930|FG003|Overall Study|Death|2|||
23323963|NCT02094300|64926933|FG000|Overall Study|Death|7|||
23323964|NCT02094300|64926933|FG000|Overall Study|Lost to Follow-up|10|||
23323965|NCT02094300|64926933|FG000|Overall Study|Still be eligible for follow-up|3|||
23323966|NCT03347110|64926934|FG000|Overall Study|Other (Participant is incarcerated)|1|||
23323967|NCT03347110|64926934|FG000|Overall Study|Withdrawal by Subject|9|||
23323968|NCT03347110|64926934|FG000|Overall Study|Lost to Follow-up|1|||
23323969|NCT03347110|64926934|FG000|Overall Study|Lack of Efficacy|2|||
23323970|NCT03347110|64926934|FG000|Overall Study|Adverse Event, non-fatal|9|||
23340858|NCT01936181|64992871|FG001|Randomised, Double-blind|Pregnancy|1|||
23340859|NCT01936181|64992872|FG002|Randomised, Double-blind|Pregnancy|0|||
23340860|NCT01936181|64992873|FG003|Randomised, Double-blind|Pregnancy|0|||
23340861|NCT01936181|64992870|FG000|Randomised, Double-blind|Physician Decision|4|||
23340862|NCT01936181|64992871|FG001|Randomised, Double-blind|Physician Decision|4|||
23340863|NCT01936181|64992872|FG002|Randomised, Double-blind|Physician Decision|0|||
23340864|NCT01936181|64992873|FG003|Randomised, Double-blind|Physician Decision|0|||
23340865|NCT01936181|64992870|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
23438020|NCT01564732|65344291|FG000|Overall Study|Early termination by the study sponsor|6|||
23438021|NCT01564732|65344292|FG001|Overall Study|Early termination by the study sponsor|5|||
23149846|NCT00047320|64297702|FG000|Overall Study|Lack of Efficacy|8|||
23149847|NCT00047320|64297702|FG000|Overall Study|Lost to Follow-up|1|||
23149848|NCT00047320|64297702|FG000|Overall Study|Physician Decision|8|||
23624677|NCT00745498|66011762|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
23624678|NCT00745498|66011763|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
23624679|NCT00745498|66011761|FG000|Overall Study|Non-PDR related VH|0|||
23624680|NCT00745498|66011762|FG001|Overall Study|Non-PDR related VH|1|||
23624681|NCT00745498|66011763|FG002|Overall Study|Non-PDR related VH|1|||
23624682|NCT00745498|66011761|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
23624683|NCT00745498|66011762|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
23624684|NCT00745498|66011763|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
23560387|NCT03573908|65779711|FG002|Treatment Period|Protocol Violation|0|||
23560388|NCT03573908|65779712|FG003|Treatment Period|Protocol Violation|0|||
23560389|NCT03573908|65779713|FG004|Treatment Period|Protocol Violation|0|||
23560390|NCT03573908|65779709|FG000|Treatment Period|Withdrawal by Subject|7|||
23560391|NCT03573908|65779710|FG001|Treatment Period|Withdrawal by Subject|5|||
23560392|NCT03573908|65779711|FG002|Treatment Period|Withdrawal by Subject|0|||
23323971|NCT02287922|64930160|FG000|Overall Study|Adverse Event|1|||
23323972|NCT02287922|64930161|FG001|Overall Study|Adverse Event|1|||
23323973|NCT02287922|64930162|FG002|Overall Study|Adverse Event|3|||
23323974|NCT02287922|64930163|FG003|Overall Study|Adverse Event|4|||
23323975|NCT02287922|64930160|FG000|Overall Study|Withdrawal by Subject|1|||
23560393|NCT03573908|65779712|FG003|Treatment Period|Withdrawal by Subject|0|||
23560394|NCT03573908|65779713|FG004|Treatment Period|Withdrawal by Subject|0|||
23560395|NCT03573908|65779709|FG000|Treatment Period|Lost to Follow-up|7|||
23560396|NCT03573908|65779710|FG001|Treatment Period|Lost to Follow-up|6|||
23560397|NCT03573908|65779711|FG002|Treatment Period|Lost to Follow-up|0|||
23560398|NCT03573908|65779712|FG003|Treatment Period|Lost to Follow-up|0|||
23560399|NCT03573908|65779713|FG004|Treatment Period|Lost to Follow-up|0|||
23560400|NCT03573908|65779709|FG000|Treatment Period|Pregnancy|1|||
23560401|NCT03573908|65779710|FG001|Treatment Period|Pregnancy|0|||
23560402|NCT03573908|65779711|FG002|Treatment Period|Pregnancy|0|||
23560403|NCT03573908|65779712|FG003|Treatment Period|Pregnancy|0|||
23560404|NCT03573908|65779713|FG004|Treatment Period|Pregnancy|0|||
23560405|NCT03573908|65779709|FG000|Treatment Period|Other, Not Specified|4|||
23560406|NCT03573908|65779710|FG001|Treatment Period|Other, Not Specified|6|||
23560407|NCT03573908|65779711|FG002|Treatment Period|Other, Not Specified|0|||
23560408|NCT03573908|65779712|FG003|Treatment Period|Other, Not Specified|0|||
23560409|NCT03573908|65779713|FG004|Treatment Period|Other, Not Specified|0|||
23560410|NCT03573908|65779709|FG000|Randomized Withdrawal Period|Adverse Event|0|||
23560411|NCT03573908|65779710|FG001|Randomized Withdrawal Period|Adverse Event|0|||
23560412|NCT03573908|65779711|FG002|Randomized Withdrawal Period|Adverse Event|3|||
23560413|NCT03573908|65779712|FG003|Randomized Withdrawal Period|Adverse Event|0|||
23560414|NCT03573908|65779713|FG004|Randomized Withdrawal Period|Adverse Event|0|||
23560415|NCT03573908|65779709|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23560416|NCT03573908|65779710|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23560417|NCT03573908|65779711|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23560418|NCT03573908|65779712|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23560419|NCT03573908|65779713|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
23560420|NCT03573908|65779709|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
23560421|NCT03573908|65779710|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
23560422|NCT03573908|65779711|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
23560423|NCT03573908|65779712|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
23560424|NCT03573908|65779713|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
23560425|NCT03573908|65779709|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
23560426|NCT03573908|65779710|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
23560427|NCT03573908|65779711|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
23560428|NCT03573908|65779712|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
23560429|NCT03573908|65779713|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
23560430|NCT00847405|65779714|FG000|First Intervention|Adverse Event|0|||
23560431|NCT00847405|65779715|FG001|First Intervention|Adverse Event|1|||
23560432|NCT00847405|65779714|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23624685|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
23624686|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
23624687|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
23624688|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Death|0|||
23624689|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Death|0|||
23560433|NCT00847405|65779715|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23560434|NCT03585296|65779718|FG000|Overall Study|Adverse Event|1|||
23560435|NCT03585296|65779718|FG000|Overall Study|Lost to Follow-up|2|||
23560436|NCT03585296|65779718|FG000|Overall Study|Withdrawal by Subject|2|||
23560437|NCT03928028|65779719|FG000|Overall Study|Physician Decision|9|||
23560438|NCT03928028|65779720|FG001|Overall Study|Physician Decision|6|||
23624690|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Death|1|||
23624691|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
23624692|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
23323976|NCT02287922|64930161|FG001|Overall Study|Withdrawal by Subject|1|||
23560439|NCT03928028|65779721|FG002|Overall Study|Physician Decision|3|||
23149849|NCT00047320|64297702|FG000|Overall Study|Withdrawal by Subject|9|||
23149850|NCT00047320|64297702|FG000|Overall Study|Ineligible|2|||
23149851|NCT00866697|64297714|FG000|Overall Study|Study closed/terminated|156|||
23149852|NCT00866697|64297715|FG001|Overall Study|Study closed/terminated|138|||
23149853|NCT00866697|64297714|FG000|Overall Study|Lost to Follow-up|22|||
23149854|NCT00866697|64297715|FG001|Overall Study|Lost to Follow-up|28|||
23149855|NCT00866697|64297714|FG000|Overall Study|Physician Decision|3|||
23149856|NCT00866697|64297715|FG001|Overall Study|Physician Decision|5|||
23149857|NCT00866697|64297714|FG000|Overall Study|Withdrawal by Subject|33|||
23149858|NCT00866697|64297715|FG001|Overall Study|Withdrawal by Subject|57|||
23149859|NCT00973362|64297716|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
23149860|NCT00973362|64297717|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
23149861|NCT00973362|64297716|FG000|Baseline Evaluation|No colposcopy visit|62|||
23149862|NCT00973362|64297717|FG001|Baseline Evaluation|No colposcopy visit|0|||
23149863|NCT00973362|64297716|FG000|Baseline Evaluation|Inevaluable|686|||
23149864|NCT00973362|64297717|FG001|Baseline Evaluation|Inevaluable|223|||
23149865|NCT00973362|64297716|FG000|3-Year Follow-up|Lost to Follow-up|17|||
23149866|NCT00973362|64297717|FG001|3-Year Follow-up|Lost to Follow-up|0|||
23149867|NCT02653300|64297719|FG000|Overall Study|Withdrawal by Subject|2|||
23149868|NCT01975428|64297720|FG000|Overall Study|Lost to Follow-up|17|||
23149869|NCT01975428|64297721|FG001|Overall Study|Lost to Follow-up|4|||
23149870|NCT01975428|64297720|FG000|Overall Study|Withdrawal by Subject|3|||
23149871|NCT01975428|64297721|FG001|Overall Study|Withdrawal by Subject|10|||
23149872|NCT00708175|64297723|FG000|Overall Study|Adverse Event|4|||
23149873|NCT00708175|64297724|FG001|Overall Study|Adverse Event|5|||
23149874|NCT00708175|64297723|FG000|Overall Study|Protocol Violation|2|||
23149875|NCT00708175|64297724|FG001|Overall Study|Protocol Violation|3|||
23149876|NCT00708175|64297723|FG000|Overall Study|Lost to Follow-up|5|||
23149877|NCT00708175|64297724|FG001|Overall Study|Lost to Follow-up|3|||
23149878|NCT00708175|64297723|FG000|Overall Study|Withdrawal by Subject|5|||
23149879|NCT00708175|64297724|FG001|Overall Study|Withdrawal by Subject|7|||
23149880|NCT00708175|64297723|FG000|Overall Study|BMD loss >7%|2|||
23149881|NCT00708175|64297724|FG001|Overall Study|BMD loss >7%|3|||
23149882|NCT01605253|64297725|FG000|Overall Study|Physician Decision|3|||
23149883|NCT01605253|64297726|FG001|Overall Study|Physician Decision|2|||
23323977|NCT02287922|64930162|FG002|Overall Study|Withdrawal by Subject|1|||
23323978|NCT02287922|64930163|FG003|Overall Study|Withdrawal by Subject|2|||
23323979|NCT02287922|64930160|FG000|Overall Study|Lost to Follow-up|0|||
23323980|NCT02287922|64930161|FG001|Overall Study|Lost to Follow-up|0|||
23323981|NCT02287922|64930162|FG002|Overall Study|Lost to Follow-up|1|||
23323982|NCT02287922|64930163|FG003|Overall Study|Lost to Follow-up|0|||
23323983|NCT02287922|64930160|FG000|Overall Study|Sponsor's decision|0|||
23323984|NCT02287922|64930161|FG001|Overall Study|Sponsor's decision|0|||
23323985|NCT02287922|64930162|FG002|Overall Study|Sponsor's decision|0|||
23323986|NCT02287922|64930163|FG003|Overall Study|Sponsor's decision|1|||
23323987|NCT02287922|64930160|FG000|Overall Study|Other|1|||
23323988|NCT02287922|64930161|FG001|Overall Study|Other|0|||
23323989|NCT02287922|64930162|FG002|Overall Study|Other|2|||
23323990|NCT02287922|64930163|FG003|Overall Study|Other|0|||
23323991|NCT00443729|64930166|FG000|Overall Study|Never Treated|0|||
23323992|NCT00443729|64930167|FG001|Overall Study|Never Treated|1|||
23560440|NCT03928028|65779719|FG000|Overall Study|Withdrawal by Subject|12|||
23560441|NCT03928028|65779720|FG001|Overall Study|Withdrawal by Subject|3|||
23560442|NCT03928028|65779721|FG002|Overall Study|Withdrawal by Subject|3|||
23560443|NCT02296190|65779724|FG000|Overall Study|Lost to Follow-up|0|||
23149884|NCT01605253|64297725|FG000|Overall Study|Lost to Follow-up|3|||
23149885|NCT01605253|64297726|FG001|Overall Study|Lost to Follow-up|1|||
23149886|NCT00898443|64297728|FG000|Overall Study|Withdrawal by Subject|1|||
23149887|NCT00898443|64297729|FG001|Overall Study|Withdrawal by Subject|0|||
23149888|NCT01881750|64297730|FG000|Overall Study|Changes in concomitant therapies|2|||
23149889|NCT01881750|64297731|FG001|Overall Study|Changes in concomitant therapies|3|||
23149890|NCT01881750|64297730|FG000|Overall Study|Lost to Follow-up|0|||
23149891|NCT01881750|64297731|FG001|Overall Study|Lost to Follow-up|1|||
23149892|NCT00792805|64297732|FG000|Overall Study|Adverse Event|12|||
23149893|NCT00792805|64297733|FG001|Overall Study|Adverse Event|10|||
23149894|NCT00792805|64297734|FG002|Overall Study|Adverse Event|10|||
23149895|NCT00792805|64297732|FG000|Overall Study|Subject withdrew consent|5|||
23149896|NCT00792805|64297733|FG001|Overall Study|Subject withdrew consent|6|||
23149897|NCT00792805|64297734|FG002|Overall Study|Subject withdrew consent|5|||
23149898|NCT00792805|64297732|FG000|Overall Study|Administrative problems|2|||
23323993|NCT00443729|64930166|FG000|Overall Study|Lack of Efficacy|4|||
23560444|NCT02296190|65779725|FG001|Overall Study|Lost to Follow-up|0|||
23560445|NCT02296190|65779726|FG002|Overall Study|Lost to Follow-up|0|||
23149899|NCT00792805|64297733|FG001|Overall Study|Administrative problems|0|||
23149900|NCT00792805|64297734|FG002|Overall Study|Administrative problems|4|||
23323994|NCT00443729|64930167|FG001|Overall Study|Lack of Efficacy|2|||
23323995|NCT00443729|64930166|FG000|Overall Study|Lost to Follow-up|0|||
23438022|NCT02697435|65344293|FG000|Overall Study|Withdrawal by Subject|1|||
23438023|NCT02697435|65344294|FG001|Overall Study|Withdrawal by Subject|0|||
23624693|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
23624694|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
23624695|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
23624696|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
23624697|NCT00665223|66011764|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
23624698|NCT00665223|66011765|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
23624699|NCT00665223|66011766|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
23624700|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
23624701|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
23624702|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
23624703|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Death|0|||
23624704|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Death|1|||
23624705|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Death|0|||
23624706|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
23624707|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
23624708|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
23624709|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
23624710|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
23624711|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
23624712|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
23624713|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
23624714|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
23624715|NCT00665223|66011764|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
23149901|NCT00792805|64297732|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23149902|NCT00792805|64297733|FG001|Overall Study|Abnormal test procedure result(s)|2|||
23149903|NCT00792805|64297734|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23149904|NCT00792805|64297732|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23149905|NCT00792805|64297733|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
23149906|NCT00792805|64297734|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
23149907|NCT00792805|64297732|FG000|Overall Study|Lost to Follow-up|1|||
23149908|NCT00792805|64297733|FG001|Overall Study|Lost to Follow-up|1|||
23149909|NCT00792805|64297734|FG002|Overall Study|Lost to Follow-up|6|||
23560446|NCT02296190|65779727|FG003|Overall Study|Lost to Follow-up|0|||
23560447|NCT02296190|65779728|FG004|Overall Study|Lost to Follow-up|1|||
23560448|NCT02296190|65779729|FG005|Overall Study|Lost to Follow-up|0|||
23560449|NCT02296190|65779724|FG000|Overall Study|Failure to induce PSVT|6|||
23560450|NCT02296190|65779725|FG001|Overall Study|Failure to induce PSVT|10|||
23560451|NCT02296190|65779726|FG002|Overall Study|Failure to induce PSVT|5|||
23560452|NCT02296190|65779727|FG003|Overall Study|Failure to induce PSVT|13|||
23560453|NCT02296190|65779728|FG004|Overall Study|Failure to induce PSVT|8|||
23560454|NCT02296190|65779729|FG005|Overall Study|Failure to induce PSVT|0|||
23560455|NCT02296190|65779724|FG000|Overall Study|Physician Decision|1|||
23560456|NCT02296190|65779725|FG001|Overall Study|Physician Decision|1|||
23560457|NCT02296190|65779726|FG002|Overall Study|Physician Decision|0|||
23560458|NCT02296190|65779727|FG003|Overall Study|Physician Decision|1|||
23560459|NCT02296190|65779728|FG004|Overall Study|Physician Decision|2|||
23560460|NCT02296190|65779729|FG005|Overall Study|Physician Decision|0|||
23560461|NCT02296190|65779724|FG000|Overall Study|Withdrawal by Subject|0|||
23560462|NCT02296190|65779725|FG001|Overall Study|Withdrawal by Subject|1|||
23560463|NCT02296190|65779726|FG002|Overall Study|Withdrawal by Subject|0|||
23560464|NCT02296190|65779727|FG003|Overall Study|Withdrawal by Subject|0|||
23560465|NCT02296190|65779728|FG004|Overall Study|Withdrawal by Subject|0|||
23560466|NCT02296190|65779729|FG005|Overall Study|Withdrawal by Subject|0|||
23560467|NCT02296190|65779724|FG000|Overall Study|PSVT < 5 minutes|5|||
23560468|NCT02296190|65779725|FG001|Overall Study|PSVT < 5 minutes|6|||
23560469|NCT02296190|65779726|FG002|Overall Study|PSVT < 5 minutes|6|||
23560470|NCT02296190|65779727|FG003|Overall Study|PSVT < 5 minutes|6|||
23560471|NCT02296190|65779728|FG004|Overall Study|PSVT < 5 minutes|5|||
23560472|NCT02296190|65779729|FG005|Overall Study|PSVT < 5 minutes|0|||
23560473|NCT02296190|65779724|FG000|Overall Study|Patient was given Propofol|0|||
23560474|NCT02296190|65779725|FG001|Overall Study|Patient was given Propofol|1|||
23560475|NCT02296190|65779726|FG002|Overall Study|Patient was given Propofol|0|||
23560476|NCT02296190|65779727|FG003|Overall Study|Patient was given Propofol|1|||
23560477|NCT02296190|65779728|FG004|Overall Study|Patient was given Propofol|0|||
23560478|NCT02296190|65779729|FG005|Overall Study|Patient was given Propofol|0|||
23560479|NCT02296190|65779724|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
23560480|NCT02296190|65779725|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
23560481|NCT02296190|65779726|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
23560482|NCT02296190|65779727|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
23560483|NCT02296190|65779728|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
23560484|NCT02296190|65779729|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
23560485|NCT02296190|65779724|FG000|Overall Study|Blood pressure <100 after sedation|0|||
23323996|NCT00443729|64930167|FG001|Overall Study|Lost to Follow-up|1|||
23323997|NCT00443729|64930166|FG000|Overall Study|Physician Decision|2|||
23323998|NCT00443729|64930167|FG001|Overall Study|Physician Decision|1|||
23323999|NCT00443729|64930166|FG000|Overall Study|Protocol Violation|1|||
23324000|NCT00443729|64930167|FG001|Overall Study|Protocol Violation|1|||
23324001|NCT00443729|64930166|FG000|Overall Study|Withdrawal by Subject|3|||
23324002|NCT00443729|64930167|FG001|Overall Study|Withdrawal by Subject|1|||
23324003|NCT00955617|64930168|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
23324004|NCT00955617|64930169|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
23324005|NCT00955617|64930168|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
23324006|NCT00955617|64930169|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
23324007|NCT00955617|64930168|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
23324008|NCT00955617|64930169|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
23324009|NCT00955617|64930168|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
23324010|NCT00955617|64930169|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
23324011|NCT02857816|64930170|FG000|Overall Study|Screen Failure|33|||
23324012|NCT02857816|64930170|FG000|Overall Study|Withdrawal by Subject|4|||
23324013|NCT02857816|64930170|FG000|Overall Study|Lost to Follow-up|1|||
23149910|NCT00792805|64297732|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23149911|NCT00792805|64297733|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23149912|NCT00792805|64297734|FG002|Overall Study|Abnormal laboratory value(s)|1|||
23149913|NCT00792805|64297732|FG000|Overall Study|Protocol deviation|0|||
23149914|NCT00792805|64297733|FG001|Overall Study|Protocol deviation|1|||
23149915|NCT00792805|64297734|FG002|Overall Study|Protocol deviation|1|||
23149916|NCT02881957|64297735|FG000|Overall Study|Comfort care|0|||
23560486|NCT02296190|65779725|FG001|Overall Study|Blood pressure <100 after sedation|0|||
23560487|NCT02296190|65779726|FG002|Overall Study|Blood pressure <100 after sedation|0|||
23560488|NCT02296190|65779727|FG003|Overall Study|Blood pressure <100 after sedation|1|||
23560489|NCT02296190|65779728|FG004|Overall Study|Blood pressure <100 after sedation|0|||
23560490|NCT02296190|65779729|FG005|Overall Study|Blood pressure <100 after sedation|0|||
23560491|NCT02296190|65779724|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
23560492|NCT02296190|65779725|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
23560493|NCT02296190|65779726|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
23149917|NCT02881957|64297736|FG001|Overall Study|Comfort care|1|||
23149918|NCT02881957|64297735|FG000|Overall Study|Concurrent trial enrollment|0|||
23149919|NCT02881957|64297736|FG001|Overall Study|Concurrent trial enrollment|1|||
23149920|NCT02881957|64297735|FG000|Overall Study|Discharged within 48 hours|0|||
23149921|NCT02881957|64297736|FG001|Overall Study|Discharged within 48 hours|1|||
23149922|NCT02881957|64297735|FG000|Overall Study|Withdrawal by Subject|2|||
23560494|NCT02296190|65779727|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
23560495|NCT02296190|65779728|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
23560496|NCT02296190|65779729|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
23149923|NCT02881957|64297736|FG001|Overall Study|Withdrawal by Subject|1|||
23149924|NCT02881957|64297735|FG000|Overall Study|Protocol Violation|1|||
23149925|NCT02881957|64297736|FG001|Overall Study|Protocol Violation|0|||
23149926|NCT02921269|64297737|FG000|Overall Study|Did not complete DLT period|1|||
23149927|NCT01423253|64297738|FG000|Overall Study|Adverse Event|2|||
23149928|NCT01423253|64297738|FG000|Overall Study|Lack of Efficacy|2|||
23149929|NCT01423253|64297738|FG000|Overall Study|Lost to Follow-up|1|||
23149930|NCT01423253|64297738|FG000|Overall Study|Protocol Violation|2|||
23149931|NCT01423253|64297738|FG000|Overall Study|Withdrawal by Subject|2|||
23149932|NCT01955122|64297739|FG000|Overall Study|Physician Decision|5|||
23149933|NCT01955122|64297740|FG001|Overall Study|Physician Decision|5|||
23149934|NCT00364156|64297741|FG000|Overall Study|Withdrawal by Subject|73|||
23149935|NCT00364156|64297742|FG001|Overall Study|Withdrawal by Subject|80|||
23149936|NCT00364156|64297741|FG000|Overall Study|Protocol Violation|6|||
23149937|NCT00364156|64297742|FG001|Overall Study|Protocol Violation|1|||
23149938|NCT03310268|64297744|FG000|Overall Study|(Not specified)|1|||
23149939|NCT03310268|64297745|FG001|Overall Study|(Not specified)|5|||
23149940|NCT03310268|64297746|FG002|Overall Study|(Not specified)|0|||
23219525|NCT00527072|64544910|FG000|Overall Study|Protocol Violation|2|||
23624716|NCT00665223|66011765|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
23149941|NCT02120625|64297747|FG000|Overall Study|Physician Decision|2|||
23149942|NCT02952001|64301699|FG000|Overall Study|Adverse Event|3|||
23149943|NCT02952001|64301700|FG001|Overall Study|Adverse Event|0|||
23149944|NCT02952001|64301699|FG000|Overall Study|Prohibited therapy|10|||
23149945|NCT02952001|64301700|FG001|Overall Study|Prohibited therapy|3|||
23219526|NCT00527072|64544910|FG000|Overall Study|Withdrawal by Subject|7|||
23219527|NCT04268303|64544913|FG000|Overall Study|Lost to Follow-up|1|||
23219528|NCT04268303|64544914|FG001|Overall Study|Lost to Follow-up|1|||
23560497|NCT02296190|65779724|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
23149946|NCT02952001|64301699|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
23219529|NCT04268303|64544915|FG002|Overall Study|Lost to Follow-up|2|||
23324014|NCT00503698|64930171|FG000|Overall Study|Protocol Violation|5|||
23324015|NCT00503698|64930172|FG001|Overall Study|Protocol Violation|6|||
23560498|NCT02296190|65779725|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
23149947|NCT02952001|64301700|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
23149948|NCT00445068|64301701|FG000|Overall Study|Disease progression|26|||
23149949|NCT00445068|64301701|FG000|Overall Study|Adverse Event|5|||
23149950|NCT00445068|64301701|FG000|Overall Study|Abnormal laboratory value|2|||
23149951|NCT00445068|64301701|FG000|Overall Study|Withdrawal by Subject|2|||
23149952|NCT00445068|64301701|FG000|Overall Study|Death|1|||
23149953|NCT01009203|64301702|FG000|Overall Study|Withdrawal by Subject|1|||
23149954|NCT01009203|64301702|FG000|Overall Study|Adverse Event|5|||
23149955|NCT01009203|64301702|FG000|Overall Study|Treatment-unrelated death|1|||
23149956|NCT01009554|64301703|FG000|Overall Study|Adverse Event|1|||
23149957|NCT01009554|64301704|FG001|Overall Study|Adverse Event|1|||
23149958|NCT01009554|64301703|FG000|Overall Study|Withdrawal by Subject|1|||
23149959|NCT01009554|64301704|FG001|Overall Study|Withdrawal by Subject|3|||
23149960|NCT01009554|64301703|FG000|Overall Study|Noncompliant with Study Product|0|||
23149961|NCT01009554|64301704|FG001|Overall Study|Noncompliant with Study Product|3|||
23149962|NCT01032382|64301705|FG000|Overall Study|Disease dissemination|1|||
23149963|NCT01032382|64301706|FG001|Overall Study|Disease dissemination|1|||
23149964|NCT01032382|64301705|FG000|Overall Study|Treatment failure|3|||
23149965|NCT01032382|64301706|FG001|Overall Study|Treatment failure|1|||
23149966|NCT01032382|64301705|FG000|Overall Study|Index lesion relapse|1|||
23149967|NCT01032382|64301706|FG001|Overall Study|Index lesion relapse|3|||
23149968|NCT01180998|64301707|FG000|Overall Study|Poor Vision|0|||
23149969|NCT01180998|64301708|FG001|Overall Study|Poor Vision|2|||
23149970|NCT01180998|64301709|FG002|Overall Study|Poor Vision|2|||
23149971|NCT01180998|64301707|FG000|Overall Study|Lost to Follow-up|0|||
23149972|NCT01180998|64301708|FG001|Overall Study|Lost to Follow-up|0|||
23149973|NCT01180998|64301709|FG002|Overall Study|Lost to Follow-up|1|||
23149974|NCT01180998|64301707|FG000|Overall Study|Protocol Violation|1|||
23149975|NCT01180998|64301708|FG001|Overall Study|Protocol Violation|2|||
23149976|NCT01180998|64301709|FG002|Overall Study|Protocol Violation|0|||
23149977|NCT01180998|64301707|FG000|Overall Study|Withdrawal by Subject|0|||
23149978|NCT01180998|64301708|FG001|Overall Study|Withdrawal by Subject|0|||
23149979|NCT01180998|64301709|FG002|Overall Study|Withdrawal by Subject|1|||
23149980|NCT01180998|64301707|FG000|Overall Study|Poor comfort|3|||
23149981|NCT01180998|64301708|FG001|Overall Study|Poor comfort|0|||
23149982|NCT01180998|64301709|FG002|Overall Study|Poor comfort|4|||
23149983|NCT01180998|64301707|FG000|Overall Study|Poor lens handling|0|||
23149984|NCT01180998|64301708|FG001|Overall Study|Poor lens handling|0|||
23149985|NCT01180998|64301709|FG002|Overall Study|Poor lens handling|2|||
23149986|NCT00892177|64301710|FG000|Phase II|Ineligible|0|||
23149987|NCT00892177|64301711|FG001|Phase II|Ineligible|0|||
23149988|NCT00892177|64301712|FG002|Phase II|Ineligible|0|||
23149989|NCT00892177|64301713|FG003|Phase II|Ineligible|0|||
23149990|NCT00892177|64301714|FG004|Phase II|Ineligible|1|||
23149991|NCT00892177|64301715|FG005|Phase II|Ineligible|1|||
23149992|NCT00892177|64301710|FG000|Phase II|Withdrawal by Subject|0|||
23149993|NCT00892177|64301711|FG001|Phase II|Withdrawal by Subject|0|||
23149994|NCT00892177|64301712|FG002|Phase II|Withdrawal by Subject|0|||
23149995|NCT00892177|64301713|FG003|Phase II|Withdrawal by Subject|0|||
23149996|NCT00892177|64301714|FG004|Phase II|Withdrawal by Subject|4|||
23149997|NCT00892177|64301715|FG005|Phase II|Withdrawal by Subject|1|||
23149998|NCT00671554|64301716|FG000|Overall Study|Disease progression|3|||
23149999|NCT00757003|64301720|FG000|Overall Study|Death|33|||
23150000|NCT00757003|64301720|FG000|Overall Study|Lost to Follow-up|9|||
23150001|NCT00757003|64301720|FG000|Overall Study|Withdrawal by Subject|4|||
23150002|NCT00757003|64301720|FG000|Overall Study|Surgically explanted|2|||
23150003|NCT00757003|64301720|FG000|Overall Study|Not implanted|1|||
23150004|NCT00120406|64301721|FG000|Overall Study|Death|9|||
23150005|NCT00120406|64301722|FG001|Overall Study|Death|4|||
23150006|NCT00120406|64301721|FG000|Overall Study|Withdrawal by Subject|5|||
23150007|NCT00120406|64301722|FG001|Overall Study|Withdrawal by Subject|7|||
23150008|NCT00120406|64301721|FG000|Overall Study|Lost to Follow-up|5|||
23150009|NCT00120406|64301722|FG001|Overall Study|Lost to Follow-up|2|||
23150010|NCT00120406|64301721|FG000|Overall Study|received non-study stent|0|||
23560499|NCT02296190|65779726|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
23150011|NCT00120406|64301722|FG001|Overall Study|received non-study stent|2|||
23150012|NCT00120406|64301721|FG000|Overall Study|patient moved but has not withdrawn|0|||
23150013|NCT00120406|64301722|FG001|Overall Study|patient moved but has not withdrawn|1|||
23150014|NCT03434353|64301723|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
23150015|NCT03434353|64301724|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
23150016|NCT03434353|64301725|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
23150017|NCT03434353|64301726|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
23150018|NCT03434353|64301727|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
23150019|NCT03434353|64301723|FG000|Overall Study|Withdrew consent|1|||
23150020|NCT03434353|64301724|FG001|Overall Study|Withdrew consent|0|||
23150021|NCT03434353|64301725|FG002|Overall Study|Withdrew consent|3|||
23150022|NCT03434353|64301726|FG003|Overall Study|Withdrew consent|0|||
23150023|NCT03434353|64301727|FG004|Overall Study|Withdrew consent|0|||
23560500|NCT02296190|65779727|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
23560501|NCT02296190|65779728|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
23560502|NCT02296190|65779729|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
23624717|NCT00665223|66011766|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
23624718|NCT04582669|66011767|FG000|Overall Study|Subject missed appointment(s).|1|||
23624719|NCT04582669|66011768|FG001|Overall Study|Subject missed appointment(s).|0|||
23624720|NCT04582669|66011769|FG002|Overall Study|Subject missed appointment(s).|1|||
23624721|NCT04582669|66011770|FG003|Overall Study|Subject missed appointment(s).|2|||
23624722|NCT04582669|66011767|FG000|Overall Study|Protocol Violation|0|||
23624723|NCT04582669|66011768|FG001|Overall Study|Protocol Violation|1|||
23624724|NCT04582669|66011769|FG002|Overall Study|Protocol Violation|1|||
23624725|NCT04582669|66011770|FG003|Overall Study|Protocol Violation|0|||
23624726|NCT02418845|66011771|FG000|Overall Study|Lost to Follow-up|7|||
23624727|NCT02418845|66011772|FG001|Overall Study|Lost to Follow-up|2|||
23624728|NCT02418845|66011771|FG000|Overall Study|Lack of Efficacy|0|||
23624729|NCT02418845|66011772|FG001|Overall Study|Lack of Efficacy|3|||
23624730|NCT02418845|66011771|FG000|Overall Study|Physician Decision|5|||
23624731|NCT02418845|66011772|FG001|Overall Study|Physician Decision|5|||
23624732|NCT02418845|66011771|FG000|Overall Study|Protocol Violation|1|||
23624733|NCT02418845|66011772|FG001|Overall Study|Protocol Violation|0|||
23624734|NCT02418845|66011771|FG000|Overall Study|Withdrawal by Subject|3|||
23624735|NCT02418845|66011772|FG001|Overall Study|Withdrawal by Subject|2|||
23624736|NCT00508274|66011773|FG000|Overall Study|Adverse Event|5|||
23624737|NCT00508274|66011773|FG000|Overall Study|Death|7|||
23624738|NCT00508274|66011773|FG000|Overall Study|Disease progression|32|||
23624739|NCT00508274|66011773|FG000|Overall Study|Withdrawal by Subject|1|||
23624740|NCT00508274|66011773|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
23624741|NCT00508274|66011773|FG000|Overall Study|Missing|3|||
23624742|NCT00715117|66011774|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
23624743|NCT00715117|66011775|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
23150024|NCT03434353|64301723|FG000|Overall Study|Adverse Event|1|||
23324016|NCT00503698|64930171|FG000|Overall Study|Adverse Event|52|||
23324017|NCT00503698|64930172|FG001|Overall Study|Adverse Event|41|||
23324018|NCT00503698|64930171|FG000|Overall Study|Death|1|||
23324019|NCT00503698|64930172|FG001|Overall Study|Death|0|||
23324020|NCT00503698|64930171|FG000|Overall Study|Lack of Efficacy|3|||
23324021|NCT00503698|64930172|FG001|Overall Study|Lack of Efficacy|4|||
23324022|NCT00503698|64930171|FG000|Overall Study|Trial terminated|216|||
23324023|NCT00503698|64930172|FG001|Overall Study|Trial terminated|253|||
23324024|NCT00503698|64930171|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
23560503|NCT02296190|65779724|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560504|NCT02296190|65779725|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
23324025|NCT00503698|64930172|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
23324026|NCT00503698|64930171|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
23560505|NCT02296190|65779726|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560506|NCT02296190|65779727|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560507|NCT02296190|65779728|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560508|NCT02296190|65779729|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
23560509|NCT02296190|65779724|FG000|Overall Study|Lab result not available in time|1|||
23560510|NCT02296190|65779725|FG001|Overall Study|Lab result not available in time|0|||
23560511|NCT02296190|65779726|FG002|Overall Study|Lab result not available in time|0|||
23560512|NCT02296190|65779727|FG003|Overall Study|Lab result not available in time|0|||
23560513|NCT02296190|65779728|FG004|Overall Study|Lab result not available in time|0|||
23560514|NCT02296190|65779729|FG005|Overall Study|Lab result not available in time|0|||
23560515|NCT03642938|65779731|FG000|Overall Study|Withdrawal by Subject|0|||
23560516|NCT03642938|65779732|FG001|Overall Study|Withdrawal by Subject|0|||
23150025|NCT03434353|64301724|FG001|Overall Study|Adverse Event|0|||
23150026|NCT03434353|64301725|FG002|Overall Study|Adverse Event|0|||
23150027|NCT03434353|64301726|FG003|Overall Study|Adverse Event|0|||
23150028|NCT03434353|64301727|FG004|Overall Study|Adverse Event|1|||
23150029|NCT03434353|64301723|FG000|Overall Study|Lost to Follow-up|2|||
23150030|NCT03434353|64301724|FG001|Overall Study|Lost to Follow-up|0|||
23150031|NCT03434353|64301725|FG002|Overall Study|Lost to Follow-up|0|||
23150032|NCT03434353|64301726|FG003|Overall Study|Lost to Follow-up|0|||
23150033|NCT03434353|64301727|FG004|Overall Study|Lost to Follow-up|0|||
23150034|NCT01729156|64301728|FG000|Overall Study|Withdrawal by Subject|1|||
23560517|NCT03642938|65779733|FG002|Overall Study|Withdrawal by Subject|0|||
23324027|NCT00503698|64930172|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
23324028|NCT00503698|64930171|FG000|Overall Study|Any condition in exclusion criteria|4|||
23150035|NCT01729156|64301729|FG001|Overall Study|Withdrawal by Subject|0|||
23324029|NCT00503698|64930172|FG001|Overall Study|Any condition in exclusion criteria|6|||
23560518|NCT03642938|65779734|FG003|Overall Study|Withdrawal by Subject|1|||
23560519|NCT03078816|65779745|FG000|Overall Study|Withdrawal by Subject|1|||
23324030|NCT00503698|64930171|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
23560520|NCT01966003|65779752|FG000|Overall Study|Death|43|||
23560521|NCT01966003|65779753|FG001|Overall Study|Death|36|||
23560522|NCT01966003|65779752|FG000|Overall Study|Protocol Violation|6|||
23560523|NCT01966003|65779753|FG001|Overall Study|Protocol Violation|4|||
23560524|NCT01966003|65779752|FG000|Overall Study|Lost to Follow-up|4|||
23560525|NCT01966003|65779753|FG001|Overall Study|Lost to Follow-up|3|||
23560526|NCT01966003|65779752|FG000|Overall Study|Physician Decision|12|||
23560527|NCT01966003|65779753|FG001|Overall Study|Physician Decision|13|||
23560528|NCT01966003|65779752|FG000|Overall Study|Withdrawal by Subject|29|||
23560529|NCT01966003|65779753|FG001|Overall Study|Withdrawal by Subject|19|||
23560530|NCT01966003|65779752|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
23560531|NCT01966003|65779753|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
23560532|NCT01966003|65779752|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
23560533|NCT01966003|65779753|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
23560534|NCT01966003|65779752|FG000|Overall Study|Other|1|||
23560535|NCT01966003|65779753|FG001|Overall Study|Other|1|||
23560536|NCT01644734|65779756|FG000|Overall Study|Adverse Event|4|||
23560537|NCT01644734|65779756|FG000|Overall Study|Lost to Follow-up|17|||
23560538|NCT01644734|65779756|FG000|Overall Study|Reasons other than stated above|7|||
23560539|NCT01644734|65779756|FG000|Overall Study|Missing documentation|238|||
23560540|NCT01226511|65779762|FG000|Acute Treatment Period|Adverse Event|7|||
23560541|NCT01226511|65779763|FG001|Acute Treatment Period|Adverse Event|6|||
23560542|NCT01226511|65779762|FG000|Acute Treatment Period|Lack of Efficacy|2|||
23560543|NCT01226511|65779763|FG001|Acute Treatment Period|Lack of Efficacy|1|||
23560544|NCT01226511|65779762|FG000|Acute Treatment Period|Lost to Follow-up|3|||
23560545|NCT01226511|65779763|FG001|Acute Treatment Period|Lost to Follow-up|6|||
23560546|NCT01226511|65779762|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
23560547|NCT01226511|65779763|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
23560548|NCT01226511|65779762|FG000|Acute Treatment Period|Protocol Violation|5|||
23560549|NCT01226511|65779763|FG001|Acute Treatment Period|Protocol Violation|5|||
23560550|NCT01226511|65779762|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
23560551|NCT01226511|65779763|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
23560552|NCT01226511|65779762|FG000|Extension Treatment Period|Adverse Event|8|||
23560553|NCT01226511|65779763|FG001|Extension Treatment Period|Adverse Event|8|||
23560554|NCT01226511|65779762|FG000|Extension Treatment Period|Lack of Efficacy|3|||
23560555|NCT01226511|65779763|FG001|Extension Treatment Period|Lack of Efficacy|2|||
23560556|NCT01226511|65779762|FG000|Extension Treatment Period|Lost to Follow-up|4|||
23560557|NCT01226511|65779763|FG001|Extension Treatment Period|Lost to Follow-up|3|||
23560558|NCT01226511|65779762|FG000|Extension Treatment Period|Protocol Violation|2|||
23560559|NCT01226511|65779763|FG001|Extension Treatment Period|Protocol Violation|2|||
23560560|NCT01226511|65779762|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
23560561|NCT01226511|65779763|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
23560562|NCT01226511|65779762|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
23560563|NCT01226511|65779763|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
23560564|NCT01226511|65779762|FG000|Extension Treatment Period|Sponsor Decision|1|||
23560565|NCT01226511|65779763|FG001|Extension Treatment Period|Sponsor Decision|1|||
23560566|NCT01226511|65779762|FG000|Taper Period|Adverse Event|1|||
23560567|NCT01226511|65779763|FG001|Taper Period|Adverse Event|0|||
23560568|NCT01226511|65779762|FG000|Taper Period|Lost to Follow-up|2|||
23560569|NCT01226511|65779763|FG001|Taper Period|Lost to Follow-up|2|||
23560570|NCT01226511|65779762|FG000|Taper Period|Protocol Violation|1|||
23560571|NCT01226511|65779763|FG001|Taper Period|Protocol Violation|0|||
23560572|NCT01226511|65779762|FG000|Taper Period|Parent/Caregiver Decision|1|||
23560573|NCT01226511|65779763|FG001|Taper Period|Parent/Caregiver Decision|1|||
23560574|NCT01987817|65779764|FG000|Overall Study|Adverse Event|4|||
23560575|NCT01987817|65779765|FG001|Overall Study|Adverse Event|0|||
23560576|NCT01987817|65779764|FG000|Overall Study|Withdrawal by Subject|1|||
23560577|NCT01987817|65779765|FG001|Overall Study|Withdrawal by Subject|1|||
23560578|NCT01987817|65779764|FG000|Overall Study|Physician Decision|1|||
23150036|NCT01729156|64301730|FG002|Overall Study|Withdrawal by Subject|0|||
23150037|NCT00778622|64301732|FG000|Overall Study|Adverse Event|5|||
23150038|NCT00778622|64301733|FG001|Overall Study|Adverse Event|4|||
23150039|NCT00778622|64301734|FG002|Overall Study|Adverse Event|7|||
23150040|NCT00778622|64301732|FG000|Overall Study|Withdrawal by Subject|4|||
23150041|NCT00778622|64301733|FG001|Overall Study|Withdrawal by Subject|5|||
23560579|NCT01987817|65779765|FG001|Overall Study|Physician Decision|0|||
23560580|NCT00909428|65779782|FG000|Overall Study|Lost to Follow-up|13|||
23560581|NCT00909428|65779783|FG001|Overall Study|Lost to Follow-up|10|||
23560582|NCT00909428|65779784|FG002|Overall Study|Lost to Follow-up|9|||
23560583|NCT00652938|65779785|FG000|Overall Study|Adverse Event|1|||
23150042|NCT00778622|64301734|FG002|Overall Study|Withdrawal by Subject|5|||
23560584|NCT00652938|65779786|FG001|Overall Study|Adverse Event|0|||
23560585|NCT00652938|65779787|FG002|Overall Study|Adverse Event|2|||
23560586|NCT00652938|65779785|FG000|Overall Study|Withdrawal by Subject|0|||
23560587|NCT00652938|65779786|FG001|Overall Study|Withdrawal by Subject|6|||
23560588|NCT00652938|65779787|FG002|Overall Study|Withdrawal by Subject|1|||
23560589|NCT00652938|65779785|FG000|Overall Study|Lost to Follow-up|0|||
23560590|NCT00652938|65779786|FG001|Overall Study|Lost to Follow-up|0|||
23560591|NCT00652938|65779787|FG002|Overall Study|Lost to Follow-up|2|||
23560592|NCT00652938|65779785|FG000|Overall Study|fear of blood sampling|0|||
23560593|NCT00652938|65779786|FG001|Overall Study|fear of blood sampling|1|||
23560594|NCT00652938|65779787|FG002|Overall Study|fear of blood sampling|0|||
23324031|NCT00503698|64930172|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
23324032|NCT00503698|64930171|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
23324033|NCT00503698|64930172|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
23324034|NCT00503698|64930171|FG000|Overall Study|Critically ill|2|||
23324035|NCT00503698|64930172|FG001|Overall Study|Critically ill|0|||
23324036|NCT00503698|64930171|FG000|Overall Study|Unclassified|48|||
23324037|NCT00503698|64930172|FG001|Overall Study|Unclassified|32|||
23324038|NCT00503698|64930171|FG000|Overall Study|Not exposed to trial drug|11|||
23560595|NCT00903786|65779790|FG000|Overall Study|Physician Decision|6|||
23560596|NCT00903786|65779790|FG000|Overall Study|Lack of Efficacy|5|||
23560597|NCT00903786|65779790|FG000|Overall Study|Reason other than lack of efficacy|4|||
23560598|NCT01949870|65782343|FG000|Overall Study|Lack of Efficacy|2|||
23560599|NCT01949870|65782343|FG000|Overall Study|Adverse Event|1|||
23560600|NCT01949870|65782343|FG000|Overall Study|Study termination|1|||
23560601|NCT01949870|65782343|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
23324039|NCT00503698|64930172|FG001|Overall Study|Not exposed to trial drug|6|||
23324040|NCT01214655|64930173|FG000|Part A|Progressive Disease|7|||
23324041|NCT01214655|64930174|FG001|Part A|Progressive Disease|0|||
23324042|NCT01214655|64930175|FG002|Part A|Progressive Disease|0|||
23324043|NCT01214655|64930173|FG000|Part A|Physician Decision|1|||
23150043|NCT00778622|64301732|FG000|Overall Study|Lost to Follow-up|3|||
23150044|NCT00778622|64301733|FG001|Overall Study|Lost to Follow-up|3|||
23150045|NCT00778622|64301734|FG002|Overall Study|Lost to Follow-up|2|||
23150046|NCT00778622|64301732|FG000|Overall Study|Protocol Violation|0|||
23324044|NCT01214655|64930174|FG001|Part A|Physician Decision|0|||
23324045|NCT01214655|64930175|FG002|Part A|Physician Decision|0|||
23324046|NCT01214655|64930173|FG000|Part B|Progressive disease|0|||
23150047|NCT00778622|64301733|FG001|Overall Study|Protocol Violation|3|||
23150048|NCT00778622|64301734|FG002|Overall Study|Protocol Violation|0|||
23150049|NCT00778622|64301732|FG000|Overall Study|Lack of Efficacy|2|||
23150050|NCT00778622|64301733|FG001|Overall Study|Lack of Efficacy|0|||
23150051|NCT00778622|64301734|FG002|Overall Study|Lack of Efficacy|0|||
23150052|NCT00778622|64301732|FG000|Overall Study|immigration|1|||
23150053|NCT00778622|64301733|FG001|Overall Study|immigration|0|||
23150054|NCT00778622|64301734|FG002|Overall Study|immigration|0|||
23150055|NCT00778622|64301732|FG000|Overall Study|Other|1|||
23150056|NCT00778622|64301733|FG001|Overall Study|Other|0|||
23150057|NCT00778622|64301734|FG002|Overall Study|Other|1|||
23150058|NCT00294554|64301735|FG000|Overall Study|Lack of Efficacy|0|||
23150059|NCT00294554|64301736|FG001|Overall Study|Lack of Efficacy|1|||
23150060|NCT00294554|64301735|FG000|Overall Study|Physician Decision|0|||
23150061|NCT00294554|64301736|FG001|Overall Study|Physician Decision|1|||
23150062|NCT05116046|64301738|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23150063|NCT05116046|64301739|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23150064|NCT05116046|64301740|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23150065|NCT05116046|64301738|FG000|Overall Study|Study terminated by sponsor|14|||
23150066|NCT05116046|64301739|FG001|Overall Study|Study terminated by sponsor|16|||
23150067|NCT05116046|64301740|FG002|Overall Study|Study terminated by sponsor|1|||
23150068|NCT01130051|64301743|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
23150069|NCT01130051|64301744|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
23438024|NCT02697435|65344293|FG000|Overall Study|Physician Decision|0|||
23438025|NCT02697435|65344294|FG001|Overall Study|Physician Decision|4|||
23438026|NCT02038075|65344295|FG000|Overall Study|Withdrawal by Subject|3|||
23438027|NCT02038075|65344296|FG001|Overall Study|Withdrawal by Subject|0|||
23438028|NCT00319254|65348453|FG000|Overall Study|Withdrawal by Subject|4|||
23438029|NCT00319254|65348453|FG000|Overall Study|Death|46|||
23150070|NCT01130051|64301743|FG000|Washout Period of 14 Days|Protocol Violation|1|||
23150071|NCT01130051|64301744|FG001|Washout Period of 14 Days|Protocol Violation|1|||
23150072|NCT02743819|64301745|FG000|Overall Study|Lack of Efficacy|5|||
23150073|NCT02743819|64301745|FG000|Overall Study|Death|2|||
23438030|NCT00319254|65348453|FG000|Overall Study|Lost to Follow-up|2|||
23438031|NCT00319254|65348453|FG000|Overall Study|Enrolled, Not Treated|2|||
23560602|NCT05158296|65782344|FG000|Overall Study|Sponsor Decision|2|||
23150074|NCT02743819|64301745|FG000|Overall Study|Adverse Event|1|||
23150075|NCT02684279|64301746|FG000|Overall Study|Adverse Event|87|||
23150076|NCT02684279|64301746|FG000|Overall Study|Lack of Efficacy|4|||
23150077|NCT02684279|64301746|FG000|Overall Study|Lost to Follow-up|61|||
23324047|NCT01214655|64930174|FG001|Part B|Progressive disease|10|||
23324048|NCT01214655|64930175|FG002|Part B|Progressive disease|0|||
23324049|NCT01214655|64930173|FG000|Part B|Death|0|||
23324050|NCT01214655|64930174|FG001|Part B|Death|1|||
23438032|NCT05513053|65348454|FG000|Overall Study|Lost to Follow-up|9|||
23560603|NCT05158296|65782345|FG001|Overall Study|Sponsor Decision|3|||
23324051|NCT01214655|64930175|FG002|Part B|Death|0|||
23324052|NCT01214655|64930173|FG000|Part B|Withdrawal by Subject|0|||
23324053|NCT01214655|64930174|FG001|Part B|Withdrawal by Subject|2|||
23324054|NCT01214655|64930175|FG002|Part B|Withdrawal by Subject|0|||
23324055|NCT01214655|64930173|FG000|Part C|Progressive Disease|0|||
23324056|NCT01214655|64930174|FG001|Part C|Progressive Disease|0|||
23324057|NCT01214655|64930175|FG002|Part C|Progressive Disease|5|||
23324058|NCT01214655|64930173|FG000|Part C|Death|0|||
23150078|NCT02684279|64301746|FG000|Overall Study|Protocol Violation|6|||
23150079|NCT02684279|64301746|FG000|Overall Study|Pregnancy|8|||
23219530|NCT04268303|64544913|FG000|Overall Study|Withdrawal by Subject|0|||
23219531|NCT04268303|64544914|FG001|Overall Study|Withdrawal by Subject|1|||
23219532|NCT04268303|64544915|FG002|Overall Study|Withdrawal by Subject|1|||
23219533|NCT04268303|64544913|FG000|Overall Study|Adverse Event|2|||
23219534|NCT04268303|64544914|FG001|Overall Study|Adverse Event|0|||
23219535|NCT04268303|64544915|FG002|Overall Study|Adverse Event|0|||
23219536|NCT04153929|64544916|FG000|Overall Study|Other than listed|2|||
23219537|NCT04153929|64544917|FG001|Overall Study|Other than listed|2|||
23219538|NCT04153929|64544918|FG002|Overall Study|Other than listed|0|||
23219539|NCT04153929|64544919|FG003|Overall Study|Other than listed|1|||
23219540|NCT04153929|64544920|FG004|Overall Study|Other than listed|0|||
23150080|NCT02684279|64301746|FG000|Overall Study|Withdrawal by Subject|92|||
23438033|NCT05513053|65348455|FG001|Overall Study|Lost to Follow-up|11|||
23438034|NCT05513053|65348454|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23150081|NCT02684279|64301746|FG000|Overall Study|non-compliance with study drug|9|||
23150082|NCT02684279|64301746|FG000|Overall Study|non compliance with study visits|2|||
23150083|NCT02684279|64301746|FG000|Overall Study|subject to have surgery|1|||
23150084|NCT02684279|64301746|FG000|Overall Study|family emergency|1|||
23150085|NCT02684279|64301746|FG000|Overall Study|Site closures|7|||
23150086|NCT02684279|64301746|FG000|Overall Study|Physician Decision|1|||
23150087|NCT01026142|64301748|FG000|Overall Study|Death|136|||
23150088|NCT01026142|64301749|FG001|Overall Study|Death|134|||
23150089|NCT01026142|64301748|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
23150090|NCT01026142|64301749|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
23150091|NCT04875533|64301752|FG000|Overall Study|Adverse Event|6|||
23150092|NCT04875533|64301753|FG001|Overall Study|Adverse Event|4|||
23150093|NCT04875533|64301752|FG000|Overall Study|Protocol Violation|4|||
23150094|NCT04875533|64301753|FG001|Overall Study|Protocol Violation|0|||
23150095|NCT04875533|64301752|FG000|Overall Study|Withdrawal by Subject|8|||
23150096|NCT04875533|64301753|FG001|Overall Study|Withdrawal by Subject|5|||
23150097|NCT04875533|64301752|FG000|Overall Study|No longer meets eligibility criteria|1|||
23150098|NCT04875533|64301753|FG001|Overall Study|No longer meets eligibility criteria|0|||
23150099|NCT04875533|64301752|FG000|Overall Study|Other|0|||
23150100|NCT04875533|64301753|FG001|Overall Study|Other|2|||
23150101|NCT01309230|64301756|FG000|Overall Study|Withdrawal by Subject|0|||
23150102|NCT01309230|64301757|FG001|Overall Study|Withdrawal by Subject|2|||
23150103|NCT01309230|64301756|FG000|Overall Study|Observation arm closed|0|||
23438035|NCT05513053|65348455|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23438036|NCT05513053|65348454|FG000|Overall Study|Withdrawal by Subject|2|||
23150104|NCT01309230|64301757|FG001|Overall Study|Observation arm closed|2|||
23150105|NCT01128894|64301758|FG000|Overall Study|Adverse Event|31|||
23150106|NCT01128894|64301759|FG001|Overall Study|Adverse Event|41|||
23150107|NCT01128894|64301758|FG000|Overall Study|Protocol Violation|2|||
23219541|NCT04153929|64544921|FG005|Overall Study|Other than listed|2|||
23219542|NCT04153929|64544922|FG006|Overall Study|Other than listed|2|||
23219543|NCT04153929|64544923|FG007|Overall Study|Other than listed|1|||
23219544|NCT04153929|64544916|FG000|Overall Study|Lost to Follow-up|2|||
23219545|NCT04153929|64544917|FG001|Overall Study|Lost to Follow-up|1|||
23219546|NCT04153929|64544918|FG002|Overall Study|Lost to Follow-up|0|||
23438037|NCT05513053|65348455|FG001|Overall Study|Withdrawal by Subject|9|||
23438038|NCT05513053|65348454|FG000|Overall Study|Protocol Violation|6|||
23324059|NCT01214655|64930174|FG001|Part C|Death|0|||
23150108|NCT01128894|64301759|FG001|Overall Study|Protocol Violation|1|||
23150109|NCT01128894|64301758|FG000|Overall Study|Noncompliance|4|||
23150110|NCT01128894|64301759|FG001|Overall Study|Noncompliance|5|||
23150111|NCT01128894|64301758|FG000|Overall Study|Lost to Follow-up|8|||
23324060|NCT01214655|64930175|FG002|Part C|Death|1|||
23324061|NCT01214655|64930173|FG000|Part C|Physician Decision|0|||
23150112|NCT01128894|64301759|FG001|Overall Study|Lost to Follow-up|8|||
23150113|NCT01128894|64301758|FG000|Overall Study|Withdrawal by Subject|10|||
23150114|NCT01128894|64301759|FG001|Overall Study|Withdrawal by Subject|12|||
23150115|NCT01128894|64301758|FG000|Overall Study|Physician Decision|2|||
23150116|NCT01128894|64301759|FG001|Overall Study|Physician Decision|1|||
23219547|NCT04153929|64544919|FG003|Overall Study|Lost to Follow-up|1|||
23219548|NCT04153929|64544920|FG004|Overall Study|Lost to Follow-up|1|||
23150117|NCT01128894|64301758|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
23219549|NCT04153929|64544921|FG005|Overall Study|Lost to Follow-up|0|||
23219550|NCT04153929|64544922|FG006|Overall Study|Lost to Follow-up|0|||
23324062|NCT01214655|64930174|FG001|Part C|Physician Decision|0|||
23560604|NCT05158296|65782346|FG002|Overall Study|Sponsor Decision|2|||
23324063|NCT01214655|64930175|FG002|Part C|Physician Decision|1|||
23324064|NCT02762929|64930176|FG000|Overall Study|Adverse Event|0|||
23624744|NCT01169636|66015332|FG000|Overall Study|Adverse Event|0|||
23624745|NCT01169636|66015333|FG001|Overall Study|Adverse Event|0|||
23624746|NCT01169636|66015334|FG002|Overall Study|Adverse Event|1|||
23624747|NCT01169636|66015335|FG003|Overall Study|Adverse Event|1|||
23624748|NCT01169636|66015336|FG004|Overall Study|Adverse Event|0|||
23624749|NCT01169636|66015332|FG000|Overall Study|Screen failure|0|||
23624750|NCT01169636|66015333|FG001|Overall Study|Screen failure|0|||
23624751|NCT01169636|66015334|FG002|Overall Study|Screen failure|2|||
23624752|NCT01169636|66015335|FG003|Overall Study|Screen failure|0|||
23624753|NCT01169636|66015336|FG004|Overall Study|Screen failure|0|||
23150118|NCT01128894|64301759|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
23150119|NCT01296035|64301760|FG000|Overall Study|Withdrawal by Subject|1|||
23150120|NCT02003014|64301765|FG000|Overall Study|Case report forms uncollected|9|||
23560605|NCT05076149|65782347|FG000|Overall Study|Adverse Event|3|||
23560606|NCT05076149|65782348|FG001|Overall Study|Adverse Event|9|||
23560607|NCT05076149|65782347|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
23560608|NCT05076149|65782348|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
23560609|NCT05076149|65782347|FG000|Overall Study|Lost to Follow-up|0|||
23560610|NCT05076149|65782348|FG001|Overall Study|Lost to Follow-up|1|||
23560611|NCT05076149|65782347|FG000|Overall Study|Commercial drug is available for participant|0|||
23560612|NCT05076149|65782348|FG001|Overall Study|Commercial drug is available for participant|1|||
23560613|NCT05076149|65782347|FG000|Overall Study|Other non compliance|1|||
23560614|NCT05076149|65782348|FG001|Overall Study|Other non compliance|1|||
23560615|NCT05076149|65782347|FG000|Overall Study|Physician Decision|0|||
23560616|NCT05076149|65782348|FG001|Overall Study|Physician Decision|1|||
23560617|NCT05076149|65782347|FG000|Overall Study|Other|5|||
23560618|NCT05076149|65782348|FG001|Overall Study|Other|4|||
23560619|NCT00116272|65782349|FG000|Overall Study|Lost to Follow-up|11|||
23560620|NCT00116272|65782350|FG001|Overall Study|Lost to Follow-up|6|||
23560621|NCT00118092|65782355|FG000|Overall Study|Withdrawal by Subject|1|||
23560622|NCT00118092|65782355|FG000|Overall Study|Protocol Violation|1|||
23560623|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
23624754|NCT01169636|66015332|FG000|Overall Study|Withdrawal by Subject|0|||
23624755|NCT01169636|66015333|FG001|Overall Study|Withdrawal by Subject|0|||
23624756|NCT01169636|66015334|FG002|Overall Study|Withdrawal by Subject|0|||
23624757|NCT01169636|66015335|FG003|Overall Study|Withdrawal by Subject|0|||
23624758|NCT01169636|66015336|FG004|Overall Study|Withdrawal by Subject|3|||
23624759|NCT03119688|66015341|FG000|Overall Study|Adverse Event|4|||
23624760|NCT01834586|66015342|FG000|Overall Study|Adverse Event|1|||
23624761|NCT00621192|66015356|FG000|Overall Study|Withdrawal by Subject|0|||
23624762|NCT00621192|66015357|FG001|Overall Study|Withdrawal by Subject|0|||
23624763|NCT00621192|66015358|FG002|Overall Study|Withdrawal by Subject|2|||
23624764|NCT00621192|66015359|FG003|Overall Study|Withdrawal by Subject|0|||
23624765|NCT00621192|66015356|FG000|Overall Study|Physician Decision|1|||
23624766|NCT00621192|66015357|FG001|Overall Study|Physician Decision|3|||
23624767|NCT00621192|66015358|FG002|Overall Study|Physician Decision|0|||
23624768|NCT00621192|66015359|FG003|Overall Study|Physician Decision|0|||
23624769|NCT00621192|66015356|FG000|Overall Study|Protocol Violation|1|||
23624770|NCT00621192|66015357|FG001|Overall Study|Protocol Violation|0|||
23624771|NCT00621192|66015358|FG002|Overall Study|Protocol Violation|0|||
23624772|NCT00621192|66015359|FG003|Overall Study|Protocol Violation|1|||
23624773|NCT00621192|66015356|FG000|Overall Study|Adverse Event|0|||
23624774|NCT00621192|66015357|FG001|Overall Study|Adverse Event|1|||
23624775|NCT00621192|66015358|FG002|Overall Study|Adverse Event|0|||
23624776|NCT00621192|66015359|FG003|Overall Study|Adverse Event|1|||
23624777|NCT00621192|66015356|FG000|Overall Study|Death|2|||
23624778|NCT00621192|66015357|FG001|Overall Study|Death|5|||
23624779|NCT00621192|66015358|FG002|Overall Study|Death|0|||
23624780|NCT00621192|66015359|FG003|Overall Study|Death|0|||
23624781|NCT00621192|66015356|FG000|Overall Study|Final Assessments not Completed|0|||
23624782|NCT00621192|66015357|FG001|Overall Study|Final Assessments not Completed|0|||
23624783|NCT00621192|66015358|FG002|Overall Study|Final Assessments not Completed|3|||
23624784|NCT00621192|66015359|FG003|Overall Study|Final Assessments not Completed|1|||
23150121|NCT02003014|64301765|FG000|Overall Study|Treatment started after contract period|1|||
23324065|NCT02762929|64930177|FG001|Overall Study|Adverse Event|0|||
23560624|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
23560625|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
23560626|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
23560627|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
23560628|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
23624785|NCT00988533|66015362|FG000|Overall Study|Lost to Follow-up|3|||
23624786|NCT00740870|66015363|FG000|Overall Study|Not Catheterized|4|||
23624787|NCT00740870|66015363|FG000|Overall Study|Further testing contraindicated implant|17|||
23624788|NCT04629443|66015365|FG000|Overall Study|Adverse Event|2|||
23624789|NCT04629443|66015366|FG001|Overall Study|Adverse Event|1|||
23624790|NCT04629443|66015367|FG002|Overall Study|Adverse Event|2|||
23624791|NCT04629443|66015365|FG000|Overall Study|Progressive Disease|2|||
23624792|NCT04629443|66015366|FG001|Overall Study|Progressive Disease|3|||
23624793|NCT04629443|66015367|FG002|Overall Study|Progressive Disease|3|||
23624794|NCT04629443|66015365|FG000|Overall Study|Physician Decision|1|||
23624795|NCT04629443|66015366|FG001|Overall Study|Physician Decision|3|||
23624796|NCT04629443|66015367|FG002|Overall Study|Physician Decision|0|||
23624797|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
23624798|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
23219551|NCT04153929|64544923|FG007|Overall Study|Lost to Follow-up|0|||
23219552|NCT04153929|64544916|FG000|Overall Study|Withdrawal by Subject|3|||
23219553|NCT04153929|64544917|FG001|Overall Study|Withdrawal by Subject|1|||
23219554|NCT04153929|64544918|FG002|Overall Study|Withdrawal by Subject|0|||
23219555|NCT04153929|64544919|FG003|Overall Study|Withdrawal by Subject|3|||
23219556|NCT04153929|64544920|FG004|Overall Study|Withdrawal by Subject|1|||
23219557|NCT04153929|64544921|FG005|Overall Study|Withdrawal by Subject|0|||
23219558|NCT04153929|64544922|FG006|Overall Study|Withdrawal by Subject|1|||
23219559|NCT04153929|64544923|FG007|Overall Study|Withdrawal by Subject|0|||
23219560|NCT04153929|64544916|FG000|Overall Study|Protocol Violation|0|||
23219561|NCT04153929|64544917|FG001|Overall Study|Protocol Violation|0|||
23219562|NCT04153929|64544918|FG002|Overall Study|Protocol Violation|0|||
23219563|NCT04153929|64544919|FG003|Overall Study|Protocol Violation|0|||
23219564|NCT04153929|64544920|FG004|Overall Study|Protocol Violation|0|||
23219565|NCT04153929|64544921|FG005|Overall Study|Protocol Violation|0|||
23219566|NCT04153929|64544922|FG006|Overall Study|Protocol Violation|1|||
23219567|NCT04153929|64544923|FG007|Overall Study|Protocol Violation|2|||
23560629|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
23560630|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
23560631|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
23560632|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
23560633|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
23560634|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
23560635|NCT01493687|65782360|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
23560636|NCT01493687|65782361|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
23560637|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
23560638|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
23560639|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
23560640|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
23560641|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
23560642|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
23560643|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
23560644|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
23560645|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
23560646|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
23560647|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
23560648|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
23624799|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
23624800|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
23624801|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
23624802|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
23624803|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
23219568|NCT04153929|64544916|FG000|Overall Study|Adverse Event|3|||
23219569|NCT04153929|64544917|FG001|Overall Study|Adverse Event|5|||
23219570|NCT04153929|64544918|FG002|Overall Study|Adverse Event|5|||
23219571|NCT04153929|64544919|FG003|Overall Study|Adverse Event|11|||
23219572|NCT04153929|64544920|FG004|Overall Study|Adverse Event|15|||
23219573|NCT04153929|64544921|FG005|Overall Study|Adverse Event|4|||
23219574|NCT04153929|64544922|FG006|Overall Study|Adverse Event|8|||
23219575|NCT04153929|64544923|FG007|Overall Study|Adverse Event|2|||
23219576|NCT04153929|64544916|FG000|Overall Study|Not treated|1|||
23438039|NCT05513053|65348455|FG001|Overall Study|Protocol Violation|3|||
23438040|NCT05513053|65348454|FG000|Overall Study|Adverse Event|0|||
23438041|NCT05513053|65348455|FG001|Overall Study|Adverse Event|2|||
23219577|NCT04153929|64544917|FG001|Overall Study|Not treated|0|||
23438042|NCT01223183|65348456|FG000|Imaging Day 1|Physician Decision|0|||
23438043|NCT01223183|65348457|FG001|Imaging Day 1|Physician Decision|1|||
23438044|NCT01223183|65348456|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
23624804|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
23624805|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
23219578|NCT04153929|64544918|FG002|Overall Study|Not treated|0|||
23219579|NCT04153929|64544919|FG003|Overall Study|Not treated|0|||
23219580|NCT04153929|64544920|FG004|Overall Study|Not treated|0|||
23324066|NCT02762929|64930178|FG002|Overall Study|Adverse Event|0|||
23150122|NCT02003014|64301765|FG000|Overall Study|Patient did not visit the study site|5|||
23150123|NCT02003014|64301765|FG000|Overall Study|Investigator's transfer|4|||
23150124|NCT00800683|64301766|FG000|Overall Study|Adverse Event|11|||
23150125|NCT00800683|64301767|FG001|Overall Study|Adverse Event|8|||
23150126|NCT00800683|64301766|FG000|Overall Study|Lost to Follow-up|3|||
23150127|NCT00800683|64301767|FG001|Overall Study|Lost to Follow-up|1|||
23150128|NCT00800683|64301766|FG000|Overall Study|Withdrawal by Subject|1|||
23150129|NCT00800683|64301767|FG001|Overall Study|Withdrawal by Subject|7|||
23150130|NCT00800683|64301766|FG000|Overall Study|Lack of Efficacy|1|||
23150131|NCT00800683|64301767|FG001|Overall Study|Lack of Efficacy|1|||
23150132|NCT00800683|64301766|FG000|Overall Study|Other|1|||
23324067|NCT02762929|64930179|FG003|Overall Study|Adverse Event|1|||
23324068|NCT02762929|64930180|FG004|Overall Study|Adverse Event|0|||
23324069|NCT02762929|64930181|FG005|Overall Study|Adverse Event|0|||
23324070|NCT02762929|64930176|FG000|Overall Study|Lost to Follow-up|1|||
23324071|NCT02762929|64930177|FG001|Overall Study|Lost to Follow-up|2|||
23324072|NCT02762929|64930178|FG002|Overall Study|Lost to Follow-up|0|||
23324073|NCT02762929|64930179|FG003|Overall Study|Lost to Follow-up|1|||
23324074|NCT02762929|64930180|FG004|Overall Study|Lost to Follow-up|0|||
23324075|NCT02762929|64930181|FG005|Overall Study|Lost to Follow-up|0|||
23324076|NCT02762929|64930176|FG000|Overall Study|Withdrawal by Subject|0|||
23324077|NCT02762929|64930177|FG001|Overall Study|Withdrawal by Subject|1|||
23324078|NCT02762929|64930178|FG002|Overall Study|Withdrawal by Subject|0|||
23324079|NCT02762929|64930179|FG003|Overall Study|Withdrawal by Subject|0|||
23324080|NCT02762929|64930180|FG004|Overall Study|Withdrawal by Subject|0|||
23324081|NCT02762929|64930181|FG005|Overall Study|Withdrawal by Subject|0|||
23324082|NCT02762929|64930176|FG000|Overall Study|exclusionary medication disclosed late|0|||
23324083|NCT02762929|64930177|FG001|Overall Study|exclusionary medication disclosed late|0|||
23324084|NCT02762929|64930178|FG002|Overall Study|exclusionary medication disclosed late|0|||
23324085|NCT02762929|64930179|FG003|Overall Study|exclusionary medication disclosed late|1|||
23324086|NCT02762929|64930180|FG004|Overall Study|exclusionary medication disclosed late|0|||
23324087|NCT02762929|64930181|FG005|Overall Study|exclusionary medication disclosed late|0|||
23324088|NCT02232984|64930186|FG000|Overall Study|Withdrawal by Subject|5|||
23324089|NCT02232984|64930186|FG000|Overall Study|Death|1|||
23324090|NCT02232984|64930186|FG000|Overall Study|Investigator withdrawal|10|||
23324091|NCT02232984|64930186|FG000|Overall Study|Device implant unsuccessful|53|||
23324092|NCT02232984|64930186|FG000|Overall Study|not disclosed by site|7|||
23324093|NCT02232984|64930186|FG000|Overall Study|Protocol Violation|1|||
23324094|NCT03093259|64930187|FG000|Overall Study|Adverse Event|1|||
23324095|NCT03093259|64930188|FG001|Overall Study|Adverse Event|0|||
23324096|NCT03093259|64930187|FG000|Overall Study|Withdrawal by Subject|1|||
23324097|NCT03093259|64930188|FG001|Overall Study|Withdrawal by Subject|0|||
23324098|NCT04263311|64930191|FG000|Overall Study|Lost to Follow-up|1|||
23324099|NCT04263311|64930192|FG001|Overall Study|Lost to Follow-up|2|||
23324100|NCT04263311|64930191|FG000|Overall Study|Health Issues|1|||
23324101|NCT04263311|64930192|FG001|Overall Study|Health Issues|0|||
23324102|NCT04263311|64930191|FG000|Overall Study|Left the country|1|||
23324103|NCT04263311|64930192|FG001|Overall Study|Left the country|0|||
23324104|NCT04263311|64930191|FG000|Overall Study|Unable to maintain time commitment|1|||
23324105|NCT04263311|64930192|FG001|Overall Study|Unable to maintain time commitment|0|||
23324106|NCT04263311|64930191|FG000|Overall Study|No longer interested|1|||
23324107|NCT04263311|64930192|FG001|Overall Study|No longer interested|0|||
23324108|NCT01812109|64930193|FG000|Overall Study|research personnel delay|16|||
23324109|NCT01812109|64930193|FG000|Overall Study|NIRS Unattainable|17|||
23324110|NCT02968576|64930196|FG000|Overall Study|Pregnancy|0|||
23324111|NCT02968576|64930197|FG001|Overall Study|Pregnancy|1|||
23324112|NCT00725491|64930198|FG000|Overall Study|Adverse Event|3|||
23324113|NCT00725491|64930199|FG001|Overall Study|Adverse Event|2|||
23324114|NCT00725491|64930198|FG000|Overall Study|Pregnancy|0|||
23324115|NCT00725491|64930199|FG001|Overall Study|Pregnancy|3|||
23324116|NCT00725491|64930198|FG000|Overall Study|Risk for hyperstimulation|2|||
23324117|NCT00725491|64930199|FG001|Overall Study|Risk for hyperstimulation|9|||
23324118|NCT00725491|64930198|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
23324119|NCT00725491|64930199|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
23324120|NCT00725491|64930198|FG000|Overall Study|Fertilization failure|0|||
23324121|NCT00725491|64930199|FG001|Overall Study|Fertilization failure|1|||
23324122|NCT00725491|64930198|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
23150133|NCT00800683|64301767|FG001|Overall Study|Other|2|||
23150134|NCT00752622|64301769|FG000|Induction Phase|Adverse Event|3|||
23150135|NCT00752622|64301769|FG000|Induction Phase|Other|3|||
23150136|NCT00752622|64301769|FG000|Induction Phase|Non-responder|14|||
23324123|NCT00725491|64930199|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
23324124|NCT04123405|64930206|FG000|Overall Study|Adverse Event|1|||
23324125|NCT04123405|64930207|FG001|Overall Study|Adverse Event|2|||
23324126|NCT04123405|64930208|FG002|Overall Study|Adverse Event|3|||
23324127|NCT04123405|64930209|FG003|Overall Study|Adverse Event|3|||
23324128|NCT04123405|64930206|FG000|Overall Study|Exclusion criteria met|1|||
23324129|NCT04123405|64930207|FG001|Overall Study|Exclusion criteria met|2|||
23324130|NCT04123405|64930208|FG002|Overall Study|Exclusion criteria met|0|||
23324131|NCT04123405|64930209|FG003|Overall Study|Exclusion criteria met|2|||
23324132|NCT04123405|64930206|FG000|Overall Study|Withdrawal by Subject|1|||
23324133|NCT04123405|64930207|FG001|Overall Study|Withdrawal by Subject|3|||
23324134|NCT04123405|64930208|FG002|Overall Study|Withdrawal by Subject|0|||
23324135|NCT04123405|64930209|FG003|Overall Study|Withdrawal by Subject|2|||
23324136|NCT04123405|64930206|FG000|Overall Study|Contact to subject lost|0|||
23324137|NCT04123405|64930207|FG001|Overall Study|Contact to subject lost|0|||
23324138|NCT04123405|64930208|FG002|Overall Study|Contact to subject lost|0|||
23324139|NCT04123405|64930209|FG003|Overall Study|Contact to subject lost|1|||
23324140|NCT04123405|64930206|FG000|Overall Study|screening failure|1|||
23324141|NCT04123405|64930207|FG001|Overall Study|screening failure|0|||
23324142|NCT04123405|64930208|FG002|Overall Study|screening failure|0|||
23324143|NCT04123405|64930209|FG003|Overall Study|screening failure|0|||
23324144|NCT01062425|64930210|FG000|Overall Study|Protocol Violation|3|||
23324145|NCT01062425|64930211|FG001|Overall Study|Protocol Violation|6|||
23324146|NCT00365794|64930212|FG000|Overall Study|Withdrawal by Subject|2|||
23324147|NCT01006122|64930215|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
23324148|NCT01006122|64930216|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
23324149|NCT01006122|64930215|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
23324150|NCT01006122|64930216|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
23324151|NCT01006122|64930215|FG000|First Double-blind Intervention Period|Pregnancy|0|||
23324152|NCT01006122|64930216|FG001|First Double-blind Intervention Period|Pregnancy|1|||
23324153|NCT01006122|64930215|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
23324154|NCT01006122|64930216|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
23438045|NCT01223183|65348457|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
23438046|NCT01223183|65348456|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
23438047|NCT01223183|65348457|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
23438048|NCT00847197|65348462|FG000|Overall Study|Adverse Event|21|||
23438049|NCT00847197|65348463|FG001|Overall Study|Adverse Event|3|||
23438050|NCT00847197|65348462|FG000|Overall Study|Protocol Violation|0|||
23438051|NCT00847197|65348463|FG001|Overall Study|Protocol Violation|1|||
23438052|NCT00847197|65348462|FG000|Overall Study|Withdrawal by Subject|3|||
23438053|NCT00847197|65348463|FG001|Overall Study|Withdrawal by Subject|1|||
23438054|NCT00465647|65348464|FG000|Overall Study|Administrative|2|||
23438055|NCT00465647|65348465|FG001|Overall Study|Administrative|2|||
23438056|NCT00465647|65348466|FG002|Overall Study|Administrative|3|||
23438057|NCT00465647|65348467|FG003|Overall Study|Administrative|2|||
23438058|NCT00465647|65348464|FG000|Overall Study|Adverse Event|2|||
23438059|NCT00465647|65348465|FG001|Overall Study|Adverse Event|0|||
23438060|NCT00465647|65348466|FG002|Overall Study|Adverse Event|3|||
23438061|NCT00465647|65348467|FG003|Overall Study|Adverse Event|2|||
23438062|NCT00465647|65348464|FG000|Overall Study|Withdrawal by Subject|1|||
23438063|NCT00465647|65348465|FG001|Overall Study|Withdrawal by Subject|2|||
23438064|NCT00465647|65348466|FG002|Overall Study|Withdrawal by Subject|2|||
23438065|NCT00465647|65348467|FG003|Overall Study|Withdrawal by Subject|7|||
23438066|NCT00465647|65348464|FG000|Overall Study|"The other reasons included loss of IV"|8|||
23438067|NCT00465647|65348465|FG001|Overall Study|"The other reasons included loss of IV"|4|||
23438068|NCT00465647|65348466|FG002|Overall Study|"The other reasons included loss of IV"|3|||
23438069|NCT00465647|65348467|FG003|Overall Study|"The other reasons included loss of IV"|2|||
23438070|NCT02578186|65348468|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
23438071|NCT02578186|65348469|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
23438072|NCT02578186|65348468|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
23438073|NCT02578186|65348469|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
23438074|NCT00106353|65348470|FG000|Part 1|Disease progression|3|||
23438075|NCT00106353|65348471|FG001|Part 1|Disease progression|4|||
23438076|NCT00106353|65348472|FG002|Part 1|Disease progression|1|||
23438077|NCT00106353|65348473|FG003|Part 1|Disease progression|3|||
23438078|NCT00106353|65348474|FG004|Part 1|Disease progression|0|||
23438079|NCT00106353|65348475|FG005|Part 1|Disease progression|0|||
23438080|NCT00106353|65348476|FG006|Part 1|Disease progression|0|||
23150137|NCT00752622|64301769|FG000|Induction Phase|Withdrawal by Subject|1|||
23438081|NCT00106353|65348470|FG000|Part 1|Withdrawal by Subject|0|||
23438082|NCT00106353|65348471|FG001|Part 1|Withdrawal by Subject|0|||
23438083|NCT00106353|65348472|FG002|Part 1|Withdrawal by Subject|1|||
23438084|NCT00106353|65348473|FG003|Part 1|Withdrawal by Subject|2|||
23150138|NCT00752622|64301769|FG000|Induction Phase|Premature study termination|14|||
23150139|NCT00752622|64301769|FG000|Observational Phase|Premature Study Termination|36|||
23324155|NCT01006122|64930215|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
23324156|NCT01006122|64930216|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
23324157|NCT01006122|64930215|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
23438085|NCT00106353|65348474|FG004|Part 1|Withdrawal by Subject|0|||
23438086|NCT00106353|65348475|FG005|Part 1|Withdrawal by Subject|0|||
23438087|NCT00106353|65348476|FG006|Part 1|Withdrawal by Subject|0|||
23438088|NCT00106353|65348470|FG000|Part 1|Symptomatic deterioration|0|||
23438089|NCT00106353|65348471|FG001|Part 1|Symptomatic deterioration|0|||
23438090|NCT00106353|65348472|FG002|Part 1|Symptomatic deterioration|1|||
23438091|NCT00106353|65348473|FG003|Part 1|Symptomatic deterioration|0|||
23438092|NCT00106353|65348474|FG004|Part 1|Symptomatic deterioration|0|||
23438093|NCT00106353|65348475|FG005|Part 1|Symptomatic deterioration|0|||
23438094|NCT00106353|65348476|FG006|Part 1|Symptomatic deterioration|0|||
23150140|NCT00752622|64301769|FG000|Observational Phase|Non-responder|2|||
23150141|NCT00752622|64301769|FG000|Observational Phase|Withdrawal by Subject|2|||
23150142|NCT00752622|64301769|FG000|Observational Phase|Adverse Event|1|||
23150143|NCT00752622|64301769|FG000|Observational Phase|Other|2|||
23150144|NCT00752622|64301769|FG000|Interventional Phase|Non-responder|2|||
23150145|NCT00752622|64301769|FG000|Interventional Phase|Physician Decision|1|||
23150146|NCT00752622|64301769|FG000|Interventional Phase|Premature Study Termination|5|||
23150147|NCT00108069|64301770|FG000|Overall Study|Never rec'd study drug|0|||
23150148|NCT00108069|64301771|FG001|Overall Study|Never rec'd study drug|1|||
23150149|NCT00108069|64301770|FG000|Overall Study|Adverse Event|1|||
23150150|NCT00108069|64301771|FG001|Overall Study|Adverse Event|1|||
23150151|NCT00108069|64301770|FG000|Overall Study|Withdrawal by Subject|1|||
23150152|NCT00108069|64301771|FG001|Overall Study|Withdrawal by Subject|0|||
23150153|NCT00108069|64301770|FG000|Overall Study|Death|1|||
23150154|NCT00108069|64301771|FG001|Overall Study|Death|0|||
23150155|NCT00108069|64301770|FG000|Overall Study|Progessive disease|27|||
23150156|NCT00108069|64301771|FG001|Overall Study|Progessive disease|11|||
23150157|NCT01028222|64301790|FG000|Overall Study|Protocol deviation|1|||
23150158|NCT01028222|64301791|FG001|Overall Study|Protocol deviation|0|||
23150159|NCT01028222|64301790|FG000|Overall Study|Disease progression|33|||
23150160|NCT01028222|64301791|FG001|Overall Study|Disease progression|9|||
23150161|NCT01028222|64301790|FG000|Overall Study|Administrative problems|1|||
23150162|NCT01028222|64301791|FG001|Overall Study|Administrative problems|1|||
23150163|NCT01028222|64301790|FG000|Overall Study|Lost to Follow-up|0|||
23150164|NCT01028222|64301791|FG001|Overall Study|Lost to Follow-up|1|||
23150165|NCT01028222|64301790|FG000|Overall Study|Withdrawal by Subject|1|||
23150166|NCT01028222|64301791|FG001|Overall Study|Withdrawal by Subject|0|||
23150167|NCT01028222|64301790|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
23150168|NCT01028222|64301791|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
23150169|NCT01028222|64301790|FG000|Overall Study|Adverse Event|2|||
23150170|NCT01028222|64301791|FG001|Overall Study|Adverse Event|0|||
23150171|NCT04880447|64301792|FG000|Overall Study|No vaccination information|1|||
23150172|NCT04880447|64301792|FG000|Overall Study|No adverse event information (missing information)|1|||
23150173|NCT04880447|64301792|FG000|Overall Study|Disease not covered in this study|35|||
23150174|NCT03044886|64301793|FG000|Overall Study|Lost to Follow-up|15|||
23150175|NCT03044886|64301794|FG001|Overall Study|Lost to Follow-up|10|||
23150176|NCT03044886|64301795|FG002|Overall Study|Lost to Follow-up|12|||
23150177|NCT02593786|64301796|FG000|Overall Study|Disease progression|12|||
23150178|NCT02593786|64301797|FG001|Overall Study|Disease progression|16|||
23150179|NCT02593786|64301798|FG002|Overall Study|Disease progression|10|||
23150180|NCT02593786|64301799|FG003|Overall Study|Disease progression|7|||
23150181|NCT02593786|64301796|FG000|Overall Study|Study drug toxicity|1|||
23150182|NCT02593786|64301797|FG001|Overall Study|Study drug toxicity|0|||
23150183|NCT02593786|64301798|FG002|Overall Study|Study drug toxicity|0|||
23150184|NCT02593786|64301799|FG003|Overall Study|Study drug toxicity|0|||
23150185|NCT02593786|64301796|FG000|Overall Study|Adverse event unrelated to study drug|1|||
23150186|NCT02593786|64301797|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23150187|NCT02593786|64301798|FG002|Overall Study|Adverse event unrelated to study drug|1|||
23150188|NCT02593786|64301799|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23150189|NCT02593786|64301796|FG000|Overall Study|Participant request to discontinue study therapy|0|||
23150190|NCT02593786|64301797|FG001|Overall Study|Participant request to discontinue study therapy|2|||
23150191|NCT02593786|64301798|FG002|Overall Study|Participant request to discontinue study therapy|0|||
23150192|NCT02593786|64301799|FG003|Overall Study|Participant request to discontinue study therapy|0|||
23438095|NCT00106353|65348470|FG000|Part 1|Entered follow-up phase|1|||
23438096|NCT00106353|65348471|FG001|Part 1|Entered follow-up phase|1|||
23438097|NCT00106353|65348472|FG002|Part 1|Entered follow-up phase|0|||
23150193|NCT02593786|64301796|FG000|Overall Study|Other reasons|1|||
23150194|NCT02593786|64301797|FG001|Overall Study|Other reasons|1|||
23150195|NCT02593786|64301798|FG002|Overall Study|Other reasons|0|||
23150196|NCT02593786|64301799|FG003|Overall Study|Other reasons|5|||
23150197|NCT00059839|64301800|FG000|Overall Study|Death|1|||
23150198|NCT00059839|64301801|FG001|Overall Study|Death|1|||
23150199|NCT00059839|64301800|FG000|Overall Study|Lack of Efficacy|6|||
23150200|NCT00059839|64301801|FG001|Overall Study|Lack of Efficacy|5|||
23150201|NCT00059839|64301800|FG000|Overall Study|Lost to Follow-up|2|||
23438098|NCT00106353|65348473|FG003|Part 1|Entered follow-up phase|1|||
23438099|NCT00106353|65348474|FG004|Part 1|Entered follow-up phase|0|||
23324158|NCT01006122|64930216|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
23324159|NCT01006122|64930215|FG000|First Double-blind Intervention Period|Other|3|||
23324160|NCT01006122|64930216|FG001|First Double-blind Intervention Period|Other|0|||
23324161|NCT01006122|64930215|FG000|First Double-blind Intervention Period|Adverse Event|0|||
23324162|NCT01006122|64930216|FG001|First Double-blind Intervention Period|Adverse Event|4|||
23324163|NCT01006122|64930215|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
23324164|NCT01006122|64930216|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
23324165|NCT01006122|64930215|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
23324166|NCT01006122|64930216|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
23324167|NCT01006122|64930215|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
23324168|NCT01006122|64930216|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
23324169|NCT01006122|64930215|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
23324170|NCT01006122|64930216|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
23324171|NCT01006122|64930215|FG000|Second Double-blind Intervention Period|Death|0|||
23324172|NCT01006122|64930216|FG001|Second Double-blind Intervention Period|Death|1|||
23324173|NCT00967330|64930219|FG000|Overall Study|Protocol Violation|3|||
23324174|NCT00967330|64930220|FG001|Overall Study|Protocol Violation|4|||
23324175|NCT00967330|64930219|FG000|Overall Study|Regular|10|||
23324176|NCT00967330|64930220|FG001|Overall Study|Regular|3|||
23324177|NCT00967330|64930219|FG000|Overall Study|Withdrawal by Subject|6|||
23324178|NCT00967330|64930220|FG001|Overall Study|Withdrawal by Subject|0|||
23324179|NCT00967330|64930219|FG000|Overall Study|Lost to Follow-up|1|||
23324180|NCT00967330|64930220|FG001|Overall Study|Lost to Follow-up|1|||
23324181|NCT00967330|64930219|FG000|Overall Study|Death|102|||
23324182|NCT00967330|64930220|FG001|Overall Study|Death|51|||
23324183|NCT00967330|64930219|FG000|Overall Study|Severe protocol deviation|0|||
23324184|NCT00967330|64930220|FG001|Overall Study|Severe protocol deviation|1|||
23324185|NCT01977417|64930221|FG000|Overall Study|Adverse Event|1|||
23324186|NCT01977417|64930222|FG001|Overall Study|Adverse Event|0|||
23324187|NCT01977417|64930221|FG000|Overall Study|Withdrawal by Subject|2|||
23324188|NCT01977417|64930222|FG001|Overall Study|Withdrawal by Subject|4|||
23324189|NCT01977417|64930221|FG000|Overall Study|Female enrollment goal met|0|||
23324190|NCT01977417|64930222|FG001|Overall Study|Female enrollment goal met|2|||
23324191|NCT01895777|64930223|FG000|Overall Study|Adverse Event|1|||
23324192|NCT01895777|64930224|FG001|Overall Study|Adverse Event|2|||
23324193|NCT01895777|64930223|FG000|Overall Study|Lost to Follow-up|2|||
23324194|NCT01895777|64930224|FG001|Overall Study|Lost to Follow-up|0|||
23324195|NCT01895777|64930223|FG000|Overall Study|Not treated|1|||
23324196|NCT01895777|64930224|FG001|Overall Study|Not treated|0|||
23324197|NCT01895777|64930223|FG000|Overall Study|Other reasons|3|||
23324198|NCT01895777|64930224|FG001|Overall Study|Other reasons|2|||
23324199|NCT01895777|64930223|FG000|Overall Study|Non-compliance with the CTP|2|||
23324200|NCT01895777|64930224|FG001|Overall Study|Non-compliance with the CTP|1|||
23324201|NCT02654054|64930225|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
23324202|NCT02654054|64930226|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
23324203|NCT02654054|64930227|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
23324204|NCT02654054|64930225|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
23324205|NCT02654054|64930226|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23324206|NCT02654054|64930227|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
23324207|NCT02654054|64930225|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
23324208|NCT02654054|64930226|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
23324209|NCT02654054|64930227|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
23324210|NCT02654054|64930225|FG000|Post-Treatment Follow-Up Period|Other|1|||
23324211|NCT02654054|64930226|FG001|Post-Treatment Follow-Up Period|Other|0|||
23324212|NCT02654054|64930227|FG002|Post-Treatment Follow-Up Period|Other|4|||
23324213|NCT02654054|64930225|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23324214|NCT02654054|64930226|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23324215|NCT02654054|64930227|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
23324216|NCT00235755|64930228|FG000|4-Week Titration Phase|Adverse Event|6|||
23324217|NCT00235755|64930229|FG001|4-Week Titration Phase|Adverse Event|14|||
23324218|NCT00235755|64930230|FG002|4-Week Titration Phase|Adverse Event|20|||
23324219|NCT00235755|64930228|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
23324220|NCT00235755|64930229|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
23324221|NCT00235755|64930230|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
23324222|NCT00235755|64930228|FG000|4-Week Titration Phase|Protocol Violation|2|||
23324223|NCT00235755|64930229|FG001|4-Week Titration Phase|Protocol Violation|2|||
23324224|NCT00235755|64930230|FG002|4-Week Titration Phase|Protocol Violation|1|||
23324225|NCT00235755|64930228|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
23324226|NCT00235755|64930229|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
23324227|NCT00235755|64930230|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
23324228|NCT00235755|64930228|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
23324229|NCT00235755|64930229|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
23324230|NCT00235755|64930230|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
23324231|NCT00235755|64930228|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
23324232|NCT00235755|64930229|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
23324233|NCT00235755|64930230|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
23324234|NCT00235755|64930228|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
23324235|NCT00235755|64930229|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
23324236|NCT00235755|64930230|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
23324237|NCT00235755|64930228|FG000|12-Week Maintenance Phase|Adverse Event|8|||
23324238|NCT00235755|64930229|FG001|12-Week Maintenance Phase|Adverse Event|12|||
23324239|NCT00235755|64930230|FG002|12-Week Maintenance Phase|Adverse Event|26|||
23324240|NCT00235755|64930228|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
23324241|NCT00235755|64930229|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
23324242|NCT00235755|64930230|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
23324243|NCT00235755|64930228|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
23324244|NCT00235755|64930229|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
23324245|NCT00235755|64930230|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
23324246|NCT00235755|64930228|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
23324247|NCT00235755|64930229|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
23324248|NCT00235755|64930230|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
23324249|NCT00235755|64930228|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
23324250|NCT00235755|64930229|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
23324251|NCT00235755|64930230|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
23624806|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
23324252|NCT00235755|64930228|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
23324253|NCT00235755|64930229|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
23324254|NCT00235755|64930230|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
23324255|NCT03657797|64930232|FG000|Overall Study|Lost to Follow-up|0|||
23324256|NCT03657797|64930233|FG001|Overall Study|Lost to Follow-up|1|||
23324257|NCT03657797|64930234|FG002|Overall Study|Lost to Follow-up|1|||
23324258|NCT03657797|64930235|FG003|Overall Study|Lost to Follow-up|0|||
23324259|NCT03657797|64930232|FG000|Overall Study|Physician Decision|0|||
23324260|NCT03657797|64930233|FG001|Overall Study|Physician Decision|1|||
23324261|NCT03657797|64930234|FG002|Overall Study|Physician Decision|0|||
23324262|NCT03657797|64930235|FG003|Overall Study|Physician Decision|0|||
23324263|NCT03657797|64930232|FG000|Overall Study|Withdrawal by Subject|0|||
23324264|NCT03657797|64930233|FG001|Overall Study|Withdrawal by Subject|1|||
23324265|NCT03657797|64930234|FG002|Overall Study|Withdrawal by Subject|2|||
23324266|NCT03657797|64930235|FG003|Overall Study|Withdrawal by Subject|0|||
23324267|NCT03657797|64930232|FG000|Overall Study|Adverse Event|0|||
23324268|NCT03657797|64930233|FG001|Overall Study|Adverse Event|0|||
23324269|NCT03657797|64930234|FG002|Overall Study|Adverse Event|2|||
23324270|NCT03657797|64930235|FG003|Overall Study|Adverse Event|0|||
23324271|NCT01707290|64930236|FG000|Overall Study|Adverse event (AE)|1|||
23324272|NCT01707290|64930237|FG001|Overall Study|Adverse event (AE)|0|||
23324273|NCT01707290|64930236|FG000|Overall Study|Physician Decision|1|||
23324274|NCT01707290|64930237|FG001|Overall Study|Physician Decision|0|||
23324275|NCT01707290|64930236|FG000|Overall Study|Lost to Follow-up|3|||
23324276|NCT01707290|64930237|FG001|Overall Study|Lost to Follow-up|0|||
23324277|NCT01707290|64930236|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
23324278|NCT01707290|64930237|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
23324279|NCT01707290|64930236|FG000|Overall Study|Commercial drug available|60|||
23324280|NCT01707290|64930237|FG001|Overall Study|Commercial drug available|1|||
23324281|NCT01707290|64930236|FG000|Overall Study|Other unspecified|17|||
23324282|NCT01707290|64930237|FG001|Overall Study|Other unspecified|0|||
23324283|NCT03871543|64930240|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
23324284|NCT03871543|64930240|FG000|Period 1|Investigator Error|1|||
23324285|NCT03871543|64930240|FG000|Period 1|Protocol Violation|2|||
23324286|NCT03871543|64930240|FG000|Period 1|COVID-19 Related|1|||
23324287|NCT03871543|64930240|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
23324288|NCT03871543|64930240|FG000|Period 1|Withdrawal by Subject|10|||
23324289|NCT03871543|64930240|FG000|Period 2|Adverse Event|1|||
23324290|NCT03871543|64930240|FG000|Period 2|Withdrawal by Subject|1|||
23324291|NCT02235454|64930241|FG000|Overall Study|Withdrawal by Subject|2|||
23324292|NCT03500198|64930242|FG000|Overall Study|Lost to Follow-up|0|||
23438100|NCT00106353|65348475|FG005|Part 1|Entered follow-up phase|0|||
23324293|NCT03500198|64930243|FG001|Overall Study|Lost to Follow-up|1|||
23324294|NCT00266630|64930246|FG000|Overall Study|Adverse Event|8|||
23438101|NCT00106353|65348476|FG006|Part 1|Entered follow-up phase|0|||
23438102|NCT00106353|65348470|FG000|Part 1|Adverse Event|0|||
23150202|NCT00059839|64301801|FG001|Overall Study|Lost to Follow-up|0|||
23324295|NCT00266630|64930247|FG001|Overall Study|Adverse Event|6|||
23324296|NCT00266630|64930246|FG000|Overall Study|Lack of Efficacy|1|||
23324297|NCT00266630|64930247|FG001|Overall Study|Lack of Efficacy|4|||
23324298|NCT00266630|64930246|FG000|Overall Study|Entry Criteria not met|1|||
23324299|NCT00266630|64930247|FG001|Overall Study|Entry Criteria not met|0|||
23324300|NCT00266630|64930246|FG000|Overall Study|Protocol Violation|1|||
23324301|NCT00266630|64930247|FG001|Overall Study|Protocol Violation|3|||
23324302|NCT00266630|64930246|FG000|Overall Study|Physician Decision|1|||
23324303|NCT00266630|64930247|FG001|Overall Study|Physician Decision|2|||
23324304|NCT00266630|64930246|FG000|Overall Study|Withdrawal by Subject|10|||
23324305|NCT00266630|64930247|FG001|Overall Study|Withdrawal by Subject|2|||
23324306|NCT00266630|64930246|FG000|Overall Study|Lost to Follow-up|1|||
23324307|NCT00266630|64930247|FG001|Overall Study|Lost to Follow-up|0|||
23324308|NCT00266630|64930246|FG000|Overall Study|Other|19|||
23324309|NCT00266630|64930247|FG001|Overall Study|Other|11|||
23324310|NCT00654095|64930248|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
23324311|NCT00654095|64930248|FG000|Overall Study|Elevated triglyceride level (2)|1|||
23324312|NCT00654095|64930248|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
23324313|NCT00654095|64930248|FG000|Overall Study|Adverse Event|11|||
23324314|NCT00654095|64930248|FG000|Overall Study|Withdrawal by Subject|5|||
23324315|NCT00654095|64930248|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
23324316|NCT00654095|64930248|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
23324317|NCT00654095|64930248|FG000|Overall Study|Did not meet inclusion criteria|1|||
23324318|NCT00765102|64930255|FG000|Overall Study|Progressive disease|18|||
23324319|NCT00765102|64930255|FG000|Overall Study|Adverse Event|6|||
23324320|NCT00765102|64930255|FG000|Overall Study|Physician Decision|4|||
23324321|NCT00765102|64930255|FG000|Overall Study|Withdrawal by Subject|2|||
23324322|NCT00765102|64930255|FG000|Overall Study|Protocol Violation|1|||
23324323|NCT02324582|64930256|FG000|Overall Study|Screen Failures|0|||
23324324|NCT02324582|64930257|FG001|Overall Study|Screen Failures|5|||
23324325|NCT02115269|64930260|FG000|Overall Study|Lost to Follow-up|43|||
23324326|NCT02115269|64930260|FG000|Overall Study|Did not complete patient diary|3|||
23324327|NCT02115269|64930260|FG000|Overall Study|Moved to another city|7|||
23324328|NCT02115269|64930260|FG000|Overall Study|Withdrawal by Subject|2|||
23324329|NCT02115269|64930260|FG000|Overall Study|Didn't take study drug|2|||
23324330|NCT03351608|64930263|FG000|Overall Study|Lost to Follow-up|0|||
23324331|NCT03351608|64930264|FG001|Overall Study|Lost to Follow-up|1|||
23324332|NCT03351608|64930265|FG002|Overall Study|Lost to Follow-up|1|||
23324333|NCT03351608|64930266|FG003|Overall Study|Lost to Follow-up|1|||
23324334|NCT03351608|64930267|FG004|Overall Study|Lost to Follow-up|1|||
23150203|NCT00059839|64301800|FG000|Overall Study|Physician Decision|1|||
23150204|NCT00059839|64301801|FG001|Overall Study|Physician Decision|2|||
23150205|NCT00059839|64301800|FG000|Overall Study|Withdrawal by Subject|1|||
23150206|NCT00059839|64301801|FG001|Overall Study|Withdrawal by Subject|6|||
23150207|NCT00059839|64301800|FG000|Overall Study|Ineligible|1|||
23150208|NCT00059839|64301801|FG001|Overall Study|Ineligible|3|||
23150209|NCT00975715|64301802|FG000|Titration Period|Adverse Event|6|||
23150210|NCT00975715|64301803|FG001|Titration Period|Adverse Event|0|||
23150211|NCT00975715|64301802|FG000|Titration Period|Protocol Violation|1|||
23150212|NCT00975715|64301803|FG001|Titration Period|Protocol Violation|0|||
23150213|NCT00975715|64301802|FG000|Maintenance Period|Adverse Event|2|||
23150214|NCT00975715|64301803|FG001|Maintenance Period|Adverse Event|1|||
23150215|NCT01641809|64301806|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
23150216|NCT01641809|64301807|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
23150217|NCT01641809|64301808|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
23150218|NCT01641809|64301809|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
23150219|NCT01641809|64301806|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
23150220|NCT01641809|64301807|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
23150221|NCT01641809|64301808|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
23150222|NCT01641809|64301809|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
23150223|NCT01641809|64301806|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
23150224|NCT01641809|64301807|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
23150225|NCT01641809|64301808|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
23150226|NCT01641809|64301809|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
23150227|NCT01641809|64301806|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
23150228|NCT01641809|64301807|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
23150229|NCT01641809|64301808|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
23150230|NCT01641809|64301809|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
23150231|NCT01641809|64301806|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
23150232|NCT01641809|64301807|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
23150233|NCT01641809|64301808|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
23150234|NCT01641809|64301809|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
23150235|NCT01641809|64301806|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
23324335|NCT03351608|64930263|FG000|Overall Study|Physician Decision|1|||
23324336|NCT03351608|64930264|FG001|Overall Study|Physician Decision|0|||
23324337|NCT03351608|64930265|FG002|Overall Study|Physician Decision|0|||
23324338|NCT03351608|64930266|FG003|Overall Study|Physician Decision|2|||
23324339|NCT03351608|64930267|FG004|Overall Study|Physician Decision|1|||
23324340|NCT03351608|64930263|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
23150236|NCT01641809|64301807|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
23150237|NCT01641809|64301808|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
23150238|NCT01641809|64301809|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
23150239|NCT01641809|64301806|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
23150240|NCT01641809|64301807|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
23150241|NCT01641809|64301808|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
23150242|NCT01641809|64301809|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
23324341|NCT03351608|64930264|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
23560649|NCT01493687|65782360|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
23324342|NCT03351608|64930265|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
23324343|NCT03351608|64930266|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
23324344|NCT03351608|64930267|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
23324345|NCT03351608|64930263|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23324346|NCT03351608|64930264|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23324347|NCT03351608|64930265|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23324348|NCT03351608|64930266|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23150243|NCT01641809|64301806|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
23150244|NCT01641809|64301807|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
23150245|NCT01641809|64301808|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
23150246|NCT01641809|64301809|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
23150247|NCT01641809|64301806|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
23324349|NCT03351608|64930267|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23324350|NCT03351608|64930263|FG000|Overall Study|Other|0|||
23324351|NCT03351608|64930264|FG001|Overall Study|Other|1|||
23438103|NCT00106353|65348471|FG001|Part 1|Adverse Event|0|||
23438104|NCT00106353|65348472|FG002|Part 1|Adverse Event|0|||
23438105|NCT00106353|65348473|FG003|Part 1|Adverse Event|1|||
23560650|NCT01493687|65782361|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
23560651|NCT01493687|65782360|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
23560652|NCT01493687|65782361|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
23438106|NCT00106353|65348474|FG004|Part 1|Adverse Event|0|||
23438107|NCT00106353|65348475|FG005|Part 1|Adverse Event|0|||
23438108|NCT00106353|65348476|FG006|Part 1|Adverse Event|0|||
23438109|NCT00106353|65348470|FG000|Part 2|Disease progression|0|||
23438110|NCT00106353|65348471|FG001|Part 2|Disease progression|0|||
23438111|NCT00106353|65348472|FG002|Part 2|Disease progression|0|||
23438112|NCT00106353|65348473|FG003|Part 2|Disease progression|0|||
23438113|NCT00106353|65348474|FG004|Part 2|Disease progression|8|||
23438114|NCT00106353|65348475|FG005|Part 2|Disease progression|14|||
23560653|NCT01376323|65782362|FG000|Overall Study|Adverse Event|1|||
23560654|NCT01376323|65782363|FG001|Overall Study|Adverse Event|0|||
23560655|NCT01376323|65782364|FG002|Overall Study|Adverse Event|0|||
23560656|NCT01376323|65782365|FG003|Overall Study|Adverse Event|2|||
23560657|NCT01376323|65782366|FG004|Overall Study|Adverse Event|0|||
23560658|NCT01376323|65782362|FG000|Overall Study|Lost to Follow-up|0|||
23560659|NCT01376323|65782363|FG001|Overall Study|Lost to Follow-up|0|||
23150248|NCT01641809|64301807|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
23150249|NCT01641809|64301808|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
23150250|NCT01641809|64301809|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
23150251|NCT01641809|64301806|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
23150252|NCT01641809|64301807|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
23150253|NCT01641809|64301808|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
23150254|NCT01641809|64301809|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
23150255|NCT01641809|64301806|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
23150256|NCT01641809|64301807|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
23150257|NCT01641809|64301808|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
23150258|NCT01641809|64301809|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
23150259|NCT01641809|64301806|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
23150260|NCT01641809|64301807|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
23324352|NCT03351608|64930265|FG002|Overall Study|Other|1|||
23324353|NCT03351608|64930266|FG003|Overall Study|Other|3|||
23324354|NCT03351608|64930267|FG004|Overall Study|Other|0|||
23324355|NCT02969382|64930275|FG000|Overall Study|Adverse Event|8|||
23324356|NCT02969382|64930276|FG001|Overall Study|Adverse Event|10|||
23324357|NCT02969382|64930275|FG000|Overall Study|Lack of Efficacy|4|||
23438115|NCT00106353|65348476|FG006|Part 2|Disease progression|13|||
23438116|NCT00106353|65348470|FG000|Part 2|Death|0|||
23438117|NCT00106353|65348471|FG001|Part 2|Death|0|||
23438118|NCT00106353|65348472|FG002|Part 2|Death|0|||
23438119|NCT00106353|65348473|FG003|Part 2|Death|0|||
23438120|NCT00106353|65348474|FG004|Part 2|Death|3|||
23438121|NCT00106353|65348475|FG005|Part 2|Death|0|||
23560660|NCT01376323|65782364|FG002|Overall Study|Lost to Follow-up|0|||
23560661|NCT01376323|65782365|FG003|Overall Study|Lost to Follow-up|2|||
23219581|NCT04153929|64544921|FG005|Overall Study|Not treated|0|||
23219582|NCT04153929|64544922|FG006|Overall Study|Not treated|1|||
23219583|NCT04153929|64544923|FG007|Overall Study|Not treated|0|||
23219584|NCT00293241|64544925|FG000|Overall Study|Lost to Follow-up|9|||
23219585|NCT00293241|64544926|FG001|Overall Study|Lost to Follow-up|16|||
23219586|NCT00293241|64544925|FG000|Overall Study|Physician Decision|23|||
23219587|NCT00293241|64544926|FG001|Overall Study|Physician Decision|17|||
23219588|NCT00293241|64544925|FG000|Overall Study|Withdrawal by Subject|4|||
23219589|NCT00293241|64544926|FG001|Overall Study|Withdrawal by Subject|8|||
23219590|NCT00291187|64544929|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
23219591|NCT00291187|64544930|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
23324358|NCT02969382|64930276|FG001|Overall Study|Lack of Efficacy|5|||
23324359|NCT02969382|64930275|FG000|Overall Study|Death|0|||
23324360|NCT02969382|64930276|FG001|Overall Study|Death|1|||
23324361|NCT02969382|64930275|FG000|Overall Study|PROTOCOL DEVIATION|0|||
23150261|NCT01641809|64301808|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
23150262|NCT01641809|64301809|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
23150263|NCT01641809|64301806|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
23150264|NCT01641809|64301807|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
23150265|NCT01641809|64301808|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
23150266|NCT01641809|64301809|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
23150267|NCT01641809|64301806|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
23150268|NCT01641809|64301807|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
23150269|NCT01641809|64301808|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
23150270|NCT01641809|64301809|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
23150271|NCT01641809|64301806|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
23150272|NCT01641809|64301807|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
23150273|NCT01641809|64301808|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
23150274|NCT01641809|64301809|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
23150275|NCT01641809|64301806|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
23150276|NCT01641809|64301807|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
23150277|NCT01641809|64301808|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
23150278|NCT01641809|64301809|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
23150279|NCT01641809|64301806|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
23324362|NCT02969382|64930276|FG001|Overall Study|PROTOCOL DEVIATION|1|||
23324363|NCT02969382|64930275|FG000|Overall Study|Withdrawal by Subject|14|||
23324364|NCT02969382|64930276|FG001|Overall Study|Withdrawal by Subject|9|||
23324365|NCT02152137|64930286|FG000|Overall Study|Withdrawal by Subject|1|||
23324366|NCT02152137|64930286|FG000|Overall Study|Originally assigned to Arm B|3|||
23324367|NCT04211831|64930287|FG000|Overall Study|Withdrawal by Subject|4|||
23324368|NCT04211831|64930288|FG001|Overall Study|Withdrawal by Subject|1|||
23324369|NCT04211831|64930289|FG002|Overall Study|Withdrawal by Subject|1|||
23324370|NCT04211831|64930287|FG000|Overall Study|Protocol Violation|0|||
23324371|NCT04211831|64930288|FG001|Overall Study|Protocol Violation|0|||
23324372|NCT04211831|64930289|FG002|Overall Study|Protocol Violation|1|||
23324373|NCT04211831|64930287|FG000|Overall Study|Adverse Event|0|||
23324374|NCT04211831|64930288|FG001|Overall Study|Adverse Event|1|||
23324375|NCT04211831|64930289|FG002|Overall Study|Adverse Event|0|||
23150280|NCT01641809|64301807|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
23150281|NCT01641809|64301808|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
23150282|NCT01641809|64301809|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
23150283|NCT01641809|64301806|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
23150284|NCT01641809|64301807|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
23150285|NCT01641809|64301808|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
23150286|NCT01641809|64301809|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
23150287|NCT03049735|64301810|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
23150288|NCT03049735|64301811|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
23150289|NCT03049735|64301812|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
23150290|NCT03049735|64301810|FG000|Overall Study|Other|5|||
23150291|NCT03049735|64301811|FG001|Overall Study|Other|3|||
23150292|NCT03049735|64301812|FG002|Overall Study|Other|1|||
23324376|NCT04211831|64930287|FG000|Overall Study|Lack of Efficacy|0|||
23624807|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
23150293|NCT03049735|64301810|FG000|Overall Study|Lack of Efficacy|4|||
23150294|NCT03049735|64301811|FG001|Overall Study|Lack of Efficacy|0|||
23150295|NCT03049735|64301812|FG002|Overall Study|Lack of Efficacy|3|||
23150296|NCT03049735|64301810|FG000|Overall Study|Protocol deviation|1|||
23150297|NCT03049735|64301811|FG001|Overall Study|Protocol deviation|0|||
23219592|NCT00291187|64544931|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
23324377|NCT04211831|64930288|FG001|Overall Study|Lack of Efficacy|0|||
23624808|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
23219593|NCT00291187|64544932|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
23219594|NCT01041404|64544937|FG000|Overall Study|Adverse Event|45|||
23324378|NCT04211831|64930289|FG002|Overall Study|Lack of Efficacy|1|||
23324379|NCT04211831|64930287|FG000|Overall Study|Lost to Follow-up|0|||
23324380|NCT04211831|64930288|FG001|Overall Study|Lost to Follow-up|0|||
23438122|NCT00106353|65348476|FG006|Part 2|Death|1|||
23438123|NCT00106353|65348470|FG000|Part 2|Symptomatic deterioration|0|||
23438124|NCT00106353|65348471|FG001|Part 2|Symptomatic deterioration|0|||
23438125|NCT00106353|65348472|FG002|Part 2|Symptomatic deterioration|0|||
23438126|NCT00106353|65348473|FG003|Part 2|Symptomatic deterioration|0|||
23438127|NCT00106353|65348474|FG004|Part 2|Symptomatic deterioration|3|||
23438128|NCT00106353|65348475|FG005|Part 2|Symptomatic deterioration|0|||
23438129|NCT00106353|65348476|FG006|Part 2|Symptomatic deterioration|0|||
23438130|NCT00106353|65348470|FG000|Part 2|Adverse Event|0|||
23438131|NCT00106353|65348471|FG001|Part 2|Adverse Event|0|||
23150298|NCT03049735|64301812|FG002|Overall Study|Protocol deviation|0|||
23150299|NCT03049735|64301810|FG000|Overall Study|Pregnancy|0|||
23150300|NCT03049735|64301811|FG001|Overall Study|Pregnancy|0|||
23150301|NCT03049735|64301812|FG002|Overall Study|Pregnancy|1|||
23150302|NCT03049735|64301810|FG000|Overall Study|Adverse Event|7|||
23150303|NCT03049735|64301811|FG001|Overall Study|Adverse Event|18|||
23438132|NCT00106353|65348472|FG002|Part 2|Adverse Event|0|||
23438133|NCT00106353|65348473|FG003|Part 2|Adverse Event|0|||
23438134|NCT00106353|65348474|FG004|Part 2|Adverse Event|0|||
23438135|NCT00106353|65348475|FG005|Part 2|Adverse Event|2|||
23438136|NCT00106353|65348476|FG006|Part 2|Adverse Event|1|||
23150304|NCT03049735|64301812|FG002|Overall Study|Adverse Event|5|||
23150305|NCT03049735|64301810|FG000|Overall Study|Withdrawal by Subject|10|||
23150306|NCT03049735|64301811|FG001|Overall Study|Withdrawal by Subject|3|||
23150307|NCT03049735|64301812|FG002|Overall Study|Withdrawal by Subject|7|||
23150308|NCT03049735|64301810|FG000|Overall Study|Lost to Follow-up|1|||
23150309|NCT03049735|64301811|FG001|Overall Study|Lost to Follow-up|5|||
23150310|NCT03049735|64301812|FG002|Overall Study|Lost to Follow-up|5|||
23150311|NCT02020863|64301818|FG000|Overall Study|Discovery of Metastatic disease|4|||
23150312|NCT02020863|64301818|FG000|Overall Study|Team chose not to place an a line|1|||
23150313|NCT01873495|64301821|FG000|Overall Study|Withdrawal by Subject|1|||
23150314|NCT01873495|64301821|FG000|Overall Study|Physician Decision|3|||
23150315|NCT01873495|64301821|FG000|Overall Study|Adverse Event|1|||
23150316|NCT01873495|64301821|FG000|Overall Study|Removed for Transplantation|1|||
23150317|NCT01873495|64301821|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
23219595|NCT01041404|64544938|FG001|Overall Study|Adverse Event|35|||
23219596|NCT01041404|64544937|FG000|Overall Study|Lack of Efficacy|200|||
23219597|NCT01041404|64544938|FG001|Overall Study|Lack of Efficacy|210|||
23219598|NCT01041404|64544937|FG000|Overall Study|Violation of Selection Criteria|0|||
23219599|NCT01041404|64544938|FG001|Overall Study|Violation of Selection Criteria|1|||
23219600|NCT01041404|64544937|FG000|Overall Study|Protocol Violation|4|||
23219601|NCT01041404|64544938|FG001|Overall Study|Protocol Violation|0|||
23219602|NCT01041404|64544937|FG000|Overall Study|Withdrawal by Subject|29|||
23219603|NCT01041404|64544938|FG001|Overall Study|Withdrawal by Subject|23|||
23219604|NCT01041404|64544937|FG000|Overall Study|Failure to Return|1|||
23219605|NCT01041404|64544938|FG001|Overall Study|Failure to Return|2|||
23219606|NCT01041404|64544937|FG000|Overall Study|Other|11|||
23219607|NCT01041404|64544938|FG001|Overall Study|Other|23|||
23219608|NCT01849562|64544939|FG000|Overall Study|Lost to Follow-up|1|||
23219609|NCT01849562|64544940|FG001|Overall Study|Lost to Follow-up|0|||
23219610|NCT01849562|64544941|FG002|Overall Study|Lost to Follow-up|0|||
23219611|NCT01849562|64544939|FG000|Overall Study|Non-compliance with Study Drug|1|||
23219612|NCT01849562|64544940|FG001|Overall Study|Non-compliance with Study Drug|0|||
23219613|NCT01849562|64544941|FG002|Overall Study|Non-compliance with Study Drug|0|||
23219614|NCT04498468|64544944|FG000|Overall Study|Lost to Follow-up|3|||
23219615|NCT02017704|64544947|FG000|Overall Study|Withdrawal by Subject|2|||
23219616|NCT02017704|64544948|FG001|Overall Study|Withdrawal by Subject|0|||
23219617|NCT04731922|64544958|FG000|Overall Study|Adverse Event|0|||
23219618|NCT04731922|64544959|FG001|Overall Study|Adverse Event|0|||
23219619|NCT04731922|64544960|FG002|Overall Study|Adverse Event|0|||
23219620|NCT04731922|64544961|FG003|Overall Study|Adverse Event|0|||
23150318|NCT02864381|64301822|FG000|Overall Study|Death|58|||
23150319|NCT02864381|64301823|FG001|Overall Study|Death|61|||
23150320|NCT02864381|64301822|FG000|Overall Study|Withdrew Consent|5|||
23150321|NCT02864381|64301823|FG001|Overall Study|Withdrew Consent|6|||
23150322|NCT02864381|64301822|FG000|Overall Study|Reason Unknown|7|||
23219621|NCT04731922|64544962|FG004|Overall Study|Adverse Event|0|||
23219622|NCT04731922|64544963|FG005|Overall Study|Adverse Event|0|||
23219623|NCT04731922|64544964|FG006|Overall Study|Adverse Event|0|||
23324381|NCT04211831|64930289|FG002|Overall Study|Lost to Follow-up|2|||
23150323|NCT02864381|64301823|FG001|Overall Study|Reason Unknown|3|||
23150324|NCT02864381|64301822|FG000|Overall Study|Lost to Follow-up|1|||
23219624|NCT04731922|64544965|FG007|Overall Study|Adverse Event|0|||
23219625|NCT04731922|64544966|FG008|Overall Study|Adverse Event|0|||
23438137|NCT00106353|65348470|FG000|Part 2|Other|0|||
23438138|NCT00106353|65348471|FG001|Part 2|Other|0|||
23438139|NCT00106353|65348472|FG002|Part 2|Other|0|||
23438140|NCT00106353|65348473|FG003|Part 2|Other|0|||
23438141|NCT00106353|65348474|FG004|Part 2|Other|1|||
23438142|NCT00106353|65348475|FG005|Part 2|Other|1|||
23438143|NCT00106353|65348476|FG006|Part 2|Other|1|||
23438144|NCT00106353|65348470|FG000|Part 2|Withdrawal by Subject|0|||
23438145|NCT00106353|65348471|FG001|Part 2|Withdrawal by Subject|0|||
23438146|NCT00106353|65348472|FG002|Part 2|Withdrawal by Subject|0|||
23219626|NCT04731922|64544967|FG009|Overall Study|Adverse Event|0|||
23219627|NCT04731922|64544968|FG010|Overall Study|Adverse Event|1|||
23438147|NCT00106353|65348473|FG003|Part 2|Withdrawal by Subject|0|||
23438148|NCT00106353|65348474|FG004|Part 2|Withdrawal by Subject|1|||
23438149|NCT00106353|65348475|FG005|Part 2|Withdrawal by Subject|0|||
23438150|NCT00106353|65348476|FG006|Part 2|Withdrawal by Subject|0|||
23560662|NCT01376323|65782366|FG004|Overall Study|Lost to Follow-up|0|||
23560663|NCT01376323|65782362|FG000|Overall Study|Physician Decision|1|||
23560664|NCT01376323|65782363|FG001|Overall Study|Physician Decision|0|||
23560665|NCT01376323|65782364|FG002|Overall Study|Physician Decision|2|||
23560666|NCT01376323|65782365|FG003|Overall Study|Physician Decision|1|||
23560667|NCT01376323|65782366|FG004|Overall Study|Physician Decision|1|||
23560668|NCT01376323|65782362|FG000|Overall Study|Withdrawal by Subject|0|||
23219628|NCT04731922|64544969|FG011|Overall Study|Adverse Event|0|||
23219629|NCT04731922|64544970|FG012|Overall Study|Adverse Event|0|||
23438151|NCT00106353|65348470|FG000|Part 2|Physician Decision|0|||
23438152|NCT00106353|65348471|FG001|Part 2|Physician Decision|0|||
23438153|NCT00106353|65348472|FG002|Part 2|Physician Decision|0|||
23438154|NCT00106353|65348473|FG003|Part 2|Physician Decision|0|||
23438155|NCT00106353|65348474|FG004|Part 2|Physician Decision|0|||
23438156|NCT00106353|65348475|FG005|Part 2|Physician Decision|1|||
23438157|NCT00106353|65348476|FG006|Part 2|Physician Decision|0|||
23438158|NCT00477152|65348478|FG000|Overall Study|Parent withdrew consent|2|||
23219630|NCT04731922|64544971|FG013|Overall Study|Adverse Event|0|||
23219631|NCT04731922|64544972|FG014|Overall Study|Adverse Event|0|||
23219632|NCT04731922|64544973|FG015|Overall Study|Adverse Event|0|||
23219633|NCT04731922|64544974|FG016|Overall Study|Adverse Event|0|||
23219634|NCT04731922|64544958|FG000|Overall Study|Lost to Follow-up|0|||
23219635|NCT04731922|64544959|FG001|Overall Study|Lost to Follow-up|0|||
23219636|NCT04731922|64544960|FG002|Overall Study|Lost to Follow-up|0|||
23219637|NCT04731922|64544961|FG003|Overall Study|Lost to Follow-up|1|||
23219638|NCT04731922|64544962|FG004|Overall Study|Lost to Follow-up|0|||
23219639|NCT04731922|64544963|FG005|Overall Study|Lost to Follow-up|1|||
23219640|NCT04731922|64544964|FG006|Overall Study|Lost to Follow-up|0|||
23219641|NCT04731922|64544965|FG007|Overall Study|Lost to Follow-up|0|||
23219642|NCT04731922|64544966|FG008|Overall Study|Lost to Follow-up|0|||
23438159|NCT00477152|65348478|FG000|Overall Study|Adverse Event|1|||
23438160|NCT01138501|65348482|FG000|Overall Study|Protocol Violation|2|||
23438161|NCT01138501|65348482|FG000|Overall Study|Withdrawal by Subject|3|||
23438162|NCT00077649|65348483|FG000|Overall Study|Adverse Event|5|||
23438163|NCT00077649|65348484|FG001|Overall Study|Adverse Event|1|||
23438164|NCT00077649|65348485|FG002|Overall Study|Adverse Event|7|||
23438165|NCT00077649|65348486|FG003|Overall Study|Adverse Event|9|||
23438166|NCT00077649|65348483|FG000|Overall Study|Lack of Efficacy|5|||
23438167|NCT00077649|65348484|FG001|Overall Study|Lack of Efficacy|3|||
23438168|NCT00077649|65348485|FG002|Overall Study|Lack of Efficacy|3|||
23438169|NCT00077649|65348486|FG003|Overall Study|Lack of Efficacy|2|||
23438170|NCT00077649|65348483|FG000|Overall Study|Withdrawal by Subject|0|||
23438171|NCT00077649|65348484|FG001|Overall Study|Withdrawal by Subject|1|||
23438172|NCT00077649|65348485|FG002|Overall Study|Withdrawal by Subject|1|||
23438173|NCT00077649|65348486|FG003|Overall Study|Withdrawal by Subject|2|||
23438174|NCT00077649|65348483|FG000|Overall Study|Lost to Follow-up|2|||
23438175|NCT00077649|65348484|FG001|Overall Study|Lost to Follow-up|2|||
23438176|NCT00077649|65348485|FG002|Overall Study|Lost to Follow-up|3|||
23438177|NCT00077649|65348486|FG003|Overall Study|Lost to Follow-up|2|||
23438178|NCT00077649|65348483|FG000|Overall Study|Abnormality of Laboratory Test|1|||
23438179|NCT00077649|65348484|FG001|Overall Study|Abnormality of Laboratory Test|2|||
23438180|NCT00077649|65348485|FG002|Overall Study|Abnormality of Laboratory Test|1|||
23438181|NCT00077649|65348486|FG003|Overall Study|Abnormality of Laboratory Test|2|||
23219643|NCT04731922|64544967|FG009|Overall Study|Lost to Follow-up|0|||
23219644|NCT04731922|64544968|FG010|Overall Study|Lost to Follow-up|0|||
23219645|NCT04731922|64544969|FG011|Overall Study|Lost to Follow-up|0|||
23438182|NCT00077649|65348483|FG000|Overall Study|Randomized but never dosed|1|||
23438183|NCT00077649|65348484|FG001|Overall Study|Randomized but never dosed|0|||
23438184|NCT00077649|65348485|FG002|Overall Study|Randomized but never dosed|0|||
23438185|NCT00077649|65348486|FG003|Overall Study|Randomized but never dosed|0|||
23560669|NCT01376323|65782363|FG001|Overall Study|Withdrawal by Subject|1|||
23560670|NCT01376323|65782364|FG002|Overall Study|Withdrawal by Subject|1|||
23438186|NCT04541628|65348487|FG000|Overall Study|Study Terminated|1|||
23438187|NCT04541628|65348488|FG001|Overall Study|Study Terminated|1|||
23438188|NCT04541628|65348489|FG002|Overall Study|Study Terminated|1|||
23219646|NCT04731922|64544970|FG012|Overall Study|Lost to Follow-up|0|||
23219647|NCT04731922|64544971|FG013|Overall Study|Lost to Follow-up|0|||
23438189|NCT03422536|65348495|FG000|Randomized|Physician Decision|1|||
23438190|NCT03422536|65348496|FG001|Randomized|Physician Decision|1|||
23438191|NCT03422536|65348495|FG000|Allocation - Received Intervention|Disease progression|19|||
23438192|NCT03422536|65348496|FG001|Allocation - Received Intervention|Disease progression|25|||
23438193|NCT03422536|65348495|FG000|Allocation - Received Intervention|Death|1|||
23438194|NCT03422536|65348496|FG001|Allocation - Received Intervention|Death|3|||
23438195|NCT03422536|65348495|FG000|Allocation - Received Intervention|Adverse Event|1|||
23438196|NCT03422536|65348496|FG001|Allocation - Received Intervention|Adverse Event|0|||
23438197|NCT03422536|65348495|FG000|Allocation - Received Intervention|Physician Decision|1|||
23438198|NCT03422536|65348496|FG001|Allocation - Received Intervention|Physician Decision|1|||
23438199|NCT03422536|65348495|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
23438200|NCT03422536|65348496|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
23624809|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
23624810|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
23624811|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
23624812|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
23624813|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
23438201|NCT03422536|65348495|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
23438202|NCT03422536|65348496|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
23438203|NCT00766051|65348497|FG000|Overall Study|Withdrawal by Subject|2|||
23438204|NCT00766051|65348498|FG001|Overall Study|Withdrawal by Subject|0|||
23438205|NCT01743040|65348499|FG000|Overall Study|Death|1|||
23438206|NCT01743040|65348499|FG000|Overall Study|Lost to Follow-up|66|||
23438207|NCT01743040|65348499|FG000|Overall Study|Physician Decision|40|||
23438208|NCT01743040|65348499|FG000|Overall Study|Protocol Violation|1|||
23438209|NCT01743040|65348499|FG000|Overall Study|Withdrawal by Subject|121|||
23438210|NCT02687581|65348500|FG000|Overall Study|Withdrawal by Subject|1|||
23438211|NCT02687581|65348501|FG001|Overall Study|Withdrawal by Subject|0|||
23438212|NCT02687581|65348502|FG002|Overall Study|Withdrawal by Subject|0|||
23438213|NCT02687581|65348503|FG003|Overall Study|Withdrawal by Subject|1|||
23438214|NCT02687581|65348500|FG000|Overall Study|Lost to Follow-up|2|||
23438215|NCT02687581|65348501|FG001|Overall Study|Lost to Follow-up|2|||
23438216|NCT02687581|65348502|FG002|Overall Study|Lost to Follow-up|0|||
23438217|NCT02687581|65348503|FG003|Overall Study|Lost to Follow-up|0|||
23438218|NCT02687581|65348500|FG000|Overall Study|the device is too small for the patient.|1|||
23438219|NCT02687581|65348501|FG001|Overall Study|the device is too small for the patient.|0|||
23438220|NCT02687581|65348502|FG002|Overall Study|the device is too small for the patient.|0|||
23438221|NCT02687581|65348503|FG003|Overall Study|the device is too small for the patient.|0|||
23438222|NCT04302545|65348504|FG000|Overall Study|Lost to Follow-up|3|||
23438223|NCT04302545|65348505|FG001|Overall Study|Lost to Follow-up|4|||
23438224|NCT00429169|65348506|FG000|Overall Study|Lost to Follow-up|0|||
23438225|NCT00429169|65348507|FG001|Overall Study|Lost to Follow-up|1|||
23438226|NCT00429169|65348506|FG000|Overall Study|Ineligibility discovered after entry|2|||
23438227|NCT00429169|65348507|FG001|Overall Study|Ineligibility discovered after entry|1|||
23438228|NCT04090242|65348508|FG000|Overall Study|Withdrawal by Subject|1|||
23438229|NCT04090242|65348509|FG001|Overall Study|Withdrawal by Subject|0|||
23150325|NCT02864381|64301823|FG001|Overall Study|Lost to Follow-up|1|||
23150326|NCT02864381|64301822|FG000|Overall Study|Investigator's Discretion|1|||
23150327|NCT02864381|64301823|FG001|Overall Study|Investigator's Discretion|0|||
23150328|NCT02864381|64301822|FG000|Overall Study|Protocol Violation|0|||
23150329|NCT02864381|64301823|FG001|Overall Study|Protocol Violation|1|||
23150330|NCT04142450|64301827|FG000|Overall Study|Screen Failure|1|||
23150331|NCT04142450|64301827|FG000|Overall Study|Lost to Follow-up|1|||
23150332|NCT00993915|64301828|FG000|Overall Study|Insufficient clinical response|3|||
23438230|NCT02673684|65348510|FG000|Overall Study|Study not completed d/t loss of funding|9|||
23624814|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
23624815|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Missing|2|||
23624816|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Missing|1|||
23624817|NCT00443209|66015372|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
23624818|NCT00443209|66015373|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
23624819|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
23624820|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
23624821|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
23624822|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
23624823|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
23324382|NCT04211831|64930287|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
23624824|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
23624825|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
23438231|NCT02673684|65348511|FG001|Overall Study|Study not completed d/t loss of funding|8|||
23219648|NCT04731922|64544972|FG014|Overall Study|Lost to Follow-up|0|||
23438232|NCT02853435|65348524|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23438233|NCT02853435|65348525|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23438234|NCT02853435|65348526|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23624826|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
23624827|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
23624828|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
23624829|NCT00443209|66015372|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
23624830|NCT00443209|66015373|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
23438235|NCT02853435|65348527|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23438236|NCT02853435|65348528|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
23624831|NCT01190644|66015381|FG000|Overall Study|Death|2|||
23624832|NCT01190644|66015381|FG000|Overall Study|Disease progression|1|||
23624833|NCT01390441|66015382|FG000|Treatment Period|Protocol Violation|0|||
23624834|NCT01390441|66015383|FG001|Treatment Period|Protocol Violation|1|||
23624835|NCT01390441|66015384|FG002|Treatment Period|Protocol Violation|0|||
23624836|NCT01390441|66015385|FG003|Treatment Period|Protocol Violation|0|||
23438237|NCT02853435|65348529|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
23438238|NCT00042991|65348530|FG000|Overall Study|Adverse Event|1|||
23438239|NCT00042991|65348531|FG001|Overall Study|Adverse Event|4|||
23438240|NCT00042991|65348532|FG002|Overall Study|Adverse Event|2|||
23438241|NCT00042991|65348533|FG003|Overall Study|Adverse Event|0|||
23438242|NCT00042991|65348534|FG004|Overall Study|Adverse Event|0|||
23438243|NCT00042991|65348535|FG005|Overall Study|Adverse Event|1|||
23438244|NCT00042991|65348536|FG006|Overall Study|Adverse Event|0|||
23624837|NCT01390441|66015386|FG004|Treatment Period|Protocol Violation|0|||
23624838|NCT01390441|66015382|FG000|Treatment Period|Physician Decision|0|||
23624839|NCT01390441|66015383|FG001|Treatment Period|Physician Decision|0|||
23624840|NCT01390441|66015384|FG002|Treatment Period|Physician Decision|0|||
23438245|NCT00042991|65348530|FG000|Overall Study|Withdrawal by Subject|0|||
23438246|NCT00042991|65348531|FG001|Overall Study|Withdrawal by Subject|7|||
23438247|NCT00042991|65348532|FG002|Overall Study|Withdrawal by Subject|2|||
23438248|NCT00042991|65348533|FG003|Overall Study|Withdrawal by Subject|0|||
23438249|NCT00042991|65348534|FG004|Overall Study|Withdrawal by Subject|1|||
23438250|NCT00042991|65348535|FG005|Overall Study|Withdrawal by Subject|0|||
23438251|NCT00042991|65348536|FG006|Overall Study|Withdrawal by Subject|0|||
23438252|NCT00042991|65348530|FG000|Overall Study|Disease Progression|5|||
23438253|NCT00042991|65348531|FG001|Overall Study|Disease Progression|29|||
23438254|NCT00042991|65348532|FG002|Overall Study|Disease Progression|2|||
23438255|NCT00042991|65348533|FG003|Overall Study|Disease Progression|2|||
23438256|NCT00042991|65348534|FG004|Overall Study|Disease Progression|1|||
23438257|NCT00042991|65348535|FG005|Overall Study|Disease Progression|4|||
23438258|NCT00042991|65348536|FG006|Overall Study|Disease Progression|2|||
23438259|NCT00042991|65348530|FG000|Overall Study|Alternative Therapy|0|||
23438260|NCT00042991|65348531|FG001|Overall Study|Alternative Therapy|0|||
23438261|NCT00042991|65348532|FG002|Overall Study|Alternative Therapy|0|||
23438262|NCT00042991|65348533|FG003|Overall Study|Alternative Therapy|0|||
23438263|NCT00042991|65348534|FG004|Overall Study|Alternative Therapy|1|||
23438264|NCT00042991|65348535|FG005|Overall Study|Alternative Therapy|0|||
23438265|NCT00042991|65348536|FG006|Overall Study|Alternative Therapy|0|||
23438266|NCT04725500|65348541|FG000|Screening|Screen Failure|26|||
23438267|NCT04725500|65348541|FG000|Screening|Withdrawal by Subject|1|||
23438268|NCT04725500|65348541|FG000|2 Week Take Home|Screen Fail|5|||
23438269|NCT02980133|65348542|FG000|Overall Study|Other than specified|1|||
23438270|NCT02980133|65348543|FG001|Overall Study|Other than specified|1|||
23438271|NCT02980133|65348544|FG002|Overall Study|Other than specified|2|||
23438272|NCT02980133|65348545|FG003|Overall Study|Other than specified|2|||
23438273|NCT02980133|65348542|FG000|Overall Study|Lost to Follow-up|0|||
23438274|NCT02980133|65348543|FG001|Overall Study|Lost to Follow-up|0|||
23438275|NCT02980133|65348544|FG002|Overall Study|Lost to Follow-up|1|||
23438276|NCT02980133|65348545|FG003|Overall Study|Lost to Follow-up|3|||
23438277|NCT02980133|65348542|FG000|Overall Study|Protocol Violation|0|||
23438278|NCT02980133|65348543|FG001|Overall Study|Protocol Violation|1|||
23438279|NCT02980133|65348544|FG002|Overall Study|Protocol Violation|0|||
23438280|NCT02980133|65348545|FG003|Overall Study|Protocol Violation|0|||
23624841|NCT01390441|66015385|FG003|Treatment Period|Physician Decision|1|||
23624842|NCT01390441|66015386|FG004|Treatment Period|Physician Decision|0|||
23624843|NCT01390441|66015382|FG000|Treatment Period|Lack of Efficacy|0|||
23624844|NCT01390441|66015383|FG001|Treatment Period|Lack of Efficacy|0|||
23624845|NCT01390441|66015384|FG002|Treatment Period|Lack of Efficacy|0|||
23624846|NCT01390441|66015385|FG003|Treatment Period|Lack of Efficacy|0|||
23624847|NCT01390441|66015386|FG004|Treatment Period|Lack of Efficacy|1|||
23624848|NCT01390441|66015382|FG000|Treatment Period|Unknown due to early stopping of study|0|||
23624849|NCT01390441|66015383|FG001|Treatment Period|Unknown due to early stopping of study|0|||
23624850|NCT01390441|66015384|FG002|Treatment Period|Unknown due to early stopping of study|8|||
23624851|NCT01390441|66015385|FG003|Treatment Period|Unknown due to early stopping of study|11|||
23624852|NCT01390441|66015386|FG004|Treatment Period|Unknown due to early stopping of study|7|||
23438281|NCT02980133|65348542|FG000|Overall Study|Withdrawal by parent/guardian|6|||
23438282|NCT02980133|65348543|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23438283|NCT02980133|65348544|FG002|Overall Study|Withdrawal by parent/guardian|3|||
23438284|NCT02980133|65348545|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23438285|NCT02980133|65348542|FG000|Overall Study|Withdrawal by Subject|0|||
23438286|NCT02980133|65348543|FG001|Overall Study|Withdrawal by Subject|0|||
23438287|NCT02980133|65348544|FG002|Overall Study|Withdrawal by Subject|1|||
23438288|NCT02980133|65348545|FG003|Overall Study|Withdrawal by Subject|0|||
23438289|NCT01240135|65348550|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
23438290|NCT01240135|65348551|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
23438291|NCT01240135|65348550|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
23438292|NCT01240135|65348551|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
23438293|NCT03319212|65348554|FG000|Overall Study|Discontinued as moving out of local area|0|||
23438294|NCT03319212|65348555|FG001|Overall Study|Discontinued as moving out of local area|1|||
23438295|NCT03319212|65348554|FG000|Overall Study|Adverse Event|2|||
23438296|NCT03319212|65348555|FG001|Overall Study|Adverse Event|2|||
23438297|NCT03319212|65348554|FG000|Overall Study|Withdrawal by Subject|0|||
23438298|NCT03319212|65348555|FG001|Overall Study|Withdrawal by Subject|1|||
23438299|NCT03319212|65348554|FG000|Overall Study|Lost to Follow-up|0|||
23438300|NCT03319212|65348555|FG001|Overall Study|Lost to Follow-up|1|||
23438301|NCT03319212|65348554|FG000|Overall Study|Physician Decision|1|||
23438302|NCT03319212|65348555|FG001|Overall Study|Physician Decision|0|||
23438303|NCT03170193|65348556|FG000|Overall Study|Withdrawal by Subject|0|||
23438304|NCT03170193|65348557|FG001|Overall Study|Withdrawal by Subject|0|||
23438305|NCT03170193|65348558|FG002|Overall Study|Withdrawal by Subject|0|||
23624853|NCT01390441|66015382|FG000|Treatment Period|Adverse Event|0|||
23624854|NCT01390441|66015383|FG001|Treatment Period|Adverse Event|0|||
23624855|NCT01390441|66015384|FG002|Treatment Period|Adverse Event|1|||
23438306|NCT03170193|65348559|FG003|Overall Study|Withdrawal by Subject|1|||
23438307|NCT03170193|65348560|FG004|Overall Study|Withdrawal by Subject|0|||
23438308|NCT03170193|65348561|FG005|Overall Study|Withdrawal by Subject|0|||
23438309|NCT03170193|65348562|FG006|Overall Study|Withdrawal by Subject|0|||
23438310|NCT03170193|65348556|FG000|Overall Study|Lost to Follow-up|1|||
23438311|NCT03170193|65348557|FG001|Overall Study|Lost to Follow-up|1|||
23438312|NCT03170193|65348558|FG002|Overall Study|Lost to Follow-up|0|||
23438313|NCT03170193|65348559|FG003|Overall Study|Lost to Follow-up|0|||
23438314|NCT03170193|65348560|FG004|Overall Study|Lost to Follow-up|0|||
23438315|NCT03170193|65348561|FG005|Overall Study|Lost to Follow-up|0|||
23438316|NCT03170193|65348562|FG006|Overall Study|Lost to Follow-up|0|||
23438317|NCT02160145|65348563|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
23438318|NCT02160145|65348564|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
23624856|NCT01390441|66015385|FG003|Treatment Period|Adverse Event|1|||
23624857|NCT01390441|66015386|FG004|Treatment Period|Adverse Event|2|||
23624858|NCT01390441|66015382|FG000|Treatment Period|Withdrawal by Subject|0|||
23219649|NCT04731922|64544973|FG015|Overall Study|Lost to Follow-up|0|||
23438319|NCT02160145|65348565|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
23438320|NCT02160145|65348563|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
23438321|NCT02160145|65348564|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
23438322|NCT02160145|65348565|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
23438323|NCT02160145|65348563|FG000|Randomized Double-blind Period|Subject decision|0|||
23438324|NCT02160145|65348564|FG001|Randomized Double-blind Period|Subject decision|21|||
23438325|NCT02160145|65348565|FG002|Randomized Double-blind Period|Subject decision|20|||
23438326|NCT02160145|65348563|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
23438327|NCT02160145|65348564|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
23438328|NCT02160145|65348565|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
23438329|NCT02160145|65348563|FG000|Randomized Double-blind Period|Physician Decision|0|||
23438330|NCT02160145|65348564|FG001|Randomized Double-blind Period|Physician Decision|7|||
23438331|NCT02160145|65348565|FG002|Randomized Double-blind Period|Physician Decision|5|||
23438332|NCT03068767|65348566|FG000|Overall Study|Lost to Follow-up|7|||
23438333|NCT03068767|65348567|FG001|Overall Study|Lost to Follow-up|3|||
23438334|NCT03068767|65348566|FG000|Overall Study|Protocol Violation|3|||
23438335|NCT03068767|65348567|FG001|Overall Study|Protocol Violation|0|||
23438336|NCT00231413|65348568|FG000|Overall Study|Non-serious AE|0|||
23324383|NCT04211831|64930288|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
23324384|NCT04211831|64930289|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
23438337|NCT00231413|65348569|FG001|Overall Study|Non-serious AE|0|||
23438338|NCT00231413|65348570|FG002|Overall Study|Non-serious AE|1|||
23438339|NCT00231413|65348571|FG003|Overall Study|Non-serious AE|0|||
23438340|NCT00231413|65348572|FG004|Overall Study|Non-serious AE|0|||
23438341|NCT00231413|65348573|FG005|Overall Study|Non-serious AE|0|||
23438342|NCT00231413|65348574|FG006|Overall Study|Non-serious AE|1|||
23438343|NCT00231413|65348568|FG000|Overall Study|Withdrawal by Subject|3|||
23438344|NCT00231413|65348569|FG001|Overall Study|Withdrawal by Subject|1|||
23438345|NCT00231413|65348570|FG002|Overall Study|Withdrawal by Subject|4|||
23438346|NCT00231413|65348571|FG003|Overall Study|Withdrawal by Subject|2|||
23438347|NCT00231413|65348572|FG004|Overall Study|Withdrawal by Subject|2|||
23438348|NCT00231413|65348573|FG005|Overall Study|Withdrawal by Subject|0|||
23624859|NCT01390441|66015383|FG001|Treatment Period|Withdrawal by Subject|0|||
23438349|NCT00231413|65348574|FG006|Overall Study|Withdrawal by Subject|3|||
23624860|NCT01390441|66015384|FG002|Treatment Period|Withdrawal by Subject|1|||
23624861|NCT01390441|66015385|FG003|Treatment Period|Withdrawal by Subject|0|||
23624862|NCT01390441|66015386|FG004|Treatment Period|Withdrawal by Subject|1|||
23624863|NCT01390441|66015382|FG000|Treatment Period|Lost to Follow-up|1|||
23624864|NCT01390441|66015383|FG001|Treatment Period|Lost to Follow-up|0|||
23624865|NCT01390441|66015384|FG002|Treatment Period|Lost to Follow-up|0|||
23624866|NCT01390441|66015385|FG003|Treatment Period|Lost to Follow-up|0|||
23624867|NCT01390441|66015386|FG004|Treatment Period|Lost to Follow-up|0|||
23624868|NCT01390441|66015382|FG000|Extension Period|Protocol Violation|3|||
23624869|NCT01390441|66015383|FG001|Extension Period|Protocol Violation|1|||
23624870|NCT01390441|66015384|FG002|Extension Period|Protocol Violation|0|||
23624871|NCT01390441|66015385|FG003|Extension Period|Protocol Violation|1|||
23624872|NCT01390441|66015386|FG004|Extension Period|Protocol Violation|0|||
23624873|NCT00129649|66015388|FG000|Overall Study|Withdrawal by Subject|76|||
23624874|NCT00129649|66015389|FG001|Overall Study|Withdrawal by Subject|65|||
23624875|NCT00905034|66015391|FG000|Overall Study|Withdrawal by Subject|1|||
23324385|NCT04211831|64930287|FG000|Overall Study|Other|0|||
23624876|NCT01296555|66015392|FG000|Overall Study|Adverse Event|0|||
23624877|NCT01296555|66015393|FG001|Overall Study|Adverse Event|0|||
23624878|NCT01296555|66015394|FG002|Overall Study|Adverse Event|1|||
23624879|NCT01296555|66015395|FG003|Overall Study|Adverse Event|1|||
23624880|NCT01296555|66015396|FG004|Overall Study|Adverse Event|2|||
23624881|NCT01296555|66015397|FG005|Overall Study|Adverse Event|4|||
23624882|NCT01296555|66015398|FG006|Overall Study|Adverse Event|1|||
23624883|NCT01296555|66015399|FG007|Overall Study|Adverse Event|4|||
23624884|NCT01296555|66015400|FG008|Overall Study|Adverse Event|3|||
23624885|NCT01296555|66015401|FG009|Overall Study|Adverse Event|1|||
23624886|NCT01296555|66015402|FG010|Overall Study|Adverse Event|0|||
23624887|NCT01296555|66015403|FG011|Overall Study|Adverse Event|4|||
23624888|NCT01296555|66015404|FG012|Overall Study|Adverse Event|1|||
23624889|NCT01296555|66015405|FG013|Overall Study|Adverse Event|4|||
23324386|NCT04211831|64930288|FG001|Overall Study|Other|1|||
23324387|NCT04211831|64930289|FG002|Overall Study|Other|0|||
23324388|NCT02548156|64930298|FG000|Washout Period 1|Lost to Follow-up|0|||
23324389|NCT02548156|64930299|FG001|Washout Period 1|Lost to Follow-up|0|||
23324390|NCT02548156|64930300|FG002|Washout Period 1|Lost to Follow-up|0|||
23324391|NCT02548156|64930301|FG003|Washout Period 1|Lost to Follow-up|0|||
23324392|NCT02548156|64930302|FG004|Washout Period 1|Lost to Follow-up|1|||
23324393|NCT02548156|64930303|FG005|Washout Period 1|Lost to Follow-up|0|||
23324394|NCT00560391|64930304|FG000|Overall Study|Still on treatment|0|||
23324395|NCT00560391|64930305|FG001|Overall Study|Still on treatment|0|||
23324396|NCT00560391|64930306|FG002|Overall Study|Still on treatment|0|||
23324397|NCT00560391|64930307|FG003|Overall Study|Still on treatment|1|||
23324398|NCT00560391|64930308|FG004|Overall Study|Still on treatment|2|||
23324399|NCT02071225|64930312|FG000|Overall Study|Withdrawal of Consent|2|||
23324400|NCT02071225|64930312|FG000|Overall Study|Protocol Deviation|1|||
23324401|NCT02071225|64930312|FG000|Overall Study|Lost to Follow-up|2|||
23324402|NCT02071225|64930312|FG000|Overall Study|Death|25|||
23324403|NCT00349973|64930313|FG000|Overall Study|Adverse Event|3|||
23324404|NCT00349973|64930314|FG001|Overall Study|Adverse Event|3|||
23324405|NCT00349973|64930313|FG000|Overall Study|Withdrawal by Subject|1|||
23324406|NCT00349973|64930314|FG001|Overall Study|Withdrawal by Subject|0|||
23324407|NCT04158648|64930315|FG000|Overall Study|Ongoing in the Study|69|||
23324408|NCT04158648|64930315|FG000|Overall Study|Withdrawal by Subject|4|||
23324409|NCT03571828|64930316|FG000|Overall Study|Withdrawal by Subject|1|||
23324410|NCT03571828|64930317|FG001|Overall Study|Withdrawal by Subject|0|||
23324411|NCT03571828|64930316|FG000|Overall Study|Decision by sponsor|5|||
23324412|NCT03571828|64930317|FG001|Overall Study|Decision by sponsor|1|||
23324413|NCT03571828|64930316|FG000|Overall Study|Death|2|||
23324414|NCT03571828|64930317|FG001|Overall Study|Death|0|||
23324415|NCT03238651|64930318|FG000|Overall Study|Other|0|||
23438350|NCT00231413|65348568|FG000|Overall Study|Migrated/moved from study area|0|||
23438351|NCT00231413|65348569|FG001|Overall Study|Migrated/moved from study area|0|||
23438352|NCT00231413|65348570|FG002|Overall Study|Migrated/moved from study area|1|||
23324416|NCT03238651|64930319|FG001|Overall Study|Other|0|||
23324417|NCT03238651|64930320|FG002|Overall Study|Other|0|||
23324418|NCT03238651|64930321|FG003|Overall Study|Other|0|||
23324419|NCT03238651|64930322|FG004|Overall Study|Other|1|||
23324420|NCT03238651|64930318|FG000|Overall Study|Progressive Disease|2|||
23624890|NCT01296555|66015406|FG014|Overall Study|Adverse Event|0|||
23624891|NCT01296555|66015407|FG015|Overall Study|Adverse Event|0|||
23624892|NCT01296555|66015408|FG016|Overall Study|Adverse Event|0|||
23624893|NCT01296555|66015409|FG017|Overall Study|Adverse Event|0|||
23624894|NCT01296555|66015410|FG018|Overall Study|Adverse Event|0|||
23324421|NCT03238651|64930319|FG001|Overall Study|Progressive Disease|2|||
23438353|NCT00231413|65348571|FG003|Overall Study|Migrated/moved from study area|0|||
23624895|NCT01296555|66015411|FG019|Overall Study|Adverse Event|1|||
23324422|NCT03238651|64930320|FG002|Overall Study|Progressive Disease|2|||
23150333|NCT00993915|64301828|FG000|Overall Study|Withdrawal by Subject|2|||
23150334|NCT00993915|64301828|FG000|Overall Study|Other|1|||
23150335|NCT00993915|64301828|FG000|Overall Study|Ongoing|3|||
23150336|NCT01357577|64301831|FG000|Overall Study|Lost to Follow-up|20|||
23150337|NCT01357577|64301832|FG001|Overall Study|Lost to Follow-up|16|||
23150338|NCT01357577|64301831|FG000|Overall Study|Withdrawal by Subject|16|||
23150339|NCT01357577|64301832|FG001|Overall Study|Withdrawal by Subject|8|||
23150340|NCT01357577|64301831|FG000|Overall Study|look at data in database?|1|||
23150341|NCT01357577|64301832|FG001|Overall Study|look at data in database?|2|||
23150342|NCT00874770|64301833|FG000|Overall Study|Lack of Efficacy|2|||
23150343|NCT00874770|64301834|FG001|Overall Study|Lack of Efficacy|0|||
23150344|NCT00874770|64301835|FG002|Overall Study|Lack of Efficacy|0|||
23150345|NCT00874770|64301836|FG003|Overall Study|Lack of Efficacy|2|||
23150346|NCT00874770|64301833|FG000|Overall Study|Adverse Event|1|||
23150347|NCT00874770|64301834|FG001|Overall Study|Adverse Event|1|||
23150348|NCT00874770|64301835|FG002|Overall Study|Adverse Event|4|||
23150349|NCT00874770|64301836|FG003|Overall Study|Adverse Event|2|||
23150350|NCT00874770|64301833|FG000|Overall Study|Lost to Follow-up|1|||
23150351|NCT00874770|64301834|FG001|Overall Study|Lost to Follow-up|0|||
23150352|NCT00874770|64301835|FG002|Overall Study|Lost to Follow-up|0|||
23150353|NCT00874770|64301836|FG003|Overall Study|Lost to Follow-up|1|||
23150354|NCT00874770|64301833|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
23150355|NCT00874770|64301834|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
23150356|NCT00874770|64301835|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
23150357|NCT00874770|64301836|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
23150358|NCT04223830|64301837|FG000|Overall Study|Lost to Follow-up|9|||
23150359|NCT04223830|64301837|FG000|Overall Study|Adverse Event|1|||
23150360|NCT00928746|64301839|FG000|Overall Study|Adverse Event|2|||
23150361|NCT00928746|64301839|FG000|Overall Study|Protocol Violation|1|||
23150362|NCT00928746|64301839|FG000|Overall Study|Withdrawal by Subject|1|||
23150363|NCT00928746|64301839|FG000|Overall Study|Other|2|||
23150364|NCT01310803|64301840|FG000|Overall Study|Subject terminated by Sponsor|1|||
23150365|NCT01310803|64301841|FG001|Overall Study|Subject terminated by Sponsor|0|||
23150366|NCT03690141|64301842|FG000|Overall Study|Adverse Event|5|||
23150367|NCT03690141|64301842|FG000|Overall Study|Withdrawal by Subject|3|||
23150368|NCT03690141|64301842|FG000|Overall Study|Physician Decision|4|||
23150369|NCT03690141|64301842|FG000|Overall Study|Disease progression|4|||
23219650|NCT04731922|64544974|FG016|Overall Study|Lost to Follow-up|0|||
23219651|NCT04731922|64544958|FG000|Overall Study|Withdrawal by Subject|1|||
23219652|NCT04731922|64544959|FG001|Overall Study|Withdrawal by Subject|0|||
23219653|NCT04731922|64544960|FG002|Overall Study|Withdrawal by Subject|0|||
23219654|NCT04731922|64544961|FG003|Overall Study|Withdrawal by Subject|0|||
23219655|NCT04731922|64544962|FG004|Overall Study|Withdrawal by Subject|1|||
23219656|NCT04731922|64544963|FG005|Overall Study|Withdrawal by Subject|0|||
23219657|NCT04731922|64544964|FG006|Overall Study|Withdrawal by Subject|1|||
23219658|NCT04731922|64544965|FG007|Overall Study|Withdrawal by Subject|0|||
23219659|NCT04731922|64544966|FG008|Overall Study|Withdrawal by Subject|0|||
23219660|NCT04731922|64544967|FG009|Overall Study|Withdrawal by Subject|0|||
23219661|NCT04731922|64544968|FG010|Overall Study|Withdrawal by Subject|0|||
23219662|NCT04731922|64544969|FG011|Overall Study|Withdrawal by Subject|0|||
23219663|NCT04731922|64544970|FG012|Overall Study|Withdrawal by Subject|0|||
23219664|NCT04731922|64544971|FG013|Overall Study|Withdrawal by Subject|1|||
23219665|NCT04731922|64544972|FG014|Overall Study|Withdrawal by Subject|0|||
23219666|NCT04731922|64544973|FG015|Overall Study|Withdrawal by Subject|0|||
23219667|NCT04731922|64544974|FG016|Overall Study|Withdrawal by Subject|0|||
23219668|NCT04731922|64544958|FG000|Overall Study|Other|0|||
23219669|NCT04731922|64544959|FG001|Overall Study|Other|0|||
23219670|NCT04731922|64544960|FG002|Overall Study|Other|0|||
23219671|NCT04731922|64544961|FG003|Overall Study|Other|0|||
23219672|NCT04731922|64544962|FG004|Overall Study|Other|0|||
23219673|NCT04731922|64544963|FG005|Overall Study|Other|0|||
23219674|NCT04731922|64544964|FG006|Overall Study|Other|1|||
23219675|NCT04731922|64544965|FG007|Overall Study|Other|0|||
23219676|NCT04731922|64544966|FG008|Overall Study|Other|0|||
23219677|NCT04731922|64544967|FG009|Overall Study|Other|0|||
23219678|NCT04731922|64544968|FG010|Overall Study|Other|0|||
23219679|NCT04731922|64544969|FG011|Overall Study|Other|0|||
23219680|NCT04731922|64544970|FG012|Overall Study|Other|0|||
23150370|NCT03249714|64301843|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
23219681|NCT04731922|64544971|FG013|Overall Study|Other|0|||
23219682|NCT04731922|64544972|FG014|Overall Study|Other|0|||
23219683|NCT04731922|64544973|FG015|Overall Study|Other|0|||
23150371|NCT03249714|64301844|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
23150372|NCT03249714|64301843|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
23219684|NCT04731922|64544974|FG016|Overall Study|Other|0|||
23219685|NCT02443805|64544975|FG000|Overall Study|Adverse Event|100|||
23219686|NCT02443805|64544976|FG001|Overall Study|Adverse Event|18|||
23219687|NCT02443805|64544975|FG000|Overall Study|Withdrawal by Subject|73|||
23219688|NCT02443805|64544976|FG001|Overall Study|Withdrawal by Subject|74|||
23219689|NCT02443805|64544975|FG000|Overall Study|Lost to Follow-up|19|||
23150373|NCT03249714|64301844|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
23150374|NCT03249714|64301843|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
23150375|NCT03249714|64301844|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
23150376|NCT03249714|64301843|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
23150377|NCT03249714|64301844|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
23150378|NCT01979835|64301851|FG000|Primary Outcome SA Measurment|failed insertion|18|||
23150379|NCT01979835|64301851|FG000|Follow-up|Lost to Follow-up|32|||
23150380|NCT00775450|64301856|FG000|Overall Study|Serious Adverse Event|2|||
23150381|NCT00775450|64301857|FG001|Overall Study|Serious Adverse Event|0|||
23150382|NCT00775450|64301858|FG002|Overall Study|Serious Adverse Event|0|||
23150383|NCT00775450|64301859|FG003|Overall Study|Serious Adverse Event|0|||
23150384|NCT00775450|64301860|FG004|Overall Study|Serious Adverse Event|0|||
23150385|NCT00775450|64301856|FG000|Overall Study|Protocol Violation|0|||
23150386|NCT00775450|64301857|FG001|Overall Study|Protocol Violation|0|||
23150387|NCT00775450|64301858|FG002|Overall Study|Protocol Violation|0|||
23150388|NCT00775450|64301859|FG003|Overall Study|Protocol Violation|0|||
23219690|NCT02443805|64544976|FG001|Overall Study|Lost to Follow-up|14|||
23150389|NCT00775450|64301860|FG004|Overall Study|Protocol Violation|1|||
23150390|NCT00775450|64301856|FG000|Overall Study|Withdrawal by Subject|1|||
23150391|NCT00775450|64301857|FG001|Overall Study|Withdrawal by Subject|0|||
23150392|NCT00775450|64301858|FG002|Overall Study|Withdrawal by Subject|0|||
23150393|NCT00775450|64301859|FG003|Overall Study|Withdrawal by Subject|0|||
23150394|NCT00775450|64301860|FG004|Overall Study|Withdrawal by Subject|1|||
23150395|NCT01674712|64301861|FG000|Overall Study|Adverse Event|5|||
23150396|NCT01674712|64301862|FG001|Overall Study|Adverse Event|6|||
23150397|NCT01674712|64301863|FG002|Overall Study|Adverse Event|3|||
23150398|NCT01674712|64301864|FG003|Overall Study|Adverse Event|4|||
23150399|NCT01674712|64301865|FG004|Overall Study|Adverse Event|6|||
23150400|NCT01674712|64301861|FG000|Overall Study|Lost to Follow-up|1|||
23150401|NCT01674712|64301862|FG001|Overall Study|Lost to Follow-up|0|||
23150402|NCT01674712|64301863|FG002|Overall Study|Lost to Follow-up|0|||
23219691|NCT02443805|64544975|FG000|Overall Study|Pregnancy|6|||
23219692|NCT02443805|64544976|FG001|Overall Study|Pregnancy|5|||
23219693|NCT02443805|64544975|FG000|Overall Study|Protocol Violation|2|||
23219694|NCT02443805|64544976|FG001|Overall Study|Protocol Violation|4|||
23219695|NCT02443805|64544975|FG000|Overall Study|Lack of Efficacy|1|||
23219696|NCT02443805|64544976|FG001|Overall Study|Lack of Efficacy|1|||
23219697|NCT02443805|64544975|FG000|Overall Study|Non-compliance with study drug|6|||
23219698|NCT02443805|64544976|FG001|Overall Study|Non-compliance with study drug|4|||
23219699|NCT02443805|64544975|FG000|Overall Study|Withdrawal by parent/guardian|3|||
23219700|NCT02443805|64544976|FG001|Overall Study|Withdrawal by parent/guardian|5|||
23219701|NCT02443805|64544975|FG000|Overall Study|Any other reason not above-mentioned|3|||
23219702|NCT02443805|64544976|FG001|Overall Study|Any other reason not above-mentioned|2|||
23219703|NCT03124407|64544985|FG000|Overall Study|Lost to Follow-up|1|||
23219704|NCT03124407|64544986|FG001|Overall Study|Lost to Follow-up|0|||
23219705|NCT03124407|64544987|FG002|Overall Study|Lost to Follow-up|0|||
23219706|NCT03124407|64544988|FG003|Overall Study|Lost to Follow-up|0|||
23219707|NCT03124407|64544985|FG000|Overall Study|Adverse Event|0|||
23219708|NCT03124407|64544986|FG001|Overall Study|Adverse Event|0|||
23219709|NCT03124407|64544987|FG002|Overall Study|Adverse Event|1|||
23219710|NCT03124407|64544988|FG003|Overall Study|Adverse Event|0|||
23219711|NCT00688545|64544993|FG000|Overall Study|Lost to Follow-up|1|||
23219712|NCT00688545|64544994|FG001|Overall Study|Lost to Follow-up|4|||
23219713|NCT00688545|64544993|FG000|Overall Study|Insurance/cost of drug|0|||
23219714|NCT00688545|64544994|FG001|Overall Study|Insurance/cost of drug|1|||
23219715|NCT00688545|64544993|FG000|Overall Study|Withdrawal by Subject|2|||
23219716|NCT00688545|64544994|FG001|Overall Study|Withdrawal by Subject|3|||
23219717|NCT00688545|64544993|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
23219718|NCT00688545|64544994|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
23219719|NCT02583711|64544995|FG000|Overall Study|Withdrawal by Subject|0|||
23219720|NCT02583711|64544996|FG001|Overall Study|Withdrawal by Subject|10|||
23219721|NCT02583711|64544997|FG002|Overall Study|Withdrawal by Subject|0|||
23219722|NCT01095666|64544998|FG000|Overall Study|Lack of Efficacy|0|||
23219723|NCT01095666|64544999|FG001|Overall Study|Lack of Efficacy|0|||
23150403|NCT01674712|64301864|FG003|Overall Study|Lost to Follow-up|0|||
23150404|NCT01674712|64301865|FG004|Overall Study|Lost to Follow-up|0|||
23150405|NCT01674712|64301861|FG000|Overall Study|Protocol Violation|2|||
23150406|NCT01674712|64301862|FG001|Overall Study|Protocol Violation|0|||
23150407|NCT01674712|64301863|FG002|Overall Study|Protocol Violation|0|||
23150408|NCT01674712|64301864|FG003|Overall Study|Protocol Violation|0|||
23150409|NCT01674712|64301865|FG004|Overall Study|Protocol Violation|0|||
23150410|NCT01674712|64301861|FG000|Overall Study|Withdrawal by Subject|2|||
23219724|NCT01095666|64545000|FG002|Overall Study|Lack of Efficacy|1|||
23219725|NCT01095666|64544998|FG000|Overall Study|Adverse Event|2|||
23219726|NCT01095666|64544999|FG001|Overall Study|Adverse Event|1|||
23219727|NCT01095666|64545000|FG002|Overall Study|Adverse Event|3|||
23150411|NCT01674712|64301862|FG001|Overall Study|Withdrawal by Subject|2|||
23150412|NCT01674712|64301863|FG002|Overall Study|Withdrawal by Subject|5|||
23150413|NCT01674712|64301864|FG003|Overall Study|Withdrawal by Subject|4|||
23150414|NCT01674712|64301865|FG004|Overall Study|Withdrawal by Subject|3|||
23150415|NCT01674712|64301861|FG000|Overall Study|Administrative|0|||
23150416|NCT01674712|64301862|FG001|Overall Study|Administrative|1|||
23150417|NCT01674712|64301863|FG002|Overall Study|Administrative|0|||
23150418|NCT01674712|64301864|FG003|Overall Study|Administrative|0|||
23150419|NCT01674712|64301865|FG004|Overall Study|Administrative|1|||
23150420|NCT01674712|64301861|FG000|Overall Study|Lack of Efficacy|0|||
23150421|NCT01674712|64301862|FG001|Overall Study|Lack of Efficacy|0|||
23150422|NCT01674712|64301863|FG002|Overall Study|Lack of Efficacy|1|||
23150423|NCT01674712|64301864|FG003|Overall Study|Lack of Efficacy|0|||
23150424|NCT01674712|64301865|FG004|Overall Study|Lack of Efficacy|1|||
23150425|NCT01177722|64301866|FG000|Overall Study|Serious Adverse Event|0|||
23150426|NCT01177722|64301867|FG001|Overall Study|Serious Adverse Event|0|||
23150427|NCT01177722|64301868|FG002|Overall Study|Serious Adverse Event|1|||
23324423|NCT03238651|64930321|FG003|Overall Study|Progressive Disease|2|||
23324424|NCT03238651|64930322|FG004|Overall Study|Progressive Disease|0|||
23324425|NCT03238651|64930318|FG000|Overall Study|Withdrawal by Subject|0|||
23324426|NCT03238651|64930319|FG001|Overall Study|Withdrawal by Subject|1|||
23324427|NCT03238651|64930320|FG002|Overall Study|Withdrawal by Subject|0|||
23324428|NCT03238651|64930321|FG003|Overall Study|Withdrawal by Subject|1|||
23324429|NCT03238651|64930322|FG004|Overall Study|Withdrawal by Subject|0|||
23324430|NCT03238651|64930318|FG000|Overall Study|Adverse Event|1|||
23324431|NCT03238651|64930319|FG001|Overall Study|Adverse Event|3|||
23324432|NCT03238651|64930320|FG002|Overall Study|Adverse Event|2|||
23324433|NCT03238651|64930321|FG003|Overall Study|Adverse Event|0|||
23324434|NCT03238651|64930322|FG004|Overall Study|Adverse Event|0|||
23324435|NCT04135937|64930324|FG000|Overall Study|Lost to Follow-up|2|||
23324436|NCT04135937|64930324|FG000|Overall Study|Withdrawal by Subject|1|||
23324437|NCT00931411|64930325|FG000|First Intervention - 42 Days|Adverse Event|2|||
23324438|NCT00931411|64930326|FG001|First Intervention - 42 Days|Adverse Event|3|||
23324439|NCT00931411|64930325|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
23324440|NCT00931411|64930326|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
23324441|NCT00931411|64930325|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
23324442|NCT00931411|64930326|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
23324443|NCT05064397|64930328|FG000|Overall Study|Adverse Event|4|||
23324444|NCT05064397|64930328|FG000|Overall Study|Lack of Efficacy|12|||
23324445|NCT05064397|64930328|FG000|Overall Study|Withdrawal by Subject|3|||
23324446|NCT05064397|64930328|FG000|Overall Study|Lost to Follow-up|1|||
23324447|NCT05064397|64930328|FG000|Overall Study|Other reasons|3|||
23324448|NCT03832686|64930329|FG000|Overall Study|Lost to Follow-up|6|||
23324449|NCT03832686|64930330|FG001|Overall Study|Lost to Follow-up|9|||
23324450|NCT03832686|64930329|FG000|Overall Study|Discontinued Intervention|5|||
23324451|NCT03832686|64930330|FG001|Overall Study|Discontinued Intervention|4|||
23324452|NCT04495829|64930335|FG000|Overall Study|Lost to Follow-up|2|||
23324453|NCT04495829|64930335|FG000|Overall Study|Inclusion criterion not met|3|||
23324454|NCT01009814|64930336|FG000|Overall Study|No longer met study criteria|1|||
23324455|NCT01009814|64930337|FG001|Overall Study|No longer met study criteria|1|||
23324456|NCT01009814|64930338|FG002|Overall Study|No longer met study criteria|0|||
23324457|NCT01009814|64930339|FG003|Overall Study|No longer met study criteria|0|||
23324458|NCT01009814|64930340|FG004|Overall Study|No longer met study criteria|0|||
23324459|NCT01565889|64930341|FG000|Part A|Withdrawal by Subject|1|||
23324460|NCT01565889|64930342|FG001|Part A|Withdrawal by Subject|0|||
23324461|NCT01565889|64930343|FG002|Part A|Withdrawal by Subject|0|||
23324462|NCT01565889|64930344|FG003|Part A|Withdrawal by Subject|0|||
23324463|NCT01565889|64930345|FG004|Part A|Withdrawal by Subject|0|||
23324464|NCT01565889|64930346|FG005|Part A|Withdrawal by Subject|0|||
23324465|NCT01565889|64930341|FG000|Part B|Withdrawal by Subject|0|||
23324466|NCT01565889|64930342|FG001|Part B|Withdrawal by Subject|0|||
23324467|NCT01565889|64930343|FG002|Part B|Withdrawal by Subject|0|||
23324468|NCT01565889|64930344|FG003|Part B|Withdrawal by Subject|0|||
23324469|NCT01565889|64930345|FG004|Part B|Withdrawal by Subject|0|||
23324470|NCT01565889|64930346|FG005|Part B|Withdrawal by Subject|1|||
23150428|NCT01177722|64301869|FG003|Overall Study|Serious Adverse Event|0|||
23324471|NCT01565889|64930341|FG000|Part B|Lack of Efficacy|0|||
23324472|NCT01565889|64930342|FG001|Part B|Lack of Efficacy|0|||
23150429|NCT01177722|64301866|FG000|Overall Study|Protocol Violation|0|||
23150430|NCT01177722|64301867|FG001|Overall Study|Protocol Violation|0|||
23150431|NCT01177722|64301868|FG002|Overall Study|Protocol Violation|1|||
23324473|NCT01565889|64930343|FG002|Part B|Lack of Efficacy|0|||
23324474|NCT01565889|64930344|FG003|Part B|Lack of Efficacy|0|||
23324475|NCT01565889|64930345|FG004|Part B|Lack of Efficacy|0|||
23324476|NCT01565889|64930346|FG005|Part B|Lack of Efficacy|2|||
23324477|NCT01565889|64930341|FG000|Part B|Lost to Follow-up|0|||
23324478|NCT01565889|64930342|FG001|Part B|Lost to Follow-up|0|||
23324479|NCT01565889|64930343|FG002|Part B|Lost to Follow-up|0|||
23324480|NCT01565889|64930344|FG003|Part B|Lost to Follow-up|0|||
23324481|NCT01565889|64930345|FG004|Part B|Lost to Follow-up|0|||
23324482|NCT01565889|64930346|FG005|Part B|Lost to Follow-up|1|||
23324483|NCT04753216|64930347|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
23324484|NCT04753216|64930347|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
23324485|NCT04753216|64930347|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
23324486|NCT03359850|64930353|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
23324487|NCT03359850|64930354|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
23324488|NCT03359850|64930353|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
23324489|NCT03359850|64930354|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
23324490|NCT03359850|64930353|FG000|Extension Phase (Up to 28 Months)|Death|2|||
23324491|NCT03359850|64930354|FG001|Extension Phase (Up to 28 Months)|Death|4|||
23324492|NCT03359850|64930353|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
23324493|NCT03359850|64930354|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
23324494|NCT03359850|64930353|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
23560671|NCT01376323|65782365|FG003|Overall Study|Withdrawal by Subject|0|||
23560672|NCT01376323|65782366|FG004|Overall Study|Withdrawal by Subject|0|||
23324495|NCT03359850|64930354|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
23560673|NCT01224925|65782367|FG000|Overall Study|Lost to Follow-up|3|||
23560674|NCT01224925|65782368|FG001|Overall Study|Lost to Follow-up|2|||
23560675|NCT01520402|65782372|FG000|Overall Study|Withdrawal by Subject|2|||
23560676|NCT01520402|65782372|FG000|Overall Study|Physician Decision|3|||
23560677|NCT01279343|65782373|FG000|Overall Study|Did not receive treatment|2|||
23560678|NCT01279343|65782374|FG001|Overall Study|Did not receive treatment|6|||
23560679|NCT00571701|65782377|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
23324502|NCT00811733|64930361|FG000|Overall Study|Investigator Discretion|10|||
23324503|NCT00811733|64930362|FG001|Overall Study|Investigator Discretion|8|||
23324504|NCT00811733|64930361|FG000|Overall Study|Withdrawal by Subject|1|||
23324505|NCT00811733|64930362|FG001|Overall Study|Withdrawal by Subject|2|||
23324506|NCT02414958|64930365|FG000|Overall Study|Adverse Event|6|||
23324507|NCT02414958|64930366|FG001|Overall Study|Adverse Event|6|||
23324508|NCT02414958|64930367|FG002|Overall Study|Adverse Event|3|||
23324509|NCT02414958|64930365|FG000|Overall Study|Protocol Violation|10|||
23324510|NCT02414958|64930366|FG001|Overall Study|Protocol Violation|3|||
23324511|NCT02414958|64930367|FG002|Overall Study|Protocol Violation|1|||
23324512|NCT02414958|64930365|FG000|Overall Study|Lost to Follow-up|7|||
23324513|NCT02414958|64930366|FG001|Overall Study|Lost to Follow-up|4|||
23324514|NCT02414958|64930367|FG002|Overall Study|Lost to Follow-up|0|||
23324515|NCT02414958|64930365|FG000|Overall Study|Withdrawal by Subject|5|||
23324516|NCT02414958|64930366|FG001|Overall Study|Withdrawal by Subject|3|||
23324517|NCT02414958|64930367|FG002|Overall Study|Withdrawal by Subject|5|||
23324518|NCT02414958|64930365|FG000|Overall Study|Other than specified|4|||
23324519|NCT02414958|64930366|FG001|Overall Study|Other than specified|4|||
23324520|NCT02414958|64930367|FG002|Overall Study|Other than specified|5|||
23324521|NCT03333941|64930370|FG000|Overall Study|Lost to Follow-up|10|||
23324522|NCT03333941|64930370|FG000|Overall Study|Death|2|||
23324523|NCT03333941|64930370|FG000|Overall Study|Adverse Event|1|||
23324524|NCT01863667|64930371|FG000|Overall Study|Adverse Event|1|||
23324525|NCT01863667|64930372|FG001|Overall Study|Adverse Event|0|||
23324526|NCT01863667|64930371|FG000|Overall Study|Study terminated by Sponsor|30|||
23324527|NCT01863667|64930372|FG001|Overall Study|Study terminated by Sponsor|30|||
23324528|NCT01863667|64930371|FG000|Overall Study|Withdrawal by Subject|2|||
23324529|NCT01863667|64930372|FG001|Overall Study|Withdrawal by Subject|2|||
23560680|NCT00571701|65782378|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
23560681|NCT00571701|65782377|FG000|First Intervention 12 Months|Death|1|||
23150432|NCT01177722|64301869|FG003|Overall Study|Protocol Violation|0|||
23150433|NCT01177722|64301866|FG000|Overall Study|Lost to Follow-up|3|||
23150434|NCT01177722|64301867|FG001|Overall Study|Lost to Follow-up|4|||
23150435|NCT01177722|64301868|FG002|Overall Study|Lost to Follow-up|3|||
23150436|NCT01177722|64301869|FG003|Overall Study|Lost to Follow-up|1|||
23150437|NCT01177722|64301866|FG000|Overall Study|Withdrawal by Subject|10|||
23150438|NCT01177722|64301867|FG001|Overall Study|Withdrawal by Subject|6|||
23150439|NCT01177722|64301868|FG002|Overall Study|Withdrawal by Subject|4|||
23324530|NCT00668317|64930374|FG000|Overall Study|Adverse Event|2|||
23560682|NCT00571701|65782378|FG001|First Intervention 12 Months|Death|0|||
23560683|NCT00571701|65782377|FG000|Second Intervention 12 Months|Adverse Event|0|||
23150440|NCT01177722|64301869|FG003|Overall Study|Withdrawal by Subject|6|||
23324531|NCT00370552|64930375|FG000|Overall Study|Adverse Event|2|||
23324532|NCT00370552|64930376|FG001|Overall Study|Adverse Event|2|||
23560684|NCT00571701|65782378|FG001|Second Intervention 12 Months|Adverse Event|1|||
23560685|NCT00571701|65782377|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
23150441|NCT01290601|64301870|FG000|Overall Study|Adverse Event|0|||
23324533|NCT00370552|64930377|FG002|Overall Study|Adverse Event|2|||
23324534|NCT00370552|64930375|FG000|Overall Study|Disease progression|23|||
23324535|NCT00370552|64930376|FG001|Overall Study|Disease progression|23|||
23324536|NCT00370552|64930377|FG002|Overall Study|Disease progression|15|||
23324537|NCT00370552|64930375|FG000|Overall Study|Maximum clinical benefit|3|||
23324538|NCT00370552|64930376|FG001|Overall Study|Maximum clinical benefit|5|||
23324539|NCT00370552|64930377|FG002|Overall Study|Maximum clinical benefit|5|||
23324540|NCT00370552|64930375|FG000|Overall Study|Poor or noncompliance|0|||
23324541|NCT00370552|64930376|FG001|Overall Study|Poor or noncompliance|0|||
23324542|NCT00370552|64930377|FG002|Overall Study|Poor or noncompliance|1|||
23324543|NCT00370552|64930375|FG000|Overall Study|Study drug toxicity|11|||
23324544|NCT00370552|64930376|FG001|Overall Study|Study drug toxicity|8|||
23324545|NCT00370552|64930377|FG002|Overall Study|Study drug toxicity|6|||
23324546|NCT00370552|64930375|FG000|Overall Study|Withdrawal by Subject|2|||
23324547|NCT00370552|64930376|FG001|Overall Study|Withdrawal by Subject|0|||
23324548|NCT00370552|64930377|FG002|Overall Study|Withdrawal by Subject|1|||
23324549|NCT00370552|64930375|FG000|Overall Study|Still on treatment|1|||
23324550|NCT00370552|64930376|FG001|Overall Study|Still on treatment|3|||
23438354|NCT00231413|65348572|FG004|Overall Study|Migrated/moved from study area|0|||
23438355|NCT00231413|65348573|FG005|Overall Study|Migrated/moved from study area|1|||
23438356|NCT00231413|65348574|FG006|Overall Study|Migrated/moved from study area|0|||
23438357|NCT00231413|65348568|FG000|Overall Study|Lost to Follow-up|4|||
23438358|NCT00231413|65348569|FG001|Overall Study|Lost to Follow-up|4|||
23438359|NCT00231413|65348570|FG002|Overall Study|Lost to Follow-up|1|||
23438360|NCT00231413|65348571|FG003|Overall Study|Lost to Follow-up|1|||
23438361|NCT00231413|65348572|FG004|Overall Study|Lost to Follow-up|1|||
23438362|NCT00231413|65348573|FG005|Overall Study|Lost to Follow-up|4|||
23438363|NCT00231413|65348574|FG006|Overall Study|Lost to Follow-up|0|||
23624896|NCT01296555|66015412|FG020|Overall Study|Adverse Event|0|||
23624897|NCT01296555|66015413|FG021|Overall Study|Adverse Event|0|||
23624898|NCT01296555|66015414|FG022|Overall Study|Adverse Event|0|||
23624899|NCT01296555|66015415|FG023|Overall Study|Adverse Event|0|||
23150442|NCT01290601|64301871|FG001|Overall Study|Adverse Event|2|||
23150443|NCT01290601|64301872|FG002|Overall Study|Adverse Event|0|||
23150444|NCT01290601|64301873|FG003|Overall Study|Adverse Event|0|||
23150445|NCT01290601|64301870|FG000|Overall Study|Lack of Efficacy|2|||
23150446|NCT01290601|64301871|FG001|Overall Study|Lack of Efficacy|1|||
23150447|NCT01290601|64301872|FG002|Overall Study|Lack of Efficacy|0|||
23150448|NCT01290601|64301873|FG003|Overall Study|Lack of Efficacy|0|||
23150449|NCT01290601|64301870|FG000|Overall Study|Lost to Follow-up|7|||
23150450|NCT01290601|64301871|FG001|Overall Study|Lost to Follow-up|2|||
23150451|NCT01290601|64301872|FG002|Overall Study|Lost to Follow-up|0|||
23150452|NCT01290601|64301873|FG003|Overall Study|Lost to Follow-up|0|||
23219728|NCT01095666|64544998|FG000|Overall Study|Lost to Follow-up|2|||
23219729|NCT01095666|64544999|FG001|Overall Study|Lost to Follow-up|2|||
23219730|NCT01095666|64545000|FG002|Overall Study|Lost to Follow-up|0|||
23219731|NCT01095666|64544998|FG000|Overall Study|Withdrawal by Subject|6|||
23219732|NCT01095666|64544999|FG001|Overall Study|Withdrawal by Subject|6|||
23219733|NCT01095666|64545000|FG002|Overall Study|Withdrawal by Subject|1|||
23219734|NCT01095666|64544998|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
23219735|NCT01095666|64544999|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
23219736|NCT01095666|64545000|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
23219737|NCT01415908|64545001|FG000|Overall Study|Withdrawal by Subject|1|||
23219738|NCT01415908|64545002|FG001|Overall Study|Withdrawal by Subject|0|||
23219739|NCT01993667|64549935|FG000|Overall Study|Insufficient data to analyze|16|||
23219740|NCT01993667|64549936|FG001|Overall Study|Insufficient data to analyze|16|||
23219741|NCT01993667|64549935|FG000|Overall Study|Insufficient altitude reached|3|||
23219742|NCT01993667|64549936|FG001|Overall Study|Insufficient altitude reached|1|||
23219743|NCT01993667|64549935|FG000|Overall Study|Lost to Follow-up|2|||
23219744|NCT01993667|64549936|FG001|Overall Study|Lost to Follow-up|2|||
23219745|NCT03927911|64549937|FG000|Overall Study|problems with eDiary|0|||
23219746|NCT03927911|64549938|FG001|Overall Study|problems with eDiary|1|||
23219747|NCT03927911|64549939|FG002|Overall Study|problems with eDiary|0|||
23219748|NCT03927911|64549940|FG003|Overall Study|problems with eDiary|1|||
23219749|NCT03927911|64549941|FG004|Overall Study|problems with eDiary|0|||
23219750|NCT03927911|64549942|FG005|Overall Study|problems with eDiary|4|||
23324551|NCT00370552|64930377|FG002|Overall Study|Still on treatment|2|||
23438364|NCT00231413|65348568|FG000|Overall Study|Pregnancy|1|||
23150453|NCT01290601|64301870|FG000|Overall Study|Other|1|||
23150454|NCT01290601|64301871|FG001|Overall Study|Other|0|||
23219751|NCT03927911|64549937|FG000|Overall Study|Adverse Event|0|||
23219752|NCT03927911|64549938|FG001|Overall Study|Adverse Event|0|||
23219753|NCT03927911|64549939|FG002|Overall Study|Adverse Event|0|||
23219754|NCT03927911|64549940|FG003|Overall Study|Adverse Event|0|||
23624900|NCT01296555|66015416|FG024|Overall Study|Adverse Event|0|||
23624901|NCT01296555|66015417|FG025|Overall Study|Adverse Event|0|||
23150455|NCT01290601|64301872|FG002|Overall Study|Other|0|||
23150456|NCT01290601|64301873|FG003|Overall Study|Other|0|||
23219755|NCT03927911|64549941|FG004|Overall Study|Adverse Event|0|||
23324552|NCT00370552|64930375|FG000|Overall Study|Never treated|1|||
23324553|NCT00370552|64930376|FG001|Overall Study|Never treated|0|||
23324554|NCT00370552|64930377|FG002|Overall Study|Never treated|0|||
23438365|NCT00231413|65348569|FG001|Overall Study|Pregnancy|0|||
23324555|NCT00370552|64930375|FG000|Overall Study|Physician Decision|1|||
23324556|NCT00370552|64930376|FG001|Overall Study|Physician Decision|1|||
23324557|NCT00370552|64930377|FG002|Overall Study|Physician Decision|0|||
23560686|NCT00571701|65782378|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
23560687|NCT00069784|65782381|FG000|Overall Study|Adverse Event|105|||
23560688|NCT00069784|65782382|FG001|Overall Study|Adverse Event|0|||
23150457|NCT01290601|64301870|FG000|Overall Study|Protocol Violation|1|||
23150458|NCT01290601|64301871|FG001|Overall Study|Protocol Violation|0|||
23150459|NCT01290601|64301872|FG002|Overall Study|Protocol Violation|0|||
23150460|NCT01290601|64301873|FG003|Overall Study|Protocol Violation|0|||
23150461|NCT02544217|64301874|FG000|Overall Study|Withdrawal by Subject|1|||
23150462|NCT02544217|64301875|FG001|Overall Study|Withdrawal by Subject|1|||
23150463|NCT02544217|64301876|FG002|Overall Study|Withdrawal by Subject|0|||
23150464|NCT02544217|64301877|FG003|Overall Study|Withdrawal by Subject|0|||
23150465|NCT02544217|64301878|FG004|Overall Study|Withdrawal by Subject|0|||
23150466|NCT02544217|64301879|FG005|Overall Study|Withdrawal by Subject|0|||
23150467|NCT00504153|64301880|FG000|Overall Study|Withdrawal by Subject|1|||
23150468|NCT00504153|64301880|FG000|Overall Study|Adverse Event|4|||
23150469|NCT00504153|64301880|FG000|Overall Study|Death|1|||
23150470|NCT00702845|64301881|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
23219756|NCT03927911|64549942|FG005|Overall Study|Adverse Event|1|||
23219757|NCT03927911|64549937|FG000|Overall Study|not treated -study terminated by sponsor|0|||
23219758|NCT03927911|64549938|FG001|Overall Study|not treated -study terminated by sponsor|1|||
23219759|NCT03927911|64549939|FG002|Overall Study|not treated -study terminated by sponsor|0|||
23219760|NCT03927911|64549940|FG003|Overall Study|not treated -study terminated by sponsor|0|||
23219761|NCT03927911|64549941|FG004|Overall Study|not treated -study terminated by sponsor|0|||
23219762|NCT03927911|64549942|FG005|Overall Study|not treated -study terminated by sponsor|0|||
23219763|NCT03927911|64549937|FG000|Overall Study|Surgery cancelled|0|||
23150471|NCT00702845|64301882|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
23150472|NCT00702845|64301881|FG000|Overall Study|Too high ovarian response|5|||
23560689|NCT00069784|65782381|FG000|Overall Study|Withdrawal by Subject|1090|||
23560690|NCT00069784|65782382|FG001|Overall Study|Withdrawal by Subject|0|||
23560691|NCT00069784|65782381|FG000|Overall Study|Other|17|||
23560692|NCT00069784|65782382|FG001|Overall Study|Other|0|||
23560693|NCT02010632|65782384|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
23560694|NCT02010632|65782385|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
23560695|NCT02736825|65782386|FG000|Overall Study|Lost to Follow-up|10|||
23560696|NCT02736825|65782387|FG001|Overall Study|Lost to Follow-up|11|||
23560697|NCT02736825|65782386|FG000|Overall Study|Early Termination|0|||
23560698|NCT02736825|65782387|FG001|Overall Study|Early Termination|1|||
23560699|NCT03541044|65782388|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
23150473|NCT00702845|64301882|FG001|Overall Study|Too high ovarian response|1|||
23150474|NCT00702845|64301881|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
23150475|NCT00702845|64301882|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
23150476|NCT00702845|64301881|FG000|Overall Study|Insufficient ovarian response|1|||
23150477|NCT00702845|64301882|FG001|Overall Study|Insufficient ovarian response|0|||
23150478|NCT00702845|64301881|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
23150479|NCT00702845|64301882|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
23150480|NCT00702845|64301881|FG000|Overall Study|No or abnormal fertilization|4|||
23150481|NCT00702845|64301882|FG001|Overall Study|No or abnormal fertilization|2|||
23219764|NCT03927911|64549938|FG001|Overall Study|Surgery cancelled|0|||
23560700|NCT03541044|65782389|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
23560701|NCT03541044|65782388|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
23560702|NCT03541044|65782389|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
23560703|NCT00094328|65782390|FG000|Overall Study|Lost to Follow-up|1|||
23560704|NCT05597722|65782391|FG000|Overall Study|Study was terminated|6|||
23560705|NCT05597722|65782392|FG001|Overall Study|Study was terminated|1|||
23560706|NCT00106184|65782394|FG000|Overall Study|Withdrawal by Subject|3|||
23560707|NCT00106184|65782395|FG001|Overall Study|Withdrawal by Subject|2|||
23560708|NCT03188120|65782397|FG000|Overall Study|Adverse Event|4|||
23560709|NCT03188120|65782397|FG000|Overall Study|Insufficient Effectiveness|8|||
23560710|NCT03188120|65782397|FG000|Overall Study|Improved|12|||
23624902|NCT01296555|66015418|FG026|Overall Study|Adverse Event|0|||
23150482|NCT00702845|64301881|FG000|Overall Study|Patient's decision|2|||
23324558|NCT00370552|64930375|FG000|Overall Study|Investigator decision|2|||
23560711|NCT03188120|65782397|FG000|Overall Study|Lost to Follow-up|7|||
23560712|NCT03188120|65782397|FG000|Overall Study|Other than specified|3|||
23560713|NCT03188120|65782397|FG000|Overall Study|No visit after the first visit|13|||
23560714|NCT01960725|65782401|FG000|Overall Study|Lost to Follow-up|4|||
23560715|NCT01960725|65782402|FG001|Overall Study|Lost to Follow-up|3|||
23560716|NCT01960725|65782401|FG000|Overall Study|Withdrawal by Subject|1|||
23560717|NCT01960725|65782402|FG001|Overall Study|Withdrawal by Subject|0|||
23624903|NCT01296555|66015419|FG027|Overall Study|Adverse Event|0|||
23150483|NCT00702845|64301882|FG001|Overall Study|Patient's decision|1|||
23324559|NCT00370552|64930376|FG001|Overall Study|Investigator decision|1|||
23150484|NCT00702845|64301881|FG000|Overall Study|Not randomized|0|||
23150485|NCT00702845|64301882|FG001|Overall Study|Not randomized|1|||
23150486|NCT02540538|64301883|FG000|Overall Study|Pregnancy|0|||
23150487|NCT02540538|64301884|FG001|Overall Study|Pregnancy|1|||
23150488|NCT02540538|64301885|FG002|Overall Study|Pregnancy|0|||
23150489|NCT03986866|64301886|FG000|Overall Study|Withdrawal by Subject|0|||
23150490|NCT03986866|64301887|FG001|Overall Study|Withdrawal by Subject|3|||
23438366|NCT00231413|65348570|FG002|Overall Study|Pregnancy|0|||
23438367|NCT00231413|65348571|FG003|Overall Study|Pregnancy|0|||
23438368|NCT00231413|65348572|FG004|Overall Study|Pregnancy|0|||
23438369|NCT00231413|65348573|FG005|Overall Study|Pregnancy|0|||
23438370|NCT00231413|65348574|FG006|Overall Study|Pregnancy|0|||
23438371|NCT00983385|65348575|FG000|Observation Period|Not eligible to be dosed|20|||
23438372|NCT00983385|65348575|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
23438373|NCT01894243|65348576|FG000|Overall Study|Adverse Event|0|||
23438374|NCT01894243|65348577|FG001|Overall Study|Adverse Event|1|||
23438375|NCT01894243|65348578|FG002|Overall Study|Adverse Event|2|||
23438376|NCT01894243|65348576|FG000|Overall Study|Death|0|||
23438377|NCT01894243|65348577|FG001|Overall Study|Death|0|||
23560718|NCT01960725|65782401|FG000|Overall Study|unable to obtain blood sample|1|||
23560719|NCT01960725|65782402|FG001|Overall Study|unable to obtain blood sample|2|||
23560720|NCT01058304|65782403|FG000|Overall Study|Withdrawal by Subject|8|||
23560721|NCT01058304|65782404|FG001|Overall Study|Withdrawal by Subject|5|||
23560722|NCT01058304|65782403|FG000|Overall Study|Lost to Follow-up|13|||
23560723|NCT01058304|65782404|FG001|Overall Study|Lost to Follow-up|16|||
23560724|NCT01058304|65782403|FG000|Overall Study|Developed exclusion criterion|6|||
23560725|NCT01058304|65782404|FG001|Overall Study|Developed exclusion criterion|12|||
23150491|NCT03986866|64301886|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
23324560|NCT00370552|64930377|FG002|Overall Study|Investigator decision|0|||
23324561|NCT00370552|64930375|FG000|Overall Study|High risk of allergic reaction|0|||
23560726|NCT00946296|65782405|FG000|Overall Study|Physician Decision|3|||
23560727|NCT00946296|65782406|FG001|Overall Study|Physician Decision|0|||
23150492|NCT03986866|64301887|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
23150493|NCT03123250|64301888|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
23150494|NCT03836807|64301889|FG000|Overall Study|Physician Decision|1|||
23150495|NCT03836807|64301890|FG001|Overall Study|Physician Decision|0|||
23150496|NCT02598557|64301891|FG000|Overall Study|Withdrawal by Subject|1|||
23150497|NCT02598557|64301892|FG001|Overall Study|Withdrawal by Subject|0|||
23150498|NCT02598557|64301893|FG002|Overall Study|Withdrawal by Subject|1|||
23150499|NCT02598557|64301891|FG000|Overall Study|Participant did not start treatment|2|||
23150500|NCT02598557|64301892|FG001|Overall Study|Participant did not start treatment|1|||
23150501|NCT02598557|64301893|FG002|Overall Study|Participant did not start treatment|1|||
23150502|NCT02598557|64301891|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
23150503|NCT02598557|64301892|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
23150504|NCT02598557|64301893|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
23150505|NCT02598557|64301891|FG000|Overall Study|Adverse Event|1|||
23150506|NCT02598557|64301892|FG001|Overall Study|Adverse Event|1|||
23150507|NCT02598557|64301893|FG002|Overall Study|Adverse Event|0|||
23150508|NCT00604279|64301894|FG000|Overall Study|Lack of Efficacy|22|||
23150509|NCT00604279|64301895|FG001|Overall Study|Lack of Efficacy|9|||
23150510|NCT00604279|64301894|FG000|Overall Study|Lost to Follow-up|9|||
23150511|NCT00604279|64301895|FG001|Overall Study|Lost to Follow-up|14|||
23150512|NCT00604279|64301894|FG000|Overall Study|Pregnancy|2|||
23150513|NCT00604279|64301895|FG001|Overall Study|Pregnancy|0|||
23150514|NCT00604279|64301894|FG000|Overall Study|Protocol Violation|3|||
23150515|NCT00604279|64301895|FG001|Overall Study|Protocol Violation|1|||
23219765|NCT03927911|64549939|FG002|Overall Study|Surgery cancelled|0|||
23219766|NCT03927911|64549940|FG003|Overall Study|Surgery cancelled|1|||
23560728|NCT04176939|65782407|FG000|Overall Study|Adverse Event|7|||
23560729|NCT04176939|65782407|FG000|Overall Study|Unspecified reason|2|||
23219767|NCT03927911|64549941|FG004|Overall Study|Surgery cancelled|0|||
23219768|NCT03927911|64549942|FG005|Overall Study|Surgery cancelled|1|||
23324562|NCT00370552|64930376|FG001|Overall Study|High risk of allergic reaction|1|||
23438378|NCT01894243|65348578|FG002|Overall Study|Death|3|||
23438379|NCT01894243|65348576|FG000|Overall Study|Lack of Efficacy|3|||
23438380|NCT01894243|65348577|FG001|Overall Study|Lack of Efficacy|3|||
23560730|NCT04176939|65782407|FG000|Overall Study|Migrated/Moved from the study area|1|||
23150516|NCT00604279|64301894|FG000|Overall Study|Withdrawal by Subject|16|||
23150517|NCT00604279|64301895|FG001|Overall Study|Withdrawal by Subject|5|||
23150518|NCT00604279|64301894|FG000|Overall Study|Adverse Event|4|||
23150519|NCT00604279|64301895|FG001|Overall Study|Adverse Event|5|||
23150520|NCT00604279|64301894|FG000|Overall Study|Other|8|||
23150521|NCT00604279|64301895|FG001|Overall Study|Other|4|||
23219769|NCT03927911|64549937|FG000|Overall Study|Protocol Violation|0|||
23438381|NCT01894243|65348578|FG002|Overall Study|Lack of Efficacy|1|||
23560731|NCT04176939|65782407|FG000|Overall Study|Withdrawal by Subject|4|||
23560732|NCT04176939|65782407|FG000|Overall Study|In follow-up|54|||
23150522|NCT01241552|64301896|FG000|Overall Study|Lack of Efficacy|1|||
23560733|NCT00110890|65782408|FG000|Overall Study|Adverse Event|30|||
23150523|NCT01241552|64301897|FG001|Overall Study|Lack of Efficacy|0|||
23150524|NCT01241552|64301898|FG002|Overall Study|Lack of Efficacy|0|||
23150525|NCT01241552|64301899|FG003|Overall Study|Lack of Efficacy|0|||
23150526|NCT01241552|64301896|FG000|Overall Study|Death|26|||
23150527|NCT01241552|64301897|FG001|Overall Study|Death|30|||
23150528|NCT01241552|64301898|FG002|Overall Study|Death|20|||
23150529|NCT01241552|64301899|FG003|Overall Study|Death|25|||
23150530|NCT01241552|64301896|FG000|Overall Study|Adverse Event|1|||
23150531|NCT01241552|64301897|FG001|Overall Study|Adverse Event|1|||
23150532|NCT01241552|64301898|FG002|Overall Study|Adverse Event|0|||
23219770|NCT03927911|64549938|FG001|Overall Study|Protocol Violation|0|||
23219771|NCT03927911|64549939|FG002|Overall Study|Protocol Violation|0|||
23219772|NCT03927911|64549940|FG003|Overall Study|Protocol Violation|0|||
23219773|NCT03927911|64549941|FG004|Overall Study|Protocol Violation|0|||
23219774|NCT03927911|64549942|FG005|Overall Study|Protocol Violation|1|||
23219775|NCT04063865|64549943|FG000|Overall Study|Physician Decision|1|||
23219776|NCT04063865|64549944|FG001|Overall Study|Physician Decision|3|||
23219777|NCT04063865|64549943|FG000|Overall Study|Study Closed Prior to Completion|4|||
23150533|NCT01241552|64301899|FG003|Overall Study|Adverse Event|0|||
23150534|NCT01241552|64301896|FG000|Overall Study|Technical Problems|2|||
23150535|NCT01241552|64301897|FG001|Overall Study|Technical Problems|0|||
23150536|NCT01241552|64301898|FG002|Overall Study|Technical Problems|2|||
23150537|NCT01241552|64301899|FG003|Overall Study|Technical Problems|2|||
23150538|NCT01241552|64301896|FG000|Overall Study|Progressive Disease|0|||
23150539|NCT01241552|64301897|FG001|Overall Study|Progressive Disease|0|||
23438382|NCT01894243|65348576|FG000|Overall Study|Condition under investigation worsened|8|||
23438383|NCT01894243|65348577|FG001|Overall Study|Condition under investigation worsened|6|||
23438384|NCT01894243|65348578|FG002|Overall Study|Condition under investigation worsened|2|||
23438385|NCT01894243|65348576|FG000|Overall Study|Subject decision|1|||
23438386|NCT01894243|65348577|FG001|Overall Study|Subject decision|0|||
23438387|NCT01894243|65348578|FG002|Overall Study|Subject decision|0|||
23438388|NCT01894243|65348576|FG000|Overall Study|Other|1|||
23438389|NCT01894243|65348577|FG001|Overall Study|Other|0|||
23438390|NCT01894243|65348578|FG002|Overall Study|Other|0|||
23438391|NCT04000581|65348583|FG000|Overall Study|Withdrawal by Subject|0|||
23438392|NCT04000581|65348584|FG001|Overall Study|Withdrawal by Subject|1|||
23438393|NCT00767819|65348590|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
23438394|NCT00767819|65348591|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
23438395|NCT00767819|65348592|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23438396|NCT00767819|65348590|FG000|Overall Study|Withdrawal by Subject|1|||
23438397|NCT00767819|65348591|FG001|Overall Study|Withdrawal by Subject|1|||
23438398|NCT00767819|65348592|FG002|Overall Study|Withdrawal by Subject|0|||
23438399|NCT00767819|65348590|FG000|Overall Study|Administrative problems|0|||
23438400|NCT00767819|65348591|FG001|Overall Study|Administrative problems|1|||
23438401|NCT00767819|65348592|FG002|Overall Study|Administrative problems|0|||
23438402|NCT00767819|65348590|FG000|Overall Study|Death|2|||
23438403|NCT00767819|65348591|FG001|Overall Study|Death|3|||
23438404|NCT00767819|65348592|FG002|Overall Study|Death|0|||
23438405|NCT00767819|65348590|FG000|Overall Study|Adverse Event|2|||
23438406|NCT00767819|65348591|FG001|Overall Study|Adverse Event|0|||
23560734|NCT00110890|65782409|FG001|Overall Study|Adverse Event|7|||
23560735|NCT00110890|65782408|FG000|Overall Study|Death|16|||
23560736|NCT00110890|65782409|FG001|Overall Study|Death|9|||
23560737|NCT00110890|65782408|FG000|Overall Study|Lost to Follow-up|3|||
23560738|NCT00110890|65782409|FG001|Overall Study|Lost to Follow-up|1|||
23560739|NCT00110890|65782408|FG000|Overall Study|Physician Decision|4|||
23560740|NCT00110890|65782409|FG001|Overall Study|Physician Decision|5|||
23150540|NCT01241552|64301898|FG002|Overall Study|Progressive Disease|1|||
23219778|NCT04063865|64549944|FG001|Overall Study|Study Closed Prior to Completion|4|||
23219779|NCT04063865|64549943|FG000|Overall Study|Withdrawal by Subject|1|||
23219780|NCT04063865|64549944|FG001|Overall Study|Withdrawal by Subject|1|||
23219781|NCT03997760|64549945|FG000|Overall Study|Protocol Deviation|0|||
23438407|NCT00767819|65348592|FG002|Overall Study|Adverse Event|0|||
23438408|NCT00767819|65348590|FG000|Overall Study|Abnormal lab values|1|||
23438409|NCT00767819|65348591|FG001|Overall Study|Abnormal lab values|0|||
23438410|NCT00767819|65348592|FG002|Overall Study|Abnormal lab values|0|||
23438411|NCT00767819|65348590|FG000|Overall Study|Lost to Follow-up|1|||
23438412|NCT00767819|65348591|FG001|Overall Study|Lost to Follow-up|0|||
23150541|NCT01241552|64301899|FG003|Overall Study|Progressive Disease|2|||
23150542|NCT01241552|64301896|FG000|Overall Study|Protocol Violation|0|||
23219782|NCT03997760|64549946|FG001|Overall Study|Protocol Deviation|1|||
23219783|NCT03997760|64549947|FG002|Overall Study|Protocol Deviation|0|||
23560741|NCT00110890|65782408|FG000|Overall Study|Withdrawal by Subject|17|||
23560742|NCT00110890|65782409|FG001|Overall Study|Withdrawal by Subject|5|||
23560743|NCT00110890|65782408|FG000|Overall Study|Protocol Deviation|1|||
23150543|NCT01241552|64301897|FG001|Overall Study|Protocol Violation|2|||
23150544|NCT01241552|64301898|FG002|Overall Study|Protocol Violation|6|||
23219784|NCT03997760|64549948|FG003|Overall Study|Protocol Deviation|0|||
23438413|NCT00767819|65348592|FG002|Overall Study|Lost to Follow-up|0|||
23438414|NCT00900029|65348593|FG000|Overall Study|Lost to Follow-up|0|||
23438415|NCT00900029|65348594|FG001|Overall Study|Lost to Follow-up|2|||
23438416|NCT00900029|65348595|FG002|Overall Study|Lost to Follow-up|1|||
23438417|NCT00900029|65348596|FG003|Overall Study|Lost to Follow-up|4|||
23438418|NCT00900029|65348597|FG004|Overall Study|Lost to Follow-up|4|||
23438419|NCT00900029|65348593|FG000|Overall Study|Withdrawal by Subject|2|||
23438420|NCT00900029|65348594|FG001|Overall Study|Withdrawal by Subject|2|||
23438421|NCT00900029|65348595|FG002|Overall Study|Withdrawal by Subject|1|||
23438422|NCT00900029|65348596|FG003|Overall Study|Withdrawal by Subject|1|||
23438423|NCT00900029|65348597|FG004|Overall Study|Withdrawal by Subject|1|||
23438424|NCT00900029|65348593|FG000|Overall Study|Adverse Event|0|||
23438425|NCT00900029|65348594|FG001|Overall Study|Adverse Event|0|||
23438426|NCT00900029|65348595|FG002|Overall Study|Adverse Event|1|||
23438427|NCT00900029|65348596|FG003|Overall Study|Adverse Event|1|||
23438428|NCT00900029|65348597|FG004|Overall Study|Adverse Event|1|||
23438429|NCT00900029|65348593|FG000|Overall Study|Death|1|||
23438430|NCT00900029|65348594|FG001|Overall Study|Death|0|||
23438431|NCT00900029|65348595|FG002|Overall Study|Death|0|||
23438432|NCT00900029|65348596|FG003|Overall Study|Death|1|||
23438433|NCT00900029|65348597|FG004|Overall Study|Death|0|||
23438434|NCT02713828|65348598|FG000|Overall Study|Death|2|||
23438435|NCT02713828|65348599|FG001|Overall Study|Death|0|||
23438436|NCT02713828|65348598|FG000|Overall Study|Withdrawal by Subject|1|||
23438437|NCT02713828|65348599|FG001|Overall Study|Withdrawal by Subject|0|||
23438438|NCT02713828|65348598|FG000|Overall Study|study terminated but patient allowed to|2|||
23438439|NCT02713828|65348599|FG001|Overall Study|study terminated but patient allowed to|0|||
23438440|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438441|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438442|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
23438443|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
23438444|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
23438445|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438446|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
23438447|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
23438448|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
23438449|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438450|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438451|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438452|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
23438453|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
23438454|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
23438455|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
23438456|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
23438457|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
23438458|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
23438459|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
23438460|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
23438461|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
23438462|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
23438463|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
23438464|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
23438465|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
23438466|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23150545|NCT01241552|64301899|FG003|Overall Study|Protocol Violation|1|||
23150546|NCT01241552|64301896|FG000|Overall Study|Withdrawal by Subject|7|||
23150547|NCT01241552|64301897|FG001|Overall Study|Withdrawal by Subject|15|||
23150548|NCT01241552|64301898|FG002|Overall Study|Withdrawal by Subject|14|||
23150549|NCT01241552|64301899|FG003|Overall Study|Withdrawal by Subject|15|||
23150550|NCT01241552|64301896|FG000|Overall Study|Physician Decision|2|||
23150551|NCT01241552|64301897|FG001|Overall Study|Physician Decision|4|||
23150552|NCT01241552|64301898|FG002|Overall Study|Physician Decision|2|||
23150553|NCT01241552|64301899|FG003|Overall Study|Physician Decision|3|||
23438467|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
23438468|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
23438469|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438470|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438471|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
23438472|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
23438473|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23453637|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23150554|NCT01241552|64301896|FG000|Overall Study|Lost to Follow-up|2|||
23438474|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438475|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438476|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438477|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438478|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
23438479|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438480|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
23438481|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
23438482|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438483|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438484|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438485|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
23438486|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438487|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
23438488|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438489|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438490|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438491|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
23438492|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438493|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438494|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438495|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
23438496|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438497|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438498|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438499|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
23438500|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438501|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438502|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438503|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438504|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
23438505|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438506|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438507|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438508|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
23438509|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438510|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438511|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
23438512|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438513|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438514|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438515|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438516|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438517|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
23438518|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438519|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
23438520|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438521|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438522|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438523|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438524|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438525|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438526|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438527|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438528|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23219785|NCT04914819|64549949|FG000|Overall Study|Pregnancy|3|||
23438529|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438530|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
23438531|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
23150555|NCT01241552|64301897|FG001|Overall Study|Lost to Follow-up|11|||
23150556|NCT01241552|64301898|FG002|Overall Study|Lost to Follow-up|15|||
23150557|NCT01241552|64301899|FG003|Overall Study|Lost to Follow-up|16|||
23150558|NCT01096342|64301900|FG000|Overall Study|Protocol Violation|1|||
23150559|NCT02456662|64301902|FG000|Overall Study|Lost to Follow-up|2|||
23150560|NCT02456662|64301903|FG001|Overall Study|Lost to Follow-up|1|||
23150561|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
23150562|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
23150563|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
23150564|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
23438532|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438533|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438534|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438535|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438536|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438537|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438538|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438539|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438540|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438541|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438542|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438543|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
23438544|NCT03100058|65348600|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438545|NCT03100058|65348601|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438546|NCT03100058|65348602|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23150565|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
23438547|NCT03100058|65348603|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438548|NCT03100058|65348604|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438549|NCT03100058|65348605|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438550|NCT03100058|65348606|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
23438551|NCT03100058|65348607|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438552|NCT03100058|65348608|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438553|NCT03100058|65348609|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438554|NCT03100058|65348610|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438555|NCT03100058|65348611|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438556|NCT03100058|65348612|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
23438557|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438558|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438559|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23560744|NCT00110890|65782409|FG001|Overall Study|Protocol Deviation|0|||
23560745|NCT00110890|65782408|FG000|Overall Study|Noncompliance|10|||
23560746|NCT00110890|65782409|FG001|Overall Study|Noncompliance|0|||
23560747|NCT00110890|65782408|FG000|Overall Study|Kidney Transplant|16|||
23560748|NCT00110890|65782409|FG001|Overall Study|Kidney Transplant|12|||
23560749|NCT00110890|65782408|FG000|Overall Study|Invest. Product Commercially Available|217|||
23560750|NCT00110890|65782409|FG001|Overall Study|Invest. Product Commercially Available|110|||
23560751|NCT00110890|65782408|FG000|Overall Study|Other|34|||
23560752|NCT00110890|65782409|FG001|Overall Study|Other|23|||
23560753|NCT00110890|65782408|FG000|Overall Study|Ineligibility determined|3|||
23560754|NCT00110890|65782409|FG001|Overall Study|Ineligibility determined|0|||
23560755|NCT00110890|65782408|FG000|Overall Study|Requirement for alternative therapy|0|||
23560756|NCT00110890|65782409|FG001|Overall Study|Requirement for alternative therapy|1|||
23560757|NCT00110890|65782408|FG000|Overall Study|Disease progression|0|||
23560758|NCT00110890|65782409|FG001|Overall Study|Disease progression|1|||
23560759|NCT00110890|65782408|FG000|Overall Study|Parathyroidectomy|0|||
23560760|NCT00110890|65782409|FG001|Overall Study|Parathyroidectomy|1|||
23560761|NCT00110890|65782408|FG000|Overall Study|Did not enter follow-up phase|10|||
23560762|NCT00110890|65782409|FG001|Overall Study|Did not enter follow-up phase|4|||
23560763|NCT02535364|65782414|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
23560764|NCT02535364|65782414|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
23560765|NCT02535364|65782414|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
23560766|NCT02535364|65782414|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
23560767|NCT02535364|65782414|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
23560768|NCT02535364|65782414|FG000|Part B Screening|Death|2|||
23560769|NCT02535364|65782414|FG000|Part B Screening|Physician Decision|1|||
23560770|NCT02535364|65782414|FG000|Part B Screening|Withdrawal by Subject|1|||
23560771|NCT02535364|65782414|FG000|Part B Screening|Adverse Event|1|||
23560772|NCT02535364|65782414|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
23560773|NCT02535364|65782414|FG000|Study Treatment|Death|1|||
23560774|NCT02535364|65782414|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
23560775|NCT02535364|65782414|FG000|12-Month Follow-up Period|Disease progression|22|||
23560776|NCT02535364|65782414|FG000|12-Month Follow-up Period|Death|5|||
23150566|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
23438560|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438561|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438562|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23560777|NCT02535364|65782414|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
23560778|NCT02535364|65782414|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
23560779|NCT02535364|65782414|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
23582243|NCT00567879|65862410|FG000|Overall Study|Abnormal test procedure(s)|0|||
23438563|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23624904|NCT01296555|66015420|FG028|Overall Study|Adverse Event|0|||
23624905|NCT01296555|66015392|FG000|Overall Study|Reason Not Specified|0|||
23624906|NCT01296555|66015393|FG001|Overall Study|Reason Not Specified|0|||
23624907|NCT01296555|66015394|FG002|Overall Study|Reason Not Specified|0|||
23624908|NCT01296555|66015395|FG003|Overall Study|Reason Not Specified|0|||
23624909|NCT01296555|66015396|FG004|Overall Study|Reason Not Specified|0|||
23624910|NCT01296555|66015397|FG005|Overall Study|Reason Not Specified|0|||
23624911|NCT01296555|66015398|FG006|Overall Study|Reason Not Specified|0|||
23624912|NCT01296555|66015399|FG007|Overall Study|Reason Not Specified|0|||
23624913|NCT01296555|66015400|FG008|Overall Study|Reason Not Specified|0|||
23624914|NCT01296555|66015401|FG009|Overall Study|Reason Not Specified|0|||
23624915|NCT01296555|66015402|FG010|Overall Study|Reason Not Specified|0|||
23624916|NCT01296555|66015403|FG011|Overall Study|Reason Not Specified|0|||
23624917|NCT01296555|66015404|FG012|Overall Study|Reason Not Specified|0|||
23624918|NCT01296555|66015405|FG013|Overall Study|Reason Not Specified|1|||
23624919|NCT01296555|66015406|FG014|Overall Study|Reason Not Specified|2|||
23624920|NCT01296555|66015407|FG015|Overall Study|Reason Not Specified|3|||
23624921|NCT01296555|66015408|FG016|Overall Study|Reason Not Specified|7|||
23560780|NCT03995784|65782415|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
23560781|NCT02801669|65782416|FG000|Overall Study|Death|66|||
23560782|NCT02801669|65782417|FG001|Overall Study|Death|69|||
23560783|NCT02801669|65782416|FG000|Overall Study|Withdrawal by Subject|81|||
23560784|NCT02801669|65782417|FG001|Overall Study|Withdrawal by Subject|77|||
23560785|NCT02801669|65782416|FG000|Overall Study|Other|4|||
23560786|NCT02801669|65782417|FG001|Overall Study|Other|6|||
23560787|NCT02739347|65782418|FG000|Overall Study|Adverse Event|3|||
23560788|NCT02739347|65782419|FG001|Overall Study|Adverse Event|0|||
23560789|NCT02739347|65782418|FG000|Overall Study|Protocol Violation|0|||
23324563|NCT00370552|64930377|FG002|Overall Study|High risk of allergic reaction|0|||
23324564|NCT00370552|64930375|FG000|Overall Study|Planned radiation for palliation|0|||
23624922|NCT01296555|66015409|FG017|Overall Study|Reason Not Specified|4|||
23324565|NCT00370552|64930376|FG001|Overall Study|Planned radiation for palliation|1|||
23324566|NCT00370552|64930377|FG002|Overall Study|Planned radiation for palliation|0|||
23324567|NCT01709500|64930378|FG000|Overall Study|Randomized but not treated|0|||
23324568|NCT01709500|64930379|FG001|Overall Study|Randomized but not treated|1|||
23324569|NCT01709500|64930378|FG000|Overall Study|Adverse Event|5|||
23324570|NCT01709500|64930379|FG001|Overall Study|Adverse Event|1|||
23324571|NCT01709500|64930378|FG000|Overall Study|Poor compliance to protocol|2|||
23324572|NCT01709500|64930379|FG001|Overall Study|Poor compliance to protocol|1|||
23324573|NCT01709500|64930378|FG000|Overall Study|Other|3|||
23560790|NCT02739347|65782419|FG001|Overall Study|Protocol Violation|1|||
23560791|NCT02739347|65782418|FG000|Overall Study|Lost to Follow-up|0|||
23560792|NCT02739347|65782419|FG001|Overall Study|Lost to Follow-up|2|||
23560793|NCT02217280|65782422|FG000|Overall Study|Withdrawal by Subject|2|||
23560794|NCT02217280|65782422|FG000|Overall Study|Post-consent sceen fail|2|||
23560795|NCT00643123|65782426|FG000|Overall Study|Lost to Follow-up|4|||
23560796|NCT00643123|65782427|FG001|Overall Study|Lost to Follow-up|0|||
23560797|NCT00643123|65782426|FG000|Overall Study|Withdrawal by Subject|1|||
23560798|NCT00643123|65782427|FG001|Overall Study|Withdrawal by Subject|1|||
23560799|NCT04062448|65782429|FG000|Overall Study|Lost to Follow-up|1|||
23560800|NCT04062448|65782429|FG000|Overall Study|Withdrawal by Subject|2|||
23560801|NCT00962247|65782430|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
23560802|NCT00962247|65782430|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
23560803|NCT04209855|65782431|FG000|Overall Study|Adverse Event|20|||
23560804|NCT04209855|65782432|FG001|Overall Study|Adverse Event|28|||
23560805|NCT04209855|65782431|FG000|Overall Study|Death|3|||
23560806|NCT04209855|65782432|FG001|Overall Study|Death|1|||
23560807|NCT04209855|65782431|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
23560808|NCT04209855|65782432|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
23624923|NCT01296555|66015410|FG018|Overall Study|Reason Not Specified|3|||
23624924|NCT01296555|66015411|FG019|Overall Study|Reason Not Specified|7|||
23624925|NCT01296555|66015412|FG020|Overall Study|Reason Not Specified|11|||
23560809|NCT04209855|65782431|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
23560810|NCT04209855|65782432|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
23560811|NCT04209855|65782431|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
23560812|NCT04209855|65782432|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
23560813|NCT04209855|65782431|FG000|Overall Study|Progressive Disease|154|||
23560814|NCT04209855|65782432|FG001|Overall Study|Progressive Disease|145|||
23324574|NCT01709500|64930379|FG001|Overall Study|Other|1|||
23560815|NCT04209855|65782431|FG000|Overall Study|Protocol Deviation|1|||
23560816|NCT04209855|65782432|FG001|Overall Study|Protocol Deviation|1|||
23624926|NCT01296555|66015413|FG021|Overall Study|Reason Not Specified|5|||
23624927|NCT01296555|66015414|FG022|Overall Study|Reason Not Specified|5|||
23624928|NCT01296555|66015415|FG023|Overall Study|Reason Not Specified|7|||
23324575|NCT01709500|64930378|FG000|Overall Study|Related to IMP administration|1|||
23560817|NCT04209855|65782431|FG000|Overall Study|Other Than Specified|5|||
23560818|NCT04209855|65782432|FG001|Overall Study|Other Than Specified|10|||
23560819|NCT02532179|65782433|FG000|Overall Study|Lost to Follow-up|1|||
23560820|NCT02532179|65782433|FG000|Overall Study|Pregnancy|1|||
23560821|NCT02532179|65782433|FG000|Overall Study|Subject received depot steroid injection|1|||
23560822|NCT00312702|65782434|FG000|Immunization Phase|Lost to Follow-up|0|||
23560823|NCT00312702|65782435|FG001|Immunization Phase|Lost to Follow-up|1|||
23560824|NCT00312702|65782436|FG002|Immunization Phase|Lost to Follow-up|0|||
23560825|NCT02395133|65782443|FG000|Overall Study|Adverse Event|4|||
23560826|NCT02395133|65782444|FG001|Overall Study|Adverse Event|1|||
23560827|NCT02395133|65782445|FG002|Overall Study|Adverse Event|3|||
23560828|NCT02395133|65782446|FG003|Overall Study|Adverse Event|0|||
23560829|NCT02395133|65782443|FG000|Overall Study|Lack of Efficacy|1|||
23560830|NCT02395133|65782444|FG001|Overall Study|Lack of Efficacy|0|||
23560831|NCT02395133|65782445|FG002|Overall Study|Lack of Efficacy|1|||
23560832|NCT02395133|65782446|FG003|Overall Study|Lack of Efficacy|1|||
23560833|NCT02395133|65782443|FG000|Overall Study|Protocol Violation|1|||
23560834|NCT02395133|65782444|FG001|Overall Study|Protocol Violation|1|||
23560835|NCT02395133|65782445|FG002|Overall Study|Protocol Violation|0|||
23560836|NCT02395133|65782446|FG003|Overall Study|Protocol Violation|3|||
23560837|NCT02395133|65782443|FG000|Overall Study|Lost to Follow-up|0|||
23560838|NCT02395133|65782444|FG001|Overall Study|Lost to Follow-up|1|||
23560839|NCT02395133|65782445|FG002|Overall Study|Lost to Follow-up|1|||
23560840|NCT02395133|65782446|FG003|Overall Study|Lost to Follow-up|0|||
23560841|NCT02395133|65782443|FG000|Overall Study|Pregnancy|0|||
23560842|NCT02395133|65782444|FG001|Overall Study|Pregnancy|0|||
23560843|NCT02395133|65782445|FG002|Overall Study|Pregnancy|3|||
23560844|NCT02395133|65782446|FG003|Overall Study|Pregnancy|0|||
23560845|NCT02395133|65782443|FG000|Overall Study|Consent withdrawn with no reason given|1|||
23560846|NCT02395133|65782444|FG001|Overall Study|Consent withdrawn with no reason given|3|||
23560847|NCT02395133|65782445|FG002|Overall Study|Consent withdrawn with no reason given|0|||
23624929|NCT01296555|66015416|FG024|Overall Study|Reason Not Specified|2|||
23624930|NCT01296555|66015417|FG025|Overall Study|Reason Not Specified|2|||
23624931|NCT01296555|66015418|FG026|Overall Study|Reason Not Specified|19|||
23624932|NCT01296555|66015419|FG027|Overall Study|Reason Not Specified|11|||
23560848|NCT02395133|65782446|FG003|Overall Study|Consent withdrawn with no reason given|2|||
23560849|NCT02395133|65782443|FG000|Overall Study|Consent withdrawn with personal reason|0|||
23560850|NCT02395133|65782444|FG001|Overall Study|Consent withdrawn with personal reason|1|||
23560851|NCT02395133|65782445|FG002|Overall Study|Consent withdrawn with personal reason|0|||
23560852|NCT02395133|65782446|FG003|Overall Study|Consent withdrawn with personal reason|3|||
23560853|NCT02395133|65782443|FG000|Overall Study|Sponsor decision|2|||
23560854|NCT02395133|65782444|FG001|Overall Study|Sponsor decision|0|||
23560855|NCT02395133|65782445|FG002|Overall Study|Sponsor decision|0|||
23560856|NCT02395133|65782446|FG003|Overall Study|Sponsor decision|1|||
23560857|NCT02395133|65782443|FG000|Overall Study|Other than specified above|5|||
23560858|NCT02395133|65782444|FG001|Overall Study|Other than specified above|2|||
23560859|NCT02395133|65782445|FG002|Overall Study|Other than specified above|2|||
23560860|NCT02395133|65782446|FG003|Overall Study|Other than specified above|4|||
23560861|NCT02991482|65782450|FG000|Overall Study|Disease progression|56|||
23560862|NCT02991482|65782451|FG001|Overall Study|Disease progression|47|||
23560863|NCT02991482|65782450|FG000|Overall Study|Death|4|||
23560864|NCT02991482|65782451|FG001|Overall Study|Death|4|||
23560865|NCT02991482|65782450|FG000|Overall Study|Adverse Event|1|||
23560866|NCT02991482|65782451|FG001|Overall Study|Adverse Event|6|||
23560867|NCT02991482|65782450|FG000|Overall Study|Patient decision|1|||
23560868|NCT02991482|65782451|FG001|Overall Study|Patient decision|1|||
23560869|NCT02991482|65782450|FG000|Overall Study|Physician Decision|0|||
23560870|NCT02991482|65782451|FG001|Overall Study|Physician Decision|6|||
23560871|NCT02991482|65782450|FG000|Overall Study|Clinical deterioration|1|||
23560872|NCT02991482|65782451|FG001|Overall Study|Clinical deterioration|0|||
23560873|NCT02991482|65782450|FG000|Overall Study|Patient feeling too unwell|1|||
23560874|NCT02991482|65782451|FG001|Overall Study|Patient feeling too unwell|0|||
23560875|NCT02991482|65782450|FG000|Overall Study|Worsening of performance status|0|||
23624933|NCT01296555|66015420|FG028|Overall Study|Reason Not Specified|9|||
23624934|NCT01296555|66015392|FG000|Overall Study|Physician Decision|0|||
23624935|NCT01296555|66015393|FG001|Overall Study|Physician Decision|0|||
23560876|NCT02991482|65782451|FG001|Overall Study|Worsening of performance status|1|||
23560877|NCT02991482|65782450|FG000|Overall Study|Death prior to study drug initiation|1|||
23560878|NCT02991482|65782451|FG001|Overall Study|Death prior to study drug initiation|0|||
23624936|NCT01296555|66015394|FG002|Overall Study|Physician Decision|0|||
23560879|NCT02991482|65782450|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
23560880|NCT02991482|65782451|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
23560881|NCT03980184|65782452|FG000|Overall Study|Dropped out before treatment|2|||
23560882|NCT03980184|65782453|FG001|Overall Study|Dropped out before treatment|2|||
23560883|NCT03980184|65782452|FG000|Overall Study|Lost to Follow-up|11|||
23560884|NCT03980184|65782453|FG001|Overall Study|Lost to Follow-up|13|||
23150567|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
23150568|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
23150569|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
23150570|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
23150571|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
23150572|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
23150573|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Death|3|||
23150574|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Death|1|||
23150575|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
23150576|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
23150577|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Adverse Event|7|||
23150578|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Adverse Event|8|||
23150579|NCT03236246|64301906|FG000|24-Week Dose Titration Period|Captured as Other|1|||
23150580|NCT03236246|64301907|FG001|24-Week Dose Titration Period|Captured as Other|2|||
23150581|NCT03236246|64301906|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
23150582|NCT03236246|64301907|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
23150583|NCT03236246|64301906|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
23150584|NCT03236246|64301907|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
23150585|NCT03236246|64301906|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
23150586|NCT03236246|64301907|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
23150587|NCT03236246|64301906|FG000|24-Week Dose Maintenance Period|Death|0|||
23150588|NCT03236246|64301907|FG001|24-Week Dose Maintenance Period|Death|1|||
23150589|NCT03236246|64301906|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
23150590|NCT03236246|64301907|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
23150591|NCT02202551|64301908|FG000|Overall Study|Adverse Event|8|||
23150592|NCT02202551|64301909|FG001|Overall Study|Adverse Event|19|||
23150593|NCT02202551|64301910|FG002|Overall Study|Adverse Event|5|||
23150594|NCT02202551|64301911|FG003|Overall Study|Adverse Event|9|||
23150595|NCT02202551|64301908|FG000|Overall Study|Death|3|||
23150596|NCT02202551|64301909|FG001|Overall Study|Death|2|||
23150597|NCT02202551|64301910|FG002|Overall Study|Death|1|||
23150598|NCT02202551|64301911|FG003|Overall Study|Death|1|||
23150599|NCT02202551|64301908|FG000|Overall Study|Lost to Follow-up|0|||
23150600|NCT02202551|64301909|FG001|Overall Study|Lost to Follow-up|1|||
23150601|NCT02202551|64301910|FG002|Overall Study|Lost to Follow-up|0|||
23150602|NCT02202551|64301911|FG003|Overall Study|Lost to Follow-up|1|||
23150603|NCT02202551|64301908|FG000|Overall Study|Needed to take excluded medication|0|||
23150604|NCT02202551|64301909|FG001|Overall Study|Needed to take excluded medication|2|||
23150605|NCT02202551|64301910|FG002|Overall Study|Needed to take excluded medication|0|||
23150606|NCT02202551|64301911|FG003|Overall Study|Needed to take excluded medication|1|||
23150607|NCT02202551|64301908|FG000|Overall Study|Subject moved away|0|||
23150608|NCT02202551|64301909|FG001|Overall Study|Subject moved away|1|||
23324576|NCT01709500|64930379|FG001|Overall Study|Related to IMP administration|0|||
23324577|NCT01709500|64930378|FG000|Overall Study|Treatment ongoing|156|||
23324578|NCT01709500|64930379|FG001|Overall Study|Treatment ongoing|78|||
23324579|NCT00991887|64930380|FG000|Overall Study|Lost to Follow-up|2|||
23324580|NCT00991887|64930381|FG001|Overall Study|Lost to Follow-up|1|||
23324581|NCT00733005|64930384|FG000|Overall Study|Adverse Event|0|||
23324582|NCT00733005|64930385|FG001|Overall Study|Adverse Event|1|||
23324583|NCT00733005|64930384|FG000|Overall Study|Treatment Failure|0|||
23324584|NCT00733005|64930385|FG001|Overall Study|Treatment Failure|1|||
23324585|NCT00733005|64930384|FG000|Overall Study|Withdrawal by Subject|0|||
23324586|NCT00733005|64930385|FG001|Overall Study|Withdrawal by Subject|1|||
23324587|NCT00733005|64930384|FG000|Overall Study|Protocol Violation|2|||
23324588|NCT00733005|64930385|FG001|Overall Study|Protocol Violation|0|||
23324589|NCT02001987|64930386|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
23324590|NCT02001987|64930386|FG000|Core Study Period (24 Weeks)|Death|1|||
23324591|NCT02001987|64930386|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
23324592|NCT02001987|64930386|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
23324593|NCT02001987|64930386|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
23150609|NCT02202551|64301910|FG002|Overall Study|Subject moved away|0|||
23150610|NCT02202551|64301911|FG003|Overall Study|Subject moved away|0|||
23150611|NCT02202551|64301908|FG000|Overall Study|DBS surgery|3|||
23150612|NCT02202551|64301909|FG001|Overall Study|DBS surgery|0|||
23324594|NCT02001987|64930386|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
23324595|NCT02001987|64930386|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
23324596|NCT02001987|64930386|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
23324597|NCT02001987|64930386|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
23150613|NCT02202551|64301910|FG002|Overall Study|DBS surgery|0|||
23150614|NCT02202551|64301911|FG003|Overall Study|DBS surgery|0|||
23150615|NCT02202551|64301908|FG000|Overall Study|Dyskinesia upon taper|1|||
23150616|NCT02202551|64301909|FG001|Overall Study|Dyskinesia upon taper|0|||
23324598|NCT02001987|64930386|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
23324599|NCT02001987|64930386|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
23560885|NCT02227875|65782455|FG000|Overall Study|Protocol Violation|10|||
23560886|NCT02227875|65782456|FG001|Overall Study|Protocol Violation|7|||
23560887|NCT02227875|65782455|FG000|Overall Study|Other|1|||
23560888|NCT02227875|65782456|FG001|Overall Study|Other|3|||
23560889|NCT02227875|65782455|FG000|Overall Study|Physician Decision|1|||
23560890|NCT02227875|65782456|FG001|Overall Study|Physician Decision|0|||
23560891|NCT02227875|65782455|FG000|Overall Study|Adverse Event|3|||
23560892|NCT02227875|65782456|FG001|Overall Study|Adverse Event|0|||
23560893|NCT02227875|65782455|FG000|Overall Study|Withdrawal by Subject|12|||
23560894|NCT02227875|65782456|FG001|Overall Study|Withdrawal by Subject|13|||
23560895|NCT02227875|65782455|FG000|Overall Study|Lost to Follow-up|10|||
23560896|NCT02227875|65782456|FG001|Overall Study|Lost to Follow-up|10|||
23560897|NCT00895622|65782457|FG000|Overall Study|Protocol Violation|5|||
23560898|NCT00895622|65782458|FG001|Overall Study|Protocol Violation|4|||
23560899|NCT00895622|65782459|FG002|Overall Study|Protocol Violation|4|||
23560900|NCT03757234|65782461|FG000|Overall Study|Adverse Event|0|||
23560901|NCT03757234|65782462|FG001|Overall Study|Adverse Event|0|||
23624937|NCT01296555|66015395|FG003|Overall Study|Physician Decision|0|||
23624938|NCT01296555|66015396|FG004|Overall Study|Physician Decision|1|||
23624939|NCT01296555|66015397|FG005|Overall Study|Physician Decision|0|||
23624940|NCT01296555|66015398|FG006|Overall Study|Physician Decision|0|||
23624941|NCT01296555|66015399|FG007|Overall Study|Physician Decision|0|||
23624942|NCT01296555|66015400|FG008|Overall Study|Physician Decision|0|||
23624943|NCT01296555|66015401|FG009|Overall Study|Physician Decision|0|||
23624944|NCT01296555|66015402|FG010|Overall Study|Physician Decision|0|||
23624945|NCT01296555|66015403|FG011|Overall Study|Physician Decision|0|||
23560902|NCT03757234|65782463|FG002|Overall Study|Adverse Event|0|||
23560903|NCT03757234|65782464|FG003|Overall Study|Adverse Event|0|||
23560904|NCT03757234|65782465|FG004|Overall Study|Adverse Event|1|||
23560905|NCT03757234|65782461|FG000|Overall Study|Lost to Follow-up|1|||
23560906|NCT03757234|65782462|FG001|Overall Study|Lost to Follow-up|0|||
23560907|NCT03757234|65782463|FG002|Overall Study|Lost to Follow-up|0|||
23560908|NCT03757234|65782464|FG003|Overall Study|Lost to Follow-up|0|||
23624946|NCT01296555|66015404|FG012|Overall Study|Physician Decision|0|||
23624947|NCT01296555|66015405|FG013|Overall Study|Physician Decision|1|||
23624948|NCT01296555|66015406|FG014|Overall Study|Physician Decision|0|||
23624949|NCT01296555|66015407|FG015|Overall Study|Physician Decision|0|||
23624950|NCT01296555|66015408|FG016|Overall Study|Physician Decision|0|||
23624951|NCT01296555|66015409|FG017|Overall Study|Physician Decision|0|||
23624952|NCT01296555|66015410|FG018|Overall Study|Physician Decision|0|||
23624953|NCT01296555|66015411|FG019|Overall Study|Physician Decision|1|||
23624954|NCT01296555|66015412|FG020|Overall Study|Physician Decision|0|||
23624955|NCT01296555|66015413|FG021|Overall Study|Physician Decision|0|||
23624956|NCT01296555|66015414|FG022|Overall Study|Physician Decision|0|||
23624957|NCT01296555|66015415|FG023|Overall Study|Physician Decision|0|||
23150617|NCT02202551|64301910|FG002|Overall Study|Dyskinesia upon taper|0|||
23624958|NCT01296555|66015416|FG024|Overall Study|Physician Decision|0|||
23624959|NCT01296555|66015417|FG025|Overall Study|Physician Decision|0|||
23624960|NCT01296555|66015418|FG026|Overall Study|Physician Decision|0|||
23624961|NCT01296555|66015419|FG027|Overall Study|Physician Decision|0|||
23150618|NCT02202551|64301911|FG003|Overall Study|Dyskinesia upon taper|0|||
23150619|NCT02202551|64301908|FG000|Overall Study|Lack of Efficacy|0|||
23150620|NCT02202551|64301909|FG001|Overall Study|Lack of Efficacy|1|||
23150621|NCT02202551|64301910|FG002|Overall Study|Lack of Efficacy|0|||
23150622|NCT02202551|64301911|FG003|Overall Study|Lack of Efficacy|0|||
23150623|NCT02202551|64301908|FG000|Overall Study|Physician Decision|1|||
23150624|NCT02202551|64301909|FG001|Overall Study|Physician Decision|0|||
23150625|NCT02202551|64301910|FG002|Overall Study|Physician Decision|0|||
23150626|NCT02202551|64301911|FG003|Overall Study|Physician Decision|0|||
23150627|NCT02202551|64301908|FG000|Overall Study|Site closure|3|||
23150628|NCT02202551|64301909|FG001|Overall Study|Site closure|0|||
23150629|NCT02202551|64301910|FG002|Overall Study|Site closure|0|||
23150630|NCT02202551|64301911|FG003|Overall Study|Site closure|1|||
23438564|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23560909|NCT03757234|65782465|FG004|Overall Study|Lost to Follow-up|1|||
23624962|NCT01296555|66015420|FG028|Overall Study|Physician Decision|0|||
23624963|NCT01296555|66015392|FG000|Overall Study|Progressive Disease|6|||
23624964|NCT01296555|66015393|FG001|Overall Study|Progressive Disease|3|||
23624965|NCT01296555|66015394|FG002|Overall Study|Progressive Disease|3|||
23624966|NCT01296555|66015395|FG003|Overall Study|Progressive Disease|7|||
23624967|NCT01296555|66015396|FG004|Overall Study|Progressive Disease|6|||
23150631|NCT02202551|64301908|FG000|Overall Study|Unable to complete visits per protocol|1|||
23150632|NCT02202551|64301909|FG001|Overall Study|Unable to complete visits per protocol|0|||
23150633|NCT02202551|64301910|FG002|Overall Study|Unable to complete visits per protocol|0|||
23560910|NCT03757234|65782461|FG000|Overall Study|Withdrawal by Subject|1|||
23560911|NCT03757234|65782462|FG001|Overall Study|Withdrawal by Subject|1|||
23560912|NCT03757234|65782463|FG002|Overall Study|Withdrawal by Subject|0|||
23560913|NCT03757234|65782464|FG003|Overall Study|Withdrawal by Subject|1|||
23560914|NCT03757234|65782465|FG004|Overall Study|Withdrawal by Subject|2|||
23624968|NCT01296555|66015397|FG005|Overall Study|Progressive Disease|16|||
23150634|NCT02202551|64301911|FG003|Overall Study|Unable to complete visits per protocol|0|||
23150635|NCT02202551|64301908|FG000|Overall Study|Worsening Dyskinesia|0|||
23150636|NCT02202551|64301909|FG001|Overall Study|Worsening Dyskinesia|0|||
23438565|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23438566|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
23624969|NCT01296555|66015398|FG006|Overall Study|Progressive Disease|16|||
23560915|NCT03757234|65782461|FG000|Overall Study|Other|1|||
23560916|NCT03757234|65782462|FG001|Overall Study|Other|1|||
23560917|NCT03757234|65782463|FG002|Overall Study|Other|0|||
23560918|NCT03757234|65782464|FG003|Overall Study|Other|0|||
23560919|NCT03757234|65782465|FG004|Overall Study|Other|0|||
23560920|NCT02110732|65782466|FG000|Overall Study|Physician Decision|5|||
23560921|NCT02110732|65782467|FG001|Overall Study|Physician Decision|2|||
23560922|NCT02110732|65782466|FG000|Overall Study|Lost to Follow-up|1|||
23560923|NCT02110732|65782467|FG001|Overall Study|Lost to Follow-up|1|||
23560924|NCT00429663|65782468|FG000|Overall Study|Lost to Follow-up|24|||
23560925|NCT00429663|65782469|FG001|Overall Study|Lost to Follow-up|31|||
23560926|NCT00429663|65782468|FG000|Overall Study|Physician Decision|6|||
23560927|NCT00429663|65782469|FG001|Overall Study|Physician Decision|3|||
23560928|NCT00429663|65782468|FG000|Overall Study|Withdrawal by Subject|2|||
23560929|NCT00429663|65782469|FG001|Overall Study|Withdrawal by Subject|5|||
23560930|NCT00429663|65782468|FG000|Overall Study|Death|4|||
23560931|NCT00429663|65782469|FG001|Overall Study|Death|0|||
23560932|NCT01621880|65782479|FG000|Overall Study|Adverse Event|5|||
23560933|NCT01621880|65782480|FG001|Overall Study|Adverse Event|1|||
23560934|NCT01621880|65782479|FG000|Overall Study|Withdrawal by Subject|5|||
23560935|NCT01621880|65782480|FG001|Overall Study|Withdrawal by Subject|4|||
23560936|NCT03745222|65782481|FG000|Overall Study|Withdrawal by Subject|0|||
23560937|NCT03745222|65782482|FG001|Overall Study|Withdrawal by Subject|1|||
23560938|NCT03745222|65782483|FG002|Overall Study|Withdrawal by Subject|0|||
23560939|NCT01525602|65782484|FG000|Overall Study|Adverse Event|1|||
23560940|NCT01525602|65782485|FG001|Overall Study|Adverse Event|0|||
23560941|NCT01525602|65782486|FG002|Overall Study|Adverse Event|1|||
23560942|NCT01525602|65782487|FG003|Overall Study|Adverse Event|1|||
23560943|NCT01525602|65782488|FG004|Overall Study|Adverse Event|3|||
23560944|NCT01525602|65782489|FG005|Overall Study|Adverse Event|3|||
23560945|NCT01525602|65782490|FG006|Overall Study|Adverse Event|0|||
23560946|NCT01525602|65782491|FG007|Overall Study|Adverse Event|1|||
23624970|NCT01296555|66015399|FG007|Overall Study|Progressive Disease|8|||
23624971|NCT01296555|66015400|FG008|Overall Study|Progressive Disease|7|||
23624972|NCT01296555|66015401|FG009|Overall Study|Progressive Disease|18|||
23624973|NCT01296555|66015402|FG010|Overall Study|Progressive Disease|7|||
23624974|NCT01296555|66015403|FG011|Overall Study|Progressive Disease|14|||
23624975|NCT01296555|66015404|FG012|Overall Study|Progressive Disease|5|||
23624976|NCT01296555|66015405|FG013|Overall Study|Progressive Disease|12|||
23624977|NCT01296555|66015406|FG014|Overall Study|Progressive Disease|1|||
23624978|NCT01296555|66015407|FG015|Overall Study|Progressive Disease|1|||
23624979|NCT01296555|66015408|FG016|Overall Study|Progressive Disease|0|||
23624980|NCT01296555|66015409|FG017|Overall Study|Progressive Disease|0|||
23624981|NCT01296555|66015410|FG018|Overall Study|Progressive Disease|0|||
23624982|NCT01296555|66015411|FG019|Overall Study|Progressive Disease|1|||
23624983|NCT01296555|66015412|FG020|Overall Study|Progressive Disease|0|||
23624984|NCT01296555|66015413|FG021|Overall Study|Progressive Disease|0|||
23624985|NCT01296555|66015414|FG022|Overall Study|Progressive Disease|0|||
23624986|NCT01296555|66015415|FG023|Overall Study|Progressive Disease|0|||
23624987|NCT01296555|66015416|FG024|Overall Study|Progressive Disease|1|||
23624988|NCT01296555|66015417|FG025|Overall Study|Progressive Disease|0|||
23624989|NCT01296555|66015418|FG026|Overall Study|Progressive Disease|5|||
23624990|NCT01296555|66015419|FG027|Overall Study|Progressive Disease|1|||
23624991|NCT01296555|66015420|FG028|Overall Study|Progressive Disease|0|||
23624992|NCT01296555|66015392|FG000|Overall Study|Protocol Violation|0|||
23624993|NCT01296555|66015393|FG001|Overall Study|Protocol Violation|0|||
23150637|NCT02202551|64301910|FG002|Overall Study|Worsening Dyskinesia|0|||
23438567|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
23560947|NCT01525602|65782484|FG000|Overall Study|Disease progression|6|||
23560948|NCT01525602|65782485|FG001|Overall Study|Disease progression|3|||
23560949|NCT01525602|65782486|FG002|Overall Study|Disease progression|2|||
23624994|NCT01296555|66015394|FG002|Overall Study|Protocol Violation|0|||
23624995|NCT01296555|66015395|FG003|Overall Study|Protocol Violation|0|||
23624996|NCT01296555|66015396|FG004|Overall Study|Protocol Violation|0|||
23624997|NCT01296555|66015397|FG005|Overall Study|Protocol Violation|0|||
23624998|NCT01296555|66015398|FG006|Overall Study|Protocol Violation|0|||
23624999|NCT01296555|66015399|FG007|Overall Study|Protocol Violation|0|||
23625000|NCT01296555|66015400|FG008|Overall Study|Protocol Violation|0|||
23219786|NCT04914819|64549950|FG001|Overall Study|Pregnancy|1|||
23560950|NCT01525602|65782487|FG003|Overall Study|Disease progression|5|||
23560951|NCT01525602|65782488|FG004|Overall Study|Disease progression|22|||
23560952|NCT01525602|65782489|FG005|Overall Study|Disease progression|2|||
23560953|NCT01525602|65782490|FG006|Overall Study|Disease progression|3|||
23625001|NCT01296555|66015401|FG009|Overall Study|Protocol Violation|0|||
23625002|NCT01296555|66015402|FG010|Overall Study|Protocol Violation|0|||
23625003|NCT01296555|66015403|FG011|Overall Study|Protocol Violation|0|||
23625004|NCT01296555|66015404|FG012|Overall Study|Protocol Violation|0|||
23625005|NCT01296555|66015405|FG013|Overall Study|Protocol Violation|1|||
23625006|NCT01296555|66015406|FG014|Overall Study|Protocol Violation|0|||
23625007|NCT01296555|66015407|FG015|Overall Study|Protocol Violation|0|||
23625008|NCT01296555|66015408|FG016|Overall Study|Protocol Violation|0|||
23625009|NCT01296555|66015409|FG017|Overall Study|Protocol Violation|0|||
23625010|NCT01296555|66015410|FG018|Overall Study|Protocol Violation|0|||
23625011|NCT01296555|66015411|FG019|Overall Study|Protocol Violation|0|||
23625012|NCT01296555|66015412|FG020|Overall Study|Protocol Violation|0|||
23625013|NCT01296555|66015413|FG021|Overall Study|Protocol Violation|0|||
23625014|NCT01296555|66015414|FG022|Overall Study|Protocol Violation|0|||
23625015|NCT01296555|66015415|FG023|Overall Study|Protocol Violation|0|||
23625016|NCT01296555|66015416|FG024|Overall Study|Protocol Violation|0|||
23625017|NCT01296555|66015417|FG025|Overall Study|Protocol Violation|0|||
23625018|NCT01296555|66015418|FG026|Overall Study|Protocol Violation|0|||
23625019|NCT01296555|66015419|FG027|Overall Study|Protocol Violation|0|||
23625020|NCT01296555|66015420|FG028|Overall Study|Protocol Violation|0|||
23625021|NCT01296555|66015392|FG000|Overall Study|Study Terminated By Sponsor|0|||
23625022|NCT01296555|66015393|FG001|Overall Study|Study Terminated By Sponsor|0|||
23625023|NCT01296555|66015394|FG002|Overall Study|Study Terminated By Sponsor|0|||
23625024|NCT01296555|66015395|FG003|Overall Study|Study Terminated By Sponsor|0|||
23560954|NCT01525602|65782491|FG007|Overall Study|Disease progression|3|||
23560955|NCT01525602|65782484|FG000|Overall Study|Clinical progression|2|||
23560956|NCT01525602|65782485|FG001|Overall Study|Clinical progression|0|||
23560957|NCT01525602|65782486|FG002|Overall Study|Clinical progression|0|||
23560958|NCT01525602|65782487|FG003|Overall Study|Clinical progression|0|||
23560959|NCT01525602|65782488|FG004|Overall Study|Clinical progression|0|||
23560960|NCT01525602|65782489|FG005|Overall Study|Clinical progression|0|||
23560961|NCT01525602|65782490|FG006|Overall Study|Clinical progression|1|||
23560962|NCT01525602|65782491|FG007|Overall Study|Clinical progression|1|||
23560963|NCT01525602|65782484|FG000|Overall Study|Non-compliance|0|||
23560964|NCT01525602|65782485|FG001|Overall Study|Non-compliance|0|||
23560965|NCT01525602|65782486|FG002|Overall Study|Non-compliance|0|||
23560966|NCT01525602|65782487|FG003|Overall Study|Non-compliance|0|||
23560967|NCT01525602|65782488|FG004|Overall Study|Non-compliance|1|||
23625025|NCT01296555|66015396|FG004|Overall Study|Study Terminated By Sponsor|0|||
23625026|NCT01296555|66015397|FG005|Overall Study|Study Terminated By Sponsor|0|||
23625027|NCT01296555|66015398|FG006|Overall Study|Study Terminated By Sponsor|0|||
23625028|NCT01296555|66015399|FG007|Overall Study|Study Terminated By Sponsor|0|||
23625029|NCT01296555|66015400|FG008|Overall Study|Study Terminated By Sponsor|0|||
23625030|NCT01296555|66015401|FG009|Overall Study|Study Terminated By Sponsor|0|||
23324600|NCT02001987|64930386|FG000|LTE Period (52 Weeks)|Other|3|||
23324601|NCT01149863|64930390|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
23324602|NCT01609790|64930391|FG000|Overall Study|Protocol Violation|1|||
23560968|NCT01525602|65782489|FG005|Overall Study|Non-compliance|0|||
23560969|NCT01525602|65782490|FG006|Overall Study|Non-compliance|0|||
23560970|NCT01525602|65782491|FG007|Overall Study|Non-compliance|0|||
23560971|NCT01525602|65782484|FG000|Overall Study|Withdrawal by Subject|0|||
23560972|NCT01525602|65782485|FG001|Overall Study|Withdrawal by Subject|0|||
23560973|NCT01525602|65782486|FG002|Overall Study|Withdrawal by Subject|0|||
23560974|NCT01525602|65782487|FG003|Overall Study|Withdrawal by Subject|0|||
23560975|NCT01525602|65782488|FG004|Overall Study|Withdrawal by Subject|3|||
23560976|NCT01525602|65782489|FG005|Overall Study|Withdrawal by Subject|1|||
23560977|NCT01525602|65782490|FG006|Overall Study|Withdrawal by Subject|0|||
23560978|NCT01525602|65782491|FG007|Overall Study|Withdrawal by Subject|1|||
23560979|NCT01525602|65782484|FG000|Overall Study|Physician Decision|0|||
23560980|NCT01525602|65782485|FG001|Overall Study|Physician Decision|0|||
23560981|NCT01525602|65782486|FG002|Overall Study|Physician Decision|0|||
23560982|NCT01525602|65782487|FG003|Overall Study|Physician Decision|0|||
23560983|NCT01525602|65782488|FG004|Overall Study|Physician Decision|3|||
23560984|NCT01525602|65782489|FG005|Overall Study|Physician Decision|0|||
23560985|NCT01525602|65782490|FG006|Overall Study|Physician Decision|1|||
23560986|NCT01525602|65782491|FG007|Overall Study|Physician Decision|0|||
23560987|NCT01525602|65782484|FG000|Overall Study|Death|0|||
23560988|NCT01525602|65782485|FG001|Overall Study|Death|0|||
23560989|NCT01525602|65782486|FG002|Overall Study|Death|0|||
23560990|NCT01525602|65782487|FG003|Overall Study|Death|0|||
23560991|NCT01525602|65782488|FG004|Overall Study|Death|1|||
23625031|NCT01296555|66015402|FG010|Overall Study|Study Terminated By Sponsor|0|||
23625032|NCT01296555|66015403|FG011|Overall Study|Study Terminated By Sponsor|0|||
23625033|NCT01296555|66015404|FG012|Overall Study|Study Terminated By Sponsor|0|||
23625034|NCT01296555|66015405|FG013|Overall Study|Study Terminated By Sponsor|0|||
23625035|NCT01296555|66015406|FG014|Overall Study|Study Terminated By Sponsor|0|||
23150638|NCT02202551|64301911|FG003|Overall Study|Worsening Dyskinesia|1|||
23560992|NCT01525602|65782489|FG005|Overall Study|Death|1|||
23560993|NCT01525602|65782490|FG006|Overall Study|Death|0|||
23625036|NCT01296555|66015407|FG015|Overall Study|Study Terminated By Sponsor|0|||
23150639|NCT02202551|64301908|FG000|Overall Study|Protocol Violation|0|||
23324603|NCT01609790|64930392|FG001|Overall Study|Protocol Violation|7|||
23324604|NCT01609790|64930393|FG002|Overall Study|Protocol Violation|8|||
23324605|NCT03633825|64930394|FG000|Enrollment|Did not post on network|5066|||
23324606|NCT03633825|64930395|FG001|Enrollment|Did not post on network|5080|||
23324607|NCT03633825|64930394|FG000|Enrollment|Post not classified as crisis|13967|||
23324608|NCT03633825|64930395|FG001|Enrollment|Post not classified as crisis|13757|||
23324609|NCT03633825|64930394|FG000|Follow up|Lost to Follow-up|478|||
23150640|NCT02202551|64301909|FG001|Overall Study|Protocol Violation|1|||
23150641|NCT02202551|64301910|FG002|Overall Study|Protocol Violation|0|||
23150642|NCT02202551|64301911|FG003|Overall Study|Protocol Violation|0|||
23150643|NCT02202551|64301908|FG000|Overall Study|Sponsor's decision|2|||
23150644|NCT02202551|64301909|FG001|Overall Study|Sponsor's decision|0|||
23150645|NCT02202551|64301910|FG002|Overall Study|Sponsor's decision|0|||
23150646|NCT02202551|64301911|FG003|Overall Study|Sponsor's decision|0|||
23150647|NCT02202551|64301908|FG000|Overall Study|Subject unwilling to proceed|1|||
23150648|NCT02202551|64301909|FG001|Overall Study|Subject unwilling to proceed|5|||
23150649|NCT02202551|64301910|FG002|Overall Study|Subject unwilling to proceed|3|||
23150650|NCT02202551|64301911|FG003|Overall Study|Subject unwilling to proceed|5|||
23150651|NCT02202551|64301908|FG000|Overall Study|Subject consent withdrawn|0|||
23150652|NCT02202551|64301909|FG001|Overall Study|Subject consent withdrawn|3|||
23150653|NCT02202551|64301910|FG002|Overall Study|Subject consent withdrawn|1|||
23150654|NCT02202551|64301911|FG003|Overall Study|Subject consent withdrawn|2|||
23150655|NCT02202551|64301908|FG000|Overall Study|eGFR<50mL/min/m2|2|||
23150656|NCT02202551|64301909|FG001|Overall Study|eGFR<50mL/min/m2|2|||
23150657|NCT02202551|64301910|FG002|Overall Study|eGFR<50mL/min/m2|0|||
23150658|NCT02202551|64301911|FG003|Overall Study|eGFR<50mL/min/m2|1|||
23560994|NCT01525602|65782491|FG007|Overall Study|Death|0|||
23560995|NCT01525602|65782484|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
23560996|NCT01525602|65782485|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
23560997|NCT01525602|65782486|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
23560998|NCT01525602|65782487|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
23560999|NCT01525602|65782488|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
23561000|NCT01525602|65782489|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
23561001|NCT01525602|65782490|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
23561002|NCT01525602|65782491|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
23561003|NCT02228967|65782492|FG000|Overall Study|Lost to Follow-up|146|||
23561004|NCT02228967|65782493|FG001|Overall Study|Lost to Follow-up|142|||
23561005|NCT02228967|65782492|FG000|Overall Study|Withdrawal by Subject|13|||
23561006|NCT02228967|65782493|FG001|Overall Study|Withdrawal by Subject|18|||
23561007|NCT02207725|65782494|FG000|Overall Study|Did Not Receive Treatment|0|||
23561008|NCT02207725|65782495|FG001|Overall Study|Did Not Receive Treatment|1|||
23561009|NCT02207725|65782496|FG002|Overall Study|Did Not Receive Treatment|1|||
23561010|NCT02207725|65782497|FG003|Overall Study|Did Not Receive Treatment|1|||
23561011|NCT04810221|65782498|FG000|Overall Study|Physician Decision|3|||
23561012|NCT01377480|65782499|FG000|Overall Study|Protocol Violation|0|||
23561013|NCT01377480|65782500|FG001|Overall Study|Protocol Violation|0|||
23561014|NCT01377480|65782501|FG002|Overall Study|Protocol Violation|0|||
23561015|NCT01377480|65782502|FG003|Overall Study|Protocol Violation|4|||
23561016|NCT01377480|65782499|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
23561017|NCT01377480|65782500|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
23561018|NCT01377480|65782501|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
23561019|NCT01377480|65782502|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
23561020|NCT01377480|65782499|FG000|Overall Study|Withdrawal by Subject|0|||
23561021|NCT01377480|65782500|FG001|Overall Study|Withdrawal by Subject|0|||
23561022|NCT01377480|65782501|FG002|Overall Study|Withdrawal by Subject|1|||
23561023|NCT01377480|65782502|FG003|Overall Study|Withdrawal by Subject|0|||
23561024|NCT01377480|65782499|FG000|Overall Study|Serious adverse event|0|||
23561025|NCT01377480|65782500|FG001|Overall Study|Serious adverse event|0|||
23561026|NCT01377480|65782501|FG002|Overall Study|Serious adverse event|1|||
23561027|NCT01377480|65782502|FG003|Overall Study|Serious adverse event|1|||
23561028|NCT01377480|65782499|FG000|Overall Study|Other|0|||
23561029|NCT01377480|65782500|FG001|Overall Study|Other|0|||
23561030|NCT01377480|65782501|FG002|Overall Study|Other|7|||
23561031|NCT01377480|65782502|FG003|Overall Study|Other|6|||
23561032|NCT05096208|65782503|FG000|Overall Study|Lost to Follow-up|3|||
23324610|NCT03633825|64930395|FG001|Follow up|Lost to Follow-up|450|||
23561033|NCT05096208|65782504|FG001|Overall Study|Lost to Follow-up|5|||
23561034|NCT05096208|65782505|FG002|Overall Study|Lost to Follow-up|5|||
23561035|NCT05096208|65782506|FG003|Overall Study|Lost to Follow-up|2|||
23561036|NCT05096208|65782503|FG000|Overall Study|Withdrawal by Subject|0|||
23150659|NCT05085665|64301915|FG000|Overall Study|Physician Decision|2|||
23150660|NCT03933397|64301916|FG000|Overall Study|No emergency department visit|65|||
23150661|NCT03933397|64301917|FG001|Overall Study|No emergency department visit|71|||
23150662|NCT03933397|64301916|FG000|Overall Study|Missed emergency department visit|25|||
23324611|NCT03170544|64930399|FG000|Part 1|Lost to Follow-up|1|||
23625037|NCT01296555|66015408|FG016|Overall Study|Study Terminated By Sponsor|0|||
23438568|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
23438569|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
23438570|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438571|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438572|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23561037|NCT05096208|65782504|FG001|Overall Study|Withdrawal by Subject|1|||
23561038|NCT05096208|65782505|FG002|Overall Study|Withdrawal by Subject|2|||
23561039|NCT05096208|65782506|FG003|Overall Study|Withdrawal by Subject|3|||
23324612|NCT03170544|64930400|FG001|Part 1|Lost to Follow-up|0|||
23625038|NCT01296555|66015409|FG017|Overall Study|Study Terminated By Sponsor|0|||
23625039|NCT01296555|66015410|FG018|Overall Study|Study Terminated By Sponsor|0|||
23150663|NCT03933397|64301917|FG001|Overall Study|Missed emergency department visit|30|||
23150664|NCT03933397|64301916|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
23324613|NCT03170544|64930401|FG002|Part 1|Lost to Follow-up|0|||
23324614|NCT03170544|64930402|FG003|Part 1|Lost to Follow-up|0|||
23324615|NCT03170544|64930403|FG004|Part 1|Lost to Follow-up|0|||
23324616|NCT03170544|64930404|FG005|Part 1|Lost to Follow-up|0|||
23324617|NCT03170544|64930405|FG006|Part 1|Lost to Follow-up|0|||
23324618|NCT03170544|64930406|FG007|Part 1|Lost to Follow-up|0|||
23324619|NCT03170544|64930407|FG008|Part 1|Lost to Follow-up|0|||
23561040|NCT05096208|65782503|FG000|Overall Study|No longer met eligibility criteria|1|||
23561041|NCT05096208|65782504|FG001|Overall Study|No longer met eligibility criteria|0|||
23561042|NCT05096208|65782505|FG002|Overall Study|No longer met eligibility criteria|0|||
23561043|NCT05096208|65782506|FG003|Overall Study|No longer met eligibility criteria|0|||
23561044|NCT05096208|65782503|FG000|Overall Study|Other|0|||
23561045|NCT05096208|65782504|FG001|Overall Study|Other|0|||
23561046|NCT05096208|65782505|FG002|Overall Study|Other|1|||
23561047|NCT05096208|65782506|FG003|Overall Study|Other|0|||
23561048|NCT02755597|65782508|FG000|Overall Study|Withdrew consent|27|||
23561049|NCT02755597|65782509|FG001|Overall Study|Withdrew consent|11|||
23561050|NCT02755597|65782508|FG000|Overall Study|Lost to Follow-up|1|||
23561051|NCT02755597|65782509|FG001|Overall Study|Lost to Follow-up|0|||
23561052|NCT02755597|65782508|FG000|Overall Study|Death|78|||
23561053|NCT02755597|65782509|FG001|Overall Study|Death|36|||
23561054|NCT02755597|65782508|FG000|Overall Study|Study terminated by Sponsor|67|||
23561055|NCT02755597|65782509|FG001|Overall Study|Study terminated by Sponsor|47|||
23561056|NCT02755597|65782508|FG000|Overall Study|Other, not specified|20|||
23561057|NCT02755597|65782509|FG001|Overall Study|Other, not specified|3|||
23561058|NCT02755597|65782508|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
23561059|NCT02755597|65782509|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
23561060|NCT04108000|65782510|FG000|Overall Study|Death of patient|1|||
23561061|NCT04108000|65782511|FG001|Overall Study|Death of patient|0|||
23561062|NCT04108000|65782512|FG002|Overall Study|Death of patient|1|||
23561063|NCT04108000|65782513|FG003|Overall Study|Death of patient|0|||
23561064|NCT04108000|65782510|FG000|Overall Study|Withdrawal by Subject|2|||
23561065|NCT04108000|65782511|FG001|Overall Study|Withdrawal by Subject|2|||
23561066|NCT04108000|65782512|FG002|Overall Study|Withdrawal by Subject|0|||
23561067|NCT04108000|65782513|FG003|Overall Study|Withdrawal by Subject|0|||
23561068|NCT04108000|65782510|FG000|Overall Study|Death of surrogate partner|0|||
23561069|NCT04108000|65782511|FG001|Overall Study|Death of surrogate partner|1|||
23561070|NCT04108000|65782512|FG002|Overall Study|Death of surrogate partner|0|||
23561071|NCT04108000|65782513|FG003|Overall Study|Death of surrogate partner|1|||
23561072|NCT04766086|65782516|FG000|Overall Study|Lost to Follow-up|3|||
23561073|NCT04766086|65782517|FG001|Overall Study|Lost to Follow-up|5|||
23561074|NCT04766086|65782518|FG002|Overall Study|Lost to Follow-up|3|||
23150665|NCT03933397|64301917|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
23150666|NCT03933397|64301916|FG000|Overall Study|Withdrawal by Subject|1|||
23150667|NCT03933397|64301917|FG001|Overall Study|Withdrawal by Subject|0|||
23150668|NCT03933397|64301916|FG000|Overall Study|Physician Decision|1|||
23150669|NCT03933397|64301917|FG001|Overall Study|Physician Decision|1|||
23561075|NCT04766086|65782516|FG000|Overall Study|Withdrawal by Subject|1|||
23561076|NCT04766086|65782517|FG001|Overall Study|Withdrawal by Subject|1|||
23561077|NCT04766086|65782518|FG002|Overall Study|Withdrawal by Subject|2|||
23561078|NCT04766086|65782516|FG000|Overall Study|Other|0|||
23561079|NCT04766086|65782517|FG001|Overall Study|Other|0|||
23150670|NCT03933397|64301916|FG000|Overall Study|missing pain score|1|||
23324620|NCT03170544|64930408|FG009|Part 1|Lost to Follow-up|0|||
23561080|NCT04766086|65782518|FG002|Overall Study|Other|1|||
23324621|NCT03170544|64930409|FG010|Part 1|Lost to Follow-up|0|||
23324622|NCT03170544|64930410|FG011|Part 1|Lost to Follow-up|0|||
23324623|NCT03170544|64930399|FG000|Part 1|Not treated|0|||
23324624|NCT03170544|64930400|FG001|Part 1|Not treated|0|||
23561081|NCT00457639|65782519|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
23561082|NCT00457639|65782520|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
23561083|NCT00457639|65782519|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
23625040|NCT01296555|66015411|FG019|Overall Study|Study Terminated By Sponsor|0|||
23150671|NCT03933397|64301917|FG001|Overall Study|missing pain score|1|||
23561084|NCT00457639|65782520|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
23561085|NCT00457639|65782519|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
23561086|NCT00457639|65782520|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
23561087|NCT02404389|65782524|FG000|Overall Study|Adverse Event|1|||
23561088|NCT02404389|65782525|FG001|Overall Study|Adverse Event|0|||
23561089|NCT02404389|65782526|FG002|Overall Study|Adverse Event|1|||
23561090|NCT02404389|65782527|FG003|Overall Study|Adverse Event|0|||
23561091|NCT02404389|65782528|FG004|Overall Study|Adverse Event|2|||
23561092|NCT02404389|65782524|FG000|Overall Study|Subject/guardian decision|1|||
23561093|NCT02404389|65782525|FG001|Overall Study|Subject/guardian decision|0|||
23561094|NCT02404389|65782526|FG002|Overall Study|Subject/guardian decision|0|||
23561095|NCT02404389|65782527|FG003|Overall Study|Subject/guardian decision|1|||
23561096|NCT02404389|65782528|FG004|Overall Study|Subject/guardian decision|1|||
23561097|NCT00886639|65782529|FG000|Overall Study|acute exacerbation|14|||
23561098|NCT00886639|65782529|FG000|Overall Study|non-compliance|2|||
23561099|NCT01931735|65782530|FG000|Randomized Phase|Lost to Follow-up|2|||
23561100|NCT01931735|65782531|FG001|Randomized Phase|Lost to Follow-up|2|||
23561101|NCT01931735|65782532|FG002|Randomized Phase|Lost to Follow-up|5|||
23561102|NCT01931735|65782533|FG003|Randomized Phase|Lost to Follow-up|0|||
23561103|NCT01931735|65782530|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
23561104|NCT01931735|65782531|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
23561105|NCT01931735|65782532|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
23561106|NCT01931735|65782533|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
23561107|NCT01931735|65782530|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
23561108|NCT01931735|65782531|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
23561109|NCT01931735|65782532|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
23561110|NCT01931735|65782533|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
23561111|NCT01555164|65782545|FG000|Overall Study|Adverse Event|5|||
23561112|NCT01555164|65782546|FG001|Overall Study|Adverse Event|7|||
23561113|NCT01555164|65782545|FG000|Overall Study|Hyperglycemia|0|||
23561114|NCT01555164|65782546|FG001|Overall Study|Hyperglycemia|1|||
23561115|NCT01555164|65782545|FG000|Overall Study|Investigator's Discretion|2|||
23561116|NCT01555164|65782546|FG001|Overall Study|Investigator's Discretion|2|||
23561117|NCT01555164|65782545|FG000|Overall Study|Lost to Follow-up|4|||
23561118|NCT01555164|65782546|FG001|Overall Study|Lost to Follow-up|3|||
23561119|NCT01555164|65782545|FG000|Overall Study|Protocol Violation|9|||
23561120|NCT01555164|65782546|FG001|Overall Study|Protocol Violation|5|||
23561121|NCT01555164|65782545|FG000|Overall Study|Subject Non-compliance|14|||
23561122|NCT01555164|65782546|FG001|Overall Study|Subject Non-compliance|6|||
23561123|NCT01555164|65782545|FG000|Overall Study|Subject Withdrew Consent|6|||
23561124|NCT01555164|65782546|FG001|Overall Study|Subject Withdrew Consent|11|||
23561125|NCT00215540|65782547|FG000|Overall Study|Withdrew from study medication|1|||
23561126|NCT00215540|65782548|FG001|Overall Study|Withdrew from study medication|0|||
23561127|NCT00215540|65782549|FG002|Overall Study|Withdrew from study medication|0|||
23561128|NCT02234063|65782551|FG000|Overall Study|Lost to Follow-up|235|||
23561129|NCT02234063|65782552|FG001|Overall Study|Lost to Follow-up|42|||
23561130|NCT02234063|65782551|FG000|Overall Study|Withdrawal by Subject|20|||
23561131|NCT02234063|65782552|FG001|Overall Study|Withdrawal by Subject|1|||
23561132|NCT01407354|65782557|FG000|First Intervention|Withdrawal by Subject|0|||
23561133|NCT01407354|65782558|FG001|First Intervention|Withdrawal by Subject|2|||
23561134|NCT01407354|65782557|FG000|First Intervention|Adverse Event|1|||
23561135|NCT01407354|65782558|FG001|First Intervention|Adverse Event|0|||
23561136|NCT01407354|65782557|FG000|First Intervention|Physician Decision|1|||
23561137|NCT01407354|65782558|FG001|First Intervention|Physician Decision|0|||
23561138|NCT00746096|65782559|FG000|Overall Study|Adverse Event|1|||
23561139|NCT00746096|65782560|FG001|Overall Study|Adverse Event|0|||
23561140|NCT00746096|65782559|FG000|Overall Study|Withdrawal by Subject|5|||
23561141|NCT00746096|65782560|FG001|Overall Study|Withdrawal by Subject|1|||
23561142|NCT00746096|65782559|FG000|Overall Study|Lost to Follow-up|2|||
23561143|NCT00746096|65782560|FG001|Overall Study|Lost to Follow-up|1|||
23561144|NCT00746096|65782559|FG000|Overall Study|Protocol Violation|1|||
23561145|NCT00746096|65782560|FG001|Overall Study|Protocol Violation|0|||
23561146|NCT00746096|65782559|FG000|Overall Study|No study drug treatment|1|||
23150672|NCT03933397|64301916|FG000|Overall Study|Confirmed COVID-19|1|||
23150673|NCT03933397|64301917|FG001|Overall Study|Confirmed COVID-19|2|||
23561147|NCT00746096|65782560|FG001|Overall Study|No study drug treatment|1|||
23561148|NCT04074590|65782561|FG000|Overall Study|Adverse Event|1|||
23561149|NCT04074590|65782562|FG001|Overall Study|Adverse Event|0|||
23561150|NCT04074590|65782561|FG000|Overall Study|Physician Decision|1|||
23561151|NCT04074590|65782562|FG001|Overall Study|Physician Decision|0|||
23561152|NCT04074590|65782561|FG000|Overall Study|Withdrawal by Subject|2|||
23561153|NCT04074590|65782562|FG001|Overall Study|Withdrawal by Subject|0|||
23561154|NCT03303469|65782563|FG000|Overall Study|Lost to Follow-up|2|||
23561155|NCT01682213|65782567|FG000|Overall Study|Withdrawal by Subject|2|||
23561156|NCT02944656|65782568|FG000|Overall Study|No longer eligible|3|||
23561157|NCT02944656|65782569|FG001|Overall Study|No longer eligible|0|||
23561158|NCT02944656|65782568|FG000|Overall Study|Lost to Follow-up|7|||
23561159|NCT02944656|65782569|FG001|Overall Study|Lost to Follow-up|10|||
23561160|NCT02316769|65782570|FG000|Overall Study|Physician Decision|1|||
23561161|NCT02316769|65782571|FG001|Overall Study|Physician Decision|0|||
23561162|NCT02316769|65782570|FG000|Overall Study|Withdrawal by Subject|1|||
23150674|NCT01159912|64301921|FG000|Overall Study|Adverse Event|2|||
23150675|NCT01159912|64301922|FG001|Overall Study|Adverse Event|2|||
23150676|NCT01159912|64301923|FG002|Overall Study|Adverse Event|3|||
23150677|NCT01159912|64301921|FG000|Overall Study|Lack of Efficacy|23|||
23150678|NCT01159912|64301922|FG001|Overall Study|Lack of Efficacy|15|||
23150679|NCT01159912|64301923|FG002|Overall Study|Lack of Efficacy|14|||
23150680|NCT01159912|64301921|FG000|Overall Study|Protocol Violation|1|||
23150681|NCT01159912|64301922|FG001|Overall Study|Protocol Violation|2|||
23150682|NCT01159912|64301923|FG002|Overall Study|Protocol Violation|3|||
23150683|NCT01159912|64301921|FG000|Overall Study|Lost to Follow-up|4|||
23150684|NCT01159912|64301922|FG001|Overall Study|Lost to Follow-up|0|||
23150685|NCT01159912|64301923|FG002|Overall Study|Lost to Follow-up|0|||
23150686|NCT01159912|64301921|FG000|Overall Study|Physician Decision|0|||
23150687|NCT01159912|64301922|FG001|Overall Study|Physician Decision|0|||
23150688|NCT01159912|64301923|FG002|Overall Study|Physician Decision|3|||
23150689|NCT01159912|64301921|FG000|Overall Study|Withdrawal by Subject|10|||
23150690|NCT01159912|64301922|FG001|Overall Study|Withdrawal by Subject|3|||
23150691|NCT01159912|64301923|FG002|Overall Study|Withdrawal by Subject|3|||
23150692|NCT01431534|64301928|FG000|Treatment Phase|Adverse Event|0|||
23150693|NCT01431534|64301929|FG001|Treatment Phase|Adverse Event|0|||
23150694|NCT01431534|64301930|FG002|Treatment Phase|Adverse Event|1|||
23150695|NCT01431534|64301928|FG000|Treatment Phase|Progressive Disease|4|||
23150696|NCT01431534|64301929|FG001|Treatment Phase|Progressive Disease|3|||
23150697|NCT01431534|64301930|FG002|Treatment Phase|Progressive Disease|10|||
23150698|NCT00954421|64301933|FG000|Screening|screen failures|3|||
23150699|NCT00954421|64301933|FG000|6 Months of DBS|Withdrawal by Subject|1|||
23150700|NCT00954421|64301933|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
23150701|NCT02249767|64301934|FG000|Overall Study|Did not use medication|8|||
23150702|NCT02249767|64301935|FG001|Overall Study|Did not use medication|9|||
23150703|NCT02249767|64301936|FG002|Overall Study|Did not use medication|8|||
23150704|NCT01130974|64301937|FG000|Overall Study|Protocol Violation|10|||
23324625|NCT03170544|64930401|FG002|Part 1|Not treated|0|||
23324626|NCT03170544|64930402|FG003|Part 1|Not treated|1|||
23150705|NCT01130974|64301938|FG001|Overall Study|Protocol Violation|10|||
23150706|NCT01130974|64301937|FG000|Overall Study|Withdrawal by Subject|0|||
23150707|NCT01130974|64301938|FG001|Overall Study|Withdrawal by Subject|1|||
23150708|NCT01130974|64301937|FG000|Overall Study|Ineligibility criteria|5|||
23150709|NCT01130974|64301938|FG001|Overall Study|Ineligibility criteria|2|||
23150710|NCT01672788|64301939|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
23150711|NCT01672788|64301940|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
23150712|NCT01672788|64301941|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
23150713|NCT01672788|64301942|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
23150714|NCT01137955|64301943|FG000|Overall Study|Withdrawal by Subject|5|||
23150715|NCT01137955|64301944|FG001|Overall Study|Withdrawal by Subject|4|||
23150716|NCT01444651|64301948|FG000|Overall Study|Adverse Event|3|||
23150717|NCT01444651|64301949|FG001|Overall Study|Adverse Event|2|||
23150718|NCT01444651|64301948|FG000|Overall Study|Lost to Follow-up|5|||
23324627|NCT03170544|64930403|FG004|Part 1|Not treated|0|||
23324628|NCT03170544|64930404|FG005|Part 1|Not treated|0|||
23561163|NCT02316769|65782571|FG001|Overall Study|Withdrawal by Subject|0|||
23561164|NCT00521144|65782572|FG000|Overall Study|Not Treated|0|||
23561165|NCT00521144|65782573|FG001|Overall Study|Not Treated|0|||
23561166|NCT00521144|65782574|FG002|Overall Study|Not Treated|0|||
23561167|NCT00521144|65782575|FG003|Overall Study|Not Treated|1|||
23561168|NCT00521144|65782576|FG004|Overall Study|Not Treated|0|||
23561169|NCT00521144|65782572|FG000|Overall Study|Adverse Event|0|||
23561170|NCT00521144|65782573|FG001|Overall Study|Adverse Event|1|||
23561171|NCT00521144|65782574|FG002|Overall Study|Adverse Event|0|||
23561172|NCT00521144|65782575|FG003|Overall Study|Adverse Event|0|||
23324629|NCT03170544|64930405|FG006|Part 1|Not treated|0|||
23324630|NCT03170544|64930406|FG007|Part 1|Not treated|0|||
23561173|NCT00521144|65782576|FG004|Overall Study|Adverse Event|1|||
23561174|NCT00521144|65782572|FG000|Overall Study|Progressive Disease|4|||
23561175|NCT00521144|65782573|FG001|Overall Study|Progressive Disease|2|||
23561176|NCT00521144|65782574|FG002|Overall Study|Progressive Disease|2|||
23561177|NCT00521144|65782575|FG003|Overall Study|Progressive Disease|0|||
23150719|NCT01444651|64301949|FG001|Overall Study|Lost to Follow-up|5|||
23150720|NCT01444651|64301948|FG000|Overall Study|Non-fasting|2|||
23150721|NCT01444651|64301949|FG001|Overall Study|Non-fasting|1|||
23150722|NCT01444651|64301948|FG000|Overall Study|Missing data|1|||
23150723|NCT01444651|64301949|FG001|Overall Study|Missing data|1|||
23150724|NCT01910116|64301950|FG000|Overall Study|Adverse Event|0|||
23324631|NCT03170544|64930407|FG008|Part 1|Not treated|0|||
23324632|NCT03170544|64930408|FG009|Part 1|Not treated|0|||
23561178|NCT00521144|65782576|FG004|Overall Study|Progressive Disease|6|||
23150725|NCT01910116|64301951|FG001|Overall Study|Adverse Event|3|||
23150726|NCT01910116|64301950|FG000|Overall Study|Lack of Efficacy|3|||
23150727|NCT01910116|64301951|FG001|Overall Study|Lack of Efficacy|4|||
23150728|NCT01910116|64301950|FG000|Overall Study|Lost to Follow-up|1|||
23150729|NCT01910116|64301951|FG001|Overall Study|Lost to Follow-up|0|||
23150730|NCT01910116|64301950|FG000|Overall Study|Protocol Violation|1|||
23150731|NCT01910116|64301951|FG001|Overall Study|Protocol Violation|2|||
23561179|NCT02768662|65782577|FG000|Overall Study|Adverse Event|1|||
23561180|NCT02768662|65782577|FG000|Overall Study|Lost to Follow-up|4|||
23561181|NCT02768662|65782577|FG000|Overall Study|Withdrawal by Subject|3|||
23561182|NCT02768662|65782577|FG000|Overall Study|Study terminated by Sponsor|78|||
23561183|NCT00246337|65782578|FG000|Overall Study|Lost to Follow-up|3|||
23561184|NCT00246337|65782579|FG001|Overall Study|Lost to Follow-up|0|||
23561185|NCT00246337|65782580|FG002|Overall Study|Lost to Follow-up|0|||
23561186|NCT00246337|65782581|FG003|Overall Study|Lost to Follow-up|0|||
23561187|NCT00246337|65782582|FG004|Overall Study|Lost to Follow-up|2|||
23561188|NCT00246337|65782583|FG005|Overall Study|Lost to Follow-up|2|||
23561189|NCT00246337|65782584|FG006|Overall Study|Lost to Follow-up|1|||
23561190|NCT00246337|65782585|FG007|Overall Study|Lost to Follow-up|2|||
23561191|NCT00246337|65782586|FG008|Overall Study|Lost to Follow-up|0|||
23561192|NCT00246337|65782578|FG000|Overall Study|Protocol Violation|1|||
23561193|NCT00246337|65782579|FG001|Overall Study|Protocol Violation|0|||
23561194|NCT00246337|65782580|FG002|Overall Study|Protocol Violation|0|||
23561195|NCT00246337|65782581|FG003|Overall Study|Protocol Violation|0|||
23561196|NCT00246337|65782582|FG004|Overall Study|Protocol Violation|1|||
23561197|NCT00246337|65782583|FG005|Overall Study|Protocol Violation|0|||
23561198|NCT00246337|65782584|FG006|Overall Study|Protocol Violation|1|||
23561199|NCT00246337|65782585|FG007|Overall Study|Protocol Violation|1|||
23561200|NCT00246337|65782586|FG008|Overall Study|Protocol Violation|0|||
23561201|NCT00246337|65782578|FG000|Overall Study|Withdrawal by Subject|2|||
23561202|NCT00246337|65782579|FG001|Overall Study|Withdrawal by Subject|0|||
23561203|NCT00246337|65782580|FG002|Overall Study|Withdrawal by Subject|0|||
23561204|NCT00246337|65782581|FG003|Overall Study|Withdrawal by Subject|0|||
23561205|NCT00246337|65782582|FG004|Overall Study|Withdrawal by Subject|0|||
23561206|NCT00246337|65782583|FG005|Overall Study|Withdrawal by Subject|0|||
23561207|NCT00246337|65782584|FG006|Overall Study|Withdrawal by Subject|1|||
23561208|NCT00246337|65782585|FG007|Overall Study|Withdrawal by Subject|1|||
23561209|NCT00246337|65782586|FG008|Overall Study|Withdrawal by Subject|0|||
23561210|NCT00246337|65782578|FG000|Overall Study|Lack of Qualifying Event|8|||
23561211|NCT00246337|65782579|FG001|Overall Study|Lack of Qualifying Event|2|||
23561212|NCT00246337|65782580|FG002|Overall Study|Lack of Qualifying Event|1|||
23561213|NCT00246337|65782581|FG003|Overall Study|Lack of Qualifying Event|1|||
23561214|NCT00246337|65782582|FG004|Overall Study|Lack of Qualifying Event|1|||
23561215|NCT00246337|65782583|FG005|Overall Study|Lack of Qualifying Event|3|||
23561216|NCT00246337|65782584|FG006|Overall Study|Lack of Qualifying Event|3|||
23561217|NCT00246337|65782585|FG007|Overall Study|Lack of Qualifying Event|2|||
23561218|NCT00246337|65782586|FG008|Overall Study|Lack of Qualifying Event|5|||
23561219|NCT00246337|65782578|FG000|Overall Study|Site Terminated|10|||
23561220|NCT00246337|65782579|FG001|Overall Study|Site Terminated|0|||
23561221|NCT00246337|65782580|FG002|Overall Study|Site Terminated|0|||
23561222|NCT00246337|65782581|FG003|Overall Study|Site Terminated|0|||
23561223|NCT00246337|65782582|FG004|Overall Study|Site Terminated|0|||
23561224|NCT00246337|65782583|FG005|Overall Study|Site Terminated|7|||
23561225|NCT00246337|65782584|FG006|Overall Study|Site Terminated|1|||
23561226|NCT00246337|65782585|FG007|Overall Study|Site Terminated|6|||
23561227|NCT00246337|65782586|FG008|Overall Study|Site Terminated|2|||
23561228|NCT00246337|65782578|FG000|Overall Study|Abnormal baseline lab values|7|||
23561229|NCT00246337|65782579|FG001|Overall Study|Abnormal baseline lab values|0|||
23561230|NCT00246337|65782580|FG002|Overall Study|Abnormal baseline lab values|2|||
23561231|NCT00246337|65782581|FG003|Overall Study|Abnormal baseline lab values|0|||
23561232|NCT00246337|65782582|FG004|Overall Study|Abnormal baseline lab values|0|||
23561233|NCT00246337|65782583|FG005|Overall Study|Abnormal baseline lab values|2|||
23561234|NCT00246337|65782584|FG006|Overall Study|Abnormal baseline lab values|2|||
23561235|NCT00246337|65782585|FG007|Overall Study|Abnormal baseline lab values|0|||
23561236|NCT00246337|65782586|FG008|Overall Study|Abnormal baseline lab values|4|||
23561237|NCT00246337|65782578|FG000|Overall Study|Overwhelmed|0|||
23561238|NCT00246337|65782579|FG001|Overall Study|Overwhelmed|0|||
23561239|NCT00246337|65782580|FG002|Overall Study|Overwhelmed|0|||
23561240|NCT00246337|65782581|FG003|Overall Study|Overwhelmed|0|||
23561241|NCT00246337|65782582|FG004|Overall Study|Overwhelmed|0|||
23561242|NCT00246337|65782583|FG005|Overall Study|Overwhelmed|1|||
23561243|NCT00246337|65782584|FG006|Overall Study|Overwhelmed|0|||
23150732|NCT01910116|64301950|FG000|Overall Study|Withdrawal by Subject|8|||
23150733|NCT01910116|64301951|FG001|Overall Study|Withdrawal by Subject|3|||
23150734|NCT01910116|64301950|FG000|Overall Study|uncertain allocation|1|||
23561244|NCT00246337|65782585|FG007|Overall Study|Overwhelmed|0|||
23150735|NCT01910116|64301951|FG001|Overall Study|uncertain allocation|3|||
23150736|NCT01910116|64301950|FG000|Overall Study|incomplete data|0|||
23561245|NCT00246337|65782586|FG008|Overall Study|Overwhelmed|0|||
23561246|NCT00246337|65782578|FG000|Overall Study|Protocol Violator|1|||
23561247|NCT00246337|65782579|FG001|Overall Study|Protocol Violator|0|||
23561248|NCT00246337|65782580|FG002|Overall Study|Protocol Violator|0|||
23561249|NCT00246337|65782581|FG003|Overall Study|Protocol Violator|0|||
23561250|NCT00246337|65782582|FG004|Overall Study|Protocol Violator|0|||
23561251|NCT00246337|65782583|FG005|Overall Study|Protocol Violator|0|||
23561252|NCT00246337|65782584|FG006|Overall Study|Protocol Violator|0|||
23561253|NCT00246337|65782585|FG007|Overall Study|Protocol Violator|0|||
23561254|NCT00246337|65782586|FG008|Overall Study|Protocol Violator|0|||
23561255|NCT00246337|65782578|FG000|Overall Study|Reported as completing trial in error|0|||
23561256|NCT00246337|65782579|FG001|Overall Study|Reported as completing trial in error|0|||
23561257|NCT00246337|65782580|FG002|Overall Study|Reported as completing trial in error|0|||
23561258|NCT00246337|65782581|FG003|Overall Study|Reported as completing trial in error|0|||
23561259|NCT00246337|65782582|FG004|Overall Study|Reported as completing trial in error|0|||
23561260|NCT00246337|65782583|FG005|Overall Study|Reported as completing trial in error|0|||
23561261|NCT00246337|65782584|FG006|Overall Study|Reported as completing trial in error|0|||
23561262|NCT00246337|65782585|FG007|Overall Study|Reported as completing trial in error|1|||
23561263|NCT00246337|65782586|FG008|Overall Study|Reported as completing trial in error|0|||
23561264|NCT03518125|65782587|FG000|Overall Study|Lost to Follow-up|0|||
23561265|NCT03518125|65782588|FG001|Overall Study|Lost to Follow-up|2|||
23561266|NCT03518125|65782589|FG002|Overall Study|Lost to Follow-up|0|||
23561267|NCT03518125|65782590|FG003|Overall Study|Lost to Follow-up|0|||
23561268|NCT03518125|65782591|FG004|Overall Study|Lost to Follow-up|3|||
23561269|NCT03518125|65782592|FG005|Overall Study|Lost to Follow-up|5|||
23561270|NCT03518125|65782587|FG000|Overall Study|Physician Decision|0|||
23561271|NCT03518125|65782588|FG001|Overall Study|Physician Decision|1|||
23324633|NCT03170544|64930409|FG010|Part 1|Not treated|0|||
23324634|NCT03170544|64930410|FG011|Part 1|Not treated|0|||
23561272|NCT03518125|65782589|FG002|Overall Study|Physician Decision|0|||
23561273|NCT03518125|65782590|FG003|Overall Study|Physician Decision|0|||
23324635|NCT00758524|64930411|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
23324636|NCT00758524|64930412|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
23324637|NCT00758524|64930413|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
23324638|NCT00758524|64930414|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324639|NCT00758524|64930415|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
23324640|NCT00758524|64930416|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
23324641|NCT00758524|64930417|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324642|NCT00758524|64930418|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324643|NCT00758524|64930419|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324644|NCT00758524|64930420|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23561274|NCT03518125|65782591|FG004|Overall Study|Physician Decision|0|||
23561275|NCT03518125|65782592|FG005|Overall Study|Physician Decision|0|||
23561276|NCT03518125|65782587|FG000|Overall Study|Withdrawal by Subject|1|||
23561277|NCT03518125|65782588|FG001|Overall Study|Withdrawal by Subject|1|||
23561278|NCT03518125|65782589|FG002|Overall Study|Withdrawal by Subject|0|||
23625041|NCT01296555|66015412|FG020|Overall Study|Study Terminated By Sponsor|0|||
23625042|NCT01296555|66015413|FG021|Overall Study|Study Terminated By Sponsor|0|||
23324645|NCT00758524|64930421|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324646|NCT00758524|64930422|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324647|NCT00758524|64930423|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324648|NCT00758524|64930424|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324649|NCT00758524|64930425|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324650|NCT00758524|64930426|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324651|NCT00758524|64930427|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
23324652|NCT00758524|64930411|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
23324653|NCT00758524|64930412|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23324654|NCT00758524|64930413|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
23324655|NCT00758524|64930414|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
23324656|NCT00758524|64930415|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
23324657|NCT00758524|64930416|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
23324658|NCT00758524|64930417|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23324659|NCT00758524|64930418|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23561279|NCT03518125|65782590|FG003|Overall Study|Withdrawal by Subject|1|||
23561280|NCT03518125|65782591|FG004|Overall Study|Withdrawal by Subject|1|||
23561281|NCT03518125|65782592|FG005|Overall Study|Withdrawal by Subject|3|||
23561282|NCT03518125|65782587|FG000|Overall Study|Missed Day 394 Visit|1|||
23561283|NCT03518125|65782588|FG001|Overall Study|Missed Day 394 Visit|0|||
23561284|NCT03518125|65782589|FG002|Overall Study|Missed Day 394 Visit|0|||
23561285|NCT03518125|65782590|FG003|Overall Study|Missed Day 394 Visit|0|||
23625043|NCT01296555|66015414|FG022|Overall Study|Study Terminated By Sponsor|0|||
23324660|NCT00758524|64930419|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23561286|NCT03518125|65782591|FG004|Overall Study|Missed Day 394 Visit|0|||
23324661|NCT00758524|64930420|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23219787|NCT04914819|64549949|FG000|Overall Study|Discontinued study|4|||
23219788|NCT04914819|64549950|FG001|Overall Study|Discontinued study|1|||
23219789|NCT04914819|64549949|FG000|Overall Study|Lost to Follow-up|7|||
23219790|NCT04914819|64549950|FG001|Overall Study|Lost to Follow-up|0|||
23219791|NCT03077711|64549963|FG000|Overall Study|Lost to Follow-up|2|||
23219792|NCT03077711|64549964|FG001|Overall Study|Lost to Follow-up|2|||
23561287|NCT03518125|65782592|FG005|Overall Study|Missed Day 394 Visit|0|||
23561288|NCT02178059|65782593|FG000|Washout|Physician Decision|1|||
23561289|NCT02178059|65782594|FG001|Washout|Physician Decision|0|||
23561290|NCT03205371|65782598|FG000|Overall Study|Withdrawal by Subject|4|||
23561291|NCT03205371|65782599|FG001|Overall Study|Withdrawal by Subject|1|||
23561292|NCT03205371|65782600|FG002|Overall Study|Withdrawal by Subject|0|||
23561293|NCT03205371|65782601|FG003|Overall Study|Withdrawal by Subject|0|||
23561294|NCT03205371|65782602|FG004|Overall Study|Withdrawal by Subject|0|||
23561295|NCT03205371|65782603|FG005|Overall Study|Withdrawal by Subject|0|||
23561296|NCT03205371|65782604|FG006|Overall Study|Withdrawal by Subject|4|||
23561297|NCT03205371|65782605|FG007|Overall Study|Withdrawal by Subject|0|||
23561298|NCT03205371|65782606|FG008|Overall Study|Withdrawal by Subject|2|||
23561299|NCT03205371|65782607|FG009|Overall Study|Withdrawal by Subject|0|||
23561300|NCT03205371|65782608|FG010|Overall Study|Withdrawal by Subject|0|||
23324662|NCT00758524|64930421|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23561301|NCT03205371|65782609|FG011|Overall Study|Withdrawal by Subject|1|||
23561302|NCT03205371|65782598|FG000|Overall Study|Lost to Follow-up|0|||
23561303|NCT03205371|65782599|FG001|Overall Study|Lost to Follow-up|0|||
23561304|NCT03205371|65782600|FG002|Overall Study|Lost to Follow-up|0|||
23561305|NCT03205371|65782601|FG003|Overall Study|Lost to Follow-up|0|||
23561306|NCT03205371|65782602|FG004|Overall Study|Lost to Follow-up|0|||
23561307|NCT03205371|65782603|FG005|Overall Study|Lost to Follow-up|0|||
23561308|NCT03205371|65782604|FG006|Overall Study|Lost to Follow-up|5|||
23324663|NCT00758524|64930422|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23324664|NCT00758524|64930423|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23324665|NCT00758524|64930424|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23324666|NCT00758524|64930425|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23324667|NCT00758524|64930426|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23324668|NCT00758524|64930427|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
23324669|NCT00758524|64930411|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
23324670|NCT00758524|64930412|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
23324671|NCT00758524|64930413|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
23324672|NCT00758524|64930414|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
23324673|NCT00758524|64930415|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
23324674|NCT00758524|64930416|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
23324675|NCT00758524|64930417|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324676|NCT00758524|64930418|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324677|NCT00758524|64930419|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324678|NCT00758524|64930420|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324679|NCT00758524|64930421|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324680|NCT00758524|64930422|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324681|NCT00758524|64930423|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324682|NCT00758524|64930424|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324683|NCT00758524|64930425|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324684|NCT00758524|64930426|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324685|NCT00758524|64930427|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
23324686|NCT00758524|64930411|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23561309|NCT03205371|65782605|FG007|Overall Study|Lost to Follow-up|2|||
23561310|NCT03205371|65782606|FG008|Overall Study|Lost to Follow-up|3|||
23561311|NCT03205371|65782607|FG009|Overall Study|Lost to Follow-up|0|||
23219793|NCT03077711|64549963|FG000|Overall Study|noncompliant taking medication|2|||
23219794|NCT03077711|64549964|FG001|Overall Study|noncompliant taking medication|0|||
23219795|NCT01316380|64549965|FG000|Overall Study|Adverse Event|0|||
23219796|NCT01316380|64549966|FG001|Overall Study|Adverse Event|2|||
23219797|NCT01316380|64549967|FG002|Overall Study|Adverse Event|1|||
23219798|NCT01316380|64549965|FG000|Overall Study|Protocol Violation|0|||
23219799|NCT01316380|64549966|FG001|Overall Study|Protocol Violation|0|||
23219800|NCT01316380|64549967|FG002|Overall Study|Protocol Violation|1|||
23324687|NCT00758524|64930412|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
23219801|NCT01316380|64549965|FG000|Overall Study|Withdrawal by Subject|1|||
23561312|NCT03205371|65782608|FG010|Overall Study|Lost to Follow-up|0|||
23561313|NCT03205371|65782609|FG011|Overall Study|Lost to Follow-up|0|||
23561314|NCT03205371|65782598|FG000|Overall Study|Protocol Violation|0|||
23561315|NCT03205371|65782599|FG001|Overall Study|Protocol Violation|0|||
23219802|NCT01316380|64549966|FG001|Overall Study|Withdrawal by Subject|2|||
23219803|NCT01316380|64549967|FG002|Overall Study|Withdrawal by Subject|0|||
23219804|NCT01316380|64549965|FG000|Overall Study|Other|0|||
23324688|NCT00758524|64930413|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
23324689|NCT00758524|64930414|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324690|NCT00758524|64930415|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
23324691|NCT00758524|64930416|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
23324692|NCT00758524|64930417|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324693|NCT00758524|64930418|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324694|NCT00758524|64930419|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324695|NCT00758524|64930420|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324696|NCT00758524|64930421|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324697|NCT00758524|64930422|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324698|NCT00758524|64930423|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324699|NCT00758524|64930424|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324700|NCT00758524|64930425|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324701|NCT00758524|64930426|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324702|NCT00758524|64930427|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
23324703|NCT00758524|64930411|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324704|NCT00758524|64930412|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324705|NCT00758524|64930413|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
23324706|NCT00758524|64930414|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
23324707|NCT00758524|64930415|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324708|NCT00758524|64930416|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324709|NCT00758524|64930417|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324710|NCT00758524|64930418|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324711|NCT00758524|64930419|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324712|NCT00758524|64930420|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324713|NCT00758524|64930421|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324714|NCT00758524|64930422|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324715|NCT00758524|64930423|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324716|NCT00758524|64930424|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324717|NCT00758524|64930425|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324718|NCT00758524|64930426|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324719|NCT00758524|64930427|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
23324720|NCT00758524|64930411|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324721|NCT00758524|64930412|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324722|NCT00758524|64930413|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324723|NCT00758524|64930414|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324724|NCT00758524|64930415|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
23324725|NCT00758524|64930416|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23438573|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23150737|NCT01910116|64301951|FG001|Overall Study|incomplete data|1|||
23324726|NCT00758524|64930417|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324727|NCT00758524|64930418|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324728|NCT00758524|64930419|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324729|NCT00758524|64930420|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324730|NCT00758524|64930421|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324731|NCT00758524|64930422|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324732|NCT00758524|64930423|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324733|NCT00758524|64930424|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324734|NCT00758524|64930425|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324735|NCT00758524|64930426|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324736|NCT00758524|64930427|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
23324737|NCT00758524|64930411|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324738|NCT00758524|64930412|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
23438574|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23150738|NCT02308007|64301960|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
23150739|NCT02308007|64301961|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
23150740|NCT02308007|64301962|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
23150741|NCT02308007|64301960|FG000|Overall Study|Positive for STD at Baseline|7|||
23150742|NCT02308007|64301961|FG001|Overall Study|Positive for STD at Baseline|11|||
23150743|NCT02308007|64301962|FG002|Overall Study|Positive for STD at Baseline|7|||
23150744|NCT02308007|64301960|FG000|Overall Study|Lost to Follow-up|3|||
23150745|NCT02308007|64301961|FG001|Overall Study|Lost to Follow-up|0|||
23150746|NCT02308007|64301962|FG002|Overall Study|Lost to Follow-up|1|||
23150747|NCT01423812|64301963|FG000|Overall Study|Lost to Follow-up|2|||
23150748|NCT01423812|64301964|FG001|Overall Study|Lost to Follow-up|2|||
23150749|NCT01423812|64301963|FG000|Overall Study|Withdrawal by Subject|1|||
23150750|NCT01423812|64301964|FG001|Overall Study|Withdrawal by Subject|2|||
23150751|NCT00954174|64301965|FG000|Overall Study|Adverse Event|28|||
23150752|NCT00954174|64301966|FG001|Overall Study|Adverse Event|23|||
23324739|NCT00758524|64930413|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324740|NCT00758524|64930414|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324741|NCT00758524|64930415|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324742|NCT00758524|64930416|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324743|NCT00758524|64930417|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23438575|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438576|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23324744|NCT00758524|64930418|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324745|NCT00758524|64930419|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324746|NCT00758524|64930420|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324747|NCT00758524|64930421|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324748|NCT00758524|64930422|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23438577|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438578|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23561316|NCT03205371|65782600|FG002|Overall Study|Protocol Violation|0|||
23561317|NCT03205371|65782601|FG003|Overall Study|Protocol Violation|0|||
23561318|NCT03205371|65782602|FG004|Overall Study|Protocol Violation|0|||
23561319|NCT03205371|65782603|FG005|Overall Study|Protocol Violation|0|||
23561320|NCT03205371|65782604|FG006|Overall Study|Protocol Violation|1|||
23561321|NCT03205371|65782605|FG007|Overall Study|Protocol Violation|0|||
23561322|NCT03205371|65782606|FG008|Overall Study|Protocol Violation|0|||
23561323|NCT03205371|65782607|FG009|Overall Study|Protocol Violation|0|||
23561324|NCT03205371|65782608|FG010|Overall Study|Protocol Violation|0|||
23561325|NCT03205371|65782609|FG011|Overall Study|Protocol Violation|0|||
23561326|NCT03205371|65782598|FG000|Overall Study|Adverse Event|0|||
23561327|NCT03205371|65782599|FG001|Overall Study|Adverse Event|0|||
23561328|NCT03205371|65782600|FG002|Overall Study|Adverse Event|0|||
23561329|NCT03205371|65782601|FG003|Overall Study|Adverse Event|0|||
23561330|NCT03205371|65782602|FG004|Overall Study|Adverse Event|0|||
23561331|NCT03205371|65782603|FG005|Overall Study|Adverse Event|0|||
23561332|NCT03205371|65782604|FG006|Overall Study|Adverse Event|0|||
23561333|NCT03205371|65782605|FG007|Overall Study|Adverse Event|1|||
23438579|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23561334|NCT03205371|65782606|FG008|Overall Study|Adverse Event|0|||
23561335|NCT03205371|65782607|FG009|Overall Study|Adverse Event|0|||
23561336|NCT03205371|65782608|FG010|Overall Study|Adverse Event|0|||
23561337|NCT03205371|65782609|FG011|Overall Study|Adverse Event|0|||
23561338|NCT00611858|65782610|FG000|Overall Study|Adverse Event|2|||
23561339|NCT00611858|65782610|FG000|Overall Study|Withdrawal by Subject|2|||
23561340|NCT03122119|65782615|FG000|Overall Study|Did not meet eligibility critria|1|||
23561341|NCT03124199|65782616|FG000|Overall Study|Lost to Follow-up|4|||
23561342|NCT03243422|65782617|FG000|Overall Study|Death|20|||
23561343|NCT03243422|65782618|FG001|Overall Study|Death|21|||
23561344|NCT03243422|65782617|FG000|Overall Study|Lost to Follow-up|9|||
23625044|NCT01296555|66015415|FG023|Overall Study|Study Terminated By Sponsor|0|||
23625045|NCT01296555|66015416|FG024|Overall Study|Study Terminated By Sponsor|0|||
23625046|NCT01296555|66015417|FG025|Overall Study|Study Terminated By Sponsor|1|||
23625047|NCT01296555|66015418|FG026|Overall Study|Study Terminated By Sponsor|0|||
23625048|NCT01296555|66015419|FG027|Overall Study|Study Terminated By Sponsor|0|||
23561345|NCT03243422|65782618|FG001|Overall Study|Lost to Follow-up|21|||
23561346|NCT03243422|65782617|FG000|Overall Study|Withdrawal by Subject|22|||
23561347|NCT03243422|65782618|FG001|Overall Study|Withdrawal by Subject|8|||
23561348|NCT01301274|65782619|FG000|Overall Study|Physician Decision|2|||
23561349|NCT01301274|65782620|FG001|Overall Study|Physician Decision|1|||
23561350|NCT02978443|65782621|FG000|Overall Study|Withdrawal by Subject|1|||
23561351|NCT02978443|65782621|FG000|Overall Study|Adverse Event|3|||
23625049|NCT01296555|66015420|FG028|Overall Study|Study Terminated By Sponsor|0|||
23625050|NCT01296555|66015392|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625051|NCT01296555|66015393|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23150753|NCT00954174|64301967|FG002|Overall Study|Adverse Event|4|||
23150754|NCT00954174|64301968|FG003|Overall Study|Adverse Event|9|||
23150755|NCT00954174|64301965|FG000|Overall Study|Death|4|||
23150756|NCT00954174|64301966|FG001|Overall Study|Death|2|||
23150757|NCT00954174|64301967|FG002|Overall Study|Death|0|||
23150758|NCT00954174|64301968|FG003|Overall Study|Death|0|||
23150759|NCT00954174|64301965|FG000|Overall Study|Lack of Efficacy|32|||
23150760|NCT00954174|64301966|FG001|Overall Study|Lack of Efficacy|22|||
23150761|NCT00954174|64301967|FG002|Overall Study|Lack of Efficacy|8|||
23150762|NCT00954174|64301968|FG003|Overall Study|Lack of Efficacy|6|||
23150763|NCT00954174|64301965|FG000|Overall Study|Withdrawal by Subject|14|||
23150764|NCT00954174|64301966|FG001|Overall Study|Withdrawal by Subject|10|||
23150765|NCT00954174|64301967|FG002|Overall Study|Withdrawal by Subject|4|||
23150766|NCT00954174|64301968|FG003|Overall Study|Withdrawal by Subject|3|||
23150767|NCT00954174|64301965|FG000|Overall Study|Medical Reason|4|||
23150768|NCT00954174|64301966|FG001|Overall Study|Medical Reason|2|||
23438580|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
23438581|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
23438582|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
23438583|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438584|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438585|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438586|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438587|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438588|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438589|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438590|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438591|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438592|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
23438593|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
23438594|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
23438595|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
23438596|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438597|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438598|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438599|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438600|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438601|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438602|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438603|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438604|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438605|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438606|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
23438607|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438608|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
23438609|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438610|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438611|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438612|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438613|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438614|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438615|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438616|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438617|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438618|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438619|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23438620|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
23219805|NCT01316380|64549966|FG001|Overall Study|Other|1|||
23219806|NCT01316380|64549967|FG002|Overall Study|Other|1|||
23438621|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
23438622|NCT03100058|65348600|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438623|NCT03100058|65348601|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438624|NCT03100058|65348602|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438625|NCT03100058|65348603|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438626|NCT03100058|65348604|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438627|NCT03100058|65348605|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438628|NCT03100058|65348606|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438629|NCT03100058|65348607|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23625052|NCT01296555|66015394|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625053|NCT01296555|66015395|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625054|NCT01296555|66015396|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625055|NCT01296555|66015397|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625056|NCT01296555|66015398|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625057|NCT01296555|66015399|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625058|NCT01296555|66015400|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625059|NCT01296555|66015401|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625060|NCT01296555|66015402|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625061|NCT01296555|66015403|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625062|NCT01296555|66015404|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23438630|NCT03100058|65348608|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438631|NCT03100058|65348609|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
23625063|NCT01296555|66015405|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625064|NCT01296555|66015406|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23438632|NCT03100058|65348610|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23625065|NCT01296555|66015407|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625066|NCT01296555|66015408|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625067|NCT01296555|66015409|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625068|NCT01296555|66015410|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625069|NCT01296555|66015411|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
23625070|NCT01296555|66015412|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23438633|NCT03100058|65348611|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438634|NCT03100058|65348612|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
23438635|NCT02702414|65348615|FG000|Overall Study|Death|96|||
23438636|NCT02702414|65348616|FG001|Overall Study|Death|42|||
23438637|NCT02702414|65348615|FG000|Overall Study|Lost to Follow-up|0|||
23438638|NCT02702414|65348616|FG001|Overall Study|Lost to Follow-up|1|||
23438639|NCT02702414|65348615|FG000|Overall Study|Withdrawal by Subject|0|||
23438640|NCT02702414|65348616|FG001|Overall Study|Withdrawal by Subject|1|||
23438641|NCT02702414|65348615|FG000|Overall Study|Protocol Violation|1|||
23438642|NCT02702414|65348616|FG001|Overall Study|Protocol Violation|0|||
23438643|NCT02702414|65348615|FG000|Overall Study|Sponsor Decision|8|||
23438644|NCT02702414|65348616|FG001|Overall Study|Sponsor Decision|7|||
23438645|NCT04390841|65348618|FG000|Overall Study|Withdrawal by Subject|2|||
23438646|NCT00588354|65348619|FG000|Baseline to 2 Weeks|Adverse Event|1|||
23438647|NCT00588354|65348620|FG001|Baseline to 2 Weeks|Adverse Event|0|||
23438648|NCT00588354|65348619|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
23438649|NCT00588354|65348620|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
23438650|NCT00588354|65348619|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
23438651|NCT00588354|65348620|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
23438652|NCT02485704|65348623|FG000|Overall Study|Lost to Follow-up|4|||
23438653|NCT02485704|65348624|FG001|Overall Study|Lost to Follow-up|5|||
23438654|NCT02485704|65348623|FG000|Overall Study|Withdrawal by Subject|0|||
23438655|NCT02485704|65348624|FG001|Overall Study|Withdrawal by Subject|3|||
23438656|NCT02485704|65348623|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
23438657|NCT02485704|65348624|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
23438658|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
23438659|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
23438660|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
23438661|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
23438662|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
23438663|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
23438664|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
23438665|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
23150769|NCT00954174|64301967|FG002|Overall Study|Medical Reason|1|||
23150770|NCT00954174|64301968|FG003|Overall Study|Medical Reason|0|||
23150771|NCT00954174|64301965|FG000|Overall Study|Ineligible|40|||
23150772|NCT00954174|64301966|FG001|Overall Study|Ineligible|47|||
23150773|NCT00954174|64301967|FG002|Overall Study|Ineligible|7|||
23150774|NCT00954174|64301968|FG003|Overall Study|Ineligible|4|||
23150775|NCT00954174|64301965|FG000|Overall Study|Never Treated|4|||
23150776|NCT00954174|64301966|FG001|Overall Study|Never Treated|17|||
23438666|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
23438667|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
23438668|NCT02429791|65348625|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
23438669|NCT02429791|65348626|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
23438670|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
23438671|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
23438672|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
23438673|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
23438674|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
23438675|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
23438676|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
23438677|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
23438678|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
23438679|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
23625071|NCT01296555|66015413|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625072|NCT01296555|66015414|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23219807|NCT01316380|64549965|FG000|Overall Study|Not treated|1|||
23219808|NCT01316380|64549966|FG001|Overall Study|Not treated|0|||
23438680|NCT02429791|65348625|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
23438681|NCT02429791|65348626|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
23625073|NCT01296555|66015415|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625074|NCT01296555|66015416|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23150777|NCT00954174|64301967|FG002|Overall Study|Never Treated|0|||
23150778|NCT00954174|64301968|FG003|Overall Study|Never Treated|3|||
23438682|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
23438683|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
23438684|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
23438685|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
23438686|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
23438687|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
23438688|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
23438689|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
23438690|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
23438691|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
23438692|NCT02429791|65348625|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
23438693|NCT02429791|65348626|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
23438694|NCT02008773|65348628|FG000|Overall Study|Adverse Event|3|||
23438695|NCT02008773|65348629|FG001|Overall Study|Adverse Event|3|||
23438696|NCT02008773|65348630|FG002|Overall Study|Adverse Event|1|||
23438697|NCT02008773|65348631|FG003|Overall Study|Adverse Event|2|||
23438698|NCT02008773|65348628|FG000|Overall Study|Medication Non-compliance|2|||
23438699|NCT02008773|65348629|FG001|Overall Study|Medication Non-compliance|1|||
23438700|NCT02008773|65348630|FG002|Overall Study|Medication Non-compliance|3|||
23438701|NCT02008773|65348631|FG003|Overall Study|Medication Non-compliance|2|||
23438702|NCT02008773|65348628|FG000|Overall Study|Withdrawal by Subject|8|||
23438703|NCT02008773|65348629|FG001|Overall Study|Withdrawal by Subject|4|||
23438704|NCT02008773|65348630|FG002|Overall Study|Withdrawal by Subject|7|||
23438705|NCT02008773|65348631|FG003|Overall Study|Withdrawal by Subject|6|||
23438706|NCT02008773|65348628|FG000|Overall Study|Lost to Follow-up|0|||
23438707|NCT02008773|65348629|FG001|Overall Study|Lost to Follow-up|1|||
23438708|NCT02008773|65348630|FG002|Overall Study|Lost to Follow-up|3|||
23438709|NCT02008773|65348631|FG003|Overall Study|Lost to Follow-up|2|||
23438710|NCT02834247|65348632|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
23438711|NCT02834247|65348633|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
23438712|NCT02834247|65348634|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
23438713|NCT02834247|65348635|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
23438714|NCT02834247|65348632|FG000|Dose Escalation Phase|Death|5|||
23438715|NCT02834247|65348633|FG001|Dose Escalation Phase|Death|6|||
23438716|NCT02834247|65348634|FG002|Dose Escalation Phase|Death|5|||
23438717|NCT02834247|65348635|FG003|Dose Escalation Phase|Death|0|||
23438718|NCT02834247|65348632|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
23438719|NCT02834247|65348633|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
23438720|NCT02834247|65348634|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
23438721|NCT02834247|65348635|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
23438722|NCT02834247|65348632|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
23438723|NCT02834247|65348633|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
23438724|NCT02834247|65348634|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23438725|NCT02834247|65348635|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23625075|NCT01296555|66015417|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625076|NCT01296555|66015418|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625077|NCT01296555|66015419|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625078|NCT01296555|66015420|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
23625079|NCT01296555|66015392|FG000|Overall Study|Death|0|||
23625080|NCT01296555|66015393|FG001|Overall Study|Death|0|||
23625081|NCT01296555|66015394|FG002|Overall Study|Death|0|||
23438726|NCT02834247|65348632|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
23438727|NCT02834247|65348633|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
23438728|NCT02834247|65348634|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
23438729|NCT02834247|65348635|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
23438730|NCT02834247|65348632|FG000|Dose Expansion Phase|Death|0|||
23438731|NCT02834247|65348633|FG001|Dose Expansion Phase|Death|0|||
23438732|NCT02834247|65348634|FG002|Dose Expansion Phase|Death|0|||
23438733|NCT02834247|65348635|FG003|Dose Expansion Phase|Death|8|||
23438734|NCT02834247|65348632|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
23438735|NCT02834247|65348633|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
23438736|NCT02834247|65348634|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
23438737|NCT02834247|65348635|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
23438738|NCT02834247|65348632|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
23438739|NCT02834247|65348633|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
23438740|NCT02834247|65348634|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
23625082|NCT01296555|66015395|FG003|Overall Study|Death|2|||
23438741|NCT02834247|65348635|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
23625083|NCT01296555|66015396|FG004|Overall Study|Death|1|||
23438742|NCT00417963|65348638|FG000|Overall Study|Lost to Follow-up|3|||
23438743|NCT00417963|65348638|FG000|Overall Study|Withdrawal by Subject|18|||
23438744|NCT00417963|65348638|FG000|Overall Study|Death|17|||
23625084|NCT01296555|66015397|FG005|Overall Study|Death|0|||
23625085|NCT01296555|66015398|FG006|Overall Study|Death|2|||
23625086|NCT01296555|66015399|FG007|Overall Study|Death|0|||
23625087|NCT01296555|66015400|FG008|Overall Study|Death|0|||
23625088|NCT01296555|66015401|FG009|Overall Study|Death|1|||
23625089|NCT01296555|66015402|FG010|Overall Study|Death|0|||
23625090|NCT01296555|66015403|FG011|Overall Study|Death|1|||
23438745|NCT00417963|65348638|FG000|Overall Study|Study device could not be deployed|3|||
23438746|NCT00699660|65348639|FG000|Overall Study|Lost to Follow-up|4|||
23438747|NCT00699660|65348640|FG001|Overall Study|Lost to Follow-up|2|||
23561352|NCT02978443|65782621|FG000|Overall Study|Disease Progression on study|6|||
23625091|NCT01296555|66015404|FG012|Overall Study|Death|0|||
23625092|NCT01296555|66015405|FG013|Overall Study|Death|2|||
23625093|NCT01296555|66015406|FG014|Overall Study|Death|27|||
23625094|NCT01296555|66015407|FG015|Overall Study|Death|15|||
23625095|NCT01296555|66015408|FG016|Overall Study|Death|11|||
23625096|NCT01296555|66015409|FG017|Overall Study|Death|11|||
23561353|NCT02978443|65782621|FG000|Overall Study|Death|1|||
23561354|NCT02978443|65782621|FG000|Overall Study|Physician Decision|1|||
23561355|NCT02978443|65782621|FG000|Overall Study|Switch to alternative therapy|1|||
23561356|NCT02978443|65782621|FG000|Overall Study|Refused further treatment|1|||
23561357|NCT01892345|65782624|FG000|Overall Study|Adverse Event|0|||
23561358|NCT01892345|65782625|FG001|Overall Study|Adverse Event|2|||
23561359|NCT01892345|65782624|FG000|Overall Study|Death|1|||
23561360|NCT01892345|65782625|FG001|Overall Study|Death|0|||
23561361|NCT01892345|65782624|FG000|Overall Study|Lost to Follow-up|3|||
23561362|NCT01892345|65782625|FG001|Overall Study|Lost to Follow-up|0|||
23561363|NCT01892345|65782624|FG000|Overall Study|Withdrawal by Subject|12|||
23561364|NCT01892345|65782625|FG001|Overall Study|Withdrawal by Subject|1|||
23561365|NCT00595504|65782630|FG000|Overall Study|Withdrawal by Subject|1|||
23561366|NCT00595504|65782631|FG001|Overall Study|Withdrawal by Subject|3|||
23561367|NCT00595504|65782630|FG000|Overall Study|Physician Decision|1|||
23561368|NCT00595504|65782631|FG001|Overall Study|Physician Decision|0|||
23561369|NCT01106430|65782636|FG000|Overall Study|Adverse Event|8|||
23561370|NCT01106430|65782637|FG001|Overall Study|Adverse Event|10|||
23561371|NCT01106430|65782636|FG000|Overall Study|Lack of Efficacy|2|||
23561372|NCT01106430|65782637|FG001|Overall Study|Lack of Efficacy|13|||
23561373|NCT01106430|65782636|FG000|Overall Study|Lost to Follow-up|5|||
23561374|NCT01106430|65782637|FG001|Overall Study|Lost to Follow-up|1|||
23561375|NCT01106430|65782636|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
23561376|NCT01106430|65782637|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
23561377|NCT01106430|65782636|FG000|Overall Study|Moved Out Of State|0|||
23561378|NCT01106430|65782637|FG001|Overall Study|Moved Out Of State|1|||
23561379|NCT01106430|65782636|FG000|Overall Study|Refused To Take Medication|0|||
23561380|NCT01106430|65782637|FG001|Overall Study|Refused To Take Medication|1|||
23561381|NCT01106430|65782636|FG000|Overall Study|Noncompliance|0|||
23561382|NCT01106430|65782637|FG001|Overall Study|Noncompliance|1|||
23561383|NCT01106430|65782636|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
23561384|NCT01106430|65782637|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
23561385|NCT01106430|65782636|FG000|Overall Study|Previous Use Of Marijuana|1|||
23561386|NCT01106430|65782637|FG001|Overall Study|Previous Use Of Marijuana|0|||
23561387|NCT01106430|65782636|FG000|Overall Study|Protocol Violation|7|||
23561388|NCT01106430|65782637|FG001|Overall Study|Protocol Violation|2|||
23561389|NCT01106430|65782636|FG000|Overall Study|Withdrawal by Subject|8|||
23561390|NCT01106430|65782637|FG001|Overall Study|Withdrawal by Subject|4|||
23561391|NCT01191840|65782638|FG000|Overall Study|withdrew consent|2|||
23561392|NCT01191840|65782639|FG001|Overall Study|withdrew consent|1|||
23561393|NCT01191840|65782638|FG000|Overall Study|Subject discontinued treatment|1|||
23561394|NCT01191840|65782639|FG001|Overall Study|Subject discontinued treatment|2|||
23561395|NCT01191840|65782638|FG000|Overall Study|Lost to Follow-up|4|||
23561396|NCT01191840|65782639|FG001|Overall Study|Lost to Follow-up|6|||
23625097|NCT01296555|66015410|FG018|Overall Study|Death|17|||
23625098|NCT01296555|66015411|FG019|Overall Study|Death|12|||
23625099|NCT01296555|66015412|FG020|Overall Study|Death|13|||
23625100|NCT01296555|66015413|FG021|Overall Study|Death|12|||
23625101|NCT01296555|66015414|FG022|Overall Study|Death|12|||
23625102|NCT01296555|66015415|FG023|Overall Study|Death|13|||
23625103|NCT01296555|66015416|FG024|Overall Study|Death|7|||
23625104|NCT01296555|66015417|FG025|Overall Study|Death|7|||
23625105|NCT01296555|66015418|FG026|Overall Study|Death|35|||
23625106|NCT01296555|66015419|FG027|Overall Study|Death|92|||
23561397|NCT01191840|65782638|FG000|Overall Study|Non Staph Infection|4|||
23561398|NCT01191840|65782639|FG001|Overall Study|Non Staph Infection|3|||
23561399|NCT01191840|65782638|FG000|Overall Study|ineligible at enrollment|1|||
23561400|NCT01191840|65782639|FG001|Overall Study|ineligible at enrollment|0|||
23561401|NCT01191840|65782638|FG000|Overall Study|IRB approval lapse|0|||
23561402|NCT01191840|65782639|FG001|Overall Study|IRB approval lapse|2|||
23561403|NCT01191840|65782638|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
23561404|NCT01191840|65782639|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
23561405|NCT01191840|65782638|FG000|Overall Study|Withdrawal by Subject|2|||
23625107|NCT01296555|66015420|FG028|Overall Study|Death|44|||
23625108|NCT01296555|66015392|FG000|Overall Study|Lost to Follow-up|0|||
23150779|NCT01678209|64301969|FG000|Overall Study|could not scan twice|1|||
23561406|NCT01191840|65782639|FG001|Overall Study|Withdrawal by Subject|0|||
23561407|NCT03976466|65786142|FG000|Overall Study|Lost to Follow-up|1|||
23561408|NCT03976466|65786143|FG001|Overall Study|Lost to Follow-up|3|||
23561409|NCT00642902|65786145|FG000|Overall Study|Adverse Event|0|||
23561410|NCT00642902|65786146|FG001|Overall Study|Adverse Event|1|||
23561411|NCT00642902|65786147|FG002|Overall Study|Adverse Event|3|||
23561412|NCT00642902|65786148|FG003|Overall Study|Adverse Event|1|||
23561413|NCT00642902|65786145|FG000|Overall Study|Lost to Follow-up|1|||
23561414|NCT00642902|65786146|FG001|Overall Study|Lost to Follow-up|1|||
23561415|NCT00642902|65786147|FG002|Overall Study|Lost to Follow-up|0|||
23561416|NCT00642902|65786148|FG003|Overall Study|Lost to Follow-up|0|||
23561417|NCT00642902|65786145|FG000|Overall Study|Lack of Efficacy|0|||
23150780|NCT01678209|64301970|FG001|Overall Study|could not scan twice|1|||
23150781|NCT01678209|64301971|FG002|Overall Study|could not scan twice|1|||
23561418|NCT00642902|65786146|FG001|Overall Study|Lack of Efficacy|3|||
23150782|NCT01678209|64301969|FG000|Overall Study|scheduling conflicts|0|||
23150783|NCT01678209|64301970|FG001|Overall Study|scheduling conflicts|0|||
23324749|NCT00758524|64930423|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324750|NCT00758524|64930424|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324751|NCT00758524|64930425|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324752|NCT00758524|64930426|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324753|NCT00758524|64930427|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
23324754|NCT00758524|64930411|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324755|NCT00758524|64930412|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
23324756|NCT00758524|64930413|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324757|NCT00758524|64930414|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324758|NCT00758524|64930415|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324759|NCT00758524|64930416|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324760|NCT00758524|64930417|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324761|NCT00758524|64930418|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324762|NCT00758524|64930419|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324763|NCT00758524|64930420|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324764|NCT00758524|64930421|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324765|NCT00758524|64930422|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324766|NCT00758524|64930423|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324767|NCT00758524|64930424|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324768|NCT00758524|64930425|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324769|NCT00758524|64930426|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324770|NCT00758524|64930427|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
23324771|NCT00758524|64930411|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324772|NCT00758524|64930412|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23438748|NCT00699660|65348639|FG000|Overall Study|missing reports and recording failures|10|||
23438749|NCT00699660|65348640|FG001|Overall Study|missing reports and recording failures|6|||
23438750|NCT02868229|65348641|FG000|Overall Study|Adverse Event|1|||
23438751|NCT02868229|65348642|FG001|Overall Study|Adverse Event|0|||
23438752|NCT02868229|65348643|FG002|Overall Study|Adverse Event|0|||
23438753|NCT02868229|65348644|FG003|Overall Study|Adverse Event|1|||
23438754|NCT02868229|65348641|FG000|Overall Study|Death|0|||
23438755|NCT02868229|65348642|FG001|Overall Study|Death|0|||
23438756|NCT02868229|65348643|FG002|Overall Study|Death|1|||
23438757|NCT02868229|65348644|FG003|Overall Study|Death|1|||
23438758|NCT02868229|65348641|FG000|Overall Study|Missed dose|0|||
23438759|NCT02868229|65348642|FG001|Overall Study|Missed dose|0|||
23438760|NCT02868229|65348643|FG002|Overall Study|Missed dose|0|||
23438761|NCT02868229|65348644|FG003|Overall Study|Missed dose|3|||
23438762|NCT04752358|65348646|FG000|Overall Study|Death|2|||
23438763|NCT04752358|65348647|FG001|Overall Study|Death|1|||
23438764|NCT01628965|65348648|FG000|Overall Study|Adverse Event|30|||
23438765|NCT01628965|65348648|FG000|Overall Study|Lack of Efficacy|7|||
23438766|NCT01628965|65348648|FG000|Overall Study|Withdrawal by Subject|3|||
23438767|NCT01628965|65348648|FG000|Overall Study|Lost to Follow-up|1|||
23438768|NCT01628965|65348648|FG000|Overall Study|Discontinuation criteria|8|||
23150784|NCT01678209|64301971|FG002|Overall Study|scheduling conflicts|1|||
23150785|NCT01678209|64301969|FG000|Overall Study|screen fail|16|||
23438769|NCT00061633|65348650|FG000|Overall Study|Adverse Event|1|||
23438770|NCT00061633|65348651|FG001|Overall Study|Adverse Event|2|||
23438771|NCT00061633|65348650|FG000|Overall Study|Withdrawal by Subject|2|||
23438772|NCT00061633|65348651|FG001|Overall Study|Withdrawal by Subject|2|||
23438773|NCT00061633|65348650|FG000|Overall Study|Lost to Follow-up|1|||
23438774|NCT00061633|65348651|FG001|Overall Study|Lost to Follow-up|4|||
23561419|NCT00642902|65786147|FG002|Overall Study|Lack of Efficacy|3|||
23561420|NCT00642902|65786148|FG003|Overall Study|Lack of Efficacy|0|||
23561421|NCT00642902|65786145|FG000|Overall Study|Death|1|||
23324773|NCT00758524|64930413|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324774|NCT00758524|64930414|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324775|NCT00758524|64930415|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324776|NCT00758524|64930416|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324777|NCT00758524|64930417|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324778|NCT00758524|64930418|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324779|NCT00758524|64930419|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
23324780|NCT00758524|64930420|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324781|NCT00758524|64930421|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324782|NCT00758524|64930422|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324783|NCT00758524|64930423|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324784|NCT00758524|64930424|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324785|NCT00758524|64930425|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324786|NCT00758524|64930426|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324787|NCT00758524|64930427|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
23324788|NCT00758524|64930411|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324789|NCT00758524|64930412|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324790|NCT00758524|64930413|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324791|NCT00758524|64930414|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324792|NCT00758524|64930415|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324793|NCT00758524|64930416|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324794|NCT00758524|64930417|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
23324795|NCT00758524|64930418|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324796|NCT00758524|64930419|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324797|NCT00758524|64930420|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324798|NCT00758524|64930421|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324799|NCT00758524|64930422|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324800|NCT00758524|64930423|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324801|NCT00758524|64930424|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324802|NCT00758524|64930425|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324803|NCT00758524|64930426|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324804|NCT00758524|64930427|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
23324805|NCT00312338|64930428|FG000|Overall Study|Adverse Event|7|||
23324806|NCT00312338|64930429|FG001|Overall Study|Adverse Event|2|||
23324807|NCT00312338|64930428|FG000|Overall Study|Lost to Follow-up|9|||
23324808|NCT00312338|64930429|FG001|Overall Study|Lost to Follow-up|1|||
23324809|NCT00312338|64930428|FG000|Overall Study|Withdrawal by Subject|4|||
23324810|NCT00312338|64930429|FG001|Overall Study|Withdrawal by Subject|0|||
23324811|NCT00312338|64930428|FG000|Overall Study|Subsequent infection|2|||
23324812|NCT00312338|64930429|FG001|Overall Study|Subsequent infection|0|||
23324813|NCT00182325|64930434|FG000|Overall Study|Lost to Follow-up|7|||
23324814|NCT00182325|64930435|FG001|Overall Study|Lost to Follow-up|7|||
23324815|NCT00182325|64930434|FG000|Overall Study|Miscarriage|5|||
23324816|NCT00182325|64930435|FG001|Overall Study|Miscarriage|3|||
23324817|NCT00182325|64930434|FG000|Overall Study|Did not complete survey|22|||
23324818|NCT00182325|64930435|FG001|Overall Study|Did not complete survey|43|||
23324819|NCT00974922|64930438|FG000|Overall Study|study terminated|24|||
23324820|NCT01342081|64930441|FG000|Overall Study|Did not receive allocated intervention|0|||
23324821|NCT01342081|64930442|FG001|Overall Study|Did not receive allocated intervention|0|||
23324822|NCT01342081|64930443|FG002|Overall Study|Did not receive allocated intervention|1|||
23324823|NCT01342081|64930441|FG000|Overall Study|Adverse Event|1|||
23324824|NCT01342081|64930442|FG001|Overall Study|Adverse Event|0|||
23324825|NCT01342081|64930443|FG002|Overall Study|Adverse Event|0|||
23324826|NCT01342081|64930441|FG000|Overall Study|Physician Decision|0|||
23150786|NCT01678209|64301970|FG001|Overall Study|screen fail|17|||
23150787|NCT01678209|64301971|FG002|Overall Study|screen fail|16|||
23150788|NCT00615836|64301972|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
23150789|NCT00615836|64301973|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
23150790|NCT00615836|64301974|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
23150791|NCT00615836|64301975|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
23150792|NCT00615836|64301976|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
23150793|NCT00615836|64301972|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
23150794|NCT00615836|64301973|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
23150795|NCT00615836|64301974|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
23150796|NCT00615836|64301975|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
23150797|NCT00615836|64301976|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
23219809|NCT01316380|64549967|FG002|Overall Study|Not treated|0|||
23324827|NCT01342081|64930442|FG001|Overall Study|Physician Decision|1|||
23324828|NCT01342081|64930443|FG002|Overall Study|Physician Decision|0|||
23324829|NCT01342081|64930441|FG000|Overall Study|Withdrawal by Subject|1|||
23324830|NCT01342081|64930442|FG001|Overall Study|Withdrawal by Subject|1|||
23324831|NCT01342081|64930443|FG002|Overall Study|Withdrawal by Subject|0|||
23324832|NCT02540083|64930444|FG000|Overall Study|Withdrawal by Subject|16|||
23324833|NCT00610129|64930445|FG000|Overall Study|Not treated since patients ineligible|3|||
23324834|NCT04720105|64930446|FG000|Overall Study|Lack of Efficacy|1|||
23324835|NCT04720105|64930446|FG000|Overall Study|Lost to Follow-up|1|||
23324836|NCT04720105|64930446|FG000|Overall Study|Withdrawal by Subject|3|||
23324837|NCT04479787|64930447|FG000|Overall Study|Withdrawal by Subject|19|||
23324838|NCT04479787|64930448|FG001|Overall Study|Withdrawal by Subject|27|||
23324839|NCT04479787|64930447|FG000|Overall Study|Unsuccessful Trial|17|||
23324840|NCT04479787|64930448|FG001|Overall Study|Unsuccessful Trial|7|||
23324841|NCT04479787|64930447|FG000|Overall Study|Subject Participation Terminated By Investigator|14|||
23324842|NCT04479787|64930448|FG001|Overall Study|Subject Participation Terminated By Investigator|5|||
23324843|NCT04479787|64930447|FG000|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
23324844|NCT04479787|64930448|FG001|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
23324845|NCT04479787|64930447|FG000|Overall Study|Lost to Follow-up|3|||
23324846|NCT04479787|64930448|FG001|Overall Study|Lost to Follow-up|3|||
23324847|NCT04479787|64930447|FG000|Overall Study|Death|4|||
23324848|NCT04479787|64930448|FG001|Overall Study|Death|0|||
23324849|NCT04479787|64930447|FG000|Overall Study|Inclusion/Exclusion|2|||
23324850|NCT04479787|64930448|FG001|Overall Study|Inclusion/Exclusion|1|||
23324851|NCT04479787|64930447|FG000|Overall Study|Subject Became Pregnant|1|||
23324852|NCT04479787|64930448|FG001|Overall Study|Subject Became Pregnant|1|||
23324853|NCT04479787|64930447|FG000|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
23324854|NCT04479787|64930448|FG001|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
23324855|NCT04479787|64930447|FG000|Overall Study|Patient's Health Significantly Declined|0|||
23324856|NCT04479787|64930448|FG001|Overall Study|Patient's Health Significantly Declined|1|||
23324857|NCT04479787|64930447|FG000|Overall Study|Subject Had Back Surgery On March 1st|0|||
23324858|NCT04479787|64930448|FG001|Overall Study|Subject Had Back Surgery On March 1st|1|||
23324859|NCT04479787|64930447|FG000|Overall Study|Withdrawn At Sponsor's Request|1|||
23324860|NCT04479787|64930448|FG001|Overall Study|Withdrawn At Sponsor's Request|0|||
23324861|NCT04479787|64930447|FG000|Overall Study|Subject Failed To Comply With The Protocol Requirements|1|||
23324862|NCT04479787|64930448|FG001|Overall Study|Subject Failed To Comply With The Protocol Requirements|0|||
23324863|NCT01777282|64930451|FG000|Overall Study|Persistent Hyperglycemia|0|||
23324864|NCT01777282|64930452|FG001|Overall Study|Persistent Hyperglycemia|0|||
23324865|NCT01777282|64930453|FG002|Overall Study|Persistent Hyperglycemia|1|||
23324866|NCT01777282|64930454|FG003|Overall Study|Persistent Hyperglycemia|0|||
23324867|NCT01777282|64930455|FG004|Overall Study|Persistent Hyperglycemia|0|||
23324868|NCT01777282|64930451|FG000|Overall Study|New Antidiabetic Medication|0|||
23324869|NCT01777282|64930452|FG001|Overall Study|New Antidiabetic Medication|0|||
23324870|NCT01777282|64930453|FG002|Overall Study|New Antidiabetic Medication|1|||
23324871|NCT01777282|64930454|FG003|Overall Study|New Antidiabetic Medication|0|||
23324872|NCT01777282|64930455|FG004|Overall Study|New Antidiabetic Medication|0|||
23324873|NCT01777282|64930451|FG000|Overall Study|Adverse Event|4|||
23324874|NCT01777282|64930452|FG001|Overall Study|Adverse Event|4|||
23324875|NCT01777282|64930453|FG002|Overall Study|Adverse Event|2|||
23324876|NCT01777282|64930454|FG003|Overall Study|Adverse Event|1|||
23324877|NCT01777282|64930455|FG004|Overall Study|Adverse Event|3|||
23324878|NCT01777282|64930451|FG000|Overall Study|Withdrawal by Subject|4|||
23324879|NCT01777282|64930452|FG001|Overall Study|Withdrawal by Subject|0|||
23324880|NCT01777282|64930453|FG002|Overall Study|Withdrawal by Subject|0|||
23324881|NCT01777282|64930454|FG003|Overall Study|Withdrawal by Subject|1|||
23324882|NCT01777282|64930455|FG004|Overall Study|Withdrawal by Subject|2|||
23324883|NCT01777282|64930451|FG000|Overall Study|Protocol Violation|2|||
23324884|NCT01777282|64930452|FG001|Overall Study|Protocol Violation|0|||
23438775|NCT00061633|65348650|FG000|Overall Study|Other|1|||
23150798|NCT00615836|64301972|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
23324885|NCT01777282|64930453|FG002|Overall Study|Protocol Violation|1|||
23324886|NCT01777282|64930454|FG003|Overall Study|Protocol Violation|0|||
23324887|NCT01777282|64930455|FG004|Overall Study|Protocol Violation|2|||
23324888|NCT01777282|64930451|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
23324889|NCT01777282|64930452|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
23324890|NCT01777282|64930453|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
23561422|NCT00642902|65786146|FG001|Overall Study|Death|0|||
23324891|NCT01777282|64930454|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
23324892|NCT01777282|64930455|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
23324893|NCT00529373|64930456|FG000|Base Study|Adverse Event|525|||
23324894|NCT00529373|64930457|FG001|Base Study|Adverse Event|470|||
23324895|NCT00529373|64930456|FG000|Base Study|Lack of Efficacy|16|||
23324896|NCT00529373|64930457|FG001|Base Study|Lack of Efficacy|75|||
23324897|NCT00529373|64930456|FG000|Base Study|Lost to Follow-up|221|||
23438776|NCT00061633|65348651|FG001|Overall Study|Other|1|||
23561423|NCT00642902|65786147|FG002|Overall Study|Death|0|||
23561424|NCT00642902|65786148|FG003|Overall Study|Death|0|||
23561425|NCT00642902|65786145|FG000|Overall Study|Premature termination of clinical trial|37|||
23561426|NCT00642902|65786146|FG001|Overall Study|Premature termination of clinical trial|32|||
23561427|NCT00642902|65786147|FG002|Overall Study|Premature termination of clinical trial|35|||
23561428|NCT00642902|65786148|FG003|Overall Study|Premature termination of clinical trial|35|||
23561429|NCT00642902|65786145|FG000|Overall Study|Randomized, but not treated|0|||
23561430|NCT00642902|65786146|FG001|Overall Study|Randomized, but not treated|0|||
23561431|NCT00642902|65786147|FG002|Overall Study|Randomized, but not treated|1|||
23561432|NCT00642902|65786148|FG003|Overall Study|Randomized, but not treated|0|||
23561433|NCT00642902|65786145|FG000|Overall Study|Other|1|||
23561434|NCT00642902|65786146|FG001|Overall Study|Other|5|||
23561435|NCT00642902|65786147|FG002|Overall Study|Other|1|||
23561436|NCT00642902|65786148|FG003|Overall Study|Other|4|||
23561437|NCT02567825|65786149|FG000|Overall Study|No follow-up post-randomization|5|||
23561438|NCT02567825|65786150|FG001|Overall Study|No follow-up post-randomization|1|||
23561439|NCT02567825|65786149|FG000|Overall Study|Follow-up less than 23 months|16|||
23561440|NCT02567825|65786150|FG001|Overall Study|Follow-up less than 23 months|20|||
23561441|NCT00885352|65786151|FG000|Overall Study|Adverse Event|2|||
23561442|NCT00885352|65786152|FG001|Overall Study|Adverse Event|3|||
23561443|NCT00885352|65786151|FG000|Overall Study|Lost to Follow-up|2|||
23561444|NCT00885352|65786152|FG001|Overall Study|Lost to Follow-up|2|||
23561445|NCT00885352|65786151|FG000|Overall Study|Physician Decision|0|||
23561446|NCT00885352|65786152|FG001|Overall Study|Physician Decision|3|||
23561447|NCT00885352|65786151|FG000|Overall Study|Protocol Violation|0|||
23561448|NCT00885352|65786152|FG001|Overall Study|Protocol Violation|2|||
23561449|NCT00885352|65786151|FG000|Overall Study|Withdrawal by Subject|1|||
23561450|NCT00885352|65786152|FG001|Overall Study|Withdrawal by Subject|5|||
23561451|NCT00885352|65786151|FG000|Overall Study|Contradiction to study medication|0|||
23561452|NCT00885352|65786152|FG001|Overall Study|Contradiction to study medication|2|||
23561453|NCT00885352|65786151|FG000|Overall Study|Excluded medication|2|||
23561454|NCT00885352|65786152|FG001|Overall Study|Excluded medication|2|||
23561455|NCT00885352|65786151|FG000|Overall Study|Lab abnormalities|1|||
23561456|NCT00885352|65786152|FG001|Overall Study|Lab abnormalities|1|||
23561457|NCT04006925|65786153|FG000|Overall Study|Side effects|2|||
23561458|NCT04006925|65786154|FG001|Overall Study|Side effects|0|||
23561459|NCT03333915|65786158|FG000|Overall Study|Lost to Follow-up|0|||
23561460|NCT03333915|65786159|FG001|Overall Study|Lost to Follow-up|0|||
23561461|NCT03333915|65786160|FG002|Overall Study|Lost to Follow-up|1|||
23561462|NCT03333915|65786161|FG003|Overall Study|Lost to Follow-up|0|||
23561463|NCT03333915|65786162|FG004|Overall Study|Lost to Follow-up|0|||
23561464|NCT03333915|65786158|FG000|Overall Study|Disease Progression|0|||
23561465|NCT03333915|65786159|FG001|Overall Study|Disease Progression|1|||
23561466|NCT03333915|65786160|FG002|Overall Study|Disease Progression|0|||
23561467|NCT03333915|65786161|FG003|Overall Study|Disease Progression|0|||
23561468|NCT03333915|65786162|FG004|Overall Study|Disease Progression|0|||
23561469|NCT03333915|65786158|FG000|Overall Study|Death|0|||
23561470|NCT03333915|65786159|FG001|Overall Study|Death|0|||
23561471|NCT03333915|65786160|FG002|Overall Study|Death|0|||
23561472|NCT03333915|65786161|FG003|Overall Study|Death|37|||
23561473|NCT03333915|65786162|FG004|Overall Study|Death|18|||
23561474|NCT03333915|65786158|FG000|Overall Study|Sponsor's Decision|0|||
23150799|NCT00615836|64301973|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
23150800|NCT00615836|64301974|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
23150801|NCT00615836|64301975|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
23150802|NCT00615836|64301976|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
23150803|NCT00615836|64301972|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
23150804|NCT00615836|64301973|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
23150805|NCT00615836|64301974|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
23150806|NCT00615836|64301975|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
23150807|NCT00615836|64301976|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
23150808|NCT00615836|64301972|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
23150809|NCT00615836|64301973|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
23150810|NCT00615836|64301974|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
23561475|NCT03333915|65786159|FG001|Overall Study|Sponsor's Decision|0|||
23561476|NCT03333915|65786160|FG002|Overall Study|Sponsor's Decision|0|||
23561477|NCT03333915|65786161|FG003|Overall Study|Sponsor's Decision|48|||
23561478|NCT03333915|65786162|FG004|Overall Study|Sponsor's Decision|4|||
23561479|NCT03333915|65786158|FG000|Overall Study|Withdrawal by Subject|0|||
23561480|NCT03333915|65786159|FG001|Overall Study|Withdrawal by Subject|0|||
23561481|NCT03333915|65786160|FG002|Overall Study|Withdrawal by Subject|0|||
23561482|NCT03333915|65786161|FG003|Overall Study|Withdrawal by Subject|5|||
23561483|NCT03333915|65786162|FG004|Overall Study|Withdrawal by Subject|1|||
23561484|NCT00768430|65786163|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
23561485|NCT00768430|65786164|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
23561486|NCT02759185|65786167|FG000|Stage 1|Adverse Event|0|||
23625109|NCT01296555|66015393|FG001|Overall Study|Lost to Follow-up|0|||
23625110|NCT01296555|66015394|FG002|Overall Study|Lost to Follow-up|0|||
23625111|NCT01296555|66015395|FG003|Overall Study|Lost to Follow-up|0|||
23625112|NCT01296555|66015396|FG004|Overall Study|Lost to Follow-up|0|||
23625113|NCT01296555|66015397|FG005|Overall Study|Lost to Follow-up|0|||
23625114|NCT01296555|66015398|FG006|Overall Study|Lost to Follow-up|0|||
23625115|NCT01296555|66015399|FG007|Overall Study|Lost to Follow-up|0|||
23625116|NCT01296555|66015400|FG008|Overall Study|Lost to Follow-up|0|||
23625117|NCT01296555|66015401|FG009|Overall Study|Lost to Follow-up|0|||
23625118|NCT01296555|66015402|FG010|Overall Study|Lost to Follow-up|0|||
23625119|NCT01296555|66015403|FG011|Overall Study|Lost to Follow-up|0|||
23625120|NCT01296555|66015404|FG012|Overall Study|Lost to Follow-up|0|||
23625121|NCT01296555|66015405|FG013|Overall Study|Lost to Follow-up|0|||
23625122|NCT01296555|66015406|FG014|Overall Study|Lost to Follow-up|2|||
23625123|NCT01296555|66015407|FG015|Overall Study|Lost to Follow-up|1|||
23625124|NCT01296555|66015408|FG016|Overall Study|Lost to Follow-up|0|||
23625125|NCT01296555|66015409|FG017|Overall Study|Lost to Follow-up|2|||
23625126|NCT01296555|66015410|FG018|Overall Study|Lost to Follow-up|0|||
23625127|NCT01296555|66015411|FG019|Overall Study|Lost to Follow-up|2|||
23625128|NCT01296555|66015412|FG020|Overall Study|Lost to Follow-up|3|||
23625129|NCT01296555|66015413|FG021|Overall Study|Lost to Follow-up|2|||
23625130|NCT01296555|66015414|FG022|Overall Study|Lost to Follow-up|0|||
23625131|NCT01296555|66015415|FG023|Overall Study|Lost to Follow-up|0|||
23625132|NCT01296555|66015416|FG024|Overall Study|Lost to Follow-up|0|||
23625133|NCT01296555|66015417|FG025|Overall Study|Lost to Follow-up|0|||
23625134|NCT01296555|66015418|FG026|Overall Study|Lost to Follow-up|3|||
23625135|NCT01296555|66015419|FG027|Overall Study|Lost to Follow-up|13|||
23625136|NCT01296555|66015420|FG028|Overall Study|Lost to Follow-up|5|||
23219810|NCT01352845|64549970|FG000|Overall Study|Lost to Follow-up|313|||
23219811|NCT01352845|64549971|FG001|Overall Study|Lost to Follow-up|92|||
23219812|NCT01352845|64549970|FG000|Overall Study|No Longer Willing to Participate|205|||
23219813|NCT01352845|64549971|FG001|Overall Study|No Longer Willing to Participate|58|||
23219814|NCT01352845|64549970|FG000|Overall Study|Withdrawal by Subject|48|||
23324898|NCT00529373|64930457|FG001|Base Study|Lost to Follow-up|208|||
23324899|NCT00529373|64930456|FG000|Base Study|Other Protocol Specified Criteria|19|||
23324900|NCT00529373|64930457|FG001|Base Study|Other Protocol Specified Criteria|20|||
23324901|NCT00529373|64930456|FG000|Base Study|Physician Decision|60|||
23324902|NCT00529373|64930457|FG001|Base Study|Physician Decision|52|||
23219815|NCT01352845|64549971|FG001|Overall Study|Withdrawal by Subject|16|||
23219816|NCT01352845|64549970|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
23219817|NCT01352845|64549971|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
23219818|NCT01352845|64549970|FG000|Overall Study|Pregnancy|27|||
23324903|NCT00529373|64930456|FG000|Base Study|Protocol Violation|48|||
23324904|NCT00529373|64930457|FG001|Base Study|Protocol Violation|38|||
23324905|NCT00529373|64930456|FG000|Base Study|Withdrawal by Subject|1062|||
23324906|NCT00529373|64930457|FG001|Base Study|Withdrawal by Subject|967|||
23324907|NCT00529373|64930456|FG000|Base Study|Did not continue into Extension|1795|||
23324908|NCT00529373|64930457|FG001|Base Study|Did not continue into Extension|2238|||
23324909|NCT00529373|64930456|FG000|First Extension Study|Adverse Event|162|||
23219819|NCT01352845|64549971|FG001|Overall Study|Pregnancy|7|||
23219820|NCT01352845|64549970|FG000|Overall Study|Adverse Event|22|||
23219821|NCT01352845|64549971|FG001|Overall Study|Adverse Event|6|||
23219822|NCT01352845|64549970|FG000|Overall Study|Other|17|||
23219823|NCT01352845|64549971|FG001|Overall Study|Other|7|||
23219824|NCT01352845|64549970|FG000|Overall Study|Protocol Violation|12|||
23219825|NCT01352845|64549971|FG001|Overall Study|Protocol Violation|6|||
23219826|NCT01352845|64549970|FG000|Overall Study|Death|3|||
23219827|NCT01352845|64549971|FG001|Overall Study|Death|0|||
23219828|NCT01802515|64549972|FG000|Overall Study|Withdrawal by Subject|3|||
23219829|NCT01802515|64549973|FG001|Overall Study|Withdrawal by Subject|0|||
23219830|NCT01802515|64549974|FG002|Overall Study|Withdrawal by Subject|0|||
23219831|NCT01770145|64549980|FG000|Baseline|Adverse Event|20|||
23219832|NCT01770145|64549980|FG000|Baseline|Withdrawal by Subject|1|||
23324910|NCT00529373|64930457|FG001|First Extension Study|Adverse Event|142|||
23625137|NCT01296555|66015392|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23625138|NCT01296555|66015393|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23625139|NCT01296555|66015394|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23625140|NCT01296555|66015395|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23625141|NCT01296555|66015396|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23625142|NCT01296555|66015397|FG005|Overall Study|Non-Compliance With Study Drug|0|||
23219833|NCT01770145|64549980|FG000|Baseline|Lost to Follow-up|1|||
23219834|NCT01770145|64549980|FG000|Baseline|Unable to define optimal dose|4|||
23219835|NCT01770145|64549980|FG000|Treatment|Adverse Event|3|||
23219836|NCT01770145|64549980|FG000|Treatment|Withdrawal by Subject|1|||
23324911|NCT00529373|64930456|FG000|First Extension Study|Lack of Efficacy|65|||
23324912|NCT00529373|64930457|FG001|First Extension Study|Lack of Efficacy|427|||
23324913|NCT00529373|64930456|FG000|First Extension Study|Lost to Follow-up|41|||
23625143|NCT01296555|66015398|FG006|Overall Study|Non-Compliance With Study Drug|0|||
23561487|NCT02759185|65786168|FG001|Stage 1|Adverse Event|1|||
23561488|NCT02759185|65786169|FG002|Stage 1|Adverse Event|3|||
23561489|NCT02759185|65786170|FG003|Stage 1|Adverse Event|0|||
23561490|NCT02759185|65786171|FG004|Stage 1|Adverse Event|0|||
23561491|NCT02759185|65786172|FG005|Stage 1|Adverse Event|0|||
23561492|NCT02759185|65786173|FG006|Stage 1|Adverse Event|0|||
23561493|NCT02759185|65786167|FG000|Stage 1|Withdrawal by Subject|1|||
23561494|NCT02759185|65786168|FG001|Stage 1|Withdrawal by Subject|0|||
23561495|NCT02759185|65786169|FG002|Stage 1|Withdrawal by Subject|0|||
23561496|NCT02759185|65786170|FG003|Stage 1|Withdrawal by Subject|0|||
23561497|NCT02759185|65786171|FG004|Stage 1|Withdrawal by Subject|0|||
23561498|NCT02759185|65786172|FG005|Stage 1|Withdrawal by Subject|0|||
23561499|NCT02759185|65786173|FG006|Stage 1|Withdrawal by Subject|0|||
23561500|NCT02759185|65786167|FG000|Stage 2|Adverse Event|0|||
23561501|NCT02759185|65786168|FG001|Stage 2|Adverse Event|0|||
23561502|NCT02759185|65786169|FG002|Stage 2|Adverse Event|0|||
23561503|NCT02759185|65786170|FG003|Stage 2|Adverse Event|0|||
23561504|NCT02759185|65786171|FG004|Stage 2|Adverse Event|1|||
23561505|NCT02759185|65786172|FG005|Stage 2|Adverse Event|2|||
23561506|NCT02759185|65786173|FG006|Stage 2|Adverse Event|0|||
23561507|NCT02759185|65786167|FG000|Stage 2|Withdrawal by Subject|0|||
23561508|NCT02759185|65786168|FG001|Stage 2|Withdrawal by Subject|0|||
23561509|NCT02759185|65786169|FG002|Stage 2|Withdrawal by Subject|0|||
23561510|NCT02759185|65786170|FG003|Stage 2|Withdrawal by Subject|0|||
23150811|NCT00615836|64301975|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
23150812|NCT00615836|64301976|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
23561511|NCT02759185|65786171|FG004|Stage 2|Withdrawal by Subject|1|||
23561512|NCT02759185|65786172|FG005|Stage 2|Withdrawal by Subject|1|||
23561513|NCT02759185|65786173|FG006|Stage 2|Withdrawal by Subject|1|||
23561514|NCT04207840|65786174|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
23561515|NCT04207840|65786175|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
23561516|NCT04207840|65786176|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
23561517|NCT04207840|65786174|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
23561518|NCT04207840|65786175|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
23561519|NCT04207840|65786176|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
23561520|NCT00612534|65786177|FG000|Overall Study|Adverse Event|0|||
23561521|NCT00612534|65786178|FG001|Overall Study|Adverse Event|4|||
23561522|NCT00612534|65786179|FG002|Overall Study|Adverse Event|2|||
23561523|NCT00612534|65786180|FG003|Overall Study|Adverse Event|1|||
23561524|NCT00612534|65786177|FG000|Overall Study|Lack of Efficacy|13|||
23561525|NCT00612534|65786178|FG001|Overall Study|Lack of Efficacy|12|||
23561526|NCT00612534|65786179|FG002|Overall Study|Lack of Efficacy|5|||
23150813|NCT00615836|64301972|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
23150814|NCT00615836|64301973|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
23150815|NCT00615836|64301974|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
23150816|NCT00615836|64301975|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
23150817|NCT00615836|64301976|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
23150818|NCT00615836|64301972|FG000|Extension Study (FE992026 CS31)|Other|10|||
23150819|NCT00615836|64301973|FG001|Extension Study (FE992026 CS31)|Other|7|||
23150820|NCT00615836|64301974|FG002|Extension Study (FE992026 CS31)|Other|8|||
23150821|NCT00615836|64301975|FG003|Extension Study (FE992026 CS31)|Other|8|||
23438777|NCT00061633|65348650|FG000|Overall Study|Never received study treatment|0|||
23561527|NCT00612534|65786180|FG003|Overall Study|Lack of Efficacy|16|||
23561528|NCT00612534|65786177|FG000|Overall Study|Other Reason|0|||
23561529|NCT00612534|65786178|FG001|Overall Study|Other Reason|1|||
23561530|NCT00612534|65786179|FG002|Overall Study|Other Reason|0|||
23561531|NCT00612534|65786180|FG003|Overall Study|Other Reason|0|||
23561532|NCT03315130|65786181|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
23561533|NCT03315130|65786182|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
23561534|NCT03315130|65786183|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
23561535|NCT03315130|65786184|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
23438778|NCT00061633|65348651|FG001|Overall Study|Never received study treatment|2|||
23561536|NCT03315130|65786181|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
23561537|NCT03315130|65786182|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
23561538|NCT03315130|65786183|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
23561539|NCT03315130|65786184|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
23561540|NCT03315130|65786181|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
23561541|NCT03315130|65786182|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
23561542|NCT03315130|65786183|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
23150822|NCT00615836|64301976|FG004|Extension Study (FE992026 CS31)|Other|0|||
23150823|NCT00615836|64301972|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
23150824|NCT00615836|64301973|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
23561543|NCT03315130|65786184|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
23561544|NCT03315130|65786181|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
23561545|NCT03315130|65786182|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
23561546|NCT03315130|65786183|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
23219837|NCT03788967|64549984|FG000|Overall Study|Lost to Follow-up|14|||
23219838|NCT03788967|64549985|FG001|Overall Study|Lost to Follow-up|10|||
23219839|NCT03788967|64549984|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
23219840|NCT03788967|64549985|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
23219841|NCT03788967|64549984|FG000|Overall Study|Participant Withdrawal of Consent|13|||
23219842|NCT03788967|64549985|FG001|Overall Study|Participant Withdrawal of Consent|5|||
23219843|NCT03788967|64549984|FG000|Overall Study|Adverse Event|1|||
23219844|NCT03788967|64549985|FG001|Overall Study|Adverse Event|1|||
23219845|NCT03788967|64549984|FG000|Overall Study|COVID-19|1|||
23219846|NCT03788967|64549985|FG001|Overall Study|COVID-19|2|||
23219847|NCT01055457|64549986|FG000|Overall Study|Lost to Follow-up|0|||
23438779|NCT03245775|65348652|FG000|Overall Study|Lost to Follow-up|25|||
23438780|NCT03245775|65348653|FG001|Overall Study|Lost to Follow-up|26|||
23438781|NCT03245775|65348654|FG002|Overall Study|Lost to Follow-up|16|||
23438782|NCT03245775|65348655|FG003|Overall Study|Lost to Follow-up|16|||
23561547|NCT03315130|65786184|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
23561548|NCT03315130|65786181|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
23561549|NCT03315130|65786182|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
23561550|NCT03315130|65786183|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
23561551|NCT03315130|65786184|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
23561552|NCT03315130|65786181|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
23561553|NCT03315130|65786182|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
23561554|NCT03315130|65786183|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
23561555|NCT03315130|65786184|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
23561556|NCT03474549|65786189|FG000|Overall Study|Death|31|||
23561557|NCT03474549|65786189|FG000|Overall Study|Lost to Follow-up|4|||
23150825|NCT00615836|64301974|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
23150826|NCT00615836|64301975|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
23150827|NCT00615836|64301976|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
23150828|NCT00615836|64301972|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
23150829|NCT00615836|64301973|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
23150830|NCT00615836|64301974|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
23150831|NCT00615836|64301975|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
23150832|NCT00615836|64301976|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
23150833|NCT03716050|64301984|FG000|Overall Study|Lost to Follow-up|0|||
23150834|NCT03716050|64301985|FG001|Overall Study|Lost to Follow-up|0|||
23150835|NCT03716050|64301986|FG002|Overall Study|Lost to Follow-up|1|||
23150836|NCT03716050|64301987|FG003|Overall Study|Lost to Follow-up|0|||
23150837|NCT03716050|64301988|FG004|Overall Study|Lost to Follow-up|0|||
23150838|NCT03716050|64301989|FG005|Overall Study|Lost to Follow-up|0|||
23150839|NCT03716050|64301990|FG006|Overall Study|Lost to Follow-up|0|||
23150840|NCT03716050|64301991|FG007|Overall Study|Lost to Follow-up|0|||
23150841|NCT03716050|64301984|FG000|Overall Study|Physician Decision|0|||
23150842|NCT03716050|64301985|FG001|Overall Study|Physician Decision|0|||
23150843|NCT03716050|64301986|FG002|Overall Study|Physician Decision|0|||
23150844|NCT03716050|64301987|FG003|Overall Study|Physician Decision|1|||
23150845|NCT03716050|64301988|FG004|Overall Study|Physician Decision|0|||
23150846|NCT03716050|64301989|FG005|Overall Study|Physician Decision|0|||
23219848|NCT01055457|64549987|FG001|Overall Study|Lost to Follow-up|1|||
23219849|NCT01055457|64549988|FG002|Overall Study|Lost to Follow-up|0|||
23438783|NCT02464410|65348656|FG000|Overall Study|Death|3|||
23438784|NCT02464410|65348657|FG001|Overall Study|Death|4|||
23438785|NCT02464410|65348656|FG000|Overall Study|Lost to Follow-up|7|||
23438786|NCT02464410|65348657|FG001|Overall Study|Lost to Follow-up|9|||
23438787|NCT02464410|65348656|FG000|Overall Study|Withdrawal by Subject|12|||
23438788|NCT02464410|65348657|FG001|Overall Study|Withdrawal by Subject|3|||
23438789|NCT00940498|65348658|FG000|Overall Study|Death|2|||
23438790|NCT00940498|65348659|FG001|Overall Study|Death|0|||
23561558|NCT03474549|65786189|FG000|Overall Study|Withdrawal by Subject|2|||
23561559|NCT01782742|65786190|FG000|Double-blind Treatment Phase|Adverse Event|1|||
23561560|NCT01782742|65786191|FG001|Double-blind Treatment Phase|Adverse Event|0|||
23150847|NCT03716050|64301990|FG006|Overall Study|Physician Decision|0|||
23150848|NCT03716050|64301991|FG007|Overall Study|Physician Decision|0|||
23219850|NCT01055457|64549989|FG003|Overall Study|Lost to Follow-up|0|||
23150849|NCT03716050|64301984|FG000|Overall Study|Protocol Violation|0|||
23150850|NCT03716050|64301985|FG001|Overall Study|Protocol Violation|0|||
23219851|NCT01055457|64549990|FG004|Overall Study|Lost to Follow-up|0|||
23219852|NCT01055457|64549991|FG005|Overall Study|Lost to Follow-up|1|||
23219853|NCT01055457|64549992|FG006|Overall Study|Lost to Follow-up|0|||
23219854|NCT01055457|64549993|FG007|Overall Study|Lost to Follow-up|0|||
23438791|NCT00940498|65348660|FG002|Overall Study|Death|0|||
23438792|NCT00940498|65348661|FG003|Overall Study|Death|1|||
23438793|NCT00940498|65348662|FG004|Overall Study|Death|5|||
23561561|NCT02696902|65786192|FG000|Overall Study|Lost to Follow-up|0|||
23561562|NCT02696902|65786193|FG001|Overall Study|Lost to Follow-up|1|||
23438794|NCT00940498|65348663|FG005|Overall Study|Death|0|||
23438795|NCT00940498|65348664|FG006|Overall Study|Death|1|||
23438796|NCT00940498|65348665|FG007|Overall Study|Death|0|||
23438797|NCT00940498|65348658|FG000|Overall Study|Lost to Follow-up|1|||
23438798|NCT00940498|65348659|FG001|Overall Study|Lost to Follow-up|1|||
23438799|NCT00940498|65348660|FG002|Overall Study|Lost to Follow-up|2|||
23438800|NCT00940498|65348661|FG003|Overall Study|Lost to Follow-up|0|||
23438801|NCT00940498|65348662|FG004|Overall Study|Lost to Follow-up|1|||
23438802|NCT00940498|65348663|FG005|Overall Study|Lost to Follow-up|0|||
23438803|NCT00940498|65348664|FG006|Overall Study|Lost to Follow-up|0|||
23438804|NCT00940498|65348665|FG007|Overall Study|Lost to Follow-up|1|||
23438805|NCT00940498|65348658|FG000|Overall Study|Disease Progression|0|||
23438806|NCT00940498|65348659|FG001|Overall Study|Disease Progression|0|||
23438807|NCT00940498|65348660|FG002|Overall Study|Disease Progression|1|||
23438808|NCT00940498|65348661|FG003|Overall Study|Disease Progression|1|||
23438809|NCT00940498|65348662|FG004|Overall Study|Disease Progression|0|||
23438810|NCT00940498|65348663|FG005|Overall Study|Disease Progression|1|||
23438811|NCT00940498|65348664|FG006|Overall Study|Disease Progression|0|||
23438812|NCT00940498|65348665|FG007|Overall Study|Disease Progression|0|||
23438813|NCT00940498|65348658|FG000|Overall Study|Physician Decision|0|||
23438814|NCT00940498|65348659|FG001|Overall Study|Physician Decision|0|||
23438815|NCT00940498|65348660|FG002|Overall Study|Physician Decision|0|||
23438816|NCT00940498|65348661|FG003|Overall Study|Physician Decision|0|||
23438817|NCT00940498|65348662|FG004|Overall Study|Physician Decision|2|||
23438818|NCT00940498|65348663|FG005|Overall Study|Physician Decision|0|||
23438819|NCT00940498|65348664|FG006|Overall Study|Physician Decision|0|||
23438820|NCT00940498|65348665|FG007|Overall Study|Physician Decision|0|||
23324914|NCT00529373|64930457|FG001|First Extension Study|Lost to Follow-up|37|||
23324915|NCT00529373|64930456|FG000|First Extension Study|Other|27|||
23324916|NCT00529373|64930457|FG001|First Extension Study|Other|47|||
23324917|NCT00529373|64930456|FG000|First Extension Study|Physician Decision|50|||
23438821|NCT00940498|65348658|FG000|Overall Study|Not treated due to disease related pain|0|||
23438822|NCT00940498|65348659|FG001|Overall Study|Not treated due to disease related pain|0|||
23438823|NCT00940498|65348660|FG002|Overall Study|Not treated due to disease related pain|0|||
23438824|NCT00940498|65348661|FG003|Overall Study|Not treated due to disease related pain|0|||
23438825|NCT00940498|65348662|FG004|Overall Study|Not treated due to disease related pain|1|||
23438826|NCT00940498|65348663|FG005|Overall Study|Not treated due to disease related pain|0|||
23438827|NCT00940498|65348664|FG006|Overall Study|Not treated due to disease related pain|0|||
23438828|NCT00940498|65348665|FG007|Overall Study|Not treated due to disease related pain|0|||
23438829|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
23438830|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
23438831|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
23438832|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Death|0|||
23438833|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Death|2|||
23150851|NCT03716050|64301986|FG002|Overall Study|Protocol Violation|0|||
23150852|NCT03716050|64301987|FG003|Overall Study|Protocol Violation|1|||
23561563|NCT02696902|65786194|FG002|Overall Study|Lost to Follow-up|1|||
23150853|NCT03716050|64301988|FG004|Overall Study|Protocol Violation|0|||
23150854|NCT03716050|64301989|FG005|Overall Study|Protocol Violation|0|||
23150855|NCT03716050|64301990|FG006|Overall Study|Protocol Violation|0|||
23150856|NCT03716050|64301991|FG007|Overall Study|Protocol Violation|2|||
23150857|NCT01829425|64301992|FG000|Overall Study|Withdrawal by Subject|4|||
23438834|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Death|0|||
23438835|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
23438836|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
23438837|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
23438838|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
23438839|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
23438840|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
23438841|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
23438842|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
23438843|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
23150858|NCT01829425|64301993|FG001|Overall Study|Withdrawal by Subject|3|||
23150859|NCT01829425|64301992|FG000|Overall Study|Lost to Follow-up|2|||
23150860|NCT01829425|64301993|FG001|Overall Study|Lost to Follow-up|1|||
23150861|NCT03503513|64305266|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
23150862|NCT03503513|64305266|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
23150863|NCT03503513|64305266|FG000|Overall Study|Physician Decision|3|||
23150864|NCT03503513|64305266|FG000|Overall Study|Withdrawal by Subject|2|||
23150865|NCT03503513|64305266|FG000|Overall Study|Lost to Follow-up|1|||
23438844|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
23150866|NCT02974088|64305268|FG000|Overall Study|Lost to Follow-up|0|||
23561564|NCT02696902|65786192|FG000|Overall Study|Withdrawal by Subject|0|||
23150867|NCT02974088|64305269|FG001|Overall Study|Lost to Follow-up|2|||
23324918|NCT00529373|64930457|FG001|First Extension Study|Physician Decision|45|||
23324919|NCT00529373|64930456|FG000|First Extension Study|Protocol Violation|16|||
23324920|NCT00529373|64930457|FG001|First Extension Study|Protocol Violation|13|||
23150868|NCT02974088|64305268|FG000|Overall Study|Adverse Event|0|||
23150869|NCT02974088|64305269|FG001|Overall Study|Adverse Event|1|||
23561565|NCT02696902|65786193|FG001|Overall Study|Withdrawal by Subject|0|||
23561566|NCT02696902|65786194|FG002|Overall Study|Withdrawal by Subject|1|||
23561567|NCT02696902|65786192|FG000|Overall Study|Death|19|||
23561568|NCT02696902|65786193|FG001|Overall Study|Death|3|||
23561569|NCT02696902|65786194|FG002|Overall Study|Death|24|||
23561570|NCT02696902|65786192|FG000|Overall Study|Participant not fit post-randomization|0|||
23150870|NCT00448435|64305270|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
23324921|NCT00529373|64930456|FG000|First Extension Study|Withdrawal by Subject|296|||
23324922|NCT00529373|64930457|FG001|First Extension Study|Withdrawal by Subject|287|||
23324923|NCT00529373|64930456|FG000|First Extension Study|Disposition record non-existing|0|||
23438845|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
23150871|NCT00448435|64305271|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
23324924|NCT00529373|64930457|FG001|First Extension Study|Disposition record non-existing|1|||
23438846|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
23561571|NCT02696902|65786193|FG001|Overall Study|Participant not fit post-randomization|0|||
23561572|NCT02696902|65786194|FG002|Overall Study|Participant not fit post-randomization|1|||
23561573|NCT02696902|65786192|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
23561574|NCT02696902|65786193|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
23561575|NCT02696902|65786194|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
23561576|NCT02696902|65786192|FG000|Overall Study|Principal investigator's decision|1|||
23561577|NCT02696902|65786193|FG001|Overall Study|Principal investigator's decision|0|||
23561578|NCT02696902|65786194|FG002|Overall Study|Principal investigator's decision|0|||
23561579|NCT02696902|65786192|FG000|Overall Study|Sponsor's decision|1|||
23561580|NCT02696902|65786193|FG001|Overall Study|Sponsor's decision|0|||
23561581|NCT02696902|65786194|FG002|Overall Study|Sponsor's decision|0|||
23561582|NCT02696902|65786192|FG000|Overall Study|Transferred to other hospital|1|||
23561583|NCT02696902|65786193|FG001|Overall Study|Transferred to other hospital|0|||
23561584|NCT02696902|65786194|FG002|Overall Study|Transferred to other hospital|0|||
23561585|NCT01392300|65786195|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
23561586|NCT01392300|65786196|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
23625144|NCT01296555|66015399|FG007|Overall Study|Non-Compliance With Study Drug|1|||
23438847|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
23438848|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
23438849|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
23438850|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Recovery|1|||
23438851|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Recovery|0|||
23438852|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Recovery|1|||
23438853|NCT00195663|65348666|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
23438854|NCT00195663|65348667|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
23438855|NCT00195663|65348668|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
23438856|NCT00195663|65348666|FG000|Open-Label Extension Period|Adverse Event|21|||
23438857|NCT00195663|65348667|FG001|Open-Label Extension Period|Adverse Event|32|||
23438858|NCT00195663|65348668|FG002|Open-Label Extension Period|Adverse Event|36|||
23438859|NCT00195663|65348666|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
23438860|NCT00195663|65348667|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
23438861|NCT00195663|65348668|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
23438862|NCT00195663|65348666|FG000|Open-Label Extension Period|Recovery|0|||
23438863|NCT00195663|65348667|FG001|Open-Label Extension Period|Recovery|2|||
23438864|NCT00195663|65348668|FG002|Open-Label Extension Period|Recovery|2|||
23438865|NCT00195663|65348666|FG000|Open-Label Extension Period|Protocol Violation|3|||
23438866|NCT00195663|65348667|FG001|Open-Label Extension Period|Protocol Violation|4|||
23438867|NCT00195663|65348668|FG002|Open-Label Extension Period|Protocol Violation|4|||
23438868|NCT00195663|65348666|FG000|Open-Label Extension Period|Death|2|||
23438869|NCT00195663|65348667|FG001|Open-Label Extension Period|Death|2|||
23438870|NCT00195663|65348668|FG002|Open-Label Extension Period|Death|2|||
23438871|NCT00195663|65348666|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
23438872|NCT00195663|65348667|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
23438873|NCT00195663|65348668|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
23438874|NCT00195663|65348666|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
23625145|NCT01296555|66015400|FG008|Overall Study|Non-Compliance With Study Drug|0|||
23625146|NCT01296555|66015401|FG009|Overall Study|Non-Compliance With Study Drug|0|||
23438875|NCT00195663|65348667|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
23561587|NCT01392300|65786197|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
23561588|NCT01392300|65786195|FG000|Main Period (MP)|Withdrawal by Subject|5|||
23561589|NCT01392300|65786196|FG001|Main Period (MP)|Withdrawal by Subject|1|||
23625147|NCT01296555|66015402|FG010|Overall Study|Non-Compliance With Study Drug|0|||
23150872|NCT01230554|64305276|FG000|Overall Study|Lost to Follow-up|2|||
23438876|NCT00195663|65348668|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
23438877|NCT00195663|65348666|FG000|Open-Label Extension Period|Administrative reasons|11|||
23438878|NCT00195663|65348667|FG001|Open-Label Extension Period|Administrative reasons|11|||
23438879|NCT00195663|65348668|FG002|Open-Label Extension Period|Administrative reasons|13|||
23438880|NCT03304873|65348669|FG000|Overall Study|Lost to Follow-up|1|||
23438881|NCT03304873|65348670|FG001|Overall Study|Lost to Follow-up|8|||
23438882|NCT01817959|65348671|FG000|Overall Study|Graft loss|1|||
23438883|NCT01817959|65348672|FG001|Overall Study|Graft loss|1|||
23438884|NCT01817959|65348671|FG000|Overall Study|forbidden medication|1|||
23438885|NCT01817959|65348672|FG001|Overall Study|forbidden medication|1|||
23438886|NCT01817959|65348671|FG000|Overall Study|Adverse Event|1|||
23438887|NCT01817959|65348672|FG001|Overall Study|Adverse Event|0|||
23438888|NCT01817959|65348671|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
23438889|NCT01817959|65348672|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
23438890|NCT01912339|65348675|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
23438891|NCT01912339|65348676|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
23438892|NCT01912339|65348677|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
23438893|NCT01912339|65348675|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
23438894|NCT01912339|65348676|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
23438895|NCT01912339|65348677|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
23438896|NCT01912339|65348675|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
23438897|NCT01912339|65348676|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
23438898|NCT01912339|65348677|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
23438899|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
23438900|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
23438901|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
23438902|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
23438903|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
23438904|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
23438905|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
23438906|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
23438907|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
23438908|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
23438909|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
23438910|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
23438911|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
23438912|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
23438913|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
23438914|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
23438915|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
23438916|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
23438917|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
23438918|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
23438919|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
23438920|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
23438921|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
23438922|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
23438923|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
23438924|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
23438925|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
23438926|NCT01912339|65348675|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
23438927|NCT01912339|65348676|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
23438928|NCT01912339|65348677|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
23438929|NCT03878758|65348680|FG000|Overall Study|Withdrawal by Subject|1|||
23438930|NCT03878758|65348680|FG000|Overall Study|Protocol defined|2|||
23438931|NCT03878758|65348680|FG000|Overall Study|Improper consent documentation|1|||
23438932|NCT01069705|65348681|FG000|Overall Study|Adverse Event|1|||
23438933|NCT01069705|65348681|FG000|Overall Study|Withdrawal by Subject|2|||
23438934|NCT02577016|65348682|FG000|Overall Study|Adverse Event|2|||
23438935|NCT02577016|65348683|FG001|Overall Study|Adverse Event|1|||
23219855|NCT01055457|64549994|FG008|Overall Study|Lost to Follow-up|0|||
23219856|NCT01055457|64549995|FG009|Overall Study|Lost to Follow-up|0|||
23219857|NCT01055457|64549986|FG000|Overall Study|Protocol Violation|0|||
23324925|NCT00529373|64930456|FG000|First Extension Study|Discontinued after 5 years completion|208|||
23438936|NCT02577016|65348682|FG000|Overall Study|Physician Decision|0|||
23438937|NCT02577016|65348683|FG001|Overall Study|Physician Decision|1|||
23438938|NCT04294147|65348684|FG000|Overall Study|Protocol Violation|2|||
23324926|NCT00529373|64930457|FG001|First Extension Study|Discontinued after 5 years completion|346|||
23438939|NCT04294147|65348685|FG001|Overall Study|Protocol Violation|0|||
23438940|NCT01023672|65348690|FG000|Overall Study|Worsening disease|2|||
23438941|NCT01023672|65348690|FG000|Overall Study|Death|1|||
23438942|NCT01068769|65348691|FG000|Overall Study|Ineligible|1|||
23438943|NCT02783599|65348692|FG000|Overall Study|Progressive disease|23|||
23438944|NCT02783599|65348692|FG000|Overall Study|Surgical Resection|10|||
23438945|NCT02783599|65348692|FG000|Overall Study|Adverse Event|4|||
23219858|NCT01055457|64549987|FG001|Overall Study|Protocol Violation|0|||
23219859|NCT01055457|64549988|FG002|Overall Study|Protocol Violation|1|||
23219860|NCT01055457|64549989|FG003|Overall Study|Protocol Violation|1|||
23219861|NCT01055457|64549990|FG004|Overall Study|Protocol Violation|1|||
23219862|NCT01055457|64549991|FG005|Overall Study|Protocol Violation|2|||
23219863|NCT01055457|64549992|FG006|Overall Study|Protocol Violation|1|||
23324927|NCT00529373|64930456|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
23438946|NCT02783599|65348692|FG000|Overall Study|Physician Decision|2|||
23438947|NCT02783599|65348692|FG000|Overall Study|Death|1|||
23561590|NCT01392300|65786197|FG002|Main Period (MP)|Withdrawal by Subject|0|||
23561591|NCT01392300|65786195|FG000|Main Period (MP)|Lost to Follow-up|3|||
23561592|NCT01392300|65786196|FG001|Main Period (MP)|Lost to Follow-up|3|||
23561593|NCT01392300|65786197|FG002|Main Period (MP)|Lost to Follow-up|0|||
23438948|NCT02188849|65348693|FG000|Overall Study|Lost to Follow-up|3|||
23438949|NCT02188849|65348694|FG001|Overall Study|Lost to Follow-up|8|||
23438950|NCT00619307|65348696|FG000|Overall Study|Adverse Event|0|||
23438951|NCT00619307|65348697|FG001|Overall Study|Adverse Event|1|||
23438952|NCT00619307|65348696|FG000|Overall Study|Lost to Follow-up|0|||
23438953|NCT00619307|65348697|FG001|Overall Study|Lost to Follow-up|1|||
23438954|NCT00619307|65348696|FG000|Overall Study|Protocol Violation|3|||
23438955|NCT00619307|65348697|FG001|Overall Study|Protocol Violation|0|||
23438956|NCT00619307|65348696|FG000|Overall Study|Withdrew consent|1|||
23438957|NCT00619307|65348697|FG001|Overall Study|Withdrew consent|0|||
23438958|NCT00619307|65348696|FG000|Overall Study|Severe migraine|0|||
23438959|NCT00619307|65348697|FG001|Overall Study|Severe migraine|1|||
23438960|NCT00619307|65348696|FG000|Overall Study|MS attack plus steroids|0|||
23438961|NCT00619307|65348697|FG001|Overall Study|MS attack plus steroids|1|||
23438962|NCT01045694|65348698|FG000|Overall Study|Withdrawal by Subject|2|||
23438963|NCT01153724|65348701|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23438964|NCT01153724|65348701|FG000|Treatment Period 2|Adverse Event|1|||
23438965|NCT01153724|65348701|FG000|Treatment Period 2|Other reason not defined above|1|||
23438966|NCT02504580|65348708|FG000|Overall Study|Other|1|||
23438967|NCT02504580|65348709|FG001|Overall Study|Other|0|||
23438968|NCT02504580|65348710|FG002|Overall Study|Other|0|||
23438969|NCT02504580|65348711|FG003|Overall Study|Other|2|||
23438970|NCT02504580|65348712|FG004|Overall Study|Other|1|||
23438971|NCT02504580|65348713|FG005|Overall Study|Other|1|||
23438972|NCT02504580|65348714|FG006|Overall Study|Other|1|||
23438973|NCT02504580|65348715|FG007|Overall Study|Other|2|||
23438974|NCT02504580|65348716|FG008|Overall Study|Other|0|||
23438975|NCT02504580|65348717|FG009|Overall Study|Other|0|||
23561594|NCT01392300|65786195|FG000|Main Period (MP)|Non-compliance|1|||
23561595|NCT01392300|65786196|FG001|Main Period (MP)|Non-compliance|0|||
23561596|NCT01392300|65786197|FG002|Main Period (MP)|Non-compliance|0|||
23561597|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
23561598|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
23561599|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
23561600|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
23561601|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
23561602|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
23561603|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
23561604|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
23561605|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
23561606|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Death|0|||
23561607|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Death|0|||
23561608|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Death|4|||
23561609|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
23438976|NCT02504580|65348718|FG010|Overall Study|Other|0|||
23438977|NCT02504580|65348719|FG011|Overall Study|Other|2|||
23438978|NCT02504580|65348708|FG000|Overall Study|Subject refusal to continue|0|||
23561610|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
23219864|NCT01055457|64549993|FG007|Overall Study|Protocol Violation|0|||
23561611|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
23438979|NCT02504580|65348709|FG001|Overall Study|Subject refusal to continue|1|||
23438980|NCT02504580|65348710|FG002|Overall Study|Subject refusal to continue|0|||
23438981|NCT02504580|65348711|FG003|Overall Study|Subject refusal to continue|0|||
23438982|NCT02504580|65348712|FG004|Overall Study|Subject refusal to continue|0|||
23219865|NCT01055457|64549994|FG008|Overall Study|Protocol Violation|0|||
23438983|NCT02504580|65348713|FG005|Overall Study|Subject refusal to continue|0|||
23438984|NCT02504580|65348714|FG006|Overall Study|Subject refusal to continue|0|||
23438985|NCT02504580|65348715|FG007|Overall Study|Subject refusal to continue|0|||
23438986|NCT02504580|65348716|FG008|Overall Study|Subject refusal to continue|0|||
23438987|NCT02504580|65348717|FG009|Overall Study|Subject refusal to continue|0|||
23438988|NCT02504580|65348718|FG010|Overall Study|Subject refusal to continue|0|||
23438989|NCT02504580|65348719|FG011|Overall Study|Subject refusal to continue|0|||
23438990|NCT00604695|65348721|FG000|Overall Study|Did not receive first bolus.|0|||
23438991|NCT00604695|65348722|FG001|Overall Study|Did not receive first bolus.|4|||
23438992|NCT01887353|65348725|FG000|Overall Study|Study stopped early|4|||
23438993|NCT01887353|65348726|FG001|Overall Study|Study stopped early|3|||
23438994|NCT04371666|65348727|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
23438995|NCT04371666|65348728|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
23438996|NCT04371666|65348727|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
23438997|NCT04371666|65348728|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
23438998|NCT04371666|65348727|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
23438999|NCT04371666|65348728|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
23439000|NCT04371666|65348727|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
23439001|NCT04371666|65348728|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
23439002|NCT04371666|65348727|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
23439003|NCT04371666|65348728|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
23439004|NCT04371666|65348727|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
23439005|NCT04371666|65348728|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
23625148|NCT01296555|66015403|FG011|Overall Study|Non-Compliance With Study Drug|0|||
23625149|NCT01296555|66015404|FG012|Overall Study|Non-Compliance With Study Drug|0|||
23219866|NCT01055457|64549995|FG009|Overall Study|Protocol Violation|1|||
23219867|NCT01055457|64549986|FG000|Overall Study|Subject Disinterest|0|||
23219868|NCT01055457|64549987|FG001|Overall Study|Subject Disinterest|0|||
23219869|NCT01055457|64549988|FG002|Overall Study|Subject Disinterest|0|||
23219870|NCT01055457|64549989|FG003|Overall Study|Subject Disinterest|0|||
23219871|NCT01055457|64549990|FG004|Overall Study|Subject Disinterest|0|||
23219872|NCT01055457|64549991|FG005|Overall Study|Subject Disinterest|0|||
23625150|NCT01296555|66015405|FG013|Overall Study|Non-Compliance With Study Drug|0|||
23625151|NCT01296555|66015406|FG014|Overall Study|Non-Compliance With Study Drug|0|||
23625152|NCT01296555|66015407|FG015|Overall Study|Non-Compliance With Study Drug|0|||
23625153|NCT01296555|66015408|FG016|Overall Study|Non-Compliance With Study Drug|0|||
23625154|NCT01296555|66015409|FG017|Overall Study|Non-Compliance With Study Drug|0|||
23625155|NCT01296555|66015410|FG018|Overall Study|Non-Compliance With Study Drug|0|||
23625156|NCT01296555|66015411|FG019|Overall Study|Non-Compliance With Study Drug|0|||
23625157|NCT01296555|66015412|FG020|Overall Study|Non-Compliance With Study Drug|0|||
23625158|NCT01296555|66015413|FG021|Overall Study|Non-Compliance With Study Drug|0|||
23625159|NCT01296555|66015414|FG022|Overall Study|Non-Compliance With Study Drug|0|||
23625160|NCT01296555|66015415|FG023|Overall Study|Non-Compliance With Study Drug|0|||
23625161|NCT01296555|66015416|FG024|Overall Study|Non-Compliance With Study Drug|0|||
23625162|NCT01296555|66015417|FG025|Overall Study|Non-Compliance With Study Drug|0|||
23625163|NCT01296555|66015418|FG026|Overall Study|Non-Compliance With Study Drug|0|||
23625164|NCT01296555|66015419|FG027|Overall Study|Non-Compliance With Study Drug|0|||
23625165|NCT01296555|66015420|FG028|Overall Study|Non-Compliance With Study Drug|0|||
23625166|NCT01296555|66015392|FG000|Overall Study|Withdrawal by Subject|0|||
23625167|NCT01296555|66015393|FG001|Overall Study|Withdrawal by Subject|0|||
23625168|NCT01296555|66015394|FG002|Overall Study|Withdrawal by Subject|0|||
23625169|NCT01296555|66015395|FG003|Overall Study|Withdrawal by Subject|0|||
23625170|NCT01296555|66015396|FG004|Overall Study|Withdrawal by Subject|1|||
23625171|NCT01296555|66015397|FG005|Overall Study|Withdrawal by Subject|0|||
23625172|NCT01296555|66015398|FG006|Overall Study|Withdrawal by Subject|1|||
23625173|NCT01296555|66015399|FG007|Overall Study|Withdrawal by Subject|0|||
23625174|NCT01296555|66015400|FG008|Overall Study|Withdrawal by Subject|0|||
23625175|NCT01296555|66015401|FG009|Overall Study|Withdrawal by Subject|0|||
23625176|NCT01296555|66015402|FG010|Overall Study|Withdrawal by Subject|1|||
23625177|NCT01296555|66015403|FG011|Overall Study|Withdrawal by Subject|1|||
23625178|NCT01296555|66015404|FG012|Overall Study|Withdrawal by Subject|0|||
23625179|NCT01296555|66015405|FG013|Overall Study|Withdrawal by Subject|0|||
23625180|NCT01296555|66015406|FG014|Overall Study|Withdrawal by Subject|3|||
23625181|NCT01296555|66015407|FG015|Overall Study|Withdrawal by Subject|0|||
23625182|NCT01296555|66015408|FG016|Overall Study|Withdrawal by Subject|2|||
23625183|NCT01296555|66015409|FG017|Overall Study|Withdrawal by Subject|1|||
23219873|NCT01055457|64549992|FG006|Overall Study|Subject Disinterest|0|||
23219874|NCT01055457|64549993|FG007|Overall Study|Subject Disinterest|1|||
23219875|NCT01055457|64549994|FG008|Overall Study|Subject Disinterest|0|||
23219876|NCT01055457|64549995|FG009|Overall Study|Subject Disinterest|0|||
23439006|NCT01971008|65348729|FG000|Overall Study|Protocol Violation|2|||
23625184|NCT01296555|66015410|FG018|Overall Study|Withdrawal by Subject|0|||
23219877|NCT01055457|64549986|FG000|Overall Study|Subject Ineligible|1|||
23625185|NCT01296555|66015411|FG019|Overall Study|Withdrawal by Subject|1|||
23219878|NCT01055457|64549987|FG001|Overall Study|Subject Ineligible|0|||
23625186|NCT01296555|66015412|FG020|Overall Study|Withdrawal by Subject|1|||
23625187|NCT01296555|66015413|FG021|Overall Study|Withdrawal by Subject|1|||
23625188|NCT01296555|66015414|FG022|Overall Study|Withdrawal by Subject|3|||
23625189|NCT01296555|66015415|FG023|Overall Study|Withdrawal by Subject|0|||
23439007|NCT01971008|65348730|FG001|Overall Study|Protocol Violation|1|||
23439008|NCT04207060|65348731|FG000|Overall Study|Lost to Follow-up|2|||
23439009|NCT04207060|65348732|FG001|Overall Study|Lost to Follow-up|0|||
23439010|NCT04378114|65348735|FG000|Overall Study|Withdrawal by Subject|5|||
23439011|NCT00989963|65348736|FG000|Overall Study|Adverse Event|1|||
23439012|NCT00989963|65348737|FG001|Overall Study|Adverse Event|1|||
23439013|NCT00989963|65348738|FG002|Overall Study|Adverse Event|1|||
23439014|NCT02465203|65348743|FG000|Overall Study|Protocol Violation|1|||
23439015|NCT02465203|65348744|FG001|Overall Study|Protocol Violation|1|||
23439016|NCT02465203|65348745|FG002|Overall Study|Protocol Violation|1|||
23439017|NCT02465203|65348743|FG000|Overall Study|Study terminated by sponsor|50|||
23439018|NCT02465203|65348744|FG001|Overall Study|Study terminated by sponsor|34|||
23439019|NCT02465203|65348745|FG002|Overall Study|Study terminated by sponsor|11|||
23439020|NCT02465203|65348743|FG000|Overall Study|New therapy for study indication|4|||
23439021|NCT02465203|65348744|FG001|Overall Study|New therapy for study indication|0|||
23439022|NCT02465203|65348745|FG002|Overall Study|New therapy for study indication|0|||
23439023|NCT02465203|65348743|FG000|Overall Study|Patient/guardian decision|1|||
23439024|NCT02465203|65348744|FG001|Overall Study|Patient/guardian decision|1|||
23439025|NCT02465203|65348745|FG002|Overall Study|Patient/guardian decision|1|||
23439026|NCT00615992|65348751|FG000|Overall Study|Protocol Violation|67|||
23439027|NCT02560012|65348752|FG000|Overall Study|Study Terminated|2|||
23439028|NCT00151476|65348756|FG000|FAP Identified Subjects|Protocol Violation|0|||
23439029|NCT00151476|65348757|FG001|FAP Identified Subjects|Protocol Violation|1|||
23439030|NCT00151476|65348756|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
23439031|NCT00151476|65348757|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
23439032|NCT00151476|65348756|FG000|FAP Analyzed Subjects|Other study participation|0|||
23439033|NCT00151476|65348757|FG001|FAP Analyzed Subjects|Other study participation|1|||
23439034|NCT00151372|65348763|FG000|Overall Study|Death|12|||
23439035|NCT00151372|65348764|FG001|Overall Study|Death|11|||
23439036|NCT00151372|65348763|FG000|Overall Study|Lost to Follow-up|5|||
23439037|NCT00151372|65348764|FG001|Overall Study|Lost to Follow-up|5|||
23439038|NCT00151372|65348763|FG000|Overall Study|Too sick medically to continue|5|||
23439039|NCT00151372|65348764|FG001|Overall Study|Too sick medically to continue|6|||
23439040|NCT00151372|65348763|FG000|Overall Study|Withdrawal by Subject|7|||
23439041|NCT00151372|65348764|FG001|Overall Study|Withdrawal by Subject|7|||
23439042|NCT01345669|65348765|FG000|Overall Study|Primary tumour recurrence|53|||
23439043|NCT01345669|65348766|FG001|Overall Study|Primary tumour recurrence|32|||
23439044|NCT01345669|65348765|FG000|Overall Study|Second primary tumour|4|||
23439045|NCT01345669|65348766|FG001|Overall Study|Second primary tumour|3|||
23439046|NCT01345669|65348765|FG000|Overall Study|Adverse Event|63|||
23439047|NCT01345669|65348766|FG001|Overall Study|Adverse Event|9|||
23439048|NCT01345669|65348765|FG000|Overall Study|Protocol Violation|3|||
23439049|NCT01345669|65348766|FG001|Overall Study|Protocol Violation|1|||
23439050|NCT01345669|65348765|FG000|Overall Study|Lost to Follow-up|1|||
23439051|NCT01345669|65348766|FG001|Overall Study|Lost to Follow-up|1|||
23439052|NCT01345669|65348765|FG000|Overall Study|Withdrawal by Subject|52|||
23439053|NCT01345669|65348766|FG001|Overall Study|Withdrawal by Subject|13|||
23439054|NCT01345669|65348765|FG000|Overall Study|Other Reasons|111|||
23439055|NCT01345669|65348766|FG001|Overall Study|Other Reasons|60|||
23439056|NCT03364738|65348767|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
23439057|NCT03364738|65348767|FG000|Overall Study|Withdrawal by Subject|1|||
23439058|NCT03364738|65348767|FG000|Overall Study|Adverse Event|1|||
23439059|NCT01990612|65348768|FG000|Overall Study|Lost to Follow-up|2|||
23439060|NCT01990612|65348769|FG001|Overall Study|Lost to Follow-up|1|||
23439061|NCT01990612|65348768|FG000|Overall Study|Withdrawal by Subject|5|||
23439062|NCT01990612|65348769|FG001|Overall Study|Withdrawal by Subject|2|||
23439063|NCT02593825|65348774|FG000|Intervention|Lost to Follow-up|10|||
23439064|NCT02593825|65348775|FG001|Intervention|Lost to Follow-up|12|||
23439065|NCT01815840|65348779|FG000|Overall Study|Missing|1|||
23439066|NCT01815840|65348780|FG001|Overall Study|Missing|0|||
23439067|NCT01815840|65348779|FG000|Overall Study|Withdrew Consent|31|||
23439068|NCT01815840|65348780|FG001|Overall Study|Withdrew Consent|30|||
23625190|NCT01296555|66015416|FG024|Overall Study|Withdrawal by Subject|0|||
23625191|NCT01296555|66015417|FG025|Overall Study|Withdrawal by Subject|0|||
23625192|NCT01296555|66015418|FG026|Overall Study|Withdrawal by Subject|8|||
23439069|NCT01815840|65348779|FG000|Overall Study|Administrative/Other|1|||
23439070|NCT01815840|65348780|FG001|Overall Study|Administrative/Other|3|||
23439071|NCT01815840|65348779|FG000|Overall Study|Adverse Event|10|||
23439072|NCT01815840|65348780|FG001|Overall Study|Adverse Event|16|||
23439073|NCT01815840|65348779|FG000|Overall Study|Death|2|||
23439074|NCT01815840|65348780|FG001|Overall Study|Death|2|||
23439075|NCT01815840|65348779|FG000|Overall Study|Disease progression|3|||
23439076|NCT01815840|65348780|FG001|Overall Study|Disease progression|2|||
23439077|NCT01815840|65348779|FG000|Overall Study|Investigators Decision|2|||
23439078|NCT01815840|65348780|FG001|Overall Study|Investigators Decision|3|||
23439079|NCT01815840|65348779|FG000|Overall Study|Lost to Follow-up|3|||
23439080|NCT01815840|65348780|FG001|Overall Study|Lost to Follow-up|6|||
23439081|NCT01815840|65348779|FG000|Overall Study|Refused Treatment|5|||
23439082|NCT01815840|65348780|FG001|Overall Study|Refused Treatment|1|||
23439083|NCT01815840|65348779|FG000|Overall Study|Sponsor Termination Treatment|1|||
23439084|NCT01815840|65348780|FG001|Overall Study|Sponsor Termination Treatment|0|||
23439085|NCT00646399|65348781|FG000|Overall Study|Death|63|||
23439086|NCT00646399|65348782|FG001|Overall Study|Death|53|||
23439087|NCT00646399|65348781|FG000|Overall Study|Withdrawal by Subject|9|||
23439088|NCT00646399|65348782|FG001|Overall Study|Withdrawal by Subject|10|||
23439089|NCT00646399|65348781|FG000|Overall Study|Other Reason|11|||
23439090|NCT00646399|65348782|FG001|Overall Study|Other Reason|11|||
23439091|NCT04072887|65348783|FG000|Overall Study|Withdrawal by Subject|3|||
23439092|NCT04072887|65348784|FG001|Overall Study|Withdrawal by Subject|8|||
23439093|NCT04072887|65348785|FG002|Overall Study|Withdrawal by Subject|1|||
23439094|NCT04072887|65348786|FG003|Overall Study|Withdrawal by Subject|3|||
23439095|NCT04072887|65348787|FG004|Overall Study|Withdrawal by Subject|3|||
23439096|NCT04072887|65348788|FG005|Overall Study|Withdrawal by Subject|13|||
23439097|NCT04072887|65348783|FG000|Overall Study|Adverse Event|2|||
23439098|NCT04072887|65348784|FG001|Overall Study|Adverse Event|4|||
23439099|NCT04072887|65348785|FG002|Overall Study|Adverse Event|1|||
23439100|NCT04072887|65348786|FG003|Overall Study|Adverse Event|4|||
23439101|NCT04072887|65348787|FG004|Overall Study|Adverse Event|0|||
23439102|NCT04072887|65348788|FG005|Overall Study|Adverse Event|1|||
23439103|NCT04072887|65348783|FG000|Overall Study|Physician Decision|2|||
23439104|NCT04072887|65348784|FG001|Overall Study|Physician Decision|0|||
23439105|NCT04072887|65348785|FG002|Overall Study|Physician Decision|0|||
23439106|NCT04072887|65348786|FG003|Overall Study|Physician Decision|0|||
23439107|NCT04072887|65348787|FG004|Overall Study|Physician Decision|0|||
23439108|NCT04072887|65348788|FG005|Overall Study|Physician Decision|1|||
23439109|NCT04072887|65348783|FG000|Overall Study|Lost to Follow-up|1|||
23439110|NCT04072887|65348784|FG001|Overall Study|Lost to Follow-up|3|||
23439111|NCT04072887|65348785|FG002|Overall Study|Lost to Follow-up|0|||
23439112|NCT04072887|65348786|FG003|Overall Study|Lost to Follow-up|0|||
23439113|NCT04072887|65348787|FG004|Overall Study|Lost to Follow-up|0|||
23439114|NCT04072887|65348788|FG005|Overall Study|Lost to Follow-up|0|||
23439115|NCT04072887|65348783|FG000|Overall Study|Death|0|||
23439116|NCT04072887|65348784|FG001|Overall Study|Death|2|||
23439117|NCT04072887|65348785|FG002|Overall Study|Death|0|||
23439118|NCT04072887|65348786|FG003|Overall Study|Death|2|||
23439119|NCT04072887|65348787|FG004|Overall Study|Death|3|||
23439120|NCT04072887|65348788|FG005|Overall Study|Death|0|||
23439121|NCT00296140|65352311|FG000|Overall Study|Lost to Follow-up|1|||
23439122|NCT00296140|65352312|FG001|Overall Study|Lost to Follow-up|0|||
23439123|NCT00296140|65352311|FG000|Overall Study|Withdrawal by Subject|1|||
23439124|NCT00296140|65352312|FG001|Overall Study|Withdrawal by Subject|0|||
23439125|NCT00296140|65352311|FG000|Overall Study|Discharge to Nursing Home|1|||
23439126|NCT00296140|65352312|FG001|Overall Study|Discharge to Nursing Home|0|||
23439127|NCT02006979|65352313|FG000|Overall Study|Withdrawal by Subject|1|||
23439128|NCT02006979|65352314|FG001|Overall Study|Withdrawal by Subject|1|||
23439129|NCT02006979|65352313|FG000|Overall Study|Protocol Violation|0|||
23439130|NCT02006979|65352314|FG001|Overall Study|Protocol Violation|1|||
23439131|NCT00411632|65352315|FG000|Overall Study|Death|1|||
23439132|NCT00794950|65352317|FG000|BCG Induction|Withdrawal by Subject|2|||
23439133|NCT00794950|65352317|FG000|BCG Induction|ineligible|3|||
23439134|NCT00794950|65352317|FG000|BCG Induction|noncompliant w. BCG|1|||
23439135|NCT00794950|65352317|FG000|BCG Induction|Adverse Event|1|||
23439136|NCT00794950|65352317|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
23439137|NCT00794950|65352317|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
23439138|NCT00794950|65352317|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
23439139|NCT00794950|65352317|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
23150873|NCT01230554|64305276|FG000|Overall Study|Inability to maintain visit schedule|1|||
23150874|NCT01667107|64305277|FG000|Overall Study|Adverse Event|4|||
23150875|NCT01667107|64305278|FG001|Overall Study|Adverse Event|3|||
23439140|NCT01266590|65352318|FG000|Overall Study|Adverse Event|3|||
23439141|NCT01266590|65352318|FG000|Overall Study|Lost to Follow-up|1|||
23150876|NCT01667107|64305277|FG000|Overall Study|Tolerability issues|0|||
23150877|NCT01667107|64305278|FG001|Overall Study|Tolerability issues|2|||
23439142|NCT01266590|65352318|FG000|Overall Study|Withdrawal by Subject|1|||
23439143|NCT01266590|65352318|FG000|Overall Study|Physician Decision|1|||
23439144|NCT02241343|65352319|FG000|Overall Study|Adverse Event|1|||
23439145|NCT02328027|65352320|FG000|Overall Study|Withdrawal by Subject|0|||
23439146|NCT02328027|65352321|FG001|Overall Study|Withdrawal by Subject|1|||
23439147|NCT04369950|65352323|FG000|Overall Study|Protocol Violation|2|||
23439148|NCT04369950|65352324|FG001|Overall Study|Protocol Violation|2|||
23150878|NCT01667107|64305277|FG000|Overall Study|Protocol Violation|0|||
23439149|NCT03477838|65352325|FG000|Overall Study|Lost to Follow-up|14|||
23219879|NCT01055457|64549988|FG002|Overall Study|Subject Ineligible|1|||
23625193|NCT01296555|66015419|FG027|Overall Study|Withdrawal by Subject|4|||
23625194|NCT01296555|66015420|FG028|Overall Study|Withdrawal by Subject|2|||
23625195|NCT02806505|66015434|FG000|Overall Study|Adverse event/intercurrent illness|1|||
23625196|NCT02806505|66015435|FG001|Overall Study|Adverse event/intercurrent illness|3|||
23219880|NCT01055457|64549989|FG003|Overall Study|Subject Ineligible|0|||
23219881|NCT01055457|64549990|FG004|Overall Study|Subject Ineligible|1|||
23439150|NCT01546688|65352326|FG000|Overall Study|Adverse Event|0|||
23439151|NCT01546688|65352327|FG001|Overall Study|Adverse Event|4|||
23439152|NCT01546688|65352326|FG000|Overall Study|Withdrawal by Subject|2|||
23561612|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
23561613|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
23561614|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
23561615|NCT01392300|65786195|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
23561616|NCT01392300|65786196|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
23561617|NCT01392300|65786197|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
23561618|NCT03916744|65786200|FG000|Overall Study|Withdrawal by Subject|0|||
23439153|NCT01546688|65352327|FG001|Overall Study|Withdrawal by Subject|1|||
23561619|NCT03916744|65786201|FG001|Overall Study|Withdrawal by Subject|1|||
23561620|NCT03916744|65786202|FG002|Overall Study|Withdrawal by Subject|2|||
23561621|NCT00058422|65786206|FG000|Overall Study|Not treated|2|||
23561622|NCT01691521|65786210|FG000|Overall Study|Adverse Event|4|||
23561623|NCT01691521|65786211|FG001|Overall Study|Adverse Event|0|||
23561624|NCT01691521|65786212|FG002|Overall Study|Adverse Event|1|||
23561625|NCT01691521|65786210|FG000|Overall Study|Lack of Efficacy|1|||
23561626|NCT01691521|65786211|FG001|Overall Study|Lack of Efficacy|1|||
23561627|NCT01691521|65786212|FG002|Overall Study|Lack of Efficacy|2|||
23561628|NCT01691521|65786210|FG000|Overall Study|Protocol Violation|0|||
23561629|NCT01691521|65786211|FG001|Overall Study|Protocol Violation|3|||
23561630|NCT01691521|65786212|FG002|Overall Study|Protocol Violation|0|||
23561631|NCT01691521|65786210|FG000|Overall Study|Lost to Follow-up|0|||
23561632|NCT01691521|65786211|FG001|Overall Study|Lost to Follow-up|2|||
23561633|NCT01691521|65786212|FG002|Overall Study|Lost to Follow-up|2|||
23561634|NCT01691521|65786210|FG000|Overall Study|Physician Decision|2|||
23561635|NCT01691521|65786211|FG001|Overall Study|Physician Decision|1|||
23561636|NCT01691521|65786212|FG002|Overall Study|Physician Decision|0|||
23561637|NCT01691521|65786210|FG000|Overall Study|Withdrawal by Subject|5|||
23561638|NCT01691521|65786211|FG001|Overall Study|Withdrawal by Subject|9|||
23561639|NCT01691521|65786212|FG002|Overall Study|Withdrawal by Subject|4|||
23561640|NCT01889186|65786213|FG000|Overall Study|Adverse event- not related to progression|18|||
23561641|NCT01889186|65786214|FG001|Overall Study|Adverse event- not related to progression|5|||
23561642|NCT01889186|65786213|FG000|Overall Study|Adverse event- related to progression|7|||
23561643|NCT01889186|65786214|FG001|Overall Study|Adverse event- related to progression|2|||
23561644|NCT01889186|65786213|FG000|Overall Study|COVID-19 logistical restrictions|1|||
23561645|NCT01889186|65786214|FG001|Overall Study|COVID-19 logistical restrictions|0|||
23561646|NCT01889186|65786213|FG000|Overall Study|Investigator request|1|||
23561647|NCT01889186|65786214|FG001|Overall Study|Investigator request|1|||
23561648|NCT01889186|65786213|FG000|Overall Study|Progressive disease- Richter's|12|||
23561649|NCT01889186|65786214|FG001|Overall Study|Progressive disease- Richter's|7|||
23561650|NCT01889186|65786213|FG000|Overall Study|Progressive disease per protocol|46|||
23561651|NCT01889186|65786214|FG001|Overall Study|Progressive disease per protocol|17|||
23561652|NCT01889186|65786213|FG000|Overall Study|Stem cell transplant|2|||
23561653|NCT01889186|65786214|FG001|Overall Study|Stem cell transplant|1|||
23561654|NCT01889186|65786213|FG000|Overall Study|Withdrew consent|2|||
23561655|NCT01889186|65786214|FG001|Overall Study|Withdrew consent|3|||
23561656|NCT01889186|65786213|FG000|Overall Study|Other, not specified|18|||
23561657|NCT01889186|65786214|FG001|Overall Study|Other, not specified|15|||
23561658|NCT03559218|65786218|FG000|Overall Study|Withdrawal by Subject|1|||
23561659|NCT03559218|65786219|FG001|Overall Study|Withdrawal by Subject|0|||
23561660|NCT01807156|65786220|FG000|Overall Study|Physician Decision|1|||
23561661|NCT04067401|65786232|FG000|Overall Study|Withdrawal by Subject|7|||
23561662|NCT04067401|65786233|FG001|Overall Study|Withdrawal by Subject|0|||
23561663|NCT04067401|65786232|FG000|Overall Study|no data provided|1|||
23561664|NCT04067401|65786233|FG001|Overall Study|no data provided|0|||
23561665|NCT03237858|65786236|FG000|Overall Study|Death|19|||
23561666|NCT03237858|65786236|FG000|Overall Study|Withdrawal by Subject|37|||
23561667|NCT03704584|65786237|FG000|Overall Study|Withdrawal by Subject|1|||
23561668|NCT03704584|65786238|FG001|Overall Study|Withdrawal by Subject|0|||
23625197|NCT02806505|66015434|FG000|Overall Study|Death|4|||
23625198|NCT02806505|66015435|FG001|Overall Study|Death|0|||
23625199|NCT02806505|66015434|FG000|Overall Study|Did not cooperate/refused treatment|3|||
23561669|NCT02832622|65786244|FG000|Overall Study|MPP not programmed|1259|||
23625200|NCT02806505|66015435|FG001|Overall Study|Did not cooperate/refused treatment|3|||
23439154|NCT01546688|65352326|FG000|Overall Study|Lack of Efficacy|1|||
23561670|NCT02832622|65786244|FG000|Overall Study|Withdrawal by Subject|123|||
23561671|NCT02832622|65786244|FG000|Overall Study|Death|119|||
23439155|NCT01546688|65352327|FG001|Overall Study|Lack of Efficacy|0|||
23439156|NCT01059318|65352328|FG000|Core Study (26 Week)|Adverse Event|3|||
23439157|NCT01059318|65352328|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
23439158|NCT01059318|65352328|FG000|Extension (36 Week)|Adverse Event|3|||
23439159|NCT00793325|65352329|FG000|Overall Study|Protocol Violation|18|||
23439160|NCT00793325|65352329|FG000|Overall Study|Lost to Follow-up|1|||
23439161|NCT00422383|65352330|FG000|Overall Study|Adverse Event|5|||
23439162|NCT00422383|65352331|FG001|Overall Study|Adverse Event|3|||
23439163|NCT00422383|65352332|FG002|Overall Study|Adverse Event|1|||
23439164|NCT00422383|65352333|FG003|Overall Study|Adverse Event|1|||
23439165|NCT00422383|65352334|FG004|Overall Study|Adverse Event|0|||
23439166|NCT00422383|65352330|FG000|Overall Study|Lack of Efficacy|4|||
23439167|NCT00422383|65352331|FG001|Overall Study|Lack of Efficacy|4|||
23439168|NCT00422383|65352332|FG002|Overall Study|Lack of Efficacy|2|||
23439169|NCT00422383|65352333|FG003|Overall Study|Lack of Efficacy|1|||
23439170|NCT00422383|65352334|FG004|Overall Study|Lack of Efficacy|1|||
23439171|NCT00422383|65352330|FG000|Overall Study|Lost to Follow-up|0|||
23439172|NCT00422383|65352331|FG001|Overall Study|Lost to Follow-up|1|||
23439173|NCT00422383|65352332|FG002|Overall Study|Lost to Follow-up|0|||
23439174|NCT00422383|65352333|FG003|Overall Study|Lost to Follow-up|0|||
23439175|NCT00422383|65352334|FG004|Overall Study|Lost to Follow-up|1|||
23439176|NCT00422383|65352330|FG000|Overall Study|Protocol Violation|1|||
23439177|NCT00422383|65352331|FG001|Overall Study|Protocol Violation|1|||
23439178|NCT00422383|65352332|FG002|Overall Study|Protocol Violation|1|||
23439179|NCT00422383|65352333|FG003|Overall Study|Protocol Violation|0|||
23439180|NCT00422383|65352334|FG004|Overall Study|Protocol Violation|0|||
23439181|NCT00422383|65352330|FG000|Overall Study|Withdrawal by Subject|5|||
23439182|NCT00422383|65352331|FG001|Overall Study|Withdrawal by Subject|5|||
23439183|NCT00422383|65352332|FG002|Overall Study|Withdrawal by Subject|0|||
23439184|NCT00422383|65352333|FG003|Overall Study|Withdrawal by Subject|0|||
23439185|NCT00422383|65352334|FG004|Overall Study|Withdrawal by Subject|1|||
23439186|NCT00761527|65352342|FG000|Overall Study|Adverse Event|3|||
23439187|NCT00761527|65352342|FG000|Overall Study|Poor Compliance|8|||
23439188|NCT00761527|65352342|FG000|Overall Study|Lost to Follow-up|9|||
23439189|NCT00761527|65352342|FG000|Overall Study|Unknown reason|2|||
23439190|NCT02283788|65352345|FG000|Overall Study|Adverse Event|1|||
23439191|NCT02283788|65352346|FG001|Overall Study|Adverse Event|3|||
23439192|NCT02283788|65352347|FG002|Overall Study|Adverse Event|5|||
23439193|NCT02283788|65352348|FG003|Overall Study|Adverse Event|1|||
23439194|NCT02283788|65352345|FG000|Overall Study|Withdrawal by Subject|0|||
23439195|NCT02283788|65352346|FG001|Overall Study|Withdrawal by Subject|1|||
23439196|NCT02283788|65352347|FG002|Overall Study|Withdrawal by Subject|0|||
23439197|NCT02283788|65352348|FG003|Overall Study|Withdrawal by Subject|1|||
23439198|NCT01371734|65352349|FG000|Overall Study|Other|2|||
23439199|NCT01371734|65352350|FG001|Overall Study|Other|1|||
23439200|NCT01371734|65352351|FG002|Overall Study|Other|2|||
23439201|NCT01371734|65352349|FG000|Overall Study|Withdrawal by Subject|3|||
23439202|NCT01371734|65352350|FG001|Overall Study|Withdrawal by Subject|4|||
23439203|NCT01371734|65352351|FG002|Overall Study|Withdrawal by Subject|9|||
23439204|NCT01371734|65352349|FG000|Overall Study|Lost to Follow-up|5|||
23439205|NCT01371734|65352350|FG001|Overall Study|Lost to Follow-up|3|||
23439206|NCT01371734|65352351|FG002|Overall Study|Lost to Follow-up|1|||
23439207|NCT01371734|65352349|FG000|Overall Study|Protocol Violation|3|||
23439208|NCT01371734|65352350|FG001|Overall Study|Protocol Violation|1|||
23439209|NCT01371734|65352351|FG002|Overall Study|Protocol Violation|2|||
23439210|NCT01371734|65352349|FG000|Overall Study|Adverse Event|8|||
23439211|NCT01371734|65352350|FG001|Overall Study|Adverse Event|8|||
23439212|NCT01371734|65352351|FG002|Overall Study|Adverse Event|3|||
23439213|NCT01371734|65352349|FG000|Overall Study|Lack of Efficacy|2|||
23439214|NCT01371734|65352350|FG001|Overall Study|Lack of Efficacy|2|||
23561672|NCT02832622|65786244|FG000|Overall Study|Unsuccessful CRT implant|93|||
23324928|NCT00529373|64930457|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
23439215|NCT01371734|65352351|FG002|Overall Study|Lack of Efficacy|0|||
23439216|NCT03772665|65352352|FG000|Overall Study|Protocol Violation|1|||
23561673|NCT02832622|65786244|FG000|Overall Study|Lost to Follow-up|45|||
23439217|NCT03772665|65352353|FG001|Overall Study|Protocol Violation|0|||
23439218|NCT03193736|65352354|FG000|Overall Study|Death|2|||
23439219|NCT03193736|65352354|FG000|Overall Study|Withdrawal by Subject|1|||
23439220|NCT03193736|65352354|FG000|Overall Study|Lost to Follow-up|1|||
23439221|NCT03193736|65352354|FG000|Overall Study|implant not received|1|||
23439222|NCT00811174|65352355|FG000|Overall Study|Protocol Violation|2|||
23439223|NCT00811174|65352355|FG000|Overall Study|Sponsors Decision|1|||
23439224|NCT04439318|65352356|FG000|Overall Study|Ineligible|1|||
23439225|NCT04439318|65352356|FG000|Overall Study|Never Started Treatment|3|||
23439226|NCT04439318|65352356|FG000|Overall Study|Adverse Event|10|||
23439227|NCT04439318|65352356|FG000|Overall Study|Death|2|||
23439228|NCT04439318|65352356|FG000|Overall Study|Disease Progression|25|||
23439229|NCT04439318|65352356|FG000|Overall Study|Other Complicating Disease|2|||
23439230|NCT04439318|65352356|FG000|Overall Study|Withdrawal by Subject|4|||
23561674|NCT02832622|65786244|FG000|Overall Study|Patient non-compliance|42|||
23561675|NCT02832622|65786244|FG000|Overall Study|Withdrawal by other reasons|25|||
23625201|NCT02806505|66015434|FG000|Overall Study|Failure to return|0|||
23625202|NCT02806505|66015435|FG001|Overall Study|Failure to return|1|||
23439231|NCT04439318|65352356|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
23439232|NCT04439318|65352356|FG000|Overall Study|Non-Compliance|1|||
23439233|NCT04439318|65352356|FG000|Overall Study|Still on Treatment|1|||
23439234|NCT02503501|65352357|FG000|Overall Study|Physician Decision|1|||
23439235|NCT02503501|65352358|FG001|Overall Study|Physician Decision|0|||
23439236|NCT02503501|65352357|FG000|Overall Study|Protocol Violation|0|||
23439237|NCT02503501|65352358|FG001|Overall Study|Protocol Violation|1|||
23439238|NCT02503501|65352357|FG000|Overall Study|Withdrawal by Subject|0|||
23439239|NCT02503501|65352358|FG001|Overall Study|Withdrawal by Subject|2|||
23439240|NCT00320515|65352360|FG000|Overall Study|Death|33|||
23439241|NCT00320515|65352360|FG000|Overall Study|Lost to Follow-up|6|||
23439242|NCT00320515|65352360|FG000|Overall Study|Physician Decision|2|||
23561676|NCT02832622|65786244|FG000|Overall Study|System explant|24|||
23625203|NCT02806505|66015434|FG000|Overall Study|Insufficient therapeutic response|2|||
23625204|NCT02806505|66015435|FG001|Overall Study|Insufficient therapeutic response|4|||
23625205|NCT00839332|66015436|FG000|Phase 1|Disease Progression|38|||
23625206|NCT00839332|66015437|FG001|Phase 1|Disease Progression|0|||
23625207|NCT00839332|66015438|FG002|Phase 1|Disease Progression|0|||
23625208|NCT00839332|66015436|FG000|Phase 1|Adverse Event|6|||
23625209|NCT00839332|66015437|FG001|Phase 1|Adverse Event|0|||
23625210|NCT00839332|66015438|FG002|Phase 1|Adverse Event|0|||
23150879|NCT01667107|64305278|FG001|Overall Study|Protocol Violation|1|||
23324929|NCT00529373|64930456|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
23561677|NCT02832622|65786244|FG000|Overall Study|Physician Decision|6|||
23561678|NCT01287520|65786247|FG000|Overall Study|Adverse Event|2|||
23561679|NCT01287520|65786248|FG001|Overall Study|Adverse Event|2|||
23561680|NCT01287520|65786249|FG002|Overall Study|Adverse Event|2|||
23561681|NCT01287520|65786250|FG003|Overall Study|Adverse Event|1|||
23324930|NCT00529373|64930457|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
23324931|NCT00529373|64930456|FG000|Second Extension Study|Adverse Event|101|||
23324932|NCT00529373|64930457|FG001|Second Extension Study|Adverse Event|51|||
23324933|NCT00529373|64930456|FG000|Second Extension Study|Lack of Efficacy|7|||
23324934|NCT00529373|64930457|FG001|Second Extension Study|Lack of Efficacy|15|||
23324935|NCT00529373|64930456|FG000|Second Extension Study|Lost to Follow-up|18|||
23324936|NCT00529373|64930457|FG001|Second Extension Study|Lost to Follow-up|12|||
23324937|NCT00529373|64930456|FG000|Second Extension Study|Other|7|||
23324938|NCT00529373|64930457|FG001|Second Extension Study|Other|12|||
23324939|NCT00529373|64930456|FG000|Second Extension Study|Physician Decision|63|||
23324940|NCT00529373|64930457|FG001|Second Extension Study|Physician Decision|26|||
23324941|NCT00529373|64930456|FG000|Second Extension Study|Protocol Violation|2|||
23324942|NCT00529373|64930457|FG001|Second Extension Study|Protocol Violation|1|||
23324943|NCT00529373|64930456|FG000|Second Extension Study|Withdrawal by Subject|97|||
23324944|NCT00529373|64930457|FG001|Second Extension Study|Withdrawal by Subject|75|||
23324945|NCT00529373|64930456|FG000|Second Extension Study|Status Missing|5|||
23324946|NCT00529373|64930457|FG001|Second Extension Study|Status Missing|5|||
23324947|NCT01119859|64930460|FG000|Overall Study|Adverse Event|9|||
23324948|NCT01119859|64930461|FG001|Overall Study|Adverse Event|10|||
23324949|NCT01119859|64930460|FG000|Overall Study|Death|2|||
23324950|NCT01119859|64930461|FG001|Overall Study|Death|0|||
23324951|NCT01119859|64930460|FG000|Overall Study|Insufficient therapeutic response|7|||
23324952|NCT01119859|64930461|FG001|Overall Study|Insufficient therapeutic response|14|||
23324953|NCT01119859|64930460|FG000|Overall Study|Refused treatment|3|||
23324954|NCT01119859|64930461|FG001|Overall Study|Refused treatment|6|||
23324955|NCT01119859|64930460|FG000|Overall Study|Failure to return|3|||
23324956|NCT01119859|64930461|FG001|Overall Study|Failure to return|0|||
23324957|NCT02137252|64930462|FG000|Overall Study|trial terminated early|2|||
23324958|NCT02137252|64930463|FG001|Overall Study|trial terminated early|1|||
23324959|NCT02152605|64930466|FG000|Overall Study|Adverse Event|6|||
23324960|NCT02152605|64930467|FG001|Overall Study|Adverse Event|8|||
23439243|NCT00320515|65352360|FG000|Overall Study|Withdrawal by Subject|8|||
23439244|NCT01180296|65352361|FG000|Overall Study|Protocol Violation|1|||
23439245|NCT01180296|65352362|FG001|Overall Study|Protocol Violation|2|||
23439246|NCT02587819|65352372|FG000|Overall Study|Adverse Event|1|||
23625211|NCT00839332|66015436|FG000|Phase 1|Withdrawal by Subject|4|||
23625212|NCT00839332|66015437|FG001|Phase 1|Withdrawal by Subject|0|||
23150880|NCT01667107|64305277|FG000|Overall Study|Lack of Efficacy|0|||
23324961|NCT02152605|64930466|FG000|Overall Study|Lack of Efficacy|7|||
23439247|NCT02587819|65352372|FG000|Overall Study|Lost to Follow-up|1|||
23439248|NCT01867086|65352373|FG000|Overall Study|Disease Progression|1|||
23561682|NCT01287520|65786251|FG004|Overall Study|Adverse Event|1|||
23324962|NCT02152605|64930467|FG001|Overall Study|Lack of Efficacy|4|||
23324963|NCT02152605|64930466|FG000|Overall Study|Protocol deviation|1|||
23324964|NCT02152605|64930467|FG001|Overall Study|Protocol deviation|4|||
23324965|NCT02152605|64930466|FG000|Overall Study|Lost to Follow-up|1|||
23324966|NCT02152605|64930467|FG001|Overall Study|Lost to Follow-up|0|||
23324967|NCT02152605|64930466|FG000|Overall Study|Withdrew consent|4|||
23324968|NCT02152605|64930467|FG001|Overall Study|Withdrew consent|2|||
23324969|NCT04054765|64933657|FG000|Baseline|Withdrawal by Subject|5|||
23324970|NCT04054765|64933658|FG001|Baseline|Withdrawal by Subject|3|||
23324971|NCT04054765|64933657|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
23324972|NCT04054765|64933658|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
23324973|NCT04054765|64933657|FG000|3-month Follow up|Withdrawal by Subject|0|||
23324974|NCT04054765|64933658|FG001|3-month Follow up|Withdrawal by Subject|3|||
23324975|NCT04054765|64933657|FG000|6-month Follow up|Lost to Follow-up|32|||
23324976|NCT04054765|64933658|FG001|6-month Follow up|Lost to Follow-up|32|||
23324977|NCT00595621|64933661|FG000|Open Label Run in|Adverse Event|1|||
23324978|NCT00595621|64933662|FG001|Open Label Run in|Adverse Event|0|||
23324979|NCT00595621|64933661|FG000|Open Label Run in|Physician Decision|1|||
23324980|NCT00595621|64933662|FG001|Open Label Run in|Physician Decision|0|||
23324981|NCT00595621|64933661|FG000|Open Label Run in|Withdrawal by Subject|1|||
23324982|NCT00595621|64933662|FG001|Open Label Run in|Withdrawal by Subject|0|||
23324983|NCT00595621|64933661|FG000|Randomization and Study|Adverse Event|2|||
23324984|NCT00595621|64933662|FG001|Randomization and Study|Adverse Event|0|||
23324985|NCT00595621|64933661|FG000|Randomization and Study|Withdrawal by Subject|0|||
23324986|NCT00595621|64933662|FG001|Randomization and Study|Withdrawal by Subject|1|||
23324987|NCT03866577|64933663|FG000|Overall Study|Protocol Violation|0|||
23324988|NCT03866577|64933664|FG001|Overall Study|Protocol Violation|0|||
23324989|NCT03866577|64933665|FG002|Overall Study|Protocol Violation|0|||
23324990|NCT03866577|64933666|FG003|Overall Study|Protocol Violation|0|||
23324991|NCT03866577|64933667|FG004|Overall Study|Protocol Violation|0|||
23324992|NCT03866577|64933668|FG005|Overall Study|Protocol Violation|0|||
23324993|NCT03866577|64933669|FG006|Overall Study|Protocol Violation|0|||
23324994|NCT03866577|64933670|FG007|Overall Study|Protocol Violation|0|||
23324995|NCT03866577|64933671|FG008|Overall Study|Protocol Violation|0|||
23324996|NCT03866577|64933672|FG009|Overall Study|Protocol Violation|0|||
23324997|NCT03866577|64933673|FG010|Overall Study|Protocol Violation|0|||
23324998|NCT03866577|64933674|FG011|Overall Study|Protocol Violation|1|||
23324999|NCT03866577|64933675|FG012|Overall Study|Protocol Violation|0|||
23325000|NCT03866577|64933663|FG000|Overall Study|Withdrawal by Subject|0|||
23325001|NCT03866577|64933664|FG001|Overall Study|Withdrawal by Subject|0|||
23325002|NCT03866577|64933665|FG002|Overall Study|Withdrawal by Subject|0|||
23325003|NCT03866577|64933666|FG003|Overall Study|Withdrawal by Subject|0|||
23325004|NCT03866577|64933667|FG004|Overall Study|Withdrawal by Subject|0|||
23325005|NCT03866577|64933668|FG005|Overall Study|Withdrawal by Subject|0|||
23325006|NCT03866577|64933669|FG006|Overall Study|Withdrawal by Subject|0|||
23325007|NCT03866577|64933670|FG007|Overall Study|Withdrawal by Subject|0|||
23325008|NCT03866577|64933671|FG008|Overall Study|Withdrawal by Subject|1|||
23325009|NCT03866577|64933672|FG009|Overall Study|Withdrawal by Subject|1|||
23325010|NCT03866577|64933673|FG010|Overall Study|Withdrawal by Subject|0|||
23325011|NCT03866577|64933674|FG011|Overall Study|Withdrawal by Subject|0|||
23325012|NCT03866577|64933675|FG012|Overall Study|Withdrawal by Subject|0|||
23325013|NCT03866577|64933663|FG000|Overall Study|Not qualified for IVIg infusion|0|||
23325014|NCT03866577|64933664|FG001|Overall Study|Not qualified for IVIg infusion|0|||
23325015|NCT03866577|64933665|FG002|Overall Study|Not qualified for IVIg infusion|0|||
23325016|NCT03866577|64933666|FG003|Overall Study|Not qualified for IVIg infusion|0|||
23325017|NCT03866577|64933667|FG004|Overall Study|Not qualified for IVIg infusion|0|||
23325018|NCT03866577|64933668|FG005|Overall Study|Not qualified for IVIg infusion|0|||
23325019|NCT03866577|64933669|FG006|Overall Study|Not qualified for IVIg infusion|0|||
23325020|NCT03866577|64933670|FG007|Overall Study|Not qualified for IVIg infusion|0|||
23325021|NCT03866577|64933671|FG008|Overall Study|Not qualified for IVIg infusion|0|||
23325022|NCT03866577|64933672|FG009|Overall Study|Not qualified for IVIg infusion|1|||
23325023|NCT03866577|64933673|FG010|Overall Study|Not qualified for IVIg infusion|0|||
23325024|NCT03866577|64933674|FG011|Overall Study|Not qualified for IVIg infusion|0|||
23325025|NCT03866577|64933675|FG012|Overall Study|Not qualified for IVIg infusion|0|||
23325026|NCT02550561|64933679|FG000|Overall Study|Lost to Follow-up|5|||
23325027|NCT02550561|64933679|FG000|Overall Study|Withdrawal by Subject|1|||
23325028|NCT02747108|64933680|FG000|Overall Study|Death|2|||
23150881|NCT01667107|64305278|FG001|Overall Study|Lack of Efficacy|1|||
23150882|NCT02982239|64305282|FG000|Overall Study|Lost to Follow-up|3|||
23325029|NCT02747108|64933681|FG001|Overall Study|Death|2|||
23325030|NCT02747108|64933680|FG000|Overall Study|Withdrawal by Subject|1|||
23325031|NCT02747108|64933681|FG001|Overall Study|Withdrawal by Subject|0|||
23325032|NCT02747108|64933680|FG000|Overall Study|Protocol Violation|2|||
23325033|NCT02747108|64933681|FG001|Overall Study|Protocol Violation|0|||
23325034|NCT02892331|64933682|FG000|Overall Study|Withdrawal by Subject|0|||
23325035|NCT02892331|64933683|FG001|Overall Study|Withdrawal by Subject|1|||
23325036|NCT02892331|64933684|FG002|Overall Study|Withdrawal by Subject|1|||
23325037|NCT02892331|64933682|FG000|Overall Study|Sick family member|0|||
23325038|NCT02892331|64933683|FG001|Overall Study|Sick family member|0|||
23325039|NCT02892331|64933684|FG002|Overall Study|Sick family member|1|||
23439249|NCT01393639|65352374|FG000|Overall Study|Protocol Violation|0|||
23325040|NCT02892331|64933682|FG000|Overall Study|Corona virus pandemic|1|||
23325041|NCT02892331|64933683|FG001|Overall Study|Corona virus pandemic|0|||
23325042|NCT02892331|64933684|FG002|Overall Study|Corona virus pandemic|1|||
23325043|NCT02892331|64933682|FG000|Overall Study|Lost to Follow-up|1|||
23219882|NCT01055457|64549991|FG005|Overall Study|Subject Ineligible|0|||
23219883|NCT01055457|64549992|FG006|Overall Study|Subject Ineligible|0|||
23219884|NCT01055457|64549993|FG007|Overall Study|Subject Ineligible|0|||
23219885|NCT01055457|64549994|FG008|Overall Study|Subject Ineligible|0|||
23219886|NCT01055457|64549995|FG009|Overall Study|Subject Ineligible|0|||
23219887|NCT01055457|64549986|FG000|Overall Study|Discomfort|0|||
23219888|NCT01055457|64549987|FG001|Overall Study|Discomfort|0|||
23219889|NCT01055457|64549988|FG002|Overall Study|Discomfort|0|||
23219890|NCT01055457|64549989|FG003|Overall Study|Discomfort|0|||
23219891|NCT01055457|64549990|FG004|Overall Study|Discomfort|1|||
23219892|NCT01055457|64549991|FG005|Overall Study|Discomfort|0|||
23219893|NCT01055457|64549992|FG006|Overall Study|Discomfort|0|||
23219894|NCT01055457|64549993|FG007|Overall Study|Discomfort|0|||
23219895|NCT01055457|64549994|FG008|Overall Study|Discomfort|0|||
23219896|NCT01055457|64549995|FG009|Overall Study|Discomfort|0|||
23219897|NCT01055457|64549986|FG000|Overall Study|Pregnancy|0|||
23219898|NCT01055457|64549987|FG001|Overall Study|Pregnancy|0|||
23219899|NCT01055457|64549988|FG002|Overall Study|Pregnancy|0|||
23219900|NCT01055457|64549989|FG003|Overall Study|Pregnancy|1|||
23219901|NCT01055457|64549990|FG004|Overall Study|Pregnancy|0|||
23219902|NCT01055457|64549991|FG005|Overall Study|Pregnancy|0|||
23219903|NCT01055457|64549992|FG006|Overall Study|Pregnancy|0|||
23219904|NCT01055457|64549993|FG007|Overall Study|Pregnancy|0|||
23219905|NCT01055457|64549994|FG008|Overall Study|Pregnancy|0|||
23219906|NCT01055457|64549995|FG009|Overall Study|Pregnancy|0|||
23219907|NCT01055457|64549986|FG000|Overall Study|Adverse Event|0|||
23219908|NCT01055457|64549987|FG001|Overall Study|Adverse Event|0|||
23219909|NCT01055457|64549988|FG002|Overall Study|Adverse Event|0|||
23219910|NCT01055457|64549989|FG003|Overall Study|Adverse Event|1|||
23219911|NCT01055457|64549990|FG004|Overall Study|Adverse Event|0|||
23219912|NCT01055457|64549991|FG005|Overall Study|Adverse Event|0|||
23219913|NCT01055457|64549992|FG006|Overall Study|Adverse Event|0|||
23219914|NCT01055457|64549993|FG007|Overall Study|Adverse Event|0|||
23219915|NCT01055457|64549994|FG008|Overall Study|Adverse Event|0|||
23219916|NCT01055457|64549995|FG009|Overall Study|Adverse Event|0|||
23219917|NCT02177812|64549998|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23219918|NCT02177812|64549999|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23219919|NCT02177812|64550000|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23219920|NCT02177812|64550001|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23219921|NCT02177812|64550002|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23219922|NCT02177812|64550003|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
23219923|NCT02177812|64550004|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
23219924|NCT02177812|64550005|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
23219925|NCT02177812|64550006|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
23219926|NCT02177812|64549998|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23219927|NCT02177812|64549999|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23219928|NCT02177812|64550000|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23219929|NCT02177812|64550001|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23219930|NCT02177812|64550002|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23219931|NCT02177812|64550003|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
23219932|NCT02177812|64550004|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
23219933|NCT02177812|64550005|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23219934|NCT02177812|64550006|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
23219935|NCT02177812|64549998|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
23219936|NCT02177812|64549999|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
23219937|NCT02177812|64550000|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
23219938|NCT02177812|64550001|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
23219939|NCT02177812|64550002|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
23219940|NCT02177812|64550003|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
23219941|NCT02177812|64550004|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
23219942|NCT02177812|64550005|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
23561683|NCT01287520|65786252|FG005|Overall Study|Adverse Event|2|||
23219943|NCT02177812|64550006|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
23219944|NCT01505114|64550007|FG000|Overall Study|Withdrawal by Subject|5|||
23219945|NCT01505114|64550008|FG001|Overall Study|Withdrawal by Subject|4|||
23219946|NCT01505114|64550009|FG002|Overall Study|Withdrawal by Subject|4|||
23219947|NCT01505114|64550010|FG003|Overall Study|Withdrawal by Subject|7|||
23219948|NCT01505114|64550007|FG000|Overall Study|Death|1|||
23219949|NCT01505114|64550008|FG001|Overall Study|Death|0|||
23219950|NCT01505114|64550009|FG002|Overall Study|Death|0|||
23219951|NCT01505114|64550010|FG003|Overall Study|Death|1|||
23325044|NCT02892331|64933683|FG001|Overall Study|Lost to Follow-up|0|||
23561684|NCT01287520|65786253|FG006|Overall Study|Adverse Event|0|||
23561685|NCT01287520|65786254|FG007|Overall Study|Adverse Event|2|||
23561686|NCT01287520|65786255|FG008|Overall Study|Adverse Event|0|||
23150883|NCT02982239|64305283|FG001|Overall Study|Lost to Follow-up|2|||
23150884|NCT01103245|64305284|FG000|Overall Study|Withdrawal by Subject|1|||
23150885|NCT01103245|64305285|FG001|Overall Study|Withdrawal by Subject|0|||
23150886|NCT01103245|64305286|FG002|Overall Study|Withdrawal by Subject|3|||
23150887|NCT01103245|64305287|FG003|Overall Study|Withdrawal by Subject|0|||
23150888|NCT01103245|64305284|FG000|Overall Study|Inadequate IV access|1|||
23150889|NCT01103245|64305285|FG001|Overall Study|Inadequate IV access|0|||
23150890|NCT01103245|64305286|FG002|Overall Study|Inadequate IV access|0|||
23150891|NCT01103245|64305287|FG003|Overall Study|Inadequate IV access|0|||
23150892|NCT01103245|64305284|FG000|Overall Study|Adverse Event|0|||
23150893|NCT01103245|64305285|FG001|Overall Study|Adverse Event|2|||
23150894|NCT01103245|64305286|FG002|Overall Study|Adverse Event|1|||
23150895|NCT01103245|64305287|FG003|Overall Study|Adverse Event|0|||
23150896|NCT01103245|64305284|FG000|Overall Study|Physician Decision|1|||
23150897|NCT01103245|64305285|FG001|Overall Study|Physician Decision|0|||
23150898|NCT01103245|64305286|FG002|Overall Study|Physician Decision|0|||
23150899|NCT01103245|64305287|FG003|Overall Study|Physician Decision|0|||
23150900|NCT01854645|64305288|FG000|Overall Study|Protocol-Specified Criteria|13|||
23150901|NCT01854645|64305289|FG001|Overall Study|Protocol-Specified Criteria|10|||
23150902|NCT01854645|64305290|FG002|Overall Study|Protocol-Specified Criteria|8|||
23150903|NCT01854645|64305291|FG003|Overall Study|Protocol-Specified Criteria|5|||
23150904|NCT01854645|64305292|FG004|Overall Study|Protocol-Specified Criteria|7|||
23150905|NCT01854645|64305288|FG000|Overall Study|Administrative Reasons / Missing|0|||
23150906|NCT01854645|64305289|FG001|Overall Study|Administrative Reasons / Missing|0|||
23150907|NCT01854645|64305290|FG002|Overall Study|Administrative Reasons / Missing|0|||
23150908|NCT01854645|64305291|FG003|Overall Study|Administrative Reasons / Missing|1|||
23150909|NCT01854645|64305292|FG004|Overall Study|Administrative Reasons / Missing|1|||
23150910|NCT01854645|64305288|FG000|Overall Study|Protocol Violation|3|||
23150911|NCT01854645|64305289|FG001|Overall Study|Protocol Violation|0|||
23150912|NCT01854645|64305290|FG002|Overall Study|Protocol Violation|5|||
23150913|NCT01854645|64305291|FG003|Overall Study|Protocol Violation|4|||
23150914|NCT01854645|64305292|FG004|Overall Study|Protocol Violation|1|||
23150915|NCT01854645|64305288|FG000|Overall Study|Lost to Follow-up|10|||
23150916|NCT01854645|64305289|FG001|Overall Study|Lost to Follow-up|7|||
23150917|NCT01854645|64305290|FG002|Overall Study|Lost to Follow-up|8|||
23150918|NCT01854645|64305291|FG003|Overall Study|Lost to Follow-up|5|||
23150919|NCT01854645|64305292|FG004|Overall Study|Lost to Follow-up|0|||
23150920|NCT01854645|64305288|FG000|Overall Study|Physician Decision|1|||
23150921|NCT01854645|64305289|FG001|Overall Study|Physician Decision|5|||
23150922|NCT01854645|64305290|FG002|Overall Study|Physician Decision|3|||
23150923|NCT01854645|64305291|FG003|Overall Study|Physician Decision|3|||
23150924|NCT01854645|64305292|FG004|Overall Study|Physician Decision|7|||
23150925|NCT01854645|64305288|FG000|Overall Study|Withdrawal by Subject|31|||
23150926|NCT01854645|64305289|FG001|Overall Study|Withdrawal by Subject|41|||
23150927|NCT01854645|64305290|FG002|Overall Study|Withdrawal by Subject|30|||
23150928|NCT01854645|64305291|FG003|Overall Study|Withdrawal by Subject|21|||
23150929|NCT01854645|64305292|FG004|Overall Study|Withdrawal by Subject|24|||
23150930|NCT01854645|64305288|FG000|Overall Study|Lack of Efficacy|7|||
23150931|NCT01854645|64305289|FG001|Overall Study|Lack of Efficacy|12|||
23150932|NCT01854645|64305290|FG002|Overall Study|Lack of Efficacy|9|||
23150933|NCT01854645|64305291|FG003|Overall Study|Lack of Efficacy|3|||
23150934|NCT01854645|64305292|FG004|Overall Study|Lack of Efficacy|9|||
23150935|NCT01854645|64305288|FG000|Overall Study|Adverse Event|33|||
23150936|NCT01854645|64305289|FG001|Overall Study|Adverse Event|31|||
23150937|NCT01854645|64305290|FG002|Overall Study|Adverse Event|19|||
23150938|NCT01854645|64305291|FG003|Overall Study|Adverse Event|20|||
23150939|NCT01854645|64305292|FG004|Overall Study|Adverse Event|11|||
23150940|NCT00150969|64305293|FG000|24 Month Main Study|Adverse Event|3|||
23150941|NCT00150969|64305294|FG001|24 Month Main Study|Adverse Event|4|||
23150942|NCT00150969|64305293|FG000|24 Month Main Study|Death|1|||
23150943|NCT00150969|64305294|FG001|24 Month Main Study|Death|1|||
23150944|NCT00150969|64305293|FG000|24 Month Main Study|Lack of Efficacy|1|||
23150945|NCT00150969|64305294|FG001|24 Month Main Study|Lack of Efficacy|8|||
23150946|NCT00150969|64305293|FG000|24 Month Main Study|Lost to Follow-up|3|||
23150947|NCT00150969|64305294|FG001|24 Month Main Study|Lost to Follow-up|2|||
23150948|NCT00150969|64305293|FG000|24 Month Main Study|Protocol Violation|4|||
23150949|NCT00150969|64305294|FG001|24 Month Main Study|Protocol Violation|2|||
23150950|NCT00150969|64305293|FG000|24 Month Main Study|Withdrawal by Subject|7|||
23150951|NCT00150969|64305294|FG001|24 Month Main Study|Withdrawal by Subject|4|||
23150952|NCT00150969|64305293|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
23150953|NCT00150969|64305294|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
23150954|NCT00150969|64305293|FG000|24-48 Month Extension|Lack of Efficacy|0|||
23150955|NCT00150969|64305294|FG001|24-48 Month Extension|Lack of Efficacy|1|||
23561687|NCT01287520|65786247|FG000|Overall Study|Physician Decision|1|||
23150956|NCT00150969|64305293|FG000|24-48 Month Extension|Adverse Event|1|||
23150957|NCT00150969|64305294|FG001|24-48 Month Extension|Adverse Event|3|||
23561688|NCT01287520|65786248|FG001|Overall Study|Physician Decision|1|||
23561689|NCT01287520|65786249|FG002|Overall Study|Physician Decision|2|||
23625213|NCT00839332|66015438|FG002|Phase 1|Withdrawal by Subject|0|||
23625214|NCT00839332|66015436|FG000|Phase 1|Physician Decision|2|||
23625215|NCT00839332|66015437|FG001|Phase 1|Physician Decision|0|||
23625216|NCT00839332|66015438|FG002|Phase 1|Physician Decision|0|||
23625217|NCT00839332|66015436|FG000|Phase 2|Protocol Violation|0|||
23625218|NCT00839332|66015437|FG001|Phase 2|Protocol Violation|1|||
23625219|NCT00839332|66015438|FG002|Phase 2|Protocol Violation|0|||
23625220|NCT00839332|66015436|FG000|Phase 2|Disease Progression|0|||
23625221|NCT00839332|66015437|FG001|Phase 2|Disease Progression|46|||
23625222|NCT00839332|66015438|FG002|Phase 2|Disease Progression|21|||
23625223|NCT00839332|66015436|FG000|Phase 2|Adverse Event|0|||
23625224|NCT00839332|66015437|FG001|Phase 2|Adverse Event|8|||
23625225|NCT00839332|66015438|FG002|Phase 2|Adverse Event|6|||
23625226|NCT00839332|66015436|FG000|Phase 2|Death|0|||
23625227|NCT00839332|66015437|FG001|Phase 2|Death|4|||
23625228|NCT00839332|66015438|FG002|Phase 2|Death|2|||
23150958|NCT00150969|64305293|FG000|24-48 Month Extension|Other Reason|81|||
23150959|NCT00150969|64305294|FG001|24-48 Month Extension|Other Reason|91|||
23150960|NCT00651157|64305295|FG000|Overall Study|Death|1|||
23150961|NCT00651157|64305295|FG000|Overall Study|Protocol Violation|1|||
23150962|NCT00974090|64305296|FG000|Period 1: Double Blind Period|Adverse Event|2|||
23150963|NCT00974090|64305297|FG001|Period 1: Double Blind Period|Adverse Event|1|||
23150964|NCT00974090|64305296|FG000|Period 1: Double Blind Period|Physician Decision|1|||
23150965|NCT00974090|64305297|FG001|Period 1: Double Blind Period|Physician Decision|0|||
23150966|NCT00974090|64305296|FG000|Period 2: Open-label Period|Adverse Event|4|||
23150967|NCT00974090|64305297|FG001|Period 2: Open-label Period|Adverse Event|6|||
23150968|NCT00974090|64305296|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
23150969|NCT00974090|64305297|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
23150970|NCT00974090|64305296|FG000|Period 2: Open-label Period|Physician Decision|0|||
23150971|NCT00974090|64305297|FG001|Period 2: Open-label Period|Physician Decision|3|||
23150972|NCT00974090|64305296|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
23150973|NCT00974090|64305297|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
23150974|NCT02401412|64305302|FG000|Overall Study|Lost to Follow-up|1|||
23150975|NCT02401412|64305303|FG001|Overall Study|Lost to Follow-up|0|||
23150976|NCT02401412|64305302|FG000|Overall Study|Discontinued Intervention|15|||
23150977|NCT02401412|64305303|FG001|Overall Study|Discontinued Intervention|21|||
23150978|NCT02401412|64305302|FG000|Overall Study|Withdrawal by Subject|4|||
23150979|NCT02401412|64305303|FG001|Overall Study|Withdrawal by Subject|4|||
23150980|NCT02401412|64305302|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
23150981|NCT02401412|64305303|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
23150982|NCT02401412|64305302|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
23150983|NCT02401412|64305303|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
23150984|NCT00597753|64305304|FG000|Overall Study|Adverse Event|6|||
23150985|NCT00597753|64305305|FG001|Overall Study|Adverse Event|2|||
23150986|NCT00597753|64305304|FG000|Overall Study|Death|55|||
23150987|NCT00597753|64305305|FG001|Overall Study|Death|29|||
23150988|NCT00597753|64305304|FG000|Overall Study|Lack of Efficacy|2|||
23150989|NCT00597753|64305305|FG001|Overall Study|Lack of Efficacy|0|||
23150990|NCT00597753|64305304|FG000|Overall Study|Lost to Follow-up|10|||
23150991|NCT00597753|64305305|FG001|Overall Study|Lost to Follow-up|3|||
23150992|NCT00597753|64305304|FG000|Overall Study|Physician Decision|5|||
23150993|NCT00597753|64305305|FG001|Overall Study|Physician Decision|1|||
23150994|NCT00597753|64305304|FG000|Overall Study|Pregnancy|1|||
23150995|NCT00597753|64305305|FG001|Overall Study|Pregnancy|0|||
23150996|NCT00597753|64305304|FG000|Overall Study|Withdrawal by Subject|35|||
23150997|NCT00597753|64305305|FG001|Overall Study|Withdrawal by Subject|12|||
23150998|NCT00597753|64305304|FG000|Overall Study|Discontinued Dialysis|0|||
23150999|NCT00597753|64305305|FG001|Overall Study|Discontinued Dialysis|1|||
23151000|NCT00597753|64305304|FG000|Overall Study|Never dosed|2|||
23151001|NCT00597753|64305305|FG001|Overall Study|Never dosed|0|||
23151002|NCT00597753|64305304|FG000|Overall Study|Noncompliance|2|||
23151003|NCT00597753|64305305|FG001|Overall Study|Noncompliance|1|||
23151004|NCT00597753|64305304|FG000|Overall Study|Relocation|17|||
23151005|NCT00597753|64305305|FG001|Overall Study|Relocation|6|||
23151006|NCT00597753|64305304|FG000|Overall Study|Renal transplant|10|||
23625229|NCT00839332|66015436|FG000|Phase 2|Withdrawal by Subject|0|||
23151007|NCT00597753|64305305|FG001|Overall Study|Renal transplant|3|||
23151008|NCT00597753|64305304|FG000|Overall Study|Site closed by sponsor|19|||
23151009|NCT00597753|64305305|FG001|Overall Study|Site closed by sponsor|7|||
23151010|NCT00597753|64305304|FG000|Overall Study|Site elected to close|2|||
23151011|NCT00597753|64305305|FG001|Overall Study|Site elected to close|4|||
23151012|NCT02536755|64305313|FG000|Overall Study|Adverse Event|4|||
23151013|NCT02366728|64305317|FG000|Overall Study|Death|0|||
23151014|NCT02366728|64305318|FG001|Overall Study|Death|0|||
23151015|NCT02366728|64305319|FG002|Overall Study|Death|1|||
23151016|NCT02366728|64305317|FG000|Overall Study|Adverse Event|1|||
23625230|NCT00839332|66015437|FG001|Phase 2|Withdrawal by Subject|5|||
23625231|NCT00839332|66015438|FG002|Phase 2|Withdrawal by Subject|8|||
23625232|NCT00839332|66015436|FG000|Phase 2|Physician Decision|0|||
23625233|NCT00839332|66015437|FG001|Phase 2|Physician Decision|4|||
23625234|NCT00839332|66015438|FG002|Phase 2|Physician Decision|1|||
23625235|NCT00839332|66015436|FG000|Phase 2|Lost to Follow-up|0|||
23625236|NCT00839332|66015437|FG001|Phase 2|Lost to Follow-up|0|||
23625237|NCT00839332|66015438|FG002|Phase 2|Lost to Follow-up|1|||
23625238|NCT02509312|66015441|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
23625239|NCT02509312|66015442|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
23625240|NCT02509312|66015441|FG000|Overall Study|Obstetrician refusal|0|||
23625241|NCT02509312|66015442|FG001|Overall Study|Obstetrician refusal|1|||
23625242|NCT02509312|66015441|FG000|Overall Study|Patient elected for TOLAC|1|||
23625243|NCT02509312|66015442|FG001|Overall Study|Patient elected for TOLAC|0|||
23625244|NCT02509312|66015441|FG000|Overall Study|Cesarean deemed stat|1|||
23625245|NCT02509312|66015442|FG001|Overall Study|Cesarean deemed stat|0|||
23625246|NCT02509312|66015441|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
23625247|NCT02509312|66015442|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
23625248|NCT00727506|66015443|FG000|Overall Study|Adverse Event|0|||
23625249|NCT00727506|66015444|FG001|Overall Study|Adverse Event|0|||
23625250|NCT00727506|66015445|FG002|Overall Study|Adverse Event|4|||
23625251|NCT00727506|66015446|FG003|Overall Study|Adverse Event|4|||
23625252|NCT00727506|66015447|FG004|Overall Study|Adverse Event|1|||
23625253|NCT00727506|66015448|FG005|Overall Study|Adverse Event|8|||
23625254|NCT00727506|66015443|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23625255|NCT00727506|66015444|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23625256|NCT00727506|66015445|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23625257|NCT00727506|66015446|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23625258|NCT00727506|66015447|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23625259|NCT00727506|66015448|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23625260|NCT00727506|66015443|FG000|Overall Study|Progressive disease|4|||
23625261|NCT00727506|66015444|FG001|Overall Study|Progressive disease|7|||
23625262|NCT00727506|66015445|FG002|Overall Study|Progressive disease|9|||
23625263|NCT00727506|66015446|FG003|Overall Study|Progressive disease|28|||
23625264|NCT00727506|66015447|FG004|Overall Study|Progressive disease|38|||
23625265|NCT00727506|66015448|FG005|Overall Study|Progressive disease|28|||
23625266|NCT00727506|66015443|FG000|Overall Study|Refused to continue medication|0|||
23625267|NCT00727506|66015444|FG001|Overall Study|Refused to continue medication|1|||
23625268|NCT00727506|66015445|FG002|Overall Study|Refused to continue medication|2|||
23625269|NCT00727506|66015446|FG003|Overall Study|Refused to continue medication|3|||
23625270|NCT00727506|66015447|FG004|Overall Study|Refused to continue medication|1|||
23625271|NCT00727506|66015448|FG005|Overall Study|Refused to continue medication|2|||
23625272|NCT00727506|66015443|FG000|Overall Study|Other reason not described above|0|||
23625273|NCT00727506|66015444|FG001|Overall Study|Other reason not described above|0|||
23625274|NCT00727506|66015445|FG002|Overall Study|Other reason not described above|1|||
23625275|NCT00727506|66015446|FG003|Overall Study|Other reason not described above|4|||
23625276|NCT00727506|66015447|FG004|Overall Study|Other reason not described above|1|||
23625277|NCT00727506|66015448|FG005|Overall Study|Other reason not described above|1|||
23625278|NCT01340300|66015449|FG000|Overall Study|Lost to Follow-up|3|||
23625279|NCT01340300|66015450|FG001|Overall Study|Lost to Follow-up|0|||
23625280|NCT01340300|66015451|FG002|Overall Study|Lost to Follow-up|5|||
23625281|NCT01340300|66015452|FG003|Overall Study|Lost to Follow-up|10|||
23625282|NCT01340300|66015449|FG000|Overall Study|Withdrawal by Subject|5|||
23625283|NCT01340300|66015450|FG001|Overall Study|Withdrawal by Subject|6|||
23625284|NCT01340300|66015451|FG002|Overall Study|Withdrawal by Subject|6|||
23625285|NCT01340300|66015452|FG003|Overall Study|Withdrawal by Subject|3|||
23625286|NCT01340300|66015449|FG000|Overall Study|Adverse Event|1|||
23625287|NCT01340300|66015450|FG001|Overall Study|Adverse Event|0|||
23625288|NCT01340300|66015451|FG002|Overall Study|Adverse Event|4|||
23625289|NCT01340300|66015452|FG003|Overall Study|Adverse Event|0|||
23625290|NCT01340300|66015449|FG000|Overall Study|Physician Decision|0|||
23625291|NCT01340300|66015450|FG001|Overall Study|Physician Decision|1|||
23625292|NCT01340300|66015451|FG002|Overall Study|Physician Decision|0|||
23625293|NCT01340300|66015452|FG003|Overall Study|Physician Decision|0|||
23625294|NCT01340300|66015449|FG000|Overall Study|Unrelated sickness|0|||
23625295|NCT01340300|66015450|FG001|Overall Study|Unrelated sickness|2|||
23625296|NCT01340300|66015451|FG002|Overall Study|Unrelated sickness|0|||
23625297|NCT01340300|66015452|FG003|Overall Study|Unrelated sickness|1|||
23625298|NCT03371823|66015457|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
23625299|NCT03371823|66015458|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
23151017|NCT02366728|64305318|FG001|Overall Study|Adverse Event|0|||
23151018|NCT02366728|64305319|FG002|Overall Study|Adverse Event|0|||
23625300|NCT02057575|66015459|FG000|Overall Study|Adverse Event|0|||
23625301|NCT02057575|66015460|FG001|Overall Study|Adverse Event|2|||
23625302|NCT02057575|66015461|FG002|Overall Study|Adverse Event|0|||
23625303|NCT02057575|66015462|FG003|Overall Study|Adverse Event|1|||
23625304|NCT02057575|66015459|FG000|Overall Study|Withdrawal by Subject|1|||
23625305|NCT02057575|66015460|FG001|Overall Study|Withdrawal by Subject|0|||
23625306|NCT02057575|66015461|FG002|Overall Study|Withdrawal by Subject|0|||
23625307|NCT02057575|66015462|FG003|Overall Study|Withdrawal by Subject|0|||
23625308|NCT02057575|66015459|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
23625309|NCT02057575|66015460|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
23625310|NCT02057575|66015461|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
23625311|NCT02057575|66015462|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
23625312|NCT02057575|66015459|FG000|Overall Study|Protocol Violation|0|||
23151019|NCT02366728|64305317|FG000|Overall Study|Screen Failure|2|||
23151020|NCT02366728|64305318|FG001|Overall Study|Screen Failure|1|||
23151021|NCT02366728|64305319|FG002|Overall Study|Screen Failure|0|||
23151022|NCT02366728|64305317|FG000|Overall Study|Only yielded 2 vaccines|1|||
23151023|NCT02366728|64305318|FG001|Overall Study|Only yielded 2 vaccines|0|||
23151024|NCT02366728|64305319|FG002|Overall Study|Only yielded 2 vaccines|0|||
23151025|NCT03037619|64305321|FG000|Overall Study|Lost to Follow-up|0|||
23151026|NCT03037619|64305322|FG001|Overall Study|Lost to Follow-up|1|||
23151027|NCT02973425|64305327|FG000|Overall Study|Lost to Follow-up|49|||
23151028|NCT02973425|64305328|FG001|Overall Study|Lost to Follow-up|53|||
23151029|NCT01765179|64305329|FG000|Overall Study|Adverse Event|3|||
23151030|NCT01765179|64305329|FG000|Overall Study|Lost to Follow-up|5|||
23151031|NCT01765179|64305329|FG000|Overall Study|Non-compliance with study drug|2|||
23151032|NCT01765179|64305329|FG000|Overall Study|Protocol Violation|1|||
23151033|NCT01765179|64305329|FG000|Overall Study|Withdrawal by Subject|8|||
23151034|NCT01765179|64305329|FG000|Overall Study|Hematocrit >54%|3|||
23151035|NCT01765179|64305329|FG000|Overall Study|prohibited med|1|||
23151036|NCT01765179|64305329|FG000|Overall Study|Out of country unable to finish study|1|||
23151037|NCT01765179|64305329|FG000|Overall Study|lack of venous access|1|||
23151038|NCT01765179|64305329|FG000|Overall Study|work conflict|1|||
23219952|NCT01505114|64550007|FG000|Overall Study|unable to adhere to visit schedule|3|||
23219953|NCT01505114|64550008|FG001|Overall Study|unable to adhere to visit schedule|2|||
23219954|NCT01505114|64550009|FG002|Overall Study|unable to adhere to visit schedule|3|||
23219955|NCT01505114|64550010|FG003|Overall Study|unable to adhere to visit schedule|3|||
23219956|NCT01505114|64550007|FG000|Overall Study|Lost to Follow-up|11|||
23219957|NCT01505114|64550008|FG001|Overall Study|Lost to Follow-up|5|||
23219958|NCT01505114|64550009|FG002|Overall Study|Lost to Follow-up|8|||
23219959|NCT01505114|64550010|FG003|Overall Study|Lost to Follow-up|7|||
23219960|NCT01505114|64550007|FG000|Overall Study|relocated|4|||
23219961|NCT01505114|64550008|FG001|Overall Study|relocated|2|||
23219962|NCT01505114|64550009|FG002|Overall Study|relocated|2|||
23219963|NCT01505114|64550010|FG003|Overall Study|relocated|3|||
23219964|NCT01505114|64550007|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
23219965|NCT01505114|64550008|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
23219966|NCT01505114|64550009|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
23219967|NCT01505114|64550010|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
23219968|NCT01505114|64550007|FG000|Overall Study|staff safety concerns|0|||
23219969|NCT01505114|64550008|FG001|Overall Study|staff safety concerns|0|||
23219970|NCT01505114|64550009|FG002|Overall Study|staff safety concerns|0|||
23219971|NCT01505114|64550010|FG003|Overall Study|staff safety concerns|1|||
23219972|NCT01505114|64550007|FG000|Overall Study|investigator decision|1|||
23219973|NCT01505114|64550008|FG001|Overall Study|investigator decision|0|||
23219974|NCT01505114|64550009|FG002|Overall Study|investigator decision|1|||
23219975|NCT01505114|64550010|FG003|Overall Study|investigator decision|0|||
23561690|NCT01287520|65786250|FG003|Overall Study|Physician Decision|0|||
23561691|NCT01287520|65786251|FG004|Overall Study|Physician Decision|1|||
23561692|NCT01287520|65786252|FG005|Overall Study|Physician Decision|1|||
23561693|NCT01287520|65786253|FG006|Overall Study|Physician Decision|0|||
23561694|NCT01287520|65786254|FG007|Overall Study|Physician Decision|1|||
23561695|NCT01287520|65786255|FG008|Overall Study|Physician Decision|0|||
23561696|NCT01287520|65786247|FG000|Overall Study|Progressive disease|0|||
23561697|NCT01287520|65786248|FG001|Overall Study|Progressive disease|4|||
23561698|NCT01287520|65786249|FG002|Overall Study|Progressive disease|1|||
23561699|NCT01287520|65786250|FG003|Overall Study|Progressive disease|6|||
23561700|NCT01287520|65786251|FG004|Overall Study|Progressive disease|1|||
23561701|NCT01287520|65786252|FG005|Overall Study|Progressive disease|0|||
23561702|NCT01287520|65786253|FG006|Overall Study|Progressive disease|2|||
23561703|NCT01287520|65786254|FG007|Overall Study|Progressive disease|2|||
23561704|NCT01287520|65786255|FG008|Overall Study|Progressive disease|4|||
23561705|NCT01287520|65786247|FG000|Overall Study|Withdrawal by Subject|0|||
23561706|NCT01287520|65786248|FG001|Overall Study|Withdrawal by Subject|0|||
23561707|NCT01287520|65786249|FG002|Overall Study|Withdrawal by Subject|0|||
23561708|NCT01287520|65786250|FG003|Overall Study|Withdrawal by Subject|0|||
23561709|NCT01287520|65786251|FG004|Overall Study|Withdrawal by Subject|0|||
23561710|NCT01287520|65786252|FG005|Overall Study|Withdrawal by Subject|1|||
23561711|NCT01287520|65786253|FG006|Overall Study|Withdrawal by Subject|0|||
23561712|NCT01287520|65786254|FG007|Overall Study|Withdrawal by Subject|0|||
23561713|NCT01287520|65786255|FG008|Overall Study|Withdrawal by Subject|1|||
23561714|NCT02924389|65786261|FG000|Overall Study|Lost to Follow-up|1|||
23561715|NCT02924389|65786262|FG001|Overall Study|Lost to Follow-up|0|||
23561716|NCT02924389|65786261|FG000|Overall Study|Physician Decision|2|||
23561717|NCT02924389|65786262|FG001|Overall Study|Physician Decision|0|||
23561718|NCT02924389|65786261|FG000|Overall Study|Withdrawal by Subject|3|||
23561719|NCT02924389|65786262|FG001|Overall Study|Withdrawal by Subject|0|||
23561720|NCT02924389|65786261|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
23561721|NCT02924389|65786262|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
23561722|NCT00782496|65786264|FG000|Overall Study|Lost to Follow-up|14|||
23561723|NCT00782496|65786265|FG001|Overall Study|Lost to Follow-up|15|||
23561724|NCT00622180|65786268|FG000|Overall Study|Lost to Follow-up|1|||
23561725|NCT00622180|65786269|FG001|Overall Study|Lost to Follow-up|2|||
23561726|NCT01669798|65786270|FG000|Overall Study|Physician Decision|5|||
23561727|NCT02259517|65786272|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
23561728|NCT02259517|65786273|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
23561729|NCT02259517|65786274|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
23561730|NCT02259517|65786272|FG000|Overall Study|Withdrawal by Subject|0|||
23561731|NCT02259517|65786273|FG001|Overall Study|Withdrawal by Subject|0|||
23561732|NCT02259517|65786274|FG002|Overall Study|Withdrawal by Subject|3|||
23561733|NCT01370525|65786275|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
23561734|NCT01370525|65786276|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
23561735|NCT01370525|65786275|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23561736|NCT01370525|65786276|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23561737|NCT01370525|65786275|FG000|Overall Study|Adverse Event|0|||
23561738|NCT01370525|65786276|FG001|Overall Study|Adverse Event|1|||
23561739|NCT01370525|65786275|FG000|Overall Study|Protocol Violation|2|||
23561740|NCT01370525|65786276|FG001|Overall Study|Protocol Violation|1|||
23561741|NCT01370525|65786275|FG000|Overall Study|Lost to follow up|2|||
23561742|NCT01370525|65786276|FG001|Overall Study|Lost to follow up|6|||
23561743|NCT02552238|65786279|FG000|Overall Study|Withdrawal by Subject|2|||
23561744|NCT02552238|65786279|FG000|Overall Study|Adverse Event|2|||
23561745|NCT02583425|65786284|FG000|Screening|Did not meet entry criteria|12|||
23561746|NCT02583425|65786284|FG000|Baseline|Did not meet continued criteria|5|||
23561747|NCT02583425|65786284|FG000|Treatment Period|Adverse Event|1|||
23561748|NCT01330433|65786285|FG000|Overall Study|Death|1|||
23561749|NCT01330433|65786286|FG001|Overall Study|Death|3|||
23561750|NCT01330433|65786285|FG000|Overall Study|Lost to Follow-up|1|||
23561751|NCT01330433|65786286|FG001|Overall Study|Lost to Follow-up|0|||
23561752|NCT02946918|65786287|FG000|Overall Study|Patient unblinded himself|1|||
23561753|NCT02946918|65786288|FG001|Overall Study|Patient unblinded himself|0|||
23561754|NCT02946918|65786287|FG000|Overall Study|Physician Decision|0|||
23561755|NCT02946918|65786288|FG001|Overall Study|Physician Decision|2|||
23561756|NCT02946918|65786287|FG000|Overall Study|Ran out of study medication|0|||
23561757|NCT02946918|65786288|FG001|Overall Study|Ran out of study medication|1|||
23561758|NCT01650519|65786289|FG000|Overall Study|Withdrawal by Subject|1|||
23561759|NCT01650519|65786290|FG001|Overall Study|Withdrawal by Subject|0|||
23561760|NCT00758459|65786291|FG000|Overall Study|Adverse Event|3|||
23561761|NCT00758459|65786292|FG001|Overall Study|Adverse Event|2|||
23561762|NCT00758459|65786291|FG000|Overall Study|Protocol Violation|0|||
23561763|NCT00758459|65786292|FG001|Overall Study|Protocol Violation|1|||
23561764|NCT00758459|65786291|FG000|Overall Study|Withdrawal by Subject|0|||
23561765|NCT00758459|65786292|FG001|Overall Study|Withdrawal by Subject|1|||
23561766|NCT00550550|65786295|FG000|Overall Study|Adverse Event|13|||
23561767|NCT00550550|65786296|FG001|Overall Study|Adverse Event|5|||
23561768|NCT00550550|65786295|FG000|Overall Study|Treatment Failure|0|||
23561769|NCT00550550|65786296|FG001|Overall Study|Treatment Failure|1|||
23625313|NCT02057575|66015460|FG001|Overall Study|Protocol Violation|1|||
23561770|NCT00550550|65786295|FG000|Overall Study|Lost to Follow-up|4|||
23561771|NCT00550550|65786296|FG001|Overall Study|Lost to Follow-up|0|||
23561772|NCT00550550|65786295|FG000|Overall Study|Withdrawal by Subject|10|||
23561773|NCT00550550|65786296|FG001|Overall Study|Withdrawal by Subject|8|||
23561774|NCT00550550|65786295|FG000|Overall Study|Protocol Violation|5|||
23561775|NCT00550550|65786296|FG001|Overall Study|Protocol Violation|14|||
23561776|NCT00550550|65786295|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
23561777|NCT00550550|65786296|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
23561778|NCT00550550|65786295|FG000|Overall Study|Randomized But Not Treated|1|||
23561779|NCT00550550|65786296|FG001|Overall Study|Randomized But Not Treated|0|||
23561780|NCT05044325|65786297|FG000|Part A:Treatment Period 1|Adverse Event|0|||
23561781|NCT05044325|65786298|FG001|Part A:Treatment Period 1|Adverse Event|0|||
23561782|NCT05044325|65786299|FG002|Part A:Treatment Period 1|Adverse Event|0|||
23561783|NCT05044325|65786300|FG003|Part A:Treatment Period 1|Adverse Event|0|||
23561784|NCT05044325|65786301|FG004|Part A:Treatment Period 1|Adverse Event|0|||
23561785|NCT05044325|65786302|FG005|Part A:Treatment Period 1|Adverse Event|1|||
23561786|NCT05044325|65786303|FG006|Part A:Treatment Period 1|Adverse Event|0|||
23561787|NCT05044325|65786304|FG007|Part A:Treatment Period 1|Adverse Event|1|||
23561788|NCT05044325|65786305|FG008|Part A:Treatment Period 1|Adverse Event|0|||
23561789|NCT05044325|65786306|FG009|Part A:Treatment Period 1|Adverse Event|0|||
23561790|NCT05044325|65786297|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23151039|NCT01765179|64305329|FG000|Overall Study|Ca elevated 10.6|1|||
23151040|NCT02545322|64305332|FG000|Overall Study|Withdrawal by Subject|3|||
23151041|NCT01749540|64305333|FG000|Overall Study|Protocol Violation|0|||
23151042|NCT01749540|64305334|FG001|Overall Study|Protocol Violation|0|||
23151043|NCT01749540|64305335|FG002|Overall Study|Protocol Violation|0|||
23151044|NCT01749540|64305336|FG003|Overall Study|Protocol Violation|0|||
23151045|NCT01749540|64305337|FG004|Overall Study|Protocol Violation|0|||
23151046|NCT01749540|64305338|FG005|Overall Study|Protocol Violation|1|||
23219976|NCT05166603|64550012|FG000|Overall Study|Withdrawal by Subject|68|||
23325045|NCT02892331|64933684|FG002|Overall Study|Lost to Follow-up|1|||
23325046|NCT02892331|64933682|FG000|Overall Study|Blood pressure was too elevated|0|||
23325047|NCT02892331|64933683|FG001|Overall Study|Blood pressure was too elevated|1|||
23325048|NCT02892331|64933684|FG002|Overall Study|Blood pressure was too elevated|0|||
23325049|NCT02892331|64933682|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
23325050|NCT02892331|64933683|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
23325051|NCT02892331|64933684|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
23325052|NCT01418378|64933688|FG000|Overall Study|Death|1|||
23325053|NCT01418378|64933689|FG001|Overall Study|Death|2|||
23219977|NCT05166603|64550013|FG001|Overall Study|Withdrawal by Subject|0|||
23219978|NCT04363944|64550014|FG000|Overall Study|Withdrawal by Subject|2|||
23219979|NCT04363944|64550015|FG001|Overall Study|Withdrawal by Subject|0|||
23325054|NCT01418378|64933688|FG000|Overall Study|Physician Decision|0|||
23325055|NCT01418378|64933689|FG001|Overall Study|Physician Decision|1|||
23325056|NCT01418378|64933688|FG000|Overall Study|ligament imbalance|0|||
23325057|NCT01418378|64933689|FG001|Overall Study|ligament imbalance|1|||
23325058|NCT01418378|64933688|FG000|Overall Study|developed chronic myopathy|0|||
23325059|NCT01418378|64933689|FG001|Overall Study|developed chronic myopathy|1|||
23325060|NCT00882518|64933690|FG000|Overall Study|Adverse Event|9|||
23325061|NCT00882518|64933691|FG001|Overall Study|Adverse Event|18|||
23219980|NCT03892707|64550016|FG000|Overall Study|Screen failure|6|||
23219981|NCT03892707|64550017|FG001|Overall Study|Screen failure|0|||
23219982|NCT03892707|64550016|FG000|Overall Study|Pain resolution|0|||
23219983|NCT03892707|64550017|FG001|Overall Study|Pain resolution|4|||
23561791|NCT05044325|65786298|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23561792|NCT05044325|65786299|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23561793|NCT05044325|65786300|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
23561794|NCT05044325|65786301|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
23561795|NCT05044325|65786302|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
23561796|NCT05044325|65786303|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23561797|NCT05044325|65786304|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23625314|NCT02057575|66015461|FG002|Overall Study|Protocol Violation|0|||
23625315|NCT02057575|66015462|FG003|Overall Study|Protocol Violation|0|||
23151047|NCT01749540|64305339|FG006|Overall Study|Protocol Violation|1|||
23151048|NCT01749540|64305333|FG000|Overall Study|Withdrawal by Subject|0|||
23219984|NCT03892707|64550016|FG000|Overall Study|Withdrawal by Subject|0|||
23219985|NCT03892707|64550017|FG001|Overall Study|Withdrawal by Subject|1|||
23219986|NCT03892707|64550016|FG000|Overall Study|Other (long business trip)|0|||
23219987|NCT03892707|64550017|FG001|Overall Study|Other (long business trip)|1|||
23219988|NCT03796195|64550018|FG000|Overall Study|Study closed early|1|||
23219989|NCT00150345|64550019|FG000|Overall Study|Death|5|||
23219990|NCT00150345|64550020|FG001|Overall Study|Death|2|||
23219991|NCT00150345|64550019|FG000|Overall Study|Adverse Event|8|||
23219992|NCT00150345|64550020|FG001|Overall Study|Adverse Event|6|||
23219993|NCT00150345|64550019|FG000|Overall Study|Lack of Efficacy|5|||
23219994|NCT00150345|64550020|FG001|Overall Study|Lack of Efficacy|4|||
23219995|NCT00150345|64550019|FG000|Overall Study|Withdrawal by Subject|3|||
23219996|NCT00150345|64550020|FG001|Overall Study|Withdrawal by Subject|4|||
23325062|NCT00882518|64933690|FG000|Overall Study|Withdrawal by Subject|9|||
23325063|NCT00882518|64933691|FG001|Overall Study|Withdrawal by Subject|13|||
23325064|NCT00882518|64933690|FG000|Overall Study|Lack of Efficacy|12|||
23219997|NCT00150345|64550019|FG000|Overall Study|Laboratory abnormality|1|||
23219998|NCT00150345|64550020|FG001|Overall Study|Laboratory abnormality|2|||
23325065|NCT00882518|64933691|FG001|Overall Study|Lack of Efficacy|9|||
23325066|NCT00882518|64933690|FG000|Overall Study|Severe non-compliance to protocol|3|||
23325067|NCT00882518|64933691|FG001|Overall Study|Severe non-compliance to protocol|1|||
23561798|NCT05044325|65786305|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23561799|NCT05044325|65786306|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
23151049|NCT01749540|64305334|FG001|Overall Study|Withdrawal by Subject|0|||
23219999|NCT00150345|64550019|FG000|Overall Study|Other|12|||
23220000|NCT00150345|64550020|FG001|Overall Study|Other|14|||
23220001|NCT02786836|64550023|FG000|Overall Study|Death|1|||
23220002|NCT02786836|64550023|FG000|Overall Study|Lack of Efficacy|2|||
23220003|NCT02786836|64550023|FG000|Overall Study|Protocol Violation|3|||
23325068|NCT00882518|64933690|FG000|Overall Study|Incorrect enrolment|4|||
23439250|NCT01393639|65352375|FG001|Overall Study|Protocol Violation|0|||
23439251|NCT01393639|65352376|FG002|Overall Study|Protocol Violation|0|||
23439252|NCT01393639|65352377|FG003|Overall Study|Protocol Violation|1|||
23439253|NCT01393639|65352378|FG004|Overall Study|Protocol Violation|0|||
23439254|NCT01393639|65352379|FG005|Overall Study|Protocol Violation|0|||
23439255|NCT01393639|65352380|FG006|Overall Study|Protocol Violation|0|||
23439256|NCT01393639|65352374|FG000|Overall Study|Other|0|||
23439257|NCT01393639|65352375|FG001|Overall Study|Other|2|||
23439258|NCT01393639|65352376|FG002|Overall Study|Other|0|||
23439259|NCT01393639|65352377|FG003|Overall Study|Other|2|||
23439260|NCT01393639|65352378|FG004|Overall Study|Other|1|||
23439261|NCT01393639|65352379|FG005|Overall Study|Other|0|||
23439262|NCT01393639|65352380|FG006|Overall Study|Other|1|||
23439263|NCT01393639|65352374|FG000|Overall Study|Withdrawal by Subject|1|||
23439264|NCT01393639|65352375|FG001|Overall Study|Withdrawal by Subject|1|||
23439265|NCT01393639|65352376|FG002|Overall Study|Withdrawal by Subject|0|||
23439266|NCT01393639|65352377|FG003|Overall Study|Withdrawal by Subject|0|||
23439267|NCT01393639|65352378|FG004|Overall Study|Withdrawal by Subject|0|||
23439268|NCT01393639|65352379|FG005|Overall Study|Withdrawal by Subject|0|||
23439269|NCT01393639|65352380|FG006|Overall Study|Withdrawal by Subject|1|||
23439270|NCT01393639|65352374|FG000|Overall Study|Medication error without associated AE|0|||
23439271|NCT01393639|65352375|FG001|Overall Study|Medication error without associated AE|0|||
23439272|NCT01393639|65352376|FG002|Overall Study|Medication error without associated AE|0|||
23439273|NCT01393639|65352377|FG003|Overall Study|Medication error without associated AE|0|||
23439274|NCT01393639|65352378|FG004|Overall Study|Medication error without associated AE|0|||
23439275|NCT01393639|65352379|FG005|Overall Study|Medication error without associated AE|0|||
23439276|NCT01393639|65352380|FG006|Overall Study|Medication error without associated AE|1|||
23439277|NCT01393639|65352374|FG000|Overall Study|Lost to Follow-up|0|||
23439278|NCT01393639|65352375|FG001|Overall Study|Lost to Follow-up|1|||
23439279|NCT01393639|65352376|FG002|Overall Study|Lost to Follow-up|0|||
23439280|NCT01393639|65352377|FG003|Overall Study|Lost to Follow-up|0|||
23439281|NCT01393639|65352378|FG004|Overall Study|Lost to Follow-up|0|||
23439282|NCT01393639|65352379|FG005|Overall Study|Lost to Follow-up|0|||
23439283|NCT01393639|65352380|FG006|Overall Study|Lost to Follow-up|1|||
23439284|NCT01393639|65352374|FG000|Overall Study|Lack of Efficacy|0|||
23439285|NCT01393639|65352375|FG001|Overall Study|Lack of Efficacy|0|||
23439286|NCT01393639|65352376|FG002|Overall Study|Lack of Efficacy|0|||
23439287|NCT01393639|65352377|FG003|Overall Study|Lack of Efficacy|0|||
23439288|NCT01393639|65352378|FG004|Overall Study|Lack of Efficacy|0|||
23439289|NCT01393639|65352379|FG005|Overall Study|Lack of Efficacy|0|||
23439290|NCT01393639|65352380|FG006|Overall Study|Lack of Efficacy|1|||
23439291|NCT01393639|65352374|FG000|Overall Study|Adverse Event|2|||
23439292|NCT01393639|65352375|FG001|Overall Study|Adverse Event|3|||
23439293|NCT01393639|65352376|FG002|Overall Study|Adverse Event|1|||
23439294|NCT01393639|65352377|FG003|Overall Study|Adverse Event|2|||
23439295|NCT01393639|65352378|FG004|Overall Study|Adverse Event|0|||
23439296|NCT01393639|65352379|FG005|Overall Study|Adverse Event|2|||
23439297|NCT01393639|65352380|FG006|Overall Study|Adverse Event|3|||
23439298|NCT03647267|65352392|FG000|Overall Study|Lost to Follow-up|1|||
23439299|NCT03647267|65352393|FG001|Overall Study|Lost to Follow-up|0|||
23561800|NCT05044325|65786297|FG000|Part A:Treatment Period 1|Physician Decision|0|||
23561801|NCT05044325|65786298|FG001|Part A:Treatment Period 1|Physician Decision|0|||
23561802|NCT05044325|65786299|FG002|Part A:Treatment Period 1|Physician Decision|0|||
23561803|NCT05044325|65786300|FG003|Part A:Treatment Period 1|Physician Decision|0|||
23561804|NCT05044325|65786301|FG004|Part A:Treatment Period 1|Physician Decision|0|||
23561805|NCT05044325|65786302|FG005|Part A:Treatment Period 1|Physician Decision|0|||
23561806|NCT05044325|65786303|FG006|Part A:Treatment Period 1|Physician Decision|1|||
23561807|NCT05044325|65786304|FG007|Part A:Treatment Period 1|Physician Decision|0|||
23561808|NCT05044325|65786305|FG008|Part A:Treatment Period 1|Physician Decision|0|||
23561809|NCT05044325|65786306|FG009|Part A:Treatment Period 1|Physician Decision|0|||
23151050|NCT01749540|64305335|FG002|Overall Study|Withdrawal by Subject|0|||
23151051|NCT01749540|64305336|FG003|Overall Study|Withdrawal by Subject|1|||
23151052|NCT01749540|64305337|FG004|Overall Study|Withdrawal by Subject|0|||
23561810|NCT05044325|65786297|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561811|NCT05044325|65786298|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561812|NCT05044325|65786299|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
23439300|NCT03052049|65352395|FG000|Overall Study|Withdrawal by Subject|2|||
23439301|NCT01278797|65352396|FG000|Period 1|Adverse Event|0|||
23439302|NCT01278797|65352397|FG001|Period 1|Adverse Event|1|||
23439303|NCT01278797|65352396|FG000|Period 1|Protocol Violation|1|||
23439304|NCT01278797|65352397|FG001|Period 1|Protocol Violation|0|||
23439305|NCT02218008|65352398|FG000|Stage 1 (S1)|Adverse Event|6|||
23439306|NCT02218008|65352399|FG001|Stage 1 (S1)|Adverse Event|5|||
23439307|NCT02218008|65352400|FG002|Stage 1 (S1)|Adverse Event|11|||
23439308|NCT02218008|65352401|FG003|Stage 1 (S1)|Adverse Event|0|||
23439309|NCT02218008|65352402|FG004|Stage 1 (S1)|Adverse Event|0|||
23439310|NCT02218008|65352403|FG005|Stage 1 (S1)|Adverse Event|0|||
23439311|NCT02218008|65352398|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
23439312|NCT02218008|65352399|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
23439313|NCT02218008|65352400|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
23439314|NCT02218008|65352401|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
23439315|NCT02218008|65352402|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
23439316|NCT02218008|65352403|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
23439317|NCT02218008|65352398|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
23439318|NCT02218008|65352399|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
23439319|NCT02218008|65352400|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
23439320|NCT02218008|65352401|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
23439321|NCT02218008|65352402|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
23439322|NCT02218008|65352403|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
23439323|NCT02218008|65352398|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
23439324|NCT02218008|65352399|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
23439325|NCT02218008|65352400|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
23439326|NCT02218008|65352401|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
23439327|NCT02218008|65352402|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
23439328|NCT02218008|65352403|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
23439329|NCT02218008|65352398|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
23439330|NCT02218008|65352399|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
23439331|NCT02218008|65352400|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
23439332|NCT02218008|65352401|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
23439333|NCT02218008|65352402|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
23439334|NCT02218008|65352403|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
23439335|NCT02218008|65352398|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
23439336|NCT02218008|65352399|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
23439337|NCT02218008|65352400|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
23439338|NCT02218008|65352401|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
23439339|NCT02218008|65352402|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
23439340|NCT02218008|65352403|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
23439341|NCT02218008|65352398|FG000|Stage 1 (S1)|Pregnancy|0|||
23439342|NCT02218008|65352399|FG001|Stage 1 (S1)|Pregnancy|0|||
23439343|NCT02218008|65352400|FG002|Stage 1 (S1)|Pregnancy|1|||
23439344|NCT02218008|65352401|FG003|Stage 1 (S1)|Pregnancy|0|||
23439345|NCT02218008|65352402|FG004|Stage 1 (S1)|Pregnancy|0|||
23439346|NCT02218008|65352403|FG005|Stage 1 (S1)|Pregnancy|0|||
23439347|NCT02218008|65352398|FG000|Stage 1 (S1)|Protocol Violation|0|||
23439348|NCT02218008|65352399|FG001|Stage 1 (S1)|Protocol Violation|0|||
23439349|NCT02218008|65352400|FG002|Stage 1 (S1)|Protocol Violation|1|||
23439350|NCT02218008|65352401|FG003|Stage 1 (S1)|Protocol Violation|0|||
23439351|NCT02218008|65352402|FG004|Stage 1 (S1)|Protocol Violation|0|||
23439352|NCT02218008|65352403|FG005|Stage 1 (S1)|Protocol Violation|0|||
23561813|NCT05044325|65786300|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561814|NCT05044325|65786301|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561815|NCT05044325|65786302|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561816|NCT05044325|65786303|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561817|NCT05044325|65786304|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561818|NCT05044325|65786305|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561819|NCT05044325|65786306|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
23561820|NCT05044325|65786297|FG000|Part A:Treatment Period 2|Adverse Event|0|||
23561821|NCT05044325|65786298|FG001|Part A:Treatment Period 2|Adverse Event|1|||
23561822|NCT05044325|65786299|FG002|Part A:Treatment Period 2|Adverse Event|0|||
23561823|NCT05044325|65786300|FG003|Part A:Treatment Period 2|Adverse Event|0|||
23561824|NCT05044325|65786301|FG004|Part A:Treatment Period 2|Adverse Event|1|||
23561825|NCT05044325|65786302|FG005|Part A:Treatment Period 2|Adverse Event|1|||
23561826|NCT05044325|65786303|FG006|Part A:Treatment Period 2|Adverse Event|0|||
23561827|NCT05044325|65786304|FG007|Part A:Treatment Period 2|Adverse Event|0|||
23561828|NCT05044325|65786305|FG008|Part A:Treatment Period 2|Adverse Event|0|||
23561829|NCT05044325|65786306|FG009|Part A:Treatment Period 2|Adverse Event|0|||
23561830|NCT05044325|65786297|FG000|Part A:Treatment Period 2|Physician Decision|0|||
23561831|NCT05044325|65786298|FG001|Part A:Treatment Period 2|Physician Decision|0|||
23561832|NCT05044325|65786299|FG002|Part A:Treatment Period 2|Physician Decision|0|||
23439353|NCT02218008|65352398|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
23561833|NCT05044325|65786300|FG003|Part A:Treatment Period 2|Physician Decision|0|||
23561834|NCT05044325|65786301|FG004|Part A:Treatment Period 2|Physician Decision|0|||
23561835|NCT05044325|65786302|FG005|Part A:Treatment Period 2|Physician Decision|1|||
23561836|NCT05044325|65786303|FG006|Part A:Treatment Period 2|Physician Decision|0|||
23439354|NCT02218008|65352399|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439355|NCT02218008|65352400|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439356|NCT02218008|65352401|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439357|NCT02218008|65352402|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439358|NCT02218008|65352403|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
23439359|NCT02218008|65352398|FG000|Stage 2 (S2)|Adverse Event|0|||
23439360|NCT02218008|65352399|FG001|Stage 2 (S2)|Adverse Event|0|||
23439361|NCT02218008|65352400|FG002|Stage 2 (S2)|Adverse Event|0|||
23439362|NCT02218008|65352401|FG003|Stage 2 (S2)|Adverse Event|2|||
23439363|NCT02218008|65352402|FG004|Stage 2 (S2)|Adverse Event|3|||
23439364|NCT02218008|65352403|FG005|Stage 2 (S2)|Adverse Event|3|||
23439365|NCT02218008|65352398|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
23439366|NCT02218008|65352399|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
23439367|NCT02218008|65352400|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
23220004|NCT02786836|64550023|FG000|Overall Study|Withdrawal by Subject|3|||
23220005|NCT02786836|64550023|FG000|Overall Study|Liver Transplantation|2|||
23439368|NCT02218008|65352401|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
23439369|NCT02218008|65352402|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
23439370|NCT02218008|65352403|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
23439371|NCT02218008|65352398|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
23439372|NCT02218008|65352399|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
23439373|NCT02218008|65352400|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
23220006|NCT02786836|64550023|FG000|Overall Study|Device or Pharmacy Issues|3|||
23220007|NCT01094808|64550024|FG000|Overall Study|Withdrawal by Subject|1|||
23220008|NCT01094808|64550025|FG001|Overall Study|Withdrawal by Subject|1|||
23220009|NCT01094808|64550026|FG002|Overall Study|Withdrawal by Subject|0|||
23220010|NCT03991936|64550031|FG000|Overall Study|Lost to Follow-up|1|||
23220011|NCT03991936|64550032|FG001|Overall Study|Lost to Follow-up|1|||
23220012|NCT03991936|64550033|FG002|Overall Study|Lost to Follow-up|1|||
23220013|NCT03991936|64550034|FG003|Overall Study|Lost to Follow-up|1|||
23439374|NCT02218008|65352401|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
23439375|NCT02218008|65352402|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
23439376|NCT02218008|65352403|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
23439377|NCT02218008|65352398|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23561837|NCT05044325|65786304|FG007|Part A:Treatment Period 2|Physician Decision|0|||
23561838|NCT05044325|65786305|FG008|Part A:Treatment Period 2|Physician Decision|0|||
23561839|NCT05044325|65786306|FG009|Part A:Treatment Period 2|Physician Decision|0|||
23561840|NCT05044325|65786297|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561841|NCT05044325|65786298|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561842|NCT05044325|65786299|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23439378|NCT02218008|65352399|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23439379|NCT02218008|65352400|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23439380|NCT02218008|65352401|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
23439381|NCT02218008|65352402|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23439382|NCT02218008|65352403|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
23439383|NCT02218008|65352398|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
23439384|NCT02218008|65352399|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
23439385|NCT02218008|65352400|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
23439386|NCT02218008|65352401|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
23439387|NCT02218008|65352402|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
23439388|NCT02218008|65352403|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
23439389|NCT01108523|65352404|FG000|Overall Study|Protocol Violation|4|||
23439390|NCT01463306|65352413|FG000|Overall Study|Adverse Event|6|||
23439391|NCT01463306|65352414|FG001|Overall Study|Adverse Event|9|||
23439392|NCT01463306|65352415|FG002|Overall Study|Adverse Event|3|||
23439393|NCT01463306|65352413|FG000|Overall Study|Death|3|||
23439394|NCT01463306|65352414|FG001|Overall Study|Death|3|||
23439395|NCT01463306|65352415|FG002|Overall Study|Death|0|||
23439396|NCT01463306|65352413|FG000|Overall Study|Lack of Efficacy|22|||
23439397|NCT01463306|65352414|FG001|Overall Study|Lack of Efficacy|16|||
23439398|NCT01463306|65352415|FG002|Overall Study|Lack of Efficacy|1|||
23439399|NCT01463306|65352413|FG000|Overall Study|Lost to Follow-up|5|||
23439400|NCT01463306|65352414|FG001|Overall Study|Lost to Follow-up|2|||
23439401|NCT01463306|65352415|FG002|Overall Study|Lost to Follow-up|0|||
23439402|NCT01463306|65352413|FG000|Overall Study|Protocol Violation|4|||
23439403|NCT01463306|65352414|FG001|Overall Study|Protocol Violation|0|||
23439404|NCT01463306|65352415|FG002|Overall Study|Protocol Violation|0|||
23439405|NCT01463306|65352413|FG000|Overall Study|Withdrawal by Subject|19|||
23439406|NCT01463306|65352414|FG001|Overall Study|Withdrawal by Subject|9|||
23439407|NCT01463306|65352415|FG002|Overall Study|Withdrawal by Subject|1|||
23439408|NCT01463306|65352413|FG000|Overall Study|Other|26|||
23439409|NCT01463306|65352414|FG001|Overall Study|Other|13|||
23561843|NCT05044325|65786300|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
23561844|NCT05044325|65786301|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
23220014|NCT03991936|64550035|FG004|Overall Study|Lost to Follow-up|1|||
23439410|NCT01463306|65352415|FG002|Overall Study|Other|0|||
23220015|NCT01804842|64550038|FG000|Overall Study|Adverse Event|1|||
23325069|NCT00882518|64933691|FG001|Overall Study|Incorrect enrolment|2|||
23439411|NCT01463306|65352413|FG000|Overall Study|Approval expiry at site|1|||
23325070|NCT00882518|64933690|FG000|Overall Study|Central lab closure for National day|1|||
23439412|NCT01463306|65352414|FG001|Overall Study|Approval expiry at site|0|||
23439413|NCT01463306|65352415|FG002|Overall Study|Approval expiry at site|0|||
23439414|NCT03182907|65352416|FG000|Overall Study|Death|3|||
23439415|NCT03182907|65352417|FG001|Overall Study|Death|0|||
23439416|NCT03182907|65352416|FG000|Overall Study|Protocol Violation|4|||
23220016|NCT01804842|64550039|FG001|Overall Study|Adverse Event|1|||
23439417|NCT03182907|65352417|FG001|Overall Study|Protocol Violation|0|||
23439418|NCT03182907|65352416|FG000|Overall Study|Lost to Follow-up|1|||
23439419|NCT03182907|65352417|FG001|Overall Study|Lost to Follow-up|0|||
23439420|NCT03182907|65352416|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23439421|NCT03182907|65352417|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23439422|NCT00235716|65352424|FG000|Overall Study|Death|26|||
23439423|NCT00235716|65352425|FG001|Overall Study|Death|39|||
23439424|NCT00235716|65352426|FG002|Overall Study|Death|32|||
23439425|NCT00235716|65352427|FG003|Overall Study|Death|31|||
23439426|NCT00235716|65352424|FG000|Overall Study|Withdrawal by Subject|23|||
23439427|NCT00235716|65352425|FG001|Overall Study|Withdrawal by Subject|19|||
23439428|NCT00235716|65352426|FG002|Overall Study|Withdrawal by Subject|17|||
23439429|NCT00235716|65352427|FG003|Overall Study|Withdrawal by Subject|18|||
23439430|NCT00235716|65352424|FG000|Overall Study|Lost to Follow-up|12|||
23439431|NCT00235716|65352425|FG001|Overall Study|Lost to Follow-up|7|||
23439432|NCT00235716|65352426|FG002|Overall Study|Lost to Follow-up|14|||
23439433|NCT00235716|65352427|FG003|Overall Study|Lost to Follow-up|10|||
23439434|NCT00235716|65352424|FG000|Overall Study|Adverse Event|1|||
23439435|NCT00235716|65352425|FG001|Overall Study|Adverse Event|1|||
23439436|NCT00235716|65352426|FG002|Overall Study|Adverse Event|1|||
23439437|NCT00235716|65352427|FG003|Overall Study|Adverse Event|0|||
23439438|NCT00235716|65352424|FG000|Overall Study|Physician Decision|0|||
23439439|NCT00235716|65352425|FG001|Overall Study|Physician Decision|1|||
23439440|NCT00235716|65352426|FG002|Overall Study|Physician Decision|1|||
23439441|NCT00235716|65352427|FG003|Overall Study|Physician Decision|3|||
23439442|NCT02413489|65352428|FG000|Overall Study|Death|11|||
23439443|NCT02413489|65352429|FG001|Overall Study|Death|3|||
23439444|NCT02413489|65352430|FG002|Overall Study|Death|4|||
23561845|NCT05044325|65786302|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561846|NCT05044325|65786303|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561847|NCT05044325|65786304|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561848|NCT05044325|65786305|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561849|NCT05044325|65786306|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
23561850|NCT00085202|65786307|FG000|Overall Study|Still on therapy|2|||
23561851|NCT00085202|65786308|FG001|Overall Study|Still on therapy|0|||
23561852|NCT00085202|65786307|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
23561853|NCT00085202|65786308|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
23561854|NCT00085202|65786307|FG000|Overall Study|Excessive toxicity|6|||
23561855|NCT00085202|65786308|FG001|Overall Study|Excessive toxicity|5|||
23561856|NCT00085202|65786307|FG000|Overall Study|Non-specified|3|||
23561857|NCT00085202|65786308|FG001|Overall Study|Non-specified|5|||
23561858|NCT00085202|65786307|FG000|Overall Study|Withdrawal by Subject|2|||
23561859|NCT00085202|65786308|FG001|Overall Study|Withdrawal by Subject|1|||
23561860|NCT00085202|65786307|FG000|Overall Study|Physician Decision|4|||
23561861|NCT00085202|65786308|FG001|Overall Study|Physician Decision|1|||
23561862|NCT00085202|65786307|FG000|Overall Study|Progressive disease|1|||
23561863|NCT00085202|65786308|FG001|Overall Study|Progressive disease|11|||
23561864|NCT03183388|65786316|FG000|Overall Study|Lost to Follow-up|3|||
23561865|NCT03183388|65786317|FG001|Overall Study|Lost to Follow-up|5|||
23561866|NCT03183388|65786316|FG000|Overall Study|Physician Decision|1|||
23561867|NCT03183388|65786317|FG001|Overall Study|Physician Decision|4|||
23561868|NCT03183388|65786316|FG000|Overall Study|Withdrawal by Subject|4|||
23561869|NCT03183388|65786317|FG001|Overall Study|Withdrawal by Subject|1|||
23561870|NCT03183388|65786316|FG000|Overall Study|Moved|1|||
23561871|NCT03183388|65786317|FG001|Overall Study|Moved|0|||
23561872|NCT03183388|65786316|FG000|Overall Study|Met Exclusion Criteria|2|||
23561873|NCT03183388|65786317|FG001|Overall Study|Met Exclusion Criteria|2|||
23561874|NCT03183388|65786316|FG000|Overall Study|COVID Pandemic Related|2|||
23561875|NCT03183388|65786317|FG001|Overall Study|COVID Pandemic Related|4|||
23561876|NCT03299686|65786318|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
23561877|NCT03299686|65786319|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
23561878|NCT03299686|65786318|FG000|Treatment Epoch|Physician Decision|1|||
23561879|NCT03299686|65786319|FG001|Treatment Epoch|Physician Decision|0|||
23561880|NCT03299686|65786318|FG000|Treatment Epoch|Adverse Event|8|||
23561881|NCT03299686|65786319|FG001|Treatment Epoch|Adverse Event|4|||
23325071|NCT00882518|64933691|FG001|Overall Study|Central lab closure for National day|0|||
23561882|NCT03299686|65786318|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
23561883|NCT03299686|65786319|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
23561884|NCT03138733|65786326|FG000|Overall Study|Death|17|||
23561885|NCT03138733|65786327|FG001|Overall Study|Death|18|||
23439445|NCT02413489|65352428|FG000|Overall Study|Withdrawal by Subject|2|||
23439446|NCT02413489|65352429|FG001|Overall Study|Withdrawal by Subject|0|||
23439447|NCT02413489|65352430|FG002|Overall Study|Withdrawal by Subject|0|||
23439448|NCT02413489|65352428|FG000|Overall Study|Study Terminated By Sponsor|2|||
23561886|NCT03138733|65786326|FG000|Overall Study|Withdrawal by Subject|11|||
23561887|NCT03138733|65786327|FG001|Overall Study|Withdrawal by Subject|6|||
23561888|NCT03138733|65786326|FG000|Overall Study|Lost to Follow-up|3|||
23561889|NCT03138733|65786327|FG001|Overall Study|Lost to Follow-up|2|||
23561890|NCT03138733|65786326|FG000|Overall Study|Adverse Event|1|||
23561891|NCT03138733|65786327|FG001|Overall Study|Adverse Event|0|||
23561892|NCT03138733|65786326|FG000|Overall Study|Protocol Violation|1|||
23561893|NCT03138733|65786327|FG001|Overall Study|Protocol Violation|3|||
23561894|NCT03138733|65786326|FG000|Overall Study|Administrative or logistical reason|1|||
23561895|NCT03138733|65786327|FG001|Overall Study|Administrative or logistical reason|0|||
23561896|NCT03138733|65786326|FG000|Overall Study|The patient was transferred to another hospital|1|||
23561897|NCT03138733|65786327|FG001|Overall Study|The patient was transferred to another hospital|0|||
23561898|NCT02287584|65786328|FG000|the Double-blind Phase|Adverse Event|17|||
23561899|NCT02287584|65786329|FG001|the Double-blind Phase|Adverse Event|17|||
23561900|NCT02287584|65786330|FG002|the Double-blind Phase|Adverse Event|12|||
23561901|NCT02287584|65786331|FG003|the Double-blind Phase|Adverse Event|0|||
23561902|NCT02287584|65786332|FG004|the Double-blind Phase|Adverse Event|0|||
23561903|NCT02287584|65786333|FG005|the Double-blind Phase|Adverse Event|0|||
23561904|NCT02287584|65786328|FG000|the Double-blind Phase|Lack of Efficacy|18|||
23561905|NCT02287584|65786329|FG001|the Double-blind Phase|Lack of Efficacy|8|||
23561906|NCT02287584|65786330|FG002|the Double-blind Phase|Lack of Efficacy|8|||
23561907|NCT02287584|65786331|FG003|the Double-blind Phase|Lack of Efficacy|0|||
23561908|NCT02287584|65786332|FG004|the Double-blind Phase|Lack of Efficacy|0|||
23561909|NCT02287584|65786333|FG005|the Double-blind Phase|Lack of Efficacy|0|||
23561910|NCT02287584|65786328|FG000|the Double-blind Phase|Lost to Follow-up|0|||
23561911|NCT02287584|65786329|FG001|the Double-blind Phase|Lost to Follow-up|1|||
23561912|NCT02287584|65786330|FG002|the Double-blind Phase|Lost to Follow-up|1|||
23561913|NCT02287584|65786331|FG003|the Double-blind Phase|Lost to Follow-up|0|||
23439449|NCT02413489|65352429|FG001|Overall Study|Study Terminated By Sponsor|13|||
23439450|NCT02413489|65352430|FG002|Overall Study|Study Terminated By Sponsor|1|||
23439451|NCT00483938|65352431|FG000|Overall Study|Protocol Violation|0|||
23439452|NCT00483938|65352432|FG001|Overall Study|Protocol Violation|0|||
23561914|NCT02287584|65786332|FG004|the Double-blind Phase|Lost to Follow-up|0|||
23561915|NCT02287584|65786333|FG005|the Double-blind Phase|Lost to Follow-up|0|||
23561916|NCT02287584|65786328|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
23561917|NCT02287584|65786329|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
23561918|NCT02287584|65786330|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
23561919|NCT02287584|65786331|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
23561920|NCT02287584|65786332|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
23561921|NCT02287584|65786333|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
23561922|NCT02287584|65786328|FG000|the Double-blind Phase|Pregnancy|0|||
23561923|NCT02287584|65786329|FG001|the Double-blind Phase|Pregnancy|1|||
23561924|NCT02287584|65786330|FG002|the Double-blind Phase|Pregnancy|0|||
23561925|NCT02287584|65786331|FG003|the Double-blind Phase|Pregnancy|0|||
23561926|NCT02287584|65786332|FG004|the Double-blind Phase|Pregnancy|0|||
23561927|NCT02287584|65786333|FG005|the Double-blind Phase|Pregnancy|0|||
23561928|NCT02287584|65786328|FG000|the Double-blind Phase|Protocol Violation|0|||
23561929|NCT02287584|65786329|FG001|the Double-blind Phase|Protocol Violation|3|||
23561930|NCT02287584|65786330|FG002|the Double-blind Phase|Protocol Violation|0|||
23561931|NCT02287584|65786331|FG003|the Double-blind Phase|Protocol Violation|0|||
23561932|NCT02287584|65786332|FG004|the Double-blind Phase|Protocol Violation|0|||
23561933|NCT02287584|65786333|FG005|the Double-blind Phase|Protocol Violation|0|||
23561934|NCT02287584|65786328|FG000|the Double-blind Phase|other reasons|0|||
23561935|NCT02287584|65786329|FG001|the Double-blind Phase|other reasons|0|||
23561936|NCT02287584|65786330|FG002|the Double-blind Phase|other reasons|1|||
23561937|NCT02287584|65786331|FG003|the Double-blind Phase|other reasons|0|||
23561938|NCT02287584|65786332|FG004|the Double-blind Phase|other reasons|0|||
23561939|NCT02287584|65786333|FG005|the Double-blind Phase|other reasons|0|||
23561940|NCT02287584|65786328|FG000|the Open-label Phase|Did not receive drug|0|||
23561941|NCT02287584|65786329|FG001|the Open-label Phase|Did not receive drug|0|||
23151053|NCT01749540|64305338|FG005|Overall Study|Withdrawal by Subject|0|||
23325072|NCT00882518|64933690|FG000|Overall Study|Allocating random number by mistake|0|||
23325073|NCT00882518|64933691|FG001|Overall Study|Allocating random number by mistake|1|||
23439453|NCT00483938|65352433|FG002|Overall Study|Protocol Violation|0|||
23561942|NCT02287584|65786330|FG002|the Open-label Phase|Did not receive drug|0|||
23561943|NCT02287584|65786331|FG003|the Open-label Phase|Did not receive drug|7|||
23561944|NCT02287584|65786332|FG004|the Open-label Phase|Did not receive drug|6|||
23561945|NCT02287584|65786333|FG005|the Open-label Phase|Did not receive drug|4|||
23561946|NCT02287584|65786328|FG000|the Open-label Phase|Adverse Event|0|||
23561947|NCT02287584|65786329|FG001|the Open-label Phase|Adverse Event|0|||
23439454|NCT00483938|65352434|FG003|Overall Study|Protocol Violation|0|||
23561948|NCT02287584|65786330|FG002|the Open-label Phase|Adverse Event|0|||
23561949|NCT02287584|65786331|FG003|the Open-label Phase|Adverse Event|15|||
23561950|NCT02287584|65786332|FG004|the Open-label Phase|Adverse Event|12|||
23561951|NCT02287584|65786333|FG005|the Open-label Phase|Adverse Event|16|||
23561952|NCT02287584|65786328|FG000|the Open-label Phase|Lack of Efficacy|0|||
23561953|NCT02287584|65786329|FG001|the Open-label Phase|Lack of Efficacy|0|||
23561954|NCT02287584|65786330|FG002|the Open-label Phase|Lack of Efficacy|0|||
23561955|NCT02287584|65786331|FG003|the Open-label Phase|Lack of Efficacy|8|||
23561956|NCT02287584|65786332|FG004|the Open-label Phase|Lack of Efficacy|3|||
23561957|NCT02287584|65786333|FG005|the Open-label Phase|Lack of Efficacy|7|||
23561958|NCT02287584|65786328|FG000|the Open-label Phase|Lost to Follow-up|0|||
23561959|NCT02287584|65786329|FG001|the Open-label Phase|Lost to Follow-up|0|||
23561960|NCT02287584|65786330|FG002|the Open-label Phase|Lost to Follow-up|0|||
23561961|NCT02287584|65786331|FG003|the Open-label Phase|Lost to Follow-up|4|||
23561962|NCT02287584|65786332|FG004|the Open-label Phase|Lost to Follow-up|1|||
23561963|NCT02287584|65786333|FG005|the Open-label Phase|Lost to Follow-up|2|||
23561964|NCT02287584|65786328|FG000|the Open-label Phase|Withdrawal by Subject|0|||
23561965|NCT02287584|65786329|FG001|the Open-label Phase|Withdrawal by Subject|0|||
23561966|NCT02287584|65786330|FG002|the Open-label Phase|Withdrawal by Subject|0|||
23561967|NCT02287584|65786331|FG003|the Open-label Phase|Withdrawal by Subject|18|||
23561968|NCT02287584|65786332|FG004|the Open-label Phase|Withdrawal by Subject|29|||
23561969|NCT02287584|65786333|FG005|the Open-label Phase|Withdrawal by Subject|21|||
23561970|NCT02287584|65786328|FG000|the Open-label Phase|non-compliance|0|||
23561971|NCT02287584|65786329|FG001|the Open-label Phase|non-compliance|0|||
23561972|NCT02287584|65786330|FG002|the Open-label Phase|non-compliance|0|||
23561973|NCT02287584|65786331|FG003|the Open-label Phase|non-compliance|2|||
23561974|NCT02287584|65786332|FG004|the Open-label Phase|non-compliance|5|||
23561975|NCT02287584|65786333|FG005|the Open-label Phase|non-compliance|1|||
23561976|NCT02287584|65786328|FG000|the Open-label Phase|other reasons|0|||
23561977|NCT02287584|65786329|FG001|the Open-label Phase|other reasons|0|||
23561978|NCT02287584|65786330|FG002|the Open-label Phase|other reasons|0|||
23561979|NCT02287584|65786331|FG003|the Open-label Phase|other reasons|3|||
23561980|NCT02287584|65786332|FG004|the Open-label Phase|other reasons|6|||
23561981|NCT02287584|65786333|FG005|the Open-label Phase|other reasons|6|||
23561982|NCT01436201|65786339|FG000|Overall Study|Adverse Event|2|||
23561983|NCT01436201|65786339|FG000|Overall Study|Withdrawal by Subject|1|||
23561984|NCT01436201|65786339|FG000|Overall Study|Protocol Violation|1|||
23325074|NCT03591874|64933692|FG000|Overall Study|Adverse Event|4|||
23325075|NCT03591874|64933693|FG001|Overall Study|Adverse Event|0|||
23325076|NCT03591874|64933692|FG000|Overall Study|Withdrawal by Subject|2|||
23325077|NCT03591874|64933693|FG001|Overall Study|Withdrawal by Subject|1|||
23325078|NCT03591874|64933692|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
23439455|NCT00483938|65352435|FG004|Overall Study|Protocol Violation|0|||
23439456|NCT00483938|65352436|FG005|Overall Study|Protocol Violation|0|||
23561985|NCT00117156|65786343|FG000|Overall Study|Adverse Event|9|||
23561986|NCT00117156|65786343|FG000|Overall Study|Physician Decision|1|||
23561987|NCT00117156|65786343|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
23561988|NCT02036645|65786347|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561989|NCT02036645|65786348|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561990|NCT02036645|65786349|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561991|NCT02036645|65786350|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561992|NCT02036645|65786351|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561993|NCT02036645|65786352|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561994|NCT02036645|65786353|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
23561995|NCT02036645|65786354|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561996|NCT02036645|65786355|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561997|NCT02036645|65786356|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561998|NCT02036645|65786357|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23561999|NCT02036645|65786358|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
23562000|NCT02036645|65786347|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562001|NCT02036645|65786348|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562002|NCT02036645|65786349|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562003|NCT02036645|65786350|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
23562004|NCT02036645|65786351|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562005|NCT02036645|65786352|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562006|NCT02036645|65786353|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562007|NCT02036645|65786354|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562008|NCT02036645|65786355|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562009|NCT02036645|65786356|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562010|NCT02036645|65786357|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562011|NCT02036645|65786358|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
23562012|NCT04525547|65786359|FG000|Overall Study|Not treated with Ofev|2|||
23562013|NCT04525547|65786359|FG000|Overall Study|Off-label use|2|||
23220017|NCT01804842|64550040|FG002|Overall Study|Adverse Event|0|||
23220018|NCT01804842|64550038|FG000|Overall Study|Lost to Follow-up|1|||
23562014|NCT04525547|65786359|FG000|Overall Study|Lost to Follow-up|1|||
23562015|NCT01641926|65786366|FG000|Overall Study|Adverse Event|5|||
23562016|NCT01641926|65786367|FG001|Overall Study|Adverse Event|2|||
23562017|NCT01641926|65786368|FG002|Overall Study|Adverse Event|3|||
23562018|NCT01641926|65786369|FG003|Overall Study|Adverse Event|1|||
23562019|NCT01641926|65786366|FG000|Overall Study|Lost to Follow-up|2|||
23439457|NCT00483938|65352437|FG006|Overall Study|Protocol Violation|3|||
23439458|NCT00483938|65352431|FG000|Overall Study|Withdrawal by Subject|1|||
23439459|NCT00483938|65352432|FG001|Overall Study|Withdrawal by Subject|6|||
23439460|NCT00483938|65352433|FG002|Overall Study|Withdrawal by Subject|0|||
23439461|NCT00483938|65352434|FG003|Overall Study|Withdrawal by Subject|0|||
23439462|NCT00483938|65352435|FG004|Overall Study|Withdrawal by Subject|1|||
23439463|NCT00483938|65352436|FG005|Overall Study|Withdrawal by Subject|3|||
23439464|NCT00483938|65352437|FG006|Overall Study|Withdrawal by Subject|2|||
23439465|NCT00483938|65352431|FG000|Overall Study|Lost to Follow-up|1|||
23439466|NCT00483938|65352432|FG001|Overall Study|Lost to Follow-up|2|||
23439467|NCT00483938|65352433|FG002|Overall Study|Lost to Follow-up|0|||
23439468|NCT00483938|65352434|FG003|Overall Study|Lost to Follow-up|2|||
23439469|NCT00483938|65352435|FG004|Overall Study|Lost to Follow-up|1|||
23439470|NCT00483938|65352436|FG005|Overall Study|Lost to Follow-up|1|||
23439471|NCT00483938|65352437|FG006|Overall Study|Lost to Follow-up|3|||
23439472|NCT00483938|65352431|FG000|Overall Study|Death|0|||
23439473|NCT00483938|65352432|FG001|Overall Study|Death|2|||
23439474|NCT00483938|65352433|FG002|Overall Study|Death|0|||
23439475|NCT00483938|65352434|FG003|Overall Study|Death|0|||
23439476|NCT00483938|65352435|FG004|Overall Study|Death|0|||
23439477|NCT00483938|65352436|FG005|Overall Study|Death|0|||
23439478|NCT00483938|65352437|FG006|Overall Study|Death|0|||
23439479|NCT00483938|65352431|FG000|Overall Study|Other|3|||
23439480|NCT00483938|65352432|FG001|Overall Study|Other|9|||
23439481|NCT00483938|65352433|FG002|Overall Study|Other|0|||
23439482|NCT00483938|65352434|FG003|Overall Study|Other|4|||
23439483|NCT00483938|65352435|FG004|Overall Study|Other|0|||
23439484|NCT00483938|65352436|FG005|Overall Study|Other|4|||
23439485|NCT00483938|65352437|FG006|Overall Study|Other|32|||
23439486|NCT03214406|65352438|FG000|Overall Study|did not meet enrollment criteria|9|||
23439487|NCT03214406|65352439|FG001|Overall Study|did not meet enrollment criteria|13|||
23439488|NCT03214406|65352438|FG000|Overall Study|Withdrawal by Subject|1|||
23439489|NCT03214406|65352439|FG001|Overall Study|Withdrawal by Subject|0|||
23439490|NCT03214406|65352438|FG000|Overall Study|Lost to Follow-up|0|||
23439491|NCT03214406|65352439|FG001|Overall Study|Lost to Follow-up|2|||
23439492|NCT00621140|65352440|FG000|Overall Study|Adverse Event|4|||
23439493|NCT00621140|65352441|FG001|Overall Study|Adverse Event|5|||
23439494|NCT00621140|65352440|FG000|Overall Study|Lost to Follow-up|1|||
23439495|NCT00621140|65352441|FG001|Overall Study|Lost to Follow-up|2|||
23439496|NCT00621140|65352440|FG000|Overall Study|Withdrawal by Subject|4|||
23439497|NCT00621140|65352441|FG001|Overall Study|Withdrawal by Subject|6|||
23439498|NCT00621140|65352440|FG000|Overall Study|Other incl. lack of efficacy|6|||
23439499|NCT00621140|65352441|FG001|Overall Study|Other incl. lack of efficacy|5|||
23439500|NCT00635882|65352442|FG000|Overall Study|Protocol Violation|1|||
23439501|NCT00635882|65352443|FG001|Overall Study|Protocol Violation|0|||
23439502|NCT00635882|65352444|FG002|Overall Study|Protocol Violation|0|||
23439503|NCT00635882|65352445|FG003|Overall Study|Protocol Violation|0|||
23439504|NCT00635882|65352446|FG004|Overall Study|Protocol Violation|0|||
23439505|NCT00635882|65352447|FG005|Overall Study|Protocol Violation|0|||
23439506|NCT01611194|65352448|FG000|Overall Study|Lost to Follow-up|0|||
23439507|NCT01611194|65352449|FG001|Overall Study|Lost to Follow-up|1|||
23439508|NCT01611194|65352448|FG000|Overall Study|Withdrawal by Subject|0|||
23439509|NCT01611194|65352449|FG001|Overall Study|Withdrawal by Subject|1|||
23439510|NCT01611194|65352448|FG000|Overall Study|drug use|0|||
23439511|NCT01611194|65352449|FG001|Overall Study|drug use|1|||
23439512|NCT00599755|65352450|FG000|Overall Study|Adverse Event|11|||
23439513|NCT00599755|65352450|FG000|Overall Study|Withdrawal by Subject|2|||
23562020|NCT01641926|65786367|FG001|Overall Study|Lost to Follow-up|2|||
23562021|NCT01641926|65786368|FG002|Overall Study|Lost to Follow-up|1|||
23562022|NCT01641926|65786369|FG003|Overall Study|Lost to Follow-up|0|||
23220019|NCT01804842|64550039|FG001|Overall Study|Lost to Follow-up|0|||
23220020|NCT01804842|64550040|FG002|Overall Study|Lost to Follow-up|0|||
23220021|NCT01804842|64550038|FG000|Overall Study|Non-Compliance|1|||
23325079|NCT03591874|64933693|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
23325080|NCT03591874|64933692|FG000|Overall Study|On Study at Time of Study Termination|12|||
23439514|NCT00599755|65352450|FG000|Overall Study|Progression of Disease|3|||
23439515|NCT00599755|65352450|FG000|Overall Study|Other Reason|2|||
23439516|NCT00599755|65352450|FG000|Overall Study|No data available|1|||
23439517|NCT02119663|65352451|FG000|Overall Study|Disease progression|26|||
23439518|NCT02119663|65352452|FG001|Overall Study|Disease progression|27|||
23439519|NCT02119663|65352451|FG000|Overall Study|Adverse Event|5|||
23439520|NCT02119663|65352452|FG001|Overall Study|Adverse Event|5|||
23562023|NCT01641926|65786366|FG000|Overall Study|Physician Decision|6|||
23220022|NCT01804842|64550039|FG001|Overall Study|Non-Compliance|1|||
23220023|NCT01804842|64550040|FG002|Overall Study|Non-Compliance|0|||
23439521|NCT02119663|65352451|FG000|Overall Study|Death|3|||
23439522|NCT02119663|65352452|FG001|Overall Study|Death|2|||
23439523|NCT02119663|65352451|FG000|Overall Study|Physician Decision|1|||
23439524|NCT02119663|65352452|FG001|Overall Study|Physician Decision|2|||
23439525|NCT02119663|65352451|FG000|Overall Study|Other unspecified|2|||
23325081|NCT03591874|64933693|FG001|Overall Study|On Study at Time of Study Termination|6|||
23325082|NCT01306305|64933694|FG000|Overall Study|Lost to Follow-up|1|||
23325083|NCT01306305|64933695|FG001|Overall Study|Lost to Follow-up|0|||
23325084|NCT01306305|64933694|FG000|Overall Study|Withdrew consent|1|||
23325085|NCT01306305|64933695|FG001|Overall Study|Withdrew consent|0|||
23325086|NCT03597295|64933696|FG000|Overall Study|Death|70|||
23325087|NCT03597295|64933696|FG000|Overall Study|Lost to Follow-up|7|||
23325088|NCT03640312|64933701|FG000|Overall Study|Lost to Follow-up|3|||
23562024|NCT01641926|65786367|FG001|Overall Study|Physician Decision|5|||
23562025|NCT01641926|65786368|FG002|Overall Study|Physician Decision|0|||
23562026|NCT01641926|65786369|FG003|Overall Study|Physician Decision|1|||
23562027|NCT01641926|65786366|FG000|Overall Study|Protocol Violation|1|||
23562028|NCT01641926|65786367|FG001|Overall Study|Protocol Violation|0|||
23562029|NCT01641926|65786368|FG002|Overall Study|Protocol Violation|0|||
23562030|NCT01641926|65786369|FG003|Overall Study|Protocol Violation|1|||
23562031|NCT01641926|65786366|FG000|Overall Study|Withdrawal by Subject|13|||
23562032|NCT01641926|65786367|FG001|Overall Study|Withdrawal by Subject|5|||
23562033|NCT01641926|65786368|FG002|Overall Study|Withdrawal by Subject|6|||
23562034|NCT01641926|65786369|FG003|Overall Study|Withdrawal by Subject|1|||
23562035|NCT01641926|65786366|FG000|Overall Study|Not Treated|1|||
23562036|NCT01641926|65786367|FG001|Overall Study|Not Treated|1|||
23562037|NCT01641926|65786368|FG002|Overall Study|Not Treated|1|||
23562038|NCT01641926|65786369|FG003|Overall Study|Not Treated|0|||
23562039|NCT02799784|65786370|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
23562040|NCT02799784|65786371|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
23562041|NCT02799784|65786370|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
23562042|NCT02799784|65786371|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
23562043|NCT02799784|65786370|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
23562044|NCT02799784|65786371|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
23562045|NCT02799784|65786370|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
23562046|NCT02799784|65786371|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
23562047|NCT02799784|65786370|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
23562048|NCT02799784|65786371|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
23562049|NCT02799784|65786370|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
23562050|NCT02799784|65786371|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
23562051|NCT01800201|65786372|FG000|Overall Study|Withdrawal by Subject|2|||
23562052|NCT01800201|65786373|FG001|Overall Study|Withdrawal by Subject|0|||
23151054|NCT01749540|64305339|FG006|Overall Study|Withdrawal by Subject|0|||
23151055|NCT01749540|64305333|FG000|Overall Study|Initiated into extension study A536-06|0|||
23151056|NCT01749540|64305334|FG001|Overall Study|Initiated into extension study A536-06|0|||
23151057|NCT01749540|64305335|FG002|Overall Study|Initiated into extension study A536-06|0|||
23151058|NCT01749540|64305336|FG003|Overall Study|Initiated into extension study A536-06|0|||
23325089|NCT03640312|64933702|FG001|Overall Study|Lost to Follow-up|6|||
23151059|NCT01749540|64305337|FG004|Overall Study|Initiated into extension study A536-06|0|||
23325090|NCT01890122|64933703|FG000|Overall Study|Adverse Event|1|||
23325091|NCT01890122|64933704|FG001|Overall Study|Adverse Event|1|||
23562053|NCT01800201|65786372|FG000|Overall Study|patient privacy concerns|1|||
23562054|NCT01800201|65786373|FG001|Overall Study|patient privacy concerns|1|||
23562055|NCT01800201|65786372|FG000|Overall Study|did not want to use device|0|||
23562056|NCT01800201|65786373|FG001|Overall Study|did not want to use device|1|||
23562057|NCT01800201|65786372|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
23562058|NCT01800201|65786373|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
23562059|NCT05674890|65786374|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
23562060|NCT05674890|65786375|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
23562061|NCT05674890|65786374|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
23562062|NCT05674890|65786375|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
23562063|NCT05674890|65786374|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
23562064|NCT05674890|65786375|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
23562065|NCT03012061|65786376|FG000|Overall Study|Withdrawal by Subject|1|||
23562066|NCT03012061|65786377|FG001|Overall Study|Withdrawal by Subject|5|||
23562067|NCT03012061|65786378|FG002|Overall Study|Withdrawal by Subject|4|||
23562068|NCT03012061|65786376|FG000|Overall Study|Investigator Site Closed|1|||
23562069|NCT03012061|65786377|FG001|Overall Study|Investigator Site Closed|2|||
23562070|NCT03012061|65786378|FG002|Overall Study|Investigator Site Closed|0|||
23562071|NCT03012061|65786376|FG000|Overall Study|Lost to Follow-up|2|||
23562072|NCT03012061|65786377|FG001|Overall Study|Lost to Follow-up|1|||
23325092|NCT01890122|64933705|FG002|Overall Study|Adverse Event|1|||
23562073|NCT03012061|65786378|FG002|Overall Study|Lost to Follow-up|0|||
23562074|NCT03012061|65786376|FG000|Overall Study|Study closed/ Terminated|0|||
23325093|NCT01890122|64933706|FG003|Overall Study|Adverse Event|2|||
23325094|NCT01890122|64933703|FG000|Overall Study|Major Protocol Deviation|3|||
23220024|NCT01804842|64550038|FG000|Overall Study|Personal Reason|0|||
23220025|NCT01804842|64550039|FG001|Overall Study|Personal Reason|0|||
23562075|NCT03012061|65786377|FG001|Overall Study|Study closed/ Terminated|0|||
23562076|NCT03012061|65786378|FG002|Overall Study|Study closed/ Terminated|1|||
23562077|NCT03012061|65786376|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
23562078|NCT03012061|65786377|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
23562079|NCT03012061|65786378|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
23562080|NCT03012061|65786376|FG000|Overall Study|Protocol Violation|0|||
23325095|NCT01890122|64933704|FG001|Overall Study|Major Protocol Deviation|1|||
23325096|NCT01890122|64933705|FG002|Overall Study|Major Protocol Deviation|0|||
23151060|NCT01749540|64305338|FG005|Overall Study|Initiated into extension study A536-06|2|||
23151061|NCT01749540|64305339|FG006|Overall Study|Initiated into extension study A536-06|24|||
23151062|NCT03952806|64305340|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
23151063|NCT03952806|64305341|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
23151064|NCT03952806|64305340|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
23151065|NCT03952806|64305341|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
23151066|NCT03952806|64305340|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
23151067|NCT03952806|64305341|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
23151068|NCT03952806|64305340|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
23151069|NCT03952806|64305341|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
23151070|NCT03952806|64305340|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
23151071|NCT03952806|64305341|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
23151072|NCT03952806|64305340|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
23151073|NCT03952806|64305341|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
23151074|NCT03952806|64305340|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
23151075|NCT03952806|64305341|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
23151076|NCT03952806|64305340|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
23151077|NCT03952806|64305341|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
23151078|NCT03952806|64305340|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
23151079|NCT03952806|64305341|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
23151080|NCT03952806|64305340|FG000|OLE Phase (48 Weeks)|Other|16|||
23151081|NCT03952806|64305341|FG001|OLE Phase (48 Weeks)|Other|13|||
23151082|NCT00375219|64305348|FG000|Overall Study|Failure to achieve a response|16|||
23151083|NCT00375219|64305349|FG001|Overall Study|Failure to achieve a response|2|||
23151084|NCT00375219|64305350|FG002|Overall Study|Failure to achieve a response|0|||
23151085|NCT00375219|64305348|FG000|Overall Study|Adverse Event|8|||
23151086|NCT00375219|64305349|FG001|Overall Study|Adverse Event|2|||
23151087|NCT00375219|64305350|FG002|Overall Study|Adverse Event|1|||
23151088|NCT00375219|64305348|FG000|Overall Study|Protocol Violation|1|||
23151089|NCT00375219|64305349|FG001|Overall Study|Protocol Violation|0|||
23151090|NCT00375219|64305350|FG002|Overall Study|Protocol Violation|1|||
23220026|NCT01804842|64550040|FG002|Overall Study|Personal Reason|1|||
23220027|NCT02671760|64550041|FG000|Overall Study|Lost to Follow-up|0|||
23562081|NCT03012061|65786377|FG001|Overall Study|Protocol Violation|0|||
23562082|NCT03012061|65786378|FG002|Overall Study|Protocol Violation|2|||
23562083|NCT03012061|65786376|FG000|Overall Study|Lack of Efficacy|0|||
23562084|NCT03012061|65786377|FG001|Overall Study|Lack of Efficacy|1|||
23220028|NCT02671760|64550042|FG001|Overall Study|Lost to Follow-up|1|||
23220029|NCT02671760|64550043|FG002|Overall Study|Lost to Follow-up|0|||
23220030|NCT00611767|64550044|FG000|Overall Study|Withdrawal by Subject|4|||
23325097|NCT01890122|64933706|FG003|Overall Study|Major Protocol Deviation|1|||
23562085|NCT03012061|65786378|FG002|Overall Study|Lack of Efficacy|0|||
23562086|NCT03012061|65786376|FG000|Overall Study|Adverse Event|2|||
23562087|NCT03012061|65786377|FG001|Overall Study|Adverse Event|0|||
23562088|NCT03012061|65786378|FG002|Overall Study|Adverse Event|0|||
23562089|NCT03287414|65786379|FG000|Treatment Epoch|Adverse Event|0|||
23562090|NCT03287414|65786380|FG001|Treatment Epoch|Adverse Event|1|||
23562091|NCT03287414|65786379|FG000|Treatment Epoch|Study terminated by sponsor|2|||
23562092|NCT03287414|65786380|FG001|Treatment Epoch|Study terminated by sponsor|2|||
23220031|NCT00611767|64550045|FG001|Overall Study|Withdrawal by Subject|1|||
23220032|NCT00611767|64550044|FG000|Overall Study|Thiopental not available|3|||
23220033|NCT00611767|64550045|FG001|Overall Study|Thiopental not available|0|||
23220034|NCT00611767|64550044|FG000|Overall Study|didn't like the medication|1|||
23562093|NCT03287414|65786379|FG000|Treatment Epoch|Subject/Guardian decision|4|||
23562094|NCT03287414|65786380|FG001|Treatment Epoch|Subject/Guardian decision|0|||
23562095|NCT03287414|65786379|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
23151091|NCT00375219|64305348|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
23220035|NCT00611767|64550045|FG001|Overall Study|didn't like the medication|1|||
23220036|NCT00611767|64550044|FG000|Overall Study|Physician Decision|1|||
23220037|NCT00611767|64550045|FG001|Overall Study|Physician Decision|0|||
23220038|NCT03907969|64550046|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
23562096|NCT03287414|65786380|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
23562097|NCT03287414|65786379|FG000|Treatment Epoch|Withdrawal by Subject|1|||
23151092|NCT00375219|64305349|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
23151093|NCT00375219|64305350|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
23151094|NCT00375219|64305348|FG000|Overall Study|Lost to Follow-up|1|||
23151095|NCT00375219|64305349|FG001|Overall Study|Lost to Follow-up|1|||
23151096|NCT00375219|64305350|FG002|Overall Study|Lost to Follow-up|0|||
23151097|NCT00375219|64305348|FG000|Overall Study|Disease progression|18|||
23151098|NCT00375219|64305349|FG001|Overall Study|Disease progression|9|||
23151099|NCT00375219|64305350|FG002|Overall Study|Disease progression|12|||
23151100|NCT00375219|64305348|FG000|Overall Study|Death|4|||
23151101|NCT00375219|64305349|FG001|Overall Study|Death|3|||
23151102|NCT00375219|64305350|FG002|Overall Study|Death|7|||
23151103|NCT00375219|64305348|FG000|Overall Study|Hematologic resistance|1|||
23151104|NCT00375219|64305349|FG001|Overall Study|Hematologic resistance|0|||
23151105|NCT00375219|64305350|FG002|Overall Study|Hematologic resistance|0|||
23151106|NCT00375219|64305348|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
23151107|NCT00375219|64305349|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
23562098|NCT03287414|65786380|FG001|Treatment Epoch|Withdrawal by Subject|0|||
23151108|NCT00375219|64305350|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
23151109|NCT00375219|64305348|FG000|Overall Study|Allograft|2|||
23151110|NCT00375219|64305349|FG001|Overall Study|Allograft|0|||
23151111|NCT00375219|64305350|FG002|Overall Study|Allograft|0|||
23151112|NCT00375219|64305348|FG000|Overall Study|Cord blood transplantation|1|||
23151113|NCT00375219|64305349|FG001|Overall Study|Cord blood transplantation|0|||
23562099|NCT03287414|65786379|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
23562100|NCT03287414|65786380|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
23562101|NCT03287414|65786379|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
23562102|NCT03287414|65786380|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
23562103|NCT00638235|65786387|FG000|Overall Study|Lost to Follow-up|31|||
23562104|NCT00638235|65786388|FG001|Overall Study|Lost to Follow-up|3|||
23562105|NCT00638235|65786389|FG002|Overall Study|Lost to Follow-up|18|||
23562106|NCT00638235|65786390|FG003|Overall Study|Lost to Follow-up|10|||
23562107|NCT00638235|65786391|FG004|Overall Study|Lost to Follow-up|13|||
23562108|NCT00638235|65786392|FG005|Overall Study|Lost to Follow-up|26|||
23562109|NCT00638235|65786393|FG006|Overall Study|Lost to Follow-up|0|||
23562110|NCT00638235|65786394|FG007|Overall Study|Lost to Follow-up|1|||
23562111|NCT00638235|65786395|FG008|Overall Study|Lost to Follow-up|18|||
23562112|NCT00245102|65786397|FG000|Overall Study|Not Treated|1|||
23562113|NCT00245102|65786398|FG001|Overall Study|Not Treated|0|||
23562114|NCT00245102|65786399|FG002|Overall Study|Not Treated|1|||
23562115|NCT00245102|65786400|FG003|Overall Study|Not Treated|0|||
23562116|NCT00245102|65786401|FG004|Overall Study|Not Treated|0|||
23562117|NCT00245102|65786402|FG005|Overall Study|Not Treated|0|||
23562118|NCT00245102|65786397|FG000|Overall Study|Protocol Violation|1|||
23562119|NCT00245102|65786398|FG001|Overall Study|Protocol Violation|0|||
23562120|NCT00245102|65786399|FG002|Overall Study|Protocol Violation|0|||
23562121|NCT00245102|65786400|FG003|Overall Study|Protocol Violation|0|||
23562122|NCT00245102|65786401|FG004|Overall Study|Protocol Violation|0|||
23562123|NCT00245102|65786402|FG005|Overall Study|Protocol Violation|0|||
23562124|NCT00245102|65786397|FG000|Overall Study|Death|0|||
23562125|NCT00245102|65786398|FG001|Overall Study|Death|0|||
23562126|NCT00245102|65786399|FG002|Overall Study|Death|0|||
23562127|NCT00245102|65786400|FG003|Overall Study|Death|1|||
23562128|NCT00245102|65786401|FG004|Overall Study|Death|0|||
23562129|NCT00245102|65786402|FG005|Overall Study|Death|0|||
23562130|NCT00245102|65786397|FG000|Overall Study|Adverse Event|4|||
23562131|NCT00245102|65786398|FG001|Overall Study|Adverse Event|2|||
23562132|NCT00245102|65786399|FG002|Overall Study|Adverse Event|5|||
23562133|NCT00245102|65786400|FG003|Overall Study|Adverse Event|1|||
23562134|NCT00245102|65786401|FG004|Overall Study|Adverse Event|0|||
23562135|NCT00245102|65786402|FG005|Overall Study|Adverse Event|2|||
23562136|NCT00245102|65786397|FG000|Overall Study|Decline in performance|0|||
23562137|NCT00245102|65786398|FG001|Overall Study|Decline in performance|2|||
23562138|NCT00245102|65786399|FG002|Overall Study|Decline in performance|0|||
23562139|NCT00245102|65786400|FG003|Overall Study|Decline in performance|1|||
23562140|NCT00245102|65786401|FG004|Overall Study|Decline in performance|0|||
23151114|NCT00375219|64305350|FG002|Overall Study|Cord blood transplantation|0|||
23151115|NCT00375219|64305348|FG000|Overall Study|Withdrawal by Subject|1|||
23151116|NCT00375219|64305349|FG001|Overall Study|Withdrawal by Subject|0|||
23220039|NCT03907969|64550047|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
23220040|NCT03907969|64550048|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
23562141|NCT00245102|65786402|FG005|Overall Study|Decline in performance|2|||
23562142|NCT00245102|65786397|FG000|Overall Study|Participant needed surgery|0|||
23562143|NCT00245102|65786398|FG001|Overall Study|Participant needed surgery|0|||
23562144|NCT00245102|65786399|FG002|Overall Study|Participant needed surgery|1|||
23562145|NCT00245102|65786400|FG003|Overall Study|Participant needed surgery|0|||
23562146|NCT00245102|65786401|FG004|Overall Study|Participant needed surgery|0|||
23562147|NCT00245102|65786402|FG005|Overall Study|Participant needed surgery|0|||
23562148|NCT00245102|65786397|FG000|Overall Study|Clinical progression|1|||
23562149|NCT00245102|65786398|FG001|Overall Study|Clinical progression|0|||
23151117|NCT00375219|64305350|FG002|Overall Study|Withdrawal by Subject|0|||
23151118|NCT05395104|64305351|FG000|Overall Study|Met Liver Stopping Criteria|1|||
23151119|NCT05395104|64305351|FG000|Overall Study|Withdrawal by Subject|1|||
23151120|NCT03144804|64305352|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
23151121|NCT01055262|64305353|FG000|Overall Study|Adverse Event|5|||
23151122|NCT01055262|64305353|FG000|Overall Study|Protocol Violation|3|||
23151123|NCT01055262|64305353|FG000|Overall Study|Uncooperativeness|1|||
23151124|NCT00517751|64305354|FG000|Overall Study|Death|3|||
23151125|NCT00517751|64305354|FG000|Overall Study|Withdrawal by Subject|37|||
23151126|NCT00517751|64305354|FG000|Overall Study|Lost to Follow-up|4|||
23151127|NCT00517751|64305354|FG000|Overall Study|patient not over due|6|||
23151128|NCT00517751|64305354|FG000|Overall Study|Patient not due for visit|76|||
23151129|NCT00517751|64305354|FG000|Overall Study|Missing|3|||
23151130|NCT00369785|64305355|FG000|Overall Study|Physician Decision|3|||
23151131|NCT00369785|64305356|FG001|Overall Study|Physician Decision|2|||
23151132|NCT00369785|64305355|FG000|Overall Study|Death|1|||
23151133|NCT00369785|64305356|FG001|Overall Study|Death|2|||
23151134|NCT00369785|64305355|FG000|Overall Study|Withdrawal by Subject|7|||
23151135|NCT00369785|64305356|FG001|Overall Study|Withdrawal by Subject|6|||
23151136|NCT00369785|64305355|FG000|Overall Study|Toxicity|6|||
23151137|NCT00369785|64305356|FG001|Overall Study|Toxicity|4|||
23151138|NCT00369785|64305355|FG000|Overall Study|Never started|0|||
23151139|NCT00369785|64305356|FG001|Overall Study|Never started|2|||
23151140|NCT00369785|64305355|FG000|Overall Study|Progression|4|||
23151141|NCT00369785|64305356|FG001|Overall Study|Progression|4|||
23151142|NCT00369785|64305355|FG000|Overall Study|Multiple reasons|6|||
23151143|NCT00369785|64305356|FG001|Overall Study|Multiple reasons|5|||
23151144|NCT01215422|64305357|FG000|Overall Study|Relocation|1|||
23151145|NCT01215422|64305358|FG001|Overall Study|Relocation|0|||
23151146|NCT01215422|64305359|FG002|Overall Study|Relocation|0|||
23151147|NCT01215422|64305360|FG003|Overall Study|Relocation|0|||
23151148|NCT01215422|64305357|FG000|Overall Study|Failed intubations|0|||
23562150|NCT00245102|65786399|FG002|Overall Study|Clinical progression|0|||
23562151|NCT00245102|65786400|FG003|Overall Study|Clinical progression|0|||
23562152|NCT00245102|65786401|FG004|Overall Study|Clinical progression|0|||
23562153|NCT00245102|65786402|FG005|Overall Study|Clinical progression|0|||
23151149|NCT01215422|64305358|FG001|Overall Study|Failed intubations|0|||
23151150|NCT01215422|64305359|FG002|Overall Study|Failed intubations|3|||
23151151|NCT01215422|64305360|FG003|Overall Study|Failed intubations|8|||
23151152|NCT01215422|64305357|FG000|Overall Study|Did not complete all intubations|7|||
23151153|NCT01215422|64305358|FG001|Overall Study|Did not complete all intubations|0|||
23151154|NCT01215422|64305359|FG002|Overall Study|Did not complete all intubations|0|||
23151155|NCT01215422|64305360|FG003|Overall Study|Did not complete all intubations|0|||
23151156|NCT04585646|64305362|FG000|First Intervention|Physician Decision|1|||
23151157|NCT04585646|64305363|FG001|First Intervention|Physician Decision|0|||
23151158|NCT04585646|64305362|FG000|First Intervention|Lost to Follow-up|0|||
23151159|NCT04585646|64305363|FG001|First Intervention|Lost to Follow-up|3|||
23151160|NCT04585646|64305362|FG000|First Intervention|Withdrawal by Subject|0|||
23151161|NCT04585646|64305363|FG001|First Intervention|Withdrawal by Subject|1|||
23151162|NCT02383589|64305370|FG000|Treatment Period|Adverse Event|1|||
23151163|NCT02383589|64305371|FG001|Treatment Period|Adverse Event|3|||
23151164|NCT02383589|64305370|FG000|Treatment Period|Lost to Follow-up|0|||
23151165|NCT02383589|64305371|FG001|Treatment Period|Lost to Follow-up|1|||
23151166|NCT02383589|64305370|FG000|Treatment Period|Withdrawal by Subject|0|||
23151167|NCT02383589|64305371|FG001|Treatment Period|Withdrawal by Subject|5|||
23151168|NCT02383589|64305370|FG000|Treatment Period|Non-compliance with study drug|0|||
23151169|NCT02383589|64305371|FG001|Treatment Period|Non-compliance with study drug|1|||
23151170|NCT02383589|64305370|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
23562154|NCT00459342|65786403|FG000|Overall Study|Not eligible|1|||
23562155|NCT00717314|65786404|FG000|Overall Study|Adverse Event|3|||
23562156|NCT00717314|65786405|FG001|Overall Study|Adverse Event|2|||
23562157|NCT00717314|65786404|FG000|Overall Study|Protocol Violation|1|||
23562158|NCT00717314|65786405|FG001|Overall Study|Protocol Violation|0|||
23151171|NCT02383589|64305371|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
23562159|NCT00717314|65786404|FG000|Overall Study|Lost to Follow-up|1|||
23151172|NCT02383589|64305370|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
23151173|NCT02383589|64305371|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
23151174|NCT02383589|64305370|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
23151175|NCT02383589|64305371|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
23151176|NCT01386658|64305375|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
23151177|NCT01386658|64305376|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
23151178|NCT01386658|64305375|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
23151179|NCT01386658|64305376|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
23151180|NCT00404066|64305377|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
23562160|NCT00717314|65786405|FG001|Overall Study|Lost to Follow-up|5|||
23562161|NCT00717314|65786404|FG000|Overall Study|Withdrawal by Subject|1|||
23562162|NCT00717314|65786405|FG001|Overall Study|Withdrawal by Subject|3|||
23562163|NCT05178121|65786406|FG000|Overall Study|Other|4|||
23562164|NCT05178121|65786406|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
23562165|NCT03386032|65786407|FG000|Overall Study|Lack of Efficacy|6|||
23562166|NCT03386032|65786408|FG001|Overall Study|Lack of Efficacy|2|||
23562167|NCT03386032|65786409|FG002|Overall Study|Lack of Efficacy|0|||
23151181|NCT00404066|64305377|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
23625316|NCT01103232|66015463|FG000|Overall Study|Withdrawal by Subject|1|||
23625317|NCT01103232|66015464|FG001|Overall Study|Withdrawal by Subject|1|||
23625318|NCT01103232|66015463|FG000|Overall Study|Protocol Violation|0|||
23625319|NCT01103232|66015464|FG001|Overall Study|Protocol Violation|1|||
23625320|NCT00853372|66015465|FG000|Overall Study|Death|30|||
23151182|NCT02072434|64305385|FG000|Overall Study|Protocol Violation|10|||
23151183|NCT02072434|64305386|FG001|Overall Study|Protocol Violation|9|||
23151184|NCT02072434|64305385|FG000|Overall Study|Physician Decision|5|||
23439526|NCT02119663|65352452|FG001|Overall Study|Other unspecified|0|||
23439527|NCT02119663|65352451|FG000|Overall Study|Subject decision|0|||
23439528|NCT02119663|65352452|FG001|Overall Study|Subject decision|1|||
23439529|NCT02119663|65352451|FG000|Overall Study|Study Terminated by the Sponsor|3|||
23439530|NCT02119663|65352452|FG001|Overall Study|Study Terminated by the Sponsor|4|||
23439531|NCT00384332|65352453|FG000|Overall Study|Lost to Follow-up|4|||
23439532|NCT00384332|65352454|FG001|Overall Study|Lost to Follow-up|0|||
23439533|NCT05198843|65352455|FG000|Overall Study|Lack of Efficacy|1|||
23439534|NCT03781778|65352456|FG000|Overall Study|Withdrawal by Subject|2|||
23439535|NCT03781778|65352457|FG001|Overall Study|Withdrawal by Subject|2|||
23439536|NCT05090852|65352458|FG000|Overall Study|Physician Decision|5|||
23151185|NCT02072434|64305386|FG001|Overall Study|Physician Decision|10|||
23151186|NCT02072434|64305385|FG000|Overall Study|Adverse event, serious fatal|1|||
23439537|NCT01357551|65352461|FG000|Overall Study|Withdrawal by Subject|6|||
23439538|NCT01357551|65352462|FG001|Overall Study|Withdrawal by Subject|4|||
23439539|NCT01357551|65352461|FG000|Overall Study|Death|0|||
23439540|NCT01357551|65352462|FG001|Overall Study|Death|1|||
23439541|NCT01357551|65352461|FG000|Overall Study|Lost to Follow-up|16|||
23439542|NCT01357551|65352462|FG001|Overall Study|Lost to Follow-up|6|||
23439543|NCT00842543|65352463|FG000|Overall Study|Withdrawal by Subject|2|||
23439544|NCT00842543|65352464|FG001|Overall Study|Withdrawal by Subject|0|||
23439545|NCT00842543|65352465|FG002|Overall Study|Withdrawal by Subject|3|||
23439546|NCT00842543|65352466|FG003|Overall Study|Withdrawal by Subject|4|||
23439547|NCT00856297|65352472|FG000|Overall Study|Unable to classify|2|||
23439548|NCT00856297|65352473|FG001|Overall Study|Unable to classify|0|||
23439549|NCT00856297|65352474|FG002|Overall Study|Unable to classify|0|||
23439550|NCT00856297|65352475|FG003|Overall Study|Unable to classify|0|||
23439551|NCT00856297|65352476|FG004|Overall Study|Unable to classify|0|||
23439552|NCT03691571|65352477|FG000|Overall Study|Withdrawal by Subject|9|||
23439553|NCT03691571|65352478|FG001|Overall Study|Withdrawal by Subject|2|||
23439554|NCT02513472|65352489|FG000|Overall Study|Radiological Disease Progression|45|||
23439555|NCT02513472|65352490|FG001|Overall Study|Radiological Disease Progression|57|||
23439556|NCT02513472|65352489|FG000|Overall Study|Clinical Disease Progression|5|||
23439557|NCT02513472|65352490|FG001|Overall Study|Clinical Disease Progression|13|||
23439558|NCT02513472|65352489|FG000|Overall Study|Adverse Event|8|||
23439559|NCT02513472|65352490|FG001|Overall Study|Adverse Event|11|||
23439560|NCT02513472|65352489|FG000|Overall Study|Withdrawal by Subject|0|||
23439561|NCT02513472|65352490|FG001|Overall Study|Withdrawal by Subject|4|||
23439562|NCT02513472|65352489|FG000|Overall Study|Subject Choice|2|||
23439563|NCT02513472|65352490|FG001|Overall Study|Subject Choice|7|||
23439564|NCT02513472|65352489|FG000|Overall Study|Treatment Completed as per Protocol|3|||
23439565|NCT02513472|65352490|FG001|Overall Study|Treatment Completed as per Protocol|3|||
23439566|NCT02513472|65352489|FG000|Overall Study|Other|3|||
23439567|NCT02513472|65352490|FG001|Overall Study|Other|6|||
23439568|NCT00048347|65352491|FG000|Overall Study|Screen failure|2|||
23562168|NCT03386032|65786407|FG000|Overall Study|Adverse Event|2|||
23562169|NCT03386032|65786408|FG001|Overall Study|Adverse Event|2|||
23151187|NCT02072434|64305386|FG001|Overall Study|Adverse event, serious fatal|6|||
23151188|NCT02072434|64305385|FG000|Overall Study|Adverse Event|7|||
23151189|NCT02072434|64305386|FG001|Overall Study|Adverse Event|6|||
23439569|NCT00416455|65352496|FG000|Overall Study|PET / CT not done|3|||
23439570|NCT00416455|65352497|FG001|Overall Study|PET / CT not done|5|||
23439571|NCT00416455|65352496|FG000|Overall Study|PET / CT poor quality|2|||
23439572|NCT00416455|65352497|FG001|Overall Study|PET / CT poor quality|1|||
23439573|NCT00416455|65352496|FG000|Overall Study|Inadequate pathology|11|||
23439574|NCT00416455|65352497|FG001|Overall Study|Inadequate pathology|2|||
23439575|NCT03043651|65352498|FG000|Overall Study|Death|1|||
23625321|NCT00853372|66015466|FG001|Overall Study|Death|26|||
23625322|NCT00853372|66015465|FG000|Overall Study|Lost to Follow-up|1|||
23562170|NCT03386032|65786409|FG002|Overall Study|Adverse Event|0|||
23562171|NCT03386032|65786407|FG000|Overall Study|Withdrawal by Subject|1|||
23439576|NCT03043651|65352498|FG000|Overall Study|Progressive Disease|2|||
23625323|NCT00853372|66015466|FG001|Overall Study|Lost to Follow-up|2|||
23439577|NCT03043651|65352498|FG000|Overall Study|Adverse Event|2|||
23439578|NCT03043651|65352498|FG000|Overall Study|Withdrawal by Subject|4|||
23439579|NCT03043651|65352498|FG000|Overall Study|Study Terminated by Sponsor|39|||
23439580|NCT00947115|65352499|FG000|Overall Study|Missed reporting interval|3|||
23439581|NCT00947115|65352500|FG001|Overall Study|Missed reporting interval|4|||
23439582|NCT00947115|65352501|FG002|Overall Study|Missed reporting interval|2|||
23439583|NCT00947115|65352499|FG000|Overall Study|Physician Decision|0|||
23439584|NCT00947115|65352500|FG001|Overall Study|Physician Decision|2|||
23439585|NCT00947115|65352501|FG002|Overall Study|Physician Decision|0|||
23562172|NCT03386032|65786408|FG001|Overall Study|Withdrawal by Subject|0|||
23562173|NCT03386032|65786409|FG002|Overall Study|Withdrawal by Subject|0|||
23562174|NCT03386032|65786407|FG000|Overall Study|Lost to Follow-up|9|||
23562175|NCT03386032|65786408|FG001|Overall Study|Lost to Follow-up|3|||
23562176|NCT03386032|65786409|FG002|Overall Study|Lost to Follow-up|0|||
23562177|NCT00224770|65786417|FG000|Overall Study|Lost to Follow-up|4|||
23562178|NCT00224770|65786418|FG001|Overall Study|Lost to Follow-up|2|||
23562179|NCT00224770|65786419|FG002|Overall Study|Lost to Follow-up|0|||
23562180|NCT02293395|65786422|FG000|Overall Study|Lost to Follow-up|1|||
23562181|NCT02293395|65786423|FG001|Overall Study|Lost to Follow-up|0|||
23562182|NCT02293395|65786422|FG000|Overall Study|Withdrawal by Subject|8|||
23562183|NCT02293395|65786423|FG001|Overall Study|Withdrawal by Subject|7|||
23562184|NCT00838682|65786428|FG000|Overall Study|Lost to Follow-up|21|||
23562185|NCT00838682|65786429|FG001|Overall Study|Lost to Follow-up|14|||
23562186|NCT00838682|65786428|FG000|Overall Study|detection of exclusion criteria|4|||
23562187|NCT00838682|65786429|FG001|Overall Study|detection of exclusion criteria|3|||
23562188|NCT00838682|65786428|FG000|Overall Study|Protocol Violation|0|||
23562189|NCT00838682|65786429|FG001|Overall Study|Protocol Violation|1|||
23151190|NCT02072434|64305385|FG000|Overall Study|Withdrawal by Subject|17|||
23151191|NCT02072434|64305386|FG001|Overall Study|Withdrawal by Subject|29|||
23151192|NCT02072434|64305385|FG000|Overall Study|Other|14|||
23151193|NCT02072434|64305386|FG001|Overall Study|Other|29|||
23562190|NCT00838682|65786428|FG000|Overall Study|Withdrawal by Subject|0|||
23562191|NCT00838682|65786429|FG001|Overall Study|Withdrawal by Subject|1|||
23562192|NCT04043962|65786431|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
23562193|NCT04043962|65786431|FG000|Post-Treatment|Withdrawal by Subject|5|||
23562194|NCT04043962|65786431|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
23562195|NCT03092375|65786432|FG000|Overall Study|Lack of Efficacy|0|||
23562196|NCT03092375|65786433|FG001|Overall Study|Lack of Efficacy|1|||
23562197|NCT03092375|65786434|FG002|Overall Study|Lack of Efficacy|1|||
23562198|NCT03092375|65786435|FG003|Overall Study|Lack of Efficacy|0|||
23562199|NCT00738101|65786437|FG000|Overall Study|Physician Decision|5|||
23562200|NCT00738101|65786437|FG000|Overall Study|Death|1|||
23151194|NCT02072434|64305385|FG000|Overall Study|Lost to Follow-up|0|||
23439586|NCT00947115|65352499|FG000|Overall Study|Death|0|||
23439587|NCT00947115|65352500|FG001|Overall Study|Death|1|||
23439588|NCT00947115|65352501|FG002|Overall Study|Death|1|||
23439589|NCT00947115|65352499|FG000|Overall Study|Migrated from study area|2|||
23439590|NCT00947115|65352500|FG001|Overall Study|Migrated from study area|0|||
23439591|NCT00947115|65352501|FG002|Overall Study|Migrated from study area|0|||
23439592|NCT00947115|65352499|FG000|Overall Study|Withdrawal by Subject|1|||
23439593|NCT00947115|65352500|FG001|Overall Study|Withdrawal by Subject|3|||
23439594|NCT00947115|65352501|FG002|Overall Study|Withdrawal by Subject|4|||
23439595|NCT00947115|65352499|FG000|Overall Study|Lost to Follow-up|11|||
23439596|NCT00947115|65352500|FG001|Overall Study|Lost to Follow-up|12|||
23439597|NCT00947115|65352501|FG002|Overall Study|Lost to Follow-up|8|||
23439598|NCT02593318|65352502|FG000|Overall Study|Withdrawal by Subject|1|||
23439599|NCT02593318|65352503|FG001|Overall Study|Withdrawal by Subject|1|||
23439600|NCT01022424|65352510|FG000|Overall Study|Adverse Event|1|||
23439601|NCT01022424|65352510|FG000|Overall Study|Physician Decision|1|||
23439602|NCT01022424|65352510|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
23439603|NCT00662909|65352511|FG000|Overall Study|Adverse Event|17|||
23439604|NCT00662909|65352512|FG001|Overall Study|Adverse Event|18|||
23439605|NCT00662909|65352513|FG002|Overall Study|Adverse Event|19|||
23439606|NCT00662909|65352511|FG000|Overall Study|Lack of Efficacy|9|||
23151195|NCT02072434|64305386|FG001|Overall Study|Lost to Follow-up|1|||
23151196|NCT01170039|64305388|FG000|Overall Study|Withdrawal by Subject|5|||
23439607|NCT00662909|65352512|FG001|Overall Study|Lack of Efficacy|1|||
23439608|NCT00662909|65352513|FG002|Overall Study|Lack of Efficacy|5|||
23562201|NCT00738101|65786437|FG000|Overall Study|Repeat enrollment|1|||
23562202|NCT02277990|65786440|FG000|Overall Study|Death|170|||
23562203|NCT02277990|65786441|FG001|Overall Study|Death|188|||
23562204|NCT02277990|65786440|FG000|Overall Study|Withdrawal by Subject|64|||
23562205|NCT02277990|65786441|FG001|Overall Study|Withdrawal by Subject|53|||
23151197|NCT01170039|64305389|FG001|Overall Study|Withdrawal by Subject|3|||
23439609|NCT00662909|65352511|FG000|Overall Study|Withdrawal by Subject|29|||
23151198|NCT01170039|64305388|FG000|Overall Study|Lack of funding, drug not available|3|||
23562206|NCT02277990|65786440|FG000|Overall Study|Physician Decision|40|||
23562207|NCT02277990|65786441|FG001|Overall Study|Physician Decision|34|||
23439610|NCT00662909|65352512|FG001|Overall Study|Withdrawal by Subject|22|||
23439611|NCT00662909|65352513|FG002|Overall Study|Withdrawal by Subject|16|||
23439612|NCT00662909|65352511|FG000|Overall Study|Lost to Follow-up|2|||
23439613|NCT00662909|65352512|FG001|Overall Study|Lost to Follow-up|9|||
23439614|NCT00662909|65352513|FG002|Overall Study|Lost to Follow-up|3|||
23439615|NCT00662909|65352511|FG000|Overall Study|Protocol Violation|7|||
23439616|NCT00662909|65352512|FG001|Overall Study|Protocol Violation|4|||
23439617|NCT00662909|65352513|FG002|Overall Study|Protocol Violation|5|||
23439618|NCT00662909|65352511|FG000|Overall Study|Randomized- never received study drug|1|||
23439619|NCT00662909|65352512|FG001|Overall Study|Randomized- never received study drug|0|||
23439620|NCT00662909|65352513|FG002|Overall Study|Randomized- never received study drug|0|||
23439621|NCT00662909|65352511|FG000|Overall Study|Non-compliance with study procedures|3|||
23439622|NCT00662909|65352512|FG001|Overall Study|Non-compliance with study procedures|3|||
23439623|NCT00662909|65352513|FG002|Overall Study|Non-compliance with study procedures|2|||
23562208|NCT02277990|65786440|FG000|Overall Study|Lost to Follow-up|66|||
23151199|NCT01170039|64305389|FG001|Overall Study|Lack of funding, drug not available|3|||
23151200|NCT01505010|64305390|FG000|Overall Study|Protocol Violation|0|||
23151201|NCT01505010|64305391|FG001|Overall Study|Protocol Violation|1|||
23151202|NCT01505010|64305390|FG000|Overall Study|Lost to Follow-up|0|||
23151203|NCT01505010|64305391|FG001|Overall Study|Lost to Follow-up|1|||
23151204|NCT03189862|64305392|FG000|Overall Study|Withdrawal by Subject|1|||
23439624|NCT00662909|65352511|FG000|Overall Study|Physician Decision|1|||
23439625|NCT00662909|65352512|FG001|Overall Study|Physician Decision|1|||
23562209|NCT02277990|65786441|FG001|Overall Study|Lost to Follow-up|69|||
23562210|NCT02277990|65786440|FG000|Overall Study|Had other reason|26|||
23562211|NCT02277990|65786441|FG001|Overall Study|Had other reason|32|||
23562212|NCT02127372|65786442|FG000|Overall Study|Withdrawal by Subject|1|||
23562213|NCT02127372|65786443|FG001|Overall Study|Withdrawal by Subject|0|||
23562214|NCT03131960|65786446|FG000|Overall Study|Adverse Event|0|||
23562215|NCT03131960|65786447|FG001|Overall Study|Adverse Event|1|||
23562216|NCT01395823|65786448|FG000|Overall Study|Death|4|||
23562217|NCT01395823|65786449|FG001|Overall Study|Death|4|||
23562218|NCT01395823|65786448|FG000|Overall Study|Physician Decision|3|||
23562219|NCT01395823|65786449|FG001|Overall Study|Physician Decision|1|||
23562220|NCT01395823|65786448|FG000|Overall Study|Lost to Follow-up|1|||
23439626|NCT00662909|65352513|FG002|Overall Study|Physician Decision|2|||
23439627|NCT00662909|65352511|FG000|Overall Study|Eligibility criterion not met|0|||
23439628|NCT00662909|65352512|FG001|Overall Study|Eligibility criterion not met|1|||
23439629|NCT00662909|65352513|FG002|Overall Study|Eligibility criterion not met|1|||
23439630|NCT02451124|65352514|FG000|Overall Study|Withdrawal by Subject|1|||
23439631|NCT01103063|65352521|FG000|Overall Study|Adverse Event|3|||
23439632|NCT01103063|65352522|FG001|Overall Study|Adverse Event|1|||
23439633|NCT01103063|65352521|FG000|Overall Study|Lost to Follow-up|68|||
23562221|NCT01395823|65786449|FG001|Overall Study|Lost to Follow-up|0|||
23562222|NCT01395823|65786448|FG000|Overall Study|Transplant|1|||
23562223|NCT01395823|65786449|FG001|Overall Study|Transplant|0|||
23562224|NCT01395823|65786448|FG000|Overall Study|GI symptoms|1|||
23562225|NCT01395823|65786449|FG001|Overall Study|GI symptoms|0|||
23562226|NCT01395823|65786448|FG000|Overall Study|Withdrawal by Subject|5|||
23562227|NCT01395823|65786449|FG001|Overall Study|Withdrawal by Subject|4|||
23562228|NCT02696564|65786458|FG000|Overall Study|Death|1|||
23439634|NCT01103063|65352522|FG001|Overall Study|Lost to Follow-up|51|||
23439635|NCT01103063|65352521|FG000|Overall Study|Withdrawal by Subject|60|||
23439636|NCT01103063|65352522|FG001|Overall Study|Withdrawal by Subject|15|||
23439637|NCT01103063|65352521|FG000|Overall Study|Other|16|||
23439638|NCT01103063|65352522|FG001|Overall Study|Other|11|||
23439639|NCT01103063|65352521|FG000|Overall Study|Protocol Violation|1|||
23439640|NCT01103063|65352522|FG001|Overall Study|Protocol Violation|0|||
23562229|NCT02696564|65786459|FG001|Overall Study|Death|2|||
23562230|NCT02696564|65786458|FG000|Overall Study|Withdrawal by Subject|3|||
23562231|NCT02696564|65786459|FG001|Overall Study|Withdrawal by Subject|2|||
23562232|NCT02696564|65786458|FG000|Overall Study|Lost to Follow-up|3|||
23562233|NCT02696564|65786459|FG001|Overall Study|Lost to Follow-up|3|||
23562234|NCT02696564|65786458|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
23562235|NCT02696564|65786459|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
23562236|NCT02696564|65786458|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
23562237|NCT02696564|65786459|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
23562238|NCT02696564|65786458|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
23439641|NCT01103063|65352521|FG000|Overall Study|Study terminated by Sponsor|326|||
23562239|NCT02696564|65786459|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
23625324|NCT00853372|66015465|FG000|Overall Study|Full Consent Withdrawn|1|||
23151205|NCT03189862|64305393|FG001|Overall Study|Withdrawal by Subject|0|||
23562240|NCT02696564|65786458|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
23625325|NCT00853372|66015466|FG001|Overall Study|Full Consent Withdrawn|1|||
23151206|NCT03189862|64305392|FG000|Overall Study|Lost to Follow-up|54|||
23562241|NCT02696564|65786459|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
23562242|NCT02696564|65786458|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
23562243|NCT02696564|65786459|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
23562244|NCT04899245|65790217|FG000|Overall Study|Withdrawal by Subject|3|||
23562245|NCT04899245|65790218|FG001|Overall Study|Withdrawal by Subject|5|||
23562246|NCT04899245|65790219|FG002|Overall Study|Withdrawal by Subject|2|||
23562247|NCT04899245|65790217|FG000|Overall Study|No longer eligible - Left staff position|0|||
23562248|NCT04899245|65790218|FG001|Overall Study|No longer eligible - Left staff position|0|||
23562249|NCT04899245|65790219|FG002|Overall Study|No longer eligible - Left staff position|1|||
23562250|NCT04899245|65790217|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
23562251|NCT04899245|65790218|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
23562252|NCT04899245|65790219|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
23562253|NCT04899245|65790217|FG000|Overall Study|No longer eligible - Moved away from area|2|||
23562254|NCT04899245|65790218|FG001|Overall Study|No longer eligible - Moved away from area|2|||
23562255|NCT04899245|65790219|FG002|Overall Study|No longer eligible - Moved away from area|0|||
23562256|NCT01164228|65790220|FG000|Overall Study|Progression|24|||
23562257|NCT01164228|65790221|FG001|Overall Study|Progression|25|||
23562258|NCT01164228|65790220|FG000|Overall Study|Adverse Event|13|||
23562259|NCT01164228|65790221|FG001|Overall Study|Adverse Event|7|||
23562260|NCT01164228|65790220|FG000|Overall Study|Death|1|||
23562261|NCT01164228|65790221|FG001|Overall Study|Death|1|||
23562262|NCT01164228|65790220|FG000|Overall Study|Withdrawal by Subject|2|||
23562263|NCT01164228|65790221|FG001|Overall Study|Withdrawal by Subject|0|||
23562264|NCT01164228|65790220|FG000|Overall Study|Physician Decision|1|||
23562265|NCT01164228|65790221|FG001|Overall Study|Physician Decision|2|||
23562266|NCT01164228|65790220|FG000|Overall Study|Symptomatic deterioration|1|||
23562267|NCT01164228|65790221|FG001|Overall Study|Symptomatic deterioration|0|||
23562268|NCT01164228|65790220|FG000|Overall Study|Never started treatment|1|||
23562269|NCT01164228|65790221|FG001|Overall Study|Never started treatment|3|||
23562270|NCT01164228|65790220|FG000|Overall Study|Ineligible|1|||
23562271|NCT01164228|65790221|FG001|Overall Study|Ineligible|0|||
23562272|NCT00708435|65790222|FG000|Overall Study|Death / Serious Adverse Event|10|||
23562273|NCT00708435|65790223|FG001|Overall Study|Death / Serious Adverse Event|5|||
23562274|NCT00708435|65790222|FG000|Overall Study|Lost to Follow-up|9|||
23562275|NCT00708435|65790223|FG001|Overall Study|Lost to Follow-up|4|||
23562276|NCT00708435|65790222|FG000|Overall Study|Withdrawal by Subject|3|||
23562277|NCT00708435|65790223|FG001|Overall Study|Withdrawal by Subject|7|||
23562278|NCT00708435|65790222|FG000|Overall Study|Adverse Event|1|||
23562279|NCT00708435|65790223|FG001|Overall Study|Adverse Event|0|||
23562280|NCT00708435|65790222|FG000|Overall Study|Protocol Violation|0|||
23562281|NCT00708435|65790223|FG001|Overall Study|Protocol Violation|1|||
23562282|NCT00708435|65790222|FG000|Overall Study|Intervention by primary care physician|1|||
23562283|NCT00708435|65790223|FG001|Overall Study|Intervention by primary care physician|0|||
23562284|NCT00708435|65790222|FG000|Overall Study|Refused hospitalization|1|||
23562285|NCT00708435|65790223|FG001|Overall Study|Refused hospitalization|0|||
23562286|NCT01121484|65790224|FG000|Overall Study|Adverse Event|12|||
23562287|NCT01121484|65790225|FG001|Overall Study|Adverse Event|5|||
23562288|NCT01121484|65790224|FG000|Overall Study|Lack of Efficacy|3|||
23562289|NCT01121484|65790225|FG001|Overall Study|Lack of Efficacy|11|||
23562290|NCT01121484|65790224|FG000|Overall Study|Lost to Follow-up|5|||
23562291|NCT01121484|65790225|FG001|Overall Study|Lost to Follow-up|9|||
23562292|NCT01121484|65790224|FG000|Overall Study|Physician Decision|0|||
23562293|NCT01121484|65790225|FG001|Overall Study|Physician Decision|3|||
23562294|NCT01121484|65790224|FG000|Overall Study|Protocol Violation|1|||
23439642|NCT01103063|65352522|FG001|Overall Study|Study terminated by Sponsor|342|||
23439643|NCT01103063|65352521|FG000|Overall Study|Death|3|||
23439644|NCT01103063|65352522|FG001|Overall Study|Death|1|||
23439645|NCT02429830|65352526|FG000|Overall Study|Lost to Follow-up|1|||
23439646|NCT02429830|65352526|FG000|Overall Study|Device Explant|2|||
23439647|NCT00605345|65352527|FG000|Overall Study|Withdrawal by Subject|1|||
23439648|NCT00605345|65352528|FG001|Overall Study|Withdrawal by Subject|0|||
23562295|NCT01121484|65790225|FG001|Overall Study|Protocol Violation|0|||
23562296|NCT01121484|65790224|FG000|Overall Study|Withdrawal by Subject|8|||
23439649|NCT00605345|65352527|FG000|Overall Study|Adverse Event|0|||
23439650|NCT00605345|65352528|FG001|Overall Study|Adverse Event|1|||
23562297|NCT01121484|65790225|FG001|Overall Study|Withdrawal by Subject|7|||
23562298|NCT01121484|65790224|FG000|Overall Study|Discontinuation of study by sponsor|0|||
23562299|NCT01121484|65790225|FG001|Overall Study|Discontinuation of study by sponsor|1|||
23562300|NCT01121484|65790224|FG000|Overall Study|Other|3|||
23562301|NCT01121484|65790225|FG001|Overall Study|Other|3|||
23562302|NCT01121484|65790224|FG000|Overall Study|Randomized, not treated|1|||
23562303|NCT01121484|65790225|FG001|Overall Study|Randomized, not treated|4|||
23439651|NCT00605345|65352527|FG000|Overall Study|Protocol Violation|0|||
23439652|NCT00605345|65352528|FG001|Overall Study|Protocol Violation|2|||
23439653|NCT01712204|65352529|FG000|Overall Study|Adverse Event|3|||
23562304|NCT01521884|65790226|FG000|Overall Study|Non Responders|10|||
23562305|NCT01521884|65790226|FG000|Overall Study|Adverse Event|5|||
23562306|NCT01521884|65790226|FG000|Overall Study|Pregnancy|1|||
23562307|NCT01521884|65790226|FG000|Overall Study|Withdrawal by Subject|1|||
23562308|NCT01521884|65790226|FG000|Overall Study|Physician Decision|2|||
23562309|NCT01521884|65790226|FG000|Overall Study|Protocol Violation|3|||
23562310|NCT01521884|65790226|FG000|Overall Study|Participant non-eligible|1|||
23562311|NCT01521884|65790226|FG000|Overall Study|Lost to Follow-up|4|||
23562312|NCT02073097|65790227|FG000|Overall Study|Adverse Event|0|||
23562313|NCT02073097|65790228|FG001|Overall Study|Adverse Event|0|||
23562314|NCT02073097|65790229|FG002|Overall Study|Adverse Event|0|||
23562315|NCT02073097|65790230|FG003|Overall Study|Adverse Event|0|||
23562316|NCT02073097|65790231|FG004|Overall Study|Adverse Event|0|||
23562317|NCT02073097|65790232|FG005|Overall Study|Adverse Event|0|||
23562318|NCT02073097|65790233|FG006|Overall Study|Adverse Event|0|||
23151207|NCT03189862|64305393|FG001|Overall Study|Lost to Follow-up|62|||
23151208|NCT01790126|64305396|FG000|Overall Study|PSA Progression|12|||
23151209|NCT01790126|64305397|FG001|Overall Study|PSA Progression|16|||
23151210|NCT01790126|64305398|FG002|Overall Study|PSA Progression|16|||
23151211|NCT01790126|64305396|FG000|Overall Study|Other|5|||
23439654|NCT01712204|65352530|FG001|Overall Study|Adverse Event|1|||
23439655|NCT01712204|65352529|FG000|Overall Study|Withdrawal by Subject|3|||
23439656|NCT01712204|65352530|FG001|Overall Study|Withdrawal by Subject|3|||
23439657|NCT01712204|65352529|FG000|Overall Study|Lost to Follow-up|1|||
23439658|NCT01712204|65352530|FG001|Overall Study|Lost to Follow-up|0|||
23439659|NCT01712204|65352529|FG000|Overall Study|Protocol Violation|1|||
23439660|NCT01712204|65352530|FG001|Overall Study|Protocol Violation|1|||
23439661|NCT01279681|65352533|FG000|Overall Study|Disease Progression|9|||
23439662|NCT01279681|65352534|FG001|Overall Study|Disease Progression|6|||
23439663|NCT01279681|65352533|FG000|Overall Study|Withdrawal by Subject|3|||
23562319|NCT02073097|65790234|FG007|Overall Study|Adverse Event|2|||
23562320|NCT02073097|65790227|FG000|Overall Study|Withdrawal by Subject|0|||
23562321|NCT02073097|65790228|FG001|Overall Study|Withdrawal by Subject|0|||
23562322|NCT02073097|65790229|FG002|Overall Study|Withdrawal by Subject|0|||
23562323|NCT02073097|65790230|FG003|Overall Study|Withdrawal by Subject|0|||
23562324|NCT02073097|65790231|FG004|Overall Study|Withdrawal by Subject|0|||
23562325|NCT02073097|65790232|FG005|Overall Study|Withdrawal by Subject|0|||
23562326|NCT02073097|65790233|FG006|Overall Study|Withdrawal by Subject|0|||
23562327|NCT02073097|65790234|FG007|Overall Study|Withdrawal by Subject|2|||
23562328|NCT02073097|65790227|FG000|Overall Study|Death|0|||
23562329|NCT02073097|65790228|FG001|Overall Study|Death|0|||
23562330|NCT02073097|65790229|FG002|Overall Study|Death|0|||
23439664|NCT01279681|65352534|FG001|Overall Study|Withdrawal by Subject|4|||
23562331|NCT02073097|65790230|FG003|Overall Study|Death|0|||
23562332|NCT02073097|65790231|FG004|Overall Study|Death|0|||
23562333|NCT02073097|65790232|FG005|Overall Study|Death|0|||
23562334|NCT02073097|65790233|FG006|Overall Study|Death|0|||
23562335|NCT02073097|65790234|FG007|Overall Study|Death|1|||
23562336|NCT02073097|65790227|FG000|Overall Study|Physician Decision|0|||
23562337|NCT02073097|65790228|FG001|Overall Study|Physician Decision|0|||
23562338|NCT02073097|65790229|FG002|Overall Study|Physician Decision|0|||
23562339|NCT02073097|65790230|FG003|Overall Study|Physician Decision|0|||
23562340|NCT02073097|65790231|FG004|Overall Study|Physician Decision|0|||
23562341|NCT02073097|65790232|FG005|Overall Study|Physician Decision|0|||
23562342|NCT02073097|65790233|FG006|Overall Study|Physician Decision|0|||
23562343|NCT02073097|65790234|FG007|Overall Study|Physician Decision|1|||
23562344|NCT01483937|65790235|FG000|Overall Study|Withdrawal by Subject|4|||
23562345|NCT01483937|65790236|FG001|Overall Study|Withdrawal by Subject|3|||
23562346|NCT02087501|65790237|FG000|Overall Study|Death|7|||
23562347|NCT02087501|65790237|FG000|Overall Study|Open repair of aneurysm|1|||
23562348|NCT02087501|65790237|FG000|Overall Study|Lost to Follow-up|2|||
23562349|NCT03682705|65790238|FG000|Overall Study|Adverse Event|1|||
23562350|NCT03682705|65790239|FG001|Overall Study|Adverse Event|1|||
23625326|NCT01270828|66015467|FG000|Pregabalin CR SB|Reason Unspecified|0|||
23151212|NCT01790126|64305397|FG001|Overall Study|Other|4|||
23439665|NCT01279681|65352533|FG000|Overall Study|Adverse Event|2|||
23562351|NCT03682705|65790240|FG002|Overall Study|Adverse Event|1|||
23562352|NCT03682705|65790241|FG003|Overall Study|Adverse Event|0|||
23562353|NCT03682705|65790242|FG004|Overall Study|Adverse Event|1|||
23562354|NCT03682705|65790243|FG005|Overall Study|Adverse Event|1|||
23562355|NCT03682705|65790238|FG000|Overall Study|Withdrawal by Subject|1|||
23562356|NCT03682705|65790239|FG001|Overall Study|Withdrawal by Subject|3|||
23562357|NCT03682705|65790240|FG002|Overall Study|Withdrawal by Subject|2|||
23439666|NCT01279681|65352534|FG001|Overall Study|Adverse Event|3|||
23562358|NCT03682705|65790241|FG003|Overall Study|Withdrawal by Subject|4|||
23562359|NCT03682705|65790242|FG004|Overall Study|Withdrawal by Subject|0|||
23562360|NCT03682705|65790243|FG005|Overall Study|Withdrawal by Subject|1|||
23562361|NCT03682705|65790238|FG000|Overall Study|Other, not specified|0|||
23562362|NCT03682705|65790239|FG001|Overall Study|Other, not specified|0|||
23625327|NCT01270828|66015468|FG001|Pregabalin CR SB|Reason Unspecified|0|||
23562363|NCT03682705|65790240|FG002|Overall Study|Other, not specified|0|||
23562364|NCT03682705|65790241|FG003|Overall Study|Other, not specified|1|||
23562365|NCT03682705|65790242|FG004|Overall Study|Other, not specified|2|||
23562366|NCT03682705|65790243|FG005|Overall Study|Other, not specified|0|||
23562367|NCT03682705|65790238|FG000|Overall Study|Lost to Follow-up|0|||
23562368|NCT03682705|65790239|FG001|Overall Study|Lost to Follow-up|0|||
23562369|NCT03682705|65790240|FG002|Overall Study|Lost to Follow-up|0|||
23439667|NCT01279681|65352533|FG000|Overall Study|Death|0|||
23562370|NCT03682705|65790241|FG003|Overall Study|Lost to Follow-up|0|||
23562371|NCT03682705|65790242|FG004|Overall Study|Lost to Follow-up|3|||
23562372|NCT03682705|65790243|FG005|Overall Study|Lost to Follow-up|0|||
23562373|NCT02202434|65790249|FG000|Overall Study|Death|70|||
23562374|NCT02202434|65790250|FG001|Overall Study|Death|39|||
23562375|NCT02202434|65790251|FG002|Overall Study|Death|13|||
23562376|NCT02202434|65790252|FG003|Overall Study|Death|27|||
23562377|NCT02202434|65790249|FG000|Overall Study|Lost to Follow-up|1|||
23562378|NCT02202434|65790250|FG001|Overall Study|Lost to Follow-up|1|||
23562379|NCT02202434|65790251|FG002|Overall Study|Lost to Follow-up|1|||
23562380|NCT02202434|65790252|FG003|Overall Study|Lost to Follow-up|0|||
23562381|NCT02202434|65790249|FG000|Overall Study|Physician Decision|2|||
23562382|NCT02202434|65790250|FG001|Overall Study|Physician Decision|3|||
23439668|NCT01279681|65352534|FG001|Overall Study|Death|1|||
23439669|NCT01279681|65352533|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
23439670|NCT01279681|65352534|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
23439671|NCT01279681|65352533|FG000|Overall Study|Physician Decision|1|||
23439672|NCT01279681|65352534|FG001|Overall Study|Physician Decision|0|||
23439673|NCT01279681|65352533|FG000|Overall Study|Other Reason|0|||
23439674|NCT01279681|65352534|FG001|Overall Study|Other Reason|2|||
23439675|NCT00423449|65352537|FG000|Overall Study|Clinical Adverse Event|1|||
23439676|NCT00423449|65352538|FG001|Overall Study|Clinical Adverse Event|0|||
23439677|NCT00423449|65352539|FG002|Overall Study|Clinical Adverse Event|1|||
23439678|NCT00423449|65352540|FG003|Overall Study|Clinical Adverse Event|8|||
23439679|NCT00423449|65352541|FG004|Overall Study|Clinical Adverse Event|2|||
23439680|NCT00423449|65352537|FG000|Overall Study|Death|1|||
23439681|NCT00423449|65352538|FG001|Overall Study|Death|0|||
23439682|NCT00423449|65352539|FG002|Overall Study|Death|2|||
23439683|NCT00423449|65352540|FG003|Overall Study|Death|1|||
23439684|NCT00423449|65352541|FG004|Overall Study|Death|1|||
23439685|NCT00423449|65352537|FG000|Overall Study|Progressive Disease|1|||
23439686|NCT00423449|65352538|FG001|Overall Study|Progressive Disease|3|||
23439687|NCT00423449|65352539|FG002|Overall Study|Progressive Disease|8|||
23439688|NCT00423449|65352540|FG003|Overall Study|Progressive Disease|11|||
23439689|NCT00423449|65352541|FG004|Overall Study|Progressive Disease|4|||
23439690|NCT00423449|65352537|FG000|Overall Study|Laboratory Adverse Event|0|||
23439691|NCT00423449|65352538|FG001|Overall Study|Laboratory Adverse Event|1|||
23439692|NCT00423449|65352539|FG002|Overall Study|Laboratory Adverse Event|2|||
23439693|NCT00423449|65352540|FG003|Overall Study|Laboratory Adverse Event|0|||
23439694|NCT00423449|65352541|FG004|Overall Study|Laboratory Adverse Event|0|||
23439695|NCT00423449|65352537|FG000|Overall Study|Other|0|||
23439696|NCT00423449|65352538|FG001|Overall Study|Other|0|||
23439697|NCT00423449|65352539|FG002|Overall Study|Other|0|||
23439698|NCT00423449|65352540|FG003|Overall Study|Other|1|||
23439699|NCT00423449|65352541|FG004|Overall Study|Other|0|||
23439700|NCT00423449|65352537|FG000|Overall Study|Protocol Violation|0|||
23439701|NCT00423449|65352538|FG001|Overall Study|Protocol Violation|0|||
23439702|NCT00423449|65352539|FG002|Overall Study|Protocol Violation|2|||
23439703|NCT00423449|65352540|FG003|Overall Study|Protocol Violation|1|||
23439704|NCT00423449|65352541|FG004|Overall Study|Protocol Violation|0|||
23439705|NCT01629953|65352542|FG000|Overall Study|Death|3|||
23562383|NCT02202434|65790251|FG002|Overall Study|Physician Decision|0|||
23439706|NCT01629953|65352543|FG001|Overall Study|Death|1|||
23439707|NCT01629953|65352542|FG000|Overall Study|Lost to Follow-up|10|||
23562384|NCT02202434|65790252|FG003|Overall Study|Physician Decision|0|||
23625328|NCT01270828|66015469|FG002|Pregabalin CR SB|Reason Unspecified|8|||
23439708|NCT01629953|65352543|FG001|Overall Study|Lost to Follow-up|14|||
23439709|NCT00615030|65352544|FG000|Period I|Administrative problem|0|||
23439710|NCT00615030|65352545|FG001|Period I|Administrative problem|0|||
23439711|NCT00615030|65352546|FG002|Period I|Administrative problem|0|||
23439712|NCT00615030|65352547|FG003|Period I|Administrative problem|0|||
23439713|NCT00615030|65352548|FG004|Period I|Administrative problem|1|||
23439714|NCT00615030|65352549|FG005|Period I|Administrative problem|0|||
23439715|NCT00615030|65352550|FG006|Period I|Administrative problem|0|||
23562385|NCT02202434|65790249|FG000|Overall Study|Withdrawal by Subject|13|||
23562386|NCT02202434|65790250|FG001|Overall Study|Withdrawal by Subject|14|||
23562387|NCT02202434|65790251|FG002|Overall Study|Withdrawal by Subject|1|||
23562388|NCT02202434|65790252|FG003|Overall Study|Withdrawal by Subject|4|||
23439716|NCT00615030|65352551|FG007|Period I|Administrative problem|0|||
23439717|NCT00615030|65352552|FG008|Period I|Administrative problem|0|||
23562389|NCT02202434|65790249|FG000|Overall Study|Completed Study|1|||
23562390|NCT02202434|65790250|FG001|Overall Study|Completed Study|0|||
23625329|NCT01270828|66015467|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
23562391|NCT02202434|65790251|FG002|Overall Study|Completed Study|0|||
23439718|NCT00615030|65352553|FG009|Period I|Administrative problem|0|||
23439719|NCT00615030|65352554|FG010|Period I|Administrative problem|0|||
23439720|NCT00615030|65352555|FG011|Period I|Administrative problem|0|||
23439721|NCT00615030|65352544|FG000|Period I|Protocol deviation|1|||
23439722|NCT00615030|65352545|FG001|Period I|Protocol deviation|0|||
23439723|NCT00615030|65352546|FG002|Period I|Protocol deviation|0|||
23439724|NCT00615030|65352547|FG003|Period I|Protocol deviation|0|||
23439725|NCT00615030|65352548|FG004|Period I|Protocol deviation|0|||
23439726|NCT00615030|65352549|FG005|Period I|Protocol deviation|0|||
23439727|NCT00615030|65352550|FG006|Period I|Protocol deviation|0|||
23439728|NCT00615030|65352551|FG007|Period I|Protocol deviation|0|||
23439729|NCT00615030|65352552|FG008|Period I|Protocol deviation|0|||
23439730|NCT00615030|65352553|FG009|Period I|Protocol deviation|0|||
23439731|NCT00615030|65352554|FG010|Period I|Protocol deviation|0|||
23439732|NCT00615030|65352555|FG011|Period I|Protocol deviation|0|||
23562392|NCT02202434|65790252|FG003|Overall Study|Completed Study|0|||
23562393|NCT02202434|65790249|FG000|Overall Study|Visit Missed|21|||
23562394|NCT02202434|65790250|FG001|Overall Study|Visit Missed|12|||
23562395|NCT02202434|65790251|FG002|Overall Study|Visit Missed|0|||
23562396|NCT02202434|65790252|FG003|Overall Study|Visit Missed|5|||
23562397|NCT02202434|65790249|FG000|Overall Study|Other|1|||
23562398|NCT02202434|65790250|FG001|Overall Study|Other|0|||
23562399|NCT02202434|65790251|FG002|Overall Study|Other|0|||
23562400|NCT02202434|65790252|FG003|Overall Study|Other|1|||
23562401|NCT04461795|65790253|FG000|Overall Study|Lost to Follow-up|2|||
23562402|NCT04461795|65790253|FG000|Overall Study|Withdrawal by Subject|2|||
23562403|NCT04461795|65790253|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
23562404|NCT00990340|65790256|FG000|First 14-day Treatment|Not Compliant|2|||
23562405|NCT00990340|65790257|FG001|First 14-day Treatment|Not Compliant|1|||
23562406|NCT00990340|65790256|FG000|First 14-day Treatment|Lost to Follow-up|2|||
23562407|NCT00990340|65790257|FG001|First 14-day Treatment|Lost to Follow-up|1|||
23562408|NCT00990340|65790256|FG000|First 14-day Treatment|Protocol Violation|2|||
23562409|NCT00990340|65790257|FG001|First 14-day Treatment|Protocol Violation|2|||
23562410|NCT00927355|65790258|FG000|Overall Study|Adverse Event|1|||
23562411|NCT00927355|65790259|FG001|Overall Study|Adverse Event|1|||
23562412|NCT00100932|65790263|FG000|Overall Study|Adverse Event|11|||
23562413|NCT00100932|65790264|FG001|Overall Study|Adverse Event|2|||
23562414|NCT00100932|65790263|FG000|Overall Study|Withdrawal by Subject|6|||
23562415|NCT00100932|65790264|FG001|Overall Study|Withdrawal by Subject|0|||
23562416|NCT00100932|65790263|FG000|Overall Study|Progressive Disease|44|||
23562417|NCT00100932|65790264|FG001|Overall Study|Progressive Disease|18|||
23562418|NCT00100932|65790263|FG000|Overall Study|Physician Decision|7|||
23562419|NCT00100932|65790264|FG001|Overall Study|Physician Decision|5|||
23562420|NCT00100932|65790263|FG000|Overall Study|Other|5|||
23562421|NCT00100932|65790264|FG001|Overall Study|Other|2|||
23562422|NCT03673462|65790265|FG000|Overall Study|Adverse Event|11|||
23562423|NCT03673462|65790266|FG001|Overall Study|Adverse Event|1|||
23562424|NCT03673462|65790265|FG000|Overall Study|Protocol Violation|25|||
23562425|NCT03673462|65790266|FG001|Overall Study|Protocol Violation|11|||
23562426|NCT03673462|65790265|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
23562427|NCT03673462|65790266|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
23562428|NCT03673462|65790265|FG000|Overall Study|Lost to Follow-up|102|||
23562429|NCT03673462|65790266|FG001|Overall Study|Lost to Follow-up|19|||
23562430|NCT01986881|65790267|FG000|Overall Study|Death|228|||
23562431|NCT01986881|65790268|FG001|Overall Study|Death|233|||
23562432|NCT01986881|65790269|FG002|Overall Study|Death|247|||
23151213|NCT01790126|64305398|FG002|Overall Study|Other|8|||
23151214|NCT01790126|64305396|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
23151215|NCT01790126|64305397|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
23151216|NCT01790126|64305398|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
23151217|NCT01790126|64305396|FG000|Overall Study|Withdrawal by Physician|1|||
23151218|NCT01790126|64305397|FG001|Overall Study|Withdrawal by Physician|1|||
23151219|NCT01790126|64305398|FG002|Overall Study|Withdrawal by Physician|2|||
23151220|NCT01790126|64305396|FG000|Overall Study|Withdrawal by Subject|3|||
23439733|NCT00615030|65352544|FG000|Period I|Subject withdrew consent|0|||
23562433|NCT01986881|65790267|FG000|Overall Study|Lost to Follow-up|51|||
23562434|NCT01986881|65790268|FG001|Overall Study|Lost to Follow-up|44|||
23625330|NCT01270828|66015468|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
23151221|NCT01790126|64305397|FG001|Overall Study|Withdrawal by Subject|1|||
23439734|NCT00615030|65352545|FG001|Period I|Subject withdrew consent|0|||
23439735|NCT00615030|65352546|FG002|Period I|Subject withdrew consent|0|||
23439736|NCT00615030|65352547|FG003|Period I|Subject withdrew consent|0|||
23439737|NCT00615030|65352548|FG004|Period I|Subject withdrew consent|0|||
23439738|NCT00615030|65352549|FG005|Period I|Subject withdrew consent|0|||
23439739|NCT00615030|65352550|FG006|Period I|Subject withdrew consent|0|||
23439740|NCT00615030|65352551|FG007|Period I|Subject withdrew consent|0|||
23562435|NCT01986881|65790269|FG002|Overall Study|Lost to Follow-up|55|||
23562436|NCT01986881|65790267|FG000|Overall Study|Physician Decision|7|||
23625331|NCT01270828|66015469|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
23562437|NCT01986881|65790268|FG001|Overall Study|Physician Decision|4|||
23562438|NCT01986881|65790269|FG002|Overall Study|Physician Decision|6|||
23562439|NCT01986881|65790267|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
23562440|NCT01986881|65790268|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
23562441|NCT01986881|65790269|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
23151222|NCT01790126|64305398|FG002|Overall Study|Withdrawal by Subject|2|||
23151223|NCT01790126|64305396|FG000|Overall Study|Lost to Follow-up|1|||
23151224|NCT01790126|64305397|FG001|Overall Study|Lost to Follow-up|0|||
23151225|NCT01790126|64305398|FG002|Overall Study|Lost to Follow-up|1|||
23151226|NCT01790126|64305396|FG000|Overall Study|Adverse Event|0|||
23151227|NCT01790126|64305397|FG001|Overall Study|Adverse Event|2|||
23151228|NCT01790126|64305398|FG002|Overall Study|Adverse Event|0|||
23151229|NCT01790126|64305396|FG000|Overall Study|Death|2|||
23151230|NCT01790126|64305397|FG001|Overall Study|Death|0|||
23151231|NCT01790126|64305398|FG002|Overall Study|Death|0|||
23151232|NCT01790126|64305396|FG000|Overall Study|Radiographic Progression|3|||
23151233|NCT01790126|64305397|FG001|Overall Study|Radiographic Progression|1|||
23151234|NCT01790126|64305398|FG002|Overall Study|Radiographic Progression|0|||
23151235|NCT00616434|64305403|FG000|Overall Study|Adverse Event|5|||
23151236|NCT00616434|64305404|FG001|Overall Study|Adverse Event|2|||
23151237|NCT00616434|64305403|FG000|Overall Study|Physician Decision|0|||
23151238|NCT00616434|64305404|FG001|Overall Study|Physician Decision|4|||
23151239|NCT00616434|64305403|FG000|Overall Study|Withdrawal by Subject|1|||
23151240|NCT00616434|64305404|FG001|Overall Study|Withdrawal by Subject|1|||
23151241|NCT00616434|64305403|FG000|Overall Study|Protocol deviation|0|||
23151242|NCT00616434|64305404|FG001|Overall Study|Protocol deviation|1|||
23151243|NCT01289821|64305406|FG000|Treatment Period|Withdrawal by Subject|1|||
23151244|NCT01289821|64305406|FG000|Treatment Period|Physician Decision|3|||
23151245|NCT01289821|64305406|FG000|Treatment Period|Adverse Event|4|||
23151246|NCT01289821|64305406|FG000|Treatment Period|Radiological Progression|43|||
23220041|NCT03907969|64550049|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
23220042|NCT03907969|64550050|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
23439741|NCT00615030|65352552|FG008|Period I|Subject withdrew consent|1|||
23439742|NCT00615030|65352553|FG009|Period I|Subject withdrew consent|0|||
23439743|NCT00615030|65352554|FG010|Period I|Subject withdrew consent|1|||
23439744|NCT00615030|65352555|FG011|Period I|Subject withdrew consent|1|||
23439745|NCT00615030|65352544|FG000|Period I|Abnormal laboratory value(s)|0|||
23439746|NCT00615030|65352545|FG001|Period I|Abnormal laboratory value(s)|0|||
23439747|NCT00615030|65352546|FG002|Period I|Abnormal laboratory value(s)|0|||
23439748|NCT00615030|65352547|FG003|Period I|Abnormal laboratory value(s)|0|||
23439749|NCT00615030|65352548|FG004|Period I|Abnormal laboratory value(s)|0|||
23439750|NCT00615030|65352549|FG005|Period I|Abnormal laboratory value(s)|1|||
23439751|NCT00615030|65352550|FG006|Period I|Abnormal laboratory value(s)|0|||
23439752|NCT00615030|65352551|FG007|Period I|Abnormal laboratory value(s)|0|||
23439753|NCT00615030|65352552|FG008|Period I|Abnormal laboratory value(s)|0|||
23439754|NCT00615030|65352553|FG009|Period I|Abnormal laboratory value(s)|0|||
23439755|NCT00615030|65352554|FG010|Period I|Abnormal laboratory value(s)|0|||
23439756|NCT00615030|65352555|FG011|Period I|Abnormal laboratory value(s)|0|||
23439757|NCT00615030|65352544|FG000|Period II|Adverse Event|0|||
23439758|NCT00615030|65352545|FG001|Period II|Adverse Event|0|||
23439759|NCT00615030|65352546|FG002|Period II|Adverse Event|1|||
23439760|NCT00615030|65352547|FG003|Period II|Adverse Event|0|||
23439761|NCT00615030|65352548|FG004|Period II|Adverse Event|0|||
23439762|NCT00615030|65352549|FG005|Period II|Adverse Event|0|||
23439763|NCT00615030|65352550|FG006|Period II|Adverse Event|0|||
23439764|NCT00615030|65352551|FG007|Period II|Adverse Event|0|||
23439765|NCT00615030|65352552|FG008|Period II|Adverse Event|1|||
23439766|NCT00615030|65352553|FG009|Period II|Adverse Event|0|||
23439767|NCT00615030|65352554|FG010|Period II|Adverse Event|0|||
23439768|NCT00615030|65352555|FG011|Period II|Adverse Event|0|||
23439769|NCT00615030|65352544|FG000|Period II|Subject withdrew consent|0|||
23562442|NCT01986881|65790267|FG000|Overall Study|Withdrawal by Subject|41|||
23562443|NCT01986881|65790268|FG001|Overall Study|Withdrawal by Subject|60|||
23562444|NCT01986881|65790269|FG002|Overall Study|Withdrawal by Subject|45|||
23562445|NCT01986881|65790267|FG000|Overall Study|Subject Moved|0|||
23151247|NCT01289821|64305406|FG000|Treatment Period|Clinical Progression|2|||
23151248|NCT01289821|64305406|FG000|Treatment Period|Therapeutic procedure required|1|||
23151249|NCT01289821|64305406|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
23439770|NCT00615030|65352545|FG001|Period II|Subject withdrew consent|0|||
23439771|NCT00615030|65352546|FG002|Period II|Subject withdrew consent|0|||
23562446|NCT01986881|65790268|FG001|Overall Study|Subject Moved|1|||
23562447|NCT01986881|65790269|FG002|Overall Study|Subject Moved|0|||
23151250|NCT01289821|64305406|FG000|Safety Follow-up Period|Protocol Violation|3|||
23151251|NCT01289821|64305406|FG000|Safety Follow-up Period|Unspecified reason|1|||
23220043|NCT03907969|64550051|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
23220044|NCT03907969|64550052|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
23439772|NCT00615030|65352547|FG003|Period II|Subject withdrew consent|1|||
23562448|NCT01986881|65790267|FG000|Overall Study|Other|1|||
23439773|NCT00615030|65352548|FG004|Period II|Subject withdrew consent|0|||
23562449|NCT01986881|65790268|FG001|Overall Study|Other|2|||
23562450|NCT01986881|65790269|FG002|Overall Study|Other|2|||
23562451|NCT02002884|65790274|FG000|Main Period (MP)|Other|0|||
23562452|NCT02002884|65790275|FG001|Main Period (MP)|Other|3|||
23562453|NCT02002884|65790276|FG002|Main Period (MP)|Other|3|||
23562454|NCT02002884|65790277|FG003|Main Period (MP)|Other|0|||
23562455|NCT02002884|65790274|FG000|Main Period (MP)|Adverse Event|0|||
23439774|NCT00615030|65352549|FG005|Period II|Subject withdrew consent|0|||
23439775|NCT00615030|65352550|FG006|Period II|Subject withdrew consent|1|||
23439776|NCT00615030|65352551|FG007|Period II|Subject withdrew consent|0|||
23439777|NCT00615030|65352552|FG008|Period II|Subject withdrew consent|0|||
23439778|NCT00615030|65352553|FG009|Period II|Subject withdrew consent|0|||
23439779|NCT00615030|65352554|FG010|Period II|Subject withdrew consent|0|||
23562456|NCT02002884|65790275|FG001|Main Period (MP)|Adverse Event|1|||
23562457|NCT02002884|65790276|FG002|Main Period (MP)|Adverse Event|1|||
23562458|NCT02002884|65790277|FG003|Main Period (MP)|Adverse Event|0|||
23562459|NCT02002884|65790274|FG000|Main Period (MP)|Withdrawal by Subject|6|||
23562460|NCT02002884|65790275|FG001|Main Period (MP)|Withdrawal by Subject|2|||
23562461|NCT02002884|65790276|FG002|Main Period (MP)|Withdrawal by Subject|2|||
23562462|NCT02002884|65790277|FG003|Main Period (MP)|Withdrawal by Subject|0|||
23562463|NCT02002884|65790274|FG000|Main Period (MP)|Lost to Follow-up|0|||
23562464|NCT02002884|65790275|FG001|Main Period (MP)|Lost to Follow-up|0|||
23562465|NCT02002884|65790276|FG002|Main Period (MP)|Lost to Follow-up|2|||
23562466|NCT02002884|65790277|FG003|Main Period (MP)|Lost to Follow-up|0|||
23562467|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Other|0|||
23562468|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Other|0|||
23562469|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Other|0|||
23562470|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Other|24|||
23439780|NCT00615030|65352555|FG011|Period II|Subject withdrew consent|0|||
23439781|NCT00615030|65352544|FG000|Period III|Administrative problems|1|||
23439782|NCT00615030|65352545|FG001|Period III|Administrative problems|0|||
23439783|NCT00615030|65352546|FG002|Period III|Administrative problems|0|||
23439784|NCT00615030|65352547|FG003|Period III|Administrative problems|1|||
23562471|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
23562472|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
23562473|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
23562474|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
23562475|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
23562476|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
23562477|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
23151252|NCT01289821|64305406|FG000|Survival Follow-up Period|Protocol Violation|1|||
23151253|NCT01289821|64305406|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
23439785|NCT00615030|65352548|FG004|Period III|Administrative problems|0|||
23439786|NCT00615030|65352549|FG005|Period III|Administrative problems|0|||
23439787|NCT00615030|65352550|FG006|Period III|Administrative problems|0|||
23439788|NCT00615030|65352551|FG007|Period III|Administrative problems|0|||
23439789|NCT00615030|65352552|FG008|Period III|Administrative problems|0|||
23439790|NCT00615030|65352553|FG009|Period III|Administrative problems|0|||
23439791|NCT00615030|65352554|FG010|Period III|Administrative problems|0|||
23439792|NCT00615030|65352555|FG011|Period III|Administrative problems|0|||
23439793|NCT00958165|65352556|FG000|Overall Study|Lost to Follow-up|5|||
23439794|NCT00958165|65352556|FG000|Overall Study|Not eligible|9|||
23439795|NCT01235234|65352558|FG000|Overall Study|Adverse Event|2|||
23439796|NCT01235234|65352559|FG001|Overall Study|Adverse Event|2|||
23439797|NCT01235234|65352560|FG002|Overall Study|Adverse Event|1|||
23439798|NCT02663622|65352561|FG000|Overall Study|Death|3|||
23439799|NCT02663622|65352562|FG001|Overall Study|Death|1|||
23439800|NCT02663622|65352563|FG002|Overall Study|Death|1|||
23439801|NCT02663622|65352564|FG003|Overall Study|Death|8|||
23562478|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
23562479|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
23562480|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
23562481|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
23562482|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
23151254|NCT01289821|64305406|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
23151255|NCT04695392|64305407|FG000|Overall Study|Withdrawn by parent/guardian|0|||
23439802|NCT02663622|65352561|FG000|Overall Study|Protocol Violation|0|||
23439803|NCT02663622|65352562|FG001|Overall Study|Protocol Violation|0|||
23439804|NCT02663622|65352563|FG002|Overall Study|Protocol Violation|0|||
23439805|NCT02663622|65352564|FG003|Overall Study|Protocol Violation|1|||
23439806|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Adverse Event|3|||
23439807|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Adverse Event|0|||
23439808|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
23439809|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
23439810|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Physician Decision|1|||
23439811|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Physician Decision|0|||
23439812|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
23439813|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
23439814|NCT02081599|65352566|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
23439815|NCT02081599|65352567|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
23439816|NCT02081599|65352566|FG000|Period 1：Double-blind Period|stopping criteria|1|||
23439817|NCT02081599|65352567|FG001|Period 1：Double-blind Period|stopping criteria|0|||
23439818|NCT02081599|65352566|FG000|Period 2：Open-label Period|Adverse Event|1|||
23439819|NCT02081599|65352567|FG001|Period 2：Open-label Period|Adverse Event|0|||
23439820|NCT02081599|65352566|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
23439821|NCT02081599|65352567|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
23439822|NCT02081599|65352566|FG000|Period 2：Open-label Period|Physician Decision|1|||
23439823|NCT02081599|65352567|FG001|Period 2：Open-label Period|Physician Decision|0|||
23562483|NCT02002884|65790274|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
23562484|NCT02002884|65790275|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
23562485|NCT02002884|65790276|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
23562486|NCT02002884|65790277|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
23562487|NCT01755702|65790284|FG000|Wash Out Period I|Other Reason|3|||
23562488|NCT01755702|65790284|FG000|Washout Period II|Other Reason|5|||
23562489|NCT05340751|65790285|FG000|Overall Study|Physician Decision|3|||
23562490|NCT01396317|65790286|FG000|Overall Study|Adverse Event|1|||
23439824|NCT02081599|65352566|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
23439825|NCT02081599|65352567|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
23439826|NCT01301833|65352570|FG000|Overall Study|Adverse Event|7|||
23439827|NCT01301833|65352571|FG001|Overall Study|Adverse Event|5|||
23562491|NCT01396317|65790287|FG001|Overall Study|Adverse Event|0|||
23562492|NCT01119768|65790292|FG000|Treatment Period|Lack of Efficacy|18|||
23562493|NCT01119768|65790293|FG001|Treatment Period|Lack of Efficacy|25|||
23562494|NCT01919970|65790297|FG000|Overall Study|Withdrawal by Subject|3|||
23562495|NCT01919970|65790298|FG001|Overall Study|Withdrawal by Subject|0|||
23562496|NCT00510458|65790299|FG000|Overall Study|5 year not evaluable/missed|21|||
23562497|NCT00510458|65790299|FG000|Overall Study|Death|1|||
23562498|NCT00510458|65790299|FG000|Overall Study|Terminated|14|||
23562499|NCT00510458|65790299|FG000|Overall Study|Lost to Follow-up|6|||
23562500|NCT00510458|65790299|FG000|Overall Study|Withdrawal by Subject|3|||
23562501|NCT00510458|65790299|FG000|Overall Study|Revision|2|||
23562502|NCT02613221|65790300|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
23562503|NCT02613221|65790300|FG000|Overall Study|Adverse Event|2|||
23562504|NCT02613221|65790300|FG000|Overall Study|Voluntary Discontinuation|1|||
23562505|NCT02613221|65790300|FG000|Overall Study|Delayed Treatment|1|||
23562506|NCT02613221|65790300|FG000|Overall Study|Enrolled but Not Treated|1|||
23562507|NCT01352585|65790301|FG000|Overall Study|Adverse Event|2|||
23562508|NCT01352585|65790302|FG001|Overall Study|Adverse Event|1|||
23562509|NCT01352585|65790301|FG000|Overall Study|Lost to Follow-up|1|||
23562510|NCT01352585|65790302|FG001|Overall Study|Lost to Follow-up|0|||
23562511|NCT01352585|65790301|FG000|Overall Study|Other|5|||
23562512|NCT01352585|65790302|FG001|Overall Study|Other|2|||
23562513|NCT00041756|65790303|FG000|Overall Study|Adverse Event|4|||
23562514|NCT00041756|65790304|FG001|Overall Study|Adverse Event|10|||
23562515|NCT00041756|65790305|FG002|Overall Study|Adverse Event|6|||
23562516|NCT00041756|65790306|FG003|Overall Study|Adverse Event|11|||
23562517|NCT00041756|65790307|FG004|Overall Study|Adverse Event|34|||
23562518|NCT00041756|65790303|FG000|Overall Study|Protocol Violation|1|||
23562519|NCT00041756|65790304|FG001|Overall Study|Protocol Violation|1|||
23562520|NCT00041756|65790305|FG002|Overall Study|Protocol Violation|2|||
23562521|NCT00041756|65790306|FG003|Overall Study|Protocol Violation|2|||
23562522|NCT00041756|65790307|FG004|Overall Study|Protocol Violation|1|||
23562523|NCT00041756|65790303|FG000|Overall Study|Withdrawal by Subject|3|||
23562524|NCT00041756|65790304|FG001|Overall Study|Withdrawal by Subject|3|||
23562525|NCT00041756|65790305|FG002|Overall Study|Withdrawal by Subject|4|||
23562526|NCT00041756|65790306|FG003|Overall Study|Withdrawal by Subject|2|||
23562527|NCT00041756|65790307|FG004|Overall Study|Withdrawal by Subject|3|||
23562528|NCT00041756|65790303|FG000|Overall Study|Lost to Follow-up|0|||
23562529|NCT00041756|65790304|FG001|Overall Study|Lost to Follow-up|1|||
23562530|NCT00041756|65790305|FG002|Overall Study|Lost to Follow-up|0|||
23562531|NCT00041756|65790306|FG003|Overall Study|Lost to Follow-up|1|||
23562532|NCT00041756|65790307|FG004|Overall Study|Lost to Follow-up|0|||
23439828|NCT01301833|65352572|FG002|Overall Study|Adverse Event|5|||
23439829|NCT01301833|65352573|FG003|Overall Study|Adverse Event|5|||
23439830|NCT01301833|65352570|FG000|Overall Study|Lack of Efficacy|1|||
23439831|NCT01301833|65352571|FG001|Overall Study|Lack of Efficacy|1|||
23439832|NCT01301833|65352572|FG002|Overall Study|Lack of Efficacy|0|||
23439833|NCT01301833|65352573|FG003|Overall Study|Lack of Efficacy|0|||
23439834|NCT01301833|65352570|FG000|Overall Study|Physician Decision|3|||
23562533|NCT00041756|65790303|FG000|Overall Study|Unable to meet protocol criteria|0|||
23439835|NCT01301833|65352571|FG001|Overall Study|Physician Decision|1|||
23439836|NCT01301833|65352572|FG002|Overall Study|Physician Decision|1|||
23562534|NCT00041756|65790304|FG001|Overall Study|Unable to meet protocol criteria|0|||
23562535|NCT00041756|65790305|FG002|Overall Study|Unable to meet protocol criteria|1|||
23562536|NCT00041756|65790306|FG003|Overall Study|Unable to meet protocol criteria|0|||
23562537|NCT00041756|65790307|FG004|Overall Study|Unable to meet protocol criteria|1|||
23562538|NCT00041756|65790303|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
23562539|NCT00041756|65790304|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
23562540|NCT00041756|65790305|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
23562541|NCT00041756|65790306|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
23562542|NCT00041756|65790307|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
23562543|NCT01013792|65790308|FG000|Overall Study|Study suspended|2|||
23562544|NCT01013792|65790309|FG001|Overall Study|Study suspended|1|||
23562545|NCT01013792|65790308|FG000|Overall Study|Adverse Event|0|||
23562546|NCT01013792|65790309|FG001|Overall Study|Adverse Event|3|||
23439837|NCT01301833|65352573|FG003|Overall Study|Physician Decision|0|||
23439838|NCT01301833|65352570|FG000|Overall Study|Withdrawal by Subject|3|||
23439839|NCT01301833|65352571|FG001|Overall Study|Withdrawal by Subject|1|||
23439840|NCT01301833|65352572|FG002|Overall Study|Withdrawal by Subject|1|||
23439841|NCT01301833|65352573|FG003|Overall Study|Withdrawal by Subject|2|||
23562547|NCT01013792|65790308|FG000|Overall Study|Lost to Follow-up|0|||
23562548|NCT01013792|65790309|FG001|Overall Study|Lost to Follow-up|1|||
23562549|NCT04555096|65790312|FG000|Overall Study|Death|4|||
23562550|NCT04555096|65790313|FG001|Overall Study|Death|4|||
23562551|NCT04555096|65790312|FG000|Overall Study|Withdrawal by Subject|1|||
23562552|NCT04555096|65790313|FG001|Overall Study|Withdrawal by Subject|0|||
23562553|NCT04555096|65790312|FG000|Overall Study|Other|0|||
23562554|NCT04555096|65790313|FG001|Overall Study|Other|1|||
23562555|NCT01852058|65790314|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
23562556|NCT01852058|65790315|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562557|NCT01852058|65790316|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562558|NCT01852058|65790317|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562559|NCT01852058|65790318|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562560|NCT01852058|65790319|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562561|NCT01852058|65790320|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562562|NCT01852058|65790321|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562563|NCT01852058|65790322|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562564|NCT01852058|65790323|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23439842|NCT01301833|65352570|FG000|Overall Study|Personal matter|1|||
23439843|NCT01301833|65352571|FG001|Overall Study|Personal matter|0|||
23439844|NCT01301833|65352572|FG002|Overall Study|Personal matter|0|||
23439845|NCT01301833|65352573|FG003|Overall Study|Personal matter|0|||
23562565|NCT01852058|65790324|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562566|NCT01852058|65790325|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
23562567|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562568|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562569|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562570|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562571|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
23151256|NCT04695392|64305408|FG001|Overall Study|Withdrawn by parent/guardian|1|||
23439846|NCT01943591|65352574|FG000|Overall Study|Lost to Follow-up|3|||
23439847|NCT01943591|65352575|FG001|Overall Study|Lost to Follow-up|4|||
23151257|NCT04695392|64305407|FG000|Overall Study|Withdrawn by physician|0|||
23151258|NCT04695392|64305408|FG001|Overall Study|Withdrawn by physician|1|||
23439848|NCT01943591|65352574|FG000|Overall Study|Death|2|||
23439849|NCT01943591|65352575|FG001|Overall Study|Death|7|||
23439850|NCT00372697|65352578|FG000|Overall Study|Protocol Violation|1|||
23439851|NCT00372697|65352579|FG001|Overall Study|Protocol Violation|1|||
23439852|NCT00534976|65352584|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
23439853|NCT00534976|65352585|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
23439854|NCT00534976|65352584|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
23439855|NCT00534976|65352585|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
23439856|NCT00534976|65352584|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
23439857|NCT00534976|65352585|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
23325098|NCT01890122|64933703|FG000|Overall Study|Lost to Follow-up|0|||
23439858|NCT01007838|65352588|FG000|Overall Study|Withdrawal by Subject|1|||
23439859|NCT01007838|65352589|FG001|Overall Study|Withdrawal by Subject|0|||
23439860|NCT01007838|65352590|FG002|Overall Study|Withdrawal by Subject|0|||
23439861|NCT01007838|65352591|FG003|Overall Study|Withdrawal by Subject|0|||
23439862|NCT01007838|65352588|FG000|Overall Study|Physician Decision|1|||
23439863|NCT01007838|65352589|FG001|Overall Study|Physician Decision|0|||
23562572|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562573|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23439864|NCT01007838|65352590|FG002|Overall Study|Physician Decision|0|||
23439865|NCT01007838|65352591|FG003|Overall Study|Physician Decision|0|||
23439866|NCT01007838|65352588|FG000|Overall Study|Started home haemodialysis|1|||
23439867|NCT01007838|65352589|FG001|Overall Study|Started home haemodialysis|0|||
23439868|NCT01007838|65352590|FG002|Overall Study|Started home haemodialysis|0|||
23439869|NCT01007838|65352591|FG003|Overall Study|Started home haemodialysis|0|||
23439870|NCT01748825|65352592|FG000|Dose Escalation|Refused further treatment|2|||
23439871|NCT01748825|65352593|FG001|Dose Escalation|Refused further treatment|2|||
23439872|NCT01748825|65352594|FG002|Dose Escalation|Refused further treatment|0|||
23439873|NCT01748825|65352595|FG003|Dose Escalation|Refused further treatment|0|||
23439874|NCT01748825|65352596|FG004|Dose Escalation|Refused further treatment|1|||
23439875|NCT01748825|65352597|FG005|Dose Escalation|Refused further treatment|2|||
23439876|NCT01748825|65352598|FG006|Dose Escalation|Refused further treatment|0|||
23439877|NCT01748825|65352599|FG007|Dose Escalation|Refused further treatment|0|||
23439878|NCT01748825|65352600|FG008|Dose Escalation|Refused further treatment|0|||
23439879|NCT01748825|65352601|FG009|Dose Escalation|Refused further treatment|0|||
23439880|NCT01748825|65352592|FG000|Dose Escalation|Switched to alternative treatment|0|||
23439881|NCT01748825|65352593|FG001|Dose Escalation|Switched to alternative treatment|0|||
23439882|NCT01748825|65352594|FG002|Dose Escalation|Switched to alternative treatment|0|||
23439883|NCT01748825|65352595|FG003|Dose Escalation|Switched to alternative treatment|1|||
23439884|NCT01748825|65352596|FG004|Dose Escalation|Switched to alternative treatment|0|||
23439885|NCT01748825|65352597|FG005|Dose Escalation|Switched to alternative treatment|0|||
23562574|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562575|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562576|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562577|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562578|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
23562579|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562580|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562581|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562582|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562583|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
23562584|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
23562585|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562586|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562587|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562588|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562589|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562590|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
23562591|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562592|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562593|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562594|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23151259|NCT00992511|64305409|FG000|Overall Study|Migrated/moved from study area|1|||
23151260|NCT00992511|64305410|FG001|Overall Study|Migrated/moved from study area|0|||
23151261|NCT00992511|64305411|FG002|Overall Study|Migrated/moved from study area|1|||
23151262|NCT00992511|64305412|FG003|Overall Study|Migrated/moved from study area|2|||
23151263|NCT00992511|64305409|FG000|Overall Study|Lost to Follow-up|1|||
23151264|NCT00992511|64305410|FG001|Overall Study|Lost to Follow-up|0|||
23151265|NCT00992511|64305411|FG002|Overall Study|Lost to Follow-up|0|||
23151266|NCT00992511|64305412|FG003|Overall Study|Lost to Follow-up|2|||
23151267|NCT00992511|64305409|FG000|Overall Study|Withdrawal by Subject|0|||
23151268|NCT00992511|64305410|FG001|Overall Study|Withdrawal by Subject|0|||
23151269|NCT00992511|64305411|FG002|Overall Study|Withdrawal by Subject|1|||
23151270|NCT00992511|64305412|FG003|Overall Study|Withdrawal by Subject|1|||
23151271|NCT02495233|64305415|FG000|Overall Study|Miscellaneous|0|||
23151272|NCT02495233|64305416|FG001|Overall Study|Miscellaneous|1|||
23151273|NCT00928564|64305418|FG000|Overall Study|Lost to Follow-up|6|||
23151274|NCT00928564|64305419|FG001|Overall Study|Lost to Follow-up|0|||
23151275|NCT01383096|64305420|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
23151276|NCT01383096|64305421|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
23151277|NCT01383096|64305422|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
23151278|NCT01383096|64305420|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
23151279|NCT01383096|64305421|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
23151280|NCT01383096|64305422|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
23439886|NCT01748825|65352598|FG006|Dose Escalation|Switched to alternative treatment|0|||
23439887|NCT01748825|65352599|FG007|Dose Escalation|Switched to alternative treatment|0|||
23439888|NCT01748825|65352600|FG008|Dose Escalation|Switched to alternative treatment|0|||
23562595|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
23439889|NCT01748825|65352601|FG009|Dose Escalation|Switched to alternative treatment|0|||
23439890|NCT01748825|65352592|FG000|Dose Escalation|Adverse Event|0|||
23439891|NCT01748825|65352593|FG001|Dose Escalation|Adverse Event|0|||
23439892|NCT01748825|65352594|FG002|Dose Escalation|Adverse Event|0|||
23439893|NCT01748825|65352595|FG003|Dose Escalation|Adverse Event|0|||
23439894|NCT01748825|65352596|FG004|Dose Escalation|Adverse Event|0|||
23439895|NCT01748825|65352597|FG005|Dose Escalation|Adverse Event|0|||
23325099|NCT01890122|64933704|FG001|Overall Study|Lost to Follow-up|1|||
23325100|NCT01890122|64933705|FG002|Overall Study|Lost to Follow-up|2|||
23325101|NCT01890122|64933706|FG003|Overall Study|Lost to Follow-up|2|||
23325102|NCT01890122|64933703|FG000|Overall Study|Voluntary Withdrawal|8|||
23439896|NCT01748825|65352598|FG006|Dose Escalation|Adverse Event|1|||
23439897|NCT01748825|65352599|FG007|Dose Escalation|Adverse Event|0|||
23439898|NCT01748825|65352600|FG008|Dose Escalation|Adverse Event|0|||
23439899|NCT01748825|65352601|FG009|Dose Escalation|Adverse Event|0|||
23325103|NCT01890122|64933704|FG001|Overall Study|Voluntary Withdrawal|8|||
23325104|NCT01890122|64933705|FG002|Overall Study|Voluntary Withdrawal|2|||
23325105|NCT01890122|64933706|FG003|Overall Study|Voluntary Withdrawal|11|||
23325106|NCT01890122|64933703|FG000|Overall Study|Lack of Efficacy|14|||
23325107|NCT01890122|64933704|FG001|Overall Study|Lack of Efficacy|24|||
23325108|NCT01890122|64933705|FG002|Overall Study|Lack of Efficacy|7|||
23325109|NCT01890122|64933706|FG003|Overall Study|Lack of Efficacy|41|||
23325110|NCT01890122|64933703|FG000|Overall Study|Reason not Specified|0|||
23325111|NCT01890122|64933704|FG001|Overall Study|Reason not Specified|1|||
23325112|NCT01890122|64933705|FG002|Overall Study|Reason not Specified|1|||
23325113|NCT01890122|64933706|FG003|Overall Study|Reason not Specified|2|||
23325114|NCT01890122|64933703|FG000|Overall Study|Randomized but not Treated|1|||
23325115|NCT01890122|64933704|FG001|Overall Study|Randomized but not Treated|1|||
23325116|NCT01890122|64933705|FG002|Overall Study|Randomized but not Treated|0|||
23325117|NCT01890122|64933706|FG003|Overall Study|Randomized but not Treated|0|||
23325118|NCT01827111|64933707|FG000|Overall Study|Disease Progression|1|||
23439900|NCT01748825|65352592|FG000|Dose Expansion|Refused further treatment|0|||
23439901|NCT01748825|65352593|FG001|Dose Expansion|Refused further treatment|0|||
23439902|NCT01748825|65352594|FG002|Dose Expansion|Refused further treatment|0|||
23625332|NCT01270828|66015467|FG000|Pregabalin CR SB|Related adverse event|0|||
23625333|NCT01270828|66015468|FG001|Pregabalin CR SB|Related adverse event|0|||
23625334|NCT01270828|66015469|FG002|Pregabalin CR SB|Related adverse event|46|||
23625335|NCT01270828|66015467|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
23625336|NCT01270828|66015468|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
23625337|NCT01270828|66015469|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
23625338|NCT01270828|66015467|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
23625339|NCT01270828|66015468|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
23625340|NCT01270828|66015469|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
23625341|NCT01270828|66015467|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
23625342|NCT01270828|66015468|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
23625343|NCT01270828|66015469|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
23625344|NCT01270828|66015467|FG000|Pregabalin CR SB|Unrelated AE|0|||
23625345|NCT01270828|66015468|FG001|Pregabalin CR SB|Unrelated AE|0|||
23625346|NCT01270828|66015469|FG002|Pregabalin CR SB|Unrelated AE|8|||
23625347|NCT01270828|66015467|FG000|Pregabalin CR SB|Protocol Violation|0|||
23625348|NCT01270828|66015468|FG001|Pregabalin CR SB|Protocol Violation|0|||
23625349|NCT01270828|66015469|FG002|Pregabalin CR SB|Protocol Violation|8|||
23625350|NCT01270828|66015467|FG000|Double Blind Phase|Death|0|||
23151281|NCT01383096|64305420|FG000|Third Intervention (8 Days)|Elevated AST|0|||
23151282|NCT01383096|64305421|FG001|Third Intervention (8 Days)|Elevated AST|1|||
23151283|NCT01383096|64305422|FG002|Third Intervention (8 Days)|Elevated AST|0|||
23151284|NCT01383096|64305420|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
23151285|NCT01383096|64305421|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
23151286|NCT01383096|64305422|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
23151287|NCT01383096|64305420|FG000|Third Intervention (8 Days)|Adverse Event|1|||
23151288|NCT01383096|64305421|FG001|Third Intervention (8 Days)|Adverse Event|0|||
23151289|NCT01383096|64305422|FG002|Third Intervention (8 Days)|Adverse Event|0|||
23151290|NCT01383096|64305420|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
23151291|NCT01383096|64305421|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
23625351|NCT01270828|66015468|FG001|Double Blind Phase|Death|1|||
23625352|NCT01270828|66015469|FG002|Double Blind Phase|Death|0|||
23625353|NCT01270828|66015467|FG000|Double Blind Phase|Protocol Violation|0|||
23625354|NCT01270828|66015468|FG001|Double Blind Phase|Protocol Violation|1|||
23151292|NCT01383096|64305422|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
23325119|NCT00570063|64933708|FG000|Overall Study|Adverse Event|4|||
23325120|NCT00570063|64933709|FG001|Overall Study|Adverse Event|1|||
23325121|NCT00570063|64933708|FG000|Overall Study|Lack of Efficacy|0|||
23439903|NCT01748825|65352595|FG003|Dose Expansion|Refused further treatment|0|||
23325122|NCT00570063|64933709|FG001|Overall Study|Lack of Efficacy|1|||
23439904|NCT01748825|65352596|FG004|Dose Expansion|Refused further treatment|0|||
23325123|NCT00570063|64933708|FG000|Overall Study|Withdrawal by Subject|4|||
23625355|NCT01270828|66015469|FG002|Double Blind Phase|Protocol Violation|0|||
23325124|NCT00570063|64933709|FG001|Overall Study|Withdrawal by Subject|3|||
23325125|NCT00570063|64933708|FG000|Overall Study|Sponsor's Decision|7|||
23562596|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562597|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562598|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562599|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562600|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562601|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562602|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
23562603|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562604|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562605|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562606|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562607|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
23151293|NCT01383096|64305420|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
23151294|NCT01383096|64305421|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
23151295|NCT01383096|64305422|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
23151296|NCT01383096|64305420|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
23151297|NCT01383096|64305421|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
23151298|NCT01383096|64305422|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
23151299|NCT01383096|64305420|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
23151300|NCT01383096|64305421|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
23151301|NCT01383096|64305422|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
23562608|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
23562609|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562610|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562611|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562612|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562613|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562614|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
23562615|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562616|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562617|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562618|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
23562619|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562620|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562621|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562622|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562623|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562624|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562625|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562626|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
23562627|NCT01852058|65790314|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562628|NCT01852058|65790315|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562629|NCT01852058|65790316|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562630|NCT01852058|65790317|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562631|NCT01852058|65790318|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
23562632|NCT01852058|65790319|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
23562633|NCT01852058|65790320|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562634|NCT01852058|65790321|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562635|NCT01852058|65790322|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562636|NCT01852058|65790323|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562637|NCT01852058|65790324|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562638|NCT01852058|65790325|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
23562639|NCT01852058|65790314|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562640|NCT01852058|65790315|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562641|NCT01852058|65790316|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562642|NCT01852058|65790317|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562643|NCT01852058|65790318|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562644|NCT01852058|65790319|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562645|NCT01852058|65790320|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23625356|NCT01270828|66015467|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
23151302|NCT01383096|64305420|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
23151303|NCT01383096|64305421|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
23325126|NCT00570063|64933709|FG001|Overall Study|Sponsor's Decision|3|||
23325127|NCT02394600|64933710|FG000|Overall Study|Adverse Event|3|||
23325128|NCT02394600|64933711|FG001|Overall Study|Adverse Event|0|||
23325129|NCT02394600|64933710|FG000|Overall Study|Lost to Follow-up|0|||
23325130|NCT02394600|64933711|FG001|Overall Study|Lost to Follow-up|1|||
23325131|NCT02394600|64933710|FG000|Overall Study|Withdrawal by Subject|0|||
23325132|NCT02394600|64933711|FG001|Overall Study|Withdrawal by Subject|1|||
23325133|NCT02394600|64933710|FG000|Overall Study|Protocol Violation|1|||
23325134|NCT02394600|64933711|FG001|Overall Study|Protocol Violation|0|||
23325135|NCT03564119|64933712|FG000|Overall Study|Adverse Event|4|||
23325136|NCT03564119|64933713|FG001|Overall Study|Adverse Event|0|||
23325137|NCT03564119|64933712|FG000|Overall Study|Lost to Follow-up|1|||
23625357|NCT01270828|66015468|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
23625358|NCT01270828|66015469|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
23625359|NCT01270828|66015467|FG000|Double Blind Phase|Reason Unspecified|7|||
23625360|NCT01270828|66015468|FG001|Double Blind Phase|Reason Unspecified|4|||
23625361|NCT01270828|66015469|FG002|Double Blind Phase|Reason Unspecified|0|||
23625362|NCT01270828|66015467|FG000|Double Blind Phase|Withdrawal by Subject|6|||
23625363|NCT01270828|66015468|FG001|Double Blind Phase|Withdrawal by Subject|15|||
23151304|NCT01383096|64305422|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
23325138|NCT03564119|64933713|FG001|Overall Study|Lost to Follow-up|4|||
23325139|NCT03564119|64933712|FG000|Overall Study|Protocol Violation|1|||
23325140|NCT03564119|64933713|FG001|Overall Study|Protocol Violation|0|||
23325141|NCT03564119|64933712|FG000|Overall Study|Withdrawal by Subject|9|||
23325142|NCT03564119|64933713|FG001|Overall Study|Withdrawal by Subject|4|||
23325143|NCT03564119|64933712|FG000|Overall Study|Other Than Specified|0|||
23325144|NCT03564119|64933713|FG001|Overall Study|Other Than Specified|1|||
23325145|NCT05377749|64933714|FG000|3 Weeks|Lost to Follow-up|2|||
23325146|NCT05377749|64933715|FG001|3 Weeks|Lost to Follow-up|4|||
23325147|NCT05377749|64933714|FG000|3 Weeks|Withdrawal by Subject|1|||
23325148|NCT05377749|64933715|FG001|3 Weeks|Withdrawal by Subject|1|||
23325149|NCT00662649|64933718|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
23325150|NCT00662649|64933719|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
23439905|NCT01748825|65352597|FG005|Dose Expansion|Refused further treatment|0|||
23151305|NCT01383096|64305420|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
23151306|NCT01383096|64305421|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
23151307|NCT01383096|64305422|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
23151308|NCT04166383|64305423|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
23220045|NCT03907969|64550053|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
23220046|NCT03907969|64550054|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
23220047|NCT03907969|64550055|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
23220048|NCT03907969|64550056|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
23220049|NCT03907969|64550046|FG000|Monotherapy Part A|Progressive Disease|0|||
23220050|NCT03907969|64550047|FG001|Monotherapy Part A|Progressive Disease|1|||
23220051|NCT03907969|64550048|FG002|Monotherapy Part A|Progressive Disease|0|||
23220052|NCT03907969|64550049|FG003|Monotherapy Part A|Progressive Disease|0|||
23220053|NCT03907969|64550050|FG004|Monotherapy Part A|Progressive Disease|0|||
23220054|NCT03907969|64550051|FG005|Monotherapy Part A|Progressive Disease|1|||
23220055|NCT03907969|64550052|FG006|Monotherapy Part A|Progressive Disease|2|||
23220056|NCT03907969|64550053|FG007|Monotherapy Part A|Progressive Disease|0|||
23220057|NCT03907969|64550054|FG008|Monotherapy Part A|Progressive Disease|0|||
23220058|NCT03907969|64550055|FG009|Monotherapy Part A|Progressive Disease|0|||
23220059|NCT03907969|64550056|FG010|Monotherapy Part A|Progressive Disease|0|||
23220060|NCT03907969|64550046|FG000|Monotherapy Part A|Death|0|||
23220061|NCT03907969|64550047|FG001|Monotherapy Part A|Death|0|||
23220062|NCT03907969|64550048|FG002|Monotherapy Part A|Death|1|||
23220063|NCT03907969|64550049|FG003|Monotherapy Part A|Death|1|||
23220064|NCT03907969|64550050|FG004|Monotherapy Part A|Death|0|||
23220065|NCT03907969|64550051|FG005|Monotherapy Part A|Death|1|||
23220066|NCT03907969|64550052|FG006|Monotherapy Part A|Death|0|||
23220067|NCT03907969|64550053|FG007|Monotherapy Part A|Death|0|||
23220068|NCT03907969|64550054|FG008|Monotherapy Part A|Death|0|||
23220069|NCT03907969|64550055|FG009|Monotherapy Part A|Death|0|||
23220070|NCT03907969|64550056|FG010|Monotherapy Part A|Death|0|||
23220071|NCT03907969|64550046|FG000|Combination Therapy Part A|Adverse Event|0|||
23220072|NCT03907969|64550047|FG001|Combination Therapy Part A|Adverse Event|0|||
23325151|NCT00662649|64933720|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
23325152|NCT00662649|64933721|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
23325153|NCT00662649|64933722|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
23439906|NCT01748825|65352598|FG006|Dose Expansion|Refused further treatment|0|||
23325154|NCT00662649|64933718|FG000|Core Study (24 Months)|Adverse Event|22|||
23325155|NCT00662649|64933719|FG001|Core Study (24 Months)|Adverse Event|13|||
23325156|NCT00662649|64933720|FG002|Core Study (24 Months)|Adverse Event|18|||
23325157|NCT00662649|64933721|FG003|Core Study (24 Months)|Adverse Event|0|||
23151309|NCT04166383|64305423|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
23151310|NCT04166383|64305423|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
23151311|NCT00907257|64305428|FG000|Overall Study|Adverse Event|0|||
23151312|NCT00907257|64305429|FG001|Overall Study|Adverse Event|4|||
23151313|NCT00907257|64305428|FG000|Overall Study|Protocol Violation|1|||
23151314|NCT00907257|64305429|FG001|Overall Study|Protocol Violation|2|||
23151315|NCT00907257|64305428|FG000|Overall Study|Lost to Follow-up|3|||
23151316|NCT00907257|64305429|FG001|Overall Study|Lost to Follow-up|3|||
23151317|NCT00907257|64305428|FG000|Overall Study|Withdrawal by Subject|1|||
23151318|NCT00907257|64305429|FG001|Overall Study|Withdrawal by Subject|2|||
23151319|NCT00907257|64305428|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
23151320|NCT00907257|64305429|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
23151321|NCT00907257|64305428|FG000|Overall Study|Moved|1|||
23151322|NCT00907257|64305429|FG001|Overall Study|Moved|0|||
23151323|NCT00907257|64305428|FG000|Overall Study|Personal Reasons|6|||
23151324|NCT00907257|64305429|FG001|Overall Study|Personal Reasons|1|||
23151325|NCT03224325|64305434|FG000|Overall Study|Adverse Event|1|||
23151326|NCT03224325|64305435|FG001|Overall Study|Adverse Event|0|||
23151327|NCT03224325|64305436|FG002|Overall Study|Adverse Event|0|||
23151328|NCT03224325|64305437|FG003|Overall Study|Adverse Event|0|||
23151329|NCT03224325|64305438|FG004|Overall Study|Adverse Event|0|||
23151330|NCT03224325|64305439|FG005|Overall Study|Adverse Event|0|||
23151331|NCT03224325|64305440|FG006|Overall Study|Adverse Event|1|||
23151332|NCT03224325|64305434|FG000|Overall Study|Withdrawal by Subject|0|||
23151333|NCT03224325|64305435|FG001|Overall Study|Withdrawal by Subject|0|||
23151334|NCT03224325|64305436|FG002|Overall Study|Withdrawal by Subject|0|||
23151335|NCT03224325|64305437|FG003|Overall Study|Withdrawal by Subject|1|||
23151336|NCT03224325|64305438|FG004|Overall Study|Withdrawal by Subject|0|||
23151337|NCT03224325|64305439|FG005|Overall Study|Withdrawal by Subject|0|||
23151338|NCT03224325|64305440|FG006|Overall Study|Withdrawal by Subject|0|||
23151339|NCT03239483|64305443|FG000|Overall Study|Lost to Follow-up|1|||
23151340|NCT03239483|64305444|FG001|Overall Study|Lost to Follow-up|0|||
23151341|NCT03239483|64305443|FG000|Overall Study|Withdrawal by Subject|1|||
23151342|NCT03239483|64305444|FG001|Overall Study|Withdrawal by Subject|0|||
23151343|NCT00993954|64305447|FG000|Overall Study|Protocol Violation|21|||
23151344|NCT00993954|64305448|FG001|Overall Study|Protocol Violation|2|||
23151345|NCT00685685|64305449|FG000|Washout Period of 7 Days|Adverse Event|2|||
23151346|NCT00685685|64305450|FG001|Washout Period of 7 Days|Adverse Event|0|||
23151347|NCT00685685|64305449|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23151348|NCT00685685|64305450|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23151349|NCT01479829|64305452|FG000|Overall Study|Withdrawal by Subject|8|||
23151350|NCT01479829|64305453|FG001|Overall Study|Withdrawal by Subject|10|||
23151351|NCT03606980|64305454|FG000|Overall Study|Lost to Follow-up|3|||
23151352|NCT03606980|64305455|FG001|Overall Study|Lost to Follow-up|2|||
23151353|NCT03606980|64305456|FG002|Overall Study|Lost to Follow-up|3|||
23151354|NCT03606980|64305454|FG000|Overall Study|Withdrawal by Subject|1|||
23151355|NCT03606980|64305455|FG001|Overall Study|Withdrawal by Subject|0|||
23151356|NCT03606980|64305456|FG002|Overall Study|Withdrawal by Subject|4|||
23151357|NCT00659529|64305459|FG000|Overall Study|Withdrawal by Subject|4|||
23151358|NCT00659529|64305459|FG000|Overall Study|Protocol Violation|3|||
23151359|NCT00659529|64305459|FG000|Overall Study|Screen failure|9|||
23151360|NCT01708291|64305460|FG000|Overall Study|fighting|2|||
23151361|NCT01708291|64305461|FG001|Overall Study|fighting|1|||
23151362|NCT01990534|64305462|FG000|Overall Study|Death|22|||
23151363|NCT01990534|64305462|FG000|Overall Study|Progressive disease|3|||
23151364|NCT01990534|64305462|FG000|Overall Study|Protocol Violation|1|||
23151365|NCT01990534|64305462|FG000|Overall Study|Withdrawal of Informed Consent|2|||
23151366|NCT01990534|64305462|FG000|Overall Study|Symptomatic Deterioration|1|||
23151367|NCT01990534|64305462|FG000|Overall Study|Withdrawal by Subject|3|||
23151368|NCT01990534|64305462|FG000|Overall Study|Reason not Specified|2|||
23151369|NCT01990534|64305462|FG000|Overall Study|Lost to Follow-up|1|||
23151370|NCT02525861|64305463|FG000|Overall Study|Adverse Event|1|||
23151371|NCT02525861|64305464|FG001|Overall Study|Adverse Event|0|||
23151372|NCT02525861|64305463|FG000|Overall Study|Withdrawal by Subject|0|||
23151373|NCT02525861|64305464|FG001|Overall Study|Withdrawal by Subject|1|||
23151374|NCT02525861|64305463|FG000|Overall Study|Physician Decision|0|||
23151375|NCT02525861|64305464|FG001|Overall Study|Physician Decision|1|||
23151376|NCT00292461|64305465|FG000|Overall Study|Adverse Event|4|||
23151377|NCT00292461|64305466|FG001|Overall Study|Adverse Event|2|||
23151378|NCT00292461|64305465|FG000|Overall Study|Lack of Efficacy|1|||
23151379|NCT00292461|64305466|FG001|Overall Study|Lack of Efficacy|0|||
23151380|NCT00292461|64305465|FG000|Overall Study|Withdrawal by Subject|0|||
23151381|NCT00292461|64305466|FG001|Overall Study|Withdrawal by Subject|1|||
23151382|NCT00292461|64305465|FG000|Overall Study|Protocol Violation|4|||
23151383|NCT00292461|64305466|FG001|Overall Study|Protocol Violation|3|||
23151384|NCT00292461|64305465|FG000|Overall Study|Lost to Follow-up|1|||
23151385|NCT00292461|64305466|FG001|Overall Study|Lost to Follow-up|0|||
23151386|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
23325158|NCT00662649|64933722|FG004|Core Study (24 Months)|Adverse Event|0|||
23325159|NCT00662649|64933718|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
23325160|NCT00662649|64933719|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
23325161|NCT00662649|64933720|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
23325162|NCT00662649|64933721|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
23325163|NCT00662649|64933722|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
23325164|NCT00662649|64933718|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
23325165|NCT00662649|64933719|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
23325166|NCT00662649|64933720|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
23325167|NCT00662649|64933721|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
23325168|NCT00662649|64933722|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
23325169|NCT00662649|64933718|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
23325170|NCT00662649|64933719|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
23325171|NCT00662649|64933720|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
23325172|NCT00662649|64933721|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
23325173|NCT00662649|64933722|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
23325174|NCT00662649|64933718|FG000|Core Study (24 Months)|Protocol Violation|5|||
23325175|NCT00662649|64933719|FG001|Core Study (24 Months)|Protocol Violation|5|||
23325176|NCT00662649|64933720|FG002|Core Study (24 Months)|Protocol Violation|4|||
23325177|NCT00662649|64933721|FG003|Core Study (24 Months)|Protocol Violation|0|||
23325178|NCT00662649|64933722|FG004|Core Study (24 Months)|Protocol Violation|0|||
23325179|NCT00662649|64933718|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
23325180|NCT00662649|64933719|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
23325181|NCT00662649|64933720|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
23325182|NCT00662649|64933721|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
23325183|NCT00662649|64933722|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
23325184|NCT00662649|64933718|FG000|Core Study (24 Months)|Death|1|||
23325185|NCT00662649|64933719|FG001|Core Study (24 Months)|Death|0|||
23325186|NCT00662649|64933720|FG002|Core Study (24 Months)|Death|2|||
23325187|NCT00662649|64933721|FG003|Core Study (24 Months)|Death|0|||
23325188|NCT00662649|64933722|FG004|Core Study (24 Months)|Death|0|||
23325189|NCT00662649|64933718|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
23325190|NCT00662649|64933719|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
23325191|NCT00662649|64933720|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
23325192|NCT00662649|64933721|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
23325193|NCT00662649|64933722|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
23325194|NCT00662649|64933718|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
23325195|NCT00662649|64933719|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
23325196|NCT00662649|64933720|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
23325197|NCT00662649|64933721|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
23325198|NCT00662649|64933722|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
23325199|NCT00662649|64933718|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
23325200|NCT00662649|64933719|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
23325201|NCT00662649|64933720|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
23325202|NCT00662649|64933721|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
23325203|NCT00662649|64933722|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
23325204|NCT00662649|64933718|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
23325205|NCT00662649|64933719|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
23325206|NCT00662649|64933720|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
23325207|NCT00662649|64933721|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
23325208|NCT00662649|64933722|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
23325209|NCT00662649|64933718|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
23325210|NCT00662649|64933719|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
23325211|NCT00662649|64933720|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
23325212|NCT00662649|64933721|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
23325213|NCT00662649|64933722|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
23325214|NCT00662649|64933718|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
23325215|NCT00662649|64933719|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
23325216|NCT00662649|64933720|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
23325217|NCT00662649|64933721|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
23325218|NCT00662649|64933722|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
23562646|NCT01852058|65790321|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
23325219|NCT00662649|64933718|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
23325220|NCT00662649|64933719|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
23325221|NCT00662649|64933720|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
23325222|NCT00662649|64933721|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
23325223|NCT00662649|64933722|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
23325224|NCT00662649|64933718|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
23325225|NCT00662649|64933719|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
23325226|NCT00662649|64933720|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
23325227|NCT00662649|64933721|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
23325228|NCT00662649|64933722|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
23325229|NCT00662649|64933718|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
23325230|NCT00662649|64933719|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
23325231|NCT00662649|64933720|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
23325232|NCT00662649|64933721|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
23325233|NCT00662649|64933722|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
23325234|NCT00979654|64933734|FG000|Overall Study|Lost to Follow-up|1|||
23325235|NCT00979654|64933734|FG000|Overall Study|Withdrawal by Subject|22|||
23325236|NCT00979654|64933734|FG000|Overall Study|Death|1|||
23325237|NCT00979654|64933734|FG000|Overall Study|Lack of Efficacy|6|||
23325238|NCT00979654|64933734|FG000|Overall Study|Adverse Event|1|||
23325239|NCT00979654|64933734|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
23325240|NCT00979654|64933734|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
23325241|NCT00979654|64933734|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
23325242|NCT00979654|64933734|FG000|Overall Study|Serious Adverse Event|1|||
23325243|NCT00979654|64933734|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
23325244|NCT01779440|64933752|FG000|Overall Study|Withdrawal by Subject|3|||
23325245|NCT01779440|64933753|FG001|Overall Study|Withdrawal by Subject|5|||
23325246|NCT01383174|64933760|FG000|3 Month Assessment|Death|0|||
23151387|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
23151388|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
23151389|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
23151390|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
23151391|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
23151392|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
23151393|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
23151394|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Death|1|||
23151395|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Death|1|||
23151396|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
23151397|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
23151398|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
23151399|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
23151400|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
23151401|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
23151402|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
23151403|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
23151404|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
23151405|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
23151406|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
23151407|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
23151408|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
23151409|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
23151410|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
23151411|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
23151412|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
23151413|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
23151414|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
23151415|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
23151416|NCT00559585|64305467|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
23151417|NCT00559585|64305468|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
23151418|NCT00559585|64305467|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
23151419|NCT00559585|64305468|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
23151420|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
23151421|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
23220073|NCT03907969|64550048|FG002|Combination Therapy Part A|Adverse Event|0|||
23220074|NCT03907969|64550049|FG003|Combination Therapy Part A|Adverse Event|0|||
23325247|NCT01383174|64933761|FG001|3 Month Assessment|Death|1|||
23220075|NCT03907969|64550050|FG004|Combination Therapy Part A|Adverse Event|0|||
23325248|NCT01383174|64933760|FG000|3 Month Assessment|Lost to Follow-up|2|||
23325249|NCT01383174|64933761|FG001|3 Month Assessment|Lost to Follow-up|0|||
23325250|NCT01383174|64933760|FG000|3 Month Assessment|Refused to complete|4|||
23325251|NCT01383174|64933761|FG001|3 Month Assessment|Refused to complete|0|||
23325252|NCT01383174|64933760|FG000|6 Month Assessment|Lost to Follow-up|1|||
23325253|NCT01383174|64933761|FG001|6 Month Assessment|Lost to Follow-up|1|||
23325254|NCT01383174|64933760|FG000|6 Month Assessment|Refused to complete|4|||
23325255|NCT01383174|64933761|FG001|6 Month Assessment|Refused to complete|0|||
23325256|NCT01129557|64933766|FG000|Overall Study|Adverse Event|1|||
23325257|NCT01129557|64933767|FG001|Overall Study|Adverse Event|2|||
23325258|NCT01129557|64933768|FG002|Overall Study|Adverse Event|2|||
23325259|NCT01129557|64933766|FG000|Overall Study|Novartis terminated study early|3|||
23325260|NCT01129557|64933767|FG001|Overall Study|Novartis terminated study early|3|||
23325261|NCT01129557|64933768|FG002|Overall Study|Novartis terminated study early|2|||
23325262|NCT01578239|64933769|FG000|Treatment Period|Progressive Disease|19|||
23325263|NCT01578239|64933770|FG001|Treatment Period|Progressive Disease|64|||
23325264|NCT01578239|64933769|FG000|Treatment Period|Physician Decision|17|||
23325265|NCT01578239|64933770|FG001|Treatment Period|Physician Decision|17|||
23325266|NCT01578239|64933769|FG000|Treatment Period|Adverse Event|13|||
23325267|NCT01578239|64933770|FG001|Treatment Period|Adverse Event|10|||
23325268|NCT01578239|64933769|FG000|Treatment Period|Non-compliance|2|||
23325269|NCT01578239|64933770|FG001|Treatment Period|Non-compliance|0|||
23325270|NCT01578239|64933769|FG000|Treatment Period|Withdrawal by Subject|10|||
23325271|NCT01578239|64933770|FG001|Treatment Period|Withdrawal by Subject|9|||
23325272|NCT01578239|64933769|FG000|Treatment Period|Other|6|||
23325273|NCT01578239|64933770|FG001|Treatment Period|Other|1|||
23325274|NCT01578239|64933769|FG000|Long-term Follow-Up Period|Death|69|||
23325275|NCT01578239|64933770|FG001|Long-term Follow-Up Period|Death|64|||
23325276|NCT01578239|64933769|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
23325277|NCT01578239|64933770|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
23325278|NCT01578239|64933769|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
23325279|NCT01578239|64933770|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
23325280|NCT01578239|64933769|FG000|Long-term Follow-Up Period|Other|2|||
23325281|NCT01578239|64933770|FG001|Long-term Follow-Up Period|Other|2|||
23325282|NCT01753570|64933773|FG000|Overall Study|Adverse Event|1|||
23439907|NCT01748825|65352599|FG007|Dose Expansion|Refused further treatment|0|||
23439908|NCT01748825|65352600|FG008|Dose Expansion|Refused further treatment|1|||
23439909|NCT01748825|65352601|FG009|Dose Expansion|Refused further treatment|1|||
23439910|NCT01748825|65352592|FG000|Dose Expansion|Switched to alternative treatment|0|||
23439911|NCT01748825|65352593|FG001|Dose Expansion|Switched to alternative treatment|0|||
23439912|NCT01748825|65352594|FG002|Dose Expansion|Switched to alternative treatment|0|||
23151422|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
23151423|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
23151424|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
23151425|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
23151426|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
23151427|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
23151428|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
23151429|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
23151430|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
23151431|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
23151432|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
23151433|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
23151434|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
23151435|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
23151436|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
23151437|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
23151438|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
23151439|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
23151440|NCT00559585|64305467|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
23151441|NCT00559585|64305468|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
23151442|NCT00325039|64305471|FG000|Overall Study|Lost to Follow-up|18|||
23151443|NCT00325039|64305472|FG001|Overall Study|Lost to Follow-up|14|||
23151444|NCT02119325|64305473|FG000|Washout Period 1|Adverse Event|0|||
23151445|NCT02119325|64305474|FG001|Washout Period 1|Adverse Event|1|||
23325283|NCT01753570|64933774|FG001|Overall Study|Adverse Event|0|||
23325284|NCT01753570|64933775|FG002|Overall Study|Adverse Event|1|||
23325285|NCT01753570|64933773|FG000|Overall Study|Physician Decision|0|||
23325286|NCT01753570|64933774|FG001|Overall Study|Physician Decision|1|||
23325287|NCT01753570|64933775|FG002|Overall Study|Physician Decision|0|||
23325288|NCT01753570|64933773|FG000|Overall Study|Withdrawal by Subject|1|||
23325289|NCT01753570|64933774|FG001|Overall Study|Withdrawal by Subject|4|||
23325290|NCT01753570|64933775|FG002|Overall Study|Withdrawal by Subject|0|||
23325291|NCT00226499|64933776|FG000|Overall Study|Adverse Event|10|||
23325292|NCT00226499|64933777|FG001|Overall Study|Adverse Event|6|||
23325293|NCT00226499|64933778|FG002|Overall Study|Adverse Event|3|||
23325294|NCT00226499|64933776|FG000|Overall Study|Others|1064|||
23325295|NCT00226499|64933777|FG001|Overall Study|Others|1066|||
23562647|NCT01852058|65790322|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23151446|NCT03250832|64305478|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
23151447|NCT03250832|64305479|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
23151448|NCT03250832|64305480|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
23151449|NCT03250832|64305481|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
23151450|NCT03250832|64305482|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
23151451|NCT03250832|64305483|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
23151452|NCT03250832|64305484|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
23151453|NCT03250832|64305485|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
23325296|NCT00226499|64933778|FG002|Overall Study|Others|356|||
23325297|NCT02969044|64933781|FG000|Overall Study|Withdrawal by Subject|2|||
23562648|NCT01852058|65790323|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562649|NCT01852058|65790324|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562650|NCT01852058|65790325|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
23562651|NCT01852058|65790314|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562652|NCT01852058|65790315|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562653|NCT01852058|65790316|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562654|NCT01852058|65790317|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562655|NCT01852058|65790318|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562656|NCT01852058|65790319|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562657|NCT01852058|65790320|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562658|NCT01852058|65790321|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562659|NCT01852058|65790322|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
23562660|NCT01852058|65790323|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562661|NCT01852058|65790324|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562662|NCT01852058|65790325|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
23562663|NCT00263328|65790326|FG000|Overall Study|Death|0|||
23562664|NCT00263328|65790327|FG001|Overall Study|Death|0|||
23562665|NCT00263328|65790328|FG002|Overall Study|Death|1|||
23562666|NCT00263328|65790326|FG000|Overall Study|Lost to Follow-up|1|||
23562667|NCT00263328|65790327|FG001|Overall Study|Lost to Follow-up|1|||
23562668|NCT00263328|65790328|FG002|Overall Study|Lost to Follow-up|0|||
23562669|NCT00263328|65790326|FG000|Overall Study|Withdrawal by Subject|3|||
23562670|NCT00263328|65790327|FG001|Overall Study|Withdrawal by Subject|0|||
23562671|NCT00263328|65790328|FG002|Overall Study|Withdrawal by Subject|1|||
23562672|NCT00263328|65790326|FG000|Overall Study|Other|3|||
23562673|NCT00263328|65790327|FG001|Overall Study|Other|0|||
23562674|NCT00263328|65790328|FG002|Overall Study|Other|1|||
23562675|NCT00263328|65790326|FG000|Overall Study|Adverse Event|1|||
23562676|NCT00263328|65790327|FG001|Overall Study|Adverse Event|1|||
23562677|NCT00263328|65790328|FG002|Overall Study|Adverse Event|4|||
23562678|NCT02323646|65790329|FG000|Treatment Course 1|Adverse Event|1|||
23562679|NCT02323646|65790330|FG001|Treatment Course 1|Adverse Event|0|||
23562680|NCT02323646|65790331|FG002|Treatment Course 1|Adverse Event|1|||
23562681|NCT02323646|65790329|FG000|Treatment Course 1|Heavy Bleeding|1|||
23562682|NCT02323646|65790330|FG001|Treatment Course 1|Heavy Bleeding|1|||
23562683|NCT02323646|65790331|FG002|Treatment Course 1|Heavy Bleeding|0|||
23562684|NCT02323646|65790329|FG000|Treatment Course 1|Lost to Follow-up|1|||
23562685|NCT02323646|65790330|FG001|Treatment Course 1|Lost to Follow-up|0|||
23562686|NCT02323646|65790331|FG002|Treatment Course 1|Lost to Follow-up|2|||
23562687|NCT02323646|65790329|FG000|Treatment Course 1|Withdrawal by Subject|0|||
23562688|NCT02323646|65790330|FG001|Treatment Course 1|Withdrawal by Subject|2|||
23562689|NCT02323646|65790331|FG002|Treatment Course 1|Withdrawal by Subject|0|||
23562690|NCT02323646|65790329|FG000|Treatment Course 2|Adverse Event|1|||
23562691|NCT02323646|65790330|FG001|Treatment Course 2|Adverse Event|0|||
23562692|NCT02323646|65790331|FG002|Treatment Course 2|Adverse Event|1|||
23562693|NCT02323646|65790329|FG000|Treatment Course 2|Lost to Follow-up|0|||
23562694|NCT02323646|65790330|FG001|Treatment Course 2|Lost to Follow-up|0|||
23562695|NCT02323646|65790331|FG002|Treatment Course 2|Lost to Follow-up|1|||
23562696|NCT02323646|65790329|FG000|Treatment Course 2|Non-compliance|0|||
23625364|NCT01270828|66015469|FG002|Double Blind Phase|Withdrawal by Subject|0|||
23625365|NCT01270828|66015467|FG000|Double Blind Phase|Lost to Follow-up|1|||
23325298|NCT02969044|64933782|FG001|Overall Study|Withdrawal by Subject|6|||
23562697|NCT02323646|65790330|FG001|Treatment Course 2|Non-compliance|1|||
23562698|NCT02323646|65790331|FG002|Treatment Course 2|Non-compliance|1|||
23562699|NCT01672853|65790332|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
23562700|NCT01672853|65790333|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
23562701|NCT01672853|65790334|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
23562702|NCT01672853|65790332|FG000|Overall Study|Pregnancy|0|||
23625366|NCT01270828|66015468|FG001|Double Blind Phase|Lost to Follow-up|2|||
23625367|NCT01270828|66015469|FG002|Double Blind Phase|Lost to Follow-up|0|||
23625368|NCT01270828|66015467|FG000|Double Blind Phase|Lack of Efficacy|2|||
23625369|NCT01270828|66015468|FG001|Double Blind Phase|Lack of Efficacy|11|||
23151454|NCT03250832|64305486|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
23151455|NCT03250832|64305487|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
23151456|NCT03250832|64305488|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
23151457|NCT03250832|64305489|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
23151458|NCT03250832|64305478|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
23151459|NCT03250832|64305479|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
23151460|NCT03250832|64305480|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
23151461|NCT03250832|64305481|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
23151462|NCT03250832|64305482|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
23151463|NCT03250832|64305483|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
23151464|NCT03250832|64305484|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
23151465|NCT03250832|64305485|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23151466|NCT03250832|64305486|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23151467|NCT03250832|64305487|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23151468|NCT03250832|64305488|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23151469|NCT03250832|64305489|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
23151470|NCT03250832|64305478|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151471|NCT03250832|64305479|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151472|NCT03250832|64305480|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
23151473|NCT03250832|64305481|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151474|NCT03250832|64305482|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151475|NCT03250832|64305483|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151476|NCT03250832|64305484|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151477|NCT03250832|64305485|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151478|NCT03250832|64305486|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151479|NCT03250832|64305487|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151480|NCT03250832|64305488|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151481|NCT03250832|64305489|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
23151482|NCT03250832|64305478|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151483|NCT03250832|64305479|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151484|NCT03250832|64305480|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151485|NCT03250832|64305481|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151486|NCT03250832|64305482|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151487|NCT03250832|64305483|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151488|NCT03250832|64305484|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151489|NCT03250832|64305485|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
23151490|NCT03250832|64305486|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151491|NCT03250832|64305487|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151492|NCT03250832|64305488|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151493|NCT03250832|64305489|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
23151494|NCT03250832|64305478|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151495|NCT03250832|64305479|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151496|NCT03250832|64305480|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151497|NCT03250832|64305481|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151498|NCT03250832|64305482|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151499|NCT03250832|64305483|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151500|NCT03250832|64305484|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151501|NCT03250832|64305485|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
23151502|NCT03250832|64305486|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151503|NCT03250832|64305487|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151504|NCT03250832|64305488|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151505|NCT03250832|64305489|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
23151506|NCT03250832|64305478|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151507|NCT03250832|64305479|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151508|NCT03250832|64305480|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151509|NCT03250832|64305481|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151510|NCT03250832|64305482|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151511|NCT03250832|64305483|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151512|NCT03250832|64305484|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23562703|NCT01672853|65790333|FG001|Overall Study|Pregnancy|1|||
23562704|NCT01672853|65790334|FG002|Overall Study|Pregnancy|0|||
23562705|NCT01672853|65790332|FG000|Overall Study|Investigator's Discretion|1|||
23562706|NCT01672853|65790333|FG001|Overall Study|Investigator's Discretion|0|||
23562707|NCT01672853|65790334|FG002|Overall Study|Investigator's Discretion|0|||
23562708|NCT01672853|65790332|FG000|Overall Study|Withdrew Consent|5|||
23562709|NCT01672853|65790333|FG001|Overall Study|Withdrew Consent|5|||
23562710|NCT01672853|65790334|FG002|Overall Study|Withdrew Consent|5|||
23151513|NCT03250832|64305485|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
23151514|NCT03250832|64305486|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151515|NCT03250832|64305487|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151516|NCT03250832|64305488|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151517|NCT03250832|64305489|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
23151518|NCT03250832|64305478|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151519|NCT03250832|64305479|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151520|NCT03250832|64305480|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151521|NCT03250832|64305481|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151522|NCT03250832|64305482|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151523|NCT03250832|64305483|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151524|NCT03250832|64305484|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151525|NCT03250832|64305485|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
23151526|NCT03250832|64305486|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151527|NCT03250832|64305487|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151528|NCT03250832|64305488|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151529|NCT03250832|64305489|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
23151530|NCT03250832|64305478|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151531|NCT03250832|64305479|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151532|NCT03250832|64305480|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151533|NCT03250832|64305481|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151534|NCT03250832|64305482|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151535|NCT03250832|64305483|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151536|NCT03250832|64305484|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151537|NCT03250832|64305485|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
23151538|NCT03250832|64305486|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151539|NCT03250832|64305487|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151540|NCT03250832|64305488|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151541|NCT03250832|64305489|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
23151542|NCT03250832|64305478|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151543|NCT03250832|64305479|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151544|NCT03250832|64305480|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151545|NCT03250832|64305481|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151546|NCT03250832|64305482|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151547|NCT03250832|64305483|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151548|NCT03250832|64305484|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151549|NCT03250832|64305485|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151550|NCT03250832|64305486|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
23151551|NCT03250832|64305487|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
23562711|NCT01672853|65790332|FG000|Overall Study|Adverse Event|4|||
23562712|NCT01672853|65790333|FG001|Overall Study|Adverse Event|6|||
23562713|NCT01672853|65790334|FG002|Overall Study|Adverse Event|8|||
23562714|NCT01672853|65790332|FG000|Overall Study|Lost to Follow-up|0|||
23151552|NCT03250832|64305488|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151553|NCT03250832|64305489|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
23151554|NCT03250832|64305478|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23151555|NCT03250832|64305479|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23151556|NCT03250832|64305480|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23151557|NCT03250832|64305481|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23151558|NCT03250832|64305482|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23151559|NCT03250832|64305483|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23151560|NCT03250832|64305484|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23151561|NCT03250832|64305485|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23151562|NCT03250832|64305486|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
23151563|NCT03250832|64305487|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
23151564|NCT03250832|64305488|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23151565|NCT03250832|64305489|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
23220076|NCT03907969|64550051|FG005|Combination Therapy Part A|Adverse Event|0|||
23220077|NCT03907969|64550052|FG006|Combination Therapy Part A|Adverse Event|0|||
23562715|NCT01672853|65790333|FG001|Overall Study|Lost to Follow-up|1|||
23562716|NCT01672853|65790334|FG002|Overall Study|Lost to Follow-up|0|||
23562717|NCT01672853|65790332|FG000|Overall Study|Randomized but Never Treated|0|||
23562718|NCT01672853|65790333|FG001|Overall Study|Randomized but Never Treated|0|||
23562719|NCT01672853|65790334|FG002|Overall Study|Randomized but Never Treated|1|||
23220078|NCT03907969|64550053|FG007|Combination Therapy Part A|Adverse Event|0|||
23220079|NCT03907969|64550054|FG008|Combination Therapy Part A|Adverse Event|0|||
23562720|NCT02966002|65790335|FG000|Overall Study|Withdrawal by Subject|2|||
23562721|NCT02966002|65790335|FG000|Overall Study|Adverse Event|1|||
23151566|NCT03250832|64305478|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151567|NCT03250832|64305479|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151568|NCT03250832|64305480|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151569|NCT03250832|64305481|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151570|NCT03250832|64305482|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151571|NCT03250832|64305483|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151572|NCT03250832|64305484|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151573|NCT03250832|64305485|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151574|NCT03250832|64305486|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
23151575|NCT03250832|64305487|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
23151576|NCT03250832|64305488|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151577|NCT03250832|64305489|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
23151578|NCT03250832|64305478|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151579|NCT03250832|64305479|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151580|NCT03250832|64305480|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151581|NCT03250832|64305481|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151582|NCT03250832|64305482|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151583|NCT03250832|64305483|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151584|NCT03250832|64305484|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151585|NCT03250832|64305485|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151586|NCT03250832|64305486|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151587|NCT03250832|64305487|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151588|NCT03250832|64305488|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
23151589|NCT03250832|64305489|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
23151590|NCT01034540|64305490|FG000|Overall Study|Adverse Event|0|||
23151591|NCT01034540|64305491|FG001|Overall Study|Adverse Event|1|||
23151592|NCT00860951|64305492|FG000|Overall Study|Withdrawal by Subject|2|||
23151593|NCT00860951|64305492|FG000|Overall Study|Lost to Follow-up|5|||
23151594|NCT00826111|64305493|FG000|Overall Study|Lost to Follow-up|0|||
23151595|NCT00826111|64305494|FG001|Overall Study|Lost to Follow-up|1|||
23151596|NCT00826111|64305493|FG000|Overall Study|Protocol Violation|1|||
23151597|NCT00826111|64305494|FG001|Overall Study|Protocol Violation|0|||
23151598|NCT00826111|64305493|FG000|Overall Study|Withdrawal by Subject|5|||
23151599|NCT00826111|64305494|FG001|Overall Study|Withdrawal by Subject|0|||
23151600|NCT00826111|64305493|FG000|Overall Study|Physician Decision|1|||
23151601|NCT00826111|64305494|FG001|Overall Study|Physician Decision|1|||
23151602|NCT02805725|64305495|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
23151603|NCT02805725|64305496|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
23151604|NCT02805725|64305497|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
23151605|NCT02805725|64305498|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
23151606|NCT02805725|64305499|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
23151607|NCT02805725|64305495|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
23151608|NCT02805725|64305496|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
23151609|NCT02805725|64305497|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
23151610|NCT02805725|64305498|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
23151611|NCT02805725|64305499|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
23151612|NCT02805725|64305495|FG000|Phase II|Protocol Violation|0|||
23151613|NCT02805725|64305496|FG001|Phase II|Protocol Violation|0|||
23325299|NCT02969044|64933781|FG000|Overall Study|Adverse Event|3|||
23325300|NCT02969044|64933782|FG001|Overall Study|Adverse Event|0|||
23325301|NCT01103180|64933783|FG000|Overall Study|Withdrawal by Subject|8|||
23325302|NCT01103180|64933784|FG001|Overall Study|Withdrawal by Subject|13|||
23325303|NCT01103180|64933783|FG000|Overall Study|Lost to Follow-up|13|||
23325304|NCT01103180|64933784|FG001|Overall Study|Lost to Follow-up|7|||
23325305|NCT01103180|64933783|FG000|Overall Study|Physician Decision|1|||
23325306|NCT01103180|64933784|FG001|Overall Study|Physician Decision|0|||
23325307|NCT01103180|64933783|FG000|Overall Study|Protocol Violation|0|||
23325308|NCT01103180|64933784|FG001|Overall Study|Protocol Violation|1|||
23325309|NCT01403051|64933788|FG000|Overall Study|Protocol Violation|2|||
23325310|NCT01403051|64933789|FG001|Overall Study|Protocol Violation|0|||
23325311|NCT01403051|64933788|FG000|Overall Study|Death|1|||
23325312|NCT01403051|64933789|FG001|Overall Study|Death|0|||
23325313|NCT01403051|64933788|FG000|Overall Study|Withdrawal by Subject|2|||
23325314|NCT01403051|64933789|FG001|Overall Study|Withdrawal by Subject|1|||
23562722|NCT02966002|65790335|FG000|Overall Study|Lost to Follow-up|1|||
23151614|NCT02805725|64305497|FG002|Phase II|Protocol Violation|0|||
23151615|NCT02805725|64305498|FG003|Phase II|Protocol Violation|0|||
23151616|NCT02805725|64305499|FG004|Phase II|Protocol Violation|6|||
23151617|NCT00458341|64305500|FG000|Cycle 1|Adverse Event|1|||
23220080|NCT03907969|64550055|FG009|Combination Therapy Part A|Adverse Event|1|||
23325315|NCT01403051|64933788|FG000|Overall Study|Lost to Follow-up|5|||
23325316|NCT01403051|64933789|FG001|Overall Study|Lost to Follow-up|5|||
23151618|NCT00458341|64305501|FG001|Cycle 1|Adverse Event|0|||
23151619|NCT03548987|64305504|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
23151620|NCT03548987|64305505|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
23151621|NCT03548987|64305504|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
23151622|NCT03548987|64305505|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
23151623|NCT03548987|64305504|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
23151624|NCT03548987|64305505|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
23151625|NCT03548987|64305504|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
23151626|NCT03548987|64305505|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
23220081|NCT03907969|64550056|FG010|Combination Therapy Part A|Adverse Event|1|||
23220082|NCT03907969|64550046|FG000|Combination Therapy Part A|Progressive disease|0|||
23439913|NCT01748825|65352595|FG003|Dose Expansion|Switched to alternative treatment|0|||
23439914|NCT01748825|65352596|FG004|Dose Expansion|Switched to alternative treatment|0|||
23439915|NCT01748825|65352597|FG005|Dose Expansion|Switched to alternative treatment|0|||
23439916|NCT01748825|65352598|FG006|Dose Expansion|Switched to alternative treatment|0|||
23439917|NCT01748825|65352599|FG007|Dose Expansion|Switched to alternative treatment|0|||
23439918|NCT01748825|65352600|FG008|Dose Expansion|Switched to alternative treatment|0|||
23439919|NCT01748825|65352601|FG009|Dose Expansion|Switched to alternative treatment|1|||
23439920|NCT01748825|65352592|FG000|Dose Expansion|Adverse Event|0|||
23439921|NCT01748825|65352593|FG001|Dose Expansion|Adverse Event|0|||
23439922|NCT01748825|65352594|FG002|Dose Expansion|Adverse Event|0|||
23439923|NCT01748825|65352595|FG003|Dose Expansion|Adverse Event|0|||
23439924|NCT01748825|65352596|FG004|Dose Expansion|Adverse Event|0|||
23439925|NCT01748825|65352597|FG005|Dose Expansion|Adverse Event|0|||
23439926|NCT01748825|65352598|FG006|Dose Expansion|Adverse Event|0|||
23439927|NCT01748825|65352599|FG007|Dose Expansion|Adverse Event|0|||
23439928|NCT01748825|65352600|FG008|Dose Expansion|Adverse Event|0|||
23439929|NCT01748825|65352601|FG009|Dose Expansion|Adverse Event|3|||
23439930|NCT01748825|65352592|FG000|Dose Expansion|Physician Decision|0|||
23439931|NCT01748825|65352593|FG001|Dose Expansion|Physician Decision|0|||
23439932|NCT01748825|65352594|FG002|Dose Expansion|Physician Decision|0|||
23439933|NCT01748825|65352595|FG003|Dose Expansion|Physician Decision|0|||
23439934|NCT01748825|65352596|FG004|Dose Expansion|Physician Decision|0|||
23439935|NCT01748825|65352597|FG005|Dose Expansion|Physician Decision|0|||
23439936|NCT01748825|65352598|FG006|Dose Expansion|Physician Decision|0|||
23439937|NCT01748825|65352599|FG007|Dose Expansion|Physician Decision|0|||
23220083|NCT03907969|64550047|FG001|Combination Therapy Part A|Progressive disease|0|||
23220084|NCT03907969|64550048|FG002|Combination Therapy Part A|Progressive disease|0|||
23220085|NCT03907969|64550049|FG003|Combination Therapy Part A|Progressive disease|0|||
23220086|NCT03907969|64550050|FG004|Combination Therapy Part A|Progressive disease|0|||
23220087|NCT03907969|64550051|FG005|Combination Therapy Part A|Progressive disease|0|||
23220088|NCT03907969|64550052|FG006|Combination Therapy Part A|Progressive disease|0|||
23220089|NCT03907969|64550053|FG007|Combination Therapy Part A|Progressive disease|1|||
23220090|NCT03907969|64550054|FG008|Combination Therapy Part A|Progressive disease|0|||
23439938|NCT01748825|65352600|FG008|Dose Expansion|Physician Decision|1|||
23439939|NCT01748825|65352601|FG009|Dose Expansion|Physician Decision|0|||
23439940|NCT03887221|65352602|FG000|Overall Study|Protocol Violation|1|||
23439941|NCT03887221|65352603|FG001|Overall Study|Protocol Violation|0|||
23439942|NCT02720692|65352604|FG000|Overall Study|Withdrawal by Subject|3|||
23439943|NCT02720692|65352605|FG001|Overall Study|Withdrawal by Subject|0|||
23439944|NCT02720692|65352604|FG000|Overall Study|Physician Decision|1|||
23439945|NCT02720692|65352605|FG001|Overall Study|Physician Decision|0|||
23439946|NCT02720692|65352604|FG000|Overall Study|Lost to Follow-up|8|||
23439947|NCT02720692|65352605|FG001|Overall Study|Lost to Follow-up|3|||
23439948|NCT02720692|65352604|FG000|Overall Study|Subject unable to return for visit|1|||
23562723|NCT00514943|65790336|FG000|Stage 1|Progressive disease|4|||
23562724|NCT00514943|65790337|FG001|Stage 1|Progressive disease|8|||
23562725|NCT00514943|65790336|FG000|Stage 1|Other Adverse Event|16|||
23562726|NCT00514943|65790337|FG001|Stage 1|Other Adverse Event|6|||
23562727|NCT00514943|65790336|FG000|Stage 1|Not treated|1|||
23562728|NCT00514943|65790337|FG001|Stage 1|Not treated|2|||
23562729|NCT00514943|65790336|FG000|Stage 1|Patient refused to continue study meds|8|||
23562730|NCT00514943|65790337|FG001|Stage 1|Patient refused to continue study meds|3|||
23562731|NCT00514943|65790336|FG000|Stage 1|Other than stated above|1|||
23562732|NCT00514943|65790337|FG001|Stage 1|Other than stated above|7|||
23220091|NCT03907969|64550055|FG009|Combination Therapy Part A|Progressive disease|2|||
23220092|NCT03907969|64550056|FG010|Combination Therapy Part A|Progressive disease|3|||
23439949|NCT02720692|65352605|FG001|Overall Study|Subject unable to return for visit|0|||
23439950|NCT00310817|65352606|FG000|Overall Study|AE or Death|3|||
23439951|NCT00310817|65352607|FG001|Overall Study|AE or Death|1|||
23439952|NCT00310817|65352608|FG002|Overall Study|AE or Death|0|||
23439953|NCT00310817|65352609|FG003|Overall Study|AE or Death|0|||
23439954|NCT00310817|65352606|FG000|Overall Study|Withdrawal by Subject|1|||
23439955|NCT00310817|65352607|FG001|Overall Study|Withdrawal by Subject|4|||
23562733|NCT00514943|65790336|FG000|Stage 2|Progressive disease|27|||
23439956|NCT00310817|65352608|FG002|Overall Study|Withdrawal by Subject|6|||
23439957|NCT00310817|65352609|FG003|Overall Study|Withdrawal by Subject|7|||
23439958|NCT00310817|65352606|FG000|Overall Study|Lost to Follow-up|2|||
23439959|NCT00310817|65352607|FG001|Overall Study|Lost to Follow-up|1|||
23439960|NCT00310817|65352608|FG002|Overall Study|Lost to Follow-up|0|||
23439961|NCT00310817|65352609|FG003|Overall Study|Lost to Follow-up|0|||
23439962|NCT00310817|65352606|FG000|Overall Study|Inappropriate Enrollment|1|||
23439963|NCT00310817|65352607|FG001|Overall Study|Inappropriate Enrollment|0|||
23439964|NCT00310817|65352608|FG002|Overall Study|Inappropriate Enrollment|1|||
23439965|NCT00310817|65352609|FG003|Overall Study|Inappropriate Enrollment|0|||
23439966|NCT00310817|65352606|FG000|Overall Study|Protocol Violation|1|||
23439967|NCT00310817|65352607|FG001|Overall Study|Protocol Violation|1|||
23439968|NCT00310817|65352608|FG002|Overall Study|Protocol Violation|1|||
23439969|NCT00310817|65352609|FG003|Overall Study|Protocol Violation|1|||
23439970|NCT00310817|65352606|FG000|Overall Study|Unable to classify|3|||
23439971|NCT00310817|65352607|FG001|Overall Study|Unable to classify|1|||
23439972|NCT00310817|65352608|FG002|Overall Study|Unable to classify|0|||
23439973|NCT00310817|65352609|FG003|Overall Study|Unable to classify|0|||
23439974|NCT00869518|65352610|FG000|Overall Study|Lost to Follow-up|1|||
23439975|NCT00869518|65352611|FG001|Overall Study|Lost to Follow-up|1|||
23439976|NCT00934128|65352612|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
23439977|NCT00934128|65352613|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
23439978|NCT00934128|65352612|FG000|First Intervention (2 Hours)|Adverse Event|4|||
23439979|NCT00934128|65352613|FG001|First Intervention (2 Hours)|Adverse Event|1|||
23439980|NCT00934128|65352612|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
23439981|NCT00934128|65352613|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
23439982|NCT00934128|65352612|FG000|Washout Period (1 Hour)|Patient preference|1|||
23439983|NCT00934128|65352613|FG001|Washout Period (1 Hour)|Patient preference|3|||
23439984|NCT00934128|65352612|FG000|Washout Period (1 Hour)|Pain|1|||
23439985|NCT00934128|65352613|FG001|Washout Period (1 Hour)|Pain|0|||
23439986|NCT00934128|65352612|FG000|Washout Period (1 Hour)|Too tired|1|||
23439987|NCT00934128|65352613|FG001|Washout Period (1 Hour)|Too tired|0|||
23439988|NCT00934128|65352612|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
23439989|NCT00934128|65352613|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
23439990|NCT00934128|65352612|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
23439991|NCT00934128|65352613|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
23439992|NCT04680975|65352614|FG000|Overall Study|Adverse Event|3|||
23439993|NCT04680975|65352614|FG000|Overall Study|Death|1|||
23439994|NCT04680975|65352614|FG000|Overall Study|Progressive Disease|1|||
23439995|NCT04680975|65352614|FG000|Overall Study|Withdrawal by Subject|1|||
23439996|NCT01161537|65352617|FG000|Part B|Withdrawal by Subject|2|||
23439997|NCT02227199|65352618|FG000|Overall Study|Physician Decision|0|||
23439998|NCT02227199|65352619|FG001|Overall Study|Physician Decision|0|||
23439999|NCT02227199|65352620|FG002|Overall Study|Physician Decision|1|||
23440000|NCT02227199|65352618|FG000|Overall Study|Adverse Event|0|||
23440001|NCT02227199|65352619|FG001|Overall Study|Adverse Event|0|||
23440002|NCT02227199|65352620|FG002|Overall Study|Adverse Event|3|||
23440003|NCT00528801|65352623|FG000|Overall Study|Withdrawal by Subject|1|||
23440004|NCT00528801|65352624|FG001|Overall Study|Withdrawal by Subject|1|||
23440005|NCT00528801|65352623|FG000|Overall Study|Protocol Violation|11|||
23440006|NCT00528801|65352624|FG001|Overall Study|Protocol Violation|5|||
23440007|NCT00528801|65352623|FG000|Overall Study|Lost to Follow-up|15|||
23220093|NCT03907969|64550046|FG000|Combination Therapy Part A|Death|0|||
23440008|NCT00528801|65352624|FG001|Overall Study|Lost to Follow-up|4|||
23440009|NCT00528801|65352623|FG000|Overall Study|Administrative Reasons|0|||
23440010|NCT00528801|65352624|FG001|Overall Study|Administrative Reasons|1|||
23440011|NCT00856544|65352625|FG000|Overall Study|Randomized but not treated|3|||
23440012|NCT00856544|65352626|FG001|Overall Study|Randomized but not treated|0|||
23440013|NCT00856544|65352627|FG002|Overall Study|Randomized but not treated|0|||
23440014|NCT00856544|65352628|FG003|Overall Study|Randomized but not treated|0|||
23440015|NCT00856544|65352625|FG000|Overall Study|Death|0|||
23440016|NCT00856544|65352626|FG001|Overall Study|Death|2|||
23440017|NCT00856544|65352627|FG002|Overall Study|Death|0|||
23440018|NCT00856544|65352628|FG003|Overall Study|Death|0|||
23440019|NCT00856544|65352625|FG000|Overall Study|Adverse Event|20|||
23440020|NCT00856544|65352626|FG001|Overall Study|Adverse Event|29|||
23440021|NCT00856544|65352627|FG002|Overall Study|Adverse Event|2|||
23440022|NCT00856544|65352628|FG003|Overall Study|Adverse Event|3|||
23440023|NCT00856544|65352625|FG000|Overall Study|Lack of Efficacy|16|||
23625370|NCT01270828|66015469|FG002|Double Blind Phase|Lack of Efficacy|0|||
23625371|NCT01270828|66015467|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
23440024|NCT00856544|65352626|FG001|Overall Study|Lack of Efficacy|12|||
23440025|NCT00856544|65352627|FG002|Overall Study|Lack of Efficacy|3|||
23440026|NCT00856544|65352628|FG003|Overall Study|Lack of Efficacy|3|||
23440027|NCT00856544|65352625|FG000|Overall Study|Other|9|||
23440028|NCT00856544|65352626|FG001|Overall Study|Other|16|||
23440029|NCT00856544|65352627|FG002|Overall Study|Other|1|||
23440030|NCT00856544|65352628|FG003|Overall Study|Other|6|||
23562734|NCT00514943|65790337|FG001|Stage 2|Progressive disease|24|||
23562735|NCT00514943|65790336|FG000|Stage 2|Other Adverse Event|3|||
23440031|NCT00856544|65352625|FG000|Overall Study|Lost to Follow-up|1|||
23440032|NCT00856544|65352626|FG001|Overall Study|Lost to Follow-up|2|||
23440033|NCT00856544|65352627|FG002|Overall Study|Lost to Follow-up|2|||
23440034|NCT00856544|65352628|FG003|Overall Study|Lost to Follow-up|0|||
23440035|NCT00856544|65352625|FG000|Overall Study|Withdrawal by Subject|8|||
23440036|NCT00856544|65352626|FG001|Overall Study|Withdrawal by Subject|5|||
23440037|NCT00856544|65352627|FG002|Overall Study|Withdrawal by Subject|0|||
23440038|NCT00856544|65352628|FG003|Overall Study|Withdrawal by Subject|1|||
23440039|NCT00895310|65352631|FG000|Overall Study|Withdrawal by Subject|1|||
23440040|NCT00799591|65352632|FG000|Overall Study|De-escalation of doses|20|||
23440041|NCT00799591|65352632|FG000|Overall Study|Death|14|||
23440042|NCT00799591|65352632|FG000|Overall Study|Technical failure|12|||
23440043|NCT00799591|65352632|FG000|Overall Study|Resistant germ|11|||
23440044|NCT00799591|65352632|FG000|Overall Study|New infection|4|||
23440045|NCT00799591|65352632|FG000|Overall Study|Resistance germ and technical failure|2|||
23440046|NCT00799591|65352632|FG000|Overall Study|Persistance of fever undetermined origin|1|||
23440047|NCT00799591|65352632|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
23440048|NCT00799591|65352632|FG000|Overall Study|Infectious origin not probable|1|||
23440049|NCT00652951|65352633|FG000|Booster Phase|Adverse event, non-fatal|0|||
23440050|NCT00652951|65352634|FG001|Booster Phase|Adverse event, non-fatal|1|||
23440051|NCT00652951|65352635|FG002|Booster Phase|Adverse event, non-fatal|0|||
23440052|NCT00652951|65352633|FG000|Booster Phase|Other|1|||
23220094|NCT03907969|64550047|FG001|Combination Therapy Part A|Death|0|||
23220095|NCT03907969|64550048|FG002|Combination Therapy Part A|Death|0|||
23220096|NCT03907969|64550049|FG003|Combination Therapy Part A|Death|0|||
23440053|NCT00652951|65352634|FG001|Booster Phase|Other|0|||
23440054|NCT00652951|65352635|FG002|Booster Phase|Other|0|||
23625372|NCT01270828|66015468|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
23625373|NCT01270828|66015469|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
23625374|NCT01270828|66015467|FG000|Double Blind Phase|Adverse event related to study drug|5|||
23151627|NCT03548987|64305504|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
23440055|NCT02106403|65352637|FG000|Follow-Up Visit 3|Other Reason|0|||
23562736|NCT00514943|65790337|FG001|Stage 2|Other Adverse Event|10|||
23562737|NCT00514943|65790336|FG000|Stage 2|Patient refused to continue study meds|2|||
23151628|NCT03548987|64305505|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
23151629|NCT03548987|64305504|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
23151630|NCT03548987|64305505|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
23151631|NCT03548987|64305504|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
23151632|NCT03548987|64305505|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
23151633|NCT03548987|64305504|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
23562738|NCT00514943|65790337|FG001|Stage 2|Patient refused to continue study meds|0|||
23562739|NCT00514943|65790336|FG000|Stage 2|Other than stated above|0|||
23562740|NCT00514943|65790337|FG001|Stage 2|Other than stated above|2|||
23562741|NCT00112580|65790340|FG000|Overall Study|Adverse Event|1|||
23562742|NCT00112580|65790341|FG001|Overall Study|Adverse Event|2|||
23562743|NCT00112580|65790340|FG000|Overall Study|Disease progression|5|||
23562744|NCT00112580|65790341|FG001|Overall Study|Disease progression|16|||
23151634|NCT03548987|64305505|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
23151635|NCT03548987|64305504|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
23151636|NCT03548987|64305505|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
23151637|NCT03548987|64305504|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
23220097|NCT03907969|64550050|FG004|Combination Therapy Part A|Death|0|||
23220098|NCT03907969|64550051|FG005|Combination Therapy Part A|Death|0|||
23440056|NCT02106403|65352638|FG001|Follow-Up Visit 3|Other Reason|0|||
23562745|NCT00112580|65790340|FG000|Overall Study|Participant withdrew consent|2|||
23562746|NCT00112580|65790341|FG001|Overall Study|Participant withdrew consent|1|||
23562747|NCT04539821|65790356|FG000|Overall Study|Withdrawal by Subject|2|||
23562748|NCT04539821|65790356|FG000|Overall Study|continued care with their physician|20|||
23562749|NCT04539821|65790356|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
23562750|NCT01662063|65790357|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
23562751|NCT01662063|65790358|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
23440057|NCT02106403|65352639|FG002|Follow-Up Visit 3|Other Reason|0|||
23562752|NCT01662063|65790359|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
23562753|NCT01662063|65790357|FG000|Overall Study|Lack of Efficacy|1|||
23562754|NCT01662063|65790358|FG001|Overall Study|Lack of Efficacy|6|||
23440058|NCT02106403|65352640|FG003|Follow-Up Visit 3|Other Reason|0|||
23562755|NCT01662063|65790359|FG002|Overall Study|Lack of Efficacy|0|||
23562756|NCT01662063|65790357|FG000|Overall Study|Lost to Follow-up|0|||
23625375|NCT01270828|66015468|FG001|Double Blind Phase|Adverse event related to study drug|7|||
23151638|NCT03548987|64305505|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
23440059|NCT02106403|65352641|FG004|Follow-Up Visit 3|Other Reason|0|||
23440060|NCT02106403|65352642|FG005|Follow-Up Visit 3|Other Reason|1|||
23440061|NCT00650845|65352647|FG000|Overall Study|Withdrawal by Subject|5|||
23151639|NCT03548987|64305504|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
23151640|NCT03548987|64305505|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
23440062|NCT00650845|65352648|FG001|Overall Study|Withdrawal by Subject|0|||
23440063|NCT00650845|65352647|FG000|Overall Study|Protocol Violation|0|||
23440064|NCT00650845|65352648|FG001|Overall Study|Protocol Violation|13|||
23440065|NCT02718716|65352649|FG000|Overall Study|Lack of Efficacy|1|||
23440066|NCT02718716|65352650|FG001|Overall Study|Lack of Efficacy|0|||
23440067|NCT02718716|65352651|FG002|Overall Study|Lack of Efficacy|0|||
23440068|NCT02718716|65352652|FG003|Overall Study|Lack of Efficacy|0|||
23440069|NCT02718716|65352653|FG004|Overall Study|Lack of Efficacy|0|||
23440070|NCT00448747|65352654|FG000|Overall Study|collapsed veins|1|||
23440071|NCT00448747|65352655|FG001|Overall Study|collapsed veins|0|||
23440072|NCT02147288|65355140|FG000|Overall Study|post-operative hematoma|1|||
23440073|NCT02147288|65355141|FG001|Overall Study|post-operative hematoma|1|||
23440074|NCT02147288|65355142|FG002|Overall Study|post-operative hematoma|0|||
23440075|NCT02147288|65355143|FG003|Overall Study|post-operative hematoma|0|||
23440076|NCT02147288|65355144|FG004|Overall Study|post-operative hematoma|0|||
23440077|NCT02147288|65355145|FG005|Overall Study|post-operative hematoma|0|||
23440078|NCT02147288|65355146|FG006|Overall Study|post-operative hematoma|0|||
23440079|NCT02147288|65355147|FG007|Overall Study|post-operative hematoma|0|||
23440080|NCT02147288|65355148|FG008|Overall Study|post-operative hematoma|0|||
23440081|NCT02147288|65355149|FG009|Overall Study|post-operative hematoma|0|||
23440082|NCT02147288|65355140|FG000|Overall Study|complications from concurrent hernia rep|0|||
23440083|NCT02147288|65355141|FG001|Overall Study|complications from concurrent hernia rep|1|||
23440084|NCT02147288|65355142|FG002|Overall Study|complications from concurrent hernia rep|0|||
23440085|NCT02147288|65355143|FG003|Overall Study|complications from concurrent hernia rep|0|||
23440086|NCT02147288|65355144|FG004|Overall Study|complications from concurrent hernia rep|0|||
23151641|NCT03548987|64305504|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
23440087|NCT02147288|65355145|FG005|Overall Study|complications from concurrent hernia rep|0|||
23440088|NCT02147288|65355146|FG006|Overall Study|complications from concurrent hernia rep|0|||
23440089|NCT02147288|65355147|FG007|Overall Study|complications from concurrent hernia rep|0|||
23440090|NCT02147288|65355148|FG008|Overall Study|complications from concurrent hernia rep|0|||
23440091|NCT02147288|65355149|FG009|Overall Study|complications from concurrent hernia rep|0|||
23440092|NCT02161380|65355150|FG000|Overall Study|Lost to Follow-up|0|||
23440093|NCT02161380|65355151|FG001|Overall Study|Lost to Follow-up|1|||
23440094|NCT02161380|65355152|FG002|Overall Study|Lost to Follow-up|0|||
23440095|NCT02161380|65355153|FG003|Overall Study|Lost to Follow-up|0|||
23440096|NCT01433172|65355154|FG000|Overall Study|Withdrawal by Subject|0|||
23440097|NCT01433172|65355155|FG001|Overall Study|Withdrawal by Subject|1|||
23440098|NCT01433172|65355156|FG002|Overall Study|Withdrawal by Subject|0|||
23440099|NCT01433172|65355154|FG000|Overall Study|Disease Progression|0|||
23440100|NCT01433172|65355155|FG001|Overall Study|Disease Progression|0|||
23440101|NCT01433172|65355156|FG002|Overall Study|Disease Progression|1|||
23440102|NCT01433172|65355154|FG000|Overall Study|Death|0|||
23440103|NCT01433172|65355155|FG001|Overall Study|Death|2|||
23440104|NCT01433172|65355156|FG002|Overall Study|Death|0|||
23151642|NCT03548987|64305505|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
23151643|NCT03548987|64305504|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
23151644|NCT03548987|64305505|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
23151645|NCT03548987|64305504|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
23151646|NCT03548987|64305505|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
23151647|NCT01399190|64305509|FG000|Overall Study|Not Eligible for Final Analysis|5|||
23151648|NCT01399190|64305509|FG000|Overall Study|Adverse Event|8|||
23151649|NCT01399190|64305509|FG000|Overall Study|Participant's Request|5|||
23151650|NCT01399190|64305509|FG000|Overall Study|Physician Decision|2|||
23151651|NCT01717989|64305510|FG000|Overall Study|Ineligibility determined|6|||
23151652|NCT01717989|64305510|FG000|Overall Study|Protocol deviation|6|||
23440105|NCT00350844|65355157|FG000|Overall Study|Lost to Follow-up|1|||
23440106|NCT03517228|65355164|FG000|Overall Study|Withdrawal by Subject|2|||
23440107|NCT03517228|65355164|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
23440108|NCT03517228|65355164|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
23440109|NCT03517228|65355164|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
23440110|NCT03517228|65355164|FG000|Overall Study|Canceled due to device being updated|1|||
23151653|NCT01717989|64305510|FG000|Overall Study|Withdrawal by Subject|11|||
23151654|NCT01717989|64305510|FG000|Overall Study|Physician Decision|2|||
23151655|NCT01717989|64305510|FG000|Overall Study|Lost to Follow-up|11|||
23151656|NCT01717989|64305510|FG000|Overall Study|Death|439|||
23151657|NCT01717989|64305510|FG000|Overall Study|Protocol-specified criteria|551|||
23220099|NCT03907969|64550052|FG006|Combination Therapy Part A|Death|0|||
23440111|NCT03517228|65355164|FG000|Overall Study|No V Cares in stock|1|||
23440112|NCT03517228|65355164|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
23440113|NCT03302247|65355165|FG000|Overall Study|the study has closed prematurely|2|||
23440114|NCT03302247|65355165|FG000|Overall Study|Death|1|||
23440115|NCT00986362|65355166|FG000|Overall Study|Death|2|||
23440116|NCT00986362|65355167|FG001|Overall Study|Death|0|||
23440117|NCT00986362|65355166|FG000|Overall Study|Lost to Follow-up|0|||
23440118|NCT00986362|65355167|FG001|Overall Study|Lost to Follow-up|1|||
23440119|NCT00779025|65355168|FG000|Overall Study|Withdrawal by Subject|1|||
23440120|NCT01807299|65355169|FG000|Overall Study|Protocol Violation|3|||
23440121|NCT01807299|65355170|FG001|Overall Study|Protocol Violation|1|||
23440122|NCT01807299|65355171|FG002|Overall Study|Protocol Violation|0|||
23440123|NCT01807299|65355172|FG003|Overall Study|Protocol Violation|2|||
23440124|NCT02008227|65355174|FG000|Overall Study|Lost to Follow-up|7|||
23440125|NCT02008227|65355175|FG001|Overall Study|Lost to Follow-up|9|||
23440126|NCT02008227|65355174|FG000|Overall Study|Death|494|||
23440127|NCT02008227|65355175|FG001|Overall Study|Death|485|||
23440128|NCT02008227|65355174|FG000|Overall Study|Withdrawal by Subject|67|||
23440129|NCT02008227|65355175|FG001|Overall Study|Withdrawal by Subject|36|||
23440130|NCT02008227|65355174|FG000|Overall Study|Study Terminated By Sponsor|44|||
23440131|NCT02008227|65355175|FG001|Overall Study|Study Terminated By Sponsor|83|||
23440132|NCT00555217|65355176|FG000|Overall Study|Withdrawal by Subject|35|||
23440133|NCT00555217|65355177|FG001|Overall Study|Withdrawal by Subject|31|||
23440134|NCT00555217|65355176|FG000|Overall Study|Lost to Follow-up|19|||
23440135|NCT00555217|65355177|FG001|Overall Study|Lost to Follow-up|20|||
23440136|NCT00555217|65355176|FG000|Overall Study|close out sites|21|||
23440137|NCT00555217|65355177|FG001|Overall Study|close out sites|17|||
23440138|NCT00707954|65355185|FG000|Overall Study|Physician Decision|0|||
23440139|NCT00707954|65355186|FG001|Overall Study|Physician Decision|0|||
23440140|NCT00707954|65355187|FG002|Overall Study|Physician Decision|0|||
23440141|NCT00707954|65355188|FG003|Overall Study|Physician Decision|0|||
23440142|NCT00707954|65355189|FG004|Overall Study|Physician Decision|1|||
23440143|NCT00850538|65355190|FG000|Overall Study|unable/unwilling to complete MRI|13|||
23440144|NCT00850538|65355190|FG000|Overall Study|specimen missed due to scheduling error|14|||
23440145|NCT00850538|65355190|FG000|Overall Study|specimen unusable|7|||
23440146|NCT00850538|65355190|FG000|Overall Study|Withdrawal by Subject|3|||
23440147|NCT00850538|65355190|FG000|Overall Study|radiology error|2|||
23440148|NCT00850538|65355190|FG000|Overall Study|Protocol Violation|2|||
23440149|NCT00774800|65355205|FG000|Intervention 4|Withdrawal by Subject|1|||
23440150|NCT01364389|65355206|FG000|Overall Study|Withdrawal by Subject|0|||
23440151|NCT01364389|65355207|FG001|Overall Study|Withdrawal by Subject|1|||
23440152|NCT01364389|65355208|FG002|Overall Study|Withdrawal by Subject|0|||
23440153|NCT01364389|65355206|FG000|Overall Study|Protocol deviation|0|||
23440154|NCT01364389|65355207|FG001|Overall Study|Protocol deviation|0|||
23440155|NCT01364389|65355208|FG002|Overall Study|Protocol deviation|1|||
23440156|NCT01364389|65355206|FG000|Overall Study|Administrative problems|1|||
23440157|NCT01364389|65355207|FG001|Overall Study|Administrative problems|0|||
23440158|NCT01364389|65355208|FG002|Overall Study|Administrative problems|0|||
23440159|NCT01364389|65355206|FG000|Overall Study|Adverse Event|1|||
23440160|NCT01364389|65355207|FG001|Overall Study|Adverse Event|0|||
23440161|NCT01364389|65355208|FG002|Overall Study|Adverse Event|0|||
23440162|NCT03698019|65355211|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
23440163|NCT03698019|65355212|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
23440164|NCT03698019|65355211|FG000|Step 1: Registration|Withdrawal by Subject|7|||
23440165|NCT03698019|65355212|FG001|Step 1: Registration|Withdrawal by Subject|2|||
23562757|NCT01662063|65790358|FG001|Overall Study|Lost to Follow-up|4|||
23562758|NCT01662063|65790359|FG002|Overall Study|Lost to Follow-up|0|||
23440166|NCT03698019|65355211|FG000|Step 1: Registration|Toxicity|0|||
23440167|NCT03698019|65355212|FG001|Step 1: Registration|Toxicity|1|||
23440168|NCT03698019|65355211|FG000|Step 1: Registration|Disease Progression|0|||
23440169|NCT03698019|65355212|FG001|Step 1: Registration|Disease Progression|12|||
23440170|NCT03698019|65355211|FG000|Step 1: Registration|Co-morbidities|0|||
23440171|NCT03698019|65355212|FG001|Step 1: Registration|Co-morbidities|1|||
23440172|NCT03698019|65355211|FG000|Step 1: Registration|Scheduling Issues|1|||
23440173|NCT03698019|65355212|FG001|Step 1: Registration|Scheduling Issues|0|||
23440174|NCT03698019|65355211|FG000|Step 1: Registration|Participant Refusal|0|||
23440175|NCT03698019|65355212|FG001|Step 1: Registration|Participant Refusal|1|||
23440176|NCT03698019|65355211|FG000|Step 2: Surgery|Participant Refusal|2|||
23440177|NCT03698019|65355212|FG001|Step 2: Surgery|Participant Refusal|1|||
23440178|NCT03698019|65355211|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
23562759|NCT01662063|65790357|FG000|Overall Study|Protocol Violation|1|||
23562760|NCT01662063|65790358|FG001|Overall Study|Protocol Violation|0|||
23440179|NCT03698019|65355212|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
23440180|NCT03698019|65355211|FG000|Step 2: Surgery|Metastatic Disease|16|||
23440181|NCT03698019|65355212|FG001|Step 2: Surgery|Metastatic Disease|9|||
23440182|NCT03698019|65355211|FG000|Step 2: Surgery|Residual Disease|2|||
23440183|NCT03698019|65355212|FG001|Step 2: Surgery|Residual Disease|1|||
23440184|NCT03698019|65355211|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
23440185|NCT03698019|65355212|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
23440186|NCT03698019|65355211|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
23440187|NCT03698019|65355212|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
23440188|NCT03698019|65355211|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
23440189|NCT03698019|65355212|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
23440190|NCT03698019|65355211|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
23440191|NCT03698019|65355212|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
23440192|NCT03698019|65355211|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
23440193|NCT03698019|65355212|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
23440194|NCT03698019|65355211|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
23440195|NCT03698019|65355212|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
23440196|NCT03698019|65355211|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
23440197|NCT03698019|65355212|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
23440198|NCT03698019|65355211|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
23440199|NCT03698019|65355212|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
23440200|NCT04677504|65355217|FG000|Overall Study|Death|51|||
23440201|NCT04677504|65355218|FG001|Overall Study|Death|49|||
23440202|NCT04677504|65355217|FG000|Overall Study|Progressive Disease|1|||
23440203|NCT04677504|65355218|FG001|Overall Study|Progressive Disease|0|||
23440204|NCT04677504|65355217|FG000|Overall Study|Symptomatic Deterioration|1|||
23440205|NCT04677504|65355218|FG001|Overall Study|Symptomatic Deterioration|0|||
23440206|NCT04677504|65355217|FG000|Overall Study|Withdrawal by Subject|2|||
23440207|NCT04677504|65355218|FG001|Overall Study|Withdrawal by Subject|5|||
23440208|NCT04677504|65355217|FG000|Overall Study|Study Terminated By Sponsor|28|||
23440209|NCT04677504|65355218|FG001|Overall Study|Study Terminated By Sponsor|24|||
23440210|NCT04677504|65355217|FG000|Overall Study|Adverse Event|0|||
23562761|NCT01662063|65790359|FG002|Overall Study|Protocol Violation|0|||
23562762|NCT01662063|65790357|FG000|Overall Study|Withdrawal by Subject|2|||
23562763|NCT01662063|65790358|FG001|Overall Study|Withdrawal by Subject|4|||
23562764|NCT01662063|65790359|FG002|Overall Study|Withdrawal by Subject|1|||
23562765|NCT01662063|65790357|FG000|Overall Study|Physician Decision|0|||
23562766|NCT01662063|65790358|FG001|Overall Study|Physician Decision|2|||
23151658|NCT01717989|64305510|FG000|Overall Study|Other|40|||
23562767|NCT01662063|65790359|FG002|Overall Study|Physician Decision|0|||
23562768|NCT01662063|65790357|FG000|Overall Study|Other|0|||
23562769|NCT01662063|65790358|FG001|Overall Study|Other|1|||
23562770|NCT01662063|65790359|FG002|Overall Study|Other|0|||
23562771|NCT01780935|65790360|FG000|Overall Study|Admin problems due to early termination|321|||
23562772|NCT01780935|65790361|FG001|Overall Study|Admin problems due to early termination|309|||
23562773|NCT01780935|65790360|FG000|Overall Study|Adverse Event|2|||
23562774|NCT01780935|65790361|FG001|Overall Study|Adverse Event|4|||
23562775|NCT01780935|65790360|FG000|Overall Study|Death|1|||
23562776|NCT01780935|65790361|FG001|Overall Study|Death|6|||
23562777|NCT01780935|65790360|FG000|Overall Study|Lost to Follow-up|2|||
23562778|NCT01780935|65790361|FG001|Overall Study|Lost to Follow-up|6|||
23562779|NCT01780935|65790360|FG000|Overall Study|Physician Decision|1|||
23562780|NCT01780935|65790361|FG001|Overall Study|Physician Decision|1|||
23562781|NCT01780935|65790360|FG000|Overall Study|Protocol deviation|0|||
23562782|NCT01780935|65790361|FG001|Overall Study|Protocol deviation|1|||
23562783|NCT01780935|65790360|FG000|Overall Study|Patient withdrew consent|8|||
23562784|NCT01780935|65790361|FG001|Overall Study|Patient withdrew consent|9|||
23562785|NCT01728792|65790367|FG000|Overall Study|Withdrawal of Consent|1|||
23562786|NCT01728792|65790368|FG001|Overall Study|Withdrawal of Consent|1|||
23562787|NCT01728792|65790369|FG002|Overall Study|Withdrawal of Consent|0|||
23562788|NCT01728792|65790370|FG003|Overall Study|Withdrawal of Consent|1|||
23562789|NCT01728792|65790371|FG004|Overall Study|Withdrawal of Consent|0|||
23562790|NCT01728792|65790367|FG000|Overall Study|Lost to Follow-up|2|||
23562791|NCT01728792|65790368|FG001|Overall Study|Lost to Follow-up|1|||
23562792|NCT01728792|65790369|FG002|Overall Study|Lost to Follow-up|4|||
23562793|NCT01728792|65790370|FG003|Overall Study|Lost to Follow-up|2|||
23562794|NCT01728792|65790371|FG004|Overall Study|Lost to Follow-up|0|||
23562795|NCT01763788|65790373|FG000|Overall Study|Lost to Follow-up|0|||
23562796|NCT01763788|65790374|FG001|Overall Study|Lost to Follow-up|0|||
23562797|NCT01763788|65790375|FG002|Overall Study|Lost to Follow-up|1|||
23151659|NCT02678416|64305526|FG000|Part 1|Withdrawal by Subject|1|||
23562798|NCT01763788|65790376|FG003|Overall Study|Lost to Follow-up|0|||
23625376|NCT01270828|66015469|FG002|Double Blind Phase|Adverse event related to study drug|0|||
23440211|NCT04677504|65355218|FG001|Overall Study|Adverse Event|1|||
23440212|NCT00527904|65355219|FG000|Overall Study|Adverse Event|45|||
23440213|NCT00527904|65355219|FG000|Overall Study|Withdrawal by Subject|21|||
23440214|NCT00527904|65355219|FG000|Overall Study|Lost to Follow-up|8|||
23562799|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
23562800|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
23151660|NCT02678416|64305526|FG000|Part 2|Adverse Event|2|||
23151661|NCT02678416|64305526|FG000|Part 2|Withdrawal by Subject|1|||
23440215|NCT00527904|65355219|FG000|Overall Study|misc|22|||
23562801|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
23562802|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
23562803|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
23562804|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
23562805|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
23562806|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
23562807|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
23562808|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
23562809|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
23562810|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
23562811|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562812|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562813|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562814|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562815|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
23562816|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
23562817|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
23562818|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
23562819|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
23562820|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
23562821|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
23562822|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
23562823|NCT02778399|65790377|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
23562824|NCT02778399|65790378|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
23562825|NCT02778399|65790379|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
23562826|NCT02778399|65790380|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
23562827|NCT02778399|65790381|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
23562828|NCT02778399|65790382|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
23562829|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
23562830|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
23562831|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
23562832|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
23562833|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
23562834|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
23562835|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
23562836|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
23562837|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
23562838|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
23562839|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
23562840|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
23325317|NCT00129389|64933791|FG000|Overall Study|Adverse Event|19|||
23325318|NCT00129389|64933792|FG001|Overall Study|Adverse Event|87|||
23325319|NCT00129389|64933791|FG000|Overall Study|Death|0|||
23325320|NCT00129389|64933792|FG001|Overall Study|Death|1|||
23325321|NCT00129389|64933791|FG000|Overall Study|Lost to Follow-up|2|||
23325322|NCT00129389|64933792|FG001|Overall Study|Lost to Follow-up|1|||
23325323|NCT00129389|64933791|FG000|Overall Study|Physician Decision|0|||
23325324|NCT00129389|64933792|FG001|Overall Study|Physician Decision|4|||
23325325|NCT00129389|64933791|FG000|Overall Study|Protocol Violation|0|||
23325326|NCT00129389|64933792|FG001|Overall Study|Protocol Violation|6|||
23325327|NCT00129389|64933791|FG000|Overall Study|Withdrawal by Subject|9|||
23325328|NCT00129389|64933792|FG001|Overall Study|Withdrawal by Subject|23|||
23325329|NCT00129389|64933791|FG000|Overall Study|Relapse|1|||
23325330|NCT00129389|64933792|FG001|Overall Study|Relapse|0|||
23325331|NCT00129389|64933791|FG000|Overall Study|Not eligible|1|||
23325332|NCT00129389|64933792|FG001|Overall Study|Not eligible|2|||
23325333|NCT00129389|64933791|FG000|Overall Study|Crossed to the other arm|1|||
23325334|NCT00129389|64933792|FG001|Overall Study|Crossed to the other arm|16|||
23325335|NCT01217112|64933796|FG000|Overall Study|Adverse Event|0|||
23325336|NCT01217112|64933797|FG001|Overall Study|Adverse Event|2|||
23325337|NCT01217112|64933798|FG002|Overall Study|Adverse Event|0|||
23562841|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23562842|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
23562843|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23562844|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23562845|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23625377|NCT00585078|66015472|FG000|Overall Study|Withdrawal by Subject|4|||
23220100|NCT03907969|64550053|FG007|Combination Therapy Part A|Death|0|||
23325338|NCT01217112|64933799|FG003|Overall Study|Adverse Event|2|||
23325339|NCT01217112|64933800|FG004|Overall Study|Adverse Event|0|||
23325340|NCT01217112|64933796|FG000|Overall Study|Withdrawal by Subject|0|||
23325341|NCT01217112|64933797|FG001|Overall Study|Withdrawal by Subject|0|||
23325342|NCT01217112|64933798|FG002|Overall Study|Withdrawal by Subject|1|||
23325343|NCT01217112|64933799|FG003|Overall Study|Withdrawal by Subject|0|||
23325344|NCT01217112|64933800|FG004|Overall Study|Withdrawal by Subject|0|||
23562846|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
23325345|NCT01217112|64933796|FG000|Overall Study|Physician Decision|0|||
23325346|NCT01217112|64933797|FG001|Overall Study|Physician Decision|0|||
23325347|NCT01217112|64933798|FG002|Overall Study|Physician Decision|0|||
23325348|NCT01217112|64933799|FG003|Overall Study|Physician Decision|0|||
23325349|NCT01217112|64933800|FG004|Overall Study|Physician Decision|1|||
23325350|NCT04021914|64933801|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
23325351|NCT03103087|64933805|FG000|Overall Study|Did not receive any study drug|1|||
23325352|NCT03103087|64933806|FG001|Overall Study|Did not receive any study drug|0|||
23325353|NCT03103087|64933807|FG002|Overall Study|Did not receive any study drug|0|||
23325354|NCT03103087|64933805|FG000|Overall Study|Protocol Violation|1|||
23325355|NCT03103087|64933806|FG001|Overall Study|Protocol Violation|2|||
23325356|NCT03103087|64933807|FG002|Overall Study|Protocol Violation|1|||
23325357|NCT03103087|64933805|FG000|Overall Study|Lack of Efficacy|2|||
23325358|NCT03103087|64933806|FG001|Overall Study|Lack of Efficacy|1|||
23325359|NCT03103087|64933807|FG002|Overall Study|Lack of Efficacy|1|||
23325360|NCT03103087|64933805|FG000|Overall Study|Pregnancy|0|||
23325361|NCT03103087|64933806|FG001|Overall Study|Pregnancy|0|||
23325362|NCT03103087|64933807|FG002|Overall Study|Pregnancy|1|||
23325363|NCT03103087|64933805|FG000|Overall Study|Adverse Event|2|||
23325364|NCT03103087|64933806|FG001|Overall Study|Adverse Event|15|||
23325365|NCT03103087|64933807|FG002|Overall Study|Adverse Event|6|||
23325366|NCT03103087|64933805|FG000|Overall Study|Withdrawal by Subject|13|||
23325367|NCT03103087|64933806|FG001|Overall Study|Withdrawal by Subject|6|||
23325368|NCT03103087|64933807|FG002|Overall Study|Withdrawal by Subject|6|||
23325369|NCT03103087|64933805|FG000|Overall Study|Lost to Follow-up|4|||
23325370|NCT03103087|64933806|FG001|Overall Study|Lost to Follow-up|2|||
23325371|NCT03103087|64933807|FG002|Overall Study|Lost to Follow-up|7|||
23325372|NCT03103087|64933805|FG000|Overall Study|Other reason not reported|1|||
23325373|NCT03103087|64933806|FG001|Overall Study|Other reason not reported|3|||
23325374|NCT03103087|64933807|FG002|Overall Study|Other reason not reported|5|||
23325375|NCT03642262|64933811|FG000|Period 1|Withdrawal by Subject|1|||
23325376|NCT03642262|64933812|FG001|Period 1|Withdrawal by Subject|1|||
23325377|NCT03642262|64933811|FG000|Period 1|Adverse Event|0|||
23325378|NCT03642262|64933812|FG001|Period 1|Adverse Event|1|||
23325379|NCT04650204|64933820|FG000|Overall Study|Study was Terminated|2|||
23325380|NCT04650204|64933821|FG001|Overall Study|Study was Terminated|1|||
23325381|NCT01482312|64933826|FG000|Period 1, 90 Minutes of Wear|Other|1|||
23325382|NCT01482312|64933827|FG001|Period 1, 90 Minutes of Wear|Other|0|||
23325383|NCT01482312|64933828|FG002|Period 1, 90 Minutes of Wear|Other|0|||
23325384|NCT01482312|64933826|FG000|Period 2, 90 Minutes of Wear|Other|1|||
23325385|NCT01482312|64933827|FG001|Period 2, 90 Minutes of Wear|Other|0|||
23325386|NCT01482312|64933828|FG002|Period 2, 90 Minutes of Wear|Other|0|||
23325387|NCT00459355|64933829|FG000|Overall Study|Subject no longer met inc criteria|20|||
23325388|NCT00459355|64933830|FG001|Overall Study|Subject no longer met inc criteria|18|||
23325389|NCT00513240|64933866|FG000|Overall Study|Did not have intended surgery|3|||
23325390|NCT00513240|64933867|FG001|Overall Study|Did not have intended surgery|0|||
23325391|NCT00513240|64933866|FG000|Overall Study|Death|3|||
23325392|NCT00513240|64933867|FG001|Overall Study|Death|3|||
23325393|NCT00513240|64933866|FG000|Overall Study|Withdrawal by Subject|7|||
23325394|NCT00513240|64933867|FG001|Overall Study|Withdrawal by Subject|4|||
23325395|NCT02069015|64933875|FG000|Overall Study|Lost to Follow-up|39|||
23325396|NCT02069015|64933876|FG001|Overall Study|Lost to Follow-up|32|||
23325397|NCT02069015|64933875|FG000|Overall Study|Withdrawal by Subject|1|||
23325398|NCT02069015|64933876|FG001|Overall Study|Withdrawal by Subject|1|||
23325399|NCT01321879|64933877|FG000|Overall Study|Lack of Efficacy|5|||
23325400|NCT01321879|64933877|FG000|Overall Study|Adverse Event|5|||
23325401|NCT01321879|64933877|FG000|Overall Study|Death|3|||
23562847|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
23325402|NCT01321879|64933877|FG000|Overall Study|Withdrawal by Subject|1|||
23325403|NCT03518008|64933878|FG000|Period 2, Second Week of Wear|Family emergency|0|||
23325404|NCT03518008|64933879|FG001|Period 2, Second Week of Wear|Family emergency|1|||
23325405|NCT01515423|64933882|FG000|Open Label Phase|Adverse Event|57|||
23325406|NCT01515423|64933883|FG001|Open Label Phase|Adverse Event|0|||
23325407|NCT01515423|64933884|FG002|Open Label Phase|Adverse Event|0|||
23325408|NCT01515423|64933882|FG000|Open Label Phase|Death|2|||
23325409|NCT01515423|64933883|FG001|Open Label Phase|Death|0|||
23325410|NCT01515423|64933884|FG002|Open Label Phase|Death|0|||
23325411|NCT01515423|64933882|FG000|Open Label Phase|Lack of Efficacy|117|||
23325412|NCT01515423|64933883|FG001|Open Label Phase|Lack of Efficacy|0|||
23325413|NCT01515423|64933884|FG002|Open Label Phase|Lack of Efficacy|0|||
23325414|NCT01515423|64933882|FG000|Open Label Phase|Lost to Follow-up|21|||
23325415|NCT01515423|64933883|FG001|Open Label Phase|Lost to Follow-up|0|||
23325416|NCT01515423|64933884|FG002|Open Label Phase|Lost to Follow-up|0|||
23325417|NCT01515423|64933882|FG000|Open Label Phase|Withdrawal by Subject|118|||
23325418|NCT01515423|64933883|FG001|Open Label Phase|Withdrawal by Subject|0|||
23325419|NCT01515423|64933884|FG002|Open Label Phase|Withdrawal by Subject|0|||
23325420|NCT01515423|64933882|FG000|Open Label Phase|excluded from DB Phase|70|||
23325421|NCT01515423|64933883|FG001|Open Label Phase|excluded from DB Phase|0|||
23325422|NCT01515423|64933884|FG002|Open Label Phase|excluded from DB Phase|0|||
23325423|NCT01515423|64933882|FG000|Open Label Phase|Other|28|||
23325424|NCT01515423|64933883|FG001|Open Label Phase|Other|0|||
23325425|NCT01515423|64933884|FG002|Open Label Phase|Other|0|||
23325426|NCT01515423|64933882|FG000|DOUBLE BLIND|Adverse Event|0|||
23325427|NCT01515423|64933883|FG001|DOUBLE BLIND|Adverse Event|15|||
23325428|NCT01515423|64933884|FG002|DOUBLE BLIND|Adverse Event|13|||
23325429|NCT01515423|64933882|FG000|DOUBLE BLIND|Death|0|||
23325430|NCT01515423|64933883|FG001|DOUBLE BLIND|Death|1|||
23325431|NCT01515423|64933884|FG002|DOUBLE BLIND|Death|2|||
23325432|NCT01515423|64933882|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
23325433|NCT01515423|64933883|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
23325434|NCT01515423|64933884|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
23325435|NCT01515423|64933882|FG000|DOUBLE BLIND|Pregnancy|0|||
23325436|NCT01515423|64933883|FG001|DOUBLE BLIND|Pregnancy|2|||
23325437|NCT01515423|64933884|FG002|DOUBLE BLIND|Pregnancy|0|||
23325438|NCT01515423|64933882|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
23325439|NCT01515423|64933883|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
23562848|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
23562849|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
23562850|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
23562851|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
23625378|NCT00585078|66015472|FG000|Overall Study|Poor performance status|1|||
23625379|NCT00585078|66015472|FG000|Overall Study|Disease Progression|24|||
23625380|NCT00585078|66015472|FG000|Overall Study|Adverse Event|10|||
23625381|NCT00585078|66015472|FG000|Overall Study|Death|1|||
23625382|NCT01983462|66015477|FG000|Overall Study|Adverse Event|1|||
23625383|NCT01983462|66015478|FG001|Overall Study|Adverse Event|0|||
23625384|NCT01983462|66015479|FG002|Overall Study|Adverse Event|0|||
23625385|NCT02658175|66015481|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
23625386|NCT02658175|66015482|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
23625387|NCT02658175|66015483|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
23625388|NCT02658175|66015481|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
23625389|NCT02658175|66015482|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
23625390|NCT02658175|66015483|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
23151662|NCT01138007|64305527|FG000|Overall Study|Adverse Event|4|||
23151663|NCT01138007|64305528|FG001|Overall Study|Adverse Event|12|||
23151664|NCT01138007|64305529|FG002|Overall Study|Adverse Event|9|||
23151665|NCT01138007|64305527|FG000|Overall Study|Lack of Efficacy|2|||
23151666|NCT01138007|64305528|FG001|Overall Study|Lack of Efficacy|0|||
23151667|NCT01138007|64305529|FG002|Overall Study|Lack of Efficacy|6|||
23151668|NCT01138007|64305527|FG000|Overall Study|Protocol Violation|2|||
23151669|NCT01138007|64305528|FG001|Overall Study|Protocol Violation|3|||
23151670|NCT01138007|64305529|FG002|Overall Study|Protocol Violation|2|||
23151671|NCT01138007|64305527|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
23151672|NCT01138007|64305528|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
23151673|NCT01138007|64305529|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
23151674|NCT01138007|64305527|FG000|Overall Study|Lost to Follow-up|3|||
23151675|NCT01138007|64305528|FG001|Overall Study|Lost to Follow-up|3|||
23151676|NCT01138007|64305529|FG002|Overall Study|Lost to Follow-up|5|||
23151677|NCT01138007|64305527|FG000|Overall Study|Physician Decision|0|||
23151678|NCT01138007|64305528|FG001|Overall Study|Physician Decision|5|||
23151679|NCT01138007|64305529|FG002|Overall Study|Physician Decision|3|||
23151680|NCT01138007|64305527|FG000|Overall Study|Withdrawal by Subject|5|||
23151681|NCT01138007|64305528|FG001|Overall Study|Withdrawal by Subject|6|||
23562852|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
23562853|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
23562854|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
23562855|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
23562856|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
23625391|NCT02658175|66015481|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
23625392|NCT02658175|66015482|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
23151682|NCT01138007|64305529|FG002|Overall Study|Withdrawal by Subject|15|||
23151683|NCT00146328|64305533|FG000|Overall Study|Adverse Event|39|||
23151684|NCT00146328|64305534|FG001|Overall Study|Adverse Event|48|||
23151685|NCT00146328|64305535|FG002|Overall Study|Adverse Event|79|||
23625393|NCT02658175|66015483|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
23151686|NCT00146328|64305533|FG000|Overall Study|Protocol Violation|11|||
23151687|NCT00146328|64305534|FG001|Overall Study|Protocol Violation|6|||
23325440|NCT01515423|64933884|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
23325441|NCT01515423|64933882|FG000|DOUBLE BLIND|Other|0|||
23325442|NCT01515423|64933883|FG001|DOUBLE BLIND|Other|6|||
23325443|NCT01515423|64933884|FG002|DOUBLE BLIND|Other|12|||
23325444|NCT01515423|64933882|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
23325445|NCT01515423|64933883|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
23562857|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
23562858|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
23562859|NCT02778399|65790377|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
23562860|NCT02778399|65790378|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
23562861|NCT02778399|65790379|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
23562862|NCT02778399|65790380|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
23562863|NCT02778399|65790381|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
23562864|NCT02778399|65790382|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
23562865|NCT01264380|65790383|FG000|Period C|Disease Progression|0|||
23562866|NCT01264380|65790384|FG001|Period C|Disease Progression|0|||
23151688|NCT00146328|64305535|FG002|Overall Study|Protocol Violation|12|||
23151689|NCT00146328|64305533|FG000|Overall Study|Lost to Follow-up|7|||
23151690|NCT00146328|64305534|FG001|Overall Study|Lost to Follow-up|4|||
23151691|NCT00146328|64305535|FG002|Overall Study|Lost to Follow-up|7|||
23151692|NCT00146328|64305533|FG000|Overall Study|Withdrawal by Subject|16|||
23151693|NCT00146328|64305534|FG001|Overall Study|Withdrawal by Subject|16|||
23151694|NCT00146328|64305535|FG002|Overall Study|Withdrawal by Subject|22|||
23151695|NCT00146328|64305533|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
23151696|NCT00146328|64305534|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
23151697|NCT00146328|64305535|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
23151698|NCT00146328|64305533|FG000|Overall Study|Trial ended/site closed|8|||
23151699|NCT00146328|64305534|FG001|Overall Study|Trial ended/site closed|2|||
23151700|NCT00146328|64305535|FG002|Overall Study|Trial ended/site closed|19|||
23151701|NCT00146328|64305533|FG000|Overall Study|Patient decision to end|0|||
23151702|NCT00146328|64305534|FG001|Overall Study|Patient decision to end|1|||
23151703|NCT00146328|64305535|FG002|Overall Study|Patient decision to end|6|||
23151704|NCT00146328|64305533|FG000|Overall Study|Enroll into other trial|2|||
23151705|NCT00146328|64305534|FG001|Overall Study|Enroll into other trial|4|||
23151706|NCT00146328|64305535|FG002|Overall Study|Enroll into other trial|2|||
23151707|NCT00146328|64305533|FG000|Overall Study|Death|0|||
23151708|NCT00146328|64305534|FG001|Overall Study|Death|1|||
23151709|NCT00146328|64305535|FG002|Overall Study|Death|1|||
23151710|NCT00146328|64305533|FG000|Overall Study|Moved|2|||
23151711|NCT00146328|64305534|FG001|Overall Study|Moved|0|||
23151712|NCT00146328|64305535|FG002|Overall Study|Moved|0|||
23151713|NCT00146328|64305533|FG000|Overall Study|Interaction with other medication|2|||
23151714|NCT00146328|64305534|FG001|Overall Study|Interaction with other medication|0|||
23151715|NCT00146328|64305535|FG002|Overall Study|Interaction with other medication|1|||
23151716|NCT01891721|64305536|FG000|Overall Study|Lost to Follow-up|10|||
23151717|NCT01891721|64305537|FG001|Overall Study|Lost to Follow-up|5|||
23151718|NCT01891721|64305538|FG002|Overall Study|Lost to Follow-up|1|||
23151719|NCT00935272|64305542|FG000|Overall Study|Lost to Follow-up|10|||
23151720|NCT00935272|64305543|FG001|Overall Study|Lost to Follow-up|3|||
23151721|NCT00935272|64305542|FG000|Overall Study|Withdrawal by Subject|8|||
23151722|NCT00935272|64305543|FG001|Overall Study|Withdrawal by Subject|2|||
23151723|NCT00935272|64305542|FG000|Overall Study|Physician Decision|1|||
23220101|NCT03907969|64550054|FG008|Combination Therapy Part A|Death|1|||
23325446|NCT01515423|64933884|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
23562867|NCT01264380|65790385|FG002|Period C|Disease Progression|4|||
23625394|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
23625395|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
23625396|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
23625397|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
23625398|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
23625399|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
23625400|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
23625401|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
23625402|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
23625403|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
23625404|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
23625405|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
23151724|NCT00935272|64305543|FG001|Overall Study|Physician Decision|0|||
23151725|NCT00935272|64305542|FG000|Overall Study|Protocol Violation|0|||
23151726|NCT00935272|64305543|FG001|Overall Study|Protocol Violation|1|||
23151727|NCT01211535|64305544|FG000|Overall Study|Adverse Event|0|||
23151728|NCT01211535|64305545|FG001|Overall Study|Adverse Event|1|||
23151729|NCT01179672|64305546|FG000|Overall Study|Adverse Event|17|||
23151730|NCT01179672|64305547|FG001|Overall Study|Adverse Event|8|||
23151731|NCT01179672|64305546|FG000|Overall Study|Withdrawal by Subject|10|||
23151732|NCT01179672|64305547|FG001|Overall Study|Withdrawal by Subject|12|||
23151733|NCT01179672|64305546|FG000|Overall Study|Entry Criteria Not Met|0|||
23151734|NCT01179672|64305547|FG001|Overall Study|Entry Criteria Not Met|2|||
23151735|NCT01179672|64305546|FG000|Overall Study|Lost to Follow-up|0|||
23151736|NCT01179672|64305547|FG001|Overall Study|Lost to Follow-up|1|||
23440216|NCT00595478|65355220|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
23440217|NCT00595478|65355221|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
23440218|NCT00595478|65355220|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
23440219|NCT00595478|65355221|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
23440220|NCT03915470|65355224|FG000|Overall Study|Death|3|||
23440221|NCT03915470|65355225|FG001|Overall Study|Death|1|||
23440222|NCT03915470|65355224|FG000|Overall Study|Adverse Event|1|||
23440223|NCT03915470|65355225|FG001|Overall Study|Adverse Event|0|||
23440224|NCT03915470|65355224|FG000|Overall Study|Physician Decision|1|||
23440225|NCT03915470|65355225|FG001|Overall Study|Physician Decision|0|||
23440226|NCT03915470|65355224|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
23440227|NCT03915470|65355225|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
23440228|NCT00704288|65355226|FG000|Overall Treatment Period|Adverse Event|11|||
23440229|NCT00704288|65355227|FG001|Overall Treatment Period|Adverse Event|8|||
23440230|NCT00704288|65355228|FG002|Overall Treatment Period|Adverse Event|22|||
23440231|NCT00704288|65355226|FG000|Overall Treatment Period|Death|0|||
23440232|NCT00704288|65355227|FG001|Overall Treatment Period|Death|0|||
23440233|NCT00704288|65355228|FG002|Overall Treatment Period|Death|1|||
23440234|NCT00704288|65355226|FG000|Overall Treatment Period|Physician Decision|0|||
23440235|NCT00704288|65355227|FG001|Overall Treatment Period|Physician Decision|2|||
23440236|NCT00704288|65355228|FG002|Overall Treatment Period|Physician Decision|0|||
23440237|NCT00704288|65355226|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
23440238|NCT00704288|65355227|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
23440239|NCT00704288|65355228|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
23440240|NCT00704288|65355226|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
23440241|NCT00704288|65355227|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
23440242|NCT00704288|65355228|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
23440243|NCT00704288|65355226|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
23440244|NCT00704288|65355227|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
23440245|NCT00704288|65355228|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
23440246|NCT00704288|65355226|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
23440247|NCT00704288|65355227|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
23440248|NCT00704288|65355228|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
23440249|NCT00704288|65355226|FG000|Overall Treatment Period|Roll-over to another study|1|||
23440250|NCT00704288|65355227|FG001|Overall Treatment Period|Roll-over to another study|0|||
23440251|NCT00704288|65355228|FG002|Overall Treatment Period|Roll-over to another study|4|||
23440252|NCT00704288|65355226|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
23440253|NCT00704288|65355227|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
23440254|NCT00704288|65355228|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
23440255|NCT00704288|65355226|FG000|Extended Post Treatment Follow Up Period|Death|41|||
23440256|NCT00704288|65355227|FG001|Extended Post Treatment Follow Up Period|Death|50|||
23440257|NCT00704288|65355228|FG002|Extended Post Treatment Follow Up Period|Death|93|||
23440258|NCT00704288|65355226|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
23440259|NCT00704288|65355227|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
23440260|NCT00704288|65355228|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
23440261|NCT00704288|65355226|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
23440262|NCT00704288|65355227|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
23440263|NCT00704288|65355228|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
23440264|NCT00704288|65355226|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
23440265|NCT00704288|65355227|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
23440266|NCT00704288|65355228|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
23440267|NCT01635855|65355231|FG000|Overall Study|Withdrawal by Subject|4|||
23440268|NCT00511238|65355232|FG000|Overall Study|Adverse Event|13|||
23440269|NCT00511238|65355233|FG001|Overall Study|Adverse Event|33|||
23440270|NCT00511238|65355232|FG000|Overall Study|Withdrawal by Subject|2|||
23440271|NCT00511238|65355233|FG001|Overall Study|Withdrawal by Subject|22|||
23440272|NCT00511238|65355232|FG000|Overall Study|Progressive Disease|23|||
23440273|NCT00511238|65355233|FG001|Overall Study|Progressive Disease|157|||
23440274|NCT00511238|65355232|FG000|Overall Study|various reasons|4|||
23440275|NCT00511238|65355233|FG001|Overall Study|various reasons|14|||
23440276|NCT00924508|65355236|FG000|Overall Study|Withdrawal by Subject|3|||
23440277|NCT00434109|65355237|FG000|Overall Study|Physician Decision|9|||
23440278|NCT00434109|65355237|FG000|Overall Study|Adverse Event|5|||
23440279|NCT00434109|65355237|FG000|Overall Study|Protocol Violation|1|||
23440280|NCT00434109|65355237|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
23151737|NCT01179672|64305546|FG000|Overall Study|Protocol Violation|2|||
23440281|NCT02799745|65355243|FG000|Overall Study|Participant moved out of state|1|||
23151738|NCT01179672|64305547|FG001|Overall Study|Protocol Violation|2|||
23325447|NCT02738138|64933885|FG000|Overall Study|Adverse Event|0|||
23325448|NCT02738138|64933886|FG001|Overall Study|Adverse Event|1|||
23325449|NCT02738138|64933885|FG000|Overall Study|Lost to Follow-up|2|||
23325450|NCT02738138|64933886|FG001|Overall Study|Lost to Follow-up|0|||
23325451|NCT02738138|64933885|FG000|Overall Study|Other - not further specified|1|||
23325452|NCT02738138|64933886|FG001|Overall Study|Other - not further specified|0|||
23325453|NCT01796392|64933887|FG000|Overall Study|Withdrawal by Subject|2|||
23325454|NCT01796392|64933888|FG001|Overall Study|Withdrawal by Subject|0|||
23325455|NCT01796392|64933887|FG000|Overall Study|Death|5|||
23325456|NCT01796392|64933888|FG001|Overall Study|Death|1|||
23325457|NCT01796392|64933887|FG000|Overall Study|Excluded for medical reasons|1|||
23325458|NCT01796392|64933888|FG001|Overall Study|Excluded for medical reasons|2|||
23325459|NCT01796392|64933887|FG000|Overall Study|Lost to Follow-up|1|||
23325460|NCT01796392|64933888|FG001|Overall Study|Lost to Follow-up|0|||
23325461|NCT02347813|64933890|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
23325462|NCT02347813|64933891|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
23325463|NCT02347813|64933890|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
23325464|NCT02347813|64933891|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
23325465|NCT00470470|64933893|FG000|Overall Study|Adverse Event|2|||
23325466|NCT00470470|64933893|FG000|Overall Study|Death|2|||
23325467|NCT00470470|64933893|FG000|Overall Study|Not treated|1|||
23325468|NCT00118157|64933894|FG000|Overall Study|Adverse Event|2|||
23325469|NCT00118157|64933894|FG000|Overall Study|Death|8|||
23325470|NCT00118157|64933894|FG000|Overall Study|Withdrawal by Subject|2|||
23325471|NCT01922037|64933895|FG000|Overall Study|Withdrawal by Subject|2|||
23325472|NCT01922037|64933896|FG001|Overall Study|Withdrawal by Subject|44|||
23325473|NCT01922037|64933895|FG000|Overall Study|Adverse Event|1|||
23325474|NCT01922037|64933896|FG001|Overall Study|Adverse Event|7|||
23325475|NCT01922037|64933895|FG000|Overall Study|Death|0|||
23325476|NCT01922037|64933896|FG001|Overall Study|Death|5|||
23325477|NCT01922037|64933895|FG000|Overall Study|Pregnancy|0|||
23325478|NCT01922037|64933896|FG001|Overall Study|Pregnancy|2|||
23325479|NCT01922037|64933895|FG000|Overall Study|Participant non-compliance|4|||
23325480|NCT01922037|64933896|FG001|Overall Study|Participant non-compliance|46|||
23325481|NCT01922037|64933895|FG000|Overall Study|Investigator/Sponsor decision|1|||
23325482|NCT01922037|64933896|FG001|Overall Study|Investigator/Sponsor decision|4|||
23325483|NCT01922037|64933895|FG000|Overall Study|Other unspecified|2|||
23325484|NCT01922037|64933896|FG001|Overall Study|Other unspecified|66|||
23325485|NCT03170362|64933897|FG000|Overall Study|Death|2|||
23325486|NCT03170362|64933898|FG001|Overall Study|Death|2|||
23325487|NCT03170362|64933897|FG000|Overall Study|Withdrawal by Subject|23|||
23325488|NCT03170362|64933898|FG001|Overall Study|Withdrawal by Subject|22|||
23325489|NCT03170362|64933897|FG000|Overall Study|Lost to Follow-up|187|||
23325490|NCT03170362|64933898|FG001|Overall Study|Lost to Follow-up|167|||
23325491|NCT01330303|64933899|FG000|Period 1|Adverse Event|1|||
23325492|NCT01330303|64933900|FG001|Period 1|Adverse Event|0|||
23325493|NCT01330303|64933899|FG000|Period 1|Protocol Violation|0|||
23325494|NCT01330303|64933900|FG001|Period 1|Protocol Violation|1|||
23325495|NCT01330303|64933899|FG000|Period 1|Withdrawal by Subject|0|||
23325496|NCT01330303|64933900|FG001|Period 1|Withdrawal by Subject|1|||
23325497|NCT02301169|64933903|FG000|Overall Study|Adverse Event|1|||
23325498|NCT02301169|64933904|FG001|Overall Study|Adverse Event|0|||
23325499|NCT02328014|64933907|FG000|Overall Study|Adverse Event|1|||
23325500|NCT02328014|64933908|FG001|Overall Study|Adverse Event|0|||
23325501|NCT02328014|64933909|FG002|Overall Study|Adverse Event|0|||
23325502|NCT02328014|64933910|FG003|Overall Study|Adverse Event|1|||
23325503|NCT02328014|64933907|FG000|Overall Study|Death|0|||
23325504|NCT02328014|64933908|FG001|Overall Study|Death|0|||
23325505|NCT02328014|64933909|FG002|Overall Study|Death|0|||
23562868|NCT01264380|65790383|FG000|Period C|Death|0|||
23562869|NCT01264380|65790384|FG001|Period C|Death|0|||
23562870|NCT01264380|65790385|FG002|Period C|Death|2|||
23325506|NCT02328014|64933910|FG003|Overall Study|Death|4|||
23562871|NCT01264380|65790383|FG000|Period C|Follow-up for survival status|0|||
23562872|NCT01264380|65790384|FG001|Period C|Follow-up for survival status|0|||
23562873|NCT01264380|65790385|FG002|Period C|Follow-up for survival status|6|||
23562874|NCT01264380|65790383|FG000|Period C|Withdrawal by Subject|0|||
23325507|NCT02328014|64933907|FG000|Overall Study|Physician Decision|0|||
23325508|NCT02328014|64933908|FG001|Overall Study|Physician Decision|0|||
23325509|NCT02328014|64933909|FG002|Overall Study|Physician Decision|0|||
23325510|NCT02328014|64933910|FG003|Overall Study|Physician Decision|1|||
23325511|NCT02328014|64933907|FG000|Overall Study|Disease Progression|1|||
23325512|NCT02328014|64933908|FG001|Overall Study|Disease Progression|0|||
23325513|NCT02328014|64933909|FG002|Overall Study|Disease Progression|1|||
23325514|NCT02328014|64933910|FG003|Overall Study|Disease Progression|3|||
23562875|NCT01264380|65790384|FG001|Period C|Withdrawal by Subject|0|||
23325515|NCT02328014|64933907|FG000|Overall Study|Study Terminated by Sponsor|4|||
23325516|NCT02328014|64933908|FG001|Overall Study|Study Terminated by Sponsor|1|||
23562876|NCT01264380|65790385|FG002|Period C|Withdrawal by Subject|1|||
23325517|NCT02328014|64933909|FG002|Overall Study|Study Terminated by Sponsor|1|||
23440282|NCT02799745|65355244|FG001|Overall Study|Participant moved out of state|0|||
23440283|NCT02799745|65355243|FG000|Overall Study|Discontinued due to planned surgery|1|||
23440284|NCT02799745|65355244|FG001|Overall Study|Discontinued due to planned surgery|0|||
23440285|NCT02799745|65355243|FG000|Overall Study|Withdrawal by Subject|16|||
23440286|NCT02799745|65355244|FG001|Overall Study|Withdrawal by Subject|25|||
23440287|NCT02799745|65355243|FG000|Overall Study|Protocol Deviation|4|||
23440288|NCT02799745|65355244|FG001|Overall Study|Protocol Deviation|5|||
23440289|NCT02799745|65355243|FG000|Overall Study|Progressive Disease|28|||
23440290|NCT02799745|65355244|FG001|Overall Study|Progressive Disease|38|||
23440291|NCT02799745|65355243|FG000|Overall Study|Lost to Follow-up|3|||
23440292|NCT02799745|65355244|FG001|Overall Study|Lost to Follow-up|2|||
23440293|NCT02799745|65355243|FG000|Overall Study|Death|3|||
23440294|NCT02799745|65355244|FG001|Overall Study|Death|0|||
23440295|NCT02799745|65355243|FG000|Overall Study|Adverse Event|0|||
23440296|NCT02799745|65355244|FG001|Overall Study|Adverse Event|1|||
23440297|NCT00163020|65355246|FG000|Overall Study|Lost to Follow-up|0|||
23440298|NCT00163020|65355247|FG001|Overall Study|Lost to Follow-up|2|||
23440299|NCT02564978|65355250|FG000|Overall Study|Adverse Event|8|||
23440300|NCT02564978|65355250|FG000|Overall Study|Death|1|||
23440301|NCT02564978|65355250|FG000|Overall Study|Lost to Follow-up|1|||
23440302|NCT02564978|65355250|FG000|Overall Study|Withdrawal by Subject|15|||
23440303|NCT02564978|65355250|FG000|Overall Study|Early Study Closure|2|||
23440304|NCT02564978|65355250|FG000|Overall Study|Other Reason|5|||
23440305|NCT00892775|65355251|FG000|Overall Study|Protocol Violation|1|||
23440306|NCT00892775|65355252|FG001|Overall Study|Protocol Violation|0|||
23440307|NCT00892775|65355251|FG000|Overall Study|Subject difficulties with blood drawing|1|||
23440308|NCT00892775|65355252|FG001|Overall Study|Subject difficulties with blood drawing|0|||
23440309|NCT00892775|65355251|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
23440310|NCT00892775|65355252|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
23440311|NCT00892775|65355251|FG000|Overall Study|Migrated/ moved from study area|1|||
23440312|NCT00892775|65355252|FG001|Overall Study|Migrated/ moved from study area|0|||
23440313|NCT00892775|65355251|FG000|Overall Study|Withdrawal by Subject|0|||
23440314|NCT00892775|65355252|FG001|Overall Study|Withdrawal by Subject|1|||
23440315|NCT00892775|65355251|FG000|Overall Study|Lost to Follow-up|1|||
23440316|NCT00892775|65355252|FG001|Overall Study|Lost to Follow-up|0|||
23440317|NCT00782483|65355253|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
23440318|NCT01754493|65355256|FG000|Overall Study|Adverse Event|1|||
23440319|NCT01754493|65355256|FG000|Overall Study|Lost to Follow-up|3|||
23440320|NCT01754493|65355256|FG000|Overall Study|Withdrawal by Subject|1|||
23440321|NCT01754493|65355256|FG000|Overall Study|Moved out of town|1|||
23440322|NCT01754493|65355256|FG000|Overall Study|Scheduling conflict|1|||
23440323|NCT03364309|65355257|FG000|Induction Period|Adverse Event|4|||
23440324|NCT03364309|65355258|FG001|Induction Period|Adverse Event|0|||
23440325|NCT03364309|65355259|FG002|Induction Period|Adverse Event|1|||
23440326|NCT03364309|65355260|FG003|Induction Period|Adverse Event|0|||
23440327|NCT03364309|65355261|FG004|Induction Period|Adverse Event|0|||
23440328|NCT03364309|65355262|FG005|Induction Period|Adverse Event|0|||
23440329|NCT03364309|65355263|FG006|Induction Period|Adverse Event|0|||
23440330|NCT03364309|65355264|FG007|Induction Period|Adverse Event|0|||
23440331|NCT03364309|65355265|FG008|Induction Period|Adverse Event|0|||
23440332|NCT03364309|65355266|FG009|Induction Period|Adverse Event|0|||
23440333|NCT03364309|65355267|FG010|Induction Period|Adverse Event|0|||
23440334|NCT03364309|65355268|FG011|Induction Period|Adverse Event|0|||
23562877|NCT01264380|65790383|FG000|Period C|Adverse Event|0|||
23562878|NCT01264380|65790384|FG001|Period C|Adverse Event|0|||
23562879|NCT01264380|65790385|FG002|Period C|Adverse Event|1|||
23151739|NCT01179672|64305546|FG000|Overall Study|Physician Decision|1|||
23151740|NCT01179672|64305547|FG001|Overall Study|Physician Decision|1|||
23151741|NCT01886313|64305548|FG000|Overall Study|Adverse Event|1|||
23151742|NCT01886313|64305549|FG001|Overall Study|Adverse Event|1|||
23151743|NCT02464228|64305550|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
23151744|NCT02464228|64305551|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
23151745|NCT02464228|64305552|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
23151746|NCT02464228|64305553|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
23151747|NCT02464228|64305550|FG000|Overall Study|Physician Decision|2|||
23151748|NCT02464228|64305551|FG001|Overall Study|Physician Decision|0|||
23151749|NCT02464228|64305552|FG002|Overall Study|Physician Decision|1|||
23440335|NCT03364309|65355269|FG012|Induction Period|Adverse Event|0|||
23440336|NCT03364309|65355270|FG013|Induction Period|Adverse Event|0|||
23440337|NCT03364309|65355271|FG014|Induction Period|Adverse Event|0|||
23440338|NCT03364309|65355272|FG015|Induction Period|Adverse Event|0|||
23440339|NCT03364309|65355273|FG016|Induction Period|Adverse Event|0|||
23440340|NCT03364309|65355274|FG017|Induction Period|Adverse Event|0|||
23440341|NCT03364309|65355275|FG018|Induction Period|Adverse Event|0|||
23440342|NCT03364309|65355257|FG000|Induction Period|Withdrawal by Subject|1|||
23440343|NCT03364309|65355258|FG001|Induction Period|Withdrawal by Subject|3|||
23440344|NCT03364309|65355259|FG002|Induction Period|Withdrawal by Subject|0|||
23440345|NCT03364309|65355260|FG003|Induction Period|Withdrawal by Subject|0|||
23562880|NCT02508532|65790391|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562881|NCT02508532|65790392|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562882|NCT02508532|65790393|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562883|NCT02508532|65790394|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562884|NCT02508532|65790395|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562885|NCT02508532|65790396|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562886|NCT02508532|65790397|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
23562887|NCT02508532|65790398|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562888|NCT02508532|65790399|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
23562889|NCT02508532|65790391|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562890|NCT02508532|65790392|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562891|NCT02508532|65790393|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562892|NCT02508532|65790394|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562893|NCT02508532|65790395|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562894|NCT02508532|65790396|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562895|NCT02508532|65790397|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562896|NCT02508532|65790398|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
23562897|NCT02508532|65790399|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
23562898|NCT02508532|65790391|FG000|Part 2 - Treatment|Disease Progression|0|||
23625406|NCT02658175|66015481|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
23625407|NCT02658175|66015482|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
23625408|NCT02658175|66015483|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
23625409|NCT02658175|66015481|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
23625410|NCT02658175|66015482|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
23625411|NCT02658175|66015483|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
23625412|NCT02658175|66015481|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
23625413|NCT02658175|66015482|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
23625414|NCT02658175|66015483|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
23625415|NCT01447576|66015484|FG000|Overall Study|Lost to Follow-up|52|||
23625416|NCT01447576|66015484|FG000|Overall Study|Adverse Event|127|||
23625417|NCT01447576|66015484|FG000|Overall Study|Participant met withdrawal criteria|40|||
23625418|NCT01447576|66015484|FG000|Overall Study|Withdrawal by Subject|100|||
23625419|NCT01447576|66015484|FG000|Overall Study|Protocol deviation|83|||
23562899|NCT02508532|65790392|FG001|Part 2 - Treatment|Disease Progression|0|||
23562900|NCT02508532|65790393|FG002|Part 2 - Treatment|Disease Progression|0|||
23325518|NCT02328014|64933910|FG003|Overall Study|Study Terminated by Sponsor|0|||
23325519|NCT02328014|64933907|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
23325520|NCT02328014|64933908|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
23325521|NCT02328014|64933909|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
23325522|NCT02328014|64933910|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
23325523|NCT02328014|64933907|FG000|Overall Study|Withdrawal by Subject|0|||
23325524|NCT02328014|64933908|FG001|Overall Study|Withdrawal by Subject|0|||
23325525|NCT02328014|64933909|FG002|Overall Study|Withdrawal by Subject|0|||
23325526|NCT02328014|64933910|FG003|Overall Study|Withdrawal by Subject|1|||
23325527|NCT01431079|64933911|FG000|Overall Study|Lost to Follow-up|35|||
23325528|NCT01431079|64933912|FG001|Overall Study|Lost to Follow-up|39|||
23325529|NCT01213966|64933916|FG000|Overall Study|Protocol Violation|1|||
23325530|NCT01213966|64933917|FG001|Overall Study|Protocol Violation|0|||
23325531|NCT01213966|64933918|FG002|Overall Study|Protocol Violation|3|||
23325532|NCT01213966|64933919|FG003|Overall Study|Protocol Violation|1|||
23325533|NCT02203357|64933920|FG000|Overall Study|Lost to Follow-up|58|||
23325534|NCT02203357|64933921|FG001|Overall Study|Lost to Follow-up|66|||
23325535|NCT02203357|64933922|FG002|Overall Study|Lost to Follow-up|70|||
23325536|NCT02389829|64933929|FG000|Overall Study|Lost to Follow-up|0|||
23325537|NCT02389829|64933930|FG001|Overall Study|Lost to Follow-up|1|||
23325538|NCT01215136|64933933|FG000|Overall Study|Adverse Event|2|||
23625420|NCT01447576|66015484|FG000|Overall Study|Lack of Efficacy|68|||
23625421|NCT01447576|66015484|FG000|Overall Study|Physician Decision|6|||
23325539|NCT01215136|64933934|FG001|Overall Study|Adverse Event|9|||
23325540|NCT01215136|64933933|FG000|Overall Study|Disease Progression|3|||
23220102|NCT03907969|64550055|FG009|Combination Therapy Part A|Death|0|||
23325541|NCT01215136|64933934|FG001|Overall Study|Disease Progression|14|||
23325542|NCT01215136|64933933|FG000|Overall Study|Symptomatic Deterioration|1|||
23325543|NCT01215136|64933934|FG001|Overall Study|Symptomatic Deterioration|1|||
23325544|NCT01215136|64933933|FG000|Overall Study|Death|0|||
23325545|NCT01215136|64933934|FG001|Overall Study|Death|2|||
23325546|NCT01215136|64933933|FG000|Overall Study|Withdrawal by Subject|0|||
23325547|NCT01215136|64933934|FG001|Overall Study|Withdrawal by Subject|1|||
23325548|NCT02383017|64933940|FG000|Overall Study|Injury Sustained Outside Study|1|||
23325549|NCT02383017|64933941|FG001|Overall Study|Injury Sustained Outside Study|0|||
23625422|NCT01667549|66015487|FG000|Overall Study|Withdrawal by Subject|3|||
23625423|NCT01667549|66015488|FG001|Overall Study|Withdrawal by Subject|5|||
23625424|NCT01667549|66015489|FG002|Overall Study|Withdrawal by Subject|7|||
23625425|NCT01667549|66015490|FG003|Overall Study|Withdrawal by Subject|6|||
23625426|NCT01667549|66015491|FG004|Overall Study|Withdrawal by Subject|1|||
23625427|NCT03414047|66015499|FG000|Overall Study|Adverse Event|0|||
23625428|NCT03414047|66015500|FG001|Overall Study|Adverse Event|0|||
23625429|NCT03414047|66015501|FG002|Overall Study|Adverse Event|1|||
23625430|NCT03414047|66015502|FG003|Overall Study|Adverse Event|1|||
23625431|NCT03414047|66015499|FG000|Overall Study|Physician Decision|1|||
23625432|NCT03414047|66015500|FG001|Overall Study|Physician Decision|0|||
23625433|NCT03414047|66015501|FG002|Overall Study|Physician Decision|0|||
23625434|NCT03414047|66015502|FG003|Overall Study|Physician Decision|1|||
23625435|NCT03414047|66015499|FG000|Overall Study|Withdrawal by Subject|1|||
23625436|NCT03414047|66015500|FG001|Overall Study|Withdrawal by Subject|0|||
23625437|NCT03414047|66015501|FG002|Overall Study|Withdrawal by Subject|2|||
23440346|NCT03364309|65355261|FG004|Induction Period|Withdrawal by Subject|0|||
23440347|NCT03364309|65355262|FG005|Induction Period|Withdrawal by Subject|0|||
23440348|NCT03364309|65355263|FG006|Induction Period|Withdrawal by Subject|0|||
23440349|NCT03364309|65355264|FG007|Induction Period|Withdrawal by Subject|0|||
23440350|NCT03364309|65355265|FG008|Induction Period|Withdrawal by Subject|0|||
23440351|NCT03364309|65355266|FG009|Induction Period|Withdrawal by Subject|0|||
23440352|NCT03364309|65355267|FG010|Induction Period|Withdrawal by Subject|0|||
23440353|NCT03364309|65355268|FG011|Induction Period|Withdrawal by Subject|0|||
23440354|NCT03364309|65355269|FG012|Induction Period|Withdrawal by Subject|0|||
23440355|NCT03364309|65355270|FG013|Induction Period|Withdrawal by Subject|0|||
23440356|NCT03364309|65355271|FG014|Induction Period|Withdrawal by Subject|0|||
23440357|NCT03364309|65355272|FG015|Induction Period|Withdrawal by Subject|0|||
23440358|NCT03364309|65355273|FG016|Induction Period|Withdrawal by Subject|0|||
23562901|NCT02508532|65790394|FG003|Part 2 - Treatment|Disease Progression|0|||
23562902|NCT02508532|65790395|FG004|Part 2 - Treatment|Disease Progression|0|||
23562903|NCT02508532|65790396|FG005|Part 2 - Treatment|Disease Progression|0|||
23562904|NCT02508532|65790397|FG006|Part 2 - Treatment|Disease Progression|0|||
23562905|NCT02508532|65790398|FG007|Part 2 - Treatment|Disease Progression|0|||
23562906|NCT02508532|65790399|FG008|Part 2 - Treatment|Disease Progression|118|||
23562907|NCT02508532|65790391|FG000|Part 2 - Treatment|Adverse Event|0|||
23562908|NCT02508532|65790392|FG001|Part 2 - Treatment|Adverse Event|0|||
23562909|NCT02508532|65790393|FG002|Part 2 - Treatment|Adverse Event|0|||
23625438|NCT03414047|66015502|FG003|Overall Study|Withdrawal by Subject|0|||
23625439|NCT03443414|66015503|FG000|Overall Study|Adverse Event|6|||
23625440|NCT03443414|66015504|FG001|Overall Study|Adverse Event|0|||
23625441|NCT03443414|66015505|FG002|Overall Study|Adverse Event|4|||
23562910|NCT02508532|65790394|FG003|Part 2 - Treatment|Adverse Event|0|||
23562911|NCT02508532|65790395|FG004|Part 2 - Treatment|Adverse Event|0|||
23562912|NCT02508532|65790396|FG005|Part 2 - Treatment|Adverse Event|0|||
23625442|NCT03443414|66015506|FG003|Overall Study|Adverse Event|2|||
23625443|NCT03443414|66015507|FG004|Overall Study|Adverse Event|3|||
23625444|NCT03443414|66015503|FG000|Overall Study|Withdrawal by Subject|3|||
23625445|NCT03443414|66015504|FG001|Overall Study|Withdrawal by Subject|2|||
23625446|NCT03443414|66015505|FG002|Overall Study|Withdrawal by Subject|2|||
23625447|NCT03443414|66015506|FG003|Overall Study|Withdrawal by Subject|2|||
23151750|NCT02464228|64305553|FG003|Overall Study|Physician Decision|0|||
23151751|NCT02464228|64305550|FG000|Overall Study|Miscellaneous|1|||
23151752|NCT02464228|64305551|FG001|Overall Study|Miscellaneous|0|||
23151753|NCT02464228|64305552|FG002|Overall Study|Miscellaneous|1|||
23151754|NCT02464228|64305553|FG003|Overall Study|Miscellaneous|0|||
23151755|NCT02464228|64305550|FG000|Overall Study|Adverse Event|9|||
23151756|NCT02464228|64305551|FG001|Overall Study|Adverse Event|0|||
23151757|NCT02464228|64305552|FG002|Overall Study|Adverse Event|3|||
23151758|NCT02464228|64305553|FG003|Overall Study|Adverse Event|0|||
23151759|NCT02464228|64305550|FG000|Overall Study|Withdrawal by Subject|1|||
23151760|NCT02464228|64305551|FG001|Overall Study|Withdrawal by Subject|1|||
23151761|NCT02464228|64305552|FG002|Overall Study|Withdrawal by Subject|1|||
23151762|NCT02464228|64305553|FG003|Overall Study|Withdrawal by Subject|0|||
23151763|NCT02464228|64305550|FG000|Overall Study|Disease Progression|22|||
23151764|NCT02464228|64305551|FG001|Overall Study|Disease Progression|12|||
23151765|NCT02464228|64305552|FG002|Overall Study|Disease Progression|5|||
23151766|NCT02464228|64305553|FG003|Overall Study|Disease Progression|2|||
23151767|NCT01776424|64305559|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
23151768|NCT01776424|64305560|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
23151769|NCT01776424|64305561|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
23151770|NCT01776424|64305559|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
23151771|NCT01776424|64305560|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
23151772|NCT01776424|64305561|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
23151773|NCT01776424|64305559|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
23625448|NCT03443414|66015507|FG004|Overall Study|Withdrawal by Subject|1|||
23625449|NCT03443414|66015503|FG000|Overall Study|Death|0|||
23625450|NCT03443414|66015504|FG001|Overall Study|Death|1|||
23625451|NCT03443414|66015505|FG002|Overall Study|Death|0|||
23625452|NCT03443414|66015506|FG003|Overall Study|Death|1|||
23625453|NCT03443414|66015507|FG004|Overall Study|Death|0|||
23625454|NCT03443414|66015503|FG000|Overall Study|Reason not specified|2|||
23625455|NCT03443414|66015504|FG001|Overall Study|Reason not specified|0|||
23625456|NCT03443414|66015505|FG002|Overall Study|Reason not specified|0|||
23625457|NCT03443414|66015506|FG003|Overall Study|Reason not specified|0|||
23625458|NCT03443414|66015507|FG004|Overall Study|Reason not specified|1|||
23625459|NCT00623363|66015513|FG000|Overall Study|Adverse Event|2|||
23625460|NCT00623363|66015514|FG001|Overall Study|Adverse Event|2|||
23625461|NCT01587118|66015517|FG000|Overall Study|Adverse Event|3|||
23625462|NCT01587118|66015517|FG000|Overall Study|Lost to Follow-up|2|||
23625463|NCT01587118|66015517|FG000|Overall Study|Relocation|1|||
23625464|NCT01587118|66015517|FG000|Overall Study|nonresponse|1|||
23625465|NCT01242371|66015518|FG000|Overall Study|Withdrawal by Subject|2|||
23625466|NCT01242371|66015519|FG001|Overall Study|Withdrawal by Subject|2|||
23625467|NCT01242371|66015518|FG000|Overall Study|Protocol Violation|0|||
23625468|NCT01242371|66015519|FG001|Overall Study|Protocol Violation|3|||
23625469|NCT00174447|66015520|FG000|Overall Study|Adverse Event|19|||
23625470|NCT00174447|66015520|FG000|Overall Study|Withdrawal by Subject|15|||
23625471|NCT00174447|66015520|FG000|Overall Study|Protocol Violation|1|||
23625472|NCT00174447|66015520|FG000|Overall Study|Lack of Efficacy|1|||
23625473|NCT00174447|66015520|FG000|Overall Study|Administrative reason/Other|2|||
23625474|NCT01151423|66015521|FG000|Overall Study|Study terminated by Sponsor|9|||
23625475|NCT01151423|66015522|FG001|Overall Study|Study terminated by Sponsor|10|||
23625476|NCT01151423|66015521|FG000|Overall Study|Protocol Violation|0|||
23625477|NCT01151423|66015522|FG001|Overall Study|Protocol Violation|1|||
23625478|NCT01151423|66015521|FG000|Overall Study|Physician Decision|1|||
23625479|NCT01151423|66015522|FG001|Overall Study|Physician Decision|1|||
23625480|NCT01151423|66015521|FG000|Overall Study|Pregnancy|0|||
23625481|NCT01151423|66015522|FG001|Overall Study|Pregnancy|1|||
23625482|NCT01151423|66015521|FG000|Overall Study|Death|0|||
23625483|NCT01151423|66015522|FG001|Overall Study|Death|1|||
23625484|NCT01151423|66015521|FG000|Overall Study|Adverse Event|3|||
23625485|NCT01151423|66015522|FG001|Overall Study|Adverse Event|0|||
23625486|NCT01151423|66015521|FG000|Overall Study|Withdrawal by Subject|1|||
23625487|NCT01151423|66015522|FG001|Overall Study|Withdrawal by Subject|3|||
23625488|NCT01151423|66015521|FG000|Overall Study|Lost to Follow-up|1|||
23625489|NCT01151423|66015522|FG001|Overall Study|Lost to Follow-up|0|||
23625490|NCT01151423|66015521|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
23151774|NCT01776424|64305560|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
23440359|NCT03364309|65355274|FG017|Induction Period|Withdrawal by Subject|0|||
23440360|NCT03364309|65355275|FG018|Induction Period|Withdrawal by Subject|0|||
23440361|NCT03364309|65355257|FG000|Induction Period|Lost to Follow-up|1|||
23440362|NCT03364309|65355258|FG001|Induction Period|Lost to Follow-up|0|||
23440363|NCT03364309|65355259|FG002|Induction Period|Lost to Follow-up|0|||
23440364|NCT03364309|65355260|FG003|Induction Period|Lost to Follow-up|0|||
23440365|NCT03364309|65355261|FG004|Induction Period|Lost to Follow-up|0|||
23440366|NCT03364309|65355262|FG005|Induction Period|Lost to Follow-up|0|||
23440367|NCT03364309|65355263|FG006|Induction Period|Lost to Follow-up|0|||
23440368|NCT03364309|65355264|FG007|Induction Period|Lost to Follow-up|0|||
23440369|NCT03364309|65355265|FG008|Induction Period|Lost to Follow-up|0|||
23440370|NCT03364309|65355266|FG009|Induction Period|Lost to Follow-up|0|||
23440371|NCT03364309|65355267|FG010|Induction Period|Lost to Follow-up|0|||
23440372|NCT03364309|65355268|FG011|Induction Period|Lost to Follow-up|0|||
23440373|NCT03364309|65355269|FG012|Induction Period|Lost to Follow-up|0|||
23440374|NCT03364309|65355270|FG013|Induction Period|Lost to Follow-up|0|||
23440375|NCT03364309|65355271|FG014|Induction Period|Lost to Follow-up|0|||
23440376|NCT03364309|65355272|FG015|Induction Period|Lost to Follow-up|0|||
23440377|NCT03364309|65355273|FG016|Induction Period|Lost to Follow-up|0|||
23440378|NCT03364309|65355274|FG017|Induction Period|Lost to Follow-up|0|||
23440379|NCT03364309|65355275|FG018|Induction Period|Lost to Follow-up|0|||
23440380|NCT03364309|65355257|FG000|Induction Period|Physician Decision|0|||
23440381|NCT03364309|65355258|FG001|Induction Period|Physician Decision|1|||
23440382|NCT03364309|65355259|FG002|Induction Period|Physician Decision|0|||
23440383|NCT03364309|65355260|FG003|Induction Period|Physician Decision|0|||
23440384|NCT03364309|65355261|FG004|Induction Period|Physician Decision|0|||
23625491|NCT01151423|66015522|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
23625492|NCT01151423|66015521|FG000|Overall Study|Participated in other clinical trial|1|||
23625493|NCT01151423|66015522|FG001|Overall Study|Participated in other clinical trial|0|||
23625494|NCT01585298|66015524|FG000|Overall Study|Study completion was not documented.|1|||
23625495|NCT01585298|66015524|FG000|Overall Study|Protocol deviation|1|||
23625496|NCT01585298|66015524|FG000|Overall Study|Administrative problems|4|||
23625497|NCT01585298|66015524|FG000|Overall Study|Lost to Follow-up|2|||
23625498|NCT01585298|66015524|FG000|Overall Study|Withdrawal by Subject|4|||
23625499|NCT01585298|66015524|FG000|Overall Study|Abnormal test procedure results|1|||
23625500|NCT01585298|66015524|FG000|Overall Study|Adverse Event|24|||
23625501|NCT01111240|66015525|FG000|Overall Study|Adverse Event|190|||
23562913|NCT02508532|65790397|FG006|Part 2 - Treatment|Adverse Event|0|||
23562914|NCT02508532|65790398|FG007|Part 2 - Treatment|Adverse Event|0|||
23562915|NCT02508532|65790399|FG008|Part 2 - Treatment|Adverse Event|49|||
23562916|NCT02508532|65790391|FG000|Part 2 - Treatment|Physician Decision|0|||
23562917|NCT02508532|65790392|FG001|Part 2 - Treatment|Physician Decision|0|||
23562918|NCT02508532|65790393|FG002|Part 2 - Treatment|Physician Decision|0|||
23562919|NCT02508532|65790394|FG003|Part 2 - Treatment|Physician Decision|0|||
23562920|NCT02508532|65790395|FG004|Part 2 - Treatment|Physician Decision|0|||
23562921|NCT02508532|65790396|FG005|Part 2 - Treatment|Physician Decision|0|||
23562922|NCT02508532|65790397|FG006|Part 2 - Treatment|Physician Decision|0|||
23562923|NCT02508532|65790398|FG007|Part 2 - Treatment|Physician Decision|0|||
23562924|NCT02508532|65790399|FG008|Part 2 - Treatment|Physician Decision|12|||
23562925|NCT02508532|65790391|FG000|Part 2 - Treatment|Administrative|0|||
23562926|NCT02508532|65790392|FG001|Part 2 - Treatment|Administrative|0|||
23562927|NCT02508532|65790393|FG002|Part 2 - Treatment|Administrative|0|||
23562928|NCT02508532|65790394|FG003|Part 2 - Treatment|Administrative|0|||
23562929|NCT02508532|65790395|FG004|Part 2 - Treatment|Administrative|0|||
23562930|NCT02508532|65790396|FG005|Part 2 - Treatment|Administrative|0|||
23562931|NCT02508532|65790397|FG006|Part 2 - Treatment|Administrative|0|||
23562932|NCT02508532|65790398|FG007|Part 2 - Treatment|Administrative|0|||
23562933|NCT02508532|65790399|FG008|Part 2 - Treatment|Administrative|3|||
23562934|NCT02508532|65790391|FG000|Part 2 - Treatment|Sponsor Decision|0|||
23562935|NCT02508532|65790392|FG001|Part 2 - Treatment|Sponsor Decision|0|||
23562936|NCT02508532|65790393|FG002|Part 2 - Treatment|Sponsor Decision|0|||
23625502|NCT01111240|66015525|FG000|Overall Study|Lack of Efficacy|545|||
23625503|NCT01111240|66015525|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
23625504|NCT01111240|66015525|FG000|Overall Study|Other|312|||
23625505|NCT03020069|66015526|FG000|Overall Study|Lost to Follow-up|0|||
23625506|NCT03020069|66015527|FG001|Overall Study|Lost to Follow-up|1|||
23625507|NCT01438840|66015531|FG000|Core Study|Adverse Event|0|||
23625508|NCT01438840|66015532|FG001|Core Study|Adverse Event|3|||
23625509|NCT01438840|66015533|FG002|Core Study|Adverse Event|0|||
23625510|NCT01438840|66015531|FG000|Core Study|Lack of Efficacy|15|||
23151775|NCT01776424|64305561|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
23151776|NCT01776424|64305559|FG000|LTOLE Part (Open Label)|Refused|5|||
23151777|NCT01776424|64305560|FG001|LTOLE Part (Open Label)|Refused|2|||
23151778|NCT01776424|64305561|FG002|LTOLE Part (Open Label)|Refused|11|||
23151779|NCT01776424|64305559|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
23151780|NCT01776424|64305560|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
23151781|NCT01776424|64305561|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
23151782|NCT00129623|64305564|FG000|Overall Study|Adverse Event|3|||
23151783|NCT00129623|64305565|FG001|Overall Study|Adverse Event|7|||
23151784|NCT00129623|64305564|FG000|Overall Study|Refused Treatment|5|||
23151785|NCT00129623|64305565|FG001|Overall Study|Refused Treatment|3|||
23151786|NCT00129623|64305564|FG000|Overall Study|Failure to Return|1|||
23151787|NCT00129623|64305565|FG001|Overall Study|Failure to Return|1|||
23151788|NCT00129623|64305564|FG000|Overall Study|Relocated job out of state|1|||
23151789|NCT00129623|64305565|FG001|Overall Study|Relocated job out of state|0|||
23151790|NCT00129623|64305564|FG000|Overall Study|Uncertainty to return|0|||
23151791|NCT00129623|64305565|FG001|Overall Study|Uncertainty to return|1|||
23151792|NCT00596934|64305566|FG000|Overall Study|Protocol Violation|1|||
23151793|NCT00596934|64305566|FG000|Overall Study|Withdrawal by Subject|1|||
23151794|NCT01660451|64305568|FG000|Overall Study|Protocol Violation|0|||
23151795|NCT01660451|64305569|FG001|Overall Study|Protocol Violation|1|||
23151796|NCT01660451|64305570|FG002|Overall Study|Protocol Violation|1|||
23151797|NCT01660451|64305568|FG000|Overall Study|AE not associated with clinical disease progression|13|||
23151798|NCT01660451|64305569|FG001|Overall Study|AE not associated with clinical disease progression|10|||
23151799|NCT01660451|64305570|FG002|Overall Study|AE not associated with clinical disease progression|40|||
23151800|NCT01660451|64305568|FG000|Overall Study|AE associated with clinical disease progression|1|||
23151801|NCT01660451|64305569|FG001|Overall Study|AE associated with clinical disease progression|3|||
23151802|NCT01660451|64305570|FG002|Overall Study|AE associated with clinical disease progression|11|||
23151803|NCT01660451|64305568|FG000|Overall Study|Sponsor Decision|0|||
23151804|NCT01660451|64305569|FG001|Overall Study|Sponsor Decision|0|||
23562937|NCT02508532|65790394|FG003|Part 2 - Treatment|Sponsor Decision|0|||
23562938|NCT02508532|65790395|FG004|Part 2 - Treatment|Sponsor Decision|0|||
23562939|NCT02508532|65790396|FG005|Part 2 - Treatment|Sponsor Decision|0|||
23562940|NCT02508532|65790397|FG006|Part 2 - Treatment|Sponsor Decision|0|||
23625511|NCT01438840|66015532|FG001|Core Study|Lack of Efficacy|7|||
23151805|NCT01660451|64305570|FG002|Overall Study|Sponsor Decision|1|||
23562941|NCT02508532|65790398|FG007|Part 2 - Treatment|Sponsor Decision|0|||
23562942|NCT02508532|65790399|FG008|Part 2 - Treatment|Sponsor Decision|28|||
23562943|NCT02508532|65790391|FG000|Part 2 - Treatment|Death|0|||
23562944|NCT02508532|65790392|FG001|Part 2 - Treatment|Death|0|||
23625512|NCT01438840|66015533|FG002|Core Study|Lack of Efficacy|0|||
23625513|NCT01438840|66015531|FG000|Core Study|Withdrawal of consent|1|||
23562945|NCT02508532|65790393|FG002|Part 2 - Treatment|Death|0|||
23562946|NCT02508532|65790394|FG003|Part 2 - Treatment|Death|0|||
23562947|NCT02508532|65790395|FG004|Part 2 - Treatment|Death|0|||
23562948|NCT02508532|65790396|FG005|Part 2 - Treatment|Death|0|||
23562949|NCT02508532|65790397|FG006|Part 2 - Treatment|Death|0|||
23562950|NCT02508532|65790398|FG007|Part 2 - Treatment|Death|0|||
23562951|NCT02508532|65790399|FG008|Part 2 - Treatment|Death|1|||
23562952|NCT02508532|65790391|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
23562953|NCT02508532|65790392|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
23562954|NCT02508532|65790393|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
23562955|NCT02508532|65790394|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
23562956|NCT02508532|65790395|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
23562957|NCT02508532|65790396|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
23562958|NCT02508532|65790397|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
23562959|NCT02508532|65790398|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
23562960|NCT02508532|65790399|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
23562961|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
23562962|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562963|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
23625514|NCT01438840|66015532|FG001|Core Study|Withdrawal of consent|0|||
23625515|NCT01438840|66015533|FG002|Core Study|Withdrawal of consent|0|||
23625516|NCT01438840|66015531|FG000|Extension Phase|Adverse Event|0|||
23625517|NCT01438840|66015532|FG001|Extension Phase|Adverse Event|0|||
23625518|NCT01438840|66015533|FG002|Extension Phase|Adverse Event|3|||
23625519|NCT01438840|66015531|FG000|Extension Phase|Lost to Follow-up|0|||
23625520|NCT01438840|66015532|FG001|Extension Phase|Lost to Follow-up|0|||
23625521|NCT01438840|66015533|FG002|Extension Phase|Lost to Follow-up|1|||
23625522|NCT01438840|66015531|FG000|Extension Phase|Withdrawal by Subject|0|||
23625523|NCT01438840|66015532|FG001|Extension Phase|Withdrawal by Subject|0|||
23625524|NCT01438840|66015533|FG002|Extension Phase|Withdrawal by Subject|3|||
23625525|NCT01438840|66015531|FG000|Extension Phase|Lack of Efficacy|0|||
23625526|NCT01438840|66015532|FG001|Extension Phase|Lack of Efficacy|0|||
23625527|NCT01438840|66015533|FG002|Extension Phase|Lack of Efficacy|2|||
23625528|NCT01438840|66015531|FG000|Extension Phase|Other|0|||
23625529|NCT01438840|66015532|FG001|Extension Phase|Other|0|||
23625530|NCT01438840|66015533|FG002|Extension Phase|Other|1|||
23625531|NCT01458522|66015539|FG000|Overall Study|Withdrawal by Subject|2|||
23625532|NCT01458522|66015540|FG001|Overall Study|Withdrawal by Subject|2|||
23625533|NCT01458522|66015539|FG000|Overall Study|Physician Decision|1|||
23625534|NCT01458522|66015540|FG001|Overall Study|Physician Decision|9|||
23625535|NCT00966979|66015543|FG000|Overall Study|Death|1|||
23625536|NCT00966979|66015543|FG000|Overall Study|Lost to Follow-up|6|||
23625537|NCT00966979|66015543|FG000|Overall Study|Withdrawal by Subject|14|||
23625538|NCT00966979|66015543|FG000|Overall Study|Adverse Event|5|||
23625539|NCT00966979|66015543|FG000|Overall Study|Sponsor terminated early|49|||
23625540|NCT00966979|66015543|FG000|Overall Study|Censored because surgery not done|2|||
23625541|NCT00966979|66015543|FG000|Overall Study|Censored because study device was not implanted|14|||
23625542|NCT00966979|66015543|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
23625543|NCT03616964|66015544|FG000|Overall Study|Adverse Event|15|||
23625544|NCT03616964|66015545|FG001|Overall Study|Adverse Event|10|||
23625545|NCT03616964|66015546|FG002|Overall Study|Adverse Event|16|||
23625546|NCT03616964|66015544|FG000|Overall Study|Death|3|||
23625547|NCT03616964|66015545|FG001|Overall Study|Death|0|||
23625548|NCT03616964|66015546|FG002|Overall Study|Death|4|||
23625549|NCT03616964|66015544|FG000|Overall Study|Lack of Efficacy|4|||
23625550|NCT03616964|66015545|FG001|Overall Study|Lack of Efficacy|8|||
23625551|NCT03616964|66015546|FG002|Overall Study|Lack of Efficacy|8|||
23625552|NCT03616964|66015544|FG000|Overall Study|Lost to Follow-up|2|||
23625553|NCT03616964|66015545|FG001|Overall Study|Lost to Follow-up|1|||
23625554|NCT03616964|66015546|FG002|Overall Study|Lost to Follow-up|3|||
23625555|NCT03616964|66015544|FG000|Overall Study|Withdrawal by Subject|18|||
23151806|NCT01660451|64305568|FG000|Overall Study|Protocol Deviation|0|||
23562964|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562965|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562966|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562967|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
23562968|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
23625556|NCT03616964|66015545|FG001|Overall Study|Withdrawal by Subject|14|||
23625557|NCT03616964|66015546|FG002|Overall Study|Withdrawal by Subject|21|||
23625558|NCT03616964|66015544|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
23625559|NCT03616964|66015545|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
23625560|NCT03616964|66015546|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
23625561|NCT03616964|66015544|FG000|Overall Study|Sponsor's Decision|1|||
23625562|NCT03616964|66015545|FG001|Overall Study|Sponsor's Decision|0|||
23625563|NCT03616964|66015546|FG002|Overall Study|Sponsor's Decision|0|||
23625564|NCT03616964|66015544|FG000|Overall Study|Physician Decision|0|||
23562969|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
23325550|NCT02383017|64933940|FG000|Overall Study|Compliance|3|||
23325551|NCT02383017|64933941|FG001|Overall Study|Compliance|2|||
23325552|NCT02383017|64933940|FG000|Overall Study|Found to be Hypogonadal|1|||
23325553|NCT02383017|64933941|FG001|Overall Study|Found to be Hypogonadal|0|||
23325554|NCT01350271|64933944|FG000|Overall Study|Lost to Follow-up|21|||
23325555|NCT01350271|64933945|FG001|Overall Study|Lost to Follow-up|17|||
23325556|NCT01350271|64933946|FG002|Overall Study|Lost to Follow-up|26|||
23325557|NCT01487525|64933947|FG000|Overall Study|Withdrawal by Subject|0|||
23325558|NCT01487525|64933948|FG001|Overall Study|Withdrawal by Subject|1|||
23325559|NCT00468819|64933949|FG000|Overall Study|Withdrawal by Subject|4|||
23325560|NCT00468819|64933950|FG001|Overall Study|Withdrawal by Subject|0|||
23325561|NCT00468819|64933951|FG002|Overall Study|Withdrawal by Subject|1|||
23325562|NCT00468819|64933949|FG000|Overall Study|Lost to Follow-up|0|||
23325563|NCT00468819|64933950|FG001|Overall Study|Lost to Follow-up|0|||
23325564|NCT00468819|64933951|FG002|Overall Study|Lost to Follow-up|1|||
23325565|NCT00468819|64933949|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
23325566|NCT00468819|64933950|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
23325567|NCT00468819|64933951|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
23325568|NCT00708461|64933952|FG000|Overall Study|Lost to Follow-up|18|||
23325569|NCT00708461|64933953|FG001|Overall Study|Lost to Follow-up|11|||
23325570|NCT00708461|64933952|FG000|Overall Study|Withdrawal by Subject|8|||
23325571|NCT00708461|64933953|FG001|Overall Study|Withdrawal by Subject|9|||
23325572|NCT00708461|64933952|FG000|Overall Study|left workforce|115|||
23325573|NCT00708461|64933953|FG001|Overall Study|left workforce|180|||
23325574|NCT01486446|64933956|FG000|Overall Study|Adverse Event|1|||
23325575|NCT01486446|64933957|FG001|Overall Study|Adverse Event|0|||
23325576|NCT00116779|64933960|FG000|Overall Study|Adverse Event|4|||
23325577|NCT00116779|64933961|FG001|Overall Study|Adverse Event|2|||
23325578|NCT00116779|64933960|FG000|Overall Study|Protocol Violation|1|||
23325579|NCT00116779|64933961|FG001|Overall Study|Protocol Violation|4|||
23325580|NCT00116779|64933960|FG000|Overall Study|Withdrawal by Subject|4|||
23325581|NCT00116779|64933961|FG001|Overall Study|Withdrawal by Subject|1|||
23325582|NCT00116779|64933960|FG000|Overall Study|Inadequate testosterone suppression|7|||
23325583|NCT00116779|64933961|FG001|Overall Study|Inadequate testosterone suppression|9|||
23325584|NCT00116779|64933960|FG000|Overall Study|Physician Decision|3|||
23325585|NCT00116779|64933961|FG001|Overall Study|Physician Decision|1|||
23325586|NCT00116779|64933960|FG000|Overall Study|Elevated PSA levels|2|||
23325587|NCT00116779|64933961|FG001|Overall Study|Elevated PSA levels|2|||
23325588|NCT02090725|64933962|FG000|Overall Study|Withdrawal by Subject|1|||
23325589|NCT02090725|64933962|FG000|Overall Study|participants moved from area|3|||
23325590|NCT02077140|64933963|FG000|Overall Study|Lost to Follow-up|4|||
23325591|NCT02077140|64933964|FG001|Overall Study|Lost to Follow-up|1|||
23325592|NCT02077140|64933965|FG002|Overall Study|Lost to Follow-up|2|||
23325593|NCT02077140|64933966|FG003|Overall Study|Lost to Follow-up|2|||
23325594|NCT02077140|64933967|FG004|Overall Study|Lost to Follow-up|3|||
23325595|NCT02077140|64933963|FG000|Overall Study|Withdrawal by Subject|0|||
23325596|NCT02077140|64933964|FG001|Overall Study|Withdrawal by Subject|1|||
23325597|NCT02077140|64933965|FG002|Overall Study|Withdrawal by Subject|0|||
23325598|NCT02077140|64933966|FG003|Overall Study|Withdrawal by Subject|2|||
23325599|NCT02077140|64933967|FG004|Overall Study|Withdrawal by Subject|2|||
23325600|NCT00942084|64933968|FG000|Overall Study|Death|2|||
23325601|NCT02503540|64933971|FG000|Overall Study|Death|2|||
23325602|NCT02503540|64933971|FG000|Overall Study|Withdrawal by Subject|1|||
23325603|NCT00485264|64933972|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
23325604|NCT00485264|64933973|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
23325605|NCT00485264|64933974|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
23325606|NCT00485264|64933975|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
23325607|NCT00485264|64933976|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
23325608|NCT00485264|64933977|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
23325609|NCT00485264|64933972|FG000|Overall Study|Death|1|||
23325610|NCT00485264|64933973|FG001|Overall Study|Death|0|||
23325611|NCT00485264|64933974|FG002|Overall Study|Death|0|||
23151807|NCT01660451|64305569|FG001|Overall Study|Protocol Deviation|0|||
23325612|NCT00485264|64933975|FG003|Overall Study|Death|0|||
23325613|NCT00485264|64933976|FG004|Overall Study|Death|1|||
23325614|NCT00485264|64933977|FG005|Overall Study|Death|0|||
23325615|NCT00485264|64933972|FG000|Overall Study|Adverse Event|1|||
23325616|NCT00485264|64933973|FG001|Overall Study|Adverse Event|0|||
23325617|NCT00485264|64933974|FG002|Overall Study|Adverse Event|2|||
23325618|NCT00485264|64933975|FG003|Overall Study|Adverse Event|3|||
23325619|NCT00485264|64933976|FG004|Overall Study|Adverse Event|1|||
23325620|NCT00485264|64933977|FG005|Overall Study|Adverse Event|3|||
23325621|NCT00485264|64933972|FG000|Overall Study|Pregnancy|4|||
23325622|NCT00485264|64933973|FG001|Overall Study|Pregnancy|0|||
23325623|NCT00485264|64933974|FG002|Overall Study|Pregnancy|0|||
23325624|NCT00485264|64933975|FG003|Overall Study|Pregnancy|0|||
23325625|NCT00485264|64933976|FG004|Overall Study|Pregnancy|0|||
23325626|NCT00485264|64933977|FG005|Overall Study|Pregnancy|0|||
23325627|NCT00485264|64933972|FG000|Overall Study|Disallowed Medication|0|||
23325628|NCT00485264|64933973|FG001|Overall Study|Disallowed Medication|0|||
23325629|NCT00485264|64933974|FG002|Overall Study|Disallowed Medication|0|||
23325630|NCT00485264|64933975|FG003|Overall Study|Disallowed Medication|0|||
23325631|NCT00485264|64933976|FG004|Overall Study|Disallowed Medication|0|||
23325632|NCT00485264|64933977|FG005|Overall Study|Disallowed Medication|1|||
23325633|NCT00485264|64933972|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
23325634|NCT00485264|64933973|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
23325635|NCT00485264|64933974|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
23440385|NCT03364309|65355262|FG005|Induction Period|Physician Decision|0|||
23440386|NCT03364309|65355263|FG006|Induction Period|Physician Decision|0|||
23440387|NCT03364309|65355264|FG007|Induction Period|Physician Decision|0|||
23440388|NCT03364309|65355265|FG008|Induction Period|Physician Decision|0|||
23440389|NCT03364309|65355266|FG009|Induction Period|Physician Decision|0|||
23440390|NCT03364309|65355267|FG010|Induction Period|Physician Decision|0|||
23440391|NCT03364309|65355268|FG011|Induction Period|Physician Decision|0|||
23440392|NCT03364309|65355269|FG012|Induction Period|Physician Decision|0|||
23440393|NCT03364309|65355270|FG013|Induction Period|Physician Decision|0|||
23440394|NCT03364309|65355271|FG014|Induction Period|Physician Decision|0|||
23440395|NCT03364309|65355272|FG015|Induction Period|Physician Decision|0|||
23440396|NCT03364309|65355273|FG016|Induction Period|Physician Decision|0|||
23440397|NCT03364309|65355274|FG017|Induction Period|Physician Decision|0|||
23440398|NCT03364309|65355275|FG018|Induction Period|Physician Decision|0|||
23440399|NCT03364309|65355257|FG000|Maintenance Period|Withdrawal by Subject|0|||
23440400|NCT03364309|65355258|FG001|Maintenance Period|Withdrawal by Subject|0|||
23440401|NCT03364309|65355259|FG002|Maintenance Period|Withdrawal by Subject|0|||
23440402|NCT03364309|65355260|FG003|Maintenance Period|Withdrawal by Subject|1|||
23440403|NCT03364309|65355261|FG004|Maintenance Period|Withdrawal by Subject|3|||
23440404|NCT03364309|65355262|FG005|Maintenance Period|Withdrawal by Subject|1|||
23440405|NCT03364309|65355263|FG006|Maintenance Period|Withdrawal by Subject|3|||
23440406|NCT03364309|65355264|FG007|Maintenance Period|Withdrawal by Subject|0|||
23440407|NCT03364309|65355265|FG008|Maintenance Period|Withdrawal by Subject|1|||
23440408|NCT03364309|65355266|FG009|Maintenance Period|Withdrawal by Subject|1|||
23440409|NCT03364309|65355267|FG010|Maintenance Period|Withdrawal by Subject|2|||
23440410|NCT03364309|65355268|FG011|Maintenance Period|Withdrawal by Subject|0|||
23440411|NCT03364309|65355269|FG012|Maintenance Period|Withdrawal by Subject|0|||
23440412|NCT03364309|65355270|FG013|Maintenance Period|Withdrawal by Subject|0|||
23440413|NCT03364309|65355271|FG014|Maintenance Period|Withdrawal by Subject|0|||
23440414|NCT03364309|65355272|FG015|Maintenance Period|Withdrawal by Subject|0|||
23440415|NCT03364309|65355273|FG016|Maintenance Period|Withdrawal by Subject|0|||
23440416|NCT03364309|65355274|FG017|Maintenance Period|Withdrawal by Subject|0|||
23440417|NCT03364309|65355275|FG018|Maintenance Period|Withdrawal by Subject|0|||
23440418|NCT03364309|65355257|FG000|Maintenance Period|Adverse Event|0|||
23440419|NCT03364309|65355258|FG001|Maintenance Period|Adverse Event|0|||
23440420|NCT03364309|65355259|FG002|Maintenance Period|Adverse Event|0|||
23440421|NCT03364309|65355260|FG003|Maintenance Period|Adverse Event|0|||
23440422|NCT03364309|65355261|FG004|Maintenance Period|Adverse Event|2|||
23440423|NCT03364309|65355262|FG005|Maintenance Period|Adverse Event|0|||
23440424|NCT03364309|65355263|FG006|Maintenance Period|Adverse Event|3|||
23440425|NCT03364309|65355264|FG007|Maintenance Period|Adverse Event|0|||
23440426|NCT03364309|65355265|FG008|Maintenance Period|Adverse Event|1|||
23440427|NCT03364309|65355266|FG009|Maintenance Period|Adverse Event|0|||
23440428|NCT03364309|65355267|FG010|Maintenance Period|Adverse Event|2|||
23562970|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
23562971|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
23440429|NCT03364309|65355268|FG011|Maintenance Period|Adverse Event|0|||
23440430|NCT03364309|65355269|FG012|Maintenance Period|Adverse Event|0|||
23440431|NCT03364309|65355270|FG013|Maintenance Period|Adverse Event|0|||
23440432|NCT03364309|65355271|FG014|Maintenance Period|Adverse Event|0|||
23440433|NCT03364309|65355272|FG015|Maintenance Period|Adverse Event|0|||
23440434|NCT03364309|65355273|FG016|Maintenance Period|Adverse Event|0|||
23440435|NCT03364309|65355274|FG017|Maintenance Period|Adverse Event|0|||
23440436|NCT03364309|65355275|FG018|Maintenance Period|Adverse Event|0|||
23440437|NCT03364309|65355257|FG000|Maintenance Period|Relapsed|0|||
23440438|NCT03364309|65355258|FG001|Maintenance Period|Relapsed|0|||
23440439|NCT03364309|65355259|FG002|Maintenance Period|Relapsed|0|||
23151808|NCT01660451|64305570|FG002|Overall Study|Protocol Deviation|1|||
23325636|NCT00485264|64933975|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
23325637|NCT00485264|64933976|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
23440440|NCT03364309|65355260|FG003|Maintenance Period|Relapsed|43|||
23440441|NCT03364309|65355261|FG004|Maintenance Period|Relapsed|7|||
23440442|NCT03364309|65355262|FG005|Maintenance Period|Relapsed|45|||
23440443|NCT03364309|65355263|FG006|Maintenance Period|Relapsed|10|||
23440444|NCT03364309|65355264|FG007|Maintenance Period|Relapsed|2|||
23440445|NCT03364309|65355265|FG008|Maintenance Period|Relapsed|0|||
23440446|NCT03364309|65355266|FG009|Maintenance Period|Relapsed|0|||
23440447|NCT03364309|65355267|FG010|Maintenance Period|Relapsed|0|||
23562972|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
23625565|NCT03616964|66015545|FG001|Overall Study|Physician Decision|2|||
23625566|NCT03616964|66015546|FG002|Overall Study|Physician Decision|0|||
23625567|NCT03616964|66015544|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
23151809|NCT01660451|64305568|FG000|Overall Study|Physician Decision|1|||
23151810|NCT01660451|64305569|FG001|Overall Study|Physician Decision|2|||
23151811|NCT01660451|64305570|FG002|Overall Study|Physician Decision|5|||
23151812|NCT01660451|64305568|FG000|Overall Study|Withdrawal by Subject|1|||
23220103|NCT03907969|64550056|FG010|Combination Therapy Part A|Death|1|||
23220104|NCT03907969|64550046|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
23151813|NCT01660451|64305569|FG001|Overall Study|Withdrawal by Subject|1|||
23151814|NCT01660451|64305570|FG002|Overall Study|Withdrawal by Subject|20|||
23325638|NCT00485264|64933977|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
23325639|NCT00485264|64933972|FG000|Overall Study|Lack of Efficacy|0|||
23325640|NCT00485264|64933973|FG001|Overall Study|Lack of Efficacy|1|||
23325641|NCT00485264|64933974|FG002|Overall Study|Lack of Efficacy|0|||
23325642|NCT00485264|64933975|FG003|Overall Study|Lack of Efficacy|0|||
23325643|NCT00485264|64933976|FG004|Overall Study|Lack of Efficacy|0|||
23325644|NCT00485264|64933977|FG005|Overall Study|Lack of Efficacy|0|||
23325645|NCT00485264|64933972|FG000|Overall Study|Guardian Consent Withdrawn|1|||
23325646|NCT00485264|64933973|FG001|Overall Study|Guardian Consent Withdrawn|0|||
23325647|NCT00485264|64933974|FG002|Overall Study|Guardian Consent Withdrawn|0|||
23151815|NCT01660451|64305568|FG000|Overall Study|Trial closure.|0|||
23151816|NCT01660451|64305569|FG001|Overall Study|Trial closure.|0|||
23151817|NCT01660451|64305570|FG002|Overall Study|Trial closure.|1|||
23151818|NCT01660451|64305568|FG000|Overall Study|Switching to other therapy|0|||
23151819|NCT01660451|64305569|FG001|Overall Study|Switching to other therapy|1|||
23151820|NCT01660451|64305570|FG002|Overall Study|Switching to other therapy|1|||
23151821|NCT01660451|64305568|FG000|Overall Study|Progressive disease - clinical progression|4|||
23151822|NCT01660451|64305569|FG001|Overall Study|Progressive disease - clinical progression|10|||
23151823|NCT01660451|64305570|FG002|Overall Study|Progressive disease - clinical progression|9|||
23151824|NCT01660451|64305568|FG000|Overall Study|Progressive disease - radiological progression|12|||
23151825|NCT01660451|64305569|FG001|Overall Study|Progressive disease - radiological progression|23|||
23151826|NCT01660451|64305570|FG002|Overall Study|Progressive disease - radiological progression|50|||
23151827|NCT01660451|64305568|FG000|Overall Study|Death|1|||
23151828|NCT01660451|64305569|FG001|Overall Study|Death|0|||
23151829|NCT01660451|64305570|FG002|Overall Study|Death|1|||
23151830|NCT01660451|64305568|FG000|Overall Study|Other|0|||
23151831|NCT01660451|64305569|FG001|Overall Study|Other|0|||
23151832|NCT01660451|64305570|FG002|Overall Study|Other|1|||
23151833|NCT02224599|64305571|FG000|Overall Study|Physician Decision|1|||
23151834|NCT02224599|64305571|FG000|Overall Study|Progression of Disease|1|||
23151835|NCT01008696|64305572|FG000|Overall Study|Participant's evasion of hospital visit|5|||
23151836|NCT01008696|64305573|FG001|Overall Study|Participant's evasion of hospital visit|4|||
23151837|NCT01008696|64305572|FG000|Overall Study|Withdrawal by Subject|2|||
23220105|NCT03907969|64550047|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
23220106|NCT03907969|64550048|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
23220107|NCT03907969|64550049|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
23220108|NCT03907969|64550050|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
23220109|NCT03907969|64550051|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
23220110|NCT03907969|64550052|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
23220111|NCT03907969|64550053|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
23220112|NCT03907969|64550054|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
23220113|NCT03907969|64550055|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
23220114|NCT03907969|64550056|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
23220115|NCT03907969|64550046|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
23220116|NCT03907969|64550047|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
23220117|NCT03907969|64550048|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
23220118|NCT03907969|64550049|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
23220119|NCT03907969|64550050|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
23220120|NCT03907969|64550051|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
23220121|NCT03907969|64550052|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
23220122|NCT03907969|64550053|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
23220123|NCT03907969|64550054|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
23220124|NCT03907969|64550055|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
23151838|NCT01008696|64305573|FG001|Overall Study|Withdrawal by Subject|4|||
23151839|NCT01008696|64305572|FG000|Overall Study|Physician Decision|5|||
23220125|NCT03907969|64550056|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
23325648|NCT00485264|64933975|FG003|Overall Study|Guardian Consent Withdrawn|0|||
23325649|NCT00485264|64933976|FG004|Overall Study|Guardian Consent Withdrawn|1|||
23325650|NCT00485264|64933977|FG005|Overall Study|Guardian Consent Withdrawn|0|||
23151840|NCT01008696|64305573|FG001|Overall Study|Physician Decision|1|||
23151841|NCT01008696|64305572|FG000|Overall Study|Adverse Event|1|||
23151842|NCT01008696|64305573|FG001|Overall Study|Adverse Event|0|||
23151843|NCT01008696|64305572|FG000|Overall Study|Participants' non-cooperation|2|||
23151844|NCT01008696|64305573|FG001|Overall Study|Participants' non-cooperation|3|||
23151845|NCT01008696|64305572|FG000|Overall Study|Other|2|||
23151846|NCT01008696|64305573|FG001|Overall Study|Other|3|||
23151847|NCT01008696|64305572|FG000|Overall Study|Other|0|||
23151848|NCT01008696|64305573|FG001|Overall Study|Other|2|||
23151849|NCT01284062|64309098|FG000|Overall Study|Adverse Event|4|||
23151850|NCT01284062|64309099|FG001|Overall Study|Adverse Event|5|||
23151851|NCT01284062|64309100|FG002|Overall Study|Adverse Event|0|||
23151852|NCT01284062|64309101|FG003|Overall Study|Adverse Event|5|||
23151853|NCT01284062|64309098|FG000|Overall Study|Lack of Efficacy|3|||
23151854|NCT01284062|64309099|FG001|Overall Study|Lack of Efficacy|2|||
23151855|NCT01284062|64309100|FG002|Overall Study|Lack of Efficacy|2|||
23151856|NCT01284062|64309101|FG003|Overall Study|Lack of Efficacy|1|||
23151857|NCT01284062|64309098|FG000|Overall Study|Medication error without adverse event|0|||
23151858|NCT01284062|64309099|FG001|Overall Study|Medication error without adverse event|0|||
23325651|NCT00485264|64933972|FG000|Overall Study|Physician Decision|0|||
23325652|NCT00485264|64933973|FG001|Overall Study|Physician Decision|2|||
23325653|NCT00485264|64933974|FG002|Overall Study|Physician Decision|0|||
23325654|NCT00485264|64933975|FG003|Overall Study|Physician Decision|0|||
23325655|NCT00485264|64933976|FG004|Overall Study|Physician Decision|0|||
23325656|NCT00485264|64933977|FG005|Overall Study|Physician Decision|0|||
23325657|NCT00485264|64933972|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23325658|NCT00485264|64933973|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23325659|NCT00485264|64933974|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
23325660|NCT00485264|64933975|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23325661|NCT00485264|64933976|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23325662|NCT00485264|64933977|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
23325663|NCT00485264|64933972|FG000|Overall Study|Not Able to Attend Clinic|5|||
23325664|NCT00485264|64933973|FG001|Overall Study|Not Able to Attend Clinic|0|||
23325665|NCT00485264|64933974|FG002|Overall Study|Not Able to Attend Clinic|0|||
23325666|NCT00485264|64933975|FG003|Overall Study|Not Able to Attend Clinic|1|||
23325667|NCT00485264|64933976|FG004|Overall Study|Not Able to Attend Clinic|1|||
23151859|NCT01284062|64309100|FG002|Overall Study|Medication error without adverse event|1|||
23151860|NCT01284062|64309101|FG003|Overall Study|Medication error without adverse event|0|||
23151861|NCT01284062|64309098|FG000|Overall Study|Protocol Violation|1|||
23151862|NCT01284062|64309099|FG001|Overall Study|Protocol Violation|0|||
23151863|NCT01284062|64309100|FG002|Overall Study|Protocol Violation|0|||
23151864|NCT01284062|64309101|FG003|Overall Study|Protocol Violation|2|||
23151865|NCT01284062|64309098|FG000|Overall Study|Withdrawal by Subject|3|||
23151866|NCT01284062|64309099|FG001|Overall Study|Withdrawal by Subject|1|||
23151867|NCT01284062|64309100|FG002|Overall Study|Withdrawal by Subject|2|||
23151868|NCT01284062|64309101|FG003|Overall Study|Withdrawal by Subject|5|||
23151869|NCT01284062|64309098|FG000|Overall Study|Other|0|||
23151870|NCT01284062|64309099|FG001|Overall Study|Other|0|||
23151871|NCT01284062|64309100|FG002|Overall Study|Other|0|||
23151872|NCT01284062|64309101|FG003|Overall Study|Other|1|||
23151873|NCT01284062|64309098|FG000|Overall Study|Site Closed|0|||
23151874|NCT01284062|64309099|FG001|Overall Study|Site Closed|0|||
23151875|NCT01284062|64309100|FG002|Overall Study|Site Closed|1|||
23151876|NCT01284062|64309101|FG003|Overall Study|Site Closed|0|||
23151877|NCT01704287|64309102|FG000|Initial Treatment Period|Death|139|||
23151878|NCT01704287|64309103|FG001|Initial Treatment Period|Death|129|||
23151879|NCT01704287|64309104|FG002|Initial Treatment Period|Death|71|||
23151880|NCT01704287|64309105|FG003|Initial Treatment Period|Death|0|||
23151881|NCT01704287|64309106|FG004|Initial Treatment Period|Death|0|||
23220126|NCT03907969|64550046|FG000|Combination Therapy Part A|Physician Decision|0|||
23220127|NCT03907969|64550047|FG001|Combination Therapy Part A|Physician Decision|0|||
23220128|NCT03907969|64550048|FG002|Combination Therapy Part A|Physician Decision|0|||
23220129|NCT03907969|64550049|FG003|Combination Therapy Part A|Physician Decision|0|||
23220130|NCT03907969|64550050|FG004|Combination Therapy Part A|Physician Decision|0|||
23220131|NCT03907969|64550051|FG005|Combination Therapy Part A|Physician Decision|0|||
23220132|NCT03907969|64550052|FG006|Combination Therapy Part A|Physician Decision|0|||
23220133|NCT03907969|64550053|FG007|Combination Therapy Part A|Physician Decision|1|||
23325668|NCT00485264|64933977|FG005|Overall Study|Not Able to Attend Clinic|2|||
23151882|NCT01704287|64309102|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
23151883|NCT01704287|64309103|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
23151884|NCT01704287|64309104|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
23151885|NCT01704287|64309105|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
23325669|NCT00485264|64933972|FG000|Overall Study|Non-Compliant|17|||
23325670|NCT00485264|64933973|FG001|Overall Study|Non-Compliant|2|||
23325671|NCT00485264|64933974|FG002|Overall Study|Non-Compliant|1|||
23325672|NCT00485264|64933975|FG003|Overall Study|Non-Compliant|0|||
23151886|NCT01704287|64309106|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
23151887|NCT01704287|64309102|FG000|Initial Treatment Period|Lost to Follow-up|5|||
23151888|NCT01704287|64309103|FG001|Initial Treatment Period|Lost to Follow-up|3|||
23220134|NCT03907969|64550054|FG008|Combination Therapy Part A|Physician Decision|0|||
23220135|NCT03907969|64550055|FG009|Combination Therapy Part A|Physician Decision|0|||
23220136|NCT03907969|64550056|FG010|Combination Therapy Part A|Physician Decision|1|||
23220137|NCT03682055|64550057|FG000|Overall Study|Lack of Efficacy|1|||
23220138|NCT03682055|64550058|FG001|Overall Study|Lack of Efficacy|2|||
23220139|NCT03682055|64550059|FG002|Overall Study|Lack of Efficacy|1|||
23220140|NCT03682055|64550060|FG003|Overall Study|Lack of Efficacy|2|||
23220141|NCT03682055|64550061|FG004|Overall Study|Lack of Efficacy|1|||
23220142|NCT03682055|64550062|FG005|Overall Study|Lack of Efficacy|3|||
23220143|NCT03682055|64550057|FG000|Overall Study|Withdrawal by Subject|0|||
23220144|NCT03682055|64550058|FG001|Overall Study|Withdrawal by Subject|0|||
23220145|NCT03682055|64550059|FG002|Overall Study|Withdrawal by Subject|0|||
23220146|NCT03682055|64550060|FG003|Overall Study|Withdrawal by Subject|0|||
23220147|NCT03682055|64550061|FG004|Overall Study|Withdrawal by Subject|0|||
23220148|NCT03682055|64550062|FG005|Overall Study|Withdrawal by Subject|1|||
23220149|NCT03682055|64550057|FG000|Overall Study|Termination of Study by Sponsor|0|||
23220150|NCT03682055|64550058|FG001|Overall Study|Termination of Study by Sponsor|0|||
23220151|NCT03682055|64550059|FG002|Overall Study|Termination of Study by Sponsor|0|||
23220152|NCT03682055|64550060|FG003|Overall Study|Termination of Study by Sponsor|0|||
23220153|NCT03682055|64550061|FG004|Overall Study|Termination of Study by Sponsor|0|||
23220154|NCT03682055|64550062|FG005|Overall Study|Termination of Study by Sponsor|3|||
23220155|NCT03984812|64550066|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220156|NCT03984812|64550067|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220157|NCT03984812|64550068|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
23220158|NCT03984812|64550069|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220159|NCT03984812|64550070|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220160|NCT03984812|64550071|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220161|NCT03984812|64550072|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220162|NCT03984812|64550073|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220163|NCT03984812|64550074|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220164|NCT03984812|64550075|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220165|NCT03984812|64550076|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
23220166|NCT00481988|64550077|FG000|Overall Study|Withdrawal by Subject|1|||
23220167|NCT00481988|64550078|FG001|Overall Study|Withdrawal by Subject|1|||
23220168|NCT00753623|64550083|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
23220169|NCT00753623|64550084|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
23151889|NCT01704287|64309104|FG002|Initial Treatment Period|Lost to Follow-up|0|||
23151890|NCT01704287|64309105|FG003|Initial Treatment Period|Lost to Follow-up|0|||
23151891|NCT01704287|64309106|FG004|Initial Treatment Period|Lost to Follow-up|0|||
23151892|NCT01704287|64309102|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
23151893|NCT01704287|64309103|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
23151894|NCT01704287|64309104|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
23151895|NCT01704287|64309105|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
23151896|NCT01704287|64309106|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
23151897|NCT01704287|64309102|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
23151898|NCT01704287|64309103|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
23151899|NCT01704287|64309104|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
23220170|NCT00753623|64550083|FG000|Phase I (14 Days)|Physician Decision|1|||
23220171|NCT00753623|64550084|FG001|Phase I (14 Days)|Physician Decision|2|||
23220172|NCT00753623|64550083|FG000|Phase I (14 Days)|Adverse Event|0|||
23325673|NCT00485264|64933976|FG004|Overall Study|Non-Compliant|1|||
23325674|NCT00485264|64933977|FG005|Overall Study|Non-Compliant|0|||
23325675|NCT00485264|64933972|FG000|Overall Study|Lost to Follow-up|2|||
23440448|NCT03364309|65355268|FG011|Maintenance Period|Relapsed|0|||
23625568|NCT03616964|66015545|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
23625569|NCT03616964|66015546|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
23625570|NCT03616964|66015544|FG000|Overall Study|Protocol Violation|0|||
23625571|NCT03616964|66015545|FG001|Overall Study|Protocol Violation|1|||
23625572|NCT03616964|66015546|FG002|Overall Study|Protocol Violation|0|||
23625573|NCT03616964|66015544|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
23625574|NCT03616964|66015545|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
23625575|NCT03616964|66015546|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
23625576|NCT03616964|66015544|FG000|Overall Study|Randomized but Never Treated|1|||
23151900|NCT01704287|64309105|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
23220173|NCT00753623|64550084|FG001|Phase I (14 Days)|Adverse Event|1|||
23220174|NCT00753623|64550083|FG000|Washout (7 Days)|Physician Decision|1|||
23220175|NCT00753623|64550084|FG001|Washout (7 Days)|Physician Decision|0|||
23220176|NCT00753623|64550083|FG000|Phase II (14 Days)|Physician Decision|0|||
23220177|NCT00753623|64550084|FG001|Phase II (14 Days)|Physician Decision|1|||
23440449|NCT03364309|65355269|FG012|Maintenance Period|Relapsed|0|||
23220178|NCT00429572|64550093|FG000|Overall Study|Disease progression|1|||
23220179|NCT01822223|64550094|FG000|Overall Study|Death|0|||
23325676|NCT00485264|64933973|FG001|Overall Study|Lost to Follow-up|1|||
23325677|NCT00485264|64933974|FG002|Overall Study|Lost to Follow-up|1|||
23325678|NCT00485264|64933975|FG003|Overall Study|Lost to Follow-up|0|||
23325679|NCT00485264|64933976|FG004|Overall Study|Lost to Follow-up|0|||
23325680|NCT00485264|64933977|FG005|Overall Study|Lost to Follow-up|1|||
23440450|NCT03364309|65355270|FG013|Maintenance Period|Relapsed|0|||
23440451|NCT03364309|65355271|FG014|Maintenance Period|Relapsed|0|||
23440452|NCT03364309|65355272|FG015|Maintenance Period|Relapsed|0|||
23440453|NCT03364309|65355273|FG016|Maintenance Period|Relapsed|0|||
23440454|NCT03364309|65355274|FG017|Maintenance Period|Relapsed|0|||
23440455|NCT03364309|65355275|FG018|Maintenance Period|Relapsed|0|||
23440456|NCT03364309|65355257|FG000|Maintenance Period|Lack of Efficacy|0|||
23440457|NCT03364309|65355258|FG001|Maintenance Period|Lack of Efficacy|0|||
23440458|NCT03364309|65355259|FG002|Maintenance Period|Lack of Efficacy|0|||
23440459|NCT03364309|65355260|FG003|Maintenance Period|Lack of Efficacy|0|||
23440460|NCT03364309|65355261|FG004|Maintenance Period|Lack of Efficacy|0|||
23440461|NCT03364309|65355262|FG005|Maintenance Period|Lack of Efficacy|0|||
23440462|NCT03364309|65355263|FG006|Maintenance Period|Lack of Efficacy|0|||
23440463|NCT03364309|65355264|FG007|Maintenance Period|Lack of Efficacy|0|||
23440464|NCT03364309|65355265|FG008|Maintenance Period|Lack of Efficacy|1|||
23440465|NCT03364309|65355266|FG009|Maintenance Period|Lack of Efficacy|3|||
23440466|NCT03364309|65355267|FG010|Maintenance Period|Lack of Efficacy|2|||
23440467|NCT03364309|65355268|FG011|Maintenance Period|Lack of Efficacy|0|||
23440468|NCT03364309|65355269|FG012|Maintenance Period|Lack of Efficacy|0|||
23440469|NCT03364309|65355270|FG013|Maintenance Period|Lack of Efficacy|0|||
23440470|NCT03364309|65355271|FG014|Maintenance Period|Lack of Efficacy|0|||
23440471|NCT03364309|65355272|FG015|Maintenance Period|Lack of Efficacy|0|||
23440472|NCT03364309|65355273|FG016|Maintenance Period|Lack of Efficacy|0|||
23440473|NCT03364309|65355274|FG017|Maintenance Period|Lack of Efficacy|0|||
23440474|NCT03364309|65355275|FG018|Maintenance Period|Lack of Efficacy|0|||
23440475|NCT03364309|65355257|FG000|Maintenance Period|Death|0|||
23440476|NCT03364309|65355258|FG001|Maintenance Period|Death|0|||
23440477|NCT03364309|65355259|FG002|Maintenance Period|Death|0|||
23440478|NCT03364309|65355260|FG003|Maintenance Period|Death|0|||
23440479|NCT03364309|65355261|FG004|Maintenance Period|Death|0|||
23440480|NCT03364309|65355262|FG005|Maintenance Period|Death|0|||
23440481|NCT03364309|65355263|FG006|Maintenance Period|Death|0|||
23440482|NCT03364309|65355264|FG007|Maintenance Period|Death|0|||
23440483|NCT03364309|65355265|FG008|Maintenance Period|Death|1|||
23440484|NCT03364309|65355266|FG009|Maintenance Period|Death|0|||
23440485|NCT03364309|65355267|FG010|Maintenance Period|Death|0|||
23440486|NCT03364309|65355268|FG011|Maintenance Period|Death|0|||
23440487|NCT03364309|65355269|FG012|Maintenance Period|Death|0|||
23440488|NCT03364309|65355270|FG013|Maintenance Period|Death|0|||
23440489|NCT03364309|65355271|FG014|Maintenance Period|Death|0|||
23440490|NCT03364309|65355272|FG015|Maintenance Period|Death|0|||
23440491|NCT03364309|65355273|FG016|Maintenance Period|Death|0|||
23440492|NCT03364309|65355274|FG017|Maintenance Period|Death|0|||
23440493|NCT03364309|65355275|FG018|Maintenance Period|Death|0|||
23440494|NCT03364309|65355257|FG000|Maintenance Period|Lost to Follow-up|0|||
23440495|NCT03364309|65355258|FG001|Maintenance Period|Lost to Follow-up|0|||
23440496|NCT03364309|65355259|FG002|Maintenance Period|Lost to Follow-up|0|||
23440497|NCT03364309|65355260|FG003|Maintenance Period|Lost to Follow-up|0|||
23440498|NCT03364309|65355261|FG004|Maintenance Period|Lost to Follow-up|0|||
23440499|NCT03364309|65355262|FG005|Maintenance Period|Lost to Follow-up|0|||
23440500|NCT03364309|65355263|FG006|Maintenance Period|Lost to Follow-up|0|||
23440501|NCT03364309|65355264|FG007|Maintenance Period|Lost to Follow-up|0|||
23625577|NCT03616964|66015545|FG001|Overall Study|Randomized but Never Treated|1|||
23625578|NCT03616964|66015546|FG002|Overall Study|Randomized but Never Treated|1|||
23625579|NCT04333147|66015547|FG000|Overall Study|Adverse Event|43|||
23440502|NCT03364309|65355265|FG008|Maintenance Period|Lost to Follow-up|1|||
23440503|NCT03364309|65355266|FG009|Maintenance Period|Lost to Follow-up|0|||
23625580|NCT04333147|66015548|FG001|Overall Study|Adverse Event|40|||
23625581|NCT04333147|66015547|FG000|Overall Study|Lack of Efficacy|49|||
23625582|NCT04333147|66015548|FG001|Overall Study|Lack of Efficacy|48|||
23325681|NCT00485264|64933972|FG000|Overall Study|Other Reason|3|||
23325682|NCT00485264|64933973|FG001|Overall Study|Other Reason|0|||
23325683|NCT00485264|64933974|FG002|Overall Study|Other Reason|0|||
23440504|NCT03364309|65355267|FG010|Maintenance Period|Lost to Follow-up|0|||
23440505|NCT03364309|65355268|FG011|Maintenance Period|Lost to Follow-up|0|||
23440506|NCT03364309|65355269|FG012|Maintenance Period|Lost to Follow-up|0|||
23440507|NCT03364309|65355270|FG013|Maintenance Period|Lost to Follow-up|0|||
23440508|NCT03364309|65355271|FG014|Maintenance Period|Lost to Follow-up|0|||
23440509|NCT03364309|65355272|FG015|Maintenance Period|Lost to Follow-up|0|||
23440510|NCT03364309|65355273|FG016|Maintenance Period|Lost to Follow-up|0|||
23325684|NCT00485264|64933975|FG003|Overall Study|Other Reason|0|||
23440511|NCT03364309|65355274|FG017|Maintenance Period|Lost to Follow-up|0|||
23440512|NCT03364309|65355275|FG018|Maintenance Period|Lost to Follow-up|0|||
23440513|NCT03364309|65355257|FG000|Maintenance Period|Miscellaneous|0|||
23625583|NCT04333147|66015547|FG000|Overall Study|Lost to Follow-up|19|||
23562973|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562974|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562975|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562976|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562977|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
23562978|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
23562979|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Death|0|||
23562980|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Death|4|||
23562981|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Death|2|||
23562982|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Death|4|||
23562983|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Death|3|||
23562984|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Death|0|||
23562985|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Death|0|||
23562986|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Death|1|||
23562987|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Death|111|||
23562988|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
23562989|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
23562990|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
23562991|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562992|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562993|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562994|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562995|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
23562996|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
23562997|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23562998|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23562999|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563000|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563001|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563002|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23151901|NCT01704287|64309106|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
23151902|NCT01704287|64309102|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
23151903|NCT01704287|64309103|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
23151904|NCT01704287|64309104|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
23151905|NCT01704287|64309105|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
23563003|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563004|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
23563005|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
23563006|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563007|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563008|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
23563009|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563010|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
23563011|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
23625584|NCT04333147|66015548|FG001|Overall Study|Lost to Follow-up|16|||
23625585|NCT04333147|66015547|FG000|Overall Study|Physician Decision|17|||
23625586|NCT04333147|66015548|FG001|Overall Study|Physician Decision|20|||
23625587|NCT04333147|66015547|FG000|Overall Study|Withdrawal by Subject|65|||
23625588|NCT04333147|66015548|FG001|Overall Study|Withdrawal by Subject|68|||
23625589|NCT04333147|66015547|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
23625590|NCT04333147|66015548|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
23625591|NCT04333147|66015547|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
23625592|NCT04333147|66015548|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
23563012|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563013|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
23563014|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
23563015|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563016|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563017|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563018|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563019|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563020|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563021|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23563022|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
23625593|NCT04333147|66015547|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
23625594|NCT04333147|66015548|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
23625595|NCT01093599|66015549|FG000|Overall Study|Lost to Follow-up|32|||
23625596|NCT01093599|66015550|FG001|Overall Study|Lost to Follow-up|46|||
23151906|NCT01704287|64309106|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
23563023|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
23563024|NCT02508532|65790391|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
23563025|NCT02508532|65790392|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
23563026|NCT02508532|65790393|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
23563027|NCT02508532|65790394|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
23563028|NCT02508532|65790395|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
23563029|NCT02508532|65790396|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
23625597|NCT01728623|66015551|FG000|Overall Study|Disease progression|26|||
23625598|NCT01728623|66015551|FG000|Overall Study|Adverse Event|1|||
23625599|NCT01728623|66015551|FG000|Overall Study|Withdrawal by Subject|1|||
23151907|NCT01704287|64309102|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
23325685|NCT00485264|64933976|FG004|Overall Study|Other Reason|0|||
23563030|NCT02508532|65790397|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
23563031|NCT02508532|65790398|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
23563032|NCT02508532|65790399|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
23563033|NCT03391765|65790400|FG000|Overall Study|Adverse Event|2|||
23563034|NCT03391765|65790401|FG001|Overall Study|Adverse Event|0|||
23563035|NCT03391765|65790402|FG002|Overall Study|Adverse Event|0|||
23563036|NCT03391765|65790403|FG003|Overall Study|Adverse Event|2|||
23563037|NCT03391765|65790400|FG000|Overall Study|Withdrew consent|5|||
23563038|NCT03391765|65790401|FG001|Overall Study|Withdrew consent|7|||
23563039|NCT03391765|65790402|FG002|Overall Study|Withdrew consent|2|||
23563040|NCT03391765|65790403|FG003|Overall Study|Withdrew consent|5|||
23563041|NCT03391765|65790400|FG000|Overall Study|Other, not specified|44|||
23563042|NCT03391765|65790401|FG001|Overall Study|Other, not specified|38|||
23563043|NCT03391765|65790402|FG002|Overall Study|Other, not specified|21|||
23563044|NCT03391765|65790403|FG003|Overall Study|Other, not specified|16|||
23563045|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
23563046|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
23563047|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23563048|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
23563049|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
23563050|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
23563051|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
23563052|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
23563053|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
23563054|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
23563055|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
23563056|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
23563057|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
23563058|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
23563059|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
23563060|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
23563061|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
23563062|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
23151908|NCT01704287|64309103|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
23151909|NCT01704287|64309104|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
23151910|NCT01704287|64309105|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
23151911|NCT01704287|64309106|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
23151912|NCT03942406|64309107|FG000|Overall Study|Lost to Follow-up|4|||
23151913|NCT03942406|64309108|FG001|Overall Study|Lost to Follow-up|5|||
23151914|NCT03942406|64309109|FG002|Overall Study|Lost to Follow-up|3|||
23151915|NCT03942406|64309110|FG003|Overall Study|Lost to Follow-up|7|||
23151916|NCT03942406|64309111|FG004|Overall Study|Lost to Follow-up|1|||
23151917|NCT03942406|64309112|FG005|Overall Study|Lost to Follow-up|0|||
23151918|NCT03942406|64309113|FG006|Overall Study|Lost to Follow-up|0|||
23151919|NCT03942406|64309107|FG000|Overall Study|Withdrawal by Subject|3|||
23151920|NCT03942406|64309108|FG001|Overall Study|Withdrawal by Subject|1|||
23151921|NCT03942406|64309109|FG002|Overall Study|Withdrawal by Subject|1|||
23151922|NCT03942406|64309110|FG003|Overall Study|Withdrawal by Subject|3|||
23151923|NCT03942406|64309111|FG004|Overall Study|Withdrawal by Subject|0|||
23151924|NCT03942406|64309112|FG005|Overall Study|Withdrawal by Subject|0|||
23151925|NCT03942406|64309113|FG006|Overall Study|Withdrawal by Subject|0|||
23151926|NCT03942406|64309107|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
23151927|NCT03942406|64309108|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
23151928|NCT03942406|64309109|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
23151929|NCT03942406|64309110|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
23151930|NCT03942406|64309111|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
23563063|NCT00365378|65790406|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
23563064|NCT00365378|65790407|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
23563065|NCT00365378|65790408|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
23563066|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
23625600|NCT03277352|66015552|FG000|Overall Study|Study Terminated By Sponsor|2|||
23625601|NCT03277352|66015552|FG000|Overall Study|Withdrawal by Subject|4|||
23625602|NCT03277352|66015552|FG000|Overall Study|Death|4|||
23625603|NCT01918371|66015553|FG000|Overall Study|Missing Data|1|||
23625604|NCT01918371|66015554|FG001|Overall Study|Missing Data|1|||
23625605|NCT03470545|66015555|FG000|Overall Study|Death|0|||
23625606|NCT03470545|66015556|FG001|Overall Study|Death|1|||
23625607|NCT03470545|66015555|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
23625608|NCT03470545|66015556|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
23625609|NCT03470545|66015555|FG000|Overall Study|Adverse Event|2|||
23625610|NCT03470545|66015556|FG001|Overall Study|Adverse Event|0|||
23625611|NCT03470545|66015555|FG000|Overall Study|Withdrawal by Subject|1|||
23625612|NCT03470545|66015556|FG001|Overall Study|Withdrawal by Subject|1|||
23625613|NCT03470545|66015555|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
23625614|NCT03470545|66015556|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
23625615|NCT02725528|66015557|FG000|Overall Study|Lost to Follow-up|1|||
23625616|NCT02725528|66015558|FG001|Overall Study|Lost to Follow-up|4|||
23625617|NCT02725528|66015557|FG000|Overall Study|Withdrawal by Subject|0|||
23625618|NCT02725528|66015558|FG001|Overall Study|Withdrawal by Subject|1|||
23625619|NCT02575950|66015559|FG000|Overall Study|Withdrawal by Subject|0|||
23625620|NCT02575950|66015560|FG001|Overall Study|Withdrawal by Subject|0|||
23625621|NCT02575950|66015561|FG002|Overall Study|Withdrawal by Subject|0|||
23625622|NCT02575950|66015562|FG003|Overall Study|Withdrawal by Subject|2|||
23625623|NCT02575950|66015559|FG000|Overall Study|Lost to Follow-up|0|||
23625624|NCT02575950|66015560|FG001|Overall Study|Lost to Follow-up|1|||
23625625|NCT02575950|66015561|FG002|Overall Study|Lost to Follow-up|0|||
23625626|NCT02575950|66015562|FG003|Overall Study|Lost to Follow-up|3|||
23625627|NCT01263054|66015577|FG000|Overall Study|Death|1|||
23625628|NCT01263054|66015578|FG001|Overall Study|Death|0|||
23625629|NCT01263054|66015577|FG000|Overall Study|Lost to Follow-up|2|||
23625630|NCT01263054|66015578|FG001|Overall Study|Lost to Follow-up|2|||
23625631|NCT01263054|66015577|FG000|Overall Study|Withdrawal by Subject|1|||
23625632|NCT01263054|66015578|FG001|Overall Study|Withdrawal by Subject|3|||
23625633|NCT01263054|66015577|FG000|Overall Study|Qualification Violation|1|||
23625634|NCT01263054|66015578|FG001|Overall Study|Qualification Violation|0|||
23625635|NCT01263054|66015577|FG000|Overall Study|Other|0|||
23625636|NCT01263054|66015578|FG001|Overall Study|Other|1|||
23625637|NCT03636373|66015581|FG000|Overall Study|Study closure due to Covid-19|1|||
23625638|NCT03636373|66015582|FG001|Overall Study|Study closure due to Covid-19|0|||
23625639|NCT01017263|66015583|FG000|Overall Study|not eligible|12|||
23625640|NCT00025506|66015584|FG000|Overall Study|Ineligible: clerical error|1|||
23625641|NCT00025506|66015584|FG000|Overall Study|Ineligible: wrong cell type|5|||
23625642|NCT00025506|66015584|FG000|Overall Study|Ineligible: inadequate pathology|2|||
23625643|NCT00025506|66015584|FG000|Overall Study|Never Treated|2|||
23625644|NCT00307164|66015589|FG000|Overall Study|Death|1|||
23625645|NCT00307164|66015590|FG001|Overall Study|Death|0|||
23625646|NCT00307164|66015589|FG000|Overall Study|Severe debilitation, unable to continue|1|||
23625647|NCT00307164|66015590|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23625648|NCT00307164|66015589|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
23625649|NCT00307164|66015590|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
23625650|NCT00307164|66015589|FG000|Overall Study|Withdrawal by Subject|1|||
23625651|NCT00307164|66015590|FG001|Overall Study|Withdrawal by Subject|8|||
23625652|NCT00307164|66015589|FG000|Overall Study|Not compliant with requirements|4|||
23625653|NCT00307164|66015590|FG001|Overall Study|Not compliant with requirements|4|||
23625654|NCT00307164|66015589|FG000|Overall Study|Lost to Follow-up|6|||
23151931|NCT03942406|64309112|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
23151932|NCT03942406|64309113|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
23151933|NCT00068588|64309114|FG000|Overall Study|Adverse Event|0|||
23151934|NCT00068588|64309115|FG001|Overall Study|Adverse Event|0|||
23151935|NCT00068588|64309116|FG002|Overall Study|Adverse Event|2|||
23151936|NCT00068588|64309114|FG000|Overall Study|Withdrawal by Subject|0|||
23151937|NCT00068588|64309115|FG001|Overall Study|Withdrawal by Subject|0|||
23151938|NCT00068588|64309116|FG002|Overall Study|Withdrawal by Subject|1|||
23151939|NCT00068588|64309114|FG000|Overall Study|Poor KPS|0|||
23151940|NCT00068588|64309115|FG001|Overall Study|Poor KPS|0|||
23151941|NCT00068588|64309116|FG002|Overall Study|Poor KPS|1|||
23625655|NCT00307164|66015590|FG001|Overall Study|Lost to Follow-up|1|||
23625656|NCT00827775|66015592|FG000|Overall Study|Withdrawal by Subject|0|||
23625657|NCT00827775|66015593|FG001|Overall Study|Withdrawal by Subject|5|||
23151942|NCT00995007|64309117|FG000|Overall Study|Withdrew consent|1|||
23151943|NCT00995007|64309118|FG001|Overall Study|Withdrew consent|0|||
23151944|NCT00995007|64309117|FG000|Overall Study|Refused further treatment|8|||
23625658|NCT01772563|66015594|FG000|Cycle 1|Dose limiting toxicity|2|||
23625659|NCT01772563|66015594|FG000|Cycle 1|Progressive disease|2|||
23625660|NCT01772563|66015594|FG000|Cycle 2 and Beyond|Progressive disease|17|||
23625661|NCT01772563|66015594|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
23625662|NCT01772563|66015594|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
23625663|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
23625664|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
23625665|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
23625666|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
23625667|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
23325686|NCT00485264|64933977|FG005|Overall Study|Other Reason|0|||
23325687|NCT00360282|64933978|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
23325688|NCT00360282|64933979|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
23325689|NCT00360282|64933980|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
23325690|NCT00360282|64933981|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
23325691|NCT00360282|64933978|FG000|Second Intervention|Adverse Event|0|||
23325692|NCT00360282|64933979|FG001|Second Intervention|Adverse Event|1|||
23325693|NCT00360282|64933980|FG002|Second Intervention|Adverse Event|0|||
23325694|NCT00360282|64933981|FG003|Second Intervention|Adverse Event|0|||
23325695|NCT01037218|64933982|FG000|Overall Study|Adverse Event|4|||
23325696|NCT01037218|64933983|FG001|Overall Study|Adverse Event|2|||
23325697|NCT01037218|64933984|FG002|Overall Study|Adverse Event|2|||
23325698|NCT01037218|64933985|FG003|Overall Study|Adverse Event|1|||
23325699|NCT01037218|64933982|FG000|Overall Study|Lack of Efficacy|0|||
23325700|NCT01037218|64933983|FG001|Overall Study|Lack of Efficacy|2|||
23325701|NCT01037218|64933984|FG002|Overall Study|Lack of Efficacy|1|||
23325702|NCT01037218|64933985|FG003|Overall Study|Lack of Efficacy|5|||
23325703|NCT01037218|64933982|FG000|Overall Study|Lost to Follow-up|3|||
23325704|NCT01037218|64933983|FG001|Overall Study|Lost to Follow-up|5|||
23325705|NCT01037218|64933984|FG002|Overall Study|Lost to Follow-up|4|||
23325706|NCT01037218|64933985|FG003|Overall Study|Lost to Follow-up|2|||
23325707|NCT01037218|64933982|FG000|Overall Study|Withdrawal by Subject|6|||
23325708|NCT01037218|64933983|FG001|Overall Study|Withdrawal by Subject|7|||
23325709|NCT01037218|64933984|FG002|Overall Study|Withdrawal by Subject|7|||
23325710|NCT01037218|64933985|FG003|Overall Study|Withdrawal by Subject|4|||
23563067|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
23563068|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
23563069|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
23563070|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
23563071|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
23563072|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
23563073|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
23563074|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
23563075|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
23563076|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
23563077|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
23563078|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
23563079|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
23563080|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
23563081|NCT00365378|65790406|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
23563082|NCT00365378|65790407|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
23563083|NCT00365378|65790408|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
23563084|NCT00365378|65790406|FG000|Extension|Adverse Event|0|||
23563085|NCT00365378|65790407|FG001|Extension|Adverse Event|0|||
23563086|NCT00365378|65790408|FG002|Extension|Adverse Event|1|||
23563087|NCT00365378|65790406|FG000|Extension|Moved|0|||
23563088|NCT00365378|65790407|FG001|Extension|Moved|0|||
23563089|NCT00365378|65790408|FG002|Extension|Moved|8|||
23563090|NCT00365378|65790406|FG000|Extension|Lost to Follow-up|0|||
23563091|NCT00365378|65790407|FG001|Extension|Lost to Follow-up|0|||
23563092|NCT00365378|65790408|FG002|Extension|Lost to Follow-up|57|||
23563093|NCT00365378|65790406|FG000|Extension|Protocol Violation|0|||
23563094|NCT00365378|65790407|FG001|Extension|Protocol Violation|0|||
23563095|NCT00365378|65790408|FG002|Extension|Protocol Violation|2|||
23563096|NCT00365378|65790406|FG000|Extension|Withdrawal by Subject|0|||
23563097|NCT00365378|65790407|FG001|Extension|Withdrawal by Subject|0|||
23563098|NCT00365378|65790408|FG002|Extension|Withdrawal by Subject|98|||
23563099|NCT00365378|65790406|FG000|Extension|Other|0|||
23563100|NCT00365378|65790407|FG001|Extension|Other|0|||
23563101|NCT00365378|65790408|FG002|Extension|Other|31|||
23325711|NCT01037218|64933982|FG000|Overall Study|Partner Withdrew Consent|0|||
23563102|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
23325712|NCT01037218|64933983|FG001|Overall Study|Partner Withdrew Consent|3|||
23325713|NCT01037218|64933984|FG002|Overall Study|Partner Withdrew Consent|2|||
23325714|NCT01037218|64933985|FG003|Overall Study|Partner Withdrew Consent|1|||
23325715|NCT01037218|64933982|FG000|Overall Study|Protocol Violation|0|||
23325716|NCT01037218|64933983|FG001|Overall Study|Protocol Violation|0|||
23325717|NCT01037218|64933984|FG002|Overall Study|Protocol Violation|2|||
23563103|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
23325718|NCT01037218|64933985|FG003|Overall Study|Protocol Violation|2|||
23325719|NCT01037218|64933982|FG000|Overall Study|Various|3|||
23325720|NCT01037218|64933983|FG001|Overall Study|Various|2|||
23325721|NCT01037218|64933984|FG002|Overall Study|Various|3|||
23325722|NCT01037218|64933985|FG003|Overall Study|Various|1|||
23325723|NCT01153815|64933986|FG000|Overall Study|Adverse Event|3|||
23325724|NCT01153815|64933987|FG001|Overall Study|Adverse Event|1|||
23325725|NCT01153815|64933986|FG000|Overall Study|Withdrawal by Subject|6|||
23325726|NCT01153815|64933987|FG001|Overall Study|Withdrawal by Subject|4|||
23325727|NCT03539302|64937724|FG000|Overall Study|Spontaneous cardio version|0|||
23325728|NCT03539302|64937725|FG001|Overall Study|Spontaneous cardio version|0|||
23325729|NCT03539302|64937726|FG002|Overall Study|Spontaneous cardio version|0|||
23325730|NCT03539302|64937727|FG003|Overall Study|Spontaneous cardio version|0|||
23325731|NCT03539302|64937728|FG004|Overall Study|Spontaneous cardio version|0|||
23325732|NCT03539302|64937729|FG005|Overall Study|Spontaneous cardio version|1|||
23325733|NCT03539302|64937730|FG006|Overall Study|Spontaneous cardio version|1|||
23325734|NCT00350207|64937737|FG000|Overall Study|Adverse Event|5|||
23325735|NCT00350207|64937738|FG001|Overall Study|Adverse Event|2|||
23325736|NCT00350207|64937739|FG002|Overall Study|Adverse Event|2|||
23325737|NCT00350207|64937737|FG000|Overall Study|Lack of Efficacy|1|||
23325738|NCT00350207|64937738|FG001|Overall Study|Lack of Efficacy|0|||
23325739|NCT00350207|64937739|FG002|Overall Study|Lack of Efficacy|2|||
23325740|NCT00350207|64937737|FG000|Overall Study|Lost to Follow-up|1|||
23325741|NCT00350207|64937738|FG001|Overall Study|Lost to Follow-up|0|||
23325742|NCT00350207|64937739|FG002|Overall Study|Lost to Follow-up|1|||
23325743|NCT00350207|64937737|FG000|Overall Study|Withdrawal by Subject|0|||
23325744|NCT00350207|64937738|FG001|Overall Study|Withdrawal by Subject|1|||
23325745|NCT00350207|64937739|FG002|Overall Study|Withdrawal by Subject|1|||
23325746|NCT00350207|64937737|FG000|Overall Study|Other|1|||
23151945|NCT00995007|64309118|FG001|Overall Study|Refused further treatment|2|||
23151946|NCT00995007|64309117|FG000|Overall Study|Toxicity|8|||
23151947|NCT00995007|64309118|FG001|Overall Study|Toxicity|0|||
23151948|NCT01050205|64309122|FG000|Overall Study|Lost to Follow-up|7|||
23151949|NCT01050205|64309123|FG001|Overall Study|Lost to Follow-up|1|||
23151950|NCT01050205|64309122|FG000|Overall Study|Withdrawal by Subject|1|||
23151951|NCT01050205|64309123|FG001|Overall Study|Withdrawal by Subject|1|||
23151952|NCT01050205|64309122|FG000|Overall Study|Relocated from area|1|||
23151953|NCT01050205|64309123|FG001|Overall Study|Relocated from area|2|||
23151954|NCT01050205|64309122|FG000|Overall Study|Discontinued Intervention|2|||
23151955|NCT01050205|64309123|FG001|Overall Study|Discontinued Intervention|0|||
23151956|NCT03675776|64309139|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
23151957|NCT03675776|64309140|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
23151958|NCT03675776|64309141|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
23151959|NCT03675776|64309139|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
23151960|NCT03675776|64309140|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
23151961|NCT03675776|64309141|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
23151962|NCT01301456|64309142|FG000|Stage 1|Withdrawal by Subject|0|||
23151963|NCT01301456|64309143|FG001|Stage 1|Withdrawal by Subject|0|||
23151964|NCT01301456|64309144|FG002|Stage 1|Withdrawal by Subject|1|||
23151965|NCT01301456|64309145|FG003|Stage 1|Withdrawal by Subject|0|||
23151966|NCT01301456|64309146|FG004|Stage 1|Withdrawal by Subject|1|||
23151967|NCT01301456|64309147|FG005|Stage 1|Withdrawal by Subject|0|||
23151968|NCT01301456|64309148|FG006|Stage 1|Withdrawal by Subject|0|||
23151969|NCT01301456|64309149|FG007|Stage 1|Withdrawal by Subject|0|||
23151970|NCT01301456|64309150|FG008|Stage 1|Withdrawal by Subject|0|||
23151971|NCT01301456|64309151|FG009|Stage 1|Withdrawal by Subject|0|||
23151972|NCT01301456|64309152|FG010|Stage 1|Withdrawal by Subject|0|||
23151973|NCT01301456|64309153|FG011|Stage 1|Withdrawal by Subject|0|||
23151974|NCT01301456|64309142|FG000|Stage 1|Randomized but not treated|0|||
23151975|NCT01301456|64309143|FG001|Stage 1|Randomized but not treated|0|||
23325747|NCT00350207|64937738|FG001|Overall Study|Other|3|||
23325748|NCT00350207|64937739|FG002|Overall Study|Other|1|||
23325749|NCT01202175|64937740|FG000|Overall Study|Lost to Follow-up|2|||
23325750|NCT01202175|64937740|FG000|Overall Study|Withdrawal by Subject|1|||
23325751|NCT01202175|64937740|FG000|Overall Study|Adverse Event|2|||
23325752|NCT02568072|64937743|FG000|Overall Study|Unavailable for appointment|23|||
23325753|NCT02568072|64937743|FG000|Overall Study|Unable to contact|3|||
23151976|NCT01301456|64309144|FG002|Stage 1|Randomized but not treated|0|||
23151977|NCT01301456|64309145|FG003|Stage 1|Randomized but not treated|0|||
23151978|NCT01301456|64309146|FG004|Stage 1|Randomized but not treated|0|||
23151979|NCT01301456|64309147|FG005|Stage 1|Randomized but not treated|0|||
23151980|NCT01301456|64309148|FG006|Stage 1|Randomized but not treated|1|||
23151981|NCT01301456|64309149|FG007|Stage 1|Randomized but not treated|0|||
23151982|NCT01301456|64309150|FG008|Stage 1|Randomized but not treated|0|||
23325754|NCT02568072|64937743|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
23325755|NCT02568072|64937743|FG000|Overall Study|Withdrawal by Subject|1|||
23325756|NCT02568072|64937743|FG000|Overall Study|Sustained injury, marathon not run|24|||
23220180|NCT01822223|64550095|FG001|Overall Study|Death|1|||
23151983|NCT01301456|64309151|FG009|Stage 1|Randomized but not treated|0|||
23151984|NCT01301456|64309152|FG010|Stage 1|Randomized but not treated|0|||
23625668|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
23625669|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
23625670|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
23625671|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
23625672|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
23625673|NCT01772823|66015595|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
23625674|NCT01772823|66015596|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
23625675|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
23625676|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
23625677|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
23625678|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
23625679|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
23625680|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
23625681|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
23625682|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
23625683|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
23625684|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
23625685|NCT01772823|66015595|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
23625686|NCT01772823|66015596|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
23625687|NCT01772823|66015595|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
23625688|NCT01772823|66015596|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
23625689|NCT01772823|66015595|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
23625690|NCT01772823|66015596|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
23625691|NCT01772823|66015595|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
23151985|NCT01301456|64309153|FG011|Stage 1|Randomized but not treated|0|||
23151986|NCT01301456|64309142|FG000|Stage 2|Adverse Event|0|||
23151987|NCT01301456|64309143|FG001|Stage 2|Adverse Event|0|||
23151988|NCT01301456|64309144|FG002|Stage 2|Adverse Event|0|||
23151989|NCT01301456|64309145|FG003|Stage 2|Adverse Event|0|||
23151990|NCT01301456|64309146|FG004|Stage 2|Adverse Event|0|||
23563104|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
23563105|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
23563106|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
23563107|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
23563108|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
23563109|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Physician Decision|4|||
23563110|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Physician Decision|1|||
23563111|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Physician Decision|3|||
23563112|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Physician Decision|0|||
23563113|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Physician Decision|0|||
23563114|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Physician Decision|1|||
23563115|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Physician Decision|0|||
23563116|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Other|0|||
23563117|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Other|1|||
23563118|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Other|0|||
23563119|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Other|0|||
23563120|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Other|0|||
23563121|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Other|0|||
23563122|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Other|0|||
23563123|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563124|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563125|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563126|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563127|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563128|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
23563129|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
23563130|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
23563131|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
23563132|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
23563133|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
23563134|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
23563135|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
23563136|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
23563137|NCT05375955|65790409|FG000|Treatment (12 Weeks)|Pregnancy|0|||
23563138|NCT05375955|65790410|FG001|Treatment (12 Weeks)|Pregnancy|0|||
23563139|NCT05375955|65790411|FG002|Treatment (12 Weeks)|Pregnancy|1|||
23563140|NCT05375955|65790412|FG003|Treatment (12 Weeks)|Pregnancy|0|||
23563141|NCT05375955|65790413|FG004|Treatment (12 Weeks)|Pregnancy|0|||
23325757|NCT00071110|64937744|FG000|Overall Study|Protocol Violation|0|||
23325758|NCT00071110|64937745|FG001|Overall Study|Protocol Violation|4|||
23325759|NCT01372618|64937746|FG000|Overall Study|PI Died. Study Terminated|9|||
23325760|NCT00699816|64937747|FG000|Overall Study|Protocol Violation|1|||
23325761|NCT00699816|64937748|FG001|Overall Study|Protocol Violation|3|||
23325762|NCT01730053|64937751|FG000|Overall Study|Participant moved|0|||
23325763|NCT01730053|64937752|FG001|Overall Study|Participant moved|0|||
23325764|NCT01730053|64937753|FG002|Overall Study|Participant moved|1|||
23325765|NCT01730053|64937754|FG003|Overall Study|Participant moved|0|||
23325766|NCT01730053|64937755|FG004|Overall Study|Participant moved|0|||
23325767|NCT01730053|64937756|FG005|Overall Study|Participant moved|0|||
23325768|NCT01730053|64937751|FG000|Overall Study|Physician Decision|0|||
23325769|NCT01730053|64937752|FG001|Overall Study|Physician Decision|0|||
23325770|NCT01730053|64937753|FG002|Overall Study|Physician Decision|0|||
23325771|NCT01730053|64937754|FG003|Overall Study|Physician Decision|1|||
23325772|NCT01730053|64937755|FG004|Overall Study|Physician Decision|0|||
23325773|NCT01730053|64937756|FG005|Overall Study|Physician Decision|0|||
23325774|NCT01730053|64937751|FG000|Overall Study|Adverse Event|2|||
23325775|NCT01730053|64937752|FG001|Overall Study|Adverse Event|6|||
23325776|NCT01730053|64937753|FG002|Overall Study|Adverse Event|3|||
23325777|NCT01730053|64937754|FG003|Overall Study|Adverse Event|3|||
23325778|NCT01730053|64937755|FG004|Overall Study|Adverse Event|2|||
23325779|NCT01730053|64937756|FG005|Overall Study|Adverse Event|2|||
23325780|NCT01730053|64937751|FG000|Overall Study|Poor compliance to protocol|1|||
23325781|NCT01730053|64937752|FG001|Overall Study|Poor compliance to protocol|2|||
23325782|NCT01730053|64937753|FG002|Overall Study|Poor compliance to protocol|2|||
23325783|NCT01730053|64937754|FG003|Overall Study|Poor compliance to protocol|0|||
23325784|NCT01730053|64937755|FG004|Overall Study|Poor compliance to protocol|0|||
23325785|NCT01730053|64937756|FG005|Overall Study|Poor compliance to protocol|2|||
23325786|NCT01730053|64937751|FG000|Overall Study|Other than specified|2|||
23325787|NCT01730053|64937752|FG001|Overall Study|Other than specified|6|||
23325788|NCT01730053|64937753|FG002|Overall Study|Other than specified|5|||
23325789|NCT01730053|64937754|FG003|Overall Study|Other than specified|4|||
23325790|NCT01730053|64937755|FG004|Overall Study|Other than specified|7|||
23325791|NCT01730053|64937756|FG005|Overall Study|Other than specified|9|||
23325792|NCT01169350|64937757|FG000|Overall Study|Physician Decision|3|||
23325793|NCT01169350|64937757|FG000|Overall Study|Lost to Follow-up|2|||
23325794|NCT00725920|64937758|FG000|Overall Study|Lack of Efficacy|3|||
23325795|NCT00725920|64937759|FG001|Overall Study|Lack of Efficacy|6|||
23325796|NCT01995513|64937767|FG000|Period 1: First Open Label Treatment|Other|34|||
23325797|NCT01995513|64937768|FG001|Period 1: First Open Label Treatment|Other|0|||
23325798|NCT01995513|64937769|FG002|Period 1: First Open Label Treatment|Other|0|||
23325799|NCT01995513|64937770|FG003|Period 1: First Open Label Treatment|Other|0|||
23325800|NCT01995513|64937767|FG000|Period 1: First Open Label Treatment|Death|14|||
23325801|NCT01995513|64937768|FG001|Period 1: First Open Label Treatment|Death|0|||
23325802|NCT01995513|64937769|FG002|Period 1: First Open Label Treatment|Death|0|||
23325803|NCT01995513|64937770|FG003|Period 1: First Open Label Treatment|Death|0|||
23325804|NCT01995513|64937767|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
23325805|NCT01995513|64937768|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
23325806|NCT01995513|64937769|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
23325807|NCT01995513|64937770|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
23325808|NCT01995513|64937767|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
23325809|NCT01995513|64937768|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
23325810|NCT01995513|64937769|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
23325811|NCT01995513|64937770|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
23325812|NCT01995513|64937767|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
23325813|NCT01995513|64937768|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
23325814|NCT01995513|64937769|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
23325815|NCT01995513|64937770|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
23325816|NCT01995513|64937767|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
23325817|NCT01995513|64937768|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
23325818|NCT01995513|64937769|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
23325819|NCT01995513|64937770|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
23325820|NCT01995513|64937767|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
23325821|NCT01995513|64937768|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
23325822|NCT01995513|64937769|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
23151991|NCT01301456|64309147|FG005|Stage 2|Adverse Event|0|||
23325823|NCT01995513|64937770|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
23325824|NCT01995513|64937767|FG000|Period 1: Second Open Label Treatment|Other|0|||
23325825|NCT01995513|64937768|FG001|Period 1: Second Open Label Treatment|Other|2|||
23325826|NCT01995513|64937769|FG002|Period 1: Second Open Label Treatment|Other|0|||
23151992|NCT01301456|64309148|FG006|Stage 2|Adverse Event|0|||
23325827|NCT01995513|64937770|FG003|Period 1: Second Open Label Treatment|Other|0|||
23325828|NCT01995513|64937767|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
23325829|NCT01995513|64937768|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
23325830|NCT01995513|64937769|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
23325831|NCT01995513|64937770|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
23325832|NCT01995513|64937767|FG000|Period 2: Double Blind Treatment|Death|0|||
23325833|NCT01995513|64937768|FG001|Period 2: Double Blind Treatment|Death|0|||
23325834|NCT01995513|64937769|FG002|Period 2: Double Blind Treatment|Death|0|||
23325835|NCT01995513|64937770|FG003|Period 2: Double Blind Treatment|Death|1|||
23325836|NCT01995513|64937767|FG000|Period 2: Double Blind Treatment|Other|0|||
23325837|NCT01995513|64937768|FG001|Period 2: Double Blind Treatment|Other|0|||
23325838|NCT01995513|64937769|FG002|Period 2: Double Blind Treatment|Other|3|||
23325839|NCT01995513|64937770|FG003|Period 2: Double Blind Treatment|Other|3|||
23325840|NCT01995513|64937767|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
23325841|NCT01995513|64937768|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
23325842|NCT01995513|64937769|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
23325843|NCT01995513|64937770|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
23325844|NCT01995513|64937767|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
23325845|NCT01995513|64937768|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
23325846|NCT01995513|64937769|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
23325847|NCT01995513|64937770|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
23440514|NCT03364309|65355258|FG001|Maintenance Period|Miscellaneous|0|||
23625692|NCT01772823|66015596|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
23625693|NCT01772823|66015595|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
23625694|NCT01772823|66015596|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
23625695|NCT00412880|66015597|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
23625696|NCT00412880|66015597|FG000|Overall Study|Consent withdrawn|1|||
23625697|NCT00412880|66015597|FG000|Overall Study|Adverse Event|1|||
23625698|NCT00412880|66015597|FG000|Overall Study|Progressive disease|20|||
23625699|NCT02485899|66015598|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
23625700|NCT02485899|66015599|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23625701|NCT02485899|66015598|FG000|Overall Study|Withdrawal by Subject|1|||
23625702|NCT02485899|66015599|FG001|Overall Study|Withdrawal by Subject|0|||
23625703|NCT02485899|66015598|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
23625704|NCT02485899|66015599|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
23625705|NCT04035577|66015601|FG000|Overall Study|Lost to Follow-up|1|||
23625706|NCT04035577|66015601|FG000|Overall Study|Withdrawal by Subject|1|||
23625707|NCT00639769|66015606|FG000|Overall Study|Death|2|||
23625708|NCT00639769|66015606|FG000|Overall Study|Adverse Event|7|||
23625709|NCT00639769|66015606|FG000|Overall Study|Lack of Efficacy|1|||
23625710|NCT00639769|66015606|FG000|Overall Study|Disease progression|26|||
23625711|NCT00639769|66015606|FG000|Overall Study|Withdrawal by Subject|4|||
23625712|NCT01006616|66015607|FG000|Period 1 (6 Months)|Adverse Event|10|||
23625713|NCT01006616|66015608|FG001|Period 1 (6 Months)|Adverse Event|31|||
23625714|NCT01006616|66015609|FG002|Period 1 (6 Months)|Adverse Event|37|||
23625715|NCT01006616|66015610|FG003|Period 1 (6 Months)|Adverse Event|9|||
23625716|NCT01006616|66015607|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
23625717|NCT01006616|66015608|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
23625718|NCT01006616|66015609|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
23625719|NCT01006616|66015610|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
23625720|NCT01006616|66015607|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
23625721|NCT01006616|66015608|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
23220181|NCT04445688|64550096|FG000|Washout (One Week)|Adverse Event|2|||
23220182|NCT04445688|64550096|FG000|Washout (One Week)|Withdrawal by Subject|1|||
23220183|NCT02000219|64550101|FG000|14-Week Study Period|Physician Decision|1|||
23220184|NCT02000219|64550101|FG000|14-Week Study Period|Adverse Event|1|||
23220185|NCT02000219|64550101|FG000|14-Week Study Period|Underwent transplantation|1|||
23220186|NCT02000219|64550101|FG000|Continuation Period|Withdrawal by Subject|1|||
23220187|NCT02000219|64550101|FG000|Continuation Period|Had liver transplant|2|||
23220188|NCT02000219|64550101|FG000|Continuation Period|Non-compliance with study drug|2|||
23325848|NCT01995513|64937767|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
23325849|NCT01995513|64937768|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
23440515|NCT03364309|65355259|FG002|Maintenance Period|Miscellaneous|0|||
23625722|NCT01006616|66015609|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
23325850|NCT01995513|64937769|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
23325851|NCT01995513|64937770|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
23325852|NCT01995513|64937767|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
23440516|NCT03364309|65355260|FG003|Maintenance Period|Miscellaneous|0|||
23625723|NCT01006616|66015610|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
23625724|NCT01006616|66015607|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
23625725|NCT01006616|66015608|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
23625726|NCT01006616|66015609|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
23220189|NCT02657434|64550102|FG000|Overall Study|Study Terminated By Sponsor|64|||
23220190|NCT02657434|64550103|FG001|Overall Study|Study Terminated By Sponsor|82|||
23220191|NCT02657434|64550102|FG000|Overall Study|Death|189|||
23220192|NCT02657434|64550103|FG001|Overall Study|Death|190|||
23220193|NCT02657434|64550102|FG000|Overall Study|Lost to Follow-up|2|||
23220194|NCT02657434|64550103|FG001|Overall Study|Lost to Follow-up|2|||
23220195|NCT02657434|64550102|FG000|Overall Study|Randomization by Error|2|||
23220196|NCT02657434|64550103|FG001|Overall Study|Randomization by Error|0|||
23220197|NCT02657434|64550102|FG000|Overall Study|Withdrawal by Subject|28|||
23220198|NCT02657434|64550103|FG001|Overall Study|Withdrawal by Subject|17|||
23220199|NCT02657434|64550102|FG000|Overall Study|Protocol Violation|1|||
23220200|NCT02657434|64550103|FG001|Overall Study|Protocol Violation|0|||
23220201|NCT02657434|64550102|FG000|Overall Study|Physician Decision|0|||
23325853|NCT01995513|64937768|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
23325854|NCT01995513|64937769|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
23325855|NCT01995513|64937770|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
23563142|NCT05375955|65790414|FG005|Treatment (12 Weeks)|Pregnancy|0|||
23563143|NCT05375955|65790415|FG006|Treatment (12 Weeks)|Pregnancy|0|||
23325856|NCT04515147|64937775|FG000|Overall Study|Withdrawal by Subject|1|||
23325857|NCT04515147|64937776|FG001|Overall Study|Withdrawal by Subject|0|||
23325858|NCT04515147|64937777|FG002|Overall Study|Withdrawal by Subject|10|||
23325859|NCT04515147|64937778|FG003|Overall Study|Withdrawal by Subject|18|||
23325860|NCT04515147|64937779|FG004|Overall Study|Withdrawal by Subject|1|||
23325861|NCT04515147|64937780|FG005|Overall Study|Withdrawal by Subject|8|||
23325862|NCT04515147|64937775|FG000|Overall Study|Lost to Follow-up|0|||
23325863|NCT04515147|64937776|FG001|Overall Study|Lost to Follow-up|1|||
23151993|NCT01301456|64309149|FG007|Stage 2|Adverse Event|0|||
23563144|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563145|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563146|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
23563147|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563148|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563149|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563150|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
23563151|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
23563152|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
23563153|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
23563154|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
23151994|NCT01301456|64309150|FG008|Stage 2|Adverse Event|0|||
23151995|NCT01301456|64309151|FG009|Stage 2|Adverse Event|0|||
23151996|NCT01301456|64309152|FG010|Stage 2|Adverse Event|1|||
23151997|NCT01301456|64309153|FG011|Stage 2|Adverse Event|0|||
23325864|NCT04515147|64937777|FG002|Overall Study|Lost to Follow-up|5|||
23325865|NCT04515147|64937778|FG003|Overall Study|Lost to Follow-up|6|||
23325866|NCT04515147|64937779|FG004|Overall Study|Lost to Follow-up|2|||
23325867|NCT04515147|64937780|FG005|Overall Study|Lost to Follow-up|1|||
23325868|NCT04515147|64937775|FG000|Overall Study|Adverse Event|0|||
23325869|NCT04515147|64937776|FG001|Overall Study|Adverse Event|0|||
23325870|NCT04515147|64937777|FG002|Overall Study|Adverse Event|0|||
23325871|NCT04515147|64937778|FG003|Overall Study|Adverse Event|2|||
23325872|NCT04515147|64937779|FG004|Overall Study|Adverse Event|0|||
23325873|NCT04515147|64937780|FG005|Overall Study|Adverse Event|0|||
23325874|NCT04515147|64937775|FG000|Overall Study|Miscellaneous|0|||
23563155|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
23563156|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
23563157|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
23151998|NCT00631189|64309154|FG000|Initial Phase|Protocol Violation|347|||
23151999|NCT00631189|64309155|FG001|Initial Phase|Protocol Violation|0|||
23152000|NCT00631189|64309156|FG002|Initial Phase|Protocol Violation|0|||
23152001|NCT00631189|64309157|FG003|Initial Phase|Protocol Violation|0|||
23152002|NCT00631189|64309154|FG000|Initial Phase|Withdrawal by Subject|4|||
23152003|NCT00631189|64309155|FG001|Initial Phase|Withdrawal by Subject|0|||
23220202|NCT02657434|64550103|FG001|Overall Study|Physician Decision|1|||
23220203|NCT02025530|64550106|FG000|Overall Study|No longer met elligibility criteria|5|||
23220204|NCT02025530|64550107|FG001|Overall Study|No longer met elligibility criteria|1|||
23220205|NCT00262314|64550110|FG000|Overall Study|Changing physicians|38|||
23325875|NCT04515147|64937776|FG001|Overall Study|Miscellaneous|0|||
23563158|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Other|0|||
23563159|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Other|1|||
23152004|NCT00631189|64309156|FG002|Initial Phase|Withdrawal by Subject|0|||
23563160|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Other|0|||
23325876|NCT04515147|64937777|FG002|Overall Study|Miscellaneous|0|||
23325877|NCT04515147|64937778|FG003|Overall Study|Miscellaneous|1|||
23152005|NCT00631189|64309157|FG003|Initial Phase|Withdrawal by Subject|0|||
23152006|NCT00631189|64309154|FG000|Treatment Phase|Withdrawal by Subject|0|||
23220206|NCT00262314|64550110|FG000|Overall Study|Death|12|||
23220207|NCT00262314|64550110|FG000|Overall Study|Patient's decision|92|||
23563161|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Other|0|||
23563162|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Other|0|||
23563163|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Other|0|||
23563164|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Other|0|||
23563165|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
23563166|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563167|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
23563168|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563169|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563170|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563171|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
23563172|NCT05375955|65790409|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
23563173|NCT05375955|65790410|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
23563174|NCT05375955|65790411|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
23563175|NCT05375955|65790412|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
23563176|NCT05375955|65790413|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
23563177|NCT05375955|65790414|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
23625727|NCT01006616|66015610|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
23625728|NCT01006616|66015607|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
23625729|NCT01006616|66015608|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
23152007|NCT00631189|64309155|FG001|Treatment Phase|Withdrawal by Subject|2|||
23152008|NCT00631189|64309156|FG002|Treatment Phase|Withdrawal by Subject|1|||
23152009|NCT00631189|64309157|FG003|Treatment Phase|Withdrawal by Subject|1|||
23152010|NCT00631189|64309154|FG000|Treatment Phase|Protocol Violation|0|||
23325878|NCT04515147|64937779|FG004|Overall Study|Miscellaneous|0|||
23152011|NCT00631189|64309155|FG001|Treatment Phase|Protocol Violation|1|||
23152012|NCT00631189|64309156|FG002|Treatment Phase|Protocol Violation|6|||
23152013|NCT00631189|64309157|FG003|Treatment Phase|Protocol Violation|2|||
23152014|NCT00631189|64309154|FG000|Treatment Phase|Adverse Event|0|||
23220208|NCT00262314|64550110|FG000|Overall Study|Other|95|||
23220209|NCT00262314|64550110|FG000|Overall Study|Lost to Follow-up|70|||
23220210|NCT00262314|64550110|FG000|Overall Study|Administrative withdrawal|30|||
23220211|NCT01680991|64550111|FG000|Overall Study|Adverse Event|1|||
23220212|NCT01680991|64550112|FG001|Overall Study|Adverse Event|0|||
23220213|NCT01680991|64550113|FG002|Overall Study|Adverse Event|0|||
23220214|NCT01680991|64550111|FG000|Overall Study|Death|1|||
23220215|NCT01680991|64550112|FG001|Overall Study|Death|0|||
23220216|NCT01680991|64550113|FG002|Overall Study|Death|1|||
23220217|NCT01680991|64550111|FG000|Overall Study|Protocol Violation|0|||
23220218|NCT01680991|64550112|FG001|Overall Study|Protocol Violation|1|||
23220219|NCT01680991|64550113|FG002|Overall Study|Protocol Violation|0|||
23325879|NCT04515147|64937780|FG005|Overall Study|Miscellaneous|1|||
23325880|NCT01894919|64937791|FG000|Overall Study|Withdrawal by Subject|1|||
23325881|NCT01894919|64937792|FG001|Overall Study|Withdrawal by Subject|0|||
23325882|NCT01894919|64937793|FG002|Overall Study|Withdrawal by Subject|0|||
23563178|NCT05375955|65790415|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
23563179|NCT04244396|65790416|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
23625730|NCT01006616|66015609|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
23625731|NCT01006616|66015610|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
23625732|NCT01006616|66015607|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
23625733|NCT01006616|66015608|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
23625734|NCT01006616|66015609|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
23625735|NCT01006616|66015610|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
23625736|NCT01006616|66015607|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
23625737|NCT01006616|66015608|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
23625738|NCT01006616|66015609|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
23625739|NCT01006616|66015610|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
23625740|NCT01006616|66015607|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
23625741|NCT01006616|66015608|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
23625742|NCT01006616|66015609|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
23152015|NCT00631189|64309155|FG001|Treatment Phase|Adverse Event|3|||
23563180|NCT04244396|65790416|FG000|Overall Study|Withdrawal by Subject|2|||
23152016|NCT00631189|64309156|FG002|Treatment Phase|Adverse Event|2|||
23220220|NCT01680991|64550111|FG000|Overall Study|Withdrawal by Subject|5|||
23220221|NCT01680991|64550112|FG001|Overall Study|Withdrawal by Subject|1|||
23563181|NCT04244396|65790416|FG000|Overall Study|Study termination|37|||
23563182|NCT03066622|65790423|FG000|Overall Study|Lost to Follow-up|24|||
23152017|NCT00631189|64309157|FG003|Treatment Phase|Adverse Event|4|||
23152018|NCT00631189|64309154|FG000|Treatment Phase|Lost to Follow-up|0|||
23220222|NCT01680991|64550113|FG002|Overall Study|Withdrawal by Subject|0|||
23325883|NCT01894919|64937794|FG003|Overall Study|Withdrawal by Subject|0|||
23563183|NCT03066622|65790424|FG001|Overall Study|Lost to Follow-up|25|||
23563184|NCT03066622|65790423|FG000|Overall Study|Withdrawal by Subject|2|||
23220223|NCT01680991|64550111|FG000|Overall Study|Progressive disease (PD)|0|||
23325884|NCT01894919|64937795|FG004|Overall Study|Withdrawal by Subject|1|||
23325885|NCT01894919|64937796|FG005|Overall Study|Withdrawal by Subject|0|||
23325886|NCT01894919|64937797|FG006|Overall Study|Withdrawal by Subject|0|||
23325887|NCT01894919|64937798|FG007|Overall Study|Withdrawal by Subject|0|||
23325888|NCT01894919|64937799|FG008|Overall Study|Withdrawal by Subject|0|||
23325889|NCT01894919|64937800|FG009|Overall Study|Withdrawal by Subject|1|||
23325890|NCT01894919|64937801|FG010|Overall Study|Withdrawal by Subject|1|||
23325891|NCT01894919|64937802|FG011|Overall Study|Withdrawal by Subject|0|||
23325892|NCT01894919|64937803|FG012|Overall Study|Withdrawal by Subject|0|||
23325893|NCT01894919|64937791|FG000|Overall Study|Adverse Event|0|||
23325894|NCT01894919|64937792|FG001|Overall Study|Adverse Event|0|||
23325895|NCT01894919|64937793|FG002|Overall Study|Adverse Event|0|||
23325896|NCT01894919|64937794|FG003|Overall Study|Adverse Event|0|||
23325897|NCT01894919|64937795|FG004|Overall Study|Adverse Event|0|||
23325898|NCT01894919|64937796|FG005|Overall Study|Adverse Event|0|||
23325899|NCT01894919|64937797|FG006|Overall Study|Adverse Event|0|||
23325900|NCT01894919|64937798|FG007|Overall Study|Adverse Event|0|||
23325901|NCT01894919|64937799|FG008|Overall Study|Adverse Event|0|||
23325902|NCT01894919|64937800|FG009|Overall Study|Adverse Event|0|||
23325903|NCT01894919|64937801|FG010|Overall Study|Adverse Event|1|||
23325904|NCT01894919|64937802|FG011|Overall Study|Adverse Event|0|||
23325905|NCT01894919|64937803|FG012|Overall Study|Adverse Event|0|||
23325906|NCT01894919|64937791|FG000|Overall Study|Other-Unspecified|1|||
23325907|NCT01894919|64937792|FG001|Overall Study|Other-Unspecified|0|||
23325908|NCT01894919|64937793|FG002|Overall Study|Other-Unspecified|0|||
23325909|NCT01894919|64937794|FG003|Overall Study|Other-Unspecified|0|||
23325910|NCT01894919|64937795|FG004|Overall Study|Other-Unspecified|0|||
23325911|NCT01894919|64937796|FG005|Overall Study|Other-Unspecified|0|||
23325912|NCT01894919|64937797|FG006|Overall Study|Other-Unspecified|0|||
23325913|NCT01894919|64937798|FG007|Overall Study|Other-Unspecified|0|||
23325914|NCT01894919|64937799|FG008|Overall Study|Other-Unspecified|0|||
23325915|NCT01894919|64937800|FG009|Overall Study|Other-Unspecified|0|||
23325916|NCT01894919|64937801|FG010|Overall Study|Other-Unspecified|0|||
23325917|NCT01894919|64937802|FG011|Overall Study|Other-Unspecified|0|||
23325918|NCT01894919|64937803|FG012|Overall Study|Other-Unspecified|0|||
23325919|NCT01894919|64937791|FG000|Overall Study|Lost to Follow-up|0|||
23325920|NCT01894919|64937792|FG001|Overall Study|Lost to Follow-up|0|||
23325921|NCT01894919|64937793|FG002|Overall Study|Lost to Follow-up|0|||
23625743|NCT01006616|66015610|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
23625744|NCT01006616|66015607|FG000|Period 1 (6 Months)|Not Treated|0|||
23625745|NCT01006616|66015608|FG001|Period 1 (6 Months)|Not Treated|0|||
23625746|NCT01006616|66015609|FG002|Period 1 (6 Months)|Not Treated|1|||
23625747|NCT01006616|66015610|FG003|Period 1 (6 Months)|Not Treated|1|||
23625748|NCT01006616|66015607|FG000|Period 2 (18 Months)|Adverse Event|6|||
23625749|NCT01006616|66015608|FG001|Period 2 (18 Months)|Adverse Event|6|||
23625750|NCT01006616|66015609|FG002|Period 2 (18 Months)|Adverse Event|6|||
23625751|NCT01006616|66015610|FG003|Period 2 (18 Months)|Adverse Event|4|||
23625752|NCT01006616|66015607|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
23625753|NCT01006616|66015608|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
23625754|NCT01006616|66015609|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
23625755|NCT01006616|66015610|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
23625756|NCT01006616|66015607|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
23625757|NCT01006616|66015608|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
23625758|NCT01006616|66015609|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
23625759|NCT01006616|66015610|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
23625760|NCT01006616|66015607|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
23625761|NCT01006616|66015608|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
23625762|NCT01006616|66015609|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
23625763|NCT01006616|66015610|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
23625764|NCT01006616|66015607|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
23625765|NCT01006616|66015608|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
23625766|NCT01006616|66015609|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
23625767|NCT01006616|66015610|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
23325922|NCT01894919|64937794|FG003|Overall Study|Lost to Follow-up|0|||
23325923|NCT01894919|64937795|FG004|Overall Study|Lost to Follow-up|2|||
23625768|NCT01006616|66015607|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
23325924|NCT01894919|64937796|FG005|Overall Study|Lost to Follow-up|0|||
23325925|NCT01894919|64937797|FG006|Overall Study|Lost to Follow-up|0|||
23325926|NCT01894919|64937798|FG007|Overall Study|Lost to Follow-up|0|||
23325927|NCT01894919|64937799|FG008|Overall Study|Lost to Follow-up|0|||
23325928|NCT01894919|64937800|FG009|Overall Study|Lost to Follow-up|0|||
23325929|NCT01894919|64937801|FG010|Overall Study|Lost to Follow-up|0|||
23325930|NCT01894919|64937802|FG011|Overall Study|Lost to Follow-up|0|||
23325931|NCT01894919|64937803|FG012|Overall Study|Lost to Follow-up|0|||
23325932|NCT00413699|64937806|FG000|Initial Period|Death|25|||
23325933|NCT00413699|64937807|FG001|Initial Period|Death|30|||
23152019|NCT00631189|64309155|FG001|Treatment Phase|Lost to Follow-up|1|||
23152020|NCT00631189|64309156|FG002|Treatment Phase|Lost to Follow-up|0|||
23152021|NCT00631189|64309157|FG003|Treatment Phase|Lost to Follow-up|0|||
23152022|NCT00631189|64309154|FG000|Treatment Phase|Pregnancy|0|||
23152023|NCT00631189|64309155|FG001|Treatment Phase|Pregnancy|0|||
23152024|NCT00631189|64309156|FG002|Treatment Phase|Pregnancy|1|||
23152025|NCT00631189|64309157|FG003|Treatment Phase|Pregnancy|0|||
23152026|NCT00631189|64309154|FG000|Treatment Phase|patient did not take pravastatin|0|||
23152027|NCT00631189|64309155|FG001|Treatment Phase|patient did not take pravastatin|0|||
23152028|NCT00631189|64309156|FG002|Treatment Phase|patient did not take pravastatin|1|||
23152029|NCT00631189|64309157|FG003|Treatment Phase|patient did not take pravastatin|0|||
23152030|NCT01326728|64309160|FG000|Overall Study|Death|13|||
23152031|NCT01326728|64309161|FG001|Overall Study|Death|0|||
23152032|NCT01326728|64309160|FG000|Overall Study|Early closure of study|34|||
23152033|NCT01326728|64309161|FG001|Overall Study|Early closure of study|9|||
23152034|NCT00929656|64309162|FG000|Overall Study|Lost to Follow-up|0|||
23152035|NCT00929656|64309163|FG001|Overall Study|Lost to Follow-up|1|||
23152036|NCT01555151|64309166|FG000|Overall Study|Withdrawal by Subject|6|||
23152037|NCT01555151|64309167|FG001|Overall Study|Withdrawal by Subject|2|||
23152038|NCT01555151|64309168|FG002|Overall Study|Withdrawal by Subject|0|||
23152039|NCT01555151|64309169|FG003|Overall Study|Withdrawal by Subject|2|||
23152040|NCT01555151|64309166|FG000|Overall Study|Administrative|3|||
23152041|NCT01555151|64309167|FG001|Overall Study|Administrative|1|||
23152042|NCT01555151|64309168|FG002|Overall Study|Administrative|2|||
23152043|NCT01555151|64309169|FG003|Overall Study|Administrative|0|||
23152044|NCT01555151|64309166|FG000|Overall Study|Protocol Violation|3|||
23152045|NCT01555151|64309167|FG001|Overall Study|Protocol Violation|3|||
23152046|NCT01555151|64309168|FG002|Overall Study|Protocol Violation|3|||
23152047|NCT01555151|64309169|FG003|Overall Study|Protocol Violation|5|||
23152048|NCT01555151|64309166|FG000|Overall Study|Adverse Event|1|||
23152049|NCT01555151|64309167|FG001|Overall Study|Adverse Event|2|||
23152050|NCT01555151|64309168|FG002|Overall Study|Adverse Event|1|||
23152051|NCT01555151|64309169|FG003|Overall Study|Adverse Event|2|||
23152052|NCT01555151|64309166|FG000|Overall Study|Lost to Follow-up|0|||
23152053|NCT01555151|64309167|FG001|Overall Study|Lost to Follow-up|0|||
23152054|NCT01555151|64309168|FG002|Overall Study|Lost to Follow-up|0|||
23152055|NCT01555151|64309169|FG003|Overall Study|Lost to Follow-up|1|||
23152056|NCT01968070|64309170|FG000|Period 1|Withdrawal by Subject|0|||
23152057|NCT01968070|64309171|FG001|Period 1|Withdrawal by Subject|1|||
23152058|NCT01968070|64309172|FG002|Period 1|Withdrawal by Subject|0|||
23152059|NCT01968070|64309173|FG003|Period 1|Withdrawal by Subject|0|||
23152060|NCT01968070|64309174|FG004|Period 1|Withdrawal by Subject|0|||
23152061|NCT01968070|64309175|FG005|Period 1|Withdrawal by Subject|0|||
23152062|NCT01968070|64309176|FG006|Period 1|Withdrawal by Subject|1|||
23152063|NCT01968070|64309177|FG007|Period 1|Withdrawal by Subject|0|||
23152064|NCT01968070|64309178|FG008|Period 1|Withdrawal by Subject|0|||
23152065|NCT01968070|64309179|FG009|Period 1|Withdrawal by Subject|0|||
23152066|NCT01968070|64309180|FG010|Period 1|Withdrawal by Subject|0|||
23152067|NCT01968070|64309181|FG011|Period 1|Withdrawal by Subject|0|||
23152068|NCT01968070|64309182|FG012|Period 1|Withdrawal by Subject|0|||
23152069|NCT01968070|64309183|FG013|Period 1|Withdrawal by Subject|0|||
23152070|NCT01968070|64309184|FG014|Period 1|Withdrawal by Subject|0|||
23152071|NCT01968070|64309185|FG015|Period 1|Withdrawal by Subject|1|||
23152072|NCT01968070|64309186|FG016|Period 1|Withdrawal by Subject|0|||
23152073|NCT01968070|64309187|FG017|Period 1|Withdrawal by Subject|0|||
23152074|NCT01968070|64309170|FG000|Period 1|Protocol Violation|0|||
23325934|NCT00413699|64937808|FG002|Initial Period|Death|0|||
23563185|NCT03066622|65790424|FG001|Overall Study|Withdrawal by Subject|1|||
23325935|NCT00413699|64937806|FG000|Initial Period|Lack of Efficacy|59|||
23563186|NCT04534114|65790425|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
23563187|NCT04534114|65790426|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
23563188|NCT04534114|65790427|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
23563189|NCT04534114|65790428|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
23152075|NCT01968070|64309171|FG001|Period 1|Protocol Violation|0|||
23152076|NCT01968070|64309172|FG002|Period 1|Protocol Violation|0|||
23220224|NCT01680991|64550112|FG001|Overall Study|Progressive disease (PD)|10|||
23220225|NCT01680991|64550113|FG002|Overall Study|Progressive disease (PD)|0|||
23440517|NCT03364309|65355261|FG004|Maintenance Period|Miscellaneous|0|||
23152077|NCT01968070|64309173|FG003|Period 1|Protocol Violation|1|||
23152078|NCT01968070|64309174|FG004|Period 1|Protocol Violation|1|||
23152079|NCT01968070|64309175|FG005|Period 1|Protocol Violation|0|||
23152080|NCT01968070|64309176|FG006|Period 1|Protocol Violation|0|||
23563190|NCT04534114|65790425|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
23152081|NCT01968070|64309177|FG007|Period 1|Protocol Violation|0|||
23152082|NCT01968070|64309178|FG008|Period 1|Protocol Violation|0|||
23152083|NCT01968070|64309179|FG009|Period 1|Protocol Violation|0|||
23440518|NCT03364309|65355262|FG005|Maintenance Period|Miscellaneous|0|||
23563191|NCT04534114|65790426|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
23563192|NCT04534114|65790427|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
23563193|NCT04534114|65790428|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
23563194|NCT04534114|65790425|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
23563195|NCT04534114|65790426|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
23563196|NCT04534114|65790427|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
23563197|NCT04534114|65790428|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
23563198|NCT04534114|65790425|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
23563199|NCT04534114|65790426|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
23563200|NCT04534114|65790427|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
23563201|NCT04534114|65790428|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
23563202|NCT04534114|65790425|FG000|Main Treatment Period|Physician Decision|0|||
23563203|NCT04534114|65790426|FG001|Main Treatment Period|Physician Decision|0|||
23563204|NCT04534114|65790427|FG002|Main Treatment Period|Physician Decision|0|||
23563205|NCT04534114|65790428|FG003|Main Treatment Period|Physician Decision|1|||
23563206|NCT04534114|65790425|FG000|Main Treatment Period|Death|1|||
23563207|NCT04534114|65790426|FG001|Main Treatment Period|Death|0|||
23563208|NCT04534114|65790427|FG002|Main Treatment Period|Death|0|||
23563209|NCT04534114|65790428|FG003|Main Treatment Period|Death|1|||
23563210|NCT04534114|65790425|FG000|Main Treatment Period|Other reason|1|||
23563211|NCT04534114|65790426|FG001|Main Treatment Period|Other reason|1|||
23563212|NCT04534114|65790427|FG002|Main Treatment Period|Other reason|0|||
23563213|NCT04534114|65790428|FG003|Main Treatment Period|Other reason|0|||
23563214|NCT04534114|65790425|FG000|Main Treatment Period|Participant decision|1|||
23563215|NCT04534114|65790426|FG001|Main Treatment Period|Participant decision|3|||
23563216|NCT04534114|65790427|FG002|Main Treatment Period|Participant decision|3|||
23563217|NCT04534114|65790428|FG003|Main Treatment Period|Participant decision|1|||
23563218|NCT04534114|65790425|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
23563219|NCT04534114|65790426|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
23563220|NCT04534114|65790427|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
23563221|NCT04534114|65790428|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
23563222|NCT04534114|65790425|FG000|Main Treatment Period|Adverse Event|4|||
23563223|NCT04534114|65790426|FG001|Main Treatment Period|Adverse Event|2|||
23563224|NCT04534114|65790427|FG002|Main Treatment Period|Adverse Event|1|||
23563225|NCT04534114|65790428|FG003|Main Treatment Period|Adverse Event|2|||
23563226|NCT04534114|65790425|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
23563227|NCT04534114|65790426|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
23563228|NCT04534114|65790427|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
23440519|NCT03364309|65355263|FG006|Maintenance Period|Miscellaneous|0|||
23440520|NCT03364309|65355264|FG007|Maintenance Period|Miscellaneous|0|||
23440521|NCT03364309|65355265|FG008|Maintenance Period|Miscellaneous|1|||
23440522|NCT03364309|65355266|FG009|Maintenance Period|Miscellaneous|0|||
23440523|NCT03364309|65355267|FG010|Maintenance Period|Miscellaneous|0|||
23440524|NCT03364309|65355268|FG011|Maintenance Period|Miscellaneous|0|||
23440525|NCT03364309|65355269|FG012|Maintenance Period|Miscellaneous|0|||
23440526|NCT03364309|65355270|FG013|Maintenance Period|Miscellaneous|0|||
23440527|NCT03364309|65355271|FG014|Maintenance Period|Miscellaneous|0|||
23440528|NCT03364309|65355272|FG015|Maintenance Period|Miscellaneous|0|||
23440529|NCT03364309|65355273|FG016|Maintenance Period|Miscellaneous|0|||
23440530|NCT03364309|65355274|FG017|Maintenance Period|Miscellaneous|0|||
23440531|NCT03364309|65355275|FG018|Maintenance Period|Miscellaneous|0|||
23440532|NCT03364309|65355257|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440533|NCT03364309|65355258|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440534|NCT03364309|65355259|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440535|NCT03364309|65355260|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440536|NCT03364309|65355261|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440537|NCT03364309|65355262|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440538|NCT03364309|65355263|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440539|NCT03364309|65355264|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440540|NCT03364309|65355265|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440541|NCT03364309|65355266|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440542|NCT03364309|65355267|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440543|NCT03364309|65355268|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440544|NCT03364309|65355269|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440545|NCT03364309|65355270|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
23563229|NCT04534114|65790428|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
23563230|NCT04534114|65790425|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
23582244|NCT00567879|65862411|FG001|Overall Study|Abnormal test procedure(s)|0|||
23625769|NCT01006616|66015608|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
23440546|NCT03364309|65355271|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
23440547|NCT03364309|65355272|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
23563231|NCT04534114|65790426|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
23563232|NCT04534114|65790427|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
23563233|NCT04534114|65790428|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
23563234|NCT04534114|65790425|FG000|Extension Treatment Period|Other reason|0|||
23563235|NCT04534114|65790426|FG001|Extension Treatment Period|Other reason|1|||
23563236|NCT04534114|65790427|FG002|Extension Treatment Period|Other reason|0|||
23563237|NCT04534114|65790428|FG003|Extension Treatment Period|Other reason|0|||
23563238|NCT04534114|65790425|FG000|Extension Treatment Period|Death|0|||
23563239|NCT04534114|65790426|FG001|Extension Treatment Period|Death|0|||
23563240|NCT04534114|65790427|FG002|Extension Treatment Period|Death|1|||
23563241|NCT04534114|65790428|FG003|Extension Treatment Period|Death|2|||
23563242|NCT04534114|65790425|FG000|Extension Treatment Period|Adverse Event|0|||
23563243|NCT04534114|65790426|FG001|Extension Treatment Period|Adverse Event|1|||
23563244|NCT04534114|65790427|FG002|Extension Treatment Period|Adverse Event|0|||
23563245|NCT04534114|65790428|FG003|Extension Treatment Period|Adverse Event|1|||
23563246|NCT04534114|65790425|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
23563247|NCT04534114|65790426|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
23563248|NCT04534114|65790427|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
23563249|NCT04534114|65790428|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
23563250|NCT01498822|65790432|FG000|Overall Study|Protocol Violation|8|||
23563251|NCT01498822|65790433|FG001|Overall Study|Protocol Violation|4|||
23563252|NCT01498822|65790432|FG000|Overall Study|Other Reason|5|||
23563253|NCT01498822|65790433|FG001|Overall Study|Other Reason|2|||
23563254|NCT01498822|65790432|FG000|Overall Study|Lack of Efficacy|7|||
23563255|NCT01498822|65790433|FG001|Overall Study|Lack of Efficacy|2|||
23563256|NCT01498822|65790432|FG000|Overall Study|AE, non-serious non-fatal|8|||
23563257|NCT01498822|65790433|FG001|Overall Study|AE, non-serious non-fatal|17|||
23563258|NCT01498822|65790432|FG000|Overall Study|SAE, non-fatal|2|||
23563259|NCT01498822|65790433|FG001|Overall Study|SAE, non-fatal|2|||
23563260|NCT01498822|65790432|FG000|Overall Study|Adverse Event, serious fatal|1|||
23563261|NCT01498822|65790433|FG001|Overall Study|Adverse Event, serious fatal|1|||
23563262|NCT01498822|65790432|FG000|Overall Study|Withdrawal by Subject|15|||
23563263|NCT01498822|65790433|FG001|Overall Study|Withdrawal by Subject|25|||
23563264|NCT01498822|65790432|FG000|Overall Study|Lost to Follow-up|8|||
23563265|NCT01498822|65790433|FG001|Overall Study|Lost to Follow-up|3|||
23563266|NCT02835339|65790434|FG000|Overall Study|Did not receive allocated intervention|13|||
23563267|NCT02835339|65790435|FG001|Overall Study|Did not receive allocated intervention|16|||
23563268|NCT00553501|65790442|FG000|Overall Study|Adverse Event|2|||
23563269|NCT00553501|65790442|FG000|Overall Study|Death|1|||
23563270|NCT00553501|65790442|FG000|Overall Study|Progression|1|||
23563271|NCT02237508|65790443|FG000|Overall Study|Withdrawal by Subject|0|||
23563272|NCT02237508|65790444|FG001|Overall Study|Withdrawal by Subject|2|||
23563273|NCT02237508|65790445|FG002|Overall Study|Withdrawal by Subject|0|||
23563274|NCT02237508|65790446|FG003|Overall Study|Withdrawal by Subject|1|||
23563275|NCT02237508|65790447|FG004|Overall Study|Withdrawal by Subject|0|||
23563276|NCT02237508|65790448|FG005|Overall Study|Withdrawal by Subject|1|||
23563277|NCT02237508|65790449|FG006|Overall Study|Withdrawal by Subject|1|||
23563278|NCT02237508|65790450|FG007|Overall Study|Withdrawal by Subject|0|||
23563279|NCT02237508|65790451|FG008|Overall Study|Withdrawal by Subject|1|||
23563280|NCT02237508|65790452|FG009|Overall Study|Withdrawal by Subject|0|||
23563281|NCT02237508|65790443|FG000|Overall Study|Physician Decision|0|||
23563282|NCT02237508|65790444|FG001|Overall Study|Physician Decision|1|||
23563283|NCT02237508|65790445|FG002|Overall Study|Physician Decision|0|||
23563284|NCT02237508|65790446|FG003|Overall Study|Physician Decision|0|||
23563285|NCT02237508|65790447|FG004|Overall Study|Physician Decision|0|||
23563286|NCT02237508|65790448|FG005|Overall Study|Physician Decision|0|||
23563287|NCT02237508|65790449|FG006|Overall Study|Physician Decision|0|||
23563288|NCT02237508|65790450|FG007|Overall Study|Physician Decision|0|||
23563289|NCT02237508|65790451|FG008|Overall Study|Physician Decision|0|||
23563290|NCT02237508|65790452|FG009|Overall Study|Physician Decision|0|||
23563291|NCT02237508|65790443|FG000|Overall Study|Protocol Violation|0|||
23563292|NCT02237508|65790444|FG001|Overall Study|Protocol Violation|0|||
23563293|NCT02237508|65790445|FG002|Overall Study|Protocol Violation|1|||
23563294|NCT02237508|65790446|FG003|Overall Study|Protocol Violation|0|||
23563295|NCT02237508|65790447|FG004|Overall Study|Protocol Violation|0|||
23563296|NCT02237508|65790448|FG005|Overall Study|Protocol Violation|0|||
23152084|NCT01968070|64309180|FG010|Period 1|Protocol Violation|0|||
23563297|NCT02237508|65790449|FG006|Overall Study|Protocol Violation|0|||
23563298|NCT02237508|65790450|FG007|Overall Study|Protocol Violation|0|||
23563299|NCT02237508|65790451|FG008|Overall Study|Protocol Violation|0|||
23563300|NCT02237508|65790452|FG009|Overall Study|Protocol Violation|0|||
23563301|NCT01364922|65790456|FG000|Open-label (OL) Period|Adverse Event|7|||
23563302|NCT01364922|65790457|FG001|Open-label (OL) Period|Adverse Event|0|||
23563303|NCT01364922|65790458|FG002|Open-label (OL) Period|Adverse Event|0|||
23152085|NCT01968070|64309181|FG011|Period 1|Protocol Violation|0|||
23563304|NCT01364922|65790456|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
23563305|NCT01364922|65790457|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
23563306|NCT01364922|65790458|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
23563307|NCT01364922|65790456|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
23563308|NCT01364922|65790457|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
23563309|NCT01364922|65790458|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
23563310|NCT01364922|65790456|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
23563311|NCT01364922|65790457|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
23563312|NCT01364922|65790458|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
23325936|NCT00413699|64937807|FG001|Initial Period|Lack of Efficacy|115|||
23325937|NCT00413699|64937808|FG002|Initial Period|Lack of Efficacy|0|||
23325938|NCT00413699|64937806|FG000|Initial Period|Lost to Follow-up|31|||
23325939|NCT00413699|64937807|FG001|Initial Period|Lost to Follow-up|101|||
23325940|NCT00413699|64937808|FG002|Initial Period|Lost to Follow-up|0|||
23325941|NCT00413699|64937806|FG000|Initial Period|Protocol Violation|38|||
23325942|NCT00413699|64937807|FG001|Initial Period|Protocol Violation|89|||
23325943|NCT00413699|64937808|FG002|Initial Period|Protocol Violation|0|||
23325944|NCT00413699|64937806|FG000|Initial Period|Pregnancy|10|||
23325945|NCT00413699|64937807|FG001|Initial Period|Pregnancy|8|||
23325946|NCT00413699|64937808|FG002|Initial Period|Pregnancy|0|||
23325947|NCT00413699|64937806|FG000|Initial Period|Did not meet entrance criteria|2|||
23325948|NCT00413699|64937807|FG001|Initial Period|Did not meet entrance criteria|2|||
23325949|NCT00413699|64937808|FG002|Initial Period|Did not meet entrance criteria|0|||
23563313|NCT01364922|65790456|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
23563314|NCT01364922|65790457|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
23563315|NCT01364922|65790458|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
23563316|NCT01364922|65790456|FG000|Open-label (OL) Period|Other, Unspecified|1|||
23563317|NCT01364922|65790457|FG001|Open-label (OL) Period|Other, Unspecified|0|||
23563318|NCT01364922|65790458|FG002|Open-label (OL) Period|Other, Unspecified|0|||
23563319|NCT01364922|65790456|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
23563320|NCT01364922|65790457|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
23563321|NCT01364922|65790458|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
23563322|NCT01364922|65790456|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
23563323|NCT01364922|65790457|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
23563324|NCT01364922|65790458|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
23563325|NCT01364922|65790456|FG000|Double-Blind (DB) Period|Adverse Event|0|||
23563326|NCT01364922|65790457|FG001|Double-Blind (DB) Period|Adverse Event|0|||
23563327|NCT01364922|65790458|FG002|Double-Blind (DB) Period|Adverse Event|1|||
23563328|NCT01364922|65790456|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
23563329|NCT01364922|65790457|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
23563330|NCT01364922|65790458|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
23563331|NCT05061537|65790460|FG000|Treatment Phase|Progressive disease|0|||
23563332|NCT05061537|65790461|FG001|Treatment Phase|Progressive disease|1|||
23563333|NCT05061537|65790462|FG002|Treatment Phase|Progressive disease|2|||
23563334|NCT05061537|65790463|FG003|Treatment Phase|Progressive disease|0|||
23563335|NCT05061537|65790464|FG004|Treatment Phase|Progressive disease|0|||
23563336|NCT05061537|65790460|FG000|Treatment Phase|Adverse Event|0|||
23563337|NCT05061537|65790461|FG001|Treatment Phase|Adverse Event|0|||
23563338|NCT05061537|65790462|FG002|Treatment Phase|Adverse Event|2|||
23563339|NCT05061537|65790463|FG003|Treatment Phase|Adverse Event|0|||
23563340|NCT05061537|65790464|FG004|Treatment Phase|Adverse Event|0|||
23563341|NCT05061537|65790460|FG000|Treatment Phase|Global deterioration of health status|0|||
23563342|NCT05061537|65790461|FG001|Treatment Phase|Global deterioration of health status|1|||
23563343|NCT05061537|65790462|FG002|Treatment Phase|Global deterioration of health status|0|||
23563344|NCT05061537|65790463|FG003|Treatment Phase|Global deterioration of health status|0|||
23563345|NCT05061537|65790464|FG004|Treatment Phase|Global deterioration of health status|0|||
23563346|NCT05061537|65790460|FG000|Follow up|Other|2|||
23563347|NCT05061537|65790461|FG001|Follow up|Other|0|||
23563348|NCT05061537|65790462|FG002|Follow up|Other|2|||
23563349|NCT05061537|65790463|FG003|Follow up|Other|0|||
23563350|NCT05061537|65790464|FG004|Follow up|Other|0|||
23563351|NCT05061537|65790460|FG000|Follow up|Study terminated by sponsor|0|||
23563352|NCT05061537|65790461|FG001|Follow up|Study terminated by sponsor|0|||
23625770|NCT01006616|66015609|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
23563353|NCT05061537|65790462|FG002|Follow up|Study terminated by sponsor|2|||
23563354|NCT05061537|65790463|FG003|Follow up|Study terminated by sponsor|0|||
23563355|NCT05061537|65790464|FG004|Follow up|Study terminated by sponsor|0|||
23563356|NCT05061537|65790460|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
23563357|NCT05061537|65790461|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
23563358|NCT05061537|65790462|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
23625771|NCT01006616|66015610|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
23625772|NCT01006616|66015607|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
23325950|NCT00413699|64937806|FG000|Initial Period|Medication error without adverse event|0|||
23325951|NCT00413699|64937807|FG001|Initial Period|Medication error without adverse event|1|||
23563359|NCT05061537|65790463|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
23563360|NCT05061537|65790464|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
23563361|NCT05061537|65790460|FG000|Long-term Follow-up|Death|0|||
23563362|NCT05061537|65790461|FG001|Long-term Follow-up|Death|1|||
23563363|NCT05061537|65790462|FG002|Long-term Follow-up|Death|0|||
23563364|NCT05061537|65790463|FG003|Long-term Follow-up|Death|0|||
23563365|NCT05061537|65790464|FG004|Long-term Follow-up|Death|0|||
23563366|NCT02313909|65790465|FG000|Overall Study|Consent withdrawn by participant|33|||
23563367|NCT02313909|65790466|FG001|Overall Study|Consent withdrawn by participant|33|||
23563368|NCT02313909|65790465|FG000|Overall Study|Lost to Follow-up|24|||
23563369|NCT02313909|65790466|FG001|Overall Study|Lost to Follow-up|17|||
23563370|NCT00576732|65790467|FG000|DOUBLE BLIND|Adverse Event|0|||
23563371|NCT00576732|65790468|FG001|DOUBLE BLIND|Adverse Event|0|||
23563372|NCT00576732|65790469|FG002|DOUBLE BLIND|Adverse Event|1|||
23563373|NCT00576732|65790470|FG003|DOUBLE BLIND|Adverse Event|0|||
23563374|NCT00576732|65790471|FG004|DOUBLE BLIND|Adverse Event|0|||
23563375|NCT00576732|65790472|FG005|DOUBLE BLIND|Adverse Event|0|||
23563376|NCT00576732|65790467|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
23563377|NCT00576732|65790468|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
23563378|NCT00576732|65790469|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
23563379|NCT00576732|65790470|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
23563380|NCT00576732|65790471|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
23563381|NCT00576732|65790472|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
23563382|NCT00576732|65790467|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
23563383|NCT00576732|65790468|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
23563384|NCT00576732|65790469|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
23563385|NCT00576732|65790470|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
23563386|NCT00576732|65790471|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
23563387|NCT00576732|65790472|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
23563388|NCT00576732|65790467|FG000|DOUBLE BLIND|OTHER|0|||
23563389|NCT00576732|65790468|FG001|DOUBLE BLIND|OTHER|2|||
23563390|NCT00576732|65790469|FG002|DOUBLE BLIND|OTHER|1|||
23563391|NCT00576732|65790470|FG003|DOUBLE BLIND|OTHER|0|||
23563392|NCT00576732|65790471|FG004|DOUBLE BLIND|OTHER|0|||
23563393|NCT00576732|65790472|FG005|DOUBLE BLIND|OTHER|0|||
23440548|NCT03364309|65355273|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440549|NCT03364309|65355274|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440550|NCT03364309|65355275|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
23440551|NCT03364309|65355257|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440552|NCT03364309|65355258|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440553|NCT03364309|65355259|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440554|NCT03364309|65355260|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
23563394|NCT00576732|65790467|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
23563395|NCT00576732|65790468|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
23563396|NCT00576732|65790469|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
23625773|NCT01006616|66015608|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
23625774|NCT01006616|66015609|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
23440555|NCT03364309|65355261|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440556|NCT03364309|65355262|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440557|NCT03364309|65355263|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440558|NCT03364309|65355264|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440559|NCT03364309|65355265|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440560|NCT03364309|65355266|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440561|NCT03364309|65355267|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440562|NCT03364309|65355268|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440563|NCT03364309|65355269|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440564|NCT03364309|65355270|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440565|NCT03364309|65355271|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
23440566|NCT03364309|65355272|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440567|NCT03364309|65355273|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440568|NCT03364309|65355274|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440569|NCT03364309|65355275|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
23440570|NCT03364309|65355257|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
23440571|NCT03364309|65355258|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
23440572|NCT03364309|65355259|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
23563397|NCT00576732|65790470|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
23563398|NCT00576732|65790471|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
23563399|NCT00576732|65790472|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
23563400|NCT00576732|65790467|FG000|DOUBLE BLIND|Protocol Violation|1|||
23563401|NCT00576732|65790468|FG001|DOUBLE BLIND|Protocol Violation|0|||
23563402|NCT00576732|65790469|FG002|DOUBLE BLIND|Protocol Violation|0|||
23625775|NCT01006616|66015610|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
23440573|NCT03364309|65355260|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
23563403|NCT00576732|65790470|FG003|DOUBLE BLIND|Protocol Violation|0|||
23563404|NCT00576732|65790471|FG004|DOUBLE BLIND|Protocol Violation|0|||
23563405|NCT00576732|65790472|FG005|DOUBLE BLIND|Protocol Violation|0|||
23440574|NCT03364309|65355261|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
23440575|NCT03364309|65355262|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
23440576|NCT03364309|65355263|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
23440577|NCT03364309|65355264|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
23440578|NCT03364309|65355265|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
23440579|NCT03364309|65355266|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
23440580|NCT03364309|65355267|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
23440581|NCT03364309|65355268|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
23440582|NCT03364309|65355269|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
23440583|NCT03364309|65355270|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
23440584|NCT03364309|65355271|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
23440585|NCT03364309|65355272|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
23440586|NCT03364309|65355273|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
23440587|NCT03364309|65355274|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
23440588|NCT03364309|65355275|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
23440589|NCT03364309|65355257|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440590|NCT03364309|65355258|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440591|NCT03364309|65355259|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440592|NCT03364309|65355260|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440593|NCT03364309|65355261|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440594|NCT03364309|65355262|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440595|NCT03364309|65355263|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440596|NCT03364309|65355264|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440597|NCT03364309|65355265|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23325952|NCT00413699|64937808|FG002|Initial Period|Medication error without adverse event|0|||
23325953|NCT00413699|64937806|FG000|Initial Period|Study terminated by Sponsor|0|||
23440598|NCT03364309|65355266|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440599|NCT03364309|65355267|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440600|NCT03364309|65355268|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440601|NCT03364309|65355269|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440602|NCT03364309|65355270|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440603|NCT03364309|65355271|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440604|NCT03364309|65355272|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23440605|NCT03364309|65355273|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
23440606|NCT03364309|65355274|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
23440607|NCT03364309|65355275|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
23440608|NCT03364309|65355257|FG000|Post-Treatment Followup Period|Adverse Event|0|||
23440609|NCT03364309|65355258|FG001|Post-Treatment Followup Period|Adverse Event|0|||
23440610|NCT03364309|65355259|FG002|Post-Treatment Followup Period|Adverse Event|0|||
23440611|NCT03364309|65355260|FG003|Post-Treatment Followup Period|Adverse Event|0|||
23440612|NCT03364309|65355261|FG004|Post-Treatment Followup Period|Adverse Event|0|||
23440613|NCT03364309|65355262|FG005|Post-Treatment Followup Period|Adverse Event|0|||
23440614|NCT03364309|65355263|FG006|Post-Treatment Followup Period|Adverse Event|0|||
23440615|NCT03364309|65355264|FG007|Post-Treatment Followup Period|Adverse Event|0|||
23440616|NCT03364309|65355265|FG008|Post-Treatment Followup Period|Adverse Event|0|||
23440617|NCT03364309|65355266|FG009|Post-Treatment Followup Period|Adverse Event|0|||
23440618|NCT03364309|65355267|FG010|Post-Treatment Followup Period|Adverse Event|0|||
23440619|NCT03364309|65355268|FG011|Post-Treatment Followup Period|Adverse Event|0|||
23440620|NCT03364309|65355269|FG012|Post-Treatment Followup Period|Adverse Event|0|||
23440621|NCT03364309|65355270|FG013|Post-Treatment Followup Period|Adverse Event|0|||
23440622|NCT03364309|65355271|FG014|Post-Treatment Followup Period|Adverse Event|0|||
23325954|NCT00413699|64937807|FG001|Initial Period|Study terminated by Sponsor|1|||
23325955|NCT00413699|64937808|FG002|Initial Period|Study terminated by Sponsor|0|||
23325956|NCT00413699|64937806|FG000|Initial Period|Other|67|||
23325957|NCT00413699|64937807|FG001|Initial Period|Other|211|||
23325958|NCT00413699|64937808|FG002|Initial Period|Other|0|||
23325959|NCT00413699|64937806|FG000|Initial Period|Adverse event related to study drug|178|||
23325960|NCT00413699|64937807|FG001|Initial Period|Adverse event related to study drug|527|||
23325961|NCT00413699|64937808|FG002|Initial Period|Adverse event related to study drug|0|||
23325962|NCT00413699|64937806|FG000|Initial Period|Adverse event not related to study drug|113|||
23325963|NCT00413699|64937807|FG001|Initial Period|Adverse event not related to study drug|248|||
23325964|NCT00413699|64937808|FG002|Initial Period|Adverse event not related to study drug|0|||
23325965|NCT00413699|64937806|FG000|Initial Period|Missing end of study page|0|||
23325966|NCT00413699|64937807|FG001|Initial Period|Missing end of study page|4|||
23325967|NCT00413699|64937808|FG002|Initial Period|Missing end of study page|0|||
23325968|NCT00413699|64937806|FG000|Initial Period|No longer willing to participate|116|||
23325969|NCT00413699|64937807|FG001|Initial Period|No longer willing to participate|368|||
23440623|NCT03364309|65355272|FG015|Post-Treatment Followup Period|Adverse Event|0|||
23440624|NCT03364309|65355273|FG016|Post-Treatment Followup Period|Adverse Event|2|||
23440625|NCT03364309|65355274|FG017|Post-Treatment Followup Period|Adverse Event|6|||
23440626|NCT03364309|65355275|FG018|Post-Treatment Followup Period|Adverse Event|1|||
23440627|NCT03364309|65355257|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440628|NCT03364309|65355258|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440629|NCT03364309|65355259|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440630|NCT03364309|65355260|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440631|NCT03364309|65355261|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440632|NCT03364309|65355262|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440633|NCT03364309|65355263|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440634|NCT03364309|65355264|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440635|NCT03364309|65355265|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440636|NCT03364309|65355266|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440637|NCT03364309|65355267|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440638|NCT03364309|65355268|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440639|NCT03364309|65355269|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440640|NCT03364309|65355270|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440641|NCT03364309|65355271|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440642|NCT03364309|65355272|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440643|NCT03364309|65355273|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440644|NCT03364309|65355274|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
23440645|NCT03364309|65355275|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
23440646|NCT03364309|65355257|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
23440647|NCT03364309|65355258|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
23440648|NCT03364309|65355259|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
23440649|NCT03364309|65355260|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
23440650|NCT03364309|65355261|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
23440651|NCT03364309|65355262|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
23440652|NCT03364309|65355263|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
23440653|NCT03364309|65355264|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
23440654|NCT03364309|65355265|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
23440655|NCT03364309|65355266|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
23440656|NCT03364309|65355267|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
23440657|NCT03364309|65355268|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
23440658|NCT03364309|65355269|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
23440659|NCT03364309|65355270|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
23440660|NCT03364309|65355271|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
23440661|NCT03364309|65355272|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
23440662|NCT03364309|65355273|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
23440663|NCT03364309|65355274|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
23440664|NCT03364309|65355275|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
23440665|NCT00387725|65355276|FG000|Overall Study|Adverse Event|0|||
23440666|NCT00387725|65355277|FG001|Overall Study|Adverse Event|0|||
23440667|NCT00387725|65355278|FG002|Overall Study|Adverse Event|0|||
23440668|NCT00387725|65355279|FG003|Overall Study|Adverse Event|1|||
23440669|NCT00387725|65355276|FG000|Overall Study|Protocol Violation|0|||
23440670|NCT00387725|65355277|FG001|Overall Study|Protocol Violation|1|||
23440671|NCT00387725|65355278|FG002|Overall Study|Protocol Violation|0|||
23440672|NCT00387725|65355279|FG003|Overall Study|Protocol Violation|0|||
23440673|NCT00387725|65355276|FG000|Overall Study|Withdrawal by Subject|1|||
23440674|NCT00387725|65355277|FG001|Overall Study|Withdrawal by Subject|0|||
23440675|NCT00387725|65355278|FG002|Overall Study|Withdrawal by Subject|1|||
23563406|NCT00576732|65790467|FG000|OPEN LABEL|Adverse Event|0|||
23325970|NCT00413699|64937808|FG002|Initial Period|No longer willing to participate|0|||
23325971|NCT00413699|64937806|FG000|Extension Period|No Longer Willing to Participate|0|||
23325972|NCT00413699|64937807|FG001|Extension Period|No Longer Willing to Participate|0|||
23325973|NCT00413699|64937808|FG002|Extension Period|No Longer Willing to Participate|2|||
23325974|NCT00413699|64937806|FG000|Extension Period|Protocol Violation|0|||
23325975|NCT00413699|64937807|FG001|Extension Period|Protocol Violation|0|||
23325976|NCT00413699|64937808|FG002|Extension Period|Protocol Violation|1|||
23325977|NCT00413699|64937806|FG000|Extension Period|Adverse Event|0|||
23325978|NCT00413699|64937807|FG001|Extension Period|Adverse Event|0|||
23325979|NCT00413699|64937808|FG002|Extension Period|Adverse Event|2|||
23325980|NCT04871776|64937809|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
23325981|NCT04871776|64937810|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
23325982|NCT04871776|64937811|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
23325983|NCT04871776|64937809|FG000|Overall Study|Did not meet eligibility criteria|1|||
23325984|NCT04871776|64937810|FG001|Overall Study|Did not meet eligibility criteria|1|||
23563407|NCT00576732|65790468|FG001|OPEN LABEL|Adverse Event|0|||
23325985|NCT04871776|64937811|FG002|Overall Study|Did not meet eligibility criteria|1|||
23563408|NCT00576732|65790469|FG002|OPEN LABEL|Adverse Event|0|||
23563409|NCT00576732|65790470|FG003|OPEN LABEL|Adverse Event|4|||
23563410|NCT00576732|65790471|FG004|OPEN LABEL|Adverse Event|0|||
23563411|NCT00576732|65790472|FG005|OPEN LABEL|Adverse Event|1|||
23440676|NCT00387725|65355279|FG003|Overall Study|Withdrawal by Subject|0|||
23440677|NCT00387725|65355276|FG000|Overall Study|Parent/legal guardian request|0|||
23440678|NCT00387725|65355277|FG001|Overall Study|Parent/legal guardian request|0|||
23152086|NCT01968070|64309182|FG012|Period 1|Protocol Violation|0|||
23152087|NCT01968070|64309183|FG013|Period 1|Protocol Violation|0|||
23325986|NCT00564850|64937815|FG000|Overall Study|Protocol Violation|2|||
23325987|NCT00586703|64937822|FG000|Overall Study|Death|12|||
23325988|NCT01199939|64937823|FG000|Overall Study|Adverse Event|4|||
23325989|NCT01199939|64937823|FG000|Overall Study|Protocol Violation|3|||
23325990|NCT01199939|64937823|FG000|Overall Study|Lost to Follow-up|2|||
23325991|NCT01199939|64937823|FG000|Overall Study|Reached a virologic endpoint|4|||
23325992|NCT02604407|64937827|FG000|Overall Study|Adverse Event|0|||
23325993|NCT02604407|64937828|FG001|Overall Study|Adverse Event|7|||
23440679|NCT00387725|65355278|FG002|Overall Study|Parent/legal guardian request|1|||
23440680|NCT00387725|65355279|FG003|Overall Study|Parent/legal guardian request|1|||
23440681|NCT00348309|65355280|FG000|Overall Study|Adverse Event|56|||
23440682|NCT00348309|65355281|FG001|Overall Study|Adverse Event|28|||
23440683|NCT00348309|65355282|FG002|Overall Study|Adverse Event|63|||
23440684|NCT00348309|65355280|FG000|Overall Study|Lost to Follow-up|6|||
23440685|NCT00348309|65355281|FG001|Overall Study|Lost to Follow-up|7|||
23440686|NCT00348309|65355282|FG002|Overall Study|Lost to Follow-up|4|||
23440687|NCT00348309|65355280|FG000|Overall Study|Protocol Violation|7|||
23440688|NCT00348309|65355281|FG001|Overall Study|Protocol Violation|12|||
23440689|NCT00348309|65355282|FG002|Overall Study|Protocol Violation|7|||
23440690|NCT00348309|65355280|FG000|Overall Study|Withdrawal by Subject|33|||
23563412|NCT00576732|65790467|FG000|OPEN LABEL|Lost to Follow-up|0|||
23563413|NCT00576732|65790468|FG001|OPEN LABEL|Lost to Follow-up|0|||
23563414|NCT00576732|65790469|FG002|OPEN LABEL|Lost to Follow-up|0|||
23563415|NCT00576732|65790470|FG003|OPEN LABEL|Lost to Follow-up|2|||
23563416|NCT00576732|65790471|FG004|OPEN LABEL|Lost to Follow-up|1|||
23563417|NCT00576732|65790472|FG005|OPEN LABEL|Lost to Follow-up|1|||
23563418|NCT00576732|65790467|FG000|OPEN LABEL|Withdrawal by Subject|0|||
23563419|NCT00576732|65790468|FG001|OPEN LABEL|Withdrawal by Subject|0|||
23563420|NCT00576732|65790469|FG002|OPEN LABEL|Withdrawal by Subject|0|||
23563421|NCT00576732|65790470|FG003|OPEN LABEL|Withdrawal by Subject|1|||
23563422|NCT00576732|65790471|FG004|OPEN LABEL|Withdrawal by Subject|0|||
23563423|NCT00576732|65790472|FG005|OPEN LABEL|Withdrawal by Subject|1|||
23563424|NCT00576732|65790467|FG000|OPEN LABEL|OTHER|0|||
23563425|NCT00576732|65790468|FG001|OPEN LABEL|OTHER|0|||
23563426|NCT00576732|65790469|FG002|OPEN LABEL|OTHER|0|||
23563427|NCT00576732|65790470|FG003|OPEN LABEL|OTHER|0|||
23563428|NCT00576732|65790471|FG004|OPEN LABEL|OTHER|0|||
23563429|NCT00576732|65790472|FG005|OPEN LABEL|OTHER|2|||
23563430|NCT00576732|65790467|FG000|OPEN LABEL|Lack of Efficacy|0|||
23563431|NCT00576732|65790468|FG001|OPEN LABEL|Lack of Efficacy|0|||
23563432|NCT00576732|65790469|FG002|OPEN LABEL|Lack of Efficacy|0|||
23563433|NCT00576732|65790470|FG003|OPEN LABEL|Lack of Efficacy|2|||
23563434|NCT00576732|65790471|FG004|OPEN LABEL|Lack of Efficacy|2|||
23563435|NCT00576732|65790472|FG005|OPEN LABEL|Lack of Efficacy|3|||
23563436|NCT00576732|65790467|FG000|OPEN LABEL|Protocol Violation|0|||
23563437|NCT00576732|65790468|FG001|OPEN LABEL|Protocol Violation|0|||
23563438|NCT00576732|65790469|FG002|OPEN LABEL|Protocol Violation|0|||
23563439|NCT00576732|65790470|FG003|OPEN LABEL|Protocol Violation|2|||
23563440|NCT00576732|65790471|FG004|OPEN LABEL|Protocol Violation|1|||
23563441|NCT00576732|65790472|FG005|OPEN LABEL|Protocol Violation|0|||
23563442|NCT02799472|65790473|FG000|Overall Study|Withdrawal by Subject|2|||
23563443|NCT02799472|65790474|FG001|Overall Study|Withdrawal by Subject|4|||
23563444|NCT02799472|65790473|FG000|Overall Study|Lack of Efficacy|2|||
23563445|NCT02799472|65790474|FG001|Overall Study|Lack of Efficacy|0|||
23563446|NCT02799472|65790473|FG000|Overall Study|Lost to Follow-up|0|||
23563447|NCT02799472|65790474|FG001|Overall Study|Lost to Follow-up|1|||
23152088|NCT01968070|64309184|FG014|Period 1|Protocol Violation|0|||
23325994|NCT02604407|64937829|FG002|Overall Study|Adverse Event|5|||
23325995|NCT02604407|64937827|FG000|Overall Study|Protocol Violation|2|||
23440691|NCT00348309|65355281|FG001|Overall Study|Withdrawal by Subject|37|||
23563448|NCT00909480|65790475|FG000|Overall Study|Adverse Event|5|||
23563449|NCT00909480|65790476|FG001|Overall Study|Adverse Event|3|||
23563450|NCT00909480|65790475|FG000|Overall Study|Protocol Violation|6|||
23563451|NCT00909480|65790476|FG001|Overall Study|Protocol Violation|8|||
23563452|NCT00909480|65790475|FG000|Overall Study|Withdrawal criteria|9|||
23563453|NCT00909480|65790476|FG001|Overall Study|Withdrawal criteria|11|||
23563454|NCT00909480|65790475|FG000|Overall Study|Unclassified|18|||
23563455|NCT00909480|65790476|FG001|Overall Study|Unclassified|19|||
23563456|NCT02716038|65790477|FG000|Overall Study|Not evaluable|1|||
23563457|NCT02716038|65790477|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
23563458|NCT02716038|65790477|FG000|Overall Study|Unresectable|3|||
23563459|NCT00792103|65790478|FG000|Overall Study|Enrolled, not treated|15|||
23563460|NCT00792103|65790478|FG000|Overall Study|Lost to Follow-up|17|||
23563461|NCT00792103|65790478|FG000|Overall Study|Adverse Event|25|||
23563462|NCT00792103|65790478|FG000|Overall Study|Withdrawal by Subject|52|||
23152089|NCT01968070|64309185|FG015|Period 1|Protocol Violation|0|||
23152090|NCT01968070|64309186|FG016|Period 1|Protocol Violation|0|||
23152091|NCT01968070|64309187|FG017|Period 1|Protocol Violation|0|||
23152092|NCT01968070|64309170|FG000|Period 1|Lost to Follow-up|0|||
23152093|NCT01968070|64309171|FG001|Period 1|Lost to Follow-up|0|||
23152094|NCT01968070|64309172|FG002|Period 1|Lost to Follow-up|0|||
23152095|NCT01968070|64309173|FG003|Period 1|Lost to Follow-up|1|||
23152096|NCT01968070|64309174|FG004|Period 1|Lost to Follow-up|0|||
23152097|NCT01968070|64309175|FG005|Period 1|Lost to Follow-up|0|||
23152098|NCT01968070|64309176|FG006|Period 1|Lost to Follow-up|0|||
23152099|NCT01968070|64309177|FG007|Period 1|Lost to Follow-up|0|||
23152100|NCT01968070|64309178|FG008|Period 1|Lost to Follow-up|0|||
23152101|NCT01968070|64309179|FG009|Period 1|Lost to Follow-up|0|||
23152102|NCT01968070|64309180|FG010|Period 1|Lost to Follow-up|0|||
23152103|NCT01968070|64309181|FG011|Period 1|Lost to Follow-up|0|||
23152104|NCT01968070|64309182|FG012|Period 1|Lost to Follow-up|0|||
23152105|NCT01968070|64309183|FG013|Period 1|Lost to Follow-up|0|||
23152106|NCT01968070|64309184|FG014|Period 1|Lost to Follow-up|0|||
23152107|NCT01968070|64309185|FG015|Period 1|Lost to Follow-up|0|||
23152108|NCT01968070|64309186|FG016|Period 1|Lost to Follow-up|0|||
23152109|NCT01968070|64309187|FG017|Period 1|Lost to Follow-up|0|||
23152110|NCT01968070|64309170|FG000|Period 1|Adverse Event|0|||
23152111|NCT01968070|64309171|FG001|Period 1|Adverse Event|0|||
23152112|NCT01968070|64309172|FG002|Period 1|Adverse Event|0|||
23152113|NCT01968070|64309173|FG003|Period 1|Adverse Event|0|||
23152114|NCT01968070|64309174|FG004|Period 1|Adverse Event|0|||
23152115|NCT01968070|64309175|FG005|Period 1|Adverse Event|0|||
23152116|NCT01968070|64309176|FG006|Period 1|Adverse Event|1|||
23152117|NCT01968070|64309177|FG007|Period 1|Adverse Event|0|||
23152118|NCT01968070|64309178|FG008|Period 1|Adverse Event|0|||
23152119|NCT01968070|64309179|FG009|Period 1|Adverse Event|0|||
23152120|NCT01968070|64309180|FG010|Period 1|Adverse Event|0|||
23152121|NCT01968070|64309181|FG011|Period 1|Adverse Event|0|||
23152122|NCT01968070|64309182|FG012|Period 1|Adverse Event|0|||
23152123|NCT01968070|64309183|FG013|Period 1|Adverse Event|0|||
23152124|NCT01968070|64309184|FG014|Period 1|Adverse Event|0|||
23152125|NCT01968070|64309185|FG015|Period 1|Adverse Event|0|||
23152126|NCT01968070|64309186|FG016|Period 1|Adverse Event|0|||
23152127|NCT01968070|64309187|FG017|Period 1|Adverse Event|0|||
23152128|NCT01968070|64309170|FG000|Period 1|Physician Decision|0|||
23152129|NCT01968070|64309171|FG001|Period 1|Physician Decision|0|||
23152130|NCT01968070|64309172|FG002|Period 1|Physician Decision|0|||
23152131|NCT01968070|64309173|FG003|Period 1|Physician Decision|0|||
23152132|NCT01968070|64309174|FG004|Period 1|Physician Decision|0|||
23152133|NCT01968070|64309175|FG005|Period 1|Physician Decision|0|||
23152134|NCT01968070|64309176|FG006|Period 1|Physician Decision|0|||
23152135|NCT01968070|64309177|FG007|Period 1|Physician Decision|0|||
23152136|NCT01968070|64309178|FG008|Period 1|Physician Decision|0|||
23152137|NCT01968070|64309179|FG009|Period 1|Physician Decision|0|||
23152138|NCT01968070|64309180|FG010|Period 1|Physician Decision|0|||
23152139|NCT01968070|64309181|FG011|Period 1|Physician Decision|1|||
23152140|NCT01968070|64309182|FG012|Period 1|Physician Decision|0|||
23152141|NCT01968070|64309183|FG013|Period 1|Physician Decision|0|||
23152142|NCT01968070|64309184|FG014|Period 1|Physician Decision|0|||
23152143|NCT01968070|64309185|FG015|Period 1|Physician Decision|0|||
23152144|NCT01968070|64309186|FG016|Period 1|Physician Decision|0|||
23152145|NCT01968070|64309187|FG017|Period 1|Physician Decision|0|||
23152146|NCT01968070|64309170|FG000|Period 2|Withdrawal by Subject|0|||
23152147|NCT01968070|64309171|FG001|Period 2|Withdrawal by Subject|0|||
23152148|NCT01968070|64309172|FG002|Period 2|Withdrawal by Subject|0|||
23152149|NCT01968070|64309173|FG003|Period 2|Withdrawal by Subject|0|||
23152150|NCT01968070|64309174|FG004|Period 2|Withdrawal by Subject|1|||
23152151|NCT01968070|64309175|FG005|Period 2|Withdrawal by Subject|0|||
23152152|NCT01968070|64309176|FG006|Period 2|Withdrawal by Subject|0|||
23152153|NCT01968070|64309177|FG007|Period 2|Withdrawal by Subject|0|||
23152154|NCT01968070|64309178|FG008|Period 2|Withdrawal by Subject|0|||
23152155|NCT01968070|64309179|FG009|Period 2|Withdrawal by Subject|0|||
23152156|NCT01968070|64309180|FG010|Period 2|Withdrawal by Subject|0|||
23152157|NCT01968070|64309181|FG011|Period 2|Withdrawal by Subject|0|||
23152158|NCT01968070|64309182|FG012|Period 2|Withdrawal by Subject|0|||
23152159|NCT01968070|64309183|FG013|Period 2|Withdrawal by Subject|0|||
23152160|NCT01968070|64309184|FG014|Period 2|Withdrawal by Subject|0|||
23152161|NCT01968070|64309185|FG015|Period 2|Withdrawal by Subject|0|||
23152162|NCT01968070|64309186|FG016|Period 2|Withdrawal by Subject|0|||
23152163|NCT01968070|64309187|FG017|Period 2|Withdrawal by Subject|0|||
23152164|NCT00387764|64309189|FG000|Overall Study|Adverse Event|12|||
23152165|NCT00387764|64309189|FG000|Overall Study|Withdrawal by Subject|8|||
23152166|NCT00387764|64309189|FG000|Overall Study|Sponsor Terminated Study|1|||
23152167|NCT00387764|64309189|FG000|Overall Study|Physician Decision|1|||
23152168|NCT00387764|64309189|FG000|Overall Study|Other|2|||
23152169|NCT00387764|64309189|FG000|Overall Study|Death|7|||
23152170|NCT00509067|64309190|FG000|Overall Study|Lost to Follow-up|1|||
23152171|NCT00509067|64309191|FG001|Overall Study|Lost to Follow-up|1|||
23625776|NCT01006616|66015607|FG000|Period 2 (18 Months)|Study Terminated|63|||
23625777|NCT01006616|66015608|FG001|Period 2 (18 Months)|Study Terminated|46|||
23625778|NCT01006616|66015609|FG002|Period 2 (18 Months)|Study Terminated|44|||
23625779|NCT01006616|66015610|FG003|Period 2 (18 Months)|Study Terminated|70|||
23625780|NCT00863798|66015611|FG000|Overall Study|Adverse Event|5|||
23625781|NCT00863798|66015612|FG001|Overall Study|Adverse Event|2|||
23625782|NCT00863798|66015613|FG002|Overall Study|Adverse Event|4|||
23625783|NCT00863798|66015611|FG000|Overall Study|Participant failed to return|2|||
23625784|NCT00863798|66015612|FG001|Overall Study|Participant failed to return|1|||
23625785|NCT00863798|66015613|FG002|Overall Study|Participant failed to return|0|||
23625786|NCT00863798|66015611|FG000|Overall Study|Investigator request|1|||
23625787|NCT00863798|66015612|FG001|Overall Study|Investigator request|2|||
23152172|NCT00509067|64309190|FG000|Overall Study|Adverse Event|3|||
23152173|NCT00509067|64309191|FG001|Overall Study|Adverse Event|1|||
23152174|NCT00509067|64309190|FG000|Overall Study|Protocol Violation|0|||
23152175|NCT00509067|64309191|FG001|Overall Study|Protocol Violation|3|||
23152176|NCT03492554|64309192|FG000|Overall Study|Protocol Violation|0|||
23325996|NCT02604407|64937828|FG001|Overall Study|Protocol Violation|0|||
23325997|NCT02604407|64937829|FG002|Overall Study|Protocol Violation|0|||
23325998|NCT02604407|64937827|FG000|Overall Study|Withdrawal by Subject|3|||
23325999|NCT02604407|64937828|FG001|Overall Study|Withdrawal by Subject|3|||
23326000|NCT02604407|64937829|FG002|Overall Study|Withdrawal by Subject|5|||
23326001|NCT02604407|64937827|FG000|Overall Study|Lost to Follow-up|2|||
23326002|NCT02604407|64937828|FG001|Overall Study|Lost to Follow-up|1|||
23326003|NCT02604407|64937829|FG002|Overall Study|Lost to Follow-up|2|||
23440692|NCT00348309|65355282|FG002|Overall Study|Withdrawal by Subject|40|||
23440693|NCT00348309|65355280|FG000|Overall Study|Non-compliance|8|||
23563463|NCT00792103|65790478|FG000|Overall Study|Protocol Violation|10|||
23563464|NCT00792103|65790478|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
23563465|NCT01933880|65790479|FG000|Overall Study|Withdrawal by Subject|5|||
23563466|NCT01933880|65790480|FG001|Overall Study|Withdrawal by Subject|0|||
23563467|NCT01933880|65790479|FG000|Overall Study|Lack of Efficacy|1|||
23563468|NCT01933880|65790480|FG001|Overall Study|Lack of Efficacy|0|||
23563469|NCT01933880|65790479|FG000|Overall Study|Concomitant medication Interference|0|||
23563470|NCT01933880|65790480|FG001|Overall Study|Concomitant medication Interference|1|||
23563471|NCT01933880|65790479|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
23563472|NCT01933880|65790480|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
23563473|NCT01933880|65790479|FG000|Overall Study|Other|4|||
23563474|NCT01933880|65790480|FG001|Overall Study|Other|0|||
23563475|NCT01933880|65790479|FG000|Overall Study|Protocol Violation|1|||
23563476|NCT01933880|65790480|FG001|Overall Study|Protocol Violation|0|||
23563477|NCT02923739|65790482|FG000|Overall Study|Withdrawal by Subject|2|||
23563478|NCT02923739|65790483|FG001|Overall Study|Withdrawal by Subject|0|||
23563479|NCT02923739|65790484|FG002|Overall Study|Withdrawal by Subject|0|||
23563480|NCT02923739|65790485|FG003|Overall Study|Withdrawal by Subject|0|||
23563481|NCT02923739|65790482|FG000|Overall Study|Failed Screening|3|||
23563482|NCT02923739|65790483|FG001|Overall Study|Failed Screening|0|||
23563483|NCT02923739|65790484|FG002|Overall Study|Failed Screening|0|||
23563484|NCT02923739|65790485|FG003|Overall Study|Failed Screening|0|||
23563485|NCT01529008|65790486|FG000|Bone Marrow Harvesting|Physician Decision|1|||
23563486|NCT01529008|65790487|FG001|Bone Marrow Harvesting|Physician Decision|1|||
23563487|NCT01529008|65790486|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
23563488|NCT01529008|65790487|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
23563489|NCT01529008|65790486|FG000|Treatment|Adverse Event|6|||
23563490|NCT01529008|65790487|FG001|Treatment|Adverse Event|0|||
23563491|NCT01529008|65790486|FG000|Treatment|Other|3|||
23563492|NCT01529008|65790487|FG001|Treatment|Other|1|||
23563493|NCT01529008|65790486|FG000|Efficacy Analysis|Protocol Violation|2|||
23563494|NCT01529008|65790487|FG001|Efficacy Analysis|Protocol Violation|0|||
23563495|NCT01529008|65790486|FG000|Efficacy Analysis|Physician Decision|0|||
23563496|NCT01529008|65790487|FG001|Efficacy Analysis|Physician Decision|1|||
23563497|NCT01529008|65790486|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
23563498|NCT01529008|65790487|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
23625788|NCT00863798|66015613|FG002|Overall Study|Investigator request|1|||
23625789|NCT00863798|66015611|FG000|Overall Study|Lack of Efficacy|4|||
23326004|NCT02604407|64937827|FG000|Overall Study|Lack of Efficacy|1|||
23326005|NCT02604407|64937828|FG001|Overall Study|Lack of Efficacy|0|||
23563499|NCT00603265|65790494|FG000|Overall Study|Adverse Event|2|||
23152177|NCT03492554|64309193|FG001|Overall Study|Protocol Violation|14|||
23563500|NCT00603265|65790495|FG001|Overall Study|Adverse Event|11|||
23563501|NCT00603265|65790496|FG002|Overall Study|Adverse Event|1|||
23563502|NCT00603265|65790494|FG000|Overall Study|Withdrawal by Subject|1|||
23563503|NCT00603265|65790495|FG001|Overall Study|Withdrawal by Subject|2|||
23563504|NCT00603265|65790496|FG002|Overall Study|Withdrawal by Subject|1|||
23563505|NCT00603265|65790494|FG000|Overall Study|Lack of Efficacy|3|||
23563506|NCT00603265|65790495|FG001|Overall Study|Lack of Efficacy|0|||
23625790|NCT00863798|66015612|FG001|Overall Study|Lack of Efficacy|3|||
23625791|NCT00863798|66015613|FG002|Overall Study|Lack of Efficacy|6|||
23625792|NCT00863798|66015611|FG000|Overall Study|Lost to Follow-up|6|||
23625793|NCT00863798|66015612|FG001|Overall Study|Lost to Follow-up|9|||
23625794|NCT00863798|66015613|FG002|Overall Study|Lost to Follow-up|5|||
23625795|NCT00863798|66015611|FG000|Overall Study|Other|2|||
23625796|NCT00863798|66015612|FG001|Overall Study|Other|3|||
23625797|NCT00863798|66015613|FG002|Overall Study|Other|1|||
23625798|NCT00863798|66015611|FG000|Overall Study|Protocol Violation|0|||
23625799|NCT00863798|66015612|FG001|Overall Study|Protocol Violation|1|||
23625800|NCT00863798|66015613|FG002|Overall Study|Protocol Violation|1|||
23625801|NCT00863798|66015611|FG000|Overall Study|Withdrawal by Subject|8|||
23625802|NCT00863798|66015612|FG001|Overall Study|Withdrawal by Subject|7|||
23326006|NCT02604407|64937829|FG002|Overall Study|Lack of Efficacy|0|||
23326007|NCT02604407|64937827|FG000|Overall Study|Other|3|||
23326008|NCT02604407|64937828|FG001|Overall Study|Other|1|||
23326009|NCT02604407|64937829|FG002|Overall Study|Other|4|||
23326010|NCT04982575|64937830|FG000|Overall Study|Withdrawal by Subject|2|||
23326011|NCT04982575|64937831|FG001|Overall Study|Withdrawal by Subject|0|||
23326012|NCT04982575|64937832|FG002|Overall Study|Withdrawal by Subject|2|||
23326013|NCT01778855|64937835|FG000|Overall Study|Death|0|||
23326014|NCT01778855|64937836|FG001|Overall Study|Death|1|||
23326015|NCT00666328|64937839|FG000|Overall Study|Death|2|||
23326016|NCT00666328|64937839|FG000|Overall Study|Lost to Follow-up|2|||
23326017|NCT00666328|64937839|FG000|Overall Study|No longer met eligibility criteria|1|||
23326018|NCT00942357|64937845|FG000|Overall Study|Ineligible|37|||
23326019|NCT00942357|64937846|FG001|Overall Study|Ineligible|40|||
23326020|NCT01791894|64937850|FG000|Overall Study|Adverse Event|1|||
23326021|NCT02291237|64937858|FG000|Overall Study|Study Terminated by Sponsor|72|||
23326022|NCT02291237|64937859|FG001|Overall Study|Study Terminated by Sponsor|67|||
23326023|NCT02291237|64937858|FG000|Overall Study|Adverse Event|1|||
23326024|NCT02291237|64937859|FG001|Overall Study|Adverse Event|3|||
23326025|NCT02291237|64937858|FG000|Overall Study|Investigator's Discretion|0|||
23326026|NCT02291237|64937859|FG001|Overall Study|Investigator's Discretion|3|||
23326027|NCT02291237|64937858|FG000|Overall Study|Withdrew Consent|11|||
23326028|NCT02291237|64937859|FG001|Overall Study|Withdrew Consent|11|||
23326029|NCT02291237|64937858|FG000|Overall Study|Lost to Follow-up|0|||
23625803|NCT00863798|66015613|FG002|Overall Study|Withdrawal by Subject|4|||
23625804|NCT00863798|66015611|FG000|Overall Study|Randomized not treated|4|||
23625805|NCT00863798|66015612|FG001|Overall Study|Randomized not treated|2|||
23625806|NCT00863798|66015613|FG002|Overall Study|Randomized not treated|3|||
23625807|NCT00443898|66015617|FG000|Overall Study|Adverse Event|0|||
23625808|NCT00443898|66015618|FG001|Overall Study|Adverse Event|0|||
23625809|NCT00443898|66015619|FG002|Overall Study|Adverse Event|1|||
23625810|NCT00443898|66015620|FG003|Overall Study|Adverse Event|1|||
23625811|NCT00443898|66015617|FG000|Overall Study|Lack of Efficacy|2|||
23625812|NCT00443898|66015618|FG001|Overall Study|Lack of Efficacy|3|||
23625813|NCT00443898|66015619|FG002|Overall Study|Lack of Efficacy|3|||
23625814|NCT00443898|66015620|FG003|Overall Study|Lack of Efficacy|1|||
23625815|NCT00443898|66015617|FG000|Overall Study|Protocol Violation|1|||
23625816|NCT00443898|66015618|FG001|Overall Study|Protocol Violation|1|||
23152178|NCT03715153|64309194|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
23152179|NCT03715153|64309195|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
23152180|NCT03715153|64309194|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
23152181|NCT03715153|64309195|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
23152182|NCT03715153|64309194|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
23152183|NCT03715153|64309195|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
23625817|NCT00443898|66015619|FG002|Overall Study|Protocol Violation|1|||
23625818|NCT00443898|66015620|FG003|Overall Study|Protocol Violation|0|||
23625819|NCT00443898|66015617|FG000|Overall Study|Withdrawal by Subject|11|||
23625820|NCT00443898|66015618|FG001|Overall Study|Withdrawal by Subject|10|||
23625821|NCT00443898|66015619|FG002|Overall Study|Withdrawal by Subject|10|||
23625822|NCT00443898|66015620|FG003|Overall Study|Withdrawal by Subject|6|||
23625823|NCT00443898|66015617|FG000|Overall Study|Lost to Follow-up|10|||
23152184|NCT03715153|64309194|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
23326030|NCT02291237|64937859|FG001|Overall Study|Lost to Follow-up|2|||
23326031|NCT02291237|64937858|FG000|Overall Study|Subject Required Prohibited Medication|2|||
23326032|NCT02291237|64937859|FG001|Overall Study|Subject Required Prohibited Medication|0|||
23326033|NCT01942993|64937860|FG000|Overall Study|Lost to Follow-up|1|||
23326034|NCT01942993|64937860|FG000|Overall Study|Physician Decision|1|||
23326035|NCT03408639|64937864|FG000|Overall Study|Death|5|||
23326036|NCT03408639|64937865|FG001|Overall Study|Death|5|||
23326037|NCT03408639|64937864|FG000|Overall Study|Lost to Follow-up|1|||
23625824|NCT00443898|66015618|FG001|Overall Study|Lost to Follow-up|10|||
23625825|NCT00443898|66015619|FG002|Overall Study|Lost to Follow-up|14|||
23625826|NCT00443898|66015620|FG003|Overall Study|Lost to Follow-up|10|||
23625827|NCT00443898|66015617|FG000|Overall Study|Death|0|||
23625828|NCT00443898|66015618|FG001|Overall Study|Death|1|||
23625829|NCT00443898|66015619|FG002|Overall Study|Death|0|||
23625830|NCT00443898|66015620|FG003|Overall Study|Death|0|||
23625831|NCT00394589|66015621|FG000|Overall Study|Adverse Event|2|||
23563507|NCT00603265|65790496|FG002|Overall Study|Lack of Efficacy|3|||
23563508|NCT00603265|65790494|FG000|Overall Study|Lost to Follow-up|0|||
23563509|NCT00603265|65790495|FG001|Overall Study|Lost to Follow-up|1|||
23563510|NCT00603265|65790496|FG002|Overall Study|Lost to Follow-up|0|||
23563511|NCT00603265|65790494|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
23563512|NCT00603265|65790495|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
23563513|NCT00603265|65790496|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
23563514|NCT00603265|65790494|FG000|Overall Study|Participant Left Country, No Responses|0|||
23563515|NCT00603265|65790495|FG001|Overall Study|Participant Left Country, No Responses|1|||
23563516|NCT00603265|65790496|FG002|Overall Study|Participant Left Country, No Responses|0|||
23563517|NCT00603265|65790494|FG000|Overall Study|Protocol Violation|1|||
23563518|NCT00603265|65790495|FG001|Overall Study|Protocol Violation|0|||
23563519|NCT00603265|65790496|FG002|Overall Study|Protocol Violation|0|||
23563520|NCT04860518|65790497|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
23563521|NCT04860518|65790498|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
23563522|NCT00462670|65790499|FG000|Overall Study|Adverse Event|3|||
23563523|NCT00462670|65790500|FG001|Overall Study|Adverse Event|5|||
23563524|NCT00462670|65790499|FG000|Overall Study|Lack of Efficacy|1|||
23152185|NCT03715153|64309195|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
23152186|NCT03715153|64309194|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
23563525|NCT00462670|65790500|FG001|Overall Study|Lack of Efficacy|0|||
23563526|NCT00462670|65790499|FG000|Overall Study|Protocol Violation|1|||
23563527|NCT00462670|65790500|FG001|Overall Study|Protocol Violation|0|||
23563528|NCT00462670|65790499|FG000|Overall Study|Resolution of signs and symptoms|0|||
23563529|NCT00462670|65790500|FG001|Overall Study|Resolution of signs and symptoms|2|||
23563530|NCT01364597|65790501|FG000|Overall Study|Adverse Event|4|||
23563531|NCT01364597|65790502|FG001|Overall Study|Adverse Event|5|||
23563532|NCT01364597|65790503|FG002|Overall Study|Adverse Event|16|||
23563533|NCT01364597|65790504|FG003|Overall Study|Adverse Event|7|||
23563534|NCT01364597|65790501|FG000|Overall Study|Lack of Efficacy|4|||
23563535|NCT01364597|65790502|FG001|Overall Study|Lack of Efficacy|4|||
23152187|NCT03715153|64309195|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
23152188|NCT03715153|64309194|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
23152189|NCT03715153|64309195|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
23563536|NCT01364597|65790503|FG002|Overall Study|Lack of Efficacy|23|||
23563537|NCT01364597|65790504|FG003|Overall Study|Lack of Efficacy|8|||
23563538|NCT01364597|65790501|FG000|Overall Study|Protocol Violation|0|||
23152190|NCT02877927|64309196|FG000|Overall Study|Adverse Event|1|||
23152191|NCT02877927|64309197|FG001|Overall Study|Adverse Event|0|||
23152192|NCT02877927|64309196|FG000|Overall Study|Lost to Follow-up|37|||
23152193|NCT02877927|64309197|FG001|Overall Study|Lost to Follow-up|38|||
23152194|NCT02877927|64309196|FG000|Overall Study|Withdrawal by Subject|11|||
23152195|NCT02877927|64309197|FG001|Overall Study|Withdrawal by Subject|12|||
23152196|NCT02877927|64309196|FG000|Overall Study|Physician Decision|0|||
23152197|NCT02877927|64309197|FG001|Overall Study|Physician Decision|1|||
23152198|NCT02877927|64309196|FG000|Overall Study|Missed EOT/PTE Visit|5|||
23152199|NCT02877927|64309197|FG001|Overall Study|Missed EOT/PTE Visit|6|||
23152200|NCT02409290|64309200|FG000|Overall Study|Protocol Violation|3|||
23152201|NCT02409290|64309201|FG001|Overall Study|Protocol Violation|6|||
23152202|NCT02409290|64309202|FG002|Overall Study|Protocol Violation|9|||
23152203|NCT02409290|64309203|FG003|Overall Study|Protocol Violation|4|||
23152204|NCT02409290|64309200|FG000|Overall Study|No positive culture/no baseline sample|3|||
23152205|NCT02409290|64309201|FG001|Overall Study|No positive culture/no baseline sample|9|||
23152206|NCT02409290|64309202|FG002|Overall Study|No positive culture/no baseline sample|6|||
23152207|NCT02409290|64309203|FG003|Overall Study|No positive culture/no baseline sample|5|||
23152208|NCT02409290|64309200|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
23152209|NCT02409290|64309201|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
23152210|NCT02409290|64309202|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
23152211|NCT02409290|64309203|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
23152212|NCT00146757|64309204|FG000|Overall Study|Death|1|||
23152213|NCT00146757|64309205|FG001|Overall Study|Death|0|||
23563539|NCT01364597|65790502|FG001|Overall Study|Protocol Violation|0|||
23563540|NCT01364597|65790503|FG002|Overall Study|Protocol Violation|2|||
23563541|NCT01364597|65790504|FG003|Overall Study|Protocol Violation|0|||
23563542|NCT01364597|65790501|FG000|Overall Study|Lost to Follow-up|0|||
23563543|NCT01364597|65790502|FG001|Overall Study|Lost to Follow-up|0|||
23563544|NCT01364597|65790503|FG002|Overall Study|Lost to Follow-up|5|||
23563545|NCT01364597|65790504|FG003|Overall Study|Lost to Follow-up|3|||
23563546|NCT01364597|65790501|FG000|Overall Study|Withdrawal by Subject|4|||
23563547|NCT01364597|65790502|FG001|Overall Study|Withdrawal by Subject|1|||
23152214|NCT00146757|64309204|FG000|Overall Study|Adverse Event|1|||
23152215|NCT00146757|64309205|FG001|Overall Study|Adverse Event|0|||
23152216|NCT00216203|64309206|FG000|Overall Study|Withdrawal by Subject|2|||
23152217|NCT02673619|64309211|FG000|Overall Study|Lost to Follow-up|1|||
23152218|NCT02673619|64309212|FG001|Overall Study|Lost to Follow-up|0|||
23152219|NCT02673619|64309213|FG002|Overall Study|Lost to Follow-up|0|||
23563548|NCT01364597|65790503|FG002|Overall Study|Withdrawal by Subject|18|||
23563549|NCT01364597|65790504|FG003|Overall Study|Withdrawal by Subject|6|||
23563550|NCT01364597|65790501|FG000|Overall Study|Non compliance|1|||
23563551|NCT01364597|65790502|FG001|Overall Study|Non compliance|0|||
23563552|NCT01364597|65790503|FG002|Overall Study|Non compliance|1|||
23563553|NCT01364597|65790504|FG003|Overall Study|Non compliance|0|||
23563554|NCT01364597|65790501|FG000|Overall Study|Lack of compliance|1|||
23563555|NCT01364597|65790502|FG001|Overall Study|Lack of compliance|0|||
23563556|NCT01364597|65790503|FG002|Overall Study|Lack of compliance|0|||
23563557|NCT01364597|65790504|FG003|Overall Study|Lack of compliance|0|||
23563558|NCT01364597|65790501|FG000|Overall Study|End of treatment epilepsy|1|||
23563559|NCT01364597|65790502|FG001|Overall Study|End of treatment epilepsy|0|||
23563560|NCT01364597|65790503|FG002|Overall Study|End of treatment epilepsy|0|||
23563561|NCT01364597|65790504|FG003|Overall Study|End of treatment epilepsy|0|||
23563562|NCT01364597|65790501|FG000|Overall Study|No Seizures|1|||
23563563|NCT01364597|65790502|FG001|Overall Study|No Seizures|0|||
23152220|NCT02673619|64309214|FG003|Overall Study|Lost to Follow-up|0|||
23152221|NCT02673619|64309211|FG000|Overall Study|Withdrawal by Subject|1|||
23152222|NCT02673619|64309212|FG001|Overall Study|Withdrawal by Subject|1|||
23152223|NCT02673619|64309213|FG002|Overall Study|Withdrawal by Subject|1|||
23152224|NCT02673619|64309214|FG003|Overall Study|Withdrawal by Subject|0|||
23152225|NCT02673619|64309211|FG000|Overall Study|Adverse Event|0|||
23152226|NCT02673619|64309212|FG001|Overall Study|Adverse Event|0|||
23152227|NCT02673619|64309213|FG002|Overall Study|Adverse Event|1|||
23152228|NCT02673619|64309214|FG003|Overall Study|Adverse Event|0|||
23152229|NCT02673619|64309211|FG000|Overall Study|Lack of Efficacy|0|||
23152230|NCT02673619|64309212|FG001|Overall Study|Lack of Efficacy|0|||
23152231|NCT02673619|64309213|FG002|Overall Study|Lack of Efficacy|1|||
23563564|NCT01364597|65790503|FG002|Overall Study|No Seizures|0|||
23563565|NCT01364597|65790504|FG003|Overall Study|No Seizures|0|||
23563566|NCT01364597|65790501|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
23563567|NCT01364597|65790502|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
23563568|NCT01364597|65790503|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
23563569|NCT01364597|65790504|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
23563570|NCT01364597|65790501|FG000|Overall Study|Cure|1|||
23563571|NCT01364597|65790502|FG001|Overall Study|Cure|0|||
23563572|NCT01364597|65790503|FG002|Overall Study|Cure|0|||
23563573|NCT01364597|65790504|FG003|Overall Study|Cure|0|||
23563574|NCT01364597|65790501|FG000|Overall Study|Patient was moving|0|||
23563575|NCT01364597|65790502|FG001|Overall Study|Patient was moving|1|||
23563576|NCT01364597|65790503|FG002|Overall Study|Patient was moving|0|||
23563577|NCT01364597|65790504|FG003|Overall Study|Patient was moving|0|||
23563578|NCT01364597|65790501|FG000|Overall Study|Seizures resolved|0|||
23563579|NCT01364597|65790502|FG001|Overall Study|Seizures resolved|0|||
23563580|NCT01364597|65790503|FG002|Overall Study|Seizures resolved|1|||
23563581|NCT01364597|65790504|FG003|Overall Study|Seizures resolved|0|||
23563582|NCT01364597|65790501|FG000|Overall Study|Patient became seizure-free after surgery|0|||
23563583|NCT01364597|65790502|FG001|Overall Study|Patient became seizure-free after surgery|0|||
23563584|NCT01364597|65790503|FG002|Overall Study|Patient became seizure-free after surgery|1|||
23563585|NCT01364597|65790504|FG003|Overall Study|Patient became seizure-free after surgery|0|||
23563586|NCT01364597|65790501|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
23563587|NCT01364597|65790502|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
23563588|NCT01364597|65790503|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
23563589|NCT01364597|65790504|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
23563590|NCT01364597|65790501|FG000|Overall Study|Patient cured from Epilepsy|0|||
23563591|NCT01364597|65790502|FG001|Overall Study|Patient cured from Epilepsy|0|||
23563592|NCT01364597|65790503|FG002|Overall Study|Patient cured from Epilepsy|1|||
23563593|NCT01364597|65790504|FG003|Overall Study|Patient cured from Epilepsy|0|||
23563594|NCT01364597|65790501|FG000|Overall Study|Investigator decision|0|||
23563595|NCT01364597|65790502|FG001|Overall Study|Investigator decision|0|||
23563596|NCT01364597|65790503|FG002|Overall Study|Investigator decision|1|||
23152232|NCT02673619|64309214|FG003|Overall Study|Lack of Efficacy|0|||
23563597|NCT01364597|65790504|FG003|Overall Study|Investigator decision|0|||
23563598|NCT01364597|65790501|FG000|Overall Study|Sponsor recommended discontinuation|0|||
23563599|NCT01364597|65790502|FG001|Overall Study|Sponsor recommended discontinuation|0|||
23563600|NCT01364597|65790503|FG002|Overall Study|Sponsor recommended discontinuation|0|||
23563601|NCT01364597|65790504|FG003|Overall Study|Sponsor recommended discontinuation|1|||
23563602|NCT01364597|65790501|FG000|Overall Study|Parents went abroad with the patient|0|||
23152233|NCT00355056|64309215|FG000|Randomization Period|Early Termination|4|||
23152234|NCT00355056|64309216|FG001|Randomization Period|Early Termination|6|||
23152235|NCT00932425|64309219|FG000|Overall Study|Lost to Follow-up|0|||
23563603|NCT01364597|65790502|FG001|Overall Study|Parents went abroad with the patient|0|||
23563604|NCT01364597|65790503|FG002|Overall Study|Parents went abroad with the patient|1|||
23152236|NCT00932425|64309220|FG001|Overall Study|Lost to Follow-up|1|||
23563605|NCT01364597|65790504|FG003|Overall Study|Parents went abroad with the patient|0|||
23563606|NCT01364597|65790501|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
23563607|NCT01364597|65790502|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
23563608|NCT01364597|65790503|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
23563609|NCT01364597|65790504|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
23563610|NCT01364597|65790501|FG000|Overall Study|BRV administration dropout|0|||
23563611|NCT01364597|65790502|FG001|Overall Study|BRV administration dropout|0|||
23563612|NCT01364597|65790503|FG002|Overall Study|BRV administration dropout|1|||
23563613|NCT01364597|65790504|FG003|Overall Study|BRV administration dropout|0|||
23563614|NCT01364597|65790501|FG000|Overall Study|Dropout|0|||
23563615|NCT01364597|65790502|FG001|Overall Study|Dropout|0|||
23563616|NCT01364597|65790503|FG002|Overall Study|Dropout|3|||
23563617|NCT01364597|65790504|FG003|Overall Study|Dropout|1|||
23563618|NCT01364597|65790501|FG000|Overall Study|Unreliable subject|0|||
23563619|NCT01364597|65790502|FG001|Overall Study|Unreliable subject|0|||
23563620|NCT01364597|65790503|FG002|Overall Study|Unreliable subject|0|||
23563621|NCT01364597|65790504|FG003|Overall Study|Unreliable subject|1|||
23563622|NCT01364597|65790501|FG000|Overall Study|Other|0|||
23563623|NCT01364597|65790502|FG001|Overall Study|Other|0|||
23563624|NCT01364597|65790503|FG002|Overall Study|Other|0|||
23152237|NCT00932425|64309219|FG000|Overall Study|Withdrawal by Subject|0|||
23152238|NCT00932425|64309220|FG001|Overall Study|Withdrawal by Subject|1|||
23152239|NCT01098812|64309221|FG000|Overall Study|Death|2|||
23152240|NCT01098812|64309222|FG001|Overall Study|Death|0|||
23152241|NCT01098812|64309223|FG002|Overall Study|Death|1|||
23152242|NCT01098812|64309221|FG000|Overall Study|Lost to Follow-up|0|||
23152243|NCT01098812|64309222|FG001|Overall Study|Lost to Follow-up|1|||
23152244|NCT01098812|64309223|FG002|Overall Study|Lost to Follow-up|0|||
23152245|NCT00633061|64309226|FG000|Overall Study|Study closed|86|||
23152246|NCT00633061|64309227|FG001|Overall Study|Study closed|0|||
23152247|NCT02060383|64309228|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
23152248|NCT02060383|64309229|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
23152249|NCT02060383|64309230|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
23152250|NCT02060383|64309231|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
23152251|NCT02060383|64309232|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
23152252|NCT02060383|64309228|FG000|Core Phase|Adverse Event|2|||
23152253|NCT02060383|64309229|FG001|Core Phase|Adverse Event|0|||
23152254|NCT02060383|64309230|FG002|Core Phase|Adverse Event|0|||
23152255|NCT02060383|64309231|FG003|Core Phase|Adverse Event|2|||
23152256|NCT02060383|64309232|FG004|Core Phase|Adverse Event|6|||
23152257|NCT02060383|64309228|FG000|Core Phase|Administrative problems|0|||
23152258|NCT02060383|64309229|FG001|Core Phase|Administrative problems|1|||
23152259|NCT02060383|64309230|FG002|Core Phase|Administrative problems|0|||
23152260|NCT02060383|64309231|FG003|Core Phase|Administrative problems|0|||
23152261|NCT02060383|64309232|FG004|Core Phase|Administrative problems|0|||
23152262|NCT02060383|64309228|FG000|Core Phase|Protocol Violation|0|||
23152263|NCT02060383|64309229|FG001|Core Phase|Protocol Violation|0|||
23152264|NCT02060383|64309230|FG002|Core Phase|Protocol Violation|0|||
23152265|NCT02060383|64309231|FG003|Core Phase|Protocol Violation|1|||
23152266|NCT02060383|64309232|FG004|Core Phase|Protocol Violation|0|||
23152267|NCT02060383|64309228|FG000|Core Phase|Withdrawal by Subject|0|||
23563625|NCT01364597|65790504|FG003|Overall Study|Other|1|||
23563626|NCT00067990|65790505|FG000|Overall Study|Death|5|||
23152268|NCT02060383|64309229|FG001|Core Phase|Withdrawal by Subject|0|||
23152269|NCT02060383|64309230|FG002|Core Phase|Withdrawal by Subject|0|||
23152270|NCT02060383|64309231|FG003|Core Phase|Withdrawal by Subject|4|||
23152271|NCT02060383|64309232|FG004|Core Phase|Withdrawal by Subject|2|||
23152272|NCT02060383|64309228|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
23152273|NCT02060383|64309229|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
23152274|NCT02060383|64309230|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
23152275|NCT02060383|64309231|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
23152276|NCT02060383|64309232|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
23152277|NCT02060383|64309228|FG000|Extension Phase|Adverse Event|1|||
23152278|NCT02060383|64309229|FG001|Extension Phase|Adverse Event|1|||
23152279|NCT02060383|64309230|FG002|Extension Phase|Adverse Event|2|||
23563627|NCT00067990|65790506|FG001|Overall Study|Death|7|||
23563628|NCT00067990|65790505|FG000|Overall Study|ESRD, Non IF/TA|1|||
23563629|NCT00067990|65790506|FG001|Overall Study|ESRD, Non IF/TA|3|||
23563630|NCT00067990|65790505|FG000|Overall Study|Withdrawal by Subject|4|||
23563631|NCT00067990|65790506|FG001|Overall Study|Withdrawal by Subject|12|||
23563632|NCT03035032|65790512|FG000|Overall Study|Adverse Event|2|||
23563633|NCT03035032|65790512|FG000|Overall Study|Death|9|||
23563634|NCT03035032|65790512|FG000|Overall Study|Lost to Follow-up|1|||
23152280|NCT02060383|64309231|FG003|Extension Phase|Adverse Event|0|||
23152281|NCT02060383|64309232|FG004|Extension Phase|Adverse Event|1|||
23152282|NCT02060383|64309228|FG000|Extension Phase|Withdrawal by Subject|0|||
23563635|NCT03035032|65790512|FG000|Overall Study|Progressive Disease|22|||
23152283|NCT02060383|64309229|FG001|Extension Phase|Withdrawal by Subject|1|||
23625832|NCT00394589|66015622|FG001|Overall Study|Adverse Event|1|||
23625833|NCT00394589|66015623|FG002|Overall Study|Adverse Event|2|||
23625834|NCT00394589|66015621|FG000|Overall Study|Lack of Efficacy|2|||
23625835|NCT00394589|66015622|FG001|Overall Study|Lack of Efficacy|2|||
23625836|NCT00394589|66015623|FG002|Overall Study|Lack of Efficacy|3|||
23625837|NCT00394589|66015621|FG000|Overall Study|Protocol Violation|4|||
23625838|NCT00394589|66015622|FG001|Overall Study|Protocol Violation|0|||
23625839|NCT00394589|66015623|FG002|Overall Study|Protocol Violation|2|||
23625840|NCT03409731|66015628|FG000|Overall Study|Withdrawal by Subject|17|||
23625841|NCT03409731|66015628|FG000|Overall Study|Death|4|||
23625842|NCT01407276|66015631|FG000|Overall Study|Withdrawal by Subject|0|||
23625843|NCT01407276|66015632|FG001|Overall Study|Withdrawal by Subject|0|||
23625844|NCT01407276|66015633|FG002|Overall Study|Withdrawal by Subject|0|||
23625845|NCT01407276|66015634|FG003|Overall Study|Withdrawal by Subject|0|||
23625846|NCT01407276|66015635|FG004|Overall Study|Withdrawal by Subject|0|||
23625847|NCT01407276|66015636|FG005|Overall Study|Withdrawal by Subject|0|||
23625848|NCT01407276|66015637|FG006|Overall Study|Withdrawal by Subject|0|||
23220226|NCT01680991|64550111|FG000|Overall Study|Physician Decision|0|||
23220227|NCT01680991|64550112|FG001|Overall Study|Physician Decision|7|||
23220228|NCT01680991|64550113|FG002|Overall Study|Physician Decision|2|||
23220229|NCT01680991|64550111|FG000|Overall Study|Bad physical condition|0|||
23220230|NCT01680991|64550112|FG001|Overall Study|Bad physical condition|0|||
23220231|NCT01680991|64550113|FG002|Overall Study|Bad physical condition|1|||
23220232|NCT01680991|64550111|FG000|Overall Study|PD confirmed in other hospital|1|||
23220233|NCT01680991|64550112|FG001|Overall Study|PD confirmed in other hospital|0|||
23220234|NCT01680991|64550113|FG002|Overall Study|PD confirmed in other hospital|0|||
23220235|NCT00294684|64550114|FG000|Overall Study|Lost to Follow-up|5|||
23220236|NCT00294684|64550115|FG001|Overall Study|Lost to Follow-up|8|||
23220237|NCT00588523|64550116|FG000|Overall Study|Not treated|3|||
23220238|NCT00003838|64550117|FG000|Overall Study|Death|0|||
23220239|NCT00003838|64550118|FG001|Overall Study|Death|12|||
23220240|NCT00003838|64550119|FG002|Overall Study|Death|7|||
23220241|NCT00003838|64550117|FG000|Overall Study|Lost to Follow-up|0|||
23220242|NCT00003838|64550118|FG001|Overall Study|Lost to Follow-up|1|||
23326038|NCT03408639|64937865|FG001|Overall Study|Lost to Follow-up|4|||
23326039|NCT03408639|64937864|FG000|Overall Study|Withdrawal by Subject|2|||
23326040|NCT03408639|64937865|FG001|Overall Study|Withdrawal by Subject|7|||
23326041|NCT03408639|64937864|FG000|Overall Study|Physician Decision|3|||
23326042|NCT03408639|64937865|FG001|Overall Study|Physician Decision|6|||
23326043|NCT02462603|64937866|FG000|Overall Study|Investigator Decision|1|||
23326044|NCT02462603|64937866|FG000|Overall Study|Non-Compliance|1|||
23625849|NCT01407276|66015638|FG007|Overall Study|Withdrawal by Subject|1|||
23625850|NCT01689363|66015639|FG000|Overall Study|Protocol Violation|0|||
23625851|NCT01689363|66015640|FG001|Overall Study|Protocol Violation|1|||
23152284|NCT02060383|64309230|FG002|Extension Phase|Withdrawal by Subject|0|||
23152285|NCT02060383|64309231|FG003|Extension Phase|Withdrawal by Subject|0|||
23152286|NCT02060383|64309232|FG004|Extension Phase|Withdrawal by Subject|2|||
23152287|NCT02060383|64309228|FG000|Extension Phase|Administrative problems|1|||
23152288|NCT02060383|64309229|FG001|Extension Phase|Administrative problems|0|||
23152289|NCT02060383|64309230|FG002|Extension Phase|Administrative problems|0|||
23152290|NCT02060383|64309231|FG003|Extension Phase|Administrative problems|0|||
23152291|NCT02060383|64309232|FG004|Extension Phase|Administrative problems|0|||
23152292|NCT02060383|64309228|FG000|Extension Phase|Death|0|||
23152293|NCT02060383|64309229|FG001|Extension Phase|Death|0|||
23152294|NCT02060383|64309230|FG002|Extension Phase|Death|1|||
23152295|NCT02060383|64309231|FG003|Extension Phase|Death|0|||
23152296|NCT02060383|64309232|FG004|Extension Phase|Death|1|||
23152297|NCT02060383|64309228|FG000|Extension Phase|Protocol Violation|0|||
23152298|NCT02060383|64309229|FG001|Extension Phase|Protocol Violation|0|||
23152299|NCT02060383|64309230|FG002|Extension Phase|Protocol Violation|0|||
23152300|NCT02060383|64309231|FG003|Extension Phase|Protocol Violation|0|||
23152301|NCT02060383|64309232|FG004|Extension Phase|Protocol Violation|1|||
23152302|NCT01770912|64309233|FG000|Overall Study|Lost to Follow-up|2|||
23220243|NCT00003838|64550119|FG002|Overall Study|Lost to Follow-up|1|||
23152303|NCT01770912|64309234|FG001|Overall Study|Lost to Follow-up|0|||
23152304|NCT01717768|64309236|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23152305|NCT01717768|64309237|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
23152306|NCT01717768|64309238|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23220244|NCT00003838|64550117|FG000|Overall Study|Disease Progression|0|||
23220245|NCT00003838|64550118|FG001|Overall Study|Disease Progression|12|||
23220246|NCT00003838|64550119|FG002|Overall Study|Disease Progression|0|||
23220247|NCT04599972|64550124|FG000|Overall Study|Withdrawal by Subject|6|||
23326045|NCT02462603|64937866|FG000|Overall Study|Withdrawal by Subject|2|||
23326046|NCT00075816|64937867|FG000|Overall Study|Did not undergo transplantation|14|||
23326047|NCT00075816|64937868|FG001|Overall Study|Did not undergo transplantation|11|||
23625852|NCT01689363|66015641|FG002|Overall Study|Protocol Violation|0|||
23625853|NCT01689363|66015642|FG003|Overall Study|Protocol Violation|0|||
23625854|NCT01689363|66015643|FG004|Overall Study|Protocol Violation|0|||
23440694|NCT00348309|65355281|FG001|Overall Study|Non-compliance|6|||
23440695|NCT00348309|65355282|FG002|Overall Study|Non-compliance|8|||
23440696|NCT00348309|65355280|FG000|Overall Study|Death of caregiver|1|||
23440697|NCT00348309|65355281|FG001|Overall Study|Death of caregiver|0|||
23440698|NCT00348309|65355282|FG002|Overall Study|Death of caregiver|1|||
23440699|NCT00348309|65355280|FG000|Overall Study|Lack of insight, dementia|1|||
23563636|NCT03035032|65790512|FG000|Overall Study|Protocol Violation|2|||
23563637|NCT03035032|65790512|FG000|Overall Study|Withdrawal by Subject|2|||
23563638|NCT03035032|65790512|FG000|Overall Study|Physician Decision|5|||
23563639|NCT02322814|65790513|FG000|Overall Study|Death|7|||
23563640|NCT02322814|65790514|FG001|Overall Study|Death|29|||
23563641|NCT02322814|65790515|FG002|Overall Study|Death|32|||
23563642|NCT02322814|65790516|FG003|Overall Study|Death|23|||
23563643|NCT02322814|65790517|FG004|Overall Study|Death|14|||
23152307|NCT01717768|64309239|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23152308|NCT01717768|64309240|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23440700|NCT00348309|65355281|FG001|Overall Study|Lack of insight, dementia|0|||
23440701|NCT00348309|65355282|FG002|Overall Study|Lack of insight, dementia|0|||
23440702|NCT00348309|65355280|FG000|Overall Study|Wrong bottle allocated|1|||
23440703|NCT00348309|65355281|FG001|Overall Study|Wrong bottle allocated|0|||
23440704|NCT00348309|65355282|FG002|Overall Study|Wrong bottle allocated|0|||
23440705|NCT00348309|65355280|FG000|Overall Study|Caregiver sick|1|||
23440706|NCT00348309|65355281|FG001|Overall Study|Caregiver sick|0|||
23440707|NCT00348309|65355282|FG002|Overall Study|Caregiver sick|0|||
23440708|NCT00348309|65355280|FG000|Overall Study|Use of prohibited medication|5|||
23440709|NCT00348309|65355281|FG001|Overall Study|Use of prohibited medication|2|||
23440710|NCT00348309|65355282|FG002|Overall Study|Use of prohibited medication|2|||
23440711|NCT00348309|65355280|FG000|Overall Study|Caregiver withdrawal|3|||
23440712|NCT00348309|65355281|FG001|Overall Study|Caregiver withdrawal|0|||
23440713|NCT00348309|65355282|FG002|Overall Study|Caregiver withdrawal|7|||
23440714|NCT00348309|65355280|FG000|Overall Study|Unable to complete ET visit|1|||
23440715|NCT00348309|65355281|FG001|Overall Study|Unable to complete ET visit|0|||
23440716|NCT00348309|65355282|FG002|Overall Study|Unable to complete ET visit|0|||
23440717|NCT00348309|65355280|FG000|Overall Study|PI closing medical practice|1|||
23440718|NCT00348309|65355281|FG001|Overall Study|PI closing medical practice|0|||
23440719|NCT00348309|65355282|FG002|Overall Study|PI closing medical practice|0|||
23440720|NCT00348309|65355280|FG000|Overall Study|Principal investigator's decision|1|||
23440721|NCT00348309|65355281|FG001|Overall Study|Principal investigator's decision|0|||
23440722|NCT00348309|65355282|FG002|Overall Study|Principal investigator's decision|0|||
23440723|NCT00348309|65355280|FG000|Overall Study|No disponibility of medication|1|||
23440724|NCT00348309|65355281|FG001|Overall Study|No disponibility of medication|0|||
23440725|NCT00348309|65355282|FG002|Overall Study|No disponibility of medication|0|||
23440726|NCT00348309|65355280|FG000|Overall Study|Worsened neurodegenerative disease|1|||
23440727|NCT00348309|65355281|FG001|Overall Study|Worsened neurodegenerative disease|0|||
23440728|NCT00348309|65355282|FG002|Overall Study|Worsened neurodegenerative disease|0|||
23440729|NCT00348309|65355280|FG000|Overall Study|Cognitive and behaviour worsening|2|||
23440730|NCT00348309|65355281|FG001|Overall Study|Cognitive and behaviour worsening|0|||
23440731|NCT00348309|65355282|FG002|Overall Study|Cognitive and behaviour worsening|0|||
23152309|NCT01717768|64309241|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23440732|NCT00348309|65355280|FG000|Overall Study|Worsening of alzheimer|1|||
23440733|NCT00348309|65355281|FG001|Overall Study|Worsening of alzheimer|0|||
23440734|NCT00348309|65355282|FG002|Overall Study|Worsening of alzheimer|1|||
23440735|NCT00348309|65355280|FG000|Overall Study|Did not appear in time for Visit 3|1|||
23440736|NCT00348309|65355281|FG001|Overall Study|Did not appear in time for Visit 3|0|||
23440737|NCT00348309|65355282|FG002|Overall Study|Did not appear in time for Visit 3|0|||
23152310|NCT01717768|64309242|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23152311|NCT01717768|64309243|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23152312|NCT01717768|64309244|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23152313|NCT01717768|64309245|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23152314|NCT01717768|64309246|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23152315|NCT01717768|64309247|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
23152316|NCT01717768|64309236|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23563644|NCT02322814|65790513|FG000|Overall Study|Lost to Follow-up|1|||
23563645|NCT02322814|65790514|FG001|Overall Study|Lost to Follow-up|3|||
23563646|NCT02322814|65790515|FG002|Overall Study|Lost to Follow-up|3|||
23152317|NCT01717768|64309237|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23152318|NCT01717768|64309238|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23152319|NCT01717768|64309239|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23440738|NCT00348309|65355280|FG000|Overall Study|Participant died|2|||
23440739|NCT00348309|65355281|FG001|Overall Study|Participant died|1|||
23440740|NCT00348309|65355282|FG002|Overall Study|Participant died|1|||
23440741|NCT00348309|65355280|FG000|Overall Study|Decision of sponsor|1|||
23440742|NCT00348309|65355281|FG001|Overall Study|Decision of sponsor|0|||
23563647|NCT02322814|65790516|FG003|Overall Study|Lost to Follow-up|1|||
23220248|NCT04599972|64550125|FG001|Overall Study|Withdrawal by Subject|1|||
23220249|NCT04599972|64550124|FG000|Overall Study|Adverse Event|1|||
23220250|NCT04599972|64550125|FG001|Overall Study|Adverse Event|1|||
23563648|NCT02322814|65790517|FG004|Overall Study|Lost to Follow-up|0|||
23152320|NCT01717768|64309240|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23152321|NCT01717768|64309241|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23152322|NCT01717768|64309242|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23152323|NCT01717768|64309243|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23152324|NCT01717768|64309244|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23152325|NCT01717768|64309245|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23152326|NCT01717768|64309246|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
23152327|NCT01717768|64309247|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
23152328|NCT01717768|64309236|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152329|NCT01717768|64309237|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152330|NCT01717768|64309238|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152331|NCT01717768|64309239|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152332|NCT01717768|64309240|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152333|NCT01717768|64309241|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152334|NCT01717768|64309242|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152335|NCT01717768|64309243|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
23152336|NCT01717768|64309244|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152337|NCT01717768|64309245|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152338|NCT01717768|64309246|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152339|NCT01717768|64309247|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
23152340|NCT01717768|64309236|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152341|NCT01717768|64309237|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152342|NCT01717768|64309238|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152343|NCT01717768|64309239|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152344|NCT01717768|64309240|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152345|NCT01717768|64309241|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152346|NCT01717768|64309242|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152347|NCT01717768|64309243|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152348|NCT01717768|64309244|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152349|NCT01717768|64309245|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
23152350|NCT01717768|64309246|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152351|NCT01717768|64309247|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
23152352|NCT01105091|64309249|FG000|Overall Study|Death|2|||
23152353|NCT01105091|64309250|FG001|Overall Study|Death|0|||
23152354|NCT04029961|64309251|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
23152355|NCT04029961|64309252|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
23152356|NCT04029961|64309251|FG000|Overall Study|Change in Treatment Course|0|||
23152357|NCT04029961|64309252|FG001|Overall Study|Change in Treatment Course|1|||
23152358|NCT01521897|64309253|FG000|Overall Study|Protocol Violation|18|||
23152359|NCT01521897|64309253|FG000|Overall Study|Lost to Follow-up|5|||
23152360|NCT01970488|64309254|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
23152361|NCT01970488|64309255|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
23152362|NCT01970488|64309256|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
23152363|NCT01970488|64309257|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
23152364|NCT01970488|64309258|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
23152365|NCT01970488|64309254|FG000|Part 1: Through Week 16|Protocol Violation|1|||
23152366|NCT01970488|64309255|FG001|Part 1: Through Week 16|Protocol Violation|2|||
23152367|NCT01970488|64309256|FG002|Part 1: Through Week 16|Protocol Violation|0|||
23152368|NCT01970488|64309257|FG003|Part 1: Through Week 16|Protocol Violation|0|||
23152369|NCT01970488|64309258|FG004|Part 1: Through Week 16|Protocol Violation|0|||
23152370|NCT01970488|64309254|FG000|Part 1: Through Week 16|Adverse Event|6|||
23220251|NCT04599972|64550124|FG000|Overall Study|Lost to Follow-up|1|||
23220252|NCT04599972|64550125|FG001|Overall Study|Lost to Follow-up|6|||
23563649|NCT02322814|65790513|FG000|Overall Study|Various Reasons|2|||
23563650|NCT02322814|65790514|FG001|Overall Study|Various Reasons|0|||
23563651|NCT02322814|65790515|FG002|Overall Study|Various Reasons|1|||
23563652|NCT02322814|65790516|FG003|Overall Study|Various Reasons|1|||
23152371|NCT01970488|64309255|FG001|Part 1: Through Week 16|Adverse Event|5|||
23220253|NCT04599972|64550124|FG000|Overall Study|Protocol Violation|1|||
23563653|NCT02322814|65790517|FG004|Overall Study|Various Reasons|0|||
23563654|NCT02322814|65790513|FG000|Overall Study|Progressive Disease|0|||
23563655|NCT02322814|65790514|FG001|Overall Study|Progressive Disease|0|||
23563656|NCT02322814|65790515|FG002|Overall Study|Progressive Disease|0|||
23326048|NCT01891864|64937871|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
23152372|NCT01970488|64309256|FG002|Part 1: Through Week 16|Adverse Event|0|||
23152373|NCT01970488|64309257|FG003|Part 1: Through Week 16|Adverse Event|0|||
23152374|NCT01970488|64309258|FG004|Part 1: Through Week 16|Adverse Event|0|||
23152375|NCT01970488|64309254|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
23152376|NCT01970488|64309255|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
23152377|NCT01970488|64309256|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
23152378|NCT01970488|64309257|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
23152379|NCT01970488|64309258|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
23152380|NCT01970488|64309254|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
23152381|NCT01970488|64309255|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
23152382|NCT01970488|64309256|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
23152383|NCT01970488|64309257|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
23152384|NCT01970488|64309258|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
23326049|NCT01891864|64937872|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
23440743|NCT00348309|65355282|FG002|Overall Study|Decision of sponsor|0|||
23440744|NCT00348309|65355280|FG000|Overall Study|Ineffectiveness of treatment|0|||
23440745|NCT00348309|65355281|FG001|Overall Study|Ineffectiveness of treatment|1|||
23152385|NCT01970488|64309254|FG000|Part 2: Post Week 16|Physician Decision|0|||
23326050|NCT01891864|64937873|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
23326051|NCT01891864|64937874|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
23326052|NCT01891864|64937875|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
23326053|NCT01891864|64937876|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
23326054|NCT01891864|64937871|FG000|Treatment Period 1|Physician Decision|0|||
23326055|NCT01891864|64937872|FG001|Treatment Period 1|Physician Decision|1|||
23326056|NCT01891864|64937873|FG002|Treatment Period 1|Physician Decision|0|||
23326057|NCT01891864|64937874|FG003|Treatment Period 1|Physician Decision|0|||
23326058|NCT01891864|64937875|FG004|Treatment Period 1|Physician Decision|0|||
23326059|NCT01891864|64937876|FG005|Treatment Period 1|Physician Decision|0|||
23326060|NCT01891864|64937871|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23326061|NCT01891864|64937872|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
23326062|NCT01891864|64937873|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23326063|NCT01891864|64937874|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23326064|NCT01891864|64937875|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23326065|NCT01891864|64937876|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
23326066|NCT01891864|64937871|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
23326067|NCT01891864|64937872|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
23326068|NCT01891864|64937873|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
23326069|NCT01891864|64937874|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
23326070|NCT01891864|64937875|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
23326071|NCT01891864|64937876|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
23326072|NCT01891864|64937871|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23326073|NCT01891864|64937872|FG001|Treatment Period 1|Withdrawal by Subject|5|||
23326074|NCT01891864|64937873|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23326075|NCT01891864|64937874|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23326076|NCT01891864|64937875|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23326077|NCT01891864|64937876|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23326078|NCT01891864|64937871|FG000|Treatment Period 1|Lost to Follow-up|1|||
23326079|NCT01891864|64937872|FG001|Treatment Period 1|Lost to Follow-up|0|||
23326080|NCT01891864|64937873|FG002|Treatment Period 1|Lost to Follow-up|0|||
23326081|NCT01891864|64937874|FG003|Treatment Period 1|Lost to Follow-up|0|||
23326082|NCT01891864|64937875|FG004|Treatment Period 1|Lost to Follow-up|0|||
23326083|NCT01891864|64937876|FG005|Treatment Period 1|Lost to Follow-up|0|||
23326084|NCT01891864|64937871|FG000|Treatment Period 2|Protocol Violation|0|||
23440746|NCT00348309|65355282|FG002|Overall Study|Ineffectiveness of treatment|0|||
23152386|NCT01970488|64309255|FG001|Part 2: Post Week 16|Physician Decision|0|||
23326085|NCT01891864|64937872|FG001|Treatment Period 2|Protocol Violation|0|||
23326086|NCT01891864|64937873|FG002|Treatment Period 2|Protocol Violation|0|||
23326087|NCT01891864|64937874|FG003|Treatment Period 2|Protocol Violation|1|||
23326088|NCT01891864|64937875|FG004|Treatment Period 2|Protocol Violation|0|||
23326089|NCT01891864|64937876|FG005|Treatment Period 2|Protocol Violation|0|||
23326090|NCT01891864|64937871|FG000|Treatment Period 2|Physician Decision|0|||
23326091|NCT01891864|64937872|FG001|Treatment Period 2|Physician Decision|0|||
23326092|NCT01891864|64937873|FG002|Treatment Period 2|Physician Decision|1|||
23326093|NCT01891864|64937874|FG003|Treatment Period 2|Physician Decision|0|||
23326094|NCT01891864|64937875|FG004|Treatment Period 2|Physician Decision|0|||
23326095|NCT01891864|64937876|FG005|Treatment Period 2|Physician Decision|0|||
23326096|NCT01891864|64937871|FG000|Treatment Period 2|Site Termination|0|||
23326097|NCT01891864|64937872|FG001|Treatment Period 2|Site Termination|0|||
23326098|NCT01891864|64937873|FG002|Treatment Period 2|Site Termination|1|||
23625855|NCT01689363|66015644|FG005|Overall Study|Protocol Violation|0|||
23625856|NCT01689363|66015645|FG006|Overall Study|Protocol Violation|0|||
23326099|NCT01891864|64937874|FG003|Treatment Period 2|Site Termination|2|||
23326100|NCT01891864|64937875|FG004|Treatment Period 2|Site Termination|0|||
23326101|NCT01891864|64937876|FG005|Treatment Period 2|Site Termination|0|||
23326102|NCT01891864|64937871|FG000|Treatment Period 2|Lack of Efficacy|0|||
23326103|NCT01891864|64937872|FG001|Treatment Period 2|Lack of Efficacy|0|||
23326104|NCT01891864|64937873|FG002|Treatment Period 2|Lack of Efficacy|1|||
23326105|NCT01891864|64937874|FG003|Treatment Period 2|Lack of Efficacy|0|||
23326106|NCT01891864|64937875|FG004|Treatment Period 2|Lack of Efficacy|1|||
23326107|NCT01891864|64937876|FG005|Treatment Period 2|Lack of Efficacy|0|||
23326108|NCT01891864|64937871|FG000|Treatment Period 2|Adverse Event|0|||
23326109|NCT01891864|64937872|FG001|Treatment Period 2|Adverse Event|0|||
23326110|NCT01891864|64937873|FG002|Treatment Period 2|Adverse Event|1|||
23326111|NCT01891864|64937874|FG003|Treatment Period 2|Adverse Event|2|||
23326112|NCT01891864|64937875|FG004|Treatment Period 2|Adverse Event|0|||
23326113|NCT01891864|64937876|FG005|Treatment Period 2|Adverse Event|4|||
23326114|NCT01891864|64937871|FG000|Treatment Period 2|Termination of Site|0|||
23326115|NCT01891864|64937872|FG001|Treatment Period 2|Termination of Site|0|||
23326116|NCT01891864|64937873|FG002|Treatment Period 2|Termination of Site|0|||
23326117|NCT01891864|64937874|FG003|Treatment Period 2|Termination of Site|0|||
23326118|NCT01891864|64937875|FG004|Treatment Period 2|Termination of Site|2|||
23326119|NCT01891864|64937876|FG005|Treatment Period 2|Termination of Site|0|||
23326120|NCT01891864|64937871|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23326121|NCT01891864|64937872|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23326122|NCT01891864|64937873|FG002|Treatment Period 2|Withdrawal by Subject|3|||
23326123|NCT01891864|64937874|FG003|Treatment Period 2|Withdrawal by Subject|4|||
23326124|NCT01891864|64937875|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23326125|NCT01891864|64937876|FG005|Treatment Period 2|Withdrawal by Subject|1|||
23326126|NCT01891864|64937871|FG000|Extension Period|Lack of Efficacy|0|||
23326127|NCT01891864|64937872|FG001|Extension Period|Lack of Efficacy|0|||
23326128|NCT01891864|64937873|FG002|Extension Period|Lack of Efficacy|0|||
23326129|NCT01891864|64937874|FG003|Extension Period|Lack of Efficacy|1|||
23326130|NCT01891864|64937875|FG004|Extension Period|Lack of Efficacy|1|||
23326131|NCT01891864|64937876|FG005|Extension Period|Lack of Efficacy|0|||
23326132|NCT01891864|64937871|FG000|Extension Period|Pregnancy|0|||
23326133|NCT01891864|64937872|FG001|Extension Period|Pregnancy|0|||
23326134|NCT01891864|64937873|FG002|Extension Period|Pregnancy|1|||
23326135|NCT01891864|64937874|FG003|Extension Period|Pregnancy|0|||
23326136|NCT01891864|64937875|FG004|Extension Period|Pregnancy|0|||
23326137|NCT01891864|64937876|FG005|Extension Period|Pregnancy|0|||
23326138|NCT01891864|64937871|FG000|Extension Period|Adverse Event|0|||
23326139|NCT01891864|64937872|FG001|Extension Period|Adverse Event|0|||
23326140|NCT01891864|64937873|FG002|Extension Period|Adverse Event|4|||
23326141|NCT01891864|64937874|FG003|Extension Period|Adverse Event|2|||
23326142|NCT01891864|64937875|FG004|Extension Period|Adverse Event|2|||
23326143|NCT01891864|64937876|FG005|Extension Period|Adverse Event|0|||
23326144|NCT01891864|64937871|FG000|Extension Period|Withdrawal by Subject|0|||
23326145|NCT01891864|64937872|FG001|Extension Period|Withdrawal by Subject|0|||
23326146|NCT01891864|64937873|FG002|Extension Period|Withdrawal by Subject|1|||
23326147|NCT01891864|64937874|FG003|Extension Period|Withdrawal by Subject|2|||
23326148|NCT01891864|64937875|FG004|Extension Period|Withdrawal by Subject|4|||
23326149|NCT01891864|64937876|FG005|Extension Period|Withdrawal by Subject|0|||
23326150|NCT01891864|64937871|FG000|Extension Period|Lost to Follow-up|0|||
23625857|NCT01689363|66015646|FG007|Overall Study|Protocol Violation|0|||
23152387|NCT01970488|64309256|FG002|Part 2: Post Week 16|Physician Decision|0|||
23152388|NCT01970488|64309257|FG003|Part 2: Post Week 16|Physician Decision|0|||
23152389|NCT01970488|64309258|FG004|Part 2: Post Week 16|Physician Decision|1|||
23152390|NCT01970488|64309254|FG000|Part 2: Post Week 16|Non-compliance|0|||
23152391|NCT01970488|64309255|FG001|Part 2: Post Week 16|Non-compliance|0|||
23152392|NCT01970488|64309256|FG002|Part 2: Post Week 16|Non-compliance|1|||
23152393|NCT01970488|64309257|FG003|Part 2: Post Week 16|Non-compliance|0|||
23152394|NCT01970488|64309258|FG004|Part 2: Post Week 16|Non-compliance|0|||
23152395|NCT01970488|64309254|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
23152396|NCT01970488|64309255|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
23152397|NCT01970488|64309256|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
23152398|NCT01970488|64309257|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
23152399|NCT01970488|64309258|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
23152400|NCT01970488|64309254|FG000|Part 2: Post Week 16|Adverse Event|0|||
23152401|NCT01970488|64309255|FG001|Part 2: Post Week 16|Adverse Event|0|||
23326151|NCT01891864|64937872|FG001|Extension Period|Lost to Follow-up|0|||
23326152|NCT01891864|64937873|FG002|Extension Period|Lost to Follow-up|2|||
23326153|NCT01891864|64937874|FG003|Extension Period|Lost to Follow-up|0|||
23326154|NCT01891864|64937875|FG004|Extension Period|Lost to Follow-up|0|||
23326155|NCT01891864|64937876|FG005|Extension Period|Lost to Follow-up|0|||
23326156|NCT03850483|64937880|FG000|Treatment for Stage 1|Adverse Event|1|||
23326157|NCT03850483|64937881|FG001|Treatment for Stage 1|Adverse Event|1|||
23326158|NCT03850483|64937882|FG002|Treatment for Stage 1|Adverse Event|3|||
23326159|NCT03850483|64937883|FG003|Treatment for Stage 1|Adverse Event|0|||
23326160|NCT03850483|64937884|FG004|Treatment for Stage 1|Adverse Event|2|||
23326161|NCT03850483|64937885|FG005|Treatment for Stage 1|Adverse Event|0|||
23152402|NCT01970488|64309256|FG002|Part 2: Post Week 16|Adverse Event|5|||
23152403|NCT01970488|64309257|FG003|Part 2: Post Week 16|Adverse Event|1|||
23152404|NCT01970488|64309258|FG004|Part 2: Post Week 16|Adverse Event|1|||
23152405|NCT01970488|64309254|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
23152406|NCT01970488|64309255|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
23152407|NCT01970488|64309256|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
23152408|NCT01970488|64309257|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
23152409|NCT01970488|64309258|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
23152410|NCT01970488|64309254|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
23152411|NCT01970488|64309255|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
23152412|NCT01970488|64309256|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
23152413|NCT01970488|64309257|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
23152414|NCT01970488|64309258|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
23152415|NCT01630434|64309259|FG000|Overall Study|Donor lungs turned down|1|||
23152416|NCT01630434|64309260|FG001|Overall Study|Donor lungs turned down|0|||
23152417|NCT01630434|64309259|FG000|Overall Study|Protocol Violation|9|||
23152418|NCT01630434|64309260|FG001|Overall Study|Protocol Violation|4|||
23152419|NCT01630434|64309259|FG000|Overall Study|Death|20|||
23152420|NCT01630434|64309260|FG001|Overall Study|Death|26|||
23152421|NCT01109173|64309261|FG000|Overall Study|Adverse Event|15|||
23152422|NCT01109173|64309262|FG001|Overall Study|Adverse Event|17|||
23152423|NCT01109173|64309263|FG002|Overall Study|Adverse Event|9|||
23152424|NCT01109173|64309264|FG003|Overall Study|Adverse Event|6|||
23152425|NCT01109173|64309261|FG000|Overall Study|Lost to Follow-up|0|||
23152426|NCT01109173|64309262|FG001|Overall Study|Lost to Follow-up|1|||
23152427|NCT01109173|64309263|FG002|Overall Study|Lost to Follow-up|0|||
23152428|NCT01109173|64309264|FG003|Overall Study|Lost to Follow-up|0|||
23152429|NCT01109173|64309261|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
23152430|NCT01109173|64309262|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
23152431|NCT01109173|64309263|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
23326162|NCT03850483|64937886|FG006|Treatment for Stage 1|Adverse Event|2|||
23326163|NCT03850483|64937887|FG007|Treatment for Stage 1|Adverse Event|2|||
23326164|NCT03850483|64937888|FG008|Treatment for Stage 1|Adverse Event|0|||
23326165|NCT03850483|64937889|FG009|Treatment for Stage 1|Adverse Event|0|||
23152432|NCT01109173|64309264|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
23326166|NCT03850483|64937880|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
23326167|NCT03850483|64937881|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
23326168|NCT03850483|64937882|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
23326169|NCT03850483|64937883|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
23326170|NCT03850483|64937884|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
23326171|NCT03850483|64937885|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
23326172|NCT03850483|64937886|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
23326173|NCT03850483|64937887|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
23326174|NCT03850483|64937888|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
23326175|NCT03850483|64937889|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
23326176|NCT03850483|64937880|FG000|Treatment for Stage 1|Protocol Violation|1|||
23326177|NCT03850483|64937881|FG001|Treatment for Stage 1|Protocol Violation|0|||
23326178|NCT03850483|64937882|FG002|Treatment for Stage 1|Protocol Violation|0|||
23326179|NCT03850483|64937883|FG003|Treatment for Stage 1|Protocol Violation|0|||
23326180|NCT03850483|64937884|FG004|Treatment for Stage 1|Protocol Violation|0|||
23326181|NCT03850483|64937885|FG005|Treatment for Stage 1|Protocol Violation|0|||
23326182|NCT03850483|64937886|FG006|Treatment for Stage 1|Protocol Violation|1|||
23326183|NCT03850483|64937887|FG007|Treatment for Stage 1|Protocol Violation|0|||
23326184|NCT03850483|64937888|FG008|Treatment for Stage 1|Protocol Violation|0|||
23326185|NCT03850483|64937889|FG009|Treatment for Stage 1|Protocol Violation|0|||
23326186|NCT03850483|64937880|FG000|Treatment for Stage 1|Physician Decision|0|||
23326187|NCT03850483|64937881|FG001|Treatment for Stage 1|Physician Decision|0|||
23326188|NCT03850483|64937882|FG002|Treatment for Stage 1|Physician Decision|0|||
23326189|NCT03850483|64937883|FG003|Treatment for Stage 1|Physician Decision|0|||
23326190|NCT03850483|64937884|FG004|Treatment for Stage 1|Physician Decision|0|||
23326191|NCT03850483|64937885|FG005|Treatment for Stage 1|Physician Decision|1|||
23326192|NCT03850483|64937886|FG006|Treatment for Stage 1|Physician Decision|0|||
23326193|NCT03850483|64937887|FG007|Treatment for Stage 1|Physician Decision|0|||
23625858|NCT01336205|66015647|FG000|Overall Study|Other|22|||
23152433|NCT01109173|64309261|FG000|Overall Study|Noncompliance|0|||
23152434|NCT01109173|64309262|FG001|Overall Study|Noncompliance|1|||
23326194|NCT03850483|64937888|FG008|Treatment for Stage 1|Physician Decision|0|||
23152435|NCT01109173|64309263|FG002|Overall Study|Noncompliance|0|||
23152436|NCT01109173|64309264|FG003|Overall Study|Noncompliance|0|||
23152437|NCT01109173|64309261|FG000|Overall Study|Treatment Failure|25|||
23326195|NCT03850483|64937889|FG009|Treatment for Stage 1|Physician Decision|0|||
23326196|NCT03850483|64937880|FG000|Treatment for Stage 1|Other|0|||
23326197|NCT03850483|64937881|FG001|Treatment for Stage 1|Other|0|||
23326198|NCT03850483|64937882|FG002|Treatment for Stage 1|Other|0|||
23326199|NCT03850483|64937883|FG003|Treatment for Stage 1|Other|0|||
23326200|NCT03850483|64937884|FG004|Treatment for Stage 1|Other|2|||
23326201|NCT03850483|64937885|FG005|Treatment for Stage 1|Other|1|||
23326202|NCT03850483|64937886|FG006|Treatment for Stage 1|Other|0|||
23326203|NCT03850483|64937887|FG007|Treatment for Stage 1|Other|0|||
23326204|NCT03850483|64937888|FG008|Treatment for Stage 1|Other|0|||
23326205|NCT03850483|64937889|FG009|Treatment for Stage 1|Other|0|||
23326206|NCT03850483|64937880|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23326207|NCT03850483|64937881|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23326208|NCT03850483|64937882|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
23326209|NCT03850483|64937883|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23326210|NCT03850483|64937884|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23326211|NCT03850483|64937885|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23440747|NCT00348309|65355280|FG000|Overall Study|A foul of exclusion criteria|0|||
23440748|NCT00348309|65355281|FG001|Overall Study|A foul of exclusion criteria|1|||
23440749|NCT00348309|65355282|FG002|Overall Study|A foul of exclusion criteria|0|||
23440750|NCT00348309|65355280|FG000|Overall Study|Participant was hospitalized|0|||
23440751|NCT00348309|65355281|FG001|Overall Study|Participant was hospitalized|1|||
23440752|NCT00348309|65355282|FG002|Overall Study|Participant was hospitalized|0|||
23440753|NCT00348309|65355280|FG000|Overall Study|Sponsor refuseal|0|||
23440754|NCT00348309|65355281|FG001|Overall Study|Sponsor refuseal|1|||
23440755|NCT00348309|65355282|FG002|Overall Study|Sponsor refuseal|1|||
23440756|NCT00348309|65355280|FG000|Overall Study|Forgot often medication|0|||
23440757|NCT00348309|65355281|FG001|Overall Study|Forgot often medication|1|||
23440758|NCT00348309|65355282|FG002|Overall Study|Forgot often medication|0|||
23440759|NCT00348309|65355280|FG000|Overall Study|Medical Monitor decision|0|||
23440760|NCT00348309|65355281|FG001|Overall Study|Medical Monitor decision|0|||
23440761|NCT00348309|65355282|FG002|Overall Study|Medical Monitor decision|1|||
23440762|NCT00348309|65355280|FG000|Overall Study|Increased dose of Aricept|0|||
23440763|NCT00348309|65355281|FG001|Overall Study|Increased dose of Aricept|0|||
23440764|NCT00348309|65355282|FG002|Overall Study|Increased dose of Aricept|1|||
23440765|NCT00348309|65355280|FG000|Overall Study|Site closure|0|||
23440766|NCT00348309|65355281|FG001|Overall Study|Site closure|0|||
23440767|NCT00348309|65355282|FG002|Overall Study|Site closure|1|||
23440768|NCT00348309|65355280|FG000|Overall Study|Adverse event not attended|0|||
23440769|NCT00348309|65355281|FG001|Overall Study|Adverse event not attended|0|||
23440770|NCT00348309|65355282|FG002|Overall Study|Adverse event not attended|1|||
23440771|NCT00348309|65355280|FG000|Overall Study|ECG abnormal|0|||
23440772|NCT00348309|65355281|FG001|Overall Study|ECG abnormal|0|||
23440773|NCT00348309|65355282|FG002|Overall Study|ECG abnormal|2|||
23440774|NCT00348309|65355280|FG000|Overall Study|Cardiologist recommendations|0|||
23440775|NCT00348309|65355281|FG001|Overall Study|Cardiologist recommendations|0|||
23440776|NCT00348309|65355282|FG002|Overall Study|Cardiologist recommendations|1|||
23440777|NCT00348309|65355280|FG000|Overall Study|HCV career|0|||
23440778|NCT00348309|65355281|FG001|Overall Study|HCV career|0|||
23440779|NCT00348309|65355282|FG002|Overall Study|HCV career|1|||
23440780|NCT04310566|65355283|FG000|Period 1|Study Termination due to COVID-19|15|||
23440781|NCT04310566|65355284|FG001|Period 1|Study Termination due to COVID-19|17|||
23440782|NCT04310566|65355283|FG000|Period 1|Protocol Violation|0|||
23440783|NCT04310566|65355284|FG001|Period 1|Protocol Violation|1|||
23440784|NCT04310566|65355283|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
23440785|NCT04310566|65355284|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
23440786|NCT04310566|65355283|FG000|Period 1|Lost to Follow-up|1|||
23440787|NCT04310566|65355284|FG001|Period 1|Lost to Follow-up|0|||
23440788|NCT04310566|65355283|FG000|Period 1|Withdrawal by Subject|0|||
23440789|NCT04310566|65355284|FG001|Period 1|Withdrawal by Subject|1|||
23440790|NCT04310566|65355283|FG000|Period 2|Study Termination|7|||
23440791|NCT04310566|65355284|FG001|Period 2|Study Termination|5|||
23440792|NCT00211887|65355287|FG000|Overall Study|Adverse Event|8|||
23440793|NCT00211887|65355288|FG001|Overall Study|Adverse Event|4|||
23440794|NCT00211887|65355289|FG002|Overall Study|Adverse Event|6|||
23152438|NCT01109173|64309262|FG001|Overall Study|Treatment Failure|32|||
23326212|NCT03850483|64937886|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23326213|NCT03850483|64937887|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23440795|NCT00211887|65355287|FG000|Overall Study|Death|1|||
23440796|NCT00211887|65355288|FG001|Overall Study|Death|1|||
23440797|NCT00211887|65355289|FG002|Overall Study|Death|1|||
23440798|NCT00211887|65355287|FG000|Overall Study|Lost to Follow-up|28|||
23440799|NCT00211887|65355288|FG001|Overall Study|Lost to Follow-up|13|||
23440800|NCT00211887|65355289|FG002|Overall Study|Lost to Follow-up|9|||
23440801|NCT00211887|65355287|FG000|Overall Study|Non-medical reason|31|||
23440802|NCT00211887|65355288|FG001|Overall Study|Non-medical reason|14|||
23440803|NCT00211887|65355289|FG002|Overall Study|Non-medical reason|8|||
23326214|NCT03850483|64937888|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23440804|NCT00211887|65355287|FG000|Overall Study|Other medical reason|15|||
23563657|NCT02322814|65790516|FG003|Overall Study|Progressive Disease|1|||
23563658|NCT02322814|65790517|FG004|Overall Study|Progressive Disease|1|||
23563659|NCT02322814|65790513|FG000|Overall Study|Protocol Violation|1|||
23563660|NCT02322814|65790514|FG001|Overall Study|Protocol Violation|0|||
23563661|NCT02322814|65790515|FG002|Overall Study|Protocol Violation|0|||
23563662|NCT02322814|65790516|FG003|Overall Study|Protocol Violation|0|||
23563663|NCT02322814|65790517|FG004|Overall Study|Protocol Violation|0|||
23563664|NCT02322814|65790513|FG000|Overall Study|Study Terminated by Sponsor|0|||
23563665|NCT02322814|65790514|FG001|Overall Study|Study Terminated by Sponsor|7|||
23326215|NCT03850483|64937889|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
23326216|NCT03850483|64937880|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23326217|NCT03850483|64937881|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23326218|NCT03850483|64937882|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23326219|NCT03850483|64937883|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23326220|NCT03850483|64937884|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23326221|NCT03850483|64937885|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
23326222|NCT03850483|64937886|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23326223|NCT03850483|64937887|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23326224|NCT03850483|64937888|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23326225|NCT03850483|64937889|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
23326226|NCT03850483|64937880|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
23326227|NCT03850483|64937881|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
23326228|NCT03850483|64937882|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
23326229|NCT03850483|64937883|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
23563666|NCT02322814|65790515|FG002|Overall Study|Study Terminated by Sponsor|9|||
23563667|NCT02322814|65790516|FG003|Overall Study|Study Terminated by Sponsor|5|||
23563668|NCT02322814|65790517|FG004|Overall Study|Study Terminated by Sponsor|13|||
23563669|NCT02322814|65790513|FG000|Overall Study|Withdrawal by Subject|5|||
23563670|NCT02322814|65790514|FG001|Overall Study|Withdrawal by Subject|4|||
23563671|NCT02322814|65790515|FG002|Overall Study|Withdrawal by Subject|2|||
23563672|NCT02322814|65790516|FG003|Overall Study|Withdrawal by Subject|1|||
23563673|NCT02322814|65790517|FG004|Overall Study|Withdrawal by Subject|3|||
23563674|NCT04707196|65790518|FG000|Overall Study|Withdrawal by Subject|9|||
23563675|NCT04707196|65790519|FG001|Overall Study|Withdrawal by Subject|6|||
23563676|NCT04707196|65790518|FG000|Overall Study|Lost to Follow-up|1|||
23563677|NCT04707196|65790519|FG001|Overall Study|Lost to Follow-up|0|||
23563678|NCT04707196|65790518|FG000|Overall Study|Protocol Violation|4|||
23563679|NCT04707196|65790519|FG001|Overall Study|Protocol Violation|1|||
23563680|NCT04707196|65790518|FG000|Overall Study|Adverse Event|2|||
23563681|NCT04707196|65790519|FG001|Overall Study|Adverse Event|2|||
23563682|NCT04707196|65790518|FG000|Overall Study|Death|3|||
23563683|NCT04707196|65790519|FG001|Overall Study|Death|1|||
23563684|NCT04707196|65790518|FG000|Overall Study|Non-compliance with study drug|1|||
23563685|NCT04707196|65790519|FG001|Overall Study|Non-compliance with study drug|0|||
23563686|NCT04707196|65790518|FG000|Overall Study|Progressive disease|9|||
23563687|NCT04707196|65790519|FG001|Overall Study|Progressive disease|10|||
23563688|NCT01785563|65790520|FG000|Overall Study|Physician Decision|10|||
23563689|NCT01785563|65790520|FG000|Overall Study|Withdrawal by Subject|1|||
23563690|NCT01785563|65790520|FG000|Overall Study|Protocol Violation|2|||
23152439|NCT01109173|64309263|FG002|Overall Study|Treatment Failure|69|||
23152440|NCT01109173|64309264|FG003|Overall Study|Treatment Failure|64|||
23152441|NCT01109173|64309261|FG000|Overall Study|Protocol Violation|4|||
23152442|NCT01109173|64309262|FG001|Overall Study|Protocol Violation|5|||
23152443|NCT01109173|64309263|FG002|Overall Study|Protocol Violation|1|||
23152444|NCT01109173|64309264|FG003|Overall Study|Protocol Violation|2|||
23152445|NCT01109173|64309261|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
23326230|NCT03850483|64937884|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
23326231|NCT03850483|64937885|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
23563691|NCT01255592|65790521|FG000|Overall Study|Adverse Event|5|||
23563692|NCT01255592|65790522|FG001|Overall Study|Adverse Event|0|||
23563693|NCT01255592|65790521|FG000|Overall Study|Withdrawal by Subject|1|||
23563694|NCT01255592|65790522|FG001|Overall Study|Withdrawal by Subject|0|||
23563695|NCT01255592|65790521|FG000|Overall Study|Other|0|||
23152446|NCT01109173|64309262|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
23326232|NCT03850483|64937886|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
23440805|NCT00211887|65355288|FG001|Overall Study|Other medical reason|11|||
23563696|NCT01255592|65790522|FG001|Overall Study|Other|1|||
23563697|NCT00661661|65790523|FG000|Overall Study|Adverse Event|99|||
23563698|NCT00661661|65790524|FG001|Overall Study|Adverse Event|24|||
23563699|NCT00661661|65790523|FG000|Overall Study|Lack of Efficacy|3|||
23563700|NCT00661661|65790524|FG001|Overall Study|Lack of Efficacy|2|||
23563701|NCT00661661|65790523|FG000|Overall Study|Lost to Follow-up|0|||
23563702|NCT00661661|65790524|FG001|Overall Study|Lost to Follow-up|1|||
23152447|NCT01109173|64309263|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
23563703|NCT00661661|65790523|FG000|Overall Study|Withdrawal by Subject|15|||
23563704|NCT00661661|65790524|FG001|Overall Study|Withdrawal by Subject|5|||
23152448|NCT01109173|64309264|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
23152449|NCT01109173|64309261|FG000|Overall Study|Not Specifiied|5|||
23152450|NCT01109173|64309262|FG001|Overall Study|Not Specifiied|4|||
23152451|NCT01109173|64309263|FG002|Overall Study|Not Specifiied|9|||
23152452|NCT01109173|64309264|FG003|Overall Study|Not Specifiied|14|||
23152453|NCT00617604|64309266|FG000|Overall Study|Death|2|||
23152454|NCT00617604|64309267|FG001|Overall Study|Death|1|||
23152455|NCT00617604|64309266|FG000|Overall Study|Lost to Follow-up|1|||
23152456|NCT00617604|64309267|FG001|Overall Study|Lost to Follow-up|0|||
23152457|NCT00617604|64309266|FG000|Overall Study|Miscellaneous Reasons|8|||
23152458|NCT00617604|64309267|FG001|Overall Study|Miscellaneous Reasons|10|||
23152459|NCT00617604|64309266|FG000|Overall Study|Withdrawal by Subject|4|||
23152460|NCT00617604|64309267|FG001|Overall Study|Withdrawal by Subject|6|||
23152461|NCT00617604|64309266|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
23440806|NCT00211887|65355289|FG002|Overall Study|Other medical reason|7|||
23440807|NCT00211887|65355287|FG000|Overall Study|Side effects|19|||
23440808|NCT00211887|65355288|FG001|Overall Study|Side effects|13|||
23440809|NCT00211887|65355289|FG002|Overall Study|Side effects|5|||
23440810|NCT04522141|65355290|FG000|Overall Study|Withdrawal by Subject|1|||
23440811|NCT04522141|65355291|FG001|Overall Study|Withdrawal by Subject|0|||
23440812|NCT01657292|65355292|FG000|Overall Study|Adverse Event|6|||
23440813|NCT01657292|65355292|FG000|Overall Study|Withdrawal by Subject|2|||
23440814|NCT01657292|65355292|FG000|Overall Study|Violation of eligibility criteria|1|||
23440815|NCT01657292|65355292|FG000|Overall Study|Change of therapy|1|||
23440816|NCT02775916|65355293|FG000|Overall Study|Adverse Event|1|||
23440817|NCT02775916|65355294|FG001|Overall Study|Adverse Event|0|||
23440818|NCT02775916|65355293|FG000|Overall Study|Subject/Guardian Decision|2|||
23440819|NCT02775916|65355294|FG001|Overall Study|Subject/Guardian Decision|0|||
23440820|NCT01128946|65355295|FG000|Period I|Protocol Violation|0|||
23440821|NCT01128946|65355296|FG001|Period I|Protocol Violation|1|||
23440822|NCT01128946|65355297|FG002|Period I|Protocol Violation|0|||
23440823|NCT01128946|65355298|FG003|Period I|Protocol Violation|0|||
23440824|NCT01128946|65355295|FG000|Period I|Withdrawal by Subject|0|||
23440825|NCT01128946|65355296|FG001|Period I|Withdrawal by Subject|0|||
23440826|NCT01128946|65355297|FG002|Period I|Withdrawal by Subject|1|||
23440827|NCT01128946|65355298|FG003|Period I|Withdrawal by Subject|1|||
23440828|NCT01128946|65355295|FG000|Period II|Protocol Violation|0|||
23440829|NCT01128946|65355296|FG001|Period II|Protocol Violation|1|||
23440830|NCT01128946|65355297|FG002|Period II|Protocol Violation|0|||
23440831|NCT01128946|65355298|FG003|Period II|Protocol Violation|0|||
23440832|NCT01128946|65355295|FG000|Period II|Withdrawal by Subject|0|||
23440833|NCT01128946|65355296|FG001|Period II|Withdrawal by Subject|0|||
23440834|NCT01128946|65355297|FG002|Period II|Withdrawal by Subject|0|||
23440835|NCT01128946|65355298|FG003|Period II|Withdrawal by Subject|1|||
23440836|NCT01128946|65355295|FG000|Period III|Protocol Violation|1|||
23440837|NCT01128946|65355296|FG001|Period III|Protocol Violation|0|||
23440838|NCT01128946|65355297|FG002|Period III|Protocol Violation|0|||
23440839|NCT01128946|65355298|FG003|Period III|Protocol Violation|0|||
23440840|NCT04178720|65355301|FG000|Overall Study|Withdrawal by Subject|2|||
23440841|NCT04178720|65355302|FG001|Overall Study|Withdrawal by Subject|0|||
23440842|NCT04178720|65355301|FG000|Overall Study|Relocation|0|||
23440843|NCT04178720|65355302|FG001|Overall Study|Relocation|1|||
23440844|NCT01196026|65355307|FG000|Overall Study|Withdrawal by Subject|1|||
23440845|NCT01196026|65355308|FG001|Overall Study|Withdrawal by Subject|4|||
23440846|NCT01196026|65355309|FG002|Overall Study|Withdrawal by Subject|0|||
23440847|NCT01196026|65355310|FG003|Overall Study|Withdrawal by Subject|0|||
23440848|NCT01196026|65355311|FG004|Overall Study|Withdrawal by Subject|0|||
23440849|NCT01196026|65355312|FG005|Overall Study|Withdrawal by Subject|0|||
23440850|NCT01196026|65355307|FG000|Overall Study|Lost to Follow-up|0|||
23440851|NCT01196026|65355308|FG001|Overall Study|Lost to Follow-up|3|||
23440852|NCT01196026|65355309|FG002|Overall Study|Lost to Follow-up|0|||
23440853|NCT01196026|65355310|FG003|Overall Study|Lost to Follow-up|0|||
23440854|NCT01196026|65355311|FG004|Overall Study|Lost to Follow-up|1|||
23440855|NCT01196026|65355312|FG005|Overall Study|Lost to Follow-up|0|||
23440856|NCT01196026|65355307|FG000|Overall Study|Other|0|||
23152462|NCT00617604|64309267|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
23220254|NCT04599972|64550125|FG001|Overall Study|Protocol Violation|0|||
23220255|NCT04599972|64550124|FG000|Overall Study|Other reason|1|||
23220256|NCT04599972|64550125|FG001|Overall Study|Other reason|0|||
23440857|NCT01196026|65355308|FG001|Overall Study|Other|1|||
23440858|NCT01196026|65355309|FG002|Overall Study|Other|0|||
23440859|NCT01196026|65355310|FG003|Overall Study|Other|0|||
23440860|NCT01196026|65355311|FG004|Overall Study|Other|0|||
23220257|NCT03597503|64550127|FG000|Overall Study|Withdrawal by Subject|0|||
23440861|NCT01196026|65355312|FG005|Overall Study|Other|0|||
23440862|NCT03790917|65355313|FG000|Overall Study|Death|1|||
23440863|NCT01114828|65355320|FG000|Overall Study|Adverse Event|1|||
23440864|NCT01114828|65355321|FG001|Overall Study|Adverse Event|1|||
23440865|NCT01114828|65355320|FG000|Overall Study|Lack of Efficacy|0|||
23440866|NCT01114828|65355321|FG001|Overall Study|Lack of Efficacy|2|||
23152463|NCT01681628|64309270|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
23625859|NCT01336205|66015648|FG001|Overall Study|Other|9|||
23625860|NCT01336205|66015647|FG000|Overall Study|Lost to Follow-up|40|||
23625861|NCT01336205|66015648|FG001|Overall Study|Lost to Follow-up|20|||
23625862|NCT01336205|66015647|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
23625863|NCT01336205|66015648|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
23625864|NCT01336205|66015647|FG000|Overall Study|Lack of Efficacy|4|||
23625865|NCT01336205|66015648|FG001|Overall Study|Lack of Efficacy|0|||
23625866|NCT01336205|66015647|FG000|Overall Study|Severe noncompliance with protocol|9|||
23625867|NCT01336205|66015648|FG001|Overall Study|Severe noncompliance with protocol|2|||
23625868|NCT01336205|66015647|FG000|Overall Study|Adverse Event|56|||
23625869|NCT01336205|66015648|FG001|Overall Study|Adverse Event|6|||
23625870|NCT01336205|66015647|FG000|Overall Study|Death|1|||
23625871|NCT01336205|66015648|FG001|Overall Study|Death|1|||
23625872|NCT01336205|66015647|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
23625873|NCT01336205|66015648|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
23625874|NCT01336205|66015647|FG000|Overall Study|Withdrawal by Subject|72|||
23625875|NCT01336205|66015648|FG001|Overall Study|Withdrawal by Subject|38|||
23625876|NCT01336205|66015647|FG000|Overall Study|Did not receive treatment|4|||
23625877|NCT01336205|66015648|FG001|Overall Study|Did not receive treatment|0|||
23625878|NCT01402063|66015649|FG000|Overall Study|Withdrawal by Subject|3|||
23625879|NCT01402063|66015650|FG001|Overall Study|Withdrawal by Subject|3|||
23625880|NCT02650466|66015651|FG000|Overall Study|Physician Decision|1|||
23625881|NCT02650466|66015651|FG000|Overall Study|Withdrawal by Subject|5|||
23625882|NCT02650466|66015651|FG000|Overall Study|Lost to Follow-up|1|||
23625883|NCT01057251|66015652|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
23625884|NCT01057251|66015653|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
23625885|NCT01057251|66015652|FG000|Overall Study|Adverse Event|4|||
23440867|NCT01114828|65355320|FG000|Overall Study|Protocol Violation|2|||
23625886|NCT01057251|66015653|FG001|Overall Study|Adverse Event|2|||
23625887|NCT01057251|66015652|FG000|Overall Study|Lack of Efficacy|2|||
23625888|NCT01057251|66015653|FG001|Overall Study|Lack of Efficacy|11|||
23625889|NCT01057251|66015652|FG000|Overall Study|Protocol Violation|6|||
23625890|NCT01057251|66015653|FG001|Overall Study|Protocol Violation|2|||
23625891|NCT01057251|66015652|FG000|Overall Study|Withdrawal by Subject|4|||
23625892|NCT01057251|66015653|FG001|Overall Study|Withdrawal by Subject|5|||
23625893|NCT01057251|66015652|FG000|Overall Study|Lost to Follow-up|7|||
23625894|NCT01057251|66015653|FG001|Overall Study|Lost to Follow-up|6|||
23152464|NCT01681628|64309271|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
23152465|NCT01681628|64309270|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
23152466|NCT01681628|64309271|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
23152467|NCT01681628|64309270|FG000|19 Months Follow-up|Death|1|||
23152468|NCT01681628|64309271|FG001|19 Months Follow-up|Death|0|||
23152469|NCT01681628|64309270|FG000|19 Months Follow-up|Lost to Follow-up|61|||
23152470|NCT01681628|64309271|FG001|19 Months Follow-up|Lost to Follow-up|43|||
23152471|NCT01303965|64309276|FG000|Overall Study|Adverse Event|1|||
23152472|NCT01303965|64309277|FG001|Overall Study|Adverse Event|1|||
23152473|NCT01303965|64309276|FG000|Overall Study|Death|0|||
23152474|NCT01303965|64309277|FG001|Overall Study|Death|3|||
23152475|NCT01303965|64309276|FG000|Overall Study|Withdrawal by Subject|1|||
23152476|NCT01303965|64309277|FG001|Overall Study|Withdrawal by Subject|0|||
23152477|NCT01303965|64309276|FG000|Overall Study|Disease Progression|1|||
23152478|NCT01303965|64309277|FG001|Overall Study|Disease Progression|6|||
23152479|NCT02113579|64309283|FG000|Overall Study|Adverse Event|1|||
23152480|NCT02113579|64309284|FG001|Overall Study|Adverse Event|0|||
23152481|NCT02113579|64309283|FG000|Overall Study|Withdrawal by Subject|3|||
23152482|NCT02113579|64309284|FG001|Overall Study|Withdrawal by Subject|2|||
23152483|NCT02113579|64309283|FG000|Overall Study|Lost to Follow-up|6|||
23152484|NCT02113579|64309284|FG001|Overall Study|Lost to Follow-up|2|||
23152485|NCT04556136|64309288|FG000|Overall Study|Lost to Follow-up|6|||
23152486|NCT04556136|64309289|FG001|Overall Study|Lost to Follow-up|6|||
23152487|NCT04556136|64309288|FG000|Overall Study|Physician Decision|2|||
23152488|NCT04556136|64309289|FG001|Overall Study|Physician Decision|1|||
23152489|NCT04556136|64309288|FG000|Overall Study|Withdrawal by Subject|2|||
23152490|NCT04556136|64309289|FG001|Overall Study|Withdrawal by Subject|1|||
23440868|NCT01114828|65355321|FG001|Overall Study|Protocol Violation|0|||
23625895|NCT01057251|66015652|FG000|Overall Study|Other Reason|1|||
23625896|NCT01057251|66015653|FG001|Overall Study|Other Reason|1|||
23625897|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
23625898|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
23625899|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
23625900|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
23152491|NCT04004429|64309290|FG000|Overall Study|Protocol Violation|1|||
23152492|NCT04004429|64309291|FG001|Overall Study|Protocol Violation|0|||
23152493|NCT04004429|64309292|FG002|Overall Study|Protocol Violation|0|||
23440869|NCT01114828|65355320|FG000|Overall Study|Withdrawal by Subject|0|||
23625901|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
23625902|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
23625903|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
23625904|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
23625905|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
23625906|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
23625907|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
23625908|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
23625909|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
23625910|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
23625911|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
23625912|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
23625913|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
23625914|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
23625915|NCT03569475|66015656|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
23625916|NCT03569475|66015657|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
23625917|NCT03569475|66015658|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
23625918|NCT03569475|66015656|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
23625919|NCT03569475|66015657|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
23625920|NCT03569475|66015658|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
23625921|NCT03569475|66015656|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
23625922|NCT03569475|66015657|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
23625923|NCT03569475|66015658|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
23625924|NCT01930214|66015659|FG000|Overall Study|Death|4|||
23625925|NCT01930214|66015660|FG001|Overall Study|Death|4|||
23625926|NCT01930214|66015661|FG002|Overall Study|Death|11|||
23625927|NCT01930214|66015659|FG000|Overall Study|Lost to Follow-up|12|||
23625928|NCT01930214|66015660|FG001|Overall Study|Lost to Follow-up|13|||
23625929|NCT01930214|66015661|FG002|Overall Study|Lost to Follow-up|12|||
23625930|NCT01930214|66015659|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
23625931|NCT01930214|66015660|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
23625932|NCT01930214|66015661|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
23625933|NCT01930214|66015659|FG000|Overall Study|Physician Decision|2|||
23625934|NCT01930214|66015660|FG001|Overall Study|Physician Decision|0|||
23625935|NCT01930214|66015661|FG002|Overall Study|Physician Decision|0|||
23625936|NCT03589300|66015662|FG000|Overall Study|Adverse Event|2|||
23625937|NCT03589300|66015662|FG000|Overall Study|Death|4|||
23625938|NCT03589300|66015662|FG000|Overall Study|Lost to Follow-up|12|||
23625939|NCT03589300|66015662|FG000|Overall Study|Withdrawal by Subject|5|||
23625940|NCT00243022|66015663|FG000|Overall Study|Withdrawal by Subject|1|||
23625941|NCT00243022|66015664|FG001|Overall Study|Withdrawal by Subject|0|||
23625942|NCT00243022|66015663|FG000|Overall Study|Death|1|||
23625943|NCT00243022|66015664|FG001|Overall Study|Death|0|||
23625944|NCT00243022|66015663|FG000|Overall Study|Difficult Travel Distance|0|||
23625945|NCT00243022|66015664|FG001|Overall Study|Difficult Travel Distance|1|||
23625946|NCT01917006|66015665|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
23625947|NCT01917006|66015666|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
23625948|NCT01917006|66015667|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
23625949|NCT01917006|66015668|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
23625950|NCT01917006|66015669|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
23625951|NCT01917006|66015670|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
23625952|NCT01917006|66015671|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
23625953|NCT01917006|66015672|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
23625954|NCT01917006|66015665|FG000|Randomized-treatment Period|Personal Reasons|0|||
23625955|NCT01917006|66015666|FG001|Randomized-treatment Period|Personal Reasons|0|||
23625956|NCT01917006|66015667|FG002|Randomized-treatment Period|Personal Reasons|0|||
23625957|NCT01917006|66015668|FG003|Randomized-treatment Period|Personal Reasons|0|||
23625958|NCT01917006|66015669|FG004|Randomized-treatment Period|Personal Reasons|0|||
23440870|NCT01114828|65355321|FG001|Overall Study|Withdrawal by Subject|1|||
23440871|NCT00206440|65355322|FG000|Overall Study|Protocol Violation|1|||
23625959|NCT01917006|66015670|FG005|Randomized-treatment Period|Personal Reasons|1|||
23625960|NCT01917006|66015671|FG006|Randomized-treatment Period|Personal Reasons|0|||
23625961|NCT01917006|66015672|FG007|Randomized-treatment Period|Personal Reasons|0|||
23625962|NCT01917006|66015665|FG000|Randomized-treatment Period|Protocol Violation|1|||
23625963|NCT01917006|66015666|FG001|Randomized-treatment Period|Protocol Violation|0|||
23625964|NCT01917006|66015667|FG002|Randomized-treatment Period|Protocol Violation|0|||
23440872|NCT00206440|65355323|FG001|Overall Study|Protocol Violation|2|||
23220258|NCT03597503|64550128|FG001|Overall Study|Withdrawal by Subject|2|||
23440873|NCT00206440|65355322|FG000|Overall Study|Adverse Event|4|||
23440874|NCT00206440|65355323|FG001|Overall Study|Adverse Event|2|||
23625965|NCT01917006|66015668|FG003|Randomized-treatment Period|Protocol Violation|0|||
23220259|NCT03597503|64550127|FG000|Overall Study|Lost to Follow-up|1|||
23220260|NCT03597503|64550128|FG001|Overall Study|Lost to Follow-up|2|||
23220261|NCT03597503|64550127|FG000|Overall Study|Protocol Violation|1|||
23220262|NCT03597503|64550128|FG001|Overall Study|Protocol Violation|0|||
23220263|NCT01665768|64550133|FG000|Overall Study|Adverse Event|3|||
23220264|NCT01665768|64550133|FG000|Overall Study|Lack of Efficacy|19|||
23220265|NCT01665768|64550133|FG000|Overall Study|Withdrawal by Subject|1|||
23220266|NCT00324740|64550134|FG000|Overall Study|Withdrawal by Subject|1|||
23220267|NCT00324740|64550135|FG001|Overall Study|Withdrawal by Subject|0|||
23220268|NCT00324740|64550136|FG002|Overall Study|Withdrawal by Subject|1|||
23220269|NCT03799627|64550140|FG000|Overall Study|Adverse Event|1|||
23220270|NCT03799627|64550141|FG001|Overall Study|Adverse Event|2|||
23220271|NCT03799627|64550142|FG002|Overall Study|Adverse Event|0|||
23220272|NCT03799627|64550143|FG003|Overall Study|Adverse Event|0|||
23220273|NCT03799627|64550144|FG004|Overall Study|Adverse Event|2|||
23220274|NCT03799627|64550145|FG005|Overall Study|Adverse Event|5|||
23220275|NCT03799627|64550146|FG006|Overall Study|Adverse Event|0|||
23220276|NCT03799627|64550147|FG007|Overall Study|Adverse Event|2|||
23220277|NCT03799627|64550148|FG008|Overall Study|Adverse Event|0|||
23220278|NCT03799627|64550140|FG000|Overall Study|Physician Decision|2|||
23220279|NCT03799627|64550141|FG001|Overall Study|Physician Decision|2|||
23220280|NCT03799627|64550142|FG002|Overall Study|Physician Decision|0|||
23220281|NCT03799627|64550143|FG003|Overall Study|Physician Decision|0|||
23220282|NCT03799627|64550144|FG004|Overall Study|Physician Decision|2|||
23220283|NCT03799627|64550145|FG005|Overall Study|Physician Decision|2|||
23220284|NCT03799627|64550146|FG006|Overall Study|Physician Decision|0|||
23625966|NCT01917006|66015669|FG004|Randomized-treatment Period|Protocol Violation|0|||
23625967|NCT01917006|66015670|FG005|Randomized-treatment Period|Protocol Violation|0|||
23625968|NCT01917006|66015671|FG006|Randomized-treatment Period|Protocol Violation|0|||
23625969|NCT01917006|66015672|FG007|Randomized-treatment Period|Protocol Violation|0|||
23625970|NCT01917006|66015665|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625971|NCT01917006|66015666|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625972|NCT01917006|66015667|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625973|NCT01917006|66015668|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23326233|NCT03850483|64937887|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
23326234|NCT03850483|64937888|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
23326235|NCT03850483|64937889|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
23326236|NCT03850483|64937880|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
23326237|NCT03850483|64937881|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
23326238|NCT03850483|64937882|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
23326239|NCT03850483|64937883|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
23625974|NCT01917006|66015669|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23220285|NCT03799627|64550147|FG007|Overall Study|Physician Decision|0|||
23220286|NCT03799627|64550148|FG008|Overall Study|Physician Decision|0|||
23220287|NCT03799627|64550140|FG000|Overall Study|Withdrawal by Subject|1|||
23220288|NCT03799627|64550141|FG001|Overall Study|Withdrawal by Subject|1|||
23220289|NCT03799627|64550142|FG002|Overall Study|Withdrawal by Subject|0|||
23220290|NCT03799627|64550143|FG003|Overall Study|Withdrawal by Subject|2|||
23220291|NCT03799627|64550144|FG004|Overall Study|Withdrawal by Subject|0|||
23220292|NCT03799627|64550145|FG005|Overall Study|Withdrawal by Subject|3|||
23220293|NCT03799627|64550146|FG006|Overall Study|Withdrawal by Subject|0|||
23220294|NCT03799627|64550147|FG007|Overall Study|Withdrawal by Subject|0|||
23220295|NCT03799627|64550148|FG008|Overall Study|Withdrawal by Subject|0|||
23220296|NCT03799627|64550140|FG000|Overall Study|Lack of Efficacy|0|||
23220297|NCT03799627|64550141|FG001|Overall Study|Lack of Efficacy|0|||
23625975|NCT01917006|66015670|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625976|NCT01917006|66015671|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
23625977|NCT01917006|66015672|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
23625978|NCT01917006|66015665|FG000|Open-label Period|Adverse Event|0|||
23625979|NCT01917006|66015666|FG001|Open-label Period|Adverse Event|0|||
23625980|NCT01917006|66015667|FG002|Open-label Period|Adverse Event|0|||
23625981|NCT01917006|66015668|FG003|Open-label Period|Adverse Event|0|||
23625982|NCT01917006|66015669|FG004|Open-label Period|Adverse Event|0|||
23220298|NCT03799627|64550142|FG002|Overall Study|Lack of Efficacy|0|||
23220299|NCT03799627|64550143|FG003|Overall Study|Lack of Efficacy|1|||
23220300|NCT03799627|64550144|FG004|Overall Study|Lack of Efficacy|0|||
23625983|NCT01917006|66015670|FG005|Open-label Period|Adverse Event|0|||
23625984|NCT01917006|66015671|FG006|Open-label Period|Adverse Event|0|||
23625985|NCT01917006|66015672|FG007|Open-label Period|Adverse Event|1|||
23625986|NCT01917006|66015665|FG000|Open-label Period|Lost to Follow-up|0|||
23220301|NCT03799627|64550145|FG005|Overall Study|Lack of Efficacy|0|||
23220302|NCT03799627|64550146|FG006|Overall Study|Lack of Efficacy|0|||
23220303|NCT03799627|64550147|FG007|Overall Study|Lack of Efficacy|0|||
23220304|NCT03799627|64550148|FG008|Overall Study|Lack of Efficacy|0|||
23220305|NCT03799627|64550140|FG000|Overall Study|Lost to Follow-up|0|||
23326240|NCT03850483|64937884|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
23152494|NCT04004429|64309290|FG000|Overall Study|Physician Decision|0|||
23152495|NCT04004429|64309291|FG001|Overall Study|Physician Decision|1|||
23152496|NCT04004429|64309292|FG002|Overall Study|Physician Decision|1|||
23152497|NCT04004429|64309290|FG000|Overall Study|Withdrawal by Subject|1|||
23152498|NCT04004429|64309291|FG001|Overall Study|Withdrawal by Subject|1|||
23152499|NCT04004429|64309292|FG002|Overall Study|Withdrawal by Subject|1|||
23152500|NCT01210690|64309293|FG000|Overall Study|Adverse Event|7|||
23152501|NCT01210690|64309293|FG000|Overall Study|Lack of Efficacy|12|||
23152502|NCT01210690|64309293|FG000|Overall Study|Lost to Follow-up|3|||
23152503|NCT01210690|64309293|FG000|Overall Study|Disease Remission|1|||
23152504|NCT01210690|64309293|FG000|Overall Study|Withdrawal by Subject|1|||
23152505|NCT01210690|64309293|FG000|Overall Study|Patient refused to swallow|1|||
23152506|NCT01210690|64309293|FG000|Overall Study|Patient could not take glucose|1|||
23152507|NCT01849497|64309295|FG000|Overall Study|Withdrawal by Subject|1|||
23152508|NCT01849497|64309296|FG001|Overall Study|Withdrawal by Subject|2|||
23152509|NCT01849497|64309295|FG000|Overall Study|Sponsor Decision|0|||
23152510|NCT01849497|64309296|FG001|Overall Study|Sponsor Decision|1|||
23152511|NCT01849497|64309295|FG000|Overall Study|Lost to Follow-up|0|||
23152512|NCT01849497|64309296|FG001|Overall Study|Lost to Follow-up|1|||
23152513|NCT01323621|64309302|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
23326241|NCT03850483|64937885|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
23326242|NCT03850483|64937886|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
23326243|NCT03850483|64937887|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
23326244|NCT03850483|64937888|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
23326245|NCT03850483|64937889|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
23326246|NCT03850483|64937880|FG000|Treatment for Stage 1|Death|0|||
23326247|NCT03850483|64937881|FG001|Treatment for Stage 1|Death|0|||
23326248|NCT03850483|64937882|FG002|Treatment for Stage 1|Death|0|||
23326249|NCT03850483|64937883|FG003|Treatment for Stage 1|Death|0|||
23326250|NCT03850483|64937884|FG004|Treatment for Stage 1|Death|0|||
23326251|NCT03850483|64937885|FG005|Treatment for Stage 1|Death|1|||
23326252|NCT03850483|64937886|FG006|Treatment for Stage 1|Death|0|||
23326253|NCT03850483|64937887|FG007|Treatment for Stage 1|Death|0|||
23326254|NCT03850483|64937888|FG008|Treatment for Stage 1|Death|0|||
23326255|NCT03850483|64937889|FG009|Treatment for Stage 1|Death|0|||
23326256|NCT03850483|64937880|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
23326257|NCT03850483|64937881|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
23326258|NCT03850483|64937882|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
23326259|NCT03850483|64937883|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
23326260|NCT03850483|64937884|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
23326261|NCT03850483|64937885|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
23440875|NCT02397057|65355324|FG000|Overall Study|Withdrawal by Subject|6|||
23440876|NCT02397057|65355325|FG001|Overall Study|Withdrawal by Subject|7|||
23563705|NCT00661661|65790523|FG000|Overall Study|Other|22|||
23563706|NCT00661661|65790524|FG001|Overall Study|Other|7|||
23563707|NCT00661661|65790523|FG000|Overall Study|Not assigned treatment|1|||
23563708|NCT00661661|65790524|FG001|Overall Study|Not assigned treatment|0|||
23563709|NCT02459093|65790525|FG000|Overall Study|Protocol Violation|6|||
23563710|NCT02459093|65790526|FG001|Overall Study|Protocol Violation|11|||
23563711|NCT02459093|65790525|FG000|Overall Study|Lost to Follow-up|6|||
23563712|NCT02459093|65790526|FG001|Overall Study|Lost to Follow-up|7|||
23563713|NCT02086552|65790529|FG000|Overall Study|Withdrawal by Subject|1|||
23563714|NCT00944658|65790532|FG000|Treatment 12 Weeks|Adverse Event|0|||
23563715|NCT00944658|65790533|FG001|Treatment 12 Weeks|Adverse Event|2|||
23563716|NCT03560258|65790534|FG000|Overall Study|Lost to Follow-up|3|||
23563717|NCT03560258|65790535|FG001|Overall Study|Lost to Follow-up|0|||
23563718|NCT03560258|65790536|FG002|Overall Study|Lost to Follow-up|0|||
23563719|NCT03560258|65790534|FG000|Overall Study|Protocol Violation|0|||
23563720|NCT03560258|65790535|FG001|Overall Study|Protocol Violation|1|||
23563721|NCT03560258|65790536|FG002|Overall Study|Protocol Violation|0|||
23563722|NCT03560258|65790534|FG000|Overall Study|Withdrawal by Subject|0|||
23563723|NCT03560258|65790535|FG001|Overall Study|Withdrawal by Subject|0|||
23563724|NCT03560258|65790536|FG002|Overall Study|Withdrawal by Subject|1|||
23563725|NCT00695786|65790540|FG000|Overall Study|Adverse Event|0|||
23563726|NCT00695786|65790541|FG001|Overall Study|Adverse Event|3|||
23563727|NCT00695786|65790542|FG002|Overall Study|Adverse Event|4|||
23563728|NCT00695786|65790543|FG003|Overall Study|Adverse Event|2|||
23563729|NCT00695786|65790540|FG000|Overall Study|Lost to Follow-up|0|||
23563730|NCT00695786|65790541|FG001|Overall Study|Lost to Follow-up|5|||
23563731|NCT00695786|65790542|FG002|Overall Study|Lost to Follow-up|1|||
23152514|NCT01323621|64309303|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
23220306|NCT03799627|64550141|FG001|Overall Study|Lost to Follow-up|0|||
23326262|NCT03850483|64937886|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
23326263|NCT03850483|64937887|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
23326264|NCT03850483|64937888|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
23440877|NCT02397057|65355324|FG000|Overall Study|Lost to Follow-up|4|||
23563732|NCT00695786|65790543|FG003|Overall Study|Lost to Follow-up|1|||
23152515|NCT01323621|64309304|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
23152516|NCT01323621|64309302|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
23152517|NCT01323621|64309303|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
23152518|NCT01323621|64309304|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
23152519|NCT01323621|64309302|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
23152520|NCT01323621|64309303|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
23152521|NCT01323621|64309304|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
23152522|NCT01323621|64309302|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
23152523|NCT01323621|64309303|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
23152524|NCT01323621|64309304|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
23563733|NCT00695786|65790540|FG000|Overall Study|Withdrawal by Subject|0|||
23563734|NCT00695786|65790541|FG001|Overall Study|Withdrawal by Subject|4|||
23563735|NCT00695786|65790542|FG002|Overall Study|Withdrawal by Subject|3|||
23152525|NCT01323621|64309302|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
23152526|NCT01323621|64309303|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
23152527|NCT01323621|64309304|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
23152528|NCT01323621|64309302|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
23152529|NCT01323621|64309303|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
23152530|NCT01323621|64309304|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
23152531|NCT01323621|64309302|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
23152532|NCT01323621|64309303|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
23152533|NCT01323621|64309304|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
23152534|NCT01323621|64309302|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
23152535|NCT01323621|64309303|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
23152536|NCT01323621|64309304|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
23152537|NCT01323621|64309302|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
23152538|NCT01323621|64309303|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
23152539|NCT01323621|64309304|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
23152540|NCT01323621|64309302|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23152541|NCT01323621|64309303|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23152542|NCT01323621|64309304|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23152543|NCT01323621|64309302|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
23152544|NCT01323621|64309303|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
23152545|NCT01323621|64309304|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
23152546|NCT01323621|64309302|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23152547|NCT01323621|64309303|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
23152548|NCT01323621|64309304|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
23152549|NCT00931944|64309306|FG000|Overall Study|Adverse Event|4|||
23152550|NCT00931944|64309306|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
23152551|NCT00931944|64309306|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
23152552|NCT00931944|64309306|FG000|Overall Study|Death|28|||
23152553|NCT00931944|64309306|FG000|Overall Study|Other|2|||
23152554|NCT03471871|64309330|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
23152555|NCT03471871|64309331|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
23152556|NCT03471871|64309332|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
23152557|NCT03471871|64309333|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
23152558|NCT03471871|64309334|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
23152559|NCT03471871|64309330|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
23152560|NCT03471871|64309331|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
23152561|NCT03471871|64309332|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
23152562|NCT03471871|64309333|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
23152563|NCT03471871|64309334|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
23152564|NCT03471871|64309330|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
23152565|NCT03471871|64309331|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
23152566|NCT03471871|64309332|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
23152567|NCT03471871|64309333|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
23152568|NCT03471871|64309334|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
23563736|NCT00695786|65790543|FG003|Overall Study|Withdrawal by Subject|1|||
23563737|NCT00695786|65790540|FG000|Overall Study|Deemed Ineligible|1|||
23563738|NCT00695786|65790541|FG001|Overall Study|Deemed Ineligible|0|||
23563739|NCT00695786|65790542|FG002|Overall Study|Deemed Ineligible|0|||
23152569|NCT03471871|64309330|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
23152570|NCT03471871|64309331|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
23152571|NCT03471871|64309332|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
23152572|NCT03471871|64309333|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
23326265|NCT03850483|64937889|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
23152573|NCT03471871|64309334|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
23152574|NCT03471871|64309330|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
23152575|NCT03471871|64309331|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
23152576|NCT03471871|64309332|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
23152577|NCT03471871|64309333|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
23152578|NCT03471871|64309334|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
23152579|NCT02717754|64309335|FG000|Overall Study|Incorrect Infusion Duration|0|||
23152580|NCT02717754|64309336|FG001|Overall Study|Incorrect Infusion Duration|0|||
23152581|NCT02717754|64309337|FG002|Overall Study|Incorrect Infusion Duration|0|||
23152582|NCT02717754|64309338|FG003|Overall Study|Incorrect Infusion Duration|10|||
23152583|NCT02717754|64309339|FG004|Overall Study|Incorrect Infusion Duration|20|||
23152584|NCT02717754|64309340|FG005|Overall Study|Incorrect Infusion Duration|20|||
23152585|NCT04195581|64309343|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
23152586|NCT04195581|64309343|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
23152587|NCT04195581|64309343|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
23152588|NCT04195581|64309343|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
23152589|NCT04195581|64309343|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
23152590|NCT04195581|64309343|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
23152591|NCT01428661|64309344|FG000|Double-Masked Phase|Protocol Violation|9|||
23326266|NCT03850483|64937880|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
23326267|NCT03850483|64937881|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
23326268|NCT03850483|64937882|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
23326269|NCT03850483|64937883|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
23326270|NCT03850483|64937884|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
23326271|NCT03850483|64937885|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
23326272|NCT03850483|64937886|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
23326273|NCT03850483|64937887|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
23326274|NCT03850483|64937888|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
23152592|NCT01428661|64309345|FG001|Double-Masked Phase|Protocol Violation|4|||
23152593|NCT01428661|64309346|FG002|Double-Masked Phase|Protocol Violation|0|||
23152594|NCT01428661|64309344|FG000|Double-Masked Phase|Adverse Event|13|||
23326275|NCT03850483|64937889|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
23326276|NCT03850483|64937880|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
23326277|NCT03850483|64937881|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
23326278|NCT03850483|64937882|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
23326279|NCT03850483|64937883|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
23326280|NCT03850483|64937884|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
23326281|NCT03850483|64937885|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
23326282|NCT03850483|64937886|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
23326283|NCT03850483|64937887|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
23326284|NCT03850483|64937888|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
23326285|NCT03850483|64937889|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
23326286|NCT03850483|64937880|FG000|Follow-up for Stage 1|Physician Decision|0|||
23326287|NCT03850483|64937881|FG001|Follow-up for Stage 1|Physician Decision|0|||
23326288|NCT03850483|64937882|FG002|Follow-up for Stage 1|Physician Decision|0|||
23326289|NCT03850483|64937883|FG003|Follow-up for Stage 1|Physician Decision|0|||
23326290|NCT03850483|64937884|FG004|Follow-up for Stage 1|Physician Decision|1|||
23326291|NCT03850483|64937885|FG005|Follow-up for Stage 1|Physician Decision|0|||
23326292|NCT03850483|64937886|FG006|Follow-up for Stage 1|Physician Decision|1|||
23326293|NCT03850483|64937887|FG007|Follow-up for Stage 1|Physician Decision|0|||
23326294|NCT03850483|64937888|FG008|Follow-up for Stage 1|Physician Decision|0|||
23326295|NCT03850483|64937889|FG009|Follow-up for Stage 1|Physician Decision|0|||
23326296|NCT03850483|64937880|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
23326297|NCT03850483|64937881|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
23326298|NCT03850483|64937882|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
23326299|NCT03850483|64937883|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
23326300|NCT03850483|64937884|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
23326301|NCT03850483|64937885|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
23440878|NCT02397057|65355325|FG001|Overall Study|Lost to Follow-up|3|||
23440879|NCT02397057|65355324|FG000|Overall Study|Death|1|||
23152595|NCT01428661|64309345|FG001|Double-Masked Phase|Adverse Event|4|||
23152596|NCT01428661|64309346|FG002|Double-Masked Phase|Adverse Event|0|||
23152597|NCT01428661|64309344|FG000|Double-Masked Phase|Lost to Follow-up|14|||
23152598|NCT01428661|64309345|FG001|Double-Masked Phase|Lost to Follow-up|14|||
23152599|NCT01428661|64309346|FG002|Double-Masked Phase|Lost to Follow-up|0|||
23326302|NCT03850483|64937886|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
23326303|NCT03850483|64937887|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
23326304|NCT03850483|64937888|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
23326305|NCT03850483|64937889|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
23326306|NCT03850483|64937880|FG000|Follow-up for Stage 1|Adverse Event|0|||
23440880|NCT02397057|65355325|FG001|Overall Study|Death|0|||
23440881|NCT02397057|65355324|FG000|Overall Study|Adverse Event|0|||
23326307|NCT03850483|64937881|FG001|Follow-up for Stage 1|Adverse Event|0|||
23326308|NCT03850483|64937882|FG002|Follow-up for Stage 1|Adverse Event|1|||
23326309|NCT03850483|64937883|FG003|Follow-up for Stage 1|Adverse Event|0|||
23326310|NCT03850483|64937884|FG004|Follow-up for Stage 1|Adverse Event|0|||
23326311|NCT03850483|64937885|FG005|Follow-up for Stage 1|Adverse Event|1|||
23326312|NCT03850483|64937886|FG006|Follow-up for Stage 1|Adverse Event|0|||
23326313|NCT03850483|64937887|FG007|Follow-up for Stage 1|Adverse Event|0|||
23326314|NCT03850483|64937888|FG008|Follow-up for Stage 1|Adverse Event|0|||
23326315|NCT03850483|64937889|FG009|Follow-up for Stage 1|Adverse Event|0|||
23326316|NCT03850483|64937880|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23326317|NCT03850483|64937881|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
23326318|NCT03850483|64937882|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23326319|NCT03850483|64937883|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23326320|NCT03850483|64937884|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
23326321|NCT03850483|64937885|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
23326322|NCT03850483|64937886|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23326323|NCT03850483|64937887|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23326324|NCT03850483|64937888|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23326325|NCT03850483|64937889|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
23326326|NCT03850483|64937880|FG000|Follow-up for Stage 1|Other|0|||
23326327|NCT03850483|64937881|FG001|Follow-up for Stage 1|Other|2|||
23326328|NCT03850483|64937882|FG002|Follow-up for Stage 1|Other|0|||
23326329|NCT03850483|64937883|FG003|Follow-up for Stage 1|Other|2|||
23326330|NCT03850483|64937884|FG004|Follow-up for Stage 1|Other|0|||
23326331|NCT03850483|64937885|FG005|Follow-up for Stage 1|Other|1|||
23326332|NCT03850483|64937886|FG006|Follow-up for Stage 1|Other|0|||
23326333|NCT03850483|64937887|FG007|Follow-up for Stage 1|Other|0|||
23326334|NCT03850483|64937888|FG008|Follow-up for Stage 1|Other|0|||
23326335|NCT03850483|64937889|FG009|Follow-up for Stage 1|Other|0|||
23326336|NCT03850483|64937880|FG000|Treatment for Stage 2|Adverse Event|0|||
23326337|NCT03850483|64937881|FG001|Treatment for Stage 2|Adverse Event|0|||
23326338|NCT03850483|64937882|FG002|Treatment for Stage 2|Adverse Event|0|||
23326339|NCT03850483|64937883|FG003|Treatment for Stage 2|Adverse Event|0|||
23326340|NCT03850483|64937884|FG004|Treatment for Stage 2|Adverse Event|0|||
23326341|NCT03850483|64937885|FG005|Treatment for Stage 2|Adverse Event|0|||
23326342|NCT03850483|64937886|FG006|Treatment for Stage 2|Adverse Event|0|||
23326343|NCT03850483|64937887|FG007|Treatment for Stage 2|Adverse Event|0|||
23326344|NCT03850483|64937888|FG008|Treatment for Stage 2|Adverse Event|0|||
23326345|NCT03850483|64937889|FG009|Treatment for Stage 2|Adverse Event|1|||
23326346|NCT03850483|64937880|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
23326347|NCT03850483|64937881|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
23326348|NCT03850483|64937882|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
23326349|NCT03850483|64937883|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
23326350|NCT03850483|64937884|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
23326351|NCT03850483|64937885|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
23326352|NCT03850483|64937886|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
23326353|NCT03850483|64937887|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
23326354|NCT03850483|64937888|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
23326355|NCT03850483|64937889|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
23326356|NCT03850483|64937880|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
23326357|NCT03850483|64937881|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
23326358|NCT03850483|64937882|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
23326359|NCT03850483|64937883|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
23326360|NCT03850483|64937884|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
23326361|NCT03850483|64937885|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
23326362|NCT03850483|64937886|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
23326363|NCT03850483|64937887|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
23440882|NCT02397057|65355325|FG001|Overall Study|Adverse Event|1|||
23440883|NCT02397057|65355324|FG000|Overall Study|Physician Decision|0|||
23440884|NCT02397057|65355325|FG001|Overall Study|Physician Decision|1|||
23440885|NCT02397057|65355324|FG000|Overall Study|Subject did not receive study drug|0|||
23326364|NCT03850483|64937888|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
23326365|NCT03850483|64937889|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
23326366|NCT03850483|64937880|FG000|Treatment for Stage 2|Physician Decision|0|||
23326367|NCT03850483|64937881|FG001|Treatment for Stage 2|Physician Decision|0|||
23326368|NCT03850483|64937882|FG002|Treatment for Stage 2|Physician Decision|0|||
23326369|NCT03850483|64937883|FG003|Treatment for Stage 2|Physician Decision|0|||
23326370|NCT03850483|64937884|FG004|Treatment for Stage 2|Physician Decision|0|||
23326371|NCT03850483|64937885|FG005|Treatment for Stage 2|Physician Decision|0|||
23326372|NCT03850483|64937886|FG006|Treatment for Stage 2|Physician Decision|0|||
23326373|NCT03850483|64937887|FG007|Treatment for Stage 2|Physician Decision|0|||
23326374|NCT03850483|64937888|FG008|Treatment for Stage 2|Physician Decision|0|||
23440886|NCT02397057|65355325|FG001|Overall Study|Subject did not receive study drug|1|||
23440887|NCT00880191|65355326|FG000|Overall Study|Refused further treatment|4|||
23563740|NCT00695786|65790543|FG003|Overall Study|Deemed Ineligible|0|||
23326375|NCT03850483|64937889|FG009|Treatment for Stage 2|Physician Decision|1|||
23326376|NCT03850483|64937880|FG000|Treatment for Stage 2|Protocol Violation|0|||
23326377|NCT03850483|64937881|FG001|Treatment for Stage 2|Protocol Violation|0|||
23326378|NCT03850483|64937882|FG002|Treatment for Stage 2|Protocol Violation|0|||
23326379|NCT03850483|64937883|FG003|Treatment for Stage 2|Protocol Violation|0|||
23326380|NCT03850483|64937884|FG004|Treatment for Stage 2|Protocol Violation|0|||
23326381|NCT03850483|64937885|FG005|Treatment for Stage 2|Protocol Violation|0|||
23326382|NCT03850483|64937886|FG006|Treatment for Stage 2|Protocol Violation|0|||
23326383|NCT03850483|64937887|FG007|Treatment for Stage 2|Protocol Violation|0|||
23326384|NCT03850483|64937888|FG008|Treatment for Stage 2|Protocol Violation|1|||
23326385|NCT03850483|64937889|FG009|Treatment for Stage 2|Protocol Violation|0|||
23326386|NCT03850483|64937880|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
23326387|NCT03850483|64937881|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
23326388|NCT03850483|64937882|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
23326389|NCT03850483|64937883|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
23326390|NCT03850483|64937884|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
23326391|NCT03850483|64937885|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
23326392|NCT03850483|64937886|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
23152600|NCT01428661|64309344|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
23152601|NCT01428661|64309345|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
23152602|NCT01428661|64309346|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
23152603|NCT01428661|64309344|FG000|Double-Masked Phase|Lack of Efficacy|2|||
23152604|NCT01428661|64309345|FG001|Double-Masked Phase|Lack of Efficacy|1|||
23152605|NCT01428661|64309346|FG002|Double-Masked Phase|Lack of Efficacy|0|||
23152606|NCT01428661|64309344|FG000|Double-Masked Phase|*Various|1|||
23152607|NCT01428661|64309345|FG001|Double-Masked Phase|*Various|6|||
23152608|NCT01428661|64309346|FG002|Double-Masked Phase|*Various|0|||
23152609|NCT01428661|64309344|FG000|Open Label Extension|Protocol Violation|0|||
23152610|NCT01428661|64309345|FG001|Open Label Extension|Protocol Violation|0|||
23152611|NCT01428661|64309346|FG002|Open Label Extension|Protocol Violation|9|||
23152612|NCT01428661|64309344|FG000|Open Label Extension|Adverse Event|0|||
23152613|NCT01428661|64309345|FG001|Open Label Extension|Adverse Event|0|||
23152614|NCT01428661|64309346|FG002|Open Label Extension|Adverse Event|15|||
23152615|NCT01428661|64309344|FG000|Open Label Extension|Lost to Follow-up|0|||
23152616|NCT01428661|64309345|FG001|Open Label Extension|Lost to Follow-up|0|||
23326393|NCT03850483|64937887|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
23326394|NCT03850483|64937888|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
23326395|NCT03850483|64937889|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
23326396|NCT03850483|64937880|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23440888|NCT00880191|65355327|FG001|Overall Study|Refused further treatment|1|||
23152617|NCT01428661|64309346|FG002|Open Label Extension|Lost to Follow-up|38|||
23152618|NCT01428661|64309344|FG000|Open Label Extension|Withdrawal by Subject|0|||
23152619|NCT01428661|64309345|FG001|Open Label Extension|Withdrawal by Subject|0|||
23152620|NCT01428661|64309346|FG002|Open Label Extension|Withdrawal by Subject|49|||
23152621|NCT01428661|64309344|FG000|Open Label Extension|Lack of Efficacy|0|||
23152622|NCT01428661|64309345|FG001|Open Label Extension|Lack of Efficacy|0|||
23152623|NCT01428661|64309346|FG002|Open Label Extension|Lack of Efficacy|24|||
23152624|NCT01428661|64309344|FG000|Open Label Extension|**Various|0|||
23152625|NCT01428661|64309345|FG001|Open Label Extension|**Various|0|||
23563741|NCT00695786|65790540|FG000|Overall Study|Lack of Efficacy|0|||
23563742|NCT00695786|65790541|FG001|Overall Study|Lack of Efficacy|0|||
23563743|NCT00695786|65790542|FG002|Overall Study|Lack of Efficacy|0|||
23152626|NCT01428661|64309346|FG002|Open Label Extension|**Various|185|||
23152627|NCT04439071|64309347|FG000|Overall Study|Lost to Follow-up|0|||
23152628|NCT04439071|64309348|FG001|Overall Study|Lost to Follow-up|3|||
23152629|NCT04439071|64309347|FG000|Overall Study|Withdrawal by Subject|3|||
23152630|NCT04439071|64309348|FG001|Overall Study|Withdrawal by Subject|8|||
23152631|NCT04439071|64309347|FG000|Overall Study|Death|6|||
23152632|NCT04439071|64309348|FG001|Overall Study|Death|4|||
23152633|NCT04439071|64309347|FG000|Overall Study|Other than specified|3|||
23152634|NCT04439071|64309348|FG001|Overall Study|Other than specified|3|||
23152635|NCT04439071|64309347|FG000|Overall Study|Randomized but not treated|2|||
23152636|NCT04439071|64309348|FG001|Overall Study|Randomized but not treated|0|||
23152637|NCT00667355|64309351|FG000|Overall Study|Adverse Event|5|||
23152638|NCT00667355|64309351|FG000|Overall Study|Lost to Follow-up|1|||
23152639|NCT00667355|64309351|FG000|Overall Study|Other reason was not specified|5|||
23563744|NCT00695786|65790543|FG003|Overall Study|Lack of Efficacy|4|||
23152640|NCT01610687|64309352|FG000|Overall Study|Lack of Efficacy|26|||
23152641|NCT01610687|64309352|FG000|Overall Study|Adverse Event|18|||
23152642|NCT01610687|64309352|FG000|Overall Study|Moved out of area|6|||
23152643|NCT01610687|64309352|FG000|Overall Study|Withdrawal by Subject|7|||
23152644|NCT01610687|64309352|FG000|Overall Study|Lost to Follow-up|4|||
23152645|NCT01610687|64309352|FG000|Overall Study|Symptom control without study medication|2|||
23440889|NCT00880191|65355326|FG000|Overall Study|Adverse Event|8|||
23152646|NCT01610687|64309352|FG000|Overall Study|Unable to make journey|1|||
23563745|NCT02093663|65790544|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
23563746|NCT02093663|65790545|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
23563747|NCT02093663|65790546|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
23563748|NCT02093663|65790547|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
23563749|NCT02093663|65790548|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
23152647|NCT01610687|64309352|FG000|Overall Study|Death|1|||
23152648|NCT01610687|64309352|FG000|Overall Study|Cannabis affecting job|1|||
23152649|NCT01610687|64309352|FG000|Overall Study|Felt more alter without study medication|1|||
23152650|NCT02465463|64309356|FG000|Overall Study|Lost to Follow-up|2|||
23152651|NCT02465463|64309357|FG001|Overall Study|Lost to Follow-up|1|||
23152652|NCT02465463|64309356|FG000|Overall Study|Death|1|||
23152653|NCT02465463|64309357|FG001|Overall Study|Death|0|||
23152654|NCT02465463|64309356|FG000|Overall Study|Protocol Violation|1|||
23152655|NCT02465463|64309357|FG001|Overall Study|Protocol Violation|0|||
23152656|NCT02700997|64309358|FG000|Overall Study|Did not undergo CT imaging|1|||
23152657|NCT02700997|64309358|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
23152658|NCT02592018|64309362|FG000|Overall Study|Adverse Event|1|||
23152659|NCT02592018|64309362|FG000|Overall Study|Lost to Follow-up|1|||
23152660|NCT02811549|64309363|FG000|Overall Study|Lost to Follow-up|1|||
23152661|NCT02811549|64309363|FG000|Overall Study|Withdrawal by Subject|3|||
23152662|NCT02811549|64309363|FG000|Overall Study|Subject screen failed|4|||
23152663|NCT02811549|64309363|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
23152664|NCT03739762|64309364|FG000|Overall Study|Lost to Follow-up|1|||
23152665|NCT03739762|64309365|FG001|Overall Study|Lost to Follow-up|1|||
23152666|NCT03739762|64309364|FG000|Overall Study|Withdrawal by Subject|2|||
23152667|NCT03739762|64309365|FG001|Overall Study|Withdrawal by Subject|6|||
23152668|NCT00576836|64309366|FG000|Overall Study|Death|0|||
23152669|NCT00576836|64309367|FG001|Overall Study|Death|1|||
23152670|NCT00576836|64309366|FG000|Overall Study|Physician Decision|0|||
23152671|NCT00576836|64309367|FG001|Overall Study|Physician Decision|1|||
23152672|NCT04060563|64309369|FG000|Overall Study|Lost to Follow-up|1|||
23152673|NCT04060563|64309370|FG001|Overall Study|Lost to Follow-up|1|||
23152674|NCT04060563|64309369|FG000|Overall Study|Physician Decision|0|||
23152675|NCT04060563|64309370|FG001|Overall Study|Physician Decision|1|||
23152676|NCT00234494|64309373|FG000|Overall Study|Protocol Violation|2|||
23152677|NCT05093322|64309374|FG000|Overall Study|Death|6|||
23152678|NCT05093322|64309375|FG001|Overall Study|Death|2|||
23152679|NCT05093322|64309374|FG000|Overall Study|Other|4|||
23152680|NCT05093322|64309375|FG001|Overall Study|Other|1|||
23152681|NCT01524133|64309376|FG000|Treatment Phase|Withdrawal by Subject|13|||
23152682|NCT01524133|64309377|FG001|Treatment Phase|Withdrawal by Subject|28|||
23152683|NCT01524133|64309378|FG002|Treatment Phase|Withdrawal by Subject|31|||
23152684|NCT01524133|64309376|FG000|Treatment Phase|Physician Decision|6|||
23152685|NCT01524133|64309377|FG001|Treatment Phase|Physician Decision|3|||
23152686|NCT01524133|64309378|FG002|Treatment Phase|Physician Decision|3|||
23152687|NCT01524133|64309376|FG000|Treatment Phase|Lost to Follow-up|0|||
23152688|NCT01524133|64309377|FG001|Treatment Phase|Lost to Follow-up|1|||
23152689|NCT01524133|64309378|FG002|Treatment Phase|Lost to Follow-up|2|||
23152690|NCT01524133|64309376|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
23152691|NCT01524133|64309377|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
23152692|NCT01524133|64309378|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
23152693|NCT01524133|64309376|FG000|Overall Study 52 Weeks|Physician Decision|1|||
23152694|NCT01524133|64309377|FG001|Overall Study 52 Weeks|Physician Decision|0|||
23152695|NCT01524133|64309378|FG002|Overall Study 52 Weeks|Physician Decision|2|||
23152696|NCT01524133|64309376|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
23152697|NCT01524133|64309377|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
23152698|NCT01524133|64309378|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
23152699|NCT05097716|64309379|FG000|Period 1|Adverse Event|1|||
23152700|NCT05097716|64309379|FG000|Period 1|Close contact with highly-transmissible infection|1|||
23152701|NCT02566577|64309380|FG000|Overall Study|Withdrawal by Subject|1|||
23152702|NCT02566577|64309381|FG001|Overall Study|Withdrawal by Subject|1|||
23152703|NCT02566577|64309380|FG000|Overall Study|Equipment failure|1|||
23152704|NCT02566577|64309381|FG001|Overall Study|Equipment failure|1|||
23563750|NCT02093663|65790544|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
23563751|NCT02093663|65790545|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563752|NCT02093663|65790546|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563753|NCT02093663|65790547|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23625987|NCT01917006|66015666|FG001|Open-label Period|Lost to Follow-up|0|||
23625988|NCT01917006|66015667|FG002|Open-label Period|Lost to Follow-up|0|||
23152705|NCT02566577|64309380|FG000|Overall Study|Physical limitation|1|||
23152706|NCT02566577|64309381|FG001|Overall Study|Physical limitation|0|||
23152707|NCT01294150|64309382|FG000|Overall Study|Physician Decision|2|||
23152708|NCT01294150|64309383|FG001|Overall Study|Physician Decision|2|||
23152709|NCT01807923|64309384|FG000|Overall Study|Adverse Event|2|||
23152710|NCT01807923|64309385|FG001|Overall Study|Adverse Event|1|||
23152711|NCT01807923|64309386|FG002|Overall Study|Adverse Event|2|||
23152712|NCT01807923|64309384|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
23152713|NCT01807923|64309385|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
23152714|NCT01807923|64309386|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
23152715|NCT01807923|64309384|FG000|Overall Study|Physician Decision|0|||
23152716|NCT01807923|64309385|FG001|Overall Study|Physician Decision|0|||
23152717|NCT01807923|64309386|FG002|Overall Study|Physician Decision|1|||
23152718|NCT01807923|64309384|FG000|Overall Study|Not Eligible (Genotype)|0|||
23152719|NCT01807923|64309385|FG001|Overall Study|Not Eligible (Genotype)|0|||
23152720|NCT01807923|64309386|FG002|Overall Study|Not Eligible (Genotype)|1|||
23152721|NCT01807923|64309384|FG000|Overall Study|Randomized But Not Treated|3|||
23152722|NCT01807923|64309385|FG001|Overall Study|Randomized But Not Treated|2|||
23152723|NCT01807923|64309386|FG002|Overall Study|Randomized But Not Treated|5|||
23152724|NCT02322229|64309387|FG000|Overall Study|Physician Decision|2|||
23152725|NCT01117454|64309390|FG000|Overall Study|Pregnancy|0|||
23152726|NCT01117454|64309391|FG001|Overall Study|Pregnancy|1|||
23152727|NCT02966223|64309394|FG000|Overall Study|Physician Decision|3|||
23152728|NCT02966223|64309394|FG000|Overall Study|Withdrawal by Subject|11|||
23152729|NCT02966223|64309394|FG000|Overall Study|Lost to Follow-up|1|||
23152730|NCT00890929|64309395|FG000|Overall Study|Death before treatment|2|||
23152731|NCT00890929|64309395|FG000|Overall Study|Withdrawal by Subject|3|||
23152732|NCT00890929|64309395|FG000|Overall Study|Physician Decision|1|||
23152733|NCT00529451|64309401|FG000|Overall Study|Subject withdrew consent|16|||
23152734|NCT00529451|64309402|FG001|Overall Study|Subject withdrew consent|21|||
23152735|NCT00529451|64309403|FG002|Overall Study|Subject withdrew consent|13|||
23152736|NCT00529451|64309404|FG003|Overall Study|Subject withdrew consent|12|||
23152737|NCT00529451|64309401|FG000|Overall Study|Adverse Event|9|||
23152738|NCT00529451|64309402|FG001|Overall Study|Adverse Event|16|||
23152739|NCT00529451|64309403|FG002|Overall Study|Adverse Event|14|||
23152740|NCT00529451|64309404|FG003|Overall Study|Adverse Event|8|||
23152741|NCT00529451|64309401|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
23220307|NCT03799627|64550142|FG002|Overall Study|Lost to Follow-up|0|||
23220308|NCT03799627|64550143|FG003|Overall Study|Lost to Follow-up|0|||
23220309|NCT03799627|64550144|FG004|Overall Study|Lost to Follow-up|0|||
23220310|NCT03799627|64550145|FG005|Overall Study|Lost to Follow-up|0|||
23220311|NCT03799627|64550146|FG006|Overall Study|Lost to Follow-up|1|||
23220312|NCT03799627|64550147|FG007|Overall Study|Lost to Follow-up|0|||
23326397|NCT03850483|64937881|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23326398|NCT03850483|64937882|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23326399|NCT03850483|64937883|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23326400|NCT03850483|64937884|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23326401|NCT03850483|64937885|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23326402|NCT03850483|64937886|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23326403|NCT03850483|64937887|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23326404|NCT03850483|64937888|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
23326405|NCT03850483|64937889|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
23326406|NCT03850483|64937880|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
23326407|NCT03850483|64937881|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
23326408|NCT03850483|64937882|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
23326409|NCT03850483|64937883|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
23326410|NCT03850483|64937884|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
23326411|NCT03850483|64937885|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
23326412|NCT03850483|64937886|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
23326413|NCT03850483|64937887|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
23326414|NCT03850483|64937888|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
23440890|NCT00880191|65355327|FG001|Overall Study|Adverse Event|6|||
23440891|NCT00880191|65355326|FG000|Overall Study|Hospitalization/efficacy|1|||
23440892|NCT00880191|65355327|FG001|Overall Study|Hospitalization/efficacy|1|||
23440893|NCT04177212|65355332|FG000|Overall Study|Withdrawal by Subject|9|||
23440894|NCT04177212|65355333|FG001|Overall Study|Withdrawal by Subject|7|||
23440895|NCT04177212|65355332|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
23440896|NCT04177212|65355333|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
23440897|NCT04177212|65355332|FG000|Overall Study|Physician Decision|1|||
23152742|NCT00529451|64309402|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
23152743|NCT00529451|64309403|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
23152744|NCT00529451|64309404|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
23152745|NCT00529451|64309401|FG000|Overall Study|Lost to Follow-up|4|||
23220313|NCT03799627|64550148|FG008|Overall Study|Lost to Follow-up|1|||
23220314|NCT03799627|64550140|FG000|Overall Study|Death|0|||
23440898|NCT04177212|65355333|FG001|Overall Study|Physician Decision|0|||
23440899|NCT04177212|65355332|FG000|Overall Study|Lost to Follow-up|0|||
23220315|NCT03799627|64550141|FG001|Overall Study|Death|0|||
23440900|NCT04177212|65355333|FG001|Overall Study|Lost to Follow-up|3|||
23440901|NCT04177212|65355332|FG000|Overall Study|Adverse Event|0|||
23440902|NCT04177212|65355333|FG001|Overall Study|Adverse Event|1|||
23440903|NCT04177212|65355332|FG000|Overall Study|Other|1|||
23440904|NCT04177212|65355333|FG001|Overall Study|Other|2|||
23440905|NCT00166439|65355337|FG000|Overall Study|Ineligible|5|||
23440906|NCT01711645|65355338|FG000|Overall Study|Withdrawal by Subject|8|||
23440907|NCT01711645|65355338|FG000|Overall Study|Lost to Follow-up|6|||
23440908|NCT01711645|65355338|FG000|Overall Study|Physician Decision|5|||
23440909|NCT00269633|65355345|FG000|Overall Study|Withdrawal by Subject|1|||
23440910|NCT00269633|65355346|FG001|Overall Study|Withdrawal by Subject|0|||
23440911|NCT03857542|65355351|FG000|Overall Study|Adverse Event|1|||
23440912|NCT03857542|65355352|FG001|Overall Study|Adverse Event|3|||
23440913|NCT03857542|65355351|FG000|Overall Study|Withdrawal by Subject|2|||
23440914|NCT03857542|65355352|FG001|Overall Study|Withdrawal by Subject|1|||
23440915|NCT03857542|65355351|FG000|Overall Study|Lost to Follow-up|2|||
23440916|NCT03857542|65355352|FG001|Overall Study|Lost to Follow-up|1|||
23440917|NCT03857542|65355351|FG000|Overall Study|Reason not Specified|1|||
23440918|NCT03857542|65355352|FG001|Overall Study|Reason not Specified|0|||
23440919|NCT03679624|65355353|FG000|Overall Study|Adverse Event|1|||
23440920|NCT03679624|65355354|FG001|Overall Study|Adverse Event|0|||
23440921|NCT01063153|65355355|FG000|Overall Study|Found Ineligible During Screening|2|||
23440922|NCT01063153|65355356|FG001|Overall Study|Found Ineligible During Screening|0|||
23440923|NCT01063153|65355355|FG000|Overall Study|Lost to Follow-up|0|||
23440924|NCT01063153|65355356|FG001|Overall Study|Lost to Follow-up|7|||
23440925|NCT01063153|65355355|FG000|Overall Study|Withdrawal by Subject|0|||
23440926|NCT01063153|65355356|FG001|Overall Study|Withdrawal by Subject|1|||
23440927|NCT01063153|65355355|FG000|Overall Study|Physician Decision|0|||
23440928|NCT01063153|65355356|FG001|Overall Study|Physician Decision|4|||
23440929|NCT02942485|65355357|FG000|Overall Study|Lost to Follow-up|1|||
23440930|NCT02942485|65355358|FG001|Overall Study|Lost to Follow-up|0|||
23440931|NCT03992846|65355362|FG000|Overall Study|Adverse Event|8|||
23440932|NCT03992846|65355363|FG001|Overall Study|Adverse Event|6|||
23440933|NCT03992846|65355364|FG002|Overall Study|Adverse Event|3|||
23440934|NCT03992846|65355362|FG000|Overall Study|Lost to Follow-up|0|||
23440935|NCT03992846|65355363|FG001|Overall Study|Lost to Follow-up|1|||
23440936|NCT03992846|65355364|FG002|Overall Study|Lost to Follow-up|1|||
23440937|NCT03992846|65355362|FG000|Overall Study|Pregnancy|2|||
23440938|NCT03992846|65355363|FG001|Overall Study|Pregnancy|0|||
23440939|NCT03992846|65355364|FG002|Overall Study|Pregnancy|1|||
23440940|NCT03992846|65355362|FG000|Overall Study|Protocol Violation|1|||
23440941|NCT03992846|65355363|FG001|Overall Study|Protocol Violation|2|||
23440942|NCT03992846|65355364|FG002|Overall Study|Protocol Violation|0|||
23440943|NCT03992846|65355362|FG000|Overall Study|Withdrawal by Subject|8|||
23563754|NCT02093663|65790548|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563755|NCT02093663|65790544|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
23220316|NCT03799627|64550142|FG002|Overall Study|Death|0|||
23220317|NCT03799627|64550143|FG003|Overall Study|Death|1|||
23220318|NCT03799627|64550144|FG004|Overall Study|Death|0|||
23440944|NCT03992846|65355363|FG001|Overall Study|Withdrawal by Subject|10|||
23440945|NCT03992846|65355364|FG002|Overall Study|Withdrawal by Subject|20|||
23440946|NCT03992846|65355362|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
23440947|NCT03992846|65355363|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
23440948|NCT03992846|65355364|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
23440949|NCT00302211|65355365|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
23440950|NCT00302211|65355366|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
23440951|NCT00302211|65355367|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
23440952|NCT00302211|65355368|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
23440953|NCT00302211|65355369|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
23440954|NCT00302211|65355365|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
23440955|NCT00302211|65355366|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
23440956|NCT00302211|65355367|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
23440957|NCT00302211|65355368|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
23440958|NCT00302211|65355369|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
23440959|NCT00302211|65355365|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
23440960|NCT00302211|65355366|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
23440961|NCT00302211|65355367|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
23440962|NCT00302211|65355368|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
23440963|NCT00302211|65355369|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
23440964|NCT00302211|65355365|FG000|Double Blind Period (New Patients)|Disease progression|0|||
23440965|NCT00302211|65355366|FG001|Double Blind Period (New Patients)|Disease progression|1|||
23440966|NCT00302211|65355367|FG002|Double Blind Period (New Patients)|Disease progression|1|||
23440967|NCT00302211|65355368|FG003|Double Blind Period (New Patients)|Disease progression|0|||
23440968|NCT00302211|65355369|FG004|Double Blind Period (New Patients)|Disease progression|0|||
23563756|NCT02093663|65790545|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
23563757|NCT02093663|65790546|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
23563758|NCT02093663|65790547|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
23582245|NCT00567879|65862412|FG002|Overall Study|Abnormal test procedure(s)|1|||
23440969|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
23440970|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
23440971|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
23440972|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
23440973|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
23440974|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
23440975|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
23440976|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
23440977|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
23440978|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
23440979|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
23440980|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
23440981|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
23440982|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
23440983|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
23440984|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
23440985|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
23440986|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
23440987|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
23440988|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
23440989|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Death|0|||
23440990|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Death|0|||
23563759|NCT02093663|65790548|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
23563760|NCT02093663|65790544|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
23563761|NCT02093663|65790545|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
23563762|NCT02093663|65790546|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
23220319|NCT03799627|64550145|FG005|Overall Study|Death|0|||
23220320|NCT03799627|64550146|FG006|Overall Study|Death|0|||
23220321|NCT03799627|64550147|FG007|Overall Study|Death|0|||
23220322|NCT03799627|64550148|FG008|Overall Study|Death|0|||
23220323|NCT03799627|64550140|FG000|Overall Study|Study Drug Put on Hold|1|||
23563763|NCT02093663|65790547|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
23563764|NCT02093663|65790548|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
23563765|NCT02093663|65790544|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563766|NCT02093663|65790545|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563767|NCT02093663|65790546|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
23563768|NCT02093663|65790547|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563769|NCT02093663|65790548|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
23563770|NCT02093663|65790544|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
23563771|NCT02093663|65790545|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
23563772|NCT02093663|65790546|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
23563773|NCT02093663|65790547|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
23563774|NCT02093663|65790548|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
23563775|NCT02093663|65790544|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
23563776|NCT02093663|65790545|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
23563777|NCT02093663|65790546|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
23563778|NCT02093663|65790547|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
23563779|NCT02093663|65790548|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
23563780|NCT02093663|65790544|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
23563781|NCT02093663|65790545|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
23563782|NCT02093663|65790546|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
23563783|NCT02093663|65790547|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
23563784|NCT02093663|65790548|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
23563785|NCT02093663|65790544|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
23563786|NCT02093663|65790545|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
23563787|NCT02093663|65790546|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
23563788|NCT02093663|65790547|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
23563789|NCT02093663|65790548|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
23563790|NCT03321006|65790549|FG000|Overall Study|Death|1|||
23563791|NCT03321006|65790550|FG001|Overall Study|Death|0|||
23563792|NCT03321006|65790549|FG000|Overall Study|Lack of Efficacy|1|||
23563793|NCT03321006|65790550|FG001|Overall Study|Lack of Efficacy|0|||
23563794|NCT01161472|65793536|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
23563795|NCT01161472|65793537|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
23220324|NCT03799627|64550141|FG001|Overall Study|Study Drug Put on Hold|0|||
23220325|NCT03799627|64550142|FG002|Overall Study|Study Drug Put on Hold|0|||
23440991|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Death|0|||
23625989|NCT01917006|66015668|FG003|Open-label Period|Lost to Follow-up|0|||
23625990|NCT01917006|66015669|FG004|Open-label Period|Lost to Follow-up|0|||
23625991|NCT01917006|66015670|FG005|Open-label Period|Lost to Follow-up|0|||
23625992|NCT01917006|66015671|FG006|Open-label Period|Lost to Follow-up|0|||
23625993|NCT01917006|66015672|FG007|Open-label Period|Lost to Follow-up|1|||
23625994|NCT01947517|66015676|FG000|Overall Study|Withdrawal by Subject|1|||
23625995|NCT01947517|66015677|FG001|Overall Study|Withdrawal by Subject|1|||
23625996|NCT02561806|66015678|FG000|Induction Period|Adverse Event|0|||
23625997|NCT02561806|66015679|FG001|Induction Period|Adverse Event|2|||
23625998|NCT02561806|66015678|FG000|Induction Period|Lack of Efficacy|1|||
23625999|NCT02561806|66015679|FG001|Induction Period|Lack of Efficacy|0|||
23626000|NCT02561806|66015678|FG000|Induction Period|Withdrawal by Subject|0|||
23626001|NCT02561806|66015679|FG001|Induction Period|Withdrawal by Subject|2|||
23626002|NCT02561806|66015678|FG000|Induction Period|Site staff became unblinded|1|||
23626003|NCT02561806|66015679|FG001|Induction Period|Site staff became unblinded|0|||
23626004|NCT02561806|66015678|FG000|Induction Period|Randomized but not treated|0|||
23152746|NCT00529451|64309402|FG001|Overall Study|Lost to Follow-up|7|||
23152747|NCT00529451|64309403|FG002|Overall Study|Lost to Follow-up|4|||
23152748|NCT00529451|64309404|FG003|Overall Study|Lost to Follow-up|4|||
23152749|NCT00529451|64309401|FG000|Overall Study|Protocol deviation|1|||
23152750|NCT00529451|64309402|FG001|Overall Study|Protocol deviation|1|||
23152751|NCT00529451|64309403|FG002|Overall Study|Protocol deviation|4|||
23152752|NCT00529451|64309404|FG003|Overall Study|Protocol deviation|1|||
23152753|NCT00529451|64309401|FG000|Overall Study|Administrative problems|1|||
23152754|NCT00529451|64309402|FG001|Overall Study|Administrative problems|1|||
23152755|NCT00529451|64309403|FG002|Overall Study|Administrative problems|0|||
23152756|NCT00529451|64309404|FG003|Overall Study|Administrative problems|2|||
23152757|NCT00727649|64309409|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
23152758|NCT00727649|64309410|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
23152759|NCT00727649|64309409|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
23152760|NCT00727649|64309410|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
23152761|NCT00727649|64309409|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
23152762|NCT00727649|64309410|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
23152763|NCT00727649|64309409|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
23152764|NCT00727649|64309410|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
23152765|NCT00727649|64309409|FG000|Second Intervention (4-weeks)|Death|1|||
23152766|NCT00727649|64309410|FG001|Second Intervention (4-weeks)|Death|0|||
23152767|NCT00727649|64309409|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
23152768|NCT00727649|64309410|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
23152769|NCT00727649|64309409|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
23152770|NCT00727649|64309410|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
23152771|NCT02289352|64309411|FG000|Overall Study|Withdrawal by Subject|1|||
23152772|NCT02289352|64309412|FG001|Overall Study|Withdrawal by Subject|1|||
23152773|NCT02289352|64309413|FG002|Overall Study|Withdrawal by Subject|0|||
23152774|NCT03374995|64309414|FG000|Overall Study|Withdrawal by Subject|0|||
23152775|NCT03374995|64309415|FG001|Overall Study|Withdrawal by Subject|1|||
23152776|NCT01557348|64309421|FG000|Overall Study|Adverse Event|6|||
23152777|NCT01557348|64309422|FG001|Overall Study|Adverse Event|16|||
23152778|NCT01557348|64309421|FG000|Overall Study|Infusion reaction event|5|||
23152779|NCT01557348|64309422|FG001|Overall Study|Infusion reaction event|5|||
23152780|NCT01557348|64309421|FG000|Overall Study|Death|7|||
23152781|NCT01557348|64309422|FG001|Overall Study|Death|4|||
23152782|NCT01557348|64309421|FG000|Overall Study|Insufficient Therapeutic Response|13|||
23152783|NCT01557348|64309422|FG001|Overall Study|Insufficient Therapeutic Response|28|||
23152784|NCT01557348|64309421|FG000|Overall Study|Withdrawal by Subject|5|||
23152785|NCT01557348|64309422|FG001|Overall Study|Withdrawal by Subject|4|||
23152786|NCT01557348|64309421|FG000|Overall Study|Lost to Follow-up|26|||
23152787|NCT01557348|64309422|FG001|Overall Study|Lost to Follow-up|22|||
23152788|NCT01557348|64309421|FG000|Overall Study|Administrative|18|||
23152789|NCT01557348|64309422|FG001|Overall Study|Administrative|11|||
23152790|NCT00867113|64309423|FG000|Treatment Period|Adverse Event|15|||
23152791|NCT00867113|64309423|FG000|Treatment Period|Death|2|||
23152792|NCT00867113|64309423|FG000|Treatment Period|Withdrawal by Subject|19|||
23152793|NCT00867113|64309423|FG000|Treatment Period|Lost to Follow-up|3|||
23152794|NCT00867113|64309423|FG000|Treatment Period|Administrative problems|1|||
23152795|NCT00867113|64309423|FG000|Treatment Period|Disease progression/relapse|1|||
23152796|NCT00867113|64309423|FG000|Treatment Period|Protocol Violation|4|||
23152797|NCT00867113|64309423|FG000|Post Treatment After Survival Follow-up|Death|1|||
23152798|NCT00867113|64309423|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
23152799|NCT00867113|64309423|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
23152800|NCT00867113|64309423|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
23152801|NCT01829360|64309424|FG000|Overall Study|Protocol Violation|0|||
23152802|NCT01829360|64309425|FG001|Overall Study|Protocol Violation|0|||
23152803|NCT01829360|64309426|FG002|Overall Study|Protocol Violation|1|||
23152804|NCT01829360|64309427|FG003|Overall Study|Protocol Violation|0|||
23152805|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
23152806|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
23152807|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
23152808|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
23152809|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
23152810|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
23152811|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
23152812|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
23152813|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
23152814|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
23152815|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
23152816|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
23152817|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
23152818|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
23152819|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
23152820|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
23152821|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
23152822|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
23152823|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
23152824|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
23152825|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
23152826|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
23152827|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
23152828|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
23563796|NCT01161472|65793538|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
23563797|NCT01161472|65793539|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
23563798|NCT04277455|65793540|FG000|Overall Study|Lost to Follow-up|1|||
23563799|NCT03882801|65793543|FG000|Period 1|Adverse Event|0|||
23152829|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
23152830|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
23152831|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
23152832|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
23152833|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
23152834|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
23152835|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
23152836|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
23563800|NCT03882801|65793544|FG001|Period 1|Adverse Event|1|||
23563801|NCT03882801|65793543|FG000|Period 1|Non-compliance with study drug|1|||
23563802|NCT03882801|65793544|FG001|Period 1|Non-compliance with study drug|1|||
23563803|NCT03882801|65793543|FG000|Period 1|Never treated with study drug|1|||
23563804|NCT03882801|65793544|FG001|Period 1|Never treated with study drug|0|||
23563805|NCT03882801|65793543|FG000|Washout Period|Physician Decision|0|||
23563806|NCT03882801|65793544|FG001|Washout Period|Physician Decision|1|||
23563807|NCT03882801|65793543|FG000|Period 2|Non-compliance with study drug|0|||
23563808|NCT03882801|65793544|FG001|Period 2|Non-compliance with study drug|1|||
23563809|NCT01871558|65793545|FG000|Overall Study|Other reason|0|||
23563810|NCT01871558|65793546|FG001|Overall Study|Other reason|1|||
23563811|NCT01871558|65793545|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
23563812|NCT01871558|65793546|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
23563813|NCT01871558|65793545|FG000|Overall Study|Withdrawal by Subject|2|||
23563814|NCT01871558|65793546|FG001|Overall Study|Withdrawal by Subject|0|||
23563815|NCT02301156|65793563|FG000|Overall Study|Adverse Event|13|||
23563816|NCT02301156|65793564|FG001|Overall Study|Adverse Event|14|||
23563817|NCT02301156|65793563|FG000|Overall Study|Death|1|||
23563818|NCT02301156|65793564|FG001|Overall Study|Death|5|||
23563819|NCT02301156|65793563|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
23563820|NCT02301156|65793564|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
23563821|NCT02301156|65793563|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
23563822|NCT02301156|65793564|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
23563823|NCT02301156|65793563|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
23563824|NCT02301156|65793564|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
23563825|NCT02301156|65793563|FG000|Overall Study|Reason not Specified|6|||
23563826|NCT02301156|65793564|FG001|Overall Study|Reason not Specified|3|||
23563827|NCT04522180|65793565|FG000|Overall Study|Investigator judgement|3|||
23563828|NCT04522180|65793566|FG001|Overall Study|Investigator judgement|4|||
23220326|NCT03799627|64550143|FG003|Overall Study|Study Drug Put on Hold|0|||
23220327|NCT03799627|64550144|FG004|Overall Study|Study Drug Put on Hold|0|||
23220328|NCT03799627|64550145|FG005|Overall Study|Study Drug Put on Hold|0|||
23220329|NCT03799627|64550146|FG006|Overall Study|Study Drug Put on Hold|0|||
23220330|NCT03799627|64550147|FG007|Overall Study|Study Drug Put on Hold|0|||
23220331|NCT03799627|64550148|FG008|Overall Study|Study Drug Put on Hold|0|||
23220332|NCT03799627|64550140|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
23220333|NCT03799627|64550141|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
23220334|NCT03799627|64550142|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
23220335|NCT03799627|64550143|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
23220336|NCT03799627|64550144|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
23220337|NCT03799627|64550145|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
23220338|NCT03799627|64550146|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
23220339|NCT03799627|64550147|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
23220340|NCT03799627|64550148|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
23220341|NCT03799627|64550140|FG000|Overall Study|Kidney Transplantation|1|||
23220342|NCT03799627|64550141|FG001|Overall Study|Kidney Transplantation|0|||
23220343|NCT03799627|64550142|FG002|Overall Study|Kidney Transplantation|0|||
23220344|NCT03799627|64550143|FG003|Overall Study|Kidney Transplantation|1|||
23220345|NCT03799627|64550144|FG004|Overall Study|Kidney Transplantation|1|||
23220346|NCT03799627|64550145|FG005|Overall Study|Kidney Transplantation|0|||
23220347|NCT03799627|64550146|FG006|Overall Study|Kidney Transplantation|0|||
23220348|NCT03799627|64550147|FG007|Overall Study|Kidney Transplantation|0|||
23220349|NCT03799627|64550148|FG008|Overall Study|Kidney Transplantation|0|||
23220350|NCT03799627|64550140|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
23220351|NCT03799627|64550141|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
23220352|NCT03799627|64550142|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
23220353|NCT03799627|64550143|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
23220354|NCT03799627|64550144|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
23220355|NCT03799627|64550145|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
23220356|NCT03799627|64550146|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
23220357|NCT03799627|64550147|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
23220358|NCT03799627|64550148|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
23220359|NCT03799627|64550140|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23220360|NCT03799627|64550141|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
23220361|NCT03799627|64550142|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23220362|NCT03799627|64550143|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23220363|NCT03799627|64550144|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23220364|NCT03799627|64550145|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23220365|NCT03799627|64550146|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23220366|NCT03799627|64550147|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23220367|NCT03799627|64550148|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
23220368|NCT03799627|64550140|FG000|Overall Study|Met Exclusion Criteria|0|||
23220369|NCT03799627|64550141|FG001|Overall Study|Met Exclusion Criteria|0|||
23220370|NCT03799627|64550142|FG002|Overall Study|Met Exclusion Criteria|0|||
23626005|NCT02561806|66015679|FG001|Induction Period|Randomized but not treated|1|||
23626006|NCT02561806|66015678|FG000|Maintenance Period|Adverse Event|2|||
23626007|NCT02561806|66015679|FG001|Maintenance Period|Adverse Event|1|||
23626008|NCT02561806|66015678|FG000|Maintenance Period|Lack of Efficacy|3|||
23626009|NCT02561806|66015679|FG001|Maintenance Period|Lack of Efficacy|1|||
23626010|NCT02561806|66015678|FG000|Maintenance Period|Lost to Follow-up|2|||
23626011|NCT02561806|66015679|FG001|Maintenance Period|Lost to Follow-up|2|||
23626012|NCT02561806|66015678|FG000|Maintenance Period|Protocol Violation|1|||
23626013|NCT02561806|66015679|FG001|Maintenance Period|Protocol Violation|0|||
23626014|NCT02561806|66015678|FG000|Maintenance Period|Withdrawal by Subject|5|||
23626015|NCT02561806|66015679|FG001|Maintenance Period|Withdrawal by Subject|3|||
23626016|NCT02561806|66015678|FG000|Maintenance Period|Site staff became unblinded|0|||
23626017|NCT02561806|66015679|FG001|Maintenance Period|Site staff became unblinded|1|||
23626018|NCT02561806|66015678|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
23152837|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
23152838|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
23152839|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
23152840|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
23152841|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
23152842|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
23152843|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
23152844|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
23152845|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
23626019|NCT02561806|66015679|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
23626020|NCT02561806|66015678|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
23626021|NCT02561806|66015679|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
23626022|NCT01099579|66015680|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
23626023|NCT01099579|66015681|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
23626024|NCT01099579|66015682|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
23626025|NCT01099579|66015680|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
23626026|NCT01099579|66015681|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
23626027|NCT01099579|66015682|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
23626028|NCT01099579|66015680|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
23626029|NCT01099579|66015681|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
23626030|NCT01099579|66015682|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
23626031|NCT01099579|66015680|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
23626032|NCT01099579|66015681|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
23626033|NCT01099579|66015682|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
23626034|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
23626035|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
23626036|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
23626037|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
23626038|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
23626039|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
23626040|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
23626041|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
23626042|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
23626043|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
23626044|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
23626045|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
23626046|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
23626047|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
23626048|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
23626049|NCT01099579|66015680|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
23626050|NCT01099579|66015681|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
23626051|NCT01099579|66015682|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
23626052|NCT02599688|66015683|FG000|Overall Study|Lack of Efficacy|1|||
23626053|NCT02599688|66015683|FG000|Overall Study|Withdrawal by Subject|1|||
23626054|NCT02599688|66015683|FG000|Overall Study|Termination by Sponsor|2|||
23626055|NCT04947436|66015684|FG000|Overall Study|Lost to Follow-up|3|||
23626056|NCT04947436|66015685|FG001|Overall Study|Lost to Follow-up|7|||
23626057|NCT04947436|66015686|FG002|Overall Study|Lost to Follow-up|5|||
23626058|NCT04947436|66015684|FG000|Overall Study|Death|1|||
23626059|NCT04947436|66015685|FG001|Overall Study|Death|1|||
23626060|NCT04947436|66015686|FG002|Overall Study|Death|1|||
23626061|NCT01233999|66015690|FG000|Overall Study|Withdrawal by Subject|1|||
23626062|NCT01233999|66015690|FG000|Overall Study|Lost to Follow-up|1|||
23626063|NCT00617929|66015691|FG000|Overall Study|Physician Decision|1|||
23626064|NCT01806389|66015692|FG000|Overall Study|Withdrawal by Subject|4|||
23626065|NCT03000348|66015693|FG000|Overall Study|Adverse Event|1|||
23626066|NCT03000348|66015694|FG001|Overall Study|Adverse Event|1|||
23626067|NCT03000348|66015695|FG002|Overall Study|Adverse Event|1|||
23626068|NCT03000348|66015696|FG003|Overall Study|Adverse Event|1|||
23626069|NCT03000348|66015697|FG004|Overall Study|Adverse Event|1|||
23626070|NCT03000348|66015698|FG005|Overall Study|Adverse Event|1|||
23626071|NCT03000348|66015693|FG000|Overall Study|Lost to Follow-up|0|||
23626072|NCT03000348|66015694|FG001|Overall Study|Lost to Follow-up|0|||
23626073|NCT03000348|66015695|FG002|Overall Study|Lost to Follow-up|1|||
23626074|NCT03000348|66015696|FG003|Overall Study|Lost to Follow-up|0|||
23626075|NCT03000348|66015697|FG004|Overall Study|Lost to Follow-up|0|||
23626076|NCT03000348|66015698|FG005|Overall Study|Lost to Follow-up|0|||
23626077|NCT03000348|66015693|FG000|Overall Study|Withdrawal by Subject|0|||
23626078|NCT03000348|66015694|FG001|Overall Study|Withdrawal by Subject|1|||
23626079|NCT03000348|66015695|FG002|Overall Study|Withdrawal by Subject|0|||
23626080|NCT03000348|66015696|FG003|Overall Study|Withdrawal by Subject|0|||
23626081|NCT03000348|66015697|FG004|Overall Study|Withdrawal by Subject|0|||
23152846|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
23152847|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
23152848|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
23152849|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
23626082|NCT03000348|66015698|FG005|Overall Study|Withdrawal by Subject|0|||
23626083|NCT03000348|66015693|FG000|Overall Study|Consent|0|||
23626084|NCT03000348|66015694|FG001|Overall Study|Consent|0|||
23626085|NCT03000348|66015695|FG002|Overall Study|Consent|0|||
23626086|NCT03000348|66015696|FG003|Overall Study|Consent|0|||
23626087|NCT03000348|66015697|FG004|Overall Study|Consent|1|||
23626088|NCT03000348|66015698|FG005|Overall Study|Consent|0|||
23626089|NCT03000348|66015693|FG000|Overall Study|Failure to expectorate sputum|1|||
23626090|NCT03000348|66015694|FG001|Overall Study|Failure to expectorate sputum|0|||
23626091|NCT03000348|66015695|FG002|Overall Study|Failure to expectorate sputum|1|||
23626092|NCT03000348|66015696|FG003|Overall Study|Failure to expectorate sputum|0|||
23626093|NCT03000348|66015697|FG004|Overall Study|Failure to expectorate sputum|1|||
23626094|NCT03000348|66015698|FG005|Overall Study|Failure to expectorate sputum|0|||
23220371|NCT03799627|64550143|FG003|Overall Study|Met Exclusion Criteria|1|||
23220372|NCT03799627|64550144|FG004|Overall Study|Met Exclusion Criteria|0|||
23220373|NCT03799627|64550145|FG005|Overall Study|Met Exclusion Criteria|0|||
23220374|NCT03799627|64550146|FG006|Overall Study|Met Exclusion Criteria|0|||
23220375|NCT03799627|64550147|FG007|Overall Study|Met Exclusion Criteria|0|||
23220376|NCT03799627|64550148|FG008|Overall Study|Met Exclusion Criteria|0|||
23220377|NCT03799627|64550140|FG000|Overall Study|Investigational Product Noncompliance|0|||
23220378|NCT03799627|64550141|FG001|Overall Study|Investigational Product Noncompliance|0|||
23220379|NCT03799627|64550142|FG002|Overall Study|Investigational Product Noncompliance|0|||
23220380|NCT03799627|64550143|FG003|Overall Study|Investigational Product Noncompliance|1|||
23326415|NCT03850483|64937889|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
23326416|NCT03850483|64937880|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
23326417|NCT03850483|64937881|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
23326418|NCT03850483|64937882|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
23326419|NCT03850483|64937883|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
23326420|NCT03850483|64937884|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
23326421|NCT03850483|64937885|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
23326422|NCT03850483|64937886|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
23326423|NCT03850483|64937887|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
23326424|NCT03850483|64937888|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
23326425|NCT03850483|64937889|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
23326426|NCT03850483|64937880|FG000|Follow-up For Stage 2|Other|0|||
23326427|NCT03850483|64937881|FG001|Follow-up For Stage 2|Other|0|||
23326428|NCT03850483|64937882|FG002|Follow-up For Stage 2|Other|0|||
23326429|NCT03850483|64937883|FG003|Follow-up For Stage 2|Other|0|||
23326430|NCT03850483|64937884|FG004|Follow-up For Stage 2|Other|0|||
23326431|NCT03850483|64937885|FG005|Follow-up For Stage 2|Other|0|||
23326432|NCT03850483|64937886|FG006|Follow-up For Stage 2|Other|0|||
23326433|NCT03850483|64937887|FG007|Follow-up For Stage 2|Other|0|||
23326434|NCT03850483|64937888|FG008|Follow-up For Stage 2|Other|0|||
23326435|NCT03850483|64937889|FG009|Follow-up For Stage 2|Other|1|||
23326436|NCT00473590|64937890|FG000|Overall Study|Adverse Event|3|||
23326437|NCT00473590|64937891|FG001|Overall Study|Adverse Event|3|||
23326438|NCT00473590|64937890|FG000|Overall Study|Death|4|||
23326439|NCT00473590|64937891|FG001|Overall Study|Death|2|||
23326440|NCT00473590|64937890|FG000|Overall Study|Progression not resulting in death|24|||
23326441|NCT00473590|64937891|FG001|Overall Study|Progression not resulting in death|20|||
23326442|NCT00473590|64937890|FG000|Overall Study|Non-protocol-specified therapy|7|||
23326443|NCT00473590|64937891|FG001|Overall Study|Non-protocol-specified therapy|5|||
23326444|NCT00473590|64937890|FG000|Overall Study|Physician Decision|2|||
23326445|NCT00473590|64937891|FG001|Overall Study|Physician Decision|4|||
23326446|NCT00473590|64937890|FG000|Overall Study|Withdrawal by Subject|5|||
23326447|NCT00473590|64937891|FG001|Overall Study|Withdrawal by Subject|3|||
23326448|NCT00473590|64937890|FG000|Overall Study|Other|0|||
23326449|NCT00473590|64937891|FG001|Overall Study|Other|1|||
23326450|NCT02568189|64937897|FG000|Overall Study|Protocol Violation|0|||
23326451|NCT02568189|64937898|FG001|Overall Study|Protocol Violation|0|||
23326452|NCT02568189|64937899|FG002|Overall Study|Protocol Violation|19|||
23326453|NCT02568189|64937900|FG003|Overall Study|Protocol Violation|18|||
23326454|NCT05266053|64937902|FG000|Overall Study|Withdrawal by Subject|8|||
23326455|NCT05266053|64937903|FG001|Overall Study|Withdrawal by Subject|4|||
23326456|NCT00725283|64937904|FG000|Overall Study|Missing Code|3|||
23326457|NCT00725283|64937904|FG000|Overall Study|Death|5|||
23326458|NCT00725283|64937904|FG000|Overall Study|Other|6|||
23326459|NCT00725283|64937904|FG000|Overall Study|Withdrawal by Subject|10|||
23326460|NCT01000155|64937905|FG000|Overall Study|Withdrawal by Subject|1|||
23326461|NCT01000155|64937905|FG000|Overall Study|Adverse Event|1|||
23326462|NCT01686373|64937908|FG000|Overall Study|Lost to Follow-up|3|||
23440992|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Death|1|||
23440993|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Death|1|||
23626095|NCT03000348|66015693|FG000|Overall Study|No gram negative|1|||
23626096|NCT03000348|66015694|FG001|Overall Study|No gram negative|2|||
23220381|NCT03799627|64550144|FG004|Overall Study|Investigational Product Noncompliance|0|||
23220382|NCT03799627|64550145|FG005|Overall Study|Investigational Product Noncompliance|0|||
23326463|NCT01686373|64937909|FG001|Overall Study|Lost to Follow-up|0|||
23326464|NCT01686373|64937908|FG000|Overall Study|Withdrawal by Subject|0|||
23326465|NCT01686373|64937909|FG001|Overall Study|Withdrawal by Subject|1|||
23326466|NCT01686373|64937908|FG000|Overall Study|Adverse Event|0|||
23326467|NCT01686373|64937909|FG001|Overall Study|Adverse Event|1|||
23326468|NCT01402570|64937910|FG000|Overall Study|Adverse Event|1|||
23326469|NCT03627546|64937911|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
23326470|NCT03627546|64937912|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
23326471|NCT03627546|64937913|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
23326472|NCT03627546|64937911|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
23326473|NCT03627546|64937912|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
23326474|NCT03627546|64937913|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
23326475|NCT03411863|64937917|FG000|Overall Study|Withdrawal by Subject|3|||
23326476|NCT03411863|64937918|FG001|Overall Study|Withdrawal by Subject|1|||
23326477|NCT03411863|64937917|FG000|Overall Study|Physician Decision|0|||
23326478|NCT03411863|64937918|FG001|Overall Study|Physician Decision|1|||
23326479|NCT01068860|64937921|FG000|Overall Study|Withdrawal by Subject|0|||
23326480|NCT01068860|64937922|FG001|Overall Study|Withdrawal by Subject|0|||
23326481|NCT01068860|64937923|FG002|Overall Study|Withdrawal by Subject|0|||
23326482|NCT01068860|64937924|FG003|Overall Study|Withdrawal by Subject|0|||
23326483|NCT01068860|64937925|FG004|Overall Study|Withdrawal by Subject|0|||
23326484|NCT01068860|64937926|FG005|Overall Study|Withdrawal by Subject|2|||
23326485|NCT01068860|64937927|FG006|Overall Study|Withdrawal by Subject|0|||
23326486|NCT01068860|64937928|FG007|Overall Study|Withdrawal by Subject|0|||
23326487|NCT01068860|64937929|FG008|Overall Study|Withdrawal by Subject|0|||
23626097|NCT03000348|66015695|FG002|Overall Study|No gram negative|1|||
23626098|NCT03000348|66015696|FG003|Overall Study|No gram negative|1|||
23626099|NCT03000348|66015697|FG004|Overall Study|No gram negative|1|||
23626100|NCT03000348|66015698|FG005|Overall Study|No gram negative|1|||
23626101|NCT03000348|66015693|FG000|Overall Study|Patient had no transport|0|||
23626102|NCT03000348|66015694|FG001|Overall Study|Patient had no transport|0|||
23626103|NCT03000348|66015695|FG002|Overall Study|Patient had no transport|0|||
23626104|NCT03000348|66015696|FG003|Overall Study|Patient had no transport|1|||
23626105|NCT03000348|66015697|FG004|Overall Study|Patient had no transport|0|||
23626106|NCT03000348|66015698|FG005|Overall Study|Patient had no transport|0|||
23626107|NCT03000348|66015693|FG000|Overall Study|Dosing|0|||
23626108|NCT03000348|66015694|FG001|Overall Study|Dosing|0|||
23626109|NCT03000348|66015695|FG002|Overall Study|Dosing|0|||
23626110|NCT03000348|66015696|FG003|Overall Study|Dosing|0|||
23626111|NCT03000348|66015697|FG004|Overall Study|Dosing|1|||
23152850|NCT03627767|64309428|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
23152851|NCT03627767|64309429|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
23326488|NCT01068860|64937930|FG009|Overall Study|Withdrawal by Subject|3|||
23626112|NCT03000348|66015698|FG005|Overall Study|Dosing|0|||
23626113|NCT00770588|66020197|FG000|Overall Study|Adverse Event|9|||
23626114|NCT00770588|66020198|FG001|Overall Study|Adverse Event|2|||
23626115|NCT00770588|66020197|FG000|Overall Study|Death caused by progression of disease|70|||
23626116|NCT00770588|66020198|FG001|Overall Study|Death caused by progression of disease|91|||
23626117|NCT00770588|66020197|FG000|Overall Study|Lost to Follow-up|1|||
23626118|NCT00770588|66020198|FG001|Overall Study|Lost to Follow-up|1|||
23626119|NCT00770588|66020197|FG000|Overall Study|Withdrawal by Subject|1|||
23626120|NCT00770588|66020198|FG001|Overall Study|Withdrawal by Subject|1|||
23626121|NCT04160988|66020201|FG000|Overall Study|poor image quality|28|||
23626122|NCT02153905|66020203|FG000|Overall Study|Death|1|||
23626123|NCT02153905|66020204|FG001|Overall Study|Death|0|||
23626124|NCT03634839|66020211|FG000|First Intervention (2 Hours)|Adverse Event|0|||
23626125|NCT03634839|66020212|FG001|First Intervention (2 Hours)|Adverse Event|2|||
23626126|NCT00912223|66020213|FG000|Overall Study|Withdrawal by Subject|1|||
23626127|NCT00912223|66020213|FG000|Overall Study|Not transplanted|1|||
23626128|NCT00912223|66020213|FG000|Overall Study|Transformed disease|1|||
23626129|NCT02561247|66020214|FG000|Overall Study|Protocol Violation|1|||
23626130|NCT02561247|66020214|FG000|Overall Study|Withdrawal by Subject|1|||
23626131|NCT02561247|66020214|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
23626132|NCT03512197|66020216|FG000|Overall Study|Guardian decision|1|||
23626133|NCT03512197|66020217|FG001|Overall Study|Guardian decision|1|||
23626134|NCT03512197|66020216|FG000|Overall Study|Lack of Efficacy|19|||
23626135|NCT03512197|66020217|FG001|Overall Study|Lack of Efficacy|11|||
23626136|NCT03512197|66020216|FG000|Overall Study|New Therapy for Study Indication|16|||
23626137|NCT03512197|66020217|FG001|Overall Study|New Therapy for Study Indication|16|||
23626138|NCT03512197|66020216|FG000|Overall Study|Physician Decision|60|||
23626139|NCT03512197|66020217|FG001|Overall Study|Physician Decision|60|||
23326489|NCT01068860|64937921|FG000|Overall Study|Administrative problems; misrandomized|0|||
23626140|NCT03512197|66020216|FG000|Overall Study|Protocol Violation|0|||
23626141|NCT03512197|66020217|FG001|Overall Study|Protocol Violation|2|||
23626142|NCT03512197|66020216|FG000|Overall Study|Terminated by Sponsored|46|||
23626143|NCT03512197|66020217|FG001|Overall Study|Terminated by Sponsored|50|||
23626144|NCT03512197|66020216|FG000|Overall Study|Subject Decision|15|||
23626145|NCT03512197|66020217|FG001|Overall Study|Subject Decision|12|||
23626146|NCT03512197|66020216|FG000|Overall Study|Withdrawal of informed consent|20|||
23326490|NCT01068860|64937922|FG001|Overall Study|Administrative problems; misrandomized|0|||
23326491|NCT01068860|64937923|FG002|Overall Study|Administrative problems; misrandomized|0|||
23626147|NCT03512197|66020217|FG001|Overall Study|Withdrawal of informed consent|14|||
23626148|NCT03512197|66020216|FG000|Overall Study|Adverse Event|30|||
23626149|NCT03512197|66020217|FG001|Overall Study|Adverse Event|34|||
23626150|NCT03512197|66020216|FG000|Overall Study|Death|14|||
23626151|NCT03512197|66020217|FG001|Overall Study|Death|9|||
23626152|NCT03512197|66020216|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
23626153|NCT03512197|66020217|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
23626154|NCT03512197|66020216|FG000|Overall Study|Missing|3|||
23626155|NCT03512197|66020217|FG001|Overall Study|Missing|13|||
23626156|NCT02804399|66020218|FG000|Period 2|Adverse Event|0|||
23626157|NCT02804399|66020219|FG001|Period 2|Adverse Event|1|||
23626158|NCT02447718|66020220|FG000|Overall Study|Lost to Follow-up|8|||
23626159|NCT02447718|66020221|FG001|Overall Study|Lost to Follow-up|0|||
23626160|NCT02447718|66020220|FG000|Overall Study|Withdrawal by Subject|3|||
23626161|NCT02447718|66020221|FG001|Overall Study|Withdrawal by Subject|0|||
23626162|NCT02447718|66020220|FG000|Overall Study|Screen Failure|1|||
23626163|NCT02447718|66020221|FG001|Overall Study|Screen Failure|0|||
23626164|NCT04042077|66020222|FG000|Overall Study|Adverse Event|0|||
23626165|NCT04042077|66020223|FG001|Overall Study|Adverse Event|1|||
23626166|NCT04042077|66020222|FG000|Overall Study|Death|2|||
23626167|NCT04042077|66020223|FG001|Overall Study|Death|1|||
23326492|NCT01068860|64937924|FG003|Overall Study|Administrative problems; misrandomized|1|||
23326493|NCT01068860|64937925|FG004|Overall Study|Administrative problems; misrandomized|0|||
23326494|NCT01068860|64937926|FG005|Overall Study|Administrative problems; misrandomized|0|||
23326495|NCT01068860|64937927|FG006|Overall Study|Administrative problems; misrandomized|0|||
23326496|NCT01068860|64937928|FG007|Overall Study|Administrative problems; misrandomized|0|||
23326497|NCT01068860|64937929|FG008|Overall Study|Administrative problems; misrandomized|0|||
23326498|NCT01068860|64937930|FG009|Overall Study|Administrative problems; misrandomized|1|||
23326499|NCT01068860|64937921|FG000|Overall Study|Lost to Follow-up|0|||
23326500|NCT01068860|64937922|FG001|Overall Study|Lost to Follow-up|1|||
23326501|NCT01068860|64937923|FG002|Overall Study|Lost to Follow-up|0|||
23326502|NCT01068860|64937924|FG003|Overall Study|Lost to Follow-up|0|||
23626168|NCT04042077|66020222|FG000|Overall Study|Physician Decision|2|||
23626169|NCT04042077|66020223|FG001|Overall Study|Physician Decision|0|||
23626170|NCT04042077|66020222|FG000|Overall Study|Withdrawal by Subject|3|||
23626171|NCT04042077|66020223|FG001|Overall Study|Withdrawal by Subject|2|||
23626172|NCT04042077|66020222|FG000|Overall Study|Lack of Efficacy|0|||
23626173|NCT04042077|66020223|FG001|Overall Study|Lack of Efficacy|1|||
23626174|NCT03174782|66020234|FG000|Overall Study|Protocol Violation|1|||
23626175|NCT03174782|66020235|FG001|Overall Study|Protocol Violation|0|||
23626176|NCT03174782|66020234|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
23626177|NCT03174782|66020235|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
23626178|NCT02573493|66020236|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
23626179|NCT02573493|66020237|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
23626180|NCT02573493|66020238|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
23626181|NCT02573493|66020239|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
23626182|NCT00723125|66020240|FG000|Overall Study|Met Dx|1|||
23626183|NCT00723125|66020241|FG001|Overall Study|Met Dx|0|||
23626184|NCT00723125|66020240|FG000|Overall Study|Withdrawal by Subject|15|||
23626185|NCT00723125|66020241|FG001|Overall Study|Withdrawal by Subject|6|||
23626186|NCT00723125|66020240|FG000|Overall Study|Adverse Event|2|||
23626187|NCT00723125|66020241|FG001|Overall Study|Adverse Event|0|||
23626188|NCT01018732|66020242|FG000|Overall Study|Lost to Follow-up|0|||
23626189|NCT01018732|66020243|FG001|Overall Study|Lost to Follow-up|0|||
23626190|NCT01018732|66020244|FG002|Overall Study|Lost to Follow-up|3|||
23626191|NCT01018732|66020242|FG000|Overall Study|Protocol Violation|1|||
23626192|NCT01018732|66020243|FG001|Overall Study|Protocol Violation|1|||
23626193|NCT01018732|66020244|FG002|Overall Study|Protocol Violation|0|||
23626194|NCT01018732|66020242|FG000|Overall Study|Inappropriate Enrollment|0|||
23626195|NCT01018732|66020243|FG001|Overall Study|Inappropriate Enrollment|1|||
23563829|NCT04522180|65793565|FG000|Overall Study|Voluntary withdrawal|1|||
23563830|NCT04522180|65793566|FG001|Overall Study|Voluntary withdrawal|0|||
23563831|NCT04522180|65793565|FG000|Overall Study|Pregnancy|0|||
23563832|NCT04522180|65793566|FG001|Overall Study|Pregnancy|1|||
23563833|NCT04522180|65793565|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
23563834|NCT04522180|65793566|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
23563835|NCT04522180|65793565|FG000|Overall Study|Reason not specified|8|||
23563836|NCT04522180|65793566|FG001|Overall Study|Reason not specified|5|||
23563837|NCT00988221|65793567|FG000|Part I|Adverse Event|0|||
23563838|NCT00988221|65793568|FG001|Part I|Adverse Event|1|||
23563839|NCT00988221|65793569|FG002|Part I|Adverse Event|2|||
23626196|NCT01018732|66020244|FG002|Overall Study|Inappropriate Enrollment|0|||
23626197|NCT01018732|66020242|FG000|Overall Study|Unable to Classify|0|||
23152852|NCT03627767|64309430|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
23626198|NCT01018732|66020243|FG001|Overall Study|Unable to Classify|0|||
23626199|NCT01018732|66020244|FG002|Overall Study|Unable to Classify|1|||
23626200|NCT04544865|66020245|FG000|Overall Study|Death|0|||
23626201|NCT04544865|66020246|FG001|Overall Study|Death|2|||
23326503|NCT01068860|64937925|FG004|Overall Study|Lost to Follow-up|0|||
23326504|NCT01068860|64937926|FG005|Overall Study|Lost to Follow-up|0|||
23326505|NCT01068860|64937927|FG006|Overall Study|Lost to Follow-up|0|||
23626202|NCT04544865|66020245|FG000|Overall Study|Lost to Follow-up|11|||
23626203|NCT04544865|66020246|FG001|Overall Study|Lost to Follow-up|7|||
23220383|NCT03799627|64550146|FG006|Overall Study|Investigational Product Noncompliance|0|||
23220384|NCT03799627|64550147|FG007|Overall Study|Investigational Product Noncompliance|0|||
23220385|NCT03799627|64550148|FG008|Overall Study|Investigational Product Noncompliance|0|||
23326506|NCT01068860|64937928|FG007|Overall Study|Lost to Follow-up|0|||
23326507|NCT01068860|64937929|FG008|Overall Study|Lost to Follow-up|0|||
23326508|NCT01068860|64937930|FG009|Overall Study|Lost to Follow-up|0|||
23326509|NCT00105079|64937939|FG000|Overall Study|Adverse Event|5|||
23326510|NCT00105079|64937940|FG001|Overall Study|Adverse Event|12|||
23326511|NCT00105079|64937939|FG000|Overall Study|Death|3|||
23326512|NCT00105079|64937940|FG001|Overall Study|Death|1|||
23326513|NCT00105079|64937939|FG000|Overall Study|Lost to Follow-up|12|||
23326514|NCT00105079|64937940|FG001|Overall Study|Lost to Follow-up|12|||
23326515|NCT00105079|64937939|FG000|Overall Study|Lack of Efficacy|9|||
23326516|NCT00105079|64937940|FG001|Overall Study|Lack of Efficacy|3|||
23326517|NCT00105079|64937939|FG000|Overall Study|Refused treatment|6|||
23626204|NCT04544865|66020245|FG000|Overall Study|Withdrawal by Subject|0|||
23626205|NCT04544865|66020246|FG001|Overall Study|Withdrawal by Subject|1|||
23626206|NCT04544865|66020245|FG000|Overall Study|Other|0|||
23626207|NCT04544865|66020246|FG001|Overall Study|Other|1|||
23626208|NCT00464945|66020247|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
23626209|NCT00464945|66020248|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
23626210|NCT00464945|66020247|FG000|Infant Series|Protocol Violation|1|||
23626211|NCT00464945|66020248|FG001|Infant Series|Protocol Violation|0|||
23626212|NCT00464945|66020247|FG000|Infant Series|Lost to Follow-up|1|||
23626213|NCT00464945|66020248|FG001|Infant Series|Lost to Follow-up|0|||
23626214|NCT00464945|66020247|FG000|After Infant Series|Withdrawal by Subject|0|||
23626215|NCT00464945|66020248|FG001|After Infant Series|Withdrawal by Subject|2|||
23626216|NCT00464945|66020247|FG000|Toddler Dose|Lost to Follow-up|0|||
23626217|NCT00464945|66020248|FG001|Toddler Dose|Lost to Follow-up|1|||
23626218|NCT02548078|66020251|FG000|Overall Study|Serious adverse event/Adverse event|1|||
23626219|NCT02548078|66020252|FG001|Overall Study|Serious adverse event/Adverse event|0|||
23626220|NCT02548078|66020251|FG000|Overall Study|Moved from study area|3|||
23626221|NCT02548078|66020252|FG001|Overall Study|Moved from study area|3|||
23626222|NCT02548078|66020251|FG000|Overall Study|Lost to Follow-up|1|||
23626223|NCT02548078|66020252|FG001|Overall Study|Lost to Follow-up|3|||
23626224|NCT01547117|66020253|FG000|Overall Study|Physician Decision|0|||
23626225|NCT01547117|66020254|FG001|Overall Study|Physician Decision|1|||
23152853|NCT03627767|64309431|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
23152854|NCT03627767|64309432|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
23152855|NCT03627767|64309428|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
23152856|NCT03627767|64309429|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
23152857|NCT03627767|64309430|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
23152858|NCT03627767|64309431|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
23152859|NCT03627767|64309432|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
23152860|NCT03627767|64309428|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23152861|NCT03627767|64309429|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23152862|NCT03627767|64309430|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
23152863|NCT03627767|64309431|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
23152864|NCT03627767|64309432|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
23152865|NCT03627767|64309428|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
23152866|NCT03627767|64309429|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
23152867|NCT03627767|64309430|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
23152868|NCT03627767|64309431|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
23152869|NCT03627767|64309432|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
23220386|NCT03799627|64550140|FG000|Overall Study|Participant Relocation|0|||
23326518|NCT00105079|64937940|FG001|Overall Study|Refused treatment|4|||
23326519|NCT00105079|64937939|FG000|Overall Study|Violation of selection criteria at entry|0|||
23563840|NCT00988221|65793570|FG003|Part I|Adverse Event|0|||
23563841|NCT00988221|65793567|FG000|Part I|Insufficient Therapeutic Response|4|||
23563842|NCT00988221|65793568|FG001|Part I|Insufficient Therapeutic Response|6|||
23563843|NCT00988221|65793569|FG002|Part I|Insufficient Therapeutic Response|5|||
23563844|NCT00988221|65793570|FG003|Part I|Insufficient Therapeutic Response|0|||
23563845|NCT00988221|65793567|FG000|Part I|Refused Treatment|0|||
23563846|NCT00988221|65793568|FG001|Part I|Refused Treatment|2|||
23563847|NCT00988221|65793569|FG002|Part I|Refused Treatment|1|||
23563848|NCT00988221|65793570|FG003|Part I|Refused Treatment|0|||
23563849|NCT00988221|65793567|FG000|Part I|Lost to Follow-up|0|||
23626226|NCT01547117|66020255|FG002|Overall Study|Physician Decision|1|||
23626227|NCT01547117|66020256|FG003|Overall Study|Physician Decision|3|||
23326520|NCT00105079|64937940|FG001|Overall Study|Violation of selection criteria at entry|2|||
23326521|NCT00105079|64937939|FG000|Overall Study|Protocol Violation|1|||
23326522|NCT00105079|64937940|FG001|Overall Study|Protocol Violation|0|||
23326523|NCT00105079|64937939|FG000|Overall Study|Other|3|||
23326524|NCT00105079|64937940|FG001|Overall Study|Other|1|||
23326525|NCT03839628|64937941|FG000|Overall Study|Withdrawal by Subject|1|||
23326526|NCT00764881|64937942|FG000|Overall Study|Adverse Event|5|||
23326527|NCT00764881|64937943|FG001|Overall Study|Adverse Event|1|||
23326528|NCT00764881|64937942|FG000|Overall Study|Withdrawal by Subject|1|||
23326529|NCT00764881|64937943|FG001|Overall Study|Withdrawal by Subject|3|||
23326530|NCT00764881|64937942|FG000|Overall Study|Protocol Violation|2|||
23326531|NCT00764881|64937943|FG001|Overall Study|Protocol Violation|2|||
23326532|NCT00764881|64937942|FG000|Overall Study|Lost to Follow-up|2|||
23326533|NCT00764881|64937943|FG001|Overall Study|Lost to Follow-up|0|||
23326534|NCT00764881|64937942|FG000|Overall Study|Noncompliant|1|||
23152870|NCT03627767|64309428|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23152871|NCT03627767|64309429|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
23152872|NCT03627767|64309430|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
23152873|NCT03627767|64309431|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
23152874|NCT03627767|64309432|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
23152875|NCT03627767|64309428|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
23326535|NCT00764881|64937943|FG001|Overall Study|Noncompliant|0|||
23326536|NCT00764881|64937942|FG000|Overall Study|Accidentally discontinued study drug|1|||
23326537|NCT00764881|64937943|FG001|Overall Study|Accidentally discontinued study drug|0|||
23326538|NCT00764881|64937942|FG000|Overall Study|Wished to become pregnant|1|||
23326539|NCT00764881|64937943|FG001|Overall Study|Wished to become pregnant|0|||
23326540|NCT00764881|64937942|FG000|Overall Study|Carcinoma detected|1|||
23326541|NCT00764881|64937943|FG001|Overall Study|Carcinoma detected|0|||
23326542|NCT00764881|64937942|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
23326543|NCT00764881|64937943|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
23326544|NCT00764881|64937942|FG000|Overall Study|no treatment or no observation|2|||
23326545|NCT00764881|64937943|FG001|Overall Study|no treatment or no observation|2|||
23326546|NCT01422213|64937946|FG000|Overall Study|Adverse Event|8|||
23326547|NCT01422213|64937947|FG001|Overall Study|Adverse Event|7|||
23326548|NCT01422213|64937948|FG002|Overall Study|Adverse Event|11|||
23326549|NCT01422213|64937946|FG000|Overall Study|Lack of Efficacy|10|||
23326550|NCT01422213|64937947|FG001|Overall Study|Lack of Efficacy|2|||
23326551|NCT01422213|64937948|FG002|Overall Study|Lack of Efficacy|2|||
23326552|NCT01422213|64937946|FG000|Overall Study|Non-compliance with study drug|0|||
23326553|NCT01422213|64937947|FG001|Overall Study|Non-compliance with study drug|1|||
23326554|NCT01422213|64937948|FG002|Overall Study|Non-compliance with study drug|0|||
23326555|NCT01422213|64937946|FG000|Overall Study|Protocol Violation|0|||
23326556|NCT01422213|64937947|FG001|Overall Study|Protocol Violation|2|||
23326557|NCT01422213|64937948|FG002|Overall Study|Protocol Violation|4|||
23326558|NCT01422213|64937946|FG000|Overall Study|Withdrawal of Consent|7|||
23326559|NCT01422213|64937947|FG001|Overall Study|Withdrawal of Consent|3|||
23326560|NCT01422213|64937948|FG002|Overall Study|Withdrawal of Consent|5|||
23326561|NCT01422213|64937946|FG000|Overall Study|Lost to Follow-up|3|||
23152876|NCT03627767|64309429|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
23152877|NCT03627767|64309430|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
23152878|NCT03627767|64309431|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
23152879|NCT03627767|64309432|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
23326562|NCT01422213|64937947|FG001|Overall Study|Lost to Follow-up|3|||
23326563|NCT01422213|64937948|FG002|Overall Study|Lost to Follow-up|5|||
23326564|NCT01422213|64937946|FG000|Overall Study|Administrative or Other Reason(s)|5|||
23326565|NCT01422213|64937947|FG001|Overall Study|Administrative or Other Reason(s)|4|||
23326566|NCT01422213|64937948|FG002|Overall Study|Administrative or Other Reason(s)|2|||
23326567|NCT03022084|64937949|FG000|Overall Study|Lost to Follow-up|2|||
23326568|NCT03022084|64937950|FG001|Overall Study|Lost to Follow-up|3|||
23563850|NCT00988221|65793568|FG001|Part I|Lost to Follow-up|1|||
23563851|NCT00988221|65793569|FG002|Part I|Lost to Follow-up|0|||
23563852|NCT00988221|65793570|FG003|Part I|Lost to Follow-up|0|||
23563853|NCT00988221|65793567|FG000|Part II|Adverse Event|1|||
23563854|NCT00988221|65793568|FG001|Part II|Adverse Event|0|||
23563855|NCT00988221|65793569|FG002|Part II|Adverse Event|0|||
23563856|NCT00988221|65793570|FG003|Part II|Adverse Event|1|||
23563857|NCT00988221|65793567|FG000|Part II|Withdrawal by Subject|0|||
23563858|NCT00988221|65793568|FG001|Part II|Withdrawal by Subject|0|||
23563859|NCT00988221|65793569|FG002|Part II|Withdrawal by Subject|2|||
23326569|NCT00450437|64937951|FG000|Overall Study|Withdrawal by Subject|10|||
23326570|NCT00450437|64937952|FG001|Overall Study|Withdrawal by Subject|2|||
23326571|NCT00450437|64937953|FG002|Overall Study|Withdrawal by Subject|0|||
23326572|NCT00450437|64937954|FG003|Overall Study|Withdrawal by Subject|1|||
23563860|NCT00988221|65793570|FG003|Part II|Withdrawal by Subject|2|||
23563861|NCT00988221|65793567|FG000|Part II|Reason not Specified|0|||
23440994|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
23440995|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
23440996|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
23440997|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
23440998|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
23440999|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
23441000|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
23441001|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
23441002|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
23441003|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
23441004|NCT00302211|65355365|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
23441005|NCT00302211|65355366|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
23441006|NCT00302211|65355367|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
23441007|NCT00302211|65355368|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
23441008|NCT00302211|65355369|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
23441009|NCT00709618|65355376|FG000|Overall Study|Withdrawal by Subject|4|||
23441010|NCT00709618|65355376|FG000|Overall Study|Lost to Follow-up|1|||
23441011|NCT00709618|65355376|FG000|Overall Study|Study Closed/Terminated|25|||
23441012|NCT00264537|65355377|FG000|Overall Study|Death|0|||
23441013|NCT00264537|65355378|FG001|Overall Study|Death|3|||
23441014|NCT00264537|65355379|FG002|Overall Study|Death|3|||
23441015|NCT00264537|65355380|FG003|Overall Study|Death|2|||
23152880|NCT03627767|64309428|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
23441016|NCT00264537|65355377|FG000|Overall Study|Lost to Follow-up|3|||
23441017|NCT00264537|65355378|FG001|Overall Study|Lost to Follow-up|4|||
23441018|NCT00264537|65355379|FG002|Overall Study|Lost to Follow-up|7|||
23563862|NCT00988221|65793568|FG001|Part II|Reason not Specified|0|||
23563863|NCT00988221|65793569|FG002|Part II|Reason not Specified|1|||
23563864|NCT00988221|65793570|FG003|Part II|Reason not Specified|0|||
23563865|NCT00988221|65793567|FG000|Part III|Adverse Event|1|||
23563866|NCT00988221|65793568|FG001|Part III|Adverse Event|0|||
23563867|NCT00988221|65793569|FG002|Part III|Adverse Event|1|||
23563868|NCT00988221|65793570|FG003|Part III|Adverse Event|0|||
23563869|NCT00988221|65793567|FG000|Part III|Insufficient Therapeutic Response|0|||
23563870|NCT00988221|65793568|FG001|Part III|Insufficient Therapeutic Response|1|||
23563871|NCT00988221|65793569|FG002|Part III|Insufficient Therapeutic Response|1|||
23563872|NCT00988221|65793570|FG003|Part III|Insufficient Therapeutic Response|0|||
23563873|NCT00988221|65793567|FG000|Part III|Refused Treatment|0|||
23563874|NCT00988221|65793568|FG001|Part III|Refused Treatment|0|||
23563875|NCT00988221|65793569|FG002|Part III|Refused Treatment|1|||
23563876|NCT00988221|65793570|FG003|Part III|Refused Treatment|0|||
23563877|NCT02013388|65793571|FG000|Overall Study|work emergency|1|||
23563878|NCT02013388|65793572|FG001|Overall Study|work emergency|0|||
23563879|NCT02013388|65793573|FG002|Overall Study|work emergency|0|||
23626228|NCT01547117|66020253|FG000|Overall Study|Withdrawal by Subject|1|||
23626229|NCT01547117|66020254|FG001|Overall Study|Withdrawal by Subject|2|||
23626230|NCT01547117|66020255|FG002|Overall Study|Withdrawal by Subject|1|||
23441019|NCT00264537|65355380|FG003|Overall Study|Lost to Follow-up|6|||
23441020|NCT00264537|65355377|FG000|Overall Study|Adverse Event|21|||
23626231|NCT01547117|66020256|FG003|Overall Study|Withdrawal by Subject|2|||
23441021|NCT00264537|65355378|FG001|Overall Study|Adverse Event|32|||
23441022|NCT00264537|65355379|FG002|Overall Study|Adverse Event|24|||
23441023|NCT00264537|65355380|FG003|Overall Study|Adverse Event|34|||
23563880|NCT02013388|65793574|FG003|Overall Study|work emergency|0|||
23563881|NCT02013388|65793575|FG004|Overall Study|work emergency|1|||
23563882|NCT02013388|65793576|FG005|Overall Study|work emergency|0|||
23626232|NCT00810342|66020257|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
23626233|NCT00810342|66020258|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
23626234|NCT00810342|66020257|FG000|Month 1 Follow-up|Pregnancy|1|||
23626235|NCT00810342|66020258|FG001|Month 1 Follow-up|Pregnancy|0|||
23626236|NCT00810342|66020257|FG000|6-month Follow-up|Lost to Follow-up|18|||
23626237|NCT00810342|66020258|FG001|6-month Follow-up|Lost to Follow-up|6|||
23626238|NCT00810342|66020257|FG000|6-month Follow-up|Pregnancy|6|||
23626239|NCT00810342|66020258|FG001|6-month Follow-up|Pregnancy|2|||
23152881|NCT03627767|64309429|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
23152882|NCT03627767|64309430|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
23563883|NCT02013388|65793577|FG006|Overall Study|work emergency|0|||
23563884|NCT02013388|65793578|FG007|Overall Study|work emergency|0|||
23563885|NCT02066402|65793585|FG000|Overall Study|Adverse Event|1|||
23563886|NCT02066402|65793586|FG001|Overall Study|Adverse Event|2|||
23563887|NCT02066402|65793585|FG000|Overall Study|Lost to Follow-up|11|||
23626240|NCT00810342|66020257|FG000|12-month Followup|Pregnancy|9|||
23441024|NCT00264537|65355377|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23563888|NCT02066402|65793586|FG001|Overall Study|Lost to Follow-up|8|||
23441025|NCT00264537|65355378|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
23441026|NCT00264537|65355379|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
23441027|NCT00264537|65355380|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
23441028|NCT00264537|65355377|FG000|Overall Study|Other|21|||
23441029|NCT00264537|65355378|FG001|Overall Study|Other|11|||
23441030|NCT00264537|65355379|FG002|Overall Study|Other|10|||
23441031|NCT00264537|65355380|FG003|Overall Study|Other|11|||
23441032|NCT00264537|65355377|FG000|Overall Study|Not treated|0|||
23441033|NCT00264537|65355378|FG001|Overall Study|Not treated|2|||
23441034|NCT00264537|65355379|FG002|Overall Study|Not treated|1|||
23441035|NCT00264537|65355380|FG003|Overall Study|Not treated|0|||
23441036|NCT04698993|65355383|FG000|Overall Study|PCR results not accessible|2|||
23441037|NCT04698993|65355384|FG001|Overall Study|PCR results not accessible|7|||
23441038|NCT04698993|65355383|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
23441039|NCT04698993|65355384|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
23441040|NCT01339897|65355385|FG000|Overall Study|Adverse Event|1|||
23441041|NCT01339897|65355386|FG001|Overall Study|Adverse Event|0|||
23441042|NCT01339897|65355387|FG002|Overall Study|Adverse Event|0|||
23441043|NCT01339897|65355388|FG003|Overall Study|Adverse Event|1|||
23441044|NCT01098305|65355389|FG000|Overall Study|Lost to Follow-up|31|||
23441045|NCT01098305|65355390|FG001|Overall Study|Lost to Follow-up|33|||
23441046|NCT02207491|65355392|FG000|Overall Study|Adverse Event|20|||
23441047|NCT02207491|65355393|FG001|Overall Study|Adverse Event|4|||
23441048|NCT02207491|65355392|FG000|Overall Study|Withdrawal by Subject|3|||
23441049|NCT02207491|65355393|FG001|Overall Study|Withdrawal by Subject|2|||
23441050|NCT02207491|65355392|FG000|Overall Study|Non-compliant|0|||
23441051|NCT02207491|65355393|FG001|Overall Study|Non-compliant|1|||
23441052|NCT02207491|65355392|FG000|Overall Study|Lost to Follow-up|0|||
23441053|NCT02207491|65355393|FG001|Overall Study|Lost to Follow-up|1|||
23441054|NCT02207491|65355392|FG000|Overall Study|Lack of Efficacy|3|||
23441055|NCT02207491|65355393|FG001|Overall Study|Lack of Efficacy|0|||
23441056|NCT02207491|65355392|FG000|Overall Study|Physician Decision|2|||
23441057|NCT02207491|65355393|FG001|Overall Study|Physician Decision|0|||
23441058|NCT02207491|65355392|FG000|Overall Study|Protocol Violation|3|||
23441059|NCT02207491|65355393|FG001|Overall Study|Protocol Violation|5|||
23441060|NCT04599465|65355396|FG000|Overall Study|Physician Decision|1|||
23441061|NCT04599465|65355396|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
23441062|NCT00950248|65355401|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
23441063|NCT00950248|65355402|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
23441064|NCT00950248|65355403|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
23563889|NCT02066402|65793585|FG000|Overall Study|Withdrawal by Subject|14|||
23563890|NCT02066402|65793586|FG001|Overall Study|Withdrawal by Subject|11|||
23563891|NCT02066402|65793585|FG000|Overall Study|Progressive disease-clinical progression|0|||
23563892|NCT02066402|65793586|FG001|Overall Study|Progressive disease-clinical progression|1|||
23563893|NCT02066402|65793585|FG000|Overall Study|Protocol driven decision point|0|||
23563894|NCT02066402|65793586|FG001|Overall Study|Protocol driven decision point|1|||
23563895|NCT01203930|65793587|FG000|Overall Study|Disease Progression|0|||
23563896|NCT01203930|65793588|FG001|Overall Study|Disease Progression|4|||
23563897|NCT01203930|65793587|FG000|Overall Study|Death|3|||
23563898|NCT01203930|65793588|FG001|Overall Study|Death|1|||
23563899|NCT01203930|65793587|FG000|Overall Study|Withdrew Consent|1|||
23563900|NCT01203930|65793588|FG001|Overall Study|Withdrew Consent|10|||
23563901|NCT01203930|65793587|FG000|Overall Study|Investigator Request|0|||
23563902|NCT01203930|65793588|FG001|Overall Study|Investigator Request|8|||
23563903|NCT01203930|65793587|FG000|Overall Study|Study Terminated by Sponsor|0|||
23563904|NCT01203930|65793588|FG001|Overall Study|Study Terminated by Sponsor|12|||
23563905|NCT01203930|65793587|FG000|Overall Study|Poor tolerance of study drug|0|||
23563906|NCT01203930|65793588|FG001|Overall Study|Poor tolerance of study drug|1|||
23563907|NCT01203930|65793587|FG000|Overall Study|Adverse Event|17|||
23563908|NCT01203930|65793588|FG001|Overall Study|Adverse Event|5|||
23563909|NCT01857622|65793589|FG000|Overall Study|Adverse Event|5|||
23563910|NCT01857622|65793590|FG001|Overall Study|Adverse Event|0|||
23563911|NCT01857622|65793591|FG002|Overall Study|Adverse Event|2|||
23441065|NCT00950248|65355401|FG000|Year 1: Baseline|worsening of symptoms|2|||
23441066|NCT00950248|65355402|FG001|Year 1: Baseline|worsening of symptoms|0|||
23441067|NCT00950248|65355403|FG002|Year 1: Baseline|worsening of symptoms|0|||
23441068|NCT00950248|65355401|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
23441069|NCT00950248|65355402|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
23441070|NCT00950248|65355403|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
23441071|NCT00950248|65355401|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
23441072|NCT00950248|65355402|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
23441073|NCT00950248|65355403|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
23441074|NCT00950248|65355401|FG000|Year 2&3 Treatment Randomization|Death|0|||
23441075|NCT00950248|65355402|FG001|Year 2&3 Treatment Randomization|Death|0|||
23563912|NCT01857622|65793589|FG000|Overall Study|Physician Decision|1|||
23563913|NCT01857622|65793590|FG001|Overall Study|Physician Decision|0|||
23563914|NCT01857622|65793591|FG002|Overall Study|Physician Decision|0|||
23563915|NCT01857622|65793589|FG000|Overall Study|Protocol Violation|4|||
23563916|NCT01857622|65793590|FG001|Overall Study|Protocol Violation|1|||
23563917|NCT01857622|65793591|FG002|Overall Study|Protocol Violation|0|||
23563918|NCT01857622|65793589|FG000|Overall Study|Withdrawal by Subject|1|||
23563919|NCT01857622|65793590|FG001|Overall Study|Withdrawal by Subject|0|||
23563920|NCT01857622|65793591|FG002|Overall Study|Withdrawal by Subject|0|||
23563921|NCT03635489|65793594|FG000|Overall Study|Death|19|||
23563922|NCT03635489|65793595|FG001|Overall Study|Death|13|||
23563923|NCT03635489|65793594|FG000|Overall Study|Lost to Follow-up|1|||
23563924|NCT03635489|65793595|FG001|Overall Study|Lost to Follow-up|2|||
23563925|NCT03635489|65793594|FG000|Overall Study|Withdrawal by Subject|1|||
23563926|NCT03635489|65793595|FG001|Overall Study|Withdrawal by Subject|2|||
23563927|NCT03635489|65793594|FG000|Overall Study|Study Ended by Sponsor|28|||
23563928|NCT03635489|65793595|FG001|Overall Study|Study Ended by Sponsor|34|||
23563929|NCT01036022|65793596|FG000|Overall Study|Adverse Event|1|||
23563930|NCT01036022|65793597|FG001|Overall Study|Adverse Event|3|||
23563931|NCT01036022|65793598|FG002|Overall Study|Adverse Event|2|||
23563932|NCT01036022|65793599|FG003|Overall Study|Adverse Event|1|||
23563933|NCT01036022|65793600|FG004|Overall Study|Adverse Event|0|||
23626241|NCT00810342|66020258|FG001|12-month Followup|Pregnancy|10|||
23626242|NCT00810342|66020257|FG000|12-month Followup|Lost to Follow-up|3|||
23626243|NCT00810342|66020258|FG001|12-month Followup|Lost to Follow-up|1|||
23626244|NCT00847132|66020263|FG000|Overall Study|Death|1|||
23626245|NCT00847132|66020264|FG001|Overall Study|Death|1|||
23626246|NCT01266018|66020265|FG000|Overall Study|Physician Decision|1|||
23326573|NCT00450437|64937951|FG000|Overall Study|Lost to Follow-up|31|||
23326574|NCT00450437|64937952|FG001|Overall Study|Lost to Follow-up|12|||
23326575|NCT00450437|64937953|FG002|Overall Study|Lost to Follow-up|19|||
23326576|NCT00450437|64937954|FG003|Overall Study|Lost to Follow-up|9|||
23326577|NCT00450437|64937951|FG000|Overall Study|Protocol Violation|0|||
23563934|NCT01036022|65793601|FG005|Overall Study|Adverse Event|2|||
23563935|NCT01036022|65793596|FG000|Overall Study|Lack of Efficacy|1|||
23326578|NCT00450437|64937952|FG001|Overall Study|Protocol Violation|1|||
23326579|NCT00450437|64937953|FG002|Overall Study|Protocol Violation|0|||
23326580|NCT00450437|64937954|FG003|Overall Study|Protocol Violation|1|||
23326581|NCT00450437|64937951|FG000|Overall Study|Inappropriate enrollment|4|||
23326582|NCT00450437|64937952|FG001|Overall Study|Inappropriate enrollment|1|||
23326583|NCT00450437|64937953|FG002|Overall Study|Inappropriate enrollment|3|||
23326584|NCT00450437|64937954|FG003|Overall Study|Inappropriate enrollment|0|||
23326585|NCT00450437|64937951|FG000|Overall Study|Administrative reason|0|||
23326586|NCT00450437|64937952|FG001|Overall Study|Administrative reason|0|||
23326587|NCT00450437|64937953|FG002|Overall Study|Administrative reason|1|||
23326588|NCT00450437|64937954|FG003|Overall Study|Administrative reason|0|||
23326589|NCT00450437|64937951|FG000|Overall Study|Unable to Classify|1|||
23326590|NCT00450437|64937952|FG001|Overall Study|Unable to Classify|0|||
23326591|NCT00450437|64937953|FG002|Overall Study|Unable to Classify|1|||
23326592|NCT00450437|64937954|FG003|Overall Study|Unable to Classify|0|||
23326593|NCT02440464|64937957|FG000|Overall Study|Withdrawal by Subject|3|||
23326594|NCT02440464|64937958|FG001|Overall Study|Withdrawal by Subject|2|||
23326595|NCT03164551|64937959|FG000|Overall Study|Imaging discontinued prior completion|8|||
23326596|NCT03164551|64937960|FG001|Overall Study|Imaging discontinued prior completion|0|||
23326597|NCT03164551|64937959|FG000|Overall Study|Participant was non-compliant|1|||
23326598|NCT03164551|64937960|FG001|Overall Study|Participant was non-compliant|0|||
23326599|NCT03164551|64937959|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
23326600|NCT03164551|64937960|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
23326601|NCT03164551|64937959|FG000|Overall Study|Other|8|||
23563936|NCT01036022|65793597|FG001|Overall Study|Lack of Efficacy|1|||
23563937|NCT01036022|65793598|FG002|Overall Study|Lack of Efficacy|1|||
23563938|NCT01036022|65793599|FG003|Overall Study|Lack of Efficacy|0|||
23563939|NCT01036022|65793600|FG004|Overall Study|Lack of Efficacy|1|||
23563940|NCT01036022|65793601|FG005|Overall Study|Lack of Efficacy|1|||
23563941|NCT01036022|65793596|FG000|Overall Study|Physician Decision|0|||
23626247|NCT01266018|66020266|FG001|Overall Study|Physician Decision|0|||
23626248|NCT01266018|66020265|FG000|Overall Study|Progressive disease|0|||
23563942|NCT01036022|65793597|FG001|Overall Study|Physician Decision|0|||
23626249|NCT01266018|66020266|FG001|Overall Study|Progressive disease|1|||
23152883|NCT03627767|64309431|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
23326602|NCT03164551|64937960|FG001|Overall Study|Other|2|||
23326603|NCT00122382|64937961|FG000|Double-Blind Study|Adverse Event|9|||
23326604|NCT00122382|64937962|FG001|Double-Blind Study|Adverse Event|11|||
23326605|NCT00122382|64937963|FG002|Double-Blind Study|Adverse Event|0|||
23326606|NCT00122382|64937961|FG000|Double-Blind Study|Death|2|||
23326607|NCT00122382|64937962|FG001|Double-Blind Study|Death|2|||
23326608|NCT00122382|64937963|FG002|Double-Blind Study|Death|0|||
23563943|NCT01036022|65793598|FG002|Overall Study|Physician Decision|1|||
23626250|NCT00992992|66020267|FG000|Overall Study|Lost to Follow-up|3|||
23326609|NCT00122382|64937961|FG000|Double-Blind Study|Lack of Efficacy|0|||
23563944|NCT01036022|65793599|FG003|Overall Study|Physician Decision|0|||
23326610|NCT00122382|64937962|FG001|Double-Blind Study|Lack of Efficacy|8|||
23326611|NCT00122382|64937963|FG002|Double-Blind Study|Lack of Efficacy|0|||
23326612|NCT00122382|64937961|FG000|Double-Blind Study|Lost to Follow-up|2|||
23326613|NCT00122382|64937962|FG001|Double-Blind Study|Lost to Follow-up|1|||
23326614|NCT00122382|64937963|FG002|Double-Blind Study|Lost to Follow-up|0|||
23326615|NCT00122382|64937961|FG000|Double-Blind Study|Pregnancy|2|||
23326616|NCT00122382|64937962|FG001|Double-Blind Study|Pregnancy|0|||
23326617|NCT00122382|64937963|FG002|Double-Blind Study|Pregnancy|0|||
23326618|NCT00122382|64937961|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
23326619|NCT00122382|64937962|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
23326620|NCT00122382|64937963|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
23326621|NCT00122382|64937961|FG000|Double-Blind Study|Withdrawal of Consent|7|||
23326622|NCT00122382|64937962|FG001|Double-Blind Study|Withdrawal of Consent|3|||
23326623|NCT00122382|64937963|FG002|Double-Blind Study|Withdrawal of Consent|0|||
23326624|NCT00122382|64937961|FG000|Double-Blind Study|Protocol Violation|1|||
23326625|NCT00122382|64937962|FG001|Double-Blind Study|Protocol Violation|0|||
23326626|NCT00122382|64937963|FG002|Double-Blind Study|Protocol Violation|0|||
23326627|NCT00122382|64937961|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
23326628|NCT00122382|64937962|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
23326629|NCT00122382|64937963|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
23326630|NCT00122382|64937961|FG000|Double-Blind Study|Randomized but not treated|0|||
23326631|NCT00122382|64937962|FG001|Double-Blind Study|Randomized but not treated|2|||
23441076|NCT00950248|65355403|FG002|Year 2&3 Treatment Randomization|Death|1|||
23563945|NCT01036022|65793600|FG004|Overall Study|Physician Decision|0|||
23220387|NCT03799627|64550141|FG001|Overall Study|Participant Relocation|0|||
23220388|NCT03799627|64550142|FG002|Overall Study|Participant Relocation|0|||
23220389|NCT03799627|64550143|FG003|Overall Study|Participant Relocation|1|||
23220390|NCT03799627|64550144|FG004|Overall Study|Participant Relocation|0|||
23220391|NCT03799627|64550145|FG005|Overall Study|Participant Relocation|1|||
23563946|NCT01036022|65793601|FG005|Overall Study|Physician Decision|0|||
23563947|NCT01036022|65793596|FG000|Overall Study|Withdrawal by Subject|0|||
23220392|NCT03799627|64550146|FG006|Overall Study|Participant Relocation|0|||
23220393|NCT03799627|64550147|FG007|Overall Study|Participant Relocation|0|||
23220394|NCT03799627|64550148|FG008|Overall Study|Participant Relocation|0|||
23626251|NCT00992992|66020267|FG000|Overall Study|Death|16|||
23626252|NCT00992992|66020267|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
23626253|NCT00992992|66020267|FG000|Overall Study|Sponsor Closed the Study|4|||
23626254|NCT04698915|66020268|FG000|Overall Study|Adverse Event|2|||
23626255|NCT04698915|66020269|FG001|Overall Study|Adverse Event|0|||
23626256|NCT04698915|66020268|FG000|Overall Study|Death|23|||
23626257|NCT04698915|66020269|FG001|Overall Study|Death|20|||
23626258|NCT04698915|66020268|FG000|Overall Study|Physician Decision|1|||
23220395|NCT03799627|64550140|FG000|Overall Study|Eurofin Issue|0|||
23220396|NCT03799627|64550141|FG001|Overall Study|Eurofin Issue|0|||
23220397|NCT03799627|64550142|FG002|Overall Study|Eurofin Issue|0|||
23441077|NCT00950248|65355401|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
23563948|NCT01036022|65793597|FG001|Overall Study|Withdrawal by Subject|0|||
23563949|NCT01036022|65793598|FG002|Overall Study|Withdrawal by Subject|0|||
23563950|NCT01036022|65793599|FG003|Overall Study|Withdrawal by Subject|1|||
23563951|NCT01036022|65793600|FG004|Overall Study|Withdrawal by Subject|2|||
23563952|NCT01036022|65793601|FG005|Overall Study|Withdrawal by Subject|0|||
23563953|NCT02243202|65793602|FG000|Overall Study|Adverse Event|5|||
23563954|NCT02243202|65793603|FG001|Overall Study|Adverse Event|6|||
23563955|NCT02243202|65793604|FG002|Overall Study|Adverse Event|10|||
23563956|NCT02243202|65793605|FG003|Overall Study|Adverse Event|4|||
23563957|NCT02243202|65793602|FG000|Overall Study|Lost to Follow-up|9|||
23563958|NCT02243202|65793603|FG001|Overall Study|Lost to Follow-up|9|||
23563959|NCT02243202|65793604|FG002|Overall Study|Lost to Follow-up|14|||
23563960|NCT02243202|65793605|FG003|Overall Study|Lost to Follow-up|11|||
23563961|NCT02243202|65793602|FG000|Overall Study|Protocol Violation|3|||
23563962|NCT02243202|65793603|FG001|Overall Study|Protocol Violation|1|||
23563963|NCT02243202|65793604|FG002|Overall Study|Protocol Violation|2|||
23563964|NCT02243202|65793605|FG003|Overall Study|Protocol Violation|1|||
23563965|NCT02243202|65793602|FG000|Overall Study|Withdrawal by Subject|7|||
23563966|NCT02243202|65793603|FG001|Overall Study|Withdrawal by Subject|6|||
23563967|NCT02243202|65793604|FG002|Overall Study|Withdrawal by Subject|4|||
23563968|NCT02243202|65793605|FG003|Overall Study|Withdrawal by Subject|4|||
23563969|NCT02243202|65793602|FG000|Overall Study|Other|1|||
23220398|NCT03799627|64550143|FG003|Overall Study|Eurofin Issue|0|||
23326632|NCT00122382|64937963|FG002|Double-Blind Study|Randomized but not treated|0|||
23563970|NCT02243202|65793603|FG001|Overall Study|Other|3|||
23626259|NCT04698915|66020269|FG001|Overall Study|Physician Decision|1|||
23326633|NCT00122382|64937961|FG000|Open-Label Study|Adverse Event|0|||
23326634|NCT00122382|64937962|FG001|Open-Label Study|Adverse Event|0|||
23326635|NCT00122382|64937963|FG002|Open-Label Study|Adverse Event|11|||
23326636|NCT00122382|64937961|FG000|Open-Label Study|Death|0|||
23563971|NCT02243202|65793604|FG002|Overall Study|Other|1|||
23326637|NCT00122382|64937962|FG001|Open-Label Study|Death|0|||
23326638|NCT00122382|64937963|FG002|Open-Label Study|Death|2|||
23326639|NCT00122382|64937961|FG000|Open-Label Study|Lack of Efficacy|0|||
23326640|NCT00122382|64937962|FG001|Open-Label Study|Lack of Efficacy|0|||
23326641|NCT00122382|64937963|FG002|Open-Label Study|Lack of Efficacy|3|||
23326642|NCT00122382|64937961|FG000|Open-Label Study|Lost to Follow-up|0|||
23326643|NCT00122382|64937962|FG001|Open-Label Study|Lost to Follow-up|0|||
23326644|NCT00122382|64937963|FG002|Open-Label Study|Lost to Follow-up|3|||
23326645|NCT00122382|64937961|FG000|Open-Label Study|Pregnancy|0|||
23326646|NCT00122382|64937962|FG001|Open-Label Study|Pregnancy|0|||
23326647|NCT00122382|64937963|FG002|Open-Label Study|Pregnancy|2|||
23326648|NCT00122382|64937961|FG000|Open-Label Study|Poor/Non-Compliance|0|||
23326649|NCT00122382|64937962|FG001|Open-Label Study|Poor/Non-Compliance|0|||
23326650|NCT00122382|64937963|FG002|Open-Label Study|Poor/Non-Compliance|1|||
23326651|NCT00122382|64937961|FG000|Open-Label Study|Withdrawal of Consent|0|||
23326652|NCT00122382|64937962|FG001|Open-Label Study|Withdrawal of Consent|0|||
23326653|NCT00122382|64937963|FG002|Open-Label Study|Withdrawal of Consent|4|||
23326654|NCT04173507|64937964|FG000|Overall Study|On Treatment|3|||
23326655|NCT04173507|64937964|FG000|Overall Study|Adverse Event|3|||
23326656|NCT04173507|64937964|FG000|Overall Study|Progression/Relapse|34|||
23326657|NCT04173507|64937964|FG000|Overall Study|Death|2|||
23326658|NCT01130532|64937965|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
23563972|NCT02243202|65793605|FG003|Overall Study|Other|2|||
23563973|NCT02243202|65793602|FG000|Overall Study|Randomized but not received treatment|0|||
23563974|NCT02243202|65793603|FG001|Overall Study|Randomized but not received treatment|0|||
23563975|NCT02243202|65793604|FG002|Overall Study|Randomized but not received treatment|0|||
23563976|NCT02243202|65793605|FG003|Overall Study|Randomized but not received treatment|1|||
23563977|NCT00659984|65793610|FG000|Overall Study|Adverse Event|1|||
23563978|NCT01518946|65793611|FG000|Open-label Phase|Other|4|||
23563979|NCT01518946|65793612|FG001|Open-label Phase|Other|0|||
23563980|NCT01518946|65793613|FG002|Open-label Phase|Other|0|||
23563981|NCT01518946|65793611|FG000|Randomized Phase (First Intervention)|Other|0|||
23563982|NCT01518946|65793612|FG001|Randomized Phase (First Intervention)|Other|1|||
23563983|NCT01518946|65793613|FG002|Randomized Phase (First Intervention)|Other|0|||
23563984|NCT03610737|65793615|FG000|Overall Study|Withdrawal by Subject|1|||
23563985|NCT03610737|65793616|FG001|Overall Study|Withdrawal by Subject|5|||
23563986|NCT03610737|65793615|FG000|Overall Study|Death|1|||
23626260|NCT04698915|66020268|FG000|Overall Study|Lost to Follow-up|1|||
23626261|NCT04698915|66020269|FG001|Overall Study|Lost to Follow-up|0|||
23626262|NCT04698915|66020268|FG000|Overall Study|Study Terminated by Sponsor|55|||
23626263|NCT04698915|66020269|FG001|Overall Study|Study Terminated by Sponsor|60|||
23626264|NCT04698915|66020268|FG000|Overall Study|Withdrawal by Subject|2|||
23626265|NCT04698915|66020269|FG001|Overall Study|Withdrawal by Subject|3|||
23626266|NCT00952848|66020271|FG000|Overall Study|Withdrawal by Subject|4|||
23626267|NCT00516139|66020274|FG000|Overall Study|Adverse Event|27|||
23626268|NCT00516139|66020274|FG000|Overall Study|Lost to Follow-up|1|||
23626269|NCT00516139|66020274|FG000|Overall Study|Protocol Violation|1|||
23626270|NCT00516139|66020274|FG000|Overall Study|Withdrawal by Subject|8|||
23626271|NCT00516139|66020274|FG000|Overall Study|Lack of Efficacy|1|||
23152884|NCT03627767|64309432|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
23152885|NCT03627767|64309428|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
23152886|NCT03627767|64309429|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
23152887|NCT03627767|64309430|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
23152888|NCT03627767|64309431|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
23152889|NCT03627767|64309432|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
23152890|NCT03627767|64309428|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
23220399|NCT03799627|64550144|FG004|Overall Study|Eurofin Issue|1|||
23326659|NCT01130532|64937966|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
23326660|NCT01130532|64937967|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
23326661|NCT01130532|64937968|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
23326662|NCT01130532|64937965|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
23326663|NCT01130532|64937966|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
23326664|NCT01130532|64937967|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
23326665|NCT01130532|64937968|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
23326666|NCT01130532|64937965|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
23152891|NCT03627767|64309429|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
23220400|NCT03799627|64550145|FG005|Overall Study|Eurofin Issue|0|||
23326667|NCT01130532|64937966|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
23326668|NCT01130532|64937967|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
23563987|NCT03610737|65793616|FG001|Overall Study|Death|0|||
23563988|NCT03610737|65793615|FG000|Overall Study|Not treated|5|||
23626272|NCT01130168|66020275|FG000|Period 1|Withdrawal by Subject|0|||
23326669|NCT01130532|64937968|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
23326670|NCT01130532|64937965|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
23326671|NCT01130532|64937966|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
23326672|NCT01130532|64937967|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
23563989|NCT03610737|65793616|FG001|Overall Study|Not treated|2|||
23563990|NCT03610737|65793615|FG000|Overall Study|Missed Visit|1|||
23563991|NCT03610737|65793616|FG001|Overall Study|Missed Visit|2|||
23152892|NCT03627767|64309430|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
23152893|NCT03627767|64309431|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
23152894|NCT03627767|64309432|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
23152895|NCT03627767|64309428|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
23152896|NCT03627767|64309429|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
23152897|NCT03627767|64309430|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
23220401|NCT03799627|64550146|FG006|Overall Study|Eurofin Issue|0|||
23220402|NCT03799627|64550147|FG007|Overall Study|Eurofin Issue|0|||
23563992|NCT04399356|65793631|FG000|Overall Study|Lost to Follow-up|1|||
23563993|NCT04399356|65793632|FG001|Overall Study|Lost to Follow-up|1|||
23563994|NCT04399356|65793631|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
23563995|NCT04399356|65793632|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
23563996|NCT04399356|65793631|FG000|Overall Study|Withdrawal by Subject|1|||
23563997|NCT04399356|65793632|FG001|Overall Study|Withdrawal by Subject|0|||
23563998|NCT03565068|65793633|FG000|Overall Study|Protocol Violation|0|||
23563999|NCT03565068|65793634|FG001|Overall Study|Protocol Violation|0|||
23564000|NCT03565068|65793635|FG002|Overall Study|Protocol Violation|0|||
23220403|NCT03799627|64550148|FG008|Overall Study|Eurofin Issue|0|||
23220404|NCT03799627|64550140|FG000|Overall Study|Noncompliance with Site Instructions|0|||
23152898|NCT03627767|64309431|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
23152899|NCT03627767|64309432|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
23152900|NCT03627767|64309428|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
23152901|NCT03627767|64309429|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
23152902|NCT03627767|64309430|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
23152903|NCT03627767|64309431|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
23152904|NCT03627767|64309432|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
23152905|NCT01102803|64309433|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
23152906|NCT01102803|64309434|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
23564001|NCT03565068|65793636|FG003|Overall Study|Protocol Violation|0|||
23626273|NCT01130168|66020276|FG001|Period 1|Withdrawal by Subject|1|||
23626274|NCT01130168|66020277|FG002|Period 1|Withdrawal by Subject|0|||
23626275|NCT01130168|66020278|FG003|Period 1|Withdrawal by Subject|1|||
23152907|NCT01102803|64309433|FG000|Post to Follow-Up|Lost to Follow-up|1|||
23152908|NCT01102803|64309434|FG001|Post to Follow-Up|Lost to Follow-up|3|||
23152909|NCT00709111|64309435|FG000|Overall Study|Withdrawal by Subject|1|||
23152910|NCT00709111|64309435|FG000|Overall Study|Unable to attend clinic visits|1|||
23152911|NCT02708095|64309436|FG000|Overall Study|Adverse Event|4|||
23152912|NCT02708095|64309437|FG001|Overall Study|Adverse Event|10|||
23152913|NCT02708095|64309438|FG002|Overall Study|Adverse Event|11|||
23152914|NCT02708095|64309436|FG000|Overall Study|Lack of Efficacy|9|||
23220405|NCT03799627|64550141|FG001|Overall Study|Noncompliance with Site Instructions|0|||
23220406|NCT03799627|64550142|FG002|Overall Study|Noncompliance with Site Instructions|0|||
23220407|NCT03799627|64550143|FG003|Overall Study|Noncompliance with Site Instructions|0|||
23626276|NCT01130168|66020279|FG004|Period 1|Withdrawal by Subject|0|||
23626277|NCT01130168|66020280|FG005|Period 1|Withdrawal by Subject|0|||
23626278|NCT01130168|66020275|FG000|Period 1|Discontinued For Other Reason|0|||
23626279|NCT01130168|66020276|FG001|Period 1|Discontinued For Other Reason|0|||
23626280|NCT01130168|66020277|FG002|Period 1|Discontinued For Other Reason|1|||
23626281|NCT01130168|66020278|FG003|Period 1|Discontinued For Other Reason|1|||
23626282|NCT01130168|66020279|FG004|Period 1|Discontinued For Other Reason|0|||
23626283|NCT01130168|66020280|FG005|Period 1|Discontinued For Other Reason|0|||
23626284|NCT01130168|66020275|FG000|Period 1|Adverse Event|0|||
23626285|NCT01130168|66020276|FG001|Period 1|Adverse Event|0|||
23626286|NCT01130168|66020277|FG002|Period 1|Adverse Event|0|||
23626287|NCT01130168|66020278|FG003|Period 1|Adverse Event|1|||
23626288|NCT01130168|66020279|FG004|Period 1|Adverse Event|0|||
23626289|NCT01130168|66020280|FG005|Period 1|Adverse Event|0|||
23626290|NCT03596242|66020281|FG000|Overall Study|Lost to Follow-up|2|||
23626291|NCT03596242|66020282|FG001|Overall Study|Lost to Follow-up|2|||
23152915|NCT02708095|64309437|FG001|Overall Study|Lack of Efficacy|3|||
23152916|NCT02708095|64309438|FG002|Overall Study|Lack of Efficacy|0|||
23152917|NCT02708095|64309436|FG000|Overall Study|Lost to Follow-up|2|||
23152918|NCT02708095|64309437|FG001|Overall Study|Lost to Follow-up|0|||
23152919|NCT02708095|64309438|FG002|Overall Study|Lost to Follow-up|0|||
23220408|NCT03799627|64550144|FG004|Overall Study|Noncompliance with Site Instructions|1|||
23564002|NCT03565068|65793637|FG004|Overall Study|Protocol Violation|1|||
23564003|NCT03565068|65793638|FG005|Overall Study|Protocol Violation|0|||
23626292|NCT04398368|66020293|FG000|Overall Study|Withdrawal by Subject|2|||
23626293|NCT01321723|66020296|FG000|Overall Study|Adverse Event|3|||
23626294|NCT01321723|66020297|FG001|Overall Study|Adverse Event|5|||
23626295|NCT01321723|66020298|FG002|Overall Study|Adverse Event|2|||
23626296|NCT01321723|66020296|FG000|Overall Study|Withdrawal by Subject|2|||
23626297|NCT01321723|66020297|FG001|Overall Study|Withdrawal by Subject|0|||
23152920|NCT02708095|64309436|FG000|Overall Study|Physician Decision|2|||
23152921|NCT02708095|64309437|FG001|Overall Study|Physician Decision|3|||
23152922|NCT02708095|64309438|FG002|Overall Study|Physician Decision|2|||
23152923|NCT02708095|64309436|FG000|Overall Study|Protocol Violation|0|||
23152924|NCT02708095|64309437|FG001|Overall Study|Protocol Violation|0|||
23152925|NCT02708095|64309438|FG002|Overall Study|Protocol Violation|1|||
23152926|NCT02708095|64309436|FG000|Overall Study|Withdrawal by Subject|5|||
23152927|NCT02708095|64309437|FG001|Overall Study|Withdrawal by Subject|3|||
23152928|NCT02708095|64309438|FG002|Overall Study|Withdrawal by Subject|4|||
23152929|NCT02092350|64309440|FG000|Overall Study|Adverse Event|0|||
23152930|NCT02092350|64309441|FG001|Overall Study|Adverse Event|3|||
23152931|NCT02092350|64309440|FG000|Overall Study|Death|2|||
23152932|NCT02092350|64309441|FG001|Overall Study|Death|5|||
23152933|NCT02092350|64309440|FG000|Overall Study|Lost to Follow-up|3|||
23152934|NCT02092350|64309441|FG001|Overall Study|Lost to Follow-up|1|||
23152935|NCT02092350|64309440|FG000|Overall Study|Protocol Violation|1|||
23152936|NCT02092350|64309441|FG001|Overall Study|Protocol Violation|0|||
23152937|NCT02092350|64309440|FG000|Overall Study|Physician Decision|1|||
23152938|NCT02092350|64309441|FG001|Overall Study|Physician Decision|1|||
23152939|NCT02092350|64309440|FG000|Overall Study|Screen Failure|1|||
23152940|NCT02092350|64309441|FG001|Overall Study|Screen Failure|0|||
23152941|NCT02092350|64309440|FG000|Overall Study|Withdrawal by Subject|2|||
23152942|NCT02092350|64309441|FG001|Overall Study|Withdrawal by Subject|2|||
23152943|NCT01494350|64309442|FG000|Overall Study|Worsening of lesion|1|||
23152944|NCT03785678|64309443|FG000|Overall Study|Death|44|||
23441078|NCT00950248|65355402|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
23441079|NCT00950248|65355403|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
23441080|NCT04565951|65355404|FG000|Overall Study|Lost to Follow-up|66|||
23441081|NCT04565951|65355405|FG001|Overall Study|Lost to Follow-up|38|||
23441082|NCT04565951|65355404|FG000|Overall Study|Withdrawal by Subject|14|||
23441083|NCT04565951|65355405|FG001|Overall Study|Withdrawal by Subject|7|||
23441084|NCT04565951|65355404|FG000|Overall Study|Death|0|||
23441085|NCT04565951|65355405|FG001|Overall Study|Death|1|||
23441086|NCT01440816|65355407|FG000|Overall Study|Disease Progression|0|||
23441087|NCT01440816|65355408|FG001|Overall Study|Disease Progression|9|||
23441088|NCT01440816|65355407|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
23441089|NCT01440816|65355408|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
23441090|NCT00517361|65355409|FG000|Overall Study|Death|6|||
23441091|NCT00517361|65355409|FG000|Overall Study|The study was terminated|5|||
23441092|NCT03775512|65355412|FG000|Overall Study|Death|1|||
23441093|NCT03775512|65355413|FG001|Overall Study|Death|1|||
23441094|NCT03775512|65355412|FG000|Overall Study|Withdrawal by Subject|7|||
23441095|NCT03775512|65355413|FG001|Overall Study|Withdrawal by Subject|4|||
23441096|NCT03775512|65355412|FG000|Overall Study|Lost to Follow-up|5|||
23441097|NCT03775512|65355413|FG001|Overall Study|Lost to Follow-up|5|||
23441098|NCT03775512|65355412|FG000|Overall Study|Excluded before Catheter insertion|14|||
23441099|NCT03775512|65355413|FG001|Overall Study|Excluded before Catheter insertion|5|||
23441100|NCT03775512|65355412|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
23441101|NCT03775512|65355413|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
23441102|NCT03775512|65355412|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
23152945|NCT03785678|64309444|FG001|Overall Study|Death|42|||
23152946|NCT03785678|64309443|FG000|Overall Study|Lost to Follow-up|4|||
23152947|NCT03785678|64309444|FG001|Overall Study|Lost to Follow-up|2|||
23152948|NCT03785678|64309443|FG000|Overall Study|Physician Decision|0|||
23152949|NCT03785678|64309444|FG001|Overall Study|Physician Decision|2|||
23152950|NCT03785678|64309443|FG000|Overall Study|Withdrawal by Subject|5|||
23152951|NCT03785678|64309444|FG001|Overall Study|Withdrawal by Subject|3|||
23152952|NCT02030405|64309445|FG000|Overall Study|Withdrawal by Subject|1|||
23152953|NCT02030405|64309445|FG000|Overall Study|Lost to Follow-up|1|||
23152954|NCT03027557|64309446|FG000|Overall Study|Adverse Event|1|||
23152955|NCT03027557|64309447|FG001|Overall Study|Adverse Event|0|||
23152956|NCT03027557|64309448|FG002|Overall Study|Adverse Event|0|||
23152957|NCT00986440|64309449|FG000|Overall Study|Progressive disease|27|||
23152958|NCT00986440|64309450|FG001|Overall Study|Progressive disease|37|||
23441103|NCT03775512|65355413|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
23441104|NCT01769196|65355418|FG000|Overall Study|Adverse Event|24|||
23441105|NCT01769196|65355419|FG001|Overall Study|Adverse Event|20|||
23441106|NCT01769196|65355418|FG000|Overall Study|Death|21|||
23441107|NCT01769196|65355419|FG001|Overall Study|Death|26|||
23441108|NCT01769196|65355418|FG000|Overall Study|Investigator Discretion|7|||
23441109|NCT01769196|65355419|FG001|Overall Study|Investigator Discretion|3|||
23152959|NCT00986440|64309449|FG000|Overall Study|Serious adverse event or adverse event|9|||
23152960|NCT00986440|64309450|FG001|Overall Study|Serious adverse event or adverse event|2|||
23152961|NCT00986440|64309449|FG000|Overall Study|Withdrawal by Subject|1|||
23152962|NCT00986440|64309450|FG001|Overall Study|Withdrawal by Subject|2|||
23152963|NCT00986440|64309449|FG000|Overall Study|Screen failure (not dosed)|4|||
23441110|NCT01769196|65355418|FG000|Overall Study|Lack of Efficacy|3|||
23441111|NCT01769196|65355419|FG001|Overall Study|Lack of Efficacy|2|||
23441112|NCT01769196|65355418|FG000|Overall Study|Progressive disease|11|||
23441113|NCT01769196|65355419|FG001|Overall Study|Progressive disease|6|||
23564004|NCT03565068|65793639|FG006|Overall Study|Protocol Violation|0|||
23564005|NCT03565068|65793640|FG007|Overall Study|Protocol Violation|1|||
23564006|NCT03565068|65793641|FG008|Overall Study|Protocol Violation|0|||
23564007|NCT03565068|65793633|FG000|Overall Study|Sponsor decision|0|||
23564008|NCT03565068|65793634|FG001|Overall Study|Sponsor decision|0|||
23564009|NCT03565068|65793635|FG002|Overall Study|Sponsor decision|0|||
23564010|NCT03565068|65793636|FG003|Overall Study|Sponsor decision|0|||
23564011|NCT03565068|65793637|FG004|Overall Study|Sponsor decision|1|||
23564012|NCT03565068|65793638|FG005|Overall Study|Sponsor decision|1|||
23564013|NCT03565068|65793639|FG006|Overall Study|Sponsor decision|0|||
23564014|NCT03565068|65793640|FG007|Overall Study|Sponsor decision|0|||
23564015|NCT03565068|65793641|FG008|Overall Study|Sponsor decision|0|||
23564016|NCT03565068|65793633|FG000|Overall Study|Withdrawal by Subject|0|||
23564017|NCT03565068|65793634|FG001|Overall Study|Withdrawal by Subject|0|||
23564018|NCT03565068|65793635|FG002|Overall Study|Withdrawal by Subject|1|||
23564019|NCT03565068|65793636|FG003|Overall Study|Withdrawal by Subject|0|||
23564020|NCT03565068|65793637|FG004|Overall Study|Withdrawal by Subject|2|||
23564021|NCT03565068|65793638|FG005|Overall Study|Withdrawal by Subject|0|||
23564022|NCT03565068|65793639|FG006|Overall Study|Withdrawal by Subject|1|||
23564023|NCT03565068|65793640|FG007|Overall Study|Withdrawal by Subject|5|||
23564024|NCT03565068|65793641|FG008|Overall Study|Withdrawal by Subject|1|||
23564025|NCT03565068|65793633|FG000|Overall Study|Physician Decision|0|||
23564026|NCT03565068|65793634|FG001|Overall Study|Physician Decision|0|||
23564027|NCT03565068|65793635|FG002|Overall Study|Physician Decision|0|||
23152964|NCT00986440|64309450|FG001|Overall Study|Screen failure (not dosed)|2|||
23152965|NCT02608879|64309451|FG000|Overall Study|Lost to Follow-up|1|||
23152966|NCT02608879|64309452|FG001|Overall Study|Lost to Follow-up|0|||
23152967|NCT02608879|64309453|FG002|Overall Study|Lost to Follow-up|0|||
23152968|NCT02608879|64309451|FG000|Overall Study|Did not meet continuation criteria|0|||
23152969|NCT02608879|64309452|FG001|Overall Study|Did not meet continuation criteria|0|||
23152970|NCT02608879|64309453|FG002|Overall Study|Did not meet continuation criteria|3|||
23152971|NCT02066051|64309454|FG000|Overall Study|Subject developed active GVHD|1|||
23326673|NCT01130532|64937968|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
23326674|NCT01130532|64937965|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
23326675|NCT01130532|64937966|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
23326676|NCT01130532|64937967|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
23326677|NCT01130532|64937968|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
23326678|NCT01130532|64937965|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
23326679|NCT01130532|64937966|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
23326680|NCT01130532|64937967|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
23326681|NCT01130532|64937968|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
23326682|NCT01130532|64937965|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
23152972|NCT01186939|64309456|FG000|Overall Study|Death|7|||
23152973|NCT01186939|64309456|FG000|Overall Study|Withdrawal by Subject|2|||
23152974|NCT01186939|64309456|FG000|Overall Study|No longer receiving clinical benefit|17|||
23152975|NCT01186939|64309456|FG000|Overall Study|Program closed|5|||
23152976|NCT01186939|64309456|FG000|Overall Study|Sponsor decision|4|||
23152977|NCT01186939|64309456|FG000|Overall Study|Started additional treatment|1|||
23152978|NCT01186939|64309456|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
23152979|NCT01186939|64309456|FG000|Overall Study|Myocardial infarction|1|||
23152980|NCT01186939|64309456|FG000|Overall Study|Bone marrow transplant|1|||
23152981|NCT01186939|64309456|FG000|Overall Study|Transformation to AML|1|||
23152982|NCT01798992|64309457|FG000|Overall Study|Administrative withdrawal|0|||
23152983|NCT01798992|64309458|FG001|Overall Study|Administrative withdrawal|1|||
23152984|NCT01798992|64309459|FG002|Overall Study|Administrative withdrawal|0|||
23152985|NCT01798992|64309460|FG003|Overall Study|Administrative withdrawal|1|||
23152986|NCT01798992|64309457|FG000|Overall Study|Lost to Follow-up|0|||
23220409|NCT03799627|64550145|FG005|Overall Study|Noncompliance with Site Instructions|0|||
23220410|NCT03799627|64550146|FG006|Overall Study|Noncompliance with Site Instructions|0|||
23564028|NCT03565068|65793636|FG003|Overall Study|Physician Decision|0|||
23564029|NCT03565068|65793637|FG004|Overall Study|Physician Decision|0|||
23152987|NCT01798992|64309458|FG001|Overall Study|Lost to Follow-up|1|||
23152988|NCT01798992|64309459|FG002|Overall Study|Lost to Follow-up|1|||
23152989|NCT01798992|64309460|FG003|Overall Study|Lost to Follow-up|0|||
23152990|NCT01798992|64309457|FG000|Overall Study|Insufficient biopsy tissue|0|||
23326683|NCT01130532|64937966|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
23564030|NCT03565068|65793638|FG005|Overall Study|Physician Decision|0|||
23564031|NCT03565068|65793639|FG006|Overall Study|Physician Decision|0|||
23564032|NCT03565068|65793640|FG007|Overall Study|Physician Decision|1|||
23152991|NCT01798992|64309458|FG001|Overall Study|Insufficient biopsy tissue|0|||
23152992|NCT01798992|64309459|FG002|Overall Study|Insufficient biopsy tissue|1|||
23152993|NCT01798992|64309460|FG003|Overall Study|Insufficient biopsy tissue|0|||
23326684|NCT01130532|64937967|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
23326685|NCT01130532|64937968|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
23326686|NCT01130532|64937965|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
23326687|NCT01130532|64937966|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
23441114|NCT01769196|65355418|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
23441115|NCT01769196|65355419|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
23441116|NCT01769196|65355418|FG000|Overall Study|Protocol Violation|0|||
23441117|NCT01769196|65355419|FG001|Overall Study|Protocol Violation|3|||
23441118|NCT01769196|65355418|FG000|Overall Study|Study terminated by sponsor|160|||
23441119|NCT01769196|65355419|FG001|Overall Study|Study terminated by sponsor|161|||
23441120|NCT01769196|65355418|FG000|Overall Study|Participant never dosed with study drug|1|||
23441121|NCT01769196|65355419|FG001|Overall Study|Participant never dosed with study drug|0|||
23441122|NCT01769196|65355418|FG000|Overall Study|Withdrew consent|36|||
23441123|NCT01769196|65355419|FG001|Overall Study|Withdrew consent|40|||
23441124|NCT00286429|65355420|FG000|Overall Study|Adverse Event|4|||
23441125|NCT00286429|65355421|FG001|Overall Study|Adverse Event|1|||
23441126|NCT00286429|65355422|FG002|Overall Study|Adverse Event|6|||
23441127|NCT00286429|65355420|FG000|Overall Study|Lack of Efficacy|52|||
23441128|NCT00286429|65355421|FG001|Overall Study|Lack of Efficacy|27|||
23441129|NCT00286429|65355422|FG002|Overall Study|Lack of Efficacy|25|||
23441130|NCT00286429|65355420|FG000|Overall Study|Lost to Follow-up|2|||
23441131|NCT00286429|65355421|FG001|Overall Study|Lost to Follow-up|4|||
23441132|NCT00286429|65355422|FG002|Overall Study|Lost to Follow-up|3|||
23441133|NCT00286429|65355420|FG000|Overall Study|Physician Decision|10|||
23441134|NCT00286429|65355421|FG001|Overall Study|Physician Decision|7|||
23441135|NCT00286429|65355422|FG002|Overall Study|Physician Decision|7|||
23441136|NCT00286429|65355420|FG000|Overall Study|Protocol Violation|3|||
23441137|NCT00286429|65355421|FG001|Overall Study|Protocol Violation|5|||
23441138|NCT00286429|65355422|FG002|Overall Study|Protocol Violation|4|||
23441139|NCT00286429|65355420|FG000|Overall Study|Withdrawal by Subject|3|||
23441140|NCT00286429|65355421|FG001|Overall Study|Withdrawal by Subject|2|||
23441141|NCT00286429|65355422|FG002|Overall Study|Withdrawal by Subject|6|||
23441142|NCT00286429|65355420|FG000|Overall Study|Administrative Error|1|||
23441143|NCT00286429|65355421|FG001|Overall Study|Administrative Error|1|||
23441144|NCT00286429|65355422|FG002|Overall Study|Administrative Error|1|||
23441145|NCT00286429|65355420|FG000|Overall Study|Administrative Decision|0|||
23441146|NCT00286429|65355421|FG001|Overall Study|Administrative Decision|1|||
23441147|NCT00286429|65355422|FG002|Overall Study|Administrative Decision|0|||
23441148|NCT01445080|65355425|FG000|Overall Study|Adverse Event|5|||
23441149|NCT01445080|65355426|FG001|Overall Study|Adverse Event|3|||
23441150|NCT01445080|65355427|FG002|Overall Study|Adverse Event|11|||
23441151|NCT01445080|65355428|FG003|Overall Study|Adverse Event|6|||
23441152|NCT01445080|65355429|FG004|Overall Study|Adverse Event|2|||
23441153|NCT01445080|65355430|FG005|Overall Study|Adverse Event|3|||
23441154|NCT01445080|65355431|FG006|Overall Study|Adverse Event|0|||
23441155|NCT01445080|65355432|FG007|Overall Study|Adverse Event|3|||
23441156|NCT01445080|65355433|FG008|Overall Study|Adverse Event|10|||
23441157|NCT01445080|65355425|FG000|Overall Study|Physician Decision|0|||
23441158|NCT01445080|65355426|FG001|Overall Study|Physician Decision|0|||
23441159|NCT01445080|65355427|FG002|Overall Study|Physician Decision|1|||
23564033|NCT03565068|65793641|FG008|Overall Study|Physician Decision|0|||
23564034|NCT03565068|65793633|FG000|Overall Study|Lost to Follow-up|0|||
23564035|NCT03565068|65793634|FG001|Overall Study|Lost to Follow-up|0|||
23564036|NCT03565068|65793635|FG002|Overall Study|Lost to Follow-up|0|||
23564037|NCT03565068|65793636|FG003|Overall Study|Lost to Follow-up|0|||
23564038|NCT03565068|65793637|FG004|Overall Study|Lost to Follow-up|0|||
23564039|NCT03565068|65793638|FG005|Overall Study|Lost to Follow-up|0|||
23564040|NCT03565068|65793639|FG006|Overall Study|Lost to Follow-up|0|||
23564041|NCT03565068|65793640|FG007|Overall Study|Lost to Follow-up|1|||
23564042|NCT03565068|65793641|FG008|Overall Study|Lost to Follow-up|0|||
23564043|NCT00691132|65793642|FG000|Overall Study|Adverse Event|2|||
23564044|NCT00691132|65793643|FG001|Overall Study|Adverse Event|3|||
23564045|NCT00691132|65793642|FG000|Overall Study|Withdrawal by Subject|10|||
23564046|NCT00691132|65793643|FG001|Overall Study|Withdrawal by Subject|10|||
23564047|NCT02204579|65793644|FG000|Overall Study|Screen failures|2|||
23564048|NCT00744263|65793654|FG000|Overall Study|Death|3006|||
23564049|NCT00744263|65793655|FG001|Overall Study|Death|3005|||
23564050|NCT00744263|65793654|FG000|Overall Study|Lost to Follow-up|2038|||
23564051|NCT00744263|65793655|FG001|Overall Study|Lost to Follow-up|2135|||
23441160|NCT01445080|65355428|FG003|Overall Study|Physician Decision|0|||
23441161|NCT01445080|65355429|FG004|Overall Study|Physician Decision|0|||
23441162|NCT01445080|65355430|FG005|Overall Study|Physician Decision|3|||
23441163|NCT01445080|65355431|FG006|Overall Study|Physician Decision|2|||
23441164|NCT01445080|65355432|FG007|Overall Study|Physician Decision|2|||
23441165|NCT01445080|65355433|FG008|Overall Study|Physician Decision|0|||
23441166|NCT01445080|65355425|FG000|Overall Study|Withdrawal by Subject|1|||
23441167|NCT01445080|65355426|FG001|Overall Study|Withdrawal by Subject|0|||
23564052|NCT00744263|65793654|FG000|Overall Study|Withdrawal by Subject|166|||
23326688|NCT01130532|64937967|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
23564053|NCT00744263|65793655|FG001|Overall Study|Withdrawal by Subject|150|||
23564054|NCT00744263|65793654|FG000|Overall Study|Physician Decision|20|||
23441168|NCT01445080|65355427|FG002|Overall Study|Withdrawal by Subject|0|||
23441169|NCT01445080|65355428|FG003|Overall Study|Withdrawal by Subject|1|||
23441170|NCT01445080|65355429|FG004|Overall Study|Withdrawal by Subject|0|||
23441171|NCT01445080|65355430|FG005|Overall Study|Withdrawal by Subject|0|||
23441172|NCT01445080|65355431|FG006|Overall Study|Withdrawal by Subject|0|||
23441173|NCT01445080|65355432|FG007|Overall Study|Withdrawal by Subject|0|||
23441174|NCT01445080|65355433|FG008|Overall Study|Withdrawal by Subject|2|||
23441175|NCT01445080|65355425|FG000|Overall Study|Ineligible/Inevaluable|1|||
23441176|NCT01445080|65355426|FG001|Overall Study|Ineligible/Inevaluable|2|||
23441177|NCT01445080|65355427|FG002|Overall Study|Ineligible/Inevaluable|0|||
23441178|NCT01445080|65355428|FG003|Overall Study|Ineligible/Inevaluable|1|||
23441179|NCT01445080|65355429|FG004|Overall Study|Ineligible/Inevaluable|2|||
23441180|NCT01445080|65355430|FG005|Overall Study|Ineligible/Inevaluable|3|||
23441181|NCT01445080|65355431|FG006|Overall Study|Ineligible/Inevaluable|0|||
23441182|NCT01445080|65355432|FG007|Overall Study|Ineligible/Inevaluable|0|||
23441183|NCT01445080|65355433|FG008|Overall Study|Ineligible/Inevaluable|6|||
23441184|NCT04440813|65355438|FG000|Overall Study|Lost to Follow-up|5|||
23441185|NCT04440813|65355439|FG001|Overall Study|Lost to Follow-up|5|||
23441186|NCT04736628|65355440|FG000|Overall Study|Not treated|0|||
23441187|NCT04736628|65355441|FG001|Overall Study|Not treated|0|||
23441188|NCT04736628|65355442|FG002|Overall Study|Not treated|0|||
23441189|NCT04736628|65355443|FG003|Overall Study|Not treated|2|||
23326689|NCT01130532|64937968|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
23326690|NCT01130532|64937965|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
23441190|NCT04736628|65355440|FG000|Overall Study|Other reason than listed|1|||
23441191|NCT04736628|65355441|FG001|Overall Study|Other reason than listed|2|||
23441192|NCT04736628|65355442|FG002|Overall Study|Other reason than listed|2|||
23441193|NCT04736628|65355443|FG003|Overall Study|Other reason than listed|3|||
23441194|NCT04736628|65355440|FG000|Overall Study|Protocol deviation|0|||
23441195|NCT04736628|65355441|FG001|Overall Study|Protocol deviation|0|||
23441196|NCT04736628|65355442|FG002|Overall Study|Protocol deviation|0|||
23441197|NCT04736628|65355443|FG003|Overall Study|Protocol deviation|1|||
23441198|NCT04736628|65355440|FG000|Overall Study|Burden of study procedures|1|||
23441199|NCT04736628|65355441|FG001|Overall Study|Burden of study procedures|0|||
23441200|NCT04736628|65355442|FG002|Overall Study|Burden of study procedures|0|||
23441201|NCT04736628|65355443|FG003|Overall Study|Burden of study procedures|1|||
23441202|NCT04736628|65355440|FG000|Overall Study|Change of residence|0|||
23441203|NCT04736628|65355441|FG001|Overall Study|Change of residence|1|||
23441204|NCT04736628|65355442|FG002|Overall Study|Change of residence|0|||
23152994|NCT01122576|64312474|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
23152995|NCT01122576|64312475|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
23152996|NCT01122576|64312476|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
23152997|NCT01122576|64312474|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
23152998|NCT01122576|64312475|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
23152999|NCT01122576|64312476|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
23153000|NCT01122576|64312474|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
23153001|NCT01122576|64312475|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
23153002|NCT01122576|64312476|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
23153003|NCT01536951|64312477|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23153004|NCT01536951|64312478|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23153005|NCT01536951|64312479|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
23153006|NCT01536951|64312480|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23153007|NCT01536951|64312481|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23153008|NCT01536951|64312482|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23153009|NCT01536951|64312483|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23153010|NCT01536951|64312484|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23153011|NCT01536951|64312485|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
23153012|NCT01536951|64312477|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
23153013|NCT01536951|64312478|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
23153014|NCT01536951|64312479|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
23153015|NCT01536951|64312480|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
23153016|NCT01536951|64312481|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
23153017|NCT01536951|64312482|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
23153018|NCT01536951|64312483|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
23153019|NCT01536951|64312484|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
23153020|NCT01536951|64312485|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
23153021|NCT00607880|64312488|FG000|Overall Study|Unable to place port due to occlusion|1|||
23326691|NCT01130532|64937966|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
23441205|NCT04736628|65355443|FG003|Overall Study|Change of residence|0|||
23441206|NCT04736628|65355440|FG000|Overall Study|Perceived lack of efficacy|1|||
23441207|NCT04736628|65355441|FG001|Overall Study|Perceived lack of efficacy|0|||
23441208|NCT04736628|65355442|FG002|Overall Study|Perceived lack of efficacy|0|||
23441209|NCT04736628|65355443|FG003|Overall Study|Perceived lack of efficacy|1|||
23441210|NCT04736628|65355440|FG000|Overall Study|Adverse Event|3|||
23441211|NCT04736628|65355441|FG001|Overall Study|Adverse Event|2|||
23441212|NCT04736628|65355442|FG002|Overall Study|Adverse Event|4|||
23441213|NCT04736628|65355443|FG003|Overall Study|Adverse Event|3|||
23441214|NCT01900652|65355445|FG000|Overall Study|Progressive Disease|1|||
23441215|NCT01900652|65355446|FG001|Overall Study|Progressive Disease|0|||
23441216|NCT01900652|65355445|FG000|Overall Study|Consent withdrawn by subject|1|||
23441217|NCT01900652|65355446|FG001|Overall Study|Consent withdrawn by subject|1|||
23441218|NCT01900652|65355445|FG000|Overall Study|Death|3|||
23441219|NCT01900652|65355446|FG001|Overall Study|Death|0|||
23441220|NCT01900652|65355445|FG000|Overall Study|Adverse Event|2|||
23441221|NCT01900652|65355446|FG001|Overall Study|Adverse Event|1|||
23441222|NCT01900652|65355445|FG000|Overall Study|Physician Decision|1|||
23441223|NCT01900652|65355446|FG001|Overall Study|Physician Decision|1|||
23220411|NCT03799627|64550147|FG007|Overall Study|Noncompliance with Site Instructions|0|||
23220412|NCT03799627|64550148|FG008|Overall Study|Noncompliance with Site Instructions|0|||
23441224|NCT01771250|65358434|FG000|Period 1|Met exclusion criteria|1|||
23441225|NCT01771250|65358435|FG001|Period 1|Met exclusion criteria|0|||
23441226|NCT03566082|65358436|FG000|Overall Study|Death|7|||
23441227|NCT03566082|65358436|FG000|Overall Study|Failures (revision required)|2|||
23441228|NCT03566082|65358436|FG000|Overall Study|Lost to Follow-up|8|||
23441229|NCT02069392|65358437|FG000|Overall Study|Withdrawal by Subject|4|||
23441230|NCT02069392|65358438|FG001|Overall Study|Withdrawal by Subject|2|||
23441231|NCT01371552|65358439|FG000|Part 1, First 3 Days|Inconvenience|0|||
23441232|NCT01371552|65358440|FG001|Part 1, First 3 Days|Inconvenience|0|||
23441233|NCT01371552|65358441|FG002|Part 1, First 3 Days|Inconvenience|1|||
23441234|NCT01371552|65358442|FG003|Part 1, First 3 Days|Inconvenience|0|||
23441235|NCT01371552|65358443|FG004|Part 1, First 3 Days|Inconvenience|0|||
23441236|NCT01371552|65358444|FG005|Part 1, First 3 Days|Inconvenience|0|||
23441237|NCT00495625|65358448|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
23441238|NCT00781859|65358449|FG000|Overall Study|Adverse Event|2|||
23441239|NCT00781859|65358450|FG001|Overall Study|Adverse Event|2|||
23441240|NCT00781859|65358449|FG000|Overall Study|Withdrawal by Subject|8|||
23441241|NCT00781859|65358450|FG001|Overall Study|Withdrawal by Subject|4|||
23441242|NCT00781859|65358449|FG000|Overall Study|Lost to Follow-up|6|||
23441243|NCT00781859|65358450|FG001|Overall Study|Lost to Follow-up|3|||
23441244|NCT00781859|65358449|FG000|Overall Study|Death|3|||
23441245|NCT00781859|65358450|FG001|Overall Study|Death|0|||
23441246|NCT00375518|65358452|FG000|Overall Study|Withdrawal by Subject|2|||
23441247|NCT00375518|65358453|FG001|Overall Study|Withdrawal by Subject|10|||
23441248|NCT00375518|65358452|FG000|Overall Study|Patient Not Treated|6|||
23441249|NCT00375518|65358453|FG001|Overall Study|Patient Not Treated|6|||
23441250|NCT00375518|65358452|FG000|Overall Study|Death|0|||
23441251|NCT00375518|65358453|FG001|Overall Study|Death|1|||
23441252|NCT02452424|65358454|FG000|Overall Study|Death|2|||
23441253|NCT02452424|65358455|FG001|Overall Study|Death|2|||
23441254|NCT02452424|65358456|FG002|Overall Study|Death|2|||
23441255|NCT02452424|65358457|FG003|Overall Study|Death|6|||
23441256|NCT02452424|65358458|FG004|Overall Study|Death|2|||
23441257|NCT02452424|65358459|FG005|Overall Study|Death|0|||
23564055|NCT00744263|65793655|FG001|Overall Study|Physician Decision|23|||
23564056|NCT00744263|65793654|FG000|Overall Study|Protocol Violation|3|||
23564057|NCT00744263|65793655|FG001|Overall Study|Protocol Violation|5|||
23564058|NCT00744263|65793654|FG000|Overall Study|Adverse Event|1|||
23564059|NCT00744263|65793655|FG001|Overall Study|Adverse Event|0|||
23564060|NCT00744263|65793654|FG000|Overall Study|Other|2|||
23564061|NCT00744263|65793655|FG001|Overall Study|Other|2|||
23564062|NCT01861522|65793658|FG000|Overall Study|Adverse Event|1|||
23564063|NCT01861522|65793659|FG001|Overall Study|Adverse Event|0|||
23564064|NCT01861522|65793658|FG000|Overall Study|Withdrawal by Subject|2|||
23564065|NCT01861522|65793659|FG001|Overall Study|Withdrawal by Subject|0|||
23564066|NCT02668016|65793660|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
23564067|NCT02668016|65793660|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
23564068|NCT02668016|65793660|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
23564069|NCT02668016|65793660|FG000|Month 4|Withdrawal due to severe symptoms|1|||
23441258|NCT02452424|65358460|FG006|Overall Study|Death|5|||
23441259|NCT02452424|65358461|FG007|Overall Study|Death|1|||
23441260|NCT02452424|65358462|FG008|Overall Study|Death|3|||
23441261|NCT02452424|65358463|FG009|Overall Study|Death|1|||
23441262|NCT02452424|65358464|FG010|Overall Study|Death|0|||
23441263|NCT02452424|65358454|FG000|Overall Study|Lost to Follow-up|0|||
23441264|NCT02452424|65358455|FG001|Overall Study|Lost to Follow-up|1|||
23441265|NCT02452424|65358456|FG002|Overall Study|Lost to Follow-up|1|||
23441266|NCT02452424|65358457|FG003|Overall Study|Lost to Follow-up|0|||
23441267|NCT02452424|65358458|FG004|Overall Study|Lost to Follow-up|0|||
23441268|NCT02452424|65358459|FG005|Overall Study|Lost to Follow-up|0|||
23441269|NCT02452424|65358460|FG006|Overall Study|Lost to Follow-up|0|||
23564070|NCT02668016|65793660|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
23564071|NCT02668016|65793660|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
23564072|NCT02668016|65793660|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
23564073|NCT02668016|65793660|FG000|Month 6|Withdrawal due to severe symptoms|2|||
23564074|NCT02668016|65793660|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
23564075|NCT02668016|65793660|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
23564076|NCT02668016|65793660|FG000|Month 8|Withdrawal due to severe symptoms|1|||
23564077|NCT02668016|65793660|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
23564078|NCT02668016|65793660|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
23564079|NCT02668016|65793660|FG000|Month 10|Withdrawal due to severe symptoms|1|||
23564080|NCT02668016|65793660|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
23564081|NCT00405639|65793667|FG000|Overall Study|Withdrawal by Subject|1|||
23564082|NCT00405639|65793668|FG001|Overall Study|Withdrawal by Subject|0|||
23564083|NCT00405639|65793667|FG000|Overall Study|Adverse Event|1|||
23564084|NCT00405639|65793668|FG001|Overall Study|Adverse Event|0|||
23564085|NCT00405639|65793667|FG000|Overall Study|Seizure prior to receiving BNP|1|||
23564086|NCT00405639|65793668|FG001|Overall Study|Seizure prior to receiving BNP|0|||
23564087|NCT03489057|65793671|FG000|Overall Study|Lost to Follow-up|16|||
23564088|NCT03489057|65793672|FG001|Overall Study|Lost to Follow-up|16|||
23564089|NCT03489057|65793673|FG002|Overall Study|Lost to Follow-up|14|||
23564090|NCT03489057|65793674|FG003|Overall Study|Lost to Follow-up|14|||
23564091|NCT03489057|65793671|FG000|Overall Study|Withdrawal by Subject|12|||
23564092|NCT03489057|65793672|FG001|Overall Study|Withdrawal by Subject|12|||
23564093|NCT03489057|65793673|FG002|Overall Study|Withdrawal by Subject|8|||
23564094|NCT03489057|65793674|FG003|Overall Study|Withdrawal by Subject|8|||
23564095|NCT03489057|65793671|FG000|Overall Study|Protocol Violation|7|||
23564096|NCT03489057|65793672|FG001|Overall Study|Protocol Violation|7|||
23564097|NCT03489057|65793673|FG002|Overall Study|Protocol Violation|2|||
23564098|NCT03489057|65793674|FG003|Overall Study|Protocol Violation|2|||
23564099|NCT00770432|65793675|FG000|Overall Study|Other|4|||
23564100|NCT00770432|65793676|FG001|Overall Study|Other|6|||
23564101|NCT00770432|65793675|FG000|Overall Study|Non-compliance|0|||
23564102|NCT00770432|65793676|FG001|Overall Study|Non-compliance|1|||
23564103|NCT02343003|65793677|FG000|Overall Study|Withdrawal by Subject|9|||
23564104|NCT02343003|65793678|FG001|Overall Study|Withdrawal by Subject|4|||
23564105|NCT02343003|65793677|FG000|Overall Study|Lost to Follow-up|5|||
23564106|NCT02343003|65793678|FG001|Overall Study|Lost to Follow-up|1|||
23564107|NCT02343003|65793677|FG000|Overall Study|Protocol Violation|1|||
23564108|NCT02343003|65793678|FG001|Overall Study|Protocol Violation|0|||
23564109|NCT02343003|65793677|FG000|Overall Study|Death|0|||
23564110|NCT02343003|65793678|FG001|Overall Study|Death|1|||
23564111|NCT02343003|65793677|FG000|Overall Study|exclusion criteria met|1|||
23564112|NCT02343003|65793678|FG001|Overall Study|exclusion criteria met|1|||
23564113|NCT02343003|65793677|FG000|Overall Study|terminated by sponsor|2|||
23564114|NCT02343003|65793678|FG001|Overall Study|terminated by sponsor|0|||
23564115|NCT00633932|65793679|FG000|Overall Study|Adverse Event|1|||
23564116|NCT00633932|65793680|FG001|Overall Study|Adverse Event|3|||
23564117|NCT00633932|65793681|FG002|Overall Study|Adverse Event|4|||
23564118|NCT00633932|65793679|FG000|Overall Study|Withdrawal by Subject|3|||
23564119|NCT00633932|65793680|FG001|Overall Study|Withdrawal by Subject|9|||
23564120|NCT00633932|65793681|FG002|Overall Study|Withdrawal by Subject|1|||
23564121|NCT00633932|65793679|FG000|Overall Study|Lost to Follow-up|1|||
23564122|NCT00633932|65793680|FG001|Overall Study|Lost to Follow-up|0|||
23564123|NCT00633932|65793681|FG002|Overall Study|Lost to Follow-up|2|||
23564124|NCT00633932|65793679|FG000|Overall Study|Protocol Violation|5|||
23564125|NCT00633932|65793680|FG001|Overall Study|Protocol Violation|2|||
23564126|NCT00633932|65793681|FG002|Overall Study|Protocol Violation|3|||
23220413|NCT03799627|64550140|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23220414|NCT03799627|64550141|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23220415|NCT03799627|64550142|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23220416|NCT03799627|64550143|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23220417|NCT03799627|64550144|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
23220418|NCT03799627|64550145|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23220419|NCT03799627|64550146|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23220420|NCT03799627|64550147|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23220421|NCT03799627|64550148|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
23220422|NCT03799627|64550140|FG000|Overall Study|Changes In Hemoglobin Values|1|||
23220423|NCT03799627|64550141|FG001|Overall Study|Changes In Hemoglobin Values|2|||
23564127|NCT00633932|65793679|FG000|Overall Study|Physician Decision|0|||
23564128|NCT00633932|65793680|FG001|Overall Study|Physician Decision|0|||
23564129|NCT00633932|65793681|FG002|Overall Study|Physician Decision|1|||
23564130|NCT00633932|65793679|FG000|Overall Study|Doctor's judgement|1|||
23326692|NCT01130532|64937967|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
23326693|NCT01130532|64937968|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
23326694|NCT01130532|64937965|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
23326695|NCT01130532|64937966|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
23626298|NCT01321723|66020298|FG002|Overall Study|Withdrawal by Subject|2|||
23626299|NCT02386839|66020300|FG000|Overall Study|Death|1|||
23626300|NCT02386839|66020301|FG001|Overall Study|Death|0|||
23626301|NCT02386839|66020300|FG000|Overall Study|Withdrawal by Subject|9|||
23626302|NCT02386839|66020301|FG001|Overall Study|Withdrawal by Subject|10|||
23626303|NCT02386839|66020300|FG000|Overall Study|Lost to Follow-up|4|||
23626304|NCT02386839|66020301|FG001|Overall Study|Lost to Follow-up|4|||
23626305|NCT02386839|66020300|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
23626306|NCT02386839|66020301|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
23626307|NCT02386839|66020300|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
23626308|NCT02386839|66020301|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
23626309|NCT02386839|66020300|FG000|Overall Study|Other (unspecified)|1|||
23626310|NCT02386839|66020301|FG001|Overall Study|Other (unspecified)|0|||
23626311|NCT00632021|66020302|FG000|Overall Study|Withdrawal/death|4|||
23626312|NCT00632021|66020303|FG001|Overall Study|Withdrawal/death|7|||
23626313|NCT00113269|66020304|FG000|Overall Study|Not transplanted, donor issues|4|||
23626314|NCT00113269|66020305|FG001|Overall Study|Not transplanted, donor issues|0|||
23626315|NCT00113269|66020306|FG002|Overall Study|Not transplanted, donor issues|2|||
23626316|NCT00113269|66020307|FG003|Overall Study|Not transplanted, donor issues|2|||
23626317|NCT00113269|66020304|FG000|Overall Study|Not transplanted, recipient issues|2|||
23626318|NCT00113269|66020305|FG001|Overall Study|Not transplanted, recipient issues|1|||
23626319|NCT00113269|66020306|FG002|Overall Study|Not transplanted, recipient issues|7|||
23626320|NCT00113269|66020307|FG003|Overall Study|Not transplanted, recipient issues|4|||
23626321|NCT00113269|66020304|FG000|Overall Study|Early graft loss, technical|0|||
23626322|NCT00113269|66020305|FG001|Overall Study|Early graft loss, technical|0|||
23626323|NCT00113269|66020306|FG002|Overall Study|Early graft loss, technical|2|||
23626324|NCT00113269|66020307|FG003|Overall Study|Early graft loss, technical|0|||
23626325|NCT00113269|66020304|FG000|Overall Study|Death in operating room|0|||
23626326|NCT00113269|66020305|FG001|Overall Study|Death in operating room|0|||
23626327|NCT00113269|66020306|FG002|Overall Study|Death in operating room|0|||
23626328|NCT00113269|66020307|FG003|Overall Study|Death in operating room|1|||
23626329|NCT00113269|66020304|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
23326696|NCT01130532|64937967|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
23326697|NCT01130532|64937968|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
23326698|NCT01130532|64937965|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
23326699|NCT01130532|64937966|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
23326700|NCT01130532|64937967|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
23326701|NCT01130532|64937968|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
23326702|NCT02750618|64937971|FG000|Overall Study|Withdrawal by Subject|1|||
23326703|NCT02832687|64937972|FG000|Overall Study|Adverse Event|0|||
23326704|NCT02832687|64937973|FG001|Overall Study|Adverse Event|2|||
23326705|NCT03896022|64937974|FG000|Overall Study|Withdrawal by Subject|1|||
23326706|NCT03896022|64937975|FG001|Overall Study|Withdrawal by Subject|0|||
23326707|NCT03896022|64937976|FG002|Overall Study|Withdrawal by Subject|0|||
23326708|NCT03896022|64937974|FG000|Overall Study|Did not have procedure|3|||
23326709|NCT03896022|64937975|FG001|Overall Study|Did not have procedure|0|||
23326710|NCT03896022|64937976|FG002|Overall Study|Did not have procedure|0|||
23326711|NCT05048329|64937977|FG000|Overall Study|Withdrawal by Subject|1|||
23326712|NCT05048329|64937977|FG000|Overall Study|Screenfail|1|||
23326713|NCT02182843|64937983|FG000|Overall Study|Withdrawal by Subject|7|||
23326714|NCT02182843|64937983|FG000|Overall Study|Lost to Follow-up|2|||
23326715|NCT02182843|64937983|FG000|Overall Study|Adverse Event|1|||
23326716|NCT02633293|64937984|FG000|Overall Study|Death|56|||
23441270|NCT02452424|65358461|FG007|Overall Study|Lost to Follow-up|0|||
23153022|NCT00607880|64312489|FG001|Overall Study|Unable to place port due to occlusion|0|||
23153023|NCT01221727|64312490|FG000|Overall Study|Physician Decision|2|||
23153024|NCT01221727|64312491|FG001|Overall Study|Physician Decision|0|||
23153025|NCT01221727|64312490|FG000|Overall Study|Withdrawal by Subject|1|||
23153026|NCT01221727|64312491|FG001|Overall Study|Withdrawal by Subject|1|||
23626330|NCT00113269|66020305|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
23626331|NCT00113269|66020306|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
23626332|NCT00113269|66020307|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
23153027|NCT01022502|64312492|FG000|Overall Study|Adverse Event|1|||
23153028|NCT01022502|64312492|FG000|Overall Study|employment related reasons|1|||
23326717|NCT02633293|64937984|FG000|Overall Study|Progressive Disease|12|||
23626333|NCT00113269|66020304|FG000|Overall Study|Adverse Event|2|||
23326718|NCT02633293|64937984|FG000|Overall Study|Adverse Event|29|||
23326719|NCT02633293|64937984|FG000|Overall Study|Withdrawal by Subject|41|||
23326720|NCT02633293|64937984|FG000|Overall Study|Protocol Violation|1|||
23326721|NCT02633293|64937984|FG000|Overall Study|Lost to Follow-up|1|||
23326722|NCT02633293|64937984|FG000|Overall Study|Study Terminated by Sponsor|24|||
23326723|NCT02633293|64937984|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
23326724|NCT02633293|64937984|FG000|Overall Study|Lung Transplant|5|||
23326725|NCT02633293|64937984|FG000|Overall Study|Lack of Efficacy|2|||
23326726|NCT02633293|64937984|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
23326727|NCT04358081|64937985|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
23326728|NCT04358081|64937986|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
23326729|NCT04358081|64937987|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
23326730|NCT04358081|64937985|FG000|Treatment Phase of Study|Adverse Event|1|||
23326731|NCT04358081|64937986|FG001|Treatment Phase of Study|Adverse Event|0|||
23326732|NCT04358081|64937987|FG002|Treatment Phase of Study|Adverse Event|1|||
23326733|NCT04358081|64937985|FG000|Treatment Phase of Study|Physician Decision|2|||
23326734|NCT04358081|64937986|FG001|Treatment Phase of Study|Physician Decision|0|||
23326735|NCT04358081|64937987|FG002|Treatment Phase of Study|Physician Decision|1|||
23326736|NCT04358081|64937985|FG000|Treatment Phase of Study|Protocol Violation|1|||
23326737|NCT04358081|64937986|FG001|Treatment Phase of Study|Protocol Violation|0|||
23326738|NCT04358081|64937987|FG002|Treatment Phase of Study|Protocol Violation|0|||
23326739|NCT04358081|64937985|FG000|Study Completion Phase|Death|0|||
23326740|NCT04358081|64937986|FG001|Study Completion Phase|Death|0|||
23326741|NCT04358081|64937987|FG002|Study Completion Phase|Death|1|||
23326742|NCT04358081|64937985|FG000|Study Completion Phase|Lost to Follow-up|1|||
23326743|NCT04358081|64937986|FG001|Study Completion Phase|Lost to Follow-up|0|||
23326744|NCT04358081|64937987|FG002|Study Completion Phase|Lost to Follow-up|1|||
23326745|NCT00359424|64937990|FG000|Overall Study|Death|99|||
23326746|NCT00359424|64937991|FG001|Overall Study|Death|58|||
23326747|NCT00359424|64937990|FG000|Overall Study|Lost to Follow-up|19|||
23326748|NCT00359424|64937991|FG001|Overall Study|Lost to Follow-up|7|||
23153029|NCT01022502|64312492|FG000|Overall Study|Withdrawal by Subject|1|||
23153030|NCT00578136|64312501|FG000|Overall Study|Not given intervention|1|||
23153031|NCT00578136|64312502|FG001|Overall Study|Not given intervention|1|||
23153032|NCT02511678|64312503|FG000|Overall Study|Withdrawal by Subject|2|||
23153033|NCT02511678|64312503|FG000|Overall Study|Lost to Follow-up|4|||
23326749|NCT00359424|64937990|FG000|Overall Study|Withdrawal by Subject|10|||
23626334|NCT00113269|66020305|FG001|Overall Study|Adverse Event|7|||
23626335|NCT00113269|66020306|FG002|Overall Study|Adverse Event|11|||
23626336|NCT00113269|66020307|FG003|Overall Study|Adverse Event|7|||
23626337|NCT00113269|66020304|FG000|Overall Study|Withdrawal by Subject|4|||
23626338|NCT00113269|66020305|FG001|Overall Study|Withdrawal by Subject|3|||
23626339|NCT00113269|66020306|FG002|Overall Study|Withdrawal by Subject|4|||
23626340|NCT00113269|66020307|FG003|Overall Study|Withdrawal by Subject|2|||
23626341|NCT00113269|66020304|FG000|Overall Study|Graft loss|6|||
23626342|NCT00113269|66020305|FG001|Overall Study|Graft loss|6|||
23626343|NCT00113269|66020306|FG002|Overall Study|Graft loss|4|||
23626344|NCT00113269|66020307|FG003|Overall Study|Graft loss|9|||
23626345|NCT00113269|66020304|FG000|Overall Study|Protocol Violation|1|||
23626346|NCT00113269|66020305|FG001|Overall Study|Protocol Violation|0|||
23153034|NCT02511678|64312503|FG000|Overall Study|Death|19|||
23326750|NCT00359424|64937991|FG001|Overall Study|Withdrawal by Subject|2|||
23326751|NCT00359424|64937990|FG000|Overall Study|follow up not conducted|2|||
23564131|NCT00633932|65793680|FG001|Overall Study|Doctor's judgement|0|||
23564132|NCT00633932|65793681|FG002|Overall Study|Doctor's judgement|0|||
23564133|NCT00633932|65793679|FG000|Overall Study|Moved Away|1|||
23564134|NCT00633932|65793680|FG001|Overall Study|Moved Away|0|||
23564135|NCT00633932|65793681|FG002|Overall Study|Moved Away|0|||
23564136|NCT01859793|65793686|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
23564137|NCT01859793|65793687|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
23564138|NCT01859793|65793686|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
23564139|NCT01859793|65793687|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
23564140|NCT01859793|65793686|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23564141|NCT01859793|65793687|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
23564142|NCT01859793|65793686|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
23564143|NCT01859793|65793687|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
23564144|NCT03342053|65793688|FG000|Overall Study|Adverse Event|2|||
23564145|NCT03342053|65793689|FG001|Overall Study|Adverse Event|0|||
23564146|NCT03342053|65793688|FG000|Overall Study|Withdrawal by Subject|0|||
23564147|NCT03342053|65793689|FG001|Overall Study|Withdrawal by Subject|1|||
23564148|NCT03713021|65793690|FG000|Overall Study|Did not have CT sim scan available|6|||
23564149|NCT03713021|65793690|FG000|Overall Study|Not eligible|4|||
23626347|NCT00113269|66020306|FG002|Overall Study|Protocol Violation|4|||
23626348|NCT00113269|66020307|FG003|Overall Study|Protocol Violation|2|||
23626349|NCT00113269|66020304|FG000|Overall Study|Lost to Follow-up|2|||
23626350|NCT00113269|66020305|FG001|Overall Study|Lost to Follow-up|3|||
23626351|NCT00113269|66020306|FG002|Overall Study|Lost to Follow-up|6|||
23326752|NCT00359424|64937991|FG001|Overall Study|follow up not conducted|0|||
23326753|NCT00287586|64937992|FG000|Overall Study|Withdrew Consent|19|||
23326754|NCT00287586|64937993|FG001|Overall Study|Withdrew Consent|30|||
23326755|NCT00287586|64937992|FG000|Overall Study|Lost to Follow-up|5|||
23326756|NCT00287586|64937993|FG001|Overall Study|Lost to Follow-up|4|||
23626352|NCT00113269|66020307|FG003|Overall Study|Lost to Follow-up|3|||
23626353|NCT00113269|66020304|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
23626354|NCT00113269|66020305|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
23626355|NCT00113269|66020306|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
23626356|NCT00113269|66020307|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
23626357|NCT00113269|66020304|FG000|Overall Study|Discontinued due to rejection|0|||
23626358|NCT00113269|66020305|FG001|Overall Study|Discontinued due to rejection|0|||
23626359|NCT00113269|66020306|FG002|Overall Study|Discontinued due to rejection|1|||
23626360|NCT00113269|66020307|FG003|Overall Study|Discontinued due to rejection|0|||
23626361|NCT00113269|66020304|FG000|Overall Study|Moved|0|||
23626362|NCT00113269|66020305|FG001|Overall Study|Moved|1|||
23626363|NCT00113269|66020306|FG002|Overall Study|Moved|0|||
23626364|NCT00113269|66020307|FG003|Overall Study|Moved|3|||
23626365|NCT00113269|66020304|FG000|Overall Study|Received pancreas transplant|0|||
23626366|NCT00113269|66020305|FG001|Overall Study|Received pancreas transplant|0|||
23626367|NCT00113269|66020306|FG002|Overall Study|Received pancreas transplant|0|||
23626368|NCT00113269|66020307|FG003|Overall Study|Received pancreas transplant|2|||
23626369|NCT00113269|66020304|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
23626370|NCT00113269|66020305|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
23626371|NCT00113269|66020306|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
23626372|NCT00113269|66020307|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
23626373|NCT00113269|66020304|FG000|Overall Study|Did not meet eligibility criteria|1|||
23626374|NCT00113269|66020305|FG001|Overall Study|Did not meet eligibility criteria|0|||
23626375|NCT00113269|66020306|FG002|Overall Study|Did not meet eligibility criteria|0|||
23626376|NCT00113269|66020307|FG003|Overall Study|Did not meet eligibility criteria|1|||
23626377|NCT00113269|66020304|FG000|Overall Study|Unable to return for follow up|2|||
23626378|NCT00113269|66020305|FG001|Overall Study|Unable to return for follow up|1|||
23626379|NCT00113269|66020306|FG002|Overall Study|Unable to return for follow up|0|||
23626380|NCT00113269|66020307|FG003|Overall Study|Unable to return for follow up|0|||
23626381|NCT02719743|66020309|FG000|Overall Study|Consent withdrawal|0|||
23626382|NCT02719743|66020310|FG001|Overall Study|Consent withdrawal|2|||
23626383|NCT02719743|66020311|FG002|Overall Study|Consent withdrawal|0|||
23626384|NCT02719743|66020312|FG003|Overall Study|Consent withdrawal|1|||
23626385|NCT02719743|66020313|FG004|Overall Study|Consent withdrawal|0|||
23626386|NCT02719743|66020309|FG000|Overall Study|Migrated/moved from study area|0|||
23626387|NCT02719743|66020310|FG001|Overall Study|Migrated/moved from study area|0|||
23626388|NCT02719743|66020311|FG002|Overall Study|Migrated/moved from study area|0|||
23626389|NCT02719743|66020312|FG003|Overall Study|Migrated/moved from study area|0|||
23626390|NCT02719743|66020313|FG004|Overall Study|Migrated/moved from study area|2|||
23626391|NCT02719743|66020309|FG000|Overall Study|Lost to Follow-up|1|||
23626392|NCT02719743|66020310|FG001|Overall Study|Lost to Follow-up|1|||
23626393|NCT02719743|66020311|FG002|Overall Study|Lost to Follow-up|0|||
23626394|NCT02719743|66020312|FG003|Overall Study|Lost to Follow-up|0|||
23626395|NCT02719743|66020313|FG004|Overall Study|Lost to Follow-up|0|||
23626396|NCT01437423|66020314|FG000|Overall Study|Lost to Follow-up|12|||
23626397|NCT01437423|66020314|FG000|Overall Study|Off label usage|3|||
23626398|NCT02284009|66020317|FG000|Overall Study|Adverse Event|3|||
23626399|NCT02284009|66020318|FG001|Overall Study|Adverse Event|0|||
23626400|NCT02284009|66020317|FG000|Overall Study|Lost to Follow-up|1|||
23626401|NCT02284009|66020318|FG001|Overall Study|Lost to Follow-up|3|||
23626402|NCT02284009|66020317|FG000|Overall Study|Physician Decision|0|||
23626403|NCT02284009|66020318|FG001|Overall Study|Physician Decision|2|||
23626404|NCT02284009|66020317|FG000|Overall Study|Withdrawal by Subject|2|||
23626405|NCT02284009|66020318|FG001|Overall Study|Withdrawal by Subject|5|||
23626406|NCT00085566|66020323|FG000|Overall Study|Adverse Event|0|||
23626407|NCT00085566|66020324|FG001|Overall Study|Adverse Event|0|||
23626408|NCT00085566|66020325|FG002|Overall Study|Adverse Event|10|||
23626409|NCT00085566|66020323|FG000|Overall Study|Patient Not treated|0|||
23626410|NCT00085566|66020324|FG001|Overall Study|Patient Not treated|0|||
23626411|NCT00085566|66020325|FG002|Overall Study|Patient Not treated|3|||
23626412|NCT00085566|66020323|FG000|Overall Study|Clinical progression|0|||
23153035|NCT02511678|64312503|FG000|Overall Study|Adverse Event|1|||
23153036|NCT02511678|64312503|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
23626413|NCT00085566|66020324|FG001|Overall Study|Clinical progression|0|||
23626414|NCT00085566|66020325|FG002|Overall Study|Clinical progression|1|||
23626415|NCT01470599|66020326|FG000|Overall Study|Did not meet entrance criteria|1|||
23626416|NCT01470599|66020327|FG001|Overall Study|Did not meet entrance criteria|0|||
23626417|NCT01470599|66020326|FG000|Overall Study|Lost to Follow-up|2|||
23626418|NCT01470599|66020327|FG001|Overall Study|Lost to Follow-up|1|||
23626419|NCT01470599|66020326|FG000|Overall Study|Withdrawal by Subject|3|||
23626420|NCT01470599|66020327|FG001|Overall Study|Withdrawal by Subject|4|||
23626421|NCT01470599|66020326|FG000|Overall Study|Other|1|||
23626422|NCT01470599|66020327|FG001|Overall Study|Other|0|||
23626423|NCT01470599|66020326|FG000|Overall Study|Protocol Violation|3|||
23626424|NCT01470599|66020327|FG001|Overall Study|Protocol Violation|1|||
23626425|NCT01470599|66020326|FG000|Overall Study|Adverse event related to study drug|2|||
23626426|NCT01470599|66020327|FG001|Overall Study|Adverse event related to study drug|5|||
23626427|NCT01470599|66020326|FG000|Overall Study|Insufficient clinical response|6|||
23626428|NCT01470599|66020327|FG001|Overall Study|Insufficient clinical response|27|||
23626429|NCT01470599|66020326|FG000|Overall Study|Adverse event not related to study drug|1|||
23626430|NCT01470599|66020327|FG001|Overall Study|Adverse event not related to study drug|5|||
23626431|NCT02994784|66020328|FG000|6 Months Follow-up|Lost to Follow-up|3|||
23626432|NCT01015677|66020329|FG000|Overall Study|Adverse Event|0|||
23626433|NCT01015677|66020330|FG001|Overall Study|Adverse Event|1|||
23153037|NCT02511678|64312503|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
23153038|NCT02511678|64312503|FG000|Overall Study|Required Radiofrequency Ablation|1|||
23564150|NCT03713021|65793690|FG000|Overall Study|Issues with TraceIT markers|5|||
23564151|NCT04146896|65793691|FG000|Overall Study|Adverse Event|5|||
23564152|NCT04146896|65793692|FG001|Overall Study|Adverse Event|8|||
23564153|NCT04146896|65793691|FG000|Overall Study|Lack of Efficacy|3|||
23564154|NCT04146896|65793692|FG001|Overall Study|Lack of Efficacy|2|||
23564155|NCT04146896|65793691|FG000|Overall Study|Lost to Follow-up|0|||
23564156|NCT04146896|65793692|FG001|Overall Study|Lost to Follow-up|1|||
23564157|NCT04146896|65793691|FG000|Overall Study|Non-compliance|5|||
23564158|NCT04146896|65793692|FG001|Overall Study|Non-compliance|4|||
23564159|NCT04146896|65793691|FG000|Overall Study|Withdrawal by Subject|3|||
23564160|NCT04146896|65793692|FG001|Overall Study|Withdrawal by Subject|5|||
23564161|NCT04146896|65793691|FG000|Overall Study|Randomized in error|1|||
23564162|NCT04146896|65793692|FG001|Overall Study|Randomized in error|2|||
23564163|NCT01492686|65793694|FG000|Double-blind Phase|Adverse Event|0|||
23564164|NCT01492686|65793695|FG001|Double-blind Phase|Adverse Event|2|||
23564165|NCT01492686|65793694|FG000|Double-blind Phase|Physician Decision|0|||
23564166|NCT01492686|65793695|FG001|Double-blind Phase|Physician Decision|1|||
23564167|NCT01492686|65793694|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23564168|NCT01492686|65793695|FG001|Double-blind Phase|Withdrawal by Subject|2|||
23564169|NCT01492686|65793694|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
23564170|NCT01492686|65793695|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
23564171|NCT01492686|65793694|FG000|Open-label Phase|Adverse Event|1|||
23564172|NCT01492686|65793695|FG001|Open-label Phase|Adverse Event|2|||
23564173|NCT01492686|65793694|FG000|Open-label Phase|Physician Decision|1|||
23564174|NCT01492686|65793695|FG001|Open-label Phase|Physician Decision|0|||
23564175|NCT01492686|65793694|FG000|Open-label Phase|Withdrawal by Subject|6|||
23564176|NCT01492686|65793695|FG001|Open-label Phase|Withdrawal by Subject|7|||
23564177|NCT01492686|65793694|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
23564178|NCT01492686|65793695|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
23564179|NCT03214081|65793699|FG000|Overall Study|Case Report Forms Uncollected|9|||
23564180|NCT03214081|65793699|FG000|Overall Study|Protocol Deviation|54|||
23564181|NCT01686581|65793703|FG000|Overall Study|Side-effects or Health Problems|15|||
23564182|NCT01686581|65793703|FG000|Overall Study|Lack of Efficacy|90|||
23564183|NCT01686581|65793703|FG000|Overall Study|Participant Concerned about Risks|6|||
23564184|NCT01686581|65793703|FG000|Overall Study|Thinks Injections Too Painful|8|||
23564185|NCT01686581|65793703|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
23564186|NCT01686581|65793703|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
23564187|NCT01686581|65793703|FG000|Overall Study|Thinks it is Inconvenient|17|||
23564188|NCT01686581|65793703|FG000|Overall Study|Other Miscellaneous Reasons|36|||
23564189|NCT01686581|65793703|FG000|Overall Study|Reason Missing|1|||
23564190|NCT01289418|65793704|FG000|Day 8 Survey|email address invalid|283|||
23564191|NCT01289418|65793704|FG000|Day 8 Survey|participants did not complete the survey|1935|||
23564192|NCT01289418|65793704|FG000|Day 29 Survey|email address invalid|283|||
23564193|NCT01289418|65793704|FG000|Day 29 Survey|participants did not complete the survey|2185|||
23564194|NCT03328143|65793705|FG000|Overall Study|Declined|3|||
23564195|NCT03328143|65793705|FG000|Overall Study|Required increased sedation|4|||
23564196|NCT03328143|65793705|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
23564197|NCT03328143|65793705|FG000|Overall Study|Surgery cancelled|1|||
23564198|NCT01540565|65793706|FG000|Overall Study|Ineligible|2|||
23564199|NCT01077544|65793710|FG000|Overall Study|New Cancer Therapy|3|||
23564200|NCT01077544|65793711|FG001|Overall Study|New Cancer Therapy|3|||
23564201|NCT01077544|65793710|FG000|Overall Study|Adverse Event|0|||
23564202|NCT01077544|65793711|FG001|Overall Study|Adverse Event|1|||
23564203|NCT01077544|65793710|FG000|Overall Study|Disease Progression|0|||
23564204|NCT01077544|65793711|FG001|Overall Study|Disease Progression|1|||
23564205|NCT02120664|65793712|FG000|Overall Study|Withdrawal by Subject|0|||
23564206|NCT02120664|65793713|FG001|Overall Study|Withdrawal by Subject|0|||
23564207|NCT02120664|65793714|FG002|Overall Study|Withdrawal by Subject|0|||
23564208|NCT02120664|65793715|FG003|Overall Study|Withdrawal by Subject|1|||
23564209|NCT02120664|65793716|FG004|Overall Study|Withdrawal by Subject|0|||
23564210|NCT01338012|65793717|FG000|Overall Study|Death|4|||
23564211|NCT01338012|65793717|FG000|Overall Study|Study terminated|4|||
23626434|NCT01015677|66020331|FG002|Overall Study|Adverse Event|0|||
23626435|NCT01015677|66020329|FG000|Overall Study|Lack of Efficacy|0|||
23220424|NCT03799627|64550142|FG002|Overall Study|Changes In Hemoglobin Values|1|||
23220425|NCT03799627|64550143|FG003|Overall Study|Changes In Hemoglobin Values|0|||
23220426|NCT03799627|64550144|FG004|Overall Study|Changes In Hemoglobin Values|0|||
23220427|NCT03799627|64550145|FG005|Overall Study|Changes In Hemoglobin Values|2|||
23220428|NCT03799627|64550146|FG006|Overall Study|Changes In Hemoglobin Values|1|||
23220429|NCT03799627|64550147|FG007|Overall Study|Changes In Hemoglobin Values|0|||
23220430|NCT03799627|64550148|FG008|Overall Study|Changes In Hemoglobin Values|1|||
23220431|NCT02715804|64550149|FG000|Overall Study|Death|222|||
23220432|NCT02715804|64550150|FG001|Overall Study|Death|106|||
23220433|NCT02715804|64550149|FG000|Overall Study|Withdrawal by Subject|5|||
23220434|NCT02715804|64550150|FG001|Overall Study|Withdrawal by Subject|4|||
23220435|NCT02715804|64550149|FG000|Overall Study|Other than specified|2|||
23220436|NCT02715804|64550150|FG001|Overall Study|Other than specified|3|||
23220437|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
23220438|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
23220439|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
23220440|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
23220441|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
23220442|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
23220443|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
23220444|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
23220445|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
23220446|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
23220447|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
23220448|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
23220449|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
23220450|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
23220451|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
23220452|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
23220453|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
23220454|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
23220455|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
23220456|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
23220457|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
23220458|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
23220459|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
23220460|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
23220461|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
23220462|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
23220463|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
23220464|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
23220465|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
23220466|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
23220467|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
23220468|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
23220469|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
23220470|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
23220471|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
23220472|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
23564212|NCT01480596|65793718|FG000|Overall Study|Adverse Event|3|||
23564213|NCT01480596|65793719|FG001|Overall Study|Adverse Event|0|||
23564214|NCT01480596|65793718|FG000|Overall Study|MG exacerbation or change in medication|2|||
23564215|NCT01480596|65793719|FG001|Overall Study|MG exacerbation or change in medication|2|||
23564216|NCT00384059|65793726|FG000|Infant Series|Not consented|2|||
23564217|NCT00384059|65793727|FG001|Infant Series|Not consented|6|||
23564218|NCT00384059|65793726|FG000|Infant Series|Withdrawal by Subject|2|||
23564219|NCT00384059|65793727|FG001|Infant Series|Withdrawal by Subject|2|||
23564220|NCT00384059|65793726|FG000|Infant Series|Adverse Event|1|||
23564221|NCT00384059|65793727|FG001|Infant Series|Adverse Event|2|||
23564222|NCT00384059|65793726|FG000|Infant Series|Protocol Violation|1|||
23564223|NCT00384059|65793727|FG001|Infant Series|Protocol Violation|2|||
23564224|NCT00384059|65793726|FG000|Infant Series|Lost to Follow-up|0|||
23564225|NCT00384059|65793727|FG001|Infant Series|Lost to Follow-up|1|||
23564226|NCT00384059|65793726|FG000|After Infant Series|Protocol Violation|2|||
23564227|NCT00384059|65793727|FG001|After Infant Series|Protocol Violation|3|||
23564228|NCT00384059|65793726|FG000|After Infant Series|Withdrawal by Subject|2|||
23564229|NCT00384059|65793727|FG001|After Infant Series|Withdrawal by Subject|2|||
23564230|NCT00384059|65793726|FG000|After Infant Series|Failed to Return|0|||
23564231|NCT00384059|65793727|FG001|After Infant Series|Failed to Return|2|||
23564232|NCT00384059|65793726|FG000|After Infant Series|Adverse Event|0|||
23326757|NCT00287586|64937992|FG000|Overall Study|Death|2|||
23326758|NCT00287586|64937993|FG001|Overall Study|Death|3|||
23326759|NCT00287586|64937992|FG000|Overall Study|Elevated Hematocrit|3|||
23326760|NCT00287586|64937993|FG001|Overall Study|Elevated Hematocrit|0|||
23326761|NCT00287586|64937992|FG000|Overall Study|Rash|3|||
23326762|NCT00287586|64937993|FG001|Overall Study|Rash|0|||
23326763|NCT00287586|64937992|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
23326764|NCT00287586|64937993|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
23326765|NCT00287586|64937992|FG000|Overall Study|Stroke|2|||
23326766|NCT00287586|64937993|FG001|Overall Study|Stroke|0|||
23441271|NCT02452424|65358462|FG008|Overall Study|Lost to Follow-up|0|||
23626436|NCT01015677|66020330|FG001|Overall Study|Lack of Efficacy|1|||
23626437|NCT01015677|66020331|FG002|Overall Study|Lack of Efficacy|0|||
23626438|NCT01015677|66020329|FG000|Overall Study|Protocol Violation|0|||
23626439|NCT01015677|66020330|FG001|Overall Study|Protocol Violation|1|||
23626440|NCT01015677|66020331|FG002|Overall Study|Protocol Violation|0|||
23626441|NCT01015677|66020329|FG000|Overall Study|Withdrawal by Subject|1|||
23626442|NCT01015677|66020330|FG001|Overall Study|Withdrawal by Subject|1|||
23626443|NCT01015677|66020331|FG002|Overall Study|Withdrawal by Subject|0|||
23626444|NCT00321685|66020332|FG000|Overall Study|Adverse Event|18|||
23626445|NCT00321685|66020332|FG000|Overall Study|Death|2|||
23626446|NCT00321685|66020332|FG000|Overall Study|Withdrawal by Subject|8|||
23626447|NCT00321685|66020332|FG000|Overall Study|Alternative therapy|1|||
23626448|NCT00321685|66020332|FG000|Overall Study|Complicating disese|1|||
23626449|NCT00321685|66020332|FG000|Overall Study|Other|5|||
23626450|NCT00321685|66020332|FG000|Overall Study|Not start protocol therapy|2|||
23626451|NCT00321685|66020332|FG000|Overall Study|Ineligible|2|||
23626452|NCT03783689|66020333|FG000|Overall Study|Adverse Event|2|||
23626453|NCT03783689|66020334|FG001|Overall Study|Adverse Event|0|||
23626454|NCT03783689|66020333|FG000|Overall Study|Lost to Follow-up|2|||
23626455|NCT03783689|66020334|FG001|Overall Study|Lost to Follow-up|1|||
23626456|NCT03783689|66020333|FG000|Overall Study|Physician Decision|2|||
23626457|NCT03783689|66020334|FG001|Overall Study|Physician Decision|1|||
23626458|NCT03783689|66020333|FG000|Overall Study|Withdrawal by Subject|3|||
23626459|NCT03783689|66020334|FG001|Overall Study|Withdrawal by Subject|3|||
23626460|NCT00079339|66020335|FG000|Overall Study|Adverse Event|1|||
23626461|NCT00079339|66020336|FG001|Overall Study|Adverse Event|7|||
23626462|NCT00079339|66020337|FG002|Overall Study|Adverse Event|2|||
23626463|NCT00079339|66020335|FG000|Overall Study|Death|1|||
23626464|NCT00079339|66020336|FG001|Overall Study|Death|0|||
23626465|NCT00079339|66020337|FG002|Overall Study|Death|0|||
23626466|NCT00079339|66020335|FG000|Overall Study|Non-compliance|0|||
23626467|NCT00079339|66020336|FG001|Overall Study|Non-compliance|0|||
23626468|NCT00079339|66020337|FG002|Overall Study|Non-compliance|1|||
23626469|NCT00079339|66020335|FG000|Overall Study|Withdrawal by Subject|0|||
23626470|NCT00079339|66020336|FG001|Overall Study|Withdrawal by Subject|4|||
23626471|NCT00079339|66020337|FG002|Overall Study|Withdrawal by Subject|1|||
23626472|NCT00079339|66020335|FG000|Overall Study|Disease progression|3|||
23626473|NCT00079339|66020336|FG001|Overall Study|Disease progression|28|||
23626474|NCT00079339|66020337|FG002|Overall Study|Disease progression|2|||
23626475|NCT02484547|66020338|FG000|Placebo-Controlled Period|Adverse Event|10|||
23626476|NCT02484547|66020339|FG001|Placebo-Controlled Period|Adverse Event|13|||
23626477|NCT02484547|66020340|FG002|Placebo-Controlled Period|Adverse Event|20|||
23153039|NCT02511678|64312503|FG000|Overall Study|Biopsy was Negative|1|||
23153040|NCT02511678|64312503|FG000|Overall Study|Protocol Violation|1|||
23153041|NCT02511678|64312503|FG000|Overall Study|Received Radiation Treatment|1|||
23153042|NCT04340557|64312504|FG000|Overall Study|Transferred to ICU and/or death|1|||
23153043|NCT04340557|64312505|FG001|Overall Study|Transferred to ICU and/or death|2|||
23153044|NCT01843972|64312506|FG000|Overall Study|Withdrawal by Subject|0|||
23153045|NCT01843972|64312507|FG001|Overall Study|Withdrawal by Subject|0|||
23153046|NCT01843972|64312508|FG002|Overall Study|Withdrawal by Subject|0|||
23153047|NCT01843972|64312509|FG003|Overall Study|Withdrawal by Subject|0|||
23153048|NCT01843972|64312510|FG004|Overall Study|Withdrawal by Subject|1|||
23153049|NCT01843972|64312511|FG005|Overall Study|Withdrawal by Subject|0|||
23326767|NCT00287586|64937992|FG000|Overall Study|Myocardial Infarction|1|||
23626478|NCT02484547|66020341|FG003|Placebo-Controlled Period|Adverse Event|0|||
23626479|NCT02484547|66020342|FG004|Placebo-Controlled Period|Adverse Event|0|||
23626480|NCT02484547|66020343|FG005|Placebo-Controlled Period|Adverse Event|0|||
23626481|NCT02484547|66020344|FG006|Placebo-Controlled Period|Adverse Event|0|||
23626482|NCT02484547|66020338|FG000|Placebo-Controlled Period|Change of Treatment|0|||
23626483|NCT02484547|66020339|FG001|Placebo-Controlled Period|Change of Treatment|0|||
23626484|NCT02484547|66020340|FG002|Placebo-Controlled Period|Change of Treatment|1|||
23626485|NCT02484547|66020341|FG003|Placebo-Controlled Period|Change of Treatment|0|||
23626486|NCT02484547|66020342|FG004|Placebo-Controlled Period|Change of Treatment|0|||
23626487|NCT02484547|66020343|FG005|Placebo-Controlled Period|Change of Treatment|0|||
23626488|NCT02484547|66020344|FG006|Placebo-Controlled Period|Change of Treatment|0|||
23326768|NCT00287586|64937993|FG001|Overall Study|Myocardial Infarction|0|||
23441272|NCT02452424|65358463|FG009|Overall Study|Lost to Follow-up|0|||
23220473|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
23220474|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
23220475|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
23220476|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
23220477|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
23220478|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
23220479|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
23220480|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
23220481|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
23326769|NCT00287586|64937992|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
23326770|NCT00287586|64937993|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
23326771|NCT00287586|64937992|FG000|Overall Study|Cognitive Impairment|1|||
23326772|NCT00287586|64937993|FG001|Overall Study|Cognitive Impairment|0|||
23326773|NCT00287586|64937992|FG000|Overall Study|Pancreatic Cancer|1|||
23326774|NCT00287586|64937993|FG001|Overall Study|Pancreatic Cancer|3|||
23626489|NCT02484547|66020338|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
23626490|NCT02484547|66020339|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
23626491|NCT02484547|66020340|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
23626492|NCT02484547|66020341|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
23626493|NCT02484547|66020342|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
23626494|NCT02484547|66020343|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
23626495|NCT02484547|66020344|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
23626496|NCT02484547|66020338|FG000|Placebo-Controlled Period|Death|5|||
23626497|NCT02484547|66020339|FG001|Placebo-Controlled Period|Death|0|||
23626498|NCT02484547|66020340|FG002|Placebo-Controlled Period|Death|6|||
23626499|NCT02484547|66020341|FG003|Placebo-Controlled Period|Death|0|||
23626500|NCT02484547|66020342|FG004|Placebo-Controlled Period|Death|0|||
23626501|NCT02484547|66020343|FG005|Placebo-Controlled Period|Death|0|||
23626502|NCT02484547|66020344|FG006|Placebo-Controlled Period|Death|0|||
23153050|NCT01843972|64312512|FG006|Overall Study|Withdrawal by Subject|0|||
23153051|NCT01843972|64312513|FG007|Overall Study|Withdrawal by Subject|0|||
23153052|NCT01843972|64312514|FG008|Overall Study|Withdrawal by Subject|0|||
23153053|NCT01843972|64312515|FG009|Overall Study|Withdrawal by Subject|0|||
23153054|NCT01458366|64312518|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
23153055|NCT01458366|64312519|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
23153056|NCT01458366|64312520|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
23153057|NCT01458366|64312521|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
23153058|NCT01458366|64312522|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
23153059|NCT01458366|64312518|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
23153060|NCT01458366|64312519|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
23153061|NCT01458366|64312520|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
23153062|NCT01458366|64312521|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
23153063|NCT01458366|64312522|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
23153064|NCT01132612|64312523|FG000|Overall Study|Death|0|||
23153065|NCT01132612|64312524|FG001|Overall Study|Death|0|||
23153066|NCT01132612|64312525|FG002|Overall Study|Death|1|||
23153067|NCT01132612|64312523|FG000|Overall Study|Protocol deviation|0|||
23153068|NCT01132612|64312524|FG001|Overall Study|Protocol deviation|0|||
23153069|NCT01132612|64312525|FG002|Overall Study|Protocol deviation|3|||
23153070|NCT01132612|64312523|FG000|Overall Study|Lost to Follow-up|2|||
23153071|NCT01132612|64312524|FG001|Overall Study|Lost to Follow-up|2|||
23153072|NCT01132612|64312525|FG002|Overall Study|Lost to Follow-up|7|||
23153073|NCT01132612|64312523|FG000|Overall Study|Adverse Event|5|||
23153074|NCT01132612|64312524|FG001|Overall Study|Adverse Event|2|||
23153075|NCT01132612|64312525|FG002|Overall Study|Adverse Event|15|||
23153076|NCT01132612|64312523|FG000|Overall Study|Withdrawal by Subject|5|||
23153077|NCT01132612|64312524|FG001|Overall Study|Withdrawal by Subject|8|||
23153078|NCT01132612|64312525|FG002|Overall Study|Withdrawal by Subject|19|||
23153079|NCT01132612|64312523|FG000|Overall Study|Administrative problems|5|||
23153080|NCT01132612|64312524|FG001|Overall Study|Administrative problems|1|||
23153081|NCT01132612|64312525|FG002|Overall Study|Administrative problems|52|||
23326775|NCT00287586|64937992|FG000|Overall Study|Sleep Apnea|1|||
23326776|NCT00287586|64937993|FG001|Overall Study|Sleep Apnea|0|||
23326777|NCT00287586|64937992|FG000|Overall Study|Shoulder Pain|1|||
23441273|NCT02452424|65358464|FG010|Overall Study|Lost to Follow-up|0|||
23626503|NCT02484547|66020338|FG000|Placebo-Controlled Period|Disease Progression|2|||
23153082|NCT01132612|64312523|FG000|Overall Study|Lack of Efficacy|23|||
23153083|NCT01132612|64312524|FG001|Overall Study|Lack of Efficacy|22|||
23153084|NCT01132612|64312525|FG002|Overall Study|Lack of Efficacy|73|||
23153085|NCT00805025|64312526|FG000|Overall Study|Screened but not enrolled/treated|42|||
23153086|NCT00805025|64312526|FG000|Overall Study|Adverse Event|4|||
23153087|NCT00805025|64312526|FG000|Overall Study|Withdrawal by Subject|2|||
23153088|NCT00805025|64312526|FG000|Overall Study|Physician Decision|1|||
23626504|NCT02484547|66020339|FG001|Placebo-Controlled Period|Disease Progression|0|||
23626505|NCT02484547|66020340|FG002|Placebo-Controlled Period|Disease Progression|1|||
23626506|NCT02484547|66020341|FG003|Placebo-Controlled Period|Disease Progression|0|||
23626507|NCT02484547|66020342|FG004|Placebo-Controlled Period|Disease Progression|0|||
23153089|NCT01145495|64312528|FG000|Overall Study|Adverse Event|6|||
23220482|NCT03689972|64550156|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
23220483|NCT03689972|64550157|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
23220484|NCT03689972|64550158|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
23220485|NCT03689972|64550159|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
23220486|NCT03689972|64550160|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
23220487|NCT03689972|64550156|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
23220488|NCT03689972|64550157|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
23220489|NCT03689972|64550158|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
23220490|NCT03689972|64550159|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
23220491|NCT03689972|64550160|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
23153090|NCT01145495|64312528|FG000|Overall Study|Withdrawal by Subject|6|||
23153091|NCT01145495|64312528|FG000|Overall Study|Disease progression after respone|2|||
23153092|NCT04906616|64312529|FG000|Overall Study|Divorce|3|||
23153093|NCT04906616|64312530|FG001|Overall Study|Divorce|2|||
23153094|NCT00418665|64312531|FG000|Treatment Period|Ineligibility determined|1|||
23153095|NCT00418665|64312532|FG001|Treatment Period|Ineligibility determined|1|||
23153096|NCT00418665|64312533|FG002|Treatment Period|Ineligibility determined|0|||
23153097|NCT00418665|64312531|FG000|Treatment Period|Adverse Event|2|||
23153098|NCT00418665|64312532|FG001|Treatment Period|Adverse Event|2|||
23153099|NCT00418665|64312533|FG002|Treatment Period|Adverse Event|0|||
23153100|NCT00418665|64312531|FG000|Treatment Period|Withdrawal by Subject|0|||
23153101|NCT00418665|64312532|FG001|Treatment Period|Withdrawal by Subject|3|||
23153102|NCT00418665|64312533|FG002|Treatment Period|Withdrawal by Subject|1|||
23153103|NCT00418665|64312531|FG000|Treatment Period|Requirement for alternative therapy|1|||
23153104|NCT00418665|64312532|FG001|Treatment Period|Requirement for alternative therapy|0|||
23153105|NCT00418665|64312533|FG002|Treatment Period|Requirement for alternative therapy|0|||
23153106|NCT00418665|64312531|FG000|Treatment Period|Physician Decision|1|||
23153107|NCT00418665|64312532|FG001|Treatment Period|Physician Decision|0|||
23153108|NCT00418665|64312533|FG002|Treatment Period|Physician Decision|3|||
23153109|NCT00418665|64312531|FG000|Treatment Extension|Adverse Event|1|||
23153110|NCT00418665|64312532|FG001|Treatment Extension|Adverse Event|0|||
23153111|NCT00418665|64312533|FG002|Treatment Extension|Adverse Event|0|||
23153112|NCT00418665|64312531|FG000|Treatment Extension|Withdrawal by Subject|1|||
23153113|NCT00418665|64312532|FG001|Treatment Extension|Withdrawal by Subject|0|||
23153114|NCT00418665|64312533|FG002|Treatment Extension|Withdrawal by Subject|0|||
23153115|NCT00418665|64312531|FG000|Treatment Extension|Requirement for alternative therapy|2|||
23153116|NCT00418665|64312532|FG001|Treatment Extension|Requirement for alternative therapy|2|||
23153117|NCT00418665|64312533|FG002|Treatment Extension|Requirement for alternative therapy|0|||
23153118|NCT00418665|64312531|FG000|Treatment Extension|Physician Decision|2|||
23153119|NCT00418665|64312532|FG001|Treatment Extension|Physician Decision|2|||
23153120|NCT00418665|64312533|FG002|Treatment Extension|Physician Decision|1|||
23153121|NCT00418665|64312531|FG000|Treatment Extension|Death|0|||
23153122|NCT00418665|64312532|FG001|Treatment Extension|Death|0|||
23153123|NCT00418665|64312533|FG002|Treatment Extension|Death|1|||
23153124|NCT00088907|64312534|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
23153125|NCT00088907|64312535|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
23153126|NCT00088907|64312534|FG000|Randomized Study (Step 1)|Adverse Event|14|||
23153127|NCT00088907|64312535|FG001|Randomized Study (Step 1)|Adverse Event|19|||
23153128|NCT00088907|64312534|FG000|Randomized Study (Step 1)|Death|11|||
23153129|NCT00088907|64312535|FG001|Randomized Study (Step 1)|Death|12|||
23153130|NCT00088907|64312534|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
23153131|NCT00088907|64312535|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
23153132|NCT00088907|64312534|FG000|Randomized Study (Step 1)|complicating disease|3|||
23153133|NCT00088907|64312535|FG001|Randomized Study (Step 1)|complicating disease|1|||
23220492|NCT03689972|64550156|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
23220493|NCT03689972|64550157|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
23220494|NCT03689972|64550158|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
23220495|NCT03689972|64550159|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
23326778|NCT00287586|64937993|FG001|Overall Study|Shoulder Pain|0|||
23626508|NCT02484547|66020343|FG005|Placebo-Controlled Period|Disease Progression|0|||
23153134|NCT00088907|64312534|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
23153135|NCT00088907|64312535|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
23153136|NCT00088907|64312534|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
23153137|NCT00088907|64312535|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
23153138|NCT00088907|64312534|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
23153139|NCT00088907|64312535|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
23153140|NCT00088907|64312534|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
23153141|NCT00088907|64312535|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
23441274|NCT02452424|65358454|FG000|Overall Study|Withdrawal by Subject|0|||
23441275|NCT02452424|65358455|FG001|Overall Study|Withdrawal by Subject|0|||
23441276|NCT02452424|65358456|FG002|Overall Study|Withdrawal by Subject|3|||
23441277|NCT02452424|65358457|FG003|Overall Study|Withdrawal by Subject|2|||
23441278|NCT02452424|65358458|FG004|Overall Study|Withdrawal by Subject|0|||
23441279|NCT02452424|65358459|FG005|Overall Study|Withdrawal by Subject|0|||
23326779|NCT00287586|64937992|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
23326780|NCT00287586|64937993|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
23326781|NCT00287586|64937992|FG000|Overall Study|Nonadherence|1|||
23326782|NCT00287586|64937993|FG001|Overall Study|Nonadherence|1|||
23326783|NCT00287586|64937992|FG000|Overall Study|Enrolled in Another Study|1|||
23326784|NCT00287586|64937993|FG001|Overall Study|Enrolled in Another Study|0|||
23326785|NCT00287586|64937992|FG000|Overall Study|Major Depression|0|||
23326786|NCT00287586|64937993|FG001|Overall Study|Major Depression|2|||
23326787|NCT00287586|64937992|FG000|Overall Study|Lung Cancer|0|||
23326788|NCT00287586|64937993|FG001|Overall Study|Lung Cancer|2|||
23326789|NCT00287586|64937992|FG000|Overall Study|Elevated IPSS Score|0|||
23326790|NCT00287586|64937993|FG001|Overall Study|Elevated IPSS Score|1|||
23326791|NCT00287586|64937992|FG000|Overall Study|Retroperitoneal Cancer|0|||
23326792|NCT00287586|64937993|FG001|Overall Study|Retroperitoneal Cancer|1|||
23326793|NCT00287586|64937992|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
23326794|NCT00287586|64937993|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
23441280|NCT02452424|65358460|FG006|Overall Study|Withdrawal by Subject|1|||
23441281|NCT02452424|65358461|FG007|Overall Study|Withdrawal by Subject|0|||
23220496|NCT03689972|64550160|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
23220497|NCT03689972|64550156|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
23441282|NCT02452424|65358462|FG008|Overall Study|Withdrawal by Subject|1|||
23441283|NCT02452424|65358463|FG009|Overall Study|Withdrawal by Subject|1|||
23441284|NCT02452424|65358464|FG010|Overall Study|Withdrawal by Subject|0|||
23220498|NCT03689972|64550157|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
23220499|NCT03689972|64550158|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
23220500|NCT03689972|64550159|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
23220501|NCT03689972|64550160|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
23220502|NCT03689972|64550156|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
23220503|NCT03689972|64550157|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
23220504|NCT03689972|64550158|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
23220505|NCT03689972|64550159|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
23220506|NCT03689972|64550160|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
23220507|NCT03689972|64550156|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
23220508|NCT03689972|64550157|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
23220509|NCT03689972|64550158|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
23220510|NCT03689972|64550159|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
23220511|NCT03689972|64550160|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
23220512|NCT03689972|64550156|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
23220513|NCT03689972|64550157|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
23220514|NCT03689972|64550158|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
23220515|NCT03689972|64550159|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
23220516|NCT03689972|64550160|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
23220517|NCT03689972|64550156|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
23220518|NCT03689972|64550157|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
23220519|NCT03689972|64550158|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
23220520|NCT03689972|64550159|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
23441285|NCT02452424|65358454|FG000|Overall Study|Other|0|||
23441286|NCT02452424|65358455|FG001|Overall Study|Other|0|||
23441287|NCT02452424|65358456|FG002|Overall Study|Other|1|||
23441288|NCT02452424|65358457|FG003|Overall Study|Other|0|||
23441289|NCT02452424|65358458|FG004|Overall Study|Other|0|||
23441290|NCT02452424|65358459|FG005|Overall Study|Other|1|||
23441291|NCT02452424|65358460|FG006|Overall Study|Other|4|||
23441292|NCT02452424|65358461|FG007|Overall Study|Other|3|||
23441293|NCT02452424|65358462|FG008|Overall Study|Other|0|||
23441294|NCT02452424|65358463|FG009|Overall Study|Other|0|||
23441295|NCT02452424|65358464|FG010|Overall Study|Other|1|||
23326795|NCT00287586|64937992|FG000|Overall Study|Mood Swings and Irritability|0|||
23326796|NCT00287586|64937993|FG001|Overall Study|Mood Swings and Irritability|1|||
23326797|NCT00287586|64937992|FG000|Overall Study|Bradycardia|0|||
23326798|NCT00287586|64937993|FG001|Overall Study|Bradycardia|1|||
23326799|NCT00287586|64937992|FG000|Overall Study|Itchy Swollen Eyes|0|||
23441296|NCT02452424|65358454|FG000|Overall Study|Progressive disease (per RECIST)|0|||
23441297|NCT02452424|65358455|FG001|Overall Study|Progressive disease (per RECIST)|0|||
23441298|NCT02452424|65358456|FG002|Overall Study|Progressive disease (per RECIST)|0|||
23441299|NCT02452424|65358457|FG003|Overall Study|Progressive disease (per RECIST)|0|||
23564233|NCT00384059|65793727|FG001|After Infant Series|Adverse Event|1|||
23441300|NCT02452424|65358458|FG004|Overall Study|Progressive disease (per RECIST)|0|||
23441301|NCT02452424|65358459|FG005|Overall Study|Progressive disease (per RECIST)|0|||
23441302|NCT02452424|65358460|FG006|Overall Study|Progressive disease (per RECIST)|0|||
23441303|NCT02452424|65358461|FG007|Overall Study|Progressive disease (per RECIST)|0|||
23441304|NCT02452424|65358462|FG008|Overall Study|Progressive disease (per RECIST)|2|||
23441305|NCT02452424|65358463|FG009|Overall Study|Progressive disease (per RECIST)|0|||
23441306|NCT02452424|65358464|FG010|Overall Study|Progressive disease (per RECIST)|0|||
23441307|NCT02452424|65358454|FG000|Overall Study|Adverse Event|0|||
23564234|NCT00384059|65793726|FG000|After Infant Series|Physician Decision|0|||
23626509|NCT02484547|66020344|FG006|Placebo-Controlled Period|Disease Progression|0|||
23220521|NCT03689972|64550160|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
23220522|NCT03689972|64550156|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
23220523|NCT03689972|64550157|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
23220524|NCT03689972|64550158|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
23220525|NCT03689972|64550159|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
23220526|NCT03689972|64550160|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
23220527|NCT03689972|64550156|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
23220528|NCT03689972|64550157|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
23220529|NCT03689972|64550158|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
23220530|NCT03689972|64550159|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
23220531|NCT03689972|64550160|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
23220532|NCT01931150|64550161|FG000|Overall Study|Withdrawal by Subject|1|||
23220533|NCT01931150|64550162|FG001|Overall Study|Withdrawal by Subject|2|||
23220534|NCT01412151|64550163|FG000|Week 0 - 306 - Treatment Period|Death|1|||
23220535|NCT01412151|64550163|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
23220536|NCT01412151|64550163|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
23220537|NCT01412151|64550163|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
23220538|NCT06048705|64550164|FG000|Overall Study|Physician Decision|1|||
23220539|NCT06048705|64550165|FG001|Overall Study|Physician Decision|0|||
23220540|NCT06048705|64550166|FG002|Overall Study|Physician Decision|0|||
23326800|NCT00287586|64937993|FG001|Overall Study|Itchy Swollen Eyes|1|||
23326801|NCT00287586|64937992|FG000|Overall Study|Recurrent Melanoma|0|||
23326802|NCT00287586|64937993|FG001|Overall Study|Recurrent Melanoma|1|||
23326803|NCT01841593|64937994|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
23326804|NCT01841593|64937995|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
23326805|NCT01841593|64937994|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
23326806|NCT01841593|64937995|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
23326807|NCT01433471|64937996|FG000|Overall Study|Withdrawal by Subject|0|||
23326808|NCT01433471|64937997|FG001|Overall Study|Withdrawal by Subject|1|||
23326809|NCT00697463|64937998|FG000|Overall Study|Withdrawal by Subject|1|||
23326810|NCT01499095|64938000|FG000|Overall Study|Randomized But Not Treated|1|||
23441308|NCT02452424|65358455|FG001|Overall Study|Adverse Event|0|||
23626510|NCT02484547|66020338|FG000|Placebo-Controlled Period|Investigator Decision|2|||
23220541|NCT06048705|64550164|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
23220542|NCT06048705|64550165|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
23220543|NCT06048705|64550166|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
23220544|NCT06048705|64550164|FG000|Overall Study|Death prior to lymphodepletion|0|||
23220545|NCT06048705|64550165|FG001|Overall Study|Death prior to lymphodepletion|0|||
23220546|NCT06048705|64550166|FG002|Overall Study|Death prior to lymphodepletion|1|||
23220547|NCT01902173|64550167|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
23220548|NCT01902173|64550168|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23220549|NCT01902173|64550169|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23220550|NCT01902173|64550170|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23220551|NCT01902173|64550171|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23220552|NCT01902173|64550172|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
23564235|NCT00384059|65793727|FG001|After Infant Series|Physician Decision|1|||
23564236|NCT00384059|65793726|FG000|After Infant Series|Lost to Follow-up|0|||
23564237|NCT00384059|65793727|FG001|After Infant Series|Lost to Follow-up|1|||
23564238|NCT00384059|65793726|FG000|Toddler Dose|Lost to Follow-up|1|||
23564239|NCT00384059|65793727|FG001|Toddler Dose|Lost to Follow-up|1|||
23564240|NCT00384059|65793726|FG000|Toddler Dose|Failed to return|0|||
23564241|NCT00384059|65793727|FG001|Toddler Dose|Failed to return|1|||
23626511|NCT02484547|66020339|FG001|Placebo-Controlled Period|Investigator Decision|2|||
23626512|NCT02484547|66020340|FG002|Placebo-Controlled Period|Investigator Decision|5|||
23564242|NCT02914184|65793728|FG000|Overall Study|Lost to Follow-up|7|||
23326811|NCT01499095|64938001|FG001|Overall Study|Randomized But Not Treated|1|||
23326812|NCT01499095|64938000|FG000|Overall Study|Adverse Event|12|||
23326813|NCT01499095|64938001|FG001|Overall Study|Adverse Event|7|||
23441309|NCT02452424|65358456|FG002|Overall Study|Adverse Event|0|||
23564243|NCT02914184|65793729|FG001|Overall Study|Lost to Follow-up|10|||
23564244|NCT02914184|65793730|FG002|Overall Study|Lost to Follow-up|8|||
23326814|NCT01499095|64938000|FG000|Overall Study|Lack of Efficacy|2|||
23326815|NCT01499095|64938001|FG001|Overall Study|Lack of Efficacy|1|||
23326816|NCT01499095|64938000|FG000|Overall Study|Protocol Violation|6|||
23326817|NCT01499095|64938001|FG001|Overall Study|Protocol Violation|7|||
23326818|NCT01499095|64938000|FG000|Overall Study|Received Rescue Therapy|32|||
23326819|NCT01499095|64938001|FG001|Overall Study|Received Rescue Therapy|40|||
23326820|NCT01499095|64938000|FG000|Overall Study|Diverse Reasons|22|||
23326821|NCT01499095|64938001|FG001|Overall Study|Diverse Reasons|25|||
23326822|NCT01499095|64938000|FG000|Overall Study|Lost to Follow-up|6|||
23326823|NCT01499095|64938001|FG001|Overall Study|Lost to Follow-up|4|||
23326824|NCT01499095|64938000|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
23326825|NCT01499095|64938001|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
23326826|NCT01499095|64938000|FG000|Overall Study|Hypoglycemia|3|||
23326827|NCT01499095|64938001|FG001|Overall Study|Hypoglycemia|1|||
23326828|NCT01499095|64938000|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
23326829|NCT01499095|64938001|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
23326830|NCT01499095|64938000|FG000|Overall Study|Change in Injection Schedule|2|||
23326831|NCT01499095|64938001|FG001|Overall Study|Change in Injection Schedule|0|||
23326832|NCT01499095|64938000|FG000|Overall Study|Perceived Lack of Efficacy|1|||
23326833|NCT01499095|64938001|FG001|Overall Study|Perceived Lack of Efficacy|1|||
23326834|NCT00752128|64938002|FG000|Overall Study|Withdrawal by Subject|4|||
23326835|NCT01139775|64938005|FG000|Overall Study|Adverse Event|0|||
23326836|NCT01139775|64938006|FG001|Overall Study|Adverse Event|6|||
23326837|NCT01139775|64938007|FG002|Overall Study|Adverse Event|2|||
23326838|NCT01139775|64938005|FG000|Overall Study|Protocol Violation|0|||
23326839|NCT01139775|64938006|FG001|Overall Study|Protocol Violation|5|||
23326840|NCT01139775|64938007|FG002|Overall Study|Protocol Violation|0|||
23326841|NCT01139775|64938005|FG000|Overall Study|Withdrawal by Subject|1|||
23326842|NCT01139775|64938006|FG001|Overall Study|Withdrawal by Subject|0|||
23326843|NCT01139775|64938007|FG002|Overall Study|Withdrawal by Subject|2|||
23326844|NCT01139775|64938005|FG000|Overall Study|Physician Decision|0|||
23326845|NCT01139775|64938006|FG001|Overall Study|Physician Decision|2|||
23326846|NCT01139775|64938007|FG002|Overall Study|Physician Decision|2|||
23326847|NCT05317312|64938008|FG000|Overall Study|Withdrawal by Subject|0|||
23326848|NCT05317312|64938009|FG001|Overall Study|Withdrawal by Subject|1|||
23564245|NCT02914184|65793731|FG003|Overall Study|Lost to Follow-up|7|||
23564246|NCT02914184|65793728|FG000|Overall Study|Withdrawal by Subject|4|||
23564247|NCT02914184|65793729|FG001|Overall Study|Withdrawal by Subject|2|||
23564248|NCT02914184|65793730|FG002|Overall Study|Withdrawal by Subject|7|||
23564249|NCT02914184|65793731|FG003|Overall Study|Withdrawal by Subject|3|||
23564250|NCT02914184|65793728|FG000|Overall Study|Other|1|||
23564251|NCT02914184|65793729|FG001|Overall Study|Other|0|||
23564252|NCT02914184|65793730|FG002|Overall Study|Other|0|||
23564253|NCT02914184|65793731|FG003|Overall Study|Other|0|||
23564254|NCT02914184|65793728|FG000|Overall Study|Migrated/moved from the study area|2|||
23564255|NCT02914184|65793729|FG001|Overall Study|Migrated/moved from the study area|1|||
23564256|NCT02914184|65793730|FG002|Overall Study|Migrated/moved from the study area|2|||
23564257|NCT02914184|65793731|FG003|Overall Study|Migrated/moved from the study area|1|||
23564258|NCT02312856|65793732|FG000|Overall Study|Death|1|||
23564259|NCT02312856|65793732|FG000|Overall Study|Lost to Follow-up|3|||
23564260|NCT02364180|65793733|FG000|Overall Study|Screen Fail|1|||
23564261|NCT01959347|65793734|FG000|Overall Study|Protocol Violation|9|||
23564262|NCT01959347|65793735|FG001|Overall Study|Protocol Violation|7|||
23564263|NCT01576367|65793736|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23564264|NCT01576367|65793736|FG000|Overall Study|Moved to commercial use after 6 months|1|||
23564265|NCT01802437|65793739|FG000|Overall Study|Lost to Follow-up|1|||
23564266|NCT01802437|65793740|FG001|Overall Study|Lost to Follow-up|0|||
23564267|NCT01802437|65793739|FG000|Overall Study|Withdrawal by Subject|3|||
23564268|NCT01802437|65793740|FG001|Overall Study|Withdrawal by Subject|4|||
23564269|NCT01787097|65793741|FG000|Overall Study|Withdrawal by Subject|1|||
23564270|NCT01787097|65793742|FG001|Overall Study|Withdrawal by Subject|0|||
23564271|NCT01787097|65793743|FG002|Overall Study|Withdrawal by Subject|0|||
23626513|NCT02484547|66020341|FG003|Placebo-Controlled Period|Investigator Decision|0|||
23626514|NCT02484547|66020342|FG004|Placebo-Controlled Period|Investigator Decision|0|||
23626515|NCT02484547|66020343|FG005|Placebo-Controlled Period|Investigator Decision|0|||
23326849|NCT05317312|64938010|FG002|Overall Study|Withdrawal by Subject|0|||
23326850|NCT05317312|64938011|FG003|Overall Study|Withdrawal by Subject|0|||
23326851|NCT05317312|64938008|FG000|Overall Study|Lost to Follow-up|0|||
23326852|NCT05317312|64938009|FG001|Overall Study|Lost to Follow-up|0|||
23326853|NCT05317312|64938010|FG002|Overall Study|Lost to Follow-up|0|||
23326854|NCT05317312|64938011|FG003|Overall Study|Lost to Follow-up|1|||
23326855|NCT05317312|64938008|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
23326856|NCT05317312|64938009|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
23326857|NCT05317312|64938010|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
23564272|NCT01787097|65793744|FG003|Overall Study|Withdrawal by Subject|0|||
23564273|NCT00255346|65793747|FG000|Overall Study|Adverse Event|1|||
23564274|NCT00255346|65793748|FG001|Overall Study|Adverse Event|0|||
23564275|NCT00255346|65793749|FG002|Overall Study|Adverse Event|0|||
23564276|NCT00255346|65793750|FG003|Overall Study|Adverse Event|0|||
23564277|NCT00255346|65793751|FG004|Overall Study|Adverse Event|0|||
23564278|NCT03502616|65793752|FG000|Up to Week 16|Withdrawal by Subject|1|||
23564279|NCT03502616|65793753|FG001|Up to Week 16|Withdrawal by Subject|2|||
23564280|NCT03502616|65793752|FG000|Up to Week 16|Lost to Follow-up|0|||
23564281|NCT03502616|65793753|FG001|Up to Week 16|Lost to Follow-up|1|||
23564282|NCT03502616|65793752|FG000|Up to Week 16|Randomized, but not treated|1|||
23564283|NCT03502616|65793753|FG001|Up to Week 16|Randomized, but not treated|0|||
23564284|NCT03502616|65793752|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
23564285|NCT03502616|65793753|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
23564286|NCT03502616|65793752|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
23564287|NCT03502616|65793753|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
23564288|NCT00185640|65793754|FG000|Overall Study|Not Eligible|4|||
23564289|NCT00185640|65793754|FG000|Overall Study|Withdrawal by Subject|3|||
23564290|NCT00185640|65793754|FG000|Overall Study|Death|138|||
23564291|NCT01460160|65793769|FG000|Treatment Phase|Lack of Efficacy|3|||
23564292|NCT01460160|65793769|FG000|Treatment Phase|Study Drug Toxicity|2|||
23564293|NCT01460160|65793769|FG000|Treatment Phase|Adverse Event|8|||
23564294|NCT01460160|65793769|FG000|Treatment Phase|Withdrawal by Subject|4|||
23564295|NCT01460160|65793769|FG000|Treatment Phase|Death|2|||
23564296|NCT01460160|65793769|FG000|Treatment Phase|Other reasons|9|||
23564297|NCT01460160|65793769|FG000|Follow-up Phase|Withdrawal by Subject|4|||
23564298|NCT01460160|65793769|FG000|Follow-up Phase|Death|14|||
23564299|NCT01460160|65793769|FG000|Follow-up Phase|Lost to Follow-up|7|||
23564300|NCT01460160|65793769|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
23564301|NCT01460160|65793769|FG000|Follow-up Phase|Other and not reported reasons|5|||
23564302|NCT02569437|65793771|FG000|Overall Study|Lost to Follow-up|12|||
23564303|NCT02569437|65793772|FG001|Overall Study|Lost to Follow-up|14|||
23564304|NCT00744328|65793775|FG000|Overall Study|Lost to Follow-up|2|||
23564305|NCT00744328|65793776|FG001|Overall Study|Lost to Follow-up|5|||
23564306|NCT00744328|65793777|FG002|Overall Study|Lost to Follow-up|3|||
23564307|NCT00744328|65793775|FG000|Overall Study|Withdrawal by Subject|5|||
23564308|NCT00744328|65793776|FG001|Overall Study|Withdrawal by Subject|3|||
23564309|NCT00744328|65793777|FG002|Overall Study|Withdrawal by Subject|4|||
23564310|NCT00744328|65793775|FG000|Overall Study|Found ineligible after randomization|0|||
23564311|NCT00744328|65793776|FG001|Overall Study|Found ineligible after randomization|0|||
23564312|NCT00744328|65793777|FG002|Overall Study|Found ineligible after randomization|1|||
23564313|NCT04359771|65793778|FG000|Overall Study|Lack of Efficacy|2|||
23564314|NCT04359771|65793779|FG001|Overall Study|Lack of Efficacy|2|||
23564315|NCT02669095|65793780|FG000|Overall Study|Adverse Event|1|||
23564316|NCT02669095|65793781|FG001|Overall Study|Adverse Event|0|||
23564317|NCT02669095|65793780|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
23564318|NCT02669095|65793781|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
23564319|NCT02669095|65793780|FG000|Overall Study|Torn Lens|0|||
23564320|NCT02669095|65793781|FG001|Overall Study|Torn Lens|1|||
23564321|NCT02669095|65793780|FG000|Overall Study|Visit 5 assessments not completed|0|||
23564322|NCT02669095|65793781|FG001|Overall Study|Visit 5 assessments not completed|1|||
23564323|NCT02736968|65793783|FG000|Overall Study|Lost to Follow-up|0|||
23564324|NCT02736968|65793784|FG001|Overall Study|Lost to Follow-up|0|||
23564325|NCT02736968|65793785|FG002|Overall Study|Lost to Follow-up|0|||
23564326|NCT02736968|65793786|FG003|Overall Study|Lost to Follow-up|0|||
23564327|NCT02736968|65793787|FG004|Overall Study|Lost to Follow-up|0|||
23564328|NCT02736968|65793788|FG005|Overall Study|Lost to Follow-up|0|||
23564329|NCT02736968|65793789|FG006|Overall Study|Lost to Follow-up|5|||
23564330|NCT02736968|65793790|FG007|Overall Study|Lost to Follow-up|2|||
23564331|NCT02736968|65793783|FG000|Overall Study|COVID-19 Pandemic|0|||
23564332|NCT02736968|65793784|FG001|Overall Study|COVID-19 Pandemic|0|||
23564333|NCT02736968|65793785|FG002|Overall Study|COVID-19 Pandemic|0|||
23564334|NCT02736968|65793786|FG003|Overall Study|COVID-19 Pandemic|0|||
23564335|NCT02736968|65793787|FG004|Overall Study|COVID-19 Pandemic|0|||
23564336|NCT02736968|65793788|FG005|Overall Study|COVID-19 Pandemic|0|||
23564337|NCT02736968|65793789|FG006|Overall Study|COVID-19 Pandemic|2|||
23564338|NCT02736968|65793790|FG007|Overall Study|COVID-19 Pandemic|0|||
23564339|NCT02736968|65793783|FG000|Overall Study|Withdrawal by Subject|0|||
23564340|NCT02736968|65793784|FG001|Overall Study|Withdrawal by Subject|0|||
23564341|NCT02736968|65793785|FG002|Overall Study|Withdrawal by Subject|0|||
23564342|NCT02736968|65793786|FG003|Overall Study|Withdrawal by Subject|0|||
23564343|NCT02736968|65793787|FG004|Overall Study|Withdrawal by Subject|0|||
23564344|NCT02736968|65793788|FG005|Overall Study|Withdrawal by Subject|0|||
23564345|NCT02736968|65793789|FG006|Overall Study|Withdrawal by Subject|1|||
23564346|NCT02736968|65793790|FG007|Overall Study|Withdrawal by Subject|0|||
23564347|NCT04836858|65793793|FG000|Overall Study|Adverse Event|0|||
23564348|NCT04836858|65793794|FG001|Overall Study|Adverse Event|0|||
23564349|NCT04836858|65793795|FG002|Overall Study|Adverse Event|0|||
23564350|NCT04836858|65793796|FG003|Overall Study|Adverse Event|1|||
23564351|NCT04836858|65793793|FG000|Overall Study|Lost to Follow-up|1|||
23153142|NCT00088907|64312534|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
23626516|NCT02484547|66020344|FG006|Placebo-Controlled Period|Investigator Decision|0|||
23626517|NCT02484547|66020338|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
23626518|NCT02484547|66020339|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
23626519|NCT02484547|66020340|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
23626520|NCT02484547|66020341|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
23626521|NCT02484547|66020342|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
23626522|NCT02484547|66020343|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
23626523|NCT02484547|66020344|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
23626524|NCT02484547|66020338|FG000|Placebo-Controlled Period|Relocation|1|||
23626525|NCT02484547|66020339|FG001|Placebo-Controlled Period|Relocation|1|||
23626526|NCT02484547|66020340|FG002|Placebo-Controlled Period|Relocation|1|||
23626527|NCT02484547|66020341|FG003|Placebo-Controlled Period|Relocation|0|||
23626528|NCT02484547|66020342|FG004|Placebo-Controlled Period|Relocation|0|||
23626529|NCT02484547|66020343|FG005|Placebo-Controlled Period|Relocation|0|||
23626530|NCT02484547|66020344|FG006|Placebo-Controlled Period|Relocation|0|||
23626531|NCT02484547|66020338|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
23564352|NCT04836858|65793794|FG001|Overall Study|Lost to Follow-up|0|||
23564353|NCT04836858|65793795|FG002|Overall Study|Lost to Follow-up|0|||
23564354|NCT04836858|65793796|FG003|Overall Study|Lost to Follow-up|0|||
23564355|NCT04836858|65793793|FG000|Overall Study|Subject/Guardian decision|3|||
23564356|NCT04836858|65793794|FG001|Overall Study|Subject/Guardian decision|0|||
23564357|NCT04836858|65793795|FG002|Overall Study|Subject/Guardian decision|0|||
23564358|NCT04836858|65793796|FG003|Overall Study|Subject/Guardian decision|1|||
23564359|NCT04836858|65793793|FG000|Overall Study|Randomized but not treated|4|||
23564360|NCT04836858|65793794|FG001|Overall Study|Randomized but not treated|0|||
23564361|NCT04836858|65793795|FG002|Overall Study|Randomized but not treated|0|||
23564362|NCT04836858|65793796|FG003|Overall Study|Randomized but not treated|0|||
23626532|NCT02484547|66020339|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
23626533|NCT02484547|66020340|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
23626534|NCT02484547|66020341|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
23626535|NCT02484547|66020342|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
23626536|NCT02484547|66020343|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
23153143|NCT00088907|64312535|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
23153144|NCT00088907|64312534|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
23153145|NCT00088907|64312535|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
23153146|NCT00233363|64312536|FG000|Overall Study|Adverse Event|1|||
23153147|NCT00233363|64312537|FG001|Overall Study|Adverse Event|2|||
23153148|NCT00233363|64312536|FG000|Overall Study|Lack of Efficacy|0|||
23153149|NCT00233363|64312537|FG001|Overall Study|Lack of Efficacy|2|||
23564363|NCT01153269|65793797|FG000|Overall Study|Withdrawal by Subject|1|||
23564364|NCT01153269|65793797|FG000|Overall Study|Antiretroviral therapy break|1|||
23564365|NCT01722162|65793798|FG000|Overall Study|Withdrawal by Subject|1|||
23564366|NCT01722162|65793799|FG001|Overall Study|Withdrawal by Subject|1|||
23564367|NCT01722162|65793798|FG000|Overall Study|Found ineligible|1|||
23564368|NCT01722162|65793799|FG001|Overall Study|Found ineligible|0|||
23564369|NCT01722162|65793798|FG000|Overall Study|Unrelated to study adverse event|2|||
23626537|NCT02484547|66020344|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
23153150|NCT00233363|64312536|FG000|Overall Study|Withdrawal by Subject|1|||
23153151|NCT00233363|64312537|FG001|Overall Study|Withdrawal by Subject|1|||
23153152|NCT00233363|64312536|FG000|Overall Study|Aggravation of complication|1|||
23153153|NCT00233363|64312537|FG001|Overall Study|Aggravation of complication|0|||
23153154|NCT02281357|64312538|FG000|Overall Study|Adverse Event|2|||
23153155|NCT02281357|64312539|FG001|Overall Study|Adverse Event|1|||
23153156|NCT02281357|64312538|FG000|Overall Study|Lost to Follow-up|1|||
23153157|NCT02281357|64312539|FG001|Overall Study|Lost to Follow-up|0|||
23153158|NCT02281357|64312538|FG000|Overall Study|Withdrawal by Subject|4|||
23153159|NCT02281357|64312539|FG001|Overall Study|Withdrawal by Subject|3|||
23153160|NCT01817751|64312540|FG000|Overall Study|Physician Decision|1|||
23153161|NCT00865904|64312547|FG000|Overall Study|Randomized but not Treated|2|||
23153162|NCT00865904|64312548|FG001|Overall Study|Randomized but not Treated|0|||
23153163|NCT00865904|64312549|FG002|Overall Study|Randomized but not Treated|0|||
23153164|NCT00865904|64312550|FG003|Overall Study|Randomized but not Treated|1|||
23153165|NCT00865904|64312551|FG004|Overall Study|Randomized but not Treated|1|||
23153166|NCT01438151|64312552|FG000|Overall Study|study terminated|8|||
23153167|NCT00911625|64312555|FG000|Overall Study|Lost to Follow-up|7|||
23153168|NCT00911625|64312556|FG001|Overall Study|Lost to Follow-up|0|||
23153169|NCT00024167|64312557|FG000|Overall Study|Death|53|||
23564370|NCT01722162|65793799|FG001|Overall Study|Unrelated to study adverse event|2|||
23564371|NCT01722162|65793798|FG000|Overall Study|Adverse Event|1|||
23564372|NCT01722162|65793799|FG001|Overall Study|Adverse Event|1|||
23626538|NCT02484547|66020338|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
23626539|NCT02484547|66020339|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
23626540|NCT02484547|66020340|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
23326858|NCT05317312|64938011|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
23326859|NCT02837731|64938016|FG000|Allocation|Admitted to General Floor|3|||
23326860|NCT02837731|64938017|FG001|Allocation|Admitted to General Floor|4|||
23326861|NCT02837731|64938016|FG000|Allocation|Immediate surgery/withdrew|2|||
23326862|NCT02837731|64938017|FG001|Allocation|Immediate surgery/withdrew|0|||
23326863|NCT02837731|64938016|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
23326864|NCT02837731|64938017|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
23326865|NCT02837731|64938016|FG000|Allocation|Withdrawal by Subject|2|||
23326866|NCT02837731|64938017|FG001|Allocation|Withdrawal by Subject|0|||
23326867|NCT02837731|64938016|FG000|Allocation|Device not available|1|||
23326868|NCT02837731|64938017|FG001|Allocation|Device not available|0|||
23326869|NCT02837731|64938016|FG000|Allocation|Protocol not implemented|7|||
23326870|NCT02837731|64938017|FG001|Allocation|Protocol not implemented|0|||
23326871|NCT02837731|64938016|FG000|Allocation|Moribund/Do not resuscitate|2|||
23326872|NCT02837731|64938017|FG001|Allocation|Moribund/Do not resuscitate|0|||
23326873|NCT02837731|64938016|FG000|Allocation|Did not meet sepsis criteria|1|||
23441310|NCT02452424|65358457|FG003|Overall Study|Adverse Event|0|||
23564373|NCT01722162|65793798|FG000|Overall Study|Insurance denial post enrollment|0|||
23564374|NCT01722162|65793799|FG001|Overall Study|Insurance denial post enrollment|1|||
23564375|NCT01722162|65793798|FG000|Overall Study|Noncompliance|0|||
23564376|NCT01722162|65793799|FG001|Overall Study|Noncompliance|1|||
23564377|NCT02180438|65793800|FG000|Overall Study|Lost to Follow-up|1|||
23153170|NCT00024167|64312558|FG001|Overall Study|Death|47|||
23153171|NCT01306890|64312567|FG000|Overall Study|Adverse Event|2|||
23153172|NCT01306890|64312567|FG000|Overall Study|Death|1223|||
23153173|NCT01306890|64312567|FG000|Overall Study|Lost to Follow-up|58|||
23153174|NCT01306890|64312567|FG000|Overall Study|Withdrawal by Subject|88|||
23153175|NCT01306890|64312567|FG000|Overall Study|Unspecified reasons|104|||
23153176|NCT01306890|64312567|FG000|Overall Study|Study Termination|3|||
23153177|NCT01306890|64312567|FG000|Overall Study|No discontinuation documentation|41|||
23153178|NCT01069172|64312568|FG000|Overall Study|Withdrawal by Subject|1|||
23153179|NCT01069172|64312569|FG001|Overall Study|Withdrawal by Subject|0|||
23326874|NCT02837731|64938017|FG001|Allocation|Did not meet sepsis criteria|2|||
23326875|NCT02837731|64938016|FG000|Allocation|Known aortic abnormalities|0|||
23441311|NCT02452424|65358458|FG004|Overall Study|Adverse Event|0|||
23564378|NCT02460263|65796377|FG000|Transition Period|Withdrawal by Subject|1|||
23564379|NCT02460263|65796377|FG000|Transition Period|Death|1|||
23564380|NCT03176238|65796390|FG000|Overall Study|Unacceptable AEs|15|||
23564381|NCT03176238|65796391|FG001|Overall Study|Unacceptable AEs|8|||
23564382|NCT03176238|65796390|FG000|Overall Study|Abnormal lab value(s)|2|||
23564383|NCT03176238|65796391|FG001|Overall Study|Abnormal lab value(s)|0|||
23564384|NCT03176238|65796390|FG000|Overall Study|Inter-current illness|0|||
23564385|NCT03176238|65796391|FG001|Overall Study|Inter-current illness|1|||
23564386|NCT03176238|65796390|FG000|Overall Study|Consent withdrawal|14|||
23564387|NCT03176238|65796391|FG001|Overall Study|Consent withdrawal|2|||
23564388|NCT03176238|65796390|FG000|Overall Study|Lost to Follow-up|3|||
23564389|NCT03176238|65796391|FG001|Overall Study|Lost to Follow-up|0|||
23564390|NCT03176238|65796390|FG000|Overall Study|Administrative problems|1|||
23564391|NCT03176238|65796391|FG001|Overall Study|Administrative problems|0|||
23564392|NCT03176238|65796390|FG000|Overall Study|Death|3|||
23564393|NCT03176238|65796391|FG001|Overall Study|Death|0|||
23564394|NCT03176238|65796390|FG000|Overall Study|Disease Progression|133|||
23564395|NCT03176238|65796391|FG001|Overall Study|Disease Progression|22|||
23564396|NCT03176238|65796390|FG000|Overall Study|Tx duration completed per EAP|0|||
23564397|NCT03176238|65796391|FG001|Overall Study|Tx duration completed per EAP|1|||
23564398|NCT03176238|65796390|FG000|Overall Study|Patient is switched to commercial drug|16|||
23564399|NCT03176238|65796391|FG001|Overall Study|Patient is switched to commercial drug|1|||
23564400|NCT03176238|65796390|FG000|Overall Study|Protocol Violation|1|||
23564401|NCT03176238|65796391|FG001|Overall Study|Protocol Violation|0|||
23564402|NCT03176238|65796390|FG000|Overall Study|Changes in the patient's condition|2|||
23564403|NCT03176238|65796391|FG001|Overall Study|Changes in the patient's condition|1|||
23564404|NCT03176238|65796390|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
23564405|NCT03176238|65796391|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
23441312|NCT02452424|65358459|FG005|Overall Study|Adverse Event|0|||
23626541|NCT02484547|66020341|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23153180|NCT02129205|64312572|FG000|Overall Study|Withdrawal by Subject|0|||
23153181|NCT02129205|64312573|FG001|Overall Study|Withdrawal by Subject|0|||
23153182|NCT02129205|64312574|FG002|Overall Study|Withdrawal by Subject|0|||
23326876|NCT02837731|64938017|FG001|Allocation|Known aortic abnormalities|1|||
23326877|NCT01125189|64938018|FG000|Treatment Period|Lack of Efficacy|15|||
23564406|NCT04503096|65796392|FG000|Overall Study|Withdrawal by Subject|3|||
23564407|NCT03311230|65796393|FG000|Overall Study|Withdrawal by Subject|1|||
23564408|NCT03311230|65796394|FG001|Overall Study|Withdrawal by Subject|4|||
23564409|NCT03311230|65796395|FG002|Overall Study|Withdrawal by Subject|2|||
23564410|NCT03311230|65796396|FG003|Overall Study|Withdrawal by Subject|7|||
23564411|NCT03311230|65796393|FG000|Overall Study|Unrelated injury|0|||
23564412|NCT03311230|65796394|FG001|Overall Study|Unrelated injury|1|||
23564413|NCT03311230|65796395|FG002|Overall Study|Unrelated injury|0|||
23564414|NCT03311230|65796396|FG003|Overall Study|Unrelated injury|0|||
23564415|NCT03021486|65796405|FG000|Overall Study|Withdrawal by Subject|1|||
23564416|NCT03021486|65796406|FG001|Overall Study|Withdrawal by Subject|1|||
23564417|NCT03021486|65796407|FG002|Overall Study|Withdrawal by Subject|3|||
23564418|NCT03021486|65796405|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
23564419|NCT03021486|65796406|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
23564420|NCT03021486|65796407|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
23564421|NCT00998400|65796413|FG000|Overall Study|Lack of interest/motivation|1|||
23564422|NCT00998400|65796414|FG001|Overall Study|Lack of interest/motivation|2|||
23564423|NCT00998400|65796413|FG000|Overall Study|Logistical problems|1|||
23564424|NCT00998400|65796414|FG001|Overall Study|Logistical problems|0|||
23564425|NCT02118896|65796415|FG000|Overall Study|Death|4|||
23564426|NCT02118896|65796416|FG001|Overall Study|Death|0|||
23564427|NCT02118896|65796417|FG002|Overall Study|Death|4|||
23564428|NCT02118896|65796418|FG003|Overall Study|Death|6|||
23564429|NCT02118896|65796419|FG004|Overall Study|Death|3|||
23564430|NCT02118896|65796420|FG005|Overall Study|Death|1|||
23564431|NCT02118896|65796421|FG006|Overall Study|Death|0|||
23564432|NCT02118896|65796422|FG007|Overall Study|Death|0|||
23564433|NCT02118896|65796423|FG008|Overall Study|Death|0|||
23564434|NCT02118896|65796424|FG009|Overall Study|Death|0|||
23564435|NCT02118896|65796415|FG000|Overall Study|Adverse Event|5|||
23564436|NCT02118896|65796416|FG001|Overall Study|Adverse Event|4|||
23564437|NCT02118896|65796417|FG002|Overall Study|Adverse Event|4|||
23564438|NCT02118896|65796418|FG003|Overall Study|Adverse Event|5|||
23564439|NCT02118896|65796419|FG004|Overall Study|Adverse Event|5|||
23564440|NCT02118896|65796420|FG005|Overall Study|Adverse Event|9|||
23564441|NCT02118896|65796421|FG006|Overall Study|Adverse Event|1|||
23564442|NCT02118896|65796422|FG007|Overall Study|Adverse Event|1|||
23564443|NCT02118896|65796423|FG008|Overall Study|Adverse Event|4|||
23564444|NCT02118896|65796424|FG009|Overall Study|Adverse Event|0|||
23564445|NCT02118896|65796415|FG000|Overall Study|Consent withdrawn|2|||
23564446|NCT02118896|65796416|FG001|Overall Study|Consent withdrawn|0|||
23564447|NCT02118896|65796417|FG002|Overall Study|Consent withdrawn|3|||
23564448|NCT02118896|65796418|FG003|Overall Study|Consent withdrawn|4|||
23564449|NCT02118896|65796419|FG004|Overall Study|Consent withdrawn|1|||
23564450|NCT02118896|65796420|FG005|Overall Study|Consent withdrawn|4|||
23564451|NCT02118896|65796421|FG006|Overall Study|Consent withdrawn|0|||
23564452|NCT02118896|65796422|FG007|Overall Study|Consent withdrawn|0|||
23564453|NCT02118896|65796423|FG008|Overall Study|Consent withdrawn|0|||
23564454|NCT02118896|65796424|FG009|Overall Study|Consent withdrawn|0|||
23564455|NCT02118896|65796415|FG000|Overall Study|Non-compliance|2|||
23564456|NCT02118896|65796416|FG001|Overall Study|Non-compliance|1|||
23564457|NCT02118896|65796417|FG002|Overall Study|Non-compliance|1|||
23564458|NCT02118896|65796418|FG003|Overall Study|Non-compliance|5|||
23564459|NCT02118896|65796419|FG004|Overall Study|Non-compliance|0|||
23564460|NCT02118896|65796420|FG005|Overall Study|Non-compliance|1|||
23564461|NCT02118896|65796421|FG006|Overall Study|Non-compliance|0|||
23564462|NCT02118896|65796422|FG007|Overall Study|Non-compliance|1|||
23564463|NCT02118896|65796423|FG008|Overall Study|Non-compliance|0|||
23564464|NCT02118896|65796424|FG009|Overall Study|Non-compliance|0|||
23564465|NCT02118896|65796415|FG000|Overall Study|Pregnancy|1|||
23564466|NCT02118896|65796416|FG001|Overall Study|Pregnancy|1|||
23564467|NCT02118896|65796417|FG002|Overall Study|Pregnancy|0|||
23564468|NCT02118896|65796418|FG003|Overall Study|Pregnancy|0|||
23326878|NCT01125189|64938019|FG001|Treatment Period|Lack of Efficacy|18|||
23441313|NCT02452424|65358460|FG006|Overall Study|Adverse Event|0|||
23441314|NCT02452424|65358461|FG007|Overall Study|Adverse Event|0|||
23441315|NCT02452424|65358462|FG008|Overall Study|Adverse Event|0|||
23441316|NCT02452424|65358463|FG009|Overall Study|Adverse Event|0|||
23564469|NCT02118896|65796419|FG004|Overall Study|Pregnancy|1|||
23564470|NCT02118896|65796420|FG005|Overall Study|Pregnancy|3|||
23564471|NCT02118896|65796421|FG006|Overall Study|Pregnancy|1|||
23564472|NCT02118896|65796422|FG007|Overall Study|Pregnancy|0|||
23564473|NCT02118896|65796423|FG008|Overall Study|Pregnancy|0|||
23564474|NCT02118896|65796424|FG009|Overall Study|Pregnancy|0|||
23564475|NCT02118896|65796415|FG000|Overall Study|Lost to Follow-up|1|||
23564476|NCT02118896|65796416|FG001|Overall Study|Lost to Follow-up|2|||
23564477|NCT02118896|65796417|FG002|Overall Study|Lost to Follow-up|1|||
23564478|NCT02118896|65796418|FG003|Overall Study|Lost to Follow-up|0|||
23564479|NCT02118896|65796419|FG004|Overall Study|Lost to Follow-up|2|||
23564480|NCT02118896|65796420|FG005|Overall Study|Lost to Follow-up|1|||
23441317|NCT02452424|65358464|FG010|Overall Study|Adverse Event|1|||
23441318|NCT01858740|65358465|FG000|Overall Study|Death|4|||
23564481|NCT02118896|65796421|FG006|Overall Study|Lost to Follow-up|0|||
23564482|NCT02118896|65796422|FG007|Overall Study|Lost to Follow-up|0|||
23564483|NCT02118896|65796423|FG008|Overall Study|Lost to Follow-up|0|||
23564484|NCT02118896|65796424|FG009|Overall Study|Lost to Follow-up|0|||
23564485|NCT02118896|65796415|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
23564486|NCT02118896|65796416|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
23153183|NCT02129205|64312575|FG003|Overall Study|Withdrawal by Subject|0|||
23153184|NCT02129205|64312576|FG004|Overall Study|Withdrawal by Subject|1|||
23153185|NCT02129205|64312577|FG005|Overall Study|Withdrawal by Subject|1|||
23153186|NCT02129205|64312578|FG006|Overall Study|Withdrawal by Subject|1|||
23153187|NCT02129205|64312579|FG007|Overall Study|Withdrawal by Subject|0|||
23153188|NCT02129205|64312580|FG008|Overall Study|Withdrawal by Subject|1|||
23153189|NCT02129205|64312581|FG009|Overall Study|Withdrawal by Subject|0|||
23153190|NCT02129205|64312572|FG000|Overall Study|Other|1|||
23153191|NCT02129205|64312573|FG001|Overall Study|Other|0|||
23153192|NCT02129205|64312574|FG002|Overall Study|Other|0|||
23153193|NCT02129205|64312575|FG003|Overall Study|Other|0|||
23153194|NCT02129205|64312576|FG004|Overall Study|Other|2|||
23153195|NCT02129205|64312577|FG005|Overall Study|Other|3|||
23153196|NCT02129205|64312578|FG006|Overall Study|Other|3|||
23153197|NCT02129205|64312579|FG007|Overall Study|Other|2|||
23326879|NCT01125189|64938020|FG002|Treatment Period|Lack of Efficacy|25|||
23326880|NCT01125189|64938018|FG000|Treatment Period|Adverse Event|7|||
23326881|NCT01125189|64938019|FG001|Treatment Period|Adverse Event|8|||
23326882|NCT01125189|64938020|FG002|Treatment Period|Adverse Event|8|||
23441319|NCT03245398|65358466|FG000|Overall Study|Travelled to another island|1|||
23441320|NCT03245398|65358467|FG001|Overall Study|Travelled to another island|0|||
23441321|NCT02519595|65358468|FG000|Overall Study|Protocol Violation|8|||
23441322|NCT02519595|65358469|FG001|Overall Study|Protocol Violation|22|||
23441323|NCT02519595|65358470|FG002|Overall Study|Protocol Violation|16|||
23441324|NCT02649894|65358474|FG000|Overall Study|Adverse Event|1|||
23441325|NCT02649894|65358475|FG001|Overall Study|Adverse Event|0|||
23441326|NCT02649894|65358474|FG000|Overall Study|Physician Decision|0|||
23441327|NCT02649894|65358475|FG001|Overall Study|Physician Decision|1|||
23564487|NCT02118896|65796417|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
23564488|NCT02118896|65796418|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
23564489|NCT02118896|65796419|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
23564490|NCT02118896|65796420|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
23564491|NCT02118896|65796421|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
23564492|NCT02118896|65796422|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
23564493|NCT02118896|65796423|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
23564494|NCT02118896|65796424|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
23564495|NCT02118896|65796415|FG000|Overall Study|Prohibited medication|0|||
23564496|NCT02118896|65796416|FG001|Overall Study|Prohibited medication|0|||
23564497|NCT02118896|65796417|FG002|Overall Study|Prohibited medication|0|||
23564498|NCT02118896|65796418|FG003|Overall Study|Prohibited medication|0|||
23564499|NCT02118896|65796419|FG004|Overall Study|Prohibited medication|1|||
23564500|NCT02118896|65796420|FG005|Overall Study|Prohibited medication|3|||
23564501|NCT02118896|65796421|FG006|Overall Study|Prohibited medication|0|||
23564502|NCT02118896|65796422|FG007|Overall Study|Prohibited medication|0|||
23564503|NCT02118896|65796423|FG008|Overall Study|Prohibited medication|0|||
23564504|NCT02118896|65796424|FG009|Overall Study|Prohibited medication|0|||
23564505|NCT02118896|65796415|FG000|Overall Study|Miscellaneous|1|||
23564506|NCT02118896|65796416|FG001|Overall Study|Miscellaneous|2|||
23564507|NCT02118896|65796417|FG002|Overall Study|Miscellaneous|0|||
23564508|NCT02118896|65796418|FG003|Overall Study|Miscellaneous|2|||
23564509|NCT02118896|65796419|FG004|Overall Study|Miscellaneous|0|||
23564510|NCT02118896|65796420|FG005|Overall Study|Miscellaneous|4|||
23564511|NCT02118896|65796421|FG006|Overall Study|Miscellaneous|0|||
23564512|NCT02118896|65796422|FG007|Overall Study|Miscellaneous|0|||
23564513|NCT02118896|65796423|FG008|Overall Study|Miscellaneous|0|||
23564514|NCT02118896|65796424|FG009|Overall Study|Miscellaneous|0|||
23564515|NCT03560245|65796426|FG000|Overall Study|Withdrawal by Subject|3|||
23564516|NCT03560245|65796427|FG001|Overall Study|Withdrawal by Subject|2|||
23564517|NCT03560245|65796426|FG000|Overall Study|Adverse Event|1|||
23626542|NCT02484547|66020342|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23326883|NCT01125189|64938018|FG000|Treatment Period|Withdrawal by Subject|3|||
23564518|NCT03560245|65796427|FG001|Overall Study|Adverse Event|1|||
23564519|NCT03560245|65796426|FG000|Overall Study|Protocol Violation|1|||
23564520|NCT03560245|65796427|FG001|Overall Study|Protocol Violation|0|||
23564521|NCT03560245|65796426|FG000|Overall Study|Death|0|||
23564522|NCT03560245|65796427|FG001|Overall Study|Death|1|||
23153198|NCT02129205|64312580|FG008|Overall Study|Other|1|||
23153199|NCT02129205|64312581|FG009|Overall Study|Other|0|||
23153200|NCT02876835|64312582|FG000|Treatment Period (51.1 Month)|Other|1|||
23153201|NCT02876835|64312583|FG001|Treatment Period (51.1 Month)|Other|0|||
23441328|NCT02649894|65358474|FG000|Overall Study|Withdrawal by Subject|5|||
23441329|NCT02649894|65358475|FG001|Overall Study|Withdrawal by Subject|2|||
23153202|NCT02876835|64312582|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
23441330|NCT02649894|65358474|FG000|Overall Study|Lost to Follow-up|2|||
23441331|NCT02649894|65358475|FG001|Overall Study|Lost to Follow-up|1|||
23564523|NCT03560245|65796426|FG000|Overall Study|Lost to Follow-up|0|||
23564524|NCT03560245|65796427|FG001|Overall Study|Lost to Follow-up|1|||
23564525|NCT03560245|65796426|FG000|Overall Study|Physician Decision|0|||
23441332|NCT02649894|65358474|FG000|Overall Study|Death|30|||
23441333|NCT02649894|65358475|FG001|Overall Study|Death|7|||
23441334|NCT02649894|65358474|FG000|Overall Study|Other, not specified|6|||
23441335|NCT02649894|65358475|FG001|Overall Study|Other, not specified|0|||
23441336|NCT02100969|65358481|FG000|Overall Study|Did not pass screening phase|1|||
23441337|NCT00145574|65358482|FG000|Double Blind|Adverse Event|0|||
23441338|NCT00145574|65358483|FG001|Double Blind|Adverse Event|3|||
23441339|NCT00145574|65358484|FG002|Double Blind|Adverse Event|1|||
23441340|NCT00145574|65358482|FG000|Double Blind|Withdrawal by Subject|1|||
23441341|NCT00145574|65358483|FG001|Double Blind|Withdrawal by Subject|1|||
23441342|NCT00145574|65358484|FG002|Double Blind|Withdrawal by Subject|1|||
23441343|NCT00145574|65358482|FG000|Double Blind|required restricted medicine|0|||
23441344|NCT00145574|65358483|FG001|Double Blind|required restricted medicine|1|||
23441345|NCT00145574|65358484|FG002|Double Blind|required restricted medicine|0|||
23441346|NCT00145574|65358482|FG000|Open Label Long-term Extension|Adverse Event|0|||
23441347|NCT00145574|65358483|FG001|Open Label Long-term Extension|Adverse Event|0|||
23441348|NCT00145574|65358484|FG002|Open Label Long-term Extension|Adverse Event|5|||
23441349|NCT00145574|65358482|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
23441350|NCT00145574|65358483|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
23441351|NCT00145574|65358484|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
23441352|NCT00145574|65358482|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
23441353|NCT00145574|65358483|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
23441354|NCT00145574|65358484|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
23441355|NCT00145574|65358482|FG000|Open Label Long-term Extension|required restricted medicine|0|||
23441356|NCT00145574|65358483|FG001|Open Label Long-term Extension|required restricted medicine|0|||
23441357|NCT00145574|65358484|FG002|Open Label Long-term Extension|required restricted medicine|1|||
23441358|NCT01240200|65358485|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
23441359|NCT01240200|65358486|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
23441360|NCT02806960|65358489|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
23441361|NCT02806960|65358490|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
23441362|NCT02806960|65358491|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
23441363|NCT02806960|65358492|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
23441364|NCT00988091|65358495|FG000|Double-blind Period|Withdrawal by Subject|15|||
23441365|NCT00988091|65358496|FG001|Double-blind Period|Withdrawal by Subject|13|||
23441366|NCT00988091|65358495|FG000|Double-blind Period|Lost to Follow-up|12|||
23441367|NCT00988091|65358496|FG001|Double-blind Period|Lost to Follow-up|14|||
23441368|NCT00988091|65358495|FG000|Double-blind Period|Other|8|||
23441369|NCT00988091|65358496|FG001|Double-blind Period|Other|8|||
23441370|NCT00988091|65358495|FG000|Double-blind Period|Adverse Event|6|||
23441371|NCT00988091|65358496|FG001|Double-blind Period|Adverse Event|9|||
23441372|NCT00988091|65358495|FG000|Double-blind Period|Use of exclusionary medication|2|||
23441373|NCT00988091|65358496|FG001|Double-blind Period|Use of exclusionary medication|3|||
23441374|NCT00988091|65358495|FG000|Open-label Period|Adverse Event|4|||
23441375|NCT00988091|65358496|FG001|Open-label Period|Adverse Event|7|||
23441376|NCT00988091|65358495|FG000|Open-label Period|Use of exclusionary medication|1|||
23441377|NCT00988091|65358496|FG001|Open-label Period|Use of exclusionary medication|1|||
23441378|NCT00988091|65358495|FG000|Open-label Period|Protocol Violation|1|||
23441379|NCT00988091|65358496|FG001|Open-label Period|Protocol Violation|1|||
23441380|NCT00988091|65358495|FG000|Open-label Period|Withdrawal by Subject|10|||
23441381|NCT00988091|65358496|FG001|Open-label Period|Withdrawal by Subject|16|||
23441382|NCT00988091|65358495|FG000|Open-label Period|Lost to Follow-up|3|||
23441383|NCT00988091|65358496|FG001|Open-label Period|Lost to Follow-up|5|||
23441384|NCT00988091|65358495|FG000|Open-label Period|Other|2|||
23441385|NCT00988091|65358496|FG001|Open-label Period|Other|3|||
23441386|NCT00203424|65358498|FG000|Treatment Period|Withdrawal by Subject|4|||
23441387|NCT00203424|65358498|FG000|Treatment Period|Adverse Event|5|||
23441388|NCT00203424|65358498|FG000|Treatment Period|progressive disease|2|||
23441389|NCT00203424|65358498|FG000|Follow-up Period|Withdrawal by Subject|1|||
23441390|NCT00203424|65358498|FG000|Follow-up Period|progressive disease|4|||
23441391|NCT00203424|65358498|FG000|Follow-up Period|Lost to Follow-up|1|||
23441392|NCT00291486|65358499|FG000|Overall Study|Adverse Event|0|||
23441393|NCT00291486|65358500|FG001|Overall Study|Adverse Event|3|||
23441394|NCT00291486|65358501|FG002|Overall Study|Adverse Event|0|||
23441395|NCT00291486|65358502|FG003|Overall Study|Adverse Event|1|||
23441396|NCT00291486|65358503|FG004|Overall Study|Adverse Event|0|||
23441397|NCT00291486|65358499|FG000|Overall Study|Withdrawal by Subject|0|||
23441398|NCT00291486|65358500|FG001|Overall Study|Withdrawal by Subject|0|||
23441399|NCT00291486|65358501|FG002|Overall Study|Withdrawal by Subject|0|||
23441400|NCT00291486|65358502|FG003|Overall Study|Withdrawal by Subject|0|||
23441401|NCT00291486|65358503|FG004|Overall Study|Withdrawal by Subject|1|||
23441402|NCT00291486|65358499|FG000|Overall Study|Disease progression|1|||
23564526|NCT03560245|65796427|FG001|Overall Study|Physician Decision|1|||
23564527|NCT03560245|65796426|FG000|Overall Study|Other|0|||
23441403|NCT00291486|65358500|FG001|Overall Study|Disease progression|0|||
23441404|NCT00291486|65358501|FG002|Overall Study|Disease progression|1|||
23441405|NCT00291486|65358502|FG003|Overall Study|Disease progression|0|||
23441406|NCT00291486|65358503|FG004|Overall Study|Disease progression|0|||
23441407|NCT00379912|65358508|FG000|Overall Study|Lack of Efficacy|1|||
23441408|NCT00379912|65358509|FG001|Overall Study|Lack of Efficacy|0|||
23441409|NCT01286077|65358510|FG000|Overall Study|Adverse Event|2|||
23441410|NCT01286077|65358511|FG001|Overall Study|Adverse Event|0|||
23441411|NCT01286077|65358510|FG000|Overall Study|Death|1|||
23441412|NCT01286077|65358511|FG001|Overall Study|Death|0|||
23441413|NCT01286077|65358510|FG000|Overall Study|Protocol Violation|1|||
23441414|NCT01286077|65358511|FG001|Overall Study|Protocol Violation|1|||
23441415|NCT01286077|65358510|FG000|Overall Study|Withdrawal by Subject|0|||
23441416|NCT01286077|65358511|FG001|Overall Study|Withdrawal by Subject|2|||
23441417|NCT01286077|65358510|FG000|Overall Study|Intercurrent illness|1|||
23441418|NCT01286077|65358511|FG001|Overall Study|Intercurrent illness|0|||
23441419|NCT01286077|65358510|FG000|Overall Study|Non-compliance|1|||
23441420|NCT01286077|65358511|FG001|Overall Study|Non-compliance|0|||
23441421|NCT01286077|65358510|FG000|Overall Study|The subject starts with alternative MMY|0|||
23441422|NCT01286077|65358511|FG001|Overall Study|The subject starts with alternative MMY|3|||
23441423|NCT01286077|65358510|FG000|Overall Study|Patient's decision to stop treatment|3|||
23441424|NCT01286077|65358511|FG001|Overall Study|Patient's decision to stop treatment|0|||
23441425|NCT01286077|65358510|FG000|Overall Study|Progression of disease|0|||
23441426|NCT01286077|65358511|FG001|Overall Study|Progression of disease|1|||
23441427|NCT01286077|65358510|FG000|Overall Study|refill medication not received in time|1|||
23441428|NCT01286077|65358511|FG001|Overall Study|refill medication not received in time|0|||
23441429|NCT00543387|65358512|FG000|Panel 1 + Panel 2|Adverse Event|0|||
23441430|NCT00543387|65358513|FG001|Panel 1 + Panel 2|Adverse Event|1|||
23441431|NCT00543387|65358514|FG002|Panel 1 + Panel 2|Adverse Event|0|||
23441432|NCT00543387|65358515|FG003|Panel 1 + Panel 2|Adverse Event|0|||
23441433|NCT00543387|65358516|FG004|Panel 1 + Panel 2|Adverse Event|0|||
23441434|NCT00543387|65358517|FG005|Panel 1 + Panel 2|Adverse Event|0|||
23441435|NCT00543387|65358518|FG006|Panel 1 + Panel 2|Adverse Event|0|||
23441436|NCT00543387|65358519|FG007|Panel 1 + Panel 2|Adverse Event|1|||
23441437|NCT00543387|65358520|FG008|Panel 1 + Panel 2|Adverse Event|1|||
23441438|NCT00543387|65358521|FG009|Panel 1 + Panel 2|Adverse Event|0|||
23441439|NCT00543387|65358522|FG010|Panel 1 + Panel 2|Adverse Event|0|||
23441440|NCT00543387|65358512|FG000|Panel 1 + Panel 2|Physician Decision|0|||
23441441|NCT00543387|65358513|FG001|Panel 1 + Panel 2|Physician Decision|0|||
23441442|NCT00543387|65358514|FG002|Panel 1 + Panel 2|Physician Decision|1|||
23441443|NCT00543387|65358515|FG003|Panel 1 + Panel 2|Physician Decision|0|||
23441444|NCT00543387|65358516|FG004|Panel 1 + Panel 2|Physician Decision|0|||
23441445|NCT00543387|65358517|FG005|Panel 1 + Panel 2|Physician Decision|0|||
23441446|NCT00543387|65358518|FG006|Panel 1 + Panel 2|Physician Decision|0|||
23441447|NCT00543387|65358519|FG007|Panel 1 + Panel 2|Physician Decision|1|||
23441448|NCT00543387|65358520|FG008|Panel 1 + Panel 2|Physician Decision|0|||
23441449|NCT00543387|65358521|FG009|Panel 1 + Panel 2|Physician Decision|0|||
23441450|NCT00543387|65358522|FG010|Panel 1 + Panel 2|Physician Decision|0|||
23441451|NCT00543387|65358512|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
23441452|NCT00543387|65358513|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
23441453|NCT00543387|65358514|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
23441454|NCT00543387|65358515|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
23441455|NCT00543387|65358516|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
23441456|NCT00543387|65358517|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
23441457|NCT00543387|65358518|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
23441458|NCT00543387|65358519|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
23441459|NCT00543387|65358520|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
23441460|NCT00543387|65358521|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
23441461|NCT00543387|65358522|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
23441462|NCT00543387|65358512|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441463|NCT00543387|65358513|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441464|NCT00543387|65358514|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441465|NCT00543387|65358515|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441466|NCT00543387|65358516|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441467|NCT00543387|65358517|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441468|NCT00543387|65358518|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
23441469|NCT00543387|65358519|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441470|NCT00543387|65358520|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23564528|NCT03560245|65796427|FG001|Overall Study|Other|1|||
23564529|NCT01845974|65796428|FG000|Overall Study|screen failure|1|||
23564530|NCT01845974|65796429|FG001|Overall Study|screen failure|0|||
23564531|NCT00265330|65796430|FG000|Overall Study|Adverse Event|41|||
23441471|NCT00543387|65358521|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441472|NCT00543387|65358522|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
23441473|NCT00543387|65358512|FG000|Crossover Participants|Progressive Disease|0|||
23441474|NCT00543387|65358513|FG001|Crossover Participants|Progressive Disease|0|||
23564532|NCT00265330|65796430|FG000|Overall Study|Lost to Follow-up|8|||
23564533|NCT00265330|65796430|FG000|Overall Study|Withdrawal by Subject|34|||
23441475|NCT00543387|65358514|FG002|Crossover Participants|Progressive Disease|0|||
23441476|NCT00543387|65358515|FG003|Crossover Participants|Progressive Disease|0|||
23441477|NCT00543387|65358516|FG004|Crossover Participants|Progressive Disease|0|||
23441478|NCT00543387|65358517|FG005|Crossover Participants|Progressive Disease|0|||
23441479|NCT00543387|65358518|FG006|Crossover Participants|Progressive Disease|0|||
23441480|NCT00543387|65358519|FG007|Crossover Participants|Progressive Disease|0|||
23441481|NCT00543387|65358520|FG008|Crossover Participants|Progressive Disease|0|||
23441482|NCT00543387|65358521|FG009|Crossover Participants|Progressive Disease|1|||
23441483|NCT00543387|65358522|FG010|Crossover Participants|Progressive Disease|2|||
23441484|NCT00543387|65358512|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
23441485|NCT00543387|65358513|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
23153203|NCT02876835|64312583|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
23153204|NCT02876835|64312582|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
23153205|NCT02876835|64312583|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
23153206|NCT02876835|64312582|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
23153207|NCT02876835|64312583|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
23153208|NCT02043548|64312588|FG000|Overall Study|Lack of Efficacy|1|||
23153209|NCT02043548|64312589|FG001|Overall Study|Lack of Efficacy|0|||
23153210|NCT02043548|64312588|FG000|Overall Study|Adverse Event|0|||
23153211|NCT02043548|64312589|FG001|Overall Study|Adverse Event|1|||
23153212|NCT03427125|64312592|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
23153213|NCT03427125|64312593|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
23153214|NCT03427125|64312594|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
23153215|NCT00283049|64312595|FG000|Overall Study|Adverse Event|6|||
23153216|NCT00283049|64312596|FG001|Overall Study|Adverse Event|1|||
23153217|NCT00283049|64312597|FG002|Overall Study|Adverse Event|4|||
23153218|NCT00283049|64312595|FG000|Overall Study|Protocol Violation|3|||
23153219|NCT00283049|64312596|FG001|Overall Study|Protocol Violation|0|||
23153220|NCT00283049|64312597|FG002|Overall Study|Protocol Violation|3|||
23153221|NCT00283049|64312595|FG000|Overall Study|Death|1|||
23153222|NCT00283049|64312596|FG001|Overall Study|Death|1|||
23153223|NCT00283049|64312597|FG002|Overall Study|Death|1|||
23153224|NCT00283049|64312595|FG000|Overall Study|Lack of Efficacy|0|||
23153225|NCT00283049|64312596|FG001|Overall Study|Lack of Efficacy|1|||
23153226|NCT00283049|64312597|FG002|Overall Study|Lack of Efficacy|1|||
23153227|NCT00283049|64312595|FG000|Overall Study|Lost to Follow-up|4|||
23153228|NCT00283049|64312596|FG001|Overall Study|Lost to Follow-up|2|||
23153229|NCT00283049|64312597|FG002|Overall Study|Lost to Follow-up|5|||
23153230|NCT00283049|64312595|FG000|Overall Study|Withdrawal by Subject|26|||
23153231|NCT00283049|64312596|FG001|Overall Study|Withdrawal by Subject|24|||
23153232|NCT00283049|64312597|FG002|Overall Study|Withdrawal by Subject|19|||
23153233|NCT00283049|64312595|FG000|Overall Study|Discontinuation of Study|18|||
23220553|NCT01902173|64550167|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
23220554|NCT01902173|64550168|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23220555|NCT01902173|64550169|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23220556|NCT01902173|64550170|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23220557|NCT01902173|64550171|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23220558|NCT01902173|64550172|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
23220559|NCT01902173|64550167|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23220560|NCT01902173|64550168|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
23441486|NCT00543387|65358514|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
23441487|NCT00543387|65358515|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
23441488|NCT00543387|65358516|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
23441489|NCT00543387|65358517|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
23441490|NCT00543387|65358518|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
23441491|NCT00543387|65358519|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
23441492|NCT00543387|65358520|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
23441493|NCT00543387|65358521|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
23441494|NCT00543387|65358522|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
23441495|NCT00874848|65358526|FG000|Overall Study|Adverse Event|13|||
23441496|NCT00874848|65358527|FG001|Overall Study|Adverse Event|2|||
23441497|NCT00874848|65358526|FG000|Overall Study|Progressive neoplastic disease|38|||
23441498|NCT00874848|65358527|FG001|Overall Study|Progressive neoplastic disease|18|||
23441499|NCT00874848|65358526|FG000|Overall Study|Withdrawal by Subject|7|||
23153234|NCT00283049|64312596|FG001|Overall Study|Discontinuation of Study|16|||
23153235|NCT00283049|64312597|FG002|Overall Study|Discontinuation of Study|20|||
23153236|NCT00283049|64312595|FG000|Overall Study|No longer requires study treatment|0|||
23153237|NCT00283049|64312596|FG001|Overall Study|No longer requires study treatment|0|||
23153238|NCT00283049|64312597|FG002|Overall Study|No longer requires study treatment|1|||
23153239|NCT00385203|64312598|FG000|Overall Study|Adverse Event|5|||
23153240|NCT00385203|64312599|FG001|Overall Study|Adverse Event|4|||
23153241|NCT00385203|64312598|FG000|Overall Study|Death|1|||
23626543|NCT02484547|66020343|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23626544|NCT02484547|66020344|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23626545|NCT02484547|66020338|FG000|Placebo-Controlled Period|Reason not Specified|216|||
23626546|NCT02484547|66020339|FG001|Placebo-Controlled Period|Reason not Specified|194|||
23626547|NCT02484547|66020340|FG002|Placebo-Controlled Period|Reason not Specified|183|||
23626548|NCT02484547|66020341|FG003|Placebo-Controlled Period|Reason not Specified|0|||
23626549|NCT02484547|66020342|FG004|Placebo-Controlled Period|Reason not Specified|0|||
23626550|NCT02484547|66020343|FG005|Placebo-Controlled Period|Reason not Specified|0|||
23626551|NCT02484547|66020344|FG006|Placebo-Controlled Period|Reason not Specified|0|||
23626552|NCT02484547|66020338|FG000|Long-Term Extension Period|Adverse Event|0|||
23153242|NCT00385203|64312599|FG001|Overall Study|Death|0|||
23153243|NCT00385203|64312598|FG000|Overall Study|Condition under investigation worsened|18|||
23153244|NCT00385203|64312599|FG001|Overall Study|Condition under investigation worsened|3|||
23153245|NCT00385203|64312598|FG000|Overall Study|Incorrect enrollment|2|||
23153246|NCT00385203|64312599|FG001|Overall Study|Incorrect enrollment|0|||
23153247|NCT00791258|64312602|FG000|Overall Study|Adverse Event|87|||
23153248|NCT00791258|64312602|FG000|Overall Study|Lost to Follow-up|18|||
23153249|NCT00791258|64312602|FG000|Overall Study|Protocol Violation|109|||
23153250|NCT00791258|64312602|FG000|Overall Study|Withdrawal by Subject|40|||
23153251|NCT00791258|64312602|FG000|Overall Study|Did not take medication for >3 days|1|||
23153252|NCT00791258|64312602|FG000|Overall Study|subject left area|2|||
23153253|NCT00791258|64312602|FG000|Overall Study|non-compliance|3|||
23153254|NCT00791258|64312602|FG000|Overall Study|Subject incarcerated|1|||
23153255|NCT00791258|64312602|FG000|Overall Study|Subject required restricted medication|1|||
23153256|NCT00791258|64312602|FG000|Overall Study|Lack of Efficacy|1|||
23153257|NCT03876171|64312603|FG000|Overall Study|Withdrawal by Subject|3|||
23153258|NCT03876171|64312604|FG001|Overall Study|Withdrawal by Subject|3|||
23153259|NCT03876171|64312603|FG000|Overall Study|Re-arrest|0|||
23153260|NCT03876171|64312604|FG001|Overall Study|Re-arrest|4|||
23153261|NCT03065023|64312605|FG000|Overall Study|Progressive Disease|0|||
23153262|NCT03065023|64312606|FG001|Overall Study|Progressive Disease|1|||
23153263|NCT03065023|64312607|FG002|Overall Study|Progressive Disease|0|||
23153264|NCT03065023|64312608|FG003|Overall Study|Progressive Disease|0|||
23153265|NCT03065023|64312609|FG004|Overall Study|Progressive Disease|0|||
23153266|NCT03065023|64312605|FG000|Overall Study|Death|2|||
23153267|NCT03065023|64312606|FG001|Overall Study|Death|0|||
23153268|NCT03065023|64312607|FG002|Overall Study|Death|1|||
23153269|NCT03065023|64312608|FG003|Overall Study|Death|1|||
23153270|NCT03065023|64312609|FG004|Overall Study|Death|0|||
23153271|NCT03065023|64312605|FG000|Overall Study|Lost to Follow-up|0|||
23153272|NCT03065023|64312606|FG001|Overall Study|Lost to Follow-up|1|||
23153273|NCT03065023|64312607|FG002|Overall Study|Lost to Follow-up|0|||
23153274|NCT03065023|64312608|FG003|Overall Study|Lost to Follow-up|0|||
23153275|NCT03065023|64312609|FG004|Overall Study|Lost to Follow-up|0|||
23153276|NCT03065023|64312605|FG000|Overall Study|Participant Decision|0|||
23153277|NCT03065023|64312606|FG001|Overall Study|Participant Decision|0|||
23153278|NCT03065023|64312607|FG002|Overall Study|Participant Decision|0|||
23153279|NCT03065023|64312608|FG003|Overall Study|Participant Decision|1|||
23153280|NCT03065023|64312609|FG004|Overall Study|Participant Decision|0|||
23153281|NCT03065023|64312605|FG000|Overall Study|Withdrawal by Subject|0|||
23153282|NCT03065023|64312606|FG001|Overall Study|Withdrawal by Subject|0|||
23153283|NCT03065023|64312607|FG002|Overall Study|Withdrawal by Subject|0|||
23153284|NCT03065023|64312608|FG003|Overall Study|Withdrawal by Subject|1|||
23153285|NCT03065023|64312609|FG004|Overall Study|Withdrawal by Subject|0|||
23153286|NCT00210184|64312616|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
23153287|NCT04411628|64312619|FG000|Overall Study|Withdrawal by Subject|1|||
23153288|NCT04411628|64312620|FG001|Overall Study|Withdrawal by Subject|1|||
23153289|NCT04411628|64312621|FG002|Overall Study|Withdrawal by Subject|2|||
23153290|NCT04411628|64312622|FG003|Overall Study|Withdrawal by Subject|0|||
23153291|NCT04411628|64312619|FG000|Overall Study|Lost to Follow-up|0|||
23153292|NCT04411628|64312620|FG001|Overall Study|Lost to Follow-up|1|||
23153293|NCT04411628|64312621|FG002|Overall Study|Lost to Follow-up|0|||
23626553|NCT02484547|66020339|FG001|Long-Term Extension Period|Adverse Event|0|||
23626554|NCT02484547|66020340|FG002|Long-Term Extension Period|Adverse Event|0|||
23153294|NCT04411628|64312622|FG003|Overall Study|Lost to Follow-up|0|||
23153295|NCT01472380|64312623|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
23153296|NCT01472380|64312623|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
23153297|NCT04042740|64312624|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
23153298|NCT04042740|64312624|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
23153299|NCT03370471|64312625|FG000|Overall Study|Withdrawal by Subject|6|||
23153300|NCT03370471|64312626|FG001|Overall Study|Withdrawal by Subject|1|||
23153301|NCT03370471|64312625|FG000|Overall Study|Unable to access veins for blood draw|0|||
23153302|NCT03370471|64312626|FG001|Overall Study|Unable to access veins for blood draw|1|||
23153303|NCT03370471|64312625|FG000|Overall Study|Screen fail|1|||
23153304|NCT03370471|64312626|FG001|Overall Study|Screen fail|0|||
23153305|NCT00041080|64312627|FG000|Overall Study|Adverse Event|21|||
23626555|NCT02484547|66020341|FG003|Long-Term Extension Period|Adverse Event|0|||
23626556|NCT02484547|66020342|FG004|Long-Term Extension Period|Adverse Event|1|||
23626557|NCT02484547|66020343|FG005|Long-Term Extension Period|Adverse Event|3|||
23626558|NCT02484547|66020344|FG006|Long-Term Extension Period|Adverse Event|2|||
23626559|NCT02484547|66020338|FG000|Long-Term Extension Period|Death|0|||
23626560|NCT02484547|66020339|FG001|Long-Term Extension Period|Death|0|||
23626561|NCT02484547|66020340|FG002|Long-Term Extension Period|Death|0|||
23626562|NCT02484547|66020341|FG003|Long-Term Extension Period|Death|0|||
23626563|NCT02484547|66020342|FG004|Long-Term Extension Period|Death|0|||
23626564|NCT02484547|66020343|FG005|Long-Term Extension Period|Death|3|||
23626565|NCT02484547|66020344|FG006|Long-Term Extension Period|Death|0|||
23626566|NCT02484547|66020338|FG000|Long-Term Extension Period|Disease Progression|0|||
23626567|NCT02484547|66020339|FG001|Long-Term Extension Period|Disease Progression|0|||
23626568|NCT02484547|66020340|FG002|Long-Term Extension Period|Disease Progression|0|||
23626569|NCT02484547|66020341|FG003|Long-Term Extension Period|Disease Progression|0|||
23626570|NCT02484547|66020342|FG004|Long-Term Extension Period|Disease Progression|2|||
23626571|NCT02484547|66020343|FG005|Long-Term Extension Period|Disease Progression|4|||
23626572|NCT02484547|66020344|FG006|Long-Term Extension Period|Disease Progression|0|||
23626573|NCT02484547|66020338|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
23626574|NCT02484547|66020339|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
23626575|NCT02484547|66020340|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
23626576|NCT02484547|66020341|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
23626577|NCT02484547|66020342|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
23220561|NCT01902173|64550169|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23220562|NCT01902173|64550170|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23220563|NCT01902173|64550171|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23220564|NCT01902173|64550172|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
23220565|NCT01902173|64550167|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23220566|NCT01902173|64550168|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
23220567|NCT01902173|64550169|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23220568|NCT01902173|64550170|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23220569|NCT01902173|64550171|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23220570|NCT01902173|64550172|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
23220571|NCT01902173|64550167|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23220572|NCT01902173|64550168|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
23220573|NCT01902173|64550169|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23220574|NCT01902173|64550170|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23220575|NCT01902173|64550171|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23220576|NCT01902173|64550172|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
23220577|NCT01902173|64550167|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23220578|NCT01902173|64550168|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23220579|NCT01902173|64550169|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
23220580|NCT01902173|64550170|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23220581|NCT01902173|64550171|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23220582|NCT01902173|64550172|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
23220583|NCT01902173|64550167|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23220584|NCT01902173|64550168|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23220585|NCT01902173|64550169|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
23220586|NCT01902173|64550170|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23220587|NCT01902173|64550171|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23220588|NCT01902173|64550172|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
23220589|NCT01902173|64550167|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23220590|NCT01902173|64550168|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23220591|NCT01902173|64550169|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23220592|NCT01902173|64550170|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
23220593|NCT01902173|64550171|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23220594|NCT01902173|64550172|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
23220595|NCT01902173|64550167|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23220596|NCT01902173|64550168|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23220597|NCT01902173|64550169|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23220598|NCT01902173|64550170|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
23220599|NCT01902173|64550171|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23220600|NCT01902173|64550172|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
23220601|NCT01902173|64550167|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23220602|NCT01902173|64550168|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23626578|NCT02484547|66020343|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
23220603|NCT01902173|64550169|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23220604|NCT01902173|64550170|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23626579|NCT02484547|66020344|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
23626580|NCT02484547|66020338|FG000|Long-Term Extension Period|Loss of Capacity|0|||
23220605|NCT01902173|64550171|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
23220606|NCT01902173|64550172|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
23220607|NCT01902173|64550167|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23220608|NCT01902173|64550168|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23220609|NCT01902173|64550169|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23220610|NCT01902173|64550170|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23220611|NCT01902173|64550171|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
23220612|NCT01902173|64550172|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
23220613|NCT01902173|64550167|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23220614|NCT01902173|64550168|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23220615|NCT01902173|64550169|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23220616|NCT01902173|64550170|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23220617|NCT01902173|64550171|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
23220618|NCT01902173|64550172|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
23220619|NCT01902173|64550167|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23220620|NCT01902173|64550168|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23220621|NCT01902173|64550169|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23220622|NCT01902173|64550170|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23220623|NCT01902173|64550171|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
23220624|NCT01902173|64550172|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
23220625|NCT01902173|64550167|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23326884|NCT01125189|64938019|FG001|Treatment Period|Withdrawal by Subject|1|||
23326885|NCT01125189|64938020|FG002|Treatment Period|Withdrawal by Subject|1|||
23326886|NCT01125189|64938018|FG000|Treatment Period|Death|1|||
23153306|NCT00041080|64312628|FG001|Overall Study|Adverse Event|1|||
23564534|NCT00265330|65796430|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
23564535|NCT00265330|65796430|FG000|Overall Study|Lack of Efficacy|4|||
23564536|NCT00265330|65796430|FG000|Overall Study|Family Scheduling Conflicts|1|||
23564537|NCT00265330|65796430|FG000|Overall Study|Began Taking Formulary Geodon|1|||
23564538|NCT00265330|65796430|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
23564539|NCT00265330|65796430|FG000|Overall Study|Site Closed by Sponsor|1|||
23564540|NCT00265330|65796430|FG000|Overall Study|Principal Investigators Request|1|||
23564541|NCT00265330|65796430|FG000|Overall Study|Withdrew Consent|1|||
23564542|NCT00265330|65796430|FG000|Overall Study|Protocol Violation|1|||
23564543|NCT04300309|65796436|FG000|Overall Study|Lost to Follow-up|1|||
23564544|NCT04300309|65796437|FG001|Overall Study|Lost to Follow-up|0|||
23153307|NCT00041080|64312627|FG000|Overall Study|Withdrawal by Subject|6|||
23153308|NCT00041080|64312628|FG001|Overall Study|Withdrawal by Subject|6|||
23326887|NCT01125189|64938019|FG001|Treatment Period|Death|0|||
23326888|NCT01125189|64938020|FG002|Treatment Period|Death|0|||
23326889|NCT01125189|64938018|FG000|Treatment Period|Lost to Follow-up|1|||
23326890|NCT01125189|64938019|FG001|Treatment Period|Lost to Follow-up|2|||
23326891|NCT01125189|64938020|FG002|Treatment Period|Lost to Follow-up|1|||
23326892|NCT01125189|64938018|FG000|Treatment Period|Poor compliance/noncompliance|0|||
23326893|NCT01125189|64938019|FG001|Treatment Period|Poor compliance/noncompliance|1|||
23153309|NCT00041080|64312627|FG000|Overall Study|Concommitant Illness/Other|1|||
23153310|NCT00041080|64312628|FG001|Overall Study|Concommitant Illness/Other|2|||
23153311|NCT00041080|64312627|FG000|Overall Study|Did not start therapy|1|||
23153312|NCT00041080|64312628|FG001|Overall Study|Did not start therapy|1|||
23153313|NCT00041080|64312627|FG000|Overall Study|Ineligible|1|||
23153314|NCT00041080|64312628|FG001|Overall Study|Ineligible|0|||
23153315|NCT02303704|64312630|FG000|Overall Study|Protocol Violation|5|||
23153316|NCT02303704|64312631|FG001|Overall Study|Protocol Violation|9|||
23153317|NCT02108964|64312632|FG000|Overall Study|Progressive disease|12|||
23153318|NCT02108964|64312633|FG001|Overall Study|Progressive disease|25|||
23153319|NCT02108964|64312634|FG002|Overall Study|Progressive disease|50|||
23153320|NCT02108964|64312635|FG003|Overall Study|Progressive disease|6|||
23153321|NCT02108964|64312636|FG004|Overall Study|Progressive disease|18|||
23153322|NCT02108964|64312637|FG005|Overall Study|Progressive disease|5|||
23153323|NCT02108964|64312638|FG006|Overall Study|Progressive disease|7|||
23153324|NCT02108964|64312639|FG007|Overall Study|Progressive disease|9|||
23220626|NCT01902173|64550168|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23220627|NCT01902173|64550169|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23326894|NCT01125189|64938020|FG002|Treatment Period|Poor compliance/noncompliance|0|||
23326895|NCT01125189|64938018|FG000|Treatment Period|Participants requested to discontinue|1|||
23564545|NCT04300309|65796436|FG000|Overall Study|Long-term follow up on-going|0|||
23564546|NCT04300309|65796437|FG001|Overall Study|Long-term follow up on-going|2|||
23564547|NCT02821819|65796440|FG000|Overall Study|Protocol Violation|1|||
23153325|NCT02108964|64312632|FG000|Overall Study|Physician Decision|1|||
23153326|NCT02108964|64312633|FG001|Overall Study|Physician Decision|5|||
23153327|NCT02108964|64312634|FG002|Overall Study|Physician Decision|6|||
23153328|NCT02108964|64312635|FG003|Overall Study|Physician Decision|0|||
23153329|NCT02108964|64312636|FG004|Overall Study|Physician Decision|1|||
23153330|NCT02108964|64312637|FG005|Overall Study|Physician Decision|0|||
23153331|NCT02108964|64312638|FG006|Overall Study|Physician Decision|0|||
23153332|NCT02108964|64312639|FG007|Overall Study|Physician Decision|0|||
23153333|NCT02108964|64312632|FG000|Overall Study|Adverse Event|0|||
23153334|NCT02108964|64312633|FG001|Overall Study|Adverse Event|0|||
23153335|NCT02108964|64312634|FG002|Overall Study|Adverse Event|4|||
23153336|NCT02108964|64312635|FG003|Overall Study|Adverse Event|0|||
23153337|NCT02108964|64312636|FG004|Overall Study|Adverse Event|1|||
23153338|NCT02108964|64312637|FG005|Overall Study|Adverse Event|0|||
23153339|NCT02108964|64312638|FG006|Overall Study|Adverse Event|3|||
23153340|NCT02108964|64312639|FG007|Overall Study|Adverse Event|1|||
23153341|NCT02108964|64312632|FG000|Overall Study|Death|1|||
23153342|NCT02108964|64312633|FG001|Overall Study|Death|1|||
23153343|NCT02108964|64312634|FG002|Overall Study|Death|2|||
23153344|NCT02108964|64312635|FG003|Overall Study|Death|0|||
23153345|NCT02108964|64312636|FG004|Overall Study|Death|3|||
23153346|NCT02108964|64312637|FG005|Overall Study|Death|0|||
23220628|NCT01902173|64550170|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23220629|NCT01902173|64550171|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
23220630|NCT01902173|64550172|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
23220631|NCT00928512|64550173|FG000|Overall Study|Adverse Event|4|||
23220632|NCT00928512|64550174|FG001|Overall Study|Adverse Event|3|||
23220633|NCT00928512|64550175|FG002|Overall Study|Adverse Event|2|||
23153347|NCT02108964|64312638|FG006|Overall Study|Death|0|||
23153348|NCT02108964|64312639|FG007|Overall Study|Death|1|||
23153349|NCT02108964|64312632|FG000|Overall Study|Subject/Guardian decision|0|||
23153350|NCT02108964|64312633|FG001|Overall Study|Subject/Guardian decision|1|||
23220634|NCT00928512|64550176|FG003|Overall Study|Adverse Event|8|||
23220635|NCT00928512|64550177|FG004|Overall Study|Adverse Event|6|||
23220636|NCT00928512|64550173|FG000|Overall Study|Lack of Efficacy|2|||
23220637|NCT00928512|64550174|FG001|Overall Study|Lack of Efficacy|0|||
23220638|NCT00928512|64550175|FG002|Overall Study|Lack of Efficacy|4|||
23626581|NCT02484547|66020339|FG001|Long-Term Extension Period|Loss of Capacity|0|||
23626582|NCT02484547|66020340|FG002|Long-Term Extension Period|Loss of Capacity|0|||
23626583|NCT02484547|66020341|FG003|Long-Term Extension Period|Loss of Capacity|0|||
23626584|NCT02484547|66020342|FG004|Long-Term Extension Period|Loss of Capacity|1|||
23626585|NCT02484547|66020343|FG005|Long-Term Extension Period|Loss of Capacity|0|||
23626586|NCT02484547|66020344|FG006|Long-Term Extension Period|Loss of Capacity|0|||
23626587|NCT02484547|66020338|FG000|Long-Term Extension Period|Change of Treatment|0|||
23626588|NCT02484547|66020339|FG001|Long-Term Extension Period|Change of Treatment|0|||
23626589|NCT02484547|66020340|FG002|Long-Term Extension Period|Change of Treatment|0|||
23626590|NCT02484547|66020341|FG003|Long-Term Extension Period|Change of Treatment|0|||
23626591|NCT02484547|66020342|FG004|Long-Term Extension Period|Change of Treatment|0|||
23626592|NCT02484547|66020343|FG005|Long-Term Extension Period|Change of Treatment|0|||
23626593|NCT02484547|66020344|FG006|Long-Term Extension Period|Change of Treatment|1|||
23626594|NCT02484547|66020338|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
23626595|NCT02484547|66020339|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
23626596|NCT02484547|66020340|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
23626597|NCT02484547|66020341|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
23626598|NCT02484547|66020342|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
23626599|NCT02484547|66020343|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
23626600|NCT02484547|66020344|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
23626601|NCT02484547|66020338|FG000|Long-Term Extension Period|Investigator Decision|0|||
23626602|NCT02484547|66020339|FG001|Long-Term Extension Period|Investigator Decision|0|||
23626603|NCT02484547|66020340|FG002|Long-Term Extension Period|Investigator Decision|0|||
23626604|NCT02484547|66020341|FG003|Long-Term Extension Period|Investigator Decision|2|||
23626605|NCT02484547|66020342|FG004|Long-Term Extension Period|Investigator Decision|1|||
23626606|NCT02484547|66020343|FG005|Long-Term Extension Period|Investigator Decision|0|||
23626607|NCT02484547|66020344|FG006|Long-Term Extension Period|Investigator Decision|1|||
23626608|NCT02484547|66020338|FG000|Long-Term Extension Period|Relocation|0|||
23626609|NCT02484547|66020339|FG001|Long-Term Extension Period|Relocation|0|||
23626610|NCT02484547|66020340|FG002|Long-Term Extension Period|Relocation|0|||
23153351|NCT02108964|64312634|FG002|Overall Study|Subject/Guardian decision|3|||
23153352|NCT02108964|64312635|FG003|Overall Study|Subject/Guardian decision|0|||
23441500|NCT00874848|65358527|FG001|Overall Study|Withdrawal by Subject|4|||
23441501|NCT00874848|65358526|FG000|Overall Study|Noncompliance|1|||
23626611|NCT02484547|66020341|FG003|Long-Term Extension Period|Relocation|1|||
23626612|NCT02484547|66020342|FG004|Long-Term Extension Period|Relocation|1|||
23626613|NCT02484547|66020343|FG005|Long-Term Extension Period|Relocation|0|||
23153353|NCT02108964|64312636|FG004|Overall Study|Subject/Guardian decision|2|||
23153354|NCT02108964|64312637|FG005|Overall Study|Subject/Guardian decision|0|||
23153355|NCT02108964|64312638|FG006|Overall Study|Subject/Guardian decision|1|||
23220639|NCT00928512|64550176|FG003|Overall Study|Lack of Efficacy|7|||
23626614|NCT02484547|66020344|FG006|Long-Term Extension Period|Relocation|0|||
23153356|NCT02108964|64312639|FG007|Overall Study|Subject/Guardian decision|1|||
23153357|NCT01087957|64312642|FG000|Overall Study|Death|2|||
23153358|NCT01087957|64312643|FG001|Overall Study|Death|2|||
23626615|NCT02484547|66020338|FG000|Long-Term Extension Period|Study Visit Burden|0|||
23626616|NCT02484547|66020339|FG001|Long-Term Extension Period|Study Visit Burden|0|||
23626617|NCT02484547|66020340|FG002|Long-Term Extension Period|Study Visit Burden|0|||
23626618|NCT02484547|66020341|FG003|Long-Term Extension Period|Study Visit Burden|2|||
23626619|NCT02484547|66020342|FG004|Long-Term Extension Period|Study Visit Burden|0|||
23626620|NCT02484547|66020343|FG005|Long-Term Extension Period|Study Visit Burden|0|||
23626621|NCT02484547|66020344|FG006|Long-Term Extension Period|Study Visit Burden|3|||
23626622|NCT02484547|66020338|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
23626623|NCT02484547|66020339|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
23626624|NCT02484547|66020340|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
23626625|NCT02484547|66020341|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
23153359|NCT01087957|64312642|FG000|Overall Study|Lost to Follow-up|3|||
23153360|NCT01087957|64312643|FG001|Overall Study|Lost to Follow-up|4|||
23153361|NCT01087957|64312642|FG000|Overall Study|Protocol Violation|13|||
23564548|NCT00301080|65796441|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
23564549|NCT00301080|65796442|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
23564550|NCT00301080|65796443|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
23564551|NCT00301080|65796444|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
23564552|NCT00301080|65796445|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
23564553|NCT02026232|65796446|FG000|Overall Study|incomplete visit/missing data|3|||
23564554|NCT02026232|65796447|FG001|Overall Study|incomplete visit/missing data|2|||
23564555|NCT00882921|65796450|FG000|Overall Study|Death|2|||
23564556|NCT00882921|65796450|FG000|Overall Study|Other|3|||
23564557|NCT00882921|65796450|FG000|Overall Study|Lost to Follow-up|2|||
23564558|NCT00882921|65796450|FG000|Overall Study|Termination By Investigator|3|||
23564559|NCT00882921|65796450|FG000|Overall Study|Withdrawal Of Consent|1|||
23564560|NCT04887948|65796454|FG000|Overall Study|Death|1|||
23564561|NCT04887948|65796455|FG001|Overall Study|Death|0|||
23564562|NCT04887948|65796456|FG002|Overall Study|Death|0|||
23564563|NCT04887948|65796454|FG000|Overall Study|Lost to Follow-up|1|||
23564564|NCT04887948|65796455|FG001|Overall Study|Lost to Follow-up|0|||
23564565|NCT04887948|65796456|FG002|Overall Study|Lost to Follow-up|3|||
23564566|NCT04887948|65796454|FG000|Overall Study|Physician Decision|0|||
23564567|NCT04887948|65796455|FG001|Overall Study|Physician Decision|4|||
23564568|NCT04887948|65796456|FG002|Overall Study|Physician Decision|1|||
23564569|NCT04887948|65796454|FG000|Overall Study|Protocol Violation|1|||
23564570|NCT04887948|65796455|FG001|Overall Study|Protocol Violation|1|||
23564571|NCT04887948|65796456|FG002|Overall Study|Protocol Violation|0|||
23564572|NCT04887948|65796454|FG000|Overall Study|Withdrawal by Subject|0|||
23564573|NCT04887948|65796455|FG001|Overall Study|Withdrawal by Subject|6|||
23564574|NCT04887948|65796456|FG002|Overall Study|Withdrawal by Subject|1|||
23564575|NCT04887948|65796454|FG000|Overall Study|No longer met eligibility criteria|1|||
23564576|NCT04887948|65796455|FG001|Overall Study|No longer met eligibility criteria|2|||
23564577|NCT04887948|65796456|FG002|Overall Study|No longer met eligibility criteria|1|||
23564578|NCT04887948|65796454|FG000|Overall Study|Other|2|||
23564579|NCT04887948|65796455|FG001|Overall Study|Other|1|||
23564580|NCT04887948|65796456|FG002|Overall Study|Other|1|||
23564581|NCT00591864|65796468|FG000|Overall Study|Incomplete Imaging|5|||
23153362|NCT01087957|64312643|FG001|Overall Study|Protocol Violation|25|||
23153363|NCT01087957|64312642|FG000|Overall Study|Withdrawal by Subject|18|||
23153364|NCT01087957|64312643|FG001|Overall Study|Withdrawal by Subject|15|||
23153365|NCT01087957|64312642|FG000|Overall Study|Physician Decision|5|||
23153366|NCT01087957|64312643|FG001|Overall Study|Physician Decision|9|||
23153367|NCT03496012|64312644|FG000|Overall Study|Withdrawal by Subject|2|||
23153368|NCT03496012|64312645|FG001|Overall Study|Withdrawal by Subject|0|||
23153369|NCT03496012|64312646|FG002|Overall Study|Withdrawal by Subject|2|||
23153370|NCT03496012|64312644|FG000|Overall Study|Adverse Event|0|||
23153371|NCT03496012|64312645|FG001|Overall Study|Adverse Event|0|||
23153372|NCT03496012|64312646|FG002|Overall Study|Adverse Event|1|||
23153373|NCT03496012|64312644|FG000|Overall Study|Reason Not Specified|2|||
23153374|NCT03496012|64312645|FG001|Overall Study|Reason Not Specified|0|||
23326896|NCT01125189|64938019|FG001|Treatment Period|Participants requested to discontinue|3|||
23564582|NCT04152343|65796469|FG000|Overall Study|Transplanted|5|||
23564583|NCT04152343|65796469|FG000|Overall Study|Death|20|||
23564584|NCT04152343|65796469|FG000|Overall Study|Lost to Follow-up|3|||
23564585|NCT02223754|65796470|FG000|Period 1|Adverse Event|1|||
23564586|NCT02223754|65796471|FG001|Period 1|Adverse Event|0|||
23564587|NCT02223754|65796470|FG000|Period 1|Lost to Follow-up|0|||
23564588|NCT02223754|65796471|FG001|Period 1|Lost to Follow-up|1|||
23564589|NCT02223754|65796470|FG000|Period 1|Protocol Violation|2|||
23626626|NCT02484547|66020342|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
23153375|NCT03496012|64312646|FG002|Overall Study|Reason Not Specified|1|||
23153376|NCT00908583|64312647|FG000|Phase 1|Withdrawal by Subject|1|||
23153377|NCT00908583|64312647|FG000|Phase 1|Adverse Event|4|||
23564590|NCT02223754|65796471|FG001|Period 1|Protocol Violation|4|||
23564591|NCT02223754|65796470|FG000|Period 1|Withdrawal by Subject|0|||
23564592|NCT02223754|65796471|FG001|Period 1|Withdrawal by Subject|4|||
23564593|NCT02223754|65796470|FG000|Period 1|Test Article No Longer Available|1|||
23564594|NCT02223754|65796471|FG001|Period 1|Test Article No Longer Available|5|||
23564595|NCT02223754|65796470|FG000|Period 1|Unsatisfactory Visual Response|0|||
23564596|NCT02223754|65796471|FG001|Period 1|Unsatisfactory Visual Response|1|||
23564597|NCT02223754|65796470|FG000|Period 2|Adverse Event|0|||
23564598|NCT02223754|65796471|FG001|Period 2|Adverse Event|1|||
23564599|NCT02223754|65796470|FG000|Period 2|Protocol Violation|1|||
23564600|NCT02223754|65796471|FG001|Period 2|Protocol Violation|0|||
23564601|NCT02223754|65796470|FG000|Period 2|Lens Discomfort|1|||
23564602|NCT02223754|65796471|FG001|Period 2|Lens Discomfort|1|||
23564603|NCT02223754|65796470|FG000|Period 2|Lost to Follow-up|1|||
23564604|NCT02223754|65796471|FG001|Period 2|Lost to Follow-up|0|||
23564605|NCT02223754|65796470|FG000|Period 2|Test Article No Longer Available|0|||
23564606|NCT02223754|65796471|FG001|Period 2|Test Article No Longer Available|1|||
23564607|NCT05822921|65796472|FG000|Overall Study|Lost to Follow-up|1|||
23564608|NCT05822921|65796473|FG001|Overall Study|Lost to Follow-up|1|||
23564609|NCT03592277|65796474|FG000|Overall Study|Withdrawal by Subject|6|||
23564610|NCT03592277|65796475|FG001|Overall Study|Withdrawal by Subject|8|||
23564611|NCT04741802|65796476|FG000|Overall Study|Death|1|||
23564612|NCT04741802|65796476|FG000|Overall Study|Lost to Follow-up|11|||
23564613|NCT01547299|65796477|FG000|Overall Study|Withdrawal by Subject|2|||
23564614|NCT01547299|65796478|FG001|Overall Study|Withdrawal by Subject|2|||
23564615|NCT02563002|65796479|FG000|Overall Study|Death|72|||
23564616|NCT02563002|65796480|FG001|Overall Study|Death|87|||
23564617|NCT02563002|65796479|FG000|Overall Study|Lost to Follow-up|5|||
23564618|NCT02563002|65796480|FG001|Overall Study|Lost to Follow-up|0|||
23564619|NCT02563002|65796479|FG000|Overall Study|Physician Decision|0|||
23564620|NCT02563002|65796480|FG001|Overall Study|Physician Decision|2|||
23564621|NCT02563002|65796479|FG000|Overall Study|Withdrawal by Subject|2|||
23564622|NCT02563002|65796480|FG001|Overall Study|Withdrawal by Subject|10|||
23564623|NCT02563002|65796479|FG000|Overall Study|Sponsor decision|74|||
23564624|NCT02563002|65796480|FG001|Overall Study|Sponsor decision|55|||
23564625|NCT02496767|65796481|FG000|Open-label Lead-in Phase|Adverse Event|176|||
23564626|NCT02496767|65796482|FG001|Open-label Lead-in Phase|Adverse Event|0|||
23564627|NCT02496767|65796483|FG002|Open-label Lead-in Phase|Adverse Event|0|||
23564628|NCT02496767|65796484|FG003|Open-label Lead-in Phase|Adverse Event|0|||
23564629|NCT02496767|65796485|FG004|Open-label Lead-in Phase|Adverse Event|0|||
23564630|NCT02496767|65796486|FG005|Open-label Lead-in Phase|Adverse Event|0|||
23564631|NCT02496767|65796487|FG006|Open-label Lead-in Phase|Adverse Event|0|||
23564632|NCT02496767|65796488|FG007|Open-label Lead-in Phase|Adverse Event|0|||
23564633|NCT02496767|65796481|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
23564634|NCT02496767|65796482|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
23564635|NCT02496767|65796483|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
23564636|NCT02496767|65796484|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
23564637|NCT02496767|65796485|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
23564638|NCT02496767|65796486|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
23564639|NCT02496767|65796487|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
23564640|NCT02496767|65796488|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
23564641|NCT02496767|65796481|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
23564642|NCT02496767|65796482|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564643|NCT02496767|65796483|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564644|NCT02496767|65796484|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564645|NCT02496767|65796485|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564646|NCT02496767|65796486|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564647|NCT02496767|65796487|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
23564648|NCT02496767|65796488|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
23153378|NCT00908583|64312647|FG000|Phase 2|Physician Decision|1|||
23153379|NCT00908583|64312647|FG000|Phase 2|Adverse Event|1|||
23153380|NCT00908583|64312647|FG000|Phase 3|Adverse Event|2|||
23564649|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23153381|NCT00908583|64312647|FG000|Phase 4|Adverse Event|1|||
23153382|NCT00908583|64312647|FG000|Phase 4|Physician Decision|1|||
23153383|NCT00908583|64312647|FG000|Phase 5|Adverse Event|3|||
23564650|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
23564651|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
23564652|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
23564653|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
23564654|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23564655|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23564656|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23564657|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
23564658|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
23153384|NCT02012296|64312652|FG000|Overall Study|Lack of Efficacy|0|||
23153385|NCT02012296|64312653|FG001|Overall Study|Lack of Efficacy|0|||
23564659|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
23564660|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
23220640|NCT00928512|64550177|FG004|Overall Study|Lack of Efficacy|3|||
23220641|NCT00928512|64550173|FG000|Overall Study|Protocol Violation|0|||
23220642|NCT00928512|64550174|FG001|Overall Study|Protocol Violation|1|||
23220643|NCT00928512|64550175|FG002|Overall Study|Protocol Violation|0|||
23220644|NCT00928512|64550176|FG003|Overall Study|Protocol Violation|1|||
23220645|NCT00928512|64550177|FG004|Overall Study|Protocol Violation|3|||
23220646|NCT00928512|64550173|FG000|Overall Study|Withdrawal by Subject|3|||
23220647|NCT00928512|64550174|FG001|Overall Study|Withdrawal by Subject|0|||
23220648|NCT00928512|64550175|FG002|Overall Study|Withdrawal by Subject|3|||
23220649|NCT00928512|64550176|FG003|Overall Study|Withdrawal by Subject|4|||
23220650|NCT00928512|64550177|FG004|Overall Study|Withdrawal by Subject|0|||
23220651|NCT00928512|64550173|FG000|Overall Study|Lost to Follow-up|1|||
23564661|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
23564662|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
23564663|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
23626627|NCT02484547|66020343|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
23626628|NCT02484547|66020344|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
23626629|NCT02484547|66020338|FG000|Long-Term Extension Period|Reason not Specified|0|||
23626630|NCT02484547|66020339|FG001|Long-Term Extension Period|Reason not Specified|0|||
23626631|NCT02484547|66020340|FG002|Long-Term Extension Period|Reason not Specified|0|||
23626632|NCT02484547|66020341|FG003|Long-Term Extension Period|Reason not Specified|119|||
23626633|NCT02484547|66020342|FG004|Long-Term Extension Period|Reason not Specified|117|||
23626634|NCT02484547|66020343|FG005|Long-Term Extension Period|Reason not Specified|223|||
23626635|NCT02484547|66020344|FG006|Long-Term Extension Period|Reason not Specified|231|||
23626636|NCT02716298|66020345|FG000|First Intervention (1 Month)|Lens discomfort|1|||
23626637|NCT02716298|66020346|FG001|First Intervention (1 Month)|Lens discomfort|1|||
23626638|NCT00550446|66020347|FG000|Up To Week 12|Adverse Event|2|||
23626639|NCT00550446|66020348|FG001|Up To Week 12|Adverse Event|2|||
23626640|NCT00550446|66020349|FG002|Up To Week 12|Adverse Event|0|||
23626641|NCT00550446|66020350|FG003|Up To Week 12|Adverse Event|0|||
23626642|NCT00550446|66020351|FG004|Up To Week 12|Adverse Event|2|||
23626643|NCT00550446|66020352|FG005|Up To Week 12|Adverse Event|2|||
23626644|NCT00550446|66020353|FG006|Up To Week 12|Adverse Event|1|||
23626645|NCT00550446|66020354|FG007|Up To Week 12|Adverse Event|0|||
23626646|NCT00550446|66020355|FG008|Up To Week 12|Adverse Event|0|||
23626647|NCT00550446|66020356|FG009|Up To Week 12|Adverse Event|0|||
23626648|NCT00550446|66020357|FG010|Up To Week 12|Adverse Event|0|||
23626649|NCT00550446|66020347|FG000|Up To Week 12|Lack of Efficacy|3|||
23564664|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
23564665|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
23564666|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
23626650|NCT00550446|66020348|FG001|Up To Week 12|Lack of Efficacy|1|||
23626651|NCT00550446|66020349|FG002|Up To Week 12|Lack of Efficacy|0|||
23626652|NCT00550446|66020350|FG003|Up To Week 12|Lack of Efficacy|1|||
23626653|NCT00550446|66020351|FG004|Up To Week 12|Lack of Efficacy|0|||
23626654|NCT00550446|66020352|FG005|Up To Week 12|Lack of Efficacy|3|||
23626655|NCT00550446|66020353|FG006|Up To Week 12|Lack of Efficacy|3|||
23626656|NCT00550446|66020354|FG007|Up To Week 12|Lack of Efficacy|0|||
23626657|NCT00550446|66020355|FG008|Up To Week 12|Lack of Efficacy|0|||
23626658|NCT00550446|66020356|FG009|Up To Week 12|Lack of Efficacy|0|||
23626659|NCT00550446|66020357|FG010|Up To Week 12|Lack of Efficacy|0|||
23626660|NCT00550446|66020347|FG000|Up To Week 12|Lost to Follow-up|0|||
23626661|NCT00550446|66020348|FG001|Up To Week 12|Lost to Follow-up|1|||
23626662|NCT00550446|66020349|FG002|Up To Week 12|Lost to Follow-up|0|||
23626663|NCT00550446|66020350|FG003|Up To Week 12|Lost to Follow-up|0|||
23626664|NCT00550446|66020351|FG004|Up To Week 12|Lost to Follow-up|1|||
23626665|NCT00550446|66020352|FG005|Up To Week 12|Lost to Follow-up|1|||
23626666|NCT00550446|66020353|FG006|Up To Week 12|Lost to Follow-up|2|||
23626667|NCT00550446|66020354|FG007|Up To Week 12|Lost to Follow-up|0|||
23626668|NCT00550446|66020355|FG008|Up To Week 12|Lost to Follow-up|0|||
23626669|NCT00550446|66020356|FG009|Up To Week 12|Lost to Follow-up|0|||
23626670|NCT00550446|66020357|FG010|Up To Week 12|Lost to Follow-up|0|||
23220652|NCT00928512|64550174|FG001|Overall Study|Lost to Follow-up|1|||
23220653|NCT00928512|64550175|FG002|Overall Study|Lost to Follow-up|2|||
23626671|NCT00550446|66020347|FG000|Up To Week 12|Withdrawal by Subject|2|||
23626672|NCT00550446|66020348|FG001|Up To Week 12|Withdrawal by Subject|0|||
23626673|NCT00550446|66020349|FG002|Up To Week 12|Withdrawal by Subject|3|||
23626674|NCT00550446|66020350|FG003|Up To Week 12|Withdrawal by Subject|2|||
23220654|NCT00928512|64550176|FG003|Overall Study|Lost to Follow-up|1|||
23626675|NCT00550446|66020351|FG004|Up To Week 12|Withdrawal by Subject|0|||
23626676|NCT00550446|66020352|FG005|Up To Week 12|Withdrawal by Subject|1|||
23626677|NCT00550446|66020353|FG006|Up To Week 12|Withdrawal by Subject|3|||
23220655|NCT00928512|64550177|FG004|Overall Study|Lost to Follow-up|3|||
23626678|NCT00550446|66020354|FG007|Up To Week 12|Withdrawal by Subject|0|||
23626679|NCT00550446|66020355|FG008|Up To Week 12|Withdrawal by Subject|0|||
23626680|NCT00550446|66020356|FG009|Up To Week 12|Withdrawal by Subject|0|||
23626681|NCT00550446|66020357|FG010|Up To Week 12|Withdrawal by Subject|0|||
23626682|NCT00550446|66020347|FG000|Up To Week 12|Other|3|||
23626683|NCT00550446|66020348|FG001|Up To Week 12|Other|0|||
23626684|NCT00550446|66020349|FG002|Up To Week 12|Other|0|||
23564667|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
23564668|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
23564669|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
23564670|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
23564671|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
23564672|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
23564673|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
23564674|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
23564675|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
23564676|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
23564677|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
23564678|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
23564679|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
23564680|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
23564681|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23564682|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
23564683|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
23564684|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
23564685|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
23564686|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23564687|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23564688|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23564689|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564690|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
23564691|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
23564692|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564693|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564694|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564695|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564696|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23564697|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564698|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
23564699|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564700|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
23564701|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
23626685|NCT00550446|66020350|FG003|Up To Week 12|Other|0|||
23626686|NCT00550446|66020351|FG004|Up To Week 12|Other|0|||
23626687|NCT00550446|66020352|FG005|Up To Week 12|Other|1|||
23626688|NCT00550446|66020353|FG006|Up To Week 12|Other|4|||
23626689|NCT00550446|66020354|FG007|Up To Week 12|Other|0|||
23626690|NCT00550446|66020355|FG008|Up To Week 12|Other|0|||
23626691|NCT00550446|66020356|FG009|Up To Week 12|Other|0|||
23626692|NCT00550446|66020357|FG010|Up To Week 12|Other|0|||
23626693|NCT00550446|66020347|FG000|Up To Week 12|Randomized not treated|0|||
23626694|NCT00550446|66020348|FG001|Up To Week 12|Randomized not treated|1|||
23626695|NCT00550446|66020349|FG002|Up To Week 12|Randomized not treated|1|||
23626696|NCT00550446|66020350|FG003|Up To Week 12|Randomized not treated|0|||
23626697|NCT00550446|66020351|FG004|Up To Week 12|Randomized not treated|0|||
23626698|NCT00550446|66020352|FG005|Up To Week 12|Randomized not treated|0|||
23626699|NCT00550446|66020353|FG006|Up To Week 12|Randomized not treated|0|||
23153386|NCT02012296|64312654|FG002|Overall Study|Lack of Efficacy|15|||
23153387|NCT02012296|64312652|FG000|Overall Study|Adverse Event|0|||
23153388|NCT02012296|64312653|FG001|Overall Study|Adverse Event|0|||
23153389|NCT02012296|64312654|FG002|Overall Study|Adverse Event|2|||
23153390|NCT02012296|64312652|FG000|Overall Study|Early study closure|0|||
23153391|NCT02012296|64312653|FG001|Overall Study|Early study closure|0|||
23626700|NCT00550446|66020354|FG007|Up To Week 12|Randomized not treated|0|||
23153392|NCT02012296|64312654|FG002|Overall Study|Early study closure|5|||
23626701|NCT00550446|66020355|FG008|Up To Week 12|Randomized not treated|0|||
23626702|NCT00550446|66020356|FG009|Up To Week 12|Randomized not treated|0|||
23626703|NCT00550446|66020357|FG010|Up To Week 12|Randomized not treated|0|||
23626704|NCT00550446|66020347|FG000|Post Week 12|Adverse Event|2|||
23626705|NCT00550446|66020348|FG001|Post Week 12|Adverse Event|1|||
23626706|NCT00550446|66020349|FG002|Post Week 12|Adverse Event|1|||
23626707|NCT00550446|66020350|FG003|Post Week 12|Adverse Event|1|||
23153393|NCT02012296|64312652|FG000|Overall Study|Protocol Violation|0|||
23153394|NCT02012296|64312653|FG001|Overall Study|Protocol Violation|1|||
23626708|NCT00550446|66020351|FG004|Post Week 12|Adverse Event|1|||
23626709|NCT00550446|66020352|FG005|Post Week 12|Adverse Event|1|||
23626710|NCT00550446|66020353|FG006|Post Week 12|Adverse Event|0|||
23626711|NCT00550446|66020354|FG007|Post Week 12|Adverse Event|0|||
23626712|NCT00550446|66020355|FG008|Post Week 12|Adverse Event|0|||
23626713|NCT00550446|66020356|FG009|Post Week 12|Adverse Event|4|||
23626714|NCT00550446|66020357|FG010|Post Week 12|Adverse Event|0|||
23626715|NCT00550446|66020347|FG000|Post Week 12|Lack of Efficacy|0|||
23626716|NCT00550446|66020348|FG001|Post Week 12|Lack of Efficacy|0|||
23626717|NCT00550446|66020349|FG002|Post Week 12|Lack of Efficacy|1|||
23626718|NCT00550446|66020350|FG003|Post Week 12|Lack of Efficacy|0|||
23626719|NCT00550446|66020351|FG004|Post Week 12|Lack of Efficacy|0|||
23626720|NCT00550446|66020352|FG005|Post Week 12|Lack of Efficacy|0|||
23626721|NCT00550446|66020353|FG006|Post Week 12|Lack of Efficacy|0|||
23626722|NCT00550446|66020354|FG007|Post Week 12|Lack of Efficacy|1|||
23626723|NCT00550446|66020355|FG008|Post Week 12|Lack of Efficacy|1|||
23626724|NCT00550446|66020356|FG009|Post Week 12|Lack of Efficacy|2|||
23626725|NCT00550446|66020357|FG010|Post Week 12|Lack of Efficacy|1|||
23626726|NCT00550446|66020347|FG000|Post Week 12|Lost to Follow-up|0|||
23626727|NCT00550446|66020348|FG001|Post Week 12|Lost to Follow-up|0|||
23626728|NCT00550446|66020349|FG002|Post Week 12|Lost to Follow-up|1|||
23626729|NCT00550446|66020350|FG003|Post Week 12|Lost to Follow-up|1|||
23626730|NCT00550446|66020351|FG004|Post Week 12|Lost to Follow-up|0|||
23626731|NCT00550446|66020352|FG005|Post Week 12|Lost to Follow-up|0|||
23626732|NCT00550446|66020353|FG006|Post Week 12|Lost to Follow-up|1|||
23626733|NCT00550446|66020354|FG007|Post Week 12|Lost to Follow-up|0|||
23626734|NCT00550446|66020355|FG008|Post Week 12|Lost to Follow-up|0|||
23626735|NCT00550446|66020356|FG009|Post Week 12|Lost to Follow-up|0|||
23626736|NCT00550446|66020357|FG010|Post Week 12|Lost to Follow-up|0|||
23626737|NCT00550446|66020347|FG000|Post Week 12|Withdrawal by Subject|0|||
23626738|NCT00550446|66020348|FG001|Post Week 12|Withdrawal by Subject|0|||
23626739|NCT00550446|66020349|FG002|Post Week 12|Withdrawal by Subject|0|||
23626740|NCT00550446|66020350|FG003|Post Week 12|Withdrawal by Subject|0|||
23626741|NCT00550446|66020351|FG004|Post Week 12|Withdrawal by Subject|1|||
23626742|NCT00550446|66020352|FG005|Post Week 12|Withdrawal by Subject|0|||
23626743|NCT00550446|66020353|FG006|Post Week 12|Withdrawal by Subject|0|||
23626744|NCT00550446|66020354|FG007|Post Week 12|Withdrawal by Subject|0|||
23626745|NCT00550446|66020355|FG008|Post Week 12|Withdrawal by Subject|0|||
23626746|NCT00550446|66020356|FG009|Post Week 12|Withdrawal by Subject|0|||
23626747|NCT00550446|66020357|FG010|Post Week 12|Withdrawal by Subject|0|||
23626748|NCT00550446|66020347|FG000|Post Week 12|Other|1|||
23626749|NCT00550446|66020348|FG001|Post Week 12|Other|1|||
23626750|NCT00550446|66020349|FG002|Post Week 12|Other|0|||
23626751|NCT00550446|66020350|FG003|Post Week 12|Other|1|||
23626752|NCT00550446|66020351|FG004|Post Week 12|Other|0|||
23626753|NCT00550446|66020352|FG005|Post Week 12|Other|0|||
23626754|NCT00550446|66020353|FG006|Post Week 12|Other|1|||
23626755|NCT00550446|66020354|FG007|Post Week 12|Other|0|||
23626756|NCT00550446|66020355|FG008|Post Week 12|Other|1|||
23626757|NCT00550446|66020356|FG009|Post Week 12|Other|1|||
23626758|NCT00550446|66020357|FG010|Post Week 12|Other|0|||
23626759|NCT02132117|66020360|FG000|Overall Study|Adverse Event|6|||
23626760|NCT02132117|66020361|FG001|Overall Study|Adverse Event|1|||
23626761|NCT02132117|66020360|FG000|Overall Study|Lost to Follow-up|2|||
23626762|NCT02132117|66020361|FG001|Overall Study|Lost to Follow-up|2|||
23626763|NCT02132117|66020360|FG000|Overall Study|Personal Reasons|1|||
23564702|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564703|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564704|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23564705|NCT02496767|65796481|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564706|NCT02496767|65796482|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
23564707|NCT02496767|65796483|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564708|NCT02496767|65796484|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564709|NCT02496767|65796485|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564710|NCT02496767|65796486|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564711|NCT02496767|65796487|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564712|NCT02496767|65796488|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
23564713|NCT02496767|65796481|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
23626764|NCT02132117|66020361|FG001|Overall Study|Personal Reasons|2|||
23626765|NCT02132117|66020360|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23626766|NCT02132117|66020361|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23626767|NCT04156399|66020363|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
23626768|NCT04156399|66020363|FG000|Overall Study|study suspension due to COVID pandemic|3|||
23626769|NCT01790295|66020366|FG000|Overall Study|Adverse Event|1|||
23626770|NCT01790295|66020366|FG000|Overall Study|Death|4|||
23626771|NCT01790295|66020366|FG000|Overall Study|Lack of Efficacy|2|||
23626772|NCT01790295|66020366|FG000|Overall Study|Study closure|4|||
23626773|NCT00573651|66020367|FG000|Overall Study|Lost to Follow-up|3|||
23626774|NCT00573651|66020367|FG000|Overall Study|Withdrawal by Subject|1|||
23626775|NCT00224029|66020370|FG000|Overall Study|Lost to Follow-up|1|||
23626776|NCT00224029|66020370|FG000|Overall Study|Withdrawal by Subject|4|||
23153395|NCT02012296|64312654|FG002|Overall Study|Protocol Violation|0|||
23564714|NCT02496767|65796482|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564715|NCT02496767|65796483|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564716|NCT02496767|65796484|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564717|NCT02496767|65796485|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564718|NCT02496767|65796486|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
23564719|NCT02496767|65796487|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
23564720|NCT02496767|65796488|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
23564721|NCT02496767|65796481|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564722|NCT02496767|65796482|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564723|NCT02496767|65796483|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564724|NCT02496767|65796484|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564725|NCT02496767|65796485|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
23564726|NCT02496767|65796486|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
23564727|NCT02496767|65796487|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
23564728|NCT02496767|65796488|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
23564729|NCT02496767|65796481|FG000|Double-blind, Withdrawal Phase|Death|0|||
23564730|NCT02496767|65796482|FG001|Double-blind, Withdrawal Phase|Death|0|||
23564731|NCT02496767|65796483|FG002|Double-blind, Withdrawal Phase|Death|0|||
23564732|NCT02496767|65796484|FG003|Double-blind, Withdrawal Phase|Death|0|||
23564733|NCT02496767|65796485|FG004|Double-blind, Withdrawal Phase|Death|0|||
23564734|NCT02496767|65796486|FG005|Double-blind, Withdrawal Phase|Death|0|||
23626777|NCT00224029|66020370|FG000|Overall Study|Other|1|||
23626778|NCT01150045|66020373|FG000|Overall Study|Protocol Violation|0|||
23153396|NCT02906787|64312657|FG000|Overall Study|Withdrawal by Subject|12|||
23153397|NCT02906787|64312658|FG001|Overall Study|Withdrawal by Subject|10|||
23153398|NCT02906787|64312657|FG000|Overall Study|Missed|24|||
23153399|NCT02906787|64312658|FG001|Overall Study|Missed|22|||
23153400|NCT02606461|64312659|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23153401|NCT02606461|64312660|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23153402|NCT02606461|64312661|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
23153403|NCT02606461|64312662|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23153404|NCT02606461|64312663|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23153405|NCT02606461|64312664|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
23153406|NCT00122681|64312668|FG000|Overall Study|Adverse Event|20|||
23153407|NCT00122681|64312669|FG001|Overall Study|Adverse Event|16|||
23153408|NCT00122681|64312668|FG000|Overall Study|Lost to Follow-up|1080|||
23153409|NCT00122681|64312669|FG001|Overall Study|Lost to Follow-up|1097|||
23153410|NCT00122681|64312668|FG000|Overall Study|Protocol Violation|7|||
23153411|NCT00122681|64312669|FG001|Overall Study|Protocol Violation|10|||
23153412|NCT00122681|64312668|FG000|Overall Study|Withdrawal by Subject|257|||
23153413|NCT00122681|64312669|FG001|Overall Study|Withdrawal by Subject|251|||
23153414|NCT00122681|64312668|FG000|Overall Study|Personal reasons|150|||
23153415|NCT00122681|64312669|FG001|Overall Study|Personal reasons|147|||
23153416|NCT01207596|64312670|FG000|Overall Study|Physician Decision|4|||
23153417|NCT01207596|64312670|FG000|Overall Study|Lack of Efficacy|1|||
23153418|NCT01207596|64312670|FG000|Overall Study|Adverse Event|3|||
23153419|NCT01207596|64312670|FG000|Overall Study|Withdrawal by Subject|1|||
23153420|NCT00493220|64312672|FG000|Third Intervention|Withdrawal by Subject|1|||
23153421|NCT00493220|64312673|FG001|Third Intervention|Withdrawal by Subject|0|||
23153422|NCT00493220|64312674|FG002|Third Intervention|Withdrawal by Subject|0|||
23153423|NCT00493220|64312675|FG003|Third Intervention|Withdrawal by Subject|0|||
23153424|NCT00493220|64312676|FG004|Third Intervention|Withdrawal by Subject|0|||
23153425|NCT00493220|64312677|FG005|Third Intervention|Withdrawal by Subject|0|||
23153426|NCT00882310|64312678|FG000|Overall Study|Screen Failure|10|||
23153427|NCT00882310|64312678|FG000|Overall Study|Never received treatment|1|||
23153428|NCT00882310|64312678|FG000|Overall Study|Death|6|||
23153429|NCT00882310|64312678|FG000|Overall Study|Progression of disease|4|||
23153430|NCT00882310|64312678|FG000|Overall Study|Adverse Event|1|||
23153431|NCT00698451|64312679|FG000|Overall Study|Adverse Event|22|||
23153432|NCT00698451|64312679|FG000|Overall Study|Physician Decision|2|||
23564735|NCT02496767|65796487|FG006|Double-blind, Withdrawal Phase|Death|1|||
23564736|NCT02496767|65796488|FG007|Double-blind, Withdrawal Phase|Death|2|||
23564737|NCT02496767|65796481|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23564738|NCT02496767|65796482|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23626779|NCT01150045|66020374|FG001|Overall Study|Protocol Violation|1|||
23626780|NCT01150045|66020375|FG002|Overall Study|Protocol Violation|0|||
23153433|NCT00698451|64312679|FG000|Overall Study|Protocol Violation|6|||
23153434|NCT00698451|64312679|FG000|Overall Study|Withdrawal by Subject|6|||
23153435|NCT00698451|64312679|FG000|Overall Study|Disease progression|3|||
23153436|NCT01252810|64312680|FG000|Overall Study|Withdrawal by Subject|4|||
23153437|NCT01252810|64312681|FG001|Overall Study|Withdrawal by Subject|1|||
23153438|NCT01252810|64312680|FG000|Overall Study|Lost to Follow-up|0|||
23153439|NCT01252810|64312681|FG001|Overall Study|Lost to Follow-up|1|||
23564739|NCT02496767|65796483|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23564740|NCT02496767|65796484|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23564741|NCT02496767|65796485|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
23564742|NCT02496767|65796486|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
23564743|NCT02496767|65796487|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
23564744|NCT02496767|65796488|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
23564745|NCT01370005|65796489|FG000|Overall Study|Not treated|1|||
23564746|NCT01370005|65796490|FG001|Overall Study|Not treated|0|||
23564747|NCT01370005|65796491|FG002|Overall Study|Not treated|0|||
23564748|NCT01370005|65796489|FG000|Overall Study|Adverse Event|5|||
23564749|NCT01370005|65796490|FG001|Overall Study|Adverse Event|5|||
23564750|NCT01370005|65796491|FG002|Overall Study|Adverse Event|6|||
23564751|NCT01370005|65796489|FG000|Overall Study|Lack of Efficacy|1|||
23564752|NCT01370005|65796490|FG001|Overall Study|Lack of Efficacy|0|||
23564753|NCT01370005|65796491|FG002|Overall Study|Lack of Efficacy|0|||
23626781|NCT01150045|66020376|FG003|Overall Study|Protocol Violation|1|||
23626782|NCT00368641|66020377|FG000|Overall Study|Adverse Event|2|||
23626783|NCT00368641|66020378|FG001|Overall Study|Adverse Event|1|||
23626784|NCT00368641|66020377|FG000|Overall Study|Death|1|||
23626785|NCT00368641|66020378|FG001|Overall Study|Death|0|||
23626786|NCT00368641|66020377|FG000|Overall Study|Withdrawal by Subject|1|||
23626787|NCT00368641|66020378|FG001|Overall Study|Withdrawal by Subject|0|||
23626788|NCT00368641|66020377|FG000|Overall Study|Sponsor decision to terminate study|2|||
23626789|NCT00368641|66020378|FG001|Overall Study|Sponsor decision to terminate study|5|||
23626790|NCT02402322|66020381|FG000|Pretreatment|Withdrawal by Subject|3|||
23626791|NCT02402322|66020382|FG001|Pretreatment|Withdrawal by Subject|1|||
23626792|NCT02402322|66020383|FG002|Pretreatment|Withdrawal by Subject|1|||
23626793|NCT02402322|66020381|FG000|Follow-up|Withdrawal by Subject|6|||
23626794|NCT02402322|66020382|FG001|Follow-up|Withdrawal by Subject|3|||
23626795|NCT02402322|66020383|FG002|Follow-up|Withdrawal by Subject|24|||
23626796|NCT02296892|66020384|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
23626797|NCT02296892|66020385|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
23626798|NCT02296892|66020386|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
23626799|NCT02296892|66020384|FG000|Overall Study|Lost to Follow-up|5|||
23626800|NCT02296892|66020385|FG001|Overall Study|Lost to Follow-up|0|||
23626801|NCT02296892|66020386|FG002|Overall Study|Lost to Follow-up|1|||
23626802|NCT01807182|66020387|FG000|Overall Study|Death|1|||
23626803|NCT01807182|66020387|FG000|Overall Study|New therapy|1|||
23626804|NCT01807182|66020387|FG000|Overall Study|Moved to hospice care|1|||
23626805|NCT00025662|66020392|FG000|Overall Study|Withdrawal by Subject|2|||
23153440|NCT01252810|64312680|FG000|Overall Study|Physician Decision|2|||
23153441|NCT01252810|64312681|FG001|Overall Study|Physician Decision|1|||
23153442|NCT01252810|64312680|FG000|Overall Study|Various reasons|8|||
23153443|NCT01252810|64312681|FG001|Overall Study|Various reasons|0|||
23153444|NCT00478933|64312682|FG000|Overall Study|Protocol Violation|22|||
23153445|NCT00478933|64312682|FG000|Overall Study|Informed consent not verified|3|||
23153446|NCT00478933|64312682|FG000|Overall Study|Inadequate data available|53|||
23153447|NCT01493557|64312683|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
23153448|NCT01493557|64312684|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
23153449|NCT01493557|64312685|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
23153450|NCT01493557|64312683|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
23153451|NCT01493557|64312684|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
23153452|NCT01493557|64312685|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
23153453|NCT01493557|64312683|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
23153454|NCT01493557|64312684|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
23153455|NCT01493557|64312685|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
23153456|NCT01493557|64312683|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
23153457|NCT01493557|64312684|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
23153458|NCT01493557|64312685|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
23441502|NCT00874848|65358527|FG001|Overall Study|Noncompliance|1|||
23564754|NCT01370005|65796489|FG000|Overall Study|Non compliant with protocol|0|||
23564755|NCT01370005|65796490|FG001|Overall Study|Non compliant with protocol|1|||
23564756|NCT01370005|65796491|FG002|Overall Study|Non compliant with protocol|2|||
23564757|NCT01370005|65796489|FG000|Overall Study|Lost to Follow-up|1|||
23626806|NCT00025662|66020392|FG000|Overall Study|Technical failure of manipulation|1|||
23626807|NCT01056263|66020395|FG000|Overall Study|Adverse Event|12|||
23626808|NCT01056263|66020395|FG000|Overall Study|Death|1|||
23626809|NCT01056263|66020395|FG000|Overall Study|Withdrawal by Subject|1|||
23626810|NCT01056263|66020395|FG000|Overall Study|Lack of Efficacy|29|||
23626811|NCT01056263|66020395|FG000|Overall Study|Progressive disease|2|||
23153459|NCT01493557|64312683|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
23153460|NCT01493557|64312684|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
23153461|NCT01493557|64312685|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
23564758|NCT01370005|65796490|FG001|Overall Study|Lost to Follow-up|1|||
23564759|NCT01370005|65796491|FG002|Overall Study|Lost to Follow-up|1|||
23153462|NCT01493557|64312683|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
23153463|NCT01493557|64312684|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
23153464|NCT01493557|64312685|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
23153465|NCT01493557|64312683|FG000|Not Randomized to Management Strategies|Early termination|0|||
23153466|NCT01493557|64312684|FG001|Not Randomized to Management Strategies|Early termination|0|||
23153467|NCT01493557|64312685|FG002|Not Randomized to Management Strategies|Early termination|34|||
23153468|NCT01493557|64312683|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
23153469|NCT01493557|64312684|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
23153470|NCT01493557|64312685|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
23153471|NCT01493557|64312683|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
23153472|NCT01493557|64312684|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
23153473|NCT01493557|64312685|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
23153474|NCT01493557|64312683|FG000|Randomized to Management Strategies|Other adverse event|8|||
23153475|NCT01493557|64312684|FG001|Randomized to Management Strategies|Other adverse event|5|||
23153476|NCT01493557|64312685|FG002|Randomized to Management Strategies|Other adverse event|0|||
23153477|NCT01493557|64312683|FG000|Randomized to Management Strategies|Protocol Violation|3|||
23564760|NCT01370005|65796489|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
23564761|NCT01370005|65796490|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
23564762|NCT01370005|65796491|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
23564763|NCT01370005|65796489|FG000|Overall Study|Other reason not defined above|3|||
23564764|NCT01370005|65796490|FG001|Overall Study|Other reason not defined above|0|||
23153478|NCT01493557|64312684|FG001|Randomized to Management Strategies|Protocol Violation|0|||
23153479|NCT01493557|64312685|FG002|Randomized to Management Strategies|Protocol Violation|0|||
23153480|NCT01493557|64312683|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
23153481|NCT01493557|64312684|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
23153482|NCT01493557|64312685|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
23153483|NCT01493557|64312683|FG000|Randomized to Management Strategies|Other than stated above|1|||
23153484|NCT01493557|64312684|FG001|Randomized to Management Strategies|Other than stated above|3|||
23153485|NCT01493557|64312685|FG002|Randomized to Management Strategies|Other than stated above|0|||
23153486|NCT01493557|64312683|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
23153487|NCT01493557|64312684|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
23153488|NCT01493557|64312685|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
23153489|NCT01493557|64312683|FG000|Adding the Second Strategy|Other adverse event|1|||
23153490|NCT01493557|64312684|FG001|Adding the Second Strategy|Other adverse event|2|||
23153491|NCT01493557|64312685|FG002|Adding the Second Strategy|Other adverse event|0|||
23153492|NCT01493557|64312683|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
23153493|NCT01493557|64312684|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
23153494|NCT01493557|64312685|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
23153495|NCT01754857|64312686|FG000|Overall Study|Adverse Event|7|||
23153496|NCT01754857|64312686|FG000|Overall Study|Disease progression|3|||
23153497|NCT01754857|64312686|FG000|Overall Study|Physician Decision|2|||
23153498|NCT01754857|64312686|FG000|Overall Study|Withdrawal by Subject|3|||
23153499|NCT01754857|64312686|FG000|Overall Study|other complicating disease|1|||
23153500|NCT01754857|64312686|FG000|Overall Study|ineligible to continue onto maintenance|1|||
23153501|NCT01754857|64312686|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
23153502|NCT01754857|64312686|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
23153503|NCT00403754|64312687|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
23153504|NCT00403754|64312688|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
23153505|NCT00403754|64312689|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
23153506|NCT00403754|64312690|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
23153507|NCT00403754|64312687|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
23153508|NCT00403754|64312688|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
23153509|NCT00403754|64312689|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
23153510|NCT00403754|64312690|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
23153511|NCT05513625|64312695|FG000|Overall Study|Withdrawal by Subject|1|||
23153512|NCT02615470|64312696|FG000|Overall Study|Lost to Follow-up|21|||
23326897|NCT01125189|64938020|FG002|Treatment Period|Participants requested to discontinue|4|||
23326898|NCT01125189|64938018|FG000|Treatment Period|Other reasons|1|||
23153513|NCT02615470|64312697|FG001|Overall Study|Lost to Follow-up|32|||
23153514|NCT00732251|64312701|FG000|Overall Study|Lost to Follow-up|3|||
23153515|NCT00732251|64312701|FG000|Overall Study|Withdrawal by Subject|3|||
23326899|NCT01125189|64938019|FG001|Treatment Period|Other reasons|1|||
23153516|NCT00732251|64312701|FG000|Overall Study|Early Term due to Site Closure|1|||
23153517|NCT04490395|64312702|FG000|Overall Study|Lost to Follow-up|0|||
23153518|NCT04490395|64312703|FG001|Overall Study|Lost to Follow-up|1|||
23153519|NCT00786565|64312707|FG000|Enrollment Prior to Surgery|Site Closed|3|||
23153520|NCT00786565|64312707|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
23153521|NCT00786565|64312707|FG000|Post Surgery|Abnormal macular pucker|1|||
23153522|NCT00786565|64312707|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
23153523|NCT01177384|64312711|FG000|Overall Study|Adverse Event|6|||
23153524|NCT01177384|64312712|FG001|Overall Study|Adverse Event|4|||
23153525|NCT01177384|64312711|FG000|Overall Study|Lack of Efficacy|0|||
23153526|NCT01177384|64312712|FG001|Overall Study|Lack of Efficacy|1|||
23153527|NCT01177384|64312711|FG000|Overall Study|Lost to Follow-up|3|||
23153528|NCT01177384|64312712|FG001|Overall Study|Lost to Follow-up|4|||
23153529|NCT01177384|64312711|FG000|Overall Study|Physician Decision|0|||
23220656|NCT00928512|64550173|FG000|Overall Study|Administrative Problems|0|||
23220657|NCT00928512|64550174|FG001|Overall Study|Administrative Problems|1|||
23441503|NCT00874848|65358526|FG000|Overall Study|Failure to comply with protocol|0|||
23441504|NCT00874848|65358527|FG001|Overall Study|Failure to comply with protocol|1|||
23441505|NCT00874848|65358526|FG000|Overall Study|Physician Decision|0|||
23441506|NCT00874848|65358527|FG001|Overall Study|Physician Decision|2|||
23441507|NCT03221842|65358530|FG000|Period 1 (Open-label)|Adverse Event|4|||
23441508|NCT03221842|65358531|FG001|Period 1 (Open-label)|Adverse Event|0|||
23441509|NCT03221842|65358530|FG000|Period 1 (Open-label)|Physician Decision|2|||
23441510|NCT03221842|65358531|FG001|Period 1 (Open-label)|Physician Decision|0|||
23441511|NCT03221842|65358530|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
23441512|NCT03221842|65358531|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
23441513|NCT03221842|65358530|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
23441514|NCT03221842|65358531|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
23441515|NCT03221842|65358530|FG000|Period 1 (Open-label)|Other|2|||
23441516|NCT03221842|65358531|FG001|Period 1 (Open-label)|Other|0|||
23441517|NCT03221842|65358530|FG000|Period 2 (Randomized, Blinded)|Death|0|||
23441518|NCT03221842|65358531|FG001|Period 2 (Randomized, Blinded)|Death|1|||
23441519|NCT03221842|65358530|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
23441520|NCT03221842|65358531|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
23441521|NCT02881762|65358532|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23441522|NCT02881762|65358533|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23441523|NCT02522325|65358534|FG000|Overall Study|Adverse Event|0|||
23220658|NCT00928512|64550175|FG002|Overall Study|Administrative Problems|0|||
23220659|NCT00928512|64550176|FG003|Overall Study|Administrative Problems|0|||
23220660|NCT00928512|64550177|FG004|Overall Study|Administrative Problems|0|||
23220661|NCT00255034|64550178|FG000|Overall Study|Withdrawal by Subject|15|||
23220662|NCT00255034|64550179|FG001|Overall Study|Withdrawal by Subject|38|||
23220663|NCT01685203|64550180|FG000|Overall Study|Lost to Follow-up|3|||
23220664|NCT01685203|64550181|FG001|Overall Study|Lost to Follow-up|3|||
23220665|NCT01685203|64550182|FG002|Overall Study|Lost to Follow-up|0|||
23220666|NCT01685203|64550183|FG003|Overall Study|Lost to Follow-up|1|||
23220667|NCT01685203|64550184|FG004|Overall Study|Lost to Follow-up|0|||
23220668|NCT01685203|64550185|FG005|Overall Study|Lost to Follow-up|0|||
23564765|NCT01370005|65796491|FG002|Overall Study|Other reason not defined above|2|||
23564766|NCT01642602|65796492|FG000|Overall Study|Adverse Event|2|||
23153530|NCT01177384|64312712|FG001|Overall Study|Physician Decision|3|||
23220669|NCT01685203|64550186|FG006|Overall Study|Lost to Follow-up|0|||
23153531|NCT01177384|64312711|FG000|Overall Study|Protocol Violation|0|||
23153532|NCT01177384|64312712|FG001|Overall Study|Protocol Violation|2|||
23441524|NCT02522325|65358535|FG001|Overall Study|Adverse Event|1|||
23564767|NCT01396395|65796493|FG000|Overall Study|Withdrawal by Subject|10|||
23564768|NCT01396395|65796494|FG001|Overall Study|Withdrawal by Subject|12|||
23564769|NCT01396395|65796493|FG000|Overall Study|Protocol Violation|3|||
23564770|NCT01396395|65796494|FG001|Overall Study|Protocol Violation|1|||
23564771|NCT01396395|65796493|FG000|Overall Study|Adverse Event|10|||
23564772|NCT01396395|65796494|FG001|Overall Study|Adverse Event|2|||
23564773|NCT01396395|65796493|FG000|Overall Study|Lost to Follow-up|17|||
23564774|NCT01396395|65796494|FG001|Overall Study|Lost to Follow-up|11|||
23564775|NCT01396395|65796493|FG000|Overall Study|Other|0|||
23564776|NCT01396395|65796494|FG001|Overall Study|Other|1|||
23564777|NCT02044458|65796497|FG000|Overall Study|Protocol Violation|3|||
23564778|NCT02044458|65796498|FG001|Overall Study|Protocol Violation|8|||
23564779|NCT03351738|65796499|FG000|Overall Study|Withdrawal by Subject|0|||
23564780|NCT03351738|65796500|FG001|Overall Study|Withdrawal by Subject|1|||
23564781|NCT03351738|65796501|FG002|Overall Study|Withdrawal by Subject|0|||
23564782|NCT03351738|65796502|FG003|Overall Study|Withdrawal by Subject|1|||
23564783|NCT03351738|65796503|FG004|Overall Study|Withdrawal by Subject|0|||
23564784|NCT03351738|65796504|FG005|Overall Study|Withdrawal by Subject|0|||
23564785|NCT00747123|65796510|FG000|Overall Study|Investigator's request|0|||
23564786|NCT00747123|65796511|FG001|Overall Study|Investigator's request|0|||
23564787|NCT00747123|65796512|FG002|Overall Study|Investigator's request|1|||
23626812|NCT01056263|66020395|FG000|Overall Study|Neoplasm progression|1|||
23626813|NCT01056263|66020395|FG000|Overall Study|Objective progression or relapse|1|||
23626814|NCT01056263|66020395|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
23564788|NCT00747123|65796513|FG003|Overall Study|Investigator's request|0|||
23564789|NCT00747123|65796510|FG000|Overall Study|Withdrew consent|0|||
23564790|NCT00747123|65796511|FG001|Overall Study|Withdrew consent|1|||
23564791|NCT00747123|65796512|FG002|Overall Study|Withdrew consent|0|||
23564792|NCT00747123|65796513|FG003|Overall Study|Withdrew consent|0|||
23564793|NCT00747123|65796510|FG000|Overall Study|Adverse Event|0|||
23626815|NCT00760513|66020396|FG000|Overall Study|Withdrawal by Subject|5|||
23626816|NCT00760513|66020397|FG001|Overall Study|Withdrawal by Subject|7|||
23626817|NCT01209598|66020400|FG000|Overall Study|Withdrawal by Subject|1|||
23626818|NCT01209598|66020401|FG001|Overall Study|Withdrawal by Subject|0|||
23626819|NCT00559377|66020403|FG000|Overall Study|Withdrawal by Subject|9|||
23626820|NCT03448536|66020406|FG000|Overall Study|Protocol Violation|2|||
23626821|NCT03448536|66020407|FG001|Overall Study|Protocol Violation|0|||
23626822|NCT03448536|66020406|FG000|Overall Study|Pregnancy|1|||
23626823|NCT03448536|66020407|FG001|Overall Study|Pregnancy|0|||
23626824|NCT03448536|66020406|FG000|Overall Study|Withdrawal by Subject|1|||
23626825|NCT03448536|66020407|FG001|Overall Study|Withdrawal by Subject|2|||
23626826|NCT03448536|66020406|FG000|Overall Study|Lost to Follow-up|3|||
23626827|NCT03448536|66020407|FG001|Overall Study|Lost to Follow-up|2|||
23626828|NCT03448536|66020406|FG000|Overall Study|Inadequate pain reporter|1|||
23626829|NCT03448536|66020407|FG001|Overall Study|Inadequate pain reporter|0|||
23626830|NCT03448536|66020406|FG000|Overall Study|Other|3|||
23626831|NCT03448536|66020407|FG001|Overall Study|Other|0|||
23626832|NCT03448536|66020406|FG000|Overall Study|Physician Decision|1|||
23626833|NCT03448536|66020407|FG001|Overall Study|Physician Decision|0|||
23626834|NCT02287233|66020408|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
23626835|NCT02287233|66020409|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
23626836|NCT02287233|66020410|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
23626837|NCT02287233|66020408|FG000|Overall Study|Adverse Event Related to Progression|0|||
23626838|NCT02287233|66020409|FG001|Overall Study|Adverse Event Related to Progression|2|||
23626839|NCT02287233|66020410|FG002|Overall Study|Adverse Event Related to Progression|8|||
23626840|NCT02287233|66020408|FG000|Overall Study|Physician Decision|1|||
23626841|NCT02287233|66020409|FG001|Overall Study|Physician Decision|2|||
23153533|NCT01177384|64312711|FG000|Overall Study|Withdrawal by Subject|5|||
23153534|NCT01177384|64312712|FG001|Overall Study|Withdrawal by Subject|12|||
23326900|NCT01125189|64938020|FG002|Treatment Period|Other reasons|0|||
23326901|NCT01125189|64938018|FG000|Treatment Period|Completed 24 week treatment period only|2|||
23564794|NCT00747123|65796511|FG001|Overall Study|Adverse Event|1|||
23564795|NCT00747123|65796512|FG002|Overall Study|Adverse Event|0|||
23564796|NCT00747123|65796513|FG003|Overall Study|Adverse Event|1|||
23564797|NCT00879996|65796514|FG000|Overall Study|Lost to Follow-up|7|||
23564798|NCT00879996|65796515|FG001|Overall Study|Lost to Follow-up|6|||
23564799|NCT00879996|65796514|FG000|Overall Study|non-compliance|6|||
23153535|NCT01237340|64312717|FG000|Overall Study|Adverse Event|3|||
23153536|NCT01237340|64312717|FG000|Overall Study|Withdrawal by Subject|1|||
23153537|NCT01237340|64312717|FG000|Overall Study|Early termination of the trial|36|||
23153538|NCT00884325|64312720|FG000|Overall Study|Lost to Follow-up|1|||
23153539|NCT00884325|64312721|FG001|Overall Study|Lost to Follow-up|2|||
23153540|NCT00884325|64312720|FG000|Overall Study|Lack of Efficacy|0|||
23153541|NCT00884325|64312721|FG001|Overall Study|Lack of Efficacy|1|||
23153542|NCT00884325|64312720|FG000|Overall Study|Withdrawal by Subject|1|||
23153543|NCT00884325|64312721|FG001|Overall Study|Withdrawal by Subject|1|||
23153544|NCT00884325|64312720|FG000|Overall Study|Not provided|1|||
23153545|NCT00884325|64312721|FG001|Overall Study|Not provided|0|||
23153546|NCT00521053|64312722|FG000|Observation Phase|Disease Progression|55|||
23153547|NCT00521053|64312722|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
23153548|NCT00521053|64312722|FG000|Observation Phase|Death|2|||
23153549|NCT00521053|64312722|FG000|Observation Phase|Adverse Event|1|||
23153550|NCT00521053|64312722|FG000|Observation Phase|Other non-study melanoma treatment|1|||
23153551|NCT00521053|64312722|FG000|Observation Phase|Physician Decision|1|||
23153552|NCT01650285|64312727|FG000|Overall Study|Adverse Event|1|||
23153553|NCT01519934|64312728|FG000|Overall Study|Lost to Follow-up|3|||
23153554|NCT02247960|64312731|FG000|Patient Consent and Randomization|Physician Decision|2|||
23153555|NCT02247960|64312732|FG001|Patient Consent and Randomization|Physician Decision|2|||
23153556|NCT02247960|64312731|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
23626842|NCT02287233|66020410|FG002|Overall Study|Physician Decision|4|||
23626843|NCT02287233|66020408|FG000|Overall Study|Progressive Disease with Death|0|||
23626844|NCT02287233|66020409|FG001|Overall Study|Progressive Disease with Death|0|||
23564800|NCT00879996|65796515|FG001|Overall Study|non-compliance|4|||
23626845|NCT02287233|66020410|FG002|Overall Study|Progressive Disease with Death|10|||
23626846|NCT02287233|66020408|FG000|Overall Study|Progressive Disease Without Death|2|||
23626847|NCT02287233|66020409|FG001|Overall Study|Progressive Disease Without Death|3|||
23626848|NCT02287233|66020410|FG002|Overall Study|Progressive Disease Without Death|20|||
23220670|NCT01685203|64550180|FG000|Overall Study|Adverse Event|0|||
23220671|NCT01685203|64550181|FG001|Overall Study|Adverse Event|0|||
23220672|NCT01685203|64550182|FG002|Overall Study|Adverse Event|0|||
23220673|NCT01685203|64550183|FG003|Overall Study|Adverse Event|0|||
23220674|NCT01685203|64550184|FG004|Overall Study|Adverse Event|0|||
23220675|NCT01685203|64550185|FG005|Overall Study|Adverse Event|2|||
23220676|NCT01685203|64550186|FG006|Overall Study|Adverse Event|0|||
23220677|NCT01685203|64550180|FG000|Overall Study|Adverse event and withdrew consent|1|||
23220678|NCT01685203|64550181|FG001|Overall Study|Adverse event and withdrew consent|0|||
23220679|NCT01685203|64550182|FG002|Overall Study|Adverse event and withdrew consent|0|||
23220680|NCT01685203|64550183|FG003|Overall Study|Adverse event and withdrew consent|0|||
23220681|NCT01685203|64550184|FG004|Overall Study|Adverse event and withdrew consent|0|||
23220682|NCT01685203|64550185|FG005|Overall Study|Adverse event and withdrew consent|0|||
23220683|NCT01685203|64550186|FG006|Overall Study|Adverse event and withdrew consent|0|||
23220684|NCT01685203|64550180|FG000|Overall Study|Patient's decision|0|||
23220685|NCT01685203|64550181|FG001|Overall Study|Patient's decision|0|||
23220686|NCT01685203|64550182|FG002|Overall Study|Patient's decision|0|||
23220687|NCT01685203|64550183|FG003|Overall Study|Patient's decision|0|||
23220688|NCT01685203|64550184|FG004|Overall Study|Patient's decision|0|||
23220689|NCT01685203|64550185|FG005|Overall Study|Patient's decision|1|||
23220690|NCT01685203|64550186|FG006|Overall Study|Patient's decision|0|||
23220691|NCT00610207|64550187|FG000|Overall Study|Lost to Follow-up|3|||
23220692|NCT01929707|64550188|FG000|Intervention Period 1|Lost to Follow-up|0|||
23220693|NCT01929707|64550189|FG001|Intervention Period 1|Lost to Follow-up|0|||
23220694|NCT01929707|64550190|FG002|Intervention Period 1|Lost to Follow-up|0|||
23220695|NCT01929707|64550191|FG003|Intervention Period 1|Lost to Follow-up|1|||
23220696|NCT01929707|64550192|FG004|Intervention Period 1|Lost to Follow-up|0|||
23220697|NCT01929707|64550193|FG005|Intervention Period 1|Lost to Follow-up|0|||
23220698|NCT01929707|64550194|FG006|Intervention Period 1|Lost to Follow-up|0|||
23220699|NCT01929707|64550195|FG007|Intervention Period 1|Lost to Follow-up|0|||
23220700|NCT01929707|64550188|FG000|Intervention Period 1|Withdrawal by Subject|0|||
23220701|NCT01929707|64550189|FG001|Intervention Period 1|Withdrawal by Subject|0|||
23220702|NCT01929707|64550190|FG002|Intervention Period 1|Withdrawal by Subject|0|||
23220703|NCT01929707|64550191|FG003|Intervention Period 1|Withdrawal by Subject|2|||
23220704|NCT01929707|64550192|FG004|Intervention Period 1|Withdrawal by Subject|0|||
23220705|NCT01929707|64550193|FG005|Intervention Period 1|Withdrawal by Subject|0|||
23220706|NCT01929707|64550194|FG006|Intervention Period 1|Withdrawal by Subject|0|||
23220707|NCT01929707|64550195|FG007|Intervention Period 1|Withdrawal by Subject|0|||
23220708|NCT01929707|64550188|FG000|Intervention Period 2|Withdrawal by Subject|0|||
23220709|NCT01929707|64550189|FG001|Intervention Period 2|Withdrawal by Subject|0|||
23220710|NCT01929707|64550190|FG002|Intervention Period 2|Withdrawal by Subject|0|||
23220711|NCT01929707|64550191|FG003|Intervention Period 2|Withdrawal by Subject|0|||
23220712|NCT01929707|64550192|FG004|Intervention Period 2|Withdrawal by Subject|0|||
23220713|NCT01929707|64550193|FG005|Intervention Period 2|Withdrawal by Subject|2|||
23220714|NCT01929707|64550194|FG006|Intervention Period 2|Withdrawal by Subject|0|||
23220715|NCT01929707|64550195|FG007|Intervention Period 2|Withdrawal by Subject|0|||
23220716|NCT04964557|64550196|FG000|Overall Study|Withdrawal by Subject|3|||
23220717|NCT04964557|64550197|FG001|Overall Study|Withdrawal by Subject|2|||
23220718|NCT04964557|64550196|FG000|Overall Study|Lost to Follow-up|1|||
23220719|NCT04964557|64550197|FG001|Overall Study|Lost to Follow-up|2|||
23220720|NCT04964557|64550196|FG000|Overall Study|Physician Decision|2|||
23220721|NCT04964557|64550197|FG001|Overall Study|Physician Decision|0|||
23220722|NCT04964557|64550196|FG000|Overall Study|Death|3|||
23220723|NCT04964557|64550197|FG001|Overall Study|Death|0|||
23220724|NCT04964557|64550196|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
23220725|NCT04964557|64550197|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
23220726|NCT01106391|64550199|FG000|Overall Study|Death|12|||
23220727|NCT01106391|64550199|FG000|Overall Study|Withdrawal by Subject|7|||
23220728|NCT03383614|64550203|FG000|Overall Study|Withdrawal by Subject|0|||
23220729|NCT03383614|64550204|FG001|Overall Study|Withdrawal by Subject|1|||
23220730|NCT03383614|64550205|FG002|Overall Study|Withdrawal by Subject|0|||
23220731|NCT03383614|64550206|FG003|Overall Study|Withdrawal by Subject|0|||
23220732|NCT01963780|64550208|FG000|Overall Study|Death|7|||
23220733|NCT01690988|64550209|FG000|Overall Study|Withdrawal by Subject|2|||
23220734|NCT01690988|64550210|FG001|Overall Study|Withdrawal by Subject|2|||
23220735|NCT01690988|64550211|FG002|Overall Study|Withdrawal by Subject|3|||
23220736|NCT01690988|64550209|FG000|Overall Study|Physician Decision|0|||
23220737|NCT01690988|64550210|FG001|Overall Study|Physician Decision|0|||
23220738|NCT01690988|64550211|FG002|Overall Study|Physician Decision|1|||
23220739|NCT01690988|64550209|FG000|Overall Study|Operation Cancelled|1|||
23326902|NCT01125189|64938019|FG001|Treatment Period|Completed 24 week treatment period only|1|||
23220740|NCT01690988|64550210|FG001|Overall Study|Operation Cancelled|1|||
23220741|NCT01690988|64550211|FG002|Overall Study|Operation Cancelled|0|||
23220742|NCT01690988|64550209|FG000|Overall Study|Determined ineligible|1|||
23564801|NCT00879996|65796514|FG000|Overall Study|Physician Decision|1|||
23220743|NCT01690988|64550210|FG001|Overall Study|Determined ineligible|0|||
23220744|NCT01690988|64550211|FG002|Overall Study|Determined ineligible|0|||
23220745|NCT01690988|64550209|FG000|Overall Study|Death|1|||
23220746|NCT01690988|64550210|FG001|Overall Study|Death|1|||
23220747|NCT01690988|64550211|FG002|Overall Study|Death|1|||
23220748|NCT01690988|64550209|FG000|Overall Study|Sedated|1|||
23220749|NCT01690988|64550210|FG001|Overall Study|Sedated|1|||
23220750|NCT01690988|64550211|FG002|Overall Study|Sedated|2|||
23220751|NCT03565991|64550212|FG000|Overall Study|Other|11|||
23220752|NCT03565991|64550213|FG001|Overall Study|Other|0|||
23220753|NCT03565991|64550212|FG000|Overall Study|Global deterioration of health status|14|||
23220754|NCT03565991|64550213|FG001|Overall Study|Global deterioration of health status|4|||
23220755|NCT03565991|64550212|FG000|Overall Study|Withdrawal by Subject|2|||
23220756|NCT03565991|64550213|FG001|Overall Study|Withdrawal by Subject|6|||
23220757|NCT03565991|64550212|FG000|Overall Study|Progressive disease|121|||
23220758|NCT03565991|64550213|FG001|Overall Study|Progressive disease|29|||
23220759|NCT03565991|64550212|FG000|Overall Study|Death|3|||
23220760|NCT03565991|64550213|FG001|Overall Study|Death|0|||
23220761|NCT03565991|64550212|FG000|Overall Study|Adverse Event|7|||
23220762|NCT03565991|64550213|FG001|Overall Study|Adverse Event|2|||
23220763|NCT02033850|64550214|FG000|Overall Study|Death|1|||
23626849|NCT02287233|66020408|FG000|Overall Study|Withdrawal by Subject|1|||
23626850|NCT02287233|66020409|FG001|Overall Study|Withdrawal by Subject|1|||
23626851|NCT02287233|66020410|FG002|Overall Study|Withdrawal by Subject|7|||
23626852|NCT02287233|66020408|FG000|Overall Study|Other|3|||
23626853|NCT02287233|66020409|FG001|Overall Study|Other|0|||
23626854|NCT02287233|66020410|FG002|Overall Study|Other|15|||
23626855|NCT02287233|66020408|FG000|Overall Study|Did Not Receive Treatment|0|||
23626856|NCT02287233|66020409|FG001|Overall Study|Did Not Receive Treatment|0|||
23626857|NCT02287233|66020410|FG002|Overall Study|Did Not Receive Treatment|2|||
23626858|NCT02438371|66020411|FG000|Overall Study|Lost to Follow-up|3|||
23626859|NCT02438371|66020412|FG001|Overall Study|Lost to Follow-up|2|||
23626860|NCT02438371|66020411|FG000|Overall Study|Withdrawal by Subject|1|||
23626861|NCT02438371|66020412|FG001|Overall Study|Withdrawal by Subject|1|||
23626862|NCT01310699|66020417|FG000|Overall Study|Patients did not complete tandem.|4|||
23626863|NCT01310699|66020418|FG001|Overall Study|Patients did not complete tandem.|6|||
23626864|NCT03297398|66020419|FG000|Overall Study|Sponsor's decision|6|||
23626865|NCT03297398|66020420|FG001|Overall Study|Sponsor's decision|9|||
23626866|NCT03297398|66020421|FG002|Overall Study|Sponsor's decision|7|||
23626867|NCT03297398|66020419|FG000|Overall Study|Adverse Event|1|||
23626868|NCT03297398|66020420|FG001|Overall Study|Adverse Event|4|||
23626869|NCT03297398|66020421|FG002|Overall Study|Adverse Event|4|||
23626870|NCT03297398|66020419|FG000|Overall Study|Withdrawal by Subject|1|||
23626871|NCT03297398|66020420|FG001|Overall Study|Withdrawal by Subject|2|||
23626872|NCT03297398|66020421|FG002|Overall Study|Withdrawal by Subject|2|||
23626873|NCT03297398|66020419|FG000|Overall Study|Protocol Violation|0|||
23626874|NCT03297398|66020420|FG001|Overall Study|Protocol Violation|2|||
23626875|NCT03297398|66020421|FG002|Overall Study|Protocol Violation|0|||
23626876|NCT03297398|66020419|FG000|Overall Study|Physician Decision|0|||
23626877|NCT03297398|66020420|FG001|Overall Study|Physician Decision|0|||
23626878|NCT03297398|66020421|FG002|Overall Study|Physician Decision|1|||
23626879|NCT03297398|66020419|FG000|Overall Study|Lost to Follow-up|0|||
23626880|NCT03297398|66020420|FG001|Overall Study|Lost to Follow-up|0|||
23626881|NCT03297398|66020421|FG002|Overall Study|Lost to Follow-up|1|||
23626882|NCT00425607|66020428|FG000|Overall Study|Death|1|||
23626883|NCT00425607|66020428|FG000|Overall Study|Withdrawal by Subject|1|||
23626884|NCT01889069|66020433|FG000|Overall Study|Death|18|||
23220764|NCT02033850|64550215|FG001|Overall Study|Death|0|||
23220765|NCT02033850|64550214|FG000|Overall Study|unrelated medical reason|1|||
23220766|NCT02033850|64550215|FG001|Overall Study|unrelated medical reason|1|||
23220767|NCT00770224|64550216|FG000|Step 1: Induction|Adverse Event|3|||
23326903|NCT01125189|64938020|FG002|Treatment Period|Completed 24 week treatment period only|2|||
23441525|NCT01067144|65358536|FG000|Treatment|Did not receive allocated intervention|4|||
23564802|NCT00879996|65796515|FG001|Overall Study|Physician Decision|2|||
23564803|NCT00879996|65796514|FG000|Overall Study|psychiatric problem|0|||
23564804|NCT00879996|65796515|FG001|Overall Study|psychiatric problem|1|||
23564805|NCT00879996|65796514|FG000|Overall Study|put on parole|1|||
23564806|NCT00879996|65796515|FG001|Overall Study|put on parole|0|||
23564807|NCT04399551|65796516|FG000|Overall Study|Adverse Event|15|||
23564808|NCT04399551|65796516|FG000|Overall Study|Withdrawal by Subject|6|||
23564809|NCT04399551|65796516|FG000|Overall Study|Physician Decision|3|||
23564810|NCT04399551|65796516|FG000|Overall Study|Lost to Follow-up|2|||
23564811|NCT04399551|65796516|FG000|Overall Study|Protocol Deviation|2|||
23564812|NCT04631705|65796517|FG000|Overall Study|Withdrawal by Subject|0|||
23564813|NCT04631705|65796518|FG001|Overall Study|Withdrawal by Subject|0|||
23564814|NCT04631705|65796519|FG002|Overall Study|Withdrawal by Subject|0|||
23626885|NCT01889069|66020433|FG000|Overall Study|Progression of Disease|14|||
23220768|NCT00770224|64550217|FG001|Step 1: Induction|Adverse Event|0|||
23220769|NCT00770224|64550216|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
23626886|NCT01889069|66020433|FG000|Overall Study|Lost to Follow-up|6|||
23626887|NCT01889069|66020433|FG000|Overall Study|Other|4|||
23626888|NCT01889069|66020433|FG000|Overall Study|Consent Withdrawal|3|||
23626889|NCT02520310|66020437|FG000|At 6 Months Clinical Follow-up|Death|1|||
23626890|NCT02520310|66020437|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
23626891|NCT02520310|66020437|FG000|AT 3 Year Clinical Follow-up|Death|2|||
23626892|NCT02520310|66020437|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
23626893|NCT02520310|66020437|FG000|AT 4 Year Clinical Follow-up|Death|1|||
23626894|NCT02520310|66020437|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
23626895|NCT02762903|66020438|FG000|Overall Study|Lost to Follow-up|0|||
23626896|NCT02762903|66020439|FG001|Overall Study|Lost to Follow-up|1|||
23626897|NCT01466790|66020440|FG000|Overall Study|Adverse Event|1|||
23626898|NCT01466790|66020441|FG001|Overall Study|Adverse Event|0|||
23626899|NCT01466790|66020442|FG002|Overall Study|Adverse Event|0|||
23626900|NCT01466790|66020443|FG003|Overall Study|Adverse Event|0|||
23626901|NCT01466790|66020444|FG004|Overall Study|Adverse Event|2|||
23626902|NCT01466790|66020445|FG005|Overall Study|Adverse Event|0|||
23626903|NCT01466790|66020446|FG006|Overall Study|Adverse Event|0|||
23626904|NCT01466790|66020447|FG007|Overall Study|Adverse Event|0|||
23626905|NCT01466790|66020440|FG000|Overall Study|Lost to Follow-up|2|||
23626906|NCT01466790|66020441|FG001|Overall Study|Lost to Follow-up|0|||
23626907|NCT01466790|66020442|FG002|Overall Study|Lost to Follow-up|0|||
23564815|NCT04631705|65796520|FG003|Overall Study|Withdrawal by Subject|0|||
23564816|NCT04631705|65796521|FG004|Overall Study|Withdrawal by Subject|0|||
23564817|NCT04631705|65796522|FG005|Overall Study|Withdrawal by Subject|0|||
23564818|NCT04631705|65796523|FG006|Overall Study|Withdrawal by Subject|1|||
23564819|NCT04631705|65796524|FG007|Overall Study|Withdrawal by Subject|0|||
23153557|NCT02247960|64312732|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
23153558|NCT02247960|64312731|FG000|Catheter Removed|Lost to Follow-up|7|||
23153559|NCT02247960|64312732|FG001|Catheter Removed|Lost to Follow-up|10|||
23153560|NCT00726622|64312739|FG000|Overall Study|Withdrawal by Subject|16|||
23153561|NCT00726622|64312740|FG001|Overall Study|Withdrawal by Subject|2|||
23153562|NCT00726622|64312739|FG000|Overall Study|Physician Decision|0|||
23153563|NCT00726622|64312740|FG001|Overall Study|Physician Decision|1|||
23153564|NCT00726622|64312739|FG000|Overall Study|Metastasis|2|||
23153565|NCT00726622|64312740|FG001|Overall Study|Metastasis|0|||
23220770|NCT00770224|64550217|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
23220771|NCT00770224|64550216|FG000|Step 1: Induction|Other reason not protocol specified|2|||
23220772|NCT00770224|64550217|FG001|Step 1: Induction|Other reason not protocol specified|0|||
23220773|NCT00770224|64550216|FG000|Step 1: Induction|Ineligible|2|||
23220774|NCT00770224|64550217|FG001|Step 1: Induction|Ineligible|0|||
23220775|NCT00770224|64550216|FG000|Step 1: Induction|No protocol treatment given|1|||
23220776|NCT00770224|64550217|FG001|Step 1: Induction|No protocol treatment given|0|||
23220777|NCT00770224|64550216|FG000|Step 2: Maintenance|Adverse Event|0|||
23326904|NCT01125189|64938018|FG000|Follow up Period|Withdrawal by Subject|3|||
23153566|NCT00773136|64312743|FG000|Overall Study|Physician Decision|2|||
23153567|NCT04422990|64312747|FG000|Overall Study|Withdrawal by Subject|0|||
23326905|NCT01125189|64938019|FG001|Follow up Period|Withdrawal by Subject|2|||
23220778|NCT00770224|64550217|FG001|Step 2: Maintenance|Adverse Event|10|||
23326906|NCT01125189|64938020|FG002|Follow up Period|Withdrawal by Subject|5|||
23326907|NCT01125189|64938018|FG000|Follow up Period|Death|1|||
23326908|NCT01125189|64938019|FG001|Follow up Period|Death|0|||
23326909|NCT01125189|64938020|FG002|Follow up Period|Death|0|||
23564820|NCT04631705|65796525|FG008|Overall Study|Withdrawal by Subject|0|||
23564821|NCT04858802|65796526|FG000|Overall Study|Lost to Follow-up|1|||
23564822|NCT04858802|65796527|FG001|Overall Study|Lost to Follow-up|1|||
23564823|NCT04858802|65796526|FG000|Overall Study|Withdrawal by Subject|1|||
23564824|NCT04858802|65796527|FG001|Overall Study|Withdrawal by Subject|1|||
23564825|NCT04737109|65796528|FG000|Study Treatment|Disease Progression|5|||
23564826|NCT04737109|65796529|FG001|Study Treatment|Disease Progression|0|||
23564827|NCT04737109|65796530|FG002|Study Treatment|Disease Progression|0|||
23564828|NCT04737109|65796531|FG003|Study Treatment|Disease Progression|0|||
23564829|NCT04737109|65796528|FG000|Study Treatment|Death on study|1|||
23626908|NCT01466790|66020443|FG003|Overall Study|Lost to Follow-up|0|||
23626909|NCT01466790|66020444|FG004|Overall Study|Lost to Follow-up|0|||
23153568|NCT04422990|64312748|FG001|Overall Study|Withdrawal by Subject|1|||
23153569|NCT04422990|64312747|FG000|Overall Study|Travel|3|||
23153570|NCT04422990|64312748|FG001|Overall Study|Travel|0|||
23153571|NCT01195545|64312749|FG000|Overall Study|Protocol Violation|4|||
23326910|NCT01125189|64938018|FG000|Follow up Period|Lost to Follow-up|12|||
23326911|NCT01125189|64938019|FG001|Follow up Period|Lost to Follow-up|9|||
23564830|NCT04737109|65796529|FG001|Study Treatment|Death on study|0|||
23626910|NCT01466790|66020445|FG005|Overall Study|Lost to Follow-up|0|||
23626911|NCT01466790|66020446|FG006|Overall Study|Lost to Follow-up|0|||
23626912|NCT01466790|66020447|FG007|Overall Study|Lost to Follow-up|0|||
23626913|NCT01466790|66020440|FG000|Overall Study|Withdrawal by Subject|1|||
23153572|NCT03047551|64312750|FG000|Overall Study|Did not receive TAS|1|||
23626914|NCT01466790|66020441|FG001|Overall Study|Withdrawal by Subject|1|||
23153573|NCT03047551|64312751|FG001|Overall Study|Did not receive TAS|0|||
23153574|NCT03047551|64312750|FG000|Overall Study|Physician Decision|1|||
23153575|NCT03047551|64312751|FG001|Overall Study|Physician Decision|0|||
23153576|NCT03047551|64312750|FG000|Overall Study|Withdrawal by Subject|0|||
23153577|NCT03047551|64312751|FG001|Overall Study|Withdrawal by Subject|1|||
23153578|NCT03047551|64312750|FG000|Overall Study|Probe malfunction|0|||
23153579|NCT03047551|64312751|FG001|Overall Study|Probe malfunction|1|||
23153580|NCT03047551|64312750|FG000|Overall Study|Ineligible|0|||
23220779|NCT00770224|64550216|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
23326912|NCT01125189|64938020|FG002|Follow up Period|Lost to Follow-up|6|||
23326913|NCT01125189|64938018|FG000|Follow up Period|Other reasons|4|||
23326914|NCT01125189|64938019|FG001|Follow up Period|Other reasons|4|||
23326915|NCT01125189|64938020|FG002|Follow up Period|Other reasons|5|||
23326916|NCT02630251|64938021|FG000|Overall Study|Physician Decision|0|||
23326917|NCT02630251|64938022|FG001|Overall Study|Physician Decision|0|||
23326918|NCT02630251|64938023|FG002|Overall Study|Physician Decision|1|||
23326919|NCT02630251|64938024|FG003|Overall Study|Physician Decision|0|||
23326920|NCT02038010|64938028|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
23220780|NCT00770224|64550217|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
23220781|NCT00770224|64550216|FG000|Step 2: Maintenance|Progression/relapse|0|||
23220782|NCT00770224|64550217|FG001|Step 2: Maintenance|Progression/relapse|1|||
23220783|NCT00770224|64550216|FG000|Step 2: Maintenance|Death|0|||
23220784|NCT00770224|64550217|FG001|Step 2: Maintenance|Death|2|||
23220785|NCT00770224|64550216|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
23220786|NCT00770224|64550217|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
23220787|NCT00770224|64550216|FG000|Step 2: Maintenance|Ineligible|0|||
23220788|NCT00770224|64550217|FG001|Step 2: Maintenance|Ineligible|2|||
23326921|NCT02038010|64938029|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
23326922|NCT02038010|64938030|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
23326923|NCT02038010|64938031|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
23326924|NCT02038010|64938028|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
23626915|NCT01466790|66020442|FG002|Overall Study|Withdrawal by Subject|0|||
23626916|NCT01466790|66020443|FG003|Overall Study|Withdrawal by Subject|0|||
23626917|NCT01466790|66020444|FG004|Overall Study|Withdrawal by Subject|1|||
23626918|NCT01466790|66020445|FG005|Overall Study|Withdrawal by Subject|0|||
23153581|NCT03047551|64312751|FG001|Overall Study|Ineligible|1|||
23153582|NCT02710136|64312757|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
23326925|NCT02038010|64938029|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
23326926|NCT02038010|64938030|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
23326927|NCT02038010|64938031|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
23326928|NCT02038010|64938028|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
23326929|NCT02038010|64938029|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
23326930|NCT02038010|64938030|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
23326931|NCT02038010|64938031|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
23326932|NCT02038010|64938028|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
23326933|NCT02038010|64938029|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
23326934|NCT02038010|64938030|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
23326935|NCT02038010|64938031|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
23326936|NCT02038010|64938028|FG000|Follow Up|Death|4|||
23326937|NCT02038010|64938029|FG001|Follow Up|Death|3|||
23326938|NCT02038010|64938030|FG002|Follow Up|Death|0|||
23326939|NCT02038010|64938031|FG003|Follow Up|Death|0|||
23564831|NCT04737109|65796530|FG002|Study Treatment|Death on study|0|||
23564832|NCT04737109|65796531|FG003|Study Treatment|Death on study|0|||
23326940|NCT02038010|64938028|FG000|Follow Up|Other|3|||
23564833|NCT03391960|65796536|FG000|Overall Study|Protocol Violation|0|||
23564834|NCT03391960|65796537|FG001|Overall Study|Protocol Violation|0|||
23564835|NCT02421666|65796539|FG000|6-month Follow-up|Lost to Follow-up|8|||
23564836|NCT02421666|65796540|FG001|6-month Follow-up|Lost to Follow-up|7|||
23564837|NCT02421666|65796539|FG000|6-month Follow-up|Withdrawal by Subject|5|||
23564838|NCT02421666|65796540|FG001|6-month Follow-up|Withdrawal by Subject|6|||
23564839|NCT02421666|65796539|FG000|12-month Follow-up|Lost to Follow-up|5|||
23564840|NCT02421666|65796540|FG001|12-month Follow-up|Lost to Follow-up|5|||
23564841|NCT02421666|65796539|FG000|12-month Follow-up|Withdrawal by Subject|6|||
23564842|NCT02421666|65796540|FG001|12-month Follow-up|Withdrawal by Subject|11|||
23564843|NCT00105586|65796545|FG000|Overall Study|Adverse Event|4|||
23564844|NCT00105586|65796546|FG001|Overall Study|Adverse Event|3|||
23564845|NCT00105586|65796545|FG000|Overall Study|Physician Decision|13|||
23564846|NCT00105586|65796546|FG001|Overall Study|Physician Decision|13|||
23153583|NCT02710136|64312758|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
23626919|NCT01466790|66020446|FG006|Overall Study|Withdrawal by Subject|1|||
23153584|NCT00436618|64312759|FG000|Overall Study|Withdrawal by Subject|5|||
23326941|NCT02038010|64938029|FG001|Follow Up|Other|0|||
23153585|NCT00436618|64312760|FG001|Overall Study|Withdrawal by Subject|8|||
23220789|NCT00322387|64550218|FG000|Treatment Period|Adverse Event|0|||
23220790|NCT00322387|64550219|FG001|Treatment Period|Adverse Event|1|||
23220791|NCT00322387|64550218|FG000|Follow-up Period|Final assessment not done|1|||
23220792|NCT00322387|64550219|FG001|Follow-up Period|Final assessment not done|3|||
23220793|NCT00322387|64550218|FG000|Follow-up Period|Death|1|||
23220794|NCT00322387|64550219|FG001|Follow-up Period|Death|0|||
23220795|NCT00329784|64550222|FG000|Overall Study|Lost to Follow-up|0|||
23220796|NCT00329784|64550223|FG001|Overall Study|Lost to Follow-up|1|||
23220797|NCT00329784|64550224|FG002|Overall Study|Lost to Follow-up|0|||
23220798|NCT00329784|64550225|FG003|Overall Study|Lost to Follow-up|0|||
23220799|NCT00329784|64550222|FG000|Overall Study|Withdrawal by Subject|4|||
23220800|NCT00329784|64550223|FG001|Overall Study|Withdrawal by Subject|2|||
23220801|NCT00329784|64550224|FG002|Overall Study|Withdrawal by Subject|0|||
23220802|NCT00329784|64550225|FG003|Overall Study|Withdrawal by Subject|0|||
23220803|NCT00329784|64550222|FG000|Overall Study|Other|1|||
23220804|NCT00329784|64550223|FG001|Overall Study|Other|2|||
23220805|NCT00329784|64550224|FG002|Overall Study|Other|0|||
23220806|NCT00329784|64550225|FG003|Overall Study|Other|0|||
23220807|NCT03250624|64550228|FG000|Overall Study|Lack of Efficacy|1|||
23220808|NCT03250624|64550229|FG001|Overall Study|Lack of Efficacy|4|||
23220809|NCT03250624|64550228|FG000|Overall Study|Adverse Event|0|||
23220810|NCT03250624|64550229|FG001|Overall Study|Adverse Event|1|||
23220811|NCT03250624|64550228|FG000|Overall Study|Other|1|||
23220812|NCT03250624|64550229|FG001|Overall Study|Other|2|||
23220813|NCT04134728|64550232|FG000|Overall Study|Adverse Event|3|||
23220814|NCT04134728|64550233|FG001|Overall Study|Adverse Event|2|||
23220815|NCT04134728|64550234|FG002|Overall Study|Adverse Event|9|||
23220816|NCT04134728|64550235|FG003|Overall Study|Adverse Event|0|||
23220817|NCT04134728|64550236|FG004|Overall Study|Adverse Event|0|||
23220818|NCT04134728|64550237|FG005|Overall Study|Adverse Event|0|||
23220819|NCT04134728|64550232|FG000|Overall Study|Lack of Efficacy|3|||
23220820|NCT04134728|64550233|FG001|Overall Study|Lack of Efficacy|3|||
23220821|NCT04134728|64550234|FG002|Overall Study|Lack of Efficacy|1|||
23220822|NCT04134728|64550235|FG003|Overall Study|Lack of Efficacy|2|||
23220823|NCT04134728|64550236|FG004|Overall Study|Lack of Efficacy|0|||
23220824|NCT04134728|64550237|FG005|Overall Study|Lack of Efficacy|0|||
23564847|NCT03724396|65796549|FG000|Overall Study|Lost to Follow-up|1|||
23564848|NCT03724396|65796550|FG001|Overall Study|Lost to Follow-up|1|||
23564849|NCT03724396|65796549|FG000|Overall Study|Withdrawal by Subject|1|||
23564850|NCT03724396|65796550|FG001|Overall Study|Withdrawal by Subject|0|||
23564851|NCT02228395|65796552|FG000|First Intervention Period|No longer willing to participate|1|||
23564852|NCT02228395|65796553|FG001|First Intervention Period|No longer willing to participate|0|||
23564853|NCT02228395|65796554|FG002|First Intervention Period|No longer willing to participate|0|||
23564854|NCT02228395|65796552|FG000|First Intervention Period|Unable to comply with study dates|0|||
23220825|NCT04134728|64550232|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
23220826|NCT04134728|64550233|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23220827|NCT04134728|64550234|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
23220828|NCT04134728|64550235|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23326942|NCT02038010|64938030|FG002|Follow Up|Other|0|||
23326943|NCT02038010|64938031|FG003|Follow Up|Other|0|||
23326944|NCT00634036|64938032|FG000|Overall Study|Lost to Follow-up|1|||
23326945|NCT00634036|64938033|FG001|Overall Study|Lost to Follow-up|1|||
23326946|NCT00634036|64938032|FG000|Overall Study|Withdrawal by Subject|1|||
23326947|NCT00634036|64938033|FG001|Overall Study|Withdrawal by Subject|1|||
23326948|NCT00886015|64938034|FG000|Overall Study|Death|0|||
23326949|NCT00886015|64938035|FG001|Overall Study|Death|2|||
23326950|NCT00273182|64938041|FG000|Overall Study|Death|450|||
23326951|NCT00273182|64938041|FG000|Overall Study|Lost to Follow-up|88|||
23326952|NCT00273182|64938041|FG000|Overall Study|Withdrawal by Subject|257|||
23326953|NCT00273182|64938041|FG000|Overall Study|Device/System Explant|154|||
23564855|NCT02228395|65796553|FG001|First Intervention Period|Unable to comply with study dates|1|||
23564856|NCT02228395|65796554|FG002|First Intervention Period|Unable to comply with study dates|1|||
23564857|NCT01872910|65796555|FG000|Overall Study|Lost to Follow-up|2|||
23564858|NCT01872910|65796556|FG001|Overall Study|Lost to Follow-up|0|||
23564859|NCT01872910|65796557|FG002|Overall Study|Lost to Follow-up|2|||
23564860|NCT01872910|65796558|FG003|Overall Study|Lost to Follow-up|0|||
23564861|NCT01872910|65796559|FG004|Overall Study|Lost to Follow-up|0|||
23220829|NCT04134728|64550236|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23220830|NCT04134728|64550237|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23220831|NCT04134728|64550232|FG000|Overall Study|Protocol Deviation|0|||
23220832|NCT04134728|64550233|FG001|Overall Study|Protocol Deviation|0|||
23220833|NCT04134728|64550234|FG002|Overall Study|Protocol Deviation|1|||
23220834|NCT04134728|64550235|FG003|Overall Study|Protocol Deviation|0|||
23220835|NCT04134728|64550236|FG004|Overall Study|Protocol Deviation|0|||
23326954|NCT00273182|64938041|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
23326955|NCT00884117|64938042|FG000|Overall Study|Adverse Event|2|||
23326956|NCT00884117|64938042|FG000|Overall Study|Withdrawal by Subject|89|||
23326957|NCT00884117|64938042|FG000|Overall Study|Death|3|||
23326958|NCT00884117|64938042|FG000|Overall Study|Lost to Follow-up|143|||
23326959|NCT00884117|64938042|FG000|Overall Study|Other|12|||
23326960|NCT00696423|64940780|FG000|Overall Study|Lost to Follow-up|0|||
23326961|NCT00696423|64940781|FG001|Overall Study|Lost to Follow-up|5|||
23220836|NCT04134728|64550237|FG005|Overall Study|Protocol Deviation|0|||
23220837|NCT04134728|64550232|FG000|Overall Study|Informed Consent Withdrawn|3|||
23220838|NCT04134728|64550233|FG001|Overall Study|Informed Consent Withdrawn|6|||
23220839|NCT04134728|64550234|FG002|Overall Study|Informed Consent Withdrawn|8|||
23220840|NCT04134728|64550235|FG003|Overall Study|Informed Consent Withdrawn|1|||
23220841|NCT04134728|64550236|FG004|Overall Study|Informed Consent Withdrawn|1|||
23220842|NCT04134728|64550237|FG005|Overall Study|Informed Consent Withdrawn|0|||
23220843|NCT04134728|64550232|FG000|Overall Study|Physician Decision|2|||
23220844|NCT04134728|64550233|FG001|Overall Study|Physician Decision|0|||
23220845|NCT04134728|64550234|FG002|Overall Study|Physician Decision|0|||
23220846|NCT04134728|64550235|FG003|Overall Study|Physician Decision|0|||
23220847|NCT04134728|64550236|FG004|Overall Study|Physician Decision|0|||
23220848|NCT04134728|64550237|FG005|Overall Study|Physician Decision|0|||
23326962|NCT01991743|64940782|FG000|Overall Study|external cephalic version not performed|0|||
23326963|NCT01991743|64940783|FG001|Overall Study|external cephalic version not performed|0|||
23326964|NCT01991743|64940784|FG002|Overall Study|external cephalic version not performed|1|||
23326965|NCT01991743|64940785|FG003|Overall Study|external cephalic version not performed|0|||
23326966|NCT02515331|64940786|FG000|Overall Study|Withdrawal by Subject|0|||
23326967|NCT02515331|64940787|FG001|Overall Study|Withdrawal by Subject|0|||
23326968|NCT02515331|64940788|FG002|Overall Study|Withdrawal by Subject|1|||
23326969|NCT02515331|64940786|FG000|Overall Study|Protocol deviation|0|||
23326970|NCT02515331|64940787|FG001|Overall Study|Protocol deviation|0|||
23326971|NCT02515331|64940788|FG002|Overall Study|Protocol deviation|3|||
23326972|NCT02515331|64940786|FG000|Overall Study|Adverse Event|2|||
23326973|NCT02515331|64940787|FG001|Overall Study|Adverse Event|0|||
23326974|NCT02515331|64940788|FG002|Overall Study|Adverse Event|0|||
23326975|NCT03877068|64940794|FG000|Overall Study|Physician Decision|9|||
23326976|NCT03877068|64940795|FG001|Overall Study|Physician Decision|3|||
23326977|NCT00840749|64940796|FG000|Overall Study|Death|1|||
23326978|NCT00840749|64940797|FG001|Overall Study|Death|2|||
23326979|NCT00840749|64940796|FG000|Overall Study|not treated on study arm|11|||
23326980|NCT00840749|64940797|FG001|Overall Study|not treated on study arm|11|||
23326981|NCT00840749|64940796|FG000|Overall Study|study closed|19|||
23326982|NCT00840749|64940797|FG001|Overall Study|study closed|14|||
23326983|NCT01052480|64940798|FG000|Overall Study|Lost to Follow-up|3|||
23326984|NCT01052480|64940799|FG001|Overall Study|Lost to Follow-up|3|||
23326985|NCT01052480|64940798|FG000|Overall Study|Protocol Violation|1|||
23326986|NCT01052480|64940799|FG001|Overall Study|Protocol Violation|0|||
23326987|NCT01052480|64940798|FG000|Overall Study|Withdrawal by Subject|3|||
23326988|NCT01052480|64940799|FG001|Overall Study|Withdrawal by Subject|7|||
23326989|NCT01052480|64940798|FG000|Overall Study|Physician Decision|0|||
23326990|NCT01052480|64940799|FG001|Overall Study|Physician Decision|2|||
23326991|NCT01052480|64940798|FG000|Overall Study|Death|1|||
23326992|NCT01052480|64940799|FG001|Overall Study|Death|5|||
23326993|NCT02640482|64940801|FG000|Overall Study|Lost to Follow-up|3|||
23326994|NCT02640482|64940802|FG001|Overall Study|Lost to Follow-up|0|||
23326995|NCT03194542|64940803|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
23326996|NCT03194542|64940804|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
23326997|NCT03194542|64940805|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
23326998|NCT03194542|64940806|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
23326999|NCT03194542|64940803|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
23327000|NCT03194542|64940804|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
23327001|NCT03194542|64940805|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
23327002|NCT03194542|64940806|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
23327003|NCT03194542|64940803|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
23327004|NCT03194542|64940804|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
23327005|NCT03194542|64940805|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
23441526|NCT01067144|65358537|FG001|Treatment|Did not receive allocated intervention|7|||
23441527|NCT01067144|65358536|FG000|Follow-up|Lost to Follow-up|22|||
23441528|NCT01067144|65358537|FG001|Follow-up|Lost to Follow-up|12|||
23220849|NCT04134728|64550232|FG000|Overall Study|Lost to Follow-up|1|||
23220850|NCT04134728|64550233|FG001|Overall Study|Lost to Follow-up|2|||
23220851|NCT04134728|64550234|FG002|Overall Study|Lost to Follow-up|1|||
23220852|NCT04134728|64550235|FG003|Overall Study|Lost to Follow-up|0|||
23220853|NCT04134728|64550236|FG004|Overall Study|Lost to Follow-up|0|||
23327006|NCT03194542|64940806|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
23327007|NCT03194542|64940803|FG000|Overall Study|Loss of Response|4|||
23327008|NCT03194542|64940804|FG001|Overall Study|Loss of Response|2|||
23327009|NCT03194542|64940805|FG002|Overall Study|Loss of Response|3|||
23327010|NCT03194542|64940806|FG003|Overall Study|Loss of Response|4|||
23564862|NCT01872910|65796560|FG005|Overall Study|Lost to Follow-up|0|||
23220854|NCT04134728|64550237|FG005|Overall Study|Lost to Follow-up|1|||
23327011|NCT03194542|64940803|FG000|Overall Study|Physician Decision|0|||
23327012|NCT03194542|64940804|FG001|Overall Study|Physician Decision|1|||
23327013|NCT03194542|64940805|FG002|Overall Study|Physician Decision|0|||
23327014|NCT03194542|64940806|FG003|Overall Study|Physician Decision|0|||
23327015|NCT03194542|64940803|FG000|Overall Study|Lack of Efficacy|2|||
23327016|NCT03194542|64940804|FG001|Overall Study|Lack of Efficacy|2|||
23327017|NCT03194542|64940805|FG002|Overall Study|Lack of Efficacy|2|||
23327018|NCT03194542|64940806|FG003|Overall Study|Lack of Efficacy|6|||
23327019|NCT03194542|64940803|FG000|Overall Study|Withdrawal by Subject|2|||
23327020|NCT03194542|64940804|FG001|Overall Study|Withdrawal by Subject|1|||
23626920|NCT01466790|66020447|FG007|Overall Study|Withdrawal by Subject|1|||
23626921|NCT00381797|66020450|FG000|Overall Study|Withdrawal by Subject|1|||
23626922|NCT00381797|66020451|FG001|Overall Study|Withdrawal by Subject|1|||
23626923|NCT00381797|66020452|FG002|Overall Study|Withdrawal by Subject|0|||
23626924|NCT00381797|66020453|FG003|Overall Study|Withdrawal by Subject|0|||
23626925|NCT00381797|66020454|FG004|Overall Study|Withdrawal by Subject|2|||
23626926|NCT00381797|66020450|FG000|Overall Study|Ineligible|0|||
23626927|NCT00381797|66020451|FG001|Overall Study|Ineligible|0|||
23327021|NCT03194542|64940805|FG002|Overall Study|Withdrawal by Subject|5|||
23327022|NCT03194542|64940806|FG003|Overall Study|Withdrawal by Subject|4|||
23327023|NCT03194542|64940803|FG000|Overall Study|Progressive Disease|1|||
23327024|NCT03194542|64940804|FG001|Overall Study|Progressive Disease|0|||
23327025|NCT03194542|64940805|FG002|Overall Study|Progressive Disease|1|||
23327026|NCT03194542|64940806|FG003|Overall Study|Progressive Disease|1|||
23327027|NCT03194542|64940803|FG000|Overall Study|Adverse Event|1|||
23327028|NCT03194542|64940804|FG001|Overall Study|Adverse Event|2|||
23327029|NCT03194542|64940805|FG002|Overall Study|Adverse Event|0|||
23327030|NCT03194542|64940806|FG003|Overall Study|Adverse Event|5|||
23327031|NCT03194542|64940803|FG000|Overall Study|Death|1|||
23327032|NCT03194542|64940804|FG001|Overall Study|Death|2|||
23327033|NCT03194542|64940805|FG002|Overall Study|Death|0|||
23327034|NCT03194542|64940806|FG003|Overall Study|Death|5|||
23327035|NCT03194542|64940803|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
23327036|NCT03194542|64940804|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
23327037|NCT03194542|64940805|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
23327038|NCT03194542|64940806|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
23327039|NCT00897715|64940807|FG000|Overall Study|Lost to Follow-up|0|||
23327040|NCT00897715|64940808|FG001|Overall Study|Lost to Follow-up|1|||
23327041|NCT00897715|64940807|FG000|Overall Study|Physician Decision|1|||
23327042|NCT00897715|64940808|FG001|Overall Study|Physician Decision|0|||
23564863|NCT03749447|65796567|FG000|Overall Study|Adverse Event|11|||
23564864|NCT03749447|65796568|FG001|Overall Study|Adverse Event|3|||
23564865|NCT03749447|65796567|FG000|Overall Study|Death|1|||
23564866|NCT03749447|65796568|FG001|Overall Study|Death|1|||
23327043|NCT00897715|64940807|FG000|Overall Study|increased risk of infection|1|||
23327044|NCT00897715|64940808|FG001|Overall Study|increased risk of infection|0|||
23327045|NCT03214224|64940810|FG000|Overall Study|Protocol Violation|1|||
23564867|NCT03749447|65796567|FG000|Overall Study|Lost to Follow-up|2|||
23564868|NCT03749447|65796568|FG001|Overall Study|Lost to Follow-up|2|||
23564869|NCT03749447|65796567|FG000|Overall Study|Reason Not Specified|0|||
23564870|NCT03749447|65796568|FG001|Overall Study|Reason Not Specified|3|||
23564871|NCT03749447|65796567|FG000|Overall Study|Physician Decision|4|||
23564872|NCT03749447|65796568|FG001|Overall Study|Physician Decision|3|||
23564873|NCT03749447|65796567|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
23564874|NCT03749447|65796568|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
23564875|NCT03749447|65796567|FG000|Overall Study|Study Terminated By Sponsor|112|||
23564876|NCT03749447|65796568|FG001|Overall Study|Study Terminated By Sponsor|105|||
23564877|NCT03749447|65796567|FG000|Overall Study|Withdrawal by Subject|12|||
23564878|NCT03749447|65796568|FG001|Overall Study|Withdrawal by Subject|6|||
23564879|NCT03749447|65796567|FG000|Overall Study|Non-compliance With Study Drug|0|||
23564880|NCT03749447|65796568|FG001|Overall Study|Non-compliance With Study Drug|1|||
23564881|NCT02667886|65796569|FG000|Dose Escalation (Part A)|Adverse Event|1|||
23626928|NCT00381797|66020452|FG002|Overall Study|Ineligible|0|||
23626929|NCT00381797|66020453|FG003|Overall Study|Ineligible|1|||
23626930|NCT00381797|66020454|FG004|Overall Study|Ineligible|0|||
23626931|NCT00755417|66020459|FG000|Overall Study|Adverse Event|28|||
23327046|NCT03214224|64940810|FG000|Overall Study|Withdrawal by Subject|2|||
23327047|NCT03214224|64940810|FG000|Overall Study|Practice controls or therapists|6|||
23327048|NCT02058069|64940811|FG000|Overall Study|Exclusion due to implant size|5|||
23327049|NCT02058069|64940811|FG000|Overall Study|Withdrawal by Subject|6|||
23564882|NCT02667886|65796570|FG001|Dose Escalation (Part A)|Adverse Event|3|||
23564883|NCT02667886|65796571|FG002|Dose Escalation (Part A)|Adverse Event|1|||
23564884|NCT02667886|65796572|FG003|Dose Escalation (Part A)|Adverse Event|0|||
23327050|NCT01836471|64940814|FG000|Overall Study|Pregnancy|1|||
23626932|NCT00755417|66020460|FG001|Overall Study|Adverse Event|20|||
23626933|NCT00755417|66020461|FG002|Overall Study|Adverse Event|7|||
23626934|NCT00755417|66020459|FG000|Overall Study|Lack of Efficacy|8|||
23327051|NCT01836471|64940815|FG001|Overall Study|Pregnancy|0|||
23327052|NCT01836471|64940816|FG002|Overall Study|Pregnancy|0|||
23153586|NCT00436618|64312761|FG002|Overall Study|Withdrawal by Subject|11|||
23220855|NCT04134728|64550232|FG000|Overall Study|Investigator Site Closed|0|||
23220856|NCT04134728|64550233|FG001|Overall Study|Investigator Site Closed|1|||
23220857|NCT04134728|64550234|FG002|Overall Study|Investigator Site Closed|1|||
23564885|NCT02667886|65796573|FG004|Dose Escalation (Part A)|Adverse Event|0|||
23564886|NCT02667886|65796569|FG000|Dose Escalation (Part A)|Disease Progression|1|||
23564887|NCT02667886|65796570|FG001|Dose Escalation (Part A)|Disease Progression|4|||
23564888|NCT02667886|65796571|FG002|Dose Escalation (Part A)|Disease Progression|3|||
23564889|NCT02667886|65796572|FG003|Dose Escalation (Part A)|Disease Progression|0|||
23564890|NCT02667886|65796573|FG004|Dose Escalation (Part A)|Disease Progression|0|||
23153587|NCT00436618|64312759|FG000|Overall Study|Adverse Event|8|||
23153588|NCT00436618|64312760|FG001|Overall Study|Adverse Event|8|||
23153589|NCT00436618|64312761|FG002|Overall Study|Adverse Event|9|||
23153590|NCT00436618|64312759|FG000|Overall Study|Alternate Treatment|3|||
23153591|NCT00436618|64312760|FG001|Overall Study|Alternate Treatment|4|||
23153592|NCT00436618|64312761|FG002|Overall Study|Alternate Treatment|12|||
23153593|NCT00436618|64312759|FG000|Overall Study|Other Medical Problems|3|||
23153594|NCT00436618|64312760|FG001|Overall Study|Other Medical Problems|1|||
23153595|NCT00436618|64312761|FG002|Overall Study|Other Medical Problems|7|||
23153596|NCT00436618|64312759|FG000|Overall Study|Death|4|||
23153597|NCT00436618|64312760|FG001|Overall Study|Death|2|||
23153598|NCT00436618|64312761|FG002|Overall Study|Death|3|||
23153599|NCT00436618|64312759|FG000|Overall Study|New Primary or Other Reasons|6|||
23153600|NCT00436618|64312760|FG001|Overall Study|New Primary or Other Reasons|2|||
23153601|NCT00436618|64312761|FG002|Overall Study|New Primary or Other Reasons|12|||
23153602|NCT00436618|64312759|FG000|Overall Study|Still on treatment|1|||
23153603|NCT00436618|64312760|FG001|Overall Study|Still on treatment|2|||
23153604|NCT00436618|64312761|FG002|Overall Study|Still on treatment|7|||
23153605|NCT03842163|64312762|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
23153606|NCT03842163|64312762|FG000|Overall Study|Scintigraphy was not performed|44|||
23153607|NCT01093625|64312763|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
23153608|NCT01093625|64312764|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
23153609|NCT01093625|64312763|FG000|2-Week Visit|Withdrawal by Subject|1|||
23153610|NCT01093625|64312764|FG001|2-Week Visit|Withdrawal by Subject|0|||
23153611|NCT01093625|64312763|FG000|1-Month Visit|Lost to Follow-up|2|||
23153612|NCT01093625|64312764|FG001|1-Month Visit|Lost to Follow-up|0|||
23153613|NCT01093625|64312763|FG000|3-Month Visit|Lost to Follow-up|2|||
23153614|NCT01093625|64312764|FG001|3-Month Visit|Lost to Follow-up|0|||
23153615|NCT01093625|64312763|FG000|6-Month Visit|Withdrawal by Subject|6|||
23153616|NCT01093625|64312764|FG001|6-Month Visit|Withdrawal by Subject|7|||
23153617|NCT01093625|64312763|FG000|6-Month Visit|Lost to Follow-up|2|||
23153618|NCT01093625|64312764|FG001|6-Month Visit|Lost to Follow-up|2|||
23153619|NCT01093625|64312763|FG000|1-Year Visit|Lost to Follow-up|5|||
23153620|NCT01093625|64312764|FG001|1-Year Visit|Lost to Follow-up|3|||
23153621|NCT00381563|64312767|FG000|Overall Study|Withdrawal by Subject|5|||
23153622|NCT00381563|64312768|FG001|Overall Study|Withdrawal by Subject|5|||
23153623|NCT00381563|64312767|FG000|Overall Study|Lost to Follow-up|2|||
23153624|NCT00381563|64312768|FG001|Overall Study|Lost to Follow-up|0|||
23153625|NCT00381563|64312767|FG000|Overall Study|Protocol Violation|0|||
23153626|NCT00381563|64312768|FG001|Overall Study|Protocol Violation|1|||
23153627|NCT03713034|64315487|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
23153628|NCT03713034|64315488|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
23153629|NCT03583450|64315501|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
23220858|NCT04134728|64550235|FG003|Overall Study|Investigator Site Closed|0|||
23220859|NCT04134728|64550236|FG004|Overall Study|Investigator Site Closed|0|||
23220860|NCT04134728|64550237|FG005|Overall Study|Investigator Site Closed|0|||
23220861|NCT02007252|64550238|FG000|Overall Study|Administrative problems|3|||
23220862|NCT02007252|64550239|FG001|Overall Study|Administrative problems|7|||
23220863|NCT02007252|64550238|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23220864|NCT02007252|64550239|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23564891|NCT02667886|65796569|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
23564892|NCT02667886|65796570|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
23153630|NCT03583450|64315502|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
23153631|NCT00356889|64315503|FG000|Overall Study|Protocol Violation|2|||
23153632|NCT00356889|64315503|FG000|Overall Study|Adverse Event|1|||
23153633|NCT00574145|64315504|FG000|Overall Study|Withdrawal by Subject|2|||
23153634|NCT00574145|64315505|FG001|Overall Study|Withdrawal by Subject|1|||
23153635|NCT01576172|64315506|FG000|Overall Study|Ineligible|2|||
23153636|NCT01576172|64315507|FG001|Overall Study|Ineligible|1|||
23220865|NCT02007252|64550238|FG000|Overall Study|Adverse Event|7|||
23564893|NCT02667886|65796571|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
23564894|NCT02667886|65796572|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
23153637|NCT01576172|64315506|FG000|Overall Study|Withdrawal by Subject|2|||
23153638|NCT01576172|64315507|FG001|Overall Study|Withdrawal by Subject|0|||
23153639|NCT01576172|64315506|FG000|Overall Study|Insurance issue|1|||
23153640|NCT01576172|64315507|FG001|Overall Study|Insurance issue|0|||
23153641|NCT02170779|64315508|FG000|Overall Study|Withdrawal by Subject|1|||
23153642|NCT02170779|64315509|FG001|Overall Study|Withdrawal by Subject|0|||
23153643|NCT02170779|64315508|FG000|Overall Study|Lost to Follow-up|0|||
23153644|NCT02170779|64315509|FG001|Overall Study|Lost to Follow-up|1|||
23153645|NCT01265615|64315510|FG000|Overall Study|Protocol Violation|2|||
23153646|NCT01265615|64315511|FG001|Overall Study|Protocol Violation|2|||
23153647|NCT01265615|64315512|FG002|Overall Study|Protocol Violation|4|||
23153648|NCT01265615|64315513|FG003|Overall Study|Protocol Violation|3|||
23153649|NCT00702325|64315514|FG000|Overall Study|Adverse Event|1|||
23153650|NCT00702325|64315515|FG001|Overall Study|Adverse Event|0|||
23153651|NCT00702325|64315514|FG000|Overall Study|Withdrawal by Subject|7|||
23153652|NCT00702325|64315515|FG001|Overall Study|Withdrawal by Subject|7|||
23153653|NCT00702325|64315514|FG000|Overall Study|Lost to Follow-up|3|||
23153654|NCT00702325|64315515|FG001|Overall Study|Lost to Follow-up|4|||
23153655|NCT00702325|64315514|FG000|Overall Study|Incorrect enrollment|5|||
23153656|NCT00702325|64315515|FG001|Overall Study|Incorrect enrollment|7|||
23153657|NCT00702325|64315514|FG000|Overall Study|Developed study discontinuation criteria|18|||
23153658|NCT00702325|64315515|FG001|Overall Study|Developed study discontinuation criteria|28|||
23153659|NCT00702325|64315514|FG000|Overall Study|Severe noncompliance to protocol|3|||
23153660|NCT00702325|64315515|FG001|Overall Study|Severe noncompliance to protocol|3|||
23153661|NCT00702325|64315514|FG000|Overall Study|Termination due to lab results|1|||
23153662|NCT00702325|64315515|FG001|Overall Study|Termination due to lab results|0|||
23153663|NCT00702325|64315514|FG000|Overall Study|Didn't follow study medication dosage|0|||
23153664|NCT00702325|64315515|FG001|Overall Study|Didn't follow study medication dosage|2|||
23153665|NCT00702325|64315514|FG000|Overall Study|Withdrew consent|0|||
23153666|NCT00702325|64315515|FG001|Overall Study|Withdrew consent|1|||
23153667|NCT00702325|64315514|FG000|Overall Study|Incorrectly Discontinued|0|||
23153668|NCT00702325|64315515|FG001|Overall Study|Incorrectly Discontinued|1|||
23153669|NCT00078325|64315519|FG000|Overall Study|Adverse Event|15|||
23153670|NCT00078325|64315520|FG001|Overall Study|Adverse Event|10|||
23153671|NCT00078325|64315521|FG002|Overall Study|Adverse Event|5|||
23153672|NCT00078325|64315519|FG000|Overall Study|Protocol Violation|2|||
23153673|NCT00078325|64315520|FG001|Overall Study|Protocol Violation|2|||
23153674|NCT00078325|64315521|FG002|Overall Study|Protocol Violation|0|||
23153675|NCT00078325|64315519|FG000|Overall Study|Withdrawal by Subject|1|||
23153676|NCT00078325|64315520|FG001|Overall Study|Withdrawal by Subject|5|||
23153677|NCT00078325|64315521|FG002|Overall Study|Withdrawal by Subject|3|||
23153678|NCT00078325|64315519|FG000|Overall Study|Lost to Follow-up|0|||
23153679|NCT00078325|64315520|FG001|Overall Study|Lost to Follow-up|1|||
23153680|NCT00078325|64315521|FG002|Overall Study|Lost to Follow-up|1|||
23153681|NCT00078325|64315519|FG000|Overall Study|Physician Decision|2|||
23153682|NCT00078325|64315520|FG001|Overall Study|Physician Decision|0|||
23153683|NCT00078325|64315521|FG002|Overall Study|Physician Decision|1|||
23153684|NCT00078325|64315519|FG000|Overall Study|Miscellaneous|1|||
23153685|NCT00078325|64315520|FG001|Overall Study|Miscellaneous|1|||
23153686|NCT00078325|64315521|FG002|Overall Study|Miscellaneous|1|||
23441529|NCT01067144|65358536|FG000|Follow-up|Censored owing to second surgery|19|||
23441530|NCT01067144|65358537|FG001|Follow-up|Censored owing to second surgery|28|||
23153687|NCT00239226|64315523|FG000|Overall Study|permAF during stabilization period|0|||
23153688|NCT00239226|64315524|FG001|Overall Study|permAF during stabilization period|0|||
23153689|NCT00239226|64315525|FG002|Overall Study|permAF during stabilization period|0|||
23153690|NCT00239226|64315526|FG003|Overall Study|permAF during stabilization period|3|||
23153691|NCT00239226|64315523|FG000|Overall Study|Lost to Follow-up|1|||
23153692|NCT00239226|64315524|FG001|Overall Study|Lost to Follow-up|0|||
23153693|NCT00239226|64315525|FG002|Overall Study|Lost to Follow-up|1|||
23153694|NCT00239226|64315526|FG003|Overall Study|Lost to Follow-up|0|||
23327053|NCT01836471|64940817|FG003|Overall Study|Pregnancy|0|||
23327054|NCT01836471|64940818|FG004|Overall Study|Pregnancy|0|||
23327055|NCT01836471|64940814|FG000|Overall Study|Withdrawal by Subject|3|||
23327056|NCT01836471|64940815|FG001|Overall Study|Withdrawal by Subject|4|||
23327057|NCT01836471|64940816|FG002|Overall Study|Withdrawal by Subject|1|||
23153695|NCT00922480|64315527|FG000|Main Study|Protocol Violation|3|||
23153696|NCT00922480|64315528|FG001|Main Study|Protocol Violation|6|||
23153697|NCT00922480|64315527|FG000|Main Study|Adverse Event|6|||
23153698|NCT00922480|64315528|FG001|Main Study|Adverse Event|7|||
23327058|NCT01836471|64940817|FG003|Overall Study|Withdrawal by Subject|0|||
23327059|NCT01836471|64940818|FG004|Overall Study|Withdrawal by Subject|2|||
23327060|NCT01836471|64940814|FG000|Overall Study|Physician Decision|0|||
23153699|NCT00922480|64315527|FG000|Main Study|Lack of Efficacy|3|||
23153700|NCT00922480|64315528|FG001|Main Study|Lack of Efficacy|0|||
23153701|NCT00922480|64315527|FG000|Main Study|Withdrawal by Subject|20|||
23153702|NCT00922480|64315528|FG001|Main Study|Withdrawal by Subject|15|||
23327061|NCT01836471|64940815|FG001|Overall Study|Physician Decision|1|||
23327062|NCT01836471|64940816|FG002|Overall Study|Physician Decision|0|||
23153703|NCT00922480|64315527|FG000|Main Study|Lost to Follow-up|5|||
23327063|NCT01836471|64940817|FG003|Overall Study|Physician Decision|0|||
23327064|NCT01836471|64940818|FG004|Overall Study|Physician Decision|0|||
23327065|NCT01836471|64940814|FG000|Overall Study|Lost to Follow-up|0|||
23153704|NCT00922480|64315528|FG001|Main Study|Lost to Follow-up|0|||
23153705|NCT00922480|64315527|FG000|Main Study|Physician Decision|0|||
23153706|NCT00922480|64315528|FG001|Main Study|Physician Decision|1|||
23153707|NCT00922480|64315527|FG000|Extension Study|Protocol Violation|3|||
23153708|NCT00922480|64315528|FG001|Extension Study|Protocol Violation|0|||
23153709|NCT00922480|64315527|FG000|Extension Study|Adverse Event|1|||
23153710|NCT00922480|64315528|FG001|Extension Study|Adverse Event|1|||
23153711|NCT00922480|64315527|FG000|Extension Study|Withdrawal by Subject|1|||
23153712|NCT00922480|64315528|FG001|Extension Study|Withdrawal by Subject|1|||
23153713|NCT00922480|64315527|FG000|Extension Study|Others|0|||
23153714|NCT00922480|64315528|FG001|Extension Study|Others|1|||
23153715|NCT01484977|64315529|FG000|Overall Study|Adverse Event|8|||
23153716|NCT01484977|64315529|FG000|Overall Study|Lack of Efficacy|4|||
23153717|NCT01484977|64315529|FG000|Overall Study|Protocol Violation|6|||
23153718|NCT01484977|64315529|FG000|Overall Study|Lost to Follow-up|1|||
23153719|NCT01484977|64315529|FG000|Overall Study|Withdrawal by Subject|4|||
23153720|NCT01484977|64315529|FG000|Overall Study|Subject Protocol Non-compliant|1|||
23153721|NCT01484977|64315529|FG000|Overall Study|Moving Overseas|1|||
23153722|NCT01484977|64315529|FG000|Overall Study|Low White Blood Cell Count|1|||
23153723|NCT01484977|64315529|FG000|Overall Study|Lack of Compliance|1|||
23153724|NCT02243865|64315532|FG000|Overall Study|Protocol Violation|1|||
23153725|NCT02243865|64315533|FG001|Overall Study|Protocol Violation|3|||
23153726|NCT02243865|64315532|FG000|Overall Study|Lost to Follow-up|1|||
23153727|NCT02243865|64315533|FG001|Overall Study|Lost to Follow-up|1|||
23327066|NCT01836471|64940815|FG001|Overall Study|Lost to Follow-up|0|||
23327067|NCT01836471|64940816|FG002|Overall Study|Lost to Follow-up|0|||
23327068|NCT01836471|64940817|FG003|Overall Study|Lost to Follow-up|1|||
23327069|NCT01836471|64940818|FG004|Overall Study|Lost to Follow-up|1|||
23327070|NCT01836471|64940814|FG000|Overall Study|Adverse Event|6|||
23327071|NCT01836471|64940815|FG001|Overall Study|Adverse Event|3|||
23441531|NCT01067144|65358536|FG000|Follow-up|Withdrawal by Subject|18|||
23441532|NCT01067144|65358537|FG001|Follow-up|Withdrawal by Subject|14|||
23441533|NCT01067144|65358536|FG000|Follow-up|Surgery cancelled|0|||
23153728|NCT02243865|64315532|FG000|Overall Study|Withdrawal by Subject|1|||
23153729|NCT02243865|64315533|FG001|Overall Study|Withdrawal by Subject|0|||
23153730|NCT02243865|64315532|FG000|Overall Study|Adverse Event|1|||
23153731|NCT02243865|64315533|FG001|Overall Study|Adverse Event|1|||
23153732|NCT02357134|64315538|FG000|Overall Study|Lost to Follow-up|1|||
23153733|NCT02357134|64315539|FG001|Overall Study|Lost to Follow-up|0|||
23441534|NCT01067144|65358537|FG001|Follow-up|Surgery cancelled|1|||
23441535|NCT01067144|65358536|FG000|Follow-up|Death|0|||
23441536|NCT01067144|65358537|FG001|Follow-up|Death|1|||
23441537|NCT03543137|65358538|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
23441538|NCT03543137|65358539|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
23441539|NCT03543137|65358538|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
23441540|NCT03543137|65358539|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
23441541|NCT03543137|65358538|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
23441542|NCT03543137|65358539|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
23441543|NCT01450098|65358544|FG000|Period 3|Protocol Violation|0|||
23441544|NCT01450098|65358545|FG001|Period 3|Protocol Violation|1|||
23441545|NCT01450098|65358544|FG000|Period 3|Withdrawal by Subject|0|||
23441546|NCT01450098|65358545|FG001|Period 3|Withdrawal by Subject|2|||
23441547|NCT00930930|65358546|FG000|Overall Study|Death|1|||
23441548|NCT00930930|65358547|FG001|Overall Study|Death|0|||
23441549|NCT00930930|65358546|FG000|Overall Study|Physician Decision|1|||
23153734|NCT02357134|64315540|FG002|Overall Study|Lost to Follow-up|0|||
23153735|NCT02357134|64315541|FG003|Overall Study|Lost to Follow-up|0|||
23153736|NCT01514136|64315542|FG000|Test Period 1; Test A|Protocol Violation|1|||
23153737|NCT01514136|64315543|FG001|Test Period 1; Test A|Protocol Violation|0|||
23327072|NCT01836471|64940816|FG002|Overall Study|Adverse Event|1|||
23327073|NCT01836471|64940817|FG003|Overall Study|Adverse Event|1|||
23327074|NCT01836471|64940818|FG004|Overall Study|Adverse Event|2|||
23327075|NCT01836471|64940814|FG000|Overall Study|Non compliance with tx|1|||
23441550|NCT00930930|65358547|FG001|Overall Study|Physician Decision|0|||
23441551|NCT00930930|65358546|FG000|Overall Study|Adverse Event|13|||
23441552|NCT00930930|65358547|FG001|Overall Study|Adverse Event|3|||
23441553|NCT00930930|65358546|FG000|Overall Study|Withdrawal by Subject|3|||
23153738|NCT01514136|64315544|FG002|Test Period 1; Test A|Protocol Violation|0|||
23153739|NCT01514136|64315545|FG003|Test Period 1; Test A|Protocol Violation|0|||
23153740|NCT01514136|64315546|FG004|Test Period 1; Test A|Protocol Violation|0|||
23153741|NCT01514136|64315547|FG005|Test Period 1; Test A|Protocol Violation|0|||
23441554|NCT00930930|65358547|FG001|Overall Study|Withdrawal by Subject|1|||
23441555|NCT00930930|65358546|FG000|Overall Study|Disease progression|2|||
23564895|NCT02667886|65796573|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
23153742|NCT01514136|64315548|FG006|Test Period 1; Test A|Protocol Violation|0|||
23327076|NCT01836471|64940815|FG001|Overall Study|Non compliance with tx|1|||
23153743|NCT01514136|64315549|FG007|Test Period 1; Test A|Protocol Violation|0|||
23153744|NCT01514136|64315542|FG000|Test Period 1; Test A|Break from study holiday|2|||
23153745|NCT01514136|64315543|FG001|Test Period 1; Test A|Break from study holiday|0|||
23153746|NCT01514136|64315544|FG002|Test Period 1; Test A|Break from study holiday|0|||
23153747|NCT01514136|64315545|FG003|Test Period 1; Test A|Break from study holiday|0|||
23153748|NCT01514136|64315546|FG004|Test Period 1; Test A|Break from study holiday|0|||
23153749|NCT01514136|64315547|FG005|Test Period 1; Test A|Break from study holiday|0|||
23153750|NCT01514136|64315548|FG006|Test Period 1; Test A|Break from study holiday|0|||
23153751|NCT01514136|64315549|FG007|Test Period 1; Test A|Break from study holiday|0|||
23153752|NCT01514136|64315542|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
23153753|NCT01514136|64315543|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
23441556|NCT00930930|65358547|FG001|Overall Study|Disease progression|3|||
23441557|NCT00930930|65358546|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
23441558|NCT00930930|65358547|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
23441559|NCT00930930|65358546|FG000|Overall Study|patients not compliant|1|||
23441560|NCT00930930|65358547|FG001|Overall Study|patients not compliant|1|||
23441561|NCT00003199|65358551|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
23441562|NCT00003199|65358551|FG000|Overall Study|Lack of insurance clearance|2|||
23441563|NCT00003199|65358551|FG000|Overall Study|Screen fail|15|||
23441564|NCT01055314|65358552|FG000|Overall Study|Adverse Event|7|||
23441565|NCT01055314|65358553|FG001|Overall Study|Adverse Event|4|||
23153754|NCT01514136|64315544|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
23153755|NCT01514136|64315545|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
23441566|NCT01055314|65358552|FG000|Overall Study|Death|2|||
23441567|NCT01055314|65358553|FG001|Overall Study|Death|1|||
23441568|NCT01055314|65358552|FG000|Overall Study|Lack of Efficacy|11|||
23441569|NCT01055314|65358553|FG001|Overall Study|Lack of Efficacy|19|||
23441570|NCT01055314|65358552|FG000|Overall Study|Physician Decision|10|||
23441571|NCT01055314|65358553|FG001|Overall Study|Physician Decision|5|||
23441572|NCT01055314|65358552|FG000|Overall Study|Withdrawal by Subject|1|||
23441573|NCT01055314|65358553|FG001|Overall Study|Withdrawal by Subject|0|||
23441574|NCT01055314|65358552|FG000|Overall Study|Ineligible|3|||
23441575|NCT01055314|65358553|FG001|Overall Study|Ineligible|5|||
23441576|NCT01055314|65358552|FG000|Overall Study|Refusal of further protocol therapy|10|||
23441577|NCT01055314|65358553|FG001|Overall Study|Refusal of further protocol therapy|4|||
23441578|NCT01055314|65358552|FG000|Overall Study|No treatment|1|||
23441579|NCT01055314|65358553|FG001|Overall Study|No treatment|0|||
23441580|NCT00549445|65358558|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
23441581|NCT00549445|65358559|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
23441582|NCT00176462|65358566|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
23441583|NCT00176462|65358567|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
23441584|NCT00176462|65358566|FG000|Induction (4 Weeks)|Death|1|||
23441585|NCT00176462|65358567|FG001|Induction (4 Weeks)|Death|2|||
23441586|NCT00176462|65358566|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
23441587|NCT00176462|65358567|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
23441588|NCT00176462|65358566|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
23441589|NCT00176462|65358567|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
23441590|NCT00176462|65358566|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
23441591|NCT00176462|65358567|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
23441592|NCT00176462|65358566|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
23441593|NCT00176462|65358567|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
23441594|NCT00176462|65358566|FG000|Consolidation (12 Weeks)|Not documented|0|||
23441595|NCT00176462|65358567|FG001|Consolidation (12 Weeks)|Not documented|1|||
23441596|NCT00176462|65358566|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
23441597|NCT00176462|65358567|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
23441598|NCT00176462|65358566|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
23564896|NCT02667886|65796569|FG000|Dose Expansion (Part B)|Adverse Event|0|||
23153756|NCT01514136|64315546|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
23441599|NCT00176462|65358567|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
23441600|NCT00773747|65358574|FG000|Overall Study|Lack of Efficacy|112|||
23441601|NCT00773747|65358575|FG001|Overall Study|Lack of Efficacy|144|||
23441602|NCT00773747|65358574|FG000|Overall Study|Physician Decision|26|||
23564897|NCT02667886|65796570|FG001|Dose Expansion (Part B)|Adverse Event|0|||
23153757|NCT01514136|64315547|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
23153758|NCT01514136|64315548|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
23441603|NCT00773747|65358575|FG001|Overall Study|Physician Decision|18|||
23441604|NCT00773747|65358574|FG000|Overall Study|Lost to Follow-up|0|||
23564898|NCT02667886|65796571|FG002|Dose Expansion (Part B)|Adverse Event|0|||
23441605|NCT00773747|65358575|FG001|Overall Study|Lost to Follow-up|1|||
23441606|NCT00773747|65358574|FG000|Overall Study|Protocol Violation|2|||
23441607|NCT00773747|65358575|FG001|Overall Study|Protocol Violation|2|||
23441608|NCT00773747|65358574|FG000|Overall Study|Withdrawal by Subject|89|||
23441609|NCT00773747|65358575|FG001|Overall Study|Withdrawal by Subject|61|||
23441610|NCT00773747|65358574|FG000|Overall Study|Adverse Event|61|||
23441611|NCT00773747|65358575|FG001|Overall Study|Adverse Event|62|||
23441612|NCT00773747|65358574|FG000|Overall Study|Death|5|||
23441613|NCT00773747|65358575|FG001|Overall Study|Death|8|||
23441614|NCT00773747|65358574|FG000|Overall Study|Not Treated|2|||
23441615|NCT00773747|65358575|FG001|Overall Study|Not Treated|0|||
23441616|NCT04412707|65358576|FG000|Cycle 1|Death|0|||
23441617|NCT04412707|65358577|FG001|Cycle 1|Death|3|||
23441618|NCT04412707|65358576|FG000|Cycle 1|Disease progression|1|||
23441619|NCT04412707|65358577|FG001|Cycle 1|Disease progression|2|||
23441620|NCT04412707|65358576|FG000|Cycle 2|Death|0|||
23441621|NCT04412707|65358577|FG001|Cycle 2|Death|1|||
23441622|NCT04412707|65358576|FG000|Cycle 2|Disease progression|3|||
23441623|NCT04412707|65358577|FG001|Cycle 2|Disease progression|0|||
23441624|NCT04412707|65358576|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
23441625|NCT04412707|65358577|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
23441626|NCT04412707|65358576|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
23441627|NCT04412707|65358577|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
23153759|NCT01514136|64315549|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
23153760|NCT01514136|64315542|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
23153761|NCT01514136|64315543|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
23153762|NCT01514136|64315544|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
23327077|NCT01836471|64940816|FG002|Overall Study|Non compliance with tx|0|||
23327078|NCT01836471|64940817|FG003|Overall Study|Non compliance with tx|0|||
23327079|NCT01836471|64940818|FG004|Overall Study|Non compliance with tx|0|||
23153763|NCT01514136|64315545|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
23153764|NCT01514136|64315546|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
23153765|NCT01514136|64315547|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
23327080|NCT04830969|64940819|FG000|Overall Study|Withdrawal by Subject|6|||
23327081|NCT04830969|64940820|FG001|Overall Study|Withdrawal by Subject|2|||
23327082|NCT04830969|64940819|FG000|Overall Study|Protocol Violation|3|||
23327083|NCT04830969|64940820|FG001|Overall Study|Protocol Violation|9|||
23327084|NCT04830969|64940819|FG000|Overall Study|Lost to Follow-up|4|||
23327085|NCT04830969|64940820|FG001|Overall Study|Lost to Follow-up|4|||
23327086|NCT00395629|64940821|FG000|Core Study|Adverse Event|0|||
23327087|NCT00395629|64940822|FG001|Core Study|Adverse Event|3|||
23327088|NCT00395629|64940823|FG002|Core Study|Adverse Event|4|||
23327089|NCT00395629|64940821|FG000|Core Study|Abnormal laboratory value(s)|0|||
23327090|NCT00395629|64940822|FG001|Core Study|Abnormal laboratory value(s)|0|||
23327091|NCT00395629|64940823|FG002|Core Study|Abnormal laboratory value(s)|1|||
23327092|NCT00395629|64940821|FG000|Core Study|Protocol Violation|1|||
23327093|NCT00395629|64940822|FG001|Core Study|Protocol Violation|0|||
23327094|NCT00395629|64940823|FG002|Core Study|Protocol Violation|0|||
23327095|NCT00395629|64940821|FG000|Core Study|Withdrawal by Subject|0|||
23327096|NCT00395629|64940822|FG001|Core Study|Withdrawal by Subject|1|||
23327097|NCT00395629|64940823|FG002|Core Study|Withdrawal by Subject|1|||
23327098|NCT00395629|64940821|FG000|Core Study|Lost to Follow-up|0|||
23327099|NCT00395629|64940822|FG001|Core Study|Lost to Follow-up|0|||
23327100|NCT00395629|64940823|FG002|Core Study|Lost to Follow-up|1|||
23327101|NCT00395629|64940821|FG000|Extension Study|Adverse Event|0|||
23327102|NCT00395629|64940822|FG001|Extension Study|Adverse Event|0|||
23327103|NCT00395629|64940823|FG002|Extension Study|Adverse Event|2|||
23327104|NCT00395629|64940821|FG000|Extension Study|Administrative problems|0|||
23564899|NCT02667886|65796572|FG003|Dose Expansion (Part B)|Adverse Event|9|||
23153766|NCT01514136|64315548|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
23153767|NCT01514136|64315549|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
23153768|NCT01514136|64315542|FG000|Test Period 2; Test A*|Adverse Event|0|||
23153769|NCT01514136|64315543|FG001|Test Period 2; Test A*|Adverse Event|0|||
23153770|NCT01514136|64315544|FG002|Test Period 2; Test A*|Adverse Event|0|||
23153771|NCT01514136|64315545|FG003|Test Period 2; Test A*|Adverse Event|0|||
23153772|NCT01514136|64315546|FG004|Test Period 2; Test A*|Adverse Event|1|||
23153773|NCT01514136|64315547|FG005|Test Period 2; Test A*|Adverse Event|0|||
23153774|NCT01514136|64315548|FG006|Test Period 2; Test A*|Adverse Event|0|||
23153775|NCT01514136|64315549|FG007|Test Period 2; Test A*|Adverse Event|0|||
23327105|NCT00395629|64940822|FG001|Extension Study|Administrative problems|0|||
23327106|NCT00395629|64940823|FG002|Extension Study|Administrative problems|1|||
23441628|NCT04412707|65358576|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
23441629|NCT04412707|65358577|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
23564900|NCT02667886|65796573|FG004|Dose Expansion (Part B)|Adverse Event|0|||
23564901|NCT02667886|65796569|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
23153776|NCT01514136|64315542|FG000|Test Period 2; Test A*|Holiday|0|||
23153777|NCT01514136|64315543|FG001|Test Period 2; Test A*|Holiday|0|||
23327107|NCT04011722|64940824|FG000|30 Days|Death|5|||
23327108|NCT04011722|64940825|FG001|30 Days|Death|1|||
23327109|NCT04011722|64940824|FG000|1 Year|Death|13|||
23327110|NCT04011722|64940825|FG001|1 Year|Death|5|||
23327111|NCT04011722|64940824|FG000|1 Year|Withdrawal by Subject|8|||
23327112|NCT04011722|64940825|FG001|1 Year|Withdrawal by Subject|2|||
23441630|NCT04412707|65358576|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
23441631|NCT04412707|65358577|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
23441632|NCT01835223|65358579|FG000|Overall Study|Adverse Event|1|||
23441633|NCT01835223|65358580|FG001|Overall Study|Adverse Event|0|||
23441634|NCT01835223|65358579|FG000|Overall Study|Withdrawal by Subject|2|||
23441635|NCT01835223|65358580|FG001|Overall Study|Withdrawal by Subject|0|||
23441636|NCT01835223|65358579|FG000|Overall Study|Disease progression|2|||
23441637|NCT01835223|65358580|FG001|Overall Study|Disease progression|1|||
23441638|NCT01835223|65358579|FG000|Overall Study|Became Inelligible|4|||
23441639|NCT01835223|65358580|FG001|Overall Study|Became Inelligible|0|||
23441640|NCT02969356|65358581|FG000|Overall Study|Adverse Event|7|||
23441641|NCT02969356|65358581|FG000|Overall Study|Consent withdrawn|2|||
23441642|NCT02969356|65358581|FG000|Overall Study|Lost to Follow-up|3|||
23441643|NCT02969356|65358581|FG000|Overall Study|Did not need to be reinjected|6|||
23441644|NCT02969356|65358581|FG000|Overall Study|Personal reasons|5|||
23441645|NCT01361178|65358585|FG000|Overall Study|Death|13|||
23441646|NCT01361178|65358586|FG001|Overall Study|Death|0|||
23441647|NCT00720343|65358587|FG000|Overall Study|Lost to Follow-up|1|||
23441648|NCT00720343|65358588|FG001|Overall Study|Lost to Follow-up|0|||
23441649|NCT00720343|65358587|FG000|Overall Study|Protocol Violation|0|||
23441650|NCT00720343|65358588|FG001|Overall Study|Protocol Violation|2|||
23327113|NCT04011722|64940824|FG000|1 Year|Missed Visit|6|||
23327114|NCT04011722|64940825|FG001|1 Year|Missed Visit|1|||
23327115|NCT04011722|64940824|FG000|1 Year|Pending Visit|0|||
23327116|NCT04011722|64940825|FG001|1 Year|Pending Visit|11|||
23327117|NCT04011722|64940824|FG000|1 Year|Not Yet Due|0|||
23327118|NCT04011722|64940825|FG001|1 Year|Not Yet Due|9|||
23441651|NCT01610336|65358589|FG000|Overall Study|Progressive Disease|4|||
23441652|NCT01610336|65358590|FG001|Overall Study|Progressive Disease|6|||
23441653|NCT01610336|65358591|FG002|Overall Study|Progressive Disease|6|||
23441654|NCT01610336|65358592|FG003|Overall Study|Progressive Disease|5|||
23441655|NCT01610336|65358593|FG004|Overall Study|Progressive Disease|3|||
23441656|NCT01610336|65358594|FG005|Overall Study|Progressive Disease|10|||
23441657|NCT01610336|65358595|FG006|Overall Study|Progressive Disease|1|||
23441658|NCT01610336|65358596|FG007|Overall Study|Progressive Disease|6|||
23441659|NCT01610336|65358597|FG008|Overall Study|Progressive Disease|6|||
23441660|NCT01610336|65358598|FG009|Overall Study|Progressive Disease|40|||
23441661|NCT01610336|65358599|FG010|Overall Study|Progressive Disease|36|||
23441662|NCT01610336|65358589|FG000|Overall Study|Adverse Event|0|||
23441663|NCT01610336|65358590|FG001|Overall Study|Adverse Event|0|||
23441664|NCT01610336|65358591|FG002|Overall Study|Adverse Event|0|||
23441665|NCT01610336|65358592|FG003|Overall Study|Adverse Event|1|||
23441666|NCT01610336|65358593|FG004|Overall Study|Adverse Event|1|||
23441667|NCT01610336|65358594|FG005|Overall Study|Adverse Event|1|||
23441668|NCT01610336|65358595|FG006|Overall Study|Adverse Event|0|||
23441669|NCT01610336|65358596|FG007|Overall Study|Adverse Event|0|||
23441670|NCT01610336|65358597|FG008|Overall Study|Adverse Event|2|||
23441671|NCT01610336|65358598|FG009|Overall Study|Adverse Event|8|||
23441672|NCT01610336|65358599|FG010|Overall Study|Adverse Event|6|||
23441673|NCT01610336|65358589|FG000|Overall Study|Subject/Guardian decision|1|||
23441674|NCT01610336|65358590|FG001|Overall Study|Subject/Guardian decision|1|||
23441675|NCT01610336|65358591|FG002|Overall Study|Subject/Guardian decision|0|||
23626935|NCT00755417|66020460|FG001|Overall Study|Lack of Efficacy|4|||
23153778|NCT01514136|64315544|FG002|Test Period 2; Test A*|Holiday|0|||
23153779|NCT01514136|64315545|FG003|Test Period 2; Test A*|Holiday|0|||
23327119|NCT04011722|64940824|FG000|2 Year|Death|16|||
23327120|NCT04011722|64940825|FG001|2 Year|Death|1|||
23327121|NCT04011722|64940824|FG000|2 Year|Withdrawal by Subject|10|||
23153780|NCT01514136|64315546|FG004|Test Period 2; Test A*|Holiday|1|||
23153781|NCT01514136|64315547|FG005|Test Period 2; Test A*|Holiday|0|||
23153782|NCT01514136|64315548|FG006|Test Period 2; Test A*|Holiday|0|||
23153783|NCT01514136|64315549|FG007|Test Period 2; Test A*|Holiday|0|||
23153784|NCT01514136|64315542|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
23153785|NCT01514136|64315543|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
23327122|NCT04011722|64940825|FG001|2 Year|Withdrawal by Subject|1|||
23441676|NCT01610336|65358592|FG003|Overall Study|Subject/Guardian decision|1|||
23441677|NCT01610336|65358593|FG004|Overall Study|Subject/Guardian decision|0|||
23441678|NCT01610336|65358594|FG005|Overall Study|Subject/Guardian decision|0|||
23626936|NCT00755417|66020461|FG002|Overall Study|Lack of Efficacy|9|||
23441679|NCT01610336|65358595|FG006|Overall Study|Subject/Guardian decision|0|||
23153786|NCT01514136|64315544|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
23327123|NCT04011722|64940824|FG000|2 Year|Missed Visit|9|||
23327124|NCT04011722|64940825|FG001|2 Year|Missed Visit|0|||
23327125|NCT04011722|64940824|FG000|2 Year|Visit Pending|1|||
23327126|NCT04011722|64940825|FG001|2 Year|Visit Pending|3|||
23441680|NCT01610336|65358596|FG007|Overall Study|Subject/Guardian decision|1|||
23441681|NCT01610336|65358597|FG008|Overall Study|Subject/Guardian decision|0|||
23441682|NCT01610336|65358598|FG009|Overall Study|Subject/Guardian decision|2|||
23441683|NCT01610336|65358599|FG010|Overall Study|Subject/Guardian decision|2|||
23441684|NCT01610336|65358589|FG000|Overall Study|Death|0|||
23441685|NCT01610336|65358590|FG001|Overall Study|Death|0|||
23441686|NCT01610336|65358591|FG002|Overall Study|Death|0|||
23441687|NCT01610336|65358592|FG003|Overall Study|Death|0|||
23220866|NCT02007252|64550239|FG001|Overall Study|Adverse Event|4|||
23220867|NCT01300767|64550243|FG000|Overall Study|Discomfort|2|||
23220868|NCT01300767|64550243|FG000|Overall Study|Biomicroscopy|1|||
23220869|NCT01300767|64550243|FG000|Overall Study|Unacceptable fit|1|||
23220870|NCT03039790|64550245|FG000|Overall Study|Lost to Follow-up|2|||
23220871|NCT03039790|64550246|FG001|Overall Study|Lost to Follow-up|0|||
23220872|NCT03039790|64550247|FG002|Overall Study|Lost to Follow-up|1|||
23220873|NCT03039790|64550248|FG003|Overall Study|Lost to Follow-up|1|||
23220874|NCT03039790|64550249|FG004|Overall Study|Lost to Follow-up|0|||
23220875|NCT03039790|64550250|FG005|Overall Study|Lost to Follow-up|1|||
23220876|NCT03039790|64550251|FG006|Overall Study|Lost to Follow-up|1|||
23220877|NCT03039790|64550252|FG007|Overall Study|Lost to Follow-up|1|||
23441688|NCT01610336|65358593|FG004|Overall Study|Death|0|||
23441689|NCT01610336|65358594|FG005|Overall Study|Death|1|||
23441690|NCT01610336|65358595|FG006|Overall Study|Death|3|||
23441691|NCT01610336|65358596|FG007|Overall Study|Death|0|||
23441692|NCT01610336|65358597|FG008|Overall Study|Death|0|||
23441693|NCT01610336|65358598|FG009|Overall Study|Death|1|||
23441694|NCT01610336|65358599|FG010|Overall Study|Death|2|||
23441695|NCT01610336|65358589|FG000|Overall Study|Non-Compliance with study treatment|0|||
23441696|NCT01610336|65358590|FG001|Overall Study|Non-Compliance with study treatment|0|||
23441697|NCT01610336|65358591|FG002|Overall Study|Non-Compliance with study treatment|0|||
23441698|NCT01610336|65358592|FG003|Overall Study|Non-Compliance with study treatment|0|||
23441699|NCT01610336|65358593|FG004|Overall Study|Non-Compliance with study treatment|0|||
23441700|NCT01610336|65358594|FG005|Overall Study|Non-Compliance with study treatment|0|||
23441701|NCT01610336|65358595|FG006|Overall Study|Non-Compliance with study treatment|0|||
23441702|NCT01610336|65358596|FG007|Overall Study|Non-Compliance with study treatment|0|||
23441703|NCT01610336|65358597|FG008|Overall Study|Non-Compliance with study treatment|0|||
23441704|NCT01610336|65358598|FG009|Overall Study|Non-Compliance with study treatment|1|||
23441705|NCT01610336|65358599|FG010|Overall Study|Non-Compliance with study treatment|0|||
23441706|NCT01610336|65358589|FG000|Overall Study|Physician Decision|0|||
23441707|NCT01610336|65358590|FG001|Overall Study|Physician Decision|0|||
23441708|NCT01610336|65358591|FG002|Overall Study|Physician Decision|0|||
23441709|NCT01610336|65358592|FG003|Overall Study|Physician Decision|0|||
23441710|NCT01610336|65358593|FG004|Overall Study|Physician Decision|0|||
23441711|NCT01610336|65358594|FG005|Overall Study|Physician Decision|0|||
23441712|NCT01610336|65358595|FG006|Overall Study|Physician Decision|1|||
23441713|NCT01610336|65358596|FG007|Overall Study|Physician Decision|0|||
23441714|NCT01610336|65358597|FG008|Overall Study|Physician Decision|0|||
23441715|NCT01610336|65358598|FG009|Overall Study|Physician Decision|0|||
23441716|NCT01610336|65358599|FG010|Overall Study|Physician Decision|0|||
23441717|NCT01610336|65358589|FG000|Overall Study|Protocol Deviation|0|||
23441718|NCT01610336|65358590|FG001|Overall Study|Protocol Deviation|0|||
23441719|NCT01610336|65358591|FG002|Overall Study|Protocol Deviation|0|||
23441720|NCT01610336|65358592|FG003|Overall Study|Protocol Deviation|0|||
23441721|NCT01610336|65358593|FG004|Overall Study|Protocol Deviation|0|||
23441722|NCT01610336|65358594|FG005|Overall Study|Protocol Deviation|0|||
23441723|NCT01610336|65358595|FG006|Overall Study|Protocol Deviation|0|||
23441724|NCT01610336|65358596|FG007|Overall Study|Protocol Deviation|0|||
23441725|NCT01610336|65358597|FG008|Overall Study|Protocol Deviation|0|||
23441726|NCT01610336|65358598|FG009|Overall Study|Protocol Deviation|1|||
23626937|NCT00755417|66020459|FG000|Overall Study|Protocol Violation|2|||
23220878|NCT03039790|64550253|FG008|Overall Study|Lost to Follow-up|0|||
23441727|NCT01610336|65358599|FG010|Overall Study|Protocol Deviation|0|||
23441728|NCT01610336|65358589|FG000|Overall Study|Transfer to another trial|0|||
23441729|NCT01610336|65358590|FG001|Overall Study|Transfer to another trial|0|||
23441730|NCT01610336|65358591|FG002|Overall Study|Transfer to another trial|0|||
23441731|NCT01610336|65358592|FG003|Overall Study|Transfer to another trial|0|||
23441732|NCT01610336|65358593|FG004|Overall Study|Transfer to another trial|0|||
23441733|NCT01610336|65358594|FG005|Overall Study|Transfer to another trial|0|||
23441734|NCT01610336|65358595|FG006|Overall Study|Transfer to another trial|0|||
23441735|NCT01610336|65358596|FG007|Overall Study|Transfer to another trial|0|||
23441736|NCT01610336|65358597|FG008|Overall Study|Transfer to another trial|0|||
23441737|NCT01610336|65358598|FG009|Overall Study|Transfer to another trial|0|||
23441738|NCT01610336|65358599|FG010|Overall Study|Transfer to another trial|1|||
23441739|NCT02679287|65358600|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
23441740|NCT02679287|65358601|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
23441741|NCT02679287|65358600|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
23441742|NCT02679287|65358601|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
23441743|NCT02679287|65358600|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
23441744|NCT02679287|65358601|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
23441745|NCT02679287|65358600|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
23441746|NCT02679287|65358601|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
23441747|NCT02679287|65358600|FG000|Period 2|Work/Scheduling Conflict|1|||
23220879|NCT03039790|64550254|FG009|Overall Study|Lost to Follow-up|1|||
23220880|NCT03039790|64550255|FG010|Overall Study|Lost to Follow-up|1|||
23441748|NCT02679287|65358601|FG001|Period 2|Work/Scheduling Conflict|0|||
23441749|NCT02679287|65358600|FG000|Period 2|Disliked Mobile System|2|||
23441750|NCT02679287|65358601|FG001|Period 2|Disliked Mobile System|0|||
23441751|NCT02679287|65358600|FG000|Period 3|Work/Scheduling Conflict|0|||
23441752|NCT02679287|65358601|FG001|Period 3|Work/Scheduling Conflict|1|||
23441753|NCT04829916|65358602|FG000|Overall Study|Withdrawal by Subject|1|||
23441754|NCT04829916|65358603|FG001|Overall Study|Withdrawal by Subject|0|||
23441755|NCT04618744|65358610|FG000|Overall Study|Adverse Event|0|||
23441756|NCT04618744|65358611|FG001|Overall Study|Adverse Event|1|||
23441757|NCT04618744|65358610|FG000|Overall Study|Withdrawal by Subject|0|||
23441758|NCT04618744|65358611|FG001|Overall Study|Withdrawal by Subject|1|||
23441759|NCT01746225|65358614|FG000|Overall Study|Death|1|||
23441760|NCT01746225|65358615|FG001|Overall Study|Death|0|||
23441761|NCT01746225|65358616|FG002|Overall Study|Death|1|||
23441762|NCT01746225|65358614|FG000|Overall Study|Withdrawal by Subject|5|||
23441763|NCT01746225|65358615|FG001|Overall Study|Withdrawal by Subject|15|||
23441764|NCT01746225|65358616|FG002|Overall Study|Withdrawal by Subject|19|||
23441765|NCT01746225|65358614|FG000|Overall Study|Physician Decision|14|||
23441766|NCT01746225|65358615|FG001|Overall Study|Physician Decision|11|||
23441767|NCT01746225|65358616|FG002|Overall Study|Physician Decision|3|||
23441768|NCT01746225|65358614|FG000|Overall Study|Adverse Event|15|||
23441769|NCT01746225|65358615|FG001|Overall Study|Adverse Event|12|||
23441770|NCT01746225|65358616|FG002|Overall Study|Adverse Event|17|||
23441771|NCT01746225|65358614|FG000|Overall Study|Continuing Treatment|5|||
23441772|NCT01746225|65358615|FG001|Overall Study|Continuing Treatment|8|||
23441773|NCT01746225|65358616|FG002|Overall Study|Continuing Treatment|3|||
23441774|NCT01740401|65358617|FG000|Overall Study|Progression of disease|6|||
23327127|NCT04011722|64940824|FG000|2 Year|Not Yet Due|43|||
23327128|NCT04011722|64940825|FG001|2 Year|Not Yet Due|54|||
23327129|NCT04011722|64940824|FG000|3 Year|Death|10|||
23327130|NCT04011722|64940825|FG001|3 Year|Death|0|||
23327131|NCT04011722|64940824|FG000|3 Year|Withdrawal by Subject|2|||
23441775|NCT01740401|65358617|FG000|Overall Study|Adverse Event|2|||
23441776|NCT01740401|65358617|FG000|Overall Study|Did not reach primary endpoint|2|||
23153787|NCT01514136|64315545|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
23153788|NCT01514136|64315546|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
23153789|NCT01514136|64315547|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
23153790|NCT01514136|64315548|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
23153791|NCT01514136|64315549|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
23153792|NCT01514136|64315542|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
23153793|NCT01514136|64315543|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
23153794|NCT01514136|64315544|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
23153795|NCT01514136|64315545|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
23441777|NCT02360228|65358618|FG000|Overall Study|Withdrawal by Subject|1|||
23441778|NCT02360228|65358619|FG001|Overall Study|Withdrawal by Subject|0|||
23441779|NCT02360228|65358620|FG002|Overall Study|Withdrawal by Subject|0|||
23626938|NCT00755417|66020460|FG001|Overall Study|Protocol Violation|1|||
23626939|NCT00755417|66020461|FG002|Overall Study|Protocol Violation|1|||
23626940|NCT00755417|66020459|FG000|Overall Study|Lost to Follow-up|3|||
23626941|NCT00755417|66020460|FG001|Overall Study|Lost to Follow-up|0|||
23626942|NCT00755417|66020461|FG002|Overall Study|Lost to Follow-up|1|||
23626943|NCT00755417|66020459|FG000|Overall Study|Withdrawal by Subject|12|||
23626944|NCT00755417|66020460|FG001|Overall Study|Withdrawal by Subject|12|||
23626945|NCT00755417|66020461|FG002|Overall Study|Withdrawal by Subject|12|||
23220881|NCT03039790|64550256|FG011|Overall Study|Lost to Follow-up|0|||
23220882|NCT03039790|64550257|FG012|Overall Study|Lost to Follow-up|1|||
23220883|NCT03039790|64550258|FG013|Overall Study|Lost to Follow-up|0|||
23220884|NCT03039790|64550259|FG014|Overall Study|Lost to Follow-up|3|||
23220885|NCT03039790|64550260|FG015|Overall Study|Lost to Follow-up|1|||
23327132|NCT04011722|64940825|FG001|3 Year|Withdrawal by Subject|0|||
23441780|NCT02360228|65358618|FG000|Overall Study|Self-discontinued medication|0|||
23441781|NCT02360228|65358619|FG001|Overall Study|Self-discontinued medication|1|||
23441782|NCT02360228|65358620|FG002|Overall Study|Self-discontinued medication|0|||
23441783|NCT02360228|65358618|FG000|Overall Study|Unstable symptoms during screening|0|||
23441784|NCT02360228|65358619|FG001|Overall Study|Unstable symptoms during screening|0|||
23441785|NCT02360228|65358620|FG002|Overall Study|Unstable symptoms during screening|1|||
23441786|NCT02141360|65358623|FG000|Overall Study|Withdrawal by Subject|6|||
23626946|NCT00755417|66020459|FG000|Overall Study|Not specified or missing data|9|||
23626947|NCT00755417|66020460|FG001|Overall Study|Not specified or missing data|18|||
23626948|NCT00755417|66020461|FG002|Overall Study|Not specified or missing data|12|||
23441787|NCT02141360|65358624|FG001|Overall Study|Withdrawal by Subject|0|||
23153796|NCT01514136|64315546|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
23441788|NCT02141360|65358625|FG002|Overall Study|Withdrawal by Subject|0|||
23441789|NCT02141360|65358623|FG000|Overall Study|Study Terminated before Visit|1|||
23153797|NCT01514136|64315547|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
23327133|NCT04011722|64940824|FG000|3 Year|Missed Visit|2|||
23626949|NCT01755546|66020462|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
23626950|NCT01755546|66020462|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
23327134|NCT04011722|64940825|FG001|3 Year|Missed Visit|0|||
23327135|NCT04011722|64940824|FG000|3 Year|Pending Visit|34|||
23327136|NCT04011722|64940825|FG001|3 Year|Pending Visit|0|||
23327137|NCT04011722|64940824|FG000|3 Year|Not Yet Due|99|||
23327138|NCT04011722|64940825|FG001|3 Year|Not Yet Due|0|||
23327139|NCT02727478|64940826|FG000|Overall Study|Withdrawal by Subject|8|||
23327140|NCT02727478|64940827|FG001|Overall Study|Withdrawal by Subject|10|||
23327141|NCT00739882|64940830|FG000|Double-blind Period|Adverse Event|1|||
23327142|NCT00739882|64940831|FG001|Double-blind Period|Adverse Event|2|||
23327143|NCT00739882|64940830|FG000|Double-blind Period|Protocol Violation|1|||
23327144|NCT00739882|64940831|FG001|Double-blind Period|Protocol Violation|0|||
23327145|NCT00739882|64940830|FG000|Double-blind Period|Lack of Efficacy|1|||
23327146|NCT00739882|64940831|FG001|Double-blind Period|Lack of Efficacy|1|||
23327147|NCT00739882|64940830|FG000|Double-blind Period|Other|16|||
23327148|NCT00739882|64940831|FG001|Double-blind Period|Other|8|||
23327149|NCT00739882|64940830|FG000|Open-label Period|Adverse Event|1|||
23327150|NCT00739882|64940831|FG001|Open-label Period|Adverse Event|0|||
23327151|NCT00739882|64940830|FG000|Open-label Period|Other|9|||
23327152|NCT00739882|64940831|FG001|Open-label Period|Other|5|||
23327153|NCT01207687|64940832|FG000|Overall Study|Adverse Event|1|||
23327154|NCT01207687|64940832|FG000|Overall Study|Withdrawal by Subject|1|||
23327155|NCT00740636|64940839|FG000|Overall Study|Adverse Event|0|||
23327156|NCT00740636|64940840|FG001|Overall Study|Adverse Event|2|||
23327157|NCT00740636|64940839|FG000|Overall Study|Patient Ineligible|0|||
23327158|NCT00740636|64940840|FG001|Overall Study|Patient Ineligible|1|||
23327159|NCT00740636|64940839|FG000|Overall Study|Patient Not Treated|0|||
23327160|NCT00740636|64940840|FG001|Overall Study|Patient Not Treated|1|||
23327161|NCT00740636|64940839|FG000|Overall Study|Progressive Disease|1|||
23626951|NCT01755546|66020462|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
23626952|NCT01755546|66020462|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
23626953|NCT01755546|66020462|FG000|Titration Phase|Adverse Event|11|||
23626954|NCT01755546|66020462|FG000|Titration Phase|Lack of Efficacy|18|||
23626955|NCT01755546|66020462|FG000|Titration Phase|Protocol Violation|9|||
23626956|NCT01755546|66020462|FG000|Titration Phase|Lost to Follow-up|2|||
23626957|NCT01755546|66020462|FG000|Titration Phase|Other and Continuing|22|||
23153798|NCT01514136|64315548|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
23153799|NCT01514136|64315549|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
23153800|NCT01514136|64315542|FG000|Test Period 2; Test C*|holiday|0|||
23153801|NCT01514136|64315543|FG001|Test Period 2; Test C*|holiday|0|||
23153802|NCT01514136|64315544|FG002|Test Period 2; Test C*|holiday|0|||
23153803|NCT01514136|64315545|FG003|Test Period 2; Test C*|holiday|0|||
23153804|NCT01514136|64315546|FG004|Test Period 2; Test C*|holiday|0|||
23153805|NCT01514136|64315547|FG005|Test Period 2; Test C*|holiday|0|||
23153806|NCT01514136|64315548|FG006|Test Period 2; Test C*|holiday|1|||
23153807|NCT01514136|64315549|FG007|Test Period 2; Test C*|holiday|0|||
23220886|NCT03039790|64550261|FG016|Overall Study|Lost to Follow-up|2|||
23220887|NCT03039790|64550262|FG017|Overall Study|Lost to Follow-up|2|||
23220888|NCT03039790|64550263|FG018|Overall Study|Lost to Follow-up|1|||
23220889|NCT03039790|64550264|FG019|Overall Study|Lost to Follow-up|3|||
23220890|NCT03039790|64550245|FG000|Overall Study|Withdrawal of Consent|1|||
23220891|NCT03039790|64550246|FG001|Overall Study|Withdrawal of Consent|0|||
23220892|NCT03039790|64550247|FG002|Overall Study|Withdrawal of Consent|0|||
23220893|NCT03039790|64550248|FG003|Overall Study|Withdrawal of Consent|1|||
23220894|NCT03039790|64550249|FG004|Overall Study|Withdrawal of Consent|0|||
23220895|NCT03039790|64550250|FG005|Overall Study|Withdrawal of Consent|0|||
23220896|NCT03039790|64550251|FG006|Overall Study|Withdrawal of Consent|0|||
23220897|NCT03039790|64550252|FG007|Overall Study|Withdrawal of Consent|0|||
23220898|NCT03039790|64550253|FG008|Overall Study|Withdrawal of Consent|0|||
23327162|NCT00740636|64940840|FG001|Overall Study|Progressive Disease|0|||
23327163|NCT00740636|64940839|FG000|Overall Study|Death|1|||
23327164|NCT00740636|64940840|FG001|Overall Study|Death|0|||
23327165|NCT03711188|64940841|FG000|Overall Study|Disease progression|11|||
23327166|NCT03711188|64940841|FG000|Overall Study|Adverse Event|1|||
23327167|NCT00987337|64940842|FG000|Overall Study|Adverse Event|10|||
23626958|NCT01755546|66020462|FG000|Titration Phase|Withdrawal by Subject|8|||
23626959|NCT01755546|66020462|FG000|Long Term Treatment|Adverse Event|12|||
23626960|NCT01755546|66020462|FG000|Long Term Treatment|Lack of Efficacy|6|||
23327168|NCT00987337|64940843|FG001|Overall Study|Adverse Event|9|||
23327169|NCT00987337|64940844|FG002|Overall Study|Adverse Event|8|||
23327170|NCT00987337|64940842|FG000|Overall Study|Insufficient Virologic Response|10|||
23327171|NCT00987337|64940843|FG001|Overall Study|Insufficient Virologic Response|7|||
23327172|NCT00987337|64940844|FG002|Overall Study|Insufficient Virologic Response|12|||
23327173|NCT00987337|64940842|FG000|Overall Study|Virologic Breakthrough|2|||
23327174|NCT00987337|64940843|FG001|Overall Study|Virologic Breakthrough|2|||
23153808|NCT01514136|64315542|FG000|Test Period 2; Test C*|Protocol Violation|0|||
23153809|NCT01514136|64315543|FG001|Test Period 2; Test C*|Protocol Violation|0|||
23153810|NCT01514136|64315544|FG002|Test Period 2; Test C*|Protocol Violation|0|||
23441790|NCT02141360|65358624|FG001|Overall Study|Study Terminated before Visit|0|||
23441791|NCT02141360|65358625|FG002|Overall Study|Study Terminated before Visit|0|||
23441792|NCT01221350|65358628|FG000|Overall Study|Discontinued intervention (GERD)|1|||
23441793|NCT01221350|65358629|FG001|Overall Study|Discontinued intervention (GERD)|0|||
23441794|NCT01221350|65358628|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
23441795|NCT01221350|65358629|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
23441796|NCT01221350|65358628|FG000|Overall Study|Withdrawal by Subject|4|||
23327175|NCT00987337|64940844|FG002|Overall Study|Virologic Breakthrough|8|||
23327176|NCT00987337|64940842|FG000|Overall Study|Lost to Follow-up|10|||
23327177|NCT00987337|64940843|FG001|Overall Study|Lost to Follow-up|6|||
23327178|NCT00987337|64940844|FG002|Overall Study|Lost to Follow-up|2|||
23327179|NCT00987337|64940842|FG000|Overall Study|Withdrawal by Subject|6|||
23327180|NCT00987337|64940843|FG001|Overall Study|Withdrawal by Subject|9|||
23327181|NCT00987337|64940844|FG002|Overall Study|Withdrawal by Subject|9|||
23327182|NCT00987337|64940842|FG000|Overall Study|Other|0|||
23327183|NCT00987337|64940843|FG001|Overall Study|Other|2|||
23327184|NCT00987337|64940844|FG002|Overall Study|Other|5|||
23327185|NCT00987337|64940842|FG000|Overall Study|Protocol Violation|1|||
23327186|NCT00987337|64940843|FG001|Overall Study|Protocol Violation|0|||
23327187|NCT00987337|64940844|FG002|Overall Study|Protocol Violation|2|||
23327188|NCT00987337|64940842|FG000|Overall Study|Participant Relapsed|18|||
23327189|NCT00987337|64940843|FG001|Overall Study|Participant Relapsed|20|||
23327190|NCT00987337|64940844|FG002|Overall Study|Participant Relapsed|5|||
23327191|NCT03181633|64940848|FG000|Overall Study|Withdrawal by Subject|1|||
23327192|NCT03181633|64940848|FG000|Overall Study|Missing follow-up visit|1|||
23327193|NCT03335475|64940851|FG000|Overall Study|Did not wear accelerometer|4|||
23327194|NCT03335475|64940852|FG001|Overall Study|Did not wear accelerometer|0|||
23327195|NCT03335475|64940851|FG000|Overall Study|Withdrawal by Subject|0|||
23327196|NCT03335475|64940852|FG001|Overall Study|Withdrawal by Subject|1|||
23327197|NCT02949973|64940853|FG000|Overall Study|Physician Decision|1|||
23327198|NCT02942017|64940854|FG000|Overall Study|Adverse Event|0|||
23441797|NCT01221350|65358629|FG001|Overall Study|Withdrawal by Subject|2|||
23441798|NCT01363661|65358636|FG000|Overall Study|Adverse Event|9|||
23564902|NCT02667886|65796570|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
23564903|NCT02667886|65796571|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
23564904|NCT02667886|65796572|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
23626961|NCT01755546|66020462|FG000|Long Term Treatment|Protocol Violation|10|||
23626962|NCT01755546|66020462|FG000|Long Term Treatment|Withdrawal by Subject|35|||
23626963|NCT01755546|66020462|FG000|Long Term Treatment|Lost to Follow-up|17|||
23626964|NCT01755546|66020462|FG000|Long Term Treatment|other and ongoing|41|||
23626965|NCT02895360|66020463|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
23626966|NCT02895360|66020464|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23564905|NCT02667886|65796573|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
23564906|NCT02667886|65796569|FG000|Dose Expansion (Part B)|Disease Progression|0|||
23564907|NCT02667886|65796570|FG001|Dose Expansion (Part B)|Disease Progression|0|||
23564908|NCT02667886|65796571|FG002|Dose Expansion (Part B)|Disease Progression|0|||
23564909|NCT02667886|65796572|FG003|Dose Expansion (Part B)|Disease Progression|38|||
23564910|NCT02667886|65796573|FG004|Dose Expansion (Part B)|Disease Progression|0|||
23564911|NCT02667886|65796569|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
23564912|NCT02667886|65796570|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
23626967|NCT02895360|66020465|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23626968|NCT02895360|66020466|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23626969|NCT02895360|66020467|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23626970|NCT02895360|66020468|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
23626971|NCT02895360|66020463|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23626972|NCT02895360|66020464|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
23153811|NCT01514136|64315545|FG003|Test Period 2; Test C*|Protocol Violation|0|||
23153812|NCT01514136|64315546|FG004|Test Period 2; Test C*|Protocol Violation|0|||
23441799|NCT01363661|65358637|FG001|Overall Study|Adverse Event|2|||
23626973|NCT02895360|66020465|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23626974|NCT02895360|66020466|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23153813|NCT01514136|64315547|FG005|Test Period 2; Test C*|Protocol Violation|0|||
23153814|NCT01514136|64315548|FG006|Test Period 2; Test C*|Protocol Violation|1|||
23327199|NCT02942017|64940855|FG001|Overall Study|Adverse Event|1|||
23327200|NCT02942017|64940854|FG000|Overall Study|Withdrawal by Subject|0|||
23327201|NCT02942017|64940855|FG001|Overall Study|Withdrawal by Subject|1|||
23327202|NCT02942017|64940854|FG000|Overall Study|Lost to Follow-up|1|||
23441800|NCT01363661|65358636|FG000|Overall Study|Withdrawal by Subject|1|||
23327203|NCT02942017|64940855|FG001|Overall Study|Lost to Follow-up|1|||
23327204|NCT02942017|64940854|FG000|Overall Study|Randomized but not dosed|1|||
23327205|NCT02942017|64940855|FG001|Overall Study|Randomized but not dosed|3|||
23327206|NCT02105987|64940859|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
23441801|NCT01363661|65358637|FG001|Overall Study|Withdrawal by Subject|1|||
23626975|NCT02895360|66020467|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23626976|NCT02895360|66020468|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
23626977|NCT02895360|66020463|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626978|NCT02895360|66020464|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626979|NCT02895360|66020465|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
23626980|NCT02895360|66020466|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626981|NCT02895360|66020467|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626982|NCT02895360|66020468|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
23626983|NCT02895360|66020463|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626984|NCT02895360|66020464|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626985|NCT02895360|66020465|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
23626986|NCT02895360|66020466|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626987|NCT02895360|66020467|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626988|NCT02895360|66020468|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
23626989|NCT02895360|66020463|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626990|NCT02895360|66020464|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626991|NCT02895360|66020465|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626992|NCT02895360|66020466|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
23626993|NCT02895360|66020467|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626994|NCT02895360|66020468|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
23626995|NCT02895360|66020463|FG000|Phase 2a|Adverse Event|0|||
23626996|NCT02895360|66020464|FG001|Phase 2a|Adverse Event|0|||
23626997|NCT02895360|66020465|FG002|Phase 2a|Adverse Event|0|||
23626998|NCT02895360|66020466|FG003|Phase 2a|Adverse Event|0|||
23626999|NCT02895360|66020467|FG004|Phase 2a|Adverse Event|0|||
23627000|NCT02895360|66020468|FG005|Phase 2a|Adverse Event|1|||
23627001|NCT02895360|66020463|FG000|Phase 2a|Progressive disease|0|||
23627002|NCT02895360|66020464|FG001|Phase 2a|Progressive disease|0|||
23627003|NCT02895360|66020465|FG002|Phase 2a|Progressive disease|0|||
23627004|NCT02895360|66020466|FG003|Phase 2a|Progressive disease|0|||
23627005|NCT02895360|66020467|FG004|Phase 2a|Progressive disease|11|||
23627006|NCT02895360|66020468|FG005|Phase 2a|Progressive disease|11|||
23627007|NCT03418493|66020476|FG000|Overall Study|Adverse Event|1|||
23627008|NCT03418493|66020477|FG001|Overall Study|Adverse Event|0|||
23627009|NCT03418493|66020478|FG002|Overall Study|Adverse Event|0|||
23627010|NCT03418493|66020479|FG003|Overall Study|Adverse Event|0|||
23627011|NCT03418493|66020480|FG004|Overall Study|Adverse Event|0|||
23627012|NCT03418493|66020481|FG005|Overall Study|Adverse Event|0|||
23627013|NCT03418493|66020482|FG006|Overall Study|Adverse Event|0|||
23627014|NCT03418493|66020483|FG007|Overall Study|Adverse Event|0|||
23627015|NCT03418493|66020484|FG008|Overall Study|Adverse Event|0|||
23627016|NCT03418493|66020485|FG009|Overall Study|Adverse Event|0|||
23627017|NCT03418493|66020486|FG010|Overall Study|Adverse Event|0|||
23627018|NCT03418493|66020476|FG000|Overall Study|Protocol Violation|0|||
23627019|NCT03418493|66020477|FG001|Overall Study|Protocol Violation|0|||
23627020|NCT03418493|66020478|FG002|Overall Study|Protocol Violation|0|||
23627021|NCT03418493|66020479|FG003|Overall Study|Protocol Violation|0|||
23627022|NCT03418493|66020480|FG004|Overall Study|Protocol Violation|0|||
23627023|NCT03418493|66020481|FG005|Overall Study|Protocol Violation|0|||
23627024|NCT03418493|66020482|FG006|Overall Study|Protocol Violation|0|||
23627025|NCT03418493|66020483|FG007|Overall Study|Protocol Violation|0|||
23627026|NCT03418493|66020484|FG008|Overall Study|Protocol Violation|0|||
23627027|NCT03418493|66020485|FG009|Overall Study|Protocol Violation|1|||
23627028|NCT03418493|66020486|FG010|Overall Study|Protocol Violation|0|||
23627029|NCT03638258|66020488|FG000|Overall Study|Adverse Event|1|||
23627030|NCT03638258|66020489|FG001|Overall Study|Adverse Event|0|||
23627031|NCT03638258|66020490|FG002|Overall Study|Adverse Event|2|||
23627032|NCT03638258|66020488|FG000|Overall Study|Lost to Follow-up|2|||
23220899|NCT03039790|64550254|FG009|Overall Study|Withdrawal of Consent|1|||
23220900|NCT03039790|64550255|FG010|Overall Study|Withdrawal of Consent|0|||
23220901|NCT03039790|64550256|FG011|Overall Study|Withdrawal of Consent|0|||
23220902|NCT03039790|64550257|FG012|Overall Study|Withdrawal of Consent|2|||
23220903|NCT03039790|64550258|FG013|Overall Study|Withdrawal of Consent|0|||
23220904|NCT03039790|64550259|FG014|Overall Study|Withdrawal of Consent|1|||
23220905|NCT03039790|64550260|FG015|Overall Study|Withdrawal of Consent|5|||
23627033|NCT03638258|66020489|FG001|Overall Study|Lost to Follow-up|4|||
23627034|NCT03638258|66020490|FG002|Overall Study|Lost to Follow-up|5|||
23627035|NCT03638258|66020488|FG000|Overall Study|Pregnancy|0|||
23220906|NCT03039790|64550261|FG016|Overall Study|Withdrawal of Consent|3|||
23220907|NCT03039790|64550262|FG017|Overall Study|Withdrawal of Consent|0|||
23220908|NCT03039790|64550263|FG018|Overall Study|Withdrawal of Consent|2|||
23627036|NCT03638258|66020489|FG001|Overall Study|Pregnancy|0|||
23627037|NCT03638258|66020490|FG002|Overall Study|Pregnancy|1|||
23627038|NCT03638258|66020488|FG000|Overall Study|Protocol Violation|0|||
23627039|NCT03638258|66020489|FG001|Overall Study|Protocol Violation|0|||
23627040|NCT03638258|66020490|FG002|Overall Study|Protocol Violation|1|||
23627041|NCT03638258|66020488|FG000|Overall Study|Withdrawal by Subject|4|||
23627042|NCT03638258|66020489|FG001|Overall Study|Withdrawal by Subject|5|||
23327207|NCT02105987|64940860|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23327208|NCT02105987|64940861|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23327209|NCT02105987|64940862|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23327210|NCT02105987|64940863|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23327211|NCT02105987|64940864|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
23327212|NCT02105987|64940859|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
23327213|NCT02105987|64940860|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
23153815|NCT01514136|64315549|FG007|Test Period 2; Test C*|Protocol Violation|0|||
23153816|NCT01101438|64315550|FG000|Overall Study|Withdrawal by Subject|8|||
23153817|NCT01101438|64315551|FG001|Overall Study|Withdrawal by Subject|9|||
23153818|NCT02459769|64315556|FG000|Overall Study|Withdrawal by Subject|7|||
23153819|NCT02459769|64315557|FG001|Overall Study|Withdrawal by Subject|4|||
23153820|NCT02459769|64315558|FG002|Overall Study|Withdrawal by Subject|8|||
23153821|NCT02459769|64315559|FG003|Overall Study|Withdrawal by Subject|5|||
23153822|NCT02459769|64315556|FG000|Overall Study|Lost to Follow-up|1|||
23220909|NCT03039790|64550264|FG019|Overall Study|Withdrawal of Consent|5|||
23220910|NCT03039790|64550245|FG000|Overall Study|Death|0|||
23327214|NCT02105987|64940861|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
23327215|NCT02105987|64940862|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
23327216|NCT02105987|64940863|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
23327217|NCT02105987|64940864|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
23327218|NCT02105987|64940859|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
23327219|NCT02105987|64940860|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
23564913|NCT02667886|65796571|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
23564914|NCT02667886|65796572|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
23564915|NCT02667886|65796573|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
23564916|NCT02667886|65796569|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
23564917|NCT02667886|65796570|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
23564918|NCT02667886|65796571|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
23564919|NCT02667886|65796572|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
23564920|NCT02667886|65796573|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
23564921|NCT02667886|65796569|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
23564922|NCT02667886|65796570|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
23564923|NCT02667886|65796571|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
23564924|NCT02667886|65796572|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
23564925|NCT02667886|65796573|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
23564926|NCT04954586|65796580|FG000|Overall Study|Withdrawal by Subject|5|||
23564927|NCT04186403|65796582|FG000|Overall Study|Adverse Event|1|||
23564928|NCT04186403|65796583|FG001|Overall Study|Adverse Event|8|||
23564929|NCT04186403|65796582|FG000|Overall Study|Lost to Follow-up|7|||
23564930|NCT04186403|65796583|FG001|Overall Study|Lost to Follow-up|3|||
23564931|NCT04186403|65796582|FG000|Overall Study|Physician Decision|1|||
23564932|NCT04186403|65796583|FG001|Overall Study|Physician Decision|0|||
23564933|NCT04186403|65796582|FG000|Overall Study|Withdrawal by Subject|7|||
23564934|NCT04186403|65796583|FG001|Overall Study|Withdrawal by Subject|8|||
23564935|NCT04186403|65796582|FG000|Overall Study|Other: Not Related to Covid-19|3|||
23564936|NCT04186403|65796583|FG001|Overall Study|Other: Not Related to Covid-19|0|||
23564937|NCT01598298|65796586|FG000|Overall Study|Not eligible|5|||
23564938|NCT01598298|65796587|FG001|Overall Study|Not eligible|5|||
23564939|NCT01598298|65796586|FG000|Overall Study|Adverse Event|21|||
23564940|NCT01598298|65796587|FG001|Overall Study|Adverse Event|19|||
23564941|NCT01598298|65796586|FG000|Overall Study|Progression/relapse|0|||
23564942|NCT01598298|65796587|FG001|Overall Study|Progression/relapse|2|||
23564943|NCT01598298|65796586|FG000|Overall Study|Withdrawal by Subject|10|||
23564944|NCT01598298|65796587|FG001|Overall Study|Withdrawal by Subject|15|||
23564945|NCT01598298|65796586|FG000|Overall Study|Other reason (not protocol specified)|4|||
23564946|NCT01598298|65796587|FG001|Overall Study|Other reason (not protocol specified)|0|||
23564947|NCT01008475|65796589|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
23564948|NCT01008475|65796590|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
23564949|NCT01008475|65796591|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
23564950|NCT01008475|65796592|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
23153823|NCT02459769|64315557|FG001|Overall Study|Lost to Follow-up|0|||
23153824|NCT02459769|64315558|FG002|Overall Study|Lost to Follow-up|1|||
23153825|NCT02459769|64315559|FG003|Overall Study|Lost to Follow-up|0|||
23153826|NCT00074581|64315564|FG000|Overall Study|Death|15|||
23220911|NCT03039790|64550246|FG001|Overall Study|Death|0|||
23441802|NCT01363661|65358636|FG000|Overall Study|Protocol Violation|1|||
23564951|NCT01008475|65796593|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
23564952|NCT01008475|65796594|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
23564953|NCT01008475|65796595|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
23564954|NCT04128293|65796597|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
23153827|NCT00074581|64315565|FG001|Overall Study|Death|16|||
23220912|NCT03039790|64550247|FG002|Overall Study|Death|0|||
23627043|NCT03638258|66020490|FG002|Overall Study|Withdrawal by Subject|12|||
23627044|NCT03638258|66020488|FG000|Overall Study|Lack of Efficacy|0|||
23627045|NCT03638258|66020489|FG001|Overall Study|Lack of Efficacy|0|||
23627046|NCT03638258|66020490|FG002|Overall Study|Lack of Efficacy|2|||
23627047|NCT00958711|66020491|FG000|Overall Study|Withdrawal by Subject|0|||
23627048|NCT00958711|66020492|FG001|Overall Study|Withdrawal by Subject|4|||
23627049|NCT00958711|66020491|FG000|Overall Study|Physician Decision|5|||
23627050|NCT00958711|66020492|FG001|Overall Study|Physician Decision|7|||
23627051|NCT00958711|66020491|FG000|Overall Study|Lost to Follow-up|4|||
23627052|NCT00958711|66020492|FG001|Overall Study|Lost to Follow-up|1|||
23627053|NCT00958711|66020491|FG000|Overall Study|Other|2|||
23627054|NCT00958711|66020492|FG001|Overall Study|Other|5|||
23627055|NCT00958711|66020491|FG000|Overall Study|Death|1|||
23627056|NCT00958711|66020492|FG001|Overall Study|Death|2|||
23627057|NCT00958711|66020491|FG000|Overall Study|Adverse Event|1|||
23627058|NCT00958711|66020492|FG001|Overall Study|Adverse Event|2|||
23627059|NCT03113383|66020493|FG000|Overall Study|Death|4|||
23627060|NCT03113383|66020494|FG001|Overall Study|Death|0|||
23627061|NCT02643628|66020495|FG000|Overall Study|Lost to Follow-up|1|||
23627062|NCT02643628|66020496|FG001|Overall Study|Lost to Follow-up|4|||
23627063|NCT02643628|66020495|FG000|Overall Study|Withdrawal by Subject|0|||
23627064|NCT02643628|66020496|FG001|Overall Study|Withdrawal by Subject|1|||
23627065|NCT02643628|66020495|FG000|Overall Study|Relocated out of state|0|||
23627066|NCT02643628|66020496|FG001|Overall Study|Relocated out of state|1|||
23327220|NCT02105987|64940861|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23627067|NCT00590564|66020499|FG000|Overall Study|Withdrawal by Subject|4|||
23627068|NCT00590564|66020499|FG000|Overall Study|Lost to Follow-up|6|||
23627069|NCT00590564|66020499|FG000|Overall Study|Protocol Violation|1|||
23627070|NCT00590564|66020499|FG000|Overall Study|Patient Found to be Ineligible|1|||
23627071|NCT00590564|66020499|FG000|Overall Study|Patient Non-compliance|6|||
23627072|NCT01845805|66020500|FG000|Overall Study|Withdrawal by Subject|1|||
23627073|NCT01845805|66020501|FG001|Overall Study|Withdrawal by Subject|2|||
23627074|NCT01845805|66020500|FG000|Overall Study|Disease Progression|13|||
23627075|NCT01845805|66020501|FG001|Overall Study|Disease Progression|14|||
23627076|NCT01845805|66020500|FG000|Overall Study|Drug-related Toxicity|4|||
23627077|NCT01845805|66020501|FG001|Overall Study|Drug-related Toxicity|0|||
23627078|NCT03672175|66020502|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
23627079|NCT03672175|66020503|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
23627080|NCT03672175|66020504|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
23627081|NCT03672175|66020502|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
23627082|NCT03672175|66020503|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
23627083|NCT03672175|66020504|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
23627084|NCT03672175|66020502|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
23627085|NCT03672175|66020503|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
23627086|NCT03672175|66020504|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
23327221|NCT02105987|64940862|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23327222|NCT02105987|64940863|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23327223|NCT02105987|64940864|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23327224|NCT02105987|64940859|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
23327225|NCT02105987|64940860|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
23327226|NCT02105987|64940861|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23327227|NCT02105987|64940862|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23327228|NCT02105987|64940863|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23327229|NCT02105987|64940864|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23327230|NCT02105987|64940859|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
23327231|NCT02105987|64940860|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
23327232|NCT02105987|64940861|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
23327233|NCT02105987|64940862|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
23627087|NCT03672175|66020502|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
23627088|NCT03672175|66020503|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
23627089|NCT03672175|66020504|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
23627090|NCT03672175|66020502|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
23627091|NCT03672175|66020503|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
23627092|NCT03672175|66020504|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
23627093|NCT03672175|66020502|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
23627094|NCT03672175|66020503|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
23627095|NCT03672175|66020504|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
23627096|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
23627097|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
23627098|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
23627099|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
23327234|NCT02105987|64940863|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
23441803|NCT01363661|65358637|FG001|Overall Study|Protocol Violation|0|||
23627100|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
23627101|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
23627102|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
23627103|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
23627104|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
23627105|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
23153828|NCT00074581|64315564|FG000|Overall Study|Withdrawal by Subject|50|||
23153829|NCT00074581|64315565|FG001|Overall Study|Withdrawal by Subject|49|||
23153830|NCT00074581|64315564|FG000|Overall Study|Unable to adhere to visit schedule|13|||
23153831|NCT00074581|64315565|FG001|Overall Study|Unable to adhere to visit schedule|14|||
23153832|NCT00074581|64315564|FG000|Overall Study|Relocated|14|||
23327235|NCT02105987|64940864|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
23327236|NCT02105987|64940859|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23327237|NCT02105987|64940860|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
23327238|NCT02105987|64940861|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23327239|NCT02105987|64940862|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23327240|NCT02105987|64940863|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23327241|NCT02105987|64940864|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
23327242|NCT02105987|64940859|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
23327243|NCT02105987|64940860|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
23327244|NCT02105987|64940861|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
23327245|NCT02105987|64940862|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
23327246|NCT02105987|64940863|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
23327247|NCT02105987|64940864|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
23327248|NCT02105987|64940859|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
23327249|NCT02105987|64940860|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
23327250|NCT02105987|64940861|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
23327251|NCT02105987|64940862|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
23327252|NCT02105987|64940863|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
23327253|NCT02105987|64940864|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
23327254|NCT02105987|64940859|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23327255|NCT02105987|64940860|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23327256|NCT02105987|64940861|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
23327257|NCT02105987|64940862|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
23327258|NCT02105987|64940863|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23327259|NCT02105987|64940864|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
23153833|NCT00074581|64315565|FG001|Overall Study|Relocated|9|||
23153834|NCT00074581|64315564|FG000|Overall Study|Were withdrawn by investigator|5|||
23153835|NCT00074581|64315565|FG001|Overall Study|Were withdrawn by investigator|2|||
23220913|NCT03039790|64550248|FG003|Overall Study|Death|0|||
23220914|NCT03039790|64550249|FG004|Overall Study|Death|0|||
23220915|NCT03039790|64550250|FG005|Overall Study|Death|0|||
23220916|NCT03039790|64550251|FG006|Overall Study|Death|0|||
23327260|NCT02105987|64940859|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23327261|NCT02105987|64940860|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23220917|NCT03039790|64550252|FG007|Overall Study|Death|0|||
23220918|NCT03039790|64550253|FG008|Overall Study|Death|0|||
23220919|NCT03039790|64550254|FG009|Overall Study|Death|0|||
23220920|NCT03039790|64550255|FG010|Overall Study|Death|0|||
23220921|NCT03039790|64550256|FG011|Overall Study|Death|0|||
23220922|NCT03039790|64550257|FG012|Overall Study|Death|0|||
23220923|NCT03039790|64550258|FG013|Overall Study|Death|0|||
23220924|NCT03039790|64550259|FG014|Overall Study|Death|0|||
23220925|NCT03039790|64550260|FG015|Overall Study|Death|1|||
23220926|NCT03039790|64550261|FG016|Overall Study|Death|3|||
23220927|NCT03039790|64550262|FG017|Overall Study|Death|0|||
23327262|NCT02105987|64940861|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
23441804|NCT01363661|65358636|FG000|Overall Study|Lost to Follow-up|3|||
23327263|NCT02105987|64940862|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
23327264|NCT02105987|64940863|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23327265|NCT02105987|64940864|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
23327266|NCT02105987|64940859|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23327267|NCT02105987|64940860|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23441805|NCT01363661|65358637|FG001|Overall Study|Lost to Follow-up|1|||
23220928|NCT03039790|64550263|FG018|Overall Study|Death|2|||
23327268|NCT02105987|64940861|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
23627106|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
23627107|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
23220929|NCT03039790|64550264|FG019|Overall Study|Death|0|||
23220930|NCT03039790|64550245|FG000|Overall Study|Reason, not Specified|1|||
23220931|NCT03039790|64550246|FG001|Overall Study|Reason, not Specified|0|||
23327269|NCT02105987|64940862|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23564955|NCT04128293|65796598|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
23564956|NCT04128293|65796599|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
23220932|NCT03039790|64550247|FG002|Overall Study|Reason, not Specified|0|||
23220933|NCT03039790|64550248|FG003|Overall Study|Reason, not Specified|0|||
23220934|NCT03039790|64550249|FG004|Overall Study|Reason, not Specified|0|||
23220935|NCT03039790|64550250|FG005|Overall Study|Reason, not Specified|0|||
23220936|NCT03039790|64550251|FG006|Overall Study|Reason, not Specified|0|||
23220937|NCT03039790|64550252|FG007|Overall Study|Reason, not Specified|0|||
23220938|NCT03039790|64550253|FG008|Overall Study|Reason, not Specified|0|||
23220939|NCT03039790|64550254|FG009|Overall Study|Reason, not Specified|0|||
23153836|NCT00074581|64315564|FG000|Overall Study|Lost to Follow-up|16|||
23153837|NCT00074581|64315565|FG001|Overall Study|Lost to Follow-up|11|||
23153838|NCT00074581|64315564|FG000|Overall Study|Ended relationship w. index participant|117|||
23220940|NCT03039790|64550255|FG010|Overall Study|Reason, not Specified|0|||
23220941|NCT03039790|64550256|FG011|Overall Study|Reason, not Specified|0|||
23220942|NCT03039790|64550257|FG012|Overall Study|Reason, not Specified|0|||
23153839|NCT00074581|64315565|FG001|Overall Study|Ended relationship w. index participant|106|||
23153840|NCT00074581|64315564|FG000|Overall Study|Other|14|||
23153841|NCT00074581|64315565|FG001|Overall Study|Other|19|||
23220943|NCT03039790|64550258|FG013|Overall Study|Reason, not Specified|0|||
23220944|NCT03039790|64550259|FG014|Overall Study|Reason, not Specified|0|||
23220945|NCT03039790|64550260|FG015|Overall Study|Reason, not Specified|0|||
23220946|NCT03039790|64550261|FG016|Overall Study|Reason, not Specified|2|||
23220947|NCT03039790|64550262|FG017|Overall Study|Reason, not Specified|0|||
23220948|NCT03039790|64550263|FG018|Overall Study|Reason, not Specified|1|||
23220949|NCT03039790|64550264|FG019|Overall Study|Reason, not Specified|0|||
23220950|NCT03192176|64550265|FG000|Overall Study|Adverse Event|1|||
23220951|NCT03192176|64550266|FG001|Overall Study|Adverse Event|0|||
23220952|NCT03192176|64550267|FG002|Overall Study|Adverse Event|4|||
23220953|NCT03192176|64550268|FG003|Overall Study|Adverse Event|5|||
23220954|NCT03192176|64550269|FG004|Overall Study|Adverse Event|3|||
23153842|NCT01287364|64315566|FG000|Overall Study|Adverse Event|0|||
23153843|NCT01287364|64315567|FG001|Overall Study|Adverse Event|3|||
23153844|NCT01287364|64315566|FG000|Overall Study|Protocol Violation|5|||
23220955|NCT03192176|64550270|FG005|Overall Study|Adverse Event|2|||
23220956|NCT03192176|64550271|FG006|Overall Study|Adverse Event|3|||
23220957|NCT03192176|64550272|FG007|Overall Study|Adverse Event|3|||
23220958|NCT03192176|64550265|FG000|Overall Study|Lost to Follow-up|0|||
23220959|NCT03192176|64550266|FG001|Overall Study|Lost to Follow-up|0|||
23220960|NCT03192176|64550267|FG002|Overall Study|Lost to Follow-up|1|||
23220961|NCT03192176|64550268|FG003|Overall Study|Lost to Follow-up|2|||
23153845|NCT01287364|64315567|FG001|Overall Study|Protocol Violation|5|||
23153846|NCT01287364|64315566|FG000|Overall Study|Other Reason|4|||
23153847|NCT01287364|64315567|FG001|Overall Study|Other Reason|2|||
23153848|NCT00590044|64315573|FG000|Overall Study|Withdrawal by Subject|2|||
23153849|NCT00590044|64315574|FG001|Overall Study|Withdrawal by Subject|2|||
23153850|NCT00590044|64315573|FG000|Overall Study|wrong insulin arm assigned|1|||
23153851|NCT00590044|64315574|FG001|Overall Study|wrong insulin arm assigned|0|||
23153852|NCT00590044|64315573|FG000|Overall Study|Protocol Violation|1|||
23153853|NCT00590044|64315574|FG001|Overall Study|Protocol Violation|0|||
23153854|NCT03308942|64315575|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
23153855|NCT03308942|64315576|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
23153856|NCT03308942|64315577|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
23153857|NCT03308942|64315578|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
23153858|NCT03308942|64315579|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
23153859|NCT03308942|64315575|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
23153860|NCT03308942|64315576|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
23153861|NCT03308942|64315577|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
23153862|NCT03308942|64315578|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
23153863|NCT03308942|64315579|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
23153864|NCT03308942|64315575|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
23153865|NCT03308942|64315576|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
23153866|NCT03308942|64315577|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
23153867|NCT03308942|64315578|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
23153868|NCT03308942|64315579|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
23220962|NCT03192176|64550269|FG004|Overall Study|Lost to Follow-up|3|||
23220963|NCT03192176|64550270|FG005|Overall Study|Lost to Follow-up|1|||
23220964|NCT03192176|64550271|FG006|Overall Study|Lost to Follow-up|1|||
23220965|NCT03192176|64550272|FG007|Overall Study|Lost to Follow-up|1|||
23564957|NCT04128293|65796600|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
23564958|NCT03820323|65796601|FG000|Overall Study|Lost to Follow-up|2|||
23564959|NCT03820323|65796602|FG001|Overall Study|Lost to Follow-up|1|||
23564960|NCT03820323|65796601|FG000|Overall Study|Missed 12-month visit|22|||
23564961|NCT03820323|65796602|FG001|Overall Study|Missed 12-month visit|14|||
23153869|NCT03308942|64315575|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
23153870|NCT03308942|64315576|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
23153871|NCT03308942|64315577|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
23153872|NCT03308942|64315578|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
23153873|NCT03308942|64315579|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
23153874|NCT03308942|64315575|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
23153875|NCT03308942|64315576|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
23153876|NCT03308942|64315577|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
23153877|NCT03308942|64315578|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
23153878|NCT03308942|64315579|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
23153879|NCT03308942|64315575|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
23153880|NCT03308942|64315576|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
23153881|NCT03308942|64315577|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
23153882|NCT03308942|64315578|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
23153883|NCT03308942|64315579|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
23153884|NCT03308942|64315575|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
23153885|NCT03308942|64315576|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
23153886|NCT03308942|64315577|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
23153887|NCT03308942|64315578|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
23153888|NCT03308942|64315579|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
23153889|NCT01378104|64315580|FG000|Overall Study|Adverse Event|8|||
23153890|NCT01378104|64315581|FG001|Overall Study|Adverse Event|8|||
23153891|NCT01378104|64315580|FG000|Overall Study|Lack of Efficacy|7|||
23153892|NCT01378104|64315581|FG001|Overall Study|Lack of Efficacy|5|||
23153893|NCT01378104|64315580|FG000|Overall Study|Withdrawal by Subject|12|||
23153894|NCT01378104|64315581|FG001|Overall Study|Withdrawal by Subject|13|||
23153895|NCT00132496|64315584|FG000|Overall Study|Withdrawal by Subject|1|||
23153896|NCT00132496|64315585|FG001|Overall Study|Withdrawal by Subject|2|||
23153897|NCT00132496|64315584|FG000|Overall Study|Physician Decision|1|||
23153898|NCT00132496|64315585|FG001|Overall Study|Physician Decision|0|||
23153899|NCT00938717|64315588|FG000|Overall Study|Adverse Event|10|||
23153900|NCT00938717|64315589|FG001|Overall Study|Adverse Event|41|||
23153901|NCT00938717|64315588|FG000|Overall Study|Protocol Violation|11|||
23153902|NCT00938717|64315589|FG001|Overall Study|Protocol Violation|8|||
23153903|NCT00938717|64315588|FG000|Overall Study|Withdrawal by Subject|26|||
23153904|NCT00938717|64315589|FG001|Overall Study|Withdrawal by Subject|24|||
23153905|NCT00938717|64315588|FG000|Overall Study|Lost to Follow-up|13|||
23153906|NCT00938717|64315589|FG001|Overall Study|Lost to Follow-up|18|||
23153907|NCT00938717|64315588|FG000|Overall Study|Lack of Efficacy|33|||
23153908|NCT00938717|64315589|FG001|Overall Study|Lack of Efficacy|15|||
23153909|NCT00938717|64315588|FG000|Overall Study|Other reason|5|||
23153910|NCT00938717|64315589|FG001|Overall Study|Other reason|2|||
23153911|NCT01509079|64315590|FG000|Overall Study|Lack of Efficacy|0|||
23153912|NCT01509079|64315591|FG001|Overall Study|Lack of Efficacy|2|||
23153913|NCT01509079|64315590|FG000|Overall Study|started an excluded medication|0|||
23153914|NCT01509079|64315591|FG001|Overall Study|started an excluded medication|1|||
23153915|NCT00832117|64315592|FG000|Overall Study|Death|1|||
23153916|NCT00832117|64315592|FG000|Overall Study|Disease Progression|11|||
23153917|NCT00798135|64315593|FG000|Overall Study|Disease progression, relapse|11|||
23153918|NCT00798135|64315593|FG000|Overall Study|Disease progression, refractory|1|||
23153919|NCT00798135|64315593|FG000|Overall Study|Physician Decision|1|||
23153920|NCT01358760|64315598|FG000|Overall Study|Adverse Event|3|||
23153921|NCT01358760|64315599|FG001|Overall Study|Adverse Event|4|||
23153922|NCT01358760|64315600|FG002|Overall Study|Adverse Event|3|||
23153923|NCT01358760|64315598|FG000|Overall Study|Lost to Follow-up|1|||
23153924|NCT01358760|64315599|FG001|Overall Study|Lost to Follow-up|1|||
23153925|NCT01358760|64315600|FG002|Overall Study|Lost to Follow-up|3|||
23153926|NCT01358760|64315598|FG000|Overall Study|Withdrawal by Subject|5|||
23153927|NCT01358760|64315599|FG001|Overall Study|Withdrawal by Subject|3|||
23441806|NCT00858637|65358638|FG000|Active Comparison Phase|Adverse Event|14|||
23153928|NCT01358760|64315600|FG002|Overall Study|Withdrawal by Subject|2|||
23153929|NCT01358760|64315598|FG000|Overall Study|Physician Decision|1|||
23441807|NCT00858637|65358639|FG001|Active Comparison Phase|Adverse Event|0|||
23441808|NCT00858637|65358640|FG002|Active Comparison Phase|Adverse Event|0|||
23441809|NCT00858637|65358641|FG003|Active Comparison Phase|Adverse Event|9|||
23441810|NCT00858637|65358642|FG004|Active Comparison Phase|Adverse Event|0|||
23153930|NCT01358760|64315599|FG001|Overall Study|Physician Decision|0|||
23153931|NCT01358760|64315600|FG002|Overall Study|Physician Decision|1|||
23153932|NCT01358760|64315598|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
23153933|NCT01358760|64315599|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
23153934|NCT01358760|64315600|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
23153935|NCT03829241|64315603|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
23220966|NCT03192176|64550265|FG000|Overall Study|Physician Decision|1|||
23153936|NCT03829241|64315604|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
23153937|NCT03829241|64315603|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
23153938|NCT03829241|64315604|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
23153939|NCT03829241|64315603|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
23153940|NCT03829241|64315604|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
23153941|NCT03829241|64315603|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
23153942|NCT03829241|64315604|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
23153943|NCT03829241|64315603|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
23153944|NCT03829241|64315604|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
23153945|NCT03829241|64315603|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
23153946|NCT03829241|64315604|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
23153947|NCT03829241|64315603|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
23153948|NCT03829241|64315604|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
23153949|NCT03829241|64315603|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
23153950|NCT03829241|64315604|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
23153951|NCT03829241|64315603|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
23153952|NCT03829241|64315604|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
23153953|NCT03829241|64315603|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
23153954|NCT03829241|64315604|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
23153955|NCT03829241|64315603|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
23153956|NCT03829241|64315604|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
23153957|NCT03829241|64315603|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
23153958|NCT03829241|64315604|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
23153959|NCT03829241|64315603|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
23153960|NCT03829241|64315604|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
23153961|NCT03829241|64315603|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
23153962|NCT03829241|64315604|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
23153963|NCT00718549|64315605|FG000|Induction Phase|Disease Progression|1|||
23153964|NCT00718549|64315606|FG001|Induction Phase|Disease Progression|0|||
23153965|NCT00718549|64315607|FG002|Induction Phase|Disease Progression|0|||
23153966|NCT00718549|64315605|FG000|Induction Phase|Eligibility Criteria Violation|2|||
23153967|NCT00718549|64315606|FG001|Induction Phase|Eligibility Criteria Violation|0|||
23153968|NCT00718549|64315607|FG002|Induction Phase|Eligibility Criteria Violation|0|||
23153969|NCT00718549|64315605|FG000|Induction Phase|Early Termination - No Additional Info|59|||
23153970|NCT00718549|64315606|FG001|Induction Phase|Early Termination - No Additional Info|0|||
23153971|NCT00718549|64315607|FG002|Induction Phase|Early Termination - No Additional Info|0|||
23153972|NCT00718549|64315605|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
23153973|NCT00718549|64315606|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
23153974|NCT00718549|64315607|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
23153975|NCT00718549|64315605|FG000|Maintenance/ Observation Phase|Death|0|||
23153976|NCT00718549|64315606|FG001|Maintenance/ Observation Phase|Death|1|||
23153977|NCT00718549|64315607|FG002|Maintenance/ Observation Phase|Death|2|||
23153978|NCT00718549|64315605|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
23153979|NCT00718549|64315606|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
23153980|NCT00718549|64315607|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
23153981|NCT00718549|64315605|FG000|Maintenance/ Observation Phase|Progression|0|||
23153982|NCT00718549|64315606|FG001|Maintenance/ Observation Phase|Progression|5|||
23153983|NCT00718549|64315607|FG002|Maintenance/ Observation Phase|Progression|14|||
23153984|NCT00718549|64315605|FG000|Maintenance/ Observation Phase|Relapse|0|||
23153985|NCT00718549|64315606|FG001|Maintenance/ Observation Phase|Relapse|3|||
23153986|NCT00718549|64315607|FG002|Maintenance/ Observation Phase|Relapse|2|||
23153987|NCT01949155|64315608|FG000|Overall Study|Lost to Follow-up|1|||
23153988|NCT01949155|64315609|FG001|Overall Study|Lost to Follow-up|0|||
23153989|NCT01949155|64315608|FG000|Overall Study|Protocol Violation|1|||
23153990|NCT01949155|64315609|FG001|Overall Study|Protocol Violation|0|||
23153991|NCT02378220|64315610|FG000|Overall Study|Death|6|||
23153992|NCT02378220|64315611|FG001|Overall Study|Death|1|||
23153993|NCT02973087|64315612|FG000|Overall Study|Withdrawal by Subject|2|||
23153994|NCT02973087|64315613|FG001|Overall Study|Withdrawal by Subject|1|||
23153995|NCT02973087|64315612|FG000|Overall Study|Adverse Event|1|||
23153996|NCT02973087|64315613|FG001|Overall Study|Adverse Event|0|||
23153997|NCT02973087|64315612|FG000|Overall Study|other|1|||
23153998|NCT02973087|64315613|FG001|Overall Study|other|1|||
23153999|NCT01129921|64315616|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
23154000|NCT01129921|64315617|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
23154001|NCT01129921|64315616|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
23154002|NCT01129921|64315617|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
23154003|NCT01129921|64315616|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
23154004|NCT01129921|64315617|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
23154005|NCT01129921|64315616|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
23154006|NCT01129921|64315617|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
23154007|NCT00818389|64315618|FG000|Overall Study|Death|1|||
23154008|NCT00818389|64315619|FG001|Overall Study|Death|3|||
23154009|NCT00818389|64315618|FG000|Overall Study|ALS Disease Progression|1|||
23154010|NCT00818389|64315619|FG001|Overall Study|ALS Disease Progression|0|||
23154011|NCT00818389|64315618|FG000|Overall Study|Withdrawal by Subject|2|||
23154012|NCT00818389|64315619|FG001|Overall Study|Withdrawal by Subject|2|||
23154013|NCT00818389|64315618|FG000|Overall Study|Adverse Event|0|||
23154014|NCT00818389|64315619|FG001|Overall Study|Adverse Event|1|||
23154015|NCT04275297|64315620|FG000|Overall Study|Lost to Follow-up|1|||
23154016|NCT04275297|64315621|FG001|Overall Study|Lost to Follow-up|1|||
23154017|NCT01235793|64315622|FG000|Overall Study|Death|6|||
23154018|NCT02019420|64315623|FG000|Overall Study|Did not receive study drug|2|||
23154019|NCT02019420|64315624|FG001|Overall Study|Did not receive study drug|2|||
23154020|NCT02019420|64315623|FG000|Overall Study|Withdrawal by Subject|1|||
23154021|NCT02019420|64315624|FG001|Overall Study|Withdrawal by Subject|3|||
23154022|NCT02019420|64315623|FG000|Overall Study|At request of sponsor or investigator|0|||
23154023|NCT02019420|64315624|FG001|Overall Study|At request of sponsor or investigator|1|||
23154024|NCT02019420|64315623|FG000|Overall Study|Death|104|||
23154025|NCT02019420|64315624|FG001|Overall Study|Death|99|||
23154026|NCT02019420|64315623|FG000|Overall Study|Transferred to other care facility|1|||
23154027|NCT02019420|64315624|FG001|Overall Study|Transferred to other care facility|1|||
23154028|NCT00880555|64315625|FG000|Overall Study|Physician Decision|0|||
23154029|NCT00880555|64315626|FG001|Overall Study|Physician Decision|8|||
23327270|NCT02105987|64940863|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23327271|NCT02105987|64940864|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
23327272|NCT02105987|64940859|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23327273|NCT02105987|64940860|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23327274|NCT02105987|64940861|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23327275|NCT02105987|64940862|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
23154030|NCT00880555|64315627|FG002|Overall Study|Physician Decision|0|||
23154031|NCT00880555|64315628|FG003|Overall Study|Physician Decision|2|||
23154032|NCT00880555|64315629|FG004|Overall Study|Physician Decision|1|||
23154033|NCT00880555|64315630|FG005|Overall Study|Physician Decision|0|||
23154034|NCT00880555|64315625|FG000|Overall Study|Withdrawal by Subject|1|||
23154035|NCT00880555|64315626|FG001|Overall Study|Withdrawal by Subject|1|||
23154036|NCT00880555|64315627|FG002|Overall Study|Withdrawal by Subject|0|||
23154037|NCT00880555|64315628|FG003|Overall Study|Withdrawal by Subject|0|||
23154038|NCT00880555|64315629|FG004|Overall Study|Withdrawal by Subject|0|||
23154039|NCT00880555|64315630|FG005|Overall Study|Withdrawal by Subject|0|||
23154040|NCT00880555|64315625|FG000|Overall Study|Lack of resources (hired rater)|9|||
23154041|NCT00880555|64315626|FG001|Overall Study|Lack of resources (hired rater)|7|||
23154042|NCT00880555|64315627|FG002|Overall Study|Lack of resources (hired rater)|5|||
23154043|NCT00880555|64315628|FG003|Overall Study|Lack of resources (hired rater)|0|||
23154044|NCT00880555|64315629|FG004|Overall Study|Lack of resources (hired rater)|0|||
23154045|NCT00880555|64315630|FG005|Overall Study|Lack of resources (hired rater)|0|||
23154046|NCT00880555|64315625|FG000|Overall Study|Death|0|||
23154047|NCT00880555|64315626|FG001|Overall Study|Death|0|||
23154048|NCT00880555|64315627|FG002|Overall Study|Death|0|||
23154049|NCT00880555|64315628|FG003|Overall Study|Death|0|||
23154050|NCT00880555|64315629|FG004|Overall Study|Death|0|||
23154051|NCT00880555|64315630|FG005|Overall Study|Death|1|||
23154052|NCT00880555|64315625|FG000|Overall Study|Lost to Follow-up|0|||
23154053|NCT00880555|64315626|FG001|Overall Study|Lost to Follow-up|1|||
23154054|NCT00880555|64315627|FG002|Overall Study|Lost to Follow-up|0|||
23154055|NCT00880555|64315628|FG003|Overall Study|Lost to Follow-up|0|||
23154056|NCT00880555|64315629|FG004|Overall Study|Lost to Follow-up|0|||
23154057|NCT00880555|64315630|FG005|Overall Study|Lost to Follow-up|0|||
23154058|NCT04784897|64315632|FG000|Overall Study|Death|4|||
23154059|NCT04784897|64315633|FG001|Overall Study|Death|2|||
23154060|NCT04784897|64315634|FG002|Overall Study|Death|1|||
23154061|NCT04784897|64315632|FG000|Overall Study|Withdrawal by Subject|0|||
23154062|NCT04784897|64315633|FG001|Overall Study|Withdrawal by Subject|0|||
23154063|NCT04784897|64315634|FG002|Overall Study|Withdrawal by Subject|1|||
23154064|NCT01794520|64315639|FG000|Overall Study|Adverse events- related to progression|0|||
23154065|NCT01794520|64315640|FG001|Overall Study|Adverse events- related to progression|0|||
23327276|NCT02105987|64940863|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23154066|NCT01794520|64315641|FG002|Overall Study|Adverse events- related to progression|1|||
23154067|NCT01794520|64315642|FG003|Overall Study|Adverse events- related to progression|2|||
23154068|NCT01794520|64315643|FG004|Overall Study|Adverse events- related to progression|0|||
23154069|NCT01794520|64315644|FG005|Overall Study|Adverse events- related to progression|1|||
23154070|NCT01794520|64315645|FG006|Overall Study|Adverse events- related to progression|0|||
23154071|NCT01794520|64315639|FG000|Overall Study|Adverse event- not related to progression|1|||
23154072|NCT01794520|64315640|FG001|Overall Study|Adverse event- not related to progression|1|||
23154073|NCT01794520|64315641|FG002|Overall Study|Adverse event- not related to progression|0|||
23154074|NCT01794520|64315642|FG003|Overall Study|Adverse event- not related to progression|0|||
23154075|NCT01794520|64315643|FG004|Overall Study|Adverse event- not related to progression|2|||
23154076|NCT01794520|64315644|FG005|Overall Study|Adverse event- not related to progression|0|||
23154077|NCT01794520|64315645|FG006|Overall Study|Adverse event- not related to progression|0|||
23154078|NCT01794520|64315639|FG000|Overall Study|Progressive disease|5|||
23154079|NCT01794520|64315640|FG001|Overall Study|Progressive disease|6|||
23154080|NCT01794520|64315641|FG002|Overall Study|Progressive disease|2|||
23154081|NCT01794520|64315642|FG003|Overall Study|Progressive disease|5|||
23154082|NCT01794520|64315643|FG004|Overall Study|Progressive disease|27|||
23154083|NCT01794520|64315644|FG005|Overall Study|Progressive disease|18|||
23154084|NCT01794520|64315645|FG006|Overall Study|Progressive disease|0|||
23154085|NCT01794520|64315639|FG000|Overall Study|Withdrew consent|0|||
23327277|NCT02105987|64940864|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
23327278|NCT02105987|64940859|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23327279|NCT02105987|64940860|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23327280|NCT02105987|64940861|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
23327281|NCT02105987|64940862|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23327282|NCT02105987|64940863|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23327283|NCT02105987|64940864|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
23327284|NCT02105987|64940859|FG000|Continuation Phase|Protocol Violation|0|||
23327285|NCT02105987|64940860|FG001|Continuation Phase|Protocol Violation|0|||
23327286|NCT02105987|64940861|FG002|Continuation Phase|Protocol Violation|0|||
23327287|NCT02105987|64940862|FG003|Continuation Phase|Protocol Violation|0|||
23327288|NCT02105987|64940863|FG004|Continuation Phase|Protocol Violation|1|||
23327289|NCT02105987|64940864|FG005|Continuation Phase|Protocol Violation|0|||
23154086|NCT01794520|64315640|FG001|Overall Study|Withdrew consent|0|||
23154087|NCT01794520|64315641|FG002|Overall Study|Withdrew consent|1|||
23154088|NCT01794520|64315642|FG003|Overall Study|Withdrew consent|1|||
23154089|NCT01794520|64315643|FG004|Overall Study|Withdrew consent|0|||
23154090|NCT01794520|64315644|FG005|Overall Study|Withdrew consent|0|||
23154091|NCT01794520|64315645|FG006|Overall Study|Withdrew consent|0|||
23154092|NCT01794520|64315639|FG000|Overall Study|Lost to Follow-up|0|||
23154093|NCT01794520|64315640|FG001|Overall Study|Lost to Follow-up|0|||
23154094|NCT01794520|64315641|FG002|Overall Study|Lost to Follow-up|0|||
23154095|NCT01794520|64315642|FG003|Overall Study|Lost to Follow-up|0|||
23154096|NCT01794520|64315643|FG004|Overall Study|Lost to Follow-up|1|||
23154097|NCT01794520|64315644|FG005|Overall Study|Lost to Follow-up|0|||
23154098|NCT01794520|64315645|FG006|Overall Study|Lost to Follow-up|0|||
23154099|NCT01794520|64315639|FG000|Overall Study|Toxicity|0|||
23154100|NCT01794520|64315640|FG001|Overall Study|Toxicity|2|||
23154101|NCT01794520|64315641|FG002|Overall Study|Toxicity|0|||
23154102|NCT01794520|64315642|FG003|Overall Study|Toxicity|0|||
23154103|NCT01794520|64315643|FG004|Overall Study|Toxicity|0|||
23154104|NCT01794520|64315644|FG005|Overall Study|Toxicity|0|||
23154105|NCT01794520|64315645|FG006|Overall Study|Toxicity|0|||
23154106|NCT01794520|64315639|FG000|Overall Study|Study terminated by sponsor|0|||
23154107|NCT01794520|64315640|FG001|Overall Study|Study terminated by sponsor|0|||
23154108|NCT01794520|64315641|FG002|Overall Study|Study terminated by sponsor|1|||
23154109|NCT01794520|64315642|FG003|Overall Study|Study terminated by sponsor|0|||
23154110|NCT01794520|64315643|FG004|Overall Study|Study terminated by sponsor|1|||
23154111|NCT01794520|64315644|FG005|Overall Study|Study terminated by sponsor|0|||
23154112|NCT01794520|64315645|FG006|Overall Study|Study terminated by sponsor|7|||
23154113|NCT01794520|64315639|FG000|Overall Study|Death|0|||
23154114|NCT01794520|64315640|FG001|Overall Study|Death|0|||
23154115|NCT01794520|64315641|FG002|Overall Study|Death|0|||
23154116|NCT01794520|64315642|FG003|Overall Study|Death|0|||
23154117|NCT01794520|64315643|FG004|Overall Study|Death|1|||
23154118|NCT01794520|64315644|FG005|Overall Study|Death|0|||
23154119|NCT01794520|64315645|FG006|Overall Study|Death|22|||
23154120|NCT01794520|64315639|FG000|Overall Study|Other, not specified|0|||
23154121|NCT01794520|64315640|FG001|Overall Study|Other, not specified|0|||
23220967|NCT03192176|64550266|FG001|Overall Study|Physician Decision|0|||
23220968|NCT03192176|64550267|FG002|Overall Study|Physician Decision|0|||
23220969|NCT03192176|64550268|FG003|Overall Study|Physician Decision|0|||
23154122|NCT01794520|64315641|FG002|Overall Study|Other, not specified|1|||
23154123|NCT01794520|64315642|FG003|Overall Study|Other, not specified|1|||
23154124|NCT01794520|64315643|FG004|Overall Study|Other, not specified|4|||
23154125|NCT01794520|64315644|FG005|Overall Study|Other, not specified|1|||
23220970|NCT03192176|64550269|FG004|Overall Study|Physician Decision|0|||
23220971|NCT03192176|64550270|FG005|Overall Study|Physician Decision|2|||
23327290|NCT03751098|64940865|FG000|Overall Study|Withdrawal by Subject|0|||
23154126|NCT01794520|64315645|FG006|Overall Study|Other, not specified|2|||
23154127|NCT00419120|64315646|FG000|Long Term Follow up Period|study ongoing|10|||
23154128|NCT01086410|64315647|FG000|Overall Study|Adverse Event|1|||
23220972|NCT03192176|64550271|FG006|Overall Study|Physician Decision|1|||
23327291|NCT03751098|64940866|FG001|Overall Study|Withdrawal by Subject|1|||
23327292|NCT00745901|64940867|FG000|Overall Study|Adverse Event|3|||
23327293|NCT00745901|64940868|FG001|Overall Study|Adverse Event|4|||
23327294|NCT00745901|64940867|FG000|Overall Study|Protocol Violation|0|||
23327295|NCT00745901|64940868|FG001|Overall Study|Protocol Violation|1|||
23327296|NCT00745901|64940867|FG000|Overall Study|Withdrawal by Subject|1|||
23327297|NCT00745901|64940868|FG001|Overall Study|Withdrawal by Subject|0|||
23327298|NCT00745901|64940867|FG000|Overall Study|Lost to Follow-up|7|||
23327299|NCT00745901|64940868|FG001|Overall Study|Lost to Follow-up|4|||
23327300|NCT00745901|64940867|FG000|Overall Study|Pregnancy|2|||
23327301|NCT00745901|64940868|FG001|Overall Study|Pregnancy|4|||
23327302|NCT00745901|64940867|FG000|Overall Study|Lack of compliance|2|||
23327303|NCT00745901|64940868|FG001|Overall Study|Lack of compliance|2|||
23327304|NCT00745901|64940867|FG000|Overall Study|Patient's next menses did not start with|1|||
23327305|NCT00745901|64940868|FG001|Overall Study|Patient's next menses did not start with|0|||
23327306|NCT00745901|64940867|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
23327307|NCT00745901|64940868|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
23327308|NCT00745901|64940867|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
23327309|NCT00745901|64940868|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
23327310|NCT00745901|64940867|FG000|Overall Study|Patient didn't take any study medication|7|||
23327311|NCT00745901|64940868|FG001|Overall Study|Patient didn't take any study medication|3|||
23327312|NCT00315458|64940871|FG000|Overall Study|Administrative|0|||
23327313|NCT00315458|64940872|FG001|Overall Study|Administrative|3|||
23327314|NCT00315458|64940873|FG002|Overall Study|Administrative|8|||
23327315|NCT00315458|64940874|FG003|Overall Study|Administrative|21|||
23327316|NCT00315458|64940871|FG000|Overall Study|Adverse Event|2|||
23327317|NCT00315458|64940872|FG001|Overall Study|Adverse Event|4|||
23327318|NCT00315458|64940873|FG002|Overall Study|Adverse Event|23|||
23327319|NCT00315458|64940874|FG003|Overall Study|Adverse Event|3|||
23327320|NCT00315458|64940871|FG000|Overall Study|Lost to Follow-up|1|||
23327321|NCT00315458|64940872|FG001|Overall Study|Lost to Follow-up|2|||
23327322|NCT00315458|64940873|FG002|Overall Study|Lost to Follow-up|0|||
23154129|NCT01086410|64315648|FG001|Overall Study|Adverse Event|0|||
23154130|NCT01086410|64315649|FG002|Overall Study|Adverse Event|0|||
23154131|NCT01086410|64315650|FG003|Overall Study|Adverse Event|2|||
23154132|NCT01086410|64315647|FG000|Overall Study|Lack of Efficacy|1|||
23154133|NCT01086410|64315648|FG001|Overall Study|Lack of Efficacy|1|||
23154134|NCT01086410|64315649|FG002|Overall Study|Lack of Efficacy|0|||
23154135|NCT01086410|64315650|FG003|Overall Study|Lack of Efficacy|0|||
23154136|NCT01086410|64315647|FG000|Overall Study|Protocol Violation|1|||
23154137|NCT01086410|64315648|FG001|Overall Study|Protocol Violation|1|||
23154138|NCT01086410|64315649|FG002|Overall Study|Protocol Violation|0|||
23154139|NCT01086410|64315650|FG003|Overall Study|Protocol Violation|0|||
23154140|NCT01086410|64315647|FG000|Overall Study|Lost to Follow-up|0|||
23154141|NCT01086410|64315648|FG001|Overall Study|Lost to Follow-up|0|||
23154142|NCT01086410|64315649|FG002|Overall Study|Lost to Follow-up|1|||
23154143|NCT01086410|64315650|FG003|Overall Study|Lost to Follow-up|0|||
23154144|NCT03794583|64315651|FG000|Overall Study|Death|8|||
23154145|NCT03794583|64315651|FG000|Overall Study|Study Terminated by Sponsor|24|||
23154146|NCT03794583|64315651|FG000|Overall Study|Withdrawal by Subject|9|||
23564962|NCT03820323|65796601|FG000|Overall Study|Death|2|||
23327323|NCT00315458|64940874|FG003|Overall Study|Lost to Follow-up|2|||
23327324|NCT00315458|64940871|FG000|Overall Study|Withdrawal by Subject|0|||
23327325|NCT00315458|64940872|FG001|Overall Study|Withdrawal by Subject|3|||
23327326|NCT00315458|64940873|FG002|Overall Study|Withdrawal by Subject|0|||
23327327|NCT00315458|64940874|FG003|Overall Study|Withdrawal by Subject|2|||
23327328|NCT00315458|64940871|FG000|Overall Study|Lack of Efficacy|0|||
23327329|NCT00315458|64940872|FG001|Overall Study|Lack of Efficacy|0|||
23441811|NCT00858637|65358643|FG005|Active Comparison Phase|Adverse Event|0|||
23441812|NCT00858637|65358638|FG000|Active Comparison Phase|Death|1|||
23441813|NCT00858637|65358639|FG001|Active Comparison Phase|Death|0|||
23441814|NCT00858637|65358640|FG002|Active Comparison Phase|Death|0|||
23441815|NCT00858637|65358641|FG003|Active Comparison Phase|Death|1|||
23441816|NCT00858637|65358642|FG004|Active Comparison Phase|Death|0|||
23441817|NCT00858637|65358643|FG005|Active Comparison Phase|Death|0|||
23441818|NCT00858637|65358638|FG000|Active Comparison Phase|Physician Decision|1|||
23441819|NCT00858637|65358639|FG001|Active Comparison Phase|Physician Decision|0|||
23327330|NCT00315458|64940873|FG002|Overall Study|Lack of Efficacy|20|||
23327331|NCT00315458|64940874|FG003|Overall Study|Lack of Efficacy|1|||
23327332|NCT00315458|64940871|FG000|Overall Study|Did not qualify|0|||
23441820|NCT00858637|65358640|FG002|Active Comparison Phase|Physician Decision|0|||
23327333|NCT00315458|64940872|FG001|Overall Study|Did not qualify|0|||
23441821|NCT00858637|65358641|FG003|Active Comparison Phase|Physician Decision|1|||
23441822|NCT00858637|65358642|FG004|Active Comparison Phase|Physician Decision|0|||
23564963|NCT03820323|65796602|FG001|Overall Study|Death|1|||
23154149|NCT04498169|64315656|FG000|Study Completion|Adverse Event|1|||
23154150|NCT04498169|64315657|FG001|Study Completion|Adverse Event|1|||
23564964|NCT03820323|65796601|FG000|Overall Study|Transferred out|13|||
23154151|NCT00916149|64315662|FG000|Overall Study|Lost to Follow-up|3|||
23154152|NCT00916149|64315663|FG001|Overall Study|Lost to Follow-up|2|||
23154153|NCT00916149|64315664|FG002|Overall Study|Lost to Follow-up|0|||
23154154|NCT00916149|64315662|FG000|Overall Study|Unable to place scalp EEG leads|1|||
23154155|NCT00916149|64315663|FG001|Overall Study|Unable to place scalp EEG leads|0|||
23154156|NCT00916149|64315664|FG002|Overall Study|Unable to place scalp EEG leads|0|||
23154157|NCT00851682|64315675|FG000|Overall Study|screen failure|5|||
23154158|NCT00851682|64315676|FG001|Overall Study|screen failure|0|||
23154159|NCT00943579|64315677|FG000|Overall Study|Adverse Event|4|||
23154160|NCT00943579|64315678|FG001|Overall Study|Adverse Event|3|||
23154161|NCT00943579|64315677|FG000|Overall Study|Lack of Efficacy|2|||
23154162|NCT00943579|64315678|FG001|Overall Study|Lack of Efficacy|2|||
23154163|NCT04246801|64315679|FG000|Overall Study|Adverse Event|1|||
23154164|NCT04246801|64315680|FG001|Overall Study|Adverse Event|1|||
23154165|NCT04246801|64315679|FG000|Overall Study|Protocol Violation|1|||
23154166|NCT04246801|64315680|FG001|Overall Study|Protocol Violation|1|||
23154167|NCT04246801|64315679|FG000|Overall Study|Lack of Efficacy|0|||
23154168|NCT04246801|64315680|FG001|Overall Study|Lack of Efficacy|2|||
23154169|NCT04246801|64315679|FG000|Overall Study|Lost to Follow-up|1|||
23154170|NCT04246801|64315680|FG001|Overall Study|Lost to Follow-up|1|||
23154171|NCT04246801|64315679|FG000|Overall Study|Withdrawal by Subject|2|||
23154172|NCT04246801|64315680|FG001|Overall Study|Withdrawal by Subject|1|||
23154173|NCT00701090|64315683|FG000|Overall Study|Adverse Event|11|||
23154174|NCT00701090|64315684|FG001|Overall Study|Adverse Event|2|||
23154175|NCT00701090|64315683|FG000|Overall Study|Death|0|||
23154176|NCT00701090|64315684|FG001|Overall Study|Death|1|||
23154177|NCT00701090|64315683|FG000|Overall Study|Lack of Efficacy|5|||
23154178|NCT00701090|64315684|FG001|Overall Study|Lack of Efficacy|4|||
23154179|NCT00701090|64315683|FG000|Overall Study|Lost to Follow-up|9|||
23220973|NCT03192176|64550272|FG007|Overall Study|Physician Decision|0|||
23220974|NCT03192176|64550265|FG000|Overall Study|Protocol Deviation|1|||
23220975|NCT03192176|64550266|FG001|Overall Study|Protocol Deviation|1|||
23220976|NCT03192176|64550267|FG002|Overall Study|Protocol Deviation|0|||
23220977|NCT03192176|64550268|FG003|Overall Study|Protocol Deviation|0|||
23441823|NCT00858637|65358643|FG005|Active Comparison Phase|Physician Decision|0|||
23441824|NCT00858637|65358638|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
23441825|NCT00858637|65358639|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
23441826|NCT00858637|65358640|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
23441827|NCT00858637|65358641|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
23441828|NCT00858637|65358642|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
23441829|NCT00858637|65358643|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
23441830|NCT00858637|65358638|FG000|Active Comparison Phase|Other Reasons|1|||
23441831|NCT00858637|65358639|FG001|Active Comparison Phase|Other Reasons|0|||
23441832|NCT00858637|65358640|FG002|Active Comparison Phase|Other Reasons|0|||
23441833|NCT00858637|65358641|FG003|Active Comparison Phase|Other Reasons|1|||
23441834|NCT00858637|65358642|FG004|Active Comparison Phase|Other Reasons|0|||
23441835|NCT00858637|65358643|FG005|Active Comparison Phase|Other Reasons|0|||
23441836|NCT00858637|65358638|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
23441837|NCT00858637|65358639|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
23441838|NCT00858637|65358640|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
23441839|NCT00858637|65358641|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
23441840|NCT00858637|65358642|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
23441841|NCT00858637|65358643|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
23441842|NCT00858637|65358638|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23441843|NCT00858637|65358639|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23441844|NCT00858637|65358640|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23441845|NCT00858637|65358641|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23154180|NCT00701090|64315684|FG001|Overall Study|Lost to Follow-up|9|||
23154181|NCT00701090|64315683|FG000|Overall Study|Physician Decision|3|||
23154182|NCT00701090|64315684|FG001|Overall Study|Physician Decision|4|||
23154183|NCT00701090|64315683|FG000|Overall Study|Protocol Violation|2|||
23220978|NCT03192176|64550269|FG004|Overall Study|Protocol Deviation|2|||
23220979|NCT03192176|64550270|FG005|Overall Study|Protocol Deviation|0|||
23220980|NCT03192176|64550271|FG006|Overall Study|Protocol Deviation|0|||
23220981|NCT03192176|64550272|FG007|Overall Study|Protocol Deviation|0|||
23441846|NCT00858637|65358642|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
23441847|NCT00858637|65358643|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
23441848|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Technical problems|0|||
23441849|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Technical problems|0|||
23154184|NCT00701090|64315684|FG001|Overall Study|Protocol Violation|3|||
23154185|NCT00701090|64315683|FG000|Overall Study|Withdrawal by Subject|11|||
23154186|NCT00701090|64315684|FG001|Overall Study|Withdrawal by Subject|16|||
23154187|NCT00701090|64315683|FG000|Overall Study|Other|7|||
23154188|NCT00701090|64315684|FG001|Overall Study|Other|12|||
23154189|NCT04029116|64315685|FG000|Overall Study|Adverse Event|0|||
23220982|NCT03192176|64550265|FG000|Overall Study|Withdrawal by Subject|3|||
23441850|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Technical problems|0|||
23220983|NCT03192176|64550266|FG001|Overall Study|Withdrawal by Subject|4|||
23220984|NCT03192176|64550267|FG002|Overall Study|Withdrawal by Subject|0|||
23220985|NCT03192176|64550268|FG003|Overall Study|Withdrawal by Subject|4|||
23220986|NCT03192176|64550269|FG004|Overall Study|Withdrawal by Subject|3|||
23220987|NCT03192176|64550270|FG005|Overall Study|Withdrawal by Subject|4|||
23220988|NCT03192176|64550271|FG006|Overall Study|Withdrawal by Subject|4|||
23220989|NCT03192176|64550272|FG007|Overall Study|Withdrawal by Subject|2|||
23220990|NCT03192176|64550265|FG000|Overall Study|Miscellaneous|1|||
23220991|NCT03192176|64550266|FG001|Overall Study|Miscellaneous|0|||
23220992|NCT03192176|64550267|FG002|Overall Study|Miscellaneous|1|||
23220993|NCT03192176|64550268|FG003|Overall Study|Miscellaneous|1|||
23220994|NCT03192176|64550269|FG004|Overall Study|Miscellaneous|1|||
23220995|NCT03192176|64550270|FG005|Overall Study|Miscellaneous|2|||
23220996|NCT03192176|64550271|FG006|Overall Study|Miscellaneous|0|||
23220997|NCT03192176|64550272|FG007|Overall Study|Miscellaneous|1|||
23220998|NCT03037307|64550273|FG000|Period 1|Did Not Meet Study Criteria|0|||
23220999|NCT03037307|64550274|FG001|Period 1|Did Not Meet Study Criteria|0|||
23221000|NCT03037307|64550275|FG002|Period 1|Did Not Meet Study Criteria|0|||
23221001|NCT03037307|64550276|FG003|Period 1|Did Not Meet Study Criteria|1|||
23221002|NCT03037307|64550277|FG004|Period 1|Did Not Meet Study Criteria|0|||
23221003|NCT03037307|64550278|FG005|Period 1|Did Not Meet Study Criteria|0|||
23221004|NCT01131078|64550282|FG000|Overall Study|Adverse Event|22|||
23221005|NCT01131078|64550283|FG001|Overall Study|Adverse Event|12|||
23221006|NCT01131078|64550284|FG002|Overall Study|Adverse Event|17|||
23221007|NCT01131078|64550282|FG000|Overall Study|Progressive Disease|58|||
23221008|NCT01131078|64550283|FG001|Overall Study|Progressive Disease|77|||
23221009|NCT01131078|64550284|FG002|Overall Study|Progressive Disease|71|||
23221010|NCT01131078|64550282|FG000|Overall Study|Protocol Violation|1|||
23221011|NCT01131078|64550283|FG001|Overall Study|Protocol Violation|0|||
23221012|NCT01131078|64550284|FG002|Overall Study|Protocol Violation|0|||
23221013|NCT01131078|64550282|FG000|Overall Study|Lost to Follow-up|1|||
23221014|NCT01131078|64550283|FG001|Overall Study|Lost to Follow-up|1|||
23221015|NCT01131078|64550284|FG002|Overall Study|Lost to Follow-up|1|||
23221016|NCT01131078|64550282|FG000|Overall Study|Withdrawal by Subject|2|||
23221017|NCT01131078|64550283|FG001|Overall Study|Withdrawal by Subject|4|||
23221018|NCT01131078|64550284|FG002|Overall Study|Withdrawal by Subject|3|||
23221019|NCT01131078|64550282|FG000|Overall Study|Non-compliance|3|||
23627108|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
23627109|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
23627110|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
23627111|NCT03672175|66020502|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
23627112|NCT03672175|66020503|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
23627113|NCT03672175|66020504|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
23627114|NCT04354168|66020510|FG000|Overall Study|Lost to Follow-up|22|||
23627115|NCT00612352|66020511|FG000|Overall Study|Adverse Event|1|||
23627116|NCT00612352|66020512|FG001|Overall Study|Adverse Event|0|||
23627117|NCT00612352|66020511|FG000|Overall Study|Withdrawal by Subject|3|||
23627118|NCT00612352|66020512|FG001|Overall Study|Withdrawal by Subject|5|||
23627119|NCT00612352|66020511|FG000|Overall Study|moved out of state|1|||
23627120|NCT00612352|66020512|FG001|Overall Study|moved out of state|0|||
23627121|NCT00612352|66020511|FG000|Overall Study|didn't return calls/show up on test date|4|||
23221020|NCT01131078|64550283|FG001|Overall Study|Non-compliance|0|||
23221021|NCT01131078|64550284|FG002|Overall Study|Non-compliance|0|||
23221022|NCT01131078|64550282|FG000|Overall Study|Physician Decision|10|||
23221023|NCT01131078|64550283|FG001|Overall Study|Physician Decision|6|||
23221024|NCT01131078|64550284|FG002|Overall Study|Physician Decision|8|||
23221025|NCT01131078|64550282|FG000|Overall Study|Death|4|||
23221026|NCT01131078|64550283|FG001|Overall Study|Death|0|||
23221027|NCT01131078|64550284|FG002|Overall Study|Death|2|||
23221028|NCT01131078|64550282|FG000|Overall Study|Other|0|||
23221029|NCT01131078|64550283|FG001|Overall Study|Other|1|||
23221030|NCT01131078|64550284|FG002|Overall Study|Other|0|||
23221031|NCT00093470|64550287|FG000|Overall Study|Disease progression|39|||
23221032|NCT00093470|64550288|FG001|Overall Study|Disease progression|0|||
23627122|NCT00612352|66020512|FG001|Overall Study|didn't return calls/show up on test date|1|||
23627123|NCT00302159|66024363|FG000|Overall Study|pt declined before treatment started|1|||
23627124|NCT00302159|66024363|FG000|Overall Study|pt started Avastin|1|||
23627125|NCT04016272|66024368|FG000|Overall Study|Withdrawal by Subject|1|||
23627126|NCT04016272|66024369|FG001|Overall Study|Withdrawal by Subject|2|||
23627127|NCT02641587|66024370|FG000|Confinement Period|Adverse Event|1|||
23627128|NCT02641587|66024371|FG001|Confinement Period|Adverse Event|0|||
23221033|NCT00093470|64550287|FG000|Overall Study|Adverse Event|15|||
23221034|NCT00093470|64550288|FG001|Overall Study|Adverse Event|0|||
23221035|NCT00093470|64550287|FG000|Overall Study|Death|2|||
23221036|NCT00093470|64550288|FG001|Overall Study|Death|0|||
23221037|NCT00093470|64550287|FG000|Overall Study|Withdrawal by Subject|8|||
23221038|NCT00093470|64550288|FG001|Overall Study|Withdrawal by Subject|0|||
23221039|NCT00093470|64550287|FG000|Overall Study|Alternative therapy|2|||
23221040|NCT00093470|64550288|FG001|Overall Study|Alternative therapy|0|||
23221041|NCT00093470|64550287|FG000|Overall Study|Other complicating disease|3|||
23221042|NCT00093470|64550288|FG001|Overall Study|Other complicating disease|0|||
23221043|NCT00093470|64550287|FG000|Overall Study|Physician Decision|2|||
23221044|NCT00093470|64550288|FG001|Overall Study|Physician Decision|0|||
23221045|NCT00093470|64550287|FG000|Overall Study|Never started treatment|1|||
23221046|NCT00093470|64550288|FG001|Overall Study|Never started treatment|0|||
23221047|NCT00093470|64550287|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
23221048|NCT00093470|64550288|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
23221049|NCT02215616|64550289|FG000|Overall Study|Sponsor requested to stop study drug|0|||
23221050|NCT02215616|64550290|FG001|Overall Study|Sponsor requested to stop study drug|0|||
23221051|NCT02215616|64550291|FG002|Overall Study|Sponsor requested to stop study drug|1|||
23221052|NCT02215616|64550292|FG003|Overall Study|Sponsor requested to stop study drug|4|||
23221053|NCT02215616|64550289|FG000|Overall Study|Death|1|||
23221054|NCT02215616|64550290|FG001|Overall Study|Death|0|||
23221055|NCT02215616|64550291|FG002|Overall Study|Death|0|||
23221056|NCT02215616|64550292|FG003|Overall Study|Death|0|||
23221057|NCT02215616|64550289|FG000|Overall Study|Adverse Event|7|||
23221058|NCT02215616|64550290|FG001|Overall Study|Adverse Event|4|||
23221059|NCT02215616|64550291|FG002|Overall Study|Adverse Event|9|||
23441851|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Technical problems|1|||
23441852|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
23441853|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
23221060|NCT02215616|64550292|FG003|Overall Study|Adverse Event|2|||
23221061|NCT02215616|64550289|FG000|Overall Study|Withdrawal by Subject|1|||
23221062|NCT02215616|64550290|FG001|Overall Study|Withdrawal by Subject|8|||
23221063|NCT02215616|64550291|FG002|Overall Study|Withdrawal by Subject|2|||
23221064|NCT02215616|64550292|FG003|Overall Study|Withdrawal by Subject|5|||
23221065|NCT02215616|64550289|FG000|Overall Study|Non-compliance|0|||
23221066|NCT02215616|64550290|FG001|Overall Study|Non-compliance|2|||
23221067|NCT02215616|64550291|FG002|Overall Study|Non-compliance|1|||
23221068|NCT02215616|64550292|FG003|Overall Study|Non-compliance|0|||
23221069|NCT02215616|64550289|FG000|Overall Study|Protocol Violation|0|||
23221070|NCT02215616|64550290|FG001|Overall Study|Protocol Violation|2|||
23221071|NCT02215616|64550291|FG002|Overall Study|Protocol Violation|0|||
23221072|NCT02215616|64550292|FG003|Overall Study|Protocol Violation|0|||
23221073|NCT02215616|64550289|FG000|Overall Study|Lost to Follow-up|1|||
23221074|NCT02215616|64550290|FG001|Overall Study|Lost to Follow-up|1|||
23221075|NCT02215616|64550291|FG002|Overall Study|Lost to Follow-up|0|||
23221076|NCT02215616|64550292|FG003|Overall Study|Lost to Follow-up|1|||
23221077|NCT02215616|64550289|FG000|Overall Study|Other than specified|1|||
23221078|NCT02215616|64550290|FG001|Overall Study|Other than specified|0|||
23221079|NCT02215616|64550291|FG002|Overall Study|Other than specified|1|||
23221080|NCT02215616|64550292|FG003|Overall Study|Other than specified|1|||
23221081|NCT00422669|64550293|FG000|Overall Study|The study was terminated early.|98|||
23221082|NCT00422669|64550294|FG001|Overall Study|The study was terminated early.|100|||
23221083|NCT00422669|64550295|FG002|Overall Study|The study was terminated early.|7|||
23221084|NCT00688623|64550297|FG000|Overall Study|Adverse Event|22|||
23221085|NCT00688623|64550297|FG000|Overall Study|abnormal lab value|1|||
23221086|NCT00688623|64550297|FG000|Overall Study|Withdrawal by Subject|4|||
23221087|NCT00688623|64550297|FG000|Overall Study|Death|3|||
23221088|NCT00688623|64550297|FG000|Overall Study|disease progression|23|||
23221089|NCT00688623|64550297|FG000|Overall Study|Protocol Violation|2|||
23221090|NCT00959894|64550298|FG000|Overall Study|Lost to Follow-up|10|||
23221091|NCT00959894|64550298|FG000|Overall Study|Adverse Event|3|||
23221092|NCT00959894|64550298|FG000|Overall Study|Withdrawal by Subject|1|||
23221093|NCT00959894|64550298|FG000|Overall Study|Need for contraindicated medication|1|||
23221094|NCT00959894|64550298|FG000|Overall Study|Subject moved out of town|1|||
23221095|NCT01688999|64550299|FG000|Overall Study|Withdrawal by Subject|5|||
23221096|NCT01688999|64550300|FG001|Overall Study|Withdrawal by Subject|1|||
23221097|NCT01688999|64550301|FG002|Overall Study|Withdrawal by Subject|1|||
23221098|NCT01688999|64550299|FG000|Overall Study|Adverse Event|2|||
23221099|NCT01688999|64550300|FG001|Overall Study|Adverse Event|0|||
23221100|NCT01688999|64550301|FG002|Overall Study|Adverse Event|2|||
23221101|NCT01688999|64550299|FG000|Overall Study|Ineligible/Not treated|1|||
23564965|NCT03820323|65796602|FG001|Overall Study|Transferred out|11|||
23564966|NCT03820323|65796601|FG000|Overall Study|Terminated|0|||
23221102|NCT01688999|64550300|FG001|Overall Study|Ineligible/Not treated|0|||
23221103|NCT01688999|64550301|FG002|Overall Study|Ineligible/Not treated|0|||
23221104|NCT01376388|64550302|FG000|Overall Study|Adverse Event|13|||
23564967|NCT03820323|65796602|FG001|Overall Study|Terminated|3|||
23441854|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
23564968|NCT03820323|65796601|FG000|Overall Study|Withdrawal by Subject|1|||
23564969|NCT03820323|65796602|FG001|Overall Study|Withdrawal by Subject|6|||
23564970|NCT04404478|65796604|FG000|Overall Study|Withdrawal by Subject|1|||
23564971|NCT04404478|65796605|FG001|Overall Study|Withdrawal by Subject|3|||
23564972|NCT04599101|65796606|FG000|Overall Study|Lost to Follow-up|5|||
23627129|NCT02641587|66024370|FG000|Confinement Period|Withdrawal by Subject|2|||
23627130|NCT02641587|66024371|FG001|Confinement Period|Withdrawal by Subject|1|||
23627131|NCT02641587|66024370|FG000|Ambulatory Period|Withdrawal by Subject|1|||
23627132|NCT02641587|66024371|FG001|Ambulatory Period|Withdrawal by Subject|0|||
23627133|NCT00664105|66024372|FG000|Overall Study|Death|3|||
23627134|NCT00664105|66024372|FG000|Overall Study|Withdrawal by Subject|5|||
23627135|NCT00664105|66024372|FG000|Overall Study|Adverse Event|9|||
23221105|NCT01376388|64550302|FG000|Overall Study|Lack of Efficacy|2|||
23221106|NCT01376388|64550302|FG000|Overall Study|Withdrawal by Subject|3|||
23221107|NCT01628393|64550303|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
23221108|NCT01628393|64550304|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23221109|NCT01628393|64550305|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23221110|NCT01628393|64550306|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23221111|NCT01628393|64550307|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23221112|NCT01628393|64550303|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
23221113|NCT01628393|64550304|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
23221114|NCT01628393|64550305|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
23221115|NCT01628393|64550306|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
23221116|NCT01628393|64550307|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
23221117|NCT01628393|64550303|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
23221118|NCT01628393|64550304|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
23221119|NCT01628393|64550305|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
23154190|NCT04029116|64315686|FG001|Overall Study|Adverse Event|2|||
23154191|NCT04029116|64315685|FG000|Overall Study|Lost to Follow-up|3|||
23154192|NCT04029116|64315686|FG001|Overall Study|Lost to Follow-up|5|||
23154193|NCT04029116|64315685|FG000|Overall Study|Physician Decision|2|||
23154194|NCT04029116|64315686|FG001|Overall Study|Physician Decision|0|||
23154195|NCT04029116|64315685|FG000|Overall Study|Pregnancy|1|||
23154196|NCT04029116|64315686|FG001|Overall Study|Pregnancy|2|||
23154197|NCT04029116|64315685|FG000|Overall Study|Withdrawal by Subject|4|||
23154198|NCT04029116|64315686|FG001|Overall Study|Withdrawal by Subject|6|||
23154199|NCT04029116|64315685|FG000|Overall Study|Other|2|||
23154200|NCT04029116|64315686|FG001|Overall Study|Other|1|||
23154201|NCT02689284|64315691|FG000|Overall Study|Adverse Event|1|||
23154202|NCT02689284|64315692|FG001|Overall Study|Adverse Event|8|||
23154203|NCT02689284|64315691|FG000|Overall Study|Death|0|||
23154204|NCT02689284|64315692|FG001|Overall Study|Death|1|||
23154205|NCT02689284|64315691|FG000|Overall Study|Physician Decision|1|||
23154206|NCT02689284|64315692|FG001|Overall Study|Physician Decision|2|||
23154207|NCT02689284|64315691|FG000|Overall Study|Withdrawal by Subject|0|||
23154208|NCT02689284|64315692|FG001|Overall Study|Withdrawal by Subject|1|||
23154209|NCT02689284|64315691|FG000|Overall Study|progression of cancer|1|||
23154210|NCT02689284|64315692|FG001|Overall Study|progression of cancer|72|||
23154211|NCT02689284|64315691|FG000|Overall Study|decreased heart function|0|||
23221120|NCT01628393|64550306|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
23221121|NCT01628393|64550307|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
23221122|NCT01628393|64550303|FG000|Blinded Active Extension Period|Adverse Event|0|||
23627136|NCT00664105|66024372|FG000|Overall Study|Disease progression|7|||
23221123|NCT01628393|64550304|FG001|Blinded Active Extension Period|Adverse Event|1|||
23221124|NCT01628393|64550305|FG002|Blinded Active Extension Period|Adverse Event|0|||
23221125|NCT01628393|64550306|FG003|Blinded Active Extension Period|Adverse Event|2|||
23221126|NCT01628393|64550307|FG004|Blinded Active Extension Period|Adverse Event|2|||
23221127|NCT01628393|64550303|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
23221128|NCT01628393|64550304|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
23221129|NCT01628393|64550305|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
23221130|NCT01628393|64550306|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
23327334|NCT00315458|64940873|FG002|Overall Study|Did not qualify|1|||
23327335|NCT00315458|64940874|FG003|Overall Study|Did not qualify|0|||
23627137|NCT03004404|66024373|FG000|Period 2|Adverse Event|0|||
23627138|NCT03004404|66024374|FG001|Period 2|Adverse Event|0|||
23627139|NCT03004404|66024375|FG002|Period 2|Adverse Event|0|||
23627140|NCT03004404|66024376|FG003|Period 2|Adverse Event|0|||
23627141|NCT03004404|66024377|FG004|Period 2|Adverse Event|0|||
23627142|NCT03004404|66024378|FG005|Period 2|Adverse Event|0|||
23154212|NCT02689284|64315692|FG001|Overall Study|decreased heart function|1|||
23327336|NCT02064816|64940875|FG000|Overall Study|Adverse Event|3|||
23327337|NCT02064816|64940876|FG001|Overall Study|Adverse Event|2|||
23627143|NCT03004404|66024379|FG006|Period 2|Adverse Event|0|||
23627144|NCT03004404|66024380|FG007|Period 2|Adverse Event|0|||
23627145|NCT03004404|66024381|FG008|Period 2|Adverse Event|1|||
23154213|NCT02689284|64315691|FG000|Overall Study|concern for anemia|0|||
23154214|NCT02689284|64315692|FG001|Overall Study|concern for anemia|1|||
23154215|NCT02689284|64315691|FG000|Overall Study|no measurable cancer for evaluation|0|||
23154216|NCT02689284|64315692|FG001|Overall Study|no measurable cancer for evaluation|1|||
23154217|NCT01987960|64315694|FG000|Period 1|Adverse Event|24|||
23154218|NCT01987960|64315695|FG001|Period 1|Adverse Event|0|||
23154219|NCT01987960|64315696|FG002|Period 1|Adverse Event|0|||
23154220|NCT01987960|64315697|FG003|Period 1|Adverse Event|0|||
23154221|NCT01987960|64315694|FG000|Period 1|Lack of Efficacy|4|||
23154222|NCT01987960|64315695|FG001|Period 1|Lack of Efficacy|0|||
23154223|NCT01987960|64315696|FG002|Period 1|Lack of Efficacy|0|||
23154224|NCT01987960|64315697|FG003|Period 1|Lack of Efficacy|0|||
23154225|NCT01987960|64315694|FG000|Period 1|Non-compliance with IMP|6|||
23154226|NCT01987960|64315695|FG001|Period 1|Non-compliance with IMP|0|||
23154227|NCT01987960|64315696|FG002|Period 1|Non-compliance with IMP|0|||
23154228|NCT01987960|64315697|FG003|Period 1|Non-compliance with IMP|0|||
23154229|NCT01987960|64315694|FG000|Period 1|Protocol Violation|12|||
23154230|NCT01987960|64315695|FG001|Period 1|Protocol Violation|0|||
23154231|NCT01987960|64315696|FG002|Period 1|Protocol Violation|0|||
23154232|NCT01987960|64315697|FG003|Period 1|Protocol Violation|0|||
23154233|NCT01987960|64315694|FG000|Period 1|Withdrawal by Subject|21|||
23154234|NCT01987960|64315695|FG001|Period 1|Withdrawal by Subject|0|||
23154235|NCT01987960|64315696|FG002|Period 1|Withdrawal by Subject|0|||
23441855|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
23441856|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
23441857|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
23441858|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
23441859|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
23441860|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
23154236|NCT01987960|64315697|FG003|Period 1|Withdrawal by Subject|0|||
23154237|NCT01987960|64315694|FG000|Period 1|Lost to Follow-up|40|||
23154238|NCT01987960|64315695|FG001|Period 1|Lost to Follow-up|0|||
23154239|NCT01987960|64315696|FG002|Period 1|Lost to Follow-up|0|||
23154240|NCT01987960|64315697|FG003|Period 1|Lost to Follow-up|0|||
23154241|NCT01987960|64315694|FG000|Period 1|administrative or other reason|75|||
23154242|NCT01987960|64315695|FG001|Period 1|administrative or other reason|0|||
23154243|NCT01987960|64315696|FG002|Period 1|administrative or other reason|0|||
23154244|NCT01987960|64315697|FG003|Period 1|administrative or other reason|0|||
23154245|NCT01987960|64315694|FG000|Period 1|Withdrawal of consent before treatment|4|||
23154246|NCT01987960|64315695|FG001|Period 1|Withdrawal of consent before treatment|0|||
23154247|NCT01987960|64315696|FG002|Period 1|Withdrawal of consent before treatment|0|||
23154248|NCT01987960|64315697|FG003|Period 1|Withdrawal of consent before treatment|0|||
23154249|NCT01987960|64315694|FG000|Period 2|Adverse Event|0|||
23154250|NCT01987960|64315695|FG001|Period 2|Adverse Event|0|||
23154251|NCT01987960|64315696|FG002|Period 2|Adverse Event|1|||
23154252|NCT01987960|64315697|FG003|Period 2|Adverse Event|0|||
23154253|NCT01987960|64315694|FG000|Period 2|Withdrawal by Subject|0|||
23154254|NCT01987960|64315695|FG001|Period 2|Withdrawal by Subject|0|||
23154255|NCT01987960|64315696|FG002|Period 2|Withdrawal by Subject|1|||
23154256|NCT01987960|64315697|FG003|Period 2|Withdrawal by Subject|0|||
23154257|NCT01987960|64315694|FG000|Period 2|Administrative or other reason|0|||
23154258|NCT01987960|64315695|FG001|Period 2|Administrative or other reason|5|||
23154259|NCT01987960|64315696|FG002|Period 2|Administrative or other reason|7|||
23154260|NCT01987960|64315697|FG003|Period 2|Administrative or other reason|0|||
23154261|NCT01987960|64315694|FG000|Period 3|Adverse Event|0|||
23154262|NCT01987960|64315695|FG001|Period 3|Adverse Event|0|||
23154263|NCT01987960|64315696|FG002|Period 3|Adverse Event|0|||
23154264|NCT01987960|64315697|FG003|Period 3|Adverse Event|7|||
23154265|NCT01987960|64315694|FG000|Period 3|Non-compliance with IMP|0|||
23154266|NCT01987960|64315695|FG001|Period 3|Non-compliance with IMP|0|||
23154267|NCT01987960|64315696|FG002|Period 3|Non-compliance with IMP|0|||
23154268|NCT01987960|64315697|FG003|Period 3|Non-compliance with IMP|1|||
23154269|NCT01987960|64315694|FG000|Period 3|Protocol Violation|0|||
23154270|NCT01987960|64315695|FG001|Period 3|Protocol Violation|0|||
23154271|NCT01987960|64315696|FG002|Period 3|Protocol Violation|0|||
23154272|NCT01987960|64315697|FG003|Period 3|Protocol Violation|6|||
23441861|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
23564973|NCT04599101|65796607|FG001|Overall Study|Lost to Follow-up|5|||
23564974|NCT01103960|65796610|FG000|Overall Study|Adverse Event|2|||
23564975|NCT01103960|65796611|FG001|Overall Study|Adverse Event|1|||
23564976|NCT01103960|65796610|FG000|Overall Study|Withdrawal by Subject|2|||
23564977|NCT01103960|65796611|FG001|Overall Study|Withdrawal by Subject|1|||
23564978|NCT01103960|65796610|FG000|Overall Study|Other|1|||
23564979|NCT01103960|65796611|FG001|Overall Study|Other|0|||
23154273|NCT01987960|64315694|FG000|Period 3|Withdrawal by Subject|0|||
23154274|NCT01987960|64315695|FG001|Period 3|Withdrawal by Subject|0|||
23441862|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
23154275|NCT01987960|64315696|FG002|Period 3|Withdrawal by Subject|0|||
23154276|NCT01987960|64315697|FG003|Period 3|Withdrawal by Subject|9|||
23154277|NCT01987960|64315694|FG000|Period 3|Lost to Follow-up|0|||
23154278|NCT01987960|64315695|FG001|Period 3|Lost to Follow-up|0|||
23154279|NCT01987960|64315696|FG002|Period 3|Lost to Follow-up|0|||
23564980|NCT00192023|65796614|FG000|Period III - Double-Blind|Adverse Event|3|||
23154280|NCT01987960|64315697|FG003|Period 3|Lost to Follow-up|5|||
23154281|NCT01987960|64315694|FG000|Period 3|Administrative or other reason|0|||
23154282|NCT01987960|64315695|FG001|Period 3|Administrative or other reason|0|||
23627146|NCT03004404|66024382|FG009|Period 2|Adverse Event|0|||
23627147|NCT03004404|66024383|FG010|Period 2|Adverse Event|0|||
23627148|NCT03004404|66024384|FG011|Period 2|Adverse Event|0|||
23627149|NCT03004404|66024385|FG012|Period 2|Adverse Event|0|||
23627150|NCT03004404|66024386|FG013|Period 2|Adverse Event|0|||
23627151|NCT03004404|66024387|FG014|Period 2|Adverse Event|0|||
23627152|NCT03004404|66024388|FG015|Period 2|Adverse Event|1|||
23627153|NCT00490945|66024389|FG000|Overall Study|Adverse Event|0|||
23627154|NCT00490945|66024390|FG001|Overall Study|Adverse Event|1|||
23627155|NCT00490945|66024391|FG002|Overall Study|Adverse Event|0|||
23627156|NCT00490945|66024392|FG003|Overall Study|Adverse Event|0|||
23627157|NCT00490945|66024393|FG004|Overall Study|Adverse Event|0|||
23627158|NCT00825305|66024394|FG000|Overall Study|Adverse Event|1|||
23627159|NCT00825305|66024395|FG001|Overall Study|Adverse Event|1|||
23627160|NCT00825305|66024394|FG000|Overall Study|Withdrawal by Subject|6|||
23627161|NCT00825305|66024395|FG001|Overall Study|Withdrawal by Subject|12|||
23627162|NCT00825305|66024394|FG000|Overall Study|Inappropriate inclusion|1|||
23627163|NCT00825305|66024395|FG001|Overall Study|Inappropriate inclusion|0|||
23627164|NCT00825305|66024394|FG000|Overall Study|Protocol Violation|9|||
23627165|NCT00825305|66024395|FG001|Overall Study|Protocol Violation|9|||
23627166|NCT00825305|66024394|FG000|Overall Study|Can not be classified|0|||
23627167|NCT00825305|66024395|FG001|Overall Study|Can not be classified|1|||
23627168|NCT03126110|66024396|FG000|Phase 1|Death|2|||
23627169|NCT03126110|66024397|FG001|Phase 1|Death|2|||
23627170|NCT03126110|66024398|FG002|Phase 1|Death|4|||
23627171|NCT03126110|66024399|FG003|Phase 1|Death|3|||
23627172|NCT03126110|66024400|FG004|Phase 1|Death|4|||
23627173|NCT03126110|66024401|FG005|Phase 1|Death|4|||
23627174|NCT03126110|66024402|FG006|Phase 1|Death|3|||
23627175|NCT03126110|66024403|FG007|Phase 1|Death|4|||
23627176|NCT03126110|66024404|FG008|Phase 1|Death|5|||
23627177|NCT03126110|66024405|FG009|Phase 1|Death|2|||
23627178|NCT03126110|66024406|FG010|Phase 1|Death|6|||
23627179|NCT03126110|66024407|FG011|Phase 1|Death|0|||
23627180|NCT03126110|66024408|FG012|Phase 1|Death|0|||
23627181|NCT03126110|66024409|FG013|Phase 1|Death|0|||
23627182|NCT03126110|66024410|FG014|Phase 1|Death|0|||
23627183|NCT03126110|66024411|FG015|Phase 1|Death|0|||
23154283|NCT01987960|64315696|FG002|Period 3|Administrative or other reason|0|||
23154284|NCT01987960|64315697|FG003|Period 3|Administrative or other reason|43|||
23154285|NCT01205438|64315698|FG000|Overall Study|Adverse Event|19|||
23154286|NCT01205438|64315699|FG001|Overall Study|Adverse Event|17|||
23154287|NCT01205438|64315700|FG002|Overall Study|Adverse Event|24|||
23154288|NCT01205438|64315698|FG000|Overall Study|Death|1|||
23154289|NCT01205438|64315699|FG001|Overall Study|Death|1|||
23154290|NCT01205438|64315700|FG002|Overall Study|Death|3|||
23154291|NCT01205438|64315698|FG000|Overall Study|Entry Criteria Not Met|16|||
23154292|NCT01205438|64315699|FG001|Overall Study|Entry Criteria Not Met|15|||
23154293|NCT01205438|64315700|FG002|Overall Study|Entry Criteria Not Met|13|||
23154294|NCT01205438|64315698|FG000|Overall Study|Lack of Efficacy|14|||
23154295|NCT01205438|64315699|FG001|Overall Study|Lack of Efficacy|11|||
23154296|NCT01205438|64315700|FG002|Overall Study|Lack of Efficacy|14|||
23154297|NCT01205438|64315698|FG000|Overall Study|Lost to Follow-up|6|||
23154298|NCT01205438|64315699|FG001|Overall Study|Lost to Follow-up|7|||
23154299|NCT01205438|64315700|FG002|Overall Study|Lost to Follow-up|8|||
23154300|NCT01205438|64315698|FG000|Overall Study|Withdrawal by Subject|19|||
23441863|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
23627184|NCT03126110|66024412|FG016|Phase 1|Death|0|||
23627185|NCT03126110|66024396|FG000|Phase 1|Lost to Follow-up|0|||
23627186|NCT03126110|66024397|FG001|Phase 1|Lost to Follow-up|1|||
23627187|NCT03126110|66024398|FG002|Phase 1|Lost to Follow-up|0|||
23627188|NCT03126110|66024399|FG003|Phase 1|Lost to Follow-up|0|||
23627189|NCT03126110|66024400|FG004|Phase 1|Lost to Follow-up|0|||
23627190|NCT03126110|66024401|FG005|Phase 1|Lost to Follow-up|0|||
23627191|NCT03126110|66024402|FG006|Phase 1|Lost to Follow-up|0|||
23627192|NCT03126110|66024403|FG007|Phase 1|Lost to Follow-up|0|||
23627193|NCT03126110|66024404|FG008|Phase 1|Lost to Follow-up|1|||
23627194|NCT03126110|66024405|FG009|Phase 1|Lost to Follow-up|0|||
23627195|NCT03126110|66024406|FG010|Phase 1|Lost to Follow-up|0|||
23627196|NCT03126110|66024407|FG011|Phase 1|Lost to Follow-up|0|||
23627197|NCT03126110|66024408|FG012|Phase 1|Lost to Follow-up|0|||
23627198|NCT03126110|66024409|FG013|Phase 1|Lost to Follow-up|0|||
23154301|NCT01205438|64315699|FG001|Overall Study|Withdrawal by Subject|25|||
23627199|NCT03126110|66024410|FG014|Phase 1|Lost to Follow-up|0|||
23627200|NCT03126110|66024411|FG015|Phase 1|Lost to Follow-up|0|||
23627201|NCT03126110|66024412|FG016|Phase 1|Lost to Follow-up|0|||
23627202|NCT03126110|66024396|FG000|Phase 1|Withdrawal by Subject|1|||
23627203|NCT03126110|66024397|FG001|Phase 1|Withdrawal by Subject|0|||
23627204|NCT03126110|66024398|FG002|Phase 1|Withdrawal by Subject|0|||
23627205|NCT03126110|66024399|FG003|Phase 1|Withdrawal by Subject|1|||
23627206|NCT03126110|66024400|FG004|Phase 1|Withdrawal by Subject|1|||
23627207|NCT03126110|66024401|FG005|Phase 1|Withdrawal by Subject|0|||
23627208|NCT03126110|66024402|FG006|Phase 1|Withdrawal by Subject|0|||
23627209|NCT03126110|66024403|FG007|Phase 1|Withdrawal by Subject|0|||
23627210|NCT03126110|66024404|FG008|Phase 1|Withdrawal by Subject|2|||
23627211|NCT03126110|66024405|FG009|Phase 1|Withdrawal by Subject|1|||
23627212|NCT03126110|66024406|FG010|Phase 1|Withdrawal by Subject|0|||
23627213|NCT03126110|66024407|FG011|Phase 1|Withdrawal by Subject|0|||
23627214|NCT03126110|66024408|FG012|Phase 1|Withdrawal by Subject|0|||
23627215|NCT03126110|66024409|FG013|Phase 1|Withdrawal by Subject|0|||
23627216|NCT03126110|66024410|FG014|Phase 1|Withdrawal by Subject|0|||
23627217|NCT03126110|66024411|FG015|Phase 1|Withdrawal by Subject|0|||
23627218|NCT03126110|66024412|FG016|Phase 1|Withdrawal by Subject|0|||
23627219|NCT03126110|66024396|FG000|Phase 1|Safety follow-up no longer necessary|1|||
23627220|NCT03126110|66024397|FG001|Phase 1|Safety follow-up no longer necessary|0|||
23627221|NCT03126110|66024398|FG002|Phase 1|Safety follow-up no longer necessary|0|||
23627222|NCT03126110|66024399|FG003|Phase 1|Safety follow-up no longer necessary|0|||
23627223|NCT03126110|66024400|FG004|Phase 1|Safety follow-up no longer necessary|0|||
23627224|NCT03126110|66024401|FG005|Phase 1|Safety follow-up no longer necessary|0|||
23627225|NCT03126110|66024402|FG006|Phase 1|Safety follow-up no longer necessary|0|||
23627226|NCT03126110|66024403|FG007|Phase 1|Safety follow-up no longer necessary|0|||
23627227|NCT03126110|66024404|FG008|Phase 1|Safety follow-up no longer necessary|0|||
23627228|NCT03126110|66024405|FG009|Phase 1|Safety follow-up no longer necessary|0|||
23627229|NCT03126110|66024406|FG010|Phase 1|Safety follow-up no longer necessary|0|||
23627230|NCT03126110|66024407|FG011|Phase 1|Safety follow-up no longer necessary|0|||
23627231|NCT03126110|66024408|FG012|Phase 1|Safety follow-up no longer necessary|0|||
23627232|NCT03126110|66024409|FG013|Phase 1|Safety follow-up no longer necessary|0|||
23627233|NCT03126110|66024410|FG014|Phase 1|Safety follow-up no longer necessary|0|||
23627234|NCT03126110|66024411|FG015|Phase 1|Safety follow-up no longer necessary|0|||
23627235|NCT03126110|66024412|FG016|Phase 1|Safety follow-up no longer necessary|0|||
23627236|NCT03126110|66024396|FG000|Phase 1|Survival follow-up no longer necessary|0|||
23627237|NCT03126110|66024397|FG001|Phase 1|Survival follow-up no longer necessary|0|||
23627238|NCT03126110|66024398|FG002|Phase 1|Survival follow-up no longer necessary|1|||
23627239|NCT03126110|66024399|FG003|Phase 1|Survival follow-up no longer necessary|0|||
23627240|NCT03126110|66024400|FG004|Phase 1|Survival follow-up no longer necessary|0|||
23627241|NCT03126110|66024401|FG005|Phase 1|Survival follow-up no longer necessary|0|||
23627242|NCT03126110|66024402|FG006|Phase 1|Survival follow-up no longer necessary|0|||
23627243|NCT03126110|66024403|FG007|Phase 1|Survival follow-up no longer necessary|0|||
23627244|NCT03126110|66024404|FG008|Phase 1|Survival follow-up no longer necessary|0|||
23627245|NCT03126110|66024405|FG009|Phase 1|Survival follow-up no longer necessary|0|||
23627246|NCT03126110|66024406|FG010|Phase 1|Survival follow-up no longer necessary|0|||
23154302|NCT01205438|64315700|FG002|Overall Study|Withdrawal by Subject|19|||
23154303|NCT01205438|64315698|FG000|Overall Study|Physician Decision|0|||
23154304|NCT01205438|64315699|FG001|Overall Study|Physician Decision|3|||
23154305|NCT01205438|64315700|FG002|Overall Study|Physician Decision|2|||
23154306|NCT01205438|64315698|FG000|Overall Study|Protocol Violation|2|||
23154307|NCT01205438|64315699|FG001|Overall Study|Protocol Violation|7|||
23154308|NCT01205438|64315700|FG002|Overall Study|Protocol Violation|4|||
23154309|NCT01205438|64315698|FG000|Overall Study|Sponsor Decision|0|||
23154310|NCT01205438|64315699|FG001|Overall Study|Sponsor Decision|1|||
23154311|NCT01205438|64315700|FG002|Overall Study|Sponsor Decision|1|||
23154312|NCT04376060|64315701|FG000|Overall Study|Physician Decision|1|||
23154313|NCT00733304|64315706|FG000|Overall Study|Adverse Event|3|||
23154314|NCT00733304|64315707|FG001|Overall Study|Adverse Event|0|||
23154315|NCT00733304|64315708|FG002|Overall Study|Adverse Event|0|||
23154316|NCT00733304|64315706|FG000|Overall Study|Lack of Efficacy|0|||
23154317|NCT00733304|64315707|FG001|Overall Study|Lack of Efficacy|0|||
23154318|NCT00733304|64315708|FG002|Overall Study|Lack of Efficacy|2|||
23154319|NCT00733304|64315706|FG000|Overall Study|Lost to Follow-up|0|||
23154320|NCT00733304|64315707|FG001|Overall Study|Lost to Follow-up|1|||
23154321|NCT00733304|64315708|FG002|Overall Study|Lost to Follow-up|0|||
23154322|NCT00733304|64315706|FG000|Overall Study|Physician Decision|3|||
23154323|NCT00733304|64315707|FG001|Overall Study|Physician Decision|1|||
23154324|NCT00733304|64315708|FG002|Overall Study|Physician Decision|3|||
23154325|NCT00733304|64315706|FG000|Overall Study|Withdrawal by Subject|1|||
23154326|NCT00733304|64315707|FG001|Overall Study|Withdrawal by Subject|1|||
23154327|NCT00733304|64315708|FG002|Overall Study|Withdrawal by Subject|0|||
23154328|NCT01162239|64315712|FG000|Treatment Phase|Withdrawal by Subject|1|||
23154329|NCT01162239|64315713|FG001|Treatment Phase|Withdrawal by Subject|3|||
23154330|NCT01162239|64315714|FG002|Treatment Phase|Withdrawal by Subject|2|||
23154331|NCT01162239|64315715|FG003|Treatment Phase|Withdrawal by Subject|3|||
23154332|NCT01162239|64315712|FG000|Treatment Phase|Death|0|||
23154333|NCT01162239|64315713|FG001|Treatment Phase|Death|0|||
23154334|NCT01162239|64315714|FG002|Treatment Phase|Death|0|||
23154335|NCT01162239|64315715|FG003|Treatment Phase|Death|1|||
23154336|NCT01162239|64315712|FG000|Treatment Phase|Lost to Follow-up|5|||
23154337|NCT01162239|64315713|FG001|Treatment Phase|Lost to Follow-up|4|||
23154338|NCT01162239|64315714|FG002|Treatment Phase|Lost to Follow-up|2|||
23154339|NCT01162239|64315715|FG003|Treatment Phase|Lost to Follow-up|1|||
23154340|NCT01162239|64315712|FG000|Extended Follow-up|Lost to Follow-up|8|||
23627247|NCT03126110|66024407|FG011|Phase 1|Survival follow-up no longer necessary|0|||
23627248|NCT03126110|66024408|FG012|Phase 1|Survival follow-up no longer necessary|0|||
23627249|NCT03126110|66024409|FG013|Phase 1|Survival follow-up no longer necessary|0|||
23627250|NCT03126110|66024410|FG014|Phase 1|Survival follow-up no longer necessary|0|||
23627251|NCT03126110|66024411|FG015|Phase 1|Survival follow-up no longer necessary|0|||
23627252|NCT03126110|66024412|FG016|Phase 1|Survival follow-up no longer necessary|0|||
23627253|NCT03126110|66024396|FG000|Phase 2|Study terminated by the sponsor|0|||
23627254|NCT03126110|66024397|FG001|Phase 2|Study terminated by the sponsor|0|||
23627255|NCT03126110|66024398|FG002|Phase 2|Study terminated by the sponsor|0|||
23627256|NCT03126110|66024399|FG003|Phase 2|Study terminated by the sponsor|0|||
23627257|NCT03126110|66024400|FG004|Phase 2|Study terminated by the sponsor|0|||
23627258|NCT03126110|66024401|FG005|Phase 2|Study terminated by the sponsor|0|||
23627259|NCT03126110|66024402|FG006|Phase 2|Study terminated by the sponsor|0|||
23627260|NCT03126110|66024403|FG007|Phase 2|Study terminated by the sponsor|0|||
23627261|NCT03126110|66024404|FG008|Phase 2|Study terminated by the sponsor|0|||
23221131|NCT01628393|64550307|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
23221132|NCT01628393|64550303|FG000|Blinded Active Extension Period|Physician Decision|0|||
23221133|NCT01628393|64550304|FG001|Blinded Active Extension Period|Physician Decision|3|||
23221134|NCT01628393|64550305|FG002|Blinded Active Extension Period|Physician Decision|0|||
23221135|NCT01628393|64550306|FG003|Blinded Active Extension Period|Physician Decision|1|||
23221136|NCT01628393|64550307|FG004|Blinded Active Extension Period|Physician Decision|0|||
23327338|NCT02064816|64940875|FG000|Overall Study|Withdrawal by Subject|2|||
23327339|NCT02064816|64940876|FG001|Overall Study|Withdrawal by Subject|1|||
23627262|NCT03126110|66024405|FG009|Phase 2|Study terminated by the sponsor|0|||
23627263|NCT03126110|66024406|FG010|Phase 2|Study terminated by the sponsor|0|||
23627264|NCT03126110|66024407|FG011|Phase 2|Study terminated by the sponsor|0|||
23627265|NCT03126110|66024408|FG012|Phase 2|Study terminated by the sponsor|0|||
23627266|NCT03126110|66024409|FG013|Phase 2|Study terminated by the sponsor|4|||
23627267|NCT03126110|66024410|FG014|Phase 2|Study terminated by the sponsor|0|||
23627268|NCT03126110|66024411|FG015|Phase 2|Study terminated by the sponsor|0|||
23627269|NCT03126110|66024412|FG016|Phase 2|Study terminated by the sponsor|0|||
23627270|NCT03126110|66024396|FG000|Phase 2|Withdrawal by Subject|0|||
23627271|NCT03126110|66024397|FG001|Phase 2|Withdrawal by Subject|0|||
23627272|NCT03126110|66024398|FG002|Phase 2|Withdrawal by Subject|0|||
23627273|NCT03126110|66024399|FG003|Phase 2|Withdrawal by Subject|0|||
23627274|NCT03126110|66024400|FG004|Phase 2|Withdrawal by Subject|0|||
23627275|NCT03126110|66024401|FG005|Phase 2|Withdrawal by Subject|0|||
23627276|NCT03126110|66024402|FG006|Phase 2|Withdrawal by Subject|0|||
23627277|NCT03126110|66024403|FG007|Phase 2|Withdrawal by Subject|0|||
23627278|NCT03126110|66024404|FG008|Phase 2|Withdrawal by Subject|0|||
23627279|NCT03126110|66024405|FG009|Phase 2|Withdrawal by Subject|0|||
23627280|NCT03126110|66024406|FG010|Phase 2|Withdrawal by Subject|0|||
23627281|NCT03126110|66024407|FG011|Phase 2|Withdrawal by Subject|1|||
23627282|NCT03126110|66024408|FG012|Phase 2|Withdrawal by Subject|3|||
23627283|NCT03126110|66024409|FG013|Phase 2|Withdrawal by Subject|3|||
23627284|NCT03126110|66024410|FG014|Phase 2|Withdrawal by Subject|2|||
23627285|NCT03126110|66024411|FG015|Phase 2|Withdrawal by Subject|1|||
23627286|NCT03126110|66024412|FG016|Phase 2|Withdrawal by Subject|0|||
23627287|NCT03126110|66024396|FG000|Phase 2|Lost to Follow-up|0|||
23627288|NCT03126110|66024397|FG001|Phase 2|Lost to Follow-up|0|||
23627289|NCT03126110|66024398|FG002|Phase 2|Lost to Follow-up|0|||
23627290|NCT03126110|66024399|FG003|Phase 2|Lost to Follow-up|0|||
23627291|NCT03126110|66024400|FG004|Phase 2|Lost to Follow-up|0|||
23627292|NCT03126110|66024401|FG005|Phase 2|Lost to Follow-up|0|||
23627293|NCT03126110|66024402|FG006|Phase 2|Lost to Follow-up|0|||
23627294|NCT03126110|66024403|FG007|Phase 2|Lost to Follow-up|0|||
23627295|NCT03126110|66024404|FG008|Phase 2|Lost to Follow-up|0|||
23627296|NCT03126110|66024405|FG009|Phase 2|Lost to Follow-up|0|||
23627297|NCT03126110|66024406|FG010|Phase 2|Lost to Follow-up|0|||
23327340|NCT02064816|64940875|FG000|Overall Study|Lost to Follow-up|2|||
23327341|NCT02064816|64940876|FG001|Overall Study|Lost to Follow-up|1|||
23327342|NCT02064816|64940875|FG000|Overall Study|Therapeutic failure|0|||
23327343|NCT02064816|64940876|FG001|Overall Study|Therapeutic failure|1|||
23327344|NCT02064816|64940875|FG000|Overall Study|Other|1|||
23327345|NCT02064816|64940876|FG001|Overall Study|Other|3|||
23327346|NCT00720213|64940879|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
23327347|NCT00720213|64940880|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
23627298|NCT03126110|66024407|FG011|Phase 2|Lost to Follow-up|1|||
23627299|NCT03126110|66024408|FG012|Phase 2|Lost to Follow-up|1|||
23627300|NCT03126110|66024409|FG013|Phase 2|Lost to Follow-up|1|||
23627301|NCT03126110|66024410|FG014|Phase 2|Lost to Follow-up|2|||
23327348|NCT00720213|64940881|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
23627302|NCT03126110|66024411|FG015|Phase 2|Lost to Follow-up|0|||
23627303|NCT03126110|66024412|FG016|Phase 2|Lost to Follow-up|0|||
23627304|NCT03126110|66024396|FG000|Phase 2|Death|0|||
23627305|NCT03126110|66024397|FG001|Phase 2|Death|0|||
23627306|NCT03126110|66024398|FG002|Phase 2|Death|0|||
23627307|NCT03126110|66024399|FG003|Phase 2|Death|0|||
23627308|NCT03126110|66024400|FG004|Phase 2|Death|0|||
23564981|NCT00192023|65796615|FG001|Period III - Double-Blind|Adverse Event|0|||
23564982|NCT00192023|65796614|FG000|Period III - Double-Blind|Physician Decision|2|||
23564983|NCT00192023|65796615|FG001|Period III - Double-Blind|Physician Decision|0|||
23564984|NCT00192023|65796614|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
23627309|NCT03126110|66024401|FG005|Phase 2|Death|0|||
23627310|NCT03126110|66024402|FG006|Phase 2|Death|0|||
23627311|NCT03126110|66024403|FG007|Phase 2|Death|0|||
23627312|NCT03126110|66024404|FG008|Phase 2|Death|0|||
23627313|NCT03126110|66024405|FG009|Phase 2|Death|0|||
23627314|NCT03126110|66024406|FG010|Phase 2|Death|0|||
23627315|NCT03126110|66024407|FG011|Phase 2|Death|6|||
23627316|NCT03126110|66024408|FG012|Phase 2|Death|12|||
23627317|NCT03126110|66024409|FG013|Phase 2|Death|25|||
23627318|NCT03126110|66024410|FG014|Phase 2|Death|11|||
23154341|NCT01162239|64315713|FG001|Extended Follow-up|Lost to Follow-up|13|||
23154342|NCT01162239|64315714|FG002|Extended Follow-up|Lost to Follow-up|8|||
23154343|NCT01162239|64315715|FG003|Extended Follow-up|Lost to Follow-up|6|||
23154344|NCT02014740|64315718|FG000|Overall Study|Lost to Follow-up|4|||
23154345|NCT02014740|64315719|FG001|Overall Study|Lost to Follow-up|4|||
23154346|NCT02014740|64315718|FG000|Overall Study|Withdrawal by Subject|2|||
23564985|NCT00192023|65796615|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
23564986|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
23564987|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
23564988|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
23564989|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
23564990|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
23564991|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
23564992|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
23564993|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
23564994|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
23564995|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
23564996|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
23564997|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
23564998|NCT00192023|65796614|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
23564999|NCT00192023|65796615|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
23565000|NCT01215357|65796616|FG000|Overall Study|Withdrawal by Subject|3|||
23565001|NCT01215357|65796616|FG000|Overall Study|Protocol Violation|9|||
23154347|NCT02014740|64315719|FG001|Overall Study|Withdrawal by Subject|1|||
23154348|NCT02818920|64315724|FG000|Overall Study|Unresectable|4|||
23154349|NCT02818920|64315724|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
23154350|NCT02818920|64315724|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
23154351|NCT02818920|64315724|FG000|Overall Study|Adverse Event|3|||
23154352|NCT02818920|64315724|FG000|Overall Study|Developed Other Disease|1|||
23154353|NCT02818920|64315724|FG000|Overall Study|Refused Further Treatment|1|||
23154354|NCT03426787|64315732|FG000|Overall Study|Withdrawal by Subject|6|||
23154355|NCT03426787|64315732|FG000|Overall Study|Lost to Follow-up|7|||
23154356|NCT03426787|64315732|FG000|Overall Study|Unrelated to intervention death|1|||
23154357|NCT00888381|64315733|FG000|Overall Study|Lost to Follow-up|0|||
23154358|NCT00888381|64315734|FG001|Overall Study|Lost to Follow-up|1|||
23154359|NCT00332839|64315735|FG000|Core (Months 0 - 12)|Administrative problems|1|||
23154360|NCT00332839|64315736|FG001|Core (Months 0 - 12)|Administrative problems|1|||
23154361|NCT00332839|64315735|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
23154362|NCT00332839|64315736|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
23154363|NCT00332839|64315735|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
23154364|NCT00332839|64315736|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
23154365|NCT00332839|64315735|FG000|Core (Months 0 - 12)|Adverse Event|5|||
23154366|NCT00332839|64315736|FG001|Core (Months 0 - 12)|Adverse Event|15|||
23154367|NCT00332839|64315735|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
23565002|NCT02254421|65796621|FG000|Overall Study|Randomized but Not Treated|1|||
23565003|NCT02254421|65796622|FG001|Overall Study|Randomized but Not Treated|0|||
23565004|NCT02254421|65796621|FG000|Overall Study|Death|0|||
23565005|NCT02254421|65796622|FG001|Overall Study|Death|2|||
23565006|NCT02254421|65796621|FG000|Overall Study|Withdrew Consent|1|||
23565007|NCT02254421|65796622|FG001|Overall Study|Withdrew Consent|1|||
23565008|NCT01282801|65796623|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
23627319|NCT03126110|66024411|FG015|Phase 2|Death|3|||
23627320|NCT03126110|66024412|FG016|Phase 2|Death|2|||
23627321|NCT03126110|66024396|FG000|Phase 2|Progressive Disease|0|||
23627322|NCT03126110|66024397|FG001|Phase 2|Progressive Disease|0|||
23154368|NCT00332839|64315736|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
23627323|NCT03126110|66024398|FG002|Phase 2|Progressive Disease|0|||
23154369|NCT00332839|64315735|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
23154370|NCT00332839|64315736|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
23627324|NCT03126110|66024399|FG003|Phase 2|Progressive Disease|0|||
23627325|NCT03126110|66024400|FG004|Phase 2|Progressive Disease|0|||
23627326|NCT03126110|66024401|FG005|Phase 2|Progressive Disease|0|||
23221137|NCT01628393|64550303|FG000|Blinded Active Extension Period|Protocol Violation|0|||
23221138|NCT01628393|64550304|FG001|Blinded Active Extension Period|Protocol Violation|0|||
23221139|NCT01628393|64550305|FG002|Blinded Active Extension Period|Protocol Violation|2|||
23221140|NCT01628393|64550306|FG003|Blinded Active Extension Period|Protocol Violation|1|||
23221141|NCT01628393|64550307|FG004|Blinded Active Extension Period|Protocol Violation|0|||
23221142|NCT01628393|64550303|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
23221143|NCT01628393|64550304|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
23221144|NCT01628393|64550305|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
23221145|NCT01628393|64550306|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
23221146|NCT01628393|64550307|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
23221147|NCT04322682|64550308|FG000|Overall Study|Withdrawal by Subject|33|||
23221148|NCT04322682|64550309|FG001|Overall Study|Withdrawal by Subject|47|||
23221149|NCT04322682|64550308|FG000|Overall Study|Death|5|||
23221150|NCT04322682|64550309|FG001|Overall Study|Death|9|||
23221151|NCT04322682|64550308|FG000|Overall Study|Lost to Follow-up|4|||
23565009|NCT01282801|65796624|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
23565010|NCT00871403|65796625|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
23221152|NCT04322682|64550309|FG001|Overall Study|Lost to Follow-up|8|||
23221153|NCT04322682|64550308|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
23221154|NCT04322682|64550309|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
23565011|NCT00871403|65796626|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
23565012|NCT00871403|65796627|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
23565013|NCT00871403|65796625|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
23565014|NCT00871403|65796626|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
23565015|NCT00871403|65796627|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
23565016|NCT00871403|65796625|FG000|Combination Treatment Phase|Adverse Event|0|||
23565017|NCT00871403|65796626|FG001|Combination Treatment Phase|Adverse Event|17|||
23565018|NCT00871403|65796627|FG002|Combination Treatment Phase|Adverse Event|2|||
23154371|NCT00332839|64315735|FG000|Follow-up (Months 12 - 60)|Death|1|||
23154372|NCT00332839|64315736|FG001|Follow-up (Months 12 - 60)|Death|1|||
23154373|NCT03805750|64315737|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
23154374|NCT03805750|64315738|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
23154375|NCT00930722|64315739|FG000|Overall Study|Lost to Follow-up|16|||
23154376|NCT00930722|64315739|FG000|Overall Study|No longer willing to participate|9|||
23154377|NCT00930722|64315739|FG000|Overall Study|Study terminated by sponsor|2|||
23154378|NCT02194062|64315741|FG000|Overall Study|Lost to Follow-up|2|||
23154379|NCT02194062|64315742|FG001|Overall Study|Lost to Follow-up|2|||
23154380|NCT02194062|64315743|FG002|Overall Study|Lost to Follow-up|5|||
23154381|NCT03472924|64315748|FG000|Overall Study|Adverse Event|1|||
23154382|NCT03472924|64315749|FG001|Overall Study|Adverse Event|0|||
23154383|NCT01200238|64315753|FG000|Overall Study|Adverse Event|2|||
23154384|NCT01200238|64315754|FG001|Overall Study|Adverse Event|1|||
23221155|NCT03148795|64550315|FG000|Overall Study|Progressive Disease|1|||
23221156|NCT05083949|64550316|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
23221157|NCT05083949|64550317|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
23221158|NCT05083949|64550316|FG000|Period 1|Adverse Event|1|||
23221159|NCT05083949|64550317|FG001|Period 1|Adverse Event|1|||
23221160|NCT05083949|64550316|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
23221161|NCT05083949|64550317|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
23221162|NCT05083949|64550316|FG000|Period 2|Adverse Event|0|||
23221163|NCT05083949|64550317|FG001|Period 2|Adverse Event|2|||
23221164|NCT03630016|64550318|FG000|Overall Study|Poor Sensor Placement|1|||
23221165|NCT04757376|64550321|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
23221166|NCT04757376|64550322|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
23221167|NCT04757376|64550323|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
23221168|NCT04757376|64550324|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
23221169|NCT04757376|64550325|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
23221170|NCT04757376|64550321|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
23221171|NCT04757376|64550322|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
23221172|NCT04757376|64550323|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
23221173|NCT04757376|64550324|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
23221174|NCT04757376|64550325|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
23327349|NCT05005507|64940888|FG000|Overall Study|Premature termination of study|1|||
23327350|NCT01464593|64940889|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
23565019|NCT00871403|65796625|FG000|Combination Treatment Phase|Disease Progression|0|||
23565020|NCT00871403|65796626|FG001|Combination Treatment Phase|Disease Progression|8|||
23565021|NCT00871403|65796627|FG002|Combination Treatment Phase|Disease Progression|5|||
23154385|NCT01200238|64315753|FG000|Overall Study|Progressive Disease|5|||
23154386|NCT01200238|64315754|FG001|Overall Study|Progressive Disease|8|||
23154387|NCT01200238|64315753|FG000|Overall Study|Withdrawal by Subject|0|||
23221175|NCT04757376|64550321|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
23221176|NCT04757376|64550322|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
23221177|NCT04757376|64550323|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
23221178|NCT04757376|64550324|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
23221179|NCT04757376|64550325|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
23221180|NCT04757376|64550321|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
23221181|NCT04757376|64550322|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
23221182|NCT04757376|64550323|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
23221183|NCT04757376|64550324|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
23221184|NCT04757376|64550325|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
23221185|NCT04757376|64550321|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
23221186|NCT04757376|64550322|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
23221187|NCT04757376|64550323|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
23221188|NCT04757376|64550324|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
23565022|NCT00871403|65796625|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
23565023|NCT00871403|65796626|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
23565024|NCT00871403|65796627|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
23565025|NCT00871403|65796625|FG000|Combination Treatment Phase|Physician Decision|0|||
23565026|NCT00871403|65796626|FG001|Combination Treatment Phase|Physician Decision|1|||
23565027|NCT00871403|65796627|FG002|Combination Treatment Phase|Physician Decision|3|||
23221189|NCT04757376|64550325|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
23221190|NCT04757376|64550321|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
23221191|NCT04757376|64550322|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
23221192|NCT04757376|64550323|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
23221193|NCT04757376|64550324|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
23221194|NCT04757376|64550325|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
23565028|NCT00871403|65796625|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
23221195|NCT04757376|64550321|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
23221196|NCT04757376|64550322|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
23221197|NCT04757376|64550323|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
23565029|NCT00871403|65796626|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
23565030|NCT00871403|65796627|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
23565031|NCT00871403|65796625|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
23565032|NCT00871403|65796626|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
23565033|NCT00871403|65796627|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
23565034|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
23565035|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
23565036|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
23565037|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
23565038|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
23565039|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
23565040|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
23565041|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
23565042|NCT01336621|65796628|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
23565043|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
23565044|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
23565045|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
23565046|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
23565047|NCT01336621|65796628|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
23565048|NCT01216163|65796630|FG000|Overall Study|Withdrawal by Subject|1|||
23565049|NCT01216163|65796631|FG001|Overall Study|Withdrawal by Subject|1|||
23565050|NCT01216163|65796632|FG002|Overall Study|Withdrawal by Subject|0|||
23565051|NCT01372605|65796633|FG000|Overall Study|Death|1|||
23565052|NCT01372605|65796634|FG001|Overall Study|Death|2|||
23154388|NCT01200238|64315754|FG001|Overall Study|Withdrawal by Subject|1|||
23154389|NCT01335009|64315755|FG000|Overall Study|Too ill to travel to study sites|1|||
23154390|NCT01335009|64315756|FG001|Overall Study|Too ill to travel to study sites|0|||
23154391|NCT01335009|64315755|FG000|Overall Study|Death|28|||
23154392|NCT01335009|64315756|FG001|Overall Study|Death|32|||
23154393|NCT01335009|64315755|FG000|Overall Study|Withdrawal by Subject|1|||
23154394|NCT01335009|64315756|FG001|Overall Study|Withdrawal by Subject|1|||
23154395|NCT01335009|64315755|FG000|Overall Study|Lost to Follow-up|1|||
23154396|NCT01335009|64315756|FG001|Overall Study|Lost to Follow-up|0|||
23154397|NCT00430482|64315757|FG000|Completed Treatment|Insufficient Treatment|7|||
23154398|NCT00430482|64315758|FG001|Completed Treatment|Insufficient Treatment|11|||
23565053|NCT01372605|65796633|FG000|Overall Study|Lost to Follow-up|2|||
23154399|NCT00545402|64315759|FG000|Overall Study|Discontinuation of treatment|17|||
23221198|NCT04757376|64550324|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
23221199|NCT04757376|64550325|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
23221200|NCT04757376|64550321|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
23221201|NCT04757376|64550322|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
23221202|NCT04757376|64550323|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
23221203|NCT04757376|64550324|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
23221204|NCT04757376|64550325|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
23221205|NCT00445341|64550326|FG000|Overall Study|refused further treatment|1|||
23221206|NCT00445341|64550326|FG000|Overall Study|taken off treatment too early|1|||
23221207|NCT00865046|64550327|FG000|Overall Study|Lost to Follow-up|1|||
23221208|NCT00865046|64550328|FG001|Overall Study|Lost to Follow-up|4|||
23221209|NCT00865046|64550329|FG002|Overall Study|Lost to Follow-up|0|||
23221210|NCT00865046|64550327|FG000|Overall Study|Death|0|||
23221211|NCT00865046|64550328|FG001|Overall Study|Death|1|||
23221212|NCT00865046|64550329|FG002|Overall Study|Death|1|||
23221213|NCT00865046|64550327|FG000|Overall Study|Withdrawal by Subject|5|||
23221214|NCT00865046|64550328|FG001|Overall Study|Withdrawal by Subject|0|||
23221215|NCT00865046|64550329|FG002|Overall Study|Withdrawal by Subject|0|||
23221216|NCT00367341|64550330|FG000|Overall Study|Physician Decision|1|||
23221217|NCT00367341|64550331|FG001|Overall Study|Physician Decision|0|||
23221218|NCT00367341|64550330|FG000|Overall Study|Protocol Violation|1|||
23221219|NCT00367341|64550331|FG001|Overall Study|Protocol Violation|0|||
23221220|NCT02076334|64550334|FG000|Overall Study|Protocol Violation|1|||
23221221|NCT02076334|64550335|FG001|Overall Study|Protocol Violation|0|||
23221222|NCT02076334|64550336|FG002|Overall Study|Protocol Violation|0|||
23221223|NCT02076334|64550337|FG003|Overall Study|Protocol Violation|0|||
23221224|NCT02076334|64550334|FG000|Overall Study|Lost to Follow-up|0|||
23221225|NCT02076334|64550335|FG001|Overall Study|Lost to Follow-up|1|||
23565054|NCT01372605|65796634|FG001|Overall Study|Lost to Follow-up|1|||
23565055|NCT01372605|65796633|FG000|Overall Study|Withdrawal by Subject|4|||
23565056|NCT01372605|65796634|FG001|Overall Study|Withdrawal by Subject|7|||
23565057|NCT01372605|65796633|FG000|Overall Study|Moved|3|||
23565058|NCT01372605|65796634|FG001|Overall Study|Moved|0|||
23565059|NCT01372605|65796633|FG000|Overall Study|Changed medical home|2|||
23565060|NCT01372605|65796634|FG001|Overall Study|Changed medical home|0|||
23565061|NCT00003511|65796635|FG000|Overall Study|Not evaluable|4|||
23565062|NCT03966053|65796641|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
23565063|NCT04844918|65796644|FG000|Overall Study|Adverse Event|7|||
23565064|NCT04844918|65796645|FG001|Overall Study|Adverse Event|8|||
23565065|NCT04844918|65796646|FG002|Overall Study|Adverse Event|5|||
23565066|NCT04844918|65796644|FG000|Overall Study|Physician Decision|0|||
23565067|NCT04844918|65796645|FG001|Overall Study|Physician Decision|1|||
23565068|NCT04844918|65796646|FG002|Overall Study|Physician Decision|0|||
23565069|NCT04844918|65796644|FG000|Overall Study|Withdrawal by Subject|6|||
23565070|NCT04844918|65796645|FG001|Overall Study|Withdrawal by Subject|3|||
23565071|NCT04844918|65796646|FG002|Overall Study|Withdrawal by Subject|3|||
23565072|NCT04844918|65796644|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
23154400|NCT00545402|64315760|FG001|Overall Study|Discontinuation of treatment|9|||
23154401|NCT00545402|64315759|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
23154402|NCT00545402|64315760|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
23154403|NCT00545402|64315759|FG000|Overall Study|Death|5|||
23154404|NCT00545402|64315760|FG001|Overall Study|Death|7|||
23154405|NCT00545402|64315759|FG000|Overall Study|Graft loss|2|||
23154406|NCT00545402|64315760|FG001|Overall Study|Graft loss|4|||
23154407|NCT00545402|64315759|FG000|Overall Study|Withdrawal by Subject|0|||
23154408|NCT00545402|64315760|FG001|Overall Study|Withdrawal by Subject|1|||
23154409|NCT00545402|64315759|FG000|Overall Study|Protocol Violation|1|||
23154410|NCT00545402|64315760|FG001|Overall Study|Protocol Violation|0|||
23154411|NCT00545402|64315759|FG000|Overall Study|Reason not specified|1|||
23154412|NCT00545402|64315760|FG001|Overall Study|Reason not specified|1|||
23154413|NCT01177683|64315761|FG000|Study Treatment|Disease Progressions during treatment|2|||
23154414|NCT01177683|64315762|FG001|Study Treatment|Disease Progressions during treatment|0|||
23154415|NCT01177683|64315763|FG002|Study Treatment|Disease Progressions during treatment|3|||
23154416|NCT01177683|64315761|FG000|Study Treatment|Adverse Event|0|||
23154417|NCT01177683|64315762|FG001|Study Treatment|Adverse Event|1|||
23154418|NCT01177683|64315763|FG002|Study Treatment|Adverse Event|12|||
23565073|NCT04844918|65796645|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
23154419|NCT01177683|64315761|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
23565074|NCT04844918|65796646|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
23154420|NCT01177683|64315762|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
23221226|NCT02076334|64550336|FG002|Overall Study|Lost to Follow-up|1|||
23441864|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Death|0|||
23565075|NCT02091739|65796651|FG000|MP: 16 Weeks|Adverse Event|1|||
23565076|NCT02091739|65796652|FG001|MP: 16 Weeks|Adverse Event|1|||
23565077|NCT02091739|65796653|FG002|MP: 16 Weeks|Adverse Event|1|||
23565078|NCT02091739|65796654|FG003|MP: 16 Weeks|Adverse Event|0|||
23565079|NCT02091739|65796655|FG004|MP: 16 Weeks|Adverse Event|0|||
23565080|NCT02091739|65796651|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
23565081|NCT02091739|65796652|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
23565082|NCT02091739|65796653|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
23565083|NCT02091739|65796654|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
23565084|NCT02091739|65796655|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
23565085|NCT02091739|65796651|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
23565086|NCT02091739|65796652|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
23565087|NCT02091739|65796653|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
23565088|NCT02091739|65796654|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
23565089|NCT02091739|65796655|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
23565090|NCT02091739|65796651|FG000|EP: 48 Weeks|Other|0|||
23565091|NCT02091739|65796652|FG001|EP: 48 Weeks|Other|0|||
23565092|NCT02091739|65796653|FG002|EP: 48 Weeks|Other|0|||
23565093|NCT02091739|65796654|FG003|EP: 48 Weeks|Other|1|||
23565094|NCT02091739|65796655|FG004|EP: 48 Weeks|Other|0|||
23565095|NCT02091739|65796651|FG000|EP: 48 Weeks|Death|0|||
23565096|NCT02091739|65796652|FG001|EP: 48 Weeks|Death|0|||
23565097|NCT02091739|65796653|FG002|EP: 48 Weeks|Death|0|||
23565098|NCT02091739|65796654|FG003|EP: 48 Weeks|Death|3|||
23565099|NCT02091739|65796655|FG004|EP: 48 Weeks|Death|2|||
23565100|NCT02091739|65796651|FG000|EP: 48 Weeks|Adverse Event|0|||
23565101|NCT02091739|65796652|FG001|EP: 48 Weeks|Adverse Event|0|||
23565102|NCT02091739|65796653|FG002|EP: 48 Weeks|Adverse Event|0|||
23565103|NCT02091739|65796654|FG003|EP: 48 Weeks|Adverse Event|2|||
23565104|NCT02091739|65796655|FG004|EP: 48 Weeks|Adverse Event|6|||
23565105|NCT02091739|65796651|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
23565106|NCT02091739|65796652|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
23565107|NCT02091739|65796653|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
23565108|NCT02091739|65796654|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
23565109|NCT02091739|65796655|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
23565110|NCT02276066|65796656|FG000|Overall Study|Lost to Follow-up|21|||
23627327|NCT03126110|66024402|FG006|Phase 2|Progressive Disease|0|||
23627328|NCT03126110|66024403|FG007|Phase 2|Progressive Disease|0|||
23627329|NCT03126110|66024404|FG008|Phase 2|Progressive Disease|0|||
23221227|NCT02076334|64550337|FG003|Overall Study|Lost to Follow-up|0|||
23221228|NCT02076334|64550334|FG000|Overall Study|muscle soreness|0|||
23221229|NCT02076334|64550335|FG001|Overall Study|muscle soreness|0|||
23221230|NCT02076334|64550336|FG002|Overall Study|muscle soreness|0|||
23221231|NCT02076334|64550337|FG003|Overall Study|muscle soreness|1|||
23221232|NCT01607073|64553588|FG000|Overall Study|Adverse Event|1|||
23221233|NCT03370913|64553589|FG000|Overall Study|Death|1|||
23221234|NCT03370913|64553589|FG000|Overall Study|Lost to Follow-up|1|||
23221235|NCT00422240|64553590|FG000|Overall Study|Lack of Efficacy|1|||
23221236|NCT00422240|64553591|FG001|Overall Study|Lack of Efficacy|2|||
23221237|NCT00422240|64553592|FG002|Overall Study|Lack of Efficacy|0|||
23221238|NCT00422240|64553593|FG003|Overall Study|Lack of Efficacy|1|||
23221239|NCT00422240|64553590|FG000|Overall Study|Adverse Event|11|||
23221240|NCT00422240|64553591|FG001|Overall Study|Adverse Event|4|||
23221241|NCT00422240|64553592|FG002|Overall Study|Adverse Event|5|||
23221242|NCT00422240|64553593|FG003|Overall Study|Adverse Event|2|||
23221243|NCT00422240|64553590|FG000|Overall Study|Subject request|21|||
23221244|NCT00422240|64553591|FG001|Overall Study|Subject request|17|||
23221245|NCT00422240|64553592|FG002|Overall Study|Subject request|18|||
23221246|NCT00422240|64553593|FG003|Overall Study|Subject request|30|||
23221247|NCT00422240|64553590|FG000|Overall Study|Protocol Violation|0|||
23221248|NCT00422240|64553591|FG001|Overall Study|Protocol Violation|1|||
23565111|NCT02276066|65796657|FG001|Overall Study|Lost to Follow-up|11|||
23565112|NCT01350505|65799507|FG000|Overall Study|Lost to Follow-up|4|||
23565113|NCT02960763|65799508|FG000|Step 1|Withdrawal by Subject|10|||
23565114|NCT02960763|65799509|FG001|Step 1|Withdrawal by Subject|8|||
23565115|NCT02960763|65799510|FG002|Step 1|Withdrawal by Subject|13|||
23565116|NCT02960763|65799511|FG003|Step 1|Withdrawal by Subject|0|||
23565117|NCT02960763|65799512|FG004|Step 1|Withdrawal by Subject|0|||
23627330|NCT03126110|66024405|FG009|Phase 2|Progressive Disease|0|||
23221249|NCT00422240|64553592|FG002|Overall Study|Protocol Violation|0|||
23221250|NCT00422240|64553593|FG003|Overall Study|Protocol Violation|1|||
23221251|NCT00422240|64553590|FG000|Overall Study|Lost to Follow-up|31|||
23221252|NCT00422240|64553591|FG001|Overall Study|Lost to Follow-up|32|||
23221253|NCT00422240|64553592|FG002|Overall Study|Lost to Follow-up|19|||
23221254|NCT00422240|64553593|FG003|Overall Study|Lost to Follow-up|34|||
23565118|NCT02960763|65799508|FG000|Step 1|Lost to Follow-up|7|||
23565119|NCT02960763|65799509|FG001|Step 1|Lost to Follow-up|9|||
23565120|NCT02960763|65799510|FG002|Step 1|Lost to Follow-up|12|||
23565121|NCT02960763|65799511|FG003|Step 1|Lost to Follow-up|0|||
23565122|NCT02960763|65799512|FG004|Step 1|Lost to Follow-up|0|||
23565123|NCT02960763|65799508|FG000|Step 1|Death|1|||
23154421|NCT01177683|64315763|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
23154422|NCT01177683|64315761|FG000|Study Treatment|Alternative therapy|0|||
23154423|NCT01177683|64315762|FG001|Study Treatment|Alternative therapy|0|||
23154424|NCT01177683|64315763|FG002|Study Treatment|Alternative therapy|4|||
23154425|NCT01177683|64315761|FG000|Study Treatment|Physician Decision|1|||
23154426|NCT01177683|64315762|FG001|Study Treatment|Physician Decision|0|||
23154427|NCT01177683|64315763|FG002|Study Treatment|Physician Decision|1|||
23154428|NCT01177683|64315761|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
23154429|NCT01177683|64315762|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
23154430|NCT01177683|64315763|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
23154431|NCT01177683|64315761|FG000|Study Treatment|Symptomatic Deterioration|0|||
23154432|NCT01177683|64315762|FG001|Study Treatment|Symptomatic Deterioration|0|||
23154433|NCT01177683|64315763|FG002|Study Treatment|Symptomatic Deterioration|1|||
23154434|NCT01177683|64315761|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
23154435|NCT01177683|64315762|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
23154436|NCT01177683|64315763|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
23154437|NCT01177683|64315761|FG000|Follow up|Patient lost to follow up|0|||
23154438|NCT01177683|64315762|FG001|Follow up|Patient lost to follow up|0|||
23154439|NCT01177683|64315763|FG002|Follow up|Patient lost to follow up|2|||
23154440|NCT01177683|64315761|FG000|Follow up|Death|2|||
23154441|NCT01177683|64315762|FG001|Follow up|Death|1|||
23154442|NCT01177683|64315763|FG002|Follow up|Death|7|||
23154443|NCT01177683|64315761|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
23327351|NCT02157935|64940890|FG000|Overall Study|Withdrawal by Subject|25|||
23154444|NCT01177683|64315762|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
23154445|NCT01177683|64315763|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
23154446|NCT01010633|64315764|FG000|Overall Study|Adverse Event|1|||
23154447|NCT01010633|64315765|FG001|Overall Study|Adverse Event|1|||
23154448|NCT01010633|64315764|FG000|Overall Study|Protocol Violation|1|||
23154449|NCT01010633|64315765|FG001|Overall Study|Protocol Violation|2|||
23154450|NCT01010633|64315764|FG000|Overall Study|Withdrawal by Subject|2|||
23154451|NCT01010633|64315765|FG001|Overall Study|Withdrawal by Subject|1|||
23154452|NCT01010633|64315764|FG000|Overall Study|Investigator decision|0|||
23154453|NCT01010633|64315765|FG001|Overall Study|Investigator decision|1|||
23154454|NCT01848353|64315766|FG000|Phase 1|Withdrawal by Subject|3|||
23154455|NCT01848353|64315767|FG001|Phase 1|Withdrawal by Subject|1|||
23154456|NCT01848353|64315768|FG002|Phase 1|Withdrawal by Subject|0|||
23154457|NCT01848353|64315769|FG003|Phase 1|Withdrawal by Subject|0|||
23154458|NCT01848353|64315766|FG000|Phase 2|Withdrawal by Subject|3|||
23154459|NCT01848353|64315767|FG001|Phase 2|Withdrawal by Subject|2|||
23154460|NCT01848353|64315768|FG002|Phase 2|Withdrawal by Subject|0|||
23154461|NCT01848353|64315769|FG003|Phase 2|Withdrawal by Subject|0|||
23154462|NCT01848353|64315766|FG000|Phase 3|Withdrawal by Subject|1|||
23154463|NCT01848353|64315767|FG001|Phase 3|Withdrawal by Subject|1|||
23154464|NCT01848353|64315768|FG002|Phase 3|Withdrawal by Subject|0|||
23154465|NCT01848353|64315769|FG003|Phase 3|Withdrawal by Subject|0|||
23154466|NCT00894686|64315770|FG000|Overall Study|Withdrawal by Subject|50|||
23154467|NCT00894686|64315770|FG000|Overall Study|Physician Decision|1|||
23154468|NCT00894686|64315770|FG000|Overall Study|Other|5|||
23154469|NCT03974334|64315771|FG000|Overall Study|Lost to Follow-up|1|||
23154470|NCT01490450|64318625|FG000|Period 1|Lack of Efficacy|2|||
23154471|NCT01490450|64318626|FG001|Period 1|Lack of Efficacy|0|||
23154472|NCT01490450|64318627|FG002|Period 1|Lack of Efficacy|3|||
23154473|NCT01490450|64318628|FG003|Period 1|Lack of Efficacy|0|||
23154474|NCT01490450|64318625|FG000|Period 1|Adverse Event|0|||
23154475|NCT01490450|64318626|FG001|Period 1|Adverse Event|0|||
23154476|NCT01490450|64318627|FG002|Period 1|Adverse Event|0|||
23154477|NCT01490450|64318628|FG003|Period 1|Adverse Event|5|||
23154478|NCT01490450|64318625|FG000|Period 1|Request to discontinue treatment|1|||
23154479|NCT01490450|64318626|FG001|Period 1|Request to discontinue treatment|0|||
23221255|NCT00422240|64553590|FG000|Overall Study|Other|1|||
23327352|NCT02157935|64940891|FG001|Overall Study|Withdrawal by Subject|39|||
23327353|NCT02157935|64940890|FG000|Overall Study|Screen failure|1|||
23327354|NCT02157935|64940891|FG001|Overall Study|Screen failure|2|||
23154480|NCT01490450|64318627|FG002|Period 1|Request to discontinue treatment|0|||
23154481|NCT01490450|64318628|FG003|Period 1|Request to discontinue treatment|0|||
23154482|NCT01490450|64318625|FG000|Period 1|Withdrawal by Subject|0|||
23154483|NCT01490450|64318626|FG001|Period 1|Withdrawal by Subject|0|||
23154484|NCT01490450|64318627|FG002|Period 1|Withdrawal by Subject|0|||
23154485|NCT01490450|64318628|FG003|Period 1|Withdrawal by Subject|3|||
23154486|NCT01490450|64318625|FG000|Period 1|No longer met study criteria|0|||
23154487|NCT01490450|64318626|FG001|Period 1|No longer met study criteria|1|||
23154488|NCT01490450|64318627|FG002|Period 1|No longer met study criteria|1|||
23154489|NCT01490450|64318628|FG003|Period 1|No longer met study criteria|0|||
23154490|NCT01490450|64318625|FG000|Period 2|Lack of Efficacy|0|||
23154491|NCT01490450|64318626|FG001|Period 2|Lack of Efficacy|0|||
23154492|NCT01490450|64318627|FG002|Period 2|Lack of Efficacy|0|||
23154493|NCT01490450|64318628|FG003|Period 2|Lack of Efficacy|1|||
23154494|NCT01490450|64318625|FG000|Period 2|Adverse Event|1|||
23154495|NCT01490450|64318626|FG001|Period 2|Adverse Event|1|||
23154496|NCT01490450|64318627|FG002|Period 2|Adverse Event|0|||
23154497|NCT01490450|64318628|FG003|Period 2|Adverse Event|1|||
23154498|NCT01490450|64318625|FG000|Period 2|Withdrawal by Subject|1|||
23154499|NCT01490450|64318626|FG001|Period 2|Withdrawal by Subject|0|||
23154500|NCT01490450|64318627|FG002|Period 2|Withdrawal by Subject|0|||
23154501|NCT01490450|64318628|FG003|Period 2|Withdrawal by Subject|0|||
23154502|NCT01490450|64318625|FG000|Period 2|Lost to Follow-up|0|||
23154503|NCT01490450|64318626|FG001|Period 2|Lost to Follow-up|0|||
23154504|NCT01490450|64318627|FG002|Period 2|Lost to Follow-up|0|||
23154505|NCT01490450|64318628|FG003|Period 2|Lost to Follow-up|2|||
23154506|NCT03519867|64318632|FG000|Overall Study|Adverse Event|1|||
23154507|NCT03519867|64318633|FG001|Overall Study|Adverse Event|1|||
23154508|NCT03519867|64318634|FG002|Overall Study|Adverse Event|0|||
23154509|NCT03519867|64318635|FG003|Overall Study|Adverse Event|0|||
23154510|NCT03519867|64318636|FG004|Overall Study|Adverse Event|0|||
23154511|NCT03519867|64318637|FG005|Overall Study|Adverse Event|0|||
23154512|NCT03519867|64318638|FG006|Overall Study|Adverse Event|0|||
23154513|NCT03519867|64318639|FG007|Overall Study|Adverse Event|0|||
23154514|NCT03519867|64318640|FG008|Overall Study|Adverse Event|0|||
23154515|NCT03519867|64318641|FG009|Overall Study|Adverse Event|0|||
23154516|NCT03519867|64318632|FG000|Overall Study|Protocol Violation|0|||
23154517|NCT03519867|64318633|FG001|Overall Study|Protocol Violation|0|||
23154518|NCT03519867|64318634|FG002|Overall Study|Protocol Violation|0|||
23154519|NCT03519867|64318635|FG003|Overall Study|Protocol Violation|0|||
23154520|NCT03519867|64318636|FG004|Overall Study|Protocol Violation|0|||
23154521|NCT03519867|64318637|FG005|Overall Study|Protocol Violation|1|||
23565124|NCT02960763|65799509|FG001|Step 1|Death|1|||
23565125|NCT02960763|65799510|FG002|Step 1|Death|1|||
23565126|NCT02960763|65799511|FG003|Step 1|Death|0|||
23565127|NCT02960763|65799512|FG004|Step 1|Death|0|||
23565128|NCT02960763|65799508|FG000|Step 1|Investigator discretion|1|||
23565129|NCT02960763|65799509|FG001|Step 1|Investigator discretion|0|||
23565130|NCT02960763|65799510|FG002|Step 1|Investigator discretion|1|||
23565131|NCT02960763|65799511|FG003|Step 1|Investigator discretion|0|||
23565132|NCT02960763|65799512|FG004|Step 1|Investigator discretion|0|||
23565133|NCT02960763|65799508|FG000|Step 1|Other|0|||
23565134|NCT02960763|65799509|FG001|Step 1|Other|0|||
23565135|NCT02960763|65799510|FG002|Step 1|Other|1|||
23565136|NCT02960763|65799511|FG003|Step 1|Other|0|||
23565137|NCT02960763|65799512|FG004|Step 1|Other|0|||
23565138|NCT02960763|65799508|FG000|Step 2|Withdrawal by Subject|0|||
23565139|NCT02960763|65799509|FG001|Step 2|Withdrawal by Subject|0|||
23565140|NCT02960763|65799510|FG002|Step 2|Withdrawal by Subject|0|||
23565141|NCT02960763|65799511|FG003|Step 2|Withdrawal by Subject|7|||
23565142|NCT02960763|65799512|FG004|Step 2|Withdrawal by Subject|3|||
23565143|NCT02960763|65799508|FG000|Step 2|Lost to Follow-up|0|||
23565144|NCT02960763|65799509|FG001|Step 2|Lost to Follow-up|0|||
23565145|NCT02960763|65799510|FG002|Step 2|Lost to Follow-up|0|||
23565146|NCT02960763|65799511|FG003|Step 2|Lost to Follow-up|4|||
23565147|NCT02960763|65799512|FG004|Step 2|Lost to Follow-up|1|||
23327355|NCT02157935|64940890|FG000|Overall Study|Protocol Violation|1|||
23565148|NCT02960763|65799508|FG000|Step 2|Investigator discretion|0|||
23565149|NCT02960763|65799509|FG001|Step 2|Investigator discretion|0|||
23565150|NCT02960763|65799510|FG002|Step 2|Investigator discretion|0|||
23565151|NCT02960763|65799511|FG003|Step 2|Investigator discretion|0|||
23154522|NCT03519867|64318638|FG006|Overall Study|Protocol Violation|0|||
23154523|NCT03519867|64318639|FG007|Overall Study|Protocol Violation|0|||
23327356|NCT02157935|64940891|FG001|Overall Study|Protocol Violation|0|||
23327357|NCT02157935|64940890|FG000|Overall Study|Progressive disease|0|||
23327358|NCT02157935|64940891|FG001|Overall Study|Progressive disease|2|||
23327359|NCT02157935|64940890|FG000|Overall Study|Other|5|||
23327360|NCT02157935|64940891|FG001|Overall Study|Other|12|||
23327361|NCT02157935|64940890|FG000|Overall Study|Lack of Efficacy|0|||
23327362|NCT02157935|64940891|FG001|Overall Study|Lack of Efficacy|1|||
23327363|NCT02157935|64940890|FG000|Overall Study|Death|4|||
23154524|NCT03519867|64318640|FG008|Overall Study|Protocol Violation|0|||
23154525|NCT03519867|64318641|FG009|Overall Study|Protocol Violation|0|||
23154526|NCT03519867|64318632|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23154527|NCT03519867|64318633|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23327364|NCT02157935|64940891|FG001|Overall Study|Death|4|||
23327365|NCT02157935|64940890|FG000|Overall Study|Adverse Event|3|||
23154528|NCT03519867|64318634|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23327366|NCT02157935|64940891|FG001|Overall Study|Adverse Event|5|||
23327367|NCT01958437|64940894|FG000|Overall Study|Incidental MRI findings|0|||
23327368|NCT01958437|64940895|FG001|Overall Study|Incidental MRI findings|0|||
23565152|NCT02960763|65799512|FG004|Step 2|Investigator discretion|1|||
23565153|NCT02306265|65799513|FG000|Overall Study|Withdrawal by Subject|1|||
23565154|NCT01446796|65799520|FG000|Overall Study|Withdrawal by Subject|1|||
23565155|NCT01446796|65799521|FG001|Overall Study|Withdrawal by Subject|0|||
23565156|NCT02213328|65799522|FG000|Overall Study|Withdrawal by Subject|10|||
23441865|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Death|3|||
23441866|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Death|1|||
23441867|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Death|0|||
23441868|NCT02152761|65358652|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
23441869|NCT02152761|65358653|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
23441870|NCT02152761|65358654|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
23441871|NCT02152761|65358655|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
23441872|NCT02152761|65358652|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
23441873|NCT02152761|65358653|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
23441874|NCT02152761|65358654|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
23565157|NCT02213328|65799522|FG000|Overall Study|Physician Decision|2|||
23565158|NCT02213328|65799522|FG000|Overall Study|Lost to Follow-up|16|||
23565159|NCT03072238|65799523|FG000|Overall Study|Withdrawal by Subject|30|||
23565160|NCT03072238|65799524|FG001|Overall Study|Withdrawal by Subject|51|||
23565161|NCT03072238|65799523|FG000|Overall Study|Lost to Follow-up|7|||
23565162|NCT03072238|65799524|FG001|Overall Study|Lost to Follow-up|4|||
23565163|NCT03072238|65799523|FG000|Overall Study|Physician Decision|1|||
23221256|NCT00422240|64553591|FG001|Overall Study|Other|0|||
23221257|NCT00422240|64553592|FG002|Overall Study|Other|0|||
23441875|NCT02152761|65358655|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
23441876|NCT02152761|65358652|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
23441877|NCT02152761|65358653|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
23441878|NCT02152761|65358654|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
23441879|NCT02152761|65358655|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
23441880|NCT02152761|65358652|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
23441881|NCT02152761|65358653|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
23441882|NCT02152761|65358654|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
23441883|NCT02152761|65358655|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
23441884|NCT02152761|65358652|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
23441885|NCT02152761|65358653|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
23441886|NCT02152761|65358654|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
23441887|NCT02152761|65358655|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
23441888|NCT02828436|65358658|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
23441889|NCT02828436|65358659|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
23441890|NCT02828436|65358658|FG000|Period 1|Lost to Follow-up|0|||
23441891|NCT02828436|65358659|FG001|Period 1|Lost to Follow-up|1|||
23441892|NCT02828436|65358658|FG000|Period 2|Withdrawal by Subject|4|||
23441893|NCT02828436|65358659|FG001|Period 2|Withdrawal by Subject|0|||
23441894|NCT02828436|65358658|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
23441895|NCT02828436|65358659|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
23441896|NCT02828436|65358658|FG000|Period 2|Lost to Follow-up|1|||
23441897|NCT02828436|65358659|FG001|Period 2|Lost to Follow-up|0|||
23441898|NCT01565694|65358660|FG000|Dose-Titration Period|Adverse Event|4|||
23441899|NCT01565694|65358660|FG000|Dose-Titration Period|Protocol Violation|10|||
23441900|NCT01565694|65358660|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
23441901|NCT00753454|65358661|FG000|Overall Study|Adverse Event|4|||
23441902|NCT00753454|65358661|FG000|Overall Study|Lack of Efficacy|1|||
23441903|NCT00753454|65358661|FG000|Overall Study|Lost to Follow-up|3|||
23441904|NCT00753454|65358661|FG000|Overall Study|Withdrawal by Subject|5|||
23441905|NCT00753454|65358661|FG000|Overall Study|Investigator Decision|1|||
23565164|NCT03072238|65799524|FG001|Overall Study|Physician Decision|3|||
23627331|NCT03126110|66024406|FG010|Phase 2|Progressive Disease|0|||
23627332|NCT03126110|66024407|FG011|Phase 2|Progressive Disease|0|||
23221258|NCT00422240|64553593|FG003|Overall Study|Other|1|||
23221259|NCT00422240|64553590|FG000|Overall Study|Pregnancy|3|||
23221260|NCT00422240|64553591|FG001|Overall Study|Pregnancy|1|||
23221261|NCT00422240|64553592|FG002|Overall Study|Pregnancy|1|||
23221262|NCT00422240|64553593|FG003|Overall Study|Pregnancy|2|||
23221263|NCT02533401|64553601|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
23441906|NCT04158583|65358662|FG000|Overall Study|Withdrawal by Subject|1|||
23441907|NCT04158583|65358663|FG001|Overall Study|Withdrawal by Subject|1|||
23441908|NCT04158583|65358664|FG002|Overall Study|Withdrawal by Subject|0|||
23441909|NCT04158583|65358665|FG003|Overall Study|Withdrawal by Subject|0|||
23441910|NCT04158583|65358666|FG004|Overall Study|Withdrawal by Subject|1|||
23441911|NCT04158583|65358667|FG005|Overall Study|Withdrawal by Subject|0|||
23441912|NCT04158583|65358668|FG006|Overall Study|Withdrawal by Subject|0|||
23565165|NCT03072238|65799523|FG000|Overall Study|Death|139|||
23221264|NCT02533401|64553601|FG000|Overall Study|Death|5|||
23221265|NCT02533401|64553601|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
23221266|NCT02533401|64553601|FG000|Overall Study|Lost to Follow-up|1|||
23441913|NCT04158583|65358669|FG007|Overall Study|Withdrawal by Subject|0|||
23441914|NCT04158583|65358670|FG008|Overall Study|Withdrawal by Subject|2|||
23441915|NCT04158583|65358671|FG009|Overall Study|Withdrawal by Subject|0|||
23441916|NCT04158583|65358662|FG000|Overall Study|Study Terminated by Sponsor|0|||
23565166|NCT03072238|65799524|FG001|Overall Study|Death|121|||
23565167|NCT03072238|65799523|FG000|Overall Study|Other|0|||
23154529|NCT03519867|64318635|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23627333|NCT03126110|66024408|FG012|Phase 2|Progressive Disease|0|||
23154530|NCT03519867|64318636|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23154531|NCT03519867|64318637|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23154532|NCT03519867|64318638|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
23154533|NCT03519867|64318639|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23154534|NCT03519867|64318640|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23154535|NCT03519867|64318641|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
23154536|NCT03519867|64318632|FG000|Overall Study|Admin. of other reversal agent|1|||
23154537|NCT03519867|64318633|FG001|Overall Study|Admin. of other reversal agent|1|||
23154538|NCT03519867|64318634|FG002|Overall Study|Admin. of other reversal agent|0|||
23154539|NCT03519867|64318635|FG003|Overall Study|Admin. of other reversal agent|0|||
23154540|NCT03519867|64318636|FG004|Overall Study|Admin. of other reversal agent|0|||
23154541|NCT03519867|64318637|FG005|Overall Study|Admin. of other reversal agent|1|||
23154542|NCT03519867|64318638|FG006|Overall Study|Admin. of other reversal agent|0|||
23154543|NCT03519867|64318639|FG007|Overall Study|Admin. of other reversal agent|0|||
23154544|NCT03519867|64318640|FG008|Overall Study|Admin. of other reversal agent|0|||
23221267|NCT02533401|64553601|FG000|Overall Study|Violation of Selection Criteria|1|||
23221268|NCT00618813|64553602|FG000|Overall Study|Lack of Efficacy|1|||
23221269|NCT00618813|64553602|FG000|Overall Study|Physician Decision|2|||
23221270|NCT00618813|64553602|FG000|Overall Study|Withdrawal by Subject|1|||
23565168|NCT03072238|65799524|FG001|Overall Study|Other|1|||
23565169|NCT03072238|65799523|FG000|Overall Study|Ongoing on study|377|||
23565170|NCT03072238|65799524|FG001|Overall Study|Ongoing on study|367|||
23565171|NCT02035332|65799526|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
23565172|NCT01512745|65799529|FG000|Overall Study|Adverse Event|22|||
23565173|NCT01512745|65799530|FG001|Overall Study|Adverse Event|3|||
23565174|NCT01512745|65799529|FG000|Overall Study|Death|9|||
23565175|NCT01512745|65799530|FG001|Overall Study|Death|13|||
23565176|NCT01512745|65799529|FG000|Overall Study|Withdrawal by Subject|2|||
23565177|NCT01512745|65799530|FG001|Overall Study|Withdrawal by Subject|2|||
23565178|NCT01512745|65799529|FG000|Overall Study|Lost to Follow-up|4|||
23565179|NCT01512745|65799530|FG001|Overall Study|Lost to Follow-up|0|||
23565180|NCT01512745|65799529|FG000|Overall Study|Lack of Efficacy|2|||
23565181|NCT01512745|65799530|FG001|Overall Study|Lack of Efficacy|2|||
23565182|NCT01512745|65799529|FG000|Overall Study|Protocol Violation|1|||
23565183|NCT01512745|65799530|FG001|Overall Study|Protocol Violation|0|||
23565184|NCT00949884|65799531|FG000|Overall Study|Adverse Event|14|||
23565185|NCT00949884|65799532|FG001|Overall Study|Adverse Event|3|||
23565186|NCT00949884|65799533|FG002|Overall Study|Adverse Event|12|||
23565187|NCT00949884|65799531|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
23221271|NCT01201967|64553603|FG000|Overall Study|Lost to Follow-up|6|||
23221272|NCT01201967|64553604|FG001|Overall Study|Lost to Follow-up|5|||
23221273|NCT02829775|64553609|FG000|Overall Study|Death|1|||
23221274|NCT02829775|64553609|FG000|Overall Study|Withdrawal by Subject|3|||
23221275|NCT02829775|64553609|FG000|Overall Study|Disease remission|1|||
23221276|NCT00643448|64553614|FG000|Overall Study|Lack of Efficacy|2|||
23221277|NCT00643448|64553615|FG001|Overall Study|Lack of Efficacy|0|||
23221278|NCT00643448|64553616|FG002|Overall Study|Lack of Efficacy|4|||
23221279|NCT00643448|64553614|FG000|Overall Study|Adverse Event|2|||
23221280|NCT00643448|64553615|FG001|Overall Study|Adverse Event|2|||
23627334|NCT03126110|66024409|FG013|Phase 2|Progressive Disease|1|||
23627335|NCT03126110|66024410|FG014|Phase 2|Progressive Disease|0|||
23627336|NCT03126110|66024411|FG015|Phase 2|Progressive Disease|0|||
23627337|NCT03126110|66024412|FG016|Phase 2|Progressive Disease|0|||
23627338|NCT03126110|66024396|FG000|Phase 2|Started new treatment|0|||
23627339|NCT03126110|66024397|FG001|Phase 2|Started new treatment|0|||
23627340|NCT03126110|66024398|FG002|Phase 2|Started new treatment|0|||
23221281|NCT00643448|64553616|FG002|Overall Study|Adverse Event|2|||
23221282|NCT00643448|64553614|FG000|Overall Study|QTcF>550 ms|0|||
23565188|NCT00949884|65799532|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
23565189|NCT00949884|65799533|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
23565190|NCT00949884|65799531|FG000|Overall Study|Lost to Follow-up|7|||
23627341|NCT03126110|66024399|FG003|Phase 2|Started new treatment|0|||
23627342|NCT03126110|66024400|FG004|Phase 2|Started new treatment|0|||
23627343|NCT03126110|66024401|FG005|Phase 2|Started new treatment|0|||
23627344|NCT03126110|66024402|FG006|Phase 2|Started new treatment|0|||
23154545|NCT03519867|64318641|FG009|Overall Study|Admin. of other reversal agent|0|||
23221283|NCT00643448|64553615|FG001|Overall Study|QTcF>550 ms|3|||
23221284|NCT00643448|64553616|FG002|Overall Study|QTcF>550 ms|0|||
23221285|NCT01136746|64553619|FG000|Overall Study|Lost to Follow-up|0|||
23221286|NCT01136746|64553620|FG001|Overall Study|Lost to Follow-up|2|||
23221287|NCT01136746|64553619|FG000|Overall Study|Protocol Violation|2|||
23565191|NCT00949884|65799532|FG001|Overall Study|Lost to Follow-up|5|||
23565192|NCT00949884|65799533|FG002|Overall Study|Lost to Follow-up|5|||
23565193|NCT00949884|65799531|FG000|Overall Study|Physician Decision|5|||
23565194|NCT00949884|65799532|FG001|Overall Study|Physician Decision|0|||
23565195|NCT00949884|65799533|FG002|Overall Study|Physician Decision|6|||
23565196|NCT00949884|65799531|FG000|Overall Study|Treatment non-compliance|5|||
23565197|NCT00949884|65799532|FG001|Overall Study|Treatment non-compliance|0|||
23565198|NCT00949884|65799533|FG002|Overall Study|Treatment non-compliance|8|||
23441917|NCT04158583|65358663|FG001|Overall Study|Study Terminated by Sponsor|0|||
23441918|NCT04158583|65358664|FG002|Overall Study|Study Terminated by Sponsor|0|||
23441919|NCT04158583|65358665|FG003|Overall Study|Study Terminated by Sponsor|1|||
23441920|NCT04158583|65358666|FG004|Overall Study|Study Terminated by Sponsor|0|||
23441921|NCT04158583|65358667|FG005|Overall Study|Study Terminated by Sponsor|0|||
23441922|NCT04158583|65358668|FG006|Overall Study|Study Terminated by Sponsor|0|||
23441923|NCT04158583|65358669|FG007|Overall Study|Study Terminated by Sponsor|0|||
23441924|NCT04158583|65358670|FG008|Overall Study|Study Terminated by Sponsor|0|||
23441925|NCT04158583|65358671|FG009|Overall Study|Study Terminated by Sponsor|0|||
23441926|NCT04158583|65358662|FG000|Overall Study|Progressive Disease|1|||
23441927|NCT04158583|65358663|FG001|Overall Study|Progressive Disease|0|||
23441928|NCT04158583|65358664|FG002|Overall Study|Progressive Disease|3|||
23441929|NCT04158583|65358665|FG003|Overall Study|Progressive Disease|5|||
23441930|NCT04158583|65358666|FG004|Overall Study|Progressive Disease|0|||
23441931|NCT04158583|65358667|FG005|Overall Study|Progressive Disease|1|||
23441932|NCT04158583|65358668|FG006|Overall Study|Progressive Disease|6|||
23441933|NCT04158583|65358669|FG007|Overall Study|Progressive Disease|2|||
23441934|NCT04158583|65358670|FG008|Overall Study|Progressive Disease|1|||
23565199|NCT00949884|65799531|FG000|Overall Study|Withdrawal by Subject|13|||
23565200|NCT00949884|65799532|FG001|Overall Study|Withdrawal by Subject|4|||
23565201|NCT00949884|65799533|FG002|Overall Study|Withdrawal by Subject|16|||
23565202|NCT00949884|65799531|FG000|Overall Study|Lack of Efficacy|4|||
23565203|NCT00949884|65799532|FG001|Overall Study|Lack of Efficacy|2|||
23565204|NCT00949884|65799533|FG002|Overall Study|Lack of Efficacy|7|||
23565205|NCT00949884|65799531|FG000|Overall Study|Study terminated by sponsor|0|||
23627345|NCT03126110|66024403|FG007|Phase 2|Started new treatment|0|||
23154546|NCT03519867|64318632|FG000|Overall Study|Reason not provided|1|||
23154547|NCT03519867|64318633|FG001|Overall Study|Reason not provided|1|||
23154548|NCT03519867|64318634|FG002|Overall Study|Reason not provided|1|||
23154549|NCT03519867|64318635|FG003|Overall Study|Reason not provided|1|||
23154550|NCT03519867|64318636|FG004|Overall Study|Reason not provided|0|||
23154551|NCT03519867|64318637|FG005|Overall Study|Reason not provided|1|||
23154552|NCT03519867|64318638|FG006|Overall Study|Reason not provided|0|||
23154553|NCT03519867|64318639|FG007|Overall Study|Reason not provided|1|||
23154554|NCT03519867|64318640|FG008|Overall Study|Reason not provided|1|||
23154555|NCT03519867|64318641|FG009|Overall Study|Reason not provided|0|||
23154556|NCT00290290|64318642|FG000|Overall Study|Death|3|||
23154557|NCT00290290|64318643|FG001|Overall Study|Death|4|||
23154558|NCT00290290|64318642|FG000|Overall Study|Withdrawal by Subject|2|||
23154559|NCT00290290|64318643|FG001|Overall Study|Withdrawal by Subject|2|||
23154560|NCT00290290|64318642|FG000|Overall Study|Underwent clean surgical procedure|13|||
23154561|NCT00290290|64318643|FG001|Overall Study|Underwent clean surgical procedure|12|||
23154562|NCT02448225|64318649|FG000|Overall Study|Withdrawal by Subject|1|||
23154563|NCT02448225|64318649|FG000|Overall Study|Did not get FSPG scan|18|||
23154564|NCT02448225|64318649|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
23154565|NCT03808688|64318651|FG000|Overall Study|Adverse Event|13|||
23154566|NCT03808688|64318652|FG001|Overall Study|Adverse Event|17|||
23154567|NCT03808688|64318651|FG000|Overall Study|Lack of Efficacy|2|||
23154568|NCT03808688|64318652|FG001|Overall Study|Lack of Efficacy|0|||
23154569|NCT03808688|64318651|FG000|Overall Study|Lost to Follow-up|0|||
23441935|NCT04158583|65358671|FG009|Overall Study|Progressive Disease|2|||
23441936|NCT04158583|65358662|FG000|Overall Study|Lost to Follow-up|0|||
23441937|NCT04158583|65358663|FG001|Overall Study|Lost to Follow-up|0|||
23441938|NCT04158583|65358664|FG002|Overall Study|Lost to Follow-up|1|||
23627346|NCT03126110|66024404|FG008|Phase 2|Started new treatment|0|||
23154570|NCT03808688|64318652|FG001|Overall Study|Lost to Follow-up|2|||
23154571|NCT03808688|64318651|FG000|Overall Study|Withdrawal by Subject|1|||
23154572|NCT03808688|64318652|FG001|Overall Study|Withdrawal by Subject|0|||
23154573|NCT03808688|64318651|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
23154574|NCT03808688|64318652|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
23154575|NCT03808688|64318651|FG000|Overall Study|IOP Too High|1|||
23441939|NCT04158583|65358665|FG003|Overall Study|Lost to Follow-up|1|||
23627347|NCT03126110|66024405|FG009|Phase 2|Started new treatment|0|||
23154576|NCT03808688|64318652|FG001|Overall Study|IOP Too High|1|||
23154577|NCT03808688|64318651|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
23441940|NCT04158583|65358666|FG004|Overall Study|Lost to Follow-up|1|||
23441941|NCT04158583|65358667|FG005|Overall Study|Lost to Follow-up|0|||
23441942|NCT04158583|65358668|FG006|Overall Study|Lost to Follow-up|0|||
23441943|NCT04158583|65358669|FG007|Overall Study|Lost to Follow-up|0|||
23565206|NCT00949884|65799532|FG001|Overall Study|Study terminated by sponsor|0|||
23154578|NCT03808688|64318652|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
23441944|NCT04158583|65358670|FG008|Overall Study|Lost to Follow-up|0|||
23565207|NCT00949884|65799533|FG002|Overall Study|Study terminated by sponsor|1|||
23154579|NCT03808688|64318651|FG000|Overall Study|Visit Out of Window|0|||
23154580|NCT03808688|64318652|FG001|Overall Study|Visit Out of Window|1|||
23154581|NCT03808688|64318651|FG000|Overall Study|Medication Non-Compliance|0|||
23154582|NCT03808688|64318652|FG001|Overall Study|Medication Non-Compliance|1|||
23154583|NCT02790138|64318653|FG000|Overall Study|Adverse Event|5|||
23154584|NCT02790138|64318654|FG001|Overall Study|Adverse Event|2|||
23154585|NCT02790138|64318653|FG000|Overall Study|Significant Protocol Deviation|0|||
23154586|NCT02790138|64318654|FG001|Overall Study|Significant Protocol Deviation|1|||
23154587|NCT02790138|64318653|FG000|Overall Study|Lost to Follow-up|1|||
23154588|NCT02790138|64318654|FG001|Overall Study|Lost to Follow-up|0|||
23154589|NCT02790138|64318653|FG000|Overall Study|Voluntary Withdrawal|8|||
23154590|NCT02790138|64318654|FG001|Overall Study|Voluntary Withdrawal|9|||
23154591|NCT02790138|64318653|FG000|Overall Study|Lack of Efficacy|6|||
23154592|NCT02790138|64318654|FG001|Overall Study|Lack of Efficacy|7|||
23154593|NCT02790138|64318653|FG000|Overall Study|Reason not Specified|1|||
23154594|NCT02790138|64318654|FG001|Overall Study|Reason not Specified|0|||
23154595|NCT01506960|64318657|FG000|Overall Study|Did not meet angiographic criteria|47|||
23154596|NCT02090413|64318658|FG000|Overall Study|Adverse Event|11|||
23154597|NCT02090413|64318659|FG001|Overall Study|Adverse Event|15|||
23154598|NCT02090413|64318660|FG002|Overall Study|Adverse Event|20|||
23154599|NCT02090413|64318658|FG000|Overall Study|Flushing event|2|||
23154600|NCT02090413|64318659|FG001|Overall Study|Flushing event|0|||
23154601|NCT02090413|64318660|FG002|Overall Study|Flushing event|1|||
23154602|NCT02090413|64318658|FG000|Overall Study|Withdrawal by Subject|2|||
23154603|NCT02090413|64318659|FG001|Overall Study|Withdrawal by Subject|2|||
23154604|NCT02090413|64318660|FG002|Overall Study|Withdrawal by Subject|2|||
23154605|NCT02090413|64318658|FG000|Overall Study|Investigator Decision|1|||
23154606|NCT02090413|64318659|FG001|Overall Study|Investigator Decision|1|||
23154607|NCT02090413|64318660|FG002|Overall Study|Investigator Decision|0|||
23154608|NCT02090413|64318658|FG000|Overall Study|Other|2|||
23154609|NCT02090413|64318659|FG001|Overall Study|Other|1|||
23154610|NCT02090413|64318660|FG002|Overall Study|Other|0|||
23154611|NCT02090413|64318658|FG000|Overall Study|Lost to Follow-up|1|||
23154612|NCT02090413|64318659|FG001|Overall Study|Lost to Follow-up|1|||
23154613|NCT02090413|64318660|FG002|Overall Study|Lost to Follow-up|0|||
23154614|NCT01007032|64318661|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
23154615|NCT01007032|64318662|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
23154616|NCT01007032|64318663|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
23154617|NCT01007032|64318664|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
23154618|NCT01007032|64318661|FG000|Overall Study|Withdrawal by Subject|0|||
23154619|NCT01007032|64318662|FG001|Overall Study|Withdrawal by Subject|0|||
23154620|NCT01007032|64318663|FG002|Overall Study|Withdrawal by Subject|0|||
23154621|NCT01007032|64318664|FG003|Overall Study|Withdrawal by Subject|1|||
23154622|NCT02181816|64318665|FG000|Overall Study|Case Report Forms Uncollected|38|||
23154623|NCT02181816|64318665|FG000|Overall Study|Protocol Deviation|21|||
23154624|NCT02576444|64318666|FG000|Overall Study|Death|1|||
23154625|NCT02576444|64318667|FG001|Overall Study|Death|1|||
23154626|NCT02576444|64318668|FG002|Overall Study|Death|0|||
23154627|NCT02576444|64318669|FG003|Overall Study|Death|0|||
23154628|NCT02576444|64318666|FG000|Overall Study|Withdrawal by Subject|0|||
23154629|NCT02576444|64318667|FG001|Overall Study|Withdrawal by Subject|0|||
23154630|NCT02576444|64318668|FG002|Overall Study|Withdrawal by Subject|2|||
23154631|NCT02576444|64318669|FG003|Overall Study|Withdrawal by Subject|0|||
23154632|NCT02576444|64318666|FG000|Overall Study|Adverse Event|0|||
23154633|NCT02576444|64318667|FG001|Overall Study|Adverse Event|0|||
23154634|NCT02576444|64318668|FG002|Overall Study|Adverse Event|1|||
23154635|NCT02576444|64318669|FG003|Overall Study|Adverse Event|0|||
23154636|NCT02576444|64318666|FG000|Overall Study|Physician Decision|0|||
23154637|NCT02576444|64318667|FG001|Overall Study|Physician Decision|0|||
23154638|NCT02576444|64318668|FG002|Overall Study|Physician Decision|1|||
23154639|NCT02576444|64318669|FG003|Overall Study|Physician Decision|0|||
23154640|NCT01353508|64318671|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
23154641|NCT01353508|64318672|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
23154642|NCT01353508|64318673|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
23154643|NCT01353508|64318674|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
23154644|NCT01353508|64318671|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
23154645|NCT01353508|64318672|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
23154646|NCT01353508|64318673|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
23154647|NCT01353508|64318674|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
23627348|NCT03126110|66024406|FG010|Phase 2|Started new treatment|0|||
23154648|NCT00763971|64318676|FG000|Overall Study|Adverse Event|5|||
23154649|NCT00763971|64318677|FG001|Overall Study|Adverse Event|2|||
23154650|NCT00763971|64318678|FG002|Overall Study|Adverse Event|4|||
23154651|NCT00763971|64318676|FG000|Overall Study|Protocol Violation|3|||
23154652|NCT00763971|64318677|FG001|Overall Study|Protocol Violation|3|||
23154653|NCT00763971|64318678|FG002|Overall Study|Protocol Violation|2|||
23154654|NCT00763971|64318676|FG000|Overall Study|Withdrawal by Subject|4|||
23154655|NCT00763971|64318677|FG001|Overall Study|Withdrawal by Subject|5|||
23154656|NCT00763971|64318678|FG002|Overall Study|Withdrawal by Subject|5|||
23154657|NCT00763971|64318676|FG000|Overall Study|Lost to Follow-up|0|||
23154658|NCT00763971|64318677|FG001|Overall Study|Lost to Follow-up|1|||
23154659|NCT00763971|64318678|FG002|Overall Study|Lost to Follow-up|0|||
23154660|NCT00763971|64318676|FG000|Overall Study|Lack of Efficacy|11|||
23154661|NCT00763971|64318677|FG001|Overall Study|Lack of Efficacy|22|||
23154662|NCT00763971|64318678|FG002|Overall Study|Lack of Efficacy|54|||
23154663|NCT00763971|64318676|FG000|Overall Study|Unable to swallow capsule|2|||
23154664|NCT00763971|64318677|FG001|Overall Study|Unable to swallow capsule|1|||
23154665|NCT00763971|64318678|FG002|Overall Study|Unable to swallow capsule|1|||
23154666|NCT00763971|64318676|FG000|Overall Study|Personal reason|3|||
23154667|NCT00763971|64318677|FG001|Overall Study|Personal reason|0|||
23154668|NCT00763971|64318678|FG002|Overall Study|Personal reason|0|||
23154669|NCT00763971|64318676|FG000|Overall Study|Exclusion criteria met|1|||
23154670|NCT00763971|64318677|FG001|Overall Study|Exclusion criteria met|0|||
23154671|NCT00763971|64318678|FG002|Overall Study|Exclusion criteria met|0|||
23154672|NCT00763971|64318676|FG000|Overall Study|Sponsor decision|1|||
23154673|NCT00763971|64318677|FG001|Overall Study|Sponsor decision|0|||
23154674|NCT00763971|64318678|FG002|Overall Study|Sponsor decision|0|||
23154675|NCT00763971|64318676|FG000|Overall Study|Due to holiday season|2|||
23154676|NCT00763971|64318677|FG001|Overall Study|Due to holiday season|0|||
23154677|NCT00763971|64318678|FG002|Overall Study|Due to holiday season|1|||
23565208|NCT02690077|65799538|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
23565209|NCT02690077|65799539|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
23565210|NCT02690077|65799538|FG000|Overall Study|Withdrawal by Subject|0|||
23565211|NCT02690077|65799539|FG001|Overall Study|Withdrawal by Subject|5|||
23565212|NCT02690077|65799538|FG000|Overall Study|Excluded by IRB|0|||
23565213|NCT02690077|65799539|FG001|Overall Study|Excluded by IRB|2|||
23565214|NCT01862796|65799547|FG000|Overall Study|Prohibited medications|0|||
23565215|NCT01862796|65799548|FG001|Overall Study|Prohibited medications|0|||
23565216|NCT01862796|65799549|FG002|Overall Study|Prohibited medications|1|||
23565217|NCT02281760|65799553|FG000|Overall Study|Withdrawal by Subject|1|||
23565218|NCT01975220|65799565|FG000|Test Period 1|Not treated|0|||
23565219|NCT01975220|65799566|FG001|Test Period 1|Not treated|1|||
23565220|NCT01975220|65799567|FG002|Test Period 1|Not treated|0|||
23565221|NCT01975220|65799568|FG003|Test Period 1|Not treated|0|||
23565222|NCT01975220|65799569|FG004|Test Period 1|Not treated|0|||
23565223|NCT01975220|65799570|FG005|Test Period 1|Not treated|0|||
23565224|NCT03101241|65799571|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
23565225|NCT03101241|65799572|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
23565226|NCT03101241|65799571|FG000|Overall Study|Participant withdrew consent|3|||
23154678|NCT00763971|64318676|FG000|Overall Study|Randomization error|0|||
23154679|NCT00763971|64318677|FG001|Overall Study|Randomization error|0|||
23154680|NCT00763971|64318678|FG002|Overall Study|Randomization error|1|||
23154681|NCT00763971|64318676|FG000|Overall Study|Medical monitor decision|0|||
23154682|NCT00763971|64318677|FG001|Overall Study|Medical monitor decision|0|||
23154683|NCT00763971|64318678|FG002|Overall Study|Medical monitor decision|1|||
23154684|NCT00763971|64318676|FG000|Overall Study|Moved to another country|0|||
23154685|NCT00763971|64318677|FG001|Overall Study|Moved to another country|1|||
23154686|NCT00763971|64318678|FG002|Overall Study|Moved to another country|0|||
23154687|NCT00763971|64318676|FG000|Overall Study|Subject wanted dose reduction|0|||
23154688|NCT00763971|64318677|FG001|Overall Study|Subject wanted dose reduction|1|||
23154689|NCT00763971|64318678|FG002|Overall Study|Subject wanted dose reduction|0|||
23154690|NCT00763971|64318676|FG000|Overall Study|Lack of availability|0|||
23154691|NCT00763971|64318677|FG001|Overall Study|Lack of availability|1|||
23154692|NCT00763971|64318678|FG002|Overall Study|Lack of availability|0|||
23154693|NCT00763971|64318676|FG000|Overall Study|Performed final visit on phone|0|||
23154694|NCT00763971|64318677|FG001|Overall Study|Performed final visit on phone|1|||
23154695|NCT00763971|64318678|FG002|Overall Study|Performed final visit on phone|0|||
23154696|NCT00763971|64318676|FG000|Overall Study|Participation in 489-326 required|1|||
23154697|NCT00763971|64318677|FG001|Overall Study|Participation in 489-326 required|0|||
23154698|NCT00763971|64318678|FG002|Overall Study|Participation in 489-326 required|0|||
23154699|NCT03768505|64318686|FG000|Overall Study|sponsor decision|76|||
23154700|NCT03768505|64318686|FG000|Overall Study|Death|35|||
23154701|NCT03768505|64318686|FG000|Overall Study|Other -Various|30|||
23154702|NCT03768505|64318686|FG000|Overall Study|Withdrawal by Subject|22|||
23154703|NCT03768505|64318686|FG000|Overall Study|Lost to Follow-up|6|||
23154704|NCT00909181|64318690|FG000|Overall Study|Lost to Follow-up|39|||
23154705|NCT00909181|64318691|FG001|Overall Study|Lost to Follow-up|18|||
23154706|NCT00909181|64318692|FG002|Overall Study|Lost to Follow-up|33|||
23154707|NCT03710486|64318693|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
23154708|NCT03710486|64318694|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
23154709|NCT03710486|64318693|FG000|Overall Study|Missing|0|||
23154710|NCT03710486|64318694|FG001|Overall Study|Missing|2|||
23565227|NCT03101241|65799572|FG001|Overall Study|Participant withdrew consent|1|||
23154711|NCT00058552|64318695|FG000|Overall Study|Died prior to receiving treatment|4|||
23154712|NCT00058552|64318696|FG001|Overall Study|Died prior to receiving treatment|2|||
23154713|NCT00058552|64318695|FG000|Overall Study|Disease progression|52|||
23154714|NCT00058552|64318696|FG001|Overall Study|Disease progression|44|||
23154715|NCT00058552|64318695|FG000|Overall Study|Adverse Event|4|||
23154716|NCT00058552|64318696|FG001|Overall Study|Adverse Event|2|||
23154717|NCT00058552|64318695|FG000|Overall Study|Withdrawal by Subject|3|||
23154718|NCT00058552|64318696|FG001|Overall Study|Withdrawal by Subject|5|||
23154719|NCT00058552|64318695|FG000|Overall Study|Physician Decision|2|||
23154720|NCT00058552|64318696|FG001|Overall Study|Physician Decision|5|||
23154721|NCT00058552|64318695|FG000|Overall Study|Clinical disease progression|0|||
23154722|NCT00058552|64318696|FG001|Overall Study|Clinical disease progression|4|||
23154723|NCT02462928|64318697|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
23154724|NCT02462928|64318698|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
23154725|NCT02462928|64318699|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
23154726|NCT02462928|64318697|FG000|Overall Study|Adverse Event|47|||
23154727|NCT02462928|64318698|FG001|Overall Study|Adverse Event|51|||
23154728|NCT02462928|64318699|FG002|Overall Study|Adverse Event|25|||
23154729|NCT02462928|64318697|FG000|Overall Study|Lack of Efficacy|3|||
23154730|NCT02462928|64318698|FG001|Overall Study|Lack of Efficacy|8|||
23154731|NCT02462928|64318699|FG002|Overall Study|Lack of Efficacy|3|||
23154732|NCT02462928|64318697|FG000|Overall Study|Lost to Follow-up|4|||
23154733|NCT02462928|64318698|FG001|Overall Study|Lost to Follow-up|4|||
23154734|NCT02462928|64318699|FG002|Overall Study|Lost to Follow-up|1|||
23154735|NCT02462928|64318697|FG000|Overall Study|Withdrawal by Patient|31|||
23154736|NCT02462928|64318698|FG001|Overall Study|Withdrawal by Patient|21|||
23154737|NCT02462928|64318699|FG002|Overall Study|Withdrawal by Patient|21|||
23154738|NCT02462928|64318697|FG000|Overall Study|Protocol Violation|0|||
23154739|NCT02462928|64318698|FG001|Overall Study|Protocol Violation|1|||
23154740|NCT02462928|64318699|FG002|Overall Study|Protocol Violation|0|||
23154741|NCT02462928|64318697|FG000|Overall Study|Reason not Specified|4|||
23154742|NCT02462928|64318698|FG001|Overall Study|Reason not Specified|6|||
23154743|NCT02462928|64318699|FG002|Overall Study|Reason not Specified|5|||
23154744|NCT03422172|64318700|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
23154745|NCT03422172|64318700|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
23154746|NCT03422172|64318700|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
23154747|NCT00362414|64318707|FG000|Overall Study|Death|2|||
23154748|NCT00362414|64318707|FG000|Overall Study|Adverse Event|1|||
23154749|NCT01721876|64318708|FG000|Overall Study|Not treated|1|||
23154750|NCT01721876|64318709|FG001|Overall Study|Not treated|4|||
23154751|NCT01721876|64318708|FG000|Overall Study|Disease progression / relapse|123|||
23154752|NCT01721876|64318709|FG001|Overall Study|Disease progression / relapse|156|||
23154753|NCT01721876|64318708|FG000|Overall Study|Death|6|||
23154754|NCT01721876|64318709|FG001|Overall Study|Death|13|||
23154755|NCT01721876|64318708|FG000|Overall Study|Adverse Event|41|||
23154756|NCT01721876|64318709|FG001|Overall Study|Adverse Event|165|||
23154757|NCT01721876|64318708|FG000|Overall Study|Protocol Violation|2|||
23154758|NCT01721876|64318709|FG001|Overall Study|Protocol Violation|1|||
23154759|NCT01721876|64318708|FG000|Overall Study|Withdrawal by Subject|15|||
23154760|NCT01721876|64318709|FG001|Overall Study|Withdrawal by Subject|38|||
23154761|NCT01721876|64318708|FG000|Overall Study|Reason not listed|34|||
23154762|NCT01721876|64318709|FG001|Overall Study|Reason not listed|63|||
23154763|NCT01721876|64318708|FG000|Overall Study|Sponsor terminated trial|0|||
23154764|NCT01721876|64318709|FG001|Overall Study|Sponsor terminated trial|4|||
23154765|NCT03945591|64318712|FG000|Overall Study|Participant not transplanted|1|||
23154766|NCT03945591|64318712|FG000|Overall Study|Change in treatment plan|3|||
23154767|NCT03945591|64318712|FG000|Overall Study|Adverse Event|1|||
23154768|NCT00962390|64318719|FG000|Overall Study|Adverse Event|0|||
23154769|NCT00962390|64318720|FG001|Overall Study|Adverse Event|0|||
23441945|NCT04158583|65358671|FG009|Overall Study|Lost to Follow-up|0|||
23441946|NCT04158583|65358662|FG000|Overall Study|Due To Patient Status|0|||
23154770|NCT00962390|64318721|FG002|Overall Study|Adverse Event|3|||
23154771|NCT00962390|64318722|FG003|Overall Study|Adverse Event|1|||
23154772|NCT00962390|64318719|FG000|Overall Study|Lost to Follow-up|2|||
23154773|NCT00962390|64318720|FG001|Overall Study|Lost to Follow-up|2|||
23154774|NCT00962390|64318721|FG002|Overall Study|Lost to Follow-up|0|||
23154775|NCT00962390|64318722|FG003|Overall Study|Lost to Follow-up|0|||
23154776|NCT00962390|64318719|FG000|Overall Study|Protocol Violation|1|||
23154777|NCT00962390|64318720|FG001|Overall Study|Protocol Violation|0|||
23154778|NCT00962390|64318721|FG002|Overall Study|Protocol Violation|0|||
23154779|NCT00962390|64318722|FG003|Overall Study|Protocol Violation|0|||
23154780|NCT00962390|64318719|FG000|Overall Study|Withdrawal by Subject|1|||
23154781|NCT00962390|64318720|FG001|Overall Study|Withdrawal by Subject|1|||
23154782|NCT00962390|64318721|FG002|Overall Study|Withdrawal by Subject|1|||
23154783|NCT00962390|64318722|FG003|Overall Study|Withdrawal by Subject|0|||
23154784|NCT00397033|64318725|FG000|Overall Study|Adverse Event|7|||
23154785|NCT00397033|64318726|FG001|Overall Study|Adverse Event|10|||
23441947|NCT04158583|65358663|FG001|Overall Study|Due To Patient Status|0|||
23441948|NCT04158583|65358664|FG002|Overall Study|Due To Patient Status|0|||
23441949|NCT04158583|65358665|FG003|Overall Study|Due To Patient Status|0|||
23441950|NCT04158583|65358666|FG004|Overall Study|Due To Patient Status|0|||
23441951|NCT04158583|65358667|FG005|Overall Study|Due To Patient Status|0|||
23441952|NCT04158583|65358668|FG006|Overall Study|Due To Patient Status|0|||
23441953|NCT04158583|65358669|FG007|Overall Study|Due To Patient Status|0|||
23441954|NCT04158583|65358670|FG008|Overall Study|Due To Patient Status|1|||
23441955|NCT04158583|65358671|FG009|Overall Study|Due To Patient Status|0|||
23441956|NCT04158583|65358662|FG000|Overall Study|Death|3|||
23441957|NCT04158583|65358663|FG001|Overall Study|Death|4|||
23565228|NCT03101241|65799571|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
23565229|NCT03101241|65799572|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
23565230|NCT03101241|65799571|FG000|Overall Study|Lost to Follow-up|2|||
23565231|NCT03101241|65799572|FG001|Overall Study|Lost to Follow-up|0|||
23565232|NCT03101241|65799571|FG000|Overall Study|Lack of Efficacy|0|||
23565233|NCT03101241|65799572|FG001|Overall Study|Lack of Efficacy|1|||
23565234|NCT03101241|65799571|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
23565235|NCT03101241|65799572|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
23565236|NCT00622713|65799578|FG000|Overall Study|Adverse Event|35|||
23565237|NCT00622713|65799578|FG000|Overall Study|Administrative problems|4|||
23565238|NCT00622713|65799578|FG000|Overall Study|Withdrawal by Subject|11|||
23565239|NCT00622713|65799578|FG000|Overall Study|Lost to Follow-up|5|||
23565240|NCT00622713|65799578|FG000|Overall Study|Death|2|||
23565241|NCT00622713|65799578|FG000|Overall Study|Subject no longer required study drug|1|||
23565242|NCT00622713|65799578|FG000|Overall Study|Did not meet eligibility criteria|1|||
23565243|NCT02396537|65799582|FG000|Overall Study|Protocol Violation|0|||
23565244|NCT02396537|65799583|FG001|Overall Study|Protocol Violation|1|||
23565245|NCT01336634|65799585|FG000|Overall Study|Study closed/terminated|5|||
23565246|NCT01336634|65799586|FG001|Overall Study|Study closed/terminated|6|||
23565247|NCT01336634|65799587|FG002|Overall Study|Study closed/terminated|6|||
23565248|NCT01336634|65799585|FG000|Overall Study|Lost to Follow-up|2|||
23565249|NCT01336634|65799586|FG001|Overall Study|Lost to Follow-up|1|||
23565250|NCT01336634|65799587|FG002|Overall Study|Lost to Follow-up|1|||
23565251|NCT01336634|65799585|FG000|Overall Study|Physician Decision|1|||
23627349|NCT03126110|66024407|FG011|Phase 2|Started new treatment|0|||
23627350|NCT03126110|66024408|FG012|Phase 2|Started new treatment|0|||
23327369|NCT01958437|64940896|FG002|Overall Study|Incidental MRI findings|1|||
23327370|NCT01958437|64940897|FG003|Overall Study|Incidental MRI findings|1|||
23327371|NCT01530464|64940898|FG000|Washout (24h)|Withdrawal by Subject|1|||
23327372|NCT01530464|64940899|FG001|Washout (24h)|Withdrawal by Subject|0|||
23327373|NCT01530464|64940898|FG000|Washout (24h)|Withdrawal by Subject|0|||
23327374|NCT01530464|64940899|FG001|Washout (24h)|Withdrawal by Subject|1|||
23327375|NCT01518322|64940900|FG000|Overall Study|FeNO measurement was missing|13|||
23327376|NCT01269918|64940901|FG000|Overall Study|Did not receive study drug|0|||
23627351|NCT03126110|66024409|FG013|Phase 2|Started new treatment|0|||
23627352|NCT03126110|66024410|FG014|Phase 2|Started new treatment|1|||
23627353|NCT03126110|66024411|FG015|Phase 2|Started new treatment|0|||
23627354|NCT03126110|66024412|FG016|Phase 2|Started new treatment|0|||
23221288|NCT01136746|64553620|FG001|Overall Study|Protocol Violation|1|||
23221289|NCT01136746|64553619|FG000|Overall Study|Death|1|||
23221290|NCT01136746|64553620|FG001|Overall Study|Death|0|||
23221291|NCT00654420|64553621|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
23221292|NCT00654420|64553622|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
23221293|NCT00654420|64553623|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
23221294|NCT00654420|64553624|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
23221295|NCT00654420|64553621|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
23221296|NCT00654420|64553622|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
23221297|NCT00654420|64553623|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
23221298|NCT00654420|64553624|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
23221299|NCT00654420|64553621|FG000|Phase II|Adverse Event|0|||
23221300|NCT00654420|64553622|FG001|Phase II|Adverse Event|0|||
23327377|NCT01269918|64940902|FG001|Overall Study|Did not receive study drug|3|||
23441958|NCT04158583|65358664|FG002|Overall Study|Death|2|||
23441959|NCT04158583|65358665|FG003|Overall Study|Death|2|||
23441960|NCT04158583|65358666|FG004|Overall Study|Death|4|||
23565252|NCT01336634|65799586|FG001|Overall Study|Physician Decision|1|||
23627355|NCT04962698|66024413|FG000|Motor Imagery|Technical difficulty|1|||
23221301|NCT00654420|64553623|FG002|Phase II|Adverse Event|3|||
23221302|NCT00654420|64553624|FG003|Phase II|Adverse Event|3|||
23327378|NCT04688671|64940903|FG000|Overall Study|Adverse Event|3|||
23327379|NCT04688671|64940904|FG001|Overall Study|Adverse Event|1|||
23441961|NCT04158583|65358667|FG005|Overall Study|Death|3|||
23441962|NCT04158583|65358668|FG006|Overall Study|Death|5|||
23441963|NCT04158583|65358669|FG007|Overall Study|Death|2|||
23565253|NCT01336634|65799587|FG002|Overall Study|Physician Decision|0|||
23565254|NCT01336634|65799585|FG000|Overall Study|Withdrawal by Subject|6|||
23565255|NCT01336634|65799586|FG001|Overall Study|Withdrawal by Subject|0|||
23441964|NCT04158583|65358670|FG008|Overall Study|Death|0|||
23441965|NCT04158583|65358671|FG009|Overall Study|Death|1|||
23441966|NCT04158583|65358662|FG000|Overall Study|Clinical Progression Disease|0|||
23441967|NCT04158583|65358663|FG001|Overall Study|Clinical Progression Disease|0|||
23441968|NCT04158583|65358664|FG002|Overall Study|Clinical Progression Disease|0|||
23441969|NCT04158583|65358665|FG003|Overall Study|Clinical Progression Disease|1|||
23441970|NCT04158583|65358666|FG004|Overall Study|Clinical Progression Disease|0|||
23441971|NCT04158583|65358667|FG005|Overall Study|Clinical Progression Disease|0|||
23441972|NCT04158583|65358668|FG006|Overall Study|Clinical Progression Disease|0|||
23441973|NCT04158583|65358669|FG007|Overall Study|Clinical Progression Disease|0|||
23441974|NCT04158583|65358670|FG008|Overall Study|Clinical Progression Disease|0|||
23441975|NCT04158583|65358671|FG009|Overall Study|Clinical Progression Disease|0|||
23441976|NCT04158583|65358662|FG000|Overall Study|Clinical Progression|0|||
23441977|NCT04158583|65358663|FG001|Overall Study|Clinical Progression|0|||
23441978|NCT04158583|65358664|FG002|Overall Study|Clinical Progression|0|||
23441979|NCT04158583|65358665|FG003|Overall Study|Clinical Progression|0|||
23441980|NCT04158583|65358666|FG004|Overall Study|Clinical Progression|1|||
23441981|NCT04158583|65358667|FG005|Overall Study|Clinical Progression|0|||
23441982|NCT04158583|65358668|FG006|Overall Study|Clinical Progression|2|||
23441983|NCT04158583|65358669|FG007|Overall Study|Clinical Progression|0|||
23441984|NCT04158583|65358670|FG008|Overall Study|Clinical Progression|0|||
23441985|NCT04158583|65358671|FG009|Overall Study|Clinical Progression|0|||
23441986|NCT04158583|65358662|FG000|Overall Study|Clinical Deterioration|0|||
23441987|NCT04158583|65358663|FG001|Overall Study|Clinical Deterioration|0|||
23441988|NCT04158583|65358664|FG002|Overall Study|Clinical Deterioration|0|||
23441989|NCT04158583|65358665|FG003|Overall Study|Clinical Deterioration|1|||
23565256|NCT01336634|65799587|FG002|Overall Study|Withdrawal by Subject|2|||
23565257|NCT00728962|65799588|FG000|Implant Placement Surgery|Adverse Event|8|||
23221303|NCT00654420|64553621|FG000|Phase II|Lost to Follow-up|0|||
23221304|NCT00654420|64553622|FG001|Phase II|Lost to Follow-up|0|||
23221305|NCT00654420|64553623|FG002|Phase II|Lost to Follow-up|0|||
23221306|NCT00654420|64553624|FG003|Phase II|Lost to Follow-up|1|||
23221307|NCT00654420|64553621|FG000|Phase II|Physician Decision|0|||
23221308|NCT00654420|64553622|FG001|Phase II|Physician Decision|0|||
23221309|NCT00654420|64553623|FG002|Phase II|Physician Decision|0|||
23221310|NCT00654420|64553624|FG003|Phase II|Physician Decision|4|||
23221311|NCT00654420|64553621|FG000|Phase II|Progressive Disease|0|||
23221312|NCT00654420|64553622|FG001|Phase II|Progressive Disease|0|||
23221313|NCT00654420|64553623|FG002|Phase II|Progressive Disease|29|||
23221314|NCT00654420|64553624|FG003|Phase II|Progressive Disease|29|||
23221315|NCT00654420|64553621|FG000|Phase II|Withdrawal by Subject|0|||
23221316|NCT00654420|64553622|FG001|Phase II|Withdrawal by Subject|0|||
23221317|NCT00654420|64553623|FG002|Phase II|Withdrawal by Subject|4|||
23221318|NCT00654420|64553624|FG003|Phase II|Withdrawal by Subject|1|||
23221319|NCT00654420|64553621|FG000|Phase II|Missing Disposition Record|0|||
23221320|NCT00654420|64553622|FG001|Phase II|Missing Disposition Record|0|||
23221321|NCT00654420|64553623|FG002|Phase II|Missing Disposition Record|1|||
23221322|NCT00654420|64553624|FG003|Phase II|Missing Disposition Record|0|||
23221323|NCT01750840|64553627|FG000|Overall Study|Lost to Follow-up|4|||
23221324|NCT00693693|64553629|FG000|Overall Study|Lost to Follow-up|1|||
23221325|NCT00693693|64553630|FG001|Overall Study|Lost to Follow-up|1|||
23221326|NCT00693693|64553631|FG002|Overall Study|Lost to Follow-up|2|||
23221327|NCT04445051|64553634|FG000|Overall Study|Adverse Event|0|||
23221328|NCT04445051|64553635|FG001|Overall Study|Adverse Event|0|||
23221329|NCT04445051|64553636|FG002|Overall Study|Adverse Event|1|||
23221330|NCT04445051|64553637|FG003|Overall Study|Adverse Event|0|||
23221331|NCT04445051|64553638|FG004|Overall Study|Adverse Event|0|||
23221332|NCT04445051|64553639|FG005|Overall Study|Adverse Event|0|||
23221333|NCT02865928|64553640|FG000|Overall Study|Withdrawal by Subject|1|||
23221334|NCT02865928|64553641|FG001|Overall Study|Withdrawal by Subject|0|||
23221335|NCT02865928|64553640|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
23441990|NCT04158583|65358666|FG004|Overall Study|Clinical Deterioration|0|||
23441991|NCT04158583|65358667|FG005|Overall Study|Clinical Deterioration|0|||
23565258|NCT00728962|65799588|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
23565259|NCT00728962|65799588|FG000|Implant Placement Surgery|Protocol Violation|1|||
23221336|NCT02865928|64553641|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
23221337|NCT02865928|64553640|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
23441992|NCT04158583|65358668|FG006|Overall Study|Clinical Deterioration|0|||
23441993|NCT04158583|65358669|FG007|Overall Study|Clinical Deterioration|0|||
23441994|NCT04158583|65358670|FG008|Overall Study|Clinical Deterioration|0|||
23441995|NCT04158583|65358671|FG009|Overall Study|Clinical Deterioration|1|||
23441996|NCT01206582|65358676|FG000|Overall Study|Withdrew prior to study|1|||
23221338|NCT02865928|64553641|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
23221339|NCT01496274|64553642|FG000|Overall Study|Protocol Violation|0|||
23221340|NCT01496274|64553643|FG001|Overall Study|Protocol Violation|1|||
23221341|NCT01496274|64553642|FG000|Overall Study|Adverse Event|1|||
23221342|NCT01496274|64553643|FG001|Overall Study|Adverse Event|1|||
23221343|NCT01496274|64553642|FG000|Overall Study|Withdrawal by Subject|2|||
23221344|NCT01496274|64553643|FG001|Overall Study|Withdrawal by Subject|0|||
23441997|NCT01206582|65358677|FG001|Overall Study|Withdrew prior to study|0|||
23441998|NCT01206582|65358676|FG000|Overall Study|Discontinued intervention before week 8|1|||
23441999|NCT01206582|65358677|FG001|Overall Study|Discontinued intervention before week 8|2|||
23442000|NCT03927144|65358678|FG000|Core Phase|Adverse Event|9|||
23154786|NCT00397033|64318727|FG002|Overall Study|Adverse Event|4|||
23154787|NCT00397033|64318725|FG000|Overall Study|Lack of Efficacy|22|||
23154788|NCT00397033|64318726|FG001|Overall Study|Lack of Efficacy|12|||
23154789|NCT00397033|64318727|FG002|Overall Study|Lack of Efficacy|9|||
23154790|NCT00397033|64318725|FG000|Overall Study|Lost to Follow-up|3|||
23154791|NCT00397033|64318726|FG001|Overall Study|Lost to Follow-up|3|||
23154792|NCT00397033|64318727|FG002|Overall Study|Lost to Follow-up|3|||
23154793|NCT00397033|64318725|FG000|Overall Study|Withdrawal by Subject|12|||
23154794|NCT00397033|64318726|FG001|Overall Study|Withdrawal by Subject|7|||
23154795|NCT00397033|64318727|FG002|Overall Study|Withdrawal by Subject|5|||
23154796|NCT00397033|64318725|FG000|Overall Study|Other|0|||
23154797|NCT00397033|64318726|FG001|Overall Study|Other|5|||
23154798|NCT00397033|64318727|FG002|Overall Study|Other|2|||
23154799|NCT02252536|64318729|FG000|Overall Study|Lost to Follow-up|5|||
23154800|NCT02252536|64318730|FG001|Overall Study|Lost to Follow-up|3|||
23154801|NCT02321930|64318732|FG000|Overall Study|Lost to Follow-up|1|||
23154802|NCT02739620|64318733|FG000|Overall Study|Lost to Follow-up|3|||
23154803|NCT02739620|64318734|FG001|Overall Study|Lost to Follow-up|1|||
23154804|NCT02739620|64318733|FG000|Overall Study|Adverse Event|0|||
23154805|NCT02739620|64318734|FG001|Overall Study|Adverse Event|1|||
23154806|NCT00589420|64318743|FG000|Overall Study|screen failure|1|||
23154807|NCT02445755|64318744|FG000|Overall Study|Withdrawal by Subject|2|||
23154808|NCT02445755|64318744|FG000|Overall Study|Protocol Violation|6|||
23154809|NCT02445755|64318744|FG000|Overall Study|Screen Failure|5|||
23565260|NCT00728962|65799588|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
23565261|NCT00728962|65799588|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
23565262|NCT03579290|65799589|FG000|Overall Study|Lost to Follow-up|9|||
23565263|NCT01108458|65799590|FG000|Overall Study|Withdrawal by Subject|1|||
23154814|NCT00770770|64318749|FG000|Overall Study|Lost to Follow-up|1|||
23154815|NCT00770770|64318750|FG001|Overall Study|Lost to Follow-up|0|||
23154816|NCT00770770|64318749|FG000|Overall Study|Withdrawal by Subject|1|||
23154817|NCT00770770|64318750|FG001|Overall Study|Withdrawal by Subject|0|||
23154818|NCT00770770|64318749|FG000|Overall Study|Death|0|||
23154819|NCT00770770|64318750|FG001|Overall Study|Death|1|||
23154820|NCT00770770|64318749|FG000|Overall Study|Study Terminated|8|||
23154821|NCT00770770|64318750|FG001|Overall Study|Study Terminated|0|||
23154822|NCT00054704|64318752|FG000|Overall Study|Lack of Efficacy|2|||
23154823|NCT00054704|64318753|FG001|Overall Study|Lack of Efficacy|3|||
23154824|NCT00054704|64318752|FG000|Overall Study|Adverse Event|3|||
23154825|NCT00054704|64318753|FG001|Overall Study|Adverse Event|1|||
23154826|NCT00054704|64318752|FG000|Overall Study|Lost to Follow-up|0|||
23154827|NCT00054704|64318753|FG001|Overall Study|Lost to Follow-up|1|||
23154828|NCT00785044|64318758|FG000|Overall Study|Dosed at non-participating sites|152|||
23154829|NCT00785044|64318758|FG000|Overall Study|Death|77|||
23154830|NCT00785044|64318758|FG000|Overall Study|Lost to Follow-up|266|||
23154831|NCT00785044|64318758|FG000|Overall Study|Withdrawal by Subject|1|||
23327380|NCT04688671|64940903|FG000|Overall Study|Withdrawal by Subject|3|||
23442001|NCT03927144|65358679|FG001|Core Phase|Adverse Event|5|||
23442002|NCT03927144|65358678|FG000|Core Phase|Lost to Follow-up|3|||
23442003|NCT03927144|65358679|FG001|Core Phase|Lost to Follow-up|2|||
23442004|NCT03927144|65358678|FG000|Core Phase|New Therapy for Study Indication|0|||
23442005|NCT03927144|65358679|FG001|Core Phase|New Therapy for Study Indication|1|||
23442006|NCT03927144|65358678|FG000|Core Phase|No Longer Clinically Benefiting|4|||
23442007|NCT03927144|65358679|FG001|Core Phase|No Longer Clinically Benefiting|4|||
23154832|NCT00596947|64318759|FG000|Overall Study|study halted due to low enrollment|5|||
23154833|NCT00596947|64318760|FG001|Overall Study|study halted due to low enrollment|3|||
23154834|NCT00596947|64318759|FG000|Overall Study|Lost to Follow-up|1|||
23154835|NCT00596947|64318760|FG001|Overall Study|Lost to Follow-up|0|||
23154836|NCT01069120|64318761|FG000|Overall Study|Study prematurely terminated|27|||
23154837|NCT00073528|64318764|FG000|Overall Study|Death|488|||
23154838|NCT00073528|64318765|FG001|Overall Study|Death|473|||
23154839|NCT00073528|64318764|FG000|Overall Study|Lost to Follow-up|52|||
23154840|NCT00073528|64318765|FG001|Overall Study|Lost to Follow-up|45|||
23154841|NCT00073528|64318764|FG000|Overall Study|Withdrawal by Subject|50|||
23154842|NCT00073528|64318765|FG001|Overall Study|Withdrawal by Subject|45|||
23442008|NCT03927144|65358678|FG000|Core Phase|Physician Decision|2|||
23154843|NCT00073528|64318764|FG000|Overall Study|Study terminated by Sponsor|10|||
23154844|NCT00073528|64318765|FG001|Overall Study|Study terminated by Sponsor|29|||
23154845|NCT00073528|64318764|FG000|Overall Study|Other|18|||
23154846|NCT00073528|64318765|FG001|Overall Study|Other|19|||
23442009|NCT03927144|65358679|FG001|Core Phase|Physician Decision|8|||
23442010|NCT03927144|65358678|FG000|Core Phase|Protocol Violation|2|||
23442011|NCT03927144|65358679|FG001|Core Phase|Protocol Violation|2|||
23442012|NCT03927144|65358678|FG000|Core Phase|Withdrawal by Subject|16|||
23442013|NCT03927144|65358679|FG001|Core Phase|Withdrawal by Subject|40|||
23442014|NCT03927144|65358678|FG000|Extension Phase|Adverse Event|2|||
23442015|NCT03927144|65358679|FG001|Extension Phase|Adverse Event|1|||
23442016|NCT03927144|65358678|FG000|Extension Phase|No longer clinically benefiting|4|||
23442017|NCT03927144|65358679|FG001|Extension Phase|No longer clinically benefiting|5|||
23442018|NCT03927144|65358678|FG000|Extension Phase|Pregnancy|1|||
23442019|NCT03927144|65358679|FG001|Extension Phase|Pregnancy|0|||
23442020|NCT03927144|65358678|FG000|Extension Phase|Protocol Violation|0|||
23442021|NCT03927144|65358679|FG001|Extension Phase|Protocol Violation|1|||
23442022|NCT03927144|65358678|FG000|Extension Phase|Withdrawal by Subject|8|||
23442023|NCT03927144|65358679|FG001|Extension Phase|Withdrawal by Subject|3|||
23442024|NCT01408459|65358683|FG000|Overall Study|Withdrawal by Subject|1|||
23442025|NCT01408459|65358684|FG001|Overall Study|Withdrawal by Subject|1|||
23442026|NCT00193180|65358693|FG000|Overall Study|Lack of Efficacy|1|||
23442027|NCT00193180|65358693|FG000|Overall Study|Adverse Event|8|||
23442028|NCT00193180|65358693|FG000|Overall Study|Protocol Violation|1|||
23442029|NCT01824355|65358694|FG000|Overall Study|Adverse Event|2|||
23442030|NCT01824355|65358694|FG000|Overall Study|unevaluable reference method results per|1|||
23442031|NCT01504412|65358695|FG000|Overall Study|Adverse Event|1|||
23442032|NCT01504412|65358696|FG001|Overall Study|Adverse Event|8|||
23442033|NCT01504412|65358697|FG002|Overall Study|Adverse Event|1|||
23442034|NCT01504412|65358698|FG003|Overall Study|Adverse Event|7|||
23442035|NCT01504412|65358699|FG004|Overall Study|Adverse Event|10|||
23442036|NCT01504412|65358695|FG000|Overall Study|Withdrawal by Subject|2|||
23442037|NCT01504412|65358696|FG001|Overall Study|Withdrawal by Subject|1|||
23442038|NCT01504412|65358697|FG002|Overall Study|Withdrawal by Subject|1|||
23442039|NCT01504412|65358698|FG003|Overall Study|Withdrawal by Subject|5|||
23442040|NCT01504412|65358699|FG004|Overall Study|Withdrawal by Subject|1|||
23442041|NCT01504412|65358695|FG000|Overall Study|Other|2|||
23442042|NCT01504412|65358696|FG001|Overall Study|Other|1|||
23442043|NCT01504412|65358697|FG002|Overall Study|Other|1|||
23442044|NCT01504412|65358698|FG003|Overall Study|Other|6|||
23442045|NCT01504412|65358699|FG004|Overall Study|Other|1|||
23442046|NCT01504412|65358695|FG000|Overall Study|Lost to Follow-up|0|||
23442047|NCT01504412|65358696|FG001|Overall Study|Lost to Follow-up|2|||
23442048|NCT01504412|65358697|FG002|Overall Study|Lost to Follow-up|0|||
23442049|NCT01504412|65358698|FG003|Overall Study|Lost to Follow-up|0|||
23442050|NCT01504412|65358699|FG004|Overall Study|Lost to Follow-up|0|||
23442051|NCT01504412|65358695|FG000|Overall Study|Lack of Efficacy|0|||
23442052|NCT01504412|65358696|FG001|Overall Study|Lack of Efficacy|0|||
23442053|NCT01504412|65358697|FG002|Overall Study|Lack of Efficacy|1|||
23442054|NCT01504412|65358698|FG003|Overall Study|Lack of Efficacy|0|||
23442055|NCT01504412|65358699|FG004|Overall Study|Lack of Efficacy|1|||
23154847|NCT00073528|64318764|FG000|Overall Study|Other|9|||
23442056|NCT01504412|65358695|FG000|Overall Study|Death|0|||
23442057|NCT01504412|65358696|FG001|Overall Study|Death|0|||
23442058|NCT01504412|65358697|FG002|Overall Study|Death|0|||
23442059|NCT01504412|65358698|FG003|Overall Study|Death|1|||
23442060|NCT01504412|65358699|FG004|Overall Study|Death|0|||
23442061|NCT01949090|65358704|FG000|Overall Study|Serious Adverse Event|0|||
23442062|NCT01949090|65358705|FG001|Overall Study|Serious Adverse Event|1|||
23442063|NCT01949090|65358706|FG002|Overall Study|Serious Adverse Event|2|||
23442064|NCT01949090|65358707|FG003|Overall Study|Serious Adverse Event|0|||
23154848|NCT00073528|64318765|FG001|Overall Study|Other|12|||
23442065|NCT01949090|65358708|FG004|Overall Study|Serious Adverse Event|1|||
23442066|NCT01949090|65358704|FG000|Overall Study|Withdrawal by Subject|2|||
23442067|NCT01949090|65358705|FG001|Overall Study|Withdrawal by Subject|0|||
23442068|NCT01949090|65358706|FG002|Overall Study|Withdrawal by Subject|0|||
23442069|NCT01949090|65358707|FG003|Overall Study|Withdrawal by Subject|0|||
23442070|NCT01949090|65358708|FG004|Overall Study|Withdrawal by Subject|1|||
23442071|NCT01949090|65358704|FG000|Overall Study|Protocol non-compliance|0|||
23154849|NCT00073528|64318764|FG000|Overall Study|Protocol Violation|3|||
23442072|NCT01949090|65358705|FG001|Overall Study|Protocol non-compliance|0|||
23154850|NCT00073528|64318765|FG001|Overall Study|Protocol Violation|5|||
23442073|NCT01949090|65358706|FG002|Overall Study|Protocol non-compliance|0|||
23442074|NCT01949090|65358707|FG003|Overall Study|Protocol non-compliance|0|||
23154851|NCT02729740|64318766|FG000|Overall Study|Early Termination|130|||
23442075|NCT01949090|65358708|FG004|Overall Study|Protocol non-compliance|1|||
23442076|NCT01949090|65358704|FG000|Overall Study|Lost to Follow-up|2|||
23442077|NCT01949090|65358705|FG001|Overall Study|Lost to Follow-up|1|||
23442078|NCT01949090|65358706|FG002|Overall Study|Lost to Follow-up|0|||
23442079|NCT01949090|65358707|FG003|Overall Study|Lost to Follow-up|1|||
23442080|NCT01949090|65358708|FG004|Overall Study|Lost to Follow-up|1|||
23442081|NCT01856582|65358709|FG000|Overall Study|Died prior to Boost infusion|1|||
23442082|NCT01504841|65358710|FG000|Overall Study|Withdrawal by Subject|1|||
23154852|NCT02729740|64318766|FG000|Overall Study|Other|1|||
23154853|NCT01022996|64318767|FG000|Overall Study|Adverse Event|14|||
23442083|NCT01504841|65358711|FG001|Overall Study|Withdrawal by Subject|1|||
23442084|NCT01504841|65358712|FG002|Overall Study|Withdrawal by Subject|0|||
23442085|NCT02709330|65358717|FG000|Overall Study|Death|5|||
23442086|NCT02709330|65358718|FG001|Overall Study|Death|0|||
23442087|NCT02709330|65358717|FG000|Overall Study|Lost to Follow-up|2|||
23442088|NCT02709330|65358718|FG001|Overall Study|Lost to Follow-up|0|||
23442089|NCT02709330|65358717|FG000|Overall Study|Physician Decision|2|||
23442090|NCT02709330|65358718|FG001|Overall Study|Physician Decision|0|||
23442091|NCT02709330|65358717|FG000|Overall Study|Withdrawal by Subject|4|||
23442092|NCT02709330|65358718|FG001|Overall Study|Withdrawal by Subject|0|||
23442093|NCT02363959|65358722|FG000|Overall Study|Medical instability|1|||
23442094|NCT02363959|65358723|FG001|Overall Study|Medical instability|0|||
23442095|NCT01777776|65358724|FG000|Overall Study|Adverse Event|2|||
23442096|NCT01777776|65358725|FG001|Overall Study|Adverse Event|4|||
23442097|NCT01777776|65358726|FG002|Overall Study|Adverse Event|0|||
23442098|NCT01777776|65358727|FG003|Overall Study|Adverse Event|0|||
23442099|NCT01777776|65358724|FG000|Overall Study|Disease Progression|4|||
23442100|NCT01777776|65358725|FG001|Overall Study|Disease Progression|8|||
23442101|NCT01777776|65358726|FG002|Overall Study|Disease Progression|6|||
23442102|NCT01777776|65358727|FG003|Overall Study|Disease Progression|3|||
23442103|NCT01777776|65358724|FG000|Overall Study|Withdrawal by Subject|0|||
23442104|NCT01777776|65358725|FG001|Overall Study|Withdrawal by Subject|0|||
23442105|NCT01777776|65358726|FG002|Overall Study|Withdrawal by Subject|0|||
23442106|NCT01777776|65358727|FG003|Overall Study|Withdrawal by Subject|1|||
23442107|NCT00825812|65358728|FG000|Overall Study|Never entered follow up|0|||
23442108|NCT00825812|65358729|FG001|Overall Study|Never entered follow up|0|||
23442109|NCT00825812|65358730|FG002|Overall Study|Never entered follow up|0|||
23442110|NCT00825812|65358731|FG003|Overall Study|Never entered follow up|1|||
23442111|NCT00825812|65358728|FG000|Overall Study|Adverse Event|0|||
23442112|NCT00825812|65358729|FG001|Overall Study|Adverse Event|0|||
23442113|NCT00825812|65358730|FG002|Overall Study|Adverse Event|0|||
23442114|NCT00825812|65358731|FG003|Overall Study|Adverse Event|1|||
23442115|NCT00825812|65358728|FG000|Overall Study|Subject withdrew consent|0|||
23442116|NCT00825812|65358729|FG001|Overall Study|Subject withdrew consent|0|||
23442117|NCT00825812|65358730|FG002|Overall Study|Subject withdrew consent|3|||
23221345|NCT01496274|64553642|FG000|Overall Study|Lost to Follow-up|0|||
23221346|NCT01496274|64553643|FG001|Overall Study|Lost to Follow-up|3|||
23442118|NCT00825812|65358731|FG003|Overall Study|Subject withdrew consent|2|||
23627356|NCT04962698|66024414|FG001|Motor Imagery|Technical difficulty|0|||
23627357|NCT04962698|66024413|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
23627358|NCT04962698|66024414|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
23442119|NCT00825812|65358728|FG000|Overall Study|Non-compliance with protocol|0|||
23442120|NCT00825812|65358729|FG001|Overall Study|Non-compliance with protocol|0|||
23627359|NCT04962698|66024413|FG000|Kinesthetic MI|Technical difficulty|1|||
23627360|NCT04962698|66024414|FG001|Kinesthetic MI|Technical difficulty|0|||
23627361|NCT04962698|66024413|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
23627362|NCT04962698|66024414|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
23627363|NCT04962698|66024413|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
23627364|NCT04962698|66024414|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
23627365|NCT04962698|66024413|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
23627366|NCT04962698|66024414|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
23627367|NCT04962698|66024413|FG000|Virtual-hand Interaction|Technical difficulty|1|||
23627368|NCT04962698|66024414|FG001|Virtual-hand Interaction|Technical difficulty|0|||
23154854|NCT01022996|64318767|FG000|Overall Study|Withdrawal by Subject|3|||
23154855|NCT01022996|64318767|FG000|Overall Study|Lost to Follow-up|1|||
23154856|NCT01022996|64318767|FG000|Overall Study|Administrative problems|6|||
23154857|NCT01022996|64318767|FG000|Overall Study|Disease Progression|32|||
23154858|NCT01022996|64318767|FG000|Overall Study|Protocol Violation|1|||
23442121|NCT00825812|65358730|FG002|Overall Study|Non-compliance with protocol|0|||
23442122|NCT00825812|65358731|FG003|Overall Study|Non-compliance with protocol|1|||
23154859|NCT00388505|64318768|FG000|Overall Study|Adverse Event or Death|43|||
23442123|NCT00825812|65358728|FG000|Overall Study|Administrative|0|||
23442124|NCT00825812|65358729|FG001|Overall Study|Administrative|1|||
23627369|NCT04962698|66024413|FG000|Robotic Action Observation|Technical difficulty|1|||
23627370|NCT04962698|66024414|FG001|Robotic Action Observation|Technical difficulty|0|||
23154860|NCT00388505|64318769|FG001|Overall Study|Adverse Event or Death|17|||
23154861|NCT00388505|64318768|FG000|Overall Study|Withdrawal by Subject|24|||
23442125|NCT00825812|65358730|FG002|Overall Study|Administrative|3|||
23442126|NCT00825812|65358731|FG003|Overall Study|Administrative|5|||
23442127|NCT01865448|65358740|FG000|Overall Study|Adverse Event|1|||
23442128|NCT01865448|65358741|FG001|Overall Study|Adverse Event|1|||
23442129|NCT01865448|65358740|FG000|Overall Study|Pregnancy|0|||
23442130|NCT01865448|65358741|FG001|Overall Study|Pregnancy|1|||
23442131|NCT01865448|65358740|FG000|Overall Study|dropout unrelated to study|1|||
23627371|NCT04962698|66024413|FG000|Rest|Technical difficulty|1|||
23627372|NCT04962698|66024414|FG001|Rest|Technical difficulty|0|||
23442132|NCT01865448|65358741|FG001|Overall Study|dropout unrelated to study|1|||
23442133|NCT00344500|65358743|FG000|Overall Study|Adverse Event|6|||
23442134|NCT00344500|65358744|FG001|Overall Study|Adverse Event|2|||
23442135|NCT00344500|65358745|FG002|Overall Study|Adverse Event|0|||
23442136|NCT00344500|65358743|FG000|Overall Study|Lost to Follow-up|5|||
23442137|NCT00344500|65358744|FG001|Overall Study|Lost to Follow-up|13|||
23442138|NCT00344500|65358745|FG002|Overall Study|Lost to Follow-up|1|||
23442139|NCT00344500|65358743|FG000|Overall Study|Withdrawal by Subject|7|||
23442140|NCT00344500|65358744|FG001|Overall Study|Withdrawal by Subject|10|||
23442141|NCT00344500|65358745|FG002|Overall Study|Withdrawal by Subject|0|||
23442142|NCT00344500|65358743|FG000|Overall Study|Protocol Violation|4|||
23442143|NCT00344500|65358744|FG001|Overall Study|Protocol Violation|7|||
23442144|NCT00344500|65358745|FG002|Overall Study|Protocol Violation|1|||
23442145|NCT00344500|65358743|FG000|Overall Study|Not Noted|1|||
23442146|NCT00344500|65358744|FG001|Overall Study|Not Noted|3|||
23442147|NCT00344500|65358745|FG002|Overall Study|Not Noted|0|||
23442148|NCT03785964|65358746|FG000|Overall Study|Adverse Event|14|||
23442149|NCT03785964|65358747|FG001|Overall Study|Adverse Event|1|||
23627373|NCT04962698|66024413|FG000|Rest|Exclusion criteria met after enrollment|0|||
23627374|NCT04962698|66024414|FG001|Rest|Exclusion criteria met after enrollment|2|||
23627375|NCT02270671|66024415|FG000|Overall Study|Withdrawal by Subject|1|||
23627376|NCT02270671|66024416|FG001|Overall Study|Withdrawal by Subject|1|||
23627377|NCT02270671|66024415|FG000|Overall Study|Protocol Violation|0|||
23627378|NCT02270671|66024416|FG001|Overall Study|Protocol Violation|1|||
23627379|NCT02270671|66024415|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
23154862|NCT00388505|64318769|FG001|Overall Study|Withdrawal by Subject|9|||
23154863|NCT00388505|64318768|FG000|Overall Study|Lost to Follow-up|5|||
23154864|NCT00388505|64318769|FG001|Overall Study|Lost to Follow-up|3|||
23154865|NCT00388505|64318768|FG000|Overall Study|Inappropriate Enrollment|0|||
23154866|NCT00388505|64318769|FG001|Overall Study|Inappropriate Enrollment|1|||
23154867|NCT00388505|64318768|FG000|Overall Study|Administrative Reason|1|||
23154868|NCT00388505|64318769|FG001|Overall Study|Administrative Reason|0|||
23154869|NCT00388505|64318768|FG000|Overall Study|Protocol Violation|6|||
23154870|NCT00388505|64318769|FG001|Overall Study|Protocol Violation|5|||
23154871|NCT00388505|64318768|FG000|Overall Study|Unable to classify|4|||
23154872|NCT00388505|64318769|FG001|Overall Study|Unable to classify|3|||
23154873|NCT00578786|64318770|FG000|Overall Study|Adverse Event|27|||
23154874|NCT00578786|64318771|FG001|Overall Study|Adverse Event|37|||
23154875|NCT00578786|64318772|FG002|Overall Study|Adverse Event|17|||
23154876|NCT00578786|64318770|FG000|Overall Study|Lack of Efficacy|2|||
23154877|NCT00578786|64318771|FG001|Overall Study|Lack of Efficacy|5|||
23154878|NCT00578786|64318772|FG002|Overall Study|Lack of Efficacy|2|||
23154879|NCT00578786|64318770|FG000|Overall Study|Early Escape from Prior Study|2|||
23154880|NCT00578786|64318771|FG001|Overall Study|Early Escape from Prior Study|1|||
23154881|NCT00578786|64318772|FG002|Overall Study|Early Escape from Prior Study|2|||
23154882|NCT00578786|64318770|FG000|Overall Study|Withdrawal by Subject|7|||
23154883|NCT00578786|64318771|FG001|Overall Study|Withdrawal by Subject|8|||
23154884|NCT00578786|64318772|FG002|Overall Study|Withdrawal by Subject|5|||
23154885|NCT00578786|64318770|FG000|Overall Study|Protocol Violation|0|||
23154886|NCT00578786|64318771|FG001|Overall Study|Protocol Violation|3|||
23154887|NCT00578786|64318772|FG002|Overall Study|Protocol Violation|1|||
23154888|NCT00578786|64318770|FG000|Overall Study|Physician Decision|1|||
23221347|NCT01826448|64553646|FG000|Overall Study|Adverse Event|1|||
23221348|NCT01826448|64553647|FG001|Overall Study|Adverse Event|3|||
23442150|NCT03785964|65358746|FG000|Overall Study|Unqualified Clinical Progression|1|||
23442151|NCT03785964|65358747|FG001|Overall Study|Unqualified Clinical Progression|1|||
23442152|NCT03785964|65358746|FG000|Overall Study|Participant non-compliance|1|||
23442153|NCT03785964|65358747|FG001|Overall Study|Participant non-compliance|1|||
23442154|NCT03785964|65358746|FG000|Overall Study|Not treated|1|||
23442155|NCT03785964|65358747|FG001|Overall Study|Not treated|0|||
23442156|NCT03785964|65358746|FG000|Overall Study|Other reason|5|||
23565264|NCT01464021|65799591|FG000|Overall Study|Withdrawal by Subject|13|||
23565265|NCT01464021|65799591|FG000|Overall Study|Lost to Follow-up|1|||
23565266|NCT01464021|65799591|FG000|Overall Study|Lack of Efficacy|1|||
23565267|NCT01464021|65799591|FG000|Overall Study|various|11|||
23565268|NCT03097861|65799597|FG000|Overall Study|Adverse Event|3|||
23565269|NCT03097861|65799598|FG001|Overall Study|Adverse Event|8|||
23565270|NCT03097861|65799599|FG002|Overall Study|Adverse Event|4|||
23565271|NCT03097861|65799597|FG000|Overall Study|Investigator Decision|0|||
23565272|NCT03097861|65799598|FG001|Overall Study|Investigator Decision|1|||
23565273|NCT03097861|65799599|FG002|Overall Study|Investigator Decision|0|||
23565274|NCT03097861|65799597|FG000|Overall Study|Lost to Follow-up|0|||
23565275|NCT03097861|65799598|FG001|Overall Study|Lost to Follow-up|7|||
23565276|NCT03097861|65799599|FG002|Overall Study|Lost to Follow-up|1|||
23565277|NCT03097861|65799597|FG000|Overall Study|Withdrawal by Subject|1|||
23565278|NCT03097861|65799598|FG001|Overall Study|Withdrawal by Subject|5|||
23154889|NCT00578786|64318771|FG001|Overall Study|Physician Decision|0|||
23154890|NCT00578786|64318772|FG002|Overall Study|Physician Decision|1|||
23154891|NCT00578786|64318770|FG000|Overall Study|Sponsor Decision|0|||
23154892|NCT00578786|64318771|FG001|Overall Study|Sponsor Decision|0|||
23154893|NCT00578786|64318772|FG002|Overall Study|Sponsor Decision|1|||
23154894|NCT00578786|64318770|FG000|Overall Study|Lost to Follow-up|0|||
23154895|NCT00578786|64318771|FG001|Overall Study|Lost to Follow-up|4|||
23154896|NCT00578786|64318772|FG002|Overall Study|Lost to Follow-up|0|||
23154897|NCT00578786|64318770|FG000|Overall Study|Pregnancy|0|||
23154898|NCT00578786|64318771|FG001|Overall Study|Pregnancy|1|||
23154899|NCT00578786|64318772|FG002|Overall Study|Pregnancy|0|||
23221349|NCT01826448|64553646|FG000|Overall Study|Disease progression|2|||
23221350|NCT01826448|64553647|FG001|Overall Study|Disease progression|4|||
23221351|NCT01826448|64553646|FG000|Overall Study|Withdrawal by Subject|1|||
23327381|NCT04688671|64940904|FG001|Overall Study|Withdrawal by Subject|1|||
23327382|NCT04688671|64940903|FG000|Overall Study|Lack of Efficacy|1|||
23327383|NCT04688671|64940904|FG001|Overall Study|Lack of Efficacy|1|||
23327384|NCT04688671|64940903|FG000|Overall Study|Protocol Violation|1|||
23327385|NCT04688671|64940904|FG001|Overall Study|Protocol Violation|0|||
23327386|NCT04688671|64940903|FG000|Overall Study|Lost to Follow-up|0|||
23327387|NCT04688671|64940904|FG001|Overall Study|Lost to Follow-up|1|||
23327388|NCT02513160|64940909|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
23327389|NCT02513160|64940910|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
23327390|NCT02513160|64940911|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
23327391|NCT02513160|64940912|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
23327392|NCT02513160|64940909|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
23327393|NCT02513160|64940910|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
23327394|NCT02513160|64940911|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
23327395|NCT02513160|64940912|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
23327396|NCT02513160|64940909|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
23327397|NCT02513160|64940910|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
23327398|NCT02513160|64940911|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
23327399|NCT02513160|64940912|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
23327400|NCT02513160|64940909|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
23327401|NCT02513160|64940910|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
23327402|NCT02513160|64940911|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
23327403|NCT02513160|64940912|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
23327404|NCT02513160|64940909|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
23221352|NCT01826448|64553647|FG001|Overall Study|Withdrawal by Subject|0|||
23221353|NCT01826448|64553646|FG000|Overall Study|Physician Decision|0|||
23221354|NCT01826448|64553647|FG001|Overall Study|Physician Decision|1|||
23221355|NCT01826448|64553646|FG000|Overall Study|2 active cancers|0|||
23221356|NCT01826448|64553647|FG001|Overall Study|2 active cancers|1|||
23221357|NCT00887068|64553650|FG000|Overall Study|Withdrawal by Subject|2|||
23221358|NCT00887068|64553651|FG001|Overall Study|Withdrawal by Subject|0|||
23327405|NCT02513160|64940910|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
23327406|NCT02513160|64940911|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
23327407|NCT02513160|64940912|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
23327408|NCT02513160|64940909|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
23327409|NCT02513160|64940910|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
23327410|NCT02513160|64940911|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
23442157|NCT03785964|65358747|FG001|Overall Study|Other reason|11|||
23442158|NCT03785964|65358746|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
23442159|NCT03785964|65358747|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
23442160|NCT01574651|65358748|FG000|Overall Study|Lost to Follow-up|2|||
23442161|NCT01574651|65358749|FG001|Overall Study|Lost to Follow-up|4|||
23442162|NCT01574651|65358748|FG000|Overall Study|Administrative problems|0|||
23442163|NCT01574651|65358749|FG001|Overall Study|Administrative problems|1|||
23442164|NCT01574651|65358748|FG000|Overall Study|Death|3|||
23442165|NCT01574651|65358749|FG001|Overall Study|Death|3|||
23442166|NCT01574651|65358748|FG000|Overall Study|Patient's inability to use the device|0|||
23442167|NCT01574651|65358749|FG001|Overall Study|Patient's inability to use the device|1|||
23154900|NCT00578786|64318770|FG000|Overall Study|Not Otherwise Specified|0|||
23154901|NCT00578786|64318771|FG001|Overall Study|Not Otherwise Specified|4|||
23154902|NCT00578786|64318772|FG002|Overall Study|Not Otherwise Specified|1|||
23327411|NCT02513160|64940912|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
23442168|NCT01574651|65358748|FG000|Overall Study|Adverse Event|36|||
23565279|NCT03097861|65799599|FG002|Overall Study|Withdrawal by Subject|3|||
23565280|NCT03097861|65799597|FG000|Overall Study|Reason not provided|3|||
23154903|NCT00578786|64318770|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
23154904|NCT00578786|64318771|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
23442169|NCT01574651|65358749|FG001|Overall Study|Adverse Event|27|||
23442170|NCT01574651|65358748|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23442171|NCT01574651|65358749|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23442172|NCT01574651|65358748|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23327412|NCT02513160|64940909|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
23327413|NCT02513160|64940910|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
23327414|NCT02513160|64940911|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
23327415|NCT02513160|64940912|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
23327416|NCT02513160|64940909|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
23327417|NCT02513160|64940910|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
23327418|NCT02513160|64940911|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
23442173|NCT01574651|65358749|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23442174|NCT01574651|65358748|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
23442175|NCT01574651|65358749|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23442176|NCT01574651|65358748|FG000|Overall Study|Protocol Violation|3|||
23442177|NCT01574651|65358749|FG001|Overall Study|Protocol Violation|5|||
23442178|NCT01574651|65358748|FG000|Overall Study|Withdrawal by Subject|9|||
23442179|NCT01574651|65358749|FG001|Overall Study|Withdrawal by Subject|10|||
23442180|NCT06359080|65358750|FG000|Overall Study|Withdrawal by Subject|3|||
23221359|NCT00887068|64553650|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
23221360|NCT00887068|64553651|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
23221361|NCT04897594|64553652|FG000|Overall Study|Lost to Follow-up|0|||
23221362|NCT04897594|64553653|FG001|Overall Study|Lost to Follow-up|1|||
23221363|NCT04897594|64553654|FG002|Overall Study|Lost to Follow-up|1|||
23221364|NCT04897594|64553652|FG000|Overall Study|Sponsor Decision|0|||
23221365|NCT04897594|64553653|FG001|Overall Study|Sponsor Decision|0|||
23221366|NCT04897594|64553654|FG002|Overall Study|Sponsor Decision|1|||
23221367|NCT04897594|64553652|FG000|Overall Study|Withdrawal by Subject|1|||
23221368|NCT04897594|64553653|FG001|Overall Study|Withdrawal by Subject|0|||
23221369|NCT04897594|64553654|FG002|Overall Study|Withdrawal by Subject|1|||
23221370|NCT00432562|64553656|FG000|Overall Study|Death|3|||
23221371|NCT00432562|64553657|FG001|Overall Study|Death|0|||
23221372|NCT03073213|64553662|FG000|Multiple Dose Period|Protocol Violation|0|||
23221373|NCT03073213|64553663|FG001|Multiple Dose Period|Protocol Violation|0|||
23221374|NCT03073213|64553664|FG002|Multiple Dose Period|Protocol Violation|1|||
23221375|NCT01915095|64553665|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
23221376|NCT01915095|64553666|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
23221377|NCT01915095|64553667|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
23221378|NCT01915095|64553668|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
23221379|NCT01915095|64553669|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
23221380|NCT00285649|64553670|FG000|Overall Study|Lost to Follow-up|6|||
23221381|NCT00285649|64553671|FG001|Overall Study|Lost to Follow-up|4|||
23221382|NCT00285649|64553672|FG002|Overall Study|Lost to Follow-up|4|||
23221383|NCT00285649|64553670|FG000|Overall Study|Withdrawal by Subject|3|||
23221384|NCT00285649|64553671|FG001|Overall Study|Withdrawal by Subject|2|||
23221385|NCT00285649|64553672|FG002|Overall Study|Withdrawal by Subject|2|||
23221386|NCT02996500|64553673|FG000|Overall Study|Adverse Event|1|||
23221387|NCT02996500|64553674|FG001|Overall Study|Adverse Event|1|||
23221388|NCT02996500|64553675|FG002|Overall Study|Adverse Event|4|||
23221389|NCT02996500|64553676|FG003|Overall Study|Adverse Event|3|||
23221390|NCT02996500|64553677|FG004|Overall Study|Adverse Event|1|||
23221391|NCT02996500|64553678|FG005|Overall Study|Adverse Event|2|||
23221392|NCT02996500|64553673|FG000|Overall Study|Lack of Efficacy|0|||
23221393|NCT02996500|64553674|FG001|Overall Study|Lack of Efficacy|0|||
23221394|NCT02996500|64553675|FG002|Overall Study|Lack of Efficacy|0|||
23221395|NCT02996500|64553676|FG003|Overall Study|Lack of Efficacy|0|||
23327419|NCT02513160|64940912|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
23327420|NCT02513160|64940909|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
23327421|NCT02513160|64940910|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
23442181|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
23442182|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
23442183|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
23565281|NCT03097861|65799598|FG001|Overall Study|Reason not provided|1|||
23221396|NCT02996500|64553677|FG004|Overall Study|Lack of Efficacy|2|||
23221397|NCT02996500|64553678|FG005|Overall Study|Lack of Efficacy|0|||
23221398|NCT02996500|64553673|FG000|Overall Study|Lost to Follow-up|1|||
23221399|NCT02996500|64553674|FG001|Overall Study|Lost to Follow-up|0|||
23221400|NCT02996500|64553675|FG002|Overall Study|Lost to Follow-up|0|||
23221401|NCT02996500|64553676|FG003|Overall Study|Lost to Follow-up|0|||
23221402|NCT02996500|64553677|FG004|Overall Study|Lost to Follow-up|0|||
23221403|NCT02996500|64553678|FG005|Overall Study|Lost to Follow-up|1|||
23221404|NCT02996500|64553673|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23442184|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
23565282|NCT03097861|65799599|FG002|Overall Study|Reason not provided|1|||
23327422|NCT02513160|64940911|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
23327423|NCT02513160|64940912|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
23627380|NCT02270671|66024416|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
23627381|NCT02270671|66024415|FG000|Overall Study|Lost to Follow-up|2|||
23627382|NCT02270671|66024416|FG001|Overall Study|Lost to Follow-up|1|||
23627383|NCT04468230|66024418|FG000|Overall Study|Adverse Event|2|||
23627384|NCT02460562|66024419|FG000|Overall Study|Lost to Follow-up|15|||
23627385|NCT02460562|66024420|FG001|Overall Study|Lost to Follow-up|16|||
23627386|NCT02392104|66024421|FG000|Overall Study|discontinuation of warfarin|3|||
23627387|NCT02392104|66024421|FG000|Overall Study|bleeding event|1|||
23627388|NCT02392104|66024421|FG000|Overall Study|transferred care to another doctor|2|||
23627389|NCT02392104|66024421|FG000|Overall Study|INR goal range changed|1|||
23627390|NCT02392104|66024421|FG000|Overall Study|admitted to skilled nursing facility|3|||
23627391|NCT02392104|66024421|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
23627392|NCT01952847|66024425|FG000|Overall Study|Ineligible|1|||
23627393|NCT01952847|66024426|FG001|Overall Study|Ineligible|0|||
23627394|NCT01952847|66024427|FG002|Overall Study|Ineligible|0|||
23627395|NCT01952847|66024428|FG003|Overall Study|Ineligible|0|||
23627396|NCT01952847|66024425|FG000|Overall Study|Lack of Insurance Coverage|0|||
23627397|NCT01952847|66024426|FG001|Overall Study|Lack of Insurance Coverage|1|||
23627398|NCT01952847|66024427|FG002|Overall Study|Lack of Insurance Coverage|0|||
23627399|NCT01952847|66024428|FG003|Overall Study|Lack of Insurance Coverage|0|||
23627400|NCT01952847|66024425|FG000|Overall Study|Withdrawal by Subject|1|||
23627401|NCT01952847|66024426|FG001|Overall Study|Withdrawal by Subject|1|||
23627402|NCT01952847|66024427|FG002|Overall Study|Withdrawal by Subject|0|||
23627403|NCT01952847|66024428|FG003|Overall Study|Withdrawal by Subject|1|||
23627404|NCT04009629|66024429|FG000|Overall Study|Withdrawal by Subject|2|||
23627405|NCT04009629|66024430|FG001|Overall Study|Withdrawal by Subject|0|||
23627406|NCT03602586|66024431|FG000|Overall Study|Withdrawal by Subject|3|||
23627407|NCT02062645|66024434|FG000|Overall Study|Adverse Event|2|||
23627408|NCT02062645|66024434|FG000|Overall Study|Protocol Violation|8|||
23627409|NCT02062645|66024434|FG000|Overall Study|Lost to Follow-up|5|||
23154905|NCT00578786|64318772|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
23154906|NCT02361944|64318773|FG000|Overall Study|surgery cancellation|0|||
23154907|NCT02361944|64318774|FG001|Overall Study|surgery cancellation|1|||
23154908|NCT01293968|64318775|FG000|Overall Study|non-cooperation|3|||
23154909|NCT01293968|64318776|FG001|Overall Study|non-cooperation|3|||
23154910|NCT03520959|64318777|FG000|Overall Study|Study terminated by Sponsor|0|||
23154911|NCT03520959|64318778|FG001|Overall Study|Study terminated by Sponsor|1|||
23154912|NCT00729378|64318783|FG000|Baseline|Did not complete study measurements|72|||
23154913|NCT00729378|64318784|FG001|Baseline|Did not complete study measurements|33|||
23154914|NCT00729378|64318783|FG000|Baseline|Withdrawal by Subject|66|||
23154915|NCT00729378|64318784|FG001|Baseline|Withdrawal by Subject|59|||
23154916|NCT00729378|64318783|FG000|12-months|Lost to Follow-up|100|||
23154917|NCT00729378|64318784|FG001|12-months|Lost to Follow-up|65|||
23154918|NCT00729378|64318783|FG000|24-months|Lost to Follow-up|72|||
23154919|NCT00729378|64318784|FG001|24-months|Lost to Follow-up|51|||
23154920|NCT00729378|64318783|FG000|36-months|Lost to Follow-up|15|||
23154921|NCT00729378|64318784|FG001|36-months|Lost to Follow-up|6|||
23154922|NCT01873417|64318785|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
23154923|NCT01873417|64318785|FG000|Overall Study|Adverse Event|24|||
23154924|NCT01873417|64318785|FG000|Overall Study|Lost to Follow-up|2|||
23154925|NCT01873417|64318785|FG000|Overall Study|Withdrawal by Subject|2|||
23154926|NCT01873417|64318785|FG000|Overall Study|Physician Decision|3|||
23154927|NCT04343248|64318786|FG000|Overall Study|Withdrawal by Subject|5|||
23154928|NCT04343248|64318787|FG001|Overall Study|Withdrawal by Subject|6|||
23154929|NCT04343248|64318786|FG000|Overall Study|Death|1|||
23154930|NCT04343248|64318787|FG001|Overall Study|Death|2|||
23154931|NCT04343248|64318786|FG000|Overall Study|Lost to Follow-up|9|||
23154932|NCT04343248|64318787|FG001|Overall Study|Lost to Follow-up|6|||
23221405|NCT02996500|64553674|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23327424|NCT02513160|64940909|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
23627410|NCT01649557|66024435|FG000|Overall Study|Lost to Follow-up|5|||
23627411|NCT01649557|66024436|FG001|Overall Study|Lost to Follow-up|0|||
23627412|NCT01649557|66024437|FG002|Overall Study|Lost to Follow-up|3|||
23627413|NCT01649557|66024435|FG000|Overall Study|Adverse Event|7|||
23627414|NCT01649557|66024436|FG001|Overall Study|Adverse Event|5|||
23627415|NCT01649557|66024437|FG002|Overall Study|Adverse Event|1|||
23627416|NCT01649557|66024435|FG000|Overall Study|Met withdrawal criteria|4|||
23627417|NCT01649557|66024436|FG001|Overall Study|Met withdrawal criteria|0|||
23627418|NCT01649557|66024437|FG002|Overall Study|Met withdrawal criteria|0|||
23627419|NCT01649557|66024435|FG000|Overall Study|Physician Decision|8|||
23627420|NCT01649557|66024436|FG001|Overall Study|Physician Decision|2|||
23627421|NCT01649557|66024437|FG002|Overall Study|Physician Decision|1|||
23154933|NCT04343248|64318786|FG000|Overall Study|Physician Decision|0|||
23154934|NCT04343248|64318787|FG001|Overall Study|Physician Decision|1|||
23154935|NCT04343248|64318786|FG000|Overall Study|Adverse Event|1|||
23327425|NCT02513160|64940910|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
23327426|NCT02513160|64940911|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
23327427|NCT02513160|64940912|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
23327428|NCT02513160|64940909|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
23154936|NCT04343248|64318787|FG001|Overall Study|Adverse Event|0|||
23154937|NCT00873366|64318789|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
23154938|NCT00873366|64318789|FG000|Overall Study|Off tamoxifen due to side effects|2|||
23327429|NCT02513160|64940910|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
23327430|NCT02513160|64940911|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
23442185|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
23442186|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
23442187|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Death|7|||
23442188|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Death|5|||
23442189|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Death|6|||
23442190|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
23442191|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
23442192|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
23442193|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
23442194|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
23442195|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
23442196|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Other|1|||
23442197|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Other|0|||
23442198|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Other|0|||
23442199|NCT00104650|65358755|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
23442200|NCT00104650|65358756|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
23442201|NCT00104650|65358757|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
23442202|NCT00104650|65358755|FG000|Follow-up Period|Physician Decision|1|||
23442203|NCT00104650|65358756|FG001|Follow-up Period|Physician Decision|1|||
23442204|NCT00104650|65358757|FG002|Follow-up Period|Physician Decision|0|||
23442205|NCT00104650|65358755|FG000|Follow-up Period|Adverse Event|1|||
23154939|NCT00873366|64318789|FG000|Overall Study|Refused to continue DM-BT testing|3|||
23154940|NCT03418129|64318790|FG000|Overall Study|Lost to Follow-up|11|||
23154941|NCT03418129|64318791|FG001|Overall Study|Lost to Follow-up|20|||
23154942|NCT03418129|64318792|FG002|Overall Study|Lost to Follow-up|15|||
23154943|NCT03418129|64318790|FG000|Overall Study|Withdrawal by Subject|3|||
23154944|NCT03418129|64318791|FG001|Overall Study|Withdrawal by Subject|6|||
23154945|NCT03418129|64318792|FG002|Overall Study|Withdrawal by Subject|4|||
23154946|NCT00314249|64318793|FG000|Overall Study|Adverse Event|73|||
23154947|NCT00314249|64318794|FG001|Overall Study|Adverse Event|94|||
23154948|NCT00314249|64318793|FG000|Overall Study|Lack of Efficacy|33|||
23154949|NCT00314249|64318794|FG001|Overall Study|Lack of Efficacy|24|||
23154950|NCT00314249|64318793|FG000|Overall Study|Withdrawal by Subject|21|||
23154951|NCT00314249|64318794|FG001|Overall Study|Withdrawal by Subject|28|||
23154952|NCT00314249|64318793|FG000|Overall Study|Lost to Follow-up|15|||
23154953|NCT00314249|64318794|FG001|Overall Study|Lost to Follow-up|9|||
23154954|NCT00314249|64318793|FG000|Overall Study|Physician Decision|1|||
23154955|NCT00314249|64318794|FG001|Overall Study|Physician Decision|1|||
23154956|NCT00314249|64318793|FG000|Overall Study|Withdrawn for other reasons|4|||
23221406|NCT02996500|64553675|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
23221407|NCT02996500|64553676|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23221408|NCT02996500|64553677|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
23327431|NCT02513160|64940912|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
23327432|NCT02513160|64940909|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
23154957|NCT00314249|64318794|FG001|Overall Study|Withdrawn for other reasons|1|||
23154958|NCT00314249|64318793|FG000|Overall Study|Non-Compliant|5|||
23154959|NCT00314249|64318794|FG001|Overall Study|Non-Compliant|6|||
23154960|NCT02486653|64318795|FG000|Overall Study|Withdrawal by Subject|1|||
23327433|NCT02513160|64940910|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
23327434|NCT02513160|64940911|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
23442206|NCT00104650|65358756|FG001|Follow-up Period|Adverse Event|0|||
23442207|NCT00104650|65358757|FG002|Follow-up Period|Adverse Event|1|||
23442208|NCT00104650|65358755|FG000|Follow-up Period|Withdrawal by Subject|0|||
23442209|NCT00104650|65358756|FG001|Follow-up Period|Withdrawal by Subject|3|||
23442210|NCT00104650|65358757|FG002|Follow-up Period|Withdrawal by Subject|3|||
23442211|NCT00104650|65358755|FG000|Follow-up Period|Death|6|||
23442212|NCT00104650|65358756|FG001|Follow-up Period|Death|6|||
23442213|NCT00104650|65358757|FG002|Follow-up Period|Death|4|||
23442214|NCT00104650|65358755|FG000|Follow-up Period|Disease progression|3|||
23154961|NCT02486653|64318796|FG001|Overall Study|Withdrawal by Subject|3|||
23154962|NCT02486653|64318795|FG000|Overall Study|Protocol Violation|1|||
23154963|NCT02486653|64318796|FG001|Overall Study|Protocol Violation|0|||
23154964|NCT02486653|64318795|FG000|Overall Study|surgery cancelled|4|||
23154965|NCT02486653|64318796|FG001|Overall Study|surgery cancelled|1|||
23221409|NCT02996500|64553678|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23442215|NCT00104650|65358756|FG001|Follow-up Period|Disease progression|1|||
23442216|NCT00104650|65358757|FG002|Follow-up Period|Disease progression|0|||
23442217|NCT00104650|65358755|FG000|Follow-up Period|Lost to Follow-up|0|||
23442218|NCT00104650|65358756|FG001|Follow-up Period|Lost to Follow-up|1|||
23442219|NCT00104650|65358757|FG002|Follow-up Period|Lost to Follow-up|2|||
23442220|NCT00104650|65358755|FG000|Follow-up Period|Other|0|||
23442221|NCT00104650|65358756|FG001|Follow-up Period|Other|1|||
23565283|NCT02401308|65799600|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
23565284|NCT02401308|65799601|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
23565285|NCT01964521|65799608|FG000|Overall Study|Lost to Follow-up|4|||
23565286|NCT01709305|65799609|FG000|Phase 1|Clinical Adverse Event|80|||
23565287|NCT01709305|65799610|FG001|Phase 1|Clinical Adverse Event|0|||
23565288|NCT01709305|65799611|FG002|Phase 1|Clinical Adverse Event|0|||
23565289|NCT01709305|65799612|FG003|Phase 1|Clinical Adverse Event|0|||
23565290|NCT01709305|65799613|FG004|Phase 1|Clinical Adverse Event|0|||
23565291|NCT01709305|65799609|FG000|Phase 1|Death|2|||
23565292|NCT01709305|65799610|FG001|Phase 1|Death|0|||
23565293|NCT01709305|65799611|FG002|Phase 1|Death|0|||
23565294|NCT01709305|65799612|FG003|Phase 1|Death|0|||
23565295|NCT01709305|65799613|FG004|Phase 1|Death|0|||
23565296|NCT01709305|65799609|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
23565297|NCT01709305|65799610|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
23565298|NCT01709305|65799611|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
23565299|NCT01709305|65799612|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
23565300|NCT01709305|65799613|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
23565301|NCT01709305|65799609|FG000|Phase 1|Laboratory Adverse Event|16|||
23565302|NCT01709305|65799610|FG001|Phase 1|Laboratory Adverse Event|0|||
23565303|NCT01709305|65799611|FG002|Phase 1|Laboratory Adverse Event|0|||
23565304|NCT01709305|65799612|FG003|Phase 1|Laboratory Adverse Event|0|||
23565305|NCT01709305|65799613|FG004|Phase 1|Laboratory Adverse Event|0|||
23565306|NCT01709305|65799609|FG000|Phase 1|Lost to Follow-up|147|||
23565307|NCT01709305|65799610|FG001|Phase 1|Lost to Follow-up|0|||
23565308|NCT01709305|65799611|FG002|Phase 1|Lost to Follow-up|0|||
23154966|NCT02146599|64318797|FG000|Overall Study|Failed to meet inclusion criteria|5|||
23154967|NCT01431274|64318798|FG000|Overall Study|Adverse Event|51|||
23565309|NCT01709305|65799612|FG003|Phase 1|Lost to Follow-up|0|||
23565310|NCT01709305|65799613|FG004|Phase 1|Lost to Follow-up|0|||
23565311|NCT01709305|65799609|FG000|Phase 1|Travel, moving, etc.|30|||
23565312|NCT01709305|65799610|FG001|Phase 1|Travel, moving, etc.|0|||
23565313|NCT01709305|65799611|FG002|Phase 1|Travel, moving, etc.|0|||
23565314|NCT01709305|65799612|FG003|Phase 1|Travel, moving, etc.|0|||
23565315|NCT01709305|65799613|FG004|Phase 1|Travel, moving, etc.|0|||
23565316|NCT01709305|65799609|FG000|Phase 1|Physician Decision|13|||
23565317|NCT01709305|65799610|FG001|Phase 1|Physician Decision|0|||
23565318|NCT01709305|65799611|FG002|Phase 1|Physician Decision|0|||
23565319|NCT01709305|65799612|FG003|Phase 1|Physician Decision|0|||
23565320|NCT01709305|65799613|FG004|Phase 1|Physician Decision|0|||
23565321|NCT01709305|65799609|FG000|Phase 1|Protocol Violation|118|||
23565322|NCT01709305|65799610|FG001|Phase 1|Protocol Violation|0|||
23565323|NCT01709305|65799611|FG002|Phase 1|Protocol Violation|0|||
23565324|NCT01709305|65799612|FG003|Phase 1|Protocol Violation|0|||
23565325|NCT01709305|65799613|FG004|Phase 1|Protocol Violation|0|||
23565326|NCT01709305|65799609|FG000|Phase 1|Withdrawal by Subject|218|||
23565327|NCT01709305|65799610|FG001|Phase 1|Withdrawal by Subject|0|||
23565328|NCT01709305|65799611|FG002|Phase 1|Withdrawal by Subject|0|||
23565329|NCT01709305|65799612|FG003|Phase 1|Withdrawal by Subject|0|||
23565330|NCT01709305|65799613|FG004|Phase 1|Withdrawal by Subject|0|||
23565331|NCT01709305|65799609|FG000|Phase 2|Clinical Adverse Event|0|||
23565332|NCT01709305|65799610|FG001|Phase 2|Clinical Adverse Event|10|||
23565333|NCT01709305|65799611|FG002|Phase 2|Clinical Adverse Event|10|||
23565334|NCT01709305|65799612|FG003|Phase 2|Clinical Adverse Event|6|||
23565335|NCT01709305|65799613|FG004|Phase 2|Clinical Adverse Event|11|||
23565336|NCT01709305|65799609|FG000|Phase 2|Death|0|||
23565337|NCT01709305|65799610|FG001|Phase 2|Death|0|||
23442222|NCT00104650|65358757|FG002|Follow-up Period|Other|0|||
23442223|NCT03268941|65358758|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442224|NCT03268941|65358759|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442225|NCT03268941|65358760|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442226|NCT03268941|65358761|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
23442227|NCT03268941|65358762|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23565338|NCT01709305|65799611|FG002|Phase 2|Death|1|||
23565339|NCT01709305|65799612|FG003|Phase 2|Death|0|||
23565340|NCT01709305|65799613|FG004|Phase 2|Death|0|||
23565341|NCT01709305|65799609|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
23565342|NCT01709305|65799610|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
23627422|NCT01649557|66024435|FG000|Overall Study|Withdrawal by Subject|15|||
23565343|NCT01709305|65799611|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
23565344|NCT01709305|65799612|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
23565345|NCT01709305|65799613|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
23565346|NCT01709305|65799609|FG000|Phase 2|Laboratory Adverse Event|0|||
23627423|NCT01649557|66024436|FG001|Overall Study|Withdrawal by Subject|5|||
23627424|NCT01649557|66024437|FG002|Overall Study|Withdrawal by Subject|4|||
23627425|NCT01649557|66024435|FG000|Overall Study|Protocol deviation|0|||
23627426|NCT01649557|66024436|FG001|Overall Study|Protocol deviation|2|||
23627427|NCT01649557|66024437|FG002|Overall Study|Protocol deviation|0|||
23627428|NCT01649557|66024435|FG000|Overall Study|Lack of Efficacy|5|||
23627429|NCT01649557|66024436|FG001|Overall Study|Lack of Efficacy|0|||
23627430|NCT01649557|66024437|FG002|Overall Study|Lack of Efficacy|0|||
23627431|NCT01948076|66024438|FG000|Overall Study|Withdrawal by Subject|0|||
23627432|NCT01948076|66024439|FG001|Overall Study|Withdrawal by Subject|1|||
23627433|NCT01814072|66024448|FG000|Overall Study|Lost to Follow-up|2|||
23627434|NCT01814072|66024449|FG001|Overall Study|Lost to Follow-up|2|||
23627435|NCT01814072|66024450|FG002|Overall Study|Lost to Follow-up|2|||
23627436|NCT01814072|66024451|FG003|Overall Study|Lost to Follow-up|0|||
23627437|NCT01814072|66024452|FG004|Overall Study|Lost to Follow-up|2|||
23627438|NCT01814072|66024453|FG005|Overall Study|Lost to Follow-up|3|||
23627439|NCT01814072|66024454|FG006|Overall Study|Lost to Follow-up|3|||
23627440|NCT01814072|66024455|FG007|Overall Study|Lost to Follow-up|1|||
23627441|NCT01814072|66024456|FG008|Overall Study|Lost to Follow-up|2|||
23627442|NCT01814072|66024457|FG009|Overall Study|Lost to Follow-up|3|||
23627443|NCT01814072|66024458|FG010|Overall Study|Lost to Follow-up|1|||
23627444|NCT01814072|66024459|FG011|Overall Study|Lost to Follow-up|2|||
23627445|NCT01814072|66024460|FG012|Overall Study|Lost to Follow-up|2|||
23627446|NCT01814072|66024461|FG013|Overall Study|Lost to Follow-up|1|||
23627447|NCT01814072|66024462|FG014|Overall Study|Lost to Follow-up|2|||
23627448|NCT01814072|66024463|FG015|Overall Study|Lost to Follow-up|1|||
23627449|NCT01814072|66024464|FG016|Overall Study|Lost to Follow-up|3|||
23627450|NCT01814072|66024465|FG017|Overall Study|Lost to Follow-up|1|||
23627451|NCT01814072|66024466|FG018|Overall Study|Lost to Follow-up|3|||
23627452|NCT01814072|66024467|FG019|Overall Study|Lost to Follow-up|3|||
23627453|NCT01814072|66024468|FG020|Overall Study|Lost to Follow-up|2|||
23627454|NCT01814072|66024469|FG021|Overall Study|Lost to Follow-up|1|||
23627455|NCT01814072|66024470|FG022|Overall Study|Lost to Follow-up|3|||
23627456|NCT01814072|66024471|FG023|Overall Study|Lost to Follow-up|1|||
23627457|NCT01814072|66024472|FG024|Overall Study|Lost to Follow-up|4|||
23627458|NCT01814072|66024473|FG025|Overall Study|Lost to Follow-up|1|||
23627459|NCT01814072|66024474|FG026|Overall Study|Lost to Follow-up|1|||
23627460|NCT01814072|66024475|FG027|Overall Study|Lost to Follow-up|2|||
23627461|NCT01814072|66024476|FG028|Overall Study|Lost to Follow-up|3|||
23627462|NCT01814072|66024477|FG029|Overall Study|Lost to Follow-up|3|||
23627463|NCT01814072|66024478|FG030|Overall Study|Lost to Follow-up|2|||
23627464|NCT01814072|66024479|FG031|Overall Study|Lost to Follow-up|0|||
23627465|NCT01814072|66024448|FG000|Overall Study|Withdrawal by Subject|2|||
23627466|NCT01814072|66024449|FG001|Overall Study|Withdrawal by Subject|0|||
23627467|NCT01814072|66024450|FG002|Overall Study|Withdrawal by Subject|1|||
23627468|NCT01814072|66024451|FG003|Overall Study|Withdrawal by Subject|0|||
23627469|NCT01814072|66024452|FG004|Overall Study|Withdrawal by Subject|2|||
23627470|NCT01814072|66024453|FG005|Overall Study|Withdrawal by Subject|3|||
23627471|NCT01814072|66024454|FG006|Overall Study|Withdrawal by Subject|1|||
23627472|NCT01814072|66024455|FG007|Overall Study|Withdrawal by Subject|0|||
23627473|NCT01814072|66024456|FG008|Overall Study|Withdrawal by Subject|1|||
23627474|NCT01814072|66024457|FG009|Overall Study|Withdrawal by Subject|2|||
23627475|NCT01814072|66024458|FG010|Overall Study|Withdrawal by Subject|0|||
23627476|NCT01814072|66024459|FG011|Overall Study|Withdrawal by Subject|0|||
23627477|NCT01814072|66024460|FG012|Overall Study|Withdrawal by Subject|1|||
23627478|NCT01814072|66024461|FG013|Overall Study|Withdrawal by Subject|1|||
23627479|NCT01814072|66024462|FG014|Overall Study|Withdrawal by Subject|1|||
23627480|NCT01814072|66024463|FG015|Overall Study|Withdrawal by Subject|1|||
23627481|NCT01814072|66024464|FG016|Overall Study|Withdrawal by Subject|0|||
23627482|NCT01814072|66024465|FG017|Overall Study|Withdrawal by Subject|0|||
23627483|NCT01814072|66024466|FG018|Overall Study|Withdrawal by Subject|0|||
23627484|NCT01814072|66024467|FG019|Overall Study|Withdrawal by Subject|2|||
23627485|NCT01814072|66024468|FG020|Overall Study|Withdrawal by Subject|0|||
23627486|NCT01814072|66024469|FG021|Overall Study|Withdrawal by Subject|0|||
23327435|NCT02513160|64940912|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
23627487|NCT01814072|66024470|FG022|Overall Study|Withdrawal by Subject|1|||
23627488|NCT01814072|66024471|FG023|Overall Study|Withdrawal by Subject|0|||
23627489|NCT01814072|66024472|FG024|Overall Study|Withdrawal by Subject|2|||
23327436|NCT01134939|64940913|FG000|Overall Study|Adverse Event|9|||
23327437|NCT01134939|64940914|FG001|Overall Study|Adverse Event|3|||
23627490|NCT01814072|66024473|FG025|Overall Study|Withdrawal by Subject|1|||
23627491|NCT01814072|66024474|FG026|Overall Study|Withdrawal by Subject|1|||
23627492|NCT01814072|66024475|FG027|Overall Study|Withdrawal by Subject|2|||
23627493|NCT01814072|66024476|FG028|Overall Study|Withdrawal by Subject|1|||
23627494|NCT01814072|66024477|FG029|Overall Study|Withdrawal by Subject|0|||
23627495|NCT01814072|66024478|FG030|Overall Study|Withdrawal by Subject|0|||
23627496|NCT01814072|66024479|FG031|Overall Study|Withdrawal by Subject|0|||
23442228|NCT03268941|65358763|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442229|NCT03268941|65358764|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
23442230|NCT03268941|65358758|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442231|NCT03268941|65358759|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442232|NCT03268941|65358760|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442233|NCT03268941|65358761|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
23565347|NCT01709305|65799610|FG001|Phase 2|Laboratory Adverse Event|1|||
23565348|NCT01709305|65799611|FG002|Phase 2|Laboratory Adverse Event|0|||
23154968|NCT01431274|64318799|FG001|Overall Study|Adverse Event|37|||
23154969|NCT01431274|64318800|FG002|Overall Study|Adverse Event|43|||
23154970|NCT01431274|64318801|FG003|Overall Study|Adverse Event|30|||
23154971|NCT01431274|64318802|FG004|Overall Study|Adverse Event|37|||
23154972|NCT01431274|64318798|FG000|Overall Study|Consent withdrawn not due to AE|29|||
23154973|NCT01431274|64318799|FG001|Overall Study|Consent withdrawn not due to AE|20|||
23154974|NCT01431274|64318800|FG002|Overall Study|Consent withdrawn not due to AE|17|||
23154975|NCT01431274|64318801|FG003|Overall Study|Consent withdrawn not due to AE|20|||
23154976|NCT01431274|64318802|FG004|Overall Study|Consent withdrawn not due to AE|11|||
23154977|NCT01431274|64318798|FG000|Overall Study|Non compliant with protocol|5|||
23154978|NCT01431274|64318799|FG001|Overall Study|Non compliant with protocol|8|||
23154979|NCT01431274|64318800|FG002|Overall Study|Non compliant with protocol|4|||
23154980|NCT01431274|64318801|FG003|Overall Study|Non compliant with protocol|4|||
23154981|NCT01431274|64318802|FG004|Overall Study|Non compliant with protocol|4|||
23154982|NCT01431274|64318798|FG000|Overall Study|Lost to Follow-up|6|||
23154983|NCT01431274|64318799|FG001|Overall Study|Lost to Follow-up|7|||
23154984|NCT01431274|64318800|FG002|Overall Study|Lost to Follow-up|1|||
23154985|NCT01431274|64318801|FG003|Overall Study|Lost to Follow-up|4|||
23154986|NCT01431274|64318802|FG004|Overall Study|Lost to Follow-up|0|||
23154987|NCT01431274|64318798|FG000|Overall Study|Other reason not stated above|6|||
23154988|NCT01431274|64318799|FG001|Overall Study|Other reason not stated above|5|||
23154989|NCT01431274|64318800|FG002|Overall Study|Other reason not stated above|7|||
23154990|NCT01431274|64318801|FG003|Overall Study|Other reason not stated above|2|||
23154991|NCT01431274|64318802|FG004|Overall Study|Other reason not stated above|4|||
23154992|NCT03337542|64318807|FG000|Overall Study|Withdrew Consent|17|||
23154993|NCT03337542|64318807|FG000|Overall Study|Allergic Adverse Event|1|||
23154994|NCT03337542|64318807|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
23154995|NCT03337542|64318807|FG000|Overall Study|Lost to Follow-up|1|||
23154996|NCT03337542|64318807|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
23154997|NCT00404820|64318813|FG000|Overall Study|Adverse Event|4|||
23154998|NCT00404820|64318814|FG001|Overall Study|Adverse Event|16|||
23154999|NCT00404820|64318813|FG000|Overall Study|Withdrawal by Subject|5|||
23155000|NCT00404820|64318814|FG001|Overall Study|Withdrawal by Subject|3|||
23155001|NCT00404820|64318813|FG000|Overall Study|Lost to Follow-up|7|||
23155002|NCT00404820|64318814|FG001|Overall Study|Lost to Follow-up|3|||
23155003|NCT00404820|64318813|FG000|Overall Study|Administrative problems|2|||
23155004|NCT00404820|64318814|FG001|Overall Study|Administrative problems|0|||
23155005|NCT00404820|64318813|FG000|Overall Study|Death|1|||
23327438|NCT01134939|64940915|FG002|Overall Study|Adverse Event|4|||
23442234|NCT03268941|65358762|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442235|NCT03268941|65358763|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442236|NCT03268941|65358764|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
23442237|NCT03268941|65358758|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
23565349|NCT01709305|65799612|FG003|Phase 2|Laboratory Adverse Event|1|||
23155006|NCT00404820|64318814|FG001|Overall Study|Death|0|||
23155007|NCT00404820|64318813|FG000|Overall Study|Other|0|||
23155008|NCT00404820|64318814|FG001|Overall Study|Other|2|||
23565350|NCT01709305|65799613|FG004|Phase 2|Laboratory Adverse Event|1|||
23565351|NCT01709305|65799609|FG000|Phase 2|Lost to Follow-up|0|||
23155009|NCT03684642|64318829|FG000|Overall Study|Adverse Event|6|||
23155010|NCT03684642|64318830|FG001|Overall Study|Adverse Event|15|||
23565352|NCT01709305|65799610|FG001|Phase 2|Lost to Follow-up|10|||
23565353|NCT01709305|65799611|FG002|Phase 2|Lost to Follow-up|6|||
23565354|NCT01709305|65799612|FG003|Phase 2|Lost to Follow-up|9|||
23565355|NCT01709305|65799613|FG004|Phase 2|Lost to Follow-up|5|||
23565356|NCT01709305|65799609|FG000|Phase 2|Travel, moving, etc.|0|||
23565357|NCT01709305|65799610|FG001|Phase 2|Travel, moving, etc.|2|||
23565358|NCT01709305|65799611|FG002|Phase 2|Travel, moving, etc.|3|||
23565359|NCT01709305|65799612|FG003|Phase 2|Travel, moving, etc.|3|||
23565360|NCT01709305|65799613|FG004|Phase 2|Travel, moving, etc.|5|||
23565361|NCT01709305|65799609|FG000|Phase 2|Physician Decision|0|||
23565362|NCT01709305|65799610|FG001|Phase 2|Physician Decision|2|||
23565363|NCT01709305|65799611|FG002|Phase 2|Physician Decision|0|||
23565364|NCT01709305|65799612|FG003|Phase 2|Physician Decision|1|||
23565365|NCT01709305|65799613|FG004|Phase 2|Physician Decision|2|||
23565366|NCT01709305|65799609|FG000|Phase 2|Protocol Violation|0|||
23565367|NCT01709305|65799610|FG001|Phase 2|Protocol Violation|19|||
23565368|NCT01709305|65799611|FG002|Phase 2|Protocol Violation|19|||
23565369|NCT01709305|65799612|FG003|Phase 2|Protocol Violation|13|||
23627497|NCT05382039|66024480|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
23627498|NCT05382039|66024481|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
23627499|NCT05382039|66024482|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
23627500|NCT05382039|66024480|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
23627501|NCT05382039|66024481|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
23627502|NCT05382039|66024482|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
23627503|NCT05382039|66024480|FG000|Overall Study|waiting for confirmation|0|||
23627504|NCT05382039|66024481|FG001|Overall Study|waiting for confirmation|0|||
23627505|NCT05382039|66024482|FG002|Overall Study|waiting for confirmation|1|||
23627506|NCT00872001|66024483|FG000|Overall Study|Adverse Event|34|||
23627507|NCT00872001|66024484|FG001|Overall Study|Adverse Event|23|||
23627508|NCT00872001|66024483|FG000|Overall Study|Protocol Defined Clinical Event|5|||
23627509|NCT00872001|66024484|FG001|Overall Study|Protocol Defined Clinical Event|7|||
23627510|NCT00872001|66024483|FG000|Overall Study|Lost to Follow-up|13|||
23221410|NCT02996500|64553673|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23221411|NCT02996500|64553674|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23327439|NCT01134939|64940916|FG003|Overall Study|Adverse Event|5|||
23327440|NCT01134939|64940917|FG004|Overall Study|Adverse Event|5|||
23327441|NCT01134939|64940918|FG005|Overall Study|Adverse Event|5|||
23327442|NCT01134939|64940919|FG006|Overall Study|Adverse Event|1|||
23327443|NCT01134939|64940920|FG007|Overall Study|Adverse Event|0|||
23327444|NCT01134939|64940913|FG000|Overall Study|Lack of Efficacy|2|||
23327445|NCT01134939|64940914|FG001|Overall Study|Lack of Efficacy|5|||
23327446|NCT01134939|64940915|FG002|Overall Study|Lack of Efficacy|1|||
23327447|NCT01134939|64940916|FG003|Overall Study|Lack of Efficacy|0|||
23327448|NCT01134939|64940917|FG004|Overall Study|Lack of Efficacy|3|||
23327449|NCT01134939|64940918|FG005|Overall Study|Lack of Efficacy|0|||
23327450|NCT01134939|64940919|FG006|Overall Study|Lack of Efficacy|1|||
23327451|NCT01134939|64940920|FG007|Overall Study|Lack of Efficacy|0|||
23327452|NCT01134939|64940913|FG000|Overall Study|Lost to Follow-up|2|||
23327453|NCT01134939|64940914|FG001|Overall Study|Lost to Follow-up|3|||
23327454|NCT01134939|64940915|FG002|Overall Study|Lost to Follow-up|0|||
23327455|NCT01134939|64940916|FG003|Overall Study|Lost to Follow-up|1|||
23327456|NCT01134939|64940917|FG004|Overall Study|Lost to Follow-up|2|||
23221412|NCT02996500|64553675|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23221413|NCT02996500|64553676|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23327457|NCT01134939|64940918|FG005|Overall Study|Lost to Follow-up|1|||
23327458|NCT01134939|64940919|FG006|Overall Study|Lost to Follow-up|0|||
23327459|NCT01134939|64940920|FG007|Overall Study|Lost to Follow-up|0|||
23327460|NCT01134939|64940913|FG000|Overall Study|Death|0|||
23327461|NCT01134939|64940914|FG001|Overall Study|Death|1|||
23327462|NCT01134939|64940915|FG002|Overall Study|Death|0|||
23327463|NCT01134939|64940916|FG003|Overall Study|Death|0|||
23327464|NCT01134939|64940917|FG004|Overall Study|Death|0|||
23327465|NCT01134939|64940918|FG005|Overall Study|Death|0|||
23327466|NCT01134939|64940919|FG006|Overall Study|Death|0|||
23327467|NCT01134939|64940920|FG007|Overall Study|Death|0|||
23327468|NCT01134939|64940913|FG000|Overall Study|Termination page not available|4|||
23327469|NCT01134939|64940914|FG001|Overall Study|Termination page not available|6|||
23442238|NCT03268941|65358759|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442239|NCT03268941|65358760|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442240|NCT03268941|65358761|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442241|NCT03268941|65358762|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442242|NCT03268941|65358763|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442243|NCT03268941|65358764|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
23442244|NCT03268941|65358758|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
23442245|NCT03268941|65358759|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
23442246|NCT03268941|65358760|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
23442247|NCT03268941|65358761|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
23442248|NCT03268941|65358762|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
23442249|NCT03268941|65358763|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
23442250|NCT03268941|65358764|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
23627511|NCT00872001|66024484|FG001|Overall Study|Lost to Follow-up|12|||
23627512|NCT00872001|66024483|FG000|Overall Study|Withdrawal by Subject|18|||
23627513|NCT00872001|66024484|FG001|Overall Study|Withdrawal by Subject|30|||
23327470|NCT01134939|64940915|FG002|Overall Study|Termination page not available|5|||
23327471|NCT01134939|64940916|FG003|Overall Study|Termination page not available|8|||
23442251|NCT03268941|65358758|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23327472|NCT01134939|64940917|FG004|Overall Study|Termination page not available|0|||
23327473|NCT01134939|64940918|FG005|Overall Study|Termination page not available|3|||
23442252|NCT03268941|65358759|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23327474|NCT01134939|64940919|FG006|Overall Study|Termination page not available|7|||
23327475|NCT01134939|64940920|FG007|Overall Study|Termination page not available|0|||
23327476|NCT02418182|64940921|FG000|Overall Study|Unable to re-consent|18|||
23327477|NCT02418182|64940922|FG001|Overall Study|Unable to re-consent|15|||
23327478|NCT02418182|64940921|FG000|Overall Study|Lost to Follow-up|0|||
23327479|NCT02418182|64940922|FG001|Overall Study|Lost to Follow-up|2|||
23327480|NCT02741076|64940923|FG000|Overall Study|Adverse Event|0|||
23327481|NCT02741076|64940924|FG001|Overall Study|Adverse Event|1|||
23327482|NCT02741076|64940925|FG002|Overall Study|Adverse Event|1|||
23327483|NCT02741076|64940926|FG003|Overall Study|Adverse Event|0|||
23327484|NCT02741076|64940923|FG000|Overall Study|Lack of Efficacy|1|||
23327485|NCT02741076|64940924|FG001|Overall Study|Lack of Efficacy|0|||
23327486|NCT02741076|64940925|FG002|Overall Study|Lack of Efficacy|0|||
23327487|NCT02741076|64940926|FG003|Overall Study|Lack of Efficacy|0|||
23327488|NCT02741076|64940923|FG000|Overall Study|Withdrawal by Subject|0|||
23327489|NCT02741076|64940924|FG001|Overall Study|Withdrawal by Subject|1|||
23327490|NCT02741076|64940925|FG002|Overall Study|Withdrawal by Subject|0|||
23442253|NCT03268941|65358760|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442254|NCT03268941|65358761|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442255|NCT03268941|65358762|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442256|NCT03268941|65358763|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
23442257|NCT03268941|65358764|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
23565370|NCT01709305|65799613|FG004|Phase 2|Protocol Violation|9|||
23565371|NCT01709305|65799609|FG000|Phase 2|Withdrawal by Subject|0|||
23565372|NCT01709305|65799610|FG001|Phase 2|Withdrawal by Subject|8|||
23565373|NCT01709305|65799611|FG002|Phase 2|Withdrawal by Subject|6|||
23565374|NCT01709305|65799612|FG003|Phase 2|Withdrawal by Subject|15|||
23565375|NCT01709305|65799613|FG004|Phase 2|Withdrawal by Subject|12|||
23565376|NCT05033080|65799614|FG000|Overall Study|Adverse Event|4|||
23627514|NCT00872001|66024483|FG000|Overall Study|Protocol Violation|5|||
23627515|NCT00872001|66024484|FG001|Overall Study|Protocol Violation|8|||
23627516|NCT00872001|66024483|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
23627517|NCT00872001|66024484|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
23627518|NCT00872001|66024483|FG000|Overall Study|Administrative|23|||
23155011|NCT03684642|64318831|FG002|Overall Study|Adverse Event|11|||
23155012|NCT03684642|64318829|FG000|Overall Study|Withdrawal by Subject|35|||
23155013|NCT03684642|64318830|FG001|Overall Study|Withdrawal by Subject|53|||
23155014|NCT03684642|64318831|FG002|Overall Study|Withdrawal by Subject|23|||
23155015|NCT03684642|64318829|FG000|Overall Study|Lack of Efficacy|0|||
23155016|NCT03684642|64318830|FG001|Overall Study|Lack of Efficacy|0|||
23155017|NCT03684642|64318831|FG002|Overall Study|Lack of Efficacy|1|||
23155018|NCT03684642|64318829|FG000|Overall Study|Poor compliance to protocol|0|||
23155019|NCT03684642|64318830|FG001|Overall Study|Poor compliance to protocol|4|||
23155020|NCT03684642|64318831|FG002|Overall Study|Poor compliance to protocol|1|||
23155021|NCT03684642|64318829|FG000|Overall Study|Other than specified|62|||
23155022|NCT03684642|64318830|FG001|Overall Study|Other than specified|60|||
23155023|NCT03684642|64318831|FG002|Overall Study|Other than specified|67|||
23155024|NCT03684642|64318829|FG000|Overall Study|Randomized and not treated|0|||
23155025|NCT03684642|64318830|FG001|Overall Study|Randomized and not treated|0|||
23155026|NCT03684642|64318831|FG002|Overall Study|Randomized and not treated|1|||
23155027|NCT03684642|64318829|FG000|Overall Study|Missing completion status but alive at last contact|0|||
23155028|NCT03684642|64318830|FG001|Overall Study|Missing completion status but alive at last contact|1|||
23155029|NCT03684642|64318831|FG002|Overall Study|Missing completion status but alive at last contact|2|||
23155030|NCT02000427|64318841|FG000|Overall Study|Death|22|||
23155031|NCT00736034|64318846|FG000|Overall Study|Adverse Event|2|||
23155032|NCT00698204|64318847|FG000|Overall Study|Withdrawal by Subject|1|||
23155033|NCT00698204|64318848|FG001|Overall Study|Withdrawal by Subject|0|||
23155034|NCT01519765|64318851|FG000|Overall Study|Adverse Event|0|||
23155035|NCT01519765|64318852|FG001|Overall Study|Adverse Event|1|||
23155036|NCT01519765|64318851|FG000|Overall Study|Lack of Efficacy|2|||
23155037|NCT01519765|64318852|FG001|Overall Study|Lack of Efficacy|0|||
23155038|NCT01519765|64318851|FG000|Overall Study|Protocol Violation|1|||
23155039|NCT01519765|64318852|FG001|Overall Study|Protocol Violation|0|||
23155040|NCT01519765|64318851|FG000|Overall Study|Withdrawal by Subject|0|||
23155041|NCT01519765|64318852|FG001|Overall Study|Withdrawal by Subject|1|||
23155042|NCT03083847|64318853|FG000|Main|Physician Decision|0|||
23155043|NCT03083847|64318854|FG001|Main|Physician Decision|0|||
23155044|NCT03083847|64318855|FG002|Main|Physician Decision|0|||
23155045|NCT03083847|64318856|FG003|Main|Physician Decision|0|||
23155046|NCT03083847|64318857|FG004|Main|Physician Decision|0|||
23155047|NCT03083847|64318858|FG005|Main|Physician Decision|1|||
23155048|NCT03083847|64318859|FG006|Main|Physician Decision|0|||
23442258|NCT00787189|65358765|FG000|Overall Study|Lost to Follow-up|2|||
23565377|NCT05033080|65799615|FG001|Overall Study|Adverse Event|4|||
23565378|NCT05033080|65799614|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
23565379|NCT05033080|65799615|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
23627519|NCT00872001|66024484|FG001|Overall Study|Administrative|15|||
23327491|NCT02741076|64940926|FG003|Overall Study|Withdrawal by Subject|0|||
23327492|NCT02741076|64940923|FG000|Overall Study|Sponsor Request|2|||
23565380|NCT05033080|65799614|FG000|Overall Study|Lost to Follow-up|1|||
23442259|NCT00787189|65358766|FG001|Overall Study|Lost to Follow-up|2|||
23442260|NCT04395690|65362012|FG000|Overall Study|Lost to Follow-up|1|||
23442261|NCT04395690|65362013|FG001|Overall Study|Lost to Follow-up|1|||
23442262|NCT01670721|65362014|FG000|Overall Study|Participant's decision|15|||
23442263|NCT01670721|65362014|FG000|Overall Study|Other than specified above|38|||
23442264|NCT03386487|65362015|FG000|Overall Study|Lost to Follow-up|5|||
23442265|NCT03386487|65362016|FG001|Overall Study|Lost to Follow-up|6|||
23442266|NCT03386487|65362015|FG000|Overall Study|Withdrawal by Subject|11|||
23442267|NCT03386487|65362016|FG001|Overall Study|Withdrawal by Subject|7|||
23442268|NCT03386487|65362015|FG000|Overall Study|Physician Decision|11|||
23442269|NCT03386487|65362016|FG001|Overall Study|Physician Decision|8|||
23442270|NCT02478164|65362017|FG000|Overall Study|Lack of Efficacy|13|||
23565381|NCT05033080|65799615|FG001|Overall Study|Lost to Follow-up|0|||
23565382|NCT05033080|65799614|FG000|Overall Study|Other non-compliance|0|||
23565383|NCT05033080|65799615|FG001|Overall Study|Other non-compliance|1|||
23565384|NCT05033080|65799614|FG000|Overall Study|Physician Decision|0|||
23565385|NCT05033080|65799615|FG001|Overall Study|Physician Decision|1|||
23565386|NCT05033080|65799614|FG000|Overall Study|Other|1|||
23565387|NCT05033080|65799615|FG001|Overall Study|Other|1|||
23565388|NCT02200939|65799618|FG000|Overall Study|Participant withdrew consent|0|||
23627520|NCT02980523|66024485|FG000|Overall Study|Lost to Follow-up|1|||
23442271|NCT02478164|65362017|FG000|Overall Study|Adverse Event|1|||
23442272|NCT02478164|65362017|FG000|Overall Study|Withdrawal by Subject|1|||
23442273|NCT02279095|65362019|FG000|Overall Study|Non-Compliance|1|||
23442274|NCT02279095|65362019|FG000|Overall Study|Withdrawal by Subject|8|||
23442275|NCT02279095|65362019|FG000|Overall Study|Adverse Event|2|||
23442276|NCT02279095|65362019|FG000|Overall Study|Other|7|||
23442277|NCT02279095|65362019|FG000|Overall Study|Lost to Follow-up|1|||
23442278|NCT01510158|65362020|FG000|Overall Study|Adverse Event|7|||
23442279|NCT01510158|65362021|FG001|Overall Study|Adverse Event|8|||
23442280|NCT01510158|65362022|FG002|Overall Study|Adverse Event|5|||
23442281|NCT01510158|65362020|FG000|Overall Study|Gout flare|1|||
23442282|NCT01510158|65362021|FG001|Overall Study|Gout flare|0|||
23627521|NCT02980523|66024486|FG001|Overall Study|Lost to Follow-up|4|||
23627522|NCT02980523|66024487|FG002|Overall Study|Lost to Follow-up|1|||
23627523|NCT02980523|66024488|FG003|Overall Study|Lost to Follow-up|2|||
23627524|NCT02980523|66024489|FG004|Overall Study|Lost to Follow-up|1|||
23627525|NCT02980523|66024485|FG000|Overall Study|Excluded from analysis|1|||
23627526|NCT02980523|66024486|FG001|Overall Study|Excluded from analysis|3|||
23442283|NCT01510158|65362022|FG002|Overall Study|Gout flare|0|||
23565389|NCT02200939|65799619|FG001|Overall Study|Participant withdrew consent|1|||
23565390|NCT02200939|65799618|FG000|Overall Study|Lost to Follow-up|2|||
23627527|NCT02980523|66024487|FG002|Overall Study|Excluded from analysis|1|||
23627528|NCT02980523|66024488|FG003|Overall Study|Excluded from analysis|1|||
23627529|NCT02980523|66024489|FG004|Overall Study|Excluded from analysis|1|||
23627530|NCT02980523|66024485|FG000|Overall Study|Lack of Efficacy|1|||
23627531|NCT02980523|66024486|FG001|Overall Study|Lack of Efficacy|4|||
23627532|NCT02980523|66024487|FG002|Overall Study|Lack of Efficacy|4|||
23627533|NCT02980523|66024488|FG003|Overall Study|Lack of Efficacy|5|||
23627534|NCT02980523|66024489|FG004|Overall Study|Lack of Efficacy|8|||
23627535|NCT02980523|66024485|FG000|Overall Study|Did not receive intervention|0|||
23627536|NCT02980523|66024486|FG001|Overall Study|Did not receive intervention|0|||
23627537|NCT02980523|66024487|FG002|Overall Study|Did not receive intervention|0|||
23627538|NCT02980523|66024488|FG003|Overall Study|Did not receive intervention|1|||
23627539|NCT02980523|66024489|FG004|Overall Study|Did not receive intervention|0|||
23627540|NCT01318876|66024491|FG000|Day 8 Survey|email address invalid|96|||
23155049|NCT03083847|64318860|FG007|Main|Physician Decision|0|||
23155050|NCT03083847|64318861|FG008|Main|Physician Decision|0|||
23155051|NCT03083847|64318862|FG009|Main|Physician Decision|0|||
23155052|NCT03083847|64318853|FG000|Main|Pregnancy|0|||
23155053|NCT03083847|64318854|FG001|Main|Pregnancy|0|||
23155054|NCT03083847|64318855|FG002|Main|Pregnancy|0|||
23155055|NCT03083847|64318856|FG003|Main|Pregnancy|0|||
23155056|NCT03083847|64318857|FG004|Main|Pregnancy|0|||
23155057|NCT03083847|64318858|FG005|Main|Pregnancy|0|||
23155058|NCT03083847|64318859|FG006|Main|Pregnancy|0|||
23155059|NCT03083847|64318860|FG007|Main|Pregnancy|1|||
23155060|NCT03083847|64318861|FG008|Main|Pregnancy|0|||
23155061|NCT03083847|64318862|FG009|Main|Pregnancy|0|||
23155062|NCT03083847|64318853|FG000|Main|Adverse Event|0|||
23442284|NCT01510158|65362020|FG000|Overall Study|Protocol Violation|17|||
23442285|NCT01510158|65362021|FG001|Overall Study|Protocol Violation|16|||
23627541|NCT01318876|66024491|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
23442286|NCT01510158|65362022|FG002|Overall Study|Protocol Violation|24|||
23155063|NCT03083847|64318854|FG001|Main|Adverse Event|0|||
23155064|NCT03083847|64318855|FG002|Main|Adverse Event|0|||
23155065|NCT03083847|64318856|FG003|Main|Adverse Event|0|||
23155066|NCT03083847|64318857|FG004|Main|Adverse Event|0|||
23442287|NCT01510158|65362020|FG000|Overall Study|Sponsor terminated study.|2|||
23565391|NCT02200939|65799619|FG001|Overall Study|Lost to Follow-up|9|||
23627542|NCT01318876|66024491|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
23627543|NCT00458393|66024493|FG000|Overall Study|Withdrawal by Subject|67|||
23627544|NCT00458393|66024494|FG001|Overall Study|Withdrawal by Subject|80|||
23627545|NCT00458393|66024493|FG000|Overall Study|Physician Decision|31|||
23627546|NCT00458393|66024494|FG001|Overall Study|Physician Decision|22|||
23627547|NCT00458393|66024493|FG000|Overall Study|Relocated|77|||
23627548|NCT00458393|66024494|FG001|Overall Study|Relocated|81|||
23565392|NCT02200939|65799618|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
23627549|NCT00458393|66024493|FG000|Overall Study|Lost to Follow-up|115|||
23627550|NCT00458393|66024494|FG001|Overall Study|Lost to Follow-up|92|||
23627551|NCT00458393|66024493|FG000|Overall Study|Sites marked other on the form.|19|||
23627552|NCT00458393|66024494|FG001|Overall Study|Sites marked other on the form.|20|||
23627553|NCT00003477|66024496|FG000|Overall Study|Not evalauable|4|||
23627554|NCT02058836|66024497|FG000|Overall Study|Withdrawal by Subject|1|||
23627555|NCT02058836|66024498|FG001|Overall Study|Withdrawal by Subject|1|||
23627556|NCT01547598|66024499|FG000|Overall Study|Withdrew consent|1|||
23627557|NCT01547598|66024500|FG001|Overall Study|Withdrew consent|1|||
23627558|NCT01547598|66024499|FG000|Overall Study|Lost to Follow-up|1|||
23627559|NCT01547598|66024500|FG001|Overall Study|Lost to Follow-up|1|||
23627560|NCT01547598|66024499|FG000|Overall Study|Adverse Event|1|||
23627561|NCT01547598|66024500|FG001|Overall Study|Adverse Event|1|||
23565393|NCT02200939|65799619|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
23565394|NCT01267253|65799620|FG000|Overall Study|Ineligible - required test not done|1|||
23565395|NCT01267253|65799620|FG000|Overall Study|Inevaluable-never received study treatme|2|||
23565396|NCT00926003|65799622|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
23627562|NCT01547598|66024499|FG000|Overall Study|Protocol Violation|1|||
23627563|NCT01547598|66024500|FG001|Overall Study|Protocol Violation|1|||
23155067|NCT03083847|64318858|FG005|Main|Adverse Event|0|||
23155068|NCT03083847|64318859|FG006|Main|Adverse Event|0|||
23155069|NCT03083847|64318860|FG007|Main|Adverse Event|2|||
23155070|NCT03083847|64318861|FG008|Main|Adverse Event|0|||
23155071|NCT03083847|64318862|FG009|Main|Adverse Event|0|||
23221414|NCT02996500|64553677|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23221415|NCT02996500|64553678|FG005|Overall Study|Non-Compliance With Study Drug|1|||
23221416|NCT02996500|64553673|FG000|Overall Study|Progressive Disease|1|||
23221417|NCT02996500|64553674|FG001|Overall Study|Progressive Disease|0|||
23221418|NCT02996500|64553675|FG002|Overall Study|Progressive Disease|0|||
23221419|NCT02996500|64553676|FG003|Overall Study|Progressive Disease|0|||
23327493|NCT02741076|64940924|FG001|Overall Study|Sponsor Request|3|||
23155072|NCT03083847|64318853|FG000|Main|Withdrawal by Subject|0|||
23155073|NCT03083847|64318854|FG001|Main|Withdrawal by Subject|0|||
23155074|NCT03083847|64318855|FG002|Main|Withdrawal by Subject|0|||
23155075|NCT03083847|64318856|FG003|Main|Withdrawal by Subject|0|||
23155076|NCT03083847|64318857|FG004|Main|Withdrawal by Subject|0|||
23155077|NCT03083847|64318858|FG005|Main|Withdrawal by Subject|0|||
23327494|NCT02741076|64940925|FG002|Overall Study|Sponsor Request|0|||
23327495|NCT02741076|64940926|FG003|Overall Study|Sponsor Request|1|||
23327496|NCT02741076|64940923|FG000|Overall Study|No additional information available|0|||
23327497|NCT02741076|64940924|FG001|Overall Study|No additional information available|0|||
23327498|NCT02741076|64940925|FG002|Overall Study|No additional information available|1|||
23565397|NCT00926003|65799623|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
23565398|NCT00926003|65799624|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
23565399|NCT00926003|65799622|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
23565400|NCT00926003|65799623|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
23565401|NCT00926003|65799624|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
23565402|NCT02961881|65799628|FG000|Overall Study|Adverse Event|1|||
23565403|NCT02961881|65799629|FG001|Overall Study|Adverse Event|2|||
23565404|NCT02961881|65799630|FG002|Overall Study|Adverse Event|2|||
23565405|NCT02961881|65799631|FG003|Overall Study|Adverse Event|0|||
23565406|NCT02961881|65799632|FG004|Overall Study|Adverse Event|1|||
23565407|NCT02961881|65799628|FG000|Overall Study|Participant request|0|||
23565408|NCT02961881|65799629|FG001|Overall Study|Participant request|2|||
23627564|NCT01547598|66024499|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23627565|NCT01547598|66024500|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23155078|NCT03083847|64318859|FG006|Main|Withdrawal by Subject|1|||
23155079|NCT03083847|64318860|FG007|Main|Withdrawal by Subject|1|||
23221420|NCT02996500|64553677|FG004|Overall Study|Progressive Disease|0|||
23221421|NCT02996500|64553678|FG005|Overall Study|Progressive Disease|0|||
23221422|NCT02996500|64553673|FG000|Overall Study|Other|2|||
23327499|NCT02741076|64940926|FG003|Overall Study|No additional information available|1|||
23327500|NCT04030299|64940927|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
23327501|NCT04030299|64940927|FG000|Overall Study|Withdrawal by Subject|3|||
23627566|NCT02397447|66024501|FG000|Overall Study|Lost to Follow-up|2|||
23155080|NCT03083847|64318861|FG008|Main|Withdrawal by Subject|0|||
23627567|NCT02397447|66024502|FG001|Overall Study|Lost to Follow-up|2|||
23155081|NCT03083847|64318862|FG009|Main|Withdrawal by Subject|0|||
23221423|NCT02996500|64553674|FG001|Overall Study|Other|0|||
23155082|NCT00853749|64318863|FG000|Overall Study|Lost to Follow-up|0|||
23155083|NCT00853749|64318864|FG001|Overall Study|Lost to Follow-up|1|||
23155084|NCT01846624|64318867|FG000|Overall Study|Died during induction, no midostaurin|1|||
23155085|NCT01809132|64318868|FG000|Overall Study|Withdrawal by Subject|0|||
23155086|NCT01809132|64318869|FG001|Overall Study|Withdrawal by Subject|0|||
23155087|NCT01809132|64318870|FG002|Overall Study|Withdrawal by Subject|1|||
23155088|NCT01379573|64318871|FG000|Overall Study|Lost to Follow-up|1|||
23155089|NCT01379573|64318871|FG000|Overall Study|Screen Failure|10|||
23155090|NCT00454857|64318872|FG000|Overall Study|Withdrawal by Subject|15|||
23155091|NCT00454857|64318872|FG000|Overall Study|Lost to Follow-up|16|||
23155092|NCT00454857|64318872|FG000|Overall Study|Noncompliance|6|||
23155093|NCT00454857|64318872|FG000|Overall Study|Death|5|||
23155094|NCT00454857|64318872|FG000|Overall Study|Other|11|||
23155095|NCT00454857|64318872|FG000|Overall Study|Reason unknown|1|||
23155096|NCT02767323|64318873|FG000|Overall Study|Withdrawal by Subject|17|||
23155097|NCT02767323|64318874|FG001|Overall Study|Withdrawal by Subject|5|||
23155098|NCT02767323|64318875|FG002|Overall Study|Withdrawal by Subject|13|||
23155099|NCT02767323|64318876|FG003|Overall Study|Withdrawal by Subject|0|||
23155100|NCT02767323|64318873|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
23155101|NCT02767323|64318874|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
23155102|NCT02767323|64318875|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
23155103|NCT02767323|64318876|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
23155104|NCT01717287|64318879|FG000|Overall Study|Lost to Follow-up|0|||
23155105|NCT01717287|64318880|FG001|Overall Study|Lost to Follow-up|2|||
23155106|NCT01717287|64318879|FG000|Overall Study|Protocol Violation|0|||
23155107|NCT01717287|64318880|FG001|Overall Study|Protocol Violation|1|||
23155108|NCT03086057|64318883|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
23155109|NCT03086057|64318884|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
23155110|NCT03086057|64318885|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
23155111|NCT03086057|64318886|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
23155112|NCT03086057|64318883|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
23155113|NCT03086057|64318884|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
23155114|NCT03086057|64318885|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
23155115|NCT03086057|64318886|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
23155116|NCT03086057|64318883|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
23155117|NCT03086057|64318884|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
23155118|NCT03086057|64318885|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
23155119|NCT03086057|64318886|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
23155120|NCT03086057|64318883|FG000|Stage 1: PrEP Uptake|Death|1|||
23155121|NCT03086057|64318884|FG001|Stage 1: PrEP Uptake|Death|0|||
23155122|NCT03086057|64318885|FG002|Stage 1: PrEP Uptake|Death|0|||
23155123|NCT03086057|64318886|FG003|Stage 1: PrEP Uptake|Death|0|||
23155124|NCT03086057|64318883|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
23155125|NCT03086057|64318884|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
23155126|NCT03086057|64318885|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
23155127|NCT03086057|64318886|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
23155128|NCT03086057|64318883|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
23155129|NCT03086057|64318884|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
23155130|NCT03086057|64318885|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
23155131|NCT03086057|64318886|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
23155132|NCT03086057|64318883|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
23155133|NCT03086057|64318884|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
23155134|NCT03086057|64318885|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
23155135|NCT03086057|64318886|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
23155136|NCT02873936|64318887|FG000|Overall Study|Withdrew Consent|4|||
23155137|NCT02873936|64318888|FG001|Overall Study|Withdrew Consent|11|||
23155138|NCT02873936|64318889|FG002|Overall Study|Withdrew Consent|20|||
23155139|NCT02873936|64318887|FG000|Overall Study|Investigator's Discretion|3|||
23155140|NCT02873936|64318888|FG001|Overall Study|Investigator's Discretion|5|||
23155141|NCT02873936|64318889|FG002|Overall Study|Investigator's Discretion|4|||
23221424|NCT02996500|64553675|FG002|Overall Study|Other|2|||
23221425|NCT02996500|64553676|FG003|Overall Study|Other|0|||
23221426|NCT02996500|64553677|FG004|Overall Study|Other|0|||
23221427|NCT02996500|64553678|FG005|Overall Study|Other|0|||
23155142|NCT02873936|64318887|FG000|Overall Study|Adverse Event|3|||
23155143|NCT02873936|64318888|FG001|Overall Study|Adverse Event|5|||
23155144|NCT02873936|64318889|FG002|Overall Study|Adverse Event|3|||
23221428|NCT02996500|64553673|FG000|Overall Study|Protocol Violation|0|||
23221429|NCT02996500|64553674|FG001|Overall Study|Protocol Violation|0|||
23155145|NCT02873936|64318887|FG000|Overall Study|Protocol Violation|0|||
23155146|NCT02873936|64318888|FG001|Overall Study|Protocol Violation|1|||
23155147|NCT02873936|64318889|FG002|Overall Study|Protocol Violation|3|||
23221430|NCT02996500|64553675|FG002|Overall Study|Protocol Violation|0|||
23221431|NCT02996500|64553676|FG003|Overall Study|Protocol Violation|1|||
23155148|NCT02873936|64318887|FG000|Overall Study|Lost to Follow-up|1|||
23221432|NCT02996500|64553677|FG004|Overall Study|Protocol Violation|0|||
23221433|NCT02996500|64553678|FG005|Overall Study|Protocol Violation|0|||
23221434|NCT02996500|64553673|FG000|Overall Study|Withdrawal by Subject|3|||
23221435|NCT02996500|64553674|FG001|Overall Study|Withdrawal by Subject|0|||
23221436|NCT02996500|64553675|FG002|Overall Study|Withdrawal by Subject|3|||
23221437|NCT02996500|64553676|FG003|Overall Study|Withdrawal by Subject|0|||
23221438|NCT02996500|64553677|FG004|Overall Study|Withdrawal by Subject|2|||
23221439|NCT02996500|64553678|FG005|Overall Study|Withdrawal by Subject|0|||
23221440|NCT01117181|64553679|FG000|Overall Study|Lost to Follow-up|1|||
23221441|NCT01117181|64553680|FG001|Overall Study|Lost to Follow-up|0|||
23221442|NCT01117181|64553679|FG000|Overall Study|Withdrawal by Subject|0|||
23221443|NCT01117181|64553680|FG001|Overall Study|Withdrawal by Subject|2|||
23221444|NCT00712270|64553681|FG000|Overall Study|Withdrawal by Subject|11|||
23221445|NCT00712270|64553681|FG000|Overall Study|Screen Failure|3|||
23221446|NCT01235507|64553682|FG000|Overall Study|Adverse Event|1|||
23221447|NCT01235507|64553682|FG000|Overall Study|Withdrawal by Subject|1|||
23221448|NCT04728815|64553684|FG000|Overall Study|Lost to Follow-up|3|||
23221449|NCT04728815|64553685|FG001|Overall Study|Lost to Follow-up|0|||
23155149|NCT02873936|64318888|FG001|Overall Study|Lost to Follow-up|1|||
23442288|NCT01510158|65362021|FG001|Overall Study|Sponsor terminated study.|0|||
23442289|NCT01510158|65362022|FG002|Overall Study|Sponsor terminated study.|2|||
23442290|NCT01510158|65362020|FG000|Overall Study|Lost to Follow-up|13|||
23155150|NCT02873936|64318889|FG002|Overall Study|Lost to Follow-up|1|||
23155151|NCT02873936|64318887|FG000|Overall Study|Non-compliance With Study Drug|1|||
23155152|NCT02873936|64318888|FG001|Overall Study|Non-compliance With Study Drug|0|||
23155153|NCT02873936|64318889|FG002|Overall Study|Non-compliance With Study Drug|1|||
23155154|NCT02873936|64318887|FG000|Overall Study|Randomized but not Dosed|1|||
23155155|NCT02873936|64318888|FG001|Overall Study|Randomized but not Dosed|0|||
23155156|NCT02873936|64318889|FG002|Overall Study|Randomized but not Dosed|0|||
23155157|NCT00711425|64318890|FG000|Overall Study|Protocol Violation|1|||
23155158|NCT00711425|64318890|FG000|Overall Study|Death|2|||
23155159|NCT00711425|64318890|FG000|Overall Study|Lost to Follow-up|1|||
23155160|NCT01816061|64321909|FG000|Overall Study|Lost to Follow-up|13|||
23155161|NCT01816061|64321910|FG001|Overall Study|Lost to Follow-up|24|||
23155162|NCT04196803|64321911|FG000|Overall Study|Withdrawal by Subject|1|||
23155163|NCT04196803|64321912|FG001|Overall Study|Withdrawal by Subject|3|||
23155164|NCT04196803|64321911|FG000|Overall Study|Adverse Event|4|||
23155165|NCT04196803|64321912|FG001|Overall Study|Adverse Event|2|||
23155166|NCT04196803|64321911|FG000|Overall Study|Lost to Follow-up|0|||
23155167|NCT04196803|64321912|FG001|Overall Study|Lost to Follow-up|1|||
23155168|NCT03021499|64321915|FG000|Overall Study|Adverse Event|1|||
23155169|NCT03021499|64321916|FG001|Overall Study|Adverse Event|0|||
23155170|NCT03021499|64321915|FG000|Overall Study|Death|1|||
23155171|NCT03021499|64321916|FG001|Overall Study|Death|5|||
23155172|NCT03021499|64321915|FG000|Overall Study|Lack of Efficacy|0|||
23155173|NCT03021499|64321916|FG001|Overall Study|Lack of Efficacy|1|||
23155174|NCT03021499|64321915|FG000|Overall Study|Lost to Follow-up|1|||
23155175|NCT03021499|64321916|FG001|Overall Study|Lost to Follow-up|3|||
23155176|NCT03021499|64321915|FG000|Overall Study|Physician Decision|2|||
23155177|NCT03021499|64321916|FG001|Overall Study|Physician Decision|3|||
23155178|NCT03021499|64321915|FG000|Overall Study|Pregnancy|1|||
23155179|NCT03021499|64321916|FG001|Overall Study|Pregnancy|0|||
23155180|NCT03021499|64321915|FG000|Overall Study|Withdrawal by Subject|7|||
23155181|NCT03021499|64321916|FG001|Overall Study|Withdrawal by Subject|14|||
23155182|NCT03021499|64321915|FG000|Overall Study|Prohibited medication required|1|||
23155183|NCT03021499|64321916|FG001|Overall Study|Prohibited medication required|0|||
23155184|NCT03021499|64321915|FG000|Overall Study|Protocol non-compliance|1|||
23155185|NCT03021499|64321916|FG001|Overall Study|Protocol non-compliance|1|||
23155186|NCT03021499|64321915|FG000|Overall Study|None of the above|0|||
23155187|NCT03021499|64321916|FG001|Overall Study|None of the above|4|||
23155188|NCT03021499|64321915|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
23155189|NCT03021499|64321916|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
23155190|NCT02953639|64321921|FG000|Overall Study|Adverse Event|2|||
23155191|NCT02953639|64321922|FG001|Overall Study|Adverse Event|0|||
23155192|NCT02953639|64321923|FG002|Overall Study|Adverse Event|1|||
23221450|NCT04728815|64553686|FG002|Overall Study|Lost to Follow-up|0|||
23442291|NCT01510158|65362021|FG001|Overall Study|Lost to Follow-up|16|||
23155193|NCT02953639|64321921|FG000|Overall Study|Lost to Follow-up|8|||
23155194|NCT02953639|64321922|FG001|Overall Study|Lost to Follow-up|4|||
23221451|NCT04728815|64553687|FG003|Overall Study|Lost to Follow-up|1|||
23221452|NCT04728815|64553688|FG004|Overall Study|Lost to Follow-up|1|||
23442292|NCT01510158|65362022|FG002|Overall Study|Lost to Follow-up|9|||
23155195|NCT02953639|64321923|FG002|Overall Study|Lost to Follow-up|3|||
23155196|NCT02953639|64321921|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23155197|NCT02953639|64321922|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23155198|NCT02953639|64321923|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23155199|NCT02953639|64321921|FG000|Overall Study|Multiple Reasons|1|||
23221453|NCT04728815|64553689|FG005|Overall Study|Lost to Follow-up|0|||
23221454|NCT04728815|64553690|FG006|Overall Study|Lost to Follow-up|2|||
23155200|NCT02953639|64321922|FG001|Overall Study|Multiple Reasons|0|||
23155201|NCT02953639|64321923|FG002|Overall Study|Multiple Reasons|1|||
23155202|NCT02953639|64321921|FG000|Overall Study|Physician Decision|1|||
23155203|NCT02953639|64321922|FG001|Overall Study|Physician Decision|0|||
23155204|NCT02953639|64321923|FG002|Overall Study|Physician Decision|0|||
23155205|NCT02953639|64321921|FG000|Overall Study|Withdrawal by Subject|7|||
23155206|NCT02953639|64321922|FG001|Overall Study|Withdrawal by Subject|8|||
23155207|NCT02953639|64321923|FG002|Overall Study|Withdrawal by Subject|10|||
23155208|NCT02953639|64321921|FG000|Overall Study|Completed or Discontinued information is missing|1|||
23155209|NCT02953639|64321922|FG001|Overall Study|Completed or Discontinued information is missing|0|||
23155210|NCT02953639|64321923|FG002|Overall Study|Completed or Discontinued information is missing|0|||
23155211|NCT03677596|64321925|FG000|Overall Study|Adverse Event|0|||
23155212|NCT03677596|64321926|FG001|Overall Study|Adverse Event|1|||
23155213|NCT03677596|64321925|FG000|Overall Study|Death|10|||
23155214|NCT03677596|64321926|FG001|Overall Study|Death|6|||
23155215|NCT03677596|64321925|FG000|Overall Study|Lost to Follow-up|0|||
23155216|NCT03677596|64321926|FG001|Overall Study|Lost to Follow-up|1|||
23155217|NCT03677596|64321925|FG000|Overall Study|Progressive Disease|8|||
23155218|NCT03677596|64321926|FG001|Overall Study|Progressive Disease|8|||
23155219|NCT03677596|64321925|FG000|Overall Study|Withdrawal by Subject|3|||
23155220|NCT03677596|64321926|FG001|Overall Study|Withdrawal by Subject|0|||
23155221|NCT03677596|64321925|FG000|Overall Study|Disease Relapse|2|||
23155222|NCT03677596|64321926|FG001|Overall Study|Disease Relapse|2|||
23155223|NCT03677596|64321925|FG000|Overall Study|Other|0|||
23155224|NCT03677596|64321926|FG001|Overall Study|Other|1|||
23155225|NCT03574753|64321927|FG000|Overall Study|Adverse Event|3|||
23155226|NCT03574753|64321927|FG000|Overall Study|Progression/relapse|19|||
23155227|NCT03574753|64321927|FG000|Overall Study|Death|1|||
23155228|NCT03838198|64321928|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
23327502|NCT03918629|64940928|FG000|Overall Study|Adverse Event|19|||
23155229|NCT03838198|64321929|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
23155230|NCT03838198|64321930|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
23155231|NCT03838198|64321931|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
23155232|NCT03838198|64321928|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
23155233|NCT03838198|64321929|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
23155234|NCT03838198|64321930|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
23155235|NCT03838198|64321931|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
23155236|NCT01279850|64321934|FG000|Overall Study|Protocol Violation|50|||
23155237|NCT01279850|64321934|FG000|Overall Study|No Drug Administration Information|7|||
23155238|NCT01279850|64321934|FG000|Overall Study|No Visit After Treatment|34|||
23155239|NCT00102960|64321937|FG000|Overall Study|Death|23|||
23155240|NCT00102960|64321938|FG001|Overall Study|Death|11|||
23155241|NCT00102960|64321939|FG002|Overall Study|Death|11|||
23155242|NCT00102960|64321937|FG000|Overall Study|Lost to Follow-up|6|||
23221455|NCT04728815|64553691|FG007|Overall Study|Lost to Follow-up|0|||
23327503|NCT03918629|64940929|FG001|Overall Study|Adverse Event|20|||
23327504|NCT03918629|64940928|FG000|Overall Study|Death|14|||
23442293|NCT01510158|65362020|FG000|Overall Study|Withdrawal by Subject|10|||
23442294|NCT01510158|65362021|FG001|Overall Study|Withdrawal by Subject|13|||
23442295|NCT01510158|65362022|FG002|Overall Study|Withdrawal by Subject|10|||
23442296|NCT01510158|65362020|FG000|Overall Study|Death|1|||
23442297|NCT01510158|65362021|FG001|Overall Study|Death|0|||
23442298|NCT01510158|65362022|FG002|Overall Study|Death|0|||
23442299|NCT03521141|65362037|FG000|Overall Study|Death|1|||
23442300|NCT03521141|65362038|FG001|Overall Study|Death|0|||
23442301|NCT03521141|65362039|FG002|Overall Study|Death|1|||
23442302|NCT02926638|65362040|FG000|Overall Study|Progression|2|||
23442303|NCT02926638|65362041|FG001|Overall Study|Progression|5|||
23442304|NCT02926638|65362040|FG000|Overall Study|Ineligible|1|||
23442305|NCT02926638|65362041|FG001|Overall Study|Ineligible|0|||
23442306|NCT02926638|65362040|FG000|Overall Study|Not protocol specified|1|||
23442307|NCT02926638|65362041|FG001|Overall Study|Not protocol specified|0|||
23442308|NCT02703324|65362042|FG000|Period Two|Withdrawal by Subject|0|||
23565409|NCT02961881|65799630|FG002|Overall Study|Participant request|0|||
23565410|NCT02961881|65799631|FG003|Overall Study|Participant request|0|||
23565411|NCT02961881|65799632|FG004|Overall Study|Participant request|0|||
23155243|NCT00102960|64321938|FG001|Overall Study|Lost to Follow-up|12|||
23155244|NCT00102960|64321939|FG002|Overall Study|Lost to Follow-up|16|||
23155245|NCT00102960|64321937|FG000|Overall Study|Withdrawal by Subject|1|||
23155246|NCT00102960|64321938|FG001|Overall Study|Withdrawal by Subject|0|||
23155247|NCT00102960|64321939|FG002|Overall Study|Withdrawal by Subject|1|||
23155248|NCT05038020|64321940|FG000|Overall Study|Early Termination|3|||
23155249|NCT05038020|64321941|FG001|Overall Study|Early Termination|0|||
23442309|NCT02703324|65362043|FG001|Period Two|Withdrawal by Subject|0|||
23442310|NCT02703324|65362044|FG002|Period Two|Withdrawal by Subject|1|||
23565412|NCT02961881|65799628|FG000|Overall Study|Disease progression|1|||
23442311|NCT02703324|65362045|FG003|Period Two|Withdrawal by Subject|0|||
23442312|NCT02703324|65362046|FG004|Period Two|Withdrawal by Subject|0|||
23442313|NCT02703324|65362047|FG005|Period Two|Withdrawal by Subject|0|||
23442314|NCT00713544|65362048|FG000|Overall Study|Adverse Event|5|||
23442315|NCT00713544|65362049|FG001|Overall Study|Adverse Event|3|||
23442316|NCT00713544|65362050|FG002|Overall Study|Adverse Event|7|||
23442317|NCT00713544|65362051|FG003|Overall Study|Adverse Event|7|||
23442318|NCT00713544|65362052|FG004|Overall Study|Adverse Event|3|||
23442319|NCT00713544|65362053|FG005|Overall Study|Adverse Event|5|||
23442320|NCT00713544|65362048|FG000|Overall Study|Withdrawal by Subject|2|||
23442321|NCT00713544|65362049|FG001|Overall Study|Withdrawal by Subject|0|||
23442322|NCT00713544|65362050|FG002|Overall Study|Withdrawal by Subject|3|||
23442323|NCT00713544|65362051|FG003|Overall Study|Withdrawal by Subject|2|||
23442324|NCT00713544|65362052|FG004|Overall Study|Withdrawal by Subject|3|||
23442325|NCT00713544|65362053|FG005|Overall Study|Withdrawal by Subject|1|||
23442326|NCT00713544|65362048|FG000|Overall Study|Protocol Violation|0|||
23442327|NCT00713544|65362049|FG001|Overall Study|Protocol Violation|0|||
23442328|NCT00713544|65362050|FG002|Overall Study|Protocol Violation|0|||
23442329|NCT00713544|65362051|FG003|Overall Study|Protocol Violation|0|||
23442330|NCT00713544|65362052|FG004|Overall Study|Protocol Violation|0|||
23442331|NCT00713544|65362053|FG005|Overall Study|Protocol Violation|1|||
23442332|NCT00713544|65362048|FG000|Overall Study|Physician Decision|0|||
23442333|NCT00713544|65362049|FG001|Overall Study|Physician Decision|0|||
23442334|NCT00713544|65362050|FG002|Overall Study|Physician Decision|0|||
23442335|NCT00713544|65362051|FG003|Overall Study|Physician Decision|0|||
23442336|NCT00713544|65362052|FG004|Overall Study|Physician Decision|0|||
23155250|NCT00228566|64321942|FG000|Overall Study|Adverse Event|31|||
23155251|NCT00228566|64321942|FG000|Overall Study|Lack of Efficacy|14|||
23155252|NCT00228566|64321942|FG000|Overall Study|Lost to Follow-up|16|||
23155253|NCT00228566|64321942|FG000|Overall Study|Physician Decision|5|||
23155254|NCT00228566|64321942|FG000|Overall Study|Withdrawal by Subject|4|||
23155255|NCT00228566|64321942|FG000|Overall Study|Miscellaneous|1|||
23442337|NCT00713544|65362053|FG005|Overall Study|Physician Decision|2|||
23442338|NCT00713544|65362048|FG000|Overall Study|Lack of Efficacy|0|||
23442339|NCT00713544|65362049|FG001|Overall Study|Lack of Efficacy|1|||
23442340|NCT00713544|65362050|FG002|Overall Study|Lack of Efficacy|0|||
23442341|NCT00713544|65362051|FG003|Overall Study|Lack of Efficacy|1|||
23442342|NCT00713544|65362052|FG004|Overall Study|Lack of Efficacy|1|||
23442343|NCT00713544|65362053|FG005|Overall Study|Lack of Efficacy|0|||
23442344|NCT00713544|65362048|FG000|Overall Study|Lost to Follow-up|0|||
23442345|NCT00713544|65362049|FG001|Overall Study|Lost to Follow-up|0|||
23442346|NCT00713544|65362050|FG002|Overall Study|Lost to Follow-up|1|||
23442347|NCT00713544|65362051|FG003|Overall Study|Lost to Follow-up|0|||
23442348|NCT00713544|65362052|FG004|Overall Study|Lost to Follow-up|0|||
23442349|NCT00713544|65362053|FG005|Overall Study|Lost to Follow-up|0|||
23442350|NCT00713544|65362048|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442351|NCT00713544|65362049|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
23442352|NCT00713544|65362050|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442353|NCT00713544|65362051|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442354|NCT00713544|65362052|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442355|NCT00713544|65362053|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
23442356|NCT00713544|65362048|FG000|Overall Study|Incorrect enrollment|0|||
23442357|NCT00713544|65362049|FG001|Overall Study|Incorrect enrollment|1|||
23442358|NCT00713544|65362050|FG002|Overall Study|Incorrect enrollment|0|||
23442359|NCT00713544|65362051|FG003|Overall Study|Incorrect enrollment|0|||
23442360|NCT00713544|65362052|FG004|Overall Study|Incorrect enrollment|0|||
23442361|NCT00713544|65362053|FG005|Overall Study|Incorrect enrollment|0|||
23442362|NCT00713544|65362048|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
23442363|NCT00713544|65362049|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
23442364|NCT00713544|65362050|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
23442365|NCT00713544|65362051|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
23442366|NCT00713544|65362052|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
23442367|NCT00713544|65362053|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
23442368|NCT03416127|65362054|FG000|Overall Study|Withdrawal by Subject|0|||
23627568|NCT01090011|66024503|FG000|Overall Study|Progressive disease|128|||
23627569|NCT01090011|66024503|FG000|Overall Study|Adverse Event|32|||
23627570|NCT01090011|66024503|FG000|Overall Study|Protocol Violation|1|||
23155256|NCT00754793|64321943|FG000|Overall Study|voluntary withdrawn from study|0|||
23155257|NCT00754793|64321944|FG001|Overall Study|voluntary withdrawn from study|1|||
23627571|NCT01090011|66024503|FG000|Overall Study|Refusal to start/continue medication|5|||
23155258|NCT00117507|64321945|FG000|Overall Study|Adverse Event|4|||
23442369|NCT03416127|65362055|FG001|Overall Study|Withdrawal by Subject|1|||
23442370|NCT03416127|65362056|FG002|Overall Study|Withdrawal by Subject|1|||
23442371|NCT00532298|65362057|FG000|Overall Study|Adverse Event|1|||
23442372|NCT00532298|65362058|FG001|Overall Study|Adverse Event|0|||
23442373|NCT00532298|65362059|FG002|Overall Study|Adverse Event|0|||
23442374|NCT00532298|65362060|FG003|Overall Study|Adverse Event|0|||
23442375|NCT00532298|65362061|FG004|Overall Study|Adverse Event|1|||
23442376|NCT00532298|65362062|FG005|Overall Study|Adverse Event|1|||
23442377|NCT00532298|65362057|FG000|Overall Study|Lost to Follow-up|1|||
23442378|NCT00532298|65362058|FG001|Overall Study|Lost to Follow-up|1|||
23442379|NCT00532298|65362059|FG002|Overall Study|Lost to Follow-up|1|||
23442380|NCT00532298|65362060|FG003|Overall Study|Lost to Follow-up|0|||
23221456|NCT04728815|64553684|FG000|Overall Study|Physician Decision|0|||
23221457|NCT04728815|64553685|FG001|Overall Study|Physician Decision|0|||
23221458|NCT04728815|64553686|FG002|Overall Study|Physician Decision|1|||
23221459|NCT04728815|64553687|FG003|Overall Study|Physician Decision|0|||
23221460|NCT04728815|64553688|FG004|Overall Study|Physician Decision|0|||
23221461|NCT04728815|64553689|FG005|Overall Study|Physician Decision|0|||
23221462|NCT04728815|64553690|FG006|Overall Study|Physician Decision|0|||
23221463|NCT04728815|64553691|FG007|Overall Study|Physician Decision|0|||
23221464|NCT04728815|64553684|FG000|Overall Study|Treatment drop|0|||
23221465|NCT04728815|64553685|FG001|Overall Study|Treatment drop|2|||
23221466|NCT04728815|64553686|FG002|Overall Study|Treatment drop|1|||
23221467|NCT04728815|64553687|FG003|Overall Study|Treatment drop|0|||
23221468|NCT04728815|64553688|FG004|Overall Study|Treatment drop|3|||
23221469|NCT04728815|64553689|FG005|Overall Study|Treatment drop|1|||
23221470|NCT04728815|64553690|FG006|Overall Study|Treatment drop|3|||
23221471|NCT04728815|64553691|FG007|Overall Study|Treatment drop|0|||
23442381|NCT00532298|65362061|FG004|Overall Study|Lost to Follow-up|0|||
23442382|NCT00532298|65362062|FG005|Overall Study|Lost to Follow-up|1|||
23442383|NCT00103740|65362064|FG000|Period 1 - Core|Adverse Event|1|||
23442384|NCT00103740|65362065|FG001|Period 1 - Core|Adverse Event|0|||
23442385|NCT00103740|65362064|FG000|Period 1 - Core|Protocol Violation|3|||
23155259|NCT00117507|64321945|FG000|Overall Study|Abnormal laboratory values|3|||
23155260|NCT00117507|64321945|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23155261|NCT00117507|64321945|FG000|Overall Study|Patient withdrew consent|4|||
23155262|NCT00117507|64321945|FG000|Overall Study|Death|3|||
23155263|NCT03349099|64321946|FG000|Overall Study|Physician Decision|3|||
23155264|NCT03349099|64321947|FG001|Overall Study|Physician Decision|4|||
23155265|NCT03349099|64321946|FG000|Overall Study|Stone migrated from the kidney|1|||
23155266|NCT03349099|64321947|FG001|Overall Study|Stone migrated from the kidney|0|||
23155267|NCT01011439|64321948|FG000|Overall Study|Death|37|||
23442386|NCT00103740|65362065|FG001|Period 1 - Core|Protocol Violation|2|||
23442387|NCT00103740|65362064|FG000|Period 1 - Core|Patient withdrew consent|3|||
23442388|NCT00103740|65362065|FG001|Period 1 - Core|Patient withdrew consent|2|||
23442389|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
23442390|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
23442391|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
23442392|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
23442393|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
23442394|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
23442395|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Death|6|||
23442396|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Death|2|||
23442397|NCT00103740|65362064|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
23442398|NCT00103740|65362065|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
23442399|NCT00466921|65362068|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
23442400|NCT00466921|65362068|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
23442401|NCT00466921|65362068|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
23442402|NCT00466921|65362068|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
23442403|NCT00466921|65362068|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
23442404|NCT00466921|65362068|FG000|Follow up for a Minimum of 1 Year|Death|6|||
23442405|NCT00847886|65362070|FG000|Overall Study|Adverse Event|0|||
23442406|NCT00847886|65362071|FG001|Overall Study|Adverse Event|1|||
23442407|NCT00719355|65362072|FG000|Overall Study|Death|0|||
23442408|NCT00719355|65362073|FG001|Overall Study|Death|1|||
23442409|NCT00719355|65362072|FG000|Overall Study|Medical|14|||
23442410|NCT00719355|65362073|FG001|Overall Study|Medical|5|||
23442411|NCT00719355|65362072|FG000|Overall Study|Compliance|4|||
23442412|NCT00719355|65362073|FG001|Overall Study|Compliance|6|||
23155268|NCT01011439|64321948|FG000|Overall Study|Lost to Follow-up|4|||
23155269|NCT01011439|64321948|FG000|Overall Study|Withdrawal by Subject|1|||
23221472|NCT04728815|64553684|FG000|Overall Study|Study drop|0|||
23221473|NCT04728815|64553685|FG001|Overall Study|Study drop|3|||
23221474|NCT04728815|64553686|FG002|Overall Study|Study drop|3|||
23221475|NCT04728815|64553687|FG003|Overall Study|Study drop|0|||
23221476|NCT04728815|64553688|FG004|Overall Study|Study drop|0|||
23221477|NCT04728815|64553689|FG005|Overall Study|Study drop|0|||
23221478|NCT04728815|64553690|FG006|Overall Study|Study drop|7|||
23221479|NCT04728815|64553691|FG007|Overall Study|Study drop|0|||
23442413|NCT00719355|65362072|FG000|Overall Study|Moved|0|||
23442414|NCT00719355|65362073|FG001|Overall Study|Moved|1|||
23442415|NCT03301350|65362074|FG000|Overall Study|Withdrawal by Subject|4|||
23442416|NCT03301350|65362074|FG000|Overall Study|Adverse Event|1|||
23221480|NCT04228445|64553694|FG000|Overall Study|Lost to Follow-up|1|||
23221481|NCT04228445|64553695|FG001|Overall Study|Lost to Follow-up|1|||
23221482|NCT04228445|64553694|FG000|Overall Study|Physician Decision|1|||
23221483|NCT04228445|64553695|FG001|Overall Study|Physician Decision|2|||
23221484|NCT04228445|64553694|FG000|Overall Study|Withdrawal by Subject|0|||
23221485|NCT04228445|64553695|FG001|Overall Study|Withdrawal by Subject|1|||
23221486|NCT04228445|64553694|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
23221487|NCT04228445|64553695|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
23221488|NCT02959970|64553696|FG000|Overall Study|Adverse Event|1|||
23221489|NCT02959970|64553697|FG001|Overall Study|Adverse Event|0|||
23221490|NCT02959970|64553696|FG000|Overall Study|Withdrawal by Subject|0|||
23221491|NCT02959970|64553697|FG001|Overall Study|Withdrawal by Subject|2|||
23327505|NCT03918629|64940929|FG001|Overall Study|Death|7|||
23565413|NCT02961881|65799629|FG001|Overall Study|Disease progression|0|||
23565414|NCT02961881|65799630|FG002|Overall Study|Disease progression|1|||
23565415|NCT02961881|65799631|FG003|Overall Study|Disease progression|0|||
23565416|NCT02961881|65799632|FG004|Overall Study|Disease progression|0|||
23565417|NCT03002038|65799633|FG000|Overall Study|Adverse Event|3|||
23565418|NCT03002038|65799634|FG001|Overall Study|Adverse Event|1|||
23565419|NCT03002038|65799633|FG000|Overall Study|Withdrawal by Subject|8|||
23565420|NCT03002038|65799634|FG001|Overall Study|Withdrawal by Subject|4|||
23565421|NCT03002038|65799633|FG000|Overall Study|Immigration to another region|0|||
23565422|NCT03002038|65799634|FG001|Overall Study|Immigration to another region|2|||
23565423|NCT03406702|65799637|FG000|Overall Study|Missed Day 27 Dosing|1|||
23565424|NCT02002182|65799641|FG000|Overall Study|Withdraw from study|3|||
23565425|NCT02002182|65799642|FG001|Overall Study|Withdraw from study|1|||
23565426|NCT02002182|65799641|FG000|Overall Study|Health Reasons|1|||
23565427|NCT02002182|65799642|FG001|Overall Study|Health Reasons|0|||
23565428|NCT02002182|65799641|FG000|Overall Study|Death|1|||
23565429|NCT02002182|65799642|FG001|Overall Study|Death|0|||
23565430|NCT02714868|65799643|FG000|Overall Study|Withdrawal by Subject|3|||
23565431|NCT02714868|65799644|FG001|Overall Study|Withdrawal by Subject|0|||
23565432|NCT02714868|65799643|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
23565433|NCT02714868|65799644|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
23565434|NCT02714868|65799643|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
23565435|NCT02714868|65799644|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
23565436|NCT01054573|65799653|FG000|Overall Study|Adverse Event|1|||
23565437|NCT01054573|65799654|FG001|Overall Study|Adverse Event|0|||
23565438|NCT01054573|65799655|FG002|Overall Study|Adverse Event|1|||
23565439|NCT01054573|65799656|FG003|Overall Study|Adverse Event|1|||
23565440|NCT01054573|65799653|FG000|Overall Study|Lost to Follow-up|0|||
23565441|NCT01054573|65799654|FG001|Overall Study|Lost to Follow-up|2|||
23565442|NCT01054573|65799655|FG002|Overall Study|Lost to Follow-up|0|||
23565443|NCT01054573|65799656|FG003|Overall Study|Lost to Follow-up|0|||
23565444|NCT01054573|65799653|FG000|Overall Study|Withdrawal by Subject|0|||
23565445|NCT01054573|65799654|FG001|Overall Study|Withdrawal by Subject|2|||
23565446|NCT01054573|65799655|FG002|Overall Study|Withdrawal by Subject|2|||
23565447|NCT01054573|65799656|FG003|Overall Study|Withdrawal by Subject|1|||
23565448|NCT04704154|65799663|FG000|Overall Study|Adverse Event|2|||
23565449|NCT04704154|65799664|FG001|Overall Study|Adverse Event|1|||
23565450|NCT04704154|65799665|FG002|Overall Study|Adverse Event|3|||
23565451|NCT04704154|65799666|FG003|Overall Study|Adverse Event|2|||
23565452|NCT04704154|65799667|FG004|Overall Study|Adverse Event|3|||
23565453|NCT04704154|65799668|FG005|Overall Study|Adverse Event|0|||
23565454|NCT04704154|65799663|FG000|Overall Study|Death|3|||
23565455|NCT04704154|65799664|FG001|Overall Study|Death|0|||
23565456|NCT04704154|65799665|FG002|Overall Study|Death|0|||
23565457|NCT04704154|65799666|FG003|Overall Study|Death|0|||
23565458|NCT04704154|65799667|FG004|Overall Study|Death|3|||
23565459|NCT04704154|65799668|FG005|Overall Study|Death|0|||
23565460|NCT04704154|65799663|FG000|Overall Study|Physician Decision|1|||
23565461|NCT04704154|65799664|FG001|Overall Study|Physician Decision|0|||
23565462|NCT04704154|65799665|FG002|Overall Study|Physician Decision|0|||
23565463|NCT04704154|65799666|FG003|Overall Study|Physician Decision|0|||
23565464|NCT04704154|65799667|FG004|Overall Study|Physician Decision|1|||
23565465|NCT04704154|65799668|FG005|Overall Study|Physician Decision|0|||
23565466|NCT04704154|65799663|FG000|Overall Study|Participant Decision|1|||
23565467|NCT04704154|65799664|FG001|Overall Study|Participant Decision|1|||
23565468|NCT04704154|65799665|FG002|Overall Study|Participant Decision|0|||
23565469|NCT04704154|65799666|FG003|Overall Study|Participant Decision|0|||
23565470|NCT04704154|65799667|FG004|Overall Study|Participant Decision|0|||
23221492|NCT02959970|64553696|FG000|Overall Study|Lost to Follow-up|1|||
23221493|NCT02959970|64553697|FG001|Overall Study|Lost to Follow-up|5|||
23221494|NCT03654560|64553702|FG000|Overall Study|Death|3|||
23565471|NCT04704154|65799668|FG005|Overall Study|Participant Decision|0|||
23565472|NCT04704154|65799663|FG000|Overall Study|Progressive Disease|16|||
23565473|NCT04704154|65799664|FG001|Overall Study|Progressive Disease|17|||
23565474|NCT04704154|65799665|FG002|Overall Study|Progressive Disease|20|||
23442417|NCT03301350|65362074|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
23442418|NCT03301350|65362074|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
23442419|NCT03301350|65362074|FG000|Overall Study|no detail provided|1|||
23442420|NCT00851786|65362075|FG000|Overall Study|Withdrawal by Subject|0|||
23442421|NCT00851786|65362076|FG001|Overall Study|Withdrawal by Subject|1|||
23442422|NCT00851786|65362075|FG000|Overall Study|Protocol Violation|0|||
23442423|NCT00851786|65362076|FG001|Overall Study|Protocol Violation|1|||
23442424|NCT00851786|65362075|FG000|Overall Study|Lost to Follow-up|1|||
23442425|NCT00851786|65362076|FG001|Overall Study|Lost to Follow-up|0|||
23442426|NCT00851786|65362075|FG000|Overall Study|Incarceration|1|||
23442427|NCT00851786|65362076|FG001|Overall Study|Incarceration|0|||
23442428|NCT00851786|65362075|FG000|Overall Study|Site Closure|1|||
23442429|NCT00851786|65362076|FG001|Overall Study|Site Closure|0|||
23442430|NCT00851786|65362075|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
23442431|NCT00851786|65362076|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
23442432|NCT00742183|65362077|FG000|Overall Study|Adverse Event|2|||
23442433|NCT00742183|65362078|FG001|Overall Study|Adverse Event|2|||
23442434|NCT00742183|65362077|FG000|Overall Study|Death|1|||
23442435|NCT00742183|65362078|FG001|Overall Study|Death|0|||
23442436|NCT00742183|65362077|FG000|Overall Study|Physician Decision|0|||
23442437|NCT00742183|65362078|FG001|Overall Study|Physician Decision|2|||
23442438|NCT00742183|65362077|FG000|Overall Study|Lost to Follow-up|4|||
23442439|NCT00742183|65362078|FG001|Overall Study|Lost to Follow-up|4|||
23442440|NCT00742183|65362077|FG000|Overall Study|Required skin-graft|1|||
23442441|NCT00742183|65362078|FG001|Overall Study|Required skin-graft|1|||
23442442|NCT00742183|65362077|FG000|Overall Study|Withdrawal by Subject|1|||
23442443|NCT00742183|65362078|FG001|Overall Study|Withdrawal by Subject|0|||
23442444|NCT00742183|65362077|FG000|Overall Study|Lack of Efficacy|0|||
23442445|NCT00742183|65362078|FG001|Overall Study|Lack of Efficacy|3|||
23442446|NCT03671304|65362079|FG000|Overall Study|study terminated|7|||
23442447|NCT03387020|65362080|FG000|Overall Study|Adverse Event|0|||
23442448|NCT03387020|65362081|FG001|Overall Study|Adverse Event|2|||
23442449|NCT03387020|65362082|FG002|Overall Study|Adverse Event|0|||
23442450|NCT03387020|65362080|FG000|Overall Study|Withdrawal by Subject|2|||
23442451|NCT03387020|65362081|FG001|Overall Study|Withdrawal by Subject|0|||
23442452|NCT03387020|65362082|FG002|Overall Study|Withdrawal by Subject|0|||
23442453|NCT00991939|65362083|FG000|Overall Study|Lost to Follow-up|0|||
23155270|NCT01011439|64321948|FG000|Overall Study|Sponsor's decision|15|||
23155271|NCT04233164|64321952|FG000|Overall Study|Unable to obtain specimen|0|||
23155272|NCT04233164|64321953|FG001|Overall Study|Unable to obtain specimen|1|||
23155273|NCT00003702|64321955|FG000|Overall Study|Ineligible cell types|2|||
23155274|NCT00003702|64321956|FG001|Overall Study|Ineligible cell types|2|||
23155275|NCT00003702|64321955|FG000|Overall Study|Did not meet criteria for persistence|8|||
23155276|NCT00003702|64321956|FG001|Overall Study|Did not meet criteria for persistence|5|||
23442454|NCT00991939|65362084|FG001|Overall Study|Lost to Follow-up|1|||
23442455|NCT00991939|65362083|FG000|Overall Study|Withdrawal by Subject|1|||
23442456|NCT00991939|65362084|FG001|Overall Study|Withdrawal by Subject|0|||
23442457|NCT00991939|65362083|FG000|Overall Study|Entire study terminated|4|||
23155277|NCT00003702|64321955|FG000|Overall Study|WHO score > 6|2|||
23442458|NCT00991939|65362084|FG001|Overall Study|Entire study terminated|1|||
23442459|NCT00348673|65362085|FG000|Stage 1|Randomized but not Treated|0|||
23442460|NCT00348673|65362086|FG001|Stage 1|Randomized but not Treated|0|||
23442461|NCT00348673|65362087|FG002|Stage 1|Randomized but not Treated|1|||
23442462|NCT00348673|65362088|FG003|Stage 1|Randomized but not Treated|0|||
23565475|NCT04704154|65799666|FG003|Overall Study|Progressive Disease|18|||
23565476|NCT04704154|65799667|FG004|Overall Study|Progressive Disease|36|||
23442463|NCT00348673|65362089|FG004|Stage 1|Randomized but not Treated|0|||
23442464|NCT00348673|65362090|FG005|Stage 1|Randomized but not Treated|0|||
23442465|NCT00348673|65362091|FG006|Stage 1|Randomized but not Treated|0|||
23442466|NCT00348673|65362092|FG007|Stage 1|Randomized but not Treated|0|||
23565477|NCT04704154|65799668|FG005|Overall Study|Progressive Disease|30|||
23565478|NCT04704154|65799663|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565479|NCT04704154|65799664|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565480|NCT04704154|65799665|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565481|NCT04704154|65799666|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565482|NCT04704154|65799667|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
23565483|NCT04704154|65799668|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
23565484|NCT01350141|65799669|FG000|Overall Study|Lost to Follow-up|1|||
23565485|NCT01350141|65799670|FG001|Overall Study|Lost to Follow-up|0|||
23565486|NCT01350141|65799671|FG002|Overall Study|Lost to Follow-up|1|||
23565487|NCT01350141|65799669|FG000|Overall Study|Withdrawal by Subject|1|||
23565488|NCT01350141|65799670|FG001|Overall Study|Withdrawal by Subject|0|||
23627572|NCT01090011|66024503|FG000|Overall Study|Other reason not defined above|5|||
23627573|NCT04411186|66024504|FG000|Overall Study|Withdrawn due to protocol violation|0|||
23627574|NCT04411186|66024505|FG001|Overall Study|Withdrawn due to protocol violation|1|||
23627575|NCT01657799|66024506|FG000|Overall Study|Adverse Event Related to progression|6|||
23627576|NCT01657799|66024507|FG001|Overall Study|Adverse Event Related to progression|8|||
23627577|NCT01657799|66024508|FG002|Overall Study|Adverse Event Related to progression|12|||
23627578|NCT01657799|66024506|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
23627579|NCT01657799|66024507|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
23627580|NCT01657799|66024508|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
23627581|NCT01657799|66024506|FG000|Overall Study|Withdrawal by Subject|13|||
23627582|NCT01657799|66024507|FG001|Overall Study|Withdrawal by Subject|10|||
23627583|NCT01657799|66024508|FG002|Overall Study|Withdrawal by Subject|10|||
23627584|NCT01657799|66024506|FG000|Overall Study|Lost to Follow-up|1|||
23627585|NCT01657799|66024507|FG001|Overall Study|Lost to Follow-up|0|||
23627586|NCT01657799|66024508|FG002|Overall Study|Lost to Follow-up|1|||
23627587|NCT01657799|66024506|FG000|Overall Study|Disease Progression|2|||
23627588|NCT01657799|66024507|FG001|Overall Study|Disease Progression|4|||
23627589|NCT01657799|66024508|FG002|Overall Study|Disease Progression|4|||
23627590|NCT01657799|66024506|FG000|Overall Study|Progressive Disease Clinical|7|||
23627591|NCT01657799|66024507|FG001|Overall Study|Progressive Disease Clinical|4|||
23627592|NCT01657799|66024508|FG002|Overall Study|Progressive Disease Clinical|7|||
23627593|NCT01657799|66024506|FG000|Overall Study|Radiographic & Clinical Progression|16|||
23627594|NCT01657799|66024507|FG001|Overall Study|Radiographic & Clinical Progression|11|||
23627595|NCT01657799|66024508|FG002|Overall Study|Radiographic & Clinical Progression|15|||
23627596|NCT01657799|66024506|FG000|Overall Study|Other|52|||
23627597|NCT01657799|66024507|FG001|Overall Study|Other|62|||
23627598|NCT01657799|66024508|FG002|Overall Study|Other|49|||
23627599|NCT00013611|66024513|FG000|Overall Study|Lost to Follow-up|91|||
23627600|NCT00013611|66024514|FG001|Overall Study|Lost to Follow-up|100|||
23627601|NCT00891046|66024515|FG000|Overall Study|Protocol Violation|1|||
23627602|NCT00891046|66024516|FG001|Overall Study|Protocol Violation|1|||
23627603|NCT00891046|66024517|FG002|Overall Study|Protocol Violation|0|||
23627604|NCT00891046|66024518|FG003|Overall Study|Protocol Violation|0|||
23627605|NCT00891046|66024519|FG004|Overall Study|Protocol Violation|1|||
23627606|NCT00891046|66024515|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23627607|NCT00891046|66024516|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23627608|NCT00891046|66024517|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
23627609|NCT00891046|66024518|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
23627610|NCT00891046|66024519|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
23627611|NCT00891046|66024515|FG000|Overall Study|Administrative problems|0|||
23627612|NCT00891046|66024516|FG001|Overall Study|Administrative problems|0|||
23627613|NCT00891046|66024517|FG002|Overall Study|Administrative problems|0|||
23627614|NCT00891046|66024518|FG003|Overall Study|Administrative problems|0|||
23627615|NCT00891046|66024519|FG004|Overall Study|Administrative problems|1|||
23627616|NCT00891046|66024515|FG000|Overall Study|Participant no longer required drug|0|||
23627617|NCT00891046|66024516|FG001|Overall Study|Participant no longer required drug|2|||
23627618|NCT00891046|66024517|FG002|Overall Study|Participant no longer required drug|0|||
23627619|NCT00891046|66024518|FG003|Overall Study|Participant no longer required drug|0|||
23627620|NCT00891046|66024519|FG004|Overall Study|Participant no longer required drug|1|||
23627621|NCT00891046|66024515|FG000|Overall Study|Adverse Event|4|||
23627622|NCT00891046|66024516|FG001|Overall Study|Adverse Event|3|||
23627623|NCT00891046|66024517|FG002|Overall Study|Adverse Event|2|||
23627624|NCT00891046|66024518|FG003|Overall Study|Adverse Event|0|||
23627625|NCT00891046|66024519|FG004|Overall Study|Adverse Event|14|||
23627626|NCT00891046|66024515|FG000|Overall Study|Withdrawal by Subject|2|||
23627627|NCT00891046|66024516|FG001|Overall Study|Withdrawal by Subject|1|||
23627628|NCT00891046|66024517|FG002|Overall Study|Withdrawal by Subject|2|||
23627629|NCT00891046|66024518|FG003|Overall Study|Withdrawal by Subject|1|||
23627630|NCT00891046|66024519|FG004|Overall Study|Withdrawal by Subject|1|||
23627631|NCT00891046|66024515|FG000|Overall Study|Lost to Follow-up|0|||
23627632|NCT00891046|66024516|FG001|Overall Study|Lost to Follow-up|0|||
23627633|NCT00891046|66024517|FG002|Overall Study|Lost to Follow-up|0|||
23155278|NCT00003702|64321956|FG001|Overall Study|WHO score > 6|1|||
23155279|NCT00003702|64321955|FG000|Overall Study|Inadequate documentation of disease|1|||
23155280|NCT00003702|64321956|FG001|Overall Study|Inadequate documentation of disease|3|||
23155281|NCT04163900|64321957|FG000|Overall Study|Radiological disease progression|112|||
23155282|NCT04163900|64321958|FG001|Overall Study|Radiological disease progression|127|||
23627634|NCT00891046|66024518|FG003|Overall Study|Lost to Follow-up|0|||
23627635|NCT00891046|66024519|FG004|Overall Study|Lost to Follow-up|1|||
23627636|NCT00030823|66024520|FG000|Overall Study|Withdrawal by Subject|1|||
23627637|NCT02367352|66024525|FG000|Overall Study|Progressive disease|7|||
23627638|NCT02367352|66024526|FG001|Overall Study|Progressive disease|0|||
23627639|NCT02367352|66024527|FG002|Overall Study|Progressive disease|0|||
23155283|NCT04163900|64321957|FG000|Overall Study|Study closure|98|||
23627640|NCT02367352|66024525|FG000|Overall Study|Participant Received Alternative Therapy|1|||
23155284|NCT04163900|64321958|FG001|Overall Study|Study closure|133|||
23155285|NCT04163900|64321957|FG000|Overall Study|Adverse Event|78|||
23155286|NCT04163900|64321958|FG001|Overall Study|Adverse Event|32|||
23155287|NCT04163900|64321957|FG000|Overall Study|Withdrawal by Subject|37|||
23155288|NCT04163900|64321958|FG001|Overall Study|Withdrawal by Subject|34|||
23155289|NCT04163900|64321957|FG000|Overall Study|Death|29|||
23155290|NCT04163900|64321958|FG001|Overall Study|Death|16|||
23155291|NCT04163900|64321957|FG000|Overall Study|Physician Decision|17|||
23155292|NCT04163900|64321958|FG001|Overall Study|Physician Decision|25|||
23155293|NCT04163900|64321957|FG000|Overall Study|Clinical disease progression|14|||
23155294|NCT04163900|64321958|FG001|Overall Study|Clinical disease progression|13|||
23155295|NCT04163900|64321957|FG000|Overall Study|Protocol Violation|3|||
23155296|NCT04163900|64321958|FG001|Overall Study|Protocol Violation|4|||
23155297|NCT04163900|64321957|FG000|Overall Study|Lost to Follow-up|0|||
23155298|NCT04163900|64321958|FG001|Overall Study|Lost to Follow-up|1|||
23155299|NCT02285998|64321959|FG000|Overall Study|Adverse Event|9|||
23155300|NCT02285998|64321960|FG001|Overall Study|Adverse Event|8|||
23221495|NCT03654560|64553703|FG001|Overall Study|Death|1|||
23221496|NCT03654560|64553702|FG000|Overall Study|Lost to Follow-up|1|||
23327506|NCT03918629|64940928|FG000|Overall Study|Lost to Follow-up|36|||
23627641|NCT02367352|66024526|FG001|Overall Study|Participant Received Alternative Therapy|0|||
23627642|NCT02367352|66024527|FG002|Overall Study|Participant Received Alternative Therapy|0|||
23627643|NCT02367352|66024525|FG000|Overall Study|Adverse Event|1|||
23627644|NCT02367352|66024526|FG001|Overall Study|Adverse Event|0|||
23627645|NCT02367352|66024527|FG002|Overall Study|Adverse Event|0|||
23627646|NCT02466243|66024528|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
23627647|NCT02466243|66024529|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
23627648|NCT02466243|66024528|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
23627649|NCT02466243|66024529|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
23627650|NCT02466243|66024528|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
23221497|NCT03654560|64553703|FG001|Overall Study|Lost to Follow-up|0|||
23221498|NCT01421069|64553704|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
23221499|NCT01421069|64553704|FG000|Parent Study|Failed to return|3|||
23221500|NCT01421069|64553704|FG000|Parent Study|Withdrawal by Subject|1|||
23627651|NCT02466243|66024529|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
23627652|NCT02466243|66024528|FG000|Part B Open-label Treatment Period|Missing|2|||
23627653|NCT02466243|66024529|FG001|Part B Open-label Treatment Period|Missing|2|||
23627654|NCT02659098|66024530|FG000|Overall Study|Withdrawal by Subject|7|||
23627655|NCT03713320|66024531|FG000|Randomized Period|Adverse Event|1|||
23627656|NCT03713320|66024532|FG001|Randomized Period|Adverse Event|5|||
23627657|NCT03713320|66024533|FG002|Randomized Period|Adverse Event|0|||
23627658|NCT03713320|66024531|FG000|Randomized Period|Physician Decision|1|||
23627659|NCT03713320|66024532|FG001|Randomized Period|Physician Decision|1|||
23627660|NCT03713320|66024533|FG002|Randomized Period|Physician Decision|0|||
23627661|NCT03713320|66024531|FG000|Randomized Period|Withdrawal by Subject|4|||
23627662|NCT03713320|66024532|FG001|Randomized Period|Withdrawal by Subject|0|||
23627663|NCT03713320|66024533|FG002|Randomized Period|Withdrawal by Subject|0|||
23627664|NCT03713320|66024531|FG000|Randomized Period|Participant decision|3|||
23627665|NCT03713320|66024532|FG001|Randomized Period|Participant decision|1|||
23627666|NCT03713320|66024533|FG002|Randomized Period|Participant decision|0|||
23627667|NCT03713320|66024531|FG000|Randomized Period|Study terminated by sponsor|6|||
23627668|NCT03713320|66024532|FG001|Randomized Period|Study terminated by sponsor|3|||
23627669|NCT03713320|66024533|FG002|Randomized Period|Study terminated by sponsor|0|||
23627670|NCT03713320|66024531|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
23627671|NCT03713320|66024532|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
23627672|NCT03713320|66024533|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
23221501|NCT01421069|64553704|FG000|Parent Study|Lost to Follow-up|2|||
23221502|NCT01421069|64553704|FG000|Parent Study|Lack of Efficacy|1|||
23221503|NCT01421069|64553704|FG000|Overall Period for Extension Study|Other|2|||
23627673|NCT03713320|66024531|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
23627674|NCT03713320|66024532|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
23627675|NCT03713320|66024533|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
23627676|NCT04952701|66024534|FG000|Control Lens|Physician Decision|4|||
23627677|NCT04952701|66024534|FG000|Test Lens|Physician Decision|1|||
23627678|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
23155301|NCT02285998|64321959|FG000|Overall Study|Physician Decision|1|||
23155302|NCT02285998|64321960|FG001|Overall Study|Physician Decision|2|||
23155303|NCT02285998|64321959|FG000|Overall Study|Lost to Follow-up|176|||
23221504|NCT01421069|64553704|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
23221505|NCT01421069|64553704|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
23627679|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
23627680|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
23627681|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
23627682|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
23155304|NCT02285998|64321960|FG001|Overall Study|Lost to Follow-up|172|||
23327507|NCT03918629|64940929|FG001|Overall Study|Lost to Follow-up|28|||
23327508|NCT03918629|64940928|FG000|Overall Study|Physician Decision|1|||
23565489|NCT01350141|65799671|FG002|Overall Study|Withdrawal by Subject|0|||
23565490|NCT01350141|65799669|FG000|Overall Study|Randomized but not treated|1|||
23565491|NCT01350141|65799670|FG001|Overall Study|Randomized but not treated|0|||
23565492|NCT01350141|65799671|FG002|Overall Study|Randomized but not treated|0|||
23565493|NCT00861614|65799672|FG000|Overall Study|Disease Progression|182|||
23565494|NCT00861614|65799673|FG001|Overall Study|Disease Progression|263|||
23565495|NCT00861614|65799672|FG000|Overall Study|Study Drug Toxicity|79|||
23565496|NCT00861614|65799673|FG001|Overall Study|Study Drug Toxicity|6|||
23565497|NCT00861614|65799672|FG000|Overall Study|Death|32|||
23565498|NCT00861614|65799673|FG001|Overall Study|Death|19|||
23565499|NCT00861614|65799672|FG000|Overall Study|Adverse Event|27|||
23565500|NCT00861614|65799673|FG001|Overall Study|Adverse Event|23|||
23565501|NCT00861614|65799672|FG000|Overall Study|Withdrawal by Subject|34|||
23565502|NCT00861614|65799673|FG001|Overall Study|Withdrawal by Subject|35|||
23565503|NCT00861614|65799672|FG000|Overall Study|Other|17|||
23565504|NCT00861614|65799673|FG001|Overall Study|Other|22|||
23565505|NCT03363659|65799674|FG000|Overall Study|Adverse Event|1|||
23565506|NCT03363659|65799674|FG000|Overall Study|Screen fail|1|||
23565507|NCT03363659|65799674|FG000|Overall Study|Withdrawal by Subject|1|||
23565508|NCT02798211|65799676|FG000|Period 1|Adverse Event|1|||
23565509|NCT02798211|65799677|FG001|Period 1|Adverse Event|1|||
23565510|NCT02798211|65799678|FG002|Period 1|Adverse Event|0|||
23565511|NCT02798211|65799679|FG003|Period 1|Adverse Event|0|||
23565512|NCT02798211|65799680|FG004|Period 1|Adverse Event|0|||
23565513|NCT02798211|65799681|FG005|Period 1|Adverse Event|0|||
23565514|NCT02798211|65799676|FG000|Period 1|Lost to Follow-up|2|||
23565515|NCT02798211|65799677|FG001|Period 1|Lost to Follow-up|1|||
23565516|NCT02798211|65799678|FG002|Period 1|Lost to Follow-up|0|||
23565517|NCT02798211|65799679|FG003|Period 1|Lost to Follow-up|0|||
23565518|NCT02798211|65799680|FG004|Period 1|Lost to Follow-up|0|||
23565519|NCT02798211|65799681|FG005|Period 1|Lost to Follow-up|0|||
23565520|NCT02798211|65799676|FG000|Period 1|Protocol Violation|0|||
23565521|NCT02798211|65799677|FG001|Period 1|Protocol Violation|0|||
23565522|NCT02798211|65799678|FG002|Period 1|Protocol Violation|2|||
23565523|NCT02798211|65799679|FG003|Period 1|Protocol Violation|0|||
23565524|NCT02798211|65799680|FG004|Period 1|Protocol Violation|0|||
23565525|NCT02798211|65799681|FG005|Period 1|Protocol Violation|0|||
23565526|NCT02798211|65799676|FG000|Period 1|Withdrawal by Subject|1|||
23565527|NCT02798211|65799677|FG001|Period 1|Withdrawal by Subject|1|||
23565528|NCT02798211|65799678|FG002|Period 1|Withdrawal by Subject|0|||
23565529|NCT02798211|65799679|FG003|Period 1|Withdrawal by Subject|0|||
23565530|NCT02798211|65799680|FG004|Period 1|Withdrawal by Subject|0|||
23565531|NCT02798211|65799681|FG005|Period 1|Withdrawal by Subject|0|||
23565532|NCT02798211|65799676|FG000|Period 1|Death|0|||
23155305|NCT02285998|64321959|FG000|Overall Study|Withdrawal by Subject|53|||
23155306|NCT02285998|64321960|FG001|Overall Study|Withdrawal by Subject|61|||
23155307|NCT02285998|64321959|FG000|Overall Study|Other Reasons|7|||
23155308|NCT02285998|64321960|FG001|Overall Study|Other Reasons|10|||
23155309|NCT01015768|64321966|FG000|Overall Study|Some subject data unuseable|4|||
23155310|NCT01015768|64321967|FG001|Overall Study|Some subject data unuseable|4|||
23155311|NCT01553188|64321968|FG000|Overall Study|Patient choice|1|||
23155312|NCT01553188|64321969|FG001|Overall Study|Patient choice|0|||
23155313|NCT01553188|64321970|FG002|Overall Study|Patient choice|0|||
23155314|NCT01553188|64321971|FG003|Overall Study|Patient choice|0|||
23155315|NCT01553188|64321968|FG000|Overall Study|Intercurrent illness and adverse event|0|||
23155316|NCT01553188|64321969|FG001|Overall Study|Intercurrent illness and adverse event|1|||
23155317|NCT01553188|64321970|FG002|Overall Study|Intercurrent illness and adverse event|2|||
23155318|NCT01553188|64321971|FG003|Overall Study|Intercurrent illness and adverse event|0|||
23155319|NCT04251910|64321972|FG000|Overall Study|Covid 19 lockdown|0|||
23155320|NCT04251910|64321973|FG001|Overall Study|Covid 19 lockdown|5|||
23155321|NCT04251910|64321974|FG002|Overall Study|Covid 19 lockdown|0|||
23155322|NCT04251910|64321975|FG003|Overall Study|Covid 19 lockdown|4|||
23155323|NCT04251910|64321976|FG004|Overall Study|Covid 19 lockdown|0|||
23155324|NCT04251910|64321977|FG005|Overall Study|Covid 19 lockdown|0|||
23155325|NCT04251910|64321972|FG000|Overall Study|Assisted living facility was closed|0|||
23155326|NCT04251910|64321973|FG001|Overall Study|Assisted living facility was closed|0|||
23155327|NCT04251910|64321974|FG002|Overall Study|Assisted living facility was closed|0|||
23155328|NCT04251910|64321975|FG003|Overall Study|Assisted living facility was closed|0|||
23155329|NCT04251910|64321976|FG004|Overall Study|Assisted living facility was closed|1|||
23155330|NCT04251910|64321977|FG005|Overall Study|Assisted living facility was closed|0|||
23155331|NCT01961349|64321982|FG000|Overall Study|Withdrawal by Subject|1|||
23155332|NCT01961349|64321983|FG001|Overall Study|Withdrawal by Subject|4|||
23155333|NCT01961349|64321984|FG002|Overall Study|Withdrawal by Subject|0|||
23155334|NCT01961349|64321982|FG000|Overall Study|Adverse Event|0|||
23155335|NCT01961349|64321983|FG001|Overall Study|Adverse Event|0|||
23221506|NCT01421069|64553704|FG000|Overall Period for Extension Study|Pregnancy|1|||
23221507|NCT01421069|64553704|FG000|Overall Period for Extension Study|Adverse Event|1|||
23221508|NCT01421069|64553704|FG000|Overall Period for Extension Study|Protocol Violation|1|||
23327509|NCT03918629|64940929|FG001|Overall Study|Physician Decision|0|||
23627683|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
23627684|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
23627685|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
23627686|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
23627687|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
23627688|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
23155336|NCT01961349|64321984|FG002|Overall Study|Adverse Event|1|||
23155337|NCT01961349|64321982|FG000|Overall Study|registration error, personal reason etc|2|||
23155338|NCT01961349|64321983|FG001|Overall Study|registration error, personal reason etc|2|||
23155339|NCT01961349|64321984|FG002|Overall Study|registration error, personal reason etc|1|||
23155340|NCT02269787|64321987|FG000|Overall Study|Lost to Follow-up|20|||
23155341|NCT02269787|64321988|FG001|Overall Study|Lost to Follow-up|6|||
23155342|NCT02269787|64321987|FG000|Overall Study|Death|2|||
23155343|NCT02269787|64321988|FG001|Overall Study|Death|3|||
23155344|NCT02269787|64321987|FG000|Overall Study|Incapacitated|0|||
23155345|NCT02269787|64321988|FG001|Overall Study|Incapacitated|1|||
23155346|NCT00555477|64321995|FG000|Overall Study|Adverse Event|0|||
23155347|NCT00555477|64321996|FG001|Overall Study|Adverse Event|9|||
23155348|NCT00555477|64321995|FG000|Overall Study|Withdrawal by Subject|1|||
23155349|NCT00555477|64321996|FG001|Overall Study|Withdrawal by Subject|2|||
23155350|NCT00555477|64321995|FG000|Overall Study|Physician Decision|1|||
23155351|NCT00555477|64321996|FG001|Overall Study|Physician Decision|2|||
23155352|NCT04857996|64321997|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
23155353|NCT04857996|64321998|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
23155354|NCT04857996|64321997|FG000|Overall Study|Lost to Follow-up|1|||
23155355|NCT04857996|64321998|FG001|Overall Study|Lost to Follow-up|3|||
23155356|NCT04857996|64321997|FG000|Overall Study|Site Closure|1|||
23155357|NCT04857996|64321998|FG001|Overall Study|Site Closure|0|||
23155358|NCT04857996|64321997|FG000|Overall Study|Withdrawal by Subject|1|||
23155359|NCT04857996|64321998|FG001|Overall Study|Withdrawal by Subject|0|||
23155360|NCT02217436|64322007|FG000|Overall Study|Protocol Violation|1|||
23155361|NCT02217436|64322008|FG001|Overall Study|Protocol Violation|1|||
23155362|NCT02217436|64322007|FG000|Overall Study|Incomplete data|0|||
23155363|NCT02217436|64322008|FG001|Overall Study|Incomplete data|1|||
23155364|NCT01830855|64322011|FG000|Overall Study|Other|7|||
23155365|NCT01830855|64322012|FG001|Overall Study|Other|1|||
23155366|NCT01830855|64322013|FG002|Overall Study|Other|4|||
23155367|NCT01830855|64322014|FG003|Overall Study|Other|4|||
23155368|NCT01830855|64322011|FG000|Overall Study|Medication error without associated AE|1|||
23155369|NCT01830855|64322012|FG001|Overall Study|Medication error without associated AE|0|||
23155370|NCT01830855|64322013|FG002|Overall Study|Medication error without associated AE|0|||
23155371|NCT01830855|64322014|FG003|Overall Study|Medication error without associated AE|1|||
23155372|NCT01830855|64322011|FG000|Overall Study|Pregnancy|3|||
23155373|NCT01830855|64322012|FG001|Overall Study|Pregnancy|1|||
23155374|NCT01830855|64322013|FG002|Overall Study|Pregnancy|2|||
23155375|NCT01830855|64322014|FG003|Overall Study|Pregnancy|1|||
23155376|NCT01830855|64322011|FG000|Overall Study|No longer meets eligibility criteria|11|||
23155377|NCT01830855|64322012|FG001|Overall Study|No longer meets eligibility criteria|2|||
23155378|NCT01830855|64322013|FG002|Overall Study|No longer meets eligibility criteria|3|||
23155379|NCT01830855|64322014|FG003|Overall Study|No longer meets eligibility criteria|5|||
23155380|NCT01830855|64322011|FG000|Overall Study|Adverse Event|11|||
23155381|NCT01830855|64322012|FG001|Overall Study|Adverse Event|5|||
23155382|NCT01830855|64322013|FG002|Overall Study|Adverse Event|6|||
23155383|NCT01830855|64322014|FG003|Overall Study|Adverse Event|3|||
23155384|NCT01830855|64322011|FG000|Overall Study|Protocol deviation|10|||
23155385|NCT01830855|64322012|FG001|Overall Study|Protocol deviation|5|||
23155386|NCT01830855|64322013|FG002|Overall Study|Protocol deviation|6|||
23155387|NCT01830855|64322014|FG003|Overall Study|Protocol deviation|6|||
23155388|NCT01830855|64322011|FG000|Overall Study|Withdrawal by Subject|33|||
23155389|NCT01830855|64322012|FG001|Overall Study|Withdrawal by Subject|14|||
23155390|NCT01830855|64322013|FG002|Overall Study|Withdrawal by Subject|10|||
23155391|NCT01830855|64322014|FG003|Overall Study|Withdrawal by Subject|12|||
23327510|NCT03918629|64940928|FG000|Overall Study|Protocol Violation|7|||
23155392|NCT01830855|64322011|FG000|Overall Study|No longer willing to participate|32|||
23155393|NCT01830855|64322012|FG001|Overall Study|No longer willing to participate|13|||
23155394|NCT01830855|64322013|FG002|Overall Study|No longer willing to participate|12|||
23155395|NCT01830855|64322014|FG003|Overall Study|No longer willing to participate|17|||
23155396|NCT01830855|64322011|FG000|Overall Study|Lost to Follow-up|47|||
23155397|NCT01830855|64322012|FG001|Overall Study|Lost to Follow-up|20|||
23155398|NCT01830855|64322013|FG002|Overall Study|Lost to Follow-up|23|||
23221509|NCT01421069|64553704|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
23155399|NCT01830855|64322014|FG003|Overall Study|Lost to Follow-up|33|||
23155400|NCT01429584|64322017|FG000|Overall Study|Withdrawal by Subject|1|||
23155401|NCT01429584|64322018|FG001|Overall Study|Withdrawal by Subject|0|||
23155402|NCT01429584|64322017|FG000|Overall Study|Protocol Violation|0|||
23155403|NCT01429584|64322018|FG001|Overall Study|Protocol Violation|1|||
23155404|NCT00097773|64322021|FG000|Overall Study|Lost to Follow-up|2|||
23155405|NCT00097773|64322022|FG001|Overall Study|Lost to Follow-up|2|||
23155406|NCT00097773|64322023|FG002|Overall Study|Lost to Follow-up|0|||
23155407|NCT00097773|64322024|FG003|Overall Study|Lost to Follow-up|1|||
23155408|NCT00097773|64322021|FG000|Overall Study|Physician Decision|2|||
23155409|NCT00097773|64322022|FG001|Overall Study|Physician Decision|2|||
23155410|NCT00097773|64322023|FG002|Overall Study|Physician Decision|3|||
23155411|NCT00097773|64322024|FG003|Overall Study|Physician Decision|1|||
23155412|NCT00097773|64322021|FG000|Overall Study|Withdrawal by Subject|3|||
23155413|NCT00097773|64322022|FG001|Overall Study|Withdrawal by Subject|3|||
23155414|NCT00097773|64322023|FG002|Overall Study|Withdrawal by Subject|3|||
23155415|NCT00097773|64322024|FG003|Overall Study|Withdrawal by Subject|1|||
23155416|NCT00097773|64322021|FG000|Overall Study|Adverse Event|0|||
23155417|NCT00097773|64322022|FG001|Overall Study|Adverse Event|1|||
23155418|NCT00097773|64322023|FG002|Overall Study|Adverse Event|0|||
23155419|NCT00097773|64322024|FG003|Overall Study|Adverse Event|0|||
23155420|NCT00097773|64322021|FG000|Overall Study|Other|1|||
23155421|NCT00097773|64322022|FG001|Overall Study|Other|0|||
23155422|NCT00097773|64322023|FG002|Overall Study|Other|2|||
23155423|NCT00097773|64322024|FG003|Overall Study|Other|0|||
23155424|NCT01187550|64322025|FG000|Overall Study|Protocol Violation|3|||
23155425|NCT01187550|64322026|FG001|Overall Study|Protocol Violation|1|||
23155426|NCT01187550|64322025|FG000|Overall Study|Other|3|||
23155427|NCT01187550|64322026|FG001|Overall Study|Other|0|||
23155428|NCT01187550|64322025|FG000|Overall Study|Randomized but not treated|8|||
23155429|NCT01187550|64322026|FG001|Overall Study|Randomized but not treated|0|||
23155430|NCT01843842|64322027|FG000|Overall Study|Do not meet inclusion criteria|1|||
23155431|NCT01843842|64322028|FG001|Overall Study|Do not meet inclusion criteria|1|||
23155432|NCT00495820|64322032|FG000|Overall Study|Adverse Event|1|||
23155433|NCT00495820|64322033|FG001|Overall Study|Adverse Event|1|||
23155434|NCT01131520|64322034|FG000|Overall Study|Computer problem|1|||
23155435|NCT01131520|64322035|FG001|Overall Study|Computer problem|0|||
23155436|NCT01131520|64322034|FG000|Overall Study|Counselor not available|0|||
23155437|NCT01131520|64322035|FG001|Overall Study|Counselor not available|3|||
23155438|NCT01131520|64322034|FG000|Overall Study|Subject changed history after enrollment|0|||
23155439|NCT01131520|64322035|FG001|Overall Study|Subject changed history after enrollment|1|||
23155440|NCT01045798|64322037|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
23155441|NCT01045798|64322038|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
23155442|NCT01045798|64322037|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
23155443|NCT01045798|64322038|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
23155444|NCT01045798|64322037|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
23155445|NCT01045798|64322038|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
23155446|NCT01045798|64322037|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
23155447|NCT01045798|64322038|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
23155448|NCT00747643|64322039|FG000|Overall Study|Withdrawal by Subject|36|||
23155449|NCT00747643|64322040|FG001|Overall Study|Withdrawal by Subject|27|||
23155450|NCT03227471|64322042|FG000|Overall Study|Withdrawal by Subject|0|||
23155451|NCT03227471|64322043|FG001|Overall Study|Withdrawal by Subject|0|||
23155452|NCT03227471|64322044|FG002|Overall Study|Withdrawal by Subject|0|||
23155453|NCT03227471|64322045|FG003|Overall Study|Withdrawal by Subject|0|||
23155454|NCT03227471|64322046|FG004|Overall Study|Withdrawal by Subject|1|||
23155455|NCT03227471|64322047|FG005|Overall Study|Withdrawal by Subject|0|||
23155456|NCT03227471|64322048|FG006|Overall Study|Withdrawal by Subject|0|||
23155457|NCT03227471|64322049|FG007|Overall Study|Withdrawal by Subject|0|||
23327511|NCT03918629|64940929|FG001|Overall Study|Protocol Violation|4|||
23327512|NCT03918629|64940928|FG000|Overall Study|Withdrawal by Subject|47|||
23327513|NCT03918629|64940929|FG001|Overall Study|Withdrawal by Subject|47|||
23327514|NCT03918629|64940928|FG000|Overall Study|Other|7|||
23155458|NCT03227471|64322050|FG008|Overall Study|Withdrawal by Subject|0|||
23155459|NCT03227471|64322051|FG009|Overall Study|Withdrawal by Subject|0|||
23155460|NCT03227471|64322052|FG010|Overall Study|Withdrawal by Subject|0|||
23155461|NCT03227471|64322053|FG011|Overall Study|Withdrawal by Subject|0|||
23155462|NCT03227471|64322054|FG012|Overall Study|Withdrawal by Subject|1|||
23155463|NCT03227471|64322055|FG013|Overall Study|Withdrawal by Subject|0|||
23155464|NCT03227471|64322056|FG014|Overall Study|Withdrawal by Subject|0|||
23155465|NCT03227471|64322042|FG000|Overall Study|Randomized, Never Dosed|0|||
23155466|NCT03227471|64322043|FG001|Overall Study|Randomized, Never Dosed|0|||
23155467|NCT03227471|64322044|FG002|Overall Study|Randomized, Never Dosed|0|||
23155468|NCT03227471|64322045|FG003|Overall Study|Randomized, Never Dosed|0|||
23155469|NCT03227471|64322046|FG004|Overall Study|Randomized, Never Dosed|0|||
23155470|NCT03227471|64322047|FG005|Overall Study|Randomized, Never Dosed|0|||
23327515|NCT03918629|64940929|FG001|Overall Study|Other|11|||
23442467|NCT00348673|65362093|FG008|Stage 1|Randomized but not Treated|0|||
23155471|NCT03227471|64322048|FG006|Overall Study|Randomized, Never Dosed|0|||
23155472|NCT03227471|64322049|FG007|Overall Study|Randomized, Never Dosed|0|||
23155473|NCT03227471|64322050|FG008|Overall Study|Randomized, Never Dosed|0|||
23155474|NCT03227471|64322051|FG009|Overall Study|Randomized, Never Dosed|0|||
23155475|NCT03227471|64322052|FG010|Overall Study|Randomized, Never Dosed|0|||
23155476|NCT03227471|64322053|FG011|Overall Study|Randomized, Never Dosed|0|||
23327516|NCT03918629|64940928|FG000|Overall Study|Randomized but not vaccinated|2|||
23327517|NCT03918629|64940929|FG001|Overall Study|Randomized but not vaccinated|1|||
23327518|NCT01982682|64940934|FG000|Overall Study|Physician Decision|1|||
23327519|NCT00661193|64940935|FG000|Overall Study|Adverse Event|2|||
23327520|NCT00661193|64940936|FG001|Overall Study|Adverse Event|1|||
23442468|NCT00992459|65362094|FG000|Overall Study|Withdrawal by Subject|0|||
23442469|NCT00992459|65362095|FG001|Overall Study|Withdrawal by Subject|1|||
23442470|NCT00992459|65362094|FG000|Overall Study|Adverse Event|1|||
23627689|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
23442471|NCT00992459|65362095|FG001|Overall Study|Adverse Event|0|||
23442472|NCT01248949|65362097|FG000|Overall Study|Lost to Follow-up|2|||
23442473|NCT01248949|65362098|FG001|Overall Study|Lost to Follow-up|2|||
23442474|NCT01248949|65362099|FG002|Overall Study|Lost to Follow-up|2|||
23442475|NCT01248949|65362100|FG003|Overall Study|Lost to Follow-up|1|||
23442476|NCT01248949|65362101|FG004|Overall Study|Lost to Follow-up|0|||
23442477|NCT01248949|65362097|FG000|Overall Study|Withdrawal by Subject|5|||
23442478|NCT01248949|65362098|FG001|Overall Study|Withdrawal by Subject|3|||
23442479|NCT01248949|65362099|FG002|Overall Study|Withdrawal by Subject|11|||
23442480|NCT01248949|65362100|FG003|Overall Study|Withdrawal by Subject|3|||
23442481|NCT01248949|65362101|FG004|Overall Study|Withdrawal by Subject|1|||
23442482|NCT01248949|65362097|FG000|Overall Study|Death|22|||
23442483|NCT01248949|65362098|FG001|Overall Study|Death|7|||
23442484|NCT01248949|65362099|FG002|Overall Study|Death|21|||
23442485|NCT01248949|65362100|FG003|Overall Study|Death|6|||
23442486|NCT01248949|65362101|FG004|Overall Study|Death|2|||
23442487|NCT01248949|65362097|FG000|Overall Study|Alternative Therapy|1|||
23442488|NCT01248949|65362098|FG001|Overall Study|Alternative Therapy|0|||
23442489|NCT01248949|65362099|FG002|Overall Study|Alternative Therapy|0|||
23442490|NCT01248949|65362100|FG003|Overall Study|Alternative Therapy|0|||
23442491|NCT01248949|65362101|FG004|Overall Study|Alternative Therapy|0|||
23442492|NCT01248949|65362097|FG000|Overall Study|Alternative Therapy.|1|||
23442493|NCT01248949|65362098|FG001|Overall Study|Alternative Therapy.|0|||
23442494|NCT01248949|65362099|FG002|Overall Study|Alternative Therapy.|0|||
23442495|NCT01248949|65362100|FG003|Overall Study|Alternative Therapy.|0|||
23442496|NCT01248949|65362101|FG004|Overall Study|Alternative Therapy.|0|||
23442497|NCT01248949|65362097|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
23442498|NCT01248949|65362098|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
23442499|NCT01248949|65362099|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
23442500|NCT01248949|65362100|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
23442501|NCT01248949|65362101|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
23442502|NCT01248949|65362097|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
23442503|NCT01248949|65362098|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
23442504|NCT01248949|65362099|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
23442505|NCT01248949|65362100|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
23442506|NCT01248949|65362101|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
23442507|NCT01248949|65362097|FG000|Overall Study|Participant Went To Hospice|0|||
23442508|NCT01248949|65362098|FG001|Overall Study|Participant Went To Hospice|0|||
23442509|NCT01248949|65362099|FG002|Overall Study|Participant Went To Hospice|1|||
23442510|NCT01248949|65362100|FG003|Overall Study|Participant Went To Hospice|0|||
23442511|NCT01248949|65362101|FG004|Overall Study|Participant Went To Hospice|0|||
23442512|NCT01248949|65362097|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
23442513|NCT01248949|65362098|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
23442514|NCT01248949|65362099|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
23442515|NCT01248949|65362100|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
23627690|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Other|4|||
23627691|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Other|4|||
23155477|NCT03227471|64322054|FG012|Overall Study|Randomized, Never Dosed|0|||
23327521|NCT00661193|64940935|FG000|Overall Study|Withdrawal by Subject|3|||
23327522|NCT00661193|64940936|FG001|Overall Study|Withdrawal by Subject|1|||
23327523|NCT00661193|64940935|FG000|Overall Study|Progression|27|||
23155478|NCT03227471|64322055|FG013|Overall Study|Randomized, Never Dosed|0|||
23155479|NCT03227471|64322056|FG014|Overall Study|Randomized, Never Dosed|1|||
23327524|NCT00661193|64940936|FG001|Overall Study|Progression|24|||
23442516|NCT01248949|65362101|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
23442517|NCT01248949|65362097|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
23442518|NCT01248949|65362098|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
23442519|NCT01248949|65362099|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
23627692|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Other|2|||
23155480|NCT00601705|64322066|FG000|Overall Study|Withdrawal by Subject|1|||
23155481|NCT02349048|64322067|FG000|Overall Study|Withdrawal by Subject|4|||
23155482|NCT02349048|64322068|FG001|Overall Study|Withdrawal by Subject|0|||
23155483|NCT02349048|64322067|FG000|Overall Study|Lost to Follow-up|1|||
23155484|NCT02349048|64322068|FG001|Overall Study|Lost to Follow-up|0|||
23155485|NCT02613884|64322069|FG000|Overall Study|Death|1|||
23155486|NCT02613884|64322069|FG000|Overall Study|Lost to Follow-up|1|||
23155487|NCT00482703|64322070|FG000|Overall Study|Poor compliance|1|||
23155488|NCT00482703|64322071|FG001|Overall Study|Poor compliance|0|||
23155489|NCT03625687|64322072|FG000|Overall Study|Death|1|||
23155490|NCT00187096|64322073|FG000|Overall Study|unacceptable toxicity|0|||
23155491|NCT00187096|64322074|FG001|Overall Study|unacceptable toxicity|0|||
23155492|NCT00187096|64322075|FG002|Overall Study|unacceptable toxicity|1|||
23155493|NCT01984164|64322076|FG000|Overall Study|Withdrawal by Subject|4|||
23155494|NCT01984164|64322077|FG001|Overall Study|Withdrawal by Subject|3|||
23155495|NCT01984164|64322076|FG000|Overall Study|Adverse Event|5|||
23155496|NCT01984164|64322077|FG001|Overall Study|Adverse Event|19|||
23155497|NCT01984164|64322076|FG000|Overall Study|Lost to Follow-up|1|||
23221510|NCT01421069|64553704|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
23221511|NCT01421069|64553704|FG000|Active Treatment Period|Other|1|||
23221512|NCT01421069|64553704|FG000|Active Treatment Period|No longer willing to participate in study|8|||
23221513|NCT01421069|64553704|FG000|Active Treatment Period|Insufficient clinical response|1|||
23627693|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Other|2|||
23627694|NCT02706847|66024535|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
23627695|NCT02706847|66024536|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
23627696|NCT02706847|66024537|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
23627697|NCT02706847|66024538|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
23627698|NCT02706847|66024535|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
23627699|NCT02706847|66024536|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
23627700|NCT02706847|66024537|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
23627701|NCT02706847|66024538|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
23627702|NCT02706847|66024535|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
23627703|NCT02706847|66024536|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
23627704|NCT02706847|66024537|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
23627705|NCT02706847|66024538|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
23627706|NCT02706847|66024535|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
23627707|NCT02706847|66024536|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
23627708|NCT02706847|66024537|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
23627709|NCT02706847|66024538|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
23627710|NCT02706847|66024535|FG000|Period 1: Week 12 to Week 24|Other|1|||
23627711|NCT02706847|66024536|FG001|Period 1: Week 12 to Week 24|Other|0|||
23627712|NCT02706847|66024537|FG002|Period 1: Week 12 to Week 24|Other|1|||
23627713|NCT02706847|66024538|FG003|Period 1: Week 12 to Week 24|Other|4|||
23627714|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
23627715|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
23627716|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
23627717|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
23627718|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
23627719|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
23627720|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
23627721|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
23627722|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
23627723|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
23627724|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
23627725|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
23627726|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
23627727|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
23627728|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
23627729|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
23627730|NCT02706847|66024535|FG000|Period 2: Week 24 to Week 260|Other|8|||
23627731|NCT02706847|66024536|FG001|Period 2: Week 24 to Week 260|Other|5|||
23627732|NCT02706847|66024537|FG002|Period 2: Week 24 to Week 260|Other|15|||
23627733|NCT02706847|66024538|FG003|Period 2: Week 24 to Week 260|Other|15|||
23627734|NCT02547441|66024539|FG000|Double-Blind Study Period|Adverse Event|4|||
23155498|NCT01984164|64322077|FG001|Overall Study|Lost to Follow-up|3|||
23155499|NCT00594516|64322078|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
23155500|NCT00594516|64322079|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
23155501|NCT00594516|64322080|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
23221514|NCT01421069|64553704|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
23627735|NCT02547441|66024540|FG001|Double-Blind Study Period|Adverse Event|9|||
23627736|NCT02547441|66024539|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
23627737|NCT02547441|66024540|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
23155502|NCT00594516|64322078|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
23155503|NCT00594516|64322079|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
23155504|NCT00594516|64322080|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
23155505|NCT00594516|64322078|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
23155506|NCT00594516|64322079|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
23155507|NCT00594516|64322080|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
23155508|NCT00594516|64322078|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
23155509|NCT00594516|64322079|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
23155510|NCT00594516|64322080|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
23155511|NCT00594516|64322078|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
23155512|NCT00594516|64322079|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
23155513|NCT00594516|64322080|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
23155514|NCT00594516|64322078|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
23155515|NCT00594516|64322079|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
23155516|NCT00594516|64322080|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
23155517|NCT00594516|64322078|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
23155518|NCT00594516|64322079|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
23155519|NCT00594516|64322080|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
23155520|NCT00594516|64322078|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
23155521|NCT00594516|64322079|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
23155522|NCT00594516|64322080|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
23155523|NCT00594516|64322078|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
23155524|NCT00594516|64322079|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
23155525|NCT00594516|64322080|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
23155526|NCT02982590|64322081|FG000|Overall Study|Lost to Follow-up|0|||
23155527|NCT02982590|64322082|FG001|Overall Study|Lost to Follow-up|1|||
23155528|NCT02982590|64322081|FG000|Overall Study|Death|4|||
23155529|NCT02982590|64322082|FG001|Overall Study|Death|0|||
23155530|NCT00395863|64322083|FG000|Overall Study|Patients did not complete both exams|2|||
23155531|NCT00395863|64322084|FG001|Overall Study|Patients did not complete both exams|3|||
23155532|NCT01735279|64322085|FG000|Overall Study|Lost to Follow-up|11|||
23155533|NCT01735279|64322086|FG001|Overall Study|Lost to Follow-up|8|||
23565533|NCT02798211|65799677|FG001|Period 1|Death|0|||
23565534|NCT02798211|65799678|FG002|Period 1|Death|1|||
23565535|NCT02798211|65799679|FG003|Period 1|Death|0|||
23565536|NCT02798211|65799680|FG004|Period 1|Death|0|||
23565537|NCT02798211|65799681|FG005|Period 1|Death|0|||
23565538|NCT02798211|65799676|FG000|Period 1|Withdrawal of Informed Consent|2|||
23565539|NCT02798211|65799677|FG001|Period 1|Withdrawal of Informed Consent|7|||
23565540|NCT02798211|65799678|FG002|Period 1|Withdrawal of Informed Consent|3|||
23565541|NCT02798211|65799679|FG003|Period 1|Withdrawal of Informed Consent|0|||
23565542|NCT02798211|65799680|FG004|Period 1|Withdrawal of Informed Consent|0|||
23565543|NCT02798211|65799681|FG005|Period 1|Withdrawal of Informed Consent|0|||
23565544|NCT02798211|65799676|FG000|Period 2|Withdrawal by Subject|2|||
23565545|NCT02798211|65799677|FG001|Period 2|Withdrawal by Subject|0|||
23565546|NCT02798211|65799678|FG002|Period 2|Withdrawal by Subject|0|||
23565547|NCT02798211|65799679|FG003|Period 2|Withdrawal by Subject|0|||
23565548|NCT02798211|65799680|FG004|Period 2|Withdrawal by Subject|2|||
23565549|NCT02798211|65799681|FG005|Period 2|Withdrawal by Subject|2|||
23565550|NCT02798211|65799676|FG000|Period 2|Adverse Event|5|||
23565551|NCT02798211|65799677|FG001|Period 2|Adverse Event|0|||
23565552|NCT02798211|65799678|FG002|Period 2|Adverse Event|0|||
23565553|NCT02798211|65799679|FG003|Period 2|Adverse Event|0|||
23155534|NCT01994382|64322091|FG000|Overall Study|Informed consent withdrawn|0|||
23155535|NCT01994382|64322092|FG001|Overall Study|Informed consent withdrawn|0|||
23155536|NCT01994382|64322093|FG002|Overall Study|Informed consent withdrawn|0|||
23155537|NCT01994382|64322094|FG003|Overall Study|Informed consent withdrawn|0|||
23155538|NCT01994382|64322095|FG004|Overall Study|Informed consent withdrawn|0|||
23155539|NCT01994382|64322096|FG005|Overall Study|Informed consent withdrawn|0|||
23155540|NCT01994382|64322097|FG006|Overall Study|Informed consent withdrawn|1|||
23155541|NCT01994382|64322098|FG007|Overall Study|Informed consent withdrawn|0|||
23155542|NCT01994382|64322099|FG008|Overall Study|Informed consent withdrawn|0|||
23221515|NCT01421069|64553704|FG000|Active Treatment Period|Pregnancy|1|||
23221516|NCT01421069|64553704|FG000|Active Treatment Period|Adverse Event|1|||
23221517|NCT01421069|64553704|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
23221518|NCT01421069|64553704|FG000|Active Treatment Period|Enrolled in observational period|29|||
23565554|NCT02798211|65799680|FG004|Period 2|Adverse Event|1|||
23565555|NCT02798211|65799681|FG005|Period 2|Adverse Event|0|||
23565556|NCT02798211|65799676|FG000|Period 2|Lack of Efficacy|1|||
23155543|NCT01994382|64322100|FG009|Overall Study|Informed consent withdrawn|0|||
23155544|NCT01994382|64322101|FG010|Overall Study|Informed consent withdrawn|0|||
23327525|NCT00661193|64940935|FG000|Overall Study|Not protocol specified|1|||
23565557|NCT02798211|65799677|FG001|Period 2|Lack of Efficacy|0|||
23565558|NCT02798211|65799678|FG002|Period 2|Lack of Efficacy|0|||
23565559|NCT02798211|65799679|FG003|Period 2|Lack of Efficacy|1|||
23155545|NCT01994382|64322102|FG011|Overall Study|Informed consent withdrawn|0|||
23155546|NCT01994382|64322103|FG012|Overall Study|Informed consent withdrawn|0|||
23155547|NCT01994382|64322104|FG013|Overall Study|Informed consent withdrawn|0|||
23155548|NCT01994382|64322105|FG014|Overall Study|Informed consent withdrawn|0|||
23155549|NCT01994382|64322106|FG015|Overall Study|Informed consent withdrawn|0|||
23155550|NCT01994382|64322107|FG016|Overall Study|Informed consent withdrawn|0|||
23155551|NCT01994382|64322091|FG000|Overall Study|Progressive disease|3|||
23155552|NCT01994382|64322092|FG001|Overall Study|Progressive disease|4|||
23155553|NCT01994382|64322093|FG002|Overall Study|Progressive disease|4|||
23155554|NCT01994382|64322094|FG003|Overall Study|Progressive disease|3|||
23155555|NCT01994382|64322095|FG004|Overall Study|Progressive disease|2|||
23155556|NCT01994382|64322096|FG005|Overall Study|Progressive disease|3|||
23155557|NCT01994382|64322097|FG006|Overall Study|Progressive disease|3|||
23155558|NCT01994382|64322098|FG007|Overall Study|Progressive disease|6|||
23155559|NCT01994382|64322099|FG008|Overall Study|Progressive disease|2|||
23155560|NCT01994382|64322100|FG009|Overall Study|Progressive disease|2|||
23155561|NCT01994382|64322101|FG010|Overall Study|Progressive disease|13|||
23155562|NCT01994382|64322102|FG011|Overall Study|Progressive disease|8|||
23155563|NCT01994382|64322103|FG012|Overall Study|Progressive disease|7|||
23155564|NCT01994382|64322104|FG013|Overall Study|Progressive disease|3|||
23155565|NCT01994382|64322105|FG014|Overall Study|Progressive disease|6|||
23155566|NCT01994382|64322106|FG015|Overall Study|Progressive disease|44|||
23155567|NCT01994382|64322107|FG016|Overall Study|Progressive disease|28|||
23155568|NCT01994382|64322091|FG000|Overall Study|Physician Decision|0|||
23155569|NCT01994382|64322092|FG001|Overall Study|Physician Decision|1|||
23155570|NCT01994382|64322093|FG002|Overall Study|Physician Decision|0|||
23155571|NCT01994382|64322094|FG003|Overall Study|Physician Decision|0|||
23155572|NCT01994382|64322095|FG004|Overall Study|Physician Decision|0|||
23155573|NCT01994382|64322096|FG005|Overall Study|Physician Decision|0|||
23155574|NCT01994382|64322097|FG006|Overall Study|Physician Decision|0|||
23155575|NCT01994382|64322098|FG007|Overall Study|Physician Decision|0|||
23155576|NCT01994382|64322099|FG008|Overall Study|Physician Decision|0|||
23155577|NCT01994382|64322100|FG009|Overall Study|Physician Decision|0|||
23155578|NCT01994382|64322101|FG010|Overall Study|Physician Decision|3|||
23155579|NCT01994382|64322102|FG011|Overall Study|Physician Decision|1|||
23155580|NCT01994382|64322103|FG012|Overall Study|Physician Decision|1|||
23155581|NCT01994382|64322104|FG013|Overall Study|Physician Decision|0|||
23155582|NCT01994382|64322105|FG014|Overall Study|Physician Decision|1|||
23155583|NCT01994382|64322106|FG015|Overall Study|Physician Decision|4|||
23155584|NCT01994382|64322107|FG016|Overall Study|Physician Decision|2|||
23155585|NCT01994382|64322091|FG000|Overall Study|Death|0|||
23155586|NCT01994382|64322092|FG001|Overall Study|Death|0|||
23155587|NCT01994382|64322093|FG002|Overall Study|Death|0|||
23155588|NCT01994382|64322094|FG003|Overall Study|Death|0|||
23155589|NCT01994382|64322095|FG004|Overall Study|Death|1|||
23155590|NCT01994382|64322096|FG005|Overall Study|Death|0|||
23155591|NCT01994382|64322097|FG006|Overall Study|Death|0|||
23155592|NCT01994382|64322098|FG007|Overall Study|Death|0|||
23155593|NCT01994382|64322099|FG008|Overall Study|Death|1|||
23155594|NCT01994382|64322100|FG009|Overall Study|Death|1|||
23155595|NCT01994382|64322101|FG010|Overall Study|Death|0|||
23155596|NCT01994382|64322102|FG011|Overall Study|Death|0|||
23155597|NCT01994382|64322103|FG012|Overall Study|Death|0|||
23155598|NCT01994382|64322104|FG013|Overall Study|Death|0|||
23155599|NCT01994382|64322105|FG014|Overall Study|Death|0|||
23155600|NCT01994382|64322106|FG015|Overall Study|Death|1|||
23155601|NCT01994382|64322107|FG016|Overall Study|Death|0|||
23155602|NCT01994382|64322091|FG000|Overall Study|Adverse Event|0|||
23155603|NCT01994382|64322092|FG001|Overall Study|Adverse Event|1|||
23155604|NCT01994382|64322093|FG002|Overall Study|Adverse Event|2|||
23155605|NCT01994382|64322094|FG003|Overall Study|Adverse Event|0|||
23155606|NCT01994382|64322095|FG004|Overall Study|Adverse Event|0|||
23155607|NCT01994382|64322096|FG005|Overall Study|Adverse Event|0|||
23221519|NCT01421069|64553704|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
23221520|NCT01421069|64553704|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
23155608|NCT01994382|64322097|FG006|Overall Study|Adverse Event|0|||
23155609|NCT01994382|64322098|FG007|Overall Study|Adverse Event|0|||
23155610|NCT01994382|64322099|FG008|Overall Study|Adverse Event|0|||
23155611|NCT01994382|64322100|FG009|Overall Study|Adverse Event|0|||
23155612|NCT01994382|64322101|FG010|Overall Study|Adverse Event|15|||
23155613|NCT01994382|64322102|FG011|Overall Study|Adverse Event|2|||
23155614|NCT01994382|64322103|FG012|Overall Study|Adverse Event|7|||
23155615|NCT01994382|64322104|FG013|Overall Study|Adverse Event|3|||
23155616|NCT01994382|64322105|FG014|Overall Study|Adverse Event|17|||
23155617|NCT01994382|64322106|FG015|Overall Study|Adverse Event|6|||
23155618|NCT01994382|64322107|FG016|Overall Study|Adverse Event|3|||
23155619|NCT01994382|64322091|FG000|Overall Study|Other than specified|0|||
23155620|NCT01994382|64322092|FG001|Overall Study|Other than specified|0|||
23155621|NCT01994382|64322093|FG002|Overall Study|Other than specified|0|||
23155622|NCT01994382|64322094|FG003|Overall Study|Other than specified|0|||
23155623|NCT01994382|64322095|FG004|Overall Study|Other than specified|0|||
23155624|NCT01994382|64322096|FG005|Overall Study|Other than specified|0|||
23155625|NCT01994382|64322097|FG006|Overall Study|Other than specified|0|||
23155626|NCT01994382|64322098|FG007|Overall Study|Other than specified|0|||
23155627|NCT01994382|64322099|FG008|Overall Study|Other than specified|0|||
23155628|NCT01994382|64322100|FG009|Overall Study|Other than specified|0|||
23155629|NCT01994382|64322101|FG010|Overall Study|Other than specified|2|||
23155630|NCT01994382|64322102|FG011|Overall Study|Other than specified|0|||
23565560|NCT02798211|65799680|FG004|Period 2|Lack of Efficacy|0|||
23565561|NCT02798211|65799681|FG005|Period 2|Lack of Efficacy|1|||
23565562|NCT02798211|65799676|FG000|Period 2|Lost to Follow-up|3|||
23442520|NCT01248949|65362100|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
23442521|NCT01248949|65362101|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
23442522|NCT01248949|65362097|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
23442523|NCT01248949|65362098|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
23155631|NCT01994382|64322103|FG012|Overall Study|Other than specified|2|||
23565563|NCT02798211|65799677|FG001|Period 2|Lost to Follow-up|0|||
23565564|NCT02798211|65799678|FG002|Period 2|Lost to Follow-up|0|||
23565565|NCT02798211|65799679|FG003|Period 2|Lost to Follow-up|0|||
23565566|NCT02798211|65799680|FG004|Period 2|Lost to Follow-up|2|||
23565567|NCT02798211|65799681|FG005|Period 2|Lost to Follow-up|0|||
23155632|NCT01994382|64322104|FG013|Overall Study|Other than specified|0|||
23155633|NCT01994382|64322105|FG014|Overall Study|Other than specified|0|||
23442524|NCT01248949|65362099|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
23442525|NCT01248949|65362100|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
23442526|NCT01248949|65362101|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
23442527|NCT01248949|65362097|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
23442528|NCT01248949|65362098|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
23442529|NCT01248949|65362099|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
23442530|NCT01248949|65362100|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
23442531|NCT01248949|65362101|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
23442532|NCT02728089|65362104|FG000|Overall Study|Physician Decision|2|||
23442533|NCT02728089|65362104|FG000|Overall Study|Withdrawal by Subject|1|||
23442534|NCT01677858|65362105|FG000|Overall Study|Adverse Event|0|||
23442535|NCT01677858|65362106|FG001|Overall Study|Adverse Event|0|||
23442536|NCT01677858|65362107|FG002|Overall Study|Adverse Event|2|||
23442537|NCT01677858|65362108|FG003|Overall Study|Adverse Event|3|||
23442538|NCT01677858|65362109|FG004|Overall Study|Adverse Event|13|||
23442539|NCT01677858|65362105|FG000|Overall Study|Death|0|||
23442540|NCT01677858|65362106|FG001|Overall Study|Death|0|||
23442541|NCT01677858|65362107|FG002|Overall Study|Death|0|||
23442542|NCT01677858|65362108|FG003|Overall Study|Death|0|||
23442543|NCT01677858|65362109|FG004|Overall Study|Death|1|||
23442544|NCT01677858|65362105|FG000|Overall Study|Physician Decision|1|||
23442545|NCT01677858|65362106|FG001|Overall Study|Physician Decision|0|||
23442546|NCT01677858|65362107|FG002|Overall Study|Physician Decision|2|||
23442547|NCT01677858|65362108|FG003|Overall Study|Physician Decision|0|||
23442548|NCT01677858|65362109|FG004|Overall Study|Physician Decision|12|||
23442549|NCT01677858|65362105|FG000|Overall Study|Progressive Disease|2|||
23442550|NCT01677858|65362106|FG001|Overall Study|Progressive Disease|1|||
23442551|NCT01677858|65362107|FG002|Overall Study|Progressive Disease|9|||
23442552|NCT01677858|65362108|FG003|Overall Study|Progressive Disease|3|||
23442553|NCT01677858|65362109|FG004|Overall Study|Progressive Disease|43|||
23442554|NCT01677858|65362105|FG000|Overall Study|Withdrawal by Subject|0|||
23442555|NCT01677858|65362106|FG001|Overall Study|Withdrawal by Subject|1|||
23442556|NCT01677858|65362107|FG002|Overall Study|Withdrawal by Subject|1|||
23442557|NCT01677858|65362108|FG003|Overall Study|Withdrawal by Subject|0|||
23565568|NCT02798211|65799676|FG000|Period 2|Physician Decision|1|||
23155634|NCT01994382|64322106|FG015|Overall Study|Other than specified|4|||
23155635|NCT01994382|64322107|FG016|Overall Study|Other than specified|4|||
23155636|NCT01994382|64322091|FG000|Overall Study|Withdrawal by Subject|0|||
23155637|NCT01994382|64322092|FG001|Overall Study|Withdrawal by Subject|0|||
23155638|NCT01994382|64322093|FG002|Overall Study|Withdrawal by Subject|0|||
23155639|NCT01994382|64322094|FG003|Overall Study|Withdrawal by Subject|0|||
23221521|NCT01421069|64553704|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
23155640|NCT01994382|64322095|FG004|Overall Study|Withdrawal by Subject|0|||
23221522|NCT01421069|64553704|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
23442558|NCT01677858|65362109|FG004|Overall Study|Withdrawal by Subject|15|||
23442559|NCT01677858|65362105|FG000|Overall Study|Lost to Follow-up|0|||
23442560|NCT01677858|65362106|FG001|Overall Study|Lost to Follow-up|0|||
23442561|NCT01677858|65362107|FG002|Overall Study|Lost to Follow-up|0|||
23442562|NCT01677858|65362108|FG003|Overall Study|Lost to Follow-up|0|||
23442563|NCT01677858|65362109|FG004|Overall Study|Lost to Follow-up|1|||
23442564|NCT01843062|65362110|FG000|Overall Study|Protocol Violation|1|||
23442565|NCT01843062|65362111|FG001|Overall Study|Protocol Violation|0|||
23442566|NCT01843062|65362110|FG000|Overall Study|New treatment following progression|2|||
23565569|NCT02798211|65799677|FG001|Period 2|Physician Decision|0|||
23565570|NCT02798211|65799678|FG002|Period 2|Physician Decision|0|||
23442567|NCT01843062|65362111|FG001|Overall Study|New treatment following progression|0|||
23442568|NCT01843062|65362110|FG000|Overall Study|Pregnancy|1|||
23442569|NCT01843062|65362111|FG001|Overall Study|Pregnancy|0|||
23442570|NCT01843062|65362110|FG000|Overall Study|Adverse Event|2|||
23442571|NCT01843062|65362111|FG001|Overall Study|Adverse Event|0|||
23442572|NCT01843062|65362110|FG000|Overall Study|Incorrect randomisation|1|||
23442573|NCT01843062|65362111|FG001|Overall Study|Incorrect randomisation|0|||
23442574|NCT01843062|65362110|FG000|Overall Study|Withdrawal by Subject|12|||
23442575|NCT01843062|65362111|FG001|Overall Study|Withdrawal by Subject|3|||
23442576|NCT01843062|65362110|FG000|Overall Study|Death|1|||
23442577|NCT01843062|65362111|FG001|Overall Study|Death|2|||
23442578|NCT01843062|65362110|FG000|Overall Study|Lost to Follow-up|2|||
23442579|NCT01843062|65362111|FG001|Overall Study|Lost to Follow-up|4|||
23442580|NCT00539305|65362112|FG000|Overall Study|Adverse Event|1|||
23442581|NCT00539305|65362113|FG001|Overall Study|Adverse Event|0|||
23442582|NCT00539305|65362112|FG000|Overall Study|Substance Use|0|||
23442583|NCT00539305|65362113|FG001|Overall Study|Substance Use|1|||
23442584|NCT00539305|65362112|FG000|Overall Study|Withdrawal by Subject|0|||
23442585|NCT00539305|65362113|FG001|Overall Study|Withdrawal by Subject|1|||
23442586|NCT00245037|65362122|FG000|Overall Study|Death|17|||
23442587|NCT02315560|65362128|FG000|Overall Study|noncompliance by subjects|3|||
23155641|NCT01994382|64322096|FG005|Overall Study|Withdrawal by Subject|0|||
23155642|NCT01994382|64322097|FG006|Overall Study|Withdrawal by Subject|0|||
23155643|NCT01994382|64322098|FG007|Overall Study|Withdrawal by Subject|0|||
23155644|NCT01994382|64322099|FG008|Overall Study|Withdrawal by Subject|0|||
23155645|NCT01994382|64322100|FG009|Overall Study|Withdrawal by Subject|0|||
23155646|NCT01994382|64322101|FG010|Overall Study|Withdrawal by Subject|6|||
23155647|NCT01994382|64322102|FG011|Overall Study|Withdrawal by Subject|0|||
23155648|NCT01994382|64322103|FG012|Overall Study|Withdrawal by Subject|2|||
23155649|NCT01994382|64322104|FG013|Overall Study|Withdrawal by Subject|0|||
23155650|NCT01994382|64322105|FG014|Overall Study|Withdrawal by Subject|4|||
23155651|NCT01994382|64322106|FG015|Overall Study|Withdrawal by Subject|3|||
23155652|NCT01994382|64322107|FG016|Overall Study|Withdrawal by Subject|0|||
23155653|NCT01994382|64322091|FG000|Overall Study|Lost to Follow-up|0|||
23155654|NCT01994382|64322092|FG001|Overall Study|Lost to Follow-up|0|||
23155655|NCT01994382|64322093|FG002|Overall Study|Lost to Follow-up|0|||
23155656|NCT01994382|64322094|FG003|Overall Study|Lost to Follow-up|0|||
23155657|NCT01994382|64322095|FG004|Overall Study|Lost to Follow-up|0|||
23155658|NCT01994382|64322096|FG005|Overall Study|Lost to Follow-up|0|||
23155659|NCT01994382|64322097|FG006|Overall Study|Lost to Follow-up|0|||
23155660|NCT01994382|64322098|FG007|Overall Study|Lost to Follow-up|0|||
23155661|NCT01994382|64322099|FG008|Overall Study|Lost to Follow-up|0|||
23155662|NCT01994382|64322100|FG009|Overall Study|Lost to Follow-up|0|||
23155663|NCT01994382|64322101|FG010|Overall Study|Lost to Follow-up|1|||
23155664|NCT01994382|64322102|FG011|Overall Study|Lost to Follow-up|0|||
23155665|NCT01994382|64322103|FG012|Overall Study|Lost to Follow-up|0|||
23155666|NCT01994382|64322104|FG013|Overall Study|Lost to Follow-up|0|||
23155667|NCT01994382|64322105|FG014|Overall Study|Lost to Follow-up|0|||
23155668|NCT01994382|64322106|FG015|Overall Study|Lost to Follow-up|0|||
23155669|NCT01994382|64322107|FG016|Overall Study|Lost to Follow-up|0|||
23155670|NCT01994382|64322091|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155671|NCT01994382|64322092|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155672|NCT01994382|64322093|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155673|NCT01994382|64322094|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155674|NCT01994382|64322095|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155675|NCT01994382|64322096|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155676|NCT01994382|64322097|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155677|NCT01994382|64322098|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155678|NCT01994382|64322099|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155679|NCT01994382|64322100|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155680|NCT01994382|64322101|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
23221523|NCT01421069|64553704|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
23221524|NCT01421069|64553704|FG000|2b. Retreatment Period|Protocol Violation|1|||
23221525|NCT01421069|64553704|FG000|Observational Period|Other|1|||
23221526|NCT01421069|64553704|FG000|Observational Period|No longer willing to participate in study|4|||
23442588|NCT02863328|65362142|FG000|Overall Study|Lost to Follow-up|4|||
23442589|NCT02863328|65362143|FG001|Overall Study|Lost to Follow-up|10|||
23442590|NCT02863328|65362142|FG000|Overall Study|Withdrawal by Subject|7|||
23442591|NCT02863328|65362143|FG001|Overall Study|Withdrawal by Subject|12|||
23442592|NCT02863328|65362142|FG000|Overall Study|Died|0|||
23442593|NCT02863328|65362143|FG001|Overall Study|Died|1|||
23442594|NCT02488005|65362146|FG000|Overall Study|Lost to Follow-up|2|||
23442595|NCT00555672|65362147|FG000|Overall Study|Death|0|||
23442596|NCT00555672|65362148|FG001|Overall Study|Death|2|||
23442597|NCT00555672|65362147|FG000|Overall Study|Adverse Event|8|||
23442598|NCT00555672|65362148|FG001|Overall Study|Adverse Event|2|||
23442599|NCT00555672|65362147|FG000|Overall Study|Objective progression or relapse|11|||
23442600|NCT00555672|65362148|FG001|Overall Study|Objective progression or relapse|5|||
23442601|NCT00555672|65362147|FG000|Overall Study|Other|3|||
23442602|NCT00555672|65362148|FG001|Overall Study|Other|1|||
23442603|NCT00555672|65362147|FG000|Overall Study|Participant refused|2|||
23442604|NCT00555672|65362148|FG001|Overall Study|Participant refused|0|||
23442605|NCT03472586|65362149|FG000|Overall Study|Physician Decision|6|||
23442606|NCT03472586|65362149|FG000|Overall Study|Death|6|||
23442607|NCT03472586|65362149|FG000|Overall Study|Adverse Event|1|||
23442608|NCT02978833|65362150|FG000|Overall Study|Study terminated|1|||
23442609|NCT02978833|65362151|FG001|Overall Study|Study terminated|1|||
23442610|NCT02717494|65362152|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
23442611|NCT02717494|65362153|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
23442612|NCT02717494|65362154|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
23442613|NCT02717494|65362152|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
23442614|NCT02717494|65362153|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
23442615|NCT02717494|65362154|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
23442616|NCT02717494|65362152|FG000|First Intervention (Step 1)|Death|0|||
23442617|NCT02717494|65362153|FG001|First Intervention (Step 1)|Death|0|||
23442618|NCT02717494|65362154|FG002|First Intervention (Step 1)|Death|1|||
23442619|NCT02717494|65362152|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
23442620|NCT02717494|65362153|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
23442621|NCT02717494|65362154|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
23442622|NCT01702246|65362155|FG000|Overall Study|Lost to Follow-up|2|||
23442623|NCT01702246|65362155|FG000|Overall Study|Withdrawal by Subject|2|||
23442624|NCT01702246|65362155|FG000|Overall Study|Physician Decision|1|||
23442625|NCT00741013|65362156|FG000|Overall Study|Adverse Event|1|||
23442626|NCT00741013|65362157|FG001|Overall Study|Adverse Event|0|||
23442627|NCT00741013|65362158|FG002|Overall Study|Adverse Event|0|||
23442628|NCT00741013|65362156|FG000|Overall Study|Withdrawal by Subject|0|||
23442629|NCT00741013|65362157|FG001|Overall Study|Withdrawal by Subject|0|||
23442630|NCT00741013|65362158|FG002|Overall Study|Withdrawal by Subject|1|||
23442631|NCT00741013|65362156|FG000|Overall Study|Discovered failed screen after enrolled|0|||
23442632|NCT00741013|65362157|FG001|Overall Study|Discovered failed screen after enrolled|2|||
23442633|NCT00741013|65362158|FG002|Overall Study|Discovered failed screen after enrolled|0|||
23442634|NCT03614325|65362159|FG000|Overall Study|Withdrawal by Subject|0|||
23442635|NCT03614325|65362160|FG001|Overall Study|Withdrawal by Subject|2|||
23442636|NCT03614325|65362159|FG000|Overall Study|Surgery Cancelled|2|||
23442637|NCT03614325|65362160|FG001|Overall Study|Surgery Cancelled|1|||
23442638|NCT03614325|65362159|FG000|Overall Study|Lost to Follow-up|2|||
23442639|NCT03614325|65362160|FG001|Overall Study|Lost to Follow-up|1|||
23442640|NCT03614325|65362159|FG000|Overall Study|Surgery never scheduled|1|||
23442641|NCT03614325|65362160|FG001|Overall Study|Surgery never scheduled|0|||
23442642|NCT02837029|65362165|FG000|Screening|Failed to meet screening requirements.|7|||
23442643|NCT02837029|65362166|FG001|Screening|Failed to meet screening requirements.|3|||
23442644|NCT02837029|65362167|FG002|Screening|Failed to meet screening requirements.|0|||
23442645|NCT02837029|65362165|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
23442646|NCT02837029|65362166|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
23442647|NCT02837029|65362167|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
23442648|NCT02837029|65362165|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
23442649|NCT02837029|65362166|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
23442650|NCT02837029|65362167|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
23442651|NCT02837029|65362165|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
23442652|NCT02837029|65362166|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
23442653|NCT02837029|65362167|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
23627738|NCT02547441|66024539|FG000|Double-Blind Study Period|Physician Decision|1|||
23627739|NCT02547441|66024540|FG001|Double-Blind Study Period|Physician Decision|0|||
23155681|NCT01994382|64322102|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23442654|NCT02837029|65362165|FG000|Cycle 2 and Beyond|Adverse Event|1|||
23442655|NCT02837029|65362166|FG001|Cycle 2 and Beyond|Adverse Event|0|||
23442656|NCT02837029|65362167|FG002|Cycle 2 and Beyond|Adverse Event|0|||
23442657|NCT02837029|65362165|FG000|2 Year Follow-up|Death|6|||
23442658|NCT02837029|65362166|FG001|2 Year Follow-up|Death|7|||
23442659|NCT02837029|65362167|FG002|2 Year Follow-up|Death|0|||
23155682|NCT01994382|64322103|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
23155683|NCT01994382|64322104|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155684|NCT01994382|64322105|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
23155685|NCT01994382|64322106|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
23155686|NCT01994382|64322107|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
23155687|NCT01994382|64322091|FG000|Overall Study|Protocol violation/noncompliance|0|||
23627740|NCT02547441|66024539|FG000|Double-Blind Study Period|Protocol Violation|1|||
23627741|NCT02547441|66024540|FG001|Double-Blind Study Period|Protocol Violation|2|||
23627742|NCT02547441|66024539|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
23627743|NCT02547441|66024540|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
23627744|NCT02547441|66024539|FG000|Double-Blind Study Period|Sponsor Decision|1|||
23627745|NCT02547441|66024540|FG001|Double-Blind Study Period|Sponsor Decision|0|||
23627746|NCT02547441|66024539|FG000|Open-Label Study Period|Adverse Event|10|||
23627747|NCT02547441|66024540|FG001|Open-Label Study Period|Adverse Event|11|||
23627748|NCT02547441|66024539|FG000|Open-Label Study Period|Lack of Efficacy|3|||
23627749|NCT02547441|66024540|FG001|Open-Label Study Period|Lack of Efficacy|2|||
23627750|NCT02547441|66024539|FG000|Open-Label Study Period|Lost to Follow-up|7|||
23627751|NCT02547441|66024540|FG001|Open-Label Study Period|Lost to Follow-up|8|||
23627752|NCT02547441|66024539|FG000|Open-Label Study Period|Physician Decision|1|||
23627753|NCT02547441|66024540|FG001|Open-Label Study Period|Physician Decision|0|||
23627754|NCT02547441|66024539|FG000|Open-Label Study Period|Protocol Violation|2|||
23627755|NCT02547441|66024540|FG001|Open-Label Study Period|Protocol Violation|0|||
23442660|NCT01792115|65362170|FG000|Overall Study|Lost to Follow-up|0|||
23442661|NCT01792115|65362171|FG001|Overall Study|Lost to Follow-up|1|||
23442662|NCT01792115|65362172|FG002|Overall Study|Lost to Follow-up|0|||
23442663|NCT00306527|65362175|FG000|Overall Study|Lost to Follow-up|3|||
23442664|NCT00306527|65362176|FG001|Overall Study|Lost to Follow-up|4|||
23565571|NCT02798211|65799679|FG003|Period 2|Physician Decision|1|||
23627756|NCT02547441|66024539|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
23627757|NCT02547441|66024540|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
23155688|NCT01994382|64322092|FG001|Overall Study|Protocol violation/noncompliance|0|||
23155689|NCT01994382|64322093|FG002|Overall Study|Protocol violation/noncompliance|0|||
23155690|NCT01994382|64322094|FG003|Overall Study|Protocol violation/noncompliance|0|||
23155691|NCT01994382|64322095|FG004|Overall Study|Protocol violation/noncompliance|0|||
23155692|NCT01994382|64322096|FG005|Overall Study|Protocol violation/noncompliance|0|||
23155693|NCT01994382|64322097|FG006|Overall Study|Protocol violation/noncompliance|0|||
23155694|NCT01994382|64322098|FG007|Overall Study|Protocol violation/noncompliance|0|||
23155695|NCT01994382|64322099|FG008|Overall Study|Protocol violation/noncompliance|0|||
23155696|NCT01994382|64322100|FG009|Overall Study|Protocol violation/noncompliance|0|||
23155697|NCT01994382|64322101|FG010|Overall Study|Protocol violation/noncompliance|0|||
23155698|NCT01994382|64322102|FG011|Overall Study|Protocol violation/noncompliance|1|||
23442665|NCT00306527|65362177|FG002|Overall Study|Lost to Follow-up|3|||
23627758|NCT02547441|66024539|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
23627759|NCT02547441|66024540|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
23627760|NCT01677299|66024541|FG000|Overall Study|Adverse Event|0|||
23627761|NCT01677299|66024542|FG001|Overall Study|Adverse Event|2|||
23627762|NCT01677299|66024543|FG002|Overall Study|Adverse Event|1|||
23155699|NCT01994382|64322103|FG012|Overall Study|Protocol violation/noncompliance|0|||
23155700|NCT01994382|64322104|FG013|Overall Study|Protocol violation/noncompliance|0|||
23442666|NCT00306527|65362178|FG003|Overall Study|Lost to Follow-up|0|||
23442667|NCT00306527|65362175|FG000|Overall Study|Withdrawal by Subject|2|||
23565572|NCT02798211|65799680|FG004|Period 2|Physician Decision|1|||
23565573|NCT02798211|65799681|FG005|Period 2|Physician Decision|0|||
23565574|NCT02798211|65799676|FG000|Period 2|Pregnancy|0|||
23565575|NCT02798211|65799677|FG001|Period 2|Pregnancy|0|||
23565576|NCT02798211|65799678|FG002|Period 2|Pregnancy|0|||
23565577|NCT02798211|65799679|FG003|Period 2|Pregnancy|2|||
23565578|NCT02798211|65799680|FG004|Period 2|Pregnancy|0|||
23565579|NCT02798211|65799681|FG005|Period 2|Pregnancy|0|||
23565580|NCT02798211|65799676|FG000|Period 2|Technical problems|1|||
23565581|NCT02798211|65799677|FG001|Period 2|Technical problems|0|||
23565582|NCT02798211|65799678|FG002|Period 2|Technical problems|0|||
23565583|NCT02798211|65799679|FG003|Period 2|Technical problems|1|||
23565584|NCT02798211|65799680|FG004|Period 2|Technical problems|0|||
23565585|NCT02798211|65799681|FG005|Period 2|Technical problems|0|||
23565586|NCT02798211|65799676|FG000|Period 2|Withdrawal of Informed Consent|1|||
23565587|NCT02798211|65799677|FG001|Period 2|Withdrawal of Informed Consent|0|||
23565588|NCT02798211|65799678|FG002|Period 2|Withdrawal of Informed Consent|0|||
23565589|NCT02798211|65799679|FG003|Period 2|Withdrawal of Informed Consent|2|||
23565590|NCT02798211|65799680|FG004|Period 2|Withdrawal of Informed Consent|2|||
23565591|NCT02798211|65799681|FG005|Period 2|Withdrawal of Informed Consent|3|||
23565592|NCT01725386|65799682|FG000|Overall Study|Death|84|||
23565593|NCT01725386|65799683|FG001|Overall Study|Death|40|||
23627763|NCT01677299|66024544|FG003|Overall Study|Adverse Event|0|||
23155701|NCT01994382|64322105|FG014|Overall Study|Protocol violation/noncompliance|0|||
23442668|NCT00306527|65362176|FG001|Overall Study|Withdrawal by Subject|3|||
23565594|NCT01725386|65799682|FG000|Overall Study|Lost to Follow-up|81|||
23565595|NCT01725386|65799683|FG001|Overall Study|Lost to Follow-up|6|||
23627764|NCT01677299|66024541|FG000|Overall Study|Withdrawal by Subject|0|||
23627765|NCT01677299|66024542|FG001|Overall Study|Withdrawal by Subject|1|||
23627766|NCT01677299|66024543|FG002|Overall Study|Withdrawal by Subject|0|||
23627767|NCT01677299|66024544|FG003|Overall Study|Withdrawal by Subject|1|||
23627768|NCT00882115|66024545|FG000|Overall Study|Withdrawal by Subject|3|||
23627769|NCT00882115|66024545|FG000|Overall Study|did not respond to DEP challe|6|||
23155702|NCT01994382|64322106|FG015|Overall Study|Protocol violation/noncompliance|0|||
23155703|NCT01994382|64322107|FG016|Overall Study|Protocol violation/noncompliance|2|||
23155704|NCT01994382|64322091|FG000|Overall Study|Rolled over to Phase 2a|0|||
23155705|NCT01994382|64322092|FG001|Overall Study|Rolled over to Phase 2a|0|||
23155706|NCT01994382|64322093|FG002|Overall Study|Rolled over to Phase 2a|1|||
23155707|NCT01994382|64322094|FG003|Overall Study|Rolled over to Phase 2a|0|||
23155708|NCT01994382|64322095|FG004|Overall Study|Rolled over to Phase 2a|0|||
23155709|NCT01994382|64322096|FG005|Overall Study|Rolled over to Phase 2a|0|||
23155710|NCT01994382|64322097|FG006|Overall Study|Rolled over to Phase 2a|0|||
23155711|NCT01994382|64322098|FG007|Overall Study|Rolled over to Phase 2a|0|||
23155712|NCT01994382|64322099|FG008|Overall Study|Rolled over to Phase 2a|0|||
23155713|NCT01994382|64322100|FG009|Overall Study|Rolled over to Phase 2a|2|||
23155714|NCT01994382|64322101|FG010|Overall Study|Rolled over to Phase 2a|0|||
23155715|NCT01994382|64322102|FG011|Overall Study|Rolled over to Phase 2a|0|||
23155716|NCT01994382|64322103|FG012|Overall Study|Rolled over to Phase 2a|0|||
23155717|NCT01994382|64322104|FG013|Overall Study|Rolled over to Phase 2a|0|||
23155718|NCT01994382|64322105|FG014|Overall Study|Rolled over to Phase 2a|0|||
23221527|NCT01421069|64553704|FG000|Observational Period|Lost to Follow-up|3|||
23221528|NCT02679781|64553705|FG000|Overall Study|Lost to Follow-up|1|||
23221529|NCT02679781|64553706|FG001|Overall Study|Lost to Follow-up|2|||
23627770|NCT04594733|66024546|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
23627771|NCT04594733|66024547|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
23221530|NCT02679781|64553705|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
23221531|NCT02679781|64553706|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
23221532|NCT03807778|64553710|FG000|Overall Study|Adverse Event|0|||
23627772|NCT04594733|66024546|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
23627773|NCT04594733|66024547|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
23627774|NCT04594733|66024546|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
23627775|NCT04594733|66024547|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
23627776|NCT02419417|66024555|FG000|Overall Study|Disease progression|5|||
23627777|NCT02419417|66024556|FG001|Overall Study|Disease progression|4|||
23627778|NCT02419417|66024557|FG002|Overall Study|Disease progression|13|||
23627779|NCT02419417|66024558|FG003|Overall Study|Disease progression|10|||
23627780|NCT02419417|66024559|FG004|Overall Study|Disease progression|10|||
23627781|NCT02419417|66024560|FG005|Overall Study|Disease progression|3|||
23627782|NCT02419417|66024561|FG006|Overall Study|Disease progression|4|||
23627783|NCT02419417|66024562|FG007|Overall Study|Disease progression|5|||
23627784|NCT02419417|66024563|FG008|Overall Study|Disease progression|13|||
23627785|NCT02419417|66024564|FG009|Overall Study|Disease progression|9|||
23627786|NCT02419417|66024565|FG010|Overall Study|Disease progression|0|||
23627787|NCT02419417|66024555|FG000|Overall Study|Study drug toxicity|0|||
23627788|NCT02419417|66024556|FG001|Overall Study|Study drug toxicity|0|||
23627789|NCT02419417|66024557|FG002|Overall Study|Study drug toxicity|0|||
23627790|NCT02419417|66024558|FG003|Overall Study|Study drug toxicity|0|||
23627791|NCT02419417|66024559|FG004|Overall Study|Study drug toxicity|1|||
23627792|NCT02419417|66024560|FG005|Overall Study|Study drug toxicity|0|||
23627793|NCT02419417|66024561|FG006|Overall Study|Study drug toxicity|0|||
23627794|NCT02419417|66024562|FG007|Overall Study|Study drug toxicity|0|||
23627795|NCT02419417|66024563|FG008|Overall Study|Study drug toxicity|0|||
23627796|NCT02419417|66024564|FG009|Overall Study|Study drug toxicity|0|||
23627797|NCT02419417|66024565|FG010|Overall Study|Study drug toxicity|0|||
23627798|NCT02419417|66024555|FG000|Overall Study|Adverse event unrelated to study drug|0|||
23627799|NCT02419417|66024556|FG001|Overall Study|Adverse event unrelated to study drug|0|||
23627800|NCT02419417|66024557|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23627801|NCT02419417|66024558|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23627802|NCT02419417|66024559|FG004|Overall Study|Adverse event unrelated to study drug|2|||
23627803|NCT02419417|66024560|FG005|Overall Study|Adverse event unrelated to study drug|1|||
23627804|NCT02419417|66024561|FG006|Overall Study|Adverse event unrelated to study drug|0|||
23627805|NCT02419417|66024562|FG007|Overall Study|Adverse event unrelated to study drug|1|||
23627806|NCT02419417|66024563|FG008|Overall Study|Adverse event unrelated to study drug|0|||
23627807|NCT02419417|66024564|FG009|Overall Study|Adverse event unrelated to study drug|0|||
23155719|NCT01994382|64322106|FG015|Overall Study|Rolled over to Phase 2a|0|||
23155720|NCT01994382|64322107|FG016|Overall Study|Rolled over to Phase 2a|0|||
23155721|NCT02535715|64322108|FG000|Overall Study|Withdrawal by Subject|0|||
23221533|NCT03807778|64553711|FG001|Overall Study|Adverse Event|0|||
23221534|NCT03807778|64553712|FG002|Overall Study|Adverse Event|3|||
23627808|NCT02419417|66024565|FG010|Overall Study|Adverse event unrelated to study drug|0|||
23627809|NCT02419417|66024555|FG000|Overall Study|Participant request to discontinue|0|||
23627810|NCT02419417|66024556|FG001|Overall Study|Participant request to discontinue|0|||
23627811|NCT02419417|66024557|FG002|Overall Study|Participant request to discontinue|0|||
23627812|NCT02419417|66024558|FG003|Overall Study|Participant request to discontinue|0|||
23627813|NCT02419417|66024559|FG004|Overall Study|Participant request to discontinue|0|||
23627814|NCT02419417|66024560|FG005|Overall Study|Participant request to discontinue|0|||
23627815|NCT02419417|66024561|FG006|Overall Study|Participant request to discontinue|0|||
23627816|NCT02419417|66024562|FG007|Overall Study|Participant request to discontinue|0|||
23627817|NCT02419417|66024563|FG008|Overall Study|Participant request to discontinue|0|||
23627818|NCT02419417|66024564|FG009|Overall Study|Participant request to discontinue|1|||
23627819|NCT02419417|66024565|FG010|Overall Study|Participant request to discontinue|0|||
23627820|NCT02419417|66024555|FG000|Overall Study|Withdrawal by Subject|0|||
23627821|NCT02419417|66024556|FG001|Overall Study|Withdrawal by Subject|0|||
23627822|NCT02419417|66024557|FG002|Overall Study|Withdrawal by Subject|0|||
23565596|NCT01725386|65799682|FG000|Overall Study|Withdrawal by Subject|10|||
23565597|NCT01725386|65799683|FG001|Overall Study|Withdrawal by Subject|0|||
23565598|NCT01306201|65799686|FG000|Overall Study|Arrhythmia|4|||
23565599|NCT01306201|65799686|FG000|Overall Study|Files could not be processed|3|||
23565600|NCT01306201|65799686|FG000|Overall Study|Files unreadable|3|||
23565601|NCT03185832|65799688|FG000|Overall Study|Death|9|||
23565602|NCT03185832|65799689|FG001|Overall Study|Death|14|||
23565603|NCT03185832|65799690|FG002|Overall Study|Death|9|||
23565604|NCT03185832|65799691|FG003|Overall Study|Death|7|||
23565605|NCT03185832|65799688|FG000|Overall Study|Withdrawn - vital status available|0|||
23565606|NCT03185832|65799689|FG001|Overall Study|Withdrawn - vital status available|1|||
23565607|NCT03185832|65799690|FG002|Overall Study|Withdrawn - vital status available|1|||
23565608|NCT03185832|65799691|FG003|Overall Study|Withdrawn - vital status available|4|||
23565609|NCT01821898|65799692|FG000|Overall Study|Withdrawal by Subject|2|||
23565610|NCT01821898|65799693|FG001|Overall Study|Withdrawal by Subject|1|||
23565611|NCT00856661|65799697|FG000|Overall Study|Death|15|||
23565612|NCT00856661|65799698|FG001|Overall Study|Death|18|||
23565613|NCT00856661|65799697|FG000|Overall Study|Protocol Violation|2|||
23565614|NCT00856661|65799698|FG001|Overall Study|Protocol Violation|1|||
23565615|NCT00856661|65799697|FG000|Overall Study|Withdrawal by Subject|1|||
23565616|NCT00856661|65799698|FG001|Overall Study|Withdrawal by Subject|2|||
23565617|NCT00856661|65799697|FG000|Overall Study|Lost to Follow-up|1|||
23565618|NCT00856661|65799698|FG001|Overall Study|Lost to Follow-up|3|||
23565619|NCT00856661|65799697|FG000|Overall Study|Physician Judgement|8|||
23565620|NCT00856661|65799698|FG001|Overall Study|Physician Judgement|5|||
23565621|NCT01078662|65799723|FG000|Overall Study|Death|41|||
23565622|NCT01078662|65799724|FG001|Overall Study|Death|103|||
23565623|NCT01078662|65799725|FG002|Overall Study|Death|18|||
23565624|NCT01078662|65799726|FG003|Overall Study|Death|5|||
23565625|NCT01078662|65799727|FG004|Overall Study|Death|8|||
23565626|NCT01078662|65799723|FG000|Overall Study|Patients reached data cut-off|12|||
23565627|NCT01078662|65799724|FG001|Overall Study|Patients reached data cut-off|53|||
23565628|NCT01078662|65799725|FG002|Overall Study|Patients reached data cut-off|2|||
23565629|NCT01078662|65799726|FG003|Overall Study|Patients reached data cut-off|2|||
23565630|NCT01078662|65799727|FG004|Overall Study|Patients reached data cut-off|3|||
23565631|NCT01078662|65799723|FG000|Overall Study|Withdrawal by Subject|4|||
23565632|NCT01078662|65799724|FG001|Overall Study|Withdrawal by Subject|11|||
23565633|NCT01078662|65799725|FG002|Overall Study|Withdrawal by Subject|1|||
23565634|NCT01078662|65799726|FG003|Overall Study|Withdrawal by Subject|0|||
23565635|NCT01078662|65799727|FG004|Overall Study|Withdrawal by Subject|0|||
23565636|NCT01078662|65799723|FG000|Overall Study|Protocol Violation|0|||
23565637|NCT01078662|65799724|FG001|Overall Study|Protocol Violation|1|||
23565638|NCT01078662|65799725|FG002|Overall Study|Protocol Violation|0|||
23565639|NCT01078662|65799726|FG003|Overall Study|Protocol Violation|0|||
23565640|NCT01078662|65799727|FG004|Overall Study|Protocol Violation|0|||
23565641|NCT01078662|65799723|FG000|Overall Study|Lost to Follow-up|1|||
23627823|NCT02419417|66024558|FG003|Overall Study|Withdrawal by Subject|0|||
23627824|NCT02419417|66024559|FG004|Overall Study|Withdrawal by Subject|0|||
23627825|NCT02419417|66024560|FG005|Overall Study|Withdrawal by Subject|0|||
23627826|NCT02419417|66024561|FG006|Overall Study|Withdrawal by Subject|0|||
23627827|NCT02419417|66024562|FG007|Overall Study|Withdrawal by Subject|0|||
23627828|NCT02419417|66024563|FG008|Overall Study|Withdrawal by Subject|0|||
23627829|NCT02419417|66024564|FG009|Overall Study|Withdrawal by Subject|0|||
23155722|NCT02535715|64322109|FG001|Overall Study|Withdrawal by Subject|0|||
23155723|NCT02535715|64322110|FG002|Overall Study|Withdrawal by Subject|1|||
23155724|NCT00621751|64322113|FG000|Overall Study|Adverse Event|0|||
23327526|NCT00661193|64940936|FG001|Overall Study|Not protocol specified|0|||
23327527|NCT02547428|64940937|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
23327528|NCT02547428|64940938|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
23565642|NCT01078662|65799724|FG001|Overall Study|Lost to Follow-up|0|||
23565643|NCT01078662|65799725|FG002|Overall Study|Lost to Follow-up|0|||
23565644|NCT01078662|65799726|FG003|Overall Study|Lost to Follow-up|0|||
23565645|NCT01078662|65799727|FG004|Overall Study|Lost to Follow-up|0|||
23565646|NCT00920621|65799728|FG000|Overall Study|Lost to Follow-up|16|||
23565647|NCT00920621|65799729|FG001|Overall Study|Lost to Follow-up|17|||
23627830|NCT02419417|66024565|FG010|Overall Study|Withdrawal by Subject|1|||
23627831|NCT00543062|66024566|FG000|Overall Study|Withdrawal by Subject|1|||
23627832|NCT00543062|66024567|FG001|Overall Study|Withdrawal by Subject|0|||
23627833|NCT00543062|66024568|FG002|Overall Study|Withdrawal by Subject|2|||
23627834|NCT00543062|66024569|FG003|Overall Study|Withdrawal by Subject|0|||
23627835|NCT00543062|66024566|FG000|Overall Study|Adverse Event|0|||
23627836|NCT00543062|66024567|FG001|Overall Study|Adverse Event|1|||
23627837|NCT00543062|66024568|FG002|Overall Study|Adverse Event|1|||
23627838|NCT00543062|66024569|FG003|Overall Study|Adverse Event|1|||
23627839|NCT00543062|66024566|FG000|Overall Study|Protocol Violation|1|||
23627840|NCT00543062|66024567|FG001|Overall Study|Protocol Violation|0|||
23627841|NCT00543062|66024568|FG002|Overall Study|Protocol Violation|0|||
23627842|NCT00543062|66024569|FG003|Overall Study|Protocol Violation|0|||
23627843|NCT00832000|66024570|FG000|Overall Study|Adverse Event|2|||
23627844|NCT00832000|66024571|FG001|Overall Study|Adverse Event|0|||
23627845|NCT00832000|66024570|FG000|Overall Study|Withdrawal by Subject|1|||
23627846|NCT00832000|66024571|FG001|Overall Study|Withdrawal by Subject|0|||
23627847|NCT00832000|66024570|FG000|Overall Study|No calls to IVR in either period|1|||
23627848|NCT00832000|66024571|FG001|Overall Study|No calls to IVR in either period|1|||
23627849|NCT00832000|66024570|FG000|Overall Study|No calls to IVR in period 2|2|||
23627850|NCT00832000|66024571|FG001|Overall Study|No calls to IVR in period 2|0|||
23627851|NCT04650698|66024574|FG000|Overall Study|Protocol Violation|2|||
23627852|NCT04650698|66024575|FG001|Overall Study|Protocol Violation|1|||
23627853|NCT04650698|66024574|FG000|Overall Study|Withdrawal by Subject|0|||
23627854|NCT04650698|66024575|FG001|Overall Study|Withdrawal by Subject|1|||
23627855|NCT02684123|66024579|FG000|Phase 1|Lack of Efficacy|5|||
23627856|NCT02684123|66024580|FG001|Phase 1|Lack of Efficacy|0|||
23627857|NCT02684123|66024579|FG000|Phase 1|Adverse Event|3|||
23627858|NCT02684123|66024580|FG001|Phase 1|Adverse Event|0|||
23627859|NCT02684123|66024579|FG000|Phase 1|Lost to Follow-up|0|||
23627860|NCT02684123|66024580|FG001|Phase 1|Lost to Follow-up|1|||
23627861|NCT02684123|66024579|FG000|Phase 2|Lack of Efficacy|1|||
23627862|NCT02684123|66024580|FG001|Phase 2|Lack of Efficacy|8|||
23627863|NCT01012947|66024581|FG000|Overall Study|Lost to Follow-up|131|||
23627864|NCT01012947|66024582|FG001|Overall Study|Lost to Follow-up|135|||
23627865|NCT01012947|66024583|FG002|Overall Study|Lost to Follow-up|130|||
23627866|NCT01012947|66024584|FG003|Overall Study|Lost to Follow-up|118|||
23627867|NCT01012947|66024585|FG004|Overall Study|Lost to Follow-up|142|||
23627868|NCT01606319|66024587|FG000|Overall Study|Lost to Follow-up|17|||
23627869|NCT01606319|66024588|FG001|Overall Study|Lost to Follow-up|14|||
23627870|NCT01606319|66024587|FG000|Overall Study|Withdrawal by Subject|9|||
23627871|NCT01606319|66024588|FG001|Overall Study|Withdrawal by Subject|12|||
23627872|NCT01606319|66024587|FG000|Overall Study|Physician Decision|1|||
23627873|NCT01606319|66024588|FG001|Overall Study|Physician Decision|2|||
23627874|NCT01606319|66024587|FG000|Overall Study|Lack of Efficacy|6|||
23627875|NCT01606319|66024588|FG001|Overall Study|Lack of Efficacy|8|||
23627876|NCT01606319|66024587|FG000|Overall Study|Adverse Event|1|||
23627877|NCT01606319|66024588|FG001|Overall Study|Adverse Event|4|||
23627878|NCT00583947|66024589|FG000|Cross-over Period|Adverse Event|2|||
23627879|NCT00583947|66024590|FG001|Cross-over Period|Adverse Event|0|||
23627880|NCT00583947|66024589|FG000|Cross-over Period|Withdrawal by Subject|2|||
23627881|NCT00583947|66024590|FG001|Cross-over Period|Withdrawal by Subject|0|||
23627882|NCT00583947|66024589|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
23627883|NCT00583947|66024590|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
23627884|NCT00583947|66024589|FG000|Cross-over Period|Other|1|||
23627885|NCT00583947|66024590|FG001|Cross-over Period|Other|1|||
23627886|NCT01114672|66024598|FG000|Overall Study|Death|0|||
23627887|NCT01114672|66024599|FG001|Overall Study|Death|1|||
23627888|NCT01114672|66024598|FG000|Overall Study|Withdrawal by Subject|2|||
23627889|NCT01114672|66024599|FG001|Overall Study|Withdrawal by Subject|1|||
23627890|NCT01114672|66024598|FG000|Overall Study|Lost to Follow-up|1|||
23627891|NCT01114672|66024599|FG001|Overall Study|Lost to Follow-up|0|||
23627892|NCT01114672|66024598|FG000|Overall Study|transplanted|1|||
23627893|NCT01114672|66024599|FG001|Overall Study|transplanted|0|||
23627894|NCT01436305|66024600|FG000|Overall Study|Death|1|||
23627895|NCT01436305|66024601|FG001|Overall Study|Death|0|||
23627896|NCT01436305|66024602|FG002|Overall Study|Death|0|||
23221535|NCT03807778|64553713|FG003|Overall Study|Adverse Event|5|||
23221536|NCT03807778|64553710|FG000|Overall Study|Progressive Disease|4|||
23627897|NCT01436305|66024600|FG000|Overall Study|Lost to Follow-up|0|||
23627898|NCT01436305|66024601|FG001|Overall Study|Lost to Follow-up|1|||
23627899|NCT01436305|66024602|FG002|Overall Study|Lost to Follow-up|0|||
23627900|NCT01436305|66024600|FG000|Overall Study|Withdrawal by Subject|1|||
23627901|NCT01436305|66024601|FG001|Overall Study|Withdrawal by Subject|3|||
23627902|NCT01436305|66024602|FG002|Overall Study|Withdrawal by Subject|0|||
23627903|NCT00823836|66024604|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
23627904|NCT00823836|66024605|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
23627905|NCT00823836|66024604|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
23627906|NCT00823836|66024605|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
23627907|NCT00823836|66024604|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
23627908|NCT00823836|66024605|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
23627909|NCT00823836|66024604|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
23627910|NCT00823836|66024605|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
23627911|NCT00823836|66024604|FG000|Long-term Phase|Adverse Event|3|||
23627912|NCT00823836|66024605|FG001|Long-term Phase|Adverse Event|2|||
23627913|NCT00823836|66024604|FG000|Long-term Phase|Physician Decision|1|||
23627914|NCT00823836|66024605|FG001|Long-term Phase|Physician Decision|2|||
23627915|NCT00823836|66024604|FG000|Long-term Phase|Withdrawal by Subject|1|||
23627916|NCT00823836|66024605|FG001|Long-term Phase|Withdrawal by Subject|1|||
23627917|NCT03065933|66024606|FG000|Overall Study|study terminated|5|||
23627918|NCT02725567|66024607|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
23627919|NCT02725567|66024608|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
23627920|NCT02725567|66024607|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
23627921|NCT02725567|66024608|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
23155725|NCT00621751|64322114|FG001|Overall Study|Adverse Event|1|||
23155726|NCT00290186|64322117|FG000|Overall Study|Adverse Event|1|||
23155727|NCT00290186|64322118|FG001|Overall Study|Adverse Event|1|||
23155728|NCT00290186|64322117|FG000|Overall Study|Lost to Follow-up|3|||
23221537|NCT03807778|64553711|FG001|Overall Study|Progressive Disease|2|||
23221538|NCT03807778|64553712|FG002|Overall Study|Progressive Disease|8|||
23221539|NCT03807778|64553713|FG003|Overall Study|Progressive Disease|15|||
23221540|NCT03807778|64553710|FG000|Overall Study|Symptomatic Deterioration|0|||
23221541|NCT03807778|64553711|FG001|Overall Study|Symptomatic Deterioration|1|||
23221542|NCT03807778|64553712|FG002|Overall Study|Symptomatic Deterioration|0|||
23221543|NCT03807778|64553713|FG003|Overall Study|Symptomatic Deterioration|1|||
23221544|NCT03807778|64553710|FG000|Overall Study|Withdrawal by Subject|0|||
23221545|NCT03807778|64553711|FG001|Overall Study|Withdrawal by Subject|1|||
23221546|NCT03807778|64553712|FG002|Overall Study|Withdrawal by Subject|0|||
23221547|NCT03807778|64553713|FG003|Overall Study|Withdrawal by Subject|1|||
23221548|NCT03807778|64553710|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
23221549|NCT03807778|64553711|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
23627922|NCT02725567|66024607|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
23155729|NCT00290186|64322118|FG001|Overall Study|Lost to Follow-up|2|||
23155730|NCT00290186|64322117|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
23155731|NCT00290186|64322118|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
23155732|NCT00290186|64322117|FG000|Overall Study|Withdrawal by Subject|0|||
23155733|NCT00290186|64322118|FG001|Overall Study|Withdrawal by Subject|1|||
23155734|NCT02495844|64322119|FG000|Overall Study|Lack of Efficacy|1|||
23155735|NCT02495844|64322120|FG001|Overall Study|Lack of Efficacy|2|||
23155736|NCT02495844|64322119|FG000|Overall Study|AE, non-fatal|0|||
23155737|NCT02495844|64322120|FG001|Overall Study|AE, non-fatal|1|||
23155738|NCT02495844|64322119|FG000|Overall Study|Hepatitis Positivity|0|||
23155739|NCT02495844|64322120|FG001|Overall Study|Hepatitis Positivity|1|||
23155740|NCT01195090|64322127|FG000|Overall Study|Adverse Event|1|||
23155741|NCT01195090|64322128|FG001|Overall Study|Adverse Event|2|||
23155742|NCT01195090|64322127|FG000|Overall Study|Lost to Follow-up|2|||
23155743|NCT01195090|64322128|FG001|Overall Study|Lost to Follow-up|2|||
23155744|NCT01195090|64322127|FG000|Overall Study|Protocol Violation|3|||
23155745|NCT01195090|64322128|FG001|Overall Study|Protocol Violation|4|||
23155746|NCT01621542|64322129|FG000|Overall Study|Adverse Event|0|||
23155747|NCT01621542|64322130|FG001|Overall Study|Adverse Event|0|||
23155748|NCT01621542|64322131|FG002|Overall Study|Adverse Event|1|||
23155749|NCT01621542|64322132|FG003|Overall Study|Adverse Event|3|||
23155750|NCT01621542|64322133|FG004|Overall Study|Adverse Event|0|||
23155751|NCT01621542|64322134|FG005|Overall Study|Adverse Event|0|||
23155752|NCT01621542|64322129|FG000|Overall Study|Death|0|||
23155753|NCT01621542|64322130|FG001|Overall Study|Death|1|||
23155754|NCT01621542|64322131|FG002|Overall Study|Death|0|||
23155755|NCT01621542|64322132|FG003|Overall Study|Death|0|||
23155756|NCT01621542|64322133|FG004|Overall Study|Death|0|||
23155757|NCT01621542|64322134|FG005|Overall Study|Death|0|||
23155758|NCT01621542|64322129|FG000|Overall Study|Physician Decision|1|||
23155759|NCT01621542|64322130|FG001|Overall Study|Physician Decision|0|||
23155760|NCT01621542|64322131|FG002|Overall Study|Physician Decision|1|||
23155761|NCT01621542|64322132|FG003|Overall Study|Physician Decision|13|||
23155762|NCT01621542|64322133|FG004|Overall Study|Physician Decision|3|||
23221550|NCT03807778|64553712|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
23221551|NCT03807778|64553713|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
23627923|NCT02725567|66024608|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
23155763|NCT01621542|64322134|FG005|Overall Study|Physician Decision|1|||
23155764|NCT01621542|64322129|FG000|Overall Study|Withdrawal by Subject|2|||
23155765|NCT01621542|64322130|FG001|Overall Study|Withdrawal by Subject|0|||
23155766|NCT01621542|64322131|FG002|Overall Study|Withdrawal by Subject|1|||
23155767|NCT01621542|64322132|FG003|Overall Study|Withdrawal by Subject|3|||
23155768|NCT01621542|64322133|FG004|Overall Study|Withdrawal by Subject|3|||
23442669|NCT00306527|65362177|FG002|Overall Study|Withdrawal by Subject|0|||
23627924|NCT00798304|66024609|FG000|Overall Study|Adverse Event|0|||
23627925|NCT00798304|66024610|FG001|Overall Study|Adverse Event|1|||
23327529|NCT02547428|64940937|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
23327530|NCT02547428|64940938|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
23327531|NCT02547428|64940937|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
23327532|NCT02547428|64940938|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
23327533|NCT02547428|64940937|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
23327534|NCT02547428|64940938|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
23327535|NCT02547428|64940937|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
23327536|NCT02547428|64940938|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
23327537|NCT02547428|64940937|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
23327538|NCT02547428|64940938|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
23327539|NCT02547428|64940937|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
23627926|NCT00798304|66024611|FG002|Overall Study|Adverse Event|1|||
23627927|NCT00798304|66024609|FG000|Overall Study|Discontinuation by Sponsor|14|||
23627928|NCT00798304|66024610|FG001|Overall Study|Discontinuation by Sponsor|21|||
23627929|NCT00798304|66024611|FG002|Overall Study|Discontinuation by Sponsor|9|||
23627930|NCT03062449|66024612|FG000|Overall Study|Withdrawal by Subject|7|||
23627931|NCT03062449|66024613|FG001|Overall Study|Withdrawal by Subject|1|||
23627932|NCT04140266|66024614|FG000|Overall Study|Physician Decision|2|||
23627933|NCT04140266|66024615|FG001|Overall Study|Physician Decision|0|||
23627934|NCT04140266|66024614|FG000|Overall Study|Withdrawal by Subject|4|||
23627935|NCT04140266|66024615|FG001|Overall Study|Withdrawal by Subject|2|||
23627936|NCT01740154|66024619|FG000|Overall Study|Adverse Event|1|||
23627937|NCT03784820|66024620|FG000|Overall Study|Lost to Follow-up|5|||
23627938|NCT03784820|66024621|FG001|Overall Study|Lost to Follow-up|5|||
23627939|NCT03784820|66024622|FG002|Overall Study|Lost to Follow-up|3|||
23627940|NCT03784820|66024623|FG003|Overall Study|Lost to Follow-up|3|||
23627941|NCT03021551|66024624|FG000|Overall Study|Equipment Issues|2|||
23627942|NCT03021551|66024624|FG000|Overall Study|Protocol Violation|1|||
23627943|NCT01712061|66024625|FG000|Overall Study|Adverse Event|4|||
23627944|NCT01712061|66024626|FG001|Overall Study|Adverse Event|9|||
23627945|NCT01712061|66024627|FG002|Overall Study|Adverse Event|5|||
23627946|NCT01712061|66024625|FG000|Overall Study|Death|0|||
23627947|NCT01712061|66024626|FG001|Overall Study|Death|0|||
23627948|NCT01712061|66024627|FG002|Overall Study|Death|1|||
23627949|NCT01712061|66024625|FG000|Overall Study|Lost to Follow-up|1|||
23627950|NCT01712061|66024626|FG001|Overall Study|Lost to Follow-up|0|||
23627951|NCT01712061|66024627|FG002|Overall Study|Lost to Follow-up|1|||
23627952|NCT01712061|66024625|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
23627953|NCT01712061|66024626|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
23627954|NCT01712061|66024627|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
23627955|NCT01712061|66024625|FG000|Overall Study|Medication Error Without Associated AE|0|||
23627956|NCT01712061|66024626|FG001|Overall Study|Medication Error Without Associated AE|1|||
23627957|NCT01712061|66024627|FG002|Overall Study|Medication Error Without Associated AE|0|||
23627958|NCT01712061|66024625|FG000|Overall Study|Withdrawal by Subject|1|||
23627959|NCT01712061|66024626|FG001|Overall Study|Withdrawal by Subject|7|||
23627960|NCT01712061|66024627|FG002|Overall Study|Withdrawal by Subject|1|||
23627961|NCT01712061|66024625|FG000|Overall Study|Other|0|||
23627962|NCT01712061|66024626|FG001|Overall Study|Other|3|||
23627963|NCT01712061|66024627|FG002|Overall Study|Other|0|||
23627964|NCT00967005|66024628|FG000|Overall Study|Lost to Follow-up|7|||
23627965|NCT00967005|66024629|FG001|Overall Study|Lost to Follow-up|10|||
23627966|NCT04927364|66024631|FG000|Overall Study|Withdrawal by Subject|3|||
23155769|NCT01621542|64322134|FG005|Overall Study|Withdrawal by Subject|3|||
23155770|NCT01621542|64322129|FG000|Overall Study|progression/treatment failure|2|||
23155771|NCT01621542|64322130|FG001|Overall Study|progression/treatment failure|4|||
23155772|NCT01621542|64322131|FG002|Overall Study|progression/treatment failure|3|||
23155773|NCT01621542|64322132|FG003|Overall Study|progression/treatment failure|7|||
23155774|NCT01621542|64322133|FG004|Overall Study|progression/treatment failure|3|||
23155775|NCT01621542|64322134|FG005|Overall Study|progression/treatment failure|5|||
23155776|NCT01621542|64322129|FG000|Overall Study|Protocol Violation|0|||
23155777|NCT01621542|64322130|FG001|Overall Study|Protocol Violation|0|||
23155778|NCT01621542|64322131|FG002|Overall Study|Protocol Violation|0|||
23155779|NCT01621542|64322132|FG003|Overall Study|Protocol Violation|1|||
23155780|NCT01621542|64322133|FG004|Overall Study|Protocol Violation|0|||
23155781|NCT01621542|64322134|FG005|Overall Study|Protocol Violation|0|||
23627967|NCT04927364|66024631|FG000|Overall Study|Unable to complete preassessment MRI|1|||
23627968|NCT00784147|66024632|FG000|Overall Study|Lost to Follow-up|2|||
23627969|NCT00784147|66024633|FG001|Overall Study|Lost to Follow-up|4|||
23627970|NCT00784147|66024632|FG000|Overall Study|Withdrawal by Subject|1|||
23627971|NCT00784147|66024633|FG001|Overall Study|Withdrawal by Subject|3|||
23627972|NCT00784147|66024632|FG000|Overall Study|Physician Decision|2|||
23627973|NCT00784147|66024633|FG001|Overall Study|Physician Decision|1|||
23627974|NCT00784147|66024632|FG000|Overall Study|Protocol Violation|1|||
23627975|NCT00784147|66024633|FG001|Overall Study|Protocol Violation|1|||
23627976|NCT00784147|66024632|FG000|Overall Study|Death|2|||
23155782|NCT01621542|64322129|FG000|Overall Study|study stopped by sponsor|0|||
23155783|NCT01621542|64322130|FG001|Overall Study|study stopped by sponsor|0|||
23155784|NCT01621542|64322131|FG002|Overall Study|study stopped by sponsor|0|||
23155785|NCT01621542|64322132|FG003|Overall Study|study stopped by sponsor|1|||
23155786|NCT01621542|64322133|FG004|Overall Study|study stopped by sponsor|0|||
23155787|NCT01621542|64322134|FG005|Overall Study|study stopped by sponsor|0|||
23155788|NCT00804570|64322135|FG000|Overall Study|Adverse Event|14|||
23155789|NCT00804570|64322136|FG001|Overall Study|Adverse Event|7|||
23155790|NCT00804570|64322135|FG000|Overall Study|Lack of Efficacy|0|||
23155791|NCT00804570|64322136|FG001|Overall Study|Lack of Efficacy|1|||
23155792|NCT00804570|64322135|FG000|Overall Study|Lost to Follow-up|18|||
23155793|NCT00804570|64322136|FG001|Overall Study|Lost to Follow-up|21|||
23155794|NCT00804570|64322135|FG000|Overall Study|Entry criteria not met|5|||
23155795|NCT00804570|64322136|FG001|Overall Study|Entry criteria not met|5|||
23155796|NCT00804570|64322135|FG000|Overall Study|Protocol Violation|12|||
23155797|NCT00804570|64322136|FG001|Overall Study|Protocol Violation|16|||
23155798|NCT00804570|64322135|FG000|Overall Study|Physician Decision|1|||
23155799|NCT00804570|64322136|FG001|Overall Study|Physician Decision|2|||
23155800|NCT00804570|64322135|FG000|Overall Study|Sponsor decision|1|||
23155801|NCT00804570|64322136|FG001|Overall Study|Sponsor decision|4|||
23155802|NCT00804570|64322135|FG000|Overall Study|Withdrawal by Subject|21|||
23155803|NCT00804570|64322136|FG001|Overall Study|Withdrawal by Subject|38|||
23155804|NCT02463071|64322137|FG000|Overall Study|Adverse Event|3|||
23155805|NCT02463071|64322138|FG001|Overall Study|Adverse Event|5|||
23565648|NCT00920621|65799730|FG002|Overall Study|Lost to Follow-up|19|||
23155806|NCT02463071|64322139|FG002|Overall Study|Adverse Event|1|||
23155807|NCT02463071|64322137|FG000|Overall Study|Death|1|||
23155808|NCT02463071|64322138|FG001|Overall Study|Death|0|||
23155809|NCT02463071|64322139|FG002|Overall Study|Death|0|||
23155810|NCT02463071|64322137|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
23155811|NCT02463071|64322138|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23155812|NCT02463071|64322139|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23155813|NCT02463071|64322137|FG000|Overall Study|Reason not specified|7|||
23155814|NCT02463071|64322138|FG001|Overall Study|Reason not specified|9|||
23155815|NCT02463071|64322139|FG002|Overall Study|Reason not specified|4|||
23155816|NCT02463071|64322137|FG000|Overall Study|Protocol Violation|0|||
23155817|NCT02463071|64322138|FG001|Overall Study|Protocol Violation|2|||
23155818|NCT02463071|64322139|FG002|Overall Study|Protocol Violation|0|||
23155819|NCT02463071|64322137|FG000|Overall Study|Lost to Follow-up|0|||
23155820|NCT02463071|64322138|FG001|Overall Study|Lost to Follow-up|0|||
23155821|NCT02463071|64322139|FG002|Overall Study|Lost to Follow-up|1|||
23155822|NCT02285920|64322140|FG000|Overall Study|Kidney transplantation|2|||
23155823|NCT02285920|64322141|FG001|Overall Study|Kidney transplantation|2|||
23155824|NCT02285920|64322142|FG002|Overall Study|Kidney transplantation|2|||
23221552|NCT00010803|64553714|FG000|Overall Study|Withdrawal by Subject|97|||
23221553|NCT00010803|64553715|FG001|Overall Study|Withdrawal by Subject|98|||
23565649|NCT00920621|65799731|FG003|Overall Study|Lost to Follow-up|21|||
23565650|NCT00920621|65799728|FG000|Overall Study|Fetal/neonatal deaths|16|||
23565651|NCT00920621|65799729|FG001|Overall Study|Fetal/neonatal deaths|14|||
23565652|NCT00920621|65799730|FG002|Overall Study|Fetal/neonatal deaths|16|||
23565653|NCT00920621|65799731|FG003|Overall Study|Fetal/neonatal deaths|14|||
23565654|NCT00920621|65799728|FG000|Overall Study|Blood sample not collected|22|||
23565655|NCT00920621|65799729|FG001|Overall Study|Blood sample not collected|14|||
23627977|NCT00784147|66024633|FG001|Overall Study|Death|0|||
23155825|NCT02285920|64322143|FG003|Overall Study|Kidney transplantation|0|||
23155826|NCT02285920|64322140|FG000|Overall Study|Change to peritoneal dialysis|0|||
23155827|NCT02285920|64322141|FG001|Overall Study|Change to peritoneal dialysis|0|||
23155828|NCT02285920|64322142|FG002|Overall Study|Change to peritoneal dialysis|1|||
23155829|NCT02285920|64322143|FG003|Overall Study|Change to peritoneal dialysis|0|||
23155830|NCT02285920|64322140|FG000|Overall Study|Transfer to non-participating unit|0|||
23155831|NCT02285920|64322141|FG001|Overall Study|Transfer to non-participating unit|1|||
23155832|NCT02285920|64322142|FG002|Overall Study|Transfer to non-participating unit|0|||
23155833|NCT02285920|64322143|FG003|Overall Study|Transfer to non-participating unit|0|||
23155834|NCT02285920|64322140|FG000|Overall Study|Dialysis discontinuation|0|||
23155835|NCT02285920|64322141|FG001|Overall Study|Dialysis discontinuation|1|||
23155836|NCT02285920|64322142|FG002|Overall Study|Dialysis discontinuation|0|||
23155837|NCT02285920|64322143|FG003|Overall Study|Dialysis discontinuation|0|||
23155838|NCT02285920|64322140|FG000|Overall Study|Death|2|||
23155839|NCT02285920|64322141|FG001|Overall Study|Death|0|||
23565656|NCT00920621|65799730|FG002|Overall Study|Blood sample not collected|0|||
23155840|NCT02285920|64322142|FG002|Overall Study|Death|2|||
23155841|NCT02285920|64322143|FG003|Overall Study|Death|1|||
23155842|NCT01368536|64322149|FG000|Overall Study|Adverse Event|5|||
23155843|NCT01368536|64322150|FG001|Overall Study|Adverse Event|6|||
23565657|NCT00920621|65799731|FG003|Overall Study|Blood sample not collected|0|||
23565658|NCT02588261|65799732|FG000|Overall Study|Study Terminated by Sponsor|157|||
23155844|NCT01368536|64322151|FG002|Overall Study|Adverse Event|8|||
23565659|NCT02588261|65799733|FG001|Overall Study|Study Terminated by Sponsor|142|||
23221554|NCT01624467|64553718|FG000|Overall Study|Withdrawal by Subject|2|||
23221555|NCT01624467|64553718|FG000|Overall Study|Lost to Follow-up|1|||
23221556|NCT01624467|64553718|FG000|Overall Study|Adverse Event|7|||
23221557|NCT01624467|64553718|FG000|Overall Study|Progressive Disease|19|||
23221558|NCT01624467|64553718|FG000|Overall Study|Per Sponsor Requirement|1|||
23221559|NCT01624467|64553718|FG000|Overall Study|Subject Withdrew from Treatment|1|||
23221560|NCT00810043|64553719|FG000|Overall Study|Withdrawal by Subject|1|||
23221561|NCT00810043|64553720|FG001|Overall Study|Withdrawal by Subject|0|||
23221562|NCT00810043|64553721|FG002|Overall Study|Withdrawal by Subject|2|||
23221563|NCT00810043|64553719|FG000|Overall Study|Lost to Follow-up|1|||
23221564|NCT00810043|64553720|FG001|Overall Study|Lost to Follow-up|0|||
23221565|NCT00810043|64553721|FG002|Overall Study|Lost to Follow-up|0|||
23221566|NCT00810043|64553719|FG000|Overall Study|Physician Decision|0|||
23221567|NCT00810043|64553720|FG001|Overall Study|Physician Decision|0|||
23221568|NCT00810043|64553721|FG002|Overall Study|Physician Decision|2|||
23221569|NCT00810043|64553719|FG000|Overall Study|Death|2|||
23221570|NCT00810043|64553720|FG001|Overall Study|Death|0|||
23221571|NCT00810043|64553721|FG002|Overall Study|Death|0|||
23221572|NCT00810043|64553719|FG000|Overall Study|Unrelated medical problem|0|||
23221573|NCT00810043|64553720|FG001|Overall Study|Unrelated medical problem|1|||
23221574|NCT00810043|64553721|FG002|Overall Study|Unrelated medical problem|0|||
23221575|NCT00810043|64553719|FG000|Overall Study|Non-medical problem|0|||
23221576|NCT00810043|64553720|FG001|Overall Study|Non-medical problem|0|||
23221577|NCT00810043|64553721|FG002|Overall Study|Non-medical problem|1|||
23221578|NCT00810043|64553719|FG000|Overall Study|No longer met enrollment criteria|0|||
23221579|NCT00810043|64553720|FG001|Overall Study|No longer met enrollment criteria|0|||
23221580|NCT00810043|64553721|FG002|Overall Study|No longer met enrollment criteria|3|||
23221581|NCT02475629|64553722|FG000|Overall Study|Adverse Event|1|||
23221582|NCT02475629|64553722|FG000|Overall Study|Death|4|||
23221583|NCT02475629|64553722|FG000|Overall Study|Physician Decision|1|||
23221584|NCT02475629|64553722|FG000|Overall Study|Withdrawal by Subject|1|||
23221585|NCT02475629|64553722|FG000|Overall Study|Lost to Follow-up|1|||
23221586|NCT02475629|64553722|FG000|Overall Study|Subject non-compliance|1|||
23221587|NCT02580591|64553723|FG000|Overall Study|Adverse Event|0|||
23221588|NCT02580591|64553724|FG001|Overall Study|Adverse Event|1|||
23221589|NCT02580591|64553725|FG002|Overall Study|Adverse Event|2|||
23221590|NCT02580591|64553726|FG003|Overall Study|Adverse Event|5|||
23221591|NCT02580591|64553723|FG000|Overall Study|Protocol Violation|3|||
23221592|NCT02580591|64553724|FG001|Overall Study|Protocol Violation|2|||
23155845|NCT01368536|64322149|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23155846|NCT01368536|64322150|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23155847|NCT01368536|64322151|FG002|Overall Study|Abnormal laboratory value(s)|2|||
23155848|NCT01368536|64322149|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23155849|NCT01368536|64322150|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23155850|NCT01368536|64322151|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23155851|NCT01368536|64322149|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
23155852|NCT01368536|64322150|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23155853|NCT01368536|64322151|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23155854|NCT01368536|64322149|FG000|Overall Study|No longer required study medication|0|||
23155855|NCT01368536|64322150|FG001|Overall Study|No longer required study medication|0|||
23155856|NCT01368536|64322151|FG002|Overall Study|No longer required study medication|1|||
23155857|NCT01368536|64322149|FG000|Overall Study|Withdrawal by Subject|2|||
23155858|NCT01368536|64322150|FG001|Overall Study|Withdrawal by Subject|5|||
23155859|NCT01368536|64322151|FG002|Overall Study|Withdrawal by Subject|4|||
23155860|NCT01368536|64322149|FG000|Overall Study|Lost to Follow-up|3|||
23155861|NCT01368536|64322150|FG001|Overall Study|Lost to Follow-up|3|||
23155862|NCT01368536|64322151|FG002|Overall Study|Lost to Follow-up|5|||
23155863|NCT01368536|64322149|FG000|Overall Study|Administrative problems|34|||
23155864|NCT01368536|64322150|FG001|Overall Study|Administrative problems|39|||
23155865|NCT01368536|64322151|FG002|Overall Study|Administrative problems|35|||
23155866|NCT01368536|64322149|FG000|Overall Study|Protocol deviation|0|||
23155867|NCT01368536|64322150|FG001|Overall Study|Protocol deviation|3|||
23155868|NCT01368536|64322151|FG002|Overall Study|Protocol deviation|1|||
23155869|NCT00359021|64322152|FG000|Overall Study|Adverse Event|26|||
23155870|NCT00359021|64322153|FG001|Overall Study|Adverse Event|8|||
23221593|NCT02580591|64553725|FG002|Overall Study|Protocol Violation|1|||
23565660|NCT02588261|65799732|FG000|Overall Study|Protocol Deviation|1|||
23155871|NCT00359021|64322152|FG000|Overall Study|Subject Non-Compliant|1|||
23155872|NCT00359021|64322153|FG001|Overall Study|Subject Non-Compliant|2|||
23155873|NCT00359021|64322152|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
23155874|NCT00359021|64322153|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
23221594|NCT02580591|64553726|FG003|Overall Study|Protocol Violation|1|||
23221595|NCT02580591|64553723|FG000|Overall Study|Lost to Follow-up|5|||
23221596|NCT02580591|64553724|FG001|Overall Study|Lost to Follow-up|3|||
23221597|NCT02580591|64553725|FG002|Overall Study|Lost to Follow-up|3|||
23221598|NCT02580591|64553726|FG003|Overall Study|Lost to Follow-up|1|||
23155875|NCT00359021|64322152|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
23155876|NCT00359021|64322153|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
23155877|NCT00359021|64322152|FG000|Overall Study|Withdrawal by Subject|2|||
23155878|NCT00359021|64322153|FG001|Overall Study|Withdrawal by Subject|9|||
23155879|NCT00359021|64322152|FG000|Overall Study|Lost to Follow-up|1|||
23155880|NCT00359021|64322153|FG001|Overall Study|Lost to Follow-up|0|||
23155881|NCT00359021|64322152|FG000|Overall Study|Other|4|||
23155882|NCT00359021|64322153|FG001|Overall Study|Other|1|||
23155883|NCT00359021|64322152|FG000|Overall Study|Pregnancy|1|||
23155884|NCT00359021|64322153|FG001|Overall Study|Pregnancy|0|||
23155885|NCT00843518|64322154|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
23155886|NCT00843518|64322155|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
23155887|NCT00843518|64322154|FG000|Period 2 (Double-blind Treatment)|Death|0|||
23155888|NCT00843518|64322155|FG001|Period 2 (Double-blind Treatment)|Death|1|||
23155889|NCT00843518|64322154|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
23155890|NCT00843518|64322155|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
23155891|NCT00843518|64322154|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
23155892|NCT00843518|64322155|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
23155893|NCT00843518|64322154|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
23155894|NCT00843518|64322155|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
23155895|NCT00843518|64322154|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
23155896|NCT00843518|64322155|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
23155897|NCT00843518|64322154|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
23155898|NCT00843518|64322155|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
23565661|NCT02588261|65799733|FG001|Overall Study|Protocol Deviation|0|||
23565662|NCT02588261|65799732|FG000|Overall Study|Death|1|||
23565663|NCT02588261|65799733|FG001|Overall Study|Death|2|||
23565664|NCT02588261|65799732|FG000|Overall Study|Withdrawal by Subject|12|||
23565665|NCT02588261|65799733|FG001|Overall Study|Withdrawal by Subject|8|||
23565666|NCT02588261|65799732|FG000|Overall Study|Noncompliance with Study Drug|0|||
23565667|NCT02588261|65799733|FG001|Overall Study|Noncompliance with Study Drug|1|||
23627978|NCT01078922|66024636|FG000|Overall Study|Adverse Event|1|||
23627979|NCT01426347|66024638|FG000|Overall Study|Lost to Follow-up|0|||
23627980|NCT01426347|66024639|FG001|Overall Study|Lost to Follow-up|3|||
23155899|NCT03034460|64322157|FG000|Overall Study|Adverse Event|0|||
23155900|NCT03034460|64322158|FG001|Overall Study|Adverse Event|1|||
23155901|NCT03034460|64322157|FG000|Overall Study|Withdrawal by Subject|2|||
23155902|NCT03034460|64322158|FG001|Overall Study|Withdrawal by Subject|2|||
23155903|NCT03034460|64322157|FG000|Overall Study|Personal Reasons|1|||
23155904|NCT03034460|64322158|FG001|Overall Study|Personal Reasons|0|||
23155905|NCT01092143|64322162|FG000|Overall Study|Adverse Event|10|||
23155906|NCT01092143|64322163|FG001|Overall Study|Adverse Event|5|||
23155907|NCT01092143|64322164|FG002|Overall Study|Adverse Event|1|||
23155908|NCT01092143|64322165|FG003|Overall Study|Adverse Event|4|||
23155909|NCT01092143|64322166|FG004|Overall Study|Adverse Event|3|||
23155910|NCT01092143|64322162|FG000|Overall Study|Lost to Follow-up|1|||
23155911|NCT01092143|64322163|FG001|Overall Study|Lost to Follow-up|0|||
23155912|NCT01092143|64322164|FG002|Overall Study|Lost to Follow-up|1|||
23155913|NCT01092143|64322165|FG003|Overall Study|Lost to Follow-up|0|||
23442670|NCT00306527|65362178|FG003|Overall Study|Withdrawal by Subject|3|||
23442671|NCT00306527|65362175|FG000|Overall Study|Adverse Event|0|||
23442672|NCT00306527|65362176|FG001|Overall Study|Adverse Event|0|||
23627981|NCT01426347|66024638|FG000|Overall Study|Protocol Violation|2|||
23627982|NCT01426347|66024639|FG001|Overall Study|Protocol Violation|0|||
23627983|NCT01426347|66024638|FG000|Overall Study|Withdrawal by Subject|5|||
23627984|NCT01426347|66024639|FG001|Overall Study|Withdrawal by Subject|0|||
23627985|NCT02906020|66024640|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
23627986|NCT02906020|66024641|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
23627987|NCT02906020|66024642|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
23627988|NCT02906020|66024643|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
23627989|NCT02906020|66024644|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
23627990|NCT02906020|66024645|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
23155914|NCT01092143|64322166|FG004|Overall Study|Lost to Follow-up|0|||
23155915|NCT01092143|64322162|FG000|Overall Study|Consent withdrawn|2|||
23155916|NCT01092143|64322163|FG001|Overall Study|Consent withdrawn|1|||
23155917|NCT01092143|64322164|FG002|Overall Study|Consent withdrawn|0|||
23155918|NCT01092143|64322165|FG003|Overall Study|Consent withdrawn|1|||
23155919|NCT01092143|64322166|FG004|Overall Study|Consent withdrawn|3|||
23221599|NCT02580591|64553723|FG000|Overall Study|Withdrawal by Subject|6|||
23442673|NCT00306527|65362177|FG002|Overall Study|Adverse Event|1|||
23442674|NCT00306527|65362178|FG003|Overall Study|Adverse Event|1|||
23442675|NCT00306527|65362175|FG000|Overall Study|Death|1|||
23565668|NCT02588261|65799732|FG000|Overall Study|Miscellaneous|5|||
23627991|NCT02906020|66024646|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
23627992|NCT02906020|66024647|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
23627993|NCT02906020|66024648|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
23442676|NCT00306527|65362176|FG001|Overall Study|Death|0|||
23442677|NCT00306527|65362177|FG002|Overall Study|Death|1|||
23442678|NCT00306527|65362178|FG003|Overall Study|Death|2|||
23442679|NCT01505374|65362185|FG000|Overall Study|Lost to Follow-up|1|||
23565669|NCT02588261|65799733|FG001|Overall Study|Miscellaneous|4|||
23565670|NCT02588261|65799732|FG000|Overall Study|Progressive Disease|61|||
23155920|NCT01092143|64322162|FG000|Overall Study|Not treated|0|||
23155921|NCT01092143|64322163|FG001|Overall Study|Not treated|0|||
23155922|NCT01092143|64322164|FG002|Overall Study|Not treated|1|||
23155923|NCT01092143|64322165|FG003|Overall Study|Not treated|0|||
23155924|NCT01092143|64322166|FG004|Overall Study|Not treated|0|||
23155925|NCT01092143|64322162|FG000|Overall Study|did not reversibility criteria|0|||
23155926|NCT01092143|64322163|FG001|Overall Study|did not reversibility criteria|0|||
23155927|NCT01092143|64322164|FG002|Overall Study|did not reversibility criteria|1|||
23155928|NCT01092143|64322165|FG003|Overall Study|did not reversibility criteria|0|||
23155929|NCT01092143|64322166|FG004|Overall Study|did not reversibility criteria|0|||
23155930|NCT01092143|64322162|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
23155931|NCT01092143|64322163|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
23155932|NCT01092143|64322164|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
23155933|NCT01092143|64322165|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
23327540|NCT02547428|64940938|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
23155934|NCT01092143|64322166|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
23155935|NCT01092143|64322162|FG000|Overall Study|Ineligible patient|1|||
23155936|NCT01092143|64322163|FG001|Overall Study|Ineligible patient|0|||
23155937|NCT01092143|64322164|FG002|Overall Study|Ineligible patient|0|||
23155938|NCT01092143|64322165|FG003|Overall Study|Ineligible patient|0|||
23155939|NCT01092143|64322166|FG004|Overall Study|Ineligible patient|0|||
23155940|NCT01092143|64322162|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
23155941|NCT01092143|64322163|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
23155942|NCT01092143|64322164|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
23155943|NCT01092143|64322165|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
23155944|NCT01092143|64322166|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
23155945|NCT01092143|64322162|FG000|Overall Study|Patient travel|0|||
23155946|NCT01092143|64322163|FG001|Overall Study|Patient travel|0|||
23155947|NCT01092143|64322164|FG002|Overall Study|Patient travel|0|||
23155948|NCT01092143|64322165|FG003|Overall Study|Patient travel|0|||
23155949|NCT01092143|64322166|FG004|Overall Study|Patient travel|1|||
23155950|NCT01092143|64322162|FG000|Overall Study|Non compliance with study medication|0|||
23155951|NCT01092143|64322163|FG001|Overall Study|Non compliance with study medication|0|||
23155952|NCT01092143|64322164|FG002|Overall Study|Non compliance with study medication|0|||
23155953|NCT01092143|64322165|FG003|Overall Study|Non compliance with study medication|0|||
23155954|NCT01092143|64322166|FG004|Overall Study|Non compliance with study medication|1|||
23155955|NCT01092143|64322162|FG000|Overall Study|Randomized by mistake|0|||
23155956|NCT01092143|64322163|FG001|Overall Study|Randomized by mistake|0|||
23155957|NCT01092143|64322164|FG002|Overall Study|Randomized by mistake|0|||
23155958|NCT01092143|64322165|FG003|Overall Study|Randomized by mistake|1|||
23155959|NCT01092143|64322166|FG004|Overall Study|Randomized by mistake|0|||
23155960|NCT01092143|64322162|FG000|Overall Study|Pregnancy|0|||
23155961|NCT01092143|64322163|FG001|Overall Study|Pregnancy|0|||
23155962|NCT01092143|64322164|FG002|Overall Study|Pregnancy|0|||
23155963|NCT01092143|64322165|FG003|Overall Study|Pregnancy|1|||
23155964|NCT01092143|64322166|FG004|Overall Study|Pregnancy|0|||
23155965|NCT02046096|64322167|FG000|Overall Study|Death|28|||
23155966|NCT02046096|64322168|FG001|Overall Study|Death|45|||
23155967|NCT02046096|64322167|FG000|Overall Study|Lost to Follow-up|9|||
23155968|NCT02046096|64322168|FG001|Overall Study|Lost to Follow-up|20|||
23155969|NCT02046096|64322167|FG000|Overall Study|Withdrawal by Subject|5|||
23155970|NCT02046096|64322168|FG001|Overall Study|Withdrawal by Subject|17|||
23155971|NCT02046096|64322167|FG000|Overall Study|Other endpoint|2|||
23155972|NCT02046096|64322168|FG001|Overall Study|Other endpoint|19|||
23155973|NCT00455013|64322169|FG000|Short Term Period|Adverse Event|2|||
23155974|NCT00455013|64322170|FG001|Short Term Period|Adverse Event|5|||
23155975|NCT00455013|64322171|FG002|Short Term Period|Adverse Event|0|||
23155976|NCT00455013|64322169|FG000|Short Term Period|Withdrawal by Subject|0|||
23155977|NCT00455013|64322170|FG001|Short Term Period|Withdrawal by Subject|0|||
23155978|NCT00455013|64322171|FG002|Short Term Period|Withdrawal by Subject|1|||
23155979|NCT00455013|64322169|FG000|Short Term Period|Lack of Efficacy|4|||
23155980|NCT00455013|64322170|FG001|Short Term Period|Lack of Efficacy|0|||
23155981|NCT00455013|64322171|FG002|Short Term Period|Lack of Efficacy|0|||
23327541|NCT02547428|64940937|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
23327542|NCT02547428|64940938|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
23442680|NCT01505374|65362186|FG001|Overall Study|Lost to Follow-up|0|||
23565671|NCT02588261|65799733|FG001|Overall Study|Progressive Disease|82|||
23155982|NCT00455013|64322169|FG000|Short Term Period|Other|0|||
23155983|NCT00455013|64322170|FG001|Short Term Period|Other|0|||
23155984|NCT00455013|64322171|FG002|Short Term Period|Other|1|||
23155985|NCT00455013|64322169|FG000|Long Term Extension (LTE)|Adverse Event|0|||
23155986|NCT00455013|64322170|FG001|Long Term Extension (LTE)|Adverse Event|1|||
23155987|NCT00455013|64322171|FG002|Long Term Extension (LTE)|Adverse Event|1|||
23155988|NCT00455013|64322169|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
23155989|NCT00455013|64322170|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
23155990|NCT00455013|64322171|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
23155991|NCT00455013|64322169|FG000|Long Term Extension (LTE)|Death|1|||
23155992|NCT00455013|64322170|FG001|Long Term Extension (LTE)|Death|1|||
23155993|NCT00455013|64322171|FG002|Long Term Extension (LTE)|Death|0|||
23155994|NCT00455013|64322169|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
23155995|NCT00455013|64322170|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
23155996|NCT00455013|64322171|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
23565672|NCT02588261|65799732|FG000|Overall Study|Adverse Event|29|||
23565673|NCT02588261|65799733|FG001|Overall Study|Adverse Event|24|||
23565674|NCT02588261|65799732|FG000|Overall Study|Lost to Follow-up|1|||
23565675|NCT02588261|65799733|FG001|Overall Study|Lost to Follow-up|0|||
23565676|NCT04615182|65799734|FG000|Overall Study|Re-transplanted|2|||
23565677|NCT04615182|65799734|FG000|Overall Study|Protocol Violation|6|||
23565678|NCT04615182|65799734|FG000|Overall Study|Death|6|||
23565679|NCT04615182|65799734|FG000|Overall Study|Death and protocol violation|1|||
23565680|NCT02712398|65799737|FG000|Overall Study|Withdrawal by Subject|6|||
23565681|NCT02712398|65799737|FG000|Overall Study|Lost to Follow-up|6|||
23565682|NCT02712398|65799737|FG000|Overall Study|Sponsor Decision|1|||
23565683|NCT02712398|65799737|FG000|Overall Study|Physician Decision|1|||
23565684|NCT02712398|65799737|FG000|Overall Study|Death|2|||
23565685|NCT02712398|65799737|FG000|Overall Study|Re-operation|21|||
23565686|NCT03203694|65799738|FG000|Overall Study|Withdrawal by Subject|2|||
23565687|NCT03203694|65799739|FG001|Overall Study|Withdrawal by Subject|0|||
23565688|NCT03203694|65799740|FG002|Overall Study|Withdrawal by Subject|0|||
23565689|NCT03203694|65799741|FG003|Overall Study|Withdrawal by Subject|0|||
23565690|NCT03203694|65799742|FG004|Overall Study|Withdrawal by Subject|0|||
23565691|NCT03203694|65799743|FG005|Overall Study|Withdrawal by Subject|0|||
23565692|NCT03439189|65799744|FG000|Overall Study|Protocol Violation|19|||
23565693|NCT03439189|65799744|FG000|Overall Study|Lack of Efficacy|63|||
23565694|NCT02387216|65799747|FG000|Overall Study|Progressive disease|2|||
23565695|NCT02387216|65799748|FG001|Overall Study|Progressive disease|0|||
23565696|NCT02387216|65799747|FG000|Overall Study|Withdrawal by Subject|3|||
23565697|NCT02387216|65799748|FG001|Overall Study|Withdrawal by Subject|5|||
23565698|NCT02387216|65799747|FG000|Overall Study|Physician Decision|2|||
23565699|NCT02387216|65799748|FG001|Overall Study|Physician Decision|0|||
23565700|NCT02387216|65799747|FG000|Overall Study|Sponsor Decision|28|||
23565701|NCT02387216|65799748|FG001|Overall Study|Sponsor Decision|12|||
23155997|NCT00455013|64322169|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
23155998|NCT00455013|64322170|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
23155999|NCT00455013|64322171|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
23156000|NCT00455013|64322169|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
23156001|NCT00455013|64322170|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
23156002|NCT00455013|64322171|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
23156003|NCT00455013|64322169|FG000|Long Term Extension (LTE)|non-specified|0|||
23156004|NCT00455013|64322170|FG001|Long Term Extension (LTE)|non-specified|0|||
23156005|NCT00455013|64322171|FG002|Long Term Extension (LTE)|non-specified|1|||
23156006|NCT00766090|64322172|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23156007|NCT00766090|64322173|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23156008|NCT00766090|64322174|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23156009|NCT00766090|64322175|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23156010|NCT00766090|64322176|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23156011|NCT00766090|64322177|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23156012|NCT00766090|64322178|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23156013|NCT00766090|64322179|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23156014|NCT00766090|64322180|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
23565702|NCT02387216|65799747|FG000|Overall Study|Death|60|||
23565703|NCT02387216|65799748|FG001|Overall Study|Death|23|||
23565704|NCT02387216|65799747|FG000|Overall Study|Other|5|||
23565705|NCT02387216|65799748|FG001|Overall Study|Other|4|||
23565706|NCT02387216|65799747|FG000|Overall Study|Lost to Follow-up|0|||
23156015|NCT00766090|64322181|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23627994|NCT02906020|66024649|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
23156016|NCT00766090|64322182|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23156017|NCT00766090|64322183|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23442681|NCT01618695|65362188|FG000|Core Phase|Adverse Event|4|||
23442682|NCT01618695|65362189|FG001|Core Phase|Adverse Event|5|||
23442683|NCT01618695|65362190|FG002|Core Phase|Adverse Event|15|||
23565707|NCT02387216|65799748|FG001|Overall Study|Lost to Follow-up|3|||
23565708|NCT01160484|65799749|FG000|Overall Study|Lack of Efficacy|9|||
23565709|NCT01160484|65799749|FG000|Overall Study|Adverse Event|6|||
23565710|NCT01160484|65799749|FG000|Overall Study|Withdrawal by Subject|2|||
23565711|NCT01160484|65799749|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
23565712|NCT01567865|65799751|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
23565713|NCT01567865|65799752|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
23565714|NCT01567865|65799753|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
23565715|NCT01567865|65799754|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
23156018|NCT00766090|64322172|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
23156019|NCT00766090|64322173|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23156020|NCT00766090|64322174|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23156021|NCT00766090|64322175|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23156022|NCT00766090|64322176|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23442684|NCT01618695|65362191|FG003|Core Phase|Adverse Event|20|||
23565716|NCT01567865|65799751|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
23565717|NCT01567865|65799752|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
23565718|NCT01567865|65799753|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
23565719|NCT01567865|65799754|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
23565720|NCT00113360|65799757|FG000|Overall Study|Adverse Event|3|||
23565721|NCT00113360|65799757|FG000|Overall Study|Subject required surgery|1|||
23565722|NCT00113360|65799757|FG000|Overall Study|Did not meet eligibility criteria|3|||
23565723|NCT00960752|65799759|FG000|Overall Study|Adverse Event|0|||
23565724|NCT00960752|65799760|FG001|Overall Study|Adverse Event|0|||
23565725|NCT00960752|65799761|FG002|Overall Study|Adverse Event|1|||
23565726|NCT00960752|65799759|FG000|Overall Study|Progression|0|||
23565727|NCT00960752|65799760|FG001|Overall Study|Progression|0|||
23565728|NCT00960752|65799761|FG002|Overall Study|Progression|1|||
23565729|NCT00954733|65799762|FG000|Overall Study|blood gas machine did not work|1|||
23565730|NCT01382602|65799763|FG000|Overall Study|Protocol Violation|0|||
23565731|NCT01382602|65799764|FG001|Overall Study|Protocol Violation|3|||
23565732|NCT01382602|65799763|FG000|Overall Study|Withdrawal by Subject|0|||
23565733|NCT01382602|65799764|FG001|Overall Study|Withdrawal by Subject|1|||
23565734|NCT04772053|65799765|FG000|Overall Study|Physician Decision|2|||
23565735|NCT04772053|65799765|FG000|Overall Study|Withdrawal by Subject|3|||
23565736|NCT04772053|65799765|FG000|Overall Study|Study Terminated by Sponsor|1|||
23565737|NCT02614066|65799766|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
23565738|NCT02614066|65799767|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
23565739|NCT02614066|65799768|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
23565740|NCT02614066|65799769|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
23565741|NCT02614066|65799766|FG000|Overall Study|Full Consent Withdrawn|0|||
23565742|NCT02614066|65799767|FG001|Overall Study|Full Consent Withdrawn|1|||
23565743|NCT02614066|65799768|FG002|Overall Study|Full Consent Withdrawn|0|||
23565744|NCT02614066|65799769|FG003|Overall Study|Full Consent Withdrawn|3|||
23565745|NCT02614066|65799766|FG000|Overall Study|Lost to Follow-up|0|||
23565746|NCT02614066|65799767|FG001|Overall Study|Lost to Follow-up|1|||
23565747|NCT02614066|65799768|FG002|Overall Study|Lost to Follow-up|0|||
23565748|NCT02614066|65799769|FG003|Overall Study|Lost to Follow-up|0|||
23565749|NCT02614066|65799766|FG000|Overall Study|Still on-study|1|||
23565750|NCT02614066|65799767|FG001|Overall Study|Still on-study|9|||
23565751|NCT02614066|65799768|FG002|Overall Study|Still on-study|5|||
23565752|NCT02614066|65799769|FG003|Overall Study|Still on-study|32|||
23565753|NCT02614066|65799766|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
23565754|NCT02614066|65799767|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
23442685|NCT01618695|65362188|FG000|Core Phase|Lost to Follow-up|0|||
23442686|NCT01618695|65362189|FG001|Core Phase|Lost to Follow-up|0|||
23442687|NCT01618695|65362190|FG002|Core Phase|Lost to Follow-up|1|||
23442688|NCT01618695|65362191|FG003|Core Phase|Lost to Follow-up|0|||
23442689|NCT01618695|65362188|FG000|Core Phase|Withdrawal by Subject|16|||
23565755|NCT02614066|65799768|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
23565756|NCT02614066|65799769|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
23442690|NCT01618695|65362189|FG001|Core Phase|Withdrawal by Subject|11|||
23442691|NCT01618695|65362190|FG002|Core Phase|Withdrawal by Subject|9|||
23442692|NCT01618695|65362191|FG003|Core Phase|Withdrawal by Subject|13|||
23442693|NCT01618695|65362188|FG000|Core Phase|Pregnancy|2|||
23442694|NCT01618695|65362189|FG001|Core Phase|Pregnancy|0|||
23627995|NCT02906020|66024650|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
23627996|NCT02906020|66024651|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
23627997|NCT02906020|66024652|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
23156023|NCT00766090|64322177|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23327543|NCT00594165|64940946|FG000|Overall Study|Major protocol violation|1|||
23442695|NCT01618695|65362190|FG002|Core Phase|Pregnancy|0|||
23442696|NCT01618695|65362191|FG003|Core Phase|Pregnancy|0|||
23565757|NCT04105972|65799772|FG000|Overall Study|Adverse Event|2|||
23565758|NCT04105972|65799773|FG001|Overall Study|Adverse Event|1|||
23565759|NCT00785707|65799774|FG000|Overall Study|Lost to Follow-up|7|||
23565760|NCT00787319|65799779|FG000|Overall Study|Lost to Follow-up|2|||
23565761|NCT00787319|65799779|FG000|Overall Study|Withdrawal by Subject|15|||
23442697|NCT01618695|65362188|FG000|Core Phase|Lack of Efficacy|1|||
23565762|NCT00787319|65799779|FG000|Overall Study|Adverse Event|3|||
23627998|NCT02906020|66024653|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
23627999|NCT02906020|66024654|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
23628000|NCT02906020|66024655|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
23628001|NCT02906020|66024640|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628002|NCT02906020|66024641|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628003|NCT02906020|66024642|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628004|NCT02906020|66024643|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628005|NCT02906020|66024644|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628006|NCT02906020|66024645|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628007|NCT02906020|66024646|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628008|NCT02906020|66024647|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628009|NCT02906020|66024648|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
23628010|NCT02906020|66024649|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
23628011|NCT02906020|66024650|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628012|NCT02906020|66024651|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628013|NCT02906020|66024652|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628014|NCT02906020|66024653|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628015|NCT02906020|66024654|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628016|NCT02906020|66024655|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
23628017|NCT02906020|66024640|FG000|Part 2: Double-blind Treatment Period|Other|0|||
23628018|NCT02906020|66024641|FG001|Part 2: Double-blind Treatment Period|Other|0|||
23628019|NCT02906020|66024642|FG002|Part 2: Double-blind Treatment Period|Other|0|||
23628020|NCT02906020|66024643|FG003|Part 2: Double-blind Treatment Period|Other|0|||
23628021|NCT02906020|66024644|FG004|Part 2: Double-blind Treatment Period|Other|0|||
23628022|NCT02906020|66024645|FG005|Part 2: Double-blind Treatment Period|Other|0|||
23628023|NCT02906020|66024646|FG006|Part 2: Double-blind Treatment Period|Other|0|||
23628024|NCT02906020|66024647|FG007|Part 2: Double-blind Treatment Period|Other|0|||
23628025|NCT02906020|66024648|FG008|Part 2: Double-blind Treatment Period|Other|6|||
23628026|NCT02906020|66024649|FG009|Part 2: Double-blind Treatment Period|Other|10|||
23628027|NCT02906020|66024650|FG010|Part 2: Double-blind Treatment Period|Other|0|||
23628028|NCT02906020|66024651|FG011|Part 2: Double-blind Treatment Period|Other|0|||
23628029|NCT02906020|66024652|FG012|Part 2: Double-blind Treatment Period|Other|0|||
23327544|NCT00594165|64940946|FG000|Overall Study|Lack of Efficacy|12|||
23327545|NCT00594165|64940946|FG000|Overall Study|Adverse Event|52|||
23327546|NCT00594165|64940946|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
23327547|NCT00594165|64940946|FG000|Overall Study|Subject withdrew consent|27|||
23327548|NCT00594165|64940946|FG000|Overall Study|Study ended per sponsor|102|||
23327549|NCT00594165|64940946|FG000|Overall Study|Lost to Follow-up|4|||
23327550|NCT00594165|64940946|FG000|Overall Study|Other: PI discretion|5|||
23327551|NCT00594165|64940946|FG000|Overall Study|Other: Subject moving|3|||
23628030|NCT02906020|66024653|FG013|Part 2: Double-blind Treatment Period|Other|0|||
23628031|NCT02906020|66024654|FG014|Part 2: Double-blind Treatment Period|Other|0|||
23628032|NCT02906020|66024655|FG015|Part 2: Double-blind Treatment Period|Other|0|||
23628033|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628034|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628035|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628036|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628037|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628038|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628039|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628040|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628041|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628042|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628043|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628044|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628045|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
23628046|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
23327552|NCT00594165|64940946|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
23327553|NCT00594165|64940946|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
23628047|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628048|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
23628049|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628050|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628051|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628052|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628053|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628054|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628055|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628056|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628057|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628058|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628059|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628060|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628061|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
23628062|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
23628063|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
23628064|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
23628065|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628066|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628067|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628068|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23156024|NCT00766090|64322178|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23156025|NCT00766090|64322179|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23156026|NCT00766090|64322180|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23156027|NCT00766090|64322181|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23156028|NCT00766090|64322182|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23327554|NCT00594165|64940946|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
23327555|NCT00594165|64940946|FG000|Overall Study|Other: Site terminated participation|2|||
23327556|NCT01787292|64940947|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
23327557|NCT01787292|64940948|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
23327558|NCT01787292|64940947|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
23327559|NCT01787292|64940948|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
23327560|NCT03382834|64940952|FG000|Step 1|Lost to Follow-up|0|||
23327561|NCT03382834|64940953|FG001|Step 1|Lost to Follow-up|1|||
23327562|NCT03382834|64940952|FG000|Step 2|Death|1|||
23327563|NCT03382834|64940953|FG001|Step 2|Death|0|||
23327564|NCT03382834|64940952|FG000|Step 2|Lost to Follow-up|2|||
23327565|NCT03382834|64940953|FG001|Step 2|Lost to Follow-up|2|||
23442698|NCT01618695|65362189|FG001|Core Phase|Lack of Efficacy|2|||
23442699|NCT01618695|65362190|FG002|Core Phase|Lack of Efficacy|1|||
23156029|NCT00766090|64322183|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
23156030|NCT00766090|64322172|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23156031|NCT00766090|64322173|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156032|NCT00766090|64322174|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156033|NCT00766090|64322175|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23156034|NCT00766090|64322176|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156035|NCT00766090|64322177|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156036|NCT00766090|64322178|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156037|NCT00766090|64322179|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156038|NCT00766090|64322180|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156039|NCT00766090|64322181|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156040|NCT00766090|64322182|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156041|NCT00766090|64322183|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23156042|NCT00766090|64322172|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
23221600|NCT02580591|64553724|FG001|Overall Study|Withdrawal by Subject|1|||
23221601|NCT02580591|64553725|FG002|Overall Study|Withdrawal by Subject|2|||
23221602|NCT02580591|64553726|FG003|Overall Study|Withdrawal by Subject|3|||
23221603|NCT02580591|64553723|FG000|Overall Study|Not treated|1|||
23221604|NCT02580591|64553724|FG001|Overall Study|Not treated|1|||
23221605|NCT02580591|64553725|FG002|Overall Study|Not treated|0|||
23221606|NCT02580591|64553726|FG003|Overall Study|Not treated|0|||
23221607|NCT02580591|64553723|FG000|Overall Study|Other than specified|3|||
23221608|NCT02580591|64553724|FG001|Overall Study|Other than specified|2|||
23221609|NCT02580591|64553725|FG002|Overall Study|Other than specified|5|||
23221610|NCT02580591|64553726|FG003|Overall Study|Other than specified|2|||
23221611|NCT02465489|64553727|FG000|Overall Study|Adverse Event|5|||
23221612|NCT02971007|64553730|FG000|Overall Study|Adverse Event|1|||
23221613|NCT02971007|64553731|FG001|Overall Study|Adverse Event|0|||
23221614|NCT02971007|64553732|FG002|Overall Study|Adverse Event|0|||
23221615|NCT02971007|64553730|FG000|Overall Study|Lost to Follow-up|0|||
23221616|NCT02971007|64553731|FG001|Overall Study|Lost to Follow-up|1|||
23221617|NCT02971007|64553732|FG002|Overall Study|Lost to Follow-up|1|||
23221618|NCT02971007|64553730|FG000|Overall Study|Withdrawal by Subject|0|||
23221619|NCT02971007|64553731|FG001|Overall Study|Withdrawal by Subject|1|||
23221620|NCT02971007|64553732|FG002|Overall Study|Withdrawal by Subject|0|||
23221621|NCT02971007|64553730|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
23221622|NCT02971007|64553731|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
23327566|NCT03382834|64940952|FG000|Step 2|Site Terminated by Sponsor|1|||
23442700|NCT01618695|65362191|FG003|Core Phase|Lack of Efficacy|1|||
23327567|NCT03382834|64940953|FG001|Step 2|Site Terminated by Sponsor|0|||
23442701|NCT01618695|65362188|FG000|Core Phase|Other than specified|1|||
23628069|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628070|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23565763|NCT00787319|65799779|FG000|Overall Study|Objective progression or relapse|30|||
23565764|NCT00787319|65799779|FG000|Overall Study|Lack of Efficacy|1|||
23565765|NCT00787319|65799779|FG000|Overall Study|Budget exhausted/exceeded|1|||
23565766|NCT00787319|65799779|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
23565767|NCT00787319|65799779|FG000|Overall Study|No health insurance reimbursement|2|||
23565768|NCT00787319|65799779|FG000|Overall Study|Stabilized disease findings|3|||
23327568|NCT03517540|64940954|FG000|Overall Study|Protocol Violation|2|||
23565769|NCT00787319|65799779|FG000|Overall Study|Inactive disease|5|||
23156043|NCT00766090|64322173|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
23156044|NCT00766090|64322174|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
23156045|NCT00766090|64322175|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
23156046|NCT00766090|64322176|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
23156047|NCT00766090|64322177|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
23156048|NCT00766090|64322178|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
23628071|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23327569|NCT03517540|64940955|FG001|Overall Study|Protocol Violation|0|||
23327570|NCT03517540|64940956|FG002|Overall Study|Protocol Violation|0|||
23156049|NCT00766090|64322179|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
23327571|NCT03517540|64940957|FG003|Overall Study|Protocol Violation|1|||
23327572|NCT03517540|64940954|FG000|Overall Study|Adverse Event|9|||
23327573|NCT03517540|64940955|FG001|Overall Study|Adverse Event|3|||
23327574|NCT03517540|64940956|FG002|Overall Study|Adverse Event|8|||
23327575|NCT03517540|64940957|FG003|Overall Study|Adverse Event|1|||
23327576|NCT03517540|64940954|FG000|Overall Study|Withdrawal by Subject|3|||
23327577|NCT03517540|64940955|FG001|Overall Study|Withdrawal by Subject|4|||
23327578|NCT03517540|64940956|FG002|Overall Study|Withdrawal by Subject|1|||
23327579|NCT03517540|64940957|FG003|Overall Study|Withdrawal by Subject|3|||
23628072|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628073|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628074|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628075|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628076|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628077|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
23628078|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
23628079|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628080|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
23628081|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628082|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628083|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628084|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628085|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628086|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628087|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628088|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628089|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628090|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628091|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628092|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628093|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
23628094|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
23628095|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628096|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
23628097|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628098|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628099|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628100|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628101|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23156050|NCT00766090|64322180|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
23156051|NCT00766090|64322181|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
23327580|NCT00380874|64940958|FG000|Overall Study|Adverse Event|7|||
23327581|NCT00380874|64940959|FG001|Overall Study|Adverse Event|7|||
23327582|NCT00380874|64940958|FG000|Overall Study|Death|1|||
23327583|NCT00380874|64940959|FG001|Overall Study|Death|0|||
23565770|NCT02823964|65799782|FG000|Overall Study|Adverse Event|2|||
23565771|NCT02823964|65799782|FG000|Overall Study|Physician Decision|1|||
23565772|NCT02823964|65799782|FG000|Overall Study|Lack of Efficacy|1|||
23327584|NCT00380874|64940958|FG000|Overall Study|Withdrawal by Subject|2|||
23628102|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628103|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23565773|NCT02823964|65799782|FG000|Overall Study|Withdrawal by Subject|1|||
23565774|NCT02914314|65799783|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
23565775|NCT02914314|65799784|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
23565776|NCT02914314|65799785|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
23565777|NCT02914314|65799786|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
23565778|NCT02914314|65799783|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
23565779|NCT02914314|65799784|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
23565780|NCT02914314|65799785|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
23565781|NCT02914314|65799786|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
23628104|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628105|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628106|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628107|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628108|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
23628109|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
23628110|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
23628111|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
23628112|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
23628113|NCT02906020|66024640|FG000|Part 2: Long-term Follow-up Period|Other|0|||
23628114|NCT02906020|66024641|FG001|Part 2: Long-term Follow-up Period|Other|0|||
23628115|NCT02906020|66024642|FG002|Part 2: Long-term Follow-up Period|Other|0|||
23628116|NCT02906020|66024643|FG003|Part 2: Long-term Follow-up Period|Other|0|||
23628117|NCT02906020|66024644|FG004|Part 2: Long-term Follow-up Period|Other|0|||
23628118|NCT02906020|66024645|FG005|Part 2: Long-term Follow-up Period|Other|0|||
23628119|NCT02906020|66024646|FG006|Part 2: Long-term Follow-up Period|Other|0|||
23628120|NCT02906020|66024647|FG007|Part 2: Long-term Follow-up Period|Other|0|||
23628121|NCT02906020|66024648|FG008|Part 2: Long-term Follow-up Period|Other|0|||
23628122|NCT02906020|66024649|FG009|Part 2: Long-term Follow-up Period|Other|0|||
23628123|NCT02906020|66024650|FG010|Part 2: Long-term Follow-up Period|Other|0|||
23628124|NCT02906020|66024651|FG011|Part 2: Long-term Follow-up Period|Other|0|||
23628125|NCT02906020|66024652|FG012|Part 2: Long-term Follow-up Period|Other|13|||
23156052|NCT00766090|64322182|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
23156053|NCT00766090|64322183|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
23156054|NCT00766090|64322172|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23628126|NCT02906020|66024653|FG013|Part 2: Long-term Follow-up Period|Other|8|||
23628127|NCT02906020|66024654|FG014|Part 2: Long-term Follow-up Period|Other|3|||
23628128|NCT02906020|66024655|FG015|Part 2: Long-term Follow-up Period|Other|2|||
23628129|NCT01628692|66024656|FG000|Overall Study|Lack of Efficacy|4|||
23628130|NCT01628692|66024657|FG001|Overall Study|Lack of Efficacy|4|||
23156055|NCT00766090|64322173|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156056|NCT00766090|64322174|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156057|NCT00766090|64322175|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156058|NCT00766090|64322176|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
23156059|NCT00766090|64322177|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156060|NCT00766090|64322178|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156061|NCT00766090|64322179|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156062|NCT00766090|64322180|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156063|NCT00766090|64322181|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156064|NCT00766090|64322182|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156065|NCT00766090|64322183|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
23156066|NCT00766090|64322172|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156067|NCT00766090|64322173|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156068|NCT00766090|64322174|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
23156069|NCT00766090|64322175|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156070|NCT00766090|64322176|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156071|NCT00766090|64322177|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156072|NCT00766090|64322178|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156073|NCT00766090|64322179|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156074|NCT00766090|64322180|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156075|NCT00766090|64322181|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156076|NCT00766090|64322182|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156077|NCT00766090|64322183|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
23156078|NCT00766090|64322172|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
23565782|NCT02914314|65799783|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
23628131|NCT01628692|66024658|FG002|Overall Study|Lack of Efficacy|5|||
23628132|NCT01628692|66024659|FG003|Overall Study|Lack of Efficacy|1|||
23628133|NCT01628692|66024660|FG004|Overall Study|Lack of Efficacy|4|||
23628134|NCT01628692|66024661|FG005|Overall Study|Lack of Efficacy|7|||
23628135|NCT01628692|66024656|FG000|Overall Study|Adverse Event|2|||
23628136|NCT01628692|66024657|FG001|Overall Study|Adverse Event|0|||
23628137|NCT01628692|66024658|FG002|Overall Study|Adverse Event|2|||
23628138|NCT01628692|66024659|FG003|Overall Study|Adverse Event|0|||
23628139|NCT01628692|66024660|FG004|Overall Study|Adverse Event|0|||
23628140|NCT01628692|66024661|FG005|Overall Study|Adverse Event|0|||
23628141|NCT01628692|66024656|FG000|Overall Study|Withdrawal by Subject|0|||
23628142|NCT01628692|66024657|FG001|Overall Study|Withdrawal by Subject|1|||
23628143|NCT01628692|66024658|FG002|Overall Study|Withdrawal by Subject|1|||
23628144|NCT01628692|66024659|FG003|Overall Study|Withdrawal by Subject|0|||
23628145|NCT01628692|66024660|FG004|Overall Study|Withdrawal by Subject|0|||
23565783|NCT02914314|65799784|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
23565784|NCT02914314|65799785|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
23565785|NCT02914314|65799786|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
23565786|NCT02914314|65799783|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
23565787|NCT02914314|65799784|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
23565788|NCT02914314|65799785|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
23628146|NCT01628692|66024661|FG005|Overall Study|Withdrawal by Subject|0|||
23628147|NCT01628692|66024656|FG000|Overall Study|Death|0|||
23628148|NCT01628692|66024657|FG001|Overall Study|Death|1|||
23628149|NCT01628692|66024658|FG002|Overall Study|Death|0|||
23628150|NCT01628692|66024659|FG003|Overall Study|Death|0|||
23628151|NCT01628692|66024660|FG004|Overall Study|Death|0|||
23628152|NCT01628692|66024661|FG005|Overall Study|Death|0|||
23628153|NCT01628692|66024656|FG000|Overall Study|Poor compliance/noncompliance|1|||
23628154|NCT01628692|66024657|FG001|Overall Study|Poor compliance/noncompliance|0|||
23628155|NCT01628692|66024658|FG002|Overall Study|Poor compliance/noncompliance|0|||
23628156|NCT01628692|66024659|FG003|Overall Study|Poor compliance/noncompliance|0|||
23628157|NCT01628692|66024660|FG004|Overall Study|Poor compliance/noncompliance|0|||
23628158|NCT01628692|66024661|FG005|Overall Study|Poor compliance/noncompliance|0|||
23628159|NCT01628692|66024656|FG000|Overall Study|Administrative reason by sponsor|0|||
23628160|NCT01628692|66024657|FG001|Overall Study|Administrative reason by sponsor|0|||
23628161|NCT01628692|66024658|FG002|Overall Study|Administrative reason by sponsor|0|||
23628162|NCT01628692|66024659|FG003|Overall Study|Administrative reason by sponsor|0|||
23628163|NCT01628692|66024660|FG004|Overall Study|Administrative reason by sponsor|0|||
23628164|NCT01628692|66024661|FG005|Overall Study|Administrative reason by sponsor|1|||
23628165|NCT01628692|66024656|FG000|Overall Study|Completed 12 Week only|0|||
23628166|NCT01628692|66024657|FG001|Overall Study|Completed 12 Week only|0|||
23628167|NCT01628692|66024658|FG002|Overall Study|Completed 12 Week only|0|||
23628168|NCT01628692|66024659|FG003|Overall Study|Completed 12 Week only|0|||
23628169|NCT01628692|66024660|FG004|Overall Study|Completed 12 Week only|0|||
23628170|NCT01628692|66024661|FG005|Overall Study|Completed 12 Week only|1|||
23628171|NCT01844726|66024664|FG000|Overall Study|Withdrawal by Subject|0|||
23628172|NCT01844726|66024665|FG001|Overall Study|Withdrawal by Subject|1|||
23628173|NCT01844726|66024664|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
23442702|NCT01618695|65362189|FG001|Core Phase|Other than specified|2|||
23565789|NCT02914314|65799786|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
23565790|NCT02914314|65799783|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
23565791|NCT02914314|65799784|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
23565792|NCT02914314|65799785|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
23565793|NCT02914314|65799786|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
23565794|NCT01874145|65799790|FG000|Core Period|Non-compliance|1|||
23565795|NCT01874145|65799791|FG001|Core Period|Non-compliance|0|||
23565796|NCT01874145|65799790|FG000|Core Period|Protocol Violation|1|||
23565797|NCT01874145|65799791|FG001|Core Period|Protocol Violation|1|||
23565798|NCT01874145|65799790|FG000|Core Period|Physician Decision|1|||
23565799|NCT01874145|65799791|FG001|Core Period|Physician Decision|1|||
23565800|NCT01874145|65799790|FG000|Core Period|Adverse Event|0|||
23565801|NCT01874145|65799791|FG001|Core Period|Adverse Event|1|||
23565802|NCT01874145|65799790|FG000|Core Period|Withdrawal by Subject|0|||
23565803|NCT01874145|65799791|FG001|Core Period|Withdrawal by Subject|4|||
23565804|NCT01874145|65799790|FG000|Extension Period|Adverse Event|3|||
23565805|NCT01874145|65799791|FG001|Extension Period|Adverse Event|2|||
23565806|NCT01874145|65799790|FG000|Extension Period|Withdrawal by Subject|2|||
23565807|NCT01874145|65799791|FG001|Extension Period|Withdrawal by Subject|1|||
23565808|NCT01874145|65799790|FG000|Extension Period|Lost to Follow-up|1|||
23628174|NCT01844726|66024665|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
23628175|NCT03229486|66024666|FG000|Overall Study|Protocol Violation|0|||
23628176|NCT03229486|66024667|FG001|Overall Study|Protocol Violation|1|||
23628177|NCT01266161|66024668|FG000|Overall Study|Ineligible|1|||
23628178|NCT01266161|66024669|FG001|Overall Study|Ineligible|0|||
23628179|NCT01266161|66024668|FG000|Overall Study|Lack of Efficacy|0|||
23628180|NCT01266161|66024669|FG001|Overall Study|Lack of Efficacy|1|||
23628181|NCT01266161|66024668|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
23628182|NCT01266161|66024669|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
23628183|NCT01256671|66024671|FG000|Overall Study|Adverse Event|29|||
23628184|NCT01256671|66024671|FG000|Overall Study|Lost to Follow-up|16|||
23628185|NCT01256671|66024671|FG000|Overall Study|Withdrawal by Subject|31|||
23628186|NCT01256671|66024671|FG000|Overall Study|Physician Decision|3|||
23628187|NCT01256671|66024671|FG000|Overall Study|Lack of Efficacy|4|||
23628188|NCT01256671|66024671|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
23628189|NCT01288209|66024674|FG000|Overall Study|Withdrawal by Subject|1|||
23628190|NCT01288209|66024675|FG001|Overall Study|Withdrawal by Subject|3|||
23628191|NCT01288209|66024674|FG000|Overall Study|Other|1|||
23628192|NCT01288209|66024675|FG001|Overall Study|Other|0|||
23628193|NCT00760747|66024676|FG000|Study Period II|Adverse Event|3|||
23628194|NCT00760747|66024677|FG001|Study Period II|Adverse Event|4|||
23628195|NCT00760747|66024676|FG000|Study Period II|Lack of Efficacy|0|||
23628196|NCT00760747|66024677|FG001|Study Period II|Lack of Efficacy|6|||
23628197|NCT00760747|66024676|FG000|Study Period II|Parent/Caregiver Decision|3|||
23628198|NCT00760747|66024677|FG001|Study Period II|Parent/Caregiver Decision|0|||
23628199|NCT00760747|66024676|FG000|Study Period II|Protocol Violation|6|||
23628200|NCT00760747|66024677|FG001|Study Period II|Protocol Violation|3|||
23628201|NCT00760747|66024676|FG000|Study Period II|Withdrawal by Subject|1|||
23628202|NCT00760747|66024677|FG001|Study Period II|Withdrawal by Subject|0|||
23628203|NCT00760747|66024676|FG000|Study Period II|No drug administered|0|||
23628204|NCT00760747|66024677|FG001|Study Period II|No drug administered|1|||
23628205|NCT00760747|66024676|FG000|Study Period III|Adverse Event|1|||
23628206|NCT00760747|66024677|FG001|Study Period III|Adverse Event|0|||
23628207|NCT00760747|66024676|FG000|Study Period III|Lack of Efficacy|1|||
23628208|NCT00760747|66024677|FG001|Study Period III|Lack of Efficacy|0|||
23628209|NCT00760747|66024676|FG000|Study Period III|Parent/Caregiver Decision|0|||
23628210|NCT00760747|66024677|FG001|Study Period III|Parent/Caregiver Decision|1|||
23628211|NCT00760747|66024676|FG000|Study Period III|Protocol Violation|1|||
23628212|NCT00760747|66024677|FG001|Study Period III|Protocol Violation|1|||
23628213|NCT00760747|66024676|FG000|Study Period III|Physician Decision|0|||
23628214|NCT00760747|66024677|FG001|Study Period III|Physician Decision|1|||
23628215|NCT01536587|66024678|FG000|Overall Study|Adverse Event|2|||
23628216|NCT02577003|66024679|FG000|Overall Study|Adverse Event|2|||
23628217|NCT02577003|66024680|FG001|Overall Study|Adverse Event|4|||
23628218|NCT02577003|66024679|FG000|Overall Study|Withdrawal by Subject|0|||
23628219|NCT02577003|66024680|FG001|Overall Study|Withdrawal by Subject|1|||
23628220|NCT02242643|66024681|FG000|Overall Study|Protocol Violation|1|||
23628221|NCT02242643|66024682|FG001|Overall Study|Protocol Violation|2|||
23628222|NCT02242643|66024681|FG000|Overall Study|Withdrawal by Subject|15|||
23628223|NCT02242643|66024682|FG001|Overall Study|Withdrawal by Subject|10|||
23628224|NCT02242643|66024681|FG000|Overall Study|Migrated/moved from study area|1|||
23628225|NCT02242643|66024682|FG001|Overall Study|Migrated/moved from study area|3|||
23628226|NCT02242643|66024681|FG000|Overall Study|Lost to Follow-up|54|||
23628227|NCT02242643|66024682|FG001|Overall Study|Lost to Follow-up|61|||
23628228|NCT02242643|66024681|FG000|Overall Study|Child placed in foster care by family|0|||
23628229|NCT02242643|66024682|FG001|Overall Study|Child placed in foster care by family|1|||
23628230|NCT02242643|66024681|FG000|Overall Study|Non-compliance|1|||
23628231|NCT02242643|66024682|FG001|Overall Study|Non-compliance|0|||
23628232|NCT02242643|66024681|FG000|Overall Study|Consent withdrawal by parent|1|||
23628233|NCT02242643|66024682|FG001|Overall Study|Consent withdrawal by parent|0|||
23628234|NCT02242643|66024681|FG000|Overall Study|Protocol requirements not followed|1|||
23628235|NCT02242643|66024682|FG001|Overall Study|Protocol requirements not followed|0|||
23628236|NCT02242643|66024681|FG000|Overall Study|Language barrier|1|||
23628237|NCT02242643|66024682|FG001|Overall Study|Language barrier|0|||
23628238|NCT02242643|66024681|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
23628239|NCT02242643|66024682|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
23628240|NCT01240915|66024685|FG000|Overall Study|Adverse Event|0|||
23628241|NCT01240915|66024686|FG001|Overall Study|Adverse Event|0|||
23628242|NCT01240915|66024687|FG002|Overall Study|Adverse Event|0|||
23565809|NCT01874145|65799791|FG001|Extension Period|Lost to Follow-up|1|||
23565810|NCT02306122|65799792|FG000|Initial Physician Randomization|Physician Decision|0|||
23565811|NCT02306122|65799793|FG001|Initial Physician Randomization|Physician Decision|0|||
23565812|NCT02306122|65799794|FG002|Initial Physician Randomization|Physician Decision|0|||
23565813|NCT02306122|65799795|FG003|Initial Physician Randomization|Physician Decision|0|||
23565814|NCT02306122|65799796|FG004|Initial Physician Randomization|Physician Decision|0|||
23565815|NCT02306122|65799797|FG005|Initial Physician Randomization|Physician Decision|0|||
23565816|NCT02306122|65799798|FG006|Initial Physician Randomization|Physician Decision|0|||
23565817|NCT02306122|65799799|FG007|Initial Physician Randomization|Physician Decision|0|||
23565818|NCT02306122|65799800|FG008|Initial Physician Randomization|Physician Decision|1|||
23628243|NCT01240915|66024688|FG003|Overall Study|Adverse Event|1|||
23628244|NCT01240915|66024689|FG004|Overall Study|Adverse Event|0|||
23628245|NCT01240915|66024690|FG005|Overall Study|Adverse Event|2|||
23628246|NCT01240915|66024691|FG006|Overall Study|Adverse Event|0|||
23628247|NCT01240915|66024692|FG007|Overall Study|Adverse Event|0|||
23628248|NCT01240915|66024693|FG008|Overall Study|Adverse Event|1|||
23628249|NCT01240915|66024685|FG000|Overall Study|Lost to Follow-up|0|||
23628250|NCT01240915|66024686|FG001|Overall Study|Lost to Follow-up|0|||
23156079|NCT00766090|64322173|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
23156080|NCT00766090|64322174|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
23156081|NCT00766090|64322175|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
23156082|NCT00766090|64322176|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
23156083|NCT00766090|64322177|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
23156084|NCT00766090|64322178|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
23156085|NCT00766090|64322179|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
23156086|NCT00766090|64322180|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
23156087|NCT00766090|64322181|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
23156088|NCT00766090|64322182|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
23156089|NCT00766090|64322183|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
23565819|NCT02306122|65799801|FG009|Initial Physician Randomization|Physician Decision|0|||
23565820|NCT02306122|65799802|FG010|Initial Physician Randomization|Physician Decision|0|||
23565821|NCT01781390|65799803|FG000|Overall Study|Withdrawal of Consent|0|||
23565822|NCT01781390|65799804|FG001|Overall Study|Withdrawal of Consent|3|||
23565823|NCT01781390|65799805|FG002|Overall Study|Withdrawal of Consent|1|||
23565824|NCT01781390|65799803|FG000|Overall Study|Lost to Follow-up|1|||
23565825|NCT01781390|65799804|FG001|Overall Study|Lost to Follow-up|1|||
23565826|NCT01781390|65799805|FG002|Overall Study|Lost to Follow-up|1|||
23565827|NCT01781390|65799803|FG000|Overall Study|Adverse Event|1|||
23565828|NCT01781390|65799804|FG001|Overall Study|Adverse Event|2|||
23565829|NCT01781390|65799805|FG002|Overall Study|Adverse Event|1|||
23565830|NCT01781390|65799803|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
23565831|NCT01781390|65799804|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
23565832|NCT01781390|65799805|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
23565833|NCT00672958|65799810|FG000|Overall Study|Adverse Event|11|||
23565834|NCT00672958|65799811|FG001|Overall Study|Adverse Event|9|||
23156090|NCT00766090|64322172|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156091|NCT00766090|64322173|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156092|NCT00766090|64322174|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156093|NCT00766090|64322175|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156094|NCT00766090|64322176|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156095|NCT00766090|64322177|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
23156096|NCT00766090|64322178|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156097|NCT00766090|64322179|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156098|NCT00766090|64322180|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156099|NCT00766090|64322181|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156100|NCT00766090|64322182|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156101|NCT00766090|64322183|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
23156102|NCT00766090|64322172|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23156103|NCT00766090|64322173|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
23156104|NCT00766090|64322174|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23156105|NCT00766090|64322175|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
23156106|NCT00766090|64322176|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23156107|NCT00766090|64322177|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23156108|NCT00766090|64322178|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23156109|NCT00766090|64322179|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23156110|NCT00766090|64322180|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23156111|NCT00766090|64322181|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23156112|NCT00766090|64322182|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
23156113|NCT00766090|64322183|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
23156114|NCT00766090|64322172|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156115|NCT00766090|64322173|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156116|NCT00766090|64322174|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156117|NCT00766090|64322175|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156118|NCT00766090|64322176|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
23156119|NCT00766090|64322177|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156120|NCT00766090|64322178|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156121|NCT00766090|64322179|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156122|NCT00766090|64322180|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156123|NCT00766090|64322181|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156124|NCT00766090|64322182|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23156125|NCT00766090|64322183|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
23565835|NCT00672958|65799810|FG000|Overall Study|Lack of Efficacy|6|||
23156126|NCT00955279|64322184|FG000|Overall Study|Other|0|||
23156127|NCT00955279|64322185|FG001|Overall Study|Other|0|||
23156128|NCT00955279|64322186|FG002|Overall Study|Other|3|||
23156129|NCT00955279|64322184|FG000|Overall Study|Death|1|||
23156130|NCT00955279|64322185|FG001|Overall Study|Death|1|||
23156131|NCT00955279|64322186|FG002|Overall Study|Death|1|||
23156132|NCT00955279|64322184|FG000|Overall Study|Lost to Follow-up|0|||
23156133|NCT00955279|64322185|FG001|Overall Study|Lost to Follow-up|3|||
23156134|NCT00955279|64322186|FG002|Overall Study|Lost to Follow-up|1|||
23156135|NCT00955279|64322184|FG000|Overall Study|Withdrawal by Subject|2|||
23156136|NCT00955279|64322185|FG001|Overall Study|Withdrawal by Subject|0|||
23156137|NCT00955279|64322186|FG002|Overall Study|Withdrawal by Subject|3|||
23156138|NCT00474708|64322191|FG000|Overall Study|Lack of Efficacy|11|||
23156139|NCT00474708|64322192|FG001|Overall Study|Lack of Efficacy|5|||
23156140|NCT00474708|64322191|FG000|Overall Study|Suicide ideation/behavior|0|||
23156141|NCT00474708|64322192|FG001|Overall Study|Suicide ideation/behavior|1|||
23156142|NCT00474708|64322191|FG000|Overall Study|Withdrawal by Subject|7|||
23156143|NCT00474708|64322192|FG001|Overall Study|Withdrawal by Subject|0|||
23156144|NCT00474708|64322191|FG000|Overall Study|Lack of compliance|12|||
23156145|NCT00474708|64322192|FG001|Overall Study|Lack of compliance|4|||
23156146|NCT00474708|64322191|FG000|Overall Study|Lost to Follow-up|18|||
23156147|NCT00474708|64322192|FG001|Overall Study|Lost to Follow-up|9|||
23156148|NCT00474708|64322191|FG000|Overall Study|Physician Decision|9|||
23156149|NCT00474708|64322192|FG001|Overall Study|Physician Decision|6|||
23156150|NCT00445224|64322196|FG000|Specific Exercises|Withdrawal by Subject|3|||
23156151|NCT00445224|64322197|FG001|Specific Exercises|Withdrawal by Subject|3|||
23156152|NCT00445224|64322196|FG000|Specific Exercises|Withdrawal by Subject|1|||
23156153|NCT00445224|64322197|FG001|Specific Exercises|Withdrawal by Subject|0|||
23156154|NCT01538628|64322198|FG000|Overall Study|Withdrawal by Subject|1|||
23156155|NCT01538628|64322199|FG001|Overall Study|Withdrawal by Subject|1|||
23156156|NCT01538628|64322198|FG000|Overall Study|Lost to Follow-up|0|||
23156157|NCT01538628|64322199|FG001|Overall Study|Lost to Follow-up|1|||
23156158|NCT03155373|64322208|FG000|Overall Study|No longer required surgery|1|||
23156159|NCT03155373|64322208|FG000|Overall Study|Protocol Violation|1|||
23156160|NCT03155373|64322208|FG000|Overall Study|Death|2|||
23156161|NCT03155373|64322208|FG000|Overall Study|Withdrawal by Subject|3|||
23156162|NCT00295633|64322211|FG000|Overall Study|Lack of Efficacy|19|||
23156163|NCT00295633|64322212|FG001|Overall Study|Lack of Efficacy|7|||
23156164|NCT00295633|64322213|FG002|Overall Study|Lack of Efficacy|16|||
23156165|NCT00295633|64322211|FG000|Overall Study|Withdrawal of consent by subject|16|||
23156166|NCT00295633|64322212|FG001|Overall Study|Withdrawal of consent by subject|16|||
23156167|NCT00295633|64322213|FG002|Overall Study|Withdrawal of consent by subject|26|||
23156168|NCT00295633|64322211|FG000|Overall Study|Adverse Event|9|||
23156169|NCT00295633|64322212|FG001|Overall Study|Adverse Event|17|||
23156170|NCT00295633|64322213|FG002|Overall Study|Adverse Event|9|||
23156171|NCT00295633|64322211|FG000|Overall Study|Lost to Follow-up|6|||
23156172|NCT00295633|64322212|FG001|Overall Study|Lost to Follow-up|11|||
23156173|NCT00295633|64322213|FG002|Overall Study|Lost to Follow-up|7|||
23156174|NCT00295633|64322211|FG000|Overall Study|Physician Decision|9|||
23156175|NCT00295633|64322212|FG001|Overall Study|Physician Decision|10|||
23156176|NCT00295633|64322213|FG002|Overall Study|Physician Decision|8|||
23156177|NCT00295633|64322211|FG000|Overall Study|Poor/Noncompliance|2|||
23156178|NCT00295633|64322212|FG001|Overall Study|Poor/Noncompliance|2|||
23156179|NCT00295633|64322213|FG002|Overall Study|Poor/Noncompliance|6|||
23156180|NCT00295633|64322211|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
23156181|NCT00295633|64322212|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
23156182|NCT00295633|64322213|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
23156183|NCT00295633|64322211|FG000|Overall Study|Death|1|||
23156184|NCT00295633|64322212|FG001|Overall Study|Death|1|||
23156185|NCT00295633|64322213|FG002|Overall Study|Death|0|||
23156186|NCT00295633|64322211|FG000|Overall Study|Administrative reason by sponsor|0|||
23156187|NCT00295633|64322212|FG001|Overall Study|Administrative reason by sponsor|0|||
23156188|NCT00295633|64322213|FG002|Overall Study|Administrative reason by sponsor|1|||
23156189|NCT01671111|64322214|FG000|Overall Study|Adverse Event|2|||
23156190|NCT01671111|64322214|FG000|Overall Study|Lack of Efficacy|1|||
23156191|NCT01671111|64322214|FG000|Overall Study|Withdrawal by Subject|2|||
23156192|NCT01671111|64322214|FG000|Overall Study|Physician Decision|1|||
23156193|NCT01671111|64322214|FG000|Overall Study|Other|24|||
23565836|NCT00672958|65799811|FG001|Overall Study|Lack of Efficacy|11|||
23156194|NCT03441334|64322215|FG000|Overall Study|Withdrawal by Subject|1|||
23156195|NCT03441334|64322216|FG001|Overall Study|Withdrawal by Subject|0|||
23156196|NCT00646906|64322223|FG000|Crossover Period 1|Withdrawal by Subject|1|||
23156197|NCT00646906|64322224|FG001|Crossover Period 1|Withdrawal by Subject|0|||
23565837|NCT00672958|65799810|FG000|Overall Study|Non-compliance with study drug|2|||
23156198|NCT00646906|64322225|FG002|Crossover Period 1|Withdrawal by Subject|0|||
23156199|NCT00646906|64322226|FG003|Crossover Period 1|Withdrawal by Subject|0|||
23156200|NCT00646906|64322227|FG004|Crossover Period 1|Withdrawal by Subject|0|||
23156201|NCT00646906|64322228|FG005|Crossover Period 1|Withdrawal by Subject|1|||
23156202|NCT00646906|64322229|FG006|Crossover Period 1|Withdrawal by Subject|0|||
23156203|NCT00646906|64322223|FG000|Crossover Period 2|Withdrawal by Subject|0|||
23156204|NCT00646906|64322224|FG001|Crossover Period 2|Withdrawal by Subject|1|||
23156205|NCT00646906|64322225|FG002|Crossover Period 2|Withdrawal by Subject|2|||
23156206|NCT00646906|64322226|FG003|Crossover Period 2|Withdrawal by Subject|1|||
23156207|NCT00646906|64322227|FG004|Crossover Period 2|Withdrawal by Subject|0|||
23156208|NCT00646906|64322228|FG005|Crossover Period 2|Withdrawal by Subject|0|||
23156209|NCT00646906|64322229|FG006|Crossover Period 2|Withdrawal by Subject|0|||
23156210|NCT00646906|64322223|FG000|Crossover Period 2|Physician Decision|0|||
23156211|NCT00646906|64322224|FG001|Crossover Period 2|Physician Decision|0|||
23156212|NCT00646906|64322225|FG002|Crossover Period 2|Physician Decision|0|||
23156213|NCT00646906|64322226|FG003|Crossover Period 2|Physician Decision|0|||
23156214|NCT00646906|64322227|FG004|Crossover Period 2|Physician Decision|0|||
23156215|NCT00646906|64322228|FG005|Crossover Period 2|Physician Decision|0|||
23156216|NCT00646906|64322229|FG006|Crossover Period 2|Physician Decision|1|||
23156217|NCT02047253|64322233|FG000|Overall Study|Lost to Follow-up|8|||
23156218|NCT01628107|64322236|FG000|Overall Study|Withdrawal by Subject|17|||
23156219|NCT01628107|64322236|FG000|Overall Study|Lost to Follow-up|4|||
23156220|NCT01628107|64322236|FG000|Overall Study|Adverse Event|33|||
23156221|NCT01628107|64322236|FG000|Overall Study|Physician Decision|2|||
23156222|NCT01628107|64322236|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
23156223|NCT01628107|64322236|FG000|Overall Study|Non-compliant with Study Procedures|10|||
23156224|NCT01628107|64322236|FG000|Overall Study|Not Treated|8|||
23156225|NCT01628107|64322236|FG000|Overall Study|Sponsor Decision|11|||
23156226|NCT01628107|64322236|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
23156227|NCT01628107|64322236|FG000|Overall Study|Relocated|8|||
23156228|NCT01628107|64322236|FG000|Overall Study|Kidney Transplant|9|||
23156229|NCT01628107|64322236|FG000|Overall Study|Use of Standard of Care|9|||
23156230|NCT04607148|64322237|FG000|Overall Study|Withdrawal by Subject|0|||
23156231|NCT04607148|64322238|FG001|Overall Study|Withdrawal by Subject|4|||
23156232|NCT04607148|64322239|FG002|Overall Study|Withdrawal by Subject|2|||
23156233|NCT04607148|64322240|FG003|Overall Study|Withdrawal by Subject|8|||
23156234|NCT04607148|64322237|FG000|Overall Study|Study Terminated by Sponsor|14|||
23156235|NCT04607148|64322238|FG001|Overall Study|Study Terminated by Sponsor|59|||
23156236|NCT04607148|64322239|FG002|Overall Study|Study Terminated by Sponsor|9|||
23156237|NCT04607148|64322240|FG003|Overall Study|Study Terminated by Sponsor|39|||
23156238|NCT04607148|64322237|FG000|Overall Study|Sponsor Decision|0|||
23156239|NCT04607148|64322238|FG001|Overall Study|Sponsor Decision|0|||
23156240|NCT04607148|64322239|FG002|Overall Study|Sponsor Decision|1|||
23156241|NCT04607148|64322240|FG003|Overall Study|Sponsor Decision|0|||
23156242|NCT04607148|64322237|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23156243|NCT04607148|64322238|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23156244|NCT04607148|64322239|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23156245|NCT04607148|64322240|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23156246|NCT04607148|64322237|FG000|Overall Study|Lost to Follow-up|0|||
23156247|NCT04607148|64322238|FG001|Overall Study|Lost to Follow-up|2|||
23156248|NCT04607148|64322239|FG002|Overall Study|Lost to Follow-up|0|||
23156249|NCT04607148|64322240|FG003|Overall Study|Lost to Follow-up|0|||
23156250|NCT04607148|64322237|FG000|Overall Study|Death|0|||
23156251|NCT04607148|64322238|FG001|Overall Study|Death|3|||
23156252|NCT04607148|64322239|FG002|Overall Study|Death|0|||
23156253|NCT04607148|64322240|FG003|Overall Study|Death|1|||
23156254|NCT04607148|64322237|FG000|Overall Study|Adverse Event|0|||
23156255|NCT04607148|64322238|FG001|Overall Study|Adverse Event|1|||
23156256|NCT04607148|64322239|FG002|Overall Study|Adverse Event|0|||
23156257|NCT04607148|64322240|FG003|Overall Study|Adverse Event|0|||
23156258|NCT01877915|64322241|FG000|Overall Study|Lost to Follow-up|10|||
23156259|NCT01877915|64322242|FG001|Overall Study|Lost to Follow-up|9|||
23156260|NCT01877915|64322241|FG000|Overall Study|Withdrawal by Subject|42|||
23156261|NCT01877915|64322242|FG001|Overall Study|Withdrawal by Subject|55|||
23156262|NCT01877915|64322241|FG000|Overall Study|Other|2|||
23156263|NCT01877915|64322242|FG001|Overall Study|Other|4|||
23156264|NCT01641237|64322246|FG000|Period II|Withdrawal by Subject|1|||
23156265|NCT01641237|64322247|FG001|Period II|Withdrawal by Subject|0|||
23156266|NCT01641237|64322248|FG002|Period II|Withdrawal by Subject|0|||
23156267|NCT01641237|64322249|FG003|Period II|Withdrawal by Subject|0|||
23156268|NCT01641237|64322246|FG000|Period III|Lost to Follow-up|1|||
23156269|NCT01641237|64322247|FG001|Period III|Lost to Follow-up|0|||
23156270|NCT01641237|64322248|FG002|Period III|Lost to Follow-up|0|||
23156271|NCT01641237|64322249|FG003|Period III|Lost to Follow-up|0|||
23156272|NCT00525044|64322250|FG000|Overall Study|Lost to Follow-up|0|||
23156273|NCT00525044|64322251|FG001|Overall Study|Lost to Follow-up|1|||
23156274|NCT02546765|64322252|FG000|Overall Study|Withdrawal by Subject|0|||
23156275|NCT02546765|64322253|FG001|Overall Study|Withdrawal by Subject|1|||
23156276|NCT02546765|64322254|FG002|Overall Study|Withdrawal by Subject|0|||
23156277|NCT02546765|64322255|FG003|Overall Study|Withdrawal by Subject|0|||
23156278|NCT00290342|64322257|FG000|Overall Study|Other|0|||
23156279|NCT00290342|64322258|FG001|Overall Study|Other|1|||
23156280|NCT00290342|64322257|FG000|Overall Study|Withdrawal by Subject|6|||
23442703|NCT01618695|65362190|FG002|Core Phase|Other than specified|2|||
23156281|NCT00290342|64322258|FG001|Overall Study|Withdrawal by Subject|4|||
23156282|NCT00290342|64322257|FG000|Overall Study|Lost to Follow-up|1|||
23156283|NCT00290342|64322258|FG001|Overall Study|Lost to Follow-up|0|||
23156284|NCT02428855|64322259|FG000|Overall Study|Withdrawal by Subject|2|||
23156285|NCT02632721|64322260|FG000|Overall Study|Adverse Event|0|||
23156286|NCT02632721|64322261|FG001|Overall Study|Adverse Event|0|||
23156287|NCT02632721|64322262|FG002|Overall Study|Adverse Event|2|||
23156288|NCT02632721|64322263|FG003|Overall Study|Adverse Event|5|||
23156289|NCT02632721|64322264|FG004|Overall Study|Adverse Event|3|||
23156290|NCT02632721|64322260|FG000|Overall Study|Dose limiting toxicity|0|||
23156291|NCT02632721|64322261|FG001|Overall Study|Dose limiting toxicity|0|||
23156292|NCT02632721|64322262|FG002|Overall Study|Dose limiting toxicity|0|||
23156293|NCT02632721|64322263|FG003|Overall Study|Dose limiting toxicity|1|||
23156294|NCT02632721|64322264|FG004|Overall Study|Dose limiting toxicity|0|||
23156295|NCT02632721|64322260|FG000|Overall Study|Progressive disease|3|||
23156296|NCT02632721|64322261|FG001|Overall Study|Progressive disease|0|||
23156297|NCT02632721|64322262|FG002|Overall Study|Progressive disease|4|||
23156298|NCT02632721|64322263|FG003|Overall Study|Progressive disease|6|||
23156299|NCT02632721|64322264|FG004|Overall Study|Progressive disease|5|||
23156300|NCT02632721|64322260|FG000|Overall Study|Refused to continue taking trial medication|0|||
23156301|NCT02632721|64322261|FG001|Overall Study|Refused to continue taking trial medication|1|||
23156302|NCT02632721|64322262|FG002|Overall Study|Refused to continue taking trial medication|1|||
23156303|NCT02632721|64322263|FG003|Overall Study|Refused to continue taking trial medication|1|||
23156304|NCT02632721|64322264|FG004|Overall Study|Refused to continue taking trial medication|2|||
23156305|NCT02632721|64322260|FG000|Overall Study|Inadequate clinical condition|0|||
23156306|NCT02632721|64322261|FG001|Overall Study|Inadequate clinical condition|0|||
23156307|NCT02632721|64322262|FG002|Overall Study|Inadequate clinical condition|0|||
23156308|NCT02632721|64322263|FG003|Overall Study|Inadequate clinical condition|0|||
23156309|NCT02632721|64322264|FG004|Overall Study|Inadequate clinical condition|1|||
23156310|NCT02632721|64322260|FG000|Overall Study|No meet eligibility|0|||
23156311|NCT02632721|64322261|FG001|Overall Study|No meet eligibility|0|||
23156312|NCT02632721|64322262|FG002|Overall Study|No meet eligibility|0|||
23156313|NCT02632721|64322263|FG003|Overall Study|No meet eligibility|0|||
23156314|NCT02632721|64322264|FG004|Overall Study|No meet eligibility|1|||
23156315|NCT02632721|64322260|FG000|Overall Study|Allergic reaction|0|||
23156316|NCT02632721|64322261|FG001|Overall Study|Allergic reaction|0|||
23156317|NCT02632721|64322262|FG002|Overall Study|Allergic reaction|0|||
23156318|NCT02632721|64322263|FG003|Overall Study|Allergic reaction|1|||
23156319|NCT02632721|64322264|FG004|Overall Study|Allergic reaction|0|||
23156320|NCT02632721|64322260|FG000|Overall Study|Receiving Decitabine locally|0|||
23156321|NCT02632721|64322261|FG001|Overall Study|Receiving Decitabine locally|0|||
23156322|NCT02632721|64322262|FG002|Overall Study|Receiving Decitabine locally|1|||
23156323|NCT02632721|64322263|FG003|Overall Study|Receiving Decitabine locally|0|||
23156324|NCT02632721|64322264|FG004|Overall Study|Receiving Decitabine locally|0|||
23156325|NCT02632721|64322260|FG000|Overall Study|No benefit from study treatment|1|||
23156326|NCT02632721|64322261|FG001|Overall Study|No benefit from study treatment|1|||
23156327|NCT02632721|64322262|FG002|Overall Study|No benefit from study treatment|0|||
23156328|NCT02632721|64322263|FG003|Overall Study|No benefit from study treatment|0|||
23156329|NCT02632721|64322264|FG004|Overall Study|No benefit from study treatment|1|||
23156330|NCT02632721|64322260|FG000|Overall Study|Patient wish for other treatment|0|||
23156331|NCT02632721|64322261|FG001|Overall Study|Patient wish for other treatment|1|||
23156332|NCT02632721|64322262|FG002|Overall Study|Patient wish for other treatment|0|||
23156333|NCT02632721|64322263|FG003|Overall Study|Patient wish for other treatment|0|||
23156334|NCT02632721|64322264|FG004|Overall Study|Patient wish for other treatment|0|||
23156335|NCT02632721|64322260|FG000|Overall Study|Relapsed Pneumonia|0|||
23156336|NCT02632721|64322261|FG001|Overall Study|Relapsed Pneumonia|0|||
23156337|NCT02632721|64322262|FG002|Overall Study|Relapsed Pneumonia|0|||
23156338|NCT02632721|64322263|FG003|Overall Study|Relapsed Pneumonia|0|||
23156339|NCT02632721|64322264|FG004|Overall Study|Relapsed Pneumonia|1|||
23156340|NCT02632721|64322260|FG000|Overall Study|Therapy refractory AML|0|||
23156341|NCT02632721|64322261|FG001|Overall Study|Therapy refractory AML|0|||
23156342|NCT02632721|64322262|FG002|Overall Study|Therapy refractory AML|0|||
23156343|NCT02632721|64322263|FG003|Overall Study|Therapy refractory AML|0|||
23565838|NCT00672958|65799811|FG001|Overall Study|Non-compliance with study drug|3|||
23156344|NCT02632721|64322264|FG004|Overall Study|Therapy refractory AML|1|||
23156345|NCT02632721|64322260|FG000|Overall Study|Increase of white blood cell count|0|||
23156346|NCT02632721|64322261|FG001|Overall Study|Increase of white blood cell count|0|||
23156347|NCT02632721|64322262|FG002|Overall Study|Increase of white blood cell count|0|||
23565839|NCT00672958|65799810|FG000|Overall Study|Protocol deviations|11|||
23565840|NCT00672958|65799811|FG001|Overall Study|Protocol deviations|5|||
23565841|NCT00672958|65799810|FG000|Overall Study|Voluntary withdrawal|12|||
23565842|NCT00672958|65799811|FG001|Overall Study|Voluntary withdrawal|8|||
23565843|NCT00672958|65799810|FG000|Overall Study|Lost to Follow-up|22|||
23565844|NCT00672958|65799811|FG001|Overall Study|Lost to Follow-up|17|||
23565845|NCT00672958|65799810|FG000|Overall Study|Reason not specified|0|||
23565846|NCT00672958|65799811|FG001|Overall Study|Reason not specified|3|||
23565847|NCT00152009|65799812|FG000|Overall Study|Adverse Event|9|||
23565848|NCT00152009|65799813|FG001|Overall Study|Adverse Event|13|||
23565849|NCT00152009|65799814|FG002|Overall Study|Adverse Event|20|||
23565850|NCT00152009|65799815|FG003|Overall Study|Adverse Event|1|||
23565851|NCT00152009|65799812|FG000|Overall Study|Protocol Violation|3|||
23156348|NCT02632721|64322263|FG003|Overall Study|Increase of white blood cell count|0|||
23156349|NCT02632721|64322264|FG004|Overall Study|Increase of white blood cell count|1|||
23156350|NCT02632721|64322260|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
23156351|NCT02632721|64322261|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
23156352|NCT02632721|64322262|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
23156353|NCT02632721|64322263|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
23156354|NCT02632721|64322264|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
23156355|NCT03275285|64322265|FG000|Overall Study|Ongoing|45|||
23156356|NCT03275285|64322266|FG001|Overall Study|Ongoing|69|||
23156357|NCT05082376|64322267|FG000|Overall Study|Lost to Follow-up|2|||
23156358|NCT00591214|64322268|FG000|Overall Study|Physician Decision|7|||
23156359|NCT00591214|64322268|FG000|Overall Study|Withdrawal by Subject|1|||
23156360|NCT00698997|64322269|FG000|Overall Study|Lost to Follow-up|3|||
23156361|NCT00698997|64322270|FG001|Overall Study|Lost to Follow-up|0|||
23156362|NCT00698997|64322269|FG000|Overall Study|Withdrawal by Subject|7|||
23156363|NCT00698997|64322270|FG001|Overall Study|Withdrawal by Subject|27|||
23156364|NCT03281668|64325211|FG000|Overall Study|Physician Decision|1|||
23156365|NCT03281668|64325211|FG000|Overall Study|scheduling conflict, family circumstance|2|||
23156366|NCT03281668|64325211|FG000|Overall Study|Withdrawal by Subject|4|||
23156367|NCT03281668|64325211|FG000|Overall Study|Lost to Follow-up|1|||
23156368|NCT00006392|64325214|FG000|Overall Study|Ineligible|11|||
23156369|NCT00006392|64325215|FG001|Overall Study|Ineligible|3|||
23156370|NCT00006392|64325216|FG002|Overall Study|Ineligible|5|||
23156371|NCT00006392|64325217|FG003|Overall Study|Ineligible|5|||
23156372|NCT00006392|64325214|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
23156373|NCT00006392|64325215|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
23156374|NCT00006392|64325216|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
23156375|NCT00006392|64325217|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
23156376|NCT01423851|64325218|FG000|Whole Study|Disease progression|2|||
23156377|NCT01423851|64325219|FG001|Whole Study|Disease progression|1|||
23156378|NCT01423851|64325220|FG002|Whole Study|Disease progression|1|||
23156379|NCT01423851|64325221|FG003|Whole Study|Disease progression|4|||
23156380|NCT01423851|64325222|FG004|Whole Study|Disease progression|1|||
23156381|NCT01423851|64325223|FG005|Whole Study|Disease progression|3|||
23156382|NCT01423851|64325224|FG006|Whole Study|Disease progression|1|||
23156383|NCT01423851|64325225|FG007|Whole Study|Disease progression|4|||
23156384|NCT01423851|64325226|FG008|Whole Study|Disease progression|0|||
23156385|NCT01423851|64325227|FG009|Whole Study|Disease progression|2|||
23156386|NCT01423851|64325228|FG010|Whole Study|Disease progression|10|||
23156387|NCT01423851|64325218|FG000|Whole Study|Physician Decision|0|||
23156388|NCT01423851|64325219|FG001|Whole Study|Physician Decision|1|||
23156389|NCT01423851|64325220|FG002|Whole Study|Physician Decision|2|||
23156390|NCT01423851|64325221|FG003|Whole Study|Physician Decision|0|||
23156391|NCT01423851|64325222|FG004|Whole Study|Physician Decision|2|||
23156392|NCT01423851|64325223|FG005|Whole Study|Physician Decision|0|||
23156393|NCT01423851|64325224|FG006|Whole Study|Physician Decision|2|||
23156394|NCT01423851|64325225|FG007|Whole Study|Physician Decision|1|||
23156395|NCT01423851|64325226|FG008|Whole Study|Physician Decision|3|||
23156396|NCT01423851|64325227|FG009|Whole Study|Physician Decision|4|||
23156397|NCT01423851|64325228|FG010|Whole Study|Physician Decision|12|||
23156398|NCT01423851|64325218|FG000|Whole Study|Withdrawal by Subject|1|||
23156399|NCT01423851|64325219|FG001|Whole Study|Withdrawal by Subject|1|||
23156400|NCT01423851|64325220|FG002|Whole Study|Withdrawal by Subject|0|||
23156401|NCT01423851|64325221|FG003|Whole Study|Withdrawal by Subject|0|||
23156402|NCT01423851|64325222|FG004|Whole Study|Withdrawal by Subject|0|||
23156403|NCT01423851|64325223|FG005|Whole Study|Withdrawal by Subject|0|||
23156404|NCT01423851|64325224|FG006|Whole Study|Withdrawal by Subject|0|||
23156405|NCT01423851|64325225|FG007|Whole Study|Withdrawal by Subject|0|||
23156406|NCT01423851|64325226|FG008|Whole Study|Withdrawal by Subject|2|||
23156407|NCT01423851|64325227|FG009|Whole Study|Withdrawal by Subject|0|||
23156408|NCT01423851|64325228|FG010|Whole Study|Withdrawal by Subject|4|||
23156409|NCT01423851|64325218|FG000|Whole Study|Adverse Event|0|||
23327585|NCT00380874|64940959|FG001|Overall Study|Withdrawal by Subject|1|||
23156410|NCT01423851|64325219|FG001|Whole Study|Adverse Event|0|||
23156411|NCT01423851|64325220|FG002|Whole Study|Adverse Event|0|||
23156412|NCT01423851|64325221|FG003|Whole Study|Adverse Event|2|||
23156413|NCT01423851|64325222|FG004|Whole Study|Adverse Event|0|||
23156414|NCT01423851|64325223|FG005|Whole Study|Adverse Event|0|||
23156415|NCT01423851|64325224|FG006|Whole Study|Adverse Event|0|||
23156416|NCT01423851|64325225|FG007|Whole Study|Adverse Event|3|||
23156417|NCT01423851|64325226|FG008|Whole Study|Adverse Event|3|||
23156418|NCT01423851|64325227|FG009|Whole Study|Adverse Event|2|||
23156419|NCT01423851|64325228|FG010|Whole Study|Adverse Event|3|||
23156420|NCT02819635|64325229|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
23327586|NCT00380874|64940958|FG000|Overall Study|Not related to study drug|3|||
23156421|NCT02819635|64325230|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
23156422|NCT02819635|64325231|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
23156423|NCT02819635|64325232|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
23156424|NCT02819635|64325233|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
23156425|NCT02819635|64325234|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
23156426|NCT02819635|64325235|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
23156427|NCT02819635|64325236|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23156428|NCT02819635|64325237|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23156429|NCT02819635|64325238|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23156430|NCT02819635|64325239|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23156431|NCT02819635|64325240|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
23156432|NCT02819635|64325229|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23156433|NCT02819635|64325230|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23156434|NCT02819635|64325231|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23156435|NCT02819635|64325232|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23156436|NCT02819635|64325233|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
23156437|NCT02819635|64325234|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
23156438|NCT02819635|64325235|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
23156439|NCT02819635|64325236|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23156440|NCT02819635|64325237|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23156441|NCT02819635|64325238|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23156442|NCT02819635|64325239|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23156443|NCT02819635|64325240|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
23156444|NCT02819635|64325229|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156445|NCT02819635|64325230|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156446|NCT02819635|64325231|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156447|NCT02819635|64325232|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156448|NCT02819635|64325233|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156449|NCT02819635|64325234|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
23156450|NCT02819635|64325235|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
23156451|NCT02819635|64325236|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156452|NCT02819635|64325237|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156453|NCT02819635|64325238|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156454|NCT02819635|64325239|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156455|NCT02819635|64325240|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
23156456|NCT02819635|64325229|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156457|NCT02819635|64325230|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156458|NCT02819635|64325231|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156459|NCT02819635|64325232|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156460|NCT02819635|64325233|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156461|NCT02819635|64325234|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156462|NCT02819635|64325235|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
23156463|NCT02819635|64325236|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156464|NCT02819635|64325237|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156465|NCT02819635|64325238|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156466|NCT02819635|64325239|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156467|NCT02819635|64325240|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
23156468|NCT02819635|64325229|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
23156469|NCT02819635|64325230|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
23156470|NCT02819635|64325231|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
23156471|NCT02819635|64325232|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
23156472|NCT02819635|64325233|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
23156473|NCT02819635|64325234|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
23156474|NCT02819635|64325235|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
23156475|NCT02819635|64325236|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23156476|NCT02819635|64325237|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23156477|NCT02819635|64325238|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23156478|NCT02819635|64325239|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23156479|NCT02819635|64325240|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
23156480|NCT02819635|64325229|FG000|Substudy 2, Part 2|Adverse Event|0|||
23156481|NCT02819635|64325230|FG001|Substudy 2, Part 2|Adverse Event|0|||
23156482|NCT02819635|64325231|FG002|Substudy 2, Part 2|Adverse Event|0|||
23156483|NCT02819635|64325232|FG003|Substudy 2, Part 2|Adverse Event|0|||
23156484|NCT02819635|64325233|FG004|Substudy 2, Part 2|Adverse Event|0|||
23156485|NCT02819635|64325234|FG005|Substudy 2, Part 2|Adverse Event|4|||
23156486|NCT02819635|64325235|FG006|Substudy 2, Part 2|Adverse Event|0|||
23156487|NCT02819635|64325236|FG007|Substudy 2, Part 2|Adverse Event|0|||
23156488|NCT02819635|64325237|FG008|Substudy 2, Part 2|Adverse Event|0|||
23156489|NCT02819635|64325238|FG009|Substudy 2, Part 2|Adverse Event|0|||
23156490|NCT02819635|64325239|FG010|Substudy 2, Part 2|Adverse Event|0|||
23327587|NCT00380874|64940959|FG001|Overall Study|Not related to study drug|2|||
23327588|NCT03762850|64940960|FG000|Overall Study|Death|0|||
23327589|NCT03762850|64940961|FG001|Overall Study|Death|1|||
23327590|NCT03762850|64940960|FG000|Overall Study|Lost to Follow-up|0|||
23327591|NCT03762850|64940961|FG001|Overall Study|Lost to Follow-up|1|||
23327592|NCT03762850|64940960|FG000|Overall Study|Physician Decision|0|||
23327593|NCT03762850|64940961|FG001|Overall Study|Physician Decision|1|||
23327594|NCT03762850|64940960|FG000|Overall Study|Withdrawal by Subject|4|||
23327595|NCT03762850|64940961|FG001|Overall Study|Withdrawal by Subject|9|||
23327596|NCT02554682|64940962|FG000|Overall Study|Lost to Follow-up|11|||
23327597|NCT02554682|64940963|FG001|Overall Study|Lost to Follow-up|9|||
23327598|NCT02554682|64940964|FG002|Overall Study|Lost to Follow-up|4|||
23327599|NCT02554682|64940965|FG003|Overall Study|Lost to Follow-up|3|||
23327600|NCT02554682|64940966|FG004|Overall Study|Lost to Follow-up|2|||
23327601|NCT02554682|64940967|FG005|Overall Study|Lost to Follow-up|1|||
23327602|NCT02554682|64940968|FG006|Overall Study|Lost to Follow-up|6|||
23156491|NCT02819635|64325240|FG011|Substudy 2, Part 2|Adverse Event|0|||
23156492|NCT02819635|64325229|FG000|Substudy 2, Part 2|Withdrew consent|0|||
23156493|NCT02819635|64325230|FG001|Substudy 2, Part 2|Withdrew consent|0|||
23156494|NCT02819635|64325231|FG002|Substudy 2, Part 2|Withdrew consent|0|||
23156495|NCT02819635|64325232|FG003|Substudy 2, Part 2|Withdrew consent|0|||
23156496|NCT02819635|64325233|FG004|Substudy 2, Part 2|Withdrew consent|0|||
23156497|NCT02819635|64325234|FG005|Substudy 2, Part 2|Withdrew consent|3|||
23156498|NCT02819635|64325235|FG006|Substudy 2, Part 2|Withdrew consent|1|||
23156499|NCT02819635|64325236|FG007|Substudy 2, Part 2|Withdrew consent|0|||
23156500|NCT02819635|64325237|FG008|Substudy 2, Part 2|Withdrew consent|0|||
23156501|NCT02819635|64325238|FG009|Substudy 2, Part 2|Withdrew consent|0|||
23156502|NCT02819635|64325239|FG010|Substudy 2, Part 2|Withdrew consent|0|||
23156503|NCT02819635|64325240|FG011|Substudy 2, Part 2|Withdrew consent|0|||
23156504|NCT02819635|64325229|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
23156505|NCT02819635|64325230|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
23156506|NCT02819635|64325231|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
23156507|NCT02819635|64325232|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
23156508|NCT02819635|64325233|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
23156509|NCT02819635|64325234|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
23156510|NCT02819635|64325235|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
23156511|NCT02819635|64325236|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
23156512|NCT02819635|64325237|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
23156513|NCT02819635|64325238|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
23156514|NCT02819635|64325239|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
23156515|NCT02819635|64325240|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
23156516|NCT02819635|64325229|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156517|NCT02819635|64325230|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156518|NCT02819635|64325231|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156519|NCT02819635|64325232|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156520|NCT02819635|64325233|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156521|NCT02819635|64325234|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156522|NCT02819635|64325235|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
23156523|NCT02819635|64325236|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156524|NCT02819635|64325237|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156525|NCT02819635|64325238|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156526|NCT02819635|64325239|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156527|NCT02819635|64325240|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
23156528|NCT02819635|64325229|FG000|Substudy 2, Part 2|Other, not specified|0|||
23156529|NCT02819635|64325230|FG001|Substudy 2, Part 2|Other, not specified|0|||
23156530|NCT02819635|64325231|FG002|Substudy 2, Part 2|Other, not specified|0|||
23156531|NCT02819635|64325232|FG003|Substudy 2, Part 2|Other, not specified|0|||
23156532|NCT02819635|64325233|FG004|Substudy 2, Part 2|Other, not specified|0|||
23156533|NCT02819635|64325234|FG005|Substudy 2, Part 2|Other, not specified|4|||
23156534|NCT02819635|64325235|FG006|Substudy 2, Part 2|Other, not specified|8|||
23156535|NCT02819635|64325236|FG007|Substudy 2, Part 2|Other, not specified|0|||
23156536|NCT02819635|64325237|FG008|Substudy 2, Part 2|Other, not specified|0|||
23156537|NCT02819635|64325238|FG009|Substudy 2, Part 2|Other, not specified|0|||
23156538|NCT02819635|64325239|FG010|Substudy 2, Part 2|Other, not specified|0|||
23156539|NCT02819635|64325240|FG011|Substudy 2, Part 2|Other, not specified|0|||
23156540|NCT02819635|64325229|FG000|Substudy 3|Adverse Event|0|||
23156541|NCT02819635|64325230|FG001|Substudy 3|Adverse Event|0|||
23156542|NCT02819635|64325231|FG002|Substudy 3|Adverse Event|0|||
23327603|NCT02554682|64940969|FG007|Overall Study|Lost to Follow-up|6|||
23156543|NCT02819635|64325232|FG003|Substudy 3|Adverse Event|0|||
23221623|NCT02971007|64553732|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
23327604|NCT02554682|64940970|FG008|Overall Study|Lost to Follow-up|2|||
23327605|NCT02554682|64940971|FG009|Overall Study|Lost to Follow-up|2|||
23327606|NCT02554682|64940962|FG000|Overall Study|Withdrawal by Subject|2|||
23156544|NCT02819635|64325233|FG004|Substudy 3|Adverse Event|0|||
23156545|NCT02819635|64325234|FG005|Substudy 3|Adverse Event|0|||
23156546|NCT02819635|64325235|FG006|Substudy 3|Adverse Event|0|||
23156547|NCT02819635|64325236|FG007|Substudy 3|Adverse Event|0|||
23156548|NCT02819635|64325237|FG008|Substudy 3|Adverse Event|32|||
23156549|NCT02819635|64325238|FG009|Substudy 3|Adverse Event|3|||
23156550|NCT02819635|64325239|FG010|Substudy 3|Adverse Event|12|||
23156551|NCT02819635|64325240|FG011|Substudy 3|Adverse Event|18|||
23156552|NCT02819635|64325229|FG000|Substudy 3|Withdrew consent|0|||
23156553|NCT02819635|64325230|FG001|Substudy 3|Withdrew consent|0|||
23156554|NCT02819635|64325231|FG002|Substudy 3|Withdrew consent|0|||
23156555|NCT02819635|64325232|FG003|Substudy 3|Withdrew consent|0|||
23156556|NCT02819635|64325233|FG004|Substudy 3|Withdrew consent|0|||
23156557|NCT02819635|64325234|FG005|Substudy 3|Withdrew consent|0|||
23327607|NCT02554682|64940963|FG001|Overall Study|Withdrawal by Subject|1|||
23327608|NCT02554682|64940964|FG002|Overall Study|Withdrawal by Subject|0|||
23327609|NCT02554682|64940965|FG003|Overall Study|Withdrawal by Subject|0|||
23442704|NCT01618695|65362191|FG003|Core Phase|Other than specified|2|||
23442705|NCT01618695|65362188|FG000|Core Phase|Not treated|1|||
23442706|NCT01618695|65362189|FG001|Core Phase|Not treated|0|||
23442707|NCT01618695|65362190|FG002|Core Phase|Not treated|2|||
23442708|NCT01618695|65362191|FG003|Core Phase|Not treated|0|||
23442709|NCT01618695|65362188|FG000|Extension Phase|Lack of Efficacy|17|||
23442710|NCT01618695|65362189|FG001|Extension Phase|Lack of Efficacy|33|||
23442711|NCT01618695|65362190|FG002|Extension Phase|Lack of Efficacy|26|||
23442712|NCT01618695|65362191|FG003|Extension Phase|Lack of Efficacy|24|||
23156558|NCT02819635|64325235|FG006|Substudy 3|Withdrew consent|0|||
23156559|NCT02819635|64325236|FG007|Substudy 3|Withdrew consent|0|||
23156560|NCT02819635|64325237|FG008|Substudy 3|Withdrew consent|11|||
23156561|NCT02819635|64325238|FG009|Substudy 3|Withdrew consent|1|||
23156562|NCT02819635|64325239|FG010|Substudy 3|Withdrew consent|4|||
23156563|NCT02819635|64325240|FG011|Substudy 3|Withdrew consent|9|||
23156564|NCT02819635|64325229|FG000|Substudy 3|Lost to Follow-up|0|||
23156565|NCT02819635|64325230|FG001|Substudy 3|Lost to Follow-up|0|||
23156566|NCT02819635|64325231|FG002|Substudy 3|Lost to Follow-up|0|||
23156567|NCT02819635|64325232|FG003|Substudy 3|Lost to Follow-up|0|||
23156568|NCT02819635|64325233|FG004|Substudy 3|Lost to Follow-up|0|||
23221624|NCT02971007|64553730|FG000|Overall Study|Patient discontinued study drug|0|||
23442713|NCT01618695|65362188|FG000|Extension Phase|Pregnancy|2|||
23442714|NCT01618695|65362189|FG001|Extension Phase|Pregnancy|0|||
23442715|NCT01618695|65362190|FG002|Extension Phase|Pregnancy|1|||
23442716|NCT01618695|65362191|FG003|Extension Phase|Pregnancy|1|||
23442717|NCT01618695|65362188|FG000|Extension Phase|Withdrawal by Subject|43|||
23442718|NCT01618695|65362189|FG001|Extension Phase|Withdrawal by Subject|48|||
23442719|NCT01618695|65362190|FG002|Extension Phase|Withdrawal by Subject|42|||
23442720|NCT01618695|65362191|FG003|Extension Phase|Withdrawal by Subject|33|||
23442721|NCT01618695|65362188|FG000|Extension Phase|Adverse Event|18|||
23442722|NCT01618695|65362189|FG001|Extension Phase|Adverse Event|16|||
23442723|NCT01618695|65362190|FG002|Extension Phase|Adverse Event|9|||
23442724|NCT01618695|65362191|FG003|Extension Phase|Adverse Event|20|||
23442725|NCT01618695|65362188|FG000|Extension Phase|Lost to Follow-up|2|||
23442726|NCT01618695|65362189|FG001|Extension Phase|Lost to Follow-up|1|||
23442727|NCT01618695|65362190|FG002|Extension Phase|Lost to Follow-up|1|||
23442728|NCT01618695|65362191|FG003|Extension Phase|Lost to Follow-up|1|||
23442729|NCT01618695|65362188|FG000|Extension Phase|Other than specified|13|||
23442730|NCT01618695|65362189|FG001|Extension Phase|Other than specified|18|||
23442731|NCT01618695|65362190|FG002|Extension Phase|Other than specified|13|||
23221625|NCT02971007|64553731|FG001|Overall Study|Patient discontinued study drug|1|||
23221626|NCT02971007|64553732|FG002|Overall Study|Patient discontinued study drug|0|||
23221627|NCT00437203|64553733|FG000|Overall Study|Death|0|||
23221628|NCT00437203|64553734|FG001|Overall Study|Death|0|||
23221629|NCT00437203|64553735|FG002|Overall Study|Death|1|||
23221630|NCT00437203|64553736|FG003|Overall Study|Death|0|||
23221631|NCT00437203|64553737|FG004|Overall Study|Death|0|||
23221632|NCT00437203|64553738|FG005|Overall Study|Death|0|||
23221633|NCT00437203|64553739|FG006|Overall Study|Death|0|||
23442732|NCT01618695|65362191|FG003|Extension Phase|Other than specified|18|||
23221634|NCT00437203|64553740|FG007|Overall Study|Death|1|||
23442733|NCT01832155|65362194|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
23442734|NCT01832155|65362195|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
23442735|NCT01832155|65362194|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
23156569|NCT02819635|64325234|FG005|Substudy 3|Lost to Follow-up|0|||
23156570|NCT02819635|64325235|FG006|Substudy 3|Lost to Follow-up|0|||
23442736|NCT01832155|65362195|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
23221635|NCT00437203|64553741|FG008|Overall Study|Death|0|||
23442737|NCT03688074|65362198|FG000|Overall Study|Adverse Event|0|||
23221636|NCT00437203|64553742|FG009|Overall Study|Death|1|||
23221637|NCT00437203|64553733|FG000|Overall Study|Adverse Event|1|||
23221638|NCT00437203|64553734|FG001|Overall Study|Adverse Event|1|||
23442738|NCT03688074|65362199|FG001|Overall Study|Adverse Event|1|||
23156571|NCT02819635|64325236|FG007|Substudy 3|Lost to Follow-up|0|||
23442739|NCT03688074|65362198|FG000|Overall Study|Other|1|||
23442740|NCT03688074|65362199|FG001|Overall Study|Other|0|||
23442741|NCT00381693|65362203|FG000|Overall Study|Death|1|||
23442742|NCT00381693|65362203|FG000|Overall Study|Adverse Event|4|||
23442743|NCT00381693|65362203|FG000|Overall Study|Patient Choice|1|||
23442744|NCT00381693|65362203|FG000|Overall Study|Progression|2|||
23442745|NCT03539601|65362204|FG000|Overall Study|Withdraw by parent/guardian|1|||
23442746|NCT03539601|65362205|FG001|Overall Study|Withdraw by parent/guardian|0|||
23442747|NCT03539601|65362206|FG002|Overall Study|Withdraw by parent/guardian|1|||
23442748|NCT03539601|65362207|FG003|Overall Study|Withdraw by parent/guardian|0|||
23442749|NCT03539601|65362204|FG000|Overall Study|Adverse Event|0|||
23442750|NCT03539601|65362205|FG001|Overall Study|Adverse Event|2|||
23442751|NCT03539601|65362206|FG002|Overall Study|Adverse Event|0|||
23442752|NCT03539601|65362207|FG003|Overall Study|Adverse Event|0|||
23442753|NCT03539601|65362204|FG000|Overall Study|Lost to Follow-up|2|||
23442754|NCT03539601|65362205|FG001|Overall Study|Lost to Follow-up|4|||
23442755|NCT03539601|65362206|FG002|Overall Study|Lost to Follow-up|5|||
23442756|NCT03539601|65362207|FG003|Overall Study|Lost to Follow-up|0|||
23442757|NCT03539601|65362204|FG000|Overall Study|Withdrawal by Subject|2|||
23442758|NCT03539601|65362205|FG001|Overall Study|Withdrawal by Subject|0|||
23442759|NCT03539601|65362206|FG002|Overall Study|Withdrawal by Subject|0|||
23442760|NCT03539601|65362207|FG003|Overall Study|Withdrawal by Subject|1|||
23442761|NCT03539601|65362204|FG000|Overall Study|Randomized but not treated|1|||
23442762|NCT03539601|65362205|FG001|Overall Study|Randomized but not treated|1|||
23442763|NCT03539601|65362206|FG002|Overall Study|Randomized but not treated|0|||
23442764|NCT03539601|65362207|FG003|Overall Study|Randomized but not treated|0|||
23442765|NCT03160898|65362208|FG000|Overall Study|Adverse Event|4|||
23442766|NCT03160898|65362209|FG001|Overall Study|Adverse Event|8|||
23442767|NCT03160898|65362210|FG002|Overall Study|Adverse Event|7|||
23442768|NCT03160898|65362211|FG003|Overall Study|Adverse Event|10|||
23442769|NCT03160898|65362208|FG000|Overall Study|Death|1|||
23442770|NCT03160898|65362209|FG001|Overall Study|Death|0|||
23442771|NCT03160898|65362210|FG002|Overall Study|Death|0|||
23442772|NCT03160898|65362211|FG003|Overall Study|Death|1|||
23442773|NCT03160898|65362208|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
23442774|NCT03160898|65362209|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
23442775|NCT03160898|65362210|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
23442776|NCT03160898|65362211|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
23442777|NCT03160898|65362208|FG000|Overall Study|Lost to Follow-up|1|||
23442778|NCT03160898|65362209|FG001|Overall Study|Lost to Follow-up|1|||
23442779|NCT03160898|65362210|FG002|Overall Study|Lost to Follow-up|1|||
23442780|NCT03160898|65362211|FG003|Overall Study|Lost to Follow-up|2|||
23442781|NCT03160898|65362208|FG000|Overall Study|Physician Decision|1|||
23442782|NCT03160898|65362209|FG001|Overall Study|Physician Decision|0|||
23442783|NCT03160898|65362210|FG002|Overall Study|Physician Decision|0|||
23442784|NCT03160898|65362211|FG003|Overall Study|Physician Decision|1|||
23442785|NCT03160898|65362208|FG000|Overall Study|Progressive Disease|4|||
23442786|NCT03160898|65362209|FG001|Overall Study|Progressive Disease|1|||
23442787|NCT03160898|65362210|FG002|Overall Study|Progressive Disease|2|||
23442788|NCT03160898|65362211|FG003|Overall Study|Progressive Disease|1|||
23442789|NCT03160898|65362208|FG000|Overall Study|Protocol Violation|1|||
23442790|NCT03160898|65362209|FG001|Overall Study|Protocol Violation|0|||
23442791|NCT03160898|65362210|FG002|Overall Study|Protocol Violation|2|||
23442792|NCT03160898|65362211|FG003|Overall Study|Protocol Violation|0|||
23442793|NCT03160898|65362208|FG000|Overall Study|Sponsor Discretion|2|||
23442794|NCT03160898|65362209|FG001|Overall Study|Sponsor Discretion|0|||
23442795|NCT03160898|65362210|FG002|Overall Study|Sponsor Discretion|0|||
23442796|NCT03160898|65362211|FG003|Overall Study|Sponsor Discretion|0|||
23442797|NCT03160898|65362208|FG000|Overall Study|Withdrawal by Subject|1|||
23442798|NCT03160898|65362209|FG001|Overall Study|Withdrawal by Subject|3|||
23442799|NCT03160898|65362210|FG002|Overall Study|Withdrawal by Subject|2|||
23442800|NCT03160898|65362211|FG003|Overall Study|Withdrawal by Subject|1|||
23442801|NCT03160898|65362208|FG000|Overall Study|Other|2|||
23442802|NCT03160898|65362209|FG001|Overall Study|Other|0|||
23442803|NCT03160898|65362210|FG002|Overall Study|Other|2|||
23156572|NCT02819635|64325237|FG008|Substudy 3|Lost to Follow-up|1|||
23442804|NCT03160898|65362211|FG003|Overall Study|Other|2|||
23442805|NCT01957202|65362212|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442806|NCT01957202|65362213|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
23442807|NCT01957202|65362214|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442808|NCT01957202|65362215|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442809|NCT01957202|65362216|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442810|NCT01957202|65362217|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442811|NCT01957202|65362218|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442812|NCT01957202|65362219|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442813|NCT01957202|65362220|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442814|NCT01957202|65362221|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442815|NCT01957202|65362222|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442816|NCT01957202|65362223|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442817|NCT01957202|65362224|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442818|NCT01957202|65362225|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23327610|NCT02554682|64940966|FG004|Overall Study|Withdrawal by Subject|0|||
23327611|NCT02554682|64940967|FG005|Overall Study|Withdrawal by Subject|0|||
23327612|NCT02554682|64940968|FG006|Overall Study|Withdrawal by Subject|0|||
23327613|NCT02554682|64940969|FG007|Overall Study|Withdrawal by Subject|0|||
23327614|NCT02554682|64940970|FG008|Overall Study|Withdrawal by Subject|0|||
23327615|NCT02554682|64940971|FG009|Overall Study|Withdrawal by Subject|0|||
23327616|NCT02554682|64940962|FG000|Overall Study|Physician Decision|2|||
23327617|NCT02554682|64940963|FG001|Overall Study|Physician Decision|2|||
23327618|NCT02554682|64940964|FG002|Overall Study|Physician Decision|0|||
23327619|NCT02554682|64940965|FG003|Overall Study|Physician Decision|0|||
23327620|NCT02554682|64940966|FG004|Overall Study|Physician Decision|0|||
23327621|NCT02554682|64940967|FG005|Overall Study|Physician Decision|0|||
23442819|NCT01957202|65362226|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23327622|NCT02554682|64940968|FG006|Overall Study|Physician Decision|0|||
23442820|NCT01957202|65362227|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442821|NCT01957202|65362228|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
23442822|NCT01957202|65362229|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
23442823|NCT01957202|65362212|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442824|NCT01957202|65362213|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442825|NCT01957202|65362214|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442826|NCT01957202|65362215|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442827|NCT01957202|65362216|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442828|NCT01957202|65362217|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
23156573|NCT02819635|64325238|FG009|Substudy 3|Lost to Follow-up|0|||
23156574|NCT02819635|64325239|FG010|Substudy 3|Lost to Follow-up|1|||
23156575|NCT02819635|64325240|FG011|Substudy 3|Lost to Follow-up|1|||
23156576|NCT02819635|64325229|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
23156577|NCT02819635|64325230|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
23156578|NCT02819635|64325231|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
23156579|NCT02819635|64325232|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
23156580|NCT02819635|64325233|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
23442829|NCT01957202|65362218|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442830|NCT01957202|65362219|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442831|NCT01957202|65362220|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442832|NCT01957202|65362221|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442833|NCT01957202|65362222|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442834|NCT01957202|65362223|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442835|NCT01957202|65362224|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442836|NCT01957202|65362225|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442837|NCT01957202|65362226|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442838|NCT01957202|65362227|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442839|NCT01957202|65362228|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
23442840|NCT01957202|65362229|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
23442841|NCT01843023|65362230|FG000|Overall Study|Death|1|||
23442842|NCT01843023|65362231|FG001|Overall Study|Death|0|||
23442843|NCT01843023|65362230|FG000|Overall Study|Lost to Follow-up|24|||
23442844|NCT01843023|65362231|FG001|Overall Study|Lost to Follow-up|29|||
23442845|NCT01843023|65362230|FG000|Overall Study|Withdrawal by Subject|8|||
23442846|NCT01843023|65362231|FG001|Overall Study|Withdrawal by Subject|6|||
23442847|NCT00887926|65362238|FG000|Overall Study|Withdrawal by Subject|0|||
23442848|NCT00887926|65362239|FG001|Overall Study|Withdrawal by Subject|1|||
23442849|NCT00887926|65362240|FG002|Overall Study|Withdrawal by Subject|0|||
23442850|NCT00887926|65362241|FG003|Overall Study|Withdrawal by Subject|0|||
23442851|NCT03472326|65362244|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
23442852|NCT03472326|65362245|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
23442853|NCT03472326|65362246|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
23442854|NCT03472326|65362247|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
23442855|NCT03472326|65362244|FG000|Part 2: Combination Therapy|Pregnancy|0|||
23442856|NCT03472326|65362245|FG001|Part 2: Combination Therapy|Pregnancy|0|||
23442857|NCT03472326|65362246|FG002|Part 2: Combination Therapy|Pregnancy|0|||
23442858|NCT03472326|65362247|FG003|Part 2: Combination Therapy|Pregnancy|1|||
23442859|NCT01550757|65362250|FG000|Overall Study|Lost to Follow-up|21|||
23442860|NCT01550757|65362251|FG001|Overall Study|Lost to Follow-up|14|||
23442861|NCT01550757|65362252|FG002|Overall Study|Lost to Follow-up|42|||
23156581|NCT02819635|64325234|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
23327623|NCT02554682|64940969|FG007|Overall Study|Physician Decision|0|||
23565852|NCT00152009|65799813|FG001|Overall Study|Protocol Violation|0|||
23156582|NCT02819635|64325235|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
23327624|NCT02554682|64940970|FG008|Overall Study|Physician Decision|0|||
23327625|NCT02554682|64940971|FG009|Overall Study|Physician Decision|0|||
23442862|NCT01550757|65362253|FG003|Overall Study|Lost to Follow-up|53|||
23442863|NCT01550757|65362250|FG000|Overall Study|Withdrawal by Subject|2|||
23442864|NCT01550757|65362251|FG001|Overall Study|Withdrawal by Subject|0|||
23442865|NCT01550757|65362252|FG002|Overall Study|Withdrawal by Subject|3|||
23442866|NCT01550757|65362253|FG003|Overall Study|Withdrawal by Subject|1|||
23442867|NCT01363908|65362254|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
23442868|NCT01363908|65362255|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
23442869|NCT01363908|65362254|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
23442870|NCT01363908|65362255|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
23442871|NCT01363908|65362254|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
23442872|NCT01363908|65362255|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
23442873|NCT01363908|65362254|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
23442874|NCT01363908|65362255|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
23442875|NCT00705367|65362256|FG000|Long-term Extension Period|Adverse Event|2|||
23442876|NCT00705367|65362257|FG001|Long-term Extension Period|Adverse Event|0|||
23442877|NCT00705367|65362256|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
23442878|NCT00705367|65362257|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
23442879|NCT00705367|65362256|FG000|Long-term Extension Period|Lack of Efficacy|1|||
23442880|NCT00705367|65362257|FG001|Long-term Extension Period|Lack of Efficacy|0|||
23442881|NCT00705367|65362256|FG000|Long-term Extension Period|No longer met study criteria|1|||
23442882|NCT00705367|65362257|FG001|Long-term Extension Period|No longer met study criteria|0|||
23442883|NCT00705367|65362256|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
23442884|NCT00705367|65362257|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
23442885|NCT00126776|65362258|FG000|Overall Study|follow up complete on all patients|0|||
23442886|NCT00126776|65362259|FG001|Overall Study|follow up complete on all patients|0|||
23442887|NCT02287467|65362260|FG000|Overall Study|Protocol Violation|12|||
23442888|NCT02287467|65362261|FG001|Overall Study|Protocol Violation|9|||
23442889|NCT02114606|65362262|FG000|Overall Study|Unable to swallow Cytosponge|6|||
23442890|NCT03654885|65362263|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
23442891|NCT03654885|65362264|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
23442892|NCT03654885|65362263|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
23442893|NCT03654885|65362264|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
23442894|NCT03654885|65362263|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
23156583|NCT02819635|64325236|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
23156584|NCT02819635|64325237|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
23156585|NCT02819635|64325238|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
23156586|NCT02819635|64325239|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
23156587|NCT02819635|64325240|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
23156588|NCT02819635|64325229|FG000|Substudy 3|Other, not specified|0|||
23156589|NCT02819635|64325230|FG001|Substudy 3|Other, not specified|0|||
23156590|NCT02819635|64325231|FG002|Substudy 3|Other, not specified|0|||
23156591|NCT02819635|64325232|FG003|Substudy 3|Other, not specified|0|||
23156592|NCT02819635|64325233|FG004|Substudy 3|Other, not specified|0|||
23156593|NCT02819635|64325234|FG005|Substudy 3|Other, not specified|0|||
23156594|NCT02819635|64325235|FG006|Substudy 3|Other, not specified|0|||
23156595|NCT02819635|64325236|FG007|Substudy 3|Other, not specified|0|||
23156596|NCT02819635|64325237|FG008|Substudy 3|Other, not specified|202|||
23156597|NCT02819635|64325238|FG009|Substudy 3|Other, not specified|5|||
23156598|NCT02819635|64325239|FG010|Substudy 3|Other, not specified|89|||
23156599|NCT02819635|64325240|FG011|Substudy 3|Other, not specified|39|||
23156600|NCT02596620|64325241|FG000|Overall Study|Lost to Follow-up|1|||
23156601|NCT02596620|64325242|FG001|Overall Study|Lost to Follow-up|1|||
23156602|NCT00310804|64325243|FG000|Overall Study|Lost to Follow-up|2|||
23156603|NCT00310804|64325244|FG001|Overall Study|Lost to Follow-up|0|||
23156604|NCT00310804|64325243|FG000|Overall Study|Withdrawal by Subject|3|||
23156605|NCT00310804|64325244|FG001|Overall Study|Withdrawal by Subject|0|||
23156606|NCT00682448|64325246|FG000|Overall Study|Adverse Event|1|||
23156607|NCT00682448|64325247|FG001|Overall Study|Adverse Event|2|||
23156608|NCT00682448|64325246|FG000|Overall Study|Lack of Efficacy|1|||
23156609|NCT00682448|64325247|FG001|Overall Study|Lack of Efficacy|0|||
23156610|NCT00682448|64325246|FG000|Overall Study|Lost to Follow-up|1|||
23156611|NCT00682448|64325247|FG001|Overall Study|Lost to Follow-up|3|||
23156612|NCT00682448|64325246|FG000|Overall Study|Pregnancy|0|||
23156613|NCT00682448|64325247|FG001|Overall Study|Pregnancy|1|||
23156614|NCT00682448|64325246|FG000|Overall Study|Withdrawal by Subject|2|||
23156615|NCT00682448|64325247|FG001|Overall Study|Withdrawal by Subject|0|||
23156616|NCT00750698|64325248|FG000|Overall Study|Withdrawal by Subject|1|||
23156617|NCT00750698|64325249|FG001|Overall Study|Withdrawal by Subject|0|||
23156618|NCT00750698|64325248|FG000|Overall Study|Progressive disease|5|||
23156619|NCT00750698|64325249|FG001|Overall Study|Progressive disease|2|||
23156620|NCT00475722|64325254|FG000|Overall Study|Withdrawal by Subject|12|||
23156621|NCT00475722|64325255|FG001|Overall Study|Withdrawal by Subject|12|||
23442895|NCT03654885|65362264|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
23565853|NCT00152009|65799814|FG002|Overall Study|Protocol Violation|0|||
23156622|NCT00475722|64325254|FG000|Overall Study|Protocol Violation|3|||
23156623|NCT00475722|64325255|FG001|Overall Study|Protocol Violation|0|||
23156624|NCT00427349|64325256|FG000|Overall Study|Lack of Efficacy|23|||
23156625|NCT00427349|64325256|FG000|Overall Study|Adverse Event|14|||
23156626|NCT00427349|64325256|FG000|Overall Study|Death|1|||
23156627|NCT00427349|64325256|FG000|Overall Study|Withdrawal by Subject|3|||
23156628|NCT00427349|64325256|FG000|Overall Study|Alternative therapy|1|||
23156629|NCT00427349|64325256|FG000|Overall Study|Other|2|||
23156630|NCT00427349|64325256|FG000|Overall Study|Ineligible|1|||
23156631|NCT00427349|64325256|FG000|Overall Study|Never started therapy|1|||
23156632|NCT00307333|64325261|FG000|Overall Study|Lost to Follow-up|11|||
23156633|NCT00307333|64325262|FG001|Overall Study|Lost to Follow-up|3|||
23156634|NCT03807349|64325263|FG000|Overall Study|Early Study Termination|9|||
23156635|NCT02294682|64325264|FG000|Overall Study|Could not swallow pills|1|||
23156636|NCT02294682|64325265|FG001|Overall Study|Could not swallow pills|0|||
23156637|NCT00618410|64325266|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
23156638|NCT00618410|64325267|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
23156639|NCT04667377|64325274|FG000|Dose Escalation Period|Other not specified below|3|||
23156640|NCT04667377|64325275|FG001|Dose Escalation Period|Other not specified below|3|||
23156641|NCT04667377|64325276|FG002|Dose Escalation Period|Other not specified below|2|||
23156642|NCT04667377|64325277|FG003|Dose Escalation Period|Other not specified below|1|||
23156643|NCT04667377|64325278|FG004|Dose Escalation Period|Other not specified below|3|||
23156644|NCT04667377|64325274|FG000|Dose Escalation Period|Protocol Violation|2|||
23156645|NCT04667377|64325275|FG001|Dose Escalation Period|Protocol Violation|2|||
23156646|NCT04667377|64325276|FG002|Dose Escalation Period|Protocol Violation|0|||
23156647|NCT04667377|64325277|FG003|Dose Escalation Period|Protocol Violation|2|||
23156648|NCT04667377|64325278|FG004|Dose Escalation Period|Protocol Violation|1|||
23442896|NCT03654885|65362263|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
23442897|NCT03654885|65362264|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
23442898|NCT03654885|65362263|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
23442899|NCT03654885|65362264|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
23442900|NCT03654885|65362263|FG000|Overall Study|Adverse Event in Study Eye|3|||
23442901|NCT03654885|65362264|FG001|Overall Study|Adverse Event in Study Eye|0|||
23442902|NCT03654885|65362263|FG000|Overall Study|Consent Withdrawn|1|||
23442903|NCT03654885|65362264|FG001|Overall Study|Consent Withdrawn|0|||
23442904|NCT03654885|65362263|FG000|Overall Study|Death|3|||
23442905|NCT03654885|65362264|FG001|Overall Study|Death|1|||
23442906|NCT03654885|65362263|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
23442907|NCT03654885|65362264|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
23442908|NCT03654885|65362263|FG000|Overall Study|Lost to Follow-up|3|||
23442909|NCT03654885|65362264|FG001|Overall Study|Lost to Follow-up|3|||
23442910|NCT02524158|65362266|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
23565854|NCT00152009|65799815|FG003|Overall Study|Protocol Violation|1|||
23565855|NCT00152009|65799812|FG000|Overall Study|Withdrawal by Subject|2|||
23565856|NCT00152009|65799813|FG001|Overall Study|Withdrawal by Subject|3|||
23565857|NCT00152009|65799814|FG002|Overall Study|Withdrawal by Subject|4|||
23156649|NCT04667377|64325274|FG000|Dose Escalation Period|Burden of study procedures|2|||
23156650|NCT04667377|64325275|FG001|Dose Escalation Period|Burden of study procedures|1|||
23156651|NCT04667377|64325276|FG002|Dose Escalation Period|Burden of study procedures|1|||
23156652|NCT04667377|64325277|FG003|Dose Escalation Period|Burden of study procedures|1|||
23156653|NCT04667377|64325278|FG004|Dose Escalation Period|Burden of study procedures|5|||
23156654|NCT04667377|64325274|FG000|Dose Escalation Period|Change of residence|0|||
23156655|NCT04667377|64325275|FG001|Dose Escalation Period|Change of residence|0|||
23156656|NCT04667377|64325276|FG002|Dose Escalation Period|Change of residence|1|||
23565858|NCT00152009|65799815|FG003|Overall Study|Withdrawal by Subject|9|||
23565859|NCT00152009|65799812|FG000|Overall Study|Lost to Follow-up|2|||
23565860|NCT00152009|65799813|FG001|Overall Study|Lost to Follow-up|4|||
23565861|NCT00152009|65799814|FG002|Overall Study|Lost to Follow-up|3|||
23156657|NCT04667377|64325277|FG003|Dose Escalation Period|Change of residence|0|||
23156658|NCT04667377|64325278|FG004|Dose Escalation Period|Change of residence|0|||
23156659|NCT04667377|64325274|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
23156660|NCT04667377|64325275|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
23156661|NCT04667377|64325276|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
23156662|NCT04667377|64325277|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
23221639|NCT00437203|64553735|FG002|Overall Study|Adverse Event|0|||
23565862|NCT00152009|65799815|FG003|Overall Study|Lost to Follow-up|3|||
23156663|NCT04667377|64325278|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
23156664|NCT04667377|64325274|FG000|Dose Escalation Period|Adverse Event|9|||
23156665|NCT04667377|64325275|FG001|Dose Escalation Period|Adverse Event|10|||
23156666|NCT04667377|64325276|FG002|Dose Escalation Period|Adverse Event|12|||
23156667|NCT04667377|64325277|FG003|Dose Escalation Period|Adverse Event|17|||
23156668|NCT04667377|64325278|FG004|Dose Escalation Period|Adverse Event|3|||
23221640|NCT00437203|64553736|FG003|Overall Study|Adverse Event|0|||
23442911|NCT02524158|65362267|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
23565863|NCT00152009|65799812|FG000|Overall Study|Lack of Efficacy|8|||
23156669|NCT04667377|64325274|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
23156670|NCT04667377|64325275|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
23442912|NCT02524158|65362266|FG000|12-weeks Assessment|Lost to Follow-up|18|||
23442913|NCT02524158|65362267|FG001|12-weeks Assessment|Lost to Follow-up|12|||
23442914|NCT02524158|65362266|FG000|6-month Assessment|Withdrawal by Subject|1|||
23442915|NCT02524158|65362267|FG001|6-month Assessment|Withdrawal by Subject|1|||
23442916|NCT02524158|65362266|FG000|6-month Assessment|Lost to Follow-up|21|||
23442917|NCT02524158|65362267|FG001|6-month Assessment|Lost to Follow-up|20|||
23442918|NCT05249569|65362268|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
23442919|NCT01036321|65362270|FG000|Overall Study|Ineligible after randomization|0|||
23442920|NCT01036321|65362271|FG001|Overall Study|Ineligible after randomization|1|||
23442921|NCT01036321|65362270|FG000|Overall Study|Withdrawal by Subject|3|||
23442922|NCT01036321|65362271|FG001|Overall Study|Withdrawal by Subject|2|||
23442923|NCT01036321|65362270|FG000|Overall Study|Adverse Event|2|||
23442924|NCT01036321|65362271|FG001|Overall Study|Adverse Event|1|||
23442925|NCT00637416|65362272|FG000|Overall Study|Lost to Follow-up|1|||
23442926|NCT00637416|65362273|FG001|Overall Study|Lost to Follow-up|1|||
23442927|NCT00637416|65362272|FG000|Overall Study|Unable to take study drug|0|||
23442928|NCT00637416|65362273|FG001|Overall Study|Unable to take study drug|1|||
23442929|NCT01529034|65362274|FG000|Overall Study|Discontinued prior to study treatment|14|||
23442930|NCT01529034|65362274|FG000|Overall Study|Site closure|62|||
23442931|NCT01529034|65362274|FG000|Overall Study|Study termination|29|||
23442932|NCT01529034|65362274|FG000|Overall Study|Withdrawal by Subject|25|||
23442933|NCT01529034|65362274|FG000|Overall Study|No treated SCs within protocol window|13|||
23442934|NCT01529034|65362274|FG000|Overall Study|Noncompliance|8|||
23442935|NCT01529034|65362274|FG000|Overall Study|Caregiver no longer available|7|||
23442936|NCT01529034|65362274|FG000|Overall Study|Adverse Event|4|||
23442937|NCT01529034|65362274|FG000|Overall Study|Protocol Violation|4|||
23442938|NCT01529034|65362274|FG000|Overall Study|Lack of Efficacy|4|||
23442939|NCT01529034|65362274|FG000|Overall Study|Investigator no longer available|2|||
23442940|NCT01529034|65362274|FG000|Overall Study|Study drug not available|2|||
23442941|NCT00770601|65362277|FG000|Overall Study|Withdrawal by Subject|1|||
23442942|NCT00742417|65362280|FG000|Randomized|Withdrawal by legal representative|0|||
23442943|NCT00742417|65362281|FG001|Randomized|Withdrawal by legal representative|1|||
23442944|NCT00742417|65362280|FG000|Randomized|Withdrawal by Subject|1|||
23442945|NCT00742417|65362281|FG001|Randomized|Withdrawal by Subject|0|||
23628251|NCT01240915|66024687|FG002|Overall Study|Lost to Follow-up|0|||
23628252|NCT01240915|66024688|FG003|Overall Study|Lost to Follow-up|0|||
23628253|NCT01240915|66024689|FG004|Overall Study|Lost to Follow-up|1|||
23628254|NCT01240915|66024690|FG005|Overall Study|Lost to Follow-up|1|||
23628255|NCT01240915|66024691|FG006|Overall Study|Lost to Follow-up|0|||
23628256|NCT01240915|66024692|FG007|Overall Study|Lost to Follow-up|1|||
23628257|NCT01240915|66024693|FG008|Overall Study|Lost to Follow-up|1|||
23628258|NCT01240915|66024685|FG000|Overall Study|Withdrawal by Subject|2|||
23628259|NCT01240915|66024686|FG001|Overall Study|Withdrawal by Subject|1|||
23156671|NCT04667377|64325276|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
23156672|NCT04667377|64325277|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
23156673|NCT04667377|64325278|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
23156674|NCT04667377|64325274|FG000|Dose Escalation Period|Not treated|1|||
23156675|NCT04667377|64325275|FG001|Dose Escalation Period|Not treated|0|||
23156676|NCT04667377|64325276|FG002|Dose Escalation Period|Not treated|0|||
23442946|NCT00742417|65362280|FG000|Randomized|Physician Decision|1|||
23442947|NCT00742417|65362281|FG001|Randomized|Physician Decision|0|||
23442948|NCT00742417|65362280|FG000|Intensive Period|Withdrawal by Subject|1|||
23442949|NCT00742417|65362281|FG001|Intensive Period|Withdrawal by Subject|1|||
23442950|NCT00742417|65362280|FG000|Intensive Period|Adverse Event|2|||
23565864|NCT00152009|65799813|FG001|Overall Study|Lack of Efficacy|6|||
23565865|NCT00152009|65799814|FG002|Overall Study|Lack of Efficacy|7|||
23565866|NCT00152009|65799815|FG003|Overall Study|Lack of Efficacy|15|||
23565867|NCT00152009|65799812|FG000|Overall Study|ECG abnormalities|2|||
23565868|NCT00152009|65799813|FG001|Overall Study|ECG abnormalities|2|||
23565869|NCT00152009|65799814|FG002|Overall Study|ECG abnormalities|2|||
23565870|NCT00152009|65799815|FG003|Overall Study|ECG abnormalities|1|||
23565871|NCT00152009|65799812|FG000|Overall Study|Sponsor's decision|3|||
23565872|NCT00152009|65799813|FG001|Overall Study|Sponsor's decision|3|||
23565873|NCT00152009|65799814|FG002|Overall Study|Sponsor's decision|1|||
23442951|NCT00742417|65362281|FG001|Intensive Period|Adverse Event|0|||
23442952|NCT03635996|65362288|FG000|Overall Study|Study terminated by Sponsor|94|||
23442953|NCT03635996|65362288|FG000|Overall Study|Withdrawal by Subject|20|||
23442954|NCT03635996|65362288|FG000|Overall Study|Ablation|26|||
23442955|NCT03635996|65362288|FG000|Overall Study|Adverse Event|7|||
23442956|NCT03635996|65362288|FG000|Overall Study|Physician Decision|3|||
23442957|NCT03635996|65362288|FG000|Overall Study|Prohibited medication|5|||
23565874|NCT00152009|65799815|FG003|Overall Study|Sponsor's decision|3|||
23628260|NCT01240915|66024687|FG002|Overall Study|Withdrawal by Subject|0|||
23628261|NCT01240915|66024688|FG003|Overall Study|Withdrawal by Subject|2|||
23442958|NCT03635996|65362288|FG000|Overall Study|Did not meet eligibility criteria|5|||
23442959|NCT03635996|65362288|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
23442960|NCT03635996|65362288|FG000|Overall Study|Protocol Violation|1|||
23442961|NCT03635996|65362288|FG000|Overall Study|Lost to Follow-up|1|||
23442962|NCT04343755|65362296|FG000|Overall Study|Death|11|||
23442963|NCT04343755|65362296|FG000|Overall Study|Screen Failure|1|||
23442964|NCT02274792|65362297|FG000|Overall Study|Withdrawal by Subject|13|||
23442965|NCT02274792|65362297|FG000|Overall Study|Lost to Follow-up|8|||
23628262|NCT01240915|66024689|FG004|Overall Study|Withdrawal by Subject|0|||
23628263|NCT01240915|66024690|FG005|Overall Study|Withdrawal by Subject|4|||
23628264|NCT01240915|66024691|FG006|Overall Study|Withdrawal by Subject|2|||
23628265|NCT01240915|66024692|FG007|Overall Study|Withdrawal by Subject|3|||
23628266|NCT01240915|66024693|FG008|Overall Study|Withdrawal by Subject|3|||
23628267|NCT01240915|66024685|FG000|Overall Study|Other|0|||
23628268|NCT01240915|66024686|FG001|Overall Study|Other|0|||
23628269|NCT01240915|66024687|FG002|Overall Study|Other|0|||
23221641|NCT00437203|64553737|FG004|Overall Study|Adverse Event|0|||
23221642|NCT00437203|64553738|FG005|Overall Study|Adverse Event|0|||
23221643|NCT00437203|64553739|FG006|Overall Study|Adverse Event|0|||
23221644|NCT00437203|64553740|FG007|Overall Study|Adverse Event|1|||
23221645|NCT00437203|64553741|FG008|Overall Study|Adverse Event|0|||
23221646|NCT00437203|64553742|FG009|Overall Study|Adverse Event|1|||
23221647|NCT00437203|64553733|FG000|Overall Study|Study terminated by sponsor|0|||
23221648|NCT00437203|64553734|FG001|Overall Study|Study terminated by sponsor|0|||
23221649|NCT00437203|64553735|FG002|Overall Study|Study terminated by sponsor|0|||
23221650|NCT00437203|64553736|FG003|Overall Study|Study terminated by sponsor|0|||
23221651|NCT00437203|64553737|FG004|Overall Study|Study terminated by sponsor|0|||
23221652|NCT00437203|64553738|FG005|Overall Study|Study terminated by sponsor|0|||
23221653|NCT00437203|64553739|FG006|Overall Study|Study terminated by sponsor|0|||
23221654|NCT00437203|64553740|FG007|Overall Study|Study terminated by sponsor|0|||
23221655|NCT00437203|64553741|FG008|Overall Study|Study terminated by sponsor|1|||
23221656|NCT00437203|64553742|FG009|Overall Study|Study terminated by sponsor|0|||
23221657|NCT00437203|64553733|FG000|Overall Study|Objective progression or relapse|5|||
23221658|NCT00437203|64553734|FG001|Overall Study|Objective progression or relapse|6|||
23221659|NCT00437203|64553735|FG002|Overall Study|Objective progression or relapse|2|||
23221660|NCT00437203|64553736|FG003|Overall Study|Objective progression or relapse|3|||
23221661|NCT00437203|64553737|FG004|Overall Study|Objective progression or relapse|3|||
23628270|NCT01240915|66024688|FG003|Overall Study|Other|0|||
23156677|NCT04667377|64325277|FG003|Dose Escalation Period|Not treated|0|||
23221662|NCT00437203|64553738|FG005|Overall Study|Objective progression or relapse|3|||
23221663|NCT00437203|64553739|FG006|Overall Study|Objective progression or relapse|6|||
23221664|NCT00437203|64553740|FG007|Overall Study|Objective progression or relapse|1|||
23156678|NCT04667377|64325278|FG004|Dose Escalation Period|Not treated|0|||
23156679|NCT04667377|64325274|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
23156680|NCT04667377|64325275|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
23156681|NCT04667377|64325276|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
23221665|NCT00437203|64553741|FG008|Overall Study|Objective progression or relapse|2|||
23442966|NCT02274792|65362297|FG000|Overall Study|Protocol Specified Criteria|2|||
23156682|NCT04667377|64325277|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
23156683|NCT04667377|64325278|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
23156684|NCT04667377|64325274|FG000|Dose Escalation Period|Lost to Follow-up|0|||
23156685|NCT04667377|64325275|FG001|Dose Escalation Period|Lost to Follow-up|1|||
23156686|NCT04667377|64325276|FG002|Dose Escalation Period|Lost to Follow-up|0|||
23156687|NCT04667377|64325277|FG003|Dose Escalation Period|Lost to Follow-up|0|||
23156688|NCT04667377|64325278|FG004|Dose Escalation Period|Lost to Follow-up|0|||
23156689|NCT04667377|64325274|FG000|Maintenance Period|Perceived lack of efficacy|0|||
23156690|NCT04667377|64325275|FG001|Maintenance Period|Perceived lack of efficacy|2|||
23156691|NCT04667377|64325276|FG002|Maintenance Period|Perceived lack of efficacy|1|||
23156692|NCT04667377|64325277|FG003|Maintenance Period|Perceived lack of efficacy|0|||
23156693|NCT04667377|64325278|FG004|Maintenance Period|Perceived lack of efficacy|1|||
23156694|NCT04667377|64325274|FG000|Maintenance Period|Adverse Event|2|||
23156695|NCT04667377|64325275|FG001|Maintenance Period|Adverse Event|8|||
23156696|NCT04667377|64325276|FG002|Maintenance Period|Adverse Event|5|||
23156697|NCT04667377|64325277|FG003|Maintenance Period|Adverse Event|4|||
23156698|NCT04667377|64325278|FG004|Maintenance Period|Adverse Event|1|||
23221666|NCT00437203|64553742|FG009|Overall Study|Objective progression or relapse|2|||
23221667|NCT00437203|64553733|FG000|Overall Study|Other|0|||
23221668|NCT00437203|64553734|FG001|Overall Study|Other|1|||
23221669|NCT00437203|64553735|FG002|Overall Study|Other|0|||
23221670|NCT00437203|64553736|FG003|Overall Study|Other|0|||
23442967|NCT02274792|65362297|FG000|Overall Study|Sponsor Decision|2|||
23442968|NCT04034004|65362302|FG000|Overall Study|Withdrawal by Subject|1|||
23442969|NCT04034004|65362303|FG001|Overall Study|Withdrawal by Subject|2|||
23628271|NCT01240915|66024689|FG004|Overall Study|Other|2|||
23628272|NCT01240915|66024690|FG005|Overall Study|Other|0|||
23628273|NCT01240915|66024691|FG006|Overall Study|Other|0|||
23327626|NCT01532934|64940972|FG000|Overall Study|Lost to Follow-up|11|||
23327627|NCT01532934|64940973|FG001|Overall Study|Lost to Follow-up|11|||
23327628|NCT01532934|64940972|FG000|Overall Study|In controlled environment|3|||
23327629|NCT01532934|64940973|FG001|Overall Study|In controlled environment|2|||
23156699|NCT04667377|64325274|FG000|Maintenance Period|Adverse event: COVID infection|0|||
23156700|NCT04667377|64325275|FG001|Maintenance Period|Adverse event: COVID infection|1|||
23156701|NCT04667377|64325276|FG002|Maintenance Period|Adverse event: COVID infection|0|||
23156702|NCT04667377|64325277|FG003|Maintenance Period|Adverse event: COVID infection|0|||
23156703|NCT04667377|64325278|FG004|Maintenance Period|Adverse event: COVID infection|0|||
23221671|NCT00437203|64553737|FG004|Overall Study|Other|0|||
23221672|NCT00437203|64553738|FG005|Overall Study|Other|0|||
23221673|NCT00437203|64553739|FG006|Overall Study|Other|1|||
23221674|NCT00437203|64553740|FG007|Overall Study|Other|0|||
23221675|NCT00437203|64553741|FG008|Overall Study|Other|0|||
23221676|NCT00437203|64553742|FG009|Overall Study|Other|0|||
23221677|NCT00368472|64553746|FG000|Overall Study|Adverse Event|22|||
23221678|NCT00368472|64553746|FG000|Overall Study|Medication non-compliance|4|||
23221679|NCT00368472|64553746|FG000|Overall Study|Protocol Violation|2|||
23221680|NCT00368472|64553746|FG000|Overall Study|Request of Investigator or Sponsor|3|||
23221681|NCT00368472|64553746|FG000|Overall Study|Withdrawal by Subject|40|||
23221682|NCT00368472|64553746|FG000|Overall Study|Diary non-compliance|1|||
23221683|NCT00368472|64553746|FG000|Overall Study|Other|32|||
23221684|NCT00368472|64553746|FG000|Overall Study|Missing Final Disposition Date|1|||
23221685|NCT03639987|64553747|FG000|Overall Study|Study terminated by sponsor|26|||
23221686|NCT03639987|64553748|FG001|Overall Study|Study terminated by sponsor|25|||
23221687|NCT03639987|64553747|FG000|Overall Study|Lost to Follow-up|0|||
23221688|NCT03639987|64553748|FG001|Overall Study|Lost to Follow-up|1|||
23221689|NCT01611298|64553749|FG000|Overall Study|Relapsed|2|||
23221690|NCT02009930|64553754|FG000|Overall Study|withdrawn|5|||
23221691|NCT00595868|64553763|FG000|Overall Study|Lost to Follow-up|45|||
23221692|NCT00595868|64553764|FG001|Overall Study|Lost to Follow-up|50|||
23221693|NCT02443155|64553768|FG000|Overall Study|Adverse Event|3|||
23221694|NCT02443155|64553769|FG001|Overall Study|Adverse Event|4|||
23221695|NCT02443155|64553770|FG002|Overall Study|Adverse Event|1|||
23156704|NCT04667377|64325274|FG000|Maintenance Period|COVID-related|0|||
23327630|NCT02656303|64940974|FG000|Overall Study|Adverse Event|3|||
23327631|NCT02656303|64940975|FG001|Overall Study|Adverse Event|2|||
23327632|NCT02656303|64940976|FG002|Overall Study|Adverse Event|0|||
23565875|NCT01535274|65799816|FG000|Overall Study|Determined to be ineligible|0|||
23565876|NCT01535274|65799817|FG001|Overall Study|Determined to be ineligible|1|||
23565877|NCT01535274|65799816|FG000|Overall Study|Misallocated to propofol intervention|0|||
23565878|NCT01535274|65799817|FG001|Overall Study|Misallocated to propofol intervention|1|||
23565879|NCT04498247|65799818|FG000|Overall Study|Lost to Follow-up|0|||
23565880|NCT04498247|65799819|FG001|Overall Study|Lost to Follow-up|0|||
23565881|NCT04498247|65799820|FG002|Overall Study|Lost to Follow-up|0|||
23565882|NCT04498247|65799821|FG003|Overall Study|Lost to Follow-up|1|||
23565883|NCT04498247|65799822|FG004|Overall Study|Lost to Follow-up|0|||
23565884|NCT04498247|65799823|FG005|Overall Study|Lost to Follow-up|0|||
23565885|NCT04498247|65799824|FG006|Overall Study|Lost to Follow-up|0|||
23565886|NCT04498247|65799825|FG007|Overall Study|Lost to Follow-up|0|||
23565887|NCT04498247|65799818|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
23565888|NCT04498247|65799819|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565889|NCT04498247|65799820|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565890|NCT04498247|65799821|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565891|NCT04498247|65799822|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565892|NCT04498247|65799823|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565893|NCT04498247|65799824|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
23565894|NCT04498247|65799825|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
23156705|NCT04667377|64325275|FG001|Maintenance Period|COVID-related|0|||
23156706|NCT04667377|64325276|FG002|Maintenance Period|COVID-related|1|||
23221696|NCT02443155|64553771|FG003|Overall Study|Adverse Event|2|||
23221697|NCT02443155|64553768|FG000|Overall Study|Unclassified|0|||
23221698|NCT02443155|64553769|FG001|Overall Study|Unclassified|0|||
23327633|NCT02656303|64940974|FG000|Overall Study|Death|12|||
23156707|NCT04667377|64325277|FG003|Maintenance Period|COVID-related|1|||
23156708|NCT04667377|64325278|FG004|Maintenance Period|COVID-related|0|||
23156709|NCT04667377|64325274|FG000|Maintenance Period|Protocol Violation|1|||
23156710|NCT04667377|64325275|FG001|Maintenance Period|Protocol Violation|0|||
23221699|NCT02443155|64553770|FG002|Overall Study|Unclassified|2|||
23327634|NCT02656303|64940975|FG001|Overall Study|Death|4|||
23221700|NCT02443155|64553771|FG003|Overall Study|Unclassified|1|||
23221701|NCT02443155|64553768|FG000|Overall Study|Withdrawal by Subject|4|||
23221702|NCT02443155|64553769|FG001|Overall Study|Withdrawal by Subject|7|||
23221703|NCT02443155|64553770|FG002|Overall Study|Withdrawal by Subject|3|||
23221704|NCT02443155|64553771|FG003|Overall Study|Withdrawal by Subject|9|||
23221705|NCT02443155|64553768|FG000|Overall Study|Pregnancy|3|||
23565895|NCT04498247|65799818|FG000|Overall Study|Withdrawal by Subject|0|||
23327635|NCT02656303|64940976|FG002|Overall Study|Death|1|||
23565896|NCT04498247|65799819|FG001|Overall Study|Withdrawal by Subject|8|||
23565897|NCT04498247|65799820|FG002|Overall Study|Withdrawal by Subject|0|||
23565898|NCT04498247|65799821|FG003|Overall Study|Withdrawal by Subject|7|||
23565899|NCT04498247|65799822|FG004|Overall Study|Withdrawal by Subject|0|||
23565900|NCT04498247|65799823|FG005|Overall Study|Withdrawal by Subject|0|||
23565901|NCT04498247|65799824|FG006|Overall Study|Withdrawal by Subject|1|||
23565902|NCT04498247|65799825|FG007|Overall Study|Withdrawal by Subject|0|||
23565903|NCT04498247|65799818|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565904|NCT04498247|65799819|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
23565905|NCT04498247|65799820|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565906|NCT04498247|65799821|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
23565907|NCT04498247|65799822|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565908|NCT04498247|65799823|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565909|NCT04498247|65799824|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
23565910|NCT04498247|65799825|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
23565911|NCT03239873|65799826|FG000|Overall Study|Lost to Follow-up|15|||
23565912|NCT03239873|65799827|FG001|Overall Study|Lost to Follow-up|16|||
23565913|NCT03239873|65799826|FG000|Overall Study|Physician Decision|1|||
23565914|NCT03239873|65799827|FG001|Overall Study|Physician Decision|0|||
23156711|NCT04667377|64325276|FG002|Maintenance Period|Protocol Violation|0|||
23221706|NCT02443155|64553769|FG001|Overall Study|Pregnancy|1|||
23221707|NCT02443155|64553770|FG002|Overall Study|Pregnancy|1|||
23221708|NCT02443155|64553771|FG003|Overall Study|Pregnancy|2|||
23221709|NCT02443155|64553768|FG000|Overall Study|Lost to Follow-up|1|||
23221710|NCT02443155|64553769|FG001|Overall Study|Lost to Follow-up|2|||
23221711|NCT02443155|64553770|FG002|Overall Study|Lost to Follow-up|0|||
23221712|NCT02443155|64553771|FG003|Overall Study|Lost to Follow-up|1|||
23221713|NCT02443155|64553768|FG000|Overall Study|Protocol Violation|1|||
23221714|NCT02443155|64553769|FG001|Overall Study|Protocol Violation|0|||
23221715|NCT02443155|64553770|FG002|Overall Study|Protocol Violation|1|||
23221716|NCT02443155|64553771|FG003|Overall Study|Protocol Violation|1|||
23221717|NCT02443155|64553768|FG000|Overall Study|Death|0|||
23156712|NCT04667377|64325277|FG003|Maintenance Period|Protocol Violation|0|||
23156713|NCT04667377|64325278|FG004|Maintenance Period|Protocol Violation|1|||
23327636|NCT02656303|64940974|FG000|Overall Study|Lack of Efficacy|1|||
23327637|NCT02656303|64940975|FG001|Overall Study|Lack of Efficacy|0|||
23327638|NCT02656303|64940976|FG002|Overall Study|Lack of Efficacy|0|||
23327639|NCT02656303|64940974|FG000|Overall Study|Non-Compliance with Study|1|||
23327640|NCT02656303|64940975|FG001|Overall Study|Non-Compliance with Study|1|||
23156714|NCT04667377|64325274|FG000|Maintenance Period|Burden of study procedures|1|||
23156715|NCT04667377|64325275|FG001|Maintenance Period|Burden of study procedures|2|||
23156716|NCT04667377|64325276|FG002|Maintenance Period|Burden of study procedures|0|||
23156717|NCT04667377|64325277|FG003|Maintenance Period|Burden of study procedures|1|||
23156718|NCT04667377|64325278|FG004|Maintenance Period|Burden of study procedures|0|||
23156719|NCT04667377|64325274|FG000|Maintenance Period|Change of residence|0|||
23156720|NCT04667377|64325275|FG001|Maintenance Period|Change of residence|1|||
23156721|NCT04667377|64325276|FG002|Maintenance Period|Change of residence|0|||
23156722|NCT04667377|64325277|FG003|Maintenance Period|Change of residence|0|||
23156723|NCT04667377|64325278|FG004|Maintenance Period|Change of residence|1|||
23156724|NCT04667377|64325274|FG000|Maintenance Period|Missing|1|||
23156725|NCT04667377|64325275|FG001|Maintenance Period|Missing|0|||
23156726|NCT04667377|64325276|FG002|Maintenance Period|Missing|0|||
23156727|NCT04667377|64325277|FG003|Maintenance Period|Missing|0|||
23156728|NCT04667377|64325278|FG004|Maintenance Period|Missing|0|||
23156729|NCT04667377|64325274|FG000|Maintenance Period|Other than listed above|2|||
23156730|NCT04667377|64325275|FG001|Maintenance Period|Other than listed above|0|||
23156731|NCT04667377|64325276|FG002|Maintenance Period|Other than listed above|3|||
23156732|NCT04667377|64325277|FG003|Maintenance Period|Other than listed above|2|||
23221718|NCT02443155|64553769|FG001|Overall Study|Death|0|||
23327641|NCT02656303|64940976|FG002|Overall Study|Non-Compliance with Study|0|||
23442970|NCT04034004|65362304|FG002|Overall Study|Withdrawal by Subject|2|||
23156733|NCT04667377|64325278|FG004|Maintenance Period|Other than listed above|6|||
23327642|NCT02656303|64940974|FG000|Overall Study|Investigator Decision|2|||
23327643|NCT02656303|64940975|FG001|Overall Study|Investigator Decision|1|||
23327644|NCT02656303|64940976|FG002|Overall Study|Investigator Decision|0|||
23327645|NCT02656303|64940974|FG000|Overall Study|Progressive Disease|25|||
23442971|NCT04034004|65362305|FG003|Overall Study|Withdrawal by Subject|3|||
23442972|NCT04034004|65362302|FG000|Overall Study|could not find vein to administer IV|2|||
23156734|NCT04667377|64325274|FG000|Maintenance Period|Withdrawal by Subject|0|||
23156735|NCT04667377|64325275|FG001|Maintenance Period|Withdrawal by Subject|1|||
23221719|NCT02443155|64553770|FG002|Overall Study|Death|1|||
23221720|NCT02443155|64553771|FG003|Overall Study|Death|0|||
23221721|NCT01080625|64553772|FG000|Overall Study|Physician Decision|0|||
23442973|NCT04034004|65362303|FG001|Overall Study|could not find vein to administer IV|1|||
23221722|NCT01080625|64553773|FG001|Overall Study|Physician Decision|2|||
23221723|NCT01080625|64553774|FG002|Overall Study|Physician Decision|1|||
23156736|NCT04667377|64325276|FG002|Maintenance Period|Withdrawal by Subject|0|||
23156737|NCT04667377|64325277|FG003|Maintenance Period|Withdrawal by Subject|0|||
23156738|NCT04667377|64325278|FG004|Maintenance Period|Withdrawal by Subject|0|||
23156739|NCT04667377|64325274|FG000|Maintenance Period|Lost to Follow-up|1|||
23156740|NCT04667377|64325275|FG001|Maintenance Period|Lost to Follow-up|0|||
23156741|NCT04667377|64325276|FG002|Maintenance Period|Lost to Follow-up|1|||
23156742|NCT04667377|64325277|FG003|Maintenance Period|Lost to Follow-up|0|||
23156743|NCT04667377|64325278|FG004|Maintenance Period|Lost to Follow-up|1|||
23156744|NCT01490814|64325279|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
23156745|NCT01490814|64325280|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
23156746|NCT01490814|64325279|FG000|Overall Study|Physician Decision|1|||
23156747|NCT01490814|64325280|FG001|Overall Study|Physician Decision|0|||
23156748|NCT01490814|64325279|FG000|Overall Study|Withdrawal by Subject|0|||
23156749|NCT01490814|64325280|FG001|Overall Study|Withdrawal by Subject|5|||
23565915|NCT03239873|65799826|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
23565916|NCT03239873|65799827|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
23565917|NCT03239873|65799826|FG000|Overall Study|Withdrawal by Subject|2|||
23565918|NCT03239873|65799827|FG001|Overall Study|Withdrawal by Subject|0|||
23565919|NCT03239873|65799826|FG000|Overall Study|Contraindication to study medication|1|||
23565920|NCT03239873|65799827|FG001|Overall Study|Contraindication to study medication|0|||
23565921|NCT03239873|65799826|FG000|Overall Study|Protocol Violation|1|||
23565922|NCT03239873|65799827|FG001|Overall Study|Protocol Violation|0|||
23565923|NCT02309112|65799828|FG000|Overall Study|Withdrawal by Subject|1|||
23565924|NCT02309112|65799829|FG001|Overall Study|Withdrawal by Subject|0|||
23565925|NCT02309112|65799830|FG002|Overall Study|Withdrawal by Subject|1|||
23565926|NCT02309112|65799828|FG000|Overall Study|Lost to Follow-up|0|||
23565927|NCT02309112|65799829|FG001|Overall Study|Lost to Follow-up|1|||
23565928|NCT02309112|65799830|FG002|Overall Study|Lost to Follow-up|0|||
23565929|NCT04827134|65799831|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
23565930|NCT04827134|65799832|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
23565931|NCT04827134|65799833|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
23565932|NCT04827134|65799834|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
23565933|NCT00876460|65799835|FG000|Combination Therapy Phase|Progressive disease|2|||
23565934|NCT00876460|65799836|FG001|Combination Therapy Phase|Progressive disease|3|||
23565935|NCT00876460|65799837|FG002|Combination Therapy Phase|Progressive disease|3|||
23565936|NCT00876460|65799838|FG003|Combination Therapy Phase|Progressive disease|3|||
23565937|NCT00876460|65799839|FG004|Combination Therapy Phase|Progressive disease|3|||
23565938|NCT00876460|65799840|FG005|Combination Therapy Phase|Progressive disease|1|||
23565939|NCT00876460|65799841|FG006|Combination Therapy Phase|Progressive disease|1|||
23565940|NCT00876460|65799842|FG007|Combination Therapy Phase|Progressive disease|1|||
23565941|NCT00876460|65799835|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
23565942|NCT00876460|65799836|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
23565943|NCT00876460|65799837|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
23565944|NCT00876460|65799838|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
23565945|NCT00876460|65799839|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
23565946|NCT00876460|65799840|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
23565947|NCT00876460|65799841|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
23565948|NCT00876460|65799842|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
23565949|NCT00876460|65799835|FG000|Combination Therapy Phase|Adverse Event|0|||
23565950|NCT00876460|65799836|FG001|Combination Therapy Phase|Adverse Event|2|||
23565951|NCT00876460|65799837|FG002|Combination Therapy Phase|Adverse Event|0|||
23565952|NCT00876460|65799838|FG003|Combination Therapy Phase|Adverse Event|2|||
23565953|NCT00876460|65799839|FG004|Combination Therapy Phase|Adverse Event|2|||
23565954|NCT00876460|65799840|FG005|Combination Therapy Phase|Adverse Event|0|||
23565955|NCT00876460|65799841|FG006|Combination Therapy Phase|Adverse Event|3|||
23565956|NCT00876460|65799842|FG007|Combination Therapy Phase|Adverse Event|2|||
23565957|NCT00876460|65799835|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
23565958|NCT00876460|65799836|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
23565959|NCT00876460|65799837|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
23565960|NCT00876460|65799838|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
23565961|NCT00876460|65799839|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
23565962|NCT00876460|65799840|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
23565963|NCT00876460|65799841|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
23565964|NCT00876460|65799842|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
23565965|NCT00876460|65799835|FG000|Combination Therapy Phase|Other reason not defined above|0|||
23156750|NCT02716675|64325282|FG000|Overall Study|Death|2|||
23565966|NCT00876460|65799836|FG001|Combination Therapy Phase|Other reason not defined above|0|||
23565967|NCT00876460|65799837|FG002|Combination Therapy Phase|Other reason not defined above|0|||
23565968|NCT00876460|65799838|FG003|Combination Therapy Phase|Other reason not defined above|0|||
23156751|NCT02716675|64325283|FG001|Overall Study|Death|3|||
23156752|NCT02716675|64325284|FG002|Overall Study|Death|0|||
23156753|NCT02716675|64325282|FG000|Overall Study|Physician Decision|2|||
23565969|NCT00876460|65799839|FG004|Combination Therapy Phase|Other reason not defined above|0|||
23156754|NCT02716675|64325283|FG001|Overall Study|Physician Decision|1|||
23156755|NCT02716675|64325284|FG002|Overall Study|Physician Decision|1|||
23156756|NCT02716675|64325282|FG000|Overall Study|Lost to Follow-up|100|||
23156757|NCT02716675|64325283|FG001|Overall Study|Lost to Follow-up|87|||
23156758|NCT02716675|64325284|FG002|Overall Study|Lost to Follow-up|99|||
23156759|NCT02716675|64325282|FG000|Overall Study|Withdrawal by Subject|22|||
23156760|NCT02716675|64325283|FG001|Overall Study|Withdrawal by Subject|25|||
23156761|NCT02716675|64325284|FG002|Overall Study|Withdrawal by Subject|20|||
23156762|NCT02716675|64325282|FG000|Overall Study|Protocol Violation|0|||
23156763|NCT02716675|64325283|FG001|Overall Study|Protocol Violation|3|||
23156764|NCT02716675|64325284|FG002|Overall Study|Protocol Violation|1|||
23156765|NCT02716675|64325282|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
23156766|NCT02716675|64325283|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
23156767|NCT02716675|64325284|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
23156768|NCT02716675|64325282|FG000|Overall Study|Other|38|||
23156769|NCT02716675|64325283|FG001|Overall Study|Other|47|||
23156770|NCT02716675|64325284|FG002|Overall Study|Other|48|||
23156771|NCT02228720|64325285|FG000|Open Label - Day 30|Lost to Follow-up|1|||
23156772|NCT00121108|64325286|FG000|Overall Study|Lost to Follow-up|10|||
23156773|NCT00121108|64325287|FG001|Overall Study|Lost to Follow-up|22|||
23156774|NCT00121108|64325286|FG000|Overall Study|Withdrawal by Subject|106|||
23156775|NCT00121108|64325287|FG001|Overall Study|Withdrawal by Subject|195|||
23156776|NCT00121108|64325286|FG000|Overall Study|Death|5|||
23156777|NCT00121108|64325287|FG001|Overall Study|Death|8|||
23156778|NCT00915772|64325288|FG000|Overall Study|Adverse Event|12|||
23156779|NCT00915772|64325289|FG001|Overall Study|Adverse Event|13|||
23156780|NCT00915772|64325290|FG002|Overall Study|Adverse Event|11|||
23156781|NCT00915772|64325288|FG000|Overall Study|Protocol Violation|4|||
23156782|NCT00915772|64325289|FG001|Overall Study|Protocol Violation|1|||
23156783|NCT00915772|64325290|FG002|Overall Study|Protocol Violation|2|||
23156784|NCT00915772|64325288|FG000|Overall Study|Lost to Follow-up|1|||
23156785|NCT00915772|64325289|FG001|Overall Study|Lost to Follow-up|2|||
23156786|NCT00915772|64325290|FG002|Overall Study|Lost to Follow-up|2|||
23156787|NCT00915772|64325288|FG000|Overall Study|Lack of Efficacy|9|||
23156788|NCT00915772|64325289|FG001|Overall Study|Lack of Efficacy|15|||
23156789|NCT00915772|64325290|FG002|Overall Study|Lack of Efficacy|3|||
23156790|NCT00915772|64325288|FG000|Overall Study|Refused to continue trial medication|6|||
23442974|NCT04034004|65362304|FG002|Overall Study|could not find vein to administer IV|0|||
23442975|NCT04034004|65362305|FG003|Overall Study|could not find vein to administer IV|0|||
23442976|NCT04034004|65362302|FG000|Overall Study|nurse accidentally unblinded subject|0|||
23442977|NCT04034004|65362303|FG001|Overall Study|nurse accidentally unblinded subject|0|||
23442978|NCT04034004|65362304|FG002|Overall Study|nurse accidentally unblinded subject|0|||
23442979|NCT04034004|65362305|FG003|Overall Study|nurse accidentally unblinded subject|1|||
23442980|NCT00571038|65362306|FG000|Overall Study|Lost to Follow-up|1|||
23442981|NCT00571038|65362307|FG001|Overall Study|Lost to Follow-up|4|||
23442982|NCT00571038|65362306|FG000|Overall Study|Death|7|||
23442983|NCT00571038|65362307|FG001|Overall Study|Death|5|||
23442984|NCT00571038|65362306|FG000|Overall Study|Withdrawal by Subject|1|||
23442985|NCT00571038|65362307|FG001|Overall Study|Withdrawal by Subject|3|||
23442986|NCT00571038|65362306|FG000|Overall Study|Moved out of state|2|||
23442987|NCT00571038|65362307|FG001|Overall Study|Moved out of state|2|||
23442988|NCT02688985|65362310|FG000|Overall Study|Adverse Event|1|||
23442989|NCT02688985|65362311|FG001|Overall Study|Adverse Event|2|||
23442990|NCT02688985|65362312|FG002|Overall Study|Adverse Event|2|||
23565970|NCT00876460|65799840|FG005|Combination Therapy Phase|Other reason not defined above|0|||
23156791|NCT00915772|64325289|FG001|Overall Study|Refused to continue trial medication|8|||
23221724|NCT01249157|64553775|FG000|Overall Study|Withdrawal by Subject|1|||
23221725|NCT03706040|64553776|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
23156792|NCT00915772|64325290|FG002|Overall Study|Refused to continue trial medication|4|||
23156793|NCT00915772|64325288|FG000|Overall Study|Any other reason|4|||
23156794|NCT00915772|64325289|FG001|Overall Study|Any other reason|7|||
23156795|NCT00915772|64325290|FG002|Overall Study|Any other reason|7|||
23156796|NCT02319668|64325297|FG000|Overall Study|Other (Not specified)|0|||
23156797|NCT02319668|64325298|FG001|Overall Study|Other (Not specified)|2|||
23156798|NCT04344301|64325299|FG000|Overall Study|Withdrawal by Subject|1|||
23156799|NCT04344301|64325300|FG001|Overall Study|Withdrawal by Subject|0|||
23221726|NCT03706040|64553777|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
23221727|NCT03706040|64553778|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
23442991|NCT02688985|65362313|FG003|Overall Study|Adverse Event|0|||
23442992|NCT02688985|65362314|FG004|Overall Study|Adverse Event|0|||
23156800|NCT04344301|64325299|FG000|Overall Study|Death|0|||
23156801|NCT04344301|64325300|FG001|Overall Study|Death|1|||
23156802|NCT03329196|64325309|FG000|Overall Study|Adverse Event|10|||
23156803|NCT03329196|64325310|FG001|Overall Study|Adverse Event|5|||
23156804|NCT03329196|64325309|FG000|Overall Study|Physician Decision|2|||
23156805|NCT03329196|64325310|FG001|Overall Study|Physician Decision|2|||
23442993|NCT02688985|65362310|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
23156806|NCT03329196|64325309|FG000|Overall Study|Withdrawal by Subject|11|||
23156807|NCT03329196|64325310|FG001|Overall Study|Withdrawal by Subject|3|||
23156808|NCT03329196|64325309|FG000|Overall Study|Hepatic function abnormalities|0|||
23156809|NCT03329196|64325310|FG001|Overall Study|Hepatic function abnormalities|1|||
23156810|NCT03329196|64325309|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
23156811|NCT03329196|64325310|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
23156812|NCT03329196|64325309|FG000|Overall Study|Difficult to control Hb|2|||
23156813|NCT03329196|64325310|FG001|Overall Study|Difficult to control Hb|3|||
23156814|NCT03329196|64325309|FG000|Overall Study|Dialysis or renal transplant|13|||
23156815|NCT03329196|64325310|FG001|Overall Study|Dialysis or renal transplant|15|||
23156816|NCT02064920|64325311|FG000|Overall Study|Adverse Event|0|||
23156817|NCT02064920|64325312|FG001|Overall Study|Adverse Event|4|||
23156818|NCT02064920|64325311|FG000|Overall Study|Physician Decision|0|||
23156819|NCT02064920|64325312|FG001|Overall Study|Physician Decision|1|||
23156820|NCT02064920|64325311|FG000|Overall Study|Technical Problems|0|||
23156821|NCT02064920|64325312|FG001|Overall Study|Technical Problems|1|||
23156822|NCT02064920|64325311|FG000|Overall Study|Withdrawal by Subject|1|||
23156823|NCT02064920|64325312|FG001|Overall Study|Withdrawal by Subject|3|||
23156824|NCT00449670|64325318|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
23156825|NCT00449670|64325319|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
23156826|NCT00449670|64325318|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
23221728|NCT03706040|64553779|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
23221729|NCT03706040|64553780|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
23156827|NCT00449670|64325319|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
23565971|NCT00876460|65799841|FG006|Combination Therapy Phase|Other reason not defined above|1|||
23565972|NCT00876460|65799842|FG007|Combination Therapy Phase|Other reason not defined above|2|||
23565973|NCT00876460|65799835|FG000|Combination Therapy Phase|Not treated|0|||
23156828|NCT00449670|64325318|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
23156829|NCT00449670|64325319|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
23156830|NCT00449670|64325318|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
23156831|NCT00449670|64325319|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
23156832|NCT00449670|64325318|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
23156833|NCT00449670|64325319|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
23156834|NCT00449670|64325318|FG000|Booster Phase (Study no.109873)|Other|0|||
23156835|NCT00449670|64325319|FG001|Booster Phase (Study no.109873)|Other|2|||
23156836|NCT00253643|64325320|FG000|Overall Study|Withdrawal by Subject|0|||
23156837|NCT00253643|64325321|FG001|Overall Study|Withdrawal by Subject|0|||
23156838|NCT00253643|64325322|FG002|Overall Study|Withdrawal by Subject|1|||
23156839|NCT00253643|64325323|FG003|Overall Study|Withdrawal by Subject|1|||
23156840|NCT00253643|64325320|FG000|Overall Study|Non-Compliance|0|||
23156841|NCT00253643|64325321|FG001|Overall Study|Non-Compliance|0|||
23565974|NCT00876460|65799836|FG001|Combination Therapy Phase|Not treated|0|||
23565975|NCT00876460|65799837|FG002|Combination Therapy Phase|Not treated|0|||
23565976|NCT00876460|65799838|FG003|Combination Therapy Phase|Not treated|0|||
23565977|NCT00876460|65799839|FG004|Combination Therapy Phase|Not treated|0|||
23565978|NCT00876460|65799840|FG005|Combination Therapy Phase|Not treated|0|||
23565979|NCT00876460|65799841|FG006|Combination Therapy Phase|Not treated|1|||
23565980|NCT00876460|65799842|FG007|Combination Therapy Phase|Not treated|0|||
23565981|NCT00876460|65799835|FG000|Mono Therapy Phase|Progressive disease|0|||
23565982|NCT00876460|65799836|FG001|Mono Therapy Phase|Progressive disease|0|||
23628274|NCT01240915|66024692|FG007|Overall Study|Other|0|||
23628275|NCT01240915|66024693|FG008|Overall Study|Other|0|||
23628276|NCT01240915|66024685|FG000|Overall Study|Insufficient Clinical Response|0|||
23628277|NCT01240915|66024686|FG001|Overall Study|Insufficient Clinical Response|0|||
23628278|NCT01240915|66024687|FG002|Overall Study|Insufficient Clinical Response|0|||
23156842|NCT00253643|64325322|FG002|Overall Study|Non-Compliance|0|||
23156843|NCT00253643|64325323|FG003|Overall Study|Non-Compliance|2|||
23156844|NCT01572675|64325324|FG000|Overall Study|End of prescribed treatment|140|||
23156845|NCT01572675|64325325|FG001|Overall Study|End of prescribed treatment|118|||
23156846|NCT01572675|64325324|FG000|Overall Study|Recovery|16|||
23221730|NCT03706040|64553781|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
23221731|NCT03706040|64553782|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
23221732|NCT03706040|64553776|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
23221733|NCT03706040|64553777|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
23221734|NCT03706040|64553778|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
23442994|NCT02688985|65362311|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
23442995|NCT02688985|65362312|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
23442996|NCT02688985|65362313|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
23565983|NCT00876460|65799837|FG002|Mono Therapy Phase|Progressive disease|0|||
23628279|NCT01240915|66024688|FG003|Overall Study|Insufficient Clinical Response|0|||
23156847|NCT01572675|64325325|FG001|Overall Study|Recovery|23|||
23156848|NCT01572675|64325324|FG000|Overall Study|Lack of Efficacy|31|||
23156849|NCT01572675|64325325|FG001|Overall Study|Lack of Efficacy|31|||
23156850|NCT01572675|64325324|FG000|Overall Study|Intolerance|6|||
23156851|NCT01572675|64325325|FG001|Overall Study|Intolerance|5|||
23156852|NCT01572675|64325324|FG000|Overall Study|Improved symptoms|8|||
23156853|NCT01572675|64325325|FG001|Overall Study|Improved symptoms|2|||
23156854|NCT01572675|64325324|FG000|Overall Study|Surgical intervention|3|||
23442997|NCT02688985|65362314|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
23442998|NCT02688985|65362310|FG000|Overall Study|Death|0|||
23442999|NCT02688985|65362311|FG001|Overall Study|Death|0|||
23443000|NCT02688985|65362312|FG002|Overall Study|Death|0|||
23327646|NCT02656303|64940975|FG001|Overall Study|Progressive Disease|14|||
23327647|NCT02656303|64940976|FG002|Overall Study|Progressive Disease|10|||
23327648|NCT02656303|64940974|FG000|Overall Study|Study Terminated by Sponsor|20|||
23327649|NCT02656303|64940975|FG001|Overall Study|Study Terminated by Sponsor|7|||
23327650|NCT02656303|64940976|FG002|Overall Study|Study Terminated by Sponsor|5|||
23327651|NCT02656303|64940974|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
23327652|NCT02656303|64940975|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
23327653|NCT02656303|64940976|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
23327654|NCT02656303|64940974|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
23327655|NCT02656303|64940975|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
23327656|NCT02656303|64940976|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
23327657|NCT02656303|64940974|FG000|Overall Study|Reason not Specified|1|||
23327658|NCT02656303|64940975|FG001|Overall Study|Reason not Specified|1|||
23327659|NCT02656303|64940976|FG002|Overall Study|Reason not Specified|2|||
23327660|NCT00837148|64940977|FG000|Overall Study|Adverse Event|1|||
23327661|NCT00837148|64940977|FG000|Overall Study|Death|1|||
23327662|NCT02342678|64940978|FG000|Overall Study|Lost to Follow-up|0|||
23327663|NCT02342678|64940979|FG001|Overall Study|Lost to Follow-up|1|||
23327664|NCT02342678|64940978|FG000|Overall Study|Too busy to complete study|0|||
23327665|NCT02342678|64940979|FG001|Overall Study|Too busy to complete study|2|||
23443001|NCT02688985|65362313|FG003|Overall Study|Death|0|||
23443002|NCT02688985|65362314|FG004|Overall Study|Death|1|||
23443003|NCT02688985|65362310|FG000|Overall Study|Lack of Efficacy|0|||
23443004|NCT02688985|65362311|FG001|Overall Study|Lack of Efficacy|0|||
23443005|NCT02688985|65362312|FG002|Overall Study|Lack of Efficacy|0|||
23443006|NCT02688985|65362313|FG003|Overall Study|Lack of Efficacy|0|||
23443007|NCT02688985|65362314|FG004|Overall Study|Lack of Efficacy|1|||
23443008|NCT02688985|65362310|FG000|Overall Study|Lost to Follow-up|2|||
23443009|NCT02688985|65362311|FG001|Overall Study|Lost to Follow-up|0|||
23443010|NCT02688985|65362312|FG002|Overall Study|Lost to Follow-up|1|||
23443011|NCT02688985|65362313|FG003|Overall Study|Lost to Follow-up|1|||
23443012|NCT02688985|65362314|FG004|Overall Study|Lost to Follow-up|1|||
23443013|NCT02688985|65362310|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23443014|NCT02688985|65362311|FG001|Overall Study|Non-Compliance With Study Drug|3|||
23443015|NCT02688985|65362312|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23443016|NCT02688985|65362313|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23443017|NCT02688985|65362314|FG004|Overall Study|Non-Compliance With Study Drug|1|||
23443018|NCT02688985|65362310|FG000|Overall Study|Other|3|||
23443019|NCT02688985|65362311|FG001|Overall Study|Other|4|||
23443020|NCT02688985|65362312|FG002|Overall Study|Other|1|||
23443021|NCT02688985|65362313|FG003|Overall Study|Other|0|||
23443022|NCT02688985|65362314|FG004|Overall Study|Other|0|||
23443023|NCT02688985|65362310|FG000|Overall Study|Physician Decision|2|||
23443024|NCT02688985|65362311|FG001|Overall Study|Physician Decision|2|||
23443025|NCT02688985|65362312|FG002|Overall Study|Physician Decision|0|||
23443026|NCT02688985|65362313|FG003|Overall Study|Physician Decision|0|||
23443027|NCT02688985|65362314|FG004|Overall Study|Physician Decision|1|||
23443028|NCT02688985|65362310|FG000|Overall Study|Pregnancy|0|||
23443029|NCT02688985|65362311|FG001|Overall Study|Pregnancy|0|||
23443030|NCT02688985|65362312|FG002|Overall Study|Pregnancy|2|||
23443031|NCT02688985|65362313|FG003|Overall Study|Pregnancy|1|||
23443032|NCT02688985|65362314|FG004|Overall Study|Pregnancy|0|||
23443033|NCT02688985|65362310|FG000|Overall Study|Study Terminated By Sponsor|0|||
23443034|NCT02688985|65362311|FG001|Overall Study|Study Terminated By Sponsor|0|||
23565984|NCT00876460|65799838|FG003|Mono Therapy Phase|Progressive disease|0|||
23565985|NCT00876460|65799839|FG004|Mono Therapy Phase|Progressive disease|2|||
23156855|NCT01572675|64325325|FG001|Overall Study|Surgical intervention|6|||
23156856|NCT01572675|64325324|FG000|Overall Study|Withdrawal by Subject|5|||
23156857|NCT01572675|64325325|FG001|Overall Study|Withdrawal by Subject|1|||
23327666|NCT02342678|64940978|FG000|Overall Study|Family illness/emergency|0|||
23443035|NCT02688985|65362312|FG002|Overall Study|Study Terminated By Sponsor|0|||
23443036|NCT02688985|65362313|FG003|Overall Study|Study Terminated By Sponsor|1|||
23443037|NCT02688985|65362314|FG004|Overall Study|Study Terminated By Sponsor|0|||
23443038|NCT02688985|65362310|FG000|Overall Study|Withdrawal by Subject|2|||
23443039|NCT02688985|65362311|FG001|Overall Study|Withdrawal by Subject|8|||
23443040|NCT02688985|65362312|FG002|Overall Study|Withdrawal by Subject|7|||
23443041|NCT02688985|65362313|FG003|Overall Study|Withdrawal by Subject|1|||
23443042|NCT02688985|65362314|FG004|Overall Study|Withdrawal by Subject|4|||
23565986|NCT00876460|65799840|FG005|Mono Therapy Phase|Progressive disease|0|||
23443043|NCT00630344|65362315|FG000|Overall Study|Adverse Event|5|||
23156858|NCT01572675|64325324|FG000|Overall Study|Physician Decision|2|||
23156859|NCT01572675|64325325|FG001|Overall Study|Physician Decision|2|||
23156860|NCT01572675|64325324|FG000|Overall Study|Death unrelated to coxibs|1|||
23156861|NCT01572675|64325325|FG001|Overall Study|Death unrelated to coxibs|1|||
23327667|NCT02342678|64940979|FG001|Overall Study|Family illness/emergency|1|||
23327668|NCT02342678|64940978|FG000|Overall Study|Illness/medical reason|1|||
23327669|NCT02342678|64940979|FG001|Overall Study|Illness/medical reason|1|||
23327670|NCT01276756|64940980|FG000|Overall Study|Lost to Follow-up|2|||
23327671|NCT01276756|64940981|FG001|Overall Study|Lost to Follow-up|0|||
23327672|NCT01276756|64940980|FG000|Overall Study|Adverse Event|3|||
23156862|NCT01572675|64325324|FG000|Overall Study|Other disease detected|1|||
23156863|NCT01572675|64325325|FG001|Overall Study|Other disease detected|1|||
23156864|NCT01572675|64325324|FG000|Overall Study|Unknown reason|1|||
23156865|NCT01572675|64325325|FG001|Overall Study|Unknown reason|1|||
23156866|NCT01572675|64325324|FG000|Overall Study|Rheumatologist new evaluation|0|||
23156867|NCT01572675|64325325|FG001|Overall Study|Rheumatologist new evaluation|1|||
23443044|NCT00630344|65362315|FG000|Overall Study|Progressive Disease|19|||
23443045|NCT00630344|65362315|FG000|Overall Study|Physician Decision|9|||
23443046|NCT00630344|65362315|FG000|Overall Study|Withdrawal by Subject|1|||
23443047|NCT00630344|65362315|FG000|Overall Study|Intercurrent Illness|1|||
23443048|NCT00630344|65362315|FG000|Overall Study|Other|1|||
23443049|NCT04124705|65362318|FG000|Titration Period|Adverse Event|9|||
23443050|NCT04124705|65362319|FG001|Titration Period|Adverse Event|5|||
23443051|NCT04124705|65362318|FG000|Titration Period|Withdrawal by Subject|6|||
23443052|NCT04124705|65362319|FG001|Titration Period|Withdrawal by Subject|3|||
23443053|NCT04124705|65362318|FG000|Titration Period|Lost to Follow-up|0|||
23443054|NCT04124705|65362319|FG001|Titration Period|Lost to Follow-up|1|||
23443055|NCT04124705|65362318|FG000|Titration Period|Death|1|||
23443056|NCT04124705|65362319|FG001|Titration Period|Death|1|||
23443057|NCT04124705|65362318|FG000|Titration Period|Lack of Efficacy|2|||
23443058|NCT04124705|65362319|FG001|Titration Period|Lack of Efficacy|0|||
23443059|NCT04124705|65362318|FG000|Titration Period|Physician Decision|2|||
23443060|NCT04124705|65362319|FG001|Titration Period|Physician Decision|0|||
23443061|NCT04124705|65362318|FG000|Titration Period|Non-compliance with Study Drug|2|||
23443062|NCT04124705|65362319|FG001|Titration Period|Non-compliance with Study Drug|0|||
23443063|NCT04124705|65362318|FG000|Titration Period|Other|4|||
23443064|NCT04124705|65362319|FG001|Titration Period|Other|9|||
23443065|NCT04124705|65362318|FG000|Stabilization Period|Adverse Event|4|||
23443066|NCT04124705|65362319|FG001|Stabilization Period|Adverse Event|2|||
23443067|NCT04124705|65362318|FG000|Stabilization Period|Withdrawal by Subject|1|||
23443068|NCT04124705|65362319|FG001|Stabilization Period|Withdrawal by Subject|1|||
23443069|NCT04124705|65362318|FG000|Stabilization Period|Lost to Follow-up|0|||
23443070|NCT04124705|65362319|FG001|Stabilization Period|Lost to Follow-up|1|||
23565987|NCT00876460|65799841|FG006|Mono Therapy Phase|Progressive disease|1|||
23565988|NCT00876460|65799842|FG007|Mono Therapy Phase|Progressive disease|3|||
23565989|NCT00876460|65799835|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
23565990|NCT00876460|65799836|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
23565991|NCT00876460|65799837|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
23565992|NCT00876460|65799838|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
23565993|NCT00876460|65799839|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
23565994|NCT00876460|65799840|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
23565995|NCT00876460|65799841|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
23565996|NCT00876460|65799842|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
23565997|NCT00876460|65799835|FG000|Mono Therapy Phase|Adverse Event|0|||
23565998|NCT00876460|65799836|FG001|Mono Therapy Phase|Adverse Event|0|||
23565999|NCT00876460|65799837|FG002|Mono Therapy Phase|Adverse Event|0|||
23566000|NCT00876460|65799838|FG003|Mono Therapy Phase|Adverse Event|1|||
23566001|NCT00876460|65799839|FG004|Mono Therapy Phase|Adverse Event|0|||
23566002|NCT00876460|65799840|FG005|Mono Therapy Phase|Adverse Event|0|||
23566003|NCT00876460|65799841|FG006|Mono Therapy Phase|Adverse Event|0|||
23566004|NCT00876460|65799842|FG007|Mono Therapy Phase|Adverse Event|0|||
23566005|NCT02176421|65803648|FG000|Overall Study|Lost to Follow-up|4|||
23566006|NCT02176421|65803648|FG000|Overall Study|Adverse Event|1|||
23156868|NCT01572675|64325324|FG000|Overall Study|Missing data|1|||
23156869|NCT01572675|64325325|FG001|Overall Study|Missing data|4|||
23156870|NCT01572675|64325324|FG000|Overall Study|Lost to Follow-up|22|||
23156871|NCT01572675|64325325|FG001|Overall Study|Lost to Follow-up|27|||
23327673|NCT01276756|64940981|FG001|Overall Study|Adverse Event|2|||
23443071|NCT04124705|65362318|FG000|Stabilization Period|Lack of Efficacy|4|||
23443072|NCT04124705|65362319|FG001|Stabilization Period|Lack of Efficacy|2|||
23443073|NCT04124705|65362318|FG000|Stabilization Period|Protocol Deviation|0|||
23443074|NCT04124705|65362319|FG001|Stabilization Period|Protocol Deviation|2|||
23443075|NCT04124705|65362318|FG000|Stabilization Period|Other|2|||
23566007|NCT01735396|65803649|FG000|Overall Study|not evaluable|1|||
23566008|NCT01190215|65803650|FG000|Up to Month 6|Lost to Follow-up|2|||
23566009|NCT01190215|65803651|FG001|Up to Month 6|Lost to Follow-up|0|||
23566010|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
23221735|NCT03706040|64553779|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
23221736|NCT03706040|64553780|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
23221737|NCT03706040|64553781|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
23221738|NCT03706040|64553782|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
23221739|NCT03706040|64553776|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
23221740|NCT03706040|64553777|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
23221741|NCT03706040|64553778|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
23221742|NCT03706040|64553779|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
23221743|NCT03706040|64553780|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
23221744|NCT03706040|64553781|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
23221745|NCT03706040|64553782|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
23221746|NCT03706040|64553776|FG000|Period A (Week 0 to Week 16)|Other|2|||
23221747|NCT03706040|64553777|FG001|Period A (Week 0 to Week 16)|Other|0|||
23221748|NCT03706040|64553778|FG002|Period A (Week 0 to Week 16)|Other|2|||
23221749|NCT03706040|64553779|FG003|Period A (Week 0 to Week 16)|Other|0|||
23221750|NCT03706040|64553780|FG004|Period A (Week 0 to Week 16)|Other|0|||
23221751|NCT03706040|64553781|FG005|Period A (Week 0 to Week 16)|Other|0|||
23221752|NCT03706040|64553782|FG006|Period A (Week 0 to Week 16)|Other|0|||
23221753|NCT03706040|64553776|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
23221754|NCT03706040|64553777|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
23221755|NCT03706040|64553778|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
23443076|NCT04124705|65362319|FG001|Stabilization Period|Other|2|||
23443077|NCT03710642|65362320|FG000|Overall Study|Adverse Event|5|||
23443078|NCT03710642|65362321|FG001|Overall Study|Adverse Event|1|||
23443079|NCT03710642|65362320|FG000|Overall Study|non-site physician recommendation|1|||
23443080|NCT03710642|65362321|FG001|Overall Study|non-site physician recommendation|0|||
23443081|NCT03710642|65362320|FG000|Overall Study|Participant unwilling or unable to participate|1|||
23156872|NCT01786603|64325334|FG000|Overall Study|Death|5|||
23156873|NCT01786603|64325335|FG001|Overall Study|Death|1|||
23443082|NCT03710642|65362321|FG001|Overall Study|Participant unwilling or unable to participate|1|||
23566011|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
23156874|NCT01786603|64325334|FG000|Overall Study|Adverse Event|6|||
23156875|NCT01786603|64325335|FG001|Overall Study|Adverse Event|2|||
23156876|NCT01786603|64325334|FG000|Overall Study|Physician decision to withdraw|6|||
23566012|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
23566013|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
23566014|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
23566015|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
23566016|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Death|0|||
23566017|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Death|1|||
23566018|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Adverse Event|11|||
23566019|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Adverse Event|11|||
23566020|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
23566021|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
23156877|NCT01786603|64325335|FG001|Overall Study|Physician decision to withdraw|7|||
23156878|NCT01786603|64325334|FG000|Overall Study|Lost to Follow-up|1|||
23156879|NCT01786603|64325335|FG001|Overall Study|Lost to Follow-up|2|||
23156880|NCT00652366|64325336|FG000|Overall Study|Adverse Event|8|||
23156881|NCT00652366|64325337|FG001|Overall Study|Adverse Event|4|||
23156882|NCT00652366|64325338|FG002|Overall Study|Adverse Event|7|||
23156883|NCT00652366|64325339|FG003|Overall Study|Adverse Event|17|||
23156884|NCT00652366|64325340|FG004|Overall Study|Adverse Event|13|||
23156885|NCT00652366|64325336|FG000|Overall Study|Death|5|||
23156886|NCT00652366|64325337|FG001|Overall Study|Death|4|||
23156887|NCT00652366|64325338|FG002|Overall Study|Death|1|||
23156888|NCT00652366|64325339|FG003|Overall Study|Death|8|||
23156889|NCT00652366|64325340|FG004|Overall Study|Death|5|||
23156890|NCT00652366|64325336|FG000|Overall Study|Lack of Efficacy|84|||
23156891|NCT00652366|64325337|FG001|Overall Study|Lack of Efficacy|58|||
23156892|NCT00652366|64325338|FG002|Overall Study|Lack of Efficacy|53|||
23156893|NCT00652366|64325339|FG003|Overall Study|Lack of Efficacy|133|||
23221756|NCT03706040|64553779|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
23566022|NCT02936037|65803654|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23156894|NCT00652366|64325340|FG004|Overall Study|Lack of Efficacy|13|||
23221757|NCT03706040|64553780|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
23221758|NCT03706040|64553781|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
23221759|NCT03706040|64553782|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
23221760|NCT03706040|64553776|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
23566023|NCT02936037|65803655|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23156895|NCT00652366|64325336|FG000|Overall Study|Violation of Selection Criteria|0|||
23156896|NCT00652366|64325337|FG001|Overall Study|Violation of Selection Criteria|0|||
23156897|NCT00652366|64325338|FG002|Overall Study|Violation of Selection Criteria|1|||
23156898|NCT00652366|64325339|FG003|Overall Study|Violation of Selection Criteria|0|||
23156899|NCT00652366|64325340|FG004|Overall Study|Violation of Selection Criteria|0|||
23443083|NCT03710642|65362320|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
23443084|NCT03710642|65362321|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
23443085|NCT03710642|65362320|FG000|Overall Study|NA-no code provided|1|||
23443086|NCT03710642|65362321|FG001|Overall Study|NA-no code provided|0|||
23443087|NCT03710642|65362320|FG000|Overall Study|Withdrawal by Subject|1|||
23443088|NCT03710642|65362321|FG001|Overall Study|Withdrawal by Subject|0|||
23443089|NCT00826618|65362327|FG000|Overall Study|Withdrawal by Subject|1|||
23443090|NCT03499314|65362328|FG000|Overall Study|Time Commitment|1|||
23443091|NCT03499314|65362329|FG001|Overall Study|Time Commitment|2|||
23443092|NCT03499314|65362328|FG000|Overall Study|Medical issue unrelated to research study|1|||
23443093|NCT03499314|65362329|FG001|Overall Study|Medical issue unrelated to research study|1|||
23443094|NCT00568126|65362330|FG000|Overall Study|Adverse Event|3|||
23443095|NCT00568126|65362331|FG001|Overall Study|Adverse Event|0|||
23443096|NCT00568126|65362330|FG000|Overall Study|Withdrawal by Subject|2|||
23443097|NCT00568126|65362331|FG001|Overall Study|Withdrawal by Subject|3|||
23443098|NCT00568126|65362330|FG000|Overall Study|Lost to Follow-up|4|||
23443099|NCT00568126|65362331|FG001|Overall Study|Lost to Follow-up|3|||
23443100|NCT00568126|65362330|FG000|Overall Study|Lack of Efficacy|0|||
23443101|NCT00568126|65362331|FG001|Overall Study|Lack of Efficacy|1|||
23443102|NCT00568126|65362330|FG000|Overall Study|Physician Decision|2|||
23443103|NCT00568126|65362331|FG001|Overall Study|Physician Decision|2|||
23443104|NCT01807598|65362334|FG000|Overall Study|Withdrawal by Subject|4|||
23443105|NCT01807598|65362334|FG000|Overall Study|Adverse Event|1|||
23443106|NCT01807598|65362334|FG000|Overall Study|Other Physician Decision|1|||
23221761|NCT03706040|64553777|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
23443107|NCT03305770|65362350|FG000|Overall Study|Physician Decision - prior to dispense|0|||
23443108|NCT03305770|65362351|FG001|Overall Study|Physician Decision - prior to dispense|1|||
23443109|NCT03305770|65362350|FG000|Overall Study|Subject moved|1|||
23443110|NCT03305770|65362351|FG001|Overall Study|Subject moved|0|||
23443111|NCT05274269|65362352|FG000|Overall Study|Adverse Event|0|||
23443112|NCT05274269|65362353|FG001|Overall Study|Adverse Event|3|||
23443113|NCT05274269|65362352|FG000|Overall Study|Death|0|||
23443114|NCT05274269|65362353|FG001|Overall Study|Death|1|||
23443115|NCT05274269|65362352|FG000|Overall Study|Other|0|||
23443116|NCT05274269|65362353|FG001|Overall Study|Other|2|||
23443117|NCT05274269|65362352|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
23443118|NCT05274269|65362353|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
23443119|NCT02473367|65362357|FG000|Wait 1|Withdrawal by Subject|1|||
23443120|NCT02473367|65362357|FG000|Period 4|Lost to Follow-up|1|||
23443121|NCT02489942|65362358|FG000|Overall Study|Request by patient|602|||
23443122|NCT02489942|65362358|FG000|Overall Study|Improvement/remission|157|||
23443123|NCT02489942|65362358|FG000|Overall Study|No change/Progressive disease|263|||
23443124|NCT02489942|65362358|FG000|Overall Study|Adverse Event|522|||
23443125|NCT02489942|65362358|FG000|Overall Study|Other personal reasons|1218|||
23443126|NCT02489942|65362358|FG000|Overall Study|Lost to Follow-up|456|||
23443127|NCT02489942|65362358|FG000|Overall Study|Not continuously investigated|7|||
23443128|NCT02489942|65362358|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
23443129|NCT02489942|65362358|FG000|Overall Study|Multiple registration|1|||
23443130|NCT02489942|65362358|FG000|Overall Study|No patient visit after entry|100|||
23443131|NCT02489942|65362358|FG000|Overall Study|No treatment with Jardiance|2|||
23443132|NCT02489942|65362358|FG000|Overall Study|Patient received Jardiance before registration|1|||
23443133|NCT02489942|65362358|FG000|Overall Study|No CRF collected|86|||
23443134|NCT00607087|65362361|FG000|Overall Study|Withdrawal by Subject|9|||
23443135|NCT00607087|65362362|FG001|Overall Study|Withdrawal by Subject|4|||
23443136|NCT00607087|65362363|FG002|Overall Study|Withdrawal by Subject|4|||
23443137|NCT00607087|65362361|FG000|Overall Study|Adverse Event|3|||
23443138|NCT00607087|65362362|FG001|Overall Study|Adverse Event|2|||
23443139|NCT00607087|65362363|FG002|Overall Study|Adverse Event|3|||
23443140|NCT00607087|65362361|FG000|Overall Study|Other reason|1|||
23443141|NCT00607087|65362362|FG001|Overall Study|Other reason|5|||
23443142|NCT00607087|65362363|FG002|Overall Study|Other reason|2|||
23443143|NCT00607087|65362361|FG000|Overall Study|Poor compliance to protocol|1|||
23443144|NCT00607087|65362362|FG001|Overall Study|Poor compliance to protocol|0|||
23443145|NCT00607087|65362363|FG002|Overall Study|Poor compliance to protocol|1|||
23443146|NCT00607087|65362361|FG000|Overall Study|Lost to Follow-up|1|||
23443147|NCT00607087|65362362|FG001|Overall Study|Lost to Follow-up|0|||
23443148|NCT00607087|65362363|FG002|Overall Study|Lost to Follow-up|0|||
23443149|NCT00607087|65362361|FG000|Period 1|Withdrawal by Subject|7|||
23443150|NCT00607087|65362362|FG001|Period 1|Withdrawal by Subject|2|||
23443151|NCT00607087|65362363|FG002|Period 1|Withdrawal by Subject|3|||
23443152|NCT00607087|65362361|FG000|Period 1|Adverse Event|3|||
23443153|NCT00607087|65362362|FG001|Period 1|Adverse Event|0|||
23443154|NCT00607087|65362363|FG002|Period 1|Adverse Event|0|||
23443155|NCT00607087|65362361|FG000|Period 1|Poor compliance to protocol|1|||
23443156|NCT00607087|65362362|FG001|Period 1|Poor compliance to protocol|0|||
23443157|NCT00607087|65362363|FG002|Period 1|Poor compliance to protocol|0|||
23628280|NCT01240915|66024689|FG004|Overall Study|Insufficient Clinical Response|1|||
23628281|NCT01240915|66024690|FG005|Overall Study|Insufficient Clinical Response|3|||
23628282|NCT01240915|66024691|FG006|Overall Study|Insufficient Clinical Response|6|||
23628283|NCT01240915|66024692|FG007|Overall Study|Insufficient Clinical Response|0|||
23628284|NCT01240915|66024693|FG008|Overall Study|Insufficient Clinical Response|3|||
23628285|NCT02872012|66024694|FG000|Overall Study|Withdrawal by Subject|1|||
23566024|NCT02936037|65803654|FG000|Open Label Extension|Adverse Event|0|||
23628286|NCT02872012|66024695|FG001|Overall Study|Withdrawal by Subject|0|||
23156900|NCT00652366|64325336|FG000|Overall Study|Protocol Violation|1|||
23156901|NCT00652366|64325337|FG001|Overall Study|Protocol Violation|0|||
23156902|NCT00652366|64325338|FG002|Overall Study|Protocol Violation|0|||
23156903|NCT00652366|64325339|FG003|Overall Study|Protocol Violation|0|||
23156904|NCT00652366|64325340|FG004|Overall Study|Protocol Violation|0|||
23566025|NCT02936037|65803655|FG001|Open Label Extension|Adverse Event|3|||
23566026|NCT02936037|65803654|FG000|Open Label Extension|Other|0|||
23566027|NCT02936037|65803655|FG001|Open Label Extension|Other|3|||
23566028|NCT02936037|65803654|FG000|Open Label Extension|Withdrawal by Subject|0|||
23566029|NCT02936037|65803655|FG001|Open Label Extension|Withdrawal by Subject|4|||
23566030|NCT01953003|65803656|FG000|Overall Study|Not treated|0|||
23566031|NCT01953003|65803657|FG001|Overall Study|Not treated|1|||
23566032|NCT01953003|65803656|FG000|Overall Study|Progressive disease|35|||
23566033|NCT01953003|65803657|FG001|Overall Study|Progressive disease|45|||
23566034|NCT01953003|65803656|FG000|Overall Study|Related Adverse events|7|||
23566035|NCT01953003|65803657|FG001|Overall Study|Related Adverse events|2|||
23566036|NCT01953003|65803656|FG000|Overall Study|Non-related adverse events|0|||
23566037|NCT01953003|65803657|FG001|Overall Study|Non-related adverse events|2|||
23566038|NCT01953003|65803656|FG000|Overall Study|Protocol Violation|0|||
23566039|NCT01953003|65803657|FG001|Overall Study|Protocol Violation|1|||
23566040|NCT01953003|65803656|FG000|Overall Study|Withdrawal by Subject|14|||
23628287|NCT02872012|66024696|FG002|Overall Study|Withdrawal by Subject|0|||
23628288|NCT02872012|66024697|FG003|Overall Study|Withdrawal by Subject|0|||
23628289|NCT02872012|66024698|FG004|Overall Study|Withdrawal by Subject|0|||
23628290|NCT00477464|66024699|FG000|Overall Study|Lost to Follow-up|1|||
23628291|NCT00477464|66024699|FG000|Overall Study|Death|36|||
23628292|NCT00477464|66024699|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
23156905|NCT00652366|64325336|FG000|Overall Study|Refused treatment|3|||
23156906|NCT00652366|64325337|FG001|Overall Study|Refused treatment|7|||
23156907|NCT00652366|64325338|FG002|Overall Study|Refused treatment|6|||
23156908|NCT00652366|64325339|FG003|Overall Study|Refused treatment|17|||
23156909|NCT00652366|64325340|FG004|Overall Study|Refused treatment|5|||
23156910|NCT00652366|64325336|FG000|Overall Study|Other|5|||
23156911|NCT00652366|64325337|FG001|Overall Study|Other|2|||
23156912|NCT00652366|64325338|FG002|Overall Study|Other|3|||
23156913|NCT00652366|64325339|FG003|Overall Study|Other|4|||
23156914|NCT00652366|64325340|FG004|Overall Study|Other|0|||
23156915|NCT02568475|64325341|FG000|Overall Study|Lost to Follow-up|40|||
23156916|NCT02568475|64325342|FG001|Overall Study|Lost to Follow-up|39|||
23156917|NCT02568475|64325341|FG000|Overall Study|Withdrawal by Subject|2|||
23156918|NCT02568475|64325342|FG001|Overall Study|Withdrawal by Subject|0|||
23156919|NCT02568475|64325341|FG000|Overall Study|Discharged home|4|||
23156920|NCT02568475|64325342|FG001|Overall Study|Discharged home|4|||
23156921|NCT02568475|64325341|FG000|Overall Study|Short-term: Discharge location unknown|4|||
23156922|NCT02568475|64325342|FG001|Overall Study|Short-term: Discharge location unknown|0|||
23156923|NCT02568475|64325341|FG000|Overall Study|Transferred to another facility|1|||
23156924|NCT02568475|64325342|FG001|Overall Study|Transferred to another facility|0|||
23156925|NCT01161043|64325345|FG000|Overall Study|Withdrawal by Subject|3|||
23156926|NCT01301950|64325346|FG000|Overall Study|Surgery was cancelled by patient|0|||
23156927|NCT01301950|64325347|FG001|Overall Study|Surgery was cancelled by patient|1|||
23156928|NCT02354222|64325350|FG000|Overall Study|Adverse Event|0|||
23156929|NCT02354222|64325351|FG001|Overall Study|Adverse Event|3|||
23156930|NCT02354222|64325350|FG000|Overall Study|Physician Decision|1|||
23156931|NCT02354222|64325351|FG001|Overall Study|Physician Decision|1|||
23156932|NCT02354222|64325350|FG000|Overall Study|Pregnancy|1|||
23156933|NCT02354222|64325351|FG001|Overall Study|Pregnancy|0|||
23156934|NCT02354222|64325350|FG000|Overall Study|Withdrawal by Subject|2|||
23156935|NCT02354222|64325351|FG001|Overall Study|Withdrawal by Subject|3|||
23156936|NCT02354222|64325350|FG000|Overall Study|Conflict with the stopping criteria|0|||
23156937|NCT02354222|64325351|FG001|Overall Study|Conflict with the stopping criteria|4|||
23156938|NCT04534491|64325352|FG000|Overall Study|Not completed end-of-study interview|24|||
23156939|NCT04534491|64325352|FG000|Overall Study|Non-users|70|||
23566041|NCT01953003|65803657|FG001|Overall Study|Withdrawal by Subject|4|||
23566042|NCT03015116|65803658|FG000|Overall Study|Lost to Follow-up|3|||
23566043|NCT03015116|65803659|FG001|Overall Study|Lost to Follow-up|0|||
23156940|NCT04534491|64325352|FG000|Overall Study|Non-verifiable users|58|||
23156941|NCT01131351|64325353|FG000|Overall Study|Adverse Event|0|||
23566044|NCT03015116|65803660|FG002|Overall Study|Lost to Follow-up|2|||
23628293|NCT02312206|66024700|FG000|Overall Study|Adverse Event|3|||
23628294|NCT02312206|66024701|FG001|Overall Study|Adverse Event|6|||
23156942|NCT01131351|64325354|FG001|Overall Study|Adverse Event|2|||
23156943|NCT01131351|64325353|FG000|Overall Study|Protocol Deviation|0|||
23156944|NCT01131351|64325354|FG001|Overall Study|Protocol Deviation|1|||
23156945|NCT00789880|64325361|FG000|Overall Study|Adverse Event|0|||
23156946|NCT00789880|64325362|FG001|Overall Study|Adverse Event|0|||
23156947|NCT00789880|64325363|FG002|Overall Study|Adverse Event|0|||
23156948|NCT00789880|64325364|FG003|Overall Study|Adverse Event|0|||
23156949|NCT00789880|64325365|FG004|Overall Study|Adverse Event|1|||
23156950|NCT00789880|64325366|FG005|Overall Study|Adverse Event|0|||
23156951|NCT00789880|64325361|FG000|Overall Study|Protocol Violation|0|||
23156952|NCT00789880|64325362|FG001|Overall Study|Protocol Violation|1|||
23156953|NCT00789880|64325363|FG002|Overall Study|Protocol Violation|0|||
23156954|NCT00789880|64325364|FG003|Overall Study|Protocol Violation|1|||
23156955|NCT00789880|64325365|FG004|Overall Study|Protocol Violation|0|||
23327674|NCT02653625|64940982|FG000|Overall Study|Adverse Event|1|||
23327675|NCT02653625|64940982|FG000|Overall Study|Non-compliance with Study Drug|1|||
23327676|NCT02653625|64940982|FG000|Overall Study|Protocol Violation|1|||
23327677|NCT02653625|64940982|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
23327678|NCT00712712|64940983|FG000|Overall Study|Protocol Violation|11|||
23327679|NCT00712712|64940983|FG000|Overall Study|Radiofrequency not done|3|||
23327680|NCT00712712|64940983|FG000|Overall Study|Death|8|||
23156956|NCT00789880|64325366|FG005|Overall Study|Protocol Violation|0|||
23156957|NCT00789880|64325361|FG000|Overall Study|Withdrawal by Subject|1|||
23156958|NCT00789880|64325362|FG001|Overall Study|Withdrawal by Subject|0|||
23327681|NCT00712712|64940983|FG000|Overall Study|Withdrawal by Subject|1|||
23327682|NCT03922321|64940984|FG000|Overall Study|Participant Moved|1|||
23327683|NCT03922321|64940984|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
23327684|NCT02505217|64940985|FG000|Overall Study|Withdrawal by Subject|1|||
23327685|NCT02505217|64940986|FG001|Overall Study|Withdrawal by Subject|2|||
23327686|NCT04526288|64940987|FG000|Overall Study|Disease Progression|1|||
23327687|NCT04526288|64940988|FG001|Overall Study|Disease Progression|0|||
23327688|NCT03207815|64940989|FG000|Overall Study|Protocol Violation|3|||
23327689|NCT03207815|64940990|FG001|Overall Study|Protocol Violation|1|||
23327690|NCT03207815|64940989|FG000|Overall Study|Adverse Event|1|||
23327691|NCT03207815|64940990|FG001|Overall Study|Adverse Event|2|||
23327692|NCT03207815|64940989|FG000|Overall Study|Lost to Follow-up|1|||
23327693|NCT03207815|64940990|FG001|Overall Study|Lost to Follow-up|2|||
23327694|NCT03207815|64940989|FG000|Overall Study|Investigator's Discretion|1|||
23327695|NCT03207815|64940990|FG001|Overall Study|Investigator's Discretion|1|||
23327696|NCT03207815|64940989|FG000|Overall Study|Lack of Efficacy|0|||
23327697|NCT03207815|64940990|FG001|Overall Study|Lack of Efficacy|1|||
23327698|NCT03207815|64940989|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
23327699|NCT03207815|64940990|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
23327700|NCT03207815|64940989|FG000|Overall Study|Withdrew Consent|1|||
23327701|NCT03207815|64940990|FG001|Overall Study|Withdrew Consent|0|||
23327702|NCT03655405|64940991|FG000|Overall Study|Death after initial data collection|4|||
23327703|NCT03655405|64940992|FG001|Overall Study|Death after initial data collection|2|||
23327704|NCT03655405|64940991|FG000|Overall Study|Died before initial data collection|1|||
23327705|NCT03655405|64940992|FG001|Overall Study|Died before initial data collection|2|||
23327706|NCT03655405|64940991|FG000|Overall Study|Protocol Violation|0|||
23327707|NCT03655405|64940992|FG001|Overall Study|Protocol Violation|1|||
23327708|NCT03534687|64940993|FG000|Overall Study|Lost to Follow-up|7|||
23327709|NCT03534687|64940994|FG001|Overall Study|Lost to Follow-up|2|||
23327710|NCT02166333|64940997|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
23327711|NCT02166333|64940998|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
23327712|NCT02166333|64940999|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
23327713|NCT02166333|64941000|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
23327714|NCT02166333|64941001|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
23327715|NCT02166333|64941002|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
23327716|NCT02166333|64940997|FG000|Stage 1|Death|4|||
23327717|NCT02166333|64940998|FG001|Stage 1|Death|0|||
23327718|NCT02166333|64940999|FG002|Stage 1|Death|2|||
23327719|NCT02166333|64941000|FG003|Stage 1|Death|0|||
23327720|NCT02166333|64941001|FG004|Stage 1|Death|3|||
23327721|NCT02166333|64941002|FG005|Stage 1|Death|2|||
23156959|NCT00789880|64325363|FG002|Overall Study|Withdrawal by Subject|0|||
23156960|NCT00789880|64325364|FG003|Overall Study|Withdrawal by Subject|0|||
23156961|NCT00789880|64325365|FG004|Overall Study|Withdrawal by Subject|2|||
23327722|NCT02166333|64940997|FG000|Stage 1|Lost to Follow-up|12|||
23156962|NCT00789880|64325366|FG005|Overall Study|Withdrawal by Subject|0|||
23327723|NCT02166333|64940998|FG001|Stage 1|Lost to Follow-up|0|||
23327724|NCT02166333|64940999|FG002|Stage 1|Lost to Follow-up|6|||
23327725|NCT02166333|64941000|FG003|Stage 1|Lost to Follow-up|0|||
23327726|NCT02166333|64941001|FG004|Stage 1|Lost to Follow-up|3|||
23327727|NCT02166333|64941002|FG005|Stage 1|Lost to Follow-up|3|||
23156963|NCT02066311|64325367|FG000|Overall Study|Adverse Event|4|||
23566045|NCT03015116|65803658|FG000|Overall Study|Withdrawal by Subject|3|||
23156964|NCT02066311|64325367|FG000|Overall Study|Withdrawal by Subject|1|||
23156965|NCT01624259|64325368|FG000|Overall Study|Adverse Event|18|||
23156966|NCT01624259|64325369|FG001|Overall Study|Adverse Event|18|||
23156967|NCT01624259|64325368|FG000|Overall Study|Protocol Violation|1|||
23156968|NCT01624259|64325369|FG001|Overall Study|Protocol Violation|2|||
23156969|NCT01624259|64325368|FG000|Overall Study|Withdrawal by Subject|5|||
23156970|NCT01624259|64325369|FG001|Overall Study|Withdrawal by Subject|7|||
23156971|NCT01624259|64325368|FG000|Overall Study|Physician Decision|1|||
23156972|NCT01624259|64325369|FG001|Overall Study|Physician Decision|1|||
23156973|NCT01624259|64325368|FG000|Overall Study|Lost to Follow-up|2|||
23156974|NCT01624259|64325369|FG001|Overall Study|Lost to Follow-up|3|||
23156975|NCT01624259|64325368|FG000|Overall Study|Abnormal laboratory measure|3|||
23156976|NCT01624259|64325369|FG001|Overall Study|Abnormal laboratory measure|0|||
23156977|NCT03901079|64325370|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
23156978|NCT01342484|64325371|FG000|Overall Study|Other Reasons|1|||
23156979|NCT01342484|64325372|FG001|Overall Study|Other Reasons|0|||
23156980|NCT01342484|64325373|FG002|Overall Study|Other Reasons|0|||
23156981|NCT01342484|64325371|FG000|Overall Study|Protocol Violation|0|||
23156982|NCT01342484|64325372|FG001|Overall Study|Protocol Violation|0|||
23156983|NCT01342484|64325373|FG002|Overall Study|Protocol Violation|1|||
23156984|NCT01342484|64325371|FG000|Overall Study|Withdrawal by Subject|1|||
23156985|NCT01342484|64325372|FG001|Overall Study|Withdrawal by Subject|0|||
23156986|NCT01342484|64325373|FG002|Overall Study|Withdrawal by Subject|0|||
23156987|NCT01543828|64325385|FG000|Treatment 2|Lost to Follow-up|1|||
23156988|NCT01543828|64325386|FG001|Treatment 2|Lost to Follow-up|0|||
23156989|NCT01667081|64325392|FG000|Overall Study|Death|43|||
23156990|NCT01667081|64325393|FG001|Overall Study|Death|3|||
23156991|NCT01667081|64325392|FG000|Overall Study|Lost to Follow-up|99|||
23156992|NCT01667081|64325393|FG001|Overall Study|Lost to Follow-up|48|||
23156993|NCT01667081|64325392|FG000|Overall Study|Physician Decision|16|||
23156994|NCT01667081|64325393|FG001|Overall Study|Physician Decision|2|||
23156995|NCT01667081|64325392|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
23156996|NCT01667081|64325393|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
23156997|NCT01667081|64325392|FG000|Overall Study|Withdrawal by Subject|90|||
23156998|NCT01667081|64325393|FG001|Overall Study|Withdrawal by Subject|35|||
23156999|NCT01056510|64325395|FG000|Overall Study|Dropout Before Start of Treatment|1|||
23157000|NCT01056510|64325396|FG001|Overall Study|Dropout Before Start of Treatment|1|||
23157001|NCT01056510|64325395|FG000|Overall Study|Withdrawal by Subject|4|||
23157002|NCT01056510|64325396|FG001|Overall Study|Withdrawal by Subject|2|||
23157003|NCT01056510|64325395|FG000|Overall Study|Death|29|||
23157004|NCT01056510|64325396|FG001|Overall Study|Death|34|||
23157005|NCT01056510|64325395|FG000|Overall Study|Noncompliance|1|||
23157006|NCT01056510|64325396|FG001|Overall Study|Noncompliance|3|||
23157007|NCT01056510|64325395|FG000|Overall Study|Physician Decision|4|||
23157008|NCT01056510|64325396|FG001|Overall Study|Physician Decision|5|||
23157009|NCT01056510|64325395|FG000|Overall Study|Lost to Follow-up|5|||
23157010|NCT01056510|64325396|FG001|Overall Study|Lost to Follow-up|6|||
23157011|NCT01056510|64325395|FG000|Overall Study|Other|10|||
23157012|NCT01056510|64325396|FG001|Overall Study|Other|12|||
23157013|NCT01056510|64325395|FG000|Overall Study|Missing|0|||
23157014|NCT01056510|64325396|FG001|Overall Study|Missing|1|||
23157015|NCT03996876|64325397|FG000|Overall Study|Incomplete Data|2|||
23157016|NCT03996876|64325398|FG001|Overall Study|Incomplete Data|4|||
23157017|NCT01087775|64325403|FG000|Overall Study|failed inclusion criteria|2|||
23157018|NCT00433914|64325404|FG000|Overall Study|Withdrawal by Subject|0|||
23157019|NCT00433914|64325405|FG001|Overall Study|Withdrawal by Subject|2|||
23157020|NCT00433914|64325404|FG000|Overall Study|Lost to Follow-up|0|||
23157021|NCT00433914|64325405|FG001|Overall Study|Lost to Follow-up|1|||
23157022|NCT04869345|64325406|FG000|Overall Study|Lost to Follow-up|8|||
23157023|NCT04869345|64325407|FG001|Overall Study|Lost to Follow-up|3|||
23157024|NCT00199836|64325408|FG000|Overall Study|Progressive Disease|5|||
23157025|NCT00199836|64325408|FG000|Overall Study|Death|1|||
23566046|NCT03015116|65803659|FG001|Overall Study|Withdrawal by Subject|1|||
23157026|NCT01147744|64325409|FG000|Overall Study|Protocol Violation|1|||
23157027|NCT01147744|64325410|FG001|Overall Study|Protocol Violation|0|||
23157028|NCT01147744|64325411|FG002|Overall Study|Protocol Violation|1|||
23157029|NCT01147744|64325412|FG003|Overall Study|Protocol Violation|0|||
23157030|NCT01147744|64325413|FG004|Overall Study|Protocol Violation|1|||
23157031|NCT01147744|64325414|FG005|Overall Study|Protocol Violation|3|||
23157032|NCT01147744|64325415|FG006|Overall Study|Protocol Violation|1|||
23221762|NCT03706040|64553778|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
23157033|NCT01147744|64325409|FG000|Overall Study|Physician Decision|0|||
23566047|NCT03015116|65803660|FG002|Overall Study|Withdrawal by Subject|0|||
23157034|NCT01147744|64325410|FG001|Overall Study|Physician Decision|1|||
23157035|NCT01147744|64325411|FG002|Overall Study|Physician Decision|1|||
23157036|NCT01147744|64325412|FG003|Overall Study|Physician Decision|0|||
23157037|NCT01147744|64325413|FG004|Overall Study|Physician Decision|0|||
23327728|NCT02166333|64940997|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
23327729|NCT02166333|64940998|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
23327730|NCT02166333|64940999|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
23327731|NCT02166333|64941000|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
23327732|NCT02166333|64941001|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
23327733|NCT02166333|64941002|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
23327734|NCT02166333|64940997|FG000|Stage 2|Death|4|||
23327735|NCT02166333|64940998|FG001|Stage 2|Death|2|||
23327736|NCT02166333|64940999|FG002|Stage 2|Death|1|||
23327737|NCT02166333|64941000|FG003|Stage 2|Death|0|||
23327738|NCT02166333|64941001|FG004|Stage 2|Death|0|||
23327739|NCT02166333|64941002|FG005|Stage 2|Death|1|||
23327740|NCT02166333|64940997|FG000|Stage 2|Lost to Follow-up|23|||
23327741|NCT02166333|64940998|FG001|Stage 2|Lost to Follow-up|4|||
23327742|NCT02166333|64940999|FG002|Stage 2|Lost to Follow-up|11|||
23327743|NCT02166333|64941000|FG003|Stage 2|Lost to Follow-up|9|||
23327744|NCT02166333|64941001|FG004|Stage 2|Lost to Follow-up|3|||
23327745|NCT02166333|64941002|FG005|Stage 2|Lost to Follow-up|6|||
23327746|NCT04152837|64941006|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
23327747|NCT04152837|64941006|FG000|Maintenance Period|Adverse Event|1|||
23327748|NCT04152837|64941006|FG000|Maintenance Period|Withdrawal by Subject|1|||
23327749|NCT04152837|64941006|FG000|Maintenance Period|Sponsor Termination of Study|2|||
23327750|NCT04341363|64941007|FG000|Overall Study|Adverse Event|1|||
23327751|NCT04341363|64941007|FG000|Overall Study|Withdrawal by Subject|1|||
23327752|NCT01431716|64941008|FG000|Overall Study|Withdrawal of consent|1|||
23327753|NCT04537078|64941009|FG000|Overall Study|Protocol Violation|3|||
23327754|NCT04537078|64941010|FG001|Overall Study|Protocol Violation|2|||
23327755|NCT04537078|64941009|FG000|Overall Study|Lost to Follow-up|1|||
23327756|NCT04537078|64941010|FG001|Overall Study|Lost to Follow-up|0|||
23327757|NCT04537078|64941009|FG000|Overall Study|Withdrawal by Subject|0|||
23327758|NCT04537078|64941010|FG001|Overall Study|Withdrawal by Subject|1|||
23327759|NCT00536939|64941011|FG000|Overall Study|Withdrawal by Subject|1|||
23327760|NCT00536939|64941012|FG001|Overall Study|Withdrawal by Subject|0|||
23327761|NCT00536939|64941011|FG000|Overall Study|Other Complicating Disease|1|||
23327762|NCT00536939|64941012|FG001|Overall Study|Other Complicating Disease|0|||
23327763|NCT05393037|64941017|FG000|Overall Study|Death|1|||
23327764|NCT05393037|64941018|FG001|Overall Study|Death|0|||
23327765|NCT05393037|64941017|FG000|Overall Study|Lost to Follow-up|1|||
23443158|NCT00607087|65362361|FG000|Period 1|Lost to Follow-up|1|||
23443159|NCT00607087|65362362|FG001|Period 1|Lost to Follow-up|0|||
23566048|NCT03015116|65803658|FG000|Overall Study|Subject has New Medical Status|1|||
23566049|NCT03015116|65803659|FG001|Overall Study|Subject has New Medical Status|0|||
23566050|NCT03015116|65803660|FG002|Overall Study|Subject has New Medical Status|0|||
23566051|NCT03015116|65803658|FG000|Overall Study|Physician Decision|0|||
23566052|NCT03015116|65803659|FG001|Overall Study|Physician Decision|1|||
23566053|NCT03015116|65803660|FG002|Overall Study|Physician Decision|0|||
23566054|NCT04488003|65803661|FG000|Assessed for Eligibility|Screen Failure|24|||
23566055|NCT04488003|65803662|FG001|Assessed for Eligibility|Screen Failure|0|||
23566056|NCT04488003|65803663|FG002|Assessed for Eligibility|Screen Failure|0|||
23566057|NCT04488003|65803661|FG000|Assessed for Eligibility|Adverse Event|1|||
23566058|NCT04488003|65803662|FG001|Assessed for Eligibility|Adverse Event|0|||
23566059|NCT04488003|65803663|FG002|Assessed for Eligibility|Adverse Event|0|||
23628295|NCT02312206|66024700|FG000|Overall Study|Withdrawal by Subject|6|||
23628296|NCT02312206|66024701|FG001|Overall Study|Withdrawal by Subject|6|||
23628297|NCT02312206|66024700|FG000|Overall Study|Physician Decision|7|||
23628298|NCT02312206|66024701|FG001|Overall Study|Physician Decision|6|||
23628299|NCT02312206|66024700|FG000|Overall Study|Death|31|||
23628300|NCT02312206|66024701|FG001|Overall Study|Death|36|||
23628301|NCT02312206|66024700|FG000|Overall Study|Study Terminated by Sponsor|81|||
23628302|NCT02312206|66024701|FG001|Overall Study|Study Terminated by Sponsor|74|||
23628303|NCT02312206|66024700|FG000|Overall Study|Patient transferred to hospice|0|||
23566060|NCT04488003|65803661|FG000|Assessed for Eligibility|Death|1|||
23628304|NCT02312206|66024701|FG001|Overall Study|Patient transferred to hospice|1|||
23628305|NCT02312206|66024700|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
23628306|NCT02312206|66024701|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
23628307|NCT02312206|66024700|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
23327766|NCT05393037|64941018|FG001|Overall Study|Lost to Follow-up|1|||
23327767|NCT05393037|64941017|FG000|Overall Study|Withdrawal by Subject|2|||
23566061|NCT04488003|65803662|FG001|Assessed for Eligibility|Death|0|||
23566062|NCT04488003|65803663|FG002|Assessed for Eligibility|Death|0|||
23628308|NCT02312206|66024701|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
23628309|NCT02312206|66024700|FG000|Overall Study|Disease Progression|1|||
23327768|NCT05393037|64941018|FG001|Overall Study|Withdrawal by Subject|4|||
23327769|NCT05393037|64941017|FG000|Overall Study|Ongoing|152|||
23327770|NCT05393037|64941018|FG001|Overall Study|Ongoing|0|||
23628310|NCT02312206|66024701|FG001|Overall Study|Disease Progression|0|||
23628311|NCT04593823|66024705|FG000|Overall Study|Withdrawal by Subject|1|||
23628312|NCT04593823|66024706|FG001|Overall Study|Withdrawal by Subject|1|||
23628313|NCT04593823|66024705|FG000|Overall Study|Lost to Follow-up|0|||
23628314|NCT04593823|66024706|FG001|Overall Study|Lost to Follow-up|1|||
23628315|NCT01896726|66024707|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
23628316|NCT01896726|66024707|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
23628317|NCT00778921|66024709|FG000|Overall Study|Adverse Event|9|||
23628318|NCT00778921|66024710|FG001|Overall Study|Adverse Event|10|||
23628319|NCT00778921|66024711|FG002|Overall Study|Adverse Event|14|||
23628320|NCT00778921|66024709|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
23628321|NCT00778921|66024710|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
23628322|NCT00778921|66024711|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
23221763|NCT03706040|64553779|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
23221764|NCT03706040|64553780|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
23221765|NCT03706040|64553781|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
23221766|NCT03706040|64553782|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
23221767|NCT03706040|64553776|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23221768|NCT03706040|64553777|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23221769|NCT03706040|64553778|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23221770|NCT03706040|64553779|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23221771|NCT03706040|64553780|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23221772|NCT03706040|64553781|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
23221773|NCT03706040|64553782|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
23221774|NCT03706040|64553776|FG000|Period B (Week 16 to Week 52)|Other|0|||
23221775|NCT03706040|64553777|FG001|Period B (Week 16 to Week 52)|Other|0|||
23221776|NCT03706040|64553778|FG002|Period B (Week 16 to Week 52)|Other|0|||
23221777|NCT03706040|64553779|FG003|Period B (Week 16 to Week 52)|Other|4|||
23221778|NCT03706040|64553780|FG004|Period B (Week 16 to Week 52)|Other|5|||
23221779|NCT03706040|64553781|FG005|Period B (Week 16 to Week 52)|Other|23|||
23221780|NCT03706040|64553782|FG006|Period B (Week 16 to Week 52)|Other|17|||
23221781|NCT02143141|64553788|FG000|Overall Study|pain scores at 24 hours not collected|1|||
23221782|NCT02143141|64553789|FG001|Overall Study|pain scores at 24 hours not collected|0|||
23221783|NCT02848313|64553790|FG000|Overall Study|Adverse Event|1|||
23221784|NCT02848313|64553791|FG001|Overall Study|Adverse Event|2|||
23221785|NCT02848313|64553790|FG000|Overall Study|Lack of Efficacy|0|||
23221786|NCT02848313|64553791|FG001|Overall Study|Lack of Efficacy|1|||
23221787|NCT02848313|64553790|FG000|Overall Study|Withdrawal by Subject|1|||
23221788|NCT02848313|64553791|FG001|Overall Study|Withdrawal by Subject|1|||
23566063|NCT04488003|65803661|FG000|Assessed for Eligibility|Physician Decision|1|||
23566064|NCT04488003|65803662|FG001|Assessed for Eligibility|Physician Decision|0|||
23566065|NCT04488003|65803663|FG002|Assessed for Eligibility|Physician Decision|0|||
23566066|NCT04488003|65803661|FG000|Allocated to Treatment|Progressive Disease|51|||
23566067|NCT04488003|65803662|FG001|Allocated to Treatment|Progressive Disease|0|||
23566068|NCT04488003|65803663|FG002|Allocated to Treatment|Progressive Disease|0|||
23566069|NCT04488003|65803661|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
23566070|NCT04488003|65803662|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
23566071|NCT04488003|65803663|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
23566072|NCT04488003|65803661|FG000|Allocated to Treatment|Adverse Event|6|||
23566073|NCT04488003|65803662|FG001|Allocated to Treatment|Adverse Event|0|||
23566074|NCT04488003|65803663|FG002|Allocated to Treatment|Adverse Event|0|||
23566075|NCT04488003|65803661|FG000|Allocated to Treatment|Other|5|||
23566076|NCT04488003|65803662|FG001|Allocated to Treatment|Other|0|||
23566077|NCT04488003|65803663|FG002|Allocated to Treatment|Other|0|||
23566078|NCT04488003|65803661|FG000|Allocated to Treatment|Physician Decision|4|||
23566079|NCT04488003|65803662|FG001|Allocated to Treatment|Physician Decision|0|||
23566080|NCT04488003|65803663|FG002|Allocated to Treatment|Physician Decision|0|||
23566081|NCT04488003|65803661|FG000|Allocated to Treatment|Death|4|||
23566082|NCT04488003|65803662|FG001|Allocated to Treatment|Death|0|||
23566083|NCT04488003|65803663|FG002|Allocated to Treatment|Death|0|||
23566084|NCT02762981|65803664|FG000|Overall Study|Adverse Event|2|||
23566085|NCT02762981|65803665|FG001|Overall Study|Adverse Event|3|||
23566086|NCT02762981|65803666|FG002|Overall Study|Adverse Event|1|||
23566087|NCT02762981|65803667|FG003|Overall Study|Adverse Event|1|||
23566088|NCT02762981|65803668|FG004|Overall Study|Adverse Event|3|||
23566089|NCT02762981|65803664|FG000|Overall Study|Physician Decision|0|||
23221789|NCT02848313|64553790|FG000|Overall Study|Lost to follow up|1|||
23221790|NCT02848313|64553791|FG001|Overall Study|Lost to follow up|0|||
23566090|NCT02762981|65803665|FG001|Overall Study|Physician Decision|1|||
23566091|NCT02762981|65803666|FG002|Overall Study|Physician Decision|0|||
23566092|NCT02762981|65803667|FG003|Overall Study|Physician Decision|0|||
23566093|NCT02762981|65803668|FG004|Overall Study|Physician Decision|1|||
23566094|NCT02762981|65803664|FG000|Overall Study|Disease progression|11|||
23628323|NCT00778921|66024709|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
23628324|NCT00778921|66024710|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23628325|NCT00778921|66024711|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
23157038|NCT01147744|64325414|FG005|Overall Study|Physician Decision|0|||
23157039|NCT01147744|64325415|FG006|Overall Study|Physician Decision|1|||
23157040|NCT01147744|64325409|FG000|Overall Study|Lack of Efficacy|11|||
23157041|NCT01147744|64325410|FG001|Overall Study|Lack of Efficacy|11|||
23157042|NCT01147744|64325411|FG002|Overall Study|Lack of Efficacy|9|||
23157043|NCT01147744|64325412|FG003|Overall Study|Lack of Efficacy|11|||
23157044|NCT01147744|64325413|FG004|Overall Study|Lack of Efficacy|13|||
23157045|NCT01147744|64325414|FG005|Overall Study|Lack of Efficacy|8|||
23157046|NCT01147744|64325415|FG006|Overall Study|Lack of Efficacy|7|||
23157047|NCT01147744|64325409|FG000|Overall Study|Adverse Event|1|||
23157048|NCT01147744|64325410|FG001|Overall Study|Adverse Event|2|||
23157049|NCT01147744|64325411|FG002|Overall Study|Adverse Event|3|||
23157050|NCT01147744|64325412|FG003|Overall Study|Adverse Event|0|||
23157051|NCT01147744|64325413|FG004|Overall Study|Adverse Event|2|||
23157052|NCT01147744|64325414|FG005|Overall Study|Adverse Event|1|||
23157053|NCT01147744|64325415|FG006|Overall Study|Adverse Event|2|||
23157054|NCT01147744|64325409|FG000|Overall Study|Withdrawal by Subject|8|||
23157055|NCT01147744|64325410|FG001|Overall Study|Withdrawal by Subject|4|||
23157056|NCT01147744|64325411|FG002|Overall Study|Withdrawal by Subject|2|||
23157057|NCT01147744|64325412|FG003|Overall Study|Withdrawal by Subject|2|||
23157058|NCT01147744|64325413|FG004|Overall Study|Withdrawal by Subject|2|||
23157059|NCT01147744|64325414|FG005|Overall Study|Withdrawal by Subject|5|||
23157060|NCT01147744|64325415|FG006|Overall Study|Withdrawal by Subject|2|||
23157061|NCT01147744|64325409|FG000|Overall Study|Lost to Follow-up|0|||
23157062|NCT01147744|64325410|FG001|Overall Study|Lost to Follow-up|1|||
23157063|NCT01147744|64325411|FG002|Overall Study|Lost to Follow-up|0|||
23157064|NCT01147744|64325412|FG003|Overall Study|Lost to Follow-up|0|||
23157065|NCT01147744|64325413|FG004|Overall Study|Lost to Follow-up|0|||
23157066|NCT01147744|64325414|FG005|Overall Study|Lost to Follow-up|0|||
23566095|NCT02762981|65803665|FG001|Overall Study|Disease progression|23|||
23566096|NCT02762981|65803666|FG002|Overall Study|Disease progression|4|||
23566097|NCT02762981|65803667|FG003|Overall Study|Disease progression|10|||
23327771|NCT01692626|64941026|FG000|Overall Study|Death|0|||
23327772|NCT01692626|64941027|FG001|Overall Study|Death|1|||
23327773|NCT01692626|64941026|FG000|Overall Study|Adverse Event|2|||
23327774|NCT01692626|64941027|FG001|Overall Study|Adverse Event|3|||
23566098|NCT02762981|65803668|FG004|Overall Study|Disease progression|1|||
23566099|NCT02762981|65803664|FG000|Overall Study|Enrolled not treated|1|||
23566100|NCT02762981|65803665|FG001|Overall Study|Enrolled not treated|5|||
23566101|NCT02762981|65803666|FG002|Overall Study|Enrolled not treated|0|||
23566102|NCT02762981|65803667|FG003|Overall Study|Enrolled not treated|2|||
23566103|NCT02762981|65803668|FG004|Overall Study|Enrolled not treated|0|||
23566104|NCT02762981|65803664|FG000|Overall Study|Other|2|||
23566105|NCT02762981|65803665|FG001|Overall Study|Other|3|||
23566106|NCT02762981|65803666|FG002|Overall Study|Other|1|||
23566107|NCT02762981|65803667|FG003|Overall Study|Other|0|||
23566108|NCT02762981|65803668|FG004|Overall Study|Other|0|||
23566109|NCT02762981|65803664|FG000|Overall Study|Missing|1|||
23566110|NCT02762981|65803665|FG001|Overall Study|Missing|0|||
23566111|NCT02762981|65803666|FG002|Overall Study|Missing|0|||
23566112|NCT02762981|65803667|FG003|Overall Study|Missing|0|||
23566113|NCT02762981|65803668|FG004|Overall Study|Missing|0|||
23566114|NCT02762981|65803664|FG000|Overall Study|Withdrawal by Subject|0|||
23566115|NCT02762981|65803665|FG001|Overall Study|Withdrawal by Subject|5|||
23566116|NCT02762981|65803666|FG002|Overall Study|Withdrawal by Subject|1|||
23566117|NCT02762981|65803667|FG003|Overall Study|Withdrawal by Subject|3|||
23566118|NCT02762981|65803668|FG004|Overall Study|Withdrawal by Subject|0|||
23566119|NCT01674621|65803669|FG000|Overall Study|Adverse Event|3|||
23157067|NCT01147744|64325415|FG006|Overall Study|Lost to Follow-up|0|||
23157068|NCT01147744|64325409|FG000|Overall Study|Sponsor decision to amend protocol|7|||
23157069|NCT01147744|64325410|FG001|Overall Study|Sponsor decision to amend protocol|4|||
23157070|NCT01147744|64325411|FG002|Overall Study|Sponsor decision to amend protocol|2|||
23157071|NCT01147744|64325412|FG003|Overall Study|Sponsor decision to amend protocol|5|||
23327775|NCT01692626|64941026|FG000|Overall Study|Protocol Violation|1|||
23566120|NCT01674621|65803670|FG001|Overall Study|Adverse Event|2|||
23566121|NCT01674621|65803671|FG002|Overall Study|Adverse Event|5|||
23566122|NCT01674621|65803672|FG003|Overall Study|Adverse Event|5|||
23566123|NCT01674621|65803673|FG004|Overall Study|Adverse Event|1|||
23566124|NCT01674621|65803669|FG000|Overall Study|Inability to Complete Study Procedures|0|||
23157072|NCT01147744|64325413|FG004|Overall Study|Sponsor decision to amend protocol|7|||
23157073|NCT01147744|64325414|FG005|Overall Study|Sponsor decision to amend protocol|2|||
23157074|NCT01147744|64325415|FG006|Overall Study|Sponsor decision to amend protocol|6|||
23157075|NCT01147744|64325409|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23157076|NCT01147744|64325410|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23157077|NCT01147744|64325411|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23566125|NCT01674621|65803670|FG001|Overall Study|Inability to Complete Study Procedures|0|||
23566126|NCT01674621|65803671|FG002|Overall Study|Inability to Complete Study Procedures|0|||
23566127|NCT01674621|65803672|FG003|Overall Study|Inability to Complete Study Procedures|0|||
23327776|NCT01692626|64941027|FG001|Overall Study|Protocol Violation|2|||
23327777|NCT01692626|64941026|FG000|Overall Study|Withdrawal by Subject|1|||
23327778|NCT01692626|64941027|FG001|Overall Study|Withdrawal by Subject|0|||
23327779|NCT01254643|64941028|FG000|Overall Study|Withdrawal by Subject|1|||
23327780|NCT02070965|64941029|FG000|Overall Study|Lost to Follow-up|0|||
23327781|NCT02070965|64941030|FG001|Overall Study|Lost to Follow-up|1|||
23327782|NCT02070965|64941031|FG002|Overall Study|Lost to Follow-up|0|||
23327783|NCT02070965|64941029|FG000|Overall Study|Withdrawal by Subject|1|||
23327784|NCT02070965|64941030|FG001|Overall Study|Withdrawal by Subject|1|||
23327785|NCT02070965|64941031|FG002|Overall Study|Withdrawal by Subject|1|||
23327786|NCT02070965|64941029|FG000|Overall Study|Subject moved|1|||
23157078|NCT01147744|64325412|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23157079|NCT01147744|64325413|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23157080|NCT01147744|64325414|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23157081|NCT01147744|64325415|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23157082|NCT00382720|64325421|FG000|Overall Study|Adverse Event|21|||
23157083|NCT00382720|64325422|FG001|Overall Study|Adverse Event|23|||
23157084|NCT00382720|64325423|FG002|Overall Study|Adverse Event|15|||
23157085|NCT00382720|64325421|FG000|Overall Study|Protocol Violation|2|||
23157086|NCT00382720|64325422|FG001|Overall Study|Protocol Violation|5|||
23157087|NCT00382720|64325423|FG002|Overall Study|Protocol Violation|1|||
23327787|NCT02070965|64941030|FG001|Overall Study|Subject moved|0|||
23327788|NCT02070965|64941031|FG002|Overall Study|Subject moved|0|||
23327789|NCT04390113|64941034|FG000|Overall Study|Not Treated|0|||
23327790|NCT04390113|64941035|FG001|Overall Study|Not Treated|1|||
23327791|NCT04390113|64941034|FG000|Overall Study|Adverse Event|1|||
23327792|NCT04390113|64941035|FG001|Overall Study|Adverse Event|0|||
23327793|NCT04390113|64941034|FG000|Overall Study|Death|2|||
23327794|NCT04390113|64941035|FG001|Overall Study|Death|1|||
23327795|NCT04390113|64941034|FG000|Overall Study|Physician Decision|1|||
23327796|NCT04390113|64941035|FG001|Overall Study|Physician Decision|3|||
23327797|NCT04390113|64941034|FG000|Overall Study|Study Terminated by Sponsor|5|||
23327798|NCT04390113|64941035|FG001|Overall Study|Study Terminated by Sponsor|3|||
23327799|NCT04390113|64941034|FG000|Overall Study|Withdrawal by Subject|10|||
23327800|NCT04390113|64941035|FG001|Overall Study|Withdrawal by Subject|5|||
23327801|NCT04390113|64941034|FG000|Overall Study|Other|1|||
23327802|NCT04390113|64941035|FG001|Overall Study|Other|0|||
23327803|NCT04390113|64941034|FG000|Overall Study|Missing|0|||
23327804|NCT04390113|64941035|FG001|Overall Study|Missing|1|||
23327805|NCT01954056|64941036|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
23327806|NCT01954056|64941037|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
23327807|NCT00858273|64941038|FG000|Overall Study|Protocol Violation|3|||
23327808|NCT00858273|64941039|FG001|Overall Study|Protocol Violation|5|||
23327809|NCT04314037|64941043|FG000|Treatment Period 2|Adverse Event|1|||
23327810|NCT04314037|64941044|FG001|Treatment Period 2|Adverse Event|0|||
23327811|NCT04314037|64941043|FG000|Treatment Period 3|Protocol Violation|1|||
23327812|NCT04314037|64941044|FG001|Treatment Period 3|Protocol Violation|0|||
23327813|NCT04314037|64941043|FG000|Treatment Period 3|Adverse Event|0|||
23327814|NCT04314037|64941044|FG001|Treatment Period 3|Adverse Event|1|||
23327815|NCT03472014|64941045|FG000|Overall Study|Lost to Follow-up|4|||
23566128|NCT01674621|65803673|FG004|Overall Study|Inability to Complete Study Procedures|2|||
23566129|NCT01674621|65803669|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
23566130|NCT01674621|65803670|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
23566131|NCT01674621|65803671|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
23566132|NCT01674621|65803672|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
23566133|NCT01674621|65803673|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
23566134|NCT01674621|65803669|FG000|Overall Study|Withdrawal by Subject|2|||
23566135|NCT01674621|65803670|FG001|Overall Study|Withdrawal by Subject|5|||
23566136|NCT01674621|65803671|FG002|Overall Study|Withdrawal by Subject|2|||
23157088|NCT00382720|64325421|FG000|Overall Study|Death|0|||
23157089|NCT00382720|64325422|FG001|Overall Study|Death|1|||
23157090|NCT00382720|64325423|FG002|Overall Study|Death|2|||
23157091|NCT00382720|64325421|FG000|Overall Study|Progressive disease|37|||
23157092|NCT00382720|64325422|FG001|Overall Study|Progressive disease|28|||
23327816|NCT02105467|64941051|FG000|Period 1|Lost to Follow-up|1|||
23327817|NCT02105467|64941052|FG001|Period 1|Lost to Follow-up|0|||
23327818|NCT02105467|64941051|FG000|Period 1|Death|1|||
23327819|NCT02105467|64941052|FG001|Period 1|Death|0|||
23566137|NCT01674621|65803672|FG003|Overall Study|Withdrawal by Subject|0|||
23157093|NCT00382720|64325423|FG002|Overall Study|Progressive disease|38|||
23157094|NCT00382720|64325421|FG000|Overall Study|Withdrew consent|1|||
23157095|NCT00382720|64325422|FG001|Overall Study|Withdrew consent|1|||
23327820|NCT02105467|64941051|FG000|Period 2|Lost to Follow-up|1|||
23327821|NCT02105467|64941052|FG001|Period 2|Lost to Follow-up|0|||
23327822|NCT02105467|64941051|FG000|Period 2|Death|1|||
23327823|NCT02105467|64941052|FG001|Period 2|Death|0|||
23327824|NCT02105467|64941051|FG000|Period 2|Withdrawal by Subject|0|||
23327825|NCT02105467|64941052|FG001|Period 2|Withdrawal by Subject|2|||
23157096|NCT00382720|64325423|FG002|Overall Study|Withdrew consent|2|||
23157097|NCT00382720|64325421|FG000|Overall Study|Withdrawal by Subject|11|||
23157098|NCT00382720|64325422|FG001|Overall Study|Withdrawal by Subject|20|||
23157099|NCT00382720|64325423|FG002|Overall Study|Withdrawal by Subject|12|||
23157100|NCT00382720|64325421|FG000|Overall Study|Surgery|1|||
23221791|NCT00918346|64553794|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
23221792|NCT00918346|64553795|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
23221793|NCT00126425|64553800|FG000|Overall Study|Withdrawal by Subject|17|||
23221794|NCT00126425|64553801|FG001|Overall Study|Withdrawal by Subject|1|||
23221795|NCT00126425|64553800|FG000|Overall Study|Lost to Follow-up|8|||
23221796|NCT00126425|64553801|FG001|Overall Study|Lost to Follow-up|4|||
23221797|NCT00126425|64553800|FG000|Overall Study|Protocol Violation|9|||
23221798|NCT00126425|64553801|FG001|Overall Study|Protocol Violation|6|||
23221799|NCT00126425|64553800|FG000|Overall Study|Adverse Event|1|||
23221800|NCT00126425|64553801|FG001|Overall Study|Adverse Event|0|||
23221801|NCT00126425|64553800|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
23221802|NCT00126425|64553801|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
23221803|NCT00126425|64553800|FG000|Overall Study|Other|5|||
23221804|NCT00126425|64553801|FG001|Overall Study|Other|0|||
23221805|NCT00572728|64553804|FG000|Overall Study|Withdrawal by Subject|10|||
23221806|NCT00572728|64553804|FG000|Overall Study|Ineligible|3|||
23221807|NCT00572728|64553804|FG000|Overall Study|Enrolled under Amendment 4|5|||
23221808|NCT00572728|64553804|FG000|Overall Study|Offstudy due to complicating disease|1|||
23221809|NCT00572728|64553804|FG000|Overall Study|FLT1 not completed|4|||
23221810|NCT00572728|64553804|FG000|Overall Study|First Chemotherapy not initiated|2|||
23221811|NCT00572728|64553804|FG000|Overall Study|FLT2 not completed|5|||
23221812|NCT00572728|64553804|FG000|Overall Study|Second chemotherapy not initiated|1|||
23327826|NCT02105467|64941051|FG000|Period 3|Lost to Follow-up|0|||
23327827|NCT02105467|64941052|FG001|Period 3|Lost to Follow-up|1|||
23628326|NCT00778921|66024709|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
23628327|NCT00778921|66024710|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
23157101|NCT00382720|64325422|FG001|Overall Study|Surgery|1|||
23628328|NCT00778921|66024711|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
23157102|NCT00382720|64325423|FG002|Overall Study|Surgery|4|||
23157103|NCT00382720|64325421|FG000|Overall Study|Patient did not receive study medication|1|||
23157104|NCT00382720|64325422|FG001|Overall Study|Patient did not receive study medication|1|||
23327828|NCT00114140|64941053|FG000|Overall Study|Protocol Violation|7|||
23327829|NCT03620708|64941056|FG000|Overall Study|Lost to Follow-up|1|||
23327830|NCT03620708|64941057|FG001|Overall Study|Lost to Follow-up|1|||
23327831|NCT03620708|64941058|FG002|Overall Study|Lost to Follow-up|2|||
23327832|NCT03620708|64941056|FG000|Overall Study|Withdrawal by Subject|0|||
23327833|NCT03620708|64941057|FG001|Overall Study|Withdrawal by Subject|0|||
23566138|NCT01674621|65803673|FG004|Overall Study|Withdrawal by Subject|1|||
23566139|NCT01674621|65803669|FG000|Overall Study|Other than specified|0|||
23566140|NCT01674621|65803670|FG001|Overall Study|Other than specified|1|||
23157105|NCT00382720|64325423|FG002|Overall Study|Patient did not receive study medication|4|||
23157106|NCT00382720|64325421|FG000|Overall Study|Clinically progressive disease|0|||
23157107|NCT00382720|64325422|FG001|Overall Study|Clinically progressive disease|1|||
23157108|NCT00382720|64325423|FG002|Overall Study|Clinically progressive disease|0|||
23157109|NCT00382720|64325421|FG000|Overall Study|Good prognosis|0|||
23157110|NCT00382720|64325422|FG001|Overall Study|Good prognosis|1|||
23157111|NCT00382720|64325423|FG002|Overall Study|Good prognosis|0|||
23157112|NCT00382720|64325421|FG000|Overall Study|Investigator/Clinical decision|5|||
23157113|NCT00382720|64325422|FG001|Overall Study|Investigator/Clinical decision|6|||
23566141|NCT01674621|65803671|FG002|Overall Study|Other than specified|0|||
23566142|NCT01674621|65803672|FG003|Overall Study|Other than specified|0|||
23566143|NCT01674621|65803673|FG004|Overall Study|Other than specified|2|||
23566144|NCT01354106|65803678|FG000|Overall Study|Withdrawal by Subject|2|||
23566145|NCT00709059|65803680|FG000|Overall Study|Lost to Follow-up|34|||
23566146|NCT00709059|65803680|FG000|Overall Study|Withdrawal by Subject|19|||
23566147|NCT00709059|65803680|FG000|Overall Study|Physician Decision|7|||
23566148|NCT00709059|65803680|FG000|Overall Study|Disease complication|3|||
23157114|NCT00382720|64325423|FG002|Overall Study|Investigator/Clinical decision|6|||
23221813|NCT00572728|64553804|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
23221814|NCT00572728|64553804|FG000|Overall Study|Pathology missing|1|||
23221815|NCT03417505|64553807|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
23221816|NCT03417505|64553808|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
23221817|NCT02707601|64553809|FG000|Overall Study|Death|0|||
23157115|NCT00382720|64325421|FG000|Overall Study|Discontinued at end of study|0|||
23157116|NCT00382720|64325422|FG001|Overall Study|Discontinued at end of study|1|||
23221818|NCT02707601|64553810|FG001|Overall Study|Death|1|||
23327834|NCT03620708|64941058|FG002|Overall Study|Withdrawal by Subject|1|||
23221819|NCT02707601|64553809|FG000|Overall Study|Lack of Efficacy|0|||
23327835|NCT00828568|64941061|FG000|Randomized|Withdrawal by Subject|1|||
23566149|NCT00709059|65803680|FG000|Overall Study|Side effects|20|||
23566150|NCT00709059|65803680|FG000|Overall Study|Serious side effects|11|||
23157117|NCT00382720|64325423|FG002|Overall Study|Discontinued at end of study|2|||
23157118|NCT03891264|64325424|FG000|Overall Study|Adverse Event|1|||
23157119|NCT03891264|64325424|FG000|Overall Study|Withdrawal by Subject|2|||
23157120|NCT03891264|64325424|FG000|Overall Study|Physician Decision|2|||
23157121|NCT02375724|64325425|FG000|Overall Study|Lack of Efficacy|1|||
23157122|NCT02375724|64325426|FG001|Overall Study|Lack of Efficacy|1|||
23157123|NCT02375724|64325425|FG000|Overall Study|Withdrawal by Subject|1|||
23157124|NCT02375724|64325426|FG001|Overall Study|Withdrawal by Subject|1|||
23157125|NCT02375724|64325425|FG000|Overall Study|Lost to Follow-up|1|||
23157126|NCT02375724|64325426|FG001|Overall Study|Lost to Follow-up|0|||
23157127|NCT02375724|64325425|FG000|Overall Study|Protocol Violation|1|||
23157128|NCT02375724|64325426|FG001|Overall Study|Protocol Violation|0|||
23157129|NCT02375724|64325425|FG000|Overall Study|Adverse Event|2|||
23157130|NCT02375724|64325426|FG001|Overall Study|Adverse Event|4|||
23157131|NCT02163187|64325427|FG000|Overall Study|Device removed|1|||
23157132|NCT02163187|64325428|FG001|Overall Study|Device removed|0|||
23157133|NCT02163187|64325427|FG000|Overall Study|Progressive disease|1|||
23157134|NCT02163187|64325428|FG001|Overall Study|Progressive disease|0|||
23157135|NCT01365039|64325432|FG000|Overall Study|Study related symptoms and complaints|1|||
23157136|NCT01365039|64325433|FG001|Overall Study|Study related symptoms and complaints|0|||
23157137|NCT04353284|64325435|FG000|Overall Study|Adverse Event|1|||
23157138|NCT04353284|64325436|FG001|Overall Study|Adverse Event|1|||
23157139|NCT04353284|64325435|FG000|Overall Study|Lost to Follow-up|1|||
23157140|NCT04353284|64325436|FG001|Overall Study|Lost to Follow-up|0|||
23157141|NCT01392677|64325439|FG000|Overall Study|Adverse Event|3|||
23157142|NCT01392677|64325440|FG001|Overall Study|Adverse Event|1|||
23157143|NCT01392677|64325439|FG000|Overall Study|Withdrawal by Subject|0|||
23157144|NCT01392677|64325440|FG001|Overall Study|Withdrawal by Subject|2|||
23157145|NCT01392677|64325439|FG000|Overall Study|Incorrect enrollment|2|||
23157146|NCT01392677|64325440|FG001|Overall Study|Incorrect enrollment|3|||
23157147|NCT01392677|64325439|FG000|Overall Study|Other reason|3|||
23157148|NCT01392677|64325440|FG001|Overall Study|Other reason|2|||
23157149|NCT02257372|64325441|FG000|Overall Study|Adverse Event|3|||
23157150|NCT02257372|64325442|FG001|Overall Study|Adverse Event|7|||
23157151|NCT02257372|64325441|FG000|Overall Study|Lack of Efficacy|2|||
23157152|NCT02257372|64325442|FG001|Overall Study|Lack of Efficacy|1|||
23157153|NCT02257372|64325441|FG000|Overall Study|Protocol Violation|1|||
23157154|NCT02257372|64325442|FG001|Overall Study|Protocol Violation|1|||
23157155|NCT02257372|64325441|FG000|Overall Study|Lost to Follow-up|0|||
23157156|NCT02257372|64325442|FG001|Overall Study|Lost to Follow-up|1|||
23157157|NCT02257372|64325441|FG000|Overall Study|Withdrew consent|1|||
23157158|NCT02257372|64325442|FG001|Overall Study|Withdrew consent|0|||
23157159|NCT01376778|64325443|FG000|Overall Study|Lost to Follow-up|3|||
23157160|NCT01376778|64325444|FG001|Overall Study|Lost to Follow-up|2|||
23157161|NCT01368042|64325445|FG000|Overall Study|Death|14|||
23157162|NCT01368042|64325445|FG000|Overall Study|Protocol Violation|11|||
23157163|NCT01368042|64325445|FG000|Overall Study|Lost to Follow-up|4|||
23157164|NCT01368042|64325445|FG000|Overall Study|Transplanted|1|||
23157165|NCT01942148|64325448|FG000|Overall Study|Adverse Event|4|||
23157166|NCT01942148|64325448|FG000|Overall Study|Lack of Efficacy|2|||
23157167|NCT01942148|64325448|FG000|Overall Study|Physician Decision|11|||
23157168|NCT01942148|64325448|FG000|Overall Study|Protocol Violation|1|||
23157169|NCT01942148|64325448|FG000|Overall Study|Withdrawal by Subject|8|||
23157170|NCT01942148|64325448|FG000|Overall Study|Use of the prohibition medicine|1|||
23157171|NCT03700320|64325449|FG000|Overall Study|Adverse Event|5|||
23157172|NCT03700320|64325450|FG001|Overall Study|Adverse Event|31|||
23566151|NCT01375205|65803681|FG000|Overall Study|Lost to Follow-up|15|||
23566152|NCT01375205|65803682|FG001|Overall Study|Lost to Follow-up|12|||
23566153|NCT01375205|65803681|FG000|Overall Study|Withdrawal by Subject|6|||
23566154|NCT01375205|65803682|FG001|Overall Study|Withdrawal by Subject|1|||
23566155|NCT02904902|65803683|FG000|Overall Study|Withdrawal by Subject|1|||
23566156|NCT03292146|65803687|FG000|Baseline to 12 Months|Relocation|1|||
23566157|NCT03292146|65803688|FG001|Baseline to 12 Months|Relocation|0|||
23566158|NCT03292146|65803687|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
23157173|NCT03700320|64325449|FG000|Overall Study|Lack of Efficacy|2|||
23157174|NCT03700320|64325450|FG001|Overall Study|Lack of Efficacy|5|||
23157175|NCT03700320|64325449|FG000|Overall Study|Withdrawal by Subject|29|||
23157176|NCT03700320|64325450|FG001|Overall Study|Withdrawal by Subject|75|||
23157177|NCT03700320|64325449|FG000|Overall Study|Lost to Follow-up|16|||
23157178|NCT03700320|64325450|FG001|Overall Study|Lost to Follow-up|23|||
23157179|NCT03700320|64325449|FG000|Overall Study|Pregnancy|2|||
23566159|NCT03292146|65803688|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
23157180|NCT03700320|64325450|FG001|Overall Study|Pregnancy|4|||
23157181|NCT03700320|64325449|FG000|Overall Study|Protocol Deviation|7|||
23157182|NCT03700320|64325450|FG001|Overall Study|Protocol Deviation|31|||
23157183|NCT03700320|64325449|FG000|Overall Study|Non-compliance with Study Drug|1|||
23157184|NCT03700320|64325450|FG001|Overall Study|Non-compliance with Study Drug|3|||
23157185|NCT03700320|64325449|FG000|Overall Study|Reason not Specified|0|||
23157186|NCT03700320|64325450|FG001|Overall Study|Reason not Specified|1|||
23157187|NCT03104075|64325451|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
23157188|NCT03104075|64325452|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
23157189|NCT02844920|64325453|FG000|Overall Study|Lost to Follow-up|2|||
23157190|NCT01553136|64325459|FG000|Overall Study|Adverse Event|3|||
23157191|NCT01553136|64325460|FG001|Overall Study|Adverse Event|2|||
23157192|NCT01553136|64325459|FG000|Overall Study|Withdrawal by Subject|2|||
23157193|NCT01553136|64325460|FG001|Overall Study|Withdrawal by Subject|3|||
23157194|NCT01553136|64325459|FG000|Overall Study|Lost to Follow-up|4|||
23157195|NCT01553136|64325460|FG001|Overall Study|Lost to Follow-up|10|||
23157196|NCT01553136|64325459|FG000|Overall Study|Physician Decision|2|||
23157197|NCT01553136|64325460|FG001|Overall Study|Physician Decision|3|||
23157198|NCT01553136|64325459|FG000|Overall Study|Scheduling Difficulties|5|||
23157199|NCT01553136|64325460|FG001|Overall Study|Scheduling Difficulties|4|||
23157200|NCT02830776|64325462|FG000|Overall Study|Lost to Follow-up|1|||
23157201|NCT01186796|64325463|FG000|Overall Study|Adverse Event|3|||
23157202|NCT01186796|64325464|FG001|Overall Study|Adverse Event|0|||
23157203|NCT01186796|64325463|FG000|Overall Study|Withdrawal by Subject|1|||
23157204|NCT01186796|64325464|FG001|Overall Study|Withdrawal by Subject|1|||
23157205|NCT01186796|64325463|FG000|Overall Study|Protocol Violation|0|||
23157206|NCT01186796|64325464|FG001|Overall Study|Protocol Violation|1|||
23157207|NCT00932360|64325465|FG000|Washout (One Week)|Withdrawal by Subject|0|||
23157208|NCT00932360|64325466|FG001|Washout (One Week)|Withdrawal by Subject|0|||
23157209|NCT00932360|64325467|FG002|Washout (One Week)|Withdrawal by Subject|0|||
23157210|NCT00932360|64325468|FG003|Washout (One Week)|Withdrawal by Subject|0|||
23157211|NCT00932360|64325469|FG004|Washout (One Week)|Withdrawal by Subject|2|||
23157212|NCT00932360|64325470|FG005|Washout (One Week)|Withdrawal by Subject|0|||
23157213|NCT01202279|64325471|FG000|Overall Study|Adverse Event|8|||
23157214|NCT01202279|64325472|FG001|Overall Study|Adverse Event|6|||
23157215|NCT01202279|64325471|FG000|Overall Study|Withdrawal by Subject|13|||
23157216|NCT01202279|64325472|FG001|Overall Study|Withdrawal by Subject|10|||
23157217|NCT01202279|64325471|FG000|Overall Study|Physician Decision|0|||
23157218|NCT01202279|64325472|FG001|Overall Study|Physician Decision|1|||
23157219|NCT01202279|64325471|FG000|Overall Study|Lost to Follow-up|10|||
23157220|NCT01202279|64325472|FG001|Overall Study|Lost to Follow-up|7|||
23157221|NCT01202279|64325471|FG000|Overall Study|Protocol Violation|1|||
23157222|NCT01202279|64325472|FG001|Overall Study|Protocol Violation|1|||
23157223|NCT01202279|64325471|FG000|Overall Study|study compliance|5|||
23157224|NCT01202279|64325472|FG001|Overall Study|study compliance|2|||
23157225|NCT01245387|64325473|FG000|Overall Study|Lost to Follow-up|106|||
23157226|NCT01245387|64325473|FG000|Overall Study|Lack of Efficacy|195|||
23157227|NCT01245387|64325473|FG000|Overall Study|Adverse Event|9|||
23157228|NCT01245387|64325473|FG000|Overall Study|Death|3|||
23157229|NCT01245387|64325473|FG000|Overall Study|Other|131|||
23157230|NCT01245387|64325473|FG000|Overall Study|Missing discontinuation status|369|||
23157231|NCT04353596|64325474|FG000|Overall Study|Protocol Violation|4|||
23157232|NCT04353596|64325475|FG001|Overall Study|Protocol Violation|4|||
23157233|NCT04353596|64325474|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
23157234|NCT04353596|64325475|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
23157235|NCT00424749|64325476|FG000|Overall Study|Withdrawal by Subject|1|||
23157236|NCT01128361|64325477|FG000|Overall Study|Lost to Follow-up|0|||
23157237|NCT01128361|64325478|FG001|Overall Study|Lost to Follow-up|1|||
23157238|NCT01128361|64325477|FG000|Overall Study|Withdrawal by Subject|5|||
23157239|NCT01128361|64325478|FG001|Overall Study|Withdrawal by Subject|2|||
23157240|NCT00470054|64325479|FG000|Overall Study|Ineligible|1|||
23221820|NCT02707601|64553810|FG001|Overall Study|Lack of Efficacy|1|||
23221821|NCT02707601|64553809|FG000|Overall Study|Investigator's Discretion|1|||
23221822|NCT02707601|64553810|FG001|Overall Study|Investigator's Discretion|0|||
23221823|NCT02707601|64553809|FG000|Overall Study|Withdrew Consent|0|||
23221824|NCT02707601|64553810|FG001|Overall Study|Withdrew Consent|1|||
23221825|NCT02707601|64553809|FG000|Overall Study|Lost to Follow-up|1|||
23221826|NCT02707601|64553810|FG001|Overall Study|Lost to Follow-up|1|||
23221827|NCT02707601|64553809|FG000|Overall Study|Participants Randomized but Not Treated|2|||
23221828|NCT02707601|64553810|FG001|Overall Study|Participants Randomized but Not Treated|0|||
23221829|NCT02688153|64553811|FG000|Overall Study|Death|7|||
23221830|NCT02688153|64553812|FG001|Overall Study|Death|5|||
23157241|NCT04416555|64325480|FG000|Overall Study|Withdrawal by Subject|0|||
23157242|NCT04416555|64325481|FG001|Overall Study|Withdrawal by Subject|3|||
23157243|NCT00516048|64325482|FG000|Overall Study|Death|0|||
23157244|NCT00516048|64325483|FG001|Overall Study|Death|0|||
23157245|NCT00516048|64325484|FG002|Overall Study|Death|1|||
23157246|NCT00516048|64325482|FG000|Overall Study|Subject Decision|0|||
23157247|NCT00516048|64325483|FG001|Overall Study|Subject Decision|2|||
23157248|NCT00516048|64325484|FG002|Overall Study|Subject Decision|0|||
23157249|NCT01444742|64325487|FG000|Overall Study|Death|1|||
23157250|NCT03007979|64325489|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
23157251|NCT01721057|64325490|FG000|Treatment Period|Withdrawal by Subject|11|||
23566160|NCT03292146|65803687|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
23566161|NCT03292146|65803688|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
23566162|NCT03292146|65803687|FG000|12 Months to 24 Months|Planning pregnancy|2|||
23566163|NCT03292146|65803688|FG001|12 Months to 24 Months|Planning pregnancy|2|||
23566164|NCT03292146|65803687|FG000|12 Months to 24 Months|Personal reasons|1|||
23566165|NCT03292146|65803688|FG001|12 Months to 24 Months|Personal reasons|0|||
23566166|NCT03292146|65803687|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
23566167|NCT03292146|65803688|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
23566168|NCT01965158|65803694|FG000|Overall Study|Adverse Event|14|||
23566169|NCT01965158|65803695|FG001|Overall Study|Adverse Event|5|||
23221831|NCT02688153|64553811|FG000|Overall Study|Withdrawal by Subject|4|||
23221832|NCT02688153|64553812|FG001|Overall Study|Withdrawal by Subject|2|||
23221833|NCT02688153|64553811|FG000|Overall Study|Valve Explant|1|||
23221834|NCT02688153|64553812|FG001|Overall Study|Valve Explant|0|||
23221835|NCT02688153|64553811|FG000|Overall Study|Conversion to Commercial Valve|3|||
23221836|NCT02688153|64553812|FG001|Overall Study|Conversion to Commercial Valve|0|||
23221837|NCT02327078|64553813|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
23221838|NCT02327078|64553814|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
23221839|NCT02327078|64553815|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
23221840|NCT02327078|64553816|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
23221841|NCT02327078|64553817|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
23221842|NCT02327078|64553818|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
23221843|NCT02327078|64553819|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
23221844|NCT02327078|64553820|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
23221845|NCT02327078|64553821|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
23221846|NCT02327078|64553813|FG000|Overall Study|Death|2|||
23443160|NCT00607087|65362363|FG002|Period 1|Lost to Follow-up|0|||
23443161|NCT00607087|65362361|FG000|Period 1|Other reason|0|||
23443162|NCT00607087|65362362|FG001|Period 1|Other reason|4|||
23443163|NCT00607087|65362363|FG002|Period 1|Other reason|2|||
23443164|NCT00607087|65362361|FG000|Period 2|Withdrawal by Subject|0|||
23443165|NCT00607087|65362362|FG001|Period 2|Withdrawal by Subject|1|||
23566170|NCT01965158|65803694|FG000|Overall Study|Withdrawal by Subject|16|||
23566171|NCT01965158|65803695|FG001|Overall Study|Withdrawal by Subject|24|||
23566172|NCT01965158|65803694|FG000|Overall Study|Lost to Follow-up|7|||
23566173|NCT01965158|65803695|FG001|Overall Study|Lost to Follow-up|5|||
23566174|NCT01965158|65803694|FG000|Overall Study|Protocol Violation|1|||
23566175|NCT01965158|65803695|FG001|Overall Study|Protocol Violation|1|||
23566176|NCT01965158|65803694|FG000|Overall Study|Other - Miscellaneous|3|||
23566177|NCT01965158|65803695|FG001|Overall Study|Other - Miscellaneous|0|||
23566178|NCT03714022|65803700|FG000|Overall Study|Adverse Event|1|||
23566179|NCT03714022|65803701|FG001|Overall Study|Adverse Event|0|||
23566180|NCT03714022|65803700|FG000|Overall Study|Consent withdrawal|0|||
23566181|NCT03714022|65803701|FG001|Overall Study|Consent withdrawal|1|||
23566182|NCT03714022|65803700|FG000|Overall Study|Lost to Follow-up|3|||
23566183|NCT03714022|65803701|FG001|Overall Study|Lost to Follow-up|2|||
23566184|NCT03077620|65803704|FG000|Overall Study|Unable to place lumbar catheter|1|||
23566185|NCT03077620|65803705|FG001|Overall Study|Unable to place lumbar catheter|0|||
23566186|NCT03077620|65803706|FG002|Overall Study|Unable to place lumbar catheter|1|||
23566187|NCT03077620|65803707|FG003|Overall Study|Unable to place lumbar catheter|0|||
23566188|NCT03077620|65803704|FG000|Overall Study|Withdrawal by Subject|0|||
23566189|NCT03077620|65803705|FG001|Overall Study|Withdrawal by Subject|1|||
23566190|NCT03077620|65803706|FG002|Overall Study|Withdrawal by Subject|0|||
23566191|NCT03077620|65803707|FG003|Overall Study|Withdrawal by Subject|0|||
23566192|NCT03077620|65803704|FG000|Overall Study|Physician Decision|0|||
23221847|NCT02327078|64553814|FG001|Overall Study|Death|4|||
23221848|NCT02327078|64553815|FG002|Overall Study|Death|10|||
23443166|NCT00607087|65362363|FG002|Period 2|Withdrawal by Subject|1|||
23443167|NCT00607087|65362361|FG000|Period 2|Other reason|1|||
23443168|NCT00607087|65362362|FG001|Period 2|Other reason|1|||
23443169|NCT00607087|65362363|FG002|Period 2|Other reason|0|||
23443170|NCT00607087|65362361|FG000|Period 2|Adverse Event|0|||
23443171|NCT00607087|65362362|FG001|Period 2|Adverse Event|1|||
23443172|NCT00607087|65362363|FG002|Period 2|Adverse Event|3|||
23443173|NCT00607087|65362361|FG000|Period 2|Poor compliance to protocol|0|||
23443174|NCT00607087|65362362|FG001|Period 2|Poor compliance to protocol|0|||
23566193|NCT03077620|65803705|FG001|Overall Study|Physician Decision|0|||
23566194|NCT03077620|65803706|FG002|Overall Study|Physician Decision|1|||
23566195|NCT03077620|65803707|FG003|Overall Study|Physician Decision|0|||
23566196|NCT03528174|65803708|FG000|Overall Study|Adverse Event|1|||
23566197|NCT03528174|65803708|FG000|Overall Study|sensors dislodged|1|||
23566198|NCT00980005|65803709|FG000|Overall Study|Withdrawal by Subject|6|||
23566199|NCT00980005|65803710|FG001|Overall Study|Withdrawal by Subject|17|||
23566200|NCT00980005|65803709|FG000|Overall Study|Lost to Follow-up|37|||
23443175|NCT00607087|65362363|FG002|Period 2|Poor compliance to protocol|1|||
23443176|NCT00607087|65362361|FG000|Period 3|Withdrawal by Subject|2|||
23443177|NCT00607087|65362362|FG001|Period 3|Withdrawal by Subject|1|||
23443178|NCT00607087|65362363|FG002|Period 3|Withdrawal by Subject|0|||
23443179|NCT00607087|65362361|FG000|Period 3|Adverse Event|0|||
23443180|NCT00607087|65362362|FG001|Period 3|Adverse Event|1|||
23443181|NCT00607087|65362363|FG002|Period 3|Adverse Event|0|||
23443182|NCT01687101|65362364|FG000|Overall Study|Lost to Follow-up|7|||
23443183|NCT01514201|65366339|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
23443184|NCT01514201|65366340|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443185|NCT01514201|65366341|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443186|NCT01514201|65366342|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443187|NCT01514201|65366339|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443188|NCT01514201|65366340|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
23443189|NCT01514201|65366341|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
23443190|NCT01514201|65366342|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443191|NCT01514201|65366339|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
23443192|NCT01514201|65366340|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
23443193|NCT01514201|65366341|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
23443194|NCT01514201|65366342|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
23443195|NCT01514201|65366339|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
23443196|NCT01514201|65366340|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
23443197|NCT01514201|65366341|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443198|NCT01514201|65366342|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443199|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
23443200|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
23443201|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
23443202|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
23443203|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
23443204|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
23443205|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
23443206|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
23443207|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
23443208|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
23443209|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
23443210|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
23443211|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443212|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443213|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
23443214|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
23443215|NCT01514201|65366339|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
23443216|NCT01514201|65366340|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
23443217|NCT01514201|65366341|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
23443218|NCT01514201|65366342|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
23443219|NCT01514201|65366339|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443220|NCT01514201|65366340|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443221|NCT01514201|65366341|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
23443222|NCT01514201|65366342|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
23443223|NCT01514201|65366339|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443224|NCT01514201|65366340|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443225|NCT01514201|65366341|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
23443226|NCT01514201|65366342|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
23443227|NCT01514201|65366339|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
23443228|NCT01514201|65366340|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
23628329|NCT00778921|66024709|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
23157252|NCT01721057|64325491|FG001|Treatment Period|Withdrawal by Subject|5|||
23157253|NCT01721057|64325492|FG002|Treatment Period|Withdrawal by Subject|8|||
23157254|NCT01721057|64325493|FG003|Treatment Period|Withdrawal by Subject|0|||
23157255|NCT01721057|64325494|FG004|Treatment Period|Withdrawal by Subject|0|||
23157256|NCT01721057|64325495|FG005|Treatment Period|Withdrawal by Subject|0|||
23157257|NCT01721057|64325496|FG006|Treatment Period|Withdrawal by Subject|0|||
23157258|NCT01721057|64325490|FG000|Treatment Period|Adverse Event|7|||
23443229|NCT01514201|65366341|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
23443230|NCT01514201|65366342|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
23443231|NCT00377858|65366345|FG000|Overall Study|Withdrawal by Subject|12|||
23443232|NCT00377858|65366346|FG001|Overall Study|Withdrawal by Subject|11|||
23443233|NCT00377858|65366345|FG000|Overall Study|Lost to Follow-up|6|||
23443234|NCT00377858|65366346|FG001|Overall Study|Lost to Follow-up|1|||
23443235|NCT00377858|65366345|FG000|Overall Study|Physician Decision|5|||
23443236|NCT00377858|65366346|FG001|Overall Study|Physician Decision|5|||
23443237|NCT00377858|65366345|FG000|Overall Study|Protocol Violation|3|||
23443238|NCT00377858|65366346|FG001|Overall Study|Protocol Violation|4|||
23443239|NCT00377858|65366345|FG000|Overall Study|Adverse Event|2|||
23443240|NCT00377858|65366346|FG001|Overall Study|Adverse Event|1|||
23443241|NCT00377858|65366345|FG000|Overall Study|Entry Criteria Not Met|2|||
23443242|NCT00377858|65366346|FG001|Overall Study|Entry Criteria Not Met|0|||
23443243|NCT00377858|65366345|FG000|Overall Study|Sponsor Decision|1|||
23443244|NCT00377858|65366346|FG001|Overall Study|Sponsor Decision|2|||
23443245|NCT00377858|65366345|FG000|Overall Study|Death|0|||
23443246|NCT00377858|65366346|FG001|Overall Study|Death|3|||
23443247|NCT01496469|65366347|FG000|Overall Study|Adverse Event|1|||
23443248|NCT01496469|65366348|FG001|Overall Study|Adverse Event|0|||
23443249|NCT01496469|65366347|FG000|Overall Study|Protocol Violation|2|||
23443250|NCT01496469|65366348|FG001|Overall Study|Protocol Violation|0|||
23443251|NCT01496469|65366347|FG000|Overall Study|Lost to Follow-up|1|||
23443252|NCT01496469|65366348|FG001|Overall Study|Lost to Follow-up|1|||
23443253|NCT01496469|65366347|FG000|Overall Study|Withdrawal by Subject|4|||
23443254|NCT01496469|65366348|FG001|Overall Study|Withdrawal by Subject|4|||
23443255|NCT01496469|65366347|FG000|Overall Study|BP exceeds protocol limits|1|||
23443256|NCT01496469|65366348|FG001|Overall Study|BP exceeds protocol limits|2|||
23443257|NCT01496469|65366347|FG000|Overall Study|Other|1|||
23443258|NCT01496469|65366348|FG001|Overall Study|Other|1|||
23443259|NCT01502228|65366349|FG000|Overall Study|Death|1|||
23443260|NCT01456169|65366350|FG000|Overall Study|Adverse Event|1|||
23443261|NCT01456169|65366351|FG001|Overall Study|Adverse Event|2|||
23443262|NCT01456169|65366352|FG002|Overall Study|Adverse Event|7|||
23157259|NCT01721057|64325491|FG001|Treatment Period|Adverse Event|10|||
23157260|NCT01721057|64325492|FG002|Treatment Period|Adverse Event|12|||
23157261|NCT01721057|64325493|FG003|Treatment Period|Adverse Event|0|||
23327836|NCT00828568|64941062|FG001|Randomized|Withdrawal by Subject|0|||
23327837|NCT00828568|64941063|FG002|Randomized|Withdrawal by Subject|2|||
23327838|NCT00828568|64941061|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
23327839|NCT00828568|64941062|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
23327840|NCT00828568|64941063|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
23327841|NCT00828568|64941061|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
23327842|NCT00828568|64941062|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
23327843|NCT00828568|64941063|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
23327844|NCT00828568|64941061|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
23327845|NCT00828568|64941062|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
23327846|NCT00828568|64941063|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
23327847|NCT00828568|64941061|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
23327848|NCT00828568|64941062|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
23327849|NCT00828568|64941063|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
23327850|NCT02375971|64945317|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
23327851|NCT02375971|64945318|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
23327852|NCT02375971|64945319|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
23327853|NCT02375971|64945317|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
23327854|NCT02375971|64945318|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
23327855|NCT02375971|64945319|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
23327856|NCT02375971|64945317|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
23327857|NCT02375971|64945318|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
23327858|NCT02375971|64945319|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
23327859|NCT02375971|64945317|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
23327860|NCT02375971|64945318|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
23327861|NCT02375971|64945319|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
23327862|NCT02375971|64945317|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
23327863|NCT02375971|64945318|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
23327864|NCT02375971|64945319|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
23443263|NCT01456169|65366350|FG000|Overall Study|Major Protocol Deviation|3|||
23443264|NCT01456169|65366351|FG001|Overall Study|Major Protocol Deviation|2|||
23443265|NCT01456169|65366352|FG002|Overall Study|Major Protocol Deviation|3|||
23157262|NCT01721057|64325494|FG004|Treatment Period|Adverse Event|0|||
23327865|NCT02375971|64945317|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
23327866|NCT02375971|64945318|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
23443266|NCT01456169|65366350|FG000|Overall Study|Voluntary Withdrawal|3|||
23443267|NCT01456169|65366351|FG001|Overall Study|Voluntary Withdrawal|0|||
23443268|NCT01456169|65366352|FG002|Overall Study|Voluntary Withdrawal|2|||
23443269|NCT01456169|65366350|FG000|Overall Study|Lack of Efficacy|2|||
23443270|NCT01456169|65366351|FG001|Overall Study|Lack of Efficacy|0|||
23157263|NCT01721057|64325495|FG005|Treatment Period|Adverse Event|0|||
23157264|NCT01721057|64325496|FG006|Treatment Period|Adverse Event|0|||
23443271|NCT01456169|65366352|FG002|Overall Study|Lack of Efficacy|0|||
23327867|NCT02375971|64945319|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
23327868|NCT02375971|64945317|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
23327869|NCT02375971|64945318|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
23327870|NCT02375971|64945319|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
23327871|NCT02375971|64945317|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
23327872|NCT02375971|64945318|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
23327873|NCT02375971|64945319|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
23327874|NCT01801865|64945322|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
23327875|NCT01801865|64945322|FG000|Overall Study|Physician Decision|7|||
23327876|NCT02288325|64945334|FG000|Run-in Period|Adverse Event|48|||
23327877|NCT02288325|64945335|FG001|Run-in Period|Adverse Event|0|||
23327878|NCT02288325|64945336|FG002|Run-in Period|Adverse Event|0|||
23327879|NCT02288325|64945334|FG000|Run-in Period|Lack of Efficacy|16|||
23327880|NCT02288325|64945335|FG001|Run-in Period|Lack of Efficacy|0|||
23327881|NCT02288325|64945336|FG002|Run-in Period|Lack of Efficacy|0|||
23327882|NCT02288325|64945334|FG000|Run-in Period|Withdrawal of Consent|28|||
23327883|NCT02288325|64945335|FG001|Run-in Period|Withdrawal of Consent|0|||
23327884|NCT02288325|64945336|FG002|Run-in Period|Withdrawal of Consent|0|||
23327885|NCT02288325|64945334|FG000|Run-in Period|Lost to Follow-up|25|||
23327886|NCT02288325|64945335|FG001|Run-in Period|Lost to Follow-up|0|||
23327887|NCT02288325|64945336|FG002|Run-in Period|Lost to Follow-up|0|||
23327888|NCT02288325|64945334|FG000|Run-in Period|Protocol Violation|17|||
23327889|NCT02288325|64945335|FG001|Run-in Period|Protocol Violation|0|||
23327890|NCT02288325|64945336|FG002|Run-in Period|Protocol Violation|0|||
23327891|NCT02288325|64945334|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
23327892|NCT02288325|64945335|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
23327893|NCT02288325|64945336|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
23327894|NCT02288325|64945334|FG000|Run-in Period|Reason not Specified|8|||
23327895|NCT02288325|64945335|FG001|Run-in Period|Reason not Specified|0|||
23327896|NCT02288325|64945336|FG002|Run-in Period|Reason not Specified|0|||
23327897|NCT02288325|64945334|FG000|Stabilization Period|Adverse Event|13|||
23327898|NCT02288325|64945335|FG001|Stabilization Period|Adverse Event|0|||
23327899|NCT02288325|64945336|FG002|Stabilization Period|Adverse Event|0|||
23327900|NCT02288325|64945334|FG000|Stabilization Period|Lack of Efficacy|22|||
23327901|NCT02288325|64945335|FG001|Stabilization Period|Lack of Efficacy|0|||
23327902|NCT02288325|64945336|FG002|Stabilization Period|Lack of Efficacy|0|||
23327903|NCT02288325|64945334|FG000|Stabilization Period|Withdrawal of Consent|23|||
23327904|NCT02288325|64945335|FG001|Stabilization Period|Withdrawal of Consent|0|||
23327905|NCT02288325|64945336|FG002|Stabilization Period|Withdrawal of Consent|0|||
23327906|NCT02288325|64945334|FG000|Stabilization Period|Lost to Follow-up|12|||
23327907|NCT02288325|64945335|FG001|Stabilization Period|Lost to Follow-up|0|||
23327908|NCT02288325|64945336|FG002|Stabilization Period|Lost to Follow-up|0|||
23327909|NCT02288325|64945334|FG000|Stabilization Period|Protocol Violation|8|||
23327910|NCT02288325|64945335|FG001|Stabilization Period|Protocol Violation|0|||
23327911|NCT02288325|64945336|FG002|Stabilization Period|Protocol Violation|0|||
23327912|NCT02288325|64945334|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
23327913|NCT02288325|64945335|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
23327914|NCT02288325|64945336|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
23327915|NCT02288325|64945334|FG000|Stabilization Period|Reason not Specified|15|||
23327916|NCT02288325|64945335|FG001|Stabilization Period|Reason not Specified|0|||
23327917|NCT02288325|64945336|FG002|Stabilization Period|Reason not Specified|0|||
23327918|NCT02288325|64945334|FG000|Double-blind Treatment Period|Adverse Event|0|||
23327919|NCT02288325|64945335|FG001|Double-blind Treatment Period|Adverse Event|2|||
23327920|NCT02288325|64945336|FG002|Double-blind Treatment Period|Adverse Event|5|||
23327921|NCT02288325|64945334|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
23327922|NCT02288325|64945335|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
23327923|NCT02288325|64945336|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
23327924|NCT02288325|64945334|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23327925|NCT02288325|64945335|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
23327926|NCT02288325|64945336|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
23566201|NCT00980005|65803710|FG001|Overall Study|Lost to Follow-up|43|||
23157265|NCT01721057|64325490|FG000|Treatment Period|Lack of Efficacy|7|||
23327927|NCT02288325|64945334|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23327928|NCT02288325|64945335|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23327929|NCT02288325|64945336|FG002|Double-blind Treatment Period|Protocol Violation|2|||
23157266|NCT01721057|64325491|FG001|Treatment Period|Lack of Efficacy|3|||
23327930|NCT02288325|64945334|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
23327931|NCT02288325|64945335|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
23327932|NCT02288325|64945336|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
23327933|NCT02288325|64945334|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
23327934|NCT02288325|64945335|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
23566202|NCT00980005|65803709|FG000|Overall Study|Other|4|||
23566203|NCT00980005|65803710|FG001|Overall Study|Other|3|||
23628330|NCT00778921|66024710|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
23628331|NCT00778921|66024711|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
23628332|NCT00778921|66024709|FG000|Overall Study|Patient withdrew request|3|||
23221849|NCT02327078|64553816|FG003|Overall Study|Death|6|||
23221850|NCT02327078|64553817|FG004|Overall Study|Death|4|||
23221851|NCT02327078|64553818|FG005|Overall Study|Death|3|||
23221852|NCT02327078|64553819|FG006|Overall Study|Death|2|||
23221853|NCT02327078|64553820|FG007|Overall Study|Death|51|||
23221854|NCT02327078|64553821|FG008|Overall Study|Death|97|||
23628333|NCT00778921|66024710|FG001|Overall Study|Patient withdrew request|1|||
23628334|NCT00778921|66024711|FG002|Overall Study|Patient withdrew request|6|||
23628335|NCT00778921|66024709|FG000|Overall Study|Lost to Follow-up|0|||
23628336|NCT00778921|66024710|FG001|Overall Study|Lost to Follow-up|2|||
23628337|NCT00778921|66024711|FG002|Overall Study|Lost to Follow-up|1|||
23157267|NCT01721057|64325492|FG002|Treatment Period|Lack of Efficacy|0|||
23157268|NCT01721057|64325493|FG003|Treatment Period|Lack of Efficacy|0|||
23157269|NCT01721057|64325494|FG004|Treatment Period|Lack of Efficacy|0|||
23157270|NCT01721057|64325495|FG005|Treatment Period|Lack of Efficacy|0|||
23157271|NCT01721057|64325496|FG006|Treatment Period|Lack of Efficacy|0|||
23157272|NCT01721057|64325490|FG000|Treatment Period|Lost to Follow-up|1|||
23157273|NCT01721057|64325491|FG001|Treatment Period|Lost to Follow-up|0|||
23157274|NCT01721057|64325492|FG002|Treatment Period|Lost to Follow-up|0|||
23157275|NCT01721057|64325493|FG003|Treatment Period|Lost to Follow-up|0|||
23157276|NCT01721057|64325494|FG004|Treatment Period|Lost to Follow-up|0|||
23157277|NCT01721057|64325495|FG005|Treatment Period|Lost to Follow-up|0|||
23157278|NCT01721057|64325496|FG006|Treatment Period|Lost to Follow-up|0|||
23157279|NCT01721057|64325490|FG000|Treatment Period|Physician Decision|0|||
23157280|NCT01721057|64325491|FG001|Treatment Period|Physician Decision|1|||
23157281|NCT01721057|64325492|FG002|Treatment Period|Physician Decision|3|||
23157282|NCT01721057|64325493|FG003|Treatment Period|Physician Decision|0|||
23157283|NCT01721057|64325494|FG004|Treatment Period|Physician Decision|0|||
23157284|NCT01721057|64325495|FG005|Treatment Period|Physician Decision|0|||
23157285|NCT01721057|64325496|FG006|Treatment Period|Physician Decision|0|||
23157286|NCT01721057|64325490|FG000|Treatment Period|Death|2|||
23157287|NCT01721057|64325491|FG001|Treatment Period|Death|0|||
23157288|NCT01721057|64325492|FG002|Treatment Period|Death|0|||
23157289|NCT01721057|64325493|FG003|Treatment Period|Death|0|||
23157290|NCT01721057|64325494|FG004|Treatment Period|Death|0|||
23157291|NCT01721057|64325495|FG005|Treatment Period|Death|0|||
23157292|NCT01721057|64325496|FG006|Treatment Period|Death|0|||
23157293|NCT01721057|64325490|FG000|Rescue Period|Adverse Event|0|||
23157294|NCT01721057|64325491|FG001|Rescue Period|Adverse Event|0|||
23157295|NCT01721057|64325492|FG002|Rescue Period|Adverse Event|0|||
23157296|NCT01721057|64325493|FG003|Rescue Period|Adverse Event|1|||
23157297|NCT01721057|64325494|FG004|Rescue Period|Adverse Event|0|||
23157298|NCT01721057|64325495|FG005|Rescue Period|Adverse Event|0|||
23157299|NCT01721057|64325496|FG006|Rescue Period|Adverse Event|0|||
23157300|NCT01721057|64325490|FG000|Rescue Period|Lack of Efficacy|0|||
23157301|NCT01721057|64325491|FG001|Rescue Period|Lack of Efficacy|0|||
23157302|NCT01721057|64325492|FG002|Rescue Period|Lack of Efficacy|0|||
23157303|NCT01721057|64325493|FG003|Rescue Period|Lack of Efficacy|2|||
23157304|NCT01721057|64325494|FG004|Rescue Period|Lack of Efficacy|0|||
23157305|NCT01721057|64325495|FG005|Rescue Period|Lack of Efficacy|0|||
23157306|NCT01721057|64325496|FG006|Rescue Period|Lack of Efficacy|0|||
23157307|NCT02865018|64325503|FG000|Overall Study|Withdrawal by Subject|1|||
23157308|NCT03302975|64325506|FG000|Overall Study|Lost to Follow-up|4|||
23157309|NCT02023242|64325509|FG000|Overall Study|Lost to Follow-up|3|||
23157310|NCT02023242|64325510|FG001|Overall Study|Lost to Follow-up|1|||
23221855|NCT02327078|64553813|FG000|Overall Study|Lost to Follow-up|0|||
23221856|NCT02327078|64553814|FG001|Overall Study|Lost to Follow-up|1|||
23221857|NCT02327078|64553815|FG002|Overall Study|Lost to Follow-up|1|||
23221858|NCT02327078|64553816|FG003|Overall Study|Lost to Follow-up|0|||
23221859|NCT02327078|64553817|FG004|Overall Study|Lost to Follow-up|0|||
23221860|NCT02327078|64553818|FG005|Overall Study|Lost to Follow-up|0|||
23221861|NCT02327078|64553819|FG006|Overall Study|Lost to Follow-up|0|||
23221862|NCT02327078|64553820|FG007|Overall Study|Lost to Follow-up|2|||
23221863|NCT02327078|64553821|FG008|Overall Study|Lost to Follow-up|5|||
23157311|NCT02023242|64325509|FG000|Overall Study|Death|0|||
23157312|NCT02023242|64325510|FG001|Overall Study|Death|1|||
23221864|NCT02327078|64553813|FG000|Overall Study|Site Terminated by Sponsor|1|||
23221865|NCT02327078|64553814|FG001|Overall Study|Site Terminated by Sponsor|0|||
23157313|NCT03184077|64325511|FG000|Overall Study|Lost to Follow-up|21|||
23157314|NCT03184077|64325512|FG001|Overall Study|Lost to Follow-up|21|||
23157315|NCT02101021|64325513|FG000|Overall Study|Death|4|||
23157316|NCT02101021|64325514|FG001|Overall Study|Death|3|||
23157317|NCT02101021|64325515|FG002|Overall Study|Death|6|||
23221866|NCT02327078|64553815|FG002|Overall Study|Site Terminated by Sponsor|1|||
23221867|NCT02327078|64553816|FG003|Overall Study|Site Terminated by Sponsor|4|||
23443272|NCT01456169|65366350|FG000|Overall Study|Other|1|||
23628338|NCT00778921|66024709|FG000|Overall Study|Administrative Problems|1|||
23157318|NCT02101021|64325516|FG003|Overall Study|Death|0|||
23157319|NCT02101021|64325517|FG004|Overall Study|Death|3|||
23157320|NCT02101021|64325513|FG000|Overall Study|Withdrew Consent from study|1|||
23157321|NCT02101021|64325514|FG001|Overall Study|Withdrew Consent from study|1|||
23157322|NCT02101021|64325515|FG002|Overall Study|Withdrew Consent from study|0|||
23157323|NCT02101021|64325516|FG003|Overall Study|Withdrew Consent from study|2|||
23443273|NCT01456169|65366351|FG001|Overall Study|Other|1|||
23443274|NCT01456169|65366352|FG002|Overall Study|Other|0|||
23443275|NCT03792256|65366357|FG000|Overall Study|Death|0|||
23443276|NCT03792256|65366358|FG001|Overall Study|Death|1|||
23443277|NCT03792256|65366357|FG000|Overall Study|Lack of Efficacy|0|||
23443278|NCT03792256|65366358|FG001|Overall Study|Lack of Efficacy|1|||
23443279|NCT03792256|65366357|FG000|Overall Study|Withdrawal by Subject|0|||
23443280|NCT03792256|65366358|FG001|Overall Study|Withdrawal by Subject|1|||
23443281|NCT00965575|65366359|FG000|Overall Study|subject unwillingness to swallow study c|1|||
23443282|NCT00965575|65366360|FG001|Overall Study|subject unwillingness to swallow study c|0|||
23443283|NCT00080301|65366361|FG000|Overall Study|Randomized but Never Treated|5|||
23443284|NCT00080301|65366362|FG001|Overall Study|Randomized but Never Treated|10|||
23443285|NCT00080301|65366361|FG000|Overall Study|Still on Treatment as of CSR date|0|||
23443286|NCT00080301|65366362|FG001|Overall Study|Still on Treatment as of CSR date|1|||
23443287|NCT00622505|65366363|FG000|Overall Study|Adverse Event|9|||
23443288|NCT00622505|65366364|FG001|Overall Study|Adverse Event|7|||
23443289|NCT00622505|65366363|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
23443290|NCT00622505|65366364|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
23157324|NCT02101021|64325517|FG004|Overall Study|Withdrew Consent from study|0|||
23157325|NCT02101021|64325513|FG000|Overall Study|Lost to Follow-up|1|||
23157326|NCT02101021|64325514|FG001|Overall Study|Lost to Follow-up|0|||
23157327|NCT02101021|64325515|FG002|Overall Study|Lost to Follow-up|0|||
23157328|NCT02101021|64325516|FG003|Overall Study|Lost to Follow-up|0|||
23157329|NCT02101021|64325517|FG004|Overall Study|Lost to Follow-up|0|||
23157330|NCT02101021|64325513|FG000|Overall Study|Study Terminated by Sponsor|1|||
23157331|NCT02101021|64325514|FG001|Overall Study|Study Terminated by Sponsor|0|||
23157332|NCT02101021|64325515|FG002|Overall Study|Study Terminated by Sponsor|1|||
23157333|NCT02101021|64325516|FG003|Overall Study|Study Terminated by Sponsor|1|||
23157334|NCT02101021|64325517|FG004|Overall Study|Study Terminated by Sponsor|1|||
23157335|NCT02230254|64325518|FG000|Overall Study|Lost to Follow-up|3|||
23157336|NCT01168973|64325519|FG000|Overall Study|Progressive Disease|341|||
23157337|NCT01168973|64325520|FG001|Overall Study|Progressive Disease|429|||
23157338|NCT01168973|64325519|FG000|Overall Study|Adverse Event|94|||
23157339|NCT01168973|64325520|FG001|Overall Study|Adverse Event|55|||
23157340|NCT01168973|64325519|FG000|Overall Study|Withdrawal by Subject|90|||
23157341|NCT01168973|64325520|FG001|Overall Study|Withdrawal by Subject|53|||
23157342|NCT01168973|64325519|FG000|Overall Study|Death|42|||
23157343|NCT01168973|64325520|FG001|Overall Study|Death|45|||
23157344|NCT01168973|64325519|FG000|Overall Study|Physician Decision|37|||
23157345|NCT01168973|64325520|FG001|Overall Study|Physician Decision|19|||
23157346|NCT01168973|64325519|FG000|Overall Study|Sponsor Decision|2|||
23157347|NCT01168973|64325520|FG001|Overall Study|Sponsor Decision|1|||
23157348|NCT01168973|64325519|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
23157349|NCT01168973|64325520|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
23157350|NCT03370120|64325523|FG000|Overall Study|Adverse event, non-fatal|24|||
23157351|NCT03370120|64325523|FG000|Overall Study|Withdrawal by Subject|6|||
23566204|NCT00154310|65803711|FG000|Overall Study|Adverse Event|19|||
23566205|NCT00154310|65803712|FG001|Overall Study|Adverse Event|9|||
23566206|NCT00154310|65803711|FG000|Overall Study|Lack of Efficacy|5|||
23566207|NCT00154310|65803712|FG001|Overall Study|Lack of Efficacy|4|||
23566208|NCT00154310|65803711|FG000|Overall Study|Protocol Violation|4|||
23566209|NCT00154310|65803712|FG001|Overall Study|Protocol Violation|2|||
23566210|NCT00154310|65803711|FG000|Overall Study|Withdrawal by Subject|9|||
23566211|NCT00154310|65803712|FG001|Overall Study|Withdrawal by Subject|3|||
23566212|NCT00154310|65803711|FG000|Overall Study|Lost to Follow-up|0|||
23566213|NCT00154310|65803712|FG001|Overall Study|Lost to Follow-up|8|||
23566214|NCT00154310|65803711|FG000|Overall Study|Administrative problems|0|||
23566215|NCT00154310|65803712|FG001|Overall Study|Administrative problems|1|||
23157352|NCT03370120|64325523|FG000|Overall Study|Lost to Follow-up|1|||
23157353|NCT03370120|64325523|FG000|Overall Study|Lack of Efficacy|37|||
23157354|NCT03370120|64325523|FG000|Overall Study|Per sponsor's instructions|1|||
23157355|NCT03370120|64325523|FG000|Overall Study|Study was terminated by parent company UCB|2|||
23157356|NCT03370120|64325523|FG000|Overall Study|The study was ended by the promoter|3|||
23157357|NCT03370120|64325523|FG000|Overall Study|Discontinuation of drug development|3|||
23157358|NCT03370120|64325523|FG000|Overall Study|End of project|2|||
23443291|NCT00622505|65366363|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
23566216|NCT00154310|65803711|FG000|Overall Study|Death|0|||
23157359|NCT03370120|64325523|FG000|Overall Study|Premature study closure|2|||
23566217|NCT00154310|65803712|FG001|Overall Study|Death|1|||
23566218|NCT01014975|65803713|FG000|Overall Study|Withdrawal by Subject|1|||
23566219|NCT01014975|65803714|FG001|Overall Study|Withdrawal by Subject|0|||
23327935|NCT02288325|64945336|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
23327936|NCT00813150|64945337|FG000|Treatment Period|Adverse Event|16|||
23327937|NCT00813150|64945338|FG001|Treatment Period|Adverse Event|15|||
23327938|NCT00813150|64945337|FG000|Treatment Period|Death|2|||
23327939|NCT00813150|64945338|FG001|Treatment Period|Death|0|||
23327940|NCT00813150|64945337|FG000|Treatment Period|Progressive disease|1|||
23327941|NCT00813150|64945338|FG001|Treatment Period|Progressive disease|0|||
23327942|NCT00813150|64945337|FG000|Treatment Period|Complete response|0|||
23327943|NCT00813150|64945338|FG001|Treatment Period|Complete response|1|||
23327944|NCT00813150|64945337|FG000|Treatment Period|Stable disease|1|||
23327945|NCT00813150|64945338|FG001|Treatment Period|Stable disease|2|||
23628339|NCT00778921|66024710|FG001|Overall Study|Administrative Problems|2|||
23628340|NCT00778921|66024711|FG002|Overall Study|Administrative Problems|0|||
23628341|NCT00778921|66024709|FG000|Overall Study|Protocol Violation|3|||
23628342|NCT00778921|66024710|FG001|Overall Study|Protocol Violation|0|||
23628343|NCT00778921|66024711|FG002|Overall Study|Protocol Violation|2|||
23628344|NCT00778921|66024709|FG000|Overall Study|Not treated|0|||
23628345|NCT00778921|66024710|FG001|Overall Study|Not treated|2|||
23628346|NCT00778921|66024711|FG002|Overall Study|Not treated|2|||
23628347|NCT01107899|66024714|FG000|Overall Study|Physician Decision|5|||
23628348|NCT01107899|66024715|FG001|Overall Study|Physician Decision|0|||
23628349|NCT01107899|66024716|FG002|Overall Study|Physician Decision|3|||
23628350|NCT01107899|66024714|FG000|Overall Study|Withdrawal by Subject|0|||
23628351|NCT01107899|66024715|FG001|Overall Study|Withdrawal by Subject|0|||
23628352|NCT01107899|66024716|FG002|Overall Study|Withdrawal by Subject|1|||
23628353|NCT02209181|66024717|FG000|Overall Study|Adverse Event|1|||
23628354|NCT02209181|66024718|FG001|Overall Study|Adverse Event|0|||
23628355|NCT02209181|66024719|FG002|Overall Study|Adverse Event|1|||
23628356|NCT02209181|66024720|FG003|Overall Study|Adverse Event|0|||
23628357|NCT02209181|66024717|FG000|Overall Study|Withdrawal by Subject|0|||
23628358|NCT02209181|66024718|FG001|Overall Study|Withdrawal by Subject|1|||
23628359|NCT02209181|66024719|FG002|Overall Study|Withdrawal by Subject|0|||
23628360|NCT02209181|66024720|FG003|Overall Study|Withdrawal by Subject|0|||
23628361|NCT01322009|66024721|FG000|Overall Study|Death|0|||
23628362|NCT01322009|66024722|FG001|Overall Study|Death|1|||
23628363|NCT01322009|66024721|FG000|Overall Study|Adverse Event|0|||
23628364|NCT01322009|66024722|FG001|Overall Study|Adverse Event|1|||
23628365|NCT01322009|66024721|FG000|Overall Study|ng tube discontinued|0|||
23327946|NCT00813150|64945337|FG000|Treatment Period|Protocol Violation|3|||
23327947|NCT00813150|64945338|FG001|Treatment Period|Protocol Violation|4|||
23327948|NCT00813150|64945337|FG000|Treatment Period|Withdrawal by Subject|5|||
23327949|NCT00813150|64945338|FG001|Treatment Period|Withdrawal by Subject|3|||
23327950|NCT00813150|64945337|FG000|Treatment Period|Non compliance|0|||
23327951|NCT00813150|64945338|FG001|Treatment Period|Non compliance|1|||
23327952|NCT00813150|64945337|FG000|Treatment Period|Reason not specified|3|||
23327953|NCT00813150|64945338|FG001|Treatment Period|Reason not specified|4|||
23327954|NCT00813150|64945337|FG000|Treatment Period|Data not available|1|||
23327955|NCT00813150|64945338|FG001|Treatment Period|Data not available|2|||
23327956|NCT00813150|64945337|FG000|Long Term Follow-up|Death|0|||
23327957|NCT00813150|64945338|FG001|Long Term Follow-up|Death|4|||
23327958|NCT00813150|64945337|FG000|Long Term Follow-up|Other|0|||
23327959|NCT00813150|64945338|FG001|Long Term Follow-up|Other|3|||
23327960|NCT00813150|64945337|FG000|Long Term Follow-up|Lost to Follow-up|2|||
23628366|NCT01322009|66024722|FG001|Overall Study|ng tube discontinued|1|||
23628367|NCT00490698|66024726|FG000|Overall Study|Withdrawal by Subject|1|||
23628368|NCT00490698|66024726|FG000|Overall Study|Disease Progression|7|||
23628369|NCT00490698|66024726|FG000|Overall Study|Physician Decision|2|||
23628370|NCT00926575|66024727|FG000|Overall Study|Adverse Event|1|||
23628371|NCT00926575|66024728|FG001|Overall Study|Adverse Event|1|||
23628372|NCT00926575|66024727|FG000|Overall Study|Death|4|||
23628373|NCT00926575|66024728|FG001|Overall Study|Death|4|||
23628374|NCT00926575|66024727|FG000|Overall Study|Lost to Follow-up|1|||
23628375|NCT00926575|66024728|FG001|Overall Study|Lost to Follow-up|1|||
23327961|NCT00813150|64945338|FG001|Long Term Follow-up|Lost to Follow-up|0|||
23327962|NCT00813150|64945337|FG000|Long Term Follow-up|Progression/Relapse|22|||
23327963|NCT00813150|64945338|FG001|Long Term Follow-up|Progression/Relapse|24|||
23443292|NCT00622505|65366364|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23628376|NCT00926575|66024727|FG000|Overall Study|Physician Decision|1|||
23628377|NCT00926575|66024728|FG001|Overall Study|Physician Decision|2|||
23628378|NCT00926575|66024727|FG000|Overall Study|Protocol Violation|1|||
23628379|NCT00926575|66024728|FG001|Overall Study|Protocol Violation|0|||
23628380|NCT00926575|66024727|FG000|Overall Study|Withdrawal by Subject|8|||
23628381|NCT00926575|66024728|FG001|Overall Study|Withdrawal by Subject|9|||
23628382|NCT01236352|66024729|FG000|Overall Study|Death|0|||
23628383|NCT01236352|66024730|FG001|Overall Study|Death|0|||
23628384|NCT01236352|66024731|FG002|Overall Study|Death|0|||
23628385|NCT01236352|66024732|FG003|Overall Study|Death|0|||
23628386|NCT01236352|66024733|FG004|Overall Study|Death|0|||
23628387|NCT01236352|66024734|FG005|Overall Study|Death|0|||
23628388|NCT01236352|66024735|FG006|Overall Study|Death|0|||
23443293|NCT00622505|65366363|FG000|Overall Study|Withdrawal by Subject|12|||
23443294|NCT00622505|65366364|FG001|Overall Study|Withdrawal by Subject|5|||
23628389|NCT01236352|66024736|FG007|Overall Study|Death|1|||
23628390|NCT01236352|66024737|FG008|Overall Study|Death|0|||
23628391|NCT01236352|66024738|FG009|Overall Study|Death|0|||
23628392|NCT01236352|66024739|FG010|Overall Study|Death|0|||
23628393|NCT01236352|66024729|FG000|Overall Study|Withdrawal by Subject|0|||
23628394|NCT01236352|66024730|FG001|Overall Study|Withdrawal by Subject|0|||
23628395|NCT01236352|66024731|FG002|Overall Study|Withdrawal by Subject|0|||
23628396|NCT01236352|66024732|FG003|Overall Study|Withdrawal by Subject|0|||
23628397|NCT01236352|66024733|FG004|Overall Study|Withdrawal by Subject|0|||
23628398|NCT01236352|66024734|FG005|Overall Study|Withdrawal by Subject|0|||
23628399|NCT01236352|66024735|FG006|Overall Study|Withdrawal by Subject|0|||
23628400|NCT01236352|66024736|FG007|Overall Study|Withdrawal by Subject|0|||
23628401|NCT01236352|66024737|FG008|Overall Study|Withdrawal by Subject|0|||
23628402|NCT01236352|66024738|FG009|Overall Study|Withdrawal by Subject|2|||
23628403|NCT01236352|66024739|FG010|Overall Study|Withdrawal by Subject|1|||
23628404|NCT01236352|66024729|FG000|Overall Study|Adverse Event|0|||
23566220|NCT01014975|65803715|FG002|Overall Study|Withdrawal by Subject|1|||
23443295|NCT00622505|65366363|FG000|Overall Study|Administrative Problems|2|||
23443296|NCT00622505|65366364|FG001|Overall Study|Administrative Problems|4|||
23443297|NCT00622505|65366363|FG000|Overall Study|Death|2|||
23443298|NCT00622505|65366364|FG001|Overall Study|Death|2|||
23443299|NCT01420926|65366365|FG000|Overall Study|Adverse Event|6|||
23443300|NCT01420926|65366366|FG001|Overall Study|Adverse Event|4|||
23443301|NCT01420926|65366365|FG000|Overall Study|Death|18|||
23566221|NCT01014975|65803713|FG000|Overall Study|Death|3|||
23566222|NCT01014975|65803714|FG001|Overall Study|Death|3|||
23566223|NCT01014975|65803715|FG002|Overall Study|Death|4|||
23566224|NCT01014975|65803713|FG000|Overall Study|Lost to Follow-up|0|||
23566225|NCT01014975|65803714|FG001|Overall Study|Lost to Follow-up|0|||
23566226|NCT01014975|65803715|FG002|Overall Study|Lost to Follow-up|1|||
23566227|NCT04145037|65803719|FG000|Overall Study|Study terminated|2|||
23566228|NCT04145037|65803720|FG001|Overall Study|Study terminated|0|||
23566229|NCT04145037|65803719|FG000|Overall Study|Withdrawal by Subject|1|||
23566230|NCT04145037|65803720|FG001|Overall Study|Withdrawal by Subject|0|||
23566231|NCT04145037|65803719|FG000|Overall Study|Lost to Follow-up|1|||
23566232|NCT04145037|65803720|FG001|Overall Study|Lost to Follow-up|0|||
23566233|NCT00399763|65803726|FG000|Overall Study|Lost to Follow-up|2|||
23566234|NCT00399763|65803727|FG001|Overall Study|Lost to Follow-up|3|||
23566235|NCT01893827|65803729|FG000|Overall Study|Lost to Follow-up|19|||
23566236|NCT01893827|65803730|FG001|Overall Study|Lost to Follow-up|26|||
23566237|NCT02344537|65803735|FG000|Overall Study|Protocol Violation|1|||
23566238|NCT02344537|65803736|FG001|Overall Study|Protocol Violation|1|||
23566239|NCT02344537|65803735|FG000|Overall Study|Subject started another treatment after wk 6|1|||
23566240|NCT02344537|65803736|FG001|Overall Study|Subject started another treatment after wk 6|0|||
23566241|NCT02344537|65803735|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
23628405|NCT01236352|66024730|FG001|Overall Study|Adverse Event|0|||
23628406|NCT01236352|66024731|FG002|Overall Study|Adverse Event|0|||
23628407|NCT01236352|66024732|FG003|Overall Study|Adverse Event|0|||
23628408|NCT01236352|66024733|FG004|Overall Study|Adverse Event|0|||
23628409|NCT01236352|66024734|FG005|Overall Study|Adverse Event|0|||
23628410|NCT01236352|66024735|FG006|Overall Study|Adverse Event|2|||
23628411|NCT01236352|66024736|FG007|Overall Study|Adverse Event|0|||
23628412|NCT01236352|66024737|FG008|Overall Study|Adverse Event|0|||
23628413|NCT01236352|66024738|FG009|Overall Study|Adverse Event|4|||
23628414|NCT01236352|66024739|FG010|Overall Study|Adverse Event|1|||
23628415|NCT01236352|66024729|FG000|Overall Study|Study drug toxicity|0|||
23628416|NCT01236352|66024730|FG001|Overall Study|Study drug toxicity|0|||
23443302|NCT01420926|65366366|FG001|Overall Study|Death|17|||
23566242|NCT02344537|65803736|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
23566243|NCT00874432|65803737|FG000|Overall Study|Withdrawal by Subject|1|||
23566244|NCT00874432|65803738|FG001|Overall Study|Withdrawal by Subject|0|||
23628417|NCT01236352|66024731|FG002|Overall Study|Study drug toxicity|0|||
23628418|NCT01236352|66024732|FG003|Overall Study|Study drug toxicity|0|||
23443303|NCT01420926|65366365|FG000|Overall Study|Withdrawal by Subject|11|||
23443304|NCT01420926|65366366|FG001|Overall Study|Withdrawal by Subject|17|||
23443305|NCT01420926|65366365|FG000|Overall Study|Non-protocol treatment|17|||
23443306|NCT01420926|65366366|FG001|Overall Study|Non-protocol treatment|20|||
23566245|NCT00874432|65803739|FG002|Overall Study|Withdrawal by Subject|0|||
23566246|NCT00874432|65803740|FG003|Overall Study|Withdrawal by Subject|0|||
23566247|NCT00874432|65803737|FG000|Overall Study|Physician Decision|1|||
23628419|NCT01236352|66024733|FG004|Overall Study|Study drug toxicity|0|||
23628420|NCT01236352|66024734|FG005|Overall Study|Study drug toxicity|1|||
23628421|NCT01236352|66024735|FG006|Overall Study|Study drug toxicity|1|||
23628422|NCT01236352|66024736|FG007|Overall Study|Study drug toxicity|0|||
23628423|NCT01236352|66024737|FG008|Overall Study|Study drug toxicity|0|||
23628424|NCT01236352|66024738|FG009|Overall Study|Study drug toxicity|2|||
23566248|NCT00874432|65803738|FG001|Overall Study|Physician Decision|0|||
23566249|NCT00874432|65803739|FG002|Overall Study|Physician Decision|0|||
23566250|NCT00874432|65803740|FG003|Overall Study|Physician Decision|0|||
23566251|NCT00874432|65803737|FG000|Overall Study|Other|1|||
23566252|NCT00874432|65803738|FG001|Overall Study|Other|2|||
23566253|NCT00874432|65803739|FG002|Overall Study|Other|8|||
23566254|NCT00874432|65803740|FG003|Overall Study|Other|3|||
23566255|NCT00860067|65803741|FG000|Overall Study|Lost to Follow-up|46|||
23566256|NCT00860067|65803742|FG001|Overall Study|Lost to Follow-up|9|||
23566257|NCT00860067|65803743|FG002|Overall Study|Lost to Follow-up|9|||
23566258|NCT00860067|65803741|FG000|Overall Study|Withdrawal by Subject|4|||
23566259|NCT00860067|65803742|FG001|Overall Study|Withdrawal by Subject|0|||
23566260|NCT00860067|65803743|FG002|Overall Study|Withdrawal by Subject|0|||
23566261|NCT00860067|65803741|FG000|Overall Study|Pregnancy|1|||
23566262|NCT00860067|65803742|FG001|Overall Study|Pregnancy|0|||
23566263|NCT00860067|65803743|FG002|Overall Study|Pregnancy|0|||
23566264|NCT01126060|65803746|FG000|Overall Study|Protocol Violation|0|||
23443307|NCT01420926|65366365|FG000|Overall Study|Physician Decision|8|||
23443308|NCT01420926|65366366|FG001|Overall Study|Physician Decision|5|||
23443309|NCT01132313|65366367|FG000|Overall Study|Lack of Efficacy|1|||
23443310|NCT01132313|65366368|FG001|Overall Study|Lack of Efficacy|0|||
23443311|NCT01132313|65366369|FG002|Overall Study|Lack of Efficacy|0|||
23443312|NCT01132313|65366370|FG003|Overall Study|Lack of Efficacy|0|||
23443313|NCT01132313|65366371|FG004|Overall Study|Lack of Efficacy|0|||
23443314|NCT01132313|65366372|FG005|Overall Study|Lack of Efficacy|0|||
23443315|NCT01132313|65366373|FG006|Overall Study|Lack of Efficacy|0|||
23443316|NCT01132313|65366374|FG007|Overall Study|Lack of Efficacy|3|||
23566265|NCT01126060|65803747|FG001|Overall Study|Protocol Violation|2|||
23566266|NCT02041923|65803748|FG000|Overall Study|Lost to Follow-up|26|||
23566267|NCT02041923|65803749|FG001|Overall Study|Lost to Follow-up|30|||
23566268|NCT04278417|65803750|FG000|Overall Study|Withdrawal by Subject|13|||
23566269|NCT04278417|65803751|FG001|Overall Study|Withdrawal by Subject|12|||
23566270|NCT04278417|65803750|FG000|Overall Study|Progressive disease|0|||
23566271|NCT04278417|65803751|FG001|Overall Study|Progressive disease|1|||
23566272|NCT04278417|65803750|FG000|Overall Study|Physician Decision|2|||
23566273|NCT04278417|65803751|FG001|Overall Study|Physician Decision|1|||
23566274|NCT04278417|65803750|FG000|Overall Study|Lost to Follow-up|7|||
23566275|NCT04278417|65803751|FG001|Overall Study|Lost to Follow-up|8|||
23628425|NCT01236352|66024739|FG010|Overall Study|Study drug toxicity|2|||
23628426|NCT01236352|66024729|FG000|Overall Study|Disease progression|1|||
23628427|NCT01236352|66024730|FG001|Overall Study|Disease progression|2|||
23221868|NCT02327078|64553817|FG004|Overall Study|Site Terminated by Sponsor|0|||
23221869|NCT02327078|64553818|FG005|Overall Study|Site Terminated by Sponsor|0|||
23327964|NCT01965860|64945339|FG000|Overall Study|Pregnancy|1|||
23327965|NCT01965860|64945340|FG001|Overall Study|Pregnancy|0|||
23566276|NCT04278417|65803750|FG000|Overall Study|Death|6|||
23566277|NCT04278417|65803751|FG001|Overall Study|Death|3|||
23566278|NCT04278417|65803750|FG000|Overall Study|Adverse Event|2|||
23566279|NCT04278417|65803751|FG001|Overall Study|Adverse Event|4|||
23566280|NCT04278417|65803750|FG000|Overall Study|Ongoing, did not complete Week 54|31|||
23566281|NCT04278417|65803751|FG001|Overall Study|Ongoing, did not complete Week 54|27|||
23566282|NCT00720902|65803754|FG000|Overall Study|Withdrawal by Subject|1|||
23566283|NCT00720902|65803755|FG001|Overall Study|Withdrawal by Subject|0|||
23566284|NCT00720902|65803754|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
23566285|NCT00720902|65803755|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
23566286|NCT02796963|65803758|FG000|Overall Study|Lost to Follow-up|89|||
23566287|NCT02796963|65803759|FG001|Overall Study|Lost to Follow-up|76|||
23566288|NCT02796963|65803760|FG002|Overall Study|Lost to Follow-up|69|||
23566289|NCT02796963|65803761|FG003|Overall Study|Lost to Follow-up|72|||
23566290|NCT00369681|65803764|FG000|Overall Study|Death|1|||
23566291|NCT03469349|65803778|FG000|Overall Study|Withdrawal by Subject|1|||
23566292|NCT03469349|65803779|FG001|Overall Study|Withdrawal by Subject|3|||
23566293|NCT03469349|65803778|FG000|Overall Study|Progressive Disease|0|||
23566294|NCT03469349|65803779|FG001|Overall Study|Progressive Disease|1|||
23566295|NCT03469349|65803778|FG000|Overall Study|Lost to Follow-up|2|||
23566296|NCT03469349|65803779|FG001|Overall Study|Lost to Follow-up|2|||
23443317|NCT01132313|65366375|FG008|Overall Study|Lack of Efficacy|14|||
23443318|NCT01132313|65366376|FG009|Overall Study|Lack of Efficacy|16|||
23443319|NCT01132313|65366377|FG010|Overall Study|Lack of Efficacy|0|||
23566297|NCT03469349|65803778|FG000|Overall Study|Adverse Event|2|||
23566298|NCT03469349|65803779|FG001|Overall Study|Adverse Event|4|||
23566299|NCT01659658|65803780|FG000|Overall Study|Withdrawal by Patient|18|||
23566300|NCT01659658|65803781|FG001|Overall Study|Withdrawal by Patient|4|||
23566301|NCT01659658|65803782|FG002|Overall Study|Withdrawal by Patient|2|||
23327966|NCT01965860|64945341|FG002|Overall Study|Pregnancy|1|||
23566302|NCT01659658|65803783|FG003|Overall Study|Withdrawal by Patient|0|||
23566303|NCT01659658|65803784|FG004|Overall Study|Withdrawal by Patient|11|||
23566304|NCT01659658|65803780|FG000|Overall Study|Study Terminated by Sponsor|9|||
23443320|NCT01132313|65366378|FG011|Overall Study|Lack of Efficacy|0|||
23157360|NCT03370120|64325523|FG000|Overall Study|Premature program termination|1|||
23157361|NCT03370120|64325523|FG000|Overall Study|Premature study termination|7|||
23566305|NCT01659658|65803781|FG001|Overall Study|Study Terminated by Sponsor|7|||
23566306|NCT01659658|65803782|FG002|Overall Study|Study Terminated by Sponsor|0|||
23157362|NCT03370120|64325523|FG000|Overall Study|Trial terminated by sponsor|2|||
23157363|NCT03370120|64325523|FG000|Overall Study|Trial discontinued by sponsor|2|||
23327967|NCT01965860|64945339|FG000|Overall Study|Logistics|1|||
23327968|NCT01965860|64945340|FG001|Overall Study|Logistics|0|||
23327969|NCT01965860|64945341|FG002|Overall Study|Logistics|0|||
23566307|NCT01659658|65803783|FG003|Overall Study|Study Terminated by Sponsor|1|||
23566308|NCT01659658|65803784|FG004|Overall Study|Study Terminated by Sponsor|4|||
23566309|NCT01659658|65803780|FG000|Overall Study|Reason not Specified|61|||
23566310|NCT01659658|65803781|FG001|Overall Study|Reason not Specified|15|||
23566311|NCT01659658|65803782|FG002|Overall Study|Reason not Specified|8|||
23566312|NCT01659658|65803783|FG003|Overall Study|Reason not Specified|1|||
23566313|NCT01659658|65803784|FG004|Overall Study|Reason not Specified|34|||
23566314|NCT01659658|65803780|FG000|Overall Study|Lost to Follow-up|2|||
23566315|NCT01659658|65803781|FG001|Overall Study|Lost to Follow-up|0|||
23566316|NCT01659658|65803782|FG002|Overall Study|Lost to Follow-up|0|||
23566317|NCT01659658|65803783|FG003|Overall Study|Lost to Follow-up|0|||
23566318|NCT01659658|65803784|FG004|Overall Study|Lost to Follow-up|0|||
23566319|NCT01679301|65803785|FG000|Screening Period|screen failure|3|||
23566320|NCT01679301|65803786|FG001|Screening Period|screen failure|0|||
23566321|NCT01679301|65803787|FG002|Screening Period|screen failure|0|||
23566322|NCT04161807|65803793|FG000|Overall Study|Withdrawal by Subject|2|||
23566323|NCT04161807|65803793|FG000|Overall Study|Performed only 1 treatment|2|||
23566324|NCT01782872|65803795|FG000|Overall Study|Protocol Violation|0|||
23566325|NCT01782872|65803796|FG001|Overall Study|Protocol Violation|0|||
23566326|NCT01782872|65803797|FG002|Overall Study|Protocol Violation|0|||
23566327|NCT01782872|65803798|FG003|Overall Study|Protocol Violation|1|||
23566328|NCT01782872|65803795|FG000|Overall Study|Withdrawal by Subject|0|||
23566329|NCT01782872|65803796|FG001|Overall Study|Withdrawal by Subject|1|||
23566330|NCT01782872|65803797|FG002|Overall Study|Withdrawal by Subject|0|||
23566331|NCT01782872|65803798|FG003|Overall Study|Withdrawal by Subject|0|||
23566332|NCT01862991|65803799|FG000|Overall Study|Lost to Follow-up|2|||
23566333|NCT01862991|65803800|FG001|Overall Study|Lost to Follow-up|1|||
23566334|NCT01862991|65803801|FG002|Overall Study|Lost to Follow-up|1|||
23566335|NCT01862991|65803799|FG000|Overall Study|Protocol Violation|1|||
23566336|NCT01862991|65803800|FG001|Overall Study|Protocol Violation|0|||
23566337|NCT01862991|65803801|FG002|Overall Study|Protocol Violation|0|||
23566338|NCT01719237|65803803|FG000|Overall Study|Physician Decision|0|||
23566339|NCT01719237|65803804|FG001|Overall Study|Physician Decision|1|||
23566340|NCT04395183|65803805|FG000|Overall Study|Withdrawal by Subject|1|||
23566341|NCT04395183|65803806|FG001|Overall Study|Withdrawal by Subject|0|||
23566342|NCT04395183|65803807|FG002|Overall Study|Withdrawal by Subject|2|||
23566343|NCT04395183|65803808|FG003|Overall Study|Withdrawal by Subject|2|||
23566344|NCT04035200|65803809|FG000|Overall Study|Lost to Follow-up|0|||
23566345|NCT04035200|65803810|FG001|Overall Study|Lost to Follow-up|1|||
23566346|NCT04035200|65803811|FG002|Overall Study|Lost to Follow-up|0|||
23566347|NCT04035200|65803809|FG000|Overall Study|Withdrawal by Subject|1|||
23566348|NCT04035200|65803810|FG001|Overall Study|Withdrawal by Subject|4|||
23566349|NCT04035200|65803811|FG002|Overall Study|Withdrawal by Subject|4|||
23566350|NCT04035200|65803809|FG000|Overall Study|COVID-19|1|||
23566351|NCT04035200|65803810|FG001|Overall Study|COVID-19|0|||
23566352|NCT04035200|65803811|FG002|Overall Study|COVID-19|0|||
23566353|NCT04035200|65803809|FG000|Overall Study|Early Termination|0|||
23566354|NCT04035200|65803810|FG001|Overall Study|Early Termination|1|||
23566355|NCT04035200|65803811|FG002|Overall Study|Early Termination|0|||
23566356|NCT04035200|65803809|FG000|Overall Study|Non-compliance|0|||
23566357|NCT04035200|65803810|FG001|Overall Study|Non-compliance|1|||
23566358|NCT04035200|65803811|FG002|Overall Study|Non-compliance|0|||
23566359|NCT01265823|65803812|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
23566360|NCT01265823|65803812|FG000|Overall Study|Failure to Return|4|||
23566361|NCT01265823|65803812|FG000|Overall Study|Protocol Violation|1|||
23566362|NCT01265823|65803812|FG000|Overall Study|Participant Request|1|||
23566363|NCT01024959|65803815|FG000|Overall Study|ineligible|12|||
23566364|NCT01024959|65803815|FG000|Overall Study|results not evaluable|12|||
23566365|NCT01024959|65803815|FG000|Overall Study|missing results required for analysis|17|||
23628428|NCT01236352|66024731|FG002|Overall Study|Disease progression|1|||
23327970|NCT02946463|64945342|FG000|Primary Evaluation Period|Physician Decision|0|||
23566366|NCT00979602|65803816|FG000|Overall Study|Serious Adverse Event|5|||
23157364|NCT03370120|64325523|FG000|Overall Study|Study ended|15|||
23157365|NCT03370120|64325523|FG000|Overall Study|Clinical trial has been cancelled|1|||
23157366|NCT03370120|64325523|FG000|Overall Study|End of study per sponsor decision|2|||
23327971|NCT02946463|64945343|FG001|Primary Evaluation Period|Physician Decision|1|||
23566367|NCT00979602|65803817|FG001|Overall Study|Serious Adverse Event|3|||
23566368|NCT00979602|65803816|FG000|Overall Study|Protocol Violation|3|||
23566369|NCT00979602|65803817|FG001|Overall Study|Protocol Violation|0|||
23221870|NCT02327078|64553819|FG006|Overall Study|Site Terminated by Sponsor|0|||
23221871|NCT02327078|64553820|FG007|Overall Study|Site Terminated by Sponsor|11|||
23221872|NCT02327078|64553821|FG008|Overall Study|Site Terminated by Sponsor|25|||
23221873|NCT02327078|64553813|FG000|Overall Study|Physician Decision|0|||
23221874|NCT02327078|64553814|FG001|Overall Study|Physician Decision|0|||
23221875|NCT02327078|64553815|FG002|Overall Study|Physician Decision|0|||
23221876|NCT02327078|64553816|FG003|Overall Study|Physician Decision|1|||
23221877|NCT02327078|64553817|FG004|Overall Study|Physician Decision|0|||
23221878|NCT02327078|64553818|FG005|Overall Study|Physician Decision|0|||
23221879|NCT02327078|64553819|FG006|Overall Study|Physician Decision|0|||
23221880|NCT02327078|64553820|FG007|Overall Study|Physician Decision|0|||
23221881|NCT02327078|64553821|FG008|Overall Study|Physician Decision|1|||
23221882|NCT02327078|64553813|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
23566370|NCT00979602|65803816|FG000|Overall Study|Withdrawal by Subject|31|||
23566371|NCT00979602|65803817|FG001|Overall Study|Withdrawal by Subject|25|||
23566372|NCT00979602|65803816|FG000|Overall Study|Lost to Follow-up|100|||
23628429|NCT01236352|66024732|FG003|Overall Study|Disease progression|2|||
23628430|NCT01236352|66024733|FG004|Overall Study|Disease progression|2|||
23628431|NCT01236352|66024734|FG005|Overall Study|Disease progression|2|||
23157367|NCT03370120|64325523|FG000|Overall Study|Promoter's decision|2|||
23566373|NCT00979602|65803817|FG001|Overall Study|Lost to Follow-up|96|||
23566374|NCT00979602|65803816|FG000|Overall Study|Migrated/moved from study area|3|||
23566375|NCT00979602|65803817|FG001|Overall Study|Migrated/moved from study area|6|||
23566376|NCT00979602|65803816|FG000|Overall Study|Others|3|||
23566377|NCT00979602|65803817|FG001|Overall Study|Others|3|||
23566378|NCT04651114|65803820|FG000|Overall Study|Withdrawal by Subject|8|||
23566379|NCT02424591|65803821|FG000|Overall Study|Protocol Violation|2|||
23566380|NCT02424591|65803822|FG001|Overall Study|Protocol Violation|3|||
23566381|NCT02118337|65803826|FG000|Overall Study|Other|1|||
23566382|NCT02118337|65803827|FG001|Overall Study|Other|0|||
23566383|NCT02118337|65803828|FG002|Overall Study|Other|0|||
23566384|NCT02118337|65803829|FG003|Overall Study|Other|0|||
23157368|NCT03370120|64325523|FG000|Overall Study|The trial has been suspended|3|||
23157369|NCT03370120|64325523|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
23157370|NCT03370120|64325523|FG000|Overall Study|Early termination by order of sponsor|2|||
23157371|NCT03370120|64325523|FG000|Overall Study|Discontinuation of the study|5|||
23157372|NCT03370120|64325523|FG000|Overall Study|End of clinical trial discontinuation|1|||
23157373|NCT03370120|64325523|FG000|Overall Study|Because the clinical trial ended halfway|4|||
23157374|NCT03370120|64325523|FG000|Overall Study|Development discontinued|5|||
23157375|NCT03370120|64325523|FG000|Overall Study|Padsenovil program closed|3|||
23157376|NCT03370120|64325523|FG000|Overall Study|End of project|2|||
23157377|NCT03370120|64325523|FG000|Overall Study|Termination of project|1|||
23157378|NCT03370120|64325523|FG000|Overall Study|The study was interrupted by sponsor|4|||
23157379|NCT03370120|64325523|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
23157380|NCT03370120|64325523|FG000|Overall Study|End of sponsor decision|1|||
23157381|NCT03370120|64325523|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
23157382|NCT03370120|64325523|FG000|Overall Study|Early termination of studies|5|||
23157383|NCT03370120|64325523|FG000|Overall Study|This study is ended early|1|||
23566385|NCT02118337|65803830|FG004|Overall Study|Other|2|||
23566386|NCT02118337|65803831|FG005|Overall Study|Other|3|||
23566387|NCT02118337|65803832|FG006|Overall Study|Other|1|||
23566388|NCT02118337|65803833|FG007|Overall Study|Other|28|||
23566389|NCT02118337|65803834|FG008|Overall Study|Other|15|||
23628432|NCT01236352|66024735|FG006|Overall Study|Disease progression|1|||
23157384|NCT03370120|64325523|FG000|Overall Study|End of padsevonil program|2|||
23157385|NCT03370120|64325523|FG000|Overall Study|Decision of sponsor|6|||
23157386|NCT03370120|64325523|FG000|Overall Study|Asked by the sponsor|3|||
23157387|NCT03370120|64325523|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
23157388|NCT03370120|64325523|FG000|Overall Study|PI decision poor compliance from participant|1|||
23157389|NCT03370120|64325523|FG000|Overall Study|Promoter ended the study|3|||
23157390|NCT03370120|64325523|FG000|Overall Study|Premature study close by sponsor's decision|4|||
23157391|NCT03370120|64325523|FG000|Overall Study|Study terminated by sponsor|33|||
23157392|NCT03370120|64325523|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
23157393|NCT03370120|64325523|FG000|Overall Study|Sponsor decision to terminate study|63|||
23221883|NCT02327078|64553814|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
23221884|NCT02327078|64553815|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
23327972|NCT02946463|64945344|FG002|Primary Evaluation Period|Physician Decision|0|||
23566390|NCT02118337|65803826|FG000|Overall Study|Lost to Follow-up|0|||
23566391|NCT02118337|65803827|FG001|Overall Study|Lost to Follow-up|0|||
23566392|NCT02118337|65803828|FG002|Overall Study|Lost to Follow-up|0|||
23566393|NCT02118337|65803829|FG003|Overall Study|Lost to Follow-up|0|||
23221885|NCT02327078|64553816|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
23566394|NCT02118337|65803830|FG004|Overall Study|Lost to Follow-up|0|||
23566395|NCT02118337|65803831|FG005|Overall Study|Lost to Follow-up|0|||
23566396|NCT02118337|65803832|FG006|Overall Study|Lost to Follow-up|0|||
23566397|NCT02118337|65803833|FG007|Overall Study|Lost to Follow-up|1|||
23157394|NCT03370120|64325523|FG000|Overall Study|Program closure|3|||
23157395|NCT03370120|64325523|FG000|Overall Study|Study ended prematurely|1|||
23157396|NCT03370120|64325523|FG000|Overall Study|Study stopped by sponsor|2|||
23157397|NCT03370120|64325523|FG000|Overall Study|Program termination|55|||
23157398|NCT03370120|64325523|FG000|Overall Study|Sponsor decision|62|||
23157399|NCT03370120|64325523|FG000|Overall Study|Sponsor study closure|10|||
23157400|NCT01732796|64325524|FG000|Overall Study|Adverse Event|16|||
23157401|NCT01732796|64325525|FG001|Overall Study|Adverse Event|16|||
23157402|NCT01732796|64325526|FG002|Overall Study|Adverse Event|4|||
23157403|NCT01732796|64325524|FG000|Overall Study|Lack of Efficacy|21|||
23157404|NCT01732796|64325525|FG001|Overall Study|Lack of Efficacy|18|||
23157405|NCT01732796|64325526|FG002|Overall Study|Lack of Efficacy|5|||
23157406|NCT01732796|64325524|FG000|Overall Study|Lost to Follow-up|2|||
23157407|NCT01732796|64325525|FG001|Overall Study|Lost to Follow-up|0|||
23157408|NCT01732796|64325526|FG002|Overall Study|Lost to Follow-up|0|||
23157409|NCT01732796|64325524|FG000|Overall Study|Withdrawal by Subject|6|||
23157410|NCT01732796|64325525|FG001|Overall Study|Withdrawal by Subject|8|||
23157411|NCT01732796|64325526|FG002|Overall Study|Withdrawal by Subject|2|||
23157412|NCT01732796|64325524|FG000|Overall Study|Other reason not defined above|1|||
23157413|NCT01732796|64325525|FG001|Overall Study|Other reason not defined above|0|||
23157414|NCT01732796|64325526|FG002|Overall Study|Other reason not defined above|2|||
23157415|NCT00698932|64325529|FG000|Overall Study|Adverse Event|0|||
23157416|NCT00698932|64325530|FG001|Overall Study|Adverse Event|2|||
23157417|NCT00698932|64325529|FG000|Overall Study|Incorrect enrollment|0|||
23157418|NCT00698932|64325530|FG001|Overall Study|Incorrect enrollment|2|||
23157419|NCT00698932|64325529|FG000|Overall Study|Study specific discontinuation criteria|3|||
23157420|NCT00698932|64325530|FG001|Overall Study|Study specific discontinuation criteria|4|||
23157421|NCT00698932|64325529|FG000|Overall Study|Withdrawal by Subject|11|||
23157422|NCT00698932|64325530|FG001|Overall Study|Withdrawal by Subject|23|||
23157423|NCT00698932|64325529|FG000|Overall Study|Lost to Follow-up|6|||
23157424|NCT00698932|64325530|FG001|Overall Study|Lost to Follow-up|1|||
23157425|NCT00698932|64325529|FG000|Overall Study|Severe non-compliance to protocol|1|||
23157426|NCT00698932|64325530|FG001|Overall Study|Severe non-compliance to protocol|2|||
23628433|NCT01236352|66024736|FG007|Overall Study|Disease progression|3|||
23628434|NCT01236352|66024737|FG008|Overall Study|Disease progression|2|||
23157427|NCT00698932|64325529|FG000|Overall Study|Safety reasons|0|||
23157428|NCT00698932|64325530|FG001|Overall Study|Safety reasons|2|||
23157429|NCT00698932|64325529|FG000|Overall Study|Death|1|||
23157430|NCT00698932|64325530|FG001|Overall Study|Death|0|||
23628435|NCT01236352|66024738|FG009|Overall Study|Disease progression|2|||
23628436|NCT01236352|66024739|FG010|Overall Study|Disease progression|2|||
23628437|NCT01236352|66024729|FG000|Overall Study|Poor/Non-compliance|1|||
23628438|NCT01236352|66024730|FG001|Overall Study|Poor/Non-compliance|0|||
23628439|NCT01236352|66024731|FG002|Overall Study|Poor/Non-compliance|0|||
23628440|NCT01236352|66024732|FG003|Overall Study|Poor/Non-compliance|0|||
23628441|NCT01236352|66024733|FG004|Overall Study|Poor/Non-compliance|0|||
23628442|NCT01236352|66024734|FG005|Overall Study|Poor/Non-compliance|0|||
23628443|NCT01236352|66024735|FG006|Overall Study|Poor/Non-compliance|0|||
23628444|NCT01236352|66024736|FG007|Overall Study|Poor/Non-compliance|0|||
23628445|NCT01236352|66024737|FG008|Overall Study|Poor/Non-compliance|0|||
23628446|NCT01236352|66024738|FG009|Overall Study|Poor/Non-compliance|0|||
23628447|NCT01236352|66024739|FG010|Overall Study|Poor/Non-compliance|0|||
23628448|NCT01236352|66024729|FG000|Overall Study|Maximum clinical benefit|1|||
23628449|NCT01236352|66024730|FG001|Overall Study|Maximum clinical benefit|1|||
23628450|NCT01236352|66024731|FG002|Overall Study|Maximum clinical benefit|1|||
23157431|NCT00766038|64328546|FG000|Overall Study|Lost to Follow-up|15|||
23628451|NCT01236352|66024732|FG003|Overall Study|Maximum clinical benefit|0|||
23628452|NCT01236352|66024733|FG004|Overall Study|Maximum clinical benefit|2|||
23628453|NCT01236352|66024734|FG005|Overall Study|Maximum clinical benefit|0|||
23157432|NCT00766038|64328547|FG001|Overall Study|Lost to Follow-up|14|||
23157433|NCT03029143|64328548|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
23157434|NCT03029143|64328549|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
23157435|NCT03029143|64328550|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
23157436|NCT03029143|64328548|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
23157437|NCT03029143|64328549|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
23157438|NCT03029143|64328550|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
23628454|NCT01236352|66024735|FG006|Overall Study|Maximum clinical benefit|3|||
23157439|NCT03029143|64328548|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
23157440|NCT03029143|64328549|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
23157441|NCT03029143|64328550|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
23628455|NCT01236352|66024736|FG007|Overall Study|Maximum clinical benefit|1|||
23157442|NCT03029143|64328548|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
23157443|NCT03029143|64328549|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
23628456|NCT01236352|66024737|FG008|Overall Study|Maximum clinical benefit|1|||
23157444|NCT03029143|64328550|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
23628457|NCT01236352|66024738|FG009|Overall Study|Maximum clinical benefit|4|||
23157445|NCT03029143|64328548|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
23157446|NCT03029143|64328549|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
23157447|NCT03029143|64328550|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
23157448|NCT03029143|64328548|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
23157449|NCT03029143|64328549|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
23157450|NCT03029143|64328550|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
23157451|NCT03029143|64328548|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
23157452|NCT03029143|64328549|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
23157453|NCT03029143|64328550|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
23157454|NCT03029143|64328548|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23157455|NCT03029143|64328549|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23157456|NCT03029143|64328550|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
23157457|NCT03029143|64328548|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
23221886|NCT02327078|64553817|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
23221887|NCT02327078|64553818|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
23221888|NCT02327078|64553819|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
23221889|NCT02327078|64553820|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
23221890|NCT02327078|64553821|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
23221891|NCT02327078|64553813|FG000|Overall Study|Reason not Specified|0|||
23221892|NCT02327078|64553814|FG001|Overall Study|Reason not Specified|0|||
23221893|NCT02327078|64553815|FG002|Overall Study|Reason not Specified|0|||
23327973|NCT02946463|64945345|FG003|Primary Evaluation Period|Physician Decision|0|||
23327974|NCT02946463|64945342|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
23327975|NCT02946463|64945343|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
23327976|NCT02946463|64945344|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
23327977|NCT02946463|64945345|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
23327978|NCT02946463|64945342|FG000|Extension Period|Death|4|||
23327979|NCT02946463|64945343|FG001|Extension Period|Death|4|||
23327980|NCT02946463|64945344|FG002|Extension Period|Death|0|||
23327981|NCT02946463|64945345|FG003|Extension Period|Death|0|||
23327982|NCT02946463|64945342|FG000|Extension Period|Withdrawal by Subject|4|||
23327983|NCT02946463|64945343|FG001|Extension Period|Withdrawal by Subject|3|||
23327984|NCT02946463|64945344|FG002|Extension Period|Withdrawal by Subject|0|||
23327985|NCT02946463|64945345|FG003|Extension Period|Withdrawal by Subject|0|||
23443321|NCT01132313|65366367|FG000|Overall Study|Not treated|2|||
23443322|NCT01132313|65366368|FG001|Overall Study|Not treated|0|||
23443323|NCT01132313|65366369|FG002|Overall Study|Not treated|0|||
23443324|NCT01132313|65366370|FG003|Overall Study|Not treated|0|||
23221894|NCT02327078|64553816|FG003|Overall Study|Reason not Specified|0|||
23221895|NCT02327078|64553817|FG004|Overall Study|Reason not Specified|0|||
23221896|NCT02327078|64553818|FG005|Overall Study|Reason not Specified|0|||
23221897|NCT02327078|64553819|FG006|Overall Study|Reason not Specified|0|||
23221898|NCT02327078|64553820|FG007|Overall Study|Reason not Specified|5|||
23221899|NCT02327078|64553821|FG008|Overall Study|Reason not Specified|12|||
23221900|NCT01047436|64553822|FG000|Overall Study|Protocol Violation|1|||
23221901|NCT01047436|64553823|FG001|Overall Study|Protocol Violation|0|||
23566398|NCT02118337|65803834|FG008|Overall Study|Lost to Follow-up|0|||
23566399|NCT02118337|65803826|FG000|Overall Study|Withdrawal by Subject|1|||
23566400|NCT02118337|65803827|FG001|Overall Study|Withdrawal by Subject|3|||
23566401|NCT02118337|65803828|FG002|Overall Study|Withdrawal by Subject|2|||
23566402|NCT02118337|65803829|FG003|Overall Study|Withdrawal by Subject|1|||
23566403|NCT02118337|65803830|FG004|Overall Study|Withdrawal by Subject|2|||
23566404|NCT02118337|65803831|FG005|Overall Study|Withdrawal by Subject|2|||
23157458|NCT03029143|64328549|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
23157459|NCT03029143|64328550|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
23157460|NCT03029143|64328548|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23157461|NCT03029143|64328549|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
23157462|NCT03029143|64328550|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
23221902|NCT01431521|64553824|FG000|Overall Study|Withdrawal by Subject|0|||
23221903|NCT01431521|64553825|FG001|Overall Study|Withdrawal by Subject|0|||
23221904|NCT01431521|64553826|FG002|Overall Study|Withdrawal by Subject|1|||
23327986|NCT02946463|64945342|FG000|Extension Period|Other than specified|2|||
23327987|NCT02946463|64945343|FG001|Extension Period|Other than specified|3|||
23327988|NCT02946463|64945344|FG002|Extension Period|Other than specified|2|||
23327989|NCT02946463|64945345|FG003|Extension Period|Other than specified|0|||
23443325|NCT01132313|65366371|FG004|Overall Study|Not treated|2|||
23566405|NCT02118337|65803832|FG006|Overall Study|Withdrawal by Subject|1|||
23566406|NCT02118337|65803833|FG007|Overall Study|Withdrawal by Subject|4|||
23566407|NCT02118337|65803834|FG008|Overall Study|Withdrawal by Subject|2|||
23327990|NCT02946463|64945342|FG000|Extension Period|Physician Decision|1|||
23443326|NCT01132313|65366372|FG005|Overall Study|Not treated|1|||
23628458|NCT01236352|66024739|FG010|Overall Study|Maximum clinical benefit|2|||
23443327|NCT01132313|65366373|FG006|Overall Study|Not treated|3|||
23443328|NCT01132313|65366374|FG007|Overall Study|Not treated|0|||
23443329|NCT01132313|65366375|FG008|Overall Study|Not treated|0|||
23443330|NCT01132313|65366376|FG009|Overall Study|Not treated|0|||
23443331|NCT01132313|65366377|FG010|Overall Study|Not treated|0|||
23443332|NCT01132313|65366378|FG011|Overall Study|Not treated|0|||
23443333|NCT01132313|65366367|FG000|Overall Study|Adverse Event|0|||
23443334|NCT01132313|65366368|FG001|Overall Study|Adverse Event|0|||
23443335|NCT01132313|65366369|FG002|Overall Study|Adverse Event|4|||
23443336|NCT01132313|65366370|FG003|Overall Study|Adverse Event|10|||
23443337|NCT01132313|65366371|FG004|Overall Study|Adverse Event|19|||
23443338|NCT01132313|65366372|FG005|Overall Study|Adverse Event|6|||
23443339|NCT01132313|65366373|FG006|Overall Study|Adverse Event|5|||
23443340|NCT01132313|65366374|FG007|Overall Study|Adverse Event|3|||
23443341|NCT01132313|65366375|FG008|Overall Study|Adverse Event|7|||
23443342|NCT01132313|65366376|FG009|Overall Study|Adverse Event|2|||
23443343|NCT01132313|65366377|FG010|Overall Study|Adverse Event|0|||
23443344|NCT01132313|65366378|FG011|Overall Study|Adverse Event|0|||
23443345|NCT01132313|65366367|FG000|Overall Study|Protocol Violation|0|||
23443346|NCT01132313|65366368|FG001|Overall Study|Protocol Violation|0|||
23443347|NCT01132313|65366369|FG002|Overall Study|Protocol Violation|0|||
23443348|NCT01132313|65366370|FG003|Overall Study|Protocol Violation|1|||
23443349|NCT01132313|65366371|FG004|Overall Study|Protocol Violation|0|||
23443350|NCT01132313|65366372|FG005|Overall Study|Protocol Violation|0|||
23443351|NCT01132313|65366373|FG006|Overall Study|Protocol Violation|0|||
23443352|NCT01132313|65366374|FG007|Overall Study|Protocol Violation|0|||
23443353|NCT01132313|65366375|FG008|Overall Study|Protocol Violation|0|||
23221905|NCT01431521|64553827|FG003|Overall Study|Withdrawal by Subject|0|||
23221906|NCT02724111|64553834|FG000|Overall Study|Protocol Violation|2|||
23443354|NCT01132313|65366376|FG009|Overall Study|Protocol Violation|0|||
23443355|NCT01132313|65366377|FG010|Overall Study|Protocol Violation|0|||
23443356|NCT01132313|65366378|FG011|Overall Study|Protocol Violation|0|||
23443357|NCT01132313|65366367|FG000|Overall Study|Lost to Follow-up|0|||
23443358|NCT01132313|65366368|FG001|Overall Study|Lost to Follow-up|0|||
23443359|NCT01132313|65366369|FG002|Overall Study|Lost to Follow-up|1|||
23443360|NCT01132313|65366370|FG003|Overall Study|Lost to Follow-up|0|||
23443361|NCT01132313|65366371|FG004|Overall Study|Lost to Follow-up|0|||
23443362|NCT01132313|65366372|FG005|Overall Study|Lost to Follow-up|0|||
23443363|NCT01132313|65366373|FG006|Overall Study|Lost to Follow-up|0|||
23443364|NCT01132313|65366374|FG007|Overall Study|Lost to Follow-up|1|||
23566408|NCT02118337|65803826|FG000|Overall Study|Death|2|||
23566409|NCT02118337|65803827|FG001|Overall Study|Death|2|||
23566410|NCT02118337|65803828|FG002|Overall Study|Death|1|||
23157463|NCT03029143|64328548|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
23157464|NCT03029143|64328549|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
23157465|NCT03029143|64328550|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
23157466|NCT02109562|64328554|FG000|Overall Study|Insufficient clinical response|2|||
23157467|NCT02109562|64328555|FG001|Overall Study|Insufficient clinical response|0|||
23157468|NCT02109562|64328556|FG002|Overall Study|Insufficient clinical response|4|||
23157469|NCT02109562|64328554|FG000|Overall Study|Adverse Event|0|||
23157470|NCT02109562|64328555|FG001|Overall Study|Adverse Event|2|||
23157471|NCT02109562|64328556|FG002|Overall Study|Adverse Event|3|||
23157472|NCT02109562|64328554|FG000|Overall Study|Lost to Follow-up|1|||
23157473|NCT02109562|64328555|FG001|Overall Study|Lost to Follow-up|0|||
23221907|NCT02724111|64553835|FG001|Overall Study|Protocol Violation|5|||
23443365|NCT01132313|65366375|FG008|Overall Study|Lost to Follow-up|0|||
23157474|NCT02109562|64328556|FG002|Overall Study|Lost to Follow-up|1|||
23157475|NCT02109562|64328554|FG000|Overall Study|Protocol Violation|0|||
23157476|NCT02109562|64328555|FG001|Overall Study|Protocol Violation|3|||
23157477|NCT02109562|64328556|FG002|Overall Study|Protocol Violation|1|||
23157478|NCT02109562|64328554|FG000|Overall Study|Withdrawal by Subject|20|||
23157479|NCT02109562|64328555|FG001|Overall Study|Withdrawal by Subject|25|||
23157480|NCT02109562|64328556|FG002|Overall Study|Withdrawal by Subject|21|||
23157481|NCT02109562|64328554|FG000|Overall Study|Physician Decision|3|||
23221908|NCT02738580|64553837|FG000|Overall Study|Adverse Event|1|||
23443366|NCT01132313|65366376|FG009|Overall Study|Lost to Follow-up|0|||
23443367|NCT01132313|65366377|FG010|Overall Study|Lost to Follow-up|0|||
23443368|NCT01132313|65366378|FG011|Overall Study|Lost to Follow-up|0|||
23443369|NCT01132313|65366367|FG000|Overall Study|Withdrawal by Subject|0|||
23443370|NCT01132313|65366368|FG001|Overall Study|Withdrawal by Subject|0|||
23443371|NCT01132313|65366369|FG002|Overall Study|Withdrawal by Subject|3|||
23443372|NCT01132313|65366370|FG003|Overall Study|Withdrawal by Subject|3|||
23566411|NCT02118337|65803829|FG003|Overall Study|Death|2|||
23157482|NCT02109562|64328555|FG001|Overall Study|Physician Decision|4|||
23221909|NCT02738580|64553838|FG001|Overall Study|Adverse Event|0|||
23443373|NCT01132313|65366371|FG004|Overall Study|Withdrawal by Subject|6|||
23443374|NCT01132313|65366372|FG005|Overall Study|Withdrawal by Subject|0|||
23443375|NCT01132313|65366373|FG006|Overall Study|Withdrawal by Subject|1|||
23443376|NCT01132313|65366374|FG007|Overall Study|Withdrawal by Subject|0|||
23566412|NCT02118337|65803830|FG004|Overall Study|Death|5|||
23443377|NCT01132313|65366375|FG008|Overall Study|Withdrawal by Subject|0|||
23443378|NCT01132313|65366376|FG009|Overall Study|Withdrawal by Subject|2|||
23443379|NCT01132313|65366377|FG010|Overall Study|Withdrawal by Subject|0|||
23443380|NCT01132313|65366378|FG011|Overall Study|Withdrawal by Subject|0|||
23443381|NCT01132313|65366367|FG000|Overall Study|Lack of antiviral response|0|||
23443382|NCT01132313|65366368|FG001|Overall Study|Lack of antiviral response|0|||
23443383|NCT01132313|65366369|FG002|Overall Study|Lack of antiviral response|12|||
23443384|NCT01132313|65366370|FG003|Overall Study|Lack of antiviral response|18|||
23443385|NCT01132313|65366371|FG004|Overall Study|Lack of antiviral response|18|||
23443386|NCT01132313|65366372|FG005|Overall Study|Lack of antiviral response|18|||
23443387|NCT01132313|65366373|FG006|Overall Study|Lack of antiviral response|21|||
23443388|NCT01132313|65366374|FG007|Overall Study|Lack of antiviral response|0|||
23443389|NCT01132313|65366375|FG008|Overall Study|Lack of antiviral response|0|||
23443390|NCT01132313|65366376|FG009|Overall Study|Lack of antiviral response|0|||
23443391|NCT01132313|65366377|FG010|Overall Study|Lack of antiviral response|1|||
23443392|NCT01132313|65366378|FG011|Overall Study|Lack of antiviral response|0|||
23443393|NCT01132313|65366367|FG000|Overall Study|Other reason not defined above|0|||
23443394|NCT01132313|65366368|FG001|Overall Study|Other reason not defined above|0|||
23327991|NCT02946463|64945343|FG001|Extension Period|Physician Decision|4|||
23327992|NCT02946463|64945344|FG002|Extension Period|Physician Decision|0|||
23327993|NCT02946463|64945345|FG003|Extension Period|Physician Decision|0|||
23327994|NCT02946463|64945342|FG000|Extension Period|Pregnancy|3|||
23327995|NCT02946463|64945343|FG001|Extension Period|Pregnancy|1|||
23327996|NCT02946463|64945344|FG002|Extension Period|Pregnancy|0|||
23327997|NCT02946463|64945345|FG003|Extension Period|Pregnancy|0|||
23327998|NCT02946463|64945342|FG000|Extension Period|Adverse Event|1|||
23327999|NCT02946463|64945343|FG001|Extension Period|Adverse Event|2|||
23328000|NCT02946463|64945344|FG002|Extension Period|Adverse Event|0|||
23328001|NCT02946463|64945345|FG003|Extension Period|Adverse Event|0|||
23157483|NCT02109562|64328556|FG002|Overall Study|Physician Decision|5|||
23328002|NCT02946463|64945342|FG000|Extension Period|Lost to Follow-up|1|||
23328003|NCT02946463|64945343|FG001|Extension Period|Lost to Follow-up|0|||
23328004|NCT02946463|64945344|FG002|Extension Period|Lost to Follow-up|0|||
23328005|NCT02946463|64945345|FG003|Extension Period|Lost to Follow-up|0|||
23328006|NCT04846569|64945346|FG000|Overall Study|Withdrawal by Subject|3|||
23328007|NCT04846569|64945347|FG001|Overall Study|Withdrawal by Subject|1|||
23328008|NCT01293695|64945348|FG000|Overall Study|Withdrawal by Subject|7|||
23328009|NCT01293695|64945349|FG001|Overall Study|Withdrawal by Subject|1|||
23328010|NCT01293695|64945348|FG000|Overall Study|Lost to Follow-up|8|||
23328011|NCT01293695|64945349|FG001|Overall Study|Lost to Follow-up|6|||
23328012|NCT00615550|64945350|FG000|Overall Study|Lost to Follow-up|6|||
23328013|NCT00615550|64945351|FG001|Overall Study|Lost to Follow-up|1|||
23443395|NCT01132313|65366369|FG002|Overall Study|Other reason not defined above|0|||
23443396|NCT01132313|65366370|FG003|Overall Study|Other reason not defined above|0|||
23443397|NCT01132313|65366371|FG004|Overall Study|Other reason not defined above|0|||
23443398|NCT01132313|65366372|FG005|Overall Study|Other reason not defined above|0|||
23443399|NCT01132313|65366373|FG006|Overall Study|Other reason not defined above|0|||
23157484|NCT03523728|64328557|FG000|Stage 1 (24 Months)|Adverse Event|2|||
23157485|NCT03523728|64328558|FG001|Stage 1 (24 Months)|Adverse Event|2|||
23157486|NCT03523728|64328559|FG002|Stage 1 (24 Months)|Adverse Event|4|||
23157487|NCT03523728|64328560|FG003|Stage 1 (24 Months)|Adverse Event|0|||
23157488|NCT03523728|64328561|FG004|Stage 1 (24 Months)|Adverse Event|0|||
23157489|NCT03523728|64328557|FG000|Stage 1 (24 Months)|Progressive disease|0|||
23157490|NCT03523728|64328558|FG001|Stage 1 (24 Months)|Progressive disease|0|||
23157491|NCT03523728|64328559|FG002|Stage 1 (24 Months)|Progressive disease|1|||
23157492|NCT03523728|64328560|FG003|Stage 1 (24 Months)|Progressive disease|0|||
23157493|NCT03523728|64328561|FG004|Stage 1 (24 Months)|Progressive disease|0|||
23157494|NCT03523728|64328557|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
23157495|NCT03523728|64328558|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
23157496|NCT03523728|64328559|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
23328014|NCT01641640|64945352|FG000|Overall Study|Enrolled but not treated|1|||
23328015|NCT01641640|64945352|FG000|Overall Study|Efficacy failure|29|||
23328016|NCT01641640|64945352|FG000|Overall Study|Lost to Follow-up|3|||
23328017|NCT01641640|64945352|FG000|Overall Study|Withdrawal by Subject|2|||
23443400|NCT01132313|65366374|FG007|Overall Study|Other reason not defined above|1|||
23443401|NCT01132313|65366375|FG008|Overall Study|Other reason not defined above|0|||
23443402|NCT01132313|65366376|FG009|Overall Study|Other reason not defined above|0|||
23443403|NCT01132313|65366377|FG010|Overall Study|Other reason not defined above|0|||
23443404|NCT01132313|65366378|FG011|Overall Study|Other reason not defined above|0|||
23157497|NCT03523728|64328560|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
23157498|NCT03523728|64328561|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
23157499|NCT03523728|64328557|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
23328018|NCT01641640|64945352|FG000|Overall Study|Adverse Event|1|||
23328019|NCT00460603|64945360|FG000|Phase 1|Death|1|||
23328020|NCT00460603|64945361|FG001|Phase 1|Death|0|||
23328021|NCT00460603|64945362|FG002|Phase 1|Death|0|||
23328022|NCT00460603|64945363|FG003|Phase 1|Death|2|||
23157500|NCT03523728|64328558|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
23443405|NCT00548145|65366383|FG000|Overall Study|Death|0|||
23443406|NCT00548145|65366384|FG001|Overall Study|Death|1|||
23443407|NCT00548145|65366383|FG000|Overall Study|Withdrawal by Subject|0|||
23443408|NCT00548145|65366384|FG001|Overall Study|Withdrawal by Subject|2|||
23443409|NCT00548145|65366383|FG000|Overall Study|Physician Decision|1|||
23443410|NCT00548145|65366384|FG001|Overall Study|Physician Decision|1|||
23443411|NCT03155724|65366389|FG000|Overall Study|Death|3|||
23443412|NCT03155724|65366389|FG000|Overall Study|Physician Decision|1|||
23443413|NCT03155724|65366389|FG000|Overall Study|Study closure|7|||
23443414|NCT00546000|65366390|FG000|Overall Study|Adverse Event|1|||
23443415|NCT00546000|65366390|FG000|Overall Study|Lost to Follow-up|1|||
23443416|NCT00546000|65366390|FG000|Overall Study|Baseline HPA Axis Supression|2|||
23443417|NCT02475278|65366391|FG000|Overall Study|Lost to Follow-up|1|||
23443418|NCT02475278|65366391|FG000|Overall Study|Reason Not Specified|1|||
23443419|NCT05258149|65366392|FG000|Period 1|Protocol Deviation|1|||
23443420|NCT05258149|65366393|FG001|Period 1|Protocol Deviation|0|||
23443421|NCT05258149|65366392|FG000|Period 1|Adverse Event|0|||
23443422|NCT05258149|65366393|FG001|Period 1|Adverse Event|1|||
23443423|NCT05258149|65366392|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
23443424|NCT05258149|65366393|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
23443425|NCT05258149|65366392|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
23443426|NCT05258149|65366393|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
23157501|NCT03523728|64328559|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
23157502|NCT03523728|64328560|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
23157503|NCT03523728|64328561|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
23157504|NCT03523728|64328557|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
23157505|NCT03523728|64328558|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
23157506|NCT03523728|64328559|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
23157507|NCT03523728|64328560|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
23157508|NCT03523728|64328561|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
23443427|NCT05258149|65366392|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
23443428|NCT05258149|65366393|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
23443429|NCT00584415|65366396|FG000|Overall Study|Adverse Event|7|||
23443430|NCT02698826|65366400|FG000|Overall Study|Death|13|||
23443431|NCT02698826|65366400|FG000|Overall Study|Adverse Event|1|||
23443432|NCT01919801|65366402|FG000|Overall Study|Withdrawal by Subject|1|||
23443433|NCT01919801|65366403|FG001|Overall Study|Withdrawal by Subject|0|||
23443434|NCT01919801|65366402|FG000|Overall Study|Physician Decision|0|||
23443435|NCT01919801|65366403|FG001|Overall Study|Physician Decision|1|||
23443436|NCT01919801|65366402|FG000|Overall Study|Lost to Follow-up|0|||
23443437|NCT01919801|65366403|FG001|Overall Study|Lost to Follow-up|1|||
23443438|NCT01919801|65366402|FG000|Overall Study|Other|0|||
23443439|NCT01919801|65366403|FG001|Overall Study|Other|1|||
23443440|NCT00649428|65366404|FG000|Overall Study|Adverse Event|2|||
23443441|NCT00649428|65366405|FG001|Overall Study|Adverse Event|2|||
23443442|NCT00649428|65366404|FG000|Overall Study|Withdrawal by Subject|6|||
23443443|NCT00649428|65366405|FG001|Overall Study|Withdrawal by Subject|6|||
23566413|NCT02118337|65803831|FG005|Overall Study|Death|1|||
23566414|NCT02118337|65803832|FG006|Overall Study|Death|2|||
23566415|NCT02118337|65803833|FG007|Overall Study|Death|9|||
23566416|NCT02118337|65803834|FG008|Overall Study|Death|4|||
23566417|NCT01032044|65803842|FG000|Overall Study|Protocol Violation|14|||
23566418|NCT01032044|65803843|FG001|Overall Study|Protocol Violation|8|||
23566419|NCT01032044|65803842|FG000|Overall Study|Adverse Event|0|||
23566420|NCT01032044|65803843|FG001|Overall Study|Adverse Event|1|||
23566421|NCT01032044|65803842|FG000|Overall Study|Lost to Follow-up|11|||
23566422|NCT01032044|65803843|FG001|Overall Study|Lost to Follow-up|11|||
23566423|NCT02392611|65803844|FG000|Overall Study|Adverse Event|0|||
23566424|NCT02392611|65803845|FG001|Overall Study|Adverse Event|0|||
23566425|NCT02392611|65803846|FG002|Overall Study|Adverse Event|0|||
23566426|NCT02392611|65803847|FG003|Overall Study|Adverse Event|1|||
23566427|NCT02392611|65803848|FG004|Overall Study|Adverse Event|0|||
23566428|NCT02392611|65803849|FG005|Overall Study|Adverse Event|0|||
23566429|NCT02392611|65803850|FG006|Overall Study|Adverse Event|0|||
23566430|NCT02392611|65803851|FG007|Overall Study|Adverse Event|0|||
23566431|NCT02392611|65803852|FG008|Overall Study|Adverse Event|0|||
23566432|NCT02392611|65803844|FG000|Overall Study|Progressive disease|0|||
23566433|NCT02392611|65803845|FG001|Overall Study|Progressive disease|0|||
23566434|NCT02392611|65803846|FG002|Overall Study|Progressive disease|0|||
23157509|NCT03523728|64328557|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
23566435|NCT02392611|65803847|FG003|Overall Study|Progressive disease|2|||
23566436|NCT02392611|65803848|FG004|Overall Study|Progressive disease|1|||
23566437|NCT02392611|65803849|FG005|Overall Study|Progressive disease|0|||
23443444|NCT00649428|65366404|FG000|Overall Study|Lost to Follow-up|1|||
23443445|NCT00649428|65366405|FG001|Overall Study|Lost to Follow-up|3|||
23566438|NCT02392611|65803850|FG006|Overall Study|Progressive disease|0|||
23566439|NCT02392611|65803851|FG007|Overall Study|Progressive disease|0|||
23566440|NCT02392611|65803852|FG008|Overall Study|Progressive disease|0|||
23443446|NCT00649428|65366404|FG000|Overall Study|Insufficient manufacturing yield|5|||
23443447|NCT00649428|65366405|FG001|Overall Study|Insufficient manufacturing yield|1|||
23443448|NCT00649428|65366404|FG000|Overall Study|Protocol Violation|6|||
23628459|NCT01236352|66024729|FG000|Overall Study|Subject request to discontinue treatment|0|||
23628460|NCT01236352|66024730|FG001|Overall Study|Subject request to discontinue treatment|0|||
23443449|NCT00649428|65366405|FG001|Overall Study|Protocol Violation|2|||
23443450|NCT00649428|65366404|FG000|Overall Study|Physician Decision|0|||
23443451|NCT00649428|65366405|FG001|Overall Study|Physician Decision|1|||
23566441|NCT02392611|65803844|FG000|Overall Study|Death|1|||
23566442|NCT02392611|65803845|FG001|Overall Study|Death|0|||
23566443|NCT02392611|65803846|FG002|Overall Study|Death|0|||
23566444|NCT02392611|65803847|FG003|Overall Study|Death|0|||
23566445|NCT02392611|65803848|FG004|Overall Study|Death|0|||
23566446|NCT02392611|65803849|FG005|Overall Study|Death|1|||
23566447|NCT02392611|65803850|FG006|Overall Study|Death|0|||
23566448|NCT02392611|65803851|FG007|Overall Study|Death|0|||
23566449|NCT02392611|65803852|FG008|Overall Study|Death|0|||
23566450|NCT02392611|65803844|FG000|Overall Study|Withdrawal by Subject|0|||
23566451|NCT02392611|65803845|FG001|Overall Study|Withdrawal by Subject|0|||
23566452|NCT02392611|65803846|FG002|Overall Study|Withdrawal by Subject|0|||
23566453|NCT02392611|65803847|FG003|Overall Study|Withdrawal by Subject|1|||
23566454|NCT02392611|65803848|FG004|Overall Study|Withdrawal by Subject|0|||
23566455|NCT02392611|65803849|FG005|Overall Study|Withdrawal by Subject|0|||
23566456|NCT02392611|65803850|FG006|Overall Study|Withdrawal by Subject|0|||
23566457|NCT02392611|65803851|FG007|Overall Study|Withdrawal by Subject|0|||
23566458|NCT02392611|65803852|FG008|Overall Study|Withdrawal by Subject|0|||
23566459|NCT02392611|65803844|FG000|Overall Study|Lost to Follow-up|0|||
23566460|NCT02392611|65803845|FG001|Overall Study|Lost to Follow-up|0|||
23566461|NCT02392611|65803846|FG002|Overall Study|Lost to Follow-up|0|||
23566462|NCT02392611|65803847|FG003|Overall Study|Lost to Follow-up|0|||
23566463|NCT02392611|65803848|FG004|Overall Study|Lost to Follow-up|0|||
23566464|NCT02392611|65803849|FG005|Overall Study|Lost to Follow-up|0|||
23566465|NCT02392611|65803850|FG006|Overall Study|Lost to Follow-up|1|||
23566466|NCT02392611|65803851|FG007|Overall Study|Lost to Follow-up|0|||
23566467|NCT02392611|65803852|FG008|Overall Study|Lost to Follow-up|0|||
23566468|NCT02392611|65803844|FG000|Overall Study|Enrolled, not treated|0|||
23566469|NCT02392611|65803845|FG001|Overall Study|Enrolled, not treated|0|||
23566470|NCT02392611|65803846|FG002|Overall Study|Enrolled, not treated|0|||
23566471|NCT02392611|65803847|FG003|Overall Study|Enrolled, not treated|2|||
23566472|NCT02392611|65803848|FG004|Overall Study|Enrolled, not treated|0|||
23566473|NCT02392611|65803849|FG005|Overall Study|Enrolled, not treated|0|||
23566474|NCT02392611|65803850|FG006|Overall Study|Enrolled, not treated|0|||
23566475|NCT02392611|65803851|FG007|Overall Study|Enrolled, not treated|0|||
23566476|NCT02392611|65803852|FG008|Overall Study|Enrolled, not treated|0|||
23566477|NCT00482274|65803858|FG000|Overall Study|Adverse Event|1|||
23566478|NCT02247804|65803859|FG000|Treatment Period 1|Adverse Event|9|||
23566479|NCT02247804|65803860|FG001|Treatment Period 1|Adverse Event|2|||
23566480|NCT02247804|65803861|FG002|Treatment Period 1|Adverse Event|0|||
23566481|NCT02247804|65803859|FG000|Treatment Period 1|Lack of Efficacy|0|||
23566482|NCT02247804|65803860|FG001|Treatment Period 1|Lack of Efficacy|0|||
23566483|NCT02247804|65803861|FG002|Treatment Period 1|Lack of Efficacy|2|||
23566484|NCT02247804|65803859|FG000|Treatment Period 1|Lost to Follow-up|1|||
23566485|NCT02247804|65803860|FG001|Treatment Period 1|Lost to Follow-up|0|||
23566486|NCT02247804|65803861|FG002|Treatment Period 1|Lost to Follow-up|2|||
23566487|NCT02247804|65803859|FG000|Treatment Period 1|Personal Reasons|7|||
23566488|NCT02247804|65803860|FG001|Treatment Period 1|Personal Reasons|1|||
23566489|NCT02247804|65803861|FG002|Treatment Period 1|Personal Reasons|2|||
23566490|NCT02247804|65803859|FG000|Treatment Period 1|Protocol Deviation|0|||
23566491|NCT02247804|65803860|FG001|Treatment Period 1|Protocol Deviation|0|||
23566492|NCT02247804|65803861|FG002|Treatment Period 1|Protocol Deviation|1|||
23566493|NCT02247804|65803859|FG000|Treatment Period 1|Randomized but not Treated|5|||
23566494|NCT02247804|65803860|FG001|Treatment Period 1|Randomized but not Treated|1|||
23566495|NCT02247804|65803861|FG002|Treatment Period 1|Randomized but not Treated|1|||
23566496|NCT02247804|65803859|FG000|Treatment Period 2|Adverse Event|6|||
23157510|NCT03523728|64328558|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
23157511|NCT03523728|64328559|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
23157512|NCT03523728|64328560|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
23157513|NCT03523728|64328561|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
23157514|NCT03523728|64328557|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
23157515|NCT03523728|64328558|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
23157516|NCT03523728|64328559|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
23157517|NCT03523728|64328560|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
23157518|NCT03523728|64328561|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
23157519|NCT03523728|64328557|FG000|Stage 2 (24 Months)|Adverse Event|0|||
23443452|NCT02352753|65366406|FG000|6-Month Dosing Period|Decision by sponsor|2|||
23566497|NCT02247804|65803860|FG001|Treatment Period 2|Adverse Event|3|||
23566498|NCT02247804|65803861|FG002|Treatment Period 2|Adverse Event|3|||
23328023|NCT00460603|64945364|FG004|Phase 1|Death|0|||
23328024|NCT00460603|64945365|FG005|Phase 1|Death|0|||
23328025|NCT00460603|64945366|FG006|Phase 1|Death|0|||
23328026|NCT00460603|64945367|FG007|Phase 1|Death|0|||
23328027|NCT00460603|64945368|FG008|Phase 1|Death|1|||
23328028|NCT00460603|64945369|FG009|Phase 1|Death|0|||
23328029|NCT00460603|64945370|FG010|Phase 1|Death|0|||
23328030|NCT00460603|64945371|FG011|Phase 1|Death|0|||
23328031|NCT00460603|64945360|FG000|Phase 1|Adverse Event|3|||
23328032|NCT00460603|64945361|FG001|Phase 1|Adverse Event|1|||
23328033|NCT00460603|64945362|FG002|Phase 1|Adverse Event|1|||
23328034|NCT00460603|64945363|FG003|Phase 1|Adverse Event|2|||
23328035|NCT00460603|64945364|FG004|Phase 1|Adverse Event|0|||
23328036|NCT00460603|64945365|FG005|Phase 1|Adverse Event|0|||
23328037|NCT00460603|64945366|FG006|Phase 1|Adverse Event|3|||
23328038|NCT00460603|64945367|FG007|Phase 1|Adverse Event|0|||
23328039|NCT00460603|64945368|FG008|Phase 1|Adverse Event|4|||
23328040|NCT00460603|64945369|FG009|Phase 1|Adverse Event|0|||
23328041|NCT00460603|64945370|FG010|Phase 1|Adverse Event|0|||
23328042|NCT00460603|64945371|FG011|Phase 1|Adverse Event|0|||
23328043|NCT00460603|64945360|FG000|Phase 1|Lack of Efficacy|1|||
23566499|NCT02247804|65803859|FG000|Treatment Period 2|Lack of Efficacy|0|||
23328044|NCT00460603|64945361|FG001|Phase 1|Lack of Efficacy|0|||
23328045|NCT00460603|64945362|FG002|Phase 1|Lack of Efficacy|1|||
23328046|NCT00460603|64945363|FG003|Phase 1|Lack of Efficacy|2|||
23328047|NCT00460603|64945364|FG004|Phase 1|Lack of Efficacy|2|||
23328048|NCT00460603|64945365|FG005|Phase 1|Lack of Efficacy|2|||
23328049|NCT00460603|64945366|FG006|Phase 1|Lack of Efficacy|2|||
23328050|NCT00460603|64945367|FG007|Phase 1|Lack of Efficacy|2|||
23328051|NCT00460603|64945368|FG008|Phase 1|Lack of Efficacy|11|||
23328052|NCT00460603|64945369|FG009|Phase 1|Lack of Efficacy|0|||
23328053|NCT00460603|64945370|FG010|Phase 1|Lack of Efficacy|0|||
23328054|NCT00460603|64945371|FG011|Phase 1|Lack of Efficacy|0|||
23328055|NCT00460603|64945360|FG000|Phase 1|Withdrawal by Subject|1|||
23328056|NCT00460603|64945361|FG001|Phase 1|Withdrawal by Subject|2|||
23328057|NCT00460603|64945362|FG002|Phase 1|Withdrawal by Subject|1|||
23328058|NCT00460603|64945363|FG003|Phase 1|Withdrawal by Subject|1|||
23328059|NCT00460603|64945364|FG004|Phase 1|Withdrawal by Subject|3|||
23328060|NCT00460603|64945365|FG005|Phase 1|Withdrawal by Subject|0|||
23328061|NCT00460603|64945366|FG006|Phase 1|Withdrawal by Subject|1|||
23328062|NCT00460603|64945367|FG007|Phase 1|Withdrawal by Subject|0|||
23328063|NCT00460603|64945368|FG008|Phase 1|Withdrawal by Subject|2|||
23328064|NCT00460603|64945369|FG009|Phase 1|Withdrawal by Subject|0|||
23328065|NCT00460603|64945370|FG010|Phase 1|Withdrawal by Subject|0|||
23328066|NCT00460603|64945371|FG011|Phase 1|Withdrawal by Subject|0|||
23328067|NCT00460603|64945360|FG000|Phase 1|Other|0|||
23328068|NCT00460603|64945361|FG001|Phase 1|Other|3|||
23328069|NCT00460603|64945362|FG002|Phase 1|Other|1|||
23328070|NCT00460603|64945363|FG003|Phase 1|Other|1|||
23328071|NCT00460603|64945364|FG004|Phase 1|Other|1|||
23566500|NCT02247804|65803860|FG001|Treatment Period 2|Lack of Efficacy|0|||
23566501|NCT02247804|65803861|FG002|Treatment Period 2|Lack of Efficacy|1|||
23566502|NCT02247804|65803859|FG000|Treatment Period 2|Lost to Follow-up|0|||
23566503|NCT02247804|65803860|FG001|Treatment Period 2|Lost to Follow-up|1|||
23566504|NCT02247804|65803861|FG002|Treatment Period 2|Lost to Follow-up|1|||
23566505|NCT02247804|65803859|FG000|Treatment Period 2|Personal Reasons|2|||
23566506|NCT02247804|65803860|FG001|Treatment Period 2|Personal Reasons|1|||
23566507|NCT02247804|65803861|FG002|Treatment Period 2|Personal Reasons|1|||
23566508|NCT02247804|65803859|FG000|Treatment Period 2|Reason not Specified|0|||
23566509|NCT02247804|65803860|FG001|Treatment Period 2|Reason not Specified|0|||
23566510|NCT02247804|65803861|FG002|Treatment Period 2|Reason not Specified|2|||
23566511|NCT02247804|65803859|FG000|Treatment Period 3|Adverse Event|4|||
23566512|NCT02247804|65803860|FG001|Treatment Period 3|Adverse Event|3|||
23157520|NCT03523728|64328558|FG001|Stage 2 (24 Months)|Adverse Event|0|||
23566513|NCT02247804|65803861|FG002|Treatment Period 3|Adverse Event|3|||
23566514|NCT02247804|65803859|FG000|Treatment Period 3|Lack of Efficacy|0|||
23566515|NCT02247804|65803860|FG001|Treatment Period 3|Lack of Efficacy|1|||
23566516|NCT02247804|65803861|FG002|Treatment Period 3|Lack of Efficacy|0|||
23157521|NCT03523728|64328559|FG002|Stage 2 (24 Months)|Adverse Event|0|||
23157522|NCT03523728|64328560|FG003|Stage 2 (24 Months)|Adverse Event|1|||
23157523|NCT03523728|64328561|FG004|Stage 2 (24 Months)|Adverse Event|2|||
23157524|NCT03523728|64328557|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
23157525|NCT03523728|64328558|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
23157526|NCT03523728|64328559|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
23157527|NCT03523728|64328560|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
23328072|NCT00460603|64945365|FG005|Phase 1|Other|2|||
23328073|NCT00460603|64945366|FG006|Phase 1|Other|0|||
23328074|NCT00460603|64945367|FG007|Phase 1|Other|1|||
23328075|NCT00460603|64945368|FG008|Phase 1|Other|0|||
23328076|NCT00460603|64945369|FG009|Phase 1|Other|0|||
23328077|NCT00460603|64945370|FG010|Phase 1|Other|0|||
23328078|NCT00460603|64945371|FG011|Phase 1|Other|0|||
23328079|NCT00460603|64945360|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328080|NCT00460603|64945361|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328081|NCT00460603|64945362|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328082|NCT00460603|64945363|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328083|NCT00460603|64945364|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328084|NCT00460603|64945365|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328085|NCT00460603|64945366|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328086|NCT00460603|64945367|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328087|NCT00460603|64945368|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328088|NCT00460603|64945369|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
23328089|NCT00460603|64945370|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328090|NCT00460603|64945371|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
23328091|NCT00460603|64945360|FG000|Phase 2|Adverse Event|0|||
23328092|NCT00460603|64945361|FG001|Phase 2|Adverse Event|0|||
23328093|NCT00460603|64945362|FG002|Phase 2|Adverse Event|0|||
23328094|NCT00460603|64945363|FG003|Phase 2|Adverse Event|0|||
23328095|NCT00460603|64945364|FG004|Phase 2|Adverse Event|0|||
23328096|NCT00460603|64945365|FG005|Phase 2|Adverse Event|0|||
23328097|NCT00460603|64945366|FG006|Phase 2|Adverse Event|0|||
23328098|NCT00460603|64945367|FG007|Phase 2|Adverse Event|0|||
23328099|NCT00460603|64945368|FG008|Phase 2|Adverse Event|0|||
23328100|NCT00460603|64945369|FG009|Phase 2|Adverse Event|12|||
23328101|NCT00460603|64945370|FG010|Phase 2|Adverse Event|9|||
23328102|NCT00460603|64945371|FG011|Phase 2|Adverse Event|10|||
23328103|NCT00460603|64945360|FG000|Phase 2|Death|0|||
23328104|NCT00460603|64945361|FG001|Phase 2|Death|0|||
23328105|NCT00460603|64945362|FG002|Phase 2|Death|0|||
23328106|NCT00460603|64945363|FG003|Phase 2|Death|0|||
23328107|NCT00460603|64945364|FG004|Phase 2|Death|0|||
23328108|NCT00460603|64945365|FG005|Phase 2|Death|0|||
23328109|NCT00460603|64945366|FG006|Phase 2|Death|0|||
23328110|NCT00460603|64945367|FG007|Phase 2|Death|0|||
23328111|NCT00460603|64945368|FG008|Phase 2|Death|0|||
23328112|NCT00460603|64945369|FG009|Phase 2|Death|4|||
23328113|NCT00460603|64945370|FG010|Phase 2|Death|2|||
23328114|NCT00460603|64945371|FG011|Phase 2|Death|2|||
23328115|NCT00460603|64945360|FG000|Phase 2|Protocol Violation|0|||
23328116|NCT00460603|64945361|FG001|Phase 2|Protocol Violation|0|||
23328117|NCT00460603|64945362|FG002|Phase 2|Protocol Violation|0|||
23328118|NCT00460603|64945363|FG003|Phase 2|Protocol Violation|0|||
23328119|NCT00460603|64945364|FG004|Phase 2|Protocol Violation|0|||
23328120|NCT00460603|64945365|FG005|Phase 2|Protocol Violation|0|||
23328121|NCT00460603|64945366|FG006|Phase 2|Protocol Violation|0|||
23328122|NCT00460603|64945367|FG007|Phase 2|Protocol Violation|0|||
23328123|NCT00460603|64945368|FG008|Phase 2|Protocol Violation|0|||
23328124|NCT00460603|64945369|FG009|Phase 2|Protocol Violation|1|||
23328125|NCT00460603|64945370|FG010|Phase 2|Protocol Violation|1|||
23328126|NCT00460603|64945371|FG011|Phase 2|Protocol Violation|0|||
23328127|NCT00460603|64945360|FG000|Phase 2|Lost to Follow-up|0|||
23328128|NCT00460603|64945361|FG001|Phase 2|Lost to Follow-up|0|||
23328129|NCT00460603|64945362|FG002|Phase 2|Lost to Follow-up|0|||
23328130|NCT00460603|64945363|FG003|Phase 2|Lost to Follow-up|0|||
23328131|NCT00460603|64945364|FG004|Phase 2|Lost to Follow-up|0|||
23328132|NCT00460603|64945365|FG005|Phase 2|Lost to Follow-up|0|||
23328133|NCT00460603|64945366|FG006|Phase 2|Lost to Follow-up|0|||
23328134|NCT00460603|64945367|FG007|Phase 2|Lost to Follow-up|0|||
23328135|NCT00460603|64945368|FG008|Phase 2|Lost to Follow-up|0|||
23328136|NCT00460603|64945369|FG009|Phase 2|Lost to Follow-up|1|||
23328137|NCT00460603|64945370|FG010|Phase 2|Lost to Follow-up|0|||
23328138|NCT00460603|64945371|FG011|Phase 2|Lost to Follow-up|0|||
23328139|NCT00460603|64945360|FG000|Phase 2|Other|0|||
23328140|NCT00460603|64945361|FG001|Phase 2|Other|0|||
23328141|NCT00460603|64945362|FG002|Phase 2|Other|0|||
23328142|NCT00460603|64945363|FG003|Phase 2|Other|0|||
23328143|NCT00460603|64945364|FG004|Phase 2|Other|0|||
23328144|NCT00460603|64945365|FG005|Phase 2|Other|0|||
23328145|NCT00460603|64945366|FG006|Phase 2|Other|0|||
23328146|NCT00460603|64945367|FG007|Phase 2|Other|0|||
23328147|NCT00460603|64945368|FG008|Phase 2|Other|0|||
23328148|NCT00460603|64945369|FG009|Phase 2|Other|6|||
23443453|NCT02352753|65366406|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
23443454|NCT02352753|65366406|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
23328149|NCT00460603|64945370|FG010|Phase 2|Other|16|||
23328150|NCT00460603|64945371|FG011|Phase 2|Other|7|||
23328151|NCT00460603|64945360|FG000|Phase 2|Objective Progression or Relapse|0|||
23328152|NCT00460603|64945361|FG001|Phase 2|Objective Progression or Relapse|0|||
23328153|NCT00460603|64945362|FG002|Phase 2|Objective Progression or Relapse|0|||
23328154|NCT00460603|64945363|FG003|Phase 2|Objective Progression or Relapse|0|||
23328155|NCT00460603|64945364|FG004|Phase 2|Objective Progression or Relapse|0|||
23328156|NCT00460603|64945365|FG005|Phase 2|Objective Progression or Relapse|0|||
23328157|NCT00460603|64945366|FG006|Phase 2|Objective Progression or Relapse|0|||
23328158|NCT00460603|64945367|FG007|Phase 2|Objective Progression or Relapse|0|||
23328159|NCT00460603|64945368|FG008|Phase 2|Objective Progression or Relapse|0|||
23328160|NCT00460603|64945369|FG009|Phase 2|Objective Progression or Relapse|9|||
23328161|NCT00460603|64945370|FG010|Phase 2|Objective Progression or Relapse|10|||
23328162|NCT00460603|64945371|FG011|Phase 2|Objective Progression or Relapse|17|||
23328163|NCT00460603|64945360|FG000|Phase 2|Global Deterioration of Health Status|0|||
23328164|NCT00460603|64945361|FG001|Phase 2|Global Deterioration of Health Status|0|||
23328165|NCT00460603|64945362|FG002|Phase 2|Global Deterioration of Health Status|0|||
23328166|NCT00460603|64945363|FG003|Phase 2|Global Deterioration of Health Status|0|||
23328167|NCT00460603|64945364|FG004|Phase 2|Global Deterioration of Health Status|0|||
23328168|NCT00460603|64945365|FG005|Phase 2|Global Deterioration of Health Status|0|||
23328169|NCT00460603|64945366|FG006|Phase 2|Global Deterioration of Health Status|0|||
23328170|NCT00460603|64945367|FG007|Phase 2|Global Deterioration of Health Status|0|||
23328171|NCT00460603|64945368|FG008|Phase 2|Global Deterioration of Health Status|0|||
23328172|NCT00460603|64945369|FG009|Phase 2|Global Deterioration of Health Status|0|||
23328173|NCT00460603|64945370|FG010|Phase 2|Global Deterioration of Health Status|1|||
23328174|NCT00460603|64945371|FG011|Phase 2|Global Deterioration of Health Status|0|||
23328175|NCT00460603|64945360|FG000|Phase 2|Withdrawal by Subject|0|||
23328176|NCT00460603|64945361|FG001|Phase 2|Withdrawal by Subject|0|||
23328177|NCT00460603|64945362|FG002|Phase 2|Withdrawal by Subject|0|||
23328178|NCT00460603|64945363|FG003|Phase 2|Withdrawal by Subject|0|||
23328179|NCT00460603|64945364|FG004|Phase 2|Withdrawal by Subject|0|||
23328180|NCT00460603|64945365|FG005|Phase 2|Withdrawal by Subject|0|||
23328181|NCT00460603|64945366|FG006|Phase 2|Withdrawal by Subject|0|||
23328182|NCT00460603|64945367|FG007|Phase 2|Withdrawal by Subject|0|||
23328183|NCT00460603|64945368|FG008|Phase 2|Withdrawal by Subject|0|||
23328184|NCT00460603|64945369|FG009|Phase 2|Withdrawal by Subject|5|||
23328185|NCT00460603|64945370|FG010|Phase 2|Withdrawal by Subject|4|||
23328186|NCT00460603|64945371|FG011|Phase 2|Withdrawal by Subject|5|||
23328187|NCT00460603|64945360|FG000|Phase 2|Randomized, but not treated|0|||
23328188|NCT00460603|64945361|FG001|Phase 2|Randomized, but not treated|0|||
23328189|NCT00460603|64945362|FG002|Phase 2|Randomized, but not treated|0|||
23328190|NCT00460603|64945363|FG003|Phase 2|Randomized, but not treated|0|||
23328191|NCT00460603|64945364|FG004|Phase 2|Randomized, but not treated|0|||
23328192|NCT00460603|64945365|FG005|Phase 2|Randomized, but not treated|0|||
23157528|NCT03523728|64328561|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
23157529|NCT03523728|64328557|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
23157530|NCT03523728|64328558|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
23157531|NCT03523728|64328559|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
23221910|NCT02738580|64553837|FG000|Overall Study|Lack of Efficacy|3|||
23221911|NCT02738580|64553838|FG001|Overall Study|Lack of Efficacy|2|||
23221912|NCT02738580|64553837|FG000|Overall Study|Withdrawal by Subject|0|||
23221913|NCT02738580|64553838|FG001|Overall Study|Withdrawal by Subject|1|||
23221914|NCT02738580|64553837|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
23221915|NCT02738580|64553838|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
23328193|NCT00460603|64945366|FG006|Phase 2|Randomized, but not treated|0|||
23221916|NCT01039428|64553848|FG000|Overall Study|Protocol Violation|1|||
23221917|NCT01039428|64553849|FG001|Overall Study|Protocol Violation|0|||
23221918|NCT01039428|64553848|FG000|Overall Study|Withdrawal by Subject|1|||
23221919|NCT01039428|64553849|FG001|Overall Study|Withdrawal by Subject|0|||
23221920|NCT02001688|64553852|FG000|Overall Study|Withdrawal by Subject|0|||
23221921|NCT02001688|64553853|FG001|Overall Study|Withdrawal by Subject|0|||
23221922|NCT02001688|64553854|FG002|Overall Study|Withdrawal by Subject|1|||
23221923|NCT02001688|64553852|FG000|Overall Study|Adverse Event|0|||
23221924|NCT02001688|64553853|FG001|Overall Study|Adverse Event|1|||
23221925|NCT02001688|64553854|FG002|Overall Study|Adverse Event|0|||
23221926|NCT01197794|64553855|FG000|Overall Study|Adverse Event|3|||
23566517|NCT02247804|65803859|FG000|Treatment Period 3|Lost to Follow-up|1|||
23566518|NCT02247804|65803860|FG001|Treatment Period 3|Lost to Follow-up|2|||
23566519|NCT02247804|65803861|FG002|Treatment Period 3|Lost to Follow-up|2|||
23566520|NCT02247804|65803859|FG000|Treatment Period 3|Personal Reasons|4|||
23566521|NCT02247804|65803860|FG001|Treatment Period 3|Personal Reasons|3|||
23157532|NCT03523728|64328560|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
23157533|NCT03523728|64328561|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
23157534|NCT03523728|64328557|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
23157535|NCT03523728|64328558|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
23157536|NCT03523728|64328559|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
23157537|NCT03523728|64328560|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
23157538|NCT03523728|64328561|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
23221927|NCT01197794|64553856|FG001|Overall Study|Adverse Event|2|||
23221928|NCT01197794|64553857|FG002|Overall Study|Adverse Event|4|||
23566522|NCT02247804|65803861|FG002|Treatment Period 3|Personal Reasons|2|||
23566523|NCT02247804|65803859|FG000|Treatment Period 3|Reason not Specified|2|||
23221929|NCT01197794|64553858|FG003|Overall Study|Adverse Event|4|||
23221930|NCT01197794|64553859|FG004|Overall Study|Adverse Event|4|||
23221931|NCT01197794|64553860|FG005|Overall Study|Adverse Event|2|||
23221932|NCT01197794|64553861|FG006|Overall Study|Adverse Event|3|||
23328194|NCT00460603|64945367|FG007|Phase 2|Randomized, but not treated|0|||
23328195|NCT00460603|64945368|FG008|Phase 2|Randomized, but not treated|0|||
23328196|NCT00460603|64945369|FG009|Phase 2|Randomized, but not treated|3|||
23328197|NCT00460603|64945370|FG010|Phase 2|Randomized, but not treated|0|||
23221933|NCT01197794|64553855|FG000|Overall Study|Protocol Violation|0|||
23221934|NCT01197794|64553856|FG001|Overall Study|Protocol Violation|0|||
23221935|NCT01197794|64553857|FG002|Overall Study|Protocol Violation|0|||
23221936|NCT01197794|64553858|FG003|Overall Study|Protocol Violation|0|||
23221937|NCT01197794|64553859|FG004|Overall Study|Protocol Violation|2|||
23221938|NCT01197794|64553860|FG005|Overall Study|Protocol Violation|0|||
23221939|NCT01197794|64553861|FG006|Overall Study|Protocol Violation|1|||
23221940|NCT01197794|64553855|FG000|Overall Study|Development of study withdrawal criteria|3|||
23221941|NCT01197794|64553856|FG001|Overall Study|Development of study withdrawal criteria|0|||
23221942|NCT01197794|64553857|FG002|Overall Study|Development of study withdrawal criteria|0|||
23221943|NCT01197794|64553858|FG003|Overall Study|Development of study withdrawal criteria|1|||
23628461|NCT01236352|66024731|FG002|Overall Study|Subject request to discontinue treatment|1|||
23628462|NCT01236352|66024732|FG003|Overall Study|Subject request to discontinue treatment|1|||
23628463|NCT01236352|66024733|FG004|Overall Study|Subject request to discontinue treatment|0|||
23628464|NCT01236352|66024734|FG005|Overall Study|Subject request to discontinue treatment|1|||
23628465|NCT01236352|66024735|FG006|Overall Study|Subject request to discontinue treatment|0|||
23628466|NCT01236352|66024736|FG007|Overall Study|Subject request to discontinue treatment|0|||
23628467|NCT01236352|66024737|FG008|Overall Study|Subject request to discontinue treatment|0|||
23628468|NCT01236352|66024738|FG009|Overall Study|Subject request to discontinue treatment|1|||
23628469|NCT01236352|66024739|FG010|Overall Study|Subject request to discontinue treatment|4|||
23628470|NCT01236352|66024729|FG000|Overall Study|Subject to receive drug via EAP|1|||
23628471|NCT01236352|66024730|FG001|Overall Study|Subject to receive drug via EAP|1|||
23628472|NCT01236352|66024731|FG002|Overall Study|Subject to receive drug via EAP|1|||
23628473|NCT01236352|66024732|FG003|Overall Study|Subject to receive drug via EAP|0|||
23628474|NCT01236352|66024733|FG004|Overall Study|Subject to receive drug via EAP|0|||
23628475|NCT01236352|66024734|FG005|Overall Study|Subject to receive drug via EAP|0|||
23628476|NCT01236352|66024735|FG006|Overall Study|Subject to receive drug via EAP|0|||
23628477|NCT01236352|66024736|FG007|Overall Study|Subject to receive drug via EAP|2|||
23628478|NCT01236352|66024737|FG008|Overall Study|Subject to receive drug via EAP|0|||
23628479|NCT01236352|66024738|FG009|Overall Study|Subject to receive drug via EAP|4|||
23628480|NCT01236352|66024739|FG010|Overall Study|Subject to receive drug via EAP|0|||
23628481|NCT01236352|66024729|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
23628482|NCT01236352|66024730|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
23628483|NCT01236352|66024731|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
23628484|NCT01236352|66024732|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
23628485|NCT01236352|66024733|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
23628486|NCT01236352|66024734|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
23628487|NCT01236352|66024735|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
23628488|NCT01236352|66024736|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
23628489|NCT01236352|66024737|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
23628490|NCT01236352|66024738|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
23628491|NCT01236352|66024739|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
23628492|NCT01236352|66024729|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628493|NCT01236352|66024730|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628494|NCT01236352|66024731|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628495|NCT01236352|66024732|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628496|NCT01236352|66024733|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628497|NCT01236352|66024734|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628498|NCT01236352|66024735|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628499|NCT01236352|66024736|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628500|NCT01236352|66024737|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628501|NCT01236352|66024738|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
23628502|NCT01236352|66024739|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
23628503|NCT01236352|66024729|FG000|Overall Study|Lack of response to drug|0|||
23628504|NCT01236352|66024730|FG001|Overall Study|Lack of response to drug|0|||
23628505|NCT01236352|66024731|FG002|Overall Study|Lack of response to drug|0|||
23628506|NCT01236352|66024732|FG003|Overall Study|Lack of response to drug|0|||
23628507|NCT01236352|66024733|FG004|Overall Study|Lack of response to drug|0|||
23628508|NCT01236352|66024734|FG005|Overall Study|Lack of response to drug|0|||
23628509|NCT01236352|66024735|FG006|Overall Study|Lack of response to drug|0|||
23628510|NCT01236352|66024736|FG007|Overall Study|Lack of response to drug|0|||
23628511|NCT01236352|66024737|FG008|Overall Study|Lack of response to drug|0|||
23628512|NCT01236352|66024738|FG009|Overall Study|Lack of response to drug|1|||
23628513|NCT01236352|66024739|FG010|Overall Study|Lack of response to drug|1|||
23628514|NCT01236352|66024729|FG000|Overall Study|Patient transferred to IST|0|||
23628515|NCT01236352|66024730|FG001|Overall Study|Patient transferred to IST|0|||
23628516|NCT01236352|66024731|FG002|Overall Study|Patient transferred to IST|0|||
23628517|NCT01236352|66024732|FG003|Overall Study|Patient transferred to IST|0|||
23628518|NCT01236352|66024733|FG004|Overall Study|Patient transferred to IST|0|||
23628519|NCT01236352|66024734|FG005|Overall Study|Patient transferred to IST|0|||
23628520|NCT01236352|66024735|FG006|Overall Study|Patient transferred to IST|0|||
23628521|NCT01236352|66024736|FG007|Overall Study|Patient transferred to IST|0|||
23628522|NCT01236352|66024737|FG008|Overall Study|Patient transferred to IST|0|||
23628523|NCT01236352|66024738|FG009|Overall Study|Patient transferred to IST|2|||
23628524|NCT01236352|66024739|FG010|Overall Study|Patient transferred to IST|6|||
23628525|NCT02581059|66024740|FG000|Study Treatment|Disease Progression|1|||
23628526|NCT02581059|66024741|FG001|Study Treatment|Disease Progression|1|||
23628527|NCT02581059|66024740|FG000|Study Treatment|Adverse Event|2|||
23628528|NCT02581059|66024741|FG001|Study Treatment|Adverse Event|1|||
23628529|NCT02581059|66024740|FG000|Study Treatment|Death|1|||
23628530|NCT02581059|66024741|FG001|Study Treatment|Death|1|||
23628531|NCT02581059|66024740|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
23628532|NCT02581059|66024741|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
23628533|NCT02581059|66024740|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
23628534|NCT02581059|66024741|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
23628535|NCT02581059|66024740|FG000|Follow up|Death|1|||
23628536|NCT02581059|66024741|FG001|Follow up|Death|3|||
23628537|NCT02581059|66024740|FG000|Follow up|study terminated|1|||
23628538|NCT02581059|66024741|FG001|Follow up|study terminated|1|||
23628539|NCT02581059|66024740|FG000|Follow up|screen failure|0|||
23628540|NCT02581059|66024741|FG001|Follow up|screen failure|1|||
23628541|NCT02581059|66024740|FG000|Follow up|Patient started new clinical trial|1|||
23628542|NCT02581059|66024741|FG001|Follow up|Patient started new clinical trial|0|||
23628543|NCT03546816|66024744|FG000|Overall Study|Adverse Event|5|||
23628544|NCT03546816|66024745|FG001|Overall Study|Adverse Event|3|||
23628545|NCT03546816|66024744|FG000|Overall Study|Lack of Efficacy|2|||
23628546|NCT03546816|66024745|FG001|Overall Study|Lack of Efficacy|4|||
23628547|NCT03546816|66024744|FG000|Overall Study|Pregnancy|1|||
23628548|NCT03546816|66024745|FG001|Overall Study|Pregnancy|0|||
23628549|NCT03546816|66024744|FG000|Overall Study|Physician Decision|2|||
23628550|NCT03546816|66024745|FG001|Overall Study|Physician Decision|0|||
23628551|NCT03546816|66024744|FG000|Overall Study|Withdrawal by Subject|8|||
23628552|NCT03546816|66024745|FG001|Overall Study|Withdrawal by Subject|10|||
23628553|NCT03546816|66024744|FG000|Overall Study|Lost to Follow-up|3|||
23628554|NCT03546816|66024745|FG001|Overall Study|Lost to Follow-up|2|||
23628555|NCT01929876|66024746|FG000|Period 2|Non-Compliance|1|||
23566524|NCT02247804|65803860|FG001|Treatment Period 3|Reason not Specified|1|||
23566525|NCT02247804|65803861|FG002|Treatment Period 3|Reason not Specified|3|||
23566526|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
23566527|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
23566528|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Adverse Event|2|||
23566529|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Adverse Event|5|||
23566530|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
23157539|NCT03523728|64328557|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
23566531|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
23566532|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
23566533|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
23566534|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Randomized by error|0|||
23566535|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Randomized by error|5|||
23566536|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
23566537|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
23566538|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
23157540|NCT03523728|64328558|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
23157541|NCT03523728|64328559|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
23157542|NCT03523728|64328560|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
23328198|NCT00460603|64945371|FG011|Phase 2|Randomized, but not treated|0|||
23157543|NCT03523728|64328561|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
23221944|NCT01197794|64553859|FG004|Overall Study|Development of study withdrawal criteria|0|||
23221945|NCT01197794|64553860|FG005|Overall Study|Development of study withdrawal criteria|0|||
23221946|NCT01197794|64553861|FG006|Overall Study|Development of study withdrawal criteria|1|||
23221947|NCT01197794|64553855|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
23221948|NCT01197794|64553856|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
23221949|NCT01197794|64553857|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
23221950|NCT01197794|64553858|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
23221951|NCT01197794|64553859|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
23221952|NCT01197794|64553860|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
23221953|NCT01197794|64553861|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
23221954|NCT01197794|64553855|FG000|Overall Study|Withdrawal by Subject|3|||
23221955|NCT01197794|64553856|FG001|Overall Study|Withdrawal by Subject|3|||
23221956|NCT01197794|64553857|FG002|Overall Study|Withdrawal by Subject|4|||
23221957|NCT01197794|64553858|FG003|Overall Study|Withdrawal by Subject|1|||
23221958|NCT01197794|64553859|FG004|Overall Study|Withdrawal by Subject|1|||
23221959|NCT01197794|64553860|FG005|Overall Study|Withdrawal by Subject|5|||
23221960|NCT01197794|64553861|FG006|Overall Study|Withdrawal by Subject|6|||
23221961|NCT01197794|64553855|FG000|Overall Study|Lost to Follow-up|1|||
23221962|NCT01197794|64553856|FG001|Overall Study|Lost to Follow-up|1|||
23221963|NCT01197794|64553857|FG002|Overall Study|Lost to Follow-up|0|||
23221964|NCT01197794|64553858|FG003|Overall Study|Lost to Follow-up|1|||
23221965|NCT01197794|64553859|FG004|Overall Study|Lost to Follow-up|0|||
23221966|NCT01197794|64553860|FG005|Overall Study|Lost to Follow-up|1|||
23221967|NCT01197794|64553861|FG006|Overall Study|Lost to Follow-up|0|||
23221968|NCT01197794|64553855|FG000|Overall Study|Other|1|||
23328199|NCT01205776|64945372|FG000|Overall Study|Lost to Follow-up|53|||
23328200|NCT01205776|64945373|FG001|Overall Study|Lost to Follow-up|61|||
23328201|NCT01205776|64945372|FG000|Overall Study|Withdrawal by Subject|11|||
23328202|NCT01205776|64945373|FG001|Overall Study|Withdrawal by Subject|34|||
23566539|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
23566540|NCT02948959|65803862|FG000|52 Weeks Treatment Period|Change of residence location|0|||
23566541|NCT02948959|65803863|FG001|52 Weeks Treatment Period|Change of residence location|1|||
23566542|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
23566543|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
23566544|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
23566545|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
23566546|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
23566547|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
23566548|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
23566549|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
23566550|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
23566551|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
23566552|NCT02948959|65803862|FG000|12 Weeks Follow-up Period|Study site closure|1|||
23566553|NCT02948959|65803863|FG001|12 Weeks Follow-up Period|Study site closure|0|||
23566554|NCT02001974|65803864|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
23566555|NCT02001974|65803865|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
23566556|NCT02001974|65803866|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
23566557|NCT02001974|65803864|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
23566558|NCT02001974|65803865|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
23566559|NCT02001974|65803866|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
23566560|NCT02001974|65803864|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
23566561|NCT02001974|65803865|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
23566562|NCT02001974|65803866|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
23566563|NCT02001974|65803864|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
23566564|NCT02001974|65803865|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
23566565|NCT02001974|65803866|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
23566566|NCT01233609|65803867|FG000|Overall Study|Death|1|||
23566567|NCT01233609|65803868|FG001|Overall Study|Death|0|||
23566568|NCT01233609|65803867|FG000|Overall Study|Lost to Follow-up|3|||
23566569|NCT01233609|65803868|FG001|Overall Study|Lost to Follow-up|1|||
23566570|NCT01233609|65803867|FG000|Overall Study|Adverse Event|2|||
23566571|NCT01233609|65803868|FG001|Overall Study|Adverse Event|1|||
23566572|NCT01233609|65803867|FG000|Overall Study|Withdrawal by Subject|3|||
23566573|NCT01233609|65803868|FG001|Overall Study|Withdrawal by Subject|0|||
23221969|NCT01197794|64553856|FG001|Overall Study|Other|1|||
23221970|NCT01197794|64553857|FG002|Overall Study|Other|3|||
23221971|NCT01197794|64553858|FG003|Overall Study|Other|0|||
23443455|NCT02352753|65366406|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
23443456|NCT02352753|65366406|FG000|3-Month Dosing Period|Decision by sponsor|14|||
23221972|NCT01197794|64553859|FG004|Overall Study|Other|2|||
23221973|NCT01197794|64553860|FG005|Overall Study|Other|2|||
23443457|NCT02352753|65366406|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
23157544|NCT01401842|64328562|FG000|Overall Study|Withdrawal by Subject|3|||
23157545|NCT01401842|64328563|FG001|Overall Study|Withdrawal by Subject|2|||
23157546|NCT01401842|64328562|FG000|Overall Study|academic reason|4|||
23157547|NCT01401842|64328563|FG001|Overall Study|academic reason|1|||
23157548|NCT01401842|64328562|FG000|Overall Study|changed companies|20|||
23157549|NCT01401842|64328563|FG001|Overall Study|changed companies|34|||
23157550|NCT01401842|64328562|FG000|Overall Study|discharged from US Army|3|||
23157551|NCT01401842|64328563|FG001|Overall Study|discharged from US Army|4|||
23157552|NCT01401842|64328562|FG000|Overall Study|invalid follow-up strength data|1|||
23157553|NCT01401842|64328563|FG001|Overall Study|invalid follow-up strength data|4|||
23157554|NCT01401842|64328562|FG000|Overall Study|on profile|9|||
23157555|NCT01401842|64328563|FG001|Overall Study|on profile|5|||
23157556|NCT01401842|64328562|FG000|Overall Study|other/unknown|28|||
23157557|NCT01401842|64328563|FG001|Overall Study|other/unknown|17|||
23157558|NCT00577642|64328564|FG000|Overall Study|Clinical Disease Progression|1|||
23157559|NCT00733954|64328565|FG000|Overall Study|Lost to Follow-up|5|||
23157560|NCT00733954|64328566|FG001|Overall Study|Lost to Follow-up|2|||
23157561|NCT00733954|64328565|FG000|Overall Study|Protocol Violation|1|||
23157562|NCT00733954|64328566|FG001|Overall Study|Protocol Violation|0|||
23157563|NCT00733954|64328565|FG000|Overall Study|Withdrawal by Subject|2|||
23157564|NCT00733954|64328566|FG001|Overall Study|Withdrawal by Subject|0|||
23157565|NCT00383084|64328567|FG000|Overall Study|Withdrawal by Subject|12|||
23157566|NCT00383084|64328568|FG001|Overall Study|Withdrawal by Subject|10|||
23157567|NCT01793142|64328569|FG000|Overall Study|Randomized not treated|7|||
23157568|NCT01299376|64328573|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
23157569|NCT01299376|64328574|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
23157570|NCT01299376|64328573|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
23157571|NCT01299376|64328574|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
23157572|NCT01299376|64328573|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
23157573|NCT01299376|64328574|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
23157574|NCT01299376|64328573|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
23157575|NCT01299376|64328574|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
23157576|NCT01299376|64328573|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
23157577|NCT01299376|64328574|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
23566574|NCT01302938|65803870|FG000|Overall Study|Withdrawal by Subject|1|||
23157578|NCT01299376|64328573|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
23157579|NCT01299376|64328574|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
23157580|NCT01299376|64328573|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
23157581|NCT01299376|64328574|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
23157582|NCT01299376|64328573|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
23157583|NCT01299376|64328574|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
23157584|NCT01299376|64328573|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
23157585|NCT01299376|64328574|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
23566575|NCT01302938|65803871|FG001|Overall Study|Withdrawal by Subject|0|||
23566576|NCT01302938|65803870|FG000|Overall Study|Adverse Event|1|||
23566577|NCT01302938|65803871|FG001|Overall Study|Adverse Event|0|||
23566578|NCT02912468|65803873|FG000|Overall Study|Adverse Event|3|||
23566579|NCT02912468|65803874|FG001|Overall Study|Adverse Event|2|||
23566580|NCT02912468|65803873|FG000|Overall Study|Withdrawal by Subject|6|||
23566581|NCT02912468|65803874|FG001|Overall Study|Withdrawal by Subject|2|||
23566582|NCT02912468|65803873|FG000|Overall Study|Randomized and not treated|0|||
23566583|NCT02912468|65803874|FG001|Overall Study|Randomized and not treated|1|||
23566584|NCT03430063|65803875|FG000|Overall Study|Adverse Event|0|||
23566585|NCT03430063|65803876|FG001|Overall Study|Adverse Event|1|||
23566586|NCT03430063|65803877|FG002|Overall Study|Adverse Event|0|||
23566587|NCT03430063|65803875|FG000|Overall Study|Death|3|||
23566588|NCT03430063|65803876|FG001|Overall Study|Death|2|||
23566589|NCT03430063|65803877|FG002|Overall Study|Death|3|||
23566590|NCT03430063|65803875|FG000|Overall Study|Lost to Follow-up|0|||
23566591|NCT03430063|65803876|FG001|Overall Study|Lost to Follow-up|1|||
23566592|NCT03430063|65803877|FG002|Overall Study|Lost to Follow-up|0|||
23566593|NCT03430063|65803875|FG000|Overall Study|Withdrawal by Subject|0|||
23566594|NCT03430063|65803876|FG001|Overall Study|Withdrawal by Subject|0|||
23157586|NCT01299376|64328573|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
23157587|NCT01299376|64328574|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
23157588|NCT01299376|64328573|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
23157589|NCT01299376|64328574|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
23157590|NCT01473563|64328580|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
23157591|NCT02625233|64328581|FG000|Overall Study|Adverse Event|2|||
23157592|NCT02625233|64328582|FG001|Overall Study|Adverse Event|0|||
23157593|NCT00467779|64328583|FG000|Stage 1|Adverse Event|1|||
23157594|NCT00467779|64328584|FG001|Stage 1|Adverse Event|0|||
23157595|NCT00467779|64328585|FG002|Stage 1|Adverse Event|0|||
23157596|NCT00467779|64328586|FG003|Stage 1|Adverse Event|0|||
23157597|NCT00467779|64328587|FG004|Stage 1|Adverse Event|0|||
23157598|NCT00467779|64328588|FG005|Stage 1|Adverse Event|1|||
23157599|NCT00467779|64328589|FG006|Stage 1|Adverse Event|2|||
23157600|NCT00467779|64328590|FG007|Stage 1|Adverse Event|1|||
23157601|NCT00467779|64328591|FG008|Stage 1|Adverse Event|0|||
23157602|NCT00467779|64328592|FG009|Stage 1|Adverse Event|0|||
23157603|NCT00467779|64328593|FG010|Stage 1|Adverse Event|0|||
23157604|NCT00467779|64328594|FG011|Stage 1|Adverse Event|0|||
23157605|NCT00467779|64328595|FG012|Stage 1|Adverse Event|0|||
23157606|NCT00467779|64328596|FG013|Stage 1|Adverse Event|0|||
23157607|NCT00467779|64328597|FG014|Stage 1|Adverse Event|0|||
23157608|NCT00467779|64328583|FG000|Stage 1|Disease Progression|2|||
23157609|NCT00467779|64328584|FG001|Stage 1|Disease Progression|2|||
23157610|NCT00467779|64328585|FG002|Stage 1|Disease Progression|2|||
23157611|NCT00467779|64328586|FG003|Stage 1|Disease Progression|3|||
23157612|NCT00467779|64328587|FG004|Stage 1|Disease Progression|2|||
23157613|NCT00467779|64328588|FG005|Stage 1|Disease Progression|2|||
23157614|NCT00467779|64328589|FG006|Stage 1|Disease Progression|4|||
23157615|NCT00467779|64328590|FG007|Stage 1|Disease Progression|5|||
23157616|NCT00467779|64328591|FG008|Stage 1|Disease Progression|0|||
23157617|NCT00467779|64328592|FG009|Stage 1|Disease Progression|0|||
23157618|NCT00467779|64328593|FG010|Stage 1|Disease Progression|0|||
23157619|NCT00467779|64328594|FG011|Stage 1|Disease Progression|0|||
23157620|NCT00467779|64328595|FG012|Stage 1|Disease Progression|0|||
23157621|NCT00467779|64328596|FG013|Stage 1|Disease Progression|0|||
23157622|NCT00467779|64328597|FG014|Stage 1|Disease Progression|0|||
23157623|NCT00467779|64328583|FG000|Stage 1|Unspecified Reason|1|||
23157624|NCT00467779|64328584|FG001|Stage 1|Unspecified Reason|0|||
23157625|NCT00467779|64328585|FG002|Stage 1|Unspecified Reason|1|||
23157626|NCT00467779|64328586|FG003|Stage 1|Unspecified Reason|0|||
23157627|NCT00467779|64328587|FG004|Stage 1|Unspecified Reason|1|||
23157628|NCT00467779|64328588|FG005|Stage 1|Unspecified Reason|2|||
23157629|NCT00467779|64328589|FG006|Stage 1|Unspecified Reason|0|||
23157630|NCT00467779|64328590|FG007|Stage 1|Unspecified Reason|0|||
23157631|NCT00467779|64328591|FG008|Stage 1|Unspecified Reason|0|||
23157632|NCT00467779|64328592|FG009|Stage 1|Unspecified Reason|0|||
23157633|NCT00467779|64328593|FG010|Stage 1|Unspecified Reason|0|||
23157634|NCT00467779|64328594|FG011|Stage 1|Unspecified Reason|0|||
23157635|NCT00467779|64328595|FG012|Stage 1|Unspecified Reason|0|||
23157636|NCT00467779|64328596|FG013|Stage 1|Unspecified Reason|0|||
23157637|NCT00467779|64328597|FG014|Stage 1|Unspecified Reason|0|||
23157638|NCT00467779|64328583|FG000|Stage 1|Physician Decision|0|||
23157639|NCT00467779|64328584|FG001|Stage 1|Physician Decision|1|||
23157640|NCT00467779|64328585|FG002|Stage 1|Physician Decision|0|||
23157641|NCT00467779|64328586|FG003|Stage 1|Physician Decision|0|||
23157642|NCT00467779|64328587|FG004|Stage 1|Physician Decision|0|||
23157643|NCT00467779|64328588|FG005|Stage 1|Physician Decision|0|||
23157644|NCT00467779|64328589|FG006|Stage 1|Physician Decision|0|||
23157645|NCT00467779|64328590|FG007|Stage 1|Physician Decision|0|||
23157646|NCT00467779|64328591|FG008|Stage 1|Physician Decision|0|||
23157647|NCT00467779|64328592|FG009|Stage 1|Physician Decision|0|||
23157648|NCT00467779|64328593|FG010|Stage 1|Physician Decision|0|||
23157649|NCT00467779|64328594|FG011|Stage 1|Physician Decision|0|||
23157650|NCT00467779|64328595|FG012|Stage 1|Physician Decision|0|||
23157651|NCT00467779|64328596|FG013|Stage 1|Physician Decision|0|||
23157652|NCT00467779|64328597|FG014|Stage 1|Physician Decision|0|||
23157653|NCT00467779|64328583|FG000|Stage 1|Withdrawal by Subject|0|||
23157654|NCT00467779|64328584|FG001|Stage 1|Withdrawal by Subject|0|||
23157655|NCT00467779|64328585|FG002|Stage 1|Withdrawal by Subject|0|||
23157656|NCT00467779|64328586|FG003|Stage 1|Withdrawal by Subject|0|||
23157657|NCT00467779|64328587|FG004|Stage 1|Withdrawal by Subject|0|||
23157658|NCT00467779|64328588|FG005|Stage 1|Withdrawal by Subject|0|||
23157659|NCT00467779|64328589|FG006|Stage 1|Withdrawal by Subject|1|||
23157660|NCT00467779|64328590|FG007|Stage 1|Withdrawal by Subject|1|||
23157661|NCT00467779|64328591|FG008|Stage 1|Withdrawal by Subject|0|||
23157662|NCT00467779|64328592|FG009|Stage 1|Withdrawal by Subject|0|||
23157663|NCT00467779|64328593|FG010|Stage 1|Withdrawal by Subject|0|||
23157664|NCT00467779|64328594|FG011|Stage 1|Withdrawal by Subject|0|||
23157665|NCT00467779|64328595|FG012|Stage 1|Withdrawal by Subject|0|||
23157666|NCT00467779|64328596|FG013|Stage 1|Withdrawal by Subject|0|||
23157667|NCT00467779|64328597|FG014|Stage 1|Withdrawal by Subject|0|||
23157668|NCT00467779|64328583|FG000|Stage 1A|Adverse Event|0|||
23157669|NCT00467779|64328584|FG001|Stage 1A|Adverse Event|0|||
23157670|NCT00467779|64328585|FG002|Stage 1A|Adverse Event|0|||
23157671|NCT00467779|64328586|FG003|Stage 1A|Adverse Event|0|||
23157672|NCT00467779|64328587|FG004|Stage 1A|Adverse Event|0|||
23157673|NCT00467779|64328588|FG005|Stage 1A|Adverse Event|0|||
23157674|NCT00467779|64328589|FG006|Stage 1A|Adverse Event|0|||
23157675|NCT00467779|64328590|FG007|Stage 1A|Adverse Event|0|||
23157676|NCT00467779|64328591|FG008|Stage 1A|Adverse Event|0|||
23157677|NCT00467779|64328592|FG009|Stage 1A|Adverse Event|0|||
23157678|NCT00467779|64328593|FG010|Stage 1A|Adverse Event|0|||
23157679|NCT00467779|64328594|FG011|Stage 1A|Adverse Event|0|||
23157680|NCT00467779|64328595|FG012|Stage 1A|Adverse Event|1|||
23157681|NCT00467779|64328596|FG013|Stage 1A|Adverse Event|0|||
23157682|NCT00467779|64328597|FG014|Stage 1A|Adverse Event|0|||
23157683|NCT00467779|64328583|FG000|Stage 1A|Death|0|||
23157684|NCT00467779|64328584|FG001|Stage 1A|Death|0|||
23157685|NCT00467779|64328585|FG002|Stage 1A|Death|0|||
23157686|NCT00467779|64328586|FG003|Stage 1A|Death|0|||
23157687|NCT00467779|64328587|FG004|Stage 1A|Death|0|||
23157688|NCT00467779|64328588|FG005|Stage 1A|Death|0|||
23157689|NCT00467779|64328589|FG006|Stage 1A|Death|0|||
23157690|NCT00467779|64328590|FG007|Stage 1A|Death|0|||
23157691|NCT00467779|64328591|FG008|Stage 1A|Death|0|||
23157692|NCT00467779|64328592|FG009|Stage 1A|Death|0|||
23157693|NCT00467779|64328593|FG010|Stage 1A|Death|0|||
23157694|NCT00467779|64328594|FG011|Stage 1A|Death|1|||
23157695|NCT00467779|64328595|FG012|Stage 1A|Death|1|||
23157696|NCT00467779|64328596|FG013|Stage 1A|Death|0|||
23157697|NCT00467779|64328597|FG014|Stage 1A|Death|0|||
23157698|NCT00467779|64328583|FG000|Stage 1A|Disease Progression|0|||
23157699|NCT00467779|64328584|FG001|Stage 1A|Disease Progression|0|||
23157700|NCT00467779|64328585|FG002|Stage 1A|Disease Progression|0|||
23157701|NCT00467779|64328586|FG003|Stage 1A|Disease Progression|0|||
23157702|NCT00467779|64328587|FG004|Stage 1A|Disease Progression|0|||
23157703|NCT00467779|64328588|FG005|Stage 1A|Disease Progression|0|||
23157704|NCT00467779|64328589|FG006|Stage 1A|Disease Progression|0|||
23157705|NCT00467779|64328590|FG007|Stage 1A|Disease Progression|0|||
23157706|NCT00467779|64328591|FG008|Stage 1A|Disease Progression|0|||
23157707|NCT00467779|64328592|FG009|Stage 1A|Disease Progression|2|||
23157708|NCT00467779|64328593|FG010|Stage 1A|Disease Progression|2|||
23157709|NCT00467779|64328594|FG011|Stage 1A|Disease Progression|5|||
23157710|NCT00467779|64328595|FG012|Stage 1A|Disease Progression|2|||
23157711|NCT00467779|64328596|FG013|Stage 1A|Disease Progression|0|||
23157712|NCT00467779|64328597|FG014|Stage 1A|Disease Progression|0|||
23157713|NCT00467779|64328583|FG000|Stage 1A|Physician Decision|0|||
23157714|NCT00467779|64328584|FG001|Stage 1A|Physician Decision|0|||
23157715|NCT00467779|64328585|FG002|Stage 1A|Physician Decision|0|||
23157716|NCT00467779|64328586|FG003|Stage 1A|Physician Decision|0|||
23157717|NCT00467779|64328587|FG004|Stage 1A|Physician Decision|0|||
23157718|NCT00467779|64328588|FG005|Stage 1A|Physician Decision|0|||
23157719|NCT00467779|64328589|FG006|Stage 1A|Physician Decision|0|||
23157720|NCT00467779|64328590|FG007|Stage 1A|Physician Decision|0|||
23157721|NCT00467779|64328591|FG008|Stage 1A|Physician Decision|0|||
23157722|NCT00467779|64328592|FG009|Stage 1A|Physician Decision|1|||
23157723|NCT00467779|64328593|FG010|Stage 1A|Physician Decision|0|||
23157724|NCT00467779|64328594|FG011|Stage 1A|Physician Decision|0|||
23157725|NCT00467779|64328595|FG012|Stage 1A|Physician Decision|0|||
23157726|NCT00467779|64328596|FG013|Stage 1A|Physician Decision|0|||
23157727|NCT00467779|64328597|FG014|Stage 1A|Physician Decision|0|||
23157728|NCT00467779|64328583|FG000|Stage 1A|Withdrawal by Subject|0|||
23157729|NCT00467779|64328584|FG001|Stage 1A|Withdrawal by Subject|0|||
23157730|NCT00467779|64328585|FG002|Stage 1A|Withdrawal by Subject|0|||
23157731|NCT00467779|64328586|FG003|Stage 1A|Withdrawal by Subject|0|||
23157732|NCT00467779|64328587|FG004|Stage 1A|Withdrawal by Subject|0|||
23157733|NCT00467779|64328588|FG005|Stage 1A|Withdrawal by Subject|0|||
23157734|NCT00467779|64328589|FG006|Stage 1A|Withdrawal by Subject|0|||
23157735|NCT00467779|64328590|FG007|Stage 1A|Withdrawal by Subject|0|||
23157736|NCT00467779|64328591|FG008|Stage 1A|Withdrawal by Subject|0|||
23157737|NCT00467779|64328592|FG009|Stage 1A|Withdrawal by Subject|0|||
23328203|NCT03307252|64945378|FG000|Part 2, Period 1|Treatment not received|0|||
23566595|NCT03430063|65803877|FG002|Overall Study|Withdrawal by Subject|1|||
23157738|NCT00467779|64328593|FG010|Stage 1A|Withdrawal by Subject|1|||
23157739|NCT00467779|64328594|FG011|Stage 1A|Withdrawal by Subject|1|||
23157740|NCT00467779|64328595|FG012|Stage 1A|Withdrawal by Subject|1|||
23157741|NCT00467779|64328596|FG013|Stage 1A|Withdrawal by Subject|0|||
23157742|NCT00467779|64328597|FG014|Stage 1A|Withdrawal by Subject|0|||
23328204|NCT03307252|64945379|FG001|Part 2, Period 1|Treatment not received|0|||
23328205|NCT03307252|64945380|FG002|Part 2, Period 1|Treatment not received|0|||
23328206|NCT03307252|64945381|FG003|Part 2, Period 1|Treatment not received|0|||
23328207|NCT03307252|64945382|FG004|Part 2, Period 1|Treatment not received|0|||
23157743|NCT00467779|64328583|FG000|Stage 1A|Unspecified Reason|0|||
23157744|NCT00467779|64328584|FG001|Stage 1A|Unspecified Reason|0|||
23157745|NCT00467779|64328585|FG002|Stage 1A|Unspecified Reason|0|||
23157746|NCT00467779|64328586|FG003|Stage 1A|Unspecified Reason|0|||
23157747|NCT00467779|64328587|FG004|Stage 1A|Unspecified Reason|0|||
23157748|NCT00467779|64328588|FG005|Stage 1A|Unspecified Reason|0|||
23157749|NCT00467779|64328589|FG006|Stage 1A|Unspecified Reason|0|||
23157750|NCT00467779|64328590|FG007|Stage 1A|Unspecified Reason|0|||
23157751|NCT00467779|64328591|FG008|Stage 1A|Unspecified Reason|0|||
23157752|NCT00467779|64328592|FG009|Stage 1A|Unspecified Reason|0|||
23157753|NCT00467779|64328593|FG010|Stage 1A|Unspecified Reason|0|||
23157754|NCT00467779|64328594|FG011|Stage 1A|Unspecified Reason|1|||
23157755|NCT00467779|64328595|FG012|Stage 1A|Unspecified Reason|1|||
23157756|NCT00467779|64328596|FG013|Stage 1A|Unspecified Reason|0|||
23157757|NCT00467779|64328597|FG014|Stage 1A|Unspecified Reason|0|||
23443458|NCT00452790|65366407|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
23443459|NCT00452790|65366408|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
23443460|NCT00452790|65366407|FG000|Infant Series|Parent/legal guardian request|8|||
23443461|NCT00452790|65366408|FG001|Infant Series|Parent/legal guardian request|6|||
23443462|NCT00452790|65366407|FG000|Infant Series|Failed to return|4|||
23443463|NCT00452790|65366408|FG001|Infant Series|Failed to return|1|||
23443464|NCT00452790|65366407|FG000|Infant Series|Protocol Violation|1|||
23443465|NCT00452790|65366408|FG001|Infant Series|Protocol Violation|3|||
23443466|NCT00452790|65366407|FG000|Infant Series|Lost to Follow-up|2|||
23443467|NCT00452790|65366408|FG001|Infant Series|Lost to Follow-up|2|||
23443468|NCT00452790|65366407|FG000|Infant Series|Adverse Event|1|||
23443469|NCT00452790|65366408|FG001|Infant Series|Adverse Event|2|||
23443470|NCT00452790|65366407|FG000|Infant Series|Other reasons|1|||
23443471|NCT00452790|65366408|FG001|Infant Series|Other reasons|2|||
23443472|NCT00452790|65366407|FG000|Infant Series|Investigator request|0|||
23443473|NCT00452790|65366408|FG001|Infant Series|Investigator request|1|||
23443474|NCT00452790|65366407|FG000|Infant Series|Death|0|||
23443475|NCT00452790|65366408|FG001|Infant Series|Death|1|||
23443476|NCT00452790|65366407|FG000|After Infant Series|Investigator request|10|||
23443477|NCT00452790|65366408|FG001|After Infant Series|Investigator request|10|||
23443478|NCT00452790|65366407|FG000|After Infant Series|Adverse Event|4|||
23443479|NCT00452790|65366408|FG001|After Infant Series|Adverse Event|1|||
23443480|NCT00452790|65366407|FG000|After Infant Series|Parent/legal guardian request|1|||
23443481|NCT00452790|65366408|FG001|After Infant Series|Parent/legal guardian request|3|||
23443482|NCT00452790|65366407|FG000|After Infant Series|Lost to Follow-up|4|||
23443483|NCT00452790|65366408|FG001|After Infant Series|Lost to Follow-up|0|||
23443484|NCT00452790|65366407|FG000|After Infant Series|Failed to return|1|||
23443485|NCT00452790|65366408|FG001|After Infant Series|Failed to return|0|||
23443486|NCT00452790|65366407|FG000|After Infant Series|Other reasons|1|||
23443487|NCT00452790|65366408|FG001|After Infant Series|Other reasons|0|||
23443488|NCT00452790|65366407|FG000|Toddler Dose|Failed to return|0|||
23443489|NCT00452790|65366408|FG001|Toddler Dose|Failed to return|1|||
23443490|NCT00452790|65366407|FG000|Toddler Dose|Parent/legal guardian request|0|||
23443491|NCT00452790|65366408|FG001|Toddler Dose|Parent/legal guardian request|1|||
23443492|NCT00358436|65366412|FG000|Overall Study|Adverse Event|29|||
23443493|NCT00358436|65366413|FG001|Overall Study|Adverse Event|13|||
23443494|NCT00358436|65366412|FG000|Overall Study|Lack of Efficacy|34|||
23443495|NCT00358436|65366413|FG001|Overall Study|Lack of Efficacy|36|||
23443496|NCT00358436|65366412|FG000|Overall Study|Lost to Follow-up|11|||
23443497|NCT00358436|65366413|FG001|Overall Study|Lost to Follow-up|6|||
23443498|NCT00358436|65366412|FG000|Overall Study|Protocol Violation|8|||
23443499|NCT00358436|65366413|FG001|Overall Study|Protocol Violation|3|||
23443500|NCT00358436|65366412|FG000|Overall Study|Withdrawal by Subject|40|||
23328208|NCT03307252|64945383|FG005|Part 2, Period 1|Treatment not received|1|||
23443501|NCT00358436|65366413|FG001|Overall Study|Withdrawal by Subject|17|||
23443502|NCT00358436|65366412|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
23443503|NCT00358436|65366413|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
23443504|NCT00358436|65366412|FG000|Overall Study|COPD exacerbation|22|||
23443505|NCT00358436|65366413|FG001|Overall Study|COPD exacerbation|10|||
23443506|NCT00358436|65366412|FG000|Overall Study|Other|6|||
23443507|NCT00358436|65366413|FG001|Overall Study|Other|1|||
23443508|NCT01415401|65366414|FG000|Overall Study|Adverse Event|5|||
23443509|NCT01415401|65366414|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
23443510|NCT01415401|65366414|FG000|Overall Study|Terminated by Sponsor|1|||
23443511|NCT01461707|65366415|FG000|Overall Study|Withdrawal by Subject|1|||
23443512|NCT01461707|65366416|FG001|Overall Study|Withdrawal by Subject|0|||
23566596|NCT03430063|65803875|FG000|Overall Study|Withdrawal of consent|3|||
23566597|NCT03430063|65803876|FG001|Overall Study|Withdrawal of consent|1|||
23443513|NCT04639219|65366417|FG000|Overall Study|Withdrawal by Subject|8|||
23443514|NCT04639219|65366417|FG000|Overall Study|Lost to Follow-up|6|||
23443515|NCT04639219|65366417|FG000|Overall Study|Death|55|||
23443516|NCT02343406|65366418|FG000|Overall Study|Progressive disease|72|||
23443517|NCT02343406|65366419|FG001|Overall Study|Progressive disease|70|||
23443518|NCT02343406|65366420|FG002|Overall Study|Progressive disease|43|||
23157758|NCT00467779|64328583|FG000|Stage 2|Adverse Event|0|||
23157759|NCT00467779|64328584|FG001|Stage 2|Adverse Event|0|||
23157760|NCT00467779|64328585|FG002|Stage 2|Adverse Event|0|||
23157761|NCT00467779|64328586|FG003|Stage 2|Adverse Event|0|||
23157762|NCT00467779|64328587|FG004|Stage 2|Adverse Event|0|||
23157763|NCT00467779|64328588|FG005|Stage 2|Adverse Event|0|||
23157764|NCT00467779|64328589|FG006|Stage 2|Adverse Event|0|||
23157765|NCT00467779|64328590|FG007|Stage 2|Adverse Event|0|||
23157766|NCT00467779|64328591|FG008|Stage 2|Adverse Event|1|||
23157767|NCT00467779|64328592|FG009|Stage 2|Adverse Event|0|||
23328209|NCT03307252|64945384|FG006|Part 2, Period 1|Treatment not received|0|||
23443519|NCT02343406|65366421|FG003|Overall Study|Progressive disease|15|||
23443520|NCT02343406|65366422|FG004|Overall Study|Progressive disease|5|||
23443521|NCT02343406|65366418|FG000|Overall Study|Adverse Event|6|||
23157768|NCT00467779|64328593|FG010|Stage 2|Adverse Event|0|||
23443522|NCT02343406|65366419|FG001|Overall Study|Adverse Event|8|||
23443523|NCT02343406|65366420|FG002|Overall Study|Adverse Event|6|||
23566598|NCT03430063|65803877|FG002|Overall Study|Withdrawal of consent|2|||
23221974|NCT01197794|64553861|FG006|Overall Study|Other|4|||
23221975|NCT01329341|64553865|FG000|Overall Study|Withdrawal by Subject|44|||
23221976|NCT02985684|64553866|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
23221977|NCT02985684|64553866|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
23566599|NCT03430063|65803875|FG000|Overall Study|Progressive disease|1|||
23157769|NCT00467779|64328594|FG011|Stage 2|Adverse Event|0|||
23157770|NCT00467779|64328595|FG012|Stage 2|Adverse Event|0|||
23157771|NCT00467779|64328596|FG013|Stage 2|Adverse Event|0|||
23157772|NCT00467779|64328597|FG014|Stage 2|Adverse Event|0|||
23157773|NCT00467779|64328583|FG000|Stage 2|Death|0|||
23157774|NCT00467779|64328584|FG001|Stage 2|Death|0|||
23157775|NCT00467779|64328585|FG002|Stage 2|Death|0|||
23157776|NCT00467779|64328586|FG003|Stage 2|Death|0|||
23157777|NCT00467779|64328587|FG004|Stage 2|Death|0|||
23157778|NCT00467779|64328588|FG005|Stage 2|Death|0|||
23157779|NCT00467779|64328589|FG006|Stage 2|Death|0|||
23157780|NCT00467779|64328590|FG007|Stage 2|Death|0|||
23157781|NCT00467779|64328591|FG008|Stage 2|Death|1|||
23157782|NCT00467779|64328592|FG009|Stage 2|Death|0|||
23157783|NCT00467779|64328593|FG010|Stage 2|Death|0|||
23157784|NCT00467779|64328594|FG011|Stage 2|Death|0|||
23157785|NCT00467779|64328595|FG012|Stage 2|Death|0|||
23157786|NCT00467779|64328596|FG013|Stage 2|Death|0|||
23157787|NCT00467779|64328597|FG014|Stage 2|Death|0|||
23157788|NCT00467779|64328583|FG000|Stage 2|Disease Progression|0|||
23157789|NCT00467779|64328584|FG001|Stage 2|Disease Progression|0|||
23157790|NCT00467779|64328585|FG002|Stage 2|Disease Progression|0|||
23157791|NCT00467779|64328586|FG003|Stage 2|Disease Progression|0|||
23157792|NCT00467779|64328587|FG004|Stage 2|Disease Progression|0|||
23221978|NCT02985684|64553866|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
23221979|NCT03510910|64553868|FG000|Overall Study|Incomplete Survey|2|||
23221980|NCT03510910|64553869|FG001|Overall Study|Incomplete Survey|3|||
23221981|NCT03128307|64553870|FG000|Overall Study|Lost to Follow-up|29|||
23221982|NCT03128307|64553870|FG000|Overall Study|Withdrawal by Subject|5|||
23221983|NCT02667236|64553871|FG000|Overall Study|Adverse Event|1|||
23221984|NCT02667236|64553872|FG001|Overall Study|Adverse Event|1|||
23221985|NCT02667236|64553871|FG000|Overall Study|Withdrawal by Subject|2|||
23221986|NCT02667236|64553872|FG001|Overall Study|Withdrawal by Subject|0|||
23221987|NCT02903368|64553875|FG000|Part 1|Adverse Event|3|||
23221988|NCT02903368|64553876|FG001|Part 1|Adverse Event|0|||
23221989|NCT02903368|64553877|FG002|Part 1|Adverse Event|0|||
23221990|NCT02903368|64553878|FG003|Part 1|Adverse Event|0|||
23221991|NCT02903368|64553875|FG000|Part 1|Withdrawal by Subject|1|||
23221992|NCT02903368|64553876|FG001|Part 1|Withdrawal by Subject|0|||
23221993|NCT02903368|64553877|FG002|Part 1|Withdrawal by Subject|0|||
23221994|NCT02903368|64553878|FG003|Part 1|Withdrawal by Subject|0|||
23221995|NCT02903368|64553875|FG000|Part 2|Adverse Event|0|||
23221996|NCT02903368|64553876|FG001|Part 2|Adverse Event|0|||
23221997|NCT02903368|64553877|FG002|Part 2|Adverse Event|5|||
23221998|NCT02903368|64553878|FG003|Part 2|Adverse Event|0|||
23221999|NCT02903368|64553875|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
23222000|NCT02903368|64553876|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
23222001|NCT02903368|64553877|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
23222002|NCT02903368|64553878|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
23222003|NCT02903368|64553875|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
23222004|NCT02903368|64553876|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
23222005|NCT02903368|64553877|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
23222006|NCT02903368|64553878|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
23222007|NCT02903368|64553875|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
23566600|NCT03430063|65803876|FG001|Overall Study|Progressive disease|2|||
23222008|NCT02903368|64553876|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
23222009|NCT02903368|64553877|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
23443524|NCT02343406|65366421|FG003|Overall Study|Adverse Event|3|||
23157793|NCT00467779|64328588|FG005|Stage 2|Disease Progression|0|||
23157794|NCT00467779|64328589|FG006|Stage 2|Disease Progression|0|||
23222010|NCT02903368|64553878|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
23222011|NCT01553591|64553879|FG000|Overall Study|Voluntarily withdrew|94|||
23443525|NCT02343406|65366422|FG004|Overall Study|Adverse Event|0|||
23157795|NCT00467779|64328590|FG007|Stage 2|Disease Progression|0|||
23157796|NCT00467779|64328591|FG008|Stage 2|Disease Progression|16|||
23157797|NCT00467779|64328592|FG009|Stage 2|Disease Progression|0|||
23157798|NCT00467779|64328593|FG010|Stage 2|Disease Progression|0|||
23157799|NCT00467779|64328594|FG011|Stage 2|Disease Progression|0|||
23157800|NCT00467779|64328595|FG012|Stage 2|Disease Progression|0|||
23157801|NCT00467779|64328596|FG013|Stage 2|Disease Progression|0|||
23157802|NCT00467779|64328597|FG014|Stage 2|Disease Progression|0|||
23157803|NCT00467779|64328583|FG000|Stage 2|Unspecified Reason|0|||
23157804|NCT00467779|64328584|FG001|Stage 2|Unspecified Reason|0|||
23157805|NCT00467779|64328585|FG002|Stage 2|Unspecified Reason|0|||
23157806|NCT00467779|64328586|FG003|Stage 2|Unspecified Reason|0|||
23157807|NCT00467779|64328587|FG004|Stage 2|Unspecified Reason|0|||
23157808|NCT00467779|64328588|FG005|Stage 2|Unspecified Reason|0|||
23157809|NCT00467779|64328589|FG006|Stage 2|Unspecified Reason|0|||
23157810|NCT00467779|64328590|FG007|Stage 2|Unspecified Reason|0|||
23157811|NCT00467779|64328591|FG008|Stage 2|Unspecified Reason|3|||
23157812|NCT00467779|64328592|FG009|Stage 2|Unspecified Reason|0|||
23157813|NCT00467779|64328593|FG010|Stage 2|Unspecified Reason|0|||
23157814|NCT00467779|64328594|FG011|Stage 2|Unspecified Reason|0|||
23157815|NCT00467779|64328595|FG012|Stage 2|Unspecified Reason|0|||
23157816|NCT00467779|64328596|FG013|Stage 2|Unspecified Reason|0|||
23157817|NCT00467779|64328597|FG014|Stage 2|Unspecified Reason|0|||
23328210|NCT03307252|64945385|FG007|Part 2, Period 1|Treatment not received|0|||
23328211|NCT03307252|64945386|FG008|Part 2, Period 1|Treatment not received|0|||
23328212|NCT03307252|64945387|FG009|Part 2, Period 1|Treatment not received|0|||
23157818|NCT00467779|64328583|FG000|Stage 2A|Adverse Event|0|||
23157819|NCT00467779|64328584|FG001|Stage 2A|Adverse Event|0|||
23157820|NCT00467779|64328585|FG002|Stage 2A|Adverse Event|0|||
23157821|NCT00467779|64328586|FG003|Stage 2A|Adverse Event|0|||
23157822|NCT00467779|64328587|FG004|Stage 2A|Adverse Event|0|||
23157823|NCT00467779|64328588|FG005|Stage 2A|Adverse Event|0|||
23157824|NCT00467779|64328589|FG006|Stage 2A|Adverse Event|0|||
23157825|NCT00467779|64328590|FG007|Stage 2A|Adverse Event|0|||
23157826|NCT00467779|64328591|FG008|Stage 2A|Adverse Event|0|||
23157827|NCT00467779|64328592|FG009|Stage 2A|Adverse Event|0|||
23157828|NCT00467779|64328593|FG010|Stage 2A|Adverse Event|0|||
23157829|NCT00467779|64328594|FG011|Stage 2A|Adverse Event|0|||
23157830|NCT00467779|64328595|FG012|Stage 2A|Adverse Event|0|||
23157831|NCT00467779|64328596|FG013|Stage 2A|Adverse Event|2|||
23157832|NCT00467779|64328597|FG014|Stage 2A|Adverse Event|0|||
23157833|NCT00467779|64328583|FG000|Stage 2A|Death|0|||
23157834|NCT00467779|64328584|FG001|Stage 2A|Death|0|||
23157835|NCT00467779|64328585|FG002|Stage 2A|Death|0|||
23157836|NCT00467779|64328586|FG003|Stage 2A|Death|0|||
23157837|NCT00467779|64328587|FG004|Stage 2A|Death|0|||
23157838|NCT00467779|64328588|FG005|Stage 2A|Death|0|||
23157839|NCT00467779|64328589|FG006|Stage 2A|Death|0|||
23157840|NCT00467779|64328590|FG007|Stage 2A|Death|0|||
23157841|NCT00467779|64328591|FG008|Stage 2A|Death|0|||
23157842|NCT00467779|64328592|FG009|Stage 2A|Death|0|||
23222012|NCT01553591|64553880|FG001|Overall Study|Voluntarily withdrew|79|||
23328213|NCT03307252|64945388|FG010|Part 2, Period 1|Treatment not received|0|||
23328214|NCT03307252|64945378|FG000|Part 2, Period 3|Other than listed|0|||
23328215|NCT03307252|64945379|FG001|Part 2, Period 3|Other than listed|0|||
23157843|NCT00467779|64328593|FG010|Stage 2A|Death|0|||
23157844|NCT00467779|64328594|FG011|Stage 2A|Death|0|||
23157845|NCT00467779|64328595|FG012|Stage 2A|Death|0|||
23157846|NCT00467779|64328596|FG013|Stage 2A|Death|1|||
23157847|NCT00467779|64328597|FG014|Stage 2A|Death|0|||
23157848|NCT00467779|64328583|FG000|Stage 2A|Disease Progression|0|||
23157849|NCT00467779|64328584|FG001|Stage 2A|Disease Progression|0|||
23328216|NCT03307252|64945380|FG002|Part 2, Period 3|Other than listed|0|||
23328217|NCT03307252|64945381|FG003|Part 2, Period 3|Other than listed|0|||
23328218|NCT03307252|64945382|FG004|Part 2, Period 3|Other than listed|1|||
23328219|NCT03307252|64945383|FG005|Part 2, Period 3|Other than listed|0|||
23328220|NCT03307252|64945384|FG006|Part 2, Period 3|Other than listed|0|||
23328221|NCT03307252|64945385|FG007|Part 2, Period 3|Other than listed|0|||
23328222|NCT03307252|64945386|FG008|Part 2, Period 3|Other than listed|0|||
23157850|NCT00467779|64328585|FG002|Stage 2A|Disease Progression|0|||
23157851|NCT00467779|64328586|FG003|Stage 2A|Disease Progression|0|||
23157852|NCT00467779|64328587|FG004|Stage 2A|Disease Progression|0|||
23157853|NCT00467779|64328588|FG005|Stage 2A|Disease Progression|0|||
23222013|NCT01553591|64553881|FG002|Overall Study|Voluntarily withdrew|96|||
23222014|NCT01553591|64553879|FG000|Overall Study|Adverse Event|36|||
23328223|NCT03307252|64945387|FG009|Part 2, Period 3|Other than listed|0|||
23157854|NCT00467779|64328589|FG006|Stage 2A|Disease Progression|0|||
23157855|NCT00467779|64328590|FG007|Stage 2A|Disease Progression|0|||
23157856|NCT00467779|64328591|FG008|Stage 2A|Disease Progression|0|||
23157857|NCT00467779|64328592|FG009|Stage 2A|Disease Progression|0|||
23157858|NCT00467779|64328593|FG010|Stage 2A|Disease Progression|0|||
23157859|NCT00467779|64328594|FG011|Stage 2A|Disease Progression|0|||
23157860|NCT00467779|64328595|FG012|Stage 2A|Disease Progression|0|||
23157861|NCT00467779|64328596|FG013|Stage 2A|Disease Progression|10|||
23157862|NCT00467779|64328597|FG014|Stage 2A|Disease Progression|0|||
23157863|NCT00467779|64328583|FG000|Stage 2A|Unspecified Reason|0|||
23157864|NCT00467779|64328584|FG001|Stage 2A|Unspecified Reason|0|||
23157865|NCT00467779|64328585|FG002|Stage 2A|Unspecified Reason|0|||
23157866|NCT00467779|64328586|FG003|Stage 2A|Unspecified Reason|0|||
23157867|NCT00467779|64328587|FG004|Stage 2A|Unspecified Reason|0|||
23157868|NCT00467779|64328588|FG005|Stage 2A|Unspecified Reason|0|||
23157869|NCT00467779|64328589|FG006|Stage 2A|Unspecified Reason|0|||
23222015|NCT01553591|64553880|FG001|Overall Study|Adverse Event|45|||
23222016|NCT01553591|64553881|FG002|Overall Study|Adverse Event|16|||
23222017|NCT01553591|64553879|FG000|Overall Study|Lost to Follow-up|25|||
23222018|NCT01553591|64553880|FG001|Overall Study|Lost to Follow-up|23|||
23222019|NCT01553591|64553881|FG002|Overall Study|Lost to Follow-up|16|||
23222020|NCT01553591|64553879|FG000|Overall Study|Physician decision: other|11|||
23222021|NCT01553591|64553880|FG001|Overall Study|Physician decision: other|14|||
23222022|NCT01553591|64553881|FG002|Overall Study|Physician decision: other|16|||
23222023|NCT01553591|64553879|FG000|Overall Study|Physician decision: lack of efficacy|2|||
23222024|NCT01553591|64553880|FG001|Overall Study|Physician decision: lack of efficacy|3|||
23222025|NCT01553591|64553881|FG002|Overall Study|Physician decision: lack of efficacy|7|||
23222026|NCT01553591|64553879|FG000|Overall Study|Protocol Violation|3|||
23222027|NCT01553591|64553880|FG001|Overall Study|Protocol Violation|4|||
23222028|NCT01553591|64553881|FG002|Overall Study|Protocol Violation|4|||
23222029|NCT01553591|64553879|FG000|Overall Study|Sponsor decision|1|||
23222030|NCT01553591|64553880|FG001|Overall Study|Sponsor decision|0|||
23222031|NCT01553591|64553881|FG002|Overall Study|Sponsor decision|3|||
23222032|NCT01553591|64553879|FG000|Overall Study|Randomized and never dispensed drug|0|||
23222033|NCT01553591|64553880|FG001|Overall Study|Randomized and never dispensed drug|1|||
23222034|NCT01553591|64553881|FG002|Overall Study|Randomized and never dispensed drug|0|||
23222035|NCT01474889|64557519|FG000|Overall Study|Physician Decision|1|||
23222036|NCT01474889|64557520|FG001|Overall Study|Physician Decision|0|||
23222037|NCT01474889|64557521|FG002|Overall Study|Physician Decision|0|||
23222038|NCT01474889|64557519|FG000|Overall Study|Did not meet inclusion|1|||
23222039|NCT01474889|64557520|FG001|Overall Study|Did not meet inclusion|0|||
23222040|NCT01474889|64557521|FG002|Overall Study|Did not meet inclusion|0|||
23222041|NCT01474889|64557519|FG000|Overall Study|Withdrawal by Subject|0|||
23222042|NCT01474889|64557520|FG001|Overall Study|Withdrawal by Subject|1|||
23157870|NCT00467779|64328590|FG007|Stage 2A|Unspecified Reason|0|||
23157871|NCT00467779|64328591|FG008|Stage 2A|Unspecified Reason|0|||
23157872|NCT00467779|64328592|FG009|Stage 2A|Unspecified Reason|0|||
23157873|NCT00467779|64328593|FG010|Stage 2A|Unspecified Reason|0|||
23157874|NCT00467779|64328594|FG011|Stage 2A|Unspecified Reason|0|||
23157875|NCT00467779|64328595|FG012|Stage 2A|Unspecified Reason|0|||
23157876|NCT00467779|64328596|FG013|Stage 2A|Unspecified Reason|7|||
23157877|NCT00467779|64328597|FG014|Stage 2A|Unspecified Reason|0|||
23157878|NCT00467779|64328583|FG000|Stage 2A|Withdrawal by Subject|0|||
23157879|NCT00467779|64328584|FG001|Stage 2A|Withdrawal by Subject|0|||
23157880|NCT00467779|64328585|FG002|Stage 2A|Withdrawal by Subject|0|||
23157881|NCT00467779|64328586|FG003|Stage 2A|Withdrawal by Subject|0|||
23157882|NCT00467779|64328587|FG004|Stage 2A|Withdrawal by Subject|0|||
23157883|NCT00467779|64328588|FG005|Stage 2A|Withdrawal by Subject|0|||
23157884|NCT00467779|64328589|FG006|Stage 2A|Withdrawal by Subject|0|||
23157885|NCT00467779|64328590|FG007|Stage 2A|Withdrawal by Subject|0|||
23157886|NCT00467779|64328591|FG008|Stage 2A|Withdrawal by Subject|0|||
23157887|NCT00467779|64328592|FG009|Stage 2A|Withdrawal by Subject|0|||
23222043|NCT01474889|64557521|FG002|Overall Study|Withdrawal by Subject|0|||
23443526|NCT02343406|65366418|FG000|Overall Study|Withdrawal by Subject|6|||
23443527|NCT02343406|65366419|FG001|Overall Study|Withdrawal by Subject|4|||
23443528|NCT02343406|65366420|FG002|Overall Study|Withdrawal by Subject|8|||
23443529|NCT02343406|65366421|FG003|Overall Study|Withdrawal by Subject|3|||
23443530|NCT02343406|65366422|FG004|Overall Study|Withdrawal by Subject|0|||
23443531|NCT02343406|65366418|FG000|Overall Study|Death|2|||
23443532|NCT02343406|65366419|FG001|Overall Study|Death|1|||
23443533|NCT02343406|65366420|FG002|Overall Study|Death|0|||
23443534|NCT02343406|65366421|FG003|Overall Study|Death|0|||
23443535|NCT02343406|65366422|FG004|Overall Study|Death|0|||
23443536|NCT02343406|65366418|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
23222044|NCT02392468|64557522|FG000|Overall Study|Adverse Event|0|||
23222045|NCT02392468|64557523|FG001|Overall Study|Adverse Event|1|||
23222046|NCT02392468|64557524|FG002|Overall Study|Adverse Event|0|||
23222047|NCT02392468|64557525|FG003|Overall Study|Adverse Event|0|||
23222048|NCT02392468|64557526|FG004|Overall Study|Adverse Event|0|||
23443537|NCT02343406|65366419|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
23443538|NCT02343406|65366420|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
23443539|NCT02343406|65366421|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
23157888|NCT00467779|64328593|FG010|Stage 2A|Withdrawal by Subject|0|||
23157889|NCT00467779|64328594|FG011|Stage 2A|Withdrawal by Subject|0|||
23157890|NCT00467779|64328595|FG012|Stage 2A|Withdrawal by Subject|0|||
23157891|NCT00467779|64328596|FG013|Stage 2A|Withdrawal by Subject|1|||
23157892|NCT00467779|64328597|FG014|Stage 2A|Withdrawal by Subject|0|||
23222049|NCT02392468|64557527|FG005|Overall Study|Adverse Event|1|||
23222050|NCT00880100|64557535|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
23222051|NCT00880100|64557535|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
23222052|NCT00880100|64557535|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
23222053|NCT00369278|64557539|FG000|Overall Study|Adverse Event|14|||
23443540|NCT02343406|65366422|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
23443541|NCT02343406|65366418|FG000|Overall Study|Other primary malignancy|0|||
23443542|NCT02343406|65366419|FG001|Overall Study|Other primary malignancy|1|||
23443543|NCT02343406|65366420|FG002|Overall Study|Other primary malignancy|0|||
23443544|NCT02343406|65366421|FG003|Overall Study|Other primary malignancy|0|||
23443545|NCT02343406|65366422|FG004|Overall Study|Other primary malignancy|0|||
23443546|NCT02343406|65366418|FG000|Overall Study|Other, not specified|2|||
23443547|NCT02343406|65366419|FG001|Overall Study|Other, not specified|1|||
23443548|NCT02343406|65366420|FG002|Overall Study|Other, not specified|1|||
23443549|NCT02343406|65366421|FG003|Overall Study|Other, not specified|4|||
23443550|NCT02343406|65366422|FG004|Overall Study|Other, not specified|0|||
23443551|NCT00650767|65366427|FG000|Overall Study|Adverse Event|0|||
23443552|NCT00650767|65366428|FG001|Overall Study|Adverse Event|3|||
23443553|NCT00650767|65366429|FG002|Overall Study|Adverse Event|10|||
23443554|NCT00650767|65366430|FG003|Overall Study|Adverse Event|8|||
23443555|NCT00650767|65366427|FG000|Overall Study|Death|1|||
23443556|NCT00650767|65366428|FG001|Overall Study|Death|0|||
23443557|NCT00650767|65366429|FG002|Overall Study|Death|0|||
23443558|NCT00650767|65366430|FG003|Overall Study|Death|0|||
23443559|NCT00650767|65366427|FG000|Overall Study|Withdrawal by Subject|2|||
23443560|NCT00650767|65366428|FG001|Overall Study|Withdrawal by Subject|4|||
23443561|NCT00650767|65366429|FG002|Overall Study|Withdrawal by Subject|3|||
23443562|NCT00650767|65366430|FG003|Overall Study|Withdrawal by Subject|3|||
23443563|NCT00650767|65366427|FG000|Overall Study|Lost to Follow-up|1|||
23443564|NCT00650767|65366428|FG001|Overall Study|Lost to Follow-up|1|||
23443565|NCT00650767|65366429|FG002|Overall Study|Lost to Follow-up|1|||
23443566|NCT00650767|65366430|FG003|Overall Study|Lost to Follow-up|0|||
23443567|NCT00650767|65366427|FG000|Overall Study|Other|1|||
23443568|NCT00650767|65366428|FG001|Overall Study|Other|1|||
23443569|NCT00650767|65366429|FG002|Overall Study|Other|0|||
23443570|NCT00650767|65366430|FG003|Overall Study|Other|0|||
23443571|NCT02950480|65366432|FG000|Overall Study|Withdrawal by Subject|1|||
23443572|NCT02950480|65366433|FG001|Overall Study|Withdrawal by Subject|0|||
23443573|NCT01150097|65366437|FG000|Months 24 to 36 Post-transplantation|Death|2|||
23443574|NCT01150097|65366438|FG001|Months 24 to 36 Post-transplantation|Death|0|||
23443575|NCT01150097|65366439|FG002|Months 24 to 36 Post-transplantation|Death|0|||
23443576|NCT01150097|65366437|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
23443577|NCT01150097|65366438|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
23443578|NCT01150097|65366439|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
23443579|NCT01150097|65366437|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
23443580|NCT01150097|65366438|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
23443581|NCT01150097|65366439|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
23443582|NCT01150097|65366437|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
23443583|NCT01150097|65366438|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
23443584|NCT01150097|65366439|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
23443585|NCT01150097|65366437|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
23443586|NCT01150097|65366438|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
23443587|NCT01150097|65366439|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
23443588|NCT01150097|65366437|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
23443589|NCT01150097|65366438|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
23443590|NCT01150097|65366439|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
23443591|NCT01150097|65366437|FG000|Months 24 to 48 Post-transplantation|Death|2|||
23443592|NCT01150097|65366438|FG001|Months 24 to 48 Post-transplantation|Death|0|||
23443593|NCT01150097|65366439|FG002|Months 24 to 48 Post-transplantation|Death|0|||
23443594|NCT00714415|65366443|FG000|Overall Study|Lack of Efficacy|1|||
23443595|NCT00714415|65366444|FG001|Overall Study|Lack of Efficacy|0|||
23443596|NCT00714415|65366443|FG000|Overall Study|Death|1|||
23443597|NCT00714415|65366444|FG001|Overall Study|Death|0|||
23443598|NCT00303485|65366445|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
23443599|NCT00303485|65366446|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
23443600|NCT00303485|65366445|FG000|Overall Study|Failure to return|0|||
23443601|NCT00303485|65366446|FG001|Overall Study|Failure to return|1|||
23443602|NCT00303485|65366445|FG000|Overall Study|Withdrawal by Subject|1|||
23443603|NCT00303485|65366446|FG001|Overall Study|Withdrawal by Subject|0|||
23443604|NCT01641601|65366448|FG000|Overall Study|Study discontinued.|3|||
23443605|NCT01641601|65366449|FG001|Overall Study|Study discontinued.|5|||
23443606|NCT00660179|65366450|FG000|Overall Study|Death|44|||
23443607|NCT00660179|65366451|FG001|Overall Study|Death|47|||
23443608|NCT00660179|65366452|FG002|Overall Study|Death|34|||
23443609|NCT00660179|65366450|FG000|Overall Study|Withdrawal of consent|4|||
23443610|NCT00660179|65366451|FG001|Overall Study|Withdrawal of consent|6|||
23443611|NCT00660179|65366452|FG002|Overall Study|Withdrawal of consent|4|||
23443612|NCT00660179|65366450|FG000|Overall Study|Lost to Follow-up|7|||
23443613|NCT00660179|65366451|FG001|Overall Study|Lost to Follow-up|5|||
23443614|NCT00660179|65366452|FG002|Overall Study|Lost to Follow-up|2|||
23443615|NCT00660179|65366450|FG000|Overall Study|Administrative reason|0|||
23443616|NCT00660179|65366451|FG001|Overall Study|Administrative reason|0|||
23443617|NCT00660179|65366452|FG002|Overall Study|Administrative reason|1|||
23443618|NCT00660179|65366450|FG000|Overall Study|Incorrect randomization|1|||
23443619|NCT00660179|65366451|FG001|Overall Study|Incorrect randomization|0|||
23443620|NCT00660179|65366452|FG002|Overall Study|Incorrect randomization|0|||
23443621|NCT00765063|65366453|FG000|Overall Study|Lack of Efficacy|5|||
23443622|NCT00765063|65366453|FG000|Overall Study|Withdrawal by Subject|1|||
23443623|NCT00765063|65366453|FG000|Overall Study|Other|16|||
23443624|NCT00765063|65366453|FG000|Overall Study|Protocol Violation|6|||
23443625|NCT00765063|65366453|FG000|Overall Study|Adverse Event|4|||
23443626|NCT01858766|65366456|FG000|Overall Study|Randomized but Never Treated|0|||
23443627|NCT01858766|65366457|FG001|Overall Study|Randomized but Never Treated|0|||
23443628|NCT01858766|65366458|FG002|Overall Study|Randomized but Never Treated|0|||
23443629|NCT01858766|65366459|FG003|Overall Study|Randomized but Never Treated|0|||
23443630|NCT01858766|65366460|FG004|Overall Study|Randomized but Never Treated|0|||
23443631|NCT01858766|65366461|FG005|Overall Study|Randomized but Never Treated|1|||
23443632|NCT01858766|65366462|FG006|Overall Study|Randomized but Never Treated|0|||
23443633|NCT01858766|65366463|FG007|Overall Study|Randomized but Never Treated|0|||
23443634|NCT01858766|65366464|FG008|Overall Study|Randomized but Never Treated|0|||
23443635|NCT01858766|65366465|FG009|Overall Study|Randomized but Never Treated|0|||
23443636|NCT01858766|65366466|FG010|Overall Study|Randomized but Never Treated|0|||
23443637|NCT01858766|65366467|FG011|Overall Study|Randomized but Never Treated|0|||
23443638|NCT01858766|65366468|FG012|Overall Study|Randomized but Never Treated|0|||
23443639|NCT01858766|65366469|FG013|Overall Study|Randomized but Never Treated|0|||
23328224|NCT03307252|64945388|FG010|Part 2, Period 3|Other than listed|0|||
23328225|NCT03307252|64945378|FG000|Part 2, Period 4|Other than listed|0|||
23328226|NCT03307252|64945379|FG001|Part 2, Period 4|Other than listed|0|||
23328227|NCT03307252|64945380|FG002|Part 2, Period 4|Other than listed|0|||
23443640|NCT01858766|65366470|FG014|Overall Study|Randomized but Never Treated|0|||
23157893|NCT00467779|64328583|FG000|Stage 3|Adverse Event|0|||
23157894|NCT00467779|64328584|FG001|Stage 3|Adverse Event|0|||
23157895|NCT00467779|64328585|FG002|Stage 3|Adverse Event|0|||
23157896|NCT00467779|64328586|FG003|Stage 3|Adverse Event|0|||
23157897|NCT00467779|64328587|FG004|Stage 3|Adverse Event|0|||
23157898|NCT00467779|64328588|FG005|Stage 3|Adverse Event|0|||
23157899|NCT00467779|64328589|FG006|Stage 3|Adverse Event|0|||
23157900|NCT00467779|64328590|FG007|Stage 3|Adverse Event|0|||
23157901|NCT00467779|64328591|FG008|Stage 3|Adverse Event|0|||
23157902|NCT00467779|64328592|FG009|Stage 3|Adverse Event|0|||
23157903|NCT00467779|64328593|FG010|Stage 3|Adverse Event|0|||
23157904|NCT00467779|64328594|FG011|Stage 3|Adverse Event|0|||
23157905|NCT00467779|64328595|FG012|Stage 3|Adverse Event|0|||
23157906|NCT00467779|64328596|FG013|Stage 3|Adverse Event|0|||
23157907|NCT00467779|64328597|FG014|Stage 3|Adverse Event|2|||
23157908|NCT00467779|64328583|FG000|Stage 3|Death|0|||
23157909|NCT00467779|64328584|FG001|Stage 3|Death|0|||
23157910|NCT00467779|64328585|FG002|Stage 3|Death|0|||
23328228|NCT03307252|64945381|FG003|Part 2, Period 4|Other than listed|0|||
23328229|NCT03307252|64945382|FG004|Part 2, Period 4|Other than listed|0|||
23443641|NCT01858766|65366471|FG015|Overall Study|Randomized but Never Treated|0|||
23443642|NCT01858766|65366472|FG016|Overall Study|Randomized but Never Treated|0|||
23443643|NCT01858766|65366473|FG017|Overall Study|Randomized but Never Treated|1|||
23443644|NCT01858766|65366474|FG018|Overall Study|Randomized but Never Treated|0|||
23443645|NCT01858766|65366456|FG000|Overall Study|Death|0|||
23328230|NCT03307252|64945383|FG005|Part 2, Period 4|Other than listed|0|||
23443646|NCT01858766|65366457|FG001|Overall Study|Death|0|||
23443647|NCT01858766|65366458|FG002|Overall Study|Death|1|||
23443648|NCT01858766|65366459|FG003|Overall Study|Death|0|||
23443649|NCT01858766|65366460|FG004|Overall Study|Death|0|||
23443650|NCT01858766|65366461|FG005|Overall Study|Death|0|||
23443651|NCT01858766|65366462|FG006|Overall Study|Death|0|||
23443652|NCT01858766|65366463|FG007|Overall Study|Death|0|||
23443653|NCT01858766|65366464|FG008|Overall Study|Death|0|||
23157911|NCT00467779|64328586|FG003|Stage 3|Death|0|||
23157912|NCT00467779|64328587|FG004|Stage 3|Death|0|||
23157913|NCT00467779|64328588|FG005|Stage 3|Death|0|||
23157914|NCT00467779|64328589|FG006|Stage 3|Death|0|||
23157915|NCT00467779|64328590|FG007|Stage 3|Death|0|||
23443654|NCT01858766|65366465|FG009|Overall Study|Death|0|||
23443655|NCT01858766|65366466|FG010|Overall Study|Death|0|||
23443656|NCT01858766|65366467|FG011|Overall Study|Death|0|||
23443657|NCT01858766|65366468|FG012|Overall Study|Death|0|||
23443658|NCT01858766|65366469|FG013|Overall Study|Death|0|||
23443659|NCT01858766|65366470|FG014|Overall Study|Death|0|||
23443660|NCT01858766|65366471|FG015|Overall Study|Death|0|||
23157916|NCT00467779|64328591|FG008|Stage 3|Death|0|||
23157917|NCT00467779|64328592|FG009|Stage 3|Death|0|||
23157918|NCT00467779|64328593|FG010|Stage 3|Death|0|||
23157919|NCT00467779|64328594|FG011|Stage 3|Death|0|||
23443661|NCT01858766|65366472|FG016|Overall Study|Death|0|||
23443662|NCT01858766|65366473|FG017|Overall Study|Death|0|||
23443663|NCT01858766|65366474|FG018|Overall Study|Death|0|||
23443664|NCT01858766|65366456|FG000|Overall Study|Lack of Efficacy|1|||
23443665|NCT01858766|65366457|FG001|Overall Study|Lack of Efficacy|0|||
23443666|NCT01858766|65366458|FG002|Overall Study|Lack of Efficacy|0|||
23443667|NCT01858766|65366459|FG003|Overall Study|Lack of Efficacy|0|||
23443668|NCT01858766|65366460|FG004|Overall Study|Lack of Efficacy|1|||
23443669|NCT01858766|65366461|FG005|Overall Study|Lack of Efficacy|2|||
23443670|NCT01858766|65366462|FG006|Overall Study|Lack of Efficacy|0|||
23443671|NCT01858766|65366463|FG007|Overall Study|Lack of Efficacy|0|||
23443672|NCT01858766|65366464|FG008|Overall Study|Lack of Efficacy|0|||
23443673|NCT01858766|65366465|FG009|Overall Study|Lack of Efficacy|0|||
23443674|NCT01858766|65366466|FG010|Overall Study|Lack of Efficacy|0|||
23443675|NCT01858766|65366467|FG011|Overall Study|Lack of Efficacy|3|||
23443676|NCT01858766|65366468|FG012|Overall Study|Lack of Efficacy|5|||
23443677|NCT01858766|65366469|FG013|Overall Study|Lack of Efficacy|3|||
23443678|NCT01858766|65366470|FG014|Overall Study|Lack of Efficacy|5|||
23443679|NCT01858766|65366471|FG015|Overall Study|Lack of Efficacy|5|||
23443680|NCT01858766|65366472|FG016|Overall Study|Lack of Efficacy|2|||
23443681|NCT01858766|65366473|FG017|Overall Study|Lack of Efficacy|3|||
23443682|NCT01858766|65366474|FG018|Overall Study|Lack of Efficacy|3|||
23443683|NCT01858766|65366456|FG000|Overall Study|Lost to Follow-up|0|||
23443684|NCT01858766|65366457|FG001|Overall Study|Lost to Follow-up|0|||
23443685|NCT01858766|65366458|FG002|Overall Study|Lost to Follow-up|0|||
23443686|NCT01858766|65366459|FG003|Overall Study|Lost to Follow-up|0|||
23443687|NCT01858766|65366460|FG004|Overall Study|Lost to Follow-up|0|||
23566601|NCT03430063|65803877|FG002|Overall Study|Progressive disease|1|||
23566602|NCT03430063|65803875|FG000|Overall Study|Other un-specified|1|||
23566603|NCT03430063|65803876|FG001|Overall Study|Other un-specified|1|||
23566604|NCT03430063|65803877|FG002|Overall Study|Other un-specified|0|||
23566605|NCT03430063|65803875|FG000|Overall Study|Randomized, but never treated|0|||
23566606|NCT03430063|65803876|FG001|Overall Study|Randomized, but never treated|0|||
23328231|NCT03307252|64945384|FG006|Part 2, Period 4|Other than listed|1|||
23328232|NCT03307252|64945385|FG007|Part 2, Period 4|Other than listed|0|||
23328233|NCT03307252|64945386|FG008|Part 2, Period 4|Other than listed|0|||
23566607|NCT03430063|65803877|FG002|Overall Study|Randomized, but never treated|1|||
23566608|NCT00803101|65803878|FG000|Overall Study|Death / Serious Adverse Event|4|||
23566609|NCT00803101|65803879|FG001|Overall Study|Death / Serious Adverse Event|6|||
23566610|NCT00803101|65803878|FG000|Overall Study|Withdrawal by Subject|6|||
23566611|NCT00803101|65803879|FG001|Overall Study|Withdrawal by Subject|4|||
23566612|NCT00803101|65803878|FG000|Overall Study|Lost to Follow-up|2|||
23566613|NCT00803101|65803879|FG001|Overall Study|Lost to Follow-up|2|||
23566614|NCT00803101|65803878|FG000|Overall Study|Protocol Violation|1|||
23222054|NCT00369278|64557540|FG001|Overall Study|Adverse Event|11|||
23566615|NCT00803101|65803879|FG001|Overall Study|Protocol Violation|7|||
23566616|NCT00803101|65803878|FG000|Overall Study|Surgery finished outside protocol window|1|||
23566617|NCT00803101|65803879|FG001|Overall Study|Surgery finished outside protocol window|1|||
23566618|NCT00803101|65803878|FG000|Overall Study|Patient died outside SAE report period|1|||
23222055|NCT00369278|64557539|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23222056|NCT00369278|64557540|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
23222057|NCT00369278|64557539|FG000|Overall Study|Protocol Violation|2|||
23222058|NCT00369278|64557540|FG001|Overall Study|Protocol Violation|1|||
23566619|NCT00803101|65803879|FG001|Overall Study|Patient died outside SAE report period|0|||
23566620|NCT00803101|65803878|FG000|Overall Study|Patient did not attend scheduled visit|2|||
23222059|NCT00369278|64557539|FG000|Overall Study|Withdrawal by Subject|2|||
23222060|NCT00369278|64557540|FG001|Overall Study|Withdrawal by Subject|2|||
23222061|NCT00369278|64557539|FG000|Overall Study|Lost to Follow-up|1|||
23222062|NCT00369278|64557540|FG001|Overall Study|Lost to Follow-up|0|||
23222063|NCT00369278|64557539|FG000|Overall Study|Graft loss|1|||
23222064|NCT00369278|64557540|FG001|Overall Study|Graft loss|2|||
23222065|NCT03748420|64557541|FG000|Overall Study|No 12 month medication adherence data available|0|||
23222066|NCT03748420|64557542|FG001|Overall Study|No 12 month medication adherence data available|1|||
23222067|NCT03748420|64557541|FG000|Overall Study|Death|24|||
23222068|NCT03748420|64557542|FG001|Overall Study|Death|28|||
23443688|NCT01858766|65366461|FG005|Overall Study|Lost to Follow-up|1|||
23443689|NCT01858766|65366462|FG006|Overall Study|Lost to Follow-up|0|||
23443690|NCT01858766|65366463|FG007|Overall Study|Lost to Follow-up|2|||
23443691|NCT01858766|65366464|FG008|Overall Study|Lost to Follow-up|0|||
23443692|NCT01858766|65366465|FG009|Overall Study|Lost to Follow-up|0|||
23566621|NCT00803101|65803879|FG001|Overall Study|Patient did not attend scheduled visit|1|||
23566622|NCT00803101|65803878|FG000|Overall Study|Patient did not have surgery|1|||
23222069|NCT03748420|64557541|FG000|Overall Study|Lost to Follow-up|231|||
23222070|NCT03748420|64557542|FG001|Overall Study|Lost to Follow-up|230|||
23222071|NCT01833806|64557543|FG000|Overall Study|Alternative treatment|2|||
23443693|NCT01858766|65366466|FG010|Overall Study|Lost to Follow-up|0|||
23443694|NCT01858766|65366467|FG011|Overall Study|Lost to Follow-up|1|||
23566623|NCT00803101|65803879|FG001|Overall Study|Patient did not have surgery|1|||
23443695|NCT01858766|65366468|FG012|Overall Study|Lost to Follow-up|0|||
23443696|NCT01858766|65366469|FG013|Overall Study|Lost to Follow-up|0|||
23443697|NCT01858766|65366470|FG014|Overall Study|Lost to Follow-up|3|||
23443698|NCT01858766|65366471|FG015|Overall Study|Lost to Follow-up|1|||
23443699|NCT01858766|65366472|FG016|Overall Study|Lost to Follow-up|1|||
23443700|NCT01858766|65366473|FG017|Overall Study|Lost to Follow-up|0|||
23443701|NCT01858766|65366474|FG018|Overall Study|Lost to Follow-up|1|||
23443702|NCT01858766|65366456|FG000|Overall Study|Withdrew Consent|0|||
23443703|NCT01858766|65366457|FG001|Overall Study|Withdrew Consent|0|||
23443704|NCT01858766|65366458|FG002|Overall Study|Withdrew Consent|0|||
23443705|NCT01858766|65366459|FG003|Overall Study|Withdrew Consent|0|||
23443706|NCT01858766|65366460|FG004|Overall Study|Withdrew Consent|0|||
23443707|NCT01858766|65366461|FG005|Overall Study|Withdrew Consent|0|||
23443708|NCT01858766|65366462|FG006|Overall Study|Withdrew Consent|0|||
23443709|NCT01858766|65366463|FG007|Overall Study|Withdrew Consent|0|||
23443710|NCT01858766|65366464|FG008|Overall Study|Withdrew Consent|0|||
23443711|NCT01858766|65366465|FG009|Overall Study|Withdrew Consent|0|||
23443712|NCT01858766|65366466|FG010|Overall Study|Withdrew Consent|0|||
23443713|NCT01858766|65366467|FG011|Overall Study|Withdrew Consent|1|||
23443714|NCT01858766|65366468|FG012|Overall Study|Withdrew Consent|0|||
23443715|NCT01858766|65366469|FG013|Overall Study|Withdrew Consent|0|||
23443716|NCT01858766|65366470|FG014|Overall Study|Withdrew Consent|0|||
23443717|NCT01858766|65366471|FG015|Overall Study|Withdrew Consent|0|||
23443718|NCT01858766|65366472|FG016|Overall Study|Withdrew Consent|0|||
23443719|NCT01858766|65366473|FG017|Overall Study|Withdrew Consent|0|||
23443720|NCT01858766|65366474|FG018|Overall Study|Withdrew Consent|0|||
23222072|NCT01833806|64557543|FG000|Overall Study|Death|5|||
23222073|NCT01833806|64557543|FG000|Overall Study|Physician Decision|1|||
23222074|NCT01833806|64557543|FG000|Overall Study|Lost to Follow-up|1|||
23222075|NCT00420342|64557544|FG000|Overall Study|Lost to Follow-up|1|||
23222076|NCT00420342|64557545|FG001|Overall Study|Lost to Follow-up|0|||
23443721|NCT00592904|65366481|FG000|Overall Study|Adverse Event|15|||
23443722|NCT00592904|65366482|FG001|Overall Study|Adverse Event|25|||
23443723|NCT00592904|65366483|FG002|Overall Study|Adverse Event|13|||
23443724|NCT00592904|65366484|FG003|Overall Study|Adverse Event|5|||
23443725|NCT00592904|65366481|FG000|Overall Study|Protocol Violation|1|||
23443726|NCT00592904|65366482|FG001|Overall Study|Protocol Violation|1|||
23443727|NCT00592904|65366483|FG002|Overall Study|Protocol Violation|0|||
23443728|NCT00592904|65366484|FG003|Overall Study|Protocol Violation|1|||
23443729|NCT00592904|65366481|FG000|Overall Study|Withdrawal by Subject|4|||
23443730|NCT00592904|65366482|FG001|Overall Study|Withdrawal by Subject|16|||
23443731|NCT00592904|65366483|FG002|Overall Study|Withdrawal by Subject|1|||
23443732|NCT00592904|65366484|FG003|Overall Study|Withdrawal by Subject|2|||
23443733|NCT00592904|65366481|FG000|Overall Study|Lack of Efficacy|2|||
23443734|NCT00592904|65366482|FG001|Overall Study|Lack of Efficacy|7|||
23443735|NCT00592904|65366483|FG002|Overall Study|Lack of Efficacy|2|||
23443736|NCT00592904|65366484|FG003|Overall Study|Lack of Efficacy|3|||
23443737|NCT00592904|65366481|FG000|Overall Study|Physician Decision|0|||
23443738|NCT00592904|65366482|FG001|Overall Study|Physician Decision|3|||
23443739|NCT00592904|65366483|FG002|Overall Study|Physician Decision|1|||
23157920|NCT00467779|64328595|FG012|Stage 3|Death|0|||
23157921|NCT00467779|64328596|FG013|Stage 3|Death|0|||
23157922|NCT00467779|64328597|FG014|Stage 3|Death|1|||
23157923|NCT00467779|64328583|FG000|Stage 3|Disease Progression|0|||
23157924|NCT00467779|64328584|FG001|Stage 3|Disease Progression|0|||
23157925|NCT00467779|64328585|FG002|Stage 3|Disease Progression|0|||
23157926|NCT00467779|64328586|FG003|Stage 3|Disease Progression|0|||
23157927|NCT00467779|64328587|FG004|Stage 3|Disease Progression|0|||
23157928|NCT00467779|64328588|FG005|Stage 3|Disease Progression|0|||
23157929|NCT00467779|64328589|FG006|Stage 3|Disease Progression|0|||
23157930|NCT00467779|64328590|FG007|Stage 3|Disease Progression|0|||
23157931|NCT00467779|64328591|FG008|Stage 3|Disease Progression|0|||
23157932|NCT00467779|64328592|FG009|Stage 3|Disease Progression|0|||
23157933|NCT00467779|64328593|FG010|Stage 3|Disease Progression|0|||
23157934|NCT00467779|64328594|FG011|Stage 3|Disease Progression|0|||
23157935|NCT00467779|64328595|FG012|Stage 3|Disease Progression|0|||
23157936|NCT00467779|64328596|FG013|Stage 3|Disease Progression|0|||
23157937|NCT00467779|64328597|FG014|Stage 3|Disease Progression|9|||
23157938|NCT00467779|64328583|FG000|Stage 3|Unspecified Reason|0|||
23157939|NCT00467779|64328584|FG001|Stage 3|Unspecified Reason|0|||
23157940|NCT00467779|64328585|FG002|Stage 3|Unspecified Reason|0|||
23157941|NCT00467779|64328586|FG003|Stage 3|Unspecified Reason|0|||
23157942|NCT00467779|64328587|FG004|Stage 3|Unspecified Reason|0|||
23157943|NCT00467779|64328588|FG005|Stage 3|Unspecified Reason|0|||
23222077|NCT00420342|64557546|FG002|Overall Study|Lost to Follow-up|1|||
23222078|NCT00420342|64557544|FG000|Overall Study|Withdrawal by Subject|0|||
23157944|NCT00467779|64328589|FG006|Stage 3|Unspecified Reason|0|||
23157945|NCT00467779|64328590|FG007|Stage 3|Unspecified Reason|0|||
23157946|NCT00467779|64328591|FG008|Stage 3|Unspecified Reason|0|||
23443740|NCT00592904|65366484|FG003|Overall Study|Physician Decision|0|||
23443741|NCT00592904|65366481|FG000|Overall Study|Other|3|||
23443742|NCT00592904|65366482|FG001|Overall Study|Other|3|||
23222079|NCT00420342|64557545|FG001|Overall Study|Withdrawal by Subject|2|||
23222080|NCT00420342|64557546|FG002|Overall Study|Withdrawal by Subject|0|||
23328234|NCT03307252|64945387|FG009|Part 2, Period 4|Other than listed|0|||
23328235|NCT03307252|64945388|FG010|Part 2, Period 4|Other than listed|0|||
23328236|NCT03307252|64945378|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23157947|NCT00467779|64328592|FG009|Stage 3|Unspecified Reason|0|||
23328237|NCT03307252|64945379|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23328238|NCT03307252|64945380|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23328239|NCT03307252|64945381|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23443743|NCT00592904|65366483|FG002|Overall Study|Other|0|||
23443744|NCT00592904|65366484|FG003|Overall Study|Other|0|||
23566624|NCT00708305|65803881|FG000|Period 1|Protocol Violation|1|||
23566625|NCT00708305|65803882|FG001|Period 1|Protocol Violation|0|||
23566626|NCT00708305|65803883|FG002|Period 1|Protocol Violation|1|||
23566627|NCT00708305|65803884|FG003|Period 1|Protocol Violation|0|||
23566628|NCT00708305|65803881|FG000|Period 1|Other Reason|0|||
23566629|NCT00708305|65803882|FG001|Period 1|Other Reason|0|||
23566630|NCT00708305|65803883|FG002|Period 1|Other Reason|0|||
23443745|NCT01928927|65366492|FG000|Overall Study|Lost to Follow-up|1|||
23443746|NCT01928927|65366493|FG001|Overall Study|Lost to Follow-up|0|||
23443747|NCT01928927|65366492|FG000|Overall Study|Withdrawal by Subject|1|||
23566631|NCT00708305|65803884|FG003|Period 1|Other Reason|2|||
23443748|NCT01928927|65366493|FG001|Overall Study|Withdrawal by Subject|1|||
23443749|NCT00291018|65366494|FG000|Overall Study|Not Consented or Declined PAS|12|||
23443750|NCT00291018|65366495|FG001|Overall Study|Not Consented or Declined PAS|15|||
23443751|NCT00291018|65366496|FG002|Overall Study|Not Consented or Declined PAS|15|||
23443752|NCT00291018|65366494|FG000|Overall Study|Death|3|||
23443753|NCT00291018|65366495|FG001|Overall Study|Death|3|||
23443754|NCT00291018|65366496|FG002|Overall Study|Death|4|||
23443755|NCT00291018|65366494|FG000|Overall Study|Withdrawal by Subject|2|||
23443756|NCT00291018|65366495|FG001|Overall Study|Withdrawal by Subject|8|||
23443757|NCT00291018|65366496|FG002|Overall Study|Withdrawal by Subject|1|||
23443758|NCT00291018|65366494|FG000|Overall Study|Failures|5|||
23443759|NCT00291018|65366495|FG001|Overall Study|Failures|12|||
23443760|NCT00291018|65366496|FG002|Overall Study|Failures|5|||
23443761|NCT00291018|65366494|FG000|Overall Study|Lost to Follow-up|3|||
23443762|NCT00291018|65366495|FG001|Overall Study|Lost to Follow-up|4|||
23157948|NCT00467779|64328593|FG010|Stage 3|Unspecified Reason|0|||
23157949|NCT00467779|64328594|FG011|Stage 3|Unspecified Reason|0|||
23157950|NCT00467779|64328595|FG012|Stage 3|Unspecified Reason|0|||
23157951|NCT00467779|64328596|FG013|Stage 3|Unspecified Reason|0|||
23157952|NCT00467779|64328597|FG014|Stage 3|Unspecified Reason|5|||
23157953|NCT01977820|64328598|FG000|Overall Study|Sponsor terminated the study|1|||
23157954|NCT01977820|64328599|FG001|Overall Study|Sponsor terminated the study|1|||
23157955|NCT00800436|64328600|FG000|Overall Study|Withdrawal by Subject|0|||
23157956|NCT00800436|64328601|FG001|Overall Study|Withdrawal by Subject|0|||
23157957|NCT00800436|64328602|FG002|Overall Study|Withdrawal by Subject|1|||
23157958|NCT00800436|64328603|FG003|Overall Study|Withdrawal by Subject|1|||
23157959|NCT00800436|64328604|FG004|Overall Study|Withdrawal by Subject|0|||
23157960|NCT00800436|64328605|FG005|Overall Study|Withdrawal by Subject|0|||
23157961|NCT00800436|64328606|FG006|Overall Study|Withdrawal by Subject|0|||
23157962|NCT02634151|64328607|FG000|Overall Study|Withdrawal by Subject|1|||
23157963|NCT02634151|64328608|FG001|Overall Study|Withdrawal by Subject|0|||
23157964|NCT02634151|64328607|FG000|Overall Study|Non-Compliance|0|||
23157965|NCT02634151|64328608|FG001|Overall Study|Non-Compliance|1|||
23157966|NCT02634151|64328607|FG000|Overall Study|Other|0|||
23157967|NCT02634151|64328608|FG001|Overall Study|Other|1|||
23157968|NCT03511053|64328615|FG000|Overall Study|Withdrawal by Subject|1|||
23157969|NCT03593850|64328616|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
23157970|NCT03593850|64328617|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
23157971|NCT02490475|64328618|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
23157972|NCT02490475|64328619|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
23157973|NCT02490475|64328620|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
23157974|NCT02490475|64328621|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
23157975|NCT02490475|64328618|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
23157976|NCT02490475|64328619|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
23157977|NCT02490475|64328620|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
23443763|NCT00291018|65366496|FG002|Overall Study|Lost to Follow-up|18|||
23566632|NCT00708305|65803881|FG000|Period 2|Lost to Follow-up|0|||
23157978|NCT02490475|64328621|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
23157979|NCT02490475|64328618|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
23157980|NCT02490475|64328619|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
23157981|NCT02490475|64328620|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
23443764|NCT03932760|65366497|FG000|Overall Study|Became Ineligible|2|||
23566633|NCT00708305|65803882|FG001|Period 2|Lost to Follow-up|1|||
23328240|NCT03307252|64945382|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23328241|NCT03307252|64945383|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23328242|NCT03307252|64945384|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23328243|NCT03307252|64945385|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23328244|NCT03307252|64945386|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23328245|NCT03307252|64945387|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
23328246|NCT03307252|64945388|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
23328247|NCT00396656|64945389|FG000|First Treatment Period|Withdrawal by Subject|0|||
23328248|NCT00396656|64945390|FG001|First Treatment Period|Withdrawal by Subject|2|||
23328249|NCT00396656|64945389|FG000|Second Treatment Period|Adverse Event|0|||
23328250|NCT00396656|64945390|FG001|Second Treatment Period|Adverse Event|1|||
23328251|NCT02512302|64945391|FG000|Period 1|Adverse Event|0|||
23328252|NCT02512302|64945392|FG001|Period 1|Adverse Event|1|||
23328253|NCT02512302|64945393|FG002|Period 1|Adverse Event|0|||
23328254|NCT02512302|64945394|FG003|Period 1|Adverse Event|0|||
23328255|NCT02512302|64945395|FG004|Period 1|Adverse Event|0|||
23328256|NCT02512302|64945396|FG005|Period 1|Adverse Event|0|||
23328257|NCT02512302|64945397|FG006|Period 1|Adverse Event|0|||
23328258|NCT02512302|64945398|FG007|Period 1|Adverse Event|0|||
23157982|NCT02490475|64328621|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
23157983|NCT02490475|64328618|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
23157984|NCT02490475|64328619|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
23157985|NCT02490475|64328620|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
23157986|NCT02490475|64328621|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
23157987|NCT02490475|64328618|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
23328259|NCT02512302|64945399|FG008|Period 1|Adverse Event|0|||
23328260|NCT02512302|64945400|FG009|Period 1|Adverse Event|0|||
23328261|NCT02512302|64945391|FG000|Period 2|Adverse Event|0|||
23328262|NCT02512302|64945392|FG001|Period 2|Adverse Event|0|||
23328263|NCT02512302|64945393|FG002|Period 2|Adverse Event|0|||
23328264|NCT02512302|64945394|FG003|Period 2|Adverse Event|0|||
23328265|NCT02512302|64945395|FG004|Period 2|Adverse Event|0|||
23328266|NCT02512302|64945396|FG005|Period 2|Adverse Event|0|||
23328267|NCT02512302|64945397|FG006|Period 2|Adverse Event|0|||
23328268|NCT02512302|64945398|FG007|Period 2|Adverse Event|0|||
23328269|NCT02512302|64945399|FG008|Period 2|Adverse Event|0|||
23328270|NCT02512302|64945400|FG009|Period 2|Adverse Event|1|||
23328271|NCT02512302|64945391|FG000|Period 3|Lost to Follow-up|0|||
23328272|NCT02512302|64945392|FG001|Period 3|Lost to Follow-up|0|||
23328273|NCT02512302|64945393|FG002|Period 3|Lost to Follow-up|1|||
23328274|NCT02512302|64945394|FG003|Period 3|Lost to Follow-up|0|||
23328275|NCT02512302|64945395|FG004|Period 3|Lost to Follow-up|0|||
23328276|NCT02512302|64945396|FG005|Period 3|Lost to Follow-up|0|||
23328277|NCT02512302|64945397|FG006|Period 3|Lost to Follow-up|0|||
23328278|NCT02512302|64945398|FG007|Period 3|Lost to Follow-up|0|||
23328279|NCT02512302|64945399|FG008|Period 3|Lost to Follow-up|0|||
23328280|NCT02512302|64945400|FG009|Period 3|Lost to Follow-up|0|||
23328281|NCT02512302|64945391|FG000|Period 4|Adverse Event|0|||
23328282|NCT02512302|64945392|FG001|Period 4|Adverse Event|0|||
23328283|NCT02512302|64945393|FG002|Period 4|Adverse Event|0|||
23328284|NCT02512302|64945394|FG003|Period 4|Adverse Event|0|||
23328285|NCT02512302|64945395|FG004|Period 4|Adverse Event|0|||
23328286|NCT02512302|64945396|FG005|Period 4|Adverse Event|0|||
23328287|NCT02512302|64945397|FG006|Period 4|Adverse Event|1|||
23328288|NCT02512302|64945398|FG007|Period 4|Adverse Event|0|||
23328289|NCT02512302|64945399|FG008|Period 4|Adverse Event|0|||
23328290|NCT02512302|64945400|FG009|Period 4|Adverse Event|0|||
23328291|NCT02088177|64945403|FG000|Overall Study|Lost to Follow-up|3|||
23328292|NCT01218087|64945406|FG000|Overall Study|Death|2|||
23328293|NCT01218087|64945407|FG001|Overall Study|Death|1|||
23328294|NCT01218087|64945406|FG000|Overall Study|Withdrawal by Subject|5|||
23328295|NCT01218087|64945407|FG001|Overall Study|Withdrawal by Subject|0|||
23328296|NCT01218087|64945406|FG000|Overall Study|Transferred|8|||
23328297|NCT01218087|64945407|FG001|Overall Study|Transferred|5|||
23328298|NCT00571727|64945408|FG000|Overall Study|Did not enter in this study|1|||
23328299|NCT00571727|64945408|FG000|Overall Study|Non-compliance|4|||
23328300|NCT00571727|64945408|FG000|Overall Study|Lost to Follow-up|30|||
23222081|NCT01782885|64557550|FG000|Overall Study|Lost to Follow-up|4|||
23328301|NCT00571727|64945408|FG000|Overall Study|Poor growth|1|||
23328302|NCT00571727|64945408|FG000|Overall Study|Parent/patient decision|2|||
23328303|NCT00571727|64945408|FG000|Overall Study|Participant transferred to commercial drug|14|||
23328304|NCT00571727|64945408|FG000|Overall Study|Unable to provide study drug|6|||
23328305|NCT00571727|64945408|FG000|Overall Study|On-treatment at end of study|8|||
23328306|NCT01823328|64945412|FG000|Overall Study|Withdrawal by Subject|8|||
23328307|NCT01823328|64945413|FG001|Overall Study|Withdrawal by Subject|6|||
23328308|NCT00391768|64945414|FG000|Overall Study|Withdrawal by Subject|0|||
23328309|NCT00391768|64945415|FG001|Overall Study|Withdrawal by Subject|0|||
23328310|NCT00391768|64945416|FG002|Overall Study|Withdrawal by Subject|1|||
23157988|NCT02490475|64328619|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
23157989|NCT02490475|64328620|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
23157990|NCT02490475|64328621|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
23157991|NCT02490475|64328618|FG000|Period 2: Extension Phase|Refused Treatment|0|||
23157992|NCT02490475|64328619|FG001|Period 2: Extension Phase|Refused Treatment|0|||
23157993|NCT02490475|64328620|FG002|Period 2: Extension Phase|Refused Treatment|0|||
23157994|NCT02490475|64328621|FG003|Period 2: Extension Phase|Refused Treatment|1|||
23157995|NCT02490475|64328618|FG000|Period 2: Extension Phase|Adverse Event|0|||
23157996|NCT02490475|64328619|FG001|Period 2: Extension Phase|Adverse Event|0|||
23157997|NCT02490475|64328620|FG002|Period 2: Extension Phase|Adverse Event|1|||
23157998|NCT02490475|64328621|FG003|Period 2: Extension Phase|Adverse Event|0|||
23157999|NCT04206605|64328622|FG000|Overall Study|Adverse Event|0|||
23158000|NCT04206605|64328623|FG001|Overall Study|Adverse Event|1|||
23158001|NCT04206605|64328622|FG000|Overall Study|Withdrawal by Subject|1|||
23158002|NCT04206605|64328623|FG001|Overall Study|Withdrawal by Subject|0|||
23158003|NCT04425720|64328626|FG000|Overall Study|Withdrawal by Subject|0|||
23158004|NCT04425720|64328627|FG001|Overall Study|Withdrawal by Subject|20|||
23158005|NCT03199040|64328631|FG000|Overall Study|Lack of Efficacy|2|||
23158006|NCT03199040|64328632|FG001|Overall Study|Lack of Efficacy|0|||
23158007|NCT03199040|64328631|FG000|Overall Study|Withdrawal by Subject|2|||
23158008|NCT03199040|64328632|FG001|Overall Study|Withdrawal by Subject|0|||
23158009|NCT03199040|64328631|FG000|Overall Study|Adverse Event|0|||
23158010|NCT03199040|64328632|FG001|Overall Study|Adverse Event|1|||
23158011|NCT03199040|64328631|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
23158012|NCT03199040|64328632|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
23158013|NCT04641299|64328634|FG000|Overall Study|Adverse Event|0|||
23158014|NCT04641299|64328635|FG001|Overall Study|Adverse Event|0|||
23158015|NCT04641299|64328636|FG002|Overall Study|Adverse Event|2|||
23158016|NCT04641299|64328637|FG003|Overall Study|Adverse Event|0|||
23222082|NCT01782885|64557551|FG001|Overall Study|Lost to Follow-up|6|||
23222083|NCT00106249|64557552|FG000|Overall Study|Lost to Follow-up|3|||
23222084|NCT00106249|64557553|FG001|Overall Study|Lost to Follow-up|2|||
23222085|NCT04058158|64557554|FG000|Period 1|Death|1|||
23222086|NCT04058158|64557555|FG001|Period 1|Death|0|||
23222087|NCT04058158|64557554|FG000|Period 1|Adverse Event|1|||
23222088|NCT04058158|64557555|FG001|Period 1|Adverse Event|1|||
23222089|NCT04058158|64557554|FG000|Period 1|Pregnancy|0|||
23222090|NCT04058158|64557555|FG001|Period 1|Pregnancy|1|||
23222091|NCT02120469|64557556|FG000|Overall Study|HER-2/neu-amplified|1|||
23222092|NCT02120469|64557557|FG001|Overall Study|HER-2/neu-amplified|0|||
23222093|NCT02120469|64557558|FG002|Overall Study|HER-2/neu-amplified|1|||
23222094|NCT03924427|64557562|FG000|Overall Study|Adverse Event|4|||
23222095|NCT03924427|64557562|FG000|Overall Study|Lack of Efficacy|1|||
23222096|NCT03924427|64557562|FG000|Overall Study|Withdrawal by Subject|1|||
23222097|NCT01518309|64557563|FG000|Overall Study|Adverse Event|6|||
23222098|NCT01518309|64557563|FG000|Overall Study|Death|6|||
23222099|NCT01518309|64557563|FG000|Overall Study|Lack of Efficacy|7|||
23222100|NCT01518309|64557563|FG000|Overall Study|Withdrawal by Subject|6|||
23222101|NCT01518309|64557563|FG000|Overall Study|Physician Decision|3|||
23222102|NCT01518309|64557563|FG000|Overall Study|Sponsor Decision|2|||
23222103|NCT01518309|64557563|FG000|Overall Study|Not in Predefined Categories|9|||
23222104|NCT03839940|64557564|FG000|Overall Study|Withdrawal by Subject|3|||
23222105|NCT03839940|64557565|FG001|Overall Study|Withdrawal by Subject|0|||
23222106|NCT03839940|64557564|FG000|Overall Study|Protocol Violation|0|||
23222107|NCT03839940|64557565|FG001|Overall Study|Protocol Violation|1|||
23222108|NCT03839940|64557564|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
23222109|NCT03839940|64557565|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
23222110|NCT02687711|64557569|FG000|Overall Study|Adverse Event|89|||
23222111|NCT02687711|64557569|FG000|Overall Study|Lack of Efficacy|70|||
23222112|NCT02687711|64557569|FG000|Overall Study|Lost to Follow-up|20|||
23222113|NCT02687711|64557569|FG000|Overall Study|Consent withdrawn|15|||
23222114|NCT02687711|64557569|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
23222115|NCT02687711|64557569|FG000|Overall Study|Too expensive|4|||
23222116|NCT02687711|64557569|FG000|Overall Study|Participant moved abroad|1|||
23222117|NCT02687711|64557569|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
23222118|NCT02687711|64557569|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
23222119|NCT02687711|64557569|FG000|Overall Study|Disliked taste|1|||
23222120|NCT02687711|64557569|FG000|Overall Study|Low mood|1|||
23222121|NCT02687711|64557569|FG000|Overall Study|Side effects|1|||
23222122|NCT02687711|64557569|FG000|Overall Study|Change of Hospital|1|||
23158017|NCT04641299|64328634|FG000|Overall Study|Lost to Follow-up|0|||
23158018|NCT04641299|64328635|FG001|Overall Study|Lost to Follow-up|1|||
23158019|NCT04641299|64328636|FG002|Overall Study|Lost to Follow-up|0|||
23158020|NCT04641299|64328637|FG003|Overall Study|Lost to Follow-up|0|||
23158021|NCT04641299|64328634|FG000|Overall Study|Withdrawal by Subject|1|||
23158022|NCT04641299|64328635|FG001|Overall Study|Withdrawal by Subject|0|||
23566634|NCT00708305|65803883|FG002|Period 2|Lost to Follow-up|0|||
23566635|NCT00708305|65803884|FG003|Period 2|Lost to Follow-up|0|||
23566636|NCT00708305|65803881|FG000|Period 2|Protocol Violation|0|||
23566637|NCT00708305|65803882|FG001|Period 2|Protocol Violation|1|||
23566638|NCT00708305|65803883|FG002|Period 2|Protocol Violation|0|||
23566639|NCT00708305|65803884|FG003|Period 2|Protocol Violation|0|||
23566640|NCT00708305|65803881|FG000|Period 2|Other Reason|1|||
23566641|NCT00708305|65803882|FG001|Period 2|Other Reason|0|||
23566642|NCT00708305|65803883|FG002|Period 2|Other Reason|0|||
23566643|NCT00708305|65803884|FG003|Period 2|Other Reason|1|||
23566644|NCT00708305|65803881|FG000|Period 3|Protocol Violation|0|||
23566645|NCT00708305|65803882|FG001|Period 3|Protocol Violation|2|||
23566646|NCT00708305|65803883|FG002|Period 3|Protocol Violation|0|||
23566647|NCT00708305|65803884|FG003|Period 3|Protocol Violation|0|||
23158023|NCT04641299|64328636|FG002|Overall Study|Withdrawal by Subject|0|||
23158024|NCT04641299|64328637|FG003|Overall Study|Withdrawal by Subject|0|||
23158025|NCT04641299|64328634|FG000|Overall Study|Reason not given|1|||
23158026|NCT04641299|64328635|FG001|Overall Study|Reason not given|0|||
23158027|NCT04641299|64328636|FG002|Overall Study|Reason not given|0|||
23158028|NCT04641299|64328637|FG003|Overall Study|Reason not given|0|||
23158029|NCT05092919|64328638|FG000|Overall Study|Lost to Follow-up|7|||
23158030|NCT05092919|64328638|FG000|Overall Study|Withdrawal by Subject|2|||
23158031|NCT04206020|64328642|FG000|Overall Study|Adverse Event|1|||
23158032|NCT04206020|64328643|FG001|Overall Study|Adverse Event|4|||
23158033|NCT04206020|64328642|FG000|Overall Study|Protocol Violation|2|||
23158034|NCT04206020|64328643|FG001|Overall Study|Protocol Violation|0|||
23158035|NCT04206020|64328642|FG000|Overall Study|Withdrawal by Subject|2|||
23158036|NCT04206020|64328643|FG001|Overall Study|Withdrawal by Subject|0|||
23158037|NCT04206020|64328642|FG000|Overall Study|Lost to Follow-up|2|||
23158038|NCT04206020|64328643|FG001|Overall Study|Lost to Follow-up|0|||
23158039|NCT04206020|64328642|FG000|Overall Study|Pregnancy|0|||
23158040|NCT04206020|64328643|FG001|Overall Study|Pregnancy|1|||
23158041|NCT04206020|64328642|FG000|Overall Study|Unable to attend visits|1|||
23158042|NCT04206020|64328643|FG001|Overall Study|Unable to attend visits|2|||
23158043|NCT02554903|64328648|FG000|Overall Study|Death|1|||
23158044|NCT02554903|64328649|FG001|Overall Study|Death|1|||
23158045|NCT02554903|64328648|FG000|Overall Study|Physician Decision|2|||
23158046|NCT02554903|64328649|FG001|Overall Study|Physician Decision|2|||
23158047|NCT02554903|64328648|FG000|Overall Study|Heart Transplant|1|||
23158048|NCT02554903|64328649|FG001|Overall Study|Heart Transplant|2|||
23158049|NCT00257166|64328650|FG000|Overall Study|Adverse Event|18|||
23158050|NCT00257166|64328651|FG001|Overall Study|Adverse Event|13|||
23158051|NCT00257166|64328650|FG000|Overall Study|Laboratory abnormality|1|||
23158052|NCT00257166|64328651|FG001|Overall Study|Laboratory abnormality|0|||
23158053|NCT00257166|64328650|FG000|Overall Study|Lost to Follow-up|8|||
23158054|NCT00257166|64328651|FG001|Overall Study|Lost to Follow-up|1|||
23158055|NCT00257166|64328650|FG000|Overall Study|Withdrawal by Subject|9|||
23222123|NCT02687711|64557569|FG000|Overall Study|Liver Encephalopathy|1|||
23222124|NCT02687711|64557569|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
23222125|NCT02687711|64557569|FG000|Overall Study|Withdrawn due to intake interruption|1|||
23222126|NCT02687711|64557569|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
23222127|NCT02687711|64557569|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
23566648|NCT00708305|65803881|FG000|Period 3|Other Reason|1|||
23566649|NCT00708305|65803882|FG001|Period 3|Other Reason|0|||
23158056|NCT00257166|64328651|FG001|Overall Study|Withdrawal by Subject|2|||
23158057|NCT00257166|64328650|FG000|Overall Study|Other|16|||
23158058|NCT00257166|64328651|FG001|Overall Study|Other|21|||
23158059|NCT00257166|64328650|FG000|Overall Study|Randomized, but not treated|1|||
23158060|NCT00257166|64328651|FG001|Overall Study|Randomized, but not treated|0|||
23158061|NCT02161575|64328656|FG000|Overall Study|Protocol Violation|8|||
23158062|NCT02161575|64328656|FG000|Overall Study|Lack of Efficacy|1|||
23566650|NCT00708305|65803883|FG002|Period 3|Other Reason|0|||
23566651|NCT00708305|65803884|FG003|Period 3|Other Reason|0|||
23566652|NCT00669903|65803885|FG000|Overall Study|Adverse Event|0|||
23566653|NCT00669903|65803886|FG001|Overall Study|Adverse Event|1|||
23566654|NCT00669903|65803887|FG002|Overall Study|Adverse Event|3|||
23566655|NCT00669903|65803888|FG003|Overall Study|Adverse Event|1|||
23158063|NCT02161575|64328656|FG000|Overall Study|Adverse Event|2|||
23158064|NCT00829179|64328657|FG000|Overall Study|Withdrawal by Subject|1|||
23158065|NCT02437864|64328658|FG000|Overall Study|Protocol Violation|4|||
23158066|NCT02437864|64328659|FG001|Overall Study|Protocol Violation|0|||
23158067|NCT02187172|64328671|FG000|Overall Study|Lost to Follow-up|1|||
23158068|NCT02187172|64328672|FG001|Overall Study|Lost to Follow-up|2|||
23158069|NCT02187172|64328671|FG000|Overall Study|Lack of Efficacy|1|||
23158070|NCT02187172|64328672|FG001|Overall Study|Lack of Efficacy|2|||
23158071|NCT02187172|64328671|FG000|Overall Study|Adverse Event|0|||
23158072|NCT02187172|64328672|FG001|Overall Study|Adverse Event|1|||
23158073|NCT02187172|64328671|FG000|Overall Study|Physician Decision|1|||
23158074|NCT02187172|64328672|FG001|Overall Study|Physician Decision|1|||
23628556|NCT02881047|66028032|FG000|Overall Study|Adverse Event|1|||
23566656|NCT00669903|65803885|FG000|Overall Study|Withdrawal by Subject|0|||
23566657|NCT00669903|65803886|FG001|Overall Study|Withdrawal by Subject|2|||
23566658|NCT00669903|65803887|FG002|Overall Study|Withdrawal by Subject|2|||
23566659|NCT00669903|65803888|FG003|Overall Study|Withdrawal by Subject|2|||
23158075|NCT04126083|64328673|FG000|Overall Study|Withdrawal by Subject|1|||
23158076|NCT02737852|64328676|FG000|Overall Study|Withdrawal by Subject|2|||
23158077|NCT04202679|64328677|FG000|Overall Study|Adverse Event|2|||
23566660|NCT00669903|65803885|FG000|Overall Study|Lost to Follow-up|1|||
23566661|NCT00669903|65803886|FG001|Overall Study|Lost to Follow-up|1|||
23566662|NCT00669903|65803887|FG002|Overall Study|Lost to Follow-up|0|||
23566663|NCT00669903|65803888|FG003|Overall Study|Lost to Follow-up|1|||
23566664|NCT00669903|65803885|FG000|Overall Study|Protocol Violation|0|||
23566665|NCT00669903|65803886|FG001|Overall Study|Protocol Violation|1|||
23566666|NCT00669903|65803887|FG002|Overall Study|Protocol Violation|0|||
23566667|NCT00669903|65803888|FG003|Overall Study|Protocol Violation|0|||
23566668|NCT00779584|65803891|FG000|Overall Study|Protocol Violation|0|||
23158078|NCT04202679|64328678|FG001|Overall Study|Adverse Event|0|||
23158079|NCT04202679|64328677|FG000|Overall Study|Poor compliance to protocol|1|||
23158080|NCT04202679|64328678|FG001|Overall Study|Poor compliance to protocol|0|||
23158081|NCT04202679|64328677|FG000|Overall Study|Withdrawal by Subject|23|||
23158082|NCT04202679|64328678|FG001|Overall Study|Withdrawal by Subject|6|||
23158083|NCT02663453|64328680|FG000|Overall Study|Death|4|||
23158084|NCT02663453|64328681|FG001|Overall Study|Death|4|||
23222128|NCT02687711|64557569|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
23222129|NCT02741310|64557570|FG000|Overall Study|Sponsor Decision|2|||
23222130|NCT02741310|64557571|FG001|Overall Study|Sponsor Decision|2|||
23222131|NCT02244619|64557572|FG000|Overall Study|Did not receive study intervention|8|||
23222132|NCT02244619|64557573|FG001|Overall Study|Did not receive study intervention|21|||
23222133|NCT01025232|64557578|FG000|Overall Study|Study drug no longer available|3|||
23222134|NCT01025232|64557579|FG001|Overall Study|Study drug no longer available|6|||
23222135|NCT02959190|64557581|FG000|Open Label|Adverse Event|5|||
23222136|NCT02959190|64557582|FG001|Open Label|Adverse Event|7|||
23222137|NCT02959190|64557583|FG002|Open Label|Adverse Event|3|||
23222138|NCT02959190|64557584|FG003|Open Label|Adverse Event|4|||
23222139|NCT02959190|64557581|FG000|Open Label|Pregnancy|0|||
23222140|NCT02959190|64557582|FG001|Open Label|Pregnancy|1|||
23222141|NCT02959190|64557583|FG002|Open Label|Pregnancy|0|||
23222142|NCT02959190|64557584|FG003|Open Label|Pregnancy|0|||
23222143|NCT02959190|64557581|FG000|Open Label|Withdrawal by Subject|2|||
23222144|NCT02959190|64557582|FG001|Open Label|Withdrawal by Subject|8|||
23222145|NCT02959190|64557583|FG002|Open Label|Withdrawal by Subject|0|||
23222146|NCT02959190|64557584|FG003|Open Label|Withdrawal by Subject|0|||
23222147|NCT02959190|64557581|FG000|Open Label|Physician Decision|0|||
23222148|NCT02959190|64557582|FG001|Open Label|Physician Decision|0|||
23222149|NCT02959190|64557583|FG002|Open Label|Physician Decision|1|||
23222150|NCT02959190|64557584|FG003|Open Label|Physician Decision|0|||
23222151|NCT02959190|64557581|FG000|Open Label|Protocol Violation|0|||
23222152|NCT02959190|64557582|FG001|Open Label|Protocol Violation|0|||
23222153|NCT02959190|64557583|FG002|Open Label|Protocol Violation|0|||
23222154|NCT02959190|64557584|FG003|Open Label|Protocol Violation|2|||
23222155|NCT02959190|64557581|FG000|Post Treatment Follow Up|Adverse Event|1|||
23222156|NCT02959190|64557582|FG001|Post Treatment Follow Up|Adverse Event|1|||
23222157|NCT02959190|64557583|FG002|Post Treatment Follow Up|Adverse Event|0|||
23222158|NCT02959190|64557584|FG003|Post Treatment Follow Up|Adverse Event|0|||
23222159|NCT02959190|64557581|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
23222160|NCT02959190|64557582|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
23222161|NCT02959190|64557583|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
23222162|NCT02959190|64557584|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
23222163|NCT02705755|64557585|FG000|Part A (6 Days)|Adverse Event|1|||
23222164|NCT02705755|64557586|FG001|Part A (6 Days)|Adverse Event|0|||
23158085|NCT02663453|64328680|FG000|Overall Study|Withdrawal by Subject|1|||
23222165|NCT02705755|64557587|FG002|Part A (6 Days)|Adverse Event|0|||
23222166|NCT02705755|64557588|FG003|Part A (6 Days)|Adverse Event|0|||
23222167|NCT02705755|64557585|FG000|Part A (6 Days)|Physician Decision|3|||
23222168|NCT02705755|64557586|FG001|Part A (6 Days)|Physician Decision|0|||
23222169|NCT02705755|64557587|FG002|Part A (6 Days)|Physician Decision|0|||
23222170|NCT02705755|64557588|FG003|Part A (6 Days)|Physician Decision|0|||
23566669|NCT00779584|65803892|FG001|Overall Study|Protocol Violation|0|||
23566670|NCT00779584|65803893|FG002|Overall Study|Protocol Violation|0|||
23222171|NCT02705755|64557585|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
23222172|NCT02705755|64557586|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
23222173|NCT02705755|64557587|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
23222174|NCT02705755|64557588|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
23443765|NCT03932760|65366498|FG001|Overall Study|Became Ineligible|5|||
23158086|NCT02663453|64328681|FG001|Overall Study|Withdrawal by Subject|0|||
23222175|NCT02705755|64557585|FG000|Part C (20 Weeks)|Physician Decision|0|||
23566671|NCT00779584|65803894|FG003|Overall Study|Protocol Violation|0|||
23158087|NCT03000179|64328687|FG000|Overall Study|Lost to Follow-up|2|||
23222176|NCT02705755|64557586|FG001|Part C (20 Weeks)|Physician Decision|0|||
23222177|NCT02705755|64557587|FG002|Part C (20 Weeks)|Physician Decision|0|||
23222178|NCT02705755|64557588|FG003|Part C (20 Weeks)|Physician Decision|2|||
23222179|NCT02705755|64557585|FG000|Part C (20 Weeks)|Adverse Event|0|||
23222180|NCT02705755|64557586|FG001|Part C (20 Weeks)|Adverse Event|0|||
23222181|NCT02705755|64557587|FG002|Part C (20 Weeks)|Adverse Event|0|||
23222182|NCT02705755|64557588|FG003|Part C (20 Weeks)|Adverse Event|6|||
23328311|NCT00391768|64945417|FG003|Overall Study|Withdrawal by Subject|0|||
23328312|NCT00391768|64945418|FG004|Overall Study|Withdrawal by Subject|0|||
23328313|NCT00391768|64945419|FG005|Overall Study|Withdrawal by Subject|1|||
23328314|NCT00391768|64945420|FG006|Overall Study|Withdrawal by Subject|1|||
23328315|NCT00391768|64945414|FG000|Overall Study|Lost to Follow-up|0|||
23328316|NCT00391768|64945415|FG001|Overall Study|Lost to Follow-up|0|||
23566672|NCT00779584|65803895|FG004|Overall Study|Protocol Violation|0|||
23566673|NCT00779584|65803896|FG005|Overall Study|Protocol Violation|1|||
23158088|NCT00806195|64328694|FG000|Overall Study|Death|6|||
23158089|NCT00806195|64328695|FG001|Overall Study|Death|0|||
23158090|NCT00806195|64328696|FG002|Overall Study|Death|1|||
23158091|NCT00806195|64328697|FG003|Overall Study|Death|0|||
23158092|NCT00806195|64328694|FG000|Overall Study|Adverse Event|25|||
23158093|NCT00806195|64328695|FG001|Overall Study|Adverse Event|5|||
23158094|NCT00806195|64328696|FG002|Overall Study|Adverse Event|11|||
23158095|NCT00806195|64328697|FG003|Overall Study|Adverse Event|2|||
23158096|NCT00806195|64328694|FG000|Overall Study|Withdrawal by Subject|119|||
23158097|NCT00806195|64328695|FG001|Overall Study|Withdrawal by Subject|31|||
23158098|NCT00806195|64328696|FG002|Overall Study|Withdrawal by Subject|76|||
23158099|NCT00806195|64328697|FG003|Overall Study|Withdrawal by Subject|35|||
23158100|NCT00806195|64328694|FG000|Overall Study|Lost to Follow-up|217|||
23158101|NCT00806195|64328695|FG001|Overall Study|Lost to Follow-up|66|||
23158102|NCT00806195|64328696|FG002|Overall Study|Lost to Follow-up|90|||
23158103|NCT00806195|64328697|FG003|Overall Study|Lost to Follow-up|34|||
23158104|NCT00806195|64328694|FG000|Overall Study|Inappropriate Enrollment|0|||
23158105|NCT00806195|64328695|FG001|Overall Study|Inappropriate Enrollment|1|||
23158106|NCT00806195|64328696|FG002|Overall Study|Inappropriate Enrollment|0|||
23158107|NCT00806195|64328697|FG003|Overall Study|Inappropriate Enrollment|0|||
23158108|NCT00806195|64328694|FG000|Overall Study|Administrative Reason|113|||
23443766|NCT03932760|65366497|FG000|Overall Study|Withdrawal by Subject|6|||
23443767|NCT03932760|65366498|FG001|Overall Study|Withdrawal by Subject|6|||
23566674|NCT00779584|65803897|FG006|Overall Study|Protocol Violation|0|||
23566675|NCT00779584|65803898|FG007|Overall Study|Protocol Violation|0|||
23566676|NCT00779584|65803899|FG008|Overall Study|Protocol Violation|0|||
23566677|NCT00779584|65803891|FG000|Overall Study|Withdrawal by Subject|1|||
23566678|NCT00779584|65803892|FG001|Overall Study|Withdrawal by Subject|1|||
23566679|NCT00779584|65803893|FG002|Overall Study|Withdrawal by Subject|2|||
23566680|NCT00779584|65803894|FG003|Overall Study|Withdrawal by Subject|0|||
23566681|NCT00779584|65803895|FG004|Overall Study|Withdrawal by Subject|0|||
23566682|NCT00779584|65803896|FG005|Overall Study|Withdrawal by Subject|2|||
23566683|NCT00779584|65803897|FG006|Overall Study|Withdrawal by Subject|1|||
23566684|NCT00779584|65803898|FG007|Overall Study|Withdrawal by Subject|0|||
23628557|NCT02881047|66028032|FG000|Overall Study|Withdrawal by Subject|1|||
23566685|NCT00779584|65803899|FG008|Overall Study|Withdrawal by Subject|0|||
23566686|NCT00779584|65803891|FG000|Overall Study|Lost to Follow-up|0|||
23566687|NCT00779584|65803892|FG001|Overall Study|Lost to Follow-up|0|||
23566688|NCT00779584|65803893|FG002|Overall Study|Lost to Follow-up|0|||
23566689|NCT00779584|65803894|FG003|Overall Study|Lost to Follow-up|0|||
23566690|NCT00779584|65803895|FG004|Overall Study|Lost to Follow-up|1|||
23566691|NCT00779584|65803896|FG005|Overall Study|Lost to Follow-up|0|||
23566692|NCT00779584|65803897|FG006|Overall Study|Lost to Follow-up|0|||
23566693|NCT00779584|65803898|FG007|Overall Study|Lost to Follow-up|0|||
23566694|NCT00779584|65803899|FG008|Overall Study|Lost to Follow-up|0|||
23566695|NCT00779584|65803891|FG000|Overall Study|Progression of Disease|0|||
23566696|NCT00779584|65803892|FG001|Overall Study|Progression of Disease|1|||
23566697|NCT00779584|65803893|FG002|Overall Study|Progression of Disease|2|||
23628558|NCT03024996|66028033|FG000|Overall Study|Death|57|||
23222183|NCT02705755|64557585|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
23222184|NCT02705755|64557586|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
23328317|NCT00391768|64945416|FG002|Overall Study|Lost to Follow-up|0|||
23566698|NCT00779584|65803894|FG003|Overall Study|Progression of Disease|6|||
23628559|NCT03024996|66028034|FG001|Overall Study|Death|55|||
23158109|NCT00806195|64328695|FG001|Overall Study|Administrative Reason|35|||
23158110|NCT00806195|64328696|FG002|Overall Study|Administrative Reason|66|||
23158111|NCT00806195|64328697|FG003|Overall Study|Administrative Reason|26|||
23158112|NCT00806195|64328694|FG000|Overall Study|Protocol Violation|34|||
23443768|NCT01732770|65366501|FG000|Overall Study|Lost to Follow-up|2|||
23443769|NCT01732770|65366502|FG001|Overall Study|Lost to Follow-up|3|||
23443770|NCT01732770|65366501|FG000|Overall Study|Withdrawal by Subject|5|||
23443771|NCT01732770|65366502|FG001|Overall Study|Withdrawal by Subject|3|||
23443772|NCT01732770|65366501|FG000|Overall Study|Decision by Sponsor|2|||
23628560|NCT03024996|66028033|FG000|Overall Study|Disease relapse|1|||
23628561|NCT03024996|66028034|FG001|Overall Study|Disease relapse|0|||
23628562|NCT03024996|66028033|FG000|Overall Study|Lost to Follow-up|5|||
23628563|NCT03024996|66028034|FG001|Overall Study|Lost to Follow-up|10|||
23628564|NCT03024996|66028033|FG000|Overall Study|Other|3|||
23628565|NCT03024996|66028034|FG001|Overall Study|Other|3|||
23158113|NCT00806195|64328695|FG001|Overall Study|Protocol Violation|24|||
23158114|NCT00806195|64328696|FG002|Overall Study|Protocol Violation|26|||
23158115|NCT00806195|64328697|FG003|Overall Study|Protocol Violation|9|||
23158116|NCT03198520|64328700|FG000|Overall Study|Physician Decision|2|||
23158117|NCT03198520|64328700|FG000|Overall Study|Protocol Violation|2|||
23158118|NCT03198520|64328700|FG000|Overall Study|Withdrawal by Subject|1|||
23158119|NCT03198520|64328700|FG000|Overall Study|Study Ended|1|||
23158120|NCT03975920|64328701|FG000|Overall Study|Lost to Follow-up|1|||
23158121|NCT03975920|64328702|FG001|Overall Study|Lost to Follow-up|2|||
23158122|NCT03975920|64328701|FG000|Overall Study|Protocol Violation|1|||
23158123|NCT03975920|64328702|FG001|Overall Study|Protocol Violation|1|||
23158124|NCT03975920|64328701|FG000|Overall Study|Did not complete survey|2|||
23158125|NCT03975920|64328702|FG001|Overall Study|Did not complete survey|1|||
23158126|NCT00710879|64328703|FG000|Overall Study|Lost to Follow-up|2|||
23158127|NCT00710879|64328704|FG001|Overall Study|Lost to Follow-up|1|||
23328318|NCT00391768|64945417|FG003|Overall Study|Lost to Follow-up|1|||
23328319|NCT00391768|64945418|FG004|Overall Study|Lost to Follow-up|2|||
23566699|NCT00779584|65803895|FG004|Overall Study|Progression of Disease|5|||
23566700|NCT00779584|65803896|FG005|Overall Study|Progression of Disease|1|||
23566701|NCT00779584|65803897|FG006|Overall Study|Progression of Disease|4|||
23566702|NCT00779584|65803898|FG007|Overall Study|Progression of Disease|2|||
23566703|NCT00779584|65803899|FG008|Overall Study|Progression of Disease|1|||
23566704|NCT00779584|65803891|FG000|Overall Study|Adverse Event|1|||
23566705|NCT00779584|65803892|FG001|Overall Study|Adverse Event|0|||
23566706|NCT00779584|65803893|FG002|Overall Study|Adverse Event|2|||
23566707|NCT00779584|65803894|FG003|Overall Study|Adverse Event|0|||
23566708|NCT00779584|65803895|FG004|Overall Study|Adverse Event|0|||
23566709|NCT00779584|65803896|FG005|Overall Study|Adverse Event|0|||
23566710|NCT00779584|65803897|FG006|Overall Study|Adverse Event|2|||
23566711|NCT00779584|65803898|FG007|Overall Study|Adverse Event|1|||
23566712|NCT00779584|65803899|FG008|Overall Study|Adverse Event|1|||
23566713|NCT00779584|65803891|FG000|Overall Study|Symptomatic Deterioration|1|||
23566714|NCT00779584|65803892|FG001|Overall Study|Symptomatic Deterioration|1|||
23566715|NCT00779584|65803893|FG002|Overall Study|Symptomatic Deterioration|1|||
23566716|NCT00779584|65803894|FG003|Overall Study|Symptomatic Deterioration|0|||
23566717|NCT00779584|65803895|FG004|Overall Study|Symptomatic Deterioration|0|||
23566718|NCT00779584|65803896|FG005|Overall Study|Symptomatic Deterioration|1|||
23566719|NCT00779584|65803897|FG006|Overall Study|Symptomatic Deterioration|1|||
23566720|NCT00779584|65803898|FG007|Overall Study|Symptomatic Deterioration|0|||
23566721|NCT00779584|65803899|FG008|Overall Study|Symptomatic Deterioration|0|||
23566722|NCT00779584|65803891|FG000|Overall Study|Ongoing in Study|0|||
23566723|NCT00779584|65803892|FG001|Overall Study|Ongoing in Study|0|||
23566724|NCT00779584|65803893|FG002|Overall Study|Ongoing in Study|0|||
23566725|NCT00779584|65803894|FG003|Overall Study|Ongoing in Study|0|||
23566726|NCT00779584|65803895|FG004|Overall Study|Ongoing in Study|1|||
23566727|NCT00779584|65803896|FG005|Overall Study|Ongoing in Study|1|||
23566728|NCT00779584|65803897|FG006|Overall Study|Ongoing in Study|0|||
23566729|NCT00779584|65803898|FG007|Overall Study|Ongoing in Study|0|||
23566730|NCT00779584|65803899|FG008|Overall Study|Ongoing in Study|0|||
23566731|NCT02906202|65803900|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
23566732|NCT02357810|65803901|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
23566733|NCT02357810|65803901|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
23566734|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Adverse Event|5|||
23566735|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
23566736|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
23566737|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
23566738|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Death|1|||
23158128|NCT00710879|64328703|FG000|Overall Study|Protocol Violation|0|||
23328320|NCT00391768|64945419|FG005|Overall Study|Lost to Follow-up|2|||
23566739|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Physician Decision|1|||
23566740|NCT02357810|65803901|FG000|Reached 12 Weeks Response|Other|1|||
23566741|NCT02357810|65803901|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
23158129|NCT00710879|64328704|FG001|Overall Study|Protocol Violation|3|||
23158130|NCT00382018|64328708|FG000|Overall Study|Progression|0|||
23158131|NCT00382018|64328709|FG001|Overall Study|Progression|136|||
23158132|NCT00382018|64328710|FG002|Overall Study|Progression|51|||
23158133|NCT00382018|64328711|FG003|Overall Study|Progression|43|||
23328321|NCT00391768|64945420|FG006|Overall Study|Lost to Follow-up|3|||
23566742|NCT02357810|65803901|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
23566743|NCT02357810|65803901|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
23566744|NCT02357810|65803901|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
23628566|NCT03024996|66028033|FG000|Overall Study|Physician Decision|0|||
23158134|NCT00382018|64328708|FG000|Overall Study|Death|0|||
23158135|NCT00382018|64328709|FG001|Overall Study|Death|9|||
23158136|NCT00382018|64328710|FG002|Overall Study|Death|7|||
23158137|NCT00382018|64328711|FG003|Overall Study|Death|11|||
23158138|NCT00382018|64328708|FG000|Overall Study|Withdrawal by Subject|0|||
23158139|NCT00382018|64328709|FG001|Overall Study|Withdrawal by Subject|4|||
23158140|NCT00382018|64328710|FG002|Overall Study|Withdrawal by Subject|3|||
23158141|NCT00382018|64328711|FG003|Overall Study|Withdrawal by Subject|4|||
23158142|NCT00382018|64328708|FG000|Overall Study|Other, not protocol specified|0|||
23158143|NCT00382018|64328709|FG001|Overall Study|Other, not protocol specified|16|||
23158144|NCT00382018|64328710|FG002|Overall Study|Other, not protocol specified|3|||
23158145|NCT00382018|64328711|FG003|Overall Study|Other, not protocol specified|1|||
23158146|NCT01668719|64328716|FG000|Phase I|On treatment|1|||
23158147|NCT01668719|64328717|FG001|Phase I|On treatment|0|||
23158148|NCT01668719|64328718|FG002|Phase I|On treatment|0|||
23158149|NCT01668719|64328716|FG000|Phase I|Adverse Event|2|||
23158150|NCT01668719|64328717|FG001|Phase I|Adverse Event|0|||
23158151|NCT01668719|64328718|FG002|Phase I|Adverse Event|0|||
23158152|NCT01668719|64328716|FG000|Phase I|Progression/relapse|1|||
23158153|NCT01668719|64328717|FG001|Phase I|Progression/relapse|0|||
23158154|NCT01668719|64328718|FG002|Phase I|Progression/relapse|0|||
23158155|NCT01668719|64328716|FG000|Phase I|not protocol specified|2|||
23158156|NCT01668719|64328717|FG001|Phase I|not protocol specified|0|||
23158157|NCT01668719|64328718|FG002|Phase I|not protocol specified|0|||
23158158|NCT01668719|64328716|FG000|Phase II|On treatment|0|||
23158159|NCT01668719|64328717|FG001|Phase II|On treatment|4|||
23158160|NCT01668719|64328718|FG002|Phase II|On treatment|3|||
23443773|NCT01732770|65366502|FG001|Overall Study|Decision by Sponsor|2|||
23443774|NCT01732770|65366501|FG000|Overall Study|Death|1|||
23443775|NCT01732770|65366502|FG001|Overall Study|Death|0|||
23443776|NCT01559675|65366503|FG000|Overall Study|Protocol Violation|1|||
23443777|NCT01559675|65366504|FG001|Overall Study|Protocol Violation|2|||
23443778|NCT01559675|65366503|FG000|Overall Study|2nd operation on same patient excluded|14|||
23443779|NCT01559675|65366504|FG001|Overall Study|2nd operation on same patient excluded|12|||
23443780|NCT00711971|65366505|FG000|Overall Study|Lost to Follow-up|3|||
23566745|NCT02357810|65803901|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
23566746|NCT02357810|65803901|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
23566747|NCT00845871|65803902|FG000|Assessment Period|Adverse Event|2|||
23566748|NCT00845871|65803902|FG000|Assessment Period|Abnormal laboratory values|1|||
23566749|NCT00845871|65803902|FG000|Assessment Period|Abnormal test procedure results|1|||
23566750|NCT00845871|65803902|FG000|Assessment Period|Patient withdrew consent|3|||
23566751|NCT02601937|65803903|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566752|NCT02601937|65803904|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566753|NCT02601937|65803905|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566754|NCT02601937|65803906|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566755|NCT02601937|65803907|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566756|NCT02601937|65803908|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
23566757|NCT02601937|65803909|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566758|NCT02601937|65803910|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566759|NCT02601937|65803911|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566760|NCT02601937|65803912|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566761|NCT02601937|65803913|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
23566762|NCT02601937|65803903|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
23566763|NCT02601937|65803904|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566764|NCT02601937|65803905|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566765|NCT02601937|65803906|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566766|NCT02601937|65803907|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23628567|NCT03024996|66028034|FG001|Overall Study|Physician Decision|1|||
23628568|NCT03024996|66028033|FG000|Overall Study|Study terminated by sponsor|303|||
23628569|NCT03024996|66028034|FG001|Overall Study|Study terminated by sponsor|283|||
23628570|NCT03024996|66028033|FG000|Overall Study|Withdrawal by Subject|21|||
23628571|NCT03024996|66028034|FG001|Overall Study|Withdrawal by Subject|36|||
23158161|NCT01668719|64328716|FG000|Phase II|Adverse Event|0|||
23158162|NCT01668719|64328717|FG001|Phase II|Adverse Event|18|||
23158163|NCT01668719|64328718|FG002|Phase II|Adverse Event|18|||
23158164|NCT01668719|64328716|FG000|Phase II|Refusal unrelated to adverse event|0|||
23158165|NCT01668719|64328717|FG001|Phase II|Refusal unrelated to adverse event|4|||
23628572|NCT02706951|66028035|FG000|Period 1|Adverse Event|1|||
23158166|NCT01668719|64328718|FG002|Phase II|Refusal unrelated to adverse event|1|||
23158167|NCT01668719|64328716|FG000|Phase II|Progression/relapse|0|||
23158168|NCT01668719|64328717|FG001|Phase II|Progression/relapse|13|||
23158169|NCT01668719|64328718|FG002|Phase II|Progression/relapse|17|||
23443781|NCT00711971|65366506|FG001|Overall Study|Lost to Follow-up|4|||
23158170|NCT01668719|64328716|FG000|Phase II|Death|0|||
23158171|NCT01668719|64328717|FG001|Phase II|Death|0|||
23158172|NCT01668719|64328718|FG002|Phase II|Death|2|||
23158173|NCT01668719|64328716|FG000|Phase II|not protocol specified|0|||
23158174|NCT01668719|64328717|FG001|Phase II|not protocol specified|13|||
23158175|NCT01668719|64328718|FG002|Phase II|not protocol specified|7|||
23158176|NCT01436084|64328719|FG000|Overall Study|Disease Progression|2|||
23158177|NCT01436084|64328719|FG000|Overall Study|Withdrawal by Subject|1|||
23158178|NCT01436084|64328719|FG000|Overall Study|Early Closure of Study|1|||
23158179|NCT00906087|64328724|FG000|Initial Washout|Withdrawal by Subject|1|||
23158180|NCT00906087|64328724|FG000|Initial Washout|Physician Decision|1|||
23158181|NCT03829657|64328725|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
23158182|NCT03829657|64328726|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
23158183|NCT03829657|64328727|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
23158184|NCT03829657|64328728|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
23158185|NCT03829657|64328729|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
23158186|NCT03829657|64328725|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
23158187|NCT03829657|64328726|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
23158188|NCT03829657|64328727|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
23158189|NCT03829657|64328728|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
23158190|NCT03829657|64328729|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
23158191|NCT03829657|64328725|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
23158192|NCT03829657|64328726|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
23158193|NCT03829657|64328727|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
23158194|NCT03829657|64328728|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
23158195|NCT03829657|64328729|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
23158196|NCT03829657|64328725|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
23158197|NCT03829657|64328726|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
23158198|NCT03829657|64328727|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
23158199|NCT03829657|64328728|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
23158200|NCT03829657|64328729|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
23158201|NCT03829657|64328725|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
23158202|NCT03829657|64328726|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
23158203|NCT03829657|64328727|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
23158204|NCT03829657|64328728|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
23158205|NCT03829657|64328729|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
23158206|NCT03829657|64328725|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
23158207|NCT03829657|64328726|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
23158208|NCT03829657|64328727|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
23158209|NCT03829657|64328728|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
23158210|NCT03829657|64328729|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
23158211|NCT03829657|64328725|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
23158212|NCT03829657|64328726|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
23158213|NCT03829657|64328727|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
23158214|NCT03829657|64328728|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
23158215|NCT03829657|64328729|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
23158216|NCT03829657|64328725|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
23158217|NCT03829657|64328726|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
23158218|NCT03829657|64328727|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
23158219|NCT03829657|64328728|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
23158220|NCT03829657|64328729|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
23158221|NCT03829657|64328725|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
23158222|NCT03829657|64328726|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
23158223|NCT03829657|64328727|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
23158224|NCT03829657|64328728|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
23158225|NCT03829657|64328729|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
23158226|NCT03829657|64328725|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
23158227|NCT03829657|64328726|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
23158228|NCT03829657|64328727|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
23158229|NCT03829657|64328728|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
23158230|NCT03829657|64328729|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
23158231|NCT01226459|64328730|FG000|Overall Study|Adverse Event|2|||
23158232|NCT01226459|64328731|FG001|Overall Study|Adverse Event|8|||
23222185|NCT02705755|64557587|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
23328322|NCT02548143|64945421|FG000|Overall Study|Adverse Event|1|||
23566767|NCT02601937|65803908|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23158233|NCT01226459|64328730|FG000|Overall Study|Protocol Violation|4|||
23158234|NCT01226459|64328731|FG001|Overall Study|Protocol Violation|3|||
23158235|NCT01226459|64328730|FG000|Overall Study|Withdrawal by Subject|10|||
23158236|NCT01226459|64328731|FG001|Overall Study|Withdrawal by Subject|13|||
23158237|NCT01226459|64328730|FG000|Overall Study|Lost to Follow-up|4|||
23158238|NCT01226459|64328731|FG001|Overall Study|Lost to Follow-up|8|||
23158239|NCT01226459|64328730|FG000|Overall Study|Pregnancy|1|||
23158240|NCT01226459|64328731|FG001|Overall Study|Pregnancy|0|||
23158241|NCT01648790|64328738|FG000|Treatment 3|Withdrawal by Subject|0|||
23158242|NCT01648790|64328739|FG001|Treatment 3|Withdrawal by Subject|0|||
23158243|NCT01648790|64328740|FG002|Treatment 3|Withdrawal by Subject|0|||
23158244|NCT01648790|64328741|FG003|Treatment 3|Withdrawal by Subject|1|||
23158245|NCT01648790|64328742|FG004|Treatment 3|Withdrawal by Subject|0|||
23158246|NCT03610724|64328745|FG000|Overall Study|Death|17|||
23158247|NCT03610724|64328745|FG000|Overall Study|Lost to Follow-up|1|||
23158248|NCT03610724|64328745|FG000|Overall Study|Physician Decision|1|||
23158249|NCT03610724|64328745|FG000|Overall Study|Died prior to infusion|1|||
23158250|NCT03179891|64328746|FG000|First Intervention|Withdrawal by Subject|1|||
23158251|NCT03179891|64328747|FG001|First Intervention|Withdrawal by Subject|1|||
23158252|NCT03179891|64328746|FG000|First Intervention|Unspecified reason|1|||
23158253|NCT03179891|64328747|FG001|First Intervention|Unspecified reason|0|||
23158254|NCT03179891|64328746|FG000|First Intervention|Protocol Violation|0|||
23158255|NCT03179891|64328747|FG001|First Intervention|Protocol Violation|1|||
23158256|NCT02248259|64328748|FG000|Treatment Period 1|Adverse Event|0|||
23328323|NCT02548143|64945422|FG001|Overall Study|Adverse Event|0|||
23328324|NCT02548143|64945421|FG000|Overall Study|Withdrawal by Subject|0|||
23328325|NCT02548143|64945422|FG001|Overall Study|Withdrawal by Subject|1|||
23328326|NCT00314327|64945424|FG000|Overall Study|Withdrawal by Subject|1|||
23328327|NCT03859427|64945426|FG000|Overall Study|Withdrawal by Subject|4|||
23328328|NCT03859427|64945427|FG001|Overall Study|Withdrawal by Subject|7|||
23328329|NCT03859427|64945426|FG000|Overall Study|Decision by sponsor|0|||
23328330|NCT03859427|64945427|FG001|Overall Study|Decision by sponsor|3|||
23328331|NCT03859427|64945426|FG000|Overall Study|Lost to Follow-up|3|||
23328332|NCT03859427|64945427|FG001|Overall Study|Lost to Follow-up|2|||
23158257|NCT02248259|64328749|FG001|Treatment Period 1|Adverse Event|0|||
23158258|NCT02248259|64328750|FG002|Treatment Period 1|Adverse Event|1|||
23158259|NCT02248259|64328751|FG003|Treatment Period 1|Adverse Event|0|||
23158260|NCT05418673|64328752|FG000|Overall Study|Study Terminated by Sponsor|2|||
23158261|NCT05418673|64328753|FG001|Overall Study|Study Terminated by Sponsor|4|||
23158262|NCT05418673|64328752|FG000|Overall Study|Lost to Follow-up|1|||
23328333|NCT03859427|64945426|FG000|Overall Study|Death|22|||
23328334|NCT03859427|64945427|FG001|Overall Study|Death|25|||
23328335|NCT05244122|64945428|FG000|Overall Study|Withdrawal by Subject|318|||
23328336|NCT02810457|64945429|FG000|Overall Study|Randomised but no treatment received|2|||
23328337|NCT02810457|64945430|FG001|Overall Study|Randomised but no treatment received|1|||
23328338|NCT02810457|64945429|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
23328339|NCT02810457|64945430|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
23328340|NCT02810457|64945429|FG000|Overall Study|Adverse Event|37|||
23328341|NCT02810457|64945430|FG001|Overall Study|Adverse Event|43|||
23328342|NCT02810457|64945429|FG000|Overall Study|Patient decision|31|||
23328343|NCT02810457|64945430|FG001|Overall Study|Patient decision|35|||
23328344|NCT02810457|64945429|FG000|Overall Study|Patient lost to follow-up|2|||
23328345|NCT02810457|64945430|FG001|Overall Study|Patient lost to follow-up|2|||
23328346|NCT02810457|64945429|FG000|Overall Study|Death|39|||
23328347|NCT02810457|64945430|FG001|Overall Study|Death|28|||
23328348|NCT02810457|64945429|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
23328349|NCT02810457|64945430|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
23328350|NCT02810457|64945429|FG000|Overall Study|Clinical progression|15|||
23328351|NCT02810457|64945430|FG001|Overall Study|Clinical progression|16|||
23328352|NCT02810457|64945429|FG000|Overall Study|Investigator decision|3|||
23328353|NCT02810457|64945430|FG001|Overall Study|Investigator decision|2|||
23158263|NCT05418673|64328753|FG001|Overall Study|Lost to Follow-up|0|||
23158264|NCT03061175|64328756|FG000|Baseline|Participant was deemed ineligible|1|||
23328354|NCT02810457|64945429|FG000|Overall Study|Patient ineligibility|3|||
23328355|NCT02810457|64945430|FG001|Overall Study|Patient ineligibility|0|||
23328356|NCT02810457|64945429|FG000|Overall Study|Miscalculated PD|1|||
23328357|NCT02810457|64945430|FG001|Overall Study|Miscalculated PD|0|||
23328358|NCT02810457|64945429|FG000|Overall Study|Physician Decision|0|||
23328359|NCT02810457|64945430|FG001|Overall Study|Physician Decision|1|||
23328360|NCT01464424|64945431|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
23328361|NCT01464424|64945432|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
23328362|NCT01808066|64945436|FG000|Overall Study|Withdrawal by Subject|15|||
23328363|NCT02714218|64945443|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23158265|NCT03061175|64328757|FG001|Baseline|Participant was deemed ineligible|0|||
23158266|NCT03061175|64328756|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
23158267|NCT03061175|64328757|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
23158268|NCT03061175|64328756|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
23566768|NCT02601937|65803909|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
23566769|NCT02601937|65803910|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566770|NCT02601937|65803911|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566771|NCT02601937|65803912|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566772|NCT02601937|65803913|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
23566773|NCT02601937|65803903|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566774|NCT02601937|65803904|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566775|NCT02601937|65803905|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
23566776|NCT02601937|65803906|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566777|NCT02601937|65803907|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566778|NCT02601937|65803908|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566779|NCT02601937|65803909|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566780|NCT02601937|65803910|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566781|NCT02601937|65803911|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566782|NCT02601937|65803912|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566783|NCT02601937|65803913|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
23566784|NCT02601937|65803903|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
23566785|NCT02601937|65803904|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
23566786|NCT02601937|65803905|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
23566787|NCT02601937|65803906|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
23566788|NCT02601937|65803907|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
23566789|NCT02601937|65803908|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
23566790|NCT02601937|65803909|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
23566791|NCT02601937|65803910|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
23566792|NCT02601937|65803911|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
23566793|NCT02601937|65803912|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
23566794|NCT02601937|65803913|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
23566795|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566796|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566797|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566798|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566799|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566800|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566801|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566802|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566803|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566804|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
23566805|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
23566806|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566807|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566808|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566809|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566810|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566811|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566812|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566813|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
23566814|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566815|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566816|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
23566817|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566818|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566819|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566820|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566821|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566822|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566823|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566824|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566825|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
23566826|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
23158269|NCT03061175|64328757|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
23158270|NCT03061175|64328756|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
23566827|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
23158271|NCT03061175|64328757|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
23566828|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566829|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566830|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566831|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566832|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566833|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566834|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
23566835|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
23566836|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
23566837|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
23566838|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
23566839|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Other|0|||
23566840|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Other|0|||
23566841|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Other|0|||
23566842|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Other|0|||
23566843|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Other|0|||
23566844|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Other|0|||
23566845|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Other|0|||
23566846|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Other|0|||
23566847|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Other|2|||
23566848|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Other|2|||
23566849|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Other|0|||
23566850|NCT02601937|65803903|FG000|Period 2: Dose Expansion Cohort|Death|0|||
23566851|NCT02601937|65803904|FG001|Period 2: Dose Expansion Cohort|Death|0|||
23566852|NCT02601937|65803905|FG002|Period 2: Dose Expansion Cohort|Death|0|||
23566853|NCT02601937|65803906|FG003|Period 2: Dose Expansion Cohort|Death|0|||
23566854|NCT02601937|65803907|FG004|Period 2: Dose Expansion Cohort|Death|0|||
23566855|NCT02601937|65803908|FG005|Period 2: Dose Expansion Cohort|Death|0|||
23566856|NCT02601937|65803909|FG006|Period 2: Dose Expansion Cohort|Death|0|||
23566857|NCT02601937|65803910|FG007|Period 2: Dose Expansion Cohort|Death|0|||
23566858|NCT02601937|65803911|FG008|Period 2: Dose Expansion Cohort|Death|1|||
23566859|NCT02601937|65803912|FG009|Period 2: Dose Expansion Cohort|Death|0|||
23566860|NCT02601937|65803913|FG010|Period 2: Dose Expansion Cohort|Death|0|||
23566861|NCT04318093|65803918|FG000|Overall Study|Adverse Event|2|||
23566862|NCT04318093|65803919|FG001|Overall Study|Adverse Event|2|||
23566863|NCT04318093|65803918|FG000|Overall Study|Participant withdrew consent|1|||
23566864|NCT04318093|65803919|FG001|Overall Study|Participant withdrew consent|0|||
23566865|NCT04318093|65803918|FG000|Overall Study|Other reasons|0|||
23566866|NCT04318093|65803919|FG001|Overall Study|Other reasons|1|||
23566867|NCT04041440|65803920|FG000|Overall Study|Withdrawal by Subject|0|||
23566868|NCT04041440|65803921|FG001|Overall Study|Withdrawal by Subject|1|||
23566869|NCT04041440|65803920|FG000|Overall Study|Lost to Follow-up|0|||
23566870|NCT04041440|65803921|FG001|Overall Study|Lost to Follow-up|1|||
23566871|NCT01381874|65803923|FG000|Overall Study|Lost to Follow-up|1|||
23566872|NCT01381874|65803924|FG001|Overall Study|Lost to Follow-up|1|||
23566873|NCT01381874|65803925|FG002|Overall Study|Lost to Follow-up|0|||
23566874|NCT01381874|65803923|FG000|Overall Study|Withdrawal by Subject|9|||
23566875|NCT01381874|65803924|FG001|Overall Study|Withdrawal by Subject|10|||
23566876|NCT01381874|65803925|FG002|Overall Study|Withdrawal by Subject|9|||
23566877|NCT01381874|65803923|FG000|Overall Study|Other|67|||
23566878|NCT01381874|65803924|FG001|Overall Study|Other|52|||
23566879|NCT01381874|65803925|FG002|Overall Study|Other|67|||
23566880|NCT02387996|65803926|FG000|Overall Study|Disease Progression|167|||
23566881|NCT02387996|65803926|FG000|Overall Study|Study Drug Toxicity|31|||
23566882|NCT02387996|65803926|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
23158272|NCT01274715|64328758|FG000|Overall Study|Lost to Follow-up|1|||
23158273|NCT01274715|64328758|FG000|Overall Study|After consent, met exclusion criteria.|1|||
23158274|NCT01274715|64328758|FG000|Overall Study|After consent, met exclusion criteria.|1|||
23158275|NCT01274715|64328758|FG000|Overall Study|After consent, met exclusion criteria.|1|||
23158276|NCT03631784|64328759|FG000|Overall Study|Death|48|||
23158277|NCT03631784|64328760|FG001|Overall Study|Death|28|||
23158278|NCT03631784|64328759|FG000|Overall Study|Lost to Follow-up|1|||
23158279|NCT03631784|64328760|FG001|Overall Study|Lost to Follow-up|0|||
23158280|NCT03631784|64328759|FG000|Overall Study|Withdrawal by Subject|0|||
23158281|NCT03631784|64328760|FG001|Overall Study|Withdrawal by Subject|3|||
23566883|NCT02387996|65803926|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
23566884|NCT02387996|65803926|FG000|Overall Study|Subject Withdrew Consent|5|||
23566885|NCT02387996|65803926|FG000|Overall Study|Lost to Follow-up|1|||
23566886|NCT02387996|65803926|FG000|Overall Study|Poor/Non-Compliance|1|||
23566887|NCT02387996|65803926|FG000|Overall Study|Other Reasons|5|||
23566888|NCT02387996|65803926|FG000|Overall Study|Death|1|||
23566889|NCT00847301|65803931|FG000|Overall Study|Adverse Event|35|||
23566890|NCT00847301|65803931|FG000|Overall Study|Switch to other anticoagulants|16|||
23566891|NCT00847301|65803931|FG000|Overall Study|Lost to Follow-up|1|||
23566892|NCT00847301|65803931|FG000|Overall Study|No prescription after hospital discharge|1|||
23566893|NCT00847301|65803931|FG000|Overall Study|Other reason not defined above|1|||
23566894|NCT00152971|65803932|FG000|Overall Study|Adverse Event|12|||
23566895|NCT00152971|65803933|FG001|Overall Study|Adverse Event|10|||
23566896|NCT00152971|65803934|FG002|Overall Study|Adverse Event|9|||
23566897|NCT00152971|65803932|FG000|Overall Study|Protocol Violation|10|||
23566898|NCT00152971|65803933|FG001|Overall Study|Protocol Violation|11|||
23566899|NCT00152971|65803934|FG002|Overall Study|Protocol Violation|8|||
23566900|NCT00152971|65803932|FG000|Overall Study|Lost to Follow-up|17|||
23566901|NCT00152971|65803933|FG001|Overall Study|Lost to Follow-up|14|||
23158282|NCT03631784|64328759|FG000|Overall Study|Participants Ongoing|63|||
23158283|NCT03631784|64328760|FG001|Overall Study|Participants Ongoing|71|||
23158284|NCT01471015|64328761|FG000|Overall Study|Death|0|||
23158285|NCT01471015|64328762|FG001|Overall Study|Death|1|||
23158286|NCT01471015|64328763|FG002|Overall Study|Death|1|||
23158287|NCT03069352|64328764|FG000|Overall Study|Ongoing|12|||
23158288|NCT03069352|64328765|FG001|Overall Study|Ongoing|40|||
23158289|NCT01469182|64328770|FG000|Overall Study|Adverse Event|21|||
23158290|NCT01469182|64328771|FG001|Overall Study|Adverse Event|3|||
23158291|NCT01469182|64328770|FG000|Overall Study|Lost to Follow-up|3|||
23158292|NCT01469182|64328771|FG001|Overall Study|Lost to Follow-up|0|||
23566902|NCT00152971|65803934|FG002|Overall Study|Lost to Follow-up|13|||
23158293|NCT01469182|64328770|FG000|Overall Study|Withdrawal by Subject|4|||
23158294|NCT01469182|64328771|FG001|Overall Study|Withdrawal by Subject|1|||
23158295|NCT01469182|64328770|FG000|Overall Study|Protocol Violation|4|||
23158296|NCT01469182|64328771|FG001|Overall Study|Protocol Violation|2|||
23158297|NCT01469182|64328770|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
23158298|NCT01469182|64328771|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
23158299|NCT00432042|64328772|FG000|Overall Study|Protocol Violation|2|||
23158300|NCT00432042|64328773|FG001|Overall Study|Protocol Violation|0|||
23158301|NCT00432042|64328774|FG002|Overall Study|Protocol Violation|0|||
23158302|NCT00432042|64328772|FG000|Overall Study|Withdrawal by Subject|0|||
23158303|NCT00432042|64328773|FG001|Overall Study|Withdrawal by Subject|0|||
23158304|NCT00432042|64328774|FG002|Overall Study|Withdrawal by Subject|2|||
23158305|NCT00432042|64328772|FG000|Overall Study|Lost to Follow-up|5|||
23158306|NCT00432042|64328773|FG001|Overall Study|Lost to Follow-up|1|||
23158307|NCT00432042|64328774|FG002|Overall Study|Lost to Follow-up|0|||
23158308|NCT01054144|64328775|FG000|Overall Study|Death|2|||
23158309|NCT01876251|64328778|FG000|Overall Study|Clinical progression|1|||
23158310|NCT01876251|64328779|FG001|Overall Study|Clinical progression|0|||
23158311|NCT01876251|64328780|FG002|Overall Study|Clinical progression|0|||
23158312|NCT01876251|64328778|FG000|Overall Study|Death|2|||
23158313|NCT01876251|64328779|FG001|Overall Study|Death|0|||
23158314|NCT01876251|64328780|FG002|Overall Study|Death|1|||
23158315|NCT01876251|64328778|FG000|Overall Study|Participant started new treatment|1|||
23158316|NCT01876251|64328779|FG001|Overall Study|Participant started new treatment|0|||
23158317|NCT01876251|64328780|FG002|Overall Study|Participant started new treatment|1|||
23158318|NCT01876251|64328778|FG000|Overall Study|Participant refused further follow-up|0|||
23158319|NCT01876251|64328779|FG001|Overall Study|Participant refused further follow-up|0|||
23158320|NCT01876251|64328780|FG002|Overall Study|Participant refused further follow-up|1|||
23443782|NCT00711971|65366507|FG002|Overall Study|Lost to Follow-up|1|||
23443783|NCT01946152|65366508|FG000|Overall Study|Adverse Event|1|||
23443784|NCT01946152|65366509|FG001|Overall Study|Adverse Event|0|||
23443785|NCT01946152|65366510|FG002|Overall Study|Adverse Event|0|||
23443786|NCT01946152|65366511|FG003|Overall Study|Adverse Event|0|||
23443787|NCT01946152|65366508|FG000|Overall Study|Withdrawal by Subject|0|||
23443788|NCT01946152|65366509|FG001|Overall Study|Withdrawal by Subject|2|||
23443789|NCT01946152|65366510|FG002|Overall Study|Withdrawal by Subject|0|||
23443790|NCT01946152|65366511|FG003|Overall Study|Withdrawal by Subject|0|||
23443791|NCT01946152|65366508|FG000|Overall Study|Progression|0|||
23443792|NCT01946152|65366509|FG001|Overall Study|Progression|1|||
23566903|NCT00152971|65803932|FG000|Overall Study|Withdrawal by Subject|9|||
23566904|NCT00152971|65803933|FG001|Overall Study|Withdrawal by Subject|8|||
23566905|NCT00152971|65803934|FG002|Overall Study|Withdrawal by Subject|14|||
23443793|NCT01946152|65366510|FG002|Overall Study|Progression|4|||
23443794|NCT01946152|65366511|FG003|Overall Study|Progression|7|||
23566906|NCT00152971|65803932|FG000|Overall Study|Other|3|||
23158321|NCT01876251|64328778|FG000|Overall Study|Study terminated|1|||
23158322|NCT01876251|64328779|FG001|Overall Study|Study terminated|0|||
23443795|NCT01946152|65366508|FG000|Overall Study|Physician Decision|0|||
23566907|NCT00152971|65803933|FG001|Overall Study|Other|5|||
23158323|NCT01876251|64328780|FG002|Overall Study|Study terminated|0|||
23158324|NCT01876251|64328778|FG000|Overall Study|Objective progression or relapse|10|||
23158325|NCT01876251|64328779|FG001|Overall Study|Objective progression or relapse|3|||
23158326|NCT01876251|64328780|FG002|Overall Study|Objective progression or relapse|8|||
23158327|NCT03668600|64328783|FG000|Overall Study|Study Terminated by the Sponsor|157|||
23443796|NCT01946152|65366509|FG001|Overall Study|Physician Decision|0|||
23443797|NCT01946152|65366510|FG002|Overall Study|Physician Decision|1|||
23566908|NCT00152971|65803934|FG002|Overall Study|Other|5|||
23566909|NCT00152971|65803932|FG000|Treatment|Adverse Event|49|||
23158328|NCT03668600|64328783|FG000|Overall Study|Protocol Violation|1|||
23158329|NCT03668600|64328783|FG000|Overall Study|Pregnancy|1|||
23158330|NCT03668600|64328783|FG000|Overall Study|Lost to Follow-up|7|||
23158331|NCT03668600|64328783|FG000|Overall Study|Withdrawal by Subject|56|||
23158332|NCT03668600|64328783|FG000|Overall Study|Lack of Efficacy|7|||
23443798|NCT01946152|65366511|FG003|Overall Study|Physician Decision|0|||
23443799|NCT01946152|65366508|FG000|Overall Study|Second malignancy|0|||
23443800|NCT01946152|65366509|FG001|Overall Study|Second malignancy|0|||
23443801|NCT01946152|65366510|FG002|Overall Study|Second malignancy|1|||
23158333|NCT03668600|64328783|FG000|Overall Study|Adverse Event|1|||
23158334|NCT01924182|64328784|FG000|Overall Study|Withdrawal by Subject|1|||
23158335|NCT01924182|64328785|FG001|Overall Study|Withdrawal by Subject|0|||
23158336|NCT03823404|64328786|FG000|Overall Study|Lost to Follow-up|1|||
23158337|NCT03823404|64328787|FG001|Overall Study|Lost to Follow-up|2|||
23158338|NCT03823404|64328788|FG002|Overall Study|Lost to Follow-up|3|||
23158339|NCT03823404|64328786|FG000|Overall Study|Protocol Violation|2|||
23158340|NCT03823404|64328787|FG001|Overall Study|Protocol Violation|0|||
23158341|NCT03823404|64328788|FG002|Overall Study|Protocol Violation|2|||
23158342|NCT03823404|64328786|FG000|Overall Study|Adverse Event|35|||
23158343|NCT03823404|64328787|FG001|Overall Study|Adverse Event|38|||
23158344|NCT03823404|64328788|FG002|Overall Study|Adverse Event|8|||
23158345|NCT03823404|64328786|FG000|Overall Study|Withdrawal by Subject|38|||
23158346|NCT03823404|64328787|FG001|Overall Study|Withdrawal by Subject|40|||
23158347|NCT03823404|64328788|FG002|Overall Study|Withdrawal by Subject|35|||
23158348|NCT03823404|64328786|FG000|Overall Study|Death|4|||
23158349|NCT03823404|64328787|FG001|Overall Study|Death|0|||
23443802|NCT01946152|65366511|FG003|Overall Study|Second malignancy|0|||
23443803|NCT01946152|65366508|FG000|Overall Study|Adverse Event|0|||
23443804|NCT01946152|65366509|FG001|Overall Study|Adverse Event|0|||
23443805|NCT01946152|65366510|FG002|Overall Study|Adverse Event|0|||
23443806|NCT01946152|65366511|FG003|Overall Study|Adverse Event|1|||
23443807|NCT01970306|65366516|FG000|Overall Study|Not eligible|3|||
23443808|NCT01970306|65366516|FG000|Overall Study|Not able to be treated|9|||
23443809|NCT00566852|65366521|FG000|Overall Study|Protocol Violation|22|||
23443810|NCT00566852|65366522|FG001|Overall Study|Protocol Violation|24|||
23443811|NCT00566852|65366521|FG000|Overall Study|Death|95|||
23443812|NCT00566852|65366522|FG001|Overall Study|Death|78|||
23443813|NCT00566852|65366521|FG000|Overall Study|Withdrawal by Subject|30|||
23443814|NCT00566852|65366522|FG001|Overall Study|Withdrawal by Subject|25|||
23443815|NCT00566852|65366521|FG000|Overall Study|Patient refusal|37|||
23443816|NCT00566852|65366522|FG001|Overall Study|Patient refusal|37|||
23443817|NCT00566852|65366521|FG000|Overall Study|Not tested due to disability|6|||
23443818|NCT00566852|65366522|FG001|Overall Study|Not tested due to disability|12|||
23443819|NCT00566852|65366521|FG000|Overall Study|Missing reason not specified|1|||
23443820|NCT00566852|65366522|FG001|Overall Study|Missing reason not specified|2|||
23443821|NCT00566852|65366521|FG000|Overall Study|Missing reason not reported|16|||
23443822|NCT00566852|65366522|FG001|Overall Study|Missing reason not reported|20|||
23443823|NCT00279916|65366528|FG000|Overall Study|Withdrawal by Subject|4|||
23443824|NCT00279916|65366529|FG001|Overall Study|Withdrawal by Subject|3|||
23443825|NCT00279916|65366528|FG000|Overall Study|Lost to Follow-up|3|||
23443826|NCT00279916|65366529|FG001|Overall Study|Lost to Follow-up|2|||
23443827|NCT01279616|65366533|FG000|Overall Study|donor could not be located|5|||
23443828|NCT01279616|65366533|FG000|Overall Study|no signs of sickle cell disease|2|||
23443829|NCT00596830|65366534|FG000|Overall Study|Death|258|||
23443830|NCT00596830|65366535|FG001|Overall Study|Death|247|||
23443831|NCT00596830|65366534|FG000|Overall Study|Lost to Follow-up|7|||
23158350|NCT03823404|64328788|FG002|Overall Study|Death|0|||
23158351|NCT03823404|64328786|FG000|Overall Study|Other: Various reasons provided|5|||
23443832|NCT00596830|65366535|FG001|Overall Study|Lost to Follow-up|11|||
23443833|NCT00596830|65366534|FG000|Overall Study|Withdrawal by Subject|22|||
23443834|NCT00596830|65366535|FG001|Overall Study|Withdrawal by Subject|12|||
23443835|NCT00596830|65366534|FG000|Overall Study|Study terminated by sponsor|51|||
23443836|NCT00596830|65366535|FG001|Overall Study|Study terminated by sponsor|62|||
23443837|NCT00596830|65366534|FG000|Overall Study|Follow-up was discontinued|1|||
23443838|NCT00596830|65366535|FG001|Overall Study|Follow-up was discontinued|0|||
23443839|NCT00596830|65366534|FG000|Overall Study|Randomized but not treated|3|||
23443840|NCT00596830|65366535|FG001|Overall Study|Randomized but not treated|7|||
23443841|NCT02292446|65366536|FG000|Overall Study|Adverse Event|12|||
23158352|NCT03823404|64328787|FG001|Overall Study|Other: Various reasons provided|5|||
23443842|NCT02292446|65366536|FG000|Overall Study|Death|1|||
23443843|NCT02292446|65366536|FG000|Overall Study|Disease progression|2|||
23158353|NCT03823404|64328788|FG002|Overall Study|Other: Various reasons provided|6|||
23158354|NCT00243386|64328789|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
23158355|NCT00243386|64328790|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
23443844|NCT02292446|65366536|FG000|Overall Study|Subject/guardian decision|2|||
23443845|NCT02292446|65366536|FG000|Overall Study|Withdrawal by Subject|3|||
23158356|NCT00243386|64328791|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
23158357|NCT00243386|64328789|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
23443846|NCT01835158|65366540|FG000|Overall Study|Withdrawal by Subject|1|||
23443847|NCT01835158|65366541|FG001|Overall Study|Withdrawal by Subject|6|||
23443848|NCT01286740|65366544|FG000|Overall Study|Enrolled but not treated|1|||
23443849|NCT01286740|65366544|FG000|Overall Study|Protocol Violation|1|||
23443850|NCT01587040|65366545|FG000|Overall Study|Protocol Violation|0|||
23443851|NCT01587040|65366546|FG001|Overall Study|Protocol Violation|0|||
23222186|NCT02705755|64557588|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
23222187|NCT02910089|64557589|FG000|Overall Study|Lost insurance eligibility|22|||
23222188|NCT02910089|64557590|FG001|Overall Study|Lost insurance eligibility|16|||
23222189|NCT00320190|64557591|FG000|First 12 Months|Completed but did not enter extension|5|||
23222190|NCT00320190|64557592|FG001|First 12 Months|Completed but did not enter extension|3|||
23222191|NCT00320190|64557591|FG000|First 12 Months|Sponsor terminated study|2|||
23222192|NCT00320190|64557592|FG001|First 12 Months|Sponsor terminated study|2|||
23222193|NCT00320190|64557591|FG000|First 12 Months|Lost to Follow-up|0|||
23222194|NCT00320190|64557592|FG001|First 12 Months|Lost to Follow-up|1|||
23222195|NCT00320190|64557591|FG000|First 12 Months|Enrollment failure|0|||
23222196|NCT00320190|64557592|FG001|First 12 Months|Enrollment failure|1|||
23222197|NCT00320190|64557591|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
23222198|NCT00320190|64557592|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
23222199|NCT00320190|64557591|FG000|First 12 Months|Investigator request|0|||
23222200|NCT00320190|64557592|FG001|First 12 Months|Investigator request|1|||
23222201|NCT00320190|64557591|FG000|First 12 Months|Study drug toxicity|0|||
23222202|NCT00320190|64557592|FG001|First 12 Months|Study drug toxicity|1|||
23222203|NCT00320190|64557591|FG000|First 12 Months|Withdrawal by Subject|0|||
23222204|NCT00320190|64557592|FG001|First 12 Months|Withdrawal by Subject|1|||
23222205|NCT00320190|64557591|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
23222206|NCT00320190|64557592|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
23222207|NCT00320190|64557591|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
23222208|NCT00320190|64557592|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
23222209|NCT00320190|64557591|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
23222210|NCT00320190|64557592|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
23222211|NCT00126672|64557593|FG000|Overall Study|Adverse Event|4|||
23222212|NCT00126672|64557593|FG000|Overall Study|Lost to Follow-up|4|||
23222213|NCT00415623|64557597|FG000|Overall Study|Adverse Event|3|||
23222214|NCT00415623|64557598|FG001|Overall Study|Adverse Event|4|||
23222215|NCT00415623|64557597|FG000|Overall Study|Death|1|||
23222216|NCT00415623|64557598|FG001|Overall Study|Death|0|||
23222217|NCT00415623|64557597|FG000|Overall Study|Withdrawal by Subject|1|||
23222218|NCT00415623|64557598|FG001|Overall Study|Withdrawal by Subject|1|||
23222219|NCT00638690|64557602|FG000|Overall Study|Death|655|||
23222220|NCT00638690|64557603|FG001|Overall Study|Death|335|||
23222221|NCT00638690|64557602|FG000|Overall Study|Withdrawal by Subject|22|||
23222222|NCT00638690|64557603|FG001|Overall Study|Withdrawal by Subject|5|||
23222223|NCT00638690|64557602|FG000|Overall Study|Lost to Follow-up|4|||
23222224|NCT00638690|64557603|FG001|Overall Study|Lost to Follow-up|2|||
23222225|NCT00636155|64557604|FG000|Overall Study|Adverse Event|8|||
23222226|NCT00636155|64557604|FG000|Overall Study|Lack of Efficacy|1|||
23222227|NCT00636155|64557604|FG000|Overall Study|Withdrawal by Subject|3|||
23222228|NCT00636155|64557604|FG000|Overall Study|Stem cell transplant|1|||
23222229|NCT00636155|64557604|FG000|Overall Study|Physician Decision|5|||
23222230|NCT02762708|64557606|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
23222231|NCT02762708|64557607|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
23222232|NCT02762708|64557608|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
23222233|NCT02762708|64557609|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
23222234|NCT00959699|64557616|FG000|Treatment Period|Adverse Event|3|||
23443852|NCT01587040|65366547|FG002|Overall Study|Protocol Violation|1|||
23443853|NCT01587040|65366548|FG003|Overall Study|Protocol Violation|0|||
23443854|NCT01587040|65366545|FG000|Overall Study|Adverse Event|0|||
23443855|NCT01587040|65366546|FG001|Overall Study|Adverse Event|1|||
23566910|NCT00152971|65803933|FG001|Treatment|Adverse Event|40|||
23566911|NCT00152971|65803934|FG002|Treatment|Adverse Event|54|||
23566912|NCT00152971|65803932|FG000|Treatment|Protocol Violation|8|||
23566913|NCT00152971|65803933|FG001|Treatment|Protocol Violation|6|||
23566914|NCT00152971|65803934|FG002|Treatment|Protocol Violation|10|||
23566915|NCT00152971|65803932|FG000|Treatment|Lost to Follow-up|1|||
23566916|NCT00152971|65803933|FG001|Treatment|Lost to Follow-up|2|||
23566917|NCT00152971|65803934|FG002|Treatment|Lost to Follow-up|1|||
23566918|NCT00152971|65803932|FG000|Treatment|Withdrawal by Subject|4|||
23566919|NCT00152971|65803933|FG001|Treatment|Withdrawal by Subject|4|||
23566920|NCT00152971|65803934|FG002|Treatment|Withdrawal by Subject|5|||
23566921|NCT00152971|65803932|FG000|Treatment|Other|9|||
23222235|NCT00959699|64557617|FG001|Treatment Period|Adverse Event|13|||
23222236|NCT00959699|64557616|FG000|Treatment Period|Lack of Efficacy|15|||
23222237|NCT00959699|64557617|FG001|Treatment Period|Lack of Efficacy|6|||
23566922|NCT00152971|65803933|FG001|Treatment|Other|11|||
23566923|NCT00152971|65803934|FG002|Treatment|Other|10|||
23566924|NCT00674323|65803935|FG000|Overall Study|Adverse Event|0|||
23222238|NCT00959699|64557616|FG000|Treatment Period|Lost to Follow-up|0|||
23222239|NCT00959699|64557617|FG001|Treatment Period|Lost to Follow-up|1|||
23222240|NCT00959699|64557616|FG000|Treatment Period|Withdrawal by Subject|1|||
23222241|NCT00959699|64557617|FG001|Treatment Period|Withdrawal by Subject|3|||
23222242|NCT00959699|64557616|FG000|Treatment Period|Non-Compliance with Protocol|0|||
23222243|NCT00959699|64557617|FG001|Treatment Period|Non-Compliance with Protocol|1|||
23222244|NCT00959699|64557616|FG000|Treatment Period|Did not receive treatment|0|||
23222245|NCT00959699|64557617|FG001|Treatment Period|Did not receive treatment|1|||
23222246|NCT00959699|64557616|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
23222247|NCT00959699|64557617|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
23328364|NCT02714218|64945444|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23328365|NCT02714218|64945445|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23328366|NCT02714218|64945443|FG000|Pre-Treatment Period|Other reasons|0|||
23328367|NCT02714218|64945444|FG001|Pre-Treatment Period|Other reasons|1|||
23328368|NCT02714218|64945445|FG002|Pre-Treatment Period|Other reasons|0|||
23328369|NCT02714218|64945443|FG000|Treatment Period|Disease Progression|55|||
23328370|NCT02714218|64945444|FG001|Treatment Period|Disease Progression|52|||
23328371|NCT02714218|64945445|FG002|Treatment Period|Disease Progression|14|||
23328372|NCT02714218|64945443|FG000|Treatment Period|Study drug toxicity|46|||
23328373|NCT02714218|64945444|FG001|Treatment Period|Study drug toxicity|70|||
23328374|NCT02714218|64945445|FG002|Treatment Period|Study drug toxicity|6|||
23328375|NCT02714218|64945443|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
23328376|NCT02714218|64945444|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
23328377|NCT02714218|64945445|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
23328378|NCT02714218|64945443|FG000|Treatment Period|Request to discontinue treatment|1|||
23328379|NCT02714218|64945444|FG001|Treatment Period|Request to discontinue treatment|4|||
23328380|NCT02714218|64945445|FG002|Treatment Period|Request to discontinue treatment|1|||
23328381|NCT02714218|64945443|FG000|Treatment Period|Participant withdrew consent|2|||
23328382|NCT02714218|64945444|FG001|Treatment Period|Participant withdrew consent|2|||
23328383|NCT02714218|64945445|FG002|Treatment Period|Participant withdrew consent|0|||
23328384|NCT02714218|64945443|FG000|Treatment Period|Maximum clinical benefit|4|||
23328385|NCT02714218|64945444|FG001|Treatment Period|Maximum clinical benefit|2|||
23328386|NCT02714218|64945445|FG002|Treatment Period|Maximum clinical benefit|0|||
23328387|NCT02714218|64945443|FG000|Treatment Period|Administrative reason by sponsor|2|||
23328388|NCT02714218|64945444|FG001|Treatment Period|Administrative reason by sponsor|1|||
23328389|NCT02714218|64945445|FG002|Treatment Period|Administrative reason by sponsor|0|||
23328390|NCT02714218|64945443|FG000|Treatment Period|Other reasons|6|||
23328391|NCT02714218|64945444|FG001|Treatment Period|Other reasons|6|||
23328392|NCT02714218|64945445|FG002|Treatment Period|Other reasons|0|||
23328393|NCT02714218|64945443|FG000|Treatment Period|Completed treatment as per protocol|36|||
23328394|NCT02714218|64945444|FG001|Treatment Period|Completed treatment as per protocol|27|||
23328395|NCT02714218|64945445|FG002|Treatment Period|Completed treatment as per protocol|3|||
23328396|NCT02714218|64945443|FG000|Treatment Period|Not reported|9|||
23328397|NCT02714218|64945444|FG001|Treatment Period|Not reported|6|||
23328398|NCT02714218|64945445|FG002|Treatment Period|Not reported|0|||
23328399|NCT00678210|64945446|FG000|Overall Study|Adverse Event|1|||
23328400|NCT00678210|64945447|FG001|Overall Study|Adverse Event|2|||
23328401|NCT00678210|64945448|FG002|Overall Study|Adverse Event|3|||
23443856|NCT01587040|65366547|FG002|Overall Study|Adverse Event|10|||
23443857|NCT01587040|65366548|FG003|Overall Study|Adverse Event|0|||
23443858|NCT01587040|65366545|FG000|Overall Study|Disease progression|12|||
23443859|NCT01587040|65366546|FG001|Overall Study|Disease progression|1|||
23158358|NCT00243386|64328790|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
23158359|NCT00243386|64328791|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
23158360|NCT00243386|64328789|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
23158361|NCT00243386|64328790|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
23158362|NCT00243386|64328791|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
23158363|NCT00243386|64328789|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
23158364|NCT00243386|64328790|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
23158365|NCT00243386|64328791|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
23158366|NCT00243386|64328789|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
23158367|NCT00243386|64328790|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
23158368|NCT00243386|64328791|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
23222248|NCT00959699|64557616|FG000|Follow-up Period|Lost to Follow-up|3|||
23222249|NCT00959699|64557617|FG001|Follow-up Period|Lost to Follow-up|2|||
23222250|NCT00959699|64557616|FG000|Follow-up Period|Withdrawal by Subject|3|||
23222251|NCT00959699|64557617|FG001|Follow-up Period|Withdrawal by Subject|4|||
23328402|NCT00678210|64945449|FG003|Overall Study|Adverse Event|3|||
23328403|NCT00678210|64945446|FG000|Overall Study|Lack of Efficacy|2|||
23328404|NCT00678210|64945447|FG001|Overall Study|Lack of Efficacy|3|||
23328405|NCT00678210|64945448|FG002|Overall Study|Lack of Efficacy|1|||
23328406|NCT00678210|64945449|FG003|Overall Study|Lack of Efficacy|9|||
23222252|NCT05116683|64557620|FG000|Overall Study|Physician Decision|4|||
23443860|NCT01587040|65366547|FG002|Overall Study|Disease progression|15|||
23443861|NCT01587040|65366548|FG003|Overall Study|Disease progression|3|||
23566925|NCT00674323|65803936|FG001|Overall Study|Adverse Event|1|||
23566926|NCT00674323|65803937|FG002|Overall Study|Adverse Event|0|||
23566927|NCT00674323|65803935|FG000|Overall Study|Protocol Violation|1|||
23566928|NCT00674323|65803936|FG001|Overall Study|Protocol Violation|0|||
23222253|NCT02332798|64557632|FG000|Overall Study|Unwilling to Participate in Study|0|||
23222254|NCT02332798|64557633|FG001|Overall Study|Unwilling to Participate in Study|1|||
23222255|NCT02332798|64557634|FG002|Overall Study|Unwilling to Participate in Study|1|||
23222256|NCT02332798|64557632|FG000|Overall Study|Positive Urine Drug Test|0|||
23222257|NCT02332798|64557633|FG001|Overall Study|Positive Urine Drug Test|1|||
23222258|NCT02332798|64557634|FG002|Overall Study|Positive Urine Drug Test|0|||
23222259|NCT02332798|64557632|FG000|Overall Study|Abnormal Laboratory Findings|1|||
23222260|NCT02332798|64557633|FG001|Overall Study|Abnormal Laboratory Findings|0|||
23222261|NCT02332798|64557634|FG002|Overall Study|Abnormal Laboratory Findings|0|||
23222262|NCT02975349|64557635|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23222263|NCT02975349|64557636|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23222264|NCT02975349|64557637|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
23222265|NCT02975349|64557638|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
23222266|NCT02975349|64557639|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23222267|NCT02975349|64557640|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23222268|NCT02975349|64557635|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23222269|NCT02975349|64557636|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23222270|NCT02975349|64557637|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23222271|NCT02975349|64557638|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23222272|NCT02975349|64557639|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23222273|NCT02975349|64557640|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23222274|NCT02975349|64557635|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
23222275|NCT02975349|64557636|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
23222276|NCT02975349|64557637|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
23222277|NCT02975349|64557638|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
23222278|NCT02975349|64557639|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
23222279|NCT02975349|64557640|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
23222280|NCT02975349|64557635|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
23222281|NCT02975349|64557636|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
23222282|NCT02975349|64557637|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
23222283|NCT02975349|64557638|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
23222284|NCT02975349|64557639|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
23222285|NCT02975349|64557640|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
23222286|NCT02975349|64557635|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
23222287|NCT02975349|64557636|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
23222288|NCT02975349|64557637|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
23222289|NCT02975349|64557638|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
23222290|NCT02975349|64557639|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
23222291|NCT02975349|64557640|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
23222292|NCT02975349|64557635|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
23222293|NCT02975349|64557636|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
23566929|NCT00674323|65803937|FG002|Overall Study|Protocol Violation|0|||
23566930|NCT01932294|65803939|FG000|Overall Study|Death|43|||
23566931|NCT01932294|65803939|FG000|Overall Study|Lost to Follow-up|8|||
23566932|NCT01932294|65803939|FG000|Overall Study|VAD Implantation|20|||
23566933|NCT01932294|65803939|FG000|Overall Study|Heart Transplantation|16|||
23566934|NCT01932294|65803939|FG000|Overall Study|Transferred to other hospitals|12|||
23566935|NCT04250337|65803942|FG000|Overall Study|Adverse Event|0|||
23566936|NCT04250337|65803943|FG001|Overall Study|Adverse Event|3|||
23566937|NCT04250337|65803942|FG000|Overall Study|Lack of Efficacy|1|||
23566938|NCT04250337|65803943|FG001|Overall Study|Lack of Efficacy|3|||
23566939|NCT04250337|65803942|FG000|Overall Study|Physician Decision|1|||
23566940|NCT04250337|65803943|FG001|Overall Study|Physician Decision|0|||
23566941|NCT04250337|65803942|FG000|Overall Study|Protocol Deviation|2|||
23566942|NCT04250337|65803943|FG001|Overall Study|Protocol Deviation|2|||
23566943|NCT04250337|65803942|FG000|Overall Study|Withdrawal by Subject|4|||
23222294|NCT02975349|64557637|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
23222295|NCT02975349|64557638|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
23222296|NCT02975349|64557639|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
23566944|NCT04250337|65803943|FG001|Overall Study|Withdrawal by Subject|3|||
23566945|NCT02254408|65803951|FG000|Overall Study|Randomized But Not Treated|1|||
23566946|NCT02254408|65803952|FG001|Overall Study|Randomized But Not Treated|3|||
23566947|NCT02254408|65803951|FG000|Overall Study|Adverse Event|1|||
23566948|NCT02254408|65803952|FG001|Overall Study|Adverse Event|0|||
23566949|NCT02254408|65803951|FG000|Overall Study|Death|2|||
23566950|NCT02254408|65803952|FG001|Overall Study|Death|3|||
23328407|NCT00678210|64945446|FG000|Overall Study|Lost to Follow-up|4|||
23328408|NCT00678210|64945447|FG001|Overall Study|Lost to Follow-up|2|||
23328409|NCT00678210|64945448|FG002|Overall Study|Lost to Follow-up|0|||
23328410|NCT00678210|64945449|FG003|Overall Study|Lost to Follow-up|1|||
23328411|NCT00678210|64945446|FG000|Overall Study|Withdrawal by Subject|3|||
23328412|NCT00678210|64945447|FG001|Overall Study|Withdrawal by Subject|4|||
23328413|NCT00678210|64945448|FG002|Overall Study|Withdrawal by Subject|1|||
23328414|NCT00678210|64945449|FG003|Overall Study|Withdrawal by Subject|7|||
23328415|NCT00678210|64945446|FG000|Overall Study|Other|1|||
23328416|NCT00678210|64945447|FG001|Overall Study|Other|0|||
23328417|NCT00678210|64945448|FG002|Overall Study|Other|1|||
23328418|NCT00678210|64945449|FG003|Overall Study|Other|0|||
23328419|NCT01252095|64945450|FG000|Overall Study|Disease progression|1|||
23328420|NCT01252095|64945451|FG001|Overall Study|Disease progression|0|||
23328421|NCT00982657|64945452|FG000|Overall Study|Death|1|||
23328422|NCT00982657|64945453|FG001|Overall Study|Death|0|||
23328423|NCT00982657|64945454|FG002|Overall Study|Death|1|||
23328424|NCT00982657|64945455|FG003|Overall Study|Death|1|||
23328425|NCT00982657|64945452|FG000|Overall Study|Withdrawal by Subject|0|||
23328426|NCT00982657|64945453|FG001|Overall Study|Withdrawal by Subject|0|||
23328427|NCT00982657|64945454|FG002|Overall Study|Withdrawal by Subject|1|||
23328428|NCT00982657|64945455|FG003|Overall Study|Withdrawal by Subject|3|||
23328429|NCT00982657|64945452|FG000|Overall Study|Other|0|||
23328430|NCT00982657|64945453|FG001|Overall Study|Other|0|||
23328431|NCT00982657|64945454|FG002|Overall Study|Other|0|||
23328432|NCT00982657|64945455|FG003|Overall Study|Other|4|||
23328433|NCT00982657|64945452|FG000|Overall Study|On going at date of cut-off|0|||
23328434|NCT00982657|64945453|FG001|Overall Study|On going at date of cut-off|0|||
23328435|NCT00982657|64945454|FG002|Overall Study|On going at date of cut-off|0|||
23328436|NCT00982657|64945455|FG003|Overall Study|On going at date of cut-off|1|||
23328437|NCT05271175|64945456|FG000|One Week Follow up|Lost to Follow-up|10|||
23328438|NCT05271175|64945457|FG001|One Week Follow up|Lost to Follow-up|7|||
23328439|NCT05271175|64945458|FG002|One Week Follow up|Lost to Follow-up|5|||
23328440|NCT05271175|64945456|FG000|One Month Follow up|Lost to Follow-up|12|||
23328441|NCT05271175|64945457|FG001|One Month Follow up|Lost to Follow-up|7|||
23328442|NCT05271175|64945458|FG002|One Month Follow up|Lost to Follow-up|9|||
23328443|NCT05271175|64945456|FG000|Six Months Follow up|Lost to Follow-up|8|||
23328444|NCT05271175|64945457|FG001|Six Months Follow up|Lost to Follow-up|2|||
23328445|NCT05271175|64945458|FG002|Six Months Follow up|Lost to Follow-up|2|||
23328446|NCT01205269|64945459|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23328447|NCT01205269|64945460|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23328448|NCT01205269|64945461|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23328449|NCT01205269|64945462|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
23566951|NCT02254408|65803951|FG000|Overall Study|Investigator's Discretion|0|||
23566952|NCT02254408|65803952|FG001|Overall Study|Investigator's Discretion|1|||
23158369|NCT00243386|64328789|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
23158370|NCT00243386|64328790|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
23158371|NCT00243386|64328791|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
23158372|NCT00243386|64328789|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
23158373|NCT00243386|64328790|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
23158374|NCT00243386|64328791|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
23158375|NCT00243386|64328789|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
23158376|NCT00243386|64328790|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
23158377|NCT00243386|64328791|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
23158378|NCT01205230|64328792|FG000|Overall Study|Adverse Event|4|||
23158379|NCT01205230|64328793|FG001|Overall Study|Adverse Event|0|||
23158380|NCT01205230|64328792|FG000|Overall Study|Physician Decision|1|||
23328450|NCT01205269|64945463|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23328451|NCT01205269|64945464|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
23328452|NCT01290068|64945466|FG000|Overall Study|Adverse Event|1|||
23328453|NCT01290068|64945467|FG001|Overall Study|Adverse Event|3|||
23328454|NCT01290068|64945466|FG000|Overall Study|Lost to Follow-up|3|||
23328455|NCT01290068|64945467|FG001|Overall Study|Lost to Follow-up|0|||
23328456|NCT01290068|64945466|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
23328457|NCT01290068|64945467|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
23328458|NCT01290068|64945466|FG000|Overall Study|Other|3|||
23328459|NCT01290068|64945467|FG001|Overall Study|Other|1|||
23328460|NCT03926117|64945469|FG000|Overall Study|Unclassified|1|||
23328461|NCT03926117|64945470|FG001|Overall Study|Unclassified|4|||
23328462|NCT03926117|64945471|FG002|Overall Study|Unclassified|1|||
23328463|NCT03926117|64945472|FG003|Overall Study|Unclassified|4|||
23328464|NCT03926117|64945469|FG000|Overall Study|Withdrawal by Subject|3|||
23566953|NCT02254408|65803951|FG000|Overall Study|Withdrawal by Subject|3|||
23566954|NCT02254408|65803952|FG001|Overall Study|Withdrawal by Subject|3|||
23566955|NCT02254408|65803951|FG000|Overall Study|Lost to Follow-up|1|||
23628573|NCT02706951|66028036|FG001|Period 1|Adverse Event|5|||
23628574|NCT02706951|66028037|FG002|Period 1|Adverse Event|3|||
23628575|NCT02706951|66028038|FG003|Period 1|Adverse Event|0|||
23628576|NCT02706951|66028039|FG004|Period 1|Adverse Event|0|||
23628577|NCT02706951|66028035|FG000|Period 1|Withdrawal by Subject|10|||
23628578|NCT02706951|66028036|FG001|Period 1|Withdrawal by Subject|6|||
23628579|NCT02706951|66028037|FG002|Period 1|Withdrawal by Subject|6|||
23628580|NCT02706951|66028038|FG003|Period 1|Withdrawal by Subject|0|||
23628581|NCT02706951|66028039|FG004|Period 1|Withdrawal by Subject|0|||
23328465|NCT03926117|64945470|FG001|Overall Study|Withdrawal by Subject|0|||
23328466|NCT03926117|64945471|FG002|Overall Study|Withdrawal by Subject|1|||
23328467|NCT03926117|64945472|FG003|Overall Study|Withdrawal by Subject|1|||
23628582|NCT02706951|66028035|FG000|Period 1|Lost to Follow-up|0|||
23222297|NCT02975349|64557640|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
23222298|NCT02975349|64557635|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23158381|NCT01205230|64328793|FG001|Overall Study|Physician Decision|0|||
23158382|NCT00282295|64328801|FG000|Overall Study|Adverse Event|0|||
23158383|NCT00282295|64328802|FG001|Overall Study|Adverse Event|1|||
23158384|NCT00282295|64328803|FG002|Overall Study|Adverse Event|0|||
23158385|NCT00282295|64328801|FG000|Overall Study|Serious Adverse Events|0|||
23158386|NCT00282295|64328802|FG001|Overall Study|Serious Adverse Events|0|||
23443862|NCT01587040|65366545|FG000|Overall Study|Other than specified|5|||
23443863|NCT01587040|65366546|FG001|Overall Study|Other than specified|1|||
23443864|NCT01587040|65366547|FG002|Overall Study|Other than specified|11|||
23158387|NCT00282295|64328803|FG002|Overall Study|Serious Adverse Events|1|||
23158388|NCT00282295|64328801|FG000|Overall Study|Protocol Violation|0|||
23158389|NCT00282295|64328802|FG001|Overall Study|Protocol Violation|2|||
23158390|NCT00282295|64328803|FG002|Overall Study|Protocol Violation|1|||
23158391|NCT00282295|64328801|FG000|Overall Study|Withdrawal by Subject|2|||
23158392|NCT00282295|64328802|FG001|Overall Study|Withdrawal by Subject|6|||
23222299|NCT02975349|64557636|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23222300|NCT02975349|64557637|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
23328468|NCT03926117|64945469|FG000|Overall Study|Lost to Follow-up|0|||
23328469|NCT03926117|64945470|FG001|Overall Study|Lost to Follow-up|2|||
23328470|NCT03926117|64945471|FG002|Overall Study|Lost to Follow-up|1|||
23328471|NCT03926117|64945472|FG003|Overall Study|Lost to Follow-up|0|||
23158393|NCT00282295|64328803|FG002|Overall Study|Withdrawal by Subject|4|||
23158394|NCT00282295|64328801|FG000|Overall Study|Lost to Follow-up|1|||
23158395|NCT00282295|64328802|FG001|Overall Study|Lost to Follow-up|7|||
23158396|NCT00282295|64328803|FG002|Overall Study|Lost to Follow-up|2|||
23158397|NCT00282295|64328801|FG000|Overall Study|Other|0|||
23158398|NCT00282295|64328802|FG001|Overall Study|Other|1|||
23158399|NCT00282295|64328803|FG002|Overall Study|Other|0|||
23158400|NCT00820950|64328804|FG000|Overall Study|Scheduling Conflict|0|||
23443865|NCT01587040|65366548|FG003|Overall Study|Other than specified|1|||
23443866|NCT01178099|65366549|FG000|Overall Study|Physician Decision|0|||
23443867|NCT01178099|65366550|FG001|Overall Study|Physician Decision|1|||
23328472|NCT03926117|64945469|FG000|Overall Study|Adverse Event|1|||
23628583|NCT02706951|66028036|FG001|Period 1|Lost to Follow-up|4|||
23628584|NCT02706951|66028037|FG002|Period 1|Lost to Follow-up|1|||
23628585|NCT02706951|66028038|FG003|Period 1|Lost to Follow-up|0|||
23628586|NCT02706951|66028039|FG004|Period 1|Lost to Follow-up|0|||
23158401|NCT00820950|64328805|FG001|Overall Study|Scheduling Conflict|0|||
23158402|NCT00820950|64328806|FG002|Overall Study|Scheduling Conflict|0|||
23158403|NCT00820950|64328807|FG003|Overall Study|Scheduling Conflict|0|||
23158404|NCT00820950|64328808|FG004|Overall Study|Scheduling Conflict|0|||
23328473|NCT03926117|64945470|FG001|Overall Study|Adverse Event|2|||
23328474|NCT03926117|64945471|FG002|Overall Study|Adverse Event|3|||
23328475|NCT03926117|64945472|FG003|Overall Study|Adverse Event|1|||
23328476|NCT03926117|64945469|FG000|Overall Study|Randomized but not treated|1|||
23443868|NCT01359943|65366551|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
23443869|NCT01359943|65366552|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
23443870|NCT01359943|65366553|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
23158405|NCT00820950|64328809|FG005|Overall Study|Scheduling Conflict|0|||
23443871|NCT01359943|65366551|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
23158406|NCT00820950|64328810|FG006|Overall Study|Scheduling Conflict|1|||
23158407|NCT00820950|64328811|FG007|Overall Study|Scheduling Conflict|1|||
23158408|NCT00820950|64328812|FG008|Overall Study|Scheduling Conflict|0|||
23158409|NCT00820950|64328813|FG009|Overall Study|Scheduling Conflict|0|||
23158410|NCT00820950|64328804|FG000|Overall Study|Protocol Violation|1|||
23158411|NCT00820950|64328805|FG001|Overall Study|Protocol Violation|1|||
23158412|NCT00820950|64328806|FG002|Overall Study|Protocol Violation|0|||
23222301|NCT02975349|64557638|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23328477|NCT03926117|64945470|FG001|Overall Study|Randomized but not treated|1|||
23328478|NCT03926117|64945471|FG002|Overall Study|Randomized but not treated|0|||
23628587|NCT02706951|66028035|FG000|Period 1|Other|2|||
23628588|NCT02706951|66028036|FG001|Period 1|Other|1|||
23158413|NCT00820950|64328807|FG003|Overall Study|Protocol Violation|0|||
23628589|NCT02706951|66028037|FG002|Period 1|Other|0|||
23566956|NCT02254408|65803952|FG001|Overall Study|Lost to Follow-up|0|||
23566957|NCT00936221|65803961|FG000|Overall Study|Withdrawal by Subject|1|||
23566958|NCT00936221|65803962|FG001|Overall Study|Withdrawal by Subject|1|||
23158414|NCT00820950|64328808|FG004|Overall Study|Protocol Violation|0|||
23158415|NCT00820950|64328809|FG005|Overall Study|Protocol Violation|0|||
23158416|NCT00820950|64328810|FG006|Overall Study|Protocol Violation|0|||
23158417|NCT00820950|64328811|FG007|Overall Study|Protocol Violation|0|||
23158418|NCT00820950|64328812|FG008|Overall Study|Protocol Violation|0|||
23158419|NCT00820950|64328813|FG009|Overall Study|Protocol Violation|0|||
23158420|NCT03349775|64328816|FG000|Overall Study|Side Effects|1|||
23158421|NCT03349775|64328817|FG001|Overall Study|Side Effects|2|||
23158422|NCT03349775|64328816|FG000|Overall Study|Withdrawal by Subject|1|||
23158423|NCT03349775|64328817|FG001|Overall Study|Withdrawal by Subject|1|||
23566959|NCT00171873|65803965|FG000|Overall Study|Withdrawal by Subject|4|||
23566960|NCT00171873|65803966|FG001|Overall Study|Withdrawal by Subject|2|||
23566961|NCT00171873|65803965|FG000|Overall Study|Adverse Event|5|||
23158424|NCT03349775|64328816|FG000|Overall Study|No primary outcome measurements|0|||
23158425|NCT03349775|64328817|FG001|Overall Study|No primary outcome measurements|1|||
23158426|NCT02536313|64328827|FG000|Overall Study|Lack of Efficacy|0|||
23158427|NCT02536313|64328828|FG001|Overall Study|Lack of Efficacy|1|||
23158428|NCT01380379|64328829|FG000|Overall Study|Pregnancy|1|||
23158429|NCT00827606|64328830|FG000|Overall Study|Protocol Violation|4|||
23158430|NCT00827606|64328831|FG001|Overall Study|Protocol Violation|3|||
23158431|NCT00827606|64328830|FG000|Overall Study|Lost to Follow-up|3|||
23566962|NCT00171873|65803966|FG001|Overall Study|Adverse Event|0|||
23158432|NCT00827606|64328831|FG001|Overall Study|Lost to Follow-up|1|||
23158433|NCT00827606|64328830|FG000|Overall Study|Withdrawal by Subject|7|||
23158434|NCT00827606|64328831|FG001|Overall Study|Withdrawal by Subject|6|||
23158435|NCT00827606|64328830|FG000|Overall Study|Pregnancy|0|||
23158436|NCT00827606|64328831|FG001|Overall Study|Pregnancy|1|||
23158437|NCT00827606|64328830|FG000|Overall Study|Other|5|||
23158438|NCT00827606|64328831|FG001|Overall Study|Other|13|||
23158439|NCT00827606|64328830|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
23158440|NCT00827606|64328831|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
23158441|NCT00827606|64328830|FG000|Overall Study|Adverse Event|4|||
23158442|NCT00827606|64328831|FG001|Overall Study|Adverse Event|2|||
23158443|NCT01505634|64331621|FG000|Overall Study|Withdrawal by Subject|2|||
23158444|NCT01505634|64331622|FG001|Overall Study|Withdrawal by Subject|5|||
23158445|NCT01505634|64331623|FG002|Overall Study|Withdrawal by Subject|1|||
23158446|NCT01505634|64331621|FG000|Overall Study|Physician Decision|1|||
23158447|NCT01505634|64331622|FG001|Overall Study|Physician Decision|1|||
23158448|NCT01505634|64331623|FG002|Overall Study|Physician Decision|0|||
23158449|NCT01505634|64331621|FG000|Overall Study|Adverse Event|1|||
23158450|NCT01505634|64331622|FG001|Overall Study|Adverse Event|0|||
23158451|NCT01505634|64331623|FG002|Overall Study|Adverse Event|0|||
23158452|NCT01505634|64331621|FG000|Overall Study|Insufficient supply of drug at site|1|||
23158453|NCT01505634|64331622|FG001|Overall Study|Insufficient supply of drug at site|0|||
23158454|NCT01505634|64331623|FG002|Overall Study|Insufficient supply of drug at site|0|||
23158455|NCT01505634|64331621|FG000|Overall Study|Protocol Violation|2|||
23158456|NCT01505634|64331622|FG001|Overall Study|Protocol Violation|0|||
23158457|NCT01505634|64331623|FG002|Overall Study|Protocol Violation|0|||
23158458|NCT01505634|64331621|FG000|Overall Study|Lost to Follow-up|1|||
23566963|NCT00171873|65803965|FG000|Overall Study|Switched to Octreotide|0|||
23566964|NCT00171873|65803966|FG001|Overall Study|Switched to Octreotide|1|||
23566965|NCT00119262|65803967|FG000|Overall Study|Lack of Efficacy|0|||
23566966|NCT00119262|65803968|FG001|Overall Study|Lack of Efficacy|3|||
23566967|NCT00119262|65803967|FG000|Overall Study|Withdrawal by Subject|12|||
23566968|NCT00119262|65803968|FG001|Overall Study|Withdrawal by Subject|11|||
23566969|NCT00119262|65803967|FG000|Overall Study|Adverse Event|33|||
23566970|NCT00119262|65803968|FG001|Overall Study|Adverse Event|35|||
23158459|NCT01505634|64331622|FG001|Overall Study|Lost to Follow-up|4|||
23158460|NCT01505634|64331623|FG002|Overall Study|Lost to Follow-up|4|||
23158461|NCT01505634|64331621|FG000|Overall Study|Death|1|||
23158462|NCT01505634|64331622|FG001|Overall Study|Death|0|||
23158463|NCT01505634|64331623|FG002|Overall Study|Death|0|||
23158464|NCT01505634|64331621|FG000|Overall Study|In a conflict zone|0|||
23158465|NCT01505634|64331622|FG001|Overall Study|In a conflict zone|0|||
23566971|NCT00119262|65803967|FG000|Overall Study|other disease|0|||
23566972|NCT00119262|65803968|FG001|Overall Study|other disease|2|||
23566973|NCT00119262|65803967|FG000|Overall Study|ineligble|1|||
23158466|NCT01505634|64331623|FG002|Overall Study|In a conflict zone|1|||
23158467|NCT03861936|64331628|FG000|Overall Study|Withdrawal by Subject|4|||
23158468|NCT03861936|64331629|FG001|Overall Study|Withdrawal by Subject|1|||
23158469|NCT03861936|64331630|FG002|Overall Study|Withdrawal by Subject|3|||
23158470|NCT03861936|64331628|FG000|Overall Study|Lost to Follow-up|5|||
23158471|NCT03861936|64331629|FG001|Overall Study|Lost to Follow-up|3|||
23158472|NCT03861936|64331630|FG002|Overall Study|Lost to Follow-up|3|||
23158473|NCT03861936|64331628|FG000|Overall Study|Physician Decision|0|||
23158474|NCT03861936|64331629|FG001|Overall Study|Physician Decision|1|||
23566974|NCT00119262|65803968|FG001|Overall Study|ineligble|2|||
23443872|NCT01359943|65366552|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
23443873|NCT01359943|65366553|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
23443874|NCT01359943|65366551|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
23443875|NCT01359943|65366552|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
23443876|NCT01359943|65366553|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
23443877|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
23443878|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
23443879|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
23443880|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
23443881|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
23443882|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
23443883|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
23443884|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
23443885|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
23443886|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
23443887|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
23443888|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
23443889|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
23443890|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
23443891|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
23443892|NCT01359943|65366551|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
23443893|NCT01359943|65366552|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
23443894|NCT01359943|65366553|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
23443895|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
23443896|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
23443897|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
23443898|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
23443899|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
23443900|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
23443901|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
23443902|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
23443903|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
23443904|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
23443905|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
23443906|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
23443907|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
23443908|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
23443909|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
23443910|NCT01359943|65366551|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
23443911|NCT01359943|65366552|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
23443912|NCT01359943|65366553|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
23443913|NCT02702180|65366554|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23443914|NCT02702180|65366555|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
23443915|NCT02702180|65366556|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23443916|NCT02702180|65366554|FG000|Double-blind Treatment Period|Adverse Event|0|||
23443917|NCT02702180|65366555|FG001|Double-blind Treatment Period|Adverse Event|0|||
23443918|NCT02702180|65366556|FG002|Double-blind Treatment Period|Adverse Event|1|||
23443919|NCT02702180|65366554|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23443920|NCT02702180|65366555|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
23443921|NCT02702180|65366556|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
23628590|NCT02706951|66028038|FG003|Period 1|Other|0|||
23628591|NCT02706951|66028039|FG004|Period 1|Other|0|||
23628592|NCT02706951|66028035|FG000|Period 2|Adverse Event|0|||
23628593|NCT02706951|66028036|FG001|Period 2|Adverse Event|0|||
23628594|NCT02706951|66028037|FG002|Period 2|Adverse Event|0|||
23628595|NCT02706951|66028038|FG003|Period 2|Adverse Event|25|||
23628596|NCT02706951|66028039|FG004|Period 2|Adverse Event|34|||
23628597|NCT02706951|66028035|FG000|Period 2|Withdrawal by Subject|0|||
23628598|NCT02706951|66028036|FG001|Period 2|Withdrawal by Subject|0|||
23628599|NCT02706951|66028037|FG002|Period 2|Withdrawal by Subject|0|||
23628600|NCT02706951|66028038|FG003|Period 2|Withdrawal by Subject|38|||
23443922|NCT02702180|65366554|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23443923|NCT02702180|65366555|FG001|Double-blind Treatment Period|Protocol Violation|0|||
23443924|NCT02702180|65366556|FG002|Double-blind Treatment Period|Protocol Violation|2|||
23628601|NCT02706951|66028039|FG004|Period 2|Withdrawal by Subject|44|||
23628602|NCT02706951|66028035|FG000|Period 2|Lost to Follow-up|0|||
23628603|NCT02706951|66028036|FG001|Period 2|Lost to Follow-up|0|||
23158475|NCT03861936|64331630|FG002|Overall Study|Physician Decision|0|||
23158476|NCT03861936|64331628|FG000|Overall Study|Protocol Deviation|0|||
23158477|NCT03861936|64331629|FG001|Overall Study|Protocol Deviation|0|||
23158478|NCT03861936|64331630|FG002|Overall Study|Protocol Deviation|1|||
23443925|NCT02702180|65366554|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
23443926|NCT02702180|65366555|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
23443927|NCT02702180|65366556|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
23443928|NCT02702180|65366554|FG000|Open-label Treatment Period|Withdrawn in error|0|||
23443929|NCT02702180|65366555|FG001|Open-label Treatment Period|Withdrawn in error|0|||
23443930|NCT02702180|65366556|FG002|Open-label Treatment Period|Withdrawn in error|1|||
23443931|NCT04327024|65366562|FG000|Overall Study|Death|1|||
23443932|NCT04327024|65366563|FG001|Overall Study|Death|2|||
23443933|NCT04327024|65366564|FG002|Overall Study|Death|1|||
23443934|NCT04327024|65366562|FG000|Overall Study|Non-compliance with study drug|0|||
23443935|NCT04327024|65366563|FG001|Overall Study|Non-compliance with study drug|1|||
23443936|NCT04327024|65366564|FG002|Overall Study|Non-compliance with study drug|0|||
23443937|NCT04327024|65366562|FG000|Overall Study|Withdrawal by Subject|1|||
23443938|NCT04327024|65366563|FG001|Overall Study|Withdrawal by Subject|1|||
23443939|NCT04327024|65366564|FG002|Overall Study|Withdrawal by Subject|2|||
23443940|NCT03437577|65366565|FG000|Pre-Randomization|Withdrawal by Subject|0|||
23443941|NCT03437577|65366566|FG001|Pre-Randomization|Withdrawal by Subject|0|||
23443942|NCT03437577|65366567|FG002|Pre-Randomization|Withdrawal by Subject|10|||
23443943|NCT03437577|65366565|FG000|Post-Randomization|Physician Decision|0|||
23443944|NCT03437577|65366566|FG001|Post-Randomization|Physician Decision|2|||
23443945|NCT03437577|65366567|FG002|Post-Randomization|Physician Decision|0|||
23443946|NCT01483183|65366568|FG000|Overall Study|Physician Decision|0|||
23443947|NCT01483183|65366569|FG001|Overall Study|Physician Decision|0|||
23443948|NCT01483183|65366570|FG002|Overall Study|Physician Decision|0|||
23443949|NCT01483183|65366571|FG003|Overall Study|Physician Decision|0|||
23443950|NCT01483183|65366572|FG004|Overall Study|Physician Decision|0|||
23443951|NCT01483183|65366573|FG005|Overall Study|Physician Decision|0|||
23443952|NCT01483183|65366574|FG006|Overall Study|Physician Decision|2|||
23443953|NCT01483183|65366575|FG007|Overall Study|Physician Decision|0|||
23443954|NCT01483183|65366576|FG008|Overall Study|Physician Decision|0|||
23443955|NCT01483183|65366577|FG009|Overall Study|Physician Decision|0|||
23443956|NCT01483183|65366568|FG000|Overall Study|Withdrawal by Subject|0|||
23443957|NCT01483183|65366569|FG001|Overall Study|Withdrawal by Subject|0|||
23443958|NCT01483183|65366570|FG002|Overall Study|Withdrawal by Subject|0|||
23443959|NCT01483183|65366571|FG003|Overall Study|Withdrawal by Subject|0|||
23443960|NCT01483183|65366572|FG004|Overall Study|Withdrawal by Subject|0|||
23443961|NCT01483183|65366573|FG005|Overall Study|Withdrawal by Subject|0|||
23443962|NCT01483183|65366574|FG006|Overall Study|Withdrawal by Subject|0|||
23443963|NCT01483183|65366575|FG007|Overall Study|Withdrawal by Subject|0|||
23443964|NCT01483183|65366576|FG008|Overall Study|Withdrawal by Subject|0|||
23443965|NCT01483183|65366577|FG009|Overall Study|Withdrawal by Subject|1|||
23443966|NCT00256724|65366578|FG000|Overall Study|Physician Decision|2|||
23443967|NCT00256724|65366579|FG001|Overall Study|Physician Decision|5|||
23443968|NCT00256724|65366578|FG000|Overall Study|Protocol Violation|3|||
23443969|NCT00256724|65366579|FG001|Overall Study|Protocol Violation|3|||
23443970|NCT01427933|65366580|FG000|Overall Study|Withdrawal by Subject|5|||
23443971|NCT01427933|65366581|FG001|Overall Study|Withdrawal by Subject|8|||
23443972|NCT01427933|65366580|FG000|Overall Study|Lost to Follow-up|1|||
23443973|NCT01427933|65366581|FG001|Overall Study|Lost to Follow-up|5|||
23443974|NCT01427933|65366580|FG000|Overall Study|Other|1|||
23443975|NCT01427933|65366581|FG001|Overall Study|Other|0|||
23443976|NCT01427933|65366580|FG000|Overall Study|Investigator's Decision|1|||
23443977|NCT01427933|65366581|FG001|Overall Study|Investigator's Decision|0|||
23443978|NCT02326597|65366582|FG000|Overall Study|Lost to Follow-up|42|||
23443979|NCT02326597|65366583|FG001|Overall Study|Lost to Follow-up|32|||
23443980|NCT00226811|65366584|FG000|Overall Study|Death|8|||
23443981|NCT00226811|65366584|FG000|Overall Study|Adverse Event|11|||
23443982|NCT00226811|65366584|FG000|Overall Study|Lack of Efficacy|55|||
23443983|NCT00226811|65366584|FG000|Overall Study|Withdrawal by Subject|2|||
23158479|NCT03861936|64331628|FG000|Overall Study|Reason not Specified|5|||
23158480|NCT03861936|64331629|FG001|Overall Study|Reason not Specified|5|||
23158481|NCT03861936|64331630|FG002|Overall Study|Reason not Specified|3|||
23443984|NCT03056339|65366585|FG000|Overall Study|Failed Requirements|0|||
23443985|NCT03056339|65366586|FG001|Overall Study|Failed Requirements|2|||
23443986|NCT03056339|65366587|FG002|Overall Study|Failed Requirements|7|||
23443987|NCT03056339|65366588|FG003|Overall Study|Failed Requirements|1|||
23443988|NCT02058563|65366591|FG000|Overall Study|Lost to Follow-up|26|||
23443989|NCT02058563|65366592|FG001|Overall Study|Lost to Follow-up|22|||
23443990|NCT02058563|65366591|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
23443991|NCT02058563|65366592|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
23443992|NCT02058563|65366591|FG000|Overall Study|Consent Withdrawal|1|||
23443993|NCT02058563|65366592|FG001|Overall Study|Consent Withdrawal|1|||
23158482|NCT00917150|64331631|FG000|Overall Study|Adverse Event|12|||
23158483|NCT00917150|64331632|FG001|Overall Study|Adverse Event|7|||
23443994|NCT02058563|65366591|FG000|Overall Study|Other (patient incarcerated)|0|||
23443995|NCT02058563|65366592|FG001|Overall Study|Other (patient incarcerated)|1|||
23443996|NCT02669212|65366597|FG000|Overall Study|Lost to Follow-up|1|||
23443997|NCT02669212|65366598|FG001|Overall Study|Lost to Follow-up|0|||
23443998|NCT02669212|65366597|FG000|Overall Study|Medical Condition|3|||
23443999|NCT02669212|65366598|FG001|Overall Study|Medical Condition|4|||
23444000|NCT02669212|65366597|FG000|Overall Study|Withdrawal by Subject|0|||
23444001|NCT02669212|65366598|FG001|Overall Study|Withdrawal by Subject|2|||
23444002|NCT02669212|65366597|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
23444003|NCT02669212|65366598|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
23444004|NCT03350815|65366599|FG000|Period 1|Adverse Event|10|||
23444005|NCT03350815|65366600|FG001|Period 1|Adverse Event|0|||
23444006|NCT03350815|65366601|FG002|Period 1|Adverse Event|0|||
23444007|NCT03350815|65366602|FG003|Period 1|Adverse Event|0|||
23444008|NCT03350815|65366599|FG000|Period 1|Technical problems|1|||
23444009|NCT03350815|65366600|FG001|Period 1|Technical problems|0|||
23444010|NCT03350815|65366601|FG002|Period 1|Technical problems|0|||
23444011|NCT03350815|65366602|FG003|Period 1|Technical problems|0|||
23444012|NCT03350815|65366599|FG000|Period 1|Lost to Follow-up|3|||
23444013|NCT03350815|65366600|FG001|Period 1|Lost to Follow-up|0|||
23444014|NCT03350815|65366601|FG002|Period 1|Lost to Follow-up|0|||
23444015|NCT03350815|65366602|FG003|Period 1|Lost to Follow-up|0|||
23444016|NCT03350815|65366599|FG000|Period 1|Physician Decision|1|||
23444017|NCT03350815|65366600|FG001|Period 1|Physician Decision|0|||
23444018|NCT03350815|65366601|FG002|Period 1|Physician Decision|0|||
23444019|NCT03350815|65366602|FG003|Period 1|Physician Decision|0|||
23444020|NCT03350815|65366599|FG000|Period 1|Withdrawal by Subject|8|||
23444021|NCT03350815|65366600|FG001|Period 1|Withdrawal by Subject|0|||
23444022|NCT03350815|65366601|FG002|Period 1|Withdrawal by Subject|0|||
23444023|NCT03350815|65366602|FG003|Period 1|Withdrawal by Subject|0|||
23444024|NCT03350815|65366599|FG000|Period 1|Lack of Efficacy|15|||
23444025|NCT03350815|65366600|FG001|Period 1|Lack of Efficacy|0|||
23444026|NCT03350815|65366601|FG002|Period 1|Lack of Efficacy|0|||
23444027|NCT03350815|65366602|FG003|Period 1|Lack of Efficacy|0|||
23444028|NCT03350815|65366599|FG000|Period 1|Non-compliance with study treatment|2|||
23444029|NCT03350815|65366600|FG001|Period 1|Non-compliance with study treatment|0|||
23444030|NCT03350815|65366601|FG002|Period 1|Non-compliance with study treatment|0|||
23444031|NCT03350815|65366602|FG003|Period 1|Non-compliance with study treatment|0|||
23444032|NCT03350815|65366599|FG000|Period 1|Protocol Violation|3|||
23444033|NCT03350815|65366600|FG001|Period 1|Protocol Violation|0|||
23444034|NCT03350815|65366601|FG002|Period 1|Protocol Violation|0|||
23444035|NCT03350815|65366602|FG003|Period 1|Protocol Violation|0|||
23444036|NCT03350815|65366599|FG000|Period 2|Adverse Event|0|||
23444037|NCT03350815|65366600|FG001|Period 2|Adverse Event|3|||
23444038|NCT03350815|65366601|FG002|Period 2|Adverse Event|5|||
23444039|NCT03350815|65366602|FG003|Period 2|Adverse Event|0|||
23444040|NCT03350815|65366599|FG000|Period 2|Technical problem|0|||
23444041|NCT03350815|65366600|FG001|Period 2|Technical problem|1|||
23444042|NCT03350815|65366601|FG002|Period 2|Technical problem|0|||
23444043|NCT03350815|65366602|FG003|Period 2|Technical problem|0|||
23444044|NCT03350815|65366599|FG000|Period 2|Lost to Follow-up|0|||
23444045|NCT03350815|65366600|FG001|Period 2|Lost to Follow-up|3|||
23444046|NCT03350815|65366601|FG002|Period 2|Lost to Follow-up|3|||
23444047|NCT03350815|65366602|FG003|Period 2|Lost to Follow-up|0|||
23444048|NCT03350815|65366599|FG000|Period 2|Physician Decision|0|||
23444049|NCT03350815|65366600|FG001|Period 2|Physician Decision|0|||
23444050|NCT03350815|65366601|FG002|Period 2|Physician Decision|1|||
23444051|NCT03350815|65366602|FG003|Period 2|Physician Decision|0|||
23444052|NCT03350815|65366599|FG000|Period 2|Withdrawal by Subject|0|||
23158484|NCT00917150|64331633|FG002|Overall Study|Adverse Event|12|||
23158485|NCT00917150|64331634|FG003|Overall Study|Adverse Event|11|||
23158486|NCT00917150|64331631|FG000|Overall Study|Death|1|||
23158487|NCT00917150|64331632|FG001|Overall Study|Death|4|||
23158488|NCT00917150|64331633|FG002|Overall Study|Death|3|||
23444053|NCT03350815|65366600|FG001|Period 2|Withdrawal by Subject|3|||
23444054|NCT03350815|65366601|FG002|Period 2|Withdrawal by Subject|4|||
23444055|NCT03350815|65366602|FG003|Period 2|Withdrawal by Subject|0|||
23158489|NCT00917150|64331634|FG003|Overall Study|Death|2|||
23444056|NCT03350815|65366599|FG000|Period 2|Lack of Efficacy|0|||
23444057|NCT03350815|65366600|FG001|Period 2|Lack of Efficacy|6|||
23444058|NCT03350815|65366601|FG002|Period 2|Lack of Efficacy|2|||
23444059|NCT03350815|65366602|FG003|Period 2|Lack of Efficacy|0|||
23444060|NCT03350815|65366599|FG000|Period 2|Protocol Violation|0|||
23444061|NCT03350815|65366600|FG001|Period 2|Protocol Violation|0|||
23444062|NCT03350815|65366601|FG002|Period 2|Protocol Violation|1|||
23444063|NCT03350815|65366602|FG003|Period 2|Protocol Violation|0|||
23444064|NCT03350815|65366599|FG000|Period 2|New therapy for study indication|0|||
23444065|NCT03350815|65366600|FG001|Period 2|New therapy for study indication|0|||
23444066|NCT03350815|65366601|FG002|Period 2|New therapy for study indication|1|||
23444067|NCT03350815|65366602|FG003|Period 2|New therapy for study indication|0|||
23444068|NCT02737475|65366605|FG000|Overall Study|Other reasons|0|||
23444069|NCT02737475|65366606|FG001|Overall Study|Other reasons|0|||
23158490|NCT00917150|64331631|FG000|Overall Study|Lost to Follow-up|1|||
23444070|NCT02737475|65366607|FG002|Overall Study|Other reasons|0|||
23444071|NCT02737475|65366608|FG003|Overall Study|Other reasons|0|||
23444072|NCT02737475|65366609|FG004|Overall Study|Other reasons|1|||
23444073|NCT02737475|65366610|FG005|Overall Study|Other reasons|1|||
23444074|NCT02737475|65366611|FG006|Overall Study|Other reasons|0|||
23444075|NCT02737475|65366612|FG007|Overall Study|Other reasons|0|||
23444076|NCT02737475|65366613|FG008|Overall Study|Other reasons|1|||
23444077|NCT02737475|65366614|FG009|Overall Study|Other reasons|0|||
23444078|NCT02737475|65366615|FG010|Overall Study|Other reasons|1|||
23444079|NCT02737475|65366616|FG011|Overall Study|Other reasons|0|||
23444080|NCT02737475|65366617|FG012|Overall Study|Other reasons|0|||
23444081|NCT02737475|65366618|FG013|Overall Study|Other reasons|0|||
23444082|NCT02737475|65366619|FG014|Overall Study|Other reasons|0|||
23444083|NCT02737475|65366620|FG015|Overall Study|Other reasons|0|||
23444084|NCT02737475|65366621|FG016|Overall Study|Other reasons|0|||
23444085|NCT02737475|65366622|FG017|Overall Study|Other reasons|0|||
23444086|NCT02737475|65366623|FG018|Overall Study|Other reasons|0|||
23444087|NCT02737475|65366624|FG019|Overall Study|Other reasons|0|||
23444088|NCT02737475|65366625|FG020|Overall Study|Other reasons|0|||
23444089|NCT02737475|65366626|FG021|Overall Study|Other reasons|1|||
23444090|NCT02737475|65366627|FG022|Overall Study|Other reasons|0|||
23444091|NCT02737475|65366628|FG023|Overall Study|Other reasons|1|||
23444092|NCT02737475|65366629|FG024|Overall Study|Other reasons|1|||
23444093|NCT02737475|65366630|FG025|Overall Study|Other reasons|1|||
23444094|NCT02737475|65366631|FG026|Overall Study|Other reasons|0|||
23444095|NCT02737475|65366605|FG000|Overall Study|Death|1|||
23444096|NCT02737475|65366606|FG001|Overall Study|Death|0|||
23444097|NCT02737475|65366607|FG002|Overall Study|Death|0|||
23444098|NCT02737475|65366608|FG003|Overall Study|Death|1|||
23444099|NCT02737475|65366609|FG004|Overall Study|Death|0|||
23444100|NCT02737475|65366610|FG005|Overall Study|Death|0|||
23444101|NCT02737475|65366611|FG006|Overall Study|Death|0|||
23444102|NCT02737475|65366612|FG007|Overall Study|Death|2|||
23444103|NCT02737475|65366613|FG008|Overall Study|Death|0|||
23444104|NCT02737475|65366614|FG009|Overall Study|Death|0|||
23444105|NCT02737475|65366615|FG010|Overall Study|Death|0|||
23444106|NCT02737475|65366616|FG011|Overall Study|Death|4|||
23444107|NCT02737475|65366617|FG012|Overall Study|Death|2|||
23444108|NCT02737475|65366618|FG013|Overall Study|Death|2|||
23444109|NCT02737475|65366619|FG014|Overall Study|Death|0|||
23444110|NCT02737475|65366620|FG015|Overall Study|Death|2|||
23444111|NCT02737475|65366621|FG016|Overall Study|Death|2|||
23444112|NCT02737475|65366622|FG017|Overall Study|Death|2|||
23444113|NCT02737475|65366623|FG018|Overall Study|Death|1|||
23444114|NCT02737475|65366624|FG019|Overall Study|Death|0|||
23158491|NCT00917150|64331632|FG001|Overall Study|Lost to Follow-up|0|||
23158492|NCT00917150|64331633|FG002|Overall Study|Lost to Follow-up|4|||
23158493|NCT00917150|64331634|FG003|Overall Study|Lost to Follow-up|2|||
23158494|NCT00917150|64331631|FG000|Overall Study|Physician Decision|0|||
23158495|NCT00917150|64331632|FG001|Overall Study|Physician Decision|2|||
23158496|NCT00917150|64331633|FG002|Overall Study|Physician Decision|0|||
23158497|NCT00917150|64331634|FG003|Overall Study|Physician Decision|1|||
23158498|NCT00917150|64331631|FG000|Overall Study|Protocol Violation|5|||
23158499|NCT00917150|64331632|FG001|Overall Study|Protocol Violation|5|||
23158500|NCT00917150|64331633|FG002|Overall Study|Protocol Violation|3|||
23158501|NCT00917150|64331634|FG003|Overall Study|Protocol Violation|5|||
23158502|NCT00917150|64331631|FG000|Overall Study|Withdrawal by Subject|15|||
23158503|NCT00917150|64331632|FG001|Overall Study|Withdrawal by Subject|16|||
23158504|NCT00917150|64331633|FG002|Overall Study|Withdrawal by Subject|18|||
23158505|NCT00917150|64331634|FG003|Overall Study|Withdrawal by Subject|11|||
23158506|NCT00917150|64331631|FG000|Overall Study|Other than specified|3|||
23158507|NCT00917150|64331632|FG001|Overall Study|Other than specified|3|||
23158508|NCT00917150|64331633|FG002|Overall Study|Other than specified|2|||
23158509|NCT00917150|64331634|FG003|Overall Study|Other than specified|2|||
23444115|NCT02737475|65366625|FG020|Overall Study|Death|0|||
23158510|NCT03215771|64331635|FG000|Overall Study|Withdrawal by Subject|2|||
23158511|NCT03215771|64331635|FG000|Overall Study|Physician Decision|1|||
23444116|NCT02737475|65366626|FG021|Overall Study|Death|0|||
23444117|NCT02737475|65366627|FG022|Overall Study|Death|0|||
23444118|NCT02737475|65366628|FG023|Overall Study|Death|0|||
23158512|NCT02953340|64331638|FG000|Overall Study|Death|0|||
23158513|NCT02953340|64331639|FG001|Overall Study|Death|1|||
23158514|NCT02953340|64331638|FG000|Overall Study|Investigator Decision|3|||
23444119|NCT02737475|65366629|FG024|Overall Study|Death|0|||
23444120|NCT02737475|65366630|FG025|Overall Study|Death|0|||
23444121|NCT02737475|65366631|FG026|Overall Study|Death|0|||
23158515|NCT02953340|64331639|FG001|Overall Study|Investigator Decision|3|||
23444122|NCT02737475|65366605|FG000|Overall Study|Participant withdrew consent|0|||
23444123|NCT02737475|65366606|FG001|Overall Study|Participant withdrew consent|0|||
23444124|NCT02737475|65366607|FG002|Overall Study|Participant withdrew consent|0|||
23444125|NCT02737475|65366608|FG003|Overall Study|Participant withdrew consent|0|||
23444126|NCT02737475|65366609|FG004|Overall Study|Participant withdrew consent|0|||
23444127|NCT02737475|65366610|FG005|Overall Study|Participant withdrew consent|2|||
23444128|NCT02737475|65366611|FG006|Overall Study|Participant withdrew consent|0|||
23444129|NCT02737475|65366612|FG007|Overall Study|Participant withdrew consent|0|||
23444130|NCT02737475|65366613|FG008|Overall Study|Participant withdrew consent|0|||
23444131|NCT02737475|65366614|FG009|Overall Study|Participant withdrew consent|0|||
23444132|NCT02737475|65366615|FG010|Overall Study|Participant withdrew consent|0|||
23444133|NCT02737475|65366616|FG011|Overall Study|Participant withdrew consent|0|||
23444134|NCT02737475|65366617|FG012|Overall Study|Participant withdrew consent|0|||
23444135|NCT02737475|65366618|FG013|Overall Study|Participant withdrew consent|0|||
23444136|NCT02737475|65366619|FG014|Overall Study|Participant withdrew consent|1|||
23444137|NCT02737475|65366620|FG015|Overall Study|Participant withdrew consent|0|||
23444138|NCT02737475|65366621|FG016|Overall Study|Participant withdrew consent|0|||
23444139|NCT02737475|65366622|FG017|Overall Study|Participant withdrew consent|2|||
23444140|NCT02737475|65366623|FG018|Overall Study|Participant withdrew consent|1|||
23444141|NCT02737475|65366624|FG019|Overall Study|Participant withdrew consent|0|||
23158516|NCT02953340|64331638|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
23158517|NCT02953340|64331639|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
23158518|NCT02953340|64331638|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
23444142|NCT02737475|65366625|FG020|Overall Study|Participant withdrew consent|2|||
23444143|NCT02737475|65366626|FG021|Overall Study|Participant withdrew consent|0|||
23444144|NCT02737475|65366627|FG022|Overall Study|Participant withdrew consent|0|||
23444145|NCT02737475|65366628|FG023|Overall Study|Participant withdrew consent|0|||
23158519|NCT02953340|64331639|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
23158520|NCT02953340|64331638|FG000|Overall Study|Withdrawal by Subject|9|||
23158521|NCT02953340|64331639|FG001|Overall Study|Withdrawal by Subject|9|||
23158522|NCT02953340|64331638|FG000|Overall Study|Sponsor decision|0|||
23158523|NCT02953340|64331639|FG001|Overall Study|Sponsor decision|2|||
23158524|NCT02953340|64331638|FG000|Overall Study|Lost to Follow-up|3|||
23158525|NCT02953340|64331639|FG001|Overall Study|Lost to Follow-up|2|||
23158526|NCT02953340|64331638|FG000|Overall Study|Reason not specified|2|||
23158527|NCT02953340|64331639|FG001|Overall Study|Reason not specified|2|||
23158528|NCT01543152|64331640|FG000|Overall Study|Withdrawal by Subject|0|||
23444146|NCT02737475|65366629|FG024|Overall Study|Participant withdrew consent|0|||
23444147|NCT02737475|65366630|FG025|Overall Study|Participant withdrew consent|0|||
23444148|NCT02737475|65366631|FG026|Overall Study|Participant withdrew consent|0|||
23444149|NCT02737475|65366605|FG000|Overall Study|Lost to Follow-up|0|||
23444150|NCT02737475|65366606|FG001|Overall Study|Lost to Follow-up|0|||
23444151|NCT02737475|65366607|FG002|Overall Study|Lost to Follow-up|0|||
23444152|NCT02737475|65366608|FG003|Overall Study|Lost to Follow-up|0|||
23444153|NCT02737475|65366609|FG004|Overall Study|Lost to Follow-up|0|||
23444154|NCT02737475|65366610|FG005|Overall Study|Lost to Follow-up|0|||
23444155|NCT02737475|65366611|FG006|Overall Study|Lost to Follow-up|0|||
23444156|NCT02737475|65366612|FG007|Overall Study|Lost to Follow-up|0|||
23444157|NCT02737475|65366613|FG008|Overall Study|Lost to Follow-up|0|||
23158529|NCT01543152|64331641|FG001|Overall Study|Withdrawal by Subject|2|||
23158530|NCT01543152|64331642|FG002|Overall Study|Withdrawal by Subject|0|||
23158531|NCT01543152|64331643|FG003|Overall Study|Withdrawal by Subject|0|||
23158532|NCT01543152|64331644|FG004|Overall Study|Withdrawal by Subject|0|||
23158533|NCT02311153|64331645|FG000|Overall Study|Lost to Follow-up|5|||
23158534|NCT02311153|64331646|FG001|Overall Study|Lost to Follow-up|7|||
23158535|NCT04305275|64331657|FG000|Overall Study|Adverse Event|4|||
23158536|NCT04305275|64331658|FG001|Overall Study|Adverse Event|0|||
23158537|NCT04305275|64331657|FG000|Overall Study|Lost to Follow-up|1|||
23158538|NCT04305275|64331658|FG001|Overall Study|Lost to Follow-up|1|||
23444158|NCT02737475|65366614|FG009|Overall Study|Lost to Follow-up|0|||
23444159|NCT02737475|65366615|FG010|Overall Study|Lost to Follow-up|0|||
23158539|NCT04305275|64331657|FG000|Overall Study|Withdrawal by Participant|8|||
23444160|NCT02737475|65366616|FG011|Overall Study|Lost to Follow-up|0|||
23444161|NCT02737475|65366617|FG012|Overall Study|Lost to Follow-up|0|||
23444162|NCT02737475|65366618|FG013|Overall Study|Lost to Follow-up|0|||
23566975|NCT00119262|65803967|FG000|Overall Study|others|0|||
23566976|NCT00119262|65803968|FG001|Overall Study|others|5|||
23566977|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
23566978|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23566979|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23566980|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23158540|NCT04305275|64331658|FG001|Overall Study|Withdrawal by Participant|1|||
23444163|NCT02737475|65366619|FG014|Overall Study|Lost to Follow-up|0|||
23444164|NCT02737475|65366620|FG015|Overall Study|Lost to Follow-up|1|||
23158541|NCT00942175|64331661|FG000|Overall Study|Adverse Event|2|||
23444165|NCT02737475|65366621|FG016|Overall Study|Lost to Follow-up|0|||
23444166|NCT02737475|65366622|FG017|Overall Study|Lost to Follow-up|0|||
23158542|NCT00942175|64331662|FG001|Overall Study|Adverse Event|1|||
23444167|NCT02737475|65366623|FG018|Overall Study|Lost to Follow-up|0|||
23158543|NCT00942175|64331663|FG002|Overall Study|Adverse Event|0|||
23158544|NCT00942175|64331664|FG003|Overall Study|Adverse Event|0|||
23628604|NCT02706951|66028037|FG002|Period 2|Lost to Follow-up|0|||
23628605|NCT02706951|66028038|FG003|Period 2|Lost to Follow-up|17|||
23628606|NCT02706951|66028039|FG004|Period 2|Lost to Follow-up|9|||
23628607|NCT02706951|66028035|FG000|Period 2|COVID-19 Related|0|||
23628608|NCT02706951|66028036|FG001|Period 2|COVID-19 Related|0|||
23628609|NCT02706951|66028037|FG002|Period 2|COVID-19 Related|0|||
23628610|NCT02706951|66028038|FG003|Period 2|COVID-19 Related|1|||
23628611|NCT02706951|66028039|FG004|Period 2|COVID-19 Related|2|||
23628612|NCT02706951|66028035|FG000|Period 2|Other|0|||
23628613|NCT02706951|66028036|FG001|Period 2|Other|0|||
23628614|NCT02706951|66028037|FG002|Period 2|Other|0|||
23628615|NCT02706951|66028038|FG003|Period 2|Other|37|||
23628616|NCT02706951|66028039|FG004|Period 2|Other|31|||
23628617|NCT03432390|66028045|FG000|Apnea Period|Protocol Violation|2|||
23628618|NCT03432390|66028046|FG001|Apnea Period|Protocol Violation|2|||
23628619|NCT02498236|66028047|FG000|Overall Study|Did not show for testing|1|||
23628620|NCT02498236|66028048|FG001|Overall Study|Did not show for testing|0|||
23328479|NCT03926117|64945472|FG003|Overall Study|Randomized but not treated|1|||
23444168|NCT02737475|65366624|FG019|Overall Study|Lost to Follow-up|0|||
23444169|NCT02737475|65366625|FG020|Overall Study|Lost to Follow-up|0|||
23444170|NCT02737475|65366626|FG021|Overall Study|Lost to Follow-up|0|||
23444171|NCT02737475|65366627|FG022|Overall Study|Lost to Follow-up|0|||
23444172|NCT02737475|65366628|FG023|Overall Study|Lost to Follow-up|0|||
23444173|NCT02737475|65366629|FG024|Overall Study|Lost to Follow-up|0|||
23444174|NCT02737475|65366630|FG025|Overall Study|Lost to Follow-up|0|||
23444175|NCT02737475|65366631|FG026|Overall Study|Lost to Follow-up|0|||
23444176|NCT02737475|65366605|FG000|Overall Study|Disease Progression|0|||
23444177|NCT02737475|65366606|FG001|Overall Study|Disease Progression|0|||
23444178|NCT02737475|65366607|FG002|Overall Study|Disease Progression|0|||
23444179|NCT02737475|65366608|FG003|Overall Study|Disease Progression|0|||
23444180|NCT02737475|65366609|FG004|Overall Study|Disease Progression|0|||
23444181|NCT02737475|65366610|FG005|Overall Study|Disease Progression|0|||
23444182|NCT02737475|65366611|FG006|Overall Study|Disease Progression|0|||
23444183|NCT02737475|65366612|FG007|Overall Study|Disease Progression|0|||
23444184|NCT02737475|65366613|FG008|Overall Study|Disease Progression|0|||
23444185|NCT02737475|65366614|FG009|Overall Study|Disease Progression|0|||
23444186|NCT02737475|65366615|FG010|Overall Study|Disease Progression|0|||
23444187|NCT02737475|65366616|FG011|Overall Study|Disease Progression|0|||
23444188|NCT02737475|65366617|FG012|Overall Study|Disease Progression|0|||
23444189|NCT02737475|65366618|FG013|Overall Study|Disease Progression|0|||
23444190|NCT02737475|65366619|FG014|Overall Study|Disease Progression|0|||
23444191|NCT02737475|65366620|FG015|Overall Study|Disease Progression|0|||
23444192|NCT02737475|65366621|FG016|Overall Study|Disease Progression|0|||
23444193|NCT02737475|65366622|FG017|Overall Study|Disease Progression|0|||
23444194|NCT02737475|65366623|FG018|Overall Study|Disease Progression|0|||
23444195|NCT02737475|65366624|FG019|Overall Study|Disease Progression|0|||
23444196|NCT02737475|65366625|FG020|Overall Study|Disease Progression|0|||
23444197|NCT02737475|65366626|FG021|Overall Study|Disease Progression|0|||
23444198|NCT02737475|65366627|FG022|Overall Study|Disease Progression|0|||
23444199|NCT02737475|65366628|FG023|Overall Study|Disease Progression|0|||
23444200|NCT02737475|65366629|FG024|Overall Study|Disease Progression|0|||
23444201|NCT02737475|65366630|FG025|Overall Study|Disease Progression|0|||
23444202|NCT02737475|65366631|FG026|Overall Study|Disease Progression|1|||
23444203|NCT01450761|65366634|FG000|Randomization|Subject no longer meets study criteria|1|||
23444204|NCT01450761|65366635|FG001|Randomization|Subject no longer meets study criteria|2|||
23444205|NCT01450761|65366634|FG000|Randomization|Withdrawal by Subject|2|||
23444206|NCT01450761|65366635|FG001|Randomization|Withdrawal by Subject|0|||
23628621|NCT02498236|66028049|FG002|Overall Study|Did not show for testing|0|||
23628622|NCT02498236|66028050|FG003|Overall Study|Did not show for testing|0|||
23628623|NCT02498236|66028051|FG004|Overall Study|Did not show for testing|0|||
23628624|NCT02498236|66028052|FG005|Overall Study|Did not show for testing|0|||
23328480|NCT02220764|64945473|FG000|Overall Study|Lost to Follow-up|3|||
23222302|NCT02975349|64557639|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23222303|NCT02975349|64557640|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
23444207|NCT01450761|65366634|FG000|Randomization|Disease progression|0|||
23444208|NCT01450761|65366635|FG001|Randomization|Disease progression|2|||
23444209|NCT01450761|65366634|FG000|Randomization|Adverse Event unrelated to study drug|1|||
23444210|NCT01450761|65366635|FG001|Randomization|Adverse Event unrelated to study drug|0|||
23444211|NCT01450761|65366634|FG000|Randomization|Other|0|||
23444212|NCT01450761|65366635|FG001|Randomization|Other|1|||
23444213|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Disease progression|33|||
23444214|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Disease progression|32|||
23444215|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
23444216|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
23444217|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
23444218|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
23444219|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
23628625|NCT02498236|66028053|FG006|Overall Study|Did not show for testing|0|||
23628626|NCT02498236|66028054|FG007|Overall Study|Did not show for testing|1|||
23444220|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
23444221|NCT01450761|65366634|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
23444222|NCT01450761|65366635|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
23444223|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Death|3|||
23444224|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Death|3|||
23444225|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Other|2|||
23444226|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Other|2|||
23444227|NCT01450761|65366634|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
23444228|NCT01450761|65366635|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
23444229|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
23444230|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
23444231|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
23444232|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
23444233|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
23444234|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
23444235|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
23444236|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
23444237|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
23444238|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
23444239|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Death|5|||
23444240|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Death|6|||
23444241|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
23444242|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
23444243|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
23444244|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
23444245|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
23444246|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
23444247|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
23444248|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
23444249|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
23444250|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
23444251|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
23444252|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
23444253|NCT01450761|65366634|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
23444254|NCT01450761|65366635|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
23444255|NCT03831100|65366636|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
23444256|NCT03831100|65366637|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
23444257|NCT02097030|65366638|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
23444258|NCT02097030|65366639|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
23444259|NCT02097030|65366638|FG000|First Intervention (3 Days)|Visual Acuity|0|||
23444260|NCT02097030|65366639|FG001|First Intervention (3 Days)|Visual Acuity|1|||
23444261|NCT02586727|65366642|FG000|Overall Study|Lost to Follow-up|1|||
23444262|NCT02586727|65366643|FG001|Overall Study|Lost to Follow-up|0|||
23444263|NCT02652260|65366651|FG000|Overall Study|Pregnancy|0|||
23444264|NCT02652260|65366652|FG001|Overall Study|Pregnancy|1|||
23158545|NCT00942175|64331661|FG000|Overall Study|Protocol Violation|0|||
23158546|NCT00942175|64331662|FG001|Overall Study|Protocol Violation|1|||
23158547|NCT00942175|64331663|FG002|Overall Study|Protocol Violation|2|||
23158548|NCT00942175|64331664|FG003|Overall Study|Protocol Violation|0|||
23158549|NCT00942175|64331661|FG000|Overall Study|Pregnancy|0|||
23158550|NCT00942175|64331662|FG001|Overall Study|Pregnancy|0|||
23158551|NCT00942175|64331663|FG002|Overall Study|Pregnancy|0|||
23158552|NCT00942175|64331664|FG003|Overall Study|Pregnancy|1|||
23158553|NCT00942175|64331661|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
23158554|NCT00942175|64331662|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
23158555|NCT00942175|64331663|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
23158556|NCT00942175|64331664|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
23158557|NCT00942175|64331661|FG000|Overall Study|Low Platelet Count|0|||
23158558|NCT00942175|64331662|FG001|Overall Study|Low Platelet Count|2|||
23158559|NCT00942175|64331663|FG002|Overall Study|Low Platelet Count|0|||
23158560|NCT00942175|64331664|FG003|Overall Study|Low Platelet Count|0|||
23158561|NCT02700412|64331665|FG000|Overall Study|Adverse Event|6|||
23444265|NCT02652260|65366651|FG000|Overall Study|Withdrawal by Subject|0|||
23444266|NCT02652260|65366652|FG001|Overall Study|Withdrawal by Subject|1|||
23444267|NCT02255461|65366653|FG000|Overall Study|Adverse Event|0|||
23444268|NCT02255461|65366654|FG001|Overall Study|Adverse Event|1|||
23566981|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23158562|NCT02700412|64331665|FG000|Overall Study|Death|1|||
23158563|NCT02700412|64331665|FG000|Overall Study|Lack of Efficacy|19|||
23158564|NCT02700412|64331665|FG000|Overall Study|Protocol Violation|5|||
23444269|NCT02255461|65366655|FG002|Overall Study|Adverse Event|0|||
23444270|NCT02255461|65366656|FG003|Overall Study|Adverse Event|0|||
23444271|NCT02255461|65366657|FG004|Overall Study|Adverse Event|1|||
23444272|NCT02255461|65366653|FG000|Overall Study|Withdrawal by Subject|0|||
23444273|NCT02255461|65366654|FG001|Overall Study|Withdrawal by Subject|0|||
23444274|NCT02255461|65366655|FG002|Overall Study|Withdrawal by Subject|1|||
23444275|NCT02255461|65366656|FG003|Overall Study|Withdrawal by Subject|0|||
23444276|NCT02255461|65366657|FG004|Overall Study|Withdrawal by Subject|1|||
23444277|NCT02255461|65366653|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
23444278|NCT02255461|65366654|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
23444279|NCT02255461|65366655|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
23444280|NCT02255461|65366656|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
23444281|NCT02255461|65366657|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
23444282|NCT03282097|65366658|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
23444283|NCT03282097|65366659|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
23444284|NCT03282097|65366658|FG000|Intervention Visit Complete|Patient Death|13|||
23444285|NCT03282097|65366659|FG001|Intervention Visit Complete|Patient Death|15|||
23444286|NCT03282097|65366658|FG000|Intervention Visit Complete|Caregiver Death|0|||
23444287|NCT03282097|65366659|FG001|Intervention Visit Complete|Caregiver Death|3|||
23444288|NCT03282097|65366658|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
23444289|NCT03282097|65366659|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
23444290|NCT03282097|65366658|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
23444291|NCT03282097|65366659|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
23444292|NCT03282097|65366658|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
23444293|NCT03282097|65366659|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
23444294|NCT03282097|65366658|FG000|Primary Outcome Data Collection Complete|Missing|2|||
23444295|NCT03282097|65366659|FG001|Primary Outcome Data Collection Complete|Missing|3|||
23444296|NCT03282097|65366658|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
23444297|NCT03282097|65366659|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
23444298|NCT03282097|65366658|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
23444299|NCT03282097|65366659|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
23444300|NCT03282097|65366658|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
23444301|NCT03282097|65366659|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
23444302|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
23444303|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
23444304|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
23444305|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
23444306|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Death|2|||
23444307|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Death|2|||
23444308|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Death|0|||
23444309|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Death|0|||
23444310|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
23444311|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
23444312|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
23444313|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
23444314|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
23444315|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
23444316|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
23444317|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
23444318|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
23444319|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
23444320|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
23444321|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
23444322|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
23444323|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
23444324|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
23444325|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
23444326|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
23444327|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
23444328|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
23444329|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
23444330|NCT03068754|65366660|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
23444331|NCT03068754|65366661|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
23444332|NCT03068754|65366662|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
23444333|NCT03068754|65366663|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
23444334|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
23444335|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
23444336|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
23444337|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
23444338|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Death|0|||
23444339|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Death|0|||
23444340|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Death|0|||
23444341|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Death|1|||
23444342|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
23444343|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
23444344|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
23444345|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
23444346|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
23444347|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
23444348|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
23444349|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
23444350|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
23444351|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
23444352|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
23444353|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
23444354|NCT03068754|65366660|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
23444355|NCT03068754|65366661|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
23444356|NCT03068754|65366662|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
23444357|NCT03068754|65366663|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
23444358|NCT00767806|65366671|FG000|Overall Study|Adverse Event|30|||
23444359|NCT00767806|65366672|FG001|Overall Study|Adverse Event|11|||
23444360|NCT00767806|65366671|FG000|Overall Study|Withdrawal by Subject|8|||
23444361|NCT00767806|65366672|FG001|Overall Study|Withdrawal by Subject|13|||
23444362|NCT00767806|65366671|FG000|Overall Study|Protocol Violation|6|||
23444363|NCT00767806|65366672|FG001|Overall Study|Protocol Violation|5|||
23444364|NCT00767806|65366671|FG000|Overall Study|Lack of Efficacy|1|||
23444365|NCT00767806|65366672|FG001|Overall Study|Lack of Efficacy|9|||
23444366|NCT00767806|65366671|FG000|Overall Study|Physician Decision|4|||
23444367|NCT00767806|65366672|FG001|Overall Study|Physician Decision|3|||
23444368|NCT00767806|65366671|FG000|Overall Study|Lost to Follow-up|1|||
23444369|NCT00767806|65366672|FG001|Overall Study|Lost to Follow-up|4|||
23158565|NCT02700412|64331665|FG000|Overall Study|Withdrawal by Subject|2|||
23158566|NCT00113074|64331666|FG000|Overall Study|Lost to Follow-up|10|||
23158567|NCT00113074|64331667|FG001|Overall Study|Lost to Follow-up|10|||
23444370|NCT00767806|65366671|FG000|Overall Study|Entry Criteria Not Met|1|||
23444371|NCT00767806|65366672|FG001|Overall Study|Entry Criteria Not Met|1|||
23444372|NCT00767806|65366671|FG000|Overall Study|Sponsor Decision|0|||
23444373|NCT00767806|65366672|FG001|Overall Study|Sponsor Decision|1|||
23444374|NCT02134925|65366673|FG000|Overall Study|Withdrawal by Subject|1|||
23444375|NCT02134925|65366674|FG001|Overall Study|Withdrawal by Subject|0|||
23444376|NCT02134925|65366673|FG000|Overall Study|Cancel|1|||
23444377|NCT02134925|65366674|FG001|Overall Study|Cancel|6|||
23444378|NCT01797263|65366675|FG000|Overall Study|Withdrawal by Subject|21|||
23444379|NCT01797263|65366676|FG001|Overall Study|Withdrawal by Subject|25|||
23444380|NCT01797263|65366675|FG000|Overall Study|Death|1|||
23444381|NCT01797263|65366676|FG001|Overall Study|Death|0|||
23444382|NCT01797263|65366675|FG000|Overall Study|Lost to Follow-up|15|||
23444383|NCT01797263|65366676|FG001|Overall Study|Lost to Follow-up|15|||
23444384|NCT01934010|65366677|FG000|Overall Study|Adverse Event|1|||
23444385|NCT01934010|65366678|FG001|Overall Study|Adverse Event|1|||
23444386|NCT01934010|65366679|FG002|Overall Study|Adverse Event|0|||
23444387|NCT01934010|65366677|FG000|Overall Study|Withdrawal by Subject|15|||
23444388|NCT01934010|65366678|FG001|Overall Study|Withdrawal by Subject|6|||
23444389|NCT01934010|65366679|FG002|Overall Study|Withdrawal by Subject|2|||
23444390|NCT01934010|65366677|FG000|Overall Study|Lost to Follow-up|7|||
23444391|NCT01934010|65366678|FG001|Overall Study|Lost to Follow-up|4|||
23444392|NCT01934010|65366679|FG002|Overall Study|Lost to Follow-up|0|||
23444393|NCT02333799|65366680|FG000|Treatment Period|Withdrawal by Subject|1|||
23158568|NCT00113074|64331668|FG002|Overall Study|Lost to Follow-up|14|||
23444394|NCT02333799|65366680|FG000|Treatment Period|Death|6|||
23444395|NCT02333799|65366680|FG000|6 Month Follow Up Period|Physician Decision|1|||
23444396|NCT02333799|65366680|FG000|6 Month Follow Up Period|Death|1|||
23444397|NCT02333799|65366680|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
23444398|NCT02333799|65366680|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
23444399|NCT01397461|65370065|FG000|Overall Study|Withdrawal by Subject|2|||
23444400|NCT01397461|65370066|FG001|Overall Study|Withdrawal by Subject|1|||
23444401|NCT01397461|65370067|FG002|Overall Study|Withdrawal by Subject|0|||
23444402|NCT01397461|65370065|FG000|Overall Study|Lost to Follow-up|0|||
23158569|NCT01003210|64331671|FG000|Overall Study|Lost to Follow-up|1|||
23444403|NCT01397461|65370066|FG001|Overall Study|Lost to Follow-up|2|||
23158570|NCT01003210|64331672|FG001|Overall Study|Lost to Follow-up|3|||
23628627|NCT02498236|66028047|FG000|Overall Study|Equipment failure|0|||
23628628|NCT02498236|66028048|FG001|Overall Study|Equipment failure|0|||
23628629|NCT02498236|66028049|FG002|Overall Study|Equipment failure|0|||
23628630|NCT02498236|66028050|FG003|Overall Study|Equipment failure|0|||
23628631|NCT02498236|66028051|FG004|Overall Study|Equipment failure|0|||
23628632|NCT02498236|66028052|FG005|Overall Study|Equipment failure|0|||
23628633|NCT02498236|66028053|FG006|Overall Study|Equipment failure|1|||
23628634|NCT02498236|66028054|FG007|Overall Study|Equipment failure|0|||
23628635|NCT02498236|66028047|FG000|Overall Study|Withdrawal by Subject|0|||
23628636|NCT02498236|66028048|FG001|Overall Study|Withdrawal by Subject|0|||
23628637|NCT02498236|66028049|FG002|Overall Study|Withdrawal by Subject|0|||
23628638|NCT02498236|66028050|FG003|Overall Study|Withdrawal by Subject|0|||
23628639|NCT02498236|66028051|FG004|Overall Study|Withdrawal by Subject|1|||
23628640|NCT02498236|66028052|FG005|Overall Study|Withdrawal by Subject|0|||
23628641|NCT02498236|66028053|FG006|Overall Study|Withdrawal by Subject|0|||
23628642|NCT02498236|66028054|FG007|Overall Study|Withdrawal by Subject|0|||
23628643|NCT01536171|66028055|FG000|Overall Study|Withdrawal by Subject|1|||
23628644|NCT01262092|66028056|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
23628645|NCT01262092|66028057|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
23628646|NCT01262092|66028056|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
23628647|NCT01262092|66028057|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
23628648|NCT01262092|66028056|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
23628649|NCT01262092|66028057|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
23628650|NCT01262092|66028056|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
23628651|NCT01262092|66028057|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
23628652|NCT02689453|66028064|FG000|Overall Study|Progressive disease|0|||
23628653|NCT02689453|66028065|FG001|Overall Study|Progressive disease|1|||
23628654|NCT02689453|66028066|FG002|Overall Study|Progressive disease|1|||
23628655|NCT02166476|66028068|FG000|Overall Study|Withdrawal by Subject|5|||
23628656|NCT02166476|66028069|FG001|Overall Study|Withdrawal by Subject|7|||
23628657|NCT02166476|66028068|FG000|Overall Study|Adverse Event|3|||
23628658|NCT02166476|66028069|FG001|Overall Study|Adverse Event|3|||
23628659|NCT02166476|66028068|FG000|Overall Study|Lost to Follow-up|5|||
23628660|NCT02166476|66028069|FG001|Overall Study|Lost to Follow-up|10|||
23628661|NCT02166476|66028068|FG000|Overall Study|Physician Decision|1|||
23628662|NCT02166476|66028069|FG001|Overall Study|Physician Decision|0|||
23628663|NCT02166476|66028068|FG000|Overall Study|Unable to Come for Visit|0|||
23628664|NCT02166476|66028069|FG001|Overall Study|Unable to Come for Visit|3|||
23628665|NCT04092452|66028070|FG000|Overall Study|Adverse Event|1|||
23628666|NCT04092452|66028071|FG001|Overall Study|Adverse Event|3|||
23628667|NCT04092452|66028072|FG002|Overall Study|Adverse Event|3|||
23628668|NCT04092452|66028073|FG003|Overall Study|Adverse Event|7|||
23628669|NCT04092452|66028070|FG000|Overall Study|Lack of Efficacy|1|||
23628670|NCT04092452|66028071|FG001|Overall Study|Lack of Efficacy|1|||
23628671|NCT04092452|66028072|FG002|Overall Study|Lack of Efficacy|1|||
23628672|NCT04092452|66028073|FG003|Overall Study|Lack of Efficacy|0|||
23328481|NCT02220764|64945474|FG001|Overall Study|Lost to Follow-up|1|||
23444404|NCT01397461|65370067|FG002|Overall Study|Lost to Follow-up|1|||
23444405|NCT01397461|65370065|FG000|Overall Study|Lack of Efficacy|0|||
23444406|NCT01397461|65370066|FG001|Overall Study|Lack of Efficacy|3|||
23444407|NCT01397461|65370067|FG002|Overall Study|Lack of Efficacy|0|||
23444408|NCT01397461|65370065|FG000|Overall Study|Not treated|0|||
23444409|NCT01397461|65370066|FG001|Overall Study|Not treated|0|||
23444410|NCT01397461|65370067|FG002|Overall Study|Not treated|1|||
23444411|NCT01331109|65370068|FG000|Overall Study|Adverse Event|6|||
23444412|NCT01331109|65370068|FG000|Overall Study|Lack of Efficacy|2|||
23444413|NCT01331109|65370068|FG000|Overall Study|Protocol Violation|3|||
23444414|NCT01331109|65370068|FG000|Overall Study|Withdrawal by Subject|7|||
23628673|NCT04092452|66028070|FG000|Overall Study|Lost to Follow-up|4|||
23328482|NCT02220764|64945473|FG000|Overall Study|Death|1|||
23328483|NCT02220764|64945474|FG001|Overall Study|Death|0|||
23328484|NCT02286713|64945475|FG000|One Week Follow-Up|Death|1|||
23328485|NCT02286713|64945476|FG001|One Week Follow-Up|Death|0|||
23328486|NCT02286713|64945475|FG000|One Week Follow-Up|Lost to Follow-up|17|||
23444415|NCT01331109|65370068|FG000|Overall Study|Lost to Follow-up|1|||
23628674|NCT04092452|66028071|FG001|Overall Study|Lost to Follow-up|3|||
23628675|NCT04092452|66028072|FG002|Overall Study|Lost to Follow-up|5|||
23328487|NCT02286713|64945476|FG001|One Week Follow-Up|Lost to Follow-up|21|||
23328488|NCT02286713|64945475|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
23444416|NCT01331109|65370068|FG000|Overall Study|Study Terminated by Sponsor|38|||
23628676|NCT04092452|66028073|FG003|Overall Study|Lost to Follow-up|1|||
23628677|NCT04092452|66028070|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23628678|NCT04092452|66028071|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23628679|NCT04092452|66028072|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23628680|NCT04092452|66028073|FG003|Overall Study|Non-Compliance With Study Drug|1|||
23328489|NCT02286713|64945476|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
23444417|NCT02630472|65370071|FG000|Overall Study|Physician Decision|10|||
23328490|NCT02286713|64945475|FG000|Three Month Follow-Up|Death|1|||
23328491|NCT02286713|64945476|FG001|Three Month Follow-Up|Death|1|||
23328492|NCT02286713|64945475|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
23444418|NCT02630472|65370072|FG001|Overall Study|Physician Decision|0|||
23444419|NCT00719680|65370073|FG000|Overall Study|Adverse Event|1|||
23444420|NCT00719680|65370073|FG000|Overall Study|Lost to Follow-up|1|||
23444421|NCT00719680|65370073|FG000|Overall Study|Withdrawal by Subject|3|||
23444422|NCT03549104|65370074|FG000|Overall Study|Withdrawal by Subject|5|||
23444423|NCT03549104|65370075|FG001|Overall Study|Withdrawal by Subject|2|||
23444424|NCT03549104|65370074|FG000|Overall Study|Covid shelter in place|1|||
23444425|NCT03549104|65370075|FG001|Overall Study|Covid shelter in place|2|||
23444426|NCT00853151|65370076|FG000|Overall Study|Adverse Event|1|||
23444427|NCT00853151|65370077|FG001|Overall Study|Adverse Event|4|||
23444428|NCT00853151|65370078|FG002|Overall Study|Adverse Event|2|||
23444429|NCT00853151|65370079|FG003|Overall Study|Adverse Event|0|||
23444430|NCT00853151|65370076|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23444431|NCT00853151|65370077|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23444432|NCT00853151|65370078|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23444433|NCT00853151|65370079|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23444434|NCT00853151|65370076|FG000|Overall Study|Lost to Follow-up|2|||
23444435|NCT00853151|65370077|FG001|Overall Study|Lost to Follow-up|0|||
23444436|NCT00853151|65370078|FG002|Overall Study|Lost to Follow-up|3|||
23444437|NCT00853151|65370079|FG003|Overall Study|Lost to Follow-up|0|||
23444438|NCT00853151|65370076|FG000|Overall Study|Death|1|||
23444439|NCT00853151|65370077|FG001|Overall Study|Death|0|||
23444440|NCT00853151|65370078|FG002|Overall Study|Death|0|||
23444441|NCT00853151|65370079|FG003|Overall Study|Death|1|||
23444442|NCT00853151|65370076|FG000|Overall Study|Protocol Violation|0|||
23444443|NCT00853151|65370077|FG001|Overall Study|Protocol Violation|0|||
23444444|NCT00853151|65370078|FG002|Overall Study|Protocol Violation|0|||
23444445|NCT00853151|65370079|FG003|Overall Study|Protocol Violation|1|||
23444446|NCT00853151|65370076|FG000|Overall Study|Withdrawal by Subject|5|||
23222304|NCT02975349|64557635|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23222305|NCT02975349|64557636|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
23222306|NCT02975349|64557637|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23222307|NCT02975349|64557638|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23222308|NCT02975349|64557639|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23222309|NCT02975349|64557640|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
23222310|NCT02975349|64557635|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23222311|NCT02975349|64557636|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23222312|NCT02975349|64557637|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23222313|NCT02975349|64557638|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
23222314|NCT02975349|64557639|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23222315|NCT02975349|64557640|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
23222316|NCT00493467|64557641|FG000|Overall Study|Death|1|||
23222317|NCT02603172|64557642|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23222318|NCT02603172|64557643|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23222319|NCT02603172|64557644|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
23444447|NCT00853151|65370077|FG001|Overall Study|Withdrawal by Subject|4|||
23444448|NCT00853151|65370078|FG002|Overall Study|Withdrawal by Subject|2|||
23444449|NCT00853151|65370079|FG003|Overall Study|Withdrawal by Subject|1|||
23444450|NCT00853151|65370076|FG000|Overall Study|Physician Decision|0|||
23444451|NCT00853151|65370077|FG001|Overall Study|Physician Decision|2|||
23444452|NCT00853151|65370078|FG002|Overall Study|Physician Decision|1|||
23444453|NCT00853151|65370079|FG003|Overall Study|Physician Decision|0|||
23444454|NCT00853151|65370076|FG000|Overall Study|Sponsor Decision|0|||
23444455|NCT00853151|65370077|FG001|Overall Study|Sponsor Decision|3|||
23444456|NCT00853151|65370078|FG002|Overall Study|Sponsor Decision|0|||
23444457|NCT00853151|65370079|FG003|Overall Study|Sponsor Decision|0|||
23444458|NCT03592368|65370080|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
23444459|NCT03592368|65370081|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
23222320|NCT02603172|64557645|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23328493|NCT02286713|64945476|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
23444460|NCT03592368|65370082|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
23444461|NCT03592368|65370083|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
23444462|NCT03592368|65370080|FG000|Overall Study|Adverse Event|0|||
23222321|NCT02603172|64557646|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23222322|NCT02603172|64557647|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23328494|NCT02286713|64945475|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
23444463|NCT03592368|65370081|FG001|Overall Study|Adverse Event|0|||
23444464|NCT03592368|65370082|FG002|Overall Study|Adverse Event|0|||
23444465|NCT03592368|65370083|FG003|Overall Study|Adverse Event|1|||
23444466|NCT03592368|65370080|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
23444467|NCT03592368|65370081|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
23444468|NCT03592368|65370082|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
23444469|NCT03592368|65370083|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
23444470|NCT01959841|65370086|FG000|Overall Study|Adverse Event|1|||
23444471|NCT01959841|65370087|FG001|Overall Study|Adverse Event|3|||
23444472|NCT01959841|65370088|FG002|Overall Study|Adverse Event|2|||
23444473|NCT01959841|65370086|FG000|Overall Study|Lack of Efficacy|5|||
23444474|NCT01959841|65370087|FG001|Overall Study|Lack of Efficacy|0|||
23444475|NCT01959841|65370088|FG002|Overall Study|Lack of Efficacy|0|||
23444476|NCT01959841|65370086|FG000|Overall Study|Lost to Follow-up|1|||
23444477|NCT01959841|65370087|FG001|Overall Study|Lost to Follow-up|1|||
23444478|NCT01959841|65370088|FG002|Overall Study|Lost to Follow-up|0|||
23444479|NCT01959841|65370086|FG000|Overall Study|Physician Decision|0|||
23444480|NCT01959841|65370087|FG001|Overall Study|Physician Decision|2|||
23444481|NCT01959841|65370088|FG002|Overall Study|Physician Decision|3|||
23444482|NCT01959841|65370086|FG000|Overall Study|Protocol Violation|16|||
23444483|NCT01959841|65370087|FG001|Overall Study|Protocol Violation|23|||
23444484|NCT01959841|65370088|FG002|Overall Study|Protocol Violation|16|||
23444485|NCT01959841|65370086|FG000|Overall Study|Withdrawal by Subject|7|||
23444486|NCT01959841|65370087|FG001|Overall Study|Withdrawal by Subject|7|||
23444487|NCT01959841|65370088|FG002|Overall Study|Withdrawal by Subject|5|||
23444488|NCT01959841|65370086|FG000|Overall Study|Clinical laboratory value|2|||
23444489|NCT01959841|65370087|FG001|Overall Study|Clinical laboratory value|6|||
23444490|NCT01959841|65370088|FG002|Overall Study|Clinical laboratory value|6|||
23444491|NCT01959841|65370086|FG000|Overall Study|Platelet count below on day1 or 4|11|||
23444492|NCT01959841|65370087|FG001|Overall Study|Platelet count below on day1 or 4|15|||
23444493|NCT01959841|65370088|FG002|Overall Study|Platelet count below on day1 or 4|11|||
23444494|NCT02532465|65370089|FG000|Overall Study|Protocol Violation|1|||
23444495|NCT02532465|65370090|FG001|Overall Study|Protocol Violation|0|||
23444496|NCT02532465|65370089|FG000|Overall Study|Lack of Efficacy|0|||
23444497|NCT02532465|65370090|FG001|Overall Study|Lack of Efficacy|1|||
23444498|NCT02657889|65370091|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
23444499|NCT02657889|65370092|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
23444500|NCT02657889|65370093|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
23444501|NCT02657889|65370094|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
23444502|NCT02657889|65370091|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
23444503|NCT02657889|65370092|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
23444504|NCT02657889|65370093|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
23444505|NCT02657889|65370094|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
23444506|NCT02657889|65370091|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
23444507|NCT02657889|65370092|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
23444508|NCT02657889|65370093|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
23444509|NCT02657889|65370094|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
23444510|NCT02657889|65370091|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
23444511|NCT02657889|65370092|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
23444512|NCT02657889|65370093|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
23444513|NCT02657889|65370094|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
23444514|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
23444515|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
23444516|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
23444517|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
23444518|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
23158571|NCT01537198|64331673|FG000|Overall Study|RSV infection|2|||
23158572|NCT01537198|64331673|FG000|Overall Study|Adverse Event|4|||
23158573|NCT01537198|64331673|FG000|Overall Study|No Further Visits to the Clinic|37|||
23158574|NCT01537198|64331673|FG000|Overall Study|Other|111|||
23158575|NCT02322125|64331676|FG000|Overall Study|Withdrawal by Subject|2|||
23158576|NCT00916279|64331682|FG000|Overall Study|Death|2|||
23158577|NCT00916279|64331682|FG000|Overall Study|Lost to Follow-up|2|||
23158578|NCT01967628|64331696|FG000|Overall Study|Withdrawal by Subject|2|||
23158579|NCT01967628|64331697|FG001|Overall Study|Withdrawal by Subject|0|||
23158580|NCT01967628|64331696|FG000|Overall Study|Unable to complete bronchoscopy|4|||
23158581|NCT01967628|64331697|FG001|Overall Study|Unable to complete bronchoscopy|6|||
23158582|NCT01967628|64331696|FG000|Overall Study|Lost to Follow-up|1|||
23158583|NCT01967628|64331697|FG001|Overall Study|Lost to Follow-up|0|||
23158584|NCT01967628|64331696|FG000|Overall Study|Low protein concentration in sample|20|||
23158585|NCT01967628|64331697|FG001|Overall Study|Low protein concentration in sample|25|||
23158586|NCT02263079|64331703|FG000|Overall Study|Physician Decision|1|||
23158587|NCT02263079|64331704|FG001|Overall Study|Physician Decision|0|||
23158588|NCT02263079|64331705|FG002|Overall Study|Physician Decision|0|||
23444519|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
23444520|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
23158589|NCT02263079|64331703|FG000|Overall Study|Withdrawal by Subject|2|||
23328495|NCT02286713|64945476|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
23328496|NCT02286713|64945475|FG000|Six Month Follow-Up|Death|2|||
23328497|NCT02286713|64945476|FG001|Six Month Follow-Up|Death|0|||
23328498|NCT02286713|64945475|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
23328499|NCT02286713|64945476|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
23328500|NCT00444535|64945483|FG000|Overall Study|Withdrawal by Subject|5|||
23328501|NCT00444535|64945483|FG000|Overall Study|Physician Decision|5|||
23628681|NCT04092452|66028070|FG000|Overall Study|Physician Decision|1|||
23628682|NCT04092452|66028071|FG001|Overall Study|Physician Decision|0|||
23628683|NCT04092452|66028072|FG002|Overall Study|Physician Decision|1|||
23628684|NCT04092452|66028073|FG003|Overall Study|Physician Decision|0|||
23628685|NCT04092452|66028070|FG000|Overall Study|Pregnancy|2|||
23628686|NCT04092452|66028071|FG001|Overall Study|Pregnancy|0|||
23628687|NCT04092452|66028072|FG002|Overall Study|Pregnancy|0|||
23628688|NCT04092452|66028073|FG003|Overall Study|Pregnancy|0|||
23628689|NCT04092452|66028070|FG000|Overall Study|Protocol Deviation|1|||
23628690|NCT04092452|66028071|FG001|Overall Study|Protocol Deviation|0|||
23628691|NCT04092452|66028072|FG002|Overall Study|Protocol Deviation|0|||
23628692|NCT04092452|66028073|FG003|Overall Study|Protocol Deviation|0|||
23628693|NCT04092452|66028070|FG000|Overall Study|Withdrawal by Subject|3|||
23628694|NCT04092452|66028071|FG001|Overall Study|Withdrawal by Subject|10|||
23628695|NCT04092452|66028072|FG002|Overall Study|Withdrawal by Subject|3|||
23628696|NCT04092452|66028073|FG003|Overall Study|Withdrawal by Subject|5|||
23628697|NCT04092452|66028070|FG000|Overall Study|Other|0|||
23628698|NCT04092452|66028071|FG001|Overall Study|Other|0|||
23628699|NCT04092452|66028072|FG002|Overall Study|Other|1|||
23628700|NCT04092452|66028073|FG003|Overall Study|Other|2|||
23628701|NCT03933462|66028080|FG000|Overall Study|Adverse Event|2|||
23628702|NCT03933462|66028081|FG001|Overall Study|Adverse Event|0|||
23628703|NCT03482752|66028086|FG000|Overall Study|Withdrawal by Subject|2|||
23628704|NCT03482752|66028086|FG000|Overall Study|Lost to Follow-up|1|||
23628705|NCT03482752|66028086|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
23628706|NCT00416598|66028087|FG000|Induction & Intensification|Adverse Event|38|||
23628707|NCT00416598|66028087|FG000|Induction & Intensification|Death|32|||
23628708|NCT00416598|66028087|FG000|Induction & Intensification|Withdrawal by Subject|46|||
23628709|NCT00416598|66028087|FG000|Induction & Intensification|Alternative Treatment|135|||
23628710|NCT00416598|66028087|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
23628711|NCT00416598|66028087|FG000|Induction & Intensification|Relapse/progression|29|||
23628712|NCT00416598|66028087|FG000|Induction & Intensification|Failed induction|87|||
23628713|NCT00416598|66028087|FG000|Decitabine Maintenance|Adverse Event|5|||
23328502|NCT00444535|64945483|FG000|Overall Study|progressive disease|1|||
23328503|NCT00444535|64945483|FG000|Overall Study|Adverse Event|2|||
23328504|NCT02157376|64945484|FG000|Overall Study|Death|10|||
23328505|NCT02157376|64945485|FG001|Overall Study|Death|4|||
23328506|NCT02157376|64945484|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23328507|NCT02157376|64945485|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23328508|NCT02157376|64945484|FG000|Overall Study|Withdrawal by Subject|3|||
23328509|NCT02157376|64945485|FG001|Overall Study|Withdrawal by Subject|8|||
23328510|NCT02157376|64945484|FG000|Overall Study|Not treated|8|||
23328511|NCT02157376|64945485|FG001|Overall Study|Not treated|3|||
23328512|NCT02157376|64945484|FG000|Overall Study|Investigator's misjudgement|1|||
23158590|NCT02263079|64331704|FG001|Overall Study|Withdrawal by Subject|8|||
23158591|NCT02263079|64331705|FG002|Overall Study|Withdrawal by Subject|0|||
23628714|NCT00416598|66028087|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
23628715|NCT00416598|66028087|FG000|Decitabine Maintenance|Progression/relapse|38|||
23628716|NCT00416598|66028087|FG000|Decitabine Maintenance|Alternative treatment|2|||
23628717|NCT00416598|66028087|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
23628718|NCT00420784|66028088|FG000|Overall Study|Adverse Event|11|||
23628719|NCT00420784|66028089|FG001|Overall Study|Adverse Event|29|||
23158592|NCT00993265|64331714|FG000|Overall Study|Adverse Event|1|||
23158593|NCT00993265|64331715|FG001|Overall Study|Adverse Event|0|||
23158594|NCT00993265|64331714|FG000|Overall Study|Changed dose of concomitant drug|2|||
23158595|NCT00993265|64331715|FG001|Overall Study|Changed dose of concomitant drug|0|||
23158596|NCT00993265|64331714|FG000|Overall Study|Non-compliant with study medication|1|||
23158597|NCT00993265|64331715|FG001|Overall Study|Non-compliant with study medication|0|||
23222323|NCT02603172|64557648|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23328513|NCT02157376|64945485|FG001|Overall Study|Investigator's misjudgement|2|||
23328514|NCT00529087|64945486|FG000|Overall Study|Adverse Event|10|||
23328515|NCT00529087|64945487|FG001|Overall Study|Adverse Event|13|||
23628720|NCT00420784|66028090|FG002|Overall Study|Adverse Event|10|||
23328516|NCT00529087|64945488|FG002|Overall Study|Adverse Event|4|||
23328517|NCT00529087|64945486|FG000|Overall Study|Lost to Follow-up|6|||
23628721|NCT00420784|66028091|FG003|Overall Study|Adverse Event|5|||
23628722|NCT00420784|66028088|FG000|Overall Study|Withdrawal by Subject|0|||
23628723|NCT00420784|66028089|FG001|Overall Study|Withdrawal by Subject|1|||
23628724|NCT00420784|66028090|FG002|Overall Study|Withdrawal by Subject|0|||
23444521|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
23444522|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
23444523|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
23444524|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
23444525|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
23444526|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
23444527|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
23444528|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
23444529|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
23444530|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
23444531|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
23444532|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
23444533|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
23444534|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
23444535|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
23444536|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
23444537|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
23444538|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
23444539|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
23444540|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
23566982|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23566983|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
23158598|NCT01430455|64331716|FG000|Overall Study|Withdrawal by Subject|1|||
23158599|NCT01430455|64331716|FG000|Overall Study|Switched to follow-up phase|1|||
23158600|NCT03654976|64331718|FG000|Overall Study|Withdrawal by Subject|12|||
23158601|NCT03654976|64331719|FG001|Overall Study|Withdrawal by Subject|11|||
23158602|NCT03654976|64331718|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
23158603|NCT03654976|64331719|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
23158604|NCT03654976|64331718|FG000|Overall Study|Adverse Event|5|||
23158605|NCT03654976|64331719|FG001|Overall Study|Adverse Event|0|||
23158606|NCT03654976|64331718|FG000|Overall Study|Lost to Follow-up|2|||
23158607|NCT03654976|64331719|FG001|Overall Study|Lost to Follow-up|0|||
23158608|NCT03654976|64331718|FG000|Overall Study|Lack of Efficacy|0|||
23158609|NCT03654976|64331719|FG001|Overall Study|Lack of Efficacy|1|||
23158610|NCT00544648|64331728|FG000|Overall Study|Withdrawal by Subject|1|||
23158611|NCT00544648|64331729|FG001|Overall Study|Withdrawal by Subject|0|||
23158612|NCT00544648|64331728|FG000|Overall Study|Adverse Event|1|||
23158613|NCT00544648|64331729|FG001|Overall Study|Adverse Event|1|||
23158614|NCT00544648|64331728|FG000|Overall Study|progression of disease|1|||
23158615|NCT00544648|64331729|FG001|Overall Study|progression of disease|0|||
23158616|NCT00880399|64331730|FG000|Overall Study|Adverse Event|4|||
23566984|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
23566985|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566986|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23158617|NCT00880399|64331731|FG001|Overall Study|Adverse Event|6|||
23158618|NCT00880399|64331732|FG002|Overall Study|Adverse Event|5|||
23158619|NCT00880399|64331730|FG000|Overall Study|Lack of Efficacy|1|||
23158620|NCT00880399|64331731|FG001|Overall Study|Lack of Efficacy|4|||
23158621|NCT00880399|64331732|FG002|Overall Study|Lack of Efficacy|2|||
23158622|NCT00880399|64331730|FG000|Overall Study|Protocol Violation|4|||
23158623|NCT00880399|64331731|FG001|Overall Study|Protocol Violation|4|||
23158624|NCT00880399|64331732|FG002|Overall Study|Protocol Violation|6|||
23158625|NCT00880399|64331730|FG000|Overall Study|Study closed/terminated|3|||
23158626|NCT00880399|64331731|FG001|Overall Study|Study closed/terminated|7|||
23158627|NCT00880399|64331732|FG002|Overall Study|Study closed/terminated|4|||
23566987|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566988|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566989|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566990|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
23566991|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
23566992|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23566993|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23566994|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23158628|NCT00880399|64331730|FG000|Overall Study|Lost to Follow-up|8|||
23158629|NCT00880399|64331731|FG001|Overall Study|Lost to Follow-up|5|||
23158630|NCT00880399|64331732|FG002|Overall Study|Lost to Follow-up|3|||
23158631|NCT00880399|64331730|FG000|Overall Study|Physician Decision|5|||
23158632|NCT00880399|64331731|FG001|Overall Study|Physician Decision|0|||
23444541|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
23444542|NCT02657889|65370091|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
23444543|NCT02657889|65370092|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
23444544|NCT02657889|65370093|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
23444545|NCT02657889|65370094|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
23444546|NCT04207749|65370097|FG000|Overall Study|Lost to Follow-up|0|||
23444547|NCT04207749|65370098|FG001|Overall Study|Lost to Follow-up|2|||
23444548|NCT04207749|65370097|FG000|Overall Study|Protocol Violation|0|||
23444549|NCT04207749|65370098|FG001|Overall Study|Protocol Violation|1|||
23444550|NCT04207749|65370097|FG000|Overall Study|Withdrawal by Subject|3|||
23444551|NCT04207749|65370098|FG001|Overall Study|Withdrawal by Subject|0|||
23444552|NCT04207749|65370097|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
23444553|NCT04207749|65370098|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
23444554|NCT01525615|65370099|FG000|Overall Study|Adverse Event|11|||
23566995|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23158633|NCT00880399|64331732|FG002|Overall Study|Physician Decision|3|||
23444555|NCT01525615|65370100|FG001|Overall Study|Adverse Event|7|||
23628725|NCT00420784|66028091|FG003|Overall Study|Withdrawal by Subject|0|||
23628726|NCT00420784|66028088|FG000|Overall Study|Lost to Follow-up|0|||
23628727|NCT00420784|66028089|FG001|Overall Study|Lost to Follow-up|0|||
23628728|NCT00420784|66028090|FG002|Overall Study|Lost to Follow-up|2|||
23628729|NCT00420784|66028091|FG003|Overall Study|Lost to Follow-up|1|||
23628730|NCT00420784|66028088|FG000|Overall Study|Virologic Stopping Rule|17|||
23628731|NCT00420784|66028089|FG001|Overall Study|Virologic Stopping Rule|26|||
23628732|NCT00420784|66028090|FG002|Overall Study|Virologic Stopping Rule|41|||
23628733|NCT00420784|66028091|FG003|Overall Study|Virologic Stopping Rule|67|||
23628734|NCT00420784|66028088|FG000|Overall Study|Other|1|||
23566996|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23628735|NCT00420784|66028089|FG001|Overall Study|Other|2|||
23628736|NCT00420784|66028090|FG002|Overall Study|Other|0|||
23628737|NCT00420784|66028091|FG003|Overall Study|Other|5|||
23628738|NCT02161406|66028092|FG000|Overall Study|Death|2|||
23628739|NCT02161406|66028093|FG001|Overall Study|Death|1|||
23628740|NCT02161406|66028092|FG000|Overall Study|Lost to Follow-up|2|||
23628741|NCT02161406|66028093|FG001|Overall Study|Lost to Follow-up|1|||
23628742|NCT02161406|66028092|FG000|Overall Study|Withdrawal by Subject|2|||
23628743|NCT02161406|66028093|FG001|Overall Study|Withdrawal by Subject|4|||
23628744|NCT02161406|66028092|FG000|Overall Study|investigator withdrew subject|3|||
23628745|NCT02161406|66028093|FG001|Overall Study|investigator withdrew subject|1|||
23628746|NCT02161406|66028092|FG000|Overall Study|Lack of Efficacy|1|||
23628747|NCT02161406|66028093|FG001|Overall Study|Lack of Efficacy|1|||
23628748|NCT02161406|66028092|FG000|Overall Study|relocation|0|||
23628749|NCT02161406|66028093|FG001|Overall Study|relocation|1|||
23628750|NCT01441583|66028099|FG000|Overall Study|Withdrawal by Subject|1|||
23566997|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
23566998|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
23566999|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567000|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567001|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567002|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567003|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567004|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
23567005|NCT01576718|65803969|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
23567006|NCT01576718|65803970|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567007|NCT01576718|65803971|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567008|NCT01576718|65803972|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23628751|NCT01441583|66028100|FG001|Overall Study|Withdrawal by Subject|1|||
23628752|NCT01441583|66028101|FG002|Overall Study|Withdrawal by Subject|1|||
23628753|NCT01441583|66028099|FG000|Overall Study|Death|1|||
23628754|NCT01441583|66028100|FG001|Overall Study|Death|0|||
23628755|NCT01441583|66028101|FG002|Overall Study|Death|4|||
23628756|NCT01441583|66028099|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
23444556|NCT01525615|65370101|FG002|Overall Study|Adverse Event|5|||
23444557|NCT01525615|65370099|FG000|Overall Study|Lost to Follow-up|1|||
23444558|NCT01525615|65370100|FG001|Overall Study|Lost to Follow-up|0|||
23444559|NCT01525615|65370101|FG002|Overall Study|Lost to Follow-up|0|||
23628757|NCT01441583|66028100|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
23628758|NCT01441583|66028101|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
23444560|NCT01525615|65370099|FG000|Overall Study|Withdrawal by Subject|1|||
23628759|NCT01010204|66028104|FG000|Overall Study|Lost to Follow-up|2|||
23158634|NCT00880399|64331730|FG000|Overall Study|Withdrawal by Subject|6|||
23628760|NCT01010204|66028105|FG001|Overall Study|Lost to Follow-up|2|||
23328518|NCT00529087|64945487|FG001|Overall Study|Lost to Follow-up|4|||
23158635|NCT00880399|64331731|FG001|Overall Study|Withdrawal by Subject|3|||
23158636|NCT00880399|64331732|FG002|Overall Study|Withdrawal by Subject|3|||
23158637|NCT03451084|64331735|FG000|Overall Study|Withdrawal by Subject|2|||
23158638|NCT03451084|64331736|FG001|Overall Study|Withdrawal by Subject|1|||
23158639|NCT03451084|64331737|FG002|Overall Study|Withdrawal by Subject|2|||
23158640|NCT03451084|64331738|FG003|Overall Study|Withdrawal by Subject|1|||
23158641|NCT03451084|64331735|FG000|Overall Study|Disease recurrence|0|||
23158642|NCT03451084|64331736|FG001|Overall Study|Disease recurrence|2|||
23567009|NCT01576718|65803973|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567010|NCT01576718|65803974|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567011|NCT01576718|65803975|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
23567012|NCT01576718|65803969|FG000|Treatment Period|Adverse Event|0|||
23567013|NCT01576718|65803970|FG001|Treatment Period|Adverse Event|1|||
23567014|NCT01576718|65803971|FG002|Treatment Period|Adverse Event|1|||
23567015|NCT01576718|65803972|FG003|Treatment Period|Adverse Event|1|||
23567016|NCT01576718|65803973|FG004|Treatment Period|Adverse Event|1|||
23158643|NCT03451084|64331737|FG002|Overall Study|Disease recurrence|0|||
23158644|NCT03451084|64331738|FG003|Overall Study|Disease recurrence|0|||
23158645|NCT03451084|64331735|FG000|Overall Study|Lack of Efficacy|0|||
23158646|NCT03451084|64331736|FG001|Overall Study|Lack of Efficacy|3|||
23158647|NCT03451084|64331737|FG002|Overall Study|Lack of Efficacy|0|||
23158648|NCT03451084|64331738|FG003|Overall Study|Lack of Efficacy|1|||
23158649|NCT03451084|64331735|FG000|Overall Study|Death|1|||
23158650|NCT03451084|64331736|FG001|Overall Study|Death|0|||
23158651|NCT03451084|64331737|FG002|Overall Study|Death|2|||
23158652|NCT03451084|64331738|FG003|Overall Study|Death|0|||
23158653|NCT03451084|64331735|FG000|Overall Study|Physician Decision|0|||
23158654|NCT03451084|64331736|FG001|Overall Study|Physician Decision|0|||
23158655|NCT03451084|64331737|FG002|Overall Study|Physician Decision|2|||
23158656|NCT03451084|64331738|FG003|Overall Study|Physician Decision|2|||
23158657|NCT03451084|64331735|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
23158658|NCT03451084|64331736|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
23158659|NCT03451084|64331737|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
23158660|NCT03451084|64331738|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
23158661|NCT02616614|64331739|FG000|Overall Study|Withdrawal by Subject|10|||
23158662|NCT02616614|64331740|FG001|Overall Study|Withdrawal by Subject|5|||
23158663|NCT02616614|64331741|FG002|Overall Study|Withdrawal by Subject|6|||
23158664|NCT02616614|64331739|FG000|Overall Study|Physician Decision|2|||
23158665|NCT02616614|64331740|FG001|Overall Study|Physician Decision|1|||
23158666|NCT02616614|64331741|FG002|Overall Study|Physician Decision|0|||
23158667|NCT02616614|64331739|FG000|Overall Study|Adverse Event|1|||
23158668|NCT02616614|64331740|FG001|Overall Study|Adverse Event|4|||
23158669|NCT02616614|64331741|FG002|Overall Study|Adverse Event|1|||
23158670|NCT02616614|64331739|FG000|Overall Study|Protocol Violation|0|||
23158671|NCT02616614|64331740|FG001|Overall Study|Protocol Violation|3|||
23158672|NCT02616614|64331741|FG002|Overall Study|Protocol Violation|1|||
23158673|NCT02616614|64331739|FG000|Overall Study|Prohibited Medication|12|||
23158674|NCT02616614|64331740|FG001|Overall Study|Prohibited Medication|9|||
23158675|NCT02616614|64331741|FG002|Overall Study|Prohibited Medication|5|||
23158676|NCT02616614|64331739|FG000|Overall Study|More than 3 applications missed|6|||
23158677|NCT02616614|64331740|FG001|Overall Study|More than 3 applications missed|8|||
23158678|NCT02616614|64331741|FG002|Overall Study|More than 3 applications missed|1|||
23158679|NCT02616614|64331739|FG000|Overall Study|Lost to Follow-up|31|||
23158680|NCT02616614|64331740|FG001|Overall Study|Lost to Follow-up|28|||
23158681|NCT02616614|64331741|FG002|Overall Study|Lost to Follow-up|13|||
23158682|NCT02616614|64331739|FG000|Overall Study|Pregnancy|2|||
23158683|NCT02616614|64331740|FG001|Overall Study|Pregnancy|0|||
23158684|NCT02616614|64331741|FG002|Overall Study|Pregnancy|1|||
23158685|NCT02616614|64331739|FG000|Overall Study|Other|1|||
23158686|NCT02616614|64331740|FG001|Overall Study|Other|2|||
23158687|NCT02616614|64331741|FG002|Overall Study|Other|1|||
23158688|NCT02234284|64331754|FG000|Overall Study|Death|4|||
23328519|NCT00529087|64945488|FG002|Overall Study|Lost to Follow-up|1|||
23158689|NCT02234284|64331755|FG001|Overall Study|Death|2|||
23158690|NCT02234284|64331754|FG000|Overall Study|Withdrawal by Subject|1|||
23328520|NCT00529087|64945486|FG000|Overall Study|Protocol Violation|8|||
23328521|NCT00529087|64945487|FG001|Overall Study|Protocol Violation|7|||
23328522|NCT00529087|64945488|FG002|Overall Study|Protocol Violation|6|||
23567017|NCT01576718|65803974|FG005|Treatment Period|Adverse Event|1|||
23567018|NCT01576718|65803975|FG006|Treatment Period|Adverse Event|0|||
23567019|NCT01576718|65803969|FG000|Treatment Period|Withdrawal by Subject|0|||
23158691|NCT02234284|64331755|FG001|Overall Study|Withdrawal by Subject|0|||
23158692|NCT02234284|64331754|FG000|Overall Study|Lost to Follow-up|20|||
23158693|NCT02234284|64331755|FG001|Overall Study|Lost to Follow-up|7|||
23328523|NCT00529087|64945486|FG000|Overall Study|Withdrawal by Subject|3|||
23328524|NCT00529087|64945487|FG001|Overall Study|Withdrawal by Subject|3|||
23567020|NCT01576718|65803970|FG001|Treatment Period|Withdrawal by Subject|1|||
23567021|NCT01576718|65803971|FG002|Treatment Period|Withdrawal by Subject|1|||
23328525|NCT00529087|64945488|FG002|Overall Study|Withdrawal by Subject|3|||
23328526|NCT00529087|64945486|FG000|Overall Study|Protocol deviation|1|||
23158694|NCT02664272|64331756|FG000|Overall Study|Fluoroscopic images not made available|2|||
23158695|NCT02369848|64331759|FG000|Overall Study|Death|1|||
23158696|NCT02369848|64331759|FG000|Overall Study|Withdrawal by Subject|2|||
23158697|NCT02369848|64331759|FG000|Overall Study|Lost to Follow-up|1|||
23158698|NCT00312221|64331760|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
23158699|NCT00312221|64331761|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
23158700|NCT00312221|64331762|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
23158701|NCT00312221|64331763|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
23158702|NCT00312221|64331760|FG000|Open-label Run-in Period|Adverse Event|74|||
23158703|NCT00312221|64331761|FG001|Open-label Run-in Period|Adverse Event|0|||
23158704|NCT00312221|64331762|FG002|Open-label Run-in Period|Adverse Event|0|||
23158705|NCT00312221|64331763|FG003|Open-label Run-in Period|Adverse Event|0|||
23158706|NCT00312221|64331760|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
23158707|NCT00312221|64331761|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
23158708|NCT00312221|64331762|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
23158709|NCT00312221|64331763|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
23158710|NCT00312221|64331760|FG000|Open-label Run-in Period|Administrative|42|||
23158711|NCT00312221|64331761|FG001|Open-label Run-in Period|Administrative|0|||
23158712|NCT00312221|64331762|FG002|Open-label Run-in Period|Administrative|0|||
23158713|NCT00312221|64331763|FG003|Open-label Run-in Period|Administrative|0|||
23158714|NCT00312221|64331760|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
23158715|NCT00312221|64331761|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
23158716|NCT00312221|64331762|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
23158717|NCT00312221|64331763|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
23158718|NCT00312221|64331760|FG000|Open-label Run-in Period|Did not qualify|5|||
23158719|NCT00312221|64331761|FG001|Open-label Run-in Period|Did not qualify|0|||
23158720|NCT00312221|64331762|FG002|Open-label Run-in Period|Did not qualify|0|||
23158721|NCT00312221|64331763|FG003|Open-label Run-in Period|Did not qualify|0|||
23158722|NCT00312221|64331760|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23158723|NCT00312221|64331761|FG001|Double-blind Phase|Withdrawal by Subject|6|||
23158724|NCT00312221|64331762|FG002|Double-blind Phase|Withdrawal by Subject|8|||
23158725|NCT00312221|64331763|FG003|Double-blind Phase|Withdrawal by Subject|7|||
23158726|NCT00312221|64331760|FG000|Double-blind Phase|Adverse Event|0|||
23158727|NCT00312221|64331761|FG001|Double-blind Phase|Adverse Event|10|||
23158728|NCT00312221|64331762|FG002|Double-blind Phase|Adverse Event|19|||
23158729|NCT00312221|64331763|FG003|Double-blind Phase|Adverse Event|18|||
23158730|NCT00312221|64331760|FG000|Double-blind Phase|Lost to Follow-up|0|||
23158731|NCT00312221|64331761|FG001|Double-blind Phase|Lost to Follow-up|0|||
23158732|NCT00312221|64331762|FG002|Double-blind Phase|Lost to Follow-up|2|||
23158733|NCT00312221|64331763|FG003|Double-blind Phase|Lost to Follow-up|2|||
23158734|NCT00312221|64331760|FG000|Double-blind Phase|Administrative|0|||
23158735|NCT00312221|64331761|FG001|Double-blind Phase|Administrative|26|||
23158736|NCT00312221|64331762|FG002|Double-blind Phase|Administrative|37|||
23158737|NCT00312221|64331763|FG003|Double-blind Phase|Administrative|33|||
23158738|NCT00312221|64331760|FG000|Double-blind Phase|Lack of Efficacy|0|||
23158739|NCT00312221|64331761|FG001|Double-blind Phase|Lack of Efficacy|17|||
23158740|NCT00312221|64331762|FG002|Double-blind Phase|Lack of Efficacy|6|||
23158741|NCT00312221|64331763|FG003|Double-blind Phase|Lack of Efficacy|10|||
23158742|NCT00645593|64331764|FG000|Overall Study|Later found to be ineligible|1|||
23158743|NCT00645593|64331765|FG001|Overall Study|Later found to be ineligible|0|||
23158744|NCT00814892|64331766|FG000|Overall Study|Disease Progression|1|||
23158745|NCT00814892|64331766|FG000|Overall Study|Study Termination|1|||
23328527|NCT00529087|64945487|FG001|Overall Study|Protocol deviation|1|||
23328528|NCT00529087|64945488|FG002|Overall Study|Protocol deviation|2|||
23328529|NCT00014495|64945489|FG000|Overall Study|Death|0|||
23328530|NCT00014495|64945490|FG001|Overall Study|Death|0|||
23328531|NCT00014495|64945491|FG002|Overall Study|Death|1|||
23328532|NCT00014495|64945492|FG003|Overall Study|Death|0|||
23328533|NCT00014495|64945489|FG000|Overall Study|Clinical deterioration|0|||
23328534|NCT00014495|64945490|FG001|Overall Study|Clinical deterioration|0|||
23444561|NCT01525615|65370100|FG001|Overall Study|Withdrawal by Subject|0|||
23444562|NCT01525615|65370101|FG002|Overall Study|Withdrawal by Subject|0|||
23158746|NCT01372150|64331767|FG000|Overall Study|Lack of Efficacy|3|||
23444563|NCT01525615|65370099|FG000|Overall Study|Other reason not described above|1|||
23158747|NCT01372150|64331768|FG001|Overall Study|Lack of Efficacy|0|||
23158748|NCT01372150|64331769|FG002|Overall Study|Lack of Efficacy|1|||
23158749|NCT01372150|64331767|FG000|Overall Study|Lost to Follow-up|4|||
23158750|NCT01372150|64331768|FG001|Overall Study|Lost to Follow-up|5|||
23158751|NCT01372150|64331769|FG002|Overall Study|Lost to Follow-up|6|||
23158752|NCT01372150|64331767|FG000|Overall Study|Protocol Violation|1|||
23158753|NCT01372150|64331768|FG001|Overall Study|Protocol Violation|0|||
23158754|NCT01372150|64331769|FG002|Overall Study|Protocol Violation|3|||
23328535|NCT00014495|64945491|FG002|Overall Study|Clinical deterioration|0|||
23158755|NCT01372150|64331767|FG000|Overall Study|Withdrawal by Subject|2|||
23444564|NCT01525615|65370100|FG001|Overall Study|Other reason not described above|0|||
23328536|NCT00014495|64945492|FG003|Overall Study|Clinical deterioration|1|||
23328537|NCT01870973|64945494|FG000|Overall Study|Lost to Follow-up|10|||
23328538|NCT01870973|64945495|FG001|Overall Study|Lost to Follow-up|3|||
23328539|NCT03192488|64945496|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
23328540|NCT03192488|64945497|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
23328541|NCT03192488|64945498|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
23328542|NCT03192488|64945499|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
23328543|NCT03192488|64945500|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
23328544|NCT03192488|64945501|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
23328545|NCT03192488|64945496|FG000|Third Intervention (d1)|Adverse Event|0|||
23328546|NCT03192488|64945497|FG001|Third Intervention (d1)|Adverse Event|0|||
23328547|NCT03192488|64945498|FG002|Third Intervention (d1)|Adverse Event|0|||
23328548|NCT03192488|64945499|FG003|Third Intervention (d1)|Adverse Event|0|||
23328549|NCT03192488|64945500|FG004|Third Intervention (d1)|Adverse Event|1|||
23328550|NCT03192488|64945501|FG005|Third Intervention (d1)|Adverse Event|0|||
23328551|NCT02273388|64945502|FG000|Overall Study|Adverse Event|0|||
23328552|NCT02273388|64945503|FG001|Overall Study|Adverse Event|0|||
23328553|NCT02273388|64945504|FG002|Overall Study|Adverse Event|0|||
23328554|NCT02273388|64945505|FG003|Overall Study|Adverse Event|0|||
23328555|NCT02273388|64945506|FG004|Overall Study|Adverse Event|0|||
23328556|NCT02273388|64945507|FG005|Overall Study|Adverse Event|0|||
23328557|NCT02273388|64945508|FG006|Overall Study|Adverse Event|1|||
23328558|NCT02273388|64945509|FG007|Overall Study|Adverse Event|2|||
23328559|NCT02273388|64945510|FG008|Overall Study|Adverse Event|0|||
23328560|NCT02273388|64945511|FG009|Overall Study|Adverse Event|0|||
23328561|NCT02273388|64945512|FG010|Overall Study|Adverse Event|0|||
23328562|NCT02273388|64945513|FG011|Overall Study|Adverse Event|0|||
23328563|NCT02273388|64945502|FG000|Overall Study|Adverse Event study disease worse|4|||
23328564|NCT02273388|64945503|FG001|Overall Study|Adverse Event study disease worse|3|||
23328565|NCT02273388|64945504|FG002|Overall Study|Adverse Event study disease worse|3|||
23328566|NCT02273388|64945505|FG003|Overall Study|Adverse Event study disease worse|2|||
23328567|NCT02273388|64945506|FG004|Overall Study|Adverse Event study disease worse|4|||
23328568|NCT02273388|64945507|FG005|Overall Study|Adverse Event study disease worse|3|||
23328569|NCT02273388|64945508|FG006|Overall Study|Adverse Event study disease worse|14|||
23328570|NCT02273388|64945509|FG007|Overall Study|Adverse Event study disease worse|6|||
23328571|NCT02273388|64945510|FG008|Overall Study|Adverse Event study disease worse|6|||
23328572|NCT02273388|64945511|FG009|Overall Study|Adverse Event study disease worse|5|||
23328573|NCT02273388|64945512|FG010|Overall Study|Adverse Event study disease worse|10|||
23328574|NCT02273388|64945513|FG011|Overall Study|Adverse Event study disease worse|1|||
23328575|NCT02273388|64945502|FG000|Overall Study|Sponsor decision|0|||
23328576|NCT02273388|64945503|FG001|Overall Study|Sponsor decision|0|||
23328577|NCT02273388|64945504|FG002|Overall Study|Sponsor decision|0|||
23328578|NCT02273388|64945505|FG003|Overall Study|Sponsor decision|0|||
23328579|NCT02273388|64945506|FG004|Overall Study|Sponsor decision|0|||
23328580|NCT02273388|64945507|FG005|Overall Study|Sponsor decision|0|||
23328581|NCT02273388|64945508|FG006|Overall Study|Sponsor decision|0|||
23328582|NCT02273388|64945509|FG007|Overall Study|Sponsor decision|0|||
23328583|NCT02273388|64945510|FG008|Overall Study|Sponsor decision|0|||
23328584|NCT02273388|64945511|FG009|Overall Study|Sponsor decision|0|||
23328585|NCT02273388|64945512|FG010|Overall Study|Sponsor decision|0|||
23328586|NCT02273388|64945513|FG011|Overall Study|Sponsor decision|1|||
23328587|NCT00460811|64945514|FG000|Overall Study|Adverse Event|4|||
23328588|NCT00460811|64945515|FG001|Overall Study|Adverse Event|6|||
23328589|NCT00460811|64945516|FG002|Overall Study|Adverse Event|3|||
23328590|NCT00460811|64945517|FG003|Overall Study|Adverse Event|10|||
23328591|NCT00460811|64945518|FG004|Overall Study|Adverse Event|2|||
23328592|NCT00460811|64945514|FG000|Overall Study|Noncompliance|1|||
23328593|NCT00460811|64945515|FG001|Overall Study|Noncompliance|0|||
23328594|NCT00460811|64945516|FG002|Overall Study|Noncompliance|0|||
23444565|NCT01525615|65370101|FG002|Overall Study|Other reason not described above|1|||
23444566|NCT01979952|65370102|FG000|Overall Study|Adverse Event|4|||
23444567|NCT01979952|65370103|FG001|Overall Study|Adverse Event|5|||
23328595|NCT00460811|64945517|FG003|Overall Study|Noncompliance|2|||
23328596|NCT00460811|64945518|FG004|Overall Study|Noncompliance|1|||
23328597|NCT00460811|64945514|FG000|Overall Study|Withdrawal by Subject|7|||
23328598|NCT00460811|64945515|FG001|Overall Study|Withdrawal by Subject|7|||
23328599|NCT00460811|64945516|FG002|Overall Study|Withdrawal by Subject|6|||
23328600|NCT00460811|64945517|FG003|Overall Study|Withdrawal by Subject|3|||
23328601|NCT00460811|64945518|FG004|Overall Study|Withdrawal by Subject|11|||
23328602|NCT00460811|64945514|FG000|Overall Study|Physician Decision|1|||
23328603|NCT00460811|64945515|FG001|Overall Study|Physician Decision|0|||
23328604|NCT00460811|64945516|FG002|Overall Study|Physician Decision|0|||
23328605|NCT00460811|64945517|FG003|Overall Study|Physician Decision|0|||
23328606|NCT00460811|64945518|FG004|Overall Study|Physician Decision|0|||
23328607|NCT00460811|64945514|FG000|Overall Study|Lost to Follow-up|3|||
23328608|NCT00460811|64945515|FG001|Overall Study|Lost to Follow-up|2|||
23328609|NCT00460811|64945516|FG002|Overall Study|Lost to Follow-up|5|||
23444568|NCT01979952|65370102|FG000|Overall Study|Protocol Violation|1|||
23328610|NCT00460811|64945517|FG003|Overall Study|Lost to Follow-up|3|||
23328611|NCT00460811|64945518|FG004|Overall Study|Lost to Follow-up|6|||
23328612|NCT03361306|64945521|FG000|Overall Study|Death|5|||
23328613|NCT03361306|64945521|FG000|Overall Study|Still On Study (on study treatment)|3|||
23328614|NCT03361306|64945521|FG000|Overall Study|Still On Study (in follow up)|7|||
23328615|NCT02044302|64945522|FG000|Overall Study|study terminated|2|||
23328616|NCT02044302|64945523|FG001|Overall Study|study terminated|0|||
23328617|NCT01697748|64945524|FG000|Overall Study|ineligible skin incision|1|||
23328618|NCT01697748|64945525|FG001|Overall Study|ineligible skin incision|2|||
23328619|NCT01697748|64945524|FG000|Overall Study|ineligible uterine incision|4|||
23328620|NCT01697748|64945525|FG001|Overall Study|ineligible uterine incision|1|||
23328621|NCT01697748|64945524|FG000|Overall Study|Lost to Follow-up|53|||
23328622|NCT01697748|64945525|FG001|Overall Study|Lost to Follow-up|65|||
23328623|NCT01998919|64945528|FG000|Overall Study|Death|2|||
23328624|NCT01998919|64945529|FG001|Overall Study|Death|2|||
23328625|NCT01998919|64945528|FG000|Overall Study|Adverse Event|0|||
23328626|NCT01998919|64945529|FG001|Overall Study|Adverse Event|5|||
23328627|NCT01998919|64945528|FG000|Overall Study|Disease progression|31|||
23328628|NCT01998919|64945529|FG001|Overall Study|Disease progression|22|||
23328629|NCT01998919|64945528|FG000|Overall Study|Withdrawal by Subject|2|||
23328630|NCT01998919|64945529|FG001|Overall Study|Withdrawal by Subject|4|||
23328631|NCT01998919|64945528|FG000|Overall Study|Lost to Follow-up|2|||
23328632|NCT01998919|64945529|FG001|Overall Study|Lost to Follow-up|0|||
23328633|NCT01998919|64945528|FG000|Overall Study|Other|5|||
23328634|NCT01998919|64945529|FG001|Overall Study|Other|2|||
23328635|NCT02314026|64945534|FG000|Overall Study|Protocol Violation|28|||
23328636|NCT01343043|64945541|FG000|Overall Study|Disease progression before treatment|1|||
23328637|NCT01343043|64945542|FG001|Overall Study|Disease progression before treatment|0|||
23328638|NCT01343043|64945543|FG002|Overall Study|Disease progression before treatment|0|||
23328639|NCT01343043|64945544|FG003|Overall Study|Disease progression before treatment|0|||
23444569|NCT01979952|65370103|FG001|Overall Study|Protocol Violation|0|||
23444570|NCT01979952|65370102|FG000|Overall Study|Withdrawal by Subject|2|||
23444571|NCT01979952|65370103|FG001|Overall Study|Withdrawal by Subject|1|||
23444572|NCT01979952|65370102|FG000|Overall Study|Other than specified above|1|||
23444573|NCT01979952|65370103|FG001|Overall Study|Other than specified above|0|||
23444574|NCT02644343|65370104|FG000|Overall Study|Withdrawal by Subject|1|||
23444575|NCT03003962|65370112|FG000|Overall Study|Withdrawal by Subject|5|||
23444576|NCT03003962|65370113|FG001|Overall Study|Withdrawal by Subject|17|||
23444577|NCT03003962|65370112|FG000|Overall Study|Death|274|||
23444578|NCT03003962|65370113|FG001|Overall Study|Death|277|||
23444579|NCT03003962|65370112|FG000|Overall Study|Participants ongoing at DCO|55|||
23444580|NCT03003962|65370113|FG001|Overall Study|Participants ongoing at DCO|40|||
23444581|NCT01136408|65370118|FG000|Overall Study|Adverse Event|4|||
23444582|NCT01136408|65370119|FG001|Overall Study|Adverse Event|8|||
23444583|NCT01136408|65370120|FG002|Overall Study|Adverse Event|4|||
23444584|NCT01136408|65370118|FG000|Overall Study|Protocol Violation|1|||
23444585|NCT01136408|65370119|FG001|Overall Study|Protocol Violation|1|||
23444586|NCT01136408|65370120|FG002|Overall Study|Protocol Violation|1|||
23444587|NCT01378325|65370121|FG000|Overall Study|Protocol Violation|0|||
23444588|NCT01378325|65370122|FG001|Overall Study|Protocol Violation|1|||
23444589|NCT05011513|65370123|FG000|Overall Study|Death|0|||
23567022|NCT01576718|65803972|FG003|Treatment Period|Withdrawal by Subject|0|||
23567023|NCT01576718|65803973|FG004|Treatment Period|Withdrawal by Subject|2|||
23567024|NCT01576718|65803974|FG005|Treatment Period|Withdrawal by Subject|4|||
23567025|NCT01576718|65803975|FG006|Treatment Period|Withdrawal by Subject|2|||
23567026|NCT01576718|65803969|FG000|Treatment Period|Physician Decision|0|||
23567027|NCT01576718|65803970|FG001|Treatment Period|Physician Decision|1|||
23567028|NCT01576718|65803971|FG002|Treatment Period|Physician Decision|1|||
23567029|NCT01576718|65803972|FG003|Treatment Period|Physician Decision|1|||
23567030|NCT01576718|65803973|FG004|Treatment Period|Physician Decision|1|||
23567031|NCT01576718|65803974|FG005|Treatment Period|Physician Decision|0|||
23567032|NCT01576718|65803975|FG006|Treatment Period|Physician Decision|0|||
23567033|NCT01576718|65803969|FG000|Treatment Period|Protocol Violation|0|||
23567034|NCT01576718|65803970|FG001|Treatment Period|Protocol Violation|5|||
23567035|NCT01576718|65803971|FG002|Treatment Period|Protocol Violation|4|||
23328640|NCT01343043|64945541|FG000|Overall Study|Withdrawal by Subject|1|||
23567036|NCT01576718|65803972|FG003|Treatment Period|Protocol Violation|10|||
23567037|NCT01576718|65803973|FG004|Treatment Period|Protocol Violation|6|||
23328641|NCT01343043|64945542|FG001|Overall Study|Withdrawal by Subject|0|||
23328642|NCT01343043|64945543|FG002|Overall Study|Withdrawal by Subject|0|||
23328643|NCT01343043|64945544|FG003|Overall Study|Withdrawal by Subject|0|||
23328644|NCT01343043|64945541|FG000|Overall Study|Death|1|||
23444590|NCT05011513|65370124|FG001|Overall Study|Death|1|||
23567038|NCT01576718|65803974|FG005|Treatment Period|Protocol Violation|8|||
23328645|NCT01343043|64945542|FG001|Overall Study|Death|1|||
23328646|NCT01343043|64945543|FG002|Overall Study|Death|0|||
23444591|NCT05011513|65370123|FG000|Overall Study|Lost to Follow-up|4|||
23444592|NCT05011513|65370124|FG001|Overall Study|Lost to Follow-up|0|||
23628761|NCT01010204|66028104|FG000|Overall Study|Adverse Event|1|||
23628762|NCT01010204|66028105|FG001|Overall Study|Adverse Event|3|||
23628763|NCT01010204|66028104|FG000|Overall Study|Withdrawal by Subject|2|||
23628764|NCT01010204|66028105|FG001|Overall Study|Withdrawal by Subject|3|||
23628765|NCT01010204|66028104|FG000|Overall Study|psychiatric hospitalization|2|||
23628766|NCT01010204|66028105|FG001|Overall Study|psychiatric hospitalization|1|||
23628767|NCT04147195|66028106|FG000|Overall Study|Adverse Event|0|||
23628768|NCT04147195|66028107|FG001|Overall Study|Adverse Event|3|||
23628769|NCT04147195|66028106|FG000|Overall Study|Study Terminated by Sponsor|4|||
23628770|NCT04147195|66028107|FG001|Overall Study|Study Terminated by Sponsor|2|||
23628771|NCT04147195|66028106|FG000|Overall Study|Withdrawal by Subject|0|||
23328647|NCT01343043|64945544|FG003|Overall Study|Death|1|||
23328648|NCT02623725|64945545|FG000|Overall Study|Non compliance with protocol|9|||
23328649|NCT02623725|64945546|FG001|Overall Study|Non compliance with protocol|3|||
23328650|NCT02623725|64945545|FG000|Overall Study|Serious adverse event|0|||
23328651|NCT02623725|64945546|FG001|Overall Study|Serious adverse event|2|||
23328652|NCT02623725|64945545|FG000|Overall Study|Withdrawal by Subject|7|||
23328653|NCT02623725|64945546|FG001|Overall Study|Withdrawal by Subject|1|||
23328654|NCT02564900|64945553|FG000|Dose Escalation|Progressive disease per RECIST|2|||
23328655|NCT02564900|64945554|FG001|Dose Escalation|Progressive disease per RECIST|3|||
23328656|NCT02564900|64945555|FG002|Dose Escalation|Progressive disease per RECIST|3|||
23328657|NCT02564900|64945556|FG003|Dose Escalation|Progressive disease per RECIST|3|||
23328658|NCT02564900|64945557|FG004|Dose Escalation|Progressive disease per RECIST|3|||
23328659|NCT02564900|64945558|FG005|Dose Escalation|Progressive disease per RECIST|1|||
23328660|NCT02564900|64945559|FG006|Dose Escalation|Progressive disease per RECIST|0|||
23328661|NCT02564900|64945560|FG007|Dose Escalation|Progressive disease per RECIST|0|||
23328662|NCT02564900|64945561|FG008|Dose Escalation|Progressive disease per RECIST|0|||
23328663|NCT02564900|64945562|FG009|Dose Escalation|Progressive disease per RECIST|0|||
23328664|NCT02564900|64945563|FG010|Dose Escalation|Progressive disease per RECIST|0|||
23328665|NCT02564900|64945564|FG011|Dose Escalation|Progressive disease per RECIST|0|||
23628772|NCT04147195|66028107|FG001|Overall Study|Withdrawal by Subject|1|||
23628773|NCT01485120|66028108|FG000|Overall Study|Withdrawal by Subject|2|||
23222324|NCT02603172|64557649|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
23222325|NCT04847141|64557655|FG000|Overall Study|Adverse Event|1|||
23222326|NCT04847141|64557656|FG001|Overall Study|Adverse Event|0|||
23222327|NCT04847141|64557657|FG002|Overall Study|Adverse Event|1|||
23222328|NCT04847141|64557655|FG000|Overall Study|Withdrawal by Subject|2|||
23222329|NCT04847141|64557656|FG001|Overall Study|Withdrawal by Subject|4|||
23222330|NCT04847141|64557657|FG002|Overall Study|Withdrawal by Subject|3|||
23222331|NCT04847141|64557655|FG000|Overall Study|Lost to Follow-up|7|||
23222332|NCT04847141|64557656|FG001|Overall Study|Lost to Follow-up|5|||
23222333|NCT04847141|64557657|FG002|Overall Study|Lost to Follow-up|7|||
23222334|NCT04847141|64557655|FG000|Overall Study|Reason not Specified|0|||
23222335|NCT04847141|64557656|FG001|Overall Study|Reason not Specified|1|||
23222336|NCT04847141|64557657|FG002|Overall Study|Reason not Specified|0|||
23222337|NCT02756845|64557658|FG000|Overall Study|Death|12|||
23222338|NCT02756845|64557659|FG001|Overall Study|Death|2|||
23222339|NCT02756845|64557658|FG000|Overall Study|Withdrawal by Subject|1|||
23328666|NCT02564900|64945565|FG012|Dose Escalation|Progressive disease per RECIST|0|||
23628774|NCT02201901|66028110|FG000|Overall Study|Randomized but never treated|0|||
23628775|NCT02201901|66028111|FG001|Overall Study|Randomized but never treated|1|||
23628776|NCT02201901|66028112|FG002|Overall Study|Randomized but never treated|0|||
23628777|NCT02201901|66028110|FG000|Overall Study|Lack of Efficacy|7|||
23628778|NCT02201901|66028111|FG001|Overall Study|Lack of Efficacy|1|||
23628779|NCT02201901|66028112|FG002|Overall Study|Lack of Efficacy|6|||
23628780|NCT02201901|66028110|FG000|Overall Study|Death|3|||
23628781|NCT02201901|66028111|FG001|Overall Study|Death|3|||
23628782|NCT02201901|66028112|FG002|Overall Study|Death|3|||
23628783|NCT02201901|66028110|FG000|Overall Study|Lost to Follow-up|2|||
23628784|NCT02201901|66028111|FG001|Overall Study|Lost to Follow-up|3|||
23628785|NCT02201901|66028112|FG002|Overall Study|Lost to Follow-up|2|||
23222340|NCT02756845|64557659|FG001|Overall Study|Withdrawal by Subject|0|||
23328667|NCT02564900|64945566|FG013|Dose Escalation|Progressive disease per RECIST|0|||
23328668|NCT02564900|64945567|FG014|Dose Escalation|Progressive disease per RECIST|0|||
23328669|NCT02564900|64945553|FG000|Dose Escalation|Ongoing|1|||
23328670|NCT02564900|64945554|FG001|Dose Escalation|Ongoing|0|||
23328671|NCT02564900|64945555|FG002|Dose Escalation|Ongoing|0|||
23328672|NCT02564900|64945556|FG003|Dose Escalation|Ongoing|2|||
23328673|NCT02564900|64945557|FG004|Dose Escalation|Ongoing|2|||
23328674|NCT02564900|64945558|FG005|Dose Escalation|Ongoing|2|||
23328675|NCT02564900|64945559|FG006|Dose Escalation|Ongoing|0|||
23328676|NCT02564900|64945560|FG007|Dose Escalation|Ongoing|0|||
23222341|NCT01600105|64557660|FG000|Total Participants|Withdrawal by Subject|1|||
23628786|NCT02201901|66028110|FG000|Overall Study|Withdrew Consent|2|||
23628787|NCT02201901|66028111|FG001|Overall Study|Withdrew Consent|0|||
23628788|NCT02201901|66028112|FG002|Overall Study|Withdrew Consent|2|||
23628789|NCT02201901|66028110|FG000|Overall Study|Adverse Event|1|||
23328677|NCT02564900|64945561|FG008|Dose Escalation|Ongoing|0|||
23328678|NCT02564900|64945562|FG009|Dose Escalation|Ongoing|0|||
23328679|NCT02564900|64945563|FG010|Dose Escalation|Ongoing|0|||
23628790|NCT02201901|66028111|FG001|Overall Study|Adverse Event|1|||
23628791|NCT02201901|66028112|FG002|Overall Study|Adverse Event|0|||
23628792|NCT01781832|66028113|FG000|Overall Study|Withdrawal by Subject|1|||
23628793|NCT01375751|66028114|FG000|Overall Study|Other|0|||
23628794|NCT01375751|66028115|FG001|Overall Study|Other|1|||
23628795|NCT01375751|66028116|FG002|Overall Study|Other|0|||
23628796|NCT01210651|66028119|FG000|Overall Study|Lost to Follow-up|1|||
23628797|NCT01210651|66028120|FG001|Overall Study|Lost to Follow-up|1|||
23158756|NCT01372150|64331768|FG001|Overall Study|Withdrawal by Subject|7|||
23158757|NCT01372150|64331769|FG002|Overall Study|Withdrawal by Subject|2|||
23158758|NCT01372150|64331767|FG000|Overall Study|Other|1|||
23158759|NCT01372150|64331768|FG001|Overall Study|Other|0|||
23158760|NCT01372150|64331769|FG002|Overall Study|Other|2|||
23158761|NCT01372150|64331767|FG000|Overall Study|Adverse Event|2|||
23158762|NCT01372150|64331768|FG001|Overall Study|Adverse Event|1|||
23158763|NCT01372150|64331769|FG002|Overall Study|Adverse Event|2|||
23158764|NCT01372150|64331767|FG000|Overall Study|Randomized but not treated|0|||
23158765|NCT01372150|64331768|FG001|Overall Study|Randomized but not treated|1|||
23158766|NCT01372150|64331769|FG002|Overall Study|Randomized but not treated|0|||
23158767|NCT03016325|64331770|FG000|Treatment Period|Participant withdrew consent|0|||
23158768|NCT03016325|64331771|FG001|Treatment Period|Participant withdrew consent|1|||
23158769|NCT03016325|64331772|FG002|Treatment Period|Participant withdrew consent|0|||
23158770|NCT03016325|64331773|FG003|Treatment Period|Participant withdrew consent|0|||
23158771|NCT03016325|64331774|FG004|Treatment Period|Participant withdrew consent|0|||
23328680|NCT02564900|64945564|FG011|Dose Escalation|Ongoing|0|||
23328681|NCT02564900|64945565|FG012|Dose Escalation|Ongoing|0|||
23328682|NCT02564900|64945566|FG013|Dose Escalation|Ongoing|0|||
23328683|NCT02564900|64945567|FG014|Dose Escalation|Ongoing|0|||
23328684|NCT02564900|64945553|FG000|Dose Escalation|Adverse Event|0|||
23328685|NCT02564900|64945554|FG001|Dose Escalation|Adverse Event|0|||
23328686|NCT02564900|64945555|FG002|Dose Escalation|Adverse Event|0|||
23328687|NCT02564900|64945556|FG003|Dose Escalation|Adverse Event|1|||
23328688|NCT02564900|64945557|FG004|Dose Escalation|Adverse Event|1|||
23328689|NCT02564900|64945558|FG005|Dose Escalation|Adverse Event|3|||
23328690|NCT02564900|64945559|FG006|Dose Escalation|Adverse Event|0|||
23328691|NCT02564900|64945560|FG007|Dose Escalation|Adverse Event|0|||
23328692|NCT02564900|64945561|FG008|Dose Escalation|Adverse Event|0|||
23328693|NCT02564900|64945562|FG009|Dose Escalation|Adverse Event|0|||
23328694|NCT02564900|64945563|FG010|Dose Escalation|Adverse Event|0|||
23328695|NCT02564900|64945564|FG011|Dose Escalation|Adverse Event|0|||
23328696|NCT02564900|64945565|FG012|Dose Escalation|Adverse Event|0|||
23328697|NCT02564900|64945566|FG013|Dose Escalation|Adverse Event|0|||
23328698|NCT02564900|64945567|FG014|Dose Escalation|Adverse Event|0|||
23328699|NCT02564900|64945553|FG000|Dose Expansion|Progressive disease per RECIST|0|||
23328700|NCT02564900|64945554|FG001|Dose Expansion|Progressive disease per RECIST|0|||
23328701|NCT02564900|64945555|FG002|Dose Expansion|Progressive disease per RECIST|0|||
23328702|NCT02564900|64945556|FG003|Dose Expansion|Progressive disease per RECIST|0|||
23328703|NCT02564900|64945557|FG004|Dose Expansion|Progressive disease per RECIST|0|||
23328704|NCT02564900|64945558|FG005|Dose Expansion|Progressive disease per RECIST|0|||
23328705|NCT02564900|64945559|FG006|Dose Expansion|Progressive disease per RECIST|19|||
23328706|NCT02564900|64945560|FG007|Dose Expansion|Progressive disease per RECIST|17|||
23328707|NCT02564900|64945561|FG008|Dose Expansion|Progressive disease per RECIST|8|||
23328708|NCT02564900|64945562|FG009|Dose Expansion|Progressive disease per RECIST|16|||
23328709|NCT02564900|64945563|FG010|Dose Expansion|Progressive disease per RECIST|13|||
23328710|NCT02564900|64945564|FG011|Dose Expansion|Progressive disease per RECIST|19|||
23328711|NCT02564900|64945565|FG012|Dose Expansion|Progressive disease per RECIST|10|||
23328712|NCT02564900|64945566|FG013|Dose Expansion|Progressive disease per RECIST|13|||
23328713|NCT02564900|64945567|FG014|Dose Expansion|Progressive disease per RECIST|11|||
23328714|NCT02564900|64945553|FG000|Dose Expansion|Clinical progression|0|||
23328715|NCT02564900|64945554|FG001|Dose Expansion|Clinical progression|0|||
23158772|NCT03016325|64331775|FG005|Treatment Period|Participant withdrew consent|0|||
23158773|NCT03016325|64331776|FG006|Treatment Period|Participant withdrew consent|0|||
23328716|NCT02564900|64945555|FG002|Dose Expansion|Clinical progression|0|||
23328717|NCT02564900|64945556|FG003|Dose Expansion|Clinical progression|0|||
23328718|NCT02564900|64945557|FG004|Dose Expansion|Clinical progression|0|||
23328719|NCT02564900|64945558|FG005|Dose Expansion|Clinical progression|0|||
23328720|NCT02564900|64945559|FG006|Dose Expansion|Clinical progression|5|||
23328721|NCT02564900|64945560|FG007|Dose Expansion|Clinical progression|12|||
23328722|NCT02564900|64945561|FG008|Dose Expansion|Clinical progression|0|||
23628798|NCT01210651|66028119|FG000|Overall Study|schedule conflicts|1|||
23628799|NCT01210651|66028120|FG001|Overall Study|schedule conflicts|5|||
23158774|NCT03016325|64331777|FG007|Treatment Period|Participant withdrew consent|0|||
23158775|NCT03016325|64331770|FG000|Treatment Period|Death|0|||
23158776|NCT03016325|64331771|FG001|Treatment Period|Death|0|||
23328723|NCT02564900|64945562|FG009|Dose Expansion|Clinical progression|3|||
23328724|NCT02564900|64945563|FG010|Dose Expansion|Clinical progression|2|||
23328725|NCT02564900|64945564|FG011|Dose Expansion|Clinical progression|0|||
23328726|NCT02564900|64945565|FG012|Dose Expansion|Clinical progression|1|||
23328727|NCT02564900|64945566|FG013|Dose Expansion|Clinical progression|3|||
23328728|NCT02564900|64945567|FG014|Dose Expansion|Clinical progression|1|||
23328729|NCT02564900|64945553|FG000|Dose Expansion|Adverse Event|0|||
23328730|NCT02564900|64945554|FG001|Dose Expansion|Adverse Event|0|||
23328731|NCT02564900|64945555|FG002|Dose Expansion|Adverse Event|0|||
23328732|NCT02564900|64945556|FG003|Dose Expansion|Adverse Event|0|||
23328733|NCT02564900|64945557|FG004|Dose Expansion|Adverse Event|0|||
23328734|NCT02564900|64945558|FG005|Dose Expansion|Adverse Event|0|||
23328735|NCT02564900|64945559|FG006|Dose Expansion|Adverse Event|9|||
23328736|NCT02564900|64945560|FG007|Dose Expansion|Adverse Event|22|||
23328737|NCT02564900|64945561|FG008|Dose Expansion|Adverse Event|0|||
23328738|NCT02564900|64945562|FG009|Dose Expansion|Adverse Event|11|||
23328739|NCT02564900|64945563|FG010|Dose Expansion|Adverse Event|0|||
23328740|NCT02564900|64945564|FG011|Dose Expansion|Adverse Event|5|||
23328741|NCT02564900|64945565|FG012|Dose Expansion|Adverse Event|2|||
23328742|NCT02564900|64945566|FG013|Dose Expansion|Adverse Event|2|||
23328743|NCT02564900|64945567|FG014|Dose Expansion|Adverse Event|1|||
23328744|NCT02564900|64945553|FG000|Dose Expansion|Ongoing|0|||
23328745|NCT02564900|64945554|FG001|Dose Expansion|Ongoing|0|||
23328746|NCT02564900|64945555|FG002|Dose Expansion|Ongoing|0|||
23328747|NCT02564900|64945556|FG003|Dose Expansion|Ongoing|0|||
23328748|NCT02564900|64945557|FG004|Dose Expansion|Ongoing|0|||
23328749|NCT02564900|64945558|FG005|Dose Expansion|Ongoing|0|||
23328750|NCT02564900|64945559|FG006|Dose Expansion|Ongoing|9|||
23328751|NCT02564900|64945560|FG007|Dose Expansion|Ongoing|10|||
23328752|NCT02564900|64945561|FG008|Dose Expansion|Ongoing|11|||
23328753|NCT02564900|64945562|FG009|Dose Expansion|Ongoing|3|||
23328754|NCT02564900|64945563|FG010|Dose Expansion|Ongoing|0|||
23328755|NCT02564900|64945564|FG011|Dose Expansion|Ongoing|0|||
23328756|NCT02564900|64945565|FG012|Dose Expansion|Ongoing|4|||
23328757|NCT02564900|64945566|FG013|Dose Expansion|Ongoing|0|||
23328758|NCT02564900|64945567|FG014|Dose Expansion|Ongoing|6|||
23328759|NCT02564900|64945553|FG000|Dose Expansion|Death|0|||
23328760|NCT02564900|64945554|FG001|Dose Expansion|Death|0|||
23158777|NCT03016325|64331772|FG002|Treatment Period|Death|0|||
23158778|NCT03016325|64331773|FG003|Treatment Period|Death|0|||
23158779|NCT03016325|64331774|FG004|Treatment Period|Death|2|||
23158780|NCT03016325|64331775|FG005|Treatment Period|Death|0|||
23158781|NCT03016325|64331776|FG006|Treatment Period|Death|0|||
23158782|NCT03016325|64331777|FG007|Treatment Period|Death|0|||
23158783|NCT03016325|64331770|FG000|Treatment Period|Participant refuses assessments|0|||
23158784|NCT03016325|64331771|FG001|Treatment Period|Participant refuses assessments|0|||
23158785|NCT03016325|64331772|FG002|Treatment Period|Participant refuses assessments|1|||
23158786|NCT03016325|64331773|FG003|Treatment Period|Participant refuses assessments|0|||
23158787|NCT03016325|64331774|FG004|Treatment Period|Participant refuses assessments|0|||
23158788|NCT03016325|64331775|FG005|Treatment Period|Participant refuses assessments|0|||
23158789|NCT03016325|64331776|FG006|Treatment Period|Participant refuses assessments|0|||
23158790|NCT03016325|64331777|FG007|Treatment Period|Participant refuses assessments|0|||
23158791|NCT03016325|64331770|FG000|32-Day Follow-Up Period|Death|2|||
23158792|NCT03016325|64331771|FG001|32-Day Follow-Up Period|Death|0|||
23158793|NCT03016325|64331772|FG002|32-Day Follow-Up Period|Death|5|||
23158794|NCT03016325|64331773|FG003|32-Day Follow-Up Period|Death|6|||
23158795|NCT03016325|64331774|FG004|32-Day Follow-Up Period|Death|3|||
23158796|NCT03016325|64331775|FG005|32-Day Follow-Up Period|Death|0|||
23158797|NCT03016325|64331776|FG006|32-Day Follow-Up Period|Death|0|||
23158798|NCT03016325|64331777|FG007|32-Day Follow-Up Period|Death|0|||
23158799|NCT03016325|64331770|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
23158800|NCT03016325|64331771|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
23158801|NCT03016325|64331772|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
23158802|NCT03016325|64331773|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
23158803|NCT03016325|64331774|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
23158804|NCT03016325|64331775|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
23158805|NCT03016325|64331776|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
23328761|NCT02564900|64945555|FG002|Dose Expansion|Death|0|||
23328762|NCT02564900|64945556|FG003|Dose Expansion|Death|0|||
23328763|NCT02564900|64945557|FG004|Dose Expansion|Death|0|||
23328764|NCT02564900|64945558|FG005|Dose Expansion|Death|0|||
23328765|NCT02564900|64945559|FG006|Dose Expansion|Death|1|||
23328766|NCT02564900|64945560|FG007|Dose Expansion|Death|0|||
23328767|NCT02564900|64945561|FG008|Dose Expansion|Death|0|||
23328768|NCT02564900|64945562|FG009|Dose Expansion|Death|0|||
23328769|NCT02564900|64945563|FG010|Dose Expansion|Death|1|||
23158806|NCT03016325|64331777|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
23158807|NCT03016325|64331770|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
23328770|NCT02564900|64945564|FG011|Dose Expansion|Death|0|||
23328771|NCT02564900|64945565|FG012|Dose Expansion|Death|1|||
23328772|NCT02564900|64945566|FG013|Dose Expansion|Death|1|||
23328773|NCT02564900|64945567|FG014|Dose Expansion|Death|0|||
23158808|NCT03016325|64331771|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
23158809|NCT03016325|64331772|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
23158810|NCT03016325|64331773|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
23158811|NCT03016325|64331774|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
23158812|NCT03016325|64331775|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
23158813|NCT03016325|64331776|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
23158814|NCT03016325|64331777|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
23158815|NCT03016325|64331770|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
23158816|NCT03016325|64331771|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
23158817|NCT03016325|64331772|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
23158818|NCT03016325|64331773|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
23158819|NCT03016325|64331774|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
23158820|NCT03016325|64331775|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
23158821|NCT03016325|64331776|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
23158822|NCT03016325|64331777|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
23158823|NCT03016325|64331770|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
23158824|NCT03016325|64331771|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
23158825|NCT03016325|64331772|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
23158826|NCT03016325|64331773|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
23158827|NCT03016325|64331774|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
23158828|NCT03016325|64331775|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
23158829|NCT03016325|64331776|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
23158830|NCT03016325|64331777|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
23158831|NCT03016325|64331770|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23158832|NCT03016325|64331771|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23158833|NCT03016325|64331772|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
23158834|NCT03016325|64331773|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23158835|NCT03016325|64331774|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23444593|NCT05011513|65370123|FG000|Overall Study|Withdrawal by Subject|18|||
23444594|NCT05011513|65370124|FG001|Overall Study|Withdrawal by Subject|17|||
23444595|NCT05011513|65370123|FG000|Overall Study|Other|4|||
23444596|NCT05011513|65370124|FG001|Overall Study|Other|2|||
23444597|NCT00434642|65370125|FG000|Blinded Treatment Phase|Adverse Event|12|||
23444598|NCT00434642|65370126|FG001|Blinded Treatment Phase|Adverse Event|58|||
23444599|NCT00434642|65370125|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
23444600|NCT00434642|65370126|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
23444601|NCT00434642|65370125|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
23328774|NCT02564900|64945553|FG000|Dose Expansion|Withdrawal by Subject|0|||
23444602|NCT00434642|65370126|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
23444603|NCT00434642|65370125|FG000|Blinded Treatment Phase|Physician Decision|19|||
23444604|NCT00434642|65370126|FG001|Blinded Treatment Phase|Physician Decision|27|||
23444605|NCT00434642|65370125|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
23444606|NCT00434642|65370126|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
23444607|NCT00434642|65370125|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
23444608|NCT00434642|65370126|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
23444609|NCT00434642|65370125|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
23444610|NCT00434642|65370126|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
23567039|NCT01576718|65803975|FG006|Treatment Period|Protocol Violation|12|||
23567040|NCT01576718|65803969|FG000|Treatment Period|Sponsor request|0|||
23567041|NCT01576718|65803970|FG001|Treatment Period|Sponsor request|1|||
23567042|NCT01576718|65803971|FG002|Treatment Period|Sponsor request|0|||
23567043|NCT01576718|65803972|FG003|Treatment Period|Sponsor request|0|||
23567044|NCT01576718|65803973|FG004|Treatment Period|Sponsor request|0|||
23567045|NCT01576718|65803974|FG005|Treatment Period|Sponsor request|1|||
23444611|NCT00434642|65370125|FG000|Open-label Treatment Phase|Adverse Event|0|||
23567046|NCT01576718|65803975|FG006|Treatment Period|Sponsor request|0|||
23567047|NCT01576718|65803969|FG000|Treatment Period|Met stopping criteria|0|||
23567048|NCT01576718|65803970|FG001|Treatment Period|Met stopping criteria|16|||
23158836|NCT03016325|64331775|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23158837|NCT03016325|64331776|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23158838|NCT03016325|64331777|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
23158839|NCT03016325|64331770|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23328775|NCT02564900|64945554|FG001|Dose Expansion|Withdrawal by Subject|0|||
23444612|NCT00434642|65370126|FG001|Open-label Treatment Phase|Adverse Event|5|||
23444613|NCT00434642|65370125|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
23567049|NCT01576718|65803971|FG002|Treatment Period|Met stopping criteria|13|||
23567050|NCT01576718|65803972|FG003|Treatment Period|Met stopping criteria|19|||
23567051|NCT01576718|65803973|FG004|Treatment Period|Met stopping criteria|16|||
23567052|NCT01576718|65803974|FG005|Treatment Period|Met stopping criteria|33|||
23328776|NCT02564900|64945555|FG002|Dose Expansion|Withdrawal by Subject|0|||
23328777|NCT02564900|64945556|FG003|Dose Expansion|Withdrawal by Subject|0|||
23444614|NCT00434642|65370126|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
23444615|NCT03464019|65370127|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
23444616|NCT03464019|65370128|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
23444617|NCT03464019|65370129|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
23444618|NCT03464019|65370127|FG000|NODE-301 Part 1|Ablation|0|||
23444619|NCT03464019|65370128|FG001|NODE-301 Part 1|Ablation|0|||
23444620|NCT03464019|65370129|FG002|NODE-301 Part 1|Ablation|16|||
23444621|NCT03464019|65370127|FG000|NODE-301 Part 1|Test Dose Failure|0|||
23444622|NCT03464019|65370128|FG001|NODE-301 Part 1|Test Dose Failure|0|||
23444623|NCT03464019|65370129|FG002|NODE-301 Part 1|Test Dose Failure|8|||
23444624|NCT03464019|65370127|FG000|NODE-301 Part 1|Adverse Event|0|||
23444625|NCT03464019|65370128|FG001|NODE-301 Part 1|Adverse Event|0|||
23444626|NCT03464019|65370129|FG002|NODE-301 Part 1|Adverse Event|5|||
23444627|NCT03464019|65370127|FG000|NODE-301 Part 1|Physician Decision|0|||
23444628|NCT03464019|65370128|FG001|NODE-301 Part 1|Physician Decision|0|||
23444629|NCT03464019|65370129|FG002|NODE-301 Part 1|Physician Decision|4|||
23444630|NCT03464019|65370127|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
23444631|NCT03464019|65370128|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
23444632|NCT03464019|65370129|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
23444633|NCT03464019|65370127|FG000|NODE-301 Part 1|Protocol Violation|0|||
23444634|NCT03464019|65370128|FG001|NODE-301 Part 1|Protocol Violation|0|||
23444635|NCT03464019|65370129|FG002|NODE-301 Part 1|Protocol Violation|2|||
23444636|NCT03464019|65370127|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
23444637|NCT03464019|65370128|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
23444638|NCT03464019|65370129|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
23444639|NCT03464019|65370127|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
23444640|NCT03464019|65370128|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
23444641|NCT03464019|65370129|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
23444642|NCT03464019|65370127|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
23444643|NCT03464019|65370128|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
23444644|NCT03464019|65370129|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
23444645|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
23444646|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
23444647|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
23444648|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
23444649|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
23444650|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
23444651|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
23444652|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
23444653|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
23444654|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
23444655|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
23444656|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
23444657|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
23444658|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
23444659|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
23444660|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
23444661|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
23444662|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
23444663|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
23444664|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
23444665|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
23444666|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
23444667|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
23444668|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
23328778|NCT02564900|64945557|FG004|Dose Expansion|Withdrawal by Subject|0|||
23328779|NCT02564900|64945558|FG005|Dose Expansion|Withdrawal by Subject|0|||
23328780|NCT02564900|64945559|FG006|Dose Expansion|Withdrawal by Subject|4|||
23444669|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
23158840|NCT03016325|64331771|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
23158841|NCT03016325|64331772|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23328781|NCT02564900|64945560|FG007|Dose Expansion|Withdrawal by Subject|0|||
23444670|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
23444671|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
23444672|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
23444673|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
23328782|NCT02564900|64945561|FG008|Dose Expansion|Withdrawal by Subject|0|||
23444674|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
23444675|NCT03464019|65370127|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
23328783|NCT02564900|64945562|FG009|Dose Expansion|Withdrawal by Subject|0|||
23444676|NCT03464019|65370128|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
23444677|NCT03464019|65370129|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
23444678|NCT00565851|65370130|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
23444679|NCT00565851|65370131|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
23444680|NCT00565851|65370132|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
23444681|NCT00565851|65370133|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
23444682|NCT00565851|65370134|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
23444683|NCT00565851|65370135|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
23444684|NCT00565851|65370136|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
23444685|NCT00565851|65370137|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
23444686|NCT00565851|65370130|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
23444687|NCT00565851|65370131|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
23444688|NCT00565851|65370132|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
23444689|NCT00565851|65370133|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
23158842|NCT03016325|64331773|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23158843|NCT03016325|64331774|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23158844|NCT03016325|64331775|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23158845|NCT03016325|64331776|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23444690|NCT00565851|65370134|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
23444691|NCT00565851|65370135|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
23444692|NCT00565851|65370136|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
23444693|NCT00565851|65370137|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
23444694|NCT00666224|65370138|FG000|Double-Blind|Adverse Event|15|||
23444695|NCT00666224|65370139|FG001|Double-Blind|Adverse Event|5|||
23444696|NCT00666224|65370138|FG000|Double-Blind|Lost to Follow-up|2|||
23444697|NCT00666224|65370139|FG001|Double-Blind|Lost to Follow-up|2|||
23444698|NCT00666224|65370138|FG000|Double-Blind|Withdrawal by Subject|18|||
23444699|NCT00666224|65370139|FG001|Double-Blind|Withdrawal by Subject|14|||
23444700|NCT00666224|65370138|FG000|Double-Blind|Physician Decision|0|||
23444701|NCT00666224|65370139|FG001|Double-Blind|Physician Decision|3|||
23444702|NCT00666224|65370138|FG000|Double-Blind|Sponsor decision|1|||
23444703|NCT00666224|65370139|FG001|Double-Blind|Sponsor decision|0|||
23444704|NCT00666224|65370138|FG000|Double-Blind|Pregnancy|3|||
23444705|NCT00666224|65370139|FG001|Double-Blind|Pregnancy|2|||
23444706|NCT00666224|65370138|FG000|Double-Blind|Noncompliance|1|||
23444707|NCT00666224|65370139|FG001|Double-Blind|Noncompliance|0|||
23444708|NCT00666224|65370138|FG000|Double-Blind|Death|1|||
23444709|NCT00666224|65370139|FG001|Double-Blind|Death|0|||
23444710|NCT00666224|65370138|FG000|Double-Blind|Undefined/Unknown|4|||
23444711|NCT00666224|65370139|FG001|Double-Blind|Undefined/Unknown|1|||
23444712|NCT00666224|65370138|FG000|Open-Label|Adverse Event|8|||
23444713|NCT00666224|65370139|FG001|Open-Label|Adverse Event|43|||
23444714|NCT00666224|65370138|FG000|Open-Label|Lost to Follow-up|4|||
23444715|NCT00666224|65370139|FG001|Open-Label|Lost to Follow-up|5|||
23444716|NCT00666224|65370138|FG000|Open-Label|Withdrawal by Subject|12|||
23444717|NCT00666224|65370139|FG001|Open-Label|Withdrawal by Subject|25|||
23567053|NCT01576718|65803975|FG006|Treatment Period|Met stopping criteria|15|||
23567054|NCT01576718|65803969|FG000|Treatment Period|Lost to Follow-up|0|||
23567055|NCT01576718|65803970|FG001|Treatment Period|Lost to Follow-up|0|||
23567056|NCT01576718|65803971|FG002|Treatment Period|Lost to Follow-up|0|||
23567057|NCT01576718|65803972|FG003|Treatment Period|Lost to Follow-up|0|||
23567058|NCT01576718|65803973|FG004|Treatment Period|Lost to Follow-up|1|||
23158846|NCT03016325|64331777|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
23158847|NCT03016325|64331770|FG000|182-Day Follow-Up Period|Death|3|||
23158848|NCT03016325|64331771|FG001|182-Day Follow-Up Period|Death|3|||
23158849|NCT03016325|64331772|FG002|182-Day Follow-Up Period|Death|11|||
23158850|NCT03016325|64331773|FG003|182-Day Follow-Up Period|Death|12|||
23158851|NCT03016325|64331774|FG004|182-Day Follow-Up Period|Death|9|||
23158852|NCT03016325|64331775|FG005|182-Day Follow-Up Period|Death|0|||
23158853|NCT03016325|64331776|FG006|182-Day Follow-Up Period|Death|0|||
23158854|NCT03016325|64331777|FG007|182-Day Follow-Up Period|Death|1|||
23158855|NCT03016325|64331770|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
23158856|NCT03016325|64331771|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23158857|NCT03016325|64331772|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23158858|NCT03016325|64331773|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23158859|NCT03016325|64331774|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23328784|NCT02564900|64945563|FG010|Dose Expansion|Withdrawal by Subject|1|||
23444718|NCT00666224|65370138|FG000|Open-Label|Physician Decision|7|||
23567059|NCT01576718|65803974|FG005|Treatment Period|Lost to Follow-up|0|||
23567060|NCT01576718|65803975|FG006|Treatment Period|Lost to Follow-up|0|||
23158860|NCT03016325|64331775|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23328785|NCT02564900|64945564|FG011|Dose Expansion|Withdrawal by Subject|0|||
23444719|NCT00666224|65370139|FG001|Open-Label|Physician Decision|5|||
23444720|NCT00666224|65370138|FG000|Open-Label|Pregnancy|1|||
23444721|NCT00666224|65370139|FG001|Open-Label|Pregnancy|5|||
23444722|NCT00666224|65370138|FG000|Open-Label|Noncompliance|2|||
23444723|NCT00666224|65370139|FG001|Open-Label|Noncompliance|1|||
23444724|NCT00666224|65370138|FG000|Open-Label|Undefined/Unknown|1|||
23444725|NCT00666224|65370139|FG001|Open-Label|Undefined/Unknown|1|||
23444726|NCT03081884|65370145|FG000|Overall Study|deferred prostate cancer treatment|1|||
23444727|NCT03081884|65370145|FG000|Overall Study|metastasis managed with systemic therapy|3|||
23444728|NCT01080807|65370146|FG000|Overall Study|Adverse Event|9|||
23444729|NCT01080807|65370147|FG001|Overall Study|Adverse Event|1|||
23444730|NCT01080807|65370146|FG000|Overall Study|Lack of Efficacy|0|||
23444731|NCT01080807|65370147|FG001|Overall Study|Lack of Efficacy|1|||
23444732|NCT01080807|65370146|FG000|Overall Study|Withdrawal by Subject|7|||
23444733|NCT01080807|65370147|FG001|Overall Study|Withdrawal by Subject|2|||
23444734|NCT01080807|65370146|FG000|Overall Study|Protocol Violation|7|||
23444735|NCT01080807|65370147|FG001|Overall Study|Protocol Violation|6|||
23444736|NCT01080807|65370146|FG000|Overall Study|Lost to Follow-up|6|||
23444737|NCT01080807|65370147|FG001|Overall Study|Lost to Follow-up|4|||
23444738|NCT01080807|65370146|FG000|Overall Study|Noncompliance with drug administration|1|||
23444739|NCT01080807|65370147|FG001|Overall Study|Noncompliance with drug administration|1|||
23444740|NCT01080807|65370146|FG000|Overall Study|Noncompliance to study procedures|1|||
23444741|NCT01080807|65370147|FG001|Overall Study|Noncompliance to study procedures|1|||
23444742|NCT01080807|65370146|FG000|Overall Study|Began working day shift|0|||
23444743|NCT01080807|65370147|FG001|Overall Study|Began working day shift|2|||
23444744|NCT01080807|65370146|FG000|Overall Study|Laid off or terminated from job|1|||
23444745|NCT01080807|65370147|FG001|Overall Study|Laid off or terminated from job|2|||
23444746|NCT01080807|65370146|FG000|Overall Study|Stopped working consistent night shifts|0|||
23328786|NCT02564900|64945565|FG012|Dose Expansion|Withdrawal by Subject|0|||
23328787|NCT02564900|64945566|FG013|Dose Expansion|Withdrawal by Subject|1|||
23328788|NCT02564900|64945567|FG014|Dose Expansion|Withdrawal by Subject|1|||
23328789|NCT02564900|64945553|FG000|Dose Expansion|Other|0|||
23328790|NCT02564900|64945554|FG001|Dose Expansion|Other|0|||
23328791|NCT02564900|64945555|FG002|Dose Expansion|Other|0|||
23328792|NCT02564900|64945556|FG003|Dose Expansion|Other|0|||
23444747|NCT01080807|65370147|FG001|Overall Study|Stopped working consistent night shifts|1|||
23444748|NCT01080807|65370146|FG000|Overall Study|Work schedule changing|1|||
23444749|NCT01080807|65370147|FG001|Overall Study|Work schedule changing|1|||
23444750|NCT01080807|65370146|FG000|Overall Study|Work schedule and travel|0|||
23444751|NCT01080807|65370147|FG001|Overall Study|Work schedule and travel|1|||
23444752|NCT01080807|65370146|FG000|Overall Study|Switched to first shift|1|||
23444753|NCT01080807|65370147|FG001|Overall Study|Switched to first shift|0|||
23444754|NCT01080807|65370146|FG000|Overall Study|Moved away without notifying center|1|||
23444755|NCT01080807|65370147|FG001|Overall Study|Moved away without notifying center|0|||
23444756|NCT02652156|65370148|FG000|Overall Study|Physician Decision|1|||
23444757|NCT02652156|65370149|FG001|Overall Study|Physician Decision|0|||
23444758|NCT02652156|65370150|FG002|Overall Study|Physician Decision|0|||
23444759|NCT00740584|65370151|FG000|Overall Study|Withdrawal by Subject|1|||
23567061|NCT01576718|65803969|FG000|Treatment Period|Noncompliance to study medication|0|||
23567062|NCT01576718|65803970|FG001|Treatment Period|Noncompliance to study medication|0|||
23567063|NCT01576718|65803971|FG002|Treatment Period|Noncompliance to study medication|0|||
23567064|NCT01576718|65803972|FG003|Treatment Period|Noncompliance to study medication|0|||
23567065|NCT01576718|65803973|FG004|Treatment Period|Noncompliance to study medication|0|||
23567066|NCT01576718|65803974|FG005|Treatment Period|Noncompliance to study medication|1|||
23567067|NCT01576718|65803975|FG006|Treatment Period|Noncompliance to study medication|1|||
23567068|NCT00544544|65803976|FG000|Overall Study|Withdrawal by Subject|1|||
23567069|NCT00544544|65803976|FG000|Overall Study|Adverse Event|1|||
23567070|NCT00544544|65803976|FG000|Overall Study|Lost to Follow-up|1|||
23567071|NCT01993017|65803977|FG000|Overall Study|Death|23|||
23567072|NCT01993017|65803978|FG001|Overall Study|Death|26|||
23567073|NCT01993017|65803979|FG002|Overall Study|Death|18|||
23567074|NCT01993017|65803977|FG000|Overall Study|Could not be contacted|43|||
23567075|NCT01993017|65803978|FG001|Overall Study|Could not be contacted|42|||
23158861|NCT03016325|64331776|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23158862|NCT03016325|64331777|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
23158863|NCT03016325|64331770|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
23328793|NCT02564900|64945557|FG004|Dose Expansion|Other|0|||
23328794|NCT02564900|64945558|FG005|Dose Expansion|Other|0|||
23444760|NCT01518374|65370155|FG000|Overall Study|Withdrawal by Subject|2|||
23444761|NCT01518374|65370155|FG000|Overall Study|Protocol Violation|3|||
23444762|NCT01518374|65370155|FG000|Overall Study|Lost to Follow-up|2|||
23444763|NCT00731679|65370156|FG000|Overall Study|Adverse Event|7|||
23567076|NCT01993017|65803979|FG002|Overall Study|Could not be contacted|38|||
23567077|NCT01993017|65803977|FG000|Overall Study|Dropped out|19|||
23567078|NCT01993017|65803978|FG001|Overall Study|Dropped out|6|||
23567079|NCT01993017|65803979|FG002|Overall Study|Dropped out|11|||
23444764|NCT00731679|65370157|FG001|Overall Study|Adverse Event|8|||
23444765|NCT00731679|65370156|FG000|Overall Study|Withdrawal by Subject|8|||
23444766|NCT00731679|65370157|FG001|Overall Study|Withdrawal by Subject|8|||
23444767|NCT00731679|65370156|FG000|Overall Study|Lost to Follow-up|7|||
23444768|NCT00731679|65370157|FG001|Overall Study|Lost to Follow-up|8|||
23444769|NCT00731679|65370156|FG000|Overall Study|Noncompliance|0|||
23444770|NCT00731679|65370157|FG001|Overall Study|Noncompliance|1|||
23444771|NCT00731679|65370156|FG000|Overall Study|Pregnancy|0|||
23444772|NCT00731679|65370157|FG001|Overall Study|Pregnancy|1|||
23444773|NCT03116685|65370158|FG000|Overall Study|Physician Decision|0|||
23444774|NCT03116685|65370159|FG001|Overall Study|Physician Decision|1|||
23444775|NCT00479856|65370161|FG000|Overall Study|Adverse Event|1|||
23444776|NCT00479856|65370161|FG000|Overall Study|Withdrawal by Subject|1|||
23444777|NCT00479856|65370161|FG000|Overall Study|Physician Decision|1|||
23444778|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
23444779|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
23444780|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
23444781|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
23444782|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
23444783|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
23444784|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
23444785|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
23444786|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
23444787|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
23444788|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
23444789|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
23444790|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
23444791|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
23444792|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
23444793|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
23444794|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
23444795|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
23444796|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
23444797|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
23444798|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
23444799|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
23444800|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
23444801|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
23444802|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
23444803|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
23444804|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
23444805|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
23444806|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
23444807|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
23444808|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
23444809|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
23444810|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
23444811|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
23444812|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
23444813|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
23567080|NCT01993017|65803977|FG000|Overall Study|Other reasons|17|||
23567081|NCT01993017|65803978|FG001|Overall Study|Other reasons|11|||
23567082|NCT01993017|65803979|FG002|Overall Study|Other reasons|7|||
23567083|NCT01993017|65803977|FG000|Overall Study|Ineligible after randomization|4|||
23567084|NCT01993017|65803978|FG001|Overall Study|Ineligible after randomization|5|||
23567085|NCT01993017|65803979|FG002|Overall Study|Ineligible after randomization|5|||
23628800|NCT01210651|66028119|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
23628801|NCT01210651|66028120|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
23628802|NCT01210651|66028119|FG000|Overall Study|Withdrawal by Subject|1|||
23628803|NCT01210651|66028120|FG001|Overall Study|Withdrawal by Subject|1|||
23328795|NCT02564900|64945559|FG006|Dose Expansion|Other|1|||
23444814|NCT02586623|65370162|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
23444815|NCT02586623|65370163|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
23567086|NCT02961374|65803980|FG000|Overall Study|Adverse Event|4|||
23567087|NCT03872388|65803981|FG000|Overall Study|Disease Progression|0|||
23567088|NCT03872388|65803982|FG001|Overall Study|Disease Progression|0|||
23567089|NCT03872388|65803983|FG002|Overall Study|Disease Progression|0|||
23567090|NCT03872388|65803984|FG003|Overall Study|Disease Progression|0|||
23567091|NCT03872388|65803985|FG004|Overall Study|Disease Progression|0|||
23567092|NCT03872388|65803986|FG005|Overall Study|Disease Progression|0|||
23567093|NCT03872388|65803987|FG006|Overall Study|Disease Progression|1|||
23628804|NCT01210651|66028119|FG000|Overall Study|Injury outside study|2|||
23628805|NCT01210651|66028120|FG001|Overall Study|Injury outside study|0|||
23628806|NCT03566979|66028121|FG000|Overall Study|Withdrawal by Subject|2|||
23628807|NCT03566979|66028122|FG001|Overall Study|Withdrawal by Subject|0|||
23628808|NCT03566979|66028123|FG002|Overall Study|Withdrawal by Subject|1|||
23628809|NCT03566979|66028124|FG003|Overall Study|Withdrawal by Subject|1|||
23628810|NCT03566979|66028121|FG000|Overall Study|Lost to Follow-up|2|||
23628811|NCT03566979|66028122|FG001|Overall Study|Lost to Follow-up|7|||
23628812|NCT03566979|66028123|FG002|Overall Study|Lost to Follow-up|9|||
23628813|NCT03566979|66028124|FG003|Overall Study|Lost to Follow-up|5|||
23628814|NCT03566979|66028121|FG000|Overall Study|Adverse Event|1|||
23628815|NCT03566979|66028122|FG001|Overall Study|Adverse Event|0|||
23628816|NCT03566979|66028123|FG002|Overall Study|Adverse Event|0|||
23628817|NCT03566979|66028124|FG003|Overall Study|Adverse Event|0|||
23628818|NCT00208325|66028131|FG000|Overall Study|Death|18|||
23628819|NCT00208325|66028132|FG001|Overall Study|Death|19|||
23628820|NCT00208325|66028133|FG002|Overall Study|Death|7|||
23628821|NCT00208325|66028134|FG003|Overall Study|Death|5|||
23628822|NCT00208325|66028131|FG000|Overall Study|Withdrawal by Subject|0|||
23628823|NCT00208325|66028132|FG001|Overall Study|Withdrawal by Subject|1|||
23628824|NCT00208325|66028133|FG002|Overall Study|Withdrawal by Subject|0|||
23628825|NCT00208325|66028134|FG003|Overall Study|Withdrawal by Subject|0|||
23628826|NCT00208325|66028131|FG000|Overall Study|Revision|4|||
23628827|NCT00208325|66028132|FG001|Overall Study|Revision|1|||
23628828|NCT00208325|66028133|FG002|Overall Study|Revision|0|||
23628829|NCT00208325|66028134|FG003|Overall Study|Revision|4|||
23628830|NCT00208325|66028131|FG000|Overall Study|Lost to Follow-up|1|||
23628831|NCT00208325|66028132|FG001|Overall Study|Lost to Follow-up|0|||
23628832|NCT00208325|66028133|FG002|Overall Study|Lost to Follow-up|2|||
23628833|NCT00208325|66028134|FG003|Overall Study|Lost to Follow-up|0|||
23628834|NCT00208325|66028131|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
23628835|NCT00208325|66028132|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
23628836|NCT00208325|66028133|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
23222342|NCT01600105|64557661|FG001|Total Participants|Withdrawal by Subject|0|||
23222343|NCT01600105|64557660|FG000|Total Participants|No images in PACS|10|||
23222344|NCT01600105|64557661|FG001|Total Participants|No images in PACS|0|||
23222345|NCT01600105|64557660|FG000|Total Participants|Insufficient image quality|30|||
23222346|NCT01600105|64557661|FG001|Total Participants|Insufficient image quality|10|||
23222347|NCT01600105|64557660|FG000|Sub Study I|Insufficient image quality|0|||
23222348|NCT01600105|64557661|FG001|Sub Study I|Insufficient image quality|10|||
23222349|NCT01600105|64557660|FG000|Sub Study II|Withdrawal by Subject|1|||
23222350|NCT01600105|64557661|FG001|Sub Study II|Withdrawal by Subject|0|||
23222351|NCT01600105|64557660|FG000|Sub Study II|No images in PACS|1|||
23222352|NCT01600105|64557661|FG001|Sub Study II|No images in PACS|0|||
23222353|NCT01600105|64557660|FG000|Sub Study II|Insufficient image quality|3|||
23222354|NCT01600105|64557661|FG001|Sub Study II|Insufficient image quality|0|||
23222355|NCT01600105|64557660|FG000|Sub Study III|Insufficient image quality|5|||
23222356|NCT01600105|64557661|FG001|Sub Study III|Insufficient image quality|0|||
23222357|NCT01600105|64557660|FG000|Sub Study V|Poor Image Quality|2|||
23222358|NCT01600105|64557661|FG001|Sub Study V|Poor Image Quality|0|||
23222359|NCT02963766|64557662|FG000|Double-Blind Period|Adverse Event|1|||
23222360|NCT02963766|64557663|FG001|Double-Blind Period|Adverse Event|0|||
23222361|NCT02963766|64557664|FG002|Double-Blind Period|Adverse Event|1|||
23222362|NCT02963766|64557662|FG000|Double-Blind Period|Physician Decision|1|||
23222363|NCT02963766|64557663|FG001|Double-Blind Period|Physician Decision|0|||
23222364|NCT02963766|64557664|FG002|Double-Blind Period|Physician Decision|0|||
23222365|NCT02963766|64557662|FG000|Double-Blind Period|Withdrawal by Subject|1|||
23328796|NCT02564900|64945560|FG007|Dose Expansion|Other|0|||
23628837|NCT00208325|66028134|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
23628838|NCT00208325|66028131|FG000|Overall Study|Does not wish to Continue in Study|5|||
23628839|NCT00208325|66028132|FG001|Overall Study|Does not wish to Continue in Study|8|||
23222366|NCT02963766|64557663|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23222367|NCT02963766|64557664|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23222368|NCT02963766|64557662|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
23222369|NCT02963766|64557663|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
23222370|NCT02963766|64557664|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
23222371|NCT02963766|64557662|FG000|Double-Blind Period|Protocol Violation|1|||
23222372|NCT02963766|64557663|FG001|Double-Blind Period|Protocol Violation|0|||
23328797|NCT02564900|64945561|FG008|Dose Expansion|Other|1|||
23328798|NCT02564900|64945562|FG009|Dose Expansion|Other|0|||
23628840|NCT00208325|66028133|FG002|Overall Study|Does not wish to Continue in Study|3|||
23628841|NCT00208325|66028134|FG003|Overall Study|Does not wish to Continue in Study|2|||
23628842|NCT00208325|66028131|FG000|Overall Study|Other|2|||
23628843|NCT00208325|66028132|FG001|Overall Study|Other|1|||
23628844|NCT00208325|66028133|FG002|Overall Study|Other|1|||
23628845|NCT00208325|66028134|FG003|Overall Study|Other|0|||
23628846|NCT00208325|66028131|FG000|Overall Study|Mis-Randomized|17|||
23628847|NCT00208325|66028132|FG001|Overall Study|Mis-Randomized|20|||
23628848|NCT00208325|66028133|FG002|Overall Study|Mis-Randomized|0|||
23222373|NCT02963766|64557664|FG002|Double-Blind Period|Protocol Violation|0|||
23222374|NCT02963766|64557662|FG000|Double-Blind Period|Lost to Follow-up|0|||
23222375|NCT02963766|64557663|FG001|Double-Blind Period|Lost to Follow-up|1|||
23328799|NCT02564900|64945563|FG010|Dose Expansion|Other|0|||
23328800|NCT02564900|64945564|FG011|Dose Expansion|Other|0|||
23328801|NCT02564900|64945565|FG012|Dose Expansion|Other|0|||
23328802|NCT02564900|64945566|FG013|Dose Expansion|Other|0|||
23328803|NCT02564900|64945567|FG014|Dose Expansion|Other|1|||
23328804|NCT02564900|64945553|FG000|Dose Expansion|Did not receive treatment|0|||
23328805|NCT02564900|64945554|FG001|Dose Expansion|Did not receive treatment|0|||
23328806|NCT02564900|64945555|FG002|Dose Expansion|Did not receive treatment|0|||
23328807|NCT02564900|64945556|FG003|Dose Expansion|Did not receive treatment|0|||
23328808|NCT02564900|64945557|FG004|Dose Expansion|Did not receive treatment|0|||
23328809|NCT02564900|64945558|FG005|Dose Expansion|Did not receive treatment|0|||
23328810|NCT02564900|64945559|FG006|Dose Expansion|Did not receive treatment|1|||
23328811|NCT02564900|64945560|FG007|Dose Expansion|Did not receive treatment|1|||
23328812|NCT02564900|64945561|FG008|Dose Expansion|Did not receive treatment|0|||
23328813|NCT02564900|64945562|FG009|Dose Expansion|Did not receive treatment|0|||
23328814|NCT02564900|64945563|FG010|Dose Expansion|Did not receive treatment|0|||
23328815|NCT02564900|64945564|FG011|Dose Expansion|Did not receive treatment|0|||
23328816|NCT02564900|64945565|FG012|Dose Expansion|Did not receive treatment|0|||
23328817|NCT02564900|64945566|FG013|Dose Expansion|Did not receive treatment|0|||
23328818|NCT02564900|64945567|FG014|Dose Expansion|Did not receive treatment|1|||
23328819|NCT00495391|64945568|FG000|Overall Study|Lack of Efficacy|34|||
23328820|NCT00495391|64945569|FG001|Overall Study|Lack of Efficacy|18|||
23328821|NCT00495391|64945568|FG000|Overall Study|Withdrawal by Subject|2|||
23328822|NCT00495391|64945569|FG001|Overall Study|Withdrawal by Subject|3|||
23328823|NCT00733421|64945570|FG000|Overall Study|Withdrawal by Subject|1|||
23328824|NCT00733421|64945571|FG001|Overall Study|Withdrawal by Subject|1|||
23328825|NCT03631706|64945572|FG000|Overall Study|Randomized, not treated|1|||
23328826|NCT03631706|64945573|FG001|Overall Study|Randomized, not treated|0|||
23328827|NCT03631706|64945572|FG000|Overall Study|Treatment ongoing|26|||
23328828|NCT03631706|64945573|FG001|Overall Study|Treatment ongoing|57|||
23328829|NCT03631706|64945572|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
23328830|NCT03631706|64945573|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
23328831|NCT04200651|64945574|FG000|Overall Study|Moved to another country during follow-up|2|||
23328832|NCT04200651|64945575|FG001|Overall Study|Moved to another country during follow-up|2|||
23328833|NCT04200651|64945574|FG000|Overall Study|Lost to Follow-up|1|||
23328834|NCT04200651|64945575|FG001|Overall Study|Lost to Follow-up|3|||
23328835|NCT00764660|64945576|FG000|Overall Study|Adverse Event|6|||
23328836|NCT00764660|64945577|FG001|Overall Study|Adverse Event|3|||
23328837|NCT00764660|64945576|FG000|Overall Study|Lost to Follow-up|3|||
23328838|NCT00764660|64945577|FG001|Overall Study|Lost to Follow-up|4|||
23328839|NCT00764660|64945576|FG000|Overall Study|Withdrawal by Subject|7|||
23328840|NCT00764660|64945577|FG001|Overall Study|Withdrawal by Subject|3|||
23328841|NCT00764660|64945576|FG000|Overall Study|Noncompliance With Protocol|5|||
23328842|NCT00764660|64945577|FG001|Overall Study|Noncompliance With Protocol|1|||
23328843|NCT00764660|64945576|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
23328844|NCT00764660|64945577|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
23328845|NCT00658723|64945578|FG000|Overall Study|Lost to Follow-up|0|||
23328846|NCT00658723|64945579|FG001|Overall Study|Lost to Follow-up|2|||
23328847|NCT00658723|64945580|FG002|Overall Study|Lost to Follow-up|2|||
23328848|NCT00658723|64945578|FG000|Overall Study|Death|2|||
23328849|NCT00658723|64945579|FG001|Overall Study|Death|1|||
23328850|NCT00658723|64945580|FG002|Overall Study|Death|4|||
23222376|NCT02963766|64557664|FG002|Double-Blind Period|Lost to Follow-up|0|||
23222377|NCT02963766|64557662|FG000|Open Label Extension (OLE)|Physician Decision|1|||
23222378|NCT02963766|64557663|FG001|Open Label Extension (OLE)|Physician Decision|2|||
23222379|NCT02963766|64557664|FG002|Open Label Extension (OLE)|Physician Decision|2|||
23222380|NCT02963766|64557662|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
23222381|NCT02963766|64557663|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
23222382|NCT02963766|64557664|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
23222383|NCT04083794|64557670|FG000|Overall Study|Lost to Follow-up|9|||
23222384|NCT02723019|64557671|FG000|Overall Study|Death|17|||
23222385|NCT02723019|64557672|FG001|Overall Study|Death|13|||
23222386|NCT02723019|64557671|FG000|Overall Study|Withdrawal by Subject|11|||
23328851|NCT00658723|64945578|FG000|Overall Study|Scheduling Issue|1|||
23567094|NCT03872388|65803988|FG007|Overall Study|Disease Progression|1|||
23567095|NCT00332332|65803989|FG000|Overall Study|Adverse Event|13|||
23567096|NCT00332332|65803989|FG000|Overall Study|Death|1|||
23222387|NCT02723019|64557672|FG001|Overall Study|Withdrawal by Subject|7|||
23328852|NCT00658723|64945579|FG001|Overall Study|Scheduling Issue|1|||
23328853|NCT00658723|64945580|FG002|Overall Study|Scheduling Issue|0|||
23328854|NCT00658723|64945578|FG000|Overall Study|Withdrawal by Subject|1|||
23567097|NCT00332332|65803989|FG000|Overall Study|Withdrawal by Subject|8|||
23328855|NCT00658723|64945579|FG001|Overall Study|Withdrawal by Subject|0|||
23328856|NCT00658723|64945580|FG002|Overall Study|Withdrawal by Subject|1|||
23328857|NCT02549859|64945581|FG000|Long-term 60 Hz DBS|Study Closed|1|||
23328858|NCT03802825|64945582|FG000|Overall Study|Lost to follow-up for intervention|12|||
23328859|NCT03802825|64945583|FG001|Overall Study|Lost to follow-up for intervention|3|||
23328860|NCT03802825|64945582|FG000|Overall Study|Received only 1 component of intervention|0|||
23328861|NCT03802825|64945583|FG001|Overall Study|Received only 1 component of intervention|13|||
23328862|NCT01113892|64945584|FG000|Overall Study|Lost to Follow-up|2|||
23328863|NCT01113892|64945585|FG001|Overall Study|Lost to Follow-up|2|||
23328864|NCT01113892|64945584|FG000|Overall Study|Withdrawal by Subject|1|||
23328865|NCT01113892|64945585|FG001|Overall Study|Withdrawal by Subject|1|||
23328866|NCT01113892|64945584|FG000|Overall Study|Death|2|||
23328867|NCT01113892|64945585|FG001|Overall Study|Death|4|||
23328868|NCT01113892|64945584|FG000|Overall Study|Graft no longer evaluable|9|||
23328869|NCT01113892|64945585|FG001|Overall Study|Graft no longer evaluable|9|||
23328870|NCT00954941|64945586|FG000|Overall Study|Received treatment at home|1|||
23328871|NCT00954941|64945587|FG001|Overall Study|Received treatment at home|0|||
23328872|NCT00954941|64945586|FG000|Overall Study|Withdrawal by Subject|1|||
23328873|NCT00954941|64945587|FG001|Overall Study|Withdrawal by Subject|0|||
23328874|NCT00954941|64945586|FG000|Overall Study|Insurance Denial|2|||
23328875|NCT00954941|64945587|FG001|Overall Study|Insurance Denial|2|||
23328876|NCT00954941|64945586|FG000|Overall Study|Physician Decision|2|||
23328877|NCT00954941|64945587|FG001|Overall Study|Physician Decision|2|||
23328878|NCT00954941|64945586|FG000|Overall Study|Ineligible|2|||
23328879|NCT00954941|64945587|FG001|Overall Study|Ineligible|2|||
23328880|NCT00954941|64945586|FG000|Overall Study|Adverse Event|0|||
23328881|NCT00954941|64945587|FG001|Overall Study|Adverse Event|1|||
23328882|NCT03367819|64945588|FG000|Overall Study|Adverse Event|4|||
23328883|NCT03367819|64945589|FG001|Overall Study|Adverse Event|4|||
23328884|NCT03367819|64945588|FG000|Overall Study|Progressive Disease|15|||
23328885|NCT03367819|64945589|FG001|Overall Study|Progressive Disease|13|||
23328886|NCT03367819|64945588|FG000|Overall Study|Withdrawal by Subject|1|||
23328887|NCT03367819|64945589|FG001|Overall Study|Withdrawal by Subject|0|||
23328888|NCT03367819|64945588|FG000|Overall Study|Other|4|||
23328889|NCT03367819|64945589|FG001|Overall Study|Other|2|||
23328890|NCT00669669|64945590|FG000|Overall Study|To late to start treatment|1|||
23158864|NCT03016325|64331771|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
23158865|NCT03016325|64331772|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
23158866|NCT03016325|64331773|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
23567098|NCT00332332|65803989|FG000|Overall Study|Physician Decision|1|||
23158867|NCT03016325|64331774|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
23222388|NCT02723019|64557671|FG000|Overall Study|Lost to Follow-up|57|||
23222389|NCT02723019|64557672|FG001|Overall Study|Lost to Follow-up|70|||
23328891|NCT00793871|64945593|FG000|Overall Study|Death|50|||
23158868|NCT03016325|64331775|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
23158869|NCT03016325|64331776|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
23158870|NCT03016325|64331777|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
23158871|NCT03016325|64331770|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23158872|NCT03016325|64331771|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23158873|NCT03016325|64331772|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23158874|NCT03016325|64331773|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23158875|NCT03016325|64331774|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
23158876|NCT03016325|64331775|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23158877|NCT03016325|64331776|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23158878|NCT03016325|64331777|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
23158879|NCT03016325|64331770|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
23158880|NCT03016325|64331771|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
23158881|NCT03016325|64331772|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
23158882|NCT03016325|64331773|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
23158883|NCT03016325|64331774|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
23158884|NCT03016325|64331775|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
23158885|NCT03016325|64331776|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
23158886|NCT03016325|64331777|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
23158887|NCT03016325|64331770|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23328892|NCT00793871|64945593|FG000|Overall Study|Lost to Follow-up|3|||
23328893|NCT00793871|64945593|FG000|Overall Study|Study terminated by the Sponsor|7|||
23328894|NCT00707239|64945596|FG000|Overall Study|Adverse Event|5|||
23222390|NCT05041062|64557680|FG000|Overall Study|Adverse Event|2|||
23328895|NCT00707239|64945597|FG001|Overall Study|Adverse Event|3|||
23328896|NCT00707239|64945598|FG002|Overall Study|Adverse Event|2|||
23328897|NCT00707239|64945596|FG000|Overall Study|Death|3|||
23567099|NCT00332332|65803989|FG000|Overall Study|Lost to Follow-up|3|||
23567100|NCT00332332|65803989|FG000|Overall Study|Protocol deviation|4|||
23567101|NCT00332332|65803989|FG000|Overall Study|Noncompliance|2|||
23567102|NCT00332332|65803989|FG000|Overall Study|Disease progression|2|||
23567103|NCT00332332|65803989|FG000|Overall Study|Other|18|||
23328898|NCT00707239|64945597|FG001|Overall Study|Death|1|||
23328899|NCT00707239|64945598|FG002|Overall Study|Death|3|||
23328900|NCT00707239|64945596|FG000|Overall Study|Physician Decision|1|||
23328901|NCT00707239|64945597|FG001|Overall Study|Physician Decision|1|||
23328902|NCT00707239|64945598|FG002|Overall Study|Physician Decision|2|||
23328903|NCT00707239|64945596|FG000|Overall Study|Protocol Violation|0|||
23328904|NCT00707239|64945597|FG001|Overall Study|Protocol Violation|0|||
23328905|NCT00707239|64945598|FG002|Overall Study|Protocol Violation|1|||
23328906|NCT00707239|64945596|FG000|Overall Study|Lack of Efficacy|1|||
23328907|NCT00707239|64945597|FG001|Overall Study|Lack of Efficacy|2|||
23328908|NCT00707239|64945598|FG002|Overall Study|Lack of Efficacy|0|||
23328909|NCT00707239|64945596|FG000|Overall Study|Randomized, but not treated|1|||
23328910|NCT00707239|64945597|FG001|Overall Study|Randomized, but not treated|1|||
23328911|NCT00707239|64945598|FG002|Overall Study|Randomized, but not treated|1|||
23328912|NCT00707239|64945596|FG000|Overall Study|Other|8|||
23328913|NCT00707239|64945597|FG001|Overall Study|Other|3|||
23328914|NCT00707239|64945598|FG002|Overall Study|Other|5|||
23328915|NCT01277601|64945602|FG000|Overall Study|Adverse Event|5|||
23328916|NCT01277601|64945603|FG001|Overall Study|Adverse Event|3|||
23328917|NCT01277601|64945604|FG002|Overall Study|Adverse Event|0|||
23328918|NCT01277601|64945605|FG003|Overall Study|Adverse Event|7|||
23328919|NCT01277601|64945602|FG000|Overall Study|Withdrawal by Subject|18|||
23328920|NCT01277601|64945603|FG001|Overall Study|Withdrawal by Subject|21|||
23328921|NCT01277601|64945604|FG002|Overall Study|Withdrawal by Subject|8|||
23328922|NCT01277601|64945605|FG003|Overall Study|Withdrawal by Subject|17|||
23328923|NCT01277601|64945602|FG000|Overall Study|Lost to Follow-up|7|||
23328924|NCT01277601|64945603|FG001|Overall Study|Lost to Follow-up|9|||
23328925|NCT01277601|64945604|FG002|Overall Study|Lost to Follow-up|4|||
23328926|NCT01277601|64945605|FG003|Overall Study|Lost to Follow-up|2|||
23328927|NCT01277601|64945602|FG000|Overall Study|Physician Decision|3|||
23328928|NCT01277601|64945603|FG001|Overall Study|Physician Decision|5|||
23328929|NCT01277601|64945604|FG002|Overall Study|Physician Decision|1|||
23328930|NCT01277601|64945605|FG003|Overall Study|Physician Decision|6|||
23328931|NCT01277601|64945602|FG000|Overall Study|Pregnancy|2|||
23328932|NCT01277601|64945603|FG001|Overall Study|Pregnancy|2|||
23328933|NCT01277601|64945604|FG002|Overall Study|Pregnancy|4|||
23328934|NCT01277601|64945605|FG003|Overall Study|Pregnancy|1|||
23328935|NCT01277601|64945602|FG000|Overall Study|Noncompliance with Study Drug|1|||
23328936|NCT01277601|64945603|FG001|Overall Study|Noncompliance with Study Drug|3|||
23328937|NCT01277601|64945604|FG002|Overall Study|Noncompliance with Study Drug|2|||
23328938|NCT01277601|64945605|FG003|Overall Study|Noncompliance with Study Drug|0|||
23328939|NCT01277601|64945602|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
23328940|NCT01277601|64945603|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
23328941|NCT01277601|64945604|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
23328942|NCT01277601|64945605|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
23328943|NCT01277601|64945602|FG000|Overall Study|Protocol Violation|0|||
23328944|NCT01277601|64945603|FG001|Overall Study|Protocol Violation|2|||
23328945|NCT01277601|64945604|FG002|Overall Study|Protocol Violation|5|||
23328946|NCT01277601|64945605|FG003|Overall Study|Protocol Violation|0|||
23328947|NCT01277601|64945602|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
23328948|NCT01277601|64945603|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
23328949|NCT01277601|64945604|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
23328950|NCT01277601|64945605|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
23328951|NCT02502149|64945606|FG000|Intermediate|Discontinued prematurely|1|||
23328952|NCT02502149|64945607|FG001|Intermediate|Discontinued prematurely|0|||
23328953|NCT02502149|64945608|FG002|Intermediate|Discontinued prematurely|0|||
23328954|NCT02502149|64945609|FG003|Intermediate|Discontinued prematurely|0|||
23328955|NCT02502149|64945610|FG004|Intermediate|Discontinued prematurely|0|||
23328956|NCT00568451|64945611|FG000|Overall Study|Disease Progression|0|||
23328957|NCT00568451|64945612|FG001|Overall Study|Disease Progression|0|||
23328958|NCT00568451|64945613|FG002|Overall Study|Disease Progression|2|||
23328959|NCT00568451|64945614|FG003|Overall Study|Disease Progression|7|||
23328960|NCT04421131|64945616|FG000|Overall Study|Lost to Follow-up|1|||
23328961|NCT04421131|64945616|FG000|Overall Study|Protocol Violation|2|||
23328962|NCT04421131|64945616|FG000|Overall Study|App crashed|5|||
23222391|NCT01838213|64557681|FG000|Overall Study|Ineligible|166|||
23328963|NCT02570308|64945619|FG000|Overall Study|Death|1|||
23328964|NCT02570308|64945620|FG001|Overall Study|Death|5|||
23328965|NCT02570308|64945621|FG002|Overall Study|Death|4|||
23328966|NCT02570308|64945622|FG003|Overall Study|Death|4|||
23328967|NCT02570308|64945623|FG004|Overall Study|Death|69|||
23328968|NCT02570308|64945619|FG000|Overall Study|Lost to Follow-up|0|||
23328969|NCT02570308|64945620|FG001|Overall Study|Lost to Follow-up|0|||
23328970|NCT02570308|64945621|FG002|Overall Study|Lost to Follow-up|0|||
23328971|NCT02570308|64945622|FG003|Overall Study|Lost to Follow-up|0|||
23328972|NCT02570308|64945623|FG004|Overall Study|Lost to Follow-up|2|||
23328973|NCT02570308|64945619|FG000|Overall Study|Withdrawal by Subject|0|||
23328974|NCT02570308|64945620|FG001|Overall Study|Withdrawal by Subject|0|||
23328975|NCT02570308|64945621|FG002|Overall Study|Withdrawal by Subject|0|||
23328976|NCT02570308|64945622|FG003|Overall Study|Withdrawal by Subject|0|||
23328977|NCT02570308|64945623|FG004|Overall Study|Withdrawal by Subject|1|||
23328978|NCT02570308|64945619|FG000|Overall Study|Other|0|||
23328979|NCT02570308|64945620|FG001|Overall Study|Other|0|||
23328980|NCT02570308|64945621|FG002|Overall Study|Other|0|||
23328981|NCT02570308|64945622|FG003|Overall Study|Other|0|||
23328982|NCT02570308|64945623|FG004|Overall Study|Other|2|||
23328983|NCT01537042|64945624|FG000|Overall Study|Adverse Event|0|||
23328984|NCT01537042|64945625|FG001|Overall Study|Adverse Event|2|||
23328985|NCT01537042|64945624|FG000|Overall Study|Lack of Efficacy|0|||
23328986|NCT01537042|64945625|FG001|Overall Study|Lack of Efficacy|1|||
23328987|NCT01537042|64945624|FG000|Overall Study|Protocol Violation|0|||
23328988|NCT01537042|64945625|FG001|Overall Study|Protocol Violation|1|||
23328989|NCT01537042|64945624|FG000|Overall Study|Other|0|||
23328990|NCT01537042|64945625|FG001|Overall Study|Other|1|||
23328991|NCT00063934|64945626|FG000|Overall Study|Ineligible|1|||
23328992|NCT03759392|64945635|FG000|Overall Study|Adverse Event|12|||
23328993|NCT03759392|64945636|FG001|Overall Study|Adverse Event|4|||
23328994|NCT03759392|64945635|FG000|Overall Study|Death|2|||
23158888|NCT03016325|64331771|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23158889|NCT03016325|64331772|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23328995|NCT03759392|64945636|FG001|Overall Study|Death|1|||
23328996|NCT03759392|64945635|FG000|Overall Study|Withdrawal by Subject|2|||
23328997|NCT03759392|64945636|FG001|Overall Study|Withdrawal by Subject|0|||
23158890|NCT03016325|64331773|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
23158891|NCT03016325|64331774|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23158892|NCT03016325|64331775|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23158893|NCT03016325|64331776|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23158894|NCT03016325|64331777|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
23158895|NCT03016325|64331770|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23158896|NCT03016325|64331771|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
23158897|NCT03016325|64331772|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23158898|NCT03016325|64331773|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23158899|NCT03016325|64331774|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23158900|NCT03016325|64331775|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23158901|NCT03016325|64331776|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23158902|NCT03016325|64331777|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
23158903|NCT03016325|64331770|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23158904|NCT03016325|64331771|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23158905|NCT03016325|64331772|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23158906|NCT03016325|64331773|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23158907|NCT03016325|64331774|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
23158908|NCT03016325|64331775|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
23158909|NCT03016325|64331776|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
23328998|NCT03759392|64945635|FG000|Overall Study|Protocol Violation|2|||
23328999|NCT03759392|64945636|FG001|Overall Study|Protocol Violation|0|||
23329000|NCT03759392|64945635|FG000|Overall Study|Physician Decision|0|||
23329001|NCT03759392|64945636|FG001|Overall Study|Physician Decision|1|||
23329002|NCT03759392|64945635|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
23329003|NCT03759392|64945636|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
23329004|NCT03759392|64945635|FG000|Overall Study|No longer able to take medicines|1|||
23329005|NCT03759392|64945636|FG001|Overall Study|No longer able to take medicines|0|||
23329006|NCT03759392|64945635|FG000|Overall Study|Stopped taking study drug|1|||
23329007|NCT03759392|64945636|FG001|Overall Study|Stopped taking study drug|0|||
23329008|NCT03379727|64945637|FG000|Overall Study|Lack of Efficacy|73|||
23329009|NCT03379727|64945637|FG000|Overall Study|Adverse Event|32|||
23329010|NCT03379727|64945637|FG000|Overall Study|Death|18|||
23329011|NCT03379727|64945637|FG000|Overall Study|Patient/guardian decision|17|||
23329012|NCT03379727|64945637|FG000|Overall Study|Physician Decision|104|||
23329013|NCT03379727|64945637|FG000|Overall Study|Protocol Violation|4|||
23329014|NCT03379727|64945637|FG000|Overall Study|Lost to Follow-up|1|||
23329015|NCT00478777|64945642|FG000|Overall Study|Adverse Event|29|||
23329016|NCT00478777|64945642|FG000|Overall Study|Lack of Efficacy|23|||
23329017|NCT00478777|64945642|FG000|Overall Study|Withdrawal by Subject|4|||
23329018|NCT00478777|64945642|FG000|Overall Study|Death|3|||
23329019|NCT00478777|64945642|FG000|Overall Study|Protocol Violation|3|||
23158910|NCT03016325|64331777|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
23158911|NCT01485627|64331779|FG000|Overall Study|Patient withdrew|6|||
23329020|NCT00478777|64945642|FG000|Overall Study|Lost to Follow-up|3|||
23329021|NCT00478777|64945642|FG000|Overall Study|Physician Decision|1|||
23567104|NCT00332332|65803989|FG000|Overall Study|Did not receive study treatment|16|||
23329022|NCT00478777|64945642|FG000|Overall Study|Intolerance of therapy|1|||
23444816|NCT02586623|65370164|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
23329023|NCT00478777|64945642|FG000|Overall Study|Lack of compliance|1|||
23329024|NCT00478777|64945642|FG000|Overall Study|Lymphocytes infusion|1|||
23329025|NCT00478777|64945642|FG000|Overall Study|End of therapy|2|||
23329026|NCT00478777|64945642|FG000|Overall Study|Not treated with lenalidomide|6|||
23329027|NCT01956773|64945643|FG000|Overall Study|Lost to Follow-up|628|||
23329028|NCT01956773|64945644|FG001|Overall Study|Lost to Follow-up|1|||
23329029|NCT00778817|64945645|FG000|Overall Study|Adverse Event|2|||
23329030|NCT00778817|64945645|FG000|Overall Study|Withdrawal by Subject|2|||
23329031|NCT03817125|64945646|FG000|Overall Study|Adverse Event|1|||
23329032|NCT03817125|64945647|FG001|Overall Study|Adverse Event|0|||
23329033|NCT03817125|64945646|FG000|Overall Study|Physician Decision|0|||
23329034|NCT03817125|64945647|FG001|Overall Study|Physician Decision|1|||
23628849|NCT00208325|66028134|FG003|Overall Study|Mis-Randomized|0|||
23628850|NCT03325777|66028136|FG000|Overall Study|Lost to Follow-up|9|||
23158912|NCT01485627|64331780|FG001|Overall Study|Patient withdrew|5|||
23158913|NCT01485627|64331779|FG000|Overall Study|Patient died|3|||
23158914|NCT01485627|64331780|FG001|Overall Study|Patient died|1|||
23158915|NCT01485627|64331779|FG000|Overall Study|Patient lost to followup|0|||
23158916|NCT01485627|64331780|FG001|Overall Study|Patient lost to followup|1|||
23158917|NCT01485627|64331779|FG000|Overall Study|Caregiver withdrew|3|||
23158918|NCT01485627|64331780|FG001|Overall Study|Caregiver withdrew|3|||
23158919|NCT01485627|64331779|FG000|Overall Study|Caregiver lost to follow up|11|||
23158920|NCT01485627|64331780|FG001|Overall Study|Caregiver lost to follow up|12|||
23158921|NCT01485627|64331779|FG000|Overall Study|Caregiver died|1|||
23329035|NCT03817125|64945646|FG000|Overall Study|Lack of Efficacy|1|||
23329036|NCT03817125|64945647|FG001|Overall Study|Lack of Efficacy|5|||
23329037|NCT03313180|64945655|FG000|Overall Study|Adverse Event|120|||
23329038|NCT03313180|64945655|FG000|Overall Study|Lost to Follow-up|3|||
23329039|NCT03313180|64945655|FG000|Overall Study|Withdrawal by Subject|39|||
23567105|NCT00313911|65803997|FG000|Overall Study|Serious adverse event|6|||
23329040|NCT03313180|64945655|FG000|Overall Study|Other than listed above|15|||
23329041|NCT03313180|64945655|FG000|Overall Study|Covid-19 related|2|||
23329042|NCT02222922|64945656|FG000|Overall Study|Death|0|||
23329043|NCT02222922|64945657|FG001|Overall Study|Death|0|||
23329044|NCT02222922|64945658|FG002|Overall Study|Death|0|||
23329045|NCT02222922|64945659|FG003|Overall Study|Death|0|||
23567106|NCT00313911|65803998|FG001|Overall Study|Serious adverse event|1|||
23567107|NCT00313911|65803997|FG000|Overall Study|Adverse Event|2|||
23567108|NCT00313911|65803998|FG001|Overall Study|Adverse Event|3|||
23567109|NCT00313911|65803997|FG000|Overall Study|Protocol Violation|19|||
23567110|NCT00313911|65803998|FG001|Overall Study|Protocol Violation|10|||
23567111|NCT00313911|65803997|FG000|Overall Study|Lost to Follow-up|27|||
23158922|NCT01485627|64331780|FG001|Overall Study|Caregiver died|0|||
23158923|NCT01485627|64331779|FG000|Overall Study|caregiver was not bereaved|42|||
23158924|NCT01485627|64331780|FG001|Overall Study|caregiver was not bereaved|35|||
23158925|NCT05162027|64331781|FG000|Overall Study|Adverse Event|1|||
23158926|NCT05162027|64331782|FG001|Overall Study|Adverse Event|0|||
23158927|NCT03335163|64331783|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
23158928|NCT03335163|64331783|FG000|Overall Study|Withdrawal by Subject|18|||
23158929|NCT04037748|64331785|FG000|Treatment Period 1|Withdrawal by Subject|3|||
23158930|NCT04037748|64331786|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23158931|NCT04037748|64331785|FG000|Treatment Period 1|Adverse Event|1|||
23158932|NCT04037748|64331786|FG001|Treatment Period 1|Adverse Event|1|||
23158933|NCT04037748|64331785|FG000|Treatment Period 1|Protocol Violation|4|||
23158934|NCT04037748|64331786|FG001|Treatment Period 1|Protocol Violation|5|||
23158935|NCT04037748|64331785|FG000|Treatment Period 2|Adverse Event|0|||
23158936|NCT04037748|64331786|FG001|Treatment Period 2|Adverse Event|1|||
23158937|NCT04037748|64331785|FG000|Treatment Period 2|Protocol Violation|2|||
23158938|NCT04037748|64331786|FG001|Treatment Period 2|Protocol Violation|0|||
23158939|NCT00928889|64331789|FG000|Overall Study|Lost to Follow-up|3|||
23158940|NCT00928889|64331790|FG001|Overall Study|Lost to Follow-up|1|||
23158941|NCT00928889|64331789|FG000|Overall Study|Protocol Violation|0|||
23158942|NCT00928889|64331790|FG001|Overall Study|Protocol Violation|1|||
23158943|NCT00928889|64331789|FG000|Overall Study|Adverse Event|1|||
23158944|NCT00928889|64331790|FG001|Overall Study|Adverse Event|0|||
23158945|NCT00928889|64331789|FG000|Overall Study|Other|1|||
23158946|NCT00928889|64331790|FG001|Overall Study|Other|0|||
23329046|NCT02222922|64945660|FG004|Overall Study|Death|13|||
23567112|NCT00313911|65803998|FG001|Overall Study|Lost to Follow-up|14|||
23628851|NCT03325777|66028137|FG001|Overall Study|Lost to Follow-up|12|||
23628852|NCT02615509|66028138|FG000|Overall Study|Lost to Follow-up|134|||
23158947|NCT00530894|64331791|FG000|Overall Study|Death|84|||
23158948|NCT00530894|64331792|FG001|Overall Study|Death|89|||
23158949|NCT00530894|64331793|FG002|Overall Study|Death|55|||
23222392|NCT01838213|64557682|FG001|Overall Study|Ineligible|191|||
23329047|NCT02222922|64945661|FG005|Overall Study|Death|0|||
23329048|NCT02222922|64945662|FG006|Overall Study|Death|0|||
23329049|NCT02222922|64945663|FG007|Overall Study|Death|0|||
23329050|NCT02222922|64945664|FG008|Overall Study|Death|2|||
23567113|NCT00313911|65803997|FG000|Overall Study|Withdrawal by Subject|39|||
23222393|NCT04159701|64557683|FG000|Period 1: Treatment Period|Pregnancy|1|||
23222394|NCT04159701|64557684|FG001|Period 1: Treatment Period|Pregnancy|0|||
23222395|NCT04159701|64557683|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
23222396|NCT04159701|64557684|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
23222397|NCT04159701|64557683|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
23222398|NCT04159701|64557684|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
23222399|NCT04159701|64557683|FG000|Washout Period|site terminated by sponsor|0|||
23222400|NCT04159701|64557684|FG001|Washout Period|site terminated by sponsor|1|||
23222401|NCT04159701|64557683|FG000|Washout Period|study terminated by sponsor|10|||
23222402|NCT04159701|64557684|FG001|Washout Period|study terminated by sponsor|3|||
23222403|NCT04159701|64557683|FG000|Washout Period|Withdrawal by Subject|1|||
23222404|NCT04159701|64557684|FG001|Washout Period|Withdrawal by Subject|0|||
23222405|NCT04159701|64557683|FG000|Washout Period|Inadvertent Enrollment|1|||
23222406|NCT04159701|64557684|FG001|Washout Period|Inadvertent Enrollment|0|||
23222407|NCT04159701|64557683|FG000|Washout Period|Miscellaneous|1|||
23222408|NCT04159701|64557684|FG001|Washout Period|Miscellaneous|0|||
23222409|NCT04159701|64557683|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
23222410|NCT04159701|64557684|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
23222411|NCT04159701|64557683|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
23222412|NCT04159701|64557684|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
23222413|NCT04159701|64557683|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
23222414|NCT04159701|64557684|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
23222415|NCT04159701|64557683|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
23222416|NCT04159701|64557684|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
23222417|NCT04159701|64557683|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
23222418|NCT04159701|64557684|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
23222419|NCT04362189|64557686|FG000|Overall Study|Lost to Follow-up|0|||
23222420|NCT04362189|64557687|FG001|Overall Study|Lost to Follow-up|1|||
23222421|NCT04362189|64557686|FG000|Overall Study|Withdrawal by Subject|1|||
23222422|NCT04362189|64557687|FG001|Overall Study|Withdrawal by Subject|0|||
23222423|NCT04362189|64557686|FG000|Overall Study|FDA Clinical Hold|7|||
23222424|NCT04362189|64557687|FG001|Overall Study|FDA Clinical Hold|2|||
23222425|NCT04362189|64557686|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
23222426|NCT04362189|64557687|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
23222427|NCT04362189|64557686|FG000|Overall Study|Adverse Event|0|||
23222428|NCT04362189|64557687|FG001|Overall Study|Adverse Event|2|||
23222429|NCT04362189|64557686|FG000|Overall Study|Death|4|||
23222430|NCT04362189|64557687|FG001|Overall Study|Death|1|||
23222431|NCT04624672|64557688|FG000|Overall Study|Early Study Closure|2|||
23222432|NCT04624672|64557689|FG001|Overall Study|Early Study Closure|1|||
23222433|NCT01929018|64557690|FG000|Overall Study|Lost to Follow-up|1|||
23567114|NCT00313911|65803998|FG001|Overall Study|Withdrawal by Subject|12|||
23567115|NCT00313911|65803997|FG000|Overall Study|Did not meet age criteria|1|||
23567116|NCT00313911|65803998|FG001|Overall Study|Did not meet age criteria|1|||
23567117|NCT03107377|65803999|FG000|Overall Study|Adverse Event|3|||
23567118|NCT03107377|65804000|FG001|Overall Study|Adverse Event|3|||
23222434|NCT01929018|64557691|FG001|Overall Study|Lost to Follow-up|0|||
23222435|NCT01929018|64557690|FG000|Overall Study|Hospitalization|0|||
23222436|NCT01929018|64557691|FG001|Overall Study|Hospitalization|1|||
23222437|NCT04259346|64557692|FG000|Overall Study|Lost to Follow-up|1|||
23222438|NCT04259346|64557693|FG001|Overall Study|Lost to Follow-up|3|||
23222439|NCT04259346|64557692|FG000|Overall Study|Protocol Violation|1|||
23222440|NCT04259346|64557693|FG001|Overall Study|Protocol Violation|0|||
23222441|NCT04259346|64557692|FG000|Overall Study|Withdrawal by Subject|1|||
23222442|NCT04259346|64557693|FG001|Overall Study|Withdrawal by Subject|0|||
23222443|NCT04259346|64557692|FG000|Overall Study|Adverse Event|1|||
23222444|NCT04259346|64557693|FG001|Overall Study|Adverse Event|1|||
23222445|NCT00608881|64557694|FG000|Overall Study|Death|22|||
23222446|NCT00608881|64557695|FG001|Overall Study|Death|13|||
23222447|NCT00608881|64557694|FG000|Overall Study|Adverse Event|5|||
23222448|NCT00608881|64557695|FG001|Overall Study|Adverse Event|3|||
23222449|NCT00608881|64557694|FG000|Overall Study|Lost to Follow-up|28|||
23222450|NCT00608881|64557695|FG001|Overall Study|Lost to Follow-up|14|||
23222451|NCT00608881|64557694|FG000|Overall Study|Withdrawal by Subject|18|||
23222452|NCT00608881|64557695|FG001|Overall Study|Withdrawal by Subject|29|||
23222453|NCT00608881|64557694|FG000|Overall Study|Physician Decision|5|||
23222454|NCT00608881|64557695|FG001|Overall Study|Physician Decision|5|||
23222455|NCT00608881|64557694|FG000|Overall Study|Institutionalized|1|||
23567119|NCT03107377|65803999|FG000|Overall Study|Protocol Violation|9|||
23222456|NCT00608881|64557695|FG001|Overall Study|Institutionalized|2|||
23567120|NCT03107377|65804000|FG001|Overall Study|Protocol Violation|12|||
23222457|NCT00981682|64557696|FG000|Overall Study|Adverse Event|48|||
23222458|NCT00981682|64557696|FG000|Overall Study|Withdrawal by Subject|52|||
23222459|NCT00981682|64557696|FG000|Overall Study|Lost to Follow-up|14|||
23222460|NCT00981682|64557696|FG000|Overall Study|Lack of Efficacy|13|||
23567121|NCT03107377|65803999|FG000|Overall Study|Physician Decision|3|||
23329051|NCT02222922|64945656|FG000|Overall Study|Lost to Follow-up|0|||
23329052|NCT02222922|64945657|FG001|Overall Study|Lost to Follow-up|0|||
23329053|NCT02222922|64945658|FG002|Overall Study|Lost to Follow-up|1|||
23329054|NCT02222922|64945659|FG003|Overall Study|Lost to Follow-up|0|||
23329055|NCT02222922|64945660|FG004|Overall Study|Lost to Follow-up|9|||
23329056|NCT02222922|64945661|FG005|Overall Study|Lost to Follow-up|1|||
23329057|NCT02222922|64945662|FG006|Overall Study|Lost to Follow-up|0|||
23329058|NCT02222922|64945663|FG007|Overall Study|Lost to Follow-up|0|||
23329059|NCT02222922|64945664|FG008|Overall Study|Lost to Follow-up|0|||
23329060|NCT02222922|64945656|FG000|Overall Study|Other|0|||
23329061|NCT02222922|64945657|FG001|Overall Study|Other|0|||
23329062|NCT02222922|64945658|FG002|Overall Study|Other|0|||
23329063|NCT02222922|64945659|FG003|Overall Study|Other|2|||
23329064|NCT02222922|64945660|FG004|Overall Study|Other|10|||
23329065|NCT02222922|64945661|FG005|Overall Study|Other|2|||
23329066|NCT02222922|64945662|FG006|Overall Study|Other|2|||
23158950|NCT00530894|64331794|FG003|Overall Study|Death|89|||
23158951|NCT00530894|64331791|FG000|Overall Study|Lost to Follow-up|1|||
23158952|NCT00530894|64331792|FG001|Overall Study|Lost to Follow-up|3|||
23158953|NCT00530894|64331793|FG002|Overall Study|Lost to Follow-up|0|||
23158954|NCT00530894|64331794|FG003|Overall Study|Lost to Follow-up|0|||
23158955|NCT00530894|64331791|FG000|Overall Study|Withdrawal by Subject|1|||
23158956|NCT00530894|64331792|FG001|Overall Study|Withdrawal by Subject|23|||
23158957|NCT00530894|64331793|FG002|Overall Study|Withdrawal by Subject|0|||
23329067|NCT02222922|64945663|FG007|Overall Study|Other|4|||
23329068|NCT02222922|64945664|FG008|Overall Study|Other|1|||
23329069|NCT02222922|64945656|FG000|Overall Study|Participant refused further follow-up|1|||
23329070|NCT02222922|64945657|FG001|Overall Study|Participant refused further follow-up|0|||
23329071|NCT02222922|64945658|FG002|Overall Study|Participant refused further follow-up|0|||
23329072|NCT02222922|64945659|FG003|Overall Study|Participant refused further follow-up|1|||
23329073|NCT02222922|64945660|FG004|Overall Study|Participant refused further follow-up|6|||
23329074|NCT02222922|64945661|FG005|Overall Study|Participant refused further follow-up|0|||
23158958|NCT00530894|64331794|FG003|Overall Study|Withdrawal by Subject|5|||
23158959|NCT00530894|64331791|FG000|Overall Study|Alive and censored prior to 1 year|2|||
23158960|NCT00530894|64331792|FG001|Overall Study|Alive and censored prior to 1 year|0|||
23158961|NCT00530894|64331793|FG002|Overall Study|Alive and censored prior to 1 year|0|||
23158962|NCT00530894|64331794|FG003|Overall Study|Alive and censored prior to 1 year|0|||
23158963|NCT01979536|64331797|FG000|Overall Study|Physician Decision|2|||
23567122|NCT03107377|65804000|FG001|Overall Study|Physician Decision|6|||
23567123|NCT03107377|65803999|FG000|Overall Study|Pregnancy|7|||
23567124|NCT03107377|65804000|FG001|Overall Study|Pregnancy|7|||
23567125|NCT03107377|65803999|FG000|Overall Study|Withdrawal by Subject|16|||
23567126|NCT03107377|65804000|FG001|Overall Study|Withdrawal by Subject|22|||
23567127|NCT03107377|65803999|FG000|Overall Study|Lost to Follow-up|37|||
23158964|NCT01979536|64331798|FG001|Overall Study|Physician Decision|3|||
23158965|NCT01979536|64331797|FG000|Overall Study|Withdrawal by Subject|0|||
23158966|NCT01979536|64331798|FG001|Overall Study|Withdrawal by Subject|1|||
23158967|NCT01979536|64331797|FG000|Overall Study|Refusal|0|||
23158968|NCT01979536|64331798|FG001|Overall Study|Refusal|1|||
23158969|NCT01979536|64331797|FG000|Overall Study|Relapse|0|||
23158970|NCT01979536|64331798|FG001|Overall Study|Relapse|1|||
23158971|NCT01979536|64331797|FG000|Overall Study|Study terminated by Sponsor|0|||
23158972|NCT01979536|64331798|FG001|Overall Study|Study terminated by Sponsor|1|||
23158973|NCT01979536|64331797|FG000|Overall Study|Did not start treatment|0|||
23158974|NCT01979536|64331798|FG001|Overall Study|Did not start treatment|1|||
23567128|NCT03107377|65804000|FG001|Overall Study|Lost to Follow-up|34|||
23567129|NCT03107377|65803999|FG000|Overall Study|Other reason not specified|16|||
23567130|NCT03107377|65804000|FG001|Overall Study|Other reason not specified|15|||
23567131|NCT01118455|65804002|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
23567132|NCT01118455|65804003|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
23628853|NCT02615509|66028138|FG000|Overall Study|Death|4|||
23628854|NCT02615509|66028138|FG000|Overall Study|Withdrawal by Subject|8|||
23628855|NCT01774305|66028139|FG000|Overall Study|Physician Decision|1|||
23158975|NCT00841568|64331799|FG000|Overall Study|Adverse Event|1|||
23158976|NCT00841568|64331799|FG000|Overall Study|Death|1|||
23158977|NCT00841568|64331799|FG000|Overall Study|Withdrawal by Subject|2|||
23158978|NCT00841568|64331799|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
23158979|NCT02592551|64331801|FG000|Overall Study|Not evaluable|1|||
23158980|NCT02592551|64331802|FG001|Overall Study|Not evaluable|3|||
23158981|NCT02592551|64331803|FG002|Overall Study|Not evaluable|0|||
23329075|NCT02222922|64945662|FG006|Overall Study|Participant refused further follow-up|0|||
23329076|NCT02222922|64945663|FG007|Overall Study|Participant refused further follow-up|0|||
23158982|NCT01225731|64331804|FG000|Part 1|Did not meet eligibility criteria|1|||
23329077|NCT02222922|64945664|FG008|Overall Study|Participant refused further follow-up|3|||
23329078|NCT00915018|64945669|FG000|Overall Study|Death|75|||
23329079|NCT00915018|64945670|FG001|Overall Study|Death|70|||
23329080|NCT00915018|64945669|FG000|Overall Study|Lost to Follow-up|10|||
23567133|NCT01536145|65804004|FG000|Overall Study|Progressive disease|3|||
23158983|NCT01225731|64331805|FG001|Part 1|Did not meet eligibility criteria|0|||
23158984|NCT01225731|64331806|FG002|Part 1|Did not meet eligibility criteria|0|||
23158985|NCT01225731|64331807|FG003|Part 1|Did not meet eligibility criteria|0|||
23158986|NCT01225731|64331808|FG004|Part 1|Did not meet eligibility criteria|1|||
23158987|NCT01225731|64331809|FG005|Part 1|Did not meet eligibility criteria|0|||
23158988|NCT01225731|64331810|FG006|Part 1|Did not meet eligibility criteria|0|||
23158989|NCT01225731|64331811|FG007|Part 1|Did not meet eligibility criteria|0|||
23158990|NCT01225731|64331812|FG008|Part 1|Did not meet eligibility criteria|0|||
23222461|NCT00981682|64557696|FG000|Overall Study|Protocol Violation|6|||
23444817|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
23444818|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
23444819|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
23444820|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
23444821|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
23444822|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
23444823|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
23444824|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
23444825|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
23444826|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
23444827|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
23444828|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
23444829|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
23444830|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
23444831|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
23444832|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
23444833|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
23444834|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
23444835|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
23222462|NCT00981682|64557696|FG000|Overall Study|administrative|9|||
23222463|NCT00641706|64557697|FG000|Overall Study|Adverse Event|2|||
23444836|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
23444837|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
23444838|NCT02586623|65370162|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
23444839|NCT02586623|65370163|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
23444840|NCT02586623|65370164|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
23444841|NCT00858208|65370165|FG000|Overall Study|Adverse Event|3|||
23444842|NCT00858208|65370165|FG000|Overall Study|Lost to Follow-up|26|||
23444843|NCT00858208|65370165|FG000|Overall Study|Participant refused|40|||
23444844|NCT00858208|65370165|FG000|Overall Study|Other|10|||
23444845|NCT02462720|65370166|FG000|Part 2|Withdrawal by Subject|1|||
23444846|NCT02462720|65370167|FG001|Part 2|Withdrawal by Subject|0|||
23444847|NCT02462720|65370166|FG000|Part 2|Protocol Violation|0|||
23444848|NCT02462720|65370167|FG001|Part 2|Protocol Violation|1|||
23444849|NCT04050618|65370168|FG000|First Intervention|Withdrawal by Subject|2|||
23444850|NCT04050618|65370169|FG001|First Intervention|Withdrawal by Subject|0|||
23444851|NCT04050618|65370168|FG000|Second Intervention|Withdrawal by Subject|1|||
23444852|NCT04050618|65370169|FG001|Second Intervention|Withdrawal by Subject|0|||
23444853|NCT01012258|65370170|FG000|Overall Study|Death|14|||
23444854|NCT01012258|65370170|FG000|Overall Study|Lost to Follow-up|1|||
23158991|NCT01225731|64331813|FG009|Part 1|Did not meet eligibility criteria|0|||
23222464|NCT00641706|64557698|FG001|Overall Study|Adverse Event|1|||
23222465|NCT00641706|64557697|FG000|Overall Study|Withdrawal by Subject|6|||
23222466|NCT00641706|64557698|FG001|Overall Study|Withdrawal by Subject|1|||
23222467|NCT00641706|64557697|FG000|Overall Study|Clinical Decline|1|||
23222468|NCT00641706|64557698|FG001|Overall Study|Clinical Decline|0|||
23222469|NCT00641706|64557697|FG000|Overall Study|Lead Investigator Decision|0|||
23222470|NCT00641706|64557698|FG001|Overall Study|Lead Investigator Decision|1|||
23222471|NCT04737759|64557699|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
23222472|NCT04737759|64557700|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
23222473|NCT04737759|64557699|FG000|Overall Study|Death|2|||
23222474|NCT04737759|64557700|FG001|Overall Study|Death|0|||
23222475|NCT04737759|64557699|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
23329081|NCT00915018|64945670|FG001|Overall Study|Lost to Follow-up|5|||
23444855|NCT01012258|65370170|FG000|Overall Study|Adverse Event|1|||
23444856|NCT01012258|65370170|FG000|Overall Study|Progressive Disease (PD)|18|||
23158992|NCT01225731|64331814|FG010|Part 1|Did not meet eligibility criteria|0|||
23158993|NCT01225731|64331815|FG011|Part 1|Did not meet eligibility criteria|0|||
23158994|NCT01225731|64331816|FG012|Part 1|Did not meet eligibility criteria|0|||
23222476|NCT04737759|64557700|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
23222477|NCT04737759|64557699|FG000|Overall Study|Lost to Follow-up|4|||
23444857|NCT01012258|65370170|FG000|Overall Study|Symptomatic Deterioration|1|||
23444858|NCT01012258|65370170|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
23567134|NCT01536145|65804005|FG001|Overall Study|Progressive disease|4|||
23444859|NCT01012258|65370170|FG000|Overall Study|Another Tumor Discovered|1|||
23444860|NCT01012258|65370170|FG000|Overall Study|Ongoing|29|||
23444861|NCT00567359|65370173|FG000|Overall Study|Withdrawal by Subject|1|||
23444862|NCT01636986|65370174|FG000|Overall Study|Withdrawal by Subject|0|||
23444863|NCT01636986|65370175|FG001|Overall Study|Withdrawal by Subject|1|||
23444864|NCT01636986|65370174|FG000|Overall Study|Corneal Staining|0|||
23444865|NCT01636986|65370175|FG001|Overall Study|Corneal Staining|1|||
23444866|NCT00891228|65370178|FG000|Overall Study|Adverse Event|0|||
23444867|NCT00891228|65370179|FG001|Overall Study|Adverse Event|2|||
23444868|NCT00891228|65370180|FG002|Overall Study|Adverse Event|3|||
23444869|NCT00891228|65370178|FG000|Overall Study|Withdrawal by Subject|2|||
23444870|NCT00891228|65370179|FG001|Overall Study|Withdrawal by Subject|4|||
23444871|NCT00891228|65370180|FG002|Overall Study|Withdrawal by Subject|5|||
23444872|NCT00891228|65370178|FG000|Overall Study|Protocol Violation|3|||
23444873|NCT00891228|65370179|FG001|Overall Study|Protocol Violation|1|||
23444874|NCT00891228|65370180|FG002|Overall Study|Protocol Violation|2|||
23444875|NCT00891228|65370178|FG000|Overall Study|Physician Decision|2|||
23444876|NCT00891228|65370179|FG001|Overall Study|Physician Decision|1|||
23444877|NCT00891228|65370180|FG002|Overall Study|Physician Decision|0|||
23444878|NCT00891228|65370178|FG000|Overall Study|Lost to Follow-up|4|||
23444879|NCT00891228|65370179|FG001|Overall Study|Lost to Follow-up|4|||
23444880|NCT00891228|65370180|FG002|Overall Study|Lost to Follow-up|5|||
23444881|NCT00891228|65370178|FG000|Overall Study|Pregnancy|0|||
23444882|NCT00891228|65370179|FG001|Overall Study|Pregnancy|1|||
23444883|NCT00891228|65370180|FG002|Overall Study|Pregnancy|0|||
23444884|NCT01388907|65370181|FG000|Overall Study|Adverse Event|2|||
23444885|NCT01388907|65370182|FG001|Overall Study|Adverse Event|0|||
23444886|NCT04089761|65370183|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
23444887|NCT04089761|65370183|FG000|"Run In Phase"|Lost to Follow-up|1|||
23444888|NCT04089761|65370183|FG000|"Treatment Phase"|No evaluable data|5|||
23444889|NCT04089761|65370183|FG000|"Treatment Phase"|Lost to Follow-up|1|||
23444890|NCT00479713|65370184|FG000|Overall Study|Adverse Event|8|||
23444891|NCT00479713|65370185|FG001|Overall Study|Adverse Event|6|||
23444892|NCT00479713|65370184|FG000|Overall Study|Death|1|||
23444893|NCT00479713|65370185|FG001|Overall Study|Death|0|||
23444894|NCT00479713|65370184|FG000|Overall Study|Lost to Follow-up|0|||
23444895|NCT00479713|65370185|FG001|Overall Study|Lost to Follow-up|1|||
23444896|NCT00479713|65370184|FG000|Overall Study|Protocol Violation|0|||
23444897|NCT00479713|65370185|FG001|Overall Study|Protocol Violation|1|||
23444898|NCT00479713|65370184|FG000|Overall Study|Withdrawal by Subject|4|||
23444899|NCT00479713|65370185|FG001|Overall Study|Withdrawal by Subject|1|||
23444900|NCT00321464|65370186|FG000|Overall Study|Death|169|||
23444901|NCT00321464|65370187|FG001|Overall Study|Death|174|||
23222478|NCT04737759|64557700|FG001|Overall Study|Lost to Follow-up|12|||
23222479|NCT02579863|64557701|FG000|Overall Study|Final Disposition Unknown|2|||
23444902|NCT00321464|65370186|FG000|Overall Study|Disease progression|124|||
23444903|NCT00321464|65370187|FG001|Overall Study|Disease progression|124|||
23444904|NCT00321464|65370186|FG000|Overall Study|Withdrawal by Subject|117|||
23444905|NCT00321464|65370187|FG001|Overall Study|Withdrawal by Subject|118|||
23444906|NCT00321464|65370186|FG000|Overall Study|Participant request|57|||
23444907|NCT00321464|65370187|FG001|Overall Study|Participant request|61|||
23444908|NCT00321464|65370186|FG000|Overall Study|Adverse Event|43|||
23444909|NCT00321464|65370187|FG001|Overall Study|Adverse Event|28|||
23444910|NCT00321464|65370186|FG000|Overall Study|Physician Decision|15|||
23444911|NCT00321464|65370187|FG001|Overall Study|Physician Decision|14|||
23444912|NCT00321464|65370186|FG000|Overall Study|Noncompliance|4|||
23444913|NCT00321464|65370187|FG001|Overall Study|Noncompliance|10|||
23444914|NCT00321464|65370186|FG000|Overall Study|Lost to Follow-up|7|||
23444915|NCT00321464|65370187|FG001|Overall Study|Lost to Follow-up|8|||
23444916|NCT00321464|65370186|FG000|Overall Study|Protocol deviation|0|||
23444917|NCT00321464|65370187|FG001|Overall Study|Protocol deviation|2|||
23444918|NCT00321464|65370186|FG000|Overall Study|Ineligibility determined|2|||
23222480|NCT02579863|64557702|FG001|Overall Study|Final Disposition Unknown|1|||
23222481|NCT02579863|64557701|FG000|Overall Study|Adverse Event|18|||
23222482|NCT02579863|64557702|FG001|Overall Study|Adverse Event|11|||
23222483|NCT02579863|64557701|FG000|Overall Study|Death|31|||
23329082|NCT00915018|64945669|FG000|Overall Study|Withdrawal by Subject|38|||
23329083|NCT00915018|64945670|FG001|Overall Study|Withdrawal by Subject|27|||
23444919|NCT00321464|65370187|FG001|Overall Study|Ineligibility determined|1|||
23444920|NCT00321464|65370186|FG000|Overall Study|Other|21|||
23444921|NCT00321464|65370187|FG001|Overall Study|Other|18|||
23444922|NCT02396212|65370200|FG000|Overall Study|Adverse Event|1|||
23444923|NCT02396212|65370200|FG000|Overall Study|Lack of Efficacy|2|||
23444924|NCT00981461|65370202|FG000|Overall Study|Lost to Follow-up|5|||
23444925|NCT00981461|65370203|FG001|Overall Study|Lost to Follow-up|2|||
23444926|NCT04531241|65370204|FG000|Period 1|Withdrawal by Subject|2|||
23444927|NCT04531241|65370205|FG001|Period 1|Withdrawal by Subject|0|||
23567135|NCT01536145|65804006|FG002|Overall Study|Progressive disease|1|||
23222484|NCT02579863|64557702|FG001|Overall Study|Death|29|||
23444928|NCT04531241|65370204|FG000|Period 1|Dispesed incorrect lens power|1|||
23222485|NCT02579863|64557701|FG000|Overall Study|Lost to Follow-up|2|||
23222486|NCT02579863|64557702|FG001|Overall Study|Lost to Follow-up|1|||
23222487|NCT02579863|64557701|FG000|Overall Study|Physician Decision|1|||
23444929|NCT04531241|65370205|FG001|Period 1|Dispesed incorrect lens power|0|||
23444930|NCT04531241|65370204|FG000|Period 1|Protocol Violation|1|||
23567136|NCT01536145|65804007|FG003|Overall Study|Progressive disease|2|||
23567137|NCT01536145|65804008|FG004|Overall Study|Progressive disease|1|||
23567138|NCT01536145|65804009|FG005|Overall Study|Progressive disease|2|||
23567139|NCT01536145|65804010|FG006|Overall Study|Progressive disease|1|||
23567140|NCT01536145|65804011|FG007|Overall Study|Progressive disease|2|||
23158995|NCT01225731|64331804|FG000|Part 1|Adverse Event|1|||
23158996|NCT01225731|64331805|FG001|Part 1|Adverse Event|2|||
23158997|NCT01225731|64331806|FG002|Part 1|Adverse Event|1|||
23158998|NCT01225731|64331807|FG003|Part 1|Adverse Event|1|||
23158999|NCT01225731|64331808|FG004|Part 1|Adverse Event|1|||
23159000|NCT01225731|64331809|FG005|Part 1|Adverse Event|0|||
23159001|NCT01225731|64331810|FG006|Part 1|Adverse Event|0|||
23159002|NCT01225731|64331811|FG007|Part 1|Adverse Event|0|||
23159003|NCT01225731|64331812|FG008|Part 1|Adverse Event|0|||
23159004|NCT01225731|64331813|FG009|Part 1|Adverse Event|0|||
23159005|NCT01225731|64331814|FG010|Part 1|Adverse Event|0|||
23159006|NCT01225731|64331815|FG011|Part 1|Adverse Event|0|||
23159007|NCT01225731|64331816|FG012|Part 1|Adverse Event|0|||
23159008|NCT01225731|64331804|FG000|Part 1|Withdrawal by Subject|0|||
23159009|NCT01225731|64331805|FG001|Part 1|Withdrawal by Subject|3|||
23159010|NCT01225731|64331806|FG002|Part 1|Withdrawal by Subject|0|||
23159011|NCT01225731|64331807|FG003|Part 1|Withdrawal by Subject|0|||
23159012|NCT01225731|64331808|FG004|Part 1|Withdrawal by Subject|4|||
23159013|NCT01225731|64331809|FG005|Part 1|Withdrawal by Subject|0|||
23159014|NCT01225731|64331810|FG006|Part 1|Withdrawal by Subject|0|||
23159015|NCT01225731|64331811|FG007|Part 1|Withdrawal by Subject|0|||
23159016|NCT01225731|64331812|FG008|Part 1|Withdrawal by Subject|0|||
23159017|NCT01225731|64331813|FG009|Part 1|Withdrawal by Subject|0|||
23159018|NCT01225731|64331814|FG010|Part 1|Withdrawal by Subject|0|||
23159019|NCT01225731|64331815|FG011|Part 1|Withdrawal by Subject|0|||
23159020|NCT01225731|64331816|FG012|Part 1|Withdrawal by Subject|0|||
23159021|NCT01225731|64331804|FG000|Part 1|Protocol Violation|0|||
23159022|NCT01225731|64331805|FG001|Part 1|Protocol Violation|0|||
23159023|NCT01225731|64331806|FG002|Part 1|Protocol Violation|0|||
23159024|NCT01225731|64331807|FG003|Part 1|Protocol Violation|1|||
23159025|NCT01225731|64331808|FG004|Part 1|Protocol Violation|0|||
23159026|NCT01225731|64331809|FG005|Part 1|Protocol Violation|0|||
23159027|NCT01225731|64331810|FG006|Part 1|Protocol Violation|0|||
23159028|NCT01225731|64331811|FG007|Part 1|Protocol Violation|0|||
23159029|NCT01225731|64331812|FG008|Part 1|Protocol Violation|0|||
23159030|NCT01225731|64331813|FG009|Part 1|Protocol Violation|0|||
23159031|NCT01225731|64331814|FG010|Part 1|Protocol Violation|0|||
23159032|NCT01225731|64331815|FG011|Part 1|Protocol Violation|0|||
23159033|NCT01225731|64331816|FG012|Part 1|Protocol Violation|0|||
23159034|NCT01225731|64331804|FG000|Part 2|Protocol Violation|0|||
23159035|NCT01225731|64331805|FG001|Part 2|Protocol Violation|0|||
23159036|NCT01225731|64331806|FG002|Part 2|Protocol Violation|0|||
23159037|NCT01225731|64331807|FG003|Part 2|Protocol Violation|0|||
23159038|NCT01225731|64331808|FG004|Part 2|Protocol Violation|0|||
23159039|NCT01225731|64331809|FG005|Part 2|Protocol Violation|1|||
23159040|NCT01225731|64331810|FG006|Part 2|Protocol Violation|0|||
23159041|NCT01225731|64331811|FG007|Part 2|Protocol Violation|0|||
23159042|NCT01225731|64331812|FG008|Part 2|Protocol Violation|1|||
23159043|NCT01225731|64331813|FG009|Part 2|Protocol Violation|0|||
23159044|NCT01225731|64331814|FG010|Part 2|Protocol Violation|0|||
23159045|NCT01225731|64331815|FG011|Part 2|Protocol Violation|0|||
23159046|NCT01225731|64331816|FG012|Part 2|Protocol Violation|0|||
23159047|NCT01225731|64331804|FG000|Part 2|Adverse Event|0|||
23159048|NCT01225731|64331805|FG001|Part 2|Adverse Event|0|||
23159049|NCT01225731|64331806|FG002|Part 2|Adverse Event|0|||
23159050|NCT01225731|64331807|FG003|Part 2|Adverse Event|0|||
23159051|NCT01225731|64331808|FG004|Part 2|Adverse Event|0|||
23159052|NCT01225731|64331809|FG005|Part 2|Adverse Event|0|||
23222488|NCT02579863|64557702|FG001|Overall Study|Physician Decision|2|||
23444931|NCT04531241|65370205|FG001|Period 1|Protocol Violation|0|||
23159053|NCT01225731|64331810|FG006|Part 2|Adverse Event|4|||
23159054|NCT01225731|64331811|FG007|Part 2|Adverse Event|4|||
23222489|NCT02579863|64557701|FG000|Overall Study|Screen Failure|0|||
23222490|NCT02579863|64557702|FG001|Overall Study|Screen Failure|2|||
23567141|NCT01536145|65804012|FG008|Overall Study|Progressive disease|1|||
23159055|NCT01225731|64331812|FG008|Part 2|Adverse Event|2|||
23159056|NCT01225731|64331813|FG009|Part 2|Adverse Event|0|||
23159057|NCT01225731|64331814|FG010|Part 2|Adverse Event|0|||
23159058|NCT01225731|64331815|FG011|Part 2|Adverse Event|0|||
23159059|NCT01225731|64331816|FG012|Part 2|Adverse Event|0|||
23159060|NCT01225731|64331804|FG000|Part 2|Lack of Efficacy|0|||
23159061|NCT01225731|64331805|FG001|Part 2|Lack of Efficacy|0|||
23159062|NCT01225731|64331806|FG002|Part 2|Lack of Efficacy|0|||
23159063|NCT01225731|64331807|FG003|Part 2|Lack of Efficacy|0|||
23567142|NCT01536145|65804013|FG009|Overall Study|Progressive disease|3|||
23567143|NCT01536145|65804014|FG010|Overall Study|Progressive disease|3|||
23159064|NCT01225731|64331808|FG004|Part 2|Lack of Efficacy|0|||
23159065|NCT01225731|64331809|FG005|Part 2|Lack of Efficacy|1|||
23159066|NCT01225731|64331810|FG006|Part 2|Lack of Efficacy|0|||
23159067|NCT01225731|64331811|FG007|Part 2|Lack of Efficacy|12|||
23159068|NCT01225731|64331812|FG008|Part 2|Lack of Efficacy|3|||
23159069|NCT01225731|64331813|FG009|Part 2|Lack of Efficacy|0|||
23159070|NCT01225731|64331814|FG010|Part 2|Lack of Efficacy|0|||
23159071|NCT01225731|64331815|FG011|Part 2|Lack of Efficacy|0|||
23159072|NCT01225731|64331816|FG012|Part 2|Lack of Efficacy|0|||
23159073|NCT01225731|64331804|FG000|Part 2|Pregnancy|0|||
23159074|NCT01225731|64331805|FG001|Part 2|Pregnancy|0|||
23159075|NCT01225731|64331806|FG002|Part 2|Pregnancy|0|||
23159076|NCT01225731|64331807|FG003|Part 2|Pregnancy|0|||
23159077|NCT01225731|64331808|FG004|Part 2|Pregnancy|0|||
23159078|NCT01225731|64331809|FG005|Part 2|Pregnancy|0|||
23159079|NCT01225731|64331810|FG006|Part 2|Pregnancy|1|||
23159080|NCT01225731|64331811|FG007|Part 2|Pregnancy|0|||
23159081|NCT01225731|64331812|FG008|Part 2|Pregnancy|1|||
23159082|NCT01225731|64331813|FG009|Part 2|Pregnancy|0|||
23159083|NCT01225731|64331814|FG010|Part 2|Pregnancy|0|||
23159084|NCT01225731|64331815|FG011|Part 2|Pregnancy|0|||
23159085|NCT01225731|64331816|FG012|Part 2|Pregnancy|0|||
23159086|NCT01225731|64331804|FG000|Part 2|Lost to Follow-up|0|||
23159087|NCT01225731|64331805|FG001|Part 2|Lost to Follow-up|0|||
23159088|NCT01225731|64331806|FG002|Part 2|Lost to Follow-up|0|||
23159089|NCT01225731|64331807|FG003|Part 2|Lost to Follow-up|0|||
23329084|NCT00915018|64945669|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
23329085|NCT00915018|64945670|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
23444932|NCT04531241|65370204|FG000|Period 1|No longer eligible|0|||
23444933|NCT04531241|65370205|FG001|Period 1|No longer eligible|1|||
23444934|NCT04531241|65370204|FG000|Period 1|Lens Discomfort|0|||
23444935|NCT04531241|65370205|FG001|Period 1|Lens Discomfort|1|||
23444936|NCT04531241|65370204|FG000|Period 2|Covid-19 Related|1|||
23444937|NCT04531241|65370205|FG001|Period 2|Covid-19 Related|1|||
23444938|NCT00832416|65370206|FG000|Overall Study|Lack of Efficacy|17|||
23444939|NCT00832416|65370207|FG001|Overall Study|Lack of Efficacy|15|||
23444940|NCT00832416|65370208|FG002|Overall Study|Lack of Efficacy|13|||
23444941|NCT00832416|65370209|FG003|Overall Study|Lack of Efficacy|52|||
23444942|NCT00832416|65370206|FG000|Overall Study|Withdrawal by Subject|5|||
23444943|NCT00832416|65370207|FG001|Overall Study|Withdrawal by Subject|7|||
23567144|NCT01536145|65804004|FG000|Overall Study|Withdrawal by Subject|0|||
23567145|NCT01536145|65804005|FG001|Overall Study|Withdrawal by Subject|0|||
23567146|NCT01536145|65804006|FG002|Overall Study|Withdrawal by Subject|1|||
23567147|NCT01536145|65804007|FG003|Overall Study|Withdrawal by Subject|0|||
23567148|NCT01536145|65804008|FG004|Overall Study|Withdrawal by Subject|0|||
23567149|NCT01536145|65804009|FG005|Overall Study|Withdrawal by Subject|1|||
23567150|NCT01536145|65804010|FG006|Overall Study|Withdrawal by Subject|0|||
23567151|NCT01536145|65804011|FG007|Overall Study|Withdrawal by Subject|0|||
23567152|NCT01536145|65804012|FG008|Overall Study|Withdrawal by Subject|2|||
23567153|NCT01536145|65804013|FG009|Overall Study|Withdrawal by Subject|0|||
23567154|NCT01536145|65804014|FG010|Overall Study|Withdrawal by Subject|2|||
23567155|NCT01536145|65804004|FG000|Overall Study|Other|0|||
23567156|NCT01536145|65804005|FG001|Overall Study|Other|0|||
23567157|NCT01536145|65804006|FG002|Overall Study|Other|0|||
23567158|NCT01536145|65804007|FG003|Overall Study|Other|0|||
23567159|NCT01536145|65804008|FG004|Overall Study|Other|1|||
23567160|NCT01536145|65804009|FG005|Overall Study|Other|0|||
23567161|NCT01536145|65804010|FG006|Overall Study|Other|0|||
23567162|NCT01536145|65804011|FG007|Overall Study|Other|0|||
23567163|NCT01536145|65804012|FG008|Overall Study|Other|0|||
23567164|NCT01536145|65804013|FG009|Overall Study|Other|3|||
23567165|NCT01536145|65804014|FG010|Overall Study|Other|2|||
23628856|NCT01774305|66028140|FG001|Overall Study|Physician Decision|0|||
23159090|NCT01225731|64331808|FG004|Part 2|Lost to Follow-up|0|||
23159091|NCT01225731|64331809|FG005|Part 2|Lost to Follow-up|0|||
23159092|NCT01225731|64331810|FG006|Part 2|Lost to Follow-up|0|||
23159093|NCT01225731|64331811|FG007|Part 2|Lost to Follow-up|3|||
23159094|NCT01225731|64331812|FG008|Part 2|Lost to Follow-up|1|||
23329086|NCT02025725|64945676|FG000|Overall Study|Adverse Event|5|||
23444944|NCT00832416|65370208|FG002|Overall Study|Withdrawal by Subject|2|||
23567166|NCT01536145|65804004|FG000|Overall Study|Death|0|||
23567167|NCT01536145|65804005|FG001|Overall Study|Death|0|||
23567168|NCT01536145|65804006|FG002|Overall Study|Death|0|||
23567169|NCT01536145|65804007|FG003|Overall Study|Death|0|||
23567170|NCT01536145|65804008|FG004|Overall Study|Death|0|||
23159095|NCT01225731|64331813|FG009|Part 2|Lost to Follow-up|0|||
23444945|NCT00832416|65370209|FG003|Overall Study|Withdrawal by Subject|10|||
23567171|NCT01536145|65804009|FG005|Overall Study|Death|0|||
23567172|NCT01536145|65804010|FG006|Overall Study|Death|1|||
23159096|NCT01225731|64331814|FG010|Part 2|Lost to Follow-up|0|||
23159097|NCT01225731|64331815|FG011|Part 2|Lost to Follow-up|0|||
23159098|NCT01225731|64331816|FG012|Part 2|Lost to Follow-up|0|||
23159099|NCT01225731|64331804|FG000|Part 2|Physician Decision|0|||
23159100|NCT01225731|64331805|FG001|Part 2|Physician Decision|0|||
23567173|NCT01536145|65804011|FG007|Overall Study|Death|0|||
23628857|NCT04547023|66028141|FG000|Overall Study|Did Not Receive Intervention|3|||
23628858|NCT04547023|66028142|FG001|Overall Study|Did Not Receive Intervention|2|||
23628859|NCT04547023|66028141|FG000|Overall Study|Lost to Follow-up|1|||
23628860|NCT04547023|66028142|FG001|Overall Study|Lost to Follow-up|1|||
23628861|NCT03721705|66028145|FG000|Overall Study|Adverse Event|2|||
23628862|NCT03721705|66028146|FG001|Overall Study|Adverse Event|0|||
23628863|NCT03721705|66028145|FG000|Overall Study|Withdrawal by Subject|4|||
23628864|NCT03721705|66028146|FG001|Overall Study|Withdrawal by Subject|10|||
23628865|NCT03721705|66028145|FG000|Overall Study|No Suitable Study Partner|1|||
23628866|NCT03721705|66028146|FG001|Overall Study|No Suitable Study Partner|0|||
23628867|NCT03721705|66028145|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
23628868|NCT03721705|66028146|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
23628869|NCT03721705|66028145|FG000|Overall Study|Death|0|||
23628870|NCT03721705|66028146|FG001|Overall Study|Death|1|||
23628871|NCT01001390|66028147|FG000|Overall Study|Failure to wear AFO device|2|||
23628872|NCT01001390|66028148|FG001|Overall Study|Failure to wear AFO device|0|||
23628873|NCT01496365|66028149|FG000|Overall Study|Adverse Event|2|||
23628874|NCT01496365|66028150|FG001|Overall Study|Adverse Event|3|||
23628875|NCT01496365|66028151|FG002|Overall Study|Adverse Event|3|||
23628876|NCT01496365|66028152|FG003|Overall Study|Adverse Event|2|||
23628877|NCT01496365|66028153|FG004|Overall Study|Adverse Event|5|||
23628878|NCT01496365|66028154|FG005|Overall Study|Adverse Event|6|||
23628879|NCT01496365|66028155|FG006|Overall Study|Adverse Event|4|||
23628880|NCT01496365|66028149|FG000|Overall Study|Withdrawal by Subject|6|||
23628881|NCT01496365|66028150|FG001|Overall Study|Withdrawal by Subject|6|||
23628882|NCT01496365|66028151|FG002|Overall Study|Withdrawal by Subject|0|||
23628883|NCT01496365|66028152|FG003|Overall Study|Withdrawal by Subject|1|||
23628884|NCT01496365|66028153|FG004|Overall Study|Withdrawal by Subject|3|||
23628885|NCT01496365|66028154|FG005|Overall Study|Withdrawal by Subject|2|||
23628886|NCT01496365|66028155|FG006|Overall Study|Withdrawal by Subject|1|||
23628887|NCT01496365|66028149|FG000|Overall Study|Protocol Violation|2|||
23628888|NCT01496365|66028150|FG001|Overall Study|Protocol Violation|1|||
23628889|NCT01496365|66028151|FG002|Overall Study|Protocol Violation|1|||
23628890|NCT01496365|66028152|FG003|Overall Study|Protocol Violation|0|||
23628891|NCT01496365|66028153|FG004|Overall Study|Protocol Violation|0|||
23628892|NCT01496365|66028154|FG005|Overall Study|Protocol Violation|1|||
23628893|NCT01496365|66028155|FG006|Overall Study|Protocol Violation|0|||
23628894|NCT01496365|66028149|FG000|Overall Study|Lack of Efficacy|1|||
23628895|NCT01496365|66028150|FG001|Overall Study|Lack of Efficacy|0|||
23628896|NCT01496365|66028151|FG002|Overall Study|Lack of Efficacy|0|||
23628897|NCT01496365|66028152|FG003|Overall Study|Lack of Efficacy|0|||
23628898|NCT01496365|66028153|FG004|Overall Study|Lack of Efficacy|0|||
23628899|NCT01496365|66028154|FG005|Overall Study|Lack of Efficacy|1|||
23159101|NCT01225731|64331806|FG002|Part 2|Physician Decision|0|||
23159102|NCT01225731|64331807|FG003|Part 2|Physician Decision|0|||
23159103|NCT01225731|64331808|FG004|Part 2|Physician Decision|0|||
23159104|NCT01225731|64331809|FG005|Part 2|Physician Decision|0|||
23159105|NCT01225731|64331810|FG006|Part 2|Physician Decision|0|||
23159106|NCT01225731|64331811|FG007|Part 2|Physician Decision|2|||
23159107|NCT01225731|64331812|FG008|Part 2|Physician Decision|2|||
23159108|NCT01225731|64331813|FG009|Part 2|Physician Decision|0|||
23159109|NCT01225731|64331814|FG010|Part 2|Physician Decision|0|||
23159110|NCT01225731|64331815|FG011|Part 2|Physician Decision|0|||
23159111|NCT01225731|64331816|FG012|Part 2|Physician Decision|0|||
23159112|NCT01225731|64331804|FG000|Part 2|Withdrawal by Subject|0|||
23159113|NCT01225731|64331805|FG001|Part 2|Withdrawal by Subject|0|||
23159114|NCT01225731|64331806|FG002|Part 2|Withdrawal by Subject|0|||
23159115|NCT01225731|64331807|FG003|Part 2|Withdrawal by Subject|0|||
23159116|NCT01225731|64331808|FG004|Part 2|Withdrawal by Subject|0|||
23159117|NCT01225731|64331809|FG005|Part 2|Withdrawal by Subject|1|||
23159118|NCT01225731|64331810|FG006|Part 2|Withdrawal by Subject|3|||
23159119|NCT01225731|64331811|FG007|Part 2|Withdrawal by Subject|4|||
23567174|NCT01536145|65804012|FG008|Overall Study|Death|0|||
23567175|NCT01536145|65804013|FG009|Overall Study|Death|0|||
23567176|NCT01536145|65804014|FG010|Overall Study|Death|0|||
23567177|NCT01536145|65804004|FG000|Overall Study|Adverse Event|0|||
23567178|NCT01536145|65804005|FG001|Overall Study|Adverse Event|0|||
23567179|NCT01536145|65804006|FG002|Overall Study|Adverse Event|0|||
23567180|NCT01536145|65804007|FG003|Overall Study|Adverse Event|0|||
23567181|NCT01536145|65804008|FG004|Overall Study|Adverse Event|0|||
23567182|NCT01536145|65804009|FG005|Overall Study|Adverse Event|0|||
23159120|NCT01225731|64331812|FG008|Part 2|Withdrawal by Subject|1|||
23159121|NCT01225731|64331813|FG009|Part 2|Withdrawal by Subject|0|||
23444946|NCT00832416|65370206|FG000|Overall Study|Physician Decision|2|||
23628900|NCT01496365|66028155|FG006|Overall Study|Lack of Efficacy|0|||
23159122|NCT01225731|64331814|FG010|Part 2|Withdrawal by Subject|0|||
23628901|NCT01496365|66028149|FG000|Overall Study|Lost to Follow-up|0|||
23159123|NCT01225731|64331815|FG011|Part 2|Withdrawal by Subject|0|||
23159124|NCT01225731|64331816|FG012|Part 2|Withdrawal by Subject|0|||
23567183|NCT01536145|65804010|FG006|Overall Study|Adverse Event|0|||
23222491|NCT02579863|64557701|FG000|Overall Study|Study Terminated at Selected Sites|82|||
23222492|NCT02579863|64557702|FG001|Overall Study|Study Terminated at Selected Sites|88|||
23222493|NCT02579863|64557701|FG000|Overall Study|Withdrawal by Subject|20|||
23222494|NCT02579863|64557702|FG001|Overall Study|Withdrawal by Subject|20|||
23222495|NCT00741260|64557703|FG000|Overall Study|Disease Progression|3|||
23222496|NCT00741260|64557704|FG001|Overall Study|Disease Progression|5|||
23222497|NCT00741260|64557705|FG002|Overall Study|Disease Progression|3|||
23222498|NCT00741260|64557706|FG003|Overall Study|Disease Progression|3|||
23222499|NCT00741260|64557707|FG004|Overall Study|Disease Progression|5|||
23222500|NCT00741260|64557708|FG005|Overall Study|Disease Progression|37|||
23222501|NCT00741260|64557709|FG006|Overall Study|Disease Progression|4|||
23222502|NCT00741260|64557703|FG000|Overall Study|Death|0|||
23222503|NCT00741260|64557704|FG001|Overall Study|Death|1|||
23222504|NCT00741260|64557705|FG002|Overall Study|Death|0|||
23222505|NCT00741260|64557706|FG003|Overall Study|Death|1|||
23222506|NCT00741260|64557707|FG004|Overall Study|Death|2|||
23222507|NCT00741260|64557708|FG005|Overall Study|Death|2|||
23222508|NCT00741260|64557709|FG006|Overall Study|Death|1|||
23628902|NCT01496365|66028150|FG001|Overall Study|Lost to Follow-up|1|||
23628903|NCT01496365|66028151|FG002|Overall Study|Lost to Follow-up|0|||
23628904|NCT01496365|66028152|FG003|Overall Study|Lost to Follow-up|0|||
23628905|NCT01496365|66028153|FG004|Overall Study|Lost to Follow-up|2|||
23628906|NCT01496365|66028154|FG005|Overall Study|Lost to Follow-up|0|||
23628907|NCT01496365|66028155|FG006|Overall Study|Lost to Follow-up|0|||
23628908|NCT01496365|66028149|FG000|Overall Study|Other|4|||
23628909|NCT01496365|66028150|FG001|Overall Study|Other|4|||
23628910|NCT01496365|66028151|FG002|Overall Study|Other|2|||
23628911|NCT01496365|66028152|FG003|Overall Study|Other|1|||
23628912|NCT01496365|66028153|FG004|Overall Study|Other|3|||
23628913|NCT01496365|66028154|FG005|Overall Study|Other|0|||
23628914|NCT01496365|66028155|FG006|Overall Study|Other|1|||
23628915|NCT00979953|66028156|FG000|Overall Study|Adverse Event|5|||
23628916|NCT00979953|66028157|FG001|Overall Study|Adverse Event|2|||
23628917|NCT00979953|66028158|FG002|Overall Study|Adverse Event|17|||
23628918|NCT00979953|66028159|FG003|Overall Study|Adverse Event|4|||
23628919|NCT00979953|66028156|FG000|Overall Study|Lack of Efficacy|1|||
23628920|NCT00979953|66028157|FG001|Overall Study|Lack of Efficacy|2|||
23628921|NCT00979953|66028158|FG002|Overall Study|Lack of Efficacy|0|||
23628922|NCT00979953|66028159|FG003|Overall Study|Lack of Efficacy|0|||
23628923|NCT00979953|66028156|FG000|Overall Study|Lost to Follow-up|1|||
23628924|NCT00979953|66028157|FG001|Overall Study|Lost to Follow-up|1|||
23628925|NCT00979953|66028158|FG002|Overall Study|Lost to Follow-up|1|||
23628926|NCT00979953|66028159|FG003|Overall Study|Lost to Follow-up|0|||
23628927|NCT00979953|66028156|FG000|Overall Study|Withdrawal by Subject|0|||
23628928|NCT00979953|66028157|FG001|Overall Study|Withdrawal by Subject|0|||
23628929|NCT00979953|66028158|FG002|Overall Study|Withdrawal by Subject|2|||
23628930|NCT00979953|66028159|FG003|Overall Study|Withdrawal by Subject|1|||
23628931|NCT00979953|66028156|FG000|Overall Study|Protocol Violation|1|||
23628932|NCT00979953|66028157|FG001|Overall Study|Protocol Violation|0|||
23628933|NCT00979953|66028158|FG002|Overall Study|Protocol Violation|2|||
23628934|NCT00979953|66028159|FG003|Overall Study|Protocol Violation|2|||
23628935|NCT00475644|66028160|FG000|Overall Study|Protocol Violation|13|||
23628936|NCT00193479|66028161|FG000|Induction Chemotherapy|Adverse Event|2|||
23628937|NCT00193479|66028161|FG000|Induction Chemotherapy|Disease Progression|1|||
23628938|NCT00193479|66028161|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
23628939|NCT00193479|66028161|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
23628940|NCT00903760|66028162|FG000|Overall Study|Disease Progression/Death|8|||
23628941|NCT00903760|66028163|FG001|Overall Study|Disease Progression/Death|6|||
23628942|NCT00903760|66028162|FG000|Overall Study|Stem Cell Transplant|8|||
23628943|NCT00903760|66028163|FG001|Overall Study|Stem Cell Transplant|4|||
23628944|NCT00903760|66028162|FG000|Overall Study|Physician Decision|1|||
23628945|NCT00903760|66028163|FG001|Overall Study|Physician Decision|2|||
23628946|NCT00903760|66028162|FG000|Overall Study|Death|0|||
23628947|NCT00903760|66028163|FG001|Overall Study|Death|1|||
23628948|NCT00903760|66028162|FG000|Overall Study|Lost to Follow-up|1|||
23222509|NCT00741260|64557703|FG000|Overall Study|Withdrawal by Subject|0|||
23222510|NCT00741260|64557704|FG001|Overall Study|Withdrawal by Subject|0|||
23222511|NCT00741260|64557705|FG002|Overall Study|Withdrawal by Subject|0|||
23222512|NCT00741260|64557706|FG003|Overall Study|Withdrawal by Subject|0|||
23628949|NCT00903760|66028163|FG001|Overall Study|Lost to Follow-up|0|||
23628950|NCT00903760|66028162|FG000|Overall Study|Withdrawal by Subject|1|||
23628951|NCT00903760|66028163|FG001|Overall Study|Withdrawal by Subject|2|||
23628952|NCT00903760|66028162|FG000|Overall Study|Off treatment for long period|0|||
23222513|NCT00741260|64557707|FG004|Overall Study|Withdrawal by Subject|1|||
23222514|NCT00741260|64557708|FG005|Overall Study|Withdrawal by Subject|3|||
23222515|NCT00741260|64557709|FG006|Overall Study|Withdrawal by Subject|1|||
23444947|NCT00832416|65370207|FG001|Overall Study|Physician Decision|12|||
23628953|NCT00903760|66028163|FG001|Overall Study|Off treatment for long period|1|||
23628954|NCT00356759|66028164|FG000|Overall Study|Death|5|||
23628955|NCT00356759|66028165|FG001|Overall Study|Death|2|||
23159125|NCT01225731|64331804|FG000|Part 3|Adverse Event|0|||
23159126|NCT01225731|64331805|FG001|Part 3|Adverse Event|0|||
23159127|NCT01225731|64331806|FG002|Part 3|Adverse Event|0|||
23159128|NCT01225731|64331807|FG003|Part 3|Adverse Event|0|||
23159129|NCT01225731|64331808|FG004|Part 3|Adverse Event|0|||
23159130|NCT01225731|64331809|FG005|Part 3|Adverse Event|0|||
23329087|NCT02025725|64945677|FG001|Overall Study|Adverse Event|0|||
23329088|NCT02025725|64945676|FG000|Overall Study|Lost to Follow-up|2|||
23329089|NCT02025725|64945677|FG001|Overall Study|Lost to Follow-up|0|||
23329090|NCT02025725|64945676|FG000|Overall Study|Protocol Violation|1|||
23159131|NCT01225731|64331810|FG006|Part 3|Adverse Event|0|||
23159132|NCT01225731|64331811|FG007|Part 3|Adverse Event|0|||
23159133|NCT01225731|64331812|FG008|Part 3|Adverse Event|0|||
23159134|NCT01225731|64331813|FG009|Part 3|Adverse Event|0|||
23159135|NCT01225731|64331814|FG010|Part 3|Adverse Event|1|||
23159136|NCT01225731|64331815|FG011|Part 3|Adverse Event|1|||
23159137|NCT01225731|64331816|FG012|Part 3|Adverse Event|0|||
23159138|NCT01225731|64331804|FG000|Part 3|Lost to Follow-up|0|||
23159139|NCT01225731|64331805|FG001|Part 3|Lost to Follow-up|0|||
23159140|NCT01225731|64331806|FG002|Part 3|Lost to Follow-up|0|||
23159141|NCT01225731|64331807|FG003|Part 3|Lost to Follow-up|0|||
23159142|NCT01225731|64331808|FG004|Part 3|Lost to Follow-up|0|||
23159143|NCT01225731|64331809|FG005|Part 3|Lost to Follow-up|0|||
23159144|NCT01225731|64331810|FG006|Part 3|Lost to Follow-up|0|||
23159145|NCT01225731|64331811|FG007|Part 3|Lost to Follow-up|0|||
23159146|NCT01225731|64331812|FG008|Part 3|Lost to Follow-up|0|||
23159147|NCT01225731|64331813|FG009|Part 3|Lost to Follow-up|0|||
23159148|NCT01225731|64331814|FG010|Part 3|Lost to Follow-up|1|||
23159149|NCT01225731|64331815|FG011|Part 3|Lost to Follow-up|2|||
23159150|NCT01225731|64331816|FG012|Part 3|Lost to Follow-up|1|||
23159151|NCT01225731|64331804|FG000|Part 3|Physician Decision|0|||
23222516|NCT00741260|64557703|FG000|Overall Study|Physician Decision|1|||
23222517|NCT00741260|64557704|FG001|Overall Study|Physician Decision|1|||
23222518|NCT00741260|64557705|FG002|Overall Study|Physician Decision|0|||
23222519|NCT00741260|64557706|FG003|Overall Study|Physician Decision|0|||
23329091|NCT02025725|64945677|FG001|Overall Study|Protocol Violation|1|||
23329092|NCT02025725|64945676|FG000|Overall Study|Withdrawal by Subject|3|||
23329093|NCT02025725|64945677|FG001|Overall Study|Withdrawal by Subject|2|||
23329094|NCT02025725|64945676|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
23329095|NCT02025725|64945677|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
23329096|NCT02259010|64945678|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
23329097|NCT02712320|64945679|FG000|Overall Study|Lost to Follow-up|1|||
23567184|NCT01536145|65804011|FG007|Overall Study|Adverse Event|2|||
23567185|NCT01536145|65804012|FG008|Overall Study|Adverse Event|0|||
23567186|NCT01536145|65804013|FG009|Overall Study|Adverse Event|0|||
23567187|NCT01536145|65804014|FG010|Overall Study|Adverse Event|3|||
23567188|NCT02294474|65804015|FG000|Overall Study|Adverse Event|7|||
23567189|NCT02294474|65804016|FG001|Overall Study|Adverse Event|7|||
23567190|NCT02294474|65804015|FG000|Overall Study|Lack of Efficacy|2|||
23567191|NCT02294474|65804016|FG001|Overall Study|Lack of Efficacy|1|||
23567192|NCT02294474|65804015|FG000|Overall Study|Protocol Violation|4|||
23628956|NCT00356759|66028164|FG000|Overall Study|Withdrawal by Subject|2|||
23159152|NCT01225731|64331805|FG001|Part 3|Physician Decision|0|||
23159153|NCT01225731|64331806|FG002|Part 3|Physician Decision|0|||
23159154|NCT01225731|64331807|FG003|Part 3|Physician Decision|0|||
23159155|NCT01225731|64331808|FG004|Part 3|Physician Decision|0|||
23159156|NCT01225731|64331809|FG005|Part 3|Physician Decision|0|||
23159157|NCT01225731|64331810|FG006|Part 3|Physician Decision|0|||
23222520|NCT00741260|64557707|FG004|Overall Study|Physician Decision|0|||
23222521|NCT00741260|64557708|FG005|Overall Study|Physician Decision|0|||
23222522|NCT00741260|64557709|FG006|Overall Study|Physician Decision|0|||
23222523|NCT00741260|64557703|FG000|Overall Study|Other|2|||
23222524|NCT00741260|64557704|FG001|Overall Study|Other|1|||
23222525|NCT00741260|64557705|FG002|Overall Study|Other|1|||
23222526|NCT00741260|64557706|FG003|Overall Study|Other|2|||
23222527|NCT00741260|64557707|FG004|Overall Study|Other|1|||
23159158|NCT01225731|64331811|FG007|Part 3|Physician Decision|0|||
23329098|NCT02712320|64945679|FG000|Overall Study|Withdrawal by Subject|1|||
23159159|NCT01225731|64331812|FG008|Part 3|Physician Decision|0|||
23222528|NCT00741260|64557708|FG005|Overall Study|Other|3|||
23222529|NCT00741260|64557709|FG006|Overall Study|Other|1|||
23329099|NCT02712320|64945679|FG000|Overall Study|Transferred to another facility|1|||
23567193|NCT02294474|65804016|FG001|Overall Study|Protocol Violation|2|||
23159160|NCT01225731|64331813|FG009|Part 3|Physician Decision|0|||
23329100|NCT02712320|64945679|FG000|Overall Study|Treating with the prohibited medications|2|||
23222530|NCT00633893|64557716|FG000|Overall Study|Death|1|||
23329101|NCT03442751|64948493|FG000|Overall Study|Withdrawal by Subject|3|||
23159161|NCT01225731|64331814|FG010|Part 3|Physician Decision|0|||
23159162|NCT01225731|64331815|FG011|Part 3|Physician Decision|1|||
23159163|NCT01225731|64331816|FG012|Part 3|Physician Decision|2|||
23159164|NCT01225731|64331804|FG000|Part 3|Withdrawal by Subject|0|||
23222531|NCT00633893|64557717|FG001|Overall Study|Death|3|||
23222532|NCT00633893|64557718|FG002|Overall Study|Death|9|||
23567194|NCT02294474|65804015|FG000|Overall Study|Other than specified above|12|||
23567195|NCT02294474|65804016|FG001|Overall Study|Other than specified above|12|||
23567196|NCT01719224|65806956|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
23567197|NCT01719224|65806957|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
23567198|NCT00636792|65806960|FG000|Overall Study|Adverse Event|16|||
23567199|NCT00636792|65806960|FG000|Overall Study|Physician Decision|7|||
23567200|NCT00636792|65806960|FG000|Overall Study|Progressive Disease|4|||
23567201|NCT00636792|65806960|FG000|Overall Study|Withdrawal by Subject|3|||
23159165|NCT01225731|64331805|FG001|Part 3|Withdrawal by Subject|0|||
23159166|NCT01225731|64331806|FG002|Part 3|Withdrawal by Subject|0|||
23159167|NCT01225731|64331807|FG003|Part 3|Withdrawal by Subject|0|||
23159168|NCT01225731|64331808|FG004|Part 3|Withdrawal by Subject|0|||
23159169|NCT01225731|64331809|FG005|Part 3|Withdrawal by Subject|0|||
23159170|NCT01225731|64331810|FG006|Part 3|Withdrawal by Subject|0|||
23222533|NCT00633893|64557716|FG000|Overall Study|Adverse Event|65|||
23222534|NCT00633893|64557717|FG001|Overall Study|Adverse Event|58|||
23222535|NCT00633893|64557718|FG002|Overall Study|Adverse Event|126|||
23222536|NCT00633893|64557716|FG000|Overall Study|Withdrawal by Subject|7|||
23222537|NCT00633893|64557717|FG001|Overall Study|Withdrawal by Subject|12|||
23222538|NCT00633893|64557718|FG002|Overall Study|Withdrawal by Subject|6|||
23222539|NCT00633893|64557716|FG000|Overall Study|Lost to Follow-up|2|||
23159171|NCT01225731|64331811|FG007|Part 3|Withdrawal by Subject|0|||
23159172|NCT01225731|64331812|FG008|Part 3|Withdrawal by Subject|0|||
23159173|NCT01225731|64331813|FG009|Part 3|Withdrawal by Subject|0|||
23159174|NCT01225731|64331814|FG010|Part 3|Withdrawal by Subject|4|||
23159175|NCT01225731|64331815|FG011|Part 3|Withdrawal by Subject|6|||
23159176|NCT01225731|64331816|FG012|Part 3|Withdrawal by Subject|4|||
23159177|NCT00687440|64331817|FG000|Overall Study|Adverse Event|3|||
23159178|NCT00687440|64331817|FG000|Overall Study|Lost to Follow-up|3|||
23159179|NCT00687440|64331817|FG000|Overall Study|Lack of Efficacy|2|||
23567202|NCT00636792|65806960|FG000|Overall Study|Other|3|||
23567203|NCT00758160|65806961|FG000|Overall Study|No Longer Requires Study Medication|4|||
23567204|NCT00758160|65806961|FG000|Overall Study|Administration Problems|3|||
23159180|NCT00687440|64331817|FG000|Overall Study|Death|2|||
23159181|NCT00687440|64331817|FG000|Overall Study|Other|1|||
23159182|NCT00687440|64331817|FG000|Overall Study|Missing|1|||
23159183|NCT01378858|64331818|FG000|Overall Study|Withdrawal by Subject|4|||
23159184|NCT01378858|64331819|FG001|Overall Study|Withdrawal by Subject|4|||
23159185|NCT02053168|64331828|FG000|Overall Study|Withdrawal by Subject|1|||
23159186|NCT02053168|64331828|FG000|Overall Study|Physician Decision|1|||
23159187|NCT02053168|64331828|FG000|Overall Study|Lost to Follow-up|1|||
23159188|NCT02230384|64331831|FG000|Phase 1|Lost to Follow-up|1|||
23159189|NCT02230384|64331832|FG001|Phase 1|Lost to Follow-up|0|||
23159190|NCT02230384|64331831|FG000|Phase 1|Physician Decision|0|||
23159191|NCT02230384|64331832|FG001|Phase 1|Physician Decision|1|||
23159192|NCT02230384|64331831|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
23159193|NCT02230384|64331832|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
23159194|NCT02230384|64331831|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
23159195|NCT02230384|64331832|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
23159196|NCT02230384|64331831|FG000|Phase 2 - Switch|Adverse Event|2|||
23159197|NCT02230384|64331832|FG001|Phase 2 - Switch|Adverse Event|0|||
23159198|NCT00677820|64331833|FG000|Overall Study|Lost to Follow-up|1|||
23159199|NCT00677820|64331834|FG001|Overall Study|Lost to Follow-up|0|||
23159200|NCT01230242|64331835|FG000|Overall Study|Physician Decision|2|||
23159201|NCT01230242|64331835|FG000|Overall Study|Withdrawal by Subject|1|||
23159202|NCT04854434|64331840|FG000|Overall Study|Death|1|||
23159203|NCT04854434|64331841|FG001|Overall Study|Death|3|||
23159204|NCT04854434|64331842|FG002|Overall Study|Death|4|||
23222540|NCT00633893|64557717|FG001|Overall Study|Lost to Follow-up|4|||
23329102|NCT03442751|64948494|FG001|Overall Study|Withdrawal by Subject|1|||
23329103|NCT03442751|64948493|FG000|Overall Study|Lost to Follow-up|3|||
23329104|NCT03442751|64948494|FG001|Overall Study|Lost to Follow-up|0|||
23329105|NCT01842438|64948498|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
23329106|NCT01842438|64948499|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
23159205|NCT04854434|64331840|FG000|Overall Study|Study Terminated by Sponsor|2|||
23159206|NCT04854434|64331841|FG001|Overall Study|Study Terminated by Sponsor|0|||
23159207|NCT04854434|64331842|FG002|Overall Study|Study Terminated by Sponsor|0|||
23159208|NCT04854434|64331840|FG000|Overall Study|Other|1|||
23159209|NCT04854434|64331841|FG001|Overall Study|Other|1|||
23329107|NCT01842438|64948498|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
23329108|NCT01842438|64948499|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
23567205|NCT00758160|65806961|FG000|Overall Study|Adverse Event|15|||
23567206|NCT00758160|65806961|FG000|Overall Study|Lack of Efficacy|10|||
23567207|NCT00758160|65806961|FG000|Overall Study|Lost to Follow-up|14|||
23159210|NCT04854434|64331842|FG002|Overall Study|Other|0|||
23159211|NCT00545298|64331843|FG000|Overall Study|Issues with Standard of Care|2|||
23159212|NCT00545298|64331844|FG001|Overall Study|Issues with Standard of Care|0|||
23159213|NCT00545298|64331845|FG002|Overall Study|Issues with Standard of Care|1|||
23159214|NCT01210807|64331846|FG000|Overall Study|Lost to Follow-up|1|||
23567208|NCT00758160|65806961|FG000|Overall Study|Protocol Violation|12|||
23159215|NCT01210807|64331847|FG001|Overall Study|Lost to Follow-up|2|||
23159216|NCT01210807|64331846|FG000|Overall Study|Not implanted bilaterally|2|||
23159217|NCT01210807|64331847|FG001|Overall Study|Not implanted bilaterally|1|||
23159218|NCT02246582|64331853|FG000|Overall Study|Withdrawal by Subject|3|||
23159219|NCT02246582|64331854|FG001|Overall Study|Withdrawal by Subject|4|||
23159220|NCT00912028|64331855|FG000|Overall Study|Lost to Follow-up|2|||
23329109|NCT01842438|64948498|FG000|T2: 6month Follow-up|Death|0|||
23329110|NCT01842438|64948499|FG001|T2: 6month Follow-up|Death|1|||
23329111|NCT01234350|64948500|FG000|Overall Study|Adverse Event|277|||
23329112|NCT01234350|64948501|FG001|Overall Study|Adverse Event|92|||
23329113|NCT01234350|64948500|FG000|Overall Study|Withdrawal by Subject|61|||
23329114|NCT01234350|64948501|FG001|Overall Study|Withdrawal by Subject|36|||
23329115|NCT01234350|64948500|FG000|Overall Study|Lost to Follow-up|115|||
23329116|NCT01234350|64948501|FG001|Overall Study|Lost to Follow-up|47|||
23329117|NCT01234350|64948500|FG000|Overall Study|Covers a diverse set of reasons|234|||
23329118|NCT01234350|64948501|FG001|Overall Study|Covers a diverse set of reasons|92|||
23329119|NCT03511105|64948502|FG000|Overall Study|Adverse Event|1|||
23329120|NCT03511105|64948503|FG001|Overall Study|Adverse Event|0|||
23329121|NCT03511105|64948502|FG000|Overall Study|Withdrew consent|1|||
23329122|NCT03511105|64948503|FG001|Overall Study|Withdrew consent|0|||
23329123|NCT01173523|64948504|FG000|Overall Study|Clinical Progression|1|||
23329124|NCT01173523|64948505|FG001|Overall Study|Clinical Progression|1|||
23329125|NCT01173523|64948504|FG000|Overall Study|Progressive Disease|10|||
23329126|NCT01173523|64948505|FG001|Overall Study|Progressive Disease|8|||
23329127|NCT01173523|64948504|FG000|Overall Study|Other|2|||
23329128|NCT01173523|64948505|FG001|Overall Study|Other|3|||
23329129|NCT01082328|64948508|FG000|Overall Study|Adverse Event|1|||
23329130|NCT01420068|64948513|FG000|Overall Study|Administrative problems|1|||
23329131|NCT01420068|64948514|FG001|Overall Study|Administrative problems|3|||
23329132|NCT01420068|64948513|FG000|Overall Study|Withdrawal by Subject|1|||
23329133|NCT01420068|64948514|FG001|Overall Study|Withdrawal by Subject|2|||
23329134|NCT03885661|64948515|FG000|Overall Study|Withdrawal by Subject|0|||
23567209|NCT00758160|65806961|FG000|Overall Study|Withdrawal by Subject|8|||
23567210|NCT02367716|65806966|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
23567211|NCT02006121|65806969|FG000|Double Blind Phase|Adverse Event|6|||
23567212|NCT02006121|65806970|FG001|Double Blind Phase|Adverse Event|0|||
23567213|NCT02006121|65806969|FG000|Double Blind Phase|Lack of Efficacy|1|||
23567214|NCT02006121|65806970|FG001|Double Blind Phase|Lack of Efficacy|16|||
23159221|NCT00912028|64331856|FG001|Overall Study|Lost to Follow-up|3|||
23159222|NCT00912028|64331857|FG002|Overall Study|Lost to Follow-up|0|||
23159223|NCT00912028|64331858|FG003|Overall Study|Lost to Follow-up|1|||
23159224|NCT00912028|64331859|FG004|Overall Study|Lost to Follow-up|3|||
23159225|NCT00912028|64331855|FG000|Overall Study|Withdrawal by Subject|3|||
23159226|NCT00912028|64331856|FG001|Overall Study|Withdrawal by Subject|0|||
23159227|NCT00912028|64331857|FG002|Overall Study|Withdrawal by Subject|0|||
23159228|NCT00912028|64331858|FG003|Overall Study|Withdrawal by Subject|0|||
23159229|NCT00912028|64331859|FG004|Overall Study|Withdrawal by Subject|0|||
23159230|NCT00632099|64331860|FG000|Overall Study|Lost to Follow-up|3|||
23159231|NCT00632099|64331861|FG001|Overall Study|Lost to Follow-up|3|||
23159232|NCT02716987|64331862|FG000|Overall Study|Ligand synthesis failure|0|||
23159233|NCT02716987|64331863|FG001|Overall Study|Ligand synthesis failure|0|||
23159234|NCT02716987|64331864|FG002|Overall Study|Ligand synthesis failure|1|||
23159235|NCT02716987|64331865|FG003|Overall Study|Ligand synthesis failure|0|||
23159236|NCT02716987|64331866|FG004|Overall Study|Ligand synthesis failure|0|||
23159237|NCT02716987|64331867|FG005|Overall Study|Ligand synthesis failure|0|||
23567215|NCT02006121|65806969|FG000|Double Blind Phase|Withdrawal by Subject|3|||
23567216|NCT02006121|65806970|FG001|Double Blind Phase|Withdrawal by Subject|4|||
23159238|NCT02716987|64331862|FG000|Overall Study|Withdrawal by Subject|0|||
23159239|NCT02716987|64331863|FG001|Overall Study|Withdrawal by Subject|0|||
23159240|NCT02716987|64331864|FG002|Overall Study|Withdrawal by Subject|0|||
23159241|NCT02716987|64331865|FG003|Overall Study|Withdrawal by Subject|0|||
23329135|NCT03885661|64948516|FG001|Overall Study|Withdrawal by Subject|1|||
23329136|NCT03885661|64948515|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
23567217|NCT02006121|65806969|FG000|Double Blind Phase|Non-compliance with study drug|1|||
23567218|NCT02006121|65806970|FG001|Double Blind Phase|Non-compliance with study drug|3|||
23567219|NCT02006121|65806969|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
23159242|NCT02716987|64331866|FG004|Overall Study|Withdrawal by Subject|1|||
23159243|NCT02716987|64331867|FG005|Overall Study|Withdrawal by Subject|1|||
23159244|NCT01380730|64331868|FG000|Overall Study|Death|0|||
23159245|NCT01380730|64331869|FG001|Overall Study|Death|0|||
23159246|NCT01380730|64331870|FG002|Overall Study|Death|0|||
23159247|NCT01380730|64331871|FG003|Overall Study|Death|0|||
23159248|NCT01380730|64331872|FG004|Overall Study|Death|1|||
23329137|NCT03885661|64948516|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
23329138|NCT01611883|64948517|FG000|Overall Study|Adverse Event|1|||
23329139|NCT01611883|64948518|FG001|Overall Study|Adverse Event|1|||
23329140|NCT00866281|64948519|FG000|Overall Study|Adverse Event|1|||
23159249|NCT01380730|64331873|FG005|Overall Study|Death|0|||
23159250|NCT01380730|64331874|FG006|Overall Study|Death|0|||
23159251|NCT01380730|64331875|FG007|Overall Study|Death|0|||
23159252|NCT02039375|64331876|FG000|Overall Study|Lost to Follow-up|2|||
23159253|NCT01349465|64331882|FG000|Overall Study|Adverse Event|1|||
23159254|NCT01349465|64331883|FG001|Overall Study|Adverse Event|0|||
23159255|NCT01349465|64331882|FG000|Overall Study|Death|3|||
23159256|NCT01349465|64331883|FG001|Overall Study|Death|0|||
23159257|NCT01349465|64331882|FG000|Overall Study|Lost to Follow-up|10|||
23159258|NCT01349465|64331883|FG001|Overall Study|Lost to Follow-up|1|||
23159259|NCT01349465|64331882|FG000|Overall Study|Withdrawal by Subject|4|||
23159260|NCT01349465|64331883|FG001|Overall Study|Withdrawal by Subject|2|||
23159261|NCT01349465|64331882|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
23159262|NCT01349465|64331883|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
23159263|NCT02663271|64331885|FG000|Overall Study|Withdrawal by Subject|5|||
23159264|NCT02663271|64331885|FG000|Overall Study|Lack of Efficacy|1|||
23159265|NCT00923130|64331888|FG000|Overall Study|Stopped treatment due to progression|17|||
23159266|NCT00923130|64331888|FG000|Overall Study|Death|1|||
23159267|NCT00923130|64331888|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
23159268|NCT00923130|64331888|FG000|Overall Study|Switched to alternative treatment|2|||
23159269|NCT00923130|64331888|FG000|Overall Study|Refused further treatment|2|||
23567220|NCT02006121|65806970|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
23567221|NCT02006121|65806969|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
23567222|NCT02006121|65806970|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
23567223|NCT02006121|65806969|FG000|Open Label Phase|Adverse Event|15|||
23567224|NCT02006121|65806970|FG001|Open Label Phase|Adverse Event|0|||
23567225|NCT02006121|65806969|FG000|Open Label Phase|Lack of Efficacy|2|||
23567226|NCT02006121|65806970|FG001|Open Label Phase|Lack of Efficacy|0|||
23567227|NCT02006121|65806969|FG000|Open Label Phase|Protocol Violation|2|||
23567228|NCT02006121|65806970|FG001|Open Label Phase|Protocol Violation|0|||
23567229|NCT02006121|65806969|FG000|Open Label Phase|Withdrawal by Subject|3|||
23567230|NCT02006121|65806970|FG001|Open Label Phase|Withdrawal by Subject|0|||
23567231|NCT02006121|65806969|FG000|Open Label Phase|Non-compliance with study drug|3|||
23567232|NCT02006121|65806970|FG001|Open Label Phase|Non-compliance with study drug|0|||
23567233|NCT01616771|65806971|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
23567234|NCT03691948|65806975|FG000|Overall Study|Lost to Follow-up|1|||
23567235|NCT03691948|65806976|FG001|Overall Study|Lost to Follow-up|3|||
23567236|NCT00393523|65806977|FG000|Overall Study|Lost to Follow-up|0|||
23567237|NCT00393523|65806978|FG001|Overall Study|Lost to Follow-up|0|||
23567238|NCT00393523|65806979|FG002|Overall Study|Lost to Follow-up|0|||
23567239|NCT00393523|65806980|FG003|Overall Study|Lost to Follow-up|2|||
23567240|NCT00393523|65806981|FG004|Overall Study|Lost to Follow-up|1|||
23567241|NCT00393523|65806977|FG000|Overall Study|Protocol Violation|6|||
23567242|NCT00393523|65806978|FG001|Overall Study|Protocol Violation|2|||
23567243|NCT00393523|65806979|FG002|Overall Study|Protocol Violation|0|||
23567244|NCT00393523|65806980|FG003|Overall Study|Protocol Violation|1|||
23567245|NCT00393523|65806981|FG004|Overall Study|Protocol Violation|0|||
23567246|NCT00393523|65806977|FG000|Overall Study|Withdrawal by Subject|6|||
23567247|NCT00393523|65806978|FG001|Overall Study|Withdrawal by Subject|7|||
23567248|NCT00393523|65806979|FG002|Overall Study|Withdrawal by Subject|2|||
23567249|NCT00393523|65806980|FG003|Overall Study|Withdrawal by Subject|3|||
23567250|NCT00393523|65806981|FG004|Overall Study|Withdrawal by Subject|0|||
23567251|NCT00393523|65806977|FG000|Overall Study|Difficulties in specimen collection|0|||
23567252|NCT00393523|65806978|FG001|Overall Study|Difficulties in specimen collection|0|||
23567253|NCT00393523|65806979|FG002|Overall Study|Difficulties in specimen collection|1|||
23567254|NCT00393523|65806980|FG003|Overall Study|Difficulties in specimen collection|0|||
23159270|NCT00636675|64331889|FG000|Overall Study|Lost to Follow-up|121|||
23159271|NCT00636675|64331890|FG001|Overall Study|Lost to Follow-up|31|||
23159272|NCT00636675|64331889|FG000|Overall Study|Withdrawal by Subject|19|||
23159273|NCT00636675|64331890|FG001|Overall Study|Withdrawal by Subject|10|||
23159274|NCT00003895|64331891|FG000|Overall Study|Adverse Event|4|||
23159275|NCT00003895|64331892|FG001|Overall Study|Adverse Event|0|||
23159276|NCT00003895|64331891|FG000|Overall Study|Lack of Efficacy|1|||
23159277|NCT00003895|64331892|FG001|Overall Study|Lack of Efficacy|1|||
23159278|NCT00003895|64331891|FG000|Overall Study|Patient Vacation|2|||
23567255|NCT00393523|65806981|FG004|Overall Study|Difficulties in specimen collection|0|||
23567256|NCT00393523|65806977|FG000|Overall Study|Vaccine supply issue|0|||
23567257|NCT00393523|65806978|FG001|Overall Study|Vaccine supply issue|0|||
23567258|NCT00393523|65806979|FG002|Overall Study|Vaccine supply issue|1|||
23567259|NCT00393523|65806980|FG003|Overall Study|Vaccine supply issue|0|||
23159279|NCT00003895|64331892|FG001|Overall Study|Patient Vacation|0|||
23567260|NCT00393523|65806981|FG004|Overall Study|Vaccine supply issue|0|||
23567261|NCT02153359|65806982|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
23567262|NCT02153359|65806983|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
23567263|NCT00684762|65806987|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
23567264|NCT00684762|65806988|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
23159280|NCT00003895|64331891|FG000|Overall Study|Withdrawal by Subject|0|||
23159281|NCT00003895|64331892|FG001|Overall Study|Withdrawal by Subject|3|||
23159282|NCT03703102|64331893|FG000|Overall Study|Adverse Event|4|||
23159283|NCT03703102|64331894|FG001|Overall Study|Adverse Event|3|||
23159284|NCT03703102|64331895|FG002|Overall Study|Adverse Event|7|||
23159285|NCT03703102|64331896|FG003|Overall Study|Adverse Event|3|||
23159286|NCT03703102|64331897|FG004|Overall Study|Adverse Event|13|||
23159287|NCT03703102|64331893|FG000|Overall Study|Lack of Efficacy|4|||
23159288|NCT03703102|64331894|FG001|Overall Study|Lack of Efficacy|0|||
23159289|NCT03703102|64331895|FG002|Overall Study|Lack of Efficacy|1|||
23444948|NCT00832416|65370208|FG002|Overall Study|Physician Decision|5|||
23329141|NCT00866281|64948520|FG001|Overall Study|Adverse Event|0|||
23329142|NCT00866281|64948519|FG000|Overall Study|Withdrawal by participants|3|||
23329143|NCT00866281|64948520|FG001|Overall Study|Withdrawal by participants|0|||
23329144|NCT00866281|64948519|FG000|Overall Study|Disease progression|3|||
23329145|NCT00866281|64948520|FG001|Overall Study|Disease progression|11|||
23329146|NCT00866281|64948519|FG000|Overall Study|New cancer therapy|0|||
23329147|NCT00866281|64948520|FG001|Overall Study|New cancer therapy|4|||
23329148|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
23329149|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
23329150|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
23329151|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
23329152|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
23329153|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
23329154|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
23329155|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
23329156|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
23329157|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
23329158|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
23329159|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
23329160|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
23329161|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
23329162|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
23329163|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
23329164|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
23329165|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
23329166|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
23329167|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
23329168|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
23329169|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
23329170|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
23329171|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
23329172|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
23329173|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
23329174|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
23329175|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
23329176|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
23329177|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
23329178|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
23329179|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
23329180|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
23329181|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
23329182|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
23444949|NCT00832416|65370209|FG003|Overall Study|Physician Decision|10|||
23444950|NCT00832416|65370206|FG000|Overall Study|Administrative|0|||
23159290|NCT03703102|64331896|FG003|Overall Study|Lack of Efficacy|4|||
23159291|NCT03703102|64331897|FG004|Overall Study|Lack of Efficacy|1|||
23159292|NCT03703102|64331893|FG000|Overall Study|Lost to Follow-up|0|||
23159293|NCT03703102|64331894|FG001|Overall Study|Lost to Follow-up|0|||
23159294|NCT03703102|64331895|FG002|Overall Study|Lost to Follow-up|1|||
23159295|NCT03703102|64331896|FG003|Overall Study|Lost to Follow-up|2|||
23159296|NCT03703102|64331897|FG004|Overall Study|Lost to Follow-up|2|||
23159297|NCT03703102|64331893|FG000|Overall Study|Physician Decision|2|||
23159298|NCT03703102|64331894|FG001|Overall Study|Physician Decision|2|||
23159299|NCT03703102|64331895|FG002|Overall Study|Physician Decision|2|||
23159300|NCT03703102|64331896|FG003|Overall Study|Physician Decision|2|||
23159301|NCT03703102|64331897|FG004|Overall Study|Physician Decision|4|||
23159302|NCT03703102|64331893|FG000|Overall Study|Withdrawal by Subject|7|||
23159303|NCT03703102|64331894|FG001|Overall Study|Withdrawal by Subject|5|||
23159304|NCT03703102|64331895|FG002|Overall Study|Withdrawal by Subject|5|||
23159305|NCT03703102|64331896|FG003|Overall Study|Withdrawal by Subject|5|||
23159306|NCT03703102|64331897|FG004|Overall Study|Withdrawal by Subject|9|||
23159307|NCT03703102|64331893|FG000|Overall Study|Ineligibility|0|||
23159308|NCT03703102|64331894|FG001|Overall Study|Ineligibility|0|||
23159309|NCT03703102|64331895|FG002|Overall Study|Ineligibility|1|||
23159310|NCT03703102|64331896|FG003|Overall Study|Ineligibility|0|||
23159311|NCT03703102|64331897|FG004|Overall Study|Ineligibility|0|||
23159312|NCT03703102|64331893|FG000|Overall Study|Protocol Deviation|4|||
23159313|NCT03703102|64331894|FG001|Overall Study|Protocol Deviation|4|||
23159314|NCT03703102|64331895|FG002|Overall Study|Protocol Deviation|3|||
23159315|NCT03703102|64331896|FG003|Overall Study|Protocol Deviation|0|||
23329183|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
23329184|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
23329185|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
23329186|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
23329187|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
23329188|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
23329189|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
23329190|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
23329191|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
23329192|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
23329193|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
23329194|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
23329195|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
23329196|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
23329197|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
23329198|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
23329199|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
23329200|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Site closed|0|||
23329201|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Site closed|0|||
23329202|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Site closed|1|||
23329203|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Site closed|0|||
23329204|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
23329205|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
23329206|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
23329207|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
23329208|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
23329209|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
23329210|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
23329211|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
23329212|NCT00838903|64948521|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
23329213|NCT00838903|64948522|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
23329214|NCT00838903|64948523|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
23329215|NCT00838903|64948524|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
23329216|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
23329217|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
23329218|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
23329219|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
23329220|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
23329221|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
23329222|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
23329223|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
23329224|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
23329225|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
23329226|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
23329227|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
23329228|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
23329229|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
23329230|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
23329231|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
23329232|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
23329233|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
23329234|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
23329235|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
23329236|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
23329237|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
23444951|NCT00832416|65370207|FG001|Overall Study|Administrative|0|||
23444952|NCT00832416|65370208|FG002|Overall Study|Administrative|0|||
23444953|NCT00832416|65370209|FG003|Overall Study|Administrative|1|||
23444954|NCT00832416|65370206|FG000|Overall Study|Adverse Event|21|||
23159316|NCT03703102|64331897|FG004|Overall Study|Protocol Deviation|0|||
23159317|NCT03703102|64331893|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23329238|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
23329239|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
23329240|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
23329241|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
23329242|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
23329243|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
23329244|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
23329245|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
23329246|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
23329247|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
23329248|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
23329249|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
23329250|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
23444955|NCT00832416|65370207|FG001|Overall Study|Adverse Event|19|||
23444956|NCT00832416|65370208|FG002|Overall Study|Adverse Event|41|||
23444957|NCT00832416|65370209|FG003|Overall Study|Adverse Event|10|||
23444958|NCT00832416|65370206|FG000|Overall Study|Death|1|||
23444959|NCT00832416|65370207|FG001|Overall Study|Death|0|||
23444960|NCT00832416|65370208|FG002|Overall Study|Death|0|||
23444961|NCT00832416|65370209|FG003|Overall Study|Death|0|||
23444962|NCT00994422|65370210|FG000|Overall Study|Lost to Follow-up|7|||
23444963|NCT00994422|65370211|FG001|Overall Study|Lost to Follow-up|1|||
23444964|NCT01726582|65370212|FG000|Overall Study|Physician Decision|99|||
23444965|NCT01726582|65370212|FG000|Overall Study|Death|85|||
23444966|NCT01391663|65370222|FG000|Overall Study|Withdrawal by Subject|0|||
23444967|NCT01391663|65370223|FG001|Overall Study|Withdrawal by Subject|0|||
23444968|NCT01391663|65370224|FG002|Overall Study|Withdrawal by Subject|1|||
23444969|NCT01391663|65370225|FG003|Overall Study|Withdrawal by Subject|0|||
23444970|NCT03077542|65370226|FG000|Overall Study|Death|4|||
23329251|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
23329252|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
23329253|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
23329254|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
23444971|NCT03077542|65370227|FG001|Overall Study|Death|0|||
23444972|NCT03077542|65370226|FG000|Overall Study|Physician Decision|6|||
23444973|NCT03077542|65370227|FG001|Overall Study|Physician Decision|1|||
23444974|NCT03077542|65370226|FG000|Overall Study|Withdrawal by Subject|0|||
23444975|NCT03077542|65370227|FG001|Overall Study|Withdrawal by Subject|1|||
23444976|NCT02629822|65370228|FG000|Base Study|Lost to Follow-up|2|||
23444977|NCT02629822|65370228|FG000|Base Study|Non-Compliance With Study Drug|1|||
23444978|NCT02629822|65370228|FG000|Extension Study|Adverse Event|1|||
23444979|NCT02629822|65370228|FG000|Extension Study|Lost to Follow-up|1|||
23444980|NCT03461146|65370229|FG000|Overall Study|Adverse Event|2|||
23444981|NCT03461146|65370229|FG000|Overall Study|Physician Decision|1|||
23444982|NCT01871519|65370230|FG000|Overall Study|Death|26|||
23444983|NCT01871519|65370230|FG000|Overall Study|Lost to Follow-up|15|||
23567265|NCT04000594|65806991|FG000|Overall Study|Withdrawal by Subject|1|||
23567266|NCT04000594|65806992|FG001|Overall Study|Withdrawal by Subject|0|||
23567267|NCT04000594|65806993|FG002|Overall Study|Withdrawal by Subject|0|||
23567268|NCT04422639|65806998|FG000|Overall Study|Death|1|||
23567269|NCT04422639|65806999|FG001|Overall Study|Death|0|||
23567270|NCT04422639|65806998|FG000|Overall Study|study closed prior to completion of FU visits|0|||
23567271|NCT04422639|65806999|FG001|Overall Study|study closed prior to completion of FU visits|2|||
23567272|NCT01844115|65807000|FG000|Overall Study|Adverse Event|4|||
23567273|NCT01844115|65807001|FG001|Overall Study|Adverse Event|22|||
23567274|NCT01844115|65807000|FG000|Overall Study|Lack of Efficacy|1|||
23567275|NCT01844115|65807001|FG001|Overall Study|Lack of Efficacy|4|||
23567276|NCT01844115|65807000|FG000|Overall Study|Protocol Violation|12|||
23567277|NCT01844115|65807001|FG001|Overall Study|Protocol Violation|10|||
23567278|NCT01844115|65807000|FG000|Overall Study|Withdrawal by Subject|11|||
23567279|NCT01844115|65807001|FG001|Overall Study|Withdrawal by Subject|11|||
23567280|NCT01844115|65807000|FG000|Overall Study|Lost to Follow-up|11|||
23567281|NCT01844115|65807001|FG001|Overall Study|Lost to Follow-up|10|||
23567282|NCT01844115|65807000|FG000|Overall Study|Pregnancy|0|||
23444984|NCT01871519|65370230|FG000|Overall Study|Withdrawal by Subject|49|||
23444985|NCT02206035|65370231|FG000|Overall Study|Physician Decision|10|||
23444986|NCT02206035|65370232|FG001|Overall Study|Physician Decision|0|||
23444987|NCT02206035|65370233|FG002|Overall Study|Physician Decision|175|||
23567283|NCT01844115|65807001|FG001|Overall Study|Pregnancy|1|||
23444988|NCT03600740|65370234|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
23567284|NCT05593211|65807005|FG000|Overall Study|Withdrawal by Subject|1|||
23567285|NCT03447730|65807006|FG000|Overall Study|Adverse Event|0|||
23567286|NCT03447730|65807007|FG001|Overall Study|Adverse Event|2|||
23567287|NCT03447730|65807008|FG002|Overall Study|Adverse Event|0|||
23567288|NCT01493960|65807009|FG000|Overall Study|Adverse Event|0|||
23567289|NCT01493960|65807010|FG001|Overall Study|Adverse Event|1|||
23444989|NCT00394706|65370236|FG000|Overall Study|Withdrawal by Subject|2|||
23444990|NCT00394706|65370237|FG001|Overall Study|Withdrawal by Subject|0|||
23444991|NCT00394706|65370238|FG002|Overall Study|Withdrawal by Subject|1|||
23444992|NCT00394706|65370239|FG003|Overall Study|Withdrawal by Subject|0|||
23444993|NCT00394706|65370240|FG004|Overall Study|Withdrawal by Subject|0|||
23444994|NCT00394706|65370241|FG005|Overall Study|Withdrawal by Subject|2|||
23444995|NCT00394706|65370242|FG006|Overall Study|Withdrawal by Subject|1|||
23444996|NCT00394706|65370243|FG007|Overall Study|Withdrawal by Subject|0|||
23444997|NCT00394706|65370236|FG000|Overall Study|Lost to Follow-up|2|||
23444998|NCT00394706|65370237|FG001|Overall Study|Lost to Follow-up|2|||
23444999|NCT00394706|65370238|FG002|Overall Study|Lost to Follow-up|8|||
23445000|NCT00394706|65370239|FG003|Overall Study|Lost to Follow-up|1|||
23445001|NCT00394706|65370240|FG004|Overall Study|Lost to Follow-up|2|||
23445002|NCT00394706|65370241|FG005|Overall Study|Lost to Follow-up|5|||
23445003|NCT00394706|65370242|FG006|Overall Study|Lost to Follow-up|2|||
23445004|NCT00394706|65370243|FG007|Overall Study|Lost to Follow-up|0|||
23567290|NCT01493960|65807009|FG000|Overall Study|Lack of Efficacy|15|||
23567291|NCT01493960|65807010|FG001|Overall Study|Lack of Efficacy|9|||
23567292|NCT01493960|65807009|FG000|Overall Study|Protocol Violation|3|||
23567293|NCT01493960|65807010|FG001|Overall Study|Protocol Violation|0|||
23567294|NCT01493960|65807009|FG000|Overall Study|Withdrawal by Subject|10|||
23567295|NCT01493960|65807010|FG001|Overall Study|Withdrawal by Subject|4|||
23567296|NCT01493960|65807009|FG000|Overall Study|Non-specified|4|||
23567297|NCT01493960|65807010|FG001|Overall Study|Non-specified|4|||
23567298|NCT04567693|65807011|FG000|Overall Study|Death|0|||
23567299|NCT04567693|65807012|FG001|Overall Study|Death|0|||
23567300|NCT04567693|65807013|FG002|Overall Study|Death|2|||
23567301|NCT04567693|65807011|FG000|Overall Study|Lost to Follow-up|1|||
23567302|NCT04567693|65807012|FG001|Overall Study|Lost to Follow-up|0|||
23567303|NCT04567693|65807013|FG002|Overall Study|Lost to Follow-up|2|||
23567304|NCT04567693|65807011|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
23567305|NCT04567693|65807012|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
23567306|NCT04567693|65807013|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
23567307|NCT01984424|65807014|FG000|Overall Study|Withdrawal by Subject|3|||
23567308|NCT01984424|65807015|FG001|Overall Study|Withdrawal by Subject|5|||
23567309|NCT01984424|65807014|FG000|Overall Study|Sponsor Decision|0|||
23567310|NCT01984424|65807015|FG001|Overall Study|Sponsor Decision|1|||
23567311|NCT01984424|65807014|FG000|Overall Study|Lost to Follow-up|0|||
23567312|NCT01984424|65807015|FG001|Overall Study|Lost to Follow-up|1|||
23567313|NCT00525265|65807016|FG000|Overall Study|Protocol Violation|1|||
23567314|NCT00525265|65807017|FG001|Overall Study|Protocol Violation|0|||
23567315|NCT02305381|65807022|FG000|Overall Study|Unclassified|5|||
23567316|NCT02305381|65807023|FG001|Overall Study|Unclassified|5|||
23567317|NCT02305381|65807024|FG002|Overall Study|Unclassified|7|||
23567318|NCT01597505|65807031|FG000|Overall Study|Physician Decision|5|||
23567319|NCT01597505|65807032|FG001|Overall Study|Physician Decision|0|||
23567320|NCT01597505|65807031|FG000|Overall Study|Adverse Event|19|||
23567321|NCT01597505|65807032|FG001|Overall Study|Adverse Event|7|||
23567322|NCT01597505|65807031|FG000|Overall Study|Lost to Follow-up|4|||
23567323|NCT01597505|65807032|FG001|Overall Study|Lost to Follow-up|2|||
23567324|NCT01597505|65807031|FG000|Overall Study|Withdrawal by Subject|10|||
23567325|NCT01597505|65807032|FG001|Overall Study|Withdrawal by Subject|18|||
23567326|NCT01597505|65807031|FG000|Overall Study|Other|5|||
23567327|NCT01597505|65807032|FG001|Overall Study|Other|6|||
23567328|NCT01597505|65807031|FG000|Overall Study|Missing|1|||
23567329|NCT01597505|65807032|FG001|Overall Study|Missing|0|||
23567330|NCT00474929|65807033|FG000|Overall Study|Withdrawal by Subject|0|||
23567331|NCT00474929|65807034|FG001|Overall Study|Withdrawal by Subject|1|||
23567332|NCT00474929|65807035|FG002|Overall Study|Withdrawal by Subject|0|||
23567333|NCT00474929|65807036|FG003|Overall Study|Withdrawal by Subject|0|||
23567334|NCT00474929|65807037|FG004|Overall Study|Withdrawal by Subject|0|||
23567335|NCT00474929|65807033|FG000|Overall Study|Unrelated medical condition|0|||
23567336|NCT00474929|65807034|FG001|Overall Study|Unrelated medical condition|0|||
23567337|NCT00474929|65807035|FG002|Overall Study|Unrelated medical condition|1|||
23567338|NCT00474929|65807036|FG003|Overall Study|Unrelated medical condition|0|||
23567339|NCT00474929|65807037|FG004|Overall Study|Unrelated medical condition|0|||
23567340|NCT00474929|65807033|FG000|Overall Study|Physician Decision|0|||
23567341|NCT00474929|65807034|FG001|Overall Study|Physician Decision|0|||
23567342|NCT00474929|65807035|FG002|Overall Study|Physician Decision|1|||
23567343|NCT00474929|65807036|FG003|Overall Study|Physician Decision|2|||
23567344|NCT00474929|65807037|FG004|Overall Study|Physician Decision|0|||
23567345|NCT00337662|65807040|FG000|Study Period II|Lost to Follow-up|0|||
23567346|NCT00337662|65807041|FG001|Study Period II|Lost to Follow-up|0|||
23445005|NCT03712787|65370244|FG000|Overall Study|Adverse Event|2|||
23445006|NCT03712787|65370245|FG001|Overall Study|Adverse Event|3|||
23445007|NCT03712787|65370246|FG002|Overall Study|Adverse Event|0|||
23445008|NCT03712787|65370247|FG003|Overall Study|Adverse Event|4|||
23567347|NCT00337662|65807042|FG002|Study Period II|Lost to Follow-up|0|||
23222541|NCT00633893|64557718|FG002|Overall Study|Lost to Follow-up|8|||
23222542|NCT00633893|64557716|FG000|Overall Study|Poor/non-compliance|5|||
23329255|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
23329256|NCT00838903|64948521|FG000|Follow-up Period (8 Weeks)|Missing|1|||
23329257|NCT00838903|64948522|FG001|Follow-up Period (8 Weeks)|Missing|2|||
23445009|NCT03712787|65370244|FG000|Overall Study|Withdrawal by Subject|4|||
23567348|NCT00337662|65807043|FG003|Study Period II|Lost to Follow-up|35|||
23567349|NCT00337662|65807040|FG000|Study Period II|Withdrawal by Subject|0|||
23567350|NCT00337662|65807041|FG001|Study Period II|Withdrawal by Subject|0|||
23567351|NCT00337662|65807042|FG002|Study Period II|Withdrawal by Subject|0|||
23567352|NCT00337662|65807043|FG003|Study Period II|Withdrawal by Subject|20|||
23567353|NCT00337662|65807040|FG000|Study Period II|Adverse Event|0|||
23567354|NCT00337662|65807041|FG001|Study Period II|Adverse Event|0|||
23567355|NCT00337662|65807042|FG002|Study Period II|Adverse Event|0|||
23567356|NCT00337662|65807043|FG003|Study Period II|Adverse Event|16|||
23567357|NCT00337662|65807040|FG000|Study Period II|Physician Decision|0|||
23567358|NCT00337662|65807041|FG001|Study Period II|Physician Decision|0|||
23567359|NCT00337662|65807042|FG002|Study Period II|Physician Decision|0|||
23567360|NCT00337662|65807043|FG003|Study Period II|Physician Decision|13|||
23567361|NCT00337662|65807040|FG000|Study Period II|Entry Criteria Not Met|0|||
23567362|NCT00337662|65807041|FG001|Study Period II|Entry Criteria Not Met|0|||
23567363|NCT00337662|65807042|FG002|Study Period II|Entry Criteria Not Met|0|||
23567364|NCT00337662|65807043|FG003|Study Period II|Entry Criteria Not Met|6|||
23567365|NCT00337662|65807040|FG000|Study Period II|Protocol Violation|0|||
23567366|NCT00337662|65807041|FG001|Study Period II|Protocol Violation|0|||
23567367|NCT00337662|65807042|FG002|Study Period II|Protocol Violation|0|||
23567368|NCT00337662|65807043|FG003|Study Period II|Protocol Violation|6|||
23567369|NCT00337662|65807040|FG000|Study Period II|Lack of Efficacy|0|||
23567370|NCT00337662|65807041|FG001|Study Period II|Lack of Efficacy|0|||
23567371|NCT00337662|65807042|FG002|Study Period II|Lack of Efficacy|0|||
23567372|NCT00337662|65807043|FG003|Study Period II|Lack of Efficacy|7|||
23567373|NCT00337662|65807040|FG000|Study Period II|Sponsor Decision|0|||
23567374|NCT00337662|65807041|FG001|Study Period II|Sponsor Decision|0|||
23567375|NCT00337662|65807042|FG002|Study Period II|Sponsor Decision|0|||
23567376|NCT00337662|65807043|FG003|Study Period II|Sponsor Decision|2|||
23567377|NCT00337662|65807040|FG000|Study Period II|Parent/Caregiver Decision|0|||
23567378|NCT00337662|65807041|FG001|Study Period II|Parent/Caregiver Decision|0|||
23159318|NCT03703102|64331894|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23159319|NCT03703102|64331895|FG002|Overall Study|Non-Compliance with Study Drug|2|||
23159320|NCT03703102|64331896|FG003|Overall Study|Non-Compliance with Study Drug|1|||
23159321|NCT03703102|64331897|FG004|Overall Study|Non-Compliance with Study Drug|4|||
23159322|NCT01892163|64331900|FG000|Overall Study|Death|1|||
23159323|NCT01892163|64331901|FG001|Overall Study|Death|1|||
23159324|NCT01892163|64331900|FG000|Overall Study|Lost to Follow-up|1|||
23159325|NCT01892163|64331901|FG001|Overall Study|Lost to Follow-up|0|||
23159326|NCT04912245|64331903|FG000|Overall Study|Withdrawal by Subject|21|||
23159327|NCT04912245|64331904|FG001|Overall Study|Withdrawal by Subject|4|||
23159328|NCT04912245|64331903|FG000|Overall Study|Lost to Follow-up|5|||
23159329|NCT04912245|64331904|FG001|Overall Study|Lost to Follow-up|11|||
23159330|NCT02113436|64331905|FG000|Period 1: 8 Weeks|Adverse Event|1|||
23159331|NCT02113436|64331906|FG001|Period 1: 8 Weeks|Adverse Event|0|||
23159332|NCT02113436|64331907|FG002|Period 1: 8 Weeks|Adverse Event|0|||
23159333|NCT02113436|64331908|FG003|Period 1: 8 Weeks|Adverse Event|0|||
23159334|NCT02113436|64331905|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
23159335|NCT02113436|64331906|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
23159336|NCT02113436|64331907|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
23159337|NCT02113436|64331908|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
23159338|NCT02113436|64331905|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
23159339|NCT02113436|64331906|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
23159340|NCT02113436|64331907|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
23329258|NCT00838903|64948523|FG002|Follow-up Period (8 Weeks)|Missing|1|||
23445010|NCT03712787|65370245|FG001|Overall Study|Withdrawal by Subject|14|||
23445011|NCT03712787|65370246|FG002|Overall Study|Withdrawal by Subject|12|||
23567379|NCT00337662|65807042|FG002|Study Period II|Parent/Caregiver Decision|0|||
23567380|NCT00337662|65807043|FG003|Study Period II|Parent/Caregiver Decision|1|||
23567381|NCT00337662|65807040|FG000|Study Period III|Lost to Follow-up|14|||
23567382|NCT00337662|65807041|FG001|Study Period III|Lost to Follow-up|16|||
23567383|NCT00337662|65807042|FG002|Study Period III|Lost to Follow-up|14|||
23567384|NCT00337662|65807043|FG003|Study Period III|Lost to Follow-up|0|||
23567385|NCT00337662|65807040|FG000|Study Period III|Withdrawal by Subject|18|||
23567386|NCT00337662|65807041|FG001|Study Period III|Withdrawal by Subject|14|||
23628957|NCT00356759|66028165|FG001|Overall Study|Withdrawal by Subject|2|||
23445012|NCT03712787|65370247|FG003|Overall Study|Withdrawal by Subject|8|||
23159341|NCT02113436|64331908|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
23159342|NCT02113436|64331905|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
23159343|NCT02113436|64331906|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
23222543|NCT00633893|64557717|FG001|Overall Study|Poor/non-compliance|12|||
23222544|NCT00633893|64557718|FG002|Overall Study|Poor/non-compliance|3|||
23222545|NCT00633893|64557716|FG000|Overall Study|Pregnancy|2|||
23222546|NCT00633893|64557717|FG001|Overall Study|Pregnancy|1|||
23222547|NCT00633893|64557718|FG002|Overall Study|Pregnancy|1|||
23222548|NCT00633893|64557716|FG000|Overall Study|Not meet/no longer meets criteria|4|||
23222549|NCT00633893|64557717|FG001|Overall Study|Not meet/no longer meets criteria|6|||
23222550|NCT00633893|64557718|FG002|Overall Study|Not meet/no longer meets criteria|4|||
23222551|NCT00633893|64557716|FG000|Overall Study|Other|28|||
23222552|NCT00633893|64557717|FG001|Overall Study|Other|33|||
23222553|NCT00633893|64557718|FG002|Overall Study|Other|31|||
23222554|NCT00515099|64557719|FG000|Overall Study|Lost to Follow-up|0|||
23222555|NCT00515099|64557720|FG001|Overall Study|Lost to Follow-up|4|||
23222556|NCT00515099|64557719|FG000|Overall Study|Withdrawal by Subject|2|||
23222557|NCT00515099|64557720|FG001|Overall Study|Withdrawal by Subject|0|||
23222558|NCT00515099|64557719|FG000|Overall Study|IRB Recommendation|1|||
23222559|NCT00515099|64557720|FG001|Overall Study|IRB Recommendation|0|||
23222560|NCT00107172|64557728|FG000|Overall Study|Withdrawal by Subject|1|||
23222561|NCT00107172|64557729|FG001|Overall Study|Withdrawal by Subject|0|||
23222562|NCT00107172|64557728|FG000|Overall Study|Death|0|||
23222563|NCT00107172|64557729|FG001|Overall Study|Death|2|||
23222564|NCT00107172|64557728|FG000|Overall Study|Other Reason|4|||
23222565|NCT00107172|64557729|FG001|Overall Study|Other Reason|3|||
23222566|NCT00498368|64557733|FG000|Overall Study|Withdrawal by Subject|3|||
23222567|NCT00498368|64557734|FG001|Overall Study|Withdrawal by Subject|2|||
23222568|NCT03342404|64557735|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
23222569|NCT03342404|64557736|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
23222570|NCT03342404|64557735|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
23222571|NCT03342404|64557736|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
23222572|NCT03342404|64557735|FG000|Blinded Treatment Phase|Adverse Event|5|||
23222573|NCT03342404|64557736|FG001|Blinded Treatment Phase|Adverse Event|4|||
23222574|NCT03342404|64557735|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
23222575|NCT03342404|64557736|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
23222576|NCT03342404|64557735|FG000|Blinded Treatment Phase|Other reasons|1|||
23222577|NCT03342404|64557736|FG001|Blinded Treatment Phase|Other reasons|0|||
23222578|NCT03342404|64557735|FG000|Blinded Treatment Phase|Physician Decision|1|||
23222579|NCT03342404|64557736|FG001|Blinded Treatment Phase|Physician Decision|0|||
23222580|NCT03342404|64557735|FG000|Blinded Treatment Phase|Death|1|||
23222581|NCT03342404|64557736|FG001|Blinded Treatment Phase|Death|0|||
23222582|NCT03342404|64557735|FG000|Open-Label Phase|Lost to Follow-up|0|||
23222583|NCT03342404|64557736|FG001|Open-Label Phase|Lost to Follow-up|1|||
23222584|NCT03342404|64557735|FG000|Open-Label Phase|Other reasons|0|||
23222585|NCT03342404|64557736|FG001|Open-Label Phase|Other reasons|1|||
23222586|NCT03342404|64557735|FG000|Open-Label Phase|Adverse Event|0|||
23222587|NCT03342404|64557736|FG001|Open-Label Phase|Adverse Event|3|||
23222588|NCT03342404|64557735|FG000|Open-Label Phase|Withdrawal by Subject|0|||
23222589|NCT03342404|64557736|FG001|Open-Label Phase|Withdrawal by Subject|6|||
23222590|NCT01673490|64557748|FG000|Overall Study|Lost to Follow-up|1|||
23222591|NCT01673490|64557748|FG000|Overall Study|Adverse Event|3|||
23222592|NCT01673490|64557748|FG000|Overall Study|Withdrawal by Subject|3|||
23222593|NCT00479167|64557753|FG000|Overall Study|Withdrawal by Subject|1|||
23222594|NCT00633360|64557755|FG000|Overall Study|Lost to Follow-up|1|||
23222595|NCT00633360|64557756|FG001|Overall Study|Lost to Follow-up|1|||
23222596|NCT00633360|64557755|FG000|Overall Study|Adverse Event|3|||
23222597|NCT00633360|64557756|FG001|Overall Study|Adverse Event|1|||
23222598|NCT00633360|64557755|FG000|Overall Study|Protocol Violation|0|||
23222599|NCT00633360|64557756|FG001|Overall Study|Protocol Violation|1|||
23567387|NCT00337662|65807042|FG002|Study Period III|Withdrawal by Subject|12|||
23222600|NCT01175590|64557758|FG000|Overall Study|Lost to Follow-up|1|||
23222601|NCT01175590|64557759|FG001|Overall Study|Lost to Follow-up|0|||
23567388|NCT00337662|65807043|FG003|Study Period III|Withdrawal by Subject|0|||
23567389|NCT00337662|65807040|FG000|Study Period III|Adverse Event|9|||
23567390|NCT00337662|65807041|FG001|Study Period III|Adverse Event|10|||
23567391|NCT00337662|65807042|FG002|Study Period III|Adverse Event|8|||
23222602|NCT01175590|64557758|FG000|Overall Study|Withdrawal by Subject|0|||
23222603|NCT01175590|64557759|FG001|Overall Study|Withdrawal by Subject|2|||
23222604|NCT01175590|64557758|FG000|Overall Study|Adverse Event|4|||
23222605|NCT01175590|64557759|FG001|Overall Study|Adverse Event|0|||
23222606|NCT01175590|64557758|FG000|Overall Study|Physician Decision|1|||
23222607|NCT01175590|64557759|FG001|Overall Study|Physician Decision|4|||
23567392|NCT00337662|65807043|FG003|Study Period III|Adverse Event|0|||
23222608|NCT01175590|64557758|FG000|Overall Study|Lack of Efficacy|1|||
23222609|NCT01175590|64557759|FG001|Overall Study|Lack of Efficacy|1|||
23222610|NCT01175590|64557758|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
23567393|NCT00337662|65807040|FG000|Study Period III|Protocol Violation|3|||
23567394|NCT00337662|65807041|FG001|Study Period III|Protocol Violation|8|||
23567395|NCT00337662|65807042|FG002|Study Period III|Protocol Violation|2|||
23567396|NCT00337662|65807043|FG003|Study Period III|Protocol Violation|0|||
23222611|NCT01175590|64557759|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
23222612|NCT01175590|64557758|FG000|Overall Study|Treated not as randomized|3|||
23222613|NCT01175590|64557759|FG001|Overall Study|Treated not as randomized|2|||
23222614|NCT01175590|64557758|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
23222615|NCT01175590|64557759|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
23222616|NCT01175590|64557758|FG000|Overall Study|Protocol Violation|0|||
23222617|NCT01175590|64557759|FG001|Overall Study|Protocol Violation|1|||
23222618|NCT02977507|64557760|FG000|Overall Study|Protocol Deviation|1|||
23222619|NCT02977507|64557761|FG001|Overall Study|Protocol Deviation|0|||
23222620|NCT02977507|64557760|FG000|Overall Study|Lost to Follow-up|1|||
23222621|NCT02977507|64557761|FG001|Overall Study|Lost to Follow-up|0|||
23222622|NCT01098032|64557765|FG000|Overall Study|Withdrawal by Subject|1|||
23222623|NCT01098032|64557766|FG001|Overall Study|Withdrawal by Subject|1|||
23222624|NCT01190020|64557768|FG000|Overall Study|Adverse Event|2|||
23222625|NCT01190020|64557769|FG001|Overall Study|Adverse Event|0|||
23222626|NCT01190020|64557768|FG000|Overall Study|Lost to Follow-up|2|||
23222627|NCT01190020|64557769|FG001|Overall Study|Lost to Follow-up|0|||
23222628|NCT01190020|64557768|FG000|Overall Study|Withdrawal by Subject|3|||
23222629|NCT01190020|64557769|FG001|Overall Study|Withdrawal by Subject|0|||
23222630|NCT00839436|64557770|FG000|Overall Study|Developed exclusionary condition|1|||
23222631|NCT00839436|64557771|FG001|Overall Study|Developed exclusionary condition|0|||
23445013|NCT03712787|65370244|FG000|Overall Study|Lost to Follow-up|1|||
23445014|NCT03712787|65370245|FG001|Overall Study|Lost to Follow-up|1|||
23445015|NCT03712787|65370246|FG002|Overall Study|Lost to Follow-up|2|||
23445016|NCT03712787|65370247|FG003|Overall Study|Lost to Follow-up|1|||
23567397|NCT00337662|65807040|FG000|Study Period III|Physician Decision|6|||
23567398|NCT00337662|65807041|FG001|Study Period III|Physician Decision|5|||
23567399|NCT00337662|65807042|FG002|Study Period III|Physician Decision|0|||
23567400|NCT00337662|65807043|FG003|Study Period III|Physician Decision|0|||
23567401|NCT00337662|65807040|FG000|Study Period III|Entry Criteria Not Met|4|||
23567402|NCT00337662|65807041|FG001|Study Period III|Entry Criteria Not Met|1|||
23567403|NCT00337662|65807042|FG002|Study Period III|Entry Criteria Not Met|3|||
23567404|NCT00337662|65807043|FG003|Study Period III|Entry Criteria Not Met|0|||
23567405|NCT00337662|65807040|FG000|Study Period III|Lack of Efficacy|4|||
23567406|NCT00337662|65807041|FG001|Study Period III|Lack of Efficacy|4|||
23567407|NCT00337662|65807042|FG002|Study Period III|Lack of Efficacy|2|||
23567408|NCT00337662|65807043|FG003|Study Period III|Lack of Efficacy|0|||
23567409|NCT00337662|65807040|FG000|Study Period III|Parent/Caregiver Decision|0|||
23567410|NCT00337662|65807041|FG001|Study Period III|Parent/Caregiver Decision|0|||
23567411|NCT00337662|65807042|FG002|Study Period III|Parent/Caregiver Decision|2|||
23567412|NCT00337662|65807043|FG003|Study Period III|Parent/Caregiver Decision|0|||
23567413|NCT00337662|65807040|FG000|Study Period III|Sponsor Decision|1|||
23628958|NCT00356759|66028164|FG000|Overall Study|Adverse Event|1|||
23159344|NCT02113436|64331907|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
23159345|NCT02113436|64331908|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
23159346|NCT02113436|64331905|FG000|Period 2: 16 Weeks|Adverse Event|0|||
23159347|NCT02113436|64331906|FG001|Period 2: 16 Weeks|Adverse Event|0|||
23159348|NCT02113436|64331907|FG002|Period 2: 16 Weeks|Adverse Event|4|||
23159349|NCT02113436|64331908|FG003|Period 2: 16 Weeks|Adverse Event|5|||
23159350|NCT02113436|64331905|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
23159351|NCT02113436|64331906|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
23159352|NCT02113436|64331907|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
23159353|NCT02113436|64331908|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
23159354|NCT02113436|64331905|FG000|Period 2: 16 Weeks|Physician Decision|0|||
23159355|NCT02113436|64331906|FG001|Period 2: 16 Weeks|Physician Decision|0|||
23159356|NCT02113436|64331907|FG002|Period 2: 16 Weeks|Physician Decision|2|||
23159357|NCT02113436|64331908|FG003|Period 2: 16 Weeks|Physician Decision|0|||
23159358|NCT02113436|64331905|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
23159359|NCT02113436|64331906|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
23159360|NCT02113436|64331907|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
23159361|NCT02113436|64331908|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
23159362|NCT02665052|64331911|FG000|Overall Study|Lost to Follow-up|1|||
23159363|NCT02665052|64331912|FG001|Overall Study|Lost to Follow-up|0|||
23159364|NCT02665052|64331913|FG002|Overall Study|Lost to Follow-up|0|||
23159365|NCT02665052|64331914|FG003|Overall Study|Lost to Follow-up|0|||
23159366|NCT02665052|64331911|FG000|Overall Study|Withdrawal by Subject|1|||
23159367|NCT02665052|64331912|FG001|Overall Study|Withdrawal by Subject|1|||
23159368|NCT02665052|64331913|FG002|Overall Study|Withdrawal by Subject|0|||
23159369|NCT02665052|64331914|FG003|Overall Study|Withdrawal by Subject|5|||
23159370|NCT02665052|64331911|FG000|Overall Study|Adverse Event|1|||
23159371|NCT02665052|64331912|FG001|Overall Study|Adverse Event|1|||
23159372|NCT02665052|64331913|FG002|Overall Study|Adverse Event|0|||
23159373|NCT02665052|64331914|FG003|Overall Study|Adverse Event|0|||
23159374|NCT00268437|64331915|FG000|Overall Study|Ineligible|1|||
23159375|NCT01486927|64334864|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
23159376|NCT01486927|64334864|FG000|Overall Study|Physician Decision|1|||
23628959|NCT00356759|66028165|FG001|Overall Study|Adverse Event|3|||
23628960|NCT00356759|66028164|FG000|Overall Study|Lost to Follow-up|1|||
23628961|NCT00356759|66028165|FG001|Overall Study|Lost to Follow-up|1|||
23628962|NCT00356759|66028164|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
23628963|NCT00356759|66028165|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
23628964|NCT00943722|66028170|FG000|Base Study|Adverse Event|0|||
23628965|NCT00943722|66028171|FG001|Base Study|Adverse Event|0|||
23628966|NCT00943722|66028172|FG002|Base Study|Adverse Event|0|||
23628967|NCT00943722|66028173|FG003|Base Study|Adverse Event|1|||
23222632|NCT00839436|64557772|FG002|Overall Study|Developed exclusionary condition|0|||
23222633|NCT00839436|64557770|FG000|Overall Study|Withdrawal by Subject|0|||
23222634|NCT00839436|64557771|FG001|Overall Study|Withdrawal by Subject|1|||
23222635|NCT00839436|64557772|FG002|Overall Study|Withdrawal by Subject|0|||
23222636|NCT00839436|64557770|FG000|Overall Study|Study drug no longer available|0|||
23222637|NCT00839436|64557771|FG001|Overall Study|Study drug no longer available|0|||
23222638|NCT00839436|64557772|FG002|Overall Study|Study drug no longer available|1|||
23222639|NCT00247273|64557776|FG000|Overall Study|Adverse Event|85|||
23222640|NCT00247273|64557777|FG001|Overall Study|Adverse Event|80|||
23222641|NCT00247273|64557776|FG000|Overall Study|Physician Decision|6|||
23222642|NCT00247273|64557777|FG001|Overall Study|Physician Decision|3|||
23222643|NCT00247273|64557776|FG000|Overall Study|Lost to Follow-up|7|||
23222644|NCT00247273|64557777|FG001|Overall Study|Lost to Follow-up|7|||
23222645|NCT00247273|64557776|FG000|Overall Study|Withdrawal by Subject|46|||
23222646|NCT00247273|64557777|FG001|Overall Study|Withdrawal by Subject|47|||
23222647|NCT00247273|64557776|FG000|Overall Study|Did not take any study drug|2|||
23222648|NCT00247273|64557777|FG001|Overall Study|Did not take any study drug|0|||
23222649|NCT02187224|64557782|FG000|Overall Study|Did not show up for test day|1|||
23222650|NCT02187224|64557783|FG001|Overall Study|Did not show up for test day|0|||
23222651|NCT03238352|64557784|FG000|Overall Study|Lost to Follow-up|0|||
23222652|NCT03238352|64557785|FG001|Overall Study|Lost to Follow-up|2|||
23222653|NCT03238352|64557786|FG002|Overall Study|Lost to Follow-up|1|||
23222654|NCT03238352|64557784|FG000|Overall Study|Withdrawal by Subject|0|||
23222655|NCT03238352|64557785|FG001|Overall Study|Withdrawal by Subject|1|||
23222656|NCT03238352|64557786|FG002|Overall Study|Withdrawal by Subject|0|||
23222657|NCT01060124|64557793|FG000|Overall Study|Other|16|||
23628968|NCT00943722|66028174|FG004|Base Study|Adverse Event|0|||
23628969|NCT00943722|66028175|FG005|Base Study|Adverse Event|0|||
23628970|NCT00943722|66028176|FG006|Base Study|Adverse Event|0|||
23628971|NCT00943722|66028170|FG000|Base Study|Lost to Follow-up|12|||
23628972|NCT00943722|66028171|FG001|Base Study|Lost to Follow-up|8|||
23628973|NCT00943722|66028172|FG002|Base Study|Lost to Follow-up|10|||
23628974|NCT00943722|66028173|FG003|Base Study|Lost to Follow-up|8|||
23628975|NCT00943722|66028174|FG004|Base Study|Lost to Follow-up|11|||
23159377|NCT01486927|64334864|FG000|Overall Study|50 Exposure days not reached|2|||
23159378|NCT01486927|64334864|FG000|Overall Study|Withdrawal by Subject|8|||
23159379|NCT01486927|64334864|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
23159380|NCT03462576|64334865|FG000|Overall Study|Protocol Violation|5|||
23159381|NCT03462576|64334866|FG001|Overall Study|Protocol Violation|11|||
23159382|NCT03462576|64334867|FG002|Overall Study|Protocol Violation|7|||
23159383|NCT03462576|64334865|FG000|Overall Study|Device Malfunction|0|||
23159384|NCT03462576|64334866|FG001|Overall Study|Device Malfunction|0|||
23159385|NCT03462576|64334867|FG002|Overall Study|Device Malfunction|1|||
23159386|NCT02829138|64334874|FG000|Overall Study|Withdrawal by Subject|1|||
23159387|NCT02829138|64334875|FG001|Overall Study|Withdrawal by Subject|0|||
23159388|NCT04544475|64334876|FG000|Overall Study|Withdrawal by Subject|1|||
23159389|NCT04544475|64334877|FG001|Overall Study|Withdrawal by Subject|3|||
23159390|NCT04518462|64334878|FG000|Overall Study|Withdrawal by Subject|0|||
23159391|NCT04518462|64334879|FG001|Overall Study|Withdrawal by Subject|0|||
23159392|NCT04518462|64334880|FG002|Overall Study|Withdrawal by Subject|1|||
23159393|NCT04518462|64334878|FG000|Overall Study|Physician Decision|1|||
23159394|NCT04518462|64334879|FG001|Overall Study|Physician Decision|1|||
23159395|NCT04518462|64334880|FG002|Overall Study|Physician Decision|0|||
23159396|NCT02055820|64334882|FG000|Phase I: Dose-Finding|Death|1|||
23159397|NCT02055820|64334883|FG001|Phase I: Dose-Finding|Death|0|||
23222658|NCT01060124|64557793|FG000|Overall Study|Adverse Event|14|||
23222659|NCT01060124|64557793|FG000|Overall Study|Withdrawal by Subject|7|||
23222660|NCT00592072|64557794|FG000|Wash Out Period|Lost to Follow-up|1|||
23222661|NCT00592072|64557795|FG001|Wash Out Period|Lost to Follow-up|1|||
23222662|NCT02348840|64557798|FG000|Overall Study|Withdrawal by Subject|2|||
23159398|NCT02055820|64334884|FG002|Phase I: Dose-Finding|Death|1|||
23628976|NCT00943722|66028175|FG005|Base Study|Lost to Follow-up|0|||
23159399|NCT02055820|64334885|FG003|Phase I: Dose-Finding|Death|2|||
23159400|NCT02055820|64334886|FG004|Phase I: Dose-Finding|Death|0|||
23159401|NCT02055820|64334887|FG005|Phase I: Dose-Finding|Death|1|||
23159402|NCT02055820|64334888|FG006|Phase I: Dose-Finding|Death|1|||
23159403|NCT02055820|64334889|FG007|Phase I: Dose-Finding|Death|0|||
23222663|NCT02348840|64557799|FG001|Overall Study|Withdrawal by Subject|1|||
23222664|NCT02348840|64557800|FG002|Overall Study|Withdrawal by Subject|0|||
23159404|NCT02055820|64334890|FG008|Phase I: Dose-Finding|Death|0|||
23159405|NCT02055820|64334891|FG009|Phase I: Dose-Finding|Death|0|||
23159406|NCT02055820|64334882|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23159407|NCT02055820|64334883|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23159408|NCT02055820|64334884|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23159409|NCT02055820|64334885|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23159410|NCT02055820|64334886|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23159411|NCT02055820|64334887|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
23159412|NCT02055820|64334888|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23159413|NCT02055820|64334889|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23159414|NCT02055820|64334890|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23159415|NCT02055820|64334891|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
23159416|NCT02055820|64334882|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
23159417|NCT02055820|64334883|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
23159418|NCT02055820|64334884|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
23159419|NCT02055820|64334885|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
23159420|NCT02055820|64334886|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
23329259|NCT00838903|64948524|FG003|Follow-up Period (8 Weeks)|Missing|1|||
23329260|NCT02712554|64948525|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
23329261|NCT02712554|64948526|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
23567414|NCT00337662|65807041|FG001|Study Period III|Sponsor Decision|0|||
23567415|NCT00337662|65807042|FG002|Study Period III|Sponsor Decision|1|||
23567416|NCT00337662|65807043|FG003|Study Period III|Sponsor Decision|0|||
23567417|NCT00337662|65807040|FG000|Study Period III|Clinical Relapse|1|||
23567418|NCT00337662|65807041|FG001|Study Period III|Clinical Relapse|0|||
23567419|NCT00337662|65807042|FG002|Study Period III|Clinical Relapse|0|||
23567420|NCT00337662|65807043|FG003|Study Period III|Clinical Relapse|0|||
23567421|NCT00409786|65807044|FG000|Overall Study|Withdrawal by Subject|3|||
23567422|NCT01027364|65807045|FG000|Overall Study|Adverse Event|1|||
23567423|NCT01027364|65807046|FG001|Overall Study|Adverse Event|0|||
23567424|NCT01027364|65807047|FG002|Overall Study|Adverse Event|1|||
23567425|NCT01027364|65807048|FG003|Overall Study|Adverse Event|0|||
23567426|NCT01027364|65807045|FG000|Overall Study|Lost to Follow-up|1|||
23567427|NCT01027364|65807046|FG001|Overall Study|Lost to Follow-up|0|||
23567428|NCT01027364|65807047|FG002|Overall Study|Lost to Follow-up|0|||
23159421|NCT02055820|64334887|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
23159422|NCT02055820|64334888|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
23159423|NCT02055820|64334889|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
23159424|NCT02055820|64334890|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
23159425|NCT02055820|64334891|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
23159426|NCT02055820|64334882|FG000|Phase II: Expansion|Death|0|||
23159427|NCT02055820|64334883|FG001|Phase II: Expansion|Death|0|||
23159428|NCT02055820|64334884|FG002|Phase II: Expansion|Death|0|||
23159429|NCT02055820|64334885|FG003|Phase II: Expansion|Death|0|||
23159430|NCT02055820|64334886|FG004|Phase II: Expansion|Death|33|||
23159431|NCT02055820|64334887|FG005|Phase II: Expansion|Death|0|||
23159432|NCT02055820|64334888|FG006|Phase II: Expansion|Death|0|||
23159433|NCT02055820|64334889|FG007|Phase II: Expansion|Death|0|||
23567429|NCT01027364|65807048|FG003|Overall Study|Lost to Follow-up|0|||
23567430|NCT01027364|65807045|FG000|Overall Study|Protocol Violation|1|||
23567431|NCT01027364|65807046|FG001|Overall Study|Protocol Violation|0|||
23567432|NCT01027364|65807047|FG002|Overall Study|Protocol Violation|0|||
23567433|NCT01027364|65807048|FG003|Overall Study|Protocol Violation|1|||
23567434|NCT01027364|65807045|FG000|Overall Study|Withdrawal by Subject|1|||
23567435|NCT01027364|65807046|FG001|Overall Study|Withdrawal by Subject|2|||
23567436|NCT01027364|65807047|FG002|Overall Study|Withdrawal by Subject|0|||
23567437|NCT01027364|65807048|FG003|Overall Study|Withdrawal by Subject|0|||
23567438|NCT01462162|65807053|FG000|Overall Study|Adverse Event|5|||
23567439|NCT01462162|65807053|FG000|Overall Study|Lack of Efficacy|4|||
23567440|NCT01462162|65807053|FG000|Overall Study|Abnormal laboratory parameters|1|||
23567441|NCT01462162|65807053|FG000|Overall Study|Other|2|||
23628977|NCT00943722|66028176|FG006|Base Study|Lost to Follow-up|0|||
23159434|NCT02055820|64334890|FG008|Phase II: Expansion|Death|0|||
23159435|NCT02055820|64334891|FG009|Phase II: Expansion|Death|0|||
23159436|NCT02055820|64334882|FG000|Phase II: Expansion|Lost to Follow-up|0|||
23329262|NCT02712554|64948525|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
23567442|NCT00692406|65807054|FG000|Overall Study|PI dropped, bad data|57|||
23567443|NCT04397523|65807057|FG000|Overall Study|Lost to Follow-up|3|||
23567444|NCT04397523|65807057|FG000|Overall Study|Transfer from/to other hospital|8|||
23567445|NCT03151395|65807058|FG000|Overall Study|Adverse Event|2|||
23159437|NCT02055820|64334883|FG001|Phase II: Expansion|Lost to Follow-up|0|||
23159438|NCT02055820|64334884|FG002|Phase II: Expansion|Lost to Follow-up|0|||
23159439|NCT02055820|64334885|FG003|Phase II: Expansion|Lost to Follow-up|0|||
23159440|NCT02055820|64334886|FG004|Phase II: Expansion|Lost to Follow-up|4|||
23567446|NCT03151395|65807058|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
23567447|NCT03151395|65807058|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
23628978|NCT00943722|66028170|FG000|Base Study|Physician Decision|1|||
23222665|NCT02348840|64557801|FG003|Overall Study|Withdrawal by Subject|0|||
23222666|NCT01040728|64557802|FG000|Overall Study|Adverse Event|4|||
23222667|NCT01040728|64557803|FG001|Overall Study|Adverse Event|8|||
23329263|NCT02712554|64948526|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
23329264|NCT02712554|64948525|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
23329265|NCT02712554|64948526|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
23329266|NCT02712554|64948525|FG000|Part B: Qualification Phase|Adverse Event|0|||
23329267|NCT02712554|64948526|FG001|Part B: Qualification Phase|Adverse Event|1|||
23329268|NCT02712554|64948525|FG000|Part B: Treatment Phase|Adverse Event|0|||
23329269|NCT02712554|64948526|FG001|Part B: Treatment Phase|Adverse Event|1|||
23329270|NCT02712554|64948525|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
23329271|NCT02712554|64948526|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
23329272|NCT02712554|64948525|FG000|Part B: Treatment Phase|Other|0|||
23329273|NCT02712554|64948526|FG001|Part B: Treatment Phase|Other|1|||
23329274|NCT04231825|64948527|FG000|Overall Study|Protocol Violation|3|||
23329275|NCT04231825|64948528|FG001|Overall Study|Protocol Violation|3|||
23329276|NCT04231825|64948527|FG000|Overall Study|Lost to Follow-up|0|||
23329277|NCT04231825|64948528|FG001|Overall Study|Lost to Follow-up|1|||
23329278|NCT00722137|64948529|FG000|Overall Study|Overt Disease Progression|5|||
23329279|NCT00722137|64948530|FG001|Overall Study|Overt Disease Progression|4|||
23329280|NCT00722137|64948529|FG000|Overall Study|Adverse Event|17|||
23222668|NCT01040728|64557804|FG002|Overall Study|Adverse Event|0|||
23222669|NCT01040728|64557805|FG003|Overall Study|Adverse Event|4|||
23222670|NCT01040728|64557802|FG000|Overall Study|Withdrawal by Subject|0|||
23222671|NCT01040728|64557803|FG001|Overall Study|Withdrawal by Subject|1|||
23222672|NCT01040728|64557804|FG002|Overall Study|Withdrawal by Subject|1|||
23222673|NCT01040728|64557805|FG003|Overall Study|Withdrawal by Subject|0|||
23222674|NCT01040728|64557802|FG000|Overall Study|Protocol Violation|0|||
23222675|NCT01040728|64557803|FG001|Overall Study|Protocol Violation|0|||
23222676|NCT01040728|64557804|FG002|Overall Study|Protocol Violation|0|||
23222677|NCT01040728|64557805|FG003|Overall Study|Protocol Violation|1|||
23222678|NCT01040728|64557802|FG000|Overall Study|Lack of Efficacy|0|||
23222679|NCT01040728|64557803|FG001|Overall Study|Lack of Efficacy|1|||
23329281|NCT00722137|64948530|FG001|Overall Study|Adverse Event|21|||
23329282|NCT00722137|64948529|FG000|Overall Study|Death|12|||
23329283|NCT00722137|64948530|FG001|Overall Study|Death|7|||
23329284|NCT00722137|64948529|FG000|Overall Study|Withdrawal by Subject|6|||
23329285|NCT00722137|64948530|FG001|Overall Study|Withdrawal by Subject|9|||
23329286|NCT00722137|64948529|FG000|Overall Study|Other Reason Unknown|3|||
23329287|NCT00722137|64948530|FG001|Overall Study|Other Reason Unknown|4|||
23329288|NCT00722137|64948529|FG000|Overall Study|Randomized But Not Treated|2|||
23329289|NCT00722137|64948530|FG001|Overall Study|Randomized But Not Treated|3|||
23329290|NCT04570670|64948531|FG000|Overall Study|Withdrawal by Subject|1|||
23329291|NCT04570670|64948532|FG001|Overall Study|Withdrawal by Subject|0|||
23329292|NCT03711786|64948533|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
23222680|NCT01040728|64557804|FG002|Overall Study|Lack of Efficacy|0|||
23222681|NCT01040728|64557805|FG003|Overall Study|Lack of Efficacy|1|||
23222682|NCT01040728|64557802|FG000|Overall Study|Other reasons not listed above|0|||
23222683|NCT01040728|64557803|FG001|Overall Study|Other reasons not listed above|1|||
23222684|NCT01040728|64557804|FG002|Overall Study|Other reasons not listed above|0|||
23222685|NCT01040728|64557805|FG003|Overall Study|Other reasons not listed above|0|||
23222686|NCT03099304|64557806|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
23222687|NCT03099304|64557807|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
23222688|NCT03099304|64557808|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
23222689|NCT03099304|64557809|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
23222690|NCT03099304|64557810|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
23222691|NCT03099304|64557811|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
23222692|NCT03099304|64557806|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
23222693|NCT03099304|64557807|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
23222694|NCT03099304|64557808|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
23222695|NCT03099304|64557809|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
23222696|NCT03099304|64557810|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
23222697|NCT03099304|64557811|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
23222698|NCT03099304|64557806|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
23222699|NCT03099304|64557807|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
23329293|NCT03711786|64948534|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
23329294|NCT03711786|64948533|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
23329295|NCT03711786|64948534|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
23329296|NCT03711786|64948533|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
23222700|NCT03099304|64557808|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
23222701|NCT03099304|64557809|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
23222702|NCT03099304|64557810|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
23222703|NCT03099304|64557811|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
23329297|NCT03711786|64948534|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
23567448|NCT03151395|65807058|FG000|Overall Study|Unspecified reason|4|||
23222704|NCT03099304|64557806|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
23222705|NCT03099304|64557807|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
23222706|NCT03099304|64557808|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
23222707|NCT03099304|64557809|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
23222708|NCT03099304|64557810|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
23222709|NCT03099304|64557811|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
23222710|NCT03099304|64557806|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
23222711|NCT03099304|64557807|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
23222712|NCT03099304|64557808|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
23222713|NCT03099304|64557809|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
23222714|NCT03099304|64557810|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
23222715|NCT03099304|64557811|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
23222716|NCT03099304|64557806|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23222717|NCT03099304|64557807|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23222718|NCT03099304|64557808|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
23222719|NCT03099304|64557809|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23222720|NCT03099304|64557810|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23222721|NCT03099304|64557811|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
23222722|NCT03099304|64557806|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
23222723|NCT03099304|64557807|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
23222724|NCT03099304|64557808|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
23222725|NCT03099304|64557809|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
23222726|NCT03099304|64557810|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
23222727|NCT03099304|64557811|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
23222728|NCT03099304|64557806|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
23222729|NCT03099304|64557807|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
23222730|NCT03099304|64557808|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
23222731|NCT03099304|64557809|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
23222732|NCT03099304|64557810|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
23222733|NCT03099304|64557811|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
23222734|NCT03099304|64557806|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
23222735|NCT03099304|64557807|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
23222736|NCT03099304|64557808|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
23222737|NCT03099304|64557809|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
23222738|NCT03099304|64557810|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
23222739|NCT03099304|64557811|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
23159441|NCT02055820|64334887|FG005|Phase II: Expansion|Lost to Follow-up|0|||
23159442|NCT02055820|64334888|FG006|Phase II: Expansion|Lost to Follow-up|0|||
23159443|NCT02055820|64334889|FG007|Phase II: Expansion|Lost to Follow-up|0|||
23159444|NCT02055820|64334890|FG008|Phase II: Expansion|Lost to Follow-up|0|||
23159445|NCT02055820|64334891|FG009|Phase II: Expansion|Lost to Follow-up|0|||
23159446|NCT02055820|64334882|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
23159447|NCT02055820|64334883|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
23159448|NCT02055820|64334884|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
23159449|NCT02055820|64334885|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
23159450|NCT02055820|64334886|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
23159451|NCT02055820|64334887|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
23159452|NCT02055820|64334888|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
23159453|NCT02055820|64334889|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
23159454|NCT02055820|64334890|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
23159455|NCT02055820|64334891|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
23159456|NCT00282334|64334892|FG000|Overall Study|Withdrawal by Subject|8|||
23159457|NCT00282334|64334893|FG001|Overall Study|Withdrawal by Subject|5|||
23159458|NCT02374099|64334894|FG000|Overall Study|Adverse Event|1|||
23159459|NCT02374099|64334895|FG001|Overall Study|Adverse Event|0|||
23159460|NCT02374099|64334894|FG000|Overall Study|Progressive Disease|35|||
23159461|NCT02374099|64334895|FG001|Overall Study|Progressive Disease|40|||
23159462|NCT02374099|64334894|FG000|Overall Study|Withdrawal by Subject|5|||
23159463|NCT02374099|64334895|FG001|Overall Study|Withdrawal by Subject|1|||
23159464|NCT02374099|64334894|FG000|Overall Study|Miscellaneous|2|||
23159465|NCT02374099|64334895|FG001|Overall Study|Miscellaneous|3|||
23159466|NCT02374099|64334894|FG000|Overall Study|Randomized, but not treated|2|||
23159467|NCT02374099|64334895|FG001|Overall Study|Randomized, but not treated|1|||
23222740|NCT03099304|64557806|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
23222741|NCT03099304|64557807|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
23222742|NCT03099304|64557808|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
23222743|NCT03099304|64557809|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
23222744|NCT03099304|64557810|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
23222745|NCT03099304|64557811|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
23159468|NCT02374099|64334894|FG000|Overall Study|Study Terminated by Sponsor|3|||
23159469|NCT02374099|64334895|FG001|Overall Study|Study Terminated by Sponsor|4|||
23159470|NCT01230307|64334900|FG000|Overall Study|LVAD Placement|0|||
23159471|NCT01230307|64334901|FG001|Overall Study|LVAD Placement|2|||
23567449|NCT00383240|65807061|FG000|Overall Study|Adverse Event|4|||
23567450|NCT00383240|65807062|FG001|Overall Study|Adverse Event|6|||
23567451|NCT00383240|65807063|FG002|Overall Study|Adverse Event|9|||
23567452|NCT00383240|65807064|FG003|Overall Study|Adverse Event|7|||
23222746|NCT03099304|64557806|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
23567453|NCT00383240|65807061|FG000|Overall Study|Treatment Failure|8|||
23567454|NCT00383240|65807062|FG001|Overall Study|Treatment Failure|13|||
23567455|NCT00383240|65807063|FG002|Overall Study|Treatment Failure|47|||
23567456|NCT00383240|65807064|FG003|Overall Study|Treatment Failure|46|||
23567457|NCT00383240|65807061|FG000|Overall Study|Lost to Follow-up|3|||
23567458|NCT00383240|65807062|FG001|Overall Study|Lost to Follow-up|0|||
23567459|NCT00383240|65807063|FG002|Overall Study|Lost to Follow-up|0|||
23567460|NCT00383240|65807064|FG003|Overall Study|Lost to Follow-up|2|||
23567461|NCT00383240|65807061|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
23567462|NCT00383240|65807062|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
23567463|NCT00383240|65807063|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
23567464|NCT00383240|65807064|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
23567465|NCT00383240|65807061|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
23567466|NCT00383240|65807062|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
23567467|NCT00383240|65807063|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
23567468|NCT00383240|65807064|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
23159472|NCT01517893|64334905|FG000|Overall Study|Withdrawal by Subject|3|||
23159473|NCT01517893|64334906|FG001|Overall Study|Withdrawal by Subject|0|||
23159474|NCT01439555|64334914|FG000|Overall Study|Protocol Violation|1|||
23159475|NCT01627899|64334915|FG000|Overall Study|Study terminated early by sponsor.|5|||
23159476|NCT02943564|64334916|FG000|Overall Study|Miscellaneous Reasons|0|||
23159477|NCT02943564|64334917|FG001|Overall Study|Miscellaneous Reasons|0|||
23159478|NCT02943564|64334918|FG002|Overall Study|Miscellaneous Reasons|3|||
23159479|NCT02943564|64334916|FG000|Overall Study|Site terminated by sponsor|0|||
23159480|NCT02943564|64334917|FG001|Overall Study|Site terminated by sponsor|1|||
23159481|NCT02943564|64334918|FG002|Overall Study|Site terminated by sponsor|0|||
23159482|NCT02943564|64334916|FG000|Overall Study|Non-compliance with study drug|0|||
23159483|NCT02943564|64334917|FG001|Overall Study|Non-compliance with study drug|1|||
23567469|NCT00383240|65807061|FG000|Overall Study|Protocol Violation|4|||
23567470|NCT00383240|65807062|FG001|Overall Study|Protocol Violation|5|||
23567471|NCT00383240|65807063|FG002|Overall Study|Protocol Violation|9|||
23567472|NCT00383240|65807064|FG003|Overall Study|Protocol Violation|6|||
23567473|NCT00383240|65807061|FG000|Overall Study|Did not meet protocol eligibility|9|||
23567474|NCT00383240|65807062|FG001|Overall Study|Did not meet protocol eligibility|4|||
23567475|NCT00383240|65807063|FG002|Overall Study|Did not meet protocol eligibility|9|||
23567476|NCT00383240|65807064|FG003|Overall Study|Did not meet protocol eligibility|3|||
23567477|NCT00383240|65807061|FG000|Overall Study|Administrative|1|||
23567478|NCT00383240|65807062|FG001|Overall Study|Administrative|1|||
23567479|NCT00383240|65807063|FG002|Overall Study|Administrative|0|||
23159484|NCT02943564|64334918|FG002|Overall Study|Non-compliance with study drug|0|||
23159485|NCT02943564|64334916|FG000|Overall Study|Pregnancy|0|||
23159486|NCT02943564|64334917|FG001|Overall Study|Pregnancy|1|||
23159487|NCT02943564|64334918|FG002|Overall Study|Pregnancy|1|||
23159488|NCT02943564|64334916|FG000|Overall Study|Protocol Violation|2|||
23159489|NCT02943564|64334917|FG001|Overall Study|Protocol Violation|2|||
23159490|NCT02943564|64334918|FG002|Overall Study|Protocol Violation|2|||
23159491|NCT02943564|64334916|FG000|Overall Study|Lost to Follow-up|1|||
23159492|NCT02943564|64334917|FG001|Overall Study|Lost to Follow-up|0|||
23159493|NCT02943564|64334918|FG002|Overall Study|Lost to Follow-up|0|||
23159494|NCT02943564|64334916|FG000|Overall Study|Withdrawal by Subject|6|||
23159495|NCT02943564|64334917|FG001|Overall Study|Withdrawal by Subject|5|||
23159496|NCT02943564|64334918|FG002|Overall Study|Withdrawal by Subject|2|||
23159497|NCT02943564|64334916|FG000|Overall Study|Adverse Event|1|||
23159498|NCT02943564|64334917|FG001|Overall Study|Adverse Event|2|||
23159499|NCT02943564|64334918|FG002|Overall Study|Adverse Event|1|||
23159500|NCT02943564|64334916|FG000|Overall Study|Lack of Efficacy|0|||
23159501|NCT02943564|64334917|FG001|Overall Study|Lack of Efficacy|1|||
23222747|NCT03099304|64557807|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
23222748|NCT03099304|64557808|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
23222749|NCT03099304|64557809|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
23222750|NCT03099304|64557810|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
23222751|NCT03099304|64557811|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
23567480|NCT00383240|65807064|FG003|Overall Study|Administrative|0|||
23567481|NCT01777321|65807065|FG000|Overall Study|Withdrawal by Subject|0|||
23567482|NCT01777321|65807066|FG001|Overall Study|Withdrawal by Subject|1|||
23567483|NCT02998021|65807067|FG000|Overall Study|Withdrawal by Subject|3|||
23159502|NCT02943564|64334918|FG002|Overall Study|Lack of Efficacy|0|||
23159503|NCT00133991|64334919|FG000|Overall Study|Death|4|||
23159504|NCT03697720|64334924|FG000|Overall Study|Lost to Follow-up|7|||
23159505|NCT02713542|64334926|FG000|Overall Study|Use of prohibited medication|14|||
23567484|NCT02998021|65807068|FG001|Overall Study|Withdrawal by Subject|1|||
23159506|NCT02713542|64334927|FG001|Overall Study|Use of prohibited medication|5|||
23159507|NCT02713542|64334926|FG000|Overall Study|Withdrawal by Subject|4|||
23159508|NCT02713542|64334927|FG001|Overall Study|Withdrawal by Subject|1|||
23159509|NCT00823823|64334929|FG000|Overall Study|Lost to Follow-up|3|||
23159510|NCT00823823|64334930|FG001|Overall Study|Lost to Follow-up|1|||
23159511|NCT00823823|64334929|FG000|Overall Study|Protocol Violation|5|||
23159512|NCT00823823|64334930|FG001|Overall Study|Protocol Violation|5|||
23159513|NCT05289570|64334931|FG000|Overall Study|Physician Decision|1|||
23159514|NCT00974675|64334932|FG000|Overall Study|Adverse Event|2|||
23159515|NCT00974675|64334933|FG001|Overall Study|Adverse Event|1|||
23159516|NCT00974675|64334934|FG002|Overall Study|Adverse Event|1|||
23159517|NCT00974675|64334935|FG003|Overall Study|Adverse Event|1|||
23159518|NCT00974675|64334932|FG000|Overall Study|Physician Decision|0|||
23159519|NCT00974675|64334933|FG001|Overall Study|Physician Decision|0|||
23159520|NCT00974675|64334934|FG002|Overall Study|Physician Decision|1|||
23159521|NCT00974675|64334935|FG003|Overall Study|Physician Decision|0|||
23567485|NCT02998021|65807067|FG000|Overall Study|unsafe home|0|||
23567486|NCT02998021|65807068|FG001|Overall Study|unsafe home|1|||
23567487|NCT02086162|65807072|FG000|Overall Study|Withdrawal by Subject|4|||
23567488|NCT02086162|65807073|FG001|Overall Study|Withdrawal by Subject|4|||
23567489|NCT02086162|65807072|FG000|Overall Study|moved|1|||
23567490|NCT02086162|65807073|FG001|Overall Study|moved|1|||
23567491|NCT02086162|65807072|FG000|Overall Study|Lost to Follow-up|4|||
23567492|NCT02086162|65807073|FG001|Overall Study|Lost to Follow-up|2|||
23567493|NCT02086162|65807072|FG000|Overall Study|Death|1|||
23567494|NCT02086162|65807073|FG001|Overall Study|Death|0|||
23628979|NCT00943722|66028171|FG001|Base Study|Physician Decision|0|||
23628980|NCT00943722|66028172|FG002|Base Study|Physician Decision|0|||
23628981|NCT00943722|66028173|FG003|Base Study|Physician Decision|0|||
23628982|NCT00943722|66028174|FG004|Base Study|Physician Decision|1|||
23628983|NCT00943722|66028175|FG005|Base Study|Physician Decision|0|||
23159522|NCT00974675|64334932|FG000|Overall Study|Participant on holiday; unable to attend|0|||
23159523|NCT00974675|64334933|FG001|Overall Study|Participant on holiday; unable to attend|0|||
23159524|NCT00974675|64334934|FG002|Overall Study|Participant on holiday; unable to attend|0|||
23159525|NCT00974675|64334935|FG003|Overall Study|Participant on holiday; unable to attend|1|||
23159526|NCT01670539|64334936|FG000|Overall Study|Death|3|||
23159527|NCT01670539|64334937|FG001|Overall Study|Death|5|||
23159528|NCT01670539|64334936|FG000|Overall Study|Withdrawal by Subject|3|||
23159529|NCT01670539|64334937|FG001|Overall Study|Withdrawal by Subject|0|||
23159530|NCT01033825|64334938|FG000|Overall Study|Withdrawal by Subject|2|||
23159531|NCT01033825|64334939|FG001|Overall Study|Withdrawal by Subject|3|||
23159532|NCT01033825|64334940|FG002|Overall Study|Withdrawal by Subject|2|||
23159533|NCT01033825|64334941|FG003|Overall Study|Withdrawal by Subject|1|||
23159534|NCT01033825|64334942|FG004|Overall Study|Withdrawal by Subject|1|||
23159535|NCT01033825|64334943|FG005|Overall Study|Withdrawal by Subject|0|||
23159536|NCT01033825|64334944|FG006|Overall Study|Withdrawal by Subject|0|||
23159537|NCT01033825|64334938|FG000|Overall Study|Adverse Event|0|||
23567495|NCT00114634|65807074|FG000|Overall Study|failure to return forms|3|||
23567496|NCT02058290|65807078|FG000|Overall Study|Protocol Violation|2|||
23567497|NCT02058290|65807079|FG001|Overall Study|Protocol Violation|1|||
23567498|NCT02058290|65807078|FG000|Overall Study|Physician Decision|1|||
23628984|NCT00943722|66028176|FG006|Base Study|Physician Decision|0|||
23628985|NCT00943722|66028170|FG000|Base Study|Pregnancy|0|||
23628986|NCT00943722|66028171|FG001|Base Study|Pregnancy|0|||
23628987|NCT00943722|66028172|FG002|Base Study|Pregnancy|1|||
23628988|NCT00943722|66028173|FG003|Base Study|Pregnancy|0|||
23628989|NCT00943722|66028174|FG004|Base Study|Pregnancy|2|||
23628990|NCT00943722|66028175|FG005|Base Study|Pregnancy|0|||
23628991|NCT00943722|66028176|FG006|Base Study|Pregnancy|0|||
23628992|NCT00943722|66028170|FG000|Base Study|Protocol Violation|0|||
23628993|NCT00943722|66028171|FG001|Base Study|Protocol Violation|1|||
23628994|NCT00943722|66028172|FG002|Base Study|Protocol Violation|0|||
23628995|NCT00943722|66028173|FG003|Base Study|Protocol Violation|0|||
23628996|NCT00943722|66028174|FG004|Base Study|Protocol Violation|2|||
23628997|NCT00943722|66028175|FG005|Base Study|Protocol Violation|0|||
23628998|NCT00943722|66028176|FG006|Base Study|Protocol Violation|0|||
23628999|NCT00943722|66028170|FG000|Base Study|Withdrawal by Subject|12|||
23629000|NCT00943722|66028171|FG001|Base Study|Withdrawal by Subject|13|||
23159538|NCT01033825|64334939|FG001|Overall Study|Adverse Event|0|||
23159539|NCT01033825|64334940|FG002|Overall Study|Adverse Event|0|||
23159540|NCT01033825|64334941|FG003|Overall Study|Adverse Event|1|||
23159541|NCT01033825|64334942|FG004|Overall Study|Adverse Event|0|||
23159542|NCT01033825|64334943|FG005|Overall Study|Adverse Event|0|||
23629001|NCT00943722|66028172|FG002|Base Study|Withdrawal by Subject|2|||
23629002|NCT00943722|66028173|FG003|Base Study|Withdrawal by Subject|13|||
23159543|NCT01033825|64334944|FG006|Overall Study|Adverse Event|0|||
23159544|NCT01033825|64334938|FG000|Overall Study|Protocol Violation|1|||
23629003|NCT00943722|66028174|FG004|Base Study|Withdrawal by Subject|8|||
23629004|NCT00943722|66028175|FG005|Base Study|Withdrawal by Subject|0|||
23629005|NCT00943722|66028176|FG006|Base Study|Withdrawal by Subject|0|||
23159545|NCT01033825|64334939|FG001|Overall Study|Protocol Violation|0|||
23159546|NCT01033825|64334940|FG002|Overall Study|Protocol Violation|0|||
23159547|NCT01033825|64334941|FG003|Overall Study|Protocol Violation|0|||
23159548|NCT01033825|64334942|FG004|Overall Study|Protocol Violation|0|||
23159549|NCT01033825|64334943|FG005|Overall Study|Protocol Violation|0|||
23159550|NCT01033825|64334944|FG006|Overall Study|Protocol Violation|0|||
23159551|NCT01033825|64334938|FG000|Overall Study|Other|0|||
23159552|NCT01033825|64334939|FG001|Overall Study|Other|0|||
23159553|NCT01033825|64334940|FG002|Overall Study|Other|0|||
23159554|NCT01033825|64334941|FG003|Overall Study|Other|0|||
23159555|NCT01033825|64334942|FG004|Overall Study|Other|1|||
23159556|NCT01033825|64334943|FG005|Overall Study|Other|0|||
23159557|NCT01033825|64334944|FG006|Overall Study|Other|0|||
23159558|NCT02347098|64334945|FG000|Overall Study|Death|1|||
23159559|NCT02347098|64334946|FG001|Overall Study|Death|0|||
23159560|NCT02347098|64334945|FG000|Overall Study|Withdrawal by Subject|1|||
23159561|NCT02347098|64334946|FG001|Overall Study|Withdrawal by Subject|0|||
23159562|NCT02347098|64334945|FG000|Overall Study|Lost to Follow-up|2|||
23159563|NCT02347098|64334946|FG001|Overall Study|Lost to Follow-up|2|||
23159564|NCT02347098|64334945|FG000|Overall Study|Refuse Follow-up Visit|1|||
23159565|NCT02347098|64334946|FG001|Overall Study|Refuse Follow-up Visit|5|||
23159566|NCT02347098|64334945|FG000|Overall Study|no visit due to illness|2|||
23222752|NCT03099304|64557806|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
23222753|NCT03099304|64557807|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
23222754|NCT03099304|64557808|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
23445017|NCT03712787|65370244|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
23567499|NCT02058290|65807079|FG001|Overall Study|Physician Decision|0|||
23567500|NCT02058290|65807078|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
23567501|NCT02058290|65807079|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
23567502|NCT02058290|65807078|FG000|Overall Study|Withdrawal by Subject|0|||
23567503|NCT02058290|65807079|FG001|Overall Study|Withdrawal by Subject|1|||
23567504|NCT03734991|65807082|FG000|Overall Study|Adverse Event|4|||
23567505|NCT03734991|65807083|FG001|Overall Study|Adverse Event|0|||
23567506|NCT03734991|65807082|FG000|Overall Study|Lost to Follow-up|4|||
23567507|NCT03734991|65807083|FG001|Overall Study|Lost to Follow-up|0|||
23567508|NCT03734991|65807082|FG000|Overall Study|Physician Decision|0|||
23567509|NCT03734991|65807083|FG001|Overall Study|Physician Decision|1|||
23567510|NCT03734991|65807082|FG000|Overall Study|Pregnancy|1|||
23567511|NCT03734991|65807083|FG001|Overall Study|Pregnancy|0|||
23629006|NCT00943722|66028170|FG000|Base Study|Month 12 visit not completed|0|||
23629007|NCT00943722|66028171|FG001|Base Study|Month 12 visit not completed|0|||
23629008|NCT00943722|66028172|FG002|Base Study|Month 12 visit not completed|0|||
23629009|NCT00943722|66028173|FG003|Base Study|Month 12 visit not completed|0|||
23629010|NCT00943722|66028174|FG004|Base Study|Month 12 visit not completed|2|||
23567512|NCT03734991|65807082|FG000|Overall Study|Withdrawal by Subject|6|||
23567513|NCT03734991|65807083|FG001|Overall Study|Withdrawal by Subject|3|||
23629011|NCT00943722|66028175|FG005|Base Study|Month 12 visit not completed|0|||
23629012|NCT00943722|66028176|FG006|Base Study|Month 12 visit not completed|0|||
23629013|NCT00943722|66028170|FG000|First Extension Study: EXT 1|Adverse Event|0|||
23629014|NCT00943722|66028171|FG001|First Extension Study: EXT 1|Adverse Event|0|||
23629015|NCT00943722|66028172|FG002|First Extension Study: EXT 1|Adverse Event|0|||
23629016|NCT00943722|66028173|FG003|First Extension Study: EXT 1|Adverse Event|0|||
23629017|NCT00943722|66028174|FG004|First Extension Study: EXT 1|Adverse Event|0|||
23629018|NCT00943722|66028175|FG005|First Extension Study: EXT 1|Adverse Event|1|||
23629019|NCT00943722|66028176|FG006|First Extension Study: EXT 1|Adverse Event|0|||
23629020|NCT00943722|66028170|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629021|NCT00943722|66028171|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629022|NCT00943722|66028172|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629023|NCT00943722|66028173|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629024|NCT00943722|66028174|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
23629025|NCT00943722|66028175|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
23629026|NCT00943722|66028176|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
23629027|NCT00943722|66028170|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23629028|NCT00943722|66028171|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23567514|NCT03734991|65807082|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
23629029|NCT00943722|66028172|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23159567|NCT02347098|64334946|FG001|Overall Study|no visit due to illness|1|||
23159568|NCT00549939|64334947|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
23159569|NCT00549939|64334948|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
23159570|NCT00549939|64334949|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
23159571|NCT00549939|64334947|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
23567515|NCT03734991|65807083|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
23159572|NCT00549939|64334948|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
23629030|NCT00943722|66028173|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23159573|NCT00549939|64334949|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
23159574|NCT00549939|64334947|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
23159575|NCT00549939|64334948|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
23159576|NCT00549939|64334949|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
23159577|NCT00549939|64334947|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
23159578|NCT00549939|64334948|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
23159579|NCT00549939|64334949|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
23159580|NCT00549939|64334947|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
23159581|NCT00549939|64334948|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
23159582|NCT00549939|64334949|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
23159583|NCT00549939|64334947|FG000|40-week Open Label Treatment Period|Other|0|||
23159584|NCT00549939|64334948|FG001|40-week Open Label Treatment Period|Other|1|||
23159585|NCT00549939|64334949|FG002|40-week Open Label Treatment Period|Other|4|||
23159586|NCT02316340|64334956|FG000|First Progression|Clinical progression|2|||
23159587|NCT02316340|64334957|FG001|First Progression|Clinical progression|1|||
23159588|NCT02316340|64334956|FG000|First Progression|Withdrawal by Subject|1|||
23159589|NCT02316340|64334957|FG001|First Progression|Withdrawal by Subject|0|||
23159590|NCT01462435|64334958|FG000|Overall Study|Lack of Efficacy|1|||
23159591|NCT01462435|64334959|FG001|Overall Study|Lack of Efficacy|0|||
23159592|NCT01462435|64334960|FG002|Overall Study|Lack of Efficacy|0|||
23159593|NCT01462435|64334961|FG003|Overall Study|Lack of Efficacy|3|||
23159594|NCT01462435|64334958|FG000|Overall Study|Physician Decision|0|||
23159595|NCT01462435|64334959|FG001|Overall Study|Physician Decision|0|||
23159596|NCT01462435|64334960|FG002|Overall Study|Physician Decision|1|||
23159597|NCT01462435|64334961|FG003|Overall Study|Physician Decision|0|||
23159598|NCT01462435|64334958|FG000|Overall Study|Withdrawal by Subject|0|||
23159599|NCT01462435|64334959|FG001|Overall Study|Withdrawal by Subject|0|||
23159600|NCT01462435|64334960|FG002|Overall Study|Withdrawal by Subject|0|||
23159601|NCT01462435|64334961|FG003|Overall Study|Withdrawal by Subject|1|||
23159602|NCT01462435|64334958|FG000|Overall Study|Lost to Follow-up|0|||
23159603|NCT01462435|64334959|FG001|Overall Study|Lost to Follow-up|0|||
23159604|NCT01462435|64334960|FG002|Overall Study|Lost to Follow-up|0|||
23159605|NCT01462435|64334961|FG003|Overall Study|Lost to Follow-up|1|||
23159606|NCT01422915|64334962|FG000|Overall Study|Adverse Event|1|||
23159607|NCT00607386|64334968|FG000|Overall Study|Physician Decision|1|||
23159608|NCT04143009|64334969|FG000|Pilot Trial|Lost to Follow-up|0|||
23159609|NCT04143009|64334970|FG001|Pilot Trial|Lost to Follow-up|1|||
23159610|NCT04143009|64334971|FG002|Pilot Trial|Lost to Follow-up|1|||
23159611|NCT01516970|64334972|FG000|Overall Study|Lost to Follow-up|7|||
23159612|NCT01516970|64334973|FG001|Overall Study|Lost to Follow-up|8|||
23159613|NCT01516970|64334972|FG000|Overall Study|Adverse Event|1|||
23159614|NCT01516970|64334973|FG001|Overall Study|Adverse Event|5|||
23159615|NCT01516970|64334972|FG000|Overall Study|Withdrawal by Subject|1|||
23159616|NCT01516970|64334973|FG001|Overall Study|Withdrawal by Subject|1|||
23159617|NCT01516970|64334972|FG000|Overall Study|Other|9|||
23159618|NCT01516970|64334973|FG001|Overall Study|Other|7|||
23159619|NCT00631020|64334974|FG000|Overall Study|Lost to Follow-up|7|||
23159620|NCT00631020|64334974|FG000|Overall Study|Incarcerated|1|||
23159621|NCT00175877|64334976|FG000|Overall Study|Adverse Event|136|||
23159622|NCT00175877|64334976|FG000|Overall Study|Withdrawal by Subject|141|||
23159623|NCT00175877|64334976|FG000|Overall Study|Lost to Follow-up|9|||
23159624|NCT00175877|64334976|FG000|Overall Study|Lack of Efficacy|26|||
23159625|NCT00175877|64334976|FG000|Overall Study|Protocol Violation|15|||
23159626|NCT00175877|64334976|FG000|Overall Study|Other Reason|20|||
23159627|NCT00175877|64334976|FG000|Overall Study|AE & Other|1|||
23159628|NCT00175877|64334976|FG000|Overall Study|Withdrawal by subject & Other|1|||
23159629|NCT00894556|64334977|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
23159630|NCT00894556|64334978|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
23159631|NCT00894556|64334979|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
23159632|NCT00894556|64334980|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
23159633|NCT00894556|64334977|FG000|Treatment Phase|Lost to Follow-up|2|||
23159634|NCT00894556|64334978|FG001|Treatment Phase|Lost to Follow-up|3|||
23159635|NCT00894556|64334979|FG002|Treatment Phase|Lost to Follow-up|1|||
23159636|NCT00894556|64334980|FG003|Treatment Phase|Lost to Follow-up|0|||
23159637|NCT00894556|64334977|FG000|Treatment Phase|Lack of Qualifying Event|2|||
23159638|NCT00894556|64334978|FG001|Treatment Phase|Lack of Qualifying Event|1|||
23159639|NCT00894556|64334979|FG002|Treatment Phase|Lack of Qualifying Event|0|||
23159640|NCT00894556|64334980|FG003|Treatment Phase|Lack of Qualifying Event|0|||
23159641|NCT00736255|64334981|FG000|Overall Study|Adverse Event|1|||
23159642|NCT00736255|64334982|FG001|Overall Study|Adverse Event|0|||
23159643|NCT00736255|64334981|FG000|Overall Study|Physician Decision|1|||
23159644|NCT00736255|64334982|FG001|Overall Study|Physician Decision|0|||
23159645|NCT00736255|64334981|FG000|Overall Study|Non-compliance|1|||
23159646|NCT00736255|64334982|FG001|Overall Study|Non-compliance|1|||
23159647|NCT02004262|64334983|FG000|Overall Study|Death|67|||
23159648|NCT02004262|64334984|FG001|Overall Study|Death|64|||
23159649|NCT02004262|64334985|FG002|Overall Study|Death|66|||
23159650|NCT02004262|64334986|FG003|Overall Study|Death|28|||
23159651|NCT02004262|64334987|FG004|Overall Study|Death|29|||
23159652|NCT02004262|64334988|FG005|Overall Study|Death|22|||
23159653|NCT02004262|64334983|FG000|Overall Study|Withdrawal by Subject|1|||
23159654|NCT02004262|64334984|FG001|Overall Study|Withdrawal by Subject|0|||
23159655|NCT02004262|64334985|FG002|Overall Study|Withdrawal by Subject|4|||
23159656|NCT02004262|64334986|FG003|Overall Study|Withdrawal by Subject|0|||
23159657|NCT02004262|64334987|FG004|Overall Study|Withdrawal by Subject|1|||
23159658|NCT02004262|64334988|FG005|Overall Study|Withdrawal by Subject|3|||
23159659|NCT02004262|64334983|FG000|Overall Study|Lost to Follow-up|1|||
23159660|NCT02004262|64334984|FG001|Overall Study|Lost to Follow-up|1|||
23159661|NCT02004262|64334985|FG002|Overall Study|Lost to Follow-up|0|||
23159662|NCT02004262|64334986|FG003|Overall Study|Lost to Follow-up|0|||
23159663|NCT02004262|64334987|FG004|Overall Study|Lost to Follow-up|0|||
23159664|NCT02004262|64334988|FG005|Overall Study|Lost to Follow-up|0|||
23159665|NCT02004262|64334983|FG000|Overall Study|Study Terminated by Sponsor|4|||
23159666|NCT02004262|64334984|FG001|Overall Study|Study Terminated by Sponsor|3|||
23159667|NCT02004262|64334985|FG002|Overall Study|Study Terminated by Sponsor|2|||
23159668|NCT02004262|64334986|FG003|Overall Study|Study Terminated by Sponsor|1|||
23159669|NCT02004262|64334987|FG004|Overall Study|Study Terminated by Sponsor|1|||
23159670|NCT02004262|64334988|FG005|Overall Study|Study Terminated by Sponsor|5|||
23159671|NCT04640272|64334992|FG000|Overall Study|Subject moved out of area|1|||
23159672|NCT00715026|64334993|FG000|Overall Study|Withdrawal by Subject|5|||
23159673|NCT00715026|64334993|FG000|Overall Study|Lost to Follow-up|3|||
23159674|NCT00715026|64334993|FG000|Overall Study|Protocol Violation|1|||
23159675|NCT00715026|64334993|FG000|Overall Study|Surgery done on non-study consented hip|1|||
23159676|NCT01476475|64334994|FG000|Overall Study|Adverse Event|6|||
23159677|NCT01476475|64334995|FG001|Overall Study|Adverse Event|0|||
23159678|NCT01476475|64334994|FG000|Overall Study|Poor compliance to protocol|1|||
23159679|NCT01476475|64334995|FG001|Overall Study|Poor compliance to protocol|1|||
23159680|NCT01476475|64334994|FG000|Overall Study|Other reasons|4|||
23159681|NCT01476475|64334995|FG001|Overall Study|Other reasons|2|||
23159682|NCT02025907|64334996|FG000|Overall Study|Lack of Efficacy|1|||
23159683|NCT02025907|64334997|FG001|Overall Study|Lack of Efficacy|0|||
23159684|NCT02025907|64334996|FG000|Overall Study|Withdrawal by Subject|15|||
23159685|NCT02025907|64334997|FG001|Overall Study|Withdrawal by Subject|8|||
23159686|NCT02025907|64334996|FG000|Overall Study|Protocol Violation|2|||
23159687|NCT02025907|64334997|FG001|Overall Study|Protocol Violation|0|||
23159688|NCT02025907|64334996|FG000|Overall Study|Physician Decision|2|||
23159689|NCT02025907|64334997|FG001|Overall Study|Physician Decision|0|||
23159690|NCT02025907|64334996|FG000|Overall Study|Lost to Follow-up|2|||
23159691|NCT02025907|64334997|FG001|Overall Study|Lost to Follow-up|2|||
23159692|NCT02025907|64334996|FG000|Overall Study|Adverse Event|3|||
23445018|NCT03712787|65370245|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
23629031|NCT00943722|66028174|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
23629032|NCT00943722|66028175|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
23629033|NCT00943722|66028176|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
23629034|NCT00943722|66028170|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
23629035|NCT00943722|66028171|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
23629036|NCT00943722|66028172|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
23629037|NCT00943722|66028173|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
23629038|NCT00943722|66028174|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
23629039|NCT00943722|66028175|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
23159693|NCT02025907|64334997|FG001|Overall Study|Adverse Event|1|||
23159694|NCT02025907|64334996|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
23159695|NCT02025907|64334997|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
23159696|NCT00528021|64335004|FG000|Overall Study|Lack of Efficacy|17|||
23159697|NCT00528021|64335005|FG001|Overall Study|Lack of Efficacy|13|||
23159698|NCT00528021|64335006|FG002|Overall Study|Lack of Efficacy|7|||
23159699|NCT00528021|64335007|FG003|Overall Study|Lack of Efficacy|9|||
23159700|NCT00688155|64335008|FG000|Overall Study|Withdrawal by Subject|2|||
23159701|NCT00688155|64335009|FG001|Overall Study|Withdrawal by Subject|2|||
23567516|NCT03734991|65807082|FG000|Overall Study|Other|2|||
23567517|NCT03734991|65807083|FG001|Overall Study|Other|2|||
23567518|NCT01834222|65807085|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
23567519|NCT01062763|65807086|FG000|Overall Study|Adverse Event|3|||
23567520|NCT01062763|65807087|FG001|Overall Study|Adverse Event|4|||
23567521|NCT00390455|65807094|FG000|Overall Study|Adverse Event|17|||
23567522|NCT00390455|65807095|FG001|Overall Study|Adverse Event|3|||
23567523|NCT00390455|65807094|FG000|Overall Study|Withdrawal by Subject|8|||
23567524|NCT00390455|65807095|FG001|Overall Study|Withdrawal by Subject|8|||
23567525|NCT00390455|65807094|FG000|Overall Study|Alternate Treatment|0|||
23567526|NCT00390455|65807095|FG001|Overall Study|Alternate Treatment|1|||
23567527|NCT00390455|65807094|FG000|Overall Study|Other Medical Reasons|7|||
23567528|NCT00390455|65807095|FG001|Overall Study|Other Medical Reasons|11|||
23567529|NCT01913639|65807099|FG000|Overall Study|Not Eligible|3|||
23567530|NCT00284141|65807100|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
23159702|NCT00688155|64335010|FG002|Overall Study|Withdrawal by Subject|1|||
23159703|NCT00688155|64335011|FG003|Overall Study|Withdrawal by Subject|1|||
23159704|NCT03680911|64335012|FG000|At Home Treatment|Study Termination|3|||
23159705|NCT03680911|64335013|FG001|At Home Treatment|Study Termination|0|||
23159706|NCT03680911|64335012|FG000|At Home Treatment|Lost to Follow-up|0|||
23159707|NCT03680911|64335013|FG001|At Home Treatment|Lost to Follow-up|1|||
23159708|NCT03680911|64335012|FG000|At Home Treatment|Withdrawal by Subject|0|||
23159709|NCT03680911|64335013|FG001|At Home Treatment|Withdrawal by Subject|2|||
23159710|NCT03680911|64335012|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
23159711|NCT03680911|64335013|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
23159712|NCT00219284|64335014|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
23159713|NCT00219284|64335015|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
23159714|NCT00219284|64335014|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
23159715|NCT00219284|64335015|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
23159716|NCT00219284|64335014|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
23159717|NCT00219284|64335015|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
23159718|NCT00219284|64335014|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
23159719|NCT00219284|64335015|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
23159720|NCT00219284|64335014|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
23159721|NCT00219284|64335015|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
23159722|NCT00219284|64335014|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
23159723|NCT00219284|64335015|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
23159724|NCT00219284|64335014|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
23159725|NCT00219284|64335015|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
23159726|NCT00219284|64335014|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
23159727|NCT00219284|64335015|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
23159728|NCT00219284|64335014|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
23159729|NCT00219284|64335015|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
23159730|NCT01549275|64335016|FG000|Overall Study|Lost to Follow-up|1|||
23159731|NCT01549275|64335017|FG001|Overall Study|Lost to Follow-up|0|||
23159732|NCT04439175|64335018|FG000|Overall Study|Never started treatment|4|||
23159733|NCT04439175|64335018|FG000|Overall Study|Ineligible|5|||
23159734|NCT04439175|64335018|FG000|Overall Study|Adverse Event|6|||
23159735|NCT04439175|64335018|FG000|Overall Study|Death|4|||
23159736|NCT04439175|64335018|FG000|Overall Study|Disease progression|44|||
23159737|NCT04439175|64335018|FG000|Overall Study|Withdrawal by Subject|4|||
23159738|NCT04439175|64335018|FG000|Overall Study|Alternative Therapy|1|||
23159739|NCT04439175|64335018|FG000|Overall Study|Other|2|||
23159740|NCT02142738|64335019|FG000|Overall Study|Adverse Event|13|||
23159741|NCT02142738|64335020|FG001|Overall Study|Adverse Event|9|||
23159742|NCT02142738|64335019|FG000|Overall Study|Death|92|||
23159743|NCT02142738|64335020|FG001|Overall Study|Death|112|||
23159744|NCT02142738|64335019|FG000|Overall Study|Lost to Follow-up|0|||
23159745|NCT02142738|64335020|FG001|Overall Study|Lost to Follow-up|3|||
23159746|NCT02142738|64335019|FG000|Overall Study|Withdrawal by Subject|6|||
23159747|NCT02142738|64335020|FG001|Overall Study|Withdrawal by Subject|7|||
23159748|NCT02142738|64335019|FG000|Overall Study|Follow up ended by sponsor|43|||
23159749|NCT02142738|64335020|FG001|Overall Study|Follow up ended by sponsor|20|||
23159750|NCT00365456|64335021|FG000|Trial Period I (12 Months)|Adverse Event|84|||
23159751|NCT00365456|64335022|FG001|Trial Period I (12 Months)|Adverse Event|0|||
23159752|NCT00365456|64335021|FG000|Trial Period I (12 Months)|Non-compliance|3|||
23159753|NCT00365456|64335022|FG001|Trial Period I (12 Months)|Non-compliance|0|||
23159754|NCT00365456|64335021|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
23159755|NCT00365456|64335022|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
23159756|NCT00365456|64335021|FG000|Trial Period I (12 Months)|Other|11|||
23159757|NCT00365456|64335022|FG001|Trial Period I (12 Months)|Other|0|||
23159758|NCT00365456|64335021|FG000|Trial Period II (12 Months)|Adverse Event|0|||
23159759|NCT00365456|64335022|FG001|Trial Period II (12 Months)|Adverse Event|6|||
23159760|NCT00365456|64335021|FG000|Trial Period II (12 Months)|Non-compliance|0|||
23159761|NCT00365456|64335022|FG001|Trial Period II (12 Months)|Non-compliance|2|||
23159762|NCT00365456|64335021|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
23159763|NCT00365456|64335022|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
23159764|NCT00365456|64335021|FG000|Trial Period II (12 Months)|Other|0|||
23159765|NCT00365456|64335022|FG001|Trial Period II (12 Months)|Other|1|||
23222755|NCT03099304|64557809|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
23159766|NCT00365456|64335021|FG000|Trial Period III (12 Months)|Adverse Event|13|||
23222756|NCT03099304|64557810|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
23222757|NCT03099304|64557811|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
23159767|NCT00365456|64335022|FG001|Trial Period III (12 Months)|Adverse Event|3|||
23159768|NCT00365456|64335021|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
23159769|NCT00365456|64335022|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
23222758|NCT03099304|64557806|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
23159770|NCT00365456|64335021|FG000|Trial Period III (12 Months)|Other|1|||
23159771|NCT00365456|64335022|FG001|Trial Period III (12 Months)|Other|1|||
23445019|NCT03712787|65370246|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
23445020|NCT03712787|65370247|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
23445021|NCT03712787|65370244|FG000|Overall Study|COVID-19 Infection|0|||
23445022|NCT03712787|65370245|FG001|Overall Study|COVID-19 Infection|1|||
23445023|NCT03712787|65370246|FG002|Overall Study|COVID-19 Infection|0|||
23445024|NCT03712787|65370247|FG003|Overall Study|COVID-19 Infection|0|||
23445025|NCT03712787|65370244|FG000|Overall Study|Other, Not Specified|79|||
23445026|NCT03712787|65370245|FG001|Overall Study|Other, Not Specified|77|||
23445027|NCT03712787|65370246|FG002|Overall Study|Other, Not Specified|74|||
23445028|NCT03712787|65370247|FG003|Overall Study|Other, Not Specified|78|||
23445029|NCT02291419|65370252|FG000|Overall Study|Early study termination|1|||
23445030|NCT02291419|65370253|FG001|Overall Study|Early study termination|5|||
23445031|NCT01959139|65370254|FG000|Phase II|Disease progression|0|||
23445032|NCT01959139|65370255|FG001|Phase II|Disease progression|0|||
23445033|NCT01959139|65370256|FG002|Phase II|Disease progression|26|||
23445034|NCT01959139|65370257|FG003|Phase II|Disease progression|34|||
23445035|NCT01959139|65370254|FG000|Phase II|Adverse Event|0|||
23445036|NCT01959139|65370255|FG001|Phase II|Adverse Event|0|||
23445037|NCT01959139|65370256|FG002|Phase II|Adverse Event|10|||
23445038|NCT01959139|65370257|FG003|Phase II|Adverse Event|11|||
23445039|NCT01959139|65370254|FG000|Phase II|Patient Refusal|0|||
23445040|NCT01959139|65370255|FG001|Phase II|Patient Refusal|0|||
23445041|NCT01959139|65370256|FG002|Phase II|Patient Refusal|5|||
23445042|NCT01959139|65370257|FG003|Phase II|Patient Refusal|4|||
23445043|NCT01959139|65370254|FG000|Phase II|Death|0|||
23445044|NCT01959139|65370255|FG001|Phase II|Death|0|||
23445045|NCT01959139|65370256|FG002|Phase II|Death|3|||
23445046|NCT01959139|65370257|FG003|Phase II|Death|1|||
23445047|NCT01959139|65370254|FG000|Phase II|Other/Unknown|0|||
23445048|NCT01959139|65370255|FG001|Phase II|Other/Unknown|0|||
23445049|NCT01959139|65370256|FG002|Phase II|Other/Unknown|8|||
23445050|NCT01959139|65370257|FG003|Phase II|Other/Unknown|5|||
23445051|NCT01959139|65370254|FG000|Phase II|On treatment|0|||
23445052|NCT01959139|65370255|FG001|Phase II|On treatment|0|||
23445053|NCT01959139|65370256|FG002|Phase II|On treatment|4|||
23445054|NCT01959139|65370257|FG003|Phase II|On treatment|0|||
23445055|NCT01919229|65370258|FG000|Overall Study|Subject/guardian decision|0|||
23445056|NCT01919229|65370259|FG001|Overall Study|Subject/guardian decision|0|||
23445057|NCT01919229|65370260|FG002|Overall Study|Subject/guardian decision|1|||
23445058|NCT00536471|65370266|FG000|Overall Study|Lost to Follow-up|48|||
23445059|NCT00536471|65370267|FG001|Overall Study|Lost to Follow-up|23|||
23445060|NCT00536471|65370268|FG002|Overall Study|Lost to Follow-up|48|||
23445061|NCT00536471|65370269|FG003|Overall Study|Lost to Follow-up|22|||
23445062|NCT00536471|65370266|FG000|Overall Study|Adverse Event|32|||
23445063|NCT00536471|65370267|FG001|Overall Study|Adverse Event|16|||
23445064|NCT00536471|65370268|FG002|Overall Study|Adverse Event|28|||
23222759|NCT03099304|64557807|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
23445065|NCT00536471|65370269|FG003|Overall Study|Adverse Event|13|||
23445066|NCT00536471|65370266|FG000|Overall Study|Withdrawal by Subject|40|||
23445067|NCT00536471|65370267|FG001|Overall Study|Withdrawal by Subject|24|||
23445068|NCT00536471|65370268|FG002|Overall Study|Withdrawal by Subject|43|||
23445069|NCT00536471|65370269|FG003|Overall Study|Withdrawal by Subject|21|||
23629040|NCT00943722|66028176|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
23629041|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
23629042|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
23629043|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
23629044|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
23629045|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
23629046|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
23629047|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
23629048|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23445070|NCT00536471|65370266|FG000|Overall Study|Lack of Efficacy|17|||
23445071|NCT00536471|65370267|FG001|Overall Study|Lack of Efficacy|18|||
23445072|NCT00536471|65370268|FG002|Overall Study|Lack of Efficacy|11|||
23445073|NCT00536471|65370269|FG003|Overall Study|Lack of Efficacy|9|||
23629049|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23629050|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23445074|NCT00536471|65370266|FG000|Overall Study|Protocol Violation|8|||
23445075|NCT00536471|65370267|FG001|Overall Study|Protocol Violation|1|||
23445076|NCT00536471|65370268|FG002|Overall Study|Protocol Violation|2|||
23445077|NCT00536471|65370269|FG003|Overall Study|Protocol Violation|3|||
23445078|NCT00536471|65370266|FG000|Overall Study|Physician Decision|11|||
23445079|NCT00536471|65370267|FG001|Overall Study|Physician Decision|1|||
23445080|NCT00536471|65370268|FG002|Overall Study|Physician Decision|3|||
23445081|NCT00536471|65370269|FG003|Overall Study|Physician Decision|2|||
23445082|NCT00536471|65370266|FG000|Overall Study|Death|0|||
23445083|NCT00536471|65370267|FG001|Overall Study|Death|0|||
23445084|NCT00536471|65370268|FG002|Overall Study|Death|1|||
23445085|NCT00536471|65370269|FG003|Overall Study|Death|2|||
23445086|NCT00536471|65370266|FG000|Overall Study|Sponsor Decision|0|||
23445087|NCT00536471|65370267|FG001|Overall Study|Sponsor Decision|1|||
23445088|NCT00536471|65370268|FG002|Overall Study|Sponsor Decision|3|||
23445089|NCT00536471|65370269|FG003|Overall Study|Sponsor Decision|2|||
23445090|NCT02735343|65370270|FG000|Overall Study|screen fail|0|||
23445091|NCT02735343|65370271|FG001|Overall Study|screen fail|2|||
23445092|NCT02045095|65370279|FG000|Overall Study|Other|0|||
23445093|NCT02045095|65370280|FG001|Overall Study|Other|0|||
23445094|NCT02045095|65370281|FG002|Overall Study|Other|1|||
23445095|NCT02045095|65370282|FG003|Overall Study|Other|0|||
23445096|NCT02045095|65370283|FG004|Overall Study|Other|0|||
23445097|NCT02045095|65370284|FG005|Overall Study|Other|2|||
23445098|NCT02045095|65370285|FG006|Overall Study|Other|0|||
23445099|NCT02045095|65370279|FG000|Overall Study|Progressive Disease|3|||
23445100|NCT02045095|65370280|FG001|Overall Study|Progressive Disease|3|||
23445101|NCT02045095|65370281|FG002|Overall Study|Progressive Disease|2|||
23445102|NCT02045095|65370282|FG003|Overall Study|Progressive Disease|4|||
23445103|NCT02045095|65370283|FG004|Overall Study|Progressive Disease|2|||
23445104|NCT02045095|65370284|FG005|Overall Study|Progressive Disease|4|||
23445105|NCT02045095|65370285|FG006|Overall Study|Progressive Disease|1|||
23445106|NCT02045095|65370279|FG000|Overall Study|Withdrawal by Subject|0|||
23445107|NCT02045095|65370280|FG001|Overall Study|Withdrawal by Subject|0|||
23445108|NCT02045095|65370281|FG002|Overall Study|Withdrawal by Subject|0|||
23445109|NCT02045095|65370282|FG003|Overall Study|Withdrawal by Subject|0|||
23445110|NCT02045095|65370283|FG004|Overall Study|Withdrawal by Subject|3|||
23445111|NCT02045095|65370284|FG005|Overall Study|Withdrawal by Subject|0|||
23445112|NCT02045095|65370285|FG006|Overall Study|Withdrawal by Subject|0|||
23445113|NCT02045095|65370279|FG000|Overall Study|Adverse Event|0|||
23445114|NCT02045095|65370280|FG001|Overall Study|Adverse Event|1|||
23445115|NCT02045095|65370281|FG002|Overall Study|Adverse Event|1|||
23445116|NCT02045095|65370282|FG003|Overall Study|Adverse Event|0|||
23445117|NCT02045095|65370283|FG004|Overall Study|Adverse Event|0|||
23445118|NCT02045095|65370284|FG005|Overall Study|Adverse Event|2|||
23445119|NCT02045095|65370285|FG006|Overall Study|Adverse Event|0|||
23445120|NCT01156714|65370286|FG000|Overall Study|Withdrawal by Subject|9|||
23445121|NCT01156714|65370287|FG001|Overall Study|Withdrawal by Subject|4|||
23445122|NCT01156714|65370288|FG002|Overall Study|Withdrawal by Subject|3|||
23445123|NCT01008943|65370295|FG000|Overall Study|Withdrawal by Subject|1|||
23445124|NCT04862065|65370296|FG000|Screening|Protocol Violation|54|||
23445125|NCT04862065|65370297|FG001|Screening|Protocol Violation|0|||
23445126|NCT04862065|65370298|FG002|Screening|Protocol Violation|0|||
23445127|NCT04862065|65370296|FG000|Screening|Insufficient Sample|1|||
23445128|NCT04862065|65370297|FG001|Screening|Insufficient Sample|0|||
23445129|NCT04862065|65370298|FG002|Screening|Insufficient Sample|0|||
23445130|NCT04862065|65370296|FG000|Follow-Up|Lost to Follow-up|3|||
23445131|NCT04862065|65370297|FG001|Follow-Up|Lost to Follow-up|0|||
23445132|NCT04862065|65370298|FG002|Follow-Up|Lost to Follow-up|0|||
23445133|NCT02292719|65370299|FG000|Overall Study|Withdrawal by Subject|0|||
23445134|NCT02292719|65370300|FG001|Overall Study|Withdrawal by Subject|0|||
23445135|NCT02292719|65370301|FG002|Overall Study|Withdrawal by Subject|0|||
23445136|NCT02292719|65370302|FG003|Overall Study|Withdrawal by Subject|1|||
23445137|NCT02292719|65370303|FG004|Overall Study|Withdrawal by Subject|1|||
23445138|NCT02292719|65370304|FG005|Overall Study|Withdrawal by Subject|0|||
23445139|NCT02292719|65370299|FG000|Overall Study|Subject enrolled in new study.|0|||
23445140|NCT02292719|65370300|FG001|Overall Study|Subject enrolled in new study.|0|||
23445141|NCT02292719|65370301|FG002|Overall Study|Subject enrolled in new study.|1|||
23445142|NCT02292719|65370302|FG003|Overall Study|Subject enrolled in new study.|0|||
23445143|NCT02292719|65370303|FG004|Overall Study|Subject enrolled in new study.|0|||
23445144|NCT02292719|65370304|FG005|Overall Study|Subject enrolled in new study.|0|||
23629051|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23629052|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
23222760|NCT03099304|64557808|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
23222761|NCT03099304|64557809|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
23222762|NCT03099304|64557810|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
23222763|NCT03099304|64557811|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
23222764|NCT03099304|64557806|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
23445145|NCT02640547|65370307|FG000|Overall Study|Failure to Return|1|||
23445146|NCT02640547|65370307|FG000|Overall Study|Withdrawal by Subject|1|||
23445147|NCT02640547|65370307|FG000|Overall Study|Death|6|||
23445148|NCT02640547|65370307|FG000|Overall Study|Miscellaneous|3|||
23445149|NCT01787461|65370308|FG000|Overall Study|Adverse Event|4|||
23445150|NCT01787461|65370309|FG001|Overall Study|Adverse Event|3|||
23445151|NCT01787461|65370308|FG000|Overall Study|Lost to Follow-up|3|||
23445152|NCT01787461|65370309|FG001|Overall Study|Lost to Follow-up|2|||
23445153|NCT01787461|65370308|FG000|Overall Study|No longer met eligibility criteria|1|||
23445154|NCT01787461|65370309|FG001|Overall Study|No longer met eligibility criteria|0|||
23445155|NCT01787461|65370308|FG000|Overall Study|Withdrawal by Subject|3|||
23445156|NCT01787461|65370309|FG001|Overall Study|Withdrawal by Subject|4|||
23222765|NCT03099304|64557807|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
23222766|NCT03099304|64557808|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
23222767|NCT03099304|64557809|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
23222768|NCT03099304|64557810|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
23222769|NCT03099304|64557811|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
23222770|NCT03099304|64557806|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
23222771|NCT03099304|64557807|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
23222772|NCT03099304|64557808|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
23445157|NCT01787461|65370308|FG000|Overall Study|Protocol Violation|3|||
23445158|NCT01787461|65370309|FG001|Overall Study|Protocol Violation|0|||
23445159|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
23445160|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445161|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445162|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445163|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445164|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23445165|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
23445166|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445167|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445168|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445169|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445170|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23445171|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
23445172|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445173|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445174|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445175|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445176|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23445177|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
23445178|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445179|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445180|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445181|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445182|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
23445183|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
23445184|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445185|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445186|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445187|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445188|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
23445189|NCT01053988|65370310|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
23445190|NCT01053988|65370311|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445191|NCT01053988|65370312|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445192|NCT01053988|65370313|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445193|NCT01053988|65370314|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445194|NCT01053988|65370315|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23445195|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
23445196|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
23445197|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
23445198|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
23445199|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
23445200|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
23453638|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
23159772|NCT01236573|64335023|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23159773|NCT01236573|64335024|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23159774|NCT01236573|64335025|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23159775|NCT01236573|64335026|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23159776|NCT01236573|64335027|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23159777|NCT01236573|64335028|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23159778|NCT01236573|64335029|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
23159779|NCT01236573|64335030|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23159780|NCT01236573|64335031|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
23159781|NCT01236573|64335032|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
23159782|NCT01236573|64335033|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
23159783|NCT01236573|64335023|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23159784|NCT01236573|64335024|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23159785|NCT01236573|64335025|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23159786|NCT01236573|64335026|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23159787|NCT01236573|64335027|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23445201|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23445202|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
23445203|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
23445204|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
23445205|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
23445206|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23445207|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
23445208|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
23445209|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
23445210|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
23445211|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
23629053|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
23159788|NCT01236573|64335028|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23159789|NCT01236573|64335029|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23159790|NCT01236573|64335030|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23445212|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
23445213|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23445214|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
23445215|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
23445216|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
23445217|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
23445218|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
23445219|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23445220|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
23445221|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
23445222|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
23329298|NCT03711786|64948533|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
23329299|NCT03711786|64948534|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
23329300|NCT03711786|64948533|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
23329301|NCT03711786|64948534|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
23329302|NCT03711786|64948533|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
23329303|NCT03711786|64948534|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
23445223|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
23445224|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
23445225|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23445226|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
23445227|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23445228|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
23445229|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23445230|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
23445231|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
23445232|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
23445233|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
23445234|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
23445235|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
23445236|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
23567531|NCT00284141|65807100|FG000|Overall Study|Adverse Event|19|||
23567532|NCT00284141|65807100|FG000|Overall Study|Participant's request|9|||
23567533|NCT00284141|65807100|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
23567534|NCT00284141|65807100|FG000|Overall Study|Clinical deterioration / death|2|||
23567535|NCT00284141|65807100|FG000|Overall Study|General decline|1|||
23567536|NCT00284141|65807100|FG000|Overall Study|Pneumonia|1|||
23567537|NCT00284141|65807100|FG000|Overall Study|Did not take study medication|2|||
23567538|NCT00284141|65807100|FG000|Overall Study|Ongoing treatment|2|||
23567539|NCT03556358|65807101|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
23159791|NCT01236573|64335031|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
23159792|NCT01236573|64335032|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23159793|NCT01236573|64335033|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
23159794|NCT01236573|64335023|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23159795|NCT01236573|64335024|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23445237|NCT01053988|65370310|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23445238|NCT01053988|65370311|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
23445239|NCT01053988|65370312|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23445240|NCT01053988|65370313|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
23445241|NCT01053988|65370314|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
23445242|NCT01053988|65370315|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23445243|NCT00193206|65370316|FG000|Preoperative Therapy|Lack of Efficacy|2|||
23445244|NCT00193206|65370316|FG000|Preoperative Therapy|Adverse Event|2|||
23445245|NCT00193206|65370316|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
23445246|NCT00193206|65370316|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
23445247|NCT00193206|65370316|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
23445248|NCT00193206|65370316|FG000|Postoperative Therapy|Physician Decision|3|||
23445249|NCT00193206|65370316|FG000|Postoperative Therapy|Intercurrent Illness|2|||
23445250|NCT00193206|65370316|FG000|Postoperative Therapy|Lack of Efficacy|1|||
23445251|NCT00193206|65370316|FG000|Postoperative Therapy|Protocol Violation|1|||
23445252|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Death|0|||
23445253|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Death|0|||
23445254|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Death|0|||
23445255|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Death|0|||
23445256|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Death|1|||
23445257|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Death|0|||
23445258|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Death|0|||
23445259|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Death|0|||
23445260|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
23445261|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
23445262|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
23445263|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
23445264|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
23445265|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
23445266|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
23445267|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
23445268|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
23445269|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445270|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445271|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
23445272|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445273|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
23445274|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445275|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
23445276|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
23445277|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
23445278|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
23445279|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
23445280|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
23445281|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
23445282|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
23445283|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
23445284|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
23445285|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
23445286|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
23445287|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
23445288|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
23445289|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
23445290|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
23445291|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
23445292|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
23445293|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
23445294|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
23445295|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
23445296|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
23445297|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
23445298|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
23445299|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
23445300|NCT00726232|65370317|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
23629054|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
23629055|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
23629056|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
23445301|NCT00726232|65370318|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445302|NCT00726232|65370319|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445303|NCT00726232|65370320|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445304|NCT00726232|65370321|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445305|NCT00726232|65370322|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445306|NCT00726232|65370323|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445307|NCT00726232|65370324|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
23445308|NCT00726232|65370317|FG000|Expansion Phase|Death|0|||
23445309|NCT00726232|65370318|FG001|Expansion Phase|Death|0|||
23445310|NCT00726232|65370319|FG002|Expansion Phase|Death|0|||
23445311|NCT00726232|65370320|FG003|Expansion Phase|Death|0|||
23445312|NCT00726232|65370321|FG004|Expansion Phase|Death|0|||
23445313|NCT00726232|65370322|FG005|Expansion Phase|Death|0|||
23445314|NCT00726232|65370323|FG006|Expansion Phase|Death|0|||
23445315|NCT00726232|65370324|FG007|Expansion Phase|Death|1|||
23445316|NCT00726232|65370317|FG000|Expansion Phase|Adverse Event|0|||
23445317|NCT00726232|65370318|FG001|Expansion Phase|Adverse Event|0|||
23445318|NCT00726232|65370319|FG002|Expansion Phase|Adverse Event|0|||
23445319|NCT00726232|65370320|FG003|Expansion Phase|Adverse Event|0|||
23445320|NCT00726232|65370321|FG004|Expansion Phase|Adverse Event|0|||
23445321|NCT00726232|65370322|FG005|Expansion Phase|Adverse Event|0|||
23445322|NCT00726232|65370323|FG006|Expansion Phase|Adverse Event|6|||
23445323|NCT00726232|65370324|FG007|Expansion Phase|Adverse Event|11|||
23445324|NCT00726232|65370317|FG000|Expansion Phase|Withdrawal by Subject|0|||
23445325|NCT00726232|65370318|FG001|Expansion Phase|Withdrawal by Subject|0|||
23445326|NCT00726232|65370319|FG002|Expansion Phase|Withdrawal by Subject|0|||
23445327|NCT00726232|65370320|FG003|Expansion Phase|Withdrawal by Subject|0|||
23445328|NCT00726232|65370321|FG004|Expansion Phase|Withdrawal by Subject|0|||
23445329|NCT00726232|65370322|FG005|Expansion Phase|Withdrawal by Subject|0|||
23445330|NCT00726232|65370323|FG006|Expansion Phase|Withdrawal by Subject|2|||
23445331|NCT00726232|65370324|FG007|Expansion Phase|Withdrawal by Subject|3|||
23445332|NCT00726232|65370317|FG000|Expansion Phase|Disease progression|0|||
23445333|NCT00726232|65370318|FG001|Expansion Phase|Disease progression|0|||
23445334|NCT00726232|65370319|FG002|Expansion Phase|Disease progression|0|||
23445335|NCT00726232|65370320|FG003|Expansion Phase|Disease progression|0|||
23445336|NCT00726232|65370321|FG004|Expansion Phase|Disease progression|0|||
23445337|NCT00726232|65370322|FG005|Expansion Phase|Disease progression|0|||
23445338|NCT00726232|65370323|FG006|Expansion Phase|Disease progression|4|||
23445339|NCT00726232|65370324|FG007|Expansion Phase|Disease progression|0|||
23445340|NCT00726232|65370317|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
23445341|NCT00726232|65370318|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
23445342|NCT00726232|65370319|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
23445343|NCT00726232|65370320|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
23445344|NCT00726232|65370321|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
23445345|NCT00726232|65370322|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
23445346|NCT00726232|65370323|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
23445347|NCT00726232|65370324|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
23445348|NCT00726232|65370317|FG000|Expansion Phase|Per Investigator: lack of response|0|||
23445349|NCT00726232|65370318|FG001|Expansion Phase|Per Investigator: lack of response|0|||
23445350|NCT00726232|65370319|FG002|Expansion Phase|Per Investigator: lack of response|0|||
23445351|NCT00726232|65370320|FG003|Expansion Phase|Per Investigator: lack of response|0|||
23445352|NCT00726232|65370321|FG004|Expansion Phase|Per Investigator: lack of response|0|||
23445353|NCT00726232|65370322|FG005|Expansion Phase|Per Investigator: lack of response|0|||
23445354|NCT00726232|65370323|FG006|Expansion Phase|Per Investigator: lack of response|1|||
23445355|NCT00726232|65370324|FG007|Expansion Phase|Per Investigator: lack of response|7|||
23445356|NCT00726232|65370317|FG000|Expansion Phase|Unspecified reason|0|||
23445357|NCT00726232|65370318|FG001|Expansion Phase|Unspecified reason|0|||
23445358|NCT00726232|65370319|FG002|Expansion Phase|Unspecified reason|0|||
23445359|NCT00726232|65370320|FG003|Expansion Phase|Unspecified reason|0|||
23445360|NCT00726232|65370321|FG004|Expansion Phase|Unspecified reason|0|||
23445361|NCT00726232|65370322|FG005|Expansion Phase|Unspecified reason|0|||
23445362|NCT00726232|65370323|FG006|Expansion Phase|Unspecified reason|1|||
23445363|NCT00726232|65370324|FG007|Expansion Phase|Unspecified reason|0|||
23445364|NCT03755882|65370325|FG000|Period 1|Protocol Violation|1|||
23445365|NCT03755882|65370326|FG001|Period 1|Protocol Violation|0|||
23445366|NCT03755882|65370325|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
23445367|NCT03755882|65370326|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
23445368|NCT01922271|65370327|FG000|WASHOUT Period|Withdrawal by Subject|1|||
23445369|NCT01922271|65370328|FG001|WASHOUT Period|Withdrawal by Subject|0|||
23445370|NCT00930553|65370334|FG000|Overall Study|Adverse Event|1|||
23445371|NCT00930553|65370334|FG000|Overall Study|Lack of Efficacy|7|||
23445372|NCT00930553|65370334|FG000|Overall Study|Physician Decision|39|||
23445373|NCT00930553|65370334|FG000|Overall Study|Protocol Violation|1|||
23445374|NCT00930553|65370334|FG000|Overall Study|Pregnancy|1|||
23445375|NCT00930553|65370334|FG000|Overall Study|Withdrawal by Subject|88|||
23445376|NCT00930553|65370334|FG000|Overall Study|Lost to Follow-up|25|||
23445377|NCT00930553|65370334|FG000|Overall Study|Death|9|||
23445378|NCT00930553|65370334|FG000|Overall Study|Study terminated by sponsor|24|||
23445379|NCT00930553|65370334|FG000|Overall Study|Other than specified above|28|||
23445380|NCT02128724|65370335|FG000|Overall Study|Death|1|||
23445381|NCT02128724|65370336|FG001|Overall Study|Death|0|||
23445382|NCT02128724|65370337|FG002|Overall Study|Death|0|||
23445383|NCT02128724|65370338|FG003|Overall Study|Death|0|||
23445384|NCT02128724|65370335|FG000|Overall Study|Adverse Event|0|||
23445385|NCT02128724|65370336|FG001|Overall Study|Adverse Event|1|||
23445386|NCT02128724|65370337|FG002|Overall Study|Adverse Event|0|||
23445387|NCT02128724|65370338|FG003|Overall Study|Adverse Event|0|||
23445388|NCT02128724|65370335|FG000|Overall Study|Physician Decision|0|||
23445389|NCT02128724|65370336|FG001|Overall Study|Physician Decision|0|||
23445390|NCT02128724|65370337|FG002|Overall Study|Physician Decision|0|||
23445391|NCT02128724|65370338|FG003|Overall Study|Physician Decision|2|||
23445392|NCT02128724|65370335|FG000|Overall Study|Withdrawal by Subject|0|||
23445393|NCT02128724|65370336|FG001|Overall Study|Withdrawal by Subject|0|||
23445394|NCT02128724|65370337|FG002|Overall Study|Withdrawal by Subject|0|||
23445395|NCT02128724|65370338|FG003|Overall Study|Withdrawal by Subject|1|||
23445396|NCT00699608|65370339|FG000|First Intervention|Withdrawal by Subject|0|||
23445397|NCT00699608|65370340|FG001|First Intervention|Withdrawal by Subject|0|||
23445398|NCT00699608|65370341|FG002|First Intervention|Withdrawal by Subject|1|||
23445399|NCT00699608|65370342|FG003|First Intervention|Withdrawal by Subject|0|||
23445400|NCT00699608|65370343|FG004|First Intervention|Withdrawal by Subject|0|||
23445401|NCT00699608|65370344|FG005|First Intervention|Withdrawal by Subject|0|||
23445402|NCT00699608|65370339|FG000|First Intervention|Protocol Violation|0|||
23445403|NCT00699608|65370340|FG001|First Intervention|Protocol Violation|0|||
23445404|NCT00699608|65370341|FG002|First Intervention|Protocol Violation|0|||
23445405|NCT00699608|65370342|FG003|First Intervention|Protocol Violation|0|||
23445406|NCT00699608|65370343|FG004|First Intervention|Protocol Violation|1|||
23445407|NCT00699608|65370344|FG005|First Intervention|Protocol Violation|0|||
23445408|NCT00699608|65370339|FG000|Second Intervention|Adverse Event|0|||
23445409|NCT00699608|65370340|FG001|Second Intervention|Adverse Event|0|||
23445410|NCT00699608|65370341|FG002|Second Intervention|Adverse Event|1|||
23445411|NCT00699608|65370342|FG003|Second Intervention|Adverse Event|0|||
23445412|NCT00699608|65370343|FG004|Second Intervention|Adverse Event|0|||
23445413|NCT00699608|65370344|FG005|Second Intervention|Adverse Event|0|||
23445414|NCT00699608|65370339|FG000|Second Intervention|Withdrawal by Subject|0|||
23629057|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
23629058|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
23629059|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
23629060|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
23629061|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
23445415|NCT00699608|65370340|FG001|Second Intervention|Withdrawal by Subject|0|||
23629062|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
23629063|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
23629064|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
23629065|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
23629066|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
23629067|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
23629068|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
23629069|NCT00943722|66028170|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629070|NCT00943722|66028171|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629071|NCT00943722|66028172|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629072|NCT00943722|66028173|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629073|NCT00943722|66028174|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
23629074|NCT00943722|66028175|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
23629075|NCT00943722|66028176|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
23629076|NCT01443923|66028177|FG000|Overall Study|Adverse Event|1|||
23629077|NCT01443923|66028178|FG001|Overall Study|Adverse Event|0|||
23629078|NCT00263211|66028179|FG000|Overall Study|Death|1|||
23629079|NCT00263211|66028180|FG001|Overall Study|Death|0|||
23629080|NCT00263211|66028179|FG000|Overall Study|Withdrawal by Subject|3|||
23629081|NCT00263211|66028180|FG001|Overall Study|Withdrawal by Subject|0|||
23629082|NCT00263211|66028179|FG000|Overall Study|Protocol Violation|1|||
23629083|NCT00263211|66028180|FG001|Overall Study|Protocol Violation|0|||
23445416|NCT00699608|65370341|FG002|Second Intervention|Withdrawal by Subject|0|||
23445417|NCT00699608|65370342|FG003|Second Intervention|Withdrawal by Subject|1|||
23445418|NCT00699608|65370343|FG004|Second Intervention|Withdrawal by Subject|0|||
23445419|NCT00699608|65370344|FG005|Second Intervention|Withdrawal by Subject|0|||
23445420|NCT02391363|65370345|FG000|Overall Study|Lost to Follow-up|5|||
23629084|NCT00263211|66028179|FG000|Overall Study|Disease Progression|0|||
23629085|NCT00263211|66028180|FG001|Overall Study|Disease Progression|1|||
23629086|NCT04936685|66028181|FG000|Overall Study|Protocol Violation|1|||
23629087|NCT04936685|66028182|FG001|Overall Study|Protocol Violation|0|||
23159796|NCT01236573|64335025|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23159797|NCT01236573|64335026|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23159798|NCT01236573|64335027|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23159799|NCT01236573|64335028|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23159800|NCT01236573|64335029|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23159801|NCT01236573|64335030|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23159802|NCT01236573|64335031|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23159803|NCT01236573|64335032|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
23159804|NCT01236573|64335033|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
23159805|NCT02603120|64335037|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
23159806|NCT02603120|64335038|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
23159807|NCT02603120|64335037|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
23159808|NCT02603120|64335038|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
23159809|NCT02603120|64335037|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
23159810|NCT02603120|64335038|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
23159811|NCT02603120|64335037|FG000|Double-Blind Treatment Phase|Death|2|||
23445421|NCT02391363|65370346|FG001|Overall Study|Lost to Follow-up|5|||
23445422|NCT02391363|65370345|FG000|Overall Study|Withdrawal by Subject|6|||
23445423|NCT02391363|65370346|FG001|Overall Study|Withdrawal by Subject|3|||
23445424|NCT03018691|65370347|FG000|Overall Study|Adverse Event|1|||
23445425|NCT03018691|65370348|FG001|Overall Study|Adverse Event|1|||
23445426|NCT03018691|65370349|FG002|Overall Study|Adverse Event|4|||
23445427|NCT03018691|65370347|FG000|Overall Study|Lack of Efficacy|0|||
23445428|NCT03018691|65370348|FG001|Overall Study|Lack of Efficacy|0|||
23445429|NCT03018691|65370349|FG002|Overall Study|Lack of Efficacy|1|||
23445430|NCT03018691|65370347|FG000|Overall Study|Withdrawal by Subject|0|||
23445431|NCT03018691|65370348|FG001|Overall Study|Withdrawal by Subject|0|||
23445432|NCT03018691|65370349|FG002|Overall Study|Withdrawal by Subject|1|||
23445433|NCT03018691|65370347|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23445434|NCT03018691|65370348|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23445435|NCT03018691|65370349|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23445436|NCT00786799|65370351|FG000|Overall Study|Lost to Follow-up|1|||
23445437|NCT00786799|65370352|FG001|Overall Study|Lost to Follow-up|1|||
23445438|NCT03089580|65370353|FG000|Overall Study|Lost to Follow-up|2|||
23445439|NCT03354273|65370356|FG000|Overall Study|Adverse Event|5|||
23445440|NCT03354273|65370356|FG000|Overall Study|Screen Failure|21|||
23445441|NCT03354273|65370356|FG000|Overall Study|Withdrawal by Subject|34|||
23445442|NCT03354273|65370356|FG000|Overall Study|Technical Problems|30|||
23445443|NCT03354273|65370356|FG000|Overall Study|Lost to Follow-up|4|||
23445444|NCT03354273|65370356|FG000|Overall Study|Investigator Decision|3|||
23445445|NCT03354273|65370356|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
23445446|NCT03354273|65370356|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
23445447|NCT03354273|65370356|FG000|Overall Study|COVID-19 Restrictions|9|||
23445448|NCT03354273|65370356|FG000|Overall Study|Other|5|||
23445449|NCT03495102|65370357|FG000|Overall Study|Adverse Event|5|||
23445450|NCT03495102|65370358|FG001|Overall Study|Adverse Event|7|||
23445451|NCT03495102|65370359|FG002|Overall Study|Adverse Event|10|||
23445452|NCT03495102|65370357|FG000|Overall Study|Death|3|||
23445453|NCT03495102|65370358|FG001|Overall Study|Death|4|||
23445454|NCT03495102|65370359|FG002|Overall Study|Death|4|||
23445455|NCT03495102|65370357|FG000|Overall Study|Lost to Follow-up|15|||
23445456|NCT03495102|65370358|FG001|Overall Study|Lost to Follow-up|16|||
23445457|NCT03495102|65370359|FG002|Overall Study|Lost to Follow-up|17|||
23445458|NCT03495102|65370357|FG000|Overall Study|Physician Decision|2|||
23445459|NCT03495102|65370358|FG001|Overall Study|Physician Decision|0|||
23445460|NCT03495102|65370359|FG002|Overall Study|Physician Decision|2|||
23445461|NCT03495102|65370357|FG000|Overall Study|Withdrawal by Subject|25|||
23445462|NCT03495102|65370358|FG001|Overall Study|Withdrawal by Subject|36|||
23445463|NCT03495102|65370359|FG002|Overall Study|Withdrawal by Subject|18|||
23445464|NCT03495102|65370357|FG000|Overall Study|Protocol Violation|1|||
23445465|NCT03495102|65370358|FG001|Overall Study|Protocol Violation|1|||
23445466|NCT03495102|65370359|FG002|Overall Study|Protocol Violation|0|||
23445467|NCT03495102|65370357|FG000|Overall Study|Site Closure|3|||
23445468|NCT03495102|65370358|FG001|Overall Study|Site Closure|1|||
23445469|NCT03495102|65370359|FG002|Overall Study|Site Closure|2|||
23445470|NCT03495102|65370357|FG000|Overall Study|Non-compliance|1|||
23445471|NCT03495102|65370358|FG001|Overall Study|Non-compliance|0|||
23445472|NCT03495102|65370359|FG002|Overall Study|Non-compliance|0|||
23445473|NCT03495102|65370357|FG000|Overall Study|Participant Duplicated at Another Site|0|||
23445474|NCT03495102|65370358|FG001|Overall Study|Participant Duplicated at Another Site|0|||
23445475|NCT03495102|65370359|FG002|Overall Study|Participant Duplicated at Another Site|1|||
23567540|NCT03556358|65807102|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
23445476|NCT03495102|65370357|FG000|Overall Study|Primary Care Physician Recommendation|0|||
23445477|NCT03495102|65370358|FG001|Overall Study|Primary Care Physician Recommendation|1|||
23159812|NCT02603120|64335038|FG001|Double-Blind Treatment Phase|Death|0|||
23445478|NCT03495102|65370359|FG002|Overall Study|Primary Care Physician Recommendation|0|||
23445479|NCT03495102|65370357|FG000|Overall Study|Relocated to Another Country|0|||
23445480|NCT03495102|65370358|FG001|Overall Study|Relocated to Another Country|1|||
23445481|NCT03495102|65370359|FG002|Overall Study|Relocated to Another Country|0|||
23445482|NCT03495102|65370357|FG000|Overall Study|Participant was in Rehabilitation|1|||
23445483|NCT03495102|65370358|FG001|Overall Study|Participant was in Rehabilitation|0|||
23445484|NCT03495102|65370359|FG002|Overall Study|Participant was in Rehabilitation|0|||
23445485|NCT02073682|65370360|FG000|Overall Study|Low Creatinine Clearance|1|||
23445486|NCT02073682|65370361|FG001|Overall Study|Low Creatinine Clearance|2|||
23445487|NCT02073682|65370360|FG000|Overall Study|Death|86|||
23445488|NCT02073682|65370361|FG001|Overall Study|Death|100|||
23445489|NCT02073682|65370360|FG000|Overall Study|Cancer Cured|10|||
23445490|NCT02073682|65370361|FG001|Overall Study|Cancer Cured|15|||
23445491|NCT02073682|65370360|FG000|Overall Study|ID: Patient Noncompliance|1|||
23445492|NCT02073682|65370361|FG001|Overall Study|ID: Patient Noncompliance|2|||
23445493|NCT02073682|65370360|FG000|Overall Study|ID: Palliative Treatment Only|10|||
23445494|NCT02073682|65370361|FG001|Overall Study|ID: Palliative Treatment Only|7|||
23445495|NCT02073682|65370360|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
23445496|NCT02073682|65370361|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
23445497|NCT02073682|65370360|FG000|Overall Study|Platelet Count <50,000/mL|1|||
23159813|NCT02603120|64335037|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
23159814|NCT02603120|64335038|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
23445498|NCT02073682|65370361|FG001|Overall Study|Platelet Count <50,000/mL|2|||
23445499|NCT02073682|65370360|FG000|Overall Study|Surgery/Medical Procedure|3|||
23445500|NCT02073682|65370361|FG001|Overall Study|Surgery/Medical Procedure|1|||
23445501|NCT02073682|65370360|FG000|Overall Study|Withdrawal by Subject|6|||
23445502|NCT02073682|65370361|FG001|Overall Study|Withdrawal by Subject|8|||
23445503|NCT02073682|65370360|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
23445504|NCT02073682|65370361|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
23445505|NCT02073682|65370360|FG000|Overall Study|Cancer Progression|53|||
23445506|NCT02073682|65370361|FG001|Overall Study|Cancer Progression|33|||
23445507|NCT02073682|65370360|FG000|Overall Study|Protocol Violation|1|||
23445508|NCT02073682|65370361|FG001|Overall Study|Protocol Violation|0|||
23445509|NCT02073682|65370360|FG000|Overall Study|Adverse Event|79|||
23445510|NCT02073682|65370361|FG001|Overall Study|Adverse Event|62|||
23445511|NCT02073682|65370360|FG000|Overall Study|No reason provided|11|||
23445512|NCT02073682|65370361|FG001|Overall Study|No reason provided|9|||
23445513|NCT02073682|65370360|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
23445514|NCT02073682|65370361|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
23445515|NCT02073682|65370360|FG000|Overall Study|Lost to Follow-up|1|||
23445516|NCT02073682|65370361|FG001|Overall Study|Lost to Follow-up|1|||
23445517|NCT02073682|65370360|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
23445518|NCT02073682|65370361|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
23445519|NCT01369784|65370362|FG000|Overall Study|Protocol Violation|12|||
23445520|NCT01359904|65370363|FG000|Overall Study|Withdrawal by Subject|1|||
23445521|NCT01359904|65370364|FG001|Overall Study|Withdrawal by Subject|0|||
23445522|NCT00413036|65370365|FG000|Overall Study|Adverse Event|44|||
23445523|NCT00413036|65370365|FG000|Overall Study|Lack of Efficacy|129|||
23445524|NCT00413036|65370365|FG000|Overall Study|Withdrawal by Subject|7|||
23445525|NCT00413036|65370365|FG000|Overall Study|Death|9|||
23445526|NCT00413036|65370365|FG000|Overall Study|Other|26|||
23445527|NCT00413036|65370365|FG000|Overall Study|Missing|2|||
23445528|NCT00577824|65370366|FG000|Overall Study|Adverse Event|6|||
23445529|NCT00577824|65370367|FG001|Overall Study|Adverse Event|18|||
23445530|NCT00577824|65370368|FG002|Overall Study|Adverse Event|1|||
23445531|NCT00577824|65370366|FG000|Overall Study|Patient decision|0|||
23445532|NCT00577824|65370367|FG001|Overall Study|Patient decision|1|||
23445533|NCT00577824|65370368|FG002|Overall Study|Patient decision|1|||
23445534|NCT00577824|65370366|FG000|Overall Study|Protocol Violation|1|||
23445535|NCT00577824|65370367|FG001|Overall Study|Protocol Violation|1|||
23445536|NCT00577824|65370368|FG002|Overall Study|Protocol Violation|0|||
23445537|NCT01487265|65370369|FG000|Overall Study|Adverse Event|8|||
23445538|NCT01487265|65370369|FG000|Overall Study|Withdrawal by Subject|5|||
23445539|NCT01487265|65370369|FG000|Overall Study|Disease Progression|21|||
23159815|NCT02603120|64335037|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
23445540|NCT01487265|65370369|FG000|Overall Study|Death|2|||
23445541|NCT01487265|65370369|FG000|Overall Study|Still on Treatment|1|||
23445542|NCT01442714|65370370|FG000|Overall Study|Death|11|||
23445543|NCT01442714|65370370|FG000|Overall Study|Withdrawal by Subject|1|||
23445544|NCT03801174|65373663|FG000|Overall Study|Withdrawal by Subject|14|||
23445545|NCT03801174|65373664|FG001|Overall Study|Withdrawal by Subject|15|||
23445546|NCT03801174|65373663|FG000|Overall Study|Death|1|||
23159816|NCT02603120|64335038|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
23445547|NCT03801174|65373664|FG001|Overall Study|Death|0|||
23445548|NCT03801174|65373663|FG000|Overall Study|Pregnancy|2|||
23445549|NCT03801174|65373664|FG001|Overall Study|Pregnancy|2|||
23445550|NCT03801174|65373663|FG000|Overall Study|Lost to Follow-up|19|||
23445551|NCT03801174|65373664|FG001|Overall Study|Lost to Follow-up|10|||
23445552|NCT03801174|65373663|FG000|Overall Study|Other|4|||
23445553|NCT03801174|65373664|FG001|Overall Study|Other|3|||
23445554|NCT03801174|65373663|FG000|Overall Study|Lack of Efficacy|4|||
23445555|NCT03801174|65373664|FG001|Overall Study|Lack of Efficacy|0|||
23445556|NCT03801174|65373663|FG000|Overall Study|Unwilling to complete activities|5|||
23445557|NCT03801174|65373664|FG001|Overall Study|Unwilling to complete activities|6|||
23445558|NCT03801174|65373663|FG000|Overall Study|Moved out of area|3|||
23445559|NCT03801174|65373664|FG001|Overall Study|Moved out of area|0|||
23445560|NCT01128244|65373665|FG000|Overall Study|Adverse Event|1|||
23445561|NCT01128244|65373665|FG000|Overall Study|Scheduling conflict|2|||
23445562|NCT01272635|65373667|FG000|Overall Study|Lost to Follow-up|31|||
23445563|NCT01272635|65373668|FG001|Overall Study|Lost to Follow-up|20|||
23445564|NCT01272635|65373669|FG002|Overall Study|Lost to Follow-up|31|||
23445565|NCT01272635|65373670|FG003|Overall Study|Lost to Follow-up|23|||
23445566|NCT00806988|65373674|FG000|Overall Study|Death|15|||
23445567|NCT00806988|65373675|FG001|Overall Study|Death|16|||
23445568|NCT00806988|65373674|FG000|Overall Study|Withdrawal by Subject|8|||
23445569|NCT00806988|65373675|FG001|Overall Study|Withdrawal by Subject|8|||
23445570|NCT00806988|65373674|FG000|Overall Study|Lost to Follow-up|4|||
23445571|NCT00806988|65373675|FG001|Overall Study|Lost to Follow-up|19|||
23445572|NCT01685697|65373678|FG000|Overall Study|Protocol Violation|3|||
23445573|NCT01685697|65373679|FG001|Overall Study|Protocol Violation|3|||
23445574|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
23445575|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
23445576|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
23445577|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
23445578|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
23445579|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
23445580|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
23445581|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
23445582|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
23445583|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
23445584|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
23445585|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
23445586|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
23445587|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
23445588|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
23445589|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
23445590|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
23445591|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
23445592|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
23445593|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
23629088|NCT01639742|66028183|FG000|Overall Study|Study Ongoing|17|||
23629089|NCT01639742|66028183|FG000|Overall Study|Lost to Follow-up|1|||
23629090|NCT02165826|66028187|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
23629091|NCT02165826|66028188|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
23629092|NCT02165826|66028189|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
23629093|NCT02165826|66028187|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
23629094|NCT02165826|66028188|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
23629095|NCT02165826|66028189|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
23629096|NCT02165826|66028187|FG000|Main Treatment Period|Lost to Follow-up|4|||
23629097|NCT02165826|66028188|FG001|Main Treatment Period|Lost to Follow-up|2|||
23629098|NCT02165826|66028189|FG002|Main Treatment Period|Lost to Follow-up|1|||
23629099|NCT02165826|66028187|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
23629100|NCT02165826|66028188|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
23629101|NCT02165826|66028189|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
23629102|NCT02165826|66028187|FG000|Main Treatment Period|Lack of Efficacy|2|||
23629103|NCT02165826|66028188|FG001|Main Treatment Period|Lack of Efficacy|0|||
23629104|NCT02165826|66028189|FG002|Main Treatment Period|Lack of Efficacy|0|||
23629105|NCT02165826|66028187|FG000|Main Treatment Period|Reason Not Specified|8|||
23629106|NCT02165826|66028188|FG001|Main Treatment Period|Reason Not Specified|5|||
23629107|NCT02165826|66028189|FG002|Main Treatment Period|Reason Not Specified|16|||
23629108|NCT02165826|66028187|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
23445594|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
23445595|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
23159817|NCT02603120|64335037|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
23445596|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
23445597|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
23445598|NCT03777059|65373683|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
23445599|NCT03777059|65373684|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
23629109|NCT02165826|66028188|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
23629110|NCT02165826|66028189|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
23629111|NCT02165826|66028187|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
23629112|NCT02165826|66028188|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
23629113|NCT02165826|66028189|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
23629114|NCT02165826|66028187|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
23629115|NCT02165826|66028188|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
23629116|NCT02165826|66028189|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
23629117|NCT02165826|66028187|FG000|Down-Titration Period|Reason Not Specified|1|||
23629118|NCT02165826|66028188|FG001|Down-Titration Period|Reason Not Specified|0|||
23629119|NCT02165826|66028189|FG002|Down-Titration Period|Reason Not Specified|2|||
23629120|NCT02763215|66028190|FG000|Overall Study|Participants withdrew from study|3|||
23629121|NCT02763215|66028190|FG000|Overall Study|Missed visit|1|||
23629122|NCT02763215|66028190|FG000|Overall Study|Visit outside visit-window|1|||
23629123|NCT02763215|66028190|FG000|Overall Study|Death|1|||
23629124|NCT02763215|66028190|FG000|Overall Study|Lost to Follow-up|1|||
23629125|NCT03865953|66028191|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
23222773|NCT03099304|64557809|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
23222774|NCT03099304|64557810|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
23222775|NCT03099304|64557811|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
23222776|NCT03099304|64557806|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
23629126|NCT03865953|66028192|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
23629127|NCT03865953|66028191|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
23445600|NCT03777059|65373685|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
23445601|NCT03777059|65373686|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
23567541|NCT03556358|65807101|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
23629128|NCT03865953|66028192|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
23629129|NCT03865953|66028191|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
23629130|NCT03865953|66028192|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
23629131|NCT00356811|66028193|FG000|Overall Study|Death|35|||
23629132|NCT00356811|66028193|FG000|Overall Study|Lost to Follow-up|2|||
23629133|NCT00356811|66028193|FG000|Overall Study|Withdrawal by Subject|6|||
23159818|NCT02603120|64335038|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
23159819|NCT02603120|64335037|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
23159820|NCT02603120|64335038|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
23159821|NCT02603120|64335037|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
23159822|NCT02603120|64335038|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
23159823|NCT02603120|64335037|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
23222777|NCT03099304|64557807|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
23222778|NCT03099304|64557808|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
23222779|NCT03099304|64557809|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
23445602|NCT03777059|65373683|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
23567542|NCT03556358|65807102|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
23567543|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
23567544|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
23567545|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
23567546|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
23567547|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
23567548|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
23567549|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
23567550|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
23567551|NCT03556358|65807101|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
23567552|NCT03556358|65807102|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
23567553|NCT02500979|65807109|FG000|Period 1|Hyperglycemia|1|||
23567554|NCT02500979|65807110|FG001|Period 1|Hyperglycemia|0|||
23567555|NCT02500979|65807109|FG000|Period 1|Severe non-compliance to protocol|0|||
23567556|NCT02500979|65807110|FG001|Period 1|Severe non-compliance to protocol|1|||
23567557|NCT02500979|65807109|FG000|Period 1|Adverse Event|1|||
23567558|NCT02500979|65807110|FG001|Period 1|Adverse Event|0|||
23567559|NCT02500979|65807109|FG000|Period 1|Subject decision|2|||
23567560|NCT02500979|65807110|FG001|Period 1|Subject decision|0|||
23567561|NCT02500979|65807109|FG000|Period 2|Change in risk|1|||
23567562|NCT02500979|65807110|FG001|Period 2|Change in risk|0|||
23567563|NCT03086018|65807111|FG000|Final Testing for End of Trial|Adverse Event|1|||
23567564|NCT03086018|65807111|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
23629134|NCT00356811|66028193|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
23629135|NCT00356811|66028193|FG000|Overall Study|Study Is Terminating|3|||
23629136|NCT00356811|66028193|FG000|Overall Study|Site Closed during Follow-up|2|||
23629137|NCT01986114|66028194|FG000|Overall Study|Adverse Event|59|||
23629138|NCT01986114|66028194|FG000|Overall Study|Lack of Efficacy|23|||
23629139|NCT01986114|66028194|FG000|Overall Study|Withdrawal by Subject|58|||
23629140|NCT01986114|66028194|FG000|Overall Study|Noncompliance|3|||
23629141|NCT01986114|66028194|FG000|Overall Study|Protocol Violation|1|||
23629142|NCT01986114|66028194|FG000|Overall Study|Lost to Follow-up|5|||
23629143|NCT01986114|66028194|FG000|Overall Study|Other reason|7|||
23629144|NCT01163474|66028196|FG000|Overall Study|Withdrawal by Subject|1|||
23629145|NCT01163474|66028196|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
23629146|NCT01163474|66028196|FG000|Overall Study|Lost to Follow-up|3|||
23629147|NCT01304498|66028198|FG000|Overall Study|Adverse Event|1|||
23629148|NCT01304498|66028199|FG001|Overall Study|Adverse Event|1|||
23629149|NCT01304498|66028198|FG000|Overall Study|Withdrawal by Subject|2|||
23629150|NCT01304498|66028199|FG001|Overall Study|Withdrawal by Subject|3|||
23629151|NCT01304498|66028198|FG000|Overall Study|Protocol Violation|1|||
23629152|NCT01304498|66028199|FG001|Overall Study|Protocol Violation|0|||
23629153|NCT01304498|66028198|FG000|Overall Study|Lost to Follow-up|2|||
23629154|NCT01304498|66028199|FG001|Overall Study|Lost to Follow-up|1|||
23629155|NCT04292470|66028202|FG000|Overall Study|Withdrawal by Subject|0|||
23629156|NCT04292470|66028203|FG001|Overall Study|Withdrawal by Subject|1|||
23629157|NCT02595372|66028204|FG000|Overall Study|Adverse Event|6|||
23629158|NCT02595372|66028204|FG000|Overall Study|Physician Decision|2|||
23629159|NCT02595372|66028204|FG000|Overall Study|Disease Progression|1|||
23629160|NCT00694109|66028205|FG000|Overall Study|Physician Decision|3|||
23629161|NCT00694109|66028205|FG000|Overall Study|Adverse Event|74|||
23629162|NCT00694109|66028205|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
23629163|NCT00694109|66028205|FG000|Overall Study|Lack of Efficacy|2|||
23629164|NCT00694109|66028205|FG000|Overall Study|Withdrawal by Subject|13|||
23629165|NCT00694109|66028205|FG000|Overall Study|Pregnancy|1|||
23629166|NCT00694109|66028205|FG000|Overall Study|Enrolled but not treated|1|||
23629167|NCT00694109|66028205|FG000|Overall Study|Other|2|||
23629168|NCT00694109|66028205|FG000|Overall Study|Consented but no additional treatment|3|||
23629169|NCT00844597|66028208|FG000|Overall Study|Adverse Event|0|||
23629170|NCT00844597|66028209|FG001|Overall Study|Adverse Event|0|||
23629171|NCT00844597|66028210|FG002|Overall Study|Adverse Event|0|||
23629172|NCT00844597|66028211|FG003|Overall Study|Adverse Event|1|||
23629173|NCT00844597|66028212|FG004|Overall Study|Adverse Event|0|||
23629174|NCT00844597|66028213|FG005|Overall Study|Adverse Event|0|||
23445603|NCT03777059|65373684|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
23445604|NCT03777059|65373685|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
23445605|NCT03777059|65373686|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
23445606|NCT03777059|65373683|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
23445607|NCT03777059|65373684|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
23159824|NCT02603120|64335038|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
23159825|NCT02603120|64335037|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
23159826|NCT02603120|64335038|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
23159827|NCT02603120|64335037|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
23159828|NCT02603120|64335038|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
23159829|NCT02603120|64335037|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
23159830|NCT02603120|64335038|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
23159831|NCT02603120|64335037|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
23159832|NCT02603120|64335038|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
23159833|NCT01877187|64335039|FG000|Overall Study|Death|2|||
23159834|NCT01877187|64335039|FG000|Overall Study|Withdrawal by Subject|4|||
23159835|NCT01877187|64335039|FG000|Overall Study|Lost to Follow-up|3|||
23159836|NCT01877187|64335039|FG000|Overall Study|Declining clinical status|11|||
23159837|NCT01877187|64335039|FG000|Overall Study|Liver transplant|2|||
23159838|NCT01199042|64335043|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
23159839|NCT01199042|64335043|FG000|At Home (3 Months)|Lost to Follow-up|1|||
23159840|NCT04770389|64335045|FG000|Overall Study|Adverse Event|1|||
23159841|NCT04770389|64335046|FG001|Overall Study|Adverse Event|2|||
23159842|NCT04770389|64335047|FG002|Overall Study|Adverse Event|0|||
23159843|NCT04770389|64335048|FG003|Overall Study|Adverse Event|1|||
23159844|NCT04770389|64335045|FG000|Overall Study|Withdrawal by Subject|0|||
23159845|NCT04770389|64335046|FG001|Overall Study|Withdrawal by Subject|2|||
23159846|NCT04770389|64335047|FG002|Overall Study|Withdrawal by Subject|1|||
23159847|NCT04770389|64335048|FG003|Overall Study|Withdrawal by Subject|0|||
23159848|NCT04770389|64335045|FG000|Overall Study|Failed attempt to draw blood|1|||
23629175|NCT02844777|66028214|FG000|Overall Study|Withdrawal by Subject|2|||
23629176|NCT02844777|66028215|FG001|Overall Study|Withdrawal by Subject|0|||
23629177|NCT02844777|66028216|FG002|Overall Study|Withdrawal by Subject|0|||
23629178|NCT00884650|66028222|FG000|Overall Study|Did not return complete pain diaries|7|||
23629179|NCT00884650|66028223|FG001|Overall Study|Did not return complete pain diaries|7|||
23629180|NCT00884650|66028222|FG000|Overall Study|Admitted Post-Op|1|||
23629181|NCT00884650|66028223|FG001|Overall Study|Admitted Post-Op|0|||
23329304|NCT01367886|64948539|FG000|Overall Study|Lost to Follow-up|4|||
23329305|NCT01367886|64948539|FG000|Overall Study|Lack of Efficacy|2|||
23329306|NCT01367886|64948539|FG000|Overall Study|Death|1|||
23329307|NCT02268916|64948542|FG000|Overall Study|Lost to Follow-up|1|||
23629182|NCT00884650|66028222|FG000|Overall Study|Femoral Stress Fracture|1|||
23629183|NCT00884650|66028223|FG001|Overall Study|Femoral Stress Fracture|0|||
23629184|NCT00884650|66028222|FG000|Overall Study|Pain Pump Complication|0|||
23629185|NCT00884650|66028223|FG001|Overall Study|Pain Pump Complication|1|||
23629186|NCT00504075|66028224|FG000|Overall Study|Adverse Event|1|||
23629187|NCT00504075|66028224|FG000|Overall Study|Lost to Follow-up|5|||
23629188|NCT00504075|66028224|FG000|Overall Study|Withdrawal by Subject|1|||
23629189|NCT00504075|66028224|FG000|Overall Study|Required other therapeutic intervention|1|||
23629190|NCT02567708|66028225|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
23629191|NCT02567708|66028226|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
23629192|NCT02567708|66028225|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
23629193|NCT02567708|66028226|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
23629194|NCT02567708|66028225|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
23629195|NCT02567708|66028226|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
23629196|NCT02567708|66028225|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
23629197|NCT02567708|66028226|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
23629198|NCT02593123|66028240|FG000|Overall Study|Physician Decision|2|||
23629199|NCT02593123|66028241|FG001|Overall Study|Physician Decision|1|||
23629200|NCT02593123|66028240|FG000|Overall Study|Relapse|1|||
23629201|NCT02593123|66028241|FG001|Overall Study|Relapse|1|||
23629202|NCT01821937|66028242|FG000|Overall Study|Adverse Event|0|||
23629203|NCT01821937|66028243|FG001|Overall Study|Adverse Event|3|||
23629204|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
23629205|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
23629206|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
23629207|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
23629208|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
23629209|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
23629210|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
23629211|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
23629212|NCT00781937|66028244|FG000|Main Trial Period Through Week 56|Unclassified|10|||
23629213|NCT00781937|66028245|FG001|Main Trial Period Through Week 56|Unclassified|15|||
23629214|NCT00781937|66028244|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
23629215|NCT00781937|66028245|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
23629216|NCT00781937|66028244|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
23629217|NCT00781937|66028245|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
23629218|NCT00250432|66028246|FG000|Overall Study|Adverse Event|25|||
23629219|NCT00250432|66028247|FG001|Overall Study|Adverse Event|29|||
23629220|NCT00250432|66028246|FG000|Overall Study|Lack of Efficacy|2|||
23629221|NCT00250432|66028247|FG001|Overall Study|Lack of Efficacy|1|||
23629222|NCT00250432|66028246|FG000|Overall Study|Lost to Follow-up|6|||
23629223|NCT00250432|66028247|FG001|Overall Study|Lost to Follow-up|5|||
23629224|NCT00250432|66028246|FG000|Overall Study|Patient Moved|0|||
23629225|NCT00250432|66028247|FG001|Overall Study|Patient Moved|1|||
23629226|NCT00250432|66028246|FG000|Overall Study|Protocol Violation|0|||
23629227|NCT00250432|66028247|FG001|Overall Study|Protocol Violation|3|||
23629228|NCT00250432|66028246|FG000|Overall Study|Withdrawal by Subject|6|||
23629229|NCT00250432|66028247|FG001|Overall Study|Withdrawal by Subject|2|||
23629230|NCT00250432|66028246|FG000|Overall Study|Pt died out of posttherapy report period|6|||
23629231|NCT00250432|66028247|FG001|Overall Study|Pt died out of posttherapy report period|5|||
23629232|NCT00250432|66028246|FG000|Overall Study|Pt was considered untreatable|0|||
23629233|NCT00250432|66028247|FG001|Overall Study|Pt was considered untreatable|1|||
23629234|NCT02229578|66028251|FG000|Overall Study|Withdrawal by Subject|1|||
23629235|NCT02229578|66028252|FG001|Overall Study|Withdrawal by Subject|3|||
23629236|NCT02229578|66028251|FG000|Overall Study|Protocol Violation|2|||
23629237|NCT02229578|66028252|FG001|Overall Study|Protocol Violation|0|||
23629238|NCT02563548|66028253|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
23629239|NCT02563548|66028254|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
23629240|NCT02563548|66028255|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
23629241|NCT02563548|66028256|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
23159849|NCT04770389|64335046|FG001|Overall Study|Failed attempt to draw blood|0|||
23159850|NCT04770389|64335047|FG002|Overall Study|Failed attempt to draw blood|0|||
23159851|NCT04770389|64335048|FG003|Overall Study|Failed attempt to draw blood|0|||
23159852|NCT04770389|64335045|FG000|Overall Study|Left the country|0|||
23159853|NCT04770389|64335046|FG001|Overall Study|Left the country|0|||
23159854|NCT04770389|64335047|FG002|Overall Study|Left the country|1|||
23159855|NCT04770389|64335048|FG003|Overall Study|Left the country|2|||
23159856|NCT04770389|64335045|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
23629242|NCT02563548|66028257|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
23629243|NCT02563548|66028258|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
23629244|NCT02563548|66028253|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
23629245|NCT02563548|66028254|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
23629246|NCT02563548|66028255|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
23629247|NCT02563548|66028256|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
23629248|NCT02563548|66028257|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
23629249|NCT02563548|66028258|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
23629250|NCT02563548|66028253|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629251|NCT02563548|66028254|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629252|NCT02563548|66028255|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
23629253|NCT02563548|66028256|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629254|NCT02563548|66028257|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629255|NCT02563548|66028258|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
23629256|NCT02563548|66028253|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
23629257|NCT02563548|66028254|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
23629258|NCT02563548|66028255|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
23629259|NCT02563548|66028256|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
23629260|NCT02563548|66028257|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
23629261|NCT02563548|66028258|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
23629262|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
23629263|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
23629264|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
23159857|NCT04770389|64335046|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
23567565|NCT01960790|65807116|FG000|Overall Study|Survey forms could not be recovered|3|||
23567566|NCT01960790|65807116|FG000|Overall Study|Treat with Humira outside survey period|3|||
23567567|NCT01960790|65807116|FG000|Overall Study|Transferred to another hospital|4|||
23567568|NCT01960790|65807116|FG000|Overall Study|Unevaluable for safety|1|||
23567569|NCT02917941|65807117|FG000|Treatment Period|Adverse Event|11|||
23567570|NCT02917941|65807117|FG000|Treatment Period|Progressive Disease|11|||
23567571|NCT02917941|65807117|FG000|Treatment Period|Reason not Specified|2|||
23567572|NCT02917941|65807117|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
23567573|NCT02917941|65807117|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
23567574|NCT02959671|65807119|FG000|Overall Study|Adverse Event|2|||
23567575|NCT02959671|65807119|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
23567576|NCT00951509|65807120|FG000|Overall Study|Withdrawal by Subject|2|||
23567577|NCT03485911|65807123|FG000|Part 1|Perceived lack of efficacy|1|||
23567578|NCT03485911|65807124|FG001|Part 1|Perceived lack of efficacy|1|||
23567579|NCT03485911|65807125|FG002|Part 1|Perceived lack of efficacy|2|||
23567580|NCT03485911|65807126|FG003|Part 1|Perceived lack of efficacy|0|||
23567581|NCT03485911|65807123|FG000|Part 1|Subject withdrew consent|0|||
23567582|NCT03485911|65807124|FG001|Part 1|Subject withdrew consent|1|||
23567583|NCT03485911|65807125|FG002|Part 1|Subject withdrew consent|0|||
23567584|NCT03485911|65807126|FG003|Part 1|Subject withdrew consent|1|||
23567585|NCT03485911|65807123|FG000|Part 1|Lab abnormalities/AEs|3|||
23567586|NCT03485911|65807124|FG001|Part 1|Lab abnormalities/AEs|1|||
23567587|NCT03485911|65807125|FG002|Part 1|Lab abnormalities/AEs|1|||
23567588|NCT03485911|65807126|FG003|Part 1|Lab abnormalities/AEs|0|||
23567589|NCT03485911|65807123|FG000|Part 1|Withdrew Consent prior to dosing|0|||
23567590|NCT03485911|65807124|FG001|Part 1|Withdrew Consent prior to dosing|0|||
23567591|NCT03485911|65807125|FG002|Part 1|Withdrew Consent prior to dosing|0|||
23567592|NCT03485911|65807126|FG003|Part 1|Withdrew Consent prior to dosing|1|||
23567593|NCT03485911|65807123|FG000|Part 1|Other NOS|0|||
23567594|NCT03485911|65807124|FG001|Part 1|Other NOS|0|||
23567595|NCT03485911|65807125|FG002|Part 1|Other NOS|0|||
23567596|NCT03485911|65807126|FG003|Part 1|Other NOS|1|||
23629265|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
23159858|NCT04770389|64335047|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
23159859|NCT04770389|64335048|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
23159860|NCT04770389|64335045|FG000|Overall Study|Lost to Follow-up|0|||
23159861|NCT04770389|64335046|FG001|Overall Study|Lost to Follow-up|0|||
23159862|NCT04770389|64335047|FG002|Overall Study|Lost to Follow-up|0|||
23159863|NCT04770389|64335048|FG003|Overall Study|Lost to Follow-up|1|||
23159864|NCT04770389|64335045|FG000|Overall Study|Moved away from study site|0|||
23159865|NCT04770389|64335046|FG001|Overall Study|Moved away from study site|1|||
23159866|NCT04770389|64335047|FG002|Overall Study|Moved away from study site|0|||
23159867|NCT04770389|64335048|FG003|Overall Study|Moved away from study site|0|||
23159868|NCT02687542|64335049|FG000|Overall Study|Medication error without associated AEs|0|||
23159869|NCT02687542|64335050|FG001|Overall Study|Medication error without associated AEs|0|||
23222780|NCT03099304|64557810|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
23567597|NCT03485911|65807123|FG000|Part 2|Perceived lack of efficacy|5|||
23567598|NCT03485911|65807124|FG001|Part 2|Perceived lack of efficacy|3|||
23567599|NCT03485911|65807125|FG002|Part 2|Perceived lack of efficacy|0|||
23222781|NCT03099304|64557811|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
23222782|NCT03099304|64557806|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
23222783|NCT03099304|64557807|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
23222784|NCT03099304|64557808|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
23222785|NCT03099304|64557809|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
23222786|NCT03099304|64557810|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
23222787|NCT03099304|64557811|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
23222788|NCT01468701|64557812|FG000|Overall Study|Not eligible|91|||
23222789|NCT01468701|64557813|FG001|Overall Study|Not eligible|140|||
23222790|NCT01468701|64557814|FG002|Overall Study|Not eligible|29|||
23222791|NCT01468701|64557815|FG003|Overall Study|Not eligible|12|||
23222792|NCT01468701|64557816|FG004|Overall Study|Not eligible|22|||
23222793|NCT01468701|64557817|FG005|Overall Study|Not eligible|2|||
23222794|NCT01468701|64557818|FG006|Overall Study|Not eligible|39|||
23222795|NCT01468701|64557819|FG007|Overall Study|Not eligible|1|||
23222796|NCT01468701|64557820|FG008|Overall Study|Not eligible|40|||
23222797|NCT01468701|64557821|FG009|Overall Study|Not eligible|126|||
23222798|NCT01468701|64557822|FG010|Overall Study|Not eligible|39|||
23222799|NCT01468701|64557823|FG011|Overall Study|Not eligible|33|||
23222800|NCT01468701|64557824|FG012|Overall Study|Not eligible|1|||
23222801|NCT01468701|64557825|FG013|Overall Study|Not eligible|19|||
23222802|NCT01468701|64557826|FG014|Overall Study|Not eligible|1|||
23222803|NCT01468701|64557827|FG015|Overall Study|Not eligible|32|||
23222804|NCT01468701|64557828|FG016|Overall Study|Not eligible|0|||
23222805|NCT01468701|64557812|FG000|Overall Study|Lost to Follow-up|306|||
23222806|NCT01468701|64557813|FG001|Overall Study|Lost to Follow-up|0|||
23222807|NCT01468701|64557814|FG002|Overall Study|Lost to Follow-up|0|||
23222808|NCT01468701|64557815|FG003|Overall Study|Lost to Follow-up|0|||
23222809|NCT01468701|64557816|FG004|Overall Study|Lost to Follow-up|0|||
23222810|NCT01468701|64557817|FG005|Overall Study|Lost to Follow-up|0|||
23222811|NCT01468701|64557818|FG006|Overall Study|Lost to Follow-up|0|||
23222812|NCT01468701|64557819|FG007|Overall Study|Lost to Follow-up|0|||
23222813|NCT01468701|64557820|FG008|Overall Study|Lost to Follow-up|215|||
23222814|NCT01468701|64557821|FG009|Overall Study|Lost to Follow-up|309|||
23222815|NCT01468701|64557822|FG010|Overall Study|Lost to Follow-up|224|||
23222816|NCT01468701|64557823|FG011|Overall Study|Lost to Follow-up|212|||
23222817|NCT01468701|64557824|FG012|Overall Study|Lost to Follow-up|11|||
23222818|NCT01468701|64557825|FG013|Overall Study|Lost to Follow-up|164|||
23222819|NCT01468701|64557826|FG014|Overall Study|Lost to Follow-up|17|||
23222820|NCT01468701|64557827|FG015|Overall Study|Lost to Follow-up|127|||
23222821|NCT01468701|64557828|FG016|Overall Study|Lost to Follow-up|1|||
23222822|NCT01468701|64557812|FG000|Overall Study|Withdrawal by Subject|165|||
23222823|NCT01468701|64557813|FG001|Overall Study|Withdrawal by Subject|0|||
23222824|NCT01468701|64557814|FG002|Overall Study|Withdrawal by Subject|0|||
23222825|NCT01468701|64557815|FG003|Overall Study|Withdrawal by Subject|0|||
23222826|NCT01468701|64557816|FG004|Overall Study|Withdrawal by Subject|0|||
23222827|NCT01468701|64557817|FG005|Overall Study|Withdrawal by Subject|0|||
23222828|NCT01468701|64557818|FG006|Overall Study|Withdrawal by Subject|0|||
23222829|NCT01468701|64557819|FG007|Overall Study|Withdrawal by Subject|0|||
23222830|NCT01468701|64557820|FG008|Overall Study|Withdrawal by Subject|83|||
23222831|NCT01468701|64557821|FG009|Overall Study|Withdrawal by Subject|88|||
23222832|NCT01468701|64557822|FG010|Overall Study|Withdrawal by Subject|100|||
23222833|NCT01468701|64557823|FG011|Overall Study|Withdrawal by Subject|114|||
23222834|NCT01468701|64557824|FG012|Overall Study|Withdrawal by Subject|9|||
23222835|NCT01468701|64557825|FG013|Overall Study|Withdrawal by Subject|47|||
23222836|NCT01468701|64557826|FG014|Overall Study|Withdrawal by Subject|6|||
23222837|NCT01468701|64557827|FG015|Overall Study|Withdrawal by Subject|31|||
23222838|NCT01468701|64557828|FG016|Overall Study|Withdrawal by Subject|0|||
23222839|NCT01468701|64557812|FG000|Overall Study|Other reasons than listed|437|||
23222840|NCT01468701|64557813|FG001|Overall Study|Other reasons than listed|0|||
23222841|NCT01468701|64557814|FG002|Overall Study|Other reasons than listed|0|||
23222842|NCT01468701|64557815|FG003|Overall Study|Other reasons than listed|0|||
23329308|NCT02268916|64948543|FG001|Overall Study|Lost to Follow-up|1|||
23329309|NCT02268916|64948542|FG000|Overall Study|Withdrawal by Subject|6|||
23445608|NCT03777059|65373685|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
23222843|NCT01468701|64557816|FG004|Overall Study|Other reasons than listed|0|||
23222844|NCT01468701|64557817|FG005|Overall Study|Other reasons than listed|0|||
23222845|NCT01468701|64557818|FG006|Overall Study|Other reasons than listed|0|||
23222846|NCT01468701|64557819|FG007|Overall Study|Other reasons than listed|0|||
23445609|NCT03777059|65373686|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
23222847|NCT01468701|64557820|FG008|Overall Study|Other reasons than listed|318|||
23222848|NCT01468701|64557821|FG009|Overall Study|Other reasons than listed|658|||
23222849|NCT01468701|64557822|FG010|Overall Study|Other reasons than listed|433|||
23222850|NCT01468701|64557823|FG011|Overall Study|Other reasons than listed|504|||
23222851|NCT01468701|64557824|FG012|Overall Study|Other reasons than listed|28|||
23222852|NCT01468701|64557825|FG013|Overall Study|Other reasons than listed|239|||
23222853|NCT01468701|64557826|FG014|Overall Study|Other reasons than listed|39|||
23222854|NCT01468701|64557827|FG015|Overall Study|Other reasons than listed|172|||
23222855|NCT01468701|64557828|FG016|Overall Study|Other reasons than listed|0|||
23222856|NCT01468701|64557812|FG000|Overall Study|No end of study case report form|0|||
23222857|NCT01468701|64557813|FG001|Overall Study|No end of study case report form|0|||
23222858|NCT01468701|64557814|FG002|Overall Study|No end of study case report form|0|||
23222859|NCT01468701|64557815|FG003|Overall Study|No end of study case report form|0|||
23222860|NCT01468701|64557816|FG004|Overall Study|No end of study case report form|0|||
23222861|NCT01468701|64557817|FG005|Overall Study|No end of study case report form|0|||
23222862|NCT01468701|64557818|FG006|Overall Study|No end of study case report form|0|||
23222863|NCT01468701|64557819|FG007|Overall Study|No end of study case report form|0|||
23222864|NCT01468701|64557820|FG008|Overall Study|No end of study case report form|4|||
23222865|NCT01468701|64557821|FG009|Overall Study|No end of study case report form|1|||
23222866|NCT01468701|64557822|FG010|Overall Study|No end of study case report form|2|||
23222867|NCT01468701|64557823|FG011|Overall Study|No end of study case report form|3|||
23222868|NCT01468701|64557824|FG012|Overall Study|No end of study case report form|0|||
23222869|NCT01468701|64557825|FG013|Overall Study|No end of study case report form|1|||
23222870|NCT01468701|64557826|FG014|Overall Study|No end of study case report form|0|||
23222871|NCT01468701|64557827|FG015|Overall Study|No end of study case report form|0|||
23222872|NCT01468701|64557828|FG016|Overall Study|No end of study case report form|0|||
23222873|NCT01468701|64557812|FG000|Overall Study|Not being followed up|0|||
23222874|NCT01468701|64557813|FG001|Overall Study|Not being followed up|4963|||
23222875|NCT01468701|64557814|FG002|Overall Study|Not being followed up|1755|||
23222876|NCT01468701|64557815|FG003|Overall Study|Not being followed up|703|||
23222877|NCT01468701|64557816|FG004|Overall Study|Not being followed up|1714|||
23222878|NCT01468701|64557817|FG005|Overall Study|Not being followed up|126|||
23222879|NCT01468701|64557818|FG006|Overall Study|Not being followed up|1170|||
23222880|NCT01468701|64557819|FG007|Overall Study|Not being followed up|4|||
23222881|NCT01468701|64557820|FG008|Overall Study|Not being followed up|0|||
23222882|NCT01468701|64557821|FG009|Overall Study|Not being followed up|0|||
23222883|NCT01468701|64557822|FG010|Overall Study|Not being followed up|0|||
23222884|NCT01468701|64557823|FG011|Overall Study|Not being followed up|0|||
23222885|NCT01468701|64557824|FG012|Overall Study|Not being followed up|0|||
23222886|NCT01468701|64557825|FG013|Overall Study|Not being followed up|0|||
23222887|NCT01468701|64557826|FG014|Overall Study|Not being followed up|0|||
23222888|NCT01468701|64557827|FG015|Overall Study|Not being followed up|0|||
23222889|NCT01468701|64557828|FG016|Overall Study|Not being followed up|0|||
23222890|NCT02972593|64557829|FG000|Overall Study|Lost to Follow-up|19|||
23222891|NCT02972593|64557830|FG001|Overall Study|Lost to Follow-up|15|||
23222892|NCT02972593|64557829|FG000|Overall Study|Protocol Violation|1|||
23222893|NCT02972593|64557830|FG001|Overall Study|Protocol Violation|0|||
23222894|NCT01678313|64557831|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
23222895|NCT01678313|64557832|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
23222896|NCT01678313|64557831|FG000|Completed the 3-month Therapy|Physician Decision|3|||
23567600|NCT03485911|65807126|FG003|Part 2|Perceived lack of efficacy|2|||
23222897|NCT01678313|64557832|FG001|Completed the 3-month Therapy|Physician Decision|4|||
23222898|NCT01678313|64557831|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
23329310|NCT02268916|64948543|FG001|Overall Study|Withdrawal by Subject|5|||
23222899|NCT01678313|64557832|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
23567601|NCT03485911|65807123|FG000|Part 2|Subject withdrew consent|1|||
23567602|NCT03485911|65807124|FG001|Part 2|Subject withdrew consent|0|||
23567603|NCT03485911|65807125|FG002|Part 2|Subject withdrew consent|2|||
23567604|NCT03485911|65807126|FG003|Part 2|Subject withdrew consent|1|||
23567605|NCT03485911|65807123|FG000|Part 2|Lab abnormalities/AEs|1|||
23567606|NCT03485911|65807124|FG001|Part 2|Lab abnormalities/AEs|2|||
23567607|NCT03485911|65807125|FG002|Part 2|Lab abnormalities/AEs|0|||
23567608|NCT03485911|65807126|FG003|Part 2|Lab abnormalities/AEs|0|||
23567609|NCT03485911|65807123|FG000|Part 2|Other NOS|0|||
23567610|NCT03485911|65807124|FG001|Part 2|Other NOS|1|||
23567611|NCT03485911|65807125|FG002|Part 2|Other NOS|0|||
23567612|NCT03485911|65807126|FG003|Part 2|Other NOS|0|||
23567613|NCT03485911|65807123|FG000|Part 2|Intercurrent illness/new medical condition|1|||
23567614|NCT03485911|65807124|FG001|Part 2|Intercurrent illness/new medical condition|0|||
23567615|NCT03485911|65807125|FG002|Part 2|Intercurrent illness/new medical condition|0|||
23567616|NCT03485911|65807126|FG003|Part 2|Intercurrent illness/new medical condition|0|||
23567617|NCT03485911|65807123|FG000|Part 2|Investigator judgement|1|||
23567618|NCT03485911|65807124|FG001|Part 2|Investigator judgement|0|||
23567619|NCT03485911|65807125|FG002|Part 2|Investigator judgement|0|||
23567620|NCT03485911|65807126|FG003|Part 2|Investigator judgement|0|||
23567621|NCT03485911|65807123|FG000|Part 3|Perceived lack of efficacy|2|||
23567622|NCT03485911|65807124|FG001|Part 3|Perceived lack of efficacy|2|||
23567623|NCT03485911|65807125|FG002|Part 3|Perceived lack of efficacy|2|||
23567624|NCT03485911|65807126|FG003|Part 3|Perceived lack of efficacy|0|||
23567625|NCT03485911|65807123|FG000|Part 3|Subject withdrew consent|1|||
23567626|NCT03485911|65807124|FG001|Part 3|Subject withdrew consent|4|||
23629266|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
23629267|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
23629268|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
23629269|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
23629270|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
23629271|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
23629272|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
23629273|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
23629274|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629275|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629276|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629277|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629278|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
23629279|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
23629280|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
23629281|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
23629282|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
23629283|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
23629284|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
23629285|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
23629286|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629287|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629288|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629289|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629290|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
23629291|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
23629292|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629293|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629294|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629295|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629296|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
23629297|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
23629298|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629299|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629300|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629301|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629302|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
23629303|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
23629304|NCT02563548|66028253|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629305|NCT02563548|66028254|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629306|NCT02563548|66028255|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629307|NCT02563548|66028256|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629308|NCT02563548|66028257|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
23629309|NCT02563548|66028258|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
23629310|NCT01333111|66028259|FG000|Overall Study|patient undergoing major surgery|0|||
23629311|NCT01333111|66028260|FG001|Overall Study|patient undergoing major surgery|2|||
23629312|NCT01333111|66028261|FG002|Overall Study|patient undergoing major surgery|0|||
23629313|NCT01333111|66028259|FG000|Overall Study|personal reasons|0|||
23629314|NCT01333111|66028260|FG001|Overall Study|personal reasons|0|||
23629315|NCT01333111|66028261|FG002|Overall Study|personal reasons|1|||
23629316|NCT01333111|66028259|FG000|Overall Study|unclassified|1|||
23629317|NCT01333111|66028260|FG001|Overall Study|unclassified|0|||
23629318|NCT01333111|66028261|FG002|Overall Study|unclassified|0|||
23629319|NCT01333111|66028259|FG000|Overall Study|withdrawal criteria|0|||
23629320|NCT01333111|66028260|FG001|Overall Study|withdrawal criteria|1|||
23629321|NCT01333111|66028261|FG002|Overall Study|withdrawal criteria|0|||
23629322|NCT01333111|66028259|FG000|Overall Study|Non-compliance|1|||
23629323|NCT01333111|66028260|FG001|Overall Study|Non-compliance|0|||
23629324|NCT01333111|66028261|FG002|Overall Study|Non-compliance|0|||
23629325|NCT01333111|66028259|FG000|Overall Study|Ineffective therapy|0|||
23629326|NCT01333111|66028260|FG001|Overall Study|Ineffective therapy|0|||
23629327|NCT01333111|66028261|FG002|Overall Study|Ineffective therapy|1|||
23629328|NCT01013961|66028265|FG000|Overall Study|Adverse Event|2|||
23629329|NCT01013961|66028266|FG001|Overall Study|Adverse Event|2|||
23159870|NCT02687542|64335051|FG002|Overall Study|Medication error without associated AEs|0|||
23159871|NCT02687542|64335052|FG003|Overall Study|Medication error without associated AEs|0|||
23159872|NCT02687542|64335053|FG004|Overall Study|Medication error without associated AEs|1|||
23629330|NCT01013961|66028265|FG000|Overall Study|Withdrawal by Subject|1|||
23629331|NCT01013961|66028266|FG001|Overall Study|Withdrawal by Subject|0|||
23629332|NCT01013961|66028265|FG000|Overall Study|Physician Decision|0|||
23629333|NCT01013961|66028266|FG001|Overall Study|Physician Decision|1|||
23629334|NCT00478205|66028269|FG000|Overall Study|Adverse Event|182|||
23629335|NCT00478205|66028270|FG001|Overall Study|Adverse Event|39|||
23629336|NCT00478205|66028269|FG000|Overall Study|Medication Non-compliance|9|||
23629337|NCT00478205|66028270|FG001|Overall Study|Medication Non-compliance|4|||
23629338|NCT00478205|66028269|FG000|Overall Study|Protocol Violation|15|||
23629339|NCT00478205|66028270|FG001|Overall Study|Protocol Violation|5|||
23629340|NCT00478205|66028269|FG000|Overall Study|Request of Investigator or Sponsor|4|||
23629341|NCT00478205|66028270|FG001|Overall Study|Request of Investigator or Sponsor|5|||
23629342|NCT00478205|66028269|FG000|Overall Study|Withdrawal by Subject|61|||
23629343|NCT00478205|66028270|FG001|Overall Study|Withdrawal by Subject|22|||
23629344|NCT00478205|66028269|FG000|Overall Study|Lack of Efficacy|1|||
23629345|NCT00478205|66028270|FG001|Overall Study|Lack of Efficacy|0|||
23629346|NCT00478205|66028269|FG000|Overall Study|Other|24|||
23629347|NCT00478205|66028270|FG001|Overall Study|Other|12|||
23629348|NCT01468077|66028277|FG000|Overall Study|Adverse Event|2|||
23629349|NCT01468077|66028278|FG001|Overall Study|Adverse Event|2|||
23567627|NCT03485911|65807125|FG002|Part 3|Subject withdrew consent|0|||
23567628|NCT03485911|65807126|FG003|Part 3|Subject withdrew consent|1|||
23567629|NCT03485911|65807123|FG000|Part 3|Lab abnormalities/AEs|1|||
23567630|NCT03485911|65807124|FG001|Part 3|Lab abnormalities/AEs|1|||
23567631|NCT03485911|65807125|FG002|Part 3|Lab abnormalities/AEs|0|||
23567632|NCT03485911|65807126|FG003|Part 3|Lab abnormalities/AEs|2|||
23567633|NCT03485911|65807123|FG000|Part 3|Other NOS|1|||
23567634|NCT03485911|65807124|FG001|Part 3|Other NOS|1|||
23567635|NCT03485911|65807125|FG002|Part 3|Other NOS|0|||
23567636|NCT03485911|65807126|FG003|Part 3|Other NOS|0|||
23567637|NCT03485911|65807123|FG000|Part 3|Intercurrent illness/new medical condition|0|||
23567638|NCT03485911|65807124|FG001|Part 3|Intercurrent illness/new medical condition|1|||
23567639|NCT03485911|65807125|FG002|Part 3|Intercurrent illness/new medical condition|1|||
23567640|NCT03485911|65807126|FG003|Part 3|Intercurrent illness/new medical condition|0|||
23567641|NCT03485911|65807123|FG000|Part 3|Sponsor discontinuation|1|||
23567642|NCT03485911|65807124|FG001|Part 3|Sponsor discontinuation|0|||
23567643|NCT03485911|65807125|FG002|Part 3|Sponsor discontinuation|0|||
23567644|NCT03485911|65807126|FG003|Part 3|Sponsor discontinuation|0|||
23567645|NCT03485911|65807123|FG000|Part 3|Berotralstat provided by alternative means|13|||
23567646|NCT03485911|65807124|FG001|Part 3|Berotralstat provided by alternative means|13|||
23567647|NCT03485911|65807125|FG002|Part 3|Berotralstat provided by alternative means|7|||
23567648|NCT03485911|65807126|FG003|Part 3|Berotralstat provided by alternative means|7|||
23567649|NCT02593305|65807127|FG000|Post 1|Comparison only group. No intervention.|0|||
23567650|NCT02593305|65807128|FG001|Post 1|Comparison only group. No intervention.|0|||
23567651|NCT02593305|65807129|FG002|Post 1|Comparison only group. No intervention.|10|||
23567652|NCT00810082|65807130|FG000|Overall Study|Lost to Follow-up|0|||
23567653|NCT00810082|65807131|FG001|Overall Study|Lost to Follow-up|4|||
23567654|NCT01678820|65807135|FG000|Overall Study|Study Terminated by Sponsor|45|||
23567655|NCT01678820|65807136|FG001|Overall Study|Study Terminated by Sponsor|43|||
23567656|NCT01678820|65807137|FG002|Overall Study|Study Terminated by Sponsor|43|||
23567657|NCT01678820|65807135|FG000|Overall Study|Withdrawal by Subject|2|||
23567658|NCT01678820|65807136|FG001|Overall Study|Withdrawal by Subject|5|||
23567659|NCT01678820|65807137|FG002|Overall Study|Withdrawal by Subject|2|||
23567660|NCT01678820|65807135|FG000|Overall Study|Protocol Specified Criteria|2|||
23567661|NCT01678820|65807136|FG001|Overall Study|Protocol Specified Criteria|3|||
23567662|NCT01678820|65807137|FG002|Overall Study|Protocol Specified Criteria|1|||
23567663|NCT01678820|65807135|FG000|Overall Study|Adverse Event|2|||
23567664|NCT01678820|65807136|FG001|Overall Study|Adverse Event|2|||
23567665|NCT01678820|65807137|FG002|Overall Study|Adverse Event|2|||
23567666|NCT01678820|65807135|FG000|Overall Study|Lost to Follow-up|7|||
23567667|NCT01678820|65807136|FG001|Overall Study|Lost to Follow-up|2|||
23567668|NCT01678820|65807137|FG002|Overall Study|Lost to Follow-up|2|||
23567669|NCT01678820|65807135|FG000|Overall Study|Non-compliance with study drug|0|||
23567670|NCT01678820|65807136|FG001|Overall Study|Non-compliance with study drug|1|||
23567671|NCT01678820|65807137|FG002|Overall Study|Non-compliance with study drug|0|||
23567672|NCT01678820|65807135|FG000|Overall Study|Physician Decision|0|||
23567673|NCT01678820|65807136|FG001|Overall Study|Physician Decision|0|||
23567674|NCT01678820|65807137|FG002|Overall Study|Physician Decision|1|||
23567675|NCT01678820|65807135|FG000|Overall Study|Protocol Violation|4|||
23567676|NCT01678820|65807136|FG001|Overall Study|Protocol Violation|5|||
23567677|NCT01678820|65807137|FG002|Overall Study|Protocol Violation|4|||
23567678|NCT01678820|65807135|FG000|Overall Study|Not treated with double-blind study drug|0|||
23567679|NCT01678820|65807136|FG001|Overall Study|Not treated with double-blind study drug|2|||
23567680|NCT01678820|65807137|FG002|Overall Study|Not treated with double-blind study drug|2|||
23567681|NCT04789577|65807140|FG000|Overall Study|Withdrawal by Subject|1|||
23567682|NCT04789577|65807141|FG001|Overall Study|Withdrawal by Subject|1|||
23567683|NCT04789577|65807142|FG002|Overall Study|Withdrawal by Subject|1|||
23629350|NCT01468077|66028277|FG000|Overall Study|Lack of Efficacy|1|||
23629351|NCT01468077|66028278|FG001|Overall Study|Lack of Efficacy|1|||
23629352|NCT01468077|66028277|FG000|Overall Study|Physician Decision|1|||
23629353|NCT01468077|66028278|FG001|Overall Study|Physician Decision|0|||
23629354|NCT03334253|66028283|FG000|Overall Study|Withdrawal by Subject|1|||
23629355|NCT03334253|66028284|FG001|Overall Study|Withdrawal by Subject|0|||
23629356|NCT03334253|66028283|FG000|Overall Study|Lost to Follow-up|4|||
23629357|NCT03334253|66028284|FG001|Overall Study|Lost to Follow-up|3|||
23629358|NCT03334253|66028283|FG000|Overall Study|Moved residence|2|||
23629359|NCT03334253|66028284|FG001|Overall Study|Moved residence|2|||
23629360|NCT02818998|66028285|FG000|Overall Study|Adverse Event|3|||
23629361|NCT02818998|66028286|FG001|Overall Study|Adverse Event|2|||
23629362|NCT02818998|66028287|FG002|Overall Study|Adverse Event|1|||
23629363|NCT02818998|66028285|FG000|Overall Study|Lost to Follow-up|4|||
23159873|NCT02687542|64335049|FG000|Overall Study|Lost to Follow-up|0|||
23159874|NCT02687542|64335050|FG001|Overall Study|Lost to Follow-up|0|||
23159875|NCT02687542|64335051|FG002|Overall Study|Lost to Follow-up|0|||
23159876|NCT02687542|64335052|FG003|Overall Study|Lost to Follow-up|0|||
23159877|NCT02687542|64335053|FG004|Overall Study|Lost to Follow-up|1|||
23159878|NCT02687542|64335049|FG000|Overall Study|Protocol Violation|0|||
23159879|NCT02687542|64335050|FG001|Overall Study|Protocol Violation|1|||
23159880|NCT02687542|64335051|FG002|Overall Study|Protocol Violation|0|||
23159881|NCT02687542|64335052|FG003|Overall Study|Protocol Violation|0|||
23159882|NCT02687542|64335053|FG004|Overall Study|Protocol Violation|0|||
23567684|NCT04789577|65807143|FG003|Overall Study|Withdrawal by Subject|3|||
23159883|NCT02687542|64335049|FG000|Overall Study|Other|5|||
23159884|NCT02687542|64335050|FG001|Overall Study|Other|9|||
23159885|NCT02687542|64335051|FG002|Overall Study|Other|10|||
23159886|NCT02687542|64335052|FG003|Overall Study|Other|6|||
23159887|NCT02687542|64335053|FG004|Overall Study|Other|5|||
23159888|NCT02687542|64335049|FG000|Overall Study|Adverse Event|3|||
23159889|NCT02687542|64335050|FG001|Overall Study|Adverse Event|1|||
23159890|NCT02687542|64335051|FG002|Overall Study|Adverse Event|3|||
23159891|NCT02687542|64335052|FG003|Overall Study|Adverse Event|2|||
23159892|NCT02687542|64335053|FG004|Overall Study|Adverse Event|9|||
23159893|NCT02687542|64335049|FG000|Overall Study|Withdrawal by Subject|0|||
23159894|NCT02687542|64335050|FG001|Overall Study|Withdrawal by Subject|1|||
23159895|NCT02687542|64335051|FG002|Overall Study|Withdrawal by Subject|1|||
23159896|NCT02687542|64335052|FG003|Overall Study|Withdrawal by Subject|2|||
23159897|NCT02687542|64335053|FG004|Overall Study|Withdrawal by Subject|4|||
23159898|NCT00176605|64335054|FG000|Overall Study|Withdrawal by Subject|2|||
23159899|NCT00552175|64335055|FG000|Overall Study|Lack of Efficacy|2|||
23159900|NCT00552175|64335056|FG001|Overall Study|Lack of Efficacy|0|||
23159901|NCT00552175|64335057|FG002|Overall Study|Lack of Efficacy|1|||
23159902|NCT00552175|64335055|FG000|Overall Study|Adverse Event|9|||
23159903|NCT00552175|64335056|FG001|Overall Study|Adverse Event|9|||
23159904|NCT00552175|64335057|FG002|Overall Study|Adverse Event|10|||
23159905|NCT00552175|64335055|FG000|Overall Study|Withdrawal by Subject|2|||
23159906|NCT00552175|64335056|FG001|Overall Study|Withdrawal by Subject|2|||
23159907|NCT00552175|64335057|FG002|Overall Study|Withdrawal by Subject|1|||
23159908|NCT00552175|64335055|FG000|Overall Study|Lost to Follow-up|0|||
23159909|NCT00552175|64335056|FG001|Overall Study|Lost to Follow-up|0|||
23159910|NCT00552175|64335057|FG002|Overall Study|Lost to Follow-up|1|||
23159911|NCT00552175|64335055|FG000|Overall Study|Entry Criteria Not Met|1|||
23159912|NCT00552175|64335056|FG001|Overall Study|Entry Criteria Not Met|1|||
23159913|NCT00552175|64335057|FG002|Overall Study|Entry Criteria Not Met|0|||
23159914|NCT00552175|64335055|FG000|Overall Study|Reason Not Specified|3|||
23159915|NCT00552175|64335056|FG001|Overall Study|Reason Not Specified|1|||
23159916|NCT00552175|64335057|FG002|Overall Study|Reason Not Specified|1|||
23159917|NCT02285777|64335058|FG000|Overall Study|Withdrawal by Subject|1|||
23567685|NCT04789577|65807144|FG004|Overall Study|Withdrawal by Subject|1|||
23567686|NCT04789577|65807145|FG005|Overall Study|Withdrawal by Subject|7|||
23567687|NCT04789577|65807146|FG006|Overall Study|Withdrawal by Subject|1|||
23567688|NCT04789577|65807140|FG000|Overall Study|Lost to Follow-up|7|||
23567689|NCT04789577|65807141|FG001|Overall Study|Lost to Follow-up|12|||
23567690|NCT04789577|65807142|FG002|Overall Study|Lost to Follow-up|7|||
23567691|NCT04789577|65807143|FG003|Overall Study|Lost to Follow-up|10|||
23629364|NCT02818998|66028286|FG001|Overall Study|Lost to Follow-up|1|||
23159918|NCT02285777|64335059|FG001|Overall Study|Withdrawal by Subject|1|||
23629365|NCT02818998|66028287|FG002|Overall Study|Lost to Follow-up|2|||
23629366|NCT02818998|66028285|FG000|Overall Study|Withdrawal by sponsor|0|||
23629367|NCT02818998|66028286|FG001|Overall Study|Withdrawal by sponsor|1|||
23159919|NCT02285777|64335058|FG000|Overall Study|Lost to Follow-up|4|||
23159920|NCT02285777|64335059|FG001|Overall Study|Lost to Follow-up|2|||
23159921|NCT01834274|64335069|FG000|Overall Study|Study Termination|41|||
23159922|NCT01834274|64335070|FG001|Overall Study|Study Termination|38|||
23159923|NCT01834274|64335069|FG000|Overall Study|Withdrawal by Subject|1|||
23567692|NCT04789577|65807144|FG004|Overall Study|Lost to Follow-up|8|||
23567693|NCT04789577|65807145|FG005|Overall Study|Lost to Follow-up|6|||
23629368|NCT02818998|66028287|FG002|Overall Study|Withdrawal by sponsor|1|||
23629369|NCT02818998|66028285|FG000|Overall Study|Death|3|||
23629370|NCT02818998|66028286|FG001|Overall Study|Death|6|||
23629371|NCT02818998|66028287|FG002|Overall Study|Death|8|||
23629372|NCT02818998|66028285|FG000|Overall Study|Withdrawal by Subject|7|||
23629373|NCT02818998|66028286|FG001|Overall Study|Withdrawal by Subject|6|||
23629374|NCT02818998|66028287|FG002|Overall Study|Withdrawal by Subject|6|||
23629375|NCT02818998|66028285|FG000|Overall Study|Physician Decision|1|||
23629376|NCT02818998|66028286|FG001|Overall Study|Physician Decision|0|||
23629377|NCT02818998|66028287|FG002|Overall Study|Physician Decision|0|||
23629378|NCT01261247|66028288|FG000|Overall Study|Ineligible|2|||
23629379|NCT00681668|66028289|FG000|Overall Study|Protocol Violation|1|||
23629380|NCT00681668|66028289|FG000|Overall Study|Withdrawal by Subject|1|||
23629381|NCT01594827|66028290|FG000|Overall Study|Adverse Event|1|||
23629382|NCT01594827|66028291|FG001|Overall Study|Adverse Event|0|||
23629383|NCT01594827|66028290|FG000|Overall Study|Physician Decision|3|||
23629384|NCT01594827|66028291|FG001|Overall Study|Physician Decision|0|||
23629385|NCT02636608|66028298|FG000|Overall Study|Failure to Return|4|||
23629386|NCT02636608|66028298|FG000|Overall Study|Insufficient Virological Response|1|||
23629387|NCT02636608|66028298|FG000|Overall Study|Death|3|||
23629388|NCT02636608|66028298|FG000|Overall Study|Other|2|||
23629389|NCT02636608|66028298|FG000|Overall Study|Did Not Receive Treatment|1|||
23629390|NCT02522728|66028301|FG000|Overall Study|Withdrawal by Subject|6|||
23629391|NCT02522728|66028302|FG001|Overall Study|Withdrawal by Subject|6|||
23629392|NCT02522728|66028301|FG000|Overall Study|Death|4|||
23629393|NCT02522728|66028302|FG001|Overall Study|Death|3|||
23629394|NCT02522728|66028301|FG000|Overall Study|Adverse Event|2|||
23629395|NCT02522728|66028302|FG001|Overall Study|Adverse Event|1|||
23629396|NCT02522728|66028301|FG000|Overall Study|Did not receive randomized study device|0|||
23629397|NCT02522728|66028302|FG001|Overall Study|Did not receive randomized study device|1|||
23629398|NCT00936598|66028303|FG000|Overall Study|Withdrawal by Subject|1|||
23629399|NCT00936598|66028304|FG001|Overall Study|Withdrawal by Subject|0|||
23629400|NCT00936598|66028303|FG000|Overall Study|Ineligible after consent|1|||
23629401|NCT00936598|66028304|FG001|Overall Study|Ineligible after consent|0|||
23629402|NCT01660256|66028307|FG000|Overall Study|Adverse Event|4|||
23629403|NCT01660256|66028308|FG001|Overall Study|Adverse Event|0|||
23629404|NCT01660256|66028309|FG002|Overall Study|Adverse Event|2|||
23629405|NCT01660256|66028307|FG000|Overall Study|Withdrawal by Subject|1|||
23629406|NCT01660256|66028308|FG001|Overall Study|Withdrawal by Subject|0|||
23629407|NCT01660256|66028309|FG002|Overall Study|Withdrawal by Subject|2|||
23629408|NCT03513068|66028311|FG000|Overall Study|Death|1|||
23629409|NCT03513068|66028312|FG001|Overall Study|Death|0|||
23629410|NCT03513068|66028311|FG000|Overall Study|Withdrawal by Subject|4|||
23629411|NCT03513068|66028312|FG001|Overall Study|Withdrawal by Subject|6|||
23629412|NCT00916305|66028313|FG000|Overall Study|Lost to Follow-up|21|||
23629413|NCT00916305|66028314|FG001|Overall Study|Lost to Follow-up|27|||
23629414|NCT00916305|66028313|FG000|Overall Study|Withdrawal by Subject|0|||
23629415|NCT00916305|66028314|FG001|Overall Study|Withdrawal by Subject|1|||
23629416|NCT02344342|66028315|FG000|Overall Study|Industry partner dropped out|11|||
23629417|NCT02344342|66028316|FG001|Overall Study|Industry partner dropped out|9|||
23629418|NCT02344342|66028317|FG002|Overall Study|Industry partner dropped out|14|||
23629419|NCT02344342|66028318|FG003|Overall Study|Industry partner dropped out|10|||
23629420|NCT03178045|66028320|FG000|Overall Study|Withdrawal by Subject|5|||
23629421|NCT03178045|66028321|FG001|Overall Study|Withdrawal by Subject|7|||
23629422|NCT03178045|66028320|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
23629423|NCT03178045|66028321|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
23629424|NCT03178045|66028320|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
23629425|NCT03178045|66028321|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
23629426|NCT00913523|66028322|FG000|Overall Study|Withdrawal by Subject|3|||
23629427|NCT00913523|66028323|FG001|Overall Study|Withdrawal by Subject|2|||
23159924|NCT01834274|64335070|FG001|Overall Study|Withdrawal by Subject|1|||
23159925|NCT01834274|64335069|FG000|Overall Study|Lost to Follow-up|3|||
23159926|NCT01834274|64335070|FG001|Overall Study|Lost to Follow-up|1|||
23159927|NCT01834274|64335069|FG000|Overall Study|Other|2|||
23159928|NCT01834274|64335070|FG001|Overall Study|Other|1|||
23629428|NCT00913523|66028324|FG002|Overall Study|Withdrawal by Subject|2|||
23629429|NCT00913523|66028322|FG000|Overall Study|Lost to Follow-up|1|||
23629430|NCT00913523|66028323|FG001|Overall Study|Lost to Follow-up|1|||
23629431|NCT00913523|66028324|FG002|Overall Study|Lost to Follow-up|1|||
23629432|NCT00913523|66028322|FG000|Overall Study|Adverse Event|1|||
23629433|NCT00913523|66028323|FG001|Overall Study|Adverse Event|0|||
23629434|NCT00913523|66028324|FG002|Overall Study|Adverse Event|0|||
23629435|NCT00913523|66028322|FG000|Overall Study|Protocol Violation|5|||
23629436|NCT00913523|66028323|FG001|Overall Study|Protocol Violation|8|||
23629437|NCT00913523|66028324|FG002|Overall Study|Protocol Violation|8|||
23629438|NCT00913523|66028322|FG000|Overall Study|Pregnancy|1|||
23629439|NCT00913523|66028323|FG001|Overall Study|Pregnancy|3|||
23629440|NCT00913523|66028324|FG002|Overall Study|Pregnancy|0|||
23629441|NCT00913523|66028322|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
23629442|NCT00913523|66028323|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
23629443|NCT00913523|66028324|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
23629444|NCT00383123|66028325|FG000|Overall Study|Adverse Event|1|||
23629445|NCT00383123|66028326|FG001|Overall Study|Adverse Event|0|||
23629446|NCT00383123|66028325|FG000|Overall Study|Lost to Follow-up|68|||
23629447|NCT00383123|66028326|FG001|Overall Study|Lost to Follow-up|61|||
23629448|NCT00383123|66028325|FG000|Overall Study|Protocol Violation|5|||
23629449|NCT00383123|66028326|FG001|Overall Study|Protocol Violation|1|||
23629450|NCT00383123|66028325|FG000|Overall Study|Withdrawal by Subject|27|||
23629451|NCT00383123|66028326|FG001|Overall Study|Withdrawal by Subject|18|||
23629452|NCT00383123|66028325|FG000|Overall Study|Other reason|10|||
23629453|NCT00383123|66028326|FG001|Overall Study|Other reason|6|||
23629454|NCT02825251|66028327|FG000|Overall Study|Adverse Event|0|||
23629455|NCT02825251|66028328|FG001|Overall Study|Adverse Event|1|||
23629456|NCT02825251|66028327|FG000|Overall Study|Lost to Follow-up|0|||
23629457|NCT02825251|66028328|FG001|Overall Study|Lost to Follow-up|1|||
23629458|NCT02825251|66028327|FG000|Overall Study|Withdrawal by Subject|1|||
23629459|NCT02825251|66028328|FG001|Overall Study|Withdrawal by Subject|4|||
23629460|NCT02825251|66028327|FG000|Overall Study|Unclassified|2|||
23629461|NCT02825251|66028328|FG001|Overall Study|Unclassified|0|||
23629462|NCT01791413|66028329|FG000|Overall Study|Lost to Follow-up|5|||
23629463|NCT01791413|66028330|FG001|Overall Study|Lost to Follow-up|1|||
23629464|NCT00475228|66028331|FG000|Overall Study|Lost to Follow-up|17|||
23629465|NCT00475228|66028332|FG001|Overall Study|Lost to Follow-up|17|||
23629466|NCT00447590|66028339|FG000|Overall Study|Withdrawal by Subject|26|||
23629467|NCT00447590|66028339|FG000|Overall Study|Lost to Follow-up|24|||
23629468|NCT00447590|66028339|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
23629469|NCT03358238|66028340|FG000|Overall Study|Withdrawal by Subject|0|||
23629470|NCT03358238|66028341|FG001|Overall Study|Withdrawal by Subject|1|||
23629471|NCT00839956|66028344|FG000|Overall Study|Adverse Event|2|||
23629472|NCT00839956|66028344|FG000|Overall Study|Lack of Efficacy|6|||
23629473|NCT00839956|66028344|FG000|Overall Study|Physician Decision|1|||
23629474|NCT00839956|66028344|FG000|Overall Study|Withdrawal by Subject|3|||
23159929|NCT01835015|64335071|FG000|Overall Study|Adverse Event|0|||
23567694|NCT04789577|65807146|FG006|Overall Study|Lost to Follow-up|10|||
23567695|NCT04789577|65807140|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
23567696|NCT04789577|65807141|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
23567697|NCT04789577|65807142|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
23567698|NCT04789577|65807143|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
23567699|NCT04789577|65807144|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
23567700|NCT04789577|65807145|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
23567701|NCT04789577|65807146|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
23567702|NCT04789577|65807140|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
23567703|NCT04789577|65807141|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
23567704|NCT04789577|65807142|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
23567705|NCT04789577|65807143|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
23567706|NCT04789577|65807144|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
23567707|NCT04789577|65807145|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
23567708|NCT04789577|65807146|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
23567709|NCT01486758|65807147|FG000|Overall Study|Lost to Follow-up|0|||
23567710|NCT01486758|65807148|FG001|Overall Study|Lost to Follow-up|1|||
23567711|NCT00976482|65807153|FG000|Overall Study|Death|208|||
23567712|NCT00976482|65807153|FG000|Overall Study|Withdrawal by Subject|45|||
23567713|NCT00976482|65807153|FG000|Overall Study|Center terminated|1|||
23329311|NCT02268916|64948542|FG000|Overall Study|Participant did not have diabetes|1|||
23329312|NCT02268916|64948543|FG001|Overall Study|Participant did not have diabetes|0|||
23329313|NCT02268916|64948542|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
23329314|NCT02268916|64948543|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
23329315|NCT02068508|64948544|FG000|Overall Study|Case report forms uncollected|27|||
23329316|NCT02068508|64948544|FG000|Overall Study|Patient did not visit the study site|1|||
23329317|NCT02068508|64948544|FG000|Overall Study|Protocol Violation|4|||
23329318|NCT03187301|64948545|FG000|Titration Period|Adverse Event|0|||
23329319|NCT03187301|64948546|FG001|Titration Period|Adverse Event|0|||
23329320|NCT03187301|64948547|FG002|Titration Period|Adverse Event|0|||
23329321|NCT03187301|64948548|FG003|Titration Period|Adverse Event|0|||
23329322|NCT03187301|64948549|FG004|Titration Period|Adverse Event|0|||
23329323|NCT03187301|64948550|FG005|Titration Period|Adverse Event|0|||
23329324|NCT03187301|64948551|FG006|Titration Period|Adverse Event|5|||
23329325|NCT03187301|64948545|FG000|Titration Period|Withdrawal by Subject|0|||
23329326|NCT03187301|64948546|FG001|Titration Period|Withdrawal by Subject|0|||
23445610|NCT03777059|65373683|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
23159930|NCT01835015|64335072|FG001|Overall Study|Adverse Event|0|||
23159931|NCT01835015|64335073|FG002|Overall Study|Adverse Event|1|||
23159932|NCT01835015|64335074|FG003|Overall Study|Adverse Event|0|||
23159933|NCT01835015|64335075|FG004|Overall Study|Adverse Event|0|||
23159934|NCT01075412|64335078|FG000|Overall Study|Withdrawal by Subject|0|||
23159935|NCT01075412|64335079|FG001|Overall Study|Withdrawal by Subject|1|||
23159936|NCT02054897|64335080|FG000|Overall Study|Withdrawal by Subject|2|||
23159937|NCT02054897|64335081|FG001|Overall Study|Withdrawal by Subject|0|||
23159938|NCT02054897|64335082|FG002|Overall Study|Withdrawal by Subject|2|||
23159939|NCT02054897|64335080|FG000|Overall Study|Missing follow-up information|3|||
23159940|NCT02054897|64335081|FG001|Overall Study|Missing follow-up information|5|||
23159941|NCT02054897|64335082|FG002|Overall Study|Missing follow-up information|3|||
23159942|NCT02054897|64335080|FG000|Overall Study|Lost to Follow-up|4|||
23445611|NCT03777059|65373684|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
23159943|NCT02054897|64335081|FG001|Overall Study|Lost to Follow-up|2|||
23159944|NCT02054897|64335082|FG002|Overall Study|Lost to Follow-up|7|||
23159945|NCT02054897|64335080|FG000|Overall Study|Randomized but not exposed|1|||
23329327|NCT03187301|64948547|FG002|Titration Period|Withdrawal by Subject|0|||
23329328|NCT03187301|64948548|FG003|Titration Period|Withdrawal by Subject|0|||
23329329|NCT03187301|64948549|FG004|Titration Period|Withdrawal by Subject|0|||
23329330|NCT03187301|64948550|FG005|Titration Period|Withdrawal by Subject|0|||
23329331|NCT03187301|64948551|FG006|Titration Period|Withdrawal by Subject|1|||
23329332|NCT03187301|64948545|FG000|Titration Period|Exclusion Criteria Met|0|||
23329333|NCT03187301|64948546|FG001|Titration Period|Exclusion Criteria Met|0|||
23329334|NCT03187301|64948547|FG002|Titration Period|Exclusion Criteria Met|0|||
23329335|NCT03187301|64948548|FG003|Titration Period|Exclusion Criteria Met|0|||
23329336|NCT03187301|64948549|FG004|Titration Period|Exclusion Criteria Met|0|||
23329337|NCT03187301|64948550|FG005|Titration Period|Exclusion Criteria Met|0|||
23329338|NCT03187301|64948551|FG006|Titration Period|Exclusion Criteria Met|1|||
23329339|NCT03187301|64948545|FG000|Pre-Intervention|Withdrawal by Subject|1|||
23329340|NCT03187301|64948546|FG001|Pre-Intervention|Withdrawal by Subject|0|||
23329341|NCT03187301|64948547|FG002|Pre-Intervention|Withdrawal by Subject|0|||
23329342|NCT03187301|64948548|FG003|Pre-Intervention|Withdrawal by Subject|0|||
23329343|NCT03187301|64948549|FG004|Pre-Intervention|Withdrawal by Subject|0|||
23329344|NCT03187301|64948550|FG005|Pre-Intervention|Withdrawal by Subject|0|||
23329345|NCT03187301|64948551|FG006|Pre-Intervention|Withdrawal by Subject|0|||
23329346|NCT02929589|64948552|FG000|Overall Study|Withdrawal by Subject|1|||
23329347|NCT02929589|64948553|FG001|Overall Study|Withdrawal by Subject|0|||
23329348|NCT02929589|64948554|FG002|Overall Study|Withdrawal by Subject|0|||
23329349|NCT02929589|64948555|FG003|Overall Study|Withdrawal by Subject|0|||
23329350|NCT02929589|64948552|FG000|Overall Study|Physician Decision|2|||
23329351|NCT02929589|64948553|FG001|Overall Study|Physician Decision|0|||
23329352|NCT02929589|64948554|FG002|Overall Study|Physician Decision|0|||
23329353|NCT02929589|64948555|FG003|Overall Study|Physician Decision|0|||
23329354|NCT00191477|64948556|FG000|Overall Study|Tumor Recurrence|49|||
23159946|NCT02054897|64335081|FG001|Overall Study|Randomized but not exposed|0|||
23159947|NCT02054897|64335082|FG002|Overall Study|Randomized but not exposed|0|||
23159948|NCT01911442|64335089|FG000|Overall Study|Adverse Event|2|||
23159949|NCT01911442|64335090|FG001|Overall Study|Adverse Event|2|||
23159950|NCT01911442|64335091|FG002|Overall Study|Adverse Event|4|||
23159951|NCT01911442|64335089|FG000|Overall Study|Lack of Efficacy|1|||
23159952|NCT01911442|64335090|FG001|Overall Study|Lack of Efficacy|1|||
23159953|NCT01911442|64335091|FG002|Overall Study|Lack of Efficacy|1|||
23159954|NCT01911442|64335089|FG000|Overall Study|Lost to Follow-up|2|||
23159955|NCT01911442|64335090|FG001|Overall Study|Lost to Follow-up|0|||
23159956|NCT01911442|64335091|FG002|Overall Study|Lost to Follow-up|1|||
23159957|NCT01911442|64335089|FG000|Overall Study|Withdrawal by Subject|1|||
23159958|NCT01911442|64335090|FG001|Overall Study|Withdrawal by Subject|0|||
23159959|NCT01911442|64335091|FG002|Overall Study|Withdrawal by Subject|6|||
23159960|NCT01911442|64335089|FG000|Overall Study|Mother's Work Schedule|0|||
23159961|NCT01911442|64335090|FG001|Overall Study|Mother's Work Schedule|1|||
23159962|NCT01911442|64335091|FG002|Overall Study|Mother's Work Schedule|0|||
23159963|NCT03200366|64335093|FG000|Patient Navigation Intervention Given|Death|0|||
23159964|NCT03200366|64335094|FG001|Patient Navigation Intervention Given|Death|2|||
23159965|NCT03200366|64335095|FG002|Patient Navigation Intervention Given|Death|0|||
23159966|NCT03200366|64335093|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
23159967|NCT03200366|64335094|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
23159968|NCT03200366|64335095|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
23159969|NCT03200366|64335093|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
23159970|NCT03200366|64335094|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
23159971|NCT03200366|64335095|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
23159972|NCT03200366|64335093|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
23329355|NCT00191477|64948557|FG001|Overall Study|Tumor Recurrence|48|||
23222900|NCT01678313|64557831|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
23329356|NCT00191477|64948556|FG000|Overall Study|Death, Study Disease|1|||
23329357|NCT00191477|64948557|FG001|Overall Study|Death, Study Disease|1|||
23329358|NCT00191477|64948556|FG000|Overall Study|Death, Other Cause|3|||
23159973|NCT03200366|64335094|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
23159974|NCT03200366|64335095|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
23329359|NCT00191477|64948557|FG001|Overall Study|Death, Other Cause|6|||
23159975|NCT03200366|64335093|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
23159976|NCT03200366|64335094|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
23159977|NCT03200366|64335095|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
23329360|NCT00191477|64948556|FG000|Overall Study|Lost to Follow-up|23|||
23159978|NCT03200366|64335093|FG000|6 Month Post-Baseline Interview|Death|1|||
23159979|NCT03200366|64335094|FG001|6 Month Post-Baseline Interview|Death|1|||
23159980|NCT03200366|64335095|FG002|6 Month Post-Baseline Interview|Death|1|||
23159981|NCT03200366|64335093|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
23159982|NCT03200366|64335094|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
23159983|NCT03200366|64335095|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
23159984|NCT03200366|64335093|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
23159985|NCT03200366|64335094|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
23159986|NCT03200366|64335095|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
23159987|NCT03200366|64335093|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
23159988|NCT03200366|64335094|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
23159989|NCT03200366|64335095|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
23159990|NCT03200366|64335093|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
23159991|NCT03200366|64335094|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
23159992|NCT03200366|64335095|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
23159993|NCT03200366|64335093|FG000|9 Month Post-Baseline Interview|Death|1|||
23329361|NCT00191477|64948557|FG001|Overall Study|Lost to Follow-up|21|||
23329362|NCT00191477|64948556|FG000|Overall Study|Protocol Violation|1|||
23329363|NCT00191477|64948557|FG001|Overall Study|Protocol Violation|1|||
23329364|NCT00191477|64948556|FG000|Overall Study|Treatment Change|2|||
23329365|NCT00191477|64948557|FG001|Overall Study|Treatment Change|0|||
23329366|NCT00191477|64948556|FG000|Overall Study|Withdrawal by Subject|2|||
23567714|NCT00976482|65807153|FG000|Overall Study|Protocol Violation|5|||
23567715|NCT02468934|65807165|FG000|Overall Study|Withdrawal by Subject|4|||
23567716|NCT02468934|65807165|FG000|Overall Study|Screen Failure|3|||
23329367|NCT00191477|64948557|FG001|Overall Study|Withdrawal by Subject|0|||
23567717|NCT01794117|65807166|FG000|Overall Study|Adverse Event|1|||
23567718|NCT01794117|65807167|FG001|Overall Study|Adverse Event|0|||
23567719|NCT01794117|65807168|FG002|Overall Study|Adverse Event|0|||
23567720|NCT01794117|65807169|FG003|Overall Study|Adverse Event|0|||
23567721|NCT01794117|65807166|FG000|Overall Study|Participant noncompliance|0|||
23567722|NCT01794117|65807167|FG001|Overall Study|Participant noncompliance|1|||
23567723|NCT01794117|65807168|FG002|Overall Study|Participant noncompliance|0|||
23567724|NCT01794117|65807169|FG003|Overall Study|Participant noncompliance|0|||
23567725|NCT01794117|65807166|FG000|Overall Study|Refused further treatment|0|||
23567726|NCT01794117|65807167|FG001|Overall Study|Refused further treatment|2|||
23567727|NCT01794117|65807168|FG002|Overall Study|Refused further treatment|0|||
23567728|NCT01794117|65807169|FG003|Overall Study|Refused further treatment|0|||
23567729|NCT01848834|65807170|FG000|Overall Study|Adverse Event|3|||
23567730|NCT01848834|65807171|FG001|Overall Study|Adverse Event|11|||
23567731|NCT01848834|65807172|FG002|Overall Study|Adverse Event|3|||
23567732|NCT01848834|65807173|FG003|Overall Study|Adverse Event|5|||
23567733|NCT01848834|65807174|FG004|Overall Study|Adverse Event|9|||
23567734|NCT01848834|65807170|FG000|Overall Study|Death|2|||
23567735|NCT01848834|65807171|FG001|Overall Study|Death|11|||
23567736|NCT01848834|65807172|FG002|Overall Study|Death|1|||
23567737|NCT01848834|65807173|FG003|Overall Study|Death|8|||
23567738|NCT01848834|65807174|FG004|Overall Study|Death|27|||
23567739|NCT01848834|65807170|FG000|Overall Study|Excluded Medication|5|||
23567740|NCT01848834|65807171|FG001|Overall Study|Excluded Medication|4|||
23567741|NCT01848834|65807172|FG002|Overall Study|Excluded Medication|3|||
23329368|NCT00191477|64948556|FG000|Overall Study|Other|2|||
23329369|NCT00191477|64948557|FG001|Overall Study|Other|0|||
23329370|NCT00191477|64948556|FG000|Overall Study|Not Eligible|41|||
23329371|NCT00191477|64948557|FG001|Overall Study|Not Eligible|38|||
23329372|NCT00191477|64948556|FG000|Overall Study|Pathological Specimen Lost|1|||
23329373|NCT00191477|64948557|FG001|Overall Study|Pathological Specimen Lost|0|||
23329374|NCT00191477|64948556|FG000|Overall Study|Discontinued Prior to Instillation|13|||
23329375|NCT00191477|64948557|FG001|Overall Study|Discontinued Prior to Instillation|14|||
23329376|NCT02588612|64948559|FG000|Overall Study|Physician Decision|1|||
23329377|NCT02588612|64948559|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
23329378|NCT02588612|64948559|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
23329379|NCT02588612|64948559|FG000|Overall Study|Death prior to T-cell infusion|1|||
23329380|NCT01422889|64948560|FG000|Overall Study|No Data Entered for Study Stent|9|||
23329381|NCT02013817|64948561|FG000|Overall Study|Adverse Event|12|||
23567742|NCT01848834|65807173|FG003|Overall Study|Excluded Medication|6|||
23567743|NCT01848834|65807174|FG004|Overall Study|Excluded Medication|6|||
23567744|NCT01848834|65807170|FG000|Overall Study|Lost to Follow-up|5|||
23567745|NCT01848834|65807171|FG001|Overall Study|Lost to Follow-up|5|||
23329382|NCT02013817|64948561|FG000|Overall Study|Withdrawal by Subject|4|||
23329383|NCT02013817|64948561|FG000|Overall Study|Death|2|||
23329384|NCT02013817|64948561|FG000|Overall Study|Other|9|||
23329385|NCT01408303|64948562|FG000|Overall Study|Adverse Event|3|||
23329386|NCT01408303|64948563|FG001|Overall Study|Adverse Event|7|||
23329387|NCT01408303|64948564|FG002|Overall Study|Adverse Event|2|||
23329388|NCT01408303|64948562|FG000|Overall Study|Lost to Follow-up|0|||
23329389|NCT01408303|64948563|FG001|Overall Study|Lost to Follow-up|1|||
23445612|NCT03777059|65373685|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
23445613|NCT03777059|65373686|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
23445614|NCT03777059|65373683|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
23445615|NCT03777059|65373684|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
23445616|NCT03777059|65373685|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
23445617|NCT03777059|65373686|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
23445618|NCT00685165|65373700|FG000|Washout Period of 14 Days|Adverse Event|1|||
23445619|NCT00685165|65373701|FG001|Washout Period of 14 Days|Adverse Event|0|||
23445620|NCT01288989|65373703|FG000|Overall Study|Death|0|||
23445621|NCT01288989|65373704|FG001|Overall Study|Death|0|||
23445622|NCT01288989|65373705|FG002|Overall Study|Death|0|||
23445623|NCT01288989|65373706|FG003|Overall Study|Death|1|||
23445624|NCT01288989|65373707|FG004|Overall Study|Death|0|||
23445625|NCT01288989|65373703|FG000|Overall Study|Dose limiting toxicity|1|||
23445626|NCT01288989|65373704|FG001|Overall Study|Dose limiting toxicity|0|||
23445627|NCT01288989|65373705|FG002|Overall Study|Dose limiting toxicity|0|||
23445628|NCT01288989|65373706|FG003|Overall Study|Dose limiting toxicity|0|||
23445629|NCT01288989|65373707|FG004|Overall Study|Dose limiting toxicity|0|||
23445630|NCT01288989|65373703|FG000|Overall Study|Adverse Event|0|||
23445631|NCT01288989|65373704|FG001|Overall Study|Adverse Event|0|||
23445632|NCT01288989|65373705|FG002|Overall Study|Adverse Event|0|||
23445633|NCT01288989|65373706|FG003|Overall Study|Adverse Event|0|||
23445634|NCT01288989|65373707|FG004|Overall Study|Adverse Event|2|||
23445635|NCT01288989|65373703|FG000|Overall Study|Physician Decision|0|||
23445636|NCT01288989|65373704|FG001|Overall Study|Physician Decision|0|||
23445637|NCT01288989|65373705|FG002|Overall Study|Physician Decision|0|||
23329390|NCT01408303|64948564|FG002|Overall Study|Lost to Follow-up|2|||
23329391|NCT01408303|64948562|FG000|Overall Study|Withdrawal by Subject|2|||
23329392|NCT01408303|64948563|FG001|Overall Study|Withdrawal by Subject|3|||
23329393|NCT01408303|64948564|FG002|Overall Study|Withdrawal by Subject|1|||
23445638|NCT01288989|65373706|FG003|Overall Study|Physician Decision|0|||
23445639|NCT01288989|65373707|FG004|Overall Study|Physician Decision|1|||
23445640|NCT01288989|65373703|FG000|Overall Study|Withdrawal by Subject|0|||
23445641|NCT01288989|65373704|FG001|Overall Study|Withdrawal by Subject|0|||
23445642|NCT01288989|65373705|FG002|Overall Study|Withdrawal by Subject|0|||
23445643|NCT01288989|65373706|FG003|Overall Study|Withdrawal by Subject|0|||
23445644|NCT01288989|65373707|FG004|Overall Study|Withdrawal by Subject|3|||
23445645|NCT02045862|65373712|FG000|Overall Study|Death|0|||
23445646|NCT02045862|65373713|FG001|Overall Study|Death|0|||
23445647|NCT02045862|65373714|FG002|Overall Study|Death|1|||
23445648|NCT02045862|65373712|FG000|Overall Study|Miscellaneous|5|||
23445649|NCT02045862|65373713|FG001|Overall Study|Miscellaneous|0|||
23445650|NCT02045862|65373714|FG002|Overall Study|Miscellaneous|8|||
23445651|NCT02045862|65373712|FG000|Overall Study|Withdrawal by Patient|18|||
23445652|NCT02045862|65373713|FG001|Overall Study|Withdrawal by Patient|27|||
23445653|NCT02045862|65373714|FG002|Overall Study|Withdrawal by Patient|57|||
23445654|NCT02045862|65373712|FG000|Overall Study|Protocol Violation|0|||
23445655|NCT02045862|65373713|FG001|Overall Study|Protocol Violation|0|||
23445656|NCT02045862|65373714|FG002|Overall Study|Protocol Violation|6|||
23445657|NCT02045862|65373712|FG000|Overall Study|Lack of Efficacy|8|||
23567746|NCT01848834|65807172|FG002|Overall Study|Lost to Follow-up|3|||
23567747|NCT01848834|65807173|FG003|Overall Study|Lost to Follow-up|0|||
23567748|NCT01848834|65807174|FG004|Overall Study|Lost to Follow-up|3|||
23567749|NCT01848834|65807170|FG000|Overall Study|Physician Decision|1|||
23567750|NCT01848834|65807171|FG001|Overall Study|Physician Decision|3|||
23567751|NCT01848834|65807172|FG002|Overall Study|Physician Decision|4|||
23567752|NCT01848834|65807173|FG003|Overall Study|Physician Decision|0|||
23567753|NCT01848834|65807174|FG004|Overall Study|Physician Decision|11|||
23567754|NCT01848834|65807170|FG000|Overall Study|Protocol Violation|0|||
23567755|NCT01848834|65807171|FG001|Overall Study|Protocol Violation|0|||
23567756|NCT01848834|65807172|FG002|Overall Study|Protocol Violation|0|||
23567757|NCT01848834|65807173|FG003|Overall Study|Protocol Violation|0|||
23567758|NCT01848834|65807174|FG004|Overall Study|Protocol Violation|1|||
23567759|NCT01848834|65807170|FG000|Overall Study|Sponsor Decision|1|||
23329394|NCT01408303|64948562|FG000|Overall Study|Protocol Violation|0|||
23329395|NCT01408303|64948563|FG001|Overall Study|Protocol Violation|1|||
23329396|NCT01408303|64948564|FG002|Overall Study|Protocol Violation|0|||
23567760|NCT01848834|65807171|FG001|Overall Study|Sponsor Decision|1|||
23329397|NCT01408303|64948562|FG000|Overall Study|Noncompliance|1|||
23445658|NCT02045862|65373713|FG001|Overall Study|Lack of Efficacy|4|||
23445659|NCT02045862|65373714|FG002|Overall Study|Lack of Efficacy|13|||
23222901|NCT01678313|64557832|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
23222902|NCT00246376|64557833|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
23222903|NCT00246376|64557834|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
23222904|NCT00246376|64557835|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
23222905|NCT00246376|64557836|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
23222906|NCT00246376|64557837|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
23222907|NCT00246376|64557833|FG000|Overall Study|Adverse Event|2|||
23222908|NCT00246376|64557834|FG001|Overall Study|Adverse Event|3|||
23222909|NCT00246376|64557835|FG002|Overall Study|Adverse Event|1|||
23222910|NCT00246376|64557836|FG003|Overall Study|Adverse Event|3|||
23222911|NCT00246376|64557837|FG004|Overall Study|Adverse Event|1|||
23222912|NCT00246376|64557833|FG000|Overall Study|Lost to Follow-up|2|||
23222913|NCT00246376|64557834|FG001|Overall Study|Lost to Follow-up|11|||
23222914|NCT00246376|64557835|FG002|Overall Study|Lost to Follow-up|11|||
23222915|NCT00246376|64557836|FG003|Overall Study|Lost to Follow-up|16|||
23222916|NCT00246376|64557837|FG004|Overall Study|Lost to Follow-up|13|||
23222917|NCT02940860|64557840|FG000|Overall Study|Non-serious AE|1|||
23222918|NCT02940860|64557841|FG001|Overall Study|Non-serious AE|2|||
23222919|NCT02940860|64557840|FG000|Overall Study|Serious AE|7|||
23222920|NCT02940860|64557841|FG001|Overall Study|Serious AE|3|||
23222921|NCT02940860|64557840|FG000|Overall Study|Withdrawal by Subject|19|||
23222922|NCT02940860|64557841|FG001|Overall Study|Withdrawal by Subject|9|||
23222923|NCT02940860|64557840|FG000|Overall Study|Lost to Follow-up|13|||
23222924|NCT02940860|64557841|FG001|Overall Study|Lost to Follow-up|7|||
23222925|NCT02940860|64557840|FG000|Overall Study|Physician Decision|5|||
23567761|NCT01848834|65807172|FG002|Overall Study|Sponsor Decision|0|||
23159994|NCT03200366|64335094|FG001|9 Month Post-Baseline Interview|Death|1|||
23159995|NCT03200366|64335095|FG002|9 Month Post-Baseline Interview|Death|1|||
23159996|NCT03200366|64335093|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
23159997|NCT03200366|64335094|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
23159998|NCT03200366|64335095|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
23159999|NCT03200366|64335093|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
23160000|NCT03200366|64335094|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
23160001|NCT03200366|64335095|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
23160002|NCT03200366|64335093|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
23160003|NCT03200366|64335094|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
23160004|NCT03200366|64335095|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
23160005|NCT01081912|64335098|FG000|Conversion/Titration|Adverse Event|47|||
23160006|NCT01081912|64335099|FG001|Conversion/Titration|Adverse Event|0|||
23160007|NCT01081912|64335100|FG002|Conversion/Titration|Adverse Event|0|||
23160008|NCT01081912|64335098|FG000|Conversion/Titration|Lack of Efficacy|17|||
23160009|NCT01081912|64335099|FG001|Conversion/Titration|Lack of Efficacy|0|||
23160010|NCT01081912|64335100|FG002|Conversion/Titration|Lack of Efficacy|0|||
23160011|NCT01081912|64335098|FG000|Conversion/Titration|Lost to Follow-up|5|||
23160012|NCT01081912|64335099|FG001|Conversion/Titration|Lost to Follow-up|0|||
23160013|NCT01081912|64335100|FG002|Conversion/Titration|Lost to Follow-up|0|||
23160014|NCT01081912|64335098|FG000|Conversion/Titration|Physician Decision|2|||
23160015|NCT01081912|64335099|FG001|Conversion/Titration|Physician Decision|0|||
23160016|NCT01081912|64335100|FG002|Conversion/Titration|Physician Decision|0|||
23160017|NCT01081912|64335098|FG000|Conversion/Titration|Protocol Violation|67|||
23160018|NCT01081912|64335099|FG001|Conversion/Titration|Protocol Violation|0|||
23160019|NCT01081912|64335100|FG002|Conversion/Titration|Protocol Violation|0|||
23160020|NCT01081912|64335098|FG000|Conversion/Titration|Withdrawal by Subject|23|||
23160021|NCT01081912|64335099|FG001|Conversion/Titration|Withdrawal by Subject|0|||
23160022|NCT01081912|64335100|FG002|Conversion/Titration|Withdrawal by Subject|0|||
23160023|NCT01081912|64335098|FG000|Conversion/Titration|Non-Compliance|47|||
23222926|NCT02940860|64557841|FG001|Overall Study|Physician Decision|3|||
23222927|NCT02940860|64557840|FG000|Overall Study|Sponsor Decision|0|||
23567762|NCT01848834|65807173|FG003|Overall Study|Sponsor Decision|1|||
23160024|NCT01081912|64335099|FG001|Conversion/Titration|Non-Compliance|0|||
23160025|NCT01081912|64335100|FG002|Conversion/Titration|Non-Compliance|0|||
23160026|NCT01081912|64335098|FG000|Maintenance Treatment|Adverse Event|0|||
23160027|NCT01081912|64335099|FG001|Maintenance Treatment|Adverse Event|2|||
23160028|NCT01081912|64335100|FG002|Maintenance Treatment|Adverse Event|12|||
23567763|NCT01848834|65807174|FG004|Overall Study|Sponsor Decision|1|||
23567764|NCT01848834|65807170|FG000|Overall Study|Withdrawal by Subject|2|||
23567765|NCT01848834|65807171|FG001|Overall Study|Withdrawal by Subject|13|||
23567766|NCT01848834|65807172|FG002|Overall Study|Withdrawal by Subject|10|||
23567767|NCT01848834|65807173|FG003|Overall Study|Withdrawal by Subject|6|||
23567768|NCT01848834|65807174|FG004|Overall Study|Withdrawal by Subject|36|||
23567769|NCT01868035|65807175|FG000|Overall Study|Lost to Follow-up|3|||
23567770|NCT01868035|65807175|FG000|Overall Study|Withdrawal by Subject|1|||
23567771|NCT01868035|65807175|FG000|Overall Study|Progressive Disease|2|||
23567772|NCT01868035|65807175|FG000|Overall Study|Non-compliance|1|||
23567773|NCT00406419|65807179|FG000|Overall Study|Death|3|||
23445660|NCT02045862|65373712|FG000|Overall Study|Randomized but not Received Study Drug|0|||
23445661|NCT02045862|65373713|FG001|Overall Study|Randomized but not Received Study Drug|2|||
23445662|NCT02045862|65373714|FG002|Overall Study|Randomized but not Received Study Drug|8|||
23445663|NCT02045862|65373712|FG000|Overall Study|Adverse Event|7|||
23445664|NCT02045862|65373713|FG001|Overall Study|Adverse Event|5|||
23445665|NCT02045862|65373714|FG002|Overall Study|Adverse Event|27|||
23445666|NCT02045862|65373712|FG000|Overall Study|Lost to Follow-up|1|||
23445667|NCT02045862|65373713|FG001|Overall Study|Lost to Follow-up|2|||
23445668|NCT02045862|65373714|FG002|Overall Study|Lost to Follow-up|6|||
23445669|NCT02342223|65373715|FG000|Overall Study|Lost to Follow-up|1|||
23445670|NCT00511134|65373716|FG000|Overall Study|Withdrawal by Subject|0|||
23445671|NCT00511134|65373717|FG001|Overall Study|Withdrawal by Subject|2|||
23445672|NCT00132808|65373718|FG000|Stratum I|Adverse Event|2|||
23445673|NCT00132808|65373719|FG001|Stratum I|Adverse Event|1|||
23445674|NCT00132808|65373720|FG002|Stratum I|Adverse Event|0|||
23445675|NCT00132808|65373718|FG000|Stratum I|Lost to Follow-up|3|||
23445676|NCT00132808|65373719|FG001|Stratum I|Lost to Follow-up|4|||
23445677|NCT00132808|65373720|FG002|Stratum I|Lost to Follow-up|1|||
23445678|NCT00132808|65373718|FG000|Stratum I|Withdrawal by Subject|4|||
23445679|NCT00132808|65373719|FG001|Stratum I|Withdrawal by Subject|7|||
23445680|NCT00132808|65373720|FG002|Stratum I|Withdrawal by Subject|3|||
23445681|NCT00132808|65373718|FG000|Stratum I|Abnormal test procedure result (s)|0|||
23445682|NCT00132808|65373719|FG001|Stratum I|Abnormal test procedure result (s)|0|||
23445683|NCT00132808|65373720|FG002|Stratum I|Abnormal test procedure result (s)|1|||
23445684|NCT00132808|65373718|FG000|Stratum II|Adverse Event|1|||
23445685|NCT00132808|65373719|FG001|Stratum II|Adverse Event|2|||
23445686|NCT00132808|65373720|FG002|Stratum II|Adverse Event|1|||
23445687|NCT00132808|65373718|FG000|Stratum II|Death|1|||
23445688|NCT00132808|65373719|FG001|Stratum II|Death|0|||
23445689|NCT00132808|65373720|FG002|Stratum II|Death|0|||
23445690|NCT00132808|65373718|FG000|Stratum II|Lost to Follow-up|2|||
23445691|NCT00132808|65373719|FG001|Stratum II|Lost to Follow-up|2|||
23445692|NCT00132808|65373720|FG002|Stratum II|Lost to Follow-up|1|||
23445693|NCT00132808|65373718|FG000|Stratum II|Protocol Violation|0|||
23445694|NCT00132808|65373719|FG001|Stratum II|Protocol Violation|2|||
23445695|NCT00132808|65373720|FG002|Stratum II|Protocol Violation|1|||
23445696|NCT00132808|65373718|FG000|Stratum II|Withdrawal by Subject|4|||
23445697|NCT00132808|65373719|FG001|Stratum II|Withdrawal by Subject|9|||
23445698|NCT00132808|65373720|FG002|Stratum II|Withdrawal by Subject|6|||
23445699|NCT00782717|65373721|FG000|Overall Study|Adverse Event|2|||
23445700|NCT00782717|65373722|FG001|Overall Study|Adverse Event|5|||
23445701|NCT00782717|65373721|FG000|Overall Study|Patient decision unrelated to AE|6|||
23445702|NCT00782717|65373722|FG001|Overall Study|Patient decision unrelated to AE|3|||
23445703|NCT00782717|65373721|FG000|Overall Study|Noncompliance|2|||
23445704|NCT00782717|65373722|FG001|Overall Study|Noncompliance|1|||
23445705|NCT00782717|65373721|FG000|Overall Study|Treatment failure|3|||
23445706|NCT00782717|65373722|FG001|Overall Study|Treatment failure|14|||
23445707|NCT00782717|65373721|FG000|Overall Study|Enrollment close prior to surgery|1|||
23445708|NCT00782717|65373722|FG001|Overall Study|Enrollment close prior to surgery|0|||
23445709|NCT00782717|65373721|FG000|Overall Study|Did not meet entrance criteria|1|||
23445710|NCT00782717|65373722|FG001|Overall Study|Did not meet entrance criteria|3|||
23445711|NCT00782717|65373721|FG000|Overall Study|Exited in error|0|||
23445712|NCT00782717|65373722|FG001|Overall Study|Exited in error|2|||
23445713|NCT03738618|65373730|FG000|Overall Study|Protocol deviation|23|||
23445714|NCT03738618|65373731|FG001|Overall Study|Protocol deviation|0|||
23445715|NCT03738618|65373730|FG000|Overall Study|Adverse Event|4|||
23445716|NCT03738618|65373731|FG001|Overall Study|Adverse Event|0|||
23445717|NCT03738618|65373730|FG000|Overall Study|Lost to Follow-up|2|||
23445718|NCT03738618|65373731|FG001|Overall Study|Lost to Follow-up|0|||
23445719|NCT03738618|65373730|FG000|Overall Study|Randomization failure|1|||
23445720|NCT03738618|65373731|FG001|Overall Study|Randomization failure|0|||
23445721|NCT03738618|65373730|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
23445722|NCT03738618|65373731|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
23445723|NCT03738618|65373730|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
23445724|NCT03738618|65373731|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
23445725|NCT00931606|65373734|FG000|Overall Study|Death|1|||
23445726|NCT00931606|65373735|FG001|Overall Study|Death|3|||
23445727|NCT00931606|65373736|FG002|Overall Study|Death|2|||
23445728|NCT00931606|65373737|FG003|Overall Study|Death|0|||
23445729|NCT00931606|65373734|FG000|Overall Study|Lost to Follow-up|0|||
23445730|NCT00931606|65373735|FG001|Overall Study|Lost to Follow-up|1|||
23445731|NCT00931606|65373736|FG002|Overall Study|Lost to Follow-up|0|||
23445732|NCT00931606|65373737|FG003|Overall Study|Lost to Follow-up|0|||
23445733|NCT00931606|65373734|FG000|Overall Study|Physician Decision|0|||
23445734|NCT00931606|65373735|FG001|Overall Study|Physician Decision|0|||
23445735|NCT00931606|65373736|FG002|Overall Study|Physician Decision|3|||
23445736|NCT00931606|65373737|FG003|Overall Study|Physician Decision|0|||
23445737|NCT00931606|65373734|FG000|Overall Study|Sponsor Decision|1|||
23445738|NCT00931606|65373735|FG001|Overall Study|Sponsor Decision|4|||
23445739|NCT00931606|65373736|FG002|Overall Study|Sponsor Decision|0|||
23445740|NCT00931606|65373737|FG003|Overall Study|Sponsor Decision|2|||
23445741|NCT00931606|65373734|FG000|Overall Study|Withdrawal by Subject|3|||
23445742|NCT00931606|65373735|FG001|Overall Study|Withdrawal by Subject|1|||
23445743|NCT00931606|65373736|FG002|Overall Study|Withdrawal by Subject|1|||
23445744|NCT00931606|65373737|FG003|Overall Study|Withdrawal by Subject|1|||
23445745|NCT02223715|65373738|FG000|Overall Study|Death|31|||
23445746|NCT02223715|65373738|FG000|Overall Study|Lost to Follow-up|73|||
23445747|NCT01010971|65373739|FG000|Overall Study|Adverse Event|2|||
23445748|NCT01010971|65373740|FG001|Overall Study|Adverse Event|4|||
23445749|NCT01010971|65373741|FG002|Overall Study|Adverse Event|3|||
23445750|NCT01010971|65373739|FG000|Overall Study|Withdrawal by Subject|0|||
23445751|NCT01010971|65373740|FG001|Overall Study|Withdrawal by Subject|2|||
23445752|NCT01010971|65373741|FG002|Overall Study|Withdrawal by Subject|5|||
23445753|NCT01010971|65373739|FG000|Overall Study|Lost to Follow-up|0|||
23445754|NCT01010971|65373740|FG001|Overall Study|Lost to Follow-up|2|||
23445755|NCT01010971|65373741|FG002|Overall Study|Lost to Follow-up|3|||
23445756|NCT01010971|65373739|FG000|Overall Study|Other|1|||
23445757|NCT01010971|65373740|FG001|Overall Study|Other|0|||
23445758|NCT01010971|65373741|FG002|Overall Study|Other|2|||
23445759|NCT03386721|65373742|FG000|Overall Study|Death|12|||
23445760|NCT03386721|65373743|FG001|Overall Study|Death|21|||
23445761|NCT03386721|65373744|FG002|Overall Study|Death|2|||
23445762|NCT03386721|65373745|FG003|Overall Study|Death|5|||
23445763|NCT03386721|65373746|FG004|Overall Study|Death|1|||
23445764|NCT03386721|65373747|FG005|Overall Study|Death|12|||
23445765|NCT03386721|65373748|FG006|Overall Study|Death|1|||
23445766|NCT03386721|65373749|FG007|Overall Study|Death|1|||
23445767|NCT03386721|65373750|FG008|Overall Study|Death|12|||
23445768|NCT03386721|65373751|FG009|Overall Study|Death|20|||
23445769|NCT03386721|65373752|FG010|Overall Study|Death|21|||
23445770|NCT03386721|65373753|FG011|Overall Study|Death|21|||
23445771|NCT03386721|65373754|FG012|Overall Study|Death|14|||
23445772|NCT03386721|65373755|FG013|Overall Study|Death|2|||
23445773|NCT03386721|65373756|FG014|Overall Study|Death|1|||
23445774|NCT03386721|65373742|FG000|Overall Study|Lost to Follow-up|1|||
23445775|NCT03386721|65373743|FG001|Overall Study|Lost to Follow-up|3|||
23445776|NCT03386721|65373744|FG002|Overall Study|Lost to Follow-up|0|||
23445777|NCT03386721|65373745|FG003|Overall Study|Lost to Follow-up|0|||
23445778|NCT03386721|65373746|FG004|Overall Study|Lost to Follow-up|0|||
23445779|NCT03386721|65373747|FG005|Overall Study|Lost to Follow-up|2|||
23445780|NCT03386721|65373748|FG006|Overall Study|Lost to Follow-up|1|||
23445781|NCT03386721|65373749|FG007|Overall Study|Lost to Follow-up|0|||
23445782|NCT03386721|65373750|FG008|Overall Study|Lost to Follow-up|1|||
23445783|NCT03386721|65373751|FG009|Overall Study|Lost to Follow-up|2|||
23160029|NCT01081912|64335098|FG000|Maintenance Treatment|Lack of Efficacy|0|||
23445784|NCT03386721|65373752|FG010|Overall Study|Lost to Follow-up|1|||
23445785|NCT03386721|65373753|FG011|Overall Study|Lost to Follow-up|0|||
23445786|NCT03386721|65373754|FG012|Overall Study|Lost to Follow-up|0|||
23445787|NCT03386721|65373755|FG013|Overall Study|Lost to Follow-up|0|||
23567774|NCT00406419|65807180|FG001|Overall Study|Death|1|||
23567775|NCT00406419|65807181|FG002|Overall Study|Death|4|||
23567776|NCT00406419|65807179|FG000|Overall Study|Protocol Violation|6|||
23567777|NCT00406419|65807180|FG001|Overall Study|Protocol Violation|2|||
23567778|NCT00406419|65807181|FG002|Overall Study|Protocol Violation|5|||
23567779|NCT00406419|65807179|FG000|Overall Study|Study Terminated by Sponsor|260|||
23567780|NCT00406419|65807180|FG001|Overall Study|Study Terminated by Sponsor|288|||
23567781|NCT00406419|65807181|FG002|Overall Study|Study Terminated by Sponsor|282|||
23567782|NCT00406419|65807179|FG000|Overall Study|Withdrawal by Subject|17|||
23567783|NCT00406419|65807180|FG001|Overall Study|Withdrawal by Subject|24|||
23567784|NCT00406419|65807181|FG002|Overall Study|Withdrawal by Subject|26|||
23567785|NCT00406419|65807179|FG000|Overall Study|Lack of Efficacy|12|||
23445788|NCT03386721|65373756|FG014|Overall Study|Lost to Follow-up|0|||
23445789|NCT03386721|65373742|FG000|Overall Study|Reason not specified|3|||
23445790|NCT03386721|65373743|FG001|Overall Study|Reason not specified|0|||
23567786|NCT00406419|65807180|FG001|Overall Study|Lack of Efficacy|1|||
23567787|NCT00406419|65807181|FG002|Overall Study|Lack of Efficacy|6|||
23445791|NCT03386721|65373744|FG002|Overall Study|Reason not specified|0|||
23445792|NCT03386721|65373745|FG003|Overall Study|Reason not specified|0|||
23445793|NCT03386721|65373746|FG004|Overall Study|Reason not specified|0|||
23445794|NCT03386721|65373747|FG005|Overall Study|Reason not specified|3|||
23445795|NCT03386721|65373748|FG006|Overall Study|Reason not specified|1|||
23445796|NCT03386721|65373749|FG007|Overall Study|Reason not specified|0|||
23222928|NCT02940860|64557841|FG001|Overall Study|Sponsor Decision|1|||
23222929|NCT02940860|64557840|FG000|Overall Study|Protocol Violation|0|||
23222930|NCT02940860|64557841|FG001|Overall Study|Protocol Violation|2|||
23160030|NCT01081912|64335099|FG001|Maintenance Treatment|Lack of Efficacy|14|||
23222931|NCT02940860|64557840|FG000|Overall Study|Death|3|||
23222932|NCT02940860|64557841|FG001|Overall Study|Death|2|||
23222933|NCT02940860|64557840|FG000|Overall Study|Moved, poor venous access, transport|6|||
23160031|NCT01081912|64335100|FG002|Maintenance Treatment|Lack of Efficacy|64|||
23160032|NCT01081912|64335098|FG000|Maintenance Treatment|Lost to Follow-up|0|||
23160033|NCT01081912|64335099|FG001|Maintenance Treatment|Lost to Follow-up|1|||
23160034|NCT01081912|64335100|FG002|Maintenance Treatment|Lost to Follow-up|0|||
23160035|NCT01081912|64335098|FG000|Maintenance Treatment|Physician Decision|0|||
23160036|NCT01081912|64335099|FG001|Maintenance Treatment|Physician Decision|0|||
23160037|NCT01081912|64335100|FG002|Maintenance Treatment|Physician Decision|1|||
23160038|NCT01081912|64335098|FG000|Maintenance Treatment|Protocol Violation|0|||
23160039|NCT01081912|64335099|FG001|Maintenance Treatment|Protocol Violation|1|||
23160040|NCT01081912|64335100|FG002|Maintenance Treatment|Protocol Violation|2|||
23160041|NCT01081912|64335098|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
23160042|NCT01081912|64335099|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
23160043|NCT01081912|64335100|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
23160044|NCT01081912|64335098|FG000|Maintenance Treatment|Non-Compliance|0|||
23160045|NCT01081912|64335099|FG001|Maintenance Treatment|Non-Compliance|4|||
23160046|NCT01081912|64335100|FG002|Maintenance Treatment|Non-Compliance|7|||
23160047|NCT01081912|64335098|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
23160048|NCT01081912|64335099|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
23160049|NCT01081912|64335100|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
23160050|NCT01197521|64335103|FG000|Overall Study|Not reported|24|||
23160051|NCT01197521|64335104|FG001|Overall Study|Not reported|25|||
23160052|NCT01197521|64335105|FG002|Overall Study|Not reported|21|||
23160053|NCT01197521|64335103|FG000|Overall Study|Enrolment in long term extension|42|||
23160054|NCT01197521|64335104|FG001|Overall Study|Enrolment in long term extension|36|||
23160055|NCT01197521|64335105|FG002|Overall Study|Enrolment in long term extension|87|||
23160056|NCT01197521|64335103|FG000|Overall Study|Severe non-compliance to protocol|1|||
23160057|NCT01197521|64335104|FG001|Overall Study|Severe non-compliance to protocol|3|||
23160058|NCT01197521|64335105|FG002|Overall Study|Severe non-compliance to protocol|3|||
23160059|NCT01197521|64335103|FG000|Overall Study|Lack of therapeutic response|2|||
23160060|NCT01197521|64335104|FG001|Overall Study|Lack of therapeutic response|3|||
23160061|NCT01197521|64335105|FG002|Overall Study|Lack of therapeutic response|4|||
23160062|NCT01197521|64335103|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
23160063|NCT01197521|64335104|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
23160064|NCT01197521|64335105|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
23160065|NCT01197521|64335103|FG000|Overall Study|Lost to Follow-up|3|||
23160066|NCT01197521|64335104|FG001|Overall Study|Lost to Follow-up|2|||
23160067|NCT01197521|64335105|FG002|Overall Study|Lost to Follow-up|2|||
23160068|NCT01197521|64335103|FG000|Overall Study|Adverse Event|25|||
23160069|NCT01197521|64335104|FG001|Overall Study|Adverse Event|28|||
23222934|NCT02940860|64557841|FG001|Overall Study|Moved, poor venous access, transport|4|||
23222935|NCT02940860|64557840|FG000|Overall Study|Not treated|2|||
23222936|NCT02940860|64557841|FG001|Overall Study|Not treated|2|||
23329398|NCT01408303|64948563|FG001|Overall Study|Noncompliance|0|||
23329399|NCT01408303|64948564|FG002|Overall Study|Noncompliance|1|||
23329400|NCT02877004|64948565|FG000|Overall Study|Pregnancy|0|||
23329401|NCT02877004|64948566|FG001|Overall Study|Pregnancy|0|||
23329402|NCT02877004|64948567|FG002|Overall Study|Pregnancy|1|||
23329403|NCT01198470|64948569|FG000|Overall Study|Adverse Event|2|||
23329404|NCT02362360|64948570|FG000|Period 1|Lack of Efficacy|1|||
23329405|NCT02362360|64948571|FG001|Period 1|Lack of Efficacy|0|||
23329406|NCT02362360|64948570|FG000|Period 1|Withdrawal by Subject|2|||
23329407|NCT02362360|64948571|FG001|Period 1|Withdrawal by Subject|1|||
23329408|NCT02285361|64948575|FG000|Overall Study|Protocol Violation|43|||
23329409|NCT02285361|64948575|FG000|Overall Study|Lost to Follow-up|5|||
23329410|NCT02285361|64948575|FG000|Overall Study|Not taken GIOTRIF|2|||
23329411|NCT02285361|64948575|FG000|Overall Study|Consented prior to the contract date|1|||
23567788|NCT00406419|65807179|FG000|Overall Study|Non-Compliance with Study Drug|5|||
23567789|NCT00406419|65807180|FG001|Overall Study|Non-Compliance with Study Drug|6|||
23567790|NCT00406419|65807181|FG002|Overall Study|Non-Compliance with Study Drug|3|||
23567791|NCT00406419|65807179|FG000|Overall Study|Adverse Event|10|||
23567792|NCT00406419|65807180|FG001|Overall Study|Adverse Event|12|||
23567793|NCT00406419|65807181|FG002|Overall Study|Adverse Event|16|||
23567794|NCT00406419|65807179|FG000|Overall Study|Lost to Follow-up|11|||
23567795|NCT00406419|65807180|FG001|Overall Study|Lost to Follow-up|10|||
23567796|NCT00406419|65807181|FG002|Overall Study|Lost to Follow-up|5|||
23567797|NCT00857805|65807182|FG000|Overall Study|Withdrawal by Subject|1|||
23567798|NCT00857805|65807183|FG001|Overall Study|Withdrawal by Subject|1|||
23567799|NCT00996580|65807186|FG000|Overall Study|Adverse Event|466|||
23567800|NCT00996580|65807186|FG000|Overall Study|Lost to Follow-up|480|||
23567801|NCT00996580|65807186|FG000|Overall Study|Noncompliance with the protocol|137|||
23567802|NCT00996580|65807186|FG000|Overall Study|Physician Decision|5|||
23567803|NCT00996580|65807186|FG000|Overall Study|Pregnancy|68|||
23567804|NCT00996580|65807186|FG000|Overall Study|Protocol Violation|16|||
23567805|NCT00996580|65807186|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
23567806|NCT00996580|65807186|FG000|Overall Study|Withdrawal by Subject|217|||
23567807|NCT00996580|65807186|FG000|Overall Study|Other|29|||
23567808|NCT01317875|65807187|FG000|Overall Study|Other|0|||
23567809|NCT01317875|65807188|FG001|Overall Study|Other|0|||
23160070|NCT01197521|64335105|FG002|Overall Study|Adverse Event|24|||
23160071|NCT00496730|64335109|FG000|Overall Study|Lost to Follow-up|4|||
23160072|NCT00496730|64335110|FG001|Overall Study|Lost to Follow-up|3|||
23160073|NCT00496730|64335109|FG000|Overall Study|Withdrawal by Subject|2|||
23160074|NCT00496730|64335110|FG001|Overall Study|Withdrawal by Subject|2|||
23160075|NCT03077685|64335111|FG000|Overall Study|Lost to Follow-up|0|||
23160076|NCT03077685|64335112|FG001|Overall Study|Lost to Follow-up|0|||
23160077|NCT03077685|64335113|FG002|Overall Study|Lost to Follow-up|0|||
23160078|NCT03077685|64335114|FG003|Overall Study|Lost to Follow-up|0|||
23160079|NCT03077685|64335115|FG004|Overall Study|Lost to Follow-up|1|||
23160080|NCT03077685|64335111|FG000|Overall Study|Death|0|||
23160081|NCT03077685|64335112|FG001|Overall Study|Death|0|||
23160082|NCT03077685|64335113|FG002|Overall Study|Death|1|||
23160083|NCT03077685|64335114|FG003|Overall Study|Death|1|||
23160084|NCT03077685|64335115|FG004|Overall Study|Death|3|||
23160085|NCT03077685|64335111|FG000|Overall Study|Withdrawal by Subject|0|||
23160086|NCT03077685|64335112|FG001|Overall Study|Withdrawal by Subject|0|||
23160087|NCT03077685|64335113|FG002|Overall Study|Withdrawal by Subject|0|||
23160088|NCT03077685|64335114|FG003|Overall Study|Withdrawal by Subject|2|||
23160089|NCT03077685|64335115|FG004|Overall Study|Withdrawal by Subject|1|||
23160090|NCT03077685|64335111|FG000|Overall Study|Physician Decision|0|||
23160091|NCT03077685|64335112|FG001|Overall Study|Physician Decision|0|||
23160092|NCT03077685|64335113|FG002|Overall Study|Physician Decision|1|||
23160093|NCT03077685|64335114|FG003|Overall Study|Physician Decision|0|||
23160094|NCT03077685|64335115|FG004|Overall Study|Physician Decision|3|||
23160095|NCT03077685|64335111|FG000|Overall Study|Disease Progression|1|||
23160096|NCT03077685|64335112|FG001|Overall Study|Disease Progression|0|||
23160097|NCT03077685|64335113|FG002|Overall Study|Disease Progression|0|||
23160098|NCT03077685|64335114|FG003|Overall Study|Disease Progression|2|||
23160099|NCT03077685|64335115|FG004|Overall Study|Disease Progression|1|||
23160100|NCT03077685|64335111|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
23160101|NCT03077685|64335112|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
23160102|NCT03077685|64335113|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
23160103|NCT03077685|64335114|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
23160104|NCT03077685|64335115|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
23160105|NCT03077685|64335111|FG000|Overall Study|Subject entered hospice care|0|||
23160106|NCT03077685|64335112|FG001|Overall Study|Subject entered hospice care|0|||
23160107|NCT03077685|64335113|FG002|Overall Study|Subject entered hospice care|0|||
23160108|NCT03077685|64335114|FG003|Overall Study|Subject entered hospice care|0|||
23160109|NCT03077685|64335115|FG004|Overall Study|Subject entered hospice care|1|||
23160110|NCT00609986|64335123|FG000|Overall Study|Did not receive transplant or treatment|8|||
23222937|NCT00707486|64557844|FG000|Overall Study|Withdrawal by Subject|1|||
23222938|NCT02658968|64557845|FG000|Received Rituximab|Adverse Event|0|||
23222939|NCT02658968|64557846|FG001|Received Rituximab|Adverse Event|0|||
23222940|NCT02658968|64557847|FG002|Received Rituximab|Adverse Event|0|||
23222941|NCT02658968|64557848|FG003|Received Rituximab|Adverse Event|0|||
23222942|NCT02658968|64557849|FG004|Received Rituximab|Adverse Event|1|||
23222943|NCT02658968|64557845|FG000|Received Rituximab|Progressive disease|0|||
23222944|NCT02658968|64557846|FG001|Received Rituximab|Progressive disease|0|||
23222945|NCT02658968|64557847|FG002|Received Rituximab|Progressive disease|0|||
23160111|NCT00609986|64335124|FG001|Overall Study|Did not receive transplant or treatment|3|||
23160112|NCT03127384|64335125|FG000|Overall Study|Lost to Follow-up|4|||
23160113|NCT03127384|64335125|FG000|Overall Study|Subject request|2|||
23160114|NCT03150862|64335129|FG000|Overall Study|Death|2|||
23160115|NCT03150862|64335130|FG001|Overall Study|Death|7|||
23160116|NCT03150862|64335131|FG002|Overall Study|Death|8|||
23160117|NCT03150862|64335132|FG003|Overall Study|Death|27|||
23160118|NCT03150862|64335133|FG004|Overall Study|Death|4|||
23160119|NCT03150862|64335134|FG005|Overall Study|Death|8|||
23160120|NCT03150862|64335135|FG006|Overall Study|Death|6|||
23160121|NCT03150862|64335136|FG007|Overall Study|Death|21|||
23160122|NCT03150862|64335129|FG000|Overall Study|Withdrawal by Subject|1|||
23222946|NCT02658968|64557848|FG003|Received Rituximab|Progressive disease|0|||
23160123|NCT03150862|64335130|FG001|Overall Study|Withdrawal by Subject|1|||
23160124|NCT03150862|64335131|FG002|Overall Study|Withdrawal by Subject|0|||
23222947|NCT02658968|64557849|FG004|Received Rituximab|Progressive disease|1|||
23222948|NCT02658968|64557845|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
23222949|NCT02658968|64557846|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
23222950|NCT02658968|64557847|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
23222951|NCT02658968|64557848|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
23222952|NCT02658968|64557849|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
23222953|NCT02658968|64557845|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
23222954|NCT02658968|64557846|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
23567810|NCT01317875|65807189|FG002|Overall Study|Other|1|||
23567811|NCT01317875|65807190|FG003|Overall Study|Other|0|||
23567812|NCT01317875|65807191|FG004|Overall Study|Other|0|||
23567813|NCT01317875|65807192|FG005|Overall Study|Other|0|||
23567814|NCT01317875|65807193|FG006|Overall Study|Other|0|||
23160125|NCT03150862|64335132|FG003|Overall Study|Withdrawal by Subject|3|||
23160126|NCT03150862|64335133|FG004|Overall Study|Withdrawal by Subject|1|||
23160127|NCT03150862|64335134|FG005|Overall Study|Withdrawal by Subject|1|||
23160128|NCT03150862|64335135|FG006|Overall Study|Withdrawal by Subject|1|||
23160129|NCT03150862|64335136|FG007|Overall Study|Withdrawal by Subject|3|||
23160130|NCT03150862|64335129|FG000|Overall Study|Lost to Follow-up|0|||
23160131|NCT03150862|64335130|FG001|Overall Study|Lost to Follow-up|0|||
23160132|NCT03150862|64335131|FG002|Overall Study|Lost to Follow-up|1|||
23160133|NCT03150862|64335132|FG003|Overall Study|Lost to Follow-up|0|||
23160134|NCT03150862|64335133|FG004|Overall Study|Lost to Follow-up|0|||
23160135|NCT03150862|64335134|FG005|Overall Study|Lost to Follow-up|0|||
23160136|NCT03150862|64335135|FG006|Overall Study|Lost to Follow-up|0|||
23160137|NCT03150862|64335136|FG007|Overall Study|Lost to Follow-up|2|||
23160138|NCT03150862|64335129|FG000|Overall Study|Sponsor's decision|0|||
23160139|NCT03150862|64335130|FG001|Overall Study|Sponsor's decision|0|||
23160140|NCT03150862|64335131|FG002|Overall Study|Sponsor's decision|0|||
23160141|NCT03150862|64335132|FG003|Overall Study|Sponsor's decision|10|||
23160142|NCT03150862|64335133|FG004|Overall Study|Sponsor's decision|3|||
23160143|NCT03150862|64335134|FG005|Overall Study|Sponsor's decision|0|||
23160144|NCT03150862|64335135|FG006|Overall Study|Sponsor's decision|1|||
23160145|NCT03150862|64335136|FG007|Overall Study|Sponsor's decision|1|||
23160146|NCT03150862|64335129|FG000|Overall Study|Change in Methylation status|0|||
23160147|NCT03150862|64335130|FG001|Overall Study|Change in Methylation status|0|||
23160148|NCT03150862|64335131|FG002|Overall Study|Change in Methylation status|0|||
23160149|NCT03150862|64335132|FG003|Overall Study|Change in Methylation status|0|||
23160150|NCT03150862|64335133|FG004|Overall Study|Change in Methylation status|1|||
23160151|NCT03150862|64335134|FG005|Overall Study|Change in Methylation status|0|||
23567815|NCT01317875|65807194|FG007|Overall Study|Other|0|||
23567816|NCT01317875|65807195|FG008|Overall Study|Other|0|||
23567817|NCT01317875|65807196|FG009|Overall Study|Other|0|||
23567818|NCT01317875|65807187|FG000|Overall Study|Noncompliance with study drug|0|||
23567819|NCT01317875|65807188|FG001|Overall Study|Noncompliance with study drug|0|||
23567820|NCT01317875|65807189|FG002|Overall Study|Noncompliance with study drug|1|||
23567821|NCT01317875|65807190|FG003|Overall Study|Noncompliance with study drug|0|||
23567822|NCT01317875|65807191|FG004|Overall Study|Noncompliance with study drug|0|||
23160152|NCT03150862|64335135|FG006|Overall Study|Change in Methylation status|0|||
23160153|NCT03150862|64335136|FG007|Overall Study|Change in Methylation status|0|||
23160154|NCT03150862|64335129|FG000|Overall Study|Roll over in to Long Term Extension|0|||
23160155|NCT03150862|64335130|FG001|Overall Study|Roll over in to Long Term Extension|0|||
23160156|NCT03150862|64335131|FG002|Overall Study|Roll over in to Long Term Extension|0|||
23160157|NCT03150862|64335132|FG003|Overall Study|Roll over in to Long Term Extension|0|||
23567823|NCT01317875|65807192|FG005|Overall Study|Noncompliance with study drug|0|||
23567824|NCT01317875|65807193|FG006|Overall Study|Noncompliance with study drug|0|||
23567825|NCT01317875|65807194|FG007|Overall Study|Noncompliance with study drug|0|||
23567826|NCT01317875|65807195|FG008|Overall Study|Noncompliance with study drug|0|||
23567827|NCT01317875|65807196|FG009|Overall Study|Noncompliance with study drug|0|||
23567828|NCT01317875|65807187|FG000|Overall Study|Progressive Disease|1|||
23567829|NCT01317875|65807188|FG001|Overall Study|Progressive Disease|0|||
23567830|NCT01317875|65807189|FG002|Overall Study|Progressive Disease|2|||
23567831|NCT01317875|65807190|FG003|Overall Study|Progressive Disease|0|||
23567832|NCT01317875|65807191|FG004|Overall Study|Progressive Disease|1|||
23567833|NCT01317875|65807192|FG005|Overall Study|Progressive Disease|0|||
23567834|NCT01317875|65807193|FG006|Overall Study|Progressive Disease|0|||
23567835|NCT01317875|65807194|FG007|Overall Study|Progressive Disease|1|||
23567836|NCT01317875|65807195|FG008|Overall Study|Progressive Disease|0|||
23567837|NCT01317875|65807196|FG009|Overall Study|Progressive Disease|0|||
23567838|NCT01317875|65807187|FG000|Overall Study|Withdrawal by Subject|0|||
23567839|NCT01317875|65807188|FG001|Overall Study|Withdrawal by Subject|0|||
23567840|NCT01317875|65807189|FG002|Overall Study|Withdrawal by Subject|0|||
23567841|NCT01317875|65807190|FG003|Overall Study|Withdrawal by Subject|0|||
23567842|NCT01317875|65807191|FG004|Overall Study|Withdrawal by Subject|1|||
23567843|NCT01317875|65807192|FG005|Overall Study|Withdrawal by Subject|0|||
23567844|NCT01317875|65807193|FG006|Overall Study|Withdrawal by Subject|0|||
23567845|NCT01317875|65807194|FG007|Overall Study|Withdrawal by Subject|3|||
23567846|NCT01317875|65807195|FG008|Overall Study|Withdrawal by Subject|0|||
23567847|NCT01317875|65807196|FG009|Overall Study|Withdrawal by Subject|0|||
23567848|NCT01317875|65807187|FG000|Overall Study|Physician Decision|0|||
23567849|NCT01317875|65807188|FG001|Overall Study|Physician Decision|1|||
23567850|NCT01317875|65807189|FG002|Overall Study|Physician Decision|1|||
23567851|NCT01317875|65807190|FG003|Overall Study|Physician Decision|0|||
23567852|NCT01317875|65807191|FG004|Overall Study|Physician Decision|2|||
23567853|NCT01317875|65807192|FG005|Overall Study|Physician Decision|0|||
23567854|NCT01317875|65807193|FG006|Overall Study|Physician Decision|0|||
23567855|NCT01317875|65807194|FG007|Overall Study|Physician Decision|2|||
23567856|NCT01317875|65807195|FG008|Overall Study|Physician Decision|0|||
23567857|NCT01317875|65807196|FG009|Overall Study|Physician Decision|0|||
23567858|NCT01317875|65807187|FG000|Overall Study|Death|0|||
23567859|NCT01317875|65807188|FG001|Overall Study|Death|0|||
23567860|NCT01317875|65807189|FG002|Overall Study|Death|2|||
23567861|NCT01317875|65807190|FG003|Overall Study|Death|1|||
23567862|NCT01317875|65807191|FG004|Overall Study|Death|0|||
23567863|NCT01317875|65807192|FG005|Overall Study|Death|1|||
23567864|NCT01317875|65807193|FG006|Overall Study|Death|0|||
23567865|NCT01317875|65807194|FG007|Overall Study|Death|4|||
23567866|NCT01317875|65807195|FG008|Overall Study|Death|0|||
23567867|NCT01317875|65807196|FG009|Overall Study|Death|0|||
23567868|NCT01317875|65807187|FG000|Overall Study|Adverse Event|2|||
23567869|NCT01317875|65807188|FG001|Overall Study|Adverse Event|1|||
23567870|NCT01317875|65807189|FG002|Overall Study|Adverse Event|2|||
23567871|NCT01317875|65807190|FG003|Overall Study|Adverse Event|1|||
23567872|NCT01317875|65807191|FG004|Overall Study|Adverse Event|5|||
23567873|NCT01317875|65807192|FG005|Overall Study|Adverse Event|1|||
23567874|NCT01317875|65807193|FG006|Overall Study|Adverse Event|2|||
23567875|NCT01317875|65807194|FG007|Overall Study|Adverse Event|5|||
23160158|NCT03150862|64335133|FG004|Overall Study|Roll over in to Long Term Extension|0|||
23160159|NCT03150862|64335134|FG005|Overall Study|Roll over in to Long Term Extension|0|||
23567876|NCT01317875|65807195|FG008|Overall Study|Adverse Event|0|||
23567877|NCT01317875|65807196|FG009|Overall Study|Adverse Event|0|||
23567878|NCT02291432|65807198|FG000|Overall Study|Withdrawal by Subject|2|||
23567879|NCT00077636|65807199|FG000|Overall Study|Refused Treatment|9|||
23567880|NCT00077636|65807200|FG001|Overall Study|Refused Treatment|31|||
23567881|NCT00077636|65807199|FG000|Overall Study|Admin|3|||
23567882|NCT00077636|65807200|FG001|Overall Study|Admin|3|||
23567883|NCT00077636|65807199|FG000|Overall Study|Withdrawal by Subject|2|||
23567884|NCT00077636|65807200|FG001|Overall Study|Withdrawal by Subject|2|||
23567885|NCT00077636|65807199|FG000|Overall Study|Adverse Event|17|||
23567886|NCT00077636|65807200|FG001|Overall Study|Adverse Event|34|||
23567887|NCT00077636|65807199|FG000|Overall Study|Protocol Violation|0|||
23567888|NCT00077636|65807200|FG001|Overall Study|Protocol Violation|2|||
23567889|NCT00077636|65807199|FG000|Overall Study|Lost to Follow-up|10|||
23567890|NCT00077636|65807200|FG001|Overall Study|Lost to Follow-up|18|||
23567891|NCT00077636|65807199|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
23567892|NCT00077636|65807200|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
23567893|NCT01478113|65807207|FG000|Overall Study|Withdrawal by Subject|0|||
23567894|NCT01478113|65807208|FG001|Overall Study|Withdrawal by Subject|1|||
23567895|NCT01478113|65807207|FG000|Overall Study|Physician Decision|1|||
23567896|NCT01478113|65807208|FG001|Overall Study|Physician Decision|0|||
23567897|NCT00655551|65807209|FG000|All Periods Combined|Adverse Event|0|||
23567898|NCT00655551|65807210|FG001|All Periods Combined|Adverse Event|3|||
23567899|NCT00655551|65807211|FG002|All Periods Combined|Adverse Event|4|||
23567900|NCT00655551|65807209|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
23567901|NCT00655551|65807210|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
23567902|NCT00655551|65807211|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
23567903|NCT00655551|65807209|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
23567904|NCT00655551|65807210|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
23567905|NCT00655551|65807211|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
23567906|NCT00655551|65807209|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
23567907|NCT00655551|65807210|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
23567908|NCT00655551|65807211|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
23567909|NCT01613027|65807212|FG000|Overall Study|Lost to Follow-up|5|||
23567910|NCT01613027|65807212|FG000|Overall Study|Switched Physician|1|||
23567911|NCT01613027|65807212|FG000|Overall Study|Lack of Efficacy|1|||
23567912|NCT01613027|65807212|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
23567913|NCT01734434|65807213|FG000|Overall Study|Death Infant|3|||
23567914|NCT01734434|65807214|FG001|Overall Study|Death Infant|1|||
23567915|NCT01734434|65807215|FG002|Overall Study|Death Infant|17|||
23567916|NCT01734434|65807216|FG003|Overall Study|Death Infant|5|||
23567917|NCT01734434|65807213|FG000|Overall Study|Lost to Follow-up|2|||
23567918|NCT01734434|65807214|FG001|Overall Study|Lost to Follow-up|9|||
23567919|NCT01734434|65807215|FG002|Overall Study|Lost to Follow-up|67|||
23567920|NCT01734434|65807216|FG003|Overall Study|Lost to Follow-up|11|||
23567921|NCT01734434|65807213|FG000|Overall Study|No Live Birth|1|||
23567922|NCT01734434|65807214|FG001|Overall Study|No Live Birth|2|||
23567923|NCT01734434|65807215|FG002|Overall Study|No Live Birth|32|||
23567924|NCT01734434|65807216|FG003|Overall Study|No Live Birth|6|||
23567925|NCT01734434|65807213|FG000|Overall Study|Withdrawal by Subject|4|||
23567926|NCT01734434|65807214|FG001|Overall Study|Withdrawal by Subject|0|||
23567927|NCT01734434|65807215|FG002|Overall Study|Withdrawal by Subject|8|||
23567928|NCT01734434|65807216|FG003|Overall Study|Withdrawal by Subject|1|||
23567929|NCT01734434|65807213|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
23567930|NCT01734434|65807214|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
23567931|NCT01734434|65807215|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
23567932|NCT01734434|65807216|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
23567933|NCT01734434|65807213|FG000|Overall Study|Subject Not Reachable|0|||
23567934|NCT01734434|65807214|FG001|Overall Study|Subject Not Reachable|0|||
23160160|NCT03150862|64335135|FG006|Overall Study|Roll over in to Long Term Extension|0|||
23160161|NCT03150862|64335136|FG007|Overall Study|Roll over in to Long Term Extension|1|||
23160162|NCT03150862|64335129|FG000|Overall Study|Progressive Disease|0|||
23160163|NCT03150862|64335130|FG001|Overall Study|Progressive Disease|0|||
23160164|NCT03150862|64335131|FG002|Overall Study|Progressive Disease|0|||
23160165|NCT03150862|64335132|FG003|Overall Study|Progressive Disease|0|||
23160166|NCT03150862|64335133|FG004|Overall Study|Progressive Disease|0|||
23160167|NCT03150862|64335134|FG005|Overall Study|Progressive Disease|0|||
23160168|NCT03150862|64335135|FG006|Overall Study|Progressive Disease|0|||
23160169|NCT03150862|64335136|FG007|Overall Study|Progressive Disease|2|||
23160170|NCT00761306|64335139|FG000|Overall Study|Adverse Event|5|||
23160171|NCT00761306|64335139|FG000|Overall Study|Lack of Efficacy|4|||
23160172|NCT00761306|64335139|FG000|Overall Study|Protocol Violation|2|||
23160173|NCT00761306|64335139|FG000|Overall Study|Withdrawal of Consent|3|||
23160174|NCT00761306|64335139|FG000|Overall Study|Lost to Follow-up|1|||
23160175|NCT00761306|64335139|FG000|Overall Study|Administrative or Other Reasons|5|||
23160176|NCT03719690|64335143|FG000|Overall Study|Withdrawal by Subject|5|||
23160177|NCT03719690|64335144|FG001|Overall Study|Withdrawal by Subject|10|||
23160178|NCT03719690|64335143|FG000|Overall Study|Death|40|||
23160179|NCT03719690|64335144|FG001|Overall Study|Death|149|||
23160180|NCT03719690|64335143|FG000|Overall Study|Miscellaneous|12|||
23160181|NCT03719690|64335144|FG001|Overall Study|Miscellaneous|56|||
23160182|NCT03719690|64335143|FG000|Overall Study|Lost to Follow-up|2|||
23160183|NCT03719690|64335144|FG001|Overall Study|Lost to Follow-up|18|||
23160184|NCT03719690|64335143|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
23160185|NCT03719690|64335144|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
23160186|NCT01858532|64335145|FG000|Overall Study|Adverse Event|58|||
23160187|NCT01858532|64335146|FG001|Overall Study|Adverse Event|50|||
23160188|NCT01858532|64335147|FG002|Overall Study|Adverse Event|23|||
23160189|NCT01858532|64335148|FG003|Overall Study|Adverse Event|28|||
23160190|NCT01858532|64335145|FG000|Overall Study|Withdrew consent|71|||
23567935|NCT01734434|65807215|FG002|Overall Study|Subject Not Reachable|1|||
23160191|NCT01858532|64335146|FG001|Overall Study|Withdrew consent|93|||
23160192|NCT01858532|64335147|FG002|Overall Study|Withdrew consent|46|||
23160193|NCT01858532|64335148|FG003|Overall Study|Withdrew consent|27|||
23567936|NCT01734434|65807216|FG003|Overall Study|Subject Not Reachable|0|||
23567937|NCT01734434|65807213|FG000|Overall Study|Treatment Defaulter|0|||
23567938|NCT01734434|65807214|FG001|Overall Study|Treatment Defaulter|0|||
23567939|NCT01734434|65807215|FG002|Overall Study|Treatment Defaulter|1|||
23567940|NCT01734434|65807216|FG003|Overall Study|Treatment Defaulter|0|||
23567941|NCT01734434|65807213|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
23567942|NCT01734434|65807214|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
23567943|NCT01734434|65807215|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
23567944|NCT01734434|65807216|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
23567945|NCT01734434|65807213|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
23222955|NCT02658968|64557847|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
23222956|NCT02658968|64557848|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
23222957|NCT02658968|64557849|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
23222958|NCT02658968|64557845|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
23329412|NCT01562782|64948578|FG000|Overall Study|Withdrawal by Subject|3|||
23329413|NCT01562782|64948579|FG001|Overall Study|Withdrawal by Subject|3|||
23329414|NCT01562782|64948578|FG000|Overall Study|screen failure|1|||
23329415|NCT01562782|64948579|FG001|Overall Study|screen failure|2|||
23445797|NCT03386721|65373750|FG008|Overall Study|Reason not specified|0|||
23445798|NCT03386721|65373751|FG009|Overall Study|Reason not specified|1|||
23445799|NCT03386721|65373752|FG010|Overall Study|Reason not specified|2|||
23445800|NCT03386721|65373753|FG011|Overall Study|Reason not specified|6|||
23445801|NCT03386721|65373754|FG012|Overall Study|Reason not specified|1|||
23329416|NCT00314340|64948580|FG000|Overall Study|lost interest|1|||
23329417|NCT01167140|64948581|FG000|Overall Study|Withdrawal by Subject|1|||
23329418|NCT03817853|64948584|FG000|Induction Phase|Adverse Event|5|||
23329419|NCT03817853|64948585|FG001|Induction Phase|Adverse Event|0|||
23329420|NCT03817853|64948586|FG002|Induction Phase|Adverse Event|0|||
23329421|NCT03817853|64948584|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
23329422|NCT03817853|64948585|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
23329423|NCT03817853|64948586|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
23329424|NCT03817853|64948584|FG000|Induction Phase|Physician Decision|2|||
23329425|NCT03817853|64948585|FG001|Induction Phase|Physician Decision|0|||
23445802|NCT03386721|65373755|FG013|Overall Study|Reason not specified|0|||
23445803|NCT03386721|65373756|FG014|Overall Study|Reason not specified|0|||
23222959|NCT02658968|64557846|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
23222960|NCT02658968|64557847|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
23222961|NCT02658968|64557848|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
23222962|NCT02658968|64557849|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
23222963|NCT02658968|64557845|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
23222964|NCT02658968|64557846|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
23222965|NCT02658968|64557847|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
23222966|NCT02658968|64557848|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
23222967|NCT02658968|64557849|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
23222968|NCT02658968|64557845|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
23222969|NCT02658968|64557846|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
23222970|NCT02658968|64557847|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
23222971|NCT02658968|64557848|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
23329426|NCT03817853|64948586|FG002|Induction Phase|Physician Decision|0|||
23329427|NCT03817853|64948584|FG000|Induction Phase|Progressive Disease|6|||
23329428|NCT03817853|64948585|FG001|Induction Phase|Progressive Disease|0|||
23329429|NCT03817853|64948586|FG002|Induction Phase|Progressive Disease|0|||
23329430|NCT03817853|64948584|FG000|Induction Phase|Withdrawal by Subject|4|||
23329431|NCT03817853|64948585|FG001|Induction Phase|Withdrawal by Subject|0|||
23329432|NCT03817853|64948586|FG002|Induction Phase|Withdrawal by Subject|0|||
23445804|NCT03386721|65373742|FG000|Overall Study|Progressive Disease|0|||
23445805|NCT03386721|65373743|FG001|Overall Study|Progressive Disease|0|||
23329433|NCT03817853|64948584|FG000|Maintenance Phase|Adverse Event|0|||
23445806|NCT03386721|65373744|FG002|Overall Study|Progressive Disease|1|||
23329434|NCT03817853|64948585|FG001|Maintenance Phase|Adverse Event|8|||
23329435|NCT03817853|64948586|FG002|Maintenance Phase|Adverse Event|0|||
23329436|NCT03817853|64948584|FG000|Maintenance Phase|Death|0|||
23329437|NCT03817853|64948585|FG001|Maintenance Phase|Death|5|||
23329438|NCT03817853|64948586|FG002|Maintenance Phase|Death|0|||
23329439|NCT03817853|64948584|FG000|Maintenance Phase|Progressive Disease|0|||
23329440|NCT03817853|64948585|FG001|Maintenance Phase|Progressive Disease|7|||
23329441|NCT03817853|64948586|FG002|Maintenance Phase|Progressive Disease|0|||
23329442|NCT03817853|64948584|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23329443|NCT03817853|64948585|FG001|Maintenance Phase|Withdrawal by Subject|2|||
23329444|NCT03817853|64948586|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23329445|NCT03817853|64948584|FG000|Maintenance Phase|Physician Decision|0|||
23329446|NCT03817853|64948585|FG001|Maintenance Phase|Physician Decision|1|||
23329447|NCT03817853|64948586|FG002|Maintenance Phase|Physician Decision|0|||
23329448|NCT03817853|64948584|FG000|Maintenance Phase|Various reasons|0|||
23329449|NCT03817853|64948585|FG001|Maintenance Phase|Various reasons|4|||
23329450|NCT03817853|64948586|FG002|Maintenance Phase|Various reasons|0|||
23329451|NCT03817853|64948584|FG000|Maintenance Phase|Protocol Deviation|0|||
23329452|NCT03817853|64948585|FG001|Maintenance Phase|Protocol Deviation|1|||
23329453|NCT03817853|64948586|FG002|Maintenance Phase|Protocol Deviation|0|||
23329454|NCT03817853|64948584|FG000|Follow-up Phase|Adverse Event|0|||
23329455|NCT03817853|64948585|FG001|Follow-up Phase|Adverse Event|0|||
23329456|NCT03817853|64948586|FG002|Follow-up Phase|Adverse Event|2|||
23329457|NCT03817853|64948584|FG000|Follow-up Phase|Death|0|||
23329458|NCT03817853|64948585|FG001|Follow-up Phase|Death|0|||
23329459|NCT03817853|64948586|FG002|Follow-up Phase|Death|1|||
23329460|NCT03817853|64948584|FG000|Follow-up Phase|Progressive Disease|0|||
23329461|NCT03817853|64948585|FG001|Follow-up Phase|Progressive Disease|0|||
23329462|NCT03817853|64948586|FG002|Follow-up Phase|Progressive Disease|3|||
23329463|NCT03817853|64948584|FG000|Follow-up Phase|Withdrawal by Subject|0|||
23329464|NCT03817853|64948585|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23329465|NCT03817853|64948586|FG002|Follow-up Phase|Withdrawal by Subject|1|||
23160194|NCT01858532|64335145|FG000|Overall Study|Lost to Follow-up|17|||
23329466|NCT00462709|64948587|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
23329467|NCT00462709|64948587|FG000|Overall Study|Lost to Follow-up|10|||
23329468|NCT00462709|64948587|FG000|Overall Study|Withdrawal by Subject|8|||
23329469|NCT00462709|64948587|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
23329470|NCT00462709|64948587|FG000|Overall Study|Death|2|||
23329471|NCT00462709|64948587|FG000|Overall Study|Logistical reasons|2|||
23329472|NCT00462709|64948587|FG000|Overall Study|Physician Decision|1|||
23329473|NCT00462709|64948587|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
23329474|NCT02291510|64948591|FG000|Overall Study|Adverse Event|0|||
23329475|NCT02291510|64948592|FG001|Overall Study|Adverse Event|0|||
23329476|NCT02291510|64948593|FG002|Overall Study|Adverse Event|0|||
23329477|NCT02291510|64948594|FG003|Overall Study|Adverse Event|1|||
23329478|NCT02801617|64948596|FG000|Overall Study|Protocol Violation|2|||
23329479|NCT02801617|64948597|FG001|Overall Study|Protocol Violation|6|||
23329480|NCT01164579|64948598|FG000|Overall Study|Lack of Efficacy|0|||
23329481|NCT01164579|64948599|FG001|Overall Study|Lack of Efficacy|0|||
23329482|NCT01164579|64948600|FG002|Overall Study|Lack of Efficacy|6|||
23329483|NCT01164579|64948598|FG000|Overall Study|Lost to Follow-up|1|||
23329484|NCT01164579|64948599|FG001|Overall Study|Lost to Follow-up|1|||
23329485|NCT01164579|64948600|FG002|Overall Study|Lost to Follow-up|0|||
23445807|NCT03386721|65373745|FG003|Overall Study|Progressive Disease|0|||
23567946|NCT01734434|65807214|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
23329486|NCT01164579|64948598|FG000|Overall Study|Withdrawal by Subject|2|||
23329487|NCT01164579|64948599|FG001|Overall Study|Withdrawal by Subject|5|||
23329488|NCT01164579|64948600|FG002|Overall Study|Withdrawal by Subject|3|||
23329489|NCT01164579|64948598|FG000|Overall Study|Protocol Violation|0|||
23329490|NCT01164579|64948599|FG001|Overall Study|Protocol Violation|1|||
23329491|NCT01164579|64948600|FG002|Overall Study|Protocol Violation|2|||
23329492|NCT01164579|64948598|FG000|Overall Study|Adverse Event|4|||
23329493|NCT01164579|64948599|FG001|Overall Study|Adverse Event|2|||
23329494|NCT01164579|64948600|FG002|Overall Study|Adverse Event|5|||
23329495|NCT01164579|64948598|FG000|Overall Study|Reason not specified|1|||
23329496|NCT01164579|64948599|FG001|Overall Study|Reason not specified|0|||
23567947|NCT01734434|65807215|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
23567948|NCT01734434|65807216|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
23567949|NCT01351025|65807217|FG000|Week 0 - 20|Lost to Follow-up|2|||
23160195|NCT01858532|64335146|FG001|Overall Study|Lost to Follow-up|26|||
23567950|NCT01351025|65807218|FG001|Week 0 - 20|Lost to Follow-up|1|||
23567951|NCT01351025|65807217|FG000|Week 0 - 20|Withdrawal by Subject|1|||
23567952|NCT01351025|65807218|FG001|Week 0 - 20|Withdrawal by Subject|0|||
23567953|NCT01351025|65807217|FG000|Week 24 - 44|Lost to Follow-up|0|||
23567954|NCT01351025|65807218|FG001|Week 24 - 44|Lost to Follow-up|2|||
23567955|NCT01351025|65807217|FG000|Week 24 - 44|Site closed|0|||
23567956|NCT01351025|65807218|FG001|Week 24 - 44|Site closed|1|||
23567957|NCT01351025|65807217|FG000|Week 24 - 44|unable to get to clinic|1|||
23329497|NCT01164579|64948600|FG002|Overall Study|Reason not specified|0|||
23329498|NCT01703260|64948601|FG000|Overall Study|Adverse Event|1|||
23329499|NCT01703260|64948602|FG001|Overall Study|Adverse Event|2|||
23329500|NCT01703260|64948603|FG002|Overall Study|Adverse Event|2|||
23329501|NCT01703260|64948601|FG000|Overall Study|Lost to Follow-up|1|||
23329502|NCT01703260|64948602|FG001|Overall Study|Lost to Follow-up|0|||
23329503|NCT01703260|64948603|FG002|Overall Study|Lost to Follow-up|0|||
23329504|NCT01703260|64948601|FG000|Overall Study|Withdrawal by Subject|0|||
23329505|NCT01703260|64948602|FG001|Overall Study|Withdrawal by Subject|0|||
23329506|NCT01703260|64948603|FG002|Overall Study|Withdrawal by Subject|1|||
23329507|NCT01703260|64948601|FG000|Overall Study|Study Termination|1|||
23329508|NCT01703260|64948602|FG001|Overall Study|Study Termination|2|||
23329509|NCT01703260|64948603|FG002|Overall Study|Study Termination|0|||
23329510|NCT00848718|64948604|FG000|Overall Study|Adverse Event|2|||
23329511|NCT00848718|64948605|FG001|Overall Study|Adverse Event|2|||
23329512|NCT00848718|64948606|FG002|Overall Study|Adverse Event|1|||
23329513|NCT00848718|64948607|FG003|Overall Study|Adverse Event|1|||
23445808|NCT03386721|65373746|FG004|Overall Study|Progressive Disease|0|||
23445809|NCT03386721|65373747|FG005|Overall Study|Progressive Disease|1|||
23445810|NCT03386721|65373748|FG006|Overall Study|Progressive Disease|0|||
23445811|NCT03386721|65373749|FG007|Overall Study|Progressive Disease|0|||
23445812|NCT03386721|65373750|FG008|Overall Study|Progressive Disease|2|||
23445813|NCT03386721|65373751|FG009|Overall Study|Progressive Disease|1|||
23445814|NCT03386721|65373752|FG010|Overall Study|Progressive Disease|1|||
23329514|NCT00848718|64948608|FG004|Overall Study|Adverse Event|1|||
23329515|NCT00848718|64948609|FG005|Overall Study|Adverse Event|0|||
23329516|NCT00848718|64948610|FG006|Overall Study|Adverse Event|0|||
23329517|NCT00848718|64948611|FG007|Overall Study|Adverse Event|1|||
23329518|NCT00848718|64948612|FG008|Overall Study|Adverse Event|1|||
23329519|NCT00848718|64948613|FG009|Overall Study|Adverse Event|0|||
23329520|NCT00848718|64948614|FG010|Overall Study|Adverse Event|0|||
23329521|NCT00848718|64948615|FG011|Overall Study|Adverse Event|0|||
23329522|NCT00848718|64948616|FG012|Overall Study|Adverse Event|2|||
23329523|NCT00848718|64948604|FG000|Overall Study|Lack of Efficacy|0|||
23329524|NCT00848718|64948605|FG001|Overall Study|Lack of Efficacy|0|||
23329525|NCT00848718|64948606|FG002|Overall Study|Lack of Efficacy|1|||
23329526|NCT00848718|64948607|FG003|Overall Study|Lack of Efficacy|0|||
23329527|NCT00848718|64948608|FG004|Overall Study|Lack of Efficacy|0|||
23329528|NCT00848718|64948609|FG005|Overall Study|Lack of Efficacy|0|||
23160196|NCT01858532|64335147|FG002|Overall Study|Lost to Follow-up|11|||
23160197|NCT01858532|64335148|FG003|Overall Study|Lost to Follow-up|14|||
23160198|NCT01858532|64335145|FG000|Overall Study|Deterioration of medical status|3|||
23160199|NCT01858532|64335146|FG001|Overall Study|Deterioration of medical status|4|||
23160200|NCT01858532|64335147|FG002|Overall Study|Deterioration of medical status|3|||
23160201|NCT01858532|64335148|FG003|Overall Study|Deterioration of medical status|7|||
23329529|NCT00848718|64948610|FG006|Overall Study|Lack of Efficacy|1|||
23329530|NCT00848718|64948611|FG007|Overall Study|Lack of Efficacy|0|||
23329531|NCT00848718|64948612|FG008|Overall Study|Lack of Efficacy|0|||
23329532|NCT00848718|64948613|FG009|Overall Study|Lack of Efficacy|0|||
23329533|NCT00848718|64948614|FG010|Overall Study|Lack of Efficacy|0|||
23329534|NCT00848718|64948615|FG011|Overall Study|Lack of Efficacy|0|||
23329535|NCT00848718|64948616|FG012|Overall Study|Lack of Efficacy|0|||
23329536|NCT00848718|64948604|FG000|Overall Study|Physician Decision|0|||
23329537|NCT00848718|64948605|FG001|Overall Study|Physician Decision|1|||
23329538|NCT00848718|64948606|FG002|Overall Study|Physician Decision|0|||
23329539|NCT00848718|64948607|FG003|Overall Study|Physician Decision|0|||
23329540|NCT00848718|64948608|FG004|Overall Study|Physician Decision|1|||
23329541|NCT00848718|64948609|FG005|Overall Study|Physician Decision|1|||
23329542|NCT00848718|64948610|FG006|Overall Study|Physician Decision|0|||
23329543|NCT00848718|64948611|FG007|Overall Study|Physician Decision|0|||
23329544|NCT00848718|64948612|FG008|Overall Study|Physician Decision|1|||
23445815|NCT03386721|65373753|FG011|Overall Study|Progressive Disease|0|||
23445816|NCT03386721|65373754|FG012|Overall Study|Progressive Disease|1|||
23329545|NCT00848718|64948613|FG009|Overall Study|Physician Decision|2|||
23329546|NCT00848718|64948614|FG010|Overall Study|Physician Decision|0|||
23329547|NCT00848718|64948615|FG011|Overall Study|Physician Decision|0|||
23329548|NCT00848718|64948616|FG012|Overall Study|Physician Decision|1|||
23329549|NCT00848718|64948604|FG000|Overall Study|Progressive disease before treatment|1|||
23329550|NCT00848718|64948605|FG001|Overall Study|Progressive disease before treatment|5|||
23160202|NCT01858532|64335145|FG000|Overall Study|Investigator request|3|||
23329551|NCT00848718|64948606|FG002|Overall Study|Progressive disease before treatment|1|||
23329552|NCT00848718|64948607|FG003|Overall Study|Progressive disease before treatment|3|||
23329553|NCT00848718|64948608|FG004|Overall Study|Progressive disease before treatment|4|||
23329554|NCT00848718|64948609|FG005|Overall Study|Progressive disease before treatment|4|||
23329555|NCT00848718|64948610|FG006|Overall Study|Progressive disease before treatment|2|||
23329556|NCT00848718|64948611|FG007|Overall Study|Progressive disease before treatment|1|||
23445817|NCT03386721|65373755|FG013|Overall Study|Progressive Disease|0|||
23445818|NCT03386721|65373756|FG014|Overall Study|Progressive Disease|0|||
23329557|NCT00848718|64948612|FG008|Overall Study|Progressive disease before treatment|2|||
23329558|NCT00848718|64948613|FG009|Overall Study|Progressive disease before treatment|7|||
23329559|NCT00848718|64948614|FG010|Overall Study|Progressive disease before treatment|3|||
23329560|NCT00848718|64948615|FG011|Overall Study|Progressive disease before treatment|6|||
23329561|NCT00848718|64948616|FG012|Overall Study|Progressive disease before treatment|2|||
23329562|NCT00848718|64948604|FG000|Overall Study|Protocol Violation|0|||
23329563|NCT00848718|64948605|FG001|Overall Study|Protocol Violation|1|||
23329564|NCT00848718|64948606|FG002|Overall Study|Protocol Violation|0|||
23329565|NCT00848718|64948607|FG003|Overall Study|Protocol Violation|0|||
23329566|NCT00848718|64948608|FG004|Overall Study|Protocol Violation|0|||
23329567|NCT00848718|64948609|FG005|Overall Study|Protocol Violation|0|||
23329568|NCT00848718|64948610|FG006|Overall Study|Protocol Violation|0|||
23329569|NCT00848718|64948611|FG007|Overall Study|Protocol Violation|1|||
23329570|NCT00848718|64948612|FG008|Overall Study|Protocol Violation|0|||
23329571|NCT00848718|64948613|FG009|Overall Study|Protocol Violation|0|||
23329572|NCT00848718|64948614|FG010|Overall Study|Protocol Violation|0|||
23329573|NCT00848718|64948615|FG011|Overall Study|Protocol Violation|0|||
23329574|NCT00848718|64948616|FG012|Overall Study|Protocol Violation|1|||
23329575|NCT00848718|64948604|FG000|Overall Study|Withdrawal by Subject|1|||
23329576|NCT00848718|64948605|FG001|Overall Study|Withdrawal by Subject|0|||
23160203|NCT01858532|64335146|FG001|Overall Study|Investigator request|4|||
23160204|NCT01858532|64335147|FG002|Overall Study|Investigator request|2|||
23160205|NCT01858532|64335148|FG003|Overall Study|Investigator request|6|||
23160206|NCT01858532|64335145|FG000|Overall Study|Other, not specified|29|||
23329577|NCT00848718|64948606|FG002|Overall Study|Withdrawal by Subject|0|||
23329578|NCT00848718|64948607|FG003|Overall Study|Withdrawal by Subject|1|||
23329579|NCT00848718|64948608|FG004|Overall Study|Withdrawal by Subject|0|||
23329580|NCT00848718|64948609|FG005|Overall Study|Withdrawal by Subject|0|||
23329581|NCT00848718|64948610|FG006|Overall Study|Withdrawal by Subject|0|||
23329582|NCT00848718|64948611|FG007|Overall Study|Withdrawal by Subject|0|||
23329583|NCT00848718|64948612|FG008|Overall Study|Withdrawal by Subject|0|||
23329584|NCT00848718|64948613|FG009|Overall Study|Withdrawal by Subject|0|||
23329585|NCT00848718|64948614|FG010|Overall Study|Withdrawal by Subject|1|||
23329586|NCT00848718|64948615|FG011|Overall Study|Withdrawal by Subject|0|||
23329587|NCT00848718|64948616|FG012|Overall Study|Withdrawal by Subject|0|||
23329588|NCT00848718|64948604|FG000|Overall Study|Progressive disease during treatment|3|||
23329589|NCT00848718|64948605|FG001|Overall Study|Progressive disease during treatment|0|||
23160207|NCT01858532|64335146|FG001|Overall Study|Other, not specified|15|||
23160208|NCT01858532|64335147|FG002|Overall Study|Other, not specified|13|||
23160209|NCT01858532|64335148|FG003|Overall Study|Other, not specified|11|||
23160210|NCT01357655|64335149|FG000|Overall Study|Administrative Reason by Sponsor|45|||
23160211|NCT01357655|64335150|FG001|Overall Study|Administrative Reason by Sponsor|0|||
23160212|NCT01357655|64335149|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23160213|NCT01357655|64335150|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23160214|NCT01357655|64335149|FG000|Overall Study|Disease Progression|1|||
23160215|NCT01357655|64335150|FG001|Overall Study|Disease Progression|0|||
23567958|NCT01351025|65807218|FG001|Week 24 - 44|unable to get to clinic|1|||
23329590|NCT00848718|64948606|FG002|Overall Study|Progressive disease during treatment|3|||
23329591|NCT00848718|64948607|FG003|Overall Study|Progressive disease during treatment|0|||
23567959|NCT00308737|65807219|FG000|Overall Study|Adverse Event|104|||
23160216|NCT01357655|64335149|FG000|Overall Study|Lost to Follow-up|2|||
23160217|NCT01357655|64335150|FG001|Overall Study|Lost to Follow-up|0|||
23160218|NCT01357655|64335149|FG000|Overall Study|Maximum Clinical Benefit|2|||
23160219|NCT01357655|64335150|FG001|Overall Study|Maximum Clinical Benefit|0|||
23160220|NCT01357655|64335149|FG000|Overall Study|Reason Unspecified|1|||
23160221|NCT01357655|64335150|FG001|Overall Study|Reason Unspecified|0|||
23160222|NCT01357655|64335149|FG000|Overall Study|Study Drug Toxicity|11|||
23160223|NCT01357655|64335150|FG001|Overall Study|Study Drug Toxicity|0|||
23567960|NCT00308737|65807220|FG001|Overall Study|Adverse Event|9|||
23567961|NCT00308737|65807221|FG002|Overall Study|Adverse Event|0|||
23567962|NCT00308737|65807219|FG000|Overall Study|Death|4|||
23567963|NCT00308737|65807220|FG001|Overall Study|Death|3|||
23567964|NCT00308737|65807221|FG002|Overall Study|Death|0|||
23567965|NCT00308737|65807219|FG000|Overall Study|Lost to Follow-up|56|||
23567966|NCT00308737|65807220|FG001|Overall Study|Lost to Follow-up|80|||
23160224|NCT01357655|64335149|FG000|Overall Study|Subject Withdrew Consent|1|||
23160225|NCT01357655|64335150|FG001|Overall Study|Subject Withdrew Consent|0|||
23160226|NCT01379274|64335151|FG000|Overall Study|funding withdrawn|1|||
23160227|NCT01999465|64335152|FG000|Overall Study|Lost to Follow-up|0|||
23329592|NCT00848718|64948608|FG004|Overall Study|Progressive disease during treatment|0|||
23329593|NCT00848718|64948609|FG005|Overall Study|Progressive disease during treatment|0|||
23329594|NCT00848718|64948610|FG006|Overall Study|Progressive disease during treatment|0|||
23567967|NCT00308737|65807221|FG002|Overall Study|Lost to Follow-up|5|||
23160228|NCT01999465|64335153|FG001|Overall Study|Lost to Follow-up|2|||
23567968|NCT00308737|65807219|FG000|Overall Study|Physician Decision|15|||
23567969|NCT00308737|65807220|FG001|Overall Study|Physician Decision|2|||
23329595|NCT00848718|64948611|FG007|Overall Study|Progressive disease during treatment|2|||
23329596|NCT00848718|64948612|FG008|Overall Study|Progressive disease during treatment|0|||
23329597|NCT00848718|64948613|FG009|Overall Study|Progressive disease during treatment|0|||
23329598|NCT00848718|64948614|FG010|Overall Study|Progressive disease during treatment|0|||
23160229|NCT01999465|64335152|FG000|Overall Study|Protocol Violation|0|||
23160230|NCT01999465|64335153|FG001|Overall Study|Protocol Violation|1|||
23160231|NCT01617070|64335154|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
23160232|NCT03357731|64335159|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
23160233|NCT03357731|64335160|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
23160234|NCT03357731|64335161|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
23160235|NCT03357731|64335162|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
23160236|NCT03357731|64335163|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
23160237|NCT03357731|64335164|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
23160238|NCT03357731|64335159|FG000|Overall Study|Acute bradycardia and hypotension|0|||
23160239|NCT03357731|64335160|FG001|Overall Study|Acute bradycardia and hypotension|0|||
23160240|NCT03357731|64335161|FG002|Overall Study|Acute bradycardia and hypotension|0|||
23160241|NCT03357731|64335162|FG003|Overall Study|Acute bradycardia and hypotension|1|||
23160242|NCT03357731|64335163|FG004|Overall Study|Acute bradycardia and hypotension|0|||
23160243|NCT03357731|64335164|FG005|Overall Study|Acute bradycardia and hypotension|0|||
23160244|NCT03357731|64335159|FG000|Overall Study|Adverse Event|0|||
23160245|NCT03357731|64335160|FG001|Overall Study|Adverse Event|0|||
23160246|NCT03357731|64335161|FG002|Overall Study|Adverse Event|0|||
23567970|NCT00308737|65807221|FG002|Overall Study|Physician Decision|1|||
23567971|NCT00308737|65807219|FG000|Overall Study|Protocol Violation|34|||
23160247|NCT03357731|64335162|FG003|Overall Study|Adverse Event|0|||
23160248|NCT03357731|64335163|FG004|Overall Study|Adverse Event|0|||
23160249|NCT03357731|64335164|FG005|Overall Study|Adverse Event|1|||
23160250|NCT03357731|64335159|FG000|Overall Study|Hypotension|0|||
23160251|NCT03357731|64335160|FG001|Overall Study|Hypotension|0|||
23160252|NCT03357731|64335161|FG002|Overall Study|Hypotension|1|||
23160253|NCT03357731|64335162|FG003|Overall Study|Hypotension|1|||
23160254|NCT03357731|64335163|FG004|Overall Study|Hypotension|0|||
23160255|NCT03357731|64335164|FG005|Overall Study|Hypotension|0|||
23160256|NCT03357731|64335159|FG000|Overall Study|Lost to Follow-up|0|||
23160257|NCT03357731|64335160|FG001|Overall Study|Lost to Follow-up|0|||
23160258|NCT03357731|64335161|FG002|Overall Study|Lost to Follow-up|0|||
23160259|NCT03357731|64335162|FG003|Overall Study|Lost to Follow-up|1|||
23160260|NCT03357731|64335163|FG004|Overall Study|Lost to Follow-up|0|||
23160261|NCT03357731|64335164|FG005|Overall Study|Lost to Follow-up|0|||
23160262|NCT03882970|64338828|FG000|Overall Study|Adverse Event|5|||
23160263|NCT03882970|64338829|FG001|Overall Study|Adverse Event|7|||
23160264|NCT03882970|64338830|FG002|Overall Study|Adverse Event|3|||
23160265|NCT03882970|64338831|FG003|Overall Study|Adverse Event|1|||
23160266|NCT03882970|64338828|FG000|Overall Study|Death|1|||
23160267|NCT03882970|64338829|FG001|Overall Study|Death|2|||
23160268|NCT03882970|64338830|FG002|Overall Study|Death|1|||
23160269|NCT03882970|64338831|FG003|Overall Study|Death|1|||
23160270|NCT03882970|64338828|FG000|Overall Study|Lost to Follow-up|8|||
23160271|NCT03882970|64338829|FG001|Overall Study|Lost to Follow-up|9|||
23160272|NCT03882970|64338830|FG002|Overall Study|Lost to Follow-up|5|||
23160273|NCT03882970|64338831|FG003|Overall Study|Lost to Follow-up|5|||
23160274|NCT03882970|64338828|FG000|Overall Study|Physician Decision|0|||
23160275|NCT03882970|64338829|FG001|Overall Study|Physician Decision|2|||
23160276|NCT03882970|64338830|FG002|Overall Study|Physician Decision|2|||
23160277|NCT03882970|64338831|FG003|Overall Study|Physician Decision|2|||
23160278|NCT03882970|64338828|FG000|Overall Study|Protocol Violation|2|||
23160279|NCT03882970|64338829|FG001|Overall Study|Protocol Violation|0|||
23160280|NCT03882970|64338830|FG002|Overall Study|Protocol Violation|0|||
23160281|NCT03882970|64338831|FG003|Overall Study|Protocol Violation|0|||
23160282|NCT03882970|64338828|FG000|Overall Study|Withdrawal by Subject|8|||
23160283|NCT03882970|64338829|FG001|Overall Study|Withdrawal by Subject|17|||
23160284|NCT03882970|64338830|FG002|Overall Study|Withdrawal by Subject|7|||
23160285|NCT03882970|64338831|FG003|Overall Study|Withdrawal by Subject|22|||
23329599|NCT00848718|64948615|FG011|Overall Study|Progressive disease during treatment|0|||
23329600|NCT00848718|64948616|FG012|Overall Study|Progressive disease during treatment|2|||
23329601|NCT00455403|64948617|FG000|Overall Study|Lost to Follow-up|2|||
23567972|NCT00308737|65807220|FG001|Overall Study|Protocol Violation|9|||
23567973|NCT00308737|65807221|FG002|Overall Study|Protocol Violation|5|||
23160286|NCT03882970|64338828|FG000|Overall Study|Personal Reason|2|||
23160287|NCT03882970|64338829|FG001|Overall Study|Personal Reason|3|||
23160288|NCT03882970|64338830|FG002|Overall Study|Personal Reason|1|||
23160289|NCT03882970|64338831|FG003|Overall Study|Personal Reason|3|||
23329602|NCT00455403|64948618|FG001|Overall Study|Lost to Follow-up|1|||
23160290|NCT03159091|64338832|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
23160291|NCT03159091|64338833|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
23567974|NCT00308737|65807219|FG000|Overall Study|Withdrawal by Subject|218|||
23567975|NCT00308737|65807220|FG001|Overall Study|Withdrawal by Subject|166|||
23160292|NCT03159091|64338832|FG000|Overall Study|Patient has taken no dose of study drug|0|||
23160293|NCT03159091|64338833|FG001|Overall Study|Patient has taken no dose of study drug|1|||
23160294|NCT00388973|64338836|FG000|Overall Study|Adverse Event|16|||
23160295|NCT00388973|64338837|FG001|Overall Study|Adverse Event|6|||
23160296|NCT00388973|64338836|FG000|Overall Study|Lack of Efficacy|1|||
23160297|NCT00388973|64338837|FG001|Overall Study|Lack of Efficacy|12|||
23160298|NCT00388973|64338836|FG000|Overall Study|Protocol Violation|3|||
23160299|NCT00388973|64338837|FG001|Overall Study|Protocol Violation|0|||
23160300|NCT00388973|64338836|FG000|Overall Study|Withdrawal by Subject|14|||
23160301|NCT00388973|64338837|FG001|Overall Study|Withdrawal by Subject|17|||
23160302|NCT00388973|64338836|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
23160303|NCT00388973|64338837|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
23160304|NCT00388973|64338836|FG000|Overall Study|Did not complete 61 days of treatment|5|||
23160305|NCT00388973|64338837|FG001|Overall Study|Did not complete 61 days of treatment|4|||
23160306|NCT00388973|64338836|FG000|Overall Study|Left region|0|||
23160307|NCT00388973|64338837|FG001|Overall Study|Left region|1|||
23160308|NCT00388973|64338836|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
23160309|NCT00388973|64338837|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
23160310|NCT04194528|64338838|FG000|Overall Study|Adverse Event|1|||
23160311|NCT04649255|64338839|FG000|Overall Study|Death|9|||
23160312|NCT04649255|64338839|FG000|Overall Study|Withdrawal by Subject|1|||
23160313|NCT01073267|64338840|FG000|Overall Study|Disease Progression|3|||
23160314|NCT00271817|64338841|FG000|Part 1|Adverse Event|68|||
23160315|NCT00271817|64338842|FG001|Part 1|Adverse Event|25|||
23160316|NCT00271817|64338843|FG002|Part 1|Adverse Event|156|||
23160317|NCT00271817|64338841|FG000|Part 1|Lost to Follow-up|6|||
23160318|NCT00271817|64338842|FG001|Part 1|Lost to Follow-up|8|||
23160319|NCT00271817|64338843|FG002|Part 1|Lost to Follow-up|24|||
23160320|NCT00271817|64338841|FG000|Part 1|Protocol Violation|5|||
23160321|NCT00271817|64338842|FG001|Part 1|Protocol Violation|4|||
23160322|NCT00271817|64338843|FG002|Part 1|Protocol Violation|7|||
23329603|NCT00455403|64948617|FG000|Overall Study|Withdrawal by Subject|1|||
23329604|NCT00455403|64948618|FG001|Overall Study|Withdrawal by Subject|3|||
23329605|NCT00455403|64948617|FG000|Overall Study|Protocol Violation|0|||
23329606|NCT00455403|64948618|FG001|Overall Study|Protocol Violation|2|||
23329607|NCT00461630|64948619|FG000|Overall Study|Death|798|||
23329608|NCT00461630|64948620|FG001|Overall Study|Death|732|||
23329609|NCT00461630|64948619|FG000|Overall Study|Lost to Follow-up|108|||
23329610|NCT00461630|64948620|FG001|Overall Study|Lost to Follow-up|95|||
23329611|NCT04620746|64948626|FG000|Overall Study|Adverse Event|2|||
23329612|NCT04620746|64948627|FG001|Overall Study|Adverse Event|0|||
23329613|NCT04620746|64948626|FG000|Overall Study|Uniterpretable skin test|1|||
23329614|NCT04620746|64948627|FG001|Overall Study|Uniterpretable skin test|0|||
23329615|NCT04620746|64948626|FG000|Overall Study|Withdrawal by Subject|0|||
23329616|NCT04620746|64948627|FG001|Overall Study|Withdrawal by Subject|1|||
23329617|NCT03776357|64948632|FG000|Overall Study|Lost to Follow-up|3|||
23329618|NCT00288626|64948633|FG000|Overall Study|Death|3|||
23329619|NCT00288626|64948633|FG000|Overall Study|Withdrawal by Subject|4|||
23329620|NCT00683618|64948634|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
23329621|NCT00683618|64948635|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
23329622|NCT00683618|64948636|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
23329623|NCT00683618|64948634|FG000|Randomised Treatment Period|Protocol Violation|0|||
23329624|NCT00683618|64948635|FG001|Randomised Treatment Period|Protocol Violation|1|||
23329625|NCT00683618|64948636|FG002|Randomised Treatment Period|Protocol Violation|0|||
23329626|NCT00683618|64948634|FG000|Randomised Treatment Period|Adverse Event|2|||
23329627|NCT00683618|64948635|FG001|Randomised Treatment Period|Adverse Event|0|||
23329628|NCT00683618|64948636|FG002|Randomised Treatment Period|Adverse Event|2|||
23329629|NCT00683618|64948634|FG000|Randomised Treatment Period|Reason not provided|0|||
23329630|NCT00683618|64948635|FG001|Randomised Treatment Period|Reason not provided|0|||
23329631|NCT00683618|64948636|FG002|Randomised Treatment Period|Reason not provided|2|||
23329632|NCT00683618|64948634|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
23329633|NCT00683618|64948635|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23329634|NCT00683618|64948636|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
23329635|NCT00683618|64948634|FG000|Extension Treatment Period|Adverse Event|1|||
23329636|NCT00683618|64948635|FG001|Extension Treatment Period|Adverse Event|0|||
23329637|NCT00683618|64948636|FG002|Extension Treatment Period|Adverse Event|0|||
23329638|NCT00683618|64948634|FG000|Extension Treatment Period|Protocol Violation|1|||
23329639|NCT00683618|64948635|FG001|Extension Treatment Period|Protocol Violation|0|||
23329640|NCT00683618|64948636|FG002|Extension Treatment Period|Protocol Violation|0|||
23445819|NCT03386721|65373742|FG000|Overall Study|Site Terminated by Sponsor|5|||
23160323|NCT00271817|64338841|FG000|Part 1|Patient Moved|3|||
23160324|NCT00271817|64338842|FG001|Part 1|Patient Moved|1|||
23160325|NCT00271817|64338843|FG002|Part 1|Patient Moved|5|||
23160326|NCT00271817|64338841|FG000|Part 1|Withdrawal by Subject|23|||
23160327|NCT00271817|64338842|FG001|Part 1|Withdrawal by Subject|17|||
23160328|NCT00271817|64338843|FG002|Part 1|Withdrawal by Subject|45|||
23445820|NCT03386721|65373743|FG001|Overall Study|Site Terminated by Sponsor|5|||
23445821|NCT03386721|65373744|FG002|Overall Study|Site Terminated by Sponsor|0|||
23445822|NCT03386721|65373745|FG003|Overall Study|Site Terminated by Sponsor|0|||
23445823|NCT03386721|65373746|FG004|Overall Study|Site Terminated by Sponsor|1|||
23445824|NCT03386721|65373747|FG005|Overall Study|Site Terminated by Sponsor|3|||
23445825|NCT03386721|65373748|FG006|Overall Study|Site Terminated by Sponsor|0|||
23445826|NCT03386721|65373749|FG007|Overall Study|Site Terminated by Sponsor|1|||
23160329|NCT00271817|64338841|FG000|Part 1|LDL < 50 mg/dL|1|||
23160330|NCT00271817|64338842|FG001|Part 1|LDL < 50 mg/dL|4|||
23445827|NCT03386721|65373750|FG008|Overall Study|Site Terminated by Sponsor|4|||
23445828|NCT03386721|65373751|FG009|Overall Study|Site Terminated by Sponsor|5|||
23445829|NCT03386721|65373752|FG010|Overall Study|Site Terminated by Sponsor|3|||
23445830|NCT03386721|65373753|FG011|Overall Study|Site Terminated by Sponsor|11|||
23160331|NCT00271817|64338843|FG002|Part 1|LDL < 50 mg/dL|48|||
23160332|NCT00271817|64338841|FG000|Part 2|Adverse Event|0|||
23160333|NCT00271817|64338842|FG001|Part 2|Adverse Event|17|||
23160334|NCT00271817|64338843|FG002|Part 2|Adverse Event|33|||
23160335|NCT00271817|64338841|FG000|Part 2|Lack of Efficacy|0|||
23160336|NCT00271817|64338842|FG001|Part 2|Lack of Efficacy|1|||
23445831|NCT03386721|65373754|FG012|Overall Study|Site Terminated by Sponsor|6|||
23445832|NCT03386721|65373755|FG013|Overall Study|Site Terminated by Sponsor|0|||
23445833|NCT03386721|65373756|FG014|Overall Study|Site Terminated by Sponsor|0|||
23445834|NCT03386721|65373742|FG000|Overall Study|Symptomatic Deterioration|0|||
23445835|NCT03386721|65373743|FG001|Overall Study|Symptomatic Deterioration|0|||
23445836|NCT03386721|65373744|FG002|Overall Study|Symptomatic Deterioration|0|||
23445837|NCT03386721|65373745|FG003|Overall Study|Symptomatic Deterioration|0|||
23445838|NCT03386721|65373746|FG004|Overall Study|Symptomatic Deterioration|0|||
23445839|NCT03386721|65373747|FG005|Overall Study|Symptomatic Deterioration|0|||
23445840|NCT03386721|65373748|FG006|Overall Study|Symptomatic Deterioration|0|||
23445841|NCT03386721|65373749|FG007|Overall Study|Symptomatic Deterioration|0|||
23445842|NCT03386721|65373750|FG008|Overall Study|Symptomatic Deterioration|1|||
23445843|NCT03386721|65373751|FG009|Overall Study|Symptomatic Deterioration|0|||
23445844|NCT03386721|65373752|FG010|Overall Study|Symptomatic Deterioration|0|||
23445845|NCT03386721|65373753|FG011|Overall Study|Symptomatic Deterioration|1|||
23445846|NCT03386721|65373754|FG012|Overall Study|Symptomatic Deterioration|0|||
23445847|NCT03386721|65373755|FG013|Overall Study|Symptomatic Deterioration|0|||
23445848|NCT03386721|65373756|FG014|Overall Study|Symptomatic Deterioration|0|||
23445849|NCT03386721|65373742|FG000|Overall Study|Withdrawal by Subject|1|||
23445850|NCT03386721|65373743|FG001|Overall Study|Withdrawal by Subject|2|||
23445851|NCT03386721|65373744|FG002|Overall Study|Withdrawal by Subject|0|||
23445852|NCT03386721|65373745|FG003|Overall Study|Withdrawal by Subject|0|||
23445853|NCT03386721|65373746|FG004|Overall Study|Withdrawal by Subject|0|||
23445854|NCT03386721|65373747|FG005|Overall Study|Withdrawal by Subject|0|||
23445855|NCT03386721|65373748|FG006|Overall Study|Withdrawal by Subject|0|||
23445856|NCT03386721|65373749|FG007|Overall Study|Withdrawal by Subject|0|||
23445857|NCT03386721|65373750|FG008|Overall Study|Withdrawal by Subject|2|||
23445858|NCT03386721|65373751|FG009|Overall Study|Withdrawal by Subject|1|||
23445859|NCT03386721|65373752|FG010|Overall Study|Withdrawal by Subject|3|||
23445860|NCT03386721|65373753|FG011|Overall Study|Withdrawal by Subject|2|||
23445861|NCT03386721|65373754|FG012|Overall Study|Withdrawal by Subject|3|||
23445862|NCT03386721|65373755|FG013|Overall Study|Withdrawal by Subject|0|||
23445863|NCT03386721|65373756|FG014|Overall Study|Withdrawal by Subject|0|||
23445864|NCT04170543|65373757|FG000|Overall Study|Death|1|||
23445865|NCT04170543|65373758|FG001|Overall Study|Death|1|||
23445866|NCT04170543|65373759|FG002|Overall Study|Death|1|||
23445867|NCT04170543|65373760|FG003|Overall Study|Death|1|||
23445868|NCT04170543|65373761|FG004|Overall Study|Death|1|||
23445869|NCT04170543|65373757|FG000|Overall Study|Lost to Follow-up|3|||
23445870|NCT04170543|65373758|FG001|Overall Study|Lost to Follow-up|3|||
23160337|NCT00271817|64338843|FG002|Part 2|Lack of Efficacy|6|||
23160338|NCT00271817|64338841|FG000|Part 2|Lost to Follow-up|0|||
23160339|NCT00271817|64338842|FG001|Part 2|Lost to Follow-up|6|||
23160340|NCT00271817|64338843|FG002|Part 2|Lost to Follow-up|18|||
23160341|NCT00271817|64338841|FG000|Part 2|Protocol Violation|0|||
23160342|NCT00271817|64338842|FG001|Part 2|Protocol Violation|3|||
23445871|NCT04170543|65373759|FG002|Overall Study|Lost to Follow-up|0|||
23445872|NCT04170543|65373760|FG003|Overall Study|Lost to Follow-up|3|||
23445873|NCT04170543|65373761|FG004|Overall Study|Lost to Follow-up|1|||
23445874|NCT04170543|65373757|FG000|Overall Study|Withdrawal by Subject|13|||
23445875|NCT04170543|65373758|FG001|Overall Study|Withdrawal by Subject|6|||
23160343|NCT00271817|64338843|FG002|Part 2|Protocol Violation|5|||
23160344|NCT00271817|64338841|FG000|Part 2|Patient Moved|0|||
23160345|NCT00271817|64338842|FG001|Part 2|Patient Moved|0|||
23160346|NCT00271817|64338843|FG002|Part 2|Patient Moved|5|||
23160347|NCT00271817|64338841|FG000|Part 2|Withdrawal by Subject|0|||
23160348|NCT00271817|64338842|FG001|Part 2|Withdrawal by Subject|2|||
23445876|NCT04170543|65373759|FG002|Overall Study|Withdrawal by Subject|5|||
23445877|NCT04170543|65373760|FG003|Overall Study|Withdrawal by Subject|4|||
23445878|NCT04170543|65373761|FG004|Overall Study|Withdrawal by Subject|9|||
23445879|NCT04170543|65373757|FG000|Overall Study|Not able to transition to phase 2b|8|||
23445880|NCT04170543|65373758|FG001|Overall Study|Not able to transition to phase 2b|0|||
23445881|NCT04170543|65373759|FG002|Overall Study|Not able to transition to phase 2b|10|||
23445882|NCT04170543|65373760|FG003|Overall Study|Not able to transition to phase 2b|0|||
23445883|NCT04170543|65373761|FG004|Overall Study|Not able to transition to phase 2b|6|||
23445884|NCT04170543|65373757|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
23445885|NCT04170543|65373758|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
23445886|NCT04170543|65373759|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
23445887|NCT04170543|65373760|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
23445888|NCT04170543|65373761|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
23445889|NCT04170543|65373757|FG000|Overall Study|Not Treated|0|||
23445890|NCT04170543|65373758|FG001|Overall Study|Not Treated|0|||
23445891|NCT04170543|65373759|FG002|Overall Study|Not Treated|0|||
23160349|NCT00271817|64338843|FG002|Part 2|Withdrawal by Subject|13|||
23160350|NCT00271817|64338841|FG000|Part 2|LDL < 50 mg/dL|0|||
23160351|NCT00271817|64338842|FG001|Part 2|LDL < 50 mg/dL|3|||
23160352|NCT00271817|64338843|FG002|Part 2|LDL < 50 mg/dL|4|||
23160353|NCT00766532|64338844|FG000|Overall Study|Protocol Violation|2|||
23160354|NCT04995055|64338845|FG000|Period 1|COVID-19 Related|1|||
23445892|NCT04170543|65373760|FG003|Overall Study|Not Treated|0|||
23445893|NCT04170543|65373761|FG004|Overall Study|Not Treated|2|||
23445894|NCT04170543|65373757|FG000|Overall Study|(CRF)|16|||
23445895|NCT04170543|65373758|FG001|Overall Study|(CRF)|15|||
23445896|NCT04170543|65373759|FG002|Overall Study|(CRF)|12|||
23445897|NCT04170543|65373760|FG003|Overall Study|(CRF)|17|||
23445898|NCT04170543|65373761|FG004|Overall Study|(CRF)|17|||
23445899|NCT04170543|65373757|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
23445900|NCT04170543|65373758|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
23445901|NCT04170543|65373759|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
23445902|NCT04170543|65373760|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
23445903|NCT04170543|65373761|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
23445904|NCT01687296|65373765|FG000|Overall Study|Lack of Efficacy|1|||
23445905|NCT01687296|65373766|FG001|Overall Study|Lack of Efficacy|1|||
23445906|NCT01687296|65373765|FG000|Overall Study|Protocol Violation|0|||
23445907|NCT01687296|65373766|FG001|Overall Study|Protocol Violation|1|||
23445908|NCT01687296|65373765|FG000|Overall Study|Withdrawal by Subject|6|||
23445909|NCT01687296|65373766|FG001|Overall Study|Withdrawal by Subject|3|||
23445910|NCT01818596|65373769|FG000|Overall Study|Enrolled but Not Treated|4|||
23445911|NCT01818596|65373770|FG001|Overall Study|Enrolled but Not Treated|0|||
23445912|NCT01818596|65373769|FG000|Overall Study|Adverse Event|7|||
23445913|NCT01818596|65373770|FG001|Overall Study|Adverse Event|0|||
23445914|NCT01818596|65373769|FG000|Overall Study|Death|3|||
23445915|NCT01818596|65373770|FG001|Overall Study|Death|0|||
23445916|NCT01818596|65373769|FG000|Overall Study|Investigator's Discretion|4|||
23445917|NCT01818596|65373770|FG001|Overall Study|Investigator's Discretion|0|||
23445918|NCT01818596|65373769|FG000|Overall Study|Protocol Violation|1|||
23445919|NCT01818596|65373770|FG001|Overall Study|Protocol Violation|0|||
23445920|NCT01818596|65373769|FG000|Overall Study|Withdrew Consent|5|||
23445921|NCT01818596|65373770|FG001|Overall Study|Withdrew Consent|0|||
23445922|NCT01818596|65373769|FG000|Overall Study|Lost to Follow-up|7|||
23445923|NCT01818596|65373770|FG001|Overall Study|Lost to Follow-up|0|||
23445924|NCT02454478|65373774|FG000|Overall Study|Incomplete DLT Evaluation|1|||
23445925|NCT00183625|65373775|FG000|Overall Study|Withdrawal by Subject|18|||
23445926|NCT00183625|65373776|FG001|Overall Study|Withdrawal by Subject|18|||
23445927|NCT00183625|65373777|FG002|Overall Study|Withdrawal by Subject|19|||
23445928|NCT00183625|65373778|FG003|Overall Study|Withdrawal by Subject|14|||
23445929|NCT00602420|65373779|FG000|Overall Study|Death|1|||
23160355|NCT04995055|64338846|FG001|Period 1|COVID-19 Related|0|||
23160356|NCT04995055|64338845|FG000|Period 1|Withdrawal by Subject|0|||
23445930|NCT00602420|65373780|FG001|Overall Study|Death|4|||
23445931|NCT00602420|65373779|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
23445932|NCT00602420|65373780|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
23445933|NCT00602420|65373779|FG000|Overall Study|Withdrawal by Subject|18|||
23445934|NCT00602420|65373780|FG001|Overall Study|Withdrawal by Subject|17|||
23160357|NCT04995055|64338846|FG001|Period 1|Withdrawal by Subject|1|||
23160358|NCT04995055|64338845|FG000|Period 1|Subject discontinued due to timing|4|||
23445935|NCT00602420|65373779|FG000|Overall Study|Adverse Event|1|||
23445936|NCT00602420|65373780|FG001|Overall Study|Adverse Event|0|||
23160359|NCT04995055|64338846|FG001|Period 1|Subject discontinued due to timing|4|||
23160360|NCT00960843|64338847|FG000|Overall Study|Lost to Follow-up|2|||
23160361|NCT00960843|64338848|FG001|Overall Study|Lost to Follow-up|0|||
23160362|NCT00960843|64338847|FG000|Overall Study|Protocol Violation|0|||
23160363|NCT00960843|64338848|FG001|Overall Study|Protocol Violation|4|||
23160364|NCT00960843|64338847|FG000|Overall Study|Repeated needle dislodgment|0|||
23160365|NCT00960843|64338848|FG001|Overall Study|Repeated needle dislodgment|1|||
23160366|NCT01231659|64338853|FG000|Overall Study|Adverse Event|9|||
23160367|NCT01231659|64338853|FG000|Overall Study|Disease Progression|48|||
23160368|NCT01231659|64338853|FG000|Overall Study|Death|2|||
23160369|NCT01231659|64338853|FG000|Overall Study|Patient refused to complete study visit|1|||
23160370|NCT01231659|64338853|FG000|Overall Study|Other protocol defined criteria|12|||
23329641|NCT02418949|64948637|FG000|Overall Study|Withdrawal by Subject|1|||
23329642|NCT02418949|64948638|FG001|Overall Study|Withdrawal by Subject|0|||
23329643|NCT02418949|64948639|FG002|Overall Study|Withdrawal by Subject|1|||
23160371|NCT00405067|64338854|FG000|Overall Study|Adverse Event|4|||
23160372|NCT00405067|64338855|FG001|Overall Study|Adverse Event|9|||
23160373|NCT00405067|64338856|FG002|Overall Study|Adverse Event|4|||
23160374|NCT00405067|64338854|FG000|Overall Study|Lost to Follow-up|0|||
23160375|NCT00405067|64338855|FG001|Overall Study|Lost to Follow-up|0|||
23160376|NCT00405067|64338856|FG002|Overall Study|Lost to Follow-up|1|||
23160377|NCT00402649|64338857|FG000|Overall Study|Lost to Follow-up|1|||
23160378|NCT00402649|64338857|FG000|Overall Study|Withdrawal by Subject|1|||
23329644|NCT02418949|64948640|FG003|Overall Study|Withdrawal by Subject|1|||
23329645|NCT02418949|64948637|FG000|Overall Study|Lost to Follow-up|1|||
23329646|NCT02418949|64948638|FG001|Overall Study|Lost to Follow-up|0|||
23329647|NCT02418949|64948639|FG002|Overall Study|Lost to Follow-up|1|||
23329648|NCT02418949|64948640|FG003|Overall Study|Lost to Follow-up|0|||
23329649|NCT02418949|64948637|FG000|Overall Study|Physician Decision|1|||
23329650|NCT02418949|64948638|FG001|Overall Study|Physician Decision|1|||
23329651|NCT02418949|64948639|FG002|Overall Study|Physician Decision|1|||
23329652|NCT02418949|64948640|FG003|Overall Study|Physician Decision|0|||
23329653|NCT03660930|64948644|FG000|Overall Study|Adverse Event|0|||
23329654|NCT03660930|64948645|FG001|Overall Study|Adverse Event|0|||
23329655|NCT03660930|64948646|FG002|Overall Study|Adverse Event|0|||
23160379|NCT00550680|64338858|FG000|Overall Study|Administrative Reasons|1|||
23160380|NCT00550680|64338858|FG000|Overall Study|Adverse Event|5|||
23329656|NCT03660930|64948647|FG003|Overall Study|Adverse Event|2|||
23329657|NCT03660930|64948648|FG004|Overall Study|Adverse Event|0|||
23329658|NCT03660930|64948649|FG005|Overall Study|Adverse Event|1|||
23329659|NCT03660930|64948650|FG006|Overall Study|Adverse Event|0|||
23329660|NCT03660930|64948651|FG007|Overall Study|Adverse Event|0|||
23329661|NCT03660930|64948644|FG000|Overall Study|Withdrawal by Subject|0|||
23329662|NCT03660930|64948645|FG001|Overall Study|Withdrawal by Subject|0|||
23329663|NCT03660930|64948646|FG002|Overall Study|Withdrawal by Subject|0|||
23445937|NCT03594773|65373786|FG000|Overall Study|Withdrawal by Subject|3|||
23160381|NCT00550680|64338858|FG000|Overall Study|Death|3|||
23160382|NCT00550680|64338858|FG000|Overall Study|Early Improvement|1|||
23160383|NCT00550680|64338858|FG000|Overall Study|Lost to Follow-up|3|||
23160384|NCT00550680|64338858|FG000|Overall Study|Lack of Efficacy|1|||
23160385|NCT00550680|64338858|FG000|Overall Study|Other|10|||
23160386|NCT00550680|64338858|FG000|Overall Study|Protocol Violation|7|||
23160387|NCT00550680|64338858|FG000|Overall Study|Refused Treatment|19|||
23160388|NCT00550680|64338858|FG000|Overall Study|Screen Failure|6|||
23160389|NCT00847145|64338859|FG000|Overall Study|AE or Death|0|||
23160390|NCT00847145|64338860|FG001|Overall Study|AE or Death|1|||
23160391|NCT00847145|64338861|FG002|Overall Study|AE or Death|1|||
23160392|NCT00847145|64338862|FG003|Overall Study|AE or Death|0|||
23160393|NCT00847145|64338863|FG004|Overall Study|AE or Death|0|||
23160394|NCT00847145|64338864|FG005|Overall Study|AE or Death|0|||
23160395|NCT00847145|64338865|FG006|Overall Study|AE or Death|0|||
23160396|NCT00847145|64338866|FG007|Overall Study|AE or Death|0|||
23160397|NCT00847145|64338859|FG000|Overall Study|Withdrawal by Subject|3|||
23160398|NCT00847145|64338860|FG001|Overall Study|Withdrawal by Subject|4|||
23160399|NCT00847145|64338861|FG002|Overall Study|Withdrawal by Subject|6|||
23160400|NCT00847145|64338862|FG003|Overall Study|Withdrawal by Subject|1|||
23222972|NCT02658968|64557849|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
23329664|NCT03660930|64948647|FG003|Overall Study|Withdrawal by Subject|0|||
23329665|NCT03660930|64948648|FG004|Overall Study|Withdrawal by Subject|0|||
23329666|NCT03660930|64948649|FG005|Overall Study|Withdrawal by Subject|1|||
23329667|NCT03660930|64948650|FG006|Overall Study|Withdrawal by Subject|0|||
23329668|NCT03660930|64948651|FG007|Overall Study|Withdrawal by Subject|0|||
23329669|NCT03660930|64948644|FG000|Overall Study|On Treatment|0|||
23329670|NCT03660930|64948645|FG001|Overall Study|On Treatment|0|||
23160401|NCT00847145|64338863|FG004|Overall Study|Withdrawal by Subject|0|||
23160402|NCT00847145|64338864|FG005|Overall Study|Withdrawal by Subject|0|||
23160403|NCT00847145|64338865|FG006|Overall Study|Withdrawal by Subject|1|||
23160404|NCT00847145|64338866|FG007|Overall Study|Withdrawal by Subject|1|||
23329671|NCT03660930|64948646|FG002|Overall Study|On Treatment|0|||
23160405|NCT00847145|64338859|FG000|Overall Study|Lost to Follow-up|3|||
23160406|NCT00847145|64338860|FG001|Overall Study|Lost to Follow-up|1|||
23160407|NCT00847145|64338861|FG002|Overall Study|Lost to Follow-up|1|||
23160408|NCT00847145|64338862|FG003|Overall Study|Lost to Follow-up|0|||
23160409|NCT00847145|64338863|FG004|Overall Study|Lost to Follow-up|4|||
23445938|NCT03594773|65373787|FG001|Overall Study|Withdrawal by Subject|2|||
23567976|NCT00308737|65807221|FG002|Overall Study|Withdrawal by Subject|18|||
23160410|NCT00847145|64338864|FG005|Overall Study|Lost to Follow-up|4|||
23160411|NCT00847145|64338865|FG006|Overall Study|Lost to Follow-up|8|||
23160412|NCT00847145|64338866|FG007|Overall Study|Lost to Follow-up|2|||
23160413|NCT00847145|64338859|FG000|Overall Study|Inappropriate enrollment|0|||
23160414|NCT00847145|64338860|FG001|Overall Study|Inappropriate enrollment|0|||
23160415|NCT00847145|64338861|FG002|Overall Study|Inappropriate enrollment|0|||
23160416|NCT00847145|64338862|FG003|Overall Study|Inappropriate enrollment|0|||
23567977|NCT00308737|65807219|FG000|Overall Study|Various|32|||
23160417|NCT00847145|64338863|FG004|Overall Study|Inappropriate enrollment|1|||
23160418|NCT00847145|64338864|FG005|Overall Study|Inappropriate enrollment|0|||
23160419|NCT00847145|64338865|FG006|Overall Study|Inappropriate enrollment|0|||
23160420|NCT00847145|64338866|FG007|Overall Study|Inappropriate enrollment|0|||
23160421|NCT00847145|64338859|FG000|Overall Study|Protocol Violation|0|||
23160422|NCT00847145|64338860|FG001|Overall Study|Protocol Violation|0|||
23160423|NCT00847145|64338861|FG002|Overall Study|Protocol Violation|3|||
23160424|NCT00847145|64338862|FG003|Overall Study|Protocol Violation|0|||
23160425|NCT00847145|64338863|FG004|Overall Study|Protocol Violation|1|||
23160426|NCT00847145|64338864|FG005|Overall Study|Protocol Violation|0|||
23160427|NCT00847145|64338865|FG006|Overall Study|Protocol Violation|0|||
23160428|NCT00847145|64338866|FG007|Overall Study|Protocol Violation|1|||
23160429|NCT02703311|64338867|FG000|Overall Study|Death|5|||
23160430|NCT02703311|64338867|FG000|Overall Study|Withdrawal by Subject|3|||
23160431|NCT02116777|64338872|FG000|Overall Study|Adverse Event|0|||
23160432|NCT02116777|64338873|FG001|Overall Study|Adverse Event|0|||
23160433|NCT02116777|64338874|FG002|Overall Study|Adverse Event|0|||
23160434|NCT02116777|64338875|FG003|Overall Study|Adverse Event|0|||
23160435|NCT02116777|64338876|FG004|Overall Study|Adverse Event|2|||
23160436|NCT02116777|64338877|FG005|Overall Study|Adverse Event|2|||
23160437|NCT02116777|64338878|FG006|Overall Study|Adverse Event|0|||
23160438|NCT02116777|64338872|FG000|Overall Study|Death|0|||
23160439|NCT02116777|64338873|FG001|Overall Study|Death|0|||
23160440|NCT02116777|64338874|FG002|Overall Study|Death|0|||
23160441|NCT02116777|64338875|FG003|Overall Study|Death|1|||
23160442|NCT02116777|64338876|FG004|Overall Study|Death|0|||
23160443|NCT02116777|64338877|FG005|Overall Study|Death|0|||
23160444|NCT02116777|64338878|FG006|Overall Study|Death|0|||
23160445|NCT02116777|64338872|FG000|Overall Study|Lack of Efficacy|3|||
23160446|NCT02116777|64338873|FG001|Overall Study|Lack of Efficacy|3|||
23160447|NCT02116777|64338874|FG002|Overall Study|Lack of Efficacy|3|||
23160448|NCT02116777|64338875|FG003|Overall Study|Lack of Efficacy|8|||
23160449|NCT02116777|64338876|FG004|Overall Study|Lack of Efficacy|4|||
23160450|NCT02116777|64338877|FG005|Overall Study|Lack of Efficacy|1|||
23160451|NCT02116777|64338878|FG006|Overall Study|Lack of Efficacy|9|||
23160452|NCT02116777|64338872|FG000|Overall Study|Physician Decision|0|||
23160453|NCT02116777|64338873|FG001|Overall Study|Physician Decision|0|||
23160454|NCT02116777|64338874|FG002|Overall Study|Physician Decision|0|||
23445939|NCT03594773|65373786|FG000|Overall Study|Lost to Follow-up|3|||
23445940|NCT03594773|65373787|FG001|Overall Study|Lost to Follow-up|4|||
23567978|NCT00308737|65807220|FG001|Overall Study|Various|20|||
23567979|NCT00308737|65807221|FG002|Overall Study|Various|8|||
23567980|NCT00245856|65807222|FG000|Period Two|Withdrawal by Subject|0|||
23567981|NCT00245856|65807223|FG001|Period Two|Withdrawal by Subject|1|||
23567982|NCT02009696|65807224|FG000|Overall Study|Withdrawal by Subject|2|||
23567983|NCT00519636|65807227|FG000|Treatment Period 1|Adverse Event|1|||
23160455|NCT02116777|64338875|FG003|Overall Study|Physician Decision|2|||
23160456|NCT02116777|64338876|FG004|Overall Study|Physician Decision|0|||
23160457|NCT02116777|64338877|FG005|Overall Study|Physician Decision|0|||
23160458|NCT02116777|64338878|FG006|Overall Study|Physician Decision|0|||
23160459|NCT02116777|64338872|FG000|Overall Study|Protocol Violation|0|||
23160460|NCT02116777|64338873|FG001|Overall Study|Protocol Violation|0|||
23160461|NCT02116777|64338874|FG002|Overall Study|Protocol Violation|0|||
23160462|NCT02116777|64338875|FG003|Overall Study|Protocol Violation|1|||
23160463|NCT02116777|64338876|FG004|Overall Study|Protocol Violation|0|||
23160464|NCT02116777|64338877|FG005|Overall Study|Protocol Violation|0|||
23445941|NCT00391027|65373788|FG000|Overall Study|Adverse Event|8|||
23160465|NCT02116777|64338878|FG006|Overall Study|Protocol Violation|0|||
23567984|NCT00519636|65807228|FG001|Treatment Period 1|Adverse Event|0|||
23567985|NCT00519636|65807229|FG002|Treatment Period 1|Adverse Event|1|||
23567986|NCT00519636|65807230|FG003|Treatment Period 1|Adverse Event|0|||
23445942|NCT00391027|65373789|FG001|Overall Study|Adverse Event|8|||
23445943|NCT00391027|65373788|FG000|Overall Study|Lack of Efficacy|3|||
23445944|NCT00391027|65373789|FG001|Overall Study|Lack of Efficacy|0|||
23445945|NCT00391027|65373788|FG000|Overall Study|Withdrawal by Subject|10|||
23445946|NCT00391027|65373789|FG001|Overall Study|Withdrawal by Subject|1|||
23445947|NCT00391027|65373788|FG000|Overall Study|Other|4|||
23445948|NCT00391027|65373789|FG001|Overall Study|Other|3|||
23445949|NCT01625000|65373794|FG000|Overall Study|Physician Decision|15|||
23445950|NCT01625000|65373795|FG001|Overall Study|Physician Decision|7|||
23445951|NCT01625000|65373796|FG002|Overall Study|Physician Decision|7|||
23445952|NCT01625000|65373797|FG003|Overall Study|Physician Decision|2|||
23445953|NCT01625000|65373798|FG004|Overall Study|Physician Decision|15|||
23445954|NCT01625000|65373794|FG000|Overall Study|Protocol Violation|3|||
23445955|NCT01625000|65373795|FG001|Overall Study|Protocol Violation|10|||
23445956|NCT01625000|65373796|FG002|Overall Study|Protocol Violation|4|||
23445957|NCT01625000|65373797|FG003|Overall Study|Protocol Violation|1|||
23445958|NCT01625000|65373798|FG004|Overall Study|Protocol Violation|2|||
23222973|NCT00796224|64557850|FG000|Overall Study|Adverse Event|1|||
23222974|NCT00796224|64557851|FG001|Overall Study|Adverse Event|0|||
23222975|NCT00796224|64557850|FG000|Overall Study|Protocol Violation|0|||
23567987|NCT00519636|65807227|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
23567988|NCT00519636|65807228|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
23567989|NCT00519636|65807229|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
23567990|NCT00519636|65807230|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
23567991|NCT00519636|65807227|FG000|Washout Period|Adverse Event|2|||
23567992|NCT00519636|65807228|FG001|Washout Period|Adverse Event|1|||
23567993|NCT00519636|65807229|FG002|Washout Period|Adverse Event|1|||
23567994|NCT00519636|65807230|FG003|Washout Period|Adverse Event|0|||
23567995|NCT00519636|65807227|FG000|Washout Period|Lost to Follow-up|1|||
23567996|NCT00519636|65807228|FG001|Washout Period|Lost to Follow-up|0|||
23567997|NCT00519636|65807229|FG002|Washout Period|Lost to Follow-up|0|||
23567998|NCT00519636|65807230|FG003|Washout Period|Lost to Follow-up|0|||
23567999|NCT00519636|65807227|FG000|Washout Period|Protocol Violation|0|||
23568000|NCT00519636|65807228|FG001|Washout Period|Protocol Violation|0|||
23568001|NCT00519636|65807229|FG002|Washout Period|Protocol Violation|1|||
23568002|NCT00519636|65807230|FG003|Washout Period|Protocol Violation|2|||
23568003|NCT00519636|65807227|FG000|Washout Period|Withdrawal by Subject|1|||
23568004|NCT00519636|65807228|FG001|Washout Period|Withdrawal by Subject|0|||
23222976|NCT00796224|64557851|FG001|Overall Study|Protocol Violation|1|||
23222977|NCT00552344|64557852|FG000|Overall Study|Lack of Efficacy|55|||
23222978|NCT00552344|64557852|FG000|Overall Study|Loss of efficacy|75|||
23222979|NCT00552344|64557852|FG000|Overall Study|Lost to Follow-up|8|||
23222980|NCT00552344|64557852|FG000|Overall Study|Withdrawal by Subject|48|||
23445959|NCT01625000|65373794|FG000|Overall Study|Withdrawal by Subject|19|||
23445960|NCT01625000|65373795|FG001|Overall Study|Withdrawal by Subject|16|||
23445961|NCT01625000|65373796|FG002|Overall Study|Withdrawal by Subject|11|||
23568005|NCT00519636|65807229|FG002|Washout Period|Withdrawal by Subject|1|||
23568006|NCT00519636|65807230|FG003|Washout Period|Withdrawal by Subject|0|||
23568007|NCT00519636|65807227|FG000|Washout Period|Failed to meet continuation criteria|14|||
23568008|NCT00519636|65807228|FG001|Washout Period|Failed to meet continuation criteria|11|||
23160466|NCT02116777|64338872|FG000|Overall Study|Withdrawal by Subject|0|||
23160467|NCT02116777|64338873|FG001|Overall Study|Withdrawal by Subject|0|||
23160468|NCT02116777|64338874|FG002|Overall Study|Withdrawal by Subject|0|||
23160469|NCT02116777|64338875|FG003|Overall Study|Withdrawal by Subject|1|||
23160470|NCT02116777|64338876|FG004|Overall Study|Withdrawal by Subject|0|||
23160471|NCT02116777|64338877|FG005|Overall Study|Withdrawal by Subject|0|||
23160472|NCT02116777|64338878|FG006|Overall Study|Withdrawal by Subject|0|||
23160473|NCT00794677|64338883|FG000|First Intervention|Withdrawal by Subject|2|||
23160474|NCT00794677|64338884|FG001|First Intervention|Withdrawal by Subject|0|||
23160475|NCT01438489|64338885|FG000|Overall Study|Lost to Follow-up|4|||
23160476|NCT01438489|64338886|FG001|Overall Study|Lost to Follow-up|2|||
23160477|NCT01438489|64338887|FG002|Overall Study|Lost to Follow-up|2|||
23160478|NCT01438489|64338885|FG000|Overall Study|Withdrawal by Subject|11|||
23160479|NCT01438489|64338886|FG001|Overall Study|Withdrawal by Subject|3|||
23160480|NCT01438489|64338887|FG002|Overall Study|Withdrawal by Subject|8|||
23160481|NCT01438489|64338885|FG000|Overall Study|Death|0|||
23160482|NCT01438489|64338886|FG001|Overall Study|Death|0|||
23160483|NCT01438489|64338887|FG002|Overall Study|Death|1|||
23160484|NCT01438489|64338885|FG000|Overall Study|Sponsor decision|4|||
23160485|NCT01438489|64338886|FG001|Overall Study|Sponsor decision|1|||
23160486|NCT01438489|64338887|FG002|Overall Study|Sponsor decision|4|||
23160487|NCT01438489|64338885|FG000|Overall Study|Subject choice/Subject moved|2|||
23160488|NCT01438489|64338886|FG001|Overall Study|Subject choice/Subject moved|1|||
23222981|NCT00552344|64557852|FG000|Overall Study|SAE, non-fatal|6|||
23329672|NCT03660930|64948647|FG003|Overall Study|On Treatment|0|||
23568009|NCT00519636|65807229|FG002|Washout Period|Failed to meet continuation criteria|9|||
23160489|NCT01438489|64338887|FG002|Overall Study|Subject choice/Subject moved|1|||
23445962|NCT01625000|65373797|FG003|Overall Study|Withdrawal by Subject|9|||
23445963|NCT01625000|65373798|FG004|Overall Study|Withdrawal by Subject|17|||
23445964|NCT01625000|65373794|FG000|Overall Study|Adverse Event (including Death)|15|||
23445965|NCT01625000|65373795|FG001|Overall Study|Adverse Event (including Death)|19|||
23445966|NCT01625000|65373796|FG002|Overall Study|Adverse Event (including Death)|11|||
23445967|NCT01625000|65373797|FG003|Overall Study|Adverse Event (including Death)|7|||
23445968|NCT01625000|65373798|FG004|Overall Study|Adverse Event (including Death)|21|||
23445969|NCT05066165|65373799|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
23445970|NCT05066165|65373800|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
23445971|NCT05066165|65373799|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
23445972|NCT05066165|65373800|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
23160490|NCT01438489|64338885|FG000|Overall Study|Investigator decision|0|||
23160491|NCT01438489|64338886|FG001|Overall Study|Investigator decision|1|||
23160492|NCT01438489|64338887|FG002|Overall Study|Investigator decision|0|||
23160493|NCT01438489|64338885|FG000|Overall Study|AE/SAEs|2|||
23160494|NCT01438489|64338886|FG001|Overall Study|AE/SAEs|1|||
23160495|NCT01438489|64338887|FG002|Overall Study|AE/SAEs|1|||
23160496|NCT01438489|64338885|FG000|Overall Study|Received prohibited medication|1|||
23160497|NCT01438489|64338886|FG001|Overall Study|Received prohibited medication|0|||
23160498|NCT01438489|64338887|FG002|Overall Study|Received prohibited medication|0|||
23160499|NCT01438489|64338885|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
23160500|NCT01438489|64338886|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
23160501|NCT01438489|64338887|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
23160502|NCT01438489|64338885|FG000|Overall Study|Inadequate venous access|0|||
23160503|NCT01438489|64338886|FG001|Overall Study|Inadequate venous access|2|||
23160504|NCT01438489|64338887|FG002|Overall Study|Inadequate venous access|0|||
23160505|NCT00530270|64338888|FG000|Overall Study|Protocol Violation|1|||
23160506|NCT00530270|64338889|FG001|Overall Study|Protocol Violation|0|||
23160507|NCT01449461|64338890|FG000|Overall Study|Adverse Event|0|||
23160508|NCT01449461|64338891|FG001|Overall Study|Adverse Event|3|||
23160509|NCT01449461|64338892|FG002|Overall Study|Adverse Event|2|||
23160510|NCT01449461|64338893|FG003|Overall Study|Adverse Event|3|||
23160511|NCT01449461|64338894|FG004|Overall Study|Adverse Event|4|||
23445973|NCT02219334|65373801|FG000|Overall Study|Withdrawal by Subject|1|||
23568010|NCT00519636|65807230|FG003|Washout Period|Failed to meet continuation criteria|3|||
23568011|NCT00519636|65807227|FG000|Washout Period|Out of pollen area > 48 hours|1|||
23568012|NCT00519636|65807228|FG001|Washout Period|Out of pollen area > 48 hours|0|||
23568013|NCT00519636|65807229|FG002|Washout Period|Out of pollen area > 48 hours|0|||
23568014|NCT00519636|65807230|FG003|Washout Period|Out of pollen area > 48 hours|0|||
23568015|NCT00519636|65807227|FG000|Washout Period|Participating in study at another site|1|||
23568016|NCT00519636|65807228|FG001|Washout Period|Participating in study at another site|0|||
23568017|NCT00519636|65807229|FG002|Washout Period|Participating in study at another site|0|||
23568018|NCT00519636|65807230|FG003|Washout Period|Participating in study at another site|0|||
23568019|NCT00519636|65807227|FG000|Washout Period|Non-compliant|0|||
23568020|NCT00519636|65807228|FG001|Washout Period|Non-compliant|1|||
23568021|NCT00519636|65807229|FG002|Washout Period|Non-compliant|0|||
23568022|NCT00519636|65807230|FG003|Washout Period|Non-compliant|0|||
23568023|NCT00519636|65807227|FG000|Washout Period|Per doctors request|0|||
23568024|NCT00519636|65807228|FG001|Washout Period|Per doctors request|1|||
23568025|NCT00519636|65807229|FG002|Washout Period|Per doctors request|0|||
23568026|NCT00519636|65807230|FG003|Washout Period|Per doctors request|0|||
23568027|NCT00519636|65807227|FG000|Washout Period|Subject randomized in error|0|||
23160512|NCT01449461|64338895|FG005|Overall Study|Adverse Event|4|||
23160513|NCT01449461|64338890|FG000|Overall Study|Death|0|||
23222982|NCT00552344|64557852|FG000|Overall Study|AE, non-serious non-fatal|38|||
23445974|NCT02219334|65373802|FG001|Overall Study|Withdrawal by Subject|0|||
23445975|NCT02219334|65373801|FG000|Overall Study|Protocol Violation|7|||
23445976|NCT02219334|65373802|FG001|Overall Study|Protocol Violation|3|||
23568028|NCT00519636|65807228|FG001|Washout Period|Subject randomized in error|0|||
23568029|NCT00519636|65807229|FG002|Washout Period|Subject randomized in error|1|||
23160514|NCT01449461|64338891|FG001|Overall Study|Death|2|||
23160515|NCT01449461|64338892|FG002|Overall Study|Death|0|||
23160516|NCT01449461|64338893|FG003|Overall Study|Death|0|||
23160517|NCT01449461|64338894|FG004|Overall Study|Death|7|||
23160518|NCT01449461|64338895|FG005|Overall Study|Death|1|||
23160519|NCT01449461|64338890|FG000|Overall Study|Physician Decision|0|||
23160520|NCT01449461|64338891|FG001|Overall Study|Physician Decision|1|||
23160521|NCT01449461|64338892|FG002|Overall Study|Physician Decision|0|||
23160522|NCT01449461|64338893|FG003|Overall Study|Physician Decision|4|||
23160523|NCT01449461|64338894|FG004|Overall Study|Physician Decision|1|||
23222983|NCT00552344|64557852|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
23222984|NCT00552344|64557852|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
23222985|NCT00552344|64557852|FG000|Overall Study|Other Reason|22|||
23222986|NCT01057862|64557859|FG000|Overall Study|Withdrawal by Subject|1|||
23222987|NCT01057862|64557860|FG001|Overall Study|Withdrawal by Subject|2|||
23222988|NCT01819194|64557861|FG000|Overall Study|Loss of study articles|2|||
23236666|NCT05403502|64608282|FG000|Humalog Lead-In Period|Physician Decision|2|||
23236667|NCT05403502|64608282|FG000|Humalog Lead-In Period|Protocol Violation|1|||
23236668|NCT05403502|64608282|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
23236669|NCT05403502|64608282|FG000|Lyumjev Treatment Period|Physician Decision|2|||
23329673|NCT03660930|64948648|FG004|Overall Study|On Treatment|0|||
23329674|NCT03660930|64948649|FG005|Overall Study|On Treatment|0|||
23329675|NCT03660930|64948650|FG006|Overall Study|On Treatment|0|||
23329676|NCT03660930|64948651|FG007|Overall Study|On Treatment|1|||
23329677|NCT03660930|64948644|FG000|Overall Study|In Follow-up|0|||
23329678|NCT03660930|64948645|FG001|Overall Study|In Follow-up|0|||
23329679|NCT03660930|64948646|FG002|Overall Study|In Follow-up|0|||
23329680|NCT03660930|64948647|FG003|Overall Study|In Follow-up|0|||
23329681|NCT03660930|64948648|FG004|Overall Study|In Follow-up|0|||
23329682|NCT03660930|64948649|FG005|Overall Study|In Follow-up|0|||
23329683|NCT03660930|64948650|FG006|Overall Study|In Follow-up|1|||
23329684|NCT03660930|64948651|FG007|Overall Study|In Follow-up|2|||
23329685|NCT01567462|64948667|FG000|Overall Study|Withdrawal by Subject|4|||
23329686|NCT01567462|64948668|FG001|Overall Study|Withdrawal by Subject|7|||
23329687|NCT01415518|64948671|FG000|Overall Study|Withdrawal by Subject|2|||
23329688|NCT01415518|64948672|FG001|Overall Study|Withdrawal by Subject|12|||
23329689|NCT01415518|64948671|FG000|Overall Study|Protocol Violation|6|||
23329690|NCT01415518|64948672|FG001|Overall Study|Protocol Violation|8|||
23329691|NCT01415518|64948671|FG000|Overall Study|Lost to Follow-up|3|||
23236670|NCT01190839|64608287|FG000|Overall Study|Adverse Event|32|||
23236671|NCT01190839|64608288|FG001|Overall Study|Adverse Event|41|||
23236672|NCT01190839|64608287|FG000|Overall Study|Protocol Violation|2|||
23329692|NCT01415518|64948672|FG001|Overall Study|Lost to Follow-up|5|||
23329693|NCT01415518|64948671|FG000|Overall Study|Adverse Event|3|||
23329694|NCT01415518|64948672|FG001|Overall Study|Adverse Event|4|||
23329695|NCT01415518|64948671|FG000|Overall Study|Death|1|||
23329696|NCT01415518|64948672|FG001|Overall Study|Death|1|||
23329697|NCT01415518|64948671|FG000|Overall Study|Condition under Investigation Worsened|1|||
23329698|NCT01415518|64948672|FG001|Overall Study|Condition under Investigation Worsened|1|||
23329699|NCT00489918|64948673|FG000|Overall Study|Withdrawal by Subject|2|||
23329700|NCT00489918|64948674|FG001|Overall Study|Withdrawal by Subject|1|||
23329701|NCT00489918|64948675|FG002|Overall Study|Withdrawal by Subject|1|||
23329702|NCT00489918|64948676|FG003|Overall Study|Withdrawal by Subject|0|||
23568030|NCT00519636|65807230|FG003|Washout Period|Subject randomized in error|0|||
23568031|NCT00519636|65807227|FG000|Washout Period|Prohibited medications|0|||
23568032|NCT00519636|65807228|FG001|Washout Period|Prohibited medications|0|||
23160524|NCT01449461|64338895|FG005|Overall Study|Physician Decision|0|||
23160525|NCT01449461|64338890|FG000|Overall Study|Documented Progressive Disease|4|||
23329703|NCT00489918|64948677|FG004|Overall Study|Withdrawal by Subject|1|||
23329704|NCT00489918|64948673|FG000|Overall Study|Adverse Event|0|||
23329705|NCT00489918|64948674|FG001|Overall Study|Adverse Event|1|||
23329706|NCT00489918|64948675|FG002|Overall Study|Adverse Event|1|||
23329707|NCT00489918|64948676|FG003|Overall Study|Adverse Event|0|||
23329708|NCT00489918|64948677|FG004|Overall Study|Adverse Event|0|||
23329709|NCT00489918|64948673|FG000|Overall Study|Lost to Follow-up|0|||
23329710|NCT00489918|64948674|FG001|Overall Study|Lost to Follow-up|0|||
23329711|NCT00489918|64948675|FG002|Overall Study|Lost to Follow-up|1|||
23329712|NCT00489918|64948676|FG003|Overall Study|Lost to Follow-up|1|||
23329713|NCT00489918|64948677|FG004|Overall Study|Lost to Follow-up|0|||
23329714|NCT00489918|64948673|FG000|Overall Study|Physician Decision|0|||
23329715|NCT00489918|64948674|FG001|Overall Study|Physician Decision|0|||
23329716|NCT00489918|64948675|FG002|Overall Study|Physician Decision|1|||
23329717|NCT00489918|64948676|FG003|Overall Study|Physician Decision|0|||
23329718|NCT00489918|64948677|FG004|Overall Study|Physician Decision|0|||
23160526|NCT01449461|64338891|FG001|Overall Study|Documented Progressive Disease|7|||
23568033|NCT00519636|65807229|FG002|Washout Period|Prohibited medications|1|||
23236673|NCT01190839|64608288|FG001|Overall Study|Protocol Violation|2|||
23236674|NCT01190839|64608287|FG000|Overall Study|Lost to Follow-up|7|||
23329719|NCT02454608|64948678|FG000|Double-Blind Period|Lack of Efficacy|0|||
23329720|NCT02454608|64948679|FG001|Double-Blind Period|Lack of Efficacy|2|||
23329721|NCT02454608|64948680|FG002|Double-Blind Period|Lack of Efficacy|0|||
23329722|NCT02454608|64948678|FG000|Open Label Period|Lost to Follow-up|0|||
23329723|NCT02454608|64948679|FG001|Open Label Period|Lost to Follow-up|0|||
23329724|NCT02454608|64948680|FG002|Open Label Period|Lost to Follow-up|11|||
23329725|NCT02454608|64948678|FG000|Open Label Period|Withdrawal by Subject|0|||
23329726|NCT02454608|64948679|FG001|Open Label Period|Withdrawal by Subject|0|||
23329727|NCT02454608|64948680|FG002|Open Label Period|Withdrawal by Subject|8|||
23329728|NCT00449865|64948681|FG000|Overall Study|Withdrawal by Subject|110|||
23329729|NCT00449865|64948682|FG001|Overall Study|Withdrawal by Subject|110|||
23329730|NCT00449865|64948681|FG000|Overall Study|Lost to Follow-up|36|||
23329731|NCT00449865|64948682|FG001|Overall Study|Lost to Follow-up|37|||
23329732|NCT00449865|64948681|FG000|Overall Study|Physician Decision|13|||
23329733|NCT00449865|64948682|FG001|Overall Study|Physician Decision|12|||
23329734|NCT00449865|64948681|FG000|Overall Study|Death|31|||
23329735|NCT00449865|64948682|FG001|Overall Study|Death|40|||
23329736|NCT00449865|64948681|FG000|Overall Study|Protocol Violation|8|||
23329737|NCT00449865|64948682|FG001|Overall Study|Protocol Violation|7|||
23329738|NCT00449865|64948681|FG000|Overall Study|Study was stopped|324|||
23329739|NCT00449865|64948682|FG001|Overall Study|Study was stopped|328|||
23329740|NCT00086684|64948683|FG000|Overall Study|Adverse Event|12|||
23329741|NCT00086684|64948684|FG001|Overall Study|Adverse Event|17|||
23329742|NCT00086684|64948685|FG002|Overall Study|Adverse Event|14|||
23329743|NCT00086684|64948683|FG000|Overall Study|Lack of Efficacy|6|||
23329744|NCT00086684|64948684|FG001|Overall Study|Lack of Efficacy|6|||
23329745|NCT00086684|64948685|FG002|Overall Study|Lack of Efficacy|5|||
23329746|NCT00086684|64948683|FG000|Overall Study|Lost to Follow-up|15|||
23329747|NCT00086684|64948684|FG001|Overall Study|Lost to Follow-up|8|||
23329748|NCT00086684|64948685|FG002|Overall Study|Lost to Follow-up|10|||
23329749|NCT00086684|64948683|FG000|Overall Study|Protocol Violation|8|||
23329750|NCT00086684|64948684|FG001|Overall Study|Protocol Violation|3|||
23329751|NCT00086684|64948685|FG002|Overall Study|Protocol Violation|0|||
23329752|NCT00086684|64948683|FG000|Overall Study|Withdrawal by Subject|0|||
23329753|NCT00086684|64948684|FG001|Overall Study|Withdrawal by Subject|4|||
23329754|NCT00086684|64948685|FG002|Overall Study|Withdrawal by Subject|10|||
23329755|NCT00086684|64948683|FG000|Overall Study|NONCOMPLIANCE|5|||
23329756|NCT00086684|64948684|FG001|Overall Study|NONCOMPLIANCE|7|||
23329757|NCT00086684|64948685|FG002|Overall Study|NONCOMPLIANCE|6|||
23329758|NCT00086684|64948683|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23329759|NCT00086684|64948684|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
23329760|NCT00086684|64948685|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
23329761|NCT00086684|64948683|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
23329762|NCT00086684|64948684|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
23329763|NCT00086684|64948685|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
23329764|NCT00086684|64948683|FG000|Overall Study|Other|4|||
23329765|NCT00086684|64948684|FG001|Overall Study|Other|2|||
23329766|NCT00086684|64948685|FG002|Overall Study|Other|3|||
23329767|NCT03762265|64948688|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
23329768|NCT03762265|64948689|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
23329769|NCT03762265|64948688|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
23329770|NCT03762265|64948689|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
23329771|NCT03762265|64948688|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
23329772|NCT03762265|64948689|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
23329773|NCT03762265|64948688|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
23329774|NCT03762265|64948689|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
23329775|NCT03762265|64948688|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
23329776|NCT03762265|64948689|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
23329777|NCT03762265|64948688|FG000|BT Period: Weeks 1 to 37|Other|0|||
23329778|NCT03762265|64948689|FG001|BT Period: Weeks 1 to 37|Other|1|||
23329779|NCT03762265|64948688|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
23329780|NCT03762265|64948689|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
23329781|NCT03762265|64948688|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
23329782|NCT03762265|64948689|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
23329783|NCT03762265|64948688|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
23329784|NCT03762265|64948689|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
23329785|NCT03762265|64948688|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
23329786|NCT03762265|64948689|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
23568034|NCT00519636|65807230|FG003|Washout Period|Prohibited medications|0|||
23329787|NCT03762265|64948688|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
23568035|NCT00519636|65807227|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
23329788|NCT03762265|64948689|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
23329789|NCT03762265|64948688|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
23329790|NCT03762265|64948689|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
23329791|NCT03762265|64948688|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
23329792|NCT03762265|64948689|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
23568036|NCT00519636|65807228|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
23329793|NCT03762265|64948688|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
23329794|NCT03762265|64948689|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
23329795|NCT03762265|64948688|FG000|LTE Period: Weeks 61 to 109|Other|1|||
23329796|NCT03762265|64948689|FG001|LTE Period: Weeks 61 to 109|Other|0|||
23329797|NCT03743051|64948692|FG000|Overall Study|Adverse Event|5|||
23329798|NCT03743051|64948693|FG001|Overall Study|Adverse Event|9|||
23329799|NCT03743051|64948692|FG000|Overall Study|Death|27|||
23329800|NCT03743051|64948693|FG001|Overall Study|Death|26|||
23329801|NCT03743051|64948692|FG000|Overall Study|Lost to Follow-up|4|||
23329802|NCT03743051|64948693|FG001|Overall Study|Lost to Follow-up|8|||
23329803|NCT03743051|64948692|FG000|Overall Study|Withdrawal by Subject|32|||
23329804|NCT03743051|64948693|FG001|Overall Study|Withdrawal by Subject|19|||
23329805|NCT03743051|64948692|FG000|Overall Study|Physician Decision|10|||
23329806|NCT03743051|64948693|FG001|Overall Study|Physician Decision|15|||
23329807|NCT03743051|64948692|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
23329808|NCT03743051|64948693|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
23329809|NCT03922308|64948700|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
23329810|NCT03922308|64948701|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
23329811|NCT03922308|64948702|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
23329812|NCT03922308|64948700|FG000|Overall Study|Lost to Follow-up|1|||
23329813|NCT03922308|64948701|FG001|Overall Study|Lost to Follow-up|0|||
23329814|NCT03922308|64948702|FG002|Overall Study|Lost to Follow-up|0|||
23329815|NCT03922308|64948700|FG000|Overall Study|Reason not Specified|0|||
23329816|NCT03922308|64948701|FG001|Overall Study|Reason not Specified|2|||
23329817|NCT03922308|64948702|FG002|Overall Study|Reason not Specified|1|||
23329818|NCT03749330|64948706|FG000|Overall Study|Clinicians left work in the CICU|0|||
23329819|NCT03749330|64948707|FG001|Overall Study|Clinicians left work in the CICU|2|||
23329820|NCT03749330|64948708|FG002|Overall Study|Clinicians left work in the CICU|0|||
23329821|NCT03749330|64948709|FG003|Overall Study|Clinicians left work in the CICU|0|||
23329822|NCT03749330|64948710|FG004|Overall Study|Clinicians left work in the CICU|0|||
23329823|NCT03749330|64948711|FG005|Overall Study|Clinicians left work in the CICU|0|||
23329824|NCT03376789|64948712|FG000|Overall Study|Withdrawal by Subject|3|||
23568037|NCT00519636|65807229|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
23568038|NCT00519636|65807230|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
23568039|NCT00519636|65807227|FG000|Treatment Period 2|Subject randomized in error|0|||
23568040|NCT00519636|65807228|FG001|Treatment Period 2|Subject randomized in error|1|||
23568041|NCT00519636|65807229|FG002|Treatment Period 2|Subject randomized in error|0|||
23568042|NCT00519636|65807230|FG003|Treatment Period 2|Subject randomized in error|0|||
23568043|NCT00519636|65807227|FG000|Treatment Period 2|Per doctors request|0|||
23568044|NCT00519636|65807228|FG001|Treatment Period 2|Per doctors request|0|||
23568045|NCT00519636|65807229|FG002|Treatment Period 2|Per doctors request|1|||
23568046|NCT00519636|65807230|FG003|Treatment Period 2|Per doctors request|0|||
23568047|NCT00519636|65807227|FG000|Treatment Period 2|Subject misrandomized|0|||
23568048|NCT00519636|65807228|FG001|Treatment Period 2|Subject misrandomized|0|||
23568049|NCT00519636|65807229|FG002|Treatment Period 2|Subject misrandomized|0|||
23568050|NCT00519636|65807230|FG003|Treatment Period 2|Subject misrandomized|1|||
23568051|NCT00519636|65807227|FG000|Post Study Period|Subject randomized in error|0|||
23568052|NCT00519636|65807228|FG001|Post Study Period|Subject randomized in error|0|||
23568053|NCT00519636|65807229|FG002|Post Study Period|Subject randomized in error|0|||
23568054|NCT00519636|65807230|FG003|Post Study Period|Subject randomized in error|1|||
23568055|NCT01216176|65807231|FG000|Overall Study|Adverse Event|0|||
23568056|NCT01216176|65807232|FG001|Overall Study|Adverse Event|8|||
23568057|NCT01216176|65807233|FG002|Overall Study|Adverse Event|0|||
23568058|NCT01216176|65807231|FG000|Overall Study|Physician Decision|0|||
23568059|NCT01216176|65807232|FG001|Overall Study|Physician Decision|0|||
23568060|NCT01216176|65807233|FG002|Overall Study|Physician Decision|1|||
23568061|NCT03285295|65807234|FG000|Alinity s HBsAg|Protocol Violation|11|||
23568062|NCT03285295|65807235|FG001|Alinity s HBsAg|Protocol Violation|0|||
23568063|NCT03285295|65807236|FG002|Alinity s HBsAg|Protocol Violation|0|||
23160527|NCT01449461|64338892|FG002|Overall Study|Documented Progressive Disease|14|||
23160528|NCT01449461|64338893|FG003|Overall Study|Documented Progressive Disease|15|||
23160529|NCT01449461|64338894|FG004|Overall Study|Documented Progressive Disease|24|||
23329825|NCT03376789|64948713|FG001|Overall Study|Withdrawal by Subject|5|||
23329826|NCT03376789|64948712|FG000|Overall Study|Protocol Violation|0|||
23329827|NCT03376789|64948713|FG001|Overall Study|Protocol Violation|1|||
23329828|NCT03376789|64948712|FG000|Overall Study|Adverse Event|0|||
23568064|NCT03285295|65807237|FG003|Alinity s HBsAg|Protocol Violation|0|||
23568065|NCT03285295|65807238|FG004|Alinity s HBsAg|Protocol Violation|0|||
23568066|NCT03285295|65807234|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
23568067|NCT03285295|65807235|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
23568068|NCT03285295|65807236|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
23568069|NCT03285295|65807237|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
23568070|NCT03285295|65807238|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
23568071|NCT03285295|65807234|FG000|Alinity s HBsAg|No Results Generated|74|||
23568072|NCT03285295|65807235|FG001|Alinity s HBsAg|No Results Generated|6|||
23568073|NCT03285295|65807236|FG002|Alinity s HBsAg|No Results Generated|0|||
23568074|NCT03285295|65807237|FG003|Alinity s HBsAg|No Results Generated|0|||
23568075|NCT03285295|65807238|FG004|Alinity s HBsAg|No Results Generated|0|||
23568076|NCT03285295|65807234|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
23568077|NCT03285295|65807235|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
23568078|NCT03285295|65807236|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
23568079|NCT03285295|65807237|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
23568080|NCT03285295|65807238|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
23568081|NCT03285295|65807234|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
23568082|NCT03285295|65807235|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
23568083|NCT03285295|65807236|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
23568084|NCT03285295|65807237|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
23568085|NCT03285295|65807238|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
23568086|NCT03285295|65807234|FG000|Alinity s HTLV I/II|No Results Generated|70|||
23568087|NCT03285295|65807235|FG001|Alinity s HTLV I/II|No Results Generated|0|||
23568088|NCT03285295|65807236|FG002|Alinity s HTLV I/II|No Results Generated|0|||
23568089|NCT03285295|65807237|FG003|Alinity s HTLV I/II|No Results Generated|0|||
23568090|NCT03285295|65807238|FG004|Alinity s HTLV I/II|No Results Generated|0|||
23568091|NCT03285295|65807234|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
23568092|NCT03285295|65807235|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
23568093|NCT03285295|65807236|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
23568094|NCT03285295|65807237|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
23568095|NCT03285295|65807238|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
23160530|NCT01449461|64338895|FG005|Overall Study|Documented Progressive Disease|5|||
23160531|NCT01449461|64338890|FG000|Overall Study|Clinical Progressive Disease|2|||
23160532|NCT01449461|64338891|FG001|Overall Study|Clinical Progressive Disease|2|||
23222989|NCT00398138|64560318|FG000|Overall Study|Adverse Event|2|||
23222990|NCT02224274|64560321|FG000|Overall Study|Death|1|||
23222991|NCT02224274|64560322|FG001|Overall Study|Death|0|||
23568096|NCT03285295|65807234|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
23160533|NCT01449461|64338892|FG002|Overall Study|Clinical Progressive Disease|0|||
23222992|NCT03051217|64560333|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
23222993|NCT03051217|64560334|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23160534|NCT01449461|64338893|FG003|Overall Study|Clinical Progressive Disease|3|||
23160535|NCT01449461|64338894|FG004|Overall Study|Clinical Progressive Disease|4|||
23160536|NCT01449461|64338895|FG005|Overall Study|Clinical Progressive Disease|2|||
23160537|NCT01449461|64338890|FG000|Overall Study|Protocol Violation|0|||
23160538|NCT01449461|64338891|FG001|Overall Study|Protocol Violation|0|||
23160539|NCT01449461|64338892|FG002|Overall Study|Protocol Violation|0|||
23160540|NCT01449461|64338893|FG003|Overall Study|Protocol Violation|1|||
23160541|NCT01449461|64338894|FG004|Overall Study|Protocol Violation|0|||
23160542|NCT01449461|64338895|FG005|Overall Study|Protocol Violation|0|||
23160543|NCT01449461|64338890|FG000|Overall Study|Site Terminated by Sponsor|0|||
23160544|NCT01449461|64338891|FG001|Overall Study|Site Terminated by Sponsor|1|||
23160545|NCT01449461|64338892|FG002|Overall Study|Site Terminated by Sponsor|2|||
23160546|NCT01449461|64338893|FG003|Overall Study|Site Terminated by Sponsor|3|||
23160547|NCT01449461|64338894|FG004|Overall Study|Site Terminated by Sponsor|4|||
23160548|NCT01449461|64338895|FG005|Overall Study|Site Terminated by Sponsor|1|||
23160549|NCT01449461|64338890|FG000|Overall Study|Withdrawal by Subject|0|||
23160550|NCT01449461|64338891|FG001|Overall Study|Withdrawal by Subject|1|||
23160551|NCT01449461|64338892|FG002|Overall Study|Withdrawal by Subject|0|||
23160552|NCT01449461|64338893|FG003|Overall Study|Withdrawal by Subject|0|||
23160553|NCT01449461|64338894|FG004|Overall Study|Withdrawal by Subject|2|||
23160554|NCT01449461|64338895|FG005|Overall Study|Withdrawal by Subject|1|||
23160555|NCT01449461|64338890|FG000|Overall Study|Reason not Specified|0|||
23160556|NCT01449461|64338891|FG001|Overall Study|Reason not Specified|1|||
23160557|NCT01449461|64338892|FG002|Overall Study|Reason not Specified|0|||
23160558|NCT01449461|64338893|FG003|Overall Study|Reason not Specified|3|||
23160559|NCT01449461|64338894|FG004|Overall Study|Reason not Specified|2|||
23160560|NCT01449461|64338895|FG005|Overall Study|Reason not Specified|1|||
23160561|NCT00876187|64338896|FG000|Overall Study|Adverse Event|14|||
23222994|NCT03051217|64560335|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
23236675|NCT01190839|64608288|FG001|Overall Study|Lost to Follow-up|1|||
23160562|NCT00876187|64338897|FG001|Overall Study|Adverse Event|12|||
23160563|NCT00876187|64338898|FG002|Overall Study|Adverse Event|19|||
23568097|NCT03285295|65807235|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
23568098|NCT03285295|65807236|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
23160564|NCT00876187|64338899|FG003|Overall Study|Adverse Event|29|||
23160565|NCT00876187|64338900|FG004|Overall Study|Adverse Event|10|||
23160566|NCT00876187|64338896|FG000|Overall Study|Lack of Efficacy|59|||
23160567|NCT00876187|64338897|FG001|Overall Study|Lack of Efficacy|34|||
23160568|NCT00876187|64338898|FG002|Overall Study|Lack of Efficacy|45|||
23160569|NCT00876187|64338899|FG003|Overall Study|Lack of Efficacy|34|||
23160570|NCT00876187|64338900|FG004|Overall Study|Lack of Efficacy|59|||
23160571|NCT00876187|64338896|FG000|Overall Study|Lost to Follow-up|9|||
23160572|NCT00876187|64338897|FG001|Overall Study|Lost to Follow-up|10|||
23160573|NCT00876187|64338898|FG002|Overall Study|Lost to Follow-up|8|||
23160574|NCT00876187|64338899|FG003|Overall Study|Lost to Follow-up|8|||
23160575|NCT00876187|64338900|FG004|Overall Study|Lost to Follow-up|11|||
23160576|NCT00876187|64338896|FG000|Overall Study|Protocol Violation|6|||
23160577|NCT00876187|64338897|FG001|Overall Study|Protocol Violation|7|||
23160578|NCT00876187|64338898|FG002|Overall Study|Protocol Violation|7|||
23160579|NCT00876187|64338899|FG003|Overall Study|Protocol Violation|6|||
23160580|NCT00876187|64338900|FG004|Overall Study|Protocol Violation|3|||
23160581|NCT00876187|64338896|FG000|Overall Study|Withdrawal by Subject|16|||
23160582|NCT00876187|64338897|FG001|Overall Study|Withdrawal by Subject|26|||
23160583|NCT00876187|64338898|FG002|Overall Study|Withdrawal by Subject|32|||
23160584|NCT00876187|64338899|FG003|Overall Study|Withdrawal by Subject|38|||
23160585|NCT00876187|64338900|FG004|Overall Study|Withdrawal by Subject|37|||
23160586|NCT00876187|64338896|FG000|Overall Study|Entered extension study|101|||
23160587|NCT00876187|64338897|FG001|Overall Study|Entered extension study|120|||
23160588|NCT00876187|64338898|FG002|Overall Study|Entered extension study|156|||
23160589|NCT00876187|64338899|FG003|Overall Study|Entered extension study|151|||
23160590|NCT00876187|64338900|FG004|Overall Study|Entered extension study|144|||
23160591|NCT00876187|64338896|FG000|Overall Study|Randomized but not treated|3|||
23160592|NCT00876187|64338897|FG001|Overall Study|Randomized but not treated|1|||
23160593|NCT00876187|64338898|FG002|Overall Study|Randomized but not treated|3|||
23160594|NCT00876187|64338899|FG003|Overall Study|Randomized but not treated|2|||
23160595|NCT00876187|64338900|FG004|Overall Study|Randomized but not treated|3|||
23222995|NCT03051217|64560336|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23222996|NCT03051217|64560337|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23222997|NCT03051217|64560338|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23222998|NCT03051217|64560339|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23222999|NCT03051217|64560333|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23223000|NCT03051217|64560334|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
23223001|NCT03051217|64560335|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23223002|NCT03051217|64560336|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23223003|NCT03051217|64560337|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23223004|NCT03051217|64560338|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23223005|NCT03051217|64560339|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
23223006|NCT03051217|64560333|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
23223007|NCT03051217|64560334|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
23223008|NCT03051217|64560335|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
23223009|NCT03051217|64560336|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23223010|NCT03051217|64560337|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23223011|NCT03051217|64560338|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23223012|NCT03051217|64560339|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23223013|NCT03051217|64560333|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
23223014|NCT03051217|64560334|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
23223015|NCT03051217|64560335|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
23223016|NCT03051217|64560336|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
23223017|NCT03051217|64560337|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
23223018|NCT03051217|64560338|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
23223019|NCT03051217|64560339|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
23223020|NCT03051217|64560333|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23223021|NCT03051217|64560334|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23223022|NCT03051217|64560335|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23223023|NCT03051217|64560336|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
23223024|NCT03051217|64560337|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23223025|NCT03051217|64560338|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23160596|NCT00876187|64338896|FG000|Overall Study|Other|2|||
23160597|NCT00876187|64338897|FG001|Overall Study|Other|5|||
23160598|NCT00876187|64338898|FG002|Overall Study|Other|9|||
23160599|NCT00876187|64338899|FG003|Overall Study|Other|7|||
23160600|NCT00876187|64338900|FG004|Overall Study|Other|4|||
23223026|NCT03051217|64560339|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
23160601|NCT02114268|64338901|FG000|Overall Study|Lost to Follow-up|4|||
23160602|NCT02114268|64338902|FG001|Overall Study|Lost to Follow-up|1|||
23160603|NCT02114268|64338903|FG002|Overall Study|Lost to Follow-up|1|||
23160604|NCT02114268|64338904|FG003|Overall Study|Lost to Follow-up|0|||
23160605|NCT02114268|64338905|FG004|Overall Study|Lost to Follow-up|0|||
23160606|NCT02114268|64338906|FG005|Overall Study|Lost to Follow-up|2|||
23160607|NCT02114268|64338901|FG000|Overall Study|Withdrawal by Subject|1|||
23160608|NCT02114268|64338902|FG001|Overall Study|Withdrawal by Subject|0|||
23160609|NCT02114268|64338903|FG002|Overall Study|Withdrawal by Subject|0|||
23160610|NCT02114268|64338904|FG003|Overall Study|Withdrawal by Subject|0|||
23160611|NCT02114268|64338905|FG004|Overall Study|Withdrawal by Subject|0|||
23160612|NCT02114268|64338906|FG005|Overall Study|Withdrawal by Subject|1|||
23160613|NCT02114268|64338901|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
23160614|NCT02114268|64338902|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
23160615|NCT02114268|64338903|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
23160616|NCT02114268|64338904|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
23160617|NCT02114268|64338905|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
23160618|NCT02114268|64338906|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
23160619|NCT02573870|64338909|FG000|Overall Study|Adverse Event|0|||
23160620|NCT02573870|64338910|FG001|Overall Study|Adverse Event|2|||
23160621|NCT02573870|64338909|FG000|Overall Study|Lack of Efficacy|0|||
23160622|NCT02573870|64338910|FG001|Overall Study|Lack of Efficacy|1|||
23160623|NCT02573870|64338909|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
23160624|NCT02573870|64338910|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
23160625|NCT02573870|64338909|FG000|Overall Study|Lost to Follow-up|0|||
23160626|NCT02573870|64338910|FG001|Overall Study|Lost to Follow-up|1|||
23160627|NCT02573870|64338909|FG000|Overall Study|Other: Fail to Meet Visit|0|||
23160628|NCT02573870|64338910|FG001|Overall Study|Other: Fail to Meet Visit|2|||
23160629|NCT00117598|64338911|FG000|Prior to Treatment Cross Over|Death|40|||
23160630|NCT00117598|64338912|FG001|Prior to Treatment Cross Over|Death|41|||
23160631|NCT00117598|64338913|FG002|Prior to Treatment Cross Over|Death|37|||
23160632|NCT00117598|64338914|FG003|Prior to Treatment Cross Over|Death|0|||
23160633|NCT00117598|64338915|FG004|Prior to Treatment Cross Over|Death|0|||
23160634|NCT00117598|64338911|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
23160635|NCT00117598|64338912|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
23160636|NCT00117598|64338913|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
23160637|NCT00117598|64338914|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
23160638|NCT00117598|64338915|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
23160639|NCT00117598|64338911|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
23160640|NCT00117598|64338912|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
23160641|NCT00117598|64338913|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
23160642|NCT00117598|64338914|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
23160643|NCT00117598|64338915|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
23160644|NCT00117598|64338911|FG000|Prior to Treatment Cross Over|Other|15|||
23160645|NCT00117598|64338912|FG001|Prior to Treatment Cross Over|Other|9|||
23160646|NCT00117598|64338913|FG002|Prior to Treatment Cross Over|Other|9|||
23160647|NCT00117598|64338914|FG003|Prior to Treatment Cross Over|Other|0|||
23160648|NCT00117598|64338915|FG004|Prior to Treatment Cross Over|Other|0|||
23160649|NCT00117598|64338911|FG000|After Treament Cross Over|Death|0|||
23160650|NCT00117598|64338912|FG001|After Treament Cross Over|Death|0|||
23160651|NCT00117598|64338913|FG002|After Treament Cross Over|Death|0|||
23160652|NCT00117598|64338914|FG003|After Treament Cross Over|Death|1|||
23160653|NCT00117598|64338915|FG004|After Treament Cross Over|Death|2|||
23160654|NCT00117598|64338911|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
23160655|NCT00117598|64338912|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
23160656|NCT00117598|64338913|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
23160657|NCT00117598|64338914|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
23160658|NCT00117598|64338915|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
23160659|NCT00117598|64338911|FG000|After Treament Cross Over|Other|0|||
23160660|NCT00117598|64338912|FG001|After Treament Cross Over|Other|0|||
23160661|NCT00117598|64338913|FG002|After Treament Cross Over|Other|0|||
23160662|NCT00117598|64338914|FG003|After Treament Cross Over|Other|1|||
23160663|NCT00117598|64338915|FG004|After Treament Cross Over|Other|2|||
23160664|NCT02231164|64338916|FG000|Overall Study|Adverse Event|1|||
23160665|NCT02231164|64338917|FG001|Overall Study|Adverse Event|1|||
23160666|NCT02231164|64338916|FG000|Overall Study|Lack of Efficacy|4|||
23160667|NCT02231164|64338917|FG001|Overall Study|Lack of Efficacy|3|||
23160668|NCT02231164|64338916|FG000|Overall Study|Withdrawal by Subject|1|||
23160669|NCT02231164|64338917|FG001|Overall Study|Withdrawal by Subject|2|||
23160670|NCT02969187|64338918|FG000|Overall Study|Physician Decision|12|||
23160671|NCT02969187|64338919|FG001|Overall Study|Physician Decision|13|||
23160672|NCT02343159|64338920|FG000|Overall Study|Early Study Termination|16|||
23160673|NCT02343159|64338921|FG001|Overall Study|Early Study Termination|19|||
23160674|NCT02343159|64338922|FG002|Overall Study|Early Study Termination|23|||
23160675|NCT02343159|64338920|FG000|Overall Study|Physician Decision|2|||
23160676|NCT02343159|64338921|FG001|Overall Study|Physician Decision|0|||
23160677|NCT02343159|64338922|FG002|Overall Study|Physician Decision|1|||
23160678|NCT02343159|64338920|FG000|Overall Study|Withdrawal by Subject|3|||
23236676|NCT01190839|64608287|FG000|Overall Study|Death|1|||
23160679|NCT02343159|64338921|FG001|Overall Study|Withdrawal by Subject|0|||
23160680|NCT02343159|64338922|FG002|Overall Study|Withdrawal by Subject|2|||
23160681|NCT02343159|64338920|FG000|Overall Study|Lost to Follow-up|0|||
23160682|NCT02343159|64338921|FG001|Overall Study|Lost to Follow-up|2|||
23160683|NCT02343159|64338922|FG002|Overall Study|Lost to Follow-up|2|||
23160684|NCT02343159|64338920|FG000|Overall Study|Adverse Event|4|||
23160685|NCT02343159|64338921|FG001|Overall Study|Adverse Event|4|||
23160686|NCT02343159|64338922|FG002|Overall Study|Adverse Event|2|||
23160687|NCT02343159|64338920|FG000|Overall Study|Sponsor Decision|0|||
23160688|NCT02343159|64338921|FG001|Overall Study|Sponsor Decision|1|||
23160689|NCT02343159|64338922|FG002|Overall Study|Sponsor Decision|0|||
23160690|NCT02343159|64338920|FG000|Overall Study|Enrollment Error|1|||
23160691|NCT02343159|64338921|FG001|Overall Study|Enrollment Error|0|||
23223027|NCT03051217|64560333|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23223028|NCT03051217|64560334|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23223029|NCT03051217|64560335|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23223030|NCT03051217|64560336|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
23223031|NCT03051217|64560337|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23223032|NCT03051217|64560338|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23223033|NCT03051217|64560339|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
23223034|NCT03051217|64560333|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23223035|NCT03051217|64560334|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23223036|NCT03051217|64560335|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23223037|NCT03051217|64560336|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23223038|NCT03051217|64560337|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
23223039|NCT03051217|64560338|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23223040|NCT03051217|64560339|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
23329829|NCT03376789|64948713|FG001|Overall Study|Adverse Event|1|||
23568099|NCT03285295|65807237|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
23568100|NCT03285295|65807238|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
23568101|NCT03285295|65807234|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
23568102|NCT03285295|65807235|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
23329830|NCT03376789|64948712|FG000|Overall Study|Lost to Follow-up|1|||
23329831|NCT03376789|64948713|FG001|Overall Study|Lost to Follow-up|1|||
23329832|NCT03376789|64948712|FG000|Overall Study|Per sponsor due to noncompliance|1|||
23568103|NCT03285295|65807236|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
23568104|NCT03285295|65807237|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
23568105|NCT03285295|65807238|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
23568106|NCT03285295|65807234|FG000|Alinity s Anti-HCV|No Results Generated|71|||
23568107|NCT03285295|65807235|FG001|Alinity s Anti-HCV|No Results Generated|0|||
23568108|NCT03285295|65807236|FG002|Alinity s Anti-HCV|No Results Generated|0|||
23568109|NCT03285295|65807237|FG003|Alinity s Anti-HCV|No Results Generated|0|||
23568110|NCT03285295|65807238|FG004|Alinity s Anti-HCV|No Results Generated|0|||
23568111|NCT03285295|65807234|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
23568112|NCT03285295|65807235|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
23568113|NCT03285295|65807236|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
23568114|NCT03285295|65807237|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
23568115|NCT03285295|65807238|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
23568116|NCT03285295|65807234|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
23568117|NCT03285295|65807235|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
23568118|NCT03285295|65807236|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
23568119|NCT03285295|65807237|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
23568120|NCT03285295|65807238|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
23568121|NCT03285295|65807234|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
23568122|NCT03285295|65807235|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
23568123|NCT03285295|65807236|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
23568124|NCT03285295|65807237|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
23568125|NCT03285295|65807238|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
23568126|NCT03285295|65807234|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
23568127|NCT03285295|65807235|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
23568128|NCT03285295|65807236|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
23568129|NCT03285295|65807237|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
23568130|NCT03285295|65807238|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
23568131|NCT03285295|65807234|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
23160692|NCT02343159|64338922|FG002|Overall Study|Enrollment Error|0|||
23160693|NCT05376215|64338925|FG000|Overall Study|Withdrawal by Subject|2|||
23568132|NCT03285295|65807235|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
23160694|NCT05376215|64338926|FG001|Overall Study|Withdrawal by Subject|1|||
23568133|NCT03285295|65807236|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
23160695|NCT05376215|64338925|FG000|Overall Study|Lost to Follow-up|0|||
23568134|NCT03285295|65807237|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
23568135|NCT03285295|65807238|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
23568136|NCT03285295|65807234|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
23568137|NCT03285295|65807235|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
23568138|NCT03285295|65807236|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
23568139|NCT03285295|65807237|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
23568140|NCT03285295|65807238|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
23568141|NCT03285295|65807234|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
23568142|NCT03285295|65807235|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
23568143|NCT03285295|65807236|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
23568144|NCT03285295|65807237|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
23568145|NCT03285295|65807238|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
23568146|NCT03285295|65807234|FG000|Alinity s Anti-HBc|No Results Generated|70|||
23568147|NCT03285295|65807235|FG001|Alinity s Anti-HBc|No Results Generated|0|||
23568148|NCT03285295|65807236|FG002|Alinity s Anti-HBc|No Results Generated|0|||
23568149|NCT03285295|65807237|FG003|Alinity s Anti-HBc|No Results Generated|0|||
23568150|NCT03285295|65807238|FG004|Alinity s Anti-HBc|No Results Generated|0|||
23329833|NCT03376789|64948713|FG001|Overall Study|Per sponsor due to noncompliance|0|||
23329834|NCT03376789|64948712|FG000|Overall Study|Subject off study medication|0|||
23329835|NCT03376789|64948713|FG001|Overall Study|Subject off study medication|1|||
23329836|NCT02861807|64948714|FG000|Overall Study|Lost to Follow-up|7|||
23329837|NCT02861807|64948715|FG001|Overall Study|Lost to Follow-up|6|||
23329838|NCT02861807|64948714|FG000|Overall Study|Withdrawal by Subject|5|||
23329839|NCT02861807|64948715|FG001|Overall Study|Withdrawal by Subject|8|||
23329840|NCT01960413|64948718|FG000|Overall Study|Withdrawal by Subject|1|||
23329841|NCT01960413|64948719|FG001|Overall Study|Withdrawal by Subject|1|||
23329842|NCT01960413|64948718|FG000|Overall Study|Physician Decision|1|||
23329843|NCT01960413|64948719|FG001|Overall Study|Physician Decision|0|||
23329844|NCT01960413|64948718|FG000|Overall Study|Lost to Follow-up|2|||
23329845|NCT01960413|64948719|FG001|Overall Study|Lost to Follow-up|0|||
23329846|NCT02445248|64948720|FG000|Overall Study|Death|45|||
23329847|NCT02445248|64948721|FG001|Overall Study|Death|12|||
23329848|NCT02445248|64948720|FG000|Overall Study|Progressive disease|13|||
23329849|NCT02445248|64948721|FG001|Overall Study|Progressive disease|1|||
23329850|NCT02445248|64948720|FG000|Overall Study|Subject decision|8|||
23329851|NCT02445248|64948721|FG001|Overall Study|Subject decision|0|||
23329852|NCT02445248|64948720|FG000|Overall Study|Physician Decision|5|||
23329853|NCT02445248|64948721|FG001|Overall Study|Physician Decision|0|||
23329854|NCT02445248|64948720|FG000|Overall Study|Adverse Event|1|||
23329855|NCT02445248|64948721|FG001|Overall Study|Adverse Event|0|||
23329856|NCT02445248|64948720|FG000|Overall Study|Lost to Follow-up|1|||
23329857|NCT02445248|64948721|FG001|Overall Study|Lost to Follow-up|0|||
23329858|NCT00320710|64948722|FG000|Overall Study|Disease progression|24|||
23329859|NCT00320710|64948723|FG001|Overall Study|Disease progression|19|||
23329860|NCT00320710|64948724|FG002|Overall Study|Disease progression|2|||
23329861|NCT00320710|64948722|FG000|Overall Study|Death|10|||
23329862|NCT00320710|64948723|FG001|Overall Study|Death|7|||
23329863|NCT00320710|64948724|FG002|Overall Study|Death|1|||
23329864|NCT00320710|64948722|FG000|Overall Study|Administrative problems|1|||
23329865|NCT00320710|64948723|FG001|Overall Study|Administrative problems|2|||
23329866|NCT00320710|64948724|FG002|Overall Study|Administrative problems|0|||
23329867|NCT00320710|64948722|FG000|Overall Study|Withdrawal by Subject|20|||
23329868|NCT00320710|64948723|FG001|Overall Study|Withdrawal by Subject|26|||
23329869|NCT00320710|64948724|FG002|Overall Study|Withdrawal by Subject|1|||
23329870|NCT00320710|64948722|FG000|Overall Study|Protocol Violation|6|||
23329871|NCT00320710|64948723|FG001|Overall Study|Protocol Violation|5|||
23329872|NCT00320710|64948724|FG002|Overall Study|Protocol Violation|0|||
23329873|NCT00320710|64948722|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23329874|NCT00320710|64948723|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23568151|NCT03285295|65807234|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
23568152|NCT03285295|65807235|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
23568153|NCT03285295|65807236|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
23568154|NCT03285295|65807237|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
23568155|NCT03285295|65807238|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
23568156|NCT03285295|65807234|FG000|Alinity s Chagas|Protocol Violation|76|||
23568157|NCT03285295|65807235|FG001|Alinity s Chagas|Protocol Violation|0|||
23568158|NCT03285295|65807236|FG002|Alinity s Chagas|Protocol Violation|0|||
23568159|NCT03285295|65807237|FG003|Alinity s Chagas|Protocol Violation|0|||
23568160|NCT03285295|65807238|FG004|Alinity s Chagas|Protocol Violation|0|||
23568161|NCT03285295|65807234|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
23568162|NCT03285295|65807235|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
23568163|NCT03285295|65807236|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
23568164|NCT03285295|65807237|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
23568165|NCT03285295|65807238|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
23568166|NCT03285295|65807234|FG000|Alinity s Chagas|No Results Generated|105|||
23568167|NCT03285295|65807235|FG001|Alinity s Chagas|No Results Generated|0|||
23568168|NCT03285295|65807236|FG002|Alinity s Chagas|No Results Generated|0|||
23568169|NCT03285295|65807237|FG003|Alinity s Chagas|No Results Generated|0|||
23568170|NCT03285295|65807238|FG004|Alinity s Chagas|No Results Generated|0|||
23568171|NCT03285295|65807234|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
23568172|NCT03285295|65807235|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
23160696|NCT05376215|64338926|FG001|Overall Study|Lost to Follow-up|1|||
23160697|NCT00262522|64338927|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
23160698|NCT00262522|64338928|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
23160699|NCT00262522|64338929|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
23160700|NCT00262522|64338930|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
23160701|NCT00262522|64338927|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
23160702|NCT00262522|64338928|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
23160703|NCT00262522|64338929|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
23160704|NCT00262522|64338930|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
23160705|NCT00262522|64338927|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
23160706|NCT00262522|64338928|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
23160707|NCT00262522|64338929|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
23160708|NCT00262522|64338930|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
23160709|NCT00262522|64338927|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
23160710|NCT00262522|64338928|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
23160711|NCT00262522|64338929|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
23160712|NCT00262522|64338930|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
23160713|NCT00262522|64338927|FG000|Study Start Through 8 Weeks|Death|1|||
23160714|NCT00262522|64338928|FG001|Study Start Through 8 Weeks|Death|0|||
23160715|NCT00262522|64338929|FG002|Study Start Through 8 Weeks|Death|0|||
23160716|NCT00262522|64338930|FG003|Study Start Through 8 Weeks|Death|0|||
23160717|NCT00262522|64338927|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
23160718|NCT00262522|64338928|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
23160719|NCT00262522|64338929|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
23160720|NCT00262522|64338930|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
23160721|NCT00262522|64338927|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
23160722|NCT00262522|64338928|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
23160723|NCT00262522|64338929|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
23160724|NCT00262522|64338930|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
23160725|NCT00262522|64338927|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
23160726|NCT00262522|64338928|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
23160727|NCT00262522|64338929|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
23160728|NCT00262522|64338930|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
23160729|NCT00262522|64338927|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
23160730|NCT00262522|64338928|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
23160731|NCT00262522|64338929|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
23160732|NCT00262522|64338930|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
23160733|NCT00262522|64338927|FG000|Study Start Through 48 Weeks|Death|2|||
23160734|NCT00262522|64338928|FG001|Study Start Through 48 Weeks|Death|0|||
23160735|NCT00262522|64338929|FG002|Study Start Through 48 Weeks|Death|1|||
23160736|NCT00262522|64338930|FG003|Study Start Through 48 Weeks|Death|0|||
23160737|NCT00262522|64338927|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
23160738|NCT00262522|64338928|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
23160739|NCT00262522|64338929|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
23160740|NCT00262522|64338930|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
23160741|NCT00262522|64338927|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
23160742|NCT00262522|64338928|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
23160743|NCT00262522|64338929|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
23160744|NCT00262522|64338930|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
23568173|NCT03285295|65807236|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
23568174|NCT03285295|65807237|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
23568175|NCT03285295|65807238|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
23160745|NCT00262522|64338927|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
23160746|NCT00262522|64338928|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
23160747|NCT00262522|64338929|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
23160748|NCT00262522|64338930|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
23160749|NCT00262522|64338927|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
23160750|NCT00262522|64338928|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
23160751|NCT00262522|64338929|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
23160752|NCT00262522|64338930|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
23160753|NCT00262522|64338927|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
23160754|NCT00262522|64338928|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
23160755|NCT00262522|64338929|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
23160756|NCT00262522|64338930|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
23160757|NCT00262522|64338927|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
23160758|NCT00262522|64338928|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
23160759|NCT00262522|64338929|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
23160760|NCT00262522|64338930|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
23160761|NCT00262522|64338927|FG000|Study Start Through 96 Weeks|Death|2|||
23160762|NCT00262522|64338928|FG001|Study Start Through 96 Weeks|Death|0|||
23160763|NCT00262522|64338929|FG002|Study Start Through 96 Weeks|Death|2|||
23160764|NCT00262522|64338930|FG003|Study Start Through 96 Weeks|Death|0|||
23160765|NCT00262522|64338927|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
23223041|NCT03051217|64560333|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23223042|NCT03051217|64560334|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23568176|NCT01923896|65807239|FG000|Overall Study|Adverse Event|1|||
23568177|NCT01923896|65807240|FG001|Overall Study|Adverse Event|0|||
23568178|NCT01370603|65807243|FG000|Period 1|Adverse Event|5|||
23568179|NCT01370603|65807244|FG001|Period 1|Adverse Event|3|||
23568180|NCT01370603|65807243|FG000|Period 1|Lost to Follow-up|2|||
23568181|NCT01370603|65807244|FG001|Period 1|Lost to Follow-up|0|||
23568182|NCT01370603|65807243|FG000|Period 1|Protocol Violation|2|||
23568183|NCT01370603|65807244|FG001|Period 1|Protocol Violation|2|||
23568184|NCT01370603|65807243|FG000|Period 1|Withdrawal by Subject|5|||
23236677|NCT01190839|64608288|FG001|Overall Study|Death|0|||
23160766|NCT00262522|64338928|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
23160767|NCT00262522|64338929|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
23160768|NCT00262522|64338930|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
23568185|NCT01370603|65807244|FG001|Period 1|Withdrawal by Subject|5|||
23568186|NCT01370603|65807243|FG000|Crossover Washout|Adverse Event|2|||
23568187|NCT01370603|65807244|FG001|Crossover Washout|Adverse Event|1|||
23568188|NCT01370603|65807243|FG000|Crossover Washout|Lost to Follow-up|2|||
23568189|NCT01370603|65807244|FG001|Crossover Washout|Lost to Follow-up|0|||
23160769|NCT00262522|64338927|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
23160770|NCT00262522|64338928|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
23160771|NCT00262522|64338929|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
23160772|NCT00262522|64338930|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
23160773|NCT02256540|64338931|FG000|Overall Study|Withdrawal by Subject|0|||
23160774|NCT02256540|64338932|FG001|Overall Study|Withdrawal by Subject|1|||
23160775|NCT02256540|64338933|FG002|Overall Study|Withdrawal by Subject|1|||
23160776|NCT02256540|64338931|FG000|Overall Study|Back pain preventing exercise|0|||
23160777|NCT02256540|64338932|FG001|Overall Study|Back pain preventing exercise|0|||
23160778|NCT02256540|64338933|FG002|Overall Study|Back pain preventing exercise|1|||
23160779|NCT02159729|64338934|FG000|Overall Study|Adverse Event|0|||
23160780|NCT02159729|64338935|FG001|Overall Study|Adverse Event|1|||
23160781|NCT02159729|64338934|FG000|Overall Study|Subject's Request|13|||
23160782|NCT02159729|64338935|FG001|Overall Study|Subject's Request|10|||
23160783|NCT02159729|64338934|FG000|Overall Study|Lost to Follow-up|24|||
23160784|NCT02159729|64338935|FG001|Overall Study|Lost to Follow-up|9|||
23160785|NCT02159729|64338934|FG000|Overall Study|Non compliance|2|||
23160786|NCT02159729|64338935|FG001|Overall Study|Non compliance|0|||
23160787|NCT02159729|64338934|FG000|Overall Study|Other Unspecified|3|||
23160788|NCT02159729|64338935|FG001|Overall Study|Other Unspecified|1|||
23160789|NCT02289742|64338936|FG000|First Wear Period|Adverse event prior to treatment|0|||
23160790|NCT02289742|64338937|FG001|First Wear Period|Adverse event prior to treatment|1|||
23160791|NCT02289742|64338938|FG002|First Wear Period|Adverse event prior to treatment|0|||
23160792|NCT02289742|64338939|FG003|First Wear Period|Adverse event prior to treatment|0|||
23160793|NCT02289742|64338936|FG000|First Wear Period|Adverse Event|0|||
23160794|NCT02289742|64338937|FG001|First Wear Period|Adverse Event|0|||
23160795|NCT02289742|64338938|FG002|First Wear Period|Adverse Event|1|||
23160796|NCT02289742|64338939|FG003|First Wear Period|Adverse Event|0|||
23160797|NCT02289742|64338936|FG000|First Wear Period|Other prior to treatment|0|||
23160798|NCT02289742|64338937|FG001|First Wear Period|Other prior to treatment|0|||
23160799|NCT02289742|64338938|FG002|First Wear Period|Other prior to treatment|0|||
23160800|NCT02289742|64338939|FG003|First Wear Period|Other prior to treatment|1|||
23160801|NCT02289742|64338936|FG000|Third Wear Period|Adverse Event|0|||
23160802|NCT02289742|64338937|FG001|Third Wear Period|Adverse Event|1|||
23160803|NCT02289742|64338938|FG002|Third Wear Period|Adverse Event|0|||
23160804|NCT02289742|64338939|FG003|Third Wear Period|Adverse Event|0|||
23160805|NCT02289742|64338936|FG000|Third Wear Period|Reason not given|0|||
23160806|NCT02289742|64338937|FG001|Third Wear Period|Reason not given|0|||
23160807|NCT02289742|64338938|FG002|Third Wear Period|Reason not given|0|||
23160808|NCT02289742|64338939|FG003|Third Wear Period|Reason not given|1|||
23160809|NCT05003622|64338940|FG000|Overall Study|Progressive disease|2|||
23160810|NCT05003622|64338940|FG000|Overall Study|Withdrawal by Subject|1|||
23160811|NCT04053868|64338941|FG000|Overall Study|Withdrawal by Subject|1|||
23160812|NCT04053868|64338942|FG001|Overall Study|Withdrawal by Subject|0|||
23160813|NCT01744665|64338949|FG000|Monitoring Phase|Adverse Event|4|||
23445977|NCT02855268|65373810|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
23445978|NCT02855268|65373811|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
23160814|NCT01744665|64338949|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
23160815|NCT01744665|64338949|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
23160816|NCT01744665|64338949|FG000|Monitoring Phase|Withdrawal by Subject|5|||
23160817|NCT01744665|64338949|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
23160818|NCT01744665|64338949|FG000|Consolidation Phase|Adverse Event|2|||
23160819|NCT01744665|64338949|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
23160820|NCT01744665|64338949|FG000|Consolidation Phase|Withdrawal by Subject|4|||
23160821|NCT01744665|64338949|FG000|Consolidation Phase|Administrative problems|9|||
23160822|NCT01744665|64338949|FG000|Re-initiation Phase|Administrative problems|10|||
23160823|NCT01744665|64338949|FG000|Re-initiation Phase|Adverse Event|1|||
23445979|NCT02855268|65373810|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
23445980|NCT02855268|65373811|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
23445981|NCT02855268|65373810|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
23445982|NCT02855268|65373811|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
23445983|NCT02855268|65373810|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
23568190|NCT01370603|65807243|FG000|Crossover Washout|Protocol Violation|1|||
23568191|NCT01370603|65807244|FG001|Crossover Washout|Protocol Violation|0|||
23160824|NCT01744665|64338949|FG000|Re-initiation Phase|No longer required treatment|1|||
23160825|NCT01744665|64338949|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
23160826|NCT02839265|64338952|FG000|Overall Study|Screen Failure|2|||
23160827|NCT02839265|64338952|FG000|Overall Study|Death|1|||
23445984|NCT02855268|65373811|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
23445985|NCT02855268|65373810|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
23568192|NCT01370603|65807243|FG000|Crossover Washout|Withdrawal by Subject|4|||
23568193|NCT01370603|65807244|FG001|Crossover Washout|Withdrawal by Subject|1|||
23445986|NCT02855268|65373811|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
23445987|NCT02855268|65373810|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
23445988|NCT02855268|65373811|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
23445989|NCT01973998|65373812|FG000|Overall Study|Death|2|||
23445990|NCT01973998|65373813|FG001|Overall Study|Death|2|||
23445991|NCT01076036|65373814|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
23445992|NCT01380769|65373817|FG000|Overall Study|Withdrawal by Subject|7|||
23445993|NCT01380769|65373818|FG001|Overall Study|Withdrawal by Subject|11|||
23445994|NCT01380769|65373817|FG000|Overall Study|Physician Decision|1|||
23445995|NCT01380769|65373818|FG001|Overall Study|Physician Decision|1|||
23445996|NCT01380769|65373817|FG000|Overall Study|Adverse Event|1|||
23445997|NCT01380769|65373818|FG001|Overall Study|Adverse Event|1|||
23445998|NCT01380769|65373817|FG000|Overall Study|Protocol Violation|0|||
23445999|NCT01380769|65373818|FG001|Overall Study|Protocol Violation|1|||
23446000|NCT04071158|65373819|FG000|Overall Study|Lost to Follow-up|1|||
23446001|NCT04071158|65373820|FG001|Overall Study|Lost to Follow-up|2|||
23446002|NCT04071158|65373821|FG002|Overall Study|Lost to Follow-up|3|||
23446003|NCT04071158|65373822|FG003|Overall Study|Lost to Follow-up|3|||
23446004|NCT04071158|65373823|FG004|Overall Study|Lost to Follow-up|5|||
23446005|NCT04071158|65373819|FG000|Overall Study|Randomized but not treated|2|||
23446006|NCT04071158|65373820|FG001|Overall Study|Randomized but not treated|2|||
23446007|NCT04071158|65373821|FG002|Overall Study|Randomized but not treated|0|||
23446008|NCT04071158|65373822|FG003|Overall Study|Randomized but not treated|0|||
23446009|NCT04071158|65373823|FG004|Overall Study|Randomized but not treated|0|||
23446010|NCT01220167|65373824|FG000|Period 3|Urine positive for substance abuse|0|||
23446011|NCT01220167|65373825|FG001|Period 3|Urine positive for substance abuse|1|||
23446012|NCT01220167|65373826|FG002|Period 3|Urine positive for substance abuse|0|||
23446013|NCT00871338|65373830|FG000|Prior to Booster|Withdrawal by Subject|1|||
23446014|NCT00871338|65373831|FG001|Prior to Booster|Withdrawal by Subject|3|||
23446015|NCT00871338|65373830|FG000|Prior to Booster|Lost to Follow-up|1|||
23446016|NCT00871338|65373831|FG001|Prior to Booster|Lost to Follow-up|0|||
23446017|NCT02598297|65373834|FG000|Overall Study|Study terminated by Sponsor|21|||
23446018|NCT02598297|65373835|FG001|Overall Study|Study terminated by Sponsor|23|||
23446019|NCT02598297|65373834|FG000|Overall Study|Adverse Event|1|||
23446020|NCT02598297|65373835|FG001|Overall Study|Adverse Event|1|||
23446021|NCT02598297|65373834|FG000|Overall Study|Physician Decision|1|||
23446022|NCT02598297|65373835|FG001|Overall Study|Physician Decision|0|||
23446023|NCT02598297|65373834|FG000|Overall Study|Subject/guardian decision|1|||
23446024|NCT02598297|65373835|FG001|Overall Study|Subject/guardian decision|0|||
23446025|NCT02598297|65373834|FG000|Overall Study|Followed for survival|1|||
23446026|NCT02598297|65373835|FG001|Overall Study|Followed for survival|0|||
23446027|NCT01168349|65373836|FG000|Overall Study|Death|157|||
23446028|NCT01168349|65373836|FG000|Overall Study|Lost to Follow-up|34|||
23446029|NCT01168349|65373836|FG000|Overall Study|Withdrawal by Subject|9|||
23446030|NCT01168349|65373836|FG000|Overall Study|Kidney transplantation|3|||
23446031|NCT01168349|65373836|FG000|Overall Study|Other|22|||
23446032|NCT01168349|65373836|FG000|Overall Study|Protocol Violation|76|||
23446033|NCT02517541|65373837|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
23446034|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
23446035|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
23446036|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
23446037|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
23446038|NCT02517541|65373837|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
23446039|NCT03500640|65373838|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
23446040|NCT03500640|65373839|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
23446041|NCT03500640|65373840|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
23446042|NCT03500640|65373838|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
23446043|NCT03500640|65373839|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
23446044|NCT03500640|65373840|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
23446045|NCT03500640|65373838|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
23446046|NCT03500640|65373839|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
23446047|NCT03500640|65373840|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
23446048|NCT03500640|65373838|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
23446049|NCT03500640|65373839|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
23446050|NCT03500640|65373840|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
23568194|NCT01370603|65807243|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
23568195|NCT01370603|65807244|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
23568196|NCT01370603|65807243|FG000|Period 2|Adverse Event|1|||
23568197|NCT01370603|65807244|FG001|Period 2|Adverse Event|4|||
23568198|NCT01370603|65807243|FG000|Period 2|Lost to Follow-up|1|||
23446051|NCT03500640|65373838|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
23446052|NCT03500640|65373839|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
23568199|NCT01370603|65807244|FG001|Period 2|Lost to Follow-up|0|||
23446053|NCT03500640|65373840|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
23446054|NCT03500640|65373838|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
23446055|NCT03500640|65373839|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
23446056|NCT03500640|65373840|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
23446057|NCT03500640|65373838|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
23446058|NCT03500640|65373839|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
23446059|NCT03500640|65373840|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
23446060|NCT03500640|65373838|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
23446061|NCT03500640|65373839|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
23446062|NCT03500640|65373840|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
23446063|NCT03500640|65373838|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
23446064|NCT03500640|65373839|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
23446065|NCT03500640|65373840|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
23446066|NCT03500640|65373838|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
23446067|NCT03500640|65373839|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
23446068|NCT03500640|65373840|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
23446069|NCT01147055|65373841|FG000|First Intervention Period|Lost to Follow-up|1|||
23446070|NCT01147055|65373842|FG001|First Intervention Period|Lost to Follow-up|0|||
23446071|NCT01698814|65373843|FG000|Overall Study|Adverse Event|0|||
23446072|NCT01698814|65373844|FG001|Overall Study|Adverse Event|2|||
23446073|NCT01698814|65373843|FG000|Overall Study|Lost to Follow-up|0|||
23446074|NCT01698814|65373844|FG001|Overall Study|Lost to Follow-up|1|||
23446075|NCT01698814|65373843|FG000|Overall Study|Pregnancy|1|||
23446076|NCT01698814|65373844|FG001|Overall Study|Pregnancy|0|||
23446077|NCT01698814|65373843|FG000|Overall Study|Randomized in error|1|||
23446078|NCT01698814|65373844|FG001|Overall Study|Randomized in error|0|||
23446079|NCT00086047|65373847|FG000|Overall Study|Lost to Follow-up|7|||
23446080|NCT00086047|65373848|FG001|Overall Study|Lost to Follow-up|6|||
23446081|NCT00086047|65373847|FG000|Overall Study|Physician Decision|0|||
23446082|NCT00086047|65373848|FG001|Overall Study|Physician Decision|1|||
23446083|NCT00082407|65373849|FG000|Overall Study|Adverse Event|20|||
23446084|NCT00082407|65373850|FG001|Overall Study|Adverse Event|0|||
23446085|NCT00082407|65373849|FG000|Overall Study|Protocol Violation|14|||
23446086|NCT00082407|65373850|FG001|Overall Study|Protocol Violation|12|||
23446087|NCT00082407|65373849|FG000|Overall Study|Patient Decision|13|||
23446088|NCT00082407|65373850|FG001|Overall Study|Patient Decision|6|||
23446089|NCT00082407|65373849|FG000|Overall Study|Physician Decision|5|||
23446090|NCT00082407|65373850|FG001|Overall Study|Physician Decision|3|||
23446091|NCT00082407|65373849|FG000|Overall Study|Loss of Glucose Control|2|||
23446092|NCT00082407|65373850|FG001|Overall Study|Loss of Glucose Control|2|||
23446093|NCT00082407|65373849|FG000|Overall Study|Death|2|||
23446094|NCT00082407|65373850|FG001|Overall Study|Death|1|||
23446095|NCT00082407|65373849|FG000|Overall Study|Lost to Follow-up|0|||
23446096|NCT00082407|65373850|FG001|Overall Study|Lost to Follow-up|3|||
23446097|NCT03201419|65373851|FG000|Overall Study|Adverse Event|3|||
23446098|NCT03201419|65373852|FG001|Overall Study|Adverse Event|1|||
23446099|NCT03201419|65373853|FG002|Overall Study|Adverse Event|0|||
23446100|NCT03201419|65373854|FG003|Overall Study|Adverse Event|0|||
23446101|NCT03201419|65373855|FG004|Overall Study|Adverse Event|1|||
23446102|NCT03201419|65373856|FG005|Overall Study|Adverse Event|1|||
23446103|NCT03201419|65373857|FG006|Overall Study|Adverse Event|5|||
23446104|NCT03201419|65373858|FG007|Overall Study|Adverse Event|0|||
23446105|NCT03201419|65373859|FG008|Overall Study|Adverse Event|0|||
23446106|NCT03201419|65373851|FG000|Overall Study|Lost to Follow-up|1|||
23446107|NCT03201419|65373852|FG001|Overall Study|Lost to Follow-up|0|||
23446108|NCT03201419|65373853|FG002|Overall Study|Lost to Follow-up|0|||
23446109|NCT03201419|65373854|FG003|Overall Study|Lost to Follow-up|0|||
23446110|NCT03201419|65373855|FG004|Overall Study|Lost to Follow-up|0|||
23446111|NCT03201419|65373856|FG005|Overall Study|Lost to Follow-up|0|||
23446112|NCT03201419|65373857|FG006|Overall Study|Lost to Follow-up|0|||
23446113|NCT03201419|65373858|FG007|Overall Study|Lost to Follow-up|0|||
23446114|NCT03201419|65373859|FG008|Overall Study|Lost to Follow-up|0|||
23446115|NCT03201419|65373851|FG000|Overall Study|Protocol Deviation|0|||
23568200|NCT01370603|65807243|FG000|Period 2|Withdrawal by Subject|1|||
23568201|NCT01370603|65807244|FG001|Period 2|Withdrawal by Subject|0|||
23446116|NCT03201419|65373852|FG001|Overall Study|Protocol Deviation|0|||
23446117|NCT03201419|65373853|FG002|Overall Study|Protocol Deviation|0|||
23446118|NCT03201419|65373854|FG003|Overall Study|Protocol Deviation|0|||
23446119|NCT03201419|65373855|FG004|Overall Study|Protocol Deviation|0|||
23446120|NCT03201419|65373856|FG005|Overall Study|Protocol Deviation|0|||
23446121|NCT03201419|65373857|FG006|Overall Study|Protocol Deviation|1|||
23446122|NCT03201419|65373858|FG007|Overall Study|Protocol Deviation|0|||
23446123|NCT03201419|65373859|FG008|Overall Study|Protocol Deviation|0|||
23446124|NCT03201419|65373851|FG000|Overall Study|Withdrawal by Subject|4|||
23446125|NCT03201419|65373852|FG001|Overall Study|Withdrawal by Subject|2|||
23568202|NCT01263106|65807247|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
23568203|NCT01263106|65807248|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
23446126|NCT03201419|65373853|FG002|Overall Study|Withdrawal by Subject|1|||
23446127|NCT03201419|65373854|FG003|Overall Study|Withdrawal by Subject|0|||
23446128|NCT03201419|65373855|FG004|Overall Study|Withdrawal by Subject|0|||
23329875|NCT00320710|64948724|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23329876|NCT00320710|64948722|FG000|Overall Study|Abnormal laboratory value(s)|12|||
23446129|NCT03201419|65373856|FG005|Overall Study|Withdrawal by Subject|0|||
23446130|NCT03201419|65373857|FG006|Overall Study|Withdrawal by Subject|0|||
23446131|NCT03201419|65373858|FG007|Overall Study|Withdrawal by Subject|1|||
23446132|NCT03201419|65373859|FG008|Overall Study|Withdrawal by Subject|2|||
23446133|NCT03201419|65373851|FG000|Overall Study|Other|0|||
23446134|NCT03201419|65373852|FG001|Overall Study|Other|0|||
23329877|NCT00320710|64948723|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23446135|NCT03201419|65373853|FG002|Overall Study|Other|1|||
23446136|NCT03201419|65373854|FG003|Overall Study|Other|0|||
23446137|NCT03201419|65373855|FG004|Overall Study|Other|0|||
23446138|NCT03201419|65373856|FG005|Overall Study|Other|0|||
23446139|NCT03201419|65373857|FG006|Overall Study|Other|0|||
23446140|NCT03201419|65373858|FG007|Overall Study|Other|0|||
23446141|NCT03201419|65373859|FG008|Overall Study|Other|0|||
23446142|NCT01395901|65373862|FG000|Overall Study|Lost to Follow-up|4|||
23446143|NCT01395901|65373863|FG001|Overall Study|Lost to Follow-up|0|||
23446144|NCT01395901|65373862|FG000|Overall Study|Randomized but not received study drug|5|||
23446145|NCT01395901|65373863|FG001|Overall Study|Randomized but not received study drug|4|||
23446146|NCT01395901|65373862|FG000|Overall Study|Adverse Event|0|||
23568204|NCT00675506|65807251|FG000|Overall Study|Lost to Follow-up|1|||
23568205|NCT00675506|65807252|FG001|Overall Study|Lost to Follow-up|5|||
23568206|NCT00675506|65807251|FG000|Overall Study|Lost interest|3|||
23568207|NCT00675506|65807252|FG001|Overall Study|Lost interest|5|||
23568208|NCT00675506|65807251|FG000|Overall Study|Elevated fasting glucose|2|||
23568209|NCT00675506|65807252|FG001|Overall Study|Elevated fasting glucose|1|||
23568210|NCT00675506|65807251|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
23568211|NCT00675506|65807252|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
23568212|NCT00675506|65807251|FG000|Overall Study|Elevated IGF-1|2|||
23568213|NCT00675506|65807252|FG001|Overall Study|Elevated IGF-1|0|||
23568214|NCT00675506|65807251|FG000|Overall Study|Hypersensitivity Reaction|1|||
23568215|NCT00675506|65807252|FG001|Overall Study|Hypersensitivity Reaction|0|||
23568216|NCT00675506|65807251|FG000|Overall Study|Disclosed history of cancer|1|||
23568217|NCT00675506|65807252|FG001|Overall Study|Disclosed history of cancer|0|||
23568218|NCT00675506|65807251|FG000|Overall Study|Declined participation|1|||
23568219|NCT00675506|65807252|FG001|Overall Study|Declined participation|0|||
23568220|NCT00675506|65807251|FG000|Overall Study|Schedule conflict|0|||
23568221|NCT00675506|65807252|FG001|Overall Study|Schedule conflict|1|||
23568222|NCT02802319|65807253|FG000|Overall Study|Physician Decision|2|||
23568223|NCT02802319|65807254|FG001|Overall Study|Physician Decision|1|||
23568224|NCT02802319|65807253|FG000|Overall Study|Lost to Follow-up|0|||
23568225|NCT02802319|65807254|FG001|Overall Study|Lost to Follow-up|4|||
23568226|NCT00734214|65807259|FG000|Overall Study|Withdrawal by Subject|3|||
23568227|NCT00734214|65807260|FG001|Overall Study|Withdrawal by Subject|4|||
23568228|NCT00734214|65807259|FG000|Overall Study|MD withdrawal|1|||
23568229|NCT00734214|65807260|FG001|Overall Study|MD withdrawal|0|||
23568230|NCT01090310|65807261|FG000|Core Study|Adverse Event|2|||
23568231|NCT01090310|65807262|FG001|Core Study|Adverse Event|2|||
23568232|NCT01090310|65807263|FG002|Core Study|Adverse Event|1|||
23568233|NCT01090310|65807264|FG003|Core Study|Adverse Event|1|||
23568234|NCT01090310|65807261|FG000|Core Study|Subject withdrew consent|0|||
23568235|NCT01090310|65807262|FG001|Core Study|Subject withdrew consent|3|||
23568236|NCT01090310|65807263|FG002|Core Study|Subject withdrew consent|1|||
23568237|NCT01090310|65807264|FG003|Core Study|Subject withdrew consent|1|||
23568238|NCT01090310|65807261|FG000|Core Study|Abnormal test procedure result|0|||
23568239|NCT01090310|65807262|FG001|Core Study|Abnormal test procedure result|0|||
23568240|NCT01090310|65807263|FG002|Core Study|Abnormal test procedure result|1|||
23160828|NCT02839265|64338952|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
23160829|NCT04050670|64338953|FG000|Period 3|Physician Decision|0|||
23160830|NCT04050670|64338954|FG001|Period 3|Physician Decision|1|||
23160831|NCT04050670|64338955|FG002|Period 3|Physician Decision|0|||
23160832|NCT01838616|64338956|FG000|Titration Period|Adverse Event|18|||
23160833|NCT01838616|64338957|FG001|Titration Period|Adverse Event|48|||
23160834|NCT01838616|64338956|FG000|Titration Period|Lack of Efficacy|5|||
23160835|NCT01838616|64338957|FG001|Titration Period|Lack of Efficacy|12|||
23160836|NCT01838616|64338956|FG000|Titration Period|Withdrawal by Subject|5|||
23160837|NCT01838616|64338957|FG001|Titration Period|Withdrawal by Subject|5|||
23160838|NCT01838616|64338956|FG000|Titration Period|Technical problems|1|||
23160839|NCT01838616|64338957|FG001|Titration Period|Technical problems|0|||
23160840|NCT01838616|64338956|FG000|Titration Period|Other|1|||
23160841|NCT01838616|64338957|FG001|Titration Period|Other|0|||
23160842|NCT01838616|64338956|FG000|Titration Period|Protocol Violation|0|||
23160843|NCT01838616|64338957|FG001|Titration Period|Protocol Violation|1|||
23568241|NCT01090310|65807264|FG003|Core Study|Abnormal test procedure result|0|||
23568242|NCT01090310|65807261|FG000|Core Study|Administrative reasons|5|||
23568243|NCT01090310|65807262|FG001|Core Study|Administrative reasons|6|||
23568244|NCT01090310|65807263|FG002|Core Study|Administrative reasons|4|||
23568245|NCT01090310|65807264|FG003|Core Study|Administrative reasons|4|||
23568246|NCT01090310|65807261|FG000|Core Study|Protocol deviation|1|||
23568247|NCT01090310|65807262|FG001|Core Study|Protocol deviation|0|||
23568248|NCT01090310|65807263|FG002|Core Study|Protocol deviation|0|||
23568249|NCT01090310|65807264|FG003|Core Study|Protocol deviation|1|||
23568250|NCT01090310|65807261|FG000|Extension Study|Aministrative problems|13|||
23568251|NCT01090310|65807262|FG001|Extension Study|Aministrative problems|15|||
23568252|NCT01090310|65807263|FG002|Extension Study|Aministrative problems|14|||
23568253|NCT01090310|65807264|FG003|Extension Study|Aministrative problems|18|||
23446147|NCT01395901|65373863|FG001|Overall Study|Adverse Event|1|||
23568254|NCT01090310|65807261|FG000|Extension Study|Adverse Event|0|||
23160844|NCT01838616|64338956|FG000|Continuation Period|Lack of Efficacy|3|||
23160845|NCT01838616|64338957|FG001|Continuation Period|Lack of Efficacy|5|||
23160846|NCT01838616|64338956|FG000|Continuation Period|Adverse Event|8|||
23160847|NCT01838616|64338957|FG001|Continuation Period|Adverse Event|4|||
23160848|NCT01838616|64338956|FG000|Continuation Period|Protocol Violation|2|||
23160849|NCT01838616|64338957|FG001|Continuation Period|Protocol Violation|0|||
23160850|NCT01838616|64338956|FG000|Continuation Period|Lost to Follow-up|1|||
23160851|NCT01838616|64338957|FG001|Continuation Period|Lost to Follow-up|0|||
23568255|NCT01090310|65807262|FG001|Extension Study|Adverse Event|0|||
23568256|NCT01090310|65807263|FG002|Extension Study|Adverse Event|0|||
23329878|NCT00320710|64948724|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23329879|NCT00320710|64948722|FG000|Overall Study|Adverse Event|18|||
23568257|NCT01090310|65807264|FG003|Extension Study|Adverse Event|1|||
23568258|NCT01090310|65807261|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
23568259|NCT01090310|65807262|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
23568260|NCT01090310|65807263|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
23568261|NCT01090310|65807264|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
23568262|NCT01090310|65807261|FG000|Extension Study|Subject withdrew consent|0|||
23568263|NCT01090310|65807262|FG001|Extension Study|Subject withdrew consent|1|||
23568264|NCT01090310|65807263|FG002|Extension Study|Subject withdrew consent|0|||
23568265|NCT01090310|65807264|FG003|Extension Study|Subject withdrew consent|0|||
23568266|NCT01248962|65809773|FG000|Overall Study|Withdrawal by Subject|1|||
23223043|NCT03051217|64560335|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23223044|NCT03051217|64560336|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23223045|NCT03051217|64560337|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23329880|NCT00320710|64948723|FG001|Overall Study|Adverse Event|14|||
23329881|NCT00320710|64948724|FG002|Overall Study|Adverse Event|1|||
23329882|NCT00320710|64948722|FG000|Overall Study|Lost to Follow-up|1|||
23329883|NCT00320710|64948723|FG001|Overall Study|Lost to Follow-up|0|||
23329884|NCT00320710|64948724|FG002|Overall Study|Lost to Follow-up|0|||
23329885|NCT05370040|64948725|FG000|Overall Study|Lost to Follow-up|0|||
23329886|NCT05370040|64948726|FG001|Overall Study|Lost to Follow-up|0|||
23329887|NCT05370040|64948727|FG002|Overall Study|Lost to Follow-up|1|||
23329888|NCT05370040|64948728|FG003|Overall Study|Lost to Follow-up|0|||
23329889|NCT05370040|64948729|FG004|Overall Study|Lost to Follow-up|1|||
23329890|NCT05370040|64948730|FG005|Overall Study|Lost to Follow-up|0|||
23329891|NCT03150719|64948731|FG000|Overall Study|Adverse Event|0|||
23329892|NCT03150719|64948732|FG001|Overall Study|Adverse Event|1|||
23329893|NCT03150719|64948731|FG000|Overall Study|Death|0|||
23329894|NCT03150719|64948732|FG001|Overall Study|Death|1|||
23329895|NCT03150719|64948731|FG000|Overall Study|Other|1|||
23329896|NCT03150719|64948732|FG001|Overall Study|Other|0|||
23329897|NCT00634803|64948733|FG000|Overall Study|Lost to Follow-up|6|||
23329898|NCT00634803|64948734|FG001|Overall Study|Lost to Follow-up|7|||
23329899|NCT00634803|64948735|FG002|Overall Study|Lost to Follow-up|7|||
23329900|NCT00958828|64948740|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
23329901|NCT00958828|64948741|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
23329902|NCT00958828|64948740|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
23329903|NCT00958828|64948741|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
23329904|NCT02996968|64948748|FG000|Overall Study|Withdrawal by Subject|1|||
23329905|NCT02996968|64948749|FG001|Overall Study|Withdrawal by Subject|0|||
23329906|NCT04855760|64948750|FG000|Overall Study|Adverse Event|21|||
23329907|NCT04855760|64948750|FG000|Overall Study|Withdrawal by Subject|116|||
23329908|NCT04855760|64948750|FG000|Overall Study|Lack of Efficacy|21|||
23329909|NCT04855760|64948750|FG000|Overall Study|Lost to Follow-up|49|||
23329910|NCT04855760|64948750|FG000|Overall Study|Protocol Violation|2|||
23223046|NCT03051217|64560338|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
23223047|NCT03051217|64560339|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
23223048|NCT01585168|64560342|FG000|Overall Study|Lost to Follow-up|3|||
23223049|NCT01585168|64560343|FG001|Overall Study|Lost to Follow-up|1|||
23329911|NCT04855760|64948750|FG000|Overall Study|Physician Decision|5|||
23329912|NCT04855760|64948750|FG000|Overall Study|Pregnancy|1|||
23329913|NCT04855760|64948750|FG000|Overall Study|Non-Compliance with Study Drug|11|||
23329914|NCT04855760|64948750|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
23329915|NCT04855760|64948750|FG000|Overall Study|Study Completed by Sponsor|202|||
23329916|NCT04855760|64948750|FG000|Overall Study|Other|13|||
23329917|NCT01591096|64948751|FG000|Overall Study|Adverse Event|1|||
23329918|NCT01882985|64948752|FG000|Overall Study|Lost to Follow-up|1|||
23329919|NCT01882985|64948752|FG000|Overall Study|Withdrawal by Subject|1|||
23329920|NCT03989102|64948756|FG000|Year 1|Withdrawal by Subject|6|||
23329921|NCT03989102|64948757|FG001|Year 1|Withdrawal by Subject|2|||
23160852|NCT01838616|64338956|FG000|Continuation Period|Withdrawal by Subject|0|||
23160853|NCT01838616|64338957|FG001|Continuation Period|Withdrawal by Subject|4|||
23160854|NCT01838616|64338956|FG000|Continuation Period|Technical problems|0|||
23160855|NCT01838616|64338957|FG001|Continuation Period|Technical problems|1|||
23160856|NCT01838616|64338956|FG000|Pick-up Arm|Lack of Efficacy|4|||
23160857|NCT01838616|64338957|FG001|Pick-up Arm|Lack of Efficacy|0|||
23160858|NCT01838616|64338956|FG000|Pick-up Arm|Adverse Event|9|||
23329922|NCT03989102|64948758|FG002|Year 1|Withdrawal by Subject|7|||
23329923|NCT03989102|64948756|FG000|Year 1|Lost to Follow-up|5|||
23329924|NCT03989102|64948757|FG001|Year 1|Lost to Follow-up|2|||
23329925|NCT03989102|64948758|FG002|Year 1|Lost to Follow-up|5|||
23329926|NCT03989102|64948756|FG000|Year 1|Subject met withdrawal criteria|1|||
23329927|NCT03989102|64948757|FG001|Year 1|Subject met withdrawal criteria|0|||
23568267|NCT01248962|65809774|FG001|Overall Study|Withdrawal by Subject|1|||
23160859|NCT01838616|64338957|FG001|Pick-up Arm|Adverse Event|0|||
23160860|NCT01838616|64338956|FG000|Pick-up Arm|Withdrawal by Subject|1|||
23160861|NCT01838616|64338957|FG001|Pick-up Arm|Withdrawal by Subject|0|||
23160862|NCT01838616|64338956|FG000|Pick-up Arm|Technical problems|1|||
23160863|NCT01838616|64338957|FG001|Pick-up Arm|Technical problems|0|||
23160864|NCT01986920|64338958|FG000|A- 101 25%|Withdrawal by Subject|1|||
23160865|NCT01986920|64338959|FG001|A- 101 25%|Withdrawal by Subject|0|||
23160866|NCT01986920|64338960|FG002|A- 101 25%|Withdrawal by Subject|0|||
23160867|NCT01986920|64338961|FG003|A- 101 25%|Withdrawal by Subject|0|||
23160868|NCT01986920|64338958|FG000|A-101 32.5%|Withdrawal by Subject|0|||
23160869|NCT01986920|64338959|FG001|A-101 32.5%|Withdrawal by Subject|1|||
23160870|NCT01986920|64338960|FG002|A-101 32.5%|Withdrawal by Subject|0|||
23160871|NCT01986920|64338961|FG003|A-101 32.5%|Withdrawal by Subject|0|||
23160872|NCT01986920|64338958|FG000|A-101 40%|Withdrawal by Subject|0|||
23329928|NCT03989102|64948758|FG002|Year 1|Subject met withdrawal criteria|1|||
23329929|NCT03989102|64948756|FG000|Year 2|Lost to Follow-up|7|||
23568268|NCT01248962|65809773|FG000|Overall Study|Adverse Event|2|||
23568269|NCT01248962|65809774|FG001|Overall Study|Adverse Event|1|||
23568270|NCT01248962|65809773|FG000|Overall Study|Complete Response after 4 Cycles|1|||
23568271|NCT01248962|65809774|FG001|Overall Study|Complete Response after 4 Cycles|0|||
23568272|NCT01248962|65809773|FG000|Overall Study|Complete Response after 3 Cycles|0|||
23568273|NCT01248962|65809774|FG001|Overall Study|Complete Response after 3 Cycles|1|||
23568274|NCT01248962|65809773|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
23568275|NCT01248962|65809774|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
23568276|NCT02756832|65809775|FG000|Overall Study|Lost for Observation after Baseline|6|||
23568277|NCT02756832|65809775|FG000|Overall Study|Lost for Observation|13|||
23568278|NCT02756832|65809775|FG000|Overall Study|Patient's Unwillingness|12|||
23568279|NCT02756832|65809775|FG000|Overall Study|Insufficient Efficacy|2|||
23568280|NCT02756832|65809775|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
23568281|NCT02756832|65809775|FG000|Overall Study|Reason not Specified|9|||
23568282|NCT02756832|65809775|FG000|Overall Study|Protocol Deviation|10|||
23568283|NCT02302066|65809777|FG000|Overall Study|Adverse Event|1|||
23568284|NCT02302066|65809778|FG001|Overall Study|Adverse Event|1|||
23568285|NCT02302066|65809779|FG002|Overall Study|Adverse Event|3|||
23568286|NCT02302066|65809780|FG003|Overall Study|Adverse Event|0|||
23568287|NCT02302066|65809777|FG000|Overall Study|Lost to Follow-up|4|||
23568288|NCT02302066|65809778|FG001|Overall Study|Lost to Follow-up|5|||
23568289|NCT02302066|65809779|FG002|Overall Study|Lost to Follow-up|24|||
23568290|NCT02302066|65809780|FG003|Overall Study|Lost to Follow-up|7|||
23568291|NCT02302066|65809777|FG000|Overall Study|Withdrawal by Subject|25|||
23568292|NCT02302066|65809778|FG001|Overall Study|Withdrawal by Subject|58|||
23568293|NCT02302066|65809779|FG002|Overall Study|Withdrawal by Subject|124|||
23568294|NCT02302066|65809780|FG003|Overall Study|Withdrawal by Subject|33|||
23568295|NCT02302066|65809777|FG000|Overall Study|Pregnancy|2|||
23568296|NCT02302066|65809778|FG001|Overall Study|Pregnancy|10|||
23568297|NCT02302066|65809779|FG002|Overall Study|Pregnancy|12|||
23568298|NCT02302066|65809780|FG003|Overall Study|Pregnancy|0|||
23568299|NCT02302066|65809777|FG000|Overall Study|Reason Not Specified|1|||
23568300|NCT02302066|65809778|FG001|Overall Study|Reason Not Specified|1|||
23568301|NCT02302066|65809779|FG002|Overall Study|Reason Not Specified|9|||
23568302|NCT02302066|65809780|FG003|Overall Study|Reason Not Specified|1|||
23568303|NCT02609659|65809783|FG000|Overall Study|Adverse Event|1|||
23568304|NCT02609659|65809783|FG000|Overall Study|Lost to Follow-up|6|||
23568305|NCT02609659|65809783|FG000|Overall Study|Other|1|||
23568306|NCT01380990|65809784|FG000|Overall Study|Treatment Failure|1|||
23568307|NCT01380990|65809785|FG001|Overall Study|Treatment Failure|0|||
23160873|NCT01986920|64338959|FG001|A-101 40%|Withdrawal by Subject|0|||
23160874|NCT01986920|64338960|FG002|A-101 40%|Withdrawal by Subject|1|||
23160875|NCT01986920|64338961|FG003|A-101 40%|Withdrawal by Subject|0|||
23160876|NCT01986920|64338958|FG000|Placebo|Withdrawal by Subject|0|||
23160877|NCT01986920|64338959|FG001|Placebo|Withdrawal by Subject|0|||
23329930|NCT03989102|64948757|FG001|Year 2|Lost to Follow-up|3|||
23223050|NCT01585168|64560344|FG002|Overall Study|Lost to Follow-up|1|||
23223051|NCT01585168|64560345|FG003|Overall Study|Lost to Follow-up|1|||
23223052|NCT03050307|64560347|FG000|Overall Study|Adverse Event|4|||
23223053|NCT03050307|64560348|FG001|Overall Study|Adverse Event|2|||
23223054|NCT03050307|64560347|FG000|Overall Study|Significant Protocol Deviation|0|||
23223055|NCT03050307|64560348|FG001|Overall Study|Significant Protocol Deviation|1|||
23223056|NCT03050307|64560347|FG000|Overall Study|Lost to Follow-up|0|||
23223057|NCT03050307|64560348|FG001|Overall Study|Lost to Follow-up|1|||
23223058|NCT03050307|64560347|FG000|Overall Study|Voluntary Withdrawal|3|||
23223059|NCT03050307|64560348|FG001|Overall Study|Voluntary Withdrawal|4|||
23223060|NCT03050307|64560347|FG000|Overall Study|Reason not Specified|1|||
23223061|NCT03050307|64560348|FG001|Overall Study|Reason not Specified|1|||
23223062|NCT01678560|64560349|FG000|Overall Study|Physician Decision|4|||
23223063|NCT01678560|64560350|FG001|Overall Study|Physician Decision|4|||
23223064|NCT01678560|64560349|FG000|Overall Study|Death|0|||
23223065|NCT01678560|64560350|FG001|Overall Study|Death|1|||
23223066|NCT01678560|64560349|FG000|Overall Study|Withdrawal by Subject|0|||
23223067|NCT01678560|64560350|FG001|Overall Study|Withdrawal by Subject|1|||
23223068|NCT02943668|64560355|FG000|Overall Study|Disease Progression|1|||
23223069|NCT01392742|64560356|FG000|Overall Study|Premature study termination|42|||
23223070|NCT01392742|64560356|FG000|Overall Study|Failure to return|35|||
23223071|NCT01392742|64560356|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
23223072|NCT01392742|64560356|FG000|Overall Study|Lost to Follow-up|34|||
23223073|NCT01392742|64560356|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
23223074|NCT01392742|64560356|FG000|Overall Study|ITR and Protocol deviation|1|||
23223075|NCT01392742|64560356|FG000|Overall Study|Adverse event/intercurrent illness|17|||
23223076|NCT01392742|64560356|FG000|Overall Study|Protocol Violation|14|||
23223077|NCT01392742|64560356|FG000|Overall Study|Other|3|||
23223078|NCT01392742|64560356|FG000|Overall Study|Missing information|13|||
23223079|NCT04095793|64560360|FG000|Overall Study|Adverse Event|3|||
23223080|NCT04095793|64560360|FG000|Overall Study|Study Terminated by Sponsor|103|||
23223081|NCT04095793|64560360|FG000|Overall Study|Withdrawal by Subject|4|||
23223082|NCT01305941|64560363|FG000|Overall Study|Adverse Event|6|||
23329931|NCT03989102|64948758|FG002|Year 2|Lost to Follow-up|4|||
23329932|NCT03989102|64948756|FG000|Year 2|Withdrawal by Subject|3|||
23329933|NCT03989102|64948757|FG001|Year 2|Withdrawal by Subject|1|||
23329934|NCT03989102|64948758|FG002|Year 2|Withdrawal by Subject|2|||
23329935|NCT03989102|64948756|FG000|Year 2|Subject non-compliant|3|||
23329936|NCT03989102|64948757|FG001|Year 2|Subject non-compliant|2|||
23329937|NCT03989102|64948758|FG002|Year 2|Subject non-compliant|0|||
23329938|NCT03989102|64948756|FG000|Year 2|Travel|1|||
23329939|NCT03989102|64948757|FG001|Year 2|Travel|0|||
23329940|NCT03989102|64948758|FG002|Year 2|Travel|1|||
23329941|NCT03989102|64948756|FG000|Year 2|P16 missing|4|||
23329942|NCT03989102|64948757|FG001|Year 2|P16 missing|2|||
23329943|NCT03989102|64948758|FG002|Year 2|P16 missing|1|||
23329944|NCT03989102|64948756|FG000|Year 2|P11 missing|1|||
23329945|NCT03989102|64948757|FG001|Year 2|P11 missing|3|||
23329946|NCT03989102|64948758|FG002|Year 2|P11 missing|7|||
23329947|NCT03989102|64948756|FG000|Year 2|Definitive displacement outside the study site|0|||
23568308|NCT01380990|65809784|FG000|Overall Study|Death|0|||
23568309|NCT01380990|65809785|FG001|Overall Study|Death|1|||
23568310|NCT02118714|65809786|FG000|Overall Study|Lost to Follow-up|2|||
23568311|NCT02118714|65809786|FG000|Overall Study|Protocol Violation|1|||
23568312|NCT00251927|65809787|FG000|Overall Study|Adverse Event|3|||
23568313|NCT00251927|65809788|FG001|Overall Study|Adverse Event|15|||
23568314|NCT00251927|65809787|FG000|Overall Study|Lack of Efficacy|22|||
23568315|NCT00251927|65809788|FG001|Overall Study|Lack of Efficacy|16|||
23568316|NCT00251927|65809787|FG000|Overall Study|Lost to Follow-up|22|||
23223083|NCT01305941|64560363|FG000|Overall Study|Clinical decline|2|||
23223084|NCT01305941|64560363|FG000|Overall Study|Withdrawal by Subject|1|||
23223085|NCT01305941|64560363|FG000|Overall Study|Death|1|||
23223086|NCT03621189|64560372|FG000|Overall Study|Withdrawal by Subject|0|||
23223087|NCT03621189|64560373|FG001|Overall Study|Withdrawal by Subject|3|||
23223088|NCT03621189|64560372|FG000|Overall Study|Physician Decision|0|||
23223089|NCT03621189|64560373|FG001|Overall Study|Physician Decision|2|||
23223090|NCT04402385|64560378|FG000|Overall Study|Withdrawal by Subject|4|||
23223091|NCT04402385|64560379|FG001|Overall Study|Withdrawal by Subject|4|||
23223092|NCT04402385|64560378|FG000|Overall Study|Lost to Follow-up|1|||
23223093|NCT04402385|64560379|FG001|Overall Study|Lost to Follow-up|1|||
23223094|NCT04402385|64560378|FG000|Overall Study|Physician Decision|0|||
23223095|NCT04402385|64560379|FG001|Overall Study|Physician Decision|1|||
23223096|NCT03418376|64560383|FG000|Overall Study|Musculoskeletal injury|1|||
23223097|NCT03418376|64560384|FG001|Overall Study|Musculoskeletal injury|2|||
23223098|NCT03418376|64560385|FG002|Overall Study|Musculoskeletal injury|1|||
23223099|NCT03418376|64560386|FG003|Overall Study|Musculoskeletal injury|0|||
23223100|NCT03418376|64560383|FG000|Overall Study|Personal reasons|0|||
23223101|NCT03418376|64560384|FG001|Overall Study|Personal reasons|2|||
23223102|NCT03418376|64560385|FG002|Overall Study|Personal reasons|2|||
23223103|NCT03418376|64560386|FG003|Overall Study|Personal reasons|1|||
23223104|NCT03418376|64560383|FG000|Overall Study|Exacerbation|0|||
23223105|NCT03418376|64560384|FG001|Overall Study|Exacerbation|1|||
23223106|NCT03418376|64560385|FG002|Overall Study|Exacerbation|0|||
23568317|NCT00251927|65809788|FG001|Overall Study|Lost to Follow-up|8|||
23568318|NCT00251927|65809787|FG000|Overall Study|Protocol Violation|1|||
23568319|NCT00251927|65809788|FG001|Overall Study|Protocol Violation|2|||
23568320|NCT00251927|65809787|FG000|Overall Study|Pregnancy|2|||
23568321|NCT00251927|65809788|FG001|Overall Study|Pregnancy|0|||
23568322|NCT00251927|65809787|FG000|Overall Study|Withdrawal by Subject|40|||
23223107|NCT03418376|64560386|FG003|Overall Study|Exacerbation|0|||
23223108|NCT03325010|64560387|FG000|Overall Study|Adverse Event|3|||
23223109|NCT03325010|64560388|FG001|Overall Study|Adverse Event|8|||
23223110|NCT03325010|64560387|FG000|Overall Study|Protocol Violation|1|||
23223111|NCT03325010|64560388|FG001|Overall Study|Protocol Violation|8|||
23223112|NCT03325010|64560387|FG000|Overall Study|Withdrawal by Subject|1|||
23223113|NCT03325010|64560388|FG001|Overall Study|Withdrawal by Subject|3|||
23223114|NCT03325010|64560387|FG000|Overall Study|Lost to Follow-up|1|||
23329948|NCT03989102|64948757|FG001|Year 2|Definitive displacement outside the study site|1|||
23329949|NCT03989102|64948758|FG002|Year 2|Definitive displacement outside the study site|0|||
23329950|NCT03989102|64948756|FG000|Year 2|Subject missed last study visit|0|||
23223115|NCT03325010|64560388|FG001|Overall Study|Lost to Follow-up|0|||
23223116|NCT03325010|64560387|FG000|Overall Study|Physician Decision|1|||
23223117|NCT03325010|64560388|FG001|Overall Study|Physician Decision|1|||
23223118|NCT03325010|64560387|FG000|Overall Study|Lack of Efficacy|2|||
23329951|NCT03989102|64948757|FG001|Year 2|Subject missed last study visit|1|||
23568323|NCT00251927|65809788|FG001|Overall Study|Withdrawal by Subject|25|||
23223119|NCT03325010|64560388|FG001|Overall Study|Lack of Efficacy|0|||
23329952|NCT03989102|64948758|FG002|Year 2|Subject missed last study visit|0|||
23568324|NCT00251927|65809787|FG000|Overall Study|Study-specific discont. achieved|13|||
23568325|NCT00251927|65809788|FG001|Overall Study|Study-specific discont. achieved|2|||
23329953|NCT03989102|64948756|FG000|Year 2|Death|0|||
23329954|NCT03989102|64948757|FG001|Year 2|Death|1|||
23329955|NCT03989102|64948758|FG002|Year 2|Death|0|||
23568326|NCT00251927|65809787|FG000|Overall Study|Study procedure non-compliance|5|||
23568327|NCT00251927|65809788|FG001|Overall Study|Study procedure non-compliance|6|||
23568328|NCT04581200|65809794|FG000|Overall Study|Lost to Follow-up|6|||
23568329|NCT04581200|65809795|FG001|Overall Study|Lost to Follow-up|5|||
23568330|NCT01987830|65809796|FG000|Overall Study|Never received baseline scan|1|||
23568331|NCT00068380|65809797|FG000|Overall Study|Withdrawal by Subject|3|||
23568332|NCT00068380|65809797|FG000|Overall Study|Adverse Event|2|||
23568333|NCT01806740|65809798|FG000|Overall Study|Withdrawal by Subject|4|||
23568334|NCT01806740|65809798|FG000|Overall Study|Physician Decision|1|||
23568335|NCT01806740|65809798|FG000|Overall Study|Patient's refusal of treatment|1|||
23568336|NCT01406717|65809799|FG000|Overall Study|Subject non-compliance|4|||
23568337|NCT01406717|65809800|FG001|Overall Study|Subject non-compliance|3|||
23568338|NCT01406717|65809799|FG000|Overall Study|Protocol Violation|5|||
23568339|NCT01406717|65809800|FG001|Overall Study|Protocol Violation|1|||
23568340|NCT01406717|65809799|FG000|Overall Study|Lost to Follow-up|14|||
23568341|NCT01406717|65809800|FG001|Overall Study|Lost to Follow-up|8|||
23568342|NCT01406717|65809799|FG000|Overall Study|Withdrawal by Subject|19|||
23568343|NCT01406717|65809800|FG001|Overall Study|Withdrawal by Subject|15|||
23568344|NCT01406717|65809799|FG000|Overall Study|Adverse Event|1|||
23568345|NCT01406717|65809800|FG001|Overall Study|Adverse Event|2|||
23568346|NCT01406717|65809799|FG000|Overall Study|Lack of Efficacy|0|||
23568347|NCT01406717|65809800|FG001|Overall Study|Lack of Efficacy|1|||
23568348|NCT01406717|65809799|FG000|Overall Study|Non-completion of visit activity|0|||
23568349|NCT01406717|65809800|FG001|Overall Study|Non-completion of visit activity|1|||
23568350|NCT03377790|65809801|FG000|Overall Study|Withdrawal by Subject|1|||
23160878|NCT01986920|64338960|FG002|Placebo|Withdrawal by Subject|0|||
23160879|NCT01986920|64338961|FG003|Placebo|Withdrawal by Subject|1|||
23329956|NCT03989102|64948756|FG000|Year 2|Subject not reachable|0|||
23329957|NCT03989102|64948757|FG001|Year 2|Subject not reachable|0|||
23329958|NCT03989102|64948758|FG002|Year 2|Subject not reachable|1|||
23329959|NCT03989102|64948756|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
23329960|NCT03989102|64948757|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
23329961|NCT03989102|64948758|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
23329962|NCT03989102|64948756|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
23329963|NCT03989102|64948757|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
23329964|NCT03989102|64948758|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
23329965|NCT03989102|64948756|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
23329966|NCT03989102|64948757|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
23329967|NCT03989102|64948758|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
23160880|NCT01358864|64338962|FG000|Overall Study|Adverse Event|0|||
23160881|NCT01358864|64338963|FG001|Overall Study|Adverse Event|6|||
23160882|NCT01358864|64338964|FG002|Overall Study|Adverse Event|9|||
23160883|NCT01358864|64338965|FG003|Overall Study|Adverse Event|0|||
23160884|NCT01358864|64338966|FG004|Overall Study|Adverse Event|4|||
23160885|NCT01358864|64338967|FG005|Overall Study|Adverse Event|8|||
23160886|NCT01358864|64338968|FG006|Overall Study|Adverse Event|12|||
23160887|NCT01358864|64338969|FG007|Overall Study|Adverse Event|7|||
23160888|NCT01358864|64338962|FG000|Overall Study|Lack of Efficacy|26|||
23160889|NCT01358864|64338963|FG001|Overall Study|Lack of Efficacy|3|||
23160890|NCT01358864|64338964|FG002|Overall Study|Lack of Efficacy|4|||
23160891|NCT01358864|64338965|FG003|Overall Study|Lack of Efficacy|19|||
23160892|NCT01358864|64338966|FG004|Overall Study|Lack of Efficacy|7|||
23160893|NCT01358864|64338967|FG005|Overall Study|Lack of Efficacy|4|||
23160894|NCT01358864|64338968|FG006|Overall Study|Lack of Efficacy|49|||
23160895|NCT01358864|64338969|FG007|Overall Study|Lack of Efficacy|44|||
23160896|NCT01358864|64338962|FG000|Overall Study|Lost to Follow-up|0|||
23160897|NCT01358864|64338963|FG001|Overall Study|Lost to Follow-up|0|||
23160898|NCT01358864|64338964|FG002|Overall Study|Lost to Follow-up|1|||
23160899|NCT01358864|64338965|FG003|Overall Study|Lost to Follow-up|0|||
23160900|NCT01358864|64338966|FG004|Overall Study|Lost to Follow-up|0|||
23160901|NCT01358864|64338967|FG005|Overall Study|Lost to Follow-up|0|||
23160902|NCT01358864|64338968|FG006|Overall Study|Lost to Follow-up|0|||
23160903|NCT01358864|64338969|FG007|Overall Study|Lost to Follow-up|1|||
23329968|NCT03989102|64948756|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
23568351|NCT03377790|65809802|FG001|Overall Study|Withdrawal by Subject|0|||
23568352|NCT03377790|65809801|FG000|Overall Study|Adverse Event|1|||
23160904|NCT01358864|64338962|FG000|Overall Study|Withdrawal by Subject|3|||
23160905|NCT01358864|64338963|FG001|Overall Study|Withdrawal by Subject|4|||
23160906|NCT01358864|64338964|FG002|Overall Study|Withdrawal by Subject|2|||
23160907|NCT01358864|64338965|FG003|Overall Study|Withdrawal by Subject|0|||
23160908|NCT01358864|64338966|FG004|Overall Study|Withdrawal by Subject|0|||
23160909|NCT01358864|64338967|FG005|Overall Study|Withdrawal by Subject|1|||
23160910|NCT01358864|64338968|FG006|Overall Study|Withdrawal by Subject|1|||
23223120|NCT00893763|64560392|FG000|Overall Study|extubated|110|||
23329969|NCT03989102|64948757|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
23329970|NCT03989102|64948758|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
23329971|NCT03989102|64948756|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
23329972|NCT03989102|64948757|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
23329973|NCT03989102|64948758|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
23329974|NCT03989102|64948756|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
23329975|NCT03989102|64948757|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
23329976|NCT03989102|64948758|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
23329977|NCT04762160|64948764|FG000|Overall Study|Study terminated early due to business reasons|5|||
23329978|NCT05061693|64948765|FG000|Overall Study|Adverse Event|1|||
23329979|NCT05061693|64948766|FG001|Overall Study|Adverse Event|1|||
23329980|NCT05061693|64948767|FG002|Overall Study|Adverse Event|1|||
23329981|NCT05061693|64948768|FG003|Overall Study|Adverse Event|0|||
23329982|NCT05061693|64948765|FG000|Overall Study|Death|0|||
23329983|NCT05061693|64948766|FG001|Overall Study|Death|1|||
23160911|NCT01358864|64338969|FG007|Overall Study|Withdrawal by Subject|3|||
23160912|NCT01358864|64338962|FG000|Overall Study|Other reason not defined above|2|||
23160913|NCT01358864|64338963|FG001|Overall Study|Other reason not defined above|0|||
23160914|NCT01358864|64338964|FG002|Overall Study|Other reason not defined above|0|||
23160915|NCT01358864|64338965|FG003|Overall Study|Other reason not defined above|0|||
23160916|NCT01358864|64338966|FG004|Overall Study|Other reason not defined above|0|||
23160917|NCT01358864|64338967|FG005|Overall Study|Other reason not defined above|0|||
23160918|NCT01358864|64338968|FG006|Overall Study|Other reason not defined above|2|||
23160919|NCT01358864|64338969|FG007|Overall Study|Other reason not defined above|0|||
23160920|NCT01358864|64338962|FG000|Overall Study|Not treated|0|||
23160921|NCT01358864|64338963|FG001|Overall Study|Not treated|0|||
23160922|NCT01358864|64338964|FG002|Overall Study|Not treated|0|||
23160923|NCT01358864|64338965|FG003|Overall Study|Not treated|0|||
23160924|NCT01358864|64338966|FG004|Overall Study|Not treated|0|||
23160925|NCT01358864|64338967|FG005|Overall Study|Not treated|0|||
23160926|NCT01358864|64338968|FG006|Overall Study|Not treated|1|||
23160927|NCT01358864|64338969|FG007|Overall Study|Not treated|0|||
23160928|NCT00440947|64338970|FG000|36-Week Induction Phase|Adverse Event|16|||
23160929|NCT00440947|64338971|FG001|36-Week Induction Phase|Adverse Event|0|||
23160930|NCT00440947|64338972|FG002|36-Week Induction Phase|Adverse Event|0|||
23160931|NCT00440947|64338973|FG003|36-Week Induction Phase|Adverse Event|0|||
23160932|NCT00440947|64338974|FG004|36-Week Induction Phase|Adverse Event|0|||
23160933|NCT00440947|64338970|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
23160934|NCT00440947|64338971|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
23160935|NCT00440947|64338972|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
23160936|NCT00440947|64338973|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
23160937|NCT00440947|64338974|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
23160938|NCT00440947|64338970|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
23160939|NCT00440947|64338971|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
23160940|NCT00440947|64338972|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
23160941|NCT00440947|64338973|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
23160942|NCT00440947|64338974|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
23160943|NCT00440947|64338970|FG000|36-Week Induction Phase|Non-compliance|10|||
23160944|NCT00440947|64338971|FG001|36-Week Induction Phase|Non-compliance|0|||
23160945|NCT00440947|64338972|FG002|36-Week Induction Phase|Non-compliance|0|||
23160946|NCT00440947|64338973|FG003|36-Week Induction Phase|Non-compliance|0|||
23160947|NCT00440947|64338974|FG004|36-Week Induction Phase|Non-compliance|0|||
23160948|NCT00440947|64338970|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
23160949|NCT00440947|64338971|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
23160950|NCT00440947|64338972|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
23160951|NCT00440947|64338973|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
23160952|NCT00440947|64338974|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
23160953|NCT00440947|64338970|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
23160954|NCT00440947|64338971|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
23160955|NCT00440947|64338972|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
23160956|NCT00440947|64338973|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
23160957|NCT00440947|64338974|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
23160958|NCT00440947|64338970|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
23160959|NCT00440947|64338971|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
23160960|NCT00440947|64338972|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
23160961|NCT00440947|64338973|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
23160962|NCT00440947|64338974|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
23160963|NCT00440947|64338970|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
23160964|NCT00440947|64338971|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
23329984|NCT05061693|64948767|FG002|Overall Study|Death|0|||
23329985|NCT05061693|64948768|FG003|Overall Study|Death|0|||
23329986|NCT05061693|64948765|FG000|Overall Study|Lack of Efficacy|1|||
23160965|NCT00440947|64338972|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
23160966|NCT00440947|64338973|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
23160967|NCT00440947|64338974|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
23160968|NCT00440947|64338970|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
23160969|NCT00440947|64338971|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
23160970|NCT00440947|64338972|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
23160971|NCT00440947|64338973|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
23160972|NCT00440947|64338974|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
23160973|NCT00440947|64338970|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
23160974|NCT00440947|64338971|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
23160975|NCT00440947|64338972|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
23160976|NCT00440947|64338973|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
23160977|NCT00440947|64338974|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
23160978|NCT00440947|64338970|FG000|36-Week Induction Phase|Incarceration|3|||
23160979|NCT00440947|64338971|FG001|36-Week Induction Phase|Incarceration|0|||
23160980|NCT00440947|64338972|FG002|36-Week Induction Phase|Incarceration|0|||
23160981|NCT00440947|64338973|FG003|36-Week Induction Phase|Incarceration|0|||
23160982|NCT00440947|64338974|FG004|36-Week Induction Phase|Incarceration|0|||
23160983|NCT00440947|64338970|FG000|36-Week Induction Phase|Pregnancy|1|||
23160984|NCT00440947|64338971|FG001|36-Week Induction Phase|Pregnancy|0|||
23160985|NCT00440947|64338972|FG002|36-Week Induction Phase|Pregnancy|0|||
23160986|NCT00440947|64338973|FG003|36-Week Induction Phase|Pregnancy|0|||
23160987|NCT00440947|64338974|FG004|36-Week Induction Phase|Pregnancy|0|||
23160988|NCT00440947|64338970|FG000|48-Week Randomization Phase|Adverse Event|0|||
23160989|NCT00440947|64338971|FG001|48-Week Randomization Phase|Adverse Event|2|||
23160990|NCT00440947|64338972|FG002|48-Week Randomization Phase|Adverse Event|5|||
23160991|NCT00440947|64338973|FG003|48-Week Randomization Phase|Adverse Event|0|||
23160992|NCT00440947|64338974|FG004|48-Week Randomization Phase|Adverse Event|0|||
23160993|NCT00440947|64338970|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
23160994|NCT00440947|64338971|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
23160995|NCT00440947|64338972|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
23160996|NCT00440947|64338973|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
23160997|NCT00440947|64338974|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
23160998|NCT00440947|64338970|FG000|48-Week Randomization Phase|Non-compliance|0|||
23160999|NCT00440947|64338971|FG001|48-Week Randomization Phase|Non-compliance|3|||
23161000|NCT00440947|64338972|FG002|48-Week Randomization Phase|Non-compliance|4|||
23161001|NCT00440947|64338973|FG003|48-Week Randomization Phase|Non-compliance|0|||
23161002|NCT00440947|64338974|FG004|48-Week Randomization Phase|Non-compliance|0|||
23161003|NCT00440947|64338970|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
23161004|NCT00440947|64338971|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
23161005|NCT00440947|64338972|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
23161006|NCT00440947|64338973|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
23161007|NCT00440947|64338974|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
23161008|NCT00440947|64338970|FG000|48-Week Randomization Phase|Protocol Violation|0|||
23161009|NCT00440947|64338971|FG001|48-Week Randomization Phase|Protocol Violation|0|||
23161010|NCT00440947|64338972|FG002|48-Week Randomization Phase|Protocol Violation|1|||
23161011|NCT00440947|64338973|FG003|48-Week Randomization Phase|Protocol Violation|0|||
23161012|NCT00440947|64338974|FG004|48-Week Randomization Phase|Protocol Violation|0|||
23161013|NCT00440947|64338970|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
23161014|NCT00440947|64338971|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
23161015|NCT00440947|64338972|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
23161016|NCT00440947|64338973|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
23161017|NCT00440947|64338974|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
23161018|NCT00440947|64338970|FG000|48-Week Randomization Phase|Pregnancy|0|||
23161019|NCT00440947|64338971|FG001|48-Week Randomization Phase|Pregnancy|0|||
23161020|NCT00440947|64338972|FG002|48-Week Randomization Phase|Pregnancy|1|||
23161021|NCT00440947|64338973|FG003|48-Week Randomization Phase|Pregnancy|0|||
23161022|NCT00440947|64338974|FG004|48-Week Randomization Phase|Pregnancy|0|||
23329987|NCT05061693|64948766|FG001|Overall Study|Lack of Efficacy|0|||
23568353|NCT03377790|65809802|FG001|Overall Study|Adverse Event|0|||
23568354|NCT03377790|65809801|FG000|Overall Study|Lost to Follow-up|0|||
23161023|NCT00440947|64338970|FG000|48-Week Randomization Phase|Incarceration|0|||
23161024|NCT00440947|64338971|FG001|48-Week Randomization Phase|Incarceration|3|||
23568355|NCT03377790|65809802|FG001|Overall Study|Lost to Follow-up|2|||
23161025|NCT00440947|64338972|FG002|48-Week Randomization Phase|Incarceration|0|||
23161026|NCT00440947|64338973|FG003|48-Week Randomization Phase|Incarceration|0|||
23161027|NCT00440947|64338974|FG004|48-Week Randomization Phase|Incarceration|0|||
23329988|NCT05061693|64948767|FG002|Overall Study|Lack of Efficacy|0|||
23329989|NCT05061693|64948768|FG003|Overall Study|Lack of Efficacy|0|||
23329990|NCT05061693|64948765|FG000|Overall Study|Lost to Follow-up|0|||
23329991|NCT05061693|64948766|FG001|Overall Study|Lost to Follow-up|0|||
23161028|NCT00440947|64338970|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
23329992|NCT05061693|64948767|FG002|Overall Study|Lost to Follow-up|1|||
23329993|NCT05061693|64948768|FG003|Overall Study|Lost to Follow-up|0|||
23329994|NCT05061693|64948765|FG000|Overall Study|Protocol Violation|1|||
23329995|NCT05061693|64948766|FG001|Overall Study|Protocol Violation|1|||
23329996|NCT05061693|64948767|FG002|Overall Study|Protocol Violation|1|||
23329997|NCT05061693|64948768|FG003|Overall Study|Protocol Violation|2|||
23329998|NCT05061693|64948765|FG000|Overall Study|Withdrawal by Subject|2|||
23329999|NCT05061693|64948766|FG001|Overall Study|Withdrawal by Subject|4|||
23330000|NCT05061693|64948767|FG002|Overall Study|Withdrawal by Subject|2|||
23330001|NCT05061693|64948768|FG003|Overall Study|Withdrawal by Subject|2|||
23330002|NCT04615403|64948769|FG000|Overall Study|Death|1|||
23330003|NCT01283464|64948770|FG000|Overall Study|Lost to Follow-up|0|||
23330004|NCT01283464|64948771|FG001|Overall Study|Lost to Follow-up|1|||
23330005|NCT01283464|64948770|FG000|Overall Study|Withdrawal by Subject|1|||
23330006|NCT01283464|64948771|FG001|Overall Study|Withdrawal by Subject|0|||
23330007|NCT01283464|64948770|FG000|Overall Study|Physician Decision|1|||
23330008|NCT01283464|64948771|FG001|Overall Study|Physician Decision|0|||
23330009|NCT02898597|64948772|FG000|Overall Study|Protocol Violation|4|||
23330010|NCT02898597|64948773|FG001|Overall Study|Protocol Violation|2|||
23330011|NCT02898597|64948772|FG000|Overall Study|Lost to Follow-up|0|||
23330012|NCT02898597|64948773|FG001|Overall Study|Lost to Follow-up|9|||
23330013|NCT02898597|64948772|FG000|Overall Study|Death|0|||
23330014|NCT02898597|64948773|FG001|Overall Study|Death|1|||
23330015|NCT02075203|64948779|FG000|Overall Study|Withdrawal by Subject|1|||
23330016|NCT02075203|64948780|FG001|Overall Study|Withdrawal by Subject|0|||
23330017|NCT02075203|64948781|FG002|Overall Study|Withdrawal by Subject|1|||
23330018|NCT02075203|64948779|FG000|Overall Study|Adverse Event|1|||
23330019|NCT02075203|64948780|FG001|Overall Study|Adverse Event|0|||
23330020|NCT02075203|64948781|FG002|Overall Study|Adverse Event|0|||
23330021|NCT02075203|64948779|FG000|Overall Study|participant refused to use contraception|1|||
23330022|NCT02075203|64948780|FG001|Overall Study|participant refused to use contraception|0|||
23330023|NCT02075203|64948781|FG002|Overall Study|participant refused to use contraception|0|||
23330024|NCT03283566|64951861|FG000|Overall Study|Lost to Follow-up|1|||
23330025|NCT03283566|64951862|FG001|Overall Study|Lost to Follow-up|2|||
23330026|NCT01804946|64951869|FG000|Overall Study|Protocol Violation|1|||
23330027|NCT01804946|64951870|FG001|Overall Study|Protocol Violation|0|||
23330028|NCT01804946|64951869|FG000|Overall Study|Adverse Event|0|||
23330029|NCT01804946|64951870|FG001|Overall Study|Adverse Event|1|||
23330030|NCT01804946|64951869|FG000|Overall Study|Insufficient data available|0|||
23330031|NCT01804946|64951870|FG001|Overall Study|Insufficient data available|1|||
23330032|NCT01804946|64951869|FG000|Overall Study|Do not meet inclusion criteria|1|||
23330033|NCT01804946|64951870|FG001|Overall Study|Do not meet inclusion criteria|2|||
23330034|NCT03096314|64951871|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
23330035|NCT03096314|64951872|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
23330036|NCT00386360|64951873|FG000|Overall Study|Adverse Event|4|||
23330037|NCT00386360|64951874|FG001|Overall Study|Adverse Event|2|||
23330038|NCT00386360|64951873|FG000|Overall Study|Physician Decision|2|||
23330039|NCT00386360|64951874|FG001|Overall Study|Physician Decision|2|||
23330040|NCT00386360|64951873|FG000|Overall Study|Lost to Follow-up|0|||
23330041|NCT00386360|64951874|FG001|Overall Study|Lost to Follow-up|2|||
23330042|NCT00386360|64951873|FG000|Overall Study|Protocol Violation|0|||
23330043|NCT00386360|64951874|FG001|Overall Study|Protocol Violation|3|||
23330044|NCT00386360|64951873|FG000|Overall Study|Withdrawal by Subject|3|||
23330045|NCT00386360|64951874|FG001|Overall Study|Withdrawal by Subject|6|||
23330046|NCT00386360|64951873|FG000|Overall Study|Did not take any study medication|0|||
23161029|NCT00440947|64338971|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
23161030|NCT00440947|64338972|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
23161031|NCT00440947|64338973|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
23161032|NCT00440947|64338974|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
23161033|NCT00440947|64338970|FG000|48-Week Randomization Phase|Physician Decision|0|||
23161034|NCT00440947|64338971|FG001|48-Week Randomization Phase|Physician Decision|2|||
23330047|NCT00386360|64951874|FG001|Overall Study|Did not take any study medication|2|||
23330048|NCT00595920|64951883|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
23223121|NCT00893763|64560393|FG001|Overall Study|extubated|110|||
23330049|NCT00921557|64951886|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
23161035|NCT00440947|64338972|FG002|48-Week Randomization Phase|Physician Decision|0|||
23330050|NCT00921557|64951887|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
23330051|NCT00921557|64951888|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
23330052|NCT00921557|64951886|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
23330053|NCT00921557|64951887|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
23330054|NCT00921557|64951888|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
23330055|NCT00921557|64951886|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
23330056|NCT00921557|64951887|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
23330057|NCT00921557|64951888|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
23330058|NCT00921557|64951886|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
23330059|NCT00921557|64951887|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
23330060|NCT00921557|64951888|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
23330061|NCT00921557|64951886|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
23330062|NCT00921557|64951887|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
23330063|NCT00921557|64951888|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
23330064|NCT00470704|64951893|FG000|Overall Study|Withdrawal by Subject|4|||
23330065|NCT00470704|64951894|FG001|Overall Study|Withdrawal by Subject|3|||
23330066|NCT00470704|64951893|FG000|Overall Study|Relapse/Progression|37|||
23568356|NCT03377790|65809801|FG000|Overall Study|Randomized but not treated|1|||
23568357|NCT03377790|65809802|FG001|Overall Study|Randomized but not treated|0|||
23568358|NCT03377790|65809801|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
23568359|NCT03377790|65809802|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
23568360|NCT02693834|65809803|FG000|Baseline Measurement|Withdrawal by Subject|1|||
23568361|NCT02693834|65809804|FG001|Baseline Measurement|Withdrawal by Subject|0|||
23568362|NCT02693834|65809803|FG000|Baseline Measurement|Adverse Event|1|||
23223122|NCT01010776|64560397|FG000|Main Phase|Withdrawal by Subject|14|||
23223123|NCT01010776|64560397|FG000|Main Phase|Lack of Efficacy|8|||
23223124|NCT01010776|64560397|FG000|Main Phase|Adverse Event|7|||
23223125|NCT01010776|64560397|FG000|Main Phase|Lost to Follow-up|6|||
23223126|NCT01010776|64560397|FG000|Main Phase|Non-compliance to study medication|5|||
23161036|NCT00440947|64338973|FG003|48-Week Randomization Phase|Physician Decision|0|||
23161037|NCT00440947|64338974|FG004|48-Week Randomization Phase|Physician Decision|0|||
23161038|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
23161039|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
23161040|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
23161041|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
23161042|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
23161043|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
23161044|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
23161045|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
23161046|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
23161047|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
23161048|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
23161049|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
23568363|NCT02693834|65809804|FG001|Baseline Measurement|Adverse Event|0|||
23568364|NCT02693834|65809803|FG000|Week 2 Practice|Adverse Event|0|||
23568365|NCT02693834|65809804|FG001|Week 2 Practice|Adverse Event|1|||
23568366|NCT00366301|65809805|FG000|Overall Study|Lost to Follow-up|4|||
23568367|NCT00366301|65809806|FG001|Overall Study|Lost to Follow-up|4|||
23161050|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
23223127|NCT01010776|64560397|FG000|Main Phase|Selection failure|2|||
23223128|NCT01010776|64560397|FG000|Main Phase|Inform consent withdrawal|1|||
23223129|NCT01010776|64560397|FG000|Main Phase|Other|1|||
23223130|NCT01010776|64560397|FG000|Main Phase|Did not received study medication|5|||
23223131|NCT01010776|64560397|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
23223132|NCT01010776|64560397|FG000|Extension Phase|Other|3|||
23223133|NCT03127852|64560398|FG000|Overall Study|Withdrawal by Subject|4|||
23223134|NCT03127852|64560399|FG001|Overall Study|Withdrawal by Subject|1|||
23223135|NCT03127852|64560398|FG000|Overall Study|Death|1|||
23223136|NCT03127852|64560399|FG001|Overall Study|Death|1|||
23223137|NCT01235338|64560402|FG000|Overall Study|Adverse Event|3|||
23223138|NCT01235338|64560403|FG001|Overall Study|Adverse Event|2|||
23223139|NCT01235338|64560402|FG000|Overall Study|Protocol Violation|1|||
23223140|NCT01235338|64560403|FG001|Overall Study|Protocol Violation|1|||
23223141|NCT01235338|64560402|FG000|Overall Study|Withdrawal by Subject|5|||
23223142|NCT01235338|64560403|FG001|Overall Study|Withdrawal by Subject|0|||
23223143|NCT01235338|64560402|FG000|Overall Study|Exclusion criteria violations|1|||
23223144|NCT01235338|64560403|FG001|Overall Study|Exclusion criteria violations|1|||
23223145|NCT01235338|64560402|FG000|Overall Study|Positive drug screen|0|||
23568368|NCT00366301|65809807|FG002|Overall Study|Lost to Follow-up|3|||
23568369|NCT00366301|65809808|FG003|Overall Study|Lost to Follow-up|7|||
23223146|NCT01235338|64560403|FG001|Overall Study|Positive drug screen|1|||
23330067|NCT00470704|64951894|FG001|Overall Study|Relapse/Progression|42|||
23161051|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
23161052|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
23161053|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
23161054|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
23161055|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
23161056|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
23161057|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
23161058|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
23161059|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
23161060|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
23161061|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
23161062|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
23161063|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
23161064|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
23568370|NCT00366301|65809805|FG000|Overall Study|Withdrawal by Subject|4|||
23568371|NCT00366301|65809806|FG001|Overall Study|Withdrawal by Subject|2|||
23568372|NCT00366301|65809807|FG002|Overall Study|Withdrawal by Subject|1|||
23568373|NCT00366301|65809808|FG003|Overall Study|Withdrawal by Subject|1|||
23568374|NCT01973491|65809812|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
23568375|NCT01973491|65809812|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
23568376|NCT01973491|65809812|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
23568377|NCT03119610|65809813|FG000|Overall Study|Adverse Event|1|||
23568378|NCT03119610|65809814|FG001|Overall Study|Adverse Event|0|||
23568379|NCT03119610|65809813|FG000|Overall Study|Lost to Follow-up|0|||
23568380|NCT03119610|65809814|FG001|Overall Study|Lost to Follow-up|1|||
23568381|NCT02494921|65809815|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
23568382|NCT02494921|65809816|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
23568383|NCT02494921|65809817|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
23568384|NCT02494921|65809818|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
23568385|NCT02494921|65809819|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
23568386|NCT02494921|65809815|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
23161065|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
23161066|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
23161067|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
23161068|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
23161069|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
23161070|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
23161071|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
23161072|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
23161073|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
23161074|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
23161075|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
23161076|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
23161077|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
23161078|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
23161079|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
23161080|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
23161081|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
23161082|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
23161083|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
23161084|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
23161085|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
23446148|NCT01395901|65373862|FG000|Overall Study|Withdrawal of consent|1|||
23161086|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
23161087|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
23161088|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
23161089|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
23446149|NCT01395901|65373863|FG001|Overall Study|Withdrawal of consent|0|||
23446150|NCT01327599|65373866|FG000|Overall Study|Adverse Event|1|||
23161090|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
23161091|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
23161092|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
23161093|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Other|0|||
23161094|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Other|0|||
23161095|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Other|0|||
23161096|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Other|1|||
23161097|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Other|0|||
23161098|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
23161099|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
23161100|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
23161101|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
23161102|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
23161103|NCT00440947|64338970|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
23161104|NCT00440947|64338971|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
23161105|NCT00440947|64338972|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
23161106|NCT00440947|64338973|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
23161107|NCT00440947|64338974|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
23161108|NCT00361270|64338975|FG000|Overall Study|Death|0|||
23161109|NCT00361270|64338976|FG001|Overall Study|Death|0|||
23161110|NCT00361270|64338977|FG002|Overall Study|Death|0|||
23161111|NCT00361270|64338978|FG003|Overall Study|Death|2|||
23161112|NCT00361270|64338975|FG000|Overall Study|Lost to Follow-up|4|||
23161113|NCT00361270|64338976|FG001|Overall Study|Lost to Follow-up|1|||
23161114|NCT00361270|64338977|FG002|Overall Study|Lost to Follow-up|0|||
23161115|NCT00361270|64338978|FG003|Overall Study|Lost to Follow-up|0|||
23161116|NCT00361270|64338975|FG000|Overall Study|Physician Decision|0|||
23161117|NCT00361270|64338976|FG001|Overall Study|Physician Decision|0|||
23161118|NCT00361270|64338977|FG002|Overall Study|Physician Decision|1|||
23161119|NCT00361270|64338978|FG003|Overall Study|Physician Decision|0|||
23161120|NCT00361270|64338975|FG000|Overall Study|Protocol Violation|9|||
23161121|NCT00361270|64338976|FG001|Overall Study|Protocol Violation|4|||
23161122|NCT00361270|64338977|FG002|Overall Study|Protocol Violation|5|||
23161123|NCT00361270|64338978|FG003|Overall Study|Protocol Violation|4|||
23161124|NCT00361270|64338975|FG000|Overall Study|Withdrawal by Subject|6|||
23161125|NCT00361270|64338976|FG001|Overall Study|Withdrawal by Subject|6|||
23161126|NCT00361270|64338977|FG002|Overall Study|Withdrawal by Subject|3|||
23446151|NCT01327599|65373866|FG000|Overall Study|Could Not Attend Visit|1|||
23446152|NCT01327599|65373866|FG000|Overall Study|Withdrawal of Consent|1|||
23446153|NCT00785980|65373867|FG000|7 Day Washout Period|Protocol Violation|3|||
23446154|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
23446155|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
23223147|NCT01235338|64560402|FG000|Overall Study|Prohibited meds|1|||
23223148|NCT01235338|64560403|FG001|Overall Study|Prohibited meds|0|||
23446156|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
23446157|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
23446158|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
23446159|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
23568387|NCT02494921|65809816|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
23568388|NCT02494921|65809817|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
23568389|NCT02494921|65809818|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
23568390|NCT02494921|65809819|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
23568391|NCT02494921|65809815|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
23568392|NCT02494921|65809816|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
23568393|NCT02494921|65809817|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
23568394|NCT02494921|65809818|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
23568395|NCT02494921|65809819|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
23568396|NCT01193582|65809820|FG000|Vaccination Series|Withdrawal by Subject|11|||
23568397|NCT01193582|65809821|FG001|Vaccination Series|Withdrawal by Subject|13|||
23161127|NCT00361270|64338978|FG003|Overall Study|Withdrawal by Subject|7|||
23161128|NCT00361270|64338975|FG000|Overall Study|Afraid of Hypnosis|1|||
23161129|NCT00361270|64338976|FG001|Overall Study|Afraid of Hypnosis|2|||
23161130|NCT00361270|64338977|FG002|Overall Study|Afraid of Hypnosis|0|||
23161131|NCT00361270|64338978|FG003|Overall Study|Afraid of Hypnosis|0|||
23161132|NCT00361270|64338975|FG000|Overall Study|Problems with Transportation|4|||
23161133|NCT00361270|64338976|FG001|Overall Study|Problems with Transportation|0|||
23223149|NCT03922711|64560404|FG000|Overall Study|Adverse Event|3|||
23446160|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
23446161|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
23446162|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
23446163|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
23453639|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
23446164|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
23446165|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
23446166|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
23446167|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
23161134|NCT00361270|64338977|FG002|Overall Study|Problems with Transportation|0|||
23161135|NCT00361270|64338978|FG003|Overall Study|Problems with Transportation|0|||
23161136|NCT00361270|64338975|FG000|Overall Study|Adverse Event|0|||
23161137|NCT00361270|64338976|FG001|Overall Study|Adverse Event|1|||
23161138|NCT00361270|64338977|FG002|Overall Study|Adverse Event|1|||
23161139|NCT00361270|64338978|FG003|Overall Study|Adverse Event|0|||
23161140|NCT02121262|64338982|FG000|Overall Study|Adverse Event|6|||
23161141|NCT02121262|64338983|FG001|Overall Study|Adverse Event|3|||
23161142|NCT02121262|64338982|FG000|Overall Study|Lack of Efficacy|3|||
23330068|NCT00470704|64951893|FG000|Overall Study|toxicity|0|||
23330069|NCT00470704|64951894|FG001|Overall Study|toxicity|1|||
23330070|NCT03652051|64951895|FG000|Stage 1|Adverse Event|0|||
23446168|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
23568398|NCT01193582|65809822|FG002|Vaccination Series|Withdrawal by Subject|8|||
23568399|NCT01193582|65809823|FG003|Vaccination Series|Withdrawal by Subject|3|||
23568400|NCT01193582|65809820|FG000|12 Month Follow-up|Death|0|||
23568401|NCT01193582|65809821|FG001|12 Month Follow-up|Death|0|||
23568402|NCT01193582|65809822|FG002|12 Month Follow-up|Death|1|||
23568403|NCT01193582|65809823|FG003|12 Month Follow-up|Death|0|||
23568404|NCT01193582|65809820|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
23568405|NCT01193582|65809821|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
23568406|NCT01193582|65809822|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
23568407|NCT01193582|65809823|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
23568408|NCT01588990|65809824|FG000|Phase A|Withdrawal by Subject|5|||
23568409|NCT01588990|65809824|FG000|Phase A|Physician Decision|11|||
23568410|NCT01588990|65809824|FG000|Phase A|Other|14|||
23568411|NCT01588990|65809824|FG000|Phase A|Lost to Follow-up|1|||
23568412|NCT01588990|65809824|FG000|Phase A|Death|5|||
23568413|NCT01588990|65809824|FG000|Phase A|Adverse Event|28|||
23568414|NCT01588990|65809824|FG000|Phase A|Still on therapy at end of study|6|||
23568415|NCT01588990|65809824|FG000|Phase B|Adverse Event|2|||
23568416|NCT01588990|65809824|FG000|Phase B|Still on therapy at end of study|5|||
23568417|NCT01588990|65809824|FG000|Phase B|Withdrawal by Subject|3|||
23568418|NCT01588990|65809824|FG000|Phase B|Physician Decision|4|||
23568419|NCT01588990|65809824|FG000|Phase B|Other|2|||
23568420|NCT01737996|65809825|FG000|Overall Study|Adverse Event|0|||
23568421|NCT01737996|65809826|FG001|Overall Study|Adverse Event|1|||
23568422|NCT01737996|65809827|FG002|Overall Study|Adverse Event|1|||
23568423|NCT01737996|65809825|FG000|Overall Study|Withdrawal by Subject|0|||
23568424|NCT01737996|65809826|FG001|Overall Study|Withdrawal by Subject|0|||
23568425|NCT01737996|65809827|FG002|Overall Study|Withdrawal by Subject|1|||
23568426|NCT00519896|65809828|FG000|Overall Study|Protocol Violation|1|||
23568427|NCT00519896|65809828|FG000|Overall Study|Adverse Event|1|||
23568428|NCT03008122|65809830|FG000|Overall Study|Physician Decision|3|||
23568429|NCT03008122|65809831|FG001|Overall Study|Physician Decision|2|||
23568430|NCT03008122|65809832|FG002|Overall Study|Physician Decision|0|||
23568431|NCT03008122|65809830|FG000|Overall Study|Withdrawal by Subject|1|||
23568432|NCT03008122|65809831|FG001|Overall Study|Withdrawal by Subject|3|||
23568433|NCT03008122|65809832|FG002|Overall Study|Withdrawal by Subject|0|||
23568434|NCT03008122|65809830|FG000|Overall Study|Lost to Follow-up|4|||
23568435|NCT03008122|65809831|FG001|Overall Study|Lost to Follow-up|8|||
23568436|NCT03008122|65809832|FG002|Overall Study|Lost to Follow-up|3|||
23568437|NCT03008122|65809830|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
23568438|NCT03008122|65809831|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
23568439|NCT03008122|65809832|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
23568440|NCT03008122|65809830|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
23568441|NCT03008122|65809831|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
23568442|NCT03008122|65809832|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
23568443|NCT03008122|65809830|FG000|Overall Study|Death|0|||
23568444|NCT03008122|65809831|FG001|Overall Study|Death|0|||
23161143|NCT02121262|64338983|FG001|Overall Study|Lack of Efficacy|0|||
23161144|NCT02121262|64338982|FG000|Overall Study|Personal Reasons|19|||
23161145|NCT02121262|64338983|FG001|Overall Study|Personal Reasons|5|||
23161146|NCT02121262|64338982|FG000|Overall Study|Protocol Violation|1|||
23568445|NCT03008122|65809832|FG002|Overall Study|Death|1|||
23568446|NCT03321513|65809835|FG000|Overall Study|Death|11|||
23568447|NCT03321513|65809836|FG001|Overall Study|Death|5|||
23568448|NCT03321513|65809835|FG000|Overall Study|Withdrawal by Subject|5|||
23568449|NCT03321513|65809836|FG001|Overall Study|Withdrawal by Subject|10|||
23568450|NCT03321513|65809835|FG000|Overall Study|Lost to Follow-up|10|||
23568451|NCT03321513|65809836|FG001|Overall Study|Lost to Follow-up|11|||
23568452|NCT02875834|65809837|FG000|Open-label Phase|Withdrawal by Subject|3|||
23568453|NCT02875834|65809838|FG001|Open-label Phase|Withdrawal by Subject|0|||
23568454|NCT02875834|65809839|FG002|Open-label Phase|Withdrawal by Subject|0|||
23161147|NCT02121262|64338983|FG001|Overall Study|Protocol Violation|1|||
23161148|NCT02121262|64338982|FG000|Overall Study|Participant Dropped-out|0|||
23161149|NCT02121262|64338983|FG001|Overall Study|Participant Dropped-out|1|||
23161150|NCT02121262|64338982|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
23161151|NCT02121262|64338983|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
23161152|NCT02121262|64338982|FG000|Overall Study|Consent Withdrawn|1|||
23161153|NCT02121262|64338983|FG001|Overall Study|Consent Withdrawn|0|||
23161154|NCT01840579|64338984|FG000|Overall Study|Status not recorded|0|||
23223150|NCT03922711|64560405|FG001|Overall Study|Adverse Event|2|||
23223151|NCT03922711|64560406|FG002|Overall Study|Adverse Event|2|||
23223152|NCT03922711|64560404|FG000|Overall Study|Protocol Violation|1|||
23223153|NCT03922711|64560405|FG001|Overall Study|Protocol Violation|0|||
23161155|NCT01840579|64338985|FG001|Overall Study|Status not recorded|0|||
23161156|NCT01840579|64338986|FG002|Overall Study|Status not recorded|2|||
23161157|NCT01840579|64338987|FG003|Overall Study|Status not recorded|3|||
23161158|NCT01840579|64338988|FG004|Overall Study|Status not recorded|4|||
23161159|NCT01840579|64338989|FG005|Overall Study|Status not recorded|3|||
23161160|NCT01840579|64338990|FG006|Overall Study|Status not recorded|0|||
23161161|NCT01840579|64338991|FG007|Overall Study|Status not recorded|3|||
23161162|NCT01840579|64338992|FG008|Overall Study|Status not recorded|3|||
23161163|NCT01840579|64338993|FG009|Overall Study|Status not recorded|3|||
23161164|NCT01840579|64338984|FG000|Overall Study|Progressive disease|3|||
23161165|NCT01840579|64338985|FG001|Overall Study|Progressive disease|5|||
23161166|NCT01840579|64338986|FG002|Overall Study|Progressive disease|0|||
23161167|NCT01840579|64338987|FG003|Overall Study|Progressive disease|0|||
23161168|NCT01840579|64338988|FG004|Overall Study|Progressive disease|0|||
23161169|NCT01840579|64338989|FG005|Overall Study|Progressive disease|0|||
23161170|NCT01840579|64338990|FG006|Overall Study|Progressive disease|0|||
23161171|NCT01840579|64338991|FG007|Overall Study|Progressive disease|0|||
23161172|NCT01840579|64338992|FG008|Overall Study|Progressive disease|0|||
23161173|NCT01840579|64338993|FG009|Overall Study|Progressive disease|0|||
23161174|NCT01840579|64338984|FG000|Overall Study|Ongoing in study|0|||
23161175|NCT01840579|64338985|FG001|Overall Study|Ongoing in study|1|||
23161176|NCT01840579|64338986|FG002|Overall Study|Ongoing in study|0|||
23161177|NCT01840579|64338987|FG003|Overall Study|Ongoing in study|0|||
23161178|NCT01840579|64338988|FG004|Overall Study|Ongoing in study|0|||
23161179|NCT01840579|64338989|FG005|Overall Study|Ongoing in study|0|||
23161180|NCT01840579|64338990|FG006|Overall Study|Ongoing in study|0|||
23161181|NCT01840579|64338991|FG007|Overall Study|Ongoing in study|0|||
23161182|NCT01840579|64338992|FG008|Overall Study|Ongoing in study|0|||
23161183|NCT01840579|64338993|FG009|Overall Study|Ongoing in study|0|||
23161184|NCT01840579|64338984|FG000|Overall Study|Death|0|||
23161185|NCT01840579|64338985|FG001|Overall Study|Death|0|||
23161186|NCT01840579|64338986|FG002|Overall Study|Death|0|||
23161187|NCT01840579|64338987|FG003|Overall Study|Death|0|||
23161188|NCT01840579|64338988|FG004|Overall Study|Death|0|||
23161189|NCT01840579|64338989|FG005|Overall Study|Death|1|||
23161190|NCT01840579|64338990|FG006|Overall Study|Death|0|||
23161191|NCT01840579|64338991|FG007|Overall Study|Death|0|||
23161192|NCT01840579|64338992|FG008|Overall Study|Death|0|||
23161193|NCT01840579|64338993|FG009|Overall Study|Death|0|||
23161194|NCT01840579|64338984|FG000|Overall Study|Adverse Event|0|||
23161195|NCT01840579|64338985|FG001|Overall Study|Adverse Event|1|||
23161196|NCT01840579|64338986|FG002|Overall Study|Adverse Event|0|||
23161197|NCT01840579|64338987|FG003|Overall Study|Adverse Event|0|||
23161198|NCT01840579|64338988|FG004|Overall Study|Adverse Event|0|||
23161199|NCT01840579|64338989|FG005|Overall Study|Adverse Event|0|||
23161200|NCT01840579|64338990|FG006|Overall Study|Adverse Event|0|||
23161201|NCT01840579|64338991|FG007|Overall Study|Adverse Event|0|||
23161202|NCT01840579|64338992|FG008|Overall Study|Adverse Event|0|||
23161203|NCT01840579|64338993|FG009|Overall Study|Adverse Event|0|||
23161204|NCT01840579|64338984|FG000|Overall Study|Follow-up ended by Sponsor|0|||
23161205|NCT01840579|64338985|FG001|Overall Study|Follow-up ended by Sponsor|0|||
23161206|NCT01840579|64338986|FG002|Overall Study|Follow-up ended by Sponsor|0|||
23161207|NCT01840579|64338987|FG003|Overall Study|Follow-up ended by Sponsor|0|||
23161208|NCT01840579|64338988|FG004|Overall Study|Follow-up ended by Sponsor|0|||
23161209|NCT01840579|64338989|FG005|Overall Study|Follow-up ended by Sponsor|0|||
23161210|NCT01840579|64338990|FG006|Overall Study|Follow-up ended by Sponsor|2|||
23161211|NCT01840579|64338991|FG007|Overall Study|Follow-up ended by Sponsor|0|||
23161212|NCT01840579|64338992|FG008|Overall Study|Follow-up ended by Sponsor|0|||
23161213|NCT01840579|64338993|FG009|Overall Study|Follow-up ended by Sponsor|0|||
23161214|NCT02289950|64338994|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
23161215|NCT02289950|64338995|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
23161216|NCT02289950|64338994|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
23161217|NCT02289950|64338995|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
23161218|NCT02289950|64338994|FG000|Overall Study|Lost to Follow-up|1|||
23161219|NCT02289950|64338995|FG001|Overall Study|Lost to Follow-up|0|||
23161220|NCT02289950|64338994|FG000|Overall Study|Physician Decision|9|||
23161221|NCT02289950|64338995|FG001|Overall Study|Physician Decision|3|||
23161222|NCT02289950|64338994|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
23161223|NCT02289950|64338995|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
23161224|NCT02289950|64338994|FG000|Overall Study|Withdrawal by Subject|1|||
23161225|NCT02289950|64338995|FG001|Overall Study|Withdrawal by Subject|3|||
23161226|NCT02289950|64338994|FG000|Overall Study|Test article held for greater than 28 days|0|||
23161227|NCT02289950|64338995|FG001|Overall Study|Test article held for greater than 28 days|1|||
23161228|NCT02289950|64338994|FG000|Overall Study|Adverse Event|11|||
23161229|NCT02289950|64338995|FG001|Overall Study|Adverse Event|3|||
23161230|NCT02289950|64338994|FG000|Overall Study|Death|1|||
23161231|NCT02289950|64338995|FG001|Overall Study|Death|1|||
23161232|NCT02289950|64338994|FG000|Overall Study|Other|5|||
23161233|NCT02289950|64338995|FG001|Overall Study|Other|2|||
23161234|NCT02289950|64338994|FG000|Overall Study|Not Treated|2|||
23161235|NCT02289950|64338995|FG001|Overall Study|Not Treated|1|||
23161236|NCT00807742|64339009|FG000|Overall Study|Death|9|||
23161237|NCT00807742|64339010|FG001|Overall Study|Death|2|||
23161238|NCT00807742|64339009|FG000|Overall Study|Withdrawal by Subject|2|||
23161239|NCT00807742|64339010|FG001|Overall Study|Withdrawal by Subject|1|||
23161240|NCT00807742|64339009|FG000|Overall Study|Lost to Follow-up|35|||
23161241|NCT00807742|64339010|FG001|Overall Study|Lost to Follow-up|51|||
23161242|NCT03044249|64339020|FG000|Overall Study|Adverse Event|4|||
23161243|NCT03044249|64339021|FG001|Overall Study|Adverse Event|9|||
23161244|NCT03044249|64339020|FG000|Overall Study|Lost to Follow-up|1|||
23161245|NCT03044249|64339021|FG001|Overall Study|Lost to Follow-up|0|||
23161246|NCT03044249|64339020|FG000|Overall Study|Non-compliance with Study Drug|1|||
23161247|NCT03044249|64339021|FG001|Overall Study|Non-compliance with Study Drug|0|||
23161248|NCT03044249|64339020|FG000|Overall Study|Study Terminated by Sponsor|2|||
23161249|NCT03044249|64339021|FG001|Overall Study|Study Terminated by Sponsor|0|||
23161250|NCT03044249|64339020|FG000|Overall Study|Withdrawal by Subject|2|||
23161251|NCT03044249|64339021|FG001|Overall Study|Withdrawal by Subject|5|||
23161252|NCT00957528|64339023|FG000|Overall Study|Protocol Violation|0|||
23161253|NCT00957528|64339024|FG001|Overall Study|Protocol Violation|1|||
23161254|NCT00957528|64339025|FG002|Overall Study|Protocol Violation|0|||
23161255|NCT00957528|64339023|FG000|Overall Study|Withdrawal by Subject|0|||
23161256|NCT00957528|64339024|FG001|Overall Study|Withdrawal by Subject|0|||
23161257|NCT00957528|64339025|FG002|Overall Study|Withdrawal by Subject|1|||
23161258|NCT02667275|64339030|FG000|Overall Study|Protocol Violation|11|||
23161259|NCT02667275|64339031|FG001|Overall Study|Protocol Violation|7|||
23223154|NCT03922711|64560406|FG002|Overall Study|Protocol Violation|0|||
23223155|NCT03922711|64560404|FG000|Overall Study|Withdrawal by Subject|0|||
23223156|NCT03922711|64560405|FG001|Overall Study|Withdrawal by Subject|3|||
23223157|NCT03922711|64560406|FG002|Overall Study|Withdrawal by Subject|1|||
23223158|NCT03922711|64560404|FG000|Overall Study|Not further specified|0|||
23223159|NCT03922711|64560405|FG001|Overall Study|Not further specified|0|||
23223160|NCT03922711|64560406|FG002|Overall Study|Not further specified|1|||
23223161|NCT01974440|64560407|FG000|Overall Study|Lost to Follow-up|7|||
23223162|NCT01974440|64560408|FG001|Overall Study|Lost to Follow-up|7|||
23223163|NCT01974440|64560407|FG000|Overall Study|Withdrawal by Subject|24|||
23223164|NCT01974440|64560408|FG001|Overall Study|Withdrawal by Subject|20|||
23223165|NCT01974440|64560407|FG000|Overall Study|Sponsor decision|109|||
23223166|NCT01974440|64560408|FG001|Overall Study|Sponsor decision|110|||
23223167|NCT01366534|64560411|FG000|Overall Study|Lost to Follow-up|1|||
23223168|NCT01366534|64560412|FG001|Overall Study|Lost to Follow-up|0|||
23223169|NCT01366534|64560413|FG002|Overall Study|Lost to Follow-up|0|||
23223170|NCT01366534|64560411|FG000|Overall Study|Migrated|1|||
23223171|NCT01366534|64560412|FG001|Overall Study|Migrated|1|||
23223172|NCT01366534|64560413|FG002|Overall Study|Migrated|0|||
23223173|NCT01366534|64560411|FG000|Overall Study|Declined challenged|0|||
23223174|NCT01366534|64560412|FG001|Overall Study|Declined challenged|1|||
23223175|NCT01366534|64560413|FG002|Overall Study|Declined challenged|0|||
23223176|NCT04973085|64560415|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
23223177|NCT04973085|64560416|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
23223178|NCT03074318|64560418|FG000|Overall Study|Adverse Event|0|||
23223179|NCT03074318|64560419|FG001|Overall Study|Adverse Event|1|||
23223180|NCT03074318|64560420|FG002|Overall Study|Adverse Event|1|||
23223181|NCT03074318|64560421|FG003|Overall Study|Adverse Event|1|||
23223182|NCT03074318|64560418|FG000|Overall Study|Death|1|||
23223183|NCT03074318|64560419|FG001|Overall Study|Death|0|||
23223184|NCT03074318|64560420|FG002|Overall Study|Death|0|||
23223185|NCT03074318|64560421|FG003|Overall Study|Death|0|||
23223186|NCT03074318|64560418|FG000|Overall Study|Withdrawal by Subject|1|||
23223187|NCT03074318|64560419|FG001|Overall Study|Withdrawal by Subject|2|||
23223188|NCT03074318|64560420|FG002|Overall Study|Withdrawal by Subject|2|||
23223189|NCT03074318|64560421|FG003|Overall Study|Withdrawal by Subject|4|||
23223190|NCT03074318|64560418|FG000|Overall Study|Trial Closure|2|||
23223191|NCT03074318|64560419|FG001|Overall Study|Trial Closure|2|||
23223192|NCT03074318|64560420|FG002|Overall Study|Trial Closure|3|||
23223193|NCT03074318|64560421|FG003|Overall Study|Trial Closure|11|||
23223194|NCT01831804|64560425|FG000|Overall Study|Adverse Event|0|||
23223195|NCT01831804|64560426|FG001|Overall Study|Adverse Event|0|||
23223196|NCT01831804|64560427|FG002|Overall Study|Adverse Event|0|||
23223197|NCT01831804|64560428|FG003|Overall Study|Adverse Event|0|||
23223198|NCT01831804|64560429|FG004|Overall Study|Adverse Event|0|||
23223199|NCT01831804|64560430|FG005|Overall Study|Adverse Event|0|||
23223200|NCT01831804|64560431|FG006|Overall Study|Adverse Event|1|||
23223201|NCT01831804|64560432|FG007|Overall Study|Adverse Event|0|||
23223202|NCT01831804|64560433|FG008|Overall Study|Adverse Event|1|||
23223203|NCT01831804|64560425|FG000|Overall Study|Protocol Violation|0|||
23223204|NCT01831804|64560426|FG001|Overall Study|Protocol Violation|0|||
23223205|NCT01831804|64560427|FG002|Overall Study|Protocol Violation|2|||
23223206|NCT01831804|64560428|FG003|Overall Study|Protocol Violation|0|||
23223207|NCT01831804|64560429|FG004|Overall Study|Protocol Violation|0|||
23223208|NCT01831804|64560430|FG005|Overall Study|Protocol Violation|0|||
23223209|NCT01831804|64560431|FG006|Overall Study|Protocol Violation|0|||
23223210|NCT01831804|64560432|FG007|Overall Study|Protocol Violation|0|||
23223211|NCT01831804|64560433|FG008|Overall Study|Protocol Violation|0|||
23223212|NCT01831804|64560425|FG000|Overall Study|Protocol defined stopping criteria|1|||
23223213|NCT01831804|64560426|FG001|Overall Study|Protocol defined stopping criteria|1|||
23223214|NCT01831804|64560427|FG002|Overall Study|Protocol defined stopping criteria|3|||
23223215|NCT01831804|64560428|FG003|Overall Study|Protocol defined stopping criteria|0|||
23223216|NCT01831804|64560429|FG004|Overall Study|Protocol defined stopping criteria|1|||
23223217|NCT01831804|64560430|FG005|Overall Study|Protocol defined stopping criteria|0|||
23223218|NCT01831804|64560431|FG006|Overall Study|Protocol defined stopping criteria|0|||
23223219|NCT01831804|64560432|FG007|Overall Study|Protocol defined stopping criteria|0|||
23223220|NCT01831804|64560433|FG008|Overall Study|Protocol defined stopping criteria|0|||
23223221|NCT01831804|64560425|FG000|Overall Study|Lost to Follow-up|0|||
23223222|NCT01831804|64560426|FG001|Overall Study|Lost to Follow-up|0|||
23223223|NCT01831804|64560427|FG002|Overall Study|Lost to Follow-up|1|||
23223224|NCT01831804|64560428|FG003|Overall Study|Lost to Follow-up|0|||
23223225|NCT01831804|64560429|FG004|Overall Study|Lost to Follow-up|0|||
23223226|NCT01831804|64560430|FG005|Overall Study|Lost to Follow-up|0|||
23223227|NCT01831804|64560431|FG006|Overall Study|Lost to Follow-up|0|||
23223228|NCT01831804|64560432|FG007|Overall Study|Lost to Follow-up|0|||
23223229|NCT01831804|64560433|FG008|Overall Study|Lost to Follow-up|1|||
23223230|NCT01831804|64560425|FG000|Overall Study|Investigator discretion|0|||
23223231|NCT01831804|64560426|FG001|Overall Study|Investigator discretion|0|||
23223232|NCT01831804|64560427|FG002|Overall Study|Investigator discretion|0|||
23223233|NCT01831804|64560428|FG003|Overall Study|Investigator discretion|0|||
23223234|NCT01831804|64560429|FG004|Overall Study|Investigator discretion|1|||
23223235|NCT01831804|64560430|FG005|Overall Study|Investigator discretion|0|||
23223236|NCT01831804|64560431|FG006|Overall Study|Investigator discretion|0|||
23223237|NCT01831804|64560432|FG007|Overall Study|Investigator discretion|1|||
23223238|NCT01831804|64560433|FG008|Overall Study|Investigator discretion|0|||
23223239|NCT01831804|64560425|FG000|Overall Study|Withdrew Consent|0|||
23223240|NCT01831804|64560426|FG001|Overall Study|Withdrew Consent|1|||
23223241|NCT01831804|64560427|FG002|Overall Study|Withdrew Consent|0|||
23223242|NCT01831804|64560428|FG003|Overall Study|Withdrew Consent|0|||
23223243|NCT01831804|64560429|FG004|Overall Study|Withdrew Consent|0|||
23223244|NCT01831804|64560430|FG005|Overall Study|Withdrew Consent|0|||
23223245|NCT01831804|64560431|FG006|Overall Study|Withdrew Consent|0|||
23223246|NCT01831804|64560432|FG007|Overall Study|Withdrew Consent|2|||
23223247|NCT01831804|64560433|FG008|Overall Study|Withdrew Consent|0|||
23223248|NCT00486889|64560434|FG000|Overall Study|Death|3|||
23223249|NCT00486889|64560434|FG000|Overall Study|Non-compliant|2|||
23223250|NCT00486889|64560434|FG000|Overall Study|Withdrawal by Subject|6|||
23223251|NCT00899678|64560437|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
23223252|NCT00899678|64560438|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
23223253|NCT00899678|64560439|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
23223254|NCT00899678|64560437|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
23223255|NCT00899678|64560438|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
23223256|NCT00899678|64560439|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
23223257|NCT00899678|64560437|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
23223258|NCT00899678|64560438|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
23223259|NCT00899678|64560439|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
23223260|NCT00899678|64560437|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
23223261|NCT00899678|64560438|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
23223262|NCT00899678|64560439|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
23223263|NCT00899678|64560437|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
23223264|NCT00899678|64560438|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
23223265|NCT00899678|64560439|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
23223266|NCT00899678|64560437|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
23223267|NCT00899678|64560438|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
23223268|NCT00899678|64560439|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
23223269|NCT00899678|64560437|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
23223270|NCT00899678|64560438|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
23223271|NCT00899678|64560439|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
23223272|NCT00899678|64560437|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
23223273|NCT00899678|64560438|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
23223274|NCT00899678|64560439|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
23223275|NCT00899678|64560437|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
23223276|NCT00899678|64560438|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
23223277|NCT00899678|64560439|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
23223278|NCT00136357|64560440|FG000|Overall Study|Withdrawal by Subject|3|||
23223279|NCT00136357|64560441|FG001|Overall Study|Withdrawal by Subject|2|||
23223280|NCT02470429|64560442|FG000|Overall Study|Adverse Event|1|||
23223281|NCT02470429|64560443|FG001|Overall Study|Adverse Event|0|||
23223282|NCT02470429|64560442|FG000|Overall Study|Withdrawal by Subject|1|||
23223283|NCT02470429|64560443|FG001|Overall Study|Withdrawal by Subject|0|||
23223284|NCT01405027|64560444|FG000|Overall Study|Withdrawn consent|3|||
23223285|NCT01405027|64560445|FG001|Overall Study|Withdrawn consent|0|||
23223286|NCT01405027|64560444|FG000|Overall Study|Lost to Follow-up|16|||
23223287|NCT01405027|64560445|FG001|Overall Study|Lost to Follow-up|24|||
23223288|NCT01405027|64560444|FG000|Overall Study|Investigator judgement|0|||
23223289|NCT01405027|64560445|FG001|Overall Study|Investigator judgement|2|||
23223290|NCT01405027|64560444|FG000|Overall Study|Death|1|||
23223291|NCT01405027|64560445|FG001|Overall Study|Death|0|||
23223292|NCT01405027|64560444|FG000|Overall Study|Other or Unknown|12|||
23223293|NCT01405027|64560445|FG001|Overall Study|Other or Unknown|25|||
23223294|NCT05179057|64560446|FG000|Overall Study|Adverse Event|3|||
23223295|NCT05179057|64560447|FG001|Overall Study|Adverse Event|2|||
23223296|NCT05179057|64560446|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
23223297|NCT05179057|64560447|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
23223298|NCT05179057|64560446|FG000|Overall Study|Study terminated|13|||
23223299|NCT05179057|64560447|FG001|Overall Study|Study terminated|7|||
23223300|NCT05179057|64560446|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
23223301|NCT05179057|64560447|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
23223302|NCT05179057|64560446|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
23223303|NCT05179057|64560447|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
23223304|NCT01712490|64560448|FG000|Overall Study|Ongoing|601|||
23161260|NCT02667275|64339030|FG000|Overall Study|Lost to Follow-up|0|||
23161261|NCT02667275|64339031|FG001|Overall Study|Lost to Follow-up|2|||
23161262|NCT02667275|64339030|FG000|Overall Study|Withdrawal by Subject|0|||
23161263|NCT02667275|64339031|FG001|Overall Study|Withdrawal by Subject|5|||
23161264|NCT02667275|64339030|FG000|Overall Study|Discontinued early without completing|0|||
23330071|NCT03652051|64951896|FG001|Stage 1|Adverse Event|5|||
23330072|NCT03652051|64951897|FG002|Stage 1|Adverse Event|7|||
23330073|NCT03652051|64951898|FG003|Stage 1|Adverse Event|1|||
23330074|NCT03652051|64951895|FG000|Stage 1|Withdrawal by Subject|0|||
23330075|NCT03652051|64951896|FG001|Stage 1|Withdrawal by Subject|0|||
23330076|NCT03652051|64951897|FG002|Stage 1|Withdrawal by Subject|1|||
23330077|NCT03652051|64951898|FG003|Stage 1|Withdrawal by Subject|0|||
23330078|NCT03652051|64951895|FG000|Stage 2|Adverse Event|0|||
23330079|NCT03652051|64951896|FG001|Stage 2|Adverse Event|2|||
23330080|NCT03652051|64951897|FG002|Stage 2|Adverse Event|1|||
23330081|NCT03652051|64951898|FG003|Stage 2|Adverse Event|0|||
23330082|NCT03652051|64951895|FG000|Stage 2|Protocol Violation|0|||
23330083|NCT03652051|64951896|FG001|Stage 2|Protocol Violation|1|||
23330084|NCT03652051|64951897|FG002|Stage 2|Protocol Violation|6|||
23330085|NCT03652051|64951898|FG003|Stage 2|Protocol Violation|0|||
23330086|NCT03652051|64951895|FG000|Stage 2|Lost to Follow-up|0|||
23330087|NCT03652051|64951896|FG001|Stage 2|Lost to Follow-up|2|||
23330088|NCT03652051|64951897|FG002|Stage 2|Lost to Follow-up|0|||
23330089|NCT03652051|64951898|FG003|Stage 2|Lost to Follow-up|3|||
23330090|NCT03652051|64951895|FG000|Stage 2|Withdrawal by Subject|0|||
23330091|NCT03652051|64951896|FG001|Stage 2|Withdrawal by Subject|11|||
23446169|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
23446170|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
23446171|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
23446172|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
23446173|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
23446174|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
23446175|NCT00550407|65373868|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
23446176|NCT00550407|65373869|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
23446177|NCT00550407|65373870|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
23446178|NCT00550407|65373868|FG000|26-Week Randomized Phase|Adverse Event|0|||
23446179|NCT00550407|65373869|FG001|26-Week Randomized Phase|Adverse Event|5|||
23446180|NCT00550407|65373870|FG002|26-Week Randomized Phase|Adverse Event|2|||
23446181|NCT00550407|65373868|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
23446182|NCT00550407|65373869|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
23446183|NCT00550407|65373870|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
23446184|NCT00550407|65373868|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
23446185|NCT00550407|65373869|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
23446186|NCT00550407|65373870|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
23446187|NCT00550407|65373868|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
23446188|NCT00550407|65373869|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
23446189|NCT00550407|65373870|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
23161265|NCT02667275|64339031|FG001|Overall Study|Discontinued early without completing|1|||
23161266|NCT01524198|64339033|FG000|Overall Study|Protocol Violation|8|||
23161267|NCT01524198|64339034|FG001|Overall Study|Protocol Violation|6|||
23161268|NCT01524198|64339033|FG000|Overall Study|Withdrawal by Subject|15|||
23446190|NCT04137731|65373871|FG000|Overall Study|Surgery Cancellation|1|||
23446191|NCT04137731|65373872|FG001|Overall Study|Surgery Cancellation|2|||
23446192|NCT04137731|65373871|FG000|Overall Study|Withdrawal by Subject|2|||
23446193|NCT04137731|65373872|FG001|Overall Study|Withdrawal by Subject|0|||
23446194|NCT04137731|65373871|FG000|Overall Study|Protocol Violation|0|||
23446195|NCT04137731|65373872|FG001|Overall Study|Protocol Violation|1|||
23446196|NCT00398567|65373879|FG000|Overall Study|Disease Progression|3|||
23446197|NCT00398567|65373880|FG001|Overall Study|Disease Progression|4|||
23446198|NCT00398567|65373881|FG002|Overall Study|Disease Progression|27|||
23446199|NCT00398567|65373879|FG000|Overall Study|Withdrawal by Subject|1|||
23446200|NCT00398567|65373880|FG001|Overall Study|Withdrawal by Subject|0|||
23446201|NCT00398567|65373881|FG002|Overall Study|Withdrawal by Subject|4|||
23446202|NCT00398567|65373879|FG000|Overall Study|Adverse Event|0|||
23446203|NCT00398567|65373880|FG001|Overall Study|Adverse Event|0|||
23161269|NCT01524198|64339034|FG001|Overall Study|Withdrawal by Subject|10|||
23161270|NCT00950664|64339035|FG000|First Intervention|Lost to Follow-up|1|||
23161271|NCT00950664|64339036|FG001|First Intervention|Lost to Follow-up|3|||
23330092|NCT03652051|64951897|FG002|Stage 2|Withdrawal by Subject|9|||
23330093|NCT03652051|64951898|FG003|Stage 2|Withdrawal by Subject|3|||
23330094|NCT03270657|64951899|FG000|Overall Study|Withdrawal by Subject|1|||
23330095|NCT00554515|64951900|FG000|Overall Study|Withdrawal by Subject|3|||
23446204|NCT00398567|65373881|FG002|Overall Study|Adverse Event|2|||
23446205|NCT00398567|65373879|FG000|Overall Study|Protocol Violation|0|||
23446206|NCT00398567|65373880|FG001|Overall Study|Protocol Violation|0|||
23446207|NCT00398567|65373881|FG002|Overall Study|Protocol Violation|1|||
23330096|NCT00554515|64951900|FG000|Overall Study|Disease progression|52|||
23161272|NCT00950664|64339035|FG000|First Intervention|Withdrawal by Subject|2|||
23161273|NCT00950664|64339036|FG001|First Intervention|Withdrawal by Subject|2|||
23161274|NCT03803059|64339039|FG000|Overall Study|Protocol Violation|2|||
23161275|NCT03803059|64339039|FG000|Overall Study|Lost to Follow-up|1|||
23161276|NCT02184195|64339040|FG000|Overall Study|Patient decision|5|||
23161277|NCT02184195|64339041|FG001|Overall Study|Patient decision|2|||
23161278|NCT02184195|64339040|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23161279|NCT02184195|64339041|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23161280|NCT02184195|64339040|FG000|Overall Study|Death|67|||
23161281|NCT02184195|64339041|FG001|Overall Study|Death|44|||
23446208|NCT01016600|65373886|FG000|Overall Study|Did not start treatment|1|||
23446209|NCT01016600|65373887|FG001|Overall Study|Did not start treatment|0|||
23161282|NCT02184195|64339040|FG000|Overall Study|Lost to Follow-up|1|||
23161283|NCT02184195|64339041|FG001|Overall Study|Lost to Follow-up|5|||
23161284|NCT02184195|64339040|FG000|Overall Study|Other|0|||
23161285|NCT02184195|64339041|FG001|Overall Study|Other|3|||
23161286|NCT01251653|64339042|FG000|Overall Study|Progressive Disease|1|||
23161287|NCT01251653|64339043|FG001|Overall Study|Progressive Disease|7|||
23161288|NCT01251653|64339044|FG002|Overall Study|Progressive Disease|16|||
23161289|NCT01251653|64339045|FG003|Overall Study|Progressive Disease|4|||
23161290|NCT01251653|64339046|FG004|Overall Study|Progressive Disease|0|||
23161291|NCT01251653|64339047|FG005|Overall Study|Progressive Disease|17|||
23161292|NCT01251653|64339048|FG006|Overall Study|Progressive Disease|14|||
23161293|NCT01251653|64339049|FG007|Overall Study|Progressive Disease|7|||
23161294|NCT01251653|64339050|FG008|Overall Study|Progressive Disease|5|||
23161295|NCT01251653|64339042|FG000|Overall Study|Dose-limiting toxicity|0|||
23161296|NCT01251653|64339043|FG001|Overall Study|Dose-limiting toxicity|1|||
23161297|NCT01251653|64339044|FG002|Overall Study|Dose-limiting toxicity|1|||
23161298|NCT01251653|64339045|FG003|Overall Study|Dose-limiting toxicity|1|||
23161299|NCT01251653|64339046|FG004|Overall Study|Dose-limiting toxicity|0|||
23161300|NCT01251653|64339047|FG005|Overall Study|Dose-limiting toxicity|0|||
23161301|NCT01251653|64339048|FG006|Overall Study|Dose-limiting toxicity|2|||
23330097|NCT00554515|64951900|FG000|Overall Study|Physician Decision|18|||
23330098|NCT00554515|64951900|FG000|Overall Study|Withdrawal by Subject|11|||
23330099|NCT00554515|64951900|FG000|Overall Study|Adverse Event|9|||
23330100|NCT00554515|64951900|FG000|Overall Study|Death|2|||
23330101|NCT00554515|64951900|FG000|Overall Study|Achieved Stable Disease|7|||
23330102|NCT00554515|64951900|FG000|Overall Study|Other|1|||
23330103|NCT00554515|64951900|FG000|Overall Study|Misc|15|||
23330104|NCT01067105|64951903|FG000|Overall Study|Adverse Event|14|||
23330105|NCT01067105|64951903|FG000|Overall Study|Protocol Violation|48|||
23330106|NCT01067105|64951903|FG000|Overall Study|Withdrawal by Subject|36|||
23330107|NCT01067105|64951903|FG000|Overall Study|Lost to Follow-up|6|||
23330108|NCT01067105|64951903|FG000|Overall Study|Physician Decision|6|||
23330109|NCT01067105|64951903|FG000|Overall Study|Other|31|||
23330110|NCT03493854|64951904|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
23330111|NCT03493854|64951905|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
23330112|NCT03493854|64951904|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
23330113|NCT03493854|64951905|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
23330114|NCT03493854|64951904|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
23330115|NCT03493854|64951905|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
23446210|NCT01016600|65373888|FG002|Overall Study|Did not start treatment|0|||
23446211|NCT01016600|65373889|FG003|Overall Study|Did not start treatment|0|||
23446212|NCT01219985|65373895|FG000|Overall Study|Physician Decision|20|||
23446213|NCT03826186|65373896|FG000|Overall Study|Protocol Violation|2|||
23446214|NCT03826186|65373897|FG001|Overall Study|Protocol Violation|0|||
23161302|NCT01251653|64339049|FG007|Overall Study|Dose-limiting toxicity|0|||
23161303|NCT01251653|64339050|FG008|Overall Study|Dose-limiting toxicity|0|||
23161304|NCT01251653|64339042|FG000|Overall Study|Adverse Event|1|||
23330116|NCT03493854|64951904|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
23446215|NCT03826186|65373896|FG000|Overall Study|Withdrawal by Subject|1|||
23161305|NCT01251653|64339043|FG001|Overall Study|Adverse Event|0|||
23161306|NCT01251653|64339044|FG002|Overall Study|Adverse Event|2|||
23161307|NCT01251653|64339045|FG003|Overall Study|Adverse Event|1|||
23161308|NCT01251653|64339046|FG004|Overall Study|Adverse Event|1|||
23446216|NCT03826186|65373897|FG001|Overall Study|Withdrawal by Subject|0|||
23446217|NCT03250182|65373898|FG000|Overall Study|Withdrawal by Subject|1|||
23446218|NCT00239928|65373902|FG000|Overall Study|Lack of Efficacy|1|||
23446219|NCT00239928|65373902|FG000|Overall Study|Adverse Event|4|||
23446220|NCT00239928|65373902|FG000|Overall Study|Not need to continue study|3|||
23446221|NCT00239928|65373902|FG000|Overall Study|Withdrawal by Subject|2|||
23568455|NCT02875834|65809840|FG003|Open-label Phase|Withdrawal by Subject|0|||
23330117|NCT03493854|64951905|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
23330118|NCT03493854|64951904|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
23330119|NCT03493854|64951905|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
23330120|NCT03493854|64951904|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
23330121|NCT03493854|64951905|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
23330122|NCT03493854|64951904|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
23330123|NCT03493854|64951905|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
23330124|NCT03493854|64951904|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
23330125|NCT03493854|64951905|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
23330126|NCT03493854|64951904|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
23330127|NCT03493854|64951905|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
23330128|NCT03493854|64951904|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
23330129|NCT03493854|64951905|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
23330130|NCT03493854|64951904|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
23330131|NCT03493854|64951905|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
23330132|NCT03493854|64951904|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
23568456|NCT02875834|65809837|FG000|Open-label Phase|(Not collected)|4|||
23568457|NCT02875834|65809838|FG001|Open-label Phase|(Not collected)|0|||
23568458|NCT02875834|65809839|FG002|Open-label Phase|(Not collected)|0|||
23568459|NCT02875834|65809840|FG003|Open-label Phase|(Not collected)|0|||
23161309|NCT01251653|64339047|FG005|Overall Study|Adverse Event|0|||
23161310|NCT01251653|64339048|FG006|Overall Study|Adverse Event|2|||
23161311|NCT01251653|64339049|FG007|Overall Study|Adverse Event|2|||
23161312|NCT01251653|64339050|FG008|Overall Study|Adverse Event|1|||
23161313|NCT01251653|64339042|FG000|Overall Study|Withdrawal by Subject|1|||
23161314|NCT01251653|64339043|FG001|Overall Study|Withdrawal by Subject|0|||
23161315|NCT01251653|64339044|FG002|Overall Study|Withdrawal by Subject|1|||
23161316|NCT01251653|64339045|FG003|Overall Study|Withdrawal by Subject|0|||
23161317|NCT01251653|64339046|FG004|Overall Study|Withdrawal by Subject|1|||
23161318|NCT01251653|64339047|FG005|Overall Study|Withdrawal by Subject|1|||
23161319|NCT01251653|64339048|FG006|Overall Study|Withdrawal by Subject|0|||
23161320|NCT01251653|64339049|FG007|Overall Study|Withdrawal by Subject|1|||
23161321|NCT01251653|64339050|FG008|Overall Study|Withdrawal by Subject|0|||
23161322|NCT01251653|64339042|FG000|Overall Study|Other reason not mentioned above|0|||
23161323|NCT01251653|64339043|FG001|Overall Study|Other reason not mentioned above|0|||
23161324|NCT01251653|64339044|FG002|Overall Study|Other reason not mentioned above|0|||
23161325|NCT01251653|64339045|FG003|Overall Study|Other reason not mentioned above|0|||
23330133|NCT03493854|64951905|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
23330134|NCT03493854|64951904|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
23568460|NCT02875834|65809837|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
23161326|NCT01251653|64339046|FG004|Overall Study|Other reason not mentioned above|0|||
23446222|NCT02294058|65373903|FG000|Overall Study|Adverse Event|16|||
23568461|NCT02875834|65809838|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
23568462|NCT02875834|65809839|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
23568463|NCT02875834|65809840|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
23568464|NCT02875834|65809837|FG000|Randomized Treatment Phase|Protocol Violation|0|||
23568465|NCT02875834|65809838|FG001|Randomized Treatment Phase|Protocol Violation|2|||
23568466|NCT02875834|65809839|FG002|Randomized Treatment Phase|Protocol Violation|0|||
23161327|NCT01251653|64339047|FG005|Overall Study|Other reason not mentioned above|0|||
23161328|NCT01251653|64339048|FG006|Overall Study|Other reason not mentioned above|0|||
23161329|NCT01251653|64339049|FG007|Overall Study|Other reason not mentioned above|2|||
23330135|NCT03493854|64951905|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
23330136|NCT03493854|64951904|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
23330137|NCT03493854|64951905|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
23330138|NCT03493854|64951904|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
23330139|NCT03493854|64951905|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
23330140|NCT03493854|64951904|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
23330141|NCT03493854|64951905|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
23330142|NCT03493854|64951904|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
23330143|NCT03493854|64951905|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
23330144|NCT03493854|64951904|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
23330145|NCT03493854|64951905|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
23330146|NCT00734994|64951906|FG000|Overall Study|Withdrawal by Subject|1|||
23330147|NCT00420420|64951913|FG000|Overall Study|Adverse Event|5|||
23330148|NCT00420420|64951914|FG001|Overall Study|Adverse Event|3|||
23330149|NCT00420420|64951913|FG000|Overall Study|Protocol Violation|1|||
23330150|NCT00420420|64951914|FG001|Overall Study|Protocol Violation|1|||
23330151|NCT00420420|64951913|FG000|Overall Study|Withdrawal by Subject|1|||
23330152|NCT00420420|64951914|FG001|Overall Study|Withdrawal by Subject|0|||
23330153|NCT00420420|64951913|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
23330154|NCT00420420|64951914|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
23330155|NCT02476578|64951915|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
23330156|NCT02476578|64951916|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
23330157|NCT02476578|64951915|FG000|Overall Study|Lost to Follow-up|6|||
23446223|NCT02294058|65373904|FG001|Overall Study|Adverse Event|7|||
23446224|NCT02294058|65373905|FG002|Overall Study|Adverse Event|13|||
23446225|NCT02294058|65373903|FG000|Overall Study|Lack of Efficacy|3|||
23446226|NCT02294058|65373904|FG001|Overall Study|Lack of Efficacy|3|||
23446227|NCT02294058|65373905|FG002|Overall Study|Lack of Efficacy|0|||
23446228|NCT02294058|65373903|FG000|Overall Study|Lost to Follow-up|1|||
23446229|NCT02294058|65373904|FG001|Overall Study|Lost to Follow-up|0|||
23446230|NCT02294058|65373905|FG002|Overall Study|Lost to Follow-up|2|||
23446231|NCT02294058|65373903|FG000|Overall Study|Withdrawal by Subject|10|||
23446232|NCT02294058|65373904|FG001|Overall Study|Withdrawal by Subject|14|||
23446233|NCT02294058|65373905|FG002|Overall Study|Withdrawal by Subject|13|||
23446234|NCT02294058|65373903|FG000|Overall Study|Physician Decision|2|||
23446235|NCT02294058|65373904|FG001|Overall Study|Physician Decision|1|||
23446236|NCT02294058|65373905|FG002|Overall Study|Physician Decision|0|||
23446237|NCT02294058|65373903|FG000|Overall Study|Miscellaneous|4|||
23446238|NCT02294058|65373904|FG001|Overall Study|Miscellaneous|1|||
23446239|NCT02294058|65373905|FG002|Overall Study|Miscellaneous|1|||
23446240|NCT02596230|65373906|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
23446241|NCT02596230|65373907|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
23446242|NCT02596230|65373908|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
23446243|NCT02596230|65373909|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
23446244|NCT02596230|65373910|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
23446245|NCT02596230|65373906|FG000|Objective 2, One Year|Lost to Follow-up|0|||
23446246|NCT02596230|65373907|FG001|Objective 2, One Year|Lost to Follow-up|41|||
23446247|NCT02596230|65373908|FG002|Objective 2, One Year|Lost to Follow-up|41|||
23446248|NCT02596230|65373909|FG003|Objective 2, One Year|Lost to Follow-up|32|||
23446249|NCT02596230|65373910|FG004|Objective 2, One Year|Lost to Follow-up|46|||
23446250|NCT02596230|65373906|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
23446251|NCT02596230|65373907|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
23446252|NCT02596230|65373908|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
23446253|NCT02596230|65373909|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
23446254|NCT02596230|65373910|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
23446255|NCT02596230|65373906|FG000|Objective 2, One Year|Adverse drug reaction|0|||
23446256|NCT02596230|65373907|FG001|Objective 2, One Year|Adverse drug reaction|1|||
23446257|NCT02596230|65373908|FG002|Objective 2, One Year|Adverse drug reaction|0|||
23446258|NCT02596230|65373909|FG003|Objective 2, One Year|Adverse drug reaction|0|||
23446259|NCT02596230|65373910|FG004|Objective 2, One Year|Adverse drug reaction|0|||
23446260|NCT02596230|65373906|FG000|Objective 2, One Year|Death|0|||
23446261|NCT02596230|65373907|FG001|Objective 2, One Year|Death|12|||
23446262|NCT02596230|65373908|FG002|Objective 2, One Year|Death|41|||
23161330|NCT01251653|64339050|FG008|Overall Study|Other reason not mentioned above|0|||
23161331|NCT00562354|64339051|FG000|Overall Study|Physician Decision|0|||
23161332|NCT00562354|64339052|FG001|Overall Study|Physician Decision|1|||
23161333|NCT00562354|64339051|FG000|Overall Study|Lost to Follow-up|0|||
23161334|NCT00562354|64339052|FG001|Overall Study|Lost to Follow-up|1|||
23161335|NCT02164929|64339053|FG000|Overall Study|Converted to open procedure|1|||
23161336|NCT02164929|64339054|FG001|Overall Study|Converted to open procedure|0|||
23161337|NCT02164929|64339055|FG002|Overall Study|Converted to open procedure|0|||
23330158|NCT02476578|64951916|FG001|Overall Study|Lost to Follow-up|13|||
23446263|NCT02596230|65373909|FG003|Objective 2, One Year|Death|21|||
23446264|NCT02596230|65373910|FG004|Objective 2, One Year|Death|30|||
23446265|NCT02596230|65373906|FG000|Objective 2, One Year|Other|0|||
23446266|NCT02596230|65373907|FG001|Objective 2, One Year|Other|3|||
23446267|NCT02596230|65373908|FG002|Objective 2, One Year|Other|2|||
23446268|NCT02596230|65373909|FG003|Objective 2, One Year|Other|0|||
23446269|NCT02596230|65373910|FG004|Objective 2, One Year|Other|0|||
23446270|NCT03361293|65373913|FG000|Overall Study|Lost to Follow-up|0|||
23446271|NCT03361293|65373914|FG001|Overall Study|Lost to Follow-up|2|||
23446272|NCT03361293|65373913|FG000|Overall Study|Withdrawal by Subject|1|||
23446273|NCT03361293|65373914|FG001|Overall Study|Withdrawal by Subject|3|||
23446274|NCT00837213|65373917|FG000|Overall Study|Lost to Follow-up|3|||
23446275|NCT00837213|65373918|FG001|Overall Study|Lost to Follow-up|2|||
23446276|NCT00837213|65373917|FG000|Overall Study|Withdrawal by Subject|2|||
23446277|NCT00837213|65373918|FG001|Overall Study|Withdrawal by Subject|2|||
23446278|NCT00837213|65373917|FG000|Overall Study|not stated|1|||
23446279|NCT00837213|65373918|FG001|Overall Study|not stated|1|||
23446280|NCT04538417|65373920|FG000|Overall Study|Withdrawal by Subject|2|||
23446281|NCT03948334|65373930|FG000|Overall Study|Adverse Event|1|||
23446282|NCT03948334|65373931|FG001|Overall Study|Adverse Event|4|||
23446283|NCT03948334|65373930|FG000|Overall Study|Lack of Efficacy|2|||
23446284|NCT03948334|65373931|FG001|Overall Study|Lack of Efficacy|0|||
23446285|NCT03948334|65373930|FG000|Overall Study|Lost to Follow-up|1|||
23446286|NCT03948334|65373931|FG001|Overall Study|Lost to Follow-up|0|||
23446287|NCT03948334|65373930|FG000|Overall Study|Physician Decision|1|||
23446288|NCT03948334|65373931|FG001|Overall Study|Physician Decision|0|||
23446289|NCT03948334|65373930|FG000|Overall Study|Pregnancy|0|||
23446290|NCT03948334|65373931|FG001|Overall Study|Pregnancy|1|||
23446291|NCT03948334|65373930|FG000|Overall Study|Protocol Deviation|1|||
23446292|NCT03948334|65373931|FG001|Overall Study|Protocol Deviation|0|||
23446293|NCT03948334|65373930|FG000|Overall Study|Study terminated by Sponsor|50|||
23446294|NCT03948334|65373931|FG001|Overall Study|Study terminated by Sponsor|51|||
23446295|NCT03948334|65373930|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
23446296|NCT03948334|65373931|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
23446297|NCT01292187|65373932|FG000|Overall Study|Adverse Event|10|||
23446298|NCT01292187|65373933|FG001|Overall Study|Adverse Event|5|||
23446299|NCT01292187|65373932|FG000|Overall Study|Withdrawal by Subject|6|||
23446300|NCT01292187|65373933|FG001|Overall Study|Withdrawal by Subject|5|||
23446301|NCT01292187|65373932|FG000|Overall Study|All other reasons|1|||
23446302|NCT01292187|65373933|FG001|Overall Study|All other reasons|3|||
23446303|NCT04566601|65373936|FG000|Overall Study|Other than listed|13|||
23446304|NCT04566601|65373937|FG001|Overall Study|Other than listed|4|||
23446305|NCT04566601|65373938|FG002|Overall Study|Other than listed|2|||
23568467|NCT02875834|65809840|FG003|Randomized Treatment Phase|Protocol Violation|0|||
23568468|NCT02875834|65809837|FG000|Randomized Treatment Phase|(Not collected)|0|||
23330159|NCT02059135|64951921|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
23330160|NCT02059135|64951922|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
23330161|NCT02059135|64951921|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
23330162|NCT02059135|64951922|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
23330163|NCT02059135|64951921|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
23330164|NCT02059135|64951922|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
23330165|NCT02059135|64951921|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
23330166|NCT02059135|64951922|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
23330167|NCT02059135|64951921|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
23330168|NCT02059135|64951922|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
23446306|NCT04566601|65373939|FG003|Overall Study|Other than listed|1|||
23446307|NCT04566601|65373940|FG004|Overall Study|Other than listed|4|||
23446308|NCT04566601|65373936|FG000|Overall Study|Protocol deviation|3|||
23161338|NCT02164929|64339056|FG003|Overall Study|Converted to open procedure|2|||
23161339|NCT02164929|64339053|FG000|Overall Study|Failed regional block|0|||
23161340|NCT02164929|64339054|FG001|Overall Study|Failed regional block|0|||
23446309|NCT04566601|65373937|FG001|Overall Study|Protocol deviation|0|||
23446310|NCT04566601|65373938|FG002|Overall Study|Protocol deviation|1|||
23446311|NCT04566601|65373939|FG003|Overall Study|Protocol deviation|1|||
23446312|NCT04566601|65373940|FG004|Overall Study|Protocol deviation|1|||
23446313|NCT04566601|65373936|FG000|Overall Study|Technical problems|0|||
23446314|NCT04566601|65373937|FG001|Overall Study|Technical problems|0|||
23446315|NCT04566601|65373938|FG002|Overall Study|Technical problems|1|||
23568469|NCT02875834|65809838|FG001|Randomized Treatment Phase|(Not collected)|9|||
23446316|NCT04566601|65373939|FG003|Overall Study|Technical problems|0|||
23446317|NCT04566601|65373940|FG004|Overall Study|Technical problems|0|||
23446318|NCT04566601|65373936|FG000|Overall Study|No reason available|3|||
23446319|NCT04566601|65373937|FG001|Overall Study|No reason available|2|||
23446320|NCT04566601|65373938|FG002|Overall Study|No reason available|7|||
23446321|NCT04566601|65373939|FG003|Overall Study|No reason available|1|||
23446322|NCT04566601|65373940|FG004|Overall Study|No reason available|5|||
23446323|NCT04566601|65373936|FG000|Overall Study|Burden of study procedures|3|||
23446324|NCT04566601|65373937|FG001|Overall Study|Burden of study procedures|0|||
23446325|NCT04566601|65373938|FG002|Overall Study|Burden of study procedures|0|||
23446326|NCT04566601|65373939|FG003|Overall Study|Burden of study procedures|3|||
23446327|NCT04566601|65373940|FG004|Overall Study|Burden of study procedures|1|||
23446328|NCT04566601|65373936|FG000|Overall Study|Change of residence|2|||
23446329|NCT04566601|65373937|FG001|Overall Study|Change of residence|2|||
23446330|NCT04566601|65373938|FG002|Overall Study|Change of residence|0|||
23446331|NCT04566601|65373939|FG003|Overall Study|Change of residence|1|||
23446332|NCT04566601|65373940|FG004|Overall Study|Change of residence|2|||
23446333|NCT04566601|65373936|FG000|Overall Study|Perceived lack of efficacy|2|||
23446334|NCT04566601|65373937|FG001|Overall Study|Perceived lack of efficacy|0|||
23446335|NCT04566601|65373938|FG002|Overall Study|Perceived lack of efficacy|1|||
23446336|NCT04566601|65373939|FG003|Overall Study|Perceived lack of efficacy|1|||
23446337|NCT04566601|65373940|FG004|Overall Study|Perceived lack of efficacy|2|||
23446338|NCT04566601|65373936|FG000|Overall Study|Adverse Event|7|||
23446339|NCT04566601|65373937|FG001|Overall Study|Adverse Event|4|||
23446340|NCT04566601|65373938|FG002|Overall Study|Adverse Event|6|||
23446341|NCT04566601|65373939|FG003|Overall Study|Adverse Event|5|||
23446342|NCT04566601|65373940|FG004|Overall Study|Adverse Event|12|||
23446343|NCT01217463|65373941|FG000|Overall Study|Adverse Event|8|||
23446344|NCT01217463|65373942|FG001|Overall Study|Adverse Event|5|||
23446345|NCT01217463|65373941|FG000|Overall Study|Physician Decision|0|||
23446346|NCT01217463|65373942|FG001|Overall Study|Physician Decision|1|||
23446347|NCT01217463|65373941|FG000|Overall Study|Withdrawal by Subject|3|||
23446348|NCT01217463|65373942|FG001|Overall Study|Withdrawal by Subject|0|||
23446349|NCT01217463|65373941|FG000|Overall Study|Surgery on the Target Limb|0|||
23446350|NCT01217463|65373942|FG001|Overall Study|Surgery on the Target Limb|1|||
23446351|NCT01217463|65373941|FG000|Overall Study|Patient Non-compliant|1|||
23446352|NCT01217463|65373942|FG001|Overall Study|Patient Non-compliant|0|||
23446353|NCT01217463|65373941|FG000|Overall Study|Other|1|||
23446354|NCT01217463|65373942|FG001|Overall Study|Other|1|||
23446355|NCT00824473|65373953|FG000|Overall Study|Adverse Event|4|||
23446356|NCT00824473|65373954|FG001|Overall Study|Adverse Event|5|||
23446357|NCT00824473|65373953|FG000|Overall Study|Lack of Efficacy|2|||
23446358|NCT00824473|65373954|FG001|Overall Study|Lack of Efficacy|2|||
23446359|NCT00824473|65373953|FG000|Overall Study|Protocol Violation|2|||
23446360|NCT00824473|65373954|FG001|Overall Study|Protocol Violation|0|||
23446361|NCT00824473|65373953|FG000|Overall Study|Non-Compliance|4|||
23446362|NCT00824473|65373954|FG001|Overall Study|Non-Compliance|2|||
23446363|NCT00824473|65373953|FG000|Overall Study|Withdrawal by Subject|2|||
23446364|NCT00824473|65373954|FG001|Overall Study|Withdrawal by Subject|3|||
23446365|NCT00824473|65373953|FG000|Overall Study|Other|1|||
23446366|NCT00824473|65373954|FG001|Overall Study|Other|1|||
23446367|NCT02003534|65373955|FG000|Overall Study|Lost to Follow-up|47|||
23446368|NCT01031979|65373956|FG000|Overall Study|Lost to Follow-up|5|||
23446369|NCT01031979|65373957|FG001|Overall Study|Lost to Follow-up|4|||
23446370|NCT04079816|65373960|FG000|Overall Study|Request of Subject|2|||
23446371|NCT04079816|65373960|FG000|Overall Study|Unable to draw samples|1|||
23223305|NCT01712490|64560449|FG001|Overall Study|Ongoing|586|||
23223306|NCT01712490|64560448|FG000|Overall Study|Other|11|||
23223307|NCT01712490|64560449|FG001|Overall Study|Other|11|||
23223308|NCT01712490|64560448|FG000|Overall Study|Withdrawal by Subject|36|||
23223309|NCT01712490|64560449|FG001|Overall Study|Withdrawal by Subject|44|||
23446372|NCT03259087|65377615|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
23446373|NCT03259087|65377616|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
23446374|NCT03259087|65377617|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
23446375|NCT03259087|65377618|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
23446376|NCT03259087|65377619|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
23446377|NCT03259087|65377615|FG000|Period 2 of Part 2|Adverse Event|0|||
23223310|NCT01712490|64560448|FG000|Overall Study|Lost to Follow-up|16|||
23446378|NCT03259087|65377616|FG001|Period 2 of Part 2|Adverse Event|0|||
23446379|NCT03259087|65377617|FG002|Period 2 of Part 2|Adverse Event|0|||
23446380|NCT03259087|65377618|FG003|Period 2 of Part 2|Adverse Event|0|||
23446381|NCT03259087|65377619|FG004|Period 2 of Part 2|Adverse Event|1|||
23446382|NCT02678351|65377628|FG000|Overall Study|Withdrawal by Subject|1|||
23446383|NCT00191334|65377633|FG000|Overall Study|Adverse Event|4|||
23223311|NCT01712490|64560449|FG001|Overall Study|Lost to Follow-up|29|||
23446384|NCT00191334|65377633|FG000|Overall Study|Disease Progression or Relapse|8|||
23446385|NCT00191334|65377633|FG000|Overall Study|Physician Decision|1|||
23446386|NCT00191334|65377633|FG000|Overall Study|Withdrawal by Subject|4|||
23446387|NCT02330055|65377634|FG000|Overall Study|technical issues|2|||
23446388|NCT02330055|65377635|FG001|Overall Study|technical issues|0|||
23446389|NCT02330055|65377634|FG000|Overall Study|participant forgot to wear device|5|||
23446390|NCT02330055|65377635|FG001|Overall Study|participant forgot to wear device|5|||
23446391|NCT02330055|65377634|FG000|Overall Study|data for less than 60 minutes|3|||
23446392|NCT02330055|65377635|FG001|Overall Study|data for less than 60 minutes|3|||
23446393|NCT02330055|65377634|FG000|Overall Study|participant did not sleep|0|||
23446394|NCT02330055|65377635|FG001|Overall Study|participant did not sleep|1|||
23446395|NCT00191308|65377636|FG000|Overall Study|Adverse Event|1|||
23446396|NCT01691794|65377638|FG000|Overall Study|Poor/Non-Compliance|1|||
23446397|NCT01691794|65377639|FG001|Overall Study|Poor/Non-Compliance|4|||
23446398|NCT01691794|65377640|FG002|Overall Study|Poor/Non-Compliance|1|||
23446399|NCT01691794|65377638|FG000|Overall Study|Death|0|||
23446400|NCT01691794|65377639|FG001|Overall Study|Death|0|||
23446401|NCT01691794|65377640|FG002|Overall Study|Death|1|||
23446402|NCT01691794|65377638|FG000|Overall Study|Lack of Efficacy|0|||
23446403|NCT01691794|65377639|FG001|Overall Study|Lack of Efficacy|7|||
23446404|NCT01691794|65377640|FG002|Overall Study|Lack of Efficacy|1|||
23446405|NCT01691794|65377638|FG000|Overall Study|Participant request to discontinue|0|||
23446406|NCT01691794|65377639|FG001|Overall Study|Participant request to discontinue|1|||
23446407|NCT01691794|65377640|FG002|Overall Study|Participant request to discontinue|0|||
23446408|NCT01691794|65377638|FG000|Overall Study|Adverse Event|0|||
23446409|NCT01691794|65377639|FG001|Overall Study|Adverse Event|1|||
23446410|NCT01691794|65377640|FG002|Overall Study|Adverse Event|1|||
23446411|NCT01691794|65377638|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
23446412|NCT01691794|65377639|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
23568470|NCT02875834|65809839|FG002|Randomized Treatment Phase|(Not collected)|10|||
23568471|NCT02875834|65809840|FG003|Randomized Treatment Phase|(Not collected)|9|||
23446413|NCT01691794|65377640|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
23568472|NCT01992549|65809841|FG000|Overall Study|Lost to Follow-up|2|||
23568473|NCT01992549|65809841|FG000|Overall Study|Serious Adverse Event|1|||
23568474|NCT01992549|65809841|FG000|Overall Study|Product Switch to Extend Half Life|1|||
23568475|NCT01083641|65809847|FG000|Overall Study|Withdrawal by Subject|2|||
23568476|NCT04192630|65809851|FG000|Overall Study|Discontinued before surgery|2|||
23568477|NCT04192630|65809852|FG001|Overall Study|Discontinued before surgery|0|||
23568478|NCT04192630|65809851|FG000|Overall Study|Discontinued after surgery|5|||
23568479|NCT04192630|65809852|FG001|Overall Study|Discontinued after surgery|3|||
23568480|NCT02262260|65809854|FG000|Overall Study|Adverse Event|4|||
23568481|NCT02262260|65809855|FG001|Overall Study|Adverse Event|1|||
23568482|NCT02262260|65809854|FG000|Overall Study|Withdrawal of consent|4|||
23568483|NCT02262260|65809855|FG001|Overall Study|Withdrawal of consent|2|||
23568484|NCT02262260|65809854|FG000|Overall Study|Lost to Follow-up|1|||
23568485|NCT02262260|65809855|FG001|Overall Study|Lost to Follow-up|2|||
23568486|NCT02262260|65809854|FG000|Overall Study|Protocol deviation|2|||
23568487|NCT02262260|65809855|FG001|Overall Study|Protocol deviation|5|||
23568488|NCT01130883|65809858|FG000|Overall Study|Patient Noncompliance|6|||
23568489|NCT01130883|65809858|FG000|Overall Study|Reason Unknown|1|||
23568490|NCT01130883|65809858|FG000|Overall Study|Adverse Event|3|||
23568491|NCT03029247|65809859|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
23568492|NCT03029247|65809860|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
23568493|NCT03029247|65809859|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
23568494|NCT03029247|65809860|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
23568495|NCT03029247|65809859|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
23568496|NCT03029247|65809860|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
23568497|NCT03029247|65809859|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
23568498|NCT03029247|65809860|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
23568499|NCT01863043|65809862|FG000|Overall Study|Death|6|||
23568500|NCT01863043|65809863|FG001|Overall Study|Death|1|||
23568501|NCT01863043|65809862|FG000|Overall Study|Withdrawal by Subject|0|||
23446414|NCT01691794|65377638|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
23446415|NCT01691794|65377639|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
23446416|NCT01691794|65377640|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
23446417|NCT03980730|65377641|FG000|Overall Study|Study Terminated by Sponsor|0|||
23446418|NCT03980730|65377642|FG001|Overall Study|Study Terminated by Sponsor|3|||
23446419|NCT03980730|65377641|FG000|Overall Study|Adverse Event|2|||
23446420|NCT03980730|65377642|FG001|Overall Study|Adverse Event|0|||
23446421|NCT03980730|65377641|FG000|Overall Study|Sponsor Request|0|||
23446422|NCT03980730|65377642|FG001|Overall Study|Sponsor Request|1|||
23446423|NCT03040674|65377646|FG000|Overall Study|Lost to Follow-up|225|||
23446424|NCT03040674|65377646|FG000|Overall Study|Death|23|||
23446425|NCT02741245|65377647|FG000|Overall Study|Adverse Event|0|||
23446426|NCT02741245|65377648|FG001|Overall Study|Adverse Event|0|||
23446427|NCT02741245|65377649|FG002|Overall Study|Adverse Event|0|||
23446428|NCT02741245|65377650|FG003|Overall Study|Adverse Event|2|||
23446429|NCT02741245|65377651|FG004|Overall Study|Adverse Event|2|||
23446430|NCT02741245|65377647|FG000|Overall Study|Protocol Violation|0|||
23446431|NCT02741245|65377648|FG001|Overall Study|Protocol Violation|1|||
23446432|NCT02741245|65377649|FG002|Overall Study|Protocol Violation|0|||
23446433|NCT02741245|65377650|FG003|Overall Study|Protocol Violation|1|||
23446434|NCT02741245|65377651|FG004|Overall Study|Protocol Violation|0|||
23446435|NCT02741245|65377647|FG000|Overall Study|Withdrawal by Subject|0|||
23446436|NCT02741245|65377648|FG001|Overall Study|Withdrawal by Subject|0|||
23446437|NCT02741245|65377649|FG002|Overall Study|Withdrawal by Subject|0|||
23446438|NCT02741245|65377650|FG003|Overall Study|Withdrawal by Subject|1|||
23446439|NCT02741245|65377651|FG004|Overall Study|Withdrawal by Subject|0|||
23446440|NCT02611479|65377652|FG000|Baseline Enrollment|Exited study|13|||
23446441|NCT02611479|65377652|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
23446442|NCT02611479|65377652|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
23446443|NCT02611479|65377652|FG000|Data Cleaning|No baseline function or pain metrics|2|||
23446444|NCT03515824|65377654|FG000|Overall Study|Death|3|||
23446445|NCT03515824|65377655|FG001|Overall Study|Death|2|||
23446446|NCT03515824|65377656|FG002|Overall Study|Death|6|||
23446447|NCT03515824|65377657|FG003|Overall Study|Death|0|||
23446448|NCT03515824|65377654|FG000|Overall Study|Lost to Follow-up|0|||
23446449|NCT03515824|65377655|FG001|Overall Study|Lost to Follow-up|1|||
23446450|NCT03515824|65377656|FG002|Overall Study|Lost to Follow-up|1|||
23446451|NCT03515824|65377657|FG003|Overall Study|Lost to Follow-up|0|||
23446452|NCT03515824|65377654|FG000|Overall Study|Study terminated by sponsor|0|||
23446453|NCT03515824|65377655|FG001|Overall Study|Study terminated by sponsor|1|||
23446454|NCT03515824|65377656|FG002|Overall Study|Study terminated by sponsor|6|||
23446455|NCT03515824|65377657|FG003|Overall Study|Study terminated by sponsor|0|||
23446456|NCT03515824|65377654|FG000|Overall Study|Status not recorded|0|||
23446457|NCT03515824|65377655|FG001|Overall Study|Status not recorded|0|||
23446458|NCT03515824|65377656|FG002|Overall Study|Status not recorded|2|||
23446459|NCT03515824|65377657|FG003|Overall Study|Status not recorded|0|||
23446460|NCT02487095|65377658|FG000|Dose Expansion|Unable to scan/restage participant|0|||
23446461|NCT02487095|65377659|FG001|Dose Expansion|Unable to scan/restage participant|0|||
23446462|NCT02487095|65377660|FG002|Dose Expansion|Unable to scan/restage participant|0|||
23446463|NCT02487095|65377661|FG003|Dose Expansion|Unable to scan/restage participant|0|||
23568502|NCT01863043|65809863|FG001|Overall Study|Withdrawal by Subject|2|||
23568503|NCT01863043|65809862|FG000|Overall Study|Adverse Event|7|||
23568504|NCT01863043|65809863|FG001|Overall Study|Adverse Event|8|||
23568505|NCT01863043|65809862|FG000|Overall Study|exclusion criteria found after enrollment|0|||
23568506|NCT01863043|65809863|FG001|Overall Study|exclusion criteria found after enrollment|1|||
23568507|NCT01291225|65809865|FG000|Overall Study|Lost to Follow-up|85|||
23568508|NCT01291225|65809866|FG001|Overall Study|Lost to Follow-up|39|||
23568509|NCT04248465|65809871|FG000|Randomized-Controlled Period|Death|12|||
23568510|NCT04248465|65809872|FG001|Randomized-Controlled Period|Death|5|||
23568511|NCT04248465|65809871|FG000|Randomized-Controlled Period|Adverse Event|2|||
23568512|NCT04248465|65809872|FG001|Randomized-Controlled Period|Adverse Event|0|||
23568513|NCT04248465|65809871|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
23568514|NCT04248465|65809872|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
23568515|NCT04248465|65809871|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
23568516|NCT04248465|65809872|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
23568517|NCT04248465|65809871|FG000|Randomized-Controlled Period|Physician Decision|1|||
23446464|NCT02487095|65377662|FG004|Dose Expansion|Unable to scan/restage participant|1|||
23446465|NCT03078556|65377663|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
23446466|NCT03078556|65377664|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
23446467|NCT03078556|65377665|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
23446468|NCT03078556|65377666|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
23446469|NCT03078556|65377663|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
23446470|NCT03078556|65377664|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
23446471|NCT03078556|65377665|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
23446472|NCT03078556|65377666|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
23446473|NCT03078556|65377663|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
23446474|NCT03078556|65377664|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
23446475|NCT03078556|65377665|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
23446476|NCT03078556|65377666|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
23446477|NCT03078556|65377663|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
23568518|NCT04248465|65809872|FG001|Randomized-Controlled Period|Physician Decision|1|||
23568519|NCT04248465|65809871|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
23568520|NCT04248465|65809872|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
23568521|NCT04248465|65809871|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
23568522|NCT04248465|65809872|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
23568523|NCT04248465|65809871|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
23568524|NCT04248465|65809872|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
23568525|NCT02584855|65809873|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
23568526|NCT02584855|65809874|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
23446478|NCT03078556|65377664|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
23446479|NCT03078556|65377665|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
23446480|NCT03078556|65377666|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
23568527|NCT02584855|65809875|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
23568528|NCT02584855|65809876|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
23223312|NCT00653068|64560450|FG000|Overall Study|Death|9|||
23568529|NCT02584855|65809877|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
23161341|NCT02164929|64339055|FG002|Overall Study|Failed regional block|1|||
23161342|NCT02164929|64339056|FG003|Overall Study|Failed regional block|0|||
23161343|NCT02581202|64339057|FG000|Overall Study|Lack of Efficacy|2|||
23161344|NCT02581202|64339057|FG000|Overall Study|Withdrawal by Subject|4|||
23161345|NCT02581202|64339057|FG000|Overall Study|Lost to Follow-up|5|||
23161346|NCT02581202|64339057|FG000|Overall Study|Pregnancy|3|||
23161347|NCT01549002|64339062|FG000|Overall Study|Excessive pain|0|||
23161348|NCT01549002|64339063|FG001|Overall Study|Excessive pain|2|||
23161349|NCT01549002|64339062|FG000|Overall Study|Moderate sedation required|0|||
23161350|NCT01549002|64339063|FG001|Overall Study|Moderate sedation required|2|||
23568530|NCT02584855|65809878|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
23568531|NCT02584855|65809873|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
23568532|NCT02584855|65809874|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568533|NCT02584855|65809875|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568534|NCT02584855|65809876|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568535|NCT02584855|65809877|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568536|NCT02584855|65809878|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
23568537|NCT02584855|65809873|FG000|Open-Label Treatment Period|Adverse Event|14|||
23568538|NCT02584855|65809874|FG001|Open-Label Treatment Period|Adverse Event|0|||
23568539|NCT02584855|65809875|FG002|Open-Label Treatment Period|Adverse Event|0|||
23568540|NCT02584855|65809876|FG003|Open-Label Treatment Period|Adverse Event|0|||
23568541|NCT02584855|65809877|FG004|Open-Label Treatment Period|Adverse Event|0|||
23568542|NCT02584855|65809878|FG005|Open-Label Treatment Period|Adverse Event|0|||
23568543|NCT02584855|65809873|FG000|Open-Label Treatment Period|Death|2|||
23568544|NCT02584855|65809874|FG001|Open-Label Treatment Period|Death|0|||
23568545|NCT02584855|65809875|FG002|Open-Label Treatment Period|Death|0|||
23568546|NCT02584855|65809876|FG003|Open-Label Treatment Period|Death|0|||
23568547|NCT02584855|65809877|FG004|Open-Label Treatment Period|Death|0|||
23161351|NCT00254501|64339066|FG000|Overall Study|Lost to Follow-up|1|||
23161352|NCT00254501|64339067|FG001|Overall Study|Lost to Follow-up|1|||
23161353|NCT03962738|64339068|FG000|Overall Study|Protocol Deviation|3|||
23161354|NCT03962738|64339069|FG001|Overall Study|Protocol Deviation|0|||
23568548|NCT02584855|65809878|FG005|Open-Label Treatment Period|Death|0|||
23568549|NCT02584855|65809873|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
23161355|NCT03962738|64339070|FG002|Overall Study|Protocol Deviation|1|||
23161356|NCT03962738|64339071|FG003|Overall Study|Protocol Deviation|1|||
23446481|NCT00265317|65377667|FG000|Lead-In|Objective progression or relapse|6|||
23446482|NCT00265317|65377668|FG001|Lead-In|Objective progression or relapse|11|||
23446483|NCT00265317|65377669|FG002|Lead-In|Objective progression or relapse|0|||
23446484|NCT00265317|65377670|FG003|Lead-In|Objective progression or relapse|0|||
23446485|NCT00265317|65377667|FG000|Lead-In|Adverse Event|2|||
23446486|NCT00265317|65377668|FG001|Lead-In|Adverse Event|1|||
23446487|NCT00265317|65377669|FG002|Lead-In|Adverse Event|0|||
23446488|NCT00265317|65377670|FG003|Lead-In|Adverse Event|0|||
23446489|NCT00265317|65377667|FG000|Lead-In|Death|3|||
23446490|NCT00265317|65377668|FG001|Lead-In|Death|5|||
23446491|NCT00265317|65377669|FG002|Lead-In|Death|0|||
23446492|NCT00265317|65377670|FG003|Lead-In|Death|0|||
23446493|NCT00265317|65377667|FG000|Lead-In|Withdrawal/other than adverse event|1|||
23446494|NCT00265317|65377668|FG001|Lead-In|Withdrawal/other than adverse event|0|||
23446495|NCT00265317|65377669|FG002|Lead-In|Withdrawal/other than adverse event|0|||
23446496|NCT00265317|65377670|FG003|Lead-In|Withdrawal/other than adverse event|0|||
23446497|NCT00265317|65377667|FG000|Phase 2|Objective progression or relapse|0|||
23446498|NCT00265317|65377668|FG001|Phase 2|Objective progression or relapse|0|||
23446499|NCT00265317|65377669|FG002|Phase 2|Objective progression or relapse|37|||
23446500|NCT00265317|65377670|FG003|Phase 2|Objective progression or relapse|38|||
23446501|NCT00265317|65377667|FG000|Phase 2|Global deterioration of health status|0|||
23446502|NCT00265317|65377668|FG001|Phase 2|Global deterioration of health status|0|||
23446503|NCT00265317|65377669|FG002|Phase 2|Global deterioration of health status|3|||
23446504|NCT00265317|65377670|FG003|Phase 2|Global deterioration of health status|0|||
23446505|NCT00265317|65377667|FG000|Phase 2|Adverse Event|0|||
23446506|NCT00265317|65377668|FG001|Phase 2|Adverse Event|0|||
23446507|NCT00265317|65377669|FG002|Phase 2|Adverse Event|7|||
23446508|NCT00265317|65377670|FG003|Phase 2|Adverse Event|5|||
23446509|NCT00265317|65377667|FG000|Phase 2|Death|0|||
23446510|NCT00265317|65377668|FG001|Phase 2|Death|0|||
23446511|NCT00265317|65377669|FG002|Phase 2|Death|12|||
23446512|NCT00265317|65377670|FG003|Phase 2|Death|15|||
23446513|NCT00265317|65377667|FG000|Phase 2|Protocol Violation|0|||
23446514|NCT00265317|65377668|FG001|Phase 2|Protocol Violation|0|||
23446515|NCT00265317|65377669|FG002|Phase 2|Protocol Violation|1|||
23446516|NCT00265317|65377670|FG003|Phase 2|Protocol Violation|4|||
23446517|NCT00265317|65377667|FG000|Phase 2|Lost to Follow-up|0|||
23446518|NCT00265317|65377668|FG001|Phase 2|Lost to Follow-up|0|||
23446519|NCT00265317|65377669|FG002|Phase 2|Lost to Follow-up|0|||
23446520|NCT00265317|65377670|FG003|Phase 2|Lost to Follow-up|1|||
23446521|NCT00265317|65377667|FG000|Phase 2|Withdrawal/other than adverse event|0|||
23446522|NCT00265317|65377668|FG001|Phase 2|Withdrawal/other than adverse event|0|||
23446523|NCT00265317|65377669|FG002|Phase 2|Withdrawal/other than adverse event|2|||
23446524|NCT00265317|65377670|FG003|Phase 2|Withdrawal/other than adverse event|1|||
23446525|NCT00265317|65377667|FG000|Phase 2|Study terminated by sponsor|0|||
23446526|NCT00265317|65377668|FG001|Phase 2|Study terminated by sponsor|0|||
23446527|NCT00265317|65377669|FG002|Phase 2|Study terminated by sponsor|1|||
23446528|NCT00265317|65377670|FG003|Phase 2|Study terminated by sponsor|0|||
23446529|NCT00265317|65377667|FG000|Phase 2|Other|0|||
23446530|NCT00265317|65377668|FG001|Phase 2|Other|0|||
23446531|NCT00265317|65377669|FG002|Phase 2|Other|1|||
23161357|NCT03962738|64339068|FG000|Overall Study|Withdrawal by Subject|4|||
23161358|NCT03962738|64339069|FG001|Overall Study|Withdrawal by Subject|0|||
23446532|NCT00265317|65377670|FG003|Phase 2|Other|1|||
23446533|NCT00475709|65377671|FG000|Overall Study|Did not meet eligibility criteria|8|||
23446534|NCT00475709|65377671|FG000|Overall Study|Death|41|||
23446535|NCT00475709|65377671|FG000|Overall Study|Device Explant|6|||
23446536|NCT00475709|65377671|FG000|Overall Study|Lost to Follow-up|21|||
23446537|NCT03088917|65377674|FG000|Overall Study|In care/cured elsewhere|15|||
23161359|NCT03962738|64339070|FG002|Overall Study|Withdrawal by Subject|0|||
23161360|NCT03962738|64339071|FG003|Overall Study|Withdrawal by Subject|0|||
23161361|NCT03962738|64339068|FG000|Overall Study|Lost to Follow-up|0|||
23161362|NCT03962738|64339069|FG001|Overall Study|Lost to Follow-up|0|||
23161363|NCT03962738|64339070|FG002|Overall Study|Lost to Follow-up|1|||
23446538|NCT03088917|65377674|FG000|Overall Study|Refuse re-evaluation|13|||
23446539|NCT03088917|65377674|FG000|Overall Study|Contact not established|13|||
23446540|NCT03088917|65377674|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
23446541|NCT03088917|65377674|FG000|Overall Study|Moved outside study region|50|||
23446542|NCT03087513|65377675|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
23568550|NCT02584855|65809874|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
23446543|NCT00894361|65377679|FG000|Overall Study|deaths and less than 2 years followup|24|||
23446544|NCT00894361|65377680|FG001|Overall Study|deaths and less than 2 years followup|64|||
23446545|NCT01449006|65377681|FG000|Overall Study|Lost to Follow-up|1|||
23446546|NCT01449006|65377682|FG001|Overall Study|Lost to Follow-up|0|||
23446547|NCT01449006|65377681|FG000|Overall Study|Withdrawal by Subject|1|||
23446548|NCT01449006|65377682|FG001|Overall Study|Withdrawal by Subject|0|||
23446549|NCT01449006|65377681|FG000|Overall Study|Protocol Violation|1|||
23446550|NCT01449006|65377682|FG001|Overall Study|Protocol Violation|0|||
23446551|NCT01544920|65377683|FG000|Overall Study|Adverse Event|0|||
23446552|NCT01544920|65377684|FG001|Overall Study|Adverse Event|3|||
23446553|NCT01544920|65377683|FG000|Overall Study|Death|0|||
23161364|NCT03962738|64339071|FG003|Overall Study|Lost to Follow-up|0|||
23161365|NCT03693625|64339072|FG000|Overall Study|Adverse Event|2|||
23161366|NCT03693625|64339073|FG001|Overall Study|Adverse Event|0|||
23161367|NCT03693625|64339072|FG000|Overall Study|Study Terminated By Sponsor|20|||
23161368|NCT03693625|64339073|FG001|Overall Study|Study Terminated By Sponsor|7|||
23161369|NCT03693625|64339072|FG000|Overall Study|Withdrawal by Subject|1|||
23161370|NCT03693625|64339073|FG001|Overall Study|Withdrawal by Subject|1|||
23161371|NCT00434421|64339077|FG000|Overall Study|Withdrawal by Subject|1|||
23446554|NCT01544920|65377684|FG001|Overall Study|Death|1|||
23446555|NCT01544920|65377683|FG000|Overall Study|Lost to Follow-up|11|||
23446556|NCT01544920|65377684|FG001|Overall Study|Lost to Follow-up|12|||
23223313|NCT00653068|64560450|FG000|Overall Study|Lack of Efficacy|34|||
23330169|NCT02059135|64951921|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
23330170|NCT02059135|64951922|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
23161372|NCT00434421|64339077|FG000|Overall Study|Non-compliance with study treatment|1|||
23161373|NCT00441974|64339078|FG000|Overall Study|Adverse Event|6|||
23161374|NCT00441974|64339078|FG000|Overall Study|Consent Withdrawn|35|||
23161375|NCT00441974|64339078|FG000|Overall Study|Lost to Follow-up|80|||
23161376|NCT00441974|64339078|FG000|Overall Study|Protocol Violation|7|||
23161377|NCT04096274|64339088|FG000|Phase I|Lost to Follow-up|5|||
23161378|NCT04096274|64339089|FG001|Phase I|Lost to Follow-up|5|||
23161379|NCT04096274|64339088|FG000|Phase II|Lost to Follow-up|11|||
23161380|NCT04096274|64339089|FG001|Phase II|Lost to Follow-up|11|||
23161381|NCT02898259|64339090|FG000|Overall Study|Adverse Event|0|||
23161382|NCT02898259|64339091|FG001|Overall Study|Adverse Event|0|||
23161383|NCT02898259|64339092|FG002|Overall Study|Adverse Event|1|||
23223314|NCT00653068|64560450|FG000|Overall Study|Physician Decision|4|||
23330171|NCT02059135|64951921|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
23330172|NCT02059135|64951922|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
23330173|NCT02059135|64951921|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
23330174|NCT02059135|64951922|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
23446557|NCT01544920|65377683|FG000|Overall Study|Protocol Violation|0|||
23446558|NCT01544920|65377684|FG001|Overall Study|Protocol Violation|2|||
23446559|NCT01544920|65377683|FG000|Overall Study|Physician Decision|4|||
23446560|NCT01544920|65377684|FG001|Overall Study|Physician Decision|1|||
23446561|NCT01544920|65377683|FG000|Overall Study|Withdrawal by Subject|4|||
23446562|NCT01544920|65377684|FG001|Overall Study|Withdrawal by Subject|4|||
23446563|NCT02100475|65377692|FG000|Overall Study|Unclassified|1|||
23446564|NCT02100475|65377693|FG001|Overall Study|Unclassified|2|||
23446565|NCT02100475|65377692|FG000|Overall Study|Withdrawal criteria|1|||
23446566|NCT02100475|65377693|FG001|Overall Study|Withdrawal criteria|0|||
23446567|NCT00867165|65377694|FG000|Overall Study|Adverse Event|3|||
23446568|NCT00867165|65377695|FG001|Overall Study|Adverse Event|0|||
23330175|NCT03478644|64951926|FG000|Phase 2|Withdrawal by Subject|2|||
23330176|NCT03478644|64951927|FG001|Phase 2|Withdrawal by Subject|1|||
23330177|NCT03478644|64951926|FG000|Phase 2|Lost to Follow-up|1|||
23330178|NCT03478644|64951927|FG001|Phase 2|Lost to Follow-up|0|||
23330179|NCT01790984|64951928|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
23330180|NCT01790984|64951929|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
23330181|NCT01790984|64951930|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
23330182|NCT01790984|64951931|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
23330183|NCT00611923|64951932|FG000|Overall Study|Withdrawal by Subject|2|||
23330184|NCT00611923|64951933|FG001|Overall Study|Withdrawal by Subject|2|||
23446569|NCT00867165|65377694|FG000|Overall Study|Withdrawal by Subject|1|||
23446570|NCT00867165|65377695|FG001|Overall Study|Withdrawal by Subject|0|||
23446571|NCT00780416|65377696|FG000|Overall Study|Physician Decision|3|||
23568551|NCT02584855|65809875|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
23568552|NCT02584855|65809876|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
23446572|NCT00780416|65377697|FG001|Overall Study|Physician Decision|3|||
23446573|NCT00780416|65377696|FG000|Overall Study|Protocol Violation|1|||
23446574|NCT00780416|65377697|FG001|Overall Study|Protocol Violation|0|||
23568553|NCT02584855|65809877|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
23568554|NCT02584855|65809878|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
23161384|NCT02898259|64339093|FG003|Overall Study|Adverse Event|0|||
23446575|NCT00780416|65377696|FG000|Overall Study|Withdrawal by Subject|8|||
23161385|NCT02898259|64339094|FG004|Overall Study|Adverse Event|0|||
23161386|NCT02898259|64339090|FG000|Overall Study|Lack of Efficacy|1|||
23330185|NCT04565145|64951934|FG000|Overall Study|Withdrawal by Subject|1|||
23446576|NCT00780416|65377697|FG001|Overall Study|Withdrawal by Subject|6|||
23446577|NCT04492722|65377698|FG000|Overall Study|Adverse Event|7|||
23446578|NCT04492722|65377699|FG001|Overall Study|Adverse Event|2|||
23446579|NCT04492722|65377700|FG002|Overall Study|Adverse Event|3|||
23161387|NCT02898259|64339091|FG001|Overall Study|Lack of Efficacy|1|||
23223315|NCT00653068|64560450|FG000|Overall Study|Withdrawal by Subject|1|||
23446580|NCT04492722|65377701|FG003|Overall Study|Adverse Event|0|||
23446581|NCT04492722|65377698|FG000|Overall Study|Death|0|||
23446582|NCT04492722|65377699|FG001|Overall Study|Death|0|||
23446583|NCT04492722|65377700|FG002|Overall Study|Death|0|||
23446584|NCT04492722|65377701|FG003|Overall Study|Death|1|||
23330186|NCT04565145|64951935|FG001|Overall Study|Withdrawal by Subject|1|||
23446585|NCT04492722|65377698|FG000|Overall Study|Lost to Follow-up|0|||
23161388|NCT02898259|64339092|FG002|Overall Study|Lack of Efficacy|3|||
23568555|NCT02584855|65809873|FG000|Open-Label Treatment Period|Protocol Violation|1|||
23568556|NCT02584855|65809874|FG001|Open-Label Treatment Period|Protocol Violation|0|||
23568557|NCT02584855|65809875|FG002|Open-Label Treatment Period|Protocol Violation|0|||
23568558|NCT02584855|65809876|FG003|Open-Label Treatment Period|Protocol Violation|0|||
23568559|NCT02584855|65809877|FG004|Open-Label Treatment Period|Protocol Violation|0|||
23568560|NCT02584855|65809878|FG005|Open-Label Treatment Period|Protocol Violation|0|||
23568561|NCT02584855|65809873|FG000|Open-Label Treatment Period|No PI Available|2|||
23568562|NCT02584855|65809874|FG001|Open-Label Treatment Period|No PI Available|0|||
23568563|NCT02584855|65809875|FG002|Open-Label Treatment Period|No PI Available|0|||
23568564|NCT02584855|65809876|FG003|Open-Label Treatment Period|No PI Available|0|||
23568565|NCT02584855|65809877|FG004|Open-Label Treatment Period|No PI Available|0|||
23568566|NCT02584855|65809878|FG005|Open-Label Treatment Period|No PI Available|0|||
23568567|NCT02584855|65809873|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
23568568|NCT02584855|65809874|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
23568569|NCT02584855|65809875|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
23568570|NCT02584855|65809876|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
23568571|NCT02584855|65809877|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
23568572|NCT02584855|65809878|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
23568573|NCT02584855|65809873|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568574|NCT02584855|65809874|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568575|NCT02584855|65809875|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
23568576|NCT02584855|65809876|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568577|NCT02584855|65809877|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568578|NCT02584855|65809878|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
23568579|NCT02584855|65809873|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
23568580|NCT02584855|65809874|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
23568581|NCT02584855|65809875|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
23568582|NCT02584855|65809876|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
23568583|NCT02584855|65809877|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
23568584|NCT02584855|65809878|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
23568585|NCT02584855|65809873|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568586|NCT02584855|65809874|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
23568587|NCT02584855|65809875|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568588|NCT02584855|65809876|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568589|NCT02584855|65809877|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568590|NCT02584855|65809878|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
23568591|NCT02584855|65809873|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568592|NCT02584855|65809874|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
23568593|NCT02584855|65809875|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568594|NCT02584855|65809876|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568595|NCT02584855|65809877|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568596|NCT02584855|65809878|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
23568597|NCT02584855|65809873|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568598|NCT02584855|65809874|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568599|NCT02584855|65809875|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568600|NCT02584855|65809876|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568601|NCT02584855|65809877|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
23568602|NCT02584855|65809878|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23568603|NCT02584855|65809873|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
23568604|NCT02584855|65809874|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
23568605|NCT02584855|65809875|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
23568606|NCT02584855|65809876|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
23568607|NCT02584855|65809877|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
23568608|NCT02584855|65809878|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
23568609|NCT00235443|65809879|FG000|Overall Study|Adverse Event|4|||
23568610|NCT00235443|65809880|FG001|Overall Study|Adverse Event|12|||
23161389|NCT02898259|64339093|FG003|Overall Study|Lack of Efficacy|0|||
23330187|NCT04031846|64951936|FG000|Overall Study|Lost to Follow-up|4|||
23330188|NCT04031846|64951937|FG001|Overall Study|Lost to Follow-up|4|||
23330189|NCT04031846|64951936|FG000|Overall Study|Physician Decision|0|||
23330190|NCT04031846|64951937|FG001|Overall Study|Physician Decision|1|||
23330191|NCT04031846|64951936|FG000|Overall Study|Protocol Violation|1|||
23330192|NCT04031846|64951937|FG001|Overall Study|Protocol Violation|1|||
23330193|NCT04031846|64951936|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
23330194|NCT04031846|64951937|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
23330195|NCT03259425|64951938|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
23330196|NCT04090060|64951939|FG000|Overall Study|Lost to Follow-up|76|||
23330197|NCT04090060|64951940|FG001|Overall Study|Lost to Follow-up|77|||
23330198|NCT00767455|64951941|FG000|Overall Study|Investigator error|19|||
23330199|NCT02569801|64951942|FG000|Overall Study|Withdrawal by Subject|9|||
23330200|NCT02569801|64951943|FG001|Overall Study|Withdrawal by Subject|9|||
23330201|NCT02569801|64951942|FG000|Overall Study|Sponsor Decision|13|||
23330202|NCT02569801|64951943|FG001|Overall Study|Sponsor Decision|14|||
23330203|NCT02569801|64951942|FG000|Overall Study|Progressive Disease|2|||
23161390|NCT02898259|64339094|FG004|Overall Study|Lack of Efficacy|0|||
23330204|NCT02569801|64951943|FG001|Overall Study|Progressive Disease|7|||
23330205|NCT02569801|64951942|FG000|Overall Study|Lost to Follow-up|0|||
23161391|NCT02898259|64339090|FG000|Overall Study|Lost to Follow-up|0|||
23161392|NCT02898259|64339091|FG001|Overall Study|Lost to Follow-up|0|||
23568611|NCT00235443|65809881|FG002|Overall Study|Adverse Event|17|||
23568612|NCT00235443|65809882|FG003|Overall Study|Adverse Event|44|||
23568613|NCT00235443|65809883|FG004|Overall Study|Adverse Event|10|||
23568614|NCT00235443|65809884|FG005|Overall Study|Adverse Event|15|||
23568615|NCT00235443|65809879|FG000|Overall Study|Lack of Efficacy|0|||
23568616|NCT00235443|65809880|FG001|Overall Study|Lack of Efficacy|1|||
23568617|NCT00235443|65809881|FG002|Overall Study|Lack of Efficacy|5|||
23568618|NCT00235443|65809882|FG003|Overall Study|Lack of Efficacy|12|||
23568619|NCT00235443|65809883|FG004|Overall Study|Lack of Efficacy|2|||
23568620|NCT00235443|65809884|FG005|Overall Study|Lack of Efficacy|9|||
23568621|NCT00235443|65809879|FG000|Overall Study|Withdrawal by Subject|3|||
23568622|NCT00235443|65809880|FG001|Overall Study|Withdrawal by Subject|9|||
23568623|NCT00235443|65809881|FG002|Overall Study|Withdrawal by Subject|25|||
23568624|NCT00235443|65809882|FG003|Overall Study|Withdrawal by Subject|24|||
23568625|NCT00235443|65809883|FG004|Overall Study|Withdrawal by Subject|10|||
23568626|NCT00235443|65809884|FG005|Overall Study|Withdrawal by Subject|12|||
23568627|NCT00235443|65809879|FG000|Overall Study|Lost to Follow-up|0|||
23568628|NCT00235443|65809880|FG001|Overall Study|Lost to Follow-up|8|||
23568629|NCT00235443|65809881|FG002|Overall Study|Lost to Follow-up|6|||
23568630|NCT00235443|65809882|FG003|Overall Study|Lost to Follow-up|6|||
23568631|NCT00235443|65809883|FG004|Overall Study|Lost to Follow-up|4|||
23568632|NCT00235443|65809884|FG005|Overall Study|Lost to Follow-up|3|||
23568633|NCT00235443|65809879|FG000|Overall Study|Unsatisfactory compliance|0|||
23568634|NCT00235443|65809880|FG001|Overall Study|Unsatisfactory compliance|2|||
23568635|NCT00235443|65809881|FG002|Overall Study|Unsatisfactory compliance|3|||
23568636|NCT00235443|65809882|FG003|Overall Study|Unsatisfactory compliance|4|||
23568637|NCT00235443|65809883|FG004|Overall Study|Unsatisfactory compliance|1|||
23568638|NCT00235443|65809884|FG005|Overall Study|Unsatisfactory compliance|0|||
23568639|NCT00235443|65809879|FG000|Overall Study|Other reasons for premature termination|1|||
23568640|NCT00235443|65809880|FG001|Overall Study|Other reasons for premature termination|6|||
23568641|NCT00235443|65809881|FG002|Overall Study|Other reasons for premature termination|6|||
23568642|NCT00235443|65809882|FG003|Overall Study|Other reasons for premature termination|7|||
23568643|NCT00235443|65809883|FG004|Overall Study|Other reasons for premature termination|3|||
23568644|NCT00235443|65809884|FG005|Overall Study|Other reasons for premature termination|6|||
23568645|NCT00579982|65809885|FG000|Overall Study|Adverse Event|4|||
23568646|NCT00579982|65809885|FG000|Overall Study|Protocol Violation|4|||
23330206|NCT02569801|64951943|FG001|Overall Study|Lost to Follow-up|1|||
23330207|NCT02569801|64951942|FG000|Overall Study|Death|12|||
23330208|NCT02569801|64951943|FG001|Overall Study|Death|4|||
23568647|NCT04170686|65809889|FG000|Screening|Physician Decision|12|||
23161393|NCT02898259|64339092|FG002|Overall Study|Lost to Follow-up|1|||
23161394|NCT02898259|64339093|FG003|Overall Study|Lost to Follow-up|0|||
23330209|NCT00463047|64951944|FG000|Titration Period 1|Adverse Event|10|||
23330210|NCT00463047|64951945|FG001|Titration Period 1|Adverse Event|8|||
23161395|NCT02898259|64339094|FG004|Overall Study|Lost to Follow-up|0|||
23568648|NCT04170686|65809890|FG001|Screening|Physician Decision|13|||
23568649|NCT04170686|65809889|FG000|Randomization and Treatment|Lost to Follow-up|26|||
23568650|NCT04170686|65809890|FG001|Randomization and Treatment|Lost to Follow-up|15|||
23330211|NCT00463047|64951944|FG000|Titration Period 1|Lack of Efficacy|10|||
23330212|NCT00463047|64951945|FG001|Titration Period 1|Lack of Efficacy|4|||
23330213|NCT00463047|64951944|FG000|Titration Period 1|Lost to Follow-up|2|||
23330214|NCT00463047|64951945|FG001|Titration Period 1|Lost to Follow-up|0|||
23330215|NCT00463047|64951944|FG000|Titration Period 1|Non-compliance with study medication|3|||
23330216|NCT00463047|64951945|FG001|Titration Period 1|Non-compliance with study medication|5|||
23330217|NCT00463047|64951944|FG000|Titration Period 1|Protocol Violation|5|||
23330218|NCT00463047|64951945|FG001|Titration Period 1|Protocol Violation|5|||
23330219|NCT00463047|64951944|FG000|Titration Period 1|Withdrawal by Subject|3|||
23330220|NCT00463047|64951945|FG001|Titration Period 1|Withdrawal by Subject|5|||
23330221|NCT00463047|64951944|FG000|Titration Period 1|Non-compliance procedures|4|||
23223316|NCT00653068|64560450|FG000|Overall Study|Ineligible|2|||
23330222|NCT00463047|64951945|FG001|Titration Period 1|Non-compliance procedures|10|||
23330223|NCT00463047|64951944|FG000|Titration Period 1|Other|0|||
23330224|NCT00463047|64951945|FG001|Titration Period 1|Other|2|||
23330225|NCT00463047|64951944|FG000|Titration Period 2|Adverse Event|9|||
23330226|NCT00463047|64951945|FG001|Titration Period 2|Adverse Event|9|||
23330227|NCT00463047|64951944|FG000|Titration Period 2|Lack of Efficacy|6|||
23330228|NCT00463047|64951945|FG001|Titration Period 2|Lack of Efficacy|4|||
23330229|NCT00463047|64951944|FG000|Titration Period 2|Withdrawal by Subject|1|||
23330230|NCT00463047|64951945|FG001|Titration Period 2|Withdrawal by Subject|0|||
23330231|NCT00463047|64951944|FG000|Titration Period 2|Protocol Violation|2|||
23330232|NCT00463047|64951945|FG001|Titration Period 2|Protocol Violation|3|||
23330233|NCT00463047|64951944|FG000|Titration Period 2|Lost to Follow-up|1|||
23330234|NCT00463047|64951945|FG001|Titration Period 2|Lost to Follow-up|2|||
23330235|NCT00463047|64951944|FG000|Titration Period 2|Non-compliance study medication|4|||
23330236|NCT00463047|64951945|FG001|Titration Period 2|Non-compliance study medication|2|||
23330237|NCT00463047|64951944|FG000|Titration Period 2|Non-compliance procedures|4|||
23330238|NCT00463047|64951945|FG001|Titration Period 2|Non-compliance procedures|1|||
23330239|NCT00463047|64951944|FG000|Titration Period 2|Other|3|||
23330240|NCT00463047|64951945|FG001|Titration Period 2|Other|2|||
23330241|NCT00463047|64951944|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
23330242|NCT00463047|64951945|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
23330243|NCT00463047|64951944|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
23330244|NCT00463047|64951945|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
23330245|NCT00463047|64951944|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
23330246|NCT00463047|64951945|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
23330247|NCT00463047|64951944|FG000|Double-Blind Treatment Period 1|Other|1|||
23330248|NCT00463047|64951945|FG001|Double-Blind Treatment Period 1|Other|0|||
23330249|NCT00463047|64951944|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
23330250|NCT00463047|64951945|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
23330251|NCT00463047|64951944|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
23330252|NCT00463047|64951945|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
23330253|NCT00463047|64951944|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
23330254|NCT00463047|64951945|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
23330255|NCT03743415|64951948|FG000|Overall Study|Death|5|||
23330256|NCT03743415|64951949|FG001|Overall Study|Death|3|||
23330257|NCT03743415|64951950|FG002|Overall Study|Death|1|||
23330258|NCT03743415|64951951|FG003|Overall Study|Death|4|||
23330259|NCT03743415|64951952|FG004|Overall Study|Death|0|||
23330260|NCT03743415|64951953|FG005|Overall Study|Death|0|||
23330261|NCT03743415|64951954|FG006|Overall Study|Death|0|||
23330262|NCT03743415|64951955|FG007|Overall Study|Death|0|||
23330263|NCT03743415|64951956|FG008|Overall Study|Death|1|||
23330264|NCT03743415|64951957|FG009|Overall Study|Death|0|||
23330265|NCT03743415|64951948|FG000|Overall Study|Withdrawal by Subject|1|||
23330266|NCT03743415|64951949|FG001|Overall Study|Withdrawal by Subject|0|||
23330267|NCT03743415|64951950|FG002|Overall Study|Withdrawal by Subject|4|||
23330268|NCT03743415|64951951|FG003|Overall Study|Withdrawal by Subject|5|||
23330269|NCT03743415|64951952|FG004|Overall Study|Withdrawal by Subject|5|||
23330270|NCT03743415|64951953|FG005|Overall Study|Withdrawal by Subject|2|||
23330271|NCT03743415|64951954|FG006|Overall Study|Withdrawal by Subject|2|||
23330272|NCT03743415|64951955|FG007|Overall Study|Withdrawal by Subject|5|||
23330273|NCT03743415|64951956|FG008|Overall Study|Withdrawal by Subject|9|||
23330274|NCT03743415|64951957|FG009|Overall Study|Withdrawal by Subject|10|||
23330275|NCT03743415|64951948|FG000|Overall Study|Lost to Follow-up|2|||
23330276|NCT03743415|64951949|FG001|Overall Study|Lost to Follow-up|0|||
23330277|NCT03743415|64951950|FG002|Overall Study|Lost to Follow-up|2|||
23330278|NCT03743415|64951951|FG003|Overall Study|Lost to Follow-up|1|||
23161396|NCT02898259|64339090|FG000|Overall Study|Transformation before study began|0|||
23330279|NCT03743415|64951952|FG004|Overall Study|Lost to Follow-up|1|||
23330280|NCT03743415|64951953|FG005|Overall Study|Lost to Follow-up|0|||
23330281|NCT03743415|64951954|FG006|Overall Study|Lost to Follow-up|1|||
23330282|NCT03743415|64951955|FG007|Overall Study|Lost to Follow-up|4|||
23330283|NCT03743415|64951956|FG008|Overall Study|Lost to Follow-up|13|||
23330284|NCT03743415|64951957|FG009|Overall Study|Lost to Follow-up|13|||
23330285|NCT02965573|64951958|FG000|Overall Study|Lack of Efficacy|1|||
23330286|NCT02965573|64951959|FG001|Overall Study|Lack of Efficacy|0|||
23161397|NCT02898259|64339091|FG001|Overall Study|Transformation before study began|0|||
23223317|NCT03878160|64560451|FG000|Overall Study|Lost to Follow-up|1|||
23223318|NCT03878160|64560452|FG001|Overall Study|Lost to Follow-up|1|||
23223319|NCT03878160|64560453|FG002|Overall Study|Lost to Follow-up|1|||
23223320|NCT03878160|64560451|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
23223321|NCT03878160|64560452|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
23223322|NCT03878160|64560453|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
23223323|NCT03472040|64560456|FG000|Overall Study|Physician Decision|0|||
23223324|NCT03472040|64560457|FG001|Overall Study|Physician Decision|3|||
23223325|NCT03472040|64560456|FG000|Overall Study|Withdrawal by Subject|10|||
23223326|NCT03472040|64560457|FG001|Overall Study|Withdrawal by Subject|23|||
23223327|NCT03472040|64560456|FG000|Overall Study|Perceived Lack of Efficacy|29|||
23223328|NCT03472040|64560457|FG001|Overall Study|Perceived Lack of Efficacy|30|||
23223329|NCT03472040|64560456|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
23223330|NCT03472040|64560457|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
23223331|NCT03472040|64560456|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
23223332|NCT03472040|64560457|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
23446586|NCT04492722|65377699|FG001|Overall Study|Lost to Follow-up|1|||
23568651|NCT00621296|65809891|FG000|Overall Study|Adverse Event|2|||
23568652|NCT00621296|65809891|FG000|Overall Study|Lack of Efficacy|1|||
23568653|NCT00621296|65809891|FG000|Overall Study|Physician Decision|7|||
23568654|NCT00621296|65809891|FG000|Overall Study|Unmatch Criteria|1|||
23568655|NCT00621296|65809891|FG000|Overall Study|Stopping Criteria|3|||
23568656|NCT01148862|65809892|FG000|Second Intervention|Withdrawal by Subject|0|||
23568657|NCT01148862|65809893|FG001|Second Intervention|Withdrawal by Subject|2|||
23568658|NCT01912781|65809894|FG000|Overall Study|Withdrawal by Subject|2|||
23568659|NCT01912781|65809895|FG001|Overall Study|Withdrawal by Subject|0|||
23568660|NCT01250119|65809896|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
23568661|NCT01250119|65809897|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
23568662|NCT01250119|65809896|FG000|Diagnostic Phase|Participants Not Tested|44|||
23568663|NCT01250119|65809897|FG001|Diagnostic Phase|Participants Not Tested|0|||
23568664|NCT01250119|65809896|FG000|Treatment Phase|Progressive Disease|0|||
23568665|NCT01250119|65809897|FG001|Treatment Phase|Progressive Disease|32|||
23568666|NCT01250119|65809896|FG000|Treatment Phase|Death|0|||
23568667|NCT01250119|65809897|FG001|Treatment Phase|Death|2|||
23568668|NCT01250119|65809896|FG000|Treatment Phase|Withdrawal by Subject|0|||
23568669|NCT01250119|65809897|FG001|Treatment Phase|Withdrawal by Subject|1|||
23568670|NCT01250119|65809896|FG000|Treatment Phase|Adverse Event|0|||
23568671|NCT01250119|65809897|FG001|Treatment Phase|Adverse Event|2|||
23568672|NCT01250119|65809896|FG000|Treatment Phase|Unknown reason|0|||
23568673|NCT01250119|65809897|FG001|Treatment Phase|Unknown reason|4|||
23568674|NCT00098254|65809903|FG000|Overall Study|Adverse Event|2|||
23568675|NCT00098254|65809903|FG000|Overall Study|Death|1|||
23568676|NCT01463293|65809904|FG000|Overall Study|Lost to Follow-up|1|||
23568677|NCT01463293|65809905|FG001|Overall Study|Lost to Follow-up|4|||
23568678|NCT01463293|65809906|FG002|Overall Study|Lost to Follow-up|5|||
23568679|NCT01463293|65809904|FG000|Overall Study|Adverse Event|1|||
23568680|NCT01463293|65809905|FG001|Overall Study|Adverse Event|2|||
23568681|NCT01463293|65809906|FG002|Overall Study|Adverse Event|0|||
23568682|NCT01463293|65809904|FG000|Overall Study|Withdrawal by Subject|4|||
23568683|NCT01463293|65809905|FG001|Overall Study|Withdrawal by Subject|10|||
23568684|NCT01463293|65809906|FG002|Overall Study|Withdrawal by Subject|5|||
23568685|NCT01463293|65809904|FG000|Overall Study|Other|0|||
23568686|NCT01463293|65809905|FG001|Overall Study|Other|0|||
23568687|NCT01463293|65809906|FG002|Overall Study|Other|2|||
23568688|NCT00932646|65809907|FG000|Overall Study|Adverse Event|2|||
23568689|NCT00932646|65809908|FG001|Overall Study|Adverse Event|1|||
23568690|NCT00932646|65809909|FG002|Overall Study|Adverse Event|1|||
23568691|NCT00932646|65809910|FG003|Overall Study|Adverse Event|1|||
23568692|NCT00932646|65809907|FG000|Overall Study|Lost to Follow-up|2|||
23568693|NCT00932646|65809908|FG001|Overall Study|Lost to Follow-up|1|||
23568694|NCT00932646|65809909|FG002|Overall Study|Lost to Follow-up|0|||
23568695|NCT00932646|65809910|FG003|Overall Study|Lost to Follow-up|0|||
23568696|NCT00932646|65809907|FG000|Overall Study|Withdrawal by Subject|1|||
23568697|NCT00932646|65809908|FG001|Overall Study|Withdrawal by Subject|1|||
23568698|NCT00932646|65809909|FG002|Overall Study|Withdrawal by Subject|3|||
23568699|NCT00932646|65809910|FG003|Overall Study|Withdrawal by Subject|0|||
23568700|NCT01680458|65809912|FG000|Overall Study|Protocol Violation|3|||
23568701|NCT02145078|65809913|FG000|Overall Study|Death|1|||
23568702|NCT02145078|65809913|FG000|Overall Study|Reason not given|3|||
23568703|NCT00258440|65809914|FG000|Overall Study|Withdrawal by Subject|0|||
23568704|NCT00258440|65809915|FG001|Overall Study|Withdrawal by Subject|0|||
23568705|NCT00258440|65809916|FG002|Overall Study|Withdrawal by Subject|1|||
23568706|NCT02635724|65809917|FG000|Overall Study|Withdrawal by Subject|0|||
23568707|NCT02635724|65809918|FG001|Overall Study|Withdrawal by Subject|1|||
23568708|NCT02635724|65809919|FG002|Overall Study|Withdrawal by Subject|0|||
23568709|NCT00562978|65809921|FG000|Overall Study|Patient had imaging dose only|1|||
23568710|NCT00562978|65809922|FG001|Overall Study|Patient had imaging dose only|11|||
23568711|NCT00582491|65809925|FG000|Overall Study|Withdrawal by Subject|1|||
23568712|NCT00582491|65809926|FG001|Overall Study|Withdrawal by Subject|0|||
23568713|NCT01364727|65809927|FG000|Overall Study|Not Eligible|2|||
23568714|NCT00744237|65809928|FG000|Overall Study|Lack of Efficacy|1|||
23568715|NCT00744237|65809929|FG001|Overall Study|Lack of Efficacy|1|||
23568716|NCT00744237|65809930|FG002|Overall Study|Lack of Efficacy|0|||
23568717|NCT00744237|65809928|FG000|Overall Study|Withdrawal by Subject|9|||
23568718|NCT00744237|65809929|FG001|Overall Study|Withdrawal by Subject|5|||
23161398|NCT02898259|64339092|FG002|Overall Study|Transformation before study began|0|||
23161399|NCT02898259|64339093|FG003|Overall Study|Transformation before study began|1|||
23161400|NCT02898259|64339094|FG004|Overall Study|Transformation before study began|0|||
23161401|NCT03921424|64339095|FG000|Overall Study|Lost to Follow-up|0|||
23161402|NCT03921424|64339096|FG001|Overall Study|Lost to Follow-up|1|||
23161403|NCT03921424|64339095|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23161404|NCT03921424|64339096|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
23161405|NCT03134599|64339097|FG000|Week 1|Lost to Follow-up|0|||
23161406|NCT03134599|64339098|FG001|Week 1|Lost to Follow-up|0|||
23161407|NCT03134599|64339099|FG002|Week 1|Lost to Follow-up|0|||
23161408|NCT03134599|64339100|FG003|Week 1|Lost to Follow-up|0|||
23161409|NCT03134599|64339101|FG004|Week 1|Lost to Follow-up|1|||
23161410|NCT03134599|64339102|FG005|Week 1|Lost to Follow-up|0|||
23161411|NCT03134599|64339097|FG000|Week 2|Lost to Follow-up|1|||
23161412|NCT03134599|64339098|FG001|Week 2|Lost to Follow-up|0|||
23161413|NCT03134599|64339099|FG002|Week 2|Lost to Follow-up|0|||
23161414|NCT03134599|64339100|FG003|Week 2|Lost to Follow-up|1|||
23161415|NCT03134599|64339101|FG004|Week 2|Lost to Follow-up|1|||
23161416|NCT03134599|64339102|FG005|Week 2|Lost to Follow-up|0|||
23161417|NCT03134599|64339097|FG000|Week 3|Lost to Follow-up|0|||
23161418|NCT03134599|64339098|FG001|Week 3|Lost to Follow-up|0|||
23161419|NCT03134599|64339099|FG002|Week 3|Lost to Follow-up|0|||
23161420|NCT03134599|64339100|FG003|Week 3|Lost to Follow-up|1|||
23161421|NCT03134599|64339101|FG004|Week 3|Lost to Follow-up|0|||
23161422|NCT03134599|64339102|FG005|Week 3|Lost to Follow-up|1|||
23161423|NCT00531752|64339103|FG000|First Double-blind Intervention Period|Adverse Event|2|||
23161424|NCT00531752|64339104|FG001|First Double-blind Intervention Period|Adverse Event|0|||
23161425|NCT00531752|64339105|FG002|First Double-blind Intervention Period|Adverse Event|1|||
23161426|NCT00531752|64339106|FG003|First Double-blind Intervention Period|Adverse Event|1|||
23161427|NCT00531752|64339103|FG000|First Double-blind Intervention Period|Other|1|||
23161428|NCT00531752|64339104|FG001|First Double-blind Intervention Period|Other|4|||
23161429|NCT00531752|64339105|FG002|First Double-blind Intervention Period|Other|4|||
23161430|NCT00531752|64339106|FG003|First Double-blind Intervention Period|Other|0|||
23161431|NCT00531752|64339103|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
23161432|NCT00531752|64339104|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
23161433|NCT00531752|64339105|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
23161434|NCT00531752|64339106|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
23161435|NCT00531752|64339103|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
23161436|NCT00531752|64339104|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
23161437|NCT00531752|64339105|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
23161438|NCT00531752|64339106|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
23161439|NCT00531752|64339103|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
23161440|NCT00531752|64339104|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
23161441|NCT00531752|64339105|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
23161442|NCT00531752|64339106|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
23161443|NCT00531752|64339103|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
23161444|NCT00531752|64339104|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
23161445|NCT00531752|64339105|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
23161446|NCT00531752|64339106|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
23161447|NCT00531752|64339103|FG000|Second Double-blind Intervention Period|Other|1|||
23161448|NCT00531752|64339104|FG001|Second Double-blind Intervention Period|Other|1|||
23161449|NCT00531752|64339105|FG002|Second Double-blind Intervention Period|Other|0|||
23161450|NCT00531752|64339106|FG003|Second Double-blind Intervention Period|Other|0|||
23161451|NCT00531752|64339103|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
23161452|NCT00531752|64339104|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
23161453|NCT00531752|64339105|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
23161454|NCT00531752|64339106|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
23161455|NCT00531752|64339103|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
23161456|NCT00531752|64339104|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
23161457|NCT00531752|64339105|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
23161458|NCT00531752|64339106|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
23161459|NCT00777101|64339111|FG000|Overall Study|Death|48|||
23161460|NCT00777101|64339112|FG001|Overall Study|Death|43|||
23161461|NCT00777101|64339111|FG000|Overall Study|Withdrawal by Subject|11|||
23161462|NCT00777101|64339112|FG001|Overall Study|Withdrawal by Subject|6|||
23161463|NCT00777101|64339111|FG000|Overall Study|Lost to Follow-up|2|||
23568719|NCT00744237|65809930|FG002|Overall Study|Withdrawal by Subject|3|||
23568720|NCT00744237|65809928|FG000|Overall Study|Lost to Follow-up|1|||
23568721|NCT00744237|65809929|FG001|Overall Study|Lost to Follow-up|1|||
23568722|NCT00744237|65809930|FG002|Overall Study|Lost to Follow-up|1|||
23568723|NCT00744237|65809928|FG000|Overall Study|Protocol Violation|3|||
23568724|NCT00744237|65809929|FG001|Overall Study|Protocol Violation|4|||
23568725|NCT00744237|65809930|FG002|Overall Study|Protocol Violation|3|||
23568726|NCT00744237|65809928|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
23161464|NCT00777101|64339112|FG001|Overall Study|Lost to Follow-up|1|||
23330287|NCT00347958|64951960|FG000|Overall Study|Adverse Event|1|||
23330288|NCT00347958|64951960|FG000|Overall Study|Protocol Violation|2|||
23330289|NCT00347958|64951960|FG000|Overall Study|Withdrawal by Subject|1|||
23330290|NCT03048747|64951963|FG000|Overall Study|Adverse Event|2|||
23330291|NCT03048747|64951963|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
23568727|NCT00744237|65809929|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
23568728|NCT00744237|65809930|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
23568729|NCT00744237|65809928|FG000|Overall Study|Dosing Error|1|||
23568730|NCT00744237|65809929|FG001|Overall Study|Dosing Error|0|||
23568731|NCT00744237|65809930|FG002|Overall Study|Dosing Error|1|||
23568732|NCT00744237|65809928|FG000|Overall Study|Study Drug Error|1|||
23568733|NCT00744237|65809929|FG001|Overall Study|Study Drug Error|0|||
23568734|NCT00744237|65809930|FG002|Overall Study|Study Drug Error|0|||
23568735|NCT00744237|65809928|FG000|Overall Study|Prohibited Concomitant Medication|0|||
23568736|NCT00744237|65809929|FG001|Overall Study|Prohibited Concomitant Medication|0|||
23568737|NCT00744237|65809930|FG002|Overall Study|Prohibited Concomitant Medication|1|||
23568738|NCT00744237|65809928|FG000|Overall Study|Poor Compliance|0|||
23568739|NCT00744237|65809929|FG001|Overall Study|Poor Compliance|2|||
23330292|NCT03048747|64951963|FG000|Overall Study|Physician Decision|1|||
23330293|NCT01611935|64951966|FG000|Overall Study|Family Declined Participation|1|||
23330294|NCT01611935|64951967|FG001|Overall Study|Family Declined Participation|0|||
23568740|NCT00744237|65809930|FG002|Overall Study|Poor Compliance|0|||
23161465|NCT00777101|64339111|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
23568741|NCT00744237|65809928|FG000|Overall Study|Administrative. Site Closed|1|||
23330295|NCT00703157|64951968|FG000|Overall Study|Lost to Follow-up|0|||
23330296|NCT00703157|64951969|FG001|Overall Study|Lost to Follow-up|1|||
23330297|NCT00703157|64951968|FG000|Overall Study|source data permanently lost/ other|4|||
23568742|NCT00744237|65809929|FG001|Overall Study|Administrative. Site Closed|1|||
23161466|NCT00777101|64339112|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23161467|NCT00777101|64339111|FG000|Overall Study|Failed to Return|0|||
23161468|NCT00777101|64339112|FG001|Overall Study|Failed to Return|1|||
23161469|NCT00096785|64339113|FG000|Overall Study|Lost to Follow-up|1|||
23161470|NCT00096785|64339114|FG001|Overall Study|Lost to Follow-up|0|||
23161471|NCT00096785|64339113|FG000|Overall Study|Withdrawal by Subject|0|||
23161472|NCT00096785|64339114|FG001|Overall Study|Withdrawal by Subject|1|||
23161473|NCT00096785|64339113|FG000|Overall Study|Relocated|1|||
23161474|NCT00096785|64339114|FG001|Overall Study|Relocated|0|||
23161475|NCT04419610|64339119|FG000|Overall Study|Withdrawal by Subject|3|||
23161476|NCT04419610|64339120|FG001|Overall Study|Withdrawal by Subject|1|||
23223333|NCT03472040|64560456|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
23223334|NCT03472040|64560457|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
23223335|NCT03472040|64560456|FG000|Overall Study|Subject Non-compliance|2|||
23223336|NCT03472040|64560457|FG001|Overall Study|Subject Non-compliance|5|||
23223337|NCT03472040|64560456|FG000|Overall Study|Discontinuation due to Rash|0|||
23223338|NCT03472040|64560457|FG001|Overall Study|Discontinuation due to Rash|1|||
23223339|NCT03472040|64560456|FG000|Overall Study|Subsequent Ineligibility|0|||
23223340|NCT03472040|64560457|FG001|Overall Study|Subsequent Ineligibility|2|||
23223341|NCT03472040|64560456|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
23223342|NCT03472040|64560457|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
23223343|NCT00832091|64560458|FG000|Overall Study|Adverse Event|1|||
23223344|NCT00832091|64560459|FG001|Overall Study|Adverse Event|1|||
23223345|NCT00832091|64560458|FG000|Overall Study|Protocol Violation|1|||
23223346|NCT00832091|64560459|FG001|Overall Study|Protocol Violation|0|||
23223347|NCT00832091|64560458|FG000|Overall Study|Withdrawal by Subject|2|||
23223348|NCT00832091|64560459|FG001|Overall Study|Withdrawal by Subject|1|||
23223349|NCT00832091|64560458|FG000|Overall Study|Prohibited Medication|1|||
23223350|NCT00832091|64560459|FG001|Overall Study|Prohibited Medication|0|||
23223351|NCT02015104|64560463|FG000|Overall Study|Withdrew consent after first dose drug|1|||
23568743|NCT00744237|65809930|FG002|Overall Study|Administrative. Site Closed|1|||
23568744|NCT00744237|65809928|FG000|Overall Study|Adverse Event|9|||
23568745|NCT00744237|65809929|FG001|Overall Study|Adverse Event|13|||
23568746|NCT00744237|65809930|FG002|Overall Study|Adverse Event|5|||
23568747|NCT02049710|65809931|FG000|Overall Study|Lost to Follow-up|319|||
23568748|NCT02049710|65809932|FG001|Overall Study|Lost to Follow-up|324|||
23568749|NCT04076020|65809933|FG000|Overall Study|Death|4|||
23568750|NCT04076020|65809934|FG001|Overall Study|Death|6|||
23568751|NCT04076020|65809933|FG000|Overall Study|Withdrawal by Subject|12|||
23568752|NCT04076020|65809934|FG001|Overall Study|Withdrawal by Subject|8|||
23568753|NCT01473381|65809935|FG000|Overall Study|Adverse Event|8|||
23568754|NCT01473381|65809936|FG001|Overall Study|Adverse Event|20|||
23568755|NCT01473381|65809937|FG002|Overall Study|Adverse Event|25|||
23568756|NCT01473381|65809938|FG003|Overall Study|Adverse Event|17|||
23568757|NCT01473381|65809935|FG000|Overall Study|Insufficient Therapeutic Response|10|||
23568758|NCT01473381|65809936|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23568759|NCT01473381|65809937|FG002|Overall Study|Insufficient Therapeutic Response|2|||
23568760|NCT01473381|65809938|FG003|Overall Study|Insufficient Therapeutic Response|3|||
23568761|NCT01473381|65809935|FG000|Overall Study|Protocol Violation|17|||
23568762|NCT01473381|65809936|FG001|Overall Study|Protocol Violation|23|||
23568763|NCT01473381|65809937|FG002|Overall Study|Protocol Violation|19|||
23568764|NCT01473381|65809938|FG003|Overall Study|Protocol Violation|17|||
23568765|NCT01473381|65809935|FG000|Overall Study|Withdrawal of Consent|20|||
23568766|NCT01473381|65809936|FG001|Overall Study|Withdrawal of Consent|21|||
23568767|NCT01473381|65809937|FG002|Overall Study|Withdrawal of Consent|20|||
23161477|NCT04419610|64339119|FG000|Overall Study|Adverse Event|1|||
23223352|NCT02015104|64560464|FG001|Overall Study|Withdrew consent after first dose drug|0|||
23223353|NCT02015104|64560463|FG000|Overall Study|Withdrew consent prior to treatment|0|||
23330298|NCT00703157|64951969|FG001|Overall Study|source data permanently lost/ other|1|||
23330299|NCT00985504|64951971|FG000|Acute Treatment Period|Adverse Event|3|||
23330300|NCT00985504|64951972|FG001|Acute Treatment Period|Adverse Event|4|||
23446587|NCT04492722|65377700|FG002|Overall Study|Lost to Follow-up|0|||
23161478|NCT04419610|64339120|FG001|Overall Study|Adverse Event|0|||
23161479|NCT04419610|64339119|FG000|Overall Study|discharged early|1|||
23568768|NCT01473381|65809938|FG003|Overall Study|Withdrawal of Consent|26|||
23568769|NCT01473381|65809935|FG000|Overall Study|Lost to Follow-up|25|||
23568770|NCT01473381|65809936|FG001|Overall Study|Lost to Follow-up|28|||
23568771|NCT01473381|65809937|FG002|Overall Study|Lost to Follow-up|35|||
23568772|NCT01473381|65809938|FG003|Overall Study|Lost to Follow-up|23|||
23223354|NCT02015104|64560464|FG001|Overall Study|Withdrew consent prior to treatment|1|||
23223355|NCT01828567|64560465|FG000|Overall Study|Lost to Follow-up|27|||
23223356|NCT01828567|64560466|FG001|Overall Study|Lost to Follow-up|9|||
23223357|NCT01828567|64560465|FG000|Overall Study|Excluded - did not meet criteria|4|||
23223358|NCT01828567|64560466|FG001|Overall Study|Excluded - did not meet criteria|1|||
23223359|NCT01268514|64560471|FG000|Overall Study|Adverse Event|20|||
23223360|NCT01268514|64560471|FG000|Overall Study|Death|8|||
23223361|NCT01268514|64560471|FG000|Overall Study|Lost to Follow-up|5|||
23223362|NCT01268514|64560471|FG000|Overall Study|Withdrawal by Subject|3|||
23223363|NCT01268514|64560471|FG000|Overall Study|Withdrawal by Surgeon|5|||
23223364|NCT00777257|64560472|FG000|Overall Study|Adverse Event|3|||
23223365|NCT00777257|64560473|FG001|Overall Study|Adverse Event|1|||
23223366|NCT00777257|64560474|FG002|Overall Study|Adverse Event|0|||
23223367|NCT00777257|64560472|FG000|Overall Study|Lost to Follow-up|3|||
23223368|NCT00777257|64560473|FG001|Overall Study|Lost to Follow-up|3|||
23223369|NCT00777257|64560474|FG002|Overall Study|Lost to Follow-up|2|||
23223370|NCT00777257|64560472|FG000|Overall Study|Protocol Violation|2|||
23223371|NCT00777257|64560473|FG001|Overall Study|Protocol Violation|2|||
23223372|NCT00777257|64560474|FG002|Overall Study|Protocol Violation|2|||
23223373|NCT00777257|64560472|FG000|Overall Study|Withdrawal by Subject|3|||
23223374|NCT00777257|64560473|FG001|Overall Study|Withdrawal by Subject|6|||
23223375|NCT00777257|64560474|FG002|Overall Study|Withdrawal by Subject|5|||
23223376|NCT00333970|64560479|FG000|Overall Study|Withdrawal by Subject|13|||
23223377|NCT00333970|64560480|FG001|Overall Study|Withdrawal by Subject|7|||
23223378|NCT04055844|64560481|FG000|Overall Study|Adverse Event|12|||
23223379|NCT04055844|64560481|FG000|Overall Study|Poor Performance|1|||
23223380|NCT04055844|64560481|FG000|Overall Study|Death|1|||
23223381|NCT01226472|64560483|FG000|Overall Study|Progressive Disease|1|||
23223382|NCT03573804|64560484|FG000|Overall Study|claustrophobia or MRI table problems|10|||
23223383|NCT00225212|64560485|FG000|Overall Study|Disease progression|2|||
23223384|NCT00225212|64560485|FG000|Overall Study|Death|1|||
23223385|NCT00225212|64560485|FG000|Overall Study|Adverse Event|2|||
23223386|NCT00225212|64560485|FG000|Overall Study|Intercurrent illness|1|||
23223387|NCT00430027|64560486|FG000|Overall Study|Study terminated|8|||
23223388|NCT01641081|64560488|FG000|Period 1|Sponsor request (potential unblinding)|0|||
23223389|NCT01641081|64560489|FG001|Period 1|Sponsor request (potential unblinding)|0|||
23223390|NCT01641081|64560490|FG002|Period 1|Sponsor request (potential unblinding)|0|||
23223391|NCT01641081|64560491|FG003|Period 1|Sponsor request (potential unblinding)|0|||
23223392|NCT01641081|64560492|FG004|Period 1|Sponsor request (potential unblinding)|0|||
23223393|NCT01641081|64560493|FG005|Period 1|Sponsor request (potential unblinding)|0|||
23223394|NCT01641081|64560494|FG006|Period 1|Sponsor request (potential unblinding)|1|||
23223395|NCT01641081|64560495|FG007|Period 1|Sponsor request (potential unblinding)|0|||
23223396|NCT01641081|64560496|FG008|Period 1|Sponsor request (potential unblinding)|0|||
23223397|NCT01641081|64560497|FG009|Period 1|Sponsor request (potential unblinding)|0|||
23223398|NCT01641081|64560488|FG000|Period 1|Protocol Violation|0|||
23223399|NCT01641081|64560489|FG001|Period 1|Protocol Violation|0|||
23223400|NCT01641081|64560490|FG002|Period 1|Protocol Violation|0|||
23223401|NCT01641081|64560491|FG003|Period 1|Protocol Violation|0|||
23568773|NCT01473381|65809935|FG000|Overall Study|Other Reasons|0|||
23161480|NCT04419610|64339120|FG001|Overall Study|discharged early|1|||
23161481|NCT01508702|64339121|FG000|Overall Study|Adverse Event|7|||
23161482|NCT01508702|64339122|FG001|Overall Study|Adverse Event|3|||
23161483|NCT01508702|64339121|FG000|Overall Study|Gout flare|2|||
23161484|NCT01508702|64339122|FG001|Overall Study|Gout flare|0|||
23161485|NCT01508702|64339121|FG000|Overall Study|Protocol Violation|2|||
23161486|NCT01508702|64339122|FG001|Overall Study|Protocol Violation|1|||
23161487|NCT01508702|64339121|FG000|Overall Study|Lost to Follow-up|1|||
23161488|NCT01508702|64339122|FG001|Overall Study|Lost to Follow-up|2|||
23161489|NCT01508702|64339121|FG000|Overall Study|Withdrawal by Subject|11|||
23161490|NCT01508702|64339122|FG001|Overall Study|Withdrawal by Subject|7|||
23161491|NCT02300298|64339123|FG000|Disposition for Nintedanib|Progressive disease|10|||
23161492|NCT02300298|64339124|FG001|Disposition for Nintedanib|Progressive disease|0|||
23161493|NCT02300298|64339123|FG000|Disposition for Docetaxel|Progressive disease|0|||
23161494|NCT02300298|64339124|FG001|Disposition for Docetaxel|Progressive disease|6|||
23161495|NCT02300298|64339123|FG000|Disposition for Docetaxel|other adverse event|0|||
23161496|NCT02300298|64339124|FG001|Disposition for Docetaxel|other adverse event|4|||
23161497|NCT01066585|64339125|FG000|Overall Study|Protocol Violation|1|||
23161498|NCT01066585|64339126|FG001|Overall Study|Protocol Violation|0|||
23161499|NCT01066585|64339125|FG000|Overall Study|Withdrawal by Subject|0|||
23161500|NCT01066585|64339126|FG001|Overall Study|Withdrawal by Subject|3|||
23161501|NCT00143312|64339127|FG000|Overall Study|Death|11|||
23161502|NCT00143312|64339127|FG000|Overall Study|Adverse Event|2|||
23161503|NCT00143312|64339127|FG000|Overall Study|Lost to Follow-up|1|||
23161504|NCT00143312|64339127|FG000|Overall Study|Other|1|||
23161505|NCT00143312|64339127|FG000|Overall Study|Withdrawal by Subject|1|||
23161506|NCT04329702|64339128|FG000|Overall Study|illness|3|||
23161507|NCT04329702|64339129|FG001|Overall Study|illness|4|||
23161508|NCT04329702|64339130|FG002|Overall Study|illness|0|||
23223402|NCT01641081|64560492|FG004|Period 1|Protocol Violation|1|||
23223403|NCT01641081|64560493|FG005|Period 1|Protocol Violation|0|||
23223404|NCT01641081|64560494|FG006|Period 1|Protocol Violation|0|||
23223405|NCT01641081|64560495|FG007|Period 1|Protocol Violation|1|||
23223406|NCT01641081|64560496|FG008|Period 1|Protocol Violation|0|||
23223407|NCT01641081|64560497|FG009|Period 1|Protocol Violation|0|||
23223408|NCT01641081|64560488|FG000|Period 1|Adverse Event|1|||
23568774|NCT01473381|65809936|FG001|Overall Study|Other Reasons|0|||
23568775|NCT01473381|65809937|FG002|Overall Study|Other Reasons|1|||
23568776|NCT01473381|65809938|FG003|Overall Study|Other Reasons|3|||
23568777|NCT03898180|65809939|FG000|Overall Study|Ongoing in Study|133|||
23568778|NCT03898180|65809940|FG001|Overall Study|Ongoing in Study|134|||
23568779|NCT03898180|65809939|FG000|Overall Study|Withdrawal by Subject|3|||
23568780|NCT03898180|65809940|FG001|Overall Study|Withdrawal by Subject|2|||
23568781|NCT03898180|65809939|FG000|Overall Study|Death|109|||
23161509|NCT04329702|64339128|FG000|Overall Study|Lost to Follow-up|0|||
23161510|NCT04329702|64339129|FG001|Overall Study|Lost to Follow-up|0|||
23161511|NCT04329702|64339130|FG002|Overall Study|Lost to Follow-up|2|||
23161512|NCT04329702|64339128|FG000|Overall Study|Death|0|||
23161513|NCT04329702|64339129|FG001|Overall Study|Death|2|||
23161514|NCT04329702|64339130|FG002|Overall Study|Death|0|||
23161515|NCT01471782|64339134|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
23161516|NCT01471782|64339135|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
23161517|NCT01471782|64339136|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
23161518|NCT01471782|64339137|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
23161519|NCT01471782|64339138|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
23161520|NCT01471782|64339139|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
23161521|NCT01471782|64339134|FG000|Overall Study|Lack of Efficacy|1|||
23161522|NCT01471782|64339135|FG001|Overall Study|Lack of Efficacy|2|||
23161523|NCT01471782|64339136|FG002|Overall Study|Lack of Efficacy|1|||
23161524|NCT01471782|64339137|FG003|Overall Study|Lack of Efficacy|1|||
23161525|NCT01471782|64339138|FG004|Overall Study|Lack of Efficacy|5|||
23161526|NCT01471782|64339139|FG005|Overall Study|Lack of Efficacy|18|||
23568782|NCT03898180|65809940|FG001|Overall Study|Death|106|||
23161527|NCT01471782|64339134|FG000|Overall Study|Adverse Event|1|||
23161528|NCT01471782|64339135|FG001|Overall Study|Adverse Event|1|||
23161529|NCT01471782|64339136|FG002|Overall Study|Adverse Event|2|||
23161530|NCT01471782|64339137|FG003|Overall Study|Adverse Event|2|||
23161531|NCT01471782|64339138|FG004|Overall Study|Adverse Event|3|||
23161532|NCT01471782|64339139|FG005|Overall Study|Adverse Event|1|||
23161533|NCT01471782|64339134|FG000|Overall Study|Other|0|||
23161534|NCT01471782|64339135|FG001|Overall Study|Other|0|||
23161535|NCT01471782|64339136|FG002|Overall Study|Other|1|||
23223409|NCT01641081|64560489|FG001|Period 1|Adverse Event|0|||
23223410|NCT01641081|64560490|FG002|Period 1|Adverse Event|0|||
23223411|NCT01641081|64560491|FG003|Period 1|Adverse Event|0|||
23223412|NCT01641081|64560492|FG004|Period 1|Adverse Event|0|||
23223413|NCT01641081|64560493|FG005|Period 1|Adverse Event|0|||
23223414|NCT01641081|64560494|FG006|Period 1|Adverse Event|0|||
23223415|NCT01641081|64560495|FG007|Period 1|Adverse Event|2|||
23223416|NCT01641081|64560496|FG008|Period 1|Adverse Event|0|||
23223417|NCT01641081|64560497|FG009|Period 1|Adverse Event|0|||
23161536|NCT01471782|64339137|FG003|Overall Study|Other|1|||
23161537|NCT01471782|64339138|FG004|Overall Study|Other|6|||
23223418|NCT01641081|64560488|FG000|Period 2|Adverse Event|0|||
23161538|NCT01471782|64339139|FG005|Overall Study|Other|5|||
23161539|NCT01471782|64339134|FG000|Overall Study|Change of Chemotherapy|1|||
23161540|NCT01471782|64339135|FG001|Overall Study|Change of Chemotherapy|1|||
23223419|NCT01641081|64560489|FG001|Period 2|Adverse Event|0|||
23223420|NCT01641081|64560490|FG002|Period 2|Adverse Event|0|||
23568783|NCT00594906|65809941|FG000|Overall Study|Physician Decision|1|||
23568784|NCT00594906|65809942|FG001|Overall Study|Physician Decision|0|||
23568785|NCT00594906|65809941|FG000|Overall Study|Physician Decision|0|||
23223421|NCT01641081|64560491|FG003|Period 2|Adverse Event|0|||
23161541|NCT01471782|64339136|FG002|Overall Study|Change of Chemotherapy|0|||
23161542|NCT01471782|64339137|FG003|Overall Study|Change of Chemotherapy|0|||
23161543|NCT01471782|64339138|FG004|Overall Study|Change of Chemotherapy|1|||
23161544|NCT01471782|64339139|FG005|Overall Study|Change of Chemotherapy|4|||
23161545|NCT01471782|64339134|FG000|Overall Study|Disease Relapse|0|||
23161546|NCT01471782|64339135|FG001|Overall Study|Disease Relapse|0|||
23161547|NCT01471782|64339136|FG002|Overall Study|Disease Relapse|0|||
23161548|NCT01471782|64339137|FG003|Overall Study|Disease Relapse|1|||
23161549|NCT01471782|64339138|FG004|Overall Study|Disease Relapse|2|||
23161550|NCT01471782|64339139|FG005|Overall Study|Disease Relapse|1|||
23161551|NCT01471782|64339134|FG000|Overall Study|Physician Decision|0|||
23161552|NCT01471782|64339135|FG001|Overall Study|Physician Decision|0|||
23161553|NCT01471782|64339136|FG002|Overall Study|Physician Decision|0|||
23161554|NCT01471782|64339137|FG003|Overall Study|Physician Decision|0|||
23161555|NCT01471782|64339138|FG004|Overall Study|Physician Decision|3|||
23161556|NCT01471782|64339139|FG005|Overall Study|Physician Decision|8|||
23161557|NCT01471782|64339134|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23161558|NCT01471782|64339135|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23161559|NCT01471782|64339136|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23161560|NCT01471782|64339137|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23161561|NCT01471782|64339138|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
23161562|NCT01471782|64339139|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23161563|NCT01471782|64339134|FG000|Overall Study|Death|0|||
23161564|NCT01471782|64339135|FG001|Overall Study|Death|0|||
23161565|NCT01471782|64339136|FG002|Overall Study|Death|0|||
23161566|NCT01471782|64339137|FG003|Overall Study|Death|0|||
23161567|NCT01471782|64339138|FG004|Overall Study|Death|0|||
23161568|NCT01471782|64339139|FG005|Overall Study|Death|1|||
23161569|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
23161570|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
23161571|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
23161572|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
23161573|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
23161574|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
23161575|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
23161576|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
23161577|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
23161578|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
23161579|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
23161580|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
23161581|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
23161582|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
23161583|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
23568786|NCT00594906|65809942|FG001|Overall Study|Physician Decision|1|||
23568787|NCT00594906|65809941|FG000|Overall Study|Death|0|||
23568788|NCT00594906|65809942|FG001|Overall Study|Death|1|||
23568789|NCT00003458|65809943|FG000|Overall Study|Not evaluable|4|||
23568790|NCT05284019|65809944|FG000|Overall Study|Study terminated|2|||
23568791|NCT05284019|65809945|FG001|Overall Study|Study terminated|2|||
23568792|NCT05284019|65809946|FG002|Overall Study|Study terminated|2|||
23568793|NCT05284019|65809947|FG003|Overall Study|Study terminated|5|||
23568794|NCT05284019|65809948|FG004|Overall Study|Study terminated|15|||
23568795|NCT05284019|65809944|FG000|Overall Study|Withdrawal by Subject|0|||
23568796|NCT05284019|65809945|FG001|Overall Study|Withdrawal by Subject|0|||
23568797|NCT05284019|65809946|FG002|Overall Study|Withdrawal by Subject|0|||
23568798|NCT05284019|65809947|FG003|Overall Study|Withdrawal by Subject|1|||
23568799|NCT05284019|65809948|FG004|Overall Study|Withdrawal by Subject|1|||
23161584|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
23161585|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
23161586|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
23161587|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
23568800|NCT05284019|65809944|FG000|Overall Study|Lost to Follow-up|1|||
23568801|NCT05284019|65809945|FG001|Overall Study|Lost to Follow-up|0|||
23330301|NCT00985504|64951971|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
23330302|NCT00985504|64951972|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
23330303|NCT00985504|64951971|FG000|Acute Treatment Period|Protocol Violation|2|||
23161588|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
23161589|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
23161590|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
23161591|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
23161592|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
23161593|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
23161594|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
23161595|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
23161596|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
23161597|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
23161598|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
23161599|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23161600|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23161601|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23161602|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23161603|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23330304|NCT00985504|64951972|FG001|Acute Treatment Period|Protocol Violation|0|||
23330305|NCT00985504|64951971|FG000|Acute Treatment Period|Sponsor Decision|0|||
23330306|NCT00985504|64951972|FG001|Acute Treatment Period|Sponsor Decision|1|||
23330307|NCT00985504|64951971|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
23161604|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23161605|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
23161606|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
23161607|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
23175850|NCT01506882|64386591|FG000|Overall Study|Withdrawal by Subject|9|||
23330308|NCT00985504|64951972|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
23330309|NCT00985504|64951971|FG000|Optimization Period|Adverse Event|7|||
23330310|NCT00985504|64951972|FG001|Optimization Period|Adverse Event|9|||
23330311|NCT00985504|64951971|FG000|Optimization Period|Death|0|||
23330312|NCT00985504|64951972|FG001|Optimization Period|Death|1|||
23446588|NCT04492722|65377701|FG003|Overall Study|Lost to Follow-up|1|||
23446589|NCT04492722|65377698|FG000|Overall Study|Physician Decision|0|||
23446590|NCT04492722|65377699|FG001|Overall Study|Physician Decision|3|||
23446591|NCT04492722|65377700|FG002|Overall Study|Physician Decision|1|||
23568802|NCT05284019|65809946|FG002|Overall Study|Lost to Follow-up|0|||
23568803|NCT05284019|65809947|FG003|Overall Study|Lost to Follow-up|2|||
23568804|NCT05284019|65809948|FG004|Overall Study|Lost to Follow-up|1|||
23330313|NCT00985504|64951971|FG000|Optimization Period|Lack of Efficacy|5|||
23330314|NCT00985504|64951972|FG001|Optimization Period|Lack of Efficacy|3|||
23330315|NCT00985504|64951971|FG000|Optimization Period|Lost to Follow-up|0|||
23330316|NCT00985504|64951972|FG001|Optimization Period|Lost to Follow-up|1|||
23446592|NCT04492722|65377701|FG003|Overall Study|Physician Decision|1|||
23446593|NCT04492722|65377698|FG000|Overall Study|Withdrawal by Subject|6|||
23446594|NCT04492722|65377699|FG001|Overall Study|Withdrawal by Subject|6|||
23446595|NCT04492722|65377700|FG002|Overall Study|Withdrawal by Subject|0|||
23446596|NCT04492722|65377701|FG003|Overall Study|Withdrawal by Subject|3|||
23568805|NCT00244374|65809949|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
23568806|NCT00244374|65809950|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
23568807|NCT00244374|65809951|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
23568808|NCT00244374|65809952|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
23568809|NCT00244374|65809953|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
23568810|NCT00244374|65809949|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
23568811|NCT00244374|65809950|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
23568812|NCT00244374|65809951|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
23223422|NCT01641081|64560492|FG004|Period 2|Adverse Event|0|||
23223423|NCT01641081|64560493|FG005|Period 2|Adverse Event|1|||
23223424|NCT01641081|64560494|FG006|Period 2|Adverse Event|0|||
23223425|NCT01641081|64560495|FG007|Period 2|Adverse Event|0|||
23223426|NCT01641081|64560496|FG008|Period 2|Adverse Event|0|||
23223427|NCT01641081|64560497|FG009|Period 2|Adverse Event|0|||
23223428|NCT01641081|64560488|FG000|Period 2|Withdrawal by Subject|0|||
23223429|NCT01641081|64560489|FG001|Period 2|Withdrawal by Subject|0|||
23223430|NCT01641081|64560490|FG002|Period 2|Withdrawal by Subject|0|||
23223431|NCT01641081|64560491|FG003|Period 2|Withdrawal by Subject|1|||
23330317|NCT00985504|64951971|FG000|Optimization Period|Physician Decision|1|||
23330318|NCT00985504|64951972|FG001|Optimization Period|Physician Decision|0|||
23330319|NCT00985504|64951971|FG000|Optimization Period|Protocol Violation|3|||
23330320|NCT00985504|64951972|FG001|Optimization Period|Protocol Violation|1|||
23330321|NCT00985504|64951971|FG000|Optimization Period|Withdrawal by Subject|10|||
23330322|NCT00985504|64951972|FG001|Optimization Period|Withdrawal by Subject|8|||
23330323|NCT03735498|64951973|FG000|Overall Study|Withdrawal by Subject|5|||
23330324|NCT03735498|64951973|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
23330325|NCT01346696|64951974|FG000|Overall Study|Death|1|||
23330326|NCT02872714|64951976|FG000|Overall Study|Progressive Disease|1|||
23330327|NCT02872714|64951977|FG001|Overall Study|Progressive Disease|2|||
23330328|NCT02872714|64951978|FG002|Overall Study|Progressive Disease|0|||
23330329|NCT02872714|64951979|FG003|Overall Study|Progressive Disease|0|||
23330330|NCT02872714|64951980|FG004|Overall Study|Progressive Disease|0|||
23330331|NCT02872714|64951976|FG000|Overall Study|Death|87|||
23330332|NCT02872714|64951977|FG001|Overall Study|Death|36|||
23330333|NCT02872714|64951978|FG002|Overall Study|Death|8|||
23330334|NCT02872714|64951979|FG003|Overall Study|Death|81|||
23330335|NCT02872714|64951980|FG004|Overall Study|Death|2|||
23330336|NCT02872714|64951976|FG000|Overall Study|Lost to Follow-up|2|||
23330337|NCT02872714|64951977|FG001|Overall Study|Lost to Follow-up|1|||
23330338|NCT02872714|64951978|FG002|Overall Study|Lost to Follow-up|0|||
23330339|NCT02872714|64951979|FG003|Overall Study|Lost to Follow-up|3|||
23330340|NCT02872714|64951980|FG004|Overall Study|Lost to Follow-up|0|||
23330341|NCT02872714|64951976|FG000|Overall Study|Physician Decision|0|||
23330342|NCT02872714|64951977|FG001|Overall Study|Physician Decision|0|||
23446597|NCT04492722|65377698|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
23446598|NCT04492722|65377699|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
23446599|NCT04492722|65377700|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
23446600|NCT04492722|65377701|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
23446601|NCT04492722|65377698|FG000|Overall Study|Due to Covid-19 pandemic|7|||
23446602|NCT04492722|65377699|FG001|Overall Study|Due to Covid-19 pandemic|3|||
23446603|NCT04492722|65377700|FG002|Overall Study|Due to Covid-19 pandemic|7|||
23446604|NCT04492722|65377701|FG003|Overall Study|Due to Covid-19 pandemic|6|||
23446605|NCT04492722|65377698|FG000|Overall Study|Failure to meet randomisation criteria|2|||
23446606|NCT04492722|65377699|FG001|Overall Study|Failure to meet randomisation criteria|3|||
23446607|NCT04492722|65377700|FG002|Overall Study|Failure to meet randomisation criteria|4|||
23568813|NCT00244374|65809952|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
23568814|NCT00244374|65809953|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
23568815|NCT00244374|65809949|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
23568816|NCT00244374|65809950|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
23568817|NCT00244374|65809951|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
23568818|NCT00244374|65809952|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
23568819|NCT00244374|65809953|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
23568820|NCT00244374|65809949|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
23568821|NCT00244374|65809950|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
23568822|NCT00244374|65809951|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
23568823|NCT00244374|65809952|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
23568824|NCT00244374|65809953|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
23568825|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
23568826|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
23568827|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
23568828|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
23568829|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
23568830|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
23568831|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
23223432|NCT01641081|64560492|FG004|Period 2|Withdrawal by Subject|0|||
23223433|NCT01641081|64560493|FG005|Period 2|Withdrawal by Subject|0|||
23330343|NCT02872714|64951978|FG002|Overall Study|Physician Decision|0|||
23330344|NCT02872714|64951979|FG003|Overall Study|Physician Decision|1|||
23446608|NCT04492722|65377701|FG003|Overall Study|Failure to meet randomisation criteria|2|||
23446609|NCT04492722|65377698|FG000|Overall Study|Early termination from the study|54|||
23446610|NCT04492722|65377699|FG001|Overall Study|Early termination from the study|51|||
23446611|NCT04492722|65377700|FG002|Overall Study|Early termination from the study|50|||
23446612|NCT04492722|65377701|FG003|Overall Study|Early termination from the study|50|||
23446613|NCT04492722|65377698|FG000|Overall Study|Missing|3|||
23446614|NCT04492722|65377699|FG001|Overall Study|Missing|0|||
23446615|NCT04492722|65377700|FG002|Overall Study|Missing|0|||
23446616|NCT04492722|65377701|FG003|Overall Study|Missing|5|||
23446617|NCT04492722|65377698|FG000|Overall Study|Participants who did not receive treatment|0|||
23446618|NCT04492722|65377699|FG001|Overall Study|Participants who did not receive treatment|1|||
23446619|NCT04492722|65377700|FG002|Overall Study|Participants who did not receive treatment|4|||
23446620|NCT04492722|65377701|FG003|Overall Study|Participants who did not receive treatment|0|||
23446621|NCT01054456|65377702|FG000|Overall Study|Other|1|||
23568832|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
23330345|NCT02872714|64951980|FG004|Overall Study|Physician Decision|0|||
23330346|NCT02872714|64951976|FG000|Overall Study|Withdrawal by Subject|1|||
23330347|NCT02872714|64951977|FG001|Overall Study|Withdrawal by Subject|3|||
23330348|NCT02872714|64951978|FG002|Overall Study|Withdrawal by Subject|0|||
23330349|NCT02872714|64951979|FG003|Overall Study|Withdrawal by Subject|2|||
23330350|NCT02872714|64951980|FG004|Overall Study|Withdrawal by Subject|0|||
23330351|NCT02872714|64951976|FG000|Overall Study|Captured as Other|2|||
23330352|NCT02872714|64951977|FG001|Overall Study|Captured as Other|0|||
23330353|NCT02872714|64951978|FG002|Overall Study|Captured as Other|0|||
23330354|NCT02872714|64951979|FG003|Overall Study|Captured as Other|1|||
23330355|NCT02872714|64951980|FG004|Overall Study|Captured as Other|0|||
23330356|NCT01966120|64951981|FG000|Overall Study|Withdrawal by Subject|0|||
23330357|NCT01966120|64951982|FG001|Overall Study|Withdrawal by Subject|5|||
23330358|NCT01966120|64951981|FG000|Overall Study|Lost to Follow-up|1|||
23330359|NCT01966120|64951982|FG001|Overall Study|Lost to Follow-up|1|||
23330360|NCT00824772|64951983|FG000|Overall Study|Withdrawal by Subject|8|||
23330361|NCT02042014|64951985|FG000|Overall Study|Adverse Event|1|||
23330362|NCT02042014|64951985|FG000|Overall Study|Physician Decision|7|||
23330363|NCT01930162|64951986|FG000|Overall Study|Abnormal test procedure result(s)|4|||
23330364|NCT01930162|64951986|FG000|Overall Study|Death|1|||
23330365|NCT00961350|64951991|FG000|Overall Study|Adverse Event|18|||
23330366|NCT00961350|64951992|FG001|Overall Study|Adverse Event|33|||
23330367|NCT00961350|64951991|FG000|Overall Study|Withdrawal by Subject|10|||
23330368|NCT00961350|64951992|FG001|Overall Study|Withdrawal by Subject|10|||
23330369|NCT00961350|64951991|FG000|Overall Study|Lost to Follow-up|3|||
23330370|NCT00961350|64951992|FG001|Overall Study|Lost to Follow-up|3|||
23446622|NCT03294590|65377703|FG000|Overall Study|Lost to Follow-up|105|||
23446623|NCT03294590|65377704|FG001|Overall Study|Lost to Follow-up|107|||
23568833|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
23568834|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
23568835|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
23568836|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
23568837|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
23568838|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
23568839|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
23161608|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
23330371|NCT00961350|64951991|FG000|Overall Study|Misc|16|||
23330372|NCT00961350|64951992|FG001|Overall Study|Misc|21|||
23330373|NCT01286467|64951993|FG000|Overall Study|Death|1|||
23446624|NCT02370420|65377705|FG000|Overall Study|Physician Decision|3|||
23446625|NCT02370420|65377706|FG001|Overall Study|Physician Decision|3|||
23446626|NCT02370420|65377705|FG000|Overall Study|Lost to Follow-up|11|||
23446627|NCT02370420|65377706|FG001|Overall Study|Lost to Follow-up|9|||
23446628|NCT00154297|65377712|FG000|Overall Study|Death|5|||
23446629|NCT00154297|65377713|FG001|Overall Study|Death|2|||
23446630|NCT00154297|65377712|FG000|Overall Study|Withdrawal by Subject|0|||
23446631|NCT00154297|65377713|FG001|Overall Study|Withdrawal by Subject|5|||
23446632|NCT00154297|65377712|FG000|Overall Study|Lost to Follow-up|3|||
23446633|NCT00154297|65377713|FG001|Overall Study|Lost to Follow-up|0|||
23446634|NCT04524858|65377714|FG000|Overall Study|Adverse Event|1|||
23446635|NCT00920855|65377715|FG000|Overall Study|Adverse Event|1|||
23446636|NCT00920855|65377716|FG001|Overall Study|Adverse Event|1|||
23330374|NCT01286467|64951994|FG001|Overall Study|Death|1|||
23330375|NCT01286467|64951995|FG002|Overall Study|Death|1|||
23161609|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
23161610|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
23161611|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
23161612|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
23161613|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
23161614|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
23161615|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
23161616|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
23161617|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
23161618|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23161619|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23161620|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23161621|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23161622|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
23330376|NCT01286467|64951996|FG003|Overall Study|Death|0|||
23330377|NCT01286467|64951993|FG000|Overall Study|Lost to Follow-up|0|||
23330378|NCT01286467|64951994|FG001|Overall Study|Lost to Follow-up|0|||
23161623|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23161624|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
23161625|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23330379|NCT01286467|64951995|FG002|Overall Study|Lost to Follow-up|0|||
23446637|NCT00920855|65377717|FG002|Overall Study|Adverse Event|4|||
23446638|NCT00920855|65377715|FG000|Overall Study|Withdrawal by Subject|2|||
23161626|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23161627|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23161628|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
23161629|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23161630|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
23161631|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23161632|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23161633|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23161634|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
23161635|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23161636|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
23161637|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23161638|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23161639|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23161640|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
23161641|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23161642|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
23161643|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23161644|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23161645|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23161646|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
23161647|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23161648|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23223434|NCT01641081|64560494|FG006|Period 2|Withdrawal by Subject|2|||
23568840|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
23568841|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
23568842|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
23568843|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
23568844|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
23568845|NCT00244374|65809949|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
23568846|NCT00244374|65809950|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
23568847|NCT00244374|65809951|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
23568848|NCT00244374|65809952|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
23568849|NCT00244374|65809953|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
23568850|NCT03893825|65809957|FG000|Overall Study|Death|2|||
23568851|NCT03893825|65809958|FG001|Overall Study|Death|1|||
23568852|NCT03893825|65809957|FG000|Overall Study|Adverse Event|0|||
23568853|NCT03893825|65809958|FG001|Overall Study|Adverse Event|2|||
23568854|NCT03893825|65809957|FG000|Overall Study|Withdrawal by Subject|19|||
23568855|NCT03893825|65809958|FG001|Overall Study|Withdrawal by Subject|21|||
23568856|NCT03893825|65809957|FG000|Overall Study|Protocol deviation|1|||
23568857|NCT03893825|65809958|FG001|Overall Study|Protocol deviation|0|||
23568858|NCT03893825|65809957|FG000|Overall Study|Lost to Follow-up|10|||
23568859|NCT03893825|65809958|FG001|Overall Study|Lost to Follow-up|10|||
23568860|NCT03893825|65809957|FG000|Overall Study|Other than specified|7|||
23568861|NCT03893825|65809958|FG001|Overall Study|Other than specified|6|||
23568862|NCT00423293|65809960|FG000|Overall Study|Ineligible / No protocol treatment|11|||
23568863|NCT01216293|65809961|FG000|Main Study|Adverse Event|1|||
23568864|NCT01216293|65809962|FG001|Main Study|Adverse Event|4|||
23568865|NCT01216293|65809963|FG002|Main Study|Adverse Event|2|||
23568866|NCT01216293|65809961|FG000|Main Study|Major Protocol Deviation|1|||
23568867|NCT01216293|65809962|FG001|Main Study|Major Protocol Deviation|0|||
23568868|NCT01216293|65809963|FG002|Main Study|Major Protocol Deviation|1|||
23568869|NCT01216293|65809961|FG000|Main Study|Lost to Follow-up|3|||
23568870|NCT01216293|65809962|FG001|Main Study|Lost to Follow-up|1|||
23568871|NCT01216293|65809963|FG002|Main Study|Lost to Follow-up|0|||
23568872|NCT01216293|65809961|FG000|Main Study|Voluntary Withdrawal|2|||
23568873|NCT01216293|65809962|FG001|Main Study|Voluntary Withdrawal|2|||
23568874|NCT01216293|65809963|FG002|Main Study|Voluntary Withdrawal|2|||
23568875|NCT01216293|65809961|FG000|Main Study|Other Reason Not Specified|0|||
23568876|NCT01216293|65809962|FG001|Main Study|Other Reason Not Specified|1|||
23568877|NCT01216293|65809963|FG002|Main Study|Other Reason Not Specified|1|||
23568878|NCT01216293|65809961|FG000|Main Study|Randomized, Not Treated|1|||
23568879|NCT01216293|65809962|FG001|Main Study|Randomized, Not Treated|0|||
23568880|NCT01216293|65809963|FG002|Main Study|Randomized, Not Treated|0|||
23568881|NCT01216293|65809961|FG000|Calcium Absorption Substudy|Adverse Event|0|||
23568882|NCT01216293|65809962|FG001|Calcium Absorption Substudy|Adverse Event|2|||
23568883|NCT01216293|65809963|FG002|Calcium Absorption Substudy|Adverse Event|0|||
23223435|NCT01641081|64560495|FG007|Period 2|Withdrawal by Subject|0|||
23223436|NCT01641081|64560496|FG008|Period 2|Withdrawal by Subject|0|||
23223437|NCT01641081|64560497|FG009|Period 2|Withdrawal by Subject|0|||
23223438|NCT01641081|64560488|FG000|Period 2|Protocol Violation|1|||
23223439|NCT01641081|64560489|FG001|Period 2|Protocol Violation|0|||
23223440|NCT01641081|64560490|FG002|Period 2|Protocol Violation|0|||
23223441|NCT01641081|64560491|FG003|Period 2|Protocol Violation|0|||
23223442|NCT01641081|64560492|FG004|Period 2|Protocol Violation|0|||
23223443|NCT01641081|64560493|FG005|Period 2|Protocol Violation|0|||
23223444|NCT01641081|64560494|FG006|Period 2|Protocol Violation|0|||
23568884|NCT01216293|65809961|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
23568885|NCT01216293|65809962|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
23223445|NCT01641081|64560495|FG007|Period 2|Protocol Violation|0|||
23223446|NCT01641081|64560496|FG008|Period 2|Protocol Violation|0|||
23223447|NCT01641081|64560497|FG009|Period 2|Protocol Violation|0|||
23223448|NCT01641081|64560488|FG000|Period 3|Adverse Event|0|||
23223449|NCT01641081|64560489|FG001|Period 3|Adverse Event|0|||
23223450|NCT01641081|64560490|FG002|Period 3|Adverse Event|1|||
23223451|NCT01641081|64560491|FG003|Period 3|Adverse Event|0|||
23161649|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23161650|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
23161651|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23161652|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
23161653|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23161654|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23223452|NCT01641081|64560492|FG004|Period 3|Adverse Event|0|||
23223453|NCT01641081|64560493|FG005|Period 3|Adverse Event|0|||
23223454|NCT01641081|64560494|FG006|Period 3|Adverse Event|0|||
23223455|NCT01641081|64560495|FG007|Period 3|Adverse Event|0|||
23223456|NCT01641081|64560496|FG008|Period 3|Adverse Event|0|||
23223457|NCT01641081|64560497|FG009|Period 3|Adverse Event|0|||
23223458|NCT01641081|64560488|FG000|Period 3|Withdrawal by Subject|0|||
23223459|NCT01641081|64560489|FG001|Period 3|Withdrawal by Subject|0|||
23223460|NCT01641081|64560490|FG002|Period 3|Withdrawal by Subject|0|||
23223461|NCT01641081|64560491|FG003|Period 3|Withdrawal by Subject|0|||
23223462|NCT01641081|64560492|FG004|Period 3|Withdrawal by Subject|0|||
23223463|NCT01641081|64560493|FG005|Period 3|Withdrawal by Subject|0|||
23223464|NCT01641081|64560494|FG006|Period 3|Withdrawal by Subject|0|||
23223465|NCT01641081|64560495|FG007|Period 3|Withdrawal by Subject|0|||
23223466|NCT01641081|64560496|FG008|Period 3|Withdrawal by Subject|1|||
23223467|NCT01641081|64560497|FG009|Period 3|Withdrawal by Subject|0|||
23568886|NCT01216293|65809963|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
23568887|NCT01216293|65809961|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
23568888|NCT01216293|65809962|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
23568889|NCT01216293|65809963|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
23568890|NCT00147225|65809964|FG000|Overall Study|Withdrawal by Subject|1|||
23568891|NCT00147225|65809965|FG001|Overall Study|Withdrawal by Subject|0|||
23568892|NCT00147225|65809966|FG002|Overall Study|Withdrawal by Subject|1|||
23568893|NCT00147225|65809967|FG003|Overall Study|Withdrawal by Subject|0|||
23568894|NCT00147225|65809968|FG004|Overall Study|Withdrawal by Subject|0|||
23568895|NCT00147225|65809969|FG005|Overall Study|Withdrawal by Subject|1|||
23568896|NCT00147225|65809964|FG000|Overall Study|Adverse Event|0|||
23568897|NCT00147225|65809965|FG001|Overall Study|Adverse Event|0|||
23568898|NCT00147225|65809966|FG002|Overall Study|Adverse Event|1|||
23568899|NCT00147225|65809967|FG003|Overall Study|Adverse Event|1|||
23568900|NCT00147225|65809968|FG004|Overall Study|Adverse Event|0|||
23568901|NCT00147225|65809969|FG005|Overall Study|Adverse Event|0|||
23568902|NCT00147225|65809964|FG000|Overall Study|Screen Failure|0|||
23568903|NCT00147225|65809965|FG001|Overall Study|Screen Failure|0|||
23568904|NCT00147225|65809966|FG002|Overall Study|Screen Failure|0|||
23568905|NCT00147225|65809967|FG003|Overall Study|Screen Failure|0|||
23568906|NCT00147225|65809968|FG004|Overall Study|Screen Failure|1|||
23568907|NCT00147225|65809969|FG005|Overall Study|Screen Failure|0|||
23568908|NCT00147225|65809964|FG000|Overall Study|Chemotherapy Changed|0|||
23568909|NCT00147225|65809965|FG001|Overall Study|Chemotherapy Changed|0|||
23568910|NCT00147225|65809966|FG002|Overall Study|Chemotherapy Changed|0|||
23568911|NCT00147225|65809967|FG003|Overall Study|Chemotherapy Changed|0|||
23161655|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23223468|NCT01641081|64560488|FG000|Period 4|Adverse Event|0|||
23223469|NCT01641081|64560489|FG001|Period 4|Adverse Event|1|||
23223470|NCT01641081|64560490|FG002|Period 4|Adverse Event|0|||
23223471|NCT01641081|64560491|FG003|Period 4|Adverse Event|1|||
23223472|NCT01641081|64560492|FG004|Period 4|Adverse Event|0|||
23223473|NCT01641081|64560493|FG005|Period 4|Adverse Event|0|||
23223474|NCT01641081|64560494|FG006|Period 4|Adverse Event|0|||
23223475|NCT01641081|64560495|FG007|Period 4|Adverse Event|0|||
23223476|NCT01641081|64560496|FG008|Period 4|Adverse Event|0|||
23223477|NCT01641081|64560497|FG009|Period 4|Adverse Event|0|||
23446639|NCT00920855|65377716|FG001|Overall Study|Withdrawal by Subject|1|||
23446640|NCT00920855|65377717|FG002|Overall Study|Withdrawal by Subject|6|||
23446641|NCT00920855|65377715|FG000|Overall Study|Disease progression|2|||
23446642|NCT00920855|65377716|FG001|Overall Study|Disease progression|1|||
23446643|NCT00920855|65377717|FG002|Overall Study|Disease progression|10|||
23446644|NCT00920855|65377715|FG000|Overall Study|Noncompliance to study medication|0|||
23161656|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
23161657|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23161658|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
23161659|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23446645|NCT00920855|65377716|FG001|Overall Study|Noncompliance to study medication|0|||
23446646|NCT00920855|65377717|FG002|Overall Study|Noncompliance to study medication|1|||
23446647|NCT00920855|65377715|FG000|Overall Study|Response plateau; started maintenance|0|||
23446648|NCT00920855|65377716|FG001|Overall Study|Response plateau; started maintenance|0|||
23446649|NCT00920855|65377717|FG002|Overall Study|Response plateau; started maintenance|1|||
23446650|NCT02021643|65377726|FG000|Overall Study|Enrolled but Never Treated|1|||
23446651|NCT02021643|65377727|FG001|Overall Study|Enrolled but Never Treated|0|||
23446652|NCT02021643|65377728|FG002|Overall Study|Enrolled but Never Treated|0|||
23568912|NCT00147225|65809968|FG004|Overall Study|Chemotherapy Changed|0|||
23568913|NCT00147225|65809969|FG005|Overall Study|Chemotherapy Changed|1|||
23568914|NCT03443713|65809973|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
23568915|NCT03443713|65809974|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
23568916|NCT03443713|65809975|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
23568917|NCT01213173|65809976|FG000|Overall Study|Protocol Violation|2|||
23568918|NCT01213173|65809977|FG001|Overall Study|Protocol Violation|0|||
23568919|NCT01213173|65809976|FG000|Overall Study|Adverse Event|4|||
23568920|NCT01213173|65809977|FG001|Overall Study|Adverse Event|8|||
23568921|NCT01213173|65809976|FG000|Overall Study|Withdrawal by Subject|5|||
23568922|NCT01213173|65809977|FG001|Overall Study|Withdrawal by Subject|5|||
23161660|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23161661|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23161662|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23161663|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
23161664|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
23161665|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23568923|NCT01213173|65809976|FG000|Overall Study|Incorrect Enrollment|1|||
23161666|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23161667|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23161668|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23161669|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
23161670|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
23161671|NCT00111800|64339140|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23161672|NCT00111800|64339141|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23161673|NCT00111800|64339142|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23161674|NCT00111800|64339143|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23161675|NCT00111800|64339144|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
23161676|NCT00111800|64339145|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
23161677|NCT00111800|64339140|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
23330380|NCT01286467|64951996|FG003|Overall Study|Lost to Follow-up|1|||
23446653|NCT02021643|65377729|FG003|Overall Study|Enrolled but Never Treated|0|||
23446654|NCT02021643|65377726|FG000|Overall Study|Adverse Event|0|||
23446655|NCT02021643|65377727|FG001|Overall Study|Adverse Event|1|||
23446656|NCT02021643|65377728|FG002|Overall Study|Adverse Event|0|||
23446657|NCT02021643|65377729|FG003|Overall Study|Adverse Event|0|||
23223478|NCT01641081|64560488|FG000|Period 5|Adverse Event|0|||
23223479|NCT01641081|64560489|FG001|Period 5|Adverse Event|0|||
23223480|NCT01641081|64560490|FG002|Period 5|Adverse Event|2|||
23223481|NCT01641081|64560491|FG003|Period 5|Adverse Event|0|||
23223482|NCT01641081|64560492|FG004|Period 5|Adverse Event|0|||
23223483|NCT01641081|64560493|FG005|Period 5|Adverse Event|0|||
23223484|NCT01641081|64560494|FG006|Period 5|Adverse Event|0|||
23223485|NCT01641081|64560495|FG007|Period 5|Adverse Event|0|||
23223486|NCT01641081|64560496|FG008|Period 5|Adverse Event|0|||
23446658|NCT02021643|65377726|FG000|Overall Study|Death|0|||
23568924|NCT01213173|65809977|FG001|Overall Study|Incorrect Enrollment|3|||
23568925|NCT00545363|65809982|FG000|Overall Study|Adverse Event|6|||
23568926|NCT00545363|65809983|FG001|Overall Study|Adverse Event|7|||
23568927|NCT00545363|65809982|FG000|Overall Study|Withdrawal by Subject|6|||
23568928|NCT00545363|65809983|FG001|Overall Study|Withdrawal by Subject|5|||
23568929|NCT00545363|65809982|FG000|Overall Study|Non-compliance|3|||
23568930|NCT00545363|65809983|FG001|Overall Study|Non-compliance|1|||
23568931|NCT00545363|65809982|FG000|Overall Study|Did not meet entry criteria|1|||
23568932|NCT00545363|65809983|FG001|Overall Study|Did not meet entry criteria|1|||
23568933|NCT00545363|65809982|FG000|Overall Study|Lost to Follow-up|2|||
23568934|NCT00545363|65809983|FG001|Overall Study|Lost to Follow-up|0|||
23568935|NCT00545363|65809982|FG000|Overall Study|Other|1|||
23568936|NCT00545363|65809983|FG001|Overall Study|Other|1|||
23568937|NCT01671748|65809985|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
23568938|NCT01671748|65809986|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
23568939|NCT01671748|65809985|FG000|4 Week run-in Phase|Adverse Event|1|||
23568940|NCT01671748|65809986|FG001|4 Week run-in Phase|Adverse Event|0|||
23223487|NCT01641081|64560497|FG009|Period 5|Adverse Event|0|||
23223488|NCT03887052|64560498|FG000|Overall Study|Adverse Event|2|||
23568941|NCT01671748|65809985|FG000|4 Week run-in Phase|Not eligible|9|||
23568942|NCT01671748|65809986|FG001|4 Week run-in Phase|Not eligible|0|||
23568943|NCT02032173|65809987|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
23223489|NCT03887052|64560498|FG000|Overall Study|Physician Decision|2|||
23223490|NCT03887052|64560498|FG000|Overall Study|Withdrawal by Subject|3|||
23446659|NCT02021643|65377727|FG001|Overall Study|Death|1|||
23568944|NCT03856996|65809988|FG000|Overall Study|Withdrawal by Subject|1|||
23568945|NCT03856996|65809989|FG001|Overall Study|Withdrawal by Subject|0|||
23236678|NCT01190839|64608287|FG000|Overall Study|Trial stopped by Sponsor|71|||
23568946|NCT03856996|65809988|FG000|Overall Study|Lost to Follow-up|0|||
23446660|NCT02021643|65377728|FG002|Overall Study|Death|0|||
23568947|NCT03856996|65809989|FG001|Overall Study|Lost to Follow-up|1|||
23161678|NCT00111800|64339141|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
23161679|NCT00111800|64339142|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
23161680|NCT00111800|64339143|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
23161681|NCT00111800|64339144|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
23161682|NCT00111800|64339145|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
23161683|NCT00111800|64339140|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
23161684|NCT00111800|64339141|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
23161685|NCT00111800|64339142|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
23161686|NCT00111800|64339143|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
23161687|NCT00111800|64339144|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
23161688|NCT00111800|64339145|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
23161689|NCT00111800|64339140|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
23161690|NCT00111800|64339141|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
23330381|NCT01286467|64951993|FG000|Overall Study|Withdrawal by Subject|0|||
23330382|NCT01286467|64951994|FG001|Overall Study|Withdrawal by Subject|0|||
23568948|NCT03856996|65809988|FG000|Overall Study|Adverse Event|1|||
23568949|NCT03856996|65809989|FG001|Overall Study|Adverse Event|1|||
23568950|NCT03856996|65809988|FG000|Overall Study|Other|1|||
23568951|NCT03856996|65809989|FG001|Overall Study|Other|0|||
23568952|NCT01342887|65809990|FG000|Overall Study|Death|2|||
23568953|NCT00924560|65813168|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
23568954|NCT00924560|65813169|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
23568955|NCT00924560|65813170|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
23568956|NCT00924560|65813168|FG000|Overall Study|Non Compliance with the Protocol|20|||
23568957|NCT00924560|65813169|FG001|Overall Study|Non Compliance with the Protocol|15|||
23568958|NCT00924560|65813170|FG002|Overall Study|Non Compliance with the Protocol|4|||
23568959|NCT00924560|65813168|FG000|Overall Study|Physician Decision|2|||
23568960|NCT00924560|65813169|FG001|Overall Study|Physician Decision|3|||
23568961|NCT00924560|65813170|FG002|Overall Study|Physician Decision|4|||
23568962|NCT00924560|65813168|FG000|Overall Study|Withdrawal by Subject|50|||
23568963|NCT00924560|65813169|FG001|Overall Study|Withdrawal by Subject|44|||
23568964|NCT00924560|65813170|FG002|Overall Study|Withdrawal by Subject|18|||
23568965|NCT00924560|65813168|FG000|Overall Study|Adverse Event|39|||
23568966|NCT00924560|65813169|FG001|Overall Study|Adverse Event|33|||
23568967|NCT00924560|65813170|FG002|Overall Study|Adverse Event|0|||
23568968|NCT00924560|65813168|FG000|Overall Study|Pregnancy|5|||
23568969|NCT00924560|65813169|FG001|Overall Study|Pregnancy|7|||
23568970|NCT00924560|65813170|FG002|Overall Study|Pregnancy|1|||
23568971|NCT00924560|65813168|FG000|Overall Study|Lost to Follow-up|78|||
23568972|NCT00924560|65813169|FG001|Overall Study|Lost to Follow-up|94|||
23568973|NCT00924560|65813170|FG002|Overall Study|Lost to Follow-up|45|||
23568974|NCT00924560|65813168|FG000|Overall Study|Miscellaneous Reasons|13|||
23568975|NCT00924560|65813169|FG001|Overall Study|Miscellaneous Reasons|10|||
23568976|NCT00924560|65813170|FG002|Overall Study|Miscellaneous Reasons|10|||
23568977|NCT01987596|65813172|FG000|Overall Study|Physician Decision|1|||
23568978|NCT01987596|65813173|FG001|Overall Study|Physician Decision|0|||
23568979|NCT01987596|65813172|FG000|Overall Study|Progressive Disease; missing all period|0|||
23568980|NCT01987596|65813173|FG001|Overall Study|Progressive Disease; missing all period|1|||
23568981|NCT00924469|65813174|FG000|Overall Study|Adverse Event|2|||
23568982|NCT00924469|65813175|FG001|Overall Study|Adverse Event|0|||
23568983|NCT00924469|65813174|FG000|Overall Study|Withdrawal by Subject|0|||
23568984|NCT00924469|65813175|FG001|Overall Study|Withdrawal by Subject|1|||
23568985|NCT00924469|65813174|FG000|Overall Study|Lost to Follow-up|0|||
23568986|NCT00924469|65813175|FG001|Overall Study|Lost to Follow-up|1|||
23568987|NCT00088205|65813178|FG000|Overall Study|Adverse Event|4|||
23568988|NCT00088205|65813178|FG000|Overall Study|Progressive Disease|51|||
23161691|NCT00111800|64339142|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
23161692|NCT00111800|64339143|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
23161693|NCT00111800|64339144|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
23161694|NCT00111800|64339145|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
23161695|NCT00111800|64339140|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
23161696|NCT00111800|64339141|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
23161697|NCT00111800|64339142|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
23161698|NCT00111800|64339143|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
23161699|NCT00111800|64339144|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
23161700|NCT00111800|64339145|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
23161701|NCT00111800|64339140|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23161702|NCT00111800|64339141|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23161703|NCT00111800|64339142|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
23161704|NCT00111800|64339143|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23161705|NCT00111800|64339144|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23161706|NCT00111800|64339145|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
23161707|NCT00111800|64339140|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23161708|NCT00111800|64339141|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
23161709|NCT00111800|64339142|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23161710|NCT00111800|64339143|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23161711|NCT00111800|64339144|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23161712|NCT00111800|64339145|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
23161713|NCT00111800|64339140|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23161714|NCT00111800|64339141|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23161715|NCT00111800|64339142|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
23161716|NCT00111800|64339143|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23161717|NCT00111800|64339144|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23161718|NCT00111800|64339145|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
23161719|NCT00111800|64339140|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23161720|NCT00111800|64339141|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23223491|NCT03887052|64560498|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
23223492|NCT03887052|64560498|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
23223493|NCT01976624|64560499|FG000|Overall Study|Participants contraindicated|2|||
23223494|NCT01976624|64560499|FG000|Overall Study|Participants age less than 19 years|12|||
23330383|NCT01286467|64951995|FG002|Overall Study|Withdrawal by Subject|1|||
23330384|NCT01286467|64951996|FG003|Overall Study|Withdrawal by Subject|0|||
23446661|NCT02021643|65377729|FG003|Overall Study|Death|0|||
23161721|NCT00111800|64339142|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
23161722|NCT00111800|64339143|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23161723|NCT00111800|64339144|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23161724|NCT00111800|64339145|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
23161725|NCT02270242|64339146|FG000|Overall Study|Withdrawal by Subject|18|||
23446662|NCT02021643|65377726|FG000|Overall Study|Investigator's Discretion|1|||
23446663|NCT02021643|65377727|FG001|Overall Study|Investigator's Discretion|0|||
23330385|NCT01286467|64951993|FG000|Overall Study|Physician Decision|0|||
23330386|NCT01286467|64951994|FG001|Overall Study|Physician Decision|0|||
23330387|NCT01286467|64951995|FG002|Overall Study|Physician Decision|0|||
23161726|NCT02270242|64339147|FG001|Overall Study|Withdrawal by Subject|25|||
23161727|NCT02270242|64339146|FG000|Overall Study|Lost to Follow-up|41|||
23161728|NCT02270242|64339147|FG001|Overall Study|Lost to Follow-up|27|||
23161729|NCT02270242|64339146|FG000|Overall Study|Physician Decision|0|||
23161730|NCT02270242|64339147|FG001|Overall Study|Physician Decision|1|||
23161731|NCT01923285|64339154|FG000|Overall Study|Withdrawal by Subject|7|||
23161732|NCT01923285|64339155|FG001|Overall Study|Withdrawal by Subject|6|||
23161733|NCT01250379|64339165|FG000|Overall Study|Death|141|||
23161734|NCT01250379|64339166|FG001|Overall Study|Death|148|||
23161735|NCT01250379|64339165|FG000|Overall Study|Withdrawal by Subject|32|||
23161736|NCT01250379|64339166|FG001|Overall Study|Withdrawal by Subject|20|||
23161737|NCT01250379|64339165|FG000|Overall Study|Physician Decision|11|||
23161738|NCT01250379|64339166|FG001|Overall Study|Physician Decision|3|||
23161739|NCT01250379|64339165|FG000|Overall Study|Protocol Violation|2|||
23161740|NCT01250379|64339166|FG001|Overall Study|Protocol Violation|8|||
23161741|NCT01250379|64339165|FG000|Overall Study|Lost to Follow-up|9|||
23161742|NCT01250379|64339166|FG001|Overall Study|Lost to Follow-up|6|||
23161743|NCT01250379|64339165|FG000|Overall Study|Adverse Event|5|||
23161744|NCT01250379|64339166|FG001|Overall Study|Adverse Event|4|||
23161745|NCT01250379|64339165|FG000|Overall Study|Other|0|||
23330388|NCT01286467|64951996|FG003|Overall Study|Physician Decision|1|||
23330389|NCT01286467|64951993|FG000|Overall Study|Disease progression|3|||
23568989|NCT00088205|65813178|FG000|Overall Study|Physician Decision|1|||
23568990|NCT00088205|65813178|FG000|Overall Study|Death Due to Study Disease|4|||
23568991|NCT00539643|65813179|FG000|Overall Study|Adverse Event|1|||
23568992|NCT00539643|65813180|FG001|Overall Study|Adverse Event|0|||
23568993|NCT00539643|65813179|FG000|Overall Study|Death|2|||
23568994|NCT00539643|65813180|FG001|Overall Study|Death|1|||
23568995|NCT00539643|65813179|FG000|Overall Study|Physician Decision|3|||
23568996|NCT00539643|65813180|FG001|Overall Study|Physician Decision|1|||
23568997|NCT00539643|65813179|FG000|Overall Study|Withdrawal by Subject|0|||
23568998|NCT00539643|65813180|FG001|Overall Study|Withdrawal by Subject|1|||
23568999|NCT00514046|65813181|FG000|Overall Study|transferred to another protocol|2|||
23569000|NCT00514046|65813182|FG001|Overall Study|transferred to another protocol|1|||
23569001|NCT00514046|65813183|FG002|Overall Study|transferred to another protocol|3|||
23569002|NCT00514046|65813184|FG003|Overall Study|transferred to another protocol|0|||
23569003|NCT00514046|65813185|FG004|Overall Study|transferred to another protocol|1|||
23569004|NCT00514046|65813186|FG005|Overall Study|transferred to another protocol|0|||
23569005|NCT00514046|65813187|FG006|Overall Study|transferred to another protocol|0|||
23569006|NCT00514046|65813188|FG007|Overall Study|transferred to another protocol|0|||
23569007|NCT00514046|65813189|FG008|Overall Study|transferred to another protocol|0|||
23569008|NCT00514046|65813181|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
23569009|NCT00514046|65813182|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
23569010|NCT00514046|65813183|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
23569011|NCT00514046|65813184|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
23569012|NCT00514046|65813185|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
23569013|NCT00514046|65813186|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
23569014|NCT00514046|65813187|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
23569015|NCT00514046|65813188|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
23569016|NCT00514046|65813189|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
23569017|NCT00514046|65813181|FG000|Overall Study|Disease progression on study|0|||
23569018|NCT00514046|65813182|FG001|Overall Study|Disease progression on study|0|||
23569019|NCT00514046|65813183|FG002|Overall Study|Disease progression on study|2|||
23569020|NCT00514046|65813184|FG003|Overall Study|Disease progression on study|0|||
23569021|NCT00514046|65813185|FG004|Overall Study|Disease progression on study|0|||
23569022|NCT00514046|65813186|FG005|Overall Study|Disease progression on study|1|||
23569023|NCT00514046|65813187|FG006|Overall Study|Disease progression on study|0|||
23569024|NCT00514046|65813188|FG007|Overall Study|Disease progression on study|0|||
23161746|NCT01250379|64339166|FG001|Overall Study|Other|4|||
23161747|NCT01250379|64339165|FG000|Overall Study|Participant noncompliance|2|||
23161748|NCT01250379|64339166|FG001|Overall Study|Participant noncompliance|0|||
23161749|NCT03028870|64339169|FG000|Overall Study|Adverse Event|7|||
23330390|NCT01286467|64951994|FG001|Overall Study|Disease progression|2|||
23161750|NCT03028870|64339170|FG001|Overall Study|Adverse Event|4|||
23161751|NCT03028870|64339171|FG002|Overall Study|Adverse Event|3|||
23161752|NCT03028870|64339172|FG003|Overall Study|Adverse Event|3|||
23161753|NCT03028870|64339169|FG000|Overall Study|Withdrawal by Subject|1|||
23161754|NCT03028870|64339170|FG001|Overall Study|Withdrawal by Subject|1|||
23330391|NCT01286467|64951995|FG002|Overall Study|Disease progression|2|||
23330392|NCT01286467|64951996|FG003|Overall Study|Disease progression|3|||
23569025|NCT00514046|65813189|FG008|Overall Study|Disease progression on study|0|||
23569026|NCT01582789|65813192|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
23161755|NCT03028870|64339171|FG002|Overall Study|Withdrawal by Subject|1|||
23161756|NCT03028870|64339172|FG003|Overall Study|Withdrawal by Subject|2|||
23161757|NCT03028870|64339169|FG000|Overall Study|Lost to Follow-up|1|||
23161758|NCT03028870|64339170|FG001|Overall Study|Lost to Follow-up|0|||
23161759|NCT03028870|64339171|FG002|Overall Study|Lost to Follow-up|0|||
23161760|NCT03028870|64339172|FG003|Overall Study|Lost to Follow-up|0|||
23161761|NCT03028870|64339169|FG000|Overall Study|Lack of Efficacy|3|||
23161762|NCT03028870|64339170|FG001|Overall Study|Lack of Efficacy|0|||
23161763|NCT03028870|64339171|FG002|Overall Study|Lack of Efficacy|0|||
23161764|NCT03028870|64339172|FG003|Overall Study|Lack of Efficacy|0|||
23161765|NCT03028870|64339169|FG000|Overall Study|Administrative|5|||
23161766|NCT03028870|64339170|FG001|Overall Study|Administrative|5|||
23569027|NCT01582789|65813193|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
23569028|NCT01617005|65813198|FG000|Overall Study|Pregnancy|1|||
23569029|NCT01617005|65813198|FG000|Overall Study|Lack of motivation for treatment|1|||
23569030|NCT00993317|65813199|FG000|Overall Study|Adverse Event|2|||
23569031|NCT00993317|65813200|FG001|Overall Study|Adverse Event|4|||
23569032|NCT00993317|65813199|FG000|Overall Study|Lack of Efficacy|18|||
23569033|NCT00993317|65813200|FG001|Overall Study|Lack of Efficacy|18|||
23569034|NCT00993317|65813199|FG000|Overall Study|Withdrawal by Subject|0|||
23569035|NCT00993317|65813200|FG001|Overall Study|Withdrawal by Subject|2|||
23569036|NCT00993317|65813199|FG000|Overall Study|Investigator's opinion|0|||
23569037|NCT00993317|65813200|FG001|Overall Study|Investigator's opinion|1|||
23161767|NCT03028870|64339171|FG002|Overall Study|Administrative|12|||
23161768|NCT03028870|64339172|FG003|Overall Study|Administrative|4|||
23161769|NCT00808236|64339173|FG000|Overall Study|Was not resuscitated|50|||
23161770|NCT00808236|64339174|FG001|Overall Study|Was not resuscitated|56|||
23223495|NCT03954704|64560500|FG000|Overall Study|Death|1|||
23223496|NCT03954704|64560501|FG001|Overall Study|Death|1|||
23330393|NCT01286467|64951993|FG000|Overall Study|Adverse Event|0|||
23161771|NCT00808236|64339173|FG000|Overall Study|Pre-defined exclusion|13|||
23161772|NCT00808236|64339174|FG001|Overall Study|Pre-defined exclusion|3|||
23161773|NCT00808236|64339173|FG000|Overall Study|Lost to Follow-up|1|||
23161774|NCT00808236|64339174|FG001|Overall Study|Lost to Follow-up|1|||
23161775|NCT00808236|64339173|FG000|Overall Study|Physician Decision|0|||
23161776|NCT00808236|64339174|FG001|Overall Study|Physician Decision|1|||
23161777|NCT00808236|64339173|FG000|Overall Study|Death|18|||
23161778|NCT00808236|64339174|FG001|Overall Study|Death|30|||
23161779|NCT02807480|64339180|FG000|Overall Study|Withdrawal by Subject|14|||
23161780|NCT02807480|64339181|FG001|Overall Study|Withdrawal by Subject|10|||
23161781|NCT00769184|64339183|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
23161782|NCT00769184|64339184|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
23161783|NCT00769184|64339183|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
23161784|NCT00769184|64339184|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
23161785|NCT00769184|64339183|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
23161786|NCT00769184|64339184|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
23161787|NCT00492752|64341646|FG000|Double Blind Treatment|Death|13|||
23161788|NCT00492752|64341647|FG001|Double Blind Treatment|Death|0|||
23161789|NCT00492752|64341648|FG002|Double Blind Treatment|Death|2|||
23161790|NCT00492752|64341649|FG003|Double Blind Treatment|Death|0|||
23161791|NCT00492752|64341646|FG000|Double Blind Treatment|Adverse Event|1|||
23161792|NCT00492752|64341647|FG001|Double Blind Treatment|Adverse Event|0|||
23161793|NCT00492752|64341648|FG002|Double Blind Treatment|Adverse Event|0|||
23161794|NCT00492752|64341649|FG003|Double Blind Treatment|Adverse Event|0|||
23161795|NCT00492752|64341646|FG000|Double Blind Treatment|Protocol Violation|0|||
23161796|NCT00492752|64341647|FG001|Double Blind Treatment|Protocol Violation|0|||
23161797|NCT00492752|64341648|FG002|Double Blind Treatment|Protocol Violation|1|||
23161798|NCT00492752|64341649|FG003|Double Blind Treatment|Protocol Violation|0|||
23161799|NCT00492752|64341646|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
23161800|NCT00492752|64341647|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
23223497|NCT03954704|64560502|FG002|Overall Study|Death|1|||
23330394|NCT01286467|64951994|FG001|Overall Study|Adverse Event|1|||
23161801|NCT00492752|64341648|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
23161802|NCT00492752|64341649|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
23161803|NCT00492752|64341646|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
23161804|NCT00492752|64341647|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
23223498|NCT03954704|64560503|FG003|Overall Study|Death|3|||
23569038|NCT00993317|65813199|FG000|Overall Study|Early study termination at the site|1|||
23330395|NCT01286467|64951995|FG002|Overall Study|Adverse Event|2|||
23330396|NCT01286467|64951996|FG003|Overall Study|Adverse Event|3|||
23330397|NCT01286467|64951993|FG000|Overall Study|Study drug stop longer than 14 days|0|||
23330398|NCT01286467|64951994|FG001|Overall Study|Study drug stop longer than 14 days|0|||
23569039|NCT00993317|65813200|FG001|Overall Study|Early study termination at the site|0|||
23569040|NCT02388074|65813201|FG000|Overall Study|Lost in Transit|2|||
23569041|NCT02388074|65813201|FG000|Overall Study|Sample Not Returned|1|||
23569042|NCT00592319|65813204|FG000|Overall Study|Lost to Follow-up|0|||
23569043|NCT00592319|65813205|FG001|Overall Study|Lost to Follow-up|3|||
23569044|NCT00839917|65813209|FG000|Overall Study|Lost to Follow-up|1|||
23569045|NCT00839917|65813210|FG001|Overall Study|Lost to Follow-up|0|||
23569046|NCT00839917|65813209|FG000|Overall Study|Did not receive vaccine|0|||
23569047|NCT00839917|65813210|FG001|Overall Study|Did not receive vaccine|1|||
23569048|NCT02337478|65813215|FG000|Overall Study|Lack of Efficacy|5|||
23569049|NCT02285595|65813231|FG000|Overall Study|Lost to Follow-up|14|||
23569050|NCT02285595|65813231|FG000|Overall Study|Withdrawal by Subject|1|||
23569051|NCT04880161|65813235|FG000|Overall Study|Withdrawal by Subject|1|||
23569052|NCT04880161|65813236|FG001|Overall Study|Withdrawal by Subject|0|||
23569053|NCT04880161|65813235|FG000|Overall Study|Lack of Compliance|1|||
23569054|NCT04880161|65813236|FG001|Overall Study|Lack of Compliance|1|||
23569055|NCT04880161|65813235|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
23569056|NCT04880161|65813236|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
23569057|NCT04880161|65813235|FG000|Overall Study|Screen Failure|0|||
23569058|NCT04880161|65813236|FG001|Overall Study|Screen Failure|1|||
23569059|NCT03853317|65813237|FG000|Overall Study|Progressive Disease|5|||
23569060|NCT03853317|65813237|FG000|Overall Study|Adverse Event|1|||
23569061|NCT03853317|65813237|FG000|Overall Study|Death|1|||
23569062|NCT03853317|65813237|FG000|Overall Study|other event|2|||
23569063|NCT00423852|65813238|FG000|Overall Study|Removed pior to the high-dose portion|3|||
23569064|NCT01928225|65813239|FG000|Overall Study|Pregnancy|1|||
23569065|NCT01928225|65813240|FG001|Overall Study|Pregnancy|0|||
23569066|NCT01928225|65813239|FG000|Overall Study|basaloid cervical cancer|1|||
23569067|NCT01928225|65813240|FG001|Overall Study|basaloid cervical cancer|0|||
23569068|NCT01928225|65813239|FG000|Overall Study|Lost to Follow-up|1|||
23569069|NCT01928225|65813240|FG001|Overall Study|Lost to Follow-up|3|||
23569070|NCT01155661|65813241|FG000|Overall Study|Adverse Event|101|||
23569071|NCT01155661|65813241|FG000|Overall Study|Death|1|||
23569072|NCT01155661|65813241|FG000|Overall Study|Lack of Efficacy|32|||
23569073|NCT01155661|65813241|FG000|Overall Study|Lost to Follow-up|22|||
23569074|NCT01155661|65813241|FG000|Overall Study|Physician Decision|3|||
23569075|NCT01155661|65813241|FG000|Overall Study|Protocol Violation|35|||
23569076|NCT01155661|65813241|FG000|Overall Study|Withdrawal by Subject|73|||
23569077|NCT01155661|65813241|FG000|Overall Study|Sponsor Decision|13|||
23569078|NCT00904150|65813244|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
23569079|NCT00904150|65813245|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
23569080|NCT00904150|65813244|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
23569081|NCT00904150|65813245|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
23569082|NCT02572817|65813246|FG000|Overall Study|Death|6|||
23569083|NCT02572817|65813247|FG001|Overall Study|Death|3|||
23569084|NCT02572817|65813246|FG000|Overall Study|Lost to Follow-up|3|||
23569085|NCT02572817|65813247|FG001|Overall Study|Lost to Follow-up|3|||
23569086|NCT04091360|65813248|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569087|NCT04091360|65813249|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569088|NCT04091360|65813250|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569089|NCT04091360|65813251|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569090|NCT04091360|65813252|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23330399|NCT01286467|64951995|FG002|Overall Study|Study drug stop longer than 14 days|1|||
23446664|NCT02021643|65377728|FG002|Overall Study|Investigator's Discretion|0|||
23446665|NCT02021643|65377729|FG003|Overall Study|Investigator's Discretion|0|||
23569091|NCT04091360|65813253|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569092|NCT04091360|65813254|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23569093|NCT04091360|65813255|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
23330400|NCT01286467|64951996|FG003|Overall Study|Study drug stop longer than 14 days|0|||
23330401|NCT01896128|64951997|FG000|Overall Study|Withdrawal by Subject|3|||
23330402|NCT01896128|64951998|FG001|Overall Study|Withdrawal by Subject|3|||
23330403|NCT03428152|64951999|FG000|Overall Study|Physician Decision|4|||
23330404|NCT03428152|64952000|FG001|Overall Study|Physician Decision|2|||
23330405|NCT03428152|64951999|FG000|Overall Study|Protocol Violation|3|||
23330406|NCT03428152|64952000|FG001|Overall Study|Protocol Violation|5|||
23330407|NCT03428152|64951999|FG000|Overall Study|Lack of Efficacy|0|||
23446666|NCT02021643|65377726|FG000|Overall Study|Lack of Efficacy|7|||
23446667|NCT02021643|65377727|FG001|Overall Study|Lack of Efficacy|6|||
23446668|NCT02021643|65377728|FG002|Overall Study|Lack of Efficacy|0|||
23446669|NCT02021643|65377729|FG003|Overall Study|Lack of Efficacy|12|||
23446670|NCT02021643|65377726|FG000|Overall Study|Lost to Follow-up|0|||
23446671|NCT02021643|65377727|FG001|Overall Study|Lost to Follow-up|1|||
23330408|NCT03428152|64952000|FG001|Overall Study|Lack of Efficacy|4|||
23330409|NCT01058642|64952004|FG000|Treatment Period 1|Adverse Event|0|||
23330410|NCT01058642|64952005|FG001|Treatment Period 1|Adverse Event|1|||
23330411|NCT01058642|64952006|FG002|Treatment Period 1|Adverse Event|1|||
23330412|NCT01058642|64952007|FG003|Treatment Period 1|Adverse Event|0|||
23330413|NCT01058642|64952004|FG000|Treatment Period 1|Physician Decision|0|||
23330414|NCT01058642|64952005|FG001|Treatment Period 1|Physician Decision|0|||
23330415|NCT01058642|64952006|FG002|Treatment Period 1|Physician Decision|1|||
23330416|NCT01058642|64952007|FG003|Treatment Period 1|Physician Decision|0|||
23330417|NCT01058642|64952004|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23330418|NCT01058642|64952005|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23330419|NCT01058642|64952006|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23330420|NCT01058642|64952007|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23161805|NCT00492752|64341648|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
23330421|NCT01058642|64952004|FG000|Treatment Period 1|Lack of Efficacy|0|||
23161806|NCT00492752|64341649|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
23330422|NCT01058642|64952005|FG001|Treatment Period 1|Lack of Efficacy|0|||
23330423|NCT01058642|64952006|FG002|Treatment Period 1|Lack of Efficacy|0|||
23330424|NCT01058642|64952007|FG003|Treatment Period 1|Lack of Efficacy|1|||
23330425|NCT01058642|64952004|FG000|Treatment Period 1|Protocol Violation|0|||
23330426|NCT01058642|64952005|FG001|Treatment Period 1|Protocol Violation|0|||
23446672|NCT02021643|65377728|FG002|Overall Study|Lost to Follow-up|0|||
23330427|NCT01058642|64952006|FG002|Treatment Period 1|Protocol Violation|0|||
23330428|NCT01058642|64952007|FG003|Treatment Period 1|Protocol Violation|1|||
23330429|NCT01058642|64952004|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
23330430|NCT01058642|64952005|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
23330431|NCT01058642|64952006|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
23330432|NCT01058642|64952007|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
23330433|NCT01960257|64952008|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
23330434|NCT01960257|64952009|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
23330435|NCT01960257|64952010|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
23330436|NCT01960257|64952008|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
23330437|NCT01960257|64952009|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
23330438|NCT01960257|64952010|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
23330439|NCT01960257|64952008|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
23330440|NCT01960257|64952009|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
23446673|NCT02021643|65377729|FG003|Overall Study|Lost to Follow-up|0|||
23161807|NCT00492752|64341646|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
23161808|NCT00492752|64341647|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
23161809|NCT00492752|64341648|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
23161810|NCT00492752|64341649|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
23161811|NCT00492752|64341646|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
23161812|NCT00492752|64341647|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
23161813|NCT00492752|64341648|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
23161814|NCT00492752|64341649|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
23161815|NCT00492752|64341646|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
23161816|NCT00492752|64341647|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
23161817|NCT00492752|64341648|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
23223499|NCT03954704|64560504|FG004|Overall Study|Death|2|||
23223500|NCT03954704|64560505|FG005|Overall Study|Death|2|||
23223501|NCT03954704|64560506|FG006|Overall Study|Death|0|||
23330441|NCT01960257|64952010|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
23330442|NCT00603473|64952013|FG000|Overall Study|Adverse Event|4|||
23330443|NCT00603473|64952013|FG000|Overall Study|Lack of Efficacy|4|||
23446674|NCT02021643|65377726|FG000|Overall Study|Withdrew Consent|0|||
23446675|NCT02021643|65377727|FG001|Overall Study|Withdrew Consent|1|||
23330444|NCT00603473|64952013|FG000|Overall Study|Protocol Violation|1|||
23330445|NCT00364923|64952016|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
23330446|NCT00364923|64952016|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
23330447|NCT02484456|64952017|FG000|Washout Period|Withdrawal by Subject|0|||
23330448|NCT02484456|64952018|FG001|Washout Period|Withdrawal by Subject|1|||
23330449|NCT02484456|64952017|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
23330450|NCT02484456|64952018|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
23330451|NCT02484456|64952017|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
23330452|NCT02484456|64952018|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
23330453|NCT02484456|64952017|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
23330454|NCT02484456|64952018|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
23330455|NCT01928472|64952019|FG000|Overall Study|Death|0|||
23330456|NCT01928472|64952020|FG001|Overall Study|Death|0|||
23330457|NCT01928472|64952021|FG002|Overall Study|Death|1|||
23330458|NCT01928472|64952022|FG003|Overall Study|Death|0|||
23330459|NCT01928472|64952019|FG000|Overall Study|Withdrawal by Subject|4|||
23330460|NCT01928472|64952020|FG001|Overall Study|Withdrawal by Subject|4|||
23330461|NCT01928472|64952021|FG002|Overall Study|Withdrawal by Subject|1|||
23330462|NCT01928472|64952022|FG003|Overall Study|Withdrawal by Subject|2|||
23330463|NCT01928472|64952019|FG000|Overall Study|Lost to Follow-up|2|||
23330464|NCT01928472|64952020|FG001|Overall Study|Lost to Follow-up|3|||
23330465|NCT01928472|64952021|FG002|Overall Study|Lost to Follow-up|4|||
23330466|NCT01928472|64952022|FG003|Overall Study|Lost to Follow-up|0|||
23330467|NCT01928472|64952019|FG000|Overall Study|Administrative Reason|2|||
23330468|NCT01928472|64952020|FG001|Overall Study|Administrative Reason|1|||
23330469|NCT01928472|64952021|FG002|Overall Study|Administrative Reason|0|||
23330470|NCT01928472|64952022|FG003|Overall Study|Administrative Reason|0|||
23330471|NCT01928472|64952019|FG000|Overall Study|Unclassified|0|||
23330472|NCT01928472|64952020|FG001|Overall Study|Unclassified|0|||
23330473|NCT01928472|64952021|FG002|Overall Study|Unclassified|1|||
23330474|NCT01928472|64952022|FG003|Overall Study|Unclassified|0|||
23330475|NCT01532518|64952023|FG000|Overall Study|Withdrawal by Subject|0|||
23330476|NCT01532518|64952024|FG001|Overall Study|Withdrawal by Subject|0|||
23330477|NCT01532518|64952025|FG002|Overall Study|Withdrawal by Subject|1|||
23330478|NCT00077207|64952027|FG000|Overall Study|Adverse Event|5|||
23330479|NCT00077207|64952027|FG000|Overall Study|Lack of Efficacy|12|||
23330480|NCT00077207|64952027|FG000|Overall Study|Physician Decision|6|||
23330481|NCT00077207|64952027|FG000|Overall Study|Withdrawal by Subject|6|||
23330482|NCT00077207|64952027|FG000|Overall Study|Ineligible|1|||
23330483|NCT00679211|64952028|FG000|Overall Study|Progressive disease|82|||
23330484|NCT00679211|64952028|FG000|Overall Study|Adverse Event|7|||
23330485|NCT00679211|64952028|FG000|Overall Study|Withdrawal by Subject|2|||
23330486|NCT00679211|64952028|FG000|Overall Study|Physician Decision|5|||
23330487|NCT00679211|64952028|FG000|Overall Study|Refused to undergo protocol procedures|1|||
23330488|NCT00679211|64952028|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
23330489|NCT00679211|64952028|FG000|Overall Study|Other|1|||
23330490|NCT01671007|64952029|FG000|Overall Study|Other reasons than listed|166|||
23330491|NCT01671007|64952030|FG001|Overall Study|Other reasons than listed|373|||
23330492|NCT01671007|64952031|FG002|Overall Study|Other reasons than listed|197|||
23330493|NCT01671007|64952032|FG003|Overall Study|Other reasons than listed|228|||
23330494|NCT01671007|64952033|FG004|Overall Study|Other reasons than listed|14|||
23330495|NCT01671007|64952034|FG005|Overall Study|Other reasons than listed|71|||
23330496|NCT01671007|64952035|FG006|Overall Study|Other reasons than listed|17|||
23330497|NCT01671007|64952036|FG007|Overall Study|Other reasons than listed|66|||
23330498|NCT01671007|64952037|FG008|Overall Study|Other reasons than listed|0|||
23330499|NCT01671007|64952029|FG000|Overall Study|Withdrawal by Subject|36|||
23330500|NCT01671007|64952030|FG001|Overall Study|Withdrawal by Subject|59|||
23330501|NCT01671007|64952031|FG002|Overall Study|Withdrawal by Subject|53|||
23330502|NCT01671007|64952032|FG003|Overall Study|Withdrawal by Subject|58|||
23330503|NCT01671007|64952033|FG004|Overall Study|Withdrawal by Subject|4|||
23330504|NCT01671007|64952034|FG005|Overall Study|Withdrawal by Subject|15|||
23330505|NCT01671007|64952035|FG006|Overall Study|Withdrawal by Subject|1|||
23330506|NCT01671007|64952036|FG007|Overall Study|Withdrawal by Subject|19|||
23330507|NCT01671007|64952037|FG008|Overall Study|Withdrawal by Subject|0|||
23330508|NCT01671007|64952029|FG000|Overall Study|Lost to Follow-up|93|||
23330509|NCT01671007|64952030|FG001|Overall Study|Lost to Follow-up|142|||
23330510|NCT01671007|64952031|FG002|Overall Study|Lost to Follow-up|91|||
23330511|NCT01671007|64952032|FG003|Overall Study|Lost to Follow-up|63|||
23330512|NCT01671007|64952033|FG004|Overall Study|Lost to Follow-up|7|||
23330513|NCT01671007|64952034|FG005|Overall Study|Lost to Follow-up|20|||
23330514|NCT01671007|64952035|FG006|Overall Study|Lost to Follow-up|2|||
23330515|NCT01671007|64952036|FG007|Overall Study|Lost to Follow-up|28|||
23330516|NCT01671007|64952037|FG008|Overall Study|Lost to Follow-up|0|||
23330517|NCT01671007|64952029|FG000|Overall Study|No end of study case report form|3|||
23330518|NCT01671007|64952030|FG001|Overall Study|No end of study case report form|1|||
23161818|NCT00492752|64341649|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
23161819|NCT00492752|64341646|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
23161820|NCT00492752|64341647|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
23161821|NCT00492752|64341648|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
23330519|NCT01671007|64952031|FG002|Overall Study|No end of study case report form|0|||
23330520|NCT01671007|64952032|FG003|Overall Study|No end of study case report form|2|||
23330521|NCT01671007|64952033|FG004|Overall Study|No end of study case report form|0|||
23330522|NCT01671007|64952034|FG005|Overall Study|No end of study case report form|0|||
23330523|NCT01671007|64952035|FG006|Overall Study|No end of study case report form|0|||
23330524|NCT01671007|64952036|FG007|Overall Study|No end of study case report form|0|||
23330525|NCT01671007|64952037|FG008|Overall Study|No end of study case report form|0|||
23330526|NCT01671007|64952029|FG000|Overall Study|Not eligible|23|||
23330527|NCT01671007|64952030|FG001|Overall Study|Not eligible|76|||
23330528|NCT01671007|64952031|FG002|Overall Study|Not eligible|25|||
23330529|NCT01671007|64952032|FG003|Overall Study|Not eligible|17|||
23330530|NCT01671007|64952033|FG004|Overall Study|Not eligible|0|||
23330531|NCT01671007|64952034|FG005|Overall Study|Not eligible|6|||
23330532|NCT01671007|64952035|FG006|Overall Study|Not eligible|1|||
23330533|NCT01671007|64952036|FG007|Overall Study|Not eligible|19|||
23330534|NCT01671007|64952037|FG008|Overall Study|Not eligible|0|||
23330535|NCT00488644|64952038|FG000|Overall Study|Not Eligible|1|||
23330536|NCT00488644|64952038|FG000|Overall Study|Not Evaluable|1|||
23330537|NCT01516008|64952039|FG000|Overall Study|Adverse Event|0|||
23330538|NCT01516008|64952040|FG001|Overall Study|Adverse Event|2|||
23330539|NCT01516008|64952041|FG002|Overall Study|Adverse Event|7|||
23330540|NCT01516008|64952039|FG000|Overall Study|Lack of Efficacy|44|||
23330541|NCT01516008|64952040|FG001|Overall Study|Lack of Efficacy|14|||
23223502|NCT03954704|64560500|FG000|Overall Study|Withdrew Consent|0|||
23223503|NCT03954704|64560501|FG001|Overall Study|Withdrew Consent|0|||
23223504|NCT03954704|64560502|FG002|Overall Study|Withdrew Consent|1|||
23223505|NCT03954704|64560503|FG003|Overall Study|Withdrew Consent|0|||
23223506|NCT03954704|64560504|FG004|Overall Study|Withdrew Consent|0|||
23223507|NCT03954704|64560505|FG005|Overall Study|Withdrew Consent|1|||
23223508|NCT03954704|64560506|FG006|Overall Study|Withdrew Consent|0|||
23223509|NCT03954704|64560500|FG000|Overall Study|Lost to Follow-up|0|||
23223510|NCT03954704|64560501|FG001|Overall Study|Lost to Follow-up|0|||
23223511|NCT03954704|64560502|FG002|Overall Study|Lost to Follow-up|0|||
23223512|NCT03954704|64560503|FG003|Overall Study|Lost to Follow-up|0|||
23223513|NCT03954704|64560504|FG004|Overall Study|Lost to Follow-up|0|||
23223514|NCT03954704|64560505|FG005|Overall Study|Lost to Follow-up|0|||
23223515|NCT03954704|64560506|FG006|Overall Study|Lost to Follow-up|1|||
23223516|NCT03954704|64560500|FG000|Overall Study|Study Terminated by Sponsor|0|||
23223517|NCT03954704|64560501|FG001|Overall Study|Study Terminated by Sponsor|0|||
23223518|NCT03954704|64560502|FG002|Overall Study|Study Terminated by Sponsor|1|||
23223519|NCT03954704|64560503|FG003|Overall Study|Study Terminated by Sponsor|0|||
23223520|NCT03954704|64560504|FG004|Overall Study|Study Terminated by Sponsor|1|||
23223521|NCT03954704|64560505|FG005|Overall Study|Study Terminated by Sponsor|4|||
23223522|NCT03954704|64560506|FG006|Overall Study|Study Terminated by Sponsor|2|||
23223523|NCT03954704|64560500|FG000|Overall Study|Enrolled but not Treated|0|||
23223524|NCT03954704|64560501|FG001|Overall Study|Enrolled but not Treated|0|||
23223525|NCT03954704|64560502|FG002|Overall Study|Enrolled but not Treated|0|||
23223526|NCT03954704|64560503|FG003|Overall Study|Enrolled but not Treated|0|||
23223527|NCT03954704|64560504|FG004|Overall Study|Enrolled but not Treated|0|||
23223528|NCT03954704|64560505|FG005|Overall Study|Enrolled but not Treated|1|||
23223529|NCT03954704|64560506|FG006|Overall Study|Enrolled but not Treated|0|||
23223530|NCT00149890|64560508|FG000|Overall Study|Adverse Event|1|||
23223531|NCT00149890|64560509|FG001|Overall Study|Adverse Event|8|||
23223532|NCT00149890|64560508|FG000|Overall Study|Lack of Efficacy|8|||
23223533|NCT00149890|64560509|FG001|Overall Study|Lack of Efficacy|9|||
23223534|NCT00149890|64560508|FG000|Overall Study|Protocol Violation|1|||
23223535|NCT00149890|64560509|FG001|Overall Study|Protocol Violation|0|||
23223536|NCT00149890|64560508|FG000|Overall Study|Lost to Follow-up|1|||
23223537|NCT00149890|64560509|FG001|Overall Study|Lost to Follow-up|0|||
23223538|NCT00149890|64560508|FG000|Overall Study|Graft Loss|2|||
23446676|NCT02021643|65377728|FG002|Overall Study|Withdrew Consent|0|||
23446677|NCT02021643|65377729|FG003|Overall Study|Withdrew Consent|0|||
23446678|NCT03852719|65377730|FG000|Overall Study|Still on study after Week 144|49|||
23446679|NCT03852719|65377731|FG001|Overall Study|Still on study after Week 144|44|||
23223539|NCT00149890|64560509|FG001|Overall Study|Graft Loss|1|||
23223540|NCT03518034|64560511|FG000|Overall Study|Not Treated|5|||
23223541|NCT03518034|64560512|FG001|Overall Study|Not Treated|1|||
23223542|NCT03518034|64560511|FG000|Overall Study|Withdrawal by Subject|309|||
23223543|NCT03518034|64560512|FG001|Overall Study|Withdrawal by Subject|351|||
23223544|NCT03518034|64560511|FG000|Overall Study|Lost to Follow-up|446|||
23223545|NCT03518034|64560512|FG001|Overall Study|Lost to Follow-up|458|||
23223546|NCT03518034|64560511|FG000|Overall Study|Adverse Event|138|||
23223547|NCT03518034|64560512|FG001|Overall Study|Adverse Event|130|||
23223548|NCT03518034|64560511|FG000|Overall Study|Lack of Efficacy|11|||
23223549|NCT03518034|64560512|FG001|Overall Study|Lack of Efficacy|23|||
23223550|NCT03518034|64560511|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
23223551|NCT03518034|64560512|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
23223552|NCT03518034|64560511|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
23223553|NCT03518034|64560512|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
23446680|NCT03852719|65377732|FG002|Overall Study|Still on study after Week 144|44|||
23446681|NCT03852719|65377730|FG000|Overall Study|Withdrawal of consent|0|||
23446682|NCT03852719|65377731|FG001|Overall Study|Withdrawal of consent|4|||
23446683|NCT03852719|65377732|FG002|Overall Study|Withdrawal of consent|5|||
23569094|NCT04091360|65813256|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
23223554|NCT03518034|64560511|FG000|Overall Study|Other, Not Specified|84|||
23223555|NCT03518034|64560512|FG001|Overall Study|Other, Not Specified|53|||
23223556|NCT03518034|64560511|FG000|Overall Study|Reason Missing|2|||
23223557|NCT03518034|64560512|FG001|Overall Study|Reason Missing|3|||
23223558|NCT02499575|64560514|FG000|Overall Study|Protocol Violation|0|||
23223559|NCT02499575|64560515|FG001|Overall Study|Protocol Violation|1|||
23223560|NCT00615459|64560527|FG000|Period I|Adverse Event|2|||
23223561|NCT00615459|64560528|FG001|Period I|Adverse Event|0|||
23223562|NCT00615459|64560529|FG002|Period I|Adverse Event|1|||
23223563|NCT00615459|64560530|FG003|Period I|Adverse Event|0|||
23223564|NCT00615459|64560527|FG000|Period I|Subject withdrew consent|1|||
23223565|NCT00615459|64560528|FG001|Period I|Subject withdrew consent|0|||
23223566|NCT00615459|64560529|FG002|Period I|Subject withdrew consent|0|||
23223567|NCT00615459|64560530|FG003|Period I|Subject withdrew consent|1|||
23223568|NCT00615459|64560527|FG000|Period I|Abnormal test procedure results|1|||
23223569|NCT00615459|64560528|FG001|Period I|Abnormal test procedure results|1|||
23223570|NCT00615459|64560529|FG002|Period I|Abnormal test procedure results|1|||
23569095|NCT04091360|65813257|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
23569096|NCT04091360|65813248|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569097|NCT04091360|65813249|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569098|NCT04091360|65813250|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569099|NCT04091360|65813251|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569100|NCT04091360|65813252|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569101|NCT04091360|65813253|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23161822|NCT00492752|64341649|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
23161823|NCT00492752|64341646|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
23161824|NCT00492752|64341647|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
23161825|NCT00492752|64341648|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
23161826|NCT00492752|64341649|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
23161827|NCT00492752|64341646|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
23161828|NCT00492752|64341647|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
23569102|NCT04091360|65813254|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
23569103|NCT04091360|65813255|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
23569104|NCT04091360|65813256|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569105|NCT04091360|65813257|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
23569106|NCT04091360|65813248|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569107|NCT04091360|65813249|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569108|NCT04091360|65813250|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569109|NCT04091360|65813251|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569110|NCT04091360|65813252|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569111|NCT04091360|65813253|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23569112|NCT04091360|65813254|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
23569113|NCT04091360|65813255|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23161829|NCT00492752|64341648|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
23161830|NCT00492752|64341649|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
23161831|NCT00840086|64341650|FG000|Overall Study|Adverse Event|1|||
23161832|NCT00840086|64341650|FG000|Overall Study|Protocol Violation|2|||
23161833|NCT00840086|64341650|FG000|Overall Study|Lost to Follow-up|1|||
23161834|NCT00066703|64341651|FG000|Overall Study|Adverse Event|80|||
23161835|NCT00066703|64341652|FG001|Overall Study|Adverse Event|111|||
23161836|NCT00066703|64341651|FG000|Overall Study|Death|3|||
23161837|NCT00066703|64341652|FG001|Overall Study|Death|0|||
23161838|NCT00066703|64341651|FG000|Overall Study|Lack of Efficacy|114|||
23161839|NCT00066703|64341652|FG001|Overall Study|Lack of Efficacy|69|||
23161840|NCT00066703|64341651|FG000|Overall Study|Lost to Follow-up|31|||
23161841|NCT00066703|64341652|FG001|Overall Study|Lost to Follow-up|28|||
23161842|NCT00066703|64341651|FG000|Overall Study|Withdrawal by Subject|38|||
23161843|NCT00066703|64341652|FG001|Overall Study|Withdrawal by Subject|63|||
23569114|NCT04091360|65813256|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
23161844|NCT00066703|64341651|FG000|Overall Study|Treatment ongoing|346|||
23161845|NCT00066703|64341652|FG001|Overall Study|Treatment ongoing|311|||
23330542|NCT01516008|64952041|FG002|Overall Study|Lack of Efficacy|10|||
23569115|NCT04091360|65813257|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
23569116|NCT00572624|65813258|FG000|Overall Study|Lost to Follow-up|10|||
23569117|NCT00572624|65813259|FG001|Overall Study|Lost to Follow-up|4|||
23569118|NCT00572624|65813258|FG000|Overall Study|Wanted to do a different diet program|1|||
23569119|NCT00572624|65813259|FG001|Overall Study|Wanted to do a different diet program|0|||
23569120|NCT00572624|65813258|FG000|Overall Study|Medication change|1|||
23569121|NCT00572624|65813259|FG001|Overall Study|Medication change|0|||
23569122|NCT00572624|65813258|FG000|Overall Study|Started a new job-- no time for study|1|||
23569123|NCT00572624|65813259|FG001|Overall Study|Started a new job-- no time for study|0|||
23569124|NCT00572624|65813258|FG000|Overall Study|Admitted to being a smoker|1|||
23569125|NCT00572624|65813259|FG001|Overall Study|Admitted to being a smoker|0|||
23569126|NCT00572624|65813258|FG000|Overall Study|Refused to do the stress test|1|||
23569127|NCT00572624|65813259|FG001|Overall Study|Refused to do the stress test|0|||
23569128|NCT00572624|65813258|FG000|Overall Study|Problem with vascular access|1|||
23569129|NCT00572624|65813259|FG001|Overall Study|Problem with vascular access|0|||
23569130|NCT00572624|65813258|FG000|Overall Study|Health issues unrelated to the study|1|||
23569131|NCT00572624|65813259|FG001|Overall Study|Health issues unrelated to the study|0|||
23569132|NCT00195715|65813262|FG000|Overall Study|Adverse Event|122|||
23569133|NCT00195715|65813262|FG000|Overall Study|Withdrawal by Subject|58|||
23569134|NCT00195715|65813262|FG000|Overall Study|Lost to Follow-up|27|||
23569135|NCT00195715|65813262|FG000|Overall Study|Protocol Violation|13|||
23569136|NCT00195715|65813262|FG000|Overall Study|Lack of Efficacy|93|||
23569137|NCT00195715|65813262|FG000|Overall Study|Pregnancy|14|||
23569138|NCT00195715|65813262|FG000|Overall Study|Investigative site closure|8|||
23569139|NCT00195715|65813262|FG000|Overall Study|Subject moved/relocated|7|||
23569140|NCT00195715|65813262|FG000|Overall Study|Subject non-compliance|6|||
23569141|NCT00195715|65813262|FG000|Overall Study|Subject started commercial Humira|5|||
23569142|NCT00195715|65813262|FG000|Overall Study|Subject choice|3|||
23569143|NCT00195715|65813262|FG000|Overall Study|Loss of response/no improvement|3|||
23569144|NCT00195715|65813262|FG000|Overall Study|Sponsor stopped study|1|||
23569145|NCT00195715|65813262|FG000|Overall Study|Administrative reasons|2|||
23569146|NCT00195715|65813262|FG000|Overall Study|Investigator's decision|2|||
23569147|NCT00195715|65813262|FG000|Overall Study|Subject wants to get pregnant|4|||
23569148|NCT00195715|65813262|FG000|Overall Study|Use of prohibited medication|2|||
23569149|NCT00195715|65813262|FG000|Overall Study|Planned surgery|2|||
23569150|NCT00195715|65813262|FG000|Overall Study|Increased infection rate|1|||
23569151|NCT00195715|65813262|FG000|Overall Study|Ineligible|1|||
23569152|NCT00195715|65813262|FG000|Overall Study|Colonic stricture|1|||
23569153|NCT00195715|65813262|FG000|Overall Study|Sponsor discontinued trial|1|||
23569154|NCT00195715|65813262|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
23569155|NCT00210119|65813265|FG000|Overall Study|Protocol Violation|1|||
23569156|NCT00210119|65813265|FG000|Overall Study|Withdrawal by Subject|1|||
23569157|NCT03225846|65813266|FG000|Overall Study|Adverse Event|0|||
23569158|NCT03225846|65813267|FG001|Overall Study|Adverse Event|0|||
23569159|NCT03225846|65813268|FG002|Overall Study|Adverse Event|0|||
23569160|NCT03225846|65813269|FG003|Overall Study|Adverse Event|0|||
23569161|NCT03225846|65813270|FG004|Overall Study|Adverse Event|0|||
23569162|NCT03225846|65813271|FG005|Overall Study|Adverse Event|0|||
23569163|NCT03225846|65813272|FG006|Overall Study|Adverse Event|6|||
23569164|NCT03225846|65813266|FG000|Overall Study|Withdrawal by Subject|0|||
23569165|NCT03225846|65813267|FG001|Overall Study|Withdrawal by Subject|1|||
23569166|NCT03225846|65813268|FG002|Overall Study|Withdrawal by Subject|0|||
23569167|NCT03225846|65813269|FG003|Overall Study|Withdrawal by Subject|0|||
23569168|NCT03225846|65813270|FG004|Overall Study|Withdrawal by Subject|0|||
23569169|NCT03225846|65813271|FG005|Overall Study|Withdrawal by Subject|0|||
23569170|NCT03225846|65813272|FG006|Overall Study|Withdrawal by Subject|0|||
23569171|NCT03225846|65813266|FG000|Overall Study|Death|0|||
23569172|NCT03225846|65813267|FG001|Overall Study|Death|1|||
23569173|NCT03225846|65813268|FG002|Overall Study|Death|0|||
23569174|NCT03225846|65813269|FG003|Overall Study|Death|0|||
23569175|NCT03225846|65813270|FG004|Overall Study|Death|0|||
23569176|NCT03225846|65813271|FG005|Overall Study|Death|0|||
23569177|NCT03225846|65813272|FG006|Overall Study|Death|0|||
23569178|NCT03225846|65813266|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569179|NCT03225846|65813267|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
23161846|NCT02250274|64341653|FG000|Overall Study|Insufficient blood draw amount|7|||
23161847|NCT02250274|64341654|FG001|Overall Study|Insufficient blood draw amount|6|||
23569180|NCT03225846|65813268|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
23569181|NCT03225846|65813269|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569182|NCT03225846|65813270|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569183|NCT03225846|65813271|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569184|NCT03225846|65813272|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
23569185|NCT03225846|65813266|FG000|Overall Study|Patient decision|0|||
23569186|NCT03225846|65813267|FG001|Overall Study|Patient decision|0|||
23569187|NCT03225846|65813268|FG002|Overall Study|Patient decision|0|||
23569188|NCT03225846|65813269|FG003|Overall Study|Patient decision|0|||
23569189|NCT03225846|65813270|FG004|Overall Study|Patient decision|0|||
23569190|NCT03225846|65813271|FG005|Overall Study|Patient decision|0|||
23569191|NCT03225846|65813272|FG006|Overall Study|Patient decision|1|||
23569192|NCT03679767|65813274|FG000|Overall Study|Death|16|||
23569193|NCT03679767|65813275|FG001|Overall Study|Death|11|||
23569194|NCT03679767|65813276|FG002|Overall Study|Death|17|||
23569195|NCT03679767|65813277|FG003|Overall Study|Death|10|||
23569196|NCT03679767|65813274|FG000|Overall Study|Lost to Follow-up|1|||
23569197|NCT03679767|65813275|FG001|Overall Study|Lost to Follow-up|1|||
23569198|NCT03679767|65813276|FG002|Overall Study|Lost to Follow-up|1|||
23569199|NCT03679767|65813277|FG003|Overall Study|Lost to Follow-up|1|||
23569200|NCT03679767|65813274|FG000|Overall Study|Withdrawal by Subject|0|||
23569201|NCT03679767|65813275|FG001|Overall Study|Withdrawal by Subject|0|||
23569202|NCT03679767|65813276|FG002|Overall Study|Withdrawal by Subject|0|||
23569203|NCT03679767|65813277|FG003|Overall Study|Withdrawal by Subject|1|||
23569204|NCT03679767|65813274|FG000|Overall Study|Follow-up Completed|18|||
23569205|NCT03679767|65813275|FG001|Overall Study|Follow-up Completed|11|||
23569206|NCT03679767|65813276|FG002|Overall Study|Follow-up Completed|11|||
23569207|NCT03679767|65813277|FG003|Overall Study|Follow-up Completed|20|||
23569208|NCT03679767|65813274|FG000|Overall Study|Entered Hospice Care|0|||
23569209|NCT03679767|65813275|FG001|Overall Study|Entered Hospice Care|0|||
23569210|NCT03679767|65813276|FG002|Overall Study|Entered Hospice Care|0|||
23569211|NCT03679767|65813277|FG003|Overall Study|Entered Hospice Care|1|||
23569212|NCT03679767|65813274|FG000|Overall Study|Progressive Disease|0|||
23569213|NCT03679767|65813275|FG001|Overall Study|Progressive Disease|0|||
23569214|NCT03679767|65813276|FG002|Overall Study|Progressive Disease|0|||
23569215|NCT03679767|65813277|FG003|Overall Study|Progressive Disease|1|||
23569216|NCT03428815|65813279|FG000|Overall Study|Lost to Follow-up|2|||
23569217|NCT03428815|65813280|FG001|Overall Study|Lost to Follow-up|2|||
23569218|NCT03428815|65813279|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
23569219|NCT03428815|65813280|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
23569220|NCT03428815|65813279|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
23569221|NCT03428815|65813280|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
23569222|NCT02748694|65813284|FG000|Overall Study|Voluntary Withdrawal|0|||
23569223|NCT02748694|65813285|FG001|Overall Study|Voluntary Withdrawal|0|||
23569224|NCT02748694|65813286|FG002|Overall Study|Voluntary Withdrawal|0|||
23569225|NCT02748694|65813287|FG003|Overall Study|Voluntary Withdrawal|0|||
23569226|NCT02748694|65813288|FG004|Overall Study|Voluntary Withdrawal|0|||
23569227|NCT02748694|65813289|FG005|Overall Study|Voluntary Withdrawal|0|||
23569228|NCT02748694|65813290|FG006|Overall Study|Voluntary Withdrawal|0|||
23569229|NCT02748694|65813291|FG007|Overall Study|Voluntary Withdrawal|0|||
23569230|NCT02748694|65813292|FG008|Overall Study|Voluntary Withdrawal|0|||
23569231|NCT02748694|65813293|FG009|Overall Study|Voluntary Withdrawal|0|||
23569232|NCT02748694|65813294|FG010|Overall Study|Voluntary Withdrawal|0|||
23569233|NCT02748694|65813295|FG011|Overall Study|Voluntary Withdrawal|0|||
23569234|NCT02748694|65813296|FG012|Overall Study|Voluntary Withdrawal|0|||
23569235|NCT02748694|65813297|FG013|Overall Study|Voluntary Withdrawal|0|||
23569236|NCT02748694|65813298|FG014|Overall Study|Voluntary Withdrawal|2|||
23569237|NCT02589392|65813301|FG000|Overall Study|Adverse Event|1|||
23569238|NCT02589392|65813302|FG001|Overall Study|Adverse Event|1|||
23569239|NCT02589392|65813301|FG000|Overall Study|Withdrawal by Subject|1|||
23569240|NCT02589392|65813302|FG001|Overall Study|Withdrawal by Subject|2|||
23569241|NCT02589392|65813301|FG000|Overall Study|Protocol Violation|1|||
23569242|NCT02589392|65813302|FG001|Overall Study|Protocol Violation|1|||
23569243|NCT02589392|65813301|FG000|Overall Study|Lost to Follow-up|2|||
23569244|NCT02589392|65813302|FG001|Overall Study|Lost to Follow-up|2|||
23569245|NCT02589392|65813301|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
23569246|NCT02589392|65813302|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
23569247|NCT00895843|65813303|FG000|Overall Study|Protocol Violation|12|||
23569248|NCT00895843|65813304|FG001|Overall Study|Protocol Violation|12|||
23569249|NCT00553202|65813307|FG000|Overall Study|Death|16|||
23569250|NCT00553202|65813307|FG000|Overall Study|Lost to Follow-up|1|||
23569251|NCT00553202|65813307|FG000|Overall Study|Physician Decision|28|||
23569252|NCT00553202|65813307|FG000|Overall Study|Withdrawal by Subject|1|||
23569253|NCT00553202|65813307|FG000|Overall Study|No donor identified|16|||
23569254|NCT00553202|65813307|FG000|Overall Study|Fails to meet organ function|6|||
23569255|NCT00453310|65813308|FG000|Overall Study|Progression of Disease|10|||
23569256|NCT01108510|65813312|FG000|Overall Study|Randomized but Not Treated|5|||
23569257|NCT01108510|65813313|FG001|Overall Study|Randomized but Not Treated|1|||
23569258|NCT01108510|65813312|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
23569259|NCT01108510|65813313|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
23569260|NCT01108510|65813312|FG000|Overall Study|Adverse Event|26|||
23569261|NCT01108510|65813313|FG001|Overall Study|Adverse Event|19|||
23569262|NCT01108510|65813312|FG000|Overall Study|Lost to Follow-up|20|||
23569263|NCT01108510|65813313|FG001|Overall Study|Lost to Follow-up|17|||
23569264|NCT01108510|65813312|FG000|Overall Study|Withdrew Consent|21|||
23569265|NCT01108510|65813313|FG001|Overall Study|Withdrew Consent|15|||
23569266|NCT01108510|65813312|FG000|Overall Study|Investigator's Discretion|12|||
23569267|NCT01108510|65813313|FG001|Overall Study|Investigator's Discretion|10|||
23569268|NCT01108510|65813312|FG000|Overall Study|Participant Noncompliance|5|||
23569269|NCT01108510|65813313|FG001|Overall Study|Participant Noncompliance|7|||
23569270|NCT01108510|65813312|FG000|Overall Study|Lack of Efficacy|3|||
23569271|NCT01108510|65813313|FG001|Overall Study|Lack of Efficacy|0|||
23569272|NCT01108510|65813312|FG000|Overall Study|Pregnancy|0|||
23569273|NCT01108510|65813313|FG001|Overall Study|Pregnancy|3|||
23569274|NCT01108510|65813312|FG000|Overall Study|Death|1|||
23569275|NCT01108510|65813313|FG001|Overall Study|Death|1|||
23569276|NCT01051063|65813325|FG000|Overall Study|Death|2|||
23569277|NCT01051063|65813326|FG001|Overall Study|Death|2|||
23569278|NCT01051063|65813325|FG000|Overall Study|Withdrawal by Subject|1|||
23569279|NCT01051063|65813326|FG001|Overall Study|Withdrawal by Subject|1|||
23569280|NCT01051063|65813325|FG000|Overall Study|Termination of the study|5|||
23569281|NCT01051063|65813326|FG001|Overall Study|Termination of the study|0|||
23569282|NCT01051063|65813325|FG000|Overall Study|Moved from the study site area|1|||
23569283|NCT01051063|65813326|FG001|Overall Study|Moved from the study site area|0|||
23569284|NCT01051063|65813325|FG000|Overall Study|Other|1|||
23569285|NCT01051063|65813326|FG001|Overall Study|Other|0|||
23569286|NCT01051063|65813325|FG000|Overall Study|Lost to Follow-up|0|||
23569287|NCT01051063|65813326|FG001|Overall Study|Lost to Follow-up|1|||
23569288|NCT03857841|65813328|FG000|Overall Study|Death|1|||
23223571|NCT00615459|64560530|FG003|Period I|Abnormal test procedure results|0|||
23223572|NCT00615459|64560527|FG000|Period II|Adverse Event|1|||
23223573|NCT00615459|64560528|FG001|Period II|Adverse Event|0|||
23161848|NCT00139776|64341655|FG000|Period I|Did not enter Period II|575|||
23161849|NCT00139776|64341656|FG001|Period I|Did not enter Period II|0|||
23161850|NCT00139776|64341657|FG002|Period I|Did not enter Period II|0|||
23161851|NCT00139776|64341658|FG003|Period I|Did not enter Period II|0|||
23161852|NCT00139776|64341655|FG000|Period II|Not Randomized into Period III|0|||
23161853|NCT00139776|64341656|FG001|Period II|Not Randomized into Period III|322|||
23161854|NCT00139776|64341657|FG002|Period II|Not Randomized into Period III|0|||
23161855|NCT00139776|64341658|FG003|Period II|Not Randomized into Period III|0|||
23161856|NCT00139776|64341655|FG000|Period III|Adverse Event|0|||
23161857|NCT00139776|64341656|FG001|Period III|Adverse Event|0|||
23161858|NCT00139776|64341657|FG002|Period III|Adverse Event|22|||
23161859|NCT00139776|64341658|FG003|Period III|Adverse Event|23|||
23161860|NCT00139776|64341655|FG000|Period III|Other|0|||
23161861|NCT00139776|64341656|FG001|Period III|Other|0|||
23161862|NCT00139776|64341657|FG002|Period III|Other|23|||
23161863|NCT00139776|64341658|FG003|Period III|Other|34|||
23161864|NCT00139776|64341655|FG000|Period III|Lack of Efficacy|0|||
23161865|NCT00139776|64341656|FG001|Period III|Lack of Efficacy|0|||
23223574|NCT00615459|64560529|FG002|Period II|Adverse Event|0|||
23223575|NCT00615459|64560530|FG003|Period II|Adverse Event|0|||
23330543|NCT01516008|64952039|FG000|Overall Study|Protocol Violation|1|||
23330544|NCT01516008|64952040|FG001|Overall Study|Protocol Violation|0|||
23330545|NCT01516008|64952041|FG002|Overall Study|Protocol Violation|0|||
23569289|NCT03857841|65813329|FG001|Overall Study|Death|0|||
23569290|NCT03857841|65813330|FG002|Overall Study|Death|0|||
23569291|NCT03857841|65813331|FG003|Overall Study|Death|0|||
23569292|NCT03857841|65813328|FG000|Overall Study|Study Terminated by Sponsor|1|||
23569293|NCT03857841|65813329|FG001|Overall Study|Study Terminated by Sponsor|0|||
23569294|NCT03857841|65813330|FG002|Overall Study|Study Terminated by Sponsor|0|||
23569295|NCT03857841|65813331|FG003|Overall Study|Study Terminated by Sponsor|0|||
23569296|NCT03125941|65813344|FG000|Overall Study|did not receive intervention|1|||
23569297|NCT03125941|65813345|FG001|Overall Study|did not receive intervention|2|||
23569298|NCT01751113|65813356|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23569299|NCT01751113|65813357|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23569300|NCT01751113|65813358|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23161866|NCT00139776|64341657|FG002|Period III|Lack of Efficacy|10|||
23161867|NCT00139776|64341658|FG003|Period III|Lack of Efficacy|24|||
23161868|NCT00139776|64341655|FG000|Period III|Lost to Follow-up|0|||
23161869|NCT00139776|64341656|FG001|Period III|Lost to Follow-up|0|||
23223576|NCT00615459|64560527|FG000|Period II|Lost to Follow-up|0|||
23446684|NCT03852719|65377730|FG000|Overall Study|Physician Decision|0|||
23569301|NCT01751113|65813359|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
23569302|NCT01751113|65813360|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
23569303|NCT01751113|65813361|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23569304|NCT01751113|65813356|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23569305|NCT01751113|65813357|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23569306|NCT01751113|65813358|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23569307|NCT01751113|65813359|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23161870|NCT00139776|64341657|FG002|Period III|Lost to Follow-up|5|||
23161871|NCT00139776|64341658|FG003|Period III|Lost to Follow-up|4|||
23223577|NCT00615459|64560528|FG001|Period II|Lost to Follow-up|0|||
23161872|NCT00139776|64341655|FG000|Period III|Withdrawal by Subject|0|||
23161873|NCT00139776|64341656|FG001|Period III|Withdrawal by Subject|0|||
23161874|NCT00139776|64341657|FG002|Period III|Withdrawal by Subject|16|||
23569308|NCT01751113|65813360|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
23569309|NCT01751113|65813361|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
23569310|NCT00957931|65813362|FG000|Overall Study|Death|4|||
23569311|NCT02318719|65813370|FG000|Double-blind Phase|Adverse Event|7|||
23569312|NCT02318719|65813371|FG001|Double-blind Phase|Adverse Event|6|||
23569313|NCT02318719|65813372|FG002|Double-blind Phase|Adverse Event|12|||
23161875|NCT00139776|64341658|FG003|Period III|Withdrawal by Subject|21|||
23161876|NCT00257725|64341659|FG000|Overall Study|Adverse Event|3|||
23161877|NCT02255422|64341660|FG000|Overall Study|Withdrawal by Subject|0|||
23161878|NCT02255422|64341661|FG001|Overall Study|Withdrawal by Subject|0|||
23161879|NCT02255422|64341662|FG002|Overall Study|Withdrawal by Subject|0|||
23223578|NCT00615459|64560529|FG002|Period II|Lost to Follow-up|0|||
23223579|NCT00615459|64560530|FG003|Period II|Lost to Follow-up|1|||
23223580|NCT00615459|64560527|FG000|Period III|Adverse Event|0|||
23223581|NCT00615459|64560528|FG001|Period III|Adverse Event|1|||
23223582|NCT00615459|64560529|FG002|Period III|Adverse Event|0|||
23223583|NCT00615459|64560530|FG003|Period III|Adverse Event|0|||
23223584|NCT00615459|64560527|FG000|Period III|Administrative problems|0|||
23223585|NCT00615459|64560528|FG001|Period III|Administrative problems|1|||
23223586|NCT00615459|64560529|FG002|Period III|Administrative problems|1|||
23223587|NCT00615459|64560530|FG003|Period III|Administrative problems|0|||
23223588|NCT00615459|64560527|FG000|Period III|Unsatisfactory therapeutic effect|0|||
23223589|NCT00615459|64560528|FG001|Period III|Unsatisfactory therapeutic effect|1|||
23223590|NCT00615459|64560529|FG002|Period III|Unsatisfactory therapeutic effect|0|||
23223591|NCT00615459|64560530|FG003|Period III|Unsatisfactory therapeutic effect|0|||
23223592|NCT01473355|64560534|FG000|Overall Study|Protocol Violation|2|||
23223593|NCT01473355|64560534|FG000|Overall Study|Adverse Event|2|||
23569314|NCT02318719|65813373|FG003|Double-blind Phase|Adverse Event|4|||
23569315|NCT02318719|65813374|FG004|Double-blind Phase|Adverse Event|0|||
23569316|NCT02318719|65813370|FG000|Double-blind Phase|Lack of Efficacy|5|||
23569317|NCT02318719|65813371|FG001|Double-blind Phase|Lack of Efficacy|0|||
23569318|NCT02318719|65813372|FG002|Double-blind Phase|Lack of Efficacy|1|||
23569319|NCT02318719|65813373|FG003|Double-blind Phase|Lack of Efficacy|1|||
23161880|NCT02255422|64341663|FG003|Overall Study|Withdrawal by Subject|0|||
23161881|NCT02255422|64341664|FG004|Overall Study|Withdrawal by Subject|0|||
23161882|NCT02255422|64341665|FG005|Overall Study|Withdrawal by Subject|0|||
23569320|NCT02318719|65813374|FG004|Double-blind Phase|Lack of Efficacy|0|||
23161883|NCT02255422|64341666|FG006|Overall Study|Withdrawal by Subject|2|||
23161884|NCT02255422|64341660|FG000|Overall Study|Lost to Follow-up|0|||
23223594|NCT01473355|64560534|FG000|Overall Study|Lost to Follow-up|2|||
23161885|NCT02255422|64341661|FG001|Overall Study|Lost to Follow-up|0|||
23161886|NCT02255422|64341662|FG002|Overall Study|Lost to Follow-up|1|||
23161887|NCT02255422|64341663|FG003|Overall Study|Lost to Follow-up|0|||
23161888|NCT02255422|64341664|FG004|Overall Study|Lost to Follow-up|0|||
23161889|NCT02255422|64341665|FG005|Overall Study|Lost to Follow-up|0|||
23161890|NCT02255422|64341666|FG006|Overall Study|Lost to Follow-up|0|||
23161891|NCT04050982|64341682|FG000|Overall Study|Did not meet eligibility criteria|0|||
23161892|NCT04050982|64341683|FG001|Overall Study|Did not meet eligibility criteria|1|||
23223595|NCT00446641|64560537|FG000|Overall Study|Withdrawal by Subject|8|||
23223596|NCT00446641|64560538|FG001|Overall Study|Withdrawal by Subject|3|||
23223597|NCT00446641|64560537|FG000|Overall Study|poor compliance|8|||
23223598|NCT00446641|64560538|FG001|Overall Study|poor compliance|6|||
23223599|NCT00446641|64560537|FG000|Overall Study|Lost to Follow-up|1|||
23223600|NCT00446641|64560538|FG001|Overall Study|Lost to Follow-up|1|||
23223601|NCT00537771|64560539|FG000|Overall Study|Withdrawal by Subject|6|||
23223602|NCT00537771|64560540|FG001|Overall Study|Withdrawal by Subject|23|||
23161893|NCT04050982|64341684|FG002|Overall Study|Did not meet eligibility criteria|0|||
23223603|NCT00537771|64560539|FG000|Overall Study|Adverse Event|8|||
23223604|NCT00537771|64560540|FG001|Overall Study|Adverse Event|15|||
23330546|NCT01516008|64952039|FG000|Overall Study|Reason not specified|0|||
23569321|NCT02318719|65813370|FG000|Double-blind Phase|Protocol Violation|0|||
23569322|NCT02318719|65813371|FG001|Double-blind Phase|Protocol Violation|1|||
23569323|NCT02318719|65813372|FG002|Double-blind Phase|Protocol Violation|3|||
23161894|NCT04050982|64341682|FG000|Overall Study|Withdrawal by Subject|1|||
23161895|NCT04050982|64341683|FG001|Overall Study|Withdrawal by Subject|0|||
23161896|NCT04050982|64341684|FG002|Overall Study|Withdrawal by Subject|0|||
23223605|NCT00537771|64560539|FG000|Overall Study|Lost to Follow-up|9|||
23223606|NCT00537771|64560540|FG001|Overall Study|Lost to Follow-up|15|||
23330547|NCT01516008|64952040|FG001|Overall Study|Reason not specified|0|||
23223607|NCT00537771|64560539|FG000|Overall Study|Protocol Violation|2|||
23223608|NCT00537771|64560540|FG001|Overall Study|Protocol Violation|6|||
23223609|NCT00537771|64560539|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
23223610|NCT00537771|64560540|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
23223611|NCT00402285|64560549|FG000|Overall Study|insufficient RNA quality|7|||
23161897|NCT04050982|64341682|FG000|Overall Study|Unable to enroll on platform|1|||
23161898|NCT04050982|64341683|FG001|Overall Study|Unable to enroll on platform|0|||
23161899|NCT04050982|64341684|FG002|Overall Study|Unable to enroll on platform|0|||
23569324|NCT02318719|65813373|FG003|Double-blind Phase|Protocol Violation|0|||
23569325|NCT02318719|65813374|FG004|Double-blind Phase|Protocol Violation|0|||
23569326|NCT02318719|65813370|FG000|Double-blind Phase|Withdrawal by Subject|25|||
23569327|NCT02318719|65813371|FG001|Double-blind Phase|Withdrawal by Subject|7|||
23569328|NCT02318719|65813372|FG002|Double-blind Phase|Withdrawal by Subject|9|||
23569329|NCT02318719|65813373|FG003|Double-blind Phase|Withdrawal by Subject|10|||
23569330|NCT02318719|65813374|FG004|Double-blind Phase|Withdrawal by Subject|0|||
23569331|NCT02318719|65813370|FG000|Double-blind Phase|Other|1|||
23569332|NCT02318719|65813371|FG001|Double-blind Phase|Other|2|||
23569333|NCT02318719|65813372|FG002|Double-blind Phase|Other|0|||
23569334|NCT02318719|65813373|FG003|Double-blind Phase|Other|0|||
23569335|NCT02318719|65813374|FG004|Double-blind Phase|Other|0|||
23569336|NCT02318719|65813370|FG000|Open-label Extension Phase|Adverse Event|0|||
23569337|NCT02318719|65813371|FG001|Open-label Extension Phase|Adverse Event|0|||
23569338|NCT02318719|65813372|FG002|Open-label Extension Phase|Adverse Event|0|||
23161915|NCT00971178|64341688|FG000|Overall Study|Lost to Follow-up|2|||
23161916|NCT00971178|64341689|FG001|Overall Study|Lost to Follow-up|2|||
23161917|NCT00971178|64341690|FG002|Overall Study|Lost to Follow-up|2|||
23161918|NCT01502709|64341691|FG000|Overall Study|Lost to Follow-up|4|||
23161919|NCT01502709|64341692|FG001|Overall Study|Lost to Follow-up|0|||
23161920|NCT04179734|64341702|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
23161921|NCT04179734|64341703|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
23161922|NCT04179734|64341702|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
23161923|NCT04179734|64341703|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
23161924|NCT00833053|64341705|FG000|Overall Study|Adverse Event|4|||
23161925|NCT00833053|64341706|FG001|Overall Study|Adverse Event|0|||
23161926|NCT00833053|64341705|FG000|Overall Study|Treatment Failure|3|||
23161927|NCT00833053|64341706|FG001|Overall Study|Treatment Failure|1|||
23161928|NCT00833053|64341705|FG000|Overall Study|Withdrawal by Subject|0|||
23161929|NCT00833053|64341706|FG001|Overall Study|Withdrawal by Subject|1|||
23569339|NCT02318719|65813373|FG003|Open-label Extension Phase|Adverse Event|0|||
23569340|NCT02318719|65813374|FG004|Open-label Extension Phase|Adverse Event|15|||
23569341|NCT02318719|65813370|FG000|Open-label Extension Phase|Death|0|||
23569342|NCT02318719|65813371|FG001|Open-label Extension Phase|Death|0|||
23569343|NCT02318719|65813372|FG002|Open-label Extension Phase|Death|0|||
23569344|NCT02318719|65813373|FG003|Open-label Extension Phase|Death|0|||
23569345|NCT02318719|65813374|FG004|Open-label Extension Phase|Death|1|||
23569346|NCT02318719|65813370|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
23569347|NCT02318719|65813371|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
23569348|NCT02318719|65813372|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
23569349|NCT02318719|65813373|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
23569350|NCT02318719|65813374|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
23569351|NCT02318719|65813370|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
23569352|NCT02318719|65813371|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
23161930|NCT00833053|64341705|FG000|Overall Study|Protocol Violation|2|||
23161931|NCT00833053|64341706|FG001|Overall Study|Protocol Violation|1|||
23161932|NCT00343889|64341712|FG000|Overall Study|Lost to Follow-up|2|||
23330548|NCT01516008|64952041|FG002|Overall Study|Reason not specified|1|||
23569353|NCT02318719|65813372|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
23569354|NCT02318719|65813373|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
23569355|NCT02318719|65813374|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
23569356|NCT02318719|65813370|FG000|Open-label Extension Phase|Other|0|||
23569357|NCT02318719|65813371|FG001|Open-label Extension Phase|Other|0|||
23569358|NCT02318719|65813372|FG002|Open-label Extension Phase|Other|0|||
23330549|NCT00739661|64952042|FG000|Overall Study|Adverse Event|2|||
23330550|NCT00739661|64952043|FG001|Overall Study|Adverse Event|0|||
23161933|NCT00343889|64341713|FG001|Overall Study|Lost to Follow-up|0|||
23161934|NCT00343889|64341712|FG000|Overall Study|Withdrawal by Subject|0|||
23161935|NCT00343889|64341713|FG001|Overall Study|Withdrawal by Subject|1|||
23161936|NCT00343889|64341712|FG000|Overall Study|Protocol Violation|1|||
23161937|NCT00343889|64341713|FG001|Overall Study|Protocol Violation|0|||
23330551|NCT00739661|64952042|FG000|Overall Study|Physician decision to withdraw patient|1|||
23330552|NCT00739661|64952043|FG001|Overall Study|Physician decision to withdraw patient|0|||
23569359|NCT02318719|65813373|FG003|Open-label Extension Phase|Other|0|||
23569360|NCT02318719|65813374|FG004|Open-label Extension Phase|Other|7|||
23161938|NCT03221751|64341714|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
23161939|NCT03221751|64341715|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
23161940|NCT00573430|64341716|FG000|Overall Study|Incorrect enrollment of randomization|0|||
23569361|NCT01112514|65813375|FG000|Overall Study|Lost to Follow-up|1|||
23161941|NCT00573430|64341717|FG001|Overall Study|Incorrect enrollment of randomization|4|||
23161942|NCT00573430|64341718|FG002|Overall Study|Incorrect enrollment of randomization|3|||
23569362|NCT02045433|65813376|FG000|Overall Study|Withdrawal by Subject|1|||
23569363|NCT00452413|65813380|FG000|Overall Study|Progressive Disease|4|||
23569364|NCT00452413|65813381|FG001|Overall Study|Progressive Disease|11|||
23569365|NCT00452413|65813382|FG002|Overall Study|Progressive Disease|30|||
23569366|NCT00452413|65813380|FG000|Overall Study|Withdrawal by Subject|0|||
23569367|NCT00452413|65813381|FG001|Overall Study|Withdrawal by Subject|1|||
23569368|NCT00452413|65813382|FG002|Overall Study|Withdrawal by Subject|4|||
23569369|NCT00452413|65813380|FG000|Overall Study|Adverse Event|0|||
23569370|NCT00452413|65813381|FG001|Overall Study|Adverse Event|0|||
23569371|NCT00452413|65813382|FG002|Overall Study|Adverse Event|5|||
23569372|NCT00452413|65813380|FG000|Overall Study|Physician Decision|0|||
23569373|NCT00452413|65813381|FG001|Overall Study|Physician Decision|0|||
23569374|NCT00452413|65813382|FG002|Overall Study|Physician Decision|4|||
23569375|NCT00452413|65813380|FG000|Overall Study|Death due to study disease|0|||
23161943|NCT00573430|64341716|FG000|Overall Study|Adverse Event|0|||
23161944|NCT00573430|64341717|FG001|Overall Study|Adverse Event|0|||
23161945|NCT00573430|64341718|FG002|Overall Study|Adverse Event|2|||
23161946|NCT00573430|64341716|FG000|Overall Study|Withdrawal by Subject|1|||
23161947|NCT00573430|64341717|FG001|Overall Study|Withdrawal by Subject|0|||
23161948|NCT00573430|64341718|FG002|Overall Study|Withdrawal by Subject|1|||
23161949|NCT00573430|64341716|FG000|Overall Study|Protocol Violation|0|||
23161950|NCT00573430|64341717|FG001|Overall Study|Protocol Violation|1|||
23161951|NCT00573430|64341718|FG002|Overall Study|Protocol Violation|1|||
23161952|NCT00573430|64341716|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23161953|NCT00573430|64341717|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23161954|NCT00573430|64341718|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
23161955|NCT01918007|64341719|FG000|Overall Study|Baseline oximetry not acceptable|11|||
23161956|NCT01918007|64341720|FG001|Overall Study|Baseline oximetry not acceptable|7|||
23161957|NCT01918007|64341719|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
23161958|NCT01918007|64341720|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
23161959|NCT01918007|64341719|FG000|Overall Study|Lost to Follow-up|4|||
23161960|NCT01918007|64341720|FG001|Overall Study|Lost to Follow-up|7|||
23161961|NCT01146873|64341721|FG000|Overall Study|Transfer out|0|||
23161962|NCT01146873|64341722|FG001|Overall Study|Transfer out|6|||
23161963|NCT01294579|64341723|FG000|Overall Study|Disease progression|12|||
23161964|NCT01294579|64341723|FG000|Overall Study|Adverse Event|11|||
23161965|NCT01294579|64341723|FG000|Overall Study|Study closed/terminated|3|||
23161966|NCT01294579|64341723|FG000|Overall Study|Lost to Follow-up|1|||
23161967|NCT01294579|64341723|FG000|Overall Study|Physician Decision|3|||
23161968|NCT01294579|64341723|FG000|Overall Study|Withdrawal by Subject|5|||
23161969|NCT01097746|64341734|FG000|Overall Study|Adverse Event|4|||
23161970|NCT01097746|64341734|FG000|Overall Study|taken off study before any treatment given|1|||
23161971|NCT02411539|64341736|FG000|Overall Study|Lost to Follow-up|2|||
23161972|NCT02411539|64341737|FG001|Overall Study|Lost to Follow-up|0|||
23161973|NCT02411539|64341736|FG000|Overall Study|Confounding medical condition|0|||
23161974|NCT02411539|64341737|FG001|Overall Study|Confounding medical condition|1|||
23161975|NCT03962101|64341742|FG000|Overall Study|Adverse Event|1|||
23161976|NCT03962101|64341742|FG000|Overall Study|Physician Decision|2|||
23161977|NCT03962101|64341742|FG000|Overall Study|Not related to medical events|1|||
23161978|NCT01181011|64341745|FG000|Overall Study|Adverse Event|2|||
23161979|NCT01181011|64341745|FG000|Overall Study|Lost to Follow-up|1|||
23161980|NCT01827670|64341746|FG000|Overall Study|Withdrawal of Consent|3|||
23161981|NCT01827670|64341747|FG001|Overall Study|Withdrawal of Consent|2|||
23161982|NCT01827670|64341746|FG000|Overall Study|Lost to Follow-up|0|||
23161983|NCT01827670|64341747|FG001|Overall Study|Lost to Follow-up|1|||
23223612|NCT00402285|64560550|FG001|Overall Study|insufficient RNA quality|6|||
23223613|NCT00402285|64560551|FG002|Overall Study|insufficient RNA quality|2|||
23223614|NCT01224106|64560552|FG000|Double-Blind Treatment Phase|Death|3|||
23223615|NCT01224106|64560553|FG001|Double-Blind Treatment Phase|Death|0|||
23223616|NCT01224106|64560554|FG002|Double-Blind Treatment Phase|Death|0|||
23223617|NCT01224106|64560555|FG003|Double-Blind Treatment Phase|Death|0|||
23223618|NCT01224106|64560556|FG004|Double-Blind Treatment Phase|Death|0|||
23569376|NCT00452413|65813381|FG001|Overall Study|Death due to study disease|0|||
23569377|NCT00452413|65813382|FG002|Overall Study|Death due to study disease|2|||
23161984|NCT04744207|64341748|FG000|Treatment|Withdrawal by Subject|2|||
23161985|NCT04744207|64341749|FG001|Treatment|Withdrawal by Subject|0|||
23161986|NCT04744207|64341748|FG000|Treatment|Adverse Event|1|||
23161987|NCT04744207|64341749|FG001|Treatment|Adverse Event|2|||
23161988|NCT01347554|64341750|FG000|Overall Study|Lack of Efficacy|7|||
23161989|NCT01347554|64341751|FG001|Overall Study|Lack of Efficacy|11|||
23223619|NCT01224106|64560552|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
23161990|NCT03332498|64341752|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
23161991|NCT03332498|64341753|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
23223620|NCT01224106|64560553|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
23223621|NCT01224106|64560554|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
23569378|NCT00452413|65813380|FG000|Overall Study|Death due to adverse event (AE)|0|||
23569379|NCT00452413|65813381|FG001|Overall Study|Death due to adverse event (AE)|0|||
23161992|NCT03332498|64341754|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
23161993|NCT01014689|64341755|FG000|Overall Study|Lack of Efficacy|0|||
23161994|NCT01014689|64341756|FG001|Overall Study|Lack of Efficacy|1|||
23161995|NCT01014689|64341755|FG000|Overall Study|Adverse Event|3|||
23161996|NCT01014689|64341756|FG001|Overall Study|Adverse Event|0|||
23161997|NCT01014689|64341755|FG000|Overall Study|Withdrawal by Subject|5|||
23161998|NCT01014689|64341756|FG001|Overall Study|Withdrawal by Subject|4|||
23161999|NCT01014689|64341755|FG000|Overall Study|Protocol Violation|1|||
23162000|NCT01014689|64341756|FG001|Overall Study|Protocol Violation|1|||
23162001|NCT01014689|64341755|FG000|Overall Study|Lost to Follow-up|3|||
23162002|NCT01014689|64341756|FG001|Overall Study|Lost to Follow-up|7|||
23223622|NCT01224106|64560555|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
23223623|NCT01224106|64560556|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
23223624|NCT01224106|64560552|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23223625|NCT01224106|64560553|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
23223626|NCT01224106|64560554|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
23446685|NCT03852719|65377731|FG001|Overall Study|Physician Decision|0|||
23569380|NCT00452413|65813382|FG002|Overall Study|Death due to adverse event (AE)|1|||
23569381|NCT00452413|65813380|FG000|Overall Study|On treatment|0|||
23569382|NCT00452413|65813381|FG001|Overall Study|On treatment|0|||
23569383|NCT00452413|65813382|FG002|Overall Study|On treatment|3|||
23569384|NCT03661996|65813383|FG000|Overall Study|Adverse Event|0|||
23569385|NCT03661996|65813384|FG001|Overall Study|Adverse Event|0|||
23569386|NCT03661996|65813385|FG002|Overall Study|Adverse Event|1|||
23569387|NCT03661996|65813386|FG003|Overall Study|Adverse Event|1|||
23569388|NCT03661996|65813387|FG004|Overall Study|Adverse Event|0|||
23569389|NCT03661996|65813383|FG000|Overall Study|Lost to Follow-up|5|||
23569390|NCT03661996|65813384|FG001|Overall Study|Lost to Follow-up|1|||
23569391|NCT03661996|65813385|FG002|Overall Study|Lost to Follow-up|2|||
23569392|NCT03661996|65813386|FG003|Overall Study|Lost to Follow-up|2|||
23569393|NCT03661996|65813387|FG004|Overall Study|Lost to Follow-up|6|||
23569394|NCT03661996|65813383|FG000|Overall Study|Physician Decision|1|||
23569395|NCT03661996|65813384|FG001|Overall Study|Physician Decision|1|||
23569396|NCT03661996|65813385|FG002|Overall Study|Physician Decision|1|||
23569397|NCT03661996|65813386|FG003|Overall Study|Physician Decision|2|||
23569398|NCT03661996|65813387|FG004|Overall Study|Physician Decision|0|||
23569399|NCT03661996|65813383|FG000|Overall Study|Protocol Violation|0|||
23569400|NCT03661996|65813384|FG001|Overall Study|Protocol Violation|0|||
23569401|NCT03661996|65813385|FG002|Overall Study|Protocol Violation|0|||
23569402|NCT03661996|65813386|FG003|Overall Study|Protocol Violation|0|||
23569403|NCT03661996|65813387|FG004|Overall Study|Protocol Violation|1|||
23569404|NCT03661996|65813383|FG000|Overall Study|Withdrawal by Subject|3|||
23569405|NCT03661996|65813384|FG001|Overall Study|Withdrawal by Subject|5|||
23569406|NCT03661996|65813385|FG002|Overall Study|Withdrawal by Subject|1|||
23569407|NCT03661996|65813386|FG003|Overall Study|Withdrawal by Subject|7|||
23569408|NCT03661996|65813387|FG004|Overall Study|Withdrawal by Subject|7|||
23569409|NCT03661996|65813383|FG000|Overall Study|Sponsors Decision|2|||
23569410|NCT03661996|65813384|FG001|Overall Study|Sponsors Decision|0|||
23569411|NCT03661996|65813385|FG002|Overall Study|Sponsors Decision|0|||
23569412|NCT03661996|65813386|FG003|Overall Study|Sponsors Decision|0|||
23446686|NCT03852719|65377732|FG002|Overall Study|Physician Decision|1|||
23446687|NCT03852719|65377730|FG000|Overall Study|Pregnancy|1|||
23446688|NCT03852719|65377731|FG001|Overall Study|Pregnancy|1|||
23446689|NCT03852719|65377732|FG002|Overall Study|Pregnancy|0|||
23569413|NCT03661996|65813387|FG004|Overall Study|Sponsors Decision|0|||
23569414|NCT03661996|65813383|FG000|Overall Study|Other|1|||
23569415|NCT03661996|65813384|FG001|Overall Study|Other|1|||
23569416|NCT03661996|65813385|FG002|Overall Study|Other|1|||
23569417|NCT03661996|65813386|FG003|Overall Study|Other|1|||
23569418|NCT03661996|65813387|FG004|Overall Study|Other|0|||
23569419|NCT03283696|65813390|FG000|Overall Study|Physician Decision|5|||
23569420|NCT03283696|65813391|FG001|Overall Study|Physician Decision|6|||
23569421|NCT03283696|65813390|FG000|Overall Study|Withdrawal by Subject|2|||
23569422|NCT03283696|65813391|FG001|Overall Study|Withdrawal by Subject|0|||
23569423|NCT03354637|65813392|FG000|Double-blind Period|Protocol Violation|2|||
23569424|NCT03354637|65813393|FG001|Double-blind Period|Protocol Violation|0|||
23162003|NCT01014689|64341755|FG000|Overall Study|Pregnancy|1|||
23162004|NCT01014689|64341756|FG001|Overall Study|Pregnancy|0|||
23223627|NCT01224106|64560555|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23446690|NCT03852719|65377730|FG000|Overall Study|Death|1|||
23446691|NCT03852719|65377731|FG001|Overall Study|Death|0|||
23569425|NCT03354637|65813394|FG002|Double-blind Period|Protocol Violation|0|||
23569426|NCT03354637|65813392|FG000|Double-blind Period|Adverse Event|1|||
23569427|NCT03354637|65813393|FG001|Double-blind Period|Adverse Event|2|||
23569428|NCT03354637|65813394|FG002|Double-blind Period|Adverse Event|0|||
23569429|NCT03354637|65813392|FG000|Double-blind Period|Lost to Follow-up|3|||
23330553|NCT00739661|64952042|FG000|Overall Study|Patient decision to withdraw|9|||
23330554|NCT00739661|64952043|FG001|Overall Study|Patient decision to withdraw|4|||
23330555|NCT00739661|64952042|FG000|Overall Study|Disease progression, radiographic|33|||
23330556|NCT00739661|64952043|FG001|Overall Study|Disease progression, radiographic|37|||
23330557|NCT00739661|64952042|FG000|Overall Study|Reason for discontinuation not available|1|||
23330558|NCT00739661|64952043|FG001|Overall Study|Reason for discontinuation not available|1|||
23330559|NCT01662635|64952045|FG000|Overall Study|scarce samples for evaluation|30|||
23330560|NCT01445730|64952052|FG000|Overall Study|Adverse Event|1|||
23330561|NCT01445730|64952052|FG000|Overall Study|For the advice of a dentist|1|||
23330562|NCT01445730|64952052|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
23330563|NCT01303172|64952053|FG000|Overall Study|Physician Decision|9|||
23330564|NCT01303172|64952054|FG001|Overall Study|Physician Decision|6|||
23330565|NCT01303172|64952053|FG000|Overall Study|Adverse Event|5|||
23330566|NCT01303172|64952054|FG001|Overall Study|Adverse Event|2|||
23330567|NCT01303172|64952053|FG000|Overall Study|Withdrawal by Subject|4|||
23330568|NCT01303172|64952054|FG001|Overall Study|Withdrawal by Subject|2|||
23569430|NCT03354637|65813393|FG001|Double-blind Period|Lost to Follow-up|4|||
23569431|NCT03354637|65813394|FG002|Double-blind Period|Lost to Follow-up|3|||
23569432|NCT03354637|65813392|FG000|Double-blind Period|Withdrawal by Subject|10|||
23569433|NCT03354637|65813393|FG001|Double-blind Period|Withdrawal by Subject|6|||
23162005|NCT01265797|64341757|FG000|Run-in Month|Withdrawal by Subject|0|||
23223628|NCT01224106|64560556|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
23223629|NCT01224106|64560552|FG000|Double-Blind Treatment Phase|Other|0|||
23569434|NCT03354637|65813394|FG002|Double-blind Period|Withdrawal by Subject|4|||
23569435|NCT03354637|65813392|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
23569436|NCT03354637|65813393|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
23569437|NCT03354637|65813394|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
23569438|NCT03354637|65813392|FG000|Open Label Extension|Adverse Event|0|||
23569439|NCT03354637|65813393|FG001|Open Label Extension|Adverse Event|0|||
23569440|NCT03354637|65813394|FG002|Open Label Extension|Adverse Event|1|||
23569441|NCT03354637|65813392|FG000|Open Label Extension|Lost to Follow-up|0|||
23569442|NCT03354637|65813393|FG001|Open Label Extension|Lost to Follow-up|0|||
23569443|NCT03354637|65813394|FG002|Open Label Extension|Lost to Follow-up|2|||
23569444|NCT03354637|65813392|FG000|Open Label Extension|Withdrawal by Subject|0|||
23569445|NCT03354637|65813393|FG001|Open Label Extension|Withdrawal by Subject|0|||
23162006|NCT01265797|64341758|FG001|Run-in Month|Withdrawal by Subject|4|||
23162007|NCT01265797|64341757|FG000|Run-in Month|1st seizure during run-in month|0|||
23162008|NCT01265797|64341758|FG001|Run-in Month|1st seizure during run-in month|1|||
23162009|NCT01265797|64341757|FG000|Blinded Month|Lack of Efficacy|5|||
23162010|NCT01265797|64341758|FG001|Blinded Month|Lack of Efficacy|0|||
23162011|NCT01265797|64341757|FG000|Blinded Month|Lost to Follow-up|1|||
23162012|NCT01265797|64341758|FG001|Blinded Month|Lost to Follow-up|0|||
23223630|NCT01224106|64560553|FG001|Double-Blind Treatment Phase|Other|0|||
23223631|NCT01224106|64560554|FG002|Double-Blind Treatment Phase|Other|1|||
23223632|NCT01224106|64560555|FG003|Double-Blind Treatment Phase|Other|0|||
23223633|NCT01224106|64560556|FG004|Double-Blind Treatment Phase|Other|0|||
23223634|NCT01224106|64560552|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
23223635|NCT01224106|64560553|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
23223636|NCT01224106|64560554|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
23223637|NCT01224106|64560555|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
23223638|NCT01224106|64560556|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
23223639|NCT01224106|64560552|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
23223640|NCT01224106|64560553|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
23223641|NCT01224106|64560554|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
23223642|NCT01224106|64560555|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
23330569|NCT01303172|64952053|FG000|Overall Study|Death|20|||
23330570|NCT01303172|64952054|FG001|Overall Study|Death|7|||
23330571|NCT01303172|64952053|FG000|Overall Study|Lack of Efficacy|25|||
23330572|NCT01303172|64952054|FG001|Overall Study|Lack of Efficacy|17|||
23330573|NCT01074268|64952056|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
23569446|NCT03354637|65813394|FG002|Open Label Extension|Withdrawal by Subject|5|||
23162013|NCT01265797|64341757|FG000|Blinded Month|Protocol Violation|2|||
23162014|NCT01265797|64341758|FG001|Blinded Month|Protocol Violation|1|||
23569447|NCT03354637|65813392|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
23569448|NCT03354637|65813393|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
23223643|NCT01224106|64560556|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
23223644|NCT01224106|64560552|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23223645|NCT01224106|64560553|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23223646|NCT01224106|64560554|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23162015|NCT01265797|64341757|FG000|Blinded Month|Adverse Event|2|||
23162016|NCT01265797|64341758|FG001|Blinded Month|Adverse Event|0|||
23162017|NCT01265797|64341757|FG000|Blinded Month|Diary data incomplete|0|||
23162018|NCT01265797|64341758|FG001|Blinded Month|Diary data incomplete|1|||
23162019|NCT01265797|64341757|FG000|Open Label Month|Lost to Follow-up|0|||
23446692|NCT03852719|65377732|FG002|Overall Study|Death|0|||
23446693|NCT00855816|65377733|FG000|Overall Study|Withdrawal by Subject|22|||
23446694|NCT00855816|65377734|FG001|Overall Study|Withdrawal by Subject|15|||
23446695|NCT00855816|65377733|FG000|Overall Study|Lost to Follow-up|3|||
23569449|NCT03354637|65813394|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
23223647|NCT01224106|64560555|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23223648|NCT01224106|64560556|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23223649|NCT01224106|64560552|FG000|Open-Label Extension (OLE) Phase|Death|0|||
23223650|NCT01224106|64560553|FG001|Open-Label Extension (OLE) Phase|Death|0|||
23223651|NCT01224106|64560554|FG002|Open-Label Extension (OLE) Phase|Death|0|||
23223652|NCT01224106|64560555|FG003|Open-Label Extension (OLE) Phase|Death|1|||
23223653|NCT01224106|64560556|FG004|Open-Label Extension (OLE) Phase|Death|3|||
23223654|NCT01224106|64560552|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
23162020|NCT01265797|64341758|FG001|Open Label Month|Lost to Follow-up|1|||
23162021|NCT01111851|64341763|FG000|Overall Study|All planned PET scans were not obtained.|2|||
23162022|NCT01111851|64341764|FG001|Overall Study|All planned PET scans were not obtained.|0|||
23569450|NCT03354637|65813392|FG000|Open Label Extension|Subject Noncompliance|0|||
23569451|NCT03354637|65813393|FG001|Open Label Extension|Subject Noncompliance|0|||
23569452|NCT03354637|65813394|FG002|Open Label Extension|Subject Noncompliance|1|||
23569453|NCT03354637|65813392|FG000|Open Label Extension|Lack of Efficacy|0|||
23569454|NCT03354637|65813393|FG001|Open Label Extension|Lack of Efficacy|0|||
23569455|NCT03354637|65813394|FG002|Open Label Extension|Lack of Efficacy|1|||
23569456|NCT03354637|65813392|FG000|Open Label Extension|Physician Decision|0|||
23569457|NCT03354637|65813393|FG001|Open Label Extension|Physician Decision|0|||
23223655|NCT01224106|64560553|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
23223656|NCT01224106|64560554|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
23223657|NCT01224106|64560555|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
23223658|NCT01224106|64560556|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
23569458|NCT03354637|65813394|FG002|Open Label Extension|Physician Decision|1|||
23162023|NCT00889265|64341768|FG000|Overall Study|Adverse Event|1|||
23162024|NCT00889265|64341768|FG000|Overall Study|Lost to Follow-up|5|||
23162025|NCT00889265|64341768|FG000|Overall Study|Protocol Violation|1|||
23162026|NCT00562588|64341769|FG000|Overall Study|Adverse Event|40|||
23162027|NCT00562588|64341770|FG001|Overall Study|Adverse Event|58|||
23162028|NCT00562588|64341769|FG000|Overall Study|Protocol Violation|30|||
23162029|NCT00562588|64341770|FG001|Overall Study|Protocol Violation|26|||
23162030|NCT00562588|64341769|FG000|Overall Study|Lost to Follow-up|12|||
23162031|NCT00562588|64341770|FG001|Overall Study|Lost to Follow-up|4|||
23162032|NCT00562588|64341769|FG000|Overall Study|Withdrawal by Subject|10|||
23330574|NCT01074268|64952057|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
23330575|NCT01074268|64952056|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
23446696|NCT00855816|65377734|FG001|Overall Study|Lost to Follow-up|5|||
23330576|NCT01074268|64952057|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
23330577|NCT01074268|64952056|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
23223659|NCT01224106|64560552|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
23162033|NCT00562588|64341770|FG001|Overall Study|Withdrawal by Subject|9|||
23162034|NCT00562588|64341769|FG000|Overall Study|Other|0|||
23446697|NCT00855816|65377733|FG000|Overall Study|Death|1|||
23446698|NCT00855816|65377734|FG001|Overall Study|Death|0|||
23446699|NCT00855816|65377733|FG000|Overall Study|Became ineligible|0|||
23446700|NCT00855816|65377734|FG001|Overall Study|Became ineligible|1|||
23446701|NCT03369418|65377735|FG000|Overall Study|Withdrawal by Subject|3|||
23446702|NCT03369418|65377736|FG001|Overall Study|Withdrawal by Subject|3|||
23446703|NCT02634333|65377738|FG000|Overall Study|Completed out of Window|3|||
23446704|NCT02634333|65377739|FG001|Overall Study|Completed out of Window|2|||
23446705|NCT02634333|65377738|FG000|Overall Study|Missed Visit|5|||
23446706|NCT02634333|65377739|FG001|Overall Study|Missed Visit|2|||
23446707|NCT02634333|65377738|FG000|Overall Study|Lost to Follow-up|12|||
23446708|NCT02634333|65377739|FG001|Overall Study|Lost to Follow-up|7|||
23446709|NCT02634333|65377738|FG000|Overall Study|Withdrawal by Subject|9|||
23446710|NCT02634333|65377739|FG001|Overall Study|Withdrawal by Subject|13|||
23446711|NCT02634333|65377738|FG000|Overall Study|Death|11|||
23446712|NCT02634333|65377739|FG001|Overall Study|Death|8|||
23446713|NCT03010527|65377740|FG000|Overall Study|Death|0|||
23446714|NCT03010527|65377741|FG001|Overall Study|Death|0|||
23446715|NCT03010527|65377742|FG002|Overall Study|Death|1|||
23446716|NCT03010527|65377740|FG000|Overall Study|Adverse Event|0|||
23446717|NCT03010527|65377741|FG001|Overall Study|Adverse Event|4|||
23446718|NCT03010527|65377742|FG002|Overall Study|Adverse Event|2|||
23446719|NCT03010527|65377740|FG000|Overall Study|Protocol Violation|0|||
23446720|NCT03010527|65377741|FG001|Overall Study|Protocol Violation|1|||
23446721|NCT03010527|65377742|FG002|Overall Study|Protocol Violation|0|||
23446722|NCT03010527|65377740|FG000|Overall Study|Lost to Follow-up|0|||
23446723|NCT03010527|65377741|FG001|Overall Study|Lost to Follow-up|2|||
23446724|NCT03010527|65377742|FG002|Overall Study|Lost to Follow-up|1|||
23446725|NCT03010527|65377740|FG000|Overall Study|Withdrawal by Subject|0|||
23446726|NCT03010527|65377741|FG001|Overall Study|Withdrawal by Subject|3|||
23446727|NCT03010527|65377742|FG002|Overall Study|Withdrawal by Subject|4|||
23446728|NCT03010527|65377740|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
23446729|NCT03010527|65377741|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
23446730|NCT03010527|65377742|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
23446731|NCT03010527|65377740|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
23569459|NCT01679236|65813397|FG000|Overall Study|Lost to Follow-up|15|||
23162035|NCT00562588|64341770|FG001|Overall Study|Other|2|||
23162036|NCT02553265|64341772|FG000|Enrollment|Death|0|||
23162037|NCT02553265|64341773|FG001|Enrollment|Death|0|||
23162038|NCT02553265|64341774|FG002|Enrollment|Death|1|||
23162039|NCT02553265|64341772|FG000|First Intervention (28 Days)|Adverse Event|1|||
23162040|NCT02553265|64341773|FG001|First Intervention (28 Days)|Adverse Event|0|||
23162041|NCT02553265|64341774|FG002|First Intervention (28 Days)|Adverse Event|0|||
23162042|NCT02553265|64341772|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
23162043|NCT02553265|64341773|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
23162044|NCT02553265|64341774|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
23162045|NCT02553265|64341772|FG000|Second Intervention (28 Days)|Adverse Event|1|||
23162046|NCT02553265|64341773|FG001|Second Intervention (28 Days)|Adverse Event|0|||
23162047|NCT02553265|64341774|FG002|Second Intervention (28 Days)|Adverse Event|0|||
23162048|NCT02553265|64341772|FG000|Third Intervention (28 Days)|Adverse Event|1|||
23162049|NCT02553265|64341773|FG001|Third Intervention (28 Days)|Adverse Event|0|||
23162050|NCT02553265|64341774|FG002|Third Intervention (28 Days)|Adverse Event|0|||
23162051|NCT02553265|64341772|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
23162052|NCT02553265|64341773|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
23162053|NCT02553265|64341774|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
23162054|NCT01040351|64341775|FG000|Overall Study|poor ovarian response|1|||
23162055|NCT01040351|64341776|FG001|Overall Study|poor ovarian response|2|||
23162056|NCT00003535|64341780|FG000|Overall Study|Not evaluable|5|||
23162057|NCT02577146|64341781|FG000|Overall Study|Lost to Follow-up|8|||
23162058|NCT02577146|64341781|FG000|Overall Study|Physician Decision|3|||
23162059|NCT02577146|64341781|FG000|Overall Study|Screen Failure|17|||
23162060|NCT00781911|64341782|FG000|Overall Study|Adverse Event|4|||
23446732|NCT03010527|65377741|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
23446733|NCT03010527|65377742|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
23446734|NCT03010527|65377740|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
23446735|NCT03010527|65377741|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
23446736|NCT03010527|65377742|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
23446737|NCT01216683|65377743|FG000|Induction|Never started treatment|0|||
23446738|NCT01216683|65377744|FG001|Induction|Never started treatment|6|||
23446739|NCT01216683|65377745|FG002|Induction|Never started treatment|3|||
23446740|NCT01216683|65377743|FG000|Induction|Lack of Efficacy|4|||
23446741|NCT01216683|65377744|FG001|Induction|Lack of Efficacy|3|||
23446742|NCT01216683|65377745|FG002|Induction|Lack of Efficacy|7|||
23446743|NCT01216683|65377743|FG000|Induction|Adverse Event|0|||
23446744|NCT01216683|65377744|FG001|Induction|Adverse Event|5|||
23446745|NCT01216683|65377745|FG002|Induction|Adverse Event|5|||
23162061|NCT00781911|64341783|FG001|Overall Study|Adverse Event|4|||
23446746|NCT01216683|65377743|FG000|Induction|Death|0|||
23569460|NCT01679236|65813398|FG001|Overall Study|Lost to Follow-up|15|||
23569461|NCT00064025|65813403|FG000|Overall Study|Ineligible|4|||
23569462|NCT00064025|65813403|FG000|Overall Study|Inevaluable|3|||
23569463|NCT03075501|65813405|FG000|Overall Study|Scheduling difficulties|15|||
23569464|NCT03075501|65813406|FG001|Overall Study|Scheduling difficulties|9|||
23569465|NCT04489888|65813407|FG000|Overall Study|Death|61|||
23569466|NCT04489888|65813407|FG000|Overall Study|Participant On-going|40|||
23569467|NCT03327402|65813408|FG000|Overall Study|Withdrawal by Subject|1|||
23569468|NCT03327402|65813408|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
23569469|NCT04170296|65813411|FG000|Overall Study|Adverse Event|1|||
23569470|NCT04170296|65813412|FG001|Overall Study|Adverse Event|0|||
23569471|NCT04170296|65813411|FG000|Overall Study|Withdrawal by Subject|3|||
23569472|NCT04170296|65813412|FG001|Overall Study|Withdrawal by Subject|2|||
23569473|NCT04170296|65813411|FG000|Overall Study|Lost to Follow-up|4|||
23569474|NCT04170296|65813412|FG001|Overall Study|Lost to Follow-up|2|||
23569475|NCT00786474|65813413|FG000|Overall Study|Death|5|||
23569476|NCT00786474|65813414|FG001|Overall Study|Death|4|||
23330578|NCT01074268|64952057|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
23446747|NCT01216683|65377744|FG001|Induction|Death|0|||
23446748|NCT01216683|65377745|FG002|Induction|Death|2|||
23446749|NCT01216683|65377743|FG000|Induction|Withdrawal by Subject|0|||
23446750|NCT01216683|65377744|FG001|Induction|Withdrawal by Subject|4|||
23569477|NCT00786474|65813413|FG000|Overall Study|Withdrawal by Subject|23|||
23569478|NCT00786474|65813414|FG001|Overall Study|Withdrawal by Subject|31|||
23569479|NCT00786474|65813413|FG000|Overall Study|Lost to Follow-up|3|||
23569480|NCT00786474|65813414|FG001|Overall Study|Lost to Follow-up|3|||
23446751|NCT01216683|65377745|FG002|Induction|Withdrawal by Subject|2|||
23446752|NCT01216683|65377743|FG000|Induction|Other disease|0|||
23446753|NCT01216683|65377744|FG001|Induction|Other disease|1|||
23446754|NCT01216683|65377745|FG002|Induction|Other disease|2|||
23446755|NCT01216683|65377743|FG000|Continuation|Lack of Efficacy|3|||
23446756|NCT01216683|65377744|FG001|Continuation|Lack of Efficacy|2|||
23446757|NCT01216683|65377745|FG002|Continuation|Lack of Efficacy|7|||
23446758|NCT01216683|65377743|FG000|Continuation|Adverse Event|5|||
23569481|NCT00786474|65813413|FG000|Overall Study|Physician Decision|2|||
23569482|NCT00786474|65813414|FG001|Overall Study|Physician Decision|1|||
23569483|NCT00786474|65813413|FG000|Overall Study|Other|4|||
23446759|NCT01216683|65377744|FG001|Continuation|Adverse Event|3|||
23446760|NCT01216683|65377745|FG002|Continuation|Adverse Event|16|||
23569484|NCT00786474|65813414|FG001|Overall Study|Other|4|||
23569485|NCT02917265|65813415|FG000|Overall Study|Physician Decision|1|||
23569486|NCT02917265|65813416|FG001|Overall Study|Physician Decision|0|||
23569487|NCT02917265|65813415|FG000|Overall Study|Withdrawal by Subject|1|||
23569488|NCT02917265|65813416|FG001|Overall Study|Withdrawal by Subject|0|||
23569489|NCT02340520|65813418|FG000|Overall Study|Lost to Follow-up|1|||
23569490|NCT02340520|65813418|FG000|Overall Study|Patient did not take drug as specified|1|||
23569491|NCT02340520|65813418|FG000|Overall Study|Withdrawal by Subject|1|||
23569492|NCT01146574|65813425|FG000|Overall Study|Death|0|||
23446761|NCT01216683|65377743|FG000|Continuation|Death|1|||
23446762|NCT01216683|65377744|FG001|Continuation|Death|0|||
23446763|NCT01216683|65377745|FG002|Continuation|Death|2|||
23446764|NCT01216683|65377743|FG000|Continuation|Withdrawal by Subject|4|||
23446765|NCT01216683|65377744|FG001|Continuation|Withdrawal by Subject|5|||
23446766|NCT01216683|65377745|FG002|Continuation|Withdrawal by Subject|9|||
23446767|NCT01216683|65377743|FG000|Continuation|Other diseases|0|||
23569493|NCT01146574|65813426|FG001|Overall Study|Death|1|||
23569494|NCT01146574|65813427|FG002|Overall Study|Death|1|||
23569495|NCT01146574|65813428|FG003|Overall Study|Death|0|||
23569496|NCT01146574|65813429|FG004|Overall Study|Death|0|||
23569497|NCT01146574|65813430|FG005|Overall Study|Death|0|||
23569498|NCT01146574|65813431|FG006|Overall Study|Death|0|||
23569499|NCT01146574|65813425|FG000|Overall Study|Other reasons|0|||
23162062|NCT00781911|64341782|FG000|Overall Study|Withdrawal by Subject|1|||
23162063|NCT00781911|64341783|FG001|Overall Study|Withdrawal by Subject|2|||
23162064|NCT00781911|64341782|FG000|Overall Study|Physician Decision|0|||
23162065|NCT00781911|64341783|FG001|Overall Study|Physician Decision|2|||
23162066|NCT00781911|64341782|FG000|Overall Study|Sponsor Decision|1|||
23162067|NCT00781911|64341783|FG001|Overall Study|Sponsor Decision|0|||
23162068|NCT02234479|64341786|FG000|Overall Study|Withdrawal by Subject|1|||
23162069|NCT02234479|64341787|FG001|Overall Study|Withdrawal by Subject|3|||
23162070|NCT01394627|64341795|FG000|First Intervention (1 Day)|poor intravenous access|0|||
23162071|NCT01394627|64341796|FG001|First Intervention (1 Day)|poor intravenous access|1|||
23162072|NCT01394627|64341795|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
23162073|NCT01394627|64341796|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
23162074|NCT03440814|64341797|FG000|Overall Study|Adverse Event|2|||
23162075|NCT03440814|64341798|FG001|Overall Study|Adverse Event|1|||
23162076|NCT03440814|64341797|FG000|Overall Study|Lost to Follow-up|2|||
23162077|NCT03440814|64341798|FG001|Overall Study|Lost to Follow-up|0|||
23162078|NCT03440814|64341797|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
23162079|NCT03440814|64341798|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
23162080|NCT02232802|64341799|FG000|Period 1|Sponsor request|1|||
23162081|NCT02232802|64341800|FG001|Period 1|Sponsor request|0|||
23162082|NCT02232802|64341799|FG000|Period 1|Adverse Event|1|||
23162083|NCT02232802|64341800|FG001|Period 1|Adverse Event|1|||
23162084|NCT01439282|64341801|FG000|Overall Study|Adverse Event|5|||
23162085|NCT01439282|64341802|FG001|Overall Study|Adverse Event|0|||
23162086|NCT01439282|64341801|FG000|Overall Study|Withdrawal by Subject|2|||
23162087|NCT01439282|64341802|FG001|Overall Study|Withdrawal by Subject|0|||
23162088|NCT01439282|64341801|FG000|Overall Study|Other|1|||
23162089|NCT01439282|64341802|FG001|Overall Study|Other|1|||
23162090|NCT03688880|64341803|FG000|Overall Study|Withdrawal by Subject|0|||
23162091|NCT03688880|64341804|FG001|Overall Study|Withdrawal by Subject|2|||
23162092|NCT03688880|64341803|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
23162093|NCT03688880|64341804|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
23162094|NCT03688880|64341803|FG000|Overall Study|Lost to Follow-up|4|||
23162095|NCT03688880|64341804|FG001|Overall Study|Lost to Follow-up|7|||
23162096|NCT03688880|64341803|FG000|Overall Study|Adverse Event|0|||
23162097|NCT03688880|64341804|FG001|Overall Study|Adverse Event|2|||
23162098|NCT03688880|64341803|FG000|Overall Study|Device deficiencies|0|||
23162099|NCT03688880|64341804|FG001|Overall Study|Device deficiencies|2|||
23162100|NCT03688880|64341803|FG000|Overall Study|Other|10|||
23162101|NCT03688880|64341804|FG001|Overall Study|Other|16|||
23162102|NCT00706134|64341805|FG000|Overall Study|Adverse Event|8|||
23162103|NCT00706134|64341806|FG001|Overall Study|Adverse Event|7|||
23162104|NCT00706134|64341807|FG002|Overall Study|Adverse Event|2|||
23162105|NCT00706134|64341808|FG003|Overall Study|Adverse Event|3|||
23162106|NCT00706134|64341805|FG000|Overall Study|Lost to Follow-up|0|||
23162107|NCT00706134|64341806|FG001|Overall Study|Lost to Follow-up|1|||
23446768|NCT01216683|65377744|FG001|Continuation|Other diseases|2|||
23446769|NCT01216683|65377745|FG002|Continuation|Other diseases|1|||
23446770|NCT01216683|65377743|FG000|Continuation|Physician Decision|1|||
23446771|NCT01216683|65377744|FG001|Continuation|Physician Decision|0|||
23569500|NCT01146574|65813426|FG001|Overall Study|Other reasons|0|||
23569501|NCT01146574|65813427|FG002|Overall Study|Other reasons|3|||
23569502|NCT01146574|65813428|FG003|Overall Study|Other reasons|0|||
23569503|NCT01146574|65813429|FG004|Overall Study|Other reasons|0|||
23569504|NCT01146574|65813430|FG005|Overall Study|Other reasons|0|||
23569505|NCT01146574|65813431|FG006|Overall Study|Other reasons|0|||
23569506|NCT01146574|65813425|FG000|Overall Study|Kidney transplant|0|||
23569507|NCT01146574|65813426|FG001|Overall Study|Kidney transplant|0|||
23569508|NCT01146574|65813427|FG002|Overall Study|Kidney transplant|1|||
23569509|NCT01146574|65813428|FG003|Overall Study|Kidney transplant|1|||
23569510|NCT01146574|65813429|FG004|Overall Study|Kidney transplant|0|||
23569511|NCT01146574|65813430|FG005|Overall Study|Kidney transplant|0|||
23569512|NCT01146574|65813431|FG006|Overall Study|Kidney transplant|0|||
23569513|NCT01146574|65813425|FG000|Overall Study|Withdrew consent|0|||
23569514|NCT01146574|65813426|FG001|Overall Study|Withdrew consent|0|||
23569515|NCT01146574|65813427|FG002|Overall Study|Withdrew consent|1|||
23569516|NCT01146574|65813428|FG003|Overall Study|Withdrew consent|1|||
23569517|NCT01146574|65813429|FG004|Overall Study|Withdrew consent|2|||
23569518|NCT01146574|65813430|FG005|Overall Study|Withdrew consent|1|||
23569519|NCT01146574|65813431|FG006|Overall Study|Withdrew consent|1|||
23162108|NCT00706134|64341807|FG002|Overall Study|Lost to Follow-up|0|||
23569520|NCT02038764|65813433|FG000|Overall Study|Adverse Event|0|||
23162109|NCT00706134|64341808|FG003|Overall Study|Lost to Follow-up|0|||
23162110|NCT00706134|64341805|FG000|Overall Study|Protocol Violation|0|||
23162111|NCT00706134|64341806|FG001|Overall Study|Protocol Violation|6|||
23162112|NCT00706134|64341807|FG002|Overall Study|Protocol Violation|0|||
23162113|NCT00706134|64341808|FG003|Overall Study|Protocol Violation|3|||
23223660|NCT01224106|64560553|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
23446772|NCT01216683|65377745|FG002|Continuation|Physician Decision|1|||
23569521|NCT02038764|65813434|FG001|Overall Study|Adverse Event|0|||
23162114|NCT00706134|64341805|FG000|Overall Study|Withdrawal by Subject|1|||
23446773|NCT01216683|65377743|FG000|Continuation|Non-compliance|1|||
23446774|NCT01216683|65377744|FG001|Continuation|Non-compliance|0|||
23446775|NCT01216683|65377745|FG002|Continuation|Non-compliance|1|||
23446776|NCT01216683|65377743|FG000|Continuation|Insurance change|0|||
23446777|NCT01216683|65377744|FG001|Continuation|Insurance change|1|||
23446778|NCT01216683|65377745|FG002|Continuation|Insurance change|0|||
23446779|NCT01216683|65377743|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
23446780|NCT01216683|65377744|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
23446781|NCT01216683|65377745|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
23162115|NCT00706134|64341806|FG001|Overall Study|Withdrawal by Subject|2|||
23162116|NCT00706134|64341807|FG002|Overall Study|Withdrawal by Subject|1|||
23446782|NCT01216683|65377743|FG000|Continuation|Not reported|0|||
23569522|NCT02038764|65813435|FG002|Overall Study|Adverse Event|1|||
23569523|NCT02038764|65813436|FG003|Overall Study|Adverse Event|0|||
23569524|NCT02038764|65813437|FG004|Overall Study|Adverse Event|0|||
23569525|NCT02038764|65813433|FG000|Overall Study|Lost to Follow-up|0|||
23569526|NCT02038764|65813434|FG001|Overall Study|Lost to Follow-up|1|||
23446783|NCT01216683|65377744|FG001|Continuation|Not reported|0|||
23446784|NCT01216683|65377745|FG002|Continuation|Not reported|1|||
23446785|NCT01216683|65377743|FG000|Continuation|Never started treatment|0|||
23446786|NCT01216683|65377744|FG001|Continuation|Never started treatment|1|||
23446787|NCT01216683|65377745|FG002|Continuation|Never started treatment|5|||
23446788|NCT00556894|65377748|FG000|Overall Study|Adverse Event|2|||
23446789|NCT00556894|65377749|FG001|Overall Study|Adverse Event|3|||
23446790|NCT00556894|65377750|FG002|Overall Study|Adverse Event|3|||
23446791|NCT00556894|65377748|FG000|Overall Study|Death|1|||
23446792|NCT00556894|65377749|FG001|Overall Study|Death|0|||
23446793|NCT00556894|65377750|FG002|Overall Study|Death|0|||
23162117|NCT00706134|64341808|FG003|Overall Study|Withdrawal by Subject|0|||
23162118|NCT00706134|64341805|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
23162119|NCT00706134|64341806|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23162120|NCT00706134|64341807|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
23162121|NCT00706134|64341808|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
23162122|NCT00706134|64341805|FG000|Overall Study|Did not meet study criteria|2|||
23446794|NCT00556894|65377748|FG000|Overall Study|regulatory decision in Bulgaria|10|||
23446795|NCT00556894|65377749|FG001|Overall Study|regulatory decision in Bulgaria|14|||
23446796|NCT00556894|65377750|FG002|Overall Study|regulatory decision in Bulgaria|13|||
23446797|NCT00556894|65377748|FG000|Overall Study|Change in therapy|2|||
23446798|NCT00556894|65377749|FG001|Overall Study|Change in therapy|1|||
23446799|NCT00556894|65377750|FG002|Overall Study|Change in therapy|2|||
23446800|NCT00556894|65377748|FG000|Overall Study|Withdrawal by Subject|1|||
23446801|NCT00556894|65377749|FG001|Overall Study|Withdrawal by Subject|1|||
23446802|NCT00556894|65377750|FG002|Overall Study|Withdrawal by Subject|1|||
23446803|NCT01101035|65377751|FG000|Overall Study|Adverse Event|191|||
23446804|NCT01101035|65377752|FG001|Overall Study|Adverse Event|172|||
23446805|NCT01101035|65377751|FG000|Overall Study|Major Protocol Deviation|52|||
23446806|NCT01101035|65377752|FG001|Overall Study|Major Protocol Deviation|46|||
23446807|NCT01101035|65377751|FG000|Overall Study|Lost to Follow-up|226|||
23446808|NCT01101035|65377752|FG001|Overall Study|Lost to Follow-up|223|||
23446809|NCT01101035|65377751|FG000|Overall Study|Voluntary Withdrawal|595|||
23446810|NCT01101035|65377752|FG001|Overall Study|Voluntary Withdrawal|587|||
23446811|NCT01101035|65377751|FG000|Overall Study|Reason not Specified|333|||
23446812|NCT01101035|65377752|FG001|Overall Study|Reason not Specified|363|||
23446813|NCT02995980|65377754|FG000|Overall Study|Lost to Follow-up|14|||
23446814|NCT01858363|65377755|FG000|Overall Study|Death|35|||
23446815|NCT01858363|65377756|FG001|Overall Study|Death|9|||
23446816|NCT01858363|65377755|FG000|Overall Study|Withdrawal by Subject|28|||
23446817|NCT01858363|65377756|FG001|Overall Study|Withdrawal by Subject|14|||
23446818|NCT01858363|65377755|FG000|Overall Study|Lost to Follow-up|13|||
23569527|NCT02038764|65813435|FG002|Overall Study|Lost to Follow-up|0|||
23569528|NCT02038764|65813436|FG003|Overall Study|Lost to Follow-up|0|||
23569529|NCT02038764|65813437|FG004|Overall Study|Lost to Follow-up|0|||
23569530|NCT02038764|65813433|FG000|Overall Study|Withdrawal by Subject|0|||
23569531|NCT02038764|65813434|FG001|Overall Study|Withdrawal by Subject|0|||
23569532|NCT02038764|65813435|FG002|Overall Study|Withdrawal by Subject|0|||
23569533|NCT02038764|65813436|FG003|Overall Study|Withdrawal by Subject|0|||
23569534|NCT02038764|65813437|FG004|Overall Study|Withdrawal by Subject|1|||
23569535|NCT02038764|65813433|FG000|Overall Study|Other|1|||
23569536|NCT02038764|65813434|FG001|Overall Study|Other|0|||
23569537|NCT02038764|65813435|FG002|Overall Study|Other|1|||
23569538|NCT02038764|65813436|FG003|Overall Study|Other|0|||
23162123|NCT00706134|64341806|FG001|Overall Study|Did not meet study criteria|0|||
23162124|NCT00706134|64341807|FG002|Overall Study|Did not meet study criteria|0|||
23162125|NCT00706134|64341808|FG003|Overall Study|Did not meet study criteria|0|||
23162126|NCT00129766|64341809|FG000|Overall Study|Death|3|||
23162127|NCT00129766|64341810|FG001|Overall Study|Death|8|||
23162128|NCT00129766|64341809|FG000|Overall Study|Withdrawal of consent|31|||
23223661|NCT01224106|64560554|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
23446819|NCT01858363|65377756|FG001|Overall Study|Lost to Follow-up|3|||
23446820|NCT02919761|65377758|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
23446821|NCT02919761|65377759|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
23446822|NCT02919761|65377760|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
23446823|NCT02919761|65377758|FG000|Part 1: Open Label|Adverse Event|1|||
23446824|NCT02919761|65377759|FG001|Part 1: Open Label|Adverse Event|0|||
23446825|NCT02919761|65377760|FG002|Part 1: Open Label|Adverse Event|0|||
23446826|NCT02919761|65377758|FG000|Part 1: Open Label|Lost to Follow-up|1|||
23446827|NCT02919761|65377759|FG001|Part 1: Open Label|Lost to Follow-up|0|||
23446828|NCT02919761|65377760|FG002|Part 1: Open Label|Lost to Follow-up|0|||
23446829|NCT02919761|65377758|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
23569539|NCT02038764|65813437|FG004|Overall Study|Other|0|||
23569540|NCT02550873|65813439|FG000|Randomized Double Blind|Adverse Event|3|||
23569541|NCT02550873|65813440|FG001|Randomized Double Blind|Adverse Event|1|||
23569542|NCT02550873|65813441|FG002|Randomized Double Blind|Adverse Event|0|||
23446830|NCT02919761|65377759|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
23446831|NCT02919761|65377760|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
23446832|NCT02919761|65377758|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
23446833|NCT02919761|65377759|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
23446834|NCT02919761|65377760|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
23446835|NCT02919761|65377758|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
23446836|NCT02919761|65377759|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
23446837|NCT02919761|65377760|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
23446838|NCT02919761|65377758|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
23446839|NCT02919761|65377759|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
23446840|NCT02919761|65377760|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
23446841|NCT02919761|65377758|FG000|Part 1: Open Label|Termination by Sponsor|1|||
23446842|NCT02919761|65377759|FG001|Part 1: Open Label|Termination by Sponsor|0|||
23446843|NCT02919761|65377760|FG002|Part 1: Open Label|Termination by Sponsor|0|||
23446844|NCT02919761|65377758|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
23446845|NCT02919761|65377759|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
23446846|NCT02919761|65377760|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
23446847|NCT02919761|65377758|FG000|Part 2: Double-blind|Adverse Event|0|||
23446848|NCT02919761|65377759|FG001|Part 2: Double-blind|Adverse Event|1|||
23446849|NCT02919761|65377760|FG002|Part 2: Double-blind|Adverse Event|0|||
23446850|NCT02919761|65377758|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
23446851|NCT02919761|65377759|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
23446852|NCT02919761|65377760|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
23446853|NCT02919761|65377758|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
23446854|NCT02919761|65377759|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
23446855|NCT02919761|65377760|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
23569543|NCT02550873|65813439|FG000|Randomized Double Blind|Disease progression|1|||
23569544|NCT02550873|65813440|FG001|Randomized Double Blind|Disease progression|1|||
23569545|NCT02550873|65813441|FG002|Randomized Double Blind|Disease progression|0|||
23569546|NCT02550873|65813439|FG000|Open Label Extension|Study ongoing|0|||
23569547|NCT02550873|65813440|FG001|Open Label Extension|Study ongoing|0|||
23569548|NCT02550873|65813441|FG002|Open Label Extension|Study ongoing|111|||
23569549|NCT00152763|65813442|FG000|Overall Study|Death|4|||
23569550|NCT00152763|65813443|FG001|Overall Study|Death|1|||
23569551|NCT00152763|65813444|FG002|Overall Study|Death|2|||
23569552|NCT00152763|65813445|FG003|Overall Study|Death|1|||
23569553|NCT00152763|65813442|FG000|Overall Study|Lost to Follow-up|6|||
23569554|NCT00152763|65813443|FG001|Overall Study|Lost to Follow-up|4|||
23330579|NCT01074268|64952056|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
23330580|NCT01074268|64952057|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
23330581|NCT01074268|64952056|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
23330582|NCT01074268|64952057|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
23330583|NCT01074268|64952056|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
23330584|NCT01074268|64952057|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
23330585|NCT01074268|64952056|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
23446856|NCT02919761|65377758|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
23162129|NCT00129766|64341810|FG001|Overall Study|Withdrawal of consent|30|||
23162130|NCT00129766|64341809|FG000|Overall Study|Lost to Follow-up|26|||
23569555|NCT00152763|65813444|FG002|Overall Study|Lost to Follow-up|2|||
23569556|NCT00152763|65813445|FG003|Overall Study|Lost to Follow-up|13|||
23569557|NCT02611830|65813446|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
23162131|NCT00129766|64341810|FG001|Overall Study|Lost to Follow-up|21|||
23162132|NCT00939783|64341811|FG000|Overall Study|Death|6|||
23162133|NCT00939783|64341811|FG000|Overall Study|Adverse Event|39|||
23162134|NCT00939783|64341811|FG000|Overall Study|Study Terminated by Sponsor|498|||
23162135|NCT00939783|64341811|FG000|Overall Study|Withdrawal by Subject|78|||
23162136|NCT00939783|64341811|FG000|Overall Study|Other|16|||
23162137|NCT00939783|64341811|FG000|Overall Study|Lost to Follow-up|8|||
23162138|NCT00939783|64341811|FG000|Overall Study|Protocol Violation|3|||
23569558|NCT02611830|65813447|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
23569559|NCT02611830|65813448|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
23162139|NCT00939783|64341811|FG000|Overall Study|Enrolled but not treated|1|||
23446857|NCT02919761|65377759|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
23569560|NCT02611830|65813449|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
23569561|NCT02611830|65813446|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
23223662|NCT01224106|64560555|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
23223663|NCT01224106|64560556|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
23223664|NCT01224106|64560552|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
23223665|NCT01224106|64560553|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
23223666|NCT01224106|64560554|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
23223667|NCT01224106|64560555|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
23223668|NCT01224106|64560556|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
23223669|NCT01224106|64560552|FG000|Open-Label Extension (OLE) Phase|Other|0|||
23223670|NCT01224106|64560553|FG001|Open-Label Extension (OLE) Phase|Other|0|||
23223671|NCT01224106|64560554|FG002|Open-Label Extension (OLE) Phase|Other|0|||
23223672|NCT01224106|64560555|FG003|Open-Label Extension (OLE) Phase|Other|5|||
23223673|NCT01224106|64560556|FG004|Open-Label Extension (OLE) Phase|Other|3|||
23223674|NCT03938636|64560557|FG000|Overall Study|Protocol Violation|0|||
23223675|NCT03938636|64560558|FG001|Overall Study|Protocol Violation|1|||
23569562|NCT02611830|65813447|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
23569563|NCT02611830|65813448|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
23569564|NCT02611830|65813449|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
23569565|NCT02611830|65813446|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
23569566|NCT02611830|65813447|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
23569567|NCT02611830|65813448|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
23569568|NCT02611830|65813449|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
23569569|NCT02611830|65813446|FG000|OL Induction Phase|Lack of Efficacy|9|||
23223676|NCT03938636|64560559|FG002|Overall Study|Protocol Violation|1|||
23223677|NCT03938636|64560557|FG000|Overall Study|Subject withdrew due to death in family|0|||
23223678|NCT03938636|64560558|FG001|Overall Study|Subject withdrew due to death in family|1|||
23223679|NCT03938636|64560559|FG002|Overall Study|Subject withdrew due to death in family|0|||
23223680|NCT03938636|64560557|FG000|Overall Study|Missed visit|0|||
23223681|NCT03938636|64560558|FG001|Overall Study|Missed visit|1|||
23223682|NCT03938636|64560559|FG002|Overall Study|Missed visit|0|||
23223683|NCT03938636|64560557|FG000|Overall Study|Adverse Event|0|||
23223684|NCT03938636|64560558|FG001|Overall Study|Adverse Event|0|||
23223685|NCT03938636|64560559|FG002|Overall Study|Adverse Event|1|||
23223686|NCT03938636|64560557|FG000|Overall Study|Lost to Follow-up|0|||
23223687|NCT03938636|64560558|FG001|Overall Study|Lost to Follow-up|0|||
23223688|NCT03938636|64560559|FG002|Overall Study|Lost to Follow-up|1|||
23569570|NCT02611830|65813447|FG001|OL Induction Phase|Lack of Efficacy|0|||
23569571|NCT02611830|65813448|FG002|OL Induction Phase|Lack of Efficacy|0|||
23569572|NCT02611830|65813449|FG003|OL Induction Phase|Lack of Efficacy|0|||
23569573|NCT02611830|65813446|FG000|OL Induction Phase|Reason not specified|3|||
23569574|NCT02611830|65813447|FG001|OL Induction Phase|Reason not specified|0|||
23569575|NCT02611830|65813448|FG002|OL Induction Phase|Reason not specified|0|||
23223689|NCT00560794|64560562|FG000|Overall Study|Adverse Event|2|||
23223690|NCT00560794|64560562|FG000|Overall Study|Patient was not Compliant|1|||
23223691|NCT00560794|64560562|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
23223692|NCT00560794|64560562|FG000|Overall Study|Hematological Relapse|1|||
23223693|NCT00560794|64560562|FG000|Overall Study|Received Bone Marrow Transplant|6|||
23569576|NCT02611830|65813449|FG003|OL Induction Phase|Reason not specified|0|||
23569577|NCT02611830|65813446|FG000|Maintenance Phase|Lack of Efficacy|0|||
23569578|NCT02611830|65813447|FG001|Maintenance Phase|Lack of Efficacy|29|||
23569579|NCT02611830|65813448|FG002|Maintenance Phase|Lack of Efficacy|18|||
23569580|NCT02611830|65813449|FG003|Maintenance Phase|Lack of Efficacy|6|||
23569581|NCT02611830|65813446|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23569582|NCT02611830|65813447|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
23569583|NCT02611830|65813448|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
23569584|NCT02611830|65813449|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
23569585|NCT02611830|65813446|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
23569586|NCT02611830|65813447|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
23569587|NCT02611830|65813448|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
23569588|NCT02611830|65813449|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
23569589|NCT02611830|65813446|FG000|Maintenance Phase|Lost to Follow-up|0|||
23569590|NCT02611830|65813447|FG001|Maintenance Phase|Lost to Follow-up|0|||
23569591|NCT02611830|65813448|FG002|Maintenance Phase|Lost to Follow-up|0|||
23569592|NCT02611830|65813449|FG003|Maintenance Phase|Lost to Follow-up|1|||
23569593|NCT02611830|65813446|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
23569594|NCT02611830|65813447|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
23569595|NCT02611830|65813448|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
23569596|NCT02611830|65813449|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
23569597|NCT02611830|65813446|FG000|Maintenance Phase|Pregnancy|0|||
23569598|NCT02611830|65813447|FG001|Maintenance Phase|Pregnancy|0|||
23569599|NCT02611830|65813448|FG002|Maintenance Phase|Pregnancy|1|||
23569600|NCT02611830|65813449|FG003|Maintenance Phase|Pregnancy|0|||
23569601|NCT02611830|65813446|FG000|Maintenance Phase|Reason not specified|0|||
23569602|NCT02611830|65813447|FG001|Maintenance Phase|Reason not specified|1|||
23569603|NCT02611830|65813448|FG002|Maintenance Phase|Reason not specified|4|||
23569604|NCT02611830|65813449|FG003|Maintenance Phase|Reason not specified|0|||
23569605|NCT02366936|65813450|FG000|Overall Study|Withdrawal by Subject|2|||
23569606|NCT02366936|65813450|FG000|Overall Study|Lost to Follow-up|4|||
23569607|NCT02366936|65813450|FG000|Overall Study|Physician Decision|2|||
23569608|NCT01254890|65813451|FG000|Overall Study|Ineligible|0|||
23569609|NCT01254890|65813452|FG001|Overall Study|Ineligible|3|||
23569610|NCT01254890|65813451|FG000|Overall Study|Withdrawal by Subject|1|||
23569611|NCT01254890|65813452|FG001|Overall Study|Withdrawal by Subject|2|||
23569612|NCT01254890|65813451|FG000|Overall Study|Disease Progression|0|||
23569613|NCT01254890|65813452|FG001|Overall Study|Disease Progression|5|||
23569614|NCT01018563|65813456|FG000|Overall Study|Termination of the study by Sponsor|2|||
23569615|NCT01018563|65813457|FG001|Overall Study|Termination of the study by Sponsor|1|||
23569616|NCT01231503|65813459|FG000|Overall Study|Adverse Event|0|||
23569617|NCT01231503|65813460|FG001|Overall Study|Adverse Event|0|||
23569618|NCT01231503|65813461|FG002|Overall Study|Adverse Event|0|||
23569619|NCT01231503|65813462|FG003|Overall Study|Adverse Event|0|||
23569620|NCT01231503|65813463|FG004|Overall Study|Adverse Event|0|||
23569621|NCT01231503|65813464|FG005|Overall Study|Adverse Event|1|||
23569622|NCT01231503|65813465|FG006|Overall Study|Adverse Event|0|||
23569623|NCT01231503|65813466|FG007|Overall Study|Adverse Event|0|||
23569624|NCT01231503|65813459|FG000|Overall Study|Adverse event, serious fatal|0|||
23569625|NCT01231503|65813460|FG001|Overall Study|Adverse event, serious fatal|0|||
23569626|NCT01231503|65813461|FG002|Overall Study|Adverse event, serious fatal|1|||
23569627|NCT01231503|65813462|FG003|Overall Study|Adverse event, serious fatal|1|||
23569628|NCT01231503|65813463|FG004|Overall Study|Adverse event, serious fatal|0|||
23569629|NCT01231503|65813464|FG005|Overall Study|Adverse event, serious fatal|1|||
23569630|NCT01231503|65813465|FG006|Overall Study|Adverse event, serious fatal|0|||
23569631|NCT01231503|65813466|FG007|Overall Study|Adverse event, serious fatal|0|||
23569632|NCT01231503|65813459|FG000|Overall Study|Withdrawal by Subject|6|||
23569633|NCT01231503|65813460|FG001|Overall Study|Withdrawal by Subject|3|||
23569634|NCT01231503|65813461|FG002|Overall Study|Withdrawal by Subject|3|||
23569635|NCT01231503|65813462|FG003|Overall Study|Withdrawal by Subject|1|||
23569636|NCT01231503|65813463|FG004|Overall Study|Withdrawal by Subject|3|||
23569637|NCT01231503|65813464|FG005|Overall Study|Withdrawal by Subject|5|||
23569638|NCT01231503|65813465|FG006|Overall Study|Withdrawal by Subject|1|||
23569639|NCT01231503|65813466|FG007|Overall Study|Withdrawal by Subject|2|||
23569640|NCT01231503|65813459|FG000|Overall Study|Lost to Follow-up|8|||
23569641|NCT01231503|65813460|FG001|Overall Study|Lost to Follow-up|10|||
23569642|NCT01231503|65813461|FG002|Overall Study|Lost to Follow-up|8|||
23569643|NCT01231503|65813462|FG003|Overall Study|Lost to Follow-up|5|||
23569644|NCT01231503|65813463|FG004|Overall Study|Lost to Follow-up|7|||
23569645|NCT01231503|65813464|FG005|Overall Study|Lost to Follow-up|9|||
23569646|NCT01231503|65813465|FG006|Overall Study|Lost to Follow-up|6|||
23569647|NCT01231503|65813466|FG007|Overall Study|Lost to Follow-up|6|||
23569648|NCT01231503|65813459|FG000|Overall Study|Protocol Violation|0|||
23569649|NCT01231503|65813460|FG001|Overall Study|Protocol Violation|0|||
23569650|NCT01231503|65813461|FG002|Overall Study|Protocol Violation|0|||
23569651|NCT01231503|65813462|FG003|Overall Study|Protocol Violation|1|||
23569652|NCT01231503|65813463|FG004|Overall Study|Protocol Violation|0|||
23569653|NCT01231503|65813464|FG005|Overall Study|Protocol Violation|0|||
23569654|NCT01231503|65813465|FG006|Overall Study|Protocol Violation|0|||
23569655|NCT01231503|65813466|FG007|Overall Study|Protocol Violation|0|||
23569656|NCT02684903|65813471|FG000|Overall Study|COVID-19 shutdown of lab|4|||
23162140|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
23162141|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
23162142|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
23162143|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
23162144|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
23162145|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
23162146|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23162147|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23162148|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
23162149|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
23162150|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
23162151|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
23162152|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
23162153|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
23162154|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
23162155|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
23162156|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
23162157|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
23162158|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
23162159|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
23162160|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
23162161|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
23162162|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
23162163|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
23162164|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Death|2|||
23162165|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Death|1|||
23162166|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Death|0|||
23162167|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Death|0|||
23162168|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
23162169|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
23162170|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
23162171|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
23162172|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
23162173|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
23162174|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
23162175|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
23162176|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
23162177|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
23162178|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23162179|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23162180|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
23162181|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
23162182|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
23162183|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
23162184|NCT01940471|64341812|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
23162185|NCT01940471|64341813|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
23162186|NCT01940471|64341814|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
23569657|NCT02684903|65813472|FG001|Overall Study|COVID-19 shutdown of lab|6|||
23162187|NCT01940471|64341815|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
23162188|NCT01940471|64341812|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
23162189|NCT01940471|64341813|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
23162190|NCT01940471|64341814|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
23162191|NCT01940471|64341815|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
23223694|NCT01614795|64560563|FG000|Overall Study|Adverse Event|0|||
23223695|NCT01614795|64560564|FG001|Overall Study|Adverse Event|0|||
23569658|NCT02684903|65813471|FG000|Overall Study|Lost to Follow-up|31|||
23569659|NCT02684903|65813472|FG001|Overall Study|Lost to Follow-up|41|||
23569660|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
23569661|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
23569662|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
23569663|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
23569664|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
23569665|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
23569666|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
23162192|NCT01940471|64341812|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23162193|NCT01940471|64341813|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23162194|NCT01940471|64341814|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
23162195|NCT01940471|64341815|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
23162196|NCT01940471|64341812|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
23162197|NCT01940471|64341813|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
23569667|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
23569668|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
23569669|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
23569670|NCT02307513|65813489|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
23223696|NCT01614795|64560565|FG002|Overall Study|Adverse Event|1|||
23223697|NCT01614795|64560566|FG003|Overall Study|Adverse Event|1|||
23223698|NCT01614795|64560563|FG000|Overall Study|Lack of Efficacy|10|||
23223699|NCT01614795|64560564|FG001|Overall Study|Lack of Efficacy|10|||
23223700|NCT01614795|64560565|FG002|Overall Study|Lack of Efficacy|9|||
23223701|NCT01614795|64560566|FG003|Overall Study|Lack of Efficacy|8|||
23162198|NCT01940471|64341814|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
23162199|NCT01940471|64341815|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
23162200|NCT01940471|64341812|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
23162201|NCT01940471|64341813|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
23162202|NCT01940471|64341814|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
23162203|NCT01940471|64341815|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
23162204|NCT01940471|64341812|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23223702|NCT01614795|64560563|FG000|Overall Study|Physician Decision|1|||
23223703|NCT01614795|64560564|FG001|Overall Study|Physician Decision|0|||
23330586|NCT01074268|64952057|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
23330587|NCT01074268|64952056|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
23330588|NCT01074268|64952057|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
23330589|NCT01074268|64952056|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
23330590|NCT01074268|64952057|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
23330591|NCT02099110|64952058|FG000|Overall Study|Protocol Violation|2|||
23330592|NCT02099110|64952059|FG001|Overall Study|Protocol Violation|1|||
23330593|NCT02099110|64952060|FG002|Overall Study|Protocol Violation|0|||
23330594|NCT02099110|64952061|FG003|Overall Study|Protocol Violation|3|||
23330595|NCT02099110|64952062|FG004|Overall Study|Protocol Violation|1|||
23330596|NCT02099110|64952058|FG000|Overall Study|Participant moved|1|||
23330597|NCT02099110|64952059|FG001|Overall Study|Participant moved|1|||
23330598|NCT02099110|64952060|FG002|Overall Study|Participant moved|1|||
23330599|NCT02099110|64952061|FG003|Overall Study|Participant moved|0|||
23330600|NCT02099110|64952062|FG004|Overall Study|Participant moved|2|||
23330601|NCT02099110|64952058|FG000|Overall Study|Withdrawal by Subject|7|||
23330602|NCT02099110|64952059|FG001|Overall Study|Withdrawal by Subject|11|||
23330603|NCT02099110|64952060|FG002|Overall Study|Withdrawal by Subject|13|||
23330604|NCT02099110|64952061|FG003|Overall Study|Withdrawal by Subject|9|||
23330605|NCT02099110|64952062|FG004|Overall Study|Withdrawal by Subject|13|||
23330606|NCT02099110|64952058|FG000|Overall Study|Adverse Event|3|||
23330607|NCT02099110|64952059|FG001|Overall Study|Adverse Event|5|||
23330608|NCT02099110|64952060|FG002|Overall Study|Adverse Event|2|||
23330609|NCT02099110|64952061|FG003|Overall Study|Adverse Event|3|||
23330610|NCT02099110|64952062|FG004|Overall Study|Adverse Event|2|||
23330611|NCT02099110|64952058|FG000|Overall Study|Lost to Follow-up|6|||
23330612|NCT02099110|64952059|FG001|Overall Study|Lost to Follow-up|12|||
23569671|NCT02307513|65813490|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
23569672|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
23569673|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
23569674|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
23569675|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
23569676|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
23569677|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
23569678|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
23569679|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
23569680|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
23569681|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
23330613|NCT02099110|64952060|FG002|Overall Study|Lost to Follow-up|11|||
23330614|NCT02099110|64952061|FG003|Overall Study|Lost to Follow-up|5|||
23223704|NCT01614795|64560565|FG002|Overall Study|Physician Decision|1|||
23223705|NCT01614795|64560566|FG003|Overall Study|Physician Decision|1|||
23330615|NCT02099110|64952062|FG004|Overall Study|Lost to Follow-up|6|||
23330616|NCT02099110|64952058|FG000|Overall Study|Death|0|||
23330617|NCT02099110|64952059|FG001|Overall Study|Death|1|||
23162205|NCT01940471|64341813|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23162206|NCT01940471|64341814|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
23162207|NCT01940471|64341815|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
23162208|NCT01940471|64341812|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23162209|NCT01940471|64341813|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23162210|NCT01940471|64341814|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
23162211|NCT01940471|64341815|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
23162212|NCT01940471|64341812|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23162213|NCT01940471|64341813|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23162214|NCT01940471|64341814|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
23162215|NCT01940471|64341815|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23162216|NCT01940471|64341812|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
23162217|NCT01940471|64341813|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
23162218|NCT01940471|64341814|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
23162219|NCT01940471|64341815|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
23162220|NCT01940471|64341812|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23162221|NCT01940471|64341813|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23162222|NCT01940471|64341814|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
23162223|NCT01940471|64341815|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23162224|NCT00961220|64341818|FG000|Overall Study|Adverse Event|3|||
23162225|NCT00961220|64341818|FG000|Overall Study|Lack of Efficacy|1|||
23162226|NCT00961220|64341818|FG000|Overall Study|No IV access for O6BG|1|||
23162227|NCT00961220|64341818|FG000|Overall Study|O6BG no longer supplied|1|||
23162228|NCT00961220|64341818|FG000|Overall Study|Complete Response prior to 12 courses|1|||
23223706|NCT01614795|64560563|FG000|Overall Study|Withdrawal by Subject|0|||
23223707|NCT01614795|64560564|FG001|Overall Study|Withdrawal by Subject|1|||
23223708|NCT01614795|64560565|FG002|Overall Study|Withdrawal by Subject|0|||
23223709|NCT01614795|64560566|FG003|Overall Study|Withdrawal by Subject|2|||
23223710|NCT01614795|64560563|FG000|Overall Study|Ineligible|0|||
23223711|NCT01614795|64560564|FG001|Overall Study|Ineligible|1|||
23223712|NCT01614795|64560565|FG002|Overall Study|Ineligible|0|||
23223713|NCT01614795|64560566|FG003|Overall Study|Ineligible|0|||
23223714|NCT00561340|64560567|FG000|Overall Study|refused to drink pediasure|6|||
23162229|NCT00514514|64341819|FG000|Pre-phase|Death|10|||
23162230|NCT00514514|64341820|FG001|Pre-phase|Death|0|||
23162231|NCT00514514|64341821|FG002|Pre-phase|Death|0|||
23162232|NCT00514514|64341819|FG000|Pre-phase|administrative problems|2|||
23223715|NCT00561340|64560568|FG001|Overall Study|refused to drink pediasure|0|||
23223716|NCT02903966|64560572|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
23223717|NCT02903966|64560573|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
23569682|NCT02307513|65813489|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
23569683|NCT02307513|65813490|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
23569684|NCT02307513|65813489|FG000|Long-term Extension|Physician Decision|1|||
23569685|NCT02307513|65813490|FG001|Long-term Extension|Physician Decision|0|||
23569686|NCT00871351|65813492|FG000|Overall Study|Withdrawal by Subject|1|||
23569687|NCT00871351|65813493|FG001|Overall Study|Withdrawal by Subject|0|||
23569688|NCT00871351|65813494|FG002|Overall Study|Withdrawal by Subject|0|||
23569689|NCT00871351|65813492|FG000|Overall Study|Adverse Event|3|||
23569690|NCT00871351|65813493|FG001|Overall Study|Adverse Event|1|||
23569691|NCT00871351|65813494|FG002|Overall Study|Adverse Event|0|||
23569692|NCT01290822|65813503|FG000|Overall Study|Withdrawal by Subject|1|||
23569693|NCT01290822|65813503|FG000|Overall Study|Physician Decision|10|||
23569694|NCT02133924|65813504|FG000|Overall Study|Death|38|||
23569695|NCT02133924|65813504|FG000|Overall Study|Physician Decision|1|||
23569696|NCT02133924|65813504|FG000|Overall Study|Withdrawal by Subject|3|||
23569697|NCT02105636|65813507|FG000|Pre-Treatment|Disease Progression|1|||
23569698|NCT02105636|65813508|FG001|Pre-Treatment|Disease Progression|0|||
23569699|NCT02105636|65813507|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
23569700|NCT02105636|65813508|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
23569701|NCT02105636|65813507|FG000|Pre-Treatment|Participant withdrew consent|0|||
23569702|NCT02105636|65813508|FG001|Pre-Treatment|Participant withdrew consent|6|||
23569703|NCT02105636|65813507|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
23569704|NCT02105636|65813508|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
23162233|NCT00514514|64341820|FG001|Pre-phase|administrative problems|0|||
23162234|NCT00514514|64341821|FG002|Pre-phase|administrative problems|0|||
23162235|NCT00514514|64341819|FG000|Pre-phase|Protocol Violation|6|||
23162236|NCT00514514|64341820|FG001|Pre-phase|Protocol Violation|0|||
23162237|NCT00514514|64341821|FG002|Pre-phase|Protocol Violation|0|||
23162238|NCT00514514|64341819|FG000|Pre-phase|condition no longer requires study drug|7|||
23162239|NCT00514514|64341820|FG001|Pre-phase|condition no longer requires study drug|0|||
23569705|NCT02105636|65813507|FG000|Treatment|Study Drug Toxicity|14|||
23569706|NCT02105636|65813508|FG001|Treatment|Study Drug Toxicity|10|||
23569707|NCT02105636|65813507|FG000|Treatment|Adverse event unrelated to study drug|19|||
23223718|NCT02903966|64560572|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
23223719|NCT02903966|64560573|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
23223720|NCT02903966|64560572|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
23223721|NCT02903966|64560573|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
23223722|NCT04350372|64560574|FG000|Overall Study|Death|1|||
23223723|NCT01510028|64560575|FG000|Overall Study|Lack of Efficacy|1|||
23223724|NCT01510028|64560576|FG001|Overall Study|Lack of Efficacy|0|||
23223725|NCT01510028|64560577|FG002|Overall Study|Lack of Efficacy|0|||
23223726|NCT01510028|64560578|FG003|Overall Study|Lack of Efficacy|0|||
23223727|NCT02100813|64560579|FG000|Overall Study|Adverse Event|0|||
23223728|NCT02100813|64560580|FG001|Overall Study|Adverse Event|0|||
23223729|NCT02100813|64560581|FG002|Overall Study|Adverse Event|0|||
23223730|NCT02100813|64560582|FG003|Overall Study|Adverse Event|0|||
23223731|NCT02100813|64560583|FG004|Overall Study|Adverse Event|0|||
23223732|NCT02100813|64560584|FG005|Overall Study|Adverse Event|0|||
23223733|NCT02100813|64560585|FG006|Overall Study|Adverse Event|0|||
23223734|NCT02100813|64560586|FG007|Overall Study|Adverse Event|1|||
23569708|NCT02105636|65813508|FG001|Treatment|Adverse event unrelated to study drug|3|||
23569709|NCT02105636|65813507|FG000|Treatment|Participant request to discontinue study treatment|8|||
23569710|NCT02105636|65813508|FG001|Treatment|Participant request to discontinue study treatment|6|||
23569711|NCT02105636|65813507|FG000|Treatment|Participant withdrew consent|5|||
23569712|NCT02105636|65813508|FG001|Treatment|Participant withdrew consent|1|||
23569713|NCT02105636|65813507|FG000|Treatment|Lost to Follow-up|1|||
23569714|NCT02105636|65813508|FG001|Treatment|Lost to Follow-up|0|||
23569715|NCT02105636|65813507|FG000|Treatment|Maximum Clinical Benefit|1|||
23569716|NCT02105636|65813508|FG001|Treatment|Maximum Clinical Benefit|3|||
23569717|NCT02105636|65813507|FG000|Treatment|Poor/Non-compliance|0|||
23569718|NCT02105636|65813508|FG001|Treatment|Poor/Non-compliance|1|||
23223735|NCT01327573|64563876|FG000|Overall Study|Physician Decision|3|||
23223736|NCT01327573|64563877|FG001|Overall Study|Physician Decision|1|||
23223737|NCT00002981|64563878|FG000|Overall Study|Inevaluable|6|||
23223738|NCT00373880|64563879|FG000|Overall Study|Physician Decision|3|||
23223739|NCT00373880|64563879|FG000|Overall Study|Arrested|1|||
23223740|NCT00373880|64563879|FG000|Overall Study|Protocol Violation|14|||
23223741|NCT01818765|64563884|FG000|Overall Study|Death|2|||
23223742|NCT03864627|64563885|FG000|Overall Study|Adverse Event|0|||
23223743|NCT03864627|64563886|FG001|Overall Study|Adverse Event|1|||
23223744|NCT03864627|64563885|FG000|Overall Study|Lack of Efficacy|0|||
23223745|NCT03864627|64563886|FG001|Overall Study|Lack of Efficacy|1|||
23330618|NCT02099110|64952060|FG002|Overall Study|Death|0|||
23330619|NCT02099110|64952061|FG003|Overall Study|Death|0|||
23223746|NCT03864627|64563885|FG000|Overall Study|Lost to Follow-up|0|||
23223747|NCT03864627|64563886|FG001|Overall Study|Lost to Follow-up|1|||
23223748|NCT03864627|64563885|FG000|Overall Study|Withdrawal by Subject|4|||
23223749|NCT03864627|64563886|FG001|Overall Study|Withdrawal by Subject|8|||
23223750|NCT03864627|64563885|FG000|Overall Study|Study terminated by sponsor|0|||
23223751|NCT03864627|64563886|FG001|Overall Study|Study terminated by sponsor|1|||
23223752|NCT03135262|64563887|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
23223753|NCT03135262|64563888|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
23330620|NCT02099110|64952062|FG004|Overall Study|Death|0|||
23569719|NCT02105636|65813507|FG000|Treatment|Participant no longer meets study criteria|1|||
23569720|NCT02105636|65813508|FG001|Treatment|Participant no longer meets study criteria|0|||
23569721|NCT02105636|65813507|FG000|Treatment|Other reasons|1|||
23569722|NCT02105636|65813508|FG001|Treatment|Other reasons|0|||
23569723|NCT02105636|65813507|FG000|Treatment|Disease Progression|185|||
23330621|NCT02099110|64952058|FG000|Overall Study|Screen failure|0|||
23330622|NCT02099110|64952059|FG001|Overall Study|Screen failure|0|||
23569724|NCT02105636|65813508|FG001|Treatment|Disease Progression|87|||
23569725|NCT00130793|65813509|FG000|Overall Study|Lost to Follow-up|1|||
23569726|NCT00130793|65813510|FG001|Overall Study|Lost to Follow-up|4|||
23569727|NCT00130793|65813509|FG000|Overall Study|Withdrew consent|2|||
23569728|NCT00130793|65813510|FG001|Overall Study|Withdrew consent|0|||
23569729|NCT02670538|65816563|FG000|Overall Study|Withdrawal of Consent|8|||
23569730|NCT02670538|65816564|FG001|Overall Study|Withdrawal of Consent|6|||
23569731|NCT02670538|65816565|FG002|Overall Study|Withdrawal of Consent|5|||
23569732|NCT02670538|65816563|FG000|Overall Study|Lost to Follow-up|8|||
23569733|NCT02670538|65816564|FG001|Overall Study|Lost to Follow-up|12|||
23569734|NCT02670538|65816565|FG002|Overall Study|Lost to Follow-up|7|||
23569735|NCT02670538|65816563|FG000|Overall Study|Adverse Event|5|||
23569736|NCT02670538|65816564|FG001|Overall Study|Adverse Event|5|||
23569737|NCT02670538|65816565|FG002|Overall Study|Adverse Event|11|||
23569738|NCT02670538|65816563|FG000|Overall Study|Lack of Efficacy|7|||
23569739|NCT02670538|65816564|FG001|Overall Study|Lack of Efficacy|1|||
23569740|NCT02670538|65816565|FG002|Overall Study|Lack of Efficacy|2|||
23162240|NCT00514514|64341821|FG002|Pre-phase|condition no longer requires study drug|0|||
23162241|NCT00514514|64341819|FG000|Pre-phase|abnormal test procedure results|15|||
23162242|NCT00514514|64341820|FG001|Pre-phase|abnormal test procedure results|0|||
23162243|NCT00514514|64341821|FG002|Pre-phase|abnormal test procedure results|0|||
23162244|NCT00514514|64341819|FG000|Pre-phase|Lost to Follow-up|2|||
23162245|NCT00514514|64341820|FG001|Pre-phase|Lost to Follow-up|0|||
23162246|NCT00514514|64341821|FG002|Pre-phase|Lost to Follow-up|0|||
23162247|NCT00514514|64341819|FG000|Pre-phase|abnormal lab values|23|||
23162248|NCT00514514|64341820|FG001|Pre-phase|abnormal lab values|0|||
23162249|NCT00514514|64341821|FG002|Pre-phase|abnormal lab values|0|||
23162250|NCT00514514|64341819|FG000|Pre-phase|Lack of Efficacy|35|||
23162251|NCT00514514|64341820|FG001|Pre-phase|Lack of Efficacy|0|||
23162252|NCT00514514|64341821|FG002|Pre-phase|Lack of Efficacy|0|||
23162253|NCT00514514|64341819|FG000|Pre-phase|Adverse Event|137|||
23162254|NCT00514514|64341820|FG001|Pre-phase|Adverse Event|0|||
23162255|NCT00514514|64341821|FG002|Pre-phase|Adverse Event|0|||
23162256|NCT00514514|64341819|FG000|Pre-phase|Withdrawal by Subject|66|||
23162257|NCT00514514|64341820|FG001|Pre-phase|Withdrawal by Subject|0|||
23162258|NCT00514514|64341821|FG002|Pre-phase|Withdrawal by Subject|0|||
23162259|NCT00514514|64341819|FG000|Randomized - 9 Month|Death|3|||
23162260|NCT00514514|64341820|FG001|Randomized - 9 Month|Death|2|||
23162261|NCT00514514|64341821|FG002|Randomized - 9 Month|Death|2|||
23162262|NCT00514514|64341819|FG000|Randomized - 9 Month|Administrative problems|1|||
23330623|NCT02099110|64952060|FG002|Overall Study|Screen failure|0|||
23330624|NCT02099110|64952061|FG003|Overall Study|Screen failure|0|||
23330625|NCT02099110|64952062|FG004|Overall Study|Screen failure|1|||
23569741|NCT02670538|65816563|FG000|Overall Study|Protocol Violation|3|||
23330626|NCT02099110|64952058|FG000|Overall Study|Non-compliance with study drug|2|||
23330627|NCT02099110|64952059|FG001|Overall Study|Non-compliance with study drug|0|||
23330628|NCT02099110|64952060|FG002|Overall Study|Non-compliance with study drug|0|||
23330629|NCT02099110|64952061|FG003|Overall Study|Non-compliance with study drug|0|||
23330630|NCT02099110|64952062|FG004|Overall Study|Non-compliance with study drug|1|||
23330631|NCT02099110|64952058|FG000|Overall Study|Physician Decision|3|||
23330632|NCT02099110|64952059|FG001|Overall Study|Physician Decision|0|||
23330633|NCT02099110|64952060|FG002|Overall Study|Physician Decision|1|||
23330634|NCT02099110|64952061|FG003|Overall Study|Physician Decision|2|||
23330635|NCT02099110|64952062|FG004|Overall Study|Physician Decision|1|||
23330636|NCT01568892|64952063|FG000|Open-label Phase|Adverse Event|2|||
23330637|NCT01568892|64952064|FG001|Open-label Phase|Adverse Event|0|||
23162263|NCT00514514|64341820|FG001|Randomized - 9 Month|Administrative problems|1|||
23330638|NCT01568892|64952063|FG000|Open-label Phase|Lack of Efficacy|4|||
23330639|NCT01568892|64952064|FG001|Open-label Phase|Lack of Efficacy|2|||
23330640|NCT01568892|64952063|FG000|Open-label Phase|Lost to Follow-up|0|||
23162264|NCT00514514|64341821|FG002|Randomized - 9 Month|Administrative problems|2|||
23162265|NCT00514514|64341819|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
23162266|NCT00514514|64341820|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
23162267|NCT00514514|64341821|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
23162268|NCT00514514|64341819|FG000|Randomized - 9 Month|Protocol Violation|1|||
23330641|NCT01568892|64952064|FG001|Open-label Phase|Lost to Follow-up|1|||
23330642|NCT04909853|64952065|FG000|Part 1|Assigned but not treated|0|||
23330643|NCT04909853|64952066|FG001|Part 1|Assigned but not treated|0|||
23330644|NCT04909853|64952067|FG002|Part 1|Assigned but not treated|1|||
23569742|NCT02670538|65816564|FG001|Overall Study|Protocol Violation|4|||
23569743|NCT02670538|65816565|FG002|Overall Study|Protocol Violation|1|||
23569744|NCT02670538|65816563|FG000|Overall Study|Noncompliance with Study Drug|1|||
23569745|NCT02670538|65816564|FG001|Overall Study|Noncompliance with Study Drug|3|||
23330645|NCT04909853|64952068|FG003|Part 1|Assigned but not treated|0|||
23330646|NCT04909853|64952065|FG000|Part 2|Adverse Event|0|||
23330647|NCT04909853|64952066|FG001|Part 2|Adverse Event|0|||
23330648|NCT04909853|64952067|FG002|Part 2|Adverse Event|0|||
23330649|NCT04909853|64952068|FG003|Part 2|Adverse Event|1|||
23330650|NCT02755103|64952069|FG000|Overall Study|Lost to Follow-up|17|||
23330651|NCT02755103|64952070|FG001|Overall Study|Lost to Follow-up|15|||
23330652|NCT02755103|64952069|FG000|Overall Study|Death|0|||
23330653|NCT02755103|64952070|FG001|Overall Study|Death|1|||
23330654|NCT02755103|64952069|FG000|Overall Study|Physician Decision|0|||
23330655|NCT02755103|64952070|FG001|Overall Study|Physician Decision|1|||
23330656|NCT02755103|64952069|FG000|Overall Study|Pregnancy|0|||
23330657|NCT02755103|64952070|FG001|Overall Study|Pregnancy|1|||
23330658|NCT02755103|64952069|FG000|Overall Study|Withdrawal by Subject|3|||
23330659|NCT02755103|64952070|FG001|Overall Study|Withdrawal by Subject|0|||
23330660|NCT01051791|64952071|FG000|Overall Study|Failed screening|3|||
23569746|NCT02670538|65816565|FG002|Overall Study|Noncompliance with Study Drug|2|||
23569747|NCT02670538|65816563|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23569748|NCT02670538|65816564|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23569749|NCT02670538|65816565|FG002|Overall Study|Other Miscellaneous Reasons|2|||
23162269|NCT00514514|64341820|FG001|Randomized - 9 Month|Protocol Violation|1|||
23162270|NCT00514514|64341821|FG002|Randomized - 9 Month|Protocol Violation|0|||
23162271|NCT00514514|64341819|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
23162272|NCT00514514|64341820|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
23162273|NCT00514514|64341821|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
23162274|NCT00514514|64341819|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
23162275|NCT00514514|64341820|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
23162276|NCT00514514|64341821|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
23162277|NCT00514514|64341819|FG000|Randomized - 9 Month|Adverse Event|25|||
23162278|NCT00514514|64341820|FG001|Randomized - 9 Month|Adverse Event|44|||
23162279|NCT00514514|64341821|FG002|Randomized - 9 Month|Adverse Event|27|||
23162280|NCT00514514|64341819|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
23162281|NCT00514514|64341820|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
23162282|NCT00514514|64341821|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
23162283|NCT00514514|64341819|FG000|Extension - 4 Years|Lost to Follow-up|12|||
23162284|NCT00514514|64341820|FG001|Extension - 4 Years|Lost to Follow-up|10|||
23162285|NCT00514514|64341821|FG002|Extension - 4 Years|Lost to Follow-up|9|||
23162286|NCT00514514|64341819|FG000|Extension - 4 Years|Administrative problems|3|||
23162287|NCT00514514|64341820|FG001|Extension - 4 Years|Administrative problems|1|||
23330661|NCT01051791|64952071|FG000|Overall Study|Withdrawal by Subject|1|||
23330662|NCT02151851|64952072|FG000|Overall Study|Lack of Efficacy|67|||
23330663|NCT02151851|64952073|FG001|Overall Study|Lack of Efficacy|94|||
23569750|NCT03621982|65816566|FG000|Overall Study|Withdrawal by Subject|1|||
23569751|NCT03621982|65816567|FG001|Overall Study|Withdrawal by Subject|0|||
23569752|NCT03621982|65816568|FG002|Overall Study|Withdrawal by Subject|0|||
23569753|NCT03621982|65816569|FG003|Overall Study|Withdrawal by Subject|1|||
23569754|NCT03621982|65816570|FG004|Overall Study|Withdrawal by Subject|0|||
23569755|NCT03621982|65816571|FG005|Overall Study|Withdrawal by Subject|1|||
23569756|NCT03621982|65816572|FG006|Overall Study|Withdrawal by Subject|1|||
23569757|NCT03621982|65816573|FG007|Overall Study|Withdrawal by Subject|0|||
23569758|NCT03621982|65816574|FG008|Overall Study|Withdrawal by Subject|1|||
23569759|NCT03621982|65816575|FG009|Overall Study|Withdrawal by Subject|0|||
23569760|NCT03621982|65816576|FG010|Overall Study|Withdrawal by Subject|2|||
23569761|NCT03621982|65816577|FG011|Overall Study|Withdrawal by Subject|1|||
23569762|NCT03621982|65816578|FG012|Overall Study|Withdrawal by Subject|2|||
23569763|NCT03621982|65816579|FG013|Overall Study|Withdrawal by Subject|2|||
23569764|NCT03621982|65816566|FG000|Overall Study|Investigator/Sponsor decision|0|||
23569765|NCT03621982|65816567|FG001|Overall Study|Investigator/Sponsor decision|0|||
23569766|NCT03621982|65816568|FG002|Overall Study|Investigator/Sponsor decision|0|||
23569767|NCT03621982|65816569|FG003|Overall Study|Investigator/Sponsor decision|0|||
23569768|NCT03621982|65816570|FG004|Overall Study|Investigator/Sponsor decision|0|||
23569769|NCT03621982|65816571|FG005|Overall Study|Investigator/Sponsor decision|0|||
23569770|NCT03621982|65816572|FG006|Overall Study|Investigator/Sponsor decision|0|||
23569771|NCT03621982|65816573|FG007|Overall Study|Investigator/Sponsor decision|0|||
23162288|NCT00514514|64341821|FG002|Extension - 4 Years|Administrative problems|1|||
23162289|NCT00514514|64341819|FG000|Extension - 4 Years|Death|8|||
23162290|NCT00514514|64341820|FG001|Extension - 4 Years|Death|3|||
23330664|NCT02151851|64952072|FG000|Overall Study|Protocol Violation|0|||
23162291|NCT00514514|64341821|FG002|Extension - 4 Years|Death|6|||
23162292|NCT00514514|64341819|FG000|Extension - 4 Years|Adverse Event|9|||
23162293|NCT00514514|64341820|FG001|Extension - 4 Years|Adverse Event|6|||
23330665|NCT02151851|64952073|FG001|Overall Study|Protocol Violation|1|||
23569772|NCT03621982|65816574|FG008|Overall Study|Investigator/Sponsor decision|0|||
23569773|NCT03621982|65816575|FG009|Overall Study|Investigator/Sponsor decision|0|||
23569774|NCT03621982|65816576|FG010|Overall Study|Investigator/Sponsor decision|0|||
23162294|NCT00514514|64341821|FG002|Extension - 4 Years|Adverse Event|3|||
23162295|NCT01399788|64341822|FG000|First Intervention Period|Adverse Event|1|||
23162296|NCT01399788|64341823|FG001|First Intervention Period|Adverse Event|0|||
23162297|NCT00488982|64341825|FG000|Course 1|Physician Decision|0|||
23162298|NCT00488982|64341826|FG001|Course 1|Physician Decision|2|||
23162299|NCT00488982|64341827|FG002|Course 1|Physician Decision|4|||
23162300|NCT00488982|64341825|FG000|Course 1|Withdrawal by Subject|0|||
23162301|NCT00488982|64341826|FG001|Course 1|Withdrawal by Subject|8|||
23162302|NCT00488982|64341827|FG002|Course 1|Withdrawal by Subject|2|||
23162303|NCT00488982|64341825|FG000|Course 1|nonprotocol therapy|0|||
23162304|NCT00488982|64341826|FG001|Course 1|nonprotocol therapy|2|||
23162305|NCT00488982|64341827|FG002|Course 1|nonprotocol therapy|2|||
23162306|NCT00488982|64341825|FG000|Course 1|Adverse Event|0|||
23162307|NCT00488982|64341826|FG001|Course 1|Adverse Event|0|||
23162308|NCT00488982|64341827|FG002|Course 1|Adverse Event|6|||
23162309|NCT04066491|64341836|FG000|Overall Study|Randomized, not treated|0|||
23162310|NCT04066491|64341837|FG001|Overall Study|Randomized, not treated|0|||
23162311|NCT04066491|64341838|FG002|Overall Study|Randomized, not treated|2|||
23162312|NCT01970501|64341844|FG000|Overall Study|Discontinuation of study by sponsor|16|||
23162313|NCT01970501|64341845|FG001|Overall Study|Discontinuation of study by sponsor|14|||
23162314|NCT01970501|64341844|FG000|Overall Study|Withdrawal by Subject|6|||
23162315|NCT01970501|64341845|FG001|Overall Study|Withdrawal by Subject|7|||
23162316|NCT01970501|64341844|FG000|Overall Study|Adverse Event|2|||
23162317|NCT01970501|64341845|FG001|Overall Study|Adverse Event|4|||
23162318|NCT01970501|64341844|FG000|Overall Study|Death|1|||
23162319|NCT01970501|64341845|FG001|Overall Study|Death|3|||
23162320|NCT01970501|64341844|FG000|Overall Study|Physician Decision|2|||
23162321|NCT01970501|64341845|FG001|Overall Study|Physician Decision|0|||
23162322|NCT01585272|64341846|FG000|Overall Study|Adverse Event|22|||
23162323|NCT01585272|64341846|FG000|Overall Study|Protocol Violation|7|||
23162324|NCT01585272|64341846|FG000|Overall Study|Withdrawal by Subject|10|||
23162325|NCT00708123|64341847|FG000|Period 1|Protocol Violation|0|||
23162326|NCT00708123|64341848|FG001|Period 1|Protocol Violation|1|||
23162327|NCT00708123|64341849|FG002|Period 1|Protocol Violation|0|||
23162328|NCT00708123|64341850|FG003|Period 1|Protocol Violation|1|||
23162329|NCT00708123|64341851|FG004|Period 1|Protocol Violation|0|||
23162330|NCT00708123|64341847|FG000|Period 1|Adverse Event|0|||
23162331|NCT00708123|64341848|FG001|Period 1|Adverse Event|0|||
23162332|NCT00708123|64341849|FG002|Period 1|Adverse Event|1|||
23162333|NCT00708123|64341850|FG003|Period 1|Adverse Event|0|||
23162334|NCT00708123|64341851|FG004|Period 1|Adverse Event|0|||
23162335|NCT00708123|64341847|FG000|Period 2|Protocol Violation|0|||
23162336|NCT00708123|64341848|FG001|Period 2|Protocol Violation|0|||
23162337|NCT00708123|64341849|FG002|Period 2|Protocol Violation|0|||
23162338|NCT00708123|64341850|FG003|Period 2|Protocol Violation|1|||
23162339|NCT00708123|64341851|FG004|Period 2|Protocol Violation|0|||
23162340|NCT00708123|64341847|FG000|Period 2|Other Reason|1|||
23162341|NCT00708123|64341848|FG001|Period 2|Other Reason|0|||
23162342|NCT00708123|64341849|FG002|Period 2|Other Reason|0|||
23162343|NCT00708123|64341850|FG003|Period 2|Other Reason|0|||
23162344|NCT00708123|64341851|FG004|Period 2|Other Reason|0|||
23162345|NCT00708123|64341847|FG000|Period 3|Lost to Follow-up|0|||
23162346|NCT00708123|64341848|FG001|Period 3|Lost to Follow-up|0|||
23162347|NCT00708123|64341849|FG002|Period 3|Lost to Follow-up|1|||
23162348|NCT00708123|64341850|FG003|Period 3|Lost to Follow-up|1|||
23162349|NCT00708123|64341851|FG004|Period 3|Lost to Follow-up|0|||
23162350|NCT00708123|64341847|FG000|Period 4|Protocol Violation|0|||
23162351|NCT00708123|64341848|FG001|Period 4|Protocol Violation|1|||
23162352|NCT00708123|64341849|FG002|Period 4|Protocol Violation|0|||
23162353|NCT00708123|64341850|FG003|Period 4|Protocol Violation|0|||
23162354|NCT00708123|64341851|FG004|Period 4|Protocol Violation|0|||
23162355|NCT02255409|64341853|FG000|Overall Study|Administrative Reason|3|||
23162356|NCT02255409|64341854|FG001|Overall Study|Administrative Reason|7|||
23223754|NCT03135262|64563889|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
23162357|NCT02255409|64341853|FG000|Overall Study|Withdrawal by Subject|1|||
23162358|NCT02255409|64341854|FG001|Overall Study|Withdrawal by Subject|5|||
23162359|NCT02255409|64341853|FG000|Overall Study|Lost to Follow-up|10|||
23162360|NCT02255409|64341854|FG001|Overall Study|Lost to Follow-up|19|||
23162361|NCT03681119|64341856|FG000|Overall Study|No specific reason|4|||
23162362|NCT03681119|64341857|FG001|Overall Study|No specific reason|0|||
23162363|NCT03681119|64341856|FG000|Overall Study|Sickness|2|||
23223755|NCT03135262|64563890|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
23330666|NCT02151851|64952072|FG000|Overall Study|Withdrawal by Subject|2|||
23330667|NCT02151851|64952073|FG001|Overall Study|Withdrawal by Subject|5|||
23223756|NCT03135262|64563891|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
23223757|NCT03135262|64563887|FG000|Overall Study|Progression of disease|0|||
23223758|NCT03135262|64563888|FG001|Overall Study|Progression of disease|0|||
23223759|NCT03135262|64563889|FG002|Overall Study|Progression of disease|0|||
23223760|NCT03135262|64563890|FG003|Overall Study|Progression of disease|1|||
23223761|NCT03135262|64563891|FG004|Overall Study|Progression of disease|0|||
23223762|NCT03135262|64563887|FG000|Overall Study|Death|6|||
23223763|NCT03135262|64563888|FG001|Overall Study|Death|2|||
23223764|NCT03135262|64563889|FG002|Overall Study|Death|2|||
23223765|NCT03135262|64563890|FG003|Overall Study|Death|2|||
23223766|NCT03135262|64563891|FG004|Overall Study|Death|0|||
23223767|NCT03135262|64563887|FG000|Overall Study|Withdrawal by Subject|0|||
23223768|NCT03135262|64563888|FG001|Overall Study|Withdrawal by Subject|0|||
23223769|NCT03135262|64563889|FG002|Overall Study|Withdrawal by Subject|1|||
23223770|NCT03135262|64563890|FG003|Overall Study|Withdrawal by Subject|0|||
23223771|NCT03135262|64563891|FG004|Overall Study|Withdrawal by Subject|1|||
23223772|NCT03135262|64563887|FG000|Overall Study|Study terminated by sponsor|2|||
23223773|NCT03135262|64563888|FG001|Overall Study|Study terminated by sponsor|4|||
23223774|NCT03135262|64563889|FG002|Overall Study|Study terminated by sponsor|4|||
23223775|NCT03135262|64563890|FG003|Overall Study|Study terminated by sponsor|3|||
23223776|NCT03135262|64563891|FG004|Overall Study|Study terminated by sponsor|0|||
23223777|NCT00117572|64563892|FG000|Overall Study|Site withdrew before starting treatment|2|||
23223778|NCT00117572|64563893|FG001|Overall Study|Site withdrew before starting treatment|3|||
23223779|NCT00117572|64563892|FG000|Overall Study|Withdrawal by Subject|3|||
23223780|NCT00117572|64563893|FG001|Overall Study|Withdrawal by Subject|3|||
23223781|NCT00117572|64563892|FG000|Overall Study|Protocol Violation|1|||
23223782|NCT00117572|64563893|FG001|Overall Study|Protocol Violation|0|||
23223783|NCT04921969|64563905|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23223784|NCT04921969|64563906|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
23223785|NCT04921969|64563907|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
23330668|NCT02151851|64952072|FG000|Overall Study|Medical impairment|1|||
23330669|NCT02151851|64952073|FG001|Overall Study|Medical impairment|0|||
23330670|NCT02151851|64952072|FG000|Overall Study|Low compliance to study visits|0|||
23330671|NCT02151851|64952073|FG001|Overall Study|Low compliance to study visits|1|||
23330672|NCT02151851|64952072|FG000|Overall Study|Subject entered into study in error|0|||
23330673|NCT02151851|64952073|FG001|Overall Study|Subject entered into study in error|1|||
23330674|NCT02151851|64952072|FG000|Overall Study|Adverse Event|6|||
23330675|NCT02151851|64952073|FG001|Overall Study|Adverse Event|28|||
23330676|NCT04463251|64952074|FG000|Overall Study|Death|1|||
23330677|NCT04463251|64952075|FG001|Overall Study|Death|0|||
23330678|NCT04463251|64952076|FG002|Overall Study|Death|1|||
23330679|NCT04463251|64952074|FG000|Overall Study|Adverse Event|0|||
23330680|NCT04463251|64952075|FG001|Overall Study|Adverse Event|1|||
23446858|NCT02919761|65377760|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
23569775|NCT03621982|65816577|FG011|Overall Study|Investigator/Sponsor decision|4|||
23569776|NCT03621982|65816578|FG012|Overall Study|Investigator/Sponsor decision|0|||
23569777|NCT03621982|65816579|FG013|Overall Study|Investigator/Sponsor decision|2|||
23569778|NCT03621982|65816566|FG000|Overall Study|Death|2|||
23569779|NCT03621982|65816567|FG001|Overall Study|Death|4|||
23569780|NCT03621982|65816568|FG002|Overall Study|Death|4|||
23162364|NCT03681119|64341857|FG001|Overall Study|Sickness|0|||
23162365|NCT00317109|64341863|FG000|Overall Study|Withdrawal by Subject|2|||
23330681|NCT04463251|64952076|FG002|Overall Study|Adverse Event|0|||
23162366|NCT00317109|64341864|FG001|Overall Study|Withdrawal by Subject|0|||
23162367|NCT00317109|64341863|FG000|Overall Study|Migated/moved from study area|1|||
23223786|NCT04921969|64563908|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23223787|NCT04921969|64563909|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23223788|NCT04921969|64563910|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23223789|NCT04921969|64563911|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
23223790|NCT04921969|64563905|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
23223791|NCT04921969|64563906|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23330682|NCT04463251|64952074|FG000|Overall Study|Lost to Follow-up|0|||
23330683|NCT04463251|64952075|FG001|Overall Study|Lost to Follow-up|1|||
23569781|NCT03621982|65816569|FG003|Overall Study|Death|3|||
23330684|NCT04463251|64952076|FG002|Overall Study|Lost to Follow-up|0|||
23330685|NCT04463251|64952074|FG000|Overall Study|Withdrawal by Subject|0|||
23330686|NCT04463251|64952075|FG001|Overall Study|Withdrawal by Subject|2|||
23330687|NCT04463251|64952076|FG002|Overall Study|Withdrawal by Subject|2|||
23330688|NCT02172664|64952081|FG000|Overall Study|Lost to Follow-up|4|||
23330689|NCT02172664|64952082|FG001|Overall Study|Lost to Follow-up|4|||
23162368|NCT00317109|64341864|FG001|Overall Study|Migated/moved from study area|0|||
23162369|NCT02915523|64341867|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
23162370|NCT02915523|64341868|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
23162371|NCT02915523|64341869|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
23330690|NCT02172664|64952081|FG000|Overall Study|Death|1|||
23330691|NCT02172664|64952082|FG001|Overall Study|Death|1|||
23162372|NCT02915523|64341870|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
23162373|NCT02915523|64341867|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
23162374|NCT02915523|64341868|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
23162375|NCT02915523|64341869|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
23162376|NCT02915523|64341870|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
23162377|NCT02915523|64341867|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
23330692|NCT02172664|64952081|FG000|Overall Study|Moved out of area|1|||
23330693|NCT02172664|64952082|FG001|Overall Study|Moved out of area|1|||
23330694|NCT01609296|64952083|FG000|Overall Study|Death|253|||
23330695|NCT01609296|64952083|FG000|Overall Study|Withdrawal by Subject|151|||
23330696|NCT01609296|64952083|FG000|Overall Study|Lost to Follow-up|21|||
23330697|NCT01609296|64952083|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
23330698|NCT01609296|64952083|FG000|Overall Study|missed visit but known to be alive|28|||
23330699|NCT01131455|64952084|FG000|Overall Study|Death of PI|6|||
23330700|NCT01131455|64952085|FG001|Overall Study|Death of PI|4|||
23330701|NCT01131455|64952086|FG002|Overall Study|Death of PI|0|||
23330702|NCT01383707|64952091|FG000|Overall Study|Consent withdrawal|6|||
23330703|NCT01383707|64952091|FG000|Overall Study|Death|19|||
23330704|NCT01383707|64952091|FG000|Overall Study|Other|8|||
23330705|NCT01383707|64952091|FG000|Overall Study|Sponsor's decision|2|||
23330706|NCT01383707|64952091|FG000|Overall Study|Adverse Event|14|||
23330707|NCT01383707|64952091|FG000|Overall Study|Progressive disease|23|||
23330708|NCT02510664|64952094|FG000|Overall Study|Transferred Care|9|||
23330709|NCT02510664|64952095|FG001|Overall Study|Transferred Care|9|||
23330710|NCT02510664|64952096|FG002|Overall Study|Transferred Care|0|||
23330711|NCT02510664|64952094|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
23330712|NCT02510664|64952095|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
23330713|NCT02510664|64952096|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
23569782|NCT03621982|65816570|FG004|Overall Study|Death|8|||
23569783|NCT03621982|65816571|FG005|Overall Study|Death|4|||
23569784|NCT03621982|65816572|FG006|Overall Study|Death|6|||
23569785|NCT03621982|65816573|FG007|Overall Study|Death|3|||
23569786|NCT03621982|65816574|FG008|Overall Study|Death|0|||
23569787|NCT03621982|65816575|FG009|Overall Study|Death|3|||
23569788|NCT03621982|65816576|FG010|Overall Study|Death|8|||
23569789|NCT03621982|65816577|FG011|Overall Study|Death|4|||
23569790|NCT03621982|65816578|FG012|Overall Study|Death|2|||
23569791|NCT03621982|65816579|FG013|Overall Study|Death|2|||
23569792|NCT03621982|65816566|FG000|Overall Study|Lost to Follow-up|0|||
23569793|NCT03621982|65816567|FG001|Overall Study|Lost to Follow-up|0|||
23569794|NCT03621982|65816568|FG002|Overall Study|Lost to Follow-up|1|||
23569795|NCT03621982|65816569|FG003|Overall Study|Lost to Follow-up|0|||
23569796|NCT03621982|65816570|FG004|Overall Study|Lost to Follow-up|0|||
23569797|NCT03621982|65816571|FG005|Overall Study|Lost to Follow-up|0|||
23162378|NCT02915523|64341868|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
23330714|NCT02510664|64952094|FG000|Overall Study|Time Constraints|1|||
23330715|NCT02510664|64952095|FG001|Overall Study|Time Constraints|1|||
23330716|NCT02510664|64952096|FG002|Overall Study|Time Constraints|0|||
23330717|NCT01706939|64952097|FG000|Pre Randomization|Screen Failure|1|||
23330718|NCT01706939|64952098|FG001|Pre Randomization|Screen Failure|0|||
23330719|NCT01706939|64952099|FG002|Pre Randomization|Screen Failure|0|||
23330720|NCT01706939|64952097|FG000|Pre Randomization|Ineligible for Randomization|1|||
23330721|NCT01706939|64952098|FG001|Pre Randomization|Ineligible for Randomization|0|||
23330722|NCT01706939|64952099|FG002|Pre Randomization|Ineligible for Randomization|0|||
23330723|NCT01706939|64952097|FG000|Pre Randomization|Withdrawal by Subject|1|||
23330724|NCT01706939|64952098|FG001|Pre Randomization|Withdrawal by Subject|0|||
23330725|NCT01706939|64952099|FG002|Pre Randomization|Withdrawal by Subject|0|||
23330726|NCT01706939|64952097|FG000|Randomization|Insufficient QoL survey compliance|0|||
23330727|NCT01706939|64952098|FG001|Randomization|Insufficient QoL survey compliance|1|||
23330728|NCT01706939|64952099|FG002|Randomization|Insufficient QoL survey compliance|1|||
23569798|NCT03621982|65816572|FG006|Overall Study|Lost to Follow-up|1|||
23569799|NCT03621982|65816573|FG007|Overall Study|Lost to Follow-up|0|||
23569800|NCT03621982|65816574|FG008|Overall Study|Lost to Follow-up|0|||
23569801|NCT03621982|65816575|FG009|Overall Study|Lost to Follow-up|1|||
23569802|NCT03621982|65816576|FG010|Overall Study|Lost to Follow-up|0|||
23330729|NCT01706939|64952097|FG000|Randomization|Progression of disease|0|||
23330730|NCT01706939|64952098|FG001|Randomization|Progression of disease|2|||
23330731|NCT01706939|64952099|FG002|Randomization|Progression of disease|1|||
23330732|NCT03448419|64952101|FG000|Overall Study|Adverse Event|10|||
23330733|NCT03448419|64952102|FG001|Overall Study|Adverse Event|9|||
23330734|NCT03448419|64952101|FG000|Overall Study|Lost to Follow-up|0|||
23330735|NCT03448419|64952102|FG001|Overall Study|Lost to Follow-up|2|||
23330736|NCT03448419|64952101|FG000|Overall Study|Withdrawal by Subject|3|||
23330737|NCT03448419|64952102|FG001|Overall Study|Withdrawal by Subject|1|||
23330738|NCT03448419|64952101|FG000|Overall Study|Not treated|0|||
23330739|NCT03448419|64952102|FG001|Overall Study|Not treated|1|||
23330740|NCT03448419|64952101|FG000|Overall Study|Patient did not attend all visits|0|||
23330741|NCT03448419|64952102|FG001|Overall Study|Patient did not attend all visits|2|||
23330742|NCT03448419|64952101|FG000|Overall Study|Withdrawn by Sponsor|0|||
23330743|NCT03448419|64952102|FG001|Overall Study|Withdrawn by Sponsor|1|||
23330744|NCT00550043|64952103|FG000|Overall Study|Adverse Event|0|||
23330745|NCT00550043|64952104|FG001|Overall Study|Adverse Event|0|||
23330746|NCT00550043|64952105|FG002|Overall Study|Adverse Event|0|||
23330747|NCT00550043|64952106|FG003|Overall Study|Adverse Event|1|||
23330748|NCT00550043|64952107|FG004|Overall Study|Adverse Event|1|||
23330749|NCT00550043|64952103|FG000|Overall Study|Subject Withdrew Consent|0|||
23330750|NCT00550043|64952104|FG001|Overall Study|Subject Withdrew Consent|2|||
23330751|NCT00550043|64952105|FG002|Overall Study|Subject Withdrew Consent|1|||
23330752|NCT00550043|64952106|FG003|Overall Study|Subject Withdrew Consent|0|||
23330753|NCT00550043|64952107|FG004|Overall Study|Subject Withdrew Consent|0|||
23330754|NCT00550043|64952103|FG000|Overall Study|Other Reasons- Unspecified|0|||
23330755|NCT00550043|64952104|FG001|Overall Study|Other Reasons- Unspecified|1|||
23330756|NCT00550043|64952105|FG002|Overall Study|Other Reasons- Unspecified|0|||
23330757|NCT00550043|64952106|FG003|Overall Study|Other Reasons- Unspecified|1|||
23330758|NCT00550043|64952107|FG004|Overall Study|Other Reasons- Unspecified|0|||
23330759|NCT01297517|64952110|FG000|Overall Study|Adverse Event|21|||
23330760|NCT01297517|64952111|FG001|Overall Study|Adverse Event|7|||
23330761|NCT01297517|64952112|FG002|Overall Study|Adverse Event|16|||
23330762|NCT01297517|64952110|FG000|Overall Study|Lost to Follow-up|1|||
23330763|NCT01297517|64952111|FG001|Overall Study|Lost to Follow-up|0|||
23330764|NCT01297517|64952112|FG002|Overall Study|Lost to Follow-up|1|||
23330765|NCT01297517|64952110|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
23330766|NCT01297517|64952111|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
23330767|NCT01297517|64952112|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
23330768|NCT01297517|64952110|FG000|Overall Study|Noncompliance|1|||
23330769|NCT01297517|64952111|FG001|Overall Study|Noncompliance|0|||
23330770|NCT01297517|64952112|FG002|Overall Study|Noncompliance|0|||
23330771|NCT01297517|64952110|FG000|Overall Study|Protocol Violation|1|||
23330772|NCT01297517|64952111|FG001|Overall Study|Protocol Violation|1|||
23330773|NCT01297517|64952112|FG002|Overall Study|Protocol Violation|1|||
23330774|NCT01297517|64952110|FG000|Overall Study|Inadequate Control of IOP|1|||
23330775|NCT01297517|64952111|FG001|Overall Study|Inadequate Control of IOP|1|||
23330776|NCT01297517|64952112|FG002|Overall Study|Inadequate Control of IOP|2|||
23223792|NCT04921969|64563907|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23223793|NCT04921969|64563908|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23569803|NCT03621982|65816577|FG011|Overall Study|Lost to Follow-up|0|||
23569804|NCT03621982|65816578|FG012|Overall Study|Lost to Follow-up|0|||
23569805|NCT03621982|65816579|FG013|Overall Study|Lost to Follow-up|0|||
23569806|NCT02878213|65816580|FG000|Overall Study|Withdrawal by Subject|2|||
23569807|NCT02878213|65816580|FG000|Overall Study|Adverse Event|1|||
23330777|NCT01962103|64952113|FG000|Phase 1|Adverse Event|4|||
23330778|NCT01962103|64952114|FG001|Phase 1|Adverse Event|0|||
23330779|NCT01962103|64952115|FG002|Phase 1|Adverse Event|2|||
23569808|NCT02791490|65816581|FG000|Overall Study|Lost to Follow-up|1|||
23569809|NCT02791490|65816582|FG001|Overall Study|Lost to Follow-up|2|||
23569810|NCT02791490|65816581|FG000|Overall Study|Withdrawal by Subject|2|||
23569811|NCT02791490|65816582|FG001|Overall Study|Withdrawal by Subject|6|||
23569812|NCT01775930|65816583|FG000|Overall Study|Futility stopping boundary met|1|||
23569813|NCT01155388|65816584|FG000|Overall Study|Adverse Event|1|||
23569814|NCT01155388|65816585|FG001|Overall Study|Adverse Event|0|||
23569815|NCT01242176|65816589|FG000|Washout Period of 7 Days|Adverse Event|0|||
23569816|NCT01242176|65816590|FG001|Washout Period of 7 Days|Adverse Event|2|||
23569817|NCT01242176|65816589|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
23569818|NCT01242176|65816590|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
23569819|NCT00358150|65816593|FG000|Overall Study|Adverse Event|3|||
23569820|NCT00358150|65816593|FG000|Overall Study|Withdrawal by Subject|1|||
23569821|NCT00358150|65816593|FG000|Overall Study|Undefined|3|||
23569822|NCT00065468|65816594|FG000|Overall Study|Death|172|||
23569823|NCT00065468|65816595|FG001|Overall Study|Death|169|||
23223794|NCT04921969|64563909|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23223795|NCT04921969|64563910|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23223796|NCT04921969|64563911|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23223797|NCT04921969|64563905|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
23223798|NCT04921969|64563906|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
23223799|NCT04921969|64563907|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
23223800|NCT04921969|64563908|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23223801|NCT04921969|64563909|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23223802|NCT04921969|64563910|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23330780|NCT01962103|64952116|FG003|Phase 1|Adverse Event|1|||
23330781|NCT01962103|64952117|FG004|Phase 1|Adverse Event|2|||
23330782|NCT01962103|64952118|FG005|Phase 1|Adverse Event|2|||
23330783|NCT01962103|64952119|FG006|Phase 1|Adverse Event|0|||
23330784|NCT01962103|64952120|FG007|Phase 1|Adverse Event|0|||
23330785|NCT01962103|64952121|FG008|Phase 1|Adverse Event|0|||
23569824|NCT00065468|65816596|FG002|Overall Study|Death|171|||
23569825|NCT00065468|65816594|FG000|Overall Study|Withdrawal by Subject|3|||
23569826|NCT00065468|65816595|FG001|Overall Study|Withdrawal by Subject|4|||
23569827|NCT00065468|65816596|FG002|Overall Study|Withdrawal by Subject|5|||
23569828|NCT00065468|65816594|FG000|Overall Study|Lost to Follow-up|5|||
23569829|NCT00065468|65816595|FG001|Overall Study|Lost to Follow-up|3|||
23569830|NCT00065468|65816596|FG002|Overall Study|Lost to Follow-up|2|||
23569831|NCT00065468|65816594|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
23569832|NCT00065468|65816595|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
23569833|NCT00065468|65816596|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
23569834|NCT00065468|65816594|FG000|Overall Study|Disease progression|0|||
23223803|NCT04921969|64563911|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23223804|NCT04921969|64563905|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23223805|NCT04921969|64563906|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
23223806|NCT04921969|64563907|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
23223807|NCT04921969|64563908|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23330786|NCT01962103|64952113|FG000|Phase 1|Progressive Disease|8|||
23330787|NCT01962103|64952114|FG001|Phase 1|Progressive Disease|6|||
23330788|NCT01962103|64952115|FG002|Phase 1|Progressive Disease|8|||
23330789|NCT01962103|64952116|FG003|Phase 1|Progressive Disease|4|||
23330790|NCT01962103|64952117|FG004|Phase 1|Progressive Disease|5|||
23330791|NCT01962103|64952118|FG005|Phase 1|Progressive Disease|4|||
23330792|NCT01962103|64952119|FG006|Phase 1|Progressive Disease|0|||
23330793|NCT01962103|64952120|FG007|Phase 1|Progressive Disease|0|||
23330794|NCT01962103|64952121|FG008|Phase 1|Progressive Disease|0|||
23330795|NCT01962103|64952113|FG000|Phase 1|Withdrawal by Subject|0|||
23330796|NCT01962103|64952114|FG001|Phase 1|Withdrawal by Subject|0|||
23330797|NCT01962103|64952115|FG002|Phase 1|Withdrawal by Subject|0|||
23330798|NCT01962103|64952116|FG003|Phase 1|Withdrawal by Subject|2|||
23223808|NCT04921969|64563909|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23223809|NCT04921969|64563910|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23223810|NCT04921969|64563911|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
23223811|NCT04921969|64563905|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23223812|NCT04921969|64563906|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23223813|NCT04921969|64563907|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
23223814|NCT04921969|64563908|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23223815|NCT04921969|64563909|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23223816|NCT04921969|64563910|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23223817|NCT04921969|64563911|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
23223818|NCT04921969|64563905|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
23223819|NCT04921969|64563906|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
23223820|NCT04921969|64563907|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
23223821|NCT04921969|64563908|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23330799|NCT01962103|64952117|FG004|Phase 1|Withdrawal by Subject|0|||
23330800|NCT01962103|64952118|FG005|Phase 1|Withdrawal by Subject|0|||
23330801|NCT01962103|64952119|FG006|Phase 1|Withdrawal by Subject|0|||
23330802|NCT01962103|64952120|FG007|Phase 1|Withdrawal by Subject|0|||
23330803|NCT01962103|64952121|FG008|Phase 1|Withdrawal by Subject|0|||
23330804|NCT01962103|64952113|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
23330805|NCT01962103|64952114|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
23330806|NCT01962103|64952115|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
23330807|NCT01962103|64952116|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
23330808|NCT01962103|64952117|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
23330809|NCT01962103|64952118|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
23569835|NCT00065468|65816595|FG001|Overall Study|Disease progression|0|||
23569836|NCT00065468|65816596|FG002|Overall Study|Disease progression|1|||
23223822|NCT04921969|64563909|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23223823|NCT04921969|64563910|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23223824|NCT04921969|64563911|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23223825|NCT04921969|64563905|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
23223826|NCT04921969|64563906|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
23223827|NCT04921969|64563907|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23223828|NCT04921969|64563908|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23223829|NCT04921969|64563909|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23223830|NCT04921969|64563910|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23330810|NCT01962103|64952119|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
23330811|NCT01962103|64952120|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
23330812|NCT01962103|64952121|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
23330813|NCT01962103|64952113|FG000|Phase 1|Physician Decision|0|||
23330814|NCT01962103|64952114|FG001|Phase 1|Physician Decision|0|||
23330815|NCT01962103|64952115|FG002|Phase 1|Physician Decision|0|||
23330816|NCT01962103|64952116|FG003|Phase 1|Physician Decision|1|||
23330817|NCT01962103|64952117|FG004|Phase 1|Physician Decision|0|||
23569837|NCT00065468|65816594|FG000|Overall Study|Other|14|||
23330818|NCT01962103|64952118|FG005|Phase 1|Physician Decision|0|||
23330819|NCT01962103|64952119|FG006|Phase 1|Physician Decision|0|||
23330820|NCT01962103|64952120|FG007|Phase 1|Physician Decision|0|||
23569838|NCT00065468|65816595|FG001|Overall Study|Other|24|||
23223831|NCT04921969|64563911|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
23223832|NCT04921969|64563905|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23223833|NCT04921969|64563906|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23223834|NCT04921969|64563907|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23223835|NCT04921969|64563908|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23223836|NCT04921969|64563909|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23223837|NCT04921969|64563910|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
23223838|NCT04921969|64563911|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
23223839|NCT04921969|64563905|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23223840|NCT04921969|64563906|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23223841|NCT04921969|64563907|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23223842|NCT04921969|64563908|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
23223843|NCT04921969|64563909|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23569839|NCT00065468|65816596|FG002|Overall Study|Other|18|||
23569840|NCT02597933|65816599|FG000|Overall Study|Withdrawal by Subject|7|||
23569841|NCT02597933|65816600|FG001|Overall Study|Withdrawal by Subject|5|||
23569842|NCT02597933|65816599|FG000|Overall Study|Protocol Violation|2|||
23569843|NCT02597933|65816600|FG001|Overall Study|Protocol Violation|2|||
23569844|NCT02597933|65816599|FG000|Overall Study|Adverse Event|20|||
23569845|NCT02597933|65816600|FG001|Overall Study|Adverse Event|28|||
23569846|NCT02597933|65816599|FG000|Overall Study|Not treated|2|||
23569847|NCT02597933|65816600|FG001|Overall Study|Not treated|2|||
23569848|NCT02597933|65816599|FG000|Overall Study|Other than stated above|7|||
23569849|NCT02597933|65816600|FG001|Overall Study|Other than stated above|14|||
23569850|NCT01744782|65816601|FG000|Overall Study|Death|1|||
23569851|NCT01267825|65816602|FG000|Overall Study|study terminated. no data collected.|1|||
23569852|NCT01267825|65816603|FG001|Overall Study|study terminated. no data collected.|0|||
23569853|NCT00735644|65816604|FG000|Overall Study|Did not receive study vaccine|0|||
23569854|NCT00735644|65816605|FG001|Overall Study|Did not receive study vaccine|1|||
23569855|NCT00735644|65816606|FG002|Overall Study|Did not receive study vaccine|0|||
23569856|NCT00735644|65816607|FG003|Overall Study|Did not receive study vaccine|0|||
23569857|NCT00735644|65816608|FG004|Overall Study|Did not receive study vaccine|0|||
23569858|NCT00735644|65816604|FG000|Overall Study|Withdrawal by Subject|0|||
23569859|NCT00735644|65816605|FG001|Overall Study|Withdrawal by Subject|1|||
23569860|NCT00735644|65816606|FG002|Overall Study|Withdrawal by Subject|1|||
23569861|NCT00735644|65816607|FG003|Overall Study|Withdrawal by Subject|1|||
23569862|NCT00735644|65816608|FG004|Overall Study|Withdrawal by Subject|0|||
23569863|NCT01284140|65816609|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
23569864|NCT01284140|65816610|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
23569865|NCT01284140|65816609|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
23569866|NCT01284140|65816610|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
23569867|NCT01004250|65816615|FG000|Induction Therapy Period|Adverse Event|10|||
23569868|NCT01004250|65816615|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
23569869|NCT01004250|65816615|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
23569870|NCT01004250|65816615|FG000|Induction Therapy Period|Physician Decision|2|||
23569871|NCT01004250|65816615|FG000|Maintenance Therapy Period|Adverse Event|15|||
23569872|NCT01004250|65816615|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
23569873|NCT01004250|65816615|FG000|Maintenance Therapy Period|Protocol Violation|1|||
23569874|NCT01004250|65816615|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
23569875|NCT01004250|65816615|FG000|Maintenance Therapy Period|Physician Decision|4|||
23569876|NCT01004250|65816615|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
23569877|NCT01630590|65816616|FG000|Overall Study|Adverse Event|9|||
23569878|NCT01630590|65816616|FG000|Overall Study|Lack of Efficacy|37|||
23569879|NCT01630590|65816616|FG000|Overall Study|Withdrawal by Subject|4|||
23223844|NCT04921969|64563910|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
23223845|NCT04921969|64563911|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
23569880|NCT01630590|65816616|FG000|Overall Study|2nd primary tumor|2|||
23569881|NCT01630590|65816616|FG000|Overall Study|Automobile accident|1|||
23569882|NCT01630590|65816616|FG000|Overall Study|Maximum benefit|4|||
23569883|NCT00867490|65816617|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
23569884|NCT00867490|65816617|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
23569885|NCT00867490|65816617|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
23569886|NCT00867490|65816617|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
23162379|NCT02915523|64341869|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
23162380|NCT02915523|64341870|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
23162381|NCT02915523|64341867|FG000|Expansion Phase (Phase 2)|Death|0|||
23162382|NCT02915523|64341868|FG001|Expansion Phase (Phase 2)|Death|0|||
23162383|NCT02915523|64341869|FG002|Expansion Phase (Phase 2)|Death|26|||
23162384|NCT02915523|64341870|FG003|Expansion Phase (Phase 2)|Death|53|||
23162385|NCT02915523|64341867|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
23162386|NCT02915523|64341868|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
23162387|NCT02915523|64341869|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
23162388|NCT02915523|64341870|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
23162389|NCT02915523|64341867|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
23162390|NCT02915523|64341868|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
23162391|NCT02915523|64341869|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
23162392|NCT02915523|64341870|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
23162393|NCT02915523|64341867|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
23162394|NCT02915523|64341868|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
23162395|NCT02915523|64341869|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
23162396|NCT02915523|64341870|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
23162397|NCT01785160|64341871|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
23162398|NCT01785160|64341871|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
23162399|NCT03765138|64341872|FG000|Overall Study|Lost to Follow-up|1|||
23162400|NCT03785925|64341877|FG000|Overall Study|Withdrawal by Subject|15|||
23162401|NCT03785925|64341877|FG000|Overall Study|Lost to Follow-up|1|||
23162402|NCT01417195|64341882|FG000|Overall Study|Stimulation failure|1|||
23162403|NCT01417195|64341883|FG001|Overall Study|Stimulation failure|0|||
23162404|NCT01417195|64341882|FG000|Overall Study|No embryos for transfer|0|||
23162405|NCT01417195|64341883|FG001|Overall Study|No embryos for transfer|1|||
23162406|NCT01417195|64341882|FG000|Overall Study|No transfer due to risk of OHSS|1|||
23162407|NCT01417195|64341883|FG001|Overall Study|No transfer due to risk of OHSS|0|||
23162408|NCT01417195|64341882|FG000|Overall Study|No transfer due to elevated progesterone|1|||
23162409|NCT01417195|64341883|FG001|Overall Study|No transfer due to elevated progesterone|0|||
23162410|NCT02431702|64341886|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
23162411|NCT02431702|64341887|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23162412|NCT02431702|64341888|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23162413|NCT02431702|64341889|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23162414|NCT02431702|64341890|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23162415|NCT02431702|64341891|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23162416|NCT02431702|64341892|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
23162417|NCT02431702|64341886|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
23162418|NCT02431702|64341887|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23162419|NCT02431702|64341888|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23162420|NCT02431702|64341889|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23162421|NCT02431702|64341890|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23162422|NCT02431702|64341891|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
23162423|NCT02431702|64341892|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
23162424|NCT02431702|64341886|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
23162425|NCT02431702|64341887|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23162426|NCT02431702|64341888|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23162427|NCT02431702|64341889|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23162428|NCT02431702|64341890|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23162429|NCT02431702|64341891|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
23162430|NCT02431702|64341892|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
23162431|NCT02431702|64341886|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
23162432|NCT02431702|64341887|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23162433|NCT02431702|64341888|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23162434|NCT02431702|64341889|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23162435|NCT02431702|64341890|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23162436|NCT02431702|64341891|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
23162437|NCT02431702|64341892|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
23162438|NCT02431702|64341886|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
23162439|NCT02431702|64341887|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23162440|NCT02431702|64341888|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23330821|NCT01962103|64952121|FG008|Phase 1|Physician Decision|0|||
23330822|NCT01962103|64952113|FG000|Phase 1|Symptomatic Deterioration|3|||
23330823|NCT01962103|64952114|FG001|Phase 1|Symptomatic Deterioration|2|||
23569887|NCT00867490|65816617|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
23569888|NCT00432835|65816619|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
23569889|NCT00432835|65816620|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
23569890|NCT01346514|65816621|FG000|Overall Study|Lost to Follow-up|19|||
23569891|NCT01346514|65816622|FG001|Overall Study|Lost to Follow-up|30|||
23569892|NCT01346514|65816621|FG000|Overall Study|Withdrawal by Subject|7|||
23569893|NCT01346514|65816622|FG001|Overall Study|Withdrawal by Subject|3|||
23569894|NCT01346514|65816621|FG000|Overall Study|Death|3|||
23569895|NCT01346514|65816622|FG001|Overall Study|Death|4|||
23569896|NCT02443103|65816623|FG000|Overall Study|Adverse Event|2|||
23569897|NCT02443103|65816623|FG000|Overall Study|Noncompliance|1|||
23569898|NCT04848662|65816633|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
23569899|NCT04848662|65816634|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
23569900|NCT00597714|65816635|FG000|Overall Study|Death|56|||
23569901|NCT00597714|65816636|FG001|Overall Study|Death|46|||
23569902|NCT00597714|65816637|FG002|Overall Study|Death|0|||
23569903|NCT00597714|65816635|FG000|Overall Study|Recipient death|0|||
23569904|NCT00597714|65816636|FG001|Overall Study|Recipient death|0|||
23569905|NCT00597714|65816637|FG002|Overall Study|Recipient death|10|||
23569906|NCT02753530|65816638|FG000|Overall Study|Adverse Event|7|||
23569907|NCT02753530|65816639|FG001|Overall Study|Adverse Event|1|||
23569908|NCT02753530|65816638|FG000|Overall Study|Death|0|||
23569909|NCT02753530|65816639|FG001|Overall Study|Death|1|||
23569910|NCT02753530|65816638|FG000|Overall Study|Physician Decision|0|||
23569911|NCT02753530|65816639|FG001|Overall Study|Physician Decision|1|||
23569912|NCT02753530|65816638|FG000|Overall Study|Protocol Violation|1|||
23569913|NCT02753530|65816639|FG001|Overall Study|Protocol Violation|0|||
23569914|NCT02753530|65816638|FG000|Overall Study|Withdrawal by Subject|4|||
23569915|NCT02753530|65816639|FG001|Overall Study|Withdrawal by Subject|3|||
23569916|NCT01651936|65816640|FG000|Base Study|Adverse Event|3|||
23569917|NCT01651936|65816641|FG001|Base Study|Adverse Event|0|||
23569918|NCT01651936|65816642|FG002|Base Study|Adverse Event|0|||
23569919|NCT01651936|65816640|FG000|Base Study|Withdrawal by Subject|1|||
23569920|NCT01651936|65816641|FG001|Base Study|Withdrawal by Subject|1|||
23569921|NCT01651936|65816642|FG002|Base Study|Withdrawal by Subject|0|||
23569922|NCT01651936|65816640|FG000|Base Study|Early Escape|2|||
23569923|NCT01651936|65816641|FG001|Base Study|Early Escape|8|||
23569924|NCT01651936|65816642|FG002|Base Study|Early Escape|0|||
23569925|NCT01651936|65816640|FG000|Base Study|Study terminated by sponsor|21|||
23569926|NCT01651936|65816641|FG001|Base Study|Study terminated by sponsor|16|||
23569927|NCT01651936|65816642|FG002|Base Study|Study terminated by sponsor|0|||
23569928|NCT01651936|65816640|FG000|Extension Study|Lack of Efficacy|0|||
23569929|NCT01651936|65816641|FG001|Extension Study|Lack of Efficacy|0|||
23569930|NCT01651936|65816642|FG002|Extension Study|Lack of Efficacy|1|||
23569931|NCT01651936|65816640|FG000|Extension Study|Study terminated by sponsor|0|||
23569932|NCT01651936|65816641|FG001|Extension Study|Study terminated by sponsor|0|||
23569933|NCT01651936|65816642|FG002|Extension Study|Study terminated by sponsor|13|||
23569934|NCT01258660|65816643|FG000|Overall Study|Adverse Event|2|||
23330824|NCT01962103|64952115|FG002|Phase 1|Symptomatic Deterioration|2|||
23330825|NCT01962103|64952116|FG003|Phase 1|Symptomatic Deterioration|2|||
23330826|NCT01962103|64952117|FG004|Phase 1|Symptomatic Deterioration|1|||
23330827|NCT01962103|64952118|FG005|Phase 1|Symptomatic Deterioration|1|||
23330828|NCT01962103|64952119|FG006|Phase 1|Symptomatic Deterioration|0|||
23446859|NCT02919761|65377758|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
23569935|NCT01258660|65816644|FG001|Overall Study|Adverse Event|4|||
23569936|NCT01258660|65816643|FG000|Overall Study|Withdrawal by Subject|3|||
23330829|NCT01962103|64952120|FG007|Phase 1|Symptomatic Deterioration|0|||
23330830|NCT01962103|64952121|FG008|Phase 1|Symptomatic Deterioration|0|||
23330831|NCT01962103|64952113|FG000|Phase 1|Miscellaneous|1|||
23569937|NCT01258660|65816644|FG001|Overall Study|Withdrawal by Subject|0|||
23569938|NCT01258660|65816643|FG000|Overall Study|due to relocation|2|||
23569939|NCT01258660|65816644|FG001|Overall Study|due to relocation|0|||
23569940|NCT01258660|65816643|FG000|Overall Study|Protocol Violation|0|||
23569941|NCT01258660|65816644|FG001|Overall Study|Protocol Violation|1|||
23569942|NCT01258660|65816643|FG000|Overall Study|Invalid for primary analysis data set|4|||
23569943|NCT01258660|65816644|FG001|Overall Study|Invalid for primary analysis data set|6|||
23569944|NCT00402337|65816645|FG000|Overall Study|Adverse Event|0|||
23330832|NCT01962103|64952114|FG001|Phase 1|Miscellaneous|0|||
23330833|NCT01962103|64952115|FG002|Phase 1|Miscellaneous|0|||
23330834|NCT01962103|64952116|FG003|Phase 1|Miscellaneous|0|||
23446860|NCT02919761|65377759|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
23446861|NCT02919761|65377760|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
23569945|NCT00402337|65816646|FG001|Overall Study|Adverse Event|2|||
23569946|NCT00402337|65816647|FG002|Overall Study|Adverse Event|2|||
23569947|NCT00402337|65816648|FG003|Overall Study|Adverse Event|3|||
23569948|NCT00402337|65816649|FG004|Overall Study|Adverse Event|2|||
23569949|NCT00402337|65816645|FG000|Overall Study|Noncompliance|0|||
23569950|NCT00402337|65816646|FG001|Overall Study|Noncompliance|0|||
23569951|NCT00402337|65816647|FG002|Overall Study|Noncompliance|0|||
23569952|NCT00402337|65816648|FG003|Overall Study|Noncompliance|0|||
23569953|NCT00402337|65816649|FG004|Overall Study|Noncompliance|2|||
23569954|NCT00402337|65816645|FG000|Overall Study|Withdrawal by Subject|5|||
23569955|NCT00402337|65816646|FG001|Overall Study|Withdrawal by Subject|3|||
23569956|NCT00402337|65816647|FG002|Overall Study|Withdrawal by Subject|1|||
23569957|NCT00402337|65816648|FG003|Overall Study|Withdrawal by Subject|6|||
23569958|NCT00402337|65816649|FG004|Overall Study|Withdrawal by Subject|4|||
23569959|NCT00402337|65816645|FG000|Overall Study|Lost to Follow-up|0|||
23569960|NCT00402337|65816646|FG001|Overall Study|Lost to Follow-up|0|||
23569961|NCT00402337|65816647|FG002|Overall Study|Lost to Follow-up|1|||
23569962|NCT00402337|65816648|FG003|Overall Study|Lost to Follow-up|2|||
23569963|NCT00402337|65816649|FG004|Overall Study|Lost to Follow-up|0|||
23569964|NCT00402337|65816645|FG000|Overall Study|Physician Decision|0|||
23569965|NCT00402337|65816646|FG001|Overall Study|Physician Decision|0|||
23569966|NCT00402337|65816647|FG002|Overall Study|Physician Decision|0|||
23569967|NCT00402337|65816648|FG003|Overall Study|Physician Decision|1|||
23569968|NCT00402337|65816649|FG004|Overall Study|Physician Decision|0|||
23446862|NCT02919761|65377758|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
23446863|NCT02919761|65377759|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
23446864|NCT02919761|65377760|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
23446865|NCT02919761|65377758|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
23446866|NCT02919761|65377759|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
23569969|NCT00402337|65816645|FG000|Overall Study|Other Reason|0|||
23330835|NCT01962103|64952117|FG004|Phase 1|Miscellaneous|0|||
23330836|NCT01962103|64952118|FG005|Phase 1|Miscellaneous|0|||
23330837|NCT01962103|64952119|FG006|Phase 1|Miscellaneous|0|||
23569970|NCT00402337|65816646|FG001|Overall Study|Other Reason|1|||
23569971|NCT00402337|65816647|FG002|Overall Study|Other Reason|0|||
23569972|NCT00402337|65816648|FG003|Overall Study|Other Reason|0|||
23569973|NCT00402337|65816649|FG004|Overall Study|Other Reason|0|||
23330838|NCT01962103|64952120|FG007|Phase 1|Miscellaneous|0|||
23569974|NCT04867785|65816652|FG000|Overall Study|Adverse Event|1|||
23569975|NCT04867785|65816653|FG001|Overall Study|Adverse Event|0|||
23162441|NCT02431702|64341889|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23162442|NCT02431702|64341890|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23162443|NCT02431702|64341891|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23162444|NCT02431702|64341892|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
23162445|NCT02431702|64341886|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23162446|NCT02431702|64341887|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
23162447|NCT02431702|64341888|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
23162448|NCT02431702|64341889|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23330839|NCT01962103|64952121|FG008|Phase 1|Miscellaneous|0|||
23330840|NCT01962103|64952113|FG000|Phase 2|Adverse Event|0|||
23330841|NCT01962103|64952114|FG001|Phase 2|Adverse Event|0|||
23330842|NCT01962103|64952115|FG002|Phase 2|Adverse Event|0|||
23569976|NCT04867785|65816654|FG002|Overall Study|Adverse Event|1|||
23569977|NCT04867785|65816655|FG003|Overall Study|Adverse Event|0|||
23569978|NCT04867785|65816656|FG004|Overall Study|Adverse Event|0|||
23330843|NCT01962103|64952116|FG003|Phase 2|Adverse Event|0|||
23330844|NCT01962103|64952117|FG004|Phase 2|Adverse Event|0|||
23330845|NCT01962103|64952118|FG005|Phase 2|Adverse Event|0|||
23330846|NCT01962103|64952119|FG006|Phase 2|Adverse Event|1|||
23330847|NCT01962103|64952120|FG007|Phase 2|Adverse Event|0|||
23330848|NCT01962103|64952121|FG008|Phase 2|Adverse Event|3|||
23330849|NCT01962103|64952113|FG000|Phase 2|Progressive Disease|0|||
23330850|NCT01962103|64952114|FG001|Phase 2|Progressive Disease|0|||
23330851|NCT01962103|64952115|FG002|Phase 2|Progressive Disease|0|||
23330852|NCT01962103|64952116|FG003|Phase 2|Progressive Disease|0|||
23330853|NCT01962103|64952117|FG004|Phase 2|Progressive Disease|0|||
23330854|NCT01962103|64952118|FG005|Phase 2|Progressive Disease|0|||
23330855|NCT01962103|64952119|FG006|Phase 2|Progressive Disease|11|||
23330856|NCT01962103|64952120|FG007|Phase 2|Progressive Disease|12|||
23330857|NCT01962103|64952121|FG008|Phase 2|Progressive Disease|11|||
23330858|NCT01962103|64952113|FG000|Phase 2|Symptomatic Deterioration|0|||
23330859|NCT01962103|64952114|FG001|Phase 2|Symptomatic Deterioration|0|||
23330860|NCT01962103|64952115|FG002|Phase 2|Symptomatic Deterioration|0|||
23330861|NCT01962103|64952116|FG003|Phase 2|Symptomatic Deterioration|0|||
23569979|NCT04867785|65816657|FG005|Overall Study|Adverse Event|0|||
23569980|NCT04867785|65816658|FG006|Overall Study|Adverse Event|0|||
23569981|NCT04867785|65816659|FG007|Overall Study|Adverse Event|2|||
23569982|NCT04867785|65816652|FG000|Overall Study|Lost to Follow-up|4|||
23569983|NCT04867785|65816653|FG001|Overall Study|Lost to Follow-up|4|||
23569984|NCT04867785|65816654|FG002|Overall Study|Lost to Follow-up|3|||
23569985|NCT04867785|65816655|FG003|Overall Study|Lost to Follow-up|2|||
23569986|NCT04867785|65816656|FG004|Overall Study|Lost to Follow-up|0|||
23569987|NCT04867785|65816657|FG005|Overall Study|Lost to Follow-up|1|||
23569988|NCT04867785|65816658|FG006|Overall Study|Lost to Follow-up|0|||
23569989|NCT04867785|65816659|FG007|Overall Study|Lost to Follow-up|1|||
23569990|NCT04867785|65816652|FG000|Overall Study|Withdrawal by Subject|6|||
23330862|NCT01962103|64952117|FG004|Phase 2|Symptomatic Deterioration|0|||
23330863|NCT01962103|64952118|FG005|Phase 2|Symptomatic Deterioration|0|||
23330864|NCT01962103|64952119|FG006|Phase 2|Symptomatic Deterioration|2|||
23330865|NCT01962103|64952120|FG007|Phase 2|Symptomatic Deterioration|2|||
23330866|NCT01962103|64952121|FG008|Phase 2|Symptomatic Deterioration|0|||
23330867|NCT03570619|64952122|FG000|Overall Study|Adverse Event|2|||
23330868|NCT03570619|64952123|FG001|Overall Study|Adverse Event|0|||
23330869|NCT03570619|64952124|FG002|Overall Study|Adverse Event|1|||
23330870|NCT03570619|64952122|FG000|Overall Study|new diagnosis of new malignancy|1|||
23569991|NCT04867785|65816653|FG001|Overall Study|Withdrawal by Subject|2|||
23569992|NCT04867785|65816654|FG002|Overall Study|Withdrawal by Subject|2|||
23569993|NCT04867785|65816655|FG003|Overall Study|Withdrawal by Subject|1|||
23330871|NCT03570619|64952123|FG001|Overall Study|new diagnosis of new malignancy|0|||
23330872|NCT03570619|64952124|FG002|Overall Study|new diagnosis of new malignancy|0|||
23330873|NCT03570619|64952122|FG000|Overall Study|Physician Decision|1|||
23330874|NCT03570619|64952123|FG001|Overall Study|Physician Decision|1|||
23330875|NCT03570619|64952124|FG002|Overall Study|Physician Decision|0|||
23330876|NCT03570619|64952122|FG000|Overall Study|Withdrawal by Subject|0|||
23330877|NCT03570619|64952123|FG001|Overall Study|Withdrawal by Subject|2|||
23569994|NCT04867785|65816656|FG004|Overall Study|Withdrawal by Subject|2|||
23569995|NCT04867785|65816657|FG005|Overall Study|Withdrawal by Subject|0|||
23569996|NCT04867785|65816658|FG006|Overall Study|Withdrawal by Subject|2|||
23569997|NCT04867785|65816659|FG007|Overall Study|Withdrawal by Subject|5|||
23569998|NCT04867785|65816652|FG000|Overall Study|Physician Decision|0|||
23569999|NCT04867785|65816653|FG001|Overall Study|Physician Decision|0|||
23570000|NCT04867785|65816654|FG002|Overall Study|Physician Decision|0|||
23570001|NCT04867785|65816655|FG003|Overall Study|Physician Decision|0|||
23162449|NCT02431702|64341890|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23162450|NCT02431702|64341891|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23162451|NCT02431702|64341892|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
23162452|NCT02431702|64341886|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23162453|NCT02431702|64341887|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
23162454|NCT02431702|64341888|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
23162455|NCT02431702|64341889|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23162456|NCT02431702|64341890|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23162457|NCT02431702|64341891|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23162458|NCT02431702|64341892|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
23162459|NCT02431702|64341886|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23162460|NCT02431702|64341887|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
23223846|NCT04921969|64563905|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23223847|NCT04921969|64563906|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23223848|NCT04921969|64563907|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23223849|NCT04921969|64563908|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
23223850|NCT04921969|64563909|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|3|||
23223851|NCT04921969|64563910|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|13|||
23570002|NCT04867785|65816656|FG004|Overall Study|Physician Decision|0|||
23162461|NCT02431702|64341888|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
23162462|NCT02431702|64341889|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23162463|NCT02431702|64341890|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23162464|NCT02431702|64341891|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23162465|NCT02431702|64341892|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
23162466|NCT02431702|64341886|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23162467|NCT02431702|64341887|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
23223852|NCT04921969|64563911|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
23223853|NCT04921969|64563905|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23223854|NCT04921969|64563906|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23330878|NCT03570619|64952124|FG002|Overall Study|Withdrawal by Subject|0|||
23570003|NCT04867785|65816657|FG005|Overall Study|Physician Decision|0|||
23330879|NCT04411810|64952125|FG000|Overall Study|Screen failure|1|||
23330880|NCT04411810|64952125|FG000|Overall Study|Withdrawal by Subject|1|||
23570004|NCT04867785|65816658|FG006|Overall Study|Physician Decision|0|||
23570005|NCT04867785|65816659|FG007|Overall Study|Physician Decision|1|||
23570006|NCT04867785|65816652|FG000|Overall Study|Inadvertent Enrollment|0|||
23162468|NCT02431702|64341888|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23162469|NCT02431702|64341889|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23162470|NCT02431702|64341890|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23162471|NCT02431702|64341891|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23162472|NCT02431702|64341892|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
23162473|NCT02431702|64341886|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
23162474|NCT02431702|64341887|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
23570007|NCT04867785|65816653|FG001|Overall Study|Inadvertent Enrollment|0|||
23570008|NCT04867785|65816654|FG002|Overall Study|Inadvertent Enrollment|0|||
23570009|NCT04867785|65816655|FG003|Overall Study|Inadvertent Enrollment|1|||
23330881|NCT05000164|64952130|FG000|Overall Study|Adverse Event|1|||
23570010|NCT04867785|65816656|FG004|Overall Study|Inadvertent Enrollment|1|||
23570011|NCT04867785|65816657|FG005|Overall Study|Inadvertent Enrollment|0|||
23570012|NCT04867785|65816658|FG006|Overall Study|Inadvertent Enrollment|0|||
23570013|NCT04867785|65816659|FG007|Overall Study|Inadvertent Enrollment|1|||
23570014|NCT04867785|65816652|FG000|Overall Study|Eligibility Criteria Not Met|0|||
23570015|NCT04867785|65816653|FG001|Overall Study|Eligibility Criteria Not Met|0|||
23162475|NCT02431702|64341888|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
23162476|NCT02431702|64341889|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
23162477|NCT02431702|64341890|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
23162478|NCT02431702|64341891|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
23162479|NCT02431702|64341892|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
23162480|NCT02431702|64341886|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23162481|NCT02431702|64341887|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23162482|NCT02431702|64341888|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
23162483|NCT02431702|64341889|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23162484|NCT02431702|64341890|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23162485|NCT02431702|64341891|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23162486|NCT02431702|64341892|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
23162487|NCT02431702|64341886|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23162488|NCT02431702|64341887|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23162489|NCT02431702|64341888|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23162490|NCT02431702|64341889|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
23162491|NCT02431702|64341890|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
23162492|NCT02431702|64341891|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23223855|NCT04921969|64563907|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23570016|NCT04867785|65816654|FG002|Overall Study|Eligibility Criteria Not Met|0|||
23570017|NCT04867785|65816655|FG003|Overall Study|Eligibility Criteria Not Met|0|||
23570018|NCT04867785|65816656|FG004|Overall Study|Eligibility Criteria Not Met|0|||
23570019|NCT04867785|65816657|FG005|Overall Study|Eligibility Criteria Not Met|0|||
23162493|NCT02431702|64341892|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
23162494|NCT02431702|64341886|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23162495|NCT02431702|64341887|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23162496|NCT02431702|64341888|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23162497|NCT02431702|64341889|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
23162498|NCT02431702|64341890|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23162499|NCT02431702|64341891|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
23162500|NCT02431702|64341892|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
23162501|NCT02431702|64341886|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
23223856|NCT04921969|64563908|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
23223857|NCT04921969|64563909|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23330882|NCT05000164|64952130|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
23330883|NCT05000164|64952130|FG000|Overall Study|Lens Discomfort|3|||
23330884|NCT05000164|64952130|FG000|Overall Study|Withdrew Consent during Study|2|||
23330885|NCT05000164|64952130|FG000|Overall Study|Subject Withdrawn by PI|2|||
23330886|NCT05000164|64952130|FG000|Overall Study|Other Fractured Test Article|1|||
23330887|NCT02841995|64952131|FG000|Overall Study|Disease progression|5|||
23330888|NCT02841995|64952132|FG001|Overall Study|Disease progression|11|||
23330889|NCT02841995|64952133|FG002|Overall Study|Disease progression|8|||
23330890|NCT02841995|64952131|FG000|Overall Study|Withdrawal by Subject|2|||
23330891|NCT02841995|64952132|FG001|Overall Study|Withdrawal by Subject|4|||
23330892|NCT02841995|64952133|FG002|Overall Study|Withdrawal by Subject|4|||
23330893|NCT02841995|64952131|FG000|Overall Study|Adverse Event|2|||
23330894|NCT02841995|64952132|FG001|Overall Study|Adverse Event|0|||
23330895|NCT02841995|64952133|FG002|Overall Study|Adverse Event|1|||
23330896|NCT02841995|64952131|FG000|Overall Study|Investigator decision|2|||
23330897|NCT02841995|64952132|FG001|Overall Study|Investigator decision|0|||
23330898|NCT02841995|64952133|FG002|Overall Study|Investigator decision|1|||
23330899|NCT02841995|64952131|FG000|Overall Study|Death|0|||
23330900|NCT02841995|64952132|FG001|Overall Study|Death|0|||
23330901|NCT02841995|64952133|FG002|Overall Study|Death|2|||
23330902|NCT02841995|64952131|FG000|Overall Study|Noncompliance to protocol|1|||
23330903|NCT02841995|64952132|FG001|Overall Study|Noncompliance to protocol|0|||
23330904|NCT02841995|64952133|FG002|Overall Study|Noncompliance to protocol|0|||
23330905|NCT02841995|64952131|FG000|Overall Study|Sponsor decision|1|||
23330906|NCT02841995|64952132|FG001|Overall Study|Sponsor decision|0|||
23330907|NCT02841995|64952133|FG002|Overall Study|Sponsor decision|0|||
23330908|NCT02841995|64952131|FG000|Overall Study|Other|4|||
23330909|NCT02841995|64952132|FG001|Overall Study|Other|1|||
23330910|NCT02841995|64952133|FG002|Overall Study|Other|5|||
23330911|NCT03225105|64952134|FG000|Overall Study|Withdrawal by Subject|1|||
23330912|NCT03225105|64952135|FG001|Overall Study|Withdrawal by Subject|0|||
23330913|NCT03225105|64952136|FG002|Overall Study|Withdrawal by Subject|0|||
23446867|NCT02919761|65377760|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
23446868|NCT00799903|65377761|FG000|Overall Study|Investigator Site Closed|25|||
23446869|NCT00799903|65377762|FG001|Overall Study|Investigator Site Closed|23|||
23446870|NCT00799903|65377761|FG000|Overall Study|Withdrawal by Subject|179|||
23446871|NCT00799903|65377762|FG001|Overall Study|Withdrawal by Subject|175|||
23446872|NCT00799903|65377761|FG000|Overall Study|Lost to Follow-up|69|||
23162502|NCT02431702|64341887|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
23162503|NCT02431702|64341888|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
23162504|NCT02431702|64341889|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
23223858|NCT04921969|64563910|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
23223859|NCT04921969|64563911|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
23223860|NCT04921969|64563905|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23223861|NCT04921969|64563906|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23223862|NCT04921969|64563907|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23223863|NCT04921969|64563908|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
23223864|NCT04921969|64563909|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
23223865|NCT04921969|64563910|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
23223866|NCT04921969|64563911|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|13|||
23223867|NCT04921969|64563905|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
23223868|NCT04921969|64563906|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
23223869|NCT04921969|64563907|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
23223870|NCT04921969|64563908|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
23223871|NCT04921969|64563909|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
23223872|NCT04921969|64563910|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
23330914|NCT03225105|64952137|FG003|Overall Study|Withdrawal by Subject|0|||
23330915|NCT03225105|64952134|FG000|Overall Study|Death|0|||
23330916|NCT03225105|64952135|FG001|Overall Study|Death|4|||
23330917|NCT03225105|64952136|FG002|Overall Study|Death|2|||
23330918|NCT03225105|64952137|FG003|Overall Study|Death|0|||
23446873|NCT00799903|65377762|FG001|Overall Study|Lost to Follow-up|80|||
23446874|NCT02910466|65377763|FG000|Overall Study|Adverse Event|1|||
23446875|NCT02910466|65377763|FG000|Overall Study|Withdrawal by Subject|3|||
23446876|NCT02910466|65377763|FG000|Overall Study|Lost to Follow-up|5|||
23446877|NCT02910466|65377763|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
23446878|NCT02910466|65377763|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
23446879|NCT03760081|65377768|FG000|Overall Study|Miscellaneous|0|||
23446880|NCT03760081|65377769|FG001|Overall Study|Miscellaneous|1|||
23446881|NCT03760081|65377768|FG000|Overall Study|Progressive Disease|5|||
23446882|NCT03760081|65377769|FG001|Overall Study|Progressive Disease|10|||
23446883|NCT03760081|65377768|FG000|Overall Study|Death|1|||
23570020|NCT04867785|65816658|FG006|Overall Study|Eligibility Criteria Not Met|0|||
23570021|NCT04867785|65816659|FG007|Overall Study|Eligibility Criteria Not Met|1|||
23570022|NCT01923428|65816663|FG000|Overall Study|Adverse Event|8|||
23446884|NCT03760081|65377769|FG001|Overall Study|Death|1|||
23446885|NCT00773513|65377770|FG000|Overall Study|Renal Transplant|254|||
23446886|NCT00773513|65377771|FG001|Overall Study|Renal Transplant|263|||
23446887|NCT00773513|65377770|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
23446888|NCT00773513|65377771|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
23446889|NCT00773513|65377770|FG000|Overall Study|Withdrew Consent|68|||
23446890|NCT00773513|65377771|FG001|Overall Study|Withdrew Consent|69|||
23570023|NCT01923428|65816664|FG001|Overall Study|Adverse Event|6|||
23570024|NCT01923428|65816665|FG002|Overall Study|Adverse Event|3|||
23570025|NCT01923428|65816666|FG003|Overall Study|Adverse Event|3|||
23570026|NCT01923428|65816663|FG000|Overall Study|Withdrawal by Subject|5|||
23570027|NCT01923428|65816664|FG001|Overall Study|Withdrawal by Subject|3|||
23570028|NCT01923428|65816665|FG002|Overall Study|Withdrawal by Subject|0|||
23570029|NCT01923428|65816666|FG003|Overall Study|Withdrawal by Subject|4|||
23570030|NCT01923428|65816663|FG000|Overall Study|Lost to Follow-up|2|||
23570031|NCT01923428|65816664|FG001|Overall Study|Lost to Follow-up|1|||
23570032|NCT01923428|65816665|FG002|Overall Study|Lost to Follow-up|5|||
23570033|NCT01923428|65816666|FG003|Overall Study|Lost to Follow-up|0|||
23570034|NCT01923428|65816663|FG000|Overall Study|Protocol Violation|3|||
23570035|NCT01923428|65816664|FG001|Overall Study|Protocol Violation|0|||
23570036|NCT01923428|65816665|FG002|Overall Study|Protocol Violation|2|||
23570037|NCT01923428|65816666|FG003|Overall Study|Protocol Violation|1|||
23162505|NCT02431702|64341890|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
23162506|NCT02431702|64341891|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
23162507|NCT02431702|64341892|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
23162508|NCT02431702|64341886|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
23162509|NCT02431702|64341887|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
23162510|NCT02431702|64341888|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
23162511|NCT02431702|64341889|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
23162512|NCT02431702|64341890|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
23162513|NCT02431702|64341891|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
23330919|NCT03225105|64952134|FG000|Overall Study|Study termination per Sponsor Decision|2|||
23446891|NCT00773513|65377770|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
23570038|NCT01923428|65816663|FG000|Overall Study|Non Compliance to treatment|1|||
23570039|NCT01923428|65816664|FG001|Overall Study|Non Compliance to treatment|2|||
23570040|NCT01923428|65816665|FG002|Overall Study|Non Compliance to treatment|0|||
23570041|NCT01923428|65816666|FG003|Overall Study|Non Compliance to treatment|1|||
23570042|NCT01923428|65816663|FG000|Overall Study|Lack of Efficacy|0|||
23570043|NCT01923428|65816664|FG001|Overall Study|Lack of Efficacy|0|||
23570044|NCT01923428|65816665|FG002|Overall Study|Lack of Efficacy|1|||
23570045|NCT01923428|65816666|FG003|Overall Study|Lack of Efficacy|1|||
23570046|NCT02638623|65816671|FG000|Overall Study|Surgery timing|5|||
23570047|NCT02638623|65816672|FG001|Overall Study|Surgery timing|6|||
23570048|NCT02638623|65816671|FG000|Overall Study|Not given intervention|2|||
23570049|NCT02638623|65816672|FG001|Overall Study|Not given intervention|0|||
23570050|NCT02982720|65816673|FG000|Overall Study|Adverse Event|3|||
23570051|NCT02982720|65816673|FG000|Overall Study|Death|1|||
23570052|NCT01556763|65816676|FG000|Overall Study|Withdrawal by Subject|0|||
23570053|NCT01556763|65816677|FG001|Overall Study|Withdrawal by Subject|1|||
23570054|NCT01556763|65816678|FG002|Overall Study|Withdrawal by Subject|0|||
23570055|NCT03358329|65816681|FG000|Overall Study|Lost to Follow-up|2|||
23570056|NCT03358329|65816681|FG000|Overall Study|Withdrawal by Subject|2|||
23570057|NCT00453102|65816687|FG000|Overall Study|Withdrawal by Subject|2|||
23570058|NCT03580356|65816688|FG000|Treatment Period|Withdrawal by Subject|13|||
23570059|NCT03580356|65816689|FG001|Treatment Period|Withdrawal by Subject|0|||
23570060|NCT03580356|65816690|FG002|Treatment Period|Withdrawal by Subject|13|||
23570061|NCT03580356|65816691|FG003|Treatment Period|Withdrawal by Subject|1|||
23446892|NCT00773513|65377771|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
23446893|NCT00773513|65377770|FG000|Overall Study|Failure to Return|22|||
23446894|NCT00773513|65377771|FG001|Overall Study|Failure to Return|8|||
23570062|NCT03580356|65816692|FG004|Treatment Period|Withdrawal by Subject|17|||
23570063|NCT03580356|65816693|FG005|Treatment Period|Withdrawal by Subject|0|||
23570064|NCT03580356|65816694|FG006|Treatment Period|Withdrawal by Subject|5|||
23570065|NCT03580356|65816695|FG007|Treatment Period|Withdrawal by Subject|0|||
23570066|NCT03580356|65816688|FG000|Treatment Period|Adverse Event|10|||
23570067|NCT03580356|65816689|FG001|Treatment Period|Adverse Event|0|||
23570068|NCT03580356|65816690|FG002|Treatment Period|Adverse Event|13|||
23446895|NCT00773513|65377770|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23446896|NCT00773513|65377771|FG001|Overall Study|Insufficient Therapeutic Response|18|||
23446897|NCT00773513|65377770|FG000|Overall Study|Reason Not Specified|159|||
23446898|NCT00773513|65377771|FG001|Overall Study|Reason Not Specified|126|||
23446899|NCT00773513|65377770|FG000|Overall Study|Death|531|||
23446900|NCT00773513|65377771|FG001|Overall Study|Death|545|||
23446901|NCT01253291|65377772|FG000|Overall Study|Withdrawal by Subject|1|||
23446902|NCT01253291|65377773|FG001|Overall Study|Withdrawal by Subject|1|||
23446903|NCT01253291|65377774|FG002|Overall Study|Withdrawal by Subject|0|||
23446904|NCT01253291|65377775|FG003|Overall Study|Withdrawal by Subject|0|||
23446905|NCT01253291|65377776|FG004|Overall Study|Withdrawal by Subject|0|||
23446906|NCT01253291|65377772|FG000|Overall Study|Adverse Event|0|||
23446907|NCT01253291|65377773|FG001|Overall Study|Adverse Event|1|||
23446908|NCT01253291|65377774|FG002|Overall Study|Adverse Event|0|||
23446909|NCT01253291|65377775|FG003|Overall Study|Adverse Event|0|||
23446910|NCT01253291|65377776|FG004|Overall Study|Adverse Event|0|||
23446911|NCT01253291|65377772|FG000|Overall Study|Lack of Efficacy|1|||
23446912|NCT01253291|65377773|FG001|Overall Study|Lack of Efficacy|0|||
23446913|NCT01253291|65377774|FG002|Overall Study|Lack of Efficacy|0|||
23446914|NCT01253291|65377775|FG003|Overall Study|Lack of Efficacy|0|||
23162514|NCT02431702|64341892|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
23162515|NCT02614859|64341895|FG000|Overall Study|Physician Decision|0|||
23162516|NCT02614859|64341896|FG001|Overall Study|Physician Decision|1|||
23162517|NCT00714285|64341899|FG000|Overall Study|Lost to Follow-up|0|||
23330920|NCT03225105|64952135|FG001|Overall Study|Study termination per Sponsor Decision|0|||
23330921|NCT03225105|64952136|FG002|Overall Study|Study termination per Sponsor Decision|3|||
23330922|NCT03225105|64952137|FG003|Overall Study|Study termination per Sponsor Decision|3|||
23330923|NCT04509076|64952138|FG000|Overall Study|Withdrawal by Subject|1|||
23330924|NCT04509076|64952139|FG001|Overall Study|Withdrawal by Subject|2|||
23330925|NCT04509076|64952138|FG000|Overall Study|Lost to Follow-up|1|||
23330926|NCT04509076|64952139|FG001|Overall Study|Lost to Follow-up|2|||
23330927|NCT00855894|64955278|FG000|Overall Study|Death|31|||
23330928|NCT00855894|64955278|FG000|Overall Study|Patient's decision|1|||
23330929|NCT00855894|64955278|FG000|Overall Study|Disease progression|1|||
23330930|NCT01100086|64955279|FG000|Period 1|Withdrawal by Subject|1|||
23330931|NCT01100086|64955280|FG001|Period 1|Withdrawal by Subject|0|||
23330932|NCT05344560|64955281|FG000|Period 1|Subject out of visit window|1|||
23330933|NCT05344560|64955282|FG001|Period 1|Subject out of visit window|1|||
23330934|NCT05344560|64955281|FG000|Period 2|Covid-19 Related|1|||
23330935|NCT05344560|64955282|FG001|Period 2|Covid-19 Related|0|||
23330936|NCT05344560|64955281|FG000|Period 2|Adverse Event|1|||
23330937|NCT05344560|64955282|FG001|Period 2|Adverse Event|0|||
23330938|NCT05344560|64955281|FG000|Period 2|Subject out of visit window|1|||
23330939|NCT05344560|64955282|FG001|Period 2|Subject out of visit window|1|||
23330940|NCT05344560|64955281|FG000|Period 3|Subject out of visit window|1|||
23330941|NCT05344560|64955282|FG001|Period 3|Subject out of visit window|0|||
23330942|NCT00984542|64955284|FG000|Overall Study|disease progression|19|||
23330943|NCT00984542|64955284|FG000|Overall Study|toxicity|7|||
23330944|NCT00984542|64955284|FG000|Overall Study|Death|7|||
23330945|NCT00984542|64955284|FG000|Overall Study|complicating disease|3|||
23330946|NCT00984542|64955284|FG000|Overall Study|Withdrawal by Subject|3|||
23330947|NCT00984542|64955284|FG000|Overall Study|clinical deterioration|2|||
23330948|NCT03319732|64955285|FG000|Overall Study|Adverse Event|40|||
23330949|NCT03319732|64955285|FG000|Overall Study|Withdrawal by Subject|50|||
23330950|NCT03319732|64955285|FG000|Overall Study|MS relapse|10|||
23330951|NCT03319732|64955285|FG000|Overall Study|reason not specified|5|||
23330952|NCT00628212|64955286|FG000|Overall Study|Adverse Event|2|||
23330953|NCT00628212|64955287|FG001|Overall Study|Adverse Event|0|||
23330954|NCT00628212|64955288|FG002|Overall Study|Adverse Event|1|||
23330955|NCT00628212|64955289|FG003|Overall Study|Adverse Event|2|||
23330956|NCT00628212|64955286|FG000|Overall Study|Physician Decision|1|||
23330957|NCT00628212|64955287|FG001|Overall Study|Physician Decision|1|||
23330958|NCT00628212|64955288|FG002|Overall Study|Physician Decision|2|||
23330959|NCT00628212|64955289|FG003|Overall Study|Physician Decision|3|||
23446915|NCT01253291|65377776|FG004|Overall Study|Lack of Efficacy|0|||
23162518|NCT00714285|64341900|FG001|Overall Study|Lost to Follow-up|2|||
23330960|NCT02626026|64955290|FG000|Overall Study|Randomized but Never Treated|0|||
23330961|NCT02626026|64955291|FG001|Overall Study|Randomized but Never Treated|0|||
23330962|NCT02626026|64955292|FG002|Overall Study|Randomized but Never Treated|0|||
23330963|NCT02626026|64955293|FG003|Overall Study|Randomized but Never Treated|0|||
23330964|NCT02626026|64955294|FG004|Overall Study|Randomized but Never Treated|1|||
23330965|NCT02626026|64955295|FG005|Overall Study|Randomized but Never Treated|0|||
23330966|NCT04176250|64955296|FG000|Overall Study|Adverse Event|0|||
23330967|NCT04176250|64955297|FG001|Overall Study|Adverse Event|1|||
23330968|NCT04176250|64955298|FG002|Overall Study|Adverse Event|0|||
23330969|NCT04176250|64955299|FG003|Overall Study|Adverse Event|1|||
23330970|NCT04176250|64955300|FG004|Overall Study|Adverse Event|0|||
23330971|NCT04176250|64955301|FG005|Overall Study|Adverse Event|1|||
23330972|NCT04176250|64955296|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
23330973|NCT04176250|64955297|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
23330974|NCT04176250|64955298|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
23162519|NCT00714285|64341901|FG002|Overall Study|Lost to Follow-up|0|||
23330975|NCT04176250|64955299|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
23570069|NCT03580356|65816691|FG003|Treatment Period|Adverse Event|0|||
23570070|NCT03580356|65816692|FG004|Treatment Period|Adverse Event|5|||
23570071|NCT03580356|65816693|FG005|Treatment Period|Adverse Event|0|||
23570072|NCT03580356|65816694|FG006|Treatment Period|Adverse Event|8|||
23570073|NCT03580356|65816695|FG007|Treatment Period|Adverse Event|0|||
23570074|NCT03580356|65816688|FG000|Treatment Period|Protocol Violation|5|||
23570075|NCT03580356|65816689|FG001|Treatment Period|Protocol Violation|0|||
23570076|NCT03580356|65816690|FG002|Treatment Period|Protocol Violation|6|||
23570077|NCT03580356|65816691|FG003|Treatment Period|Protocol Violation|1|||
23570078|NCT03580356|65816692|FG004|Treatment Period|Protocol Violation|9|||
23570079|NCT03580356|65816693|FG005|Treatment Period|Protocol Violation|1|||
23570080|NCT03580356|65816694|FG006|Treatment Period|Protocol Violation|1|||
23570081|NCT03580356|65816695|FG007|Treatment Period|Protocol Violation|0|||
23330976|NCT04176250|64955300|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
23330977|NCT04176250|64955301|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
23330978|NCT04176250|64955296|FG000|Overall Study|Withdrawal by Subject|0|||
23330979|NCT04176250|64955297|FG001|Overall Study|Withdrawal by Subject|0|||
23570082|NCT03580356|65816688|FG000|Treatment Period|Lack of Efficacy|6|||
23570083|NCT03580356|65816689|FG001|Treatment Period|Lack of Efficacy|0|||
23570084|NCT03580356|65816690|FG002|Treatment Period|Lack of Efficacy|2|||
23570085|NCT03580356|65816691|FG003|Treatment Period|Lack of Efficacy|0|||
23570086|NCT03580356|65816692|FG004|Treatment Period|Lack of Efficacy|3|||
23570087|NCT03580356|65816693|FG005|Treatment Period|Lack of Efficacy|0|||
23570088|NCT03580356|65816694|FG006|Treatment Period|Lack of Efficacy|3|||
23162520|NCT00714285|64341902|FG003|Overall Study|Lost to Follow-up|1|||
23330980|NCT04176250|64955298|FG002|Overall Study|Withdrawal by Subject|0|||
23330981|NCT04176250|64955299|FG003|Overall Study|Withdrawal by Subject|0|||
23330982|NCT04176250|64955300|FG004|Overall Study|Withdrawal by Subject|0|||
23330983|NCT04176250|64955301|FG005|Overall Study|Withdrawal by Subject|1|||
23330984|NCT04176250|64955296|FG000|Overall Study|Randomized in error|0|||
23330985|NCT04176250|64955297|FG001|Overall Study|Randomized in error|0|||
23330986|NCT04176250|64955298|FG002|Overall Study|Randomized in error|0|||
23330987|NCT04176250|64955299|FG003|Overall Study|Randomized in error|0|||
23330988|NCT04176250|64955300|FG004|Overall Study|Randomized in error|1|||
23330989|NCT04176250|64955301|FG005|Overall Study|Randomized in error|0|||
23330990|NCT01776840|64955303|FG000|Overall Study|Lost to Follow-up|4|||
23330991|NCT01776840|64955304|FG001|Overall Study|Lost to Follow-up|4|||
23330992|NCT01776840|64955303|FG000|Overall Study|Withdrawal by Subject|42|||
23330993|NCT01776840|64955304|FG001|Overall Study|Withdrawal by Subject|22|||
23330994|NCT01776840|64955303|FG000|Overall Study|Ongoing|112|||
23330995|NCT01776840|64955304|FG001|Overall Study|Ongoing|129|||
23330996|NCT04938180|64955305|FG000|Overall Study|Adverse Event|1|||
23330997|NCT00523848|64955306|FG000|Overall Study|Adverse Event|11|||
23570089|NCT03580356|65816695|FG007|Treatment Period|Lack of Efficacy|0|||
23570090|NCT03580356|65816688|FG000|Treatment Period|Pregnancy|1|||
23570091|NCT03580356|65816689|FG001|Treatment Period|Pregnancy|0|||
23570092|NCT03580356|65816690|FG002|Treatment Period|Pregnancy|7|||
23162521|NCT00714285|64341899|FG000|Overall Study|Migrated/moved from study area|0|||
23330998|NCT00523848|64955306|FG000|Overall Study|Withdrawal by Subject|2|||
23330999|NCT00523848|64955306|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
23331000|NCT00523848|64955306|FG000|Overall Study|Disease Progression|5|||
23331001|NCT00523848|64955306|FG000|Overall Study|Other, unspecified|4|||
23570093|NCT03580356|65816691|FG003|Treatment Period|Pregnancy|0|||
23570094|NCT03580356|65816692|FG004|Treatment Period|Pregnancy|2|||
23570095|NCT03580356|65816693|FG005|Treatment Period|Pregnancy|0|||
23570096|NCT03580356|65816694|FG006|Treatment Period|Pregnancy|1|||
23570097|NCT03580356|65816695|FG007|Treatment Period|Pregnancy|0|||
23570098|NCT03580356|65816688|FG000|Treatment Period|Physician Decision|2|||
23570099|NCT03580356|65816689|FG001|Treatment Period|Physician Decision|0|||
23570100|NCT03580356|65816690|FG002|Treatment Period|Physician Decision|1|||
23570101|NCT03580356|65816691|FG003|Treatment Period|Physician Decision|0|||
23570102|NCT03580356|65816692|FG004|Treatment Period|Physician Decision|4|||
23570103|NCT03580356|65816693|FG005|Treatment Period|Physician Decision|0|||
23570104|NCT03580356|65816694|FG006|Treatment Period|Physician Decision|2|||
23570105|NCT03580356|65816695|FG007|Treatment Period|Physician Decision|0|||
23570106|NCT03580356|65816688|FG000|Treatment Period|Lost to Follow-up|1|||
23570107|NCT03580356|65816689|FG001|Treatment Period|Lost to Follow-up|1|||
23570108|NCT03580356|65816690|FG002|Treatment Period|Lost to Follow-up|1|||
23570109|NCT03580356|65816691|FG003|Treatment Period|Lost to Follow-up|0|||
23570110|NCT03580356|65816692|FG004|Treatment Period|Lost to Follow-up|3|||
23570111|NCT03580356|65816693|FG005|Treatment Period|Lost to Follow-up|0|||
23570112|NCT03580356|65816694|FG006|Treatment Period|Lost to Follow-up|1|||
23570113|NCT03580356|65816695|FG007|Treatment Period|Lost to Follow-up|0|||
23570114|NCT03580356|65816688|FG000|Treatment Period|Death|0|||
23570115|NCT03580356|65816689|FG001|Treatment Period|Death|0|||
23570116|NCT03580356|65816690|FG002|Treatment Period|Death|1|||
23570117|NCT03580356|65816691|FG003|Treatment Period|Death|0|||
23570118|NCT03580356|65816692|FG004|Treatment Period|Death|0|||
23570119|NCT03580356|65816693|FG005|Treatment Period|Death|0|||
23570120|NCT03580356|65816694|FG006|Treatment Period|Death|0|||
23570121|NCT03580356|65816695|FG007|Treatment Period|Death|0|||
23446916|NCT01253291|65377772|FG000|Overall Study|Physician Decision|2|||
23570122|NCT03580356|65816688|FG000|Treatment Period|Technical problems|0|||
23570123|NCT03580356|65816689|FG001|Treatment Period|Technical problems|0|||
23570124|NCT03580356|65816690|FG002|Treatment Period|Technical problems|0|||
23570125|NCT03580356|65816691|FG003|Treatment Period|Technical problems|0|||
23570126|NCT03580356|65816692|FG004|Treatment Period|Technical problems|1|||
23570127|NCT03580356|65816693|FG005|Treatment Period|Technical problems|0|||
23162522|NCT00714285|64341900|FG001|Overall Study|Migrated/moved from study area|1|||
23162523|NCT00714285|64341901|FG002|Overall Study|Migrated/moved from study area|0|||
23162524|NCT00714285|64341902|FG003|Overall Study|Migrated/moved from study area|0|||
23162525|NCT01692275|64341905|FG000|Overall Study|Lost to Follow-up|57|||
23162526|NCT01692275|64341906|FG001|Overall Study|Lost to Follow-up|48|||
23162527|NCT01692275|64341905|FG000|Overall Study|Withdrawal by Subject|9|||
23162528|NCT01692275|64341906|FG001|Overall Study|Withdrawal by Subject|11|||
23162529|NCT02016820|64341910|FG000|Overall Study|Lost to Follow-up|2|||
23162530|NCT02016820|64341911|FG001|Overall Study|Lost to Follow-up|4|||
23446917|NCT01253291|65377773|FG001|Overall Study|Physician Decision|0|||
23446918|NCT01253291|65377774|FG002|Overall Study|Physician Decision|0|||
23446919|NCT01253291|65377775|FG003|Overall Study|Physician Decision|0|||
23446920|NCT01253291|65377776|FG004|Overall Study|Physician Decision|2|||
23446921|NCT01362608|65377779|FG000|Overall Study|Protocol Violation|0|||
23162531|NCT00574288|64341912|FG000|Overall Study|Adverse Event|2|||
23162532|NCT00574288|64341913|FG001|Overall Study|Adverse Event|0|||
23162533|NCT00574288|64341914|FG002|Overall Study|Adverse Event|0|||
23331002|NCT00078767|64955307|FG000|Overall Study|Withdrawal by Subject|1|||
23331003|NCT00078767|64955308|FG001|Overall Study|Withdrawal by Subject|1|||
23331004|NCT02968173|64955316|FG000|Overall Study|Withdrawal by Subject|1|||
23331005|NCT00757042|64955317|FG000|Overall Study|Lost to Follow-up|0|||
23446922|NCT01362608|65377780|FG001|Overall Study|Protocol Violation|1|||
23446923|NCT01362608|65377779|FG000|Overall Study|Lost to Follow-up|3|||
23162534|NCT00574288|64341915|FG003|Overall Study|Adverse Event|0|||
23162535|NCT00574288|64341916|FG004|Overall Study|Adverse Event|1|||
23162536|NCT00574288|64341917|FG005|Overall Study|Adverse Event|0|||
23162537|NCT00574288|64341918|FG006|Overall Study|Adverse Event|0|||
23162538|NCT00574288|64341912|FG000|Overall Study|Death|0|||
23162539|NCT00574288|64341913|FG001|Overall Study|Death|0|||
23162540|NCT00574288|64341914|FG002|Overall Study|Death|0|||
23162541|NCT00574288|64341915|FG003|Overall Study|Death|0|||
23162542|NCT00574288|64341916|FG004|Overall Study|Death|0|||
23162543|NCT00574288|64341917|FG005|Overall Study|Death|25|||
23162544|NCT00574288|64341918|FG006|Overall Study|Death|21|||
23162545|NCT00574288|64341912|FG000|Overall Study|Lost to Follow-up|0|||
23162546|NCT00574288|64341913|FG001|Overall Study|Lost to Follow-up|0|||
23162547|NCT00574288|64341914|FG002|Overall Study|Lost to Follow-up|0|||
23446924|NCT01362608|65377780|FG001|Overall Study|Lost to Follow-up|1|||
23446925|NCT01362608|65377779|FG000|Overall Study|Withdrawal by Subject|1|||
23446926|NCT01362608|65377780|FG001|Overall Study|Withdrawal by Subject|2|||
23446927|NCT01362608|65377779|FG000|Overall Study|Lack of Efficacy|0|||
23570128|NCT03580356|65816694|FG006|Treatment Period|Technical problems|0|||
23570129|NCT03580356|65816695|FG007|Treatment Period|Technical problems|0|||
23570130|NCT03580356|65816688|FG000|Treatment Period|Misrandomized, no treatment|0|||
23570131|NCT03580356|65816689|FG001|Treatment Period|Misrandomized, no treatment|0|||
23570132|NCT03580356|65816690|FG002|Treatment Period|Misrandomized, no treatment|1|||
23570133|NCT03580356|65816691|FG003|Treatment Period|Misrandomized, no treatment|0|||
23570134|NCT03580356|65816692|FG004|Treatment Period|Misrandomized, no treatment|2|||
23570135|NCT03580356|65816693|FG005|Treatment Period|Misrandomized, no treatment|0|||
23570136|NCT03580356|65816694|FG006|Treatment Period|Misrandomized, no treatment|0|||
23570137|NCT03580356|65816695|FG007|Treatment Period|Misrandomized, no treatment|0|||
23570138|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
23570139|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
23162548|NCT00574288|64341915|FG003|Overall Study|Lost to Follow-up|0|||
23162549|NCT00574288|64341916|FG004|Overall Study|Lost to Follow-up|0|||
23162550|NCT00574288|64341917|FG005|Overall Study|Lost to Follow-up|1|||
23162551|NCT00574288|64341918|FG006|Overall Study|Lost to Follow-up|2|||
23162552|NCT00574288|64341912|FG000|Overall Study|Study Terminated By Sponsor|0|||
23162553|NCT00574288|64341913|FG001|Overall Study|Study Terminated By Sponsor|0|||
23331006|NCT00757042|64955318|FG001|Overall Study|Lost to Follow-up|0|||
23446928|NCT01362608|65377780|FG001|Overall Study|Lack of Efficacy|2|||
23162554|NCT00574288|64341914|FG002|Overall Study|Study Terminated By Sponsor|0|||
23570140|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
23570141|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
23223873|NCT04921969|64563911|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
23223874|NCT04921969|64563905|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23223875|NCT04921969|64563906|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23223876|NCT04921969|64563907|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23223877|NCT04921969|64563908|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
23223878|NCT04921969|64563909|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23223879|NCT04921969|64563910|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23223880|NCT04921969|64563911|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
23223881|NCT04921969|64563905|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23223882|NCT04921969|64563906|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23223883|NCT04921969|64563907|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23223884|NCT04921969|64563908|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23223885|NCT04921969|64563909|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
23223886|NCT04921969|64563910|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|1|||
23223887|NCT04921969|64563911|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|2|||
23223888|NCT04921969|64563905|FG000|LTS Period (Weeks 8 to 52)|Ongoing|0|||
23223889|NCT04921969|64563906|FG001|LTS Period (Weeks 8 to 52)|Ongoing|0|||
23223890|NCT04921969|64563907|FG002|LTS Period (Weeks 8 to 52)|Ongoing|0|||
23223891|NCT04921969|64563908|FG003|LTS Period (Weeks 8 to 52)|Ongoing|14|||
23223892|NCT04921969|64563909|FG004|LTS Period (Weeks 8 to 52)|Ongoing|12|||
23223893|NCT04921969|64563910|FG005|LTS Period (Weeks 8 to 52)|Ongoing|55|||
23223894|NCT04921969|64563911|FG006|LTS Period (Weeks 8 to 52)|Ongoing|54|||
23223895|NCT01756833|64563912|FG000|Overall Study|Withdrawal by Subject|4|||
23446929|NCT01362608|65377779|FG000|Overall Study|Adverse Event|0|||
23570142|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
23570143|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
23570144|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
23570145|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
23570146|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
23570147|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570148|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
23570149|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570150|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
23570151|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570152|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570153|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
23570154|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
23570155|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
23570156|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
23570157|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
23570158|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
23570159|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
23570160|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
23570161|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
23570162|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570163|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570164|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
23570165|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570166|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
23570167|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23223896|NCT01756833|64563913|FG001|Overall Study|Withdrawal by Subject|3|||
23223897|NCT01387074|64563923|FG000|Overall Study|Lost to Follow-up|7|||
23570168|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570169|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
23570170|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
23570171|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
23570172|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
23570173|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
23570174|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
23570175|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
23570176|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
23570177|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
23570178|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
23570179|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
23570180|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
23570181|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
23570182|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
23570183|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
23570184|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
23570185|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
23570186|NCT03580356|65816688|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
23570187|NCT03580356|65816689|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
23570188|NCT03580356|65816690|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
23570189|NCT03580356|65816691|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
23570190|NCT03580356|65816692|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
23570191|NCT03580356|65816693|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
23331007|NCT00757042|64955319|FG002|Overall Study|Lost to Follow-up|0|||
23331008|NCT00757042|64955320|FG003|Overall Study|Lost to Follow-up|0|||
23331009|NCT00757042|64955321|FG004|Overall Study|Lost to Follow-up|0|||
23331010|NCT00757042|64955322|FG005|Overall Study|Lost to Follow-up|0|||
23331011|NCT00757042|64955323|FG006|Overall Study|Lost to Follow-up|0|||
23331012|NCT00757042|64955324|FG007|Overall Study|Lost to Follow-up|0|||
23331013|NCT00757042|64955325|FG008|Overall Study|Lost to Follow-up|1|||
23331014|NCT00757042|64955326|FG009|Overall Study|Lost to Follow-up|0|||
23331015|NCT00757042|64955327|FG010|Overall Study|Lost to Follow-up|0|||
23331016|NCT00757042|64955317|FG000|Overall Study|Ineligibility Determined|0|||
23331017|NCT00757042|64955318|FG001|Overall Study|Ineligibility Determined|0|||
23162555|NCT00574288|64341915|FG003|Overall Study|Study Terminated By Sponsor|0|||
23162556|NCT00574288|64341916|FG004|Overall Study|Study Terminated By Sponsor|0|||
23162557|NCT00574288|64341917|FG005|Overall Study|Study Terminated By Sponsor|0|||
23162558|NCT00574288|64341918|FG006|Overall Study|Study Terminated By Sponsor|5|||
23162559|NCT00574288|64341912|FG000|Overall Study|Progressive Disease|17|||
23162560|NCT00574288|64341913|FG001|Overall Study|Progressive Disease|2|||
23162561|NCT00574288|64341914|FG002|Overall Study|Progressive Disease|3|||
23162562|NCT00574288|64341915|FG003|Overall Study|Progressive Disease|2|||
23162563|NCT00574288|64341916|FG004|Overall Study|Progressive Disease|1|||
23162564|NCT00574288|64341917|FG005|Overall Study|Progressive Disease|0|||
23162565|NCT00574288|64341918|FG006|Overall Study|Progressive Disease|0|||
23162566|NCT00574288|64341912|FG000|Overall Study|Other|1|||
23162567|NCT00574288|64341913|FG001|Overall Study|Other|1|||
23162568|NCT00574288|64341914|FG002|Overall Study|Other|0|||
23162569|NCT00574288|64341915|FG003|Overall Study|Other|0|||
23162570|NCT00574288|64341916|FG004|Overall Study|Other|0|||
23570192|NCT03580356|65816694|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
23162571|NCT00574288|64341917|FG005|Overall Study|Other|0|||
23162572|NCT00574288|64341918|FG006|Overall Study|Other|0|||
23162573|NCT02463409|64341929|FG000|Overall Study|Withdrawal by Subject|1|||
23162574|NCT02463409|64341929|FG000|Overall Study|Screen failure|1|||
23162575|NCT02287623|64341930|FG000|Overall Study|Protocol Violation|0|||
23331018|NCT00757042|64955319|FG002|Overall Study|Ineligibility Determined|0|||
23331019|NCT00757042|64955320|FG003|Overall Study|Ineligibility Determined|0|||
23331020|NCT00757042|64955321|FG004|Overall Study|Ineligibility Determined|0|||
23331021|NCT00757042|64955322|FG005|Overall Study|Ineligibility Determined|0|||
23162576|NCT02287623|64341931|FG001|Overall Study|Protocol Violation|1|||
23162577|NCT04013529|64341932|FG000|Overall Study|Withdrawal by Subject|1|||
23162578|NCT04013529|64341933|FG001|Overall Study|Withdrawal by Subject|1|||
23162579|NCT03317795|64341934|FG000|Overall Study|IUD Expulsion|1|||
23162580|NCT03317795|64341935|FG001|Overall Study|IUD Expulsion|0|||
23162581|NCT03317795|64341934|FG000|Overall Study|Lost to Follow-up|1|||
23162582|NCT03317795|64341935|FG001|Overall Study|Lost to Follow-up|3|||
23331022|NCT00757042|64955323|FG006|Overall Study|Ineligibility Determined|0|||
23331023|NCT00757042|64955324|FG007|Overall Study|Ineligibility Determined|0|||
23331024|NCT00757042|64955325|FG008|Overall Study|Ineligibility Determined|0|||
23331025|NCT00757042|64955326|FG009|Overall Study|Ineligibility Determined|0|||
23331026|NCT00757042|64955327|FG010|Overall Study|Ineligibility Determined|1|||
23331027|NCT00757042|64955317|FG000|Overall Study|Withdrawal by Subject|0|||
23331028|NCT00757042|64955318|FG001|Overall Study|Withdrawal by Subject|0|||
23331029|NCT00757042|64955319|FG002|Overall Study|Withdrawal by Subject|0|||
23331030|NCT00757042|64955320|FG003|Overall Study|Withdrawal by Subject|0|||
23331031|NCT00757042|64955321|FG004|Overall Study|Withdrawal by Subject|0|||
23331032|NCT00757042|64955322|FG005|Overall Study|Withdrawal by Subject|0|||
23570193|NCT03580356|65816695|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
23570194|NCT02036515|65816701|FG000|Overall Study|Adverse Event|1|||
23570195|NCT02036515|65816702|FG001|Overall Study|Adverse Event|1|||
23570196|NCT02036515|65816703|FG002|Overall Study|Adverse Event|2|||
23570197|NCT02036515|65816701|FG000|Overall Study|Lost to Follow-up|0|||
23570198|NCT02036515|65816702|FG001|Overall Study|Lost to Follow-up|2|||
23570199|NCT02036515|65816703|FG002|Overall Study|Lost to Follow-up|0|||
23570200|NCT02036515|65816701|FG000|Overall Study|Non-compliance with study drug|0|||
23570201|NCT02036515|65816702|FG001|Overall Study|Non-compliance with study drug|0|||
23570202|NCT02036515|65816703|FG002|Overall Study|Non-compliance with study drug|2|||
23570203|NCT02036515|65816701|FG000|Overall Study|Screen failure|0|||
23570204|NCT02036515|65816702|FG001|Overall Study|Screen failure|2|||
23162583|NCT03317795|64341934|FG000|Overall Study|Treatment change|0|||
23162584|NCT03317795|64341935|FG001|Overall Study|Treatment change|3|||
23162585|NCT03317795|64341934|FG000|Overall Study|Intolerance of medication|0|||
23162586|NCT03317795|64341935|FG001|Overall Study|Intolerance of medication|1|||
23162587|NCT03923426|64344917|FG000|Overall Study|Other|19|||
23162588|NCT03923426|64344917|FG000|Overall Study|Lost to Follow-up|16|||
23162589|NCT03923426|64344917|FG000|Overall Study|Death|107|||
23162590|NCT03923426|64344917|FG000|Overall Study|Incomplete response to question|13|||
23162591|NCT00606320|64344918|FG000|Overall Study|Adverse Event|3|||
23162592|NCT00606320|64344918|FG000|Overall Study|Lack of Efficacy|5|||
23162593|NCT00606320|64344918|FG000|Overall Study|Physician Decision|7|||
23162594|NCT00606320|64344918|FG000|Overall Study|Protocol Violation|8|||
23162595|NCT00606320|64344918|FG000|Overall Study|Withdrawal by Subject|10|||
23162596|NCT00606320|64344918|FG000|Overall Study|Progression to depressive phase|4|||
23162597|NCT02484911|64344919|FG000|Overall Study|Withdrawal by Subject|2|||
23162598|NCT02484911|64344920|FG001|Overall Study|Withdrawal by Subject|1|||
23162599|NCT02484911|64344919|FG000|Overall Study|Protocol Violation|2|||
23331033|NCT00757042|64955323|FG006|Overall Study|Withdrawal by Subject|0|||
23331034|NCT00757042|64955324|FG007|Overall Study|Withdrawal by Subject|0|||
23331035|NCT00757042|64955325|FG008|Overall Study|Withdrawal by Subject|0|||
23331036|NCT00757042|64955326|FG009|Overall Study|Withdrawal by Subject|1|||
23331037|NCT00757042|64955327|FG010|Overall Study|Withdrawal by Subject|0|||
23331038|NCT05027451|64955329|FG000|Overall Study|Lost to Follow-up|1|||
23331039|NCT05027451|64955330|FG001|Overall Study|Lost to Follow-up|1|||
23331040|NCT04075682|64955333|FG000|Overall Study|Lost to Follow-up|5|||
23331041|NCT04075682|64955334|FG001|Overall Study|Lost to Follow-up|5|||
23331042|NCT04075682|64955335|FG002|Overall Study|Lost to Follow-up|2|||
23331043|NCT04075682|64955336|FG003|Overall Study|Lost to Follow-up|2|||
23331044|NCT04075682|64955333|FG000|Overall Study|Withdrawal by Subject|1|||
23570205|NCT02036515|65816703|FG002|Overall Study|Screen failure|0|||
23570206|NCT02036515|65816701|FG000|Overall Study|Withdrawal by Subject|4|||
23162600|NCT02484911|64344920|FG001|Overall Study|Protocol Violation|1|||
23162601|NCT00357500|64344921|FG000|Overall Study|Adverse Event|3|||
23162602|NCT00357500|64344921|FG000|Overall Study|Withdrawal by Subject|5|||
23162603|NCT00357500|64344921|FG000|Overall Study|Progressive Disease|65|||
23331045|NCT04075682|64955334|FG001|Overall Study|Withdrawal by Subject|0|||
23331046|NCT04075682|64955335|FG002|Overall Study|Withdrawal by Subject|1|||
23331047|NCT04075682|64955336|FG003|Overall Study|Withdrawal by Subject|0|||
23331048|NCT04075682|64955333|FG000|Overall Study|Protocol Violation|0|||
23331049|NCT04075682|64955334|FG001|Overall Study|Protocol Violation|1|||
23570207|NCT02036515|65816702|FG001|Overall Study|Withdrawal by Subject|7|||
23570208|NCT02036515|65816703|FG002|Overall Study|Withdrawal by Subject|9|||
23570209|NCT02036515|65816701|FG000|Overall Study|Hyperglycemia|0|||
23570210|NCT02036515|65816702|FG001|Overall Study|Hyperglycemia|0|||
23570211|NCT02036515|65816703|FG002|Overall Study|Hyperglycemia|1|||
23570212|NCT02440594|65816704|FG000|Overall Study|Lost to Follow-up|34|||
23570213|NCT02440594|65816705|FG001|Overall Study|Lost to Follow-up|33|||
23331050|NCT04075682|64955335|FG002|Overall Study|Protocol Violation|1|||
23331051|NCT04075682|64955336|FG003|Overall Study|Protocol Violation|0|||
23331052|NCT04075682|64955333|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
23331053|NCT04075682|64955334|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
23331054|NCT04075682|64955335|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
23331055|NCT04075682|64955336|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
23331056|NCT04075682|64955333|FG000|Overall Study|Lost study phone the first day of study participation|0|||
23331057|NCT04075682|64955334|FG001|Overall Study|Lost study phone the first day of study participation|1|||
23570214|NCT02440594|65816706|FG002|Overall Study|Lost to Follow-up|54|||
23570215|NCT02440594|65816707|FG003|Overall Study|Lost to Follow-up|47|||
23162604|NCT00357500|64344921|FG000|Overall Study|Not Started Protocol Therapy|4|||
23162605|NCT00825162|64344922|FG000|Overall Study|Withdrawal by Subject|11|||
23162606|NCT00825162|64344923|FG001|Overall Study|Withdrawal by Subject|13|||
23162607|NCT00825162|64344924|FG002|Overall Study|Withdrawal by Subject|3|||
23162608|NCT00825162|64344922|FG000|Overall Study|Lost to Follow-up|9|||
23162609|NCT00825162|64344923|FG001|Overall Study|Lost to Follow-up|6|||
23162610|NCT00825162|64344924|FG002|Overall Study|Lost to Follow-up|3|||
23162611|NCT00825162|64344922|FG000|Overall Study|Physician Decision|2|||
23162612|NCT00825162|64344923|FG001|Overall Study|Physician Decision|0|||
23162613|NCT00825162|64344924|FG002|Overall Study|Physician Decision|0|||
23162614|NCT00825162|64344922|FG000|Overall Study|Move away from the study area|1|||
23162615|NCT00825162|64344923|FG001|Overall Study|Move away from the study area|0|||
23162616|NCT00825162|64344924|FG002|Overall Study|Move away from the study area|0|||
23162617|NCT00825162|64344922|FG000|Overall Study|Unable to attend the study visit|5|||
23162618|NCT00825162|64344923|FG001|Overall Study|Unable to attend the study visit|2|||
23162619|NCT00825162|64344924|FG002|Overall Study|Unable to attend the study visit|0|||
23162620|NCT01118351|64344929|FG000|Overall Study|Adverse Event|3|||
23162621|NCT01118351|64344929|FG000|Overall Study|Withdrawal by Subject|1|||
23162622|NCT04317274|64344934|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
23162623|NCT04317274|64344935|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
23162624|NCT04317274|64344936|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
23162625|NCT04317274|64344937|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
23162626|NCT04839380|64344938|FG000|Overall Study|Withdrawal by Subject|2|||
23162627|NCT04839380|64344938|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
23570216|NCT02440594|65816708|FG004|Overall Study|Lost to Follow-up|5|||
23570217|NCT02440594|65816709|FG005|Overall Study|Lost to Follow-up|4|||
23570218|NCT02440594|65816710|FG006|Overall Study|Lost to Follow-up|28|||
23570219|NCT02440594|65816711|FG007|Overall Study|Lost to Follow-up|48|||
23162628|NCT01183143|64344942|FG000|Overall Study|Protocol Violation|115|||
23162629|NCT01183143|64344942|FG000|Overall Study|Withdrawal by Subject|19|||
23162630|NCT01183143|64344942|FG000|Overall Study|Subject Questionnaires not returned|5|||
23162631|NCT01183143|64344942|FG000|Overall Study|Subjects enrolled, but not treated|11|||
23162632|NCT01650636|64344946|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
23162633|NCT01650636|64344947|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
23162634|NCT01650636|64344946|FG000|Washout up to 5 Months|Physician Decision|2|||
23162635|NCT01650636|64344947|FG001|Washout up to 5 Months|Physician Decision|2|||
23162636|NCT01650636|64344946|FG000|Washout up to 5 Months|Death|1|||
23331058|NCT04075682|64955335|FG002|Overall Study|Lost study phone the first day of study participation|0|||
23331059|NCT04075682|64955336|FG003|Overall Study|Lost study phone the first day of study participation|0|||
23331060|NCT00684411|64955337|FG000|Overall Study|New Primary Cancer|1|||
23331061|NCT00684411|64955337|FG000|Overall Study|Disease Progression|10|||
23331062|NCT00684411|64955337|FG000|Overall Study|Adverse Event|1|||
23331063|NCT00777296|64955338|FG000|Overall Study|Adverse Event|0|||
23331064|NCT00777296|64955339|FG001|Overall Study|Adverse Event|1|||
23570220|NCT02440594|65816704|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
23570221|NCT02440594|65816705|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
23570222|NCT02440594|65816706|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
23570223|NCT02440594|65816707|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
23162637|NCT01650636|64344947|FG001|Washout up to 5 Months|Death|0|||
23162638|NCT01650636|64344946|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
23162639|NCT01650636|64344947|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
23162640|NCT01650636|64344946|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
23162641|NCT01650636|64344947|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
23162642|NCT01650636|64344946|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
23331065|NCT00777296|64955340|FG002|Overall Study|Adverse Event|0|||
23331066|NCT00777296|64955341|FG003|Overall Study|Adverse Event|1|||
23570224|NCT02440594|65816708|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
23570225|NCT02440594|65816709|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
23570226|NCT02440594|65816710|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
23570227|NCT02440594|65816711|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
23570228|NCT02440594|65816704|FG000|Overall Study|Withdrawal by Subject|81|||
23570229|NCT02440594|65816705|FG001|Overall Study|Withdrawal by Subject|67|||
23570230|NCT02440594|65816706|FG002|Overall Study|Withdrawal by Subject|59|||
23570231|NCT02440594|65816707|FG003|Overall Study|Withdrawal by Subject|38|||
23570232|NCT02440594|65816708|FG004|Overall Study|Withdrawal by Subject|2|||
23570233|NCT02440594|65816709|FG005|Overall Study|Withdrawal by Subject|2|||
23570234|NCT02440594|65816710|FG006|Overall Study|Withdrawal by Subject|7|||
23570235|NCT02440594|65816711|FG007|Overall Study|Withdrawal by Subject|7|||
23570236|NCT02440594|65816704|FG000|Overall Study|Administratively w/drawn|3|||
23162643|NCT01650636|64344947|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
23162644|NCT01500278|64344948|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
23162645|NCT01500278|64344949|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
23162646|NCT01500278|64344948|FG000|Week 0 - Week 12|Protocol Violation|10|||
23162647|NCT01500278|64344949|FG001|Week 0 - Week 12|Protocol Violation|16|||
23162648|NCT01500278|64344948|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
23162649|NCT01500278|64344949|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
23162650|NCT01500278|64344948|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
23162651|NCT01500278|64344949|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
23162652|NCT01500278|64344948|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
23162653|NCT01500278|64344949|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
23162654|NCT01500278|64344948|FG000|Week 0 - Week 12|Patient decision|1|||
23162655|NCT01500278|64344949|FG001|Week 0 - Week 12|Patient decision|0|||
23162656|NCT01500278|64344948|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
23162657|NCT01500278|64344949|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
23162658|NCT01500278|64344948|FG000|Week 0 - Week 12|Investigator decision|1|||
23162659|NCT01500278|64344949|FG001|Week 0 - Week 12|Investigator decision|0|||
23162660|NCT01500278|64344948|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
23162661|NCT01500278|64344949|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
23162662|NCT01500278|64344948|FG000|Week 0 - Week 12|Sponsor decision|1|||
23162663|NCT01500278|64344949|FG001|Week 0 - Week 12|Sponsor decision|0|||
23162664|NCT01500278|64344948|FG000|Week 0 - Week 12|Personal reason|0|||
23162665|NCT01500278|64344949|FG001|Week 0 - Week 12|Personal reason|1|||
23162666|NCT01500278|64344948|FG000|Week 0 - Week 12|Other serious disease|0|||
23162667|NCT01500278|64344949|FG001|Week 0 - Week 12|Other serious disease|1|||
23162668|NCT01500278|64344948|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
23162669|NCT01500278|64344949|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
23162670|NCT01500278|64344948|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
23162671|NCT01500278|64344949|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
23162672|NCT01500278|64344948|FG000|Week 13 - Week 104|Protocol Violation|6|||
23162673|NCT01500278|64344949|FG001|Week 13 - Week 104|Protocol Violation|6|||
23331067|NCT00777296|64955338|FG000|Overall Study|Withdrawal by Subject|1|||
23331068|NCT00777296|64955339|FG001|Overall Study|Withdrawal by Subject|0|||
23331069|NCT00777296|64955340|FG002|Overall Study|Withdrawal by Subject|0|||
23331070|NCT00777296|64955341|FG003|Overall Study|Withdrawal by Subject|0|||
23331071|NCT00777296|64955338|FG000|Overall Study|CRF form not completed|0|||
23331072|NCT00777296|64955339|FG001|Overall Study|CRF form not completed|0|||
23331073|NCT00777296|64955340|FG002|Overall Study|CRF form not completed|2|||
23331074|NCT00777296|64955341|FG003|Overall Study|CRF form not completed|0|||
23331075|NCT01051960|64955342|FG000|Overall Study|Adverse Event|1|||
23331076|NCT00302328|64955343|FG000|Overall Study|Physician Decision|0|||
23331077|NCT00302328|64955344|FG001|Overall Study|Physician Decision|1|||
23331078|NCT00302328|64955345|FG002|Overall Study|Physician Decision|0|||
23570237|NCT02440594|65816705|FG001|Overall Study|Administratively w/drawn|2|||
23570238|NCT02440594|65816706|FG002|Overall Study|Administratively w/drawn|0|||
23446930|NCT01362608|65377780|FG001|Overall Study|Adverse Event|2|||
23446931|NCT04303572|65377781|FG000|Overall Study|Study closed due to poor enrollment|1|||
23570239|NCT02440594|65816707|FG003|Overall Study|Administratively w/drawn|0|||
23570240|NCT02440594|65816708|FG004|Overall Study|Administratively w/drawn|0|||
23570241|NCT02440594|65816709|FG005|Overall Study|Administratively w/drawn|0|||
23570242|NCT02440594|65816710|FG006|Overall Study|Administratively w/drawn|2|||
23162674|NCT01500278|64344948|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
23162675|NCT01500278|64344949|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
23162676|NCT01500278|64344948|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
23331079|NCT02954601|64955346|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
23162677|NCT01500278|64344949|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
23162678|NCT01500278|64344948|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
23162679|NCT01500278|64344949|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
23162680|NCT01500278|64344948|FG000|Week 13 - Week 104|Non/bad compliance|7|||
23446932|NCT01633541|65377790|FG000|Overall Study|Death|1|||
23331080|NCT02954601|64955347|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
23331081|NCT02954601|64955348|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
23331082|NCT02954601|64955349|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
23331083|NCT00891020|64955350|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
23331084|NCT00891020|64955351|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
23331085|NCT00891020|64955352|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
23331086|NCT00891020|64955350|FG000|24 Week Treatment Period|Death|0|||
23331087|NCT00891020|64955351|FG001|24 Week Treatment Period|Death|2|||
23331088|NCT00891020|64955352|FG002|24 Week Treatment Period|Death|0|||
23331089|NCT00891020|64955350|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
23331090|NCT00891020|64955351|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
23331091|NCT00891020|64955352|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
23331092|NCT00891020|64955350|FG000|24 Week Treatment Period|Failure to return|4|||
23331093|NCT00891020|64955351|FG001|24 Week Treatment Period|Failure to return|5|||
23331094|NCT00891020|64955352|FG002|24 Week Treatment Period|Failure to return|5|||
23331095|NCT00891020|64955350|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
23331096|NCT00891020|64955351|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
23223898|NCT01387074|64563923|FG000|Overall Study|Lack of Efficacy|1|||
23223899|NCT01355497|64563924|FG000|Overall Study|Death|19|||
23223900|NCT01355497|64563925|FG001|Overall Study|Death|18|||
23223901|NCT01355497|64563924|FG000|Overall Study|Lost to Follow-up|3|||
23223902|NCT01355497|64563925|FG001|Overall Study|Lost to Follow-up|0|||
23223903|NCT01355497|64563924|FG000|Overall Study|Protocol Violation|0|||
23223904|NCT01355497|64563925|FG001|Overall Study|Protocol Violation|1|||
23223905|NCT01355497|64563924|FG000|Overall Study|other-not provided|9|||
23223906|NCT01355497|64563925|FG001|Overall Study|other-not provided|4|||
23162681|NCT01500278|64344949|FG001|Week 13 - Week 104|Non/bad compliance|5|||
23162682|NCT01500278|64344948|FG000|Week 13 - Week 104|Recurrent infections|1|||
23162683|NCT01500278|64344949|FG001|Week 13 - Week 104|Recurrent infections|0|||
23162684|NCT01500278|64344948|FG000|Week 13 - Week 104|False positive test|1|||
23162685|NCT01500278|64344949|FG001|Week 13 - Week 104|False positive test|2|||
23162686|NCT01500278|64344948|FG000|Week 13 - Week 104|Sponsor request|4|||
23162687|NCT01500278|64344949|FG001|Week 13 - Week 104|Sponsor request|0|||
23162688|NCT01500278|64344948|FG000|Week 13 - Week 104|Withdrawn in error|1|||
23162689|NCT01500278|64344949|FG001|Week 13 - Week 104|Withdrawn in error|0|||
23162690|NCT01500278|64344948|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
23162691|NCT01500278|64344949|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
23162692|NCT01500278|64344948|FG000|Week 13 - Week 104|Protocol deviation|1|||
23162693|NCT01500278|64344949|FG001|Week 13 - Week 104|Protocol deviation|0|||
23162694|NCT01500278|64344948|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
23162695|NCT01500278|64344949|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
23162696|NCT01500278|64344948|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
23162697|NCT01500278|64344949|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
23162698|NCT01500278|64344948|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
23162699|NCT01500278|64344949|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
23162700|NCT01500278|64344948|FG000|Week 13 - Week 104|Relocation|0|||
23162701|NCT01500278|64344949|FG001|Week 13 - Week 104|Relocation|1|||
23162702|NCT01500278|64344948|FG000|Week 13 - Week 104|Sponsor decision|0|||
23162703|NCT01500278|64344949|FG001|Week 13 - Week 104|Sponsor decision|2|||
23162704|NCT01500278|64344948|FG000|Week 13 - Week 104|Medical monitor decision|0|||
23162705|NCT01500278|64344949|FG001|Week 13 - Week 104|Medical monitor decision|2|||
23162706|NCT01500278|64344948|FG000|Week 13 - Week 104|Personal reason|0|||
23223907|NCT01355497|64563924|FG000|Overall Study|Withdrawal by Subject|12|||
23162707|NCT01500278|64344949|FG001|Week 13 - Week 104|Personal reason|1|||
23162708|NCT01500278|64344948|FG000|Week 13 - Week 104|Not completed|0|||
23162709|NCT01500278|64344949|FG001|Week 13 - Week 104|Not completed|1|||
23162710|NCT01500278|64344948|FG000|Week 13 - Week 104|Death|2|||
23162711|NCT01500278|64344949|FG001|Week 13 - Week 104|Death|4|||
23162712|NCT01500278|64344948|FG000|Week 13 - Week 104|Adverse Event|54|||
23223908|NCT01355497|64563925|FG001|Overall Study|Withdrawal by Subject|20|||
23223909|NCT01355497|64563924|FG000|Overall Study|noncompliance|1|||
23223910|NCT01355497|64563925|FG001|Overall Study|noncompliance|2|||
23223911|NCT01355497|64563924|FG000|Overall Study|progressive disease|11|||
23162713|NCT01500278|64344949|FG001|Week 13 - Week 104|Adverse Event|54|||
23162714|NCT00838331|64344950|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
23162715|NCT00879645|64344953|FG000|Overall Study|Adverse Event|1|||
23162716|NCT00879645|64344954|FG001|Overall Study|Adverse Event|0|||
23162717|NCT00879645|64344955|FG002|Overall Study|Adverse Event|0|||
23162718|NCT00879645|64344956|FG003|Overall Study|Adverse Event|0|||
23162719|NCT00751400|64344959|FG000|Overall Study|Lost to Follow-up|10|||
23162720|NCT02069899|64344960|FG000|Overall Study|Adverse Event|6|||
23162721|NCT02069899|64344961|FG001|Overall Study|Adverse Event|0|||
23162722|NCT02069899|64344962|FG002|Overall Study|Adverse Event|1|||
23162723|NCT02069899|64344960|FG000|Overall Study|Withdrawal by Participant|2|||
23570243|NCT02440594|65816711|FG007|Overall Study|Administratively w/drawn|1|||
23570244|NCT01827254|65816712|FG000|Overall Study|Death|10|||
23570245|NCT01827254|65816712|FG000|Overall Study|Case report form not completed|4|||
23570246|NCT01827254|65816712|FG000|Overall Study|Invalidated centre|3|||
23570247|NCT01827254|65816712|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
23570248|NCT01827254|65816712|FG000|Overall Study|Did not complete re-challenge|1|||
23570249|NCT01827254|65816712|FG000|Overall Study|Disease progression|36|||
23570250|NCT01827254|65816712|FG000|Overall Study|Intolerance to treatment|4|||
23570251|NCT02374593|65816713|FG000|Overall Study|non-compliant|2|||
23570252|NCT02374593|65816714|FG001|Overall Study|non-compliant|0|||
23570253|NCT00663962|65816715|FG000|Overall Study|somnolence|1|||
23570254|NCT00663962|65816716|FG001|Overall Study|somnolence|0|||
23570255|NCT00661258|65816717|FG000|Overall Study|Death|1|||
23570256|NCT00661258|65816718|FG001|Overall Study|Death|0|||
23570257|NCT00661258|65816717|FG000|Overall Study|caught by police and in detox center|2|||
23570258|NCT00661258|65816718|FG001|Overall Study|caught by police and in detox center|1|||
23570259|NCT01000376|65816721|FG000|Cycle 1 Day 1|Adverse Event|1|||
23570260|NCT01000376|65816722|FG001|Cycle 1 Day 1|Adverse Event|0|||
23570261|NCT01000376|65816721|FG000|Cycle 1 Day 1|Progressive Disease|1|||
23570262|NCT01000376|65816722|FG001|Cycle 1 Day 1|Progressive Disease|0|||
23570263|NCT01544582|65816723|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
23570264|NCT01544582|65816724|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
23570265|NCT01544582|65816725|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
23570266|NCT01544582|65816726|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
23570267|NCT01544582|65816723|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
23570268|NCT01544582|65816724|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
23570269|NCT01544582|65816725|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
23570270|NCT01544582|65816726|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
23570271|NCT01544582|65816723|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
23570272|NCT01544582|65816724|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
23570273|NCT01544582|65816725|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
23570274|NCT01544582|65816726|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
23570275|NCT01544582|65816723|FG000|Analysis Population|Physician Decision|0|||
23570276|NCT01544582|65816724|FG001|Analysis Population|Physician Decision|13|||
23570277|NCT01544582|65816725|FG002|Analysis Population|Physician Decision|10|||
23570278|NCT01544582|65816726|FG003|Analysis Population|Physician Decision|9|||
23570279|NCT01544582|65816723|FG000|Analysis Population|Safety Reason|0|||
23570280|NCT01544582|65816724|FG001|Analysis Population|Safety Reason|33|||
23570281|NCT01544582|65816725|FG002|Analysis Population|Safety Reason|31|||
23570282|NCT01544582|65816726|FG003|Analysis Population|Safety Reason|8|||
23570283|NCT01544582|65816723|FG000|Analysis Population|Effectiveness Reason|0|||
23570284|NCT01544582|65816724|FG001|Analysis Population|Effectiveness Reason|48|||
23570285|NCT01544582|65816725|FG002|Analysis Population|Effectiveness Reason|29|||
23570286|NCT01544582|65816726|FG003|Analysis Population|Effectiveness Reason|12|||
23162724|NCT02069899|64344961|FG001|Overall Study|Withdrawal by Participant|0|||
23162725|NCT02069899|64344962|FG002|Overall Study|Withdrawal by Participant|0|||
23223912|NCT01355497|64563925|FG001|Overall Study|progressive disease|8|||
23570287|NCT01544582|65816723|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
23570288|NCT01544582|65816724|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
23570289|NCT01544582|65816725|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
23570290|NCT01544582|65816726|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
23446933|NCT01633541|65377791|FG001|Overall Study|Death|0|||
23446934|NCT02043938|65377804|FG000|Overall Study|Withdrawal by Subject|7|||
23446935|NCT02043938|65377804|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
23570291|NCT01544582|65816723|FG000|Analysis Population|Lost to Follow-up|0|||
23570292|NCT01544582|65816724|FG001|Analysis Population|Lost to Follow-up|6|||
23570293|NCT01544582|65816725|FG002|Analysis Population|Lost to Follow-up|6|||
23570294|NCT01544582|65816726|FG003|Analysis Population|Lost to Follow-up|5|||
23570295|NCT01544582|65816723|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
23570296|NCT01544582|65816724|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
23570297|NCT01544582|65816725|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
23570298|NCT01544582|65816726|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
23570299|NCT01544582|65816723|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
23570300|NCT01544582|65816724|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
23570301|NCT01544582|65816725|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
23570302|NCT01544582|65816726|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
23570303|NCT01544582|65816723|FG000|Analysis Population|Intolerance|0|||
23570304|NCT01544582|65816724|FG001|Analysis Population|Intolerance|1|||
23570305|NCT01544582|65816725|FG002|Analysis Population|Intolerance|0|||
23570306|NCT01544582|65816726|FG003|Analysis Population|Intolerance|0|||
23570307|NCT01544582|65816723|FG000|Analysis Population|Liver Transplantation|0|||
23570308|NCT01544582|65816724|FG001|Analysis Population|Liver Transplantation|0|||
23162726|NCT02069899|64344960|FG000|Overall Study|Lost to Follow-up|1|||
23162727|NCT02069899|64344961|FG001|Overall Study|Lost to Follow-up|0|||
23162728|NCT02069899|64344962|FG002|Overall Study|Lost to Follow-up|1|||
23446936|NCT02043938|65377804|FG000|Overall Study|No show by subject|1|||
23162729|NCT02069899|64344960|FG000|Overall Study|Other|4|||
23162730|NCT02069899|64344961|FG001|Overall Study|Other|0|||
23570309|NCT01544582|65816725|FG002|Analysis Population|Liver Transplantation|1|||
23570310|NCT01544582|65816726|FG003|Analysis Population|Liver Transplantation|0|||
23446937|NCT02043938|65377804|FG000|Overall Study|Investigator decision|1|||
23162731|NCT02069899|64344962|FG002|Overall Study|Other|0|||
23570311|NCT01544582|65816723|FG000|Analysis Population|No Social Insurance|0|||
23570312|NCT01544582|65816724|FG001|Analysis Population|No Social Insurance|0|||
23570313|NCT01544582|65816725|FG002|Analysis Population|No Social Insurance|1|||
23570314|NCT01544582|65816726|FG003|Analysis Population|No Social Insurance|0|||
23570315|NCT01544582|65816723|FG000|Analysis Population|Poor Adherence|0|||
23570316|NCT01544582|65816724|FG001|Analysis Population|Poor Adherence|0|||
23570317|NCT01544582|65816725|FG002|Analysis Population|Poor Adherence|1|||
23570318|NCT01544582|65816726|FG003|Analysis Population|Poor Adherence|0|||
23570319|NCT01544582|65816723|FG000|Analysis Population|Poor Participant Compliance|0|||
23570320|NCT01544582|65816724|FG001|Analysis Population|Poor Participant Compliance|1|||
23570321|NCT01544582|65816725|FG002|Analysis Population|Poor Participant Compliance|0|||
23570322|NCT01544582|65816726|FG003|Analysis Population|Poor Participant Compliance|0|||
23570323|NCT01544582|65816723|FG000|Analysis Population|Programmed Surgery|0|||
23570324|NCT01544582|65816724|FG001|Analysis Population|Programmed Surgery|1|||
23570325|NCT01544582|65816725|FG002|Analysis Population|Programmed Surgery|0|||
23570326|NCT01544582|65816726|FG003|Analysis Population|Programmed Surgery|0|||
23570327|NCT01544582|65816723|FG000|Analysis Population|Participant in Jail|0|||
23570328|NCT01544582|65816724|FG001|Analysis Population|Participant in Jail|0|||
23570329|NCT01544582|65816725|FG002|Analysis Population|Participant in Jail|1|||
23570330|NCT01544582|65816726|FG003|Analysis Population|Participant in Jail|0|||
23570331|NCT03875911|65816729|FG000|Overall Study|Lost to Follow-up|3|||
23570332|NCT03875911|65816730|FG001|Overall Study|Lost to Follow-up|6|||
23570333|NCT03875911|65816731|FG002|Overall Study|Lost to Follow-up|2|||
23570334|NCT03875911|65816729|FG000|Overall Study|Surgery cancelled|1|||
23570335|NCT03875911|65816730|FG001|Overall Study|Surgery cancelled|0|||
23570336|NCT03875911|65816731|FG002|Overall Study|Surgery cancelled|1|||
23570337|NCT03875911|65816729|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
23570338|NCT03875911|65816730|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
23570339|NCT03875911|65816731|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
23570340|NCT01995357|65816732|FG000|Period 5|Lack of Efficacy|1|||
23570341|NCT01995357|65816733|FG001|Period 5|Lack of Efficacy|0|||
23570342|NCT01995357|65816734|FG002|Period 5|Lack of Efficacy|0|||
23570343|NCT01995357|65816735|FG003|Period 5|Lack of Efficacy|0|||
23570344|NCT01995357|65816736|FG004|Period 5|Lack of Efficacy|0|||
23570345|NCT01995357|65816737|FG005|Period 5|Lack of Efficacy|0|||
23570346|NCT01995357|65816732|FG000|Period 5|Adverse Event|1|||
23570347|NCT01995357|65816733|FG001|Period 5|Adverse Event|0|||
23570348|NCT01995357|65816734|FG002|Period 5|Adverse Event|1|||
23570349|NCT01995357|65816735|FG003|Period 5|Adverse Event|0|||
23570350|NCT01995357|65816736|FG004|Period 5|Adverse Event|0|||
23570351|NCT01995357|65816737|FG005|Period 5|Adverse Event|0|||
23570352|NCT02293837|65816738|FG000|Overall Study|Lost to Follow-up|0|||
23570353|NCT02293837|65816739|FG001|Overall Study|Lost to Follow-up|2|||
23570354|NCT02293837|65816740|FG002|Overall Study|Lost to Follow-up|1|||
23570355|NCT02293837|65816741|FG003|Overall Study|Lost to Follow-up|0|||
23570356|NCT02293837|65816738|FG000|Overall Study|Withdrawal by Subject|2|||
23570357|NCT02293837|65816739|FG001|Overall Study|Withdrawal by Subject|1|||
23570358|NCT02293837|65816740|FG002|Overall Study|Withdrawal by Subject|2|||
23570359|NCT02293837|65816741|FG003|Overall Study|Withdrawal by Subject|1|||
23570360|NCT02293837|65816738|FG000|Overall Study|COVID-19 Related|1|||
23570361|NCT02293837|65816739|FG001|Overall Study|COVID-19 Related|1|||
23570362|NCT02293837|65816740|FG002|Overall Study|COVID-19 Related|0|||
23570363|NCT02293837|65816741|FG003|Overall Study|COVID-19 Related|0|||
23570364|NCT02293837|65816738|FG000|Overall Study|Participant ill and could not be infused|0|||
23570365|NCT02293837|65816739|FG001|Overall Study|Participant ill and could not be infused|0|||
23570366|NCT02293837|65816740|FG002|Overall Study|Participant ill and could not be infused|1|||
23570367|NCT02293837|65816741|FG003|Overall Study|Participant ill and could not be infused|0|||
23570368|NCT03154359|65816742|FG000|Overall Study|Adverse Event|1|||
23570369|NCT03154359|65816742|FG000|Overall Study|Lack of Efficacy|2|||
23570370|NCT03154359|65816742|FG000|Overall Study|Lost to Follow-up|3|||
23570371|NCT03154359|65816742|FG000|Overall Study|Physician Decision|3|||
23570372|NCT03154359|65816742|FG000|Overall Study|Protocol Violation|4|||
23570373|NCT03154359|65816742|FG000|Overall Study|Withdrawal by Subject|5|||
23570374|NCT03154359|65816742|FG000|Overall Study|Disruption of study due to COVID-19|4|||
23570375|NCT04297241|65816745|FG000|Overall Study|Withdrawal by Subject|1|||
23570376|NCT04297241|65816745|FG000|Overall Study|Adverse Event|1|||
23570377|NCT04297241|65816745|FG000|Overall Study|Physician Decision|3|||
23570378|NCT04666922|65816746|FG000|Overall Study|Withdrawal by Subject|1|||
23570379|NCT04666922|65816747|FG001|Overall Study|Withdrawal by Subject|0|||
23570380|NCT04666922|65816748|FG002|Overall Study|Withdrawal by Subject|0|||
23570381|NCT04666922|65816749|FG003|Overall Study|Withdrawal by Subject|0|||
23570382|NCT04666922|65816750|FG004|Overall Study|Withdrawal by Subject|0|||
23223913|NCT01355497|64563924|FG000|Overall Study|Adverse Event|11|||
23570383|NCT04666922|65816751|FG005|Overall Study|Withdrawal by Subject|0|||
23570384|NCT04666922|65816752|FG006|Overall Study|Withdrawal by Subject|0|||
23570385|NCT01107743|65816753|FG000|Overall Study|Protocol Violation|46|||
23570386|NCT02746575|65816756|FG000|Overall Study|Surgery cancelled or time chaned|13|||
23570387|NCT02746575|65816756|FG000|Overall Study|Received epidural|10|||
23570388|NCT02746575|65816756|FG000|Overall Study|Withdrawal by Subject|3|||
23570389|NCT02746575|65816756|FG000|Overall Study|Bradycardia/hypotension|9|||
23570390|NCT02746575|65816756|FG000|Overall Study|Study paused|8|||
23570391|NCT02746575|65816756|FG000|Overall Study|put on beta-blocker|3|||
23570392|NCT02746575|65816756|FG000|Overall Study|type of surgery|1|||
23570393|NCT02746575|65816756|FG000|Overall Study|typ of surgery|1|||
23570394|NCT02746575|65816756|FG000|Overall Study|PI unavailable|1|||
23570395|NCT02746575|65816756|FG000|Overall Study|Unknown history of CVA|1|||
23570396|NCT01254305|65816757|FG000|Overall Study|Adverse Event|6|||
23570397|NCT01254305|65816758|FG001|Overall Study|Adverse Event|3|||
23570398|NCT01254305|65816759|FG002|Overall Study|Adverse Event|2|||
23570399|NCT01254305|65816757|FG000|Overall Study|Lack of Efficacy|1|||
23570400|NCT01254305|65816758|FG001|Overall Study|Lack of Efficacy|0|||
23570401|NCT01254305|65816759|FG002|Overall Study|Lack of Efficacy|1|||
23570402|NCT01254305|65816757|FG000|Overall Study|Protocol Violation|1|||
23570403|NCT01254305|65816758|FG001|Overall Study|Protocol Violation|7|||
23162732|NCT02069899|64344960|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
23162733|NCT02069899|64344961|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
23162734|NCT02069899|64344962|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
23162735|NCT02069899|64344960|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
23162736|NCT02069899|64344961|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
23162737|NCT02069899|64344962|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
23162738|NCT02325219|64344963|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
23162739|NCT02325219|64344964|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
23162740|NCT02325219|64344965|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
23162741|NCT02325219|64344966|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
23162742|NCT02325219|64344967|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
23162743|NCT02325219|64344963|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
23223914|NCT01355497|64563925|FG001|Overall Study|Adverse Event|10|||
23223915|NCT02201472|64563926|FG000|Overall Study|Lack of Efficacy|2|||
23223916|NCT02640755|64563927|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
23223917|NCT02640755|64563928|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
23570404|NCT01254305|65816759|FG002|Overall Study|Protocol Violation|3|||
23570405|NCT01254305|65816757|FG000|Overall Study|Withdrawal by Subject|4|||
23570406|NCT01254305|65816758|FG001|Overall Study|Withdrawal by Subject|2|||
23570407|NCT01254305|65816759|FG002|Overall Study|Withdrawal by Subject|4|||
23162744|NCT02325219|64344964|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
23162745|NCT02325219|64344965|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23162746|NCT02325219|64344966|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23162747|NCT02325219|64344967|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23223918|NCT02640755|64563927|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
23570408|NCT01254305|65816757|FG000|Overall Study|Lost to Follow-up|10|||
23570409|NCT01254305|65816758|FG001|Overall Study|Lost to Follow-up|6|||
23570410|NCT01254305|65816759|FG002|Overall Study|Lost to Follow-up|5|||
23570411|NCT01254305|65816757|FG000|Overall Study|Other Reasons|0|||
23570412|NCT01254305|65816758|FG001|Overall Study|Other Reasons|0|||
23570413|NCT01254305|65816759|FG002|Overall Study|Other Reasons|2|||
23570414|NCT00794820|65816760|FG000|Overall Study|Adverse Event|11|||
23570415|NCT00794820|65816760|FG000|Overall Study|Secondary Malignancies|2|||
23570416|NCT00794820|65816760|FG000|Overall Study|Resistant Disease|2|||
23570417|NCT00794820|65816760|FG000|Overall Study|Ineligible/Screen Failure|1|||
23570418|NCT02310126|65816761|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
23570419|NCT02310126|65816762|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
23570420|NCT02310126|65816761|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
23570421|NCT02310126|65816762|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
23570422|NCT01348776|65816763|FG000|Overall Study|Lost to Follow-up|3|||
23570423|NCT00127413|65816764|FG000|Overall Study|Lost to Follow-up|6|||
23570424|NCT00127413|65816765|FG001|Overall Study|Lost to Follow-up|4|||
23570425|NCT00127413|65816766|FG002|Overall Study|Lost to Follow-up|8|||
23570426|NCT00127413|65816767|FG003|Overall Study|Lost to Follow-up|2|||
23570427|NCT01976364|65816768|FG000|Main Study (36 Months)|Adverse Event|63|||
23570428|NCT01976364|65816769|FG001|Main Study (36 Months)|Adverse Event|0|||
23570429|NCT01976364|65816770|FG002|Main Study (36 Months)|Adverse Event|0|||
23223919|NCT02640755|64563928|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
23162748|NCT02325219|64344963|FG000|Controlled Period (Week 0 - 16)|Other|0|||
23570430|NCT01976364|65816768|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
23570431|NCT01976364|65816769|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
23570432|NCT01976364|65816770|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
23570433|NCT01976364|65816768|FG000|Main Study (36 Months)|Other|13|||
23570434|NCT01976364|65816769|FG001|Main Study (36 Months)|Other|0|||
23570435|NCT01976364|65816770|FG002|Main Study (36 Months)|Other|0|||
23162749|NCT02325219|64344964|FG001|Controlled Period (Week 0 - 16)|Other|0|||
23162750|NCT02325219|64344965|FG002|Controlled Period (Week 0 - 16)|Other|1|||
23162751|NCT02325219|64344966|FG003|Controlled Period (Week 0 - 16)|Other|0|||
23162752|NCT02325219|64344967|FG004|Controlled Period (Week 0 - 16)|Other|0|||
23162753|NCT02325219|64344963|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23162754|NCT02325219|64344964|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23162755|NCT02325219|64344965|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23162756|NCT02325219|64344966|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23162757|NCT02325219|64344967|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
23162758|NCT02325219|64344963|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
23162759|NCT02325219|64344964|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
23162760|NCT02325219|64344965|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
23162761|NCT02325219|64344966|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
23162762|NCT02325219|64344967|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
23162763|NCT02325219|64344963|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23162764|NCT02325219|64344964|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
23162765|NCT02325219|64344965|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23162766|NCT02325219|64344966|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23162767|NCT02325219|64344967|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23162768|NCT01624662|64344969|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
23162769|NCT01624662|64344970|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
23162770|NCT01624662|64344971|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
23162771|NCT01624662|64344972|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
23162772|NCT01624662|64344969|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
23162773|NCT01624662|64344970|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
23162774|NCT01624662|64344971|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
23162775|NCT01624662|64344972|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
23162776|NCT01624662|64344969|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23162777|NCT01624662|64344970|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
23162778|NCT01624662|64344971|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23162779|NCT01624662|64344972|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23162780|NCT01624662|64344969|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
23162781|NCT01624662|64344970|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
23162782|NCT01624662|64344971|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
23162783|NCT01624662|64344972|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
23162784|NCT01624662|64344969|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
23162785|NCT01624662|64344970|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
23162786|NCT01624662|64344971|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
23570436|NCT01976364|65816768|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
23570437|NCT01976364|65816769|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
23570438|NCT01976364|65816770|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
23570439|NCT01976364|65816768|FG000|Main Study (36 Months)|Medication error|1|||
23570440|NCT01976364|65816769|FG001|Main Study (36 Months)|Medication error|0|||
23570441|NCT01976364|65816770|FG002|Main Study (36 Months)|Medication error|0|||
23570442|NCT01976364|65816768|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
23570443|NCT01976364|65816769|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
23570444|NCT01976364|65816770|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
23570445|NCT01976364|65816768|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
23570446|NCT01976364|65816769|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
23570447|NCT01976364|65816770|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
23570448|NCT01976364|65816768|FG000|Main Study (36 Months)|Protocol Violation|13|||
23570449|NCT01976364|65816769|FG001|Main Study (36 Months)|Protocol Violation|0|||
23570450|NCT01976364|65816770|FG002|Main Study (36 Months)|Protocol Violation|0|||
23570451|NCT01976364|65816768|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
23570452|NCT01976364|65816769|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
23570453|NCT01976364|65816770|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
23570454|NCT01976364|65816768|FG000|Main Study (36 Months)|Death|5|||
23570455|NCT01976364|65816769|FG001|Main Study (36 Months)|Death|0|||
23570456|NCT01976364|65816770|FG002|Main Study (36 Months)|Death|0|||
23570457|NCT01976364|65816768|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
23570458|NCT01976364|65816769|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
23570459|NCT01976364|65816770|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
23570460|NCT01976364|65816768|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
23162787|NCT01624662|64344972|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
23162788|NCT01624662|64344969|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23162789|NCT01624662|64344970|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
23570461|NCT01976364|65816769|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
23570462|NCT01976364|65816770|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
23570463|NCT01976364|65816768|FG000|Sub-study (12 Months)|Protocol Violation|0|||
23570464|NCT01976364|65816769|FG001|Sub-study (12 Months)|Protocol Violation|1|||
23570465|NCT01976364|65816770|FG002|Sub-study (12 Months)|Protocol Violation|1|||
23570466|NCT01976364|65816768|FG000|Sub-study (12 Months)|Adverse Event|0|||
23570467|NCT01976364|65816769|FG001|Sub-study (12 Months)|Adverse Event|4|||
23570468|NCT01976364|65816770|FG002|Sub-study (12 Months)|Adverse Event|3|||
23570469|NCT01320735|65816775|FG000|Overall Study|Adverse Event|3|||
23570470|NCT01320735|65816775|FG000|Overall Study|Withdrawal by Subject|3|||
23570471|NCT01320735|65816775|FG000|Overall Study|Lost to Follow-up|13|||
23570472|NCT01320735|65816775|FG000|Overall Study|Administrative Reason|6|||
23570473|NCT01320735|65816775|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
23570474|NCT01320735|65816775|FG000|Overall Study|Protocol Violation|1|||
23570475|NCT01320735|65816775|FG000|Overall Study|Other|1|||
23162790|NCT01624662|64344971|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23162791|NCT01624662|64344972|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23162792|NCT01624662|64344969|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
23162793|NCT01624662|64344970|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
23162794|NCT01624662|64344971|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
23162795|NCT01624662|64344972|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
23570476|NCT01320735|65816775|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
23570477|NCT01320735|65816775|FG000|Overall Study|Investigator Unable to be Contacted|17|||
23570478|NCT04182880|65816777|FG000|Overall Study|Pregnancy|1|||
23570479|NCT04182880|65816778|FG001|Overall Study|Pregnancy|0|||
23570480|NCT01822353|65816779|FG000|Overall Study|Adverse Event|1|||
23570481|NCT01822353|65816780|FG001|Overall Study|Adverse Event|3|||
23570482|NCT01822353|65816781|FG002|Overall Study|Adverse Event|1|||
23570483|NCT01822353|65816779|FG000|Overall Study|Pregnancy|0|||
23570484|NCT01822353|65816780|FG001|Overall Study|Pregnancy|1|||
23570485|NCT01822353|65816781|FG002|Overall Study|Pregnancy|0|||
23570486|NCT01822353|65816779|FG000|Overall Study|Withdrawal by Subject|3|||
23570487|NCT01822353|65816780|FG001|Overall Study|Withdrawal by Subject|1|||
23570488|NCT01822353|65816781|FG002|Overall Study|Withdrawal by Subject|0|||
23162796|NCT01356407|64344977|FG000|Overall Study|Lost to Follow-up|2|||
23162797|NCT01356407|64344978|FG001|Overall Study|Lost to Follow-up|0|||
23162798|NCT01356407|64344977|FG000|Overall Study|Patient Withdrew Consent|2|||
23162799|NCT01356407|64344978|FG001|Overall Study|Patient Withdrew Consent|1|||
23162800|NCT01356407|64344977|FG000|Overall Study|Could not afford IMP administration|0|||
23162801|NCT01356407|64344978|FG001|Overall Study|Could not afford IMP administration|1|||
23162802|NCT01356407|64344977|FG000|Overall Study|Not complete Endoscopy|2|||
23162803|NCT01356407|64344978|FG001|Overall Study|Not complete Endoscopy|2|||
23162804|NCT00583362|64344979|FG000|Overall Study|Adverse Event|44|||
23162805|NCT00583362|64344979|FG000|Overall Study|Lack of Efficacy|22|||
23570489|NCT03306043|65816782|FG000|Overall Study|Adverse Event|1|||
23570490|NCT03306043|65816782|FG000|Overall Study|Lost to Follow-up|1|||
23570491|NCT03306043|65816782|FG000|Overall Study|Withdrawal by Subject|2|||
23570492|NCT00854295|65816783|FG000|Overall Study|Death|7|||
23570493|NCT00854295|65816784|FG001|Overall Study|Death|0|||
23570494|NCT00854295|65816785|FG002|Overall Study|Death|1|||
23570495|NCT00854295|65816786|FG003|Overall Study|Death|1|||
23570496|NCT00854295|65816783|FG000|Overall Study|Adverse Event|6|||
23570497|NCT00854295|65816784|FG001|Overall Study|Adverse Event|1|||
23570498|NCT00854295|65816785|FG002|Overall Study|Adverse Event|1|||
23570499|NCT00854295|65816786|FG003|Overall Study|Adverse Event|3|||
23570500|NCT00854295|65816783|FG000|Overall Study|Lost to Follow-up|18|||
23162806|NCT00583362|64344979|FG000|Overall Study|Lost to Follow-up|4|||
23162807|NCT00583362|64344979|FG000|Overall Study|Non-compliance with study drug|28|||
23162808|NCT00583362|64344979|FG000|Overall Study|Pregnancy|7|||
23570501|NCT00854295|65816784|FG001|Overall Study|Lost to Follow-up|5|||
23570502|NCT00854295|65816785|FG002|Overall Study|Lost to Follow-up|21|||
23570503|NCT00854295|65816786|FG003|Overall Study|Lost to Follow-up|21|||
23570504|NCT00854295|65816783|FG000|Overall Study|Physician Decision|10|||
23570505|NCT00854295|65816784|FG001|Overall Study|Physician Decision|0|||
23162809|NCT00583362|64344979|FG000|Overall Study|Miscommunication of visit window|5|||
23162810|NCT00583362|64344979|FG000|Overall Study|Current site closed|7|||
23331097|NCT00891020|64955352|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
23570506|NCT00854295|65816785|FG002|Overall Study|Physician Decision|0|||
23570507|NCT00854295|65816786|FG003|Overall Study|Physician Decision|0|||
23570508|NCT02757521|65816789|FG000|Overall Study|Adverse Event|1|||
23446938|NCT01684202|65377809|FG000|Dose-escalation Period|Adverse Event|0|||
23570509|NCT02757521|65816790|FG001|Overall Study|Adverse Event|0|||
23162811|NCT00583362|64344979|FG000|Overall Study|Subject not dosed in LBSL99|1|||
23570510|NCT00806624|65816792|FG000|Overall Study|Adverse Event|2|||
23570511|NCT00806624|65816793|FG001|Overall Study|Adverse Event|8|||
23570512|NCT00806624|65816794|FG002|Overall Study|Adverse Event|0|||
23570513|NCT00806624|65816792|FG000|Overall Study|Death|0|||
23570514|NCT00806624|65816793|FG001|Overall Study|Death|1|||
23570515|NCT00806624|65816794|FG002|Overall Study|Death|1|||
23570516|NCT00806624|65816792|FG000|Overall Study|Lost to Follow-up|1|||
23162812|NCT00583362|64344979|FG000|Overall Study|Subject moved out of the country/state|2|||
23162813|NCT00583362|64344979|FG000|Overall Study|Missed visits due to staff changes|1|||
23162814|NCT00583362|64344979|FG000|Overall Study|Misunderstanding of protocol|1|||
23162815|NCT00583362|64344979|FG000|Overall Study|Behavioral problems and non-compliance|1|||
23162816|NCT00583362|64344979|FG000|Overall Study|Sponsor request due to missed doses|1|||
23162817|NCT00583362|64344979|FG000|Overall Study|Physician Decision|19|||
23162818|NCT00583362|64344979|FG000|Overall Study|Protocol Violation|2|||
23162819|NCT00583362|64344979|FG000|Overall Study|Withdrawal by Subject|57|||
23162820|NCT00094770|64344993|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
23162821|NCT00094770|64344994|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
23570517|NCT00806624|65816793|FG001|Overall Study|Lost to Follow-up|0|||
23570518|NCT00806624|65816794|FG002|Overall Study|Lost to Follow-up|1|||
23570519|NCT00806624|65816792|FG000|Overall Study|Withdrawal by Subject|6|||
23570520|NCT00806624|65816793|FG001|Overall Study|Withdrawal by Subject|3|||
23570521|NCT00806624|65816794|FG002|Overall Study|Withdrawal by Subject|3|||
23570522|NCT00806624|65816792|FG000|Overall Study|discontinued before start of treatment|0|||
23570523|NCT00806624|65816793|FG001|Overall Study|discontinued before start of treatment|0|||
23570524|NCT00806624|65816794|FG002|Overall Study|discontinued before start of treatment|1|||
23570525|NCT01340482|65816800|FG000|Overall Study|Adverse Event|2|||
23570526|NCT01340482|65816801|FG001|Overall Study|Adverse Event|0|||
23570527|NCT01340482|65816802|FG002|Overall Study|Adverse Event|0|||
23570528|NCT02066532|65816803|FG000|Phase II|Withdrawal by Subject|1|||
23570529|NCT02066532|65816804|FG001|Phase II|Withdrawal by Subject|0|||
23570530|NCT02066532|65816805|FG002|Phase II|Withdrawal by Subject|0|||
23570531|NCT02066532|65816806|FG003|Phase II|Withdrawal by Subject|0|||
23570532|NCT01464255|65816810|FG000|Overall Study|unresolve corneal staining|0|||
23570533|NCT01464255|65816811|FG001|Overall Study|unresolve corneal staining|1|||
23570534|NCT03075904|65816812|FG000|Overall Study|Physician Decision|3|||
23570535|NCT03075904|65816812|FG000|Overall Study|Need for Medication not Permitted|1|||
23570536|NCT01590771|65816815|FG000|Overall Study|Other Protocol Specified Criteria|5|||
23570537|NCT01590771|65816816|FG001|Overall Study|Other Protocol Specified Criteria|14|||
23570538|NCT01590771|65816815|FG000|Overall Study|Withdrawal by Subject|8|||
23570539|NCT01590771|65816816|FG001|Overall Study|Withdrawal by Subject|15|||
23570540|NCT01590771|65816815|FG000|Overall Study|Protocol Violation|1|||
23570541|NCT01590771|65816816|FG001|Overall Study|Protocol Violation|2|||
23570542|NCT01590771|65816815|FG000|Overall Study|Lost to Follow-up|1|||
23570543|NCT01590771|65816816|FG001|Overall Study|Lost to Follow-up|1|||
23570544|NCT01590771|65816815|FG000|Overall Study|Lack of Efficacy|1|||
23570545|NCT01590771|65816816|FG001|Overall Study|Lack of Efficacy|0|||
23570546|NCT01590771|65816815|FG000|Overall Study|Adverse Event|3|||
23570547|NCT01590771|65816816|FG001|Overall Study|Adverse Event|7|||
23570548|NCT00472186|65816817|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
23570549|NCT00472186|65816818|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
23570550|NCT01515189|65816819|FG000|Induction|Disease Progression|109|||
23570551|NCT01515189|65816820|FG001|Induction|Disease Progression|155|||
23570552|NCT01515189|65816819|FG000|Induction|Study drug toxicity|86|||
23570553|NCT01515189|65816820|FG001|Induction|Study drug toxicity|36|||
23570554|NCT01515189|65816819|FG000|Induction|Death|24|||
23570555|NCT01515189|65816820|FG001|Induction|Death|17|||
23570556|NCT01515189|65816819|FG000|Induction|Adverse Event|14|||
23570557|NCT01515189|65816820|FG001|Induction|Adverse Event|9|||
23570558|NCT01515189|65816819|FG000|Induction|Withdrawal by Subject|3|||
23570559|NCT01515189|65816820|FG001|Induction|Withdrawal by Subject|9|||
23570560|NCT01515189|65816819|FG000|Induction|No longer meets study criteria|0|||
23570561|NCT01515189|65816820|FG001|Induction|No longer meets study criteria|2|||
23570562|NCT01515189|65816819|FG000|Induction|Lost to Follow-up|1|||
23570563|NCT01515189|65816820|FG001|Induction|Lost to Follow-up|0|||
23570564|NCT01515189|65816819|FG000|Induction|Other|0|||
23570565|NCT01515189|65816820|FG001|Induction|Other|4|||
23570566|NCT01515189|65816819|FG000|First Re-Induction Phase|Disease progression|6|||
23570567|NCT01515189|65816820|FG001|First Re-Induction Phase|Disease progression|14|||
23570568|NCT01515189|65816819|FG000|First Re-Induction Phase|Study drug toxicity|5|||
23570569|NCT01515189|65816820|FG001|First Re-Induction Phase|Study drug toxicity|0|||
23570570|NCT01515189|65816819|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
23162822|NCT00094770|64344993|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
23162823|NCT00094770|64344994|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
23162824|NCT00094770|64344993|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
23570571|NCT01515189|65816820|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
23570572|NCT01515189|65816819|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
23570573|NCT01515189|65816820|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
23570574|NCT01515189|65816819|FG000|First Re-Induction Phase|Other|1|||
23570575|NCT01515189|65816820|FG001|First Re-Induction Phase|Other|0|||
23570576|NCT01592695|65816821|FG000|Overall Study|Lost to Follow-up|8|||
23570577|NCT01592695|65816822|FG001|Overall Study|Lost to Follow-up|4|||
23570578|NCT01950273|65816823|FG000|Overall Study|Protocol Violation|1|||
23570579|NCT01950273|65816824|FG001|Overall Study|Protocol Violation|0|||
23162825|NCT00094770|64344994|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
23570580|NCT01950273|65816823|FG000|Overall Study|Withdrawal by Subject|2|||
23570581|NCT01950273|65816824|FG001|Overall Study|Withdrawal by Subject|0|||
23570582|NCT01950273|65816823|FG000|Overall Study|Other not defined above|1|||
23570583|NCT01950273|65816824|FG001|Overall Study|Other not defined above|0|||
23570584|NCT00641186|65816825|FG000|Overall Study|Adverse Event|3|||
23570585|NCT03204695|65816828|FG000|Overall Study|Death|1|||
23570586|NCT03204695|65816828|FG000|Overall Study|Participant was treated with another device|1|||
23570587|NCT03204695|65816828|FG000|Overall Study|Physician Decision|2|||
23570588|NCT02855164|65816832|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570589|NCT02855164|65816833|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570590|NCT02855164|65816834|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
23570591|NCT02855164|65816835|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
23570592|NCT02855164|65816836|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
23570593|NCT02855164|65816837|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570594|NCT02855164|65816838|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570595|NCT02855164|65816839|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
23570596|NCT02855164|65816832|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
23570597|NCT02855164|65816833|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
23570598|NCT02855164|65816834|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
23570599|NCT02855164|65816835|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
23570600|NCT02855164|65816836|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
23570601|NCT02855164|65816837|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
23570602|NCT02855164|65816838|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
23570603|NCT02855164|65816839|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
23570604|NCT02855164|65816832|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
23570605|NCT02855164|65816833|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
23570606|NCT02855164|65816834|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
23570607|NCT02855164|65816835|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
23570608|NCT02855164|65816836|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
23570609|NCT02855164|65816837|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
23570610|NCT02855164|65816838|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
23570611|NCT02855164|65816839|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
23570612|NCT02855164|65816832|FG000|Part C (Randomized Set)|Adverse Event|0|||
23570613|NCT02855164|65816833|FG001|Part C (Randomized Set)|Adverse Event|0|||
23570614|NCT02855164|65816834|FG002|Part C (Randomized Set)|Adverse Event|0|||
23570615|NCT02855164|65816835|FG003|Part C (Randomized Set)|Adverse Event|0|||
23570616|NCT02855164|65816836|FG004|Part C (Randomized Set)|Adverse Event|0|||
23570617|NCT02855164|65816837|FG005|Part C (Randomized Set)|Adverse Event|5|||
23570618|NCT02855164|65816838|FG006|Part C (Randomized Set)|Adverse Event|9|||
23570619|NCT02855164|65816839|FG007|Part C (Randomized Set)|Adverse Event|2|||
23570620|NCT02855164|65816832|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
23570621|NCT02855164|65816833|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
23570622|NCT02855164|65816834|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
23570623|NCT02855164|65816835|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
23570624|NCT02855164|65816836|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
23570625|NCT02855164|65816837|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
23570626|NCT02855164|65816838|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
23570627|NCT02855164|65816839|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
23570628|NCT02855164|65816832|FG000|Part C (Randomized Set)|Physician Decision|0|||
23570629|NCT02855164|65816833|FG001|Part C (Randomized Set)|Physician Decision|0|||
23162826|NCT00094770|64344993|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
23162827|NCT00094770|64344994|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
23162828|NCT00094770|64344993|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
23162829|NCT00094770|64344994|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
23162830|NCT00094770|64344993|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
23162831|NCT00094770|64344994|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
23162832|NCT00094770|64344993|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
23162833|NCT00094770|64344994|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
23162834|NCT00094770|64344993|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
23570630|NCT02855164|65816834|FG002|Part C (Randomized Set)|Physician Decision|0|||
23570631|NCT02855164|65816835|FG003|Part C (Randomized Set)|Physician Decision|0|||
23570632|NCT02855164|65816836|FG004|Part C (Randomized Set)|Physician Decision|0|||
23162835|NCT00094770|64344994|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
23162836|NCT00094770|64344993|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
23162837|NCT00094770|64344994|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
23570633|NCT02855164|65816837|FG005|Part C (Randomized Set)|Physician Decision|1|||
23570634|NCT02855164|65816838|FG006|Part C (Randomized Set)|Physician Decision|0|||
23570635|NCT02855164|65816839|FG007|Part C (Randomized Set)|Physician Decision|1|||
23570636|NCT02855164|65816832|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
23570637|NCT02855164|65816833|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
23570638|NCT02855164|65816834|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
23570639|NCT02855164|65816835|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
23570640|NCT02855164|65816836|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
23570641|NCT02855164|65816837|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
23570642|NCT02855164|65816838|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
23570643|NCT02855164|65816839|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
23570644|NCT02790073|65816846|FG000|Overall Study|Death|1|||
23570645|NCT02790073|65816846|FG000|Overall Study|Withdrawal from HD|1|||
23570646|NCT02790073|65816846|FG000|Overall Study|Withdrawal by Subject|1|||
23570647|NCT04320615|65816847|FG000|Overall Study|Withdrawal by Subject|4|||
23570648|NCT04320615|65816848|FG001|Overall Study|Withdrawal by Subject|10|||
23570649|NCT04320615|65816847|FG000|Overall Study|Physician Decision|2|||
23570650|NCT04320615|65816848|FG001|Overall Study|Physician Decision|0|||
23570651|NCT04320615|65816847|FG000|Overall Study|Other|2|||
23331098|NCT00891020|64955350|FG000|24 Week Treatment Period|Other protocol violation|1|||
23331099|NCT00891020|64955351|FG001|24 Week Treatment Period|Other protocol violation|1|||
23331100|NCT00891020|64955352|FG002|24 Week Treatment Period|Other protocol violation|2|||
23331101|NCT00891020|64955350|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
23331102|NCT00891020|64955351|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
23331103|NCT00891020|64955352|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
23570652|NCT04320615|65816848|FG001|Overall Study|Other|0|||
23570653|NCT04320615|65816847|FG000|Overall Study|Lost to Follow-up|5|||
23331104|NCT00891020|64955350|FG000|24 Week Treatment Period|Withdrew consent|6|||
23331105|NCT00891020|64955351|FG001|24 Week Treatment Period|Withdrew consent|3|||
23331106|NCT00891020|64955352|FG002|24 Week Treatment Period|Withdrew consent|15|||
23331107|NCT00891020|64955350|FG000|24 Week Treatment Period|Administrative/Other|5|||
23331108|NCT00891020|64955351|FG001|24 Week Treatment Period|Administrative/Other|6|||
23331109|NCT00891020|64955352|FG002|24 Week Treatment Period|Administrative/Other|1|||
23331110|NCT00891020|64955350|FG000|Long-term Extension Period|Adverse Event|1|||
23331111|NCT00891020|64955351|FG001|Long-term Extension Period|Adverse Event|11|||
23331112|NCT00891020|64955352|FG002|Long-term Extension Period|Adverse Event|10|||
23331113|NCT00891020|64955350|FG000|Long-term Extension Period|Death|0|||
23331114|NCT00891020|64955351|FG001|Long-term Extension Period|Death|0|||
23331115|NCT00891020|64955352|FG002|Long-term Extension Period|Death|1|||
23331116|NCT00891020|64955350|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
23331117|NCT00891020|64955351|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
23331118|NCT00891020|64955352|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
23570654|NCT04320615|65816848|FG001|Overall Study|Lost to Follow-up|23|||
23570655|NCT04320615|65816847|FG000|Overall Study|Death|35|||
23570656|NCT04320615|65816848|FG001|Overall Study|Death|71|||
23162838|NCT00094770|64344993|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
23162839|NCT00094770|64344994|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
23570657|NCT00318149|65816852|FG000|Overall Study|Adverse Event|0|||
23570658|NCT00318149|65816853|FG001|Overall Study|Adverse Event|0|||
23162840|NCT00094770|64344993|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
23162841|NCT00094770|64344994|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
23162842|NCT00094770|64344993|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
23162843|NCT00094770|64344994|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
23162844|NCT00094770|64344993|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
23331119|NCT00891020|64955350|FG000|Long-term Extension Period|Protocol Violation|0|||
23331120|NCT00891020|64955351|FG001|Long-term Extension Period|Protocol Violation|1|||
23570659|NCT00318149|65816854|FG002|Overall Study|Adverse Event|0|||
23570660|NCT00318149|65816855|FG003|Overall Study|Adverse Event|0|||
23570661|NCT00318149|65816856|FG004|Overall Study|Adverse Event|0|||
23570662|NCT00318149|65816857|FG005|Overall Study|Adverse Event|2|||
23570663|NCT01533714|65816860|FG000|Overall Study|Adverse Event|0|||
23570664|NCT01533714|65816861|FG001|Overall Study|Adverse Event|1|||
23570665|NCT01533714|65816862|FG002|Overall Study|Adverse Event|2|||
23570666|NCT01533714|65816863|FG003|Overall Study|Adverse Event|2|||
23570667|NCT01533714|65816864|FG004|Overall Study|Adverse Event|2|||
23570668|NCT01533714|65816865|FG005|Overall Study|Adverse Event|1|||
23570669|NCT01533714|65816860|FG000|Overall Study|Lack of Efficacy|0|||
23570670|NCT01533714|65816861|FG001|Overall Study|Lack of Efficacy|0|||
23570671|NCT01533714|65816862|FG002|Overall Study|Lack of Efficacy|0|||
23570672|NCT01533714|65816863|FG003|Overall Study|Lack of Efficacy|0|||
23570673|NCT01533714|65816864|FG004|Overall Study|Lack of Efficacy|0|||
23570674|NCT01533714|65816865|FG005|Overall Study|Lack of Efficacy|1|||
23570675|NCT01533714|65816860|FG000|Overall Study|Withdrawal by Subject|0|||
23570676|NCT01533714|65816861|FG001|Overall Study|Withdrawal by Subject|1|||
23570677|NCT01533714|65816862|FG002|Overall Study|Withdrawal by Subject|0|||
23570678|NCT01533714|65816863|FG003|Overall Study|Withdrawal by Subject|1|||
23570679|NCT01533714|65816864|FG004|Overall Study|Withdrawal by Subject|1|||
23570680|NCT01533714|65816865|FG005|Overall Study|Withdrawal by Subject|0|||
23570681|NCT01533714|65816860|FG000|Overall Study|Exclusion criteria|0|||
23570682|NCT01533714|65816861|FG001|Overall Study|Exclusion criteria|1|||
23570683|NCT01533714|65816862|FG002|Overall Study|Exclusion criteria|0|||
23570684|NCT01533714|65816863|FG003|Overall Study|Exclusion criteria|0|||
23570685|NCT01533714|65816864|FG004|Overall Study|Exclusion criteria|0|||
23570686|NCT01533714|65816865|FG005|Overall Study|Exclusion criteria|0|||
23162845|NCT00094770|64344994|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
23162846|NCT00094770|64344993|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
23162847|NCT00094770|64344994|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
23162848|NCT00094770|64344993|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
23162849|NCT00094770|64344994|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
23162850|NCT00094770|64344993|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
23162851|NCT00094770|64344994|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
23162852|NCT00094770|64344993|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
23162853|NCT00094770|64344994|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
23162854|NCT00094770|64344993|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
23162855|NCT00094770|64344994|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
23162856|NCT03505021|64344997|FG000|Overall Study|Protocol Violation|1|||
23162857|NCT03505021|64344998|FG001|Overall Study|Protocol Violation|0|||
23162858|NCT03505021|64344997|FG000|Overall Study|Death|9|||
23162859|NCT03505021|64344998|FG001|Overall Study|Death|8|||
23162860|NCT03505021|64344997|FG000|Overall Study|Consent withdrawn by subject|6|||
23162861|NCT03505021|64344998|FG001|Overall Study|Consent withdrawn by subject|1|||
23162862|NCT03505021|64344997|FG000|Overall Study|Lost to Follow-up|5|||
23162863|NCT03505021|64344998|FG001|Overall Study|Lost to Follow-up|3|||
23162864|NCT03505021|64344997|FG000|Overall Study|Adverse Event|26|||
23162865|NCT03505021|64344998|FG001|Overall Study|Adverse Event|9|||
23162866|NCT03505021|64344997|FG000|Overall Study|Disease progression|33|||
23162867|NCT03505021|64344998|FG001|Overall Study|Disease progression|17|||
23162868|NCT03505021|64344997|FG000|Overall Study|Other|11|||
23162869|NCT03505021|64344998|FG001|Overall Study|Other|5|||
23162870|NCT03505021|64344997|FG000|Overall Study|Personal reason|21|||
23162871|NCT03505021|64344998|FG001|Overall Study|Personal reason|12|||
23162872|NCT00794157|64344999|FG000|Overall Study|Adverse Event|4|||
23162873|NCT00794157|64345000|FG001|Overall Study|Adverse Event|1|||
23162874|NCT00794157|64345001|FG002|Overall Study|Adverse Event|8|||
23162875|NCT00794157|64344999|FG000|Overall Study|Subject withdrew consent|2|||
23162876|NCT00794157|64345000|FG001|Overall Study|Subject withdrew consent|0|||
23162877|NCT00794157|64345001|FG002|Overall Study|Subject withdrew consent|3|||
23162878|NCT00794157|64344999|FG000|Overall Study|Lost to Follow-up|2|||
23162879|NCT00794157|64345000|FG001|Overall Study|Lost to Follow-up|0|||
23162880|NCT00794157|64345001|FG002|Overall Study|Lost to Follow-up|1|||
23162881|NCT00794157|64344999|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23162882|NCT00794157|64345000|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23162883|NCT00794157|64345001|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23162884|NCT00794157|64344999|FG000|Overall Study|Administrative problems|1|||
23570687|NCT01533714|65816860|FG000|Overall Study|Positive for purified protein derivative|0|||
23570688|NCT01533714|65816861|FG001|Overall Study|Positive for purified protein derivative|0|||
23570689|NCT01533714|65816862|FG002|Overall Study|Positive for purified protein derivative|1|||
23162885|NCT00794157|64345000|FG001|Overall Study|Administrative problems|7|||
23570690|NCT01533714|65816863|FG003|Overall Study|Positive for purified protein derivative|0|||
23162886|NCT00794157|64345001|FG002|Overall Study|Administrative problems|4|||
23162887|NCT00794157|64344999|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23162888|NCT00794157|64345000|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23162889|NCT00794157|64345001|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23570691|NCT01533714|65816864|FG004|Overall Study|Positive for purified protein derivative|1|||
23162890|NCT00794157|64344999|FG000|Overall Study|Protocol deviation|0|||
23570692|NCT01533714|65816865|FG005|Overall Study|Positive for purified protein derivative|0|||
23570693|NCT01533714|65816860|FG000|Overall Study|Withdrawal criteria|0|||
23331121|NCT00891020|64955352|FG002|Long-term Extension Period|Protocol Violation|1|||
23331122|NCT00891020|64955350|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
23570694|NCT01533714|65816861|FG001|Overall Study|Withdrawal criteria|0|||
23570695|NCT01533714|65816862|FG002|Overall Study|Withdrawal criteria|1|||
23570696|NCT01533714|65816863|FG003|Overall Study|Withdrawal criteria|0|||
23570697|NCT01533714|65816864|FG004|Overall Study|Withdrawal criteria|3|||
23570698|NCT01533714|65816865|FG005|Overall Study|Withdrawal criteria|1|||
23570699|NCT01533714|65816860|FG000|Overall Study|Ineligibility reason|0|||
23570700|NCT01533714|65816861|FG001|Overall Study|Ineligibility reason|0|||
23570701|NCT01533714|65816862|FG002|Overall Study|Ineligibility reason|0|||
23570702|NCT01533714|65816863|FG003|Overall Study|Ineligibility reason|1|||
23570703|NCT01533714|65816864|FG004|Overall Study|Ineligibility reason|0|||
23570704|NCT01533714|65816865|FG005|Overall Study|Ineligibility reason|0|||
23570705|NCT01700348|65816866|FG000|Overall Study|Withdrawal by Subject|22|||
23570706|NCT01700348|65816866|FG000|Overall Study|Lost to Follow-up|1|||
23570707|NCT02138747|65816867|FG000|Treatment Period 1|Adverse Event|10|||
23570708|NCT02138747|65816868|FG001|Treatment Period 1|Adverse Event|14|||
23570709|NCT02138747|65816869|FG002|Treatment Period 1|Adverse Event|2|||
23570710|NCT02138747|65816870|FG003|Treatment Period 1|Adverse Event|1|||
23570711|NCT02138747|65816867|FG000|Treatment Period 1|Lost to Follow-up|0|||
23570712|NCT02138747|65816868|FG001|Treatment Period 1|Lost to Follow-up|1|||
23570713|NCT02138747|65816869|FG002|Treatment Period 1|Lost to Follow-up|1|||
23570714|NCT02138747|65816870|FG003|Treatment Period 1|Lost to Follow-up|0|||
23570715|NCT02138747|65816867|FG000|Treatment Period 1|Protocol Violation|0|||
23570716|NCT02138747|65816868|FG001|Treatment Period 1|Protocol Violation|2|||
23570717|NCT02138747|65816869|FG002|Treatment Period 1|Protocol Violation|0|||
23570718|NCT02138747|65816870|FG003|Treatment Period 1|Protocol Violation|0|||
23570719|NCT02138747|65816867|FG000|Treatment Period 1|Withdrawal by Subject|8|||
23570720|NCT02138747|65816868|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23570721|NCT02138747|65816869|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23570722|NCT02138747|65816870|FG003|Treatment Period 1|Withdrawal by Subject|3|||
23570723|NCT02138747|65816867|FG000|Treatment Period 1|Other - Miscellaneous|2|||
23331123|NCT00891020|64955351|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
23331124|NCT00891020|64955352|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
23331125|NCT00891020|64955350|FG000|Long-term Extension Period|Failure to return|0|||
23331126|NCT00891020|64955351|FG001|Long-term Extension Period|Failure to return|2|||
23331127|NCT00891020|64955352|FG002|Long-term Extension Period|Failure to return|3|||
23331128|NCT00891020|64955350|FG000|Long-term Extension Period|Administrative|1|||
23162891|NCT00794157|64345000|FG001|Overall Study|Protocol deviation|1|||
23331129|NCT00891020|64955351|FG001|Long-term Extension Period|Administrative|2|||
23331130|NCT00891020|64955352|FG002|Long-term Extension Period|Administrative|2|||
23331131|NCT03473925|64955353|FG000|Overall Study|Death|48|||
23331132|NCT03473925|64955354|FG001|Overall Study|Death|44|||
23331133|NCT03473925|64955353|FG000|Overall Study|Sponsor Decision|2|||
23162892|NCT00794157|64345001|FG002|Overall Study|Protocol deviation|1|||
23162893|NCT03374189|64345002|FG000|Overall Study|Lost to Follow-up|1|||
23162894|NCT03374189|64345003|FG001|Overall Study|Lost to Follow-up|0|||
23331134|NCT03473925|64955354|FG001|Overall Study|Sponsor Decision|7|||
23331135|NCT03473925|64955353|FG000|Overall Study|Withdrawal by Subject|1|||
23331136|NCT03473925|64955354|FG001|Overall Study|Withdrawal by Subject|3|||
23331137|NCT03473925|64955353|FG000|Overall Study|Not Treated|1|||
23331138|NCT03473925|64955354|FG001|Overall Study|Not Treated|1|||
23331139|NCT01467713|64955361|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
23331140|NCT01467713|64955362|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
23331141|NCT01467713|64955363|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
23331142|NCT01467713|64955364|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
23331143|NCT01467713|64955361|FG000|Overall Study|Major Protocol Deviation|2|||
23331144|NCT01467713|64955362|FG001|Overall Study|Major Protocol Deviation|4|||
23570724|NCT02138747|65816868|FG001|Treatment Period 1|Other - Miscellaneous|4|||
23570725|NCT02138747|65816869|FG002|Treatment Period 1|Other - Miscellaneous|0|||
23570726|NCT02138747|65816870|FG003|Treatment Period 1|Other - Miscellaneous|0|||
23570727|NCT02138747|65816867|FG000|Treatment Period 2|Adverse Event|6|||
23570728|NCT02138747|65816868|FG001|Treatment Period 2|Adverse Event|3|||
23570729|NCT02138747|65816869|FG002|Treatment Period 2|Adverse Event|1|||
23570730|NCT02138747|65816870|FG003|Treatment Period 2|Adverse Event|1|||
23570731|NCT02138747|65816867|FG000|Treatment Period 2|Lost to Follow-up|2|||
23570732|NCT02138747|65816868|FG001|Treatment Period 2|Lost to Follow-up|0|||
23570733|NCT02138747|65816869|FG002|Treatment Period 2|Lost to Follow-up|0|||
23570734|NCT02138747|65816870|FG003|Treatment Period 2|Lost to Follow-up|0|||
23570735|NCT02138747|65816867|FG000|Treatment Period 2|Protocol Violation|1|||
23570736|NCT02138747|65816868|FG001|Treatment Period 2|Protocol Violation|0|||
23570737|NCT02138747|65816869|FG002|Treatment Period 2|Protocol Violation|0|||
23570738|NCT02138747|65816870|FG003|Treatment Period 2|Protocol Violation|0|||
23570739|NCT02138747|65816867|FG000|Treatment Period 2|Withdrawal by Subject|5|||
23570740|NCT02138747|65816868|FG001|Treatment Period 2|Withdrawal by Subject|4|||
23570741|NCT02138747|65816869|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23570742|NCT02138747|65816870|FG003|Treatment Period 2|Withdrawal by Subject|2|||
23570743|NCT02138747|65816867|FG000|Treatment Period 2|Other - Miscellaneous|3|||
23570744|NCT02138747|65816868|FG001|Treatment Period 2|Other - Miscellaneous|0|||
23570745|NCT02138747|65816869|FG002|Treatment Period 2|Other - Miscellaneous|0|||
23570746|NCT02138747|65816870|FG003|Treatment Period 2|Other - Miscellaneous|0|||
23570747|NCT05764239|65816873|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
23162895|NCT00845650|64345007|FG000|Overall Study|Withdrawal by Subject|0|||
23162896|NCT00845650|64345008|FG001|Overall Study|Withdrawal by Subject|0|||
23162897|NCT00845650|64345009|FG002|Overall Study|Withdrawal by Subject|0|||
23162898|NCT00845650|64345010|FG003|Overall Study|Withdrawal by Subject|0|||
23162899|NCT00845650|64345011|FG004|Overall Study|Withdrawal by Subject|2|||
23162900|NCT00845650|64345012|FG005|Overall Study|Withdrawal by Subject|0|||
23162901|NCT00845650|64345007|FG000|Overall Study|Lost to Follow-up|0|||
23162902|NCT00845650|64345008|FG001|Overall Study|Lost to Follow-up|0|||
23162903|NCT00845650|64345009|FG002|Overall Study|Lost to Follow-up|3|||
23162904|NCT00845650|64345010|FG003|Overall Study|Lost to Follow-up|1|||
23162905|NCT00845650|64345011|FG004|Overall Study|Lost to Follow-up|0|||
23162906|NCT00845650|64345012|FG005|Overall Study|Lost to Follow-up|1|||
23162907|NCT00845650|64345007|FG000|Overall Study|Sponsor hold on dosing|0|||
23162908|NCT00845650|64345008|FG001|Overall Study|Sponsor hold on dosing|0|||
23162909|NCT00845650|64345009|FG002|Overall Study|Sponsor hold on dosing|0|||
23162910|NCT00845650|64345010|FG003|Overall Study|Sponsor hold on dosing|0|||
23162911|NCT00845650|64345011|FG004|Overall Study|Sponsor hold on dosing|1|||
23162912|NCT00845650|64345012|FG005|Overall Study|Sponsor hold on dosing|1|||
23162913|NCT00845650|64345007|FG000|Overall Study|Unable to access IV line|1|||
23162914|NCT00845650|64345008|FG001|Overall Study|Unable to access IV line|0|||
23570748|NCT05764239|65816873|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
23570749|NCT05764239|65816873|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
23570750|NCT05764239|65816873|FG000|DEP (Part 1)|Adverse Event|1|||
23570751|NCT05764239|65816873|FG000|DEP (Part 1)|Lost to Follow-up|1|||
23570752|NCT05764239|65816873|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
23570753|NCT05764239|65816873|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
23162915|NCT00845650|64345009|FG002|Overall Study|Unable to access IV line|0|||
23162916|NCT00845650|64345010|FG003|Overall Study|Unable to access IV line|0|||
23162917|NCT00845650|64345011|FG004|Overall Study|Unable to access IV line|0|||
23162918|NCT00845650|64345012|FG005|Overall Study|Unable to access IV line|0|||
23331145|NCT01467713|64955363|FG002|Overall Study|Major Protocol Deviation|4|||
23331146|NCT01467713|64955364|FG003|Overall Study|Major Protocol Deviation|1|||
23570754|NCT05764239|65816873|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
23570755|NCT05764239|65816873|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
23570756|NCT00154063|65816874|FG000|Overall Study|Adverse Event|4|||
23570757|NCT00154063|65816875|FG001|Overall Study|Adverse Event|8|||
23570758|NCT00154063|65816874|FG000|Overall Study|Protocol Violation|1|||
23570759|NCT00154063|65816875|FG001|Overall Study|Protocol Violation|1|||
23162919|NCT04712110|64345014|FG000|Overall Study|Lost to Follow-up|0|||
23331147|NCT01467713|64955361|FG000|Overall Study|Lost to Follow-up|9|||
23331148|NCT01467713|64955362|FG001|Overall Study|Lost to Follow-up|12|||
23331149|NCT01467713|64955363|FG002|Overall Study|Lost to Follow-up|6|||
23331150|NCT01467713|64955364|FG003|Overall Study|Lost to Follow-up|9|||
23331151|NCT01467713|64955361|FG000|Overall Study|Voluntary Withdrawal|18|||
23331152|NCT01467713|64955362|FG001|Overall Study|Voluntary Withdrawal|14|||
23331153|NCT01467713|64955363|FG002|Overall Study|Voluntary Withdrawal|21|||
23331154|NCT01467713|64955364|FG003|Overall Study|Voluntary Withdrawal|20|||
23331155|NCT01467713|64955361|FG000|Overall Study|Study Termination|23|||
23331156|NCT01467713|64955362|FG001|Overall Study|Study Termination|33|||
23331157|NCT01467713|64955363|FG002|Overall Study|Study Termination|28|||
23331158|NCT01467713|64955364|FG003|Overall Study|Study Termination|29|||
23331159|NCT01467713|64955361|FG000|Overall Study|Pregnancy|0|||
23331160|NCT01467713|64955362|FG001|Overall Study|Pregnancy|1|||
23331161|NCT01467713|64955363|FG002|Overall Study|Pregnancy|1|||
23331162|NCT01467713|64955364|FG003|Overall Study|Pregnancy|3|||
23331163|NCT01467713|64955361|FG000|Overall Study|Relapse|35|||
23331164|NCT01467713|64955362|FG001|Overall Study|Relapse|25|||
23331165|NCT01467713|64955363|FG002|Overall Study|Relapse|28|||
23331166|NCT01467713|64955364|FG003|Overall Study|Relapse|35|||
23331167|NCT01467713|64955361|FG000|Overall Study|Reason not Specified|6|||
23331168|NCT01467713|64955362|FG001|Overall Study|Reason not Specified|11|||
23331169|NCT01467713|64955363|FG002|Overall Study|Reason not Specified|8|||
23331170|NCT01467713|64955364|FG003|Overall Study|Reason not Specified|7|||
23331171|NCT02366689|64955365|FG000|Overall Study|Withdrawal by Subject|1|||
23331172|NCT02366689|64955366|FG001|Overall Study|Withdrawal by Subject|0|||
23331173|NCT02366689|64955367|FG002|Overall Study|Withdrawal by Subject|1|||
23331174|NCT02366689|64955365|FG000|Overall Study|Lost to Follow-up|3|||
23331175|NCT02366689|64955366|FG001|Overall Study|Lost to Follow-up|2|||
23331176|NCT02366689|64955367|FG002|Overall Study|Lost to Follow-up|0|||
23331177|NCT02366689|64955365|FG000|Overall Study|Pregnancy|0|||
23162920|NCT04712110|64345015|FG001|Overall Study|Lost to Follow-up|1|||
23162921|NCT04712110|64345014|FG000|Overall Study|Withdrawal by Subject|0|||
23331178|NCT02366689|64955366|FG001|Overall Study|Pregnancy|1|||
23331179|NCT02366689|64955367|FG002|Overall Study|Pregnancy|1|||
23331180|NCT01778530|64955368|FG000|Overall Study|Progression on study|1|||
23331181|NCT01778530|64955368|FG000|Overall Study|Adverse event/side effect|1|||
23331182|NCT02406027|64955370|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23331183|NCT02406027|64955371|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
23331184|NCT02406027|64955372|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
23331185|NCT02406027|64955373|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23331186|NCT02406027|64955374|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23331187|NCT02406027|64955375|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23331188|NCT02406027|64955376|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
23331189|NCT02406027|64955370|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
23331190|NCT02406027|64955371|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23331191|NCT02406027|64955372|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
23331192|NCT02406027|64955373|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23331193|NCT02406027|64955374|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23331194|NCT02406027|64955375|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23331195|NCT02406027|64955376|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
23331196|NCT02406027|64955370|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
23331197|NCT02406027|64955371|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
23331198|NCT02406027|64955372|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
23331199|NCT02406027|64955373|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
23331200|NCT02406027|64955374|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
23331201|NCT02406027|64955375|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
23331202|NCT02406027|64955376|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
23331203|NCT02406027|64955370|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
23331204|NCT02406027|64955371|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23331205|NCT02406027|64955372|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
23331206|NCT02406027|64955373|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23331207|NCT02406027|64955374|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23331208|NCT02406027|64955375|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23331209|NCT02406027|64955376|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
23331210|NCT02406027|64955370|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
23331211|NCT02406027|64955371|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
23331212|NCT02406027|64955372|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
23331213|NCT02406027|64955373|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
23331214|NCT02406027|64955374|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
23331215|NCT02406027|64955375|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
23331216|NCT02406027|64955376|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
23331217|NCT02406027|64955370|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
23331218|NCT02406027|64955371|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
23331219|NCT02406027|64955372|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
23331220|NCT02406027|64955373|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
23331221|NCT02406027|64955374|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
23331222|NCT02406027|64955375|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
23331223|NCT02406027|64955376|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
23331224|NCT02406027|64955370|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
23331225|NCT02406027|64955371|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
23331226|NCT02406027|64955372|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
23331227|NCT02406027|64955373|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
23331228|NCT02406027|64955374|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
23331229|NCT02406027|64955375|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
23331230|NCT02406027|64955376|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
23331231|NCT02406027|64955370|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
23331232|NCT02406027|64955371|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
23331233|NCT02406027|64955372|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
23331234|NCT02406027|64955373|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
23331235|NCT02406027|64955374|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
23331236|NCT02406027|64955375|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
23331237|NCT02406027|64955376|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
23331238|NCT02406027|64955370|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23446939|NCT01684202|65377810|FG001|Dose-escalation Period|Adverse Event|1|||
23446940|NCT01684202|65377811|FG002|Dose-escalation Period|Adverse Event|0|||
23446941|NCT01684202|65377812|FG003|Dose-escalation Period|Adverse Event|0|||
23446942|NCT01684202|65377809|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
23446943|NCT01684202|65377810|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
23446944|NCT01684202|65377811|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
23446945|NCT01684202|65377812|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
23446946|NCT01684202|65377809|FG000|Maintenance Period|Adverse Event|1|||
23446947|NCT01684202|65377810|FG001|Maintenance Period|Adverse Event|1|||
23446948|NCT01684202|65377811|FG002|Maintenance Period|Adverse Event|1|||
23446949|NCT01684202|65377812|FG003|Maintenance Period|Adverse Event|1|||
23446950|NCT01684202|65377809|FG000|Maintenance Period|Physician Decision|0|||
23446951|NCT01684202|65377810|FG001|Maintenance Period|Physician Decision|1|||
23446952|NCT01684202|65377811|FG002|Maintenance Period|Physician Decision|0|||
23446953|NCT01684202|65377812|FG003|Maintenance Period|Physician Decision|0|||
23446954|NCT01684202|65377809|FG000|Maintenance Period|Withdrawal by Subject|0|||
23446955|NCT01684202|65377810|FG001|Maintenance Period|Withdrawal by Subject|1|||
23446956|NCT01684202|65377811|FG002|Maintenance Period|Withdrawal by Subject|0|||
23446957|NCT01684202|65377812|FG003|Maintenance Period|Withdrawal by Subject|0|||
23446958|NCT00687739|65377822|FG000|Overall Study|Lost to Follow-up|2|||
23446959|NCT00687739|65377823|FG001|Overall Study|Lost to Follow-up|2|||
23446960|NCT00687739|65377824|FG002|Overall Study|Lost to Follow-up|1|||
23446961|NCT00687739|65377825|FG003|Overall Study|Lost to Follow-up|2|||
23446962|NCT00687739|65377822|FG000|Overall Study|Adverse Event|0|||
23446963|NCT00687739|65377823|FG001|Overall Study|Adverse Event|1|||
23446964|NCT00687739|65377824|FG002|Overall Study|Adverse Event|1|||
23446965|NCT00687739|65377825|FG003|Overall Study|Adverse Event|0|||
23446966|NCT00410761|65377829|FG000|Overall Study|Adverse Event|29|||
23446967|NCT00410761|65377830|FG001|Overall Study|Adverse Event|3|||
23446968|NCT00410761|65377829|FG000|Overall Study|objective disease progression|71|||
23446969|NCT00410761|65377830|FG001|Overall Study|objective disease progression|55|||
23446970|NCT00410761|65377829|FG000|Overall Study|Withdrawal by Subject|8|||
23446971|NCT00410761|65377830|FG001|Overall Study|Withdrawal by Subject|4|||
23446972|NCT00410761|65377829|FG000|Overall Study|Other|12|||
23446973|NCT00410761|65377830|FG001|Overall Study|Other|9|||
23446974|NCT00410761|65377829|FG000|Overall Study|Never received randomised treatment|0|||
23570760|NCT00154063|65816874|FG000|Overall Study|Investigator or Sponsor Request|0|||
23570761|NCT00154063|65816875|FG001|Overall Study|Investigator or Sponsor Request|1|||
23570762|NCT00154063|65816874|FG000|Overall Study|Withdrawal by Subject|4|||
23570763|NCT00154063|65816875|FG001|Overall Study|Withdrawal by Subject|9|||
23570764|NCT00154063|65816874|FG000|Overall Study|Other|3|||
23570765|NCT00154063|65816875|FG001|Overall Study|Other|3|||
23570766|NCT02243631|65816876|FG000|Overall Study|no synovial fluid on second aspirate|0|||
23570767|NCT02243631|65816877|FG001|Overall Study|no synovial fluid on second aspirate|1|||
23570768|NCT01830881|65816880|FG000|Overall Study|Changed decision to have an abortion|0|||
23570769|NCT01830881|65816881|FG001|Overall Study|Changed decision to have an abortion|1|||
23446975|NCT00410761|65377830|FG001|Overall Study|Never received randomised treatment|1|||
23446976|NCT02525588|65377837|FG000|Overall Study|Death|3|||
23446977|NCT02525588|65377838|FG001|Overall Study|Death|1|||
23446978|NCT02525588|65377837|FG000|Overall Study|Lost to Follow-up|2|||
23446979|NCT02525588|65377838|FG001|Overall Study|Lost to Follow-up|0|||
23446980|NCT02525588|65377837|FG000|Overall Study|Withdrawal by Subject|1|||
23570770|NCT04267614|65820756|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
23570771|NCT04267614|65820756|FG000|Overall Study|Lost to Follow-up|115|||
23570772|NCT03017235|65820757|FG000|Overall Study|Withdrawal by Subject|4|||
23570773|NCT03017235|65820758|FG001|Overall Study|Withdrawal by Subject|3|||
23570774|NCT03017235|65820757|FG000|Overall Study|Lost to Follow-up|2|||
23570775|NCT03017235|65820758|FG001|Overall Study|Lost to Follow-up|7|||
23570776|NCT03017235|65820757|FG000|Overall Study|Adverse Event|0|||
23570777|NCT03017235|65820758|FG001|Overall Study|Adverse Event|1|||
23570778|NCT03017235|65820757|FG000|Overall Study|Protocol Violation|2|||
23570779|NCT03017235|65820758|FG001|Overall Study|Protocol Violation|1|||
23570780|NCT03017235|65820757|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
23570781|NCT03017235|65820758|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
23570782|NCT01368211|65820759|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
23570783|NCT01368211|65820760|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
23570784|NCT00363896|65820761|FG000|Overall Study|Withdrawal by Subject|29|||
23570785|NCT00363896|65820762|FG001|Overall Study|Withdrawal by Subject|16|||
23570786|NCT00363896|65820761|FG000|Overall Study|Adverse Event|24|||
23570787|NCT00363896|65820762|FG001|Overall Study|Adverse Event|13|||
23570788|NCT00363896|65820761|FG000|Overall Study|COPD exacerbation|13|||
23570789|NCT00363896|65820762|FG001|Overall Study|COPD exacerbation|7|||
23570790|NCT00363896|65820761|FG000|Overall Study|Lack of Efficacy|12|||
23570791|NCT00363896|65820762|FG001|Overall Study|Lack of Efficacy|8|||
23570792|NCT00363896|65820761|FG000|Overall Study|Protocol Violation|6|||
23570793|NCT00363896|65820762|FG001|Overall Study|Protocol Violation|1|||
23570794|NCT00363896|65820761|FG000|Overall Study|Lost to Follow-up|3|||
23570795|NCT00363896|65820762|FG001|Overall Study|Lost to Follow-up|0|||
23570796|NCT00363896|65820761|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
23570797|NCT00363896|65820762|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
23570798|NCT00363896|65820761|FG000|Overall Study|Other|1|||
23570799|NCT00363896|65820762|FG001|Overall Study|Other|2|||
23331239|NCT02406027|64955371|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23331240|NCT02406027|64955372|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23331241|NCT02406027|64955373|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23331242|NCT02406027|64955374|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23331243|NCT02406027|64955375|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
23331244|NCT02406027|64955376|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
23331245|NCT02406027|64955370|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23331246|NCT02406027|64955371|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23331247|NCT02406027|64955372|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23331248|NCT02406027|64955373|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23331249|NCT02406027|64955374|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
23331250|NCT02406027|64955375|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23331251|NCT02406027|64955376|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
23331252|NCT02431676|64955386|FG000|Overall Study|no lab obtained|0|||
23331253|NCT02431676|64955387|FG001|Overall Study|no lab obtained|1|||
23331254|NCT02431676|64955388|FG002|Overall Study|no lab obtained|2|||
23331255|NCT00086619|64955390|FG000|Overall Study|Withdrawal by Subject|6|||
23331256|NCT00086619|64955391|FG001|Overall Study|Withdrawal by Subject|6|||
23331257|NCT00086619|64955390|FG000|Overall Study|Adverse Event|8|||
23331258|NCT00086619|64955391|FG001|Overall Study|Adverse Event|10|||
23331259|NCT00086619|64955390|FG000|Overall Study|Protocol Violation|1|||
23331260|NCT00086619|64955391|FG001|Overall Study|Protocol Violation|1|||
23331261|NCT02764762|64955392|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23331262|NCT02764762|64955392|FG000|Overall Study|Lost to Follow-up|4|||
23331263|NCT02764762|64955392|FG000|Overall Study|Voluntary Withdrawal|8|||
23331264|NCT02764762|64955392|FG000|Overall Study|Site Termination|1|||
23331265|NCT02764762|64955392|FG000|Overall Study|Lack of Efficacy|16|||
23331266|NCT02764762|64955392|FG000|Overall Study|Reason not Specified|1|||
23331267|NCT01753310|64955393|FG000|Overall Study|Entered into open label extension study|25|||
23331268|NCT01753310|64955394|FG001|Overall Study|Entered into open label extension study|22|||
23331269|NCT01753310|64955393|FG000|Overall Study|Adverse Event|1|||
23331270|NCT01753310|64955394|FG001|Overall Study|Adverse Event|0|||
23331271|NCT01753310|64955393|FG000|Overall Study|Lost to Follow-up|2|||
23446981|NCT02525588|65377838|FG001|Overall Study|Withdrawal by Subject|1|||
23446982|NCT02525588|65377837|FG000|Overall Study|Adverse Event|0|||
23570800|NCT01563978|65820763|FG000|Overall Study|Physician Decision|1|||
23570801|NCT01563978|65820764|FG001|Overall Study|Physician Decision|0|||
23570802|NCT01563978|65820763|FG000|Overall Study|Lost to Follow-up|1|||
23570803|NCT01563978|65820764|FG001|Overall Study|Lost to Follow-up|0|||
23570804|NCT01563978|65820763|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
23570805|NCT01563978|65820764|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
23331272|NCT01753310|64955394|FG001|Overall Study|Lost to Follow-up|0|||
23570806|NCT01563978|65820763|FG000|Overall Study|Adverse Event|1|||
23446983|NCT02525588|65377838|FG001|Overall Study|Adverse Event|1|||
23446984|NCT03229109|65377840|FG000|Overall Study|Withdrawal by Subject|0|||
23446985|NCT03229109|65377841|FG001|Overall Study|Withdrawal by Subject|0|||
23446986|NCT03229109|65377842|FG002|Overall Study|Withdrawal by Subject|0|||
23446987|NCT03229109|65377843|FG003|Overall Study|Withdrawal by Subject|1|||
23446988|NCT01200368|65377844|FG000|Infant Series|Adverse Event|2|||
23446989|NCT01200368|65377845|FG001|Infant Series|Adverse Event|2|||
23446990|NCT01200368|65377846|FG002|Infant Series|Adverse Event|3|||
23446991|NCT01200368|65377844|FG000|Infant Series|Withdrawal by Subject|0|||
23446992|NCT01200368|65377845|FG001|Infant Series|Withdrawal by Subject|2|||
23446993|NCT01200368|65377846|FG002|Infant Series|Withdrawal by Subject|2|||
23223920|NCT02640755|64563927|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
23223921|NCT02640755|64563928|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
23223922|NCT00085644|64563930|FG000|Double-Blind Period|Adverse Event|5|||
23223923|NCT00085644|64563931|FG001|Double-Blind Period|Adverse Event|2|||
23223924|NCT00085644|64563932|FG002|Double-Blind Period|Adverse Event|0|||
23223925|NCT00085644|64563930|FG000|Double-Blind Period|Withdrawal by Subject|3|||
23223926|NCT00085644|64563931|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23223927|NCT00085644|64563932|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23223928|NCT00085644|64563930|FG000|Double-Blind Period|Lost to Follow-up|2|||
23223929|NCT00085644|64563931|FG001|Double-Blind Period|Lost to Follow-up|1|||
23223930|NCT00085644|64563932|FG002|Double-Blind Period|Lost to Follow-up|0|||
23223931|NCT00085644|64563930|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
23223932|NCT00085644|64563931|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
23223933|NCT00085644|64563932|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
23223934|NCT00085644|64563930|FG000|Double-Blind Period|Contemplating pregnancy|1|||
23223935|NCT00085644|64563931|FG001|Double-Blind Period|Contemplating pregnancy|0|||
23223936|NCT00085644|64563932|FG002|Double-Blind Period|Contemplating pregnancy|0|||
23223937|NCT00085644|64563930|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
23223938|NCT00085644|64563931|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
23223939|NCT00085644|64563932|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
23331273|NCT01753310|64955393|FG000|Overall Study|Subject decision|2|||
23331274|NCT01753310|64955394|FG001|Overall Study|Subject decision|2|||
23331275|NCT01753310|64955393|FG000|Overall Study|Sponsor decision|1|||
23331276|NCT01753310|64955394|FG001|Overall Study|Sponsor decision|0|||
23331277|NCT01753310|64955393|FG000|Overall Study|Withdrawal by Subject|1|||
23331278|NCT01753310|64955394|FG001|Overall Study|Withdrawal by Subject|0|||
23331279|NCT01209520|64955395|FG000|Overall Study|Withdrawal by Subject|3|||
23331280|NCT00687271|64955396|FG000|Overall Study|Adverse Event|1|||
23331281|NCT00687271|64955397|FG001|Overall Study|Adverse Event|3|||
23331282|NCT00687271|64955398|FG002|Overall Study|Adverse Event|1|||
23331283|NCT00687271|64955399|FG003|Overall Study|Adverse Event|0|||
23331284|NCT00687271|64955396|FG000|Overall Study|Lost to Follow-up|0|||
23331285|NCT00687271|64955397|FG001|Overall Study|Lost to Follow-up|1|||
23331286|NCT00687271|64955398|FG002|Overall Study|Lost to Follow-up|0|||
23331287|NCT00687271|64955399|FG003|Overall Study|Lost to Follow-up|0|||
23331288|NCT00687271|64955396|FG000|Overall Study|Protocol Violation|2|||
23331289|NCT00687271|64955397|FG001|Overall Study|Protocol Violation|1|||
23331290|NCT00687271|64955398|FG002|Overall Study|Protocol Violation|1|||
23331291|NCT00687271|64955399|FG003|Overall Study|Protocol Violation|0|||
23331292|NCT00687271|64955396|FG000|Overall Study|Withdrawal by Subject|0|||
23331293|NCT00687271|64955397|FG001|Overall Study|Withdrawal by Subject|1|||
23331294|NCT00687271|64955398|FG002|Overall Study|Withdrawal by Subject|3|||
23331295|NCT00687271|64955399|FG003|Overall Study|Withdrawal by Subject|0|||
23331296|NCT00832455|64955400|FG000|Overall Study|Adverse Event|13|||
23223940|NCT00085644|64563930|FG000|Open-Label Period|Adverse Event|0|||
23223941|NCT00085644|64563931|FG001|Open-Label Period|Adverse Event|0|||
23223942|NCT00085644|64563932|FG002|Open-Label Period|Adverse Event|38|||
23223943|NCT00085644|64563930|FG000|Open-Label Period|Withdrawal by Subject|0|||
23331297|NCT00832455|64955400|FG000|Overall Study|Lost to Follow-up|26|||
23331298|NCT00832455|64955400|FG000|Overall Study|Protocol Violation|4|||
23331299|NCT00832455|64955400|FG000|Overall Study|Withdrawal by Subject|17|||
23331300|NCT00832455|64955400|FG000|Overall Study|Screening Failure|2|||
23331301|NCT00832455|64955400|FG000|Overall Study|Stopped Medication|4|||
23331302|NCT00832455|64955400|FG000|Overall Study|Parent misunderstood study|1|||
23331303|NCT00832455|64955400|FG000|Overall Study|Parent dissatisfied|1|||
23331304|NCT00832455|64955400|FG000|Overall Study|No improvement|3|||
23331305|NCT00832455|64955400|FG000|Overall Study|Patient moved|1|||
23446994|NCT01200368|65377844|FG000|Infant Series|Did not meet entrance criteria|0|||
23446995|NCT01200368|65377845|FG001|Infant Series|Did not meet entrance criteria|1|||
23223944|NCT00085644|64563931|FG001|Open-Label Period|Withdrawal by Subject|0|||
23223945|NCT00085644|64563932|FG002|Open-Label Period|Withdrawal by Subject|29|||
23223946|NCT00085644|64563930|FG000|Open-Label Period|Lost to Follow-up|0|||
23223947|NCT00085644|64563931|FG001|Open-Label Period|Lost to Follow-up|0|||
23223948|NCT00085644|64563932|FG002|Open-Label Period|Lost to Follow-up|13|||
23223949|NCT00085644|64563930|FG000|Open-Label Period|Lack of Efficacy|0|||
23223950|NCT00085644|64563931|FG001|Open-Label Period|Lack of Efficacy|0|||
23331306|NCT02028767|64955401|FG000|Treatment Period 2|Non compliant with protocol|1|||
23331307|NCT02028767|64955402|FG001|Treatment Period 2|Non compliant with protocol|0|||
23331308|NCT02028767|64955401|FG000|Treatment Period 2|Reason other than those specified above|1|||
23331309|NCT02028767|64955402|FG001|Treatment Period 2|Reason other than those specified above|0|||
23331310|NCT02195869|64955405|FG000|Overall Study|cGVHD Progression|5|||
23331311|NCT02195869|64955405|FG000|Overall Study|Malignancy Progression/relapse|2|||
23331312|NCT02195869|64955405|FG000|Overall Study|Adverse Event|15|||
23331313|NCT02195869|64955405|FG000|Overall Study|Withdrawal by Subject|7|||
23331314|NCT02195869|64955405|FG000|Overall Study|Physician Decision|4|||
23331315|NCT02195869|64955405|FG000|Overall Study|Study Terminated by Sponsor|7|||
23331316|NCT02195869|64955405|FG000|Overall Study|Noncompliance with study drug|2|||
23331317|NCT01256450|64955406|FG000|Open-label Titration|Adverse Event|39|||
23331318|NCT01256450|64955407|FG001|Open-label Titration|Adverse Event|0|||
23331319|NCT01256450|64955408|FG002|Open-label Titration|Adverse Event|0|||
23331320|NCT01256450|64955406|FG000|Open-label Titration|Lost to Follow-up|7|||
23331321|NCT01256450|64955407|FG001|Open-label Titration|Lost to Follow-up|0|||
23331322|NCT01256450|64955408|FG002|Open-label Titration|Lost to Follow-up|0|||
23331323|NCT01256450|64955406|FG000|Open-label Titration|Lack of analgesic effect|30|||
23331324|NCT01256450|64955407|FG001|Open-label Titration|Lack of analgesic effect|0|||
23331325|NCT01256450|64955408|FG002|Open-label Titration|Lack of analgesic effect|0|||
23331326|NCT01256450|64955406|FG000|Open-label Titration|Non-compliance|9|||
23331327|NCT01256450|64955407|FG001|Open-label Titration|Non-compliance|0|||
23331328|NCT01256450|64955408|FG002|Open-label Titration|Non-compliance|0|||
23331329|NCT01256450|64955406|FG000|Open-label Titration|Screen failure|1|||
23331330|NCT01256450|64955407|FG001|Open-label Titration|Screen failure|0|||
23331331|NCT01256450|64955408|FG002|Open-label Titration|Screen failure|0|||
23331332|NCT01256450|64955406|FG000|Open-label Titration|Other|13|||
23331333|NCT01256450|64955407|FG001|Open-label Titration|Other|0|||
23331334|NCT01256450|64955408|FG002|Open-label Titration|Other|0|||
23331335|NCT01256450|64955406|FG000|Double-blind Treatment|Adverse Event|0|||
23331336|NCT01256450|64955407|FG001|Double-blind Treatment|Adverse Event|8|||
23331337|NCT01256450|64955408|FG002|Double-blind Treatment|Adverse Event|6|||
23331338|NCT01256450|64955406|FG000|Double-blind Treatment|Lost to Follow-up|0|||
23331339|NCT01256450|64955407|FG001|Double-blind Treatment|Lost to Follow-up|1|||
23331340|NCT01256450|64955408|FG002|Double-blind Treatment|Lost to Follow-up|7|||
23331341|NCT01256450|64955406|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
23331342|NCT01256450|64955407|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
23331343|NCT01256450|64955408|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
23331344|NCT01256450|64955406|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
23331345|NCT01256450|64955407|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
23331346|NCT01256450|64955408|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
23570807|NCT01563978|65820764|FG001|Overall Study|Adverse Event|2|||
23570808|NCT02887989|65820769|FG000|Overall Study|Withdrawal by Subject|8|||
23570809|NCT02887989|65820770|FG001|Overall Study|Withdrawal by Subject|11|||
23570810|NCT02887989|65820769|FG000|Overall Study|Death|1|||
23570811|NCT02887989|65820770|FG001|Overall Study|Death|0|||
23570812|NCT03567993|65820771|FG000|Overall Study|Lost to Follow-up|4|||
23570813|NCT03567993|65820772|FG001|Overall Study|Lost to Follow-up|2|||
23570814|NCT03567993|65820771|FG000|Overall Study|Death|1|||
23570815|NCT03567993|65820772|FG001|Overall Study|Death|1|||
23570816|NCT03567993|65820771|FG000|Overall Study|Withdrawal by Subject|1|||
23570817|NCT03567993|65820772|FG001|Overall Study|Withdrawal by Subject|0|||
23570818|NCT01254565|65820777|FG000|Overall Study|Non-compliance to Study Procedures|0|||
23162922|NCT04712110|64345015|FG001|Overall Study|Withdrawal by Subject|4|||
23162923|NCT04712110|64345014|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
23162924|NCT04712110|64345015|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
23162925|NCT00294060|64345016|FG000|Overall Study|Death|225|||
23162926|NCT00294060|64345016|FG000|Overall Study|Other|59|||
23162927|NCT00294060|64345016|FG000|Overall Study|Lost to Follow-up|55|||
23162928|NCT00294060|64345016|FG000|Overall Study|Withdrawal by Subject|11|||
23331347|NCT01256450|64955406|FG000|Double-blind Treatment|Non-compliance|0|||
23331348|NCT01256450|64955407|FG001|Double-blind Treatment|Non-compliance|5|||
23331349|NCT01256450|64955408|FG002|Double-blind Treatment|Non-compliance|4|||
23331350|NCT01256450|64955406|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
23331351|NCT01256450|64955407|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
23331352|NCT01256450|64955408|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
23570819|NCT01254565|65820778|FG001|Overall Study|Non-compliance to Study Procedures|0|||
23570820|NCT01254565|65820779|FG002|Overall Study|Non-compliance to Study Procedures|0|||
23570821|NCT01254565|65820780|FG003|Overall Study|Non-compliance to Study Procedures|0|||
23162929|NCT00294060|64345016|FG000|Overall Study|Physician Decision|797|||
23331353|NCT01256450|64955406|FG000|Double-blind Treatment|Other|0|||
23331354|NCT01256450|64955407|FG001|Double-blind Treatment|Other|9|||
23331355|NCT01256450|64955408|FG002|Double-blind Treatment|Other|12|||
23331356|NCT01620138|64955409|FG000|Overall Study|Withdrawal by Subject|3|||
23570822|NCT01254565|65820781|FG004|Overall Study|Non-compliance to Study Procedures|1|||
23223951|NCT00085644|64563932|FG002|Open-Label Period|Lack of Efficacy|15|||
23223952|NCT00085644|64563930|FG000|Open-Label Period|Pregnancy|0|||
23223953|NCT00085644|64563931|FG001|Open-Label Period|Pregnancy|0|||
23223954|NCT00085644|64563932|FG002|Open-Label Period|Pregnancy|3|||
23331357|NCT01620138|64955410|FG001|Overall Study|Withdrawal by Subject|0|||
23331358|NCT01620138|64955409|FG000|Overall Study|Lack of Efficacy|1|||
23331359|NCT01620138|64955410|FG001|Overall Study|Lack of Efficacy|0|||
23331360|NCT01620138|64955409|FG000|Overall Study|Adverse Event|2|||
23331361|NCT01620138|64955410|FG001|Overall Study|Adverse Event|0|||
23331362|NCT02019472|64955418|FG000|Overall Study|Adverse Event|14|||
23331363|NCT02019472|64955419|FG001|Overall Study|Adverse Event|23|||
23331364|NCT02019472|64955420|FG002|Overall Study|Adverse Event|17|||
23223955|NCT00085644|64563930|FG000|Open-Label Period|Contemplating pregnancy|0|||
23223956|NCT00085644|64563931|FG001|Open-Label Period|Contemplating pregnancy|0|||
23223957|NCT00085644|64563932|FG002|Open-Label Period|Contemplating pregnancy|3|||
23223958|NCT00085644|64563930|FG000|Open-Label Period|Protocol Violation|0|||
23223959|NCT00085644|64563931|FG001|Open-Label Period|Protocol Violation|0|||
23223960|NCT00085644|64563932|FG002|Open-Label Period|Protocol Violation|4|||
23223961|NCT00085644|64563930|FG000|Open-Label Period|Personal reason|0|||
23223962|NCT00085644|64563931|FG001|Open-Label Period|Personal reason|0|||
23223963|NCT00085644|64563932|FG002|Open-Label Period|Personal reason|4|||
23223964|NCT01998906|64563938|FG000|Overall Study|Participants ongoing in follow-up|77|||
23223965|NCT01998906|64563939|FG001|Overall Study|Participants ongoing in follow-up|60|||
23223966|NCT01998906|64563940|FG002|Overall Study|Participants ongoing in follow-up|58|||
23223967|NCT01998906|64563938|FG000|Overall Study|Death|21|||
23223968|NCT01998906|64563939|FG001|Overall Study|Death|30|||
23223969|NCT01998906|64563940|FG002|Overall Study|Death|17|||
23223970|NCT01998906|64563938|FG000|Overall Study|Lack of Efficacy|10|||
23223971|NCT01998906|64563939|FG001|Overall Study|Lack of Efficacy|9|||
23223972|NCT01998906|64563940|FG002|Overall Study|Lack of Efficacy|8|||
23223973|NCT01998906|64563938|FG000|Overall Study|Failure to return|0|||
23223974|NCT01998906|64563939|FG001|Overall Study|Failure to return|2|||
23223975|NCT01998906|64563940|FG002|Overall Study|Failure to return|4|||
23223976|NCT01998906|64563938|FG000|Overall Study|Violation of Selection Criteria|0|||
23223977|NCT01998906|64563939|FG001|Overall Study|Violation of Selection Criteria|0|||
23223978|NCT01998906|64563940|FG002|Overall Study|Violation of Selection Criteria|1|||
23223979|NCT01998906|64563938|FG000|Overall Study|Withdrawal by Subject|1|||
23223980|NCT01998906|64563939|FG001|Overall Study|Withdrawal by Subject|4|||
23223981|NCT01998906|64563940|FG002|Overall Study|Withdrawal by Subject|3|||
23223982|NCT01998906|64563938|FG000|Overall Study|Administrative/Other|2|||
23223983|NCT01998906|64563939|FG001|Overall Study|Administrative/Other|1|||
23223984|NCT01998906|64563940|FG002|Overall Study|Administrative/Other|3|||
23223985|NCT01998906|64563938|FG000|Overall Study|Other|3|||
23223986|NCT01998906|64563939|FG001|Overall Study|Other|8|||
23223987|NCT01998906|64563940|FG002|Overall Study|Other|4|||
23223988|NCT02280096|64563941|FG000|Overall Study|Pregnancy|1|||
23223989|NCT02280096|64563942|FG001|Overall Study|Pregnancy|0|||
23223990|NCT02280096|64563941|FG000|Overall Study|Functional neurological disorder|1|||
23223991|NCT02280096|64563942|FG001|Overall Study|Functional neurological disorder|0|||
23223992|NCT02280096|64563941|FG000|Overall Study|Lack of attachment|0|||
23223993|NCT02280096|64563942|FG001|Overall Study|Lack of attachment|1|||
23223994|NCT04785144|64563943|FG000|Overall Study|Withdrawal by Subject|4|||
23223995|NCT04785144|64563944|FG001|Overall Study|Withdrawal by Subject|1|||
23331365|NCT02019472|64955418|FG000|Overall Study|Death|0|||
23331366|NCT02019472|64955419|FG001|Overall Study|Death|1|||
23331367|NCT02019472|64955420|FG002|Overall Study|Death|1|||
23162930|NCT00294060|64345016|FG000|Overall Study|Medical condition|3|||
23223996|NCT04785144|64563945|FG002|Overall Study|Withdrawal by Subject|0|||
23223997|NCT04785144|64563946|FG003|Overall Study|Withdrawal by Subject|0|||
23223998|NCT04785144|64563947|FG004|Overall Study|Withdrawal by Subject|0|||
23223999|NCT04785144|64563948|FG005|Overall Study|Withdrawal by Subject|2|||
23224000|NCT04785144|64563949|FG006|Overall Study|Withdrawal by Subject|2|||
23224001|NCT04785144|64563950|FG007|Overall Study|Withdrawal by Subject|0|||
23224002|NCT04785144|64563951|FG008|Overall Study|Withdrawal by Subject|1|||
23224003|NCT04785144|64563952|FG009|Overall Study|Withdrawal by Subject|0|||
23224004|NCT04785144|64563943|FG000|Overall Study|Lost to Follow-up|1|||
23224005|NCT04785144|64563944|FG001|Overall Study|Lost to Follow-up|0|||
23224006|NCT04785144|64563945|FG002|Overall Study|Lost to Follow-up|0|||
23224007|NCT04785144|64563946|FG003|Overall Study|Lost to Follow-up|0|||
23224008|NCT04785144|64563947|FG004|Overall Study|Lost to Follow-up|1|||
23224009|NCT04785144|64563948|FG005|Overall Study|Lost to Follow-up|2|||
23224010|NCT04785144|64563949|FG006|Overall Study|Lost to Follow-up|1|||
23224011|NCT04785144|64563950|FG007|Overall Study|Lost to Follow-up|2|||
23224012|NCT04785144|64563951|FG008|Overall Study|Lost to Follow-up|4|||
23331368|NCT02019472|64955418|FG000|Overall Study|Lack of Efficacy|7|||
23162931|NCT00294060|64345016|FG000|Overall Study|Device explanted/not replaced|23|||
23446996|NCT01200368|65377846|FG002|Infant Series|Did not meet entrance criteria|0|||
23446997|NCT01200368|65377844|FG000|Infant Series|Randomized, not vaccinated|0|||
23570823|NCT01254565|65820782|FG005|Overall Study|Non-compliance to Study Procedures|0|||
23570824|NCT01254565|65820777|FG000|Overall Study|Did not Receive Treatment|1|||
23570825|NCT01254565|65820778|FG001|Overall Study|Did not Receive Treatment|1|||
23570826|NCT01254565|65820779|FG002|Overall Study|Did not Receive Treatment|0|||
23570827|NCT01254565|65820780|FG003|Overall Study|Did not Receive Treatment|0|||
23570828|NCT01254565|65820781|FG004|Overall Study|Did not Receive Treatment|3|||
23570829|NCT01254565|65820782|FG005|Overall Study|Did not Receive Treatment|4|||
23570830|NCT01254565|65820777|FG000|Overall Study|Other|0|||
23570831|NCT01254565|65820778|FG001|Overall Study|Other|0|||
23570832|NCT01254565|65820779|FG002|Overall Study|Other|0|||
23570833|NCT01254565|65820780|FG003|Overall Study|Other|1|||
23570834|NCT01254565|65820781|FG004|Overall Study|Other|0|||
23570835|NCT01254565|65820782|FG005|Overall Study|Other|0|||
23570836|NCT01266993|65820783|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
23570837|NCT01266993|65820784|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
23570838|NCT01266993|65820783|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
23570839|NCT01266993|65820784|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
23570840|NCT01003184|65820788|FG000|Overall Study|Adverse Event|12|||
23570841|NCT01003184|65820789|FG001|Overall Study|Adverse Event|5|||
23570842|NCT01003184|65820788|FG000|Overall Study|Lost to Follow-up|1|||
23570843|NCT01003184|65820789|FG001|Overall Study|Lost to Follow-up|0|||
23570844|NCT01003184|65820788|FG000|Overall Study|Loss of glucose control|1|||
23570845|NCT01003184|65820789|FG001|Overall Study|Loss of glucose control|1|||
23570846|NCT01003184|65820788|FG000|Overall Study|Protocol Violation|3|||
23570847|NCT01003184|65820789|FG001|Overall Study|Protocol Violation|0|||
23570848|NCT01003184|65820788|FG000|Overall Study|Withdrawal by Subject|1|||
23570849|NCT01003184|65820789|FG001|Overall Study|Withdrawal by Subject|6|||
23570850|NCT01003184|65820788|FG000|Overall Study|Physician Decision|1|||
23570851|NCT01003184|65820789|FG001|Overall Study|Physician Decision|0|||
23570852|NCT00557622|65820812|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
23570853|NCT00557622|65820813|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
23570854|NCT00557622|65820812|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
23570855|NCT00557622|65820813|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
23570856|NCT00557622|65820812|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
23570857|NCT00557622|65820813|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
23570858|NCT01289041|65820814|FG000|Overall Study|Adverse Event|24|||
23570859|NCT01289041|65820814|FG000|Overall Study|Physician Decision|1|||
23570860|NCT01289041|65820814|FG000|Overall Study|Progressive Disease|41|||
23570861|NCT01289041|65820814|FG000|Overall Study|Withdrawal by Subject|3|||
23570862|NCT01289041|65820814|FG000|Overall Study|Death|1|||
23570863|NCT02533258|65820815|FG000|Overall Study|Adverse Event|1|||
23570864|NCT02533258|65820815|FG000|Overall Study|Death|2|||
23570865|NCT02533258|65820815|FG000|Overall Study|Other|1|||
23570866|NCT02533258|65820815|FG000|Overall Study|Economic factor|1|||
23570867|NCT02533258|65820815|FG000|Overall Study|Progression of pleural effusion|1|||
23570868|NCT02533258|65820815|FG000|Overall Study|Lack of Efficacy|2|||
23570869|NCT02141659|65820816|FG000|Overall Study|Major Protocol Deviation|0|||
23570870|NCT02141659|65820817|FG001|Overall Study|Major Protocol Deviation|1|||
23570871|NCT02141659|65820818|FG002|Overall Study|Major Protocol Deviation|0|||
23570872|NCT02141659|65820819|FG003|Overall Study|Major Protocol Deviation|0|||
23570873|NCT02141659|65820820|FG004|Overall Study|Major Protocol Deviation|0|||
23570874|NCT02141659|65820821|FG005|Overall Study|Major Protocol Deviation|0|||
23570875|NCT02141659|65820816|FG000|Overall Study|Lack of Efficacy|0|||
23570876|NCT02141659|65820817|FG001|Overall Study|Lack of Efficacy|0|||
23570877|NCT02141659|65820818|FG002|Overall Study|Lack of Efficacy|0|||
23570878|NCT02141659|65820819|FG003|Overall Study|Lack of Efficacy|0|||
23570879|NCT02141659|65820820|FG004|Overall Study|Lack of Efficacy|0|||
23570880|NCT02141659|65820821|FG005|Overall Study|Lack of Efficacy|1|||
23570881|NCT02141659|65820816|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
23162932|NCT00574275|64345021|FG000|Overall Study|Randomized but not treated|2|||
23331369|NCT02019472|64955419|FG001|Overall Study|Lack of Efficacy|4|||
23570882|NCT02141659|65820817|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
23570883|NCT02141659|65820818|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
23570884|NCT02141659|65820819|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
23570885|NCT02141659|65820820|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
23570886|NCT02141659|65820821|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
23570887|NCT01591460|65820824|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
23570888|NCT01591460|65820824|FG000|Overall Study|Futility Rule (Week 12)|7|||
23570889|NCT01591460|65820824|FG000|Overall Study|Futility Rule (Week 24)|3|||
23570890|NCT01591460|65820824|FG000|Overall Study|Rebound or Breakthrough|3|||
23570891|NCT01591460|65820824|FG000|Overall Study|Treatment Discontinued by Error|1|||
23570892|NCT01591460|65820824|FG000|Overall Study|Lost to Follow-up|1|||
23570893|NCT01591460|65820824|FG000|Overall Study|Noncompliance|1|||
23570894|NCT01591460|65820824|FG000|Overall Study|Participant Refusal|3|||
23570895|NCT01591460|65820824|FG000|Overall Study|Withdrawal by Subject|1|||
23570896|NCT01591460|65820824|FG000|Overall Study|Protocol Violation|1|||
23570897|NCT00429494|65820827|FG000|Overall Study|Withdrawal by Subject|9|||
23570898|NCT00429494|65820827|FG000|Overall Study|Death|6|||
23570899|NCT00569803|65820828|FG000|Overall Study|Lost to Follow-up|1|||
23570900|NCT00569803|65820829|FG001|Overall Study|Lost to Follow-up|0|||
23570901|NCT00569803|65820830|FG002|Overall Study|Lost to Follow-up|0|||
23570902|NCT00569803|65820831|FG003|Overall Study|Lost to Follow-up|0|||
23570903|NCT00569803|65820832|FG004|Overall Study|Lost to Follow-up|0|||
23570904|NCT00569803|65820833|FG005|Overall Study|Lost to Follow-up|0|||
23570905|NCT00569803|65820834|FG006|Overall Study|Lost to Follow-up|0|||
23570906|NCT00569803|65820835|FG007|Overall Study|Lost to Follow-up|0|||
23570907|NCT00569803|65820828|FG000|Overall Study|injection syringe leaked during dosing|0|||
23570908|NCT00569803|65820829|FG001|Overall Study|injection syringe leaked during dosing|0|||
23570909|NCT00569803|65820830|FG002|Overall Study|injection syringe leaked during dosing|0|||
23570910|NCT00569803|65820831|FG003|Overall Study|injection syringe leaked during dosing|1|||
23570911|NCT00569803|65820832|FG004|Overall Study|injection syringe leaked during dosing|0|||
23570912|NCT00569803|65820833|FG005|Overall Study|injection syringe leaked during dosing|0|||
23570913|NCT00569803|65820834|FG006|Overall Study|injection syringe leaked during dosing|0|||
23570914|NCT00569803|65820835|FG007|Overall Study|injection syringe leaked during dosing|0|||
23570915|NCT00569803|65820828|FG000|Overall Study|Withdrawal by Subject|0|||
23570916|NCT00569803|65820829|FG001|Overall Study|Withdrawal by Subject|0|||
23570917|NCT00569803|65820830|FG002|Overall Study|Withdrawal by Subject|0|||
23570918|NCT00569803|65820831|FG003|Overall Study|Withdrawal by Subject|0|||
23570919|NCT00569803|65820832|FG004|Overall Study|Withdrawal by Subject|0|||
23570920|NCT00569803|65820833|FG005|Overall Study|Withdrawal by Subject|0|||
23570921|NCT00569803|65820834|FG006|Overall Study|Withdrawal by Subject|0|||
23570922|NCT00569803|65820835|FG007|Overall Study|Withdrawal by Subject|1|||
23570923|NCT02258464|65820836|FG000|Overall Study|Progressive disease (PD)|9|||
23570924|NCT02258464|65820837|FG001|Overall Study|Progressive disease (PD)|17|||
23570925|NCT02258464|65820836|FG000|Overall Study|Study drug never administered|1|||
23570926|NCT02258464|65820837|FG001|Overall Study|Study drug never administered|1|||
23162933|NCT00574275|64345022|FG001|Overall Study|Randomized but not treated|3|||
23162934|NCT00574275|64345021|FG000|Overall Study|Adverse Event|32|||
23162935|NCT00574275|64345022|FG001|Overall Study|Adverse Event|76|||
23570927|NCT02258464|65820836|FG000|Overall Study|AE not related to clinical PD|1|||
23570928|NCT02258464|65820837|FG001|Overall Study|AE not related to clinical PD|3|||
23570929|NCT02258464|65820836|FG000|Overall Study|Withdrawal by Subject|5|||
23570930|NCT02258464|65820837|FG001|Overall Study|Withdrawal by Subject|4|||
23570931|NCT02258464|65820836|FG000|Overall Study|AE related to clinical PD|1|||
23570932|NCT02258464|65820837|FG001|Overall Study|AE related to clinical PD|0|||
23570933|NCT01558674|65820838|FG000|Part 1|Study Terminated by Sponsor|10|||
23570934|NCT01558674|65820839|FG001|Part 1|Study Terminated by Sponsor|0|||
23570935|NCT01558674|65820838|FG000|Part 1|Withdrawal by Subject|1|||
23570936|NCT01558674|65820839|FG001|Part 1|Withdrawal by Subject|0|||
23570937|NCT00785538|65820840|FG000|Treatment Period|Adverse Event|1|||
23570938|NCT00785538|65820841|FG001|Treatment Period|Adverse Event|2|||
23570939|NCT00785538|65820842|FG002|Treatment Period|Adverse Event|2|||
23570940|NCT00785538|65820843|FG003|Treatment Period|Adverse Event|0|||
23570941|NCT00785538|65820840|FG000|Treatment Period|Withdrawal by Subject|0|||
23570942|NCT00785538|65820841|FG001|Treatment Period|Withdrawal by Subject|0|||
23570943|NCT00785538|65820842|FG002|Treatment Period|Withdrawal by Subject|0|||
23331370|NCT02019472|64955420|FG002|Overall Study|Lack of Efficacy|4|||
23331371|NCT02019472|64955418|FG000|Overall Study|Lost to Follow-up|0|||
23331372|NCT02019472|64955419|FG001|Overall Study|Lost to Follow-up|2|||
23331373|NCT02019472|64955420|FG002|Overall Study|Lost to Follow-up|1|||
23331374|NCT02019472|64955418|FG000|Overall Study|Physician Decision|1|||
23331375|NCT02019472|64955419|FG001|Overall Study|Physician Decision|2|||
23331376|NCT02019472|64955420|FG002|Overall Study|Physician Decision|0|||
23331377|NCT02019472|64955418|FG000|Overall Study|Pregnancy|1|||
23331378|NCT02019472|64955419|FG001|Overall Study|Pregnancy|2|||
23331379|NCT02019472|64955420|FG002|Overall Study|Pregnancy|2|||
23331380|NCT02019472|64955418|FG000|Overall Study|Withdrawal by Subject|11|||
23331381|NCT02019472|64955419|FG001|Overall Study|Withdrawal by Subject|10|||
23331382|NCT02019472|64955420|FG002|Overall Study|Withdrawal by Subject|11|||
23331383|NCT02019472|64955418|FG000|Overall Study|Other|3|||
23331384|NCT02019472|64955419|FG001|Overall Study|Other|8|||
23331385|NCT02019472|64955420|FG002|Overall Study|Other|6|||
23331386|NCT02572570|64955421|FG000|Overall Study|Study Terminated|27|||
23331387|NCT01483027|64955422|FG000|Overall Study|Administrative Reasons|2|||
23331388|NCT01483027|64955423|FG001|Overall Study|Administrative Reasons|1|||
23331389|NCT01483027|64955422|FG000|Overall Study|Withdrawal by Subject|21|||
23331390|NCT01483027|64955423|FG001|Overall Study|Withdrawal by Subject|32|||
23331391|NCT01483027|64955422|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
23331392|NCT01483027|64955423|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
23331393|NCT01483027|64955422|FG000|Overall Study|Lost to Follow-up|1|||
23331394|NCT01483027|64955423|FG001|Overall Study|Lost to Follow-up|1|||
23331395|NCT01483027|64955422|FG000|Overall Study|Adverse Event|0|||
23570944|NCT00785538|65820843|FG003|Treatment Period|Withdrawal by Subject|1|||
23570945|NCT04022889|65820846|FG000|Stage 1: Period 1|Adverse Event|1|||
23331396|NCT01483027|64955423|FG001|Overall Study|Adverse Event|1|||
23331397|NCT01483027|64955422|FG000|Overall Study|Withdrawal by Subject|0|||
23331398|NCT01483027|64955423|FG001|Overall Study|Withdrawal by Subject|1|||
23570946|NCT04022889|65820847|FG001|Stage 1: Period 1|Adverse Event|0|||
23331399|NCT03866512|64955424|FG000|Overall Study|Lost to Follow-up|1|||
23331400|NCT03866512|64955425|FG001|Overall Study|Lost to Follow-up|2|||
23570947|NCT04022889|65820848|FG002|Stage 1: Period 1|Adverse Event|0|||
23582246|NCT00567879|65862413|FG003|Overall Study|Abnormal test procedure(s)|0|||
23570948|NCT04022889|65820846|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
23570949|NCT04022889|65820847|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
23570950|NCT04022889|65820848|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
23570951|NCT04022889|65820846|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
23570952|NCT04022889|65820847|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
23570953|NCT04022889|65820848|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
23570954|NCT04022889|65820846|FG000|Stage 2|Screen Failure|0|||
23570955|NCT04022889|65820847|FG001|Stage 2|Screen Failure|0|||
23570956|NCT04022889|65820848|FG002|Stage 2|Screen Failure|3|||
23162936|NCT00574275|64345021|FG000|Overall Study|Disease progression|160|||
23162937|NCT00574275|64345022|FG001|Overall Study|Disease progression|146|||
23162938|NCT00574275|64345021|FG000|Overall Study|Lost to Follow-up|2|||
23162939|NCT00574275|64345022|FG001|Overall Study|Lost to Follow-up|1|||
23162940|NCT00574275|64345021|FG000|Overall Study|Study stopped based on DMC decision|62|||
23162941|NCT00574275|64345022|FG001|Overall Study|Study stopped based on DMC decision|23|||
23162942|NCT00574275|64345021|FG000|Overall Study|Withdrawal by Subject|15|||
23162943|NCT00574275|64345022|FG001|Overall Study|Withdrawal by Subject|17|||
23162944|NCT00574275|64345021|FG000|Overall Study|Error calculating tumor measurement|1|||
23162945|NCT00574275|64345022|FG001|Overall Study|Error calculating tumor measurement|0|||
23570957|NCT04022889|65820846|FG000|Stage 2|Ineligible for apheresis donation|0|||
23570958|NCT04022889|65820847|FG001|Stage 2|Ineligible for apheresis donation|0|||
23570959|NCT04022889|65820848|FG002|Stage 2|Ineligible for apheresis donation|2|||
23570960|NCT04022889|65820846|FG000|Stage 2|Adverse Event|0|||
23570961|NCT04022889|65820847|FG001|Stage 2|Adverse Event|0|||
23570962|NCT04022889|65820848|FG002|Stage 2|Adverse Event|2|||
23570963|NCT04022889|65820846|FG000|Stage 2|Protocol Violation|0|||
23570964|NCT04022889|65820847|FG001|Stage 2|Protocol Violation|0|||
23570965|NCT04022889|65820848|FG002|Stage 2|Protocol Violation|1|||
23570966|NCT04022889|65820846|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
23570967|NCT04022889|65820847|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
23570968|NCT04022889|65820848|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
23331401|NCT03866512|64955426|FG002|Overall Study|Lost to Follow-up|1|||
23331402|NCT03866512|64955424|FG000|Overall Study|Cannulation issues|0|||
23331403|NCT03866512|64955425|FG001|Overall Study|Cannulation issues|1|||
23331404|NCT03866512|64955426|FG002|Overall Study|Cannulation issues|2|||
23331405|NCT02859337|64955427|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
23331406|NCT02859337|64955428|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
23331407|NCT02859337|64955429|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
23331408|NCT02859337|64955427|FG000|Overall Study|Withdrawal by Subject|3|||
23331409|NCT02859337|64955428|FG001|Overall Study|Withdrawal by Subject|1|||
23331410|NCT02859337|64955429|FG002|Overall Study|Withdrawal by Subject|0|||
23331411|NCT02859337|64955427|FG000|Overall Study|Lost to Follow-up|1|||
23331412|NCT02859337|64955428|FG001|Overall Study|Lost to Follow-up|0|||
23331413|NCT02859337|64955429|FG002|Overall Study|Lost to Follow-up|0|||
23331414|NCT01806051|64955430|FG000|Overall Study|Withdrawal by Subject|6|||
23331415|NCT03682848|64955434|FG000|Overall Study|Withdrawal by Subject|2|||
23331416|NCT03682848|64955434|FG000|Overall Study|Site closed|5|||
23331417|NCT03682848|64955434|FG000|Overall Study|Protocol Deviation|1|||
23331418|NCT03682848|64955434|FG000|Overall Study|Adverse Event|1|||
23331419|NCT05966584|64955435|FG000|Overall Study|Lost to Follow-up|1|||
23331420|NCT00030901|64955436|FG000|Initial Registration|Ineligible|167|||
23331421|NCT00030901|64955437|FG001|Initial Registration|Ineligible|0|||
23331422|NCT00030901|64955438|FG002|Initial Registration|Ineligible|0|||
23331423|NCT00030901|64955436|FG000|Randomization|Adverse Event|0|||
23331424|NCT00030901|64955437|FG001|Randomization|Adverse Event|11|||
23331425|NCT00030901|64955438|FG002|Randomization|Adverse Event|7|||
23331426|NCT00030901|64955436|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
23331427|NCT00030901|64955437|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
23331428|NCT00030901|64955438|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
23162946|NCT00574275|64345021|FG000|Overall Study|Physician Decision|1|||
23162947|NCT00574275|64345022|FG001|Overall Study|Physician Decision|1|||
23162948|NCT00574275|64345021|FG000|Overall Study|Protocol Violation|0|||
23162949|NCT00574275|64345022|FG001|Overall Study|Protocol Violation|1|||
23570969|NCT01816763|65820849|FG000|Overall Study|The main reason for an incomplete survey|4|||
23162950|NCT00574275|64345021|FG000|Overall Study|Patient and Investigator decision|0|||
23162951|NCT00574275|64345022|FG001|Overall Study|Patient and Investigator decision|1|||
23331429|NCT00030901|64955436|FG000|Randomization|Progression/Relapse|0|||
23162952|NCT00574275|64345021|FG000|Overall Study|Insurance change|0|||
23162953|NCT00574275|64345022|FG001|Overall Study|Insurance change|1|||
23331430|NCT00030901|64955437|FG001|Randomization|Progression/Relapse|22|||
23331431|NCT00030901|64955438|FG002|Randomization|Progression/Relapse|21|||
23331432|NCT00030901|64955436|FG000|Randomization|Death|0|||
23570970|NCT01816763|65820850|FG001|Overall Study|The main reason for an incomplete survey|15|||
23570971|NCT01816763|65820851|FG002|Overall Study|The main reason for an incomplete survey|11|||
23570972|NCT03548064|65820852|FG000|Overall Study|Withdrawal by Subject|0|||
23570973|NCT03548064|65820853|FG001|Overall Study|Withdrawal by Subject|0|||
23570974|NCT03548064|65820854|FG002|Overall Study|Withdrawal by Subject|0|||
23570975|NCT03548064|65820855|FG003|Overall Study|Withdrawal by Subject|1|||
23570976|NCT03548064|65820856|FG004|Overall Study|Withdrawal by Subject|0|||
23570977|NCT03548064|65820857|FG005|Overall Study|Withdrawal by Subject|0|||
23570978|NCT03548064|65820858|FG006|Overall Study|Withdrawal by Subject|0|||
23570979|NCT03548064|65820859|FG007|Overall Study|Withdrawal by Subject|0|||
23570980|NCT03548064|65820852|FG000|Overall Study|Lost to Follow-up|0|||
23570981|NCT03548064|65820853|FG001|Overall Study|Lost to Follow-up|0|||
23570982|NCT03548064|65820854|FG002|Overall Study|Lost to Follow-up|0|||
23570983|NCT03548064|65820855|FG003|Overall Study|Lost to Follow-up|0|||
23570984|NCT03548064|65820856|FG004|Overall Study|Lost to Follow-up|2|||
23570985|NCT03548064|65820857|FG005|Overall Study|Lost to Follow-up|0|||
23570986|NCT03548064|65820858|FG006|Overall Study|Lost to Follow-up|0|||
23570987|NCT03548064|65820859|FG007|Overall Study|Lost to Follow-up|0|||
23570988|NCT03548064|65820852|FG000|Overall Study|Covid-19 Pandemic|0|||
23570989|NCT03548064|65820853|FG001|Overall Study|Covid-19 Pandemic|0|||
23570990|NCT03548064|65820854|FG002|Overall Study|Covid-19 Pandemic|0|||
23570991|NCT03548064|65820855|FG003|Overall Study|Covid-19 Pandemic|0|||
23570992|NCT03548064|65820856|FG004|Overall Study|Covid-19 Pandemic|10|||
23570993|NCT03548064|65820857|FG005|Overall Study|Covid-19 Pandemic|3|||
23570994|NCT03548064|65820858|FG006|Overall Study|Covid-19 Pandemic|0|||
23570995|NCT03548064|65820859|FG007|Overall Study|Covid-19 Pandemic|0|||
23570996|NCT00238420|65820860|FG000|Overall Study|Protocol Violation|1|||
23570997|NCT00238420|65820861|FG001|Overall Study|Protocol Violation|1|||
23570998|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
23570999|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
23571000|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
23571001|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
23571002|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
23571003|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
23571004|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
23571005|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
23571006|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
23571007|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
23571008|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
23571009|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
23571010|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
23571011|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
23571012|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
23571013|NCT02023879|65820862|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
23571014|NCT02023879|65820863|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
23571015|NCT02023879|65820864|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
23571016|NCT02023879|65820862|FG000|Extension Open Label Treatment|Adverse Event|1|||
23571017|NCT02023879|65820863|FG001|Extension Open Label Treatment|Adverse Event|7|||
23571018|NCT02023879|65820864|FG002|Extension Open Label Treatment|Adverse Event|3|||
23571019|NCT02023879|65820862|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
23571020|NCT02023879|65820863|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
23571021|NCT02023879|65820864|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
23571022|NCT02023879|65820862|FG000|Extension Open Label Treatment|Participant moved|1|||
23571023|NCT02023879|65820863|FG001|Extension Open Label Treatment|Participant moved|2|||
23571024|NCT02023879|65820864|FG002|Extension Open Label Treatment|Participant moved|0|||
23571025|NCT02023879|65820862|FG000|Extension Open Label Treatment|Other than specified above|2|||
23571026|NCT02023879|65820863|FG001|Extension Open Label Treatment|Other than specified above|7|||
23571027|NCT02023879|65820864|FG002|Extension Open Label Treatment|Other than specified above|2|||
23571028|NCT01539863|65820865|FG000|Overall Study|Lost to Follow-up|5|||
23571029|NCT01539863|65820866|FG001|Overall Study|Lost to Follow-up|4|||
23571030|NCT03462706|65820867|FG000|Overall Study|Polyp was pedunculated|1|||
23571031|NCT03462706|65820868|FG001|Overall Study|Polyp was pedunculated|0|||
23571032|NCT03462706|65820869|FG002|Overall Study|Polyp was pedunculated|1|||
23571033|NCT03462706|65820870|FG003|Overall Study|Polyp was pedunculated|0|||
23571034|NCT03462706|65820867|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
23571035|NCT03462706|65820868|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
23571036|NCT03462706|65820869|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
23571037|NCT03462706|65820870|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
23571038|NCT02406261|65820871|FG000|Period 1|Lost to Follow-up|2|||
23571039|NCT02406261|65820872|FG001|Period 1|Lost to Follow-up|0|||
23571040|NCT02406261|65820871|FG000|Period 1|Adverse Event|1|||
23571041|NCT02406261|65820872|FG001|Period 1|Adverse Event|0|||
23571042|NCT02406261|65820871|FG000|Period 2|Physician Decision|0|||
23571043|NCT02406261|65820872|FG001|Period 2|Physician Decision|1|||
23571044|NCT02406261|65820871|FG000|Period 2|Protocol Violation|0|||
23571045|NCT02406261|65820872|FG001|Period 2|Protocol Violation|1|||
23571046|NCT02406261|65820871|FG000|Period 2|Withdrawal by Subject|0|||
23571047|NCT02406261|65820872|FG001|Period 2|Withdrawal by Subject|1|||
23571048|NCT00309608|65820874|FG000|Overall Study|Adverse Event|1|||
23571049|NCT00309608|65820875|FG001|Overall Study|Adverse Event|5|||
23571050|NCT00309608|65820876|FG002|Overall Study|Adverse Event|3|||
23571051|NCT00309608|65820877|FG003|Overall Study|Adverse Event|2|||
23571052|NCT00309608|65820878|FG004|Overall Study|Adverse Event|3|||
23571053|NCT00309608|65820874|FG000|Overall Study|Protocol Violation|2|||
23571054|NCT00309608|65820875|FG001|Overall Study|Protocol Violation|0|||
23571055|NCT00309608|65820876|FG002|Overall Study|Protocol Violation|0|||
23571056|NCT00309608|65820877|FG003|Overall Study|Protocol Violation|0|||
23571057|NCT00309608|65820878|FG004|Overall Study|Protocol Violation|0|||
23571058|NCT00309608|65820874|FG000|Overall Study|Lost to Follow-up|0|||
23571059|NCT00309608|65820875|FG001|Overall Study|Lost to Follow-up|0|||
23571060|NCT00309608|65820876|FG002|Overall Study|Lost to Follow-up|2|||
23571061|NCT00309608|65820877|FG003|Overall Study|Lost to Follow-up|0|||
23571062|NCT00309608|65820878|FG004|Overall Study|Lost to Follow-up|1|||
23571063|NCT00309608|65820874|FG000|Overall Study|Withdrawal by Subject|1|||
23571064|NCT00309608|65820875|FG001|Overall Study|Withdrawal by Subject|4|||
23571065|NCT00309608|65820876|FG002|Overall Study|Withdrawal by Subject|2|||
23571066|NCT00309608|65820877|FG003|Overall Study|Withdrawal by Subject|0|||
23571067|NCT00309608|65820878|FG004|Overall Study|Withdrawal by Subject|0|||
23571068|NCT00309608|65820874|FG000|Overall Study|Other incl. Lack of efficacy|10|||
23571069|NCT00309608|65820875|FG001|Overall Study|Other incl. Lack of efficacy|4|||
23571070|NCT00309608|65820876|FG002|Overall Study|Other incl. Lack of efficacy|3|||
23571071|NCT00309608|65820877|FG003|Overall Study|Other incl. Lack of efficacy|4|||
23571072|NCT00309608|65820878|FG004|Overall Study|Other incl. Lack of efficacy|0|||
23331433|NCT00030901|64955437|FG001|Randomization|Death|1|||
23331434|NCT00030901|64955438|FG002|Randomization|Death|3|||
23331435|NCT00030901|64955436|FG000|Randomization|Other|0|||
23331436|NCT00030901|64955437|FG001|Randomization|Other|36|||
23331437|NCT00030901|64955438|FG002|Randomization|Other|33|||
23331438|NCT00030901|64955436|FG000|Randomization|Ineligible|0|||
23446998|NCT01200368|65377845|FG001|Infant Series|Randomized, not vaccinated|1|||
23446999|NCT01200368|65377846|FG002|Infant Series|Randomized, not vaccinated|1|||
23571073|NCT01394250|65820880|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
23571074|NCT01394250|65820881|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
23571075|NCT01394250|65820880|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
23571076|NCT01394250|65820881|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
23571077|NCT01189890|65820884|FG000|Overall Study|Adverse Event|3|||
23571078|NCT01189890|65820885|FG001|Overall Study|Adverse Event|4|||
23571079|NCT01189890|65820884|FG000|Overall Study|Lack of Efficacy|7|||
23571080|NCT01189890|65820885|FG001|Overall Study|Lack of Efficacy|2|||
23571081|NCT01189890|65820884|FG000|Overall Study|Lost to Follow-up|1|||
23571082|NCT01189890|65820885|FG001|Overall Study|Lost to Follow-up|7|||
23571083|NCT01189890|65820884|FG000|Overall Study|Protocol Violation|1|||
23571084|NCT01189890|65820885|FG001|Overall Study|Protocol Violation|5|||
23571085|NCT01189890|65820884|FG000|Overall Study|Withdrawal by Subject|15|||
23571086|NCT01189890|65820885|FG001|Overall Study|Withdrawal by Subject|11|||
23571087|NCT01189890|65820884|FG000|Overall Study|Non Compliance|0|||
23447000|NCT01200368|65377844|FG000|Infant Series|Other|1|||
23447001|NCT01200368|65377845|FG001|Infant Series|Other|0|||
23571088|NCT01189890|65820885|FG001|Overall Study|Non Compliance|1|||
23571089|NCT01189890|65820884|FG000|Overall Study|Physician Decision|5|||
23571090|NCT01189890|65820885|FG001|Overall Study|Physician Decision|4|||
23571091|NCT01189890|65820884|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
23571092|NCT01189890|65820885|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
23571093|NCT01622348|65820892|FG000|Overall Study|Withdrawal by Subject|1|||
23571094|NCT01622348|65820893|FG001|Overall Study|Withdrawal by Subject|0|||
23571095|NCT01622348|65820894|FG002|Overall Study|Withdrawal by Subject|1|||
23571096|NCT03525574|65820898|FG000|Overall Study|Adverse Event|15|||
23571097|NCT03525574|65820899|FG001|Overall Study|Adverse Event|0|||
23571098|NCT03525574|65820898|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
23331439|NCT00030901|64955437|FG001|Randomization|Ineligible|15|||
23571099|NCT03525574|65820899|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
23571100|NCT03525574|65820898|FG000|Overall Study|Lost to Follow-up|4|||
23571101|NCT03525574|65820899|FG001|Overall Study|Lost to Follow-up|0|||
23571102|NCT03525574|65820898|FG000|Overall Study|Commercial drug is Available for participant|48|||
23571103|NCT03525574|65820899|FG001|Overall Study|Commercial drug is Available for participant|0|||
23571104|NCT03525574|65820898|FG000|Overall Study|Death|1|||
23571105|NCT03525574|65820899|FG001|Overall Study|Death|0|||
23571106|NCT03525574|65820898|FG000|Overall Study|Other non-compliance|2|||
23162954|NCT00574275|64345021|FG000|Overall Study|Operation for curative intent|0|||
23162955|NCT00574275|64345022|FG001|Overall Study|Operation for curative intent|1|||
23162956|NCT00886600|64345031|FG000|Double-blind Monotherapy|Adverse Event|1|||
23162957|NCT00886600|64345032|FG001|Double-blind Monotherapy|Adverse Event|1|||
23162958|NCT00886600|64345033|FG002|Double-blind Monotherapy|Adverse Event|1|||
23162959|NCT00886600|64345034|FG003|Double-blind Monotherapy|Adverse Event|1|||
23162960|NCT00886600|64345031|FG000|Double-blind Monotherapy|Protocol Violation|0|||
23162961|NCT00886600|64345032|FG001|Double-blind Monotherapy|Protocol Violation|0|||
23162962|NCT00886600|64345033|FG002|Double-blind Monotherapy|Protocol Violation|0|||
23162963|NCT00886600|64345034|FG003|Double-blind Monotherapy|Protocol Violation|1|||
23162964|NCT00886600|64345031|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
23162965|NCT00886600|64345032|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
23162966|NCT00886600|64345033|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
23162967|NCT00886600|64345034|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
23162968|NCT00886600|64345031|FG000|Combination Therapy Period|Adverse Event|0|||
23162969|NCT00886600|64345032|FG001|Combination Therapy Period|Adverse Event|0|||
23162970|NCT00886600|64345033|FG002|Combination Therapy Period|Adverse Event|1|||
23162971|NCT00886600|64345034|FG003|Combination Therapy Period|Adverse Event|0|||
23162972|NCT00886600|64345031|FG000|Combination Therapy Period|Protocol Violation|0|||
23162973|NCT00886600|64345032|FG001|Combination Therapy Period|Protocol Violation|0|||
23162974|NCT00886600|64345033|FG002|Combination Therapy Period|Protocol Violation|1|||
23571107|NCT03525574|65820899|FG001|Overall Study|Other non-compliance|0|||
23571108|NCT03525574|65820898|FG000|Overall Study|Physician Decision|6|||
23571109|NCT03525574|65820899|FG001|Overall Study|Physician Decision|0|||
23571110|NCT03525574|65820898|FG000|Overall Study|Other|58|||
23571111|NCT03525574|65820899|FG001|Overall Study|Other|0|||
23571112|NCT03525574|65820898|FG000|Overall Study|Enrolled but never dosed|1|||
23571113|NCT03525574|65820899|FG001|Overall Study|Enrolled but never dosed|0|||
23571114|NCT03525574|65820898|FG000|Overall Study|Not enrolled in 105 study|0|||
23571115|NCT03525574|65820899|FG001|Overall Study|Not enrolled in 105 study|3|||
23571116|NCT03918239|65820900|FG000|Overall Study|Lost to Follow-up|3|||
23571117|NCT03918239|65820901|FG001|Overall Study|Lost to Follow-up|1|||
23571118|NCT03918239|65820900|FG000|Overall Study|Pregnancy|0|||
23571119|NCT03918239|65820901|FG001|Overall Study|Pregnancy|2|||
23162975|NCT00886600|64345034|FG003|Combination Therapy Period|Protocol Violation|0|||
23162976|NCT04169373|64345036|FG000|Week 1 to Week 14|Adverse Event|1|||
23162977|NCT04169373|64345037|FG001|Week 1 to Week 14|Adverse Event|0|||
23162978|NCT04169373|64345038|FG002|Week 1 to Week 14|Adverse Event|1|||
23162979|NCT04169373|64345039|FG003|Week 1 to Week 14|Adverse Event|2|||
23162980|NCT04169373|64345036|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
23162981|NCT04169373|64345037|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
23162982|NCT04169373|64345038|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
23162983|NCT04169373|64345039|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
23162984|NCT04169373|64345036|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
23162985|NCT04169373|64345037|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
23162986|NCT04169373|64345038|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
23162987|NCT04169373|64345039|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
23162988|NCT04169373|64345036|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
23162989|NCT04169373|64345037|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
23162990|NCT04169373|64345038|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
23162991|NCT04169373|64345039|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
23162992|NCT04169373|64345036|FG000|Week 1 to Week 14|Other|1|||
23162993|NCT04169373|64345037|FG001|Week 1 to Week 14|Other|3|||
23162994|NCT04169373|64345038|FG002|Week 1 to Week 14|Other|3|||
23162995|NCT04169373|64345039|FG003|Week 1 to Week 14|Other|5|||
23162996|NCT04169373|64345036|FG000|Week 14 to Week 52|Adverse Event|1|||
23162997|NCT04169373|64345037|FG001|Week 14 to Week 52|Adverse Event|0|||
23571120|NCT03918239|65820900|FG000|Overall Study|Withdrawal by Subject|3|||
23571121|NCT03918239|65820901|FG001|Overall Study|Withdrawal by Subject|3|||
23571122|NCT03918239|65820900|FG000|Overall Study|positive urine drug screening results|4|||
23162998|NCT04169373|64345038|FG002|Week 14 to Week 52|Adverse Event|0|||
23162999|NCT04169373|64345039|FG003|Week 14 to Week 52|Adverse Event|1|||
23163000|NCT04169373|64345036|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
23571123|NCT03918239|65820901|FG001|Overall Study|positive urine drug screening results|1|||
23571124|NCT00972543|65820902|FG000|Overall Study|Adverse Event|1|||
23571125|NCT00972543|65820903|FG001|Overall Study|Adverse Event|0|||
23163001|NCT04169373|64345037|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
23163002|NCT04169373|64345038|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
23163003|NCT04169373|64345039|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
23163004|NCT04169373|64345036|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
23163005|NCT04169373|64345037|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
23163006|NCT04169373|64345038|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
23163007|NCT04169373|64345039|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
23163008|NCT04169373|64345036|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
23163009|NCT04169373|64345037|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
23163010|NCT04169373|64345038|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
23163011|NCT04169373|64345039|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
23163012|NCT04169373|64345036|FG000|Week 14 to Week 52|Other|4|||
23163013|NCT04169373|64345037|FG001|Week 14 to Week 52|Other|5|||
23163014|NCT04169373|64345038|FG002|Week 14 to Week 52|Other|4|||
23163015|NCT04169373|64345039|FG003|Week 14 to Week 52|Other|5|||
23163016|NCT04169373|64345036|FG000|Week 14 to Week 52|Ongoing|0|||
23163017|NCT04169373|64345037|FG001|Week 14 to Week 52|Ongoing|1|||
23163018|NCT04169373|64345038|FG002|Week 14 to Week 52|Ongoing|0|||
23163019|NCT04169373|64345039|FG003|Week 14 to Week 52|Ongoing|0|||
23447002|NCT01200368|65377846|FG002|Infant Series|Other|0|||
23447003|NCT01200368|65377844|FG000|After Infant Series|Adverse Event|6|||
23447004|NCT01200368|65377845|FG001|After Infant Series|Adverse Event|6|||
23447005|NCT01200368|65377846|FG002|After Infant Series|Adverse Event|3|||
23447006|NCT01200368|65377844|FG000|After Infant Series|Withdrawal by Subject|10|||
23447007|NCT01200368|65377845|FG001|After Infant Series|Withdrawal by Subject|8|||
23447008|NCT01200368|65377846|FG002|After Infant Series|Withdrawal by Subject|4|||
23447009|NCT01200368|65377844|FG000|After Infant Series|Lost to Follow-up|1|||
23447010|NCT01200368|65377845|FG001|After Infant Series|Lost to Follow-up|0|||
23447011|NCT01200368|65377846|FG002|After Infant Series|Lost to Follow-up|0|||
23447012|NCT01200368|65377844|FG000|After Infant Series|Other|1|||
23163020|NCT04360551|64345042|FG000|Overall Study|Withdrawal by Subject|1|||
23163021|NCT04360551|64345043|FG001|Overall Study|Withdrawal by Subject|0|||
23163022|NCT01087905|64345048|FG000|Overall Study|Lost to Follow-up|24|||
23163023|NCT01087905|64345049|FG001|Overall Study|Lost to Follow-up|28|||
23163024|NCT01087905|64345050|FG002|Overall Study|Lost to Follow-up|18|||
23163025|NCT01087905|64345051|FG003|Overall Study|Lost to Follow-up|31|||
23163026|NCT01087905|64345052|FG004|Overall Study|Lost to Follow-up|27|||
23163027|NCT01087905|64345053|FG005|Overall Study|Lost to Follow-up|25|||
23163028|NCT01087905|64345054|FG006|Overall Study|Lost to Follow-up|20|||
23163029|NCT01087905|64345055|FG007|Overall Study|Lost to Follow-up|24|||
23163030|NCT01087905|64345048|FG000|Overall Study|Withdrawal by Subject|5|||
23163031|NCT01087905|64345049|FG001|Overall Study|Withdrawal by Subject|4|||
23163032|NCT01087905|64345050|FG002|Overall Study|Withdrawal by Subject|4|||
23163033|NCT01087905|64345051|FG003|Overall Study|Withdrawal by Subject|5|||
23163034|NCT01087905|64345052|FG004|Overall Study|Withdrawal by Subject|4|||
23163035|NCT01087905|64345053|FG005|Overall Study|Withdrawal by Subject|3|||
23163036|NCT01087905|64345054|FG006|Overall Study|Withdrawal by Subject|3|||
23163037|NCT01087905|64345055|FG007|Overall Study|Withdrawal by Subject|5|||
23163038|NCT03287219|64345056|FG000|Overall Study|Protocol Violation|0|||
23163039|NCT03287219|64345057|FG001|Overall Study|Protocol Violation|2|||
23163040|NCT00326209|64345058|FG000|Overall Study|Adverse Event|28|||
23163041|NCT00326209|64345058|FG000|Overall Study|Withdrawal by Subject|22|||
23163042|NCT00326209|64345058|FG000|Overall Study|Lack of Efficacy|31|||
23163043|NCT00326209|64345058|FG000|Overall Study|Lost to Follow-up|18|||
23163044|NCT00326209|64345058|FG000|Overall Study|Participant non-compliant|6|||
23163045|NCT00326209|64345058|FG000|Overall Study|Sponsor closed study|173|||
23163046|NCT00326209|64345058|FG000|Overall Study|Prohibited medication use|1|||
23163047|NCT00326209|64345058|FG000|Overall Study|Violation of entry criteria|1|||
23447013|NCT01200368|65377845|FG001|After Infant Series|Other|2|||
23447014|NCT01200368|65377846|FG002|After Infant Series|Other|2|||
23447015|NCT01200368|65377844|FG000|Toddler Dose|Adverse Event|0|||
23447016|NCT01200368|65377845|FG001|Toddler Dose|Adverse Event|3|||
23163048|NCT00326209|64345058|FG000|Overall Study|Withdrawn in error|1|||
23163049|NCT00326209|64345058|FG000|Overall Study|Pregnancy|1|||
23163050|NCT01263483|64345059|FG000|Overall Study|Adverse Event|4|||
23163051|NCT01263483|64345060|FG001|Overall Study|Adverse Event|0|||
23163052|NCT01263483|64345061|FG002|Overall Study|Adverse Event|3|||
23163053|NCT01263483|64345059|FG000|Overall Study|Withdrawal by Subject|1|||
23163054|NCT01263483|64345060|FG001|Overall Study|Withdrawal by Subject|0|||
23163055|NCT01263483|64345061|FG002|Overall Study|Withdrawal by Subject|0|||
23163056|NCT01263483|64345059|FG000|Overall Study|Lack of Efficacy|2|||
23163057|NCT01263483|64345060|FG001|Overall Study|Lack of Efficacy|0|||
23163058|NCT01263483|64345061|FG002|Overall Study|Lack of Efficacy|0|||
23163059|NCT01263483|64345059|FG000|Overall Study|Protocol Violation|0|||
23163060|NCT01263483|64345060|FG001|Overall Study|Protocol Violation|1|||
23163061|NCT01263483|64345061|FG002|Overall Study|Protocol Violation|1|||
23163062|NCT01263483|64345059|FG000|Overall Study|Participant Unavailability|0|||
23447017|NCT01200368|65377846|FG002|Toddler Dose|Adverse Event|1|||
23163063|NCT01263483|64345060|FG001|Overall Study|Participant Unavailability|1|||
23163064|NCT01263483|64345061|FG002|Overall Study|Participant Unavailability|1|||
23163065|NCT01756040|64345064|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
23163066|NCT01756040|64345064|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
23163067|NCT01756040|64345064|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
23163068|NCT01251367|64345076|FG000|Overall Study|Protocol Violation|1|||
23163069|NCT01251367|64345076|FG000|Overall Study|Lack of Efficacy|2|||
23163070|NCT01251367|64345076|FG000|Overall Study|Adverse Event|19|||
23163071|NCT01251367|64345076|FG000|Overall Study|Withdrawal by Subject|36|||
23163072|NCT01251367|64345076|FG000|Overall Study|Lost to Follow-up|5|||
23163073|NCT01251367|64345076|FG000|Overall Study|Subject Required Alternative Treatment|7|||
23163074|NCT01251367|64345076|FG000|Overall Study|No Study Drug Available|1|||
23163075|NCT01251367|64345076|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
23163076|NCT01251367|64345076|FG000|Overall Study|End of Study Visit Performed in Error|1|||
23163077|NCT05054114|64345077|FG000|Overall Study|Protocol Violation|13|||
23163078|NCT05054114|64345078|FG001|Overall Study|Protocol Violation|1|||
23163079|NCT05054114|64345077|FG000|Overall Study|Pregnancy|0|||
23163080|NCT05054114|64345078|FG001|Overall Study|Pregnancy|1|||
23163081|NCT04688775|64345079|FG000|Placebo-controlled Period|Randomized, not treated|1|||
23163082|NCT04688775|64345080|FG001|Placebo-controlled Period|Randomized, not treated|1|||
23163083|NCT04688775|64345081|FG002|Placebo-controlled Period|Randomized, not treated|0|||
23163084|NCT04688775|64345082|FG003|Placebo-controlled Period|Randomized, not treated|0|||
23163085|NCT04688775|64345079|FG000|Placebo-controlled Period|Adverse Event|2|||
23163086|NCT04688775|64345080|FG001|Placebo-controlled Period|Adverse Event|0|||
23163087|NCT04688775|64345081|FG002|Placebo-controlled Period|Adverse Event|0|||
23163088|NCT04688775|64345082|FG003|Placebo-controlled Period|Adverse Event|0|||
23163089|NCT04688775|64345079|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
23163090|NCT04688775|64345080|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
23163091|NCT04688775|64345081|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
23163092|NCT04688775|64345082|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
23163093|NCT04688775|64345079|FG000|Placebo-controlled Period|Protocol Violation|0|||
23331440|NCT00030901|64955438|FG002|Randomization|Ineligible|14|||
23331441|NCT01209949|64955439|FG000|Overall Study|Lost to Follow-up|3|||
23163094|NCT04688775|64345080|FG001|Placebo-controlled Period|Protocol Violation|1|||
23163095|NCT04688775|64345081|FG002|Placebo-controlled Period|Protocol Violation|0|||
23163096|NCT04688775|64345082|FG003|Placebo-controlled Period|Protocol Violation|0|||
23163097|NCT04688775|64345079|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
23163098|NCT04688775|64345080|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
23163099|NCT04688775|64345081|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
23163100|NCT04688775|64345082|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
23163101|NCT04688775|64345079|FG000|Placebo-controlled Period|Other reasons|0|||
23163102|NCT04688775|64345080|FG001|Placebo-controlled Period|Other reasons|1|||
23163103|NCT04688775|64345081|FG002|Placebo-controlled Period|Other reasons|0|||
23163104|NCT04688775|64345082|FG003|Placebo-controlled Period|Other reasons|0|||
23163105|NCT04688775|64345079|FG000|Delayed Start Period|Adverse Event|0|||
23163106|NCT04688775|64345080|FG001|Delayed Start Period|Adverse Event|0|||
23163107|NCT04688775|64345081|FG002|Delayed Start Period|Adverse Event|1|||
23163108|NCT04688775|64345082|FG003|Delayed Start Period|Adverse Event|0|||
23163109|NCT04688775|64345079|FG000|Delayed Start Period|Lack of Efficacy|0|||
23163110|NCT04688775|64345080|FG001|Delayed Start Period|Lack of Efficacy|0|||
23163111|NCT04688775|64345081|FG002|Delayed Start Period|Lack of Efficacy|0|||
23163112|NCT04688775|64345082|FG003|Delayed Start Period|Lack of Efficacy|3|||
23163113|NCT04688775|64345079|FG000|Delayed Start Period|Withdrawal by Subject|0|||
23163114|NCT04688775|64345080|FG001|Delayed Start Period|Withdrawal by Subject|0|||
23163115|NCT04688775|64345081|FG002|Delayed Start Period|Withdrawal by Subject|2|||
23163116|NCT04688775|64345082|FG003|Delayed Start Period|Withdrawal by Subject|4|||
23331442|NCT00162981|64955440|FG000|Overall Study|Adverse Event|2|||
23331443|NCT00162981|64955441|FG001|Overall Study|Adverse Event|5|||
23331444|NCT00162981|64955440|FG000|Overall Study|Withdrawal by Subject|1|||
23331445|NCT00162981|64955441|FG001|Overall Study|Withdrawal by Subject|1|||
23331446|NCT00162981|64955440|FG000|Overall Study|Physician Decision|1|||
23331447|NCT00162981|64955441|FG001|Overall Study|Physician Decision|0|||
23331448|NCT01321749|64955442|FG000|Overall Study|Lost to Follow-up|4|||
23163117|NCT04688775|64345079|FG000|Delayed Start Period|Lost to Follow-up|0|||
23163118|NCT04688775|64345080|FG001|Delayed Start Period|Lost to Follow-up|0|||
23163119|NCT04688775|64345081|FG002|Delayed Start Period|Lost to Follow-up|2|||
23163120|NCT04688775|64345082|FG003|Delayed Start Period|Lost to Follow-up|1|||
23163121|NCT04688775|64345079|FG000|Delayed Start Period|other reasons|0|||
23163122|NCT04688775|64345080|FG001|Delayed Start Period|other reasons|0|||
23163123|NCT04688775|64345081|FG002|Delayed Start Period|other reasons|1|||
23163124|NCT04688775|64345082|FG003|Delayed Start Period|other reasons|0|||
23163125|NCT01982292|64345085|FG000|Overall Study|Adverse Event|2|||
23331449|NCT01321749|64955443|FG001|Overall Study|Lost to Follow-up|11|||
23331450|NCT01321749|64955442|FG000|Overall Study|Protocol Violation|4|||
23331451|NCT01321749|64955443|FG001|Overall Study|Protocol Violation|7|||
23331452|NCT01321749|64955442|FG000|Overall Study|Withdrawal by Subject|5|||
23331453|NCT01321749|64955443|FG001|Overall Study|Withdrawal by Subject|4|||
23331454|NCT02097745|64955444|FG000|Overall Study|Adverse Event|25|||
23331455|NCT02097745|64955444|FG000|Overall Study|Death|16|||
23331456|NCT02097745|64955444|FG000|Overall Study|Failure to Return|14|||
23331457|NCT02097745|64955444|FG000|Overall Study|Administrative/Other|27|||
23331458|NCT02097745|64955444|FG000|Overall Study|Reason Not Specified|96|||
23331459|NCT00917852|64955445|FG000|Overall Study|Death|6|||
23331460|NCT03852472|64955447|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
23331461|NCT03852472|64955448|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
23331462|NCT03852472|64955449|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
23331463|NCT03852472|64955450|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
23331464|NCT03852472|64955451|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
23331465|NCT03852472|64955447|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
23331466|NCT03852472|64955448|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
23331467|NCT03852472|64955449|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
23331468|NCT03852472|64955450|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
23331469|NCT03852472|64955451|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
23331470|NCT03852472|64955447|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
23331471|NCT03852472|64955448|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
23331472|NCT03852472|64955449|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
23331473|NCT03852472|64955450|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
23331474|NCT03852472|64955451|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
23331475|NCT03852472|64955447|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
23331476|NCT03852472|64955448|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
23331477|NCT03852472|64955449|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
23331478|NCT03852472|64955450|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
23331479|NCT03852472|64955451|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
23331480|NCT03852472|64955447|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
23331481|NCT03852472|64955448|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
23331482|NCT03852472|64955449|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
23331483|NCT03852472|64955450|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
23331484|NCT03852472|64955451|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
23331485|NCT03852472|64955447|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
23331486|NCT03852472|64955448|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
23331487|NCT03852472|64955449|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
23331488|NCT03852472|64955450|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
23331489|NCT03852472|64955451|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
23331490|NCT03852472|64955447|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
23331491|NCT03852472|64955448|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
23331492|NCT03852472|64955449|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
23331493|NCT03852472|64955450|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
23331494|NCT03852472|64955451|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
23331495|NCT03852472|64955447|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
23331496|NCT03852472|64955448|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
23331497|NCT03852472|64955449|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
23331498|NCT03852472|64955450|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
23331499|NCT03852472|64955451|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
23331500|NCT03852472|64955447|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
23331501|NCT03852472|64955448|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
23331502|NCT03852472|64955449|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
23331503|NCT03852472|64955450|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
23331504|NCT03852472|64955451|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
23331505|NCT03852472|64955447|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
23331506|NCT03852472|64955448|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
23331507|NCT03852472|64955449|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
23331508|NCT03852472|64955450|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
23331509|NCT03852472|64955451|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
23331510|NCT03852472|64955447|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
23331511|NCT03852472|64955448|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
23331512|NCT03852472|64955449|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
23331513|NCT03852472|64955450|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
23331514|NCT03852472|64955451|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
23331515|NCT03852472|64955447|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
23331516|NCT03852472|64955448|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
23331517|NCT03852472|64955449|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
23447018|NCT01633788|65377847|FG000|Overall Study|Adverse Event|1|||
23447019|NCT01633788|65377848|FG001|Overall Study|Adverse Event|3|||
23331518|NCT03852472|64955450|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
23331519|NCT03852472|64955451|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
23331520|NCT03852472|64955447|FG000|Period 2 - Week 44|Adverse Event|0|||
23331521|NCT03852472|64955448|FG001|Period 2 - Week 44|Adverse Event|3|||
23331522|NCT03852472|64955449|FG002|Period 2 - Week 44|Adverse Event|1|||
23331523|NCT03852472|64955450|FG003|Period 2 - Week 44|Adverse Event|2|||
23331524|NCT03852472|64955451|FG004|Period 2 - Week 44|Adverse Event|2|||
23331525|NCT03852472|64955447|FG000|Period 2 - Week 44|COVID-19 Related|0|||
23331526|NCT03852472|64955448|FG001|Period 2 - Week 44|COVID-19 Related|0|||
23331527|NCT03852472|64955449|FG002|Period 2 - Week 44|COVID-19 Related|0|||
23331528|NCT03852472|64955450|FG003|Period 2 - Week 44|COVID-19 Related|1|||
23331529|NCT03852472|64955451|FG004|Period 2 - Week 44|COVID-19 Related|0|||
23331530|NCT03852472|64955447|FG000|Period 2 - Week 44|Reason not stated|0|||
23331531|NCT03852472|64955448|FG001|Period 2 - Week 44|Reason not stated|0|||
23331532|NCT03852472|64955449|FG002|Period 2 - Week 44|Reason not stated|0|||
23331533|NCT03852472|64955450|FG003|Period 2 - Week 44|Reason not stated|0|||
23331534|NCT03852472|64955451|FG004|Period 2 - Week 44|Reason not stated|1|||
23331535|NCT04335123|64955452|FG000|Overall Study|Withdrawal by Subject|2|||
23331536|NCT04335123|64955453|FG001|Overall Study|Withdrawal by Subject|0|||
23331537|NCT04335123|64955452|FG000|Overall Study|Physician Decision|2|||
23331538|NCT04335123|64955453|FG001|Overall Study|Physician Decision|0|||
23331539|NCT02509507|64955454|FG000|Overall Study|Death|21|||
23331540|NCT02509507|64955455|FG001|Overall Study|Death|3|||
23163126|NCT01982292|64345086|FG001|Overall Study|Adverse Event|0|||
23163127|NCT01982292|64345085|FG000|Overall Study|Death|1|||
23163128|NCT01982292|64345086|FG001|Overall Study|Death|0|||
23163129|NCT01982292|64345085|FG000|Overall Study|Lost to Follow-up|2|||
23163130|NCT01982292|64345086|FG001|Overall Study|Lost to Follow-up|0|||
23163131|NCT01982292|64345085|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
23163132|NCT01982292|64345086|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
23163133|NCT01982292|64345085|FG000|Overall Study|Protocol Deviation|1|||
23331541|NCT02509507|64955456|FG002|Overall Study|Death|22|||
23331542|NCT02509507|64955457|FG003|Overall Study|Death|14|||
23331543|NCT02509507|64955458|FG004|Overall Study|Death|8|||
23331544|NCT02509507|64955459|FG005|Overall Study|Death|12|||
23331545|NCT02509507|64955460|FG006|Overall Study|Death|5|||
23331546|NCT02509507|64955461|FG007|Overall Study|Death|4|||
23331547|NCT02509507|64955462|FG008|Overall Study|Death|8|||
23447020|NCT01633788|65377849|FG002|Overall Study|Adverse Event|3|||
23447021|NCT01633788|65377850|FG003|Overall Study|Adverse Event|3|||
23447022|NCT01633788|65377847|FG000|Overall Study|Lost to Follow-up|2|||
23163134|NCT01982292|64345086|FG001|Overall Study|Protocol Deviation|0|||
23163135|NCT01982292|64345085|FG000|Overall Study|Patient/Guardian Decision|3|||
23163136|NCT01982292|64345086|FG001|Overall Study|Patient/Guardian Decision|1|||
23163137|NCT01982292|64345085|FG000|Overall Study|Technical Problems|2|||
23224013|NCT04785144|64563952|FG009|Overall Study|Lost to Follow-up|1|||
23224014|NCT04785144|64563943|FG000|Overall Study|Protocol Violation|0|||
23224015|NCT04785144|64563944|FG001|Overall Study|Protocol Violation|0|||
23163138|NCT01982292|64345086|FG001|Overall Study|Technical Problems|0|||
23163139|NCT02833974|64345087|FG000|Overall Study|Lost to Follow-up|1|||
23163140|NCT02833974|64345088|FG001|Overall Study|Lost to Follow-up|0|||
23224016|NCT04785144|64563945|FG002|Overall Study|Protocol Violation|0|||
23224017|NCT04785144|64563946|FG003|Overall Study|Protocol Violation|0|||
23331548|NCT02509507|64955454|FG000|Overall Study|Lost to Follow-up|0|||
23331549|NCT02509507|64955455|FG001|Overall Study|Lost to Follow-up|1|||
23447023|NCT01633788|65377848|FG001|Overall Study|Lost to Follow-up|2|||
23447024|NCT01633788|65377849|FG002|Overall Study|Lost to Follow-up|2|||
23331550|NCT02509507|64955456|FG002|Overall Study|Lost to Follow-up|0|||
23447025|NCT01633788|65377850|FG003|Overall Study|Lost to Follow-up|0|||
23163141|NCT02833974|64345087|FG000|Overall Study|Adverse Event|0|||
23163142|NCT02833974|64345088|FG001|Overall Study|Adverse Event|3|||
23163143|NCT00535132|64345089|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
23163144|NCT00535132|64345090|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
23224018|NCT04785144|64563947|FG004|Overall Study|Protocol Violation|0|||
23331551|NCT02509507|64955457|FG003|Overall Study|Lost to Follow-up|0|||
23331552|NCT02509507|64955458|FG004|Overall Study|Lost to Follow-up|0|||
23224019|NCT04785144|64563948|FG005|Overall Study|Protocol Violation|0|||
23447026|NCT01633788|65377847|FG000|Overall Study|Personal Reasons|3|||
23163145|NCT00535132|64345089|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
23331553|NCT02509507|64955459|FG005|Overall Study|Lost to Follow-up|2|||
23331554|NCT02509507|64955460|FG006|Overall Study|Lost to Follow-up|0|||
23331555|NCT02509507|64955461|FG007|Overall Study|Lost to Follow-up|0|||
23331556|NCT02509507|64955462|FG008|Overall Study|Lost to Follow-up|0|||
23331557|NCT02509507|64955454|FG000|Overall Study|Withdrawal by Subject|2|||
23331558|NCT02509507|64955455|FG001|Overall Study|Withdrawal by Subject|0|||
23331559|NCT02509507|64955456|FG002|Overall Study|Withdrawal by Subject|1|||
23331560|NCT02509507|64955457|FG003|Overall Study|Withdrawal by Subject|4|||
23331561|NCT02509507|64955458|FG004|Overall Study|Withdrawal by Subject|1|||
23331562|NCT02509507|64955459|FG005|Overall Study|Withdrawal by Subject|3|||
23331563|NCT02509507|64955460|FG006|Overall Study|Withdrawal by Subject|4|||
23331564|NCT02509507|64955461|FG007|Overall Study|Withdrawal by Subject|0|||
23331565|NCT02509507|64955462|FG008|Overall Study|Withdrawal by Subject|1|||
23331566|NCT00092118|64955463|FG000|Overall Study|Adverse Event|35|||
23331567|NCT00092118|64955464|FG001|Overall Study|Adverse Event|32|||
23447027|NCT01633788|65377848|FG001|Overall Study|Personal Reasons|1|||
23447028|NCT01633788|65377849|FG002|Overall Study|Personal Reasons|1|||
23447029|NCT01633788|65377850|FG003|Overall Study|Personal Reasons|3|||
23447030|NCT01633788|65377847|FG000|Overall Study|Protocol Violation|1|||
23163146|NCT00535132|64345090|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
23447031|NCT01633788|65377848|FG001|Overall Study|Protocol Violation|0|||
23447032|NCT01633788|65377849|FG002|Overall Study|Protocol Violation|1|||
23447033|NCT01633788|65377850|FG003|Overall Study|Protocol Violation|0|||
23447034|NCT01633788|65377847|FG000|Overall Study|Other Reasons|0|||
23447035|NCT01633788|65377848|FG001|Overall Study|Other Reasons|2|||
23447036|NCT01633788|65377849|FG002|Overall Study|Other Reasons|3|||
23447037|NCT01633788|65377850|FG003|Overall Study|Other Reasons|7|||
23447038|NCT03828617|65377852|FG000|Overall Study|Lost to Follow-up|22|||
23447039|NCT03828617|65377853|FG001|Overall Study|Lost to Follow-up|12|||
23447040|NCT03828617|65377854|FG002|Overall Study|Lost to Follow-up|23|||
23447041|NCT03828617|65377855|FG003|Overall Study|Lost to Follow-up|7|||
23447042|NCT03828617|65377852|FG000|Overall Study|No longer met eligibility criteria|0|||
23447043|NCT03828617|65377853|FG001|Overall Study|No longer met eligibility criteria|1|||
23447044|NCT03828617|65377854|FG002|Overall Study|No longer met eligibility criteria|1|||
23447045|NCT03828617|65377855|FG003|Overall Study|No longer met eligibility criteria|3|||
23447046|NCT03828617|65377852|FG000|Overall Study|Protocol Violation|0|||
23447047|NCT03828617|65377853|FG001|Overall Study|Protocol Violation|2|||
23447048|NCT03828617|65377854|FG002|Overall Study|Protocol Violation|0|||
23447049|NCT03828617|65377855|FG003|Overall Study|Protocol Violation|0|||
23447050|NCT03828617|65377852|FG000|Overall Study|Withdrawal by Subject|2|||
23447051|NCT03828617|65377853|FG001|Overall Study|Withdrawal by Subject|0|||
23447052|NCT03828617|65377854|FG002|Overall Study|Withdrawal by Subject|2|||
23447053|NCT03828617|65377855|FG003|Overall Study|Withdrawal by Subject|0|||
23447054|NCT03672292|65377856|FG000|Overall Study|Adverse Event|3|||
23447055|NCT03672292|65377857|FG001|Overall Study|Adverse Event|1|||
23447056|NCT03672292|65377856|FG000|Overall Study|Physician Decision|0|||
23571126|NCT00972543|65820902|FG000|Overall Study|Early study termination by sponsor|4|||
23571127|NCT00972543|65820903|FG001|Overall Study|Early study termination by sponsor|1|||
23571128|NCT03051659|65820904|FG000|Treatment Period|Withdrawal by Subject|0|||
23571129|NCT03051659|65820905|FG001|Treatment Period|Withdrawal by Subject|2|||
23163147|NCT01081249|64345093|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
23163148|NCT01081249|64345094|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
23163149|NCT00542269|64345096|FG000|Overall Study|Adverse Event|10|||
23163150|NCT00542269|64345097|FG001|Overall Study|Adverse Event|4|||
23163151|NCT00542269|64345098|FG002|Overall Study|Adverse Event|5|||
23163152|NCT00542269|64345096|FG000|Overall Study|Protocol Violation|1|||
23163153|NCT00542269|64345097|FG001|Overall Study|Protocol Violation|1|||
23163154|NCT00542269|64345098|FG002|Overall Study|Protocol Violation|0|||
23163155|NCT00542269|64345096|FG000|Overall Study|Withdrawal by Subject|1|||
23331568|NCT00092118|64955463|FG000|Overall Study|Lack of Efficacy|12|||
23571130|NCT03051659|65820904|FG000|Survival Follow-up|Lost to Follow-up|23|||
23571131|NCT03051659|65820905|FG001|Survival Follow-up|Lost to Follow-up|22|||
23571132|NCT01275196|65820906|FG000|Overall Study|Adverse Event|3|||
23571133|NCT01275196|65820907|FG001|Overall Study|Adverse Event|5|||
23447057|NCT03672292|65377857|FG001|Overall Study|Physician Decision|1|||
23447058|NCT03672292|65377856|FG000|Overall Study|Withdrawal by Subject|1|||
23447059|NCT03672292|65377857|FG001|Overall Study|Withdrawal by Subject|2|||
23447060|NCT00844376|65377858|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
23571134|NCT01275196|65820906|FG000|Overall Study|Withdrawal by Subject|4|||
23571135|NCT01275196|65820907|FG001|Overall Study|Withdrawal by Subject|5|||
23163156|NCT00542269|64345097|FG001|Overall Study|Withdrawal by Subject|0|||
23163157|NCT00542269|64345098|FG002|Overall Study|Withdrawal by Subject|0|||
23163158|NCT00542269|64345096|FG000|Overall Study|Administrative problems|1|||
23331569|NCT00092118|64955464|FG001|Overall Study|Lack of Efficacy|14|||
23331570|NCT00092118|64955463|FG000|Overall Study|Lost to Follow-up|4|||
23571136|NCT01275196|65820906|FG000|Overall Study|Lost to Follow-up|1|||
23163159|NCT00542269|64345097|FG001|Overall Study|Administrative problems|1|||
23163160|NCT00542269|64345098|FG002|Overall Study|Administrative problems|1|||
23163161|NCT01140451|64345099|FG000|Overall Study|Withdrawal by Subject|26|||
23163162|NCT01140451|64345100|FG001|Overall Study|Withdrawal by Subject|33|||
23163163|NCT01140451|64345099|FG000|Overall Study|Adverse Event|2|||
23331571|NCT00092118|64955464|FG001|Overall Study|Lost to Follow-up|3|||
23331572|NCT00092118|64955463|FG000|Overall Study|Protocol Violation|23|||
23331573|NCT00092118|64955464|FG001|Overall Study|Protocol Violation|25|||
23331574|NCT00092118|64955463|FG000|Overall Study|Withdrawal by Subject|4|||
23331575|NCT00092118|64955464|FG001|Overall Study|Withdrawal by Subject|10|||
23331576|NCT00092118|64955463|FG000|Overall Study|Other|6|||
23331577|NCT00092118|64955464|FG001|Overall Study|Other|5|||
23331578|NCT03123393|64955466|FG000|Overall Study|Study Terminated by Sponsor|6|||
23163164|NCT01140451|64345100|FG001|Overall Study|Adverse Event|6|||
23163165|NCT01140451|64345099|FG000|Overall Study|Physician Decision|5|||
23163166|NCT01140451|64345100|FG001|Overall Study|Physician Decision|3|||
23163167|NCT01140451|64345099|FG000|Overall Study|Lost to Follow-up|2|||
23163168|NCT01140451|64345100|FG001|Overall Study|Lost to Follow-up|0|||
23163169|NCT01140451|64345099|FG000|Overall Study|Participants Planning Pregnancy|3|||
23163170|NCT01140451|64345100|FG001|Overall Study|Participants Planning Pregnancy|0|||
23163171|NCT00346073|64345107|FG000|Overall Study|Serious Adverse Event|2|||
23163172|NCT00346073|64345108|FG001|Overall Study|Serious Adverse Event|0|||
23163173|NCT00346073|64345107|FG000|Overall Study|Lost to Follow-up|39|||
23163174|NCT00346073|64345108|FG001|Overall Study|Lost to Follow-up|24|||
23163175|NCT00761514|64345112|FG000|Overall Study|Adverse Event|1|||
23163176|NCT00761514|64345112|FG000|Overall Study|Withdrawal by Subject|2|||
23163177|NCT00761514|64345112|FG000|Overall Study|Lost to Follow-up|1|||
23163178|NCT00761514|64345112|FG000|Overall Study|Health insurance didn't cover study drug|1|||
23163179|NCT00761514|64345112|FG000|Overall Study|Problem complying with study visit|1|||
23163180|NCT00761514|64345112|FG000|Overall Study|Unable to pay for medications|1|||
23331579|NCT03123393|64955467|FG001|Overall Study|Study Terminated by Sponsor|9|||
23331580|NCT03123393|64955466|FG000|Overall Study|Withdrawal by Subject|2|||
23331581|NCT03123393|64955467|FG001|Overall Study|Withdrawal by Subject|1|||
23447061|NCT00844376|65377859|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
23163181|NCT01328951|64345113|FG000|Overall Study|Disease Progression|17|||
23331582|NCT03123393|64955466|FG000|Overall Study|Reason not Specified|13|||
23331583|NCT03123393|64955467|FG001|Overall Study|Reason not Specified|13|||
23163182|NCT01328951|64345114|FG001|Overall Study|Disease Progression|14|||
23163183|NCT01328951|64345113|FG000|Overall Study|Adverse Event|2|||
23331584|NCT02091089|64955471|FG000|Overall Study|Lost to Follow-up|2|||
23331585|NCT01435460|64955472|FG000|Overall Study|Adverse Event|2|||
23331586|NCT01435460|64955473|FG001|Overall Study|Adverse Event|1|||
23163184|NCT01328951|64345114|FG001|Overall Study|Adverse Event|0|||
23163185|NCT01328951|64345113|FG000|Overall Study|Death|243|||
23163186|NCT01328951|64345114|FG001|Overall Study|Death|258|||
23163187|NCT01328951|64345113|FG000|Overall Study|Lost to Follow-up|6|||
23163188|NCT01328951|64345114|FG001|Overall Study|Lost to Follow-up|7|||
23163189|NCT01328951|64345113|FG000|Overall Study|Withdrawal by Subject|6|||
23163190|NCT01328951|64345114|FG001|Overall Study|Withdrawal by Subject|6|||
23163191|NCT01328951|64345113|FG000|Overall Study|Study Closed by the Sponsor|36|||
23331587|NCT01435460|64955472|FG000|Overall Study|Lost to Follow-up|6|||
23331588|NCT01435460|64955473|FG001|Overall Study|Lost to Follow-up|1|||
23331589|NCT01435460|64955472|FG000|Overall Study|Withdrawal by Subject|1|||
23331590|NCT01435460|64955473|FG001|Overall Study|Withdrawal by Subject|3|||
23331591|NCT01435460|64955472|FG000|Overall Study|Protocol Violation|0|||
23331592|NCT01435460|64955473|FG001|Overall Study|Protocol Violation|1|||
23331593|NCT01435460|64955472|FG000|Overall Study|Did not meet eligibility criteria|2|||
23331594|NCT01435460|64955473|FG001|Overall Study|Did not meet eligibility criteria|0|||
23331595|NCT01028014|64955474|FG000|Overall Study|Lost to Follow-up|1|||
23331596|NCT01028014|64955475|FG001|Overall Study|Lost to Follow-up|2|||
23331597|NCT01028014|64955476|FG002|Overall Study|Lost to Follow-up|0|||
23331598|NCT01028014|64955477|FG003|Overall Study|Lost to Follow-up|1|||
23331599|NCT01028014|64955478|FG004|Overall Study|Lost to Follow-up|1|||
23331600|NCT01028014|64955479|FG005|Overall Study|Lost to Follow-up|2|||
23331601|NCT00083759|64955480|FG000|Overall Study|Adverse Event|5|||
23331602|NCT00083759|64955481|FG001|Overall Study|Adverse Event|3|||
23331603|NCT00083759|64955480|FG000|Overall Study|Lost to Follow-up|1|||
23447062|NCT03210961|65377863|FG000|Overall Study|Adverse Event|0|||
23163192|NCT01328951|64345114|FG001|Overall Study|Study Closed by the Sponsor|31|||
23163193|NCT01328951|64345113|FG000|Overall Study|Other|11|||
23163194|NCT01328951|64345114|FG001|Overall Study|Other|6|||
23163195|NCT00762892|64345116|FG000|Overall Study|Lost to Follow-up|2|||
23163196|NCT00762892|64345117|FG001|Overall Study|Lost to Follow-up|5|||
23163197|NCT00762892|64345116|FG000|Overall Study|Withdrawal by Subject|0|||
23163198|NCT00762892|64345117|FG001|Overall Study|Withdrawal by Subject|1|||
23163199|NCT00762892|64345116|FG000|Overall Study|Death|1|||
23163200|NCT00762892|64345117|FG001|Overall Study|Death|0|||
23163201|NCT00762892|64345116|FG000|Overall Study|Pregnancy|1|||
23163202|NCT00762892|64345117|FG001|Overall Study|Pregnancy|0|||
23163203|NCT00762892|64345116|FG000|Overall Study|Incarceration|1|||
23163204|NCT00762892|64345117|FG001|Overall Study|Incarceration|0|||
23163205|NCT03864653|64345118|FG000|Overall Study|Withdrawal by Subject|1|||
23163206|NCT01709149|64345121|FG000|Open-label Lead-in Phase|Adverse Event|109|||
23163207|NCT01709149|64345122|FG001|Open-label Lead-in Phase|Adverse Event|0|||
23163208|NCT01709149|64345123|FG002|Open-label Lead-in Phase|Adverse Event|0|||
23163209|NCT01709149|64345121|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
23163210|NCT01709149|64345122|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
23163211|NCT01709149|64345123|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
23163212|NCT01709149|64345121|FG000|Open-label Lead-in Phase|Death|1|||
23163213|NCT01709149|64345122|FG001|Open-label Lead-in Phase|Death|0|||
23163214|NCT01709149|64345123|FG002|Open-label Lead-in Phase|Death|0|||
23163215|NCT01709149|64345121|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
23163216|NCT01709149|64345122|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
23163217|NCT01709149|64345123|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
23163218|NCT01709149|64345121|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
23163219|NCT01709149|64345122|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
23163220|NCT01709149|64345123|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
23163221|NCT01709149|64345121|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23163222|NCT01709149|64345122|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
23163223|NCT01709149|64345123|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
23163224|NCT01709149|64345121|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
23163225|NCT01709149|64345122|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
23163226|NCT01709149|64345123|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
23163227|NCT01709149|64345121|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
23163228|NCT01709149|64345122|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
23163229|NCT01709149|64345123|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
23163230|NCT01709149|64345121|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
23331604|NCT00083759|64955481|FG001|Overall Study|Lost to Follow-up|0|||
23331605|NCT00083759|64955480|FG000|Overall Study|Death|1|||
23163231|NCT01709149|64345122|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
23163232|NCT01709149|64345123|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
23163233|NCT01709149|64345121|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23163234|NCT01709149|64345122|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
23163235|NCT01709149|64345123|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23331606|NCT00083759|64955481|FG001|Overall Study|Death|1|||
23163236|NCT01246583|64345124|FG000|Overall Study|Lost to Follow-up|0|||
23163237|NCT01246583|64345125|FG001|Overall Study|Lost to Follow-up|0|||
23163238|NCT01246583|64345126|FG002|Overall Study|Lost to Follow-up|0|||
23163239|NCT01246583|64345127|FG003|Overall Study|Lost to Follow-up|1|||
23163240|NCT01246583|64345124|FG000|Overall Study|Protocol Violation|0|||
23163241|NCT01246583|64345125|FG001|Overall Study|Protocol Violation|0|||
23163242|NCT01246583|64345126|FG002|Overall Study|Protocol Violation|1|||
23163243|NCT01246583|64345127|FG003|Overall Study|Protocol Violation|0|||
23163244|NCT01246583|64345124|FG000|Overall Study|Withdrawal by Subject|1|||
23163245|NCT01246583|64345125|FG001|Overall Study|Withdrawal by Subject|0|||
23163246|NCT01246583|64345126|FG002|Overall Study|Withdrawal by Subject|0|||
23163247|NCT01246583|64345127|FG003|Overall Study|Withdrawal by Subject|0|||
23163248|NCT01560780|64345128|FG000|Overall Study|Death|2|||
23163249|NCT01560780|64345129|FG001|Overall Study|Death|1|||
23163250|NCT01560780|64345128|FG000|Overall Study|Patient Preference|11|||
23163251|NCT01560780|64345129|FG001|Overall Study|Patient Preference|11|||
23163252|NCT02941627|64345132|FG000|Overall Study|Death|1|||
23163253|NCT02941627|64345132|FG000|Overall Study|Surgical failure|1|||
23163254|NCT02941627|64345132|FG000|Overall Study|cholesteatoma prevented implantation|1|||
23163255|NCT01326546|64345133|FG000|Overall Study|Lost to Follow-up|8|||
23163256|NCT01326546|64345134|FG001|Overall Study|Lost to Follow-up|7|||
23163257|NCT01326546|64345133|FG000|Overall Study|Protocol Violation|3|||
23163258|NCT01326546|64345134|FG001|Overall Study|Protocol Violation|4|||
23163259|NCT01326546|64345133|FG000|Overall Study|Pregnancy|0|||
23163260|NCT01326546|64345134|FG001|Overall Study|Pregnancy|1|||
23163261|NCT01326546|64345133|FG000|Overall Study|Adverse Event|1|||
23163262|NCT01326546|64345134|FG001|Overall Study|Adverse Event|0|||
23163263|NCT01326546|64345133|FG000|Overall Study|Withdrawal by Subject|5|||
23163264|NCT01326546|64345134|FG001|Overall Study|Withdrawal by Subject|1|||
23163265|NCT01187953|64345140|FG000|Overall Study|Death|11|||
23163266|NCT01187953|64345141|FG001|Overall Study|Death|13|||
23163267|NCT01187953|64345140|FG000|Overall Study|Adverse Event|1|||
23163268|NCT01187953|64345141|FG001|Overall Study|Adverse Event|2|||
23163269|NCT01187953|64345140|FG000|Overall Study|Lost to Follow-up|0|||
23163270|NCT01187953|64345141|FG001|Overall Study|Lost to Follow-up|3|||
23163271|NCT01187953|64345140|FG000|Overall Study|Withdrawal by Subject|3|||
23163272|NCT01187953|64345141|FG001|Overall Study|Withdrawal by Subject|3|||
23163273|NCT00644787|64345142|FG000|Period 1: Titration Phase|Adverse Event|11|||
23163274|NCT00644787|64345143|FG001|Period 1: Titration Phase|Adverse Event|0|||
23163275|NCT00644787|64345144|FG002|Period 1: Titration Phase|Adverse Event|0|||
23163276|NCT00644787|64345142|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
23163277|NCT00644787|64345143|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
23163278|NCT00644787|64345144|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
23163279|NCT00644787|64345142|FG000|Period 1: Titration Phase|Physician Decision|1|||
23163280|NCT00644787|64345143|FG001|Period 1: Titration Phase|Physician Decision|0|||
23163281|NCT00644787|64345144|FG002|Period 1: Titration Phase|Physician Decision|0|||
23163282|NCT00644787|64345142|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
23163283|NCT00644787|64345143|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
23163284|NCT00644787|64345144|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
23163285|NCT00644787|64345142|FG000|Period 1: Titration Phase|Worsening of complications|1|||
23163286|NCT00644787|64345143|FG001|Period 1: Titration Phase|Worsening of complications|0|||
23163287|NCT00644787|64345144|FG002|Period 1: Titration Phase|Worsening of complications|0|||
23163288|NCT00644787|64345142|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
23163289|NCT00644787|64345143|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
23163290|NCT00644787|64345144|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
23163291|NCT00644787|64345142|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
23163292|NCT00644787|64345143|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
23163293|NCT00644787|64345144|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
23163294|NCT00644787|64345142|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
23163295|NCT00644787|64345143|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
23163296|NCT00644787|64345144|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
23224020|NCT04785144|64563949|FG006|Overall Study|Protocol Violation|1|||
23224021|NCT04785144|64563950|FG007|Overall Study|Protocol Violation|0|||
23224022|NCT04785144|64563951|FG008|Overall Study|Protocol Violation|0|||
23224023|NCT04785144|64563952|FG009|Overall Study|Protocol Violation|0|||
23224024|NCT04785144|64563943|FG000|Overall Study|Physician Decision|0|||
23224025|NCT04785144|64563944|FG001|Overall Study|Physician Decision|0|||
23224026|NCT04785144|64563945|FG002|Overall Study|Physician Decision|0|||
23224027|NCT04785144|64563946|FG003|Overall Study|Physician Decision|0|||
23224028|NCT04785144|64563947|FG004|Overall Study|Physician Decision|0|||
23224029|NCT04785144|64563948|FG005|Overall Study|Physician Decision|0|||
23224030|NCT04785144|64563949|FG006|Overall Study|Physician Decision|0|||
23224031|NCT04785144|64563950|FG007|Overall Study|Physician Decision|0|||
23224032|NCT04785144|64563951|FG008|Overall Study|Physician Decision|0|||
23224033|NCT04785144|64563952|FG009|Overall Study|Physician Decision|1|||
23224034|NCT04785144|64563943|FG000|Overall Study|Unable to continue due to work schedule|0|||
23224035|NCT04785144|64563944|FG001|Overall Study|Unable to continue due to work schedule|0|||
23163297|NCT00644787|64345142|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
23163298|NCT00644787|64345143|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
23163299|NCT00644787|64345144|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
23224036|NCT04785144|64563945|FG002|Overall Study|Unable to continue due to work schedule|0|||
23224037|NCT04785144|64563946|FG003|Overall Study|Unable to continue due to work schedule|0|||
23224038|NCT04785144|64563947|FG004|Overall Study|Unable to continue due to work schedule|0|||
23224039|NCT04785144|64563948|FG005|Overall Study|Unable to continue due to work schedule|0|||
23224040|NCT04785144|64563949|FG006|Overall Study|Unable to continue due to work schedule|0|||
23163300|NCT00644787|64345142|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
23163301|NCT00644787|64345143|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
23163302|NCT00644787|64345144|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
23163303|NCT00644787|64345142|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
23163304|NCT00644787|64345143|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
23163305|NCT00644787|64345144|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
23163306|NCT00644787|64345142|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
23163307|NCT00644787|64345143|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
23163308|NCT00644787|64345144|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
23163309|NCT01131676|64345148|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
23163310|NCT01131676|64345149|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
23163311|NCT01131676|64345150|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
23163312|NCT01131676|64345148|FG000|Discontinuation From Treatment|Not treated|4|||
23163313|NCT01131676|64345149|FG001|Discontinuation From Treatment|Not treated|2|||
23163314|NCT01131676|64345150|FG002|Discontinuation From Treatment|Not treated|2|||
23163315|NCT01131676|64345148|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
23163316|NCT01131676|64345149|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
23163317|NCT01131676|64345150|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
23163318|NCT01131676|64345148|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
23163319|NCT01131676|64345149|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
23163320|NCT01131676|64345150|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
23163321|NCT01131676|64345148|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
23163322|NCT01131676|64345149|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
23163323|NCT01131676|64345150|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
23163324|NCT01131676|64345148|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
23163325|NCT01131676|64345149|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
23163326|NCT01131676|64345150|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
23163327|NCT01131676|64345148|FG000|Discontinuation From Treatment|Other than those specified|162|||
23163328|NCT01131676|64345149|FG001|Discontinuation From Treatment|Other than those specified|142|||
23163329|NCT01131676|64345150|FG002|Discontinuation From Treatment|Other than those specified|125|||
23163330|NCT01131676|64345148|FG000|Discontinuation From Treatment|Adverse Event|303|||
23224041|NCT04785144|64563950|FG007|Overall Study|Unable to continue due to work schedule|0|||
23224042|NCT04785144|64563951|FG008|Overall Study|Unable to continue due to work schedule|0|||
23163331|NCT01131676|64345149|FG001|Discontinuation From Treatment|Adverse Event|267|||
23224043|NCT04785144|64563952|FG009|Overall Study|Unable to continue due to work schedule|1|||
23224044|NCT02182999|64563953|FG000|Overall Study|Adverse Event|4|||
23224045|NCT02182999|64563954|FG001|Overall Study|Adverse Event|3|||
23224046|NCT02182999|64563953|FG000|Overall Study|Physician Decision|1|||
23224047|NCT02182999|64563954|FG001|Overall Study|Physician Decision|0|||
23224048|NCT01846208|64563955|FG000|Overall Study|Withdrew prior to treatment|1|||
23224049|NCT01846208|64563956|FG001|Overall Study|Withdrew prior to treatment|1|||
23224050|NCT01846208|64563957|FG002|Overall Study|Withdrew prior to treatment|1|||
23224051|NCT01846208|64563955|FG000|Overall Study|Dosing Symptoms|1|||
23163332|NCT01131676|64345150|FG002|Discontinuation From Treatment|Adverse Event|273|||
23163333|NCT01131676|64345148|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
23163334|NCT01131676|64345149|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
23163335|NCT01131676|64345150|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
23163336|NCT01131676|64345148|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
23163337|NCT01131676|64345149|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
23163338|NCT01131676|64345150|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
23163339|NCT01131676|64345148|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
23163340|NCT01131676|64345149|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
23163341|NCT01131676|64345150|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
23163342|NCT01131676|64345148|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
23163343|NCT01131676|64345149|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
23163344|NCT01131676|64345150|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
23163345|NCT01131676|64345148|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
23163346|NCT01131676|64345149|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
23163347|NCT01131676|64345150|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
23163348|NCT01131676|64345148|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
23163349|NCT01131676|64345149|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
23163350|NCT01131676|64345150|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
23163351|NCT01577186|64345151|FG000|Overall Study|Adverse Event|23|||
23163352|NCT01577186|64345151|FG000|Overall Study|Death|1|||
23163353|NCT01577186|64345151|FG000|Overall Study|Lost to Follow-up|28|||
23163354|NCT01577186|64345151|FG000|Overall Study|Withdrawal by Subject|35|||
23163355|NCT01577186|64345151|FG000|Overall Study|Insufficient Response|18|||
23163356|NCT01577186|64345151|FG000|Overall Study|Ineligible to Continue|15|||
23163357|NCT01577186|64345151|FG000|Overall Study|Non-Compliant|8|||
23163358|NCT01577186|64345151|FG000|Overall Study|Other|2|||
23163359|NCT04486950|64345154|FG000|Overall Study|Lost to Follow-up|0|||
23163360|NCT04486950|64345155|FG001|Overall Study|Lost to Follow-up|0|||
23163361|NCT04486950|64345156|FG002|Overall Study|Lost to Follow-up|0|||
23163362|NCT04486950|64345157|FG003|Overall Study|Lost to Follow-up|0|||
23163363|NCT04486950|64345158|FG004|Overall Study|Lost to Follow-up|0|||
23163364|NCT04486950|64345159|FG005|Overall Study|Lost to Follow-up|1|||
23163365|NCT04486950|64345160|FG006|Overall Study|Lost to Follow-up|0|||
23163366|NCT01652885|64345161|FG000|Overall Study|Adverse Event|1|||
23163367|NCT01714687|64345163|FG000|Overall Study|Withdrawal by Subject|1|||
23163368|NCT01714687|64345164|FG001|Overall Study|Withdrawal by Subject|0|||
23163369|NCT01714687|64345163|FG000|Overall Study|Lost to Follow-up|2|||
23163370|NCT01714687|64345164|FG001|Overall Study|Lost to Follow-up|4|||
23163371|NCT00930761|64345166|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
23163372|NCT00930761|64345167|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
23163373|NCT00930761|64345166|FG000|Overall Study|less than 3 music therapy sessions|0|||
23163374|NCT00930761|64345167|FG001|Overall Study|less than 3 music therapy sessions|3|||
23163375|NCT02980224|64345168|FG000|Overall Study|Adverse Event|4|||
23163376|NCT02980224|64345169|FG001|Overall Study|Adverse Event|1|||
23163377|NCT02980224|64345168|FG000|Overall Study|Withdrawal by Subject|0|||
23163378|NCT02980224|64345169|FG001|Overall Study|Withdrawal by Subject|2|||
23163379|NCT00915681|64345170|FG000|Overall Study|Screening failures|46|||
23163380|NCT04697628|64345171|FG000|Overall Study|Withdrawal by Subject|17|||
23163381|NCT04697628|64345172|FG001|Overall Study|Withdrawal by Subject|23|||
23163382|NCT04697628|64345171|FG000|Overall Study|Lost to Follow-up|0|||
23163383|NCT04697628|64345172|FG001|Overall Study|Lost to Follow-up|4|||
23163384|NCT04697628|64345171|FG000|Overall Study|On-going in study|122|||
23163385|NCT04697628|64345172|FG001|Overall Study|On-going in study|91|||
23163386|NCT01321710|64345175|FG000|Overall Study|Lost to Follow-up|4|||
23163387|NCT01321710|64345176|FG001|Overall Study|Lost to Follow-up|5|||
23163388|NCT01321710|64345177|FG002|Overall Study|Lost to Follow-up|0|||
23163389|NCT02636582|64345180|FG000|Overall Study|Surgical Pathology|1|||
23163390|NCT02636582|64345181|FG001|Overall Study|Surgical Pathology|0|||
23163391|NCT02871778|64345185|FG000|Part A: Treatment Period 1|Adverse Event|1|||
23163392|NCT02871778|64345186|FG001|Part A: Treatment Period 1|Adverse Event|1|||
23163393|NCT02871778|64345187|FG002|Part A: Treatment Period 1|Adverse Event|1|||
23163394|NCT02871778|64345188|FG003|Part A: Treatment Period 1|Adverse Event|0|||
23163395|NCT02871778|64345189|FG004|Part A: Treatment Period 1|Adverse Event|0|||
23163396|NCT02871778|64345190|FG005|Part A: Treatment Period 1|Adverse Event|0|||
23163397|NCT02871778|64345191|FG006|Part A: Treatment Period 1|Adverse Event|0|||
23163398|NCT02871778|64345192|FG007|Part A: Treatment Period 1|Adverse Event|0|||
23163399|NCT02871778|64345185|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
23163400|NCT02871778|64345186|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
23163401|NCT02871778|64345187|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23163402|NCT02871778|64345188|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
23163403|NCT02871778|64345189|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23163404|NCT02871778|64345190|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23163405|NCT02871778|64345191|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23163406|NCT02871778|64345192|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
23163407|NCT02871778|64345185|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23163408|NCT02871778|64345186|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23163409|NCT02871778|64345187|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
23163410|NCT02871778|64345188|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23163411|NCT02871778|64345189|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23163412|NCT02871778|64345190|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23163413|NCT02871778|64345191|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23163414|NCT02871778|64345192|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
23163415|NCT02871778|64345185|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23163416|NCT02871778|64345186|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23163417|NCT02871778|64345187|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
23571137|NCT01275196|65820907|FG001|Overall Study|Lost to Follow-up|0|||
23571138|NCT01275196|65820906|FG000|Overall Study|Disease Progression|6|||
23571139|NCT01275196|65820907|FG001|Overall Study|Disease Progression|5|||
23571140|NCT01275196|65820906|FG000|Overall Study|Protocol Violation|1|||
23571141|NCT01275196|65820907|FG001|Overall Study|Protocol Violation|0|||
23571142|NCT01275196|65820906|FG000|Overall Study|Suboptimal response/treatment failure|5|||
23571143|NCT01275196|65820907|FG001|Overall Study|Suboptimal response/treatment failure|6|||
23571144|NCT00917267|65820908|FG000|Overall Study|Adverse Event|15|||
23571145|NCT00917267|65820909|FG001|Overall Study|Adverse Event|36|||
23571146|NCT00917267|65820908|FG000|Overall Study|Physician Decision|2|||
23163418|NCT02871778|64345188|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23571147|NCT00917267|65820909|FG001|Overall Study|Physician Decision|4|||
23571148|NCT00917267|65820908|FG000|Overall Study|Protocol Violation|9|||
23331607|NCT00083759|64955480|FG000|Overall Study|Inadequate Therapeutic Response|32|||
23331608|NCT00083759|64955481|FG001|Overall Study|Inadequate Therapeutic Response|35|||
23331609|NCT00083759|64955480|FG000|Overall Study|Subject Withdrew Consent|2|||
23331610|NCT00083759|64955481|FG001|Overall Study|Subject Withdrew Consent|2|||
23331611|NCT00083759|64955480|FG000|Overall Study|Non-Compliance|1|||
23331612|NCT00083759|64955481|FG001|Overall Study|Non-Compliance|0|||
23331613|NCT00083759|64955480|FG000|Overall Study|Sponsor's Discretion|28|||
23571149|NCT00917267|65820909|FG001|Overall Study|Protocol Violation|18|||
23571150|NCT00917267|65820908|FG000|Overall Study|Withdrawal by Subject|5|||
23571151|NCT00917267|65820909|FG001|Overall Study|Withdrawal by Subject|12|||
23571152|NCT00917267|65820908|FG000|Overall Study|Lost to follow up|0|||
23571153|NCT00917267|65820909|FG001|Overall Study|Lost to follow up|2|||
23571154|NCT00917267|65820908|FG000|Overall Study|Entry Criteria Not Met|1|||
23163419|NCT02871778|64345189|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23163420|NCT02871778|64345190|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23163421|NCT02871778|64345191|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23163422|NCT02871778|64345192|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
23163423|NCT02871778|64345185|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
23163424|NCT02871778|64345186|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
23163425|NCT02871778|64345187|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
23163426|NCT02871778|64345188|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
23163427|NCT02871778|64345189|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
23163428|NCT02871778|64345190|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
23163429|NCT02871778|64345191|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
23163430|NCT02871778|64345192|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
23163431|NCT02871778|64345185|FG000|Part A: Treatment Period 2|Adverse Event|2|||
23163432|NCT02871778|64345186|FG001|Part A: Treatment Period 2|Adverse Event|2|||
23163433|NCT02871778|64345187|FG002|Part A: Treatment Period 2|Adverse Event|0|||
23163434|NCT02871778|64345188|FG003|Part A: Treatment Period 2|Adverse Event|0|||
23331614|NCT00083759|64955481|FG001|Overall Study|Sponsor's Discretion|29|||
23331615|NCT00083759|64955480|FG000|Overall Study|Other|14|||
23571155|NCT00917267|65820909|FG001|Overall Study|Entry Criteria Not Met|0|||
23571156|NCT00917267|65820908|FG000|Overall Study|Sponsor Decision|5|||
23331616|NCT00083759|64955481|FG001|Overall Study|Other|13|||
23571157|NCT00917267|65820909|FG001|Overall Study|Sponsor Decision|5|||
23571158|NCT00917267|65820908|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
23163435|NCT02871778|64345189|FG004|Part A: Treatment Period 2|Adverse Event|0|||
23163436|NCT02871778|64345190|FG005|Part A: Treatment Period 2|Adverse Event|0|||
23163437|NCT02871778|64345191|FG006|Part A: Treatment Period 2|Adverse Event|0|||
23163438|NCT02871778|64345192|FG007|Part A: Treatment Period 2|Adverse Event|0|||
23163439|NCT02871778|64345185|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
23163440|NCT02871778|64345186|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
23163441|NCT02871778|64345187|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
23163442|NCT02871778|64345188|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
23163443|NCT02871778|64345189|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
23163444|NCT02871778|64345190|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
23163445|NCT02871778|64345191|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
23163446|NCT02871778|64345192|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
23163447|NCT02871778|64345185|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
23163448|NCT02871778|64345186|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23163449|NCT02871778|64345187|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
23163450|NCT02871778|64345188|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23163451|NCT02871778|64345189|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23163452|NCT02871778|64345190|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23163453|NCT02871778|64345191|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23163454|NCT02871778|64345192|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
23163455|NCT02871778|64345185|FG000|Part B: Treatment Period 3|Adverse Event|0|||
23163456|NCT02871778|64345186|FG001|Part B: Treatment Period 3|Adverse Event|0|||
23163457|NCT02871778|64345187|FG002|Part B: Treatment Period 3|Adverse Event|0|||
23163458|NCT02871778|64345188|FG003|Part B: Treatment Period 3|Adverse Event|0|||
23163459|NCT02871778|64345189|FG004|Part B: Treatment Period 3|Adverse Event|1|||
23163460|NCT02871778|64345190|FG005|Part B: Treatment Period 3|Adverse Event|1|||
23163461|NCT02871778|64345191|FG006|Part B: Treatment Period 3|Adverse Event|1|||
23163462|NCT02871778|64345192|FG007|Part B: Treatment Period 3|Adverse Event|0|||
23163463|NCT00545064|64345193|FG000|Overall Study|Lost to Follow-up|3|||
23163464|NCT00545064|64345193|FG000|Overall Study|Withdrawal by Subject|2|||
23163465|NCT00545064|64345193|FG000|Overall Study|did not complete course of treatment|1|||
23163466|NCT00545064|64345193|FG000|Overall Study|cancel all appointments, no rebooking|1|||
23163467|NCT00545064|64345193|FG000|Overall Study|inclement weather|1|||
23331617|NCT02914613|64955484|FG000|Overall Study|Withdrawal by Subject|1|||
23331618|NCT02914613|64955485|FG001|Overall Study|Withdrawal by Subject|2|||
23331619|NCT02914613|64955484|FG000|Overall Study|Adverse Event|1|||
23331620|NCT02914613|64955485|FG001|Overall Study|Adverse Event|0|||
23331621|NCT01479465|64955487|FG000|Overall Study|Disease Progression|9|||
23331622|NCT01479465|64955488|FG001|Overall Study|Disease Progression|61|||
23331623|NCT01479465|64955489|FG002|Overall Study|Disease Progression|65|||
23331624|NCT01479465|64955490|FG003|Overall Study|Disease Progression|70|||
23331625|NCT01479465|64955487|FG000|Overall Study|Study Discontinued by Sponsor|0|||
23331626|NCT01479465|64955488|FG001|Overall Study|Study Discontinued by Sponsor|7|||
23331627|NCT01479465|64955489|FG002|Overall Study|Study Discontinued by Sponsor|5|||
23331628|NCT01479465|64955490|FG003|Overall Study|Study Discontinued by Sponsor|3|||
23331629|NCT01479465|64955487|FG000|Overall Study|Adverse Event|0|||
23331630|NCT01479465|64955488|FG001|Overall Study|Adverse Event|3|||
23331631|NCT01479465|64955489|FG002|Overall Study|Adverse Event|6|||
23331632|NCT01479465|64955490|FG003|Overall Study|Adverse Event|4|||
23331633|NCT01479465|64955487|FG000|Overall Study|Investigator Discretion|1|||
23331634|NCT01479465|64955488|FG001|Overall Study|Investigator Discretion|4|||
23331635|NCT01479465|64955489|FG002|Overall Study|Investigator Discretion|2|||
23331636|NCT01479465|64955490|FG003|Overall Study|Investigator Discretion|4|||
23331637|NCT01479465|64955487|FG000|Overall Study|Subject Request|1|||
23331638|NCT01479465|64955488|FG001|Overall Study|Subject Request|3|||
23331639|NCT01479465|64955489|FG002|Overall Study|Subject Request|4|||
23331640|NCT01479465|64955490|FG003|Overall Study|Subject Request|2|||
23331641|NCT01479465|64955487|FG000|Overall Study|Subject Withdrew Consent|0|||
23331642|NCT01479465|64955488|FG001|Overall Study|Subject Withdrew Consent|5|||
23331643|NCT01479465|64955489|FG002|Overall Study|Subject Withdrew Consent|2|||
23163468|NCT02554019|64345194|FG000|Overall Study|Withdrawal by Subject|1|||
23163469|NCT02554019|64345195|FG001|Overall Study|Withdrawal by Subject|0|||
23163470|NCT02554019|64345196|FG002|Overall Study|Withdrawal by Subject|2|||
23163471|NCT02554019|64345194|FG000|Overall Study|Adverse Event|1|||
23163472|NCT02554019|64345195|FG001|Overall Study|Adverse Event|0|||
23163473|NCT02554019|64345196|FG002|Overall Study|Adverse Event|0|||
23163474|NCT00631371|64345197|FG000|Overall Study|Lost to Follow-up|24|||
23163475|NCT00631371|64345198|FG001|Overall Study|Lost to Follow-up|19|||
23163476|NCT00631371|64345197|FG000|Overall Study|Other reason|5|||
23331644|NCT01479465|64955490|FG003|Overall Study|Subject Withdrew Consent|1|||
23331645|NCT01479465|64955487|FG000|Overall Study|Protocol Violation|0|||
23331646|NCT01479465|64955488|FG001|Overall Study|Protocol Violation|1|||
23331647|NCT01479465|64955489|FG002|Overall Study|Protocol Violation|1|||
23331648|NCT01479465|64955490|FG003|Overall Study|Protocol Violation|0|||
23331649|NCT01479465|64955487|FG000|Overall Study|Death|0|||
23163477|NCT00631371|64345198|FG001|Overall Study|Other reason|12|||
23163478|NCT00631371|64345197|FG000|Overall Study|subject request|38|||
23163479|NCT00631371|64345198|FG001|Overall Study|subject request|45|||
23163480|NCT00631371|64345197|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
23163481|NCT00631371|64345198|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
23163482|NCT00631371|64345197|FG000|Overall Study|Death|263|||
23163483|NCT00631371|64345198|FG001|Overall Study|Death|239|||
23163484|NCT01773109|64345200|FG000|Overall Study|Symptomatic Progression|2|||
23163485|NCT01773109|64345200|FG000|Overall Study|Death|1|||
23163486|NCT03363321|64345204|FG000|Overall Study|Withdrawal by Subject|0|||
23163487|NCT03363321|64345205|FG001|Overall Study|Withdrawal by Subject|1|||
23163488|NCT03363321|64345206|FG002|Overall Study|Withdrawal by Subject|0|||
23163489|NCT03363321|64345207|FG003|Overall Study|Withdrawal by Subject|1|||
23163490|NCT03363321|64345208|FG004|Overall Study|Withdrawal by Subject|0|||
23163491|NCT00094055|64345209|FG000|Overall Study|Adverse Event|11|||
23163492|NCT00094055|64345209|FG000|Overall Study|Death|4|||
23163493|NCT00094055|64345209|FG000|Overall Study|Lack of Efficacy|17|||
23163494|NCT00094055|64345209|FG000|Overall Study|Lost to Follow-up|2|||
23163495|NCT00094055|64345209|FG000|Overall Study|progressive disease|2|||
23163496|NCT00094055|64345209|FG000|Overall Study|clinical progression|1|||
23163497|NCT00094055|64345209|FG000|Overall Study|roll-over to another study|14|||
23163498|NCT00094055|64345209|FG000|Overall Study|Withdrawal by Subject|9|||
23163499|NCT02846532|64345210|FG000|Overall Study|Lost to Follow-up|0|||
23163500|NCT02846532|64345211|FG001|Overall Study|Lost to Follow-up|1|||
23163501|NCT02846532|64345212|FG002|Overall Study|Lost to Follow-up|1|||
23163502|NCT02846532|64345210|FG000|Overall Study|Withdrawal by Subject|1|||
23163503|NCT02846532|64345211|FG001|Overall Study|Withdrawal by Subject|2|||
23163504|NCT02846532|64345212|FG002|Overall Study|Withdrawal by Subject|0|||
23163505|NCT00501007|64345214|FG000|Overall Study|Inclusion criteria not met.|29|||
23163506|NCT00501007|64345215|FG001|Overall Study|Inclusion criteria not met.|25|||
23163507|NCT03201458|64348502|FG000|Overall Study|No longer eligible|2|||
23163508|NCT03201458|64348503|FG001|Overall Study|No longer eligible|5|||
23163509|NCT03201458|64348502|FG000|Overall Study|Health event before starting|1|||
23224052|NCT01846208|64563956|FG001|Overall Study|Dosing Symptoms|2|||
23224053|NCT01846208|64563957|FG002|Overall Study|Dosing Symptoms|6|||
23224054|NCT01846208|64563955|FG000|Overall Study|Withdrawal by Subject|5|||
23331650|NCT01479465|64955488|FG001|Overall Study|Death|0|||
23571159|NCT00917267|65820909|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
23571160|NCT01734850|65820910|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
23571161|NCT01734850|65820911|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
23571162|NCT01734850|65820912|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
23571163|NCT01734850|65820910|FG000|Overall Study|Not infused due to manufacturing failure|0|||
23571164|NCT01734850|65820911|FG001|Overall Study|Not infused due to manufacturing failure|0|||
23571165|NCT01734850|65820912|FG002|Overall Study|Not infused due to manufacturing failure|1|||
23571166|NCT00962585|65820915|FG000|Overall Study|Adverse Event|0|||
23571167|NCT00962585|65820916|FG001|Overall Study|Adverse Event|2|||
23571168|NCT00962585|65820917|FG002|Overall Study|Adverse Event|1|||
23571169|NCT00962585|65820918|FG003|Overall Study|Adverse Event|0|||
23571170|NCT00962585|65820915|FG000|Overall Study|Lost to Follow-up|3|||
23571171|NCT00962585|65820916|FG001|Overall Study|Lost to Follow-up|0|||
23571172|NCT00962585|65820917|FG002|Overall Study|Lost to Follow-up|1|||
23571173|NCT00962585|65820918|FG003|Overall Study|Lost to Follow-up|0|||
23571174|NCT00962585|65820915|FG000|Overall Study|Protocol Violation|0|||
23571175|NCT00962585|65820916|FG001|Overall Study|Protocol Violation|0|||
23571176|NCT00962585|65820917|FG002|Overall Study|Protocol Violation|1|||
23571177|NCT00962585|65820918|FG003|Overall Study|Protocol Violation|0|||
23571178|NCT00962585|65820915|FG000|Overall Study|Withdrawal by Subject|1|||
23571179|NCT00962585|65820916|FG001|Overall Study|Withdrawal by Subject|0|||
23571180|NCT00962585|65820917|FG002|Overall Study|Withdrawal by Subject|0|||
23163510|NCT03201458|64348503|FG001|Overall Study|Health event before starting|0|||
23163511|NCT03201458|64348502|FG000|Overall Study|Physician Decision|1|||
23163512|NCT03201458|64348503|FG001|Overall Study|Physician Decision|0|||
23163513|NCT01611974|64348504|FG000|Overall Study|Death|10|||
23163514|NCT01611974|64348505|FG001|Overall Study|Death|12|||
23224055|NCT01846208|64563956|FG001|Overall Study|Withdrawal by Subject|0|||
23571181|NCT00962585|65820918|FG003|Overall Study|Withdrawal by Subject|0|||
23163515|NCT01611974|64348506|FG002|Overall Study|Death|10|||
23163516|NCT01611974|64348504|FG000|Overall Study|Lost to Follow-up|0|||
23163517|NCT01611974|64348505|FG001|Overall Study|Lost to Follow-up|1|||
23571182|NCT00962585|65820915|FG000|Overall Study|Withdrew Consent|2|||
23571183|NCT00962585|65820916|FG001|Overall Study|Withdrew Consent|0|||
23571184|NCT00962585|65820917|FG002|Overall Study|Withdrew Consent|0|||
23571185|NCT00962585|65820918|FG003|Overall Study|Withdrew Consent|0|||
23163518|NCT01611974|64348506|FG002|Overall Study|Lost to Follow-up|0|||
23163519|NCT01611974|64348504|FG000|Overall Study|Physician Decision|5|||
23163520|NCT01611974|64348505|FG001|Overall Study|Physician Decision|1|||
23163521|NCT01611974|64348506|FG002|Overall Study|Physician Decision|2|||
23163522|NCT01611974|64348504|FG000|Overall Study|Withdrawal by Subject|0|||
23571186|NCT01807221|65820927|FG000|Overall Study|Progressive disease|1|||
23571187|NCT01807221|65820928|FG001|Overall Study|Progressive disease|0|||
23571188|NCT01807221|65820929|FG002|Overall Study|Progressive disease|1|||
23571189|NCT01807221|65820930|FG003|Overall Study|Progressive disease|0|||
23571190|NCT01807221|65820931|FG004|Overall Study|Progressive disease|0|||
23571191|NCT01807221|65820932|FG005|Overall Study|Progressive disease|0|||
23571192|NCT01807221|65820927|FG000|Overall Study|Death|7|||
23571193|NCT01807221|65820928|FG001|Overall Study|Death|9|||
23571194|NCT01807221|65820929|FG002|Overall Study|Death|4|||
23571195|NCT01807221|65820930|FG003|Overall Study|Death|2|||
23571196|NCT01807221|65820931|FG004|Overall Study|Death|1|||
23571197|NCT01807221|65820932|FG005|Overall Study|Death|6|||
23571198|NCT01807221|65820927|FG000|Overall Study|Physician Decision|2|||
23571199|NCT01807221|65820928|FG001|Overall Study|Physician Decision|1|||
23571200|NCT01807221|65820929|FG002|Overall Study|Physician Decision|0|||
23571201|NCT01807221|65820930|FG003|Overall Study|Physician Decision|0|||
23571202|NCT01807221|65820931|FG004|Overall Study|Physician Decision|0|||
23571203|NCT01807221|65820932|FG005|Overall Study|Physician Decision|0|||
23571204|NCT01807221|65820927|FG000|Overall Study|Adverse Event|33|||
23571205|NCT01807221|65820928|FG001|Overall Study|Adverse Event|22|||
23571206|NCT01807221|65820929|FG002|Overall Study|Adverse Event|26|||
23571207|NCT01807221|65820930|FG003|Overall Study|Adverse Event|25|||
23571208|NCT01807221|65820931|FG004|Overall Study|Adverse Event|18|||
23163523|NCT01611974|64348505|FG001|Overall Study|Withdrawal by Subject|1|||
23163524|NCT01611974|64348506|FG002|Overall Study|Withdrawal by Subject|4|||
23163525|NCT02199080|64348509|FG000|Overall Study|Protocol Violation|12|||
23163526|NCT01265550|64348510|FG000|Pre Randomization|Withdrawal by Subject|0|||
23331651|NCT01479465|64955489|FG002|Overall Study|Death|0|||
23331652|NCT01479465|64955490|FG003|Overall Study|Death|1|||
23331653|NCT01479465|64955487|FG000|Overall Study|Lost to Follow-up|0|||
23163527|NCT01265550|64348511|FG001|Pre Randomization|Withdrawal by Subject|0|||
23163528|NCT01265550|64348512|FG002|Pre Randomization|Withdrawal by Subject|0|||
23163529|NCT01265550|64348513|FG003|Pre Randomization|Withdrawal by Subject|70|||
23163530|NCT01265550|64348510|FG000|Pre Randomization|Technical Exclusions|0|||
23163531|NCT01265550|64348511|FG001|Pre Randomization|Technical Exclusions|0|||
23163532|NCT01265550|64348512|FG002|Pre Randomization|Technical Exclusions|0|||
23163533|NCT01265550|64348513|FG003|Pre Randomization|Technical Exclusions|54|||
23163534|NCT01265550|64348510|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
23163535|NCT01265550|64348511|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
23163536|NCT01265550|64348512|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
23163537|NCT01265550|64348513|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
23163538|NCT01265550|64348510|FG000|Pre Randomization|Non-GERD organic disorders|0|||
23163539|NCT01265550|64348511|FG001|Pre Randomization|Non-GERD organic disorders|0|||
23163540|NCT01265550|64348512|FG002|Pre Randomization|Non-GERD organic disorders|0|||
23163541|NCT01265550|64348513|FG003|Pre Randomization|Non-GERD organic disorders|23|||
23163542|NCT01265550|64348510|FG000|Pre Randomization|Functional heartburn|0|||
23163543|NCT01265550|64348511|FG001|Pre Randomization|Functional heartburn|0|||
23163544|NCT01265550|64348512|FG002|Pre Randomization|Functional heartburn|0|||
23163545|NCT01265550|64348513|FG003|Pre Randomization|Functional heartburn|99|||
23163546|NCT01152021|64348514|FG000|Overall Study|Adverse Event|4|||
23163547|NCT01152021|64348515|FG001|Overall Study|Adverse Event|4|||
23163548|NCT01152021|64348514|FG000|Overall Study|Study drug had expired|1|||
23331654|NCT01479465|64955488|FG001|Overall Study|Lost to Follow-up|0|||
23163549|NCT01152021|64348515|FG001|Overall Study|Study drug had expired|0|||
23163550|NCT01152021|64348514|FG000|Overall Study|Physician Decision|1|||
23163551|NCT01152021|64348515|FG001|Overall Study|Physician Decision|1|||
23331655|NCT01479465|64955489|FG002|Overall Study|Lost to Follow-up|1|||
23571209|NCT01807221|65820932|FG005|Overall Study|Adverse Event|21|||
23571210|NCT01807221|65820927|FG000|Overall Study|Protocol Violation|0|||
23571211|NCT01807221|65820928|FG001|Overall Study|Protocol Violation|2|||
23163552|NCT01152021|64348514|FG000|Overall Study|No access to study drug in Pharmacy|0|||
23163553|NCT01152021|64348515|FG001|Overall Study|No access to study drug in Pharmacy|1|||
23163554|NCT02321436|64348516|FG000|Overall Study|Withdrawal by Subject|1|||
23571212|NCT01807221|65820929|FG002|Overall Study|Protocol Violation|1|||
23163555|NCT02321436|64348517|FG001|Overall Study|Withdrawal by Subject|0|||
23331656|NCT01479465|64955490|FG003|Overall Study|Lost to Follow-up|0|||
23331657|NCT01139125|64955493|FG000|Overall Study|Withdrawal by Subject|1|||
23571213|NCT01807221|65820930|FG003|Overall Study|Protocol Violation|2|||
23571214|NCT01807221|65820931|FG004|Overall Study|Protocol Violation|0|||
23571215|NCT01807221|65820932|FG005|Overall Study|Protocol Violation|1|||
23331658|NCT00586820|64955494|FG000|Overall Study|Unsuccessful PCI|1|||
23331659|NCT00586820|64955495|FG001|Overall Study|Unsuccessful PCI|0|||
23331660|NCT03588910|64955501|FG000|Overall Study|Withdrawal by Subject|1|||
23331661|NCT03588910|64955502|FG001|Overall Study|Withdrawal by Subject|0|||
23331662|NCT03588910|64955501|FG000|Overall Study|Allergy|2|||
23331663|NCT03588910|64955502|FG001|Overall Study|Allergy|0|||
23331664|NCT03588910|64955501|FG000|Overall Study|Protocol Violation|0|||
23331665|NCT03588910|64955502|FG001|Overall Study|Protocol Violation|3|||
23331666|NCT03588910|64955501|FG000|Overall Study|Did not complete Day 1 Survey|5|||
23331667|NCT03588910|64955502|FG001|Overall Study|Did not complete Day 1 Survey|10|||
23331668|NCT03588910|64955501|FG000|Overall Study|Did not complete Day 7 Survey|5|||
23331669|NCT03588910|64955502|FG001|Overall Study|Did not complete Day 7 Survey|2|||
23331670|NCT05506046|64955511|FG000|Overall Study|Lost to Follow-up|89|||
23331671|NCT05506046|64955512|FG001|Overall Study|Lost to Follow-up|101|||
23163556|NCT02321436|64348516|FG000|Overall Study|Lost to Follow-up|0|||
23163557|NCT02321436|64348517|FG001|Overall Study|Lost to Follow-up|1|||
23163558|NCT00393887|64348526|FG000|Overall Study|Physician Decision|5|||
23163559|NCT00393887|64348527|FG001|Overall Study|Physician Decision|0|||
23163560|NCT00393887|64348526|FG000|Overall Study|Lost to Follow-up|11|||
23163561|NCT00393887|64348527|FG001|Overall Study|Lost to Follow-up|9|||
23163562|NCT02192827|64348528|FG000|Overall Study|Lost to Follow-up|25|||
23163563|NCT02192827|64348529|FG001|Overall Study|Lost to Follow-up|27|||
23163564|NCT02192827|64348528|FG000|Overall Study|Given additional steroids with admission|13|||
23163565|NCT02192827|64348529|FG001|Overall Study|Given additional steroids with admission|11|||
23163566|NCT04153188|64348530|FG000|Overall Study|Lost to Follow-up|1|||
23224056|NCT01846208|64563957|FG002|Overall Study|Withdrawal by Subject|0|||
23224057|NCT01846208|64563955|FG000|Overall Study|Non-compliance|1|||
23224058|NCT01846208|64563956|FG001|Overall Study|Non-compliance|1|||
23224059|NCT01846208|64563957|FG002|Overall Study|Non-compliance|0|||
23224060|NCT01846208|64563955|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
23224061|NCT01846208|64563956|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
23224062|NCT01846208|64563957|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
23224063|NCT01846208|64563955|FG000|Overall Study|Refused SU OFC|0|||
23224064|NCT01846208|64563956|FG001|Overall Study|Refused SU OFC|0|||
23224065|NCT01846208|64563957|FG002|Overall Study|Refused SU OFC|1|||
23224066|NCT00509028|64563958|FG000|Overall Study|Adverse Event|2|||
23224067|NCT00509028|64563959|FG001|Overall Study|Adverse Event|0|||
23331672|NCT05506046|64955513|FG002|Overall Study|Lost to Follow-up|102|||
23331673|NCT05506046|64955514|FG003|Overall Study|Lost to Follow-up|99|||
23331674|NCT01743560|64955515|FG000|Overall Study|Disease progression|26|||
23331675|NCT01743560|64955515|FG000|Overall Study|Adverse Event|8|||
23331676|NCT01743560|64955515|FG000|Overall Study|Death|3|||
23447063|NCT03210961|65377864|FG001|Overall Study|Adverse Event|0|||
23163567|NCT04153188|64348531|FG001|Overall Study|Lost to Follow-up|1|||
23163568|NCT04153188|64348530|FG000|Overall Study|Withdrawal by Subject|2|||
23163569|NCT04153188|64348531|FG001|Overall Study|Withdrawal by Subject|0|||
23163570|NCT04153188|64348530|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
23224068|NCT00509028|64563958|FG000|Overall Study|Withdrawal by Subject|4|||
23224069|NCT00509028|64563959|FG001|Overall Study|Withdrawal by Subject|3|||
23224070|NCT00509028|64563958|FG000|Overall Study|Lost to Follow-up|0|||
23331677|NCT01743560|64955515|FG000|Overall Study|Withdrawal by Subject|2|||
23331678|NCT01743560|64955515|FG000|Overall Study|Protocol Violation|1|||
23331679|NCT01743560|64955515|FG000|Overall Study|>1 dose of study drug|3|||
23331680|NCT02748213|64955518|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
23571216|NCT01807221|65820927|FG000|Overall Study|Non-compliance|1|||
23571217|NCT01807221|65820928|FG001|Overall Study|Non-compliance|2|||
23571218|NCT01807221|65820929|FG002|Overall Study|Non-compliance|0|||
23571219|NCT01807221|65820930|FG003|Overall Study|Non-compliance|1|||
23571220|NCT01807221|65820931|FG004|Overall Study|Non-compliance|0|||
23571221|NCT01807221|65820932|FG005|Overall Study|Non-compliance|0|||
23571222|NCT01807221|65820927|FG000|Overall Study|Logistical difficulties|0|||
23163571|NCT04153188|64348531|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
23571223|NCT01807221|65820928|FG001|Overall Study|Logistical difficulties|1|||
23163572|NCT03152019|64348532|FG000|Overall Study|Adverse Event|0|||
23163573|NCT03152019|64348533|FG001|Overall Study|Adverse Event|1|||
23163574|NCT04623242|64348543|FG000|Overall Study|Withdrawal by Subject|7|||
23163575|NCT04623242|64348544|FG001|Overall Study|Withdrawal by Subject|12|||
23163576|NCT04623242|64348545|FG002|Overall Study|Withdrawal by Subject|5|||
23163577|NCT04623242|64348546|FG003|Overall Study|Withdrawal by Subject|7|||
23163578|NCT04623242|64348547|FG004|Overall Study|Withdrawal by Subject|0|||
23163579|NCT04623242|64348543|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
23163580|NCT04623242|64348544|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
23163581|NCT04623242|64348545|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
23163582|NCT04623242|64348546|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
23163583|NCT04623242|64348547|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
23163584|NCT04623242|64348543|FG000|Overall Study|Subject unblinded to mutation status|0|||
23163585|NCT04623242|64348544|FG001|Overall Study|Subject unblinded to mutation status|0|||
23163586|NCT04623242|64348545|FG002|Overall Study|Subject unblinded to mutation status|0|||
23163587|NCT04623242|64348546|FG003|Overall Study|Subject unblinded to mutation status|13|||
23163588|NCT04623242|64348547|FG004|Overall Study|Subject unblinded to mutation status|0|||
23163589|NCT04418076|64348548|FG000|Overall Study|Death|1|||
23163590|NCT04418076|64348549|FG001|Overall Study|Death|0|||
23163591|NCT04418076|64348550|FG002|Overall Study|Death|0|||
23163592|NCT04418076|64348551|FG003|Overall Study|Death|0|||
23163593|NCT04418076|64348548|FG000|Overall Study|Lost to Follow-up|2|||
23163594|NCT04418076|64348549|FG001|Overall Study|Lost to Follow-up|5|||
23163595|NCT04418076|64348550|FG002|Overall Study|Lost to Follow-up|1|||
23163596|NCT04418076|64348551|FG003|Overall Study|Lost to Follow-up|2|||
23163597|NCT04418076|64348548|FG000|Overall Study|Withdrawal by Subject|1|||
23163598|NCT04418076|64348549|FG001|Overall Study|Withdrawal by Subject|0|||
23331681|NCT02748213|64955519|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
23571224|NCT01807221|65820929|FG002|Overall Study|Logistical difficulties|0|||
23571225|NCT01807221|65820930|FG003|Overall Study|Logistical difficulties|0|||
23163599|NCT04418076|64348550|FG002|Overall Study|Withdrawal by Subject|1|||
23163600|NCT04418076|64348551|FG003|Overall Study|Withdrawal by Subject|1|||
23163601|NCT04418076|64348548|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
23163602|NCT04418076|64348549|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
23163603|NCT04418076|64348550|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
23163604|NCT04418076|64348551|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
23163605|NCT01761292|64348553|FG000|Part 1|Adverse Event|1|||
23331682|NCT02748213|64955518|FG000|Overall Study|Abnormal Laboratory Test|1|||
23163606|NCT01761292|64348553|FG000|Part 1|not receiving treatment in Part 1|1|||
23163607|NCT01761292|64348553|FG000|Extension 1|Withdrawal by Subject|1|||
23331683|NCT02748213|64955519|FG001|Overall Study|Abnormal Laboratory Test|0|||
23331684|NCT02748213|64955518|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
23571226|NCT01807221|65820931|FG004|Overall Study|Logistical difficulties|1|||
23571227|NCT01807221|65820932|FG005|Overall Study|Logistical difficulties|0|||
23571228|NCT01807221|65820927|FG000|Overall Study|Withdrawal by Subject|33|||
23571229|NCT01807221|65820928|FG001|Overall Study|Withdrawal by Subject|15|||
23571230|NCT01807221|65820929|FG002|Overall Study|Withdrawal by Subject|8|||
23571231|NCT01807221|65820930|FG003|Overall Study|Withdrawal by Subject|14|||
23571232|NCT01807221|65820931|FG004|Overall Study|Withdrawal by Subject|16|||
23571233|NCT01807221|65820932|FG005|Overall Study|Withdrawal by Subject|13|||
23571234|NCT01807221|65820927|FG000|Overall Study|Sponsor decision|2|||
23571235|NCT01807221|65820928|FG001|Overall Study|Sponsor decision|0|||
23571236|NCT01807221|65820929|FG002|Overall Study|Sponsor decision|1|||
23163608|NCT00563186|64348554|FG000|Overall Study|LOS<48 hours|97|||
23163609|NCT00563186|64348555|FG001|Overall Study|LOS<48 hours|74|||
23163610|NCT00563186|64348554|FG000|Overall Study|Incomplete data|1|||
23163611|NCT00563186|64348555|FG001|Overall Study|Incomplete data|1|||
23163612|NCT03355300|64348558|FG000|Overall Study|Physician Decision|0|||
23163613|NCT03355300|64348559|FG001|Overall Study|Physician Decision|1|||
23163614|NCT03355300|64348558|FG000|Overall Study|Lack of Efficacy|2|||
23163615|NCT03355300|64348559|FG001|Overall Study|Lack of Efficacy|1|||
23163616|NCT03355300|64348558|FG000|Overall Study|Other reason|1|||
23163617|NCT03355300|64348559|FG001|Overall Study|Other reason|0|||
23447064|NCT03210961|65377865|FG002|Overall Study|Adverse Event|0|||
23447065|NCT03210961|65377866|FG003|Overall Study|Adverse Event|0|||
23571237|NCT01807221|65820930|FG003|Overall Study|Sponsor decision|1|||
23571238|NCT01807221|65820931|FG004|Overall Study|Sponsor decision|0|||
23163618|NCT00131469|64348560|FG000|Overall Study|Withdrawal by Subject|3|||
23163619|NCT00131469|64348561|FG001|Overall Study|Withdrawal by Subject|4|||
23163620|NCT00131469|64348560|FG000|Overall Study|Protocol Violation|3|||
23163621|NCT00131469|64348561|FG001|Overall Study|Protocol Violation|1|||
23163622|NCT00131469|64348560|FG000|Overall Study|Death|0|||
23163623|NCT00131469|64348561|FG001|Overall Study|Death|1|||
23163624|NCT00131469|64348560|FG000|Overall Study|Lost to Follow-up|0|||
23163625|NCT00131469|64348561|FG001|Overall Study|Lost to Follow-up|1|||
23163626|NCT00131469|64348560|FG000|Overall Study|scan not analyzable|3|||
23163627|NCT00131469|64348561|FG001|Overall Study|scan not analyzable|6|||
23163628|NCT00490451|64348562|FG000|Overall Study|Adverse Event|3|||
23163629|NCT00490451|64348563|FG001|Overall Study|Adverse Event|3|||
23163630|NCT00490451|64348562|FG000|Overall Study|Death|3|||
23163631|NCT00490451|64348563|FG001|Overall Study|Death|1|||
23163632|NCT00490451|64348562|FG000|Overall Study|Withdrawal by Subject|2|||
23163633|NCT00490451|64348563|FG001|Overall Study|Withdrawal by Subject|0|||
23163634|NCT00490451|64348562|FG000|Overall Study|Investigator Decision|1|||
23163635|NCT00490451|64348563|FG001|Overall Study|Investigator Decision|0|||
23163636|NCT00490451|64348562|FG000|Overall Study|Protocol Violation|1|||
23163637|NCT00490451|64348563|FG001|Overall Study|Protocol Violation|0|||
23163638|NCT00490451|64348562|FG000|Overall Study|Progressive Disease|53|||
23163639|NCT00490451|64348563|FG001|Overall Study|Progressive Disease|34|||
23163640|NCT02646982|64348564|FG000|Overall Study|Adverse Event|1|||
23163641|NCT02646982|64348565|FG001|Overall Study|Adverse Event|1|||
23163642|NCT02646982|64348564|FG000|Overall Study|Withdrawal by Subject|2|||
23163643|NCT02646982|64348565|FG001|Overall Study|Withdrawal by Subject|1|||
23163644|NCT00957008|64348569|FG000|Overall Study|Withdrawal by Subject|13|||
23163645|NCT00957008|64348570|FG001|Overall Study|Withdrawal by Subject|10|||
23163646|NCT00957008|64348571|FG002|Overall Study|Withdrawal by Subject|12|||
23163647|NCT00957008|64348572|FG003|Overall Study|Withdrawal by Subject|16|||
23163648|NCT00957008|64348569|FG000|Overall Study|Lost to Follow-up|3|||
23163649|NCT00957008|64348570|FG001|Overall Study|Lost to Follow-up|1|||
23163650|NCT00957008|64348571|FG002|Overall Study|Lost to Follow-up|3|||
23163651|NCT00957008|64348572|FG003|Overall Study|Lost to Follow-up|4|||
23163652|NCT00957008|64348569|FG000|Overall Study|Physician Decision|1|||
23163653|NCT00957008|64348570|FG001|Overall Study|Physician Decision|0|||
23163654|NCT00957008|64348571|FG002|Overall Study|Physician Decision|1|||
23163655|NCT00957008|64348572|FG003|Overall Study|Physician Decision|1|||
23163656|NCT00957008|64348569|FG000|Overall Study|Relocated; Family conflict|4|||
23163657|NCT00957008|64348570|FG001|Overall Study|Relocated; Family conflict|1|||
23163658|NCT00957008|64348571|FG002|Overall Study|Relocated; Family conflict|1|||
23163659|NCT00957008|64348572|FG003|Overall Study|Relocated; Family conflict|3|||
23163660|NCT01157364|64348579|FG000|Overall Study|Other Reasons|1|||
23163661|NCT01157364|64348580|FG001|Overall Study|Other Reasons|1|||
23163662|NCT01157364|64348581|FG002|Overall Study|Other Reasons|2|||
23163663|NCT01157364|64348582|FG003|Overall Study|Other Reasons|1|||
23163664|NCT01157364|64348583|FG004|Overall Study|Other Reasons|0|||
23163665|NCT01157364|64348584|FG005|Overall Study|Other Reasons|0|||
23163666|NCT01157364|64348579|FG000|Overall Study|Personal Reasons|0|||
23331685|NCT02748213|64955519|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
23331686|NCT02748213|64955518|FG000|Overall Study|Death|5|||
23163667|NCT01157364|64348580|FG001|Overall Study|Personal Reasons|2|||
23163668|NCT01157364|64348581|FG002|Overall Study|Personal Reasons|0|||
23163669|NCT01157364|64348582|FG003|Overall Study|Personal Reasons|0|||
23163670|NCT01157364|64348583|FG004|Overall Study|Personal Reasons|1|||
23163671|NCT01157364|64348584|FG005|Overall Study|Personal Reasons|1|||
23163672|NCT01157364|64348579|FG000|Overall Study|Lost to Follow-up|1|||
23163673|NCT01157364|64348580|FG001|Overall Study|Lost to Follow-up|0|||
23163674|NCT01157364|64348581|FG002|Overall Study|Lost to Follow-up|1|||
23163675|NCT01157364|64348582|FG003|Overall Study|Lost to Follow-up|0|||
23163676|NCT01157364|64348583|FG004|Overall Study|Lost to Follow-up|0|||
23163677|NCT01157364|64348584|FG005|Overall Study|Lost to Follow-up|0|||
23163678|NCT01157364|64348579|FG000|Overall Study|Lack of Efficacy|0|||
23163679|NCT01157364|64348580|FG001|Overall Study|Lack of Efficacy|0|||
23163680|NCT01157364|64348581|FG002|Overall Study|Lack of Efficacy|0|||
23163681|NCT01157364|64348582|FG003|Overall Study|Lack of Efficacy|1|||
23163682|NCT01157364|64348583|FG004|Overall Study|Lack of Efficacy|0|||
23163683|NCT01157364|64348584|FG005|Overall Study|Lack of Efficacy|0|||
23163684|NCT01157364|64348579|FG000|Overall Study|Adverse Event|0|||
23163685|NCT01157364|64348580|FG001|Overall Study|Adverse Event|1|||
23163686|NCT01157364|64348581|FG002|Overall Study|Adverse Event|1|||
23163687|NCT01157364|64348582|FG003|Overall Study|Adverse Event|0|||
23163688|NCT01157364|64348583|FG004|Overall Study|Adverse Event|1|||
23163689|NCT01157364|64348584|FG005|Overall Study|Adverse Event|0|||
23163690|NCT02018822|64348585|FG000|Overall Study|filling replaced by crown|0|||
23163691|NCT02018822|64348586|FG001|Overall Study|filling replaced by crown|1|||
23163692|NCT02018822|64348587|FG002|Overall Study|filling replaced by crown|0|||
23163693|NCT02018822|64348585|FG000|Overall Study|Physician Decision|0|||
23163694|NCT02018822|64348586|FG001|Overall Study|Physician Decision|1|||
23331687|NCT02748213|64955519|FG001|Overall Study|Death|3|||
23163695|NCT02018822|64348587|FG002|Overall Study|Physician Decision|1|||
23224071|NCT00509028|64563959|FG001|Overall Study|Lost to Follow-up|1|||
23224072|NCT00509028|64563958|FG000|Overall Study|Protocol Violation|4|||
23224073|NCT00509028|64563959|FG001|Overall Study|Protocol Violation|2|||
23224074|NCT00509028|64563958|FG000|Overall Study|Non-compliance|2|||
23224075|NCT00509028|64563959|FG001|Overall Study|Non-compliance|1|||
23224076|NCT03369704|64563960|FG000|Treatment Epoch|technical problems|1|||
23224077|NCT03369704|64563961|FG001|Treatment Epoch|technical problems|0|||
23163696|NCT02018822|64348585|FG000|Overall Study|Lost to Follow-up|6|||
23163697|NCT02018822|64348586|FG001|Overall Study|Lost to Follow-up|6|||
23163698|NCT02018822|64348587|FG002|Overall Study|Lost to Follow-up|5|||
23163699|NCT03581786|64348590|FG000|Overall Study|Death|17|||
23163700|NCT03581786|64348591|FG001|Overall Study|Death|12|||
23224078|NCT03369704|64563960|FG000|Treatment Epoch|Protocol Violation|1|||
23224079|NCT03369704|64563961|FG001|Treatment Epoch|Protocol Violation|0|||
23224080|NCT03369704|64563960|FG000|Treatment Epoch|Lost to Follow-up|0|||
23224081|NCT03369704|64563961|FG001|Treatment Epoch|Lost to Follow-up|1|||
23224082|NCT03369704|64563960|FG000|Treatment Epoch|Lack of Efficacy|0|||
23224083|NCT03369704|64563961|FG001|Treatment Epoch|Lack of Efficacy|2|||
23224084|NCT03369704|64563960|FG000|Treatment Epoch|Adverse Event|2|||
23224085|NCT03369704|64563961|FG001|Treatment Epoch|Adverse Event|0|||
23224086|NCT03369704|64563960|FG000|Follow-up Epoch|Lost to Follow-up|1|||
23224087|NCT03369704|64563961|FG001|Follow-up Epoch|Lost to Follow-up|0|||
23224088|NCT01432938|64563964|FG000|First Intervention|Protocol Violation|1|||
23224089|NCT01432938|64563965|FG001|First Intervention|Protocol Violation|0|||
23224090|NCT01432938|64563964|FG000|First Intervention|Physician Decision|1|||
23224091|NCT01432938|64563965|FG001|First Intervention|Physician Decision|0|||
23224092|NCT01432938|64563964|FG000|Second Intervention|Adverse Event|1|||
23224093|NCT01432938|64563965|FG001|Second Intervention|Adverse Event|0|||
23224094|NCT02691468|64563967|FG000|Overall Study|Bronchial blocker use|2|||
23224095|NCT02691468|64563968|FG001|Overall Study|Bronchial blocker use|1|||
23224096|NCT02691468|64563967|FG000|Overall Study|Lost to Follow-up|2|||
23224097|NCT02691468|64563968|FG001|Overall Study|Lost to Follow-up|1|||
23224098|NCT02691468|64563967|FG000|Overall Study|Failure to advance FOB|2|||
23224099|NCT02691468|64563968|FG001|Overall Study|Failure to advance FOB|0|||
23224100|NCT02623699|64563969|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224101|NCT02623699|64563970|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
23224102|NCT02623699|64563971|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224103|NCT02623699|64563972|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224104|NCT02623699|64563973|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224105|NCT02623699|64563974|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224106|NCT02623699|64563975|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224107|NCT02623699|64563976|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224108|NCT02623699|64563977|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224109|NCT02623699|64563978|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224110|NCT02623699|64563979|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224111|NCT02623699|64563980|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
23224112|NCT02623699|64563969|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224113|NCT02623699|64563970|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224114|NCT02623699|64563971|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224115|NCT02623699|64563972|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23331688|NCT02748213|64955518|FG000|Overall Study|Insufficient Therapeutic Response|56|||
23331689|NCT02748213|64955519|FG001|Overall Study|Insufficient Therapeutic Response|57|||
23331690|NCT02748213|64955518|FG000|Overall Study|Violation of Selection Criteria|2|||
23331691|NCT02748213|64955519|FG001|Overall Study|Violation of Selection Criteria|0|||
23331692|NCT02748213|64955518|FG000|Overall Study|Protocol Violation|6|||
23331693|NCT02748213|64955519|FG001|Overall Study|Protocol Violation|4|||
23571239|NCT01807221|65820932|FG005|Overall Study|Sponsor decision|0|||
23571240|NCT01807221|65820927|FG000|Overall Study|Lost to Follow-up|1|||
23571241|NCT01807221|65820928|FG001|Overall Study|Lost to Follow-up|0|||
23571242|NCT01807221|65820929|FG002|Overall Study|Lost to Follow-up|2|||
23571243|NCT01807221|65820930|FG003|Overall Study|Lost to Follow-up|1|||
23571244|NCT01807221|65820931|FG004|Overall Study|Lost to Follow-up|0|||
23224116|NCT02623699|64563973|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224117|NCT02623699|64563974|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224118|NCT02623699|64563975|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
23224119|NCT02623699|64563976|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224120|NCT02623699|64563977|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224121|NCT02623699|64563978|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224122|NCT02623699|64563979|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224123|NCT02623699|64563980|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
23224124|NCT02623699|64563969|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224125|NCT02623699|64563970|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224126|NCT02623699|64563971|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224127|NCT02623699|64563972|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224128|NCT02623699|64563973|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23331694|NCT02748213|64955518|FG000|Overall Study|Refused Treatment*|6|||
23571245|NCT01807221|65820932|FG005|Overall Study|Lost to Follow-up|0|||
23571246|NCT03387514|65820937|FG000|Overall Study|Withdrawal by Subject|2|||
23571247|NCT03387514|65820937|FG000|Overall Study|Physician Decision|1|||
23571248|NCT03387514|65820937|FG000|Overall Study|Lost to Follow-up|2|||
23571249|NCT02204293|65820943|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
23571250|NCT02204293|65820944|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
23571251|NCT02204293|65820945|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
23571252|NCT02204293|65820946|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
23571253|NCT02204293|65820947|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
23571254|NCT02204293|65820948|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
23571255|NCT02204293|65820943|FG000|Core Study Part I|Adverse Event|1|||
23571256|NCT02204293|65820944|FG001|Core Study Part I|Adverse Event|0|||
23571257|NCT02204293|65820945|FG002|Core Study Part I|Adverse Event|0|||
23571258|NCT02204293|65820946|FG003|Core Study Part I|Adverse Event|0|||
23571259|NCT02204293|65820947|FG004|Core Study Part I|Adverse Event|0|||
23571260|NCT02204293|65820948|FG005|Core Study Part I|Adverse Event|0|||
23571261|NCT02204293|65820943|FG000|Core Study Part I|Physician Decision|0|||
23331695|NCT02748213|64955519|FG001|Overall Study|Refused Treatment*|6|||
23331696|NCT02748213|64955518|FG000|Overall Study|Failure to Return|1|||
23331697|NCT02748213|64955519|FG001|Overall Study|Failure to Return|0|||
23331698|NCT02748213|64955518|FG000|Overall Study|Other|30|||
23331699|NCT02748213|64955519|FG001|Overall Study|Other|29|||
23331700|NCT02095691|64955522|FG000|Overall Study|Physician Decision|1|||
23571262|NCT02204293|65820944|FG001|Core Study Part I|Physician Decision|3|||
23571263|NCT02204293|65820945|FG002|Core Study Part I|Physician Decision|0|||
23571264|NCT02204293|65820946|FG003|Core Study Part I|Physician Decision|0|||
23571265|NCT02204293|65820947|FG004|Core Study Part I|Physician Decision|0|||
23571266|NCT02204293|65820948|FG005|Core Study Part I|Physician Decision|0|||
23571267|NCT02204293|65820943|FG000|LTE Phase|Study Suspended|0|||
23571268|NCT02204293|65820944|FG001|LTE Phase|Study Suspended|0|||
23571269|NCT02204293|65820945|FG002|LTE Phase|Study Suspended|0|||
23571270|NCT02204293|65820946|FG003|LTE Phase|Study Suspended|0|||
23571271|NCT02204293|65820947|FG004|LTE Phase|Study Suspended|0|||
23571272|NCT02204293|65820948|FG005|LTE Phase|Study Suspended|7|||
23571273|NCT01313182|65820949|FG000|Overall Study|Protocol Violation|66|||
23331701|NCT00282113|64955525|FG000|Overall Study|Removed at parents request|1|||
23331702|NCT00282113|64955526|FG001|Overall Study|Removed at parents request|0|||
23331703|NCT00282113|64955527|FG002|Overall Study|Removed at parents request|0|||
23331704|NCT02275819|64955534|FG000|Overall Study|Adverse Event|0|||
23331705|NCT02275819|64955535|FG001|Overall Study|Adverse Event|1|||
23447066|NCT03210961|65377867|FG004|Overall Study|Adverse Event|0|||
23447067|NCT03210961|65377868|FG005|Overall Study|Adverse Event|0|||
23331706|NCT01894841|64955546|FG000|Overall Study|Withdrawal by Subject|9|||
23447068|NCT03210961|65377869|FG006|Overall Study|Adverse Event|0|||
23571274|NCT01313182|65820950|FG001|Overall Study|Protocol Violation|92|||
23571275|NCT04249336|65820954|FG000|Overall Study|Lost to Follow-up|3|||
23571276|NCT04249336|65820955|FG001|Overall Study|Lost to Follow-up|3|||
23571277|NCT04249336|65820956|FG002|Overall Study|Lost to Follow-up|3|||
23163701|NCT03581786|64348590|FG000|Overall Study|Withdrawal by Subject|2|||
23163702|NCT03581786|64348591|FG001|Overall Study|Withdrawal by Subject|4|||
23163703|NCT03581786|64348590|FG000|Overall Study|Lost to Follow-up|1|||
23163704|NCT03581786|64348591|FG001|Overall Study|Lost to Follow-up|0|||
23163705|NCT03581786|64348590|FG000|Overall Study|reason other than specified above|0|||
23163706|NCT03581786|64348591|FG001|Overall Study|reason other than specified above|1|||
23163707|NCT03581786|64348590|FG000|Overall Study|Ongoing in the study|123|||
23163708|NCT03581786|64348591|FG001|Overall Study|Ongoing in the study|129|||
23331707|NCT01894841|64955547|FG001|Overall Study|Withdrawal by Subject|4|||
23331708|NCT01894841|64955546|FG000|Overall Study|Withdrawn by investigator|2|||
23331709|NCT01894841|64955547|FG001|Overall Study|Withdrawn by investigator|2|||
23331710|NCT01894841|64955546|FG000|Overall Study|Lost to Follow-up|7|||
23331711|NCT01894841|64955547|FG001|Overall Study|Lost to Follow-up|3|||
23331712|NCT03777436|64955550|FG000|Placebo-controlled Phase|Adverse Event|8|||
23331713|NCT03777436|64955551|FG001|Placebo-controlled Phase|Adverse Event|10|||
23331714|NCT03777436|64955552|FG002|Placebo-controlled Phase|Adverse Event|0|||
23331715|NCT03777436|64955550|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
23331716|NCT03777436|64955551|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
23331717|NCT03777436|64955552|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
23331718|NCT03777436|64955550|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
23331719|NCT03777436|64955551|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
23331720|NCT03777436|64955552|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
23331721|NCT03777436|64955550|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
23331722|NCT03777436|64955551|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
23331723|NCT03777436|64955552|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
23331724|NCT03777436|64955550|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
23331725|NCT03777436|64955551|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
23331726|NCT03777436|64955552|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
23331727|NCT03777436|64955550|FG000|Placebo-controlled Phase|Physician Decision|0|||
23331728|NCT03777436|64955551|FG001|Placebo-controlled Phase|Physician Decision|1|||
23331729|NCT03777436|64955552|FG002|Placebo-controlled Phase|Physician Decision|0|||
23331730|NCT03777436|64955550|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
23331731|NCT03777436|64955551|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
23331732|NCT03777436|64955552|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
23331733|NCT03777436|64955550|FG000|Apremilast Extension Phase|Adverse Event|0|||
23331734|NCT03777436|64955551|FG001|Apremilast Extension Phase|Adverse Event|0|||
23331735|NCT03777436|64955552|FG002|Apremilast Extension Phase|Adverse Event|6|||
23331736|NCT03777436|64955550|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
23331737|NCT03777436|64955551|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
23331738|NCT03777436|64955552|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
23331739|NCT03777436|64955550|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
23331740|NCT03777436|64955551|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
23331741|NCT03777436|64955552|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
23331742|NCT03777436|64955550|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
23331743|NCT03777436|64955551|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
23331744|NCT03777436|64955552|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
23331745|NCT03777436|64955550|FG000|Apremilast Extension Phase|Miscellaneous|0|||
23331746|NCT03777436|64955551|FG001|Apremilast Extension Phase|Miscellaneous|0|||
23331747|NCT03777436|64955552|FG002|Apremilast Extension Phase|Miscellaneous|1|||
23331748|NCT02395848|64955553|FG000|Overall Study|Lost to Follow-up|2|||
23331749|NCT01973439|64955554|FG000|Overall Study|Lost samples from one PK Day|2|||
23331750|NCT01973439|64955554|FG000|Overall Study|Vomiting after commencing once daily|1|||
23331751|NCT01973439|64955554|FG000|Overall Study|PK curve incomplete|2|||
23331752|NCT00513695|64955555|FG000|Overall Study|Discontinued therapy|2|||
23331753|NCT00513695|64955555|FG000|Overall Study|Progression prior to surgery|3|||
23331754|NCT00351468|64955556|FG000|Overall Study|Adverse Event|42|||
23331755|NCT00351468|64955556|FG000|Overall Study|Withdrawal by Subject|39|||
23331756|NCT00351468|64955556|FG000|Overall Study|Various -follow up w clinical team|39|||
23331757|NCT00351468|64955556|FG000|Overall Study|Lack of Efficacy|32|||
23331758|NCT00351468|64955556|FG000|Overall Study|Non-compliance|8|||
23331759|NCT00351468|64955556|FG000|Overall Study|Lost to Follow-up|4|||
23331760|NCT00351468|64955556|FG000|Overall Study|Protocol Violation|3|||
23163709|NCT00769002|64348592|FG000|Overall Study|Study was not completed, no data|9|||
23163710|NCT00769002|64348593|FG001|Overall Study|Study was not completed, no data|9|||
23163711|NCT03782376|64348596|FG000|Overall Study|Lost to Follow-up|2|||
23163712|NCT03782376|64348597|FG001|Overall Study|Lost to Follow-up|2|||
23331761|NCT02198664|64955557|FG000|Overall Study|Adverse Event|2|||
23331762|NCT02198664|64955558|FG001|Overall Study|Adverse Event|0|||
23331763|NCT02198664|64955557|FG000|Overall Study|Withdrawal by Subject|11|||
23447069|NCT03210961|65377870|FG007|Overall Study|Adverse Event|0|||
23163713|NCT03782376|64348596|FG000|Overall Study|Withdrawal by Subject|7|||
23163714|NCT03782376|64348597|FG001|Overall Study|Withdrawal by Subject|11|||
23163715|NCT03782376|64348596|FG000|Overall Study|Death|1|||
23163716|NCT03782376|64348597|FG001|Overall Study|Death|0|||
23331764|NCT02198664|64955558|FG001|Overall Study|Withdrawal by Subject|8|||
23331765|NCT02198664|64955557|FG000|Overall Study|Failure to tolerate|2|||
23331766|NCT02198664|64955558|FG001|Overall Study|Failure to tolerate|0|||
23331767|NCT02198664|64955557|FG000|Overall Study|Not stated|1|||
23331768|NCT02198664|64955558|FG001|Overall Study|Not stated|0|||
23331769|NCT04227197|64955562|FG000|Randomization|Protocol Violation|1|||
23331770|NCT04227197|64955563|FG001|Randomization|Protocol Violation|0|||
23331771|NCT04227197|64955562|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
23163717|NCT03782376|64348596|FG000|Overall Study|Other|16|||
23163718|NCT03782376|64348597|FG001|Overall Study|Other|17|||
23331772|NCT04227197|64955563|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
23331773|NCT04227197|64955562|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
23331774|NCT04227197|64955563|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
23331775|NCT04227197|64955562|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
23331776|NCT04227197|64955563|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
23331777|NCT04227197|64955562|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
23331778|NCT04227197|64955563|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
23331779|NCT04227197|64955562|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
23331780|NCT04227197|64955563|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
23331781|NCT04227197|64955562|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
23331782|NCT04227197|64955563|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
23331783|NCT02522884|64955564|FG000|Overall Study|Withdrawal by Subject|6|||
23331784|NCT02522884|64955564|FG000|Overall Study|Death|3|||
23331785|NCT02522884|64955564|FG000|Overall Study|Missed 12-month Follow-up|9|||
23331786|NCT00318474|64955568|FG000|Overall Study|Adverse Event|1|||
23331787|NCT00318474|64955569|FG001|Overall Study|Adverse Event|1|||
23331788|NCT00318474|64955568|FG000|Overall Study|Lost to Follow-up|0|||
23331789|NCT00318474|64955569|FG001|Overall Study|Lost to Follow-up|1|||
23331790|NCT00318474|64955568|FG000|Overall Study|Pregnancy|0|||
23331791|NCT00318474|64955569|FG001|Overall Study|Pregnancy|2|||
23331792|NCT00318474|64955568|FG000|Overall Study|Protocol Violation|1|||
23331793|NCT00318474|64955569|FG001|Overall Study|Protocol Violation|0|||
23331794|NCT00318474|64955568|FG000|Overall Study|Withdrawal by Subject|3|||
23331795|NCT00318474|64955569|FG001|Overall Study|Withdrawal by Subject|2|||
23331796|NCT00318474|64955568|FG000|Overall Study|Fall in GFR|3|||
23331797|NCT00318474|64955569|FG001|Overall Study|Fall in GFR|3|||
23331798|NCT00318474|64955568|FG000|Overall Study|Post-therapy hyperflycemia|0|||
23331799|NCT00318474|64955569|FG001|Overall Study|Post-therapy hyperflycemia|1|||
23331800|NCT00318474|64955568|FG000|Overall Study|Trial terminated|10|||
23331801|NCT00318474|64955569|FG001|Overall Study|Trial terminated|7|||
23331802|NCT04013672|64955570|FG000|Overall Study|Withdrawal by Subject|3|||
23331803|NCT04013672|64955571|FG001|Overall Study|Withdrawal by Subject|0|||
23331804|NCT04013672|64955570|FG000|Overall Study|Death|1|||
23331805|NCT04013672|64955571|FG001|Overall Study|Death|0|||
23331806|NCT04013672|64955570|FG000|Overall Study|Physician Decision|5|||
23331807|NCT04013672|64955571|FG001|Overall Study|Physician Decision|0|||
23331808|NCT02576847|64955574|FG000|Overall Study|Adverse Event|27|||
23331809|NCT02576847|64955574|FG000|Overall Study|Lost to Follow-up|22|||
23331810|NCT02576847|64955574|FG000|Overall Study|Physician Decision|1|||
23331811|NCT02576847|64955574|FG000|Overall Study|Pregnancy|1|||
23331812|NCT02576847|64955574|FG000|Overall Study|Protocol Violation|3|||
23331813|NCT02576847|64955574|FG000|Overall Study|Withdrawal by Subject|78|||
23331814|NCT02576847|64955574|FG000|Overall Study|Other|5|||
23331815|NCT00789698|64955582|FG000|Overall Study|Lack of Efficacy|10|||
23331816|NCT00789698|64955583|FG001|Overall Study|Lack of Efficacy|4|||
23331817|NCT00789698|64955584|FG002|Overall Study|Lack of Efficacy|5|||
23331818|NCT00789698|64955585|FG003|Overall Study|Lack of Efficacy|18|||
23331819|NCT00789698|64955582|FG000|Overall Study|Adverse Event|5|||
23331820|NCT00789698|64955583|FG001|Overall Study|Adverse Event|5|||
23331821|NCT00789698|64955584|FG002|Overall Study|Adverse Event|3|||
23331822|NCT00789698|64955585|FG003|Overall Study|Adverse Event|4|||
23331823|NCT00789698|64955582|FG000|Overall Study|Lost to Follow-up|5|||
23331824|NCT00789698|64955583|FG001|Overall Study|Lost to Follow-up|5|||
23331825|NCT00789698|64955584|FG002|Overall Study|Lost to Follow-up|2|||
23331826|NCT00789698|64955585|FG003|Overall Study|Lost to Follow-up|9|||
23331827|NCT00789698|64955582|FG000|Overall Study|Protocol Violation|6|||
23331828|NCT00789698|64955583|FG001|Overall Study|Protocol Violation|1|||
23331829|NCT00789698|64955584|FG002|Overall Study|Protocol Violation|2|||
23163719|NCT00081159|64348602|FG000|Overall Study|Withdrawal by Subject|0|||
23163720|NCT00081159|64348603|FG001|Overall Study|Withdrawal by Subject|3|||
23331830|NCT00789698|64955585|FG003|Overall Study|Protocol Violation|1|||
23331831|NCT00789698|64955582|FG000|Overall Study|Withdrawal by Subject|14|||
23331832|NCT00789698|64955583|FG001|Overall Study|Withdrawal by Subject|15|||
23331833|NCT00789698|64955584|FG002|Overall Study|Withdrawal by Subject|12|||
23331834|NCT00789698|64955585|FG003|Overall Study|Withdrawal by Subject|19|||
23331835|NCT00789698|64955582|FG000|Overall Study|Administrative|0|||
23331836|NCT00789698|64955583|FG001|Overall Study|Administrative|3|||
23331837|NCT00789698|64955584|FG002|Overall Study|Administrative|3|||
23331838|NCT00789698|64955585|FG003|Overall Study|Administrative|1|||
23331839|NCT03349060|64955593|FG000|Overall Study|Adverse Event|9|||
23331840|NCT03349060|64955594|FG001|Overall Study|Adverse Event|9|||
23331841|NCT03349060|64955595|FG002|Overall Study|Adverse Event|7|||
23331842|NCT03349060|64955593|FG000|Overall Study|Lack of Efficacy|1|||
23331843|NCT03349060|64955594|FG001|Overall Study|Lack of Efficacy|0|||
23331844|NCT03349060|64955595|FG002|Overall Study|Lack of Efficacy|2|||
23331845|NCT03349060|64955593|FG000|Overall Study|Lost to Follow-up|2|||
23331846|NCT03349060|64955594|FG001|Overall Study|Lost to Follow-up|1|||
23163721|NCT00081159|64348602|FG000|Overall Study|Myelosuppression prior to treatment|0|||
23163722|NCT00081159|64348603|FG001|Overall Study|Myelosuppression prior to treatment|1|||
23331847|NCT03349060|64955595|FG002|Overall Study|Lost to Follow-up|1|||
23331848|NCT03349060|64955593|FG000|Overall Study|Protocol Violation|2|||
23331849|NCT03349060|64955594|FG001|Overall Study|Protocol Violation|2|||
23331850|NCT03349060|64955595|FG002|Overall Study|Protocol Violation|1|||
23331851|NCT03349060|64955593|FG000|Overall Study|Withdrawal by Subject|5|||
23331852|NCT03349060|64955594|FG001|Overall Study|Withdrawal by Subject|3|||
23331853|NCT03349060|64955595|FG002|Overall Study|Withdrawal by Subject|4|||
23331854|NCT03349060|64955593|FG000|Overall Study|Medication error,no linked adverse event|0|||
23331855|NCT03349060|64955594|FG001|Overall Study|Medication error,no linked adverse event|0|||
23331856|NCT03349060|64955595|FG002|Overall Study|Medication error,no linked adverse event|1|||
23331857|NCT03349060|64955593|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23331858|NCT03349060|64955594|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
23331859|NCT03349060|64955595|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
23331860|NCT03349060|64955593|FG000|Overall Study|Other|2|||
23331861|NCT03349060|64955594|FG001|Overall Study|Other|1|||
23331862|NCT03349060|64955595|FG002|Overall Study|Other|0|||
23331863|NCT00171210|64955596|FG000|Overall Study|Adverse Event|16|||
23331864|NCT00171210|64955597|FG001|Overall Study|Adverse Event|27|||
23331865|NCT00171210|64955596|FG000|Overall Study|Abnormal laboratory value(s)|6|||
23331866|NCT00171210|64955597|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23331867|NCT00171210|64955596|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23331868|NCT00171210|64955597|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23331869|NCT00171210|64955596|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
23331870|NCT00171210|64955597|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
23331871|NCT00171210|64955596|FG000|Overall Study|Protocol Violation|0|||
23331872|NCT00171210|64955597|FG001|Overall Study|Protocol Violation|2|||
23331873|NCT00171210|64955596|FG000|Overall Study|Withdrawal by Subject|32|||
23331874|NCT00171210|64955597|FG001|Overall Study|Withdrawal by Subject|30|||
23331875|NCT00171210|64955596|FG000|Overall Study|Lost to Follow-up|1|||
23331876|NCT00171210|64955597|FG001|Overall Study|Lost to Follow-up|0|||
23331877|NCT00171210|64955596|FG000|Overall Study|Administrative problems|1|||
23331878|NCT00171210|64955597|FG001|Overall Study|Administrative problems|1|||
23331879|NCT00171210|64955596|FG000|Overall Study|Death|2|||
23331880|NCT00171210|64955597|FG001|Overall Study|Death|3|||
23331881|NCT00171210|64955596|FG000|Overall Study|Stopped at end of core|0|||
23331882|NCT00171210|64955597|FG001|Overall Study|Stopped at end of core|32|||
23331883|NCT00171210|64955596|FG000|Overall Study|Stopped at end of extension 1|0|||
23331884|NCT00171210|64955597|FG001|Overall Study|Stopped at end of extension 1|1|||
23163723|NCT00081159|64348602|FG000|Overall Study|Lost to Follow-up|2|||
23163724|NCT00081159|64348603|FG001|Overall Study|Lost to Follow-up|1|||
23163725|NCT04707157|64348604|FG000|Overall Study|Adverse Event|12|||
23163726|NCT04707157|64348605|FG001|Overall Study|Adverse Event|3|||
23331885|NCT00403481|64955598|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
23331886|NCT00403481|64955598|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
23331887|NCT00403481|64955598|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
23331888|NCT00403481|64955598|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
23447070|NCT03210961|65377871|FG008|Overall Study|Adverse Event|0|||
23163727|NCT04707157|64348604|FG000|Overall Study|Lost to Follow-up|2|||
23163728|NCT04707157|64348605|FG001|Overall Study|Lost to Follow-up|0|||
23331889|NCT00403481|64955598|FG000|Olm 40 mg|Adverse Event|2|||
23331890|NCT00403481|64955598|FG000|Olm 40 mg|Protocol Violation|1|||
23447071|NCT03210961|65377872|FG009|Overall Study|Adverse Event|0|||
23163729|NCT04707157|64348604|FG000|Overall Study|Sponsor's decision|1|||
23331891|NCT00403481|64955598|FG000|Olm 40 mg|Withdrawal by Subject|1|||
23331892|NCT00403481|64955598|FG000|Olm 40 mg|Other|1|||
23331893|NCT00403481|64955598|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
23331894|NCT00403481|64955598|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
23331895|NCT00403481|64955598|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
23447072|NCT03210961|65377873|FG010|Overall Study|Adverse Event|0|||
23224129|NCT02623699|64563974|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
23224130|NCT02623699|64563975|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224131|NCT02623699|64563976|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224132|NCT02623699|64563977|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224133|NCT02623699|64563978|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224134|NCT02623699|64563979|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224135|NCT02623699|64563980|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
23224136|NCT02623699|64563969|FG000|Part B (Up to 289 Days)|Death|0|||
23224137|NCT02623699|64563970|FG001|Part B (Up to 289 Days)|Death|0|||
23224138|NCT02623699|64563971|FG002|Part B (Up to 289 Days)|Death|0|||
23224139|NCT02623699|64563972|FG003|Part B (Up to 289 Days)|Death|0|||
23224140|NCT02623699|64563973|FG004|Part B (Up to 289 Days)|Death|0|||
23224141|NCT02623699|64563974|FG005|Part B (Up to 289 Days)|Death|1|||
23224142|NCT02623699|64563975|FG006|Part B (Up to 289 Days)|Death|1|||
23224143|NCT02623699|64563976|FG007|Part B (Up to 289 Days)|Death|0|||
23331896|NCT00403481|64955598|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
23331897|NCT00403481|64955598|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
23331898|NCT00403481|64955598|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
23331899|NCT01831635|64955599|FG000|Overall Study|Withdrawal by Subject|0|||
23331900|NCT01831635|64955600|FG001|Overall Study|Withdrawal by Subject|2|||
23331901|NCT01831635|64955601|FG002|Overall Study|Withdrawal by Subject|0|||
23331902|NCT01073605|64955606|FG000|Overall Study|Ongoing at Cutoff Date|1|||
23331903|NCT01073605|64955607|FG001|Overall Study|Ongoing at Cutoff Date|1|||
23331904|NCT01073605|64955608|FG002|Overall Study|Ongoing at Cutoff Date|0|||
23331905|NCT01073605|64955606|FG000|Overall Study|Adverse Event|2|||
23331906|NCT01073605|64955607|FG001|Overall Study|Adverse Event|1|||
23331907|NCT01073605|64955608|FG002|Overall Study|Adverse Event|0|||
23331908|NCT01073605|64955606|FG000|Overall Study|Lost to Follow-up|3|||
23331909|NCT01073605|64955607|FG001|Overall Study|Lost to Follow-up|4|||
23571278|NCT04249336|65820957|FG003|Overall Study|Lost to Follow-up|3|||
23571279|NCT03545113|65820960|FG000|Overall Study|Surgery Cancelled|1|||
23571280|NCT03545113|65820961|FG001|Overall Study|Surgery Cancelled|0|||
23571281|NCT03545113|65820960|FG000|Overall Study|Death|1|||
23571282|NCT03545113|65820961|FG001|Overall Study|Death|0|||
23571283|NCT03545113|65820960|FG000|Overall Study|Adverse Event|2|||
23571284|NCT03545113|65820961|FG001|Overall Study|Adverse Event|0|||
23571285|NCT03545113|65820960|FG000|Overall Study|Received different surgery|1|||
23571286|NCT03545113|65820961|FG001|Overall Study|Received different surgery|0|||
23571287|NCT01993823|65820964|FG000|Overall Study|Requested by the patient|6|||
23571288|NCT01993823|65820965|FG001|Overall Study|Requested by the patient|11|||
23571289|NCT01993823|65820964|FG000|Overall Study|Protocol Violation|0|||
23571290|NCT01993823|65820965|FG001|Overall Study|Protocol Violation|1|||
23571291|NCT01993823|65820964|FG000|Overall Study|Lost to Follow-up|1|||
23571292|NCT01993823|65820965|FG001|Overall Study|Lost to Follow-up|4|||
23571293|NCT01003639|65820971|FG000|Overall Study|Lost to Follow-up|6|||
23571294|NCT01003639|65820972|FG001|Overall Study|Lost to Follow-up|9|||
23571295|NCT01003639|65820971|FG000|Overall Study|Withdrawal by Subject|9|||
23571296|NCT01003639|65820972|FG001|Overall Study|Withdrawal by Subject|5|||
23571297|NCT01003639|65820971|FG000|Overall Study|Lack of Efficacy|1|||
23571298|NCT01003639|65820972|FG001|Overall Study|Lack of Efficacy|6|||
23224144|NCT02623699|64563977|FG008|Part B (Up to 289 Days)|Death|1|||
23224145|NCT02623699|64563978|FG009|Part B (Up to 289 Days)|Death|0|||
23224146|NCT02623699|64563979|FG010|Part B (Up to 289 Days)|Death|0|||
23331910|NCT01073605|64955608|FG002|Overall Study|Lost to Follow-up|9|||
23331911|NCT01073605|64955606|FG000|Overall Study|Other|25|||
23331912|NCT01073605|64955607|FG001|Overall Study|Other|21|||
23571299|NCT01003639|65820971|FG000|Overall Study|Adverse Event|0|||
23224147|NCT02623699|64563980|FG011|Part B (Up to 289 Days)|Death|0|||
23571300|NCT01003639|65820972|FG001|Overall Study|Adverse Event|1|||
23571301|NCT01003639|65820971|FG000|Overall Study|Protocol Violation|0|||
23571302|NCT01003639|65820972|FG001|Overall Study|Protocol Violation|1|||
23571303|NCT01003639|65820971|FG000|Overall Study|Physician Decision|1|||
23571304|NCT01003639|65820972|FG001|Overall Study|Physician Decision|0|||
23571305|NCT02372058|65820973|FG000|Overall Study|Withdrawal by Subject|3|||
23571306|NCT02788006|65820974|FG000|Overall Study|Patient not treated|1|||
23571307|NCT02726399|65820978|FG000|Overall Study|Participant Non-Compliance|1|||
23571308|NCT02726399|65820978|FG000|Overall Study|Adverse Event|2|||
23571309|NCT02726399|65820978|FG000|Overall Study|Progression of disease|4|||
23571310|NCT00630058|65820981|FG000|Overall Study|Adverse Event|1|||
23571311|NCT00630058|65820982|FG001|Overall Study|Adverse Event|1|||
23571312|NCT00630058|65820981|FG000|Overall Study|Withdrawal by Subject|0|||
23331913|NCT01073605|64955608|FG002|Overall Study|Other|29|||
23331914|NCT01073605|64955606|FG000|Overall Study|Withdrawal by Subject|31|||
23331915|NCT01073605|64955607|FG001|Overall Study|Withdrawal by Subject|39|||
23331916|NCT01073605|64955608|FG002|Overall Study|Withdrawal by Subject|22|||
23331917|NCT01073605|64955606|FG000|Overall Study|Randomized But Not Treated|0|||
23331918|NCT01073605|64955607|FG001|Overall Study|Randomized But Not Treated|1|||
23331919|NCT01073605|64955608|FG002|Overall Study|Randomized But Not Treated|1|||
23331920|NCT04548193|64955611|FG000|Overall Study|Lost to Follow-up|0|||
23331921|NCT04548193|64955612|FG001|Overall Study|Lost to Follow-up|1|||
23331922|NCT04548193|64955611|FG000|Overall Study|Death|0|||
23331923|NCT04548193|64955612|FG001|Overall Study|Death|1|||
23331924|NCT04548193|64955611|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
23331925|NCT04548193|64955612|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
23331926|NCT04548193|64955611|FG000|Overall Study|Withdrawal by Subject|2|||
23331927|NCT04548193|64955612|FG001|Overall Study|Withdrawal by Subject|2|||
23331928|NCT00856193|64955613|FG000|Period 2|Abnormal test procedure results|0|||
23331929|NCT00856193|64955614|FG001|Period 2|Abnormal test procedure results|1|||
23331930|NCT00856193|64955613|FG000|Period 2|Lost to Follow-up|0|||
23331931|NCT00856193|64955614|FG001|Period 2|Lost to Follow-up|1|||
23331932|NCT00031590|64955616|FG000|Overall Study|Adverse Event|1|||
23331933|NCT00031590|64955616|FG000|Overall Study|Withdrawal by parents|2|||
23331934|NCT00298272|64955620|FG000|Double-blind Phase|Adverse Event|2|||
23331935|NCT00298272|64955621|FG001|Double-blind Phase|Adverse Event|0|||
23331936|NCT00298272|64955620|FG000|Double-blind Phase|Failure to Return|2|||
23571313|NCT00630058|65820982|FG001|Overall Study|Withdrawal by Subject|1|||
23571314|NCT00630058|65820981|FG000|Overall Study|stopping criteria|3|||
23571315|NCT00630058|65820982|FG001|Overall Study|stopping criteria|2|||
23571316|NCT01129336|65820985|FG000|Overall Study|Protocol Violation|1|||
23571317|NCT01129336|65820986|FG001|Overall Study|Protocol Violation|0|||
23571318|NCT01129336|65820985|FG000|Overall Study|Disease Progression|1|||
23571319|NCT01129336|65820986|FG001|Overall Study|Disease Progression|4|||
23571320|NCT01129336|65820985|FG000|Overall Study|Lost to Follow-up|1|||
23571321|NCT01129336|65820986|FG001|Overall Study|Lost to Follow-up|0|||
23571322|NCT01129336|65820985|FG000|Overall Study|Withdrawal by Subject|7|||
23571323|NCT01129336|65820986|FG001|Overall Study|Withdrawal by Subject|4|||
23571324|NCT01129336|65820985|FG000|Overall Study|Adverse Event|0|||
23571325|NCT01129336|65820986|FG001|Overall Study|Adverse Event|1|||
23571326|NCT01129336|65820985|FG000|Overall Study|Missing Study Completion Status|2|||
23571327|NCT01129336|65820986|FG001|Overall Study|Missing Study Completion Status|3|||
23571328|NCT01129336|65820985|FG000|Overall Study|Death|0|||
23571329|NCT01129336|65820986|FG001|Overall Study|Death|4|||
23331937|NCT00298272|64955621|FG001|Double-blind Phase|Failure to Return|0|||
23331938|NCT00298272|64955620|FG000|Double-blind Phase|Protocol Violation|2|||
23331939|NCT00298272|64955621|FG001|Double-blind Phase|Protocol Violation|0|||
23331940|NCT00298272|64955620|FG000|Double-blind Phase|Withdrawal by Subject|2|||
23331941|NCT00298272|64955621|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23331942|NCT00298272|64955620|FG000|Open Label Retreatment Phase|Adverse Event|1|||
23331943|NCT00298272|64955621|FG001|Open Label Retreatment Phase|Adverse Event|2|||
23331944|NCT00298272|64955620|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
23331945|NCT00298272|64955621|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
23331946|NCT00298272|64955620|FG000|Open Label Retreatment Phase|Failure to Return|1|||
23331947|NCT00298272|64955621|FG001|Open Label Retreatment Phase|Failure to Return|0|||
23331948|NCT00298272|64955620|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
23331949|NCT00298272|64955621|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
23163730|NCT04707157|64348605|FG001|Overall Study|Sponsor's decision|0|||
23331950|NCT00298272|64955620|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
23571330|NCT02441946|65820987|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
23571331|NCT02441946|65820988|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
23571332|NCT02441946|65820989|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
23571333|NCT02441946|65820987|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
23571334|NCT02441946|65820988|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
23331951|NCT00298272|64955621|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
23331952|NCT00298272|64955620|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
23571335|NCT02441946|65820989|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
23571336|NCT02441946|65820987|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23571337|NCT02441946|65820988|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
23571338|NCT02441946|65820989|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23571339|NCT02441946|65820987|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
23571340|NCT02441946|65820988|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
23571341|NCT02441946|65820989|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
23571342|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
23571343|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
23571344|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
23571345|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
23571346|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
23571347|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
23571348|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
23571349|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
23571350|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
23571351|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
23571352|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
23571353|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
23571354|NCT02441946|65820987|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
23571355|NCT02441946|65820988|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
23571356|NCT02441946|65820989|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
23571357|NCT02441946|65820987|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
23571358|NCT02441946|65820988|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
23571359|NCT02441946|65820989|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
23571360|NCT02441946|65820987|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
23571361|NCT02441946|65820988|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23571362|NCT02441946|65820989|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23571363|NCT00975221|65820990|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
23571364|NCT00975221|65820991|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
23571365|NCT00975221|65820990|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
23571366|NCT00975221|65820991|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
23571367|NCT00975221|65820990|FG000|Titration Phase (Weeks 1-12)|Other|0|||
23571368|NCT00975221|65820991|FG001|Titration Phase (Weeks 1-12)|Other|1|||
23571369|NCT00975221|65820990|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
23571370|NCT00975221|65820991|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
23571371|NCT00975221|65820990|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
23571372|NCT00975221|65820991|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
23571373|NCT00975221|65820990|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
23571374|NCT00975221|65820991|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
23571375|NCT03881059|65820992|FG000|Treatment Period - Part A|Adverse Event|1|||
23571376|NCT03881059|65820993|FG001|Treatment Period - Part A|Adverse Event|3|||
23571377|NCT03881059|65820994|FG002|Treatment Period - Part A|Adverse Event|4|||
23571378|NCT03881059|65820992|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
23571379|NCT03881059|65820993|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
23571380|NCT03881059|65820994|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
23571381|NCT03881059|65820992|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
23571382|NCT03881059|65820993|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
23163731|NCT04707157|64348604|FG000|Overall Study|Physician Decision|8|||
23163732|NCT04707157|64348605|FG001|Overall Study|Physician Decision|5|||
23163733|NCT04707157|64348604|FG000|Overall Study|Protocol Deviation|1|||
23163734|NCT04707157|64348605|FG001|Overall Study|Protocol Deviation|0|||
23163735|NCT04707157|64348604|FG000|Overall Study|Withdrawal by Subject|1|||
23163736|NCT04707157|64348605|FG001|Overall Study|Withdrawal by Subject|1|||
23163737|NCT04818593|64348606|FG000|Overall Study|Low Oocyte Yield|8|||
23163738|NCT04818593|64348607|FG001|Overall Study|Low Oocyte Yield|8|||
23163739|NCT04818593|64348606|FG000|Overall Study|Not ICSI Insemination|7|||
23163740|NCT04818593|64348607|FG001|Overall Study|Not ICSI Insemination|7|||
23163741|NCT04818593|64348606|FG000|Overall Study|Poor Sperm Quality|2|||
23163742|NCT04818593|64348607|FG001|Overall Study|Poor Sperm Quality|2|||
23163743|NCT04818593|64348606|FG000|Overall Study|Withdrawal by Subject|2|||
23224148|NCT02623699|64563969|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
23331953|NCT00298272|64955621|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
23571383|NCT03881059|65820994|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
23571384|NCT03881059|65820992|FG000|Treatment Period - Part A|Other reasons|2|||
23571385|NCT03881059|65820993|FG001|Treatment Period - Part A|Other reasons|1|||
23571386|NCT03881059|65820994|FG002|Treatment Period - Part A|Other reasons|0|||
23163744|NCT04818593|64348607|FG001|Overall Study|Withdrawal by Subject|2|||
23163745|NCT04818593|64348606|FG000|Overall Study|Conversion to IUI due to low response|1|||
23163746|NCT04818593|64348607|FG001|Overall Study|Conversion to IUI due to low response|1|||
23163747|NCT01765920|64348609|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
23163748|NCT01765920|64348610|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
23163749|NCT01765920|64348609|FG000|Overall Study|Patient code disclosure|0|||
23163750|NCT01765920|64348610|FG001|Overall Study|Patient code disclosure|1|||
23163751|NCT03116698|64348611|FG000|Overall Study|Adverse Event|1|||
23163752|NCT03116698|64348612|FG001|Overall Study|Adverse Event|1|||
23163753|NCT03116698|64348613|FG002|Overall Study|Adverse Event|1|||
23163754|NCT03116698|64348614|FG003|Overall Study|Adverse Event|0|||
23163755|NCT03116698|64348611|FG000|Overall Study|Withdrawal by Subject|1|||
23163756|NCT03116698|64348612|FG001|Overall Study|Withdrawal by Subject|4|||
23163757|NCT03116698|64348613|FG002|Overall Study|Withdrawal by Subject|5|||
23163758|NCT03116698|64348614|FG003|Overall Study|Withdrawal by Subject|2|||
23163759|NCT03116698|64348611|FG000|Overall Study|Lost to Follow-up|2|||
23163760|NCT03116698|64348612|FG001|Overall Study|Lost to Follow-up|0|||
23163761|NCT03116698|64348613|FG002|Overall Study|Lost to Follow-up|0|||
23163762|NCT03116698|64348614|FG003|Overall Study|Lost to Follow-up|0|||
23163763|NCT03116698|64348611|FG000|Overall Study|Physician Decision|1|||
23163764|NCT03116698|64348612|FG001|Overall Study|Physician Decision|1|||
23163765|NCT03116698|64348613|FG002|Overall Study|Physician Decision|0|||
23163766|NCT03116698|64348614|FG003|Overall Study|Physician Decision|0|||
23163767|NCT03116698|64348611|FG000|Overall Study|Protocol Violation|1|||
23163768|NCT03116698|64348612|FG001|Overall Study|Protocol Violation|0|||
23163769|NCT03116698|64348613|FG002|Overall Study|Protocol Violation|0|||
23163770|NCT03116698|64348614|FG003|Overall Study|Protocol Violation|0|||
23163771|NCT03116698|64348611|FG000|Overall Study|Death|0|||
23163772|NCT03116698|64348612|FG001|Overall Study|Death|0|||
23163773|NCT03116698|64348613|FG002|Overall Study|Death|2|||
23163774|NCT03116698|64348614|FG003|Overall Study|Death|0|||
23571387|NCT03881059|65820992|FG000|Treatment Period - Part B|Adverse Event|0|||
23571388|NCT03881059|65820993|FG001|Treatment Period - Part B|Adverse Event|0|||
23571389|NCT03881059|65820994|FG002|Treatment Period - Part B|Adverse Event|3|||
23571390|NCT03881059|65820992|FG000|Treatment Period - Part B|Death|0|||
23571391|NCT03881059|65820993|FG001|Treatment Period - Part B|Death|1|||
23163775|NCT01136655|64348615|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
23163776|NCT01136655|64348615|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
23163777|NCT01136655|64348615|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
23163778|NCT01136655|64348615|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
23163779|NCT01439204|64348616|FG000|Overall Study|Withdrawal by Subject|0|||
23163780|NCT01439204|64348617|FG001|Overall Study|Withdrawal by Subject|1|||
23163781|NCT01439204|64348616|FG000|Overall Study|Lost to Follow-up|0|||
23163782|NCT01439204|64348617|FG001|Overall Study|Lost to Follow-up|2|||
23163783|NCT01439204|64348616|FG000|Overall Study|No longer meets study criteria|1|||
23163784|NCT01439204|64348617|FG001|Overall Study|No longer meets study criteria|0|||
23163785|NCT01439204|64348616|FG000|Overall Study|poor/non-compliance|3|||
23163786|NCT01439204|64348617|FG001|Overall Study|poor/non-compliance|0|||
23163787|NCT02037295|64348620|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
23163788|NCT02037295|64348621|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
23163789|NCT02037295|64348622|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
23163790|NCT02037295|64348623|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
23163791|NCT04247061|64348629|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
23163792|NCT04247061|64348629|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
23163793|NCT04247061|64348629|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
23163794|NCT01033734|64348630|FG000|Overall Study|Withdrawal by Subject|1|||
23163795|NCT00401375|64348634|FG000|Overall Study|Protocol Violation|2|||
23163796|NCT00401375|64348635|FG001|Overall Study|Protocol Violation|2|||
23163797|NCT00401375|64348636|FG002|Overall Study|Protocol Violation|1|||
23163798|NCT00401375|64348634|FG000|Overall Study|Adverse Event|6|||
23163799|NCT00401375|64348635|FG001|Overall Study|Adverse Event|11|||
23163800|NCT00401375|64348636|FG002|Overall Study|Adverse Event|10|||
23163801|NCT00401375|64348634|FG000|Overall Study|Withdrawal by Subject|9|||
23163802|NCT00401375|64348635|FG001|Overall Study|Withdrawal by Subject|7|||
23163803|NCT00401375|64348636|FG002|Overall Study|Withdrawal by Subject|7|||
23163804|NCT00401375|64348634|FG000|Overall Study|Lost to Follow-up|0|||
23163805|NCT00401375|64348635|FG001|Overall Study|Lost to Follow-up|1|||
23163806|NCT00401375|64348636|FG002|Overall Study|Lost to Follow-up|1|||
23163807|NCT00401375|64348634|FG000|Overall Study|Other than specified|2|||
23163808|NCT00401375|64348635|FG001|Overall Study|Other than specified|1|||
23163809|NCT00401375|64348636|FG002|Overall Study|Other than specified|3|||
23163810|NCT00401375|64348634|FG000|Overall Study|Randomized but not treated|3|||
23163811|NCT00401375|64348635|FG001|Overall Study|Randomized but not treated|3|||
23163812|NCT00401375|64348636|FG002|Overall Study|Randomized but not treated|3|||
23163813|NCT00916357|64348637|FG000|Period 1|Withdrawal by Subject|1|||
23163814|NCT00916357|64348638|FG001|Period 1|Withdrawal by Subject|0|||
23163815|NCT00916357|64348639|FG002|Period 1|Withdrawal by Subject|0|||
23571392|NCT03881059|65820994|FG002|Treatment Period - Part B|Death|1|||
23331954|NCT00298272|64955620|FG000|Safety Follow-up Phase|Failure to Return|1|||
23331955|NCT00298272|64955621|FG001|Safety Follow-up Phase|Failure to Return|1|||
23331956|NCT00298272|64955620|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
23331957|NCT00298272|64955621|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
23331958|NCT00298272|64955620|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
23331959|NCT00298272|64955621|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
23331960|NCT01557504|64955622|FG000|Overall Study|Physician Decision|1|||
23331961|NCT01557504|64955623|FG001|Overall Study|Physician Decision|0|||
23331962|NCT04387435|64955626|FG000|Overall Study|Physician Decision|1|||
23331963|NCT00507455|64958962|FG000|Overall Study|Adverse Event|3|||
23331964|NCT00507455|64958963|FG001|Overall Study|Adverse Event|3|||
23331965|NCT00507455|64958964|FG002|Overall Study|Adverse Event|6|||
23331966|NCT00507455|64958962|FG000|Overall Study|Withdrawal by Subject|2|||
23331967|NCT00507455|64958963|FG001|Overall Study|Withdrawal by Subject|1|||
23447073|NCT03210961|65377874|FG011|Overall Study|Adverse Event|0|||
23447074|NCT03210961|65377875|FG012|Overall Study|Adverse Event|0|||
23447075|NCT03210961|65377876|FG013|Overall Study|Adverse Event|1|||
23447076|NCT03210961|65377877|FG014|Overall Study|Adverse Event|0|||
23447077|NCT03210961|65377863|FG000|Overall Study|Lost to Follow-up|0|||
23163816|NCT00916357|64348640|FG003|Period 1|Withdrawal by Subject|0|||
23163817|NCT00916357|64348641|FG004|Period 1|Withdrawal by Subject|0|||
23163818|NCT00916357|64348642|FG005|Period 1|Withdrawal by Subject|0|||
23163819|NCT00916357|64348637|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
23331968|NCT00507455|64958964|FG002|Overall Study|Withdrawal by Subject|2|||
23447078|NCT03210961|65377864|FG001|Overall Study|Lost to Follow-up|0|||
23447079|NCT03210961|65377865|FG002|Overall Study|Lost to Follow-up|0|||
23447080|NCT03210961|65377866|FG003|Overall Study|Lost to Follow-up|0|||
23447081|NCT03210961|65377867|FG004|Overall Study|Lost to Follow-up|0|||
23447082|NCT03210961|65377868|FG005|Overall Study|Lost to Follow-up|0|||
23331969|NCT00507455|64958962|FG000|Overall Study|Protocol Violation|4|||
23331970|NCT00507455|64958963|FG001|Overall Study|Protocol Violation|1|||
23331971|NCT00507455|64958964|FG002|Overall Study|Protocol Violation|1|||
23447083|NCT03210961|65377869|FG006|Overall Study|Lost to Follow-up|0|||
23447084|NCT03210961|65377870|FG007|Overall Study|Lost to Follow-up|0|||
23447085|NCT03210961|65377871|FG008|Overall Study|Lost to Follow-up|0|||
23571393|NCT03881059|65820992|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
23571394|NCT03881059|65820993|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
23571395|NCT03881059|65820994|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
23571396|NCT03881059|65820992|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
23571397|NCT03881059|65820993|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
23571398|NCT03881059|65820994|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
23571399|NCT03881059|65820992|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
23571400|NCT03881059|65820993|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
23571401|NCT03881059|65820994|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
23571402|NCT03881059|65820992|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
23571403|NCT03881059|65820993|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
23571404|NCT03881059|65820994|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
23571405|NCT03881059|65820992|FG000|Treatment Period - Part B|Other reasons|4|||
23571406|NCT03881059|65820993|FG001|Treatment Period - Part B|Other reasons|3|||
23571407|NCT03881059|65820994|FG002|Treatment Period - Part B|Other reasons|3|||
23571408|NCT04078035|65820997|FG000|Session 2|Lost to Follow-up|3|||
23571409|NCT04078035|65820998|FG001|Session 2|Lost to Follow-up|1|||
23571410|NCT04078035|65820997|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
23571411|NCT04078035|65820998|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
23571412|NCT00649389|65821001|FG000|Overall Study|Adverse Event|22|||
23571413|NCT00649389|65821002|FG001|Overall Study|Adverse Event|46|||
23571414|NCT00649389|65821003|FG002|Overall Study|Adverse Event|38|||
23571415|NCT00649389|65821004|FG003|Overall Study|Adverse Event|48|||
23571416|NCT00649389|65821001|FG000|Overall Study|Lost to Follow-up|15|||
23571417|NCT00649389|65821002|FG001|Overall Study|Lost to Follow-up|17|||
23571418|NCT00649389|65821003|FG002|Overall Study|Lost to Follow-up|21|||
23571419|NCT00649389|65821004|FG003|Overall Study|Lost to Follow-up|26|||
23571420|NCT00649389|65821001|FG000|Overall Study|Protocol Violation|11|||
23571421|NCT00649389|65821002|FG001|Overall Study|Protocol Violation|13|||
23331972|NCT00507455|64958962|FG000|Overall Study|Lost to Follow-up|2|||
23571422|NCT00649389|65821003|FG002|Overall Study|Protocol Violation|9|||
23571423|NCT00649389|65821004|FG003|Overall Study|Protocol Violation|8|||
23447086|NCT03210961|65377872|FG009|Overall Study|Lost to Follow-up|0|||
23571424|NCT00649389|65821001|FG000|Overall Study|Withdrawal by Subject|20|||
23571425|NCT00649389|65821002|FG001|Overall Study|Withdrawal by Subject|21|||
23163820|NCT00916357|64348638|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
23163821|NCT00916357|64348639|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
23163822|NCT00916357|64348640|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
23163823|NCT00916357|64348641|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
23163824|NCT00916357|64348642|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
23163825|NCT00879229|64348643|FG000|Overall Study|Study terminated by Sponsor|13|||
23163826|NCT00879229|64348644|FG001|Overall Study|Study terminated by Sponsor|12|||
23163827|NCT00879229|64348643|FG000|Overall Study|Death|4|||
23163828|NCT00879229|64348644|FG001|Overall Study|Death|2|||
23163829|NCT00879229|64348643|FG000|Overall Study|Adverse Event|2|||
23163830|NCT00879229|64348644|FG001|Overall Study|Adverse Event|0|||
23163831|NCT00879229|64348643|FG000|Overall Study|Withdrawal by Subject|1|||
23163832|NCT00879229|64348644|FG001|Overall Study|Withdrawal by Subject|0|||
23163833|NCT00879229|64348643|FG000|Overall Study|Clinical status did not improve|1|||
23163834|NCT00879229|64348644|FG001|Overall Study|Clinical status did not improve|0|||
23163835|NCT00879229|64348643|FG000|Overall Study|Other|1|||
23163836|NCT00879229|64348644|FG001|Overall Study|Other|0|||
23163837|NCT01278745|64348645|FG000|Overall Study|Death|2|||
23163838|NCT01278745|64348646|FG001|Overall Study|Death|5|||
23163839|NCT01278745|64348647|FG002|Overall Study|Death|7|||
23163840|NCT01278745|64348648|FG003|Overall Study|Death|0|||
23163841|NCT01278745|64348645|FG000|Overall Study|Physician Decision|1|||
23163842|NCT01278745|64348646|FG001|Overall Study|Physician Decision|0|||
23163843|NCT01278745|64348647|FG002|Overall Study|Physician Decision|0|||
23163844|NCT01278745|64348648|FG003|Overall Study|Physician Decision|9|||
23163845|NCT01278745|64348645|FG000|Overall Study|Withdrawal by Subject|1|||
23163846|NCT01278745|64348646|FG001|Overall Study|Withdrawal by Subject|1|||
23163847|NCT01278745|64348647|FG002|Overall Study|Withdrawal by Subject|5|||
23163848|NCT01278745|64348648|FG003|Overall Study|Withdrawal by Subject|1|||
23163849|NCT01278745|64348645|FG000|Overall Study|Sponsor Decision|1|||
23163850|NCT01278745|64348646|FG001|Overall Study|Sponsor Decision|0|||
23163851|NCT01278745|64348647|FG002|Overall Study|Sponsor Decision|62|||
23163852|NCT01278745|64348648|FG003|Overall Study|Sponsor Decision|6|||
23163853|NCT01278745|64348645|FG000|Overall Study|Ineligible|0|||
23163854|NCT01278745|64348646|FG001|Overall Study|Ineligible|0|||
23163855|NCT01278745|64348647|FG002|Overall Study|Ineligible|42|||
23163856|NCT01278745|64348648|FG003|Overall Study|Ineligible|61|||
23163857|NCT01278745|64348645|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
23163858|NCT01278745|64348646|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
23163859|NCT01278745|64348647|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
23163860|NCT01278745|64348648|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
23163861|NCT01967550|64348650|FG000|Overall Study|Withdrawal by Subject|1|||
23163862|NCT01967550|64348651|FG001|Overall Study|Withdrawal by Subject|0|||
23163863|NCT01967550|64348650|FG000|Overall Study|Adverse Event|2|||
23163864|NCT01967550|64348651|FG001|Overall Study|Adverse Event|0|||
23163865|NCT01967550|64348650|FG000|Overall Study|Protocol Violation|2|||
23163866|NCT01967550|64348651|FG001|Overall Study|Protocol Violation|1|||
23163867|NCT01967550|64348650|FG000|Overall Study|Non Compliance|0|||
23163868|NCT01967550|64348651|FG001|Overall Study|Non Compliance|1|||
23163869|NCT03354663|64348652|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
23163870|NCT03354663|64348652|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
23163871|NCT03354663|64348652|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
23163872|NCT03354663|64348652|FG000|Completed 30-day Visit|Missed Visit|1|||
23163873|NCT01309659|64348654|FG000|Overall Study|Protocol Violation|0|||
23163874|NCT01309659|64348655|FG001|Overall Study|Protocol Violation|1|||
23163875|NCT03024970|64348656|FG000|First Intervention|Adverse Event|1|||
23163876|NCT03024970|64348657|FG001|First Intervention|Adverse Event|0|||
23163877|NCT03024970|64348656|FG000|Second Intervention|Lost to Follow-up|1|||
23163878|NCT03024970|64348657|FG001|Second Intervention|Lost to Follow-up|0|||
23163879|NCT00790907|64348658|FG000|Overall Study|Adverse Event|9|||
23571426|NCT00649389|65821003|FG002|Overall Study|Withdrawal by Subject|19|||
23163880|NCT00790907|64348659|FG001|Overall Study|Adverse Event|7|||
23163881|NCT00790907|64348660|FG002|Overall Study|Adverse Event|6|||
23163882|NCT00790907|64348658|FG000|Overall Study|Physician Decision|304|||
23163883|NCT00790907|64348659|FG001|Overall Study|Physician Decision|271|||
23571427|NCT00649389|65821004|FG003|Overall Study|Withdrawal by Subject|23|||
23571428|NCT00649389|65821001|FG000|Overall Study|Other|3|||
23571429|NCT00649389|65821002|FG001|Overall Study|Other|9|||
23163884|NCT00790907|64348660|FG002|Overall Study|Physician Decision|255|||
23163885|NCT00790907|64348658|FG000|Overall Study|Withdrawal by Subject|1|||
23163886|NCT00790907|64348659|FG001|Overall Study|Withdrawal by Subject|7|||
23163887|NCT00790907|64348660|FG002|Overall Study|Withdrawal by Subject|5|||
23163888|NCT00790907|64348658|FG000|Overall Study|Bleeding Event|11|||
23163889|NCT00790907|64348659|FG001|Overall Study|Bleeding Event|16|||
23163890|NCT00790907|64348660|FG002|Overall Study|Bleeding Event|21|||
23163891|NCT00790907|64348658|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
23331973|NCT00507455|64958963|FG001|Overall Study|Lost to Follow-up|0|||
23447087|NCT03210961|65377873|FG010|Overall Study|Lost to Follow-up|0|||
23224149|NCT02623699|64563970|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
23224150|NCT02623699|64563971|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
23224151|NCT02623699|64563972|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
23224152|NCT02623699|64563973|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
23224153|NCT02623699|64563974|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
23224154|NCT02623699|64563975|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
23224155|NCT02623699|64563976|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
23224156|NCT02623699|64563977|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
23224157|NCT02623699|64563978|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
23224158|NCT02623699|64563979|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
23224159|NCT02623699|64563980|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
23224160|NCT02623699|64563969|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23224161|NCT02623699|64563970|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23224162|NCT02623699|64563971|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23224163|NCT02623699|64563972|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23224164|NCT02623699|64563973|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23224165|NCT02623699|64563974|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23224166|NCT02623699|64563975|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23331974|NCT00507455|64958964|FG002|Overall Study|Lost to Follow-up|2|||
23447088|NCT03210961|65377874|FG011|Overall Study|Lost to Follow-up|0|||
23224167|NCT02623699|64563976|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23224168|NCT02623699|64563977|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23447089|NCT03210961|65377875|FG012|Overall Study|Lost to Follow-up|0|||
23331975|NCT00507455|64958962|FG000|Overall Study|Lack of Efficacy|0|||
23331976|NCT00507455|64958963|FG001|Overall Study|Lack of Efficacy|1|||
23331977|NCT00507455|64958964|FG002|Overall Study|Lack of Efficacy|0|||
23331978|NCT00507455|64958962|FG000|Overall Study|Other - miscellaneous reason|1|||
23163892|NCT00790907|64348659|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
23163893|NCT00790907|64348660|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
23163894|NCT00790907|64348658|FG000|Overall Study|Qualifying Condition Not Present|29|||
23163895|NCT00790907|64348659|FG001|Overall Study|Qualifying Condition Not Present|14|||
23163896|NCT00790907|64348660|FG002|Overall Study|Qualifying Condition Not Present|16|||
23163897|NCT00790907|64348658|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
23331979|NCT00507455|64958963|FG001|Overall Study|Other - miscellaneous reason|0|||
23163898|NCT00790907|64348659|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
23163899|NCT00790907|64348660|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
23163900|NCT00790907|64348658|FG000|Overall Study|Did Not Receive Study Drug|10|||
23163901|NCT00790907|64348659|FG001|Overall Study|Did Not Receive Study Drug|0|||
23163902|NCT00790907|64348660|FG002|Overall Study|Did Not Receive Study Drug|0|||
23163903|NCT00844753|64348663|FG000|Overall Study|Lack of Efficacy|1|||
23163904|NCT00844753|64348664|FG001|Overall Study|Lack of Efficacy|0|||
23163905|NCT00844753|64348665|FG002|Overall Study|Lack of Efficacy|2|||
23163906|NCT00844753|64348666|FG003|Overall Study|Lack of Efficacy|2|||
23163907|NCT00844753|64348663|FG000|Overall Study|Adverse Event|3|||
23224169|NCT02623699|64563978|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
23224170|NCT02623699|64563979|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
23224171|NCT02623699|64563980|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
23224172|NCT02623699|64563969|FG000|Part C (Up to 236 Days)|Death|0|||
23224173|NCT02623699|64563970|FG001|Part C (Up to 236 Days)|Death|0|||
23224174|NCT02623699|64563971|FG002|Part C (Up to 236 Days)|Death|0|||
23224175|NCT02623699|64563972|FG003|Part C (Up to 236 Days)|Death|0|||
23224176|NCT02623699|64563973|FG004|Part C (Up to 236 Days)|Death|0|||
23224177|NCT02623699|64563974|FG005|Part C (Up to 236 Days)|Death|0|||
23224178|NCT02623699|64563975|FG006|Part C (Up to 236 Days)|Death|0|||
23224179|NCT02623699|64563976|FG007|Part C (Up to 236 Days)|Death|0|||
23224180|NCT02623699|64563977|FG008|Part C (Up to 236 Days)|Death|0|||
23224181|NCT02623699|64563978|FG009|Part C (Up to 236 Days)|Death|0|||
23224182|NCT02623699|64563979|FG010|Part C (Up to 236 Days)|Death|0|||
23224183|NCT02623699|64563980|FG011|Part C (Up to 236 Days)|Death|1|||
23224184|NCT02623699|64563969|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
23224185|NCT02623699|64563970|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
23224186|NCT02623699|64563971|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
23224187|NCT02623699|64563972|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
23224188|NCT02623699|64563973|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
23224189|NCT02623699|64563974|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
23224190|NCT02623699|64563975|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
23224191|NCT02623699|64563976|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
23224192|NCT02623699|64563977|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
23224193|NCT02623699|64563978|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
23224194|NCT02623699|64563979|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
23331980|NCT00507455|64958964|FG002|Overall Study|Other - miscellaneous reason|1|||
23163908|NCT00844753|64348664|FG001|Overall Study|Adverse Event|2|||
23163909|NCT00844753|64348665|FG002|Overall Study|Adverse Event|5|||
23163910|NCT00844753|64348666|FG003|Overall Study|Adverse Event|5|||
23163911|NCT00844753|64348663|FG000|Overall Study|Lost to Follow-up|1|||
23224195|NCT02623699|64563980|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
23224196|NCT00732238|64563981|FG000|Overall Study|Bacteremia|4|||
23224197|NCT00732238|64563982|FG001|Overall Study|Bacteremia|1|||
23163912|NCT00844753|64348664|FG001|Overall Study|Lost to Follow-up|1|||
23163913|NCT00844753|64348665|FG002|Overall Study|Lost to Follow-up|0|||
23163914|NCT00844753|64348666|FG003|Overall Study|Lost to Follow-up|1|||
23163915|NCT00844753|64348663|FG000|Overall Study|could not swallow medication|2|||
23447090|NCT03210961|65377876|FG013|Overall Study|Lost to Follow-up|0|||
23163916|NCT00844753|64348664|FG001|Overall Study|could not swallow medication|0|||
23163917|NCT00844753|64348665|FG002|Overall Study|could not swallow medication|0|||
23163918|NCT00844753|64348666|FG003|Overall Study|could not swallow medication|0|||
23163919|NCT00844753|64348663|FG000|Overall Study|Withdrawal by Subject|1|||
23163920|NCT00844753|64348664|FG001|Overall Study|Withdrawal by Subject|0|||
23163921|NCT00844753|64348665|FG002|Overall Study|Withdrawal by Subject|0|||
23163922|NCT00844753|64348666|FG003|Overall Study|Withdrawal by Subject|3|||
23163923|NCT01970995|64348667|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
23163924|NCT01970995|64348668|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
23163925|NCT01970995|64348669|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
23163926|NCT01970995|64348667|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
23163927|NCT01970995|64348668|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
23163928|NCT01970995|64348669|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
23163929|NCT00788372|64348670|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
23163930|NCT00788372|64348670|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
23163931|NCT00788372|64348670|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
23163932|NCT00788372|64348670|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
23163933|NCT00788372|64348670|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
23163934|NCT00788372|64348670|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
23163935|NCT00788372|64348670|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
23163936|NCT01883635|64348671|FG000|Overall Study|Withdrawal by Subject|4|||
23163937|NCT01883635|64348672|FG001|Overall Study|Withdrawal by Subject|0|||
23163938|NCT03861559|64348675|FG000|Overall Study|Adverse Event|0|||
23163939|NCT03861559|64348676|FG001|Overall Study|Adverse Event|2|||
23163940|NCT03861559|64348675|FG000|Overall Study|Treatment failure|0|||
23331981|NCT02821754|64958965|FG000|Overall Study|Procedure not required prior to amendment change|13|||
23163941|NCT03861559|64348676|FG001|Overall Study|Treatment failure|2|||
23163942|NCT03861559|64348675|FG000|Overall Study|Noncompliance|1|||
23224198|NCT00732238|64563981|FG000|Overall Study|Asymptomatic bacteriuria|1|||
23224199|NCT00732238|64563982|FG001|Overall Study|Asymptomatic bacteriuria|0|||
23224200|NCT00209092|64563983|FG000|Overall Study|Progression of disease|7|||
23224201|NCT00209092|64563984|FG001|Overall Study|Progression of disease|1|||
23224202|NCT00209092|64563983|FG000|Overall Study|Adverse Event|0|||
23224203|NCT00209092|64563984|FG001|Overall Study|Adverse Event|1|||
23331982|NCT02821754|64958966|FG001|Overall Study|Procedure not required prior to amendment change|11|||
23331983|NCT02821754|64958967|FG002|Overall Study|Procedure not required prior to amendment change|0|||
23331984|NCT02821754|64958965|FG000|Overall Study|Participant's Clinical status|2|||
23163943|NCT03861559|64348676|FG001|Overall Study|Noncompliance|1|||
23331985|NCT02821754|64958966|FG001|Overall Study|Participant's Clinical status|0|||
23331986|NCT02821754|64958967|FG002|Overall Study|Participant's Clinical status|0|||
23331987|NCT02821754|64958965|FG000|Overall Study|Participant removed for noncompliance|1|||
23331988|NCT02821754|64958966|FG001|Overall Study|Participant removed for noncompliance|0|||
23331989|NCT02821754|64958967|FG002|Overall Study|Participant removed for noncompliance|0|||
23331990|NCT02821754|64958965|FG000|Overall Study|Drug not available.|0|||
23447091|NCT03210961|65377877|FG014|Overall Study|Lost to Follow-up|1|||
23447092|NCT03210961|65377863|FG000|Overall Study|Withdrawal by Subject|0|||
23447093|NCT03210961|65377864|FG001|Overall Study|Withdrawal by Subject|0|||
23447094|NCT03210961|65377865|FG002|Overall Study|Withdrawal by Subject|0|||
23447095|NCT03210961|65377866|FG003|Overall Study|Withdrawal by Subject|0|||
23447096|NCT03210961|65377867|FG004|Overall Study|Withdrawal by Subject|0|||
23447097|NCT03210961|65377868|FG005|Overall Study|Withdrawal by Subject|0|||
23447098|NCT03210961|65377869|FG006|Overall Study|Withdrawal by Subject|0|||
23447099|NCT03210961|65377870|FG007|Overall Study|Withdrawal by Subject|0|||
23447100|NCT03210961|65377871|FG008|Overall Study|Withdrawal by Subject|0|||
23447101|NCT03210961|65377872|FG009|Overall Study|Withdrawal by Subject|0|||
23163944|NCT03861559|64348675|FG000|Overall Study|Did not meet eligibility requirements|1|||
23163945|NCT03861559|64348676|FG001|Overall Study|Did not meet eligibility requirements|0|||
23163946|NCT01820364|64348677|FG000|Part I: LGX818|Death|1|||
23163947|NCT01820364|64348678|FG001|Part I: LGX818|Death|0|||
23163948|NCT01820364|64348677|FG000|Part I: LGX818|Administrative Problems|3|||
23163949|NCT01820364|64348678|FG001|Part I: LGX818|Administrative Problems|0|||
23163950|NCT01820364|64348677|FG000|Part I: LGX818|Adverse Event|6|||
23163951|NCT01820364|64348678|FG001|Part I: LGX818|Adverse Event|0|||
23331991|NCT02821754|64958966|FG001|Overall Study|Drug not available.|0|||
23447102|NCT03210961|65377873|FG010|Overall Study|Withdrawal by Subject|0|||
23447103|NCT03210961|65377874|FG011|Overall Study|Withdrawal by Subject|0|||
23447104|NCT03210961|65377875|FG012|Overall Study|Withdrawal by Subject|0|||
23447105|NCT03210961|65377876|FG013|Overall Study|Withdrawal by Subject|0|||
23224204|NCT00209092|64563983|FG000|Overall Study|Withdrawal by Subject|1|||
23224205|NCT00209092|64563984|FG001|Overall Study|Withdrawal by Subject|0|||
23224206|NCT03152110|64563990|FG000|Overall Study|Withdrawal by Subject|3|||
23224207|NCT01156363|64563994|FG000|Overall Study|Adverse Event|6|||
23224208|NCT01156363|64563994|FG000|Overall Study|Insufficient Therapeutic Response|5|||
23224209|NCT01156363|64563994|FG000|Overall Study|Failure to Return|1|||
23447106|NCT03210961|65377877|FG014|Overall Study|Withdrawal by Subject|1|||
23447107|NCT03210961|65377863|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447108|NCT03210961|65377864|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447109|NCT03210961|65377865|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447110|NCT03210961|65377866|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447111|NCT03210961|65377867|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447112|NCT03210961|65377868|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447113|NCT03210961|65377869|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447114|NCT03210961|65377870|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447115|NCT03210961|65377871|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447116|NCT03210961|65377872|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447117|NCT03210961|65377873|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447118|NCT03210961|65377874|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447119|NCT03210961|65377875|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447120|NCT03210961|65377876|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
23447121|NCT03210961|65377877|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
23447122|NCT03210961|65377863|FG000|Overall Study|Other|0|||
23447123|NCT03210961|65377864|FG001|Overall Study|Other|0|||
23447124|NCT03210961|65377865|FG002|Overall Study|Other|0|||
23447125|NCT03210961|65377866|FG003|Overall Study|Other|1|||
23447126|NCT03210961|65377867|FG004|Overall Study|Other|0|||
23447127|NCT03210961|65377868|FG005|Overall Study|Other|0|||
23447128|NCT03210961|65377869|FG006|Overall Study|Other|1|||
23447129|NCT03210961|65377870|FG007|Overall Study|Other|0|||
23447130|NCT03210961|65377871|FG008|Overall Study|Other|0|||
23447131|NCT03210961|65377872|FG009|Overall Study|Other|0|||
23447132|NCT03210961|65377873|FG010|Overall Study|Other|1|||
23571430|NCT00649389|65821003|FG002|Overall Study|Other|1|||
23571431|NCT00649389|65821004|FG003|Overall Study|Other|6|||
23571432|NCT02491892|65821009|FG000|Overall Study|Adverse Event|1|||
23571433|NCT02491892|65821010|FG001|Overall Study|Adverse Event|1|||
23571434|NCT02491892|65821009|FG000|Overall Study|Death|1|||
23571435|NCT02491892|65821010|FG001|Overall Study|Death|1|||
23571436|NCT02491892|65821009|FG000|Overall Study|Lack of Efficacy|37|||
23571437|NCT02491892|65821010|FG001|Overall Study|Lack of Efficacy|36|||
23571438|NCT02491892|65821009|FG000|Overall Study|Refused Treatment|1|||
23571439|NCT02491892|65821010|FG001|Overall Study|Refused Treatment|0|||
23571440|NCT02491892|65821009|FG000|Overall Study|Lost to Follow-up|1|||
23571441|NCT02491892|65821010|FG001|Overall Study|Lost to Follow-up|0|||
23571442|NCT00245011|65821011|FG000|Overall Study|Lack of Efficacy|1|||
23571443|NCT02111213|65821012|FG000|Overall Study|Withdrawal by Subject|3|||
23571444|NCT02111213|65821013|FG001|Overall Study|Withdrawal by Subject|2|||
23571445|NCT02111213|65821012|FG000|Overall Study|Lost to Follow-up|3|||
23571446|NCT02111213|65821013|FG001|Overall Study|Lost to Follow-up|4|||
23571447|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
23571448|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
23571449|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
23571450|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
23571451|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23571452|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
23571453|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23571454|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23571455|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
23571456|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
23571457|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23571458|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23571459|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
23571460|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
23447133|NCT03210961|65377874|FG011|Overall Study|Other|0|||
23447134|NCT03210961|65377875|FG012|Overall Study|Other|2|||
23447135|NCT03210961|65377876|FG013|Overall Study|Other|2|||
23571461|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23571462|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23224210|NCT01156363|64563994|FG000|Overall Study|Refused Treatment|4|||
23571463|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
23447136|NCT03210961|65377877|FG014|Overall Study|Other|0|||
23224211|NCT01156363|64563994|FG000|Overall Study|Other|6|||
23224212|NCT00623766|64563995|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
23224213|NCT00623766|64563996|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
23224214|NCT00623766|64563995|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
23224215|NCT00623766|64563996|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
23224216|NCT00623766|64563995|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
23224217|NCT00623766|64563996|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
23224218|NCT00623766|64563995|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
23331992|NCT02821754|64958967|FG002|Overall Study|Drug not available.|1|||
23331993|NCT02821754|64958965|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
23331994|NCT02821754|64958966|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
23331995|NCT02821754|64958967|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
23331996|NCT00957801|64958973|FG000|Overall Study|Withdrawal by Subject|0|||
23331997|NCT00957801|64958974|FG001|Overall Study|Withdrawal by Subject|0|||
23331998|NCT00957801|64958975|FG002|Overall Study|Withdrawal by Subject|0|||
23163952|NCT01820364|64348677|FG000|Part I: LGX818|Disease Progression|4|||
23163953|NCT01820364|64348678|FG001|Part I: LGX818|Disease Progression|0|||
23163954|NCT01820364|64348677|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
23163955|NCT01820364|64348678|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
23163956|NCT00075400|64348679|FG000|Overall Study|Ineligible: wrong primary|1|||
23163957|NCT00075400|64348679|FG000|Overall Study|Never treated|2|||
23163958|NCT01227187|64348680|FG000|Overall Study|Physician Decision|0|||
23163959|NCT01227187|64348681|FG001|Overall Study|Physician Decision|0|||
23163960|NCT01227187|64348682|FG002|Overall Study|Physician Decision|0|||
23163961|NCT01227187|64348683|FG003|Overall Study|Physician Decision|1|||
23331999|NCT00957801|64958976|FG003|Overall Study|Withdrawal by Subject|1|||
23332000|NCT01295827|64958977|FG000|Overall Study|Adverse Event|1|||
23332001|NCT01295827|64958978|FG001|Overall Study|Adverse Event|2|||
23332002|NCT01295827|64958979|FG002|Overall Study|Adverse Event|2|||
23332003|NCT01295827|64958980|FG003|Overall Study|Adverse Event|1|||
23332004|NCT01295827|64958981|FG004|Overall Study|Adverse Event|1|||
23332005|NCT01295827|64958982|FG005|Overall Study|Adverse Event|4|||
23332006|NCT01295827|64958983|FG006|Overall Study|Adverse Event|15|||
23332007|NCT01295827|64958984|FG007|Overall Study|Adverse Event|49|||
23332008|NCT01295827|64958985|FG008|Overall Study|Adverse Event|22|||
23332009|NCT01295827|64958986|FG009|Overall Study|Adverse Event|7|||
23332010|NCT01295827|64958987|FG010|Overall Study|Adverse Event|50|||
23571464|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
23571465|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
23163962|NCT02236520|64348684|FG000|Overall Study|Physician Decision|0|||
23163963|NCT02236520|64348685|FG001|Overall Study|Physician Decision|5|||
23163964|NCT02236520|64348686|FG002|Overall Study|Physician Decision|0|||
23163965|NCT02236520|64348687|FG003|Overall Study|Physician Decision|0|||
23163966|NCT02236520|64348684|FG000|Overall Study|Withdrawal by Subject|1|||
23163967|NCT02236520|64348685|FG001|Overall Study|Withdrawal by Subject|0|||
23163968|NCT02236520|64348686|FG002|Overall Study|Withdrawal by Subject|0|||
23163969|NCT02236520|64348687|FG003|Overall Study|Withdrawal by Subject|1|||
23163970|NCT02236520|64348684|FG000|Overall Study|Pregnancy|1|||
23163971|NCT02236520|64348685|FG001|Overall Study|Pregnancy|0|||
23163972|NCT02236520|64348686|FG002|Overall Study|Pregnancy|0|||
23163973|NCT02236520|64348687|FG003|Overall Study|Pregnancy|0|||
23163974|NCT00925015|64348688|FG000|Overall Study|Adverse Event|1|||
23163975|NCT00925015|64348689|FG001|Overall Study|Adverse Event|2|||
23163976|NCT00925015|64348690|FG002|Overall Study|Adverse Event|1|||
23224219|NCT00623766|64563996|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
23332011|NCT01295827|64958988|FG011|Overall Study|Adverse Event|21|||
23571466|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
23571467|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
23571468|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
23571469|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
23571470|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
23163977|NCT00925015|64348688|FG000|Overall Study|Physician Decision|0|||
23163978|NCT00925015|64348689|FG001|Overall Study|Physician Decision|1|||
23163979|NCT00925015|64348690|FG002|Overall Study|Physician Decision|0|||
23163980|NCT00925015|64348688|FG000|Overall Study|Progressive Disease|7|||
23163981|NCT00925015|64348689|FG001|Overall Study|Progressive Disease|3|||
23163982|NCT00925015|64348690|FG002|Overall Study|Progressive Disease|4|||
23163983|NCT00925015|64348688|FG000|Overall Study|Withdrawal by Subject|0|||
23163984|NCT00925015|64348689|FG001|Overall Study|Withdrawal by Subject|0|||
23163985|NCT00925015|64348690|FG002|Overall Study|Withdrawal by Subject|1|||
23163986|NCT02813694|64348691|FG000|Overall Study|Physician Decision|0|||
23224220|NCT00623766|64563995|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
23571471|NCT03230864|65821016|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
23571472|NCT03230864|65821017|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
23571473|NCT03230864|65821018|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
23571474|NCT03230864|65821019|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
23571475|NCT03230864|65821016|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
23571476|NCT03230864|65821017|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
23571477|NCT03230864|65821018|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
23571478|NCT03230864|65821019|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
23571479|NCT03230864|65821016|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23163987|NCT02813694|64348692|FG001|Overall Study|Physician Decision|1|||
23163988|NCT02813694|64348691|FG000|Overall Study|Withdrawal by Subject|10|||
23163989|NCT02813694|64348692|FG001|Overall Study|Withdrawal by Subject|9|||
23163990|NCT02813694|64348691|FG000|Overall Study|Lost to Follow-up|1|||
23163991|NCT02813694|64348692|FG001|Overall Study|Lost to Follow-up|1|||
23163992|NCT02813694|64348691|FG000|Overall Study|Death|3|||
23163993|NCT02813694|64348692|FG001|Overall Study|Death|3|||
23163994|NCT02813694|64348691|FG000|Overall Study|Randomized- did not receive study drug|2|||
23163995|NCT02813694|64348692|FG001|Overall Study|Randomized- did not receive study drug|0|||
23163996|NCT02813694|64348691|FG000|Overall Study|Patient hospitalized|1|||
23163997|NCT02813694|64348692|FG001|Overall Study|Patient hospitalized|0|||
23163998|NCT00473343|64348693|FG000|Overall Study|Adverse Event|9|||
23163999|NCT00473343|64348693|FG000|Overall Study|Lost to Follow-up|8|||
23164000|NCT00473343|64348693|FG000|Overall Study|Treatment failure|27|||
23164001|NCT00473343|64348693|FG000|Overall Study|Withdrew consent|3|||
23571480|NCT03230864|65821017|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23571481|NCT03230864|65821018|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
23571482|NCT03230864|65821019|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
23571483|NCT03230864|65821016|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
23571484|NCT03230864|65821017|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
23571485|NCT03230864|65821018|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
23571486|NCT03230864|65821019|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
23571487|NCT00547911|65821023|FG000|Overall Study|Adverse Event|0|||
23571488|NCT00547911|65821024|FG001|Overall Study|Adverse Event|0|||
23571489|NCT00547911|65821025|FG002|Overall Study|Adverse Event|0|||
23571490|NCT00547911|65821026|FG003|Overall Study|Adverse Event|1|||
23571491|NCT00547911|65821027|FG004|Overall Study|Adverse Event|0|||
23571492|NCT00547911|65821028|FG005|Overall Study|Adverse Event|0|||
23571493|NCT02353832|65821029|FG000|Overall Study|Ineligible after enrollment|1|||
23571494|NCT02353832|65821029|FG000|Overall Study|Lost to Follow-up|1|||
23571495|NCT01087723|65821030|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
23571496|NCT01087723|65821031|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
23571497|NCT01087723|65821030|FG000|Overall Study|Withdrawal by Subject|10|||
23571498|NCT01087723|65821031|FG001|Overall Study|Withdrawal by Subject|13|||
23571499|NCT01087723|65821030|FG000|Overall Study|Physician Decision|2|||
23571500|NCT01087723|65821031|FG001|Overall Study|Physician Decision|0|||
23571501|NCT01087723|65821030|FG000|Overall Study|Lost to Follow-up|1|||
23571502|NCT01087723|65821031|FG001|Overall Study|Lost to Follow-up|4|||
23571503|NCT01087723|65821030|FG000|Overall Study|Reason Not Specified|1|||
23571504|NCT01087723|65821031|FG001|Overall Study|Reason Not Specified|2|||
23571505|NCT04296890|65821032|FG000|Overall Study|Withdrawal by Subject|1|||
23571506|NCT04296890|65821032|FG000|Overall Study|Death|62|||
23571507|NCT04296890|65821032|FG000|Overall Study|Lost to Follow-up|3|||
23571508|NCT04296890|65821032|FG000|Overall Study|Other than specified|2|||
23571509|NCT01644474|65821035|FG000|Overall Study|Poor compliance to protocol|1|||
23571510|NCT01644474|65821036|FG001|Overall Study|Poor compliance to protocol|0|||
23571511|NCT01644474|65821035|FG000|Overall Study|Consent withdrawn by participant|0|||
23571512|NCT01644474|65821036|FG001|Overall Study|Consent withdrawn by participant|1|||
23571513|NCT01644474|65821035|FG000|Overall Study|Participant moved|0|||
23571514|NCT01644474|65821036|FG001|Overall Study|Participant moved|1|||
23571515|NCT01644474|65821035|FG000|Overall Study|Adverse Event|4|||
23164002|NCT00473343|64348693|FG000|Overall Study|Other un-specified reason|3|||
23164003|NCT03084536|64348694|FG000|Overall Study|Determined to be ineligible|0|||
23164004|NCT03084536|64348695|FG001|Overall Study|Determined to be ineligible|0|||
23164005|NCT03084536|64348696|FG002|Overall Study|Determined to be ineligible|16|||
23571516|NCT01644474|65821036|FG001|Overall Study|Adverse Event|5|||
23571517|NCT01644474|65821035|FG000|Overall Study|Site scheduling error|1|||
23571518|NCT01644474|65821036|FG001|Overall Study|Site scheduling error|1|||
23571519|NCT01644474|65821035|FG000|Overall Study|Protocol Violation|1|||
23571520|NCT01644474|65821036|FG001|Overall Study|Protocol Violation|0|||
23571521|NCT01282476|65821039|FG000|Overall Study|Death|11|||
23571522|NCT01382940|65821040|FG000|Overall Study|Adverse Event|19|||
23571523|NCT01382940|65821040|FG000|Overall Study|Lost to Follow-up|4|||
23571524|NCT01382940|65821040|FG000|Overall Study|Physician Decision|7|||
23571525|NCT01382940|65821040|FG000|Overall Study|Withdrawal by Subject|23|||
23224221|NCT00623766|64563996|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
23571526|NCT01382940|65821040|FG000|Overall Study|Protocol Violation|20|||
23571527|NCT01115491|65821041|FG000|Overall Study|Death|22|||
23571528|NCT01115491|65821041|FG000|Overall Study|Adverse Event|3|||
23571529|NCT01115491|65821041|FG000|Overall Study|Lost to Follow-up|3|||
23571530|NCT01115491|65821041|FG000|Overall Study|Withdrawal by Subject|1|||
23571531|NCT01115491|65821041|FG000|Overall Study|Physician Decision|1|||
23164006|NCT03084536|64348694|FG000|Overall Study|Withdrawal by Subject|0|||
23164007|NCT03084536|64348695|FG001|Overall Study|Withdrawal by Subject|0|||
23571532|NCT00840996|65821044|FG000|Overall Study|Withdrawal by Subject|1|||
23571533|NCT00840996|65821045|FG001|Overall Study|Withdrawal by Subject|0|||
23571534|NCT01163747|65821048|FG000|Overall Study|Adverse Event|0|||
23571535|NCT01163747|65821049|FG001|Overall Study|Adverse Event|5|||
23571536|NCT01163747|65821048|FG000|Overall Study|Insufficient Therapeutic Response|0|||
23571537|NCT01163747|65821049|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23571538|NCT01163747|65821048|FG000|Overall Study|Protocol Violation|0|||
23571539|NCT01163747|65821049|FG001|Overall Study|Protocol Violation|1|||
23571540|NCT01163747|65821048|FG000|Overall Study|Refused Treatment|6|||
23571541|NCT01163747|65821049|FG001|Overall Study|Refused Treatment|4|||
23571542|NCT03990363|65821053|FG000|Overall Study|Withdrawal by Subject|10|||
23571543|NCT03990363|65821054|FG001|Overall Study|Withdrawal by Subject|9|||
23571544|NCT03990363|65821055|FG002|Overall Study|Withdrawal by Subject|18|||
23571545|NCT03990363|65821056|FG003|Overall Study|Withdrawal by Subject|11|||
23571546|NCT03990363|65821057|FG004|Overall Study|Withdrawal by Subject|9|||
23164008|NCT03084536|64348696|FG002|Overall Study|Withdrawal by Subject|4|||
23164009|NCT03084536|64348694|FG000|Overall Study|Physician Decision|0|||
23164010|NCT03084536|64348695|FG001|Overall Study|Physician Decision|0|||
23164011|NCT03084536|64348696|FG002|Overall Study|Physician Decision|3|||
23164012|NCT03084536|64348694|FG000|Overall Study|Death|0|||
23164013|NCT03084536|64348695|FG001|Overall Study|Death|0|||
23164014|NCT03084536|64348696|FG002|Overall Study|Death|1|||
23571547|NCT03990363|65821053|FG000|Overall Study|Physician Decision|1|||
23571548|NCT03990363|65821054|FG001|Overall Study|Physician Decision|0|||
23571549|NCT03990363|65821055|FG002|Overall Study|Physician Decision|0|||
23571550|NCT03990363|65821056|FG003|Overall Study|Physician Decision|0|||
23571551|NCT03990363|65821057|FG004|Overall Study|Physician Decision|0|||
23571552|NCT03990363|65821053|FG000|Overall Study|Adverse Event|1|||
23571553|NCT03990363|65821054|FG001|Overall Study|Adverse Event|3|||
23164015|NCT03084536|64348694|FG000|Overall Study|Lost to Follow-up|0|||
23164016|NCT03084536|64348695|FG001|Overall Study|Lost to Follow-up|0|||
23164017|NCT03084536|64348696|FG002|Overall Study|Lost to Follow-up|1|||
23164018|NCT03084536|64348694|FG000|Overall Study|Protocol Violation|0|||
23164019|NCT03084536|64348695|FG001|Overall Study|Protocol Violation|0|||
23164020|NCT03084536|64348696|FG002|Overall Study|Protocol Violation|1|||
23164021|NCT03084536|64348694|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
23164022|NCT03084536|64348695|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
23332012|NCT01295827|64958989|FG012|Overall Study|Adverse Event|0|||
23164023|NCT03084536|64348696|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
23332013|NCT01295827|64958990|FG013|Overall Study|Adverse Event|0|||
23571554|NCT03990363|65821055|FG002|Overall Study|Adverse Event|2|||
23571555|NCT03990363|65821056|FG003|Overall Study|Adverse Event|2|||
23571556|NCT03990363|65821057|FG004|Overall Study|Adverse Event|0|||
23571557|NCT03990363|65821053|FG000|Overall Study|Death|14|||
23571558|NCT03990363|65821054|FG001|Overall Study|Death|8|||
23571559|NCT03990363|65821055|FG002|Overall Study|Death|14|||
23571560|NCT03990363|65821056|FG003|Overall Study|Death|10|||
23571561|NCT03990363|65821057|FG004|Overall Study|Death|11|||
23571562|NCT03990363|65821053|FG000|Overall Study|Failure to meet randomization criteria|0|||
23164024|NCT02728830|64348699|FG000|Overall Study|Exclusionary Surgery|9|||
23164025|NCT02728830|64348699|FG000|Overall Study|Exclusionary Pathology|6|||
23571563|NCT03990363|65821054|FG001|Overall Study|Failure to meet randomization criteria|1|||
23571564|NCT03990363|65821055|FG002|Overall Study|Failure to meet randomization criteria|1|||
23571565|NCT03990363|65821056|FG003|Overall Study|Failure to meet randomization criteria|0|||
23571566|NCT03990363|65821057|FG004|Overall Study|Failure to meet randomization criteria|0|||
23571567|NCT03990363|65821053|FG000|Overall Study|Lost to Follow-up|0|||
23571568|NCT03990363|65821054|FG001|Overall Study|Lost to Follow-up|0|||
23164026|NCT02728830|64348699|FG000|Overall Study|Physician Decision|3|||
23164027|NCT02728830|64348699|FG000|Overall Study|Withdrawal by Subject|2|||
23164028|NCT02728830|64348699|FG000|Overall Study|Lost to Follow-up|1|||
23164029|NCT02728830|64348699|FG000|Overall Study|Exclusionary Lab Values|1|||
23164030|NCT02728830|64348699|FG000|Overall Study|Contraindicated Illness|1|||
23164031|NCT02728830|64348699|FG000|Overall Study|Language Barrier|1|||
23164032|NCT02424253|64348704|FG000|Overall Study|Other, unspecified|1|||
23164033|NCT02424253|64348705|FG001|Overall Study|Other, unspecified|0|||
23164034|NCT02424253|64348704|FG000|Overall Study|Compliance problems|1|||
23164035|NCT02424253|64348705|FG001|Overall Study|Compliance problems|0|||
23164036|NCT02424253|64348704|FG000|Overall Study|Physician Decision|2|||
23164037|NCT02424253|64348705|FG001|Overall Study|Physician Decision|0|||
23164038|NCT02424253|64348704|FG000|Overall Study|Lack of Efficacy|0|||
23164039|NCT02424253|64348705|FG001|Overall Study|Lack of Efficacy|7|||
23164040|NCT02424253|64348704|FG000|Overall Study|Adverse Event|2|||
23164041|NCT02424253|64348705|FG001|Overall Study|Adverse Event|0|||
23164042|NCT02424253|64348704|FG000|Overall Study|Consent withdrawn by subject|4|||
23164043|NCT02424253|64348705|FG001|Overall Study|Consent withdrawn by subject|1|||
23164044|NCT02424253|64348704|FG000|Overall Study|Lost to Follow-up|1|||
23164045|NCT02424253|64348705|FG001|Overall Study|Lost to Follow-up|1|||
23164046|NCT03223428|64348706|FG000|Overall Study|No longer taking Xermelo|27|||
23164047|NCT03223428|64348706|FG000|Overall Study|Declined Consent|1|||
23164048|NCT03223428|64348706|FG000|Overall Study|Non-responders|56|||
23164049|NCT03223428|64348706|FG000|Overall Study|Withdrawal by Subject|14|||
23164050|NCT02081534|64348708|FG000|Overall Study|Adverse Event|5|||
23164051|NCT02081534|64348709|FG001|Overall Study|Adverse Event|4|||
23164052|NCT02081534|64348710|FG002|Overall Study|Adverse Event|3|||
23164053|NCT02081534|64348711|FG003|Overall Study|Adverse Event|10|||
23164054|NCT02081534|64348712|FG004|Overall Study|Adverse Event|2|||
23164055|NCT02081534|64348713|FG005|Overall Study|Adverse Event|8|||
23164056|NCT02081534|64348714|FG006|Overall Study|Adverse Event|2|||
23164057|NCT02081534|64348708|FG000|Overall Study|Withdrawal by Subject|0|||
23164058|NCT02081534|64348709|FG001|Overall Study|Withdrawal by Subject|1|||
23164059|NCT02081534|64348710|FG002|Overall Study|Withdrawal by Subject|1|||
23164060|NCT02081534|64348711|FG003|Overall Study|Withdrawal by Subject|1|||
23164061|NCT02081534|64348712|FG004|Overall Study|Withdrawal by Subject|1|||
23164062|NCT02081534|64348713|FG005|Overall Study|Withdrawal by Subject|0|||
23164063|NCT02081534|64348714|FG006|Overall Study|Withdrawal by Subject|1|||
23164064|NCT02081534|64348708|FG000|Overall Study|Protocol Violation|0|||
23164065|NCT02081534|64348709|FG001|Overall Study|Protocol Violation|3|||
23164066|NCT02081534|64348710|FG002|Overall Study|Protocol Violation|0|||
23164067|NCT02081534|64348711|FG003|Overall Study|Protocol Violation|0|||
23164068|NCT02081534|64348712|FG004|Overall Study|Protocol Violation|0|||
23164069|NCT02081534|64348713|FG005|Overall Study|Protocol Violation|0|||
23164070|NCT02081534|64348714|FG006|Overall Study|Protocol Violation|1|||
23164071|NCT02081534|64348708|FG000|Overall Study|Lost to Follow-up|0|||
23164072|NCT02081534|64348709|FG001|Overall Study|Lost to Follow-up|0|||
23164073|NCT02081534|64348710|FG002|Overall Study|Lost to Follow-up|0|||
23164074|NCT02081534|64348711|FG003|Overall Study|Lost to Follow-up|2|||
23164075|NCT02081534|64348712|FG004|Overall Study|Lost to Follow-up|1|||
23164076|NCT02081534|64348713|FG005|Overall Study|Lost to Follow-up|1|||
23164077|NCT02081534|64348714|FG006|Overall Study|Lost to Follow-up|0|||
23164078|NCT03917823|64348715|FG000|Overall Study|Lost to Follow-up|1|||
23164079|NCT03917823|64348716|FG001|Overall Study|Lost to Follow-up|1|||
23164080|NCT03917823|64348715|FG000|Overall Study|Withdrawal by Subject|0|||
23332014|NCT01295827|64958991|FG014|Overall Study|Adverse Event|0|||
23164081|NCT03917823|64348716|FG001|Overall Study|Withdrawal by Subject|1|||
23447137|NCT00502671|65377880|FG000|Overall Study|Disease Progression|13|||
23164082|NCT00817531|64348717|FG000|Overall Study|Adverse Event|1|||
23164083|NCT00817531|64348717|FG000|Overall Study|Lack of Efficacy|1|||
23164084|NCT02590588|64348718|FG000|Overall Study|Adverse Event|1|||
23164085|NCT00258674|64348719|FG000|Overall Study|Death|32|||
23164086|NCT00258674|64348720|FG001|Overall Study|Death|53|||
23164087|NCT00258674|64348721|FG002|Overall Study|Death|34|||
23164088|NCT01372384|64348728|FG000|Overall Study|Progression of disease|3|||
23332015|NCT01295827|64958977|FG000|Overall Study|Lost to Follow-up|0|||
23571569|NCT03990363|65821055|FG002|Overall Study|Lost to Follow-up|0|||
23164089|NCT03594227|64348729|FG000|Overall Study|Adverse Event|2|||
23164090|NCT03594227|64348730|FG001|Overall Study|Adverse Event|1|||
23164091|NCT03594227|64348731|FG002|Overall Study|Adverse Event|0|||
23571570|NCT03990363|65821056|FG003|Overall Study|Lost to Follow-up|1|||
23571571|NCT03990363|65821057|FG004|Overall Study|Lost to Follow-up|2|||
23571572|NCT03990363|65821053|FG000|Overall Study|Non-compliance with study drug|2|||
23571573|NCT03990363|65821054|FG001|Overall Study|Non-compliance with study drug|1|||
23571574|NCT03990363|65821055|FG002|Overall Study|Non-compliance with study drug|2|||
23571575|NCT03990363|65821056|FG003|Overall Study|Non-compliance with study drug|0|||
23571576|NCT03990363|65821057|FG004|Overall Study|Non-compliance with study drug|0|||
23164092|NCT03594227|64348732|FG003|Overall Study|Adverse Event|2|||
23164093|NCT03594227|64348729|FG000|Overall Study|Lost to Follow-up|1|||
23164094|NCT03594227|64348730|FG001|Overall Study|Lost to Follow-up|1|||
23164095|NCT03594227|64348731|FG002|Overall Study|Lost to Follow-up|1|||
23164096|NCT03594227|64348732|FG003|Overall Study|Lost to Follow-up|0|||
23164097|NCT03594227|64348729|FG000|Overall Study|Withdrawal by Subject|1|||
23164098|NCT03594227|64348730|FG001|Overall Study|Withdrawal by Subject|1|||
23164099|NCT03594227|64348731|FG002|Overall Study|Withdrawal by Subject|1|||
23164100|NCT03594227|64348732|FG003|Overall Study|Withdrawal by Subject|1|||
23164101|NCT03594227|64348729|FG000|Overall Study|Pregnancy|0|||
23164102|NCT03594227|64348730|FG001|Overall Study|Pregnancy|1|||
23164103|NCT03594227|64348731|FG002|Overall Study|Pregnancy|0|||
23164104|NCT03594227|64348732|FG003|Overall Study|Pregnancy|0|||
23164105|NCT03594227|64348729|FG000|Overall Study|Sponsor Decision|0|||
23164106|NCT03594227|64348730|FG001|Overall Study|Sponsor Decision|0|||
23164107|NCT03594227|64348731|FG002|Overall Study|Sponsor Decision|0|||
23164108|NCT03594227|64348732|FG003|Overall Study|Sponsor Decision|1|||
23224222|NCT00666536|64563997|FG000|Overall Study|Adverse Event|9|||
23224223|NCT00666536|64563998|FG001|Overall Study|Adverse Event|19|||
23224224|NCT00666536|64563997|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23224225|NCT00666536|64563998|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23224226|NCT00666536|64563997|FG000|Overall Study|Protocol deviation(s)|8|||
23224227|NCT00666536|64563998|FG001|Overall Study|Protocol deviation(s)|6|||
23224228|NCT00666536|64563997|FG000|Overall Study|Withdrawal by Subject|10|||
23224229|NCT00666536|64563998|FG001|Overall Study|Withdrawal by Subject|9|||
23224230|NCT00666536|64563997|FG000|Overall Study|Lost to Follow-up|4|||
23224231|NCT00666536|64563998|FG001|Overall Study|Lost to Follow-up|3|||
23224232|NCT03860844|64563999|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
23224233|NCT03860844|64564000|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
23224234|NCT03860844|64564001|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
23224235|NCT03860844|64563999|FG000|Overall Study|Progressive disease|5|||
23224236|NCT03860844|64564000|FG001|Overall Study|Progressive disease|3|||
23224237|NCT03860844|64564001|FG002|Overall Study|Progressive disease|4|||
23224238|NCT03860844|64563999|FG000|Overall Study|Other, Not related to COVID-19|0|||
23224239|NCT03860844|64564000|FG001|Overall Study|Other, Not related to COVID-19|1|||
23224240|NCT03860844|64564001|FG002|Overall Study|Other, Not related to COVID-19|0|||
23224241|NCT01462045|64564003|FG000|Overall Study|Family matter|0|||
23224242|NCT01462045|64564004|FG001|Overall Study|Family matter|1|||
23332016|NCT01295827|64958978|FG001|Overall Study|Lost to Follow-up|0|||
23571577|NCT03990363|65821053|FG000|Overall Study|Study terminated by sponsor|0|||
23571578|NCT03990363|65821054|FG001|Overall Study|Study terminated by sponsor|1|||
23571579|NCT03990363|65821055|FG002|Overall Study|Study terminated by sponsor|0|||
23571580|NCT03990363|65821056|FG003|Overall Study|Study terminated by sponsor|0|||
23571581|NCT03990363|65821057|FG004|Overall Study|Study terminated by sponsor|0|||
23571582|NCT03990363|65821053|FG000|Overall Study|Site terminated by sponsor|2|||
23571583|NCT03990363|65821054|FG001|Overall Study|Site terminated by sponsor|1|||
23571584|NCT03990363|65821055|FG002|Overall Study|Site terminated by sponsor|2|||
23571585|NCT03990363|65821056|FG003|Overall Study|Site terminated by sponsor|0|||
23571586|NCT03990363|65821057|FG004|Overall Study|Site terminated by sponsor|2|||
23571587|NCT03990363|65821053|FG000|Overall Study|Not categorized|5|||
23571588|NCT03990363|65821054|FG001|Overall Study|Not categorized|5|||
23571589|NCT03990363|65821055|FG002|Overall Study|Not categorized|3|||
23571590|NCT03990363|65821056|FG003|Overall Study|Not categorized|2|||
23571591|NCT03990363|65821057|FG004|Overall Study|Not categorized|2|||
23571592|NCT00287469|65821060|FG000|Overall Study|serious adverse event|1|||
23164109|NCT03594227|64348729|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
23164110|NCT03594227|64348730|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
23164111|NCT03594227|64348731|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
23164112|NCT03594227|64348732|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
23224243|NCT01462045|64564005|FG002|Overall Study|Family matter|0|||
23224244|NCT02736929|64564006|FG000|Main Study|Lost to Follow-up|7|||
23224245|NCT02736929|64564007|FG001|Main Study|Lost to Follow-up|1|||
23224246|NCT02736929|64564008|FG002|Main Study|Lost to Follow-up|0|||
23571593|NCT00287469|65821061|FG001|Overall Study|serious adverse event|6|||
23571594|NCT00287469|65821060|FG000|Overall Study|Adverse Event|1|||
23571595|NCT00287469|65821061|FG001|Overall Study|Adverse Event|1|||
23571596|NCT00287469|65821060|FG000|Overall Study|moved from area|144|||
23571597|NCT00287469|65821061|FG001|Overall Study|moved from area|138|||
23164113|NCT00677014|64348733|FG000|Overall Study|Lost to Follow-up|20|||
23224247|NCT02736929|64564006|FG000|Main Study|Withdrawal by Subject|1|||
23224248|NCT02736929|64564007|FG001|Main Study|Withdrawal by Subject|1|||
23224249|NCT02736929|64564008|FG002|Main Study|Withdrawal by Subject|0|||
23224250|NCT02736929|64564006|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
23224251|NCT02736929|64564007|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
23224252|NCT02736929|64564008|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
23224253|NCT03442595|64564011|FG000|Overall Study|Lost to Follow-up|94|||
23224254|NCT03442595|64564012|FG001|Overall Study|Lost to Follow-up|0|||
23224255|NCT00729560|64564013|FG000|Overall Study|Withdrawal by Subject|3|||
23224256|NCT01237223|64564018|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
23224257|NCT01237223|64564019|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23224258|NCT01237223|64564020|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23224259|NCT01237223|64564021|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23224260|NCT01237223|64564022|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23224261|NCT01237223|64564023|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
23332017|NCT01295827|64958979|FG002|Overall Study|Lost to Follow-up|3|||
23332018|NCT01295827|64958980|FG003|Overall Study|Lost to Follow-up|0|||
23332019|NCT01295827|64958981|FG004|Overall Study|Lost to Follow-up|1|||
23164114|NCT00677014|64348734|FG001|Overall Study|Lost to Follow-up|12|||
23164115|NCT00677014|64348735|FG002|Overall Study|Lost to Follow-up|24|||
23164116|NCT00677014|64348733|FG000|Overall Study|Death|6|||
23164117|NCT00677014|64348734|FG001|Overall Study|Death|15|||
23164118|NCT00677014|64348735|FG002|Overall Study|Death|7|||
23332020|NCT01295827|64958982|FG005|Overall Study|Lost to Follow-up|0|||
23332021|NCT01295827|64958983|FG006|Overall Study|Lost to Follow-up|4|||
23332022|NCT01295827|64958984|FG007|Overall Study|Lost to Follow-up|8|||
23332023|NCT01295827|64958985|FG008|Overall Study|Lost to Follow-up|7|||
23332024|NCT01295827|64958986|FG009|Overall Study|Lost to Follow-up|4|||
23332025|NCT01295827|64958987|FG010|Overall Study|Lost to Follow-up|7|||
23332026|NCT01295827|64958988|FG011|Overall Study|Lost to Follow-up|3|||
23332027|NCT01295827|64958989|FG012|Overall Study|Lost to Follow-up|0|||
23332028|NCT01295827|64958990|FG013|Overall Study|Lost to Follow-up|0|||
23332029|NCT01295827|64958991|FG014|Overall Study|Lost to Follow-up|0|||
23332030|NCT01295827|64958977|FG000|Overall Study|Not Reported|0|||
23332031|NCT01295827|64958978|FG001|Overall Study|Not Reported|0|||
23332032|NCT01295827|64958979|FG002|Overall Study|Not Reported|0|||
23332033|NCT01295827|64958980|FG003|Overall Study|Not Reported|1|||
23332034|NCT01295827|64958981|FG004|Overall Study|Not Reported|0|||
23332035|NCT01295827|64958982|FG005|Overall Study|Not Reported|0|||
23332036|NCT01295827|64958983|FG006|Overall Study|Not Reported|24|||
23332037|NCT01295827|64958984|FG007|Overall Study|Not Reported|58|||
23332038|NCT01295827|64958985|FG008|Overall Study|Not Reported|41|||
23332039|NCT01295827|64958986|FG009|Overall Study|Not Reported|2|||
23332040|NCT01295827|64958987|FG010|Overall Study|Not Reported|23|||
23332041|NCT01295827|64958988|FG011|Overall Study|Not Reported|13|||
23332042|NCT01295827|64958989|FG012|Overall Study|Not Reported|0|||
23332043|NCT01295827|64958990|FG013|Overall Study|Not Reported|0|||
23332044|NCT01295827|64958991|FG014|Overall Study|Not Reported|0|||
23332045|NCT01295827|64958977|FG000|Overall Study|Progressive Disease|2|||
23332046|NCT01295827|64958978|FG001|Overall Study|Progressive Disease|1|||
23332047|NCT01295827|64958979|FG002|Overall Study|Progressive Disease|5|||
23332048|NCT01295827|64958980|FG003|Overall Study|Progressive Disease|2|||
23332049|NCT01295827|64958981|FG004|Overall Study|Progressive Disease|0|||
23332050|NCT01295827|64958982|FG005|Overall Study|Progressive Disease|1|||
23332051|NCT01295827|64958983|FG006|Overall Study|Progressive Disease|87|||
23332052|NCT01295827|64958984|FG007|Overall Study|Progressive Disease|144|||
23332053|NCT01295827|64958985|FG008|Overall Study|Progressive Disease|85|||
23332054|NCT01295827|64958986|FG009|Overall Study|Progressive Disease|40|||
23332055|NCT01295827|64958987|FG010|Overall Study|Progressive Disease|175|||
23164119|NCT00677014|64348733|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
23164120|NCT00677014|64348734|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
23164121|NCT00677014|64348735|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
23224262|NCT01237223|64564018|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
23224263|NCT01237223|64564019|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23332056|NCT01295827|64958988|FG011|Overall Study|Progressive Disease|136|||
23332057|NCT01295827|64958989|FG012|Overall Study|Progressive Disease|0|||
23332058|NCT01295827|64958990|FG013|Overall Study|Progressive Disease|0|||
23332059|NCT01295827|64958991|FG014|Overall Study|Progressive Disease|0|||
23332060|NCT01295827|64958977|FG000|Overall Study|Screen Failure|0|||
23224264|NCT01237223|64564020|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23224265|NCT01237223|64564021|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23332061|NCT01295827|64958978|FG001|Overall Study|Screen Failure|0|||
23447138|NCT00502671|65377880|FG000|Overall Study|Personal Reasons|22|||
23164122|NCT00250835|64348742|FG000|Overall Study|Withdrawal by Subject|1|||
23224266|NCT01237223|64564022|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23332062|NCT01295827|64958979|FG002|Overall Study|Screen Failure|0|||
23332063|NCT01295827|64958980|FG003|Overall Study|Screen Failure|0|||
23164123|NCT00109707|64348745|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
23164124|NCT00109707|64348746|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
23164125|NCT00109707|64348747|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
23164126|NCT00109707|64348745|FG000|Overall Study|Abnormal laboratory values|1|||
23164127|NCT00109707|64348746|FG001|Overall Study|Abnormal laboratory values|0|||
23164128|NCT00109707|64348747|FG002|Overall Study|Abnormal laboratory values|0|||
23164129|NCT00109707|64348745|FG000|Overall Study|Administrative problems|2|||
23164130|NCT00109707|64348746|FG001|Overall Study|Administrative problems|0|||
23164131|NCT00109707|64348747|FG002|Overall Study|Administrative problems|1|||
23164132|NCT00109707|64348745|FG000|Overall Study|Adverse Event|10|||
23164133|NCT00109707|64348746|FG001|Overall Study|Adverse Event|2|||
23224267|NCT01237223|64564023|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
23224268|NCT01237223|64564018|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
23224269|NCT01237223|64564019|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23224270|NCT01237223|64564020|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23224271|NCT01237223|64564021|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23224272|NCT01237223|64564022|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23164134|NCT00109707|64348747|FG002|Overall Study|Adverse Event|3|||
23164135|NCT00109707|64348745|FG000|Overall Study|Death|4|||
23164136|NCT00109707|64348746|FG001|Overall Study|Death|0|||
23164137|NCT00109707|64348747|FG002|Overall Study|Death|0|||
23164138|NCT00109707|64348745|FG000|Overall Study|Disease progression|12|||
23224273|NCT01237223|64564023|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
23224274|NCT01237223|64564018|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
23224275|NCT01237223|64564019|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23164139|NCT00109707|64348746|FG001|Overall Study|Disease progression|4|||
23164140|NCT00109707|64348747|FG002|Overall Study|Disease progression|3|||
23164141|NCT00109707|64348745|FG000|Overall Study|Lost to Follow-up|3|||
23164142|NCT00109707|64348746|FG001|Overall Study|Lost to Follow-up|0|||
23164143|NCT00109707|64348747|FG002|Overall Study|Lost to Follow-up|0|||
23164144|NCT00109707|64348745|FG000|Overall Study|Protocol Violation|1|||
23164145|NCT00109707|64348746|FG001|Overall Study|Protocol Violation|0|||
23164146|NCT00109707|64348747|FG002|Overall Study|Protocol Violation|0|||
23164147|NCT00109707|64348745|FG000|Overall Study|Patient withdrew consent|6|||
23164148|NCT00109707|64348746|FG001|Overall Study|Patient withdrew consent|1|||
23571598|NCT00287469|65821060|FG000|Overall Study|Lost to Follow-up|74|||
23571599|NCT00287469|65821061|FG001|Overall Study|Lost to Follow-up|69|||
23571600|NCT01388530|65821062|FG000|Overall Study|Lost to Follow-up|5|||
23571601|NCT01077362|65821064|FG000|Overall Study|Lack of Efficacy|13|||
23571602|NCT01077362|65821065|FG001|Overall Study|Lack of Efficacy|8|||
23571603|NCT01077362|65821066|FG002|Overall Study|Lack of Efficacy|10|||
23571604|NCT01077362|65821064|FG000|Overall Study|Lost to Follow-up|1|||
23571605|NCT01077362|65821065|FG001|Overall Study|Lost to Follow-up|0|||
23571606|NCT01077362|65821066|FG002|Overall Study|Lost to Follow-up|3|||
23571607|NCT01077362|65821064|FG000|Overall Study|Adverse Event|12|||
23571608|NCT01077362|65821065|FG001|Overall Study|Adverse Event|7|||
23571609|NCT01077362|65821066|FG002|Overall Study|Adverse Event|4|||
23571610|NCT01077362|65821064|FG000|Overall Study|Withdrawal by Subject|5|||
23571611|NCT01077362|65821065|FG001|Overall Study|Withdrawal by Subject|3|||
23164149|NCT00109707|64348747|FG002|Overall Study|Patient withdrew consent|0|||
23164150|NCT00464334|64348756|FG000|Overall Study|Adverse Event|0|||
23164151|NCT00464334|64348757|FG001|Overall Study|Adverse Event|0|||
23164152|NCT00464334|64348758|FG002|Overall Study|Adverse Event|0|||
23224276|NCT01237223|64564020|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23224277|NCT01237223|64564021|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23224278|NCT01237223|64564022|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23224279|NCT01237223|64564023|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
23224280|NCT01237223|64564018|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
23224281|NCT01237223|64564019|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23224282|NCT01237223|64564020|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23224283|NCT01237223|64564021|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23224284|NCT01237223|64564022|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23224285|NCT01237223|64564023|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
23224286|NCT01237223|64564018|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
23224287|NCT01237223|64564019|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
23224288|NCT01237223|64564020|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
23224289|NCT01237223|64564021|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
23224290|NCT01237223|64564022|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
23224291|NCT01237223|64564023|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
23224292|NCT01237223|64564018|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
23224293|NCT01237223|64564019|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
23224294|NCT01237223|64564020|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
23224295|NCT01237223|64564021|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
23224296|NCT01237223|64564022|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
23224297|NCT01237223|64564023|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
23224298|NCT01237223|64564018|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
23224299|NCT01237223|64564019|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
23224300|NCT01237223|64564020|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
23224301|NCT01237223|64564021|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
23224302|NCT01237223|64564022|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
23224303|NCT01237223|64564023|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
23332064|NCT01295827|64958981|FG004|Overall Study|Screen Failure|0|||
23332065|NCT01295827|64958982|FG005|Overall Study|Screen Failure|0|||
23571612|NCT01077362|65821066|FG002|Overall Study|Withdrawal by Subject|5|||
23571613|NCT01077362|65821064|FG000|Overall Study|Other|0|||
23571614|NCT01077362|65821065|FG001|Overall Study|Other|1|||
23571615|NCT01077362|65821066|FG002|Overall Study|Other|2|||
23224304|NCT01237223|64564018|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23224305|NCT01237223|64564019|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23224306|NCT01237223|64564020|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23224307|NCT01237223|64564021|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23224308|NCT01237223|64564022|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
23224309|NCT01237223|64564023|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
23224310|NCT01237223|64564018|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
23224311|NCT01237223|64564019|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
23224312|NCT01237223|64564020|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
23224313|NCT01237223|64564021|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
23224314|NCT01237223|64564022|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
23224315|NCT01237223|64564023|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
23224316|NCT00809614|64564028|FG000|Overall Study|Lack of Efficacy|2|||
23224317|NCT00809614|64564029|FG001|Overall Study|Lack of Efficacy|3|||
23224318|NCT00809614|64564028|FG000|Overall Study|Withdrawal by Subject|1|||
23224319|NCT00809614|64564029|FG001|Overall Study|Withdrawal by Subject|1|||
23224320|NCT01685372|64564030|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
23224321|NCT01685372|64564031|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
23224322|NCT02614261|64564032|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
23224323|NCT02614261|64564033|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
23224324|NCT02614261|64564034|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
23224325|NCT02614261|64564035|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23224326|NCT02614261|64564032|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
23224327|NCT02614261|64564033|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23224328|NCT02614261|64564034|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23224329|NCT02614261|64564035|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23224330|NCT02614261|64564032|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
23571616|NCT01208415|65821067|FG000|Overall Study|Death|1|||
23571617|NCT01208415|65821067|FG000|Overall Study|Lost to Follow-up|2|||
23571618|NCT01208415|65821067|FG000|Overall Study|Withdrawal by Subject|3|||
23571619|NCT01208415|65821067|FG000|Overall Study|Device not placed|1|||
23571620|NCT01208415|65821067|FG000|Overall Study|Still be eligible for follow-up|33|||
23571621|NCT04362137|65821068|FG000|Overall Study|Death|9|||
23571622|NCT04362137|65821069|FG001|Overall Study|Death|3|||
23571623|NCT04362137|65821068|FG000|Overall Study|Patient decision|6|||
23571624|NCT04362137|65821069|FG001|Overall Study|Patient decision|3|||
23571625|NCT04362137|65821068|FG000|Overall Study|Adverse Event|1|||
23571626|NCT04362137|65821069|FG001|Overall Study|Adverse Event|0|||
23571627|NCT04362137|65821068|FG000|Overall Study|Lost to Follow-up|1|||
23571628|NCT04362137|65821069|FG001|Overall Study|Lost to Follow-up|0|||
23571629|NCT04362137|65821068|FG000|Overall Study|Protocol deviation|1|||
23224331|NCT02614261|64564033|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
23224332|NCT02614261|64564034|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23224333|NCT02614261|64564035|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23224334|NCT02614261|64564032|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
23224335|NCT02614261|64564033|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
23224336|NCT02614261|64564034|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
23224337|NCT02614261|64564035|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
23224338|NCT02614261|64564032|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
23224339|NCT02614261|64564033|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
23224340|NCT02614261|64564034|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
23224341|NCT02614261|64564035|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
23571630|NCT04362137|65821069|FG001|Overall Study|Protocol deviation|0|||
23571631|NCT01927731|65821074|FG000|Overall Study|Graft Failure|1|||
23571632|NCT01927731|65821075|FG001|Overall Study|Graft Failure|2|||
23571633|NCT01927731|65821074|FG000|Overall Study|Physician Decision|2|||
23224342|NCT02614261|64564032|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
23224343|NCT02614261|64564033|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
23224344|NCT02614261|64564034|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
23224345|NCT02614261|64564035|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
23224346|NCT02614261|64564032|FG000|Double-Blind Treatment Phase|Screen failure|0|||
23332066|NCT01295827|64958983|FG006|Overall Study|Screen Failure|2|||
23164153|NCT00464334|64348759|FG003|Overall Study|Adverse Event|1|||
23164154|NCT00464334|64348760|FG004|Overall Study|Adverse Event|1|||
23164155|NCT00464334|64348761|FG005|Overall Study|Adverse Event|1|||
23164156|NCT00464334|64348762|FG006|Overall Study|Adverse Event|0|||
23164157|NCT00464334|64348763|FG007|Overall Study|Adverse Event|0|||
23164158|NCT00464334|64348764|FG008|Overall Study|Adverse Event|2|||
23164159|NCT00464334|64348765|FG009|Overall Study|Adverse Event|1|||
23164160|NCT00464334|64348766|FG010|Overall Study|Adverse Event|2|||
23164161|NCT00464334|64348756|FG000|Overall Study|Lack of Efficacy|0|||
23164162|NCT00464334|64348757|FG001|Overall Study|Lack of Efficacy|1|||
23164163|NCT00464334|64348758|FG002|Overall Study|Lack of Efficacy|0|||
23164164|NCT00464334|64348759|FG003|Overall Study|Lack of Efficacy|0|||
23164165|NCT00464334|64348760|FG004|Overall Study|Lack of Efficacy|0|||
23164166|NCT00464334|64348761|FG005|Overall Study|Lack of Efficacy|0|||
23571634|NCT01927731|65821075|FG001|Overall Study|Physician Decision|3|||
23571635|NCT01927731|65821074|FG000|Overall Study|Withdrawal by Subject|0|||
23571636|NCT01927731|65821075|FG001|Overall Study|Withdrawal by Subject|2|||
23571637|NCT01927731|65821074|FG000|Overall Study|Death|0|||
23571638|NCT01927731|65821075|FG001|Overall Study|Death|3|||
23571639|NCT02341456|65821076|FG000|Overall Study|Disease progression|2|||
23571640|NCT02341456|65821077|FG001|Overall Study|Disease progression|3|||
23571641|NCT02341456|65821078|FG002|Overall Study|Disease progression|1|||
23571642|NCT02341456|65821076|FG000|Overall Study|Death|1|||
23571643|NCT02341456|65821077|FG001|Overall Study|Death|1|||
23571644|NCT02341456|65821078|FG002|Overall Study|Death|1|||
23571645|NCT02341456|65821076|FG000|Overall Study|Withdrawal by Subject|0|||
23571646|NCT02341456|65821077|FG001|Overall Study|Withdrawal by Subject|1|||
23571647|NCT02341456|65821078|FG002|Overall Study|Withdrawal by Subject|1|||
23571648|NCT02341456|65821076|FG000|Overall Study|Moved to local access programme.|0|||
23571649|NCT02341456|65821077|FG001|Overall Study|Moved to local access programme.|1|||
23571650|NCT02341456|65821078|FG002|Overall Study|Moved to local access programme.|1|||
23571651|NCT02341456|65821076|FG000|Overall Study|Physician Decision|1|||
23571652|NCT02341456|65821077|FG001|Overall Study|Physician Decision|0|||
23571653|NCT02341456|65821078|FG002|Overall Study|Physician Decision|0|||
23571654|NCT00570661|65821079|FG000|Overall Study|Disease worsening|5|||
23571655|NCT00570661|65821079|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
23571656|NCT00570661|65821079|FG000|Overall Study|Adverse Event|1|||
23571657|NCT01448044|65821080|FG000|Treatment Period|Adverse Event|4|||
23571658|NCT01448044|65821081|FG001|Treatment Period|Adverse Event|3|||
23571659|NCT01448044|65821080|FG000|Treatment Period|Lack of Efficacy|5|||
23571660|NCT01448044|65821081|FG001|Treatment Period|Lack of Efficacy|12|||
23571661|NCT01448044|65821080|FG000|Treatment Period|Subject requested discontinue study drug|1|||
23571662|NCT01448044|65821081|FG001|Treatment Period|Subject requested discontinue study drug|0|||
23571663|NCT01448044|65821080|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
23571664|NCT01448044|65821081|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
23571665|NCT01448044|65821080|FG000|Treatment Period|Participant does not meet study criteria|1|||
23571666|NCT01448044|65821081|FG001|Treatment Period|Participant does not meet study criteria|0|||
23571667|NCT01448044|65821080|FG000|Treatment Period|Lost to Follow-up|2|||
23571668|NCT01448044|65821081|FG001|Treatment Period|Lost to Follow-up|1|||
23571669|NCT01448044|65821080|FG000|Treatment Period|Other reason|2|||
23571670|NCT01448044|65821081|FG001|Treatment Period|Other reason|0|||
23571671|NCT01448044|65821080|FG000|Follow Up Period|Withdrawal by Subject|1|||
23571672|NCT01448044|65821081|FG001|Follow Up Period|Withdrawal by Subject|1|||
23571673|NCT01448044|65821080|FG000|Follow Up Period|Lost to Follow-up|6|||
23571674|NCT01448044|65821081|FG001|Follow Up Period|Lost to Follow-up|2|||
23571675|NCT01448044|65821080|FG000|Follow Up Period|Other|5|||
23571676|NCT01448044|65821081|FG001|Follow Up Period|Other|11|||
23164167|NCT00464334|64348762|FG006|Overall Study|Lack of Efficacy|0|||
23164168|NCT00464334|64348763|FG007|Overall Study|Lack of Efficacy|0|||
23164169|NCT00464334|64348764|FG008|Overall Study|Lack of Efficacy|0|||
23164170|NCT00464334|64348765|FG009|Overall Study|Lack of Efficacy|0|||
23164171|NCT00464334|64348766|FG010|Overall Study|Lack of Efficacy|0|||
23164172|NCT00464334|64348756|FG000|Overall Study|Lost to Follow-up|0|||
23164173|NCT00464334|64348757|FG001|Overall Study|Lost to Follow-up|0|||
23164174|NCT00464334|64348758|FG002|Overall Study|Lost to Follow-up|1|||
23164175|NCT00464334|64348759|FG003|Overall Study|Lost to Follow-up|0|||
23164176|NCT00464334|64348760|FG004|Overall Study|Lost to Follow-up|1|||
23164177|NCT00464334|64348761|FG005|Overall Study|Lost to Follow-up|0|||
23164178|NCT00464334|64348762|FG006|Overall Study|Lost to Follow-up|1|||
23224347|NCT02614261|64564033|FG001|Double-Blind Treatment Phase|Screen failure|1|||
23224348|NCT02614261|64564034|FG002|Double-Blind Treatment Phase|Screen failure|2|||
23571677|NCT01990300|65821082|FG000|Overall Study|Case Report Forms Uncollected|89|||
23571678|NCT01990300|65821082|FG000|Overall Study|Protocol Deviation|53|||
23571679|NCT01234649|65821086|FG000|Overall Study|Withdrawal by Subject|32|||
23571680|NCT01234649|65821087|FG001|Overall Study|Withdrawal by Subject|26|||
23571681|NCT01234649|65821086|FG000|Overall Study|Pregnancy|6|||
23164179|NCT00464334|64348763|FG007|Overall Study|Lost to Follow-up|0|||
23164180|NCT00464334|64348764|FG008|Overall Study|Lost to Follow-up|0|||
23164181|NCT00464334|64348765|FG009|Overall Study|Lost to Follow-up|0|||
23224349|NCT02614261|64564035|FG003|Double-Blind Treatment Phase|Screen failure|0|||
23224350|NCT02614261|64564032|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
23224351|NCT02614261|64564033|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
23224352|NCT02614261|64564034|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
23224353|NCT02614261|64564035|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23224354|NCT02614261|64564032|FG000|Open-Label Extension Phase|Adverse Event|23|||
23224355|NCT02614261|64564033|FG001|Open-Label Extension Phase|Adverse Event|12|||
23224356|NCT02614261|64564034|FG002|Open-Label Extension Phase|Adverse Event|11|||
23224357|NCT02614261|64564035|FG003|Open-Label Extension Phase|Adverse Event|0|||
23224358|NCT02614261|64564032|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
23224359|NCT02614261|64564033|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
23224360|NCT02614261|64564034|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
23224361|NCT02614261|64564035|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
23164182|NCT00464334|64348766|FG010|Overall Study|Lost to Follow-up|2|||
23164183|NCT00464334|64348756|FG000|Overall Study|Progressive Disease|0|||
23164184|NCT00464334|64348757|FG001|Overall Study|Progressive Disease|0|||
23164185|NCT00464334|64348758|FG002|Overall Study|Progressive Disease|0|||
23164186|NCT00464334|64348759|FG003|Overall Study|Progressive Disease|0|||
23164187|NCT00464334|64348760|FG004|Overall Study|Progressive Disease|0|||
23164188|NCT00464334|64348761|FG005|Overall Study|Progressive Disease|1|||
23164189|NCT00464334|64348762|FG006|Overall Study|Progressive Disease|0|||
23164190|NCT00464334|64348763|FG007|Overall Study|Progressive Disease|0|||
23164191|NCT00464334|64348764|FG008|Overall Study|Progressive Disease|1|||
23164192|NCT00464334|64348765|FG009|Overall Study|Progressive Disease|0|||
23164193|NCT00464334|64348766|FG010|Overall Study|Progressive Disease|0|||
23164194|NCT00464334|64348756|FG000|Overall Study|Study Terminated by Sponsor|0|||
23164195|NCT00464334|64348757|FG001|Overall Study|Study Terminated by Sponsor|0|||
23164196|NCT00464334|64348758|FG002|Overall Study|Study Terminated by Sponsor|0|||
23164197|NCT00464334|64348759|FG003|Overall Study|Study Terminated by Sponsor|1|||
23164198|NCT00464334|64348760|FG004|Overall Study|Study Terminated by Sponsor|0|||
23164199|NCT00464334|64348761|FG005|Overall Study|Study Terminated by Sponsor|0|||
23164200|NCT00464334|64348762|FG006|Overall Study|Study Terminated by Sponsor|0|||
23164201|NCT00464334|64348763|FG007|Overall Study|Study Terminated by Sponsor|0|||
23164202|NCT00464334|64348764|FG008|Overall Study|Study Terminated by Sponsor|0|||
23164203|NCT00464334|64348765|FG009|Overall Study|Study Terminated by Sponsor|0|||
23224362|NCT02614261|64564032|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
23224363|NCT02614261|64564033|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
23224364|NCT02614261|64564034|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
23224365|NCT02614261|64564035|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
23224366|NCT02614261|64564032|FG000|Open-Label Extension Phase|Physician Decision|2|||
23224367|NCT02614261|64564033|FG001|Open-Label Extension Phase|Physician Decision|0|||
23224368|NCT02614261|64564034|FG002|Open-Label Extension Phase|Physician Decision|0|||
23224369|NCT02614261|64564035|FG003|Open-Label Extension Phase|Physician Decision|0|||
23224370|NCT02614261|64564032|FG000|Open-Label Extension Phase|Pregnancy|1|||
23164204|NCT00464334|64348766|FG010|Overall Study|Study Terminated by Sponsor|0|||
23164205|NCT00464334|64348756|FG000|Overall Study|Withdrawal by Subject|1|||
23164206|NCT00464334|64348757|FG001|Overall Study|Withdrawal by Subject|7|||
23164207|NCT00464334|64348758|FG002|Overall Study|Withdrawal by Subject|4|||
23224371|NCT02614261|64564033|FG001|Open-Label Extension Phase|Pregnancy|2|||
23224372|NCT02614261|64564034|FG002|Open-Label Extension Phase|Pregnancy|1|||
23224373|NCT02614261|64564035|FG003|Open-Label Extension Phase|Pregnancy|0|||
23224374|NCT02614261|64564032|FG000|Open-Label Extension Phase|Protocol Violation|3|||
23224375|NCT02614261|64564033|FG001|Open-Label Extension Phase|Protocol Violation|4|||
23224376|NCT02614261|64564034|FG002|Open-Label Extension Phase|Protocol Violation|1|||
23224377|NCT02614261|64564035|FG003|Open-Label Extension Phase|Protocol Violation|0|||
23164208|NCT00464334|64348759|FG003|Overall Study|Withdrawal by Subject|2|||
23164209|NCT00464334|64348760|FG004|Overall Study|Withdrawal by Subject|2|||
23224378|NCT02614261|64564032|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
23164210|NCT00464334|64348761|FG005|Overall Study|Withdrawal by Subject|2|||
23224379|NCT02614261|64564033|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
23224380|NCT02614261|64564034|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
23224381|NCT02614261|64564035|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
23224382|NCT02614261|64564032|FG000|Follow-up Phase|Adverse Event|2|||
23224383|NCT02614261|64564033|FG001|Follow-up Phase|Adverse Event|0|||
23224384|NCT02614261|64564034|FG002|Follow-up Phase|Adverse Event|1|||
23224385|NCT02614261|64564035|FG003|Follow-up Phase|Adverse Event|0|||
23224386|NCT02614261|64564032|FG000|Follow-up Phase|Lost to Follow-up|12|||
23224387|NCT02614261|64564033|FG001|Follow-up Phase|Lost to Follow-up|5|||
23224388|NCT02614261|64564034|FG002|Follow-up Phase|Lost to Follow-up|2|||
23224389|NCT02614261|64564035|FG003|Follow-up Phase|Lost to Follow-up|0|||
23224390|NCT02614261|64564032|FG000|Follow-up Phase|Physician Decision|5|||
23224391|NCT02614261|64564033|FG001|Follow-up Phase|Physician Decision|1|||
23224392|NCT02614261|64564034|FG002|Follow-up Phase|Physician Decision|0|||
23224393|NCT02614261|64564035|FG003|Follow-up Phase|Physician Decision|0|||
23224394|NCT02614261|64564032|FG000|Follow-up Phase|Pregnancy|0|||
23224395|NCT02614261|64564033|FG001|Follow-up Phase|Pregnancy|1|||
23224396|NCT02614261|64564034|FG002|Follow-up Phase|Pregnancy|0|||
23224397|NCT02614261|64564035|FG003|Follow-up Phase|Pregnancy|0|||
23224398|NCT02614261|64564032|FG000|Follow-up Phase|Protocol Violation|1|||
23224399|NCT02614261|64564033|FG001|Follow-up Phase|Protocol Violation|0|||
23224400|NCT02614261|64564034|FG002|Follow-up Phase|Protocol Violation|0|||
23224401|NCT02614261|64564035|FG003|Follow-up Phase|Protocol Violation|0|||
23224402|NCT02614261|64564032|FG000|Follow-up Phase|Withdrawal by Subject|12|||
23224403|NCT02614261|64564033|FG001|Follow-up Phase|Withdrawal by Subject|4|||
23224404|NCT02614261|64564034|FG002|Follow-up Phase|Withdrawal by Subject|11|||
23224405|NCT02614261|64564035|FG003|Follow-up Phase|Withdrawal by Subject|0|||
23224406|NCT02614261|64564032|FG000|Israel Addendum|Withdrawal by Subject|0|||
23224407|NCT02614261|64564033|FG001|Israel Addendum|Withdrawal by Subject|0|||
23224408|NCT02614261|64564034|FG002|Israel Addendum|Withdrawal by Subject|0|||
23224409|NCT02614261|64564035|FG003|Israel Addendum|Withdrawal by Subject|4|||
23224410|NCT02043509|64564038|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
23571682|NCT01234649|65821087|FG001|Overall Study|Pregnancy|6|||
23571683|NCT01234649|65821086|FG000|Overall Study|intolerant to side effects|4|||
23571684|NCT01234649|65821087|FG001|Overall Study|intolerant to side effects|3|||
23571685|NCT01234649|65821086|FG000|Overall Study|Allergic reaction|1|||
23571686|NCT01234649|65821087|FG001|Overall Study|Allergic reaction|0|||
23571687|NCT01234649|65821086|FG000|Overall Study|Lack of Efficacy|0|||
23571688|NCT01234649|65821087|FG001|Overall Study|Lack of Efficacy|3|||
23571689|NCT01586338|65821092|FG000|Overall Study|Adverse Event|3|||
23571690|NCT01586338|65821092|FG000|Overall Study|Lost to Follow-up|1|||
23224411|NCT02043509|64564039|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
23224412|NCT02043509|64564038|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
23224413|NCT02043509|64564039|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
23224414|NCT02043509|64564038|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
23224415|NCT02043509|64564039|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
23224416|NCT02043509|64564038|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
23224417|NCT02043509|64564039|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
23224418|NCT01899768|64564041|FG000|Part A|Adverse Event|2|||
23224419|NCT01899768|64564041|FG000|Part A|Withdrawal by Subject|1|||
23224420|NCT01899768|64564041|FG000|Part B|Adverse Event|1|||
23224421|NCT01899768|64564041|FG000|Part B|Withdrawal by Subject|1|||
23224422|NCT03285490|64564042|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
23224423|NCT03285490|64564043|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
23224424|NCT03285490|64564042|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
23224425|NCT03285490|64564043|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
23224426|NCT00859573|64564052|FG000|Overall Study|Withdrawal by Subject|4|||
23224427|NCT00859573|64564053|FG001|Overall Study|Withdrawal by Subject|1|||
23224428|NCT00859573|64564052|FG000|Overall Study|Physician Decision|1|||
23224429|NCT00859573|64564053|FG001|Overall Study|Physician Decision|1|||
23224430|NCT02177786|64564054|FG000|Overall Study|Withdrew Consent|2|||
23571691|NCT01586338|65821092|FG000|Overall Study|Withdrawal by participant|3|||
23571692|NCT01586338|65821092|FG000|Overall Study|Other|1|||
23571693|NCT02065570|65821093|FG000|Induction Study|Adverse Event|5|||
23224431|NCT02177786|64564055|FG001|Overall Study|Withdrew Consent|6|||
23224432|NCT02177786|64564056|FG002|Overall Study|Withdrew Consent|9|||
23224433|NCT02177786|64564057|FG003|Overall Study|Withdrew Consent|5|||
23224434|NCT02177786|64564054|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
23224435|NCT02177786|64564055|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
23224436|NCT02177786|64564056|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
23224437|NCT02177786|64564057|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
23224438|NCT02177786|64564054|FG000|Overall Study|Adverse Event|1|||
23224439|NCT02177786|64564055|FG001|Overall Study|Adverse Event|1|||
23224440|NCT02177786|64564056|FG002|Overall Study|Adverse Event|2|||
23224441|NCT02177786|64564057|FG003|Overall Study|Adverse Event|3|||
23447139|NCT00502671|65377880|FG000|Overall Study|Lost to Follow-up|7|||
23447140|NCT00502671|65377880|FG000|Overall Study|Protocol Violation|16|||
23447141|NCT00502671|65377880|FG000|Overall Study|Adverse Event|19|||
23447142|NCT00872599|65377881|FG000|Second Washout Period|Adverse Event|1|||
23447143|NCT00872599|65377882|FG001|Second Washout Period|Adverse Event|1|||
23447144|NCT03359174|65377883|FG000|Overall Study|Adverse Event|1|||
23447145|NCT00483405|65377886|FG000|Overall Study|Adverse Event|8|||
23447146|NCT00483405|65377886|FG000|Overall Study|Lack of Efficacy|14|||
23447147|NCT00483405|65377886|FG000|Overall Study|Death|3|||
23447148|NCT00483405|65377886|FG000|Overall Study|Withdrawal by Subject|2|||
23447149|NCT00483405|65377886|FG000|Overall Study|Other complicating disease|1|||
23447150|NCT01964963|65377887|FG000|Overall Study|Case Report Forms Uncollected|888|||
23447151|NCT01964963|65377887|FG000|Overall Study|Protocol Deviation|50|||
23447152|NCT01964963|65377887|FG000|Overall Study|Data Reliability was not Assured|5|||
23447153|NCT02756338|65377892|FG000|Overall Study|Withdrawn by Investigator|1|||
23447154|NCT02756338|65377892|FG000|Overall Study|Device Replaced with Pacemaker|4|||
23447155|NCT00596752|65377896|FG000|Overall Study|Other Reason|44|||
23571694|NCT02065570|65821094|FG001|Induction Study|Adverse Event|12|||
23571695|NCT02065570|65821095|FG002|Induction Study|Adverse Event|0|||
23571696|NCT02065570|65821096|FG003|Induction Study|Adverse Event|0|||
23571697|NCT02065570|65821093|FG000|Induction Study|Withdrawal by Subject|2|||
23571698|NCT02065570|65821094|FG001|Induction Study|Withdrawal by Subject|3|||
23571699|NCT02065570|65821095|FG002|Induction Study|Withdrawal by Subject|0|||
23571700|NCT02065570|65821096|FG003|Induction Study|Withdrawal by Subject|0|||
23571701|NCT02065570|65821093|FG000|Induction Study|Lost to Follow-up|1|||
23571702|NCT02065570|65821094|FG001|Induction Study|Lost to Follow-up|1|||
23571703|NCT02065570|65821095|FG002|Induction Study|Lost to Follow-up|0|||
23571704|NCT02065570|65821096|FG003|Induction Study|Lost to Follow-up|0|||
23571705|NCT02065570|65821093|FG000|Induction Study|Other, Not Specified|6|||
23571706|NCT02065570|65821094|FG001|Induction Study|Other, Not Specified|5|||
23571707|NCT02065570|65821095|FG002|Induction Study|Other, Not Specified|0|||
23447156|NCT00596752|65377897|FG001|Overall Study|Other Reason|49|||
23447157|NCT00596752|65377896|FG000|Overall Study|Adverse Event|34|||
23571708|NCT02065570|65821096|FG003|Induction Study|Other, Not Specified|0|||
23571709|NCT02065570|65821093|FG000|Maintenance Study|Adverse Event|0|||
23571710|NCT02065570|65821094|FG001|Maintenance Study|Adverse Event|0|||
23571711|NCT02065570|65821095|FG002|Maintenance Study|Adverse Event|8|||
23164211|NCT00464334|64348762|FG006|Overall Study|Withdrawal by Subject|2|||
23164212|NCT00464334|64348763|FG007|Overall Study|Withdrawal by Subject|1|||
23164213|NCT00464334|64348764|FG008|Overall Study|Withdrawal by Subject|3|||
23164214|NCT00464334|64348765|FG009|Overall Study|Withdrawal by Subject|0|||
23164215|NCT00464334|64348766|FG010|Overall Study|Withdrawal by Subject|0|||
23164216|NCT01239342|64348767|FG000|Overall Study|Adverse Event|1|||
23164217|NCT01239342|64348768|FG001|Overall Study|Adverse Event|0|||
23164218|NCT01239342|64348767|FG000|Overall Study|Withdrawal by Subject|1|||
23164219|NCT01239342|64348768|FG001|Overall Study|Withdrawal by Subject|5|||
23164220|NCT01239342|64348767|FG000|Overall Study|Reason Unknown|1|||
23164221|NCT01239342|64348768|FG001|Overall Study|Reason Unknown|1|||
23164222|NCT00885703|64348769|FG000|Overall Study|Death|9|||
23164223|NCT00885703|64348770|FG001|Overall Study|Death|7|||
23571712|NCT02065570|65821096|FG003|Maintenance Study|Adverse Event|8|||
23164224|NCT00885703|64348771|FG002|Overall Study|Death|8|||
23164225|NCT00885703|64348772|FG003|Overall Study|Death|7|||
23447158|NCT00596752|65377897|FG001|Overall Study|Adverse Event|34|||
23447159|NCT00596752|65377896|FG000|Overall Study|Lost to Follow-up|22|||
23447160|NCT00596752|65377897|FG001|Overall Study|Lost to Follow-up|38|||
23447161|NCT00596752|65377896|FG000|Overall Study|Withdrawal by Subject|12|||
23224442|NCT02177786|64564054|FG000|Overall Study|Death|1|||
23224443|NCT02177786|64564055|FG001|Overall Study|Death|1|||
23224444|NCT02177786|64564056|FG002|Overall Study|Death|1|||
23224445|NCT02177786|64564057|FG003|Overall Study|Death|1|||
23224446|NCT02177786|64564054|FG000|Overall Study|Lost to Follow-up|0|||
23224447|NCT02177786|64564055|FG001|Overall Study|Lost to Follow-up|0|||
23224448|NCT02177786|64564056|FG002|Overall Study|Lost to Follow-up|2|||
23224449|NCT02177786|64564057|FG003|Overall Study|Lost to Follow-up|2|||
23164226|NCT00885703|64348773|FG004|Overall Study|Death|7|||
23164227|NCT00885703|64348774|FG005|Overall Study|Death|8|||
23164228|NCT00885703|64348775|FG006|Overall Study|Death|4|||
23164229|NCT00885703|64348769|FG000|Overall Study|Lost to Follow-up|0|||
23164230|NCT00885703|64348770|FG001|Overall Study|Lost to Follow-up|0|||
23164231|NCT00885703|64348771|FG002|Overall Study|Lost to Follow-up|1|||
23164232|NCT00885703|64348772|FG003|Overall Study|Lost to Follow-up|0|||
23164233|NCT00885703|64348773|FG004|Overall Study|Lost to Follow-up|0|||
23164234|NCT00885703|64348774|FG005|Overall Study|Lost to Follow-up|1|||
23164235|NCT00885703|64348775|FG006|Overall Study|Lost to Follow-up|0|||
23164236|NCT00885703|64348769|FG000|Overall Study|Withdrawal by Subject|0|||
23224450|NCT02177786|64564054|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23224451|NCT02177786|64564055|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23224452|NCT02177786|64564056|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23224453|NCT02177786|64564057|FG003|Overall Study|Non-Compliance with Study Drug|1|||
23224454|NCT02177786|64564054|FG000|Overall Study|Protocol Violation|0|||
23224455|NCT02177786|64564055|FG001|Overall Study|Protocol Violation|0|||
23224456|NCT02177786|64564056|FG002|Overall Study|Protocol Violation|2|||
23224457|NCT02177786|64564057|FG003|Overall Study|Protocol Violation|0|||
23224458|NCT02177786|64564054|FG000|Overall Study|Progressive Disease|0|||
23224459|NCT02177786|64564055|FG001|Overall Study|Progressive Disease|1|||
23224460|NCT02177786|64564056|FG002|Overall Study|Progressive Disease|0|||
23224461|NCT02177786|64564057|FG003|Overall Study|Progressive Disease|0|||
23224462|NCT02177786|64564054|FG000|Overall Study|Missing study completion status|0|||
23224463|NCT02177786|64564055|FG001|Overall Study|Missing study completion status|1|||
23224464|NCT02177786|64564056|FG002|Overall Study|Missing study completion status|0|||
23224465|NCT02177786|64564057|FG003|Overall Study|Missing study completion status|0|||
23224466|NCT00063986|64564060|FG000|Overall Study|Withdrawal by Subject|1|||
23224467|NCT00063986|64564060|FG000|Overall Study|Ineligible|1|||
23224468|NCT00063986|64564060|FG000|Overall Study|Intra-operatively ineligible|4|||
23224469|NCT01012037|64564061|FG000|Overall Study|Adverse Event|0|||
23224470|NCT01012037|64564062|FG001|Overall Study|Adverse Event|8|||
23224471|NCT01012037|64564063|FG002|Overall Study|Adverse Event|3|||
23224472|NCT01012037|64564061|FG000|Overall Study|Protocol Violation|0|||
23224473|NCT01012037|64564062|FG001|Overall Study|Protocol Violation|3|||
23224474|NCT01012037|64564063|FG002|Overall Study|Protocol Violation|5|||
23224475|NCT01012037|64564061|FG000|Overall Study|Withdrawal by Subject|0|||
23224476|NCT01012037|64564062|FG001|Overall Study|Withdrawal by Subject|4|||
23224477|NCT01012037|64564063|FG002|Overall Study|Withdrawal by Subject|1|||
23224478|NCT01012037|64564061|FG000|Overall Study|Other reason (not specified)|1|||
23224479|NCT01012037|64564062|FG001|Overall Study|Other reason (not specified)|1|||
23224480|NCT01012037|64564063|FG002|Overall Study|Other reason (not specified)|1|||
23224481|NCT04539262|64564066|FG000|Overall Study|Adverse Event|0|||
23224482|NCT04539262|64564067|FG001|Overall Study|Adverse Event|0|||
23224483|NCT04539262|64564068|FG002|Overall Study|Adverse Event|1|||
23224484|NCT04539262|64564069|FG003|Overall Study|Adverse Event|0|||
23224485|NCT04539262|64564070|FG004|Overall Study|Adverse Event|0|||
23224486|NCT04539262|64564071|FG005|Overall Study|Adverse Event|0|||
23224487|NCT04539262|64564072|FG006|Overall Study|Adverse Event|0|||
23447162|NCT00596752|65377897|FG001|Overall Study|Withdrawal by Subject|9|||
23164237|NCT00885703|64348770|FG001|Overall Study|Withdrawal by Subject|0|||
23164238|NCT00885703|64348771|FG002|Overall Study|Withdrawal by Subject|0|||
23224488|NCT04539262|64564073|FG007|Overall Study|Adverse Event|0|||
23224489|NCT04539262|64564066|FG000|Overall Study|Withdrew Consent|0|||
23447163|NCT00596752|65377896|FG000|Overall Study|Unsatisfactory Compliance|9|||
23164239|NCT00885703|64348772|FG003|Overall Study|Withdrawal by Subject|1|||
23224490|NCT04539262|64564067|FG001|Overall Study|Withdrew Consent|0|||
23224491|NCT04539262|64564068|FG002|Overall Study|Withdrew Consent|0|||
23224492|NCT04539262|64564069|FG003|Overall Study|Withdrew Consent|1|||
23224493|NCT04539262|64564070|FG004|Overall Study|Withdrew Consent|0|||
23224494|NCT04539262|64564071|FG005|Overall Study|Withdrew Consent|0|||
23224495|NCT04539262|64564072|FG006|Overall Study|Withdrew Consent|0|||
23224496|NCT04539262|64564073|FG007|Overall Study|Withdrew Consent|0|||
23164240|NCT00885703|64348773|FG004|Overall Study|Withdrawal by Subject|3|||
23164241|NCT00885703|64348774|FG005|Overall Study|Withdrawal by Subject|1|||
23224497|NCT04539262|64564066|FG000|Overall Study|Randomized, Not treated|0|||
23224498|NCT04539262|64564067|FG001|Overall Study|Randomized, Not treated|1|||
23224499|NCT04539262|64564068|FG002|Overall Study|Randomized, Not treated|0|||
23224500|NCT04539262|64564069|FG003|Overall Study|Randomized, Not treated|0|||
23224501|NCT04539262|64564070|FG004|Overall Study|Randomized, Not treated|0|||
23224502|NCT04539262|64564071|FG005|Overall Study|Randomized, Not treated|0|||
23224503|NCT04539262|64564072|FG006|Overall Study|Randomized, Not treated|1|||
23224504|NCT04539262|64564073|FG007|Overall Study|Randomized, Not treated|0|||
23224505|NCT02332876|64564074|FG000|Overall Study|Lost to Follow-up|1|||
23224506|NCT02332876|64564075|FG001|Overall Study|Lost to Follow-up|1|||
23224507|NCT02809118|64564079|FG000|Overall Study|Withdrawal by Subject|0|||
23224508|NCT02809118|64564080|FG001|Overall Study|Withdrawal by Subject|1|||
23224509|NCT02809118|64564081|FG002|Overall Study|Withdrawal by Subject|1|||
23224510|NCT01347840|64564082|FG000|Overall Study|Withdrawal by Subject|1|||
23224511|NCT00464620|64564083|FG000|Overall Study|Physician Decision|1|||
23224512|NCT00464620|64564084|FG001|Overall Study|Physician Decision|0|||
23224513|NCT00464620|64564085|FG002|Overall Study|Physician Decision|0|||
23224514|NCT00464620|64564083|FG000|Overall Study|Withdrawal by Subject|1|||
23224515|NCT00464620|64564084|FG001|Overall Study|Withdrawal by Subject|0|||
23224516|NCT00464620|64564085|FG002|Overall Study|Withdrawal by Subject|3|||
23224517|NCT00464620|64564083|FG000|Overall Study|Ineligible sarcoma subtype|0|||
23224518|NCT00464620|64564084|FG001|Overall Study|Ineligible sarcoma subtype|2|||
23224519|NCT00464620|64564085|FG002|Overall Study|Ineligible sarcoma subtype|2|||
23224520|NCT00464620|64564083|FG000|Overall Study|Use of prohibited concomitant medication|0|||
23224521|NCT00464620|64564084|FG001|Overall Study|Use of prohibited concomitant medication|0|||
23224522|NCT00464620|64564085|FG002|Overall Study|Use of prohibited concomitant medication|2|||
23224523|NCT02728206|64564086|FG000|Overall Study|Death|1|||
23224524|NCT02774291|64564089|FG000|Overall Study|Lost to Follow-up|1|||
23224525|NCT03964493|64564091|FG000|Overall Study|Withdrawal by Subject|4|||
23224526|NCT03964493|64564092|FG001|Overall Study|Withdrawal by Subject|1|||
23224527|NCT03964493|64564091|FG000|Overall Study|Lost to Follow-up|13|||
23224528|NCT03964493|64564092|FG001|Overall Study|Lost to Follow-up|4|||
23224529|NCT01983683|64564093|FG000|Overall Study|Withdrawal by Subject|14|||
23224530|NCT01983683|64564094|FG001|Overall Study|Withdrawal by Subject|18|||
23224531|NCT01983683|64564093|FG000|Overall Study|Death|11|||
23224532|NCT01983683|64564094|FG001|Overall Study|Death|15|||
23224533|NCT01983683|64564093|FG000|Overall Study|Physician Decision|8|||
23224534|NCT01983683|64564094|FG001|Overall Study|Physician Decision|9|||
23224535|NCT01983683|64564093|FG000|Overall Study|Lost to Follow-up|4|||
23224536|NCT01983683|64564094|FG001|Overall Study|Lost to Follow-up|8|||
23224537|NCT01983683|64564093|FG000|Overall Study|Sponsor Decision|1|||
23224538|NCT01983683|64564094|FG001|Overall Study|Sponsor Decision|1|||
23224539|NCT01199198|64564095|FG000|Overall Study|Adverse Event|3|||
23224540|NCT01199198|64564096|FG001|Overall Study|Adverse Event|0|||
23224541|NCT01199198|64564095|FG000|Overall Study|Lost to Follow-up|1|||
23224542|NCT01199198|64564096|FG001|Overall Study|Lost to Follow-up|5|||
23224543|NCT01199198|64564095|FG000|Overall Study|Withdrawal by Subject|1|||
23224544|NCT01199198|64564096|FG001|Overall Study|Withdrawal by Subject|2|||
23224545|NCT01199198|64564095|FG000|Overall Study|ICU Transfer|1|||
23224546|NCT01199198|64564096|FG001|Overall Study|ICU Transfer|2|||
23224547|NCT01199198|64564095|FG000|Overall Study|Hospice-care transfer|1|||
23224548|NCT01199198|64564096|FG001|Overall Study|Hospice-care transfer|2|||
23224549|NCT03073200|64564097|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23224550|NCT03073200|64564098|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23224551|NCT03073200|64564099|FG002|Double Blind Treatment Period|Protocol Violation|0|||
23224552|NCT03073200|64564100|FG003|Double Blind Treatment Period|Protocol Violation|0|||
23224553|NCT03073200|64564101|FG004|Double Blind Treatment Period|Protocol Violation|0|||
23224554|NCT03073200|64564102|FG005|Double Blind Treatment Period|Protocol Violation|0|||
23224555|NCT03073200|64564103|FG006|Double Blind Treatment Period|Protocol Violation|0|||
23224556|NCT03073200|64564104|FG007|Double Blind Treatment Period|Protocol Violation|0|||
23224557|NCT03073200|64564105|FG008|Double Blind Treatment Period|Protocol Violation|0|||
23224558|NCT03073200|64564106|FG009|Double Blind Treatment Period|Protocol Violation|0|||
23224559|NCT03073200|64564107|FG010|Double Blind Treatment Period|Protocol Violation|0|||
23224560|NCT03073200|64564108|FG011|Double Blind Treatment Period|Protocol Violation|0|||
23224561|NCT03073200|64564109|FG012|Double Blind Treatment Period|Protocol Violation|0|||
23224562|NCT03073200|64564110|FG013|Double Blind Treatment Period|Protocol Violation|0|||
23224563|NCT03073200|64564111|FG014|Double Blind Treatment Period|Protocol Violation|0|||
23224564|NCT03073200|64564097|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224565|NCT03073200|64564098|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
23224566|NCT03073200|64564099|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224567|NCT03073200|64564100|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224568|NCT03073200|64564101|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224569|NCT03073200|64564102|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224570|NCT03073200|64564103|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224571|NCT03073200|64564104|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224572|NCT03073200|64564105|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224573|NCT03073200|64564106|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224574|NCT03073200|64564107|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224575|NCT03073200|64564108|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224576|NCT03073200|64564109|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224577|NCT03073200|64564110|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224578|NCT03073200|64564111|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
23224579|NCT03073200|64564097|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
23224580|NCT03073200|64564098|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
23332067|NCT01295827|64958984|FG007|Overall Study|Screen Failure|2|||
23332068|NCT01295827|64958985|FG008|Overall Study|Screen Failure|2|||
23332069|NCT01295827|64958986|FG009|Overall Study|Screen Failure|0|||
23332070|NCT01295827|64958987|FG010|Overall Study|Screen Failure|1|||
23332071|NCT01295827|64958988|FG011|Overall Study|Screen Failure|0|||
23332072|NCT01295827|64958989|FG012|Overall Study|Screen Failure|0|||
23332073|NCT01295827|64958990|FG013|Overall Study|Screen Failure|0|||
23332074|NCT01295827|64958991|FG014|Overall Study|Screen Failure|0|||
23332075|NCT01295827|64958977|FG000|Overall Study|Withdrawal by Subject|1|||
23332076|NCT01295827|64958978|FG001|Overall Study|Withdrawal by Subject|0|||
23332077|NCT01295827|64958979|FG002|Overall Study|Withdrawal by Subject|2|||
23332078|NCT01295827|64958980|FG003|Overall Study|Withdrawal by Subject|0|||
23332079|NCT01295827|64958981|FG004|Overall Study|Withdrawal by Subject|0|||
23332080|NCT01295827|64958982|FG005|Overall Study|Withdrawal by Subject|1|||
23332081|NCT01295827|64958983|FG006|Overall Study|Withdrawal by Subject|13|||
23332082|NCT01295827|64958984|FG007|Overall Study|Withdrawal by Subject|35|||
23332083|NCT01295827|64958985|FG008|Overall Study|Withdrawal by Subject|11|||
23224581|NCT03073200|64564099|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
23332084|NCT01295827|64958986|FG009|Overall Study|Withdrawal by Subject|2|||
23571713|NCT02065570|65821093|FG000|Maintenance Study|Withdrawal by Subject|0|||
23571714|NCT02065570|65821094|FG001|Maintenance Study|Withdrawal by Subject|0|||
23571715|NCT02065570|65821095|FG002|Maintenance Study|Withdrawal by Subject|1|||
23571716|NCT02065570|65821096|FG003|Maintenance Study|Withdrawal by Subject|4|||
23571717|NCT02065570|65821093|FG000|Maintenance Study|Lost to Follow-up|0|||
23571718|NCT02065570|65821094|FG001|Maintenance Study|Lost to Follow-up|0|||
23571719|NCT02065570|65821095|FG002|Maintenance Study|Lost to Follow-up|2|||
23571720|NCT02065570|65821096|FG003|Maintenance Study|Lost to Follow-up|2|||
23571721|NCT02065570|65821093|FG000|Maintenance Study|Other, Not Specified|0|||
23571722|NCT02065570|65821094|FG001|Maintenance Study|Other, Not Specified|0|||
23571723|NCT02065570|65821095|FG002|Maintenance Study|Other, Not Specified|11|||
23571724|NCT02065570|65821096|FG003|Maintenance Study|Other, Not Specified|5|||
23571725|NCT04445155|65821101|FG000|Overall Study|Lost to Follow-up|11|||
23571726|NCT04445155|65821102|FG001|Overall Study|Lost to Follow-up|2|||
23571727|NCT04445155|65821103|FG002|Overall Study|Lost to Follow-up|3|||
23571728|NCT04445155|65821104|FG003|Overall Study|Lost to Follow-up|0|||
23571729|NCT04445155|65821101|FG000|Overall Study|Withdrawal by Subject|8|||
23571730|NCT04445155|65821102|FG001|Overall Study|Withdrawal by Subject|0|||
23571731|NCT04445155|65821103|FG002|Overall Study|Withdrawal by Subject|0|||
23571732|NCT04445155|65821104|FG003|Overall Study|Withdrawal by Subject|0|||
23571733|NCT04445155|65821101|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
23571734|NCT04445155|65821102|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
23571735|NCT04445155|65821103|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
23571736|NCT04445155|65821104|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
23571737|NCT04445155|65821101|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
23571738|NCT04445155|65821102|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
23571739|NCT04445155|65821103|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
23571740|NCT04445155|65821104|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
23571741|NCT01513967|65824532|FG000|Overall Study|Pregnancy|0|||
23571742|NCT01513967|65824533|FG001|Overall Study|Pregnancy|0|||
23571743|NCT01513967|65824534|FG002|Overall Study|Pregnancy|0|||
23571744|NCT01513967|65824535|FG003|Overall Study|Pregnancy|0|||
23571745|NCT01513967|65824536|FG004|Overall Study|Pregnancy|0|||
23571746|NCT01513967|65824537|FG005|Overall Study|Pregnancy|0|||
23571747|NCT01513967|65824538|FG006|Overall Study|Pregnancy|1|||
23571748|NCT01513967|65824539|FG007|Overall Study|Pregnancy|0|||
23224582|NCT03073200|64564100|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224583|NCT03073200|64564101|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224584|NCT03073200|64564102|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
23332085|NCT01295827|64958987|FG010|Overall Study|Withdrawal by Subject|18|||
23332086|NCT01295827|64958988|FG011|Overall Study|Withdrawal by Subject|13|||
23571749|NCT01513967|65824532|FG000|Overall Study|missed a study visit|0|||
23332087|NCT01295827|64958989|FG012|Overall Study|Withdrawal by Subject|0|||
23332088|NCT01295827|64958990|FG013|Overall Study|Withdrawal by Subject|0|||
23224585|NCT03073200|64564103|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224586|NCT03073200|64564104|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224587|NCT03073200|64564105|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224588|NCT03073200|64564106|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224589|NCT03073200|64564107|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224590|NCT03073200|64564108|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224591|NCT03073200|64564109|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224592|NCT03073200|64564110|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224593|NCT03073200|64564111|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
23224594|NCT03073200|64564097|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224595|NCT03073200|64564098|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224596|NCT03073200|64564099|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224597|NCT03073200|64564100|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
23224598|NCT03073200|64564101|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
23224599|NCT03073200|64564102|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224600|NCT03073200|64564103|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224601|NCT03073200|64564104|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224602|NCT03073200|64564105|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224603|NCT03073200|64564106|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224604|NCT03073200|64564107|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224605|NCT03073200|64564108|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224606|NCT03073200|64564109|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224607|NCT03073200|64564110|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224608|NCT03073200|64564111|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
23224609|NCT03073200|64564097|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
23224610|NCT03073200|64564098|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
23224611|NCT03073200|64564099|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
23224612|NCT03073200|64564100|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
23224613|NCT03073200|64564101|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
23224614|NCT03073200|64564102|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
23224615|NCT03073200|64564103|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
23224616|NCT03073200|64564104|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
23224617|NCT03073200|64564105|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
23224618|NCT03073200|64564106|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
23224619|NCT03073200|64564107|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
23224620|NCT03073200|64564108|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
23224621|NCT03073200|64564109|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
23224622|NCT03073200|64564110|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
23224623|NCT03073200|64564111|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
23224624|NCT03073200|64564097|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224625|NCT03073200|64564098|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224626|NCT03073200|64564099|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224627|NCT03073200|64564100|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224628|NCT03073200|64564101|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
23224629|NCT03073200|64564102|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224630|NCT03073200|64564103|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224631|NCT03073200|64564104|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224632|NCT03073200|64564105|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224633|NCT03073200|64564106|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224634|NCT03073200|64564107|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
23571750|NCT01513967|65824533|FG001|Overall Study|missed a study visit|0|||
23571751|NCT01513967|65824534|FG002|Overall Study|missed a study visit|0|||
23571752|NCT01513967|65824535|FG003|Overall Study|missed a study visit|0|||
23571753|NCT01513967|65824536|FG004|Overall Study|missed a study visit|0|||
23571754|NCT01513967|65824537|FG005|Overall Study|missed a study visit|0|||
23571755|NCT01513967|65824538|FG006|Overall Study|missed a study visit|1|||
23571756|NCT01513967|65824539|FG007|Overall Study|missed a study visit|0|||
23571757|NCT01513967|65824532|FG000|Overall Study|excluded due to positive drug screen|0|||
23571758|NCT01513967|65824533|FG001|Overall Study|excluded due to positive drug screen|0|||
23571759|NCT01513967|65824534|FG002|Overall Study|excluded due to positive drug screen|0|||
23571760|NCT01513967|65824535|FG003|Overall Study|excluded due to positive drug screen|0|||
23571761|NCT01513967|65824536|FG004|Overall Study|excluded due to positive drug screen|0|||
23571762|NCT01513967|65824537|FG005|Overall Study|excluded due to positive drug screen|0|||
23571763|NCT01513967|65824538|FG006|Overall Study|excluded due to positive drug screen|0|||
23224635|NCT03073200|64564108|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224636|NCT03073200|64564109|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224637|NCT03073200|64564110|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224638|NCT03073200|64564111|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
23224639|NCT03073200|64564097|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224640|NCT03073200|64564098|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224641|NCT03073200|64564099|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224642|NCT03073200|64564100|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
23224643|NCT03073200|64564101|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
23224644|NCT03073200|64564102|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224645|NCT03073200|64564103|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224646|NCT03073200|64564104|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224647|NCT03073200|64564105|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224648|NCT03073200|64564106|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224649|NCT03073200|64564107|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224650|NCT03073200|64564108|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224651|NCT03073200|64564109|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224652|NCT03073200|64564110|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224653|NCT03073200|64564111|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
23224654|NCT03073200|64564097|FG000|Extension Period|Lost to Follow-up|0|||
23224655|NCT03073200|64564098|FG001|Extension Period|Lost to Follow-up|0|||
23224656|NCT03073200|64564099|FG002|Extension Period|Lost to Follow-up|0|||
23224657|NCT03073200|64564100|FG003|Extension Period|Lost to Follow-up|0|||
23224658|NCT03073200|64564101|FG004|Extension Period|Lost to Follow-up|0|||
23224659|NCT03073200|64564102|FG005|Extension Period|Lost to Follow-up|0|||
23224660|NCT03073200|64564103|FG006|Extension Period|Lost to Follow-up|1|||
23571764|NCT01513967|65824539|FG007|Overall Study|excluded due to positive drug screen|2|||
23571765|NCT01513967|65824532|FG000|Overall Study|Physician Decision|0|||
23571766|NCT01513967|65824533|FG001|Overall Study|Physician Decision|0|||
23571767|NCT01513967|65824534|FG002|Overall Study|Physician Decision|0|||
23571768|NCT01513967|65824535|FG003|Overall Study|Physician Decision|0|||
23571769|NCT01513967|65824536|FG004|Overall Study|Physician Decision|0|||
23571770|NCT01513967|65824537|FG005|Overall Study|Physician Decision|1|||
23571771|NCT01513967|65824538|FG006|Overall Study|Physician Decision|0|||
23571772|NCT01513967|65824539|FG007|Overall Study|Physician Decision|0|||
23571773|NCT03929913|65824542|FG000|Overall Study|Death|4|||
23571774|NCT03929913|65824542|FG000|Overall Study|Lost to Follow-up|1|||
23571775|NCT03929913|65824542|FG000|Overall Study|Failed Procedure|2|||
23571776|NCT02771210|65824543|FG000|Period 1|Adverse Event|5|||
23571777|NCT02771210|65824544|FG001|Period 1|Adverse Event|3|||
23571778|NCT02771210|65824543|FG000|Period 1|Lack of Efficacy|3|||
23571779|NCT02771210|65824544|FG001|Period 1|Lack of Efficacy|6|||
23164242|NCT00885703|64348775|FG006|Overall Study|Withdrawal by Subject|1|||
23164243|NCT00885703|64348769|FG000|Overall Study|Ineligible (no CM)|1|||
23164244|NCT00885703|64348770|FG001|Overall Study|Ineligible (no CM)|3|||
23164245|NCT00885703|64348771|FG002|Overall Study|Ineligible (no CM)|2|||
23571780|NCT02771210|65824543|FG000|Period 1|Lost to Follow-up|2|||
23164246|NCT00885703|64348772|FG003|Overall Study|Ineligible (no CM)|1|||
23164247|NCT00885703|64348773|FG004|Overall Study|Ineligible (no CM)|2|||
23164248|NCT00885703|64348774|FG005|Overall Study|Ineligible (no CM)|3|||
23164249|NCT00885703|64348775|FG006|Overall Study|Ineligible (no CM)|1|||
23164250|NCT02290873|64348776|FG000|Overall Study|Withdrawal by Subject|0|||
23164251|NCT02290873|64348777|FG001|Overall Study|Withdrawal by Subject|1|||
23164252|NCT02290873|64348778|FG002|Overall Study|Withdrawal by Subject|1|||
23164253|NCT02290873|64348776|FG000|Overall Study|Nellcor device error|1|||
23164254|NCT02290873|64348777|FG001|Overall Study|Nellcor device error|0|||
23164255|NCT02290873|64348778|FG002|Overall Study|Nellcor device error|0|||
23164256|NCT02290873|64348776|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
23224661|NCT03073200|64564104|FG007|Extension Period|Lost to Follow-up|1|||
23224662|NCT03073200|64564105|FG008|Extension Period|Lost to Follow-up|0|||
23224663|NCT03073200|64564106|FG009|Extension Period|Lost to Follow-up|0|||
23224664|NCT03073200|64564107|FG010|Extension Period|Lost to Follow-up|0|||
23571781|NCT02771210|65824544|FG001|Period 1|Lost to Follow-up|0|||
23571782|NCT02771210|65824543|FG000|Period 1|Physician Decision|0|||
23571783|NCT02771210|65824544|FG001|Period 1|Physician Decision|1|||
23571784|NCT02771210|65824543|FG000|Period 1|Withdrawal by Subject|0|||
23571785|NCT02771210|65824544|FG001|Period 1|Withdrawal by Subject|3|||
23571786|NCT02771210|65824543|FG000|Period 1|Withdrawal of informed consent|1|||
23571787|NCT02771210|65824544|FG001|Period 1|Withdrawal of informed consent|5|||
23571788|NCT02771210|65824543|FG000|Period 2|Adverse Event|1|||
23571789|NCT02771210|65824544|FG001|Period 2|Adverse Event|0|||
23571790|NCT02771210|65824543|FG000|Period 2|Lack of Efficacy|0|||
23571791|NCT02771210|65824544|FG001|Period 2|Lack of Efficacy|1|||
23571792|NCT02771210|65824543|FG000|Period 2|Withdrawal by Subject|1|||
23571793|NCT02771210|65824544|FG001|Period 2|Withdrawal by Subject|0|||
23571794|NCT02771210|65824543|FG000|Period 2|Withdrawal of informed consent|0|||
23571795|NCT02771210|65824544|FG001|Period 2|Withdrawal of informed consent|2|||
23571796|NCT03662997|65824545|FG000|Overall Study|Adverse Event|0|||
23571797|NCT03662997|65824546|FG001|Overall Study|Adverse Event|2|||
23571798|NCT03662997|65824547|FG002|Overall Study|Adverse Event|0|||
23571799|NCT03662997|65824548|FG003|Overall Study|Adverse Event|0|||
23571800|NCT03638635|65824551|FG000|Initial Hospitalization|Study terminated prematurely|0|||
23571801|NCT03638635|65824552|FG001|Initial Hospitalization|Study terminated prematurely|1|||
23571802|NCT03638635|65824551|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
23571803|NCT03638635|65824552|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
23571804|NCT03638635|65824551|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
23224665|NCT03073200|64564108|FG011|Extension Period|Lost to Follow-up|0|||
23224666|NCT03073200|64564109|FG012|Extension Period|Lost to Follow-up|0|||
23224667|NCT03073200|64564110|FG013|Extension Period|Lost to Follow-up|0|||
23224668|NCT03073200|64564111|FG014|Extension Period|Lost to Follow-up|0|||
23224669|NCT03073200|64564097|FG000|Extension Period|Sponsor Decision|0|||
23224670|NCT03073200|64564098|FG001|Extension Period|Sponsor Decision|0|||
23224671|NCT03073200|64564099|FG002|Extension Period|Sponsor Decision|0|||
23224672|NCT03073200|64564100|FG003|Extension Period|Sponsor Decision|0|||
23224673|NCT03073200|64564101|FG004|Extension Period|Sponsor Decision|0|||
23224674|NCT03073200|64564102|FG005|Extension Period|Sponsor Decision|0|||
23224675|NCT03073200|64564103|FG006|Extension Period|Sponsor Decision|0|||
23447164|NCT00596752|65377897|FG001|Overall Study|Unsatisfactory Compliance|6|||
23571805|NCT03638635|65824552|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
23571806|NCT01058863|65824556|FG000|Overall Study|Lost to Follow-up|1|||
23571807|NCT01058863|65824556|FG000|Overall Study|Withdrawal by Subject|1|||
23571808|NCT01058863|65824556|FG000|Overall Study|Sponsor requested withdrawal|1|||
23571809|NCT01058863|65824556|FG000|Overall Study|Randomized in error|1|||
23571810|NCT05033743|65824557|FG000|Overall Study|Lost to Follow-up|1|||
23571811|NCT05033743|65824557|FG000|Overall Study|Protocol Violation|2|||
23571812|NCT05033743|65824557|FG000|Overall Study|Withdrawal by Subject|1|||
23571813|NCT01313923|65824558|FG000|Overall Study|Physician Decision|3|||
23571814|NCT00988351|65824566|FG000|Overall Study|Withdrawal by Subject|8|||
23571815|NCT00988351|65824567|FG001|Overall Study|Withdrawal by Subject|0|||
23571816|NCT00988351|65824566|FG000|Overall Study|Lost to Follow-up|6|||
23571817|NCT00988351|65824567|FG001|Overall Study|Lost to Follow-up|9|||
23571818|NCT00988351|65824566|FG000|Overall Study|not using CPAP|5|||
23571819|NCT00988351|65824567|FG001|Overall Study|not using CPAP|3|||
23224676|NCT03073200|64564104|FG007|Extension Period|Sponsor Decision|0|||
23571820|NCT03044353|65824568|FG000|Overall Study|Adverse Event|0|||
23571821|NCT03044353|65824569|FG001|Overall Study|Adverse Event|1|||
23571822|NCT03044353|65824570|FG002|Overall Study|Adverse Event|0|||
23571823|NCT01076088|65824574|FG000|Overall Study|Adverse Event|1|||
23571824|NCT01076088|65824575|FG001|Overall Study|Adverse Event|6|||
23224677|NCT03073200|64564105|FG008|Extension Period|Sponsor Decision|1|||
23224678|NCT03073200|64564106|FG009|Extension Period|Sponsor Decision|0|||
23224679|NCT03073200|64564107|FG010|Extension Period|Sponsor Decision|0|||
23224680|NCT03073200|64564108|FG011|Extension Period|Sponsor Decision|0|||
23224681|NCT03073200|64564109|FG012|Extension Period|Sponsor Decision|0|||
23224682|NCT03073200|64564110|FG013|Extension Period|Sponsor Decision|0|||
23224683|NCT03073200|64564111|FG014|Extension Period|Sponsor Decision|0|||
23224684|NCT03073200|64564097|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
23224685|NCT03073200|64564098|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
23224686|NCT03073200|64564099|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
23224687|NCT03073200|64564100|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
23224688|NCT03073200|64564101|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
23224689|NCT03073200|64564102|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
23224690|NCT03073200|64564103|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
23224691|NCT03073200|64564104|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
23224692|NCT03073200|64564105|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
23224693|NCT03073200|64564106|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
23224694|NCT03073200|64564107|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
23224695|NCT03073200|64564108|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
23224696|NCT03073200|64564109|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
23224697|NCT03073200|64564110|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
23224698|NCT03073200|64564111|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
23224699|NCT03073200|64564097|FG000|Extension Period|Withdrawal by Subject|0|||
23224700|NCT03073200|64564098|FG001|Extension Period|Withdrawal by Subject|0|||
23224701|NCT03073200|64564099|FG002|Extension Period|Withdrawal by Subject|0|||
23224702|NCT03073200|64564100|FG003|Extension Period|Withdrawal by Subject|0|||
23224703|NCT03073200|64564101|FG004|Extension Period|Withdrawal by Subject|0|||
23224704|NCT03073200|64564102|FG005|Extension Period|Withdrawal by Subject|0|||
23224705|NCT03073200|64564103|FG006|Extension Period|Withdrawal by Subject|1|||
23224706|NCT03073200|64564104|FG007|Extension Period|Withdrawal by Subject|2|||
23224707|NCT03073200|64564105|FG008|Extension Period|Withdrawal by Subject|0|||
23224708|NCT03073200|64564106|FG009|Extension Period|Withdrawal by Subject|0|||
23224709|NCT03073200|64564107|FG010|Extension Period|Withdrawal by Subject|0|||
23224710|NCT03073200|64564108|FG011|Extension Period|Withdrawal by Subject|0|||
23224711|NCT03073200|64564109|FG012|Extension Period|Withdrawal by Subject|0|||
23224712|NCT03073200|64564110|FG013|Extension Period|Withdrawal by Subject|0|||
23224713|NCT03073200|64564111|FG014|Extension Period|Withdrawal by Subject|0|||
23224714|NCT03073200|64564097|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224715|NCT03073200|64564098|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224716|NCT03073200|64564099|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224717|NCT03073200|64564100|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224718|NCT03073200|64564101|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224719|NCT03073200|64564102|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224720|NCT03073200|64564103|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224721|NCT03073200|64564104|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224722|NCT03073200|64564105|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
23571825|NCT01076088|65824576|FG002|Overall Study|Adverse Event|3|||
23571826|NCT01076088|65824577|FG003|Overall Study|Adverse Event|2|||
23571827|NCT01076088|65824578|FG004|Overall Study|Adverse Event|3|||
23571828|NCT01076088|65824579|FG005|Overall Study|Adverse Event|3|||
23571829|NCT01076088|65824574|FG000|Overall Study|Lost to Follow-up|1|||
23571830|NCT01076088|65824575|FG001|Overall Study|Lost to Follow-up|1|||
23571831|NCT01076088|65824576|FG002|Overall Study|Lost to Follow-up|0|||
23224723|NCT03073200|64564106|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224724|NCT03073200|64564107|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224725|NCT03073200|64564108|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
23571832|NCT01076088|65824577|FG003|Overall Study|Lost to Follow-up|1|||
23571833|NCT01076088|65824578|FG004|Overall Study|Lost to Follow-up|1|||
23571834|NCT01076088|65824579|FG005|Overall Study|Lost to Follow-up|2|||
23571835|NCT01076088|65824574|FG000|Overall Study|Non-compliance with study drug|0|||
23164257|NCT02290873|64348777|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
23164258|NCT02290873|64348778|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
23224726|NCT03073200|64564109|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224727|NCT03073200|64564110|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224728|NCT03073200|64564111|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
23224729|NCT03073200|64564097|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224730|NCT03073200|64564098|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224731|NCT03073200|64564099|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23164259|NCT02290873|64348776|FG000|Overall Study|Protocol Violation|0|||
23164260|NCT02290873|64348777|FG001|Overall Study|Protocol Violation|0|||
23164261|NCT02290873|64348778|FG002|Overall Study|Protocol Violation|1|||
23164262|NCT00763815|64348779|FG000|Overall Study|Adverse Event|14|||
23571836|NCT01076088|65824575|FG001|Overall Study|Non-compliance with study drug|0|||
23571837|NCT01076088|65824576|FG002|Overall Study|Non-compliance with study drug|0|||
23571838|NCT01076088|65824577|FG003|Overall Study|Non-compliance with study drug|1|||
23571839|NCT01076088|65824578|FG004|Overall Study|Non-compliance with study drug|0|||
23571840|NCT01076088|65824579|FG005|Overall Study|Non-compliance with study drug|0|||
23571841|NCT01076088|65824574|FG000|Overall Study|Physician Decision|1|||
23571842|NCT01076088|65824575|FG001|Overall Study|Physician Decision|3|||
23571843|NCT01076088|65824576|FG002|Overall Study|Physician Decision|0|||
23571844|NCT01076088|65824577|FG003|Overall Study|Physician Decision|1|||
23571845|NCT01076088|65824578|FG004|Overall Study|Physician Decision|1|||
23164263|NCT00763815|64348780|FG001|Overall Study|Adverse Event|29|||
23164264|NCT00763815|64348779|FG000|Overall Study|Lack of Efficacy|10|||
23164265|NCT00763815|64348780|FG001|Overall Study|Lack of Efficacy|11|||
23164266|NCT00763815|64348779|FG000|Overall Study|Poor Compliance to Protocol|6|||
23164267|NCT00763815|64348780|FG001|Overall Study|Poor Compliance to Protocol|6|||
23164268|NCT00763815|64348779|FG000|Overall Study|Lost to Follow-up|2|||
23164269|NCT00763815|64348780|FG001|Overall Study|Lost to Follow-up|4|||
23164270|NCT00763815|64348779|FG000|Overall Study|Early Termination|1|||
23164271|NCT00763815|64348780|FG001|Overall Study|Early Termination|0|||
23164272|NCT00763815|64348779|FG000|Overall Study|Familial and Personal Reasons|9|||
23164273|NCT00763815|64348780|FG001|Overall Study|Familial and Personal Reasons|16|||
23164274|NCT00763815|64348779|FG000|Overall Study|Physician Decision|1|||
23164275|NCT00763815|64348780|FG001|Overall Study|Physician Decision|0|||
23164276|NCT00763815|64348779|FG000|Overall Study|Withdrawal by Subject|7|||
23164277|NCT00763815|64348780|FG001|Overall Study|Withdrawal by Subject|12|||
23164278|NCT00763815|64348779|FG000|Overall Study|Protocol Violation|2|||
23164279|NCT00763815|64348780|FG001|Overall Study|Protocol Violation|5|||
23164280|NCT00763815|64348779|FG000|Overall Study|Sponsor's Decision|0|||
23164281|NCT00763815|64348780|FG001|Overall Study|Sponsor's Decision|1|||
23164282|NCT04003389|64348781|FG000|Overall Study|Adverse Event|27|||
23164283|NCT04003389|64348782|FG001|Overall Study|Adverse Event|34|||
23164284|NCT04003389|64348783|FG002|Overall Study|Adverse Event|28|||
23164285|NCT04003389|64348781|FG000|Overall Study|Lost to Follow-up|39|||
23164286|NCT04003389|64348782|FG001|Overall Study|Lost to Follow-up|30|||
23164287|NCT04003389|64348783|FG002|Overall Study|Lost to Follow-up|33|||
23164288|NCT04003389|64348781|FG000|Overall Study|Protocol Violation|1|||
23164289|NCT04003389|64348782|FG001|Overall Study|Protocol Violation|6|||
23164290|NCT04003389|64348783|FG002|Overall Study|Protocol Violation|5|||
23164291|NCT04003389|64348781|FG000|Overall Study|Withdrawal by Subject|119|||
23164292|NCT04003389|64348782|FG001|Overall Study|Withdrawal by Subject|79|||
23164293|NCT04003389|64348783|FG002|Overall Study|Withdrawal by Subject|85|||
23164294|NCT04003389|64348781|FG000|Overall Study|Miscellaneous|14|||
23164295|NCT04003389|64348782|FG001|Overall Study|Miscellaneous|11|||
23164296|NCT04003389|64348783|FG002|Overall Study|Miscellaneous|14|||
23164297|NCT04003389|64348781|FG000|Overall Study|Participant did not receive study drug|1|||
23164298|NCT04003389|64348782|FG001|Overall Study|Participant did not receive study drug|0|||
23164299|NCT04003389|64348783|FG002|Overall Study|Participant did not receive study drug|0|||
23164300|NCT02595723|64348786|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
23164301|NCT02595723|64348787|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
23164302|NCT02595723|64348788|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
23164303|NCT02595723|64348786|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
23164304|NCT02595723|64348787|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
23164305|NCT02595723|64348788|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
23164306|NCT01119248|64348794|FG000|Overall Study|Physician Decision|5|||
23164307|NCT02457637|64348799|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
23164308|NCT00385255|64348800|FG000|Overall Study|Serious Adverse Event|1|||
23164309|NCT00385255|64348801|FG001|Overall Study|Serious Adverse Event|2|||
23164310|NCT00385255|64348800|FG000|Overall Study|Protocol Violation|0|||
23164311|NCT00385255|64348801|FG001|Overall Study|Protocol Violation|4|||
23164312|NCT00385255|64348800|FG000|Overall Study|Withdrawal by Subject|0|||
23164313|NCT00385255|64348801|FG001|Overall Study|Withdrawal by Subject|8|||
23164314|NCT00385255|64348800|FG000|Overall Study|Migrated/moved from study area|0|||
23164315|NCT00385255|64348801|FG001|Overall Study|Migrated/moved from study area|1|||
23164316|NCT00385255|64348800|FG000|Overall Study|Lost to Follow-up|20|||
23164317|NCT00385255|64348801|FG001|Overall Study|Lost to Follow-up|58|||
23164318|NCT02124564|64348804|FG000|Treatment Period|Adverse Event|2|||
23164319|NCT02124564|64348804|FG000|Treatment Period|Lack of Efficacy|3|||
23164320|NCT02124564|64348804|FG000|Treatment Period|Withdrawal by Subject|2|||
23571846|NCT01076088|65824579|FG005|Overall Study|Physician Decision|0|||
23164321|NCT02443883|64348805|FG000|Overall Study|Adverse Event|0|||
23164322|NCT02443883|64348806|FG001|Overall Study|Adverse Event|1|||
23164323|NCT02443883|64348807|FG002|Overall Study|Adverse Event|0|||
23164324|NCT02443883|64348808|FG003|Overall Study|Adverse Event|0|||
23571847|NCT01076088|65824574|FG000|Overall Study|Withdrawal by Subject|8|||
23571848|NCT01076088|65824575|FG001|Overall Study|Withdrawal by Subject|8|||
23571849|NCT01076088|65824576|FG002|Overall Study|Withdrawal by Subject|14|||
23571850|NCT01076088|65824577|FG003|Overall Study|Withdrawal by Subject|10|||
23571851|NCT01076088|65824578|FG004|Overall Study|Withdrawal by Subject|11|||
23571852|NCT01076088|65824579|FG005|Overall Study|Withdrawal by Subject|17|||
23571853|NCT01076088|65824574|FG000|Overall Study|Other protocol specified criteria|0|||
23571854|NCT01076088|65824575|FG001|Overall Study|Other protocol specified criteria|0|||
23571855|NCT01076088|65824576|FG002|Overall Study|Other protocol specified criteria|0|||
23164325|NCT02443883|64348805|FG000|Overall Study|Lost to Follow-up|3|||
23164326|NCT02443883|64348806|FG001|Overall Study|Lost to Follow-up|2|||
23164327|NCT02443883|64348807|FG002|Overall Study|Lost to Follow-up|1|||
23164328|NCT02443883|64348808|FG003|Overall Study|Lost to Follow-up|0|||
23164329|NCT02443883|64348805|FG000|Overall Study|Physician Decision|1|||
23164330|NCT02443883|64348806|FG001|Overall Study|Physician Decision|1|||
23164331|NCT02443883|64348807|FG002|Overall Study|Physician Decision|0|||
23164332|NCT02443883|64348808|FG003|Overall Study|Physician Decision|3|||
23164333|NCT02443883|64348805|FG000|Overall Study|Withdrawal by Subject|1|||
23571856|NCT01076088|65824577|FG003|Overall Study|Other protocol specified criteria|0|||
23571857|NCT01076088|65824578|FG004|Overall Study|Other protocol specified criteria|0|||
23571858|NCT01076088|65824579|FG005|Overall Study|Other protocol specified criteria|1|||
23571859|NCT01778062|65824580|FG000|Overall Study|Adverse Event|1|||
23571860|NCT01778062|65824581|FG001|Overall Study|Adverse Event|3|||
23571861|NCT01778062|65824580|FG000|Overall Study|Consent Withdrawal|1|||
23571862|NCT01778062|65824581|FG001|Overall Study|Consent Withdrawal|5|||
23571863|NCT01778062|65824580|FG000|Overall Study|major protocol deviation|4|||
23571864|NCT01778062|65824581|FG001|Overall Study|major protocol deviation|3|||
23571865|NCT01454830|65824585|FG000|Overall Study|Withdrawal by Subject|4|||
23571866|NCT01454830|65824586|FG001|Overall Study|Withdrawal by Subject|4|||
23571867|NCT01454830|65824585|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
23571868|NCT01454830|65824586|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
23571869|NCT01454830|65824585|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
23571870|NCT01454830|65824586|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
23571871|NCT01454830|65824585|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
23571872|NCT01454830|65824586|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
23571873|NCT01454830|65824585|FG000|Overall Study|Withdrawal - no polysomnography|3|||
23571874|NCT01454830|65824586|FG001|Overall Study|Withdrawal - no polysomnography|2|||
23571875|NCT03632434|65824592|FG000|Overall Study|Withdrawal by Subject|2|||
23571876|NCT01310868|65824593|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
23571877|NCT03390036|65824594|FG000|Overall Study|Lost to Follow-up|1|||
23571878|NCT03390036|65824595|FG001|Overall Study|Lost to Follow-up|0|||
23164334|NCT02443883|64348806|FG001|Overall Study|Withdrawal by Subject|0|||
23571879|NCT03390036|65824596|FG002|Overall Study|Lost to Follow-up|0|||
23571880|NCT03390036|65824594|FG000|Overall Study|Lack of Efficacy|1|||
23571881|NCT03390036|65824595|FG001|Overall Study|Lack of Efficacy|0|||
23571882|NCT03390036|65824596|FG002|Overall Study|Lack of Efficacy|0|||
23571883|NCT02019602|65824597|FG000|Screening Period|Ineligibility|4|||
23571884|NCT02019602|65824598|FG001|Screening Period|Ineligibility|0|||
23571885|NCT02019602|65824597|FG000|Screening Period|Adverse Event|1|||
23571886|NCT02019602|65824598|FG001|Screening Period|Adverse Event|0|||
23571887|NCT04276090|65824604|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
23571888|NCT04276090|65824605|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
23571889|NCT03722264|65824610|FG000|Overall Study|Physician Decision|3|||
23571890|NCT00581113|65824611|FG000|Overall Study|Withdrawal by Subject|0|||
23571891|NCT00581113|65824612|FG001|Overall Study|Withdrawal by Subject|1|||
23571892|NCT02593539|65824613|FG000|Overall Study|Adverse Event|1|||
23571893|NCT04426006|65824616|FG000|Inclusion|Protocol Violation|1|||
23571894|NCT04426006|65824616|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
23571895|NCT04426006|65824616|FG000|Inclusion|Blood sample at inclusion not done|1|||
23571896|NCT04426006|65824616|FG000|3 Months|Lost to Follow-up|17|||
23571897|NCT04426006|65824616|FG000|12 Months|Lost to Follow-up|38|||
23571898|NCT01951092|65824617|FG000|Overall Study|Lost to Follow-up|10|||
23571899|NCT01951092|65824617|FG000|Overall Study|Incarceration|1|||
23224732|NCT03073200|64564100|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224733|NCT03073200|64564101|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224734|NCT03073200|64564102|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224735|NCT03073200|64564103|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224736|NCT03073200|64564104|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224737|NCT03073200|64564105|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224738|NCT03073200|64564106|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224739|NCT03073200|64564107|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224740|NCT03073200|64564108|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
23224741|NCT03073200|64564109|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224742|NCT03073200|64564110|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23224743|NCT03073200|64564111|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
23571900|NCT01951092|65824617|FG000|Overall Study|Transfer of Care|1|||
23571901|NCT04230980|65824622|FG000|Overall Study|Lost to Follow-up|1|||
23571902|NCT04230980|65824623|FG001|Overall Study|Lost to Follow-up|2|||
23571903|NCT04230980|65824622|FG000|Overall Study|Adverse Event|0|||
23571904|NCT04230980|65824623|FG001|Overall Study|Adverse Event|1|||
23571905|NCT04006366|65824624|FG000|Overall Study|Withdrawal by Subject|1|||
23571906|NCT00209274|65824625|FG000|Overall Study|Missed visit|3|||
23571907|NCT00209274|65824626|FG001|Overall Study|Missed visit|2|||
23571908|NCT00209274|65824625|FG000|Overall Study|Death|32|||
23571909|NCT00209274|65824626|FG001|Overall Study|Death|15|||
23571910|NCT00209274|65824625|FG000|Overall Study|Withdrawal by Subject|30|||
23571911|NCT00209274|65824626|FG001|Overall Study|Withdrawal by Subject|15|||
23571912|NCT00209274|65824625|FG000|Overall Study|Randomized not treated (RNT)|6|||
23571913|NCT00209274|65824626|FG001|Overall Study|Randomized not treated (RNT)|15|||
23571914|NCT03810313|65824629|FG000|Overall Study|Study terminated by sponsor|164|||
23571915|NCT03810313|65824630|FG001|Overall Study|Study terminated by sponsor|159|||
23571916|NCT03810313|65824629|FG000|Overall Study|Subject decision|10|||
23571917|NCT03810313|65824630|FG001|Overall Study|Subject decision|11|||
23571918|NCT03810313|65824629|FG000|Overall Study|Lost to Follow-up|3|||
23571919|NCT03810313|65824630|FG001|Overall Study|Lost to Follow-up|3|||
23571920|NCT03810313|65824629|FG000|Overall Study|Adverse Event|2|||
23571921|NCT03810313|65824630|FG001|Overall Study|Adverse Event|1|||
23571922|NCT03810313|65824629|FG000|Overall Study|Death|2|||
23571923|NCT03810313|65824630|FG001|Overall Study|Death|1|||
23571924|NCT03810313|65824629|FG000|Overall Study|Physician Decision|0|||
23571925|NCT03810313|65824630|FG001|Overall Study|Physician Decision|1|||
23571926|NCT01555021|65824635|FG000|Overall Study|Lost to Follow-up|1|||
23571927|NCT01555021|65824636|FG001|Overall Study|Lost to Follow-up|2|||
23571928|NCT02836613|65824637|FG000|Overall Study|Accidental drowning|1|||
23571929|NCT02836613|65824638|FG001|Overall Study|Accidental drowning|0|||
23571930|NCT02836613|65824637|FG000|Overall Study|Lost to Follow-up|0|||
23571931|NCT02836613|65824638|FG001|Overall Study|Lost to Follow-up|1|||
23571932|NCT02836613|65824637|FG000|Overall Study|Withdrawal by Subject|0|||
23571933|NCT02836613|65824638|FG001|Overall Study|Withdrawal by Subject|2|||
23571934|NCT01009047|65824642|FG000|Overall Study|Adverse Event|5|||
23571935|NCT01009047|65824643|FG001|Overall Study|Adverse Event|0|||
23571936|NCT01009047|65824642|FG000|Overall Study|Lost to Follow-up|0|||
23571937|NCT01009047|65824643|FG001|Overall Study|Lost to Follow-up|2|||
23571938|NCT01009047|65824642|FG000|Overall Study|Lack of Efficacy|4|||
23571939|NCT01009047|65824643|FG001|Overall Study|Lack of Efficacy|11|||
23571940|NCT01009047|65824642|FG000|Overall Study|Withdrawal by consent|16|||
23571941|NCT01009047|65824643|FG001|Overall Study|Withdrawal by consent|11|||
23571942|NCT01009047|65824642|FG000|Overall Study|Other|3|||
23571943|NCT01009047|65824643|FG001|Overall Study|Other|2|||
23571944|NCT02769065|65824647|FG000|Overall Study|Voluntary Withdrawal|1|||
23571945|NCT02769065|65824648|FG001|Overall Study|Voluntary Withdrawal|0|||
23571946|NCT02769065|65824649|FG002|Overall Study|Voluntary Withdrawal|0|||
23571947|NCT02769065|65824650|FG003|Overall Study|Voluntary Withdrawal|0|||
23571948|NCT02769065|65824651|FG004|Overall Study|Voluntary Withdrawal|0|||
23571949|NCT02769065|65824652|FG005|Overall Study|Voluntary Withdrawal|0|||
23571950|NCT02769065|65824653|FG006|Overall Study|Voluntary Withdrawal|0|||
23571951|NCT02769065|65824654|FG007|Overall Study|Voluntary Withdrawal|0|||
23571952|NCT02769065|65824655|FG008|Overall Study|Voluntary Withdrawal|0|||
23571953|NCT02769065|65824656|FG009|Overall Study|Voluntary Withdrawal|0|||
23571954|NCT02769065|65824657|FG010|Overall Study|Voluntary Withdrawal|0|||
23571955|NCT02769065|65824658|FG011|Overall Study|Voluntary Withdrawal|0|||
23571956|NCT02769065|65824659|FG012|Overall Study|Voluntary Withdrawal|0|||
23571957|NCT02769065|65824660|FG013|Overall Study|Voluntary Withdrawal|0|||
23571958|NCT02769065|65824661|FG014|Overall Study|Voluntary Withdrawal|0|||
23571959|NCT02769065|65824662|FG015|Overall Study|Voluntary Withdrawal|0|||
23571960|NCT02769065|65824663|FG016|Overall Study|Voluntary Withdrawal|0|||
23571961|NCT02769065|65824664|FG017|Overall Study|Voluntary Withdrawal|0|||
23571962|NCT02769065|65824665|FG018|Overall Study|Voluntary Withdrawal|0|||
23571963|NCT02769065|65824666|FG019|Overall Study|Voluntary Withdrawal|0|||
23571964|NCT02769065|65824667|FG020|Overall Study|Voluntary Withdrawal|0|||
23164335|NCT02443883|64348807|FG002|Overall Study|Withdrawal by Subject|0|||
23164336|NCT02443883|64348808|FG003|Overall Study|Withdrawal by Subject|2|||
23164337|NCT02443883|64348805|FG000|Overall Study|Randomized, but never treated|1|||
23164338|NCT02443883|64348806|FG001|Overall Study|Randomized, but never treated|0|||
23164339|NCT02443883|64348807|FG002|Overall Study|Randomized, but never treated|0|||
23164340|NCT02443883|64348808|FG003|Overall Study|Randomized, but never treated|0|||
23571965|NCT02769065|65824668|FG021|Overall Study|Voluntary Withdrawal|0|||
23571966|NCT02769065|65824669|FG022|Overall Study|Voluntary Withdrawal|0|||
23571967|NCT02769065|65824670|FG023|Overall Study|Voluntary Withdrawal|0|||
23571968|NCT02769065|65824671|FG024|Overall Study|Voluntary Withdrawal|0|||
23571969|NCT02769065|65824672|FG025|Overall Study|Voluntary Withdrawal|0|||
23571970|NCT02769065|65824673|FG026|Overall Study|Voluntary Withdrawal|0|||
23571971|NCT02769065|65824674|FG027|Overall Study|Voluntary Withdrawal|0|||
23571972|NCT02769065|65824675|FG028|Overall Study|Voluntary Withdrawal|0|||
23571973|NCT02769065|65824676|FG029|Overall Study|Voluntary Withdrawal|0|||
23571974|NCT02769065|65824647|FG000|Overall Study|Reason Not Specified|0|||
23164341|NCT02193074|64348809|FG000|Overall Study|Withdrawal by Subject|1|||
23164342|NCT02193074|64348810|FG001|Overall Study|Withdrawal by Subject|2|||
23164343|NCT02193074|64348809|FG000|Overall Study|Adverse Event|16|||
23164344|NCT02193074|64348810|FG001|Overall Study|Adverse Event|13|||
23164345|NCT03074474|64348812|FG000|Overall Study|Lost to Follow-up|10|||
23332089|NCT01295827|64958991|FG014|Overall Study|Withdrawal by Subject|0|||
23332090|NCT01295827|64958977|FG000|Overall Study|Other|0|||
23332091|NCT01295827|64958978|FG001|Overall Study|Other|0|||
23164346|NCT03074474|64348812|FG000|Overall Study|Withdrawal by Subject|10|||
23164347|NCT03074474|64348812|FG000|Overall Study|Death|4|||
23164348|NCT03074474|64348812|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
23332092|NCT01295827|64958979|FG002|Overall Study|Other|0|||
23332093|NCT01295827|64958980|FG003|Overall Study|Other|0|||
23164349|NCT00750737|64348813|FG000|Overall Study|Withdrawal by Subject|3|||
23164350|NCT00750737|64348814|FG001|Overall Study|Withdrawal by Subject|3|||
23164351|NCT03073980|64348817|FG000|Overall Study|Lost to Follow-up|10|||
23164352|NCT03073980|64348818|FG001|Overall Study|Lost to Follow-up|2|||
23164353|NCT03073980|64348819|FG002|Overall Study|Lost to Follow-up|9|||
23164354|NCT03073980|64348817|FG000|Overall Study|No post-procedure data|0|||
23164355|NCT03073980|64348818|FG001|Overall Study|No post-procedure data|0|||
23164356|NCT03073980|64348819|FG002|Overall Study|No post-procedure data|2|||
23164357|NCT03703882|64348820|FG000|Overall Study|Adverse Event|1|||
23164358|NCT03703882|64348821|FG001|Overall Study|Adverse Event|0|||
23164359|NCT03703882|64348820|FG000|Overall Study|Lost to Follow-up|0|||
23164360|NCT03703882|64348821|FG001|Overall Study|Lost to Follow-up|2|||
23164361|NCT03703882|64348820|FG000|Overall Study|Non-compliance with study drug|0|||
23164362|NCT03703882|64348821|FG001|Overall Study|Non-compliance with study drug|1|||
23164363|NCT03703882|64348820|FG000|Overall Study|Physician Decision|0|||
23164364|NCT03703882|64348821|FG001|Overall Study|Physician Decision|1|||
23164365|NCT03703882|64348820|FG000|Overall Study|Progressive disease|1|||
23164366|NCT03703882|64348821|FG001|Overall Study|Progressive disease|0|||
23164367|NCT03703882|64348820|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23332094|NCT01295827|64958981|FG004|Overall Study|Other|0|||
23332095|NCT01295827|64958982|FG005|Overall Study|Other|0|||
23332096|NCT01295827|64958983|FG006|Overall Study|Other|1|||
23164368|NCT03703882|64348821|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23164369|NCT03703882|64348820|FG000|Overall Study|Starting another treatment|0|||
23164370|NCT03703882|64348821|FG001|Overall Study|Starting another treatment|1|||
23571975|NCT02769065|65824648|FG001|Overall Study|Reason Not Specified|0|||
23571976|NCT02769065|65824649|FG002|Overall Study|Reason Not Specified|0|||
23571977|NCT02769065|65824650|FG003|Overall Study|Reason Not Specified|0|||
23571978|NCT02769065|65824651|FG004|Overall Study|Reason Not Specified|0|||
23571979|NCT02769065|65824652|FG005|Overall Study|Reason Not Specified|0|||
23571980|NCT02769065|65824653|FG006|Overall Study|Reason Not Specified|1|||
23571981|NCT02769065|65824654|FG007|Overall Study|Reason Not Specified|0|||
23571982|NCT02769065|65824655|FG008|Overall Study|Reason Not Specified|0|||
23571983|NCT02769065|65824656|FG009|Overall Study|Reason Not Specified|0|||
23571984|NCT02769065|65824657|FG010|Overall Study|Reason Not Specified|0|||
23571985|NCT02769065|65824658|FG011|Overall Study|Reason Not Specified|0|||
23571986|NCT02769065|65824659|FG012|Overall Study|Reason Not Specified|0|||
23571987|NCT02769065|65824660|FG013|Overall Study|Reason Not Specified|0|||
23571988|NCT02769065|65824661|FG014|Overall Study|Reason Not Specified|0|||
23571989|NCT02769065|65824662|FG015|Overall Study|Reason Not Specified|0|||
23571990|NCT02769065|65824663|FG016|Overall Study|Reason Not Specified|0|||
23571991|NCT02769065|65824664|FG017|Overall Study|Reason Not Specified|0|||
23571992|NCT02769065|65824665|FG018|Overall Study|Reason Not Specified|0|||
23571993|NCT02769065|65824666|FG019|Overall Study|Reason Not Specified|0|||
23571994|NCT02769065|65824667|FG020|Overall Study|Reason Not Specified|0|||
23571995|NCT02769065|65824668|FG021|Overall Study|Reason Not Specified|0|||
23571996|NCT02769065|65824669|FG022|Overall Study|Reason Not Specified|0|||
23571997|NCT02769065|65824670|FG023|Overall Study|Reason Not Specified|0|||
23571998|NCT02769065|65824671|FG024|Overall Study|Reason Not Specified|0|||
23571999|NCT02769065|65824672|FG025|Overall Study|Reason Not Specified|0|||
23572000|NCT02769065|65824673|FG026|Overall Study|Reason Not Specified|0|||
23572001|NCT02769065|65824674|FG027|Overall Study|Reason Not Specified|0|||
23572002|NCT02769065|65824675|FG028|Overall Study|Reason Not Specified|0|||
23572003|NCT02769065|65824676|FG029|Overall Study|Reason Not Specified|0|||
23572004|NCT02769065|65824647|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572005|NCT02769065|65824648|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572006|NCT02769065|65824649|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572007|NCT02769065|65824650|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572008|NCT02769065|65824651|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572009|NCT02769065|65824652|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572010|NCT02769065|65824653|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572011|NCT02769065|65824654|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572012|NCT02769065|65824655|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572013|NCT02769065|65824656|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
23164371|NCT03703882|64348820|FG000|Overall Study|noncompliance with study procedures|0|||
23164372|NCT03703882|64348821|FG001|Overall Study|noncompliance with study procedures|1|||
23572014|NCT02769065|65824657|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
23572015|NCT02769065|65824658|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572016|NCT02769065|65824659|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572017|NCT02769065|65824660|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572018|NCT02769065|65824661|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572019|NCT02769065|65824662|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572020|NCT02769065|65824663|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
23164373|NCT04417894|64348822|FG000|Overall Study|Lost to Follow-up|3|||
23332097|NCT01295827|64958984|FG007|Overall Study|Other|1|||
23164374|NCT04417894|64348823|FG001|Overall Study|Lost to Follow-up|0|||
23164375|NCT04417894|64348822|FG000|Overall Study|Withdrawal by Subject|7|||
23164376|NCT04417894|64348823|FG001|Overall Study|Withdrawal by Subject|6|||
23164377|NCT04417894|64348822|FG000|Overall Study|Lack of Efficacy|3|||
23164378|NCT04417894|64348823|FG001|Overall Study|Lack of Efficacy|1|||
23164379|NCT02551159|64348830|FG000|Overall Study|Death|352|||
23164380|NCT02551159|64348831|FG001|Overall Study|Death|174|||
23164381|NCT02551159|64348832|FG002|Overall Study|Death|161|||
23164382|NCT02551159|64348830|FG000|Overall Study|Withdrawal by Subject|8|||
23572021|NCT02769065|65824664|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572022|NCT02769065|65824665|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
23164383|NCT02551159|64348831|FG001|Overall Study|Withdrawal by Subject|5|||
23164384|NCT02551159|64348832|FG002|Overall Study|Withdrawal by Subject|16|||
23164385|NCT02551159|64348830|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
23224744|NCT03073200|64564097|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224745|NCT03073200|64564098|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224746|NCT03073200|64564099|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224747|NCT03073200|64564100|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224748|NCT03073200|64564101|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224749|NCT03073200|64564102|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224750|NCT03073200|64564103|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224751|NCT03073200|64564104|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224752|NCT03073200|64564105|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224753|NCT03073200|64564106|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224754|NCT03073200|64564107|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
23224755|NCT03073200|64564108|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
23224756|NCT03073200|64564109|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224757|NCT03073200|64564110|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224758|NCT03073200|64564111|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23224759|NCT03073200|64564097|FG000|Randomized Withdrawal Period|Adverse Event|0|||
23224760|NCT03073200|64564098|FG001|Randomized Withdrawal Period|Adverse Event|0|||
23224761|NCT03073200|64564099|FG002|Randomized Withdrawal Period|Adverse Event|0|||
23224762|NCT03073200|64564100|FG003|Randomized Withdrawal Period|Adverse Event|0|||
23224763|NCT03073200|64564101|FG004|Randomized Withdrawal Period|Adverse Event|0|||
23224764|NCT03073200|64564102|FG005|Randomized Withdrawal Period|Adverse Event|0|||
23224765|NCT03073200|64564103|FG006|Randomized Withdrawal Period|Adverse Event|0|||
23224766|NCT03073200|64564104|FG007|Randomized Withdrawal Period|Adverse Event|0|||
23224767|NCT03073200|64564105|FG008|Randomized Withdrawal Period|Adverse Event|0|||
23224768|NCT03073200|64564106|FG009|Randomized Withdrawal Period|Adverse Event|0|||
23224769|NCT03073200|64564107|FG010|Randomized Withdrawal Period|Adverse Event|1|||
23224770|NCT03073200|64564108|FG011|Randomized Withdrawal Period|Adverse Event|0|||
23224771|NCT03073200|64564109|FG012|Randomized Withdrawal Period|Adverse Event|0|||
23224772|NCT03073200|64564110|FG013|Randomized Withdrawal Period|Adverse Event|0|||
23224773|NCT03073200|64564111|FG014|Randomized Withdrawal Period|Adverse Event|0|||
23224774|NCT03073200|64564097|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224775|NCT03073200|64564098|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224776|NCT03073200|64564099|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224777|NCT03073200|64564100|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
23572023|NCT02769065|65824666|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572024|NCT02769065|65824667|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572025|NCT02769065|65824668|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572026|NCT02769065|65824669|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572027|NCT02769065|65824670|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572028|NCT02769065|65824671|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572029|NCT02769065|65824672|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572030|NCT02769065|65824673|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572031|NCT02769065|65824674|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
23572032|NCT02769065|65824675|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
23164386|NCT02551159|64348831|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
23164387|NCT02551159|64348832|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
23224778|NCT03073200|64564101|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
23164388|NCT01848288|64348833|FG000|Overall Study|Death|1|||
23164389|NCT01848288|64348833|FG000|Overall Study|Protocol Violation|1|||
23572033|NCT02769065|65824676|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
23224779|NCT03073200|64564102|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224780|NCT03073200|64564103|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224781|NCT03073200|64564104|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224782|NCT03073200|64564105|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224783|NCT03073200|64564106|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224784|NCT03073200|64564107|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224785|NCT03073200|64564108|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224786|NCT03073200|64564109|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224787|NCT03073200|64564110|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
23224788|NCT03073200|64564111|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
23224789|NCT03073200|64564097|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224790|NCT03073200|64564098|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224791|NCT03073200|64564099|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224792|NCT03073200|64564100|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224793|NCT03073200|64564101|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224794|NCT03073200|64564102|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224795|NCT03073200|64564103|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224796|NCT03073200|64564104|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224797|NCT03073200|64564105|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224798|NCT03073200|64564106|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224799|NCT03073200|64564107|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224800|NCT03073200|64564108|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224801|NCT03073200|64564109|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224802|NCT03073200|64564110|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
23224803|NCT03073200|64564111|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23224804|NCT03073200|64564097|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224805|NCT03073200|64564098|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224806|NCT03073200|64564099|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224807|NCT03073200|64564100|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224808|NCT03073200|64564101|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224809|NCT03073200|64564102|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224810|NCT03073200|64564103|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224811|NCT03073200|64564104|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224812|NCT03073200|64564105|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224813|NCT03073200|64564106|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224814|NCT03073200|64564107|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224815|NCT03073200|64564108|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224816|NCT03073200|64564109|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224817|NCT03073200|64564110|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
23224818|NCT03073200|64564111|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
23224819|NCT03073200|64564097|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224820|NCT03073200|64564098|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224821|NCT03073200|64564099|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224822|NCT03073200|64564100|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224823|NCT03073200|64564101|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224824|NCT03073200|64564102|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224825|NCT03073200|64564103|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224826|NCT03073200|64564104|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224827|NCT03073200|64564105|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224828|NCT03073200|64564106|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224829|NCT03073200|64564107|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224830|NCT03073200|64564108|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224831|NCT03073200|64564109|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224832|NCT03073200|64564110|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
23224833|NCT03073200|64564111|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23224834|NCT03073200|64564097|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224835|NCT03073200|64564098|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224836|NCT03073200|64564099|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224837|NCT03073200|64564100|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224838|NCT03073200|64564101|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224839|NCT03073200|64564102|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224840|NCT03073200|64564103|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224841|NCT03073200|64564104|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224842|NCT03073200|64564105|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224843|NCT03073200|64564106|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23332098|NCT01295827|64958985|FG008|Overall Study|Other|1|||
23164390|NCT01848288|64348833|FG000|Overall Study|Withdrawal by Subject|1|||
23164391|NCT03468855|64348835|FG000|Overall Study|Adverse Event|2|||
23164392|NCT03468855|64348835|FG000|Overall Study|Lost to Follow-up|5|||
23164393|NCT03468855|64348835|FG000|Overall Study|Withdrawal by Subject|3|||
23164394|NCT03468855|64348835|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
23164395|NCT00408694|64348837|FG000|Overall Study|Ineligible|1|||
23164396|NCT00408694|64348837|FG000|Overall Study|No protocol treatment|1|||
23164397|NCT00143455|64348838|FG000|Cohort 1|Adverse Event|8|||
23164398|NCT00143455|64348839|FG001|Cohort 1|Adverse Event|4|||
23164399|NCT00143455|64348840|FG002|Cohort 1|Adverse Event|0|||
23164400|NCT00143455|64348841|FG003|Cohort 1|Adverse Event|0|||
23164401|NCT00143455|64348838|FG000|Cohort 1|Death|5|||
23164402|NCT00143455|64348839|FG001|Cohort 1|Death|2|||
23164403|NCT00143455|64348840|FG002|Cohort 1|Death|0|||
23164404|NCT00143455|64348841|FG003|Cohort 1|Death|0|||
23164405|NCT00143455|64348838|FG000|Cohort 1|Progressive Disease|0|||
23164406|NCT00143455|64348839|FG001|Cohort 1|Progressive Disease|6|||
23164407|NCT00143455|64348840|FG002|Cohort 1|Progressive Disease|0|||
23164408|NCT00143455|64348841|FG003|Cohort 1|Progressive Disease|0|||
23164409|NCT00143455|64348838|FG000|Cohort 1|Withdrawal by Subject|1|||
23164410|NCT00143455|64348839|FG001|Cohort 1|Withdrawal by Subject|4|||
23164411|NCT00143455|64348840|FG002|Cohort 1|Withdrawal by Subject|0|||
23164412|NCT00143455|64348841|FG003|Cohort 1|Withdrawal by Subject|0|||
23164413|NCT00143455|64348838|FG000|Cohort 1|Randomized But Not Treated|0|||
23164414|NCT00143455|64348839|FG001|Cohort 1|Randomized But Not Treated|1|||
23164415|NCT00143455|64348840|FG002|Cohort 1|Randomized But Not Treated|0|||
23164416|NCT00143455|64348841|FG003|Cohort 1|Randomized But Not Treated|0|||
23164417|NCT00143455|64348838|FG000|Cohort 2|Adverse Event|0|||
23164418|NCT00143455|64348839|FG001|Cohort 2|Adverse Event|0|||
23164419|NCT00143455|64348840|FG002|Cohort 2|Adverse Event|42|||
23164420|NCT00143455|64348841|FG003|Cohort 2|Adverse Event|30|||
23164421|NCT00143455|64348838|FG000|Cohort 2|No Longer Required Study Treatment|0|||
23164422|NCT00143455|64348839|FG001|Cohort 2|No Longer Required Study Treatment|0|||
23164423|NCT00143455|64348840|FG002|Cohort 2|No Longer Required Study Treatment|1|||
23164424|NCT00143455|64348841|FG003|Cohort 2|No Longer Required Study Treatment|0|||
23164425|NCT00143455|64348838|FG000|Cohort 2|Protocol Violation|0|||
23164426|NCT00143455|64348839|FG001|Cohort 2|Protocol Violation|0|||
23164427|NCT00143455|64348840|FG002|Cohort 2|Protocol Violation|1|||
23164428|NCT00143455|64348841|FG003|Cohort 2|Protocol Violation|1|||
23164429|NCT00143455|64348838|FG000|Cohort 2|Lost to Follow-up|0|||
23164430|NCT00143455|64348839|FG001|Cohort 2|Lost to Follow-up|0|||
23164431|NCT00143455|64348840|FG002|Cohort 2|Lost to Follow-up|1|||
23164432|NCT00143455|64348841|FG003|Cohort 2|Lost to Follow-up|4|||
23164433|NCT00143455|64348838|FG000|Cohort 2|Death|0|||
23164434|NCT00143455|64348839|FG001|Cohort 2|Death|0|||
23164435|NCT00143455|64348840|FG002|Cohort 2|Death|20|||
23164436|NCT00143455|64348841|FG003|Cohort 2|Death|12|||
23164437|NCT00143455|64348838|FG000|Cohort 2|Progressive Disease|0|||
23164438|NCT00143455|64348839|FG001|Cohort 2|Progressive Disease|0|||
23164439|NCT00143455|64348840|FG002|Cohort 2|Progressive Disease|20|||
23164440|NCT00143455|64348841|FG003|Cohort 2|Progressive Disease|27|||
23164441|NCT00143455|64348838|FG000|Cohort 2|Withdrawal by Subject|0|||
23164442|NCT00143455|64348839|FG001|Cohort 2|Withdrawal by Subject|0|||
23164443|NCT00143455|64348840|FG002|Cohort 2|Withdrawal by Subject|13|||
23164444|NCT00143455|64348841|FG003|Cohort 2|Withdrawal by Subject|12|||
23164445|NCT00143455|64348838|FG000|Cohort 2|Other|0|||
23164446|NCT00143455|64348839|FG001|Cohort 2|Other|0|||
23164447|NCT00143455|64348840|FG002|Cohort 2|Other|7|||
23164448|NCT00143455|64348841|FG003|Cohort 2|Other|6|||
23164449|NCT00143455|64348838|FG000|Cohort 2|Randomized But Not Treated|0|||
23164450|NCT00143455|64348839|FG001|Cohort 2|Randomized But Not Treated|0|||
23164451|NCT00143455|64348840|FG002|Cohort 2|Randomized But Not Treated|1|||
23164452|NCT00143455|64348841|FG003|Cohort 2|Randomized But Not Treated|1|||
23164453|NCT00137111|64348842|FG000|Total Therapy|Death|35|||
23164454|NCT00137111|64348843|FG001|Total Therapy|Death|0|||
23164455|NCT00137111|64348844|FG002|Total Therapy|Death|0|||
23164456|NCT00137111|64348845|FG003|Total Therapy|Death|0|||
23164457|NCT00137111|64348842|FG000|Total Therapy|Non Compliance|5|||
23164458|NCT00137111|64348843|FG001|Total Therapy|Non Compliance|0|||
23164459|NCT00137111|64348844|FG002|Total Therapy|Non Compliance|0|||
23164460|NCT00137111|64348845|FG003|Total Therapy|Non Compliance|0|||
23164461|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
23164462|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
23164463|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
23164464|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
23164465|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
23164466|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
23164467|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
23164468|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
23164469|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
23164470|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
23164471|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
23164472|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
23224844|NCT03073200|64564107|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224845|NCT03073200|64564108|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224846|NCT03073200|64564109|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23224847|NCT03073200|64564110|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
23164473|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
23164474|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
23164475|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
23164476|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
23164477|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
23164478|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
23164479|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
23164480|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
23164481|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
23164482|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
23164483|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
23224848|NCT03073200|64564111|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
23224849|NCT03073200|64564097|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224850|NCT03073200|64564098|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224851|NCT03073200|64564099|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224852|NCT03073200|64564100|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224853|NCT03073200|64564101|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224854|NCT03073200|64564102|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224855|NCT03073200|64564103|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224856|NCT03073200|64564104|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224857|NCT03073200|64564105|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224858|NCT03073200|64564106|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224859|NCT03073200|64564107|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224860|NCT03073200|64564108|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224861|NCT03073200|64564109|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224862|NCT03073200|64564110|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
23224863|NCT03073200|64564111|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
23224864|NCT03073200|64564097|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224865|NCT03073200|64564098|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224866|NCT03073200|64564099|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224867|NCT03073200|64564100|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224868|NCT03073200|64564101|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224869|NCT03073200|64564102|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224870|NCT03073200|64564103|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224871|NCT03073200|64564104|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224872|NCT03073200|64564105|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224873|NCT03073200|64564106|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224874|NCT03073200|64564107|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224875|NCT03073200|64564108|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224876|NCT03073200|64564109|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224877|NCT03073200|64564110|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
23224878|NCT03073200|64564111|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23224879|NCT03073200|64564097|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23164484|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
23447165|NCT00596752|65377896|FG000|Overall Study|Lack of Efficacy|4|||
23447166|NCT00596752|65377897|FG001|Overall Study|Lack of Efficacy|7|||
23447167|NCT00596752|65377896|FG000|Overall Study|Protocol Violation|1|||
23224880|NCT03073200|64564098|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224881|NCT03073200|64564099|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224882|NCT03073200|64564100|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224883|NCT03073200|64564101|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23572034|NCT01349660|65824679|FG000|Overall Study|Still Receiving Study Treatment|0|||
23572035|NCT01349660|65824680|FG001|Overall Study|Still Receiving Study Treatment|0|||
23572036|NCT01349660|65824681|FG002|Overall Study|Still Receiving Study Treatment|1|||
23224884|NCT03073200|64564102|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224885|NCT03073200|64564103|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23572037|NCT01349660|65824679|FG000|Overall Study|Disease Progression|2|||
23572038|NCT01349660|65824680|FG001|Overall Study|Disease Progression|4|||
23572039|NCT01349660|65824681|FG002|Overall Study|Disease Progression|50|||
23572040|NCT01349660|65824679|FG000|Overall Study|Adverse Event|1|||
23572041|NCT01349660|65824680|FG001|Overall Study|Adverse Event|1|||
23572042|NCT01349660|65824681|FG002|Overall Study|Adverse Event|12|||
23572043|NCT01349660|65824679|FG000|Overall Study|Withdrawal by Subject|2|||
23572044|NCT01349660|65824680|FG001|Overall Study|Withdrawal by Subject|0|||
23572045|NCT01349660|65824681|FG002|Overall Study|Withdrawal by Subject|9|||
23572046|NCT01349660|65824679|FG000|Overall Study|Death|1|||
23572047|NCT01349660|65824680|FG001|Overall Study|Death|1|||
23572048|NCT01349660|65824681|FG002|Overall Study|Death|0|||
23572049|NCT01349660|65824679|FG000|Overall Study|Non-Permitted Interventions|0|||
23572050|NCT01349660|65824680|FG001|Overall Study|Non-Permitted Interventions|0|||
23572051|NCT01349660|65824681|FG002|Overall Study|Non-Permitted Interventions|2|||
23572052|NCT01349660|65824679|FG000|Overall Study|Study Compliance|0|||
23572053|NCT01349660|65824680|FG001|Overall Study|Study Compliance|0|||
23572054|NCT01349660|65824681|FG002|Overall Study|Study Compliance|1|||
23572055|NCT01349660|65824679|FG000|Overall Study|Declining Performance Status|0|||
23572056|NCT01349660|65824680|FG001|Overall Study|Declining Performance Status|0|||
23572057|NCT01349660|65824681|FG002|Overall Study|Declining Performance Status|1|||
23572058|NCT04908683|65824682|FG000|Overall Study|Failure to meet continuation criteria|34|||
23572059|NCT04908683|65824683|FG001|Overall Study|Failure to meet continuation criteria|22|||
23572060|NCT04908683|65824682|FG000|Overall Study|Initiated prohibited medication|3|||
23572061|NCT04908683|65824683|FG001|Overall Study|Initiated prohibited medication|0|||
23572062|NCT04908683|65824682|FG000|Overall Study|Randomized by mistake|1|||
23572063|NCT04908683|65824683|FG001|Overall Study|Randomized by mistake|0|||
23572064|NCT04908683|65824682|FG000|Overall Study|Lost to Follow-up|679|||
23572065|NCT04908683|65824683|FG001|Overall Study|Lost to Follow-up|341|||
23572066|NCT04908683|65824682|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
23572067|NCT04908683|65824683|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
23572068|NCT04908683|65824682|FG000|Overall Study|Physician Decision|44|||
23572069|NCT04908683|65824683|FG001|Overall Study|Physician Decision|35|||
23572070|NCT04908683|65824682|FG000|Overall Study|Technical problems|12|||
23572071|NCT04908683|65824683|FG001|Overall Study|Technical problems|9|||
23572072|NCT04908683|65824682|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
23572073|NCT04908683|65824683|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
23572074|NCT04908683|65824682|FG000|Overall Study|Protocol Violation|2|||
23572075|NCT04908683|65824683|FG001|Overall Study|Protocol Violation|0|||
23572076|NCT04908683|65824682|FG000|Overall Study|Withdrawal by Subject|1188|||
23572077|NCT04908683|65824683|FG001|Overall Study|Withdrawal by Subject|570|||
23572078|NCT04908683|65824682|FG000|Overall Study|Site Closure by Sponsor|6|||
23572079|NCT04908683|65824683|FG001|Overall Study|Site Closure by Sponsor|3|||
23572080|NCT04908683|65824682|FG000|Overall Study|Adverse Event|21|||
23572081|NCT04908683|65824683|FG001|Overall Study|Adverse Event|11|||
23572082|NCT04908683|65824682|FG000|Overall Study|Death|101|||
23572083|NCT04908683|65824683|FG001|Overall Study|Death|61|||
23572084|NCT04908683|65824682|FG000|Overall Study|Sponsor's decision|14398|||
23572085|NCT04908683|65824683|FG001|Overall Study|Sponsor's decision|7205|||
23572086|NCT04908683|65824682|FG000|Overall Study|Other|92|||
23572087|NCT04908683|65824683|FG001|Overall Study|Other|50|||
23572088|NCT04908683|65824682|FG000|Overall Study|Randomized not vaccinated|108|||
23572089|NCT04908683|65824683|FG001|Overall Study|Randomized not vaccinated|52|||
23572090|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
23572091|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
23572092|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
23572093|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
23572094|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
23572095|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
23572096|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
23572097|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
23572098|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
23572099|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
23572100|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
23572101|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
23572102|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
23572103|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
23572104|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
23572105|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
23572106|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
23572107|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
23572108|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
23572109|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
23572110|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
23572111|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
23572112|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
23164485|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
23164486|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
23164487|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
23164488|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
23164489|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
23164490|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
23164491|NCT00784654|64348846|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
23164492|NCT00784654|64348847|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
23164493|NCT00784654|64348848|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
23164494|NCT00784654|64348846|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
23164495|NCT00784654|64348847|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
23164496|NCT00784654|64348848|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
23164497|NCT00784654|64348846|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
23164498|NCT00784654|64348847|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
23164499|NCT00784654|64348848|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
23164500|NCT00784654|64348846|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
23164501|NCT00784654|64348847|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
23164502|NCT00784654|64348848|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
23164503|NCT00784654|64348846|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
23164504|NCT00784654|64348847|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
23164505|NCT00784654|64348848|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
23164506|NCT00784654|64348846|FG000|Randomized Withdrawal Period|Adverse Event|0|||
23164507|NCT00784654|64348847|FG001|Randomized Withdrawal Period|Adverse Event|1|||
23164508|NCT00784654|64348848|FG002|Randomized Withdrawal Period|Adverse Event|1|||
23164509|NCT00784654|64348846|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
23164510|NCT00784654|64348847|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
23164511|NCT00784654|64348848|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
23164512|NCT00784654|64348846|FG000|Randomized Withdrawal Period|Family reasons|0|||
23164513|NCT00784654|64348847|FG001|Randomized Withdrawal Period|Family reasons|0|||
23164514|NCT00784654|64348848|FG002|Randomized Withdrawal Period|Family reasons|1|||
23224886|NCT03073200|64564104|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224887|NCT03073200|64564105|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224888|NCT03073200|64564106|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224889|NCT03073200|64564107|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224890|NCT03073200|64564108|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224891|NCT03073200|64564109|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224892|NCT03073200|64564110|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
23224893|NCT03073200|64564111|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
23224894|NCT02109744|64564114|FG000|Overall Study|Death|1|||
23224895|NCT02109744|64564115|FG001|Overall Study|Death|1|||
23224896|NCT02109744|64564114|FG000|Overall Study|no marrow exam|1|||
23224897|NCT02109744|64564115|FG001|Overall Study|no marrow exam|0|||
23224898|NCT00242710|64564118|FG000|Core Study (up to Year 1)|Adverse Event|30|||
23224899|NCT00242710|64564119|FG001|Core Study (up to Year 1)|Adverse Event|25|||
23224900|NCT00242710|64564120|FG002|Core Study (up to Year 1)|Adverse Event|23|||
23224901|NCT00242710|64564121|FG003|Core Study (up to Year 1)|Adverse Event|14|||
23224902|NCT00242710|64564118|FG000|Core Study (up to Year 1)|Death|0|||
23224903|NCT00242710|64564119|FG001|Core Study (up to Year 1)|Death|0|||
23224904|NCT00242710|64564120|FG002|Core Study (up to Year 1)|Death|1|||
23224905|NCT00242710|64564121|FG003|Core Study (up to Year 1)|Death|0|||
23224906|NCT00242710|64564118|FG000|Core Study (up to Year 1)|Physician Decision|0|||
23447168|NCT00596752|65377897|FG001|Overall Study|Protocol Violation|0|||
23164515|NCT01368835|64348849|FG000|Overall Study|Inclusion criteria/photography quality|22|||
23164516|NCT01368835|64348849|FG000|Overall Study|Lost to Follow-up|11|||
23164517|NCT04718974|64352425|FG000|Overall Study|Death|0|||
23572113|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
23164518|NCT04718974|64352426|FG001|Overall Study|Death|2|||
23164519|NCT04718974|64352425|FG000|Overall Study|Lost to Follow-up|10|||
23164520|NCT04718974|64352426|FG001|Overall Study|Lost to Follow-up|20|||
23164521|NCT04718974|64352425|FG000|Overall Study|Transferred out|2|||
23164522|NCT04718974|64352426|FG001|Overall Study|Transferred out|4|||
23164523|NCT03461757|64352427|FG000|Overall Study|Adverse Event|1|||
23164524|NCT03461757|64352428|FG001|Overall Study|Adverse Event|0|||
23164525|NCT03461757|64352427|FG000|Overall Study|Lost to Follow-up|13|||
23164526|NCT03461757|64352428|FG001|Overall Study|Lost to Follow-up|7|||
23164527|NCT03461757|64352427|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
23164528|NCT03461757|64352428|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
23164529|NCT03461757|64352427|FG000|Overall Study|Non-compliance with study treatment|0|||
23164530|NCT03461757|64352428|FG001|Overall Study|Non-compliance with study treatment|1|||
23164531|NCT03461757|64352427|FG000|Overall Study|Pregnancy|2|||
23164532|NCT03461757|64352428|FG001|Overall Study|Pregnancy|0|||
23164533|NCT03461757|64352427|FG000|Overall Study|Protocol Violation|1|||
23164534|NCT03461757|64352428|FG001|Overall Study|Protocol Violation|1|||
23164535|NCT03461757|64352427|FG000|Overall Study|Withdrawal by Subject|7|||
23572114|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
23572115|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
23572116|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
23572117|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
23572118|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
23572119|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
23572120|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
23572121|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
23572122|NCT03890120|65824686|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
23572123|NCT03890120|65824687|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
23572124|NCT03890120|65824688|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
23572125|NCT03890120|65824689|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
23572126|NCT03890120|65824686|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
23572127|NCT03890120|65824687|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
23572128|NCT03890120|65824688|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
23572129|NCT03890120|65824689|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
23572130|NCT03890120|65824686|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
23572131|NCT03890120|65824687|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
23572132|NCT03890120|65824688|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
23572133|NCT03890120|65824689|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
23572134|NCT03890120|65824686|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
23572135|NCT03890120|65824687|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
23572136|NCT03890120|65824688|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
23572137|NCT03890120|65824689|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
23572138|NCT03890120|65824686|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
23572139|NCT03890120|65824687|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
23572140|NCT03890120|65824688|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
23572141|NCT03890120|65824689|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
23572142|NCT04642469|65824690|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
23572143|NCT04642469|65824691|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
23572144|NCT04642469|65824690|FG000|Overall Study|Death|1|||
23572145|NCT04642469|65824691|FG001|Overall Study|Death|2|||
23572146|NCT04642469|65824690|FG000|Overall Study|Study/site closed following amendment 1|11|||
23572147|NCT04642469|65824691|FG001|Overall Study|Study/site closed following amendment 1|11|||
23572148|NCT04642469|65824690|FG000|Overall Study|Other|1|||
23572149|NCT04642469|65824691|FG001|Overall Study|Other|1|||
23572150|NCT04642469|65824690|FG000|Overall Study|Withdrawal by Subject|1|||
23572151|NCT04642469|65824691|FG001|Overall Study|Withdrawal by Subject|0|||
23572152|NCT01785628|65824697|FG000|Overall Study|Lost to Follow-up|2|||
23572153|NCT01785628|65824698|FG001|Overall Study|Lost to Follow-up|3|||
23572154|NCT03685708|65824699|FG000|Overall Study|Withdrawal by Subject|0|||
23572155|NCT03685708|65824700|FG001|Overall Study|Withdrawal by Subject|0|||
23572156|NCT03685708|65824701|FG002|Overall Study|Withdrawal by Subject|1|||
23572157|NCT03685708|65824699|FG000|Overall Study|Screen Fail|0|||
23572158|NCT03685708|65824700|FG001|Overall Study|Screen Fail|1|||
23164536|NCT03461757|64352428|FG001|Overall Study|Withdrawal by Subject|7|||
23447169|NCT03077919|65377898|FG000|Overall Study|Lost to Follow-up|4|||
23447170|NCT03077919|65377899|FG001|Overall Study|Lost to Follow-up|1|||
23164537|NCT03461757|64352427|FG000|Overall Study|Other Reasons|1|||
23164538|NCT03461757|64352428|FG001|Overall Study|Other Reasons|4|||
23572159|NCT03685708|65824701|FG002|Overall Study|Screen Fail|1|||
23572160|NCT03685708|65824699|FG000|Overall Study|COVID 19 Pandemic|1|||
23572161|NCT03685708|65824700|FG001|Overall Study|COVID 19 Pandemic|1|||
23572162|NCT03685708|65824701|FG002|Overall Study|COVID 19 Pandemic|6|||
23572163|NCT03685708|65824699|FG000|Overall Study|Disease Progression|0|||
23572164|NCT03685708|65824700|FG001|Overall Study|Disease Progression|0|||
23572165|NCT03685708|65824701|FG002|Overall Study|Disease Progression|1|||
23572166|NCT01625338|65824705|FG000|Overall Study|Enrolled but not Treated|0|||
23572167|NCT01625338|65824706|FG001|Overall Study|Enrolled but not Treated|0|||
23572168|NCT01625338|65824707|FG002|Overall Study|Enrolled but not Treated|1|||
23572169|NCT01625338|65824705|FG000|Overall Study|Efficacy Failure|27|||
23164539|NCT03972969|64352432|FG000|3-month Follow-up|Death|1|||
23447171|NCT00337207|65377902|FG000|Overall Study|Withdrawal by Subject|3|||
23572170|NCT01625338|65824706|FG001|Overall Study|Efficacy Failure|39|||
23572171|NCT01625338|65824707|FG002|Overall Study|Efficacy Failure|31|||
23572172|NCT01625338|65824705|FG000|Overall Study|Lost to Follow-up|3|||
23572173|NCT01625338|65824706|FG001|Overall Study|Lost to Follow-up|3|||
23447172|NCT02741596|65377903|FG000|Overall Study|Adverse Event|1|||
23447173|NCT02741596|65377904|FG001|Overall Study|Adverse Event|5|||
23447174|NCT02741596|65377903|FG000|Overall Study|Lost to Follow-up|1|||
23447175|NCT02741596|65377904|FG001|Overall Study|Lost to Follow-up|1|||
23447176|NCT02741596|65377903|FG000|Overall Study|Physician Decision|2|||
23572174|NCT01625338|65824707|FG002|Overall Study|Lost to Follow-up|2|||
23572175|NCT01625338|65824705|FG000|Overall Study|Investigator Decision|0|||
23572176|NCT01625338|65824706|FG001|Overall Study|Investigator Decision|2|||
23572177|NCT01625338|65824707|FG002|Overall Study|Investigator Decision|1|||
23572178|NCT01625338|65824705|FG000|Overall Study|Subject Withdrew Consent|1|||
23572179|NCT01625338|65824706|FG001|Overall Study|Subject Withdrew Consent|0|||
23572180|NCT01625338|65824707|FG002|Overall Study|Subject Withdrew Consent|2|||
23572181|NCT01625338|65824705|FG000|Overall Study|Adverse Event|1|||
23572182|NCT01625338|65824706|FG001|Overall Study|Adverse Event|0|||
23572183|NCT01625338|65824707|FG002|Overall Study|Adverse Event|1|||
23572184|NCT01625338|65824705|FG000|Overall Study|Study Discontinued by Sponsor|0|||
23572185|NCT01625338|65824706|FG001|Overall Study|Study Discontinued by Sponsor|0|||
23572186|NCT01625338|65824707|FG002|Overall Study|Study Discontinued by Sponsor|1|||
23572187|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
23572188|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
23572189|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
23572190|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
23572191|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
23572192|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
23572193|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
23572194|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
23572195|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
23572196|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
23572197|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
23572198|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
23572199|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
23572200|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
23572201|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
23572202|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
23572203|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
23572204|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
23572205|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
23572206|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
23572207|NCT02555371|65824709|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
23572208|NCT02555371|65824710|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
23572209|NCT02555371|65824711|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
23572210|NCT02555371|65824712|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
23572211|NCT02555371|65824713|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
23572212|NCT02555371|65824709|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
23572213|NCT02555371|65824710|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
23572214|NCT02555371|65824711|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
23164540|NCT03972969|64352433|FG001|3-month Follow-up|Death|1|||
23164541|NCT03972969|64352434|FG002|3-month Follow-up|Death|0|||
23164542|NCT03972969|64352432|FG000|6-month Follow-up|Death|1|||
23164543|NCT03972969|64352433|FG001|6-month Follow-up|Death|1|||
23164544|NCT03972969|64352434|FG002|6-month Follow-up|Death|1|||
23164545|NCT03972969|64352432|FG000|6-month Follow-up|Lost to Follow-up|2|||
23164546|NCT03972969|64352433|FG001|6-month Follow-up|Lost to Follow-up|2|||
23447177|NCT02741596|65377904|FG001|Overall Study|Physician Decision|1|||
23572215|NCT02555371|65824712|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
23164547|NCT03972969|64352434|FG002|6-month Follow-up|Lost to Follow-up|2|||
23447178|NCT02741596|65377903|FG000|Overall Study|Pregnancy|3|||
23447179|NCT02741596|65377904|FG001|Overall Study|Pregnancy|1|||
23447180|NCT02741596|65377903|FG000|Overall Study|Other (Unspecified)|0|||
23447181|NCT02741596|65377904|FG001|Overall Study|Other (Unspecified)|3|||
23447182|NCT02741596|65377903|FG000|Overall Study|Subject withdrawn-Other|17|||
23447183|NCT02741596|65377904|FG001|Overall Study|Subject withdrawn-Other|4|||
23447184|NCT02741596|65377903|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
23447185|NCT02741596|65377904|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
23447186|NCT01011673|65377905|FG000|Randomized|Secondary headache|2|||
23572216|NCT02555371|65824713|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
23572217|NCT02555371|65824709|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
23572218|NCT02555371|65824710|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
23572219|NCT02555371|65824711|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
23572220|NCT02555371|65824712|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
23572221|NCT02555371|65824713|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
23572222|NCT02555371|65824709|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
23572223|NCT02555371|65824710|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
23572224|NCT02555371|65824711|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
23572225|NCT02555371|65824712|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
23572226|NCT02555371|65824713|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
23572227|NCT02555371|65824709|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
23572228|NCT02555371|65824710|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
23572229|NCT02555371|65824711|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
23572230|NCT02555371|65824712|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
23572231|NCT02555371|65824713|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
23572232|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
23572233|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
23572234|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
23572235|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
23572236|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
23572237|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
23572238|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
23572239|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
23572240|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
23572241|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
23572242|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
23572243|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
23572244|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
23572245|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
23572246|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
23572247|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
23572248|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
23572249|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
23572250|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
23572251|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
23572252|NCT02555371|65824709|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
23572253|NCT02555371|65824710|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
23572254|NCT02555371|65824711|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
23572255|NCT02555371|65824712|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
23572256|NCT02555371|65824713|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
23572257|NCT02207374|65824719|FG000|Overall Study|Withdrawal by Subject|5|||
23572258|NCT02207374|65824720|FG001|Overall Study|Withdrawal by Subject|9|||
23572259|NCT02207374|65824721|FG002|Overall Study|Withdrawal by Subject|4|||
23572260|NCT02207374|65824719|FG000|Overall Study|Death|1|||
23572261|NCT02207374|65824720|FG001|Overall Study|Death|0|||
23572262|NCT02207374|65824721|FG002|Overall Study|Death|1|||
23572263|NCT02207374|65824719|FG000|Overall Study|Missing follow-up information|0|||
23572264|NCT02207374|65824720|FG001|Overall Study|Missing follow-up information|1|||
23572265|NCT02207374|65824721|FG002|Overall Study|Missing follow-up information|1|||
23572266|NCT03040687|65824726|FG000|Overall Study|Withdrawal by Subject|1|||
23572267|NCT03040687|65824727|FG001|Overall Study|Withdrawal by Subject|0|||
23572268|NCT03040687|65824728|FG002|Overall Study|Withdrawal by Subject|0|||
23332099|NCT01295827|64958986|FG009|Overall Study|Other|0|||
23447187|NCT01011673|65377906|FG001|Randomized|Secondary headache|1|||
23447188|NCT01011673|65377905|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
23572269|NCT01551303|65824730|FG000|Overall Study|failed awareness check on vision test|4|||
23572270|NCT01551303|65824731|FG001|Overall Study|failed awareness check on vision test|7|||
23572271|NCT00179010|65824734|FG000|Overall Study|Muscle probe defective|1|||
23572272|NCT00179010|65824735|FG001|Overall Study|Muscle probe defective|1|||
23572273|NCT00179010|65824734|FG000|Overall Study|Failure to place arterial line|0|||
23572274|NCT00179010|65824735|FG001|Overall Study|Failure to place arterial line|1|||
23572275|NCT02765490|65824749|FG000|Overall Study|Lost to Follow-up|1|||
23572276|NCT02765490|65824750|FG001|Overall Study|Lost to Follow-up|1|||
23572277|NCT02765490|65824749|FG000|Overall Study|Other|0|||
23164548|NCT00135668|64352435|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
23164549|NCT00135668|64352436|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
23164550|NCT00135668|64352437|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
23164551|NCT00135668|64352438|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
23164552|NCT02787863|64352439|FG000|Overall Study|Death|1|||
23164553|NCT02787863|64352440|FG001|Overall Study|Death|0|||
23164554|NCT02787863|64352441|FG002|Overall Study|Death|1|||
23164555|NCT02787863|64352442|FG003|Overall Study|Death|0|||
23572278|NCT02765490|65824750|FG001|Overall Study|Other|1|||
23572279|NCT02765490|65824749|FG000|Overall Study|Death|0|||
23572280|NCT02765490|65824750|FG001|Overall Study|Death|1|||
23572281|NCT03864926|65824751|FG000|Overall Study|Death|0|||
23572282|NCT03864926|65824752|FG001|Overall Study|Death|2|||
23572283|NCT00089895|65824753|FG000|Overall Study|Consent Withdrawn|11|||
23572284|NCT00089895|65824754|FG001|Overall Study|Consent Withdrawn|14|||
23572285|NCT00089895|65824753|FG000|Overall Study|Technical reason|7|||
23572286|NCT00089895|65824754|FG001|Overall Study|Technical reason|2|||
23572287|NCT00089895|65824753|FG000|Overall Study|Surgery|0|||
23572288|NCT00089895|65824754|FG001|Overall Study|Surgery|1|||
23572289|NCT00089895|65824753|FG000|Overall Study|Bleeding|0|||
23572290|NCT00089895|65824754|FG001|Overall Study|Bleeding|2|||
23572291|NCT00089895|65824753|FG000|Overall Study|Physician Decision|3|||
23572292|NCT00089895|65824754|FG001|Overall Study|Physician Decision|7|||
23572293|NCT00089895|65824753|FG000|Overall Study|Exclusion criteria met|6|||
23572294|NCT00089895|65824754|FG001|Overall Study|Exclusion criteria met|6|||
23572295|NCT00089895|65824753|FG000|Overall Study|Not otherwise specified|4|||
23572296|NCT00089895|65824754|FG001|Overall Study|Not otherwise specified|8|||
23572297|NCT00089895|65824753|FG000|Overall Study|Missing|4|||
23572298|NCT00089895|65824754|FG001|Overall Study|Missing|2|||
23572299|NCT04147260|65824758|FG000|Overall Study|Adverse Event|1|||
23572300|NCT04147260|65824759|FG001|Overall Study|Adverse Event|0|||
23572301|NCT04147260|65824760|FG002|Overall Study|Adverse Event|1|||
23572302|NCT04147260|65824761|FG003|Overall Study|Adverse Event|2|||
23572303|NCT04147260|65824762|FG004|Overall Study|Adverse Event|0|||
23572304|NCT04147260|65824758|FG000|Overall Study|Withdrawal by Subject|0|||
23572305|NCT04147260|65824759|FG001|Overall Study|Withdrawal by Subject|0|||
23572306|NCT04147260|65824760|FG002|Overall Study|Withdrawal by Subject|1|||
23572307|NCT04147260|65824761|FG003|Overall Study|Withdrawal by Subject|1|||
23572308|NCT04147260|65824762|FG004|Overall Study|Withdrawal by Subject|0|||
23572309|NCT01225822|65824763|FG000|Overall Study|Adverse Event|13|||
23572310|NCT01225822|65824764|FG001|Overall Study|Adverse Event|31|||
23572311|NCT01225822|65824765|FG002|Overall Study|Adverse Event|18|||
23572312|NCT01225822|65824766|FG003|Overall Study|Adverse Event|23|||
23572313|NCT01225822|65824767|FG004|Overall Study|Adverse Event|14|||
23572314|NCT01225822|65824763|FG000|Overall Study|Protocol Violation|6|||
23572315|NCT01225822|65824764|FG001|Overall Study|Protocol Violation|8|||
23572316|NCT01225822|65824765|FG002|Overall Study|Protocol Violation|6|||
23572317|NCT01225822|65824766|FG003|Overall Study|Protocol Violation|7|||
23572318|NCT01225822|65824767|FG004|Overall Study|Protocol Violation|4|||
23164556|NCT02787863|64352443|FG004|Overall Study|Death|0|||
23164557|NCT02787863|64352444|FG005|Overall Study|Death|0|||
23572319|NCT01225822|65824763|FG000|Overall Study|Lost to Follow-up|0|||
23572320|NCT01225822|65824764|FG001|Overall Study|Lost to Follow-up|0|||
23572321|NCT01225822|65824765|FG002|Overall Study|Lost to Follow-up|0|||
23164558|NCT02787863|64352445|FG006|Overall Study|Death|0|||
23572322|NCT01225822|65824766|FG003|Overall Study|Lost to Follow-up|1|||
23572323|NCT01225822|65824767|FG004|Overall Study|Lost to Follow-up|0|||
23572324|NCT01225822|65824763|FG000|Overall Study|Withdrawal by Subject|6|||
23572325|NCT01225822|65824764|FG001|Overall Study|Withdrawal by Subject|7|||
23572326|NCT01225822|65824765|FG002|Overall Study|Withdrawal by Subject|7|||
23572327|NCT01225822|65824766|FG003|Overall Study|Withdrawal by Subject|11|||
23572328|NCT01225822|65824767|FG004|Overall Study|Withdrawal by Subject|6|||
23572329|NCT01225822|65824763|FG000|Overall Study|Other|13|||
23572330|NCT01225822|65824764|FG001|Overall Study|Other|10|||
23164559|NCT02787863|64352446|FG007|Overall Study|Death|0|||
23572331|NCT01225822|65824765|FG002|Overall Study|Other|7|||
23572332|NCT01225822|65824766|FG003|Overall Study|Other|10|||
23572333|NCT01225822|65824767|FG004|Overall Study|Other|7|||
23164560|NCT02787863|64352439|FG000|Overall Study|Withdrawal by Subject|0|||
23164561|NCT02787863|64352440|FG001|Overall Study|Withdrawal by Subject|1|||
23164562|NCT02787863|64352441|FG002|Overall Study|Withdrawal by Subject|1|||
23447189|NCT01011673|65377906|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
23447190|NCT03347123|65377907|FG000|Overall Study|Death|1|||
23572334|NCT00584805|65824768|FG000|Overall Study|No longer at risk of exposure|39|||
23572335|NCT00584805|65824768|FG000|Overall Study|Relocation|36|||
23572336|NCT00584805|65824768|FG000|Overall Study|Withdrawal by Subject|18|||
23572337|NCT00584805|65824768|FG000|Overall Study|Non-compliance|1|||
23572338|NCT00584805|65824768|FG000|Overall Study|Lost to follow up|3|||
23572339|NCT00584805|65824768|FG000|Overall Study|Screen failures|2|||
23572340|NCT01468922|65824769|FG000|Overall Study|Screening failure|0|||
23572341|NCT01468922|65824770|FG001|Overall Study|Screening failure|0|||
23572342|NCT01468922|65824771|FG002|Overall Study|Screening failure|0|||
23572343|NCT01468922|65824772|FG003|Overall Study|Screening failure|0|||
23572344|NCT01468922|65824773|FG004|Overall Study|Screening failure|0|||
23572345|NCT01468922|65824774|FG005|Overall Study|Screening failure|0|||
23572346|NCT01468922|65824775|FG006|Overall Study|Screening failure|0|||
23572347|NCT01468922|65824776|FG007|Overall Study|Screening failure|0|||
23572348|NCT01468922|65824777|FG008|Overall Study|Screening failure|1|||
23572349|NCT01468922|65824769|FG000|Overall Study|Per patient choice|1|||
23572350|NCT01468922|65824770|FG001|Overall Study|Per patient choice|0|||
23572351|NCT01468922|65824771|FG002|Overall Study|Per patient choice|0|||
23572352|NCT01468922|65824772|FG003|Overall Study|Per patient choice|0|||
23572353|NCT01468922|65824773|FG004|Overall Study|Per patient choice|0|||
23572354|NCT01468922|65824774|FG005|Overall Study|Per patient choice|0|||
23572355|NCT01468922|65824775|FG006|Overall Study|Per patient choice|0|||
23572356|NCT01468922|65824776|FG007|Overall Study|Per patient choice|0|||
23572357|NCT01468922|65824777|FG008|Overall Study|Per patient choice|0|||
23572358|NCT01468922|65824769|FG000|Overall Study|Switched to alternative treatment|1|||
23572359|NCT01468922|65824770|FG001|Overall Study|Switched to alternative treatment|0|||
23572360|NCT01468922|65824771|FG002|Overall Study|Switched to alternative treatment|0|||
23572361|NCT01468922|65824772|FG003|Overall Study|Switched to alternative treatment|0|||
23572362|NCT01468922|65824773|FG004|Overall Study|Switched to alternative treatment|1|||
23572363|NCT01468922|65824774|FG005|Overall Study|Switched to alternative treatment|0|||
23572364|NCT01468922|65824775|FG006|Overall Study|Switched to alternative treatment|0|||
23572365|NCT01468922|65824776|FG007|Overall Study|Switched to alternative treatment|0|||
23572366|NCT01468922|65824777|FG008|Overall Study|Switched to alternative treatment|0|||
23572367|NCT01468922|65824769|FG000|Overall Study|Enrolled on new protocol|0|||
23572368|NCT01468922|65824770|FG001|Overall Study|Enrolled on new protocol|0|||
23572369|NCT01468922|65824771|FG002|Overall Study|Enrolled on new protocol|0|||
23572370|NCT01468922|65824772|FG003|Overall Study|Enrolled on new protocol|0|||
23572371|NCT01468922|65824773|FG004|Overall Study|Enrolled on new protocol|1|||
23572372|NCT01468922|65824774|FG005|Overall Study|Enrolled on new protocol|0|||
23572373|NCT01468922|65824775|FG006|Overall Study|Enrolled on new protocol|0|||
23572374|NCT01468922|65824776|FG007|Overall Study|Enrolled on new protocol|0|||
23572375|NCT01468922|65824777|FG008|Overall Study|Enrolled on new protocol|0|||
23572376|NCT01468922|65824769|FG000|Overall Study|Adverse Event|0|||
23572377|NCT01468922|65824770|FG001|Overall Study|Adverse Event|0|||
23572378|NCT01468922|65824771|FG002|Overall Study|Adverse Event|0|||
23572379|NCT01468922|65824772|FG003|Overall Study|Adverse Event|0|||
23572380|NCT01468922|65824773|FG004|Overall Study|Adverse Event|0|||
23572381|NCT01468922|65824774|FG005|Overall Study|Adverse Event|0|||
23572382|NCT01468922|65824775|FG006|Overall Study|Adverse Event|0|||
23572383|NCT01468922|65824776|FG007|Overall Study|Adverse Event|1|||
23572384|NCT01468922|65824777|FG008|Overall Study|Adverse Event|0|||
23572385|NCT01468922|65824769|FG000|Overall Study|Infection of blood|0|||
23572386|NCT01468922|65824770|FG001|Overall Study|Infection of blood|0|||
23572387|NCT01468922|65824771|FG002|Overall Study|Infection of blood|0|||
23572388|NCT01468922|65824772|FG003|Overall Study|Infection of blood|0|||
23164563|NCT02787863|64352442|FG003|Overall Study|Withdrawal by Subject|0|||
23447191|NCT03347123|65377908|FG001|Overall Study|Death|2|||
23447192|NCT03347123|65377909|FG002|Overall Study|Death|0|||
23447193|NCT03347123|65377910|FG003|Overall Study|Death|0|||
23572389|NCT01468922|65824773|FG004|Overall Study|Infection of blood|0|||
23572390|NCT01468922|65824774|FG005|Overall Study|Infection of blood|0|||
23572391|NCT01468922|65824775|FG006|Overall Study|Infection of blood|0|||
23572392|NCT01468922|65824776|FG007|Overall Study|Infection of blood|1|||
23572393|NCT01468922|65824777|FG008|Overall Study|Infection of blood|0|||
23572394|NCT01468922|65824769|FG000|Overall Study|Patient choice - surgery|0|||
23572395|NCT01468922|65824770|FG001|Overall Study|Patient choice - surgery|0|||
23572396|NCT01468922|65824771|FG002|Overall Study|Patient choice - surgery|0|||
23572397|NCT01468922|65824772|FG003|Overall Study|Patient choice - surgery|0|||
23572398|NCT01468922|65824773|FG004|Overall Study|Patient choice - surgery|0|||
23572399|NCT01468922|65824774|FG005|Overall Study|Patient choice - surgery|0|||
23572400|NCT01468922|65824775|FG006|Overall Study|Patient choice - surgery|0|||
23447194|NCT03347123|65377911|FG004|Overall Study|Death|0|||
23572401|NCT01468922|65824776|FG007|Overall Study|Patient choice - surgery|1|||
23572402|NCT01468922|65824777|FG008|Overall Study|Patient choice - surgery|0|||
23572403|NCT01468922|65824769|FG000|Overall Study|Refused further treatment|0|||
23572404|NCT01468922|65824770|FG001|Overall Study|Refused further treatment|0|||
23572405|NCT01468922|65824771|FG002|Overall Study|Refused further treatment|0|||
23572406|NCT01468922|65824772|FG003|Overall Study|Refused further treatment|0|||
23572407|NCT01468922|65824773|FG004|Overall Study|Refused further treatment|0|||
23572408|NCT01468922|65824774|FG005|Overall Study|Refused further treatment|0|||
23572409|NCT01468922|65824775|FG006|Overall Study|Refused further treatment|0|||
23572410|NCT01468922|65824776|FG007|Overall Study|Refused further treatment|1|||
23572411|NCT01468922|65824777|FG008|Overall Study|Refused further treatment|0|||
23572412|NCT03518658|65824781|FG000|Overall Study|Other|51|||
23572413|NCT03518658|65824782|FG001|Overall Study|Other|0|||
23572414|NCT04424290|65824783|FG000|Overall Study|Not treated|0|||
23572415|NCT04424290|65824784|FG001|Overall Study|Not treated|0|||
23572416|NCT04424290|65824785|FG002|Overall Study|Not treated|1|||
23572417|NCT04424290|65824786|FG003|Overall Study|Not treated|0|||
23572418|NCT04424290|65824787|FG004|Overall Study|Not treated|1|||
23572419|NCT04424290|65824783|FG000|Overall Study|Adverse Event|0|||
23572420|NCT04424290|65824784|FG001|Overall Study|Adverse Event|0|||
23572421|NCT04424290|65824785|FG002|Overall Study|Adverse Event|0|||
23572422|NCT04424290|65824786|FG003|Overall Study|Adverse Event|2|||
23572423|NCT04424290|65824787|FG004|Overall Study|Adverse Event|0|||
23572424|NCT04424290|65824783|FG000|Overall Study|Withdrawal by Subject|0|||
23572425|NCT04424290|65824784|FG001|Overall Study|Withdrawal by Subject|0|||
23164564|NCT02787863|64352443|FG004|Overall Study|Withdrawal by Subject|0|||
23164565|NCT02787863|64352444|FG005|Overall Study|Withdrawal by Subject|0|||
23164566|NCT02787863|64352445|FG006|Overall Study|Withdrawal by Subject|0|||
23164567|NCT02787863|64352446|FG007|Overall Study|Withdrawal by Subject|0|||
23164568|NCT00732303|64352451|FG000|Overall Study|Study Terminated|2|||
23164569|NCT03099187|64352455|FG000|Double-blind Treatment|Adverse Event|19|||
23164570|NCT03099187|64352456|FG001|Double-blind Treatment|Adverse Event|1|||
23164571|NCT03099187|64352457|FG002|Double-blind Treatment|Adverse Event|0|||
23164572|NCT03099187|64352458|FG003|Double-blind Treatment|Adverse Event|0|||
23164573|NCT03099187|64352455|FG000|Double-blind Treatment|Death|1|||
23164574|NCT03099187|64352456|FG001|Double-blind Treatment|Death|3|||
23164575|NCT03099187|64352457|FG002|Double-blind Treatment|Death|0|||
23164576|NCT03099187|64352458|FG003|Double-blind Treatment|Death|0|||
23164577|NCT03099187|64352455|FG000|Double-blind Treatment|Lack of Efficacy|1|||
23164578|NCT03099187|64352456|FG001|Double-blind Treatment|Lack of Efficacy|0|||
23164579|NCT03099187|64352457|FG002|Double-blind Treatment|Lack of Efficacy|0|||
23164580|NCT03099187|64352458|FG003|Double-blind Treatment|Lack of Efficacy|0|||
23164581|NCT03099187|64352455|FG000|Double-blind Treatment|Physician Decision|2|||
23332100|NCT01295827|64958987|FG010|Overall Study|Other|2|||
23164582|NCT03099187|64352456|FG001|Double-blind Treatment|Physician Decision|1|||
23572426|NCT04424290|65824785|FG002|Overall Study|Withdrawal by Subject|0|||
23572427|NCT04424290|65824786|FG003|Overall Study|Withdrawal by Subject|0|||
23572428|NCT04424290|65824787|FG004|Overall Study|Withdrawal by Subject|1|||
23572429|NCT04424290|65824783|FG000|Overall Study|Other than listed|0|||
23572430|NCT04424290|65824784|FG001|Overall Study|Other than listed|0|||
23164583|NCT03099187|64352457|FG002|Double-blind Treatment|Physician Decision|0|||
23164584|NCT03099187|64352458|FG003|Double-blind Treatment|Physician Decision|0|||
23164585|NCT03099187|64352455|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
23572431|NCT04424290|65824785|FG002|Overall Study|Other than listed|0|||
23164586|NCT03099187|64352456|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
23224907|NCT00242710|64564119|FG001|Core Study (up to Year 1)|Physician Decision|1|||
23224908|NCT00242710|64564120|FG002|Core Study (up to Year 1)|Physician Decision|0|||
23224909|NCT00242710|64564121|FG003|Core Study (up to Year 1)|Physician Decision|1|||
23224910|NCT00242710|64564118|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
23224911|NCT00242710|64564119|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
23224912|NCT00242710|64564120|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
23224913|NCT00242710|64564121|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
23224914|NCT00242710|64564118|FG000|Core Study (up to Year 1)|Other|6|||
23224915|NCT00242710|64564119|FG001|Core Study (up to Year 1)|Other|1|||
23224916|NCT00242710|64564120|FG002|Core Study (up to Year 1)|Other|0|||
23224917|NCT00242710|64564121|FG003|Core Study (up to Year 1)|Other|2|||
23224918|NCT00242710|64564118|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
23224919|NCT00242710|64564119|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
23224920|NCT00242710|64564120|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
23224921|NCT00242710|64564121|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
23224922|NCT00242710|64564118|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
23224923|NCT00242710|64564119|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
23224924|NCT00242710|64564120|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
23224925|NCT00242710|64564121|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
23224926|NCT00242710|64564118|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
23224927|NCT00242710|64564119|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
23224928|NCT00242710|64564120|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
23224929|NCT00242710|64564121|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
23224930|NCT00242710|64564118|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
23224931|NCT00242710|64564119|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
23224932|NCT00242710|64564120|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
23224933|NCT00242710|64564121|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
23224934|NCT00242710|64564118|FG000|Period Between Core Study and Extension|Adverse Event|2|||
23224935|NCT00242710|64564119|FG001|Period Between Core Study and Extension|Adverse Event|3|||
23224936|NCT00242710|64564120|FG002|Period Between Core Study and Extension|Adverse Event|5|||
23224937|NCT00242710|64564121|FG003|Period Between Core Study and Extension|Adverse Event|2|||
23224938|NCT00242710|64564118|FG000|Period Between Core Study and Extension|Physician Decision|1|||
23572432|NCT04424290|65824786|FG003|Overall Study|Other than listed|1|||
23572433|NCT04424290|65824787|FG004|Overall Study|Other than listed|0|||
23572434|NCT01681368|65824788|FG000|Overall Study|Refused further treatment|1|||
23572435|NCT01681368|65824788|FG000|Overall Study|Refused further follow up|1|||
23572436|NCT00358215|65824791|FG000|Overall Study|Ineligibility determined|4|||
23572437|NCT00358215|65824792|FG001|Overall Study|Ineligibility determined|3|||
23572438|NCT00358215|65824791|FG000|Overall Study|Adverse Event|83|||
23572439|NCT00358215|65824792|FG001|Overall Study|Adverse Event|65|||
23572440|NCT00358215|65824791|FG000|Overall Study|Withdrawal by Subject|111|||
23572441|NCT00358215|65824792|FG001|Overall Study|Withdrawal by Subject|102|||
23572442|NCT00358215|65824791|FG000|Overall Study|Participant request|65|||
23572443|NCT00358215|65824792|FG001|Overall Study|Participant request|64|||
23572444|NCT00358215|65824791|FG000|Overall Study|Physician Decision|47|||
23572445|NCT00358215|65824792|FG001|Overall Study|Physician Decision|39|||
23332101|NCT01295827|64958988|FG011|Overall Study|Other|0|||
23572446|NCT00358215|65824791|FG000|Overall Study|Lost to Follow-up|16|||
23572447|NCT00358215|65824792|FG001|Overall Study|Lost to Follow-up|22|||
23572448|NCT00358215|65824791|FG000|Overall Study|Death|265|||
23224939|NCT00242710|64564119|FG001|Period Between Core Study and Extension|Physician Decision|1|||
23224940|NCT00242710|64564120|FG002|Period Between Core Study and Extension|Physician Decision|0|||
23224941|NCT00242710|64564121|FG003|Period Between Core Study and Extension|Physician Decision|0|||
23224942|NCT00242710|64564118|FG000|Period Between Core Study and Extension|Other|24|||
23224943|NCT00242710|64564119|FG001|Period Between Core Study and Extension|Other|24|||
23224944|NCT00242710|64564120|FG002|Period Between Core Study and Extension|Other|9|||
23224945|NCT00242710|64564121|FG003|Period Between Core Study and Extension|Other|11|||
23224946|NCT00242710|64564118|FG000|Period Between Core Study and Extension|Extension not Available|17|||
23224947|NCT00242710|64564119|FG001|Period Between Core Study and Extension|Extension not Available|21|||
23224948|NCT00242710|64564120|FG002|Period Between Core Study and Extension|Extension not Available|8|||
23224949|NCT00242710|64564121|FG003|Period Between Core Study and Extension|Extension not Available|7|||
23164587|NCT03099187|64352457|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
23164588|NCT03099187|64352458|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
23164589|NCT03099187|64352455|FG000|Double-blind Treatment|Lung transplantation|0|||
23164590|NCT03099187|64352456|FG001|Double-blind Treatment|Lung transplantation|1|||
23164591|NCT03099187|64352457|FG002|Double-blind Treatment|Lung transplantation|0|||
23164592|NCT03099187|64352458|FG003|Double-blind Treatment|Lung transplantation|0|||
23164593|NCT03099187|64352455|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
23164594|NCT03099187|64352456|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
23164595|NCT03099187|64352457|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
23164596|NCT03099187|64352458|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
23224950|NCT00242710|64564118|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
23224951|NCT00242710|64564119|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
23224952|NCT00242710|64564120|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
23224953|NCT00242710|64564121|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
23224954|NCT00242710|64564118|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
23224955|NCT00242710|64564119|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
23224956|NCT00242710|64564120|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
23224957|NCT00242710|64564121|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
23224958|NCT00242710|64564118|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
23224959|NCT00242710|64564119|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
23224960|NCT00242710|64564120|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
23224961|NCT00242710|64564121|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
23224962|NCT00242710|64564118|FG000|Study Extension (up to Year 2)|Death|0|||
23224963|NCT00242710|64564119|FG001|Study Extension (up to Year 2)|Death|0|||
23224964|NCT00242710|64564120|FG002|Study Extension (up to Year 2)|Death|0|||
23447195|NCT03347123|65377912|FG005|Overall Study|Death|0|||
23447196|NCT03347123|65377913|FG006|Overall Study|Death|0|||
23447197|NCT03347123|65377907|FG000|Overall Study|Withdrawal by Subject|1|||
23447198|NCT03347123|65377908|FG001|Overall Study|Withdrawal by Subject|0|||
23447199|NCT03347123|65377909|FG002|Overall Study|Withdrawal by Subject|0|||
23447200|NCT03347123|65377910|FG003|Overall Study|Withdrawal by Subject|0|||
23447201|NCT03347123|65377911|FG004|Overall Study|Withdrawal by Subject|0|||
23447202|NCT03347123|65377912|FG005|Overall Study|Withdrawal by Subject|0|||
23447203|NCT03347123|65377913|FG006|Overall Study|Withdrawal by Subject|0|||
23447204|NCT03347123|65377907|FG000|Overall Study|Reason not Specified|3|||
23447205|NCT03347123|65377908|FG001|Overall Study|Reason not Specified|4|||
23447206|NCT03347123|65377909|FG002|Overall Study|Reason not Specified|0|||
23447207|NCT03347123|65377910|FG003|Overall Study|Reason not Specified|0|||
23447208|NCT03347123|65377911|FG004|Overall Study|Reason not Specified|0|||
23447209|NCT03347123|65377912|FG005|Overall Study|Reason not Specified|0|||
23447210|NCT03347123|65377913|FG006|Overall Study|Reason not Specified|0|||
23447211|NCT02814175|65377914|FG000|Part 1|Adverse Event|2|||
23447212|NCT02814175|65377915|FG001|Part 1|Adverse Event|3|||
23447213|NCT02814175|65377916|FG002|Part 1|Adverse Event|0|||
23447214|NCT02814175|65377917|FG003|Part 1|Adverse Event|0|||
23447215|NCT02814175|65377918|FG004|Part 1|Adverse Event|0|||
23447216|NCT02814175|65377919|FG005|Part 1|Adverse Event|0|||
23447217|NCT02814175|65377914|FG000|Part 1|Withdrawal Consent|8|||
23447218|NCT02814175|65377915|FG001|Part 1|Withdrawal Consent|1|||
23447219|NCT02814175|65377916|FG002|Part 1|Withdrawal Consent|0|||
23447220|NCT02814175|65377917|FG003|Part 1|Withdrawal Consent|0|||
23447221|NCT02814175|65377918|FG004|Part 1|Withdrawal Consent|0|||
23447222|NCT02814175|65377919|FG005|Part 1|Withdrawal Consent|0|||
23447223|NCT02814175|65377914|FG000|Part 1|Lost to Follow-up|1|||
23164597|NCT03099187|64352455|FG000|Double-blind Treatment|Disease progression|0|||
23447224|NCT02814175|65377915|FG001|Part 1|Lost to Follow-up|0|||
23447225|NCT02814175|65377916|FG002|Part 1|Lost to Follow-up|0|||
23164598|NCT03099187|64352456|FG001|Double-blind Treatment|Disease progression|1|||
23164599|NCT03099187|64352457|FG002|Double-blind Treatment|Disease progression|0|||
23447226|NCT02814175|65377917|FG003|Part 1|Lost to Follow-up|0|||
23447227|NCT02814175|65377918|FG004|Part 1|Lost to Follow-up|0|||
23447228|NCT02814175|65377919|FG005|Part 1|Lost to Follow-up|0|||
23447229|NCT02814175|65377914|FG000|Part 1|Lack of Efficacy|1|||
23447230|NCT02814175|65377915|FG001|Part 1|Lack of Efficacy|2|||
23447231|NCT02814175|65377916|FG002|Part 1|Lack of Efficacy|0|||
23447232|NCT02814175|65377917|FG003|Part 1|Lack of Efficacy|0|||
23447233|NCT02814175|65377918|FG004|Part 1|Lack of Efficacy|0|||
23447234|NCT02814175|65377919|FG005|Part 1|Lack of Efficacy|0|||
23447235|NCT02814175|65377914|FG000|Part 2|Adverse Event|0|||
23447236|NCT02814175|65377915|FG001|Part 2|Adverse Event|0|||
23447237|NCT02814175|65377916|FG002|Part 2|Adverse Event|0|||
23447238|NCT02814175|65377917|FG003|Part 2|Adverse Event|1|||
23447239|NCT02814175|65377918|FG004|Part 2|Adverse Event|1|||
23447240|NCT02814175|65377919|FG005|Part 2|Adverse Event|2|||
23447241|NCT02814175|65377914|FG000|Part 2|Withdrawal Consent|0|||
23447242|NCT02814175|65377915|FG001|Part 2|Withdrawal Consent|0|||
23447243|NCT02814175|65377916|FG002|Part 2|Withdrawal Consent|0|||
23447244|NCT02814175|65377917|FG003|Part 2|Withdrawal Consent|2|||
23447245|NCT02814175|65377918|FG004|Part 2|Withdrawal Consent|1|||
23447246|NCT02814175|65377919|FG005|Part 2|Withdrawal Consent|1|||
23447247|NCT02814175|65377914|FG000|Part 2|Lost to Follow-up|0|||
23447248|NCT02814175|65377915|FG001|Part 2|Lost to Follow-up|0|||
23447249|NCT02814175|65377916|FG002|Part 2|Lost to Follow-up|0|||
23447250|NCT02814175|65377917|FG003|Part 2|Lost to Follow-up|1|||
23447251|NCT02814175|65377918|FG004|Part 2|Lost to Follow-up|0|||
23447252|NCT02814175|65377919|FG005|Part 2|Lost to Follow-up|0|||
23447253|NCT02814175|65377914|FG000|Part 2|Lack of Efficacy|0|||
23447254|NCT02814175|65377915|FG001|Part 2|Lack of Efficacy|0|||
23572449|NCT00358215|65824792|FG001|Overall Study|Death|281|||
23572450|NCT00358215|65824791|FG000|Overall Study|Protocol Violation|64|||
23572451|NCT00358215|65824792|FG001|Overall Study|Protocol Violation|59|||
23572452|NCT00358215|65824791|FG000|Overall Study|Pregnancy|1|||
23572453|NCT00358215|65824792|FG001|Overall Study|Pregnancy|0|||
23572454|NCT00358215|65824791|FG000|Overall Study|Other|21|||
23572455|NCT00358215|65824792|FG001|Overall Study|Other|14|||
23572456|NCT00358215|65824791|FG000|Overall Study|Did not receive investigational product|2|||
23572457|NCT00358215|65824792|FG001|Overall Study|Did not receive investigational product|3|||
23572458|NCT02494206|65824795|FG000|Overall Study|Adverse Event|1|||
23572459|NCT02494206|65824795|FG000|Overall Study|Disease Progression|1|||
23572460|NCT03537261|65824804|FG000|Overall Study|Lost to Follow-up|4|||
23572461|NCT03537261|65824805|FG001|Overall Study|Lost to Follow-up|5|||
23572462|NCT03537261|65824804|FG000|Overall Study|Withdrawal by Subject|4|||
23572463|NCT03537261|65824805|FG001|Overall Study|Withdrawal by Subject|6|||
23572464|NCT03537261|65824804|FG000|Overall Study|Did not return study questionnaires|0|||
23572465|NCT03537261|65824805|FG001|Overall Study|Did not return study questionnaires|1|||
23572466|NCT03688711|65824806|FG000|Overall Study|Withdrawal by Subject|0|||
23572467|NCT03688711|65824807|FG001|Overall Study|Withdrawal by Subject|1|||
23572468|NCT02743793|65824808|FG000|Overall Study|Death|1|||
23572469|NCT02743793|65824809|FG001|Overall Study|Death|1|||
23572470|NCT02743793|65824808|FG000|Overall Study|Withdrawal by Subject|0|||
23572471|NCT02743793|65824809|FG001|Overall Study|Withdrawal by Subject|1|||
23572472|NCT02743793|65824808|FG000|Overall Study|Screen Failure|4|||
23572473|NCT02743793|65824809|FG001|Overall Study|Screen Failure|0|||
23572474|NCT02743793|65824808|FG000|Overall Study|No Primary Care Physician|0|||
23572475|NCT02743793|65824809|FG001|Overall Study|No Primary Care Physician|1|||
23572476|NCT02743793|65824808|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
23572477|NCT02743793|65824809|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
23572478|NCT02743793|65824808|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
23572479|NCT02743793|65824809|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
23572480|NCT04039503|65824810|FG000|Overall Study|Adverse Event|3|||
23572481|NCT04039503|65824811|FG001|Overall Study|Adverse Event|0|||
23572482|NCT04039503|65824812|FG002|Overall Study|Adverse Event|2|||
23572483|NCT04039503|65824813|FG003|Overall Study|Adverse Event|0|||
23572484|NCT04039503|65824810|FG000|Overall Study|Lost to Follow-up|0|||
23572485|NCT04039503|65824811|FG001|Overall Study|Lost to Follow-up|0|||
23572486|NCT04039503|65824812|FG002|Overall Study|Lost to Follow-up|1|||
23447255|NCT02814175|65377916|FG002|Part 2|Lack of Efficacy|0|||
23447256|NCT02814175|65377917|FG003|Part 2|Lack of Efficacy|0|||
23447257|NCT02814175|65377918|FG004|Part 2|Lack of Efficacy|0|||
23447258|NCT02814175|65377919|FG005|Part 2|Lack of Efficacy|3|||
23572487|NCT04039503|65824813|FG003|Overall Study|Lost to Follow-up|0|||
23572488|NCT04039503|65824810|FG000|Overall Study|Protocol Violation|0|||
23572489|NCT04039503|65824811|FG001|Overall Study|Protocol Violation|1|||
23572490|NCT04039503|65824812|FG002|Overall Study|Protocol Violation|2|||
23447259|NCT03551626|65377920|FG000|Overall Study|Adverse Event|88|||
23447260|NCT03551626|65377920|FG000|Overall Study|Disease relapse|18|||
23447261|NCT03551626|65377920|FG000|Overall Study|Withdrawal of informed consent|6|||
23447262|NCT03551626|65377920|FG000|Overall Study|Patient decision|5|||
23572491|NCT04039503|65824813|FG003|Overall Study|Protocol Violation|1|||
23572492|NCT04039503|65824810|FG000|Overall Study|Withdrawal by Subject|4|||
23572493|NCT04039503|65824811|FG001|Overall Study|Withdrawal by Subject|3|||
23572494|NCT04039503|65824812|FG002|Overall Study|Withdrawal by Subject|5|||
23572495|NCT04039503|65824813|FG003|Overall Study|Withdrawal by Subject|2|||
23224965|NCT00242710|64564121|FG003|Study Extension (up to Year 2)|Death|1|||
23224966|NCT00242710|64564118|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
23224967|NCT00242710|64564119|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
23224968|NCT00242710|64564120|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
23224969|NCT00242710|64564121|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
23224970|NCT00242710|64564118|FG000|Study Extension (up to Year 2)|Other|3|||
23224971|NCT00242710|64564119|FG001|Study Extension (up to Year 2)|Other|5|||
23224972|NCT00242710|64564120|FG002|Study Extension (up to Year 2)|Other|4|||
23224973|NCT00242710|64564121|FG003|Study Extension (up to Year 2)|Other|3|||
23224974|NCT00242710|64564118|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
23224975|NCT00242710|64564119|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
23224976|NCT00242710|64564120|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
23224977|NCT00242710|64564121|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
23224978|NCT00242710|64564118|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
23224979|NCT00242710|64564119|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
23224980|NCT00242710|64564120|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
23224981|NCT00242710|64564121|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
23224982|NCT02635867|64564123|FG000|Overall Study|Lost to Follow-up|4|||
23224983|NCT02635867|64564124|FG001|Overall Study|Lost to Follow-up|3|||
23224984|NCT02635867|64564125|FG002|Overall Study|Lost to Follow-up|3|||
23224985|NCT02635867|64564126|FG003|Overall Study|Lost to Follow-up|4|||
23224986|NCT02635867|64564127|FG004|Overall Study|Lost to Follow-up|1|||
23224987|NCT02415595|64564128|FG000|Overall Study|Administrative reason by sponsor|39|||
23224988|NCT02415595|64564129|FG001|Overall Study|Administrative reason by sponsor|40|||
23224989|NCT02415595|64564130|FG002|Overall Study|Administrative reason by sponsor|41|||
23224990|NCT02415595|64564131|FG003|Overall Study|Administrative reason by sponsor|39|||
23224991|NCT02415595|64564128|FG000|Overall Study|Adverse Event|1|||
23224992|NCT02415595|64564129|FG001|Overall Study|Adverse Event|3|||
23224993|NCT02415595|64564130|FG002|Overall Study|Adverse Event|5|||
23224994|NCT02415595|64564131|FG003|Overall Study|Adverse Event|10|||
23224995|NCT02415595|64564128|FG000|Overall Study|Lack of Efficacy|4|||
23224996|NCT02415595|64564129|FG001|Overall Study|Lack of Efficacy|4|||
23224997|NCT02415595|64564130|FG002|Overall Study|Lack of Efficacy|0|||
23224998|NCT02415595|64564131|FG003|Overall Study|Lack of Efficacy|0|||
23224999|NCT02415595|64564128|FG000|Overall Study|Lost to Follow-up|1|||
23225000|NCT02415595|64564129|FG001|Overall Study|Lost to Follow-up|3|||
23225001|NCT02415595|64564130|FG002|Overall Study|Lost to Follow-up|1|||
23225002|NCT02415595|64564131|FG003|Overall Study|Lost to Follow-up|1|||
23225003|NCT02415595|64564128|FG000|Overall Study|Poor/Non-compliance|1|||
23225004|NCT02415595|64564129|FG001|Overall Study|Poor/Non-compliance|0|||
23225005|NCT02415595|64564130|FG002|Overall Study|Poor/Non-compliance|1|||
23225006|NCT02415595|64564131|FG003|Overall Study|Poor/Non-compliance|0|||
23225007|NCT02415595|64564128|FG000|Overall Study|Reached stopping criteria|0|||
23225008|NCT02415595|64564129|FG001|Overall Study|Reached stopping criteria|1|||
23225009|NCT02415595|64564130|FG002|Overall Study|Reached stopping criteria|1|||
23225010|NCT02415595|64564131|FG003|Overall Study|Reached stopping criteria|0|||
23225011|NCT02415595|64564128|FG000|Overall Study|Withdrawal by Subject|4|||
23225012|NCT02415595|64564129|FG001|Overall Study|Withdrawal by Subject|0|||
23225013|NCT02415595|64564130|FG002|Overall Study|Withdrawal by Subject|1|||
23225014|NCT02415595|64564131|FG003|Overall Study|Withdrawal by Subject|3|||
23225015|NCT02415595|64564128|FG000|Overall Study|Other|0|||
23225016|NCT02415595|64564129|FG001|Overall Study|Other|1|||
23225017|NCT02415595|64564130|FG002|Overall Study|Other|1|||
23225018|NCT02415595|64564131|FG003|Overall Study|Other|0|||
23225019|NCT01634100|64564134|FG000|Overall Study|Withdrawal by Subject|1|||
23225020|NCT01634100|64564135|FG001|Overall Study|Withdrawal by Subject|0|||
23225021|NCT01634100|64564136|FG002|Overall Study|Withdrawal by Subject|1|||
23225022|NCT01634100|64564137|FG003|Overall Study|Withdrawal by Subject|0|||
23225023|NCT01634100|64564138|FG004|Overall Study|Withdrawal by Subject|0|||
23225024|NCT01634100|64564139|FG005|Overall Study|Withdrawal by Subject|0|||
23225025|NCT01681836|64564142|FG000|Second Intervention|Withdrawal by Subject|0|||
23225026|NCT01681836|64564143|FG001|Second Intervention|Withdrawal by Subject|1|||
23225027|NCT00290355|64564144|FG000|Overall Study|Serious adverse event|7|||
23225028|NCT00290355|64564145|FG001|Overall Study|Serious adverse event|4|||
23225029|NCT00290355|64564144|FG000|Overall Study|Study product reactogenicity|1|||
23225030|NCT00290355|64564145|FG001|Overall Study|Study product reactogenicity|0|||
23225031|NCT00290355|64564144|FG000|Overall Study|Protocol Violation|1|||
23225032|NCT00290355|64564145|FG001|Overall Study|Protocol Violation|0|||
23225033|NCT00290355|64564144|FG000|Overall Study|Withdrawal by Subject|2|||
23225034|NCT00290355|64564145|FG001|Overall Study|Withdrawal by Subject|0|||
23225035|NCT00290355|64564144|FG000|Overall Study|Migrated / moved from the study area|1|||
23225036|NCT00290355|64564145|FG001|Overall Study|Migrated / moved from the study area|0|||
23225037|NCT00290355|64564144|FG000|Overall Study|Lost to Follow-up|3|||
23225038|NCT00290355|64564145|FG001|Overall Study|Lost to Follow-up|1|||
23225039|NCT00290355|64564144|FG000|Overall Study|Other|2|||
23225040|NCT00290355|64564145|FG001|Overall Study|Other|0|||
23447263|NCT03551626|65377920|FG000|Overall Study|Physician Decision|4|||
23447264|NCT03551626|65377920|FG000|Overall Study|Lost to Follow-up|3|||
23447265|NCT03551626|65377920|FG000|Overall Study|Pregnancy|1|||
23447266|NCT03551626|65377920|FG000|Overall Study|Protocol deviation|1|||
23572496|NCT03285113|65824818|FG000|Overall Study|Unable to implant leads|2|||
23164600|NCT03099187|64352458|FG003|Double-blind Treatment|Disease progression|0|||
23164601|NCT03099187|64352455|FG000|Double-blind Treatment|Randomization error|0|||
23164602|NCT03099187|64352456|FG001|Double-blind Treatment|Randomization error|2|||
23164603|NCT03099187|64352457|FG002|Double-blind Treatment|Randomization error|0|||
23164604|NCT03099187|64352458|FG003|Double-blind Treatment|Randomization error|0|||
23164605|NCT03099187|64352455|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
23164606|NCT03099187|64352456|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
23164607|NCT03099187|64352457|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
23164608|NCT03099187|64352458|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
23164609|NCT03099187|64352455|FG000|12-month Safety Follow-up|Adverse Event|0|||
23225041|NCT00952419|64564146|FG000|Overall Study|Adverse Event|2|||
23225042|NCT00952419|64564147|FG001|Overall Study|Adverse Event|0|||
23225043|NCT00952419|64564148|FG002|Overall Study|Adverse Event|0|||
23225044|NCT00952419|64564146|FG000|Overall Study|Protocol Violation|3|||
23225045|NCT00952419|64564147|FG001|Overall Study|Protocol Violation|7|||
23225046|NCT00952419|64564148|FG002|Overall Study|Protocol Violation|0|||
23225047|NCT00952419|64564146|FG000|Overall Study|Withdrawal by Subject|1|||
23225048|NCT00952419|64564147|FG001|Overall Study|Withdrawal by Subject|3|||
23225049|NCT00952419|64564148|FG002|Overall Study|Withdrawal by Subject|0|||
23225050|NCT03858686|64564153|FG000|Period 1|Adverse Event|1|||
23572497|NCT01091428|65824819|FG000|Phase 1|Progressive Disease|24|||
23225051|NCT03858686|64564154|FG001|Period 1|Adverse Event|1|||
23225052|NCT03858686|64564153|FG000|Period 1|Lack of compliance|0|||
23225053|NCT03858686|64564154|FG001|Period 1|Lack of compliance|1|||
23225054|NCT03858686|64564153|FG000|Period 1|Adverse Event|0|||
23225055|NCT03858686|64564154|FG001|Period 1|Adverse Event|1|||
23225056|NCT03858686|64564153|FG000|Period 2|Adverse Event|0|||
23225057|NCT03858686|64564154|FG001|Period 2|Adverse Event|1|||
23225058|NCT00102804|64564155|FG000|Overall Study|Progressive Disease (PD)|307|||
23225059|NCT00102804|64564156|FG001|Overall Study|Progressive Disease (PD)|196|||
23225060|NCT00102804|64564155|FG000|Overall Study|Withdrawal by Subject|46|||
23225061|NCT00102804|64564156|FG001|Overall Study|Withdrawal by Subject|7|||
23225062|NCT00102804|64564155|FG000|Overall Study|Adverse Event|37|||
23225063|NCT00102804|64564156|FG001|Overall Study|Adverse Event|3|||
23225064|NCT00102804|64564155|FG000|Overall Study|Physician Decision|24|||
23225065|NCT00102804|64564156|FG001|Overall Study|Physician Decision|6|||
23225066|NCT00102804|64564155|FG000|Overall Study|Death|5|||
23225067|NCT00102804|64564156|FG001|Overall Study|Death|6|||
23225068|NCT00102804|64564155|FG000|Overall Study|Enrollment Criteria Not Met|6|||
23225069|NCT00102804|64564156|FG001|Overall Study|Enrollment Criteria Not Met|0|||
23225070|NCT00102804|64564155|FG000|Overall Study|Lost to Follow-up|4|||
23225071|NCT00102804|64564156|FG001|Overall Study|Lost to Follow-up|1|||
23225072|NCT00102804|64564155|FG000|Overall Study|Protocol Violation|2|||
23225073|NCT00102804|64564156|FG001|Overall Study|Protocol Violation|1|||
23225074|NCT00102804|64564155|FG000|Overall Study|Satisfactory Response|2|||
23225075|NCT00102804|64564156|FG001|Overall Study|Satisfactory Response|0|||
23225076|NCT00102804|64564155|FG000|Overall Study|Sponsor Decision|1|||
23225077|NCT00102804|64564156|FG001|Overall Study|Sponsor Decision|0|||
23225078|NCT00102804|64564155|FG000|Overall Study|Alive, Receiving Treatment|7|||
23572498|NCT01091428|65824820|FG001|Phase 1|Progressive Disease|8|||
23572499|NCT01091428|65824821|FG002|Phase 1|Progressive Disease|0|||
23572500|NCT01091428|65824822|FG003|Phase 1|Progressive Disease|0|||
23572501|NCT01091428|65824819|FG000|Phase 1|Symptomatic Deterioration|3|||
23572502|NCT01091428|65824820|FG001|Phase 1|Symptomatic Deterioration|2|||
23164610|NCT03099187|64352456|FG001|12-month Safety Follow-up|Adverse Event|0|||
23447267|NCT03551626|65377920|FG000|Overall Study|Technical problems|1|||
23572503|NCT01091428|65824821|FG002|Phase 1|Symptomatic Deterioration|0|||
23572504|NCT01091428|65824822|FG003|Phase 1|Symptomatic Deterioration|0|||
23572505|NCT01091428|65824819|FG000|Phase 1|Adverse Event|2|||
23572506|NCT01091428|65824820|FG001|Phase 1|Adverse Event|0|||
23164611|NCT03099187|64352457|FG002|12-month Safety Follow-up|Adverse Event|5|||
23164612|NCT03099187|64352458|FG003|12-month Safety Follow-up|Adverse Event|12|||
23225079|NCT00102804|64564156|FG001|Overall Study|Alive, Receiving Treatment|2|||
23225080|NCT04280081|64564157|FG000|Overall Study|Adverse Event|4|||
23332102|NCT01295827|64958989|FG012|Overall Study|Other|0|||
23572507|NCT01091428|65824821|FG002|Phase 1|Adverse Event|0|||
23225081|NCT04280081|64564157|FG000|Overall Study|Death|2|||
23332103|NCT01295827|64958990|FG013|Overall Study|Other|0|||
23447268|NCT03109184|65377921|FG000|Overall Study|Lost to Follow-up|6|||
23572508|NCT01091428|65824822|FG003|Phase 1|Adverse Event|0|||
23164613|NCT03099187|64352455|FG000|12-month Safety Follow-up|Death|0|||
23164614|NCT03099187|64352456|FG001|12-month Safety Follow-up|Death|0|||
23164615|NCT03099187|64352457|FG002|12-month Safety Follow-up|Death|7|||
23164616|NCT03099187|64352458|FG003|12-month Safety Follow-up|Death|9|||
23164617|NCT03099187|64352455|FG000|12-month Safety Follow-up|Lung transplantation|0|||
23225082|NCT04280081|64564157|FG000|Overall Study|Progressive Disease|6|||
23225083|NCT01347073|64564158|FG000|Overall Study|Adverse Event|1|||
23225084|NCT01347073|64564158|FG000|Overall Study|Liver Transplant|1|||
23225085|NCT00518336|64564173|FG000|Year 7|Lost to Follow-up|2|||
23225086|NCT00518336|64564174|FG001|Year 7|Lost to Follow-up|0|||
23225087|NCT00518336|64564173|FG000|Year 7|Could not attend in time|0|||
23572509|NCT01091428|65824819|FG000|Phase 1|Withdrawal by Subject|7|||
23572510|NCT01091428|65824820|FG001|Phase 1|Withdrawal by Subject|0|||
23572511|NCT01091428|65824821|FG002|Phase 1|Withdrawal by Subject|0|||
23572512|NCT01091428|65824822|FG003|Phase 1|Withdrawal by Subject|0|||
23572513|NCT01091428|65824819|FG000|Phase 1|Reason not specified|0|||
23572514|NCT01091428|65824820|FG001|Phase 1|Reason not specified|1|||
23572515|NCT01091428|65824821|FG002|Phase 1|Reason not specified|0|||
23572516|NCT01091428|65824822|FG003|Phase 1|Reason not specified|0|||
23572517|NCT01091428|65824819|FG000|Phase 1|Single-Patient IND|2|||
23572518|NCT01091428|65824820|FG001|Phase 1|Single-Patient IND|0|||
23572519|NCT01091428|65824821|FG002|Phase 1|Single-Patient IND|0|||
23164618|NCT03099187|64352456|FG001|12-month Safety Follow-up|Lung transplantation|0|||
23164619|NCT03099187|64352457|FG002|12-month Safety Follow-up|Lung transplantation|2|||
23164620|NCT03099187|64352458|FG003|12-month Safety Follow-up|Lung transplantation|1|||
23164621|NCT03099187|64352455|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
23164622|NCT03099187|64352456|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
23164623|NCT03099187|64352457|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
23164624|NCT03099187|64352458|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
23164625|NCT03099187|64352455|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
23164626|NCT03099187|64352456|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
23164627|NCT03099187|64352457|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
23164628|NCT03099187|64352458|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
23164629|NCT03099187|64352455|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
23164630|NCT03099187|64352456|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
23164631|NCT03099187|64352457|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
23164632|NCT03099187|64352458|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
23164633|NCT03099187|64352455|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
23164634|NCT03099187|64352456|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
23164635|NCT03099187|64352457|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
23164636|NCT03099187|64352458|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
23164637|NCT00971945|64352459|FG000|Overall Study|Progressive Disease|3|||
23164638|NCT00971945|64352459|FG000|Overall Study|Change in treatment policy|1|||
23164639|NCT00971945|64352459|FG000|Overall Study|Other reasons|2|||
23164640|NCT01308008|64352460|FG000|4 Weeks|Illness, disinterest, time|9|||
23164641|NCT01308008|64352461|FG001|4 Weeks|Illness, disinterest, time|2|||
23164642|NCT00835237|64352462|FG000|Overall Study|Lost to Follow-up|4|||
23164643|NCT00835237|64352463|FG001|Overall Study|Lost to Follow-up|0|||
23164644|NCT00835237|64352462|FG000|Overall Study|Withdrawal by Subject|2|||
23164645|NCT00835237|64352463|FG001|Overall Study|Withdrawal by Subject|0|||
23164646|NCT02969707|64352464|FG000|Overall Study|Adverse Event|1|||
23164647|NCT02969707|64352465|FG001|Overall Study|Adverse Event|2|||
23164648|NCT02969707|64352464|FG000|Overall Study|Lost to Follow-up|3|||
23164649|NCT02969707|64352465|FG001|Overall Study|Lost to Follow-up|0|||
23164650|NCT02969707|64352464|FG000|Overall Study|Physician Decision|0|||
23164651|NCT02969707|64352465|FG001|Overall Study|Physician Decision|1|||
23164652|NCT02969707|64352464|FG000|Overall Study|Protocol Violation|1|||
23164653|NCT02969707|64352465|FG001|Overall Study|Protocol Violation|1|||
23164654|NCT02969707|64352464|FG000|Overall Study|Withdrawal by Subject|3|||
23164655|NCT02969707|64352465|FG001|Overall Study|Withdrawal by Subject|4|||
23164656|NCT01058096|64352466|FG000|Double-blind Treatment Phase|Adverse Event|11|||
23164657|NCT01058096|64352467|FG001|Double-blind Treatment Phase|Adverse Event|15|||
23164658|NCT01058096|64352466|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
23164659|NCT01058096|64352467|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
23164660|NCT01058096|64352466|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
23164661|NCT01058096|64352467|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
23164662|NCT01058096|64352466|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
23225088|NCT00518336|64564174|FG001|Year 7|Could not attend in time|3|||
23225089|NCT00518336|64564173|FG000|Year 8|Lost to Follow-up|1|||
23225090|NCT00518336|64564174|FG001|Year 8|Lost to Follow-up|1|||
23572520|NCT01091428|65824822|FG003|Phase 1|Single-Patient IND|0|||
23572521|NCT01091428|65824819|FG000|Phase 2|Progressive Disease|0|||
23572522|NCT01091428|65824820|FG001|Phase 2|Progressive Disease|0|||
23572523|NCT01091428|65824821|FG002|Phase 2|Progressive Disease|44|||
23572524|NCT01091428|65824822|FG003|Phase 2|Progressive Disease|46|||
23225091|NCT00518336|64564173|FG000|Year 8|Could not attend in time|0|||
23164663|NCT01058096|64352467|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
23164664|NCT01058096|64352466|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23164665|NCT01058096|64352467|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
23164666|NCT01058096|64352466|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
23164667|NCT01058096|64352467|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
23164668|NCT04093531|64352468|FG000|Overall Study|failed screening|4|||
23164669|NCT02318667|64352469|FG000|Overall Study|Adverse Event|1|||
23225092|NCT00518336|64564174|FG001|Year 8|Could not attend in time|1|||
23225093|NCT00518336|64564173|FG000|Year 9|Migrated/moved from study area|1|||
23225094|NCT00518336|64564174|FG001|Year 9|Migrated/moved from study area|1|||
23225095|NCT00518336|64564173|FG000|Year 9|Lost to Follow-up|3|||
23225096|NCT00518336|64564174|FG001|Year 9|Lost to Follow-up|0|||
23225097|NCT00518336|64564173|FG000|Year 9|Personal reasons|1|||
23225098|NCT00518336|64564174|FG001|Year 9|Personal reasons|0|||
23225099|NCT01894776|64564175|FG000|Overall Study|Withdrawal by Subject|1|||
23225100|NCT00255008|64564176|FG000|Overall Study|Adverse Event|1|||
23225101|NCT00255008|64564177|FG001|Overall Study|Adverse Event|1|||
23225102|NCT00255008|64564178|FG002|Overall Study|Adverse Event|2|||
23225103|NCT00255008|64564179|FG003|Overall Study|Adverse Event|0|||
23225104|NCT00255008|64564176|FG000|Overall Study|Lost to Follow-up|1|||
23225105|NCT00255008|64564177|FG001|Overall Study|Lost to Follow-up|0|||
23225106|NCT00255008|64564178|FG002|Overall Study|Lost to Follow-up|1|||
23225107|NCT00255008|64564179|FG003|Overall Study|Lost to Follow-up|2|||
23225108|NCT00255008|64564176|FG000|Overall Study|Did not meet viral reduction criteria|4|||
23225109|NCT00255008|64564177|FG001|Overall Study|Did not meet viral reduction criteria|5|||
23225110|NCT00255008|64564178|FG002|Overall Study|Did not meet viral reduction criteria|0|||
23225111|NCT00255008|64564179|FG003|Overall Study|Did not meet viral reduction criteria|1|||
23572525|NCT01091428|65824819|FG000|Phase 2|Symptomatic Deterioration|0|||
23572526|NCT01091428|65824820|FG001|Phase 2|Symptomatic Deterioration|0|||
23572527|NCT01091428|65824821|FG002|Phase 2|Symptomatic Deterioration|1|||
23572528|NCT01091428|65824822|FG003|Phase 2|Symptomatic Deterioration|6|||
23572529|NCT01091428|65824819|FG000|Phase 2|Adverse Event|0|||
23572530|NCT01091428|65824820|FG001|Phase 2|Adverse Event|0|||
23572531|NCT01091428|65824821|FG002|Phase 2|Adverse Event|12|||
23572532|NCT01091428|65824822|FG003|Phase 2|Adverse Event|5|||
23572533|NCT01091428|65824819|FG000|Phase 2|Withdrawal by Subject|0|||
23572534|NCT01091428|65824820|FG001|Phase 2|Withdrawal by Subject|0|||
23572535|NCT01091428|65824821|FG002|Phase 2|Withdrawal by Subject|9|||
23572536|NCT01091428|65824822|FG003|Phase 2|Withdrawal by Subject|8|||
23572537|NCT01091428|65824819|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
23572538|NCT01091428|65824820|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
23572539|NCT01091428|65824821|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
23572540|NCT01091428|65824822|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
23572541|NCT01091428|65824819|FG000|Phase 2|Reason not specified|0|||
23572542|NCT01091428|65824820|FG001|Phase 2|Reason not specified|0|||
23572543|NCT01091428|65824821|FG002|Phase 2|Reason not specified|4|||
23572544|NCT01091428|65824822|FG003|Phase 2|Reason not specified|3|||
23572545|NCT01091428|65824819|FG000|Phase 2|Physician Decision|0|||
23572546|NCT01091428|65824820|FG001|Phase 2|Physician Decision|0|||
23572547|NCT01091428|65824821|FG002|Phase 2|Physician Decision|2|||
23572548|NCT01091428|65824822|FG003|Phase 2|Physician Decision|0|||
23572549|NCT02213055|65824825|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
23572550|NCT02213055|65824826|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
23572551|NCT02213055|65824825|FG000|Overall Study|Protocol was not Followed during Study|1|||
23572552|NCT02213055|65824826|FG001|Overall Study|Protocol was not Followed during Study|0|||
23572553|NCT02213055|65824825|FG000|Overall Study|Documentation Issue at Enrollment|1|||
23572554|NCT02213055|65824826|FG001|Overall Study|Documentation Issue at Enrollment|0|||
23572555|NCT02213055|65824825|FG000|Overall Study|Documentation Issue during Study|10|||
23225112|NCT00255008|64564176|FG000|Overall Study|Withdrew consent|0|||
23225113|NCT00255008|64564177|FG001|Overall Study|Withdrew consent|0|||
23225114|NCT00255008|64564178|FG002|Overall Study|Withdrew consent|2|||
23225115|NCT00255008|64564179|FG003|Overall Study|Withdrew consent|0|||
23225116|NCT00255008|64564176|FG000|Overall Study|Sponsor request|18|||
23572556|NCT02213055|65824826|FG001|Overall Study|Documentation Issue during Study|0|||
23572557|NCT02213055|65824825|FG000|Overall Study|Did not have Live Lice|8|||
23225117|NCT00255008|64564177|FG001|Overall Study|Sponsor request|3|||
23225118|NCT00255008|64564178|FG002|Overall Study|Sponsor request|8|||
23225119|NCT00255008|64564179|FG003|Overall Study|Sponsor request|17|||
23572558|NCT02213055|65824826|FG001|Overall Study|Did not have Live Lice|0|||
23572559|NCT02213055|65824825|FG000|Overall Study|Had another Treatment during the Study|3|||
23572560|NCT02213055|65824826|FG001|Overall Study|Had another Treatment during the Study|0|||
23572561|NCT02213055|65824825|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
23572562|NCT02213055|65824826|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
23572563|NCT02213055|65824825|FG000|Overall Study|Did not Return to School|5|||
23572564|NCT02213055|65824826|FG001|Overall Study|Did not Return to School|0|||
23572565|NCT00432679|65824827|FG000|Overall Study|Adverse Event|2|||
23572566|NCT00432679|65824828|FG001|Overall Study|Adverse Event|1|||
23572567|NCT00432679|65824827|FG000|Overall Study|Withdrawal by Subject|3|||
23572568|NCT00432679|65824828|FG001|Overall Study|Withdrawal by Subject|2|||
23225120|NCT00255008|64564176|FG000|Overall Study|Adverse lab experience|1|||
23225121|NCT00255008|64564177|FG001|Overall Study|Adverse lab experience|0|||
23572569|NCT03317379|65824831|FG000|Overall Study|Lost to Follow-up|0|||
23572570|NCT03317379|65824832|FG001|Overall Study|Lost to Follow-up|3|||
23572571|NCT03317379|65824833|FG002|Overall Study|Lost to Follow-up|2|||
23572572|NCT03382600|65824834|FG000|Overall Study|Adverse Event|3|||
23225122|NCT00255008|64564178|FG002|Overall Study|Adverse lab experience|0|||
23225123|NCT00255008|64564179|FG003|Overall Study|Adverse lab experience|0|||
23225124|NCT00255008|64564176|FG000|Overall Study|Other|7|||
23225125|NCT00255008|64564177|FG001|Overall Study|Other|0|||
23225126|NCT00255008|64564178|FG002|Overall Study|Other|3|||
23225127|NCT00255008|64564179|FG003|Overall Study|Other|2|||
23225128|NCT04067011|64564180|FG000|Overall Study|Not Treated|8|||
23225129|NCT04067011|64564181|FG001|Overall Study|Not Treated|7|||
23225130|NCT04067011|64564182|FG002|Overall Study|Not Treated|5|||
23225131|NCT04067011|64564180|FG000|Overall Study|Adverse Event|2|||
23225132|NCT04067011|64564181|FG001|Overall Study|Adverse Event|1|||
23225133|NCT04067011|64564182|FG002|Overall Study|Adverse Event|0|||
23225134|NCT04067011|64564180|FG000|Overall Study|Withdrawal by Subject|6|||
23225135|NCT04067011|64564181|FG001|Overall Study|Withdrawal by Subject|2|||
23225136|NCT04067011|64564182|FG002|Overall Study|Withdrawal by Subject|1|||
23225137|NCT04067011|64564180|FG000|Overall Study|Lost to Follow-up|0|||
23225138|NCT04067011|64564181|FG001|Overall Study|Lost to Follow-up|0|||
23225139|NCT04067011|64564182|FG002|Overall Study|Lost to Follow-up|1|||
23225140|NCT04067011|64564180|FG000|Overall Study|Physician Decision|1|||
23225141|NCT04067011|64564181|FG001|Overall Study|Physician Decision|1|||
23225142|NCT04067011|64564182|FG002|Overall Study|Physician Decision|0|||
23225143|NCT04067011|64564180|FG000|Overall Study|Other Reasons|2|||
23225144|NCT04067011|64564181|FG001|Overall Study|Other Reasons|0|||
23225145|NCT04067011|64564182|FG002|Overall Study|Other Reasons|1|||
23225146|NCT04067011|64564180|FG000|Overall Study|Missing|0|||
23225147|NCT04067011|64564181|FG001|Overall Study|Missing|2|||
23225148|NCT04067011|64564182|FG002|Overall Study|Missing|0|||
23225149|NCT02996110|64564183|FG000|Pre-Treatment|Other Reasons|0|||
23225150|NCT02996110|64564184|FG001|Pre-Treatment|Other Reasons|1|||
23225151|NCT02996110|64564185|FG002|Pre-Treatment|Other Reasons|0|||
23225152|NCT02996110|64564186|FG003|Pre-Treatment|Other Reasons|0|||
23225153|NCT02996110|64564187|FG004|Pre-Treatment|Other Reasons|1|||
23225154|NCT02996110|64564183|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
23225155|NCT02996110|64564184|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
23225156|NCT02996110|64564185|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
23225157|NCT02996110|64564186|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
23225158|NCT02996110|64564187|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
23225159|NCT02996110|64564183|FG000|Track 1|Disease Progression|15|||
23225160|NCT02996110|64564184|FG001|Track 1|Disease Progression|17|||
23225161|NCT02996110|64564185|FG002|Track 1|Disease Progression|0|||
23225162|NCT02996110|64564186|FG003|Track 1|Disease Progression|0|||
23225163|NCT02996110|64564187|FG004|Track 1|Disease Progression|0|||
23225164|NCT02996110|64564183|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
23225165|NCT02996110|64564184|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
23225166|NCT02996110|64564185|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
23225167|NCT02996110|64564186|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
23225168|NCT02996110|64564187|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
23225169|NCT02996110|64564183|FG000|Track 1|Study Drug Toxicity|5|||
23225170|NCT02996110|64564184|FG001|Track 1|Study Drug Toxicity|3|||
23225171|NCT02996110|64564185|FG002|Track 1|Study Drug Toxicity|0|||
23225172|NCT02996110|64564186|FG003|Track 1|Study Drug Toxicity|0|||
23225173|NCT02996110|64564187|FG004|Track 1|Study Drug Toxicity|0|||
23225174|NCT02996110|64564183|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
23572573|NCT03382600|65824835|FG001|Overall Study|Adverse Event|3|||
23572574|NCT03382600|65824834|FG000|Overall Study|Clinical Disease Progression|2|||
23225175|NCT02996110|64564184|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
23225176|NCT02996110|64564185|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
23572575|NCT03382600|65824835|FG001|Overall Study|Clinical Disease Progression|4|||
23225177|NCT02996110|64564186|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
23225178|NCT02996110|64564187|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
23225179|NCT02996110|64564183|FG000|Track 1|Administrative Reason by Sponsor|0|||
23572576|NCT03382600|65824834|FG000|Overall Study|Radiological Progression|40|||
23225180|NCT02996110|64564184|FG001|Track 1|Administrative Reason by Sponsor|1|||
23225181|NCT02996110|64564185|FG002|Track 1|Administrative Reason by Sponsor|0|||
23225182|NCT02996110|64564186|FG003|Track 1|Administrative Reason by Sponsor|0|||
23225183|NCT02996110|64564187|FG004|Track 1|Administrative Reason by Sponsor|0|||
23225184|NCT02996110|64564183|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
23225185|NCT02996110|64564184|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
23225186|NCT02996110|64564185|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
23225187|NCT02996110|64564186|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
23225188|NCT02996110|64564187|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
23225189|NCT02996110|64564183|FG000|Track 2|Disease Progression|33|||
23225190|NCT02996110|64564184|FG001|Track 2|Disease Progression|26|||
23225191|NCT02996110|64564185|FG002|Track 2|Disease Progression|19|||
23225192|NCT02996110|64564186|FG003|Track 2|Disease Progression|16|||
23225193|NCT02996110|64564187|FG004|Track 2|Disease Progression|15|||
23225194|NCT02996110|64564183|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
23225195|NCT02996110|64564184|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
23225196|NCT02996110|64564185|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
23225197|NCT02996110|64564186|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
23225198|NCT02996110|64564187|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
23225199|NCT02996110|64564183|FG000|Track 2|Death|0|||
23225200|NCT02996110|64564184|FG001|Track 2|Death|0|||
23225201|NCT02996110|64564185|FG002|Track 2|Death|1|||
23225202|NCT02996110|64564186|FG003|Track 2|Death|0|||
23225203|NCT02996110|64564187|FG004|Track 2|Death|1|||
23225204|NCT02996110|64564183|FG000|Track 2|Study Drug Toxicity|4|||
23225205|NCT02996110|64564184|FG001|Track 2|Study Drug Toxicity|1|||
23225206|NCT02996110|64564185|FG002|Track 2|Study Drug Toxicity|4|||
23225207|NCT02996110|64564186|FG003|Track 2|Study Drug Toxicity|1|||
23225208|NCT02996110|64564187|FG004|Track 2|Study Drug Toxicity|0|||
23225209|NCT02996110|64564183|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
23225210|NCT02996110|64564184|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
23225211|NCT02996110|64564185|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
23225212|NCT02996110|64564186|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
23225213|NCT02996110|64564187|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
23225214|NCT02996110|64564183|FG000|Track 2|Participant Withdrew Consent|1|||
23225215|NCT02996110|64564184|FG001|Track 2|Participant Withdrew Consent|2|||
23225216|NCT02996110|64564185|FG002|Track 2|Participant Withdrew Consent|3|||
23225217|NCT02996110|64564186|FG003|Track 2|Participant Withdrew Consent|1|||
23225218|NCT02996110|64564187|FG004|Track 2|Participant Withdrew Consent|1|||
23225219|NCT02996110|64564183|FG000|Track 2|Other Reasons|0|||
23225220|NCT02996110|64564184|FG001|Track 2|Other Reasons|0|||
23225221|NCT02996110|64564185|FG002|Track 2|Other Reasons|1|||
23225222|NCT02996110|64564186|FG003|Track 2|Other Reasons|0|||
23225223|NCT02996110|64564187|FG004|Track 2|Other Reasons|1|||
23225224|NCT03512275|64564189|FG000|Overall Study|Withdrawal by Subject|1|||
23225225|NCT03512275|64564190|FG001|Overall Study|Withdrawal by Subject|3|||
23225226|NCT03512275|64564189|FG000|Overall Study|Physician Decision|0|||
23225227|NCT03512275|64564190|FG001|Overall Study|Physician Decision|1|||
23225228|NCT03512275|64564189|FG000|Overall Study|Lost to Follow-up|0|||
23225229|NCT03512275|64564190|FG001|Overall Study|Lost to Follow-up|3|||
23225230|NCT03512275|64564189|FG000|Overall Study|Other|1|||
23225231|NCT03512275|64564190|FG001|Overall Study|Other|0|||
23225232|NCT01326910|64567694|FG000|Overall Study|Withdrawal by Subject|3|||
23225233|NCT01326910|64567695|FG001|Overall Study|Withdrawal by Subject|2|||
23225234|NCT01326910|64567694|FG000|Overall Study|Protocol Violation|1|||
23225235|NCT01326910|64567695|FG001|Overall Study|Protocol Violation|1|||
23225236|NCT02485860|64567696|FG000|Overall Study|Lost to Follow-up|4|||
23225237|NCT02485860|64567697|FG001|Overall Study|Lost to Follow-up|1|||
23225238|NCT02485860|64567696|FG000|Overall Study|Physician Decision|1|||
23225239|NCT02485860|64567697|FG001|Overall Study|Physician Decision|2|||
23225240|NCT02485860|64567696|FG000|Overall Study|Health context (COVID-19)|1|||
23225241|NCT02485860|64567697|FG001|Overall Study|Health context (COVID-19)|0|||
23225242|NCT00939055|64567698|FG000|Overall Study|Discontinuation prior to procedure|4|||
23225243|NCT00939055|64567699|FG001|Overall Study|Discontinuation prior to procedure|0|||
23225244|NCT00118040|64567702|FG000|Overall Study|Adverse Event|0|||
23225245|NCT00118040|64567703|FG001|Overall Study|Adverse Event|1|||
23225246|NCT00118040|64567704|FG002|Overall Study|Adverse Event|0|||
23225247|NCT00118040|64567702|FG000|Overall Study|Withdrawal by Subject|0|||
23225248|NCT00118040|64567703|FG001|Overall Study|Withdrawal by Subject|0|||
23225249|NCT00118040|64567704|FG002|Overall Study|Withdrawal by Subject|2|||
23225250|NCT00118040|64567702|FG000|Overall Study|Medical Contraindication|0|||
23225251|NCT00118040|64567703|FG001|Overall Study|Medical Contraindication|0|||
23225252|NCT00118040|64567704|FG002|Overall Study|Medical Contraindication|1|||
23225253|NCT00118040|64567702|FG000|Overall Study|Non-Compliant Participant|1|||
23225254|NCT00118040|64567703|FG001|Overall Study|Non-Compliant Participant|1|||
23225255|NCT00118040|64567704|FG002|Overall Study|Non-Compliant Participant|2|||
23164670|NCT02318667|64352469|FG000|Overall Study|Lack of Efficacy|6|||
23164671|NCT02318667|64352469|FG000|Overall Study|Protocol Violation|2|||
23164672|NCT01180660|64352472|FG000|Overall Study|Changed to open surgery|1|||
23164673|NCT01180660|64352473|FG001|Overall Study|Changed to open surgery|0|||
23164674|NCT00490568|64352474|FG000|Overall Study|Adverse Event|116|||
23164675|NCT00490568|64352474|FG000|Overall Study|Lost to Follow-up|13|||
23164676|NCT00490568|64352474|FG000|Overall Study|Protocol Violation|45|||
23164677|NCT00490568|64352474|FG000|Overall Study|Withdrawal by Subject|135|||
23164678|NCT00490568|64352474|FG000|Overall Study|Still in the study at termination|974|||
23164679|NCT00490568|64352474|FG000|Overall Study|Other|1|||
23164680|NCT00490568|64352474|FG000|Overall Study|Exclusion criteria met|1|||
23164681|NCT00490568|64352474|FG000|Overall Study|Caregiver related|20|||
23164682|NCT00490568|64352474|FG000|Overall Study|Abnormal ECG|25|||
23164683|NCT00490568|64352474|FG000|Overall Study|Participant refused follow-up|9|||
23164684|NCT00490568|64352474|FG000|Overall Study|Legal representative withdrew consent|1|||
23164685|NCT00490568|64352474|FG000|Overall Study|Disease progression|4|||
23164686|NCT00490568|64352474|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
23164687|NCT00490568|64352474|FG000|Overall Study|Investigator decision|3|||
23164688|NCT00490568|64352474|FG000|Overall Study|Non-Compliance|7|||
23164689|NCT00490568|64352474|FG000|Overall Study|Efficacy related|3|||
23164690|NCT00490568|64352474|FG000|Overall Study|Participant died|1|||
23164691|NCT00490568|64352474|FG000|Overall Study|Participant withdrawal due to surgery|1|||
23164692|NCT03776175|64352476|FG000|Treatment Period (42 Days)|Adverse Event|0|||
23164693|NCT03776175|64352477|FG001|Treatment Period (42 Days)|Adverse Event|1|||
23164694|NCT03776175|64352478|FG002|Treatment Period (42 Days)|Adverse Event|1|||
23164695|NCT03776175|64352479|FG003|Treatment Period (42 Days)|Adverse Event|0|||
23164696|NCT03776175|64352476|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
23164697|NCT03776175|64352477|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
23164698|NCT03776175|64352478|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
23164699|NCT03776175|64352479|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
23164700|NCT03776175|64352476|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
23164701|NCT03776175|64352477|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
23164702|NCT03776175|64352478|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
23164703|NCT03776175|64352479|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
23164704|NCT03776175|64352476|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
23164705|NCT03776175|64352477|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
23164706|NCT03776175|64352478|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
23572577|NCT03382600|65824835|FG001|Overall Study|Radiological Progression|31|||
23572578|NCT03382600|65824834|FG000|Overall Study|Withdrawal by Subject|0|||
23572579|NCT03382600|65824835|FG001|Overall Study|Withdrawal by Subject|1|||
23572580|NCT03382600|65824834|FG000|Overall Study|Other|9|||
23572581|NCT03382600|65824835|FG001|Overall Study|Other|7|||
23572582|NCT00556374|65824836|FG000|Overall Study|Withdrawal by Subject|235|||
23572583|NCT00556374|65824837|FG001|Overall Study|Withdrawal by Subject|205|||
23572584|NCT00556374|65824836|FG000|Overall Study|Death|158|||
23572585|NCT00556374|65824837|FG001|Overall Study|Death|127|||
23572586|NCT00556374|65824836|FG000|Overall Study|Lost to Follow-up|24|||
23572587|NCT00556374|65824837|FG001|Overall Study|Lost to Follow-up|17|||
23164707|NCT03776175|64352479|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
23164708|NCT03776175|64352476|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
23164709|NCT03776175|64352477|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
23164710|NCT03776175|64352478|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
23164711|NCT03776175|64352479|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
23164712|NCT03776175|64352476|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
23164713|NCT03776175|64352477|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
23164714|NCT03776175|64352478|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
23164715|NCT03776175|64352479|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
23164716|NCT01999582|64352480|FG000|Overall Study|Withdrawal by Subject|0|||
23164717|NCT01999582|64352481|FG001|Overall Study|Withdrawal by Subject|0|||
23164718|NCT01999582|64352482|FG002|Overall Study|Withdrawal by Subject|0|||
23164719|NCT01999582|64352483|FG003|Overall Study|Withdrawal by Subject|1|||
23164720|NCT01999582|64352484|FG004|Overall Study|Withdrawal by Subject|0|||
23164721|NCT01999582|64352485|FG005|Overall Study|Withdrawal by Subject|0|||
23164722|NCT01999582|64352480|FG000|Overall Study|Adverse Event|0|||
23164723|NCT01999582|64352481|FG001|Overall Study|Adverse Event|0|||
23164724|NCT01999582|64352482|FG002|Overall Study|Adverse Event|3|||
23164725|NCT01999582|64352483|FG003|Overall Study|Adverse Event|0|||
23164726|NCT01999582|64352484|FG004|Overall Study|Adverse Event|1|||
23164727|NCT01999582|64352485|FG005|Overall Study|Adverse Event|0|||
23164728|NCT01999582|64352480|FG000|Overall Study|Other Reasons|1|||
23164729|NCT01999582|64352481|FG001|Overall Study|Other Reasons|0|||
23164730|NCT01999582|64352482|FG002|Overall Study|Other Reasons|3|||
23164731|NCT01999582|64352483|FG003|Overall Study|Other Reasons|1|||
23164732|NCT01999582|64352484|FG004|Overall Study|Other Reasons|1|||
23164733|NCT01999582|64352485|FG005|Overall Study|Other Reasons|2|||
23164734|NCT01999582|64352480|FG000|Overall Study|Protocol Violation|1|||
23164735|NCT01999582|64352481|FG001|Overall Study|Protocol Violation|0|||
23164736|NCT01999582|64352482|FG002|Overall Study|Protocol Violation|0|||
23164737|NCT01999582|64352483|FG003|Overall Study|Protocol Violation|0|||
23164738|NCT01999582|64352484|FG004|Overall Study|Protocol Violation|0|||
23164739|NCT01999582|64352485|FG005|Overall Study|Protocol Violation|1|||
23164740|NCT01999582|64352480|FG000|Overall Study|Lack of Efficacy|1|||
23164741|NCT01999582|64352481|FG001|Overall Study|Lack of Efficacy|3|||
23164742|NCT01999582|64352482|FG002|Overall Study|Lack of Efficacy|0|||
23164743|NCT01999582|64352483|FG003|Overall Study|Lack of Efficacy|1|||
23164744|NCT01999582|64352484|FG004|Overall Study|Lack of Efficacy|0|||
23164745|NCT01999582|64352485|FG005|Overall Study|Lack of Efficacy|0|||
23164746|NCT03259074|64352486|FG000|Overall Study|Adverse Event|9|||
23164747|NCT03259074|64352487|FG001|Overall Study|Adverse Event|12|||
23164748|NCT03259074|64352488|FG002|Overall Study|Adverse Event|8|||
23164749|NCT03259074|64352486|FG000|Overall Study|Death|1|||
23164750|NCT03259074|64352487|FG001|Overall Study|Death|1|||
23164751|NCT03259074|64352488|FG002|Overall Study|Death|3|||
23164752|NCT03259074|64352486|FG000|Overall Study|Lost to Follow-up|2|||
23164753|NCT03259074|64352487|FG001|Overall Study|Lost to Follow-up|4|||
23164754|NCT03259074|64352488|FG002|Overall Study|Lost to Follow-up|3|||
23164755|NCT03259074|64352486|FG000|Overall Study|New Therapy For Study Indication|1|||
23572588|NCT00556374|65824836|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
23572589|NCT00556374|65824837|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
23164756|NCT03259074|64352487|FG001|Overall Study|New Therapy For Study Indication|2|||
23164757|NCT03259074|64352488|FG002|Overall Study|New Therapy For Study Indication|2|||
23164758|NCT03259074|64352486|FG000|Overall Study|Physician Decision|4|||
23164759|NCT03259074|64352487|FG001|Overall Study|Physician Decision|12|||
23164760|NCT03259074|64352488|FG002|Overall Study|Physician Decision|10|||
23164761|NCT03259074|64352486|FG000|Overall Study|Pregnancy|1|||
23164762|NCT03259074|64352487|FG001|Overall Study|Pregnancy|1|||
23164763|NCT03259074|64352488|FG002|Overall Study|Pregnancy|0|||
23164764|NCT03259074|64352486|FG000|Overall Study|Progressive Disease|1|||
23164765|NCT03259074|64352487|FG001|Overall Study|Progressive Disease|0|||
23164766|NCT03259074|64352488|FG002|Overall Study|Progressive Disease|0|||
23164767|NCT03259074|64352486|FG000|Overall Study|Protocol Deviation|1|||
23572590|NCT01912222|65824840|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
23164768|NCT03259074|64352487|FG001|Overall Study|Protocol Deviation|1|||
23164769|NCT03259074|64352488|FG002|Overall Study|Protocol Deviation|3|||
23164770|NCT03259074|64352486|FG000|Overall Study|Subject/Guardian Decision|13|||
23225256|NCT00118040|64567702|FG000|Overall Study|Other|0|||
23225257|NCT00118040|64567703|FG001|Overall Study|Other|0|||
23225258|NCT00118040|64567704|FG002|Overall Study|Other|1|||
23225259|NCT00998985|64567705|FG000|Overall Study|Withdrawal by Subject|0|||
23225260|NCT00998985|64567706|FG001|Overall Study|Withdrawal by Subject|0|||
23225261|NCT00998985|64567707|FG002|Overall Study|Withdrawal by Subject|0|||
23225262|NCT00998985|64567708|FG003|Overall Study|Withdrawal by Subject|0|||
23225263|NCT00998985|64567709|FG004|Overall Study|Withdrawal by Subject|0|||
23225264|NCT00998985|64567710|FG005|Overall Study|Withdrawal by Subject|0|||
23225265|NCT00998985|64567711|FG006|Overall Study|Withdrawal by Subject|0|||
23225266|NCT00998985|64567712|FG007|Overall Study|Withdrawal by Subject|0|||
23225267|NCT00998985|64567713|FG008|Overall Study|Withdrawal by Subject|1|||
23572591|NCT01912222|65824841|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
23572592|NCT01912222|65824842|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
23572593|NCT01912222|65824840|FG000|Part B: Treatment Period|Progressive disease|10|||
23572594|NCT01912222|65824841|FG001|Part B: Treatment Period|Progressive disease|12|||
23572595|NCT01912222|65824842|FG002|Part B: Treatment Period|Progressive disease|15|||
23572596|NCT01912222|65824840|FG000|Part B: Treatment Period|Adverse Event|1|||
23572597|NCT01912222|65824841|FG001|Part B: Treatment Period|Adverse Event|2|||
23572598|NCT01912222|65824842|FG002|Part B: Treatment Period|Adverse Event|3|||
23572599|NCT01912222|65824840|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
23572600|NCT01912222|65824841|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
23572601|NCT01912222|65824842|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
23572602|NCT00211237|65824843|FG000|Baseline|Withdrew|1|||
23572603|NCT00211237|65824844|FG001|Baseline|Withdrew|3|||
23572604|NCT00211237|65824845|FG002|Baseline|Withdrew|0|||
23572605|NCT00211237|65824843|FG000|Baseline|Refused random assignment|1|||
23572606|NCT00211237|65824844|FG001|Baseline|Refused random assignment|0|||
23572607|NCT00211237|65824845|FG002|Baseline|Refused random assignment|0|||
23572608|NCT00211237|65824843|FG000|1 Month|Death|2|||
23572609|NCT00211237|65824844|FG001|1 Month|Death|1|||
23572610|NCT00211237|65824845|FG002|1 Month|Death|0|||
23572611|NCT00211237|65824843|FG000|1 Month|Lost to Follow-up|0|||
23572612|NCT00211237|65824844|FG001|1 Month|Lost to Follow-up|2|||
23572613|NCT00211237|65824845|FG002|1 Month|Lost to Follow-up|0|||
23572614|NCT00211237|65824843|FG000|1 Month|Withdrew|0|||
23572615|NCT00211237|65824844|FG001|1 Month|Withdrew|4|||
23572616|NCT00211237|65824845|FG002|1 Month|Withdrew|0|||
23572617|NCT00211237|65824843|FG000|1 Month|Additional surgery needed|1|||
23572618|NCT00211237|65824844|FG001|1 Month|Additional surgery needed|0|||
23572619|NCT00211237|65824845|FG002|1 Month|Additional surgery needed|0|||
23572620|NCT00211237|65824843|FG000|1 Month|Non-medical problem|0|||
23572621|NCT00211237|65824844|FG001|1 Month|Non-medical problem|2|||
23572622|NCT00211237|65824845|FG002|1 Month|Non-medical problem|0|||
23572623|NCT00211237|65824843|FG000|3 Months|Death|7|||
23572624|NCT00211237|65824844|FG001|3 Months|Death|3|||
23572625|NCT00211237|65824845|FG002|3 Months|Death|0|||
23572626|NCT00211237|65824843|FG000|3 Months|Could not comply with protocol|1|||
23572627|NCT00211237|65824844|FG001|3 Months|Could not comply with protocol|0|||
23572628|NCT00211237|65824845|FG002|3 Months|Could not comply with protocol|0|||
23572629|NCT00211237|65824843|FG000|3 Months|Withdrew|0|||
23572630|NCT00211237|65824844|FG001|3 Months|Withdrew|1|||
23572631|NCT00211237|65824845|FG002|3 Months|Withdrew|0|||
23572632|NCT00211237|65824843|FG000|3 Months|Non-medical problem|0|||
23572633|NCT00211237|65824844|FG001|3 Months|Non-medical problem|0|||
23572634|NCT00211237|65824845|FG002|3 Months|Non-medical problem|1|||
23572635|NCT00211237|65824843|FG000|6 Months|Death|6|||
23572636|NCT00211237|65824844|FG001|6 Months|Death|0|||
23572637|NCT00211237|65824845|FG002|6 Months|Death|3|||
23572638|NCT00211237|65824843|FG000|6 Months|Lost to Follow-up|2|||
23572639|NCT00211237|65824844|FG001|6 Months|Lost to Follow-up|0|||
23225268|NCT00998985|64567714|FG009|Overall Study|Withdrawal by Subject|0|||
23225269|NCT00998985|64567715|FG010|Overall Study|Withdrawal by Subject|0|||
23225270|NCT00998985|64567716|FG011|Overall Study|Withdrawal by Subject|0|||
23225271|NCT00998985|64567717|FG012|Overall Study|Withdrawal by Subject|0|||
23225272|NCT00998985|64567718|FG013|Overall Study|Withdrawal by Subject|0|||
23572640|NCT00211237|65824845|FG002|6 Months|Lost to Follow-up|0|||
23225273|NCT00998985|64567705|FG000|Overall Study|Protocol Violation|0|||
23225274|NCT00998985|64567706|FG001|Overall Study|Protocol Violation|0|||
23572641|NCT00211237|65824843|FG000|6 Months|Could not comply with protocol|0|||
23572642|NCT00211237|65824844|FG001|6 Months|Could not comply with protocol|2|||
23572643|NCT00211237|65824845|FG002|6 Months|Could not comply with protocol|0|||
23572644|NCT00211237|65824843|FG000|12 Months|Death|8|||
23572645|NCT00211237|65824844|FG001|12 Months|Death|2|||
23572646|NCT00211237|65824845|FG002|12 Months|Death|3|||
23572647|NCT00211237|65824843|FG000|12 Months|Lost to Follow-up|1|||
23572648|NCT00211237|65824844|FG001|12 Months|Lost to Follow-up|0|||
23572649|NCT00211237|65824845|FG002|12 Months|Lost to Follow-up|1|||
23572650|NCT00211237|65824843|FG000|12 Months|Withdrew|0|||
23572651|NCT00211237|65824844|FG001|12 Months|Withdrew|0|||
23572652|NCT00211237|65824845|FG002|12 Months|Withdrew|1|||
23572653|NCT00211237|65824843|FG000|12 Months|unrelated medical problem|0|||
23572654|NCT00211237|65824844|FG001|12 Months|unrelated medical problem|0|||
23572655|NCT00211237|65824845|FG002|12 Months|unrelated medical problem|1|||
23572656|NCT02148718|65824854|FG000|Overall Study|Protocol Violation|26|||
23572657|NCT02148718|65824854|FG000|Overall Study|Discontinued Study Prematurely|5|||
23572658|NCT00767104|65824859|FG000|Overall Study|Lost to Follow-up|1|||
23572659|NCT00767104|65824860|FG001|Overall Study|Lost to Follow-up|2|||
23572660|NCT02632786|65827363|FG000|Overall Study|Adverse Event|2|||
23572661|NCT02632786|65827364|FG001|Overall Study|Adverse Event|1|||
23572662|NCT02632786|65827363|FG000|Overall Study|Death|3|||
23572663|NCT02632786|65827364|FG001|Overall Study|Death|2|||
23572664|NCT02632786|65827363|FG000|Overall Study|Physician Decision|5|||
23572665|NCT02632786|65827364|FG001|Overall Study|Physician Decision|4|||
23572666|NCT02632786|65827363|FG000|Overall Study|Withdrawal by Subject|1|||
23572667|NCT02632786|65827364|FG001|Overall Study|Withdrawal by Subject|0|||
23572668|NCT04242875|65827365|FG000|Overall Study|Adverse Event|2|||
23572669|NCT00289770|65827366|FG000|Year 15|Withdrawal by Subject|1|||
23572670|NCT00750893|65827367|FG000|Overall Study|Adverse Event|5|||
23572671|NCT00750893|65827367|FG000|Overall Study|Withdrawal by Subject|10|||
23572672|NCT00750893|65827367|FG000|Overall Study|Lost to Follow-up|510|||
23572673|NCT00750893|65827367|FG000|Overall Study|Other|17|||
23572674|NCT03824938|65827368|FG000|Overall Study|Withdrawal by Subject|2|||
23572675|NCT03824938|65827369|FG001|Overall Study|Withdrawal by Subject|1|||
23572676|NCT03824938|65827370|FG002|Overall Study|Withdrawal by Subject|0|||
23572677|NCT03824938|65827371|FG003|Overall Study|Withdrawal by Subject|2|||
23572678|NCT03824938|65827372|FG004|Overall Study|Withdrawal by Subject|0|||
23572679|NCT03824938|65827373|FG005|Overall Study|Withdrawal by Subject|1|||
23572680|NCT03824938|65827368|FG000|Overall Study|Lost to Follow-up|0|||
23572681|NCT03824938|65827369|FG001|Overall Study|Lost to Follow-up|1|||
23572682|NCT03824938|65827370|FG002|Overall Study|Lost to Follow-up|0|||
23572683|NCT03824938|65827371|FG003|Overall Study|Lost to Follow-up|0|||
23572684|NCT03824938|65827372|FG004|Overall Study|Lost to Follow-up|1|||
23572685|NCT03824938|65827373|FG005|Overall Study|Lost to Follow-up|0|||
23572686|NCT02698436|65827377|FG000|Overall Study|Adverse Event|1|||
23572687|NCT02698436|65827378|FG001|Overall Study|Adverse Event|0|||
23164771|NCT03259074|64352487|FG001|Overall Study|Subject/Guardian Decision|16|||
23164772|NCT03259074|64352488|FG002|Overall Study|Subject/Guardian Decision|14|||
23164773|NCT01212185|64352489|FG000|Overall Study|Protocol Violation|2|||
23164774|NCT01212185|64352490|FG001|Overall Study|Protocol Violation|1|||
23572688|NCT02698436|65827377|FG000|Overall Study|Withdrawal by Subject|3|||
23164775|NCT03124784|64352491|FG000|Overall Study|Adverse Event|1|||
23164776|NCT03124784|64352491|FG000|Overall Study|Computer/Equip Malfunction|1|||
23164777|NCT01566773|64352492|FG000|Overall Study|Protocol specified criteria|4|||
23572689|NCT02698436|65827378|FG001|Overall Study|Withdrawal by Subject|3|||
23572690|NCT02698436|65827377|FG000|Overall Study|Lost to Follow-up|2|||
23572691|NCT02698436|65827378|FG001|Overall Study|Lost to Follow-up|4|||
23572692|NCT02698436|65827377|FG000|Overall Study|Non-compliance with study regimen|1|||
23572693|NCT02698436|65827378|FG001|Overall Study|Non-compliance with study regimen|0|||
23572694|NCT04102540|65827379|FG000|Overall Study|Withdrawn by PI|2|||
23572695|NCT04102540|65827379|FG000|Overall Study|Lost to Follow-up|6|||
23572696|NCT02080520|65827380|FG000|Overall Study|Self-reported symptoms|5|||
23164778|NCT01566773|64352492|FG000|Overall Study|Protocol Violation|4|||
23164779|NCT01566773|64352492|FG000|Overall Study|Withdrawal by Subject|9|||
23164780|NCT01566773|64352492|FG000|Overall Study|Administrative reason|1|||
23164781|NCT01566773|64352492|FG000|Overall Study|Adverse Event|10|||
23164782|NCT01566773|64352492|FG000|Overall Study|Physician Decision|2|||
23164783|NCT01227902|64352500|FG000|Overall Study|Adverse Event|12|||
23164784|NCT01227902|64352501|FG001|Overall Study|Adverse Event|8|||
23164785|NCT01227902|64352502|FG002|Overall Study|Adverse Event|11|||
23164786|NCT01227902|64352503|FG003|Overall Study|Adverse Event|4|||
23164787|NCT01227902|64352500|FG000|Overall Study|Lack of Efficacy|1|||
23164788|NCT01227902|64352501|FG001|Overall Study|Lack of Efficacy|2|||
23164789|NCT01227902|64352502|FG002|Overall Study|Lack of Efficacy|2|||
23164790|NCT01227902|64352503|FG003|Overall Study|Lack of Efficacy|1|||
23164791|NCT01227902|64352500|FG000|Overall Study|Protocol Violation|1|||
23164792|NCT01227902|64352501|FG001|Overall Study|Protocol Violation|0|||
23164793|NCT01227902|64352502|FG002|Overall Study|Protocol Violation|0|||
23225275|NCT00998985|64567707|FG002|Overall Study|Protocol Violation|0|||
23225276|NCT00998985|64567708|FG003|Overall Study|Protocol Violation|0|||
23225277|NCT00998985|64567709|FG004|Overall Study|Protocol Violation|0|||
23225278|NCT00998985|64567710|FG005|Overall Study|Protocol Violation|1|||
23225279|NCT00998985|64567711|FG006|Overall Study|Protocol Violation|0|||
23225280|NCT00998985|64567712|FG007|Overall Study|Protocol Violation|0|||
23225281|NCT00998985|64567713|FG008|Overall Study|Protocol Violation|0|||
23225282|NCT00998985|64567714|FG009|Overall Study|Protocol Violation|0|||
23164794|NCT01227902|64352503|FG003|Overall Study|Protocol Violation|0|||
23164795|NCT01227902|64352500|FG000|Overall Study|Lost to Follow-up|0|||
23164796|NCT01227902|64352501|FG001|Overall Study|Lost to Follow-up|0|||
23164797|NCT01227902|64352502|FG002|Overall Study|Lost to Follow-up|1|||
23164798|NCT01227902|64352503|FG003|Overall Study|Lost to Follow-up|2|||
23164799|NCT01227902|64352500|FG000|Overall Study|Physician Decision|0|||
23164800|NCT01227902|64352501|FG001|Overall Study|Physician Decision|1|||
23164801|NCT01227902|64352502|FG002|Overall Study|Physician Decision|1|||
23225283|NCT00998985|64567715|FG010|Overall Study|Protocol Violation|0|||
23225284|NCT00998985|64567716|FG011|Overall Study|Protocol Violation|0|||
23225285|NCT00998985|64567717|FG012|Overall Study|Protocol Violation|0|||
23572697|NCT02080520|65827381|FG001|Overall Study|Self-reported symptoms|6|||
23572698|NCT02080520|65827380|FG000|Overall Study|Unable to contact|2|||
23572699|NCT02080520|65827381|FG001|Overall Study|Unable to contact|1|||
23572700|NCT02080520|65827380|FG000|Overall Study|Initiated aspirin|2|||
23572701|NCT02080520|65827381|FG001|Overall Study|Initiated aspirin|0|||
23572702|NCT02080520|65827380|FG000|Overall Study|Atrial fibrillation|1|||
23572703|NCT02080520|65827381|FG001|Overall Study|Atrial fibrillation|1|||
23572704|NCT02080520|65827380|FG000|Overall Study|Cancer|1|||
23225286|NCT00998985|64567718|FG013|Overall Study|Protocol Violation|0|||
23225287|NCT00378534|64567720|FG000|Overall Study|Participants did not receive transplant|3|||
23225288|NCT00378534|64567721|FG001|Overall Study|Participants did not receive transplant|0|||
23225289|NCT02692560|64567722|FG000|Overall Study|Withdrawal by Subject|0|||
23225290|NCT02692560|64567723|FG001|Overall Study|Withdrawal by Subject|6|||
23225291|NCT02148952|64567724|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
23572705|NCT02080520|65827381|FG001|Overall Study|Cancer|2|||
23572706|NCT02080520|65827380|FG000|Overall Study|Not interested in study|1|||
23572707|NCT02080520|65827381|FG001|Overall Study|Not interested in study|3|||
23572708|NCT02080520|65827380|FG000|Overall Study|Too busy|1|||
23572709|NCT02080520|65827381|FG001|Overall Study|Too busy|1|||
23572710|NCT02080520|65827380|FG000|Overall Study|Work-related injury|1|||
23572711|NCT02080520|65827381|FG001|Overall Study|Work-related injury|0|||
23572712|NCT02080520|65827380|FG000|Overall Study|Personal reasons|0|||
23572713|NCT02080520|65827381|FG001|Overall Study|Personal reasons|3|||
23572714|NCT01900054|65827382|FG000|Overall Study|Physician Decision|1|||
23572715|NCT01900054|65827382|FG000|Overall Study|Withdrawal by Subject|1|||
23572716|NCT00550173|65827385|FG000|Overall Study|Death|45|||
23164802|NCT01227902|64352503|FG003|Overall Study|Physician Decision|0|||
23164803|NCT01227902|64352500|FG000|Overall Study|Withdrawal by Subject|4|||
23164804|NCT01227902|64352501|FG001|Overall Study|Withdrawal by Subject|2|||
23164805|NCT01227902|64352502|FG002|Overall Study|Withdrawal by Subject|4|||
23164806|NCT01227902|64352503|FG003|Overall Study|Withdrawal by Subject|3|||
23164807|NCT05661851|64352504|FG000|Overall Study|Protocol Violation|1|||
23164808|NCT05661851|64352505|FG001|Overall Study|Protocol Violation|1|||
23164809|NCT05661851|64352504|FG000|Overall Study|Covid-19 Related|3|||
23164810|NCT05661851|64352505|FG001|Overall Study|Covid-19 Related|4|||
23164811|NCT05661851|64352504|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
23164812|NCT05661851|64352505|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
23164813|NCT05661851|64352504|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
23572717|NCT00550173|65827386|FG001|Overall Study|Death|38|||
23572718|NCT00550173|65827387|FG002|Overall Study|Death|50|||
23572719|NCT00550173|65827385|FG000|Overall Study|Physician Decision|1|||
23572720|NCT00550173|65827386|FG001|Overall Study|Physician Decision|2|||
23572721|NCT00550173|65827387|FG002|Overall Study|Physician Decision|2|||
23225292|NCT02148952|64567725|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
23225293|NCT02148952|64567724|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
23225294|NCT02148952|64567725|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
23164814|NCT05661851|64352505|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
23572722|NCT00550173|65827385|FG000|Overall Study|Withdrawal by Subject|9|||
23572723|NCT00550173|65827386|FG001|Overall Study|Withdrawal by Subject|12|||
23572724|NCT00550173|65827387|FG002|Overall Study|Withdrawal by Subject|17|||
23572725|NCT00550173|65827385|FG000|Overall Study|Sponsor Decision|13|||
23164815|NCT03652662|64352510|FG000|Overall Study|Withdrawal by Subject|2|||
23164816|NCT03652662|64352511|FG001|Overall Study|Withdrawal by Subject|1|||
23164817|NCT03652662|64352510|FG000|Overall Study|Lost to Follow-up|1|||
23164818|NCT03652662|64352511|FG001|Overall Study|Lost to Follow-up|0|||
23164819|NCT01391000|64352512|FG000|Overall Study|Lost to Follow-up|2|||
23164820|NCT01391000|64352513|FG001|Overall Study|Lost to Follow-up|0|||
23164821|NCT02937818|64352514|FG000|Overall Study|Participants decision|2|||
23164822|NCT02937818|64352515|FG001|Overall Study|Participants decision|1|||
23164823|NCT02937818|64352516|FG002|Overall Study|Participants decision|1|||
23225295|NCT02148952|64567724|FG000|Follow-Up|Lost to Follow-up|219|||
23225296|NCT02148952|64567725|FG001|Follow-Up|Lost to Follow-up|231|||
23225297|NCT02148952|64567724|FG000|Follow-Up|Withdrawal by Subject|46|||
23225298|NCT02148952|64567725|FG001|Follow-Up|Withdrawal by Subject|48|||
23225299|NCT02993783|64567726|FG000|Overall Study|Reason not Specified|6|||
23225300|NCT02993783|64567727|FG001|Overall Study|Reason not Specified|9|||
23225301|NCT00985738|64567728|FG000|Overall Study|Study closed prematurely|8|||
23225302|NCT00985738|64567729|FG001|Overall Study|Study closed prematurely|8|||
23225303|NCT03745989|64567730|FG000|Overall Study|Death|3|||
23225304|NCT03745989|64567731|FG001|Overall Study|Death|7|||
23225305|NCT03745989|64567732|FG002|Overall Study|Death|4|||
23572726|NCT00550173|65827386|FG001|Overall Study|Sponsor Decision|7|||
23572727|NCT00550173|65827387|FG002|Overall Study|Sponsor Decision|1|||
23572728|NCT00550173|65827385|FG000|Overall Study|Lost to Follow-up|4|||
23572729|NCT00550173|65827386|FG001|Overall Study|Lost to Follow-up|4|||
23572730|NCT00550173|65827387|FG002|Overall Study|Lost to Follow-up|3|||
23572731|NCT00437125|65827390|FG000|Overall Study|Adverse Event|12|||
23572732|NCT00437125|65827390|FG000|Overall Study|Death|1|||
23225306|NCT03745989|64567730|FG000|Overall Study|Lost to Follow-up|0|||
23225307|NCT03745989|64567731|FG001|Overall Study|Lost to Follow-up|2|||
23225308|NCT03745989|64567732|FG002|Overall Study|Lost to Follow-up|0|||
23225309|NCT03745989|64567730|FG000|Overall Study|Sponsor Decision|0|||
23225310|NCT03745989|64567731|FG001|Overall Study|Sponsor Decision|2|||
23225311|NCT03745989|64567732|FG002|Overall Study|Sponsor Decision|8|||
23225312|NCT03745989|64567730|FG000|Overall Study|Withdrawal by Subject|0|||
23225313|NCT03745989|64567731|FG001|Overall Study|Withdrawal by Subject|1|||
23225314|NCT03745989|64567732|FG002|Overall Study|Withdrawal by Subject|3|||
23225315|NCT02656173|64567733|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
23225316|NCT02656173|64567734|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
23225317|NCT02656173|64567733|FG000|Overall Study|Adverse Event|7|||
23225318|NCT02656173|64567734|FG001|Overall Study|Adverse Event|5|||
23225319|NCT02656173|64567733|FG000|Overall Study|Withdrawal by Subject|1|||
23225320|NCT02656173|64567734|FG001|Overall Study|Withdrawal by Subject|3|||
23225321|NCT02656173|64567733|FG000|Overall Study|Protocol Violation|0|||
23225322|NCT02656173|64567734|FG001|Overall Study|Protocol Violation|1|||
23225323|NCT02656173|64567733|FG000|Overall Study|Miscellaneous|2|||
23225324|NCT02656173|64567734|FG001|Overall Study|Miscellaneous|0|||
23225325|NCT00654368|64567742|FG000|Overall Study|Ineligibility determined|6|||
23225326|NCT00654368|64567743|FG001|Overall Study|Ineligibility determined|0|||
23225327|NCT00654368|64567744|FG002|Overall Study|Ineligibility determined|0|||
23225328|NCT00654368|64567742|FG000|Overall Study|Protocol deviation|3|||
23225329|NCT00654368|64567743|FG001|Overall Study|Protocol deviation|2|||
23225330|NCT00654368|64567744|FG002|Overall Study|Protocol deviation|1|||
23225331|NCT00654368|64567742|FG000|Overall Study|Non-compliance|2|||
23225332|NCT00654368|64567743|FG001|Overall Study|Non-compliance|1|||
23225333|NCT00654368|64567744|FG002|Overall Study|Non-compliance|2|||
23225334|NCT00654368|64567742|FG000|Overall Study|Withdrawal by Subject|5|||
23225335|NCT00654368|64567743|FG001|Overall Study|Withdrawal by Subject|2|||
23164824|NCT02937818|64352517|FG003|Overall Study|Participants decision|1|||
23225336|NCT00654368|64567744|FG002|Overall Study|Withdrawal by Subject|2|||
23225337|NCT00654368|64567742|FG000|Overall Study|Disease progression|21|||
23225338|NCT00654368|64567743|FG001|Overall Study|Disease progression|31|||
23164825|NCT02937818|64352514|FG000|Overall Study|Adverse Event|2|||
23164826|NCT02937818|64352515|FG001|Overall Study|Adverse Event|4|||
23225339|NCT00654368|64567744|FG002|Overall Study|Disease progression|13|||
23225340|NCT00654368|64567742|FG000|Overall Study|Requirement for alternative therapy|1|||
23572733|NCT00437125|65827390|FG000|Overall Study|Clinical Relapse|1|||
23572734|NCT00437125|65827390|FG000|Overall Study|Lack of Efficacy|1|||
23572735|NCT00437125|65827390|FG000|Overall Study|Lost to Follow-up|1|||
23164827|NCT02937818|64352516|FG002|Overall Study|Adverse Event|1|||
23225341|NCT00654368|64567743|FG001|Overall Study|Requirement for alternative therapy|1|||
23225342|NCT00654368|64567744|FG002|Overall Study|Requirement for alternative therapy|1|||
23225343|NCT00654368|64567742|FG000|Overall Study|Physician Decision|0|||
23225344|NCT00654368|64567743|FG001|Overall Study|Physician Decision|0|||
23225345|NCT00654368|64567744|FG002|Overall Study|Physician Decision|2|||
23225346|NCT00654368|64567742|FG000|Overall Study|Death|1|||
23225347|NCT00654368|64567743|FG001|Overall Study|Death|0|||
23225348|NCT00654368|64567744|FG002|Overall Study|Death|0|||
23225349|NCT00654368|64567742|FG000|Overall Study|Pregnancy|0|||
23225350|NCT00654368|64567743|FG001|Overall Study|Pregnancy|0|||
23225351|NCT00654368|64567744|FG002|Overall Study|Pregnancy|2|||
23225352|NCT00654368|64567742|FG000|Overall Study|Other|0|||
23225353|NCT00654368|64567743|FG001|Overall Study|Other|2|||
23225354|NCT00654368|64567744|FG002|Overall Study|Other|3|||
23225355|NCT00654368|64567742|FG000|Overall Study|Adverse Event|14|||
23225356|NCT00654368|64567743|FG001|Overall Study|Adverse Event|9|||
23225357|NCT00654368|64567744|FG002|Overall Study|Adverse Event|6|||
23225358|NCT04005755|64567745|FG000|Overall Study|Adverse Event|6|||
23225359|NCT04005755|64567745|FG000|Overall Study|Physician Decision|3|||
23225360|NCT04005755|64567745|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
23225361|NCT04005755|64567745|FG000|Overall Study|Withdrawal by Subject|3|||
23572736|NCT00437125|65827390|FG000|Overall Study|Withdrawal by Subject|13|||
23572737|NCT00437125|65827390|FG000|Overall Study|Withdrawal by Caregiver|2|||
23572738|NCT00437125|65827390|FG000|Overall Study|Physician Decision|1|||
23572739|NCT01734382|65827391|FG000|Part 1|Adverse Event|2|||
23572740|NCT01734382|65827392|FG001|Part 1|Adverse Event|0|||
23572741|NCT01734382|65827393|FG002|Part 1|Adverse Event|0|||
23572742|NCT01734382|65827391|FG000|Part 2|Adverse Event|0|||
23572743|NCT01734382|65827392|FG001|Part 2|Adverse Event|0|||
23572744|NCT01734382|65827393|FG002|Part 2|Adverse Event|1|||
23572745|NCT01734382|65827391|FG000|Part 2|Lack of Efficacy|0|||
23572746|NCT01734382|65827392|FG001|Part 2|Lack of Efficacy|1|||
23572747|NCT01734382|65827393|FG002|Part 2|Lack of Efficacy|1|||
23572748|NCT01734382|65827391|FG000|Part 2|Other|0|||
23572749|NCT01734382|65827392|FG001|Part 2|Other|0|||
23572750|NCT01734382|65827393|FG002|Part 2|Other|1|||
23225362|NCT04005755|64567745|FG000|Overall Study|Lost to Follow-up|1|||
23225363|NCT03607994|64567746|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
23572751|NCT01734382|65827391|FG000|Part 2|Physician Decision|0|||
23572752|NCT01734382|65827392|FG001|Part 2|Physician Decision|0|||
23572753|NCT01734382|65827393|FG002|Part 2|Physician Decision|3|||
23572754|NCT01734382|65827391|FG000|Part 2|Protocol Violation|0|||
23572755|NCT01734382|65827392|FG001|Part 2|Protocol Violation|1|||
23572756|NCT01734382|65827393|FG002|Part 2|Protocol Violation|0|||
23225364|NCT03607994|64567747|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
23225365|NCT01572480|64567753|FG000|Participants Enrolled|Withdrawal by Subject|1|||
23225366|NCT01572480|64567753|FG000|Drug Administration|Discontinued drug/Off Study|1|||
23225367|NCT01572480|64567753|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
23225368|NCT01572480|64567753|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
23225369|NCT04007367|64567754|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
23225370|NCT04007367|64567755|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
23225371|NCT04007367|64567756|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
23225372|NCT04007367|64567754|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
23225373|NCT04007367|64567755|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
23225374|NCT04007367|64567756|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
23225375|NCT04007367|64567754|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
23225376|NCT04007367|64567755|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
23225377|NCT04007367|64567756|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
23225378|NCT04007367|64567754|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
23225379|NCT04007367|64567755|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
23225380|NCT04007367|64567756|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
23225381|NCT04007367|64567754|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
23225382|NCT04007367|64567755|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
23225383|NCT04007367|64567756|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
23225384|NCT05307523|64567757|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
23225385|NCT05307523|64567758|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
23225386|NCT05307523|64567757|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
23225387|NCT05307523|64567758|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
23225388|NCT01764022|64567763|FG000|Overall Study|Death|3|||
23225389|NCT01764022|64567764|FG001|Overall Study|Death|5|||
23225390|NCT01764022|64567763|FG000|Overall Study|Withdrawal by Subject|2|||
23225391|NCT01764022|64567764|FG001|Overall Study|Withdrawal by Subject|6|||
23225392|NCT01764022|64567763|FG000|Overall Study|Lack of Efficacy|0|||
23225393|NCT01764022|64567764|FG001|Overall Study|Lack of Efficacy|1|||
23225394|NCT01764022|64567763|FG000|Overall Study|Physician Decision|0|||
23225395|NCT01764022|64567764|FG001|Overall Study|Physician Decision|2|||
23225396|NCT01764022|64567763|FG000|Overall Study|Lost to Follow-up|2|||
23225397|NCT01764022|64567764|FG001|Overall Study|Lost to Follow-up|0|||
23225398|NCT01764022|64567763|FG000|Overall Study|Protocol Violation|1|||
23225399|NCT01764022|64567764|FG001|Overall Study|Protocol Violation|0|||
23225400|NCT00608244|64567765|FG000|Overall Study|Adverse Event|1|||
23225401|NCT00608244|64567765|FG000|Overall Study|Low trough levels|1|||
23225402|NCT02355665|64567766|FG000|Overall Study|Adverse Event|16|||
23225403|NCT02355665|64567767|FG001|Overall Study|Adverse Event|24|||
23225404|NCT02355665|64567766|FG000|Overall Study|Protocol Violation|2|||
23225405|NCT02355665|64567767|FG001|Overall Study|Protocol Violation|0|||
23225406|NCT02355665|64567766|FG000|Overall Study|Withdrawal by Subject|90|||
23225407|NCT02355665|64567767|FG001|Overall Study|Withdrawal by Subject|100|||
23225408|NCT02355665|64567766|FG000|Overall Study|Lost to Follow-up|131|||
23225409|NCT02355665|64567767|FG001|Overall Study|Lost to Follow-up|103|||
23225410|NCT02355665|64567766|FG000|Overall Study|Death|4|||
23225411|NCT02355665|64567767|FG001|Overall Study|Death|2|||
23225412|NCT02355665|64567766|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
23225413|NCT02355665|64567767|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
23225414|NCT02736474|64567768|FG000|Overall Study|Lost to Follow-up|0|||
23225415|NCT02736474|64567769|FG001|Overall Study|Lost to Follow-up|1|||
23225416|NCT02708966|64567774|FG000|Overall Study|Lost to Follow-up|2|||
23225417|NCT02708966|64567775|FG001|Overall Study|Lost to Follow-up|2|||
23225418|NCT01602744|64567776|FG000|Overall Study|Death|17|||
23225419|NCT01602744|64567777|FG001|Overall Study|Death|15|||
23225420|NCT01602744|64567776|FG000|Overall Study|Lost to Follow-up|13|||
23225421|NCT01602744|64567777|FG001|Overall Study|Lost to Follow-up|8|||
23225422|NCT00744991|64567782|FG000|Overall Study|Progressive Disease|11|||
23225423|NCT00744991|64567782|FG000|Overall Study|Withdrawal by Subject|8|||
23225424|NCT00744991|64567782|FG000|Overall Study|Physician Decision|3|||
23225425|NCT00744991|64567782|FG000|Overall Study|Adverse Event|2|||
23225426|NCT00744991|64567782|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
23225427|NCT01424306|64567783|FG000|Overall Study|Protocol Violation|0|||
23225428|NCT01424306|64567784|FG001|Overall Study|Protocol Violation|0|||
23225429|NCT01424306|64567785|FG002|Overall Study|Protocol Violation|0|||
23572757|NCT01734382|65827391|FG000|Part 2|Withdrawal by Subject|0|||
23572758|NCT01734382|65827392|FG001|Part 2|Withdrawal by Subject|0|||
23572759|NCT01734382|65827393|FG002|Part 2|Withdrawal by Subject|1|||
23225430|NCT01424306|64567786|FG003|Overall Study|Protocol Violation|0|||
23225431|NCT01424306|64567787|FG004|Overall Study|Protocol Violation|1|||
23225432|NCT01424306|64567788|FG005|Overall Study|Protocol Violation|0|||
23225433|NCT00038142|64567789|FG000|Overall Study|Ineligible|1|||
23225434|NCT00038142|64567790|FG001|Overall Study|Ineligible|0|||
23225435|NCT00038142|64567789|FG000|Overall Study|Progressive Disease|11|||
23225436|NCT00038142|64567790|FG001|Overall Study|Progressive Disease|7|||
23225437|NCT00038142|64567789|FG000|Overall Study|Death|1|||
23225438|NCT00038142|64567790|FG001|Overall Study|Death|0|||
23225439|NCT00038142|64567789|FG000|Overall Study|Adverse Event|1|||
23225440|NCT00038142|64567790|FG001|Overall Study|Adverse Event|0|||
23225441|NCT00038142|64567789|FG000|Overall Study|Unknown Reason|8|||
23225442|NCT00038142|64567790|FG001|Overall Study|Unknown Reason|0|||
23225443|NCT00517634|64567791|FG000|Second Treatment Period|Withdrawal by Subject|0|||
23225444|NCT00517634|64567792|FG001|Second Treatment Period|Withdrawal by Subject|0|||
23225445|NCT00517634|64567793|FG002|Second Treatment Period|Withdrawal by Subject|0|||
23225446|NCT00517634|64567794|FG003|Second Treatment Period|Withdrawal by Subject|0|||
23225447|NCT00517634|64567795|FG004|Second Treatment Period|Withdrawal by Subject|1|||
23225448|NCT00517634|64567796|FG005|Second Treatment Period|Withdrawal by Subject|0|||
23225449|NCT04476108|64567798|FG000|Overall Study|Adverse Event|4|||
23225450|NCT04476108|64567799|FG001|Overall Study|Adverse Event|1|||
23225451|NCT04476108|64567798|FG000|Overall Study|Lost to Follow-up|1|||
23225452|NCT04476108|64567799|FG001|Overall Study|Lost to Follow-up|0|||
23225453|NCT04476108|64567798|FG000|Overall Study|Inadvertent Enrollment|1|||
23225454|NCT04476108|64567799|FG001|Overall Study|Inadvertent Enrollment|0|||
23225455|NCT04476108|64567798|FG000|Overall Study|Protocol Violation|1|||
23225456|NCT04476108|64567799|FG001|Overall Study|Protocol Violation|1|||
23225457|NCT04476108|64567798|FG000|Overall Study|Withdrawal by Subject|1|||
23225458|NCT04476108|64567799|FG001|Overall Study|Withdrawal by Subject|1|||
23225459|NCT01836549|64567800|FG000|Overall Study|Did not receive study drug|0|||
23225460|NCT01836549|64567801|FG001|Overall Study|Did not receive study drug|0|||
23225461|NCT01836549|64567802|FG002|Overall Study|Did not receive study drug|1|||
23225462|NCT01836549|64567803|FG003|Overall Study|Did not receive study drug|0|||
23225463|NCT01836549|64567804|FG004|Overall Study|Did not receive study drug|0|||
23225464|NCT01836549|64567805|FG005|Overall Study|Did not receive study drug|0|||
23225465|NCT01836549|64567806|FG006|Overall Study|Did not receive study drug|0|||
23225466|NCT01836549|64567800|FG000|Overall Study|Patient declared ineligible|0|||
23225467|NCT01836549|64567801|FG001|Overall Study|Patient declared ineligible|0|||
23225468|NCT01836549|64567802|FG002|Overall Study|Patient declared ineligible|0|||
23225469|NCT01836549|64567803|FG003|Overall Study|Patient declared ineligible|1|||
23225470|NCT01836549|64567804|FG004|Overall Study|Patient declared ineligible|0|||
23225471|NCT01836549|64567805|FG005|Overall Study|Patient declared ineligible|0|||
23225472|NCT01836549|64567806|FG006|Overall Study|Patient declared ineligible|0|||
23225473|NCT01836549|64567800|FG000|Overall Study|Patient inevaluable to start therapy|0|||
23225474|NCT01836549|64567801|FG001|Overall Study|Patient inevaluable to start therapy|0|||
23225475|NCT01836549|64567802|FG002|Overall Study|Patient inevaluable to start therapy|0|||
23225476|NCT01836549|64567803|FG003|Overall Study|Patient inevaluable to start therapy|0|||
23225477|NCT01836549|64567804|FG004|Overall Study|Patient inevaluable to start therapy|0|||
23225478|NCT01836549|64567805|FG005|Overall Study|Patient inevaluable to start therapy|0|||
23225479|NCT01836549|64567806|FG006|Overall Study|Patient inevaluable to start therapy|1|||
23225480|NCT03236506|64567808|FG000|Overall Study|Death|1|||
23225481|NCT03236506|64567809|FG001|Overall Study|Death|1|||
23225482|NCT03236506|64567810|FG002|Overall Study|Death|1|||
23225483|NCT03236506|64567808|FG000|Overall Study|Withdrawal by Subject|3|||
23225484|NCT03236506|64567809|FG001|Overall Study|Withdrawal by Subject|3|||
23225485|NCT03236506|64567810|FG002|Overall Study|Withdrawal by Subject|4|||
23225486|NCT03236506|64567808|FG000|Overall Study|Did not initiate treatment|2|||
23225487|NCT03236506|64567809|FG001|Overall Study|Did not initiate treatment|1|||
23225488|NCT03236506|64567810|FG002|Overall Study|Did not initiate treatment|2|||
23225489|NCT00948428|64567811|FG000|Overall Study|Withdrawal by Subject|6|||
23225490|NCT00948428|64567812|FG001|Overall Study|Withdrawal by Subject|12|||
23225491|NCT00948428|64567813|FG002|Overall Study|Withdrawal by Subject|7|||
23225492|NCT00948428|64567811|FG000|Overall Study|Adverse Event|6|||
23225493|NCT00948428|64567812|FG001|Overall Study|Adverse Event|3|||
23225494|NCT00948428|64567813|FG002|Overall Study|Adverse Event|0|||
23225495|NCT00948428|64567811|FG000|Overall Study|Lost to Follow-up|2|||
23225496|NCT00948428|64567812|FG001|Overall Study|Lost to Follow-up|1|||
23225497|NCT00948428|64567813|FG002|Overall Study|Lost to Follow-up|1|||
23225498|NCT00948428|64567811|FG000|Overall Study|Death|2|||
23225499|NCT00948428|64567812|FG001|Overall Study|Death|0|||
23225500|NCT00948428|64567813|FG002|Overall Study|Death|0|||
23225501|NCT00948428|64567811|FG000|Overall Study|Intercurrent Illness|1|||
23225502|NCT00948428|64567812|FG001|Overall Study|Intercurrent Illness|0|||
23225503|NCT00948428|64567813|FG002|Overall Study|Intercurrent Illness|0|||
23225504|NCT00948428|64567811|FG000|Overall Study|Non-compliance|1|||
23225505|NCT00948428|64567812|FG001|Overall Study|Non-compliance|2|||
23225506|NCT00948428|64567813|FG002|Overall Study|Non-compliance|0|||
23225507|NCT03032523|64567818|FG000|Overall Study|Withdrawal by Subject|2|||
23225508|NCT03032523|64567819|FG001|Overall Study|Withdrawal by Subject|2|||
23225509|NCT03032523|64567818|FG000|Overall Study|Physician Decision|1|||
23225510|NCT03032523|64567819|FG001|Overall Study|Physician Decision|0|||
23225511|NCT00446797|64567821|FG000|Overall Study|Lack of Efficacy|0|||
23225512|NCT00446797|64567822|FG001|Overall Study|Lack of Efficacy|2|||
23225513|NCT00446797|64567821|FG000|Overall Study|Lost to Follow-up|5|||
23225514|NCT00446797|64567822|FG001|Overall Study|Lost to Follow-up|3|||
23225515|NCT00446797|64567821|FG000|Overall Study|Withdrawal by Subject|2|||
23225516|NCT00446797|64567822|FG001|Overall Study|Withdrawal by Subject|2|||
23225517|NCT00446797|64567821|FG000|Overall Study|Protocol Violation|1|||
23572760|NCT02411591|65827399|FG000|Overall Study|Adverse Event|0|||
23572761|NCT02411591|65827400|FG001|Overall Study|Adverse Event|4|||
23572762|NCT02411591|65827401|FG002|Overall Study|Adverse Event|2|||
23572763|NCT02411591|65827399|FG000|Overall Study|Withdrawal by Subject|0|||
23225518|NCT00446797|64567822|FG001|Overall Study|Protocol Violation|3|||
23225519|NCT00446797|64567821|FG000|Overall Study|subject entered at another site|0|||
23225520|NCT00446797|64567822|FG001|Overall Study|subject entered at another site|1|||
23225521|NCT00446797|64567821|FG000|Overall Study|did not meet entrance criteria|0|||
23225522|NCT00446797|64567822|FG001|Overall Study|did not meet entrance criteria|1|||
23225523|NCT02967562|64567823|FG000|Overall Study|Consent not obtained|1|||
23225524|NCT02967562|64567824|FG001|Overall Study|Consent not obtained|0|||
23225525|NCT02967562|64567823|FG000|Overall Study|High leak precluding analysis|1|||
23225526|NCT02967562|64567824|FG001|Overall Study|High leak precluding analysis|1|||
23225527|NCT03344562|64567833|FG000|Overall Study|Withdrawal by Subject|2|||
23225528|NCT03344562|64567834|FG001|Overall Study|Withdrawal by Subject|0|||
23225529|NCT00511108|64567835|FG000|Overall Study|Adverse Event|2|||
23225530|NCT00511108|64567836|FG001|Overall Study|Adverse Event|0|||
23225531|NCT00511108|64567837|FG002|Overall Study|Adverse Event|1|||
23225532|NCT00511108|64567838|FG003|Overall Study|Adverse Event|2|||
23225533|NCT00511108|64567835|FG000|Overall Study|Lost to Follow-up|0|||
23225534|NCT00511108|64567836|FG001|Overall Study|Lost to Follow-up|2|||
23225535|NCT00511108|64567837|FG002|Overall Study|Lost to Follow-up|1|||
23225536|NCT00511108|64567838|FG003|Overall Study|Lost to Follow-up|0|||
23225537|NCT00511108|64567835|FG000|Overall Study|Physician Decision|0|||
23225538|NCT00511108|64567836|FG001|Overall Study|Physician Decision|0|||
23225539|NCT00511108|64567837|FG002|Overall Study|Physician Decision|0|||
23225540|NCT00511108|64567838|FG003|Overall Study|Physician Decision|1|||
23225541|NCT00511108|64567835|FG000|Overall Study|Withdrawal by Subject|4|||
23225542|NCT00511108|64567836|FG001|Overall Study|Withdrawal by Subject|0|||
23225543|NCT00511108|64567837|FG002|Overall Study|Withdrawal by Subject|3|||
23225544|NCT00511108|64567838|FG003|Overall Study|Withdrawal by Subject|2|||
23225545|NCT01369069|64567839|FG000|Overall Study|Lost to Follow-up|8|||
23225546|NCT01369069|64567840|FG001|Overall Study|Lost to Follow-up|9|||
23225547|NCT01369069|64567839|FG000|Overall Study|Withdrawal by Subject|9|||
23225548|NCT01369069|64567840|FG001|Overall Study|Withdrawal by Subject|7|||
23225549|NCT03644173|64567841|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
23225550|NCT03644173|64567841|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
23225551|NCT03644173|64567841|FG000|Participants at the 1-month Follow up|Death|2|||
23225552|NCT03644173|64567841|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
23225553|NCT02008396|64567844|FG000|Overall Study|Protocol Violation|0|||
23225554|NCT02008396|64567845|FG001|Overall Study|Protocol Violation|1|||
23225555|NCT00958191|64567846|FG000|Overall Study|Death|4|||
23225556|NCT00958191|64567846|FG000|Overall Study|Lost to Follow-up|5|||
23225557|NCT00958191|64567846|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
23225558|NCT00958191|64567846|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
23225559|NCT00958191|64567846|FG000|Overall Study|Revision of study device|4|||
23225560|NCT00958191|64567846|FG000|Overall Study|Site termination|11|||
23225561|NCT00958191|64567846|FG000|Overall Study|No 5 yr x-rays|56|||
23225562|NCT01131130|64567848|FG000|Period 1 - Baseline|Pregnancy|1|||
23225563|NCT01131130|64567848|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
23225564|NCT01662986|64567852|FG000|Overall Study|Adverse Event|5|||
23225565|NCT01662986|64567853|FG001|Overall Study|Adverse Event|4|||
23225566|NCT01662986|64567852|FG000|Overall Study|Protocol Violation|2|||
23225567|NCT01662986|64567853|FG001|Overall Study|Protocol Violation|3|||
23225568|NCT01662986|64567852|FG000|Overall Study|Lost to Follow-up|5|||
23225569|NCT01662986|64567853|FG001|Overall Study|Lost to Follow-up|4|||
23225570|NCT01662986|64567852|FG000|Overall Study|Withdrawal by Subject|2|||
23225571|NCT01662986|64567853|FG001|Overall Study|Withdrawal by Subject|2|||
23225572|NCT01662986|64567852|FG000|Overall Study|Not Treated|1|||
23225573|NCT01662986|64567853|FG001|Overall Study|Not Treated|0|||
23225574|NCT01662986|64567852|FG000|Overall Study|Other than stated above|3|||
23225575|NCT01662986|64567853|FG001|Overall Study|Other than stated above|0|||
23225576|NCT01023516|64567854|FG000|Overall Study|Voluntary discontinuation|7|||
23225577|NCT01023516|64567855|FG001|Overall Study|Voluntary discontinuation|5|||
23225578|NCT01023516|64567854|FG000|Overall Study|Adverse Event|9|||
23225579|NCT01023516|64567855|FG001|Overall Study|Adverse Event|6|||
23225580|NCT01023516|64567854|FG000|Overall Study|Safety reason|0|||
23225581|NCT01023516|64567855|FG001|Overall Study|Safety reason|3|||
23225582|NCT01023516|64567854|FG000|Overall Study|Study-specific criteria|4|||
23225583|NCT01023516|64567855|FG001|Overall Study|Study-specific criteria|2|||
23225584|NCT01023516|64567854|FG000|Overall Study|Incorrect enrolment|4|||
23572764|NCT02411591|65827400|FG001|Overall Study|Withdrawal by Subject|3|||
23164828|NCT02937818|64352517|FG003|Overall Study|Adverse Event|1|||
23164829|NCT02937818|64352514|FG000|Overall Study|Disease progression|17|||
23164830|NCT02937818|64352515|FG001|Overall Study|Disease progression|15|||
23164831|NCT02937818|64352516|FG002|Overall Study|Disease progression|7|||
23164832|NCT02937818|64352517|FG003|Overall Study|Disease progression|19|||
23164833|NCT02937818|64352514|FG000|Overall Study|Condition under investigation worsened|0|||
23164834|NCT02937818|64352515|FG001|Overall Study|Condition under investigation worsened|0|||
23164835|NCT02937818|64352516|FG002|Overall Study|Condition under investigation worsened|1|||
23164836|NCT02937818|64352517|FG003|Overall Study|Condition under investigation worsened|0|||
23164837|NCT01032915|64352524|FG000|Overall Study|Adverse Event|2|||
23332104|NCT01295827|64958991|FG014|Overall Study|Other|0|||
23332105|NCT01208974|64958992|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
23332106|NCT01208974|64958993|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
23332107|NCT01208974|64958994|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
23332108|NCT01208974|64958995|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
23332109|NCT01208974|64958992|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
23332110|NCT01208974|64958993|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
23332111|NCT01208974|64958994|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
23332112|NCT01208974|64958995|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
23332113|NCT01208974|64958992|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
23332114|NCT01208974|64958993|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
23332115|NCT01208974|64958994|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
23332116|NCT01208974|64958995|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
23332117|NCT03963232|64958996|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23332118|NCT03963232|64958997|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
23332119|NCT03963232|64958996|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
23332120|NCT03963232|64958997|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
23332121|NCT03963232|64958996|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
23332122|NCT03963232|64958997|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
23332123|NCT03963232|64958996|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
23332124|NCT03963232|64958997|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
23164838|NCT01032915|64352525|FG001|Overall Study|Adverse Event|2|||
23164839|NCT01032915|64352526|FG002|Overall Study|Adverse Event|1|||
23164840|NCT01032915|64352527|FG003|Overall Study|Adverse Event|1|||
23164841|NCT01032915|64352524|FG000|Overall Study|Abnormal test procedure result|0|||
23164842|NCT01032915|64352525|FG001|Overall Study|Abnormal test procedure result|0|||
23164843|NCT01032915|64352526|FG002|Overall Study|Abnormal test procedure result|1|||
23164844|NCT01032915|64352527|FG003|Overall Study|Abnormal test procedure result|0|||
23164845|NCT01032915|64352524|FG000|Overall Study|Withdrawal by Subject|0|||
23164846|NCT01032915|64352525|FG001|Overall Study|Withdrawal by Subject|3|||
23164847|NCT01032915|64352526|FG002|Overall Study|Withdrawal by Subject|1|||
23164848|NCT01032915|64352527|FG003|Overall Study|Withdrawal by Subject|1|||
23164849|NCT01032915|64352524|FG000|Overall Study|Administrative reasons|5|||
23164850|NCT01032915|64352525|FG001|Overall Study|Administrative reasons|6|||
23164851|NCT01032915|64352526|FG002|Overall Study|Administrative reasons|4|||
23164852|NCT01032915|64352527|FG003|Overall Study|Administrative reasons|4|||
23164853|NCT01032915|64352524|FG000|Overall Study|Protocol Violation|1|||
23164854|NCT01032915|64352525|FG001|Overall Study|Protocol Violation|0|||
23164855|NCT01032915|64352526|FG002|Overall Study|Protocol Violation|0|||
23164856|NCT01032915|64352527|FG003|Overall Study|Protocol Violation|1|||
23164857|NCT01026831|64352529|FG000|Overall Study|Adverse Event|4|||
23164858|NCT01026831|64352530|FG001|Overall Study|Adverse Event|3|||
23164859|NCT01026831|64352529|FG000|Overall Study|Lost to Follow-up|2|||
23164860|NCT01026831|64352530|FG001|Overall Study|Lost to Follow-up|0|||
23164861|NCT01026831|64352529|FG000|Overall Study|Physician Decision|1|||
23164862|NCT01026831|64352530|FG001|Overall Study|Physician Decision|1|||
23164863|NCT01026831|64352529|FG000|Overall Study|Protocol Violation|0|||
23164864|NCT01026831|64352530|FG001|Overall Study|Protocol Violation|2|||
23164865|NCT01026831|64352529|FG000|Overall Study|Withdrawal by Subject|7|||
23164866|NCT01026831|64352530|FG001|Overall Study|Withdrawal by Subject|5|||
23164867|NCT01356589|64352531|FG000|Overall Study|Enrolled, but not treated|3|||
23225585|NCT01023516|64567855|FG001|Overall Study|Incorrect enrolment|2|||
23332125|NCT03963232|64958996|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
23332126|NCT03963232|64958997|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
23332127|NCT03963232|64958996|FG000|Open-Label Treatment Phase|Adverse Event|1|||
23164868|NCT01356589|64352531|FG000|Overall Study|Dose data not recorded|2|||
23164869|NCT02258451|64352532|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
23164870|NCT02258451|64352533|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
23164871|NCT02258451|64352532|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
23164872|NCT02258451|64352533|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
23332128|NCT03963232|64958997|FG001|Open-Label Treatment Phase|Adverse Event|2|||
23225586|NCT01365091|64567856|FG000|Period 1|Adverse Event|1|||
23225587|NCT01365091|64567857|FG001|Period 1|Adverse Event|0|||
23225588|NCT01365091|64567858|FG002|Period 1|Adverse Event|2|||
23225589|NCT01365091|64567859|FG003|Period 1|Adverse Event|3|||
23225590|NCT01365091|64567856|FG000|Period 1|Positive test result for drugs of abuse|1|||
23225591|NCT01365091|64567857|FG001|Period 1|Positive test result for drugs of abuse|0|||
23225592|NCT01365091|64567858|FG002|Period 1|Positive test result for drugs of abuse|0|||
23225593|NCT01365091|64567859|FG003|Period 1|Positive test result for drugs of abuse|0|||
23225594|NCT01365091|64567856|FG000|Period 1|No longer met study criteria|0|||
23225595|NCT01365091|64567857|FG001|Period 1|No longer met study criteria|1|||
23225596|NCT01365091|64567858|FG002|Period 1|No longer met study criteria|0|||
23225597|NCT01365091|64567859|FG003|Period 1|No longer met study criteria|0|||
23225598|NCT01365091|64567856|FG000|Period 1|Withdrawal by Subject|0|||
23225599|NCT01365091|64567857|FG001|Period 1|Withdrawal by Subject|1|||
23225600|NCT01365091|64567858|FG002|Period 1|Withdrawal by Subject|0|||
23225601|NCT01365091|64567859|FG003|Period 1|Withdrawal by Subject|0|||
23225602|NCT01365091|64567856|FG000|Period 1|Personal reasons|0|||
23225603|NCT01365091|64567857|FG001|Period 1|Personal reasons|0|||
23225604|NCT01365091|64567858|FG002|Period 1|Personal reasons|1|||
23225605|NCT01365091|64567859|FG003|Period 1|Personal reasons|0|||
23225606|NCT01365091|64567856|FG000|Period 2|Withdrawal by Subject|1|||
23225607|NCT01365091|64567857|FG001|Period 2|Withdrawal by Subject|0|||
23225608|NCT01365091|64567858|FG002|Period 2|Withdrawal by Subject|0|||
23225609|NCT01365091|64567859|FG003|Period 2|Withdrawal by Subject|0|||
23225610|NCT01365091|64567856|FG000|Period 2|Adverse Event|0|||
23225611|NCT01365091|64567857|FG001|Period 2|Adverse Event|0|||
23225612|NCT01365091|64567858|FG002|Period 2|Adverse Event|1|||
23225613|NCT01365091|64567859|FG003|Period 2|Adverse Event|0|||
23225614|NCT00090766|64567860|FG000|Overall Study|Nephrectomy Planned|0|||
23225615|NCT00090766|64567861|FG001|Overall Study|Nephrectomy Planned|0|||
23225616|NCT00090766|64567862|FG002|Overall Study|Nephrectomy Planned|1|||
23225617|NCT00090766|64567860|FG000|Overall Study|Death|1|||
23225618|NCT00090766|64567861|FG001|Overall Study|Death|0|||
23225619|NCT00090766|64567862|FG002|Overall Study|Death|0|||
23225620|NCT00090766|64567860|FG000|Overall Study|Admin|0|||
23225621|NCT00090766|64567861|FG001|Overall Study|Admin|2|||
23225622|NCT00090766|64567862|FG002|Overall Study|Admin|0|||
23225623|NCT00090766|64567860|FG000|Overall Study|Lost to Follow-up|2|||
23225624|NCT00090766|64567861|FG001|Overall Study|Lost to Follow-up|0|||
23225625|NCT00090766|64567862|FG002|Overall Study|Lost to Follow-up|2|||
23225626|NCT00863317|64567868|FG000|Overall Study|Lost to Follow-up|8|||
23225627|NCT00863317|64567869|FG001|Overall Study|Lost to Follow-up|9|||
23225628|NCT01388491|64567870|FG000|Overall Study|Adverse Event|10|||
23225629|NCT01388491|64567871|FG001|Overall Study|Adverse Event|9|||
23225630|NCT01388491|64567870|FG000|Overall Study|Sponsor Request|9|||
23225631|NCT01388491|64567871|FG001|Overall Study|Sponsor Request|7|||
23572765|NCT02411591|65827401|FG002|Overall Study|Withdrawal by Subject|0|||
23572766|NCT02411591|65827399|FG000|Overall Study|Physician Decision|0|||
23572767|NCT02411591|65827400|FG001|Overall Study|Physician Decision|3|||
23572768|NCT02411591|65827401|FG002|Overall Study|Physician Decision|1|||
23572769|NCT03590743|65827402|FG000|Overall Study|Withdrawal by Subject|0|||
23572770|NCT03590743|65827403|FG001|Overall Study|Withdrawal by Subject|1|||
23572771|NCT00478608|65827404|FG000|Overall Study|Adverse Event|1|||
23572772|NCT00478608|65827404|FG000|Overall Study|Serious Adverse Event|14|||
23572773|NCT00478608|65827404|FG000|Overall Study|Withdrawal by Subject|2|||
23572774|NCT00478608|65827404|FG000|Overall Study|Protocol Violation|3|||
23572775|NCT00849680|65827407|FG000|Overall Study|Adverse Event|0|||
23572776|NCT00849680|65827408|FG001|Overall Study|Adverse Event|0|||
23572777|NCT00849680|65827409|FG002|Overall Study|Adverse Event|0|||
23572778|NCT00849680|65827410|FG003|Overall Study|Adverse Event|0|||
23572779|NCT00849680|65827411|FG004|Overall Study|Adverse Event|0|||
23225632|NCT01388491|64567870|FG000|Overall Study|Withdrawal by Subject|6|||
23225633|NCT01388491|64567871|FG001|Overall Study|Withdrawal by Subject|10|||
23225634|NCT01388491|64567870|FG000|Overall Study|Lost to Follow-up|4|||
23225635|NCT01388491|64567871|FG001|Overall Study|Lost to Follow-up|3|||
23225636|NCT01388491|64567870|FG000|Overall Study|Protocol Violation|2|||
23225637|NCT01388491|64567871|FG001|Overall Study|Protocol Violation|0|||
23225638|NCT01388491|64567870|FG000|Overall Study|Noncompliance|2|||
23225639|NCT01388491|64567871|FG001|Overall Study|Noncompliance|0|||
23225640|NCT01388491|64567870|FG000|Overall Study|Pregnancy|1|||
23225641|NCT01388491|64567871|FG001|Overall Study|Pregnancy|0|||
23225642|NCT01440972|64567878|FG000|Overall Study|Withdrawal by Subject|3|||
23225643|NCT01440972|64567879|FG001|Overall Study|Withdrawal by Subject|2|||
23225644|NCT00410514|64567880|FG000|Overall Study|Adverse Event|2|||
23572780|NCT00849680|65827412|FG005|Overall Study|Adverse Event|0|||
23572781|NCT00849680|65827413|FG006|Overall Study|Adverse Event|2|||
23572782|NCT00849680|65827414|FG007|Overall Study|Adverse Event|0|||
23225645|NCT00410514|64567881|FG001|Overall Study|Adverse Event|2|||
23225646|NCT00410514|64567882|FG002|Overall Study|Adverse Event|2|||
23572783|NCT00849680|65827407|FG000|Overall Study|Lost to Follow-up|7|||
23225647|NCT00410514|64567880|FG000|Overall Study|Protocol Violation|0|||
23225648|NCT00410514|64567881|FG001|Overall Study|Protocol Violation|1|||
23225649|NCT00410514|64567882|FG002|Overall Study|Protocol Violation|1|||
23225650|NCT00410514|64567880|FG000|Overall Study|Lost to Follow-up|0|||
23225651|NCT00410514|64567881|FG001|Overall Study|Lost to Follow-up|0|||
23225652|NCT00410514|64567882|FG002|Overall Study|Lost to Follow-up|2|||
23225653|NCT00410514|64567880|FG000|Overall Study|Non-compliant with study procedures|0|||
23225654|NCT00410514|64567881|FG001|Overall Study|Non-compliant with study procedures|0|||
23225655|NCT00410514|64567882|FG002|Overall Study|Non-compliant with study procedures|2|||
23225656|NCT03742271|64567883|FG000|Overall Study|Unsatisfactory Visual Response|1|||
23225657|NCT03742271|64567883|FG000|Overall Study|Withdrawal by Subject|3|||
23225658|NCT03742271|64567883|FG000|Overall Study|Lost to Follow-up|4|||
23225659|NCT03742271|64567883|FG000|Overall Study|Failed Insertion & removal|3|||
23225660|NCT03742271|64567883|FG000|Overall Study|Protocol Violation|1|||
23225661|NCT01642004|64567884|FG000|Randomization|Adverse Event unrelated to study drug|1|||
23225662|NCT01642004|64567885|FG001|Randomization|Adverse Event unrelated to study drug|0|||
23225663|NCT01642004|64567884|FG000|Randomization|Participant withdrew consent|1|||
23225664|NCT01642004|64567885|FG001|Randomization|Participant withdrew consent|6|||
23572784|NCT00849680|65827408|FG001|Overall Study|Lost to Follow-up|3|||
23572785|NCT00849680|65827409|FG002|Overall Study|Lost to Follow-up|12|||
23572786|NCT00849680|65827410|FG003|Overall Study|Lost to Follow-up|11|||
23572787|NCT00849680|65827411|FG004|Overall Study|Lost to Follow-up|8|||
23225665|NCT01642004|64567884|FG000|Randomization|No longer meets study criteria|2|||
23332129|NCT03963232|64958996|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
23332130|NCT03963232|64958997|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
23572788|NCT00849680|65827412|FG005|Overall Study|Lost to Follow-up|11|||
23572789|NCT00849680|65827413|FG006|Overall Study|Lost to Follow-up|12|||
23572790|NCT00849680|65827414|FG007|Overall Study|Lost to Follow-up|5|||
23572791|NCT00849680|65827407|FG000|Overall Study|Subject moved|1|||
23572792|NCT00849680|65827408|FG001|Overall Study|Subject moved|0|||
23572793|NCT00849680|65827409|FG002|Overall Study|Subject moved|3|||
23572794|NCT00849680|65827410|FG003|Overall Study|Subject moved|1|||
23572795|NCT00849680|65827411|FG004|Overall Study|Subject moved|0|||
23572796|NCT00849680|65827412|FG005|Overall Study|Subject moved|2|||
23572797|NCT00849680|65827413|FG006|Overall Study|Subject moved|2|||
23572798|NCT00849680|65827414|FG007|Overall Study|Subject moved|2|||
23572799|NCT00849680|65827407|FG000|Overall Study|Withdrawal by Subject|2|||
23572800|NCT00849680|65827408|FG001|Overall Study|Withdrawal by Subject|0|||
23572801|NCT00849680|65827409|FG002|Overall Study|Withdrawal by Subject|0|||
23572802|NCT00849680|65827410|FG003|Overall Study|Withdrawal by Subject|2|||
23572803|NCT00849680|65827411|FG004|Overall Study|Withdrawal by Subject|2|||
23572804|NCT00849680|65827412|FG005|Overall Study|Withdrawal by Subject|2|||
23572805|NCT00849680|65827413|FG006|Overall Study|Withdrawal by Subject|1|||
23572806|NCT00849680|65827414|FG007|Overall Study|Withdrawal by Subject|1|||
23164873|NCT02258451|64352532|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
23164874|NCT02258451|64352533|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
23164875|NCT02258451|64352532|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
23164876|NCT02258451|64352533|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
23164877|NCT02258451|64352532|FG000|Overall Study|Discontinuation all treatment due to death|4|||
23164878|NCT02258451|64352533|FG001|Overall Study|Discontinuation all treatment due to death|3|||
23164879|NCT02258451|64352532|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
23164880|NCT02258451|64352533|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
23164881|NCT02258451|64352532|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
23164882|NCT02258451|64352533|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
23164883|NCT02258451|64352532|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
23164884|NCT02258451|64352533|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
23225666|NCT01642004|64567885|FG001|Randomization|No longer meets study criteria|2|||
23225667|NCT01642004|64567884|FG000|Treatment|Disease progression|95|||
23225668|NCT01642004|64567885|FG001|Treatment|Disease progression|79|||
23572807|NCT00849680|65827407|FG000|Overall Study|Subject unable to comply with protocol|1|||
23572808|NCT00849680|65827408|FG001|Overall Study|Subject unable to comply with protocol|0|||
23572809|NCT00849680|65827409|FG002|Overall Study|Subject unable to comply with protocol|0|||
23225669|NCT01642004|64567884|FG000|Treatment|Study drug toxicity|10|||
23572810|NCT00849680|65827410|FG003|Overall Study|Subject unable to comply with protocol|0|||
23572811|NCT00849680|65827411|FG004|Overall Study|Subject unable to comply with protocol|0|||
23332131|NCT03963232|64958996|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
23572812|NCT00849680|65827412|FG005|Overall Study|Subject unable to comply with protocol|0|||
23572813|NCT00849680|65827413|FG006|Overall Study|Subject unable to comply with protocol|0|||
23572814|NCT00849680|65827414|FG007|Overall Study|Subject unable to comply with protocol|0|||
23572815|NCT00884286|65827424|FG000|Overall Study|Progressive disease|21|||
23572816|NCT00884286|65827425|FG001|Overall Study|Progressive disease|28|||
23572817|NCT00884286|65827424|FG000|Overall Study|Toxicity|4|||
23572818|NCT00884286|65827425|FG001|Overall Study|Toxicity|1|||
23572819|NCT00884286|65827424|FG000|Overall Study|Death|2|||
23572820|NCT00884286|65827425|FG001|Overall Study|Death|2|||
23572821|NCT00884286|65827424|FG000|Overall Study|Physician Decision|1|||
23164885|NCT02258451|64352532|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
23332132|NCT03963232|64958997|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
23332133|NCT03963232|64958996|FG000|Open-Label Treatment Phase|Pregnancy|1|||
23332134|NCT03963232|64958997|FG001|Open-Label Treatment Phase|Pregnancy|0|||
23332135|NCT03963232|64958996|FG000|Follow-up Phase|Withdrawal by Subject|7|||
23332136|NCT03963232|64958997|FG001|Follow-up Phase|Withdrawal by Subject|5|||
23332137|NCT03963232|64958996|FG000|Follow-up Phase|Protocol Violation|0|||
23332138|NCT03963232|64958997|FG001|Follow-up Phase|Protocol Violation|2|||
23332139|NCT03963232|64958996|FG000|Follow-up Phase|Adverse Event|0|||
23332140|NCT03963232|64958997|FG001|Follow-up Phase|Adverse Event|1|||
23332141|NCT03963232|64958996|FG000|Follow-up Phase|Lost to Follow-up|0|||
23332142|NCT03963232|64958997|FG001|Follow-up Phase|Lost to Follow-up|1|||
23332143|NCT02644668|64959004|FG000|Overall Study|Adverse Event|2|||
23332144|NCT02644668|64959005|FG001|Overall Study|Adverse Event|0|||
23332145|NCT02644668|64959006|FG002|Overall Study|Adverse Event|1|||
23332146|NCT02644668|64959004|FG000|Overall Study|Protocol Violation|0|||
23332147|NCT02644668|64959005|FG001|Overall Study|Protocol Violation|0|||
23225670|NCT01642004|64567885|FG001|Treatment|Study drug toxicity|13|||
23225671|NCT01642004|64567884|FG000|Treatment|Death|1|||
23225672|NCT01642004|64567885|FG001|Treatment|Death|1|||
23225673|NCT01642004|64567884|FG000|Treatment|Adverse event unrelated to study drug|9|||
23225674|NCT01642004|64567885|FG001|Treatment|Adverse event unrelated to study drug|13|||
23225675|NCT01642004|64567884|FG000|Treatment|Maximum clinical benefit|1|||
23225676|NCT01642004|64567885|FG001|Treatment|Maximum clinical benefit|9|||
23225677|NCT01642004|64567884|FG000|Treatment|Poor/non-compliance|1|||
23332148|NCT02644668|64959006|FG002|Overall Study|Protocol Violation|1|||
23332149|NCT02644668|64959004|FG000|Overall Study|Withdrawal by Subject|0|||
23225678|NCT01642004|64567885|FG001|Treatment|Poor/non-compliance|0|||
23225679|NCT01642004|64567884|FG000|Treatment|No longer meets study criteria|1|||
23225680|NCT01642004|64567885|FG001|Treatment|No longer meets study criteria|2|||
23225681|NCT01642004|64567884|FG000|Treatment|Other reasons|2|||
23225682|NCT01642004|64567885|FG001|Treatment|Other reasons|0|||
23225683|NCT01642004|64567884|FG000|Treatment|Not reported|0|||
23225684|NCT01642004|64567885|FG001|Treatment|Not reported|3|||
23225685|NCT01642004|64567884|FG000|Treatment|Participant request to discontinue study treatment|6|||
23164886|NCT02258451|64352533|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
23164887|NCT02258451|64352532|FG000|Overall Study|Other reason|1|||
23164888|NCT02258451|64352533|FG001|Overall Study|Other reason|1|||
23164889|NCT02258451|64352532|FG000|Overall Study|Never treated|2|||
23164890|NCT02258451|64352533|FG001|Overall Study|Never treated|3|||
23164891|NCT00689871|64352535|FG000|Overall Study|Lost to Follow-up|123|||
23164892|NCT00689871|64352536|FG001|Overall Study|Lost to Follow-up|13|||
23164893|NCT00689871|64352537|FG002|Overall Study|Lost to Follow-up|37|||
23164894|NCT00689871|64352538|FG003|Overall Study|Lost to Follow-up|1|||
23164895|NCT00689871|64352535|FG000|Overall Study|Explanted of All Study Devices|36|||
23164896|NCT00689871|64352536|FG001|Overall Study|Explanted of All Study Devices|25|||
23164897|NCT00689871|64352537|FG002|Overall Study|Explanted of All Study Devices|29|||
23164898|NCT00689871|64352538|FG003|Overall Study|Explanted of All Study Devices|3|||
23164899|NCT00689871|64352535|FG000|Overall Study|Withdrawal by Subject|13|||
23225686|NCT01642004|64567885|FG001|Treatment|Participant request to discontinue study treatment|4|||
23225687|NCT01642004|64567884|FG000|Treatment|Participant withdrew consent|5|||
23225688|NCT01642004|64567885|FG001|Treatment|Participant withdrew consent|5|||
23225689|NCT02886338|64567886|FG000|Overall Study|Withdrawal by Subject|1|||
23225690|NCT04432376|64567887|FG000|Double-blind Treatment Period|Adverse Event|2|||
23225691|NCT04432376|64567888|FG001|Double-blind Treatment Period|Adverse Event|6|||
23332150|NCT02644668|64959005|FG001|Overall Study|Withdrawal by Subject|0|||
23164900|NCT00689871|64352536|FG001|Overall Study|Withdrawal by Subject|3|||
23225692|NCT04432376|64567889|FG002|Double-blind Treatment Period|Adverse Event|0|||
23225693|NCT04432376|64567887|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
23225694|NCT04432376|64567888|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
23225695|NCT04432376|64567889|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23225696|NCT04432376|64567887|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23332151|NCT02644668|64959006|FG002|Overall Study|Withdrawal by Subject|1|||
23332152|NCT02547220|64959011|FG000|Overall Study|Withdrawal by Subject|1|||
23332153|NCT02547220|64959012|FG001|Overall Study|Withdrawal by Subject|0|||
23332154|NCT02547220|64959011|FG000|Overall Study|Study terminated by sponsor|18|||
23332155|NCT02547220|64959012|FG001|Overall Study|Study terminated by sponsor|20|||
23225697|NCT04432376|64567888|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
23225698|NCT04432376|64567889|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23225699|NCT04432376|64567887|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23225700|NCT04432376|64567888|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23225701|NCT04432376|64567889|FG002|Double-blind Treatment Period|Protocol Violation|0|||
23225702|NCT04432376|64567887|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
23332156|NCT02134015|64959013|FG000|Overall Study|Protocol Violation|0|||
23164901|NCT00689871|64352537|FG002|Overall Study|Withdrawal by Subject|4|||
23332157|NCT02134015|64959014|FG001|Overall Study|Protocol Violation|1|||
23332158|NCT02134015|64959013|FG000|Overall Study|Death|2|||
23572822|NCT00884286|65827425|FG001|Overall Study|Physician Decision|0|||
23572823|NCT00884286|65827424|FG000|Overall Study|Septic shock|1|||
23572824|NCT00884286|65827425|FG001|Overall Study|Septic shock|0|||
23572825|NCT00884286|65827424|FG000|Overall Study|Thrombus in right auricle|1|||
23572826|NCT00884286|65827425|FG001|Overall Study|Thrombus in right auricle|0|||
23572827|NCT00884286|65827424|FG000|Overall Study|Not treated|2|||
23572828|NCT00884286|65827425|FG001|Overall Study|Not treated|1|||
23572829|NCT00884286|65827424|FG000|Overall Study|Comprised lung carcinoma|0|||
23572830|NCT00884286|65827425|FG001|Overall Study|Comprised lung carcinoma|1|||
23164902|NCT00689871|64352538|FG003|Overall Study|Withdrawal by Subject|1|||
23164903|NCT00689871|64352535|FG000|Overall Study|Death|1|||
23164904|NCT00689871|64352536|FG001|Overall Study|Death|10|||
23164905|NCT00689871|64352537|FG002|Overall Study|Death|2|||
23164906|NCT00689871|64352538|FG003|Overall Study|Death|2|||
23164907|NCT00689871|64352535|FG000|Overall Study|Physician Decision|2|||
23164908|NCT00689871|64352536|FG001|Overall Study|Physician Decision|1|||
23164909|NCT00689871|64352537|FG002|Overall Study|Physician Decision|1|||
23164910|NCT00689871|64352538|FG003|Overall Study|Physician Decision|0|||
23164911|NCT00307151|64352539|FG000|Overall Study|Death|4|||
23164912|NCT00307151|64352540|FG001|Overall Study|Death|3|||
23164913|NCT00307151|64352541|FG002|Overall Study|Death|10|||
23164914|NCT00307151|64352542|FG003|Overall Study|Death|3|||
23164915|NCT00307151|64352539|FG000|Overall Study|Severe debilitation, unable to continue|1|||
23164916|NCT00307151|64352540|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23164917|NCT00307151|64352541|FG002|Overall Study|Severe debilitation, unable to continue|0|||
23164918|NCT00307151|64352542|FG003|Overall Study|Severe debilitation, unable to continue|0|||
23164919|NCT00307151|64352539|FG000|Overall Study|Subject unable to get to clinic|1|||
23164920|NCT00307151|64352540|FG001|Overall Study|Subject unable to get to clinic|0|||
23164921|NCT00307151|64352541|FG002|Overall Study|Subject unable to get to clinic|6|||
23164922|NCT00307151|64352542|FG003|Overall Study|Subject unable to get to clinic|2|||
23164923|NCT00307151|64352539|FG000|Overall Study|Withdrew consent|0|||
23164924|NCT00307151|64352540|FG001|Overall Study|Withdrew consent|1|||
23164925|NCT00307151|64352541|FG002|Overall Study|Withdrew consent|1|||
23225703|NCT04432376|64567888|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
23225704|NCT04432376|64567889|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
23225705|NCT02408484|64567890|FG000|Overall Study|Withdrawal by Subject|3|||
23225706|NCT02408484|64567890|FG000|Overall Study|Not treated during study period|1|||
23572831|NCT02222896|65827429|FG000|Abdomen|Did not qualify|34|||
23572832|NCT02222896|65827430|FG001|Abdomen|Did not qualify|10|||
23572833|NCT02222896|65827431|FG002|Abdomen|Did not qualify|32|||
23164926|NCT00307151|64352542|FG003|Overall Study|Withdrew consent|3|||
23164927|NCT00307151|64352539|FG000|Overall Study|Not willing to adhere to study reqs|2|||
23164928|NCT00307151|64352540|FG001|Overall Study|Not willing to adhere to study reqs|0|||
23164929|NCT00307151|64352541|FG002|Overall Study|Not willing to adhere to study reqs|2|||
23164930|NCT00307151|64352542|FG003|Overall Study|Not willing to adhere to study reqs|2|||
23572834|NCT02222896|65827429|FG000|Groin|Did not qualify|43|||
23572835|NCT02222896|65827430|FG001|Groin|Did not qualify|9|||
23572836|NCT02222896|65827431|FG002|Groin|Did not qualify|40|||
23572837|NCT04537949|65827439|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
23572838|NCT04537949|65827440|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
23572839|NCT04537949|65827441|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
23572840|NCT04537949|65827442|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
23572841|NCT04537949|65827443|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
23572842|NCT04537949|65827444|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
23572843|NCT04537949|65827445|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
23572844|NCT04537949|65827446|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
23572845|NCT04537949|65827439|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
23225707|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
23572846|NCT04537949|65827440|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
23572847|NCT04537949|65827441|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
23572848|NCT04537949|65827442|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
23572849|NCT04537949|65827443|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
23572850|NCT04537949|65827444|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
23572851|NCT04537949|65827445|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
23572852|NCT04537949|65827446|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
23572853|NCT04537949|65827439|FG000|Follow-up Phase|Lost to Follow-up|0|||
23572854|NCT04537949|65827440|FG001|Follow-up Phase|Lost to Follow-up|3|||
23572855|NCT04537949|65827441|FG002|Follow-up Phase|Lost to Follow-up|0|||
23572856|NCT04537949|65827442|FG003|Follow-up Phase|Lost to Follow-up|0|||
23572857|NCT04537949|65827443|FG004|Follow-up Phase|Lost to Follow-up|0|||
23572858|NCT04537949|65827444|FG005|Follow-up Phase|Lost to Follow-up|0|||
23572859|NCT04537949|65827445|FG006|Follow-up Phase|Lost to Follow-up|0|||
23572860|NCT04537949|65827446|FG007|Follow-up Phase|Lost to Follow-up|0|||
23572861|NCT04537949|65827439|FG000|Follow-up Phase|personal reasons|0|||
23572862|NCT04537949|65827440|FG001|Follow-up Phase|personal reasons|0|||
23164931|NCT00307151|64352539|FG000|Overall Study|Clinic unable to contact subject|3|||
23225708|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
23225709|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
23225710|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
23225711|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
23164932|NCT00307151|64352540|FG001|Overall Study|Clinic unable to contact subject|3|||
23164933|NCT00307151|64352541|FG002|Overall Study|Clinic unable to contact subject|1|||
23164934|NCT00307151|64352542|FG003|Overall Study|Clinic unable to contact subject|1|||
23164935|NCT00993928|64352543|FG000|Overall Study|Withdrawal by Subject|4|||
23164936|NCT00993928|64352544|FG001|Overall Study|Withdrawal by Subject|7|||
23225712|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
23164937|NCT00993928|64352543|FG000|Overall Study|ineligible|1|||
23164938|NCT00993928|64352544|FG001|Overall Study|ineligible|0|||
23164939|NCT00811135|64352545|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
23225713|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
23225714|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
23572863|NCT04537949|65827441|FG002|Follow-up Phase|personal reasons|0|||
23572864|NCT04537949|65827442|FG003|Follow-up Phase|personal reasons|1|||
23572865|NCT04537949|65827443|FG004|Follow-up Phase|personal reasons|1|||
23572866|NCT04537949|65827444|FG005|Follow-up Phase|personal reasons|0|||
23572867|NCT04537949|65827445|FG006|Follow-up Phase|personal reasons|0|||
23572868|NCT04537949|65827446|FG007|Follow-up Phase|personal reasons|0|||
23572869|NCT04537949|65827439|FG000|Follow-up Phase|Withdrawal by Subject|0|||
23572870|NCT04537949|65827440|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23164940|NCT00811135|64352545|FG000|Overall Study|Death|3|||
23164941|NCT00811135|64352545|FG000|Overall Study|Protocol Violation|2|||
23164942|NCT00811135|64352545|FG000|Overall Study|Violation of Selection Criteria|1|||
23225715|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
23225716|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
23225717|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
23225718|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
23225719|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
23225720|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
23225721|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
23225722|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
23225723|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
23225724|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
23225725|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
23225726|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
23225727|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
23225728|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
23225729|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
23225730|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
23225731|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Other|0|||
23225732|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Other|1|||
23225733|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Other|0|||
23225734|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Other|0|||
23225735|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
23225736|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
23225737|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
23225738|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
23225739|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
23225740|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
23225741|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
23225742|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
23225743|NCT01194414|64567896|FG000|24 Weeks Double Blind Period|Death|0|||
23225744|NCT01194414|64567897|FG001|24 Weeks Double Blind Period|Death|1|||
23225745|NCT01194414|64567898|FG002|24 Weeks Double Blind Period|Death|0|||
23225746|NCT01194414|64567899|FG003|24 Weeks Double Blind Period|Death|0|||
23225747|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
23225748|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
23225749|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
23225750|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
23225751|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
23225752|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
23225753|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
23225754|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
23225755|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
23225756|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
23225757|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
23225758|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
23225759|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
23225760|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
23225761|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
23225762|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
23225763|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
23225764|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
23225765|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
23225766|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
23225767|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
23225768|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
23225769|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
23225770|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
23225771|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Other|2|||
23225772|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Other|1|||
23225773|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Other|0|||
23225774|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Other|0|||
23225775|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
23572871|NCT04537949|65827441|FG002|Follow-up Phase|Withdrawal by Subject|0|||
23225776|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
23225777|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
23225778|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
23225779|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
23225780|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
23572872|NCT04537949|65827442|FG003|Follow-up Phase|Withdrawal by Subject|0|||
23164943|NCT00811135|64352545|FG000|Overall Study|Refused Treatment|1|||
23164944|NCT00811135|64352545|FG000|Overall Study|Withdrawal by Subject|3|||
23164945|NCT00811135|64352545|FG000|Overall Study|Administrative/Other Unspecified|11|||
23164946|NCT00811135|64352545|FG000|Overall Study|Ongoing|59|||
23164947|NCT03631732|64352546|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
23164948|NCT03631732|64352547|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
23164949|NCT03631732|64352546|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
23164950|NCT03631732|64352547|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
23164951|NCT03631732|64352546|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
23164952|NCT03631732|64352547|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
23164953|NCT03631732|64352546|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
23164954|NCT03631732|64352547|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
23164955|NCT03631732|64352546|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
23164956|NCT03631732|64352547|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
23164957|NCT03631732|64352546|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
23164958|NCT03631732|64352547|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
23164959|NCT03631732|64352546|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
23164960|NCT03631732|64352547|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
23164961|NCT03631732|64352546|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
23164962|NCT03631732|64352547|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
23164963|NCT03631732|64352546|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
23164964|NCT03631732|64352547|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
23164965|NCT03631732|64352546|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
23164966|NCT03631732|64352547|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
23164967|NCT00450723|64352549|FG000|Overall Study|Physician Decision|5|||
23164968|NCT03775421|64352550|FG000|Overall Study|Lost to Follow-up|2|||
23164969|NCT03775421|64352550|FG000|Overall Study|Withdrawal by Subject|10|||
23164970|NCT03775421|64352550|FG000|Overall Study|Physician Decision|3|||
23164971|NCT03775421|64352550|FG000|Overall Study|Death|1|||
23164972|NCT03775421|64352550|FG000|Overall Study|Study Terminated by Sponsor|94|||
23164973|NCT00914927|64352551|FG000|Overall Study|Adverse Event|0|||
23164974|NCT00914927|64352552|FG001|Overall Study|Adverse Event|0|||
23164975|NCT00914927|64352553|FG002|Overall Study|Adverse Event|0|||
23164976|NCT00914927|64352554|FG003|Overall Study|Adverse Event|0|||
23164977|NCT00914927|64352555|FG004|Overall Study|Adverse Event|1|||
23164978|NCT00914927|64352556|FG005|Overall Study|Adverse Event|0|||
23164979|NCT00914927|64352557|FG006|Overall Study|Adverse Event|0|||
23164980|NCT00914927|64352551|FG000|Overall Study|Withdrawal by Subject|0|||
23164981|NCT00914927|64352552|FG001|Overall Study|Withdrawal by Subject|1|||
23164982|NCT00914927|64352553|FG002|Overall Study|Withdrawal by Subject|0|||
23164983|NCT00914927|64352554|FG003|Overall Study|Withdrawal by Subject|1|||
23164984|NCT00914927|64352555|FG004|Overall Study|Withdrawal by Subject|0|||
23164985|NCT00914927|64352556|FG005|Overall Study|Withdrawal by Subject|0|||
23164986|NCT00914927|64352557|FG006|Overall Study|Withdrawal by Subject|0|||
23164987|NCT00914927|64352551|FG000|Overall Study|Lost to Follow-up|0|||
23164988|NCT00914927|64352552|FG001|Overall Study|Lost to Follow-up|0|||
23164989|NCT00914927|64352553|FG002|Overall Study|Lost to Follow-up|0|||
23164990|NCT00914927|64352554|FG003|Overall Study|Lost to Follow-up|1|||
23164991|NCT00914927|64352555|FG004|Overall Study|Lost to Follow-up|0|||
23164992|NCT00914927|64352556|FG005|Overall Study|Lost to Follow-up|0|||
23164993|NCT00914927|64352557|FG006|Overall Study|Lost to Follow-up|0|||
23164994|NCT00914927|64352551|FG000|Overall Study|Administrative/Other|2|||
23225781|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
23225782|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
23164995|NCT00914927|64352552|FG001|Overall Study|Administrative/Other|1|||
23164996|NCT00914927|64352553|FG002|Overall Study|Administrative/Other|0|||
23164997|NCT00914927|64352554|FG003|Overall Study|Administrative/Other|0|||
23164998|NCT00914927|64352555|FG004|Overall Study|Administrative/Other|1|||
23164999|NCT00914927|64352556|FG005|Overall Study|Administrative/Other|0|||
23165000|NCT00914927|64352557|FG006|Overall Study|Administrative/Other|0|||
23165001|NCT00446511|64352559|FG000|Overall Study|Adverse Event|7|||
23165002|NCT00446511|64352560|FG001|Overall Study|Adverse Event|2|||
23165003|NCT00446511|64352561|FG002|Overall Study|Adverse Event|3|||
23225783|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
23225784|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
23225785|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
23165004|NCT00446511|64352562|FG003|Overall Study|Adverse Event|1|||
23165005|NCT00446511|64352559|FG000|Overall Study|Protocol Violation|0|||
23165006|NCT00446511|64352560|FG001|Overall Study|Protocol Violation|0|||
23165007|NCT00446511|64352561|FG002|Overall Study|Protocol Violation|0|||
23165008|NCT00446511|64352562|FG003|Overall Study|Protocol Violation|1|||
23165009|NCT00446511|64352559|FG000|Overall Study|Withdrawal by Subject|0|||
23165010|NCT00446511|64352560|FG001|Overall Study|Withdrawal by Subject|0|||
23165011|NCT00446511|64352561|FG002|Overall Study|Withdrawal by Subject|0|||
23165012|NCT00446511|64352562|FG003|Overall Study|Withdrawal by Subject|3|||
23165013|NCT00446511|64352559|FG000|Overall Study|Administrative Problems|3|||
23165014|NCT00446511|64352560|FG001|Overall Study|Administrative Problems|0|||
23165015|NCT00446511|64352561|FG002|Overall Study|Administrative Problems|4|||
23165016|NCT00446511|64352562|FG003|Overall Study|Administrative Problems|1|||
23165017|NCT04225923|64352563|FG000|Overall Study|Protocol Violation|1|||
23225786|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
23225787|NCT01194414|64567896|FG000|72 Weeks Open Label Extension|Death|1|||
23225788|NCT01194414|64567897|FG001|72 Weeks Open Label Extension|Death|2|||
23225789|NCT01194414|64567898|FG002|72 Weeks Open Label Extension|Death|0|||
23225790|NCT01194414|64567899|FG003|72 Weeks Open Label Extension|Death|2|||
23225791|NCT01975675|64567902|FG000|Overall Study|Death|0|||
23225792|NCT01975675|64567903|FG001|Overall Study|Death|1|||
23225793|NCT01975675|64567904|FG002|Overall Study|Death|0|||
23225794|NCT01975675|64567905|FG003|Overall Study|Death|0|||
23225795|NCT02735044|64567909|FG000|Overall Study|Adverse Event|3|||
23225796|NCT02735044|64567910|FG001|Overall Study|Adverse Event|3|||
23225797|NCT02735044|64567909|FG000|Overall Study|Lack of Efficacy|1|||
23225798|NCT02735044|64567910|FG001|Overall Study|Lack of Efficacy|0|||
23225799|NCT02735044|64567909|FG000|Overall Study|Poor compliance to protocol|7|||
23225800|NCT02735044|64567910|FG001|Overall Study|Poor compliance to protocol|7|||
23225801|NCT02735044|64567909|FG000|Overall Study|Randomized and not treated|0|||
23225802|NCT02735044|64567910|FG001|Overall Study|Randomized and not treated|2|||
23572873|NCT04537949|65827443|FG004|Follow-up Phase|Withdrawal by Subject|1|||
23572874|NCT04537949|65827444|FG005|Follow-up Phase|Withdrawal by Subject|0|||
23572875|NCT04537949|65827445|FG006|Follow-up Phase|Withdrawal by Subject|0|||
23572876|NCT04537949|65827446|FG007|Follow-up Phase|Withdrawal by Subject|0|||
23572877|NCT01225835|65827450|FG000|Overall Study|Completed protocol|2|||
23572878|NCT01225835|65827451|FG001|Overall Study|Completed protocol|1|||
23572879|NCT01225835|65827450|FG000|Overall Study|Did not meet hCG criterion|2|||
23572880|NCT01225835|65827451|FG001|Overall Study|Did not meet hCG criterion|0|||
23572881|NCT01225835|65827450|FG000|Overall Study|Adverse Event|2|||
23572882|NCT01225835|65827451|FG001|Overall Study|Adverse Event|1|||
23572883|NCT01225835|65827450|FG000|Overall Study|Other|1|||
23572884|NCT01225835|65827451|FG001|Overall Study|Other|1|||
23572885|NCT04467840|65827456|FG000|Overall Study|Death|35|||
23572886|NCT04467840|65827457|FG001|Overall Study|Death|39|||
23572887|NCT04467840|65827456|FG000|Overall Study|Withdrawal by Subject|8|||
23572888|NCT04467840|65827457|FG001|Overall Study|Withdrawal by Subject|4|||
23572889|NCT04467840|65827456|FG000|Overall Study|Adverse Event|2|||
23572890|NCT04467840|65827457|FG001|Overall Study|Adverse Event|0|||
23572891|NCT04467840|65827456|FG000|Overall Study|Lost to Follow-up|1|||
23572892|NCT04467840|65827457|FG001|Overall Study|Lost to Follow-up|3|||
23572893|NCT04467840|65827456|FG000|Overall Study|Physician Decision|1|||
23572894|NCT04467840|65827457|FG001|Overall Study|Physician Decision|0|||
23572895|NCT04467840|65827456|FG000|Overall Study|Other|1|||
23572896|NCT04467840|65827457|FG001|Overall Study|Other|5|||
23572897|NCT04467840|65827456|FG000|Overall Study|Missing study completion status|3|||
23572898|NCT04467840|65827457|FG001|Overall Study|Missing study completion status|1|||
23572899|NCT01818141|65827458|FG000|Overall Study|Withdrawal by Subject|2|||
23572900|NCT01818141|65827459|FG001|Overall Study|Withdrawal by Subject|0|||
23572901|NCT01818141|65827458|FG000|Overall Study|No baseline C.diff colonies|1|||
23572902|NCT01818141|65827459|FG001|Overall Study|No baseline C.diff colonies|1|||
23572903|NCT01818141|65827458|FG000|Overall Study|Lost to Follow-up|0|||
23572904|NCT01818141|65827459|FG001|Overall Study|Lost to Follow-up|2|||
23572905|NCT00451217|65827460|FG000|Overall Study|Lost to Follow-up|0|||
23572906|NCT00451217|65827461|FG001|Overall Study|Lost to Follow-up|1|||
23572907|NCT00451217|65827462|FG002|Overall Study|Lost to Follow-up|1|||
23572908|NCT00451217|65827463|FG003|Overall Study|Lost to Follow-up|1|||
23572909|NCT00451217|65827460|FG000|Overall Study|Withdrawal by Subject|1|||
23572910|NCT00451217|65827461|FG001|Overall Study|Withdrawal by Subject|0|||
23572911|NCT00451217|65827462|FG002|Overall Study|Withdrawal by Subject|0|||
23572912|NCT00451217|65827463|FG003|Overall Study|Withdrawal by Subject|0|||
23572913|NCT00451217|65827460|FG000|Overall Study|Not Treated|1|||
23572914|NCT00451217|65827461|FG001|Overall Study|Not Treated|1|||
23572915|NCT00451217|65827462|FG002|Overall Study|Not Treated|3|||
23572916|NCT00451217|65827463|FG003|Overall Study|Not Treated|4|||
23572917|NCT02169830|65827464|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
23225803|NCT02735044|64567909|FG000|Overall Study|Other, not specified above|5|||
23572918|NCT02169830|65827465|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
23572919|NCT02169830|65827466|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
23572920|NCT02169830|65827464|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
23572921|NCT02169830|65827465|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
23225804|NCT02735044|64567910|FG001|Overall Study|Other, not specified above|11|||
23572922|NCT02169830|65827466|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
23225805|NCT04412668|64567911|FG000|Overall Study|Death - multiple comorbidities|2|||
23225806|NCT04412668|64567912|FG001|Overall Study|Death - multiple comorbidities|0|||
23572923|NCT02169830|65827464|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
23572924|NCT02169830|65827465|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
23572925|NCT02169830|65827466|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
23572926|NCT02169830|65827464|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
23572927|NCT02169830|65827465|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
23572928|NCT02169830|65827466|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
23572929|NCT02169830|65827464|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
23572930|NCT02169830|65827465|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
23572931|NCT02169830|65827466|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
23572932|NCT02102464|65827467|FG000|Randomized Study|Withdrawal by Subject|0|||
23572933|NCT02102464|65827468|FG001|Randomized Study|Withdrawal by Subject|1|||
23572934|NCT02102464|65827469|FG002|Randomized Study|Withdrawal by Subject|0|||
23572935|NCT01868074|65827475|FG000|Overall Study|Lost to Follow-up|3|||
23572936|NCT01868074|65827476|FG001|Overall Study|Lost to Follow-up|2|||
23572937|NCT01868074|65827475|FG000|Overall Study|Withdrawal by Subject|4|||
23572938|NCT01868074|65827476|FG001|Overall Study|Withdrawal by Subject|2|||
23165018|NCT04225923|64352564|FG001|Overall Study|Protocol Violation|0|||
23165019|NCT04225923|64352565|FG002|Overall Study|Protocol Violation|1|||
23165020|NCT04225923|64352563|FG000|Overall Study|Withdrawal by Subject|4|||
23165021|NCT04225923|64352564|FG001|Overall Study|Withdrawal by Subject|1|||
23165022|NCT04225923|64352565|FG002|Overall Study|Withdrawal by Subject|3|||
23165023|NCT04225923|64352563|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
23165024|NCT04225923|64352564|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
23165025|NCT04225923|64352565|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
23165026|NCT01425008|64352567|FG000|Dose Escalation Phase|Progressive Disease|2|||
23165027|NCT01425008|64352568|FG001|Dose Escalation Phase|Progressive Disease|3|||
23165028|NCT01425008|64352569|FG002|Dose Escalation Phase|Progressive Disease|2|||
23165029|NCT01425008|64352570|FG003|Dose Escalation Phase|Progressive Disease|3|||
23165030|NCT01425008|64352571|FG004|Dose Escalation Phase|Progressive Disease|5|||
23165031|NCT01425008|64352572|FG005|Dose Escalation Phase|Progressive Disease|4|||
23165032|NCT01425008|64352573|FG006|Dose Escalation Phase|Progressive Disease|0|||
23165033|NCT01425008|64352574|FG007|Dose Escalation Phase|Progressive Disease|2|||
23165034|NCT01425008|64352575|FG008|Dose Escalation Phase|Progressive Disease|6|||
23165035|NCT01425008|64352576|FG009|Dose Escalation Phase|Progressive Disease|2|||
23165036|NCT01425008|64352577|FG010|Dose Escalation Phase|Progressive Disease|0|||
23165037|NCT01425008|64352578|FG011|Dose Escalation Phase|Progressive Disease|0|||
23165038|NCT01425008|64352579|FG012|Dose Escalation Phase|Progressive Disease|0|||
23165039|NCT01425008|64352580|FG013|Dose Escalation Phase|Progressive Disease|0|||
23165040|NCT01425008|64352581|FG014|Dose Escalation Phase|Progressive Disease|0|||
23165041|NCT01425008|64352582|FG015|Dose Escalation Phase|Progressive Disease|0|||
23572939|NCT00284089|65827477|FG000|Multiple Dose Phase|Adverse Event|1|||
23572940|NCT00284089|65827478|FG001|Multiple Dose Phase|Adverse Event|0|||
23572941|NCT00284089|65827479|FG002|Multiple Dose Phase|Adverse Event|1|||
23165042|NCT01425008|64352583|FG016|Dose Escalation Phase|Progressive Disease|0|||
23332159|NCT02134015|64959014|FG001|Overall Study|Death|1|||
23572942|NCT00284089|65827480|FG003|Multiple Dose Phase|Adverse Event|1|||
23572943|NCT00284089|65827477|FG000|Multiple Dose Phase|Protocol Violation|0|||
23572944|NCT00284089|65827478|FG001|Multiple Dose Phase|Protocol Violation|0|||
23572945|NCT00284089|65827479|FG002|Multiple Dose Phase|Protocol Violation|1|||
23572946|NCT00284089|65827480|FG003|Multiple Dose Phase|Protocol Violation|0|||
23572947|NCT00284089|65827477|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
23572948|NCT00284089|65827478|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
23572949|NCT00284089|65827479|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
23572950|NCT00284089|65827480|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
23572951|NCT00284089|65827477|FG000|Multiple Dose Phase|Death|0|||
23572952|NCT00284089|65827478|FG001|Multiple Dose Phase|Death|0|||
23572953|NCT00284089|65827479|FG002|Multiple Dose Phase|Death|1|||
23572954|NCT00284089|65827480|FG003|Multiple Dose Phase|Death|1|||
23572955|NCT00284089|65827477|FG000|Extension Phase|Adverse Event|0|||
23572956|NCT00284089|65827478|FG001|Extension Phase|Adverse Event|0|||
23572957|NCT00284089|65827479|FG002|Extension Phase|Adverse Event|2|||
23572958|NCT00284089|65827480|FG003|Extension Phase|Adverse Event|2|||
23572959|NCT00284089|65827477|FG000|Extension Phase|condition no longer requires study drug|2|||
23572960|NCT00284089|65827478|FG001|Extension Phase|condition no longer requires study drug|0|||
23572961|NCT00284089|65827479|FG002|Extension Phase|condition no longer requires study drug|2|||
23572962|NCT00284089|65827480|FG003|Extension Phase|condition no longer requires study drug|7|||
23572963|NCT00284089|65827477|FG000|Extension Phase|Protocol Violation|0|||
23572964|NCT00284089|65827478|FG001|Extension Phase|Protocol Violation|0|||
23572965|NCT00284089|65827479|FG002|Extension Phase|Protocol Violation|1|||
23572966|NCT00284089|65827480|FG003|Extension Phase|Protocol Violation|0|||
23572967|NCT00284089|65827477|FG000|Extension Phase|Withdrawal by Subject|0|||
23572968|NCT00284089|65827478|FG001|Extension Phase|Withdrawal by Subject|0|||
23572969|NCT00284089|65827479|FG002|Extension Phase|Withdrawal by Subject|1|||
23572970|NCT00284089|65827480|FG003|Extension Phase|Withdrawal by Subject|3|||
23572971|NCT01449721|65827486|FG000|Overall Study|Physician Decision|0|||
23572972|NCT01449721|65827487|FG001|Overall Study|Physician Decision|1|||
23572973|NCT01449721|65827486|FG000|Overall Study|Physician Decision|0|||
23572974|NCT01449721|65827487|FG001|Overall Study|Physician Decision|1|||
23572975|NCT01804816|65827490|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
23572976|NCT01804816|65827490|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
23572977|NCT04668989|65827491|FG000|First Intervention|Covid-19 related self-isolation|0|||
23572978|NCT04668989|65827492|FG001|First Intervention|Covid-19 related self-isolation|1|||
23572979|NCT04668989|65827491|FG000|Second Intervention|Adverse Event|0|||
23572980|NCT04668989|65827492|FG001|Second Intervention|Adverse Event|1|||
23572981|NCT03541642|65827502|FG000|Overall Study|Withdrawal by Subject|1|||
23572982|NCT03541642|65827503|FG001|Overall Study|Withdrawal by Subject|2|||
23572983|NCT03541642|65827502|FG000|Overall Study|Lost to Follow-up|16|||
23572984|NCT03541642|65827503|FG001|Overall Study|Lost to Follow-up|12|||
23572985|NCT03541642|65827502|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
23572986|NCT03541642|65827503|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
23572987|NCT02954575|65827504|FG000|Overall Study|Withdrawal by Subject|2|||
23572988|NCT02954575|65827504|FG000|Overall Study|Adverse Event|1|||
23572989|NCT03255941|65827505|FG000|Overall Study|Not eligible or refused injection|37|||
23572990|NCT03255941|65827506|FG001|Overall Study|Not eligible or refused injection|44|||
23572991|NCT03255941|65827507|FG002|Overall Study|Not eligible or refused injection|5|||
23572992|NCT03255941|65827508|FG003|Overall Study|Not eligible or refused injection|6|||
23572993|NCT03255941|65827505|FG000|Overall Study|Did not complete exit interview|1|||
23572994|NCT03255941|65827506|FG001|Overall Study|Did not complete exit interview|2|||
23572995|NCT03255941|65827507|FG002|Overall Study|Did not complete exit interview|0|||
23572996|NCT03255941|65827508|FG003|Overall Study|Did not complete exit interview|0|||
23572997|NCT04716881|65827509|FG000|Overall Study|Adverse Event|1|||
23572998|NCT04716881|65827509|FG000|Overall Study|Lost to Follow-up|1|||
23572999|NCT04140890|65827510|FG000|Overall Study|Withdrawal by Subject|0|||
23573000|NCT04140890|65827511|FG001|Overall Study|Withdrawal by Subject|1|||
23573001|NCT01676220|65827512|FG000|Overall Study|Randomized But Not Treated|4|||
23573002|NCT01676220|65827513|FG001|Overall Study|Randomized But Not Treated|1|||
23573003|NCT01676220|65827512|FG000|Overall Study|Adverse Event|10|||
23573004|NCT01676220|65827513|FG001|Overall Study|Adverse Event|8|||
23573005|NCT01676220|65827512|FG000|Overall Study|Lack of Efficacy|2|||
23573006|NCT01676220|65827513|FG001|Overall Study|Lack of Efficacy|5|||
23573007|NCT01676220|65827512|FG000|Overall Study|Protocol Violation|11|||
23573008|NCT01676220|65827513|FG001|Overall Study|Protocol Violation|12|||
23573009|NCT01676220|65827512|FG000|Overall Study|Received Rescue Therapy|14|||
23573010|NCT01676220|65827513|FG001|Overall Study|Received Rescue Therapy|22|||
23573011|NCT01676220|65827512|FG000|Overall Study|Personal Reason|34|||
23573012|NCT01676220|65827513|FG001|Overall Study|Personal Reason|45|||
23573013|NCT01676220|65827512|FG000|Overall Study|Lost to Follow-up|11|||
23573014|NCT01676220|65827513|FG001|Overall Study|Lost to Follow-up|18|||
23573015|NCT01676220|65827512|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
23573016|NCT01676220|65827513|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
23573017|NCT01676220|65827512|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
23573018|NCT01676220|65827513|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
23332160|NCT02134015|64959013|FG000|Overall Study|Reason not provided|1|||
23332161|NCT02134015|64959014|FG001|Overall Study|Reason not provided|2|||
23332162|NCT02134015|64959013|FG000|Overall Study|Clinical progression|14|||
23573019|NCT01676220|65827512|FG000|Overall Study|Perceived Lack of Efficacy|3|||
23573020|NCT01676220|65827513|FG001|Overall Study|Perceived Lack of Efficacy|1|||
23573021|NCT01676220|65827512|FG000|Overall Study|Non Serious Hypoglycemia|2|||
23573022|NCT01676220|65827513|FG001|Overall Study|Non Serious Hypoglycemia|0|||
23573023|NCT01676220|65827512|FG000|Overall Study|No More Need of Insulin|1|||
23573024|NCT01676220|65827513|FG001|Overall Study|No More Need of Insulin|0|||
23573025|NCT00967018|65827521|FG000|Overall Study|Adverse Event|2|||
23573026|NCT00967018|65827521|FG000|Overall Study|Physician Decision|7|||
23573027|NCT00967018|65827521|FG000|Overall Study|Lost to Follow-up|2|||
23573028|NCT00967018|65827521|FG000|Overall Study|Withdrawal by Subject|1|||
23573029|NCT00967018|65827521|FG000|Overall Study|Miscellaneous Reasons|9|||
23573030|NCT03958630|65827528|FG000|Overall Study|Withdrawal by Subject|0|||
23573031|NCT03958630|65827529|FG001|Overall Study|Withdrawal by Subject|0|||
23573032|NCT03958630|65827530|FG002|Overall Study|Withdrawal by Subject|1|||
23573033|NCT03958630|65827528|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
23573034|NCT03958630|65827529|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
23573035|NCT03958630|65827530|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
23573036|NCT02930122|65827531|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
23573037|NCT02930122|65827532|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
23573038|NCT00709592|65827533|FG000|Overall Study|Unable to proceed to transplant|0|||
23573039|NCT00709592|65827534|FG001|Overall Study|Unable to proceed to transplant|1|||
23573040|NCT02087150|65827537|FG000|Overall Study|Death|0|||
23573041|NCT02087150|65827538|FG001|Overall Study|Death|1|||
23573042|NCT02087150|65827539|FG002|Overall Study|Death|0|||
23573043|NCT02087150|65827537|FG000|Overall Study|Lost to Follow-up|6|||
23573044|NCT02087150|65827538|FG001|Overall Study|Lost to Follow-up|13|||
23573045|NCT02087150|65827539|FG002|Overall Study|Lost to Follow-up|7|||
23573046|NCT02087150|65827537|FG000|Overall Study|Withdrawal by Subject|2|||
23573047|NCT02087150|65827538|FG001|Overall Study|Withdrawal by Subject|5|||
23573048|NCT02087150|65827539|FG002|Overall Study|Withdrawal by Subject|3|||
23573049|NCT02087150|65827537|FG000|Overall Study|Physician Decision|0|||
23573050|NCT02087150|65827538|FG001|Overall Study|Physician Decision|1|||
23573051|NCT02087150|65827539|FG002|Overall Study|Physician Decision|0|||
23573052|NCT02087150|65827537|FG000|Overall Study|Procedure not done|1|||
23573053|NCT02087150|65827538|FG001|Overall Study|Procedure not done|13|||
23573054|NCT02087150|65827539|FG002|Overall Study|Procedure not done|0|||
23573055|NCT02087150|65827537|FG000|Overall Study|F/U not completed w/in study window|0|||
23573056|NCT02087150|65827538|FG001|Overall Study|F/U not completed w/in study window|0|||
23573057|NCT02087150|65827539|FG002|Overall Study|F/U not completed w/in study window|1|||
23573058|NCT02087150|65827537|FG000|Overall Study|Other|1|||
23573059|NCT02087150|65827538|FG001|Overall Study|Other|0|||
23573060|NCT02087150|65827539|FG002|Overall Study|Other|0|||
23573061|NCT02087150|65827537|FG000|Overall Study|Pt moved out of town|0|||
23573062|NCT02087150|65827538|FG001|Overall Study|Pt moved out of town|1|||
23573063|NCT02087150|65827539|FG002|Overall Study|Pt moved out of town|0|||
23573064|NCT04466618|65827540|FG000|Overall Study|Withdrawal by Subject|0|||
23573065|NCT04466618|65827541|FG001|Overall Study|Withdrawal by Subject|1|||
23573066|NCT01880554|65827545|FG000|Overall Study|Protocol Violation|14|||
23573067|NCT01880554|65827545|FG000|Overall Study|Simon's design requirements|2|||
23573068|NCT01781611|65827548|FG000|Overall Study|Adverse Event|4|||
23573069|NCT01781611|65827549|FG001|Overall Study|Adverse Event|0|||
23573070|NCT00604786|65827553|FG000|Overall Study|Lost to Follow-up|2|||
23573071|NCT00604786|65827554|FG001|Overall Study|Lost to Follow-up|0|||
23573072|NCT02269943|65827555|FG000|Treatment Period|Death|0|||
23573073|NCT02269943|65827556|FG001|Treatment Period|Death|1|||
23573074|NCT02269943|65827555|FG000|Treatment Period|Adverse Event|1|||
23573075|NCT02269943|65827556|FG001|Treatment Period|Adverse Event|10|||
23573076|NCT02269943|65827555|FG000|Treatment Period|Progressive Disease|5|||
23573077|NCT02269943|65827556|FG001|Treatment Period|Progressive Disease|17|||
23573078|NCT02269943|65827555|FG000|Treatment Period|Symptomatic Deterioration|0|||
23573079|NCT02269943|65827556|FG001|Treatment Period|Symptomatic Deterioration|2|||
23573080|NCT02269943|65827555|FG000|Follow-Up Survival Period|Death|3|||
23573081|NCT02269943|65827556|FG001|Follow-Up Survival Period|Death|16|||
23573082|NCT02269943|65827555|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
23573083|NCT02269943|65827556|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
23573084|NCT02269943|65827555|FG000|Follow-Up Survival Period|Alive|2|||
23573085|NCT02269943|65827556|FG001|Follow-Up Survival Period|Alive|8|||
23573086|NCT01425632|65827567|FG000|Overall Study|Adverse Event|0|||
23573087|NCT01425632|65827568|FG001|Overall Study|Adverse Event|1|||
23573088|NCT01425632|65827569|FG002|Overall Study|Adverse Event|1|||
23573089|NCT01425632|65827567|FG000|Overall Study|Physician Decision|1|||
23165043|NCT01425008|64352584|FG017|Dose Escalation Phase|Progressive Disease|0|||
23573090|NCT01425632|65827568|FG001|Overall Study|Physician Decision|0|||
23573091|NCT01425632|65827569|FG002|Overall Study|Physician Decision|0|||
23225807|NCT04412668|64567913|FG002|Overall Study|Death - multiple comorbidities|0|||
23225808|NCT04412668|64567911|FG000|Overall Study|Withdrawal by Subject|3|||
23225809|NCT04412668|64567912|FG001|Overall Study|Withdrawal by Subject|0|||
23225810|NCT04412668|64567913|FG002|Overall Study|Withdrawal by Subject|0|||
23225811|NCT04412668|64567911|FG000|Overall Study|Other than Specified|2|||
23225812|NCT04412668|64567912|FG001|Overall Study|Other than Specified|0|||
23225813|NCT04412668|64567913|FG002|Overall Study|Other than Specified|0|||
23225814|NCT01436357|64567914|FG000|Overall Study|Death|5|||
23573092|NCT01425632|65827567|FG000|Overall Study|Protocol Violation|0|||
23573093|NCT01425632|65827568|FG001|Overall Study|Protocol Violation|0|||
23573094|NCT01425632|65827569|FG002|Overall Study|Protocol Violation|2|||
23573095|NCT01425632|65827567|FG000|Overall Study|Withdrawal by Subject|0|||
23573096|NCT01425632|65827568|FG001|Overall Study|Withdrawal by Subject|0|||
23573097|NCT01425632|65827569|FG002|Overall Study|Withdrawal by Subject|1|||
23573098|NCT05221749|65827570|FG000|Overall Study|Lost to Follow-up|2|||
23573099|NCT05221749|65827571|FG001|Overall Study|Lost to Follow-up|3|||
23573100|NCT03257995|65827574|FG000|Overall Study|Adverse Event|0|||
23573101|NCT03257995|65827575|FG001|Overall Study|Adverse Event|1|||
23573102|NCT03257995|65827576|FG002|Overall Study|Adverse Event|0|||
23573103|NCT03257995|65827577|FG003|Overall Study|Adverse Event|0|||
23573104|NCT03257995|65827578|FG004|Overall Study|Adverse Event|0|||
23165044|NCT01425008|64352585|FG018|Dose Escalation Phase|Progressive Disease|0|||
23165045|NCT01425008|64352567|FG000|Dose Escalation Phase|Adverse Event|2|||
23165046|NCT01425008|64352568|FG001|Dose Escalation Phase|Adverse Event|0|||
23165047|NCT01425008|64352569|FG002|Dose Escalation Phase|Adverse Event|0|||
23165048|NCT01425008|64352570|FG003|Dose Escalation Phase|Adverse Event|0|||
23165049|NCT01425008|64352571|FG004|Dose Escalation Phase|Adverse Event|0|||
23165050|NCT01425008|64352572|FG005|Dose Escalation Phase|Adverse Event|2|||
23165051|NCT01425008|64352573|FG006|Dose Escalation Phase|Adverse Event|0|||
23165052|NCT01425008|64352574|FG007|Dose Escalation Phase|Adverse Event|0|||
23225815|NCT01436357|64567915|FG001|Overall Study|Death|1|||
23165053|NCT01425008|64352575|FG008|Dose Escalation Phase|Adverse Event|2|||
23165054|NCT01425008|64352576|FG009|Dose Escalation Phase|Adverse Event|0|||
23225816|NCT01436357|64567914|FG000|Overall Study|Enrolled but not vaccinated|1|||
23573105|NCT03257995|65827579|FG005|Overall Study|Adverse Event|0|||
23573106|NCT03257995|65827574|FG000|Overall Study|Protocol deviation|0|||
23573107|NCT03257995|65827575|FG001|Overall Study|Protocol deviation|0|||
23573108|NCT03257995|65827576|FG002|Overall Study|Protocol deviation|0|||
23225817|NCT01436357|64567915|FG001|Overall Study|Enrolled but not vaccinated|1|||
23165055|NCT01425008|64352577|FG010|Dose Escalation Phase|Adverse Event|0|||
23165056|NCT01425008|64352578|FG011|Dose Escalation Phase|Adverse Event|0|||
23165057|NCT01425008|64352579|FG012|Dose Escalation Phase|Adverse Event|0|||
23165058|NCT01425008|64352580|FG013|Dose Escalation Phase|Adverse Event|0|||
23165059|NCT01425008|64352581|FG014|Dose Escalation Phase|Adverse Event|0|||
23165060|NCT01425008|64352582|FG015|Dose Escalation Phase|Adverse Event|0|||
23165061|NCT01425008|64352583|FG016|Dose Escalation Phase|Adverse Event|0|||
23165062|NCT01425008|64352584|FG017|Dose Escalation Phase|Adverse Event|0|||
23165063|NCT01425008|64352585|FG018|Dose Escalation Phase|Adverse Event|0|||
23225818|NCT01436357|64567914|FG000|Overall Study|Incarceration|18|||
23225819|NCT01436357|64567915|FG001|Overall Study|Incarceration|20|||
23225820|NCT01436357|64567914|FG000|Overall Study|Lost to Follow-up|67|||
23225821|NCT01436357|64567915|FG001|Overall Study|Lost to Follow-up|61|||
23225822|NCT01436357|64567914|FG000|Overall Study|Protocol Violation|1|||
23225823|NCT01436357|64567915|FG001|Overall Study|Protocol Violation|0|||
23225824|NCT01436357|64567914|FG000|Overall Study|Withdrawal by Subject|26|||
23225825|NCT01436357|64567915|FG001|Overall Study|Withdrawal by Subject|38|||
23225826|NCT01436357|64567914|FG000|Overall Study|Physician Decision|3|||
23225827|NCT01436357|64567915|FG001|Overall Study|Physician Decision|4|||
23225828|NCT01436357|64567914|FG000|Overall Study|Moved out of area|1|||
23225829|NCT01436357|64567915|FG001|Overall Study|Moved out of area|2|||
23225830|NCT01436357|64567914|FG000|Overall Study|Subject in rehab|0|||
23225831|NCT01436357|64567915|FG001|Overall Study|Subject in rehab|1|||
23225832|NCT02668692|64567918|FG000|Overall Study|Adverse Event|1|||
23225833|NCT02668692|64567919|FG001|Overall Study|Adverse Event|0|||
23225834|NCT00976963|64567922|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
23225835|NCT00976963|64567923|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
23225836|NCT00976963|64567922|FG000|Overall Study|administrative error|1|||
23225837|NCT00976963|64567923|FG001|Overall Study|administrative error|0|||
23225838|NCT00976963|64567922|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
23225839|NCT00976963|64567923|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
23225840|NCT04247828|64567926|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
23225841|NCT02590406|64567927|FG000|Overall Study|Adverse Event|1|||
23225842|NCT02590406|64567928|FG001|Overall Study|Adverse Event|0|||
23225843|NCT02590406|64567927|FG000|Overall Study|Saturometer malfunction|0|||
23225844|NCT02590406|64567928|FG001|Overall Study|Saturometer malfunction|1|||
23225845|NCT03458234|64567929|FG000|Overall Study|Withdrawal by Subject|1|||
23225846|NCT02352090|64567930|FG000|Overall Study|general malaise|1|||
23225847|NCT02352090|64567931|FG001|Overall Study|general malaise|0|||
23225848|NCT02352090|64567932|FG002|Overall Study|general malaise|0|||
23225849|NCT02352090|64567930|FG000|Overall Study|non-specified mild side-effects|0|||
23225850|NCT02352090|64567931|FG001|Overall Study|non-specified mild side-effects|0|||
23225851|NCT02352090|64567932|FG002|Overall Study|non-specified mild side-effects|2|||
23225852|NCT00528840|64567933|FG000|Overall Study|Lost to Follow-up|10|||
23225853|NCT00528840|64567933|FG000|Overall Study|Adverse Event|1|||
23332163|NCT02134015|64959014|FG001|Overall Study|Clinical progression|7|||
23332164|NCT02134015|64959013|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
23165064|NCT01425008|64352567|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165065|NCT01425008|64352568|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165066|NCT01425008|64352569|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165067|NCT01425008|64352570|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165068|NCT01425008|64352571|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
23165069|NCT01425008|64352572|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165070|NCT01425008|64352573|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
23165071|NCT01425008|64352574|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
23165072|NCT01425008|64352575|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
23165073|NCT01425008|64352576|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165074|NCT01425008|64352577|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165075|NCT01425008|64352578|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165076|NCT01425008|64352579|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165077|NCT01425008|64352580|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165078|NCT01425008|64352581|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165079|NCT01425008|64352582|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165080|NCT01425008|64352583|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165081|NCT01425008|64352584|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23165082|NCT01425008|64352585|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23225854|NCT00528840|64567933|FG000|Overall Study|Withdrawal by Subject|17|||
23225855|NCT00528840|64567933|FG000|Overall Study|Death|2|||
23225856|NCT00528840|64567933|FG000|Overall Study|Administrative Reasons|1|||
23225857|NCT00528840|64567933|FG000|Overall Study|Other|2|||
23225858|NCT01192100|64567937|FG000|Overall Study|Withdrawal by Subject|0|||
23332165|NCT02134015|64959014|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
23332166|NCT02134015|64959013|FG000|Overall Study|Study terminated by sponsor|2|||
23332167|NCT02134015|64959014|FG001|Overall Study|Study terminated by sponsor|3|||
23332168|NCT02134015|64959013|FG000|Overall Study|Adverse Event|9|||
23332169|NCT02134015|64959014|FG001|Overall Study|Adverse Event|10|||
23332170|NCT02134015|64959013|FG000|Overall Study|Withdrawal by Subject|3|||
23332171|NCT02134015|64959014|FG001|Overall Study|Withdrawal by Subject|7|||
23332172|NCT00558467|64959017|FG000|Overall Study|Adverse Event|1|||
23332173|NCT00558467|64959018|FG001|Overall Study|Adverse Event|2|||
23332174|NCT00558467|64959017|FG000|Overall Study|Lack of Efficacy|0|||
23332175|NCT00558467|64959018|FG001|Overall Study|Lack of Efficacy|1|||
23332176|NCT00558467|64959017|FG000|Overall Study|Patient moving out of state|0|||
23165083|NCT01425008|64352567|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23165084|NCT01425008|64352568|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23165085|NCT01425008|64352569|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23165086|NCT01425008|64352570|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23165087|NCT01425008|64352571|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
23165088|NCT01425008|64352572|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
23332177|NCT00558467|64959018|FG001|Overall Study|Patient moving out of state|1|||
23165089|NCT01425008|64352573|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
23165090|NCT01425008|64352574|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
23165091|NCT01425008|64352575|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
23165092|NCT01425008|64352576|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
23165093|NCT01425008|64352577|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
23165094|NCT01425008|64352578|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
23165095|NCT01425008|64352579|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
23165096|NCT01425008|64352580|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
23165097|NCT01425008|64352581|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
23165098|NCT01425008|64352582|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
23165099|NCT01425008|64352583|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
23165100|NCT01425008|64352584|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
23165101|NCT01425008|64352585|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
23165102|NCT01425008|64352567|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165103|NCT01425008|64352568|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165104|NCT01425008|64352569|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
23165105|NCT01425008|64352570|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165106|NCT01425008|64352571|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165107|NCT01425008|64352572|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165108|NCT01425008|64352573|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165109|NCT01425008|64352574|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165110|NCT01425008|64352575|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
23165111|NCT01425008|64352576|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
23165112|NCT01425008|64352577|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165113|NCT01425008|64352578|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165114|NCT01425008|64352579|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165115|NCT01425008|64352580|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165116|NCT01425008|64352581|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165117|NCT01425008|64352582|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165118|NCT01425008|64352583|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165119|NCT01425008|64352584|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165120|NCT01425008|64352585|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
23165121|NCT01425008|64352567|FG000|Dose Escalation Phase|Other|0|||
23165122|NCT01425008|64352568|FG001|Dose Escalation Phase|Other|0|||
23165123|NCT01425008|64352569|FG002|Dose Escalation Phase|Other|0|||
23225859|NCT01192100|64567938|FG001|Overall Study|Withdrawal by Subject|0|||
23225860|NCT01192100|64567939|FG002|Overall Study|Withdrawal by Subject|0|||
23225861|NCT01192100|64567940|FG003|Overall Study|Withdrawal by Subject|0|||
23225862|NCT01192100|64567941|FG004|Overall Study|Withdrawal by Subject|1|||
23225863|NCT01192100|64567942|FG005|Overall Study|Withdrawal by Subject|0|||
23225864|NCT01192100|64567937|FG000|Overall Study|Protocol Violation|0|||
23225865|NCT01192100|64567938|FG001|Overall Study|Protocol Violation|0|||
23225866|NCT01192100|64567939|FG002|Overall Study|Protocol Violation|0|||
23332178|NCT01464333|64959019|FG000|Overall Study|Adverse Event|34|||
23332179|NCT01464333|64959019|FG000|Overall Study|Lack of Efficacy|72|||
23332180|NCT01464333|64959019|FG000|Overall Study|Withdrawal by Subject|11|||
23165124|NCT01425008|64352570|FG003|Dose Escalation Phase|Other|0|||
23165125|NCT01425008|64352571|FG004|Dose Escalation Phase|Other|0|||
23165126|NCT01425008|64352572|FG005|Dose Escalation Phase|Other|0|||
23165127|NCT01425008|64352573|FG006|Dose Escalation Phase|Other|0|||
23165128|NCT01425008|64352574|FG007|Dose Escalation Phase|Other|0|||
23225867|NCT01192100|64567940|FG003|Overall Study|Protocol Violation|1|||
23225868|NCT01192100|64567941|FG004|Overall Study|Protocol Violation|0|||
23332181|NCT01464333|64959019|FG000|Overall Study|Other|4|||
23332182|NCT01464333|64959019|FG000|Overall Study|No Hospital Visit|42|||
23225869|NCT01192100|64567942|FG005|Overall Study|Protocol Violation|0|||
23225870|NCT00957723|64567957|FG000|Overall Study|Death|3|||
23225871|NCT00957723|64567957|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
23225872|NCT00957723|64567957|FG000|Overall Study|Lost to Follow-up|8|||
23573109|NCT03257995|65827577|FG003|Overall Study|Protocol deviation|0|||
23573110|NCT03257995|65827578|FG004|Overall Study|Protocol deviation|0|||
23447269|NCT03109184|65377922|FG001|Overall Study|Lost to Follow-up|6|||
23573111|NCT03257995|65827579|FG005|Overall Study|Protocol deviation|2|||
23573112|NCT03486899|65827580|FG000|Overall Study|Lost to Follow-up|4|||
23573113|NCT03486899|65827581|FG001|Overall Study|Lost to Follow-up|1|||
23573114|NCT03486899|65827582|FG002|Overall Study|Lost to Follow-up|4|||
23573115|NCT03486899|65827583|FG003|Overall Study|Lost to Follow-up|3|||
23573116|NCT03486899|65827580|FG000|Overall Study|Death|1|||
23573117|NCT03486899|65827581|FG001|Overall Study|Death|0|||
23573118|NCT03486899|65827582|FG002|Overall Study|Death|0|||
23573119|NCT03486899|65827583|FG003|Overall Study|Death|1|||
23573120|NCT03486899|65827580|FG000|Overall Study|Adverse Event|0|||
23573121|NCT03486899|65827581|FG001|Overall Study|Adverse Event|2|||
23573122|NCT03486899|65827582|FG002|Overall Study|Adverse Event|0|||
23573123|NCT03486899|65827583|FG003|Overall Study|Adverse Event|2|||
23573124|NCT03486899|65827580|FG000|Overall Study|Withdrawal by Subject|3|||
23573125|NCT03486899|65827581|FG001|Overall Study|Withdrawal by Subject|7|||
23573126|NCT03486899|65827582|FG002|Overall Study|Withdrawal by Subject|4|||
23573127|NCT03486899|65827583|FG003|Overall Study|Withdrawal by Subject|3|||
23573128|NCT03486899|65827580|FG000|Overall Study|Other Reasons|0|||
23573129|NCT03486899|65827581|FG001|Overall Study|Other Reasons|1|||
23573130|NCT03486899|65827582|FG002|Overall Study|Other Reasons|0|||
23573131|NCT03486899|65827583|FG003|Overall Study|Other Reasons|1|||
23573132|NCT00445601|65827584|FG000|Overall Study|Withdrawal by Subject|11|||
23573133|NCT00445601|65827585|FG001|Overall Study|Withdrawal by Subject|11|||
23573134|NCT00445601|65827584|FG000|Overall Study|TURBT Complication|12|||
23573135|NCT00445601|65827585|FG001|Overall Study|TURBT Complication|8|||
23573136|NCT00445601|65827584|FG000|Overall Study|Incorrect Disease Status|6|||
23573137|NCT00445601|65827585|FG001|Overall Study|Incorrect Disease Status|6|||
23573138|NCT00445601|65827584|FG000|Overall Study|Drug Delivery Issue|2|||
23573139|NCT00445601|65827585|FG001|Overall Study|Drug Delivery Issue|2|||
23165129|NCT01425008|64352575|FG008|Dose Escalation Phase|Other|1|||
23165130|NCT01425008|64352576|FG009|Dose Escalation Phase|Other|0|||
23165131|NCT01425008|64352577|FG010|Dose Escalation Phase|Other|0|||
23165132|NCT01425008|64352578|FG011|Dose Escalation Phase|Other|0|||
23165133|NCT01425008|64352579|FG012|Dose Escalation Phase|Other|0|||
23165134|NCT01425008|64352580|FG013|Dose Escalation Phase|Other|0|||
23165135|NCT01425008|64352581|FG014|Dose Escalation Phase|Other|0|||
23165136|NCT01425008|64352582|FG015|Dose Escalation Phase|Other|0|||
23165137|NCT01425008|64352583|FG016|Dose Escalation Phase|Other|0|||
23165138|NCT01425008|64352584|FG017|Dose Escalation Phase|Other|0|||
23165139|NCT01425008|64352585|FG018|Dose Escalation Phase|Other|0|||
23573140|NCT00445601|65827584|FG000|Overall Study|Adverse Event|2|||
23165140|NCT01425008|64352567|FG000|Dose Expansion Phase|Progressive Disease|0|||
23165141|NCT01425008|64352568|FG001|Dose Expansion Phase|Progressive Disease|0|||
23225873|NCT00957723|64567957|FG000|Overall Study|Withdrawal by Subject|24|||
23573141|NCT00445601|65827585|FG001|Overall Study|Adverse Event|0|||
23225874|NCT00957723|64567957|FG000|Overall Study|Investigative Site Terminated|61|||
23447270|NCT03109184|65377921|FG000|Overall Study|Withdrawal by Subject|1|||
23573142|NCT00445601|65827584|FG000|Overall Study|Death prior to TURBT|0|||
23573143|NCT00445601|65827585|FG001|Overall Study|Death prior to TURBT|1|||
23573144|NCT00598481|65827586|FG000|Treatment|Physician Decision|1|||
23573145|NCT00474175|65827591|FG000|Overall Study|Lack of Efficacy|0|||
23573146|NCT00474175|65827592|FG001|Overall Study|Lack of Efficacy|0|||
23573147|NCT00474175|65827593|FG002|Overall Study|Lack of Efficacy|1|||
23573148|NCT00474175|65827591|FG000|Overall Study|Withdrawal by Subject|0|||
23573149|NCT00474175|65827592|FG001|Overall Study|Withdrawal by Subject|1|||
23573150|NCT00474175|65827593|FG002|Overall Study|Withdrawal by Subject|1|||
23573151|NCT00474175|65827591|FG000|Overall Study|Ineligible|1|||
23573152|NCT00474175|65827592|FG001|Overall Study|Ineligible|3|||
23573153|NCT00474175|65827593|FG002|Overall Study|Ineligible|1|||
23573154|NCT00474175|65827591|FG000|Overall Study|Protocol Violation|0|||
23573155|NCT00474175|65827592|FG001|Overall Study|Protocol Violation|2|||
23573156|NCT00474175|65827593|FG002|Overall Study|Protocol Violation|1|||
23573157|NCT00474175|65827591|FG000|Overall Study|Administrative|0|||
23573158|NCT00474175|65827592|FG001|Overall Study|Administrative|1|||
23573159|NCT00474175|65827593|FG002|Overall Study|Administrative|0|||
23573160|NCT02226172|65827598|FG000|Overall Study|Participant refused further follow-up|4|||
23573161|NCT02226172|65827598|FG000|Overall Study|Other|5|||
23573162|NCT02226172|65827598|FG000|Overall Study|Death|1|||
23573163|NCT02226172|65827598|FG000|Overall Study|Study terminated by sponsor|1|||
23573164|NCT02226172|65827598|FG000|Overall Study|Adverse Event|6|||
23573165|NCT00918749|65827599|FG000|Overall Study|Adverse Event|1|||
23573166|NCT00918749|65827600|FG001|Overall Study|Adverse Event|0|||
23573167|NCT00918749|65827601|FG002|Overall Study|Adverse Event|1|||
23573168|NCT00918749|65827599|FG000|Overall Study|Lost to Follow-up|0|||
23573169|NCT00918749|65827600|FG001|Overall Study|Lost to Follow-up|0|||
23573170|NCT00918749|65827601|FG002|Overall Study|Lost to Follow-up|1|||
23573171|NCT00918749|65827599|FG000|Overall Study|Withdrawal by Subject|5|||
23573172|NCT00918749|65827600|FG001|Overall Study|Withdrawal by Subject|3|||
23573173|NCT00918749|65827601|FG002|Overall Study|Withdrawal by Subject|5|||
23573174|NCT00918749|65827599|FG000|Overall Study|No Study Medication Taken|1|||
23573175|NCT00918749|65827600|FG001|Overall Study|No Study Medication Taken|0|||
23573176|NCT00918749|65827601|FG002|Overall Study|No Study Medication Taken|0|||
23573177|NCT00393094|65827602|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
23573178|NCT00393094|65827602|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
23573179|NCT04537897|65827603|FG000|Overall Study|Other than listed|0|||
23573180|NCT04537897|65827604|FG001|Overall Study|Other than listed|0|||
23573181|NCT04537897|65827605|FG002|Overall Study|Other than listed|0|||
23573182|NCT04537897|65827606|FG003|Overall Study|Other than listed|0|||
23573183|NCT04537897|65827607|FG004|Overall Study|Other than listed|0|||
23573184|NCT04537897|65827608|FG005|Overall Study|Other than listed|0|||
23573185|NCT04537897|65827609|FG006|Overall Study|Other than listed|1|||
23573186|NCT04537897|65827610|FG007|Overall Study|Other than listed|0|||
23573187|NCT04537897|65827611|FG008|Overall Study|Other than listed|0|||
23573188|NCT04537897|65827603|FG000|Overall Study|Adverse Event|0|||
23573189|NCT04537897|65827604|FG001|Overall Study|Adverse Event|0|||
23573190|NCT04537897|65827605|FG002|Overall Study|Adverse Event|0|||
23573191|NCT04537897|65827606|FG003|Overall Study|Adverse Event|1|||
23573192|NCT04537897|65827607|FG004|Overall Study|Adverse Event|0|||
23573193|NCT04537897|65827608|FG005|Overall Study|Adverse Event|0|||
23573194|NCT04537897|65827609|FG006|Overall Study|Adverse Event|0|||
23573195|NCT04537897|65827610|FG007|Overall Study|Adverse Event|0|||
23573196|NCT04537897|65827611|FG008|Overall Study|Adverse Event|0|||
23573197|NCT04537897|65827603|FG000|Overall Study|Withdrawal by Subject|0|||
23573198|NCT04537897|65827604|FG001|Overall Study|Withdrawal by Subject|1|||
23573199|NCT04537897|65827605|FG002|Overall Study|Withdrawal by Subject|0|||
23573200|NCT04537897|65827606|FG003|Overall Study|Withdrawal by Subject|0|||
23573201|NCT04537897|65827607|FG004|Overall Study|Withdrawal by Subject|0|||
23573202|NCT04537897|65827608|FG005|Overall Study|Withdrawal by Subject|0|||
23573203|NCT04537897|65827609|FG006|Overall Study|Withdrawal by Subject|0|||
23573204|NCT04537897|65827610|FG007|Overall Study|Withdrawal by Subject|0|||
23573205|NCT04537897|65827611|FG008|Overall Study|Withdrawal by Subject|0|||
23573206|NCT01235975|65827612|FG000|Overall Study|Serious Adverse Event|0|||
23573207|NCT01235975|65827613|FG001|Overall Study|Serious Adverse Event|1|||
23573208|NCT01235975|65827612|FG000|Overall Study|Withdrawal by Subject|8|||
23573209|NCT01235975|65827613|FG001|Overall Study|Withdrawal by Subject|2|||
23573210|NCT01235975|65827612|FG000|Overall Study|Migrated/moved from study area|2|||
23573211|NCT01235975|65827613|FG001|Overall Study|Migrated/moved from study area|1|||
23573212|NCT01235975|65827612|FG000|Overall Study|Lost to Follow-up|7|||
23573213|NCT01235975|65827613|FG001|Overall Study|Lost to Follow-up|3|||
23573214|NCT01811563|65827615|FG000|Overall Study|Lost to Follow-up|5|||
23573215|NCT01811563|65827616|FG001|Overall Study|Lost to Follow-up|2|||
23573216|NCT01811563|65827615|FG000|Overall Study|Incorrect Randomization procedure|0|||
23573217|NCT01811563|65827616|FG001|Overall Study|Incorrect Randomization procedure|1|||
23573218|NCT01461993|65827617|FG000|Overall Study|Withdrawal by Subject|60|||
23573219|NCT01461993|65827618|FG001|Overall Study|Withdrawal by Subject|53|||
23573220|NCT01461993|65827619|FG002|Overall Study|Withdrawal by Subject|16|||
23573221|NCT01461993|65827617|FG000|Overall Study|Lost to Follow-up|44|||
23573222|NCT01461993|65827618|FG001|Overall Study|Lost to Follow-up|48|||
23573223|NCT01461993|65827619|FG002|Overall Study|Lost to Follow-up|22|||
23573224|NCT01461993|65827617|FG000|Overall Study|Protocol Violation|10|||
23573225|NCT01461993|65827618|FG001|Overall Study|Protocol Violation|9|||
23573226|NCT01461993|65827619|FG002|Overall Study|Protocol Violation|7|||
23573227|NCT01461993|65827617|FG000|Overall Study|Adverse Event|9|||
23573228|NCT01461993|65827618|FG001|Overall Study|Adverse Event|11|||
23573229|NCT01461993|65827619|FG002|Overall Study|Adverse Event|3|||
23573230|NCT01461993|65827617|FG000|Overall Study|No longer met eligibility criteria|13|||
23573231|NCT01461993|65827618|FG001|Overall Study|No longer met eligibility criteria|18|||
23573232|NCT01461993|65827619|FG002|Overall Study|No longer met eligibility criteria|10|||
23573233|NCT01461993|65827617|FG000|Overall Study|Did not meet entrance criteria|2|||
23573234|NCT01461993|65827618|FG001|Overall Study|Did not meet entrance criteria|3|||
23573235|NCT01461993|65827619|FG002|Overall Study|Did not meet entrance criteria|0|||
23573236|NCT01461993|65827617|FG000|Overall Study|Other|13|||
23573237|NCT01461993|65827618|FG001|Overall Study|Other|15|||
23573238|NCT01461993|65827619|FG002|Overall Study|Other|6|||
23573239|NCT01500226|65827620|FG000|Overall Study|Adverse Event|31|||
23573240|NCT01500226|65827621|FG001|Overall Study|Adverse Event|38|||
23573241|NCT01500226|65827620|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
23573242|NCT01500226|65827621|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
23573243|NCT01500226|65827620|FG000|Overall Study|Withdrawal by Subject|93|||
23573244|NCT01500226|65827621|FG001|Overall Study|Withdrawal by Subject|96|||
23573245|NCT01500226|65827620|FG000|Overall Study|Death|12|||
23573246|NCT01500226|65827621|FG001|Overall Study|Death|4|||
23573247|NCT01500226|65827620|FG000|Overall Study|Disease Progression|16|||
23573248|NCT01500226|65827621|FG001|Overall Study|Disease Progression|14|||
23573249|NCT01500226|65827620|FG000|Overall Study|Protocol Violation|53|||
23573250|NCT01500226|65827621|FG001|Overall Study|Protocol Violation|39|||
23225875|NCT00957723|64567957|FG000|Overall Study|Intercurrent Illness|2|||
23573251|NCT01500226|65827620|FG000|Overall Study|Physician Decision|17|||
23573252|NCT01500226|65827621|FG001|Overall Study|Physician Decision|15|||
23573253|NCT01500226|65827620|FG000|Overall Study|Lack of Efficacy|14|||
23573254|NCT01500226|65827621|FG001|Overall Study|Lack of Efficacy|30|||
23573255|NCT01500226|65827620|FG000|Overall Study|Lost to Follow-up|9|||
23573256|NCT01500226|65827621|FG001|Overall Study|Lost to Follow-up|5|||
23573257|NCT01500226|65827620|FG000|Overall Study|Other Reasons|19|||
23573258|NCT01500226|65827621|FG001|Overall Study|Other Reasons|16|||
23573259|NCT04157686|65827622|FG000|Overall Study|Adverse Event|1|||
23573260|NCT04157686|65827623|FG001|Overall Study|Adverse Event|0|||
23573261|NCT04157686|65827624|FG002|Overall Study|Adverse Event|1|||
23573262|NCT04157686|65827625|FG003|Overall Study|Adverse Event|0|||
23573263|NCT04157686|65827626|FG004|Overall Study|Adverse Event|1|||
23573264|NCT04157686|65827627|FG005|Overall Study|Adverse Event|0|||
23573265|NCT04157686|65827628|FG006|Overall Study|Adverse Event|0|||
23573266|NCT04157686|65827629|FG007|Overall Study|Adverse Event|0|||
23573267|NCT04157686|65827622|FG000|Overall Study|Pregnancy|0|||
23573268|NCT04157686|65827623|FG001|Overall Study|Pregnancy|1|||
23573269|NCT04157686|65827624|FG002|Overall Study|Pregnancy|3|||
23573270|NCT04157686|65827625|FG003|Overall Study|Pregnancy|0|||
23573271|NCT04157686|65827626|FG004|Overall Study|Pregnancy|0|||
23573272|NCT04157686|65827627|FG005|Overall Study|Pregnancy|0|||
23573273|NCT04157686|65827628|FG006|Overall Study|Pregnancy|3|||
23573274|NCT04157686|65827629|FG007|Overall Study|Pregnancy|0|||
23573275|NCT04157686|65827622|FG000|Overall Study|Lost to Follow-up|1|||
23573276|NCT04157686|65827623|FG001|Overall Study|Lost to Follow-up|2|||
23573277|NCT04157686|65827624|FG002|Overall Study|Lost to Follow-up|8|||
23225876|NCT00957723|64567957|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
23225877|NCT02289833|64567963|FG000|Overall Study|Study discontinuation|0|||
23332183|NCT01323387|64959020|FG000|Overall Study|Withdrawal by Subject|41|||
23573278|NCT04157686|65827625|FG003|Overall Study|Lost to Follow-up|6|||
23573279|NCT04157686|65827626|FG004|Overall Study|Lost to Follow-up|6|||
23573280|NCT04157686|65827627|FG005|Overall Study|Lost to Follow-up|3|||
23573281|NCT04157686|65827628|FG006|Overall Study|Lost to Follow-up|7|||
23573282|NCT04157686|65827629|FG007|Overall Study|Lost to Follow-up|9|||
23573283|NCT04157686|65827622|FG000|Overall Study|Lack of Efficacy|0|||
23573284|NCT04157686|65827623|FG001|Overall Study|Lack of Efficacy|0|||
23165142|NCT01425008|64352569|FG002|Dose Expansion Phase|Progressive Disease|0|||
23165143|NCT01425008|64352570|FG003|Dose Expansion Phase|Progressive Disease|0|||
23165144|NCT01425008|64352571|FG004|Dose Expansion Phase|Progressive Disease|0|||
23165145|NCT01425008|64352572|FG005|Dose Expansion Phase|Progressive Disease|0|||
23165146|NCT01425008|64352573|FG006|Dose Expansion Phase|Progressive Disease|0|||
23165147|NCT01425008|64352574|FG007|Dose Expansion Phase|Progressive Disease|0|||
23165148|NCT01425008|64352575|FG008|Dose Expansion Phase|Progressive Disease|0|||
23165149|NCT01425008|64352576|FG009|Dose Expansion Phase|Progressive Disease|0|||
23165150|NCT01425008|64352577|FG010|Dose Expansion Phase|Progressive Disease|10|||
23165151|NCT01425008|64352578|FG011|Dose Expansion Phase|Progressive Disease|4|||
23165152|NCT01425008|64352579|FG012|Dose Expansion Phase|Progressive Disease|12|||
23165153|NCT01425008|64352580|FG013|Dose Expansion Phase|Progressive Disease|1|||
23165154|NCT01425008|64352581|FG014|Dose Expansion Phase|Progressive Disease|5|||
23165155|NCT01425008|64352582|FG015|Dose Expansion Phase|Progressive Disease|8|||
23165156|NCT01425008|64352583|FG016|Dose Expansion Phase|Progressive Disease|9|||
23165157|NCT01425008|64352584|FG017|Dose Expansion Phase|Progressive Disease|2|||
23165158|NCT01425008|64352585|FG018|Dose Expansion Phase|Progressive Disease|10|||
23165159|NCT01425008|64352567|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
23165160|NCT01425008|64352568|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
23165161|NCT01425008|64352569|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
23165162|NCT01425008|64352570|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
23165163|NCT01425008|64352571|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
23165164|NCT01425008|64352572|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
23165165|NCT01425008|64352573|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
23165166|NCT01425008|64352574|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
23165167|NCT01425008|64352575|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
23165168|NCT01425008|64352576|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
23165169|NCT01425008|64352577|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
23165170|NCT01425008|64352578|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
23165171|NCT01425008|64352579|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
23165172|NCT01425008|64352580|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
23165173|NCT01425008|64352581|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
23165174|NCT01425008|64352582|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
23165175|NCT01425008|64352583|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
23165176|NCT01425008|64352584|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
23165177|NCT01425008|64352585|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
23165178|NCT01425008|64352567|FG000|Dose Expansion Phase|Other|0|||
23165179|NCT01425008|64352568|FG001|Dose Expansion Phase|Other|0|||
23165180|NCT01425008|64352569|FG002|Dose Expansion Phase|Other|0|||
23165181|NCT01425008|64352570|FG003|Dose Expansion Phase|Other|0|||
23165182|NCT01425008|64352571|FG004|Dose Expansion Phase|Other|0|||
23165183|NCT01425008|64352572|FG005|Dose Expansion Phase|Other|0|||
23165184|NCT01425008|64352573|FG006|Dose Expansion Phase|Other|0|||
23225878|NCT02289833|64567964|FG001|Overall Study|Study discontinuation|1|||
23225879|NCT02289833|64567963|FG000|Overall Study|Lost to Follow-up|4|||
23225880|NCT02289833|64567964|FG001|Overall Study|Lost to Follow-up|0|||
23225881|NCT02289833|64567963|FG000|Overall Study|Death|23|||
23225882|NCT02289833|64567964|FG001|Overall Study|Death|16|||
23225883|NCT02870348|64567965|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
23332184|NCT01323387|64959020|FG000|Overall Study|Radiographic Data Unavailable|1|||
23332185|NCT01323387|64959020|FG000|Overall Study|Revision|14|||
23573285|NCT04157686|65827624|FG002|Overall Study|Lack of Efficacy|0|||
23573286|NCT04157686|65827625|FG003|Overall Study|Lack of Efficacy|0|||
23165185|NCT01425008|64352574|FG007|Dose Expansion Phase|Other|0|||
23165186|NCT01425008|64352575|FG008|Dose Expansion Phase|Other|0|||
23165187|NCT01425008|64352576|FG009|Dose Expansion Phase|Other|0|||
23165188|NCT01425008|64352577|FG010|Dose Expansion Phase|Other|0|||
23165189|NCT01425008|64352578|FG011|Dose Expansion Phase|Other|0|||
23165190|NCT01425008|64352579|FG012|Dose Expansion Phase|Other|1|||
23165191|NCT01425008|64352580|FG013|Dose Expansion Phase|Other|0|||
23165192|NCT01425008|64352581|FG014|Dose Expansion Phase|Other|0|||
23225884|NCT01188811|64567966|FG000|Overall Study|Withdrawal by Subject|0|||
23225885|NCT01188811|64567967|FG001|Overall Study|Withdrawal by Subject|2|||
23573287|NCT04157686|65827626|FG004|Overall Study|Lack of Efficacy|0|||
23573288|NCT04157686|65827627|FG005|Overall Study|Lack of Efficacy|2|||
23573289|NCT04157686|65827628|FG006|Overall Study|Lack of Efficacy|0|||
23165193|NCT01425008|64352582|FG015|Dose Expansion Phase|Other|0|||
23165194|NCT01425008|64352583|FG016|Dose Expansion Phase|Other|2|||
23165195|NCT01425008|64352584|FG017|Dose Expansion Phase|Other|0|||
23165196|NCT01425008|64352585|FG018|Dose Expansion Phase|Other|4|||
23165197|NCT01425008|64352567|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
23165198|NCT01425008|64352568|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
23165199|NCT01425008|64352569|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
23165200|NCT01425008|64352570|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
23165201|NCT01425008|64352571|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
23225886|NCT01188811|64567966|FG000|Overall Study|Adverse Event|6|||
23165202|NCT01425008|64352572|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
23225887|NCT01188811|64567967|FG001|Overall Study|Adverse Event|0|||
23573290|NCT04157686|65827629|FG007|Overall Study|Lack of Efficacy|1|||
23573291|NCT04157686|65827622|FG000|Overall Study|Withdrawal by Subject|10|||
23573292|NCT04157686|65827623|FG001|Overall Study|Withdrawal by Subject|10|||
23573293|NCT04157686|65827624|FG002|Overall Study|Withdrawal by Subject|12|||
23573294|NCT04157686|65827625|FG003|Overall Study|Withdrawal by Subject|20|||
23573295|NCT04157686|65827626|FG004|Overall Study|Withdrawal by Subject|12|||
23573296|NCT04157686|65827627|FG005|Overall Study|Withdrawal by Subject|11|||
23573297|NCT04157686|65827628|FG006|Overall Study|Withdrawal by Subject|18|||
23573298|NCT04157686|65827629|FG007|Overall Study|Withdrawal by Subject|24|||
23573299|NCT04157686|65827622|FG000|Overall Study|Physician Decision|0|||
23573300|NCT04157686|65827623|FG001|Overall Study|Physician Decision|0|||
23573301|NCT04157686|65827624|FG002|Overall Study|Physician Decision|1|||
23573302|NCT04157686|65827625|FG003|Overall Study|Physician Decision|0|||
23573303|NCT04157686|65827626|FG004|Overall Study|Physician Decision|1|||
23573304|NCT04157686|65827627|FG005|Overall Study|Physician Decision|0|||
23573305|NCT04157686|65827628|FG006|Overall Study|Physician Decision|3|||
23573306|NCT04157686|65827629|FG007|Overall Study|Physician Decision|0|||
23573307|NCT04157686|65827622|FG000|Overall Study|Death|0|||
23573308|NCT04157686|65827623|FG001|Overall Study|Death|0|||
23573309|NCT04157686|65827624|FG002|Overall Study|Death|0|||
23573310|NCT04157686|65827625|FG003|Overall Study|Death|2|||
23573311|NCT04157686|65827626|FG004|Overall Study|Death|0|||
23573312|NCT04157686|65827627|FG005|Overall Study|Death|0|||
23573313|NCT04157686|65827628|FG006|Overall Study|Death|0|||
23573314|NCT04157686|65827629|FG007|Overall Study|Death|0|||
23573315|NCT04157686|65827622|FG000|Overall Study|Protocol Violation|0|||
23573316|NCT04157686|65827623|FG001|Overall Study|Protocol Violation|0|||
23573317|NCT04157686|65827624|FG002|Overall Study|Protocol Violation|0|||
23573318|NCT04157686|65827625|FG003|Overall Study|Protocol Violation|0|||
23332186|NCT01323387|64959020|FG000|Overall Study|Protocol Violation|12|||
23332187|NCT01323387|64959020|FG000|Overall Study|Randomized but Never Treated|16|||
23332188|NCT01294696|64959021|FG000|Overall Study|Screening failures|7|||
23332189|NCT01294696|64959021|FG000|Overall Study|Protocol Violation|8|||
23332190|NCT01294696|64959021|FG000|Overall Study|Missing BPI Response|7|||
23332191|NCT01294696|64959021|FG000|Overall Study|Site closure|52|||
23332192|NCT04179838|64959022|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
23332193|NCT04179838|64959023|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
23573319|NCT04157686|65827626|FG004|Overall Study|Protocol Violation|1|||
23573320|NCT04157686|65827627|FG005|Overall Study|Protocol Violation|0|||
23573321|NCT04157686|65827628|FG006|Overall Study|Protocol Violation|0|||
23573322|NCT04157686|65827629|FG007|Overall Study|Protocol Violation|0|||
23573323|NCT04157686|65827622|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
23165203|NCT01425008|64352573|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
23225888|NCT00790218|64567976|FG000|Overall Study|Death|1|||
23225889|NCT00790218|64567977|FG001|Overall Study|Death|0|||
23225890|NCT00790218|64567978|FG002|Overall Study|Death|0|||
23225891|NCT02343952|64567983|FG000|Study Treatment|Disease Progression|23|||
23225892|NCT02343952|64567983|FG000|Study Treatment|Death|3|||
23225893|NCT02343952|64567983|FG000|Study Treatment|Adverse Event|19|||
23225894|NCT02343952|64567983|FG000|Study Treatment|Withdrawal by Subject|7|||
23225895|NCT02343952|64567983|FG000|Study Treatment|other complicating Diseases|1|||
23225896|NCT02343952|64567983|FG000|Follow up|Withdrawal by Subject|3|||
23573324|NCT04157686|65827623|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
23573325|NCT04157686|65827624|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
23573326|NCT04157686|65827625|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
23573327|NCT04157686|65827626|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
23573328|NCT04157686|65827627|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
23573329|NCT04157686|65827628|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
23573330|NCT04157686|65827629|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
23573331|NCT01865617|65827630|FG000|Overall Study|Death|27|||
23225897|NCT02343952|64567983|FG000|Follow up|Death|33|||
23573332|NCT01865617|65827631|FG001|Overall Study|Death|3|||
23573333|NCT01865617|65827632|FG002|Overall Study|Death|1|||
23573334|NCT01865617|65827633|FG003|Overall Study|Death|1|||
23573335|NCT01865617|65827634|FG004|Overall Study|Death|5|||
23573336|NCT01865617|65827635|FG005|Overall Study|Death|1|||
23573337|NCT01865617|65827636|FG006|Overall Study|Death|11|||
23573338|NCT01865617|65827637|FG007|Overall Study|Death|1|||
23573339|NCT01865617|65827638|FG008|Overall Study|Death|11|||
23573340|NCT01865617|65827639|FG009|Overall Study|Death|3|||
23573341|NCT01865617|65827640|FG010|Overall Study|Death|32|||
23573342|NCT01865617|65827641|FG011|Overall Study|Death|6|||
23573343|NCT01865617|65827642|FG012|Overall Study|Death|13|||
23573344|NCT01865617|65827630|FG000|Overall Study|Lost to Follow-up|2|||
23573345|NCT01865617|65827631|FG001|Overall Study|Lost to Follow-up|0|||
23573346|NCT01865617|65827632|FG002|Overall Study|Lost to Follow-up|0|||
23573347|NCT01865617|65827633|FG003|Overall Study|Lost to Follow-up|0|||
23573348|NCT01865617|65827634|FG004|Overall Study|Lost to Follow-up|0|||
23573349|NCT01865617|65827635|FG005|Overall Study|Lost to Follow-up|0|||
23573350|NCT01865617|65827636|FG006|Overall Study|Lost to Follow-up|0|||
23573351|NCT01865617|65827637|FG007|Overall Study|Lost to Follow-up|0|||
23573352|NCT01865617|65827638|FG008|Overall Study|Lost to Follow-up|0|||
23573353|NCT01865617|65827639|FG009|Overall Study|Lost to Follow-up|0|||
23573354|NCT01865617|65827640|FG010|Overall Study|Lost to Follow-up|0|||
23573355|NCT01865617|65827641|FG011|Overall Study|Lost to Follow-up|0|||
23573356|NCT01865617|65827642|FG012|Overall Study|Lost to Follow-up|0|||
23573357|NCT01865617|65827630|FG000|Overall Study|Withdrawal by Subject|1|||
23573358|NCT01865617|65827631|FG001|Overall Study|Withdrawal by Subject|0|||
23573359|NCT01865617|65827632|FG002|Overall Study|Withdrawal by Subject|0|||
23573360|NCT01865617|65827633|FG003|Overall Study|Withdrawal by Subject|0|||
23573361|NCT01865617|65827634|FG004|Overall Study|Withdrawal by Subject|0|||
23573362|NCT01865617|65827635|FG005|Overall Study|Withdrawal by Subject|0|||
23573363|NCT01865617|65827636|FG006|Overall Study|Withdrawal by Subject|0|||
23573364|NCT01865617|65827637|FG007|Overall Study|Withdrawal by Subject|0|||
23573365|NCT01865617|65827638|FG008|Overall Study|Withdrawal by Subject|0|||
23573366|NCT01865617|65827639|FG009|Overall Study|Withdrawal by Subject|0|||
23573367|NCT01865617|65827640|FG010|Overall Study|Withdrawal by Subject|0|||
23573368|NCT01865617|65827641|FG011|Overall Study|Withdrawal by Subject|0|||
23573369|NCT01865617|65827642|FG012|Overall Study|Withdrawal by Subject|0|||
23573370|NCT01865617|65827630|FG000|Overall Study|Patient proceeded to new therapy|0|||
23573371|NCT01865617|65827631|FG001|Overall Study|Patient proceeded to new therapy|0|||
23573372|NCT01865617|65827632|FG002|Overall Study|Patient proceeded to new therapy|0|||
23573373|NCT01865617|65827633|FG003|Overall Study|Patient proceeded to new therapy|0|||
23573374|NCT01865617|65827634|FG004|Overall Study|Patient proceeded to new therapy|2|||
23573375|NCT01865617|65827635|FG005|Overall Study|Patient proceeded to new therapy|0|||
23573376|NCT01865617|65827636|FG006|Overall Study|Patient proceeded to new therapy|0|||
23573377|NCT01865617|65827637|FG007|Overall Study|Patient proceeded to new therapy|0|||
23573378|NCT01865617|65827638|FG008|Overall Study|Patient proceeded to new therapy|0|||
23573379|NCT01865617|65827639|FG009|Overall Study|Patient proceeded to new therapy|0|||
23573380|NCT01865617|65827640|FG010|Overall Study|Patient proceeded to new therapy|0|||
23573381|NCT01865617|65827641|FG011|Overall Study|Patient proceeded to new therapy|0|||
23573382|NCT01865617|65827642|FG012|Overall Study|Patient proceeded to new therapy|0|||
23573383|NCT01865617|65827630|FG000|Overall Study|Other|0|||
23573384|NCT01865617|65827631|FG001|Overall Study|Other|0|||
23573385|NCT01865617|65827632|FG002|Overall Study|Other|0|||
23573386|NCT01865617|65827633|FG003|Overall Study|Other|0|||
23573387|NCT01865617|65827634|FG004|Overall Study|Other|0|||
23573388|NCT01865617|65827635|FG005|Overall Study|Other|0|||
23573389|NCT01865617|65827636|FG006|Overall Study|Other|1|||
23573390|NCT01865617|65827637|FG007|Overall Study|Other|0|||
23573391|NCT01865617|65827638|FG008|Overall Study|Other|0|||
23573392|NCT01865617|65827639|FG009|Overall Study|Other|0|||
23573393|NCT01865617|65827640|FG010|Overall Study|Other|0|||
23573394|NCT01865617|65827641|FG011|Overall Study|Other|0|||
23573395|NCT01865617|65827642|FG012|Overall Study|Other|0|||
23573396|NCT03249376|65827643|FG000|Overall Study|Adverse Event|11|||
23573397|NCT03249376|65827644|FG001|Overall Study|Adverse Event|5|||
23573398|NCT03249376|65827643|FG000|Overall Study|Lack of Efficacy|2|||
23573399|NCT03249376|65827644|FG001|Overall Study|Lack of Efficacy|4|||
23573400|NCT03249376|65827643|FG000|Overall Study|Protocol Violation|3|||
23573401|NCT03249376|65827644|FG001|Overall Study|Protocol Violation|2|||
23573402|NCT03249376|65827643|FG000|Overall Study|Physician Decision|0|||
23573403|NCT03249376|65827644|FG001|Overall Study|Physician Decision|2|||
23573404|NCT03249376|65827643|FG000|Overall Study|Withdrawal by Subject|3|||
23573405|NCT03249376|65827644|FG001|Overall Study|Withdrawal by Subject|9|||
23573406|NCT03249376|65827643|FG000|Overall Study|LTFU|2|||
23573407|NCT03249376|65827644|FG001|Overall Study|LTFU|1|||
23573408|NCT02291289|65827647|FG000|Induction Treatment|Withdrawal by Subject|0|||
23573409|NCT02291289|65827648|FG001|Induction Treatment|Withdrawal by Subject|0|||
23573410|NCT02291289|65827649|FG002|Induction Treatment|Withdrawal by Subject|0|||
23573411|NCT02291289|65827650|FG003|Induction Treatment|Withdrawal by Subject|24|||
23573412|NCT02291289|65827651|FG004|Induction Treatment|Withdrawal by Subject|0|||
23573413|NCT02291289|65827652|FG005|Induction Treatment|Withdrawal by Subject|0|||
23573414|NCT02291289|65827653|FG006|Induction Treatment|Withdrawal by Subject|0|||
23573415|NCT02291289|65827654|FG007|Induction Treatment|Withdrawal by Subject|0|||
23573416|NCT02291289|65827655|FG008|Induction Treatment|Withdrawal by Subject|0|||
23573417|NCT02291289|65827656|FG009|Induction Treatment|Withdrawal by Subject|18|||
23573418|NCT02291289|65827657|FG010|Induction Treatment|Withdrawal by Subject|0|||
23573419|NCT02291289|65827658|FG011|Induction Treatment|Withdrawal by Subject|0|||
23573420|NCT02291289|65827659|FG012|Induction Treatment|Withdrawal by Subject|0|||
23573421|NCT02291289|65827647|FG000|Induction Treatment|Adverse Event|0|||
23573422|NCT02291289|65827648|FG001|Induction Treatment|Adverse Event|0|||
23573423|NCT02291289|65827649|FG002|Induction Treatment|Adverse Event|0|||
23573424|NCT02291289|65827650|FG003|Induction Treatment|Adverse Event|3|||
23573425|NCT02291289|65827651|FG004|Induction Treatment|Adverse Event|0|||
23573426|NCT02291289|65827652|FG005|Induction Treatment|Adverse Event|0|||
23573427|NCT02291289|65827653|FG006|Induction Treatment|Adverse Event|0|||
23573428|NCT02291289|65827654|FG007|Induction Treatment|Adverse Event|0|||
23573429|NCT02291289|65827655|FG008|Induction Treatment|Adverse Event|0|||
23573430|NCT02291289|65827656|FG009|Induction Treatment|Adverse Event|1|||
23573431|NCT02291289|65827657|FG010|Induction Treatment|Adverse Event|0|||
23573432|NCT02291289|65827658|FG011|Induction Treatment|Adverse Event|0|||
23573433|NCT02291289|65827659|FG012|Induction Treatment|Adverse Event|0|||
23573434|NCT02291289|65827647|FG000|Induction Treatment|Death|25|||
23573435|NCT02291289|65827648|FG001|Induction Treatment|Death|0|||
23573436|NCT02291289|65827649|FG002|Induction Treatment|Death|0|||
23573437|NCT02291289|65827650|FG003|Induction Treatment|Death|111|||
23573438|NCT02291289|65827651|FG004|Induction Treatment|Death|0|||
23573439|NCT02291289|65827652|FG005|Induction Treatment|Death|0|||
23573440|NCT02291289|65827653|FG006|Induction Treatment|Death|1|||
23573441|NCT02291289|65827654|FG007|Induction Treatment|Death|0|||
23573442|NCT02291289|65827655|FG008|Induction Treatment|Death|0|||
23573443|NCT02291289|65827656|FG009|Induction Treatment|Death|82|||
23573444|NCT02291289|65827657|FG010|Induction Treatment|Death|0|||
23573445|NCT02291289|65827658|FG011|Induction Treatment|Death|0|||
23573446|NCT02291289|65827659|FG012|Induction Treatment|Death|0|||
23573447|NCT02291289|65827647|FG000|Induction Treatment|Lost to Follow-up|1|||
23573448|NCT02291289|65827648|FG001|Induction Treatment|Lost to Follow-up|0|||
23573449|NCT02291289|65827649|FG002|Induction Treatment|Lost to Follow-up|0|||
23573450|NCT02291289|65827650|FG003|Induction Treatment|Lost to Follow-up|12|||
23573451|NCT02291289|65827651|FG004|Induction Treatment|Lost to Follow-up|0|||
23573452|NCT02291289|65827652|FG005|Induction Treatment|Lost to Follow-up|0|||
23573453|NCT02291289|65827653|FG006|Induction Treatment|Lost to Follow-up|0|||
23573454|NCT02291289|65827654|FG007|Induction Treatment|Lost to Follow-up|0|||
23573455|NCT02291289|65827655|FG008|Induction Treatment|Lost to Follow-up|0|||
23573456|NCT02291289|65827656|FG009|Induction Treatment|Lost to Follow-up|9|||
23573457|NCT02291289|65827657|FG010|Induction Treatment|Lost to Follow-up|0|||
23573458|NCT02291289|65827658|FG011|Induction Treatment|Lost to Follow-up|0|||
23573459|NCT02291289|65827659|FG012|Induction Treatment|Lost to Follow-up|0|||
23573460|NCT02291289|65827647|FG000|Induction Treatment|Non-Compliance|0|||
23573461|NCT02291289|65827648|FG001|Induction Treatment|Non-Compliance|0|||
23573462|NCT02291289|65827649|FG002|Induction Treatment|Non-Compliance|0|||
23573463|NCT02291289|65827650|FG003|Induction Treatment|Non-Compliance|1|||
23573464|NCT02291289|65827651|FG004|Induction Treatment|Non-Compliance|0|||
23573465|NCT02291289|65827652|FG005|Induction Treatment|Non-Compliance|0|||
23573466|NCT02291289|65827653|FG006|Induction Treatment|Non-Compliance|0|||
23573467|NCT02291289|65827654|FG007|Induction Treatment|Non-Compliance|0|||
23573468|NCT02291289|65827655|FG008|Induction Treatment|Non-Compliance|0|||
23573469|NCT02291289|65827656|FG009|Induction Treatment|Non-Compliance|1|||
23573470|NCT02291289|65827657|FG010|Induction Treatment|Non-Compliance|0|||
23573471|NCT02291289|65827658|FG011|Induction Treatment|Non-Compliance|0|||
23573472|NCT02291289|65827659|FG012|Induction Treatment|Non-Compliance|0|||
23573473|NCT02291289|65827647|FG000|Induction Treatment|Reason Not Specified|0|||
23573474|NCT02291289|65827648|FG001|Induction Treatment|Reason Not Specified|0|||
23573475|NCT02291289|65827649|FG002|Induction Treatment|Reason Not Specified|0|||
23573476|NCT02291289|65827650|FG003|Induction Treatment|Reason Not Specified|4|||
23573477|NCT02291289|65827651|FG004|Induction Treatment|Reason Not Specified|0|||
23573478|NCT02291289|65827652|FG005|Induction Treatment|Reason Not Specified|0|||
23573479|NCT02291289|65827653|FG006|Induction Treatment|Reason Not Specified|0|||
23573480|NCT02291289|65827654|FG007|Induction Treatment|Reason Not Specified|0|||
23573481|NCT02291289|65827655|FG008|Induction Treatment|Reason Not Specified|0|||
23573482|NCT02291289|65827656|FG009|Induction Treatment|Reason Not Specified|7|||
23573483|NCT02291289|65827657|FG010|Induction Treatment|Reason Not Specified|0|||
23573484|NCT02291289|65827658|FG011|Induction Treatment|Reason Not Specified|0|||
23573485|NCT02291289|65827659|FG012|Induction Treatment|Reason Not Specified|0|||
23573486|NCT02291289|65827647|FG000|Induction Treatment|Physician Decision|0|||
23573487|NCT02291289|65827648|FG001|Induction Treatment|Physician Decision|0|||
23573488|NCT02291289|65827649|FG002|Induction Treatment|Physician Decision|0|||
23573489|NCT02291289|65827650|FG003|Induction Treatment|Physician Decision|3|||
23573490|NCT02291289|65827651|FG004|Induction Treatment|Physician Decision|0|||
23573491|NCT02291289|65827652|FG005|Induction Treatment|Physician Decision|0|||
23573492|NCT02291289|65827653|FG006|Induction Treatment|Physician Decision|0|||
23573493|NCT02291289|65827654|FG007|Induction Treatment|Physician Decision|0|||
23165204|NCT01425008|64352574|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
23165205|NCT01425008|64352575|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
23573494|NCT02291289|65827655|FG008|Induction Treatment|Physician Decision|0|||
23573495|NCT02291289|65827656|FG009|Induction Treatment|Physician Decision|1|||
23573496|NCT02291289|65827657|FG010|Induction Treatment|Physician Decision|0|||
23573497|NCT02291289|65827658|FG011|Induction Treatment|Physician Decision|0|||
23573498|NCT02291289|65827659|FG012|Induction Treatment|Physician Decision|0|||
23573499|NCT02291289|65827647|FG000|Induction Treatment|Protocol Violation|0|||
23573500|NCT02291289|65827648|FG001|Induction Treatment|Protocol Violation|0|||
23573501|NCT02291289|65827649|FG002|Induction Treatment|Protocol Violation|0|||
23573502|NCT02291289|65827650|FG003|Induction Treatment|Protocol Violation|3|||
23573503|NCT02291289|65827651|FG004|Induction Treatment|Protocol Violation|0|||
23573504|NCT02291289|65827652|FG005|Induction Treatment|Protocol Violation|0|||
23573505|NCT02291289|65827653|FG006|Induction Treatment|Protocol Violation|0|||
23573506|NCT02291289|65827654|FG007|Induction Treatment|Protocol Violation|0|||
23573507|NCT02291289|65827655|FG008|Induction Treatment|Protocol Violation|0|||
23573508|NCT02291289|65827656|FG009|Induction Treatment|Protocol Violation|2|||
23573509|NCT02291289|65827657|FG010|Induction Treatment|Protocol Violation|0|||
23573510|NCT02291289|65827658|FG011|Induction Treatment|Protocol Violation|0|||
23573511|NCT02291289|65827659|FG012|Induction Treatment|Protocol Violation|0|||
23573512|NCT02291289|65827647|FG000|Induction Treatment|Missing|4|||
23573513|NCT02291289|65827648|FG001|Induction Treatment|Missing|0|||
23573514|NCT02291289|65827649|FG002|Induction Treatment|Missing|0|||
23573515|NCT02291289|65827650|FG003|Induction Treatment|Missing|14|||
23573516|NCT02291289|65827651|FG004|Induction Treatment|Missing|0|||
23573517|NCT02291289|65827652|FG005|Induction Treatment|Missing|0|||
23573518|NCT02291289|65827653|FG006|Induction Treatment|Missing|0|||
23573519|NCT02291289|65827654|FG007|Induction Treatment|Missing|0|||
23573520|NCT02291289|65827655|FG008|Induction Treatment|Missing|0|||
23573521|NCT02291289|65827656|FG009|Induction Treatment|Missing|54|||
23573522|NCT02291289|65827657|FG010|Induction Treatment|Missing|0|||
23573523|NCT02291289|65827658|FG011|Induction Treatment|Missing|0|||
23573524|NCT02291289|65827659|FG012|Induction Treatment|Missing|0|||
23573525|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573526|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573527|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573528|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573529|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
23573530|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
23573531|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573532|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573533|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573534|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573535|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
23573536|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
23573537|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23573538|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Death|0|||
23573539|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Death|29|||
23573540|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Death|16|||
23573541|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Death|0|||
23573542|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Death|188|||
23573543|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Death|107|||
23573544|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Death|0|||
23573545|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Death|1|||
23573546|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Death|1|||
23573547|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Death|0|||
23573548|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Death|46|||
23573549|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Death|19|||
23573550|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Death|0|||
23573551|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Adverse Event|0|||
23573552|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Adverse Event|0|||
23573553|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Adverse Event|0|||
23573554|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Adverse Event|0|||
23573555|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Adverse Event|1|||
23573556|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Adverse Event|1|||
23573557|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Adverse Event|0|||
23573558|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Adverse Event|0|||
23573559|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Adverse Event|0|||
23573560|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Adverse Event|0|||
23225898|NCT02343952|64567983|FG000|Follow up|Patient does not meet eligibility for study.|1|||
23225899|NCT02343952|64567983|FG000|Follow up|Research department closed by the practice.|5|||
23225900|NCT02343952|64567983|FG000|Follow up|Patient went home to Russia|1|||
23225901|NCT02343952|64567983|FG000|Follow up|Disease Progression|1|||
23225902|NCT02343952|64567983|FG000|Follow up|study terminated|1|||
23225903|NCT02718625|64567984|FG000|Overall Study|Adverse Event|0|||
23225904|NCT02718625|64567985|FG001|Overall Study|Adverse Event|1|||
23225905|NCT02718625|64567984|FG000|Overall Study|Termination of Study by Sponsor|0|||
23225906|NCT02718625|64567985|FG001|Overall Study|Termination of Study by Sponsor|1|||
23225907|NCT02147691|64567986|FG000|Overall Study|Withdrawal by Subject|2|||
23225908|NCT02147691|64567987|FG001|Overall Study|Withdrawal by Subject|0|||
23225909|NCT02147691|64567986|FG000|Overall Study|Adverse Event|2|||
23225910|NCT02147691|64567987|FG001|Overall Study|Adverse Event|0|||
23225911|NCT02147691|64567986|FG000|Overall Study|Lost to Follow-up|0|||
23225912|NCT02147691|64567987|FG001|Overall Study|Lost to Follow-up|1|||
23225913|NCT00441012|64567988|FG000|Overall Study|Adverse Event|0|||
23225914|NCT00441012|64567989|FG001|Overall Study|Adverse Event|1|||
23225915|NCT00441012|64567988|FG000|Overall Study|Lost to Follow-up|3|||
23225916|NCT00441012|64567989|FG001|Overall Study|Lost to Follow-up|3|||
23225917|NCT00441012|64567988|FG000|Overall Study|Protocol Violation|10|||
23225918|NCT00441012|64567989|FG001|Overall Study|Protocol Violation|9|||
23225919|NCT00441012|64567988|FG000|Overall Study|Withdrawal by Subject|4|||
23225920|NCT00441012|64567989|FG001|Overall Study|Withdrawal by Subject|0|||
23225921|NCT00441012|64567988|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
23225922|NCT00441012|64567989|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
23225923|NCT03277794|64567990|FG000|Overall Study|Lost to Follow-up|2|||
23225924|NCT03277794|64567991|FG001|Overall Study|Lost to Follow-up|4|||
23225925|NCT03277794|64567990|FG000|Overall Study|Withdrew due to high acuity|1|||
23225926|NCT03277794|64567991|FG001|Overall Study|Withdrew due to high acuity|0|||
23225927|NCT00398086|64567995|FG000|Overall Study|Unacceptable Toxicity|2|||
23573561|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Adverse Event|0|||
23573562|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Adverse Event|0|||
23573563|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Adverse Event|0|||
23573564|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573565|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
23573566|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573567|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573568|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
23573569|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
23225928|NCT00398086|64567996|FG001|Overall Study|Unacceptable Toxicity|8|||
23225929|NCT00398086|64567997|FG002|Overall Study|Unacceptable Toxicity|2|||
23225930|NCT00398086|64567995|FG000|Overall Study|Adverse Event|1|||
23225931|NCT00398086|64567996|FG001|Overall Study|Adverse Event|4|||
23225932|NCT00398086|64567997|FG002|Overall Study|Adverse Event|0|||
23225933|NCT00398086|64567995|FG000|Overall Study|Physician Decision|1|||
23573570|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573571|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
23573572|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
23225934|NCT00398086|64567996|FG001|Overall Study|Physician Decision|4|||
23225935|NCT00398086|64567997|FG002|Overall Study|Physician Decision|0|||
23225936|NCT00398086|64567995|FG000|Overall Study|Withdrawal by Subject|5|||
23225937|NCT00398086|64567996|FG001|Overall Study|Withdrawal by Subject|7|||
23225938|NCT00398086|64567997|FG002|Overall Study|Withdrawal by Subject|0|||
23225939|NCT01135394|64567998|FG000|Screening|Lost to Follow-up|2|||
23225940|NCT01135394|64567998|FG000|Screening|Withdrawal by Subject|10|||
23225941|NCT01135394|64567998|FG000|Screening|Screening failure|16|||
23225942|NCT01135394|64567998|FG000|Screening|Physician Decision|5|||
23225943|NCT01135394|64567998|FG000|Baseline Assessment|Withdrawal by Subject|9|||
23225944|NCT01135394|64567998|FG000|Baseline Assessment|Physician Decision|3|||
23225945|NCT01135394|64567998|FG000|Baseline Assessment|Lost to Follow-up|2|||
23225946|NCT01135394|64567998|FG000|Baseline Assessment|Adverse Event|1|||
23225947|NCT01135394|64567998|FG000|Study Treatment|Withdrawal by Subject|1|||
23225948|NCT01135394|64567998|FG000|Study Treatment|Physician Decision|1|||
23225949|NCT01135394|64567998|FG000|Study Treatment|Adverse Event|2|||
23225950|NCT03424044|64568007|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23225951|NCT03424044|64568008|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23225952|NCT03424044|64568009|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
23573573|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573574|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
23573575|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
23573576|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
23573577|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
23573578|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
23573579|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
23573580|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
23573581|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
23573582|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
23573583|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
23573584|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
23573585|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
23573586|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
23573587|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
23573588|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
23573589|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
23573590|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Physician Decision|0|||
23573591|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Physician Decision|2|||
23573592|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Physician Decision|0|||
23573593|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Physician Decision|0|||
23573594|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Physician Decision|3|||
23573595|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Physician Decision|0|||
23573596|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Physician Decision|0|||
23573597|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Physician Decision|0|||
23225953|NCT03424044|64568010|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23225954|NCT03424044|64568011|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23225955|NCT03424044|64568012|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23225956|NCT03424044|64568013|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23225957|NCT03424044|64568014|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23225958|NCT03424044|64568015|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
23225959|NCT03424044|64568007|FG000|First Intervention (76 Hours)|Adverse Event|0|||
23573598|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Physician Decision|0|||
23573599|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Physician Decision|0|||
23573600|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Physician Decision|1|||
23165206|NCT01425008|64352576|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
23165207|NCT01425008|64352577|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
23165208|NCT01425008|64352578|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
23165209|NCT01425008|64352579|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
23165210|NCT01425008|64352580|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
23165211|NCT01425008|64352581|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
23165212|NCT01425008|64352582|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
23165213|NCT01425008|64352583|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
23165214|NCT01425008|64352584|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
23225960|NCT03424044|64568008|FG001|First Intervention (76 Hours)|Adverse Event|0|||
23573601|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Physician Decision|3|||
23573602|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Physician Decision|0|||
23573603|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Not Treated|0|||
23573604|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Not Treated|0|||
23573605|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Not Treated|2|||
23573606|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Not Treated|0|||
23573607|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Not Treated|0|||
23573608|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Not Treated|0|||
23225961|NCT03424044|64568009|FG002|First Intervention (76 Hours)|Adverse Event|0|||
23225962|NCT03424044|64568010|FG003|First Intervention (76 Hours)|Adverse Event|0|||
23225963|NCT03424044|64568011|FG004|First Intervention (76 Hours)|Adverse Event|1|||
23225964|NCT03424044|64568012|FG005|First Intervention (76 Hours)|Adverse Event|0|||
23225965|NCT03424044|64568013|FG006|First Intervention (76 Hours)|Adverse Event|0|||
23225966|NCT03424044|64568014|FG007|First Intervention (76 Hours)|Adverse Event|0|||
23225967|NCT03424044|64568015|FG008|First Intervention (76 Hours)|Adverse Event|0|||
23225968|NCT03424044|64568007|FG000|First Intervention (76 Hours)|device issues|0|||
23225969|NCT03424044|64568008|FG001|First Intervention (76 Hours)|device issues|0|||
23225970|NCT03424044|64568009|FG002|First Intervention (76 Hours)|device issues|0|||
23225971|NCT03424044|64568010|FG003|First Intervention (76 Hours)|device issues|0|||
23225972|NCT03424044|64568011|FG004|First Intervention (76 Hours)|device issues|0|||
23225973|NCT03424044|64568012|FG005|First Intervention (76 Hours)|device issues|0|||
23447271|NCT03109184|65377922|FG001|Overall Study|Withdrawal by Subject|1|||
23225974|NCT03424044|64568013|FG006|First Intervention (76 Hours)|device issues|1|||
23225975|NCT03424044|64568014|FG007|First Intervention (76 Hours)|device issues|1|||
23225976|NCT03424044|64568015|FG008|First Intervention (76 Hours)|device issues|1|||
23225977|NCT03424044|64568007|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
23447272|NCT03920254|65377927|FG000|Overall Study|Adverse Event|1|||
23447273|NCT03920254|65377928|FG001|Overall Study|Adverse Event|0|||
23225978|NCT03424044|64568008|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
23225979|NCT03424044|64568009|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
23225980|NCT03424044|64568010|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
23225981|NCT03424044|64568011|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
23225982|NCT03424044|64568012|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
23225983|NCT03424044|64568013|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
23332194|NCT04179838|64959022|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
23332195|NCT04179838|64959023|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
23332196|NCT01019694|64959025|FG000|Overall Study|Adverse Event|12|||
23573609|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Not Treated|0|||
23573610|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Not Treated|0|||
23573611|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Not Treated|0|||
23573612|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Not Treated|0|||
23573613|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Not Treated|0|||
23573614|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Not Treated|0|||
23573615|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Not Treated|0|||
23573616|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573617|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
23573618|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573619|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573620|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573621|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573622|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573623|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573624|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573625|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573626|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573627|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573628|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
23573629|NCT02291289|65827647|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
23573630|NCT02291289|65827648|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
23573631|NCT02291289|65827649|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
23573632|NCT02291289|65827650|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
23573633|NCT02291289|65827651|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
23573634|NCT02291289|65827652|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
23573635|NCT02291289|65827653|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
23573636|NCT02291289|65827654|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
23573637|NCT02291289|65827655|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
23573638|NCT02291289|65827656|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
23573639|NCT02291289|65827657|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
23573640|NCT02291289|65827658|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
23573641|NCT02291289|65827659|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
23573642|NCT02291289|65827647|FG000|Early Disease Progression|Death|0|||
23573643|NCT02291289|65827648|FG001|Early Disease Progression|Death|0|||
23573644|NCT02291289|65827649|FG002|Early Disease Progression|Death|0|||
23573645|NCT02291289|65827650|FG003|Early Disease Progression|Death|0|||
23573646|NCT02291289|65827651|FG004|Early Disease Progression|Death|0|||
23573647|NCT02291289|65827652|FG005|Early Disease Progression|Death|0|||
23573648|NCT02291289|65827653|FG006|Early Disease Progression|Death|0|||
23573649|NCT02291289|65827654|FG007|Early Disease Progression|Death|0|||
23573650|NCT02291289|65827655|FG008|Early Disease Progression|Death|0|||
23573651|NCT02291289|65827656|FG009|Early Disease Progression|Death|0|||
23573652|NCT02291289|65827657|FG010|Early Disease Progression|Death|0|||
23573653|NCT02291289|65827658|FG011|Early Disease Progression|Death|0|||
23332197|NCT01019694|64959026|FG001|Overall Study|Adverse Event|16|||
23332198|NCT01019694|64959027|FG002|Overall Study|Adverse Event|19|||
23332199|NCT01019694|64959025|FG000|Overall Study|Protocol Violation|2|||
23332200|NCT01019694|64959026|FG001|Overall Study|Protocol Violation|6|||
23332201|NCT01019694|64959027|FG002|Overall Study|Protocol Violation|4|||
23332202|NCT01019694|64959025|FG000|Overall Study|Lost to Follow-up|5|||
23332203|NCT01019694|64959026|FG001|Overall Study|Lost to Follow-up|3|||
23332204|NCT01019694|64959027|FG002|Overall Study|Lost to Follow-up|3|||
23332205|NCT01019694|64959025|FG000|Overall Study|Withdrawal by Subject|4|||
23332206|NCT01019694|64959026|FG001|Overall Study|Withdrawal by Subject|6|||
23447274|NCT03920254|65377929|FG002|Overall Study|Adverse Event|0|||
23573654|NCT02291289|65827659|FG012|Early Disease Progression|Death|10|||
23573655|NCT02291289|65827647|FG000|Early Disease Progression|Lost to Follow-up|0|||
23573656|NCT02291289|65827648|FG001|Early Disease Progression|Lost to Follow-up|0|||
23573657|NCT02291289|65827649|FG002|Early Disease Progression|Lost to Follow-up|0|||
23573658|NCT02291289|65827650|FG003|Early Disease Progression|Lost to Follow-up|0|||
23332207|NCT01019694|64959027|FG002|Overall Study|Withdrawal by Subject|12|||
23332208|NCT01019694|64959025|FG000|Overall Study|Not treated|0|||
23332209|NCT01019694|64959026|FG001|Overall Study|Not treated|2|||
23225984|NCT03424044|64568014|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
23225985|NCT03424044|64568015|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
23225986|NCT03424044|64568007|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23225987|NCT03424044|64568008|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23225988|NCT03424044|64568009|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23225989|NCT03424044|64568010|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
23225990|NCT03424044|64568011|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23225991|NCT03424044|64568012|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23225992|NCT03424044|64568013|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23225993|NCT03424044|64568014|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23225994|NCT03424044|64568015|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
23225995|NCT02520141|64568016|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
23225996|NCT01624974|64568017|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
23225997|NCT01624974|64568018|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
23225998|NCT01624974|64568017|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
23225999|NCT01624974|64568018|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
23226000|NCT01624974|64568017|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
23226001|NCT01624974|64568018|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
23226002|NCT01624974|64568017|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
23226003|NCT01624974|64568018|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
23226004|NCT01624974|64568017|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
23573659|NCT02291289|65827651|FG004|Early Disease Progression|Lost to Follow-up|0|||
23573660|NCT02291289|65827652|FG005|Early Disease Progression|Lost to Follow-up|0|||
23573661|NCT02291289|65827653|FG006|Early Disease Progression|Lost to Follow-up|0|||
23573662|NCT02291289|65827654|FG007|Early Disease Progression|Lost to Follow-up|0|||
23573663|NCT02291289|65827655|FG008|Early Disease Progression|Lost to Follow-up|0|||
23573664|NCT02291289|65827656|FG009|Early Disease Progression|Lost to Follow-up|0|||
23573665|NCT02291289|65827657|FG010|Early Disease Progression|Lost to Follow-up|0|||
23573666|NCT02291289|65827658|FG011|Early Disease Progression|Lost to Follow-up|0|||
23573667|NCT02291289|65827659|FG012|Early Disease Progression|Lost to Follow-up|1|||
23573668|NCT03653416|65827665|FG000|Overall Study|Protocol Violation|6|||
23573669|NCT03653416|65827666|FG001|Overall Study|Protocol Violation|1|||
23573670|NCT00791921|65831433|FG000|Overall Study|Protocol planed|24|||
23573671|NCT00791921|65831434|FG001|Overall Study|Protocol planed|88|||
23573672|NCT00791921|65831433|FG000|Overall Study|Withdrawal by Subject|1|||
23573673|NCT00791921|65831434|FG001|Overall Study|Withdrawal by Subject|2|||
23573674|NCT00791921|65831433|FG000|Overall Study|Adverse Event|8|||
23573675|NCT00791921|65831434|FG001|Overall Study|Adverse Event|2|||
23573676|NCT00791921|65831433|FG000|Overall Study|Lack of Efficacy|0|||
23573677|NCT00791921|65831434|FG001|Overall Study|Lack of Efficacy|2|||
23573678|NCT00791921|65831433|FG000|Overall Study|Lack of study drug administration|1|||
23573679|NCT00791921|65831434|FG001|Overall Study|Lack of study drug administration|1|||
23573680|NCT00791921|65831433|FG000|Overall Study|Reason other than those above|0|||
23573681|NCT00791921|65831434|FG001|Overall Study|Reason other than those above|1|||
23226005|NCT01624974|64568018|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
23226006|NCT01624974|64568017|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
23447275|NCT03920254|65377927|FG000|Overall Study|Physician Decision|0|||
23573682|NCT01799720|65831439|FG000|Overall Study|Withdrawal by Subject|3|||
23573683|NCT01799720|65831440|FG001|Overall Study|Withdrawal by Subject|0|||
23573684|NCT01799720|65831441|FG002|Overall Study|Withdrawal by Subject|0|||
23573685|NCT01799720|65831439|FG000|Overall Study|Protocol Violation|0|||
23573686|NCT01799720|65831440|FG001|Overall Study|Protocol Violation|1|||
23573687|NCT01799720|65831441|FG002|Overall Study|Protocol Violation|0|||
23332210|NCT01019694|64959027|FG002|Overall Study|Not treated|3|||
23332211|NCT01019694|64959025|FG000|Overall Study|Other reason (not specified)|1|||
23332212|NCT01019694|64959026|FG001|Overall Study|Other reason (not specified)|5|||
23332213|NCT01019694|64959027|FG002|Overall Study|Other reason (not specified)|6|||
23573688|NCT01799720|65831439|FG000|Overall Study|Pregnancy|0|||
23573689|NCT01799720|65831440|FG001|Overall Study|Pregnancy|0|||
23573690|NCT01799720|65831441|FG002|Overall Study|Pregnancy|1|||
23165215|NCT01425008|64352585|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
23165216|NCT01425008|64352567|FG000|Dose Expansion Phase|Adverse Event|0|||
23165217|NCT01425008|64352568|FG001|Dose Expansion Phase|Adverse Event|0|||
23165218|NCT01425008|64352569|FG002|Dose Expansion Phase|Adverse Event|0|||
23165219|NCT01425008|64352570|FG003|Dose Expansion Phase|Adverse Event|0|||
23165220|NCT01425008|64352571|FG004|Dose Expansion Phase|Adverse Event|0|||
23165221|NCT01425008|64352572|FG005|Dose Expansion Phase|Adverse Event|0|||
23165222|NCT01425008|64352573|FG006|Dose Expansion Phase|Adverse Event|0|||
23165223|NCT01425008|64352574|FG007|Dose Expansion Phase|Adverse Event|0|||
23165224|NCT01425008|64352575|FG008|Dose Expansion Phase|Adverse Event|0|||
23165225|NCT01425008|64352576|FG009|Dose Expansion Phase|Adverse Event|0|||
23165226|NCT01425008|64352577|FG010|Dose Expansion Phase|Adverse Event|2|||
23165227|NCT01425008|64352578|FG011|Dose Expansion Phase|Adverse Event|3|||
23165228|NCT01425008|64352579|FG012|Dose Expansion Phase|Adverse Event|3|||
23165229|NCT01425008|64352580|FG013|Dose Expansion Phase|Adverse Event|0|||
23165230|NCT01425008|64352581|FG014|Dose Expansion Phase|Adverse Event|1|||
23165231|NCT01425008|64352582|FG015|Dose Expansion Phase|Adverse Event|1|||
23165232|NCT01425008|64352583|FG016|Dose Expansion Phase|Adverse Event|5|||
23165233|NCT01425008|64352584|FG017|Dose Expansion Phase|Adverse Event|0|||
23165234|NCT01425008|64352585|FG018|Dose Expansion Phase|Adverse Event|3|||
23165235|NCT01425008|64352567|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
23165236|NCT01425008|64352568|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
23165237|NCT01425008|64352569|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
23165238|NCT01425008|64352570|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
23165239|NCT01425008|64352571|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
23165240|NCT01425008|64352572|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
23165241|NCT01425008|64352573|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
23165242|NCT01425008|64352574|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
23165243|NCT01425008|64352575|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
23165244|NCT01425008|64352576|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
23165245|NCT01425008|64352577|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
23165246|NCT01425008|64352578|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
23165247|NCT01425008|64352579|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
23165248|NCT01425008|64352580|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
23165249|NCT01425008|64352581|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
23573691|NCT03056040|65831453|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
23573692|NCT03056040|65831454|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
23573693|NCT03056040|65831453|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
23573694|NCT03056040|65831454|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
23573695|NCT03056040|65831453|FG000|Primary Evaluation Period|Pregnancy|0|||
23573696|NCT03056040|65831454|FG001|Primary Evaluation Period|Pregnancy|1|||
23573697|NCT03056040|65831453|FG000|Extension Period|Physician Decision|3|||
23165250|NCT01425008|64352582|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
23165251|NCT01425008|64352583|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
23165252|NCT01425008|64352584|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
23165253|NCT01425008|64352585|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
23165254|NCT01425008|64352567|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165255|NCT01425008|64352568|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23332214|NCT04305327|64959030|FG000|Overall Study|Study early termination|2|||
23332215|NCT04305327|64959031|FG001|Overall Study|Study early termination|5|||
23332216|NCT04305327|64959032|FG002|Overall Study|Study early termination|2|||
23573698|NCT03056040|65831454|FG001|Extension Period|Physician Decision|3|||
23573699|NCT03056040|65831453|FG000|Extension Period|Lost to Follow-up|0|||
23165256|NCT01425008|64352569|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165257|NCT01425008|64352570|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165258|NCT01425008|64352571|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165259|NCT01425008|64352572|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165260|NCT01425008|64352573|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23332217|NCT04305327|64959033|FG003|Overall Study|Study early termination|2|||
23573700|NCT03056040|65831454|FG001|Extension Period|Lost to Follow-up|1|||
23573701|NCT03056040|65831453|FG000|Extension Period|Death|0|||
23573702|NCT03056040|65831454|FG001|Extension Period|Death|3|||
23573703|NCT03056040|65831453|FG000|Extension Period|Withdrawal by Subject|1|||
23573704|NCT03056040|65831454|FG001|Extension Period|Withdrawal by Subject|0|||
23573705|NCT00653263|65831455|FG000|Overall Study|Withdrawal by Subject|1|||
23573706|NCT00653263|65831455|FG000|Overall Study|Physician Decision|1|||
23573707|NCT03873246|65831457|FG000|Overall Study|Adverse Event|1|||
23573708|NCT03873246|65831458|FG001|Overall Study|Adverse Event|3|||
23573709|NCT03873246|65831459|FG002|Overall Study|Adverse Event|3|||
23573710|NCT03873246|65831457|FG000|Overall Study|Lost to Follow-up|4|||
23573711|NCT03873246|65831458|FG001|Overall Study|Lost to Follow-up|4|||
23573712|NCT03873246|65831459|FG002|Overall Study|Lost to Follow-up|5|||
23573713|NCT03873246|65831457|FG000|Overall Study|Protocol Violation|0|||
23573714|NCT03873246|65831458|FG001|Overall Study|Protocol Violation|1|||
23573715|NCT03873246|65831459|FG002|Overall Study|Protocol Violation|0|||
23573716|NCT03873246|65831457|FG000|Overall Study|Withdrawal by Subject|0|||
23573717|NCT03873246|65831458|FG001|Overall Study|Withdrawal by Subject|4|||
23573718|NCT03873246|65831459|FG002|Overall Study|Withdrawal by Subject|1|||
23573719|NCT00729690|65831460|FG000|Overall Study|IT Catheter Malfunction|0|||
23573720|NCT00729690|65831461|FG001|Overall Study|IT Catheter Malfunction|2|||
23573721|NCT00729690|65831462|FG002|Overall Study|IT Catheter Malfunction|2|||
23573722|NCT02169219|65831463|FG000|Overall Study|Lack of Efficacy|6|||
23573723|NCT00802737|65831466|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
23573724|NCT00802737|65831467|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
23573725|NCT00802737|65831468|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
23573726|NCT00802737|65831466|FG000|Overall Study|Death|6|||
23573727|NCT00802737|65831467|FG001|Overall Study|Death|5|||
23573728|NCT00802737|65831468|FG002|Overall Study|Death|1|||
23573729|NCT00802737|65831466|FG000|Overall Study|Adverse Event|1|||
23573730|NCT00802737|65831467|FG001|Overall Study|Adverse Event|0|||
23573731|NCT00802737|65831468|FG002|Overall Study|Adverse Event|0|||
23573732|NCT00802737|65831466|FG000|Overall Study|Received Prohibited Therapy|1|||
23573733|NCT00802737|65831467|FG001|Overall Study|Received Prohibited Therapy|0|||
23573734|NCT00802737|65831468|FG002|Overall Study|Received Prohibited Therapy|0|||
23573735|NCT00802737|65831466|FG000|Overall Study|Ongoing CLL-Treatment|0|||
23573736|NCT00802737|65831467|FG001|Overall Study|Ongoing CLL-Treatment|1|||
23573737|NCT00802737|65831468|FG002|Overall Study|Ongoing CLL-Treatment|0|||
23573738|NCT00802737|65831466|FG000|Overall Study|Participant too Unwell|0|||
23573739|NCT00802737|65831467|FG001|Overall Study|Participant too Unwell|2|||
23573740|NCT00802737|65831468|FG002|Overall Study|Participant too Unwell|0|||
23573741|NCT01088529|65831470|FG000|Overall Study|Did not receive study treatment|0|||
23573742|NCT01088529|65831471|FG001|Overall Study|Did not receive study treatment|1|||
23573743|NCT01729728|65831472|FG000|Overall Study|Adverse Event|0|||
23573744|NCT01729728|65831473|FG001|Overall Study|Adverse Event|6|||
23573745|NCT01729728|65831474|FG002|Overall Study|Adverse Event|0|||
23573746|NCT01729728|65831472|FG000|Overall Study|Protocol Violation|1|||
23573747|NCT01729728|65831473|FG001|Overall Study|Protocol Violation|0|||
23165261|NCT01425008|64352574|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165262|NCT01425008|64352575|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165263|NCT01425008|64352576|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165264|NCT01425008|64352577|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23573748|NCT01729728|65831474|FG002|Overall Study|Protocol Violation|1|||
23573749|NCT03135548|65831475|FG000|Overall Study|Lost to Follow-up|3|||
23573750|NCT03135548|65831476|FG001|Overall Study|Lost to Follow-up|0|||
23165265|NCT01425008|64352578|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165266|NCT01425008|64352579|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165267|NCT01425008|64352580|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165268|NCT01425008|64352581|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165269|NCT01425008|64352582|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165270|NCT01425008|64352583|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165271|NCT01425008|64352584|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23165272|NCT01425008|64352585|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
23165273|NCT00457015|64352586|FG000|Overall Study|Left study site against medical advice|0|||
23573751|NCT03135548|65831477|FG002|Overall Study|Lost to Follow-up|0|||
23573752|NCT03135548|65831475|FG000|Overall Study|Withdrawal by Subject|2|||
23165274|NCT00457015|64352587|FG001|Overall Study|Left study site against medical advice|1|||
23165275|NCT01489527|64352588|FG000|Overall Study|Pregnancy|9|||
23447276|NCT03920254|65377928|FG001|Overall Study|Physician Decision|1|||
23573753|NCT03135548|65831476|FG001|Overall Study|Withdrawal by Subject|2|||
23573754|NCT03135548|65831477|FG002|Overall Study|Withdrawal by Subject|1|||
23573755|NCT03135548|65831475|FG000|Overall Study|Other than listed|0|||
23573756|NCT03135548|65831476|FG001|Overall Study|Other than listed|2|||
23573757|NCT03135548|65831477|FG002|Overall Study|Other than listed|2|||
23165276|NCT01489527|64352589|FG001|Overall Study|Pregnancy|14|||
23165277|NCT01489527|64352588|FG000|Overall Study|Participant moved|6|||
23573758|NCT00507026|65831478|FG000|Overall Study|Lack of Efficacy|6|||
23573759|NCT00507026|65831479|FG001|Overall Study|Lack of Efficacy|4|||
23573760|NCT00507026|65831480|FG002|Overall Study|Lack of Efficacy|21|||
23573761|NCT00507026|65831478|FG000|Overall Study|Withdrawal by Subject|2|||
23573762|NCT00507026|65831479|FG001|Overall Study|Withdrawal by Subject|0|||
23573763|NCT00507026|65831480|FG002|Overall Study|Withdrawal by Subject|0|||
23573764|NCT00507026|65831478|FG000|Overall Study|Investigator Decision|1|||
23573765|NCT00507026|65831479|FG001|Overall Study|Investigator Decision|0|||
23573766|NCT00507026|65831480|FG002|Overall Study|Investigator Decision|0|||
23573767|NCT00507026|65831478|FG000|Overall Study|Adverse Event|2|||
23573768|NCT00507026|65831479|FG001|Overall Study|Adverse Event|0|||
23573769|NCT00507026|65831480|FG002|Overall Study|Adverse Event|0|||
23573770|NCT00507026|65831478|FG000|Overall Study|Protocol Violation|1|||
23573771|NCT00507026|65831479|FG001|Overall Study|Protocol Violation|0|||
23573772|NCT00507026|65831480|FG002|Overall Study|Protocol Violation|0|||
23573773|NCT00507026|65831478|FG000|Overall Study|Other|1|||
23573774|NCT00507026|65831479|FG001|Overall Study|Other|0|||
23573775|NCT00507026|65831480|FG002|Overall Study|Other|0|||
23573776|NCT01991197|65831484|FG000|Overall Study|Lost to Follow-up|1|||
23573777|NCT01991197|65831485|FG001|Overall Study|Lost to Follow-up|1|||
23573778|NCT01991197|65831484|FG000|Overall Study|Physician Decision|0|||
23573779|NCT01991197|65831485|FG001|Overall Study|Physician Decision|2|||
23573780|NCT01991197|65831484|FG000|Overall Study|Withdrawal by Subject|2|||
23573781|NCT01991197|65831485|FG001|Overall Study|Withdrawal by Subject|0|||
23573782|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
23573783|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
23573784|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
23573785|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
23573786|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
23573787|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
23573788|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
23573789|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
23573790|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
23573791|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
23573792|NCT01646320|65831490|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
23573793|NCT01646320|65831491|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
23573794|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
23573795|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
23573796|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
23573797|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
23573798|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
23573799|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
23573800|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
23573801|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
23573802|NCT01646320|65831490|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
23573803|NCT01646320|65831491|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
23573804|NCT00802659|65831492|FG000|Overall Study|Physician Decision|0|||
23165278|NCT01489527|64352589|FG001|Overall Study|Participant moved|7|||
23165279|NCT01489527|64352588|FG000|Overall Study|Withdrawal by Subject|0|||
23226007|NCT01624974|64568018|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
23226008|NCT01624974|64568017|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
23226009|NCT01624974|64568018|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
23165280|NCT01489527|64352589|FG001|Overall Study|Withdrawal by Subject|4|||
23165281|NCT01489527|64352588|FG000|Overall Study|Lost to Follow-up|5|||
23165282|NCT01489527|64352589|FG001|Overall Study|Lost to Follow-up|1|||
23226010|NCT01624974|64568017|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
23226011|NCT01624974|64568018|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
23226012|NCT01624974|64568017|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
23226013|NCT01624974|64568018|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
23165283|NCT01489527|64352588|FG000|Overall Study|Procedures|1|||
23447277|NCT03920254|65377929|FG002|Overall Study|Physician Decision|2|||
23573805|NCT00802659|65831493|FG001|Overall Study|Physician Decision|1|||
23573806|NCT00802659|65831494|FG002|Overall Study|Physician Decision|0|||
23573807|NCT00802659|65831495|FG003|Overall Study|Physician Decision|0|||
23573808|NCT01458249|65831497|FG000|Overall Study|Not treated|1|||
23573809|NCT01458249|65831497|FG000|Overall Study|Adverse Event|4|||
23573810|NCT01458249|65831497|FG000|Overall Study|Other|2|||
23165284|NCT01489527|64352589|FG001|Overall Study|Procedures|0|||
23165285|NCT01489527|64352588|FG000|Overall Study|Not compliant|1|||
23165286|NCT01489527|64352589|FG001|Overall Study|Not compliant|0|||
23226014|NCT01624974|64568017|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
23447278|NCT03920254|65377927|FG000|Overall Study|Study Terminated By Sponsor|12|||
23447279|NCT03920254|65377928|FG001|Overall Study|Study Terminated By Sponsor|17|||
23573811|NCT01458249|65831497|FG000|Overall Study|Ongoing|1|||
23573812|NCT02139982|65831498|FG000|Overall Study|Lack of Efficacy|0|||
23573813|NCT02139982|65831499|FG001|Overall Study|Lack of Efficacy|1|||
23573814|NCT02139982|65831500|FG002|Overall Study|Lack of Efficacy|0|||
23573815|NCT02139982|65831501|FG003|Overall Study|Lack of Efficacy|1|||
23573816|NCT02139982|65831502|FG004|Overall Study|Lack of Efficacy|0|||
23573817|NCT02139982|65831503|FG005|Overall Study|Lack of Efficacy|0|||
23573818|NCT02139982|65831504|FG006|Overall Study|Lack of Efficacy|0|||
23573819|NCT02139982|65831505|FG007|Overall Study|Lack of Efficacy|0|||
23573820|NCT02139982|65831506|FG008|Overall Study|Lack of Efficacy|0|||
23573821|NCT02139982|65831507|FG009|Overall Study|Lack of Efficacy|0|||
23573822|NCT04430335|65831511|FG000|Overall Study|Withdrawal by Subject|1|||
23573823|NCT00976703|65831512|FG000|Overall Study|Physician Decision|1|||
23573824|NCT00976703|65831513|FG001|Overall Study|Physician Decision|1|||
23573825|NCT00976703|65831512|FG000|Overall Study|ineligible for study|2|||
23573826|NCT00976703|65831513|FG001|Overall Study|ineligible for study|2|||
23573827|NCT00681187|65831514|FG000|Overall Study|Withdrawal by Subject|1|||
23573828|NCT00681187|65831515|FG001|Overall Study|Withdrawal by Subject|0|||
23573829|NCT00681187|65831514|FG000|Overall Study|Death|0|||
23573830|NCT00681187|65831515|FG001|Overall Study|Death|1|||
23573831|NCT00681187|65831514|FG000|Overall Study|Adverse Event|0|||
23573832|NCT00681187|65831515|FG001|Overall Study|Adverse Event|1|||
23573833|NCT03050398|65831516|FG000|Overall Study|Study terminated by sponsor|8|||
23573834|NCT00442286|65831517|FG000|Overall Study|Death|2|||
23573835|NCT00442286|65831518|FG001|Overall Study|Death|2|||
23573836|NCT00442286|65831517|FG000|Overall Study|Lost to Follow-up|1|||
23573837|NCT00442286|65831518|FG001|Overall Study|Lost to Follow-up|0|||
23573838|NCT00442286|65831517|FG000|Overall Study|Withdrawal by Subject|2|||
23573839|NCT00442286|65831518|FG001|Overall Study|Withdrawal by Subject|0|||
23573840|NCT00442286|65831517|FG000|Overall Study|System explanted|1|||
23573841|NCT00442286|65831518|FG001|Overall Study|System explanted|0|||
23573842|NCT00442286|65831517|FG000|Overall Study|Patient Injury|1|||
23165287|NCT01006265|64352590|FG000|Overall Study|Lost to Follow-up|1|||
23165288|NCT01006265|64352591|FG001|Overall Study|Lost to Follow-up|0|||
23165289|NCT01006265|64352592|FG002|Overall Study|Lost to Follow-up|1|||
23165290|NCT01006265|64352593|FG003|Overall Study|Lost to Follow-up|0|||
23165291|NCT01006265|64352590|FG000|Overall Study|Withdrawal by Subject|4|||
23165292|NCT01006265|64352591|FG001|Overall Study|Withdrawal by Subject|7|||
23165293|NCT01006265|64352592|FG002|Overall Study|Withdrawal by Subject|5|||
23165294|NCT01006265|64352593|FG003|Overall Study|Withdrawal by Subject|5|||
23165295|NCT01006265|64352590|FG000|Overall Study|Administrative reason|1|||
23165296|NCT01006265|64352591|FG001|Overall Study|Administrative reason|2|||
23165297|NCT01006265|64352592|FG002|Overall Study|Administrative reason|3|||
23165298|NCT01006265|64352593|FG003|Overall Study|Administrative reason|0|||
23165299|NCT01687712|64352594|FG000|Cycle 1|Not Biochemically Pregnant|386|||
23165300|NCT01687712|64352595|FG001|Cycle 1|Not Biochemically Pregnant|348|||
23165301|NCT01687712|64352594|FG000|Cycle 1|Early Pregnancy Loss|43|||
23165302|NCT01687712|64352595|FG001|Cycle 1|Early Pregnancy Loss|60|||
23165303|NCT01687712|64352594|FG000|Cycle 1|Ectopic Pregnancy|5|||
23165304|NCT01687712|64352595|FG001|Cycle 1|Ectopic Pregnancy|5|||
23165305|NCT01687712|64352594|FG000|Cycle 1|Heterotropic Pregnancy|1|||
23165306|NCT01687712|64352595|FG001|Cycle 1|Heterotropic Pregnancy|0|||
23165307|NCT01687712|64352594|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
23165308|NCT01687712|64352595|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
23573843|NCT00442286|65831518|FG001|Overall Study|Patient Injury|0|||
23573844|NCT01489020|65831519|FG000|Overall Study|Withdrawal by Subject|1|||
23573845|NCT01489020|65831520|FG001|Overall Study|Withdrawal by Subject|0|||
23573846|NCT01489020|65831521|FG002|Overall Study|Withdrawal by Subject|0|||
23573847|NCT01489020|65831522|FG003|Overall Study|Withdrawal by Subject|0|||
23573848|NCT01489020|65831523|FG004|Overall Study|Withdrawal by Subject|0|||
23165309|NCT01687712|64352594|FG000|Cycle 1|Abortion|3|||
23165310|NCT01687712|64352595|FG001|Cycle 1|Abortion|0|||
23165311|NCT01687712|64352594|FG000|Cycle 1|Intrauterine Fetal Death|0|||
23165312|NCT01687712|64352595|FG001|Cycle 1|Intrauterine Fetal Death|1|||
23165313|NCT01687712|64352594|FG000|Cycle 1|Lost to Follow-up|1|||
23165314|NCT01687712|64352595|FG001|Cycle 1|Lost to Follow-up|1|||
23165315|NCT01687712|64352594|FG000|Cycle 2|Not Biochemically Pregnant|74|||
23165316|NCT01687712|64352595|FG001|Cycle 2|Not Biochemically Pregnant|77|||
23165317|NCT01687712|64352594|FG000|Cycle 2|Early Pregnancy Loss|18|||
23573849|NCT01489020|65831524|FG005|Overall Study|Withdrawal by Subject|0|||
23573850|NCT01489020|65831519|FG000|Overall Study|Adverse Event|0|||
23573851|NCT01489020|65831520|FG001|Overall Study|Adverse Event|0|||
23573852|NCT01489020|65831521|FG002|Overall Study|Adverse Event|3|||
23573853|NCT01489020|65831522|FG003|Overall Study|Adverse Event|0|||
23573854|NCT01489020|65831523|FG004|Overall Study|Adverse Event|3|||
23573855|NCT01489020|65831524|FG005|Overall Study|Adverse Event|0|||
23573856|NCT01489020|65831519|FG000|Overall Study|Concomitant disease|0|||
23573857|NCT01489020|65831520|FG001|Overall Study|Concomitant disease|0|||
23573858|NCT01489020|65831521|FG002|Overall Study|Concomitant disease|0|||
23573859|NCT01489020|65831522|FG003|Overall Study|Concomitant disease|0|||
23573860|NCT01489020|65831523|FG004|Overall Study|Concomitant disease|3|||
23573861|NCT01489020|65831524|FG005|Overall Study|Concomitant disease|0|||
23573862|NCT02696226|65831531|FG000|Overall Study|Study terminated - lack of enrollment|1|||
23573863|NCT02696226|65831532|FG001|Overall Study|Study terminated - lack of enrollment|0|||
23573864|NCT02696226|65831533|FG002|Overall Study|Study terminated - lack of enrollment|2|||
23573865|NCT02696226|65831534|FG003|Overall Study|Study terminated - lack of enrollment|0|||
23573866|NCT00896454|65831535|FG000|Overall Study|Death|10|||
23573867|NCT00896454|65831535|FG000|Overall Study|Adverse Event|8|||
23573868|NCT00896454|65831535|FG000|Overall Study|Disease Progression|5|||
23573869|NCT00896454|65831535|FG000|Overall Study|Other|4|||
23573870|NCT00896454|65831535|FG000|Overall Study|Requirement for alternative therapy|3|||
23573871|NCT00896454|65831535|FG000|Overall Study|Ongoing in study|2|||
23226015|NCT01624974|64568018|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
23226016|NCT01624974|64568017|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
23226017|NCT01624974|64568018|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
23226018|NCT01624974|64568017|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
23226019|NCT01624974|64568018|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
23226020|NCT03261037|64568019|FG000|Overall Study|Withdrawal by Subject|2|||
23226021|NCT03261037|64568020|FG001|Overall Study|Withdrawal by Subject|13|||
23226022|NCT03261037|64568021|FG002|Overall Study|Withdrawal by Subject|0|||
23226023|NCT03261037|64568022|FG003|Overall Study|Withdrawal by Subject|18|||
23226024|NCT03261037|64568019|FG000|Overall Study|Non-compliance with study procedures|0|||
23226025|NCT03261037|64568020|FG001|Overall Study|Non-compliance with study procedures|2|||
23226026|NCT03261037|64568021|FG002|Overall Study|Non-compliance with study procedures|0|||
23226027|NCT03261037|64568022|FG003|Overall Study|Non-compliance with study procedures|6|||
23226028|NCT03261037|64568019|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
23226029|NCT03261037|64568020|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
23226030|NCT03261037|64568021|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
23573872|NCT00896454|65831535|FG000|Overall Study|Withdrawal by Subject|1|||
23573873|NCT00386308|65831536|FG000|Overall Study|Adverse Event|3|||
23573874|NCT00386308|65831537|FG001|Overall Study|Adverse Event|3|||
23573875|NCT00386308|65831536|FG000|Overall Study|Protocol Violation|2|||
23573876|NCT00386308|65831537|FG001|Overall Study|Protocol Violation|5|||
23226031|NCT03261037|64568022|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
23226032|NCT03261037|64568019|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
23226033|NCT03261037|64568020|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
23226034|NCT03261037|64568021|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
23226035|NCT03261037|64568022|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
23226036|NCT03261037|64568019|FG000|Overall Study|Diagnosed but protocol deviation|1|||
23226037|NCT03261037|64568020|FG001|Overall Study|Diagnosed but protocol deviation|0|||
23226038|NCT03261037|64568021|FG002|Overall Study|Diagnosed but protocol deviation|0|||
23226039|NCT03261037|64568022|FG003|Overall Study|Diagnosed but protocol deviation|0|||
23226040|NCT03261037|64568019|FG000|Overall Study|Participant did not want to continue the study|0|||
23226041|NCT03261037|64568020|FG001|Overall Study|Participant did not want to continue the study|1|||
23226042|NCT03261037|64568021|FG002|Overall Study|Participant did not want to continue the study|0|||
23226043|NCT03261037|64568022|FG003|Overall Study|Participant did not want to continue the study|0|||
23226044|NCT03261037|64568019|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
23226045|NCT03261037|64568020|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
23226046|NCT03261037|64568021|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
23226047|NCT03261037|64568022|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
23226048|NCT03261037|64568019|FG000|Overall Study|Participant presented clinical improvement|0|||
23226049|NCT03261037|64568020|FG001|Overall Study|Participant presented clinical improvement|2|||
23226050|NCT03261037|64568021|FG002|Overall Study|Participant presented clinical improvement|0|||
23226051|NCT03261037|64568022|FG003|Overall Study|Participant presented clinical improvement|0|||
23573877|NCT00386308|65831536|FG000|Overall Study|Lack of Efficacy|0|||
23573878|NCT00386308|65831537|FG001|Overall Study|Lack of Efficacy|2|||
23573879|NCT00386308|65831536|FG000|Overall Study|Lost to Follow-up|10|||
23573880|NCT00386308|65831537|FG001|Overall Study|Lost to Follow-up|6|||
23573881|NCT00386308|65831536|FG000|Overall Study|Withdrawal by Subject|6|||
23573882|NCT00386308|65831537|FG001|Overall Study|Withdrawal by Subject|2|||
23573883|NCT00386308|65831536|FG000|Overall Study|Other Event|8|||
23573884|NCT00386308|65831537|FG001|Overall Study|Other Event|1|||
23226052|NCT03261037|64568019|FG000|Overall Study|Technical difficulties|0|||
23226053|NCT03261037|64568020|FG001|Overall Study|Technical difficulties|0|||
23226054|NCT03261037|64568021|FG002|Overall Study|Technical difficulties|0|||
23226055|NCT03261037|64568022|FG003|Overall Study|Technical difficulties|1|||
23226056|NCT03261037|64568019|FG000|Overall Study|Equipment failed to work|0|||
23226057|NCT03261037|64568020|FG001|Overall Study|Equipment failed to work|0|||
23226058|NCT03261037|64568021|FG002|Overall Study|Equipment failed to work|0|||
23226059|NCT03261037|64568022|FG003|Overall Study|Equipment failed to work|1|||
23226060|NCT03261037|64568019|FG000|Overall Study|End of study for participant and no follow up|0|||
23226061|NCT03261037|64568020|FG001|Overall Study|End of study for participant and no follow up|0|||
23226062|NCT03261037|64568021|FG002|Overall Study|End of study for participant and no follow up|0|||
23226063|NCT03261037|64568022|FG003|Overall Study|End of study for participant and no follow up|1|||
23226064|NCT03261037|64568019|FG000|Overall Study|Participant was too weak to continue in study|1|||
23226065|NCT03261037|64568020|FG001|Overall Study|Participant was too weak to continue in study|0|||
23226066|NCT03261037|64568021|FG002|Overall Study|Participant was too weak to continue in study|0|||
23226067|NCT03261037|64568022|FG003|Overall Study|Participant was too weak to continue in study|0|||
23226068|NCT01809691|64568029|FG000|Overall Study|Currently on Treatment|192|||
23226069|NCT01809691|64568030|FG001|Overall Study|Currently on Treatment|100|||
23226070|NCT01809691|64568029|FG000|Overall Study|No Protocol Treatment|10|||
23226071|NCT01809691|64568030|FG001|Overall Study|No Protocol Treatment|11|||
23226072|NCT01809691|64568029|FG000|Overall Study|Adverse Event|80|||
23226073|NCT01809691|64568030|FG001|Overall Study|Adverse Event|21|||
23226074|NCT01809691|64568029|FG000|Overall Study|Disease Progression|226|||
23226075|NCT01809691|64568030|FG001|Overall Study|Disease Progression|372|||
23226076|NCT01809691|64568029|FG000|Overall Study|Death|26|||
23226077|NCT01809691|64568030|FG001|Overall Study|Death|13|||
23226078|NCT01809691|64568029|FG000|Overall Study|Participant Refusal|70|||
23226079|NCT01809691|64568030|FG001|Overall Study|Participant Refusal|72|||
23165318|NCT01687712|64352595|FG001|Cycle 2|Early Pregnancy Loss|16|||
23165319|NCT01687712|64352594|FG000|Cycle 2|Ectopic Pregnancy|0|||
23165320|NCT01687712|64352595|FG001|Cycle 2|Ectopic Pregnancy|1|||
23165321|NCT01687712|64352594|FG000|Cycle 2|Still Birth|1|||
23165322|NCT01687712|64352595|FG001|Cycle 2|Still Birth|0|||
23165323|NCT01687712|64352594|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
23165324|NCT01687712|64352595|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
23165325|NCT01687712|64352594|FG000|Cycle 3|Not Biochemically Pregnant|21|||
23165326|NCT01687712|64352595|FG001|Cycle 3|Not Biochemically Pregnant|22|||
23165327|NCT01687712|64352594|FG000|Cycle 3|Early Pregnancy Loss|1|||
23165328|NCT01687712|64352595|FG001|Cycle 3|Early Pregnancy Loss|2|||
23165329|NCT01687712|64352594|FG000|Cycle 3|Ectopic Pregnancy|1|||
23165330|NCT01687712|64352595|FG001|Cycle 3|Ectopic Pregnancy|0|||
23165331|NCT01687712|64352594|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
23165332|NCT01687712|64352595|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
23165333|NCT01661140|64352596|FG000|Open-Label Period|Adverse Event|44|||
23165334|NCT01661140|64352597|FG001|Open-Label Period|Adverse Event|0|||
23165335|NCT01661140|64352598|FG002|Open-Label Period|Adverse Event|0|||
23165336|NCT01661140|64352596|FG000|Open-Label Period|Protocol Violation|3|||
23165337|NCT01661140|64352597|FG001|Open-Label Period|Protocol Violation|0|||
23165338|NCT01661140|64352598|FG002|Open-Label Period|Protocol Violation|0|||
23165339|NCT01661140|64352596|FG000|Open-Label Period|Withdrawal by Subject|5|||
23165340|NCT01661140|64352597|FG001|Open-Label Period|Withdrawal by Subject|0|||
23165341|NCT01661140|64352598|FG002|Open-Label Period|Withdrawal by Subject|0|||
23165342|NCT01661140|64352596|FG000|Open-Label Period|Investigator Decision|3|||
23165343|NCT01661140|64352597|FG001|Open-Label Period|Investigator Decision|0|||
23165344|NCT01661140|64352598|FG002|Open-Label Period|Investigator Decision|0|||
23165345|NCT01661140|64352596|FG000|Open-Label Period|Death|1|||
23165346|NCT01661140|64352597|FG001|Open-Label Period|Death|0|||
23165347|NCT01661140|64352598|FG002|Open-Label Period|Death|0|||
23165348|NCT01661140|64352596|FG000|Open-Label Period|Administrative/Other|1|||
23165349|NCT01661140|64352597|FG001|Open-Label Period|Administrative/Other|0|||
23165350|NCT01661140|64352598|FG002|Open-Label Period|Administrative/Other|0|||
23165351|NCT01661140|64352596|FG000|Open-Label Period|Sponsor termination|16|||
23165352|NCT01661140|64352597|FG001|Open-Label Period|Sponsor termination|0|||
23226080|NCT01809691|64568029|FG000|Overall Study|Other, Not Specified|34|||
23226081|NCT01809691|64568030|FG001|Overall Study|Other, Not Specified|52|||
23226082|NCT01867580|64568034|FG000|Overall Study|Withdrawal by Subject|2|||
23226083|NCT01867580|64568035|FG001|Overall Study|Withdrawal by Subject|3|||
23226084|NCT01867580|64568034|FG000|Overall Study|Physician Decision|17|||
23165353|NCT01661140|64352598|FG002|Open-Label Period|Sponsor termination|0|||
23165354|NCT01661140|64352596|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
23165355|NCT01661140|64352597|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
23165356|NCT01661140|64352598|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
23165357|NCT01661140|64352596|FG000|Open-Label Period|Lost to Follow-up|2|||
23165358|NCT01661140|64352597|FG001|Open-Label Period|Lost to Follow-up|0|||
23165359|NCT01661140|64352598|FG002|Open-Label Period|Lost to Follow-up|0|||
23226085|NCT01867580|64568035|FG001|Overall Study|Physician Decision|12|||
23165360|NCT01661140|64352596|FG000|Double-Blind Period|Refused Treatment|0|||
23165361|NCT01661140|64352597|FG001|Double-Blind Period|Refused Treatment|0|||
23165362|NCT01661140|64352598|FG002|Double-Blind Period|Refused Treatment|1|||
23165363|NCT01661140|64352596|FG000|Double-Blind Period|Adverse Event|0|||
23165364|NCT01661140|64352597|FG001|Double-Blind Period|Adverse Event|16|||
23165365|NCT01661140|64352598|FG002|Double-Blind Period|Adverse Event|18|||
23165366|NCT01661140|64352596|FG000|Double-Blind Period|Protocol Violation|0|||
23165367|NCT01661140|64352597|FG001|Double-Blind Period|Protocol Violation|2|||
23165368|NCT01661140|64352598|FG002|Double-Blind Period|Protocol Violation|3|||
23165369|NCT01661140|64352596|FG000|Double-Blind Period|Withdrawal by Subject|0|||
23165370|NCT01661140|64352597|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23165371|NCT01661140|64352598|FG002|Double-Blind Period|Withdrawal by Subject|3|||
23165372|NCT01661140|64352596|FG000|Double-Blind Period|Investigator's Decision|0|||
23165373|NCT01661140|64352597|FG001|Double-Blind Period|Investigator's Decision|1|||
23165374|NCT01661140|64352598|FG002|Double-Blind Period|Investigator's Decision|2|||
23165375|NCT01661140|64352596|FG000|Double-Blind Period|Sponsor Termination|0|||
23165376|NCT01661140|64352597|FG001|Double-Blind Period|Sponsor Termination|14|||
23165377|NCT01661140|64352598|FG002|Double-Blind Period|Sponsor Termination|17|||
23165378|NCT01661140|64352596|FG000|Double-Blind Period|Administrative/Other|0|||
23165379|NCT01661140|64352597|FG001|Double-Blind Period|Administrative/Other|7|||
23165380|NCT01661140|64352598|FG002|Double-Blind Period|Administrative/Other|6|||
23165381|NCT03313076|64352601|FG000|Overall Study|Withdrawal by Subject|2|||
23165382|NCT03313076|64352602|FG001|Overall Study|Withdrawal by Subject|0|||
23165383|NCT03313076|64352603|FG002|Overall Study|Withdrawal by Subject|0|||
23165384|NCT03313076|64352604|FG003|Overall Study|Withdrawal by Subject|0|||
23165385|NCT03313076|64352601|FG000|Overall Study|Lost to Follow-up|0|||
23165386|NCT03313076|64352602|FG001|Overall Study|Lost to Follow-up|2|||
23165387|NCT03313076|64352603|FG002|Overall Study|Lost to Follow-up|2|||
23165388|NCT03313076|64352604|FG003|Overall Study|Lost to Follow-up|2|||
23165389|NCT05121480|64352605|FG000|Overall Study|Lack of Efficacy|2|||
23165390|NCT05121480|64352606|FG001|Overall Study|Lack of Efficacy|2|||
23165391|NCT05121480|64352607|FG002|Overall Study|Lack of Efficacy|1|||
23165392|NCT05121480|64352608|FG003|Overall Study|Lack of Efficacy|4|||
23165393|NCT05121480|64352609|FG004|Overall Study|Lack of Efficacy|0|||
23165394|NCT05121480|64352610|FG005|Overall Study|Lack of Efficacy|1|||
23165395|NCT05121480|64352611|FG006|Overall Study|Lack of Efficacy|0|||
23332218|NCT04305327|64959030|FG000|Overall Study|Withdrawal by Subject|0|||
23332219|NCT04305327|64959031|FG001|Overall Study|Withdrawal by Subject|1|||
23332220|NCT04305327|64959032|FG002|Overall Study|Withdrawal by Subject|0|||
23332221|NCT04305327|64959033|FG003|Overall Study|Withdrawal by Subject|0|||
23332222|NCT00430573|64959034|FG000|Overall Study|Withdrawal by Subject|5|||
23332223|NCT03340454|64959036|FG000|Overall Study|Lost to Follow-up|0|||
23332224|NCT03340454|64959037|FG001|Overall Study|Lost to Follow-up|4|||
23332225|NCT02097238|64959038|FG000|Overall Study|Death|1|||
23332226|NCT02097238|64959038|FG000|Overall Study|Physician Decision|1|||
23332227|NCT02097238|64959038|FG000|Overall Study|Progressive Disease|17|||
23332228|NCT00561392|64959041|FG000|Overall Study|Adverse Event|38|||
23332229|NCT00561392|64959041|FG000|Overall Study|Lack of Efficacy|2|||
23332230|NCT00561392|64959041|FG000|Overall Study|Protocol Violation|1|||
23332231|NCT00561392|64959041|FG000|Overall Study|Withdrawal by Subject|8|||
23332232|NCT00561392|64959041|FG000|Overall Study|Administrative problems|4|||
23332233|NCT04630002|64959042|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
23332234|NCT04630002|64959043|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
23332235|NCT04630002|64959044|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
23332236|NCT04630002|64959042|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
23332237|NCT04630002|64959043|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
23332238|NCT04630002|64959044|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
23332239|NCT04630002|64959042|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
23332240|NCT04630002|64959043|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
23573885|NCT00180674|65831538|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
23573886|NCT00180674|65831538|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
23573887|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
23573888|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
23332241|NCT04630002|64959044|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
23332242|NCT04630002|64959042|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
23332243|NCT04630002|64959043|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
23573889|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
23165396|NCT05121480|64352612|FG007|Overall Study|Lack of Efficacy|2|||
23165397|NCT05121480|64352605|FG000|Overall Study|Treatment Failure|0|||
23165398|NCT05121480|64352606|FG001|Overall Study|Treatment Failure|2|||
23165399|NCT05121480|64352607|FG002|Overall Study|Treatment Failure|0|||
23165400|NCT05121480|64352608|FG003|Overall Study|Treatment Failure|1|||
23165401|NCT05121480|64352609|FG004|Overall Study|Treatment Failure|0|||
23165402|NCT05121480|64352610|FG005|Overall Study|Treatment Failure|0|||
23332244|NCT04630002|64959044|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
23165403|NCT05121480|64352611|FG006|Overall Study|Treatment Failure|0|||
23165404|NCT05121480|64352612|FG007|Overall Study|Treatment Failure|0|||
23165405|NCT05121480|64352605|FG000|Overall Study|Adverse Event|0|||
23165406|NCT05121480|64352606|FG001|Overall Study|Adverse Event|1|||
23165407|NCT05121480|64352607|FG002|Overall Study|Adverse Event|0|||
23165408|NCT05121480|64352608|FG003|Overall Study|Adverse Event|5|||
23165409|NCT05121480|64352609|FG004|Overall Study|Adverse Event|3|||
23165410|NCT05121480|64352610|FG005|Overall Study|Adverse Event|2|||
23165411|NCT05121480|64352611|FG006|Overall Study|Adverse Event|0|||
23165412|NCT05121480|64352612|FG007|Overall Study|Adverse Event|4|||
23165413|NCT05121480|64352605|FG000|Overall Study|Withdrawal by Subject|4|||
23165414|NCT05121480|64352606|FG001|Overall Study|Withdrawal by Subject|9|||
23165415|NCT05121480|64352607|FG002|Overall Study|Withdrawal by Subject|1|||
23165416|NCT05121480|64352608|FG003|Overall Study|Withdrawal by Subject|8|||
23165417|NCT05121480|64352609|FG004|Overall Study|Withdrawal by Subject|0|||
23165418|NCT05121480|64352610|FG005|Overall Study|Withdrawal by Subject|9|||
23165419|NCT05121480|64352611|FG006|Overall Study|Withdrawal by Subject|0|||
23165420|NCT05121480|64352612|FG007|Overall Study|Withdrawal by Subject|4|||
23165421|NCT05121480|64352605|FG000|Overall Study|Non-compliance with the protocol|0|||
23165422|NCT05121480|64352606|FG001|Overall Study|Non-compliance with the protocol|0|||
23165423|NCT05121480|64352607|FG002|Overall Study|Non-compliance with the protocol|0|||
23165424|NCT05121480|64352608|FG003|Overall Study|Non-compliance with the protocol|0|||
23165425|NCT05121480|64352609|FG004|Overall Study|Non-compliance with the protocol|1|||
23165426|NCT05121480|64352610|FG005|Overall Study|Non-compliance with the protocol|6|||
23165427|NCT05121480|64352611|FG006|Overall Study|Non-compliance with the protocol|0|||
23165428|NCT05121480|64352612|FG007|Overall Study|Non-compliance with the protocol|1|||
23165429|NCT05121480|64352605|FG000|Overall Study|Lost to Follow-up|0|||
23165430|NCT05121480|64352606|FG001|Overall Study|Lost to Follow-up|4|||
23165431|NCT05121480|64352607|FG002|Overall Study|Lost to Follow-up|1|||
23165432|NCT05121480|64352608|FG003|Overall Study|Lost to Follow-up|3|||
23165433|NCT05121480|64352609|FG004|Overall Study|Lost to Follow-up|1|||
23165434|NCT05121480|64352610|FG005|Overall Study|Lost to Follow-up|1|||
23573890|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
23165435|NCT05121480|64352611|FG006|Overall Study|Lost to Follow-up|1|||
23332245|NCT04630002|64959042|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
23332246|NCT04630002|64959043|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
23332247|NCT04630002|64959044|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
23573891|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
23573892|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
23573893|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
23573894|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
23573895|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
23573896|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
23573897|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
23573898|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
23573899|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
23165436|NCT05121480|64352612|FG007|Overall Study|Lost to Follow-up|4|||
23226086|NCT01867580|64568034|FG000|Overall Study|Lost to Follow-up|3|||
23226087|NCT01867580|64568035|FG001|Overall Study|Lost to Follow-up|5|||
23332248|NCT04630002|64959042|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
23332249|NCT04630002|64959043|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
23165437|NCT05121480|64352605|FG000|Overall Study|Physician Decision|0|||
23165438|NCT05121480|64352606|FG001|Overall Study|Physician Decision|0|||
23165439|NCT05121480|64352607|FG002|Overall Study|Physician Decision|0|||
23165440|NCT05121480|64352608|FG003|Overall Study|Physician Decision|0|||
23165441|NCT05121480|64352609|FG004|Overall Study|Physician Decision|0|||
23226088|NCT01867580|64568034|FG000|Overall Study|Sponsor terminated study|1|||
23226089|NCT01867580|64568035|FG001|Overall Study|Sponsor terminated study|0|||
23226090|NCT01867580|64568034|FG000|Overall Study|Missed follow-up assessment|2|||
23165442|NCT05121480|64352610|FG005|Overall Study|Physician Decision|1|||
23165443|NCT05121480|64352611|FG006|Overall Study|Physician Decision|0|||
23573900|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
23165444|NCT05121480|64352612|FG007|Overall Study|Physician Decision|1|||
23165445|NCT05121480|64352605|FG000|Overall Study|Other Reason|0|||
23165446|NCT05121480|64352606|FG001|Overall Study|Other Reason|0|||
23165447|NCT05121480|64352607|FG002|Overall Study|Other Reason|0|||
23165448|NCT05121480|64352608|FG003|Overall Study|Other Reason|0|||
23165449|NCT05121480|64352609|FG004|Overall Study|Other Reason|0|||
23165450|NCT05121480|64352610|FG005|Overall Study|Other Reason|1|||
23165451|NCT05121480|64352611|FG006|Overall Study|Other Reason|1|||
23165452|NCT05121480|64352612|FG007|Overall Study|Other Reason|1|||
23165453|NCT03344003|64352614|FG000|Overall Study|Switched to alternative treatment|1|||
23165454|NCT03344003|64352615|FG001|Overall Study|Switched to alternative treatment|0|||
23165455|NCT03344003|64352614|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
23165456|NCT03344003|64352615|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
23165457|NCT00517829|64352617|FG000|Overall Study|Adverse Event|22|||
23165458|NCT00517829|64352618|FG001|Overall Study|Adverse Event|34|||
23165459|NCT00517829|64352617|FG000|Overall Study|Disease Progression|39|||
23165460|NCT00517829|64352618|FG001|Overall Study|Disease Progression|32|||
23165461|NCT00517829|64352617|FG000|Overall Study|Patient Request|6|||
23165462|NCT00517829|64352618|FG001|Overall Study|Patient Request|5|||
23165463|NCT00517829|64352617|FG000|Overall Study|Investigator Request|5|||
23165464|NCT00517829|64352618|FG001|Overall Study|Investigator Request|3|||
23165465|NCT00517829|64352617|FG000|Overall Study|Other|3|||
23165466|NCT00517829|64352618|FG001|Overall Study|Other|1|||
23165467|NCT01389752|64352622|FG000|Study Period 1|Sponsor decision|0|||
23165468|NCT01389752|64352623|FG001|Study Period 1|Sponsor decision|2|||
23165469|NCT01389752|64352622|FG000|Study Period 2|Sponsor decision|1|||
23165470|NCT01389752|64352623|FG001|Study Period 2|Sponsor decision|0|||
23165471|NCT00996944|64352624|FG000|Double-blind Treatment Period|Adverse Event|2|||
23165472|NCT00996944|64352625|FG001|Double-blind Treatment Period|Adverse Event|1|||
23165473|NCT00996944|64352624|FG000|Double-blind Treatment Period|Protocol Violation|1|||
23573901|NCT01815736|65831539|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
23573902|NCT01815736|65831540|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
23573903|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
23573904|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
23573905|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
23573906|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
23573907|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
23573908|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
23573909|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
23573910|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
23573911|NCT01815736|65831539|FG000|Extension Treatment Phase- After Week 96|Death|1|||
23573912|NCT01815736|65831540|FG001|Extension Treatment Phase- After Week 96|Death|0|||
23573913|NCT02218489|65831543|FG000|Overall Study|Withdrawal by Subject|4|||
23573914|NCT02218489|65831544|FG001|Overall Study|Withdrawal by Subject|3|||
23573915|NCT02218489|65831543|FG000|Overall Study|Lost to Follow-up|1|||
23573916|NCT02218489|65831544|FG001|Overall Study|Lost to Follow-up|0|||
23573917|NCT02404493|65831549|FG000|Overall Study|Adverse Event|1|||
23573918|NCT02404493|65831550|FG001|Overall Study|Adverse Event|1|||
23573919|NCT00802841|65831555|FG000|Overall Study|Administrative problems|1|||
23573920|NCT00802841|65831556|FG001|Overall Study|Administrative problems|0|||
23573921|NCT00802841|65831555|FG000|Overall Study|Lost to Follow-up|2|||
23573922|NCT00802841|65831556|FG001|Overall Study|Lost to Follow-up|1|||
23573923|NCT00802841|65831555|FG000|Overall Study|Death|1|||
23573924|NCT00802841|65831556|FG001|Overall Study|Death|2|||
23573925|NCT00802841|65831555|FG000|Overall Study|Adverse Event|8|||
23573926|NCT00802841|65831556|FG001|Overall Study|Adverse Event|2|||
23573927|NCT00802841|65831555|FG000|Overall Study|Disease progression|7|||
23573928|NCT00802841|65831556|FG001|Overall Study|Disease progression|3|||
23573929|NCT00802841|65831555|FG000|Overall Study|Withdrawal by Subject|9|||
23573930|NCT00802841|65831556|FG001|Overall Study|Withdrawal by Subject|5|||
23573931|NCT00802841|65831555|FG000|Overall Study|Protocol deviation|2|||
23573932|NCT00802841|65831556|FG001|Overall Study|Protocol deviation|6|||
23573933|NCT00802841|65831555|FG000|Overall Study|Treatment duration completed|66|||
23573934|NCT00802841|65831556|FG001|Overall Study|Treatment duration completed|76|||
23573935|NCT00109928|65831559|FG000|Overall Study|Adverse Event|2|||
23573936|NCT00109928|65831559|FG000|Overall Study|Progression|6|||
23573937|NCT00109928|65831559|FG000|Overall Study|Death|2|||
23573938|NCT00109928|65831559|FG000|Overall Study|not protocol specified|2|||
23573939|NCT00109928|65831559|FG000|Overall Study|not eligible|1|||
23573940|NCT01196104|65831563|FG000|Overall Study|Lost to Follow-up|1|||
23573941|NCT01196104|65831564|FG001|Overall Study|Lost to Follow-up|0|||
23573942|NCT01196104|65831563|FG000|Overall Study|Physician Decision|0|||
23573943|NCT01196104|65831564|FG001|Overall Study|Physician Decision|1|||
23573944|NCT01196104|65831563|FG000|Overall Study|Withdrawal by Subject|3|||
23165474|NCT00996944|64352625|FG001|Double-blind Treatment Period|Protocol Violation|0|||
23165475|NCT00996944|64352624|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
23165476|NCT00996944|64352625|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
23573945|NCT01196104|65831564|FG001|Overall Study|Withdrawal by Subject|3|||
23573946|NCT01196104|65831563|FG000|Overall Study|Various|0|||
23573947|NCT01196104|65831564|FG001|Overall Study|Various|1|||
23573948|NCT01712789|65831566|FG000|Overall Study|Lack of Efficacy|2|||
23573949|NCT01712789|65831566|FG000|Overall Study|Lost to Follow-up|1|||
23573950|NCT01712789|65831566|FG000|Overall Study|Progressive Disease|504|||
23573951|NCT01712789|65831566|FG000|Overall Study|Death|57|||
23573952|NCT01712789|65831566|FG000|Overall Study|Adverse Event|52|||
23573953|NCT01712789|65831566|FG000|Overall Study|Miscellaneous|31|||
23573954|NCT01712789|65831566|FG000|Overall Study|Withdrawal by Subject|21|||
23573955|NCT01712789|65831566|FG000|Overall Study|Transition to Commercial Treatment|8|||
23573956|NCT01712789|65831566|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
23573957|NCT04213989|65831567|FG000|Overall Study|Withdrawal by Subject|3|||
23573958|NCT04213989|65831568|FG001|Overall Study|Withdrawal by Subject|2|||
23573959|NCT04213989|65831567|FG000|Overall Study|Physician Decision|1|||
23573960|NCT04213989|65831568|FG001|Overall Study|Physician Decision|0|||
23573961|NCT04213989|65831567|FG000|Overall Study|Lost to Follow-up|0|||
23573962|NCT04213989|65831568|FG001|Overall Study|Lost to Follow-up|4|||
23573963|NCT03935217|65831569|FG000|Overall Study|Adverse Event|1|||
23573964|NCT03935217|65831570|FG001|Overall Study|Adverse Event|0|||
23573965|NCT03935217|65831569|FG000|Overall Study|Lost to Follow-up|0|||
23573966|NCT03935217|65831570|FG001|Overall Study|Lost to Follow-up|1|||
23573967|NCT03935217|65831569|FG000|Overall Study|Withdrawal by Subject|0|||
23573968|NCT03935217|65831570|FG001|Overall Study|Withdrawal by Subject|2|||
23573969|NCT02942004|65831571|FG000|Overall Study|Withdrawal by Subject|0|||
23573970|NCT02942004|65831572|FG001|Overall Study|Withdrawal by Subject|2|||
23573971|NCT02942004|65831573|FG002|Overall Study|Withdrawal by Subject|3|||
23573972|NCT02942004|65831571|FG000|Overall Study|Lost to Follow-up|1|||
23573973|NCT02942004|65831572|FG001|Overall Study|Lost to Follow-up|1|||
23573974|NCT02942004|65831573|FG002|Overall Study|Lost to Follow-up|2|||
23573975|NCT02942004|65831571|FG000|Overall Study|Randomized but not dosed|3|||
23573976|NCT02942004|65831572|FG001|Overall Study|Randomized but not dosed|9|||
23573977|NCT02942004|65831573|FG002|Overall Study|Randomized but not dosed|4|||
23573978|NCT04793464|65831580|FG000|Overall Study|Lost to Follow-up|458|||
23573979|NCT04793464|65831581|FG001|Overall Study|Lost to Follow-up|168|||
23573980|NCT04793464|65831582|FG002|Overall Study|Lost to Follow-up|5|||
23573981|NCT04793464|65831580|FG000|Overall Study|Withdrawal by Subject|43|||
23573982|NCT04793464|65831581|FG001|Overall Study|Withdrawal by Subject|15|||
23573983|NCT04793464|65831582|FG002|Overall Study|Withdrawal by Subject|0|||
23573984|NCT00654238|65831583|FG000|Overall Study|Screen Failures|4|||
23573985|NCT04159896|65831584|FG000|Overall Study|Lack of Efficacy|7|||
23573986|NCT04159896|65831584|FG000|Overall Study|Withdrawal by Subject|1|||
23573987|NCT04159896|65831584|FG000|Overall Study|Adverse Event|1|||
23573988|NCT04159896|65831584|FG000|Overall Study|A transient ischaemic attack|1|||
23573989|NCT01383993|65831588|FG000|Overall Study|Adverse Event|1|||
23165477|NCT00996944|64352624|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23573990|NCT01383993|65831589|FG001|Overall Study|Adverse Event|1|||
23165478|NCT00996944|64352625|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
23165479|NCT00996944|64352624|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
23573991|NCT01383993|65831590|FG002|Overall Study|Adverse Event|0|||
23573992|NCT01383993|65831588|FG000|Overall Study|Withdrawal by Subject|0|||
23573993|NCT01383993|65831589|FG001|Overall Study|Withdrawal by Subject|0|||
23573994|NCT01383993|65831590|FG002|Overall Study|Withdrawal by Subject|1|||
23573995|NCT01383993|65831588|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
23573996|NCT01383993|65831589|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
23573997|NCT01383993|65831590|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
23573998|NCT00293462|65831593|FG000|Overall Study|Withdrawal by Subject|4|||
23573999|NCT00293462|65831594|FG001|Overall Study|Withdrawal by Subject|3|||
23574000|NCT00293462|65831595|FG002|Overall Study|Withdrawal by Subject|8|||
23574001|NCT00293462|65831593|FG000|Overall Study|Death|1|||
23165480|NCT00996944|64352625|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
23165481|NCT00193063|64352626|FG000|Overall Study|Lack of Efficacy|3|||
23226091|NCT01867580|64568035|FG001|Overall Study|Missed follow-up assessment|1|||
23226092|NCT01867580|64568034|FG000|Overall Study|Interruption to therapy|3|||
23226093|NCT01867580|64568035|FG001|Overall Study|Interruption to therapy|0|||
23226094|NCT01867580|64568034|FG000|Overall Study|Osteomyelitis|0|||
23226095|NCT01867580|64568035|FG001|Overall Study|Osteomyelitis|1|||
23226096|NCT01867580|64568034|FG000|Overall Study|Continuation of therapy|0|||
23226097|NCT01867580|64568035|FG001|Overall Study|Continuation of therapy|1|||
23226098|NCT01867580|64568034|FG000|Overall Study|Wound recurrence|0|||
23226099|NCT01867580|64568035|FG001|Overall Study|Wound recurrence|1|||
23226100|NCT03685643|64571037|FG000|Overall Study|Lost to Follow-up|14|||
23226101|NCT03685643|64571038|FG001|Overall Study|Lost to Follow-up|22|||
23226102|NCT02750501|64571039|FG000|Overall Study|Adverse Event|4|||
23226103|NCT02750501|64571039|FG000|Overall Study|Physician Decision|1|||
23226104|NCT02750501|64571039|FG000|Overall Study|Protocol Violation|1|||
23226105|NCT02750501|64571039|FG000|Overall Study|G-tube came out|1|||
23226106|NCT02750501|64571039|FG000|Overall Study|Non-compliant use of PERT|1|||
23226107|NCT02892734|64571043|FG000|Treatment on Study|Progressive Disease|2|||
23226108|NCT02892734|64571043|FG000|Follow up for 2 Years|Death|2|||
23226109|NCT02892734|64571043|FG000|Follow up for 2 Years|Study closed early|1|||
23226110|NCT02096471|64571050|FG000|Overall Study|Adverse Event|1|||
23226111|NCT02096471|64571050|FG000|Overall Study|Lack of Efficacy|7|||
23226112|NCT02096471|64571050|FG000|Overall Study|Withdrawal by Subject|3|||
23226113|NCT02096471|64571050|FG000|Overall Study|Non-Compliant|2|||
23226114|NCT00673816|64571054|FG000|Overall Study|Adverse Event|1|||
23226115|NCT00673816|64571054|FG000|Overall Study|Withdrawal by Subject|1|||
23447280|NCT03920254|65377929|FG002|Overall Study|Study Terminated By Sponsor|12|||
23574002|NCT00293462|65831594|FG001|Overall Study|Death|0|||
23165482|NCT00193063|64352626|FG000|Overall Study|Adverse Event|1|||
23165483|NCT00964743|64352628|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
23165484|NCT00522431|64352629|FG000|Overall Study|Adverse Event|5|||
23165485|NCT00522431|64352629|FG000|Overall Study|Protocol Violation|2|||
23165486|NCT00522431|64352629|FG000|Overall Study|Withdrawal by Subject|2|||
23165487|NCT00522431|64352629|FG000|Overall Study|Subject non-compliance|1|||
23165488|NCT00522431|64352629|FG000|Overall Study|Other/unknown|1|||
23165489|NCT00879697|64352630|FG000|Overall Study|Physician Decision|2|||
23165490|NCT00879697|64352631|FG001|Overall Study|Physician Decision|2|||
23165491|NCT02830880|64352635|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
23165492|NCT02830880|64352635|FG000|Overall Study|Death|1|||
23165493|NCT02830880|64352635|FG000|Overall Study|Physician Decision|1|||
23165494|NCT00746252|64352636|FG000|Overall Study|weight gain >7.5 %|1|||
23165495|NCT00746252|64352637|FG001|Overall Study|weight gain >7.5 %|2|||
23165496|NCT04342871|64352642|FG000|Overall Study|Death|4|||
23165497|NCT04342871|64352642|FG000|Overall Study|Clinical deterioration/illness progression|2|||
23165498|NCT04342871|64352642|FG000|Overall Study|Did not complete baseline assessments|5|||
23165499|NCT04342871|64352642|FG000|Overall Study|Lost to Follow-up|13|||
23165500|NCT03368170|64352643|FG000|Overall Study|Adverse Event|2|||
23165501|NCT03368170|64352644|FG001|Overall Study|Adverse Event|1|||
23165502|NCT00975156|64352645|FG000|Overall Study|Protocol Violation|0|||
23165503|NCT00975156|64352646|FG001|Overall Study|Protocol Violation|1|||
23165504|NCT04294719|64352648|FG000|Overall Study|Withdrawal by Subject|1|||
23165505|NCT00271596|64352652|FG000|Overall Study|Protocol Violation|1|||
23165506|NCT00271596|64352653|FG001|Overall Study|Protocol Violation|0|||
23165507|NCT00271596|64352652|FG000|Overall Study|Withdrawal by Subject|0|||
23165508|NCT00271596|64352653|FG001|Overall Study|Withdrawal by Subject|1|||
23165509|NCT00513409|64352654|FG000|Overall Study|Adverse Event|0|||
23165510|NCT00513409|64352655|FG001|Overall Study|Adverse Event|1|||
23165511|NCT00513409|64352654|FG000|Overall Study|Withdrawal by Subject|0|||
23165512|NCT00513409|64352655|FG001|Overall Study|Withdrawal by Subject|2|||
23574003|NCT00293462|65831595|FG002|Overall Study|Death|0|||
23574004|NCT00293462|65831593|FG000|Overall Study|Lost to Follow-up|0|||
23165513|NCT00513409|64352654|FG000|Overall Study|Lost to Follow-up|0|||
23165514|NCT00513409|64352655|FG001|Overall Study|Lost to Follow-up|1|||
23165515|NCT00513409|64352654|FG000|Overall Study|Physician Decision|1|||
23226116|NCT00472043|64571057|FG000|Overall Study|Withdrawal by Subject|1|||
23226117|NCT00472043|64571058|FG001|Overall Study|Withdrawal by Subject|0|||
23226118|NCT00472043|64571057|FG000|Overall Study|Death|1|||
23226119|NCT00472043|64571058|FG001|Overall Study|Death|0|||
23226120|NCT00772889|64571063|FG000|Overall Study|Adverse Event|7|||
23226121|NCT00772889|64571064|FG001|Overall Study|Adverse Event|4|||
23226122|NCT00772889|64571065|FG002|Overall Study|Adverse Event|0|||
23226123|NCT00772889|64571063|FG000|Overall Study|Withdrawal by Subject|9|||
23226124|NCT00772889|64571064|FG001|Overall Study|Withdrawal by Subject|8|||
23226125|NCT00772889|64571065|FG002|Overall Study|Withdrawal by Subject|9|||
23226126|NCT00772889|64571063|FG000|Overall Study|Lost to Follow-up|6|||
23226127|NCT00772889|64571064|FG001|Overall Study|Lost to Follow-up|6|||
23226128|NCT00772889|64571065|FG002|Overall Study|Lost to Follow-up|7|||
23226129|NCT01387594|64571066|FG000|Overall Study|Withdrawal by Subject|0|||
23332250|NCT04630002|64959044|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
23574005|NCT00293462|65831594|FG001|Overall Study|Lost to Follow-up|1|||
23574006|NCT00293462|65831595|FG002|Overall Study|Lost to Follow-up|0|||
23574007|NCT00293462|65831593|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
23574008|NCT00293462|65831594|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
23574009|NCT00293462|65831595|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
23574010|NCT00293462|65831593|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
23574011|NCT00293462|65831594|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
23574012|NCT00293462|65831595|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
23574013|NCT00293462|65831593|FG000|Overall Study|Refuse Radiation Treatment|1|||
23574014|NCT00293462|65831594|FG001|Overall Study|Refuse Radiation Treatment|0|||
23574015|NCT00293462|65831595|FG002|Overall Study|Refuse Radiation Treatment|0|||
23574016|NCT00293462|65831593|FG000|Overall Study|No Show|0|||
23574017|NCT00293462|65831594|FG001|Overall Study|No Show|0|||
23574018|NCT00293462|65831595|FG002|Overall Study|No Show|1|||
23574019|NCT00293462|65831593|FG000|Overall Study|Went back to his home country|0|||
23574020|NCT00293462|65831594|FG001|Overall Study|Went back to his home country|0|||
23574021|NCT00293462|65831595|FG002|Overall Study|Went back to his home country|1|||
23574022|NCT00293462|65831593|FG000|Overall Study|Blood clot after chemotherapy|0|||
23574023|NCT00293462|65831594|FG001|Overall Study|Blood clot after chemotherapy|0|||
23165516|NCT00513409|64352655|FG001|Overall Study|Physician Decision|0|||
23165517|NCT00513409|64352654|FG000|Overall Study|Visit 3 not done|1|||
23165518|NCT00513409|64352655|FG001|Overall Study|Visit 3 not done|2|||
23165519|NCT02109484|64352659|FG000|Overall Study|Lost to Follow-up|0|||
23165520|NCT02109484|64352660|FG001|Overall Study|Lost to Follow-up|0|||
23165521|NCT02109484|64352661|FG002|Overall Study|Lost to Follow-up|0|||
23165522|NCT02109484|64352662|FG003|Overall Study|Lost to Follow-up|1|||
23165523|NCT02109484|64352663|FG004|Overall Study|Lost to Follow-up|1|||
23165524|NCT02109484|64352664|FG005|Overall Study|Lost to Follow-up|0|||
23165525|NCT02109484|64352665|FG006|Overall Study|Lost to Follow-up|1|||
23165526|NCT02109484|64352666|FG007|Overall Study|Lost to Follow-up|0|||
23165527|NCT02109484|64352659|FG000|Overall Study|Withdrawal by Subject|0|||
23165528|NCT02109484|64352660|FG001|Overall Study|Withdrawal by Subject|0|||
23165529|NCT02109484|64352661|FG002|Overall Study|Withdrawal by Subject|0|||
23165530|NCT02109484|64352662|FG003|Overall Study|Withdrawal by Subject|0|||
23165531|NCT02109484|64352663|FG004|Overall Study|Withdrawal by Subject|1|||
23165532|NCT02109484|64352664|FG005|Overall Study|Withdrawal by Subject|1|||
23165533|NCT02109484|64352665|FG006|Overall Study|Withdrawal by Subject|1|||
23165534|NCT02109484|64352666|FG007|Overall Study|Withdrawal by Subject|0|||
23165535|NCT02109484|64352659|FG000|Overall Study|Physician Decision|0|||
23165536|NCT02109484|64352660|FG001|Overall Study|Physician Decision|0|||
23165537|NCT02109484|64352661|FG002|Overall Study|Physician Decision|0|||
23165538|NCT02109484|64352662|FG003|Overall Study|Physician Decision|0|||
23165539|NCT02109484|64352663|FG004|Overall Study|Physician Decision|2|||
23165540|NCT02109484|64352664|FG005|Overall Study|Physician Decision|0|||
23165541|NCT02109484|64352665|FG006|Overall Study|Physician Decision|0|||
23165542|NCT02109484|64352666|FG007|Overall Study|Physician Decision|0|||
23165543|NCT02109484|64352659|FG000|Overall Study|Death|0|||
23165544|NCT02109484|64352660|FG001|Overall Study|Death|0|||
23165545|NCT02109484|64352661|FG002|Overall Study|Death|0|||
23165546|NCT02109484|64352662|FG003|Overall Study|Death|0|||
23165547|NCT02109484|64352663|FG004|Overall Study|Death|0|||
23165548|NCT02109484|64352664|FG005|Overall Study|Death|0|||
23165549|NCT02109484|64352665|FG006|Overall Study|Death|0|||
23574024|NCT00293462|65831595|FG002|Overall Study|Blood clot after chemotherapy|1|||
23574025|NCT00293462|65831593|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
23165550|NCT02109484|64352666|FG007|Overall Study|Death|2|||
23165551|NCT02109484|64352659|FG000|Overall Study|Moved away from study area|0|||
23574026|NCT00293462|65831594|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
23165552|NCT02109484|64352660|FG001|Overall Study|Moved away from study area|0|||
23165553|NCT02109484|64352661|FG002|Overall Study|Moved away from study area|0|||
23165554|NCT02109484|64352662|FG003|Overall Study|Moved away from study area|0|||
23165555|NCT02109484|64352663|FG004|Overall Study|Moved away from study area|0|||
23226130|NCT01387594|64571067|FG001|Overall Study|Withdrawal by Subject|2|||
23226131|NCT01387594|64571066|FG000|Overall Study|Lost to Follow-up|0|||
23447281|NCT03920254|65377927|FG000|Overall Study|Withdrawal by Subject|0|||
23447282|NCT03920254|65377928|FG001|Overall Study|Withdrawal by Subject|0|||
23447283|NCT03920254|65377929|FG002|Overall Study|Withdrawal by Subject|1|||
23447284|NCT02915263|65377932|FG000|Overall Study|Covid|3|||
23165556|NCT02109484|64352664|FG005|Overall Study|Moved away from study area|0|||
23165557|NCT02109484|64352665|FG006|Overall Study|Moved away from study area|1|||
23165558|NCT02109484|64352666|FG007|Overall Study|Moved away from study area|1|||
23165559|NCT01709435|64352667|FG000|Overall Study|Adverse Event|1|||
23165560|NCT01709435|64352668|FG001|Overall Study|Adverse Event|1|||
23165561|NCT01709435|64352669|FG002|Overall Study|Adverse Event|1|||
23165562|NCT01709435|64352670|FG003|Overall Study|Adverse Event|0|||
23165563|NCT01709435|64352671|FG004|Overall Study|Adverse Event|0|||
23165564|NCT01709435|64352672|FG005|Overall Study|Adverse Event|1|||
23165565|NCT01709435|64352667|FG000|Overall Study|Lack of Efficacy|5|||
23165566|NCT01709435|64352668|FG001|Overall Study|Lack of Efficacy|7|||
23165567|NCT01709435|64352669|FG002|Overall Study|Lack of Efficacy|2|||
23165568|NCT01709435|64352670|FG003|Overall Study|Lack of Efficacy|2|||
23165569|NCT01709435|64352671|FG004|Overall Study|Lack of Efficacy|6|||
23165570|NCT01709435|64352672|FG005|Overall Study|Lack of Efficacy|3|||
23165571|NCT01709435|64352667|FG000|Overall Study|Physician Decision|0|||
23165572|NCT01709435|64352668|FG001|Overall Study|Physician Decision|1|||
23165573|NCT01709435|64352669|FG002|Overall Study|Physician Decision|0|||
23165574|NCT01709435|64352670|FG003|Overall Study|Physician Decision|1|||
23165575|NCT01709435|64352671|FG004|Overall Study|Physician Decision|2|||
23165576|NCT01709435|64352672|FG005|Overall Study|Physician Decision|0|||
23165577|NCT01709435|64352667|FG000|Overall Study|Withdrawal by Subject|0|||
23165578|NCT01709435|64352668|FG001|Overall Study|Withdrawal by Subject|0|||
23165579|NCT01709435|64352669|FG002|Overall Study|Withdrawal by Subject|3|||
23165580|NCT01709435|64352670|FG003|Overall Study|Withdrawal by Subject|0|||
23165581|NCT01709435|64352671|FG004|Overall Study|Withdrawal by Subject|2|||
23165582|NCT01709435|64352672|FG005|Overall Study|Withdrawal by Subject|2|||
23165583|NCT01277549|64352673|FG000|Overall Study|Failed to meet eligibility criteria|13|||
23165584|NCT01277549|64352674|FG001|Overall Study|Failed to meet eligibility criteria|9|||
23165585|NCT01277549|64352673|FG000|Overall Study|Withdrawal by Subject|1|||
23165586|NCT01277549|64352674|FG001|Overall Study|Withdrawal by Subject|3|||
23165587|NCT01277549|64352673|FG000|Overall Study|Protocol Violation|10|||
23165588|NCT01277549|64352674|FG001|Overall Study|Protocol Violation|1|||
23165589|NCT01277549|64352673|FG000|Overall Study|Physician Decision|2|||
23165590|NCT01277549|64352674|FG001|Overall Study|Physician Decision|1|||
23165591|NCT00262873|64352675|FG000|Overall Study|Adverse Event|3|||
23165592|NCT00262873|64352675|FG000|Overall Study|Withdrawal by Subject|5|||
23447285|NCT02915263|65377933|FG001|Overall Study|Covid|2|||
23165593|NCT00772954|64352676|FG000|Overall Study|Adverse Event|0|||
23226132|NCT01387594|64571067|FG001|Overall Study|Lost to Follow-up|1|||
23226133|NCT02142712|64571068|FG000|Overall Study|Lost to Follow-up|1|||
23226134|NCT02142712|64571069|FG001|Overall Study|Lost to Follow-up|1|||
23226135|NCT02142712|64571070|FG002|Overall Study|Lost to Follow-up|1|||
23226136|NCT02142712|64571071|FG003|Overall Study|Lost to Follow-up|0|||
23226137|NCT02853123|64571072|FG000|Treatment Period 1|Adverse Event|0|||
23226138|NCT02853123|64571073|FG001|Treatment Period 1|Adverse Event|3|||
23226139|NCT02853123|64571072|FG000|Washout Period|Worsening of COPD|0|||
23226140|NCT02853123|64571073|FG001|Washout Period|Worsening of COPD|3|||
23226141|NCT02853123|64571072|FG000|Washout Period|Adverse Event|1|||
23226142|NCT02853123|64571073|FG001|Washout Period|Adverse Event|0|||
23226143|NCT01466062|64571078|FG000|Overall Study|Adverse Event|1|||
23226144|NCT01466062|64571078|FG000|Overall Study|Withdrawal by Subject|1|||
23226145|NCT01166386|64571085|FG000|Overall Study|Withdrawal by Subject|3|||
23226146|NCT01166386|64571086|FG001|Overall Study|Withdrawal by Subject|5|||
23226147|NCT00471315|64571087|FG000|Overall Study|Adverse Event|7|||
23226148|NCT00471315|64571087|FG000|Overall Study|Withdrawal by Subject|1|||
23226149|NCT02954952|64571088|FG000|Overall Study|Withdrawal by Subject|1|||
23226150|NCT02954952|64571089|FG001|Overall Study|Withdrawal by Subject|0|||
23226151|NCT02954952|64571090|FG002|Overall Study|Withdrawal by Subject|0|||
23226152|NCT02954952|64571088|FG000|Overall Study|No data collected|0|||
23226153|NCT02954952|64571089|FG001|Overall Study|No data collected|1|||
23226154|NCT02954952|64571090|FG002|Overall Study|No data collected|0|||
23226155|NCT01081951|64571091|FG000|Overall Study|Death|54|||
23226156|NCT01081951|64571092|FG001|Overall Study|Death|47|||
23226157|NCT01081951|64571091|FG000|Overall Study|Withdrawal by Subject|2|||
23226158|NCT01081951|64571092|FG001|Overall Study|Withdrawal by Subject|6|||
23226159|NCT01081951|64571091|FG000|Overall Study|Allocated treatment but did not take it|0|||
23226160|NCT01081951|64571092|FG001|Overall Study|Allocated treatment but did not take it|1|||
23226161|NCT01081951|64571091|FG000|Overall Study|Lost to Follow-up|0|||
23226162|NCT01081951|64571092|FG001|Overall Study|Lost to Follow-up|1|||
23226163|NCT04315298|64571093|FG000|Overall Study|Withdrawal by Subject|0|||
23226164|NCT04315298|64571094|FG001|Overall Study|Withdrawal by Subject|0|||
23226165|NCT04315298|64571095|FG002|Overall Study|Withdrawal by Subject|0|||
23574027|NCT00293462|65831595|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
23574028|NCT00293462|65831593|FG000|Overall Study|Possible Tracheostomy leakage|0|||
23226166|NCT04315298|64571096|FG003|Overall Study|Withdrawal by Subject|2|||
23226167|NCT04315298|64571097|FG004|Overall Study|Withdrawal by Subject|2|||
23226168|NCT04315298|64571098|FG005|Overall Study|Withdrawal by Subject|2|||
23226169|NCT04315298|64571099|FG006|Overall Study|Withdrawal by Subject|0|||
23226170|NCT04315298|64571100|FG007|Overall Study|Withdrawal by Subject|1|||
23226171|NCT04315298|64571101|FG008|Overall Study|Withdrawal by Subject|1|||
23226172|NCT04315298|64571102|FG009|Overall Study|Withdrawal by Subject|1|||
23226173|NCT04315298|64571103|FG010|Overall Study|Withdrawal by Subject|0|||
23226174|NCT04315298|64571104|FG011|Overall Study|Withdrawal by Subject|0|||
23226175|NCT04315298|64571105|FG012|Overall Study|Withdrawal by Subject|0|||
23226176|NCT04315298|64571106|FG013|Overall Study|Withdrawal by Subject|0|||
23226177|NCT04315298|64571107|FG014|Overall Study|Withdrawal by Subject|0|||
23226178|NCT04315298|64571108|FG015|Overall Study|Withdrawal by Subject|0|||
23226179|NCT04315298|64571109|FG016|Overall Study|Withdrawal by Subject|0|||
23226180|NCT04315298|64571110|FG017|Overall Study|Withdrawal by Subject|0|||
23226181|NCT04315298|64571111|FG018|Overall Study|Withdrawal by Subject|0|||
23226182|NCT04315298|64571093|FG000|Overall Study|Physician Decision|0|||
23226183|NCT04315298|64571094|FG001|Overall Study|Physician Decision|0|||
23226184|NCT04315298|64571095|FG002|Overall Study|Physician Decision|0|||
23226185|NCT04315298|64571096|FG003|Overall Study|Physician Decision|0|||
23226186|NCT04315298|64571097|FG004|Overall Study|Physician Decision|1|||
23226187|NCT04315298|64571098|FG005|Overall Study|Physician Decision|0|||
23226188|NCT04315298|64571099|FG006|Overall Study|Physician Decision|0|||
23574029|NCT00293462|65831594|FG001|Overall Study|Possible Tracheostomy leakage|1|||
23574030|NCT00293462|65831595|FG002|Overall Study|Possible Tracheostomy leakage|0|||
23574031|NCT00293462|65831593|FG000|Overall Study|Low radiation dose in oral cavity|0|||
23574032|NCT00293462|65831594|FG001|Overall Study|Low radiation dose in oral cavity|1|||
23226189|NCT04315298|64571100|FG007|Overall Study|Physician Decision|0|||
23574033|NCT00293462|65831595|FG002|Overall Study|Low radiation dose in oral cavity|0|||
23574034|NCT00293462|65831593|FG000|Overall Study|Physician Decision|0|||
23226190|NCT04315298|64571101|FG008|Overall Study|Physician Decision|0|||
23226191|NCT04315298|64571102|FG009|Overall Study|Physician Decision|0|||
23226192|NCT04315298|64571103|FG010|Overall Study|Physician Decision|0|||
23226193|NCT04315298|64571104|FG011|Overall Study|Physician Decision|0|||
23226194|NCT04315298|64571105|FG012|Overall Study|Physician Decision|0|||
23226195|NCT04315298|64571106|FG013|Overall Study|Physician Decision|0|||
23226196|NCT04315298|64571107|FG014|Overall Study|Physician Decision|0|||
23226197|NCT04315298|64571108|FG015|Overall Study|Physician Decision|0|||
23226198|NCT04315298|64571109|FG016|Overall Study|Physician Decision|0|||
23226199|NCT04315298|64571110|FG017|Overall Study|Physician Decision|0|||
23226200|NCT04315298|64571111|FG018|Overall Study|Physician Decision|0|||
23447286|NCT00950846|65377934|FG000|Overall Study|Death|6|||
23226201|NCT04315298|64571093|FG000|Overall Study|Lost to Follow-up|5|||
23226202|NCT04315298|64571094|FG001|Overall Study|Lost to Follow-up|10|||
23226203|NCT04315298|64571095|FG002|Overall Study|Lost to Follow-up|6|||
23447287|NCT00950846|65377934|FG000|Overall Study|Lost to Follow-up|3|||
23574035|NCT00293462|65831594|FG001|Overall Study|Physician Decision|1|||
23574036|NCT00293462|65831595|FG002|Overall Study|Physician Decision|0|||
23574037|NCT00463151|65831603|FG000|Overall Study|Adverse Event|0|||
23574038|NCT00463151|65831604|FG001|Overall Study|Adverse Event|0|||
23574039|NCT00463151|65831605|FG002|Overall Study|Adverse Event|1|||
23574040|NCT00463151|65831606|FG003|Overall Study|Adverse Event|0|||
23574041|NCT00463151|65831603|FG000|Overall Study|Lack of Efficacy|2|||
23574042|NCT00463151|65831604|FG001|Overall Study|Lack of Efficacy|5|||
23574043|NCT00463151|65831605|FG002|Overall Study|Lack of Efficacy|2|||
23574044|NCT00463151|65831606|FG003|Overall Study|Lack of Efficacy|5|||
23574045|NCT00463151|65831603|FG000|Overall Study|Protocol Violation|0|||
23574046|NCT00463151|65831604|FG001|Overall Study|Protocol Violation|0|||
23574047|NCT00463151|65831605|FG002|Overall Study|Protocol Violation|0|||
23574048|NCT00463151|65831606|FG003|Overall Study|Protocol Violation|1|||
23574049|NCT00463151|65831603|FG000|Overall Study|Withdrawal by Subject|0|||
23574050|NCT00463151|65831604|FG001|Overall Study|Withdrawal by Subject|0|||
23574051|NCT00463151|65831605|FG002|Overall Study|Withdrawal by Subject|0|||
23574052|NCT00463151|65831606|FG003|Overall Study|Withdrawal by Subject|1|||
23574053|NCT03095599|65831631|FG000|Overall Study|Withdrawal by Subject|1|||
23574054|NCT03095599|65831632|FG001|Overall Study|Withdrawal by Subject|0|||
23574055|NCT03095599|65831631|FG000|Overall Study|Lost to Follow-up|1|||
23574056|NCT03095599|65831632|FG001|Overall Study|Lost to Follow-up|0|||
23574057|NCT03095599|65831631|FG000|Overall Study|Withdrawal prior to vaccination|1|||
23574058|NCT03095599|65831632|FG001|Overall Study|Withdrawal prior to vaccination|0|||
23574059|NCT01316692|65831633|FG000|Overall Study|Adverse Event|5|||
23574060|NCT01316692|65831633|FG000|Overall Study|Disease Progression|7|||
23574061|NCT01167179|65831637|FG000|Overall Study|disease recurrence|4|||
23574062|NCT01167179|65831638|FG001|Overall Study|disease recurrence|4|||
23574063|NCT01167179|65831637|FG000|Overall Study|Death|4|||
23332251|NCT04630002|64959042|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
23447288|NCT00950846|65377934|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
23226204|NCT04315298|64571096|FG003|Overall Study|Lost to Follow-up|8|||
23226205|NCT04315298|64571097|FG004|Overall Study|Lost to Follow-up|12|||
23574064|NCT01167179|65831638|FG001|Overall Study|Death|10|||
23574065|NCT01167179|65831637|FG000|Overall Study|Withdrawal by Subject|1|||
23574066|NCT01167179|65831638|FG001|Overall Study|Withdrawal by Subject|2|||
23574067|NCT01167179|65831637|FG000|Overall Study|diverse|6|||
23226206|NCT04315298|64571098|FG005|Overall Study|Lost to Follow-up|13|||
23226207|NCT04315298|64571099|FG006|Overall Study|Lost to Follow-up|9|||
23226208|NCT04315298|64571100|FG007|Overall Study|Lost to Follow-up|16|||
23226209|NCT04315298|64571101|FG008|Overall Study|Lost to Follow-up|14|||
23226210|NCT04315298|64571102|FG009|Overall Study|Lost to Follow-up|0|||
23226211|NCT04315298|64571103|FG010|Overall Study|Lost to Follow-up|2|||
23226212|NCT04315298|64571104|FG011|Overall Study|Lost to Follow-up|1|||
23226213|NCT04315298|64571105|FG012|Overall Study|Lost to Follow-up|0|||
23226214|NCT04315298|64571106|FG013|Overall Study|Lost to Follow-up|0|||
23226215|NCT04315298|64571107|FG014|Overall Study|Lost to Follow-up|0|||
23226216|NCT04315298|64571108|FG015|Overall Study|Lost to Follow-up|2|||
23226217|NCT04315298|64571109|FG016|Overall Study|Lost to Follow-up|0|||
23226218|NCT04315298|64571110|FG017|Overall Study|Lost to Follow-up|0|||
23226219|NCT04315298|64571111|FG018|Overall Study|Lost to Follow-up|0|||
23226220|NCT04315298|64571093|FG000|Overall Study|Death|24|||
23226221|NCT04315298|64571094|FG001|Overall Study|Death|60|||
23226222|NCT04315298|64571095|FG002|Overall Study|Death|49|||
23226223|NCT04315298|64571096|FG003|Overall Study|Death|59|||
23226224|NCT04315298|64571097|FG004|Overall Study|Death|70|||
23226225|NCT04315298|64571098|FG005|Overall Study|Death|114|||
23226226|NCT04315298|64571099|FG006|Overall Study|Death|9|||
23226227|NCT04315298|64571100|FG007|Overall Study|Death|12|||
23226228|NCT04315298|64571101|FG008|Overall Study|Death|21|||
23226229|NCT04315298|64571102|FG009|Overall Study|Death|16|||
23226230|NCT04315298|64571103|FG010|Overall Study|Death|40|||
23226231|NCT04315298|64571104|FG011|Overall Study|Death|40|||
23226232|NCT04315298|64571105|FG012|Overall Study|Death|3|||
23226233|NCT04315298|64571106|FG013|Overall Study|Death|4|||
23226234|NCT04315298|64571107|FG014|Overall Study|Death|6|||
23226235|NCT04315298|64571108|FG015|Overall Study|Death|4|||
23226236|NCT04315298|64571109|FG016|Overall Study|Death|3|||
23226237|NCT04315298|64571110|FG017|Overall Study|Death|1|||
23226238|NCT04315298|64571111|FG018|Overall Study|Death|0|||
23226239|NCT00610714|64571112|FG000|Overall Study|Adverse Event|3|||
23226240|NCT00610714|64571113|FG001|Overall Study|Adverse Event|1|||
23226241|NCT00610714|64571112|FG000|Overall Study|Death|12|||
23226242|NCT00610714|64571113|FG001|Overall Study|Death|18|||
23226243|NCT00610714|64571112|FG000|Overall Study|Withdrawal by Subject|9|||
23226244|NCT00610714|64571113|FG001|Overall Study|Withdrawal by Subject|3|||
23226245|NCT00610714|64571112|FG000|Overall Study|Study completion at 120 PFS events|2|||
23226246|NCT00610714|64571113|FG001|Overall Study|Study completion at 120 PFS events|2|||
23226247|NCT01362049|64571114|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
23226248|NCT01362049|64571115|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
23226249|NCT01362049|64571116|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
23447289|NCT00732875|65377935|FG000|Overall Study|Adverse Event|16|||
23574068|NCT01167179|65831638|FG001|Overall Study|diverse|5|||
23574069|NCT00278564|65831639|FG000|Overall Study|Lack of Efficacy|4|||
23574070|NCT00777803|65831642|FG000|Overall Study|Lost to Follow-up|12|||
23574071|NCT00777803|65831643|FG001|Overall Study|Lost to Follow-up|5|||
23574072|NCT00777803|65831642|FG000|Overall Study|Adverse Event|1|||
23574073|NCT00777803|65831643|FG001|Overall Study|Adverse Event|0|||
23574074|NCT00777803|65831642|FG000|Overall Study|Non-compliance|2|||
23574075|NCT00777803|65831643|FG001|Overall Study|Non-compliance|2|||
23574076|NCT00873093|65831644|FG000|Overall Study|Adverse Event|0|||
23574077|NCT00873093|65831645|FG001|Overall Study|Adverse Event|2|||
23574078|NCT00873093|65831646|FG002|Overall Study|Adverse Event|0|||
23574079|NCT00873093|65831647|FG003|Overall Study|Adverse Event|0|||
23574080|NCT00873093|65831648|FG004|Overall Study|Adverse Event|0|||
23574081|NCT00873093|65831644|FG000|Overall Study|Death|0|||
23574082|NCT00873093|65831645|FG001|Overall Study|Death|3|||
23574083|NCT00873093|65831646|FG002|Overall Study|Death|2|||
23574084|NCT00873093|65831647|FG003|Overall Study|Death|0|||
23574085|NCT00873093|65831648|FG004|Overall Study|Death|0|||
23574086|NCT00873093|65831644|FG000|Overall Study|Physician Decision|0|||
23574087|NCT00873093|65831645|FG001|Overall Study|Physician Decision|17|||
23165594|NCT00772954|64352677|FG001|Overall Study|Adverse Event|0|||
23165595|NCT00772954|64352678|FG002|Overall Study|Adverse Event|1|||
23165596|NCT03839459|64352679|FG000|Overall Study|Withdrawal by Subject|2|||
23165597|NCT03839459|64352679|FG000|Overall Study|progression of disease|3|||
23165598|NCT02187471|64352680|FG000|Overall Study|Protocol Violation|4|||
23165599|NCT02187471|64352681|FG001|Overall Study|Protocol Violation|5|||
23165600|NCT02187471|64352682|FG002|Overall Study|Protocol Violation|4|||
23165601|NCT02187471|64352683|FG003|Overall Study|Protocol Violation|4|||
23165602|NCT02187471|64352680|FG000|Overall Study|Missing|0|||
23165603|NCT02187471|64352681|FG001|Overall Study|Missing|0|||
23165604|NCT02187471|64352682|FG002|Overall Study|Missing|0|||
23165605|NCT02187471|64352683|FG003|Overall Study|Missing|1|||
23165606|NCT02187471|64352680|FG000|Overall Study|Lack of Efficacy|18|||
23165607|NCT02187471|64352681|FG001|Overall Study|Lack of Efficacy|9|||
23165608|NCT02187471|64352682|FG002|Overall Study|Lack of Efficacy|13|||
23165609|NCT02187471|64352683|FG003|Overall Study|Lack of Efficacy|11|||
23165610|NCT02187471|64352680|FG000|Overall Study|Adverse Event|24|||
23165611|NCT02187471|64352681|FG001|Overall Study|Adverse Event|34|||
23574088|NCT00873093|65831646|FG002|Overall Study|Physician Decision|10|||
23574089|NCT00873093|65831647|FG003|Overall Study|Physician Decision|10|||
23574090|NCT00873093|65831648|FG004|Overall Study|Physician Decision|2|||
23226250|NCT01362049|64571117|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
23226251|NCT01362049|64571114|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
23226252|NCT01362049|64571115|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
23226253|NCT01362049|64571116|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
23226254|NCT01362049|64571117|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
23226255|NCT01957215|64571121|FG000|Overall Study|Adverse Event|2|||
23226256|NCT01957215|64571122|FG001|Overall Study|Adverse Event|2|||
23226257|NCT01957215|64571121|FG000|Overall Study|Lost to Follow-up|3|||
23226258|NCT01957215|64571122|FG001|Overall Study|Lost to Follow-up|3|||
23226259|NCT01957215|64571121|FG000|Overall Study|Protocol Violation|1|||
23332252|NCT04630002|64959043|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
23447290|NCT00732875|65377935|FG000|Overall Study|Withdrawal by Subject|6|||
23447291|NCT00732875|65377935|FG000|Overall Study|Lack of Efficacy|13|||
23165612|NCT02187471|64352682|FG002|Overall Study|Adverse Event|44|||
23165613|NCT02187471|64352683|FG003|Overall Study|Adverse Event|36|||
23165614|NCT02187471|64352680|FG000|Overall Study|Withdrawal by Subject|23|||
23165615|NCT02187471|64352681|FG001|Overall Study|Withdrawal by Subject|29|||
23165616|NCT02187471|64352682|FG002|Overall Study|Withdrawal by Subject|22|||
23165617|NCT02187471|64352683|FG003|Overall Study|Withdrawal by Subject|24|||
23165618|NCT02187471|64352680|FG000|Overall Study|Other|7|||
23165619|NCT02187471|64352681|FG001|Overall Study|Other|5|||
23165620|NCT02187471|64352682|FG002|Overall Study|Other|3|||
23165621|NCT02187471|64352683|FG003|Overall Study|Other|4|||
23165622|NCT01806779|64352685|FG000|Overall Study|Physician Decision|2|||
23165623|NCT01806779|64352686|FG001|Overall Study|Physician Decision|0|||
23165624|NCT01806779|64352687|FG002|Overall Study|Physician Decision|1|||
23226260|NCT01957215|64571122|FG001|Overall Study|Protocol Violation|2|||
23447292|NCT01632020|65377936|FG000|Overall Study|Withdrawal by Subject|1|||
23447293|NCT01632020|65377937|FG001|Overall Study|Withdrawal by Subject|0|||
23447294|NCT01632020|65377936|FG000|Overall Study|Adverse Event|1|||
23447295|NCT01632020|65377937|FG001|Overall Study|Adverse Event|0|||
23447296|NCT01774799|65377938|FG000|Overall Study|Lost to Follow-up|1|||
23447297|NCT01774799|65377939|FG001|Overall Study|Lost to Follow-up|1|||
23447298|NCT01774799|65377940|FG002|Overall Study|Lost to Follow-up|0|||
23447299|NCT01774799|65377941|FG003|Overall Study|Lost to Follow-up|0|||
23447300|NCT04303559|65377945|FG000|Overall Study|Study closed due to poor enrollment.|1|||
23447301|NCT03384940|65380401|FG000|Overall Study|Progressive disease|36|||
23447302|NCT03384940|65380402|FG001|Overall Study|Progressive disease|11|||
23447303|NCT03384940|65380403|FG002|Overall Study|Progressive disease|13|||
23447304|NCT03384940|65380401|FG000|Overall Study|Clinical progression|4|||
23574091|NCT00873093|65831644|FG000|Overall Study|Withdrawal by Subject|1|||
23574092|NCT00873093|65831645|FG001|Overall Study|Withdrawal by Subject|4|||
23574093|NCT00873093|65831646|FG002|Overall Study|Withdrawal by Subject|4|||
23574094|NCT00873093|65831647|FG003|Overall Study|Withdrawal by Subject|0|||
23574095|NCT00873093|65831648|FG004|Overall Study|Withdrawal by Subject|0|||
23574096|NCT00873093|65831644|FG000|Overall Study|Ineligible|0|||
23574097|NCT00873093|65831645|FG001|Overall Study|Ineligible|1|||
23574098|NCT00873093|65831646|FG002|Overall Study|Ineligible|0|||
23574099|NCT00873093|65831647|FG003|Overall Study|Ineligible|1|||
23574100|NCT00873093|65831648|FG004|Overall Study|Ineligible|0|||
23574101|NCT01083160|65831653|FG000|Overall Study|Adverse Event|1|||
23574102|NCT03398356|65831655|FG000|Before Treatment|Lost to Follow-up|1|||
23574103|NCT03398356|65831656|FG001|Before Treatment|Lost to Follow-up|2|||
23574104|NCT03398356|65831657|FG002|Before Treatment|Lost to Follow-up|0|||
23574105|NCT03398356|65831655|FG000|Before Treatment|drug intolerance|2|||
23574106|NCT03398356|65831656|FG001|Before Treatment|drug intolerance|1|||
23574107|NCT03398356|65831657|FG002|Before Treatment|drug intolerance|0|||
23574108|NCT03398356|65831655|FG000|Before Treatment|Withdrawal by Subject|0|||
23574109|NCT03398356|65831656|FG001|Before Treatment|Withdrawal by Subject|5|||
23574110|NCT03398356|65831657|FG002|Before Treatment|Withdrawal by Subject|0|||
23574111|NCT03398356|65831655|FG000|Before Treatment|Physician Decision|0|||
23574112|NCT03398356|65831656|FG001|Before Treatment|Physician Decision|0|||
23165625|NCT01806779|64352685|FG000|Overall Study|Lack of Efficacy|1|||
23332253|NCT04630002|64959044|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
23574113|NCT03398356|65831657|FG002|Before Treatment|Physician Decision|11|||
23574114|NCT03398356|65831655|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
23574115|NCT03398356|65831656|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
23574116|NCT03398356|65831657|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
23165626|NCT01806779|64352686|FG001|Overall Study|Lack of Efficacy|1|||
23165627|NCT01806779|64352687|FG002|Overall Study|Lack of Efficacy|0|||
23226261|NCT01957215|64571121|FG000|Overall Study|Withdrawal by Subject|7|||
23447305|NCT03384940|65380402|FG001|Overall Study|Clinical progression|0|||
23447306|NCT03384940|65380403|FG002|Overall Study|Clinical progression|3|||
23574117|NCT00305864|65831658|FG000|Overall Study|Ineligible / No protocol treatment|0|||
23226262|NCT01957215|64571122|FG001|Overall Study|Withdrawal by Subject|5|||
23226263|NCT00948194|64571123|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
23226264|NCT00948194|64571124|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
23226265|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
23226266|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
23226267|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
23574118|NCT00305864|65831659|FG001|Overall Study|Ineligible / No protocol treatment|1|||
23574119|NCT00305864|65831660|FG002|Overall Study|Ineligible / No protocol treatment|1|||
23226268|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
23226269|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
23447307|NCT03384940|65380401|FG000|Overall Study|Adverse Event|7|||
23447308|NCT03384940|65380402|FG001|Overall Study|Adverse Event|1|||
23447309|NCT03384940|65380403|FG002|Overall Study|Adverse Event|1|||
23447310|NCT03384940|65380401|FG000|Overall Study|Withdrawal by Subject|3|||
23447311|NCT03384940|65380402|FG001|Overall Study|Withdrawal by Subject|1|||
23447312|NCT03384940|65380403|FG002|Overall Study|Withdrawal by Subject|0|||
23447313|NCT03384940|65380401|FG000|Overall Study|Physician Decision|1|||
23447314|NCT03384940|65380402|FG001|Overall Study|Physician Decision|1|||
23165628|NCT01806779|64352685|FG000|Overall Study|Lost to Follow-up|19|||
23447315|NCT03384940|65380403|FG002|Overall Study|Physician Decision|0|||
23447316|NCT03384940|65380401|FG000|Overall Study|Death|2|||
23447317|NCT03384940|65380402|FG001|Overall Study|Death|1|||
23447318|NCT03384940|65380403|FG002|Overall Study|Death|0|||
23447319|NCT03384940|65380401|FG000|Overall Study|Other|0|||
23447320|NCT03384940|65380402|FG001|Overall Study|Other|0|||
23447321|NCT03384940|65380403|FG002|Overall Study|Other|1|||
23574120|NCT00305864|65831661|FG003|Overall Study|Ineligible / No protocol treatment|13|||
23574121|NCT00422799|65831662|FG000|Overall Study|Withdrawal by Subject|6|||
23574122|NCT00422799|65831662|FG000|Overall Study|Adverse Event|7|||
23574123|NCT02248961|65831663|FG000|Overall Study|Adverse Event|1|||
23574124|NCT02248961|65831664|FG001|Overall Study|Adverse Event|0|||
23574125|NCT02248961|65831663|FG000|Overall Study|Withdrawal by Subject|1|||
23574126|NCT02248961|65831664|FG001|Overall Study|Withdrawal by Subject|2|||
23574127|NCT02248961|65831663|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
23574128|NCT02248961|65831664|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
23574129|NCT02206152|65831667|FG000|Pre-Randomization|Withdrawal by Subject|2|||
23574130|NCT03237013|65831669|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
23574131|NCT03237013|65831670|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
23165629|NCT01806779|64352686|FG001|Overall Study|Lost to Follow-up|20|||
23165630|NCT01806779|64352687|FG002|Overall Study|Lost to Follow-up|0|||
23165631|NCT01806779|64352685|FG000|Overall Study|Withdrawal by Subject|20|||
23165632|NCT01806779|64352686|FG001|Overall Study|Withdrawal by Subject|23|||
23165633|NCT01806779|64352687|FG002|Overall Study|Withdrawal by Subject|22|||
23447322|NCT03010319|65380407|FG000|Overall Study|Adverse Event|15|||
23447323|NCT03010319|65380408|FG001|Overall Study|Adverse Event|9|||
23165634|NCT03178487|64352688|FG000|Period 1|Adverse Event|1|||
23165635|NCT03178487|64352689|FG001|Period 1|Adverse Event|2|||
23165636|NCT03178487|64352688|FG000|Period 1|Withdrawal by Subject|2|||
23165637|NCT03178487|64352689|FG001|Period 1|Withdrawal by Subject|1|||
23447324|NCT03010319|65380407|FG000|Overall Study|Withdrawal by Subject|1|||
23447325|NCT03010319|65380408|FG001|Overall Study|Withdrawal by Subject|6|||
23447326|NCT03010319|65380407|FG000|Overall Study|Physician Decision|2|||
23574132|NCT03237013|65831671|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
23574133|NCT01477749|65831672|FG000|Overall Study|Physician Decision|4|||
23447327|NCT03010319|65380408|FG001|Overall Study|Physician Decision|4|||
23447328|NCT03010319|65380407|FG000|Overall Study|Sponsor requested withdrawal|2|||
23447329|NCT03010319|65380408|FG001|Overall Study|Sponsor requested withdrawal|2|||
23447330|NCT03010319|65380407|FG000|Overall Study|Death|1|||
23447331|NCT03010319|65380408|FG001|Overall Study|Death|0|||
23447332|NCT03010319|65380407|FG000|Overall Study|Lost to Follow-up|0|||
23447333|NCT03010319|65380408|FG001|Overall Study|Lost to Follow-up|1|||
23447334|NCT03010319|65380407|FG000|Overall Study|Other Reason|5|||
23447335|NCT03010319|65380408|FG001|Overall Study|Other Reason|7|||
23447336|NCT03329846|65380411|FG000|Overall Study|Disease progression|4|||
23447337|NCT03329846|65380412|FG001|Overall Study|Disease progression|6|||
23447338|NCT03329846|65380411|FG000|Overall Study|Study drug toxicity|1|||
23447339|NCT03329846|65380412|FG001|Overall Study|Study drug toxicity|0|||
23165638|NCT03178487|64352688|FG000|Period 1|Lost to Follow-up|1|||
23165639|NCT03178487|64352689|FG001|Period 1|Lost to Follow-up|0|||
23165640|NCT03178487|64352688|FG000|Period 1|Other|0|||
23165641|NCT03178487|64352689|FG001|Period 1|Other|1|||
23165642|NCT03178487|64352688|FG000|Period 2|Adverse Event|4|||
23165643|NCT03178487|64352689|FG001|Period 2|Adverse Event|4|||
23165644|NCT03178487|64352688|FG000|Period 2|Withdrawal by Subject|6|||
23165645|NCT03178487|64352689|FG001|Period 2|Withdrawal by Subject|6|||
23165646|NCT03178487|64352688|FG000|Period 2|Lost to Follow-up|2|||
23165647|NCT03178487|64352689|FG001|Period 2|Lost to Follow-up|2|||
23165648|NCT03178487|64352688|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
23165649|NCT03178487|64352689|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
23165650|NCT03178487|64352688|FG000|Period 2|Other|8|||
23165651|NCT03178487|64352689|FG001|Period 2|Other|7|||
23165652|NCT01967537|64352698|FG000|Overall Study|Withdrawal by Subject|52|||
23165653|NCT01967537|64352698|FG000|Overall Study|Refuse treatment|2|||
23165654|NCT01967537|64352698|FG000|Overall Study|Lost to Follow-up|6|||
23165655|NCT00223496|64352699|FG000|Overall Study|screen failure|9|||
23165656|NCT00223496|64352699|FG000|Overall Study|Lost to Follow-up|4|||
23165657|NCT00223496|64352699|FG000|Overall Study|Lack of Efficacy|6|||
23165658|NCT00223496|64352699|FG000|Overall Study|Withdrawal by Subject|1|||
23165659|NCT00223496|64352699|FG000|Overall Study|Physician Decision|2|||
23165660|NCT04288154|64352700|FG000|Overall Study|Withdrawal by Subject|9|||
23165661|NCT04288154|64352701|FG001|Overall Study|Withdrawal by Subject|9|||
23165662|NCT00264238|64352706|FG000|Overall Study|Protocol Violation|1|||
23165663|NCT02370615|64352707|FG000|Overall Study|Adverse Event|1|||
23165664|NCT02370615|64352708|FG001|Overall Study|Adverse Event|0|||
23165665|NCT01318109|64352709|FG000|Overall Study|Adverse Event|0|||
23165666|NCT01318109|64352710|FG001|Overall Study|Adverse Event|2|||
23165667|NCT01318109|64352711|FG002|Overall Study|Adverse Event|0|||
23226270|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
23226271|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
23226272|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
23165668|NCT01318109|64352709|FG000|Overall Study|Withdrawal by Subject|1|||
23226273|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
23332254|NCT04630002|64959042|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
23165669|NCT01318109|64352710|FG001|Overall Study|Withdrawal by Subject|0|||
23165670|NCT01318109|64352711|FG002|Overall Study|Withdrawal by Subject|0|||
23165671|NCT01318109|64352709|FG000|Overall Study|Schedule Conflict|0|||
23165672|NCT01318109|64352710|FG001|Overall Study|Schedule Conflict|1|||
23447340|NCT03329846|65380411|FG000|Overall Study|Participant request to discontinue treatment|0|||
23447341|NCT03329846|65380412|FG001|Overall Study|Participant request to discontinue treatment|1|||
23574134|NCT01628874|65831673|FG000|Overall Study|Physician Decision|1|||
23574135|NCT01628874|65831674|FG001|Overall Study|Physician Decision|1|||
23574136|NCT01628874|65831673|FG000|Overall Study|Age >4 months|4|||
23574137|NCT01628874|65831674|FG001|Overall Study|Age >4 months|2|||
23574138|NCT04496167|65831675|FG000|Overall Study|Adverse Event|6|||
23574139|NCT04496167|65831676|FG001|Overall Study|Adverse Event|2|||
23574140|NCT04496167|65831675|FG000|Overall Study|Withdrawal by Subject|7|||
23574141|NCT04496167|65831676|FG001|Overall Study|Withdrawal by Subject|6|||
23574142|NCT04496167|65831675|FG000|Overall Study|Lost to Follow-up|3|||
23165673|NCT01318109|64352711|FG002|Overall Study|Schedule Conflict|0|||
23165674|NCT03927105|64352712|FG000|Overall Study|Death|1|||
23165675|NCT03927105|64352712|FG000|Overall Study|In observation for potential re-treatment|2|||
23226274|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
23226275|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
23226276|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
23226277|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
23574143|NCT04496167|65831676|FG001|Overall Study|Lost to Follow-up|5|||
23574144|NCT04496167|65831675|FG000|Overall Study|Not Treated|1|||
23574145|NCT04496167|65831676|FG001|Overall Study|Not Treated|2|||
23574146|NCT04496167|65831675|FG000|Overall Study|Other Than Specified|1|||
23574147|NCT04496167|65831676|FG001|Overall Study|Other Than Specified|1|||
23574148|NCT02959138|65831678|FG000|Overall Study|Enrolled but Never Treated|0|||
23574149|NCT02959138|65831679|FG001|Overall Study|Enrolled but Never Treated|1|||
23574150|NCT02959138|65831680|FG002|Overall Study|Enrolled but Never Treated|0|||
23574151|NCT02846558|65831682|FG000|Overall Study|Adverse Event|1|||
23574152|NCT02846558|65831683|FG001|Overall Study|Adverse Event|0|||
23574153|NCT02846558|65831684|FG002|Overall Study|Adverse Event|0|||
23574154|NCT02846558|65831685|FG003|Overall Study|Adverse Event|0|||
23574155|NCT02846558|65831682|FG000|Overall Study|Withdrawal by Subject|5|||
23574156|NCT02846558|65831683|FG001|Overall Study|Withdrawal by Subject|4|||
23574157|NCT02846558|65831684|FG002|Overall Study|Withdrawal by Subject|2|||
23574158|NCT02846558|65831685|FG003|Overall Study|Withdrawal by Subject|2|||
23574159|NCT02846558|65831682|FG000|Overall Study|Lost to Follow-up|2|||
23574160|NCT02846558|65831683|FG001|Overall Study|Lost to Follow-up|0|||
23574161|NCT02846558|65831684|FG002|Overall Study|Lost to Follow-up|0|||
23574162|NCT02846558|65831685|FG003|Overall Study|Lost to Follow-up|0|||
23574163|NCT00647348|65831686|FG000|Overall Study|Lost to Follow-up|3|||
23574164|NCT00647348|65831687|FG001|Overall Study|Lost to Follow-up|6|||
23574165|NCT00627042|65831688|FG000|Overall Study|Withdrawal by Subject|2|||
23574166|NCT02531295|65831690|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
23574167|NCT02531295|65831691|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
23574168|NCT02531295|65831692|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
23165676|NCT03927105|64352712|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
23165677|NCT01081795|64352713|FG000|Overall Study|Adverse Event|18|||
23165678|NCT01081795|64352714|FG001|Overall Study|Adverse Event|23|||
23165679|NCT01081795|64352715|FG002|Overall Study|Adverse Event|6|||
23165680|NCT01081795|64352713|FG000|Overall Study|Lack of Efficacy|7|||
23165681|NCT01081795|64352714|FG001|Overall Study|Lack of Efficacy|5|||
23574169|NCT02531295|65831693|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
23165682|NCT01081795|64352715|FG002|Overall Study|Lack of Efficacy|19|||
23574170|NCT02531295|65831694|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
23574171|NCT02531295|65831695|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
23574172|NCT02397460|65831701|FG000|Treatment Period 2|Adverse Event|0|||
23574173|NCT02397460|65831702|FG001|Treatment Period 2|Adverse Event|0|||
23574174|NCT02397460|65831703|FG002|Treatment Period 2|Adverse Event|0|||
23574175|NCT02397460|65831704|FG003|Treatment Period 2|Adverse Event|0|||
23574176|NCT02397460|65831705|FG004|Treatment Period 2|Adverse Event|0|||
23574177|NCT02397460|65831706|FG005|Treatment Period 2|Adverse Event|0|||
23574178|NCT02397460|65831707|FG006|Treatment Period 2|Adverse Event|0|||
23574179|NCT02397460|65831708|FG007|Treatment Period 2|Adverse Event|1|||
23574180|NCT02397460|65831701|FG000|Treatment Period 4|Adverse Event|0|||
23574181|NCT02397460|65831702|FG001|Treatment Period 4|Adverse Event|1|||
23574182|NCT02397460|65831703|FG002|Treatment Period 4|Adverse Event|0|||
23574183|NCT02397460|65831704|FG003|Treatment Period 4|Adverse Event|0|||
23574184|NCT02397460|65831705|FG004|Treatment Period 4|Adverse Event|0|||
23574185|NCT02397460|65831706|FG005|Treatment Period 4|Adverse Event|0|||
23574186|NCT02397460|65831707|FG006|Treatment Period 4|Adverse Event|0|||
23574187|NCT02397460|65831708|FG007|Treatment Period 4|Adverse Event|0|||
23165683|NCT01081795|64352713|FG000|Overall Study|Subject's schedule|1|||
23165684|NCT01081795|64352714|FG001|Overall Study|Subject's schedule|1|||
23574188|NCT02397460|65831701|FG000|Treatment Period 4|Physician Decision|0|||
23574189|NCT02397460|65831702|FG001|Treatment Period 4|Physician Decision|0|||
23574190|NCT02397460|65831703|FG002|Treatment Period 4|Physician Decision|0|||
23574191|NCT02397460|65831704|FG003|Treatment Period 4|Physician Decision|0|||
23574192|NCT02397460|65831705|FG004|Treatment Period 4|Physician Decision|1|||
23574193|NCT02397460|65831706|FG005|Treatment Period 4|Physician Decision|0|||
23574194|NCT02397460|65831707|FG006|Treatment Period 4|Physician Decision|0|||
23574195|NCT02397460|65831708|FG007|Treatment Period 4|Physician Decision|0|||
23574196|NCT01579578|65831711|FG000|Overall Study|Death|4|||
23574197|NCT01579578|65831712|FG001|Overall Study|Death|1|||
23574198|NCT01579578|65831711|FG000|Overall Study|Lost to Follow-up|1|||
23574199|NCT01579578|65831712|FG001|Overall Study|Lost to Follow-up|1|||
23574200|NCT01579578|65831711|FG000|Overall Study|Withdrawal by Subject|2|||
23574201|NCT01579578|65831712|FG001|Overall Study|Withdrawal by Subject|1|||
23574202|NCT01579578|65831711|FG000|Overall Study|Eligibility criteria|3|||
23574203|NCT01579578|65831712|FG001|Overall Study|Eligibility criteria|9|||
23574204|NCT01579578|65831711|FG000|Overall Study|Ongoing|3|||
23574205|NCT01579578|65831712|FG001|Overall Study|Ongoing|0|||
23574206|NCT00776100|65831713|FG000|Overall Study|Disease Progression|1|||
23574207|NCT00776100|65831714|FG001|Overall Study|Disease Progression|0|||
23574208|NCT01244763|65831715|FG000|Overall Study|Adverse Event|1|||
23332255|NCT04630002|64959043|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
23574209|NCT01244763|65831716|FG001|Overall Study|Adverse Event|0|||
23574210|NCT01244763|65831717|FG002|Overall Study|Adverse Event|0|||
23574211|NCT01244763|65831718|FG003|Overall Study|Adverse Event|0|||
23574212|NCT01244763|65831719|FG004|Overall Study|Adverse Event|0|||
23574213|NCT01244763|65831720|FG005|Overall Study|Adverse Event|1|||
23165685|NCT01081795|64352715|FG002|Overall Study|Subject's schedule|2|||
23165686|NCT01081795|64352713|FG000|Overall Study|Revocation of informed consent|2|||
23165687|NCT01081795|64352714|FG001|Overall Study|Revocation of informed consent|0|||
23165688|NCT01081795|64352715|FG002|Overall Study|Revocation of informed consent|0|||
23165689|NCT01081795|64352713|FG000|Overall Study|Ineligible for participation|1|||
23165690|NCT01081795|64352714|FG001|Overall Study|Ineligible for participation|0|||
23165691|NCT01081795|64352715|FG002|Overall Study|Ineligible for participation|0|||
23165692|NCT01081795|64352713|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
23165693|NCT01081795|64352714|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
23165694|NCT01081795|64352715|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
23165695|NCT01081795|64352713|FG000|Overall Study|Using drug with restricted days of use|2|||
23165696|NCT01081795|64352714|FG001|Overall Study|Using drug with restricted days of use|3|||
23165697|NCT01081795|64352715|FG002|Overall Study|Using drug with restricted days of use|2|||
23165698|NCT01081795|64352713|FG000|Overall Study|Other|1|||
23165699|NCT01081795|64352714|FG001|Overall Study|Other|2|||
23165700|NCT01081795|64352715|FG002|Overall Study|Other|0|||
23165701|NCT04962022|64352721|FG000|Period 1|Withdrawal by Subject|1|||
23165702|NCT04962022|64352722|FG001|Period 1|Withdrawal by Subject|0|||
23165703|NCT04766021|64352723|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
23165704|NCT04766021|64352723|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
23165705|NCT02500121|64352724|FG000|Overall Study|Lost to Follow-up|0|||
23165706|NCT02500121|64352725|FG001|Overall Study|Lost to Follow-up|1|||
23165707|NCT02500121|64352724|FG000|Overall Study|Withdrawal by Subject|1|||
23165708|NCT02500121|64352725|FG001|Overall Study|Withdrawal by Subject|1|||
23165709|NCT02500121|64352724|FG000|Overall Study|Death|26|||
23165710|NCT02500121|64352725|FG001|Overall Study|Death|24|||
23165711|NCT01360554|64352726|FG000|Overall Study|Death|359|||
23165712|NCT01360554|64352727|FG001|Overall Study|Death|371|||
23165713|NCT01360554|64352726|FG000|Overall Study|Lost to Follow-up|4|||
23165714|NCT01360554|64352727|FG001|Overall Study|Lost to Follow-up|4|||
23165715|NCT01360554|64352726|FG000|Overall Study|Withdrawal by Subject|23|||
23165716|NCT01360554|64352727|FG001|Overall Study|Withdrawal by Subject|24|||
23165717|NCT01360554|64352726|FG000|Overall Study|Study terminated by sponsor|49|||
23165718|NCT01360554|64352727|FG001|Overall Study|Study terminated by sponsor|37|||
23165719|NCT01360554|64352726|FG000|Overall Study|Other, not specified|1|||
23165720|NCT01360554|64352727|FG001|Overall Study|Other, not specified|0|||
23165721|NCT01360554|64352726|FG000|Overall Study|Randomized but not treated.|3|||
23165722|NCT01360554|64352727|FG001|Overall Study|Randomized but not treated.|3|||
23165723|NCT03548935|64352728|FG000|Overall Study|Withdrawal by Subject|26|||
23165724|NCT03548935|64352729|FG001|Overall Study|Withdrawal by Subject|17|||
23165725|NCT03548935|64352728|FG000|Overall Study|Lost to Follow-up|39|||
23332256|NCT04630002|64959044|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
23165726|NCT03548935|64352729|FG001|Overall Study|Lost to Follow-up|28|||
23165727|NCT03548935|64352728|FG000|Overall Study|Death|1|||
23165728|NCT03548935|64352729|FG001|Overall Study|Death|1|||
23165729|NCT02228590|64352730|FG000|Overall Study|Withdrawal by Subject|1|||
23332257|NCT03193853|64959046|FG000|Overall Study|Death|6|||
23574214|NCT01244763|65831715|FG000|Overall Study|Death|1|||
23574215|NCT01244763|65831716|FG001|Overall Study|Death|0|||
23574216|NCT01244763|65831717|FG002|Overall Study|Death|1|||
23574217|NCT01244763|65831718|FG003|Overall Study|Death|0|||
23574218|NCT01244763|65831719|FG004|Overall Study|Death|2|||
23574219|NCT01244763|65831720|FG005|Overall Study|Death|0|||
23574220|NCT01244763|65831715|FG000|Overall Study|Physician Decision|0|||
23226278|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
23226279|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
23226280|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
23226281|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
23226282|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
23226283|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
23226284|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
23226285|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
23574221|NCT01244763|65831716|FG001|Overall Study|Physician Decision|0|||
23574222|NCT01244763|65831717|FG002|Overall Study|Physician Decision|1|||
23574223|NCT01244763|65831718|FG003|Overall Study|Physician Decision|0|||
23574224|NCT01244763|65831719|FG004|Overall Study|Physician Decision|0|||
23574225|NCT01244763|65831720|FG005|Overall Study|Physician Decision|0|||
23574226|NCT01244763|65831715|FG000|Overall Study|Withdrawal by Subject|1|||
23574227|NCT01244763|65831716|FG001|Overall Study|Withdrawal by Subject|2|||
23574228|NCT01244763|65831717|FG002|Overall Study|Withdrawal by Subject|0|||
23574229|NCT01244763|65831718|FG003|Overall Study|Withdrawal by Subject|1|||
23574230|NCT01244763|65831719|FG004|Overall Study|Withdrawal by Subject|1|||
23574231|NCT01244763|65831720|FG005|Overall Study|Withdrawal by Subject|2|||
23574232|NCT01244763|65831715|FG000|Overall Study|Lost to Follow-up|0|||
23574233|NCT01244763|65831716|FG001|Overall Study|Lost to Follow-up|1|||
23574234|NCT01244763|65831717|FG002|Overall Study|Lost to Follow-up|0|||
23574235|NCT01244763|65831718|FG003|Overall Study|Lost to Follow-up|0|||
23574236|NCT01244763|65831719|FG004|Overall Study|Lost to Follow-up|0|||
23574237|NCT01244763|65831720|FG005|Overall Study|Lost to Follow-up|0|||
23226286|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
23574238|NCT01244763|65831715|FG000|Overall Study|Enrolled into the Extension Study|0|||
23574239|NCT01244763|65831716|FG001|Overall Study|Enrolled into the Extension Study|0|||
23574240|NCT01244763|65831717|FG002|Overall Study|Enrolled into the Extension Study|0|||
23574241|NCT01244763|65831718|FG003|Overall Study|Enrolled into the Extension Study|0|||
23574242|NCT01244763|65831719|FG004|Overall Study|Enrolled into the Extension Study|0|||
23574243|NCT01244763|65831720|FG005|Overall Study|Enrolled into the Extension Study|1|||
23165730|NCT01391507|64352735|FG000|Overall Study|Death|0|||
23165731|NCT01391507|64352736|FG001|Overall Study|Death|0|||
23165732|NCT01391507|64352737|FG002|Overall Study|Death|0|||
23165733|NCT01391507|64352738|FG003|Overall Study|Death|1|||
23165734|NCT01391507|64352735|FG000|Overall Study|Adverse Event|1|||
23165735|NCT01391507|64352736|FG001|Overall Study|Adverse Event|1|||
23165736|NCT01391507|64352737|FG002|Overall Study|Adverse Event|2|||
23332258|NCT00502242|64959047|FG000|Overall Study|Lack of Efficacy|1|||
23332259|NCT00502242|64959048|FG001|Overall Study|Lack of Efficacy|11|||
23332260|NCT00502242|64959047|FG000|Overall Study|Adverse Event|31|||
23332261|NCT00502242|64959048|FG001|Overall Study|Adverse Event|20|||
23332262|NCT00502242|64959047|FG000|Overall Study|Physician Decision|2|||
23332263|NCT00502242|64959048|FG001|Overall Study|Physician Decision|3|||
23332264|NCT00502242|64959047|FG000|Overall Study|Other - Unspecified|8|||
23332265|NCT00502242|64959048|FG001|Overall Study|Other - Unspecified|14|||
23332266|NCT00502242|64959047|FG000|Overall Study|Protocol Violation|3|||
23332267|NCT00502242|64959048|FG001|Overall Study|Protocol Violation|1|||
23332268|NCT00502242|64959047|FG000|Overall Study|Withdrawal by Subject|6|||
23332269|NCT00502242|64959048|FG001|Overall Study|Withdrawal by Subject|7|||
23332270|NCT01314872|64959049|FG000|Treatment Period 1|Protocol Violation|2|||
23332271|NCT01314872|64959050|FG001|Treatment Period 1|Protocol Violation|1|||
23332272|NCT01314872|64959051|FG002|Treatment Period 1|Protocol Violation|1|||
23332273|NCT01314872|64959052|FG003|Treatment Period 1|Protocol Violation|0|||
23332274|NCT01314872|64959053|FG004|Treatment Period 1|Protocol Violation|1|||
23332275|NCT01314872|64959054|FG005|Treatment Period 1|Protocol Violation|0|||
23332276|NCT01314872|64959055|FG006|Treatment Period 1|Protocol Violation|0|||
23332277|NCT01314872|64959056|FG007|Treatment Period 1|Protocol Violation|0|||
23332278|NCT01314872|64959057|FG008|Treatment Period 1|Protocol Violation|0|||
23332279|NCT01314872|64959058|FG009|Treatment Period 1|Protocol Violation|1|||
23332280|NCT01314872|64959059|FG010|Treatment Period 1|Protocol Violation|1|||
23332281|NCT01314872|64959060|FG011|Treatment Period 1|Protocol Violation|0|||
23332282|NCT01314872|64959061|FG012|Treatment Period 1|Protocol Violation|0|||
23332283|NCT01314872|64959062|FG013|Treatment Period 1|Protocol Violation|0|||
23332284|NCT01314872|64959063|FG014|Treatment Period 1|Protocol Violation|0|||
23332285|NCT01314872|64959049|FG000|Treatment Period 1|Physician Decision|0|||
23332286|NCT01314872|64959050|FG001|Treatment Period 1|Physician Decision|1|||
23332287|NCT01314872|64959051|FG002|Treatment Period 1|Physician Decision|0|||
23332288|NCT01314872|64959052|FG003|Treatment Period 1|Physician Decision|1|||
23332289|NCT01314872|64959053|FG004|Treatment Period 1|Physician Decision|0|||
23332290|NCT01314872|64959054|FG005|Treatment Period 1|Physician Decision|0|||
23332291|NCT01314872|64959055|FG006|Treatment Period 1|Physician Decision|0|||
23332292|NCT01314872|64959056|FG007|Treatment Period 1|Physician Decision|0|||
23332293|NCT01314872|64959057|FG008|Treatment Period 1|Physician Decision|0|||
23332294|NCT01314872|64959058|FG009|Treatment Period 1|Physician Decision|1|||
23332295|NCT01314872|64959059|FG010|Treatment Period 1|Physician Decision|0|||
23332296|NCT01314872|64959060|FG011|Treatment Period 1|Physician Decision|0|||
23332297|NCT01314872|64959061|FG012|Treatment Period 1|Physician Decision|0|||
23332298|NCT01314872|64959062|FG013|Treatment Period 1|Physician Decision|0|||
23332299|NCT01314872|64959063|FG014|Treatment Period 1|Physician Decision|0|||
23574244|NCT00333788|65831721|FG000|Overall Study|Adverse Event|44|||
23574245|NCT00333788|65831721|FG000|Overall Study|Lack of Efficacy|80|||
23574246|NCT00333788|65831721|FG000|Overall Study|Lost to Follow-up|2|||
23574247|NCT00333788|65831721|FG000|Overall Study|Withdrawal by Subject|24|||
23574248|NCT00333788|65831721|FG000|Overall Study|Other: Non-compliance|2|||
23574249|NCT00333788|65831721|FG000|Overall Study|Other: Moved|2|||
23574250|NCT00333788|65831721|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
23574251|NCT00333788|65831721|FG000|Overall Study|Other: Investigator decision|1|||
23574252|NCT00333788|65831721|FG000|Overall Study|Other: Quality of life concern|1|||
23332300|NCT01314872|64959049|FG000|Treatment Period 1|Lack of Efficacy|1|||
23332301|NCT01314872|64959050|FG001|Treatment Period 1|Lack of Efficacy|0|||
23226287|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
23226288|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
23226289|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
23226290|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
23226291|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
23226292|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
23574253|NCT00333788|65831721|FG000|Overall Study|Other: Sponsor decision|1|||
23574254|NCT00333788|65831721|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
23332302|NCT01314872|64959051|FG002|Treatment Period 1|Lack of Efficacy|0|||
23574255|NCT00333788|65831721|FG000|Overall Study|Other: Medical monitor decision|1|||
23574256|NCT00333788|65831721|FG000|Overall Study|Other: Physician decision|1|||
23574257|NCT00333788|65831721|FG000|Overall Study|Other: Signed consent for another study|1|||
23226293|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
23226294|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
23226295|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
23332303|NCT01314872|64959052|FG003|Treatment Period 1|Lack of Efficacy|0|||
23332304|NCT01314872|64959053|FG004|Treatment Period 1|Lack of Efficacy|0|||
23332305|NCT01314872|64959054|FG005|Treatment Period 1|Lack of Efficacy|1|||
23332306|NCT01314872|64959055|FG006|Treatment Period 1|Lack of Efficacy|0|||
23332307|NCT01314872|64959056|FG007|Treatment Period 1|Lack of Efficacy|2|||
23574258|NCT01012973|65831724|FG000|Overall Study|Adverse Event|5|||
23332308|NCT01314872|64959057|FG008|Treatment Period 1|Lack of Efficacy|0|||
23332309|NCT01314872|64959058|FG009|Treatment Period 1|Lack of Efficacy|0|||
23226296|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
23226297|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
23332310|NCT01314872|64959059|FG010|Treatment Period 1|Lack of Efficacy|0|||
23332311|NCT01314872|64959060|FG011|Treatment Period 1|Lack of Efficacy|0|||
23332312|NCT01314872|64959061|FG012|Treatment Period 1|Lack of Efficacy|0|||
23332313|NCT01314872|64959062|FG013|Treatment Period 1|Lack of Efficacy|0|||
23332314|NCT01314872|64959063|FG014|Treatment Period 1|Lack of Efficacy|0|||
23332315|NCT01314872|64959049|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
23332316|NCT01314872|64959050|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
23332317|NCT01314872|64959051|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
23332318|NCT01314872|64959052|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
23332319|NCT01314872|64959053|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
23332320|NCT01314872|64959054|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
23332321|NCT01314872|64959055|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
23332322|NCT01314872|64959056|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
23332323|NCT01314872|64959057|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
23332324|NCT01314872|64959058|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
23332325|NCT01314872|64959059|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
23332326|NCT01314872|64959060|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
23332327|NCT01314872|64959061|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
23332328|NCT01314872|64959062|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
23332329|NCT01314872|64959063|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
23332330|NCT01314872|64959049|FG000|Treatment Period 1|Withdrawal by Subject|3|||
23332331|NCT01314872|64959050|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23332332|NCT01314872|64959051|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23332333|NCT01314872|64959052|FG003|Treatment Period 1|Withdrawal by Subject|2|||
23332334|NCT01314872|64959053|FG004|Treatment Period 1|Withdrawal by Subject|3|||
23332335|NCT01314872|64959054|FG005|Treatment Period 1|Withdrawal by Subject|1|||
23332336|NCT01314872|64959055|FG006|Treatment Period 1|Withdrawal by Subject|3|||
23332337|NCT01314872|64959056|FG007|Treatment Period 1|Withdrawal by Subject|2|||
23332338|NCT01314872|64959057|FG008|Treatment Period 1|Withdrawal by Subject|2|||
23332339|NCT01314872|64959058|FG009|Treatment Period 1|Withdrawal by Subject|2|||
23332340|NCT01314872|64959059|FG010|Treatment Period 1|Withdrawal by Subject|1|||
23332341|NCT01314872|64959060|FG011|Treatment Period 1|Withdrawal by Subject|0|||
23574259|NCT01012973|65831725|FG001|Overall Study|Adverse Event|5|||
23332342|NCT01314872|64959061|FG012|Treatment Period 1|Withdrawal by Subject|0|||
23332343|NCT01314872|64959062|FG013|Treatment Period 1|Withdrawal by Subject|0|||
23332344|NCT01314872|64959063|FG014|Treatment Period 1|Withdrawal by Subject|0|||
23332345|NCT01314872|64959049|FG000|Treatment Period 1|Lost to Follow-up|0|||
23332346|NCT01314872|64959050|FG001|Treatment Period 1|Lost to Follow-up|1|||
23332347|NCT01314872|64959051|FG002|Treatment Period 1|Lost to Follow-up|2|||
23332348|NCT01314872|64959052|FG003|Treatment Period 1|Lost to Follow-up|2|||
23332349|NCT01314872|64959053|FG004|Treatment Period 1|Lost to Follow-up|1|||
23574260|NCT01012973|65831724|FG000|Overall Study|Lack of Efficacy|0|||
23226298|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
23226299|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
23226300|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
23226301|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
23226302|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
23226303|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
23574261|NCT01012973|65831725|FG001|Overall Study|Lack of Efficacy|5|||
23574262|NCT01012973|65831724|FG000|Overall Study|Lost to Follow-up|1|||
23574263|NCT01012973|65831725|FG001|Overall Study|Lost to Follow-up|0|||
23574264|NCT01012973|65831724|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
23574265|NCT01012973|65831725|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
23574266|NCT01012973|65831724|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
23574267|NCT01012973|65831725|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
23574268|NCT01012973|65831724|FG000|Overall Study|Protocol Violation|5|||
23574269|NCT01012973|65831725|FG001|Overall Study|Protocol Violation|2|||
23574270|NCT01012973|65831724|FG000|Overall Study|Withdrawal by Subject|4|||
23226304|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
23226305|NCT03605836|64571125|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
23226306|NCT03605836|64571126|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
23332350|NCT01314872|64959054|FG005|Treatment Period 1|Lost to Follow-up|1|||
23332351|NCT01314872|64959055|FG006|Treatment Period 1|Lost to Follow-up|1|||
23332352|NCT01314872|64959056|FG007|Treatment Period 1|Lost to Follow-up|1|||
23332353|NCT01314872|64959057|FG008|Treatment Period 1|Lost to Follow-up|1|||
23332354|NCT01314872|64959058|FG009|Treatment Period 1|Lost to Follow-up|0|||
23332355|NCT01314872|64959059|FG010|Treatment Period 1|Lost to Follow-up|0|||
23574271|NCT01012973|65831725|FG001|Overall Study|Withdrawal by Subject|6|||
23226307|NCT03605836|64571127|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
23226308|NCT03605836|64571128|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
23226309|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
23226310|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
23226311|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
23226312|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
23226313|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
23226314|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
23226315|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
23226316|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
23226317|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
23226318|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
23226319|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
23226320|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
23226321|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
23226322|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
23226323|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
23226324|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
23226325|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
23226326|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
23226327|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
23226328|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
23226329|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
23226330|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
23226331|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
23226332|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
23226333|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
23226334|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
23226335|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
23226336|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
23226337|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
23226338|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
23226339|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
23226340|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
23226341|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
23226342|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
23226343|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
23226344|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
23226345|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
23574272|NCT02471404|65831732|FG000|Overall Study|Adverse Event|7|||
23574273|NCT02471404|65831733|FG001|Overall Study|Adverse Event|1|||
23574274|NCT02471404|65831734|FG002|Overall Study|Adverse Event|2|||
23574275|NCT02471404|65831732|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
23574276|NCT02471404|65831733|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
23574277|NCT02471404|65831734|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
23574278|NCT02471404|65831732|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
23574279|NCT02471404|65831733|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
23574280|NCT02471404|65831734|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
23574281|NCT02471404|65831732|FG000|Overall Study|Lost to Follow-up|1|||
23574282|NCT02471404|65831733|FG001|Overall Study|Lost to Follow-up|1|||
23574283|NCT02471404|65831734|FG002|Overall Study|Lost to Follow-up|3|||
23574284|NCT02471404|65831732|FG000|Overall Study|Protocol Violation|1|||
23226346|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
23226347|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
23226348|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
23226349|NCT03605836|64571125|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
23226350|NCT03605836|64571126|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
23226351|NCT03605836|64571127|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
23226352|NCT03605836|64571128|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
23574285|NCT02471404|65831733|FG001|Overall Study|Protocol Violation|0|||
23574286|NCT02471404|65831734|FG002|Overall Study|Protocol Violation|0|||
23574287|NCT02471404|65831732|FG000|Overall Study|Withdrawal by Subject|8|||
23574288|NCT02471404|65831733|FG001|Overall Study|Withdrawal by Subject|4|||
23574289|NCT02471404|65831734|FG002|Overall Study|Withdrawal by Subject|5|||
23574290|NCT02471404|65831732|FG000|Overall Study|Other reasons not specified|10|||
23574291|NCT02471404|65831733|FG001|Overall Study|Other reasons not specified|7|||
23574292|NCT02471404|65831734|FG002|Overall Study|Other reasons not specified|12|||
23574293|NCT01190176|65831744|FG000|Overall Study|Withdrawal by Subject|1|||
23574294|NCT01190176|65831744|FG000|Overall Study|Lost to Follow-up|1|||
23574295|NCT02268396|65831746|FG000|Overall Study|Adverse Event|3|||
23574296|NCT02268396|65831746|FG000|Overall Study|Administrative|2|||
23574297|NCT02268396|65831746|FG000|Overall Study|Withdrawal by Subject|1|||
23574298|NCT02268396|65831746|FG000|Overall Study|Lost to Follow-up|2|||
23574299|NCT02268396|65831746|FG000|Overall Study|Protocol-Specified Criteria|2|||
23574300|NCT02268396|65831746|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
23226353|NCT01868594|64571129|FG000|Overall Study|Do not meet inclusion criteria|4|||
23226354|NCT01868594|64571130|FG001|Overall Study|Do not meet inclusion criteria|3|||
23226355|NCT01875874|64571143|FG000|Overall Study|Death|3|||
23226356|NCT02094612|64571147|FG000|Overall Study|Lost to Follow-up|47|||
23226357|NCT02094612|64571148|FG001|Overall Study|Lost to Follow-up|47|||
23226358|NCT02094612|64571147|FG000|Overall Study|Never started ADHD medication|32|||
23226359|NCT02094612|64571148|FG001|Overall Study|Never started ADHD medication|23|||
23226360|NCT02274311|64571152|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
23226361|NCT00364832|64571158|FG000|Core Period|Early Withdrawals|2|||
23226362|NCT00364832|64571159|FG001|Core Period|Early Withdrawals|2|||
23226363|NCT00364832|64571160|FG002|Core Period|Early Withdrawals|1|||
23226364|NCT00364832|64571161|FG003|Core Period|Early Withdrawals|1|||
23226365|NCT00364832|64571162|FG004|Core Period|Early Withdrawals|0|||
23226366|NCT00364832|64571163|FG005|Core Period|Early Withdrawals|0|||
23226367|NCT00364832|64571164|FG006|Core Period|Early Withdrawals|4|||
23226368|NCT00364832|64571165|FG007|Core Period|Early Withdrawals|1|||
23226369|NCT00364832|64571166|FG008|Core Period|Early Withdrawals|0|||
23226370|NCT00364832|64571167|FG009|Core Period|Early Withdrawals|0|||
23226371|NCT00364832|64571168|FG010|Core Period|Early Withdrawals|0|||
23226372|NCT00364832|64571169|FG011|Core Period|Early Withdrawals|0|||
23574301|NCT02733042|65831747|FG000|Overall Study|Adverse Event|1|||
23574302|NCT02733042|65831748|FG001|Overall Study|Adverse Event|0|||
23574303|NCT02733042|65831749|FG002|Overall Study|Adverse Event|1|||
23574304|NCT02733042|65831750|FG003|Overall Study|Adverse Event|1|||
23574305|NCT02733042|65831751|FG004|Overall Study|Adverse Event|0|||
23574306|NCT02733042|65831752|FG005|Overall Study|Adverse Event|0|||
23226373|NCT00364832|64571158|FG000|Extension Year 1|Early Withdrawals|0|||
23226374|NCT00364832|64571159|FG001|Extension Year 1|Early Withdrawals|0|||
23226375|NCT00364832|64571160|FG002|Extension Year 1|Early Withdrawals|0|||
23226376|NCT00364832|64571161|FG003|Extension Year 1|Early Withdrawals|0|||
23226377|NCT00364832|64571162|FG004|Extension Year 1|Early Withdrawals|0|||
23226378|NCT00364832|64571163|FG005|Extension Year 1|Early Withdrawals|0|||
23574307|NCT02733042|65831753|FG006|Overall Study|Adverse Event|0|||
23226379|NCT00364832|64571164|FG006|Extension Year 1|Early Withdrawals|0|||
23226380|NCT00364832|64571165|FG007|Extension Year 1|Early Withdrawals|0|||
23226381|NCT00364832|64571166|FG008|Extension Year 1|Early Withdrawals|0|||
23226382|NCT00364832|64571167|FG009|Extension Year 1|Early Withdrawals|4|||
23226383|NCT00364832|64571168|FG010|Extension Year 1|Early Withdrawals|2|||
23574308|NCT02733042|65831754|FG007|Overall Study|Adverse Event|0|||
23574309|NCT02733042|65831755|FG008|Overall Study|Adverse Event|0|||
23574310|NCT02733042|65831756|FG009|Overall Study|Adverse Event|0|||
23226384|NCT00364832|64571169|FG011|Extension Year 1|Early Withdrawals|10|||
23226385|NCT00364832|64571158|FG000|Extension Year 2|Early Withdrawals|0|||
23226386|NCT00364832|64571159|FG001|Extension Year 2|Early Withdrawals|0|||
23574311|NCT02733042|65831757|FG010|Overall Study|Adverse Event|2|||
23226387|NCT00364832|64571160|FG002|Extension Year 2|Early Withdrawals|0|||
23226388|NCT00364832|64571161|FG003|Extension Year 2|Early Withdrawals|0|||
23226389|NCT00364832|64571162|FG004|Extension Year 2|Early Withdrawals|0|||
23226390|NCT00364832|64571163|FG005|Extension Year 2|Early Withdrawals|0|||
23226391|NCT00364832|64571164|FG006|Extension Year 2|Early Withdrawals|0|||
23574312|NCT02733042|65831758|FG011|Overall Study|Adverse Event|2|||
23574313|NCT02733042|65831759|FG012|Overall Study|Adverse Event|0|||
23574314|NCT02733042|65831760|FG013|Overall Study|Adverse Event|2|||
23574315|NCT02733042|65831761|FG014|Overall Study|Adverse Event|0|||
23574316|NCT02733042|65831762|FG015|Overall Study|Adverse Event|0|||
23226392|NCT00364832|64571165|FG007|Extension Year 2|Early Withdrawals|0|||
23226393|NCT00364832|64571166|FG008|Extension Year 2|Early Withdrawals|0|||
23226394|NCT00364832|64571167|FG009|Extension Year 2|Early Withdrawals|5|||
23226395|NCT00364832|64571168|FG010|Extension Year 2|Early Withdrawals|5|||
23226396|NCT00364832|64571169|FG011|Extension Year 2|Early Withdrawals|3|||
23226397|NCT01308853|64571172|FG000|Overall Study|Adverse Event|1|||
23226398|NCT01308853|64571172|FG000|Overall Study|Lost to Follow-up|2|||
23226399|NCT01308853|64571172|FG000|Overall Study|Insertion of permanent implants|1|||
23226400|NCT01469637|64571174|FG000|First Intervention|Unacceptable behavior|0|||
23226401|NCT01469637|64571175|FG001|First Intervention|Unacceptable behavior|1|||
23226402|NCT01469637|64571174|FG000|Second Intervention|Incarcerated|1|||
23226403|NCT01469637|64571175|FG001|Second Intervention|Incarcerated|0|||
23226404|NCT00374127|64571176|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
23226405|NCT00374127|64571176|FG000|Overall Study|Blood could not be drawn.|2|||
23226406|NCT00374127|64571176|FG000|Overall Study|Protocol Violation|5|||
23226407|NCT00374127|64571176|FG000|Overall Study|Pregnancy|1|||
23226408|NCT02574520|64571180|FG000|Overall Study|Not dosed|2|||
23226409|NCT02574520|64571181|FG001|Overall Study|Not dosed|0|||
23226410|NCT02574520|64571182|FG002|Overall Study|Not dosed|5|||
23226411|NCT02574520|64571183|FG003|Overall Study|Not dosed|4|||
23226412|NCT02574520|64571180|FG000|Overall Study|Adverse Event|0|||
23226413|NCT02574520|64571181|FG001|Overall Study|Adverse Event|0|||
23332356|NCT01314872|64959060|FG011|Treatment Period 1|Lost to Follow-up|0|||
23332357|NCT01314872|64959061|FG012|Treatment Period 1|Lost to Follow-up|0|||
23332358|NCT01314872|64959062|FG013|Treatment Period 1|Lost to Follow-up|0|||
23165737|NCT01391507|64352738|FG003|Overall Study|Adverse Event|2|||
23165738|NCT01391507|64352735|FG000|Overall Study|Withdrawal by Subject|1|||
23165739|NCT01391507|64352736|FG001|Overall Study|Withdrawal by Subject|2|||
23165740|NCT01391507|64352737|FG002|Overall Study|Withdrawal by Subject|1|||
23165741|NCT01391507|64352738|FG003|Overall Study|Withdrawal by Subject|1|||
23165742|NCT01391507|64352735|FG000|Overall Study|Lack of Efficacy|0|||
23165743|NCT01391507|64352736|FG001|Overall Study|Lack of Efficacy|0|||
23165744|NCT01391507|64352737|FG002|Overall Study|Lack of Efficacy|0|||
23165745|NCT01391507|64352738|FG003|Overall Study|Lack of Efficacy|1|||
23165746|NCT01391507|64352735|FG000|Overall Study|Protocol Violation|2|||
23165747|NCT01391507|64352736|FG001|Overall Study|Protocol Violation|1|||
23165748|NCT01391507|64352737|FG002|Overall Study|Protocol Violation|1|||
23165749|NCT01391507|64352738|FG003|Overall Study|Protocol Violation|2|||
23226414|NCT02574520|64571182|FG002|Overall Study|Adverse Event|0|||
23226415|NCT02574520|64571183|FG003|Overall Study|Adverse Event|1|||
23226416|NCT02574520|64571180|FG000|Overall Study|Withdrawal by Subject|0|||
23226417|NCT02574520|64571181|FG001|Overall Study|Withdrawal by Subject|0|||
23226418|NCT02574520|64571182|FG002|Overall Study|Withdrawal by Subject|0|||
23226419|NCT02574520|64571183|FG003|Overall Study|Withdrawal by Subject|1|||
23226420|NCT02574520|64571180|FG000|Overall Study|Other|0|||
23226421|NCT02574520|64571181|FG001|Overall Study|Other|0|||
23226422|NCT02574520|64571182|FG002|Overall Study|Other|0|||
23226423|NCT02574520|64571183|FG003|Overall Study|Other|2|||
23226424|NCT00693420|64571184|FG000|Overall Study|Adverse Event|4|||
23226425|NCT00693420|64571185|FG001|Overall Study|Adverse Event|4|||
23226426|NCT00693420|64571184|FG000|Overall Study|Lost to Follow-up|0|||
23226427|NCT00693420|64571185|FG001|Overall Study|Lost to Follow-up|3|||
23226428|NCT00693420|64571184|FG000|Overall Study|Withdrawal by Subject|1|||
23226429|NCT00693420|64571185|FG001|Overall Study|Withdrawal by Subject|0|||
23226430|NCT00693420|64571184|FG000|Overall Study|Protocol Violation|0|||
23226431|NCT00693420|64571185|FG001|Overall Study|Protocol Violation|2|||
23226432|NCT00693420|64571184|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
23226433|NCT00693420|64571185|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
23226434|NCT00693420|64571184|FG000|Overall Study|Personal Reasons|1|||
23226435|NCT00693420|64571185|FG001|Overall Study|Personal Reasons|4|||
23226436|NCT03898323|64571186|FG000|Overall Study|Physician Decision|1|||
23226437|NCT00981292|64571187|FG000|Day 1|Protocol Violation|1|||
23226438|NCT00981292|64571188|FG001|Day 1|Protocol Violation|0|||
23226439|NCT00981292|64571189|FG002|Day 1|Protocol Violation|0|||
23226440|NCT00981292|64571190|FG003|Day 1|Protocol Violation|0|||
23226441|NCT00981292|64571191|FG004|Day 1|Protocol Violation|0|||
23226442|NCT00981292|64571192|FG005|Day 1|Protocol Violation|2|||
23332359|NCT01314872|64959063|FG014|Treatment Period 1|Lost to Follow-up|0|||
23165750|NCT03311711|64352739|FG000|Overall Study|Death|1|||
23165751|NCT03311711|64352740|FG001|Overall Study|Death|0|||
23165752|NCT03311711|64352741|FG002|Overall Study|Death|0|||
23165753|NCT03311711|64352742|FG003|Overall Study|Death|0|||
23165754|NCT03311711|64352743|FG004|Overall Study|Death|0|||
23165755|NCT03311711|64352744|FG005|Overall Study|Death|0|||
23165756|NCT03311711|64352745|FG006|Overall Study|Death|1|||
23165757|NCT03311711|64352746|FG007|Overall Study|Death|0|||
23165758|NCT03311711|64352747|FG008|Overall Study|Death|1|||
23165759|NCT03311711|64352748|FG009|Overall Study|Death|0|||
23165760|NCT03311711|64352739|FG000|Overall Study|Death of dyad partner|0|||
23165761|NCT03311711|64352740|FG001|Overall Study|Death of dyad partner|1|||
23165762|NCT03311711|64352741|FG002|Overall Study|Death of dyad partner|0|||
23165763|NCT03311711|64352742|FG003|Overall Study|Death of dyad partner|0|||
23165764|NCT03311711|64352743|FG004|Overall Study|Death of dyad partner|0|||
23165765|NCT03311711|64352744|FG005|Overall Study|Death of dyad partner|0|||
23165766|NCT03311711|64352745|FG006|Overall Study|Death of dyad partner|0|||
23165767|NCT03311711|64352746|FG007|Overall Study|Death of dyad partner|1|||
23165768|NCT03311711|64352747|FG008|Overall Study|Death of dyad partner|0|||
23165769|NCT03311711|64352748|FG009|Overall Study|Death of dyad partner|1|||
23574317|NCT02733042|65831763|FG016|Overall Study|Adverse Event|0|||
23165770|NCT03311711|64352739|FG000|Overall Study|Lost to Follow-up|2|||
23165771|NCT03311711|64352740|FG001|Overall Study|Lost to Follow-up|2|||
23226443|NCT00981292|64571187|FG000|Day 2|Protocol Violation|2|||
23226444|NCT00981292|64571188|FG001|Day 2|Protocol Violation|0|||
23226445|NCT00981292|64571189|FG002|Day 2|Protocol Violation|0|||
23226446|NCT00981292|64571190|FG003|Day 2|Protocol Violation|0|||
23226447|NCT00981292|64571191|FG004|Day 2|Protocol Violation|0|||
23226448|NCT00981292|64571192|FG005|Day 2|Protocol Violation|0|||
23226449|NCT00981292|64571187|FG000|Day 3|Protocol Violation|0|||
23165772|NCT03311711|64352741|FG002|Overall Study|Lost to Follow-up|0|||
23165773|NCT03311711|64352742|FG003|Overall Study|Lost to Follow-up|0|||
23165774|NCT03311711|64352743|FG004|Overall Study|Lost to Follow-up|0|||
23165775|NCT03311711|64352744|FG005|Overall Study|Lost to Follow-up|0|||
23165776|NCT03311711|64352745|FG006|Overall Study|Lost to Follow-up|1|||
23165777|NCT03311711|64352746|FG007|Overall Study|Lost to Follow-up|1|||
23165778|NCT03311711|64352747|FG008|Overall Study|Lost to Follow-up|0|||
23165779|NCT03311711|64352748|FG009|Overall Study|Lost to Follow-up|0|||
23165780|NCT03311711|64352739|FG000|Overall Study|Withdrawal by Subject|1|||
23165781|NCT03311711|64352740|FG001|Overall Study|Withdrawal by Subject|1|||
23165782|NCT03311711|64352741|FG002|Overall Study|Withdrawal by Subject|0|||
23165783|NCT03311711|64352742|FG003|Overall Study|Withdrawal by Subject|0|||
23165784|NCT03311711|64352743|FG004|Overall Study|Withdrawal by Subject|0|||
23165785|NCT03311711|64352744|FG005|Overall Study|Withdrawal by Subject|0|||
23165786|NCT03311711|64352745|FG006|Overall Study|Withdrawal by Subject|3|||
23165787|NCT03311711|64352746|FG007|Overall Study|Withdrawal by Subject|3|||
23165788|NCT03311711|64352747|FG008|Overall Study|Withdrawal by Subject|0|||
23165789|NCT03311711|64352748|FG009|Overall Study|Withdrawal by Subject|0|||
23165790|NCT00085735|64352749|FG000|Overall Study|Adverse Event|1|||
23165791|NCT00085735|64352750|FG001|Overall Study|Adverse Event|0|||
23165792|NCT00085735|64352751|FG002|Overall Study|Adverse Event|0|||
23165793|NCT00085735|64352752|FG003|Overall Study|Adverse Event|0|||
23165794|NCT00085735|64352753|FG004|Overall Study|Adverse Event|0|||
23165795|NCT00085735|64352754|FG005|Overall Study|Adverse Event|0|||
23165796|NCT00085735|64352749|FG000|Overall Study|Lack of Efficacy|2|||
23165797|NCT00085735|64352750|FG001|Overall Study|Lack of Efficacy|4|||
23165798|NCT00085735|64352751|FG002|Overall Study|Lack of Efficacy|6|||
23165799|NCT00085735|64352752|FG003|Overall Study|Lack of Efficacy|3|||
23165800|NCT00085735|64352753|FG004|Overall Study|Lack of Efficacy|4|||
23165801|NCT00085735|64352754|FG005|Overall Study|Lack of Efficacy|3|||
23165802|NCT00085735|64352749|FG000|Overall Study|Lost to Follow-up|0|||
23165803|NCT00085735|64352750|FG001|Overall Study|Lost to Follow-up|1|||
23165804|NCT00085735|64352751|FG002|Overall Study|Lost to Follow-up|0|||
23165805|NCT00085735|64352752|FG003|Overall Study|Lost to Follow-up|0|||
23165806|NCT00085735|64352753|FG004|Overall Study|Lost to Follow-up|1|||
23165807|NCT00085735|64352754|FG005|Overall Study|Lost to Follow-up|0|||
23226450|NCT00981292|64571188|FG001|Day 3|Protocol Violation|0|||
23226451|NCT00981292|64571189|FG002|Day 3|Protocol Violation|0|||
23226452|NCT00981292|64571190|FG003|Day 3|Protocol Violation|0|||
23226453|NCT00981292|64571191|FG004|Day 3|Protocol Violation|0|||
23332360|NCT01314872|64959049|FG000|Period 2|Protocol Violation|0|||
23165808|NCT00085735|64352749|FG000|Overall Study|Physician Decision|2|||
23165809|NCT00085735|64352750|FG001|Overall Study|Physician Decision|3|||
23165810|NCT00085735|64352751|FG002|Overall Study|Physician Decision|2|||
23165811|NCT00085735|64352752|FG003|Overall Study|Physician Decision|3|||
23165812|NCT00085735|64352753|FG004|Overall Study|Physician Decision|11|||
23165813|NCT00085735|64352754|FG005|Overall Study|Physician Decision|8|||
23165814|NCT00085735|64352749|FG000|Overall Study|Protocol Violation|1|||
23165815|NCT00085735|64352750|FG001|Overall Study|Protocol Violation|0|||
23165816|NCT00085735|64352751|FG002|Overall Study|Protocol Violation|0|||
23165817|NCT00085735|64352752|FG003|Overall Study|Protocol Violation|0|||
23226454|NCT00981292|64571192|FG005|Day 3|Protocol Violation|1|||
23332361|NCT01314872|64959050|FG001|Period 2|Protocol Violation|0|||
23332362|NCT01314872|64959051|FG002|Period 2|Protocol Violation|0|||
23332363|NCT01314872|64959052|FG003|Period 2|Protocol Violation|0|||
23332364|NCT01314872|64959053|FG004|Period 2|Protocol Violation|0|||
23332365|NCT01314872|64959054|FG005|Period 2|Protocol Violation|0|||
23332366|NCT01314872|64959055|FG006|Period 2|Protocol Violation|0|||
23332367|NCT01314872|64959056|FG007|Period 2|Protocol Violation|0|||
23332368|NCT01314872|64959057|FG008|Period 2|Protocol Violation|0|||
23332369|NCT01314872|64959058|FG009|Period 2|Protocol Violation|0|||
23332370|NCT01314872|64959059|FG010|Period 2|Protocol Violation|0|||
23332371|NCT01314872|64959060|FG011|Period 2|Protocol Violation|3|||
23332372|NCT01314872|64959061|FG012|Period 2|Protocol Violation|3|||
23332373|NCT01314872|64959062|FG013|Period 2|Protocol Violation|2|||
23332374|NCT01314872|64959063|FG014|Period 2|Protocol Violation|0|||
23332375|NCT01314872|64959049|FG000|Period 2|Non-compliance with study drug|0|||
23332376|NCT01314872|64959050|FG001|Period 2|Non-compliance with study drug|0|||
23332377|NCT01314872|64959051|FG002|Period 2|Non-compliance with study drug|0|||
23332378|NCT01314872|64959052|FG003|Period 2|Non-compliance with study drug|0|||
23332379|NCT01314872|64959053|FG004|Period 2|Non-compliance with study drug|0|||
23332380|NCT01314872|64959054|FG005|Period 2|Non-compliance with study drug|0|||
23332381|NCT01314872|64959055|FG006|Period 2|Non-compliance with study drug|0|||
23332382|NCT01314872|64959056|FG007|Period 2|Non-compliance with study drug|0|||
23332383|NCT01314872|64959057|FG008|Period 2|Non-compliance with study drug|0|||
23332384|NCT01314872|64959058|FG009|Period 2|Non-compliance with study drug|0|||
23332385|NCT01314872|64959059|FG010|Period 2|Non-compliance with study drug|0|||
23332386|NCT01314872|64959060|FG011|Period 2|Non-compliance with study drug|3|||
23332387|NCT01314872|64959061|FG012|Period 2|Non-compliance with study drug|3|||
23332388|NCT01314872|64959062|FG013|Period 2|Non-compliance with study drug|1|||
23332389|NCT01314872|64959063|FG014|Period 2|Non-compliance with study drug|2|||
23332390|NCT01314872|64959049|FG000|Period 2|Lack of Efficacy|0|||
23332391|NCT01314872|64959050|FG001|Period 2|Lack of Efficacy|0|||
23165818|NCT00085735|64352753|FG004|Overall Study|Protocol Violation|0|||
23165819|NCT00085735|64352754|FG005|Overall Study|Protocol Violation|0|||
23165820|NCT00085735|64352749|FG000|Overall Study|Withdrawal by Subject|1|||
23165821|NCT00085735|64352750|FG001|Overall Study|Withdrawal by Subject|0|||
23165822|NCT00085735|64352751|FG002|Overall Study|Withdrawal by Subject|4|||
23165823|NCT00085735|64352752|FG003|Overall Study|Withdrawal by Subject|5|||
23165824|NCT00085735|64352753|FG004|Overall Study|Withdrawal by Subject|7|||
23165825|NCT00085735|64352754|FG005|Overall Study|Withdrawal by Subject|8|||
23165826|NCT00085735|64352749|FG000|Overall Study|Patient ineligible|1|||
23165827|NCT00085735|64352750|FG001|Overall Study|Patient ineligible|0|||
23165828|NCT00085735|64352751|FG002|Overall Study|Patient ineligible|3|||
23226455|NCT01708915|64571193|FG000|Overall Study|Adverse Event|1|||
23226456|NCT01708915|64571194|FG001|Overall Study|Adverse Event|0|||
23574318|NCT02733042|65831764|FG017|Overall Study|Adverse Event|1|||
23165829|NCT00085735|64352752|FG003|Overall Study|Patient ineligible|7|||
23226457|NCT01708915|64571195|FG002|Overall Study|Adverse Event|9|||
23226458|NCT01708915|64571196|FG003|Overall Study|Adverse Event|13|||
23226459|NCT01708915|64571193|FG000|Overall Study|Lack of Efficacy|84|||
23226460|NCT01708915|64571194|FG001|Overall Study|Lack of Efficacy|60|||
23226461|NCT01708915|64571195|FG002|Overall Study|Lack of Efficacy|35|||
23226462|NCT01708915|64571196|FG003|Overall Study|Lack of Efficacy|15|||
23226463|NCT01708915|64571193|FG000|Overall Study|Protocol Violation|0|||
23226464|NCT01708915|64571194|FG001|Overall Study|Protocol Violation|0|||
23226465|NCT01708915|64571195|FG002|Overall Study|Protocol Violation|0|||
23226466|NCT01708915|64571196|FG003|Overall Study|Protocol Violation|1|||
23226467|NCT01708915|64571193|FG000|Overall Study|Withdrawal by Subject|0|||
23226468|NCT01708915|64571194|FG001|Overall Study|Withdrawal by Subject|1|||
23226469|NCT01708915|64571195|FG002|Overall Study|Withdrawal by Subject|2|||
23226470|NCT01708915|64571196|FG003|Overall Study|Withdrawal by Subject|2|||
23226471|NCT01708915|64571193|FG000|Overall Study|Other reasons than stated above|1|||
23226472|NCT01708915|64571194|FG001|Overall Study|Other reasons than stated above|1|||
23226473|NCT01708915|64571195|FG002|Overall Study|Other reasons than stated above|0|||
23226474|NCT01708915|64571196|FG003|Overall Study|Other reasons than stated above|2|||
23226475|NCT03733249|64571197|FG000|Overall Study|Death|7|||
23332392|NCT01314872|64959051|FG002|Period 2|Lack of Efficacy|0|||
23332393|NCT01314872|64959052|FG003|Period 2|Lack of Efficacy|0|||
23332394|NCT01314872|64959053|FG004|Period 2|Lack of Efficacy|0|||
23332395|NCT01314872|64959054|FG005|Period 2|Lack of Efficacy|0|||
23165830|NCT00085735|64352753|FG004|Overall Study|Patient ineligible|17|||
23165831|NCT00085735|64352754|FG005|Overall Study|Patient ineligible|8|||
23226476|NCT03733249|64571197|FG000|Overall Study|Disease relapse|16|||
23226477|NCT03733249|64571197|FG000|Overall Study|Lost to Follow-up|4|||
23226478|NCT03733249|64571197|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
23332396|NCT01314872|64959055|FG006|Period 2|Lack of Efficacy|0|||
23332397|NCT01314872|64959056|FG007|Period 2|Lack of Efficacy|0|||
23332398|NCT01314872|64959057|FG008|Period 2|Lack of Efficacy|0|||
23332399|NCT01314872|64959058|FG009|Period 2|Lack of Efficacy|0|||
23332400|NCT01314872|64959059|FG010|Period 2|Lack of Efficacy|0|||
23165832|NCT00085735|64352749|FG000|Overall Study|Excess residual disease|2|||
23165833|NCT00085735|64352750|FG001|Overall Study|Excess residual disease|2|||
23165834|NCT00085735|64352751|FG002|Overall Study|Excess residual disease|1|||
23165835|NCT00085735|64352752|FG003|Overall Study|Excess residual disease|1|||
23165836|NCT00085735|64352753|FG004|Overall Study|Excess residual disease|1|||
23165837|NCT00085735|64352754|FG005|Overall Study|Excess residual disease|4|||
23165838|NCT00085735|64352749|FG000|Overall Study|Reason not documented|1|||
23165839|NCT00085735|64352750|FG001|Overall Study|Reason not documented|0|||
23165840|NCT00085735|64352751|FG002|Overall Study|Reason not documented|1|||
23165841|NCT00085735|64352752|FG003|Overall Study|Reason not documented|0|||
23165842|NCT00085735|64352753|FG004|Overall Study|Reason not documented|1|||
23165843|NCT00085735|64352754|FG005|Overall Study|Reason not documented|0|||
23165844|NCT00085735|64352749|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
23165845|NCT00085735|64352750|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
23165846|NCT00085735|64352751|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
23165847|NCT00085735|64352752|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
23165848|NCT00085735|64352753|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
23165849|NCT00085735|64352754|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
23165850|NCT03113500|64355946|FG000|Overall Study|Withdrawal by Subject|1|||
23165851|NCT00283595|64355947|FG000|Overall Study|Withdrawal by Subject|1|||
23165852|NCT00283595|64355948|FG001|Overall Study|Withdrawal by Subject|2|||
23165853|NCT00414453|64355949|FG000|Overall Study|Abnormal lab work|16|||
23165854|NCT01227044|64355954|FG000|Overall Study|Lost to Follow-up|5|||
23165855|NCT01227044|64355955|FG001|Overall Study|Lost to Follow-up|7|||
23165856|NCT01227044|64355954|FG000|Overall Study|Discontinued Intervention|1|||
23165857|NCT01227044|64355955|FG001|Overall Study|Discontinued Intervention|2|||
23165858|NCT02095535|64355956|FG000|Recruitment|Protocol Violation|2|||
23165859|NCT00253630|64355957|FG000|Overall Study|ineligible|2|||
23165860|NCT02918864|64355958|FG000|Overall Study|Withdrawal by Subject|1|||
23165861|NCT02918864|64355959|FG001|Overall Study|Withdrawal by Subject|1|||
23165862|NCT02918864|64355958|FG000|Overall Study|Lost to Follow-up|3|||
23165863|NCT02918864|64355959|FG001|Overall Study|Lost to Follow-up|2|||
23165864|NCT03809611|64355960|FG000|Overall Study|Withdrawal by Subject|1|||
23165865|NCT03809611|64355961|FG001|Overall Study|Withdrawal by Subject|1|||
23165866|NCT02821715|64355968|FG000|Overall Study|Protocol Violation|1|||
23165867|NCT02821715|64355969|FG001|Overall Study|Protocol Violation|0|||
23165868|NCT02821715|64355970|FG002|Overall Study|Protocol Violation|0|||
23165869|NCT02821715|64355971|FG003|Overall Study|Protocol Violation|0|||
23165870|NCT02821715|64355972|FG004|Overall Study|Protocol Violation|0|||
23574319|NCT02733042|65831765|FG018|Overall Study|Adverse Event|0|||
23574320|NCT02733042|65831747|FG000|Overall Study|Progressive Disease|2|||
23574321|NCT02733042|65831748|FG001|Overall Study|Progressive Disease|1|||
23574322|NCT02733042|65831749|FG002|Overall Study|Progressive Disease|3|||
23574323|NCT02733042|65831750|FG003|Overall Study|Progressive Disease|1|||
23574324|NCT02733042|65831751|FG004|Overall Study|Progressive Disease|2|||
23574325|NCT02733042|65831752|FG005|Overall Study|Progressive Disease|3|||
23574326|NCT02733042|65831753|FG006|Overall Study|Progressive Disease|0|||
23574327|NCT02733042|65831754|FG007|Overall Study|Progressive Disease|3|||
23574328|NCT02733042|65831755|FG008|Overall Study|Progressive Disease|3|||
23574329|NCT02733042|65831756|FG009|Overall Study|Progressive Disease|2|||
23574330|NCT02733042|65831757|FG010|Overall Study|Progressive Disease|2|||
23574331|NCT02733042|65831758|FG011|Overall Study|Progressive Disease|2|||
23574332|NCT02733042|65831759|FG012|Overall Study|Progressive Disease|8|||
23574333|NCT02733042|65831760|FG013|Overall Study|Progressive Disease|1|||
23574334|NCT02733042|65831761|FG014|Overall Study|Progressive Disease|4|||
23574335|NCT02733042|65831762|FG015|Overall Study|Progressive Disease|7|||
23574336|NCT02733042|65831763|FG016|Overall Study|Progressive Disease|2|||
23574337|NCT02733042|65831764|FG017|Overall Study|Progressive Disease|3|||
23574338|NCT02733042|65831765|FG018|Overall Study|Progressive Disease|4|||
23574339|NCT02733042|65831747|FG000|Overall Study|Withdrawal by Subject|0|||
23574340|NCT02733042|65831748|FG001|Overall Study|Withdrawal by Subject|1|||
23574341|NCT02733042|65831749|FG002|Overall Study|Withdrawal by Subject|2|||
23574342|NCT02733042|65831750|FG003|Overall Study|Withdrawal by Subject|1|||
23447342|NCT03329846|65380411|FG000|Overall Study|Participant withdrew consent|1|||
23574343|NCT02733042|65831751|FG004|Overall Study|Withdrawal by Subject|1|||
23574344|NCT02733042|65831752|FG005|Overall Study|Withdrawal by Subject|0|||
23574345|NCT02733042|65831753|FG006|Overall Study|Withdrawal by Subject|0|||
23574346|NCT02733042|65831754|FG007|Overall Study|Withdrawal by Subject|0|||
23447343|NCT03329846|65380412|FG001|Overall Study|Participant withdrew consent|0|||
23447344|NCT03329846|65380411|FG000|Overall Study|Other reasons|2|||
23447345|NCT03329846|65380412|FG001|Overall Study|Other reasons|2|||
23447346|NCT00795704|65380413|FG000|Overall Study|Withdrawal by Subject|3|||
23447347|NCT00795704|65380414|FG001|Overall Study|Withdrawal by Subject|2|||
23447348|NCT00795704|65380413|FG000|Overall Study|Adverse Event|1|||
23447349|NCT00795704|65380414|FG001|Overall Study|Adverse Event|1|||
23447350|NCT02792231|65380415|FG000|Overall Study|Patient/guardian decision|32|||
23574347|NCT02733042|65831755|FG008|Overall Study|Withdrawal by Subject|1|||
23332401|NCT01314872|64959060|FG011|Period 2|Lack of Efficacy|7|||
23332402|NCT01314872|64959061|FG012|Period 2|Lack of Efficacy|12|||
23332403|NCT01314872|64959062|FG013|Period 2|Lack of Efficacy|9|||
23332404|NCT01314872|64959063|FG014|Period 2|Lack of Efficacy|2|||
23332405|NCT01314872|64959049|FG000|Period 2|Pregnancy|0|||
23332406|NCT01314872|64959050|FG001|Period 2|Pregnancy|0|||
23332407|NCT01314872|64959051|FG002|Period 2|Pregnancy|0|||
23332408|NCT01314872|64959052|FG003|Period 2|Pregnancy|0|||
23165871|NCT02821715|64355973|FG005|Overall Study|Protocol Violation|0|||
23165872|NCT00980200|64355975|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
23165873|NCT00980200|64355976|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
23165874|NCT00980200|64355977|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
23165875|NCT00980200|64355978|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
23165876|NCT00980200|64355979|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
23165877|NCT00980200|64355975|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
23165878|NCT00980200|64355976|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
23165879|NCT00980200|64355977|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
23165880|NCT00980200|64355978|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
23165881|NCT00980200|64355979|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
23165882|NCT00584194|64355980|FG000|Overall Study|Other|135|||
23165883|NCT03286842|64355981|FG000|Overall Study|Patients rolled over to another study|80|||
23165884|NCT04042103|64355986|FG000|Overall Study|Lost to Follow-up|1|||
23165885|NCT04042103|64355986|FG000|Overall Study|Withdrawal by Subject|1|||
23165886|NCT03021642|64355987|FG000|Washout Period (21 Days)|Adverse Event|1|||
23165887|NCT03021642|64355988|FG001|Washout Period (21 Days)|Adverse Event|1|||
23165888|NCT00960661|64355989|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
23165889|NCT00960661|64355990|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
23165890|NCT00960661|64355991|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
23165891|NCT00960661|64355989|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
23165892|NCT00960661|64355990|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
23165893|NCT00960661|64355991|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
23165894|NCT00960661|64355989|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
23165895|NCT00960661|64355990|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
23165896|NCT00960661|64355991|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
23165897|NCT00960661|64355989|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
23165898|NCT00960661|64355990|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
23165899|NCT00960661|64355991|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
23165900|NCT00960661|64355989|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
23165901|NCT00960661|64355990|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
23165902|NCT00960661|64355991|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
23165903|NCT00960661|64355989|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
23165904|NCT00960661|64355990|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
23165905|NCT00960661|64355991|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
23165906|NCT00960661|64355989|FG000|Interventional Phase|Adverse Event|0|||
23165907|NCT00960661|64355990|FG001|Interventional Phase|Adverse Event|17|||
23165908|NCT00960661|64355991|FG002|Interventional Phase|Adverse Event|8|||
23165909|NCT00960661|64355989|FG000|Interventional Phase|Death|0|||
23165910|NCT00960661|64355990|FG001|Interventional Phase|Death|1|||
23165911|NCT00960661|64355991|FG002|Interventional Phase|Death|0|||
23165912|NCT00960661|64355989|FG000|Interventional Phase|Lost to Follow-up|0|||
23165913|NCT00960661|64355990|FG001|Interventional Phase|Lost to Follow-up|0|||
23165914|NCT00960661|64355991|FG002|Interventional Phase|Lost to Follow-up|2|||
23165915|NCT00960661|64355989|FG000|Interventional Phase|entry criteria not met|0|||
23165916|NCT00960661|64355990|FG001|Interventional Phase|entry criteria not met|3|||
23165917|NCT00960661|64355991|FG002|Interventional Phase|entry criteria not met|0|||
23165918|NCT00960661|64355989|FG000|Interventional Phase|Protocol Violation|0|||
23165919|NCT00960661|64355990|FG001|Interventional Phase|Protocol Violation|7|||
23332409|NCT01314872|64959053|FG004|Period 2|Pregnancy|0|||
23165920|NCT00960661|64355991|FG002|Interventional Phase|Protocol Violation|2|||
23165921|NCT00960661|64355989|FG000|Interventional Phase|Withdrawal by Subject|0|||
23165922|NCT00960661|64355990|FG001|Interventional Phase|Withdrawal by Subject|18|||
23165923|NCT00960661|64355991|FG002|Interventional Phase|Withdrawal by Subject|29|||
23165924|NCT00960661|64355989|FG000|Interventional Phase|Physician Decision|0|||
23165925|NCT00960661|64355990|FG001|Interventional Phase|Physician Decision|3|||
23165926|NCT00960661|64355991|FG002|Interventional Phase|Physician Decision|5|||
23165927|NCT00960661|64355989|FG000|Interventional Phase|sponsor decision|0|||
23165928|NCT00960661|64355990|FG001|Interventional Phase|sponsor decision|1|||
23226479|NCT03733249|64571197|FG000|Overall Study|Withdrawal by Subject|1|||
23226480|NCT00957034|64571198|FG000|Overall Study|Adverse Event|0|||
23332410|NCT01314872|64959054|FG005|Period 2|Pregnancy|0|||
23332411|NCT01314872|64959055|FG006|Period 2|Pregnancy|0|||
23332412|NCT01314872|64959056|FG007|Period 2|Pregnancy|0|||
23332413|NCT01314872|64959057|FG008|Period 2|Pregnancy|0|||
23332414|NCT01314872|64959058|FG009|Period 2|Pregnancy|0|||
23165929|NCT00960661|64355991|FG002|Interventional Phase|sponsor decision|0|||
23165930|NCT00960661|64355989|FG000|Interventional Phase|Lack of Efficacy|0|||
23165931|NCT00960661|64355990|FG001|Interventional Phase|Lack of Efficacy|2|||
23165932|NCT00960661|64355991|FG002|Interventional Phase|Lack of Efficacy|0|||
23165933|NCT03723707|64355992|FG000|Overall Study|Death|32|||
23165934|NCT03723707|64355993|FG001|Overall Study|Death|32|||
23165935|NCT03723707|64355992|FG000|Overall Study|Admitted to long term care|12|||
23165936|NCT03723707|64355993|FG001|Overall Study|Admitted to long term care|12|||
23165937|NCT03723707|64355992|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
23165938|NCT03723707|64355993|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
23165939|NCT03723707|64355992|FG000|Overall Study|Lost to Follow-up|40|||
23165940|NCT03723707|64355993|FG001|Overall Study|Lost to Follow-up|22|||
23165941|NCT03723707|64355992|FG000|Overall Study|Discontinued after study closure|24|||
23574348|NCT02733042|65831756|FG009|Overall Study|Withdrawal by Subject|1|||
23574349|NCT02733042|65831757|FG010|Overall Study|Withdrawal by Subject|0|||
23574350|NCT02733042|65831758|FG011|Overall Study|Withdrawal by Subject|2|||
23574351|NCT02733042|65831759|FG012|Overall Study|Withdrawal by Subject|1|||
23574352|NCT02733042|65831760|FG013|Overall Study|Withdrawal by Subject|1|||
23574353|NCT02733042|65831761|FG014|Overall Study|Withdrawal by Subject|0|||
23574354|NCT02733042|65831762|FG015|Overall Study|Withdrawal by Subject|0|||
23574355|NCT02733042|65831763|FG016|Overall Study|Withdrawal by Subject|0|||
23574356|NCT02733042|65831764|FG017|Overall Study|Withdrawal by Subject|0|||
23574357|NCT02733042|65831765|FG018|Overall Study|Withdrawal by Subject|0|||
23574358|NCT02733042|65831747|FG000|Overall Study|Other Reasons|0|||
23574359|NCT02733042|65831748|FG001|Overall Study|Other Reasons|0|||
23574360|NCT02733042|65831749|FG002|Overall Study|Other Reasons|1|||
23574361|NCT02733042|65831750|FG003|Overall Study|Other Reasons|0|||
23574362|NCT02733042|65831751|FG004|Overall Study|Other Reasons|0|||
23574363|NCT02733042|65831752|FG005|Overall Study|Other Reasons|0|||
23574364|NCT02733042|65831753|FG006|Overall Study|Other Reasons|0|||
23574365|NCT02733042|65831754|FG007|Overall Study|Other Reasons|0|||
23574366|NCT02733042|65831755|FG008|Overall Study|Other Reasons|0|||
23574367|NCT02733042|65831756|FG009|Overall Study|Other Reasons|1|||
23574368|NCT02733042|65831757|FG010|Overall Study|Other Reasons|1|||
23574369|NCT02733042|65831758|FG011|Overall Study|Other Reasons|0|||
23574370|NCT02733042|65831759|FG012|Overall Study|Other Reasons|0|||
23574371|NCT02733042|65831760|FG013|Overall Study|Other Reasons|0|||
23574372|NCT02733042|65831761|FG014|Overall Study|Other Reasons|0|||
23574373|NCT02733042|65831762|FG015|Overall Study|Other Reasons|1|||
23574374|NCT02733042|65831763|FG016|Overall Study|Other Reasons|0|||
23574375|NCT02733042|65831764|FG017|Overall Study|Other Reasons|1|||
23574376|NCT02733042|65831765|FG018|Overall Study|Other Reasons|0|||
23574377|NCT02733042|65831747|FG000|Overall Study|Death|0|||
23165942|NCT03723707|64355993|FG001|Overall Study|Discontinued after study closure|12|||
23165943|NCT01576549|64355995|FG000|Overall Study|Sponsor Decision|2|||
23165944|NCT00088374|64355996|FG000|Overall Study|patient did not receive any 17AAG|1|||
23165945|NCT00088374|64355996|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
23165946|NCT03033875|64355997|FG000|Overall Study|Withdrawal by Subject|5|||
23165947|NCT03033875|64355998|FG001|Overall Study|Withdrawal by Subject|9|||
23165948|NCT03033875|64355999|FG002|Overall Study|Withdrawal by Subject|4|||
23165949|NCT03033875|64355997|FG000|Overall Study|Other|14|||
23165950|NCT03033875|64355998|FG001|Overall Study|Other|15|||
23165951|NCT03033875|64355999|FG002|Overall Study|Other|8|||
23165952|NCT00640328|64356000|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23165953|NCT00640328|64356001|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
23165954|NCT00640328|64356002|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23165955|NCT00640328|64356003|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23165956|NCT00640328|64356004|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23165957|NCT00640328|64356005|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
23165958|NCT00640328|64356000|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23165959|NCT00640328|64356001|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23165960|NCT00640328|64356002|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23165961|NCT00640328|64356003|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23165962|NCT00640328|64356004|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
23574378|NCT02733042|65831748|FG001|Overall Study|Death|0|||
23574379|NCT02733042|65831749|FG002|Overall Study|Death|0|||
23574380|NCT02733042|65831750|FG003|Overall Study|Death|0|||
23165963|NCT00640328|64356005|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
23165964|NCT00640328|64356000|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23574381|NCT02733042|65831751|FG004|Overall Study|Death|0|||
23574382|NCT02733042|65831752|FG005|Overall Study|Death|0|||
23165965|NCT00640328|64356001|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23165966|NCT00640328|64356002|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
23574383|NCT02733042|65831753|FG006|Overall Study|Death|1|||
23574384|NCT02733042|65831754|FG007|Overall Study|Death|0|||
23574385|NCT02733042|65831755|FG008|Overall Study|Death|1|||
23574386|NCT02733042|65831756|FG009|Overall Study|Death|0|||
23574387|NCT02733042|65831757|FG010|Overall Study|Death|1|||
23574388|NCT02733042|65831758|FG011|Overall Study|Death|0|||
23574389|NCT02733042|65831759|FG012|Overall Study|Death|0|||
23574390|NCT02733042|65831760|FG013|Overall Study|Death|0|||
23574391|NCT02733042|65831761|FG014|Overall Study|Death|1|||
23574392|NCT02733042|65831762|FG015|Overall Study|Death|2|||
23574393|NCT02733042|65831763|FG016|Overall Study|Death|0|||
23574394|NCT02733042|65831764|FG017|Overall Study|Death|0|||
23574395|NCT02733042|65831765|FG018|Overall Study|Death|0|||
23574396|NCT04640571|65831766|FG000|Overall Study|Withdrawal by Subject|0|||
23574397|NCT04640571|65831767|FG001|Overall Study|Withdrawal by Subject|0|||
23574398|NCT04640571|65831768|FG002|Overall Study|Withdrawal by Subject|0|||
23574399|NCT04640571|65831769|FG003|Overall Study|Withdrawal by Subject|0|||
23574400|NCT04640571|65831770|FG004|Overall Study|Withdrawal by Subject|0|||
23574401|NCT04640571|65831771|FG005|Overall Study|Withdrawal by Subject|2|||
23574402|NCT00003509|65831774|FG000|Overall Study|Not evaluable|5|||
23574403|NCT01040780|65831776|FG000|Overall Study|Protocol Violation|1|||
23574404|NCT01040780|65831777|FG001|Overall Study|Protocol Violation|3|||
23332415|NCT01314872|64959059|FG010|Period 2|Pregnancy|0|||
23574405|NCT00312858|65831778|FG000|Overall Study|Adverse Event|0|||
23574406|NCT00312858|65831779|FG001|Overall Study|Adverse Event|1|||
23574407|NCT00312858|65831778|FG000|Overall Study|Lost to Follow-up|25|||
23574408|NCT00312858|65831779|FG001|Overall Study|Lost to Follow-up|42|||
23574409|NCT00312858|65831778|FG000|Overall Study|Protocol Violation|3|||
23574410|NCT00312858|65831779|FG001|Overall Study|Protocol Violation|8|||
23574411|NCT00312858|65831778|FG000|Overall Study|Withdraw by Participant|20|||
23574412|NCT00312858|65831779|FG001|Overall Study|Withdraw by Participant|20|||
23574413|NCT00312858|65831778|FG000|Overall Study|Participant Moved|11|||
23574414|NCT00312858|65831779|FG001|Overall Study|Participant Moved|10|||
23574415|NCT00312858|65831778|FG000|Overall Study|Other|9|||
23574416|NCT00312858|65831779|FG001|Overall Study|Other|12|||
23574417|NCT00180713|65831780|FG000|Overall Study|Withdrawal by Subject|2|||
23574418|NCT00180713|65831781|FG001|Overall Study|Withdrawal by Subject|0|||
23165967|NCT00640328|64356003|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23165968|NCT00640328|64356004|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23165969|NCT00640328|64356005|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
23165970|NCT00640328|64356000|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
23165971|NCT00640328|64356001|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
23165972|NCT00640328|64356002|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
23165973|NCT00640328|64356003|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
23165974|NCT00640328|64356004|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
23165975|NCT00640328|64356005|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
23165976|NCT03657043|64356008|FG000|Overall Study|Withdrawal by Subject|1|||
23165977|NCT03657043|64356009|FG001|Overall Study|Withdrawal by Subject|1|||
23165978|NCT03657043|64356010|FG002|Overall Study|Withdrawal by Subject|0|||
23165979|NCT03657043|64356011|FG003|Overall Study|Withdrawal by Subject|0|||
23165980|NCT03657043|64356012|FG004|Overall Study|Withdrawal by Subject|4|||
23165981|NCT03657043|64356008|FG000|Overall Study|Study closure by Sponsor|0|||
23165982|NCT03657043|64356009|FG001|Overall Study|Study closure by Sponsor|2|||
23165983|NCT03657043|64356010|FG002|Overall Study|Study closure by Sponsor|0|||
23165984|NCT03657043|64356011|FG003|Overall Study|Study closure by Sponsor|0|||
23165985|NCT03657043|64356012|FG004|Overall Study|Study closure by Sponsor|17|||
23165986|NCT03657043|64356008|FG000|Overall Study|Lost to Follow-up|0|||
23165987|NCT03657043|64356009|FG001|Overall Study|Lost to Follow-up|0|||
23165988|NCT03657043|64356010|FG002|Overall Study|Lost to Follow-up|0|||
23165989|NCT03657043|64356011|FG003|Overall Study|Lost to Follow-up|0|||
23165990|NCT03657043|64356012|FG004|Overall Study|Lost to Follow-up|4|||
23165991|NCT03657043|64356008|FG000|Overall Study|Death|6|||
23165992|NCT03657043|64356009|FG001|Overall Study|Death|5|||
23165993|NCT03657043|64356010|FG002|Overall Study|Death|0|||
23165994|NCT03657043|64356011|FG003|Overall Study|Death|0|||
23165995|NCT03657043|64356012|FG004|Overall Study|Death|53|||
23574419|NCT00180713|65831780|FG000|Overall Study|Adverse Event|3|||
23165996|NCT03657043|64356008|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
23165997|NCT03657043|64356009|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
23165998|NCT03657043|64356010|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
23165999|NCT03657043|64356011|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
23166000|NCT03657043|64356012|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
23166001|NCT03657043|64356008|FG000|Overall Study|Adverse Event|0|||
23574420|NCT00180713|65831781|FG001|Overall Study|Adverse Event|3|||
23574421|NCT02838628|65831788|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
23332416|NCT01314872|64959060|FG011|Period 2|Pregnancy|0|||
23574422|NCT02838628|65831789|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
23574423|NCT02838628|65831788|FG000|Recurrence Follow-up Period|Adverse Event|1|||
23574424|NCT02838628|65831789|FG001|Recurrence Follow-up Period|Adverse Event|0|||
23574425|NCT02838628|65831788|FG000|Recurrence Follow-up Period|Non-compliance|0|||
23574426|NCT02838628|65831789|FG001|Recurrence Follow-up Period|Non-compliance|1|||
23574427|NCT02838628|65831788|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
23574428|NCT02838628|65831789|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
23574429|NCT02838628|65831788|FG000|Recurrence Follow-up Period|Other un-specified|1|||
23574430|NCT02838628|65831789|FG001|Recurrence Follow-up Period|Other un-specified|1|||
23574431|NCT03405662|65831790|FG000|Overall Study|COVID-19 restriction|1|||
23574432|NCT03405662|65831791|FG001|Overall Study|COVID-19 restriction|0|||
23574433|NCT03405662|65831790|FG000|Overall Study|unblinding|0|||
23574434|NCT03405662|65831791|FG001|Overall Study|unblinding|1|||
23574435|NCT03405662|65831790|FG000|Overall Study|placement in memory care facility|0|||
23574436|NCT03405662|65831791|FG001|Overall Study|placement in memory care facility|2|||
23574437|NCT01007552|65831793|FG000|Overall Study|Withdrawal by Subject|1|||
23574438|NCT01066156|65835303|FG000|Overall Study|ineligible|2|||
23574439|NCT01066156|65835303|FG000|Overall Study|Lost to Follow-up|7|||
23574440|NCT01066156|65835303|FG000|Overall Study|Withdrawal by Subject|1|||
23574441|NCT03100838|65835308|FG000|Overall Study|Adverse Event|1|||
23574442|NCT03100838|65835309|FG001|Overall Study|Adverse Event|0|||
23574443|NCT03100838|65835310|FG002|Overall Study|Adverse Event|0|||
23574444|NCT03100838|65835311|FG003|Overall Study|Adverse Event|0|||
23574445|NCT03100838|65835308|FG000|Overall Study|Physician Decision|1|||
23574446|NCT03100838|65835309|FG001|Overall Study|Physician Decision|1|||
23574447|NCT03100838|65835310|FG002|Overall Study|Physician Decision|1|||
23574448|NCT03100838|65835311|FG003|Overall Study|Physician Decision|1|||
23574449|NCT03100838|65835308|FG000|Overall Study|Pregnancy|0|||
23574450|NCT03100838|65835309|FG001|Overall Study|Pregnancy|1|||
23574451|NCT03100838|65835310|FG002|Overall Study|Pregnancy|0|||
23574452|NCT03100838|65835311|FG003|Overall Study|Pregnancy|0|||
23574453|NCT03100838|65835308|FG000|Overall Study|Lost to Follow-up|0|||
23574454|NCT03100838|65835309|FG001|Overall Study|Lost to Follow-up|0|||
23574455|NCT03100838|65835310|FG002|Overall Study|Lost to Follow-up|1|||
23574456|NCT03100838|65835311|FG003|Overall Study|Lost to Follow-up|0|||
23574457|NCT01458275|65835312|FG000|Overall Study|Adverse Event|3|||
23574458|NCT01458275|65835313|FG001|Overall Study|Adverse Event|4|||
23574459|NCT01458275|65835314|FG002|Overall Study|Adverse Event|1|||
23574460|NCT01458275|65835312|FG000|Overall Study|Lost to Follow-up|3|||
23574461|NCT01458275|65835313|FG001|Overall Study|Lost to Follow-up|2|||
23574462|NCT01458275|65835314|FG002|Overall Study|Lost to Follow-up|5|||
23574463|NCT01458275|65835312|FG000|Overall Study|Protocol Violation|5|||
23574464|NCT01458275|65835313|FG001|Overall Study|Protocol Violation|5|||
23574465|NCT01458275|65835314|FG002|Overall Study|Protocol Violation|2|||
23574466|NCT01458275|65835312|FG000|Overall Study|Withdrawal by Subject|3|||
23574467|NCT01458275|65835313|FG001|Overall Study|Withdrawal by Subject|2|||
23574468|NCT01458275|65835314|FG002|Overall Study|Withdrawal by Subject|1|||
23332417|NCT01314872|64959061|FG012|Period 2|Pregnancy|0|||
23332418|NCT01314872|64959062|FG013|Period 2|Pregnancy|0|||
23574469|NCT01544491|65835315|FG000|Overall Study|Withdrawal by Subject|3|||
23574470|NCT01544491|65835316|FG001|Overall Study|Withdrawal by Subject|2|||
23166002|NCT03657043|64356009|FG001|Overall Study|Adverse Event|0|||
23166003|NCT03657043|64356010|FG002|Overall Study|Adverse Event|0|||
23166004|NCT03657043|64356011|FG003|Overall Study|Adverse Event|0|||
23166005|NCT03657043|64356012|FG004|Overall Study|Adverse Event|2|||
23166006|NCT03657043|64356008|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
23166007|NCT03657043|64356009|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
23166008|NCT03657043|64356010|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
23166009|NCT03657043|64356011|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
23166010|NCT03657043|64356012|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
23166011|NCT03657043|64356008|FG000|Overall Study|Withdrawal - declined follow-up|0|||
23166012|NCT03657043|64356009|FG001|Overall Study|Withdrawal - declined follow-up|0|||
23166013|NCT03657043|64356010|FG002|Overall Study|Withdrawal - declined follow-up|0|||
23166014|NCT03657043|64356011|FG003|Overall Study|Withdrawal - declined follow-up|0|||
23574471|NCT01544491|65835315|FG000|Overall Study|Lost to Follow-up|0|||
23574472|NCT01544491|65835316|FG001|Overall Study|Lost to Follow-up|1|||
23166015|NCT03657043|64356012|FG004|Overall Study|Withdrawal - declined follow-up|1|||
23166016|NCT03709654|64356013|FG000|Overall Study|Lost to Follow-up|1|||
23226481|NCT00957034|64571199|FG001|Overall Study|Adverse Event|1|||
23574473|NCT01544491|65835315|FG000|Overall Study|administrative problems|2|||
23574474|NCT01544491|65835316|FG001|Overall Study|administrative problems|0|||
23574475|NCT01106976|65835317|FG000|Overall Study|Lost to Follow-up|8|||
23574476|NCT00146640|65835318|FG000|Overall Study|Adverse Event|12|||
23574477|NCT00146640|65835319|FG001|Overall Study|Adverse Event|10|||
23574478|NCT00146640|65835318|FG000|Overall Study|Medical Reasons|3|||
23574479|NCT00146640|65835319|FG001|Overall Study|Medical Reasons|0|||
23166017|NCT03709654|64356014|FG001|Overall Study|Lost to Follow-up|1|||
23332419|NCT01314872|64959063|FG014|Period 2|Pregnancy|1|||
23332420|NCT01314872|64959049|FG000|Period 2|Study terminated by Sponsor|0|||
23574480|NCT00146640|65835318|FG000|Overall Study|Non-Medical Reasons|8|||
23574481|NCT00146640|65835319|FG001|Overall Study|Non-Medical Reasons|4|||
23332421|NCT01314872|64959050|FG001|Period 2|Study terminated by Sponsor|0|||
23332422|NCT01314872|64959051|FG002|Period 2|Study terminated by Sponsor|0|||
23332423|NCT01314872|64959052|FG003|Period 2|Study terminated by Sponsor|0|||
23332424|NCT01314872|64959053|FG004|Period 2|Study terminated by Sponsor|0|||
23332425|NCT01314872|64959054|FG005|Period 2|Study terminated by Sponsor|0|||
23332426|NCT01314872|64959055|FG006|Period 2|Study terminated by Sponsor|0|||
23332427|NCT01314872|64959056|FG007|Period 2|Study terminated by Sponsor|0|||
23332428|NCT01314872|64959057|FG008|Period 2|Study terminated by Sponsor|0|||
23332429|NCT01314872|64959058|FG009|Period 2|Study terminated by Sponsor|0|||
23332430|NCT01314872|64959059|FG010|Period 2|Study terminated by Sponsor|0|||
23332431|NCT01314872|64959060|FG011|Period 2|Study terminated by Sponsor|2|||
23332432|NCT01314872|64959061|FG012|Period 2|Study terminated by Sponsor|2|||
23332433|NCT01314872|64959062|FG013|Period 2|Study terminated by Sponsor|3|||
23332434|NCT01314872|64959063|FG014|Period 2|Study terminated by Sponsor|0|||
23332435|NCT01314872|64959049|FG000|Period 2|Adverse event, non-fatal|0|||
23332436|NCT01314872|64959050|FG001|Period 2|Adverse event, non-fatal|0|||
23332437|NCT01314872|64959051|FG002|Period 2|Adverse event, non-fatal|0|||
23332438|NCT01314872|64959052|FG003|Period 2|Adverse event, non-fatal|0|||
23332439|NCT01314872|64959053|FG004|Period 2|Adverse event, non-fatal|0|||
23332440|NCT01314872|64959054|FG005|Period 2|Adverse event, non-fatal|0|||
23332441|NCT01314872|64959055|FG006|Period 2|Adverse event, non-fatal|0|||
23332442|NCT01314872|64959056|FG007|Period 2|Adverse event, non-fatal|0|||
23332443|NCT01314872|64959057|FG008|Period 2|Adverse event, non-fatal|0|||
23332444|NCT01314872|64959058|FG009|Period 2|Adverse event, non-fatal|0|||
23332445|NCT01314872|64959059|FG010|Period 2|Adverse event, non-fatal|0|||
23332446|NCT01314872|64959060|FG011|Period 2|Adverse event, non-fatal|13|||
23574482|NCT01439711|65835324|FG000|Overall Study|Ineligible|13|||
23166018|NCT03709654|64356013|FG000|Overall Study|Withdrawal by Subject|1|||
23166019|NCT03709654|64356014|FG001|Overall Study|Withdrawal by Subject|1|||
23574483|NCT01439711|65835324|FG000|Overall Study|Cancel|3|||
23574484|NCT01439711|65835324|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
23574485|NCT01439711|65835324|FG000|Overall Study|Adverse Event|5|||
23574486|NCT01439711|65835324|FG000|Overall Study|Withdrawal by Subject|3|||
23574487|NCT01439711|65835324|FG000|Overall Study|Progression During Active Tx|3|||
23574488|NCT01439711|65835324|FG000|Overall Study|Noncompliance|3|||
23574489|NCT01439711|65835324|FG000|Overall Study|No MRI|9|||
23574490|NCT01804673|65835325|FG000|Overall Study|Adverse Event|4|||
23574491|NCT01804673|65835325|FG000|Overall Study|Withdrawal by Subject|1|||
23166020|NCT03709654|64356013|FG000|Overall Study|Adverse Event|1|||
23166021|NCT03709654|64356014|FG001|Overall Study|Adverse Event|0|||
23166022|NCT01452152|64356015|FG000|Overall Study|Study termination by sponsor|5|||
23166023|NCT01452152|64356016|FG001|Overall Study|Study termination by sponsor|0|||
23166024|NCT01452152|64356017|FG002|Overall Study|Study termination by sponsor|4|||
23166025|NCT03577730|64356018|FG000|Overall Study|Physician Decision|3|||
23166026|NCT03577730|64356019|FG001|Overall Study|Physician Decision|1|||
23166027|NCT03577730|64356018|FG000|Overall Study|Did not receive allocated intervention|1|||
23166028|NCT03577730|64356019|FG001|Overall Study|Did not receive allocated intervention|0|||
23166029|NCT00772668|64356033|FG000|Overall Study|Physician Decision|3|||
23166030|NCT02665286|64356034|FG000|Overall Study|Lost to Follow-up|3|||
23166031|NCT02665286|64356035|FG001|Overall Study|Lost to Follow-up|2|||
23166032|NCT02665286|64356036|FG002|Overall Study|Lost to Follow-up|1|||
23166033|NCT02966509|64356040|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
23166034|NCT02966509|64356041|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
23166035|NCT02966509|64356040|FG000|Baseline Satisfaction Survey|Death|0|||
23166036|NCT02966509|64356041|FG001|Baseline Satisfaction Survey|Death|1|||
23166037|NCT02966509|64356040|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
23166038|NCT02966509|64356041|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
23166039|NCT02966509|64356040|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
23166040|NCT02966509|64356041|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
23166041|NCT02966509|64356040|FG000|6 Month Satisfaction Decision Survey|Death|22|||
23166042|NCT02966509|64356041|FG001|6 Month Satisfaction Decision Survey|Death|25|||
23166043|NCT02966509|64356040|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
23166044|NCT02966509|64356041|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
23574492|NCT01804673|65835325|FG000|Overall Study|Lack of Efficacy|9|||
23166045|NCT02966509|64356040|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
23166046|NCT02966509|64356041|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
23226482|NCT00957034|64571200|FG002|Overall Study|Adverse Event|1|||
23226483|NCT00957034|64571198|FG000|Overall Study|Sponsor Terminated Study|6|||
23332447|NCT01314872|64959061|FG012|Period 2|Adverse event, non-fatal|16|||
23332448|NCT01314872|64959062|FG013|Period 2|Adverse event, non-fatal|24|||
23332449|NCT01314872|64959063|FG014|Period 2|Adverse event, non-fatal|9|||
23332450|NCT01314872|64959049|FG000|Period 2|Withdrawal by Subject|0|||
23332451|NCT01314872|64959050|FG001|Period 2|Withdrawal by Subject|0|||
23332452|NCT01314872|64959051|FG002|Period 2|Withdrawal by Subject|0|||
23447351|NCT02792231|65380416|FG001|Overall Study|Patient/guardian decision|42|||
23332453|NCT01314872|64959052|FG003|Period 2|Withdrawal by Subject|0|||
23332454|NCT01314872|64959053|FG004|Period 2|Withdrawal by Subject|0|||
23332455|NCT01314872|64959054|FG005|Period 2|Withdrawal by Subject|0|||
23332456|NCT01314872|64959055|FG006|Period 2|Withdrawal by Subject|0|||
23332457|NCT01314872|64959056|FG007|Period 2|Withdrawal by Subject|0|||
23332458|NCT01314872|64959057|FG008|Period 2|Withdrawal by Subject|0|||
23332459|NCT01314872|64959058|FG009|Period 2|Withdrawal by Subject|0|||
23332460|NCT01314872|64959059|FG010|Period 2|Withdrawal by Subject|0|||
23332461|NCT01314872|64959060|FG011|Period 2|Withdrawal by Subject|14|||
23332462|NCT01314872|64959061|FG012|Period 2|Withdrawal by Subject|17|||
23332463|NCT01314872|64959062|FG013|Period 2|Withdrawal by Subject|12|||
23332464|NCT01314872|64959063|FG014|Period 2|Withdrawal by Subject|4|||
23332465|NCT01314872|64959049|FG000|Period 2|Lost to Follow-up|0|||
23332466|NCT01314872|64959050|FG001|Period 2|Lost to Follow-up|0|||
23332467|NCT01314872|64959051|FG002|Period 2|Lost to Follow-up|0|||
23332468|NCT01314872|64959052|FG003|Period 2|Lost to Follow-up|0|||
23332469|NCT01314872|64959053|FG004|Period 2|Lost to Follow-up|0|||
23332470|NCT01314872|64959054|FG005|Period 2|Lost to Follow-up|0|||
23332471|NCT01314872|64959055|FG006|Period 2|Lost to Follow-up|0|||
23332472|NCT01314872|64959056|FG007|Period 2|Lost to Follow-up|0|||
23332473|NCT01314872|64959057|FG008|Period 2|Lost to Follow-up|0|||
23332474|NCT01314872|64959058|FG009|Period 2|Lost to Follow-up|0|||
23332475|NCT01314872|64959059|FG010|Period 2|Lost to Follow-up|0|||
23332476|NCT01314872|64959060|FG011|Period 2|Lost to Follow-up|6|||
23332477|NCT01314872|64959061|FG012|Period 2|Lost to Follow-up|7|||
23332478|NCT01314872|64959062|FG013|Period 2|Lost to Follow-up|2|||
23332479|NCT01314872|64959063|FG014|Period 2|Lost to Follow-up|6|||
23332480|NCT03168711|64959066|FG000|Overall Study|Adverse Event|2|||
23332481|NCT03168711|64959067|FG001|Overall Study|Adverse Event|0|||
23332482|NCT03168711|64959066|FG000|Overall Study|Withdrawal by Subject|0|||
23332483|NCT03168711|64959067|FG001|Overall Study|Withdrawal by Subject|1|||
23332484|NCT03168711|64959066|FG000|Overall Study|Death|0|||
23332485|NCT03168711|64959067|FG001|Overall Study|Death|1|||
23332486|NCT02729025|64959068|FG000|Overall Study|Sponsor Decision|0|||
23332487|NCT02729025|64959069|FG001|Overall Study|Sponsor Decision|1|||
23332488|NCT03103152|64959071|FG000|Overall Study|Physician Decision|5|||
23332489|NCT03103152|64959072|FG001|Overall Study|Physician Decision|2|||
23332490|NCT03103152|64959073|FG002|Overall Study|Physician Decision|6|||
23332491|NCT03103152|64959074|FG003|Overall Study|Physician Decision|3|||
23332492|NCT03103152|64959075|FG004|Overall Study|Physician Decision|3|||
23332493|NCT03103152|64959076|FG005|Overall Study|Physician Decision|1|||
23332494|NCT03103152|64959071|FG000|Overall Study|Protocol Violation|2|||
23332495|NCT03103152|64959072|FG001|Overall Study|Protocol Violation|2|||
23332496|NCT03103152|64959073|FG002|Overall Study|Protocol Violation|1|||
23332497|NCT03103152|64959074|FG003|Overall Study|Protocol Violation|2|||
23332498|NCT03103152|64959075|FG004|Overall Study|Protocol Violation|1|||
23332499|NCT03103152|64959076|FG005|Overall Study|Protocol Violation|1|||
23332500|NCT03103152|64959071|FG000|Overall Study|Inter-current illness|0|||
23332501|NCT03103152|64959072|FG001|Overall Study|Inter-current illness|0|||
23332502|NCT03103152|64959073|FG002|Overall Study|Inter-current illness|1|||
23332503|NCT03103152|64959074|FG003|Overall Study|Inter-current illness|0|||
23332504|NCT03103152|64959075|FG004|Overall Study|Inter-current illness|0|||
23332505|NCT03103152|64959076|FG005|Overall Study|Inter-current illness|0|||
23332506|NCT03103152|64959071|FG000|Overall Study|Death|0|||
23332507|NCT03103152|64959072|FG001|Overall Study|Death|1|||
23332508|NCT03103152|64959073|FG002|Overall Study|Death|0|||
23332509|NCT03103152|64959074|FG003|Overall Study|Death|0|||
23332510|NCT03103152|64959075|FG004|Overall Study|Death|0|||
23332511|NCT03103152|64959076|FG005|Overall Study|Death|0|||
23332512|NCT03103152|64959071|FG000|Overall Study|Adverse Event|0|||
23332513|NCT03103152|64959072|FG001|Overall Study|Adverse Event|0|||
23332514|NCT03103152|64959073|FG002|Overall Study|Adverse Event|1|||
23332515|NCT03103152|64959074|FG003|Overall Study|Adverse Event|0|||
23332516|NCT03103152|64959075|FG004|Overall Study|Adverse Event|0|||
23332517|NCT03103152|64959076|FG005|Overall Study|Adverse Event|1|||
23332518|NCT03103152|64959071|FG000|Overall Study|Withdrawal by Subject|1|||
23332519|NCT03103152|64959072|FG001|Overall Study|Withdrawal by Subject|0|||
23332520|NCT03103152|64959073|FG002|Overall Study|Withdrawal by Subject|1|||
23332521|NCT03103152|64959074|FG003|Overall Study|Withdrawal by Subject|1|||
23332522|NCT03103152|64959075|FG004|Overall Study|Withdrawal by Subject|1|||
23332523|NCT03103152|64959076|FG005|Overall Study|Withdrawal by Subject|1|||
23332524|NCT03103152|64959071|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
23332525|NCT03103152|64959072|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
23332526|NCT03103152|64959073|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
23332527|NCT03103152|64959074|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
23332528|NCT03103152|64959075|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
23332529|NCT03103152|64959076|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
23332530|NCT03103152|64959071|FG000|Overall Study|Unacceptable side effects|0|||
23447352|NCT02792231|65380415|FG000|Overall Study|Adverse Event|15|||
23332531|NCT03103152|64959072|FG001|Overall Study|Unacceptable side effects|0|||
23332532|NCT03103152|64959073|FG002|Overall Study|Unacceptable side effects|0|||
23332533|NCT03103152|64959074|FG003|Overall Study|Unacceptable side effects|0|||
23332534|NCT03103152|64959075|FG004|Overall Study|Unacceptable side effects|0|||
23332535|NCT03103152|64959076|FG005|Overall Study|Unacceptable side effects|1|||
23332536|NCT03103152|64959071|FG000|Overall Study|Lost to Follow-up|0|||
23332537|NCT03103152|64959072|FG001|Overall Study|Lost to Follow-up|1|||
23332538|NCT03103152|64959073|FG002|Overall Study|Lost to Follow-up|0|||
23332539|NCT03103152|64959074|FG003|Overall Study|Lost to Follow-up|1|||
23332540|NCT03103152|64959075|FG004|Overall Study|Lost to Follow-up|0|||
23332541|NCT03103152|64959076|FG005|Overall Study|Lost to Follow-up|1|||
23332542|NCT03103152|64959071|FG000|Overall Study|Testicular pain|0|||
23332543|NCT03103152|64959072|FG001|Overall Study|Testicular pain|0|||
23332544|NCT03103152|64959073|FG002|Overall Study|Testicular pain|0|||
23166047|NCT02966509|64356040|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
23166048|NCT02966509|64356041|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
23166049|NCT02966509|64356040|FG000|6 Month Satisfaction Survey|Death|36|||
23166050|NCT02966509|64356041|FG001|6 Month Satisfaction Survey|Death|33|||
23166051|NCT02966509|64356040|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
23166052|NCT02966509|64356041|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
23166053|NCT02966509|64356040|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
23332545|NCT03103152|64959074|FG003|Overall Study|Testicular pain|1|||
23332546|NCT03103152|64959075|FG004|Overall Study|Testicular pain|0|||
23332547|NCT03103152|64959076|FG005|Overall Study|Testicular pain|0|||
23166054|NCT02966509|64356041|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
23166055|NCT02966509|64356040|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
23166056|NCT02966509|64356041|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
23166057|NCT02966509|64356040|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
23166058|NCT02966509|64356041|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
23166059|NCT02966509|64356040|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
23166060|NCT02966509|64356041|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
23166061|NCT02970292|64356043|FG000|Overall Study|Physician Decision|1|||
23166062|NCT02970292|64356044|FG001|Overall Study|Physician Decision|1|||
23166063|NCT02970292|64356043|FG000|Overall Study|Withdrawal by Subject|11|||
23166064|NCT02970292|64356044|FG001|Overall Study|Withdrawal by Subject|5|||
23166065|NCT02970292|64356043|FG000|Overall Study|Noncompliance with study drug|2|||
23574493|NCT01804673|65835325|FG000|Overall Study|Change to Oral Therapy|37|||
23574494|NCT01804673|65835325|FG000|Overall Study|No Further Therapy Required|84|||
23574495|NCT01804673|65835325|FG000|Overall Study|Use of Prohibited Medication|1|||
23574496|NCT01804673|65835325|FG000|Overall Study|Other|4|||
23574497|NCT03053492|65835326|FG000|Overall Study|Adverse Event|1|||
23574498|NCT03053492|65835327|FG001|Overall Study|Adverse Event|1|||
23574499|NCT03053492|65835326|FG000|Overall Study|Withdrawal by Subject|7|||
23574500|NCT03053492|65835327|FG001|Overall Study|Withdrawal by Subject|5|||
23574501|NCT01824472|65835328|FG000|Overall Study|Lost to Follow-up|0|||
23574502|NCT01824472|65835329|FG001|Overall Study|Lost to Follow-up|0|||
23574503|NCT01824472|65835330|FG002|Overall Study|Lost to Follow-up|1|||
23574504|NCT01824472|65835328|FG000|Overall Study|Withdrawal by Subject|1|||
23574505|NCT01824472|65835329|FG001|Overall Study|Withdrawal by Subject|5|||
23574506|NCT01824472|65835330|FG002|Overall Study|Withdrawal by Subject|3|||
23574507|NCT01824472|65835328|FG000|Overall Study|Ineligible post randomization&screening|0|||
23574508|NCT01824472|65835329|FG001|Overall Study|Ineligible post randomization&screening|2|||
23574509|NCT01824472|65835330|FG002|Overall Study|Ineligible post randomization&screening|0|||
23574510|NCT01024751|65835336|FG000|Enrolled Participants|Ineligible at baseline|3|||
23574511|NCT01024751|65835337|FG001|Enrolled Participants|Ineligible at baseline|4|||
23574512|NCT01024751|65835336|FG000|Eligible Participants|Withdrawal by Subject|0|||
23574513|NCT01024751|65835337|FG001|Eligible Participants|Withdrawal by Subject|1|||
23574514|NCT01024751|65835336|FG000|Eligible Participants|Lost to Follow-up|0|||
23574515|NCT01024751|65835337|FG001|Eligible Participants|Lost to Follow-up|1|||
23574516|NCT01024751|65835336|FG000|Eligible Participants|Ineligible|0|||
23574517|NCT01024751|65835337|FG001|Eligible Participants|Ineligible|1|||
23574518|NCT00919893|65835338|FG000|Overall Study|Protocol Violation|19|||
23574519|NCT00919893|65835339|FG001|Overall Study|Protocol Violation|9|||
23574520|NCT04963062|65835346|FG000|Overall Study|withdrew by the study team|4|||
23574521|NCT04963062|65835347|FG001|Overall Study|withdrew by the study team|2|||
23574522|NCT00429793|65835350|FG000|Overall Study|Improper pre-protocol treatment|3|||
23332548|NCT02964208|64959079|FG000|Overall Study|Death|103|||
23226484|NCT00957034|64571199|FG001|Overall Study|Sponsor Terminated Study|1|||
23332549|NCT02964208|64959079|FG000|Overall Study|Withdrawal by Subject|6|||
23574523|NCT00429793|65835350|FG000|Overall Study|Required test not done|1|||
23166066|NCT02970292|64356044|FG001|Overall Study|Noncompliance with study drug|2|||
23226485|NCT00957034|64571200|FG002|Overall Study|Sponsor Terminated Study|5|||
23332550|NCT02964208|64959079|FG000|Overall Study|Lost to Follow-up|6|||
23332551|NCT02964208|64959079|FG000|Overall Study|Unsuccessful Procedure|5|||
23332552|NCT02964208|64959079|FG000|Overall Study|Device Explant|1|||
23332553|NCT02964208|64959079|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
23332554|NCT00806403|64959082|FG000|Overall Study|Death|4|||
23332555|NCT00806403|64959083|FG001|Overall Study|Death|3|||
23332556|NCT03058705|64959086|FG000|Overall Study|Withdrawal by Subject|2|||
23332557|NCT03058705|64959086|FG000|Overall Study|Physician Decision|2|||
23332558|NCT01168232|64959087|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
23332559|NCT01168232|64959087|FG000|Overall Study|Ineligible- Wrong cell type|6|||
23332560|NCT01168232|64959087|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
23332561|NCT04390503|64959089|FG000|Overall Study|Physician Decision|2|||
23332562|NCT04390503|64959090|FG001|Overall Study|Physician Decision|1|||
23332563|NCT04390503|64959089|FG000|Overall Study|Adverse Event|1|||
23332564|NCT04390503|64959090|FG001|Overall Study|Adverse Event|0|||
23332565|NCT02589639|64959091|FG000|Overall Study|Lost to Follow-up|1|||
23574524|NCT00429793|65835350|FG000|Overall Study|Never treated|1|||
23574525|NCT00429793|65835350|FG000|Overall Study|Non-measurable|1|||
23574526|NCT00577720|65835353|FG000|Overall Study|Adverse Event|2|||
23574527|NCT00577720|65835354|FG001|Overall Study|Adverse Event|1|||
23574528|NCT00577720|65835355|FG002|Overall Study|Adverse Event|0|||
23574529|NCT00577720|65835356|FG003|Overall Study|Adverse Event|4|||
23574530|NCT00577720|65835353|FG000|Overall Study|Lost to Follow-up|0|||
23332566|NCT02589639|64959092|FG001|Overall Study|Lost to Follow-up|0|||
23332567|NCT02589639|64959093|FG002|Overall Study|Lost to Follow-up|0|||
23332568|NCT02589639|64959091|FG000|Overall Study|Protocol Violation|1|||
23574531|NCT00577720|65835354|FG001|Overall Study|Lost to Follow-up|0|||
23574532|NCT00577720|65835355|FG002|Overall Study|Lost to Follow-up|1|||
23574533|NCT00577720|65835356|FG003|Overall Study|Lost to Follow-up|0|||
23574534|NCT00577720|65835353|FG000|Overall Study|Protocol Violation|0|||
23574535|NCT00577720|65835354|FG001|Overall Study|Protocol Violation|0|||
23574536|NCT00577720|65835355|FG002|Overall Study|Protocol Violation|0|||
23574537|NCT00577720|65835356|FG003|Overall Study|Protocol Violation|1|||
23574538|NCT00577720|65835353|FG000|Overall Study|Withdrawal by Subject|2|||
23574539|NCT00577720|65835354|FG001|Overall Study|Withdrawal by Subject|0|||
23574540|NCT00577720|65835355|FG002|Overall Study|Withdrawal by Subject|0|||
23574541|NCT00577720|65835356|FG003|Overall Study|Withdrawal by Subject|2|||
23574542|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
23574543|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
23574544|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
23574545|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
23574546|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
23574547|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
23574548|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
23574549|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
23574550|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
23574551|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
23574552|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
23574553|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
23574554|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
23574555|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
23166067|NCT02970292|64356043|FG000|Overall Study|Adverse Event|5|||
23166068|NCT02970292|64356044|FG001|Overall Study|Adverse Event|0|||
23166069|NCT02970292|64356043|FG000|Overall Study|Lack of Efficacy|1|||
23166070|NCT02970292|64356044|FG001|Overall Study|Lack of Efficacy|0|||
23166071|NCT02970292|64356043|FG000|Overall Study|Lost to Follow-up|1|||
23166072|NCT02970292|64356044|FG001|Overall Study|Lost to Follow-up|0|||
23166073|NCT02970292|64356043|FG000|Overall Study|Protocol Violation|2|||
23166074|NCT02970292|64356044|FG001|Overall Study|Protocol Violation|0|||
23166075|NCT02970292|64356043|FG000|Overall Study|Other|1|||
23166076|NCT02970292|64356044|FG001|Overall Study|Other|0|||
23166077|NCT03325673|64356046|FG000|Overall Study|Adverse Event|4|||
23166078|NCT03325673|64356047|FG001|Overall Study|Adverse Event|0|||
23166079|NCT01074190|64356048|FG000|Overall Study|Emergency Cesarean Delivery|1|||
23166080|NCT01074190|64356049|FG001|Overall Study|Emergency Cesarean Delivery|2|||
23166081|NCT01074190|64356050|FG002|Overall Study|Emergency Cesarean Delivery|1|||
23166082|NCT01074190|64356048|FG000|Overall Study|Protocol Violation|2|||
23166083|NCT01074190|64356049|FG001|Overall Study|Protocol Violation|1|||
23166084|NCT01074190|64356050|FG002|Overall Study|Protocol Violation|0|||
23166085|NCT01074190|64356048|FG000|Overall Study|Delivered in under 90 minutes|0|||
23166086|NCT01074190|64356049|FG001|Overall Study|Delivered in under 90 minutes|2|||
23332569|NCT02589639|64959092|FG001|Overall Study|Protocol Violation|0|||
23574556|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
23574557|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
23574558|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
23166087|NCT01074190|64356050|FG002|Overall Study|Delivered in under 90 minutes|1|||
23166088|NCT01074190|64356048|FG000|Overall Study|Subject withdrew consent|1|||
23166089|NCT01074190|64356049|FG001|Overall Study|Subject withdrew consent|1|||
23166090|NCT01074190|64356050|FG002|Overall Study|Subject withdrew consent|1|||
23574559|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
23574560|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
23574561|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
23574562|NCT04003142|65835357|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
23574563|NCT04003142|65835358|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
23574564|NCT04003142|65835359|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
23574565|NCT04003142|65835360|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
23574566|NCT04003142|65835361|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
23574567|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
23574568|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
23574569|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
23574570|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
23574571|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
23574572|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Death|0|||
23574573|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Death|0|||
23574574|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Death|0|||
23574575|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Death|0|||
23574576|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Death|1|||
23166091|NCT00082888|64356051|FG000|Overall Study|Ineligible|1|||
23166092|NCT00082888|64356052|FG001|Overall Study|Ineligible|0|||
23166093|NCT00082888|64356053|FG002|Overall Study|Ineligible|0|||
23166094|NCT02797808|64356054|FG000|Overall Study|Withdrawal by Subject|1|||
23166095|NCT02797808|64356055|FG001|Overall Study|Withdrawal by Subject|1|||
23166096|NCT02797808|64356054|FG000|Overall Study|Physician Decision|6|||
23166097|NCT02797808|64356055|FG001|Overall Study|Physician Decision|2|||
23166098|NCT02436876|64356056|FG000|Overall Study|Lost to Follow-up|0|||
23166099|NCT02436876|64356057|FG001|Overall Study|Lost to Follow-up|1|||
23166100|NCT02436876|64356058|FG002|Overall Study|Lost to Follow-up|1|||
23166101|NCT02436876|64356059|FG003|Overall Study|Lost to Follow-up|1|||
23166102|NCT02436876|64356056|FG000|Overall Study|Withdrawal by Subject|1|||
23166103|NCT02436876|64356057|FG001|Overall Study|Withdrawal by Subject|0|||
23166104|NCT02436876|64356058|FG002|Overall Study|Withdrawal by Subject|0|||
23166105|NCT02436876|64356059|FG003|Overall Study|Withdrawal by Subject|1|||
23166106|NCT02436876|64356056|FG000|Overall Study|Physician Decision|0|||
23166107|NCT02436876|64356057|FG001|Overall Study|Physician Decision|2|||
23166108|NCT02436876|64356058|FG002|Overall Study|Physician Decision|1|||
23166109|NCT02436876|64356059|FG003|Overall Study|Physician Decision|0|||
23166110|NCT02436876|64356056|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
23166111|NCT02436876|64356057|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
23166112|NCT02436876|64356058|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
23166113|NCT02436876|64356059|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
23166114|NCT01314716|64356060|FG000|Double-Blind Phase|Randomized but not treated|1|||
23166115|NCT01314716|64356061|FG001|Double-Blind Phase|Randomized but not treated|1|||
23166116|NCT01314716|64356060|FG000|Double-Blind Phase|Adverse Event|10|||
23166117|NCT01314716|64356061|FG001|Double-Blind Phase|Adverse Event|4|||
23166118|NCT01314716|64356060|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
23166119|NCT01314716|64356061|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
23226486|NCT00957034|64571198|FG000|Overall Study|Withdrawal by Subject|0|||
23226487|NCT00957034|64571199|FG001|Overall Study|Withdrawal by Subject|2|||
23332570|NCT02589639|64959093|FG002|Overall Study|Protocol Violation|0|||
23332571|NCT02589639|64959091|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
23332572|NCT02589639|64959092|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
23332573|NCT02589639|64959093|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
23332574|NCT02589639|64959091|FG000|Overall Study|Adverse Event|4|||
23166120|NCT01314716|64356060|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23166121|NCT01314716|64356061|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23166122|NCT01314716|64356060|FG000|Double-Blind Phase|Sponsor request|1|||
23166123|NCT01314716|64356061|FG001|Double-Blind Phase|Sponsor request|2|||
23166124|NCT01314716|64356060|FG000|Double-Blind Phase|Physician Decision|0|||
23166125|NCT01314716|64356061|FG001|Double-Blind Phase|Physician Decision|1|||
23166126|NCT01314716|64356060|FG000|Open-Label Phase|Adverse Event|4|||
23166127|NCT01314716|64356061|FG001|Open-Label Phase|Adverse Event|6|||
23166128|NCT01314716|64356060|FG000|Open-Label Phase|Withdrawal by Subject|1|||
23166129|NCT01314716|64356061|FG001|Open-Label Phase|Withdrawal by Subject|2|||
23226488|NCT00957034|64571200|FG002|Overall Study|Withdrawal by Subject|0|||
23166130|NCT01314716|64356060|FG000|Open-Label Phase|Physician Decision|5|||
23166131|NCT01314716|64356061|FG001|Open-Label Phase|Physician Decision|4|||
23226489|NCT02252588|64571201|FG000|Overall Study|Withdrawal by Subject|4|||
23332575|NCT02589639|64959092|FG001|Overall Study|Adverse Event|5|||
23574577|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
23574578|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
23574579|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
23166132|NCT03571646|64356062|FG000|Overall Study|Adverse Event|1|||
23166133|NCT03571646|64356063|FG001|Overall Study|Adverse Event|0|||
23226490|NCT02252588|64571202|FG001|Overall Study|Withdrawal by Subject|0|||
23332576|NCT02589639|64959093|FG002|Overall Study|Adverse Event|3|||
23332577|NCT02589639|64959091|FG000|Overall Study|Other reason than specified above|1|||
23332578|NCT02589639|64959092|FG001|Overall Study|Other reason than specified above|2|||
23332579|NCT02589639|64959093|FG002|Overall Study|Other reason than specified above|1|||
23332580|NCT02589639|64959091|FG000|Overall Study|Not Treated|0|||
23332581|NCT02589639|64959092|FG001|Overall Study|Not Treated|3|||
23332582|NCT02589639|64959093|FG002|Overall Study|Not Treated|0|||
23332583|NCT01749826|64959096|FG000|Overall Study|Study Terminated|20|||
23332584|NCT01749826|64959097|FG001|Overall Study|Study Terminated|0|||
23332585|NCT02062450|64959099|FG000|Overall Study|No follow-up visit|124|||
23332586|NCT02556775|64959100|FG000|Overall Study|Withdrawal by Subject|1|||
23332587|NCT02556775|64959101|FG001|Overall Study|Withdrawal by Subject|0|||
23332588|NCT02556775|64959102|FG002|Overall Study|Withdrawal by Subject|1|||
23332589|NCT02556775|64959103|FG003|Overall Study|Withdrawal by Subject|0|||
23332590|NCT02556775|64959100|FG000|Overall Study|Lost to Follow-up|1|||
23332591|NCT02556775|64959101|FG001|Overall Study|Lost to Follow-up|0|||
23332592|NCT02556775|64959102|FG002|Overall Study|Lost to Follow-up|0|||
23332593|NCT02556775|64959103|FG003|Overall Study|Lost to Follow-up|0|||
23332594|NCT02142803|64959110|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
23574580|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
23574581|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
23574582|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
23574583|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
23574584|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
23574585|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
23574586|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
23166134|NCT03571646|64356062|FG000|Overall Study|Withdrawal by Subject|1|||
23166135|NCT03571646|64356063|FG001|Overall Study|Withdrawal by Subject|1|||
23332595|NCT02142803|64959111|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
23332596|NCT02142803|64959112|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
23332597|NCT02142803|64959113|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
23332598|NCT02211209|64959114|FG000|Overall Study|Investigator judgment|0|||
23332599|NCT02211209|64959115|FG001|Overall Study|Investigator judgment|1|||
23332600|NCT02211209|64959114|FG000|Overall Study|Voluntary withdrawal|1|||
23332601|NCT02211209|64959115|FG001|Overall Study|Voluntary withdrawal|4|||
23166136|NCT03124563|64356064|FG000|Overall Study|Lost to Follow-up|1|||
23166137|NCT03124563|64356065|FG001|Overall Study|Lost to Follow-up|1|||
23166138|NCT03124563|64356064|FG000|Overall Study|Withdrawal by Subject|1|||
23166139|NCT03124563|64356065|FG001|Overall Study|Withdrawal by Subject|1|||
23166140|NCT01137773|64356071|FG000|Overall Study|Death|3|||
23166141|NCT01137773|64356072|FG001|Overall Study|Death|3|||
23166142|NCT01137773|64356071|FG000|Overall Study|Lost to Follow-up|6|||
23166143|NCT01137773|64356072|FG001|Overall Study|Lost to Follow-up|0|||
23166144|NCT00953758|64356073|FG000|Overall Study|Death|2|||
23166145|NCT00953758|64356074|FG001|Overall Study|Death|0|||
23166146|NCT00953758|64356075|FG002|Overall Study|Death|1|||
23166147|NCT00953758|64356076|FG003|Overall Study|Death|1|||
23166148|NCT00953758|64356077|FG004|Overall Study|Death|1|||
23166149|NCT00953758|64356078|FG005|Overall Study|Death|1|||
23166150|NCT00953758|64356079|FG006|Overall Study|Death|1|||
23166151|NCT00953758|64356080|FG007|Overall Study|Death|3|||
23166152|NCT00953758|64356081|FG008|Overall Study|Death|1|||
23166153|NCT00953758|64356082|FG009|Overall Study|Death|0|||
23166154|NCT00953758|64356073|FG000|Overall Study|Participant refused further follow-up|0|||
23166155|NCT00953758|64356074|FG001|Overall Study|Participant refused further follow-up|0|||
23166156|NCT00953758|64356075|FG002|Overall Study|Participant refused further follow-up|1|||
23166157|NCT00953758|64356076|FG003|Overall Study|Participant refused further follow-up|0|||
23166158|NCT00953758|64356077|FG004|Overall Study|Participant refused further follow-up|3|||
23166159|NCT00953758|64356078|FG005|Overall Study|Participant refused further follow-up|0|||
23166160|NCT00953758|64356079|FG006|Overall Study|Participant refused further follow-up|0|||
23166161|NCT00953758|64356080|FG007|Overall Study|Participant refused further follow-up|0|||
23166162|NCT00953758|64356081|FG008|Overall Study|Participant refused further follow-up|1|||
23166163|NCT00953758|64356082|FG009|Overall Study|Participant refused further follow-up|0|||
23166164|NCT00953758|64356073|FG000|Overall Study|Lost to Follow-up|0|||
23166165|NCT00953758|64356074|FG001|Overall Study|Lost to Follow-up|0|||
23166166|NCT00953758|64356075|FG002|Overall Study|Lost to Follow-up|0|||
23166167|NCT00953758|64356076|FG003|Overall Study|Lost to Follow-up|1|||
23166168|NCT00953758|64356077|FG004|Overall Study|Lost to Follow-up|0|||
23166169|NCT00953758|64356078|FG005|Overall Study|Lost to Follow-up|0|||
23332602|NCT02211209|64959114|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
23332603|NCT02211209|64959115|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
23332604|NCT02211209|64959114|FG000|Overall Study|Reason Not Specified|1|||
23166170|NCT00953758|64356079|FG006|Overall Study|Lost to Follow-up|0|||
23166171|NCT00953758|64356080|FG007|Overall Study|Lost to Follow-up|1|||
23332605|NCT02211209|64959115|FG001|Overall Study|Reason Not Specified|0|||
23226491|NCT00853112|64571203|FG000|Overall Study|Randomized but not treated|0|||
23226492|NCT00853112|64571204|FG001|Overall Study|Randomized but not treated|1|||
23226493|NCT00853112|64571205|FG002|Overall Study|Randomized but not treated|0|||
23226494|NCT00853112|64571206|FG003|Overall Study|Randomized but not treated|2|||
23226495|NCT00853112|64571207|FG004|Overall Study|Randomized but not treated|0|||
23226496|NCT00853112|64571208|FG005|Overall Study|Randomized but not treated|0|||
23226497|NCT00853112|64571209|FG006|Overall Study|Randomized but not treated|1|||
23226498|NCT00691054|64571210|FG000|Overall Study|Withdrawal by Subject|1|||
23226499|NCT00621244|64571211|FG000|Overall Study|Withdrawal by Subject|7|||
23226500|NCT00621244|64571212|FG001|Overall Study|Withdrawal by Subject|3|||
23226501|NCT00621244|64571213|FG002|Overall Study|Withdrawal by Subject|3|||
23226502|NCT00621244|64571214|FG003|Overall Study|Withdrawal by Subject|3|||
23226503|NCT00621244|64571211|FG000|Overall Study|Disease progression|44|||
23226504|NCT00621244|64571212|FG001|Overall Study|Disease progression|20|||
23226505|NCT00621244|64571213|FG002|Overall Study|Disease progression|20|||
23226506|NCT00621244|64571214|FG003|Overall Study|Disease progression|15|||
23226507|NCT00621244|64571211|FG000|Overall Study|Death|3|||
23226508|NCT00621244|64571212|FG001|Overall Study|Death|3|||
23226509|NCT00621244|64571213|FG002|Overall Study|Death|1|||
23226510|NCT00621244|64571214|FG003|Overall Study|Death|1|||
23226511|NCT00621244|64571211|FG000|Overall Study|Adverse Event|27|||
23226512|NCT00621244|64571212|FG001|Overall Study|Adverse Event|7|||
23226513|NCT00621244|64571213|FG002|Overall Study|Adverse Event|9|||
23226514|NCT00621244|64571214|FG003|Overall Study|Adverse Event|2|||
23226515|NCT00621244|64571211|FG000|Overall Study|Administrative problems|5|||
23226516|NCT00621244|64571212|FG001|Overall Study|Administrative problems|1|||
23226517|NCT00621244|64571213|FG002|Overall Study|Administrative problems|0|||
23226518|NCT00621244|64571214|FG003|Overall Study|Administrative problems|2|||
23226519|NCT03137173|64571217|FG000|Overall Study|Withdrawal by Subject|8|||
23226520|NCT03137173|64571218|FG001|Overall Study|Withdrawal by Subject|13|||
23226521|NCT03137173|64571217|FG000|Overall Study|Death|1|||
23226522|NCT03137173|64571218|FG001|Overall Study|Death|3|||
23226523|NCT03137173|64571217|FG000|Overall Study|Physician Decision|1|||
23226524|NCT03137173|64571218|FG001|Overall Study|Physician Decision|0|||
23226525|NCT03137173|64571217|FG000|Overall Study|Lost to Follow-up|13|||
23226526|NCT03137173|64571218|FG001|Overall Study|Lost to Follow-up|18|||
23226527|NCT03137173|64571217|FG000|Overall Study|Other reasons|3|||
23226528|NCT03137173|64571218|FG001|Overall Study|Other reasons|2|||
23226529|NCT01878175|64571219|FG000|Overall Study|Developed contraindicated health problem|2|||
23226530|NCT00806494|64571222|FG000|Overall Study|Adverse Event|29|||
23574587|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
23574588|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
23574589|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
23226531|NCT00806494|64571222|FG000|Overall Study|Lack of Efficacy|6|||
23226532|NCT00806494|64571222|FG000|Overall Study|Lost to Follow-up|10|||
23226533|NCT00806494|64571222|FG000|Overall Study|Other|30|||
23226534|NCT00806494|64571222|FG000|Overall Study|Withdrawal by Subject|5|||
23226535|NCT01572844|64571223|FG000|Overall Study|Physician Decision|1|||
23226536|NCT01572844|64571224|FG001|Overall Study|Physician Decision|1|||
23226537|NCT00441727|64571227|FG000|Overall Study|Protocol Violation|19|||
23332606|NCT02792062|64959116|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
23332607|NCT02792062|64959117|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23332608|NCT02792062|64959118|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23332609|NCT02792062|64959119|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23332610|NCT02792062|64959120|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23332611|NCT02792062|64959121|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
23332612|NCT00135512|64959122|FG000|Overall Study|Adverse Event|56|||
23332613|NCT00135512|64959122|FG000|Overall Study|Lack of Efficacy|25|||
23332614|NCT00135512|64959122|FG000|Overall Study|Other|42|||
23226538|NCT00441727|64571228|FG001|Overall Study|Protocol Violation|28|||
23226539|NCT00441727|64571229|FG002|Overall Study|Protocol Violation|32|||
23226540|NCT00441727|64571227|FG000|Overall Study|Adverse Event|26|||
23226541|NCT00441727|64571228|FG001|Overall Study|Adverse Event|33|||
23226542|NCT00441727|64571229|FG002|Overall Study|Adverse Event|28|||
23226543|NCT00441727|64571227|FG000|Overall Study|Lack of Efficacy|7|||
23226544|NCT00441727|64571228|FG001|Overall Study|Lack of Efficacy|8|||
23226545|NCT00441727|64571229|FG002|Overall Study|Lack of Efficacy|48|||
23226546|NCT00441727|64571227|FG000|Overall Study|Withdrawal by Subject|40|||
23226547|NCT00441727|64571228|FG001|Overall Study|Withdrawal by Subject|34|||
23226548|NCT00441727|64571229|FG002|Overall Study|Withdrawal by Subject|47|||
23226549|NCT00441727|64571227|FG000|Overall Study|Lost to Follow-up|5|||
23226550|NCT00441727|64571228|FG001|Overall Study|Lost to Follow-up|6|||
23574590|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
23226551|NCT00441727|64571229|FG002|Overall Study|Lost to Follow-up|5|||
23226552|NCT00441727|64571227|FG000|Overall Study|Safety Reasons|3|||
23226553|NCT00441727|64571228|FG001|Overall Study|Safety Reasons|1|||
23226554|NCT00441727|64571229|FG002|Overall Study|Safety Reasons|3|||
23226555|NCT00441727|64571227|FG000|Overall Study|Various reason specified|6|||
23332615|NCT00425750|64959123|FG000|Overall Study|Death|1|||
23332616|NCT00425750|64959123|FG000|Overall Study|Withdrawal by Subject|3|||
23332617|NCT00425750|64959123|FG000|Overall Study|Adverse Event|3|||
23332618|NCT00425750|64959123|FG000|Overall Study|Progression of disease|18|||
23332619|NCT00651261|64959126|FG000|Overall Study|Adverse Event|32|||
23332620|NCT00651261|64959127|FG001|Overall Study|Adverse Event|22|||
23332621|NCT00651261|64959126|FG000|Overall Study|Death|18|||
23332622|NCT00651261|64959127|FG001|Overall Study|Death|18|||
23332623|NCT00651261|64959126|FG000|Overall Study|Withdrawal by Subject|22|||
23332624|NCT00651261|64959127|FG001|Overall Study|Withdrawal by Subject|40|||
23332625|NCT00651261|64959126|FG000|Overall Study|Induction failure|24|||
23332626|NCT00651261|64959127|FG001|Overall Study|Induction failure|35|||
23332627|NCT00651261|64959126|FG000|Overall Study|Disease progression|58|||
23332628|NCT00651261|64959127|FG001|Overall Study|Disease progression|58|||
23332629|NCT00651261|64959126|FG000|Overall Study|Alternative therapy|109|||
23332630|NCT00651261|64959127|FG001|Overall Study|Alternative therapy|107|||
23332631|NCT00651261|64959126|FG000|Overall Study|Other disease or participant decisions|23|||
23332632|NCT00651261|64959127|FG001|Overall Study|Other disease or participant decisions|23|||
23332633|NCT00651261|64959126|FG000|Overall Study|Never treated|5|||
23332634|NCT00651261|64959127|FG001|Overall Study|Never treated|3|||
23332635|NCT01031680|64959128|FG000|Overall Study|Adverse Event|8|||
23332636|NCT01031680|64959129|FG001|Overall Study|Adverse Event|3|||
23332637|NCT01031680|64959128|FG000|Overall Study|Lost to Follow-up|2|||
23332638|NCT01031680|64959129|FG001|Overall Study|Lost to Follow-up|10|||
23332639|NCT01031680|64959128|FG000|Overall Study|Withdrawal by Subject|12|||
23332640|NCT01031680|64959129|FG001|Overall Study|Withdrawal by Subject|16|||
23332641|NCT01031680|64959128|FG000|Overall Study|Death|2|||
23332642|NCT01031680|64959129|FG001|Overall Study|Death|1|||
23332643|NCT01031680|64959128|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
23332644|NCT01031680|64959129|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
23332645|NCT01031680|64959128|FG000|Overall Study|Poor/Non-compliance|5|||
23332646|NCT01031680|64959129|FG001|Overall Study|Poor/Non-compliance|6|||
23332647|NCT01031680|64959128|FG000|Overall Study|Safety|1|||
23332648|NCT01031680|64959129|FG001|Overall Study|Safety|0|||
23332649|NCT01031680|64959128|FG000|Overall Study|Incorrect Enrolment|1|||
23332650|NCT01031680|64959129|FG001|Overall Study|Incorrect Enrolment|2|||
23332651|NCT01031680|64959128|FG000|Overall Study|Administrative Reason by Sponsor|0|||
23332652|NCT01031680|64959129|FG001|Overall Study|Administrative Reason by Sponsor|1|||
23332653|NCT01031680|64959128|FG000|Overall Study|Various|0|||
23332654|NCT01031680|64959129|FG001|Overall Study|Various|2|||
23332655|NCT02962648|64959130|FG000|Overall Study|Withdrawal by Subject|3|||
23332656|NCT02962648|64959130|FG000|Overall Study|Lost to Follow-up|3|||
23332657|NCT02962648|64959130|FG000|Overall Study|Physician Decision|1|||
23332658|NCT02962648|64959130|FG000|Overall Study|Subject had problems with transportation|2|||
23332659|NCT03526861|64959131|FG000|Initial Treatment Period|Not dosed|1|||
23332660|NCT03526861|64959132|FG001|Initial Treatment Period|Not dosed|1|||
23332661|NCT03526861|64959133|FG002|Initial Treatment Period|Not dosed|1|||
23332662|NCT03526861|64959134|FG003|Initial Treatment Period|Not dosed|0|||
23332663|NCT03526861|64959135|FG004|Initial Treatment Period|Not dosed|0|||
23332664|NCT03526861|64959136|FG005|Initial Treatment Period|Not dosed|0|||
23332665|NCT03526861|64959137|FG006|Initial Treatment Period|Not dosed|0|||
23332666|NCT03526861|64959138|FG007|Initial Treatment Period|Not dosed|0|||
23332667|NCT03526861|64959139|FG008|Initial Treatment Period|Not dosed|0|||
23332668|NCT03526861|64959131|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
23332669|NCT03526861|64959132|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
23332670|NCT03526861|64959133|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
23332671|NCT03526861|64959134|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332672|NCT03526861|64959135|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332673|NCT03526861|64959136|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332674|NCT03526861|64959137|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332675|NCT03526861|64959138|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332676|NCT03526861|64959139|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332677|NCT03526861|64959131|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
23332678|NCT03526861|64959132|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
23332679|NCT03526861|64959133|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
23332680|NCT03526861|64959134|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23332681|NCT03526861|64959135|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23332682|NCT03526861|64959136|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23332683|NCT03526861|64959137|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23447353|NCT02792231|65380416|FG001|Overall Study|Adverse Event|11|||
23332684|NCT03526861|64959138|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23332685|NCT03526861|64959139|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
23332686|NCT03526861|64959131|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332687|NCT03526861|64959132|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332688|NCT03526861|64959133|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332689|NCT03526861|64959134|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
23332690|NCT03526861|64959135|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
23332691|NCT03526861|64959136|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332692|NCT03526861|64959137|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
23332693|NCT03526861|64959138|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332694|NCT03526861|64959139|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332695|NCT03526861|64959131|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
23332696|NCT03526861|64959132|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
23332697|NCT03526861|64959133|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
23447354|NCT02792231|65380415|FG000|Overall Study|Physician Decision|14|||
23447355|NCT02792231|65380416|FG001|Overall Study|Physician Decision|12|||
23447356|NCT02792231|65380415|FG000|Overall Study|Lack of Efficacy|7|||
23447357|NCT02792231|65380416|FG001|Overall Study|Lack of Efficacy|9|||
23166172|NCT00953758|64356081|FG008|Overall Study|Lost to Follow-up|0|||
23166173|NCT00953758|64356082|FG009|Overall Study|Lost to Follow-up|1|||
23166174|NCT00953758|64356073|FG000|Overall Study|Physician Decision|0|||
23166175|NCT00953758|64356074|FG001|Overall Study|Physician Decision|0|||
23166176|NCT00953758|64356075|FG002|Overall Study|Physician Decision|0|||
23166177|NCT00953758|64356076|FG003|Overall Study|Physician Decision|0|||
23166178|NCT00953758|64356077|FG004|Overall Study|Physician Decision|1|||
23166179|NCT00953758|64356078|FG005|Overall Study|Physician Decision|0|||
23166180|NCT00953758|64356079|FG006|Overall Study|Physician Decision|0|||
23166181|NCT00953758|64356080|FG007|Overall Study|Physician Decision|0|||
23166182|NCT00953758|64356081|FG008|Overall Study|Physician Decision|0|||
23166183|NCT00953758|64356082|FG009|Overall Study|Physician Decision|0|||
23447358|NCT02792231|65380415|FG000|Overall Study|Lost to Follow-up|9|||
23447359|NCT02792231|65380416|FG001|Overall Study|Lost to Follow-up|5|||
23447360|NCT02792231|65380415|FG000|Overall Study|Pregnancy|1|||
23447361|NCT02792231|65380416|FG001|Overall Study|Pregnancy|3|||
23447362|NCT02792231|65380415|FG000|Overall Study|Non-compliance with study treatment|2|||
23447363|NCT02792231|65380416|FG001|Overall Study|Non-compliance with study treatment|1|||
23447364|NCT02792231|65380415|FG000|Overall Study|Protocol deviation|2|||
23447365|NCT02792231|65380416|FG001|Overall Study|Protocol deviation|0|||
23447366|NCT02792231|65380415|FG000|Overall Study|Technical problems|0|||
23447367|NCT02792231|65380416|FG001|Overall Study|Technical problems|1|||
23447368|NCT00626275|65380417|FG000|Part A - Treatment Period 1|Adverse Event|1|||
23447369|NCT00626275|65380418|FG001|Part A - Treatment Period 1|Adverse Event|0|||
23447370|NCT00626275|65380419|FG002|Part A - Treatment Period 1|Adverse Event|0|||
23447371|NCT00626275|65380420|FG003|Part A - Treatment Period 1|Adverse Event|0|||
23447372|NCT00626275|65380421|FG004|Part A - Treatment Period 1|Adverse Event|0|||
23574591|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
23574592|NCT04003142|65835357|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
23574593|NCT04003142|65835358|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
23574594|NCT04003142|65835359|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
23574595|NCT04003142|65835360|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
23574596|NCT04003142|65835361|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
23574597|NCT01177813|65835362|FG000|Overall Study|Adverse Event|8|||
23574598|NCT01177813|65835363|FG001|Overall Study|Adverse Event|2|||
23574599|NCT01177813|65835364|FG002|Overall Study|Adverse Event|4|||
23574600|NCT01177813|65835365|FG003|Overall Study|Adverse Event|6|||
23574601|NCT01177813|65835366|FG004|Overall Study|Adverse Event|3|||
23574602|NCT01177813|65835362|FG000|Overall Study|Lack of Efficacy|1|||
23574603|NCT01177813|65835363|FG001|Overall Study|Lack of Efficacy|0|||
23574604|NCT01177813|65835364|FG002|Overall Study|Lack of Efficacy|0|||
23574605|NCT01177813|65835365|FG003|Overall Study|Lack of Efficacy|0|||
23574606|NCT01177813|65835366|FG004|Overall Study|Lack of Efficacy|0|||
23574607|NCT01177813|65835362|FG000|Overall Study|Protocol Violation|3|||
23574608|NCT01177813|65835363|FG001|Overall Study|Protocol Violation|2|||
23574609|NCT01177813|65835364|FG002|Overall Study|Protocol Violation|2|||
23574610|NCT01177813|65835365|FG003|Overall Study|Protocol Violation|0|||
23574611|NCT01177813|65835366|FG004|Overall Study|Protocol Violation|1|||
23574612|NCT01177813|65835362|FG000|Overall Study|Lost to Follow-up|12|||
23166184|NCT00953758|64356073|FG000|Overall Study|Disease progression|0|||
23574613|NCT01177813|65835363|FG001|Overall Study|Lost to Follow-up|5|||
23574614|NCT01177813|65835364|FG002|Overall Study|Lost to Follow-up|6|||
23574615|NCT01177813|65835365|FG003|Overall Study|Lost to Follow-up|3|||
23574616|NCT01177813|65835366|FG004|Overall Study|Lost to Follow-up|0|||
23574617|NCT01177813|65835362|FG000|Overall Study|Withdrawal by Subject|12|||
23166185|NCT00953758|64356074|FG001|Overall Study|Disease progression|0|||
23447373|NCT00626275|65380422|FG005|Part A - Treatment Period 1|Adverse Event|0|||
23447374|NCT00626275|65380423|FG006|Part A - Treatment Period 1|Adverse Event|0|||
23447375|NCT00626275|65380424|FG007|Part A - Treatment Period 1|Adverse Event|0|||
23447376|NCT00626275|65380417|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447377|NCT00626275|65380418|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447378|NCT00626275|65380419|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
23447379|NCT00626275|65380420|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447380|NCT00626275|65380421|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23332698|NCT03526861|64959134|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
23332699|NCT03526861|64959135|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
23332700|NCT03526861|64959136|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
23332701|NCT03526861|64959137|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
23332702|NCT03526861|64959138|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
23332703|NCT03526861|64959139|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
23332704|NCT03526861|64959131|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332705|NCT03526861|64959132|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332706|NCT03526861|64959133|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23447381|NCT00626275|65380422|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23574618|NCT01177813|65835363|FG001|Overall Study|Withdrawal by Subject|7|||
23574619|NCT01177813|65835364|FG002|Overall Study|Withdrawal by Subject|6|||
23166186|NCT00953758|64356075|FG002|Overall Study|Disease progression|0|||
23166187|NCT00953758|64356076|FG003|Overall Study|Disease progression|0|||
23332707|NCT03526861|64959134|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
23332708|NCT03526861|64959135|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332709|NCT03526861|64959136|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332710|NCT03526861|64959137|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332711|NCT03526861|64959138|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332712|NCT03526861|64959139|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332713|NCT03526861|64959131|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332714|NCT03526861|64959132|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332715|NCT03526861|64959133|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332716|NCT03526861|64959134|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332717|NCT03526861|64959135|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332718|NCT03526861|64959136|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332719|NCT03526861|64959137|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332720|NCT03526861|64959138|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
23332721|NCT03526861|64959139|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
23332722|NCT03526861|64959131|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23332723|NCT03526861|64959132|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23332724|NCT03526861|64959133|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23332725|NCT03526861|64959134|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23332726|NCT03526861|64959135|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23332727|NCT03526861|64959136|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23447382|NCT00626275|65380423|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447383|NCT00626275|65380424|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
23447384|NCT00626275|65380417|FG000|Part B|Lost to Follow-up|0|||
23574620|NCT01177813|65835365|FG003|Overall Study|Withdrawal by Subject|5|||
23574621|NCT01177813|65835366|FG004|Overall Study|Withdrawal by Subject|3|||
23574622|NCT01177813|65835362|FG000|Overall Study|Other reason not defined above|5|||
23574623|NCT01177813|65835363|FG001|Overall Study|Other reason not defined above|2|||
23574624|NCT01177813|65835364|FG002|Overall Study|Other reason not defined above|2|||
23574625|NCT01177813|65835365|FG003|Overall Study|Other reason not defined above|3|||
23574626|NCT01177813|65835366|FG004|Overall Study|Other reason not defined above|2|||
23574627|NCT01327547|65835367|FG000|Overall Study|Adverse Event|4|||
23574628|NCT01327547|65835368|FG001|Overall Study|Adverse Event|1|||
23574629|NCT01327547|65835367|FG000|Overall Study|Death|1|||
23166188|NCT00953758|64356077|FG004|Overall Study|Disease progression|1|||
23166189|NCT00953758|64356078|FG005|Overall Study|Disease progression|0|||
23332728|NCT03526861|64959137|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23332729|NCT03526861|64959138|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
23332730|NCT03526861|64959139|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
23332731|NCT03526861|64959131|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332732|NCT03526861|64959132|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332733|NCT03526861|64959133|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332734|NCT03526861|64959134|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23447385|NCT00626275|65380418|FG001|Part B|Lost to Follow-up|0|||
23574630|NCT01327547|65835368|FG001|Overall Study|Death|2|||
23574631|NCT01327547|65835367|FG000|Overall Study|Lost to Follow-up|6|||
23574632|NCT01327547|65835368|FG001|Overall Study|Lost to Follow-up|6|||
23574633|NCT01327547|65835367|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
23574634|NCT01327547|65835368|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
23574635|NCT01327547|65835367|FG000|Overall Study|Withdrawal by Subject|3|||
23574636|NCT01327547|65835368|FG001|Overall Study|Withdrawal by Subject|7|||
23574637|NCT01327547|65835367|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
23574638|NCT01327547|65835368|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
23574639|NCT01327547|65835367|FG000|Overall Study|Protocol Violation|1|||
23574640|NCT01327547|65835368|FG001|Overall Study|Protocol Violation|0|||
23574641|NCT01327547|65835367|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
23574642|NCT01327547|65835368|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
23574643|NCT01327547|65835367|FG000|Overall Study|Required prohibited medication|2|||
23574644|NCT01327547|65835368|FG001|Overall Study|Required prohibited medication|0|||
23574645|NCT01327547|65835367|FG000|Overall Study|Non-compliance with study procedures|1|||
23574646|NCT01327547|65835368|FG001|Overall Study|Non-compliance with study procedures|0|||
23574647|NCT01327547|65835367|FG000|Overall Study|By investigator in subject's interest|0|||
23574648|NCT01327547|65835368|FG001|Overall Study|By investigator in subject's interest|1|||
23574649|NCT01440049|65835369|FG000|Overall Study|Adverse Event|5|||
23574650|NCT02462083|65835370|FG000|Overall Study|Sponsor request|39|||
23574651|NCT02462083|65835370|FG000|Overall Study|Withdrawal by Subject|87|||
23574652|NCT02462083|65835370|FG000|Overall Study|Lost to Follow-up|41|||
23574653|NCT02462083|65835370|FG000|Overall Study|Lack of Efficacy|151|||
23574654|NCT02462083|65835370|FG000|Overall Study|Pregnancy|1|||
23574655|NCT02462083|65835370|FG000|Overall Study|Protocol Violation|6|||
23574656|NCT02462083|65835370|FG000|Overall Study|Adverse Event|33|||
23574657|NCT02462083|65835370|FG000|Overall Study|Worsening condition|16|||
23574658|NCT02462083|65835370|FG000|Overall Study|Other than specified|45|||
23574659|NCT00378105|65835371|FG000|Overall Study|Adverse Event|3|||
23574660|NCT00378105|65835372|FG001|Overall Study|Adverse Event|1|||
23574661|NCT00378105|65835371|FG000|Overall Study|Withdrawal by Subject|3|||
23574662|NCT00378105|65835372|FG001|Overall Study|Withdrawal by Subject|3|||
23574663|NCT00378105|65835371|FG000|Overall Study|Death|1|||
23574664|NCT00378105|65835372|FG001|Overall Study|Death|0|||
23574665|NCT00378105|65835371|FG000|Overall Study|Going to transplant|7|||
23574666|NCT00378105|65835372|FG001|Overall Study|Going to transplant|8|||
23574667|NCT00378105|65835371|FG000|Overall Study|Progressive disease|3|||
23574668|NCT00378105|65835372|FG001|Overall Study|Progressive disease|3|||
23574669|NCT00378105|65835371|FG000|Overall Study|remain on study|3|||
23574670|NCT00378105|65835372|FG001|Overall Study|remain on study|11|||
23574671|NCT00378105|65835371|FG000|Overall Study|Physician Decision|0|||
23574672|NCT00378105|65835372|FG001|Overall Study|Physician Decision|2|||
23574673|NCT00378105|65835371|FG000|Overall Study|Going non-protocol therapy|0|||
23574674|NCT00378105|65835372|FG001|Overall Study|Going non-protocol therapy|1|||
23574675|NCT00378105|65835371|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
23574676|NCT00378105|65835372|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
23574677|NCT02189863|65835373|FG000|First 2 Weeks|Motion Sickness|4|||
23574678|NCT02189863|65835374|FG001|First 2 Weeks|Motion Sickness|2|||
23574679|NCT02764775|65835375|FG000|Overall Study|Death|1|||
23574680|NCT02764775|65835375|FG000|Overall Study|Lost to Follow-up|2|||
23574681|NCT02764775|65835375|FG000|Overall Study|Withdrawal by Subject|3|||
23574682|NCT02297503|65835377|FG000|Overall Study|Withdrawal by Subject|1|||
23574683|NCT02297503|65835378|FG001|Overall Study|Withdrawal by Subject|1|||
23574684|NCT02297503|65835377|FG000|Overall Study|Protocol Violation|1|||
23574685|NCT02297503|65835378|FG001|Overall Study|Protocol Violation|0|||
23574686|NCT02297503|65835377|FG000|Overall Study|Pregnancy|0|||
23574687|NCT02297503|65835378|FG001|Overall Study|Pregnancy|1|||
23574688|NCT02297503|65835377|FG000|Overall Study|Lost to Follow-up|0|||
23574689|NCT02297503|65835378|FG001|Overall Study|Lost to Follow-up|1|||
23574690|NCT02297503|65835377|FG000|Overall Study|Medical reason|0|||
23574691|NCT02297503|65835378|FG001|Overall Study|Medical reason|1|||
23574692|NCT00322374|65835381|FG000|Starting Dose|Physician Decision|2|||
23574693|NCT00322374|65835382|FG001|Starting Dose|Physician Decision|0|||
23332735|NCT03526861|64959135|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332736|NCT03526861|64959136|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332737|NCT03526861|64959137|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23332738|NCT03526861|64959138|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
23226556|NCT00441727|64571228|FG001|Overall Study|Various reason specified|8|||
23226557|NCT00441727|64571229|FG002|Overall Study|Various reason specified|5|||
23226558|NCT01100658|64571230|FG000|Overall Study|Withdrawal by Subject|1|||
23226559|NCT00994890|64571231|FG000|Overall Study|Adverse Event|13|||
23226560|NCT00994890|64571232|FG001|Overall Study|Adverse Event|9|||
23226561|NCT00994890|64571233|FG002|Overall Study|Adverse Event|11|||
23332739|NCT03526861|64959139|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
23332740|NCT01379768|64959140|FG000|Overall Study|Adverse Event|1|||
23332741|NCT01379768|64959141|FG001|Overall Study|Adverse Event|1|||
23332742|NCT01379768|64959142|FG002|Overall Study|Adverse Event|0|||
23332743|NCT01379768|64959140|FG000|Overall Study|Lost to Follow-up|2|||
23332744|NCT01379768|64959141|FG001|Overall Study|Lost to Follow-up|0|||
23332745|NCT01379768|64959142|FG002|Overall Study|Lost to Follow-up|0|||
23332746|NCT04185220|64959143|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
23332747|NCT04185220|64959144|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
23332748|NCT04185220|64959143|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
23332749|NCT04185220|64959144|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
23332750|NCT00427648|64959151|FG000|Overall Study|Protocol Violation|1|||
23332751|NCT00427648|64959152|FG001|Overall Study|Protocol Violation|2|||
23332752|NCT00427648|64959151|FG000|Overall Study|Adverse Event|0|||
23332753|NCT00427648|64959152|FG001|Overall Study|Adverse Event|1|||
23332754|NCT01346059|64959154|FG000|Overall Study|Withdrawal by Subject|1|||
23332755|NCT01346059|64959155|FG001|Overall Study|Withdrawal by Subject|0|||
23332756|NCT01057810|64959159|FG000|Overall Study|Disease progression|156|||
23332757|NCT01057810|64959160|FG001|Overall Study|Disease progression|197|||
23332758|NCT01057810|64959159|FG000|Overall Study|Study drug toxicity|5|||
23332759|NCT01057810|64959160|FG001|Overall Study|Study drug toxicity|114|||
23332760|NCT01057810|64959159|FG000|Overall Study|Adverse event unrelated to study drug|13|||
23332761|NCT01057810|64959160|FG001|Overall Study|Adverse event unrelated to study drug|29|||
23332762|NCT01057810|64959159|FG000|Overall Study|Withdrawal by Subject|10|||
23332763|NCT01057810|64959160|FG001|Overall Study|Withdrawal by Subject|25|||
23332764|NCT01057810|64959159|FG000|Overall Study|Death|2|||
23332765|NCT01057810|64959160|FG001|Overall Study|Death|12|||
23332766|NCT01057810|64959159|FG000|Overall Study|Maximum clinical benefit|5|||
23332767|NCT01057810|64959160|FG001|Overall Study|Maximum clinical benefit|5|||
23332768|NCT01057810|64959159|FG000|Overall Study|Poor/non-compliance|0|||
23332769|NCT01057810|64959160|FG001|Overall Study|Poor/non-compliance|1|||
23332770|NCT01057810|64959159|FG000|Overall Study|No longer met study criteria|0|||
23332771|NCT01057810|64959160|FG001|Overall Study|No longer met study criteria|1|||
23332772|NCT01057810|64959159|FG000|Overall Study|Other|7|||
23332773|NCT01057810|64959160|FG001|Overall Study|Other|14|||
23332774|NCT00765336|64959161|FG000|Overall Study|Protocol Violation|4|||
23332775|NCT00765336|64959162|FG001|Overall Study|Protocol Violation|2|||
23332776|NCT00765336|64959161|FG000|Overall Study|Withdrawal by Subject|6|||
23332777|NCT00765336|64959162|FG001|Overall Study|Withdrawal by Subject|4|||
23332778|NCT00765336|64959161|FG000|Overall Study|Lost to Follow-up|7|||
23332779|NCT00765336|64959162|FG001|Overall Study|Lost to Follow-up|9|||
23332780|NCT00765336|64959161|FG000|Overall Study|Adverse Event|2|||
23332781|NCT00765336|64959162|FG001|Overall Study|Adverse Event|1|||
23332782|NCT01441765|64959163|FG000|Overall Study|Death|1|||
23332783|NCT01441765|64959164|FG001|Overall Study|Death|0|||
23332784|NCT04707469|64959166|FG000|Overall Study|Site closure|0|||
23332785|NCT04707469|64959167|FG001|Overall Study|Site closure|2|||
23332786|NCT04707469|64959168|FG002|Overall Study|Site closure|0|||
23332787|NCT04707469|64959166|FG000|Overall Study|Physician Decision|2|||
23332788|NCT04707469|64959167|FG001|Overall Study|Physician Decision|2|||
23332789|NCT04707469|64959168|FG002|Overall Study|Physician Decision|2|||
23226562|NCT00994890|64571231|FG000|Overall Study|Lack of Efficacy|0|||
23226563|NCT00994890|64571232|FG001|Overall Study|Lack of Efficacy|0|||
23226564|NCT00994890|64571233|FG002|Overall Study|Lack of Efficacy|1|||
23332790|NCT04707469|64959166|FG000|Overall Study|Death|1|||
23332791|NCT04707469|64959167|FG001|Overall Study|Death|6|||
23332792|NCT04707469|64959168|FG002|Overall Study|Death|2|||
23574694|NCT00322374|65835383|FG002|Starting Dose|Physician Decision|0|||
23226565|NCT00994890|64571231|FG000|Overall Study|Lost to Follow-up|6|||
23226566|NCT00994890|64571232|FG001|Overall Study|Lost to Follow-up|1|||
23226567|NCT00994890|64571233|FG002|Overall Study|Lost to Follow-up|3|||
23226568|NCT00994890|64571231|FG000|Overall Study|No longer willing to participate|8|||
23226569|NCT00994890|64571232|FG001|Overall Study|No longer willing to participate|5|||
23226570|NCT00994890|64571233|FG002|Overall Study|No longer willing to participate|13|||
23226571|NCT00994890|64571231|FG000|Overall Study|Protocol Violation|2|||
23226572|NCT00994890|64571232|FG001|Overall Study|Protocol Violation|4|||
23226573|NCT00994890|64571233|FG002|Overall Study|Protocol Violation|0|||
23332793|NCT04707469|64959166|FG000|Overall Study|Lost to Follow-up|9|||
23332794|NCT04707469|64959167|FG001|Overall Study|Lost to Follow-up|19|||
23332795|NCT04707469|64959168|FG002|Overall Study|Lost to Follow-up|14|||
23332796|NCT04707469|64959166|FG000|Overall Study|Withdrawal by Subject|17|||
23332797|NCT04707469|64959167|FG001|Overall Study|Withdrawal by Subject|16|||
23332798|NCT04707469|64959168|FG002|Overall Study|Withdrawal by Subject|12|||
23332799|NCT02907177|64959169|FG000|Overall Study|Death|0|||
23226574|NCT00994890|64571231|FG000|Overall Study|Study terminated by sponsor|199|||
23226575|NCT00994890|64571232|FG001|Overall Study|Study terminated by sponsor|201|||
23226576|NCT00994890|64571233|FG002|Overall Study|Study terminated by sponsor|197|||
23226577|NCT00994890|64571231|FG000|Overall Study|Randomized, but not treated|1|||
23226578|NCT00994890|64571232|FG001|Overall Study|Randomized, but not treated|0|||
23226579|NCT00994890|64571233|FG002|Overall Study|Randomized, but not treated|0|||
23226580|NCT00994890|64571231|FG000|Overall Study|Other|2|||
23226581|NCT00994890|64571232|FG001|Overall Study|Other|2|||
23226582|NCT00994890|64571233|FG002|Overall Study|Other|1|||
23226583|NCT02365506|64571234|FG000|Overall Study|Investigator's Discretion|0|||
23226584|NCT02365506|64571235|FG001|Overall Study|Investigator's Discretion|0|||
23226585|NCT02365506|64571236|FG002|Overall Study|Investigator's Discretion|1|||
23332800|NCT02907177|64959170|FG001|Overall Study|Death|1|||
23332801|NCT02907177|64959169|FG000|Overall Study|Physician Decision|3|||
23332802|NCT02907177|64959170|FG001|Overall Study|Physician Decision|3|||
23332803|NCT02907177|64959169|FG000|Overall Study|Withdrawal by Subject|15|||
23332804|NCT02907177|64959170|FG001|Overall Study|Withdrawal by Subject|7|||
23332805|NCT02907177|64959169|FG000|Overall Study|Sponsor's Decision|50|||
23332806|NCT02907177|64959170|FG001|Overall Study|Sponsor's Decision|57|||
23332807|NCT02356588|64959171|FG000|Overall Study|Lack of Efficacy|4|||
23332808|NCT02356588|64959172|FG001|Overall Study|Lack of Efficacy|10|||
23332809|NCT02356588|64959171|FG000|Overall Study|Adverse Event|0|||
23332810|NCT02356588|64959172|FG001|Overall Study|Adverse Event|2|||
23332811|NCT02356588|64959171|FG000|Overall Study|Withdrawal by Subject|1|||
23332812|NCT02356588|64959172|FG001|Overall Study|Withdrawal by Subject|0|||
23332813|NCT02356588|64959171|FG000|Overall Study|Protocol Violation|0|||
23332814|NCT02356588|64959172|FG001|Overall Study|Protocol Violation|1|||
23332815|NCT00862823|64959176|FG000|First Intervention|Withdrawal by Subject|1|||
23332816|NCT00862823|64959177|FG001|First Intervention|Withdrawal by Subject|1|||
23332817|NCT00428246|64959178|FG000|Overall Study|Withdrawal by Subject|0|||
23332818|NCT00428246|64959179|FG001|Overall Study|Withdrawal by Subject|0|||
23332819|NCT00428246|64959180|FG002|Overall Study|Withdrawal by Subject|1|||
23332820|NCT00428246|64959178|FG000|Overall Study|Adverse Event|1|||
23332821|NCT00428246|64959179|FG001|Overall Study|Adverse Event|0|||
23332822|NCT00428246|64959180|FG002|Overall Study|Adverse Event|0|||
23332823|NCT00955955|64959181|FG000|Overall Study|Lost to Follow-up|2|||
23332824|NCT00955955|64959182|FG001|Overall Study|Lost to Follow-up|0|||
23332825|NCT00955955|64959183|FG002|Overall Study|Lost to Follow-up|0|||
23332826|NCT01996241|64959184|FG000|Overall Study|Lost to Follow-up|252|||
23332827|NCT01996241|64959185|FG001|Overall Study|Lost to Follow-up|235|||
23332828|NCT00961571|64959186|FG000|Overall Study|Physician Decision|39|||
23332829|NCT01134107|64959194|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
23332830|NCT01134107|64959195|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
23332831|NCT01134107|64959194|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
23332832|NCT01134107|64959195|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
23332833|NCT01134107|64959194|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
23332834|NCT01134107|64959195|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
23332835|NCT01134107|64959194|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
23226586|NCT00686699|64571238|FG000|Treatment Period 1|Adverse Event|0|||
23226587|NCT00686699|64571239|FG001|Treatment Period 1|Adverse Event|2|||
23226588|NCT00420212|64571240|FG000|Overall Study|Adverse Event|22|||
23226589|NCT00420212|64571241|FG001|Overall Study|Adverse Event|40|||
23226590|NCT00420212|64571242|FG002|Overall Study|Adverse Event|36|||
23226591|NCT00420212|64571240|FG000|Overall Study|Lost to Follow-up|9|||
23226592|NCT00420212|64571241|FG001|Overall Study|Lost to Follow-up|11|||
23332836|NCT01134107|64959195|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
23332837|NCT01134107|64959194|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
23332838|NCT01134107|64959195|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
23332839|NCT01134107|64959194|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
23332840|NCT01134107|64959195|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
23332841|NCT01134107|64959194|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
23332842|NCT01134107|64959195|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
23332843|NCT02593097|64959198|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
23447386|NCT00626275|65380419|FG002|Part B|Lost to Follow-up|0|||
23332844|NCT02593097|64959199|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
23332845|NCT02593097|64959198|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23332846|NCT02593097|64959199|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
23332847|NCT02593097|64959198|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
23332848|NCT02593097|64959199|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
23332849|NCT02593097|64959198|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
23332850|NCT02593097|64959199|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
23332851|NCT02593097|64959198|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
23332852|NCT02593097|64959199|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
23332853|NCT00952068|64959200|FG000|Overall Study|Adverse Event|3|||
23332854|NCT00952068|64959200|FG000|Overall Study|Withdrawal by Subject|4|||
23332855|NCT02019264|64959201|FG000|Overall Study|Not treated|6|||
23332856|NCT02019264|64959202|FG001|Overall Study|Not treated|4|||
23332857|NCT02019264|64959201|FG000|Overall Study|Lost to Follow-up|50|||
23332858|NCT02019264|64959202|FG001|Overall Study|Lost to Follow-up|47|||
23332859|NCT02019264|64959201|FG000|Overall Study|Withdrawal by Subject|142|||
23332860|NCT02019264|64959202|FG001|Overall Study|Withdrawal by Subject|117|||
23332861|NCT02019264|64959201|FG000|Overall Study|Administrative reason|36|||
23332862|NCT02019264|64959202|FG001|Overall Study|Administrative reason|28|||
23332863|NCT02019264|64959201|FG000|Overall Study|Missing|14|||
23332864|NCT02019264|64959202|FG001|Overall Study|Missing|11|||
23332865|NCT02088905|64959204|FG000|Overall Study|Withdrawal by Subject|5|||
23332866|NCT02088905|64959205|FG001|Overall Study|Withdrawal by Subject|1|||
23332867|NCT01964222|64959206|FG000|Overall Study|Lost to Follow-up|7|||
23332868|NCT01964222|64959207|FG001|Overall Study|Lost to Follow-up|5|||
23332869|NCT01964222|64959206|FG000|Overall Study|Withdrawal by Subject|6|||
23332870|NCT01964222|64959207|FG001|Overall Study|Withdrawal by Subject|6|||
23332871|NCT01964222|64959206|FG000|Overall Study|Screening Failure|2|||
23332872|NCT01964222|64959207|FG001|Overall Study|Screening Failure|0|||
23332873|NCT00110396|64959208|FG000|Overall Study|Adverse Event|15|||
23166190|NCT00953758|64356079|FG006|Overall Study|Disease progression|0|||
23332874|NCT00110396|64959208|FG000|Overall Study|Lost to Follow-up|1|||
23166191|NCT00953758|64356080|FG007|Overall Study|Disease progression|0|||
23166192|NCT00953758|64356081|FG008|Overall Study|Disease progression|0|||
23166193|NCT00953758|64356082|FG009|Overall Study|Disease progression|0|||
23166194|NCT00953758|64356073|FG000|Overall Study|Participant went for transplant|0|||
23166195|NCT00953758|64356074|FG001|Overall Study|Participant went for transplant|0|||
23166196|NCT00953758|64356075|FG002|Overall Study|Participant went for transplant|0|||
23166197|NCT00953758|64356076|FG003|Overall Study|Participant went for transplant|0|||
23166198|NCT00953758|64356077|FG004|Overall Study|Participant went for transplant|0|||
23166199|NCT00953758|64356078|FG005|Overall Study|Participant went for transplant|0|||
23166200|NCT00953758|64356079|FG006|Overall Study|Participant went for transplant|0|||
23166201|NCT00953758|64356080|FG007|Overall Study|Participant went for transplant|0|||
23226593|NCT00420212|64571242|FG002|Overall Study|Lost to Follow-up|11|||
23226594|NCT00420212|64571240|FG000|Overall Study|Withdrawal by Subject|31|||
23226595|NCT00420212|64571241|FG001|Overall Study|Withdrawal by Subject|22|||
23226596|NCT00420212|64571242|FG002|Overall Study|Withdrawal by Subject|19|||
23226597|NCT00420212|64571240|FG000|Overall Study|Physician Decision|4|||
23226598|NCT00420212|64571241|FG001|Overall Study|Physician Decision|4|||
23226599|NCT00420212|64571242|FG002|Overall Study|Physician Decision|3|||
23226600|NCT00420212|64571240|FG000|Overall Study|Protocol Violation|4|||
23226601|NCT00420212|64571241|FG001|Overall Study|Protocol Violation|4|||
23226602|NCT00420212|64571242|FG002|Overall Study|Protocol Violation|8|||
23226603|NCT00420212|64571240|FG000|Overall Study|Death|0|||
23226604|NCT00420212|64571241|FG001|Overall Study|Death|0|||
23226605|NCT00420212|64571242|FG002|Overall Study|Death|1|||
23226606|NCT00420212|64571240|FG000|Overall Study|Other-Unspecified|21|||
23226607|NCT00420212|64571241|FG001|Overall Study|Other-Unspecified|14|||
23226608|NCT00420212|64571242|FG002|Overall Study|Other-Unspecified|18|||
23226609|NCT01376908|64571245|FG000|Overall Study|Protocol Violation|1|||
23226610|NCT01376908|64571246|FG001|Overall Study|Protocol Violation|1|||
23226611|NCT01376908|64571245|FG000|Overall Study|Withdrawal by Subject|1|||
23226612|NCT01376908|64571246|FG001|Overall Study|Withdrawal by Subject|2|||
23226613|NCT00683774|64571248|FG000|Overall Study|Withdrawal by Subject|0|||
23226614|NCT00683774|64571249|FG001|Overall Study|Withdrawal by Subject|1|||
23226615|NCT00683774|64571248|FG000|Overall Study|Physician Decision|3|||
23226616|NCT00683774|64571249|FG001|Overall Study|Physician Decision|0|||
23226617|NCT05375838|64571250|FG000|Overall Study|Other|0|||
23226618|NCT05375838|64571251|FG001|Overall Study|Other|0|||
23226619|NCT05375838|64571252|FG002|Overall Study|Other|0|||
23226620|NCT05375838|64571253|FG003|Overall Study|Other|1|||
23226621|NCT05375838|64571254|FG004|Overall Study|Other|1|||
23226622|NCT05375838|64571255|FG005|Overall Study|Other|0|||
23332875|NCT00110396|64959208|FG000|Overall Study|Administration of plasmapheresis|1|||
23332876|NCT00110396|64959208|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
23332877|NCT00110396|64959208|FG000|Overall Study|Lack of Efficacy|1|||
23226623|NCT05375838|64571250|FG000|Overall Study|Withdrawal by Subject|2|||
23447387|NCT00626275|65380420|FG003|Part B|Lost to Follow-up|0|||
23166202|NCT00953758|64356081|FG008|Overall Study|Participant went for transplant|1|||
23166203|NCT00953758|64356082|FG009|Overall Study|Participant went for transplant|0|||
23166204|NCT01390272|64356083|FG000|Overall Study|Death|3|||
23166205|NCT01390272|64356084|FG001|Overall Study|Death|2|||
23166206|NCT01390272|64356083|FG000|Overall Study|Withdrawal by Subject|9|||
23166207|NCT01390272|64356084|FG001|Overall Study|Withdrawal by Subject|5|||
23166208|NCT01390272|64356083|FG000|Overall Study|Patient moved, no longer eligible|5|||
23166209|NCT01390272|64356084|FG001|Overall Study|Patient moved, no longer eligible|8|||
23332878|NCT00110396|64959208|FG000|Overall Study|Decided not to continue treatment|1|||
23332879|NCT00110396|64959208|FG000|Overall Study|Patient non-compliance|1|||
23332880|NCT00110396|64959208|FG000|Overall Study|Patient refused to continue|1|||
23332881|NCT00110396|64959208|FG000|Overall Study|Patient refused to participate|1|||
23332882|NCT00110396|64959208|FG000|Overall Study|Patient will|1|||
23332883|NCT00110396|64959208|FG000|Overall Study|Patient's decision|1|||
23332884|NCT00110396|64959208|FG000|Overall Study|Participation in MS vaccine study|1|||
23332885|NCT00110396|64959208|FG000|Overall Study|Pregnancy|1|||
23332886|NCT00110396|64959208|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
23332887|NCT00110396|64959208|FG000|Overall Study|Protocol Violation|2|||
23332888|NCT00110396|64959208|FG000|Overall Study|Patient refused to come back|1|||
23332889|NCT00110396|64959208|FG000|Overall Study|The patient has refused|2|||
23332890|NCT00110396|64959208|FG000|Overall Study|The patient has refused to visit site|1|||
23332891|NCT00110396|64959208|FG000|Overall Study|Patient is to be administered copaxone|1|||
23332892|NCT03051100|64959214|FG000|Overall Study|Withdrawal by Subject|1|||
23332893|NCT03051100|64959215|FG001|Overall Study|Withdrawal by Subject|0|||
23332894|NCT02525783|64959216|FG000|Overall Study|Lost to Follow-up|10|||
23332895|NCT01741688|64959217|FG000|Overall Study|Lack of insurance coverage|2|||
23332896|NCT01741688|64959217|FG000|Overall Study|Withdrawal by Subject|1|||
23332897|NCT00558701|64959226|FG000|Overall Study|Protocol Deviations|1|||
23332898|NCT00558701|64959227|FG001|Overall Study|Protocol Deviations|4|||
23332899|NCT00782626|64959228|FG000|Overall Study|Adverse Event|1|||
23332900|NCT00782626|64959228|FG000|Overall Study|Progressive Disease|5|||
23332901|NCT00782626|64959228|FG000|Overall Study|Other Complicating Disease|1|||
23332902|NCT00789373|64959232|FG000|Induction|Adverse Event|64|||
23332903|NCT00789373|64959233|FG001|Induction|Adverse Event|0|||
23332904|NCT00789373|64959234|FG002|Induction|Adverse Event|0|||
23332905|NCT00789373|64959232|FG000|Induction|Death Due to study disease|24|||
23332906|NCT00789373|64959233|FG001|Induction|Death Due to study disease|0|||
23332907|NCT00789373|64959234|FG002|Induction|Death Due to study disease|0|||
23332908|NCT00789373|64959232|FG000|Induction|Death due to adverse event|19|||
23332909|NCT00789373|64959233|FG001|Induction|Death due to adverse event|0|||
23332910|NCT00789373|64959234|FG002|Induction|Death due to adverse event|0|||
23332911|NCT00789373|64959232|FG000|Induction|Death due to toxicity|11|||
23332912|NCT00789373|64959233|FG001|Induction|Death due to toxicity|0|||
23332913|NCT00789373|64959234|FG002|Induction|Death due to toxicity|0|||
23332914|NCT00789373|64959232|FG000|Induction|Death due to procedure|1|||
23332915|NCT00789373|64959233|FG001|Induction|Death due to procedure|0|||
23332916|NCT00789373|64959234|FG002|Induction|Death due to procedure|0|||
23332917|NCT00789373|64959232|FG000|Induction|Investigator decision|7|||
23332918|NCT00789373|64959233|FG001|Induction|Investigator decision|0|||
23332919|NCT00789373|64959234|FG002|Induction|Investigator decision|0|||
23332920|NCT00789373|64959232|FG000|Induction|Protocol entry criteria not met|9|||
23332921|NCT00789373|64959233|FG001|Induction|Protocol entry criteria not met|0|||
23332922|NCT00789373|64959234|FG002|Induction|Protocol entry criteria not met|0|||
23332923|NCT00789373|64959232|FG000|Induction|Lost to Follow-up|6|||
23332924|NCT00789373|64959233|FG001|Induction|Lost to Follow-up|0|||
23332925|NCT00789373|64959234|FG002|Induction|Lost to Follow-up|0|||
23332926|NCT00789373|64959232|FG000|Induction|Protocol Violation|1|||
23332927|NCT00789373|64959233|FG001|Induction|Protocol Violation|0|||
23332928|NCT00789373|64959234|FG002|Induction|Protocol Violation|0|||
23332929|NCT00789373|64959232|FG000|Induction|Progressive Disease|220|||
23447388|NCT00626275|65380421|FG004|Part B|Lost to Follow-up|0|||
23332930|NCT00789373|64959233|FG001|Induction|Progressive Disease|0|||
23332931|NCT00789373|64959234|FG002|Induction|Progressive Disease|0|||
23332932|NCT00789373|64959232|FG000|Induction|Withdrawal by Subject|37|||
23447389|NCT00626275|65380422|FG005|Part B|Lost to Follow-up|0|||
23332933|NCT00789373|64959233|FG001|Induction|Withdrawal by Subject|0|||
23332934|NCT00789373|64959234|FG002|Induction|Withdrawal by Subject|0|||
23332935|NCT00789373|64959232|FG000|Maintenance|Adverse Event|0|||
23332936|NCT00789373|64959233|FG001|Maintenance|Adverse Event|65|||
23332937|NCT00789373|64959234|FG002|Maintenance|Adverse Event|12|||
23332938|NCT00789373|64959232|FG000|Maintenance|Death due to study disease|0|||
23332939|NCT00789373|64959233|FG001|Maintenance|Death due to study disease|3|||
23332940|NCT00789373|64959234|FG002|Maintenance|Death due to study disease|1|||
23332941|NCT00789373|64959232|FG000|Maintenance|Death due to adverse event|0|||
23332942|NCT00789373|64959233|FG001|Maintenance|Death due to adverse event|4|||
23332943|NCT00789373|64959234|FG002|Maintenance|Death due to adverse event|1|||
23332944|NCT00789373|64959232|FG000|Maintenance|Death due to toxicity|0|||
23332945|NCT00789373|64959233|FG001|Maintenance|Death due to toxicity|1|||
23332946|NCT00789373|64959234|FG002|Maintenance|Death due to toxicity|2|||
23332947|NCT00789373|64959232|FG000|Maintenance|Investigator Decision|0|||
23332948|NCT00789373|64959233|FG001|Maintenance|Investigator Decision|4|||
23332949|NCT00789373|64959234|FG002|Maintenance|Investigator Decision|2|||
23332950|NCT00789373|64959232|FG000|Maintenance|Protocol entry criteria not met|0|||
23332951|NCT00789373|64959233|FG001|Maintenance|Protocol entry criteria not met|2|||
23332952|NCT00789373|64959234|FG002|Maintenance|Protocol entry criteria not met|0|||
23332953|NCT00789373|64959232|FG000|Maintenance|Lost to Follow-up|0|||
23332954|NCT00789373|64959233|FG001|Maintenance|Lost to Follow-up|2|||
23332955|NCT00789373|64959234|FG002|Maintenance|Lost to Follow-up|0|||
23332956|NCT00789373|64959232|FG000|Maintenance|Progressive Disease|0|||
23332957|NCT00789373|64959233|FG001|Maintenance|Progressive Disease|253|||
23332958|NCT00789373|64959234|FG002|Maintenance|Progressive Disease|152|||
23332959|NCT00789373|64959232|FG000|Maintenance|Withdrawal by Subject|0|||
23332960|NCT00789373|64959233|FG001|Maintenance|Withdrawal by Subject|21|||
23332961|NCT00789373|64959234|FG002|Maintenance|Withdrawal by Subject|8|||
23332962|NCT00789373|64959232|FG000|Maintenance|Sponsor Decision|0|||
23332963|NCT00789373|64959233|FG001|Maintenance|Sponsor Decision|0|||
23332964|NCT00789373|64959234|FG002|Maintenance|Sponsor Decision|2|||
23332965|NCT00789373|64959232|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
23332966|NCT00789373|64959233|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
23332967|NCT00789373|64959234|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
23332968|NCT01592786|64959235|FG000|Overall Study|Adverse Event|60|||
23332969|NCT01592786|64959235|FG000|Overall Study|Lack of Efficacy|19|||
23332970|NCT01592786|64959235|FG000|Overall Study|Protocol Violation|14|||
23332971|NCT01592786|64959235|FG000|Overall Study|Withdrawal by Subject|23|||
23332972|NCT01592786|64959235|FG000|Overall Study|Lost to Follow-up|19|||
23332973|NCT01592786|64959235|FG000|Overall Study|Other|3|||
23332974|NCT01284348|64959236|FG000|Overall Study|Death|1|||
23332975|NCT01284348|64959237|FG001|Overall Study|Death|1|||
23332976|NCT01284348|64959236|FG000|Overall Study|Withdrew consent|0|||
23332977|NCT01284348|64959237|FG001|Overall Study|Withdrew consent|1|||
23332978|NCT01284348|64959236|FG000|Overall Study|Status not recorded|9|||
23332979|NCT01284348|64959237|FG001|Overall Study|Status not recorded|10|||
23332980|NCT02176655|64959238|FG000|Overall Study|Subjects did not treat|6|||
23332981|NCT01470248|64959239|FG000|Overall Study|Withdrawal by Subject|1|||
23332982|NCT00454246|64959240|FG000|Overall Study|Adverse Event|2|||
23332983|NCT00454246|64959241|FG001|Overall Study|Adverse Event|2|||
23332984|NCT00454246|64959242|FG002|Overall Study|Adverse Event|0|||
23332985|NCT00454246|64959240|FG000|Overall Study|Violation of selection criteria at entry|6|||
23332986|NCT00454246|64959241|FG001|Overall Study|Violation of selection criteria at entry|0|||
23332987|NCT00454246|64959242|FG002|Overall Study|Violation of selection criteria at entry|0|||
23332988|NCT00454246|64959240|FG000|Overall Study|Protocol Violation|1|||
23332989|NCT00454246|64959241|FG001|Overall Study|Protocol Violation|0|||
23332990|NCT00454246|64959242|FG002|Overall Study|Protocol Violation|0|||
23332991|NCT00454246|64959240|FG000|Overall Study|Refused Treatment|1|||
23166210|NCT01617460|64356085|FG000|Overall Study|Adverse Event|10|||
23166211|NCT01617460|64356085|FG000|Overall Study|Physician Decision|16|||
23166212|NCT01617460|64356085|FG000|Overall Study|Protocol Violation|5|||
23166213|NCT01617460|64356085|FG000|Overall Study|Withdrawal by Subject|9|||
23166214|NCT01618214|64356089|FG000|Overall Study|Adverse Event|3|||
23166215|NCT01618214|64356090|FG001|Overall Study|Adverse Event|1|||
23166216|NCT01618214|64356089|FG000|Overall Study|Lack of Efficacy|1|||
23166217|NCT01618214|64356090|FG001|Overall Study|Lack of Efficacy|1|||
23166218|NCT01618214|64356089|FG000|Overall Study|Protocol Violation|1|||
23166219|NCT01618214|64356090|FG001|Overall Study|Protocol Violation|4|||
23166220|NCT01618214|64356089|FG000|Overall Study|Withdrawal Criteria|1|||
23166221|NCT01618214|64356090|FG001|Overall Study|Withdrawal Criteria|2|||
23166222|NCT01618214|64356089|FG000|Overall Study|Unclassified|4|||
23166223|NCT01618214|64356090|FG001|Overall Study|Unclassified|5|||
23166224|NCT00390546|64356091|FG000|Overall Study|Renal impairment|1|||
23166225|NCT00390546|64356092|FG001|Overall Study|Renal impairment|0|||
23226624|NCT05375838|64571251|FG001|Overall Study|Withdrawal by Subject|1|||
23332992|NCT00454246|64959241|FG001|Overall Study|Refused Treatment|1|||
23332993|NCT00454246|64959242|FG002|Overall Study|Refused Treatment|0|||
23332994|NCT00454246|64959240|FG000|Overall Study|Failure to return|1|||
23332995|NCT00454246|64959241|FG001|Overall Study|Failure to return|0|||
23332996|NCT00454246|64959242|FG002|Overall Study|Failure to return|0|||
23332997|NCT00454246|64959240|FG000|Overall Study|Early termination of study|62|||
23332998|NCT00454246|64959241|FG001|Overall Study|Early termination of study|26|||
23166226|NCT00390546|64356091|FG000|Overall Study|Physician Decision|5|||
23226625|NCT05375838|64571252|FG002|Overall Study|Withdrawal by Subject|3|||
23332999|NCT00454246|64959242|FG002|Overall Study|Early termination of study|9|||
23333000|NCT00839800|64961838|FG000|Overall Study|Adverse Event|8|||
23333001|NCT00839800|64961839|FG001|Overall Study|Adverse Event|12|||
23166227|NCT00390546|64356092|FG001|Overall Study|Physician Decision|5|||
23166228|NCT00333359|64356095|FG000|Overall Study|Adverse Event|29|||
23226626|NCT05375838|64571253|FG003|Overall Study|Withdrawal by Subject|2|||
23333002|NCT00839800|64961838|FG000|Overall Study|Lost to Follow-up|31|||
23333003|NCT00839800|64961839|FG001|Overall Study|Lost to Follow-up|26|||
23333004|NCT00839800|64961838|FG000|Overall Study|Withdrawal by Subject|28|||
23333005|NCT00839800|64961839|FG001|Overall Study|Withdrawal by Subject|34|||
23333006|NCT00839800|64961838|FG000|Overall Study|Incorrect Enrolment|3|||
23333007|NCT00839800|64961839|FG001|Overall Study|Incorrect Enrolment|3|||
23333008|NCT00839800|64961838|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
23333009|NCT00839800|64961839|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
23333010|NCT00839800|64961838|FG000|Overall Study|Safety Reasons|2|||
23333011|NCT00839800|64961839|FG001|Overall Study|Safety Reasons|1|||
23333012|NCT00839800|64961838|FG000|Overall Study|Other|8|||
23333013|NCT00839800|64961839|FG001|Overall Study|Other|14|||
23333014|NCT00839800|64961838|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
23333015|NCT00839800|64961839|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
23333016|NCT00630825|64961841|FG000|Overall Study|Adverse Event|4|||
23333017|NCT00630825|64961842|FG001|Overall Study|Adverse Event|4|||
23333018|NCT00630825|64961843|FG002|Overall Study|Adverse Event|3|||
23333019|NCT00630825|64961844|FG003|Overall Study|Adverse Event|1|||
23333020|NCT00630825|64961841|FG000|Overall Study|Entry Criteria Not Met|1|||
23333021|NCT00630825|64961842|FG001|Overall Study|Entry Criteria Not Met|0|||
23333022|NCT00630825|64961843|FG002|Overall Study|Entry Criteria Not Met|2|||
23333023|NCT00630825|64961844|FG003|Overall Study|Entry Criteria Not Met|1|||
23333024|NCT00630825|64961841|FG000|Overall Study|Lost to Follow-up|1|||
23333025|NCT00630825|64961842|FG001|Overall Study|Lost to Follow-up|1|||
23447390|NCT00626275|65380423|FG006|Part B|Lost to Follow-up|1|||
23447391|NCT00626275|65380424|FG007|Part B|Lost to Follow-up|0|||
23447392|NCT00626275|65380417|FG000|Part B|Withdrawal by Subject|0|||
23574695|NCT00322374|65835384|FG003|Starting Dose|Physician Decision|0|||
23574696|NCT00322374|65835381|FG000|Starting Dose|Study Drug Toxicity|4|||
23574697|NCT00322374|65835382|FG001|Starting Dose|Study Drug Toxicity|0|||
23574698|NCT00322374|65835383|FG002|Starting Dose|Study Drug Toxicity|0|||
23574699|NCT00322374|65835384|FG003|Starting Dose|Study Drug Toxicity|0|||
23574700|NCT00322374|65835381|FG000|First Escalation|Documented Disease Progression|0|||
23166229|NCT00333359|64356096|FG001|Overall Study|Adverse Event|35|||
23166230|NCT00333359|64356095|FG000|Overall Study|Withdrawal by Subject|19|||
23574701|NCT00322374|65835382|FG001|First Escalation|Documented Disease Progression|6|||
23574702|NCT00322374|65835383|FG002|First Escalation|Documented Disease Progression|0|||
23574703|NCT00322374|65835384|FG003|First Escalation|Documented Disease Progression|0|||
23166231|NCT00333359|64356096|FG001|Overall Study|Withdrawal by Subject|37|||
23166232|NCT00333359|64356095|FG000|Overall Study|Physician Decision|2|||
23166233|NCT00333359|64356096|FG001|Overall Study|Physician Decision|2|||
23166234|NCT00333359|64356095|FG000|Overall Study|Protocol Non-compliance|2|||
23166235|NCT00333359|64356096|FG001|Overall Study|Protocol Non-compliance|8|||
23166236|NCT00333359|64356095|FG000|Overall Study|Lost to Follow-up|15|||
23166237|NCT00333359|64356096|FG001|Overall Study|Lost to Follow-up|25|||
23333026|NCT00630825|64961843|FG002|Overall Study|Lost to Follow-up|1|||
23333027|NCT00630825|64961844|FG003|Overall Study|Lost to Follow-up|1|||
23333028|NCT00630825|64961841|FG000|Overall Study|Physician Decision|1|||
23333029|NCT00630825|64961842|FG001|Overall Study|Physician Decision|0|||
23333030|NCT00630825|64961843|FG002|Overall Study|Physician Decision|0|||
23447393|NCT00626275|65380418|FG001|Part B|Withdrawal by Subject|0|||
23166238|NCT00333359|64356095|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
23226627|NCT05375838|64571254|FG004|Overall Study|Withdrawal by Subject|2|||
23226628|NCT05375838|64571255|FG005|Overall Study|Withdrawal by Subject|0|||
23226629|NCT05375838|64571250|FG000|Overall Study|Protocol Violation|0|||
23226630|NCT05375838|64571251|FG001|Overall Study|Protocol Violation|0|||
23574704|NCT00322374|65835381|FG000|First Escalation|Physician Decision|0|||
23574705|NCT00322374|65835382|FG001|First Escalation|Physician Decision|12|||
23574706|NCT00322374|65835383|FG002|First Escalation|Physician Decision|0|||
23574707|NCT00322374|65835384|FG003|First Escalation|Physician Decision|0|||
23574708|NCT00322374|65835381|FG000|First Escalation|Study Drug Toxicity|0|||
23574709|NCT00322374|65835382|FG001|First Escalation|Study Drug Toxicity|11|||
23574710|NCT00322374|65835383|FG002|First Escalation|Study Drug Toxicity|0|||
23574711|NCT00322374|65835384|FG003|First Escalation|Study Drug Toxicity|0|||
23574712|NCT00322374|65835381|FG000|First Escalation|Participant Request|0|||
23333031|NCT00630825|64961844|FG003|Overall Study|Physician Decision|0|||
23226631|NCT05375838|64571252|FG002|Overall Study|Protocol Violation|0|||
23226632|NCT05375838|64571253|FG003|Overall Study|Protocol Violation|0|||
23226633|NCT05375838|64571254|FG004|Overall Study|Protocol Violation|1|||
23226634|NCT05375838|64571255|FG005|Overall Study|Protocol Violation|0|||
23226635|NCT05375838|64571250|FG000|Overall Study|Physician Decision|0|||
23226636|NCT05375838|64571251|FG001|Overall Study|Physician Decision|1|||
23226637|NCT05375838|64571252|FG002|Overall Study|Physician Decision|0|||
23226638|NCT05375838|64571253|FG003|Overall Study|Physician Decision|0|||
23226639|NCT05375838|64571254|FG004|Overall Study|Physician Decision|0|||
23226640|NCT05375838|64571255|FG005|Overall Study|Physician Decision|1|||
23226641|NCT05375838|64571250|FG000|Overall Study|Lost to Follow-up|2|||
23226642|NCT05375838|64571251|FG001|Overall Study|Lost to Follow-up|7|||
23166239|NCT00333359|64356096|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
23166240|NCT00333359|64356095|FG000|Overall Study|Treatment Failure|3|||
23166241|NCT00333359|64356096|FG001|Overall Study|Treatment Failure|8|||
23166242|NCT00333359|64356095|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
23166243|NCT00333359|64356096|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
23166244|NCT01984268|64356097|FG000|Overall Study|Study Terminated|15|||
23166245|NCT03011333|64356098|FG000|Overall Study|Lost to Follow-up|0|||
23166246|NCT03011333|64356099|FG001|Overall Study|Lost to Follow-up|1|||
23166247|NCT03011333|64356100|FG002|Overall Study|Lost to Follow-up|0|||
23166248|NCT03011333|64356101|FG003|Overall Study|Lost to Follow-up|1|||
23166249|NCT03011333|64356102|FG004|Overall Study|Lost to Follow-up|4|||
23166250|NCT03011333|64356103|FG005|Overall Study|Lost to Follow-up|4|||
23166251|NCT03011333|64356104|FG006|Overall Study|Lost to Follow-up|5|||
23166252|NCT00252057|64356105|FG000|Overall Study|Withdrawal by Subject|2|||
23166253|NCT00252057|64356106|FG001|Overall Study|Withdrawal by Subject|5|||
23166254|NCT00252057|64356105|FG000|Overall Study|Death|1|||
23166255|NCT00252057|64356106|FG001|Overall Study|Death|2|||
23166256|NCT00252057|64356105|FG000|Overall Study|Participant previously enrolled|0|||
23166257|NCT00252057|64356106|FG001|Overall Study|Participant previously enrolled|1|||
23166258|NCT02064387|64356109|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23166259|NCT02064387|64356110|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23166260|NCT02064387|64356111|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23166261|NCT02064387|64356112|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23166262|NCT02064387|64356113|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23166263|NCT02064387|64356114|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23574713|NCT00322374|65835382|FG001|First Escalation|Participant Request|1|||
23574714|NCT00322374|65835383|FG002|First Escalation|Participant Request|0|||
23166264|NCT02064387|64356115|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23226643|NCT05375838|64571252|FG002|Overall Study|Lost to Follow-up|0|||
23226644|NCT05375838|64571253|FG003|Overall Study|Lost to Follow-up|4|||
23226645|NCT05375838|64571254|FG004|Overall Study|Lost to Follow-up|2|||
23574715|NCT00322374|65835384|FG003|First Escalation|Participant Request|0|||
23166265|NCT02064387|64356116|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
23226646|NCT05375838|64571255|FG005|Overall Study|Lost to Follow-up|3|||
23226647|NCT00122317|64571261|FG000|Overall Study|Death|3|||
23226648|NCT00122317|64571261|FG000|Overall Study|Adverse Event|4|||
23226649|NCT00122317|64571261|FG000|Overall Study|Physician Decision|2|||
23226650|NCT00122317|64571261|FG000|Overall Study|patient non-compliance|1|||
23574716|NCT00322374|65835381|FG000|Second Escalation|Physician Decision|0|||
23574717|NCT00322374|65835382|FG001|Second Escalation|Physician Decision|0|||
23574718|NCT00322374|65835383|FG002|Second Escalation|Physician Decision|5|||
23574719|NCT00322374|65835384|FG003|Second Escalation|Physician Decision|0|||
23574720|NCT00322374|65835381|FG000|Second Escalation|Study Drug Toxicity|0|||
23574721|NCT00322374|65835382|FG001|Second Escalation|Study Drug Toxicity|0|||
23574722|NCT00322374|65835383|FG002|Second Escalation|Study Drug Toxicity|1|||
23574723|NCT00322374|65835384|FG003|Second Escalation|Study Drug Toxicity|0|||
23574724|NCT01923389|65835386|FG000|Overall Study|Protocol Violation|1|||
23574725|NCT01923389|65835387|FG001|Overall Study|Protocol Violation|0|||
23574726|NCT04003974|65835394|FG000|Overall Study|Missing|1|||
23574727|NCT04003974|65835395|FG001|Overall Study|Missing|0|||
23574728|NCT04003974|65835394|FG000|Overall Study|Withdrawal by Subject|0|||
23574729|NCT04003974|65835395|FG001|Overall Study|Withdrawal by Subject|2|||
23574730|NCT01221181|65835396|FG000|Overall Study|Lost to Follow-up|1|||
23574731|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
23574732|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574733|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574734|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574735|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574736|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574737|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
23574738|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574739|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574740|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
23574741|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574742|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574743|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574744|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
23574745|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
23574746|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
23574747|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
23574748|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
23574749|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
23574750|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
23574751|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
23574752|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574753|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
23574754|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574755|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574756|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574757|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574758|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23574759|NCT03628924|65835397|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
23574760|NCT03628924|65835398|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574761|NCT03628924|65835399|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
23574762|NCT03628924|65835400|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574763|NCT03628924|65835401|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574764|NCT03628924|65835402|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574765|NCT03628924|65835403|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
23574766|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
23166266|NCT02064387|64356117|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23166267|NCT02064387|64356118|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
23166268|NCT02064387|64356119|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23166269|NCT02064387|64356120|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
23166270|NCT02064387|64356109|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166271|NCT02064387|64356110|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166272|NCT02064387|64356111|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166273|NCT02064387|64356112|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166274|NCT02064387|64356113|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166275|NCT02064387|64356114|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166276|NCT02064387|64356115|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166277|NCT02064387|64356116|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
23166278|NCT02064387|64356117|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166279|NCT02064387|64356118|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166280|NCT02064387|64356119|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23574767|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
23574768|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
23574769|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
23574770|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
23574771|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
23226651|NCT00122317|64571261|FG000|Overall Study|Withdrawal by Subject|1|||
23226652|NCT05104749|64571262|FG000|Overall Study|Lost to Follow-up|2|||
23226653|NCT05104749|64571263|FG001|Overall Study|Lost to Follow-up|3|||
23574772|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
23574773|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
23574774|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
23574775|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
23574776|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
23226654|NCT00844415|64571265|FG000|Overall Study|Withdrawal by Subject|1|||
23226655|NCT02044822|64571268|FG000|Overall Study|Study Terminated by Sponsor|77|||
23226656|NCT02044822|64571268|FG000|Overall Study|Investigator's Discretion|10|||
23166281|NCT02064387|64356120|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
23166282|NCT02064387|64356109|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23166283|NCT02064387|64356110|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23166284|NCT02064387|64356111|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23166285|NCT02064387|64356112|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23166286|NCT02064387|64356113|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23574777|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
23574778|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
23574779|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
23574780|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
23574781|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
23574782|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
23574783|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
23574784|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
23574785|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
23574786|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
23574787|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
23574788|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
23333032|NCT00630825|64961841|FG000|Overall Study|Withdrawal by Subject|2|||
23333033|NCT00630825|64961842|FG001|Overall Study|Withdrawal by Subject|2|||
23333034|NCT00630825|64961843|FG002|Overall Study|Withdrawal by Subject|2|||
23333035|NCT00630825|64961844|FG003|Overall Study|Withdrawal by Subject|3|||
23333036|NCT05253573|64961849|FG000|Overall Study|Death|1|||
23333037|NCT05253573|64961850|FG001|Overall Study|Death|0|||
23333038|NCT01921101|64961859|FG000|Overall Study|Death|16|||
23333039|NCT01921101|64961860|FG001|Overall Study|Death|6|||
23574789|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
23166287|NCT02064387|64356114|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23226657|NCT02044822|64571268|FG000|Overall Study|Withdrew Consent|3|||
23333040|NCT02684097|64961864|FG000|Overall Study|Lack of Efficacy|13|||
23333041|NCT02684097|64961865|FG001|Overall Study|Lack of Efficacy|6|||
23333042|NCT02283268|64961873|FG000|Overall Study|Withdrawal by Subject|1|||
23226658|NCT02044822|64571268|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
23226659|NCT02044822|64571268|FG000|Overall Study|Lost to Follow-up|1|||
23226660|NCT02513394|64571271|FG000|Overall Study|Withdrawal by Subject|11|||
23226661|NCT02513394|64571272|FG001|Overall Study|Withdrawal by Subject|23|||
23226662|NCT02513394|64571271|FG000|Overall Study|Ineligible|1|||
23226663|NCT02513394|64571272|FG001|Overall Study|Ineligible|0|||
23226664|NCT02243306|64571273|FG000|Overall Study|Adverse Event|0|||
23226665|NCT02243306|64571274|FG001|Overall Study|Adverse Event|1|||
23226666|NCT02243306|64571273|FG000|Overall Study|Other: Reached stopping criteria|0|||
23226667|NCT02243306|64571274|FG001|Overall Study|Other: Reached stopping criteria|1|||
23226668|NCT02243306|64571273|FG000|Overall Study|Physician Decision|0|||
23226669|NCT02243306|64571274|FG001|Overall Study|Physician Decision|1|||
23226670|NCT00403390|64571275|FG000|Overall Study|Withdrawal by Subject|1|||
23226671|NCT00403390|64571276|FG001|Overall Study|Withdrawal by Subject|0|||
23226672|NCT00403390|64571275|FG000|Overall Study|samples lost|1|||
23226673|NCT00403390|64571276|FG001|Overall Study|samples lost|0|||
23226674|NCT00403390|64571275|FG000|Overall Study|non-compliant|1|||
23226675|NCT00403390|64571276|FG001|Overall Study|non-compliant|0|||
23226676|NCT00589602|64571277|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
23226677|NCT02565576|64571278|FG000|Overall Study|abnormal lab value|2|||
23226678|NCT02565576|64571279|FG001|Overall Study|abnormal lab value|0|||
23226679|NCT02565576|64571278|FG000|Overall Study|subject / guardian decision|1|||
23226680|NCT02565576|64571279|FG001|Overall Study|subject / guardian decision|3|||
23226681|NCT02565576|64571278|FG000|Overall Study|Lost to Follow-up|1|||
23226682|NCT02565576|64571279|FG001|Overall Study|Lost to Follow-up|0|||
23574790|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
23574791|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
23574792|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
23574793|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
23574794|NCT03628924|65835397|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
23574795|NCT03628924|65835398|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
23574796|NCT03628924|65835399|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
23574797|NCT03628924|65835400|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
23574798|NCT03628924|65835401|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
23574799|NCT03628924|65835402|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
23574800|NCT03628924|65835403|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
23574801|NCT01959880|65835406|FG000|Overall Study|Withdrawal by Subject|11|||
23574802|NCT01959880|65835407|FG001|Overall Study|Withdrawal by Subject|13|||
23574803|NCT01959880|65835408|FG002|Overall Study|Withdrawal by Subject|8|||
23574804|NCT01959880|65835409|FG003|Overall Study|Withdrawal by Subject|7|||
23574805|NCT01959880|65835406|FG000|Overall Study|Death|1|||
23574806|NCT01959880|65835407|FG001|Overall Study|Death|10|||
23574807|NCT01959880|65835408|FG002|Overall Study|Death|1|||
23574808|NCT01959880|65835409|FG003|Overall Study|Death|2|||
23574809|NCT01959880|65835406|FG000|Overall Study|Lost to Follow-up|95|||
23574810|NCT01959880|65835407|FG001|Overall Study|Lost to Follow-up|18|||
23574811|NCT01959880|65835408|FG002|Overall Study|Lost to Follow-up|15|||
23574812|NCT01959880|65835409|FG003|Overall Study|Lost to Follow-up|8|||
23574813|NCT01959880|65835406|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
23574814|NCT01959880|65835407|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
23574815|NCT01959880|65835408|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
23574816|NCT01959880|65835409|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
23574817|NCT01959880|65835406|FG000|Overall Study|Study completed early-FDA approved|1003|||
23574818|NCT01959880|65835407|FG001|Overall Study|Study completed early-FDA approved|311|||
23574819|NCT01959880|65835408|FG002|Overall Study|Study completed early-FDA approved|179|||
23574820|NCT01959880|65835409|FG003|Overall Study|Study completed early-FDA approved|152|||
23574821|NCT01333943|65835410|FG000|Overall Study|Known neuropathy|1|||
23574822|NCT01333943|65835411|FG001|Overall Study|Known neuropathy|0|||
23574823|NCT03606460|65835412|FG000|Overall Study|Lost to Follow-up|1|||
23574824|NCT03606460|65835413|FG001|Overall Study|Lost to Follow-up|8|||
23574825|NCT01708187|65835414|FG000|Overall Study|Lost to Follow-up|0|||
23574826|NCT01708187|65835415|FG001|Overall Study|Lost to Follow-up|1|||
23574827|NCT01857323|65835418|FG000|Overall Study|Adverse Event|1|||
23574828|NCT01857323|65835418|FG000|Overall Study|Withdrawal by Subject|3|||
23226683|NCT02565576|64571278|FG000|Overall Study|Death|0|||
23226684|NCT02565576|64571279|FG001|Overall Study|Death|2|||
23226685|NCT02565576|64571278|FG000|Overall Study|Adverse Event|1|||
23226686|NCT02565576|64571279|FG001|Overall Study|Adverse Event|0|||
23226687|NCT02608892|64571280|FG000|Overall Study|Lost to Follow-up|1|||
23226688|NCT02608892|64571281|FG001|Overall Study|Lost to Follow-up|0|||
23226689|NCT00372489|64571283|FG000|Overall Study|Adverse Event|18|||
23226690|NCT00372489|64571283|FG000|Overall Study|Lack of Efficacy|1|||
23226691|NCT00372489|64571283|FG000|Overall Study|Lost to Follow-up|3|||
23226692|NCT00372489|64571283|FG000|Overall Study|Physician Decision|3|||
23226693|NCT00372489|64571283|FG000|Overall Study|Withdrawal by Subject|5|||
23226694|NCT00372489|64571283|FG000|Overall Study|Patient Relocation|2|||
23226695|NCT00372489|64571283|FG000|Overall Study|Renal transplant|6|||
23166288|NCT02064387|64356115|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23166289|NCT02064387|64356116|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23166290|NCT02064387|64356117|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
23166291|NCT02064387|64356118|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23166292|NCT02064387|64356119|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23166293|NCT02064387|64356120|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
23166294|NCT02064387|64356109|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
23166295|NCT02064387|64356110|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
23166296|NCT02064387|64356111|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
23166297|NCT02064387|64356112|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
23166298|NCT02064387|64356113|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
23166299|NCT02064387|64356114|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
23166300|NCT02064387|64356115|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
23166301|NCT02064387|64356116|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
23166302|NCT02064387|64356117|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
23166303|NCT02064387|64356118|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
23166304|NCT02064387|64356119|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
23166305|NCT02064387|64356120|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
23166306|NCT02064387|64356109|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166307|NCT02064387|64356110|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166308|NCT02064387|64356111|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166309|NCT02064387|64356112|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166310|NCT02064387|64356113|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166311|NCT02064387|64356114|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166312|NCT02064387|64356115|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166313|NCT02064387|64356116|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166314|NCT02064387|64356117|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166315|NCT02064387|64356118|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166316|NCT02064387|64356119|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
23166317|NCT02064387|64356120|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
23166318|NCT03603496|64356121|FG000|Overall Study|Death|19|||
23166319|NCT03603496|64356122|FG001|Overall Study|Death|24|||
23166320|NCT03603496|64356121|FG000|Overall Study|Lost to Follow-up|141|||
23166321|NCT03603496|64356122|FG001|Overall Study|Lost to Follow-up|141|||
23166322|NCT03603496|64356121|FG000|Overall Study|Withdrawal by Subject|26|||
23166323|NCT03603496|64356122|FG001|Overall Study|Withdrawal by Subject|20|||
23166324|NCT01536860|64356123|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
23166325|NCT01536860|64356124|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
23166326|NCT01536860|64356125|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
23166327|NCT02788747|64356130|FG000|Overall Study|Adverse Event|1|||
23166328|NCT02788747|64356131|FG001|Overall Study|Adverse Event|0|||
23166329|NCT02788747|64356132|FG002|Overall Study|Adverse Event|0|||
23166330|NCT01135498|64356135|FG000|Overall Study|Adverse Event|20|||
23166331|NCT01135498|64356135|FG000|Overall Study|Progressive disease|38|||
23166332|NCT01135498|64356135|FG000|Overall Study|Investigator judgement|25|||
23166333|NCT01135498|64356135|FG000|Overall Study|Withdrawal by Subject|4|||
23166334|NCT01135498|64356135|FG000|Overall Study|Death|1|||
23166335|NCT01135498|64356135|FG000|Overall Study|Ongoing at time of analysis|2|||
23166336|NCT00205855|64356138|FG000|Overall Study|Only received temporary implants|16|||
23166337|NCT00205855|64356138|FG000|Overall Study|Withdrawal by Subject|5|||
23166338|NCT03110900|64356141|FG000|Overall Study|Sponsor withdrew|1|||
23166339|NCT03110900|64356142|FG001|Overall Study|Sponsor withdrew|1|||
23166340|NCT02164981|64356144|FG000|Started|Withdrawal by Subject|2|||
23166341|NCT02164981|64356145|FG001|Started|Withdrawal by Subject|1|||
23166342|NCT02164981|64356146|FG002|Started|Withdrawal by Subject|0|||
23166343|NCT02164981|64356144|FG000|Started|Protocol Violation|2|||
23166344|NCT02164981|64356145|FG001|Started|Protocol Violation|0|||
23166345|NCT02164981|64356146|FG002|Started|Protocol Violation|0|||
23166346|NCT02164981|64356144|FG000|Started|Adverse Event|1|||
23166347|NCT02164981|64356145|FG001|Started|Adverse Event|2|||
23166348|NCT02164981|64356146|FG002|Started|Adverse Event|0|||
23166349|NCT02164981|64356144|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
23166350|NCT02164981|64356145|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
23166351|NCT02164981|64356146|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
23166352|NCT02164981|64356144|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
23166353|NCT02164981|64356145|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
23166354|NCT02164981|64356146|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
23166355|NCT02164981|64356144|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
23166356|NCT02164981|64356145|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
23166357|NCT02164981|64356146|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
23166358|NCT01453855|64356147|FG000|Overall Study|Adverse Event|3|||
23166359|NCT01453855|64356148|FG001|Overall Study|Adverse Event|4|||
23166360|NCT01453855|64356147|FG000|Overall Study|Lost to Follow-up|2|||
23166361|NCT01453855|64356148|FG001|Overall Study|Lost to Follow-up|1|||
23166362|NCT01453855|64356147|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
23166363|NCT01453855|64356148|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
23166364|NCT01453855|64356147|FG000|Overall Study|Noncompliance|1|||
23166365|NCT01453855|64356148|FG001|Overall Study|Noncompliance|0|||
23166366|NCT01453855|64356147|FG000|Overall Study|Inadequate Control of IOP|1|||
23166367|NCT01453855|64356148|FG001|Overall Study|Inadequate Control of IOP|5|||
23166368|NCT01453855|64356147|FG000|Overall Study|Other|0|||
23166369|NCT01453855|64356148|FG001|Overall Study|Other|1|||
23166370|NCT00513500|64356149|FG000|Overall Study|Lost to Follow-up|35|||
23166371|NCT00513500|64356150|FG001|Overall Study|Lost to Follow-up|39|||
23166372|NCT00513500|64356149|FG000|Overall Study|Death|2|||
23166373|NCT00513500|64356150|FG001|Overall Study|Death|1|||
23166374|NCT00513500|64356149|FG000|Overall Study|Hospitalized|4|||
23166375|NCT00513500|64356150|FG001|Overall Study|Hospitalized|14|||
23166376|NCT02002975|64356153|FG000|Overall Study|Case Report Forms Uncollected|135|||
23166377|NCT02002975|64356153|FG000|Overall Study|Protocol Deviation|437|||
23166378|NCT00903175|64356154|FG000|Period 1 - First Line|Adverse Event|36|||
23166379|NCT00903175|64356155|FG001|Period 1 - First Line|Adverse Event|50|||
23166380|NCT00903175|64356154|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
23166381|NCT00903175|64356155|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
23166382|NCT00903175|64356154|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
23166383|NCT00903175|64356155|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
23166384|NCT00903175|64356154|FG000|Period 1 - First Line|Protocol Violation|3|||
23166385|NCT00903175|64356155|FG001|Period 1 - First Line|Protocol Violation|3|||
23166386|NCT00903175|64356154|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
23166387|NCT00903175|64356155|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
23166388|NCT00903175|64356154|FG000|Period 1 - First Line|Administrative problems|12|||
23166389|NCT00903175|64356155|FG001|Period 1 - First Line|Administrative problems|13|||
23166390|NCT00903175|64356154|FG000|Period 1 - First Line|Death|17|||
23166391|NCT00903175|64356155|FG001|Period 1 - First Line|Death|10|||
23166392|NCT00903175|64356154|FG000|Period 2 - Second Line|Missing|1|||
23166393|NCT00903175|64356155|FG001|Period 2 - Second Line|Missing|0|||
23166394|NCT00903175|64356154|FG000|Period 2 - Second Line|Adverse Event|16|||
23166395|NCT00903175|64356155|FG001|Period 2 - Second Line|Adverse Event|20|||
23166396|NCT00903175|64356154|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
23166397|NCT00903175|64356155|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
23166398|NCT00903175|64356154|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
23166399|NCT00903175|64356155|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
23166400|NCT00903175|64356154|FG000|Period 2 - Second Line|Administrative problems|19|||
23166401|NCT00903175|64356155|FG001|Period 2 - Second Line|Administrative problems|9|||
23166402|NCT00903175|64356154|FG000|Period 2 - Second Line|Death|5|||
23166403|NCT00903175|64356155|FG001|Period 2 - Second Line|Death|2|||
23166404|NCT00430508|64356156|FG000|Overall Study|Adverse Event|2|||
23166405|NCT00430508|64356157|FG001|Overall Study|Adverse Event|3|||
23166406|NCT00430508|64356158|FG002|Overall Study|Adverse Event|5|||
23166407|NCT00430508|64356159|FG003|Overall Study|Adverse Event|3|||
23166408|NCT00430508|64356156|FG000|Overall Study|Withdrawal by Subject|0|||
23166409|NCT00430508|64356157|FG001|Overall Study|Withdrawal by Subject|1|||
23166410|NCT00430508|64356158|FG002|Overall Study|Withdrawal by Subject|1|||
23166411|NCT00430508|64356159|FG003|Overall Study|Withdrawal by Subject|1|||
23166412|NCT00430508|64356156|FG000|Overall Study|responder at visit 4|0|||
23166413|NCT00430508|64356157|FG001|Overall Study|responder at visit 4|0|||
23166414|NCT00430508|64356158|FG002|Overall Study|responder at visit 4|2|||
23166415|NCT00430508|64356159|FG003|Overall Study|responder at visit 4|0|||
23166416|NCT00430508|64356156|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
23166417|NCT00430508|64356157|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
23166418|NCT00430508|64356158|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
23166419|NCT00430508|64356159|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
23166420|NCT00430508|64356156|FG000|Overall Study|Other|1|||
23166421|NCT00430508|64356157|FG001|Overall Study|Other|1|||
23166422|NCT00430508|64356158|FG002|Overall Study|Other|3|||
23166423|NCT00430508|64356159|FG003|Overall Study|Other|0|||
23166424|NCT00845728|64356160|FG000|Overall Study|Abnormal laboratory value (s)|2|||
23166425|NCT00845728|64356161|FG001|Overall Study|Abnormal laboratory value (s)|2|||
23166426|NCT00845728|64356160|FG000|Overall Study|Patient's inability to use the device|4|||
23166427|NCT00845728|64356161|FG001|Overall Study|Patient's inability to use the device|6|||
23166428|NCT00845728|64356160|FG000|Overall Study|Abnormal test procedure result (s)|7|||
23166429|NCT00845728|64356161|FG001|Overall Study|Abnormal test procedure result (s)|2|||
23166430|NCT00845728|64356160|FG000|Overall Study|Lost to Follow-up|22|||
23166431|NCT00845728|64356161|FG001|Overall Study|Lost to Follow-up|13|||
23166432|NCT00845728|64356160|FG000|Overall Study|Death|24|||
23166433|NCT00845728|64356161|FG001|Overall Study|Death|26|||
23166434|NCT00845728|64356160|FG000|Overall Study|Administrative Problems|34|||
23166435|NCT00845728|64356161|FG001|Overall Study|Administrative Problems|26|||
23574829|NCT01857323|65835418|FG000|Overall Study|Non-compliance|1|||
23166436|NCT00845728|64356160|FG000|Overall Study|Protocol Violation|36|||
23166437|NCT00845728|64356161|FG001|Overall Study|Protocol Violation|24|||
23574830|NCT01857323|65835418|FG000|Overall Study|Protocol Violation|6|||
23574831|NCT01857323|65835418|FG000|Overall Study|Lost to Follow-up|1|||
23574832|NCT01857323|65835418|FG000|Overall Study|Other|4|||
23574833|NCT01857323|65835418|FG000|Overall Study|Did not complete 180 doses|48|||
23574834|NCT02564055|65835419|FG000|Overall Study|Adverse Event|1|||
23574835|NCT02564055|65835420|FG001|Overall Study|Adverse Event|0|||
23574836|NCT02564055|65835421|FG002|Overall Study|Adverse Event|4|||
23574837|NCT02564055|65835422|FG003|Overall Study|Adverse Event|1|||
23574838|NCT02564055|65835423|FG004|Overall Study|Adverse Event|4|||
23574839|NCT02564055|65835424|FG005|Overall Study|Adverse Event|1|||
23574840|NCT02564055|65835419|FG000|Overall Study|Protocol Violation|1|||
23574841|NCT02564055|65835420|FG001|Overall Study|Protocol Violation|0|||
23574842|NCT02564055|65835421|FG002|Overall Study|Protocol Violation|0|||
23166438|NCT00845728|64356160|FG000|Overall Study|Lack of Efficacy|51|||
23226696|NCT00372489|64571283|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
23226697|NCT01594411|64571286|FG000|Overall Study|Lost to Follow-up|2|||
23226698|NCT02253992|64571287|FG000|Overall Study|Study drug toxicity|1|||
23226699|NCT02253992|64571288|FG001|Overall Study|Study drug toxicity|0|||
23226700|NCT02253992|64571289|FG002|Overall Study|Study drug toxicity|10|||
23166439|NCT00845728|64356161|FG001|Overall Study|Lack of Efficacy|39|||
23166440|NCT00845728|64356160|FG000|Overall Study|Adverse Event|101|||
23166441|NCT00845728|64356161|FG001|Overall Study|Adverse Event|96|||
23166442|NCT00845728|64356160|FG000|Overall Study|Withdrawal by Subject|105|||
23166443|NCT00845728|64356161|FG001|Overall Study|Withdrawal by Subject|108|||
23166444|NCT01934556|64356165|FG000|Overall Study|Withdrawal by Subject|0|||
23166445|NCT01934556|64356166|FG001|Overall Study|Withdrawal by Subject|1|||
23166446|NCT01934556|64356167|FG002|Overall Study|Withdrawal by Subject|1|||
23166447|NCT01934556|64356165|FG000|Overall Study|Lost to Follow-up|4|||
23166448|NCT01934556|64356166|FG001|Overall Study|Lost to Follow-up|10|||
23166449|NCT01934556|64356167|FG002|Overall Study|Lost to Follow-up|7|||
23166450|NCT01934556|64356165|FG000|Overall Study|Death|1|||
23166451|NCT01934556|64356166|FG001|Overall Study|Death|5|||
23166452|NCT01934556|64356167|FG002|Overall Study|Death|2|||
23166453|NCT01902290|64356168|FG000|Overall Study|Withdrawal by Subject|19|||
23166454|NCT01902290|64356169|FG001|Overall Study|Withdrawal by Subject|27|||
23166455|NCT01902290|64356168|FG000|Overall Study|Lost to Follow-up|2|||
23166456|NCT01902290|64356169|FG001|Overall Study|Lost to Follow-up|2|||
23166457|NCT01902290|64356168|FG000|Overall Study|Death|1|||
23166458|NCT01902290|64356169|FG001|Overall Study|Death|0|||
23166459|NCT01902290|64356168|FG000|Overall Study|Sponsor Decision|26|||
23166460|NCT01902290|64356169|FG001|Overall Study|Sponsor Decision|24|||
23166461|NCT00091832|64356170|FG000|Overall Study|Physician Decision|1|||
23166462|NCT00091832|64356171|FG001|Overall Study|Physician Decision|0|||
23166463|NCT00091832|64356172|FG002|Overall Study|Physician Decision|0|||
23166464|NCT00091832|64356173|FG003|Overall Study|Physician Decision|0|||
23166465|NCT00091832|64356174|FG004|Overall Study|Physician Decision|0|||
23166466|NCT00091832|64356175|FG005|Overall Study|Physician Decision|0|||
23166467|NCT00091832|64356170|FG000|Overall Study|Adverse Event|0|||
23166468|NCT00091832|64356171|FG001|Overall Study|Adverse Event|0|||
23166469|NCT00091832|64356172|FG002|Overall Study|Adverse Event|0|||
23166470|NCT00091832|64356173|FG003|Overall Study|Adverse Event|1|||
23166471|NCT00091832|64356174|FG004|Overall Study|Adverse Event|3|||
23166472|NCT00091832|64356175|FG005|Overall Study|Adverse Event|0|||
23166473|NCT00091832|64356170|FG000|Overall Study|Withdrawal by Subject|4|||
23166474|NCT00091832|64356171|FG001|Overall Study|Withdrawal by Subject|5|||
23166475|NCT00091832|64356172|FG002|Overall Study|Withdrawal by Subject|0|||
23166476|NCT00091832|64356173|FG003|Overall Study|Withdrawal by Subject|1|||
23166477|NCT00091832|64356174|FG004|Overall Study|Withdrawal by Subject|3|||
23166478|NCT00091832|64356175|FG005|Overall Study|Withdrawal by Subject|1|||
23166479|NCT00091832|64356170|FG000|Overall Study|Death|6|||
23166480|NCT00091832|64356171|FG001|Overall Study|Death|4|||
23166481|NCT00091832|64356172|FG002|Overall Study|Death|5|||
23166482|NCT00091832|64356173|FG003|Overall Study|Death|8|||
23166483|NCT00091832|64356174|FG004|Overall Study|Death|5|||
23226701|NCT02253992|64571287|FG000|Overall Study|Disease progression|4|||
23226702|NCT02253992|64571288|FG001|Overall Study|Disease progression|3|||
23226703|NCT02253992|64571289|FG002|Overall Study|Disease progression|98|||
23226704|NCT02253992|64571287|FG000|Overall Study|Withdrawal by Subject|0|||
23166484|NCT00091832|64356175|FG005|Overall Study|Death|6|||
23166485|NCT00091832|64356170|FG000|Overall Study|Disease Progression|2|||
23166486|NCT00091832|64356171|FG001|Overall Study|Disease Progression|0|||
23166487|NCT00091832|64356172|FG002|Overall Study|Disease Progression|0|||
23226705|NCT02253992|64571288|FG001|Overall Study|Withdrawal by Subject|0|||
23226706|NCT02253992|64571289|FG002|Overall Study|Withdrawal by Subject|3|||
23574843|NCT02564055|65835422|FG003|Overall Study|Protocol Violation|0|||
23166488|NCT00091832|64356173|FG003|Overall Study|Disease Progression|1|||
23226707|NCT02253992|64571287|FG000|Overall Study|Adverse Event|0|||
23226708|NCT02253992|64571288|FG001|Overall Study|Adverse Event|0|||
23333043|NCT00154284|64961874|FG000|Overall Study|Adverse Event|6|||
23333044|NCT00154284|64961875|FG001|Overall Study|Adverse Event|9|||
23333045|NCT00154284|64961874|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23333046|NCT00154284|64961875|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23333047|NCT00154284|64961874|FG000|Overall Study|Lack of Efficacy|1|||
23166489|NCT00091832|64356174|FG004|Overall Study|Disease Progression|1|||
23166490|NCT00091832|64356175|FG005|Overall Study|Disease Progression|2|||
23166491|NCT00091832|64356170|FG000|Overall Study|Ineligibility Determined|0|||
23333048|NCT00154284|64961875|FG001|Overall Study|Lack of Efficacy|2|||
23333049|NCT00154284|64961874|FG000|Overall Study|Protocol Violation|0|||
23333050|NCT00154284|64961875|FG001|Overall Study|Protocol Violation|1|||
23333051|NCT00931528|64961876|FG000|Overall Study|Protocol Violation|9|||
23333052|NCT00931528|64961877|FG001|Overall Study|Protocol Violation|12|||
23333053|NCT00931528|64961876|FG000|Overall Study|Withdrawal by Subject|4|||
23333054|NCT00931528|64961877|FG001|Overall Study|Withdrawal by Subject|12|||
23333055|NCT00931528|64961876|FG000|Overall Study|Lost to Follow-up|6|||
23333056|NCT00931528|64961877|FG001|Overall Study|Lost to Follow-up|13|||
23333057|NCT00931528|64961876|FG000|Overall Study|Assessment outside of Time Frame|22|||
23333058|NCT00931528|64961877|FG001|Overall Study|Assessment outside of Time Frame|23|||
23333059|NCT02504827|64961878|FG000|Overall Study|Could not produce sputum|1|||
23333060|NCT01704495|64961879|FG000|Subjects Randomized|Other Reason|3|||
23333061|NCT01704495|64961880|FG001|Subjects Randomized|Other Reason|2|||
23333062|NCT01704495|64961881|FG002|Subjects Randomized|Other Reason|3|||
23333063|NCT01704495|64961882|FG003|Subjects Randomized|Other Reason|2|||
23333064|NCT01704495|64961879|FG000|Subjects Randomized|Discontinuation criteria met|4|||
23333065|NCT01704495|64961880|FG001|Subjects Randomized|Discontinuation criteria met|2|||
23333066|NCT01704495|64961881|FG002|Subjects Randomized|Discontinuation criteria met|2|||
23333067|NCT01704495|64961882|FG003|Subjects Randomized|Discontinuation criteria met|0|||
23333068|NCT01704495|64961879|FG000|Subjects Randomized|Adverse Event|8|||
23333069|NCT01704495|64961880|FG001|Subjects Randomized|Adverse Event|2|||
23333070|NCT01704495|64961881|FG002|Subjects Randomized|Adverse Event|0|||
23333071|NCT01704495|64961882|FG003|Subjects Randomized|Adverse Event|7|||
23333072|NCT01704495|64961879|FG000|Subjects Randomized|Withdrawal by Subject|5|||
23333073|NCT01704495|64961880|FG001|Subjects Randomized|Withdrawal by Subject|5|||
23333074|NCT01704495|64961881|FG002|Subjects Randomized|Withdrawal by Subject|5|||
23333075|NCT01704495|64961882|FG003|Subjects Randomized|Withdrawal by Subject|5|||
23447394|NCT00626275|65380419|FG002|Part B|Withdrawal by Subject|0|||
23447395|NCT00626275|65380420|FG003|Part B|Withdrawal by Subject|0|||
23574844|NCT02564055|65835423|FG004|Overall Study|Protocol Violation|0|||
23574845|NCT02564055|65835424|FG005|Overall Study|Protocol Violation|0|||
23574846|NCT02564055|65835419|FG000|Overall Study|Reached stopping criteria|0|||
23574847|NCT02564055|65835420|FG001|Overall Study|Reached stopping criteria|0|||
23574848|NCT02564055|65835421|FG002|Overall Study|Reached stopping criteria|0|||
23166492|NCT00091832|64356171|FG001|Overall Study|Ineligibility Determined|0|||
23166493|NCT00091832|64356172|FG002|Overall Study|Ineligibility Determined|1|||
23166494|NCT00091832|64356173|FG003|Overall Study|Ineligibility Determined|0|||
23166495|NCT00091832|64356174|FG004|Overall Study|Ineligibility Determined|1|||
23166496|NCT00091832|64356175|FG005|Overall Study|Ineligibility Determined|0|||
23166497|NCT00091832|64356170|FG000|Overall Study|Lost to Follow-up|1|||
23166498|NCT00091832|64356171|FG001|Overall Study|Lost to Follow-up|0|||
23166499|NCT00091832|64356172|FG002|Overall Study|Lost to Follow-up|3|||
23166500|NCT00091832|64356173|FG003|Overall Study|Lost to Follow-up|3|||
23166501|NCT00091832|64356174|FG004|Overall Study|Lost to Follow-up|2|||
23166502|NCT00091832|64356175|FG005|Overall Study|Lost to Follow-up|1|||
23166503|NCT00091832|64356170|FG000|Overall Study|Noncompliance|0|||
23166504|NCT00091832|64356171|FG001|Overall Study|Noncompliance|1|||
23166505|NCT00091832|64356172|FG002|Overall Study|Noncompliance|0|||
23166506|NCT00091832|64356173|FG003|Overall Study|Noncompliance|0|||
23166507|NCT00091832|64356174|FG004|Overall Study|Noncompliance|0|||
23333076|NCT01704495|64961879|FG000|Subjects Randomized|Protocol Violation|1|||
23333077|NCT01704495|64961880|FG001|Subjects Randomized|Protocol Violation|1|||
23333078|NCT01704495|64961881|FG002|Subjects Randomized|Protocol Violation|2|||
23333079|NCT01704495|64961882|FG003|Subjects Randomized|Protocol Violation|0|||
23333080|NCT01704495|64961879|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
23333081|NCT01704495|64961880|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
23333082|NCT01704495|64961881|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
23333083|NCT01704495|64961882|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
23333084|NCT01704495|64961879|FG000|Optional Safety Extension|Adverse Event|0|||
23333085|NCT01704495|64961880|FG001|Optional Safety Extension|Adverse Event|4|||
23333086|NCT01704495|64961881|FG002|Optional Safety Extension|Adverse Event|0|||
23333087|NCT01704495|64961882|FG003|Optional Safety Extension|Adverse Event|1|||
23166508|NCT00091832|64356175|FG005|Overall Study|Noncompliance|0|||
23166509|NCT00091832|64356170|FG000|Overall Study|Other|0|||
23166510|NCT00091832|64356171|FG001|Overall Study|Other|1|||
23166511|NCT00091832|64356172|FG002|Overall Study|Other|2|||
23166512|NCT00091832|64356173|FG003|Overall Study|Other|0|||
23166513|NCT00091832|64356174|FG004|Overall Study|Other|0|||
23333088|NCT01704495|64961879|FG000|Optional Safety Extension|Other reason|27|||
23333089|NCT01704495|64961880|FG001|Optional Safety Extension|Other reason|29|||
23333090|NCT01704495|64961881|FG002|Optional Safety Extension|Other reason|30|||
23333091|NCT01704495|64961882|FG003|Optional Safety Extension|Other reason|28|||
23333092|NCT01704495|64961879|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
23333093|NCT01704495|64961880|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
23333094|NCT01704495|64961881|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
23333095|NCT01704495|64961882|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
23333096|NCT00072280|64961883|FG000|Treatment|Found ineligible|1|||
23333097|NCT00072280|64961884|FG001|Treatment|Found ineligible|2|||
23333098|NCT00072280|64961883|FG000|Follow-up|Early termination of study|2|||
23333099|NCT00072280|64961884|FG001|Follow-up|Early termination of study|2|||
23333100|NCT01326104|64961895|FG000|Overall Study|progressed prior to vaccine|0|||
23333101|NCT01326104|64961896|FG001|Overall Study|progressed prior to vaccine|2|||
23333102|NCT01326104|64961895|FG000|Overall Study|unable to make vaccine|0|||
23333103|NCT01326104|64961896|FG001|Overall Study|unable to make vaccine|2|||
23333104|NCT00912743|64961899|FG000|Overall Study|Adverse Event|3|||
23333105|NCT00912743|64961900|FG001|Overall Study|Adverse Event|1|||
23333106|NCT00912743|64961899|FG000|Overall Study|Lack of Efficacy|9|||
23333107|NCT00912743|64961900|FG001|Overall Study|Lack of Efficacy|18|||
23333108|NCT00912743|64961899|FG000|Overall Study|Toxicity|0|||
23333109|NCT00912743|64961900|FG001|Overall Study|Toxicity|1|||
23333110|NCT00912743|64961899|FG000|Overall Study|End of treatment form was not collected|1|||
23333111|NCT00912743|64961900|FG001|Overall Study|End of treatment form was not collected|0|||
23333112|NCT00728468|64961902|FG000|Overall Study|Enrolled but not treated|1|||
23333113|NCT00728468|64961902|FG000|Overall Study|Death|1|||
23333114|NCT00728468|64961902|FG000|Overall Study|Protocol Violation|4|||
23333115|NCT00728468|64961902|FG000|Overall Study|Objective progression or relapse|9|||
23333116|NCT00728468|64961902|FG000|Overall Study|Study terminated by sponsor|1|||
23333117|NCT04577404|64961903|FG000|Overall Study|Adverse Event|31|||
23333118|NCT04577404|64961903|FG000|Overall Study|Death|1|||
23333119|NCT04577404|64961903|FG000|Overall Study|Lack of Efficacy|3|||
23333120|NCT04577404|64961903|FG000|Overall Study|Physician Decision|7|||
23333121|NCT04577404|64961903|FG000|Overall Study|Withdrawal by Subject|21|||
23333122|NCT04577404|64961903|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
23333123|NCT03474731|64961904|FG000|Overall Study|Withdrawal by Subject|36|||
23333124|NCT03474731|64961905|FG001|Overall Study|Withdrawal by Subject|29|||
23333125|NCT03474731|64961906|FG002|Overall Study|Withdrawal by Subject|11|||
23333126|NCT03474731|64961907|FG003|Overall Study|Withdrawal by Subject|27|||
23333127|NCT03474731|64961904|FG000|Overall Study|COVID|0|||
23333128|NCT03474731|64961905|FG001|Overall Study|COVID|23|||
23333129|NCT03474731|64961906|FG002|Overall Study|COVID|0|||
23333130|NCT03474731|64961907|FG003|Overall Study|COVID|0|||
23333131|NCT03474731|64961904|FG000|Overall Study|Participant moved from area|1|||
23333132|NCT03474731|64961905|FG001|Overall Study|Participant moved from area|0|||
23333133|NCT03474731|64961906|FG002|Overall Study|Participant moved from area|0|||
23447396|NCT00626275|65380421|FG004|Part B|Withdrawal by Subject|0|||
23447397|NCT00626275|65380422|FG005|Part B|Withdrawal by Subject|0|||
23447398|NCT00626275|65380423|FG006|Part B|Withdrawal by Subject|0|||
23447399|NCT00626275|65380424|FG007|Part B|Withdrawal by Subject|1|||
23447400|NCT04716426|65380425|FG000|Overall Study|Vaccination|1|||
23447401|NCT04716426|65380426|FG001|Overall Study|Vaccination|1|||
23447402|NCT04716426|65380425|FG000|Overall Study|Contamination|1|||
23166514|NCT00091832|64356175|FG005|Overall Study|Other|0|||
23166515|NCT00091832|64356170|FG000|Overall Study|Protocol Violation|0|||
23166516|NCT00091832|64356171|FG001|Overall Study|Protocol Violation|0|||
23166517|NCT00091832|64356172|FG002|Overall Study|Protocol Violation|1|||
23166518|NCT00091832|64356173|FG003|Overall Study|Protocol Violation|0|||
23166519|NCT00091832|64356174|FG004|Overall Study|Protocol Violation|0|||
23166520|NCT00091832|64356175|FG005|Overall Study|Protocol Violation|1|||
23333134|NCT03474731|64961907|FG003|Overall Study|Participant moved from area|0|||
23333135|NCT03474731|64961904|FG000|Overall Study|Lost to Follow-up|11|||
23333136|NCT03474731|64961905|FG001|Overall Study|Lost to Follow-up|3|||
23333137|NCT03474731|64961906|FG002|Overall Study|Lost to Follow-up|18|||
23333138|NCT03474731|64961907|FG003|Overall Study|Lost to Follow-up|17|||
23333139|NCT03474731|64961904|FG000|Overall Study|Death|0|||
23333140|NCT03474731|64961905|FG001|Overall Study|Death|1|||
23333141|NCT03474731|64961906|FG002|Overall Study|Death|0|||
23333142|NCT03474731|64961907|FG003|Overall Study|Death|0|||
23333143|NCT03474731|64961904|FG000|Overall Study|Participant Removed|0|||
23333144|NCT03474731|64961905|FG001|Overall Study|Participant Removed|0|||
23333145|NCT03474731|64961906|FG002|Overall Study|Participant Removed|0|||
23333146|NCT03474731|64961907|FG003|Overall Study|Participant Removed|1|||
23333147|NCT02858583|64961908|FG000|Overall Study|Declined consent|1|||
23333148|NCT02858583|64961909|FG001|Overall Study|Declined consent|1|||
23447403|NCT04716426|65380426|FG001|Overall Study|Contamination|0|||
23447404|NCT00936702|65380427|FG000|Overall Study|Disease progression|34|||
23166521|NCT02695628|64356176|FG000|Overall Study|Withdrawal by Subject|1|||
23166522|NCT00004259|64356177|FG000|Overall Study|Protocol Violation|1|||
23447405|NCT00936702|65380427|FG000|Overall Study|Adverse Event|8|||
23447406|NCT00936702|65380427|FG000|Overall Study|Withdrawal by Subject|2|||
23333149|NCT03850496|64961910|FG000|Overall Study|Withdrawal by Subject|1|||
23333150|NCT03850496|64961911|FG001|Overall Study|Withdrawal by Subject|0|||
23333151|NCT03850496|64961912|FG002|Overall Study|Withdrawal by Subject|0|||
23333152|NCT03850496|64961910|FG000|Overall Study|Lost to Follow-up|0|||
23333153|NCT03850496|64961911|FG001|Overall Study|Lost to Follow-up|1|||
23333154|NCT03850496|64961912|FG002|Overall Study|Lost to Follow-up|4|||
23447407|NCT00936702|65380427|FG000|Overall Study|Alternative Treatment|1|||
23447408|NCT00936702|65380427|FG000|Overall Study|Other|1|||
23447409|NCT04794270|65380430|FG000|Period 1|Non Compliance|1|||
23447410|NCT04794270|65380431|FG001|Period 1|Non Compliance|0|||
23447411|NCT04794270|65380430|FG000|Period 1|Adverse Event|1|||
23447412|NCT04794270|65380431|FG001|Period 1|Adverse Event|0|||
23447413|NCT04794270|65380430|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
23447414|NCT04794270|65380431|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
23447415|NCT03400852|65380432|FG000|Blinded Treatment Period|Physician Decision|0|||
23447416|NCT03400852|65380433|FG001|Blinded Treatment Period|Physician Decision|1|||
23447417|NCT03400852|65380434|FG002|Blinded Treatment Period|Physician Decision|0|||
23447418|NCT03400852|65380432|FG000|Blinded Treatment Period|Adverse Event|1|||
23447419|NCT03400852|65380433|FG001|Blinded Treatment Period|Adverse Event|1|||
23447420|NCT03400852|65380434|FG002|Blinded Treatment Period|Adverse Event|0|||
23226709|NCT02253992|64571289|FG002|Overall Study|Adverse Event|8|||
23226710|NCT02253992|64571287|FG000|Overall Study|Death|0|||
23447421|NCT03400852|65380432|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
23447422|NCT03400852|65380433|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
23447423|NCT03400852|65380434|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
23447424|NCT03400852|65380432|FG000|Open Label Period|Physician Decision|0|||
23447425|NCT03400852|65380433|FG001|Open Label Period|Physician Decision|0|||
23447426|NCT03400852|65380434|FG002|Open Label Period|Physician Decision|1|||
23447427|NCT03400852|65380432|FG000|Open Label Period|Study terminated by sponsor|0|||
23447428|NCT03400852|65380433|FG001|Open Label Period|Study terminated by sponsor|0|||
23447429|NCT03400852|65380434|FG002|Open Label Period|Study terminated by sponsor|21|||
23447430|NCT02034877|65380435|FG000|Overall Study|Lost to Follow-up|0|||
23447431|NCT02034877|65380436|FG001|Overall Study|Lost to Follow-up|3|||
23447432|NCT02034877|65380435|FG000|Overall Study|No Longer Willing to Participate|0|||
23574849|NCT02564055|65835422|FG003|Overall Study|Reached stopping criteria|0|||
23574850|NCT02564055|65835423|FG004|Overall Study|Reached stopping criteria|0|||
23574851|NCT02564055|65835424|FG005|Overall Study|Reached stopping criteria|1|||
23574852|NCT02564055|65835419|FG000|Overall Study|Lost to Follow-up|0|||
23166523|NCT00004259|64356178|FG001|Overall Study|Protocol Violation|2|||
23166524|NCT00004259|64356179|FG002|Overall Study|Protocol Violation|0|||
23166525|NCT00004259|64356180|FG003|Overall Study|Protocol Violation|0|||
23166526|NCT00004259|64356177|FG000|Overall Study|Withdrawal by Subject|0|||
23166527|NCT00004259|64356178|FG001|Overall Study|Withdrawal by Subject|2|||
23166528|NCT00004259|64356179|FG002|Overall Study|Withdrawal by Subject|0|||
23166529|NCT00004259|64356180|FG003|Overall Study|Withdrawal by Subject|0|||
23166530|NCT03237065|64356181|FG000|Overall Study|Adverse Event|0|||
23166531|NCT03237065|64356182|FG001|Overall Study|Adverse Event|2|||
23166532|NCT03237065|64356181|FG000|Overall Study|Protocol Violation|0|||
23166533|NCT03237065|64356182|FG001|Overall Study|Protocol Violation|1|||
23166534|NCT03237065|64356181|FG000|Overall Study|Withdrawal by Subject|3|||
23226711|NCT02253992|64571288|FG001|Overall Study|Death|0|||
23226712|NCT02253992|64571289|FG002|Overall Study|Death|1|||
23574853|NCT02564055|65835420|FG001|Overall Study|Lost to Follow-up|1|||
23574854|NCT02564055|65835421|FG002|Overall Study|Lost to Follow-up|4|||
23574855|NCT02564055|65835422|FG003|Overall Study|Lost to Follow-up|2|||
23574856|NCT02564055|65835423|FG004|Overall Study|Lost to Follow-up|1|||
23574857|NCT02564055|65835424|FG005|Overall Study|Lost to Follow-up|0|||
23574858|NCT02564055|65835419|FG000|Overall Study|Physician Decision|0|||
23574859|NCT02564055|65835420|FG001|Overall Study|Physician Decision|0|||
23574860|NCT02564055|65835421|FG002|Overall Study|Physician Decision|1|||
23574861|NCT02564055|65835422|FG003|Overall Study|Physician Decision|0|||
23166535|NCT03237065|64356182|FG001|Overall Study|Withdrawal by Subject|0|||
23226713|NCT02253992|64571287|FG000|Overall Study|Subject discontinued study drug|1|||
23226714|NCT02253992|64571288|FG001|Overall Study|Subject discontinued study drug|0|||
23447433|NCT02034877|65380436|FG001|Overall Study|No Longer Willing to Participate|3|||
23447434|NCT02675231|65380441|FG000|Overall Study|Withdrawal by Subject|1|||
23447435|NCT02675231|65380442|FG001|Overall Study|Withdrawal by Subject|3|||
23447436|NCT02675231|65380443|FG002|Overall Study|Withdrawal by Subject|1|||
23574862|NCT02564055|65835423|FG004|Overall Study|Physician Decision|0|||
23166536|NCT03237065|64356181|FG000|Overall Study|Lost to Follow-up|1|||
23166537|NCT03237065|64356182|FG001|Overall Study|Lost to Follow-up|0|||
23166538|NCT03237065|64356181|FG000|Overall Study|Unable to obtain venous access|0|||
23574863|NCT02564055|65835424|FG005|Overall Study|Physician Decision|0|||
23166539|NCT03237065|64356182|FG001|Overall Study|Unable to obtain venous access|1|||
23226715|NCT02253992|64571289|FG002|Overall Study|Subject discontinued study drug|1|||
23333155|NCT00326716|64961915|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
23333156|NCT00326716|64961916|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
23333157|NCT00326716|64961917|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
23333158|NCT00326716|64961918|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
23333159|NCT00506415|64961925|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
23333160|NCT00506415|64961926|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23333161|NCT00506415|64961927|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23574864|NCT02564055|65835419|FG000|Overall Study|Withdrawal by Subject|4|||
23574865|NCT02564055|65835420|FG001|Overall Study|Withdrawal by Subject|4|||
23574866|NCT02564055|65835421|FG002|Overall Study|Withdrawal by Subject|3|||
23574867|NCT02564055|65835422|FG003|Overall Study|Withdrawal by Subject|3|||
23574868|NCT02564055|65835423|FG004|Overall Study|Withdrawal by Subject|10|||
23574869|NCT02564055|65835424|FG005|Overall Study|Withdrawal by Subject|10|||
23574870|NCT04227340|65835433|FG000|Overall Study|Withdrawal by Subject|3|||
23574871|NCT00654940|65835434|FG000|Period 1|Adverse Event|0|||
23574872|NCT00654940|65835435|FG001|Period 1|Adverse Event|1|||
23574873|NCT00654940|65835434|FG000|Period 1|Intolerable Pain Level|1|||
23574874|NCT00654940|65835435|FG001|Period 1|Intolerable Pain Level|0|||
23574875|NCT02419755|65835436|FG000|Overall Study|Death|1|||
23574876|NCT02419755|65835437|FG001|Overall Study|Death|3|||
23574877|NCT02419755|65835436|FG000|Overall Study|Relapse|0|||
23574878|NCT02419755|65835437|FG001|Overall Study|Relapse|1|||
23574879|NCT02419755|65835436|FG000|Overall Study|Ineligible|1|||
23574880|NCT02419755|65835437|FG001|Overall Study|Ineligible|0|||
23574881|NCT02419755|65835436|FG000|Overall Study|Withdrawal by Subject|1|||
23574882|NCT02419755|65835437|FG001|Overall Study|Withdrawal by Subject|0|||
23574883|NCT03389893|65835445|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
23574884|NCT03389893|65835446|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
23574885|NCT03389893|65835447|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
23574886|NCT03389893|65835448|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
23574887|NCT03389893|65835445|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
23574888|NCT03389893|65835446|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
23574889|NCT03389893|65835447|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
23574890|NCT03389893|65835448|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
23574891|NCT03389893|65835445|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
23574892|NCT03389893|65835446|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
23574893|NCT03389893|65835447|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
23574894|NCT03389893|65835448|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
23574895|NCT03389893|65835445|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
23574896|NCT03389893|65835446|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
23574897|NCT03389893|65835447|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
23574898|NCT03389893|65835448|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
23574899|NCT00680056|65835449|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
23574900|NCT00680056|65835450|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
23574901|NCT00680056|65835449|FG000|Second Intervention|Protocol Violation|3|||
23574902|NCT00680056|65835450|FG001|Second Intervention|Protocol Violation|1|||
23574903|NCT03824236|65835454|FG000|Overall Study|Lost to Follow-up|0|||
23166540|NCT01888640|64356186|FG000|Overall Study|Lost to Follow-up|1|||
23166541|NCT01888640|64356187|FG001|Overall Study|Lost to Follow-up|2|||
23166542|NCT01888640|64356188|FG002|Overall Study|Lost to Follow-up|0|||
23166543|NCT01888640|64356186|FG000|Overall Study|Withdrawal by Subject|15|||
23166544|NCT01888640|64356187|FG001|Overall Study|Withdrawal by Subject|11|||
23166545|NCT01888640|64356188|FG002|Overall Study|Withdrawal by Subject|4|||
23166546|NCT01888640|64356186|FG000|Overall Study|Minimum dose not met|10|||
23166547|NCT01888640|64356187|FG001|Overall Study|Minimum dose not met|16|||
23166548|NCT01888640|64356188|FG002|Overall Study|Minimum dose not met|0|||
23166549|NCT01888640|64356186|FG000|Overall Study|Given wrong unit (placebo)|1|||
23166550|NCT01888640|64356187|FG001|Overall Study|Given wrong unit (placebo)|0|||
23166551|NCT01888640|64356188|FG002|Overall Study|Given wrong unit (placebo)|0|||
23166552|NCT01888640|64356186|FG000|Overall Study|Excluded for prior TENS|0|||
23166553|NCT01888640|64356187|FG001|Overall Study|Excluded for prior TENS|1|||
23166554|NCT01888640|64356188|FG002|Overall Study|Excluded for prior TENS|0|||
23166555|NCT01888640|64356186|FG000|Overall Study|Researcher Termination of Participant|0|||
23166556|NCT01888640|64356187|FG001|Overall Study|Researcher Termination of Participant|1|||
23166557|NCT01888640|64356188|FG002|Overall Study|Researcher Termination of Participant|1|||
23166558|NCT00179309|64356189|FG000|Treatment|Toxicity|2|||
23166559|NCT00179309|64356190|FG001|Treatment|Toxicity|3|||
23166560|NCT00179309|64356189|FG000|Treatment|Withdrawal by Subject|1|||
23574904|NCT03824236|65835455|FG001|Overall Study|Lost to Follow-up|0|||
23574905|NCT03824236|65835456|FG002|Overall Study|Lost to Follow-up|1|||
23166561|NCT00179309|64356190|FG001|Treatment|Withdrawal by Subject|2|||
23166562|NCT00179309|64356189|FG000|Treatment|Allergy|1|||
23166563|NCT00179309|64356190|FG001|Treatment|Allergy|0|||
23166564|NCT03075527|64356191|FG000|Overall Study|Ongoing treatment|2|||
23574906|NCT02117544|65835464|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
23574907|NCT02117544|65835465|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
23574908|NCT01651403|65835467|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
23574909|NCT01651403|65835468|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
23574910|NCT01651403|65835467|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
23574911|NCT01651403|65835468|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
23574912|NCT01651403|65835467|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
23574913|NCT01651403|65835468|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
23574914|NCT01651403|65835467|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
23574915|NCT01651403|65835468|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
23574916|NCT01651403|65835467|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
23574917|NCT01651403|65835468|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
23574918|NCT01651403|65835467|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
23574919|NCT01651403|65835468|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
23574920|NCT01567163|65835473|FG000|Overall Study|Progressive Disease|2|||
23574921|NCT01567163|65835473|FG000|Overall Study|Lost to Follow-up|2|||
23574922|NCT00219141|65835476|FG000|Overall Study|Adverse Event|4|||
23574923|NCT00219141|65835477|FG001|Overall Study|Adverse Event|10|||
23574924|NCT00219141|65835478|FG002|Overall Study|Adverse Event|5|||
23166565|NCT01079182|64356192|FG000|Overall Study|Lost to Follow-up|1634|||
23166566|NCT01079182|64356192|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
23166567|NCT01079182|64356192|FG000|Overall Study|Lack of Efficacy|514|||
23166568|NCT01079182|64356192|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
23166569|NCT01079182|64356192|FG000|Overall Study|Reasons not Evaluated|271|||
23166570|NCT01836783|64356193|FG000|Overall Study|Withdrawal by Subject|0|||
23574925|NCT00219141|65835476|FG000|Overall Study|Lack of Efficacy|3|||
23574926|NCT00219141|65835477|FG001|Overall Study|Lack of Efficacy|2|||
23574927|NCT00219141|65835478|FG002|Overall Study|Lack of Efficacy|0|||
23574928|NCT00219141|65835476|FG000|Overall Study|Administrative problems|0|||
23574929|NCT00219141|65835477|FG001|Overall Study|Administrative problems|1|||
23574930|NCT00219141|65835478|FG002|Overall Study|Administrative problems|0|||
23166571|NCT01836783|64356194|FG001|Overall Study|Withdrawal by Subject|2|||
23166572|NCT04191382|64356195|FG000|Overall Study|Withdrawal by Subject|1|||
23166573|NCT04191382|64356196|FG001|Overall Study|Withdrawal by Subject|0|||
23166574|NCT04191382|64356197|FG002|Overall Study|Withdrawal by Subject|0|||
23166575|NCT04677959|64356198|FG000|Overall Study|Adverse Event|1|||
23333162|NCT00506415|64961928|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23333163|NCT00506415|64961925|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
23333164|NCT00506415|64961926|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
23333165|NCT00506415|64961927|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
23333166|NCT00506415|64961928|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
23333167|NCT00506415|64961925|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
23333168|NCT00506415|64961926|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
23333169|NCT00506415|64961927|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
23333170|NCT00506415|64961928|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
23333171|NCT00506415|64961925|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
23333172|NCT00506415|64961926|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23333173|NCT00506415|64961927|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23333174|NCT00506415|64961928|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23333175|NCT00506415|64961925|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
23333176|NCT00506415|64961926|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23333177|NCT00506415|64961927|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23574931|NCT00219141|65835476|FG000|Overall Study|Lost to Follow-up|2|||
23574932|NCT00219141|65835477|FG001|Overall Study|Lost to Follow-up|4|||
23574933|NCT00219141|65835478|FG002|Overall Study|Lost to Follow-up|1|||
23574934|NCT00219141|65835476|FG000|Overall Study|Protocol Violation|3|||
23574935|NCT00219141|65835477|FG001|Overall Study|Protocol Violation|1|||
23574936|NCT00219141|65835478|FG002|Overall Study|Protocol Violation|1|||
23574937|NCT00219141|65835476|FG000|Overall Study|Withdrawal by Subject|1|||
23574938|NCT00219141|65835477|FG001|Overall Study|Withdrawal by Subject|3|||
23574939|NCT00219141|65835478|FG002|Overall Study|Withdrawal by Subject|5|||
23226716|NCT02253992|64571287|FG000|Overall Study|Completed treatment as per protocol|0|||
23226717|NCT02253992|64571288|FG001|Overall Study|Completed treatment as per protocol|1|||
23226718|NCT02253992|64571289|FG002|Overall Study|Completed treatment as per protocol|22|||
23226719|NCT02253992|64571287|FG000|Overall Study|Other|0|||
23226720|NCT02253992|64571288|FG001|Overall Study|Other|0|||
23166576|NCT04677959|64356199|FG001|Overall Study|Adverse Event|9|||
23166577|NCT04677959|64356198|FG000|Overall Study|Withdrawal by Subject|2|||
23226721|NCT02253992|64571289|FG002|Overall Study|Other|1|||
23447437|NCT02675231|65380441|FG000|Overall Study|Lost to Follow-up|2|||
23447438|NCT02675231|65380442|FG001|Overall Study|Lost to Follow-up|2|||
23447439|NCT02675231|65380443|FG002|Overall Study|Lost to Follow-up|2|||
23574940|NCT00219141|65835476|FG000|Overall Study|Condition no longer requires study drug|1|||
23574941|NCT00219141|65835477|FG001|Overall Study|Condition no longer requires study drug|0|||
23574942|NCT00219141|65835478|FG002|Overall Study|Condition no longer requires study drug|0|||
23574943|NCT02998528|65835479|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
23574944|NCT02998528|65835480|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
23574945|NCT02998528|65835481|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
23574946|NCT02998528|65835479|FG000|Randomization Period|Participant withdrew consent|0|||
23574947|NCT02998528|65835480|FG001|Randomization Period|Participant withdrew consent|3|||
23574948|NCT02998528|65835481|FG002|Randomization Period|Participant withdrew consent|0|||
23574949|NCT02998528|65835479|FG000|Randomization Period|Participant no longer meets study criteria|1|||
23574950|NCT02998528|65835480|FG001|Randomization Period|Participant no longer meets study criteria|3|||
23574951|NCT02998528|65835481|FG002|Randomization Period|Participant no longer meets study criteria|2|||
23574952|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
23574953|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
23574954|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
23574955|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
23574956|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
23574957|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
23574958|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
23574959|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
23574960|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
23574961|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
23574962|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
23574963|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
23574964|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
23574965|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
23574966|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
23574967|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Death|1|||
23574968|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Death|0|||
23574969|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Death|0|||
23574970|NCT02998528|65835479|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
23574971|NCT02998528|65835480|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
23574972|NCT02998528|65835481|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
23574973|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
23574974|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
23574975|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
23574976|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
23574977|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
23574978|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
23574979|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
23574980|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
23574981|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
23574982|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
23574983|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
23574984|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
23574985|NCT02998528|65835479|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
23574986|NCT02998528|65835480|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
23574987|NCT02998528|65835481|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
23574988|NCT01818700|65835482|FG000|Overall Study|Adverse Event|67|||
23574989|NCT01818700|65835482|FG000|Overall Study|Lack of Efficacy|2|||
23574990|NCT01818700|65835482|FG000|Overall Study|Lost to Follow-up|5|||
23574991|NCT01818700|65835482|FG000|Overall Study|Withdrawal by Subject|27|||
23574992|NCT01818700|65835482|FG000|Overall Study|Protocol Violation|2|||
23574993|NCT01818700|65835482|FG000|Overall Study|Other|1|||
23574994|NCT00972179|65835483|FG000|Overall Study|Noncompliance|1|||
23574995|NCT00972179|65835484|FG001|Overall Study|Noncompliance|0|||
23574996|NCT00972179|65835485|FG002|Overall Study|Noncompliance|0|||
23574997|NCT00972179|65835486|FG003|Overall Study|Noncompliance|0|||
23166578|NCT04677959|64356199|FG001|Overall Study|Withdrawal by Subject|15|||
23166579|NCT04677959|64356198|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23166580|NCT04677959|64356199|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23166581|NCT04677959|64356198|FG000|Overall Study|Non-compliance with study drug|0|||
23166582|NCT04677959|64356199|FG001|Overall Study|Non-compliance with study drug|2|||
23166583|NCT04677959|64356198|FG000|Overall Study|Protocol deviation|0|||
23574998|NCT00972179|65835487|FG004|Overall Study|Noncompliance|1|||
23574999|NCT00972179|65835488|FG005|Overall Study|Noncompliance|0|||
23575000|NCT00972179|65835489|FG006|Overall Study|Noncompliance|1|||
23575001|NCT00972179|65835483|FG000|Overall Study|Withdrawal by Subject|0|||
23575002|NCT00972179|65835484|FG001|Overall Study|Withdrawal by Subject|3|||
23575003|NCT00972179|65835485|FG002|Overall Study|Withdrawal by Subject|0|||
23575004|NCT00972179|65835486|FG003|Overall Study|Withdrawal by Subject|1|||
23575005|NCT00972179|65835487|FG004|Overall Study|Withdrawal by Subject|0|||
23575006|NCT00972179|65835488|FG005|Overall Study|Withdrawal by Subject|0|||
23575007|NCT00972179|65835489|FG006|Overall Study|Withdrawal by Subject|2|||
23575008|NCT00972179|65835483|FG000|Overall Study|Administrative Decision|0|||
23575009|NCT00972179|65835484|FG001|Overall Study|Administrative Decision|0|||
23575010|NCT00972179|65835485|FG002|Overall Study|Administrative Decision|0|||
23575011|NCT00972179|65835486|FG003|Overall Study|Administrative Decision|0|||
23575012|NCT00972179|65835487|FG004|Overall Study|Administrative Decision|1|||
23575013|NCT00972179|65835488|FG005|Overall Study|Administrative Decision|0|||
23575014|NCT00972179|65835489|FG006|Overall Study|Administrative Decision|0|||
23575015|NCT00972179|65835483|FG000|Overall Study|Lost to Follow-up|0|||
23575016|NCT00972179|65835484|FG001|Overall Study|Lost to Follow-up|0|||
23575017|NCT00972179|65835485|FG002|Overall Study|Lost to Follow-up|1|||
23575018|NCT00972179|65835486|FG003|Overall Study|Lost to Follow-up|0|||
23575019|NCT00972179|65835487|FG004|Overall Study|Lost to Follow-up|0|||
23575020|NCT00972179|65835488|FG005|Overall Study|Lost to Follow-up|3|||
23575021|NCT00972179|65835489|FG006|Overall Study|Lost to Follow-up|1|||
23575022|NCT04781647|65835490|FG000|Overall Study|Study terminated by Sponsor|11|||
23575023|NCT04781647|65835491|FG001|Overall Study|Study terminated by Sponsor|9|||
23575024|NCT04781647|65835492|FG002|Overall Study|Study terminated by Sponsor|9|||
23575025|NCT04781647|65835490|FG000|Overall Study|Withdrawal by Subject|1|||
23575026|NCT04781647|65835491|FG001|Overall Study|Withdrawal by Subject|2|||
23575027|NCT04781647|65835492|FG002|Overall Study|Withdrawal by Subject|0|||
23575028|NCT04781647|65835490|FG000|Overall Study|Adverse Event|0|||
23575029|NCT04781647|65835491|FG001|Overall Study|Adverse Event|1|||
23575030|NCT04781647|65835492|FG002|Overall Study|Adverse Event|1|||
23575031|NCT04781647|65835490|FG000|Overall Study|Protocol Violation|1|||
23575032|NCT04781647|65835491|FG001|Overall Study|Protocol Violation|0|||
23575033|NCT04781647|65835492|FG002|Overall Study|Protocol Violation|0|||
23575034|NCT04781647|65835490|FG000|Overall Study|Pregnancy|0|||
23575035|NCT04781647|65835491|FG001|Overall Study|Pregnancy|0|||
23575036|NCT04781647|65835492|FG002|Overall Study|Pregnancy|1|||
23575037|NCT04781647|65835490|FG000|Overall Study|Virology rebounded|1|||
23575038|NCT04781647|65835491|FG001|Overall Study|Virology rebounded|0|||
23575039|NCT04781647|65835492|FG002|Overall Study|Virology rebounded|0|||
23575040|NCT01836458|65835496|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23575041|NCT01836458|65835497|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23575042|NCT01836458|65835498|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
23575043|NCT01836458|65835499|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
23575044|NCT04747275|65835500|FG000|Overall Study|Study terminated|0|||
23575045|NCT04747275|65835501|FG001|Overall Study|Study terminated|1|||
23575046|NCT01186328|65835502|FG000|Overall Study|Death|1|||
23575047|NCT01186328|65835503|FG001|Overall Study|Death|0|||
23575048|NCT01186328|65835504|FG002|Overall Study|Death|0|||
23575049|NCT02909101|65835505|FG000|Overall Study|Lost to Follow-up|1|||
23575050|NCT02909101|65835506|FG001|Overall Study|Lost to Follow-up|1|||
23575051|NCT02886728|65835507|FG000|Overall Study|Withdrew Consent|31|||
23575052|NCT02886728|65835508|FG001|Overall Study|Withdrew Consent|13|||
23575053|NCT02886728|65835509|FG002|Overall Study|Withdrew Consent|11|||
23575054|NCT02886728|65835510|FG003|Overall Study|Withdrew Consent|47|||
23575055|NCT02886728|65835507|FG000|Overall Study|Lost to Follow-up|12|||
23575056|NCT02886728|65835508|FG001|Overall Study|Lost to Follow-up|6|||
23575057|NCT02886728|65835509|FG002|Overall Study|Lost to Follow-up|13|||
23575058|NCT02886728|65835510|FG003|Overall Study|Lost to Follow-up|12|||
23166584|NCT04677959|64356199|FG001|Overall Study|Protocol deviation|11|||
23166585|NCT04677959|64356198|FG000|Overall Study|Lost to Follow-up|9|||
23166586|NCT04677959|64356199|FG001|Overall Study|Lost to Follow-up|13|||
23166587|NCT04677959|64356198|FG000|Overall Study|Other than specified|0|||
23166588|NCT04677959|64356199|FG001|Overall Study|Other than specified|8|||
23166589|NCT03499028|64356200|FG000|Overall Study|Lost to Follow-up|12|||
23166590|NCT03499028|64356201|FG001|Overall Study|Lost to Follow-up|9|||
23166591|NCT03499028|64356200|FG000|Overall Study|Withdrawal by Subject|5|||
23575059|NCT02886728|65835507|FG000|Overall Study|Adverse Event|13|||
23575060|NCT02886728|65835508|FG001|Overall Study|Adverse Event|5|||
23166592|NCT03499028|64356201|FG001|Overall Study|Withdrawal by Subject|8|||
23166593|NCT03499028|64356200|FG000|Overall Study|Unplanned SNF discharge|5|||
23166594|NCT03499028|64356201|FG001|Overall Study|Unplanned SNF discharge|8|||
23575061|NCT02886728|65835509|FG002|Overall Study|Adverse Event|5|||
23575062|NCT02886728|65835510|FG003|Overall Study|Adverse Event|11|||
23575063|NCT02886728|65835507|FG000|Overall Study|Investigator's Discretion|11|||
23575064|NCT02886728|65835508|FG001|Overall Study|Investigator's Discretion|7|||
23166595|NCT03031301|64356202|FG000|Overall Study|Protocol Violation|4|||
23575065|NCT02886728|65835509|FG002|Overall Study|Investigator's Discretion|5|||
23166596|NCT03031301|64356203|FG001|Overall Study|Protocol Violation|8|||
23166597|NCT03031301|64356202|FG000|Overall Study|Withdrawal by Subject|7|||
23166598|NCT03031301|64356203|FG001|Overall Study|Withdrawal by Subject|4|||
23166599|NCT03031301|64356202|FG000|Overall Study|Lost to Follow-up|4|||
23166600|NCT03031301|64356203|FG001|Overall Study|Lost to Follow-up|12|||
23226722|NCT00068822|64571290|FG000|First Randomized Intervention|Lost to Follow-up|1|||
23226723|NCT00068822|64571291|FG001|First Randomized Intervention|Lost to Follow-up|2|||
23226724|NCT02431793|64571294|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
23226725|NCT02431793|64571295|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
23226726|NCT02431793|64571296|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
23226727|NCT02431793|64571294|FG000|Overall Study|Withdrawal by Subject|7|||
23226728|NCT02431793|64571295|FG001|Overall Study|Withdrawal by Subject|5|||
23226729|NCT02431793|64571296|FG002|Overall Study|Withdrawal by Subject|5|||
23226730|NCT02431793|64571294|FG000|Overall Study|Lost to Follow-up|101|||
23226731|NCT02431793|64571295|FG001|Overall Study|Lost to Follow-up|122|||
23226732|NCT02431793|64571296|FG002|Overall Study|Lost to Follow-up|104|||
23226733|NCT01222416|64571297|FG000|Overall Study|ineligible;metastasis|3|||
23226734|NCT01222416|64571298|FG001|Overall Study|ineligible;metastasis|0|||
23226735|NCT01222416|64571297|FG000|Overall Study|Adverse Event|4|||
23226736|NCT01222416|64571298|FG001|Overall Study|Adverse Event|0|||
23226737|NCT01222416|64571297|FG000|Overall Study|Withdrawal by Subject|5|||
23226738|NCT01222416|64571298|FG001|Overall Study|Withdrawal by Subject|0|||
23226739|NCT01222416|64571297|FG000|Overall Study|scheduling|6|||
23226740|NCT01222416|64571298|FG001|Overall Study|scheduling|0|||
23226741|NCT01222416|64571297|FG000|Overall Study|missed view/scan|1|||
23226742|NCT01222416|64571298|FG001|Overall Study|missed view/scan|0|||
23226743|NCT01222416|64571297|FG000|Overall Study|Death|1|||
23575066|NCT02886728|65835510|FG003|Overall Study|Investigator's Discretion|11|||
23575067|NCT02886728|65835507|FG000|Overall Study|Death|3|||
23575068|NCT02886728|65835508|FG001|Overall Study|Death|1|||
23575069|NCT02886728|65835509|FG002|Overall Study|Death|0|||
23575070|NCT02886728|65835510|FG003|Overall Study|Death|0|||
23575071|NCT02886728|65835507|FG000|Overall Study|Protocol Violation|0|||
23575072|NCT02886728|65835508|FG001|Overall Study|Protocol Violation|0|||
23575073|NCT02886728|65835509|FG002|Overall Study|Protocol Violation|0|||
23575074|NCT02886728|65835510|FG003|Overall Study|Protocol Violation|4|||
23575075|NCT02886728|65835507|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23166601|NCT03031301|64356202|FG000|Overall Study|Noncompliance|1|||
23166602|NCT03031301|64356203|FG001|Overall Study|Noncompliance|3|||
23226744|NCT01222416|64571298|FG001|Overall Study|Death|0|||
23226745|NCT03303625|64571300|FG000|Overall Study|Withdrawal by Subject|2|||
23226746|NCT03303625|64571301|FG001|Overall Study|Withdrawal by Subject|0|||
23226747|NCT03303625|64571302|FG002|Overall Study|Withdrawal by Subject|0|||
23226748|NCT03303625|64571303|FG003|Overall Study|Withdrawal by Subject|0|||
23226749|NCT00846027|64571304|FG000|Overall Study|Death|3|||
23226750|NCT00846027|64571304|FG000|Overall Study|Disease Progression|30|||
23226751|NCT00846027|64571304|FG000|Overall Study|Toxicity|12|||
23575076|NCT02886728|65835508|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23166603|NCT03031301|64356202|FG000|Overall Study|Technical issue|1|||
23166604|NCT03031301|64356203|FG001|Overall Study|Technical issue|1|||
23166605|NCT03031301|64356202|FG000|Overall Study|Adverse Event|1|||
23166606|NCT03031301|64356203|FG001|Overall Study|Adverse Event|0|||
23166607|NCT04036708|64356207|FG000|Overall Study|Lost to Follow-up|14|||
23166608|NCT04036708|64356208|FG001|Overall Study|Lost to Follow-up|4|||
23166609|NCT04036708|64356209|FG002|Overall Study|Lost to Follow-up|14|||
23166610|NCT04036708|64356210|FG003|Overall Study|Lost to Follow-up|4|||
23166611|NCT02770547|64356211|FG000|Overall Study|Patient non-compliant|1|||
23166612|NCT02770547|64356212|FG001|Overall Study|Patient non-compliant|0|||
23166613|NCT02770547|64356211|FG000|Overall Study|Adverse Event|0|||
23166614|NCT02770547|64356212|FG001|Overall Study|Adverse Event|1|||
23166615|NCT00866307|64356213|FG000|Induction|Adverse Event|5|||
23166616|NCT00866307|64356214|FG001|Induction|Adverse Event|0|||
23166617|NCT00866307|64356215|FG002|Induction|Adverse Event|0|||
23166618|NCT00866307|64356213|FG000|Induction|Death|2|||
23166619|NCT00866307|64356214|FG001|Induction|Death|0|||
23166620|NCT00866307|64356215|FG002|Induction|Death|0|||
23226752|NCT00846027|64571304|FG000|Overall Study|Patient Decision|7|||
23575077|NCT02886728|65835509|FG002|Overall Study|Non-Compliance with Study Drug|1|||
23226753|NCT00846027|64571304|FG000|Overall Study|Investigator Discretion|29|||
23226754|NCT00846027|64571304|FG000|Overall Study|Protocol Violation|2|||
23226755|NCT00846027|64571304|FG000|Overall Study|Subject Not Treated|7|||
23575078|NCT02886728|65835510|FG003|Overall Study|Non-Compliance with Study Drug|0|||
23166621|NCT00866307|64356213|FG000|Induction|Physician Decision|5|||
23166622|NCT00866307|64356214|FG001|Induction|Physician Decision|0|||
23166623|NCT00866307|64356215|FG002|Induction|Physician Decision|0|||
23166624|NCT00866307|64356213|FG000|Induction|Progressive Disease|1|||
23166625|NCT00866307|64356214|FG001|Induction|Progressive Disease|0|||
23166626|NCT00866307|64356215|FG002|Induction|Progressive Disease|0|||
23226756|NCT05283499|64571305|FG000|Overall Study|Did not receive intervention|1|||
23333178|NCT00506415|64961928|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23333179|NCT00506415|64961925|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
23166627|NCT00866307|64356213|FG000|Induction|Identification of Patients with Day 29 M|3|||
23166628|NCT00866307|64356214|FG001|Induction|Identification of Patients with Day 29 M|0|||
23166629|NCT00866307|64356215|FG002|Induction|Identification of Patients with Day 29 M|0|||
23166630|NCT00866307|64356213|FG000|Induction|Inadequate cytognetic samples th|1|||
23166631|NCT00866307|64356214|FG001|Induction|Inadequate cytognetic samples th|0|||
23166632|NCT00866307|64356215|FG002|Induction|Inadequate cytognetic samples th|0|||
23166633|NCT00866307|64356213|FG000|Induction|Improper post-induction consent|2|||
23166634|NCT00866307|64356214|FG001|Induction|Improper post-induction consent|0|||
23166635|NCT00866307|64356215|FG002|Induction|Improper post-induction consent|0|||
23166636|NCT00866307|64356213|FG000|Induction|Study was closed at the time|1|||
23166637|NCT00866307|64356214|FG001|Induction|Study was closed at the time|0|||
23166638|NCT00866307|64356215|FG002|Induction|Study was closed at the time|0|||
23166639|NCT00866307|64356213|FG000|Consolidation/Maintenance|Adverse Event|0|||
23166640|NCT00866307|64356214|FG001|Consolidation/Maintenance|Adverse Event|0|||
23166641|NCT00866307|64356215|FG002|Consolidation/Maintenance|Adverse Event|8|||
23166642|NCT00866307|64356213|FG000|Consolidation/Maintenance|Death|0|||
23166643|NCT00866307|64356214|FG001|Consolidation/Maintenance|Death|0|||
23166644|NCT00866307|64356215|FG002|Consolidation/Maintenance|Death|1|||
23166645|NCT00866307|64356213|FG000|Consolidation/Maintenance|Physician Decision|0|||
23166646|NCT00866307|64356214|FG001|Consolidation/Maintenance|Physician Decision|3|||
23166647|NCT00866307|64356215|FG002|Consolidation/Maintenance|Physician Decision|2|||
23166648|NCT00866307|64356213|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
23166649|NCT00866307|64356214|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
23166650|NCT00866307|64356215|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
23166651|NCT00866307|64356213|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
23166652|NCT00866307|64356214|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
23166653|NCT00866307|64356215|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
23166654|NCT00866307|64356213|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
23166655|NCT00866307|64356214|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
23166656|NCT00866307|64356215|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
23166657|NCT00866307|64356213|FG000|Consolidation/Maintenance|Therapy error|0|||
23166658|NCT00866307|64356214|FG001|Consolidation/Maintenance|Therapy error|1|||
23166659|NCT00866307|64356215|FG002|Consolidation/Maintenance|Therapy error|0|||
23166660|NCT00866307|64356213|FG000|Consolidation/Maintenance|Non-compliance|0|||
23166661|NCT00866307|64356214|FG001|Consolidation/Maintenance|Non-compliance|0|||
23166662|NCT00866307|64356215|FG002|Consolidation/Maintenance|Non-compliance|1|||
23166663|NCT00866307|64356213|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
23166664|NCT00866307|64356214|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
23166665|NCT00866307|64356215|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
23166666|NCT00487539|64356216|FG000|Overall Study|Adverse Event|3|||
23166667|NCT00487539|64356217|FG001|Overall Study|Adverse Event|2|||
23166668|NCT00487539|64356218|FG002|Overall Study|Adverse Event|1|||
23166669|NCT00487539|64356219|FG003|Overall Study|Adverse Event|1|||
23166670|NCT00487539|64356216|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23166671|NCT00487539|64356217|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23166672|NCT00487539|64356218|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23166673|NCT00487539|64356219|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
23166674|NCT00487539|64356216|FG000|Overall Study|Other|3|||
23166675|NCT00487539|64356217|FG001|Overall Study|Other|1|||
23166676|NCT00487539|64356218|FG002|Overall Study|Other|2|||
23166677|NCT00487539|64356219|FG003|Overall Study|Other|2|||
23166678|NCT00805480|64356220|FG000|Overall Study|Withdrawal by Subject|13|||
23166679|NCT00805480|64356221|FG001|Overall Study|Withdrawal by Subject|5|||
23166680|NCT00805480|64356222|FG002|Overall Study|Withdrawal by Subject|11|||
23166681|NCT00805480|64356223|FG003|Overall Study|Withdrawal by Subject|5|||
23166682|NCT00805480|64356220|FG000|Overall Study|Lost to Follow-up|1|||
23166683|NCT00805480|64356221|FG001|Overall Study|Lost to Follow-up|2|||
23166684|NCT00805480|64356222|FG002|Overall Study|Lost to Follow-up|0|||
23166685|NCT00805480|64356223|FG003|Overall Study|Lost to Follow-up|0|||
23166686|NCT00805480|64356220|FG000|Overall Study|Adverse Event|0|||
23166687|NCT00805480|64356221|FG001|Overall Study|Adverse Event|0|||
23226757|NCT05283499|64571306|FG001|Overall Study|Did not receive intervention|2|||
23166688|NCT00805480|64356222|FG002|Overall Study|Adverse Event|1|||
23226758|NCT01700140|64571307|FG000|Overall Study|Use of rescue drugs|3|||
23166689|NCT00805480|64356223|FG003|Overall Study|Adverse Event|0|||
23166690|NCT01681433|64356224|FG000|Overall Study|Lack of Efficacy|23|||
23166691|NCT01681433|64356225|FG001|Overall Study|Lack of Efficacy|23|||
23166692|NCT01681433|64356224|FG000|Overall Study|Withdrawal by Subject|5|||
23166693|NCT01681433|64356225|FG001|Overall Study|Withdrawal by Subject|5|||
23166694|NCT01681433|64356224|FG000|Overall Study|Protocol Violation|2|||
23166695|NCT01681433|64356225|FG001|Overall Study|Protocol Violation|0|||
23166696|NCT01681433|64356224|FG000|Overall Study|Adverse Event|2|||
23166697|NCT01681433|64356225|FG001|Overall Study|Adverse Event|4|||
23166698|NCT01681433|64356224|FG000|Overall Study|Lost to Follow-up|0|||
23166699|NCT01681433|64356225|FG001|Overall Study|Lost to Follow-up|1|||
23575079|NCT02886728|65835507|FG000|Overall Study|Pregnancy|0|||
23575080|NCT02886728|65835508|FG001|Overall Study|Pregnancy|0|||
23575081|NCT02886728|65835509|FG002|Overall Study|Pregnancy|1|||
23575082|NCT02886728|65835510|FG003|Overall Study|Pregnancy|0|||
23575083|NCT02886728|65835507|FG000|Overall Study|Randomized but Not Dosed|1|||
23166700|NCT00730639|64356226|FG000|Overall Study|Adverse Event|3|||
23166701|NCT00730639|64356227|FG001|Overall Study|Adverse Event|0|||
23166702|NCT00730639|64356228|FG002|Overall Study|Adverse Event|9|||
23166703|NCT00730639|64356229|FG003|Overall Study|Adverse Event|8|||
23166704|NCT00730639|64356230|FG004|Overall Study|Adverse Event|23|||
23166705|NCT00730639|64356226|FG000|Overall Study|Complete Response|0|||
23166706|NCT00730639|64356227|FG001|Overall Study|Complete Response|0|||
23166707|NCT00730639|64356228|FG002|Overall Study|Complete Response|2|||
23166708|NCT00730639|64356229|FG003|Overall Study|Complete Response|2|||
23166709|NCT00730639|64356230|FG004|Overall Study|Complete Response|1|||
23166710|NCT00730639|64356226|FG000|Overall Study|Completed Maximum Cycles|0|||
23166711|NCT00730639|64356227|FG001|Overall Study|Completed Maximum Cycles|0|||
23166712|NCT00730639|64356228|FG002|Overall Study|Completed Maximum Cycles|11|||
23166713|NCT00730639|64356229|FG003|Overall Study|Completed Maximum Cycles|3|||
23166714|NCT00730639|64356230|FG004|Overall Study|Completed Maximum Cycles|6|||
23166715|NCT00730639|64356226|FG000|Overall Study|Death|0|||
23166716|NCT00730639|64356227|FG001|Overall Study|Death|0|||
23166717|NCT00730639|64356228|FG002|Overall Study|Death|0|||
23166718|NCT00730639|64356229|FG003|Overall Study|Death|0|||
23166719|NCT00730639|64356230|FG004|Overall Study|Death|2|||
23166720|NCT00730639|64356226|FG000|Overall Study|Disease Progression|12|||
23166721|NCT00730639|64356227|FG001|Overall Study|Disease Progression|13|||
23166722|NCT00730639|64356228|FG002|Overall Study|Disease Progression|48|||
23166723|NCT00730639|64356229|FG003|Overall Study|Disease Progression|32|||
23166724|NCT00730639|64356230|FG004|Overall Study|Disease Progression|88|||
23166725|NCT00730639|64356226|FG000|Overall Study|non-specified|0|||
23166726|NCT00730639|64356227|FG001|Overall Study|non-specified|0|||
23166727|NCT00730639|64356228|FG002|Overall Study|non-specified|4|||
23166728|NCT00730639|64356229|FG003|Overall Study|non-specified|2|||
23166729|NCT00730639|64356230|FG004|Overall Study|non-specified|3|||
23166730|NCT00730639|64356226|FG000|Overall Study|Protocol Violation|0|||
23166731|NCT00730639|64356227|FG001|Overall Study|Protocol Violation|0|||
23166732|NCT00730639|64356228|FG002|Overall Study|Protocol Violation|1|||
23166733|NCT00730639|64356229|FG003|Overall Study|Protocol Violation|0|||
23166734|NCT00730639|64356230|FG004|Overall Study|Protocol Violation|0|||
23166735|NCT00730639|64356226|FG000|Overall Study|Withdrawal by Subject|0|||
23166736|NCT00730639|64356227|FG001|Overall Study|Withdrawal by Subject|0|||
23166737|NCT00730639|64356228|FG002|Overall Study|Withdrawal by Subject|6|||
23166738|NCT00730639|64356229|FG003|Overall Study|Withdrawal by Subject|3|||
23166739|NCT00730639|64356230|FG004|Overall Study|Withdrawal by Subject|4|||
23166740|NCT00730639|64356226|FG000|Overall Study|Treatment on-going|2|||
23166741|NCT00730639|64356227|FG001|Overall Study|Treatment on-going|5|||
23166742|NCT00730639|64356228|FG002|Overall Study|Treatment on-going|5|||
23166743|NCT00730639|64356229|FG003|Overall Study|Treatment on-going|4|||
23166744|NCT00730639|64356230|FG004|Overall Study|Treatment on-going|4|||
23166745|NCT04091087|64356231|FG000|Overall Study|Not treated|1|||
23166746|NCT04091087|64356232|FG001|Overall Study|Not treated|0|||
23166747|NCT04091087|64356231|FG000|Overall Study|Adverse Event|4|||
23166748|NCT04091087|64356232|FG001|Overall Study|Adverse Event|4|||
23333180|NCT00506415|64961926|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23447440|NCT02675231|65380441|FG000|Overall Study|On study treatment/follow up|23|||
23575084|NCT02886728|65835508|FG001|Overall Study|Randomized but Not Dosed|0|||
23166749|NCT04091087|64356231|FG000|Overall Study|Protocol Violation|0|||
23166750|NCT04091087|64356232|FG001|Overall Study|Protocol Violation|1|||
23166751|NCT04091087|64356231|FG000|Overall Study|Withdrawal by Subject|5|||
23166752|NCT04091087|64356232|FG001|Overall Study|Withdrawal by Subject|2|||
23166753|NCT02937350|64356234|FG000|Overall Study|Withdrawal by Subject|0|||
23166754|NCT02937350|64356235|FG001|Overall Study|Withdrawal by Subject|1|||
23166755|NCT02937350|64356236|FG002|Overall Study|Withdrawal by Subject|0|||
23166756|NCT03189446|64356237|FG000|Overall Study|Adverse Event|2|||
23333181|NCT00506415|64961927|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23575085|NCT02886728|65835509|FG002|Overall Study|Randomized but Not Dosed|0|||
23575086|NCT02886728|65835510|FG003|Overall Study|Randomized but Not Dosed|2|||
23166757|NCT03189446|64356237|FG000|Overall Study|Withdrawal by Subject|2|||
23575087|NCT02420327|65835511|FG000|Overall Study|Adverse Event|7|||
23166758|NCT03189446|64356237|FG000|Overall Study|Physician Decision|1|||
23166759|NCT00053417|64356238|FG000|Overall Study|Adverse Event|1|||
23166760|NCT00053417|64356239|FG001|Overall Study|Adverse Event|0|||
23166761|NCT00053417|64356240|FG002|Overall Study|Adverse Event|1|||
23226759|NCT01700140|64571308|FG001|Overall Study|Use of rescue drugs|3|||
23226760|NCT01700140|64571309|FG002|Overall Study|Use of rescue drugs|1|||
23226761|NCT01700140|64571307|FG000|Overall Study|Discontinuation of radiotherapy|1|||
23226762|NCT01700140|64571308|FG001|Overall Study|Discontinuation of radiotherapy|0|||
23575088|NCT02420327|65835511|FG000|Overall Study|Pregnancy|1|||
23575089|NCT02420327|65835511|FG000|Overall Study|Withdrawal by Subject|6|||
23575090|NCT02420327|65835511|FG000|Overall Study|Lost to Follow-up|1|||
23575091|NCT02420327|65835511|FG000|Overall Study|Protocol Violation|1|||
23575092|NCT00311155|65835517|FG000|Overall Study|Adverse Event|21|||
23575093|NCT00311155|65835517|FG000|Overall Study|Withdrawal by Subject|17|||
23575094|NCT00311155|65835517|FG000|Overall Study|Did not meet entry criteria|55|||
23575095|NCT01925170|65835525|FG000|Overall Study|Unverified cancer status|53|||
23575096|NCT00614744|65835526|FG000|Overall Study|Lost to Follow-up|5|||
23575097|NCT00614744|65835527|FG001|Overall Study|Lost to Follow-up|4|||
23575098|NCT00614744|65835526|FG000|Overall Study|Incomplete for Behavior Issues|0|||
23575099|NCT00614744|65835527|FG001|Overall Study|Incomplete for Behavior Issues|2|||
23575100|NCT01702428|65835528|FG000|Overall Study|Adverse Event|2|||
23575101|NCT01702428|65835529|FG001|Overall Study|Adverse Event|0|||
23575102|NCT01702428|65835530|FG002|Overall Study|Adverse Event|0|||
23575103|NCT01702428|65835531|FG003|Overall Study|Adverse Event|0|||
23575104|NCT01702428|65835528|FG000|Overall Study|Lost to Follow-up|33|||
23575105|NCT01702428|65835529|FG001|Overall Study|Lost to Follow-up|41|||
23575106|NCT01702428|65835530|FG002|Overall Study|Lost to Follow-up|37|||
23575107|NCT01702428|65835531|FG003|Overall Study|Lost to Follow-up|44|||
23575108|NCT01702428|65835528|FG000|Overall Study|Parents cannot assist to site|1|||
23575109|NCT01702428|65835529|FG001|Overall Study|Parents cannot assist to site|0|||
23575110|NCT01702428|65835530|FG002|Overall Study|Parents cannot assist to site|1|||
23575111|NCT01702428|65835531|FG003|Overall Study|Parents cannot assist to site|0|||
23575112|NCT01702428|65835528|FG000|Overall Study|Lost Coverage|0|||
23575113|NCT01702428|65835529|FG001|Overall Study|Lost Coverage|0|||
23575114|NCT01702428|65835530|FG002|Overall Study|Lost Coverage|0|||
23575115|NCT01702428|65835531|FG003|Overall Study|Lost Coverage|1|||
23575116|NCT01702428|65835528|FG000|Overall Study|Lost Health Plan|3|||
23575117|NCT01702428|65835529|FG001|Overall Study|Lost Health Plan|5|||
23575118|NCT01702428|65835530|FG002|Overall Study|Lost Health Plan|0|||
23575119|NCT01702428|65835531|FG003|Overall Study|Lost Health Plan|2|||
23575120|NCT01702428|65835528|FG000|Overall Study|Mother transferred care|0|||
23575121|NCT01702428|65835529|FG001|Overall Study|Mother transferred care|1|||
23226763|NCT01700140|64571309|FG002|Overall Study|Discontinuation of radiotherapy|0|||
23226764|NCT01700140|64571307|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
23226765|NCT01700140|64571308|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
23226766|NCT01700140|64571309|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
23226767|NCT01700140|64571307|FG000|Overall Study|Aggravation of symptoms|1|||
23226768|NCT01700140|64571308|FG001|Overall Study|Aggravation of symptoms|0|||
23226769|NCT01700140|64571309|FG002|Overall Study|Aggravation of symptoms|0|||
23226770|NCT01700140|64571307|FG000|Overall Study|Adverse Event|0|||
23226771|NCT01700140|64571308|FG001|Overall Study|Adverse Event|1|||
23226772|NCT01700140|64571309|FG002|Overall Study|Adverse Event|0|||
23226773|NCT01700140|64571307|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
23226774|NCT01700140|64571308|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
23575122|NCT01702428|65835530|FG002|Overall Study|Mother transferred care|0|||
23575123|NCT01702428|65835531|FG003|Overall Study|Mother transferred care|0|||
23575124|NCT01702428|65835528|FG000|Overall Study|Parents too busy|1|||
23575125|NCT01702428|65835529|FG001|Overall Study|Parents too busy|0|||
23575126|NCT01702428|65835530|FG002|Overall Study|Parents too busy|0|||
23575127|NCT01702428|65835531|FG003|Overall Study|Parents too busy|0|||
23575128|NCT01702428|65835528|FG000|Overall Study|Protocol Violation|3|||
23575129|NCT01702428|65835529|FG001|Overall Study|Protocol Violation|0|||
23575130|NCT01702428|65835530|FG002|Overall Study|Protocol Violation|1|||
23575131|NCT01702428|65835531|FG003|Overall Study|Protocol Violation|0|||
23575132|NCT01702428|65835528|FG000|Overall Study|Withdrawal by Subject|21|||
23575133|NCT01702428|65835529|FG001|Overall Study|Withdrawal by Subject|23|||
23575134|NCT01702428|65835530|FG002|Overall Study|Withdrawal by Subject|14|||
23226775|NCT01700140|64571309|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
23226776|NCT00191386|64571310|FG000|Overall Study|Adverse Event|16|||
23226777|NCT00191386|64571310|FG000|Overall Study|Lost to Follow-up|1|||
23226778|NCT00191386|64571310|FG000|Overall Study|Entry Criteria Exclusion|3|||
23226779|NCT00191386|64571310|FG000|Overall Study|Protocol Violation|18|||
23447441|NCT02675231|65380442|FG001|Overall Study|On study treatment/follow up|31|||
23226780|NCT00191386|64571310|FG000|Overall Study|Withdrawal by Subject|96|||
23575135|NCT01702428|65835531|FG003|Overall Study|Withdrawal by Subject|10|||
23575136|NCT01809210|65835532|FG000|Overall Study|Withdrawal by Subject|0|||
23575137|NCT01809210|65835533|FG001|Overall Study|Withdrawal by Subject|0|||
23575138|NCT01809210|65835534|FG002|Overall Study|Withdrawal by Subject|1|||
23575139|NCT01809210|65835535|FG003|Overall Study|Withdrawal by Subject|1|||
23575140|NCT01809210|65835536|FG004|Overall Study|Withdrawal by Subject|1|||
23226781|NCT00191386|64571310|FG000|Overall Study|Physician Decision|11|||
23226782|NCT00191386|64571310|FG000|Overall Study|Lack of Efficacy|15|||
23226783|NCT02449915|64571311|FG000|Overall Study|Exclusion criteria - drug use|1|||
23226784|NCT02449915|64571312|FG001|Overall Study|Exclusion criteria - drug use|0|||
23226785|NCT02449915|64571311|FG000|Overall Study|Withdrawal by Subject|0|||
23226786|NCT02449915|64571312|FG001|Overall Study|Withdrawal by Subject|2|||
23226787|NCT02449915|64571311|FG000|Overall Study|Intraoperative surgical findings|1|||
23226788|NCT02449915|64571312|FG001|Overall Study|Intraoperative surgical findings|1|||
23226789|NCT02449915|64571311|FG000|Overall Study|Abnormal preop lab|0|||
23226790|NCT02449915|64571312|FG001|Overall Study|Abnormal preop lab|1|||
23226791|NCT02181504|64571317|FG000|Overall Study|Adverse Event|1|||
23226792|NCT02181504|64571318|FG001|Overall Study|Adverse Event|1|||
23226793|NCT02181504|64571319|FG002|Overall Study|Adverse Event|1|||
23226794|NCT02573012|64574861|FG000|Overall Study|Adverse Event|5|||
23226795|NCT02573012|64574862|FG001|Overall Study|Adverse Event|5|||
23226796|NCT02573012|64574861|FG000|Overall Study|Lack of Efficacy|5|||
23226797|NCT02573012|64574862|FG001|Overall Study|Lack of Efficacy|4|||
23226798|NCT02573012|64574861|FG000|Overall Study|Non-compliance|1|||
23226799|NCT02573012|64574862|FG001|Overall Study|Non-compliance|2|||
23226800|NCT02573012|64574861|FG000|Overall Study|Withdrawal by Subject|2|||
23226801|NCT02573012|64574862|FG001|Overall Study|Withdrawal by Subject|2|||
23226802|NCT02573012|64574861|FG000|Overall Study|Study Ended per Protocol|1|||
23226803|NCT02573012|64574862|FG001|Overall Study|Study Ended per Protocol|0|||
23226804|NCT02573012|64574861|FG000|Overall Study|Physician Decision|1|||
23226805|NCT02573012|64574862|FG001|Overall Study|Physician Decision|2|||
23226806|NCT02447952|64574863|FG000|Overall Study|Adverse Event|2|||
23226807|NCT02447952|64574863|FG000|Overall Study|Physician Decision|1|||
23226808|NCT02447952|64574863|FG000|Overall Study|Withdrawal by Subject|4|||
23226809|NCT02463331|64574864|FG000|Overall Study|Adverse Event|4|||
23226810|NCT02463331|64574865|FG001|Overall Study|Adverse Event|2|||
23226811|NCT02463331|64574864|FG000|Overall Study|Lost to Follow-up|1|||
23226812|NCT02463331|64574865|FG001|Overall Study|Lost to Follow-up|1|||
23226813|NCT02463331|64574864|FG000|Overall Study|Pregnancy|2|||
23226814|NCT02463331|64574865|FG001|Overall Study|Pregnancy|3|||
23226815|NCT02463331|64574864|FG000|Overall Study|Lack of Efficacy|6|||
23226816|NCT02463331|64574865|FG001|Overall Study|Lack of Efficacy|0|||
23226817|NCT02463331|64574864|FG000|Overall Study|Physician Decision|3|||
23226818|NCT02463331|64574865|FG001|Overall Study|Physician Decision|0|||
23226819|NCT02159365|64574869|FG000|Overall Study|Disease Progression|23|||
23226820|NCT02159365|64574869|FG000|Overall Study|Other reasons|11|||
23226821|NCT02159365|64574869|FG000|Overall Study|Administrative reason by Sponsor|9|||
23226822|NCT02159365|64574869|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
23226823|NCT02159365|64574869|FG000|Overall Study|Study drug toxicity|7|||
23226824|NCT02159365|64574869|FG000|Overall Study|Maximum clinical benefit|3|||
23226825|NCT02159365|64574869|FG000|Overall Study|Subject request to discontinue treatment|3|||
23226826|NCT02159365|64574869|FG000|Overall Study|Subject withdrew consent|3|||
23226827|NCT02159365|64574869|FG000|Overall Study|Death|1|||
23226828|NCT02159365|64574869|FG000|Overall Study|Lost to Follow-up|1|||
23226829|NCT00808028|64574870|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
23226830|NCT00808028|64574871|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
23226831|NCT00808028|64574872|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
23226832|NCT00808028|64574873|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
23226833|NCT00808028|64574870|FG000|Stage 1 (6 Months)|Other|1|||
23226834|NCT00808028|64574871|FG001|Stage 1 (6 Months)|Other|0|||
23166762|NCT00053417|64356241|FG003|Overall Study|Adverse Event|5|||
23166763|NCT00053417|64356238|FG000|Overall Study|Non-Compliance|0|||
23166764|NCT00053417|64356239|FG001|Overall Study|Non-Compliance|0|||
23166765|NCT00053417|64356240|FG002|Overall Study|Non-Compliance|0|||
23166766|NCT00053417|64356241|FG003|Overall Study|Non-Compliance|1|||
23166767|NCT00053417|64356238|FG000|Overall Study|Withdrawal by Subject|0|||
23166768|NCT00053417|64356239|FG001|Overall Study|Withdrawal by Subject|1|||
23166769|NCT00053417|64356240|FG002|Overall Study|Withdrawal by Subject|0|||
23166770|NCT00053417|64356241|FG003|Overall Study|Withdrawal by Subject|0|||
23166771|NCT00053417|64356238|FG000|Overall Study|Lost to Follow-up|1|||
23226835|NCT00808028|64574872|FG002|Stage 1 (6 Months)|Other|2|||
23226836|NCT00808028|64574873|FG003|Stage 1 (6 Months)|Other|4|||
23226837|NCT00808028|64574870|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
23226838|NCT00808028|64574871|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
23166772|NCT00053417|64356239|FG001|Overall Study|Lost to Follow-up|1|||
23166773|NCT00053417|64356240|FG002|Overall Study|Lost to Follow-up|0|||
23166774|NCT00053417|64356241|FG003|Overall Study|Lost to Follow-up|0|||
23226839|NCT00808028|64574872|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
23226840|NCT00808028|64574873|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
23166775|NCT01464307|64356244|FG000|Main Period|Death|0|||
23166776|NCT01464307|64356245|FG001|Main Period|Death|1|||
23226841|NCT00808028|64574870|FG000|Stage 1 (6 Months)|Adverse Event|0|||
23226842|NCT00808028|64574871|FG001|Stage 1 (6 Months)|Adverse Event|0|||
23226843|NCT00808028|64574872|FG002|Stage 1 (6 Months)|Adverse Event|1|||
23166777|NCT01464307|64356244|FG000|Main Period|Adverse Event|6|||
23333182|NCT00506415|64961928|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23333183|NCT00506415|64961925|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
23333184|NCT00506415|64961926|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
23333185|NCT00506415|64961927|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
23333186|NCT00506415|64961928|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
23333187|NCT00506415|64961925|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
23333188|NCT00506415|64961926|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
23333189|NCT00506415|64961927|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
23333190|NCT00506415|64961928|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
23333191|NCT00506415|64961925|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
23333192|NCT00506415|64961926|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23333193|NCT00506415|64961927|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23333194|NCT00506415|64961928|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23333195|NCT00506415|64961925|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
23333196|NCT00506415|64961926|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
23333197|NCT00506415|64961927|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
23333198|NCT00506415|64961928|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
23333199|NCT00506415|64961925|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
23333200|NCT00506415|64961926|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
23333201|NCT00506415|64961927|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
23333202|NCT00506415|64961928|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
23333203|NCT00506415|64961925|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
23333204|NCT00506415|64961926|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
23333205|NCT00506415|64961927|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
23333206|NCT00506415|64961928|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
23333207|NCT00506415|64961925|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
23333208|NCT00506415|64961926|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
23333209|NCT00506415|64961927|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
23333210|NCT00506415|64961928|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
23333211|NCT00506415|64961925|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
23333212|NCT00506415|64961926|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
23333213|NCT00506415|64961927|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
23575141|NCT01809210|65835537|FG005|Overall Study|Withdrawal by Subject|0|||
23575142|NCT01809210|65835538|FG006|Overall Study|Withdrawal by Subject|4|||
23575143|NCT01809210|65835532|FG000|Overall Study|Death|1|||
23575144|NCT01809210|65835533|FG001|Overall Study|Death|1|||
23575145|NCT01809210|65835534|FG002|Overall Study|Death|2|||
23575146|NCT01809210|65835535|FG003|Overall Study|Death|0|||
23575147|NCT01809210|65835536|FG004|Overall Study|Death|1|||
23575148|NCT01809210|65835537|FG005|Overall Study|Death|3|||
23575149|NCT01809210|65835538|FG006|Overall Study|Death|1|||
23575150|NCT01349907|65835539|FG000|Overall Study|Adverse Event|37|||
23575151|NCT01349907|65835540|FG001|Overall Study|Adverse Event|11|||
23575152|NCT01349907|65835539|FG000|Overall Study|Treatment failure|13|||
23575153|NCT01349907|65835540|FG001|Overall Study|Treatment failure|4|||
23575154|NCT01349907|65835539|FG000|Overall Study|Lost to Follow-up|25|||
23333214|NCT00506415|64961928|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
23333215|NCT00506415|64961925|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
23333216|NCT00506415|64961926|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
23333217|NCT00506415|64961927|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
23333218|NCT00506415|64961928|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
23333219|NCT00506415|64961925|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
23333220|NCT00506415|64961926|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
23333221|NCT00506415|64961927|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
23333222|NCT00506415|64961928|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
23333223|NCT00506415|64961925|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
23333224|NCT00506415|64961926|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
23333225|NCT00506415|64961927|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
23333226|NCT00506415|64961928|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
23575155|NCT01349907|65835540|FG001|Overall Study|Lost to Follow-up|6|||
23575156|NCT01349907|65835539|FG000|Overall Study|Withdrawal by Subject|30|||
23575157|NCT01349907|65835540|FG001|Overall Study|Withdrawal by Subject|8|||
23333227|NCT00506415|64961925|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
23333228|NCT00506415|64961926|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
23575158|NCT01349907|65835539|FG000|Overall Study|Protocol Violation|33|||
23575159|NCT01349907|65835540|FG001|Overall Study|Protocol Violation|13|||
23575160|NCT01349907|65835539|FG000|Overall Study|Administrative|1|||
23575161|NCT01349907|65835540|FG001|Overall Study|Administrative|1|||
23575162|NCT01010217|65835541|FG000|Overall Study|Lost to Follow-up|4|||
23575163|NCT01010217|65835542|FG001|Overall Study|Lost to Follow-up|5|||
23333229|NCT00506415|64961927|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
23333230|NCT00506415|64961928|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
23333231|NCT00506415|64961925|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23333232|NCT00506415|64961926|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23333233|NCT00506415|64961927|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
23333234|NCT00506415|64961928|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
23333235|NCT00506415|64961925|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23333236|NCT00506415|64961926|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23333237|NCT00506415|64961927|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
23333238|NCT00506415|64961928|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
23166778|NCT01464307|64356245|FG001|Main Period|Adverse Event|1|||
23166779|NCT01464307|64356244|FG000|Main Period|Lack of Efficacy|2|||
23333239|NCT00506415|64961925|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23333240|NCT00506415|64961926|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23333241|NCT00506415|64961927|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
23333242|NCT00506415|64961928|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
23333243|NCT00506415|64961925|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23333244|NCT00506415|64961926|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23333245|NCT00506415|64961927|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
23333246|NCT00506415|64961928|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
23333247|NCT00506415|64961925|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23333248|NCT00506415|64961926|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23333249|NCT00506415|64961927|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
23166780|NCT01464307|64356245|FG001|Main Period|Lack of Efficacy|0|||
23166781|NCT01464307|64356244|FG000|Main Period|Withdrawal by Subject|5|||
23166782|NCT01464307|64356245|FG001|Main Period|Withdrawal by Subject|2|||
23166783|NCT01464307|64356244|FG000|Main Period|Predefined discontinuation criteria|2|||
23166784|NCT01464307|64356245|FG001|Main Period|Predefined discontinuation criteria|1|||
23226844|NCT00808028|64574873|FG003|Stage 1 (6 Months)|Adverse Event|2|||
23226845|NCT00808028|64574870|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
23226846|NCT00808028|64574871|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
23226847|NCT00808028|64574872|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
23226848|NCT00808028|64574873|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
23226849|NCT00808028|64574870|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
23226850|NCT00808028|64574871|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
23226851|NCT00808028|64574872|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
23226852|NCT00808028|64574873|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
23226853|NCT00808028|64574870|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
23226854|NCT00808028|64574871|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
23226855|NCT00808028|64574872|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
23226856|NCT00808028|64574873|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
23226857|NCT00808028|64574870|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
23226858|NCT00808028|64574871|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
23226859|NCT00808028|64574872|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
23226860|NCT00808028|64574873|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
23226861|NCT00808028|64574870|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
23226862|NCT00808028|64574871|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
23226863|NCT00808028|64574872|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
23226864|NCT00808028|64574873|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
23226865|NCT00808028|64574870|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
23226866|NCT00808028|64574871|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
23226867|NCT00808028|64574872|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
23226868|NCT00808028|64574873|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
23226869|NCT00808028|64574870|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
23333250|NCT00506415|64961928|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
23333251|NCT00506415|64961925|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
23333252|NCT00506415|64961926|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
23333253|NCT00506415|64961927|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
23447442|NCT02675231|65380443|FG002|Overall Study|On study treatment/follow up|23|||
23226870|NCT00808028|64574871|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
23226871|NCT00808028|64574872|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
23166785|NCT01464307|64356244|FG000|Open-Label Extension Period|Adverse Event|15|||
23226872|NCT00808028|64574873|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
23226873|NCT00808028|64574870|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
23226874|NCT00808028|64574871|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
23226875|NCT00808028|64574872|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
23226876|NCT00808028|64574873|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
23226877|NCT00808028|64574870|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
23226878|NCT00808028|64574871|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
23447443|NCT00988884|65380444|FG000|Overall Study|Adverse Event|0|||
23447444|NCT00988884|65380445|FG001|Overall Study|Adverse Event|1|||
23447445|NCT00988884|65380444|FG000|Overall Study|Lost to Follow-up|20|||
23447446|NCT00988884|65380445|FG001|Overall Study|Lost to Follow-up|16|||
23447447|NCT00988884|65380444|FG000|Overall Study|Protocol Violation|0|||
23447448|NCT00988884|65380445|FG001|Overall Study|Protocol Violation|1|||
23447449|NCT00988884|65380444|FG000|Overall Study|Withdrawal by Subject|15|||
23447450|NCT00988884|65380445|FG001|Overall Study|Withdrawal by Subject|18|||
23447451|NCT03244917|65380446|FG000|Overall Study|Lost to Follow-up|2|||
23447452|NCT03244917|65380447|FG001|Overall Study|Lost to Follow-up|2|||
23447453|NCT00684996|65380448|FG000|Overall Study|Adverse Event|1|||
23447454|NCT00684996|65380448|FG000|Overall Study|Refusal unrelated to adverse event|1|||
23447455|NCT00684996|65380448|FG000|Overall Study|Progression/relapse|2|||
23447456|NCT00684996|65380448|FG000|Overall Study|Other reasons not protocol specified|1|||
23447457|NCT00700713|65380449|FG000|Overall Study|Protocol Violation|1|||
23447458|NCT00700713|65380450|FG001|Overall Study|Protocol Violation|0|||
23447459|NCT00700713|65380451|FG002|Overall Study|Protocol Violation|1|||
23447460|NCT00700713|65380449|FG000|Overall Study|Withdrawal by Subject|0|||
23447461|NCT00700713|65380450|FG001|Overall Study|Withdrawal by Subject|0|||
23447462|NCT00700713|65380451|FG002|Overall Study|Withdrawal by Subject|1|||
23575164|NCT01010217|65835543|FG002|Overall Study|Lost to Follow-up|1|||
23333254|NCT00506415|64961928|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
23333255|NCT00492648|64961932|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
23333256|NCT00492648|64961933|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
23333257|NCT03512210|64961934|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
23226879|NCT00808028|64574872|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
23226880|NCT00808028|64574873|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
23226881|NCT00808028|64574870|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
23226882|NCT00808028|64574871|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
23226883|NCT00808028|64574872|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
23226884|NCT00808028|64574873|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
23333258|NCT03512210|64961934|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
23333259|NCT03512210|64961934|FG000|Step 2:Post-MINMON|Death|2|||
23333260|NCT03512210|64961934|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
23333261|NCT03512210|64961934|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
23333262|NCT00245466|64961936|FG000|Overall Study|Adverse Event|2|||
23333263|NCT00245466|64961937|FG001|Overall Study|Adverse Event|8|||
23333264|NCT00245466|64961938|FG002|Overall Study|Adverse Event|4|||
23333265|NCT00245466|64961936|FG000|Overall Study|Low prostate specific antigen suppr|16|||
23333266|NCT00245466|64961937|FG001|Overall Study|Low prostate specific antigen suppr|14|||
23333267|NCT00245466|64961938|FG002|Overall Study|Low prostate specific antigen suppr|5|||
23333268|NCT00245466|64961936|FG000|Overall Study|Insufficient testosterone suppr|12|||
23333269|NCT00245466|64961937|FG001|Overall Study|Insufficient testosterone suppr|12|||
23333270|NCT00245466|64961938|FG002|Overall Study|Insufficient testosterone suppr|21|||
23333271|NCT00245466|64961936|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
23333272|NCT00245466|64961937|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
23333273|NCT00245466|64961938|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
23333274|NCT00245466|64961936|FG000|Overall Study|Withdrawal by Subject|2|||
23333275|NCT00245466|64961937|FG001|Overall Study|Withdrawal by Subject|2|||
23333276|NCT00245466|64961938|FG002|Overall Study|Withdrawal by Subject|1|||
23447463|NCT01859923|65380454|FG000|Overall Study|Adverse Event|0|||
23447464|NCT01859923|65380455|FG001|Overall Study|Adverse Event|0|||
23447465|NCT01859923|65380456|FG002|Overall Study|Adverse Event|1|||
23575165|NCT01010217|65835544|FG003|Overall Study|Lost to Follow-up|0|||
23575166|NCT01010217|65835545|FG004|Overall Study|Lost to Follow-up|0|||
23575167|NCT01010217|65835541|FG000|Overall Study|Withdrawal by Subject|1|||
23575168|NCT01010217|65835542|FG001|Overall Study|Withdrawal by Subject|0|||
23575169|NCT01010217|65835543|FG002|Overall Study|Withdrawal by Subject|0|||
23575170|NCT01010217|65835544|FG003|Overall Study|Withdrawal by Subject|0|||
23575171|NCT01010217|65835545|FG004|Overall Study|Withdrawal by Subject|0|||
23575172|NCT01010217|65835541|FG000|Overall Study|Physician Decision|0|||
23226885|NCT00808028|64574870|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
23226886|NCT00808028|64574871|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
23226887|NCT00808028|64574872|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
23333277|NCT00245466|64961936|FG000|Overall Study|Lost to Follow-up|3|||
23333278|NCT00245466|64961937|FG001|Overall Study|Lost to Follow-up|0|||
23333279|NCT00245466|64961938|FG002|Overall Study|Lost to Follow-up|0|||
23333280|NCT00245466|64961936|FG000|Overall Study|Disease progression|0|||
23333281|NCT00245466|64961937|FG001|Overall Study|Disease progression|3|||
23333282|NCT00245466|64961938|FG002|Overall Study|Disease progression|1|||
23333283|NCT00245466|64961936|FG000|Overall Study|Protocol Violation|1|||
23333284|NCT00245466|64961937|FG001|Overall Study|Protocol Violation|2|||
23333285|NCT00245466|64961938|FG002|Overall Study|Protocol Violation|2|||
23333286|NCT00245466|64961936|FG000|Overall Study|Death|0|||
23575173|NCT01010217|65835542|FG001|Overall Study|Physician Decision|0|||
23575174|NCT01010217|65835543|FG002|Overall Study|Physician Decision|0|||
23575175|NCT01010217|65835544|FG003|Overall Study|Physician Decision|6|||
23575176|NCT01010217|65835545|FG004|Overall Study|Physician Decision|3|||
23575177|NCT03330119|65835547|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
23575178|NCT03330119|65835548|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
23575179|NCT02040090|65835551|FG000|Overall Study|Adverse Event|2|||
23575180|NCT02040090|65835552|FG001|Overall Study|Adverse Event|0|||
23575181|NCT02040090|65835551|FG000|Overall Study|Physician Decision|1|||
23575182|NCT02040090|65835552|FG001|Overall Study|Physician Decision|0|||
23575183|NCT02040090|65835551|FG000|Overall Study|Withdrawal by Subject|0|||
23575184|NCT02040090|65835552|FG001|Overall Study|Withdrawal by Subject|1|||
23575185|NCT02040090|65835551|FG000|Overall Study|Lost to Follow-up|0|||
23575186|NCT02040090|65835552|FG001|Overall Study|Lost to Follow-up|1|||
23575187|NCT00479674|65835556|FG000|Overall Study|Adverse Event|18|||
23575188|NCT00479674|65835556|FG000|Overall Study|Withdrawal by Subject|6|||
23575189|NCT00479674|65835556|FG000|Overall Study|Physician Decision|14|||
23575190|NCT00479674|65835556|FG000|Overall Study|none provided|3|||
23575191|NCT03023332|65835559|FG000|Overall Study|Withdrawal by Subject|10|||
23575192|NCT03023332|65835560|FG001|Overall Study|Withdrawal by Subject|5|||
23575193|NCT03023332|65835561|FG002|Overall Study|Withdrawal by Subject|4|||
23575194|NCT03023332|65835562|FG003|Overall Study|Withdrawal by Subject|7|||
23575195|NCT03023332|65835559|FG000|Overall Study|Lost to Follow-up|13|||
23575196|NCT03023332|65835560|FG001|Overall Study|Lost to Follow-up|16|||
23575197|NCT03023332|65835561|FG002|Overall Study|Lost to Follow-up|8|||
23575198|NCT03023332|65835562|FG003|Overall Study|Lost to Follow-up|13|||
23575199|NCT03023332|65835559|FG000|Overall Study|Death|1|||
23575200|NCT03023332|65835560|FG001|Overall Study|Death|0|||
23575201|NCT03023332|65835561|FG002|Overall Study|Death|0|||
23575202|NCT03023332|65835562|FG003|Overall Study|Death|0|||
23333287|NCT00245466|64961937|FG001|Overall Study|Death|2|||
23333288|NCT00245466|64961938|FG002|Overall Study|Death|0|||
23575203|NCT01723826|65835565|FG000|Overall Study|Adverse Event|4|||
23575204|NCT01723826|65835566|FG001|Overall Study|Adverse Event|1|||
23575205|NCT01723826|65835567|FG002|Overall Study|Adverse Event|4|||
23575206|NCT01723826|65835568|FG003|Overall Study|Adverse Event|5|||
23226888|NCT00808028|64574873|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
23226889|NCT05333289|64574874|FG000|Overall Study|Other|1|||
23226890|NCT05333289|64574875|FG001|Overall Study|Other|0|||
23226891|NCT05333289|64574876|FG002|Overall Study|Other|0|||
23575207|NCT01723826|65835565|FG000|Overall Study|Death according to AE eCRF|2|||
23575208|NCT01723826|65835566|FG001|Overall Study|Death according to AE eCRF|3|||
23575209|NCT01723826|65835567|FG002|Overall Study|Death according to AE eCRF|3|||
23575210|NCT01723826|65835568|FG003|Overall Study|Death according to AE eCRF|7|||
23575211|NCT01723826|65835565|FG000|Overall Study|Lost to Follow-up|1|||
23575212|NCT01723826|65835566|FG001|Overall Study|Lost to Follow-up|3|||
23226892|NCT05333289|64574877|FG003|Overall Study|Other|1|||
23226893|NCT05333289|64574878|FG004|Overall Study|Other|1|||
23226894|NCT05333289|64574879|FG005|Overall Study|Other|2|||
23226895|NCT05333289|64574880|FG006|Overall Study|Other|2|||
23226896|NCT05333289|64574881|FG007|Overall Study|Other|0|||
23226897|NCT05333289|64574874|FG000|Overall Study|Withdrawal by Subject|1|||
23226898|NCT05333289|64574875|FG001|Overall Study|Withdrawal by Subject|2|||
23226899|NCT05333289|64574876|FG002|Overall Study|Withdrawal by Subject|2|||
23333289|NCT00245466|64961936|FG000|Overall Study|Administrative reasons|0|||
23447466|NCT01859923|65380457|FG003|Overall Study|Adverse Event|1|||
23575213|NCT01723826|65835567|FG002|Overall Study|Lost to Follow-up|1|||
23575214|NCT01723826|65835568|FG003|Overall Study|Lost to Follow-up|1|||
23575215|NCT01723826|65835565|FG000|Overall Study|Non-compliance|0|||
23575216|NCT01723826|65835566|FG001|Overall Study|Non-compliance|1|||
23226900|NCT05333289|64574877|FG003|Overall Study|Withdrawal by Subject|1|||
23226901|NCT05333289|64574878|FG004|Overall Study|Withdrawal by Subject|1|||
23226902|NCT05333289|64574879|FG005|Overall Study|Withdrawal by Subject|2|||
23226903|NCT05333289|64574880|FG006|Overall Study|Withdrawal by Subject|1|||
23226904|NCT05333289|64574881|FG007|Overall Study|Withdrawal by Subject|3|||
23226905|NCT05333289|64574874|FG000|Overall Study|Protocol Violation|1|||
23575217|NCT01723826|65835567|FG002|Overall Study|Non-compliance|3|||
23333290|NCT00245466|64961937|FG001|Overall Study|Administrative reasons|1|||
23333291|NCT00245466|64961938|FG002|Overall Study|Administrative reasons|0|||
23575218|NCT01723826|65835568|FG003|Overall Study|Non-compliance|3|||
23575219|NCT01723826|65835565|FG000|Overall Study|Non-compliance With Study Drug|0|||
23575220|NCT01723826|65835566|FG001|Overall Study|Non-compliance With Study Drug|1|||
23575221|NCT01723826|65835567|FG002|Overall Study|Non-compliance With Study Drug|0|||
23575222|NCT01723826|65835568|FG003|Overall Study|Non-compliance With Study Drug|0|||
23575223|NCT01723826|65835565|FG000|Overall Study|Other Reason|8|||
23166786|NCT01464307|64356245|FG001|Open-Label Extension Period|Adverse Event|0|||
23166787|NCT01464307|64356244|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
23166788|NCT01464307|64356245|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
23166789|NCT01464307|64356244|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
23166790|NCT01464307|64356245|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
23166791|NCT01464307|64356244|FG000|Open-Label Extension Period|Death|1|||
23166792|NCT01464307|64356245|FG001|Open-Label Extension Period|Death|0|||
23166793|NCT01464307|64356244|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
23166794|NCT01464307|64356245|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
23166795|NCT01464307|64356244|FG000|Open-Label Extension Period|Non-compliance|9|||
23166796|NCT01464307|64356245|FG001|Open-Label Extension Period|Non-compliance|0|||
23166797|NCT01464307|64356244|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
23166798|NCT01464307|64356245|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
23333292|NCT02187198|64961941|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
23333293|NCT02187198|64961942|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
23333294|NCT02187198|64961941|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
23333295|NCT02187198|64961942|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
23333296|NCT06110494|64961943|FG000|Overall Study|Protocol Violation|2|||
23333297|NCT06110494|64961944|FG001|Overall Study|Protocol Violation|0|||
23333298|NCT06110494|64961945|FG002|Overall Study|Protocol Violation|1|||
23333299|NCT06110494|64961943|FG000|Overall Study|Dixon's test for outlier analysis|1|||
23333300|NCT06110494|64961944|FG001|Overall Study|Dixon's test for outlier analysis|1|||
23333301|NCT06110494|64961945|FG002|Overall Study|Dixon's test for outlier analysis|0|||
23333302|NCT00593684|64961948|FG000|Overall Study|Death|2|||
23333303|NCT00593684|64961949|FG001|Overall Study|Death|1|||
23333304|NCT02612623|64961956|FG000|Overall Study|Withdrawal by Subject|0|||
23333305|NCT02612623|64961957|FG001|Overall Study|Withdrawal by Subject|1|||
23333306|NCT02612623|64961958|FG002|Overall Study|Withdrawal by Subject|0|||
23333307|NCT02612623|64961959|FG003|Overall Study|Withdrawal by Subject|0|||
23333308|NCT02612623|64961956|FG000|Overall Study|Adverse Event|1|||
23333309|NCT02612623|64961957|FG001|Overall Study|Adverse Event|0|||
23333310|NCT02612623|64961958|FG002|Overall Study|Adverse Event|1|||
23333311|NCT02612623|64961959|FG003|Overall Study|Adverse Event|0|||
23333312|NCT00552396|64961960|FG000|Overall Study|protocol withdrawal criteria|3|||
23333313|NCT00552396|64961961|FG001|Overall Study|protocol withdrawal criteria|3|||
23333314|NCT00552396|64961962|FG002|Overall Study|protocol withdrawal criteria|3|||
23333315|NCT00552396|64961963|FG003|Overall Study|protocol withdrawal criteria|6|||
23333316|NCT00552396|64961964|FG004|Overall Study|protocol withdrawal criteria|3|||
23447467|NCT04317040|65380461|FG000|Overall Study|Lost to Follow-up|2|||
23447468|NCT04317040|65380462|FG001|Overall Study|Lost to Follow-up|0|||
23575224|NCT01723826|65835566|FG001|Overall Study|Other Reason|6|||
23575225|NCT01723826|65835567|FG002|Overall Study|Other Reason|12|||
23575226|NCT01723826|65835568|FG003|Overall Study|Other Reason|14|||
23575227|NCT01723826|65835565|FG000|Overall Study|Physician Decision|1|||
23575228|NCT01723826|65835566|FG001|Overall Study|Physician Decision|3|||
23575229|NCT01723826|65835567|FG002|Overall Study|Physician Decision|4|||
23226906|NCT05333289|64574875|FG001|Overall Study|Protocol Violation|0|||
23226907|NCT05333289|64574876|FG002|Overall Study|Protocol Violation|0|||
23226908|NCT05333289|64574877|FG003|Overall Study|Protocol Violation|0|||
23226909|NCT05333289|64574878|FG004|Overall Study|Protocol Violation|0|||
23226910|NCT05333289|64574879|FG005|Overall Study|Protocol Violation|0|||
23333317|NCT00552396|64961965|FG005|Overall Study|protocol withdrawal criteria|3|||
23575230|NCT01723826|65835568|FG003|Overall Study|Physician Decision|11|||
23575231|NCT01723826|65835565|FG000|Overall Study|Protocol Violation|1|||
23575232|NCT01723826|65835566|FG001|Overall Study|Protocol Violation|1|||
23575233|NCT01723826|65835567|FG002|Overall Study|Protocol Violation|3|||
23575234|NCT01723826|65835568|FG003|Overall Study|Protocol Violation|1|||
23575235|NCT01723826|65835565|FG000|Overall Study|Withdrawal by Subject|10|||
23575236|NCT01723826|65835566|FG001|Overall Study|Withdrawal by Subject|17|||
23226911|NCT05333289|64574880|FG006|Overall Study|Protocol Violation|0|||
23226912|NCT05333289|64574881|FG007|Overall Study|Protocol Violation|0|||
23575237|NCT01723826|65835567|FG002|Overall Study|Withdrawal by Subject|27|||
23166799|NCT00812214|64359241|FG000|Overall Study|Lost to Follow-up|3|||
23226913|NCT05333289|64574874|FG000|Overall Study|Physician Decision|0|||
23333318|NCT00552396|64961966|FG006|Overall Study|protocol withdrawal criteria|9|||
23447469|NCT04317040|65380461|FG000|Overall Study|Death|16|||
23166800|NCT00812214|64359242|FG001|Overall Study|Lost to Follow-up|1|||
23226914|NCT05333289|64574875|FG001|Overall Study|Physician Decision|0|||
23226915|NCT05333289|64574876|FG002|Overall Study|Physician Decision|1|||
23575238|NCT01723826|65835568|FG003|Overall Study|Withdrawal by Subject|48|||
23575239|NCT02091869|65835571|FG000|Overall Study|Withdrawal by Subject|0|||
23575240|NCT02091869|65835572|FG001|Overall Study|Withdrawal by Subject|3|||
23575241|NCT03268590|65835575|FG000|Overall Study|Previously unknown exclusion criteria|1|||
23575242|NCT01237678|65835576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
23575243|NCT01237678|65835577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
23575244|NCT01237678|65835578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
23575245|NCT01237678|65835576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
23575246|NCT01237678|65835577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
23575247|NCT01237678|65835578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
23575248|NCT01237678|65835576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
23575249|NCT01237678|65835577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
23575250|NCT01237678|65835578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
23575251|NCT01237678|65835576|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
23575252|NCT01237678|65835577|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
23575253|NCT01237678|65835578|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
23575254|NCT01237678|65835576|FG000|Phase II|Adverse Event|0|||
23575255|NCT01237678|65835577|FG001|Phase II|Adverse Event|39|||
23575256|NCT01237678|65835578|FG002|Phase II|Adverse Event|9|||
23575257|NCT01237678|65835576|FG000|Phase II|Death|0|||
23575258|NCT01237678|65835577|FG001|Phase II|Death|0|||
23575259|NCT01237678|65835578|FG002|Phase II|Death|2|||
23575260|NCT01237678|65835576|FG000|Phase II|Lack of Efficacy|0|||
23575261|NCT01237678|65835577|FG001|Phase II|Lack of Efficacy|25|||
23575262|NCT01237678|65835578|FG002|Phase II|Lack of Efficacy|3|||
23575263|NCT01237678|65835576|FG000|Phase II|Withdrawal by Subject|0|||
23575264|NCT01237678|65835577|FG001|Phase II|Withdrawal by Subject|1|||
23575265|NCT01237678|65835578|FG002|Phase II|Withdrawal by Subject|5|||
23575266|NCT01237678|65835576|FG000|Phase II|Completed Cycles 4-6|0|||
23575267|NCT01237678|65835577|FG001|Phase II|Completed Cycles 4-6|11|||
23575268|NCT01237678|65835578|FG002|Phase II|Completed Cycles 4-6|21|||
23575269|NCT01237678|65835576|FG000|Phase II|Sponsor Decision/Study Closed|0|||
23575270|NCT01237678|65835577|FG001|Phase II|Sponsor Decision/Study Closed|18|||
23575271|NCT01237678|65835578|FG002|Phase II|Sponsor Decision/Study Closed|7|||
23575272|NCT01237678|65835576|FG000|Phase II|Randomized but were not treated|0|||
23575273|NCT01237678|65835577|FG001|Phase II|Randomized but were not treated|4|||
23575274|NCT01237678|65835578|FG002|Phase II|Randomized but were not treated|3|||
23575275|NCT03615482|65835586|FG000|Overall Study|Death|1|||
23575276|NCT03615482|65835587|FG001|Overall Study|Death|0|||
23575277|NCT03615482|65835586|FG000|Overall Study|Lost to Follow-up|7|||
23575278|NCT03615482|65835587|FG001|Overall Study|Lost to Follow-up|7|||
23575279|NCT03615482|65835586|FG000|Overall Study|Physician Decision|2|||
23575280|NCT03615482|65835587|FG001|Overall Study|Physician Decision|3|||
23575281|NCT03615482|65835586|FG000|Overall Study|Withdrawal by Subject|7|||
23575282|NCT03615482|65835587|FG001|Overall Study|Withdrawal by Subject|7|||
23575283|NCT00197028|65835593|FG000|Overall Study|Adverse Event|2|||
23575284|NCT00197028|65835594|FG001|Overall Study|Adverse Event|2|||
23575285|NCT00197028|65835593|FG000|Overall Study|Protocol Violation|2|||
23575286|NCT00197028|65835594|FG001|Overall Study|Protocol Violation|1|||
23575287|NCT00197028|65835593|FG000|Overall Study|Withdrawal by Subject|8|||
23575288|NCT00197028|65835594|FG001|Overall Study|Withdrawal by Subject|12|||
23575289|NCT00197028|65835593|FG000|Overall Study|Lost to Follow-up|1|||
23575290|NCT00197028|65835594|FG001|Overall Study|Lost to Follow-up|0|||
23575291|NCT00197028|65835593|FG000|Overall Study|Other|3|||
23575292|NCT00197028|65835594|FG001|Overall Study|Other|6|||
23575293|NCT01163149|65835597|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
23575294|NCT01163149|65835598|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23575295|NCT01163149|65835599|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
23575296|NCT01163149|65835597|FG000|Extension Treatment Period|Adverse Event|0|||
23575297|NCT01163149|65835598|FG001|Extension Treatment Period|Adverse Event|1|||
23575298|NCT01163149|65835599|FG002|Extension Treatment Period|Adverse Event|0|||
23226916|NCT05333289|64574877|FG003|Overall Study|Physician Decision|0|||
23575299|NCT01163149|65835597|FG000|Extension Treatment Period|Noncompliance|0|||
23575300|NCT01163149|65835598|FG001|Extension Treatment Period|Noncompliance|0|||
23575301|NCT01163149|65835599|FG002|Extension Treatment Period|Noncompliance|1|||
23575302|NCT00007475|65835614|FG000|Overall Study|Withdrawal by Subject|1|||
23575303|NCT00007475|65835615|FG001|Overall Study|Withdrawal by Subject|0|||
23575304|NCT00007475|65835616|FG002|Overall Study|Withdrawal by Subject|0|||
23575305|NCT00007475|65835617|FG003|Overall Study|Withdrawal by Subject|0|||
23575306|NCT00007475|65835614|FG000|Overall Study|Adverse Event|3|||
23575307|NCT00007475|65835615|FG001|Overall Study|Adverse Event|0|||
23575308|NCT00007475|65835616|FG002|Overall Study|Adverse Event|0|||
23575309|NCT00007475|65835617|FG003|Overall Study|Adverse Event|0|||
23575310|NCT01619787|65835618|FG000|Overall Study|Lost to Follow-up|5|||
23575311|NCT00619476|65835619|FG000|Overall Study|Adverse Event|12|||
23575312|NCT00619476|65835620|FG001|Overall Study|Adverse Event|6|||
23575313|NCT00619476|65835621|FG002|Overall Study|Adverse Event|12|||
23575314|NCT00619476|65835622|FG003|Overall Study|Adverse Event|16|||
23575315|NCT00619476|65835619|FG000|Overall Study|Lack of Efficacy|6|||
23575316|NCT00619476|65835620|FG001|Overall Study|Lack of Efficacy|1|||
23575317|NCT00619476|65835621|FG002|Overall Study|Lack of Efficacy|1|||
23575318|NCT00619476|65835622|FG003|Overall Study|Lack of Efficacy|4|||
23575319|NCT00619476|65835619|FG000|Overall Study|Protocol Violation|5|||
23575320|NCT00619476|65835620|FG001|Overall Study|Protocol Violation|4|||
23575321|NCT00619476|65835621|FG002|Overall Study|Protocol Violation|4|||
23575322|NCT00619476|65835622|FG003|Overall Study|Protocol Violation|9|||
23575323|NCT00619476|65835619|FG000|Overall Study|Lost to Follow-up|1|||
23575324|NCT00619476|65835620|FG001|Overall Study|Lost to Follow-up|2|||
23575325|NCT00619476|65835621|FG002|Overall Study|Lost to Follow-up|0|||
23575326|NCT00619476|65835622|FG003|Overall Study|Lost to Follow-up|1|||
23575327|NCT00619476|65835619|FG000|Overall Study|Investigator Discretion|2|||
23575328|NCT00619476|65835620|FG001|Overall Study|Investigator Discretion|2|||
23575329|NCT00619476|65835621|FG002|Overall Study|Investigator Discretion|2|||
23575330|NCT00619476|65835622|FG003|Overall Study|Investigator Discretion|0|||
23575331|NCT00619476|65835619|FG000|Overall Study|Withdrawal by Subject|5|||
23575332|NCT00619476|65835620|FG001|Overall Study|Withdrawal by Subject|7|||
23575333|NCT00619476|65835621|FG002|Overall Study|Withdrawal by Subject|5|||
23575334|NCT00619476|65835622|FG003|Overall Study|Withdrawal by Subject|4|||
23575335|NCT00742885|65835623|FG000|Overall Study|Lost to Follow-up|1|||
23166801|NCT03979274|64359247|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23166802|NCT03979274|64359248|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23166803|NCT01964352|64359249|FG000|Overall Study|Adverse Event|13|||
23166804|NCT01964352|64359250|FG001|Overall Study|Adverse Event|3|||
23166805|NCT01964352|64359251|FG002|Overall Study|Adverse Event|4|||
23166806|NCT01964352|64359252|FG003|Overall Study|Adverse Event|3|||
23166807|NCT01964352|64359249|FG000|Overall Study|Lack of Efficacy|6|||
23166808|NCT01964352|64359250|FG001|Overall Study|Lack of Efficacy|0|||
23166809|NCT01964352|64359251|FG002|Overall Study|Lack of Efficacy|0|||
23166810|NCT01964352|64359252|FG003|Overall Study|Lack of Efficacy|0|||
23166811|NCT01964352|64359249|FG000|Overall Study|Protocol Violation|2|||
23166812|NCT01964352|64359250|FG001|Overall Study|Protocol Violation|4|||
23166813|NCT01964352|64359251|FG002|Overall Study|Protocol Violation|0|||
23166814|NCT01964352|64359252|FG003|Overall Study|Protocol Violation|2|||
23166815|NCT01964352|64359249|FG000|Overall Study|Lost to Follow-up|1|||
23166816|NCT01964352|64359250|FG001|Overall Study|Lost to Follow-up|0|||
23166817|NCT01964352|64359251|FG002|Overall Study|Lost to Follow-up|0|||
23166818|NCT01964352|64359252|FG003|Overall Study|Lost to Follow-up|1|||
23166819|NCT01964352|64359249|FG000|Overall Study|Withdrawal by Subject|4|||
23166820|NCT01964352|64359250|FG001|Overall Study|Withdrawal by Subject|2|||
23166821|NCT01964352|64359251|FG002|Overall Study|Withdrawal by Subject|1|||
23166822|NCT01964352|64359252|FG003|Overall Study|Withdrawal by Subject|0|||
23166823|NCT01964352|64359249|FG000|Overall Study|Other than stated above|0|||
23166824|NCT01964352|64359250|FG001|Overall Study|Other than stated above|2|||
23166825|NCT01964352|64359251|FG002|Overall Study|Other than stated above|1|||
23166826|NCT01964352|64359252|FG003|Overall Study|Other than stated above|2|||
23166827|NCT02286947|64359253|FG000|Overall Study|Withdrawal by Subject|2|||
23166828|NCT04899232|64359255|FG000|Screening Period|Physician Decision|1|||
23166829|NCT04899232|64359256|FG001|Screening Period|Physician Decision|0|||
23166830|NCT04899232|64359257|FG002|Screening Period|Physician Decision|0|||
23166831|NCT04899232|64359255|FG000|Screening Period|Withdrawal by Subject|1|||
23166832|NCT04899232|64359256|FG001|Screening Period|Withdrawal by Subject|0|||
23166833|NCT04899232|64359257|FG002|Screening Period|Withdrawal by Subject|0|||
23166834|NCT04899232|64359255|FG000|Screening Period|Participant discharged before receiving intervention|3|||
23166835|NCT04899232|64359256|FG001|Screening Period|Participant discharged before receiving intervention|0|||
23166836|NCT04899232|64359257|FG002|Screening Period|Participant discharged before receiving intervention|0|||
23226917|NCT05333289|64574878|FG004|Overall Study|Physician Decision|0|||
23575336|NCT00742885|65835624|FG001|Overall Study|Lost to Follow-up|0|||
23575337|NCT03293485|65835627|FG000|Overall Study|Death|1|||
23575338|NCT03293485|65835627|FG000|Overall Study|Screen Failure|2|||
23575339|NCT03293485|65835627|FG000|Overall Study|Withdrawal by Subject|2|||
23575340|NCT01349829|65835628|FG000|Overall Study|Lost to Follow-up|4|||
23575341|NCT01349829|65835629|FG001|Overall Study|Lost to Follow-up|8|||
23166837|NCT02462473|64359260|FG000|Overall Study|Death|1|||
23166838|NCT02462473|64359260|FG000|Overall Study|Other|3|||
23166839|NCT02597946|64359267|FG000|Overall Study|Withdrawal by Subject|1|||
23166840|NCT02597946|64359267|FG000|Overall Study|Progressive disease|16|||
23166841|NCT02597946|64359267|FG000|Overall Study|Other than above|1|||
23166842|NCT00498173|64359268|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
23166843|NCT00498173|64359269|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
23575342|NCT01349829|65835628|FG000|Overall Study|Consent withdrawal|3|||
23575343|NCT01349829|65835629|FG001|Overall Study|Consent withdrawal|8|||
23575344|NCT01349829|65835628|FG000|Overall Study|Migrated/moved|2|||
23575345|NCT01349829|65835629|FG001|Overall Study|Migrated/moved|7|||
23575346|NCT02839681|65835630|FG000|Overall Study|Death|2|||
23575347|NCT05124899|65835631|FG000|Overall Study|Lost to Follow-up|3|||
23575348|NCT03369951|65838710|FG000|Overall Study|Withdrawal by Subject|3|||
23575349|NCT03369951|65838710|FG000|Overall Study|Death|1|||
23575350|NCT03369951|65838710|FG000|Overall Study|Lost to Follow-up|1|||
23575351|NCT03369951|65838710|FG000|Overall Study|Protocol Violation|1|||
23575352|NCT00683449|65838711|FG000|Overall Study|Lost to Follow-up|0|||
23575353|NCT00683449|65838712|FG001|Overall Study|Lost to Follow-up|1|||
23575354|NCT00683449|65838713|FG002|Overall Study|Lost to Follow-up|0|||
23575355|NCT00683449|65838714|FG003|Overall Study|Lost to Follow-up|0|||
23575356|NCT00683449|65838715|FG004|Overall Study|Lost to Follow-up|0|||
23575357|NCT00062868|65838716|FG000|Dose Level 1|Death|2|||
23575358|NCT00062868|65838717|FG001|Dose Level 1|Death|0|||
23226918|NCT05333289|64574879|FG005|Overall Study|Physician Decision|2|||
23226919|NCT05333289|64574880|FG006|Overall Study|Physician Decision|0|||
23226920|NCT05333289|64574881|FG007|Overall Study|Physician Decision|0|||
23226921|NCT05333289|64574874|FG000|Overall Study|Lost to Follow-up|6|||
23226922|NCT05333289|64574875|FG001|Overall Study|Lost to Follow-up|0|||
23226923|NCT05333289|64574876|FG002|Overall Study|Lost to Follow-up|1|||
23226924|NCT05333289|64574877|FG003|Overall Study|Lost to Follow-up|6|||
23226925|NCT05333289|64574878|FG004|Overall Study|Lost to Follow-up|3|||
23226926|NCT05333289|64574879|FG005|Overall Study|Lost to Follow-up|3|||
23226927|NCT05333289|64574880|FG006|Overall Study|Lost to Follow-up|2|||
23226928|NCT05333289|64574881|FG007|Overall Study|Lost to Follow-up|1|||
23226929|NCT05333289|64574874|FG000|Overall Study|Death|1|||
23226930|NCT05333289|64574875|FG001|Overall Study|Death|0|||
23226931|NCT05333289|64574876|FG002|Overall Study|Death|0|||
23226932|NCT05333289|64574877|FG003|Overall Study|Death|0|||
23226933|NCT05333289|64574878|FG004|Overall Study|Death|0|||
23226934|NCT05333289|64574879|FG005|Overall Study|Death|0|||
23226935|NCT05333289|64574880|FG006|Overall Study|Death|0|||
23226936|NCT05333289|64574881|FG007|Overall Study|Death|0|||
23226937|NCT02309372|64574882|FG000|Overall Study|Lost to Follow-up|3|||
23226938|NCT02309372|64574883|FG001|Overall Study|Lost to Follow-up|2|||
23226939|NCT01536418|64574884|FG000|Overall Study|Protocol Violation|2|||
23226940|NCT01536418|64574885|FG001|Overall Study|Protocol Violation|3|||
23226941|NCT01536418|64574884|FG000|Overall Study|Physician Decision|1|||
23226942|NCT01536418|64574885|FG001|Overall Study|Physician Decision|3|||
23226943|NCT01536418|64574884|FG000|Overall Study|Study closed/terminated|41|||
23226944|NCT01536418|64574885|FG001|Overall Study|Study closed/terminated|37|||
23226945|NCT01536418|64574884|FG000|Overall Study|Lack of Efficacy|10|||
23226946|NCT01536418|64574885|FG001|Overall Study|Lack of Efficacy|16|||
23226947|NCT01536418|64574884|FG000|Overall Study|Adverse Event|9|||
23226948|NCT01536418|64574885|FG001|Overall Study|Adverse Event|4|||
23226949|NCT01536418|64574884|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
23226950|NCT01536418|64574885|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
23226951|NCT01536418|64574884|FG000|Overall Study|Withdrawal by Subject|5|||
23226952|NCT01536418|64574885|FG001|Overall Study|Withdrawal by Subject|3|||
23226953|NCT03399786|64574889|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23226954|NCT03399786|64574890|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23226955|NCT03399786|64574891|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23226956|NCT03399786|64574892|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23226957|NCT03399786|64574889|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
23226958|NCT03399786|64574890|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
23226959|NCT03399786|64574891|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
23226960|NCT03399786|64574892|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
23226961|NCT03399786|64574889|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
23226962|NCT03399786|64574890|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
23226963|NCT03399786|64574891|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
23226964|NCT03399786|64574892|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
23226965|NCT03198728|64574895|FG000|Overall Study|Adverse Event|10|||
23226966|NCT03198728|64574896|FG001|Overall Study|Adverse Event|5|||
23447470|NCT04317040|65380462|FG001|Overall Study|Death|18|||
23575359|NCT00062868|65838718|FG002|Dose Level 1|Death|0|||
23226967|NCT03198728|64574895|FG000|Overall Study|Lost to Follow-up|21|||
23575360|NCT00062868|65838719|FG003|Dose Level 1|Death|2|||
23575361|NCT00062868|65838720|FG004|Dose Level 1|Death|0|||
23226968|NCT03198728|64574896|FG001|Overall Study|Lost to Follow-up|7|||
23226969|NCT03198728|64574895|FG000|Overall Study|Physician Decision|7|||
23575362|NCT00062868|65838721|FG005|Dose Level 1|Death|0|||
23575363|NCT00062868|65838722|FG006|Dose Level 1|Death|3|||
23575364|NCT00062868|65838723|FG007|Dose Level 1|Death|0|||
23333319|NCT06098339|64961969|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
23333320|NCT06098339|64961970|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
23333321|NCT06098339|64961969|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
23333322|NCT06098339|64961970|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
23333323|NCT01757184|64961971|FG000|Double-blind Period|Adverse Event|1|||
23333324|NCT01757184|64961972|FG001|Double-blind Period|Adverse Event|0|||
23333325|NCT01757184|64961973|FG002|Double-blind Period|Adverse Event|0|||
23333326|NCT01757184|64961974|FG003|Double-blind Period|Adverse Event|0|||
23333327|NCT01757184|64961971|FG000|Open-label Period|Lost to Follow-up|0|||
23333328|NCT01757184|64961972|FG001|Open-label Period|Lost to Follow-up|0|||
23333329|NCT01757184|64961973|FG002|Open-label Period|Lost to Follow-up|2|||
23333330|NCT01757184|64961974|FG003|Open-label Period|Lost to Follow-up|0|||
23333331|NCT01757184|64961971|FG000|Open-label Period|Withdrawal by Subject|0|||
23333332|NCT01757184|64961972|FG001|Open-label Period|Withdrawal by Subject|0|||
23333333|NCT01757184|64961973|FG002|Open-label Period|Withdrawal by Subject|1|||
23333334|NCT01757184|64961974|FG003|Open-label Period|Withdrawal by Subject|1|||
23333335|NCT01757184|64961971|FG000|Open-label Period|Discontinued by Sponsor|0|||
23333336|NCT01757184|64961972|FG001|Open-label Period|Discontinued by Sponsor|0|||
23333337|NCT01757184|64961973|FG002|Open-label Period|Discontinued by Sponsor|1|||
23575365|NCT00062868|65838724|FG008|Dose Level 1|Death|0|||
23333338|NCT01757184|64961974|FG003|Open-label Period|Discontinued by Sponsor|2|||
23333339|NCT00791778|64961977|FG000|Double-blind Treatment|Adverse Event|49|||
23333340|NCT00791778|64961978|FG001|Double-blind Treatment|Adverse Event|9|||
23333341|NCT00791778|64961977|FG000|Double-blind Treatment|Physician Decision|6|||
23333342|NCT00791778|64961978|FG001|Double-blind Treatment|Physician Decision|26|||
23575366|NCT00062868|65838725|FG009|Dose Level 1|Death|0|||
23575367|NCT00062868|65838726|FG010|Dose Level 1|Death|0|||
23575368|NCT00062868|65838727|FG011|Dose Level 1|Death|0|||
23575369|NCT00062868|65838728|FG012|Dose Level 1|Death|0|||
23575370|NCT00062868|65838729|FG013|Dose Level 1|Death|0|||
23575371|NCT00062868|65838730|FG014|Dose Level 1|Death|0|||
23575372|NCT00062868|65838731|FG015|Dose Level 1|Death|0|||
23575373|NCT00062868|65838732|FG016|Dose Level 1|Death|0|||
23575374|NCT00062868|65838733|FG017|Dose Level 1|Death|0|||
23575375|NCT00062868|65838734|FG018|Dose Level 1|Death|7|||
23166844|NCT00498173|64359270|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
23333343|NCT00791778|64961977|FG000|Double-blind Treatment|Protocol Violation|0|||
23333344|NCT00791778|64961978|FG001|Double-blind Treatment|Protocol Violation|4|||
23333345|NCT00791778|64961977|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
23333346|NCT00791778|64961978|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
23333347|NCT00791778|64961977|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
23333348|NCT00791778|64961978|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
23333349|NCT00791778|64961977|FG000|Follow-up|Withdrawal by Subject|3|||
23333350|NCT00791778|64961978|FG001|Follow-up|Withdrawal by Subject|0|||
23333351|NCT00791778|64961977|FG000|Follow-up|Lost to Follow-up|2|||
23333352|NCT00791778|64961978|FG001|Follow-up|Lost to Follow-up|1|||
23333353|NCT00026494|64961979|FG000|Overall Study|Withdrawal by Subject|1|||
23333354|NCT00026494|64961980|FG001|Overall Study|Withdrawal by Subject|0|||
23333355|NCT00026494|64961981|FG002|Overall Study|Withdrawal by Subject|1|||
23333356|NCT00026494|64961982|FG003|Overall Study|Withdrawal by Subject|0|||
23333357|NCT00026494|64961979|FG000|Overall Study|Patient non-compliance|1|||
23333358|NCT00026494|64961980|FG001|Overall Study|Patient non-compliance|0|||
23333359|NCT00026494|64961981|FG002|Overall Study|Patient non-compliance|0|||
23333360|NCT00026494|64961982|FG003|Overall Study|Patient non-compliance|0|||
23333361|NCT00026494|64961979|FG000|Overall Study|Patient not treated|0|||
23333362|NCT00026494|64961980|FG001|Overall Study|Patient not treated|0|||
23333363|NCT00026494|64961981|FG002|Overall Study|Patient not treated|2|||
23333364|NCT00026494|64961982|FG003|Overall Study|Patient not treated|0|||
23333365|NCT00026494|64961979|FG000|Overall Study|Clinical progression|0|||
23575376|NCT00062868|65838735|FG019|Dose Level 1|Death|0|||
23575377|NCT00062868|65838736|FG020|Dose Level 1|Death|1|||
23575378|NCT00062868|65838716|FG000|Dose Level 1|Lost to Follow-up|0|||
23575379|NCT00062868|65838717|FG001|Dose Level 1|Lost to Follow-up|0|||
23166845|NCT01908101|64359271|FG000|Overall Study|Physician Decision|1|||
23575380|NCT00062868|65838718|FG002|Dose Level 1|Lost to Follow-up|0|||
23575381|NCT00062868|65838719|FG003|Dose Level 1|Lost to Follow-up|0|||
23333366|NCT00026494|64961980|FG001|Overall Study|Clinical progression|0|||
23333367|NCT00026494|64961981|FG002|Overall Study|Clinical progression|3|||
23333368|NCT00026494|64961982|FG003|Overall Study|Clinical progression|0|||
23333369|NCT01554527|64961983|FG000|Overall Study|Withdrawal by Subject|1|||
23333370|NCT01554527|64961984|FG001|Overall Study|Withdrawal by Subject|0|||
23333371|NCT01554527|64961985|FG002|Overall Study|Withdrawal by Subject|3|||
23333372|NCT01554527|64961983|FG000|Overall Study|Lost to Follow-up|0|||
23333373|NCT01554527|64961984|FG001|Overall Study|Lost to Follow-up|0|||
23575382|NCT00062868|65838720|FG004|Dose Level 1|Lost to Follow-up|0|||
23575383|NCT00062868|65838721|FG005|Dose Level 1|Lost to Follow-up|0|||
23333374|NCT01554527|64961985|FG002|Overall Study|Lost to Follow-up|4|||
23333375|NCT01554527|64961983|FG000|Overall Study|Physician Decision|0|||
23333376|NCT01554527|64961984|FG001|Overall Study|Physician Decision|0|||
23333377|NCT01554527|64961985|FG002|Overall Study|Physician Decision|1|||
23333378|NCT02169271|64961986|FG000|Overall Study|Protocol Violation|1|||
23333379|NCT02169271|64961987|FG001|Overall Study|Protocol Violation|2|||
23333380|NCT03806933|64961988|FG000|Main Period|Physician Decision|0|||
23333381|NCT03806933|64961989|FG001|Main Period|Physician Decision|0|||
23333382|NCT03806933|64961990|FG002|Main Period|Physician Decision|0|||
23333383|NCT03806933|64961991|FG003|Main Period|Physician Decision|1|||
23333384|NCT03806933|64961988|FG000|Main Period|Pregnancy|0|||
23333385|NCT03806933|64961989|FG001|Main Period|Pregnancy|0|||
23333386|NCT03806933|64961990|FG002|Main Period|Pregnancy|1|||
23333387|NCT03806933|64961991|FG003|Main Period|Pregnancy|0|||
23333388|NCT03806933|64961988|FG000|Main Period|Withdrawal by Subject|2|||
23333389|NCT03806933|64961989|FG001|Main Period|Withdrawal by Subject|1|||
23333390|NCT03806933|64961990|FG002|Main Period|Withdrawal by Subject|1|||
23333391|NCT03806933|64961991|FG003|Main Period|Withdrawal by Subject|2|||
23333392|NCT03806933|64961988|FG000|Main Period|Lost to Follow-up|2|||
23333393|NCT03806933|64961989|FG001|Main Period|Lost to Follow-up|2|||
23333394|NCT03806933|64961990|FG002|Main Period|Lost to Follow-up|0|||
23333395|NCT03806933|64961991|FG003|Main Period|Lost to Follow-up|0|||
23333396|NCT03806933|64961988|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
23333397|NCT03806933|64961989|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
23333398|NCT03806933|64961990|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
23333399|NCT03806933|64961991|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
23333400|NCT00546377|64961993|FG000|Overall Study|Deemed ineligible|1|||
23333401|NCT00546377|64961993|FG000|Overall Study|Adverse Event|6|||
23333402|NCT00927862|64961994|FG000|Overall Study|Missing data needed for endpt analyses|27|||
23333403|NCT00927862|64961995|FG001|Overall Study|Missing data needed for endpt analyses|45|||
23333404|NCT00356603|64961996|FG000|Overall Study|Other|6|||
23333405|NCT00356603|64961997|FG001|Overall Study|Other|3|||
23333406|NCT01288937|64962000|FG000|Overall Study|Adverse Event|1|||
23333407|NCT01288937|64962001|FG001|Overall Study|Adverse Event|0|||
23333408|NCT01129102|64962003|FG000|Overall Study|No study drug treatment|2|||
23333409|NCT01129102|64962004|FG001|Overall Study|No study drug treatment|3|||
23333410|NCT01129102|64962005|FG002|Overall Study|No study drug treatment|1|||
23333411|NCT01129102|64962003|FG000|Overall Study|Withdrawal by Subject|2|||
23333412|NCT01129102|64962004|FG001|Overall Study|Withdrawal by Subject|0|||
23333413|NCT01129102|64962005|FG002|Overall Study|Withdrawal by Subject|3|||
23333414|NCT01129102|64962003|FG000|Overall Study|Protocol Violation|0|||
23333415|NCT01129102|64962004|FG001|Overall Study|Protocol Violation|1|||
23333416|NCT01129102|64962005|FG002|Overall Study|Protocol Violation|1|||
23333417|NCT01129102|64962003|FG000|Overall Study|Pregnancy|0|||
23333418|NCT01129102|64962004|FG001|Overall Study|Pregnancy|0|||
23333419|NCT01129102|64962005|FG002|Overall Study|Pregnancy|1|||
23333420|NCT01129102|64962003|FG000|Overall Study|Adverse Event|2|||
23333421|NCT01129102|64962004|FG001|Overall Study|Adverse Event|2|||
23333422|NCT01129102|64962005|FG002|Overall Study|Adverse Event|1|||
23333423|NCT01129102|64962003|FG000|Overall Study|Lost to Follow-up|2|||
23333424|NCT01129102|64962004|FG001|Overall Study|Lost to Follow-up|0|||
23333425|NCT01129102|64962005|FG002|Overall Study|Lost to Follow-up|0|||
23333426|NCT04168112|64962011|FG000|Overall Study|Lost to Follow-up|1|||
23333427|NCT04168112|64962012|FG001|Overall Study|Lost to Follow-up|0|||
23333428|NCT04168112|64962011|FG000|Overall Study|Withdrawal by Subject|1|||
23333429|NCT04168112|64962012|FG001|Overall Study|Withdrawal by Subject|0|||
23333430|NCT02887183|64962019|FG000|Overall Study|Adverse Event|44|||
23333431|NCT02887183|64962019|FG000|Overall Study|Death|30|||
23166846|NCT01908101|64359271|FG000|Overall Study|Withdrawal by Subject|1|||
23166847|NCT01908101|64359271|FG000|Overall Study|Incorrect Diagnosis|2|||
23166848|NCT01908101|64359271|FG000|Overall Study|Incorrect Starting Dose|1|||
23166849|NCT01908101|64359271|FG000|Overall Study|Did not complete the first cycle|4|||
23333432|NCT02887183|64962019|FG000|Overall Study|Pregnancy|1|||
23333433|NCT02887183|64962019|FG000|Overall Study|Protocol Violation|6|||
23333434|NCT02887183|64962019|FG000|Overall Study|Technical Problems|2|||
23333435|NCT02887183|64962019|FG000|Overall Study|Lost to Follow-up|13|||
23333436|NCT02887183|64962019|FG000|Overall Study|Physician Decision|10|||
23333437|NCT02887183|64962019|FG000|Overall Study|Withdrawal by Subject|35|||
23333438|NCT00940823|64962021|FG000|Overall Study|Death|8|||
23333439|NCT00940823|64962022|FG001|Overall Study|Death|12|||
23333440|NCT00940823|64962021|FG000|Overall Study|Lost to Follow-up|27|||
23333441|NCT00940823|64962022|FG001|Overall Study|Lost to Follow-up|20|||
23333442|NCT05047211|64962025|FG000|Overall Study|Lost to Follow-up|8|||
23333443|NCT05047211|64962026|FG001|Overall Study|Lost to Follow-up|5|||
23333444|NCT03691207|64962027|FG000|Overall Study|Death|41|||
23333445|NCT03691207|64962028|FG001|Overall Study|Death|26|||
23333446|NCT03691207|64962027|FG000|Overall Study|Lost to Follow-up|1|||
23333447|NCT03691207|64962028|FG001|Overall Study|Lost to Follow-up|1|||
23333448|NCT03691207|64962027|FG000|Overall Study|Withdrawal by Subject|2|||
23333449|NCT03691207|64962028|FG001|Overall Study|Withdrawal by Subject|8|||
23333450|NCT03691207|64962027|FG000|Overall Study|Sponsor decision|1|||
23166850|NCT02919436|64359272|FG000|Overall Study|Did not undergo surgery|16|||
23166851|NCT02919436|64359273|FG001|Overall Study|Did not undergo surgery|20|||
23166852|NCT02919436|64359272|FG000|Overall Study|Enrolled before trial registration|44|||
23226970|NCT03198728|64574896|FG001|Overall Study|Physician Decision|2|||
23226971|NCT03198728|64574895|FG000|Overall Study|Withdrawal by Subject|14|||
23575384|NCT00062868|65838722|FG006|Dose Level 1|Lost to Follow-up|0|||
23575385|NCT00062868|65838723|FG007|Dose Level 1|Lost to Follow-up|0|||
23575386|NCT00062868|65838724|FG008|Dose Level 1|Lost to Follow-up|0|||
23575387|NCT00062868|65838725|FG009|Dose Level 1|Lost to Follow-up|0|||
23575388|NCT00062868|65838726|FG010|Dose Level 1|Lost to Follow-up|0|||
23575389|NCT00062868|65838727|FG011|Dose Level 1|Lost to Follow-up|0|||
23575390|NCT00062868|65838728|FG012|Dose Level 1|Lost to Follow-up|1|||
23575391|NCT00062868|65838729|FG013|Dose Level 1|Lost to Follow-up|0|||
23226972|NCT03198728|64574896|FG001|Overall Study|Withdrawal by Subject|10|||
23226973|NCT03452397|64574897|FG000|Overall Study|Adverse Event|1|||
23226974|NCT03452397|64574898|FG001|Overall Study|Adverse Event|0|||
23226975|NCT03452397|64574899|FG002|Overall Study|Adverse Event|0|||
23226976|NCT03452397|64574900|FG003|Overall Study|Adverse Event|0|||
23575392|NCT00062868|65838730|FG014|Dose Level 1|Lost to Follow-up|0|||
23575393|NCT00062868|65838731|FG015|Dose Level 1|Lost to Follow-up|0|||
23575394|NCT00062868|65838732|FG016|Dose Level 1|Lost to Follow-up|0|||
23575395|NCT00062868|65838733|FG017|Dose Level 1|Lost to Follow-up|0|||
23575396|NCT00062868|65838734|FG018|Dose Level 1|Lost to Follow-up|2|||
23575397|NCT00062868|65838735|FG019|Dose Level 1|Lost to Follow-up|0|||
23575398|NCT00062868|65838736|FG020|Dose Level 1|Lost to Follow-up|1|||
23333451|NCT03691207|64962028|FG001|Overall Study|Sponsor decision|7|||
23166853|NCT02919436|64359273|FG001|Overall Study|Enrolled before trial registration|33|||
23166854|NCT01534533|64359274|FG000|Overall Study|Lost to Follow-up|3|||
23166855|NCT01534533|64359275|FG001|Overall Study|Lost to Follow-up|0|||
23166856|NCT01534533|64359276|FG002|Overall Study|Lost to Follow-up|4|||
23226977|NCT03452397|64574897|FG000|Overall Study|Administrative reason|0|||
23226978|NCT03452397|64574898|FG001|Overall Study|Administrative reason|0|||
23226979|NCT03452397|64574899|FG002|Overall Study|Administrative reason|1|||
23226980|NCT03452397|64574900|FG003|Overall Study|Administrative reason|1|||
23226981|NCT03452397|64574897|FG000|Overall Study|Withdrawal by Subject|0|||
23226982|NCT03452397|64574898|FG001|Overall Study|Withdrawal by Subject|0|||
23226983|NCT03452397|64574899|FG002|Overall Study|Withdrawal by Subject|1|||
23226984|NCT03452397|64574900|FG003|Overall Study|Withdrawal by Subject|0|||
23226985|NCT01984294|64574903|FG000|Overall Study|Randomized but Never Treated|0|||
23226986|NCT01984294|64574904|FG001|Overall Study|Randomized but Never Treated|0|||
23226987|NCT01984294|64574905|FG002|Overall Study|Randomized but Never Treated|1|||
23226988|NCT01984294|64574903|FG000|Overall Study|Lack of Efficacy|4|||
23226989|NCT01984294|64574904|FG001|Overall Study|Lack of Efficacy|2|||
23226990|NCT01984294|64574905|FG002|Overall Study|Lack of Efficacy|6|||
23226991|NCT01984294|64574903|FG000|Overall Study|Adverse Event|0|||
23226992|NCT01984294|64574904|FG001|Overall Study|Adverse Event|1|||
23226993|NCT01984294|64574905|FG002|Overall Study|Adverse Event|0|||
23226994|NCT00439309|64574912|FG000|Follow-Up|Death|1|||
23226995|NCT00439309|64574913|FG001|Follow-Up|Death|0|||
23226996|NCT00439309|64574912|FG000|Follow-Up|Lost to Follow-up|2|||
23226997|NCT00439309|64574913|FG001|Follow-Up|Lost to Follow-up|0|||
23226998|NCT00439309|64574912|FG000|Follow-Up|Withdrawal by Subject|0|||
23226999|NCT00439309|64574913|FG001|Follow-Up|Withdrawal by Subject|1|||
23227000|NCT00439309|64574912|FG000|Follow-Up|Late response by subject|0|||
23227001|NCT00439309|64574913|FG001|Follow-Up|Late response by subject|1|||
23227002|NCT04489940|64574916|FG000|Overall Study|Other|2|||
23227003|NCT04489940|64574916|FG000|Overall Study|Withdrawal by Subject|2|||
23227004|NCT04489940|64574916|FG000|Overall Study|Death|5|||
23227005|NCT04489940|64574916|FG000|Overall Study|Lost to Follow-up|1|||
23166857|NCT01534533|64359277|FG003|Overall Study|Lost to Follow-up|3|||
23166858|NCT01534533|64359274|FG000|Overall Study|Withdrawal by Subject|5|||
23166859|NCT01534533|64359275|FG001|Overall Study|Withdrawal by Subject|3|||
23333452|NCT00955409|64962032|FG000|Overall Study|Lack of Efficacy|1|||
23575399|NCT00062868|65838716|FG000|Dose Level 2|Death|0|||
23166860|NCT01534533|64359276|FG002|Overall Study|Withdrawal by Subject|4|||
23227006|NCT00672139|64574918|FG000|Overall Study|Death|14|||
23227007|NCT00672139|64574919|FG001|Overall Study|Death|23|||
23227008|NCT00672139|64574918|FG000|Overall Study|Withdrawal by Subject|2|||
23227009|NCT00672139|64574919|FG001|Overall Study|Withdrawal by Subject|11|||
23227010|NCT00672139|64574918|FG000|Overall Study|Adverse Event|4|||
23227011|NCT00672139|64574919|FG001|Overall Study|Adverse Event|7|||
23227012|NCT00672139|64574918|FG000|Overall Study|Physician Decision|2|||
23575400|NCT00062868|65838717|FG001|Dose Level 2|Death|3|||
23333453|NCT00955409|64962033|FG001|Overall Study|Lack of Efficacy|0|||
23575401|NCT00062868|65838718|FG002|Dose Level 2|Death|0|||
23575402|NCT00062868|65838719|FG003|Dose Level 2|Death|0|||
23227013|NCT00672139|64574919|FG001|Overall Study|Physician Decision|0|||
23575403|NCT00062868|65838720|FG004|Dose Level 2|Death|2|||
23227014|NCT00672139|64574918|FG000|Overall Study|Lack of Efficacy|4|||
23227015|NCT00672139|64574919|FG001|Overall Study|Lack of Efficacy|1|||
23227016|NCT00672139|64574918|FG000|Overall Study|Protocol Violation|1|||
23227017|NCT00672139|64574919|FG001|Overall Study|Protocol Violation|1|||
23227018|NCT00672139|64574918|FG000|Overall Study|hospice discharge, caregiver requests|3|||
23227019|NCT00672139|64574919|FG001|Overall Study|hospice discharge, caregiver requests|2|||
23227020|NCT02299206|64574929|FG000|Overall Study|Lost to Follow-up|1|||
23227021|NCT02299206|64574929|FG000|Overall Study|Withdrawal by Subject|1|||
23227022|NCT00811395|64574930|FG000|Extension Treatment|Adverse Event|1|||
23227023|NCT00811395|64574931|FG001|Extension Treatment|Adverse Event|2|||
23227024|NCT00811395|64574932|FG002|Extension Treatment|Adverse Event|2|||
23227025|NCT00811395|64574933|FG003|Extension Treatment|Adverse Event|2|||
23227026|NCT00811395|64574934|FG004|Extension Treatment|Adverse Event|0|||
23227027|NCT00811395|64574935|FG005|Extension Treatment|Adverse Event|1|||
23227028|NCT00811395|64574930|FG000|Extension Treatment|Progressive disease|1|||
23227029|NCT00811395|64574931|FG001|Extension Treatment|Progressive disease|1|||
23227030|NCT00811395|64574932|FG002|Extension Treatment|Progressive disease|0|||
23227031|NCT00811395|64574933|FG003|Extension Treatment|Progressive disease|0|||
23227032|NCT00811395|64574934|FG004|Extension Treatment|Progressive disease|0|||
23227033|NCT00811395|64574935|FG005|Extension Treatment|Progressive disease|0|||
23227034|NCT00811395|64574930|FG000|Extension Treatment|Participant did not wish to continue|0|||
23227035|NCT00811395|64574931|FG001|Extension Treatment|Participant did not wish to continue|3|||
23227036|NCT00811395|64574932|FG002|Extension Treatment|Participant did not wish to continue|0|||
23227037|NCT00811395|64574933|FG003|Extension Treatment|Participant did not wish to continue|1|||
23227038|NCT00811395|64574934|FG004|Extension Treatment|Participant did not wish to continue|0|||
23227039|NCT00811395|64574935|FG005|Extension Treatment|Participant did not wish to continue|1|||
23227040|NCT00811395|64574930|FG000|Extension Treatment|Other than above|0|||
23227041|NCT00811395|64574931|FG001|Extension Treatment|Other than above|0|||
23227042|NCT00811395|64574932|FG002|Extension Treatment|Other than above|1|||
23227043|NCT00811395|64574933|FG003|Extension Treatment|Other than above|0|||
23227044|NCT00811395|64574934|FG004|Extension Treatment|Other than above|0|||
23227045|NCT00811395|64574935|FG005|Extension Treatment|Other than above|0|||
23227046|NCT01225211|64574936|FG000|Overall Study|Adverse Event|0|||
23227047|NCT01225211|64574937|FG001|Overall Study|Adverse Event|0|||
23227048|NCT01225211|64574938|FG002|Overall Study|Adverse Event|1|||
23227049|NCT01225211|64574939|FG003|Overall Study|Adverse Event|0|||
23227050|NCT01225211|64574940|FG004|Overall Study|Adverse Event|0|||
23227051|NCT01225211|64574941|FG005|Overall Study|Adverse Event|0|||
23227052|NCT01225211|64574942|FG006|Overall Study|Adverse Event|0|||
23227053|NCT01225211|64574943|FG007|Overall Study|Adverse Event|0|||
23227054|NCT01225211|64574944|FG008|Overall Study|Adverse Event|0|||
23227055|NCT01225211|64574945|FG009|Overall Study|Adverse Event|1|||
23227056|NCT01225211|64574936|FG000|Overall Study|Withdrawal by Subject|0|||
23227057|NCT01225211|64574937|FG001|Overall Study|Withdrawal by Subject|0|||
23227058|NCT01225211|64574938|FG002|Overall Study|Withdrawal by Subject|0|||
23227059|NCT01225211|64574939|FG003|Overall Study|Withdrawal by Subject|0|||
23227060|NCT01225211|64574940|FG004|Overall Study|Withdrawal by Subject|0|||
23227061|NCT01225211|64574941|FG005|Overall Study|Withdrawal by Subject|0|||
23227062|NCT01225211|64574942|FG006|Overall Study|Withdrawal by Subject|1|||
23227063|NCT01225211|64574943|FG007|Overall Study|Withdrawal by Subject|0|||
23227064|NCT01225211|64574944|FG008|Overall Study|Withdrawal by Subject|1|||
23227065|NCT01225211|64574945|FG009|Overall Study|Withdrawal by Subject|3|||
23227066|NCT01225211|64574936|FG000|Overall Study|Other|0|||
23227067|NCT01225211|64574937|FG001|Overall Study|Other|0|||
23227068|NCT01225211|64574938|FG002|Overall Study|Other|0|||
23227069|NCT01225211|64574939|FG003|Overall Study|Other|0|||
23575404|NCT00062868|65838721|FG005|Dose Level 2|Death|0|||
23227070|NCT01225211|64574940|FG004|Overall Study|Other|0|||
23227071|NCT01225211|64574941|FG005|Overall Study|Other|0|||
23227072|NCT01225211|64574942|FG006|Overall Study|Other|0|||
23227073|NCT01225211|64574943|FG007|Overall Study|Other|0|||
23227074|NCT01225211|64574944|FG008|Overall Study|Other|0|||
23227075|NCT01225211|64574945|FG009|Overall Study|Other|1|||
23227076|NCT01784211|64574946|FG000|Part A (Days 1-15)|Adverse Event|1|||
23227077|NCT01784211|64574947|FG001|Part A (Days 1-15)|Adverse Event|1|||
23227078|NCT01784211|64574948|FG002|Part A (Days 1-15)|Adverse Event|0|||
23227079|NCT01784211|64574949|FG003|Part A (Days 1-15)|Adverse Event|0|||
23227080|NCT01784211|64574950|FG004|Part A (Days 1-15)|Adverse Event|0|||
23227081|NCT01784211|64574951|FG005|Part A (Days 1-15)|Adverse Event|0|||
23575405|NCT00062868|65838722|FG006|Dose Level 2|Death|0|||
23227082|NCT01784211|64574946|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
23227083|NCT01784211|64574947|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
23227084|NCT01784211|64574948|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
23227085|NCT01784211|64574949|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
23227086|NCT01784211|64574950|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
23227087|NCT01784211|64574951|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
23227088|NCT01307046|64574956|FG000|Overall Study|Adverse Event|3|||
23227089|NCT01307046|64574957|FG001|Overall Study|Adverse Event|3|||
23333454|NCT00955409|64962034|FG002|Overall Study|Lack of Efficacy|0|||
23575406|NCT00062868|65838723|FG007|Dose Level 2|Death|0|||
23166861|NCT01534533|64359277|FG003|Overall Study|Withdrawal by Subject|1|||
23166862|NCT01340209|64359278|FG000|Overall Study|Adverse Event|1|||
23166863|NCT01340209|64359279|FG001|Overall Study|Adverse Event|1|||
23166864|NCT01340209|64359280|FG002|Overall Study|Adverse Event|2|||
23166865|NCT01340209|64359278|FG000|Overall Study|Protocol Violation|1|||
23166866|NCT01340209|64359279|FG001|Overall Study|Protocol Violation|2|||
23166867|NCT01340209|64359280|FG002|Overall Study|Protocol Violation|1|||
23166868|NCT01340209|64359278|FG000|Overall Study|Withdrawal by Subject|0|||
23166869|NCT01340209|64359279|FG001|Overall Study|Withdrawal by Subject|0|||
23166870|NCT01340209|64359280|FG002|Overall Study|Withdrawal by Subject|1|||
23166871|NCT01340209|64359278|FG000|Overall Study|Other reason not defined above|3|||
23166872|NCT01340209|64359279|FG001|Overall Study|Other reason not defined above|5|||
23166873|NCT01340209|64359280|FG002|Overall Study|Other reason not defined above|4|||
23166874|NCT00797823|64359282|FG000|First Period (Initial Randomization)|Physician Decision|1|||
23166875|NCT00797823|64359283|FG001|First Period (Initial Randomization)|Physician Decision|0|||
23166876|NCT00797823|64359284|FG002|First Period (Initial Randomization)|Physician Decision|0|||
23166877|NCT01445951|64359285|FG000|Overall Study|Adverse Event|16|||
23166878|NCT01445951|64359286|FG001|Overall Study|Adverse Event|9|||
23166879|NCT01445951|64359287|FG002|Overall Study|Adverse Event|0|||
23166880|NCT01445951|64359285|FG000|Overall Study|Protocol Violation|2|||
23166881|NCT01445951|64359286|FG001|Overall Study|Protocol Violation|2|||
23166882|NCT01445951|64359287|FG002|Overall Study|Protocol Violation|2|||
23166883|NCT01445951|64359285|FG000|Overall Study|Withdrawal by Subject|21|||
23166884|NCT01445951|64359286|FG001|Overall Study|Withdrawal by Subject|16|||
23166885|NCT01445951|64359287|FG002|Overall Study|Withdrawal by Subject|8|||
23166886|NCT01445951|64359285|FG000|Overall Study|Physician Decision|3|||
23166887|NCT01445951|64359286|FG001|Overall Study|Physician Decision|1|||
23166888|NCT01445951|64359287|FG002|Overall Study|Physician Decision|0|||
23166889|NCT01445951|64359285|FG000|Overall Study|Lost to Follow-up|1|||
23166890|NCT01445951|64359286|FG001|Overall Study|Lost to Follow-up|2|||
23166891|NCT01445951|64359287|FG002|Overall Study|Lost to Follow-up|4|||
23166892|NCT01445951|64359285|FG000|Overall Study|Pregnancy|0|||
23166893|NCT01445951|64359286|FG001|Overall Study|Pregnancy|1|||
23166894|NCT01445951|64359287|FG002|Overall Study|Pregnancy|4|||
23166895|NCT01445951|64359285|FG000|Overall Study|Death|0|||
23166896|NCT01445951|64359286|FG001|Overall Study|Death|0|||
23166897|NCT01445951|64359287|FG002|Overall Study|Death|1|||
23166898|NCT01445951|64359285|FG000|Overall Study|Non-compliance with study drug|1|||
23166899|NCT01445951|64359286|FG001|Overall Study|Non-compliance with study drug|2|||
23166900|NCT01445951|64359287|FG002|Overall Study|Non-compliance with study drug|0|||
23166901|NCT01445951|64359285|FG000|Overall Study|Non-compliance with protocol|0|||
23166902|NCT01445951|64359286|FG001|Overall Study|Non-compliance with protocol|1|||
23166903|NCT01445951|64359287|FG002|Overall Study|Non-compliance with protocol|0|||
23166904|NCT01445951|64359285|FG000|Overall Study|Sponsor decision - subject travel|0|||
23166905|NCT01445951|64359286|FG001|Overall Study|Sponsor decision - subject travel|1|||
23166906|NCT01445951|64359287|FG002|Overall Study|Sponsor decision - subject travel|0|||
23166907|NCT01445951|64359285|FG000|Overall Study|Cough|0|||
23166908|NCT01445951|64359286|FG001|Overall Study|Cough|1|||
23166909|NCT01445951|64359287|FG002|Overall Study|Cough|0|||
23166910|NCT04951037|64359295|FG000|Overall Study|Lost to Follow-up|16|||
23166911|NCT04951037|64359295|FG000|Overall Study|Withdrawal by Subject|5|||
23166912|NCT04951037|64359295|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
23166913|NCT02474329|64359302|FG000|Overall Study|Withdraw or did not contribute data.|13|||
23166914|NCT00424827|64359303|FG000|Overall Study|Adverse Event|1|||
23166915|NCT02926209|64359304|FG000|Study Cohort|Poor Bowel Preparation|1|||
23166916|NCT02926209|64359305|FG001|Study Cohort|Poor Bowel Preparation|0|||
23166917|NCT02264990|64359306|FG000|Overall Study|Death|255|||
23166918|NCT02264990|64359307|FG001|Overall Study|Death|250|||
23166919|NCT02264990|64359306|FG000|Overall Study|Withdrawal by Subject|4|||
23166920|NCT02264990|64359307|FG001|Overall Study|Withdrawal by Subject|5|||
23166921|NCT02264990|64359306|FG000|Overall Study|Lost to Follow-up|1|||
23166922|NCT02264990|64359307|FG001|Overall Study|Lost to Follow-up|3|||
23166923|NCT02264990|64359306|FG000|Overall Study|Other|0|||
23166924|NCT02264990|64359307|FG001|Overall Study|Other|1|||
23166925|NCT00429858|64359308|FG000|Overall Study|Withdrawal by Subject|1|||
23166926|NCT00429858|64359308|FG000|Overall Study|Study Termination|1|||
23166927|NCT01895322|64359311|FG000|Overall Study|Adverse Event|1|||
23166928|NCT01895322|64359311|FG000|Overall Study|Withdrawal by Subject|2|||
23166929|NCT01895322|64359311|FG000|Overall Study|Protocol Violation|10|||
23166930|NCT01594853|64359314|FG000|Overall Study|Withdrawal by Subject|1|||
23166931|NCT01594853|64359315|FG001|Overall Study|Withdrawal by Subject|1|||
23166932|NCT01594853|64359314|FG000|Overall Study|Lost to Follow-up|1|||
23166933|NCT01594853|64359315|FG001|Overall Study|Lost to Follow-up|1|||
23333455|NCT00955409|64962035|FG003|Overall Study|Lack of Efficacy|0|||
23333456|NCT00955409|64962036|FG004|Overall Study|Lack of Efficacy|0|||
23575407|NCT00062868|65838724|FG008|Dose Level 2|Death|0|||
23166934|NCT01594853|64359314|FG000|Overall Study|noncompliance with exercise|0|||
23166935|NCT01594853|64359315|FG001|Overall Study|noncompliance with exercise|1|||
23166936|NCT01496066|64359319|FG000|Overall Study|Lost to Follow-up|8|||
23166937|NCT01496066|64359320|FG001|Overall Study|Lost to Follow-up|5|||
23166938|NCT01496066|64359319|FG000|Overall Study|Explant|3|||
23166939|NCT01496066|64359320|FG001|Overall Study|Explant|0|||
23166940|NCT01496066|64359319|FG000|Overall Study|Death|1|||
23166941|NCT01496066|64359320|FG001|Overall Study|Death|4|||
23166942|NCT01437397|64359321|FG000|Overall Study|Lost to Follow-up|9|||
23166943|NCT01437397|64359322|FG001|Overall Study|Lost to Follow-up|4|||
23166944|NCT01437397|64359323|FG002|Overall Study|Lost to Follow-up|2|||
23166945|NCT01437397|64359324|FG003|Overall Study|Lost to Follow-up|4|||
23166946|NCT01437397|64359325|FG004|Overall Study|Lost to Follow-up|5|||
23166947|NCT01437397|64359321|FG000|Overall Study|Withdrawal by Subject|11|||
23166948|NCT01437397|64359322|FG001|Overall Study|Withdrawal by Subject|12|||
23166949|NCT01437397|64359323|FG002|Overall Study|Withdrawal by Subject|24|||
23166950|NCT01437397|64359324|FG003|Overall Study|Withdrawal by Subject|11|||
23166951|NCT01437397|64359325|FG004|Overall Study|Withdrawal by Subject|22|||
23166952|NCT01437397|64359321|FG000|Overall Study|Protocol Violation|10|||
23166953|NCT01437397|64359322|FG001|Overall Study|Protocol Violation|12|||
23166954|NCT01437397|64359323|FG002|Overall Study|Protocol Violation|13|||
23166955|NCT01437397|64359324|FG003|Overall Study|Protocol Violation|21|||
23166956|NCT01437397|64359325|FG004|Overall Study|Protocol Violation|19|||
23166957|NCT01437397|64359321|FG000|Overall Study|Lack of Efficacy|5|||
23166958|NCT01437397|64359322|FG001|Overall Study|Lack of Efficacy|4|||
23166959|NCT01437397|64359323|FG002|Overall Study|Lack of Efficacy|8|||
23166960|NCT01437397|64359324|FG003|Overall Study|Lack of Efficacy|10|||
23166961|NCT01437397|64359325|FG004|Overall Study|Lack of Efficacy|20|||
23166962|NCT01437397|64359321|FG000|Overall Study|Adverse Event|21|||
23166963|NCT01437397|64359322|FG001|Overall Study|Adverse Event|22|||
23166964|NCT01437397|64359323|FG002|Overall Study|Adverse Event|16|||
23166965|NCT01437397|64359324|FG003|Overall Study|Adverse Event|14|||
23166966|NCT01437397|64359325|FG004|Overall Study|Adverse Event|21|||
23166967|NCT01437397|64359321|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
23166968|NCT01437397|64359322|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
23166969|NCT01437397|64359323|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
23166970|NCT01437397|64359324|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
23166971|NCT01437397|64359325|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
23166972|NCT00290433|64359326|FG000|Overall Study|Disease Progression|13|||
23166973|NCT00290433|64359326|FG000|Overall Study|Adverse Event|14|||
23166974|NCT00290433|64359326|FG000|Overall Study|Withdrawal by Subject|1|||
23166975|NCT00290433|64359326|FG000|Overall Study|Non-Compliance|1|||
23166976|NCT00290433|64359326|FG000|Overall Study|Congestive Heart Failure|1|||
23166977|NCT00290433|64359326|FG000|Overall Study|Transplant in CR|5|||
23166978|NCT00290433|64359326|FG000|Overall Study|Unrelated Infection/Death|1|||
23166979|NCT01263639|64359327|FG000|Overall Study|Lost to Follow-up|66|||
23166980|NCT01263639|64359328|FG001|Overall Study|Lost to Follow-up|70|||
23166981|NCT01263639|64359327|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
23166982|NCT01263639|64359328|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
23166983|NCT02889796|64359329|FG000|Overall Study|Withdrew Consent|18|||
23166984|NCT02889796|64359330|FG001|Overall Study|Withdrew Consent|29|||
23166985|NCT02889796|64359331|FG002|Overall Study|Withdrew Consent|20|||
23166986|NCT02889796|64359332|FG003|Overall Study|Withdrew Consent|1|||
23166987|NCT02889796|64359333|FG004|Overall Study|Withdrew Consent|2|||
23166988|NCT02889796|64359334|FG005|Overall Study|Withdrew Consent|35|||
23166989|NCT02889796|64359329|FG000|Overall Study|Investigator's Discretion|10|||
23166990|NCT02889796|64359330|FG001|Overall Study|Investigator's Discretion|9|||
23166991|NCT02889796|64359331|FG002|Overall Study|Investigator's Discretion|10|||
23333457|NCT00955409|64962037|FG005|Overall Study|Lack of Efficacy|0|||
23333458|NCT00955409|64962038|FG006|Overall Study|Lack of Efficacy|0|||
23333459|NCT00955409|64962039|FG007|Overall Study|Lack of Efficacy|0|||
23333460|NCT00955409|64962040|FG008|Overall Study|Lack of Efficacy|0|||
23166992|NCT02889796|64359332|FG003|Overall Study|Investigator's Discretion|3|||
23166993|NCT02889796|64359333|FG004|Overall Study|Investigator's Discretion|0|||
23166994|NCT02889796|64359334|FG005|Overall Study|Investigator's Discretion|15|||
23166995|NCT02889796|64359329|FG000|Overall Study|Adverse Event|17|||
23166996|NCT02889796|64359330|FG001|Overall Study|Adverse Event|8|||
23166997|NCT02889796|64359331|FG002|Overall Study|Adverse Event|8|||
23166998|NCT02889796|64359332|FG003|Overall Study|Adverse Event|4|||
23166999|NCT02889796|64359333|FG004|Overall Study|Adverse Event|1|||
23167000|NCT02889796|64359334|FG005|Overall Study|Adverse Event|7|||
23167001|NCT02889796|64359329|FG000|Overall Study|Lost to Follow-up|5|||
23167002|NCT02889796|64359330|FG001|Overall Study|Lost to Follow-up|7|||
23167003|NCT02889796|64359331|FG002|Overall Study|Lost to Follow-up|2|||
23167004|NCT02889796|64359332|FG003|Overall Study|Lost to Follow-up|0|||
23167005|NCT02889796|64359333|FG004|Overall Study|Lost to Follow-up|2|||
23167006|NCT02889796|64359334|FG005|Overall Study|Lost to Follow-up|6|||
23167007|NCT02889796|64359329|FG000|Overall Study|Protocol Violation|0|||
23333461|NCT00955409|64962041|FG009|Overall Study|Lack of Efficacy|0|||
23447471|NCT04317040|65380461|FG000|Overall Study|Withdrawal by Subject|0|||
23227090|NCT01307046|64574956|FG000|Overall Study|Lack of Efficacy|0|||
23227091|NCT01307046|64574957|FG001|Overall Study|Lack of Efficacy|2|||
23227092|NCT01307046|64574956|FG000|Overall Study|Physician Decision|2|||
23227093|NCT01307046|64574957|FG001|Overall Study|Physician Decision|0|||
23167008|NCT02889796|64359330|FG001|Overall Study|Protocol Violation|1|||
23167009|NCT02889796|64359331|FG002|Overall Study|Protocol Violation|3|||
23167010|NCT02889796|64359332|FG003|Overall Study|Protocol Violation|0|||
23167011|NCT02889796|64359333|FG004|Overall Study|Protocol Violation|0|||
23167012|NCT02889796|64359334|FG005|Overall Study|Protocol Violation|4|||
23447472|NCT04317040|65380462|FG001|Overall Study|Withdrawal by Subject|1|||
23447473|NCT04317040|65380461|FG000|Overall Study|Incomplete assessments|0|||
23447474|NCT04317040|65380462|FG001|Overall Study|Incomplete assessments|1|||
23447475|NCT04972786|65380463|FG000|First Intervention (1 Day)|Adverse Event|1|||
23447476|NCT04972786|65380464|FG001|First Intervention (1 Day)|Adverse Event|0|||
23447477|NCT02038153|65380465|FG000|Overall Study|Withdrawal by Subject|1|||
23447478|NCT04528641|65380470|FG000|Overall Study|Withdrawal by Subject|0|||
23447479|NCT04528641|65380471|FG001|Overall Study|Withdrawal by Subject|0|||
23447480|NCT04528641|65380472|FG002|Overall Study|Withdrawal by Subject|0|||
23447481|NCT04528641|65380473|FG003|Overall Study|Withdrawal by Subject|1|||
23447482|NCT04528641|65380474|FG004|Overall Study|Withdrawal by Subject|0|||
23447483|NCT04528641|65380475|FG005|Overall Study|Withdrawal by Subject|1|||
23447484|NCT04701333|65380476|FG000|Overall Study|Lost to Follow-up|3|||
23447485|NCT04701333|65380477|FG001|Overall Study|Lost to Follow-up|7|||
23447486|NCT04701333|65380476|FG000|Overall Study|Withdrawal by Subject|0|||
23447487|NCT04701333|65380477|FG001|Overall Study|Withdrawal by Subject|1|||
23447488|NCT04816214|65380480|FG000|Overall Study|Progressive Disease|4|||
23447489|NCT04816214|65380481|FG001|Overall Study|Progressive Disease|0|||
23447490|NCT04816214|65380482|FG002|Overall Study|Progressive Disease|0|||
23447491|NCT04816214|65380480|FG000|Overall Study|Death|1|||
23447492|NCT04816214|65380481|FG001|Overall Study|Death|0|||
23447493|NCT04816214|65380482|FG002|Overall Study|Death|0|||
23447494|NCT04816214|65380480|FG000|Overall Study|Study Terminated by Sponsor|1|||
23447495|NCT04816214|65380481|FG001|Overall Study|Study Terminated by Sponsor|0|||
23447496|NCT04816214|65380482|FG002|Overall Study|Study Terminated by Sponsor|0|||
23447497|NCT02446717|65380488|FG000|Overall Study|Adverse Event|0|||
23447498|NCT02446717|65380489|FG001|Overall Study|Adverse Event|0|||
23447499|NCT02446717|65380490|FG002|Overall Study|Adverse Event|1|||
23447500|NCT02446717|65380491|FG003|Overall Study|Adverse Event|0|||
23447501|NCT02446717|65380492|FG004|Overall Study|Adverse Event|0|||
23447502|NCT02446717|65380488|FG000|Overall Study|Lost to Follow-up|0|||
23447503|NCT02446717|65380489|FG001|Overall Study|Lost to Follow-up|1|||
23447504|NCT02446717|65380490|FG002|Overall Study|Lost to Follow-up|1|||
23447505|NCT02446717|65380491|FG003|Overall Study|Lost to Follow-up|0|||
23447506|NCT02446717|65380492|FG004|Overall Study|Lost to Follow-up|1|||
23167013|NCT02889796|64359329|FG000|Overall Study|Non-compliance With Study Drug|0|||
23167014|NCT02889796|64359330|FG001|Overall Study|Non-compliance With Study Drug|2|||
23167015|NCT02889796|64359331|FG002|Overall Study|Non-compliance With Study Drug|0|||
23167016|NCT02889796|64359332|FG003|Overall Study|Non-compliance With Study Drug|0|||
23167017|NCT02889796|64359333|FG004|Overall Study|Non-compliance With Study Drug|1|||
23167018|NCT02889796|64359334|FG005|Overall Study|Non-compliance With Study Drug|2|||
23167019|NCT02889796|64359329|FG000|Overall Study|Death|1|||
23167020|NCT02889796|64359330|FG001|Overall Study|Death|1|||
23167021|NCT02889796|64359331|FG002|Overall Study|Death|0|||
23167022|NCT02889796|64359332|FG003|Overall Study|Death|1|||
23227094|NCT01307046|64574956|FG000|Overall Study|Withdrawal by Subject|1|||
23227095|NCT01307046|64574957|FG001|Overall Study|Withdrawal by Subject|1|||
23227096|NCT01307046|64574956|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
23227097|NCT01307046|64574957|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
23227098|NCT01307046|64574956|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
23227099|NCT01307046|64574957|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
23333462|NCT00955409|64962032|FG000|Overall Study|Withdrawal by Subject|1|||
23333463|NCT00955409|64962033|FG001|Overall Study|Withdrawal by Subject|0|||
23167023|NCT02889796|64359333|FG004|Overall Study|Death|0|||
23167024|NCT02889796|64359334|FG005|Overall Study|Death|1|||
23167025|NCT02889796|64359329|FG000|Overall Study|Pregnancy|0|||
23227100|NCT01017549|64574958|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
23333464|NCT00955409|64962034|FG002|Overall Study|Withdrawal by Subject|5|||
23447507|NCT02446717|65380488|FG000|Overall Study|Withdrew consent|0|||
23447508|NCT02446717|65380489|FG001|Overall Study|Withdrew consent|0|||
23447509|NCT02446717|65380490|FG002|Overall Study|Withdrew consent|0|||
23447510|NCT02446717|65380491|FG003|Overall Study|Withdrew consent|1|||
23447511|NCT02446717|65380492|FG004|Overall Study|Withdrew consent|0|||
23167026|NCT02889796|64359330|FG001|Overall Study|Pregnancy|1|||
23447512|NCT00549640|65380494|FG000|Overall Study|Withdrawal by Subject|6|||
23447513|NCT00549640|65380495|FG001|Overall Study|Withdrawal by Subject|12|||
23447514|NCT00549640|65380494|FG000|Overall Study|Adverse Event|5|||
23447515|NCT00549640|65380495|FG001|Overall Study|Adverse Event|0|||
23447516|NCT00549640|65380494|FG000|Overall Study|Lost to Follow-up|7|||
23447517|NCT00549640|65380495|FG001|Overall Study|Lost to Follow-up|4|||
23447518|NCT02260934|65380500|FG000|Overall Study|Lost to Follow-up|2|||
23447519|NCT02260934|65380501|FG001|Overall Study|Lost to Follow-up|1|||
23447520|NCT02260934|65380500|FG000|Overall Study|Withdrawal by Subject|0|||
23227101|NCT01017549|64574958|FG000|One-year Follow-up|Lost to Follow-up|2|||
23227102|NCT01017549|64574958|FG000|One-year Follow-up|Withdrawal by Subject|5|||
23227103|NCT01017549|64574958|FG000|5 Year Follow-up|Lost to Follow-up|9|||
23227104|NCT01017549|64574958|FG000|5 Year Follow-up|Mastectomy|3|||
23227105|NCT00252499|64574961|FG000|Overall Study|Lost to Follow-up|1|||
23227106|NCT00252499|64574962|FG001|Overall Study|Lost to Follow-up|0|||
23227107|NCT00252499|64574963|FG002|Overall Study|Lost to Follow-up|0|||
23227108|NCT02559115|64574969|FG000|Overall Study|Withdrawal by Subject|3|||
23227109|NCT01885104|64574970|FG000|Overall Study|Withdrawal of Consent|1|||
23227110|NCT01885104|64574971|FG001|Overall Study|Withdrawal of Consent|0|||
23227111|NCT01885104|64574970|FG000|Overall Study|Lost to Follow-up|0|||
23227112|NCT01885104|64574971|FG001|Overall Study|Lost to Follow-up|1|||
23227113|NCT01885104|64574970|FG000|Overall Study|Physician Decision|1|||
23227114|NCT01885104|64574971|FG001|Overall Study|Physician Decision|0|||
23227115|NCT00608894|64574976|FG000|Overall Study|Withdrawal by Subject|0|||
23227116|NCT00608894|64574977|FG001|Overall Study|Withdrawal by Subject|2|||
23227117|NCT01142791|64574978|FG000|Overall Study|Alternative Treatment|1|||
23227118|NCT01142791|64574979|FG001|Overall Study|Alternative Treatment|0|||
23227119|NCT01142791|64574978|FG000|Overall Study|Lost to Follow-up|1|||
23227120|NCT01142791|64574979|FG001|Overall Study|Lost to Follow-up|0|||
23227121|NCT01142791|64574978|FG000|Overall Study|Withdrawal by Subject|5|||
23227122|NCT01142791|64574979|FG001|Overall Study|Withdrawal by Subject|0|||
23227123|NCT01142791|64574978|FG000|Overall Study|Received only 1 sonication|0|||
23227124|NCT01142791|64574979|FG001|Overall Study|Received only 1 sonication|6|||
23227125|NCT00989664|64574980|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
23227126|NCT00989664|64574980|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
23227127|NCT00989664|64574980|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
23227128|NCT00989664|64574980|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
23227129|NCT00989664|64574980|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
23227130|NCT00989664|64574980|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
23227131|NCT00989664|64574980|FG000|Long-Term Follow-Up|Death|3|||
23227132|NCT00911144|64574981|FG000|Overall Study|Withdrawal by Subject|16|||
23227133|NCT00911144|64574982|FG001|Overall Study|Withdrawal by Subject|5|||
23227134|NCT02116582|64574985|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
23227135|NCT02116582|64574985|FG000|Overall Study|Adverse Event|22|||
23227136|NCT02116582|64574985|FG000|Overall Study|Death|9|||
23227137|NCT02116582|64574985|FG000|Overall Study|Progressive Disease|148|||
23227138|NCT02116582|64574985|FG000|Overall Study|Protocol Violation|3|||
23227139|NCT02116582|64574985|FG000|Overall Study|Withdrawal by Subject|8|||
23227140|NCT02116582|64574985|FG000|Overall Study|Other: Miscellaneous|11|||
23227141|NCT02116582|64574985|FG000|Overall Study|Lost to Follow-up|1|||
23227142|NCT02116582|64574985|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
23227143|NCT04157751|64574988|FG000|Overall Study|Withdrawal by Subject|12|||
23227144|NCT04157751|64574989|FG001|Overall Study|Withdrawal by Subject|17|||
23227145|NCT04157751|64574988|FG000|Overall Study|Lost to Follow-up|6|||
23227146|NCT04157751|64574989|FG001|Overall Study|Lost to Follow-up|2|||
23227147|NCT04157751|64574988|FG000|Overall Study|Adverse Event|34|||
23227148|NCT04157751|64574989|FG001|Overall Study|Adverse Event|23|||
23227149|NCT04157751|64574988|FG000|Overall Study|Not treated|1|||
23227150|NCT04157751|64574989|FG001|Overall Study|Not treated|5|||
23227151|NCT04157751|64574988|FG000|Overall Study|Other reason not stated above|10|||
23227152|NCT04157751|64574989|FG001|Overall Study|Other reason not stated above|10|||
23333465|NCT00955409|64962035|FG003|Overall Study|Withdrawal by Subject|2|||
23447521|NCT02260934|65380501|FG001|Overall Study|Withdrawal by Subject|2|||
23447522|NCT02260934|65380500|FG000|Overall Study|Participant Relocated|1|||
23447523|NCT02260934|65380501|FG001|Overall Study|Participant Relocated|0|||
23447524|NCT02260934|65380500|FG000|Overall Study|Site error|0|||
23575408|NCT00062868|65838725|FG009|Dose Level 2|Death|0|||
23227153|NCT00606229|64574990|FG000|Overall Study|Adverse Event|11|||
23227154|NCT00606229|64574990|FG000|Overall Study|Lack of Efficacy|1|||
23227155|NCT00606229|64574990|FG000|Overall Study|Withdrawal by Subject|4|||
23227156|NCT00606229|64574990|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
23227157|NCT00606229|64574990|FG000|Overall Study|change of residence or other commitments|2|||
23227158|NCT00742391|64574991|FG000|Overall Study|Adverse Event|2|||
23227159|NCT00742391|64574992|FG001|Overall Study|Adverse Event|1|||
23227160|NCT00742391|64574991|FG000|Overall Study|Lost to Follow-up|1|||
23227161|NCT00742391|64574992|FG001|Overall Study|Lost to Follow-up|0|||
23227162|NCT00742391|64574991|FG000|Overall Study|Protocol Violation|1|||
23227163|NCT00742391|64574992|FG001|Overall Study|Protocol Violation|0|||
23333466|NCT00955409|64962036|FG004|Overall Study|Withdrawal by Subject|0|||
23447525|NCT02260934|65380501|FG001|Overall Study|Site error|1|||
23333467|NCT00955409|64962037|FG005|Overall Study|Withdrawal by Subject|0|||
23333468|NCT00955409|64962038|FG006|Overall Study|Withdrawal by Subject|2|||
23333469|NCT00955409|64962039|FG007|Overall Study|Withdrawal by Subject|0|||
23333470|NCT00955409|64962040|FG008|Overall Study|Withdrawal by Subject|1|||
23333471|NCT00955409|64962041|FG009|Overall Study|Withdrawal by Subject|0|||
23333472|NCT00955409|64962032|FG000|Overall Study|Caregiver Request|2|||
23333473|NCT00955409|64962033|FG001|Overall Study|Caregiver Request|0|||
23333474|NCT00955409|64962034|FG002|Overall Study|Caregiver Request|6|||
23333475|NCT00955409|64962035|FG003|Overall Study|Caregiver Request|5|||
23333476|NCT00955409|64962036|FG004|Overall Study|Caregiver Request|0|||
23333477|NCT00955409|64962037|FG005|Overall Study|Caregiver Request|2|||
23333478|NCT00955409|64962038|FG006|Overall Study|Caregiver Request|3|||
23333479|NCT00955409|64962039|FG007|Overall Study|Caregiver Request|1|||
23575409|NCT00062868|65838726|FG010|Dose Level 2|Death|1|||
23575410|NCT00062868|65838727|FG011|Dose Level 2|Death|0|||
23575411|NCT00062868|65838728|FG012|Dose Level 2|Death|0|||
23575412|NCT00062868|65838729|FG013|Dose Level 2|Death|0|||
23575413|NCT00062868|65838730|FG014|Dose Level 2|Death|0|||
23575414|NCT00062868|65838731|FG015|Dose Level 2|Death|0|||
23575415|NCT00062868|65838732|FG016|Dose Level 2|Death|2|||
23575416|NCT00062868|65838733|FG017|Dose Level 2|Death|0|||
23575417|NCT00062868|65838734|FG018|Dose Level 2|Death|0|||
23227164|NCT00609167|64574995|FG000|Overall Study|Withdrawal by Subject|1|||
23227165|NCT00609167|64574996|FG001|Overall Study|Withdrawal by Subject|0|||
23227166|NCT00609167|64574995|FG000|Overall Study|Lack of Efficacy|1|||
23227167|NCT00609167|64574996|FG001|Overall Study|Lack of Efficacy|0|||
23227168|NCT00609167|64574995|FG000|Overall Study|Adverse Event|5|||
23227169|NCT00609167|64574996|FG001|Overall Study|Adverse Event|1|||
23227170|NCT00609167|64574995|FG000|Overall Study|Disease Progression|1|||
23227171|NCT00609167|64574996|FG001|Overall Study|Disease Progression|0|||
23227172|NCT00609167|64574995|FG000|Overall Study|Stem Cell Transplant|0|||
23227173|NCT00609167|64574996|FG001|Overall Study|Stem Cell Transplant|6|||
23227174|NCT03196973|64575006|FG000|Overall Study|Adverse Event|1|||
23227175|NCT03196973|64575007|FG001|Overall Study|Adverse Event|1|||
23227176|NCT03196973|64575008|FG002|Overall Study|Adverse Event|2|||
23227177|NCT03196973|64575006|FG000|Overall Study|Lack of Efficacy|2|||
23227178|NCT03196973|64575007|FG001|Overall Study|Lack of Efficacy|6|||
23227179|NCT03196973|64575008|FG002|Overall Study|Lack of Efficacy|1|||
23227180|NCT03196973|64575006|FG000|Overall Study|Lost to Follow-up|4|||
23227181|NCT03196973|64575007|FG001|Overall Study|Lost to Follow-up|3|||
23227182|NCT03196973|64575008|FG002|Overall Study|Lost to Follow-up|2|||
23227183|NCT03196973|64575006|FG000|Overall Study|Consent withdrawn|2|||
23575418|NCT00062868|65838735|FG019|Dose Level 2|Death|0|||
23575419|NCT00062868|65838736|FG020|Dose Level 2|Death|0|||
23227184|NCT03196973|64575007|FG001|Overall Study|Consent withdrawn|1|||
23333480|NCT00955409|64962040|FG008|Overall Study|Caregiver Request|3|||
23227185|NCT03196973|64575008|FG002|Overall Study|Consent withdrawn|0|||
23333481|NCT00955409|64962041|FG009|Overall Study|Caregiver Request|0|||
23333482|NCT00955409|64962032|FG000|Overall Study|Investigator Request|0|||
23575420|NCT00062868|65838716|FG000|Dose Level 2|Lost to Follow-up|0|||
23227186|NCT03196973|64575006|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
23227187|NCT03196973|64575007|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
23227188|NCT03196973|64575008|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
23227189|NCT00882362|64575009|FG000|Overall Study|Adverse Event|13|||
23227190|NCT00882362|64575010|FG001|Overall Study|Adverse Event|10|||
23227191|NCT00882362|64575009|FG000|Overall Study|Withdrawal by Subject|13|||
23227192|NCT00882362|64575010|FG001|Overall Study|Withdrawal by Subject|10|||
23227193|NCT00882362|64575009|FG000|Overall Study|Lack of Efficacy|3|||
23227194|NCT00882362|64575010|FG001|Overall Study|Lack of Efficacy|0|||
23227195|NCT00882362|64575009|FG000|Overall Study|Protocol Violation|7|||
23227196|NCT00882362|64575010|FG001|Overall Study|Protocol Violation|2|||
23227197|NCT00882362|64575009|FG000|Overall Study|Pregnancy|1|||
23227198|NCT00882362|64575010|FG001|Overall Study|Pregnancy|0|||
23227199|NCT00882362|64575009|FG000|Overall Study|Physician Decision|5|||
23227200|NCT00882362|64575010|FG001|Overall Study|Physician Decision|1|||
23227201|NCT00882362|64575009|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
23227202|NCT00882362|64575010|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
23227203|NCT00882362|64575009|FG000|Overall Study|change of residence or other commitments|5|||
23227204|NCT00882362|64575010|FG001|Overall Study|change of residence or other commitments|0|||
23227205|NCT01888965|64575013|FG000|Overall Study|Adverse Event|5|||
23227206|NCT01888965|64575013|FG000|Overall Study|Lack of Efficacy|4|||
23227207|NCT00636506|64575014|FG000|Overall Study|Lost to Follow-up|8|||
23227208|NCT00636506|64575014|FG000|Overall Study|Explanted|1|||
23227209|NCT00636506|64575014|FG000|Overall Study|Withdrawal by Subject|6|||
23227210|NCT00636506|64575014|FG000|Overall Study|Procedure aborted|1|||
23227211|NCT01646255|64575015|FG000|Overall Study|Adverse Event|7|||
23227212|NCT01646255|64575016|FG001|Overall Study|Adverse Event|8|||
23227213|NCT01646255|64575015|FG000|Overall Study|Lack of Efficacy|2|||
23227214|NCT01646255|64575016|FG001|Overall Study|Lack of Efficacy|0|||
23227215|NCT01646255|64575015|FG000|Overall Study|Withdrawal by Subject|10|||
23227216|NCT01646255|64575016|FG001|Overall Study|Withdrawal by Subject|6|||
23227217|NCT01646255|64575015|FG000|Overall Study|Compliance is not well|1|||
23227218|NCT01646255|64575016|FG001|Overall Study|Compliance is not well|0|||
23227219|NCT01646255|64575015|FG000|Overall Study|Inclusion Criteria Deviation|1|||
23227220|NCT01646255|64575016|FG001|Overall Study|Inclusion Criteria Deviation|0|||
23227221|NCT01975376|64575017|FG000|Overall Study|Adverse Event|5|||
23227222|NCT01975376|64575018|FG001|Overall Study|Adverse Event|5|||
23227223|NCT01975376|64575017|FG000|Overall Study|Death|65|||
23227224|NCT01975376|64575018|FG001|Overall Study|Death|72|||
23227225|NCT01975376|64575017|FG000|Overall Study|Lost to Follow-up|70|||
23227226|NCT01975376|64575018|FG001|Overall Study|Lost to Follow-up|66|||
23227227|NCT01975376|64575017|FG000|Overall Study|Withdrew consent|68|||
23227228|NCT01975376|64575018|FG001|Overall Study|Withdrew consent|62|||
23227229|NCT01975376|64575017|FG000|Overall Study|Other|2|||
23227230|NCT01975376|64575018|FG001|Overall Study|Other|4|||
23333483|NCT00955409|64962033|FG001|Overall Study|Investigator Request|0|||
23333484|NCT00955409|64962034|FG002|Overall Study|Investigator Request|1|||
23333485|NCT00955409|64962035|FG003|Overall Study|Investigator Request|0|||
23333486|NCT00955409|64962036|FG004|Overall Study|Investigator Request|0|||
23333487|NCT00955409|64962037|FG005|Overall Study|Investigator Request|0|||
23333488|NCT00955409|64962038|FG006|Overall Study|Investigator Request|0|||
23333489|NCT00955409|64962039|FG007|Overall Study|Investigator Request|0|||
23333490|NCT00955409|64962040|FG008|Overall Study|Investigator Request|0|||
23227231|NCT01975376|64575017|FG000|Overall Study|Randomized, Not Treated|16|||
23227232|NCT01975376|64575018|FG001|Overall Study|Randomized, Not Treated|8|||
23227233|NCT01590810|64575019|FG000|Overall Study|Physician Decision|0|||
23227234|NCT01590810|64575020|FG001|Overall Study|Physician Decision|1|||
23227235|NCT01590810|64575021|FG002|Overall Study|Physician Decision|1|||
23227236|NCT01590810|64575022|FG003|Overall Study|Physician Decision|0|||
23333491|NCT00955409|64962041|FG009|Overall Study|Investigator Request|0|||
23333492|NCT00955409|64962032|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
23333493|NCT00955409|64962033|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23333494|NCT00955409|64962034|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
23333495|NCT00955409|64962035|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
23333496|NCT00955409|64962036|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
23333497|NCT00955409|64962037|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
23333498|NCT00955409|64962038|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
23333499|NCT00955409|64962039|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
23333500|NCT00955409|64962040|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
23333501|NCT00955409|64962041|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
23333502|NCT00955409|64962032|FG000|Overall Study|Lost to Follow-up|0|||
23333503|NCT00955409|64962033|FG001|Overall Study|Lost to Follow-up|0|||
23333504|NCT00955409|64962034|FG002|Overall Study|Lost to Follow-up|1|||
23333505|NCT00955409|64962035|FG003|Overall Study|Lost to Follow-up|0|||
23333506|NCT00955409|64962036|FG004|Overall Study|Lost to Follow-up|0|||
23333507|NCT00955409|64962037|FG005|Overall Study|Lost to Follow-up|0|||
23333508|NCT00955409|64962038|FG006|Overall Study|Lost to Follow-up|1|||
23333509|NCT00955409|64962039|FG007|Overall Study|Lost to Follow-up|0|||
23333510|NCT00955409|64962040|FG008|Overall Study|Lost to Follow-up|0|||
23333511|NCT00955409|64962041|FG009|Overall Study|Lost to Follow-up|0|||
23333512|NCT00955409|64962032|FG000|Overall Study|Failed to Return|2|||
23333513|NCT00955409|64962033|FG001|Overall Study|Failed to Return|0|||
23333514|NCT00955409|64962034|FG002|Overall Study|Failed to Return|0|||
23333515|NCT00955409|64962035|FG003|Overall Study|Failed to Return|0|||
23333516|NCT00955409|64962036|FG004|Overall Study|Failed to Return|0|||
23333517|NCT00955409|64962037|FG005|Overall Study|Failed to Return|0|||
23333518|NCT00955409|64962038|FG006|Overall Study|Failed to Return|0|||
23333519|NCT00955409|64962039|FG007|Overall Study|Failed to Return|2|||
23333520|NCT00955409|64962040|FG008|Overall Study|Failed to Return|0|||
23333521|NCT00955409|64962041|FG009|Overall Study|Failed to Return|0|||
23333522|NCT00955409|64962032|FG000|Overall Study|Adverse Event (AE)|2|||
23333523|NCT00955409|64962033|FG001|Overall Study|Adverse Event (AE)|0|||
23333524|NCT00955409|64962034|FG002|Overall Study|Adverse Event (AE)|0|||
23333525|NCT00955409|64962035|FG003|Overall Study|Adverse Event (AE)|0|||
23333526|NCT00955409|64962036|FG004|Overall Study|Adverse Event (AE)|0|||
23333527|NCT00955409|64962037|FG005|Overall Study|Adverse Event (AE)|1|||
23333528|NCT00955409|64962038|FG006|Overall Study|Adverse Event (AE)|2|||
23333529|NCT00955409|64962039|FG007|Overall Study|Adverse Event (AE)|0|||
23333530|NCT00955409|64962040|FG008|Overall Study|Adverse Event (AE)|2|||
23333531|NCT00955409|64962041|FG009|Overall Study|Adverse Event (AE)|0|||
23333532|NCT00955409|64962032|FG000|Overall Study|Reason not Specified|2|||
23333533|NCT00955409|64962033|FG001|Overall Study|Reason not Specified|1|||
23333534|NCT00955409|64962034|FG002|Overall Study|Reason not Specified|13|||
23333535|NCT00955409|64962035|FG003|Overall Study|Reason not Specified|1|||
23333536|NCT00955409|64962036|FG004|Overall Study|Reason not Specified|2|||
23333537|NCT00955409|64962037|FG005|Overall Study|Reason not Specified|0|||
23333538|NCT00955409|64962038|FG006|Overall Study|Reason not Specified|16|||
23333539|NCT00955409|64962039|FG007|Overall Study|Reason not Specified|0|||
23333540|NCT00955409|64962040|FG008|Overall Study|Reason not Specified|8|||
23333541|NCT00955409|64962041|FG009|Overall Study|Reason not Specified|1|||
23333542|NCT04134767|64962050|FG000|Overall Study|Death|0|||
23333543|NCT04134767|64962051|FG001|Overall Study|Death|1|||
23333544|NCT04134767|64962050|FG000|Overall Study|Removed for harassing staff|0|||
23333545|NCT04134767|64962051|FG001|Overall Study|Removed for harassing staff|1|||
23333546|NCT04134767|64962050|FG000|Overall Study|Lost to Follow-up|44|||
23333547|NCT04134767|64962051|FG001|Overall Study|Lost to Follow-up|40|||
23575421|NCT00062868|65838717|FG001|Dose Level 2|Lost to Follow-up|0|||
23575422|NCT00062868|65838718|FG002|Dose Level 2|Lost to Follow-up|0|||
23575423|NCT00062868|65838719|FG003|Dose Level 2|Lost to Follow-up|0|||
23575424|NCT00062868|65838720|FG004|Dose Level 2|Lost to Follow-up|0|||
23575425|NCT00062868|65838721|FG005|Dose Level 2|Lost to Follow-up|0|||
23575426|NCT00062868|65838722|FG006|Dose Level 2|Lost to Follow-up|0|||
23333548|NCT01627574|64962052|FG000|Overall Study|Withdrawal by Subject|8|||
23333549|NCT01627574|64962053|FG001|Overall Study|Withdrawal by Subject|5|||
23333550|NCT01627574|64962052|FG000|Overall Study|Lost to Follow-up|13|||
23575427|NCT00062868|65838723|FG007|Dose Level 2|Lost to Follow-up|0|||
23333551|NCT01627574|64962053|FG001|Overall Study|Lost to Follow-up|13|||
23333552|NCT02519348|64962054|FG000|Overall Study|Death|31|||
23333553|NCT02519348|64962055|FG001|Overall Study|Death|74|||
23333554|NCT02519348|64962056|FG002|Overall Study|Death|47|||
23333555|NCT02519348|64962057|FG003|Overall Study|Death|54|||
23333556|NCT02519348|64962058|FG004|Overall Study|Death|63|||
23333557|NCT02519348|64962059|FG005|Overall Study|Death|18|||
23333558|NCT02519348|64962060|FG006|Overall Study|Death|2|||
23333559|NCT02519348|64962061|FG007|Overall Study|Death|5|||
23333560|NCT02519348|64962062|FG008|Overall Study|Death|5|||
23333561|NCT02519348|64962054|FG000|Overall Study|Withdrawal by Subject|4|||
23575428|NCT00062868|65838724|FG008|Dose Level 2|Lost to Follow-up|0|||
23333562|NCT02519348|64962055|FG001|Overall Study|Withdrawal by Subject|7|||
23333563|NCT02519348|64962056|FG002|Overall Study|Withdrawal by Subject|4|||
23333564|NCT02519348|64962057|FG003|Overall Study|Withdrawal by Subject|3|||
23333565|NCT02519348|64962058|FG004|Overall Study|Withdrawal by Subject|3|||
23333566|NCT02519348|64962059|FG005|Overall Study|Withdrawal by Subject|2|||
23333567|NCT02519348|64962060|FG006|Overall Study|Withdrawal by Subject|0|||
23333568|NCT02519348|64962061|FG007|Overall Study|Withdrawal by Subject|0|||
23333569|NCT02519348|64962062|FG008|Overall Study|Withdrawal by Subject|1|||
23333570|NCT02519348|64962054|FG000|Overall Study|Lost to Follow-up|0|||
23333571|NCT02519348|64962055|FG001|Overall Study|Lost to Follow-up|0|||
23333572|NCT02519348|64962056|FG002|Overall Study|Lost to Follow-up|1|||
23333573|NCT02519348|64962057|FG003|Overall Study|Lost to Follow-up|0|||
23333574|NCT02519348|64962058|FG004|Overall Study|Lost to Follow-up|2|||
23333575|NCT02519348|64962059|FG005|Overall Study|Lost to Follow-up|1|||
23333576|NCT02519348|64962060|FG006|Overall Study|Lost to Follow-up|1|||
23333577|NCT02519348|64962061|FG007|Overall Study|Lost to Follow-up|0|||
23333578|NCT02519348|64962062|FG008|Overall Study|Lost to Follow-up|0|||
23333579|NCT02519348|64962054|FG000|Overall Study|Other|0|||
23333580|NCT02519348|64962055|FG001|Overall Study|Other|3|||
23227237|NCT01590810|64575023|FG004|Overall Study|Physician Decision|0|||
23227238|NCT01408732|64575026|FG000|Overall Study|Withdrawal by Subject|2|||
23227239|NCT01408732|64575027|FG001|Overall Study|Withdrawal by Subject|2|||
23227240|NCT03797144|64575031|FG000|Enrollment|Protocol Violation|4|||
23227241|NCT03797144|64575032|FG001|Enrollment|Protocol Violation|1|||
23227242|NCT03797144|64575031|FG000|Surgery|Protocol Violation|1|||
23227243|NCT03797144|64575032|FG001|Surgery|Protocol Violation|0|||
23227244|NCT03797144|64575031|FG000|3 Month|Early termination cut-off date|2|||
23227245|NCT03797144|64575032|FG001|3 Month|Early termination cut-off date|0|||
23227246|NCT03797144|64575031|FG000|12 Month|Early termination cut-off date|8|||
23227247|NCT03797144|64575032|FG001|12 Month|Early termination cut-off date|9|||
23227248|NCT03797144|64575031|FG000|24 Month|Early termination cut-off date|1|||
23333581|NCT02519348|64962056|FG002|Overall Study|Other|0|||
23333582|NCT02519348|64962057|FG003|Overall Study|Other|0|||
23333583|NCT02519348|64962058|FG004|Overall Study|Other|1|||
23333584|NCT02519348|64962059|FG005|Overall Study|Other|0|||
23333585|NCT02519348|64962060|FG006|Overall Study|Other|0|||
23333586|NCT02519348|64962061|FG007|Overall Study|Other|0|||
23333587|NCT02519348|64962062|FG008|Overall Study|Other|0|||
23333588|NCT02519348|64962054|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
23333589|NCT02519348|64962055|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
23333590|NCT02519348|64962056|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
23333591|NCT02519348|64962057|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
23333592|NCT02519348|64962058|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
23333593|NCT02519348|64962059|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
23333594|NCT02519348|64962060|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
23333595|NCT02519348|64962061|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
23333596|NCT02519348|64962062|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
23333597|NCT00766636|64962063|FG000|Overall Study|Withdrawal by Subject|1|||
23333598|NCT00766636|64962064|FG001|Overall Study|Withdrawal by Subject|1|||
23333599|NCT00766636|64962063|FG000|Overall Study|Incomplete Treatment|0|||
23333600|NCT00766636|64962064|FG001|Overall Study|Incomplete Treatment|1|||
23333601|NCT00766636|64962063|FG000|Overall Study|Adverse Event|1|||
23333602|NCT00766636|64962064|FG001|Overall Study|Adverse Event|0|||
23333603|NCT00766636|64962063|FG000|Overall Study|Disease Progression|1|||
23333604|NCT00766636|64962064|FG001|Overall Study|Disease Progression|0|||
23333605|NCT02640664|64962065|FG000|Epoch 1|Withdrawal of informed consent|1|||
23333606|NCT02640664|64962066|FG001|Epoch 1|Withdrawal of informed consent|0|||
23333607|NCT02640664|64962067|FG002|Epoch 1|Withdrawal of informed consent|0|||
23333608|NCT02640664|64962065|FG000|Epoch 1|Death|0|||
23333609|NCT02640664|64962066|FG001|Epoch 1|Death|0|||
23333610|NCT02640664|64962067|FG002|Epoch 1|Death|1|||
23333611|NCT02640664|64962065|FG000|Epoch 2|Withdrawal of informed consent|3|||
23333612|NCT02640664|64962066|FG001|Epoch 2|Withdrawal of informed consent|4|||
23333613|NCT02640664|64962067|FG002|Epoch 2|Withdrawal of informed consent|2|||
23333614|NCT02640664|64962065|FG000|Epoch 2|Subject/guardian decision|0|||
23333615|NCT02640664|64962066|FG001|Epoch 2|Subject/guardian decision|2|||
23333616|NCT02640664|64962067|FG002|Epoch 2|Subject/guardian decision|2|||
23447526|NCT00717249|65380502|FG000|Overall Study|Lens Discomfort|4|||
23333617|NCT02640664|64962065|FG000|Epoch 2|Lost to Follow-up|3|||
23447527|NCT00717249|65380503|FG001|Overall Study|Lens Discomfort|1|||
23227249|NCT03797144|64575032|FG001|24 Month|Early termination cut-off date|1|||
23227250|NCT02158728|64575033|FG000|Overall Study|no procedure according to CIP done|3|||
23333618|NCT02640664|64962066|FG001|Epoch 2|Lost to Follow-up|4|||
23333619|NCT02640664|64962067|FG002|Epoch 2|Lost to Follow-up|1|||
23333620|NCT02640664|64962065|FG000|Epoch 2|Death|0|||
23333621|NCT02640664|64962066|FG001|Epoch 2|Death|0|||
23227251|NCT02158728|64575033|FG000|Overall Study|no qualified dataset|24|||
23333622|NCT02640664|64962067|FG002|Epoch 2|Death|1|||
23333623|NCT01757535|64962068|FG000|Overall Study|Disease Relapse|143|||
23447528|NCT00717249|65380502|FG000|Overall Study|Unsatisfactory visual Response|0|||
23333624|NCT01757535|64962069|FG001|Overall Study|Disease Relapse|180|||
23333625|NCT01757535|64962068|FG000|Overall Study|Adverse Event|29|||
23333626|NCT01757535|64962069|FG001|Overall Study|Adverse Event|11|||
23333627|NCT01757535|64962068|FG000|Overall Study|Withdrawal by Subject|9|||
23333628|NCT01757535|64962069|FG001|Overall Study|Withdrawal by Subject|13|||
23333629|NCT01757535|64962068|FG000|Overall Study|Miscellaneous|5|||
23333630|NCT01757535|64962069|FG001|Overall Study|Miscellaneous|2|||
23333631|NCT01757535|64962068|FG000|Overall Study|Physician Decision|6|||
23333632|NCT01757535|64962069|FG001|Overall Study|Physician Decision|0|||
23333633|NCT01757535|64962068|FG000|Overall Study|Death|1|||
23333634|NCT01757535|64962069|FG001|Overall Study|Death|2|||
23333635|NCT01464164|64962080|FG000|Overall Study|Screen failure|0|||
23333636|NCT01464164|64962081|FG001|Overall Study|Screen failure|1|||
23333637|NCT01464164|64962082|FG002|Overall Study|Screen failure|2|||
23333638|NCT01464164|64962083|FG003|Overall Study|Screen failure|0|||
23333639|NCT01464164|64962084|FG004|Overall Study|Screen failure|0|||
23333640|NCT01464164|64962085|FG005|Overall Study|Screen failure|0|||
23333641|NCT01464164|64962086|FG006|Overall Study|Screen failure|0|||
23333642|NCT01464164|64962080|FG000|Overall Study|Physician Decision|0|||
23333643|NCT01464164|64962081|FG001|Overall Study|Physician Decision|1|||
23333644|NCT01464164|64962082|FG002|Overall Study|Physician Decision|0|||
23333645|NCT01464164|64962083|FG003|Overall Study|Physician Decision|0|||
23333646|NCT01464164|64962084|FG004|Overall Study|Physician Decision|0|||
23333647|NCT01464164|64962085|FG005|Overall Study|Physician Decision|0|||
23575429|NCT00062868|65838725|FG009|Dose Level 2|Lost to Follow-up|0|||
23333648|NCT01464164|64962086|FG006|Overall Study|Physician Decision|2|||
23333649|NCT01120184|64962087|FG000|Overall Study|Adverse Event|0|||
23333650|NCT01120184|64962088|FG001|Overall Study|Adverse Event|1|||
23333651|NCT01120184|64962089|FG002|Overall Study|Adverse Event|0|||
23333652|NCT01120184|64962087|FG000|Overall Study|Lost to Follow-up|13|||
23333653|NCT01120184|64962088|FG001|Overall Study|Lost to Follow-up|13|||
23333654|NCT01120184|64962089|FG002|Overall Study|Lost to Follow-up|11|||
23333655|NCT01120184|64962087|FG000|Overall Study|Physician Decision|9|||
23333656|NCT01120184|64962088|FG001|Overall Study|Physician Decision|1|||
23333657|NCT01120184|64962089|FG002|Overall Study|Physician Decision|3|||
23333658|NCT01120184|64962087|FG000|Overall Study|Reason not Specified|8|||
23333659|NCT01120184|64962088|FG001|Overall Study|Reason not Specified|3|||
23167027|NCT02889796|64359331|FG002|Overall Study|Pregnancy|1|||
23167028|NCT02889796|64359332|FG003|Overall Study|Pregnancy|0|||
23167029|NCT02889796|64359333|FG004|Overall Study|Pregnancy|0|||
23167030|NCT02889796|64359334|FG005|Overall Study|Pregnancy|0|||
23167031|NCT02889796|64359329|FG000|Overall Study|Randomized but not Dosed|2|||
23167032|NCT02889796|64359330|FG001|Overall Study|Randomized but not Dosed|0|||
23447529|NCT00717249|65380503|FG001|Overall Study|Unsatisfactory visual Response|2|||
23167033|NCT02889796|64359331|FG002|Overall Study|Randomized but not Dosed|0|||
23167034|NCT02889796|64359332|FG003|Overall Study|Randomized but not Dosed|0|||
23167035|NCT02889796|64359333|FG004|Overall Study|Randomized but not Dosed|0|||
23167036|NCT02889796|64359334|FG005|Overall Study|Randomized but not Dosed|2|||
23167037|NCT02474082|64359341|FG000|Overall Study|Adverse Event|2|||
23167038|NCT02474082|64359342|FG001|Overall Study|Adverse Event|32|||
23167039|NCT02474082|64359341|FG000|Overall Study|Withdrawal of informed consent|1|||
23167040|NCT02474082|64359342|FG001|Overall Study|Withdrawal of informed consent|11|||
23167041|NCT02474082|64359341|FG000|Overall Study|Lost to Follow-up|2|||
23167042|NCT02474082|64359342|FG001|Overall Study|Lost to Follow-up|2|||
23167043|NCT02474082|64359341|FG000|Overall Study|Dose tapering not achieved|0|||
23167044|NCT02474082|64359342|FG001|Overall Study|Dose tapering not achieved|4|||
23167045|NCT02474082|64359341|FG000|Overall Study|Participant/guardian decision|1|||
23333660|NCT01120184|64962089|FG002|Overall Study|Reason not Specified|12|||
23447530|NCT00717249|65380502|FG000|Overall Study|Adverse Event|4|||
23447531|NCT00717249|65380503|FG001|Overall Study|Adverse Event|2|||
23447532|NCT00717249|65380502|FG000|Overall Study|Lost to Follow-up|2|||
23575430|NCT00062868|65838726|FG010|Dose Level 2|Lost to Follow-up|0|||
23575431|NCT00062868|65838727|FG011|Dose Level 2|Lost to Follow-up|0|||
23575432|NCT00062868|65838728|FG012|Dose Level 2|Lost to Follow-up|0|||
23575433|NCT00062868|65838729|FG013|Dose Level 2|Lost to Follow-up|1|||
23575434|NCT00062868|65838730|FG014|Dose Level 2|Lost to Follow-up|0|||
23167046|NCT02474082|64359342|FG001|Overall Study|Participant/guardian decision|2|||
23167047|NCT02474082|64359341|FG000|Overall Study|Non-compliance with study treatment|0|||
23167048|NCT02474082|64359342|FG001|Overall Study|Non-compliance with study treatment|2|||
23167049|NCT02474082|64359341|FG000|Overall Study|Protocol deviation|0|||
23333661|NCT01120184|64962087|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
23333662|NCT01120184|64962088|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
23333663|NCT01120184|64962089|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
23167050|NCT02474082|64359342|FG001|Overall Study|Protocol deviation|1|||
23227252|NCT01997892|64575036|FG000|Overall Study|Physician Decision|2|||
23333664|NCT01120184|64962087|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
23333665|NCT01120184|64962088|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
23333666|NCT01120184|64962089|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
23167051|NCT00243659|64359345|FG000|Overall Study|Withdrawal by Subject|1|||
23167052|NCT00243659|64359346|FG001|Overall Study|Withdrawal by Subject|1|||
23167053|NCT00243659|64359345|FG000|Overall Study|Protocol Violation|1|||
23167054|NCT00243659|64359346|FG001|Overall Study|Protocol Violation|2|||
23167055|NCT02573155|64359347|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
23167056|NCT02573155|64359348|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
23167057|NCT02573155|64359347|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
23167058|NCT02573155|64359348|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
23167059|NCT02573155|64359347|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
23167060|NCT02573155|64359348|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
23575435|NCT00062868|65838731|FG015|Dose Level 2|Lost to Follow-up|0|||
23575436|NCT00062868|65838732|FG016|Dose Level 2|Lost to Follow-up|1|||
23575437|NCT00062868|65838733|FG017|Dose Level 2|Lost to Follow-up|0|||
23575438|NCT00062868|65838734|FG018|Dose Level 2|Lost to Follow-up|0|||
23575439|NCT00062868|65838735|FG019|Dose Level 2|Lost to Follow-up|0|||
23575440|NCT00062868|65838736|FG020|Dose Level 2|Lost to Follow-up|0|||
23575441|NCT00062868|65838716|FG000|Dose Level 3|Death|0|||
23575442|NCT00062868|65838717|FG001|Dose Level 3|Death|0|||
23575443|NCT00062868|65838718|FG002|Dose Level 3|Death|0|||
23575444|NCT00062868|65838719|FG003|Dose Level 3|Death|0|||
23575445|NCT00062868|65838720|FG004|Dose Level 3|Death|0|||
23575446|NCT00062868|65838721|FG005|Dose Level 3|Death|0|||
23575447|NCT00062868|65838722|FG006|Dose Level 3|Death|0|||
23575448|NCT00062868|65838723|FG007|Dose Level 3|Death|0|||
23575449|NCT00062868|65838724|FG008|Dose Level 3|Death|0|||
23575450|NCT00062868|65838725|FG009|Dose Level 3|Death|0|||
23575451|NCT00062868|65838726|FG010|Dose Level 3|Death|0|||
23575452|NCT00062868|65838727|FG011|Dose Level 3|Death|1|||
23575453|NCT00062868|65838728|FG012|Dose Level 3|Death|0|||
23575454|NCT00062868|65838729|FG013|Dose Level 3|Death|0|||
23575455|NCT00062868|65838730|FG014|Dose Level 3|Death|0|||
23575456|NCT00062868|65838731|FG015|Dose Level 3|Death|0|||
23575457|NCT00062868|65838732|FG016|Dose Level 3|Death|0|||
23575458|NCT00062868|65838733|FG017|Dose Level 3|Death|1|||
23575459|NCT00062868|65838734|FG018|Dose Level 3|Death|0|||
23167061|NCT02573155|64359347|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
23167062|NCT02573155|64359348|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
23167063|NCT02573155|64359347|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
23167064|NCT02573155|64359348|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
23167065|NCT02573155|64359347|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
23167066|NCT02573155|64359348|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
23167067|NCT02573155|64359347|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
23167068|NCT02573155|64359348|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
23167069|NCT02573155|64359347|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
23167070|NCT02573155|64359348|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
23167071|NCT03048422|64359353|FG000|Overall Study|Death|1|||
23167072|NCT03048422|64359354|FG001|Overall Study|Death|0|||
23167073|NCT03048422|64359355|FG002|Overall Study|Death|0|||
23167074|NCT03048422|64359353|FG000|Overall Study|Lost to Follow-up|5|||
23167075|NCT03048422|64359354|FG001|Overall Study|Lost to Follow-up|0|||
23167076|NCT03048422|64359355|FG002|Overall Study|Lost to Follow-up|1|||
23167077|NCT03048422|64359353|FG000|Overall Study|Withdrawal by Subject|5|||
23167078|NCT03048422|64359354|FG001|Overall Study|Withdrawal by Subject|7|||
23167079|NCT03048422|64359355|FG002|Overall Study|Withdrawal by Subject|4|||
23167080|NCT03048422|64359353|FG000|Overall Study|Moved|3|||
23167081|NCT03048422|64359354|FG001|Overall Study|Moved|2|||
23167082|NCT03048422|64359355|FG002|Overall Study|Moved|2|||
23167083|NCT03048422|64359353|FG000|Overall Study|Noncompliant with Study Requirements|2|||
23167084|NCT03048422|64359354|FG001|Overall Study|Noncompliant with Study Requirements|1|||
23167085|NCT03048422|64359355|FG002|Overall Study|Noncompliant with Study Requirements|2|||
23167086|NCT03048422|64359353|FG000|Overall Study|Not Able to Get to Clinic|1|||
23575460|NCT00062868|65838735|FG019|Dose Level 3|Death|0|||
23575461|NCT00062868|65838736|FG020|Dose Level 3|Death|0|||
23333667|NCT01120184|64962087|FG000|Overall Study|Death|170|||
23575462|NCT00062868|65838716|FG000|Dose Level 3|Lost to Follow-up|0|||
23575463|NCT00062868|65838717|FG001|Dose Level 3|Lost to Follow-up|0|||
23167087|NCT03048422|64359354|FG001|Overall Study|Not Able to Get to Clinic|0|||
23167088|NCT03048422|64359355|FG002|Overall Study|Not Able to Get to Clinic|0|||
23333668|NCT01120184|64962088|FG001|Overall Study|Death|176|||
23575464|NCT00062868|65838718|FG002|Dose Level 3|Lost to Follow-up|0|||
23575465|NCT00062868|65838719|FG003|Dose Level 3|Lost to Follow-up|0|||
23575466|NCT00062868|65838720|FG004|Dose Level 3|Lost to Follow-up|0|||
23575467|NCT00062868|65838721|FG005|Dose Level 3|Lost to Follow-up|0|||
23575468|NCT00062868|65838722|FG006|Dose Level 3|Lost to Follow-up|0|||
23575469|NCT00062868|65838723|FG007|Dose Level 3|Lost to Follow-up|0|||
23167089|NCT00546052|64359357|FG000|Overall Study|Adverse Event|47|||
23167090|NCT00546052|64359357|FG000|Overall Study|Lost to Follow-up|144|||
23167091|NCT00546052|64359357|FG000|Overall Study|Protocol Violation|9|||
23167092|NCT00546052|64359357|FG000|Overall Study|Withdrawal by Subject|20|||
23167093|NCT00546052|64359357|FG000|Overall Study|Non Compliance|7|||
23167094|NCT00720109|64359360|FG000|Induction Period|Did not meet eligibility criteria|3|||
23167095|NCT00720109|64359361|FG001|Induction Period|Did not meet eligibility criteria|0|||
23167096|NCT00720109|64359362|FG002|Induction Period|Did not meet eligibility criteria|0|||
23167097|NCT00720109|64359360|FG000|Induction Period|Bone Marrow Transplant|2|||
23167098|NCT00720109|64359361|FG001|Induction Period|Bone Marrow Transplant|0|||
23167099|NCT00720109|64359362|FG002|Induction Period|Bone Marrow Transplant|0|||
23167100|NCT00720109|64359360|FG000|Induction Period|Physician Decision|1|||
23167101|NCT00720109|64359361|FG001|Induction Period|Physician Decision|0|||
23167102|NCT00720109|64359362|FG002|Induction Period|Physician Decision|0|||
23167103|NCT00720109|64359360|FG000|Risk Stratification Period|Adverse Event|0|||
23167104|NCT00720109|64359361|FG001|Risk Stratification Period|Adverse Event|1|||
23167105|NCT00720109|64359362|FG002|Risk Stratification Period|Adverse Event|0|||
23167106|NCT00720109|64359360|FG000|Risk Stratification Period|Physician Decision|0|||
23167107|NCT00720109|64359361|FG001|Risk Stratification Period|Physician Decision|2|||
23167108|NCT00720109|64359362|FG002|Risk Stratification Period|Physician Decision|1|||
23167109|NCT00720109|64359360|FG000|Risk Stratification Period|Bone marrow transplant|0|||
23167110|NCT00720109|64359361|FG001|Risk Stratification Period|Bone marrow transplant|9|||
23167111|NCT00720109|64359362|FG002|Risk Stratification Period|Bone marrow transplant|7|||
23167112|NCT00720109|64359360|FG000|Risk Stratification Period|Disease progression or relapse|0|||
23167113|NCT00720109|64359361|FG001|Risk Stratification Period|Disease progression or relapse|2|||
23167114|NCT00720109|64359362|FG002|Risk Stratification Period|Disease progression or relapse|0|||
23167115|NCT00720109|64359360|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
23167116|NCT00720109|64359361|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
23167117|NCT00720109|64359362|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
23167118|NCT00401752|64359363|FG000|Overall Study|Adverse Event|2|||
23167119|NCT00401752|64359364|FG001|Overall Study|Adverse Event|5|||
23167120|NCT00401752|64359363|FG000|Overall Study|Withdrawal by Subject|2|||
23167121|NCT00401752|64359364|FG001|Overall Study|Withdrawal by Subject|6|||
23167122|NCT00401752|64359363|FG000|Overall Study|Lost to Follow-up|1|||
23167123|NCT00401752|64359364|FG001|Overall Study|Lost to Follow-up|4|||
23167124|NCT00401752|64359363|FG000|Overall Study|Development of any exclusion criteria|4|||
23167125|NCT00401752|64359364|FG001|Overall Study|Development of any exclusion criteria|2|||
23167126|NCT00401752|64359363|FG000|Overall Study|Physician Decision|1|||
23167127|NCT00401752|64359364|FG001|Overall Study|Physician Decision|1|||
23575470|NCT00062868|65838724|FG008|Dose Level 3|Lost to Follow-up|0|||
23575471|NCT00062868|65838725|FG009|Dose Level 3|Lost to Follow-up|0|||
23575472|NCT00062868|65838726|FG010|Dose Level 3|Lost to Follow-up|0|||
23575473|NCT00062868|65838727|FG011|Dose Level 3|Lost to Follow-up|0|||
23575474|NCT00062868|65838728|FG012|Dose Level 3|Lost to Follow-up|0|||
23167133|NCT01121393|64359375|FG000|Overall Study|Progressive disease|201|||
23167134|NCT01121393|64359376|FG001|Overall Study|Progressive disease|20|||
23167135|NCT01121393|64359375|FG000|Overall Study|Other Adverse events|24|||
23167136|NCT01121393|64359376|FG001|Overall Study|Other Adverse events|45|||
23167137|NCT01121393|64359375|FG000|Overall Study|Non-compliant with protocol|0|||
23167138|NCT01121393|64359376|FG001|Overall Study|Non-compliant with protocol|3|||
23167139|NCT01121393|64359375|FG000|Overall Study|Lost to Follow-up|1|||
23167140|NCT01121393|64359376|FG001|Overall Study|Lost to Follow-up|0|||
23167141|NCT01121393|64359375|FG000|Overall Study|Refused cont. medication|7|||
23167142|NCT01121393|64359376|FG001|Overall Study|Refused cont. medication|7|||
23167143|NCT01121393|64359375|FG000|Overall Study|Not treated|3|||
23167144|NCT01121393|64359376|FG001|Overall Study|Not treated|9|||
23167145|NCT01121393|64359375|FG000|Overall Study|Other than listed|6|||
23167146|NCT01121393|64359376|FG001|Overall Study|Other than listed|0|||
23167147|NCT04029519|64359377|FG000|Overall Study|Protocol Violation|1|||
23167148|NCT04029519|64359377|FG000|Overall Study|Withdrawal by Subject|3|||
23167149|NCT04029519|64359377|FG000|Overall Study|Lost to Follow-up|1|||
23167150|NCT00411554|64359380|FG000|Overall Study|Adverse Event|2|||
23167151|NCT00411554|64359381|FG001|Overall Study|Adverse Event|4|||
23167152|NCT00411554|64359380|FG000|Overall Study|Lack of Efficacy|2|||
23167153|NCT00411554|64359381|FG001|Overall Study|Lack of Efficacy|5|||
23167154|NCT00411554|64359380|FG000|Overall Study|Withdrawal by Subject|3|||
23167155|NCT00411554|64359381|FG001|Overall Study|Withdrawal by Subject|0|||
23167156|NCT00411554|64359380|FG000|Overall Study|Patient Moved|1|||
23167157|NCT00411554|64359381|FG001|Overall Study|Patient Moved|0|||
23167158|NCT01535729|64359382|FG000|Overall Study|Withdrawal by Subject|2|||
23167159|NCT01535729|64359382|FG000|Overall Study|Disease progression|230|||
23167160|NCT01535729|64359382|FG000|Overall Study|Discontinued treatment|25|||
23167161|NCT01535729|64359382|FG000|Overall Study|Lost to Follow-up|8|||
23167162|NCT01535729|64359382|FG000|Overall Study|Death|52|||
23167163|NCT01535729|64359382|FG000|Overall Study|Other|19|||
23575475|NCT00062868|65838729|FG013|Dose Level 3|Lost to Follow-up|0|||
23167164|NCT01535729|64359382|FG000|Overall Study|Did not sign informed consent|1|||
23167165|NCT01535729|64359382|FG000|Overall Study|No previous chemotherapy|33|||
23167166|NCT01535729|64359382|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
23167167|NCT01535729|64359382|FG000|Overall Study|Protocol Violation|11|||
23167168|NCT01535729|64359382|FG000|Overall Study|Screening failure|1|||
23167169|NCT01535729|64359382|FG000|Overall Study|Not treated|9|||
23167170|NCT01535729|64359382|FG000|Overall Study|No participant record available|5|||
23167171|NCT03670953|64359384|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
23167172|NCT03670953|64359385|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
23167173|NCT03670953|64359386|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
23167174|NCT03670953|64359387|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
23167175|NCT03670953|64359384|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
23167176|NCT03670953|64359385|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
23167177|NCT03670953|64359386|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
23167178|NCT03670953|64359387|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
23167179|NCT03670953|64359384|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
23167180|NCT03670953|64359385|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
23167181|NCT03670953|64359386|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
23167182|NCT03670953|64359387|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
23167183|NCT03670953|64359384|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
23167184|NCT03670953|64359385|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
23227253|NCT01997892|64575036|FG000|Overall Study|Lost to Follow-up|6|||
23227254|NCT01997892|64575036|FG000|Overall Study|Death|14|||
23333669|NCT01120184|64962089|FG002|Overall Study|Death|169|||
23167185|NCT03670953|64359386|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
23167186|NCT03670953|64359387|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
23167187|NCT03670953|64359384|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
23167188|NCT03670953|64359385|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
23167189|NCT03670953|64359386|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
23167190|NCT03670953|64359387|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
23167191|NCT03670953|64359384|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
23167192|NCT03670953|64359385|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
23167193|NCT03670953|64359386|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
23167194|NCT03670953|64359387|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
23167195|NCT03670953|64359384|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
23167196|NCT03670953|64359385|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
23167197|NCT03670953|64359386|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
23167198|NCT03670953|64359387|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
23167199|NCT03670953|64359384|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
23167200|NCT03670953|64359385|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
23167201|NCT03670953|64359386|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
23167202|NCT03670953|64359387|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
23167203|NCT03670953|64359384|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
23167204|NCT03670953|64359385|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
23167205|NCT03670953|64359386|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
23167206|NCT03670953|64359387|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
23167207|NCT03670953|64359384|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
23167208|NCT03670953|64359385|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
23167209|NCT03670953|64359386|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
23167210|NCT03670953|64359387|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
23167211|NCT03670953|64359384|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
23167212|NCT03670953|64359385|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
23167213|NCT03670953|64359386|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
23167214|NCT03670953|64359387|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
23167215|NCT03670953|64359384|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
23167216|NCT03670953|64359385|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
23167217|NCT03670953|64359386|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
23167218|NCT03670953|64359387|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
23167219|NCT03670953|64359384|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
23167220|NCT03670953|64359385|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
23167221|NCT03670953|64359386|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
23167222|NCT03670953|64359387|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
23167223|NCT03670953|64359384|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
23167224|NCT03670953|64359385|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
23167225|NCT03670953|64359386|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
23167226|NCT03670953|64359387|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
23167227|NCT03670953|64359384|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
23227255|NCT01997892|64575036|FG000|Overall Study|Renal transplant|8|||
23575476|NCT00062868|65838730|FG014|Dose Level 3|Lost to Follow-up|1|||
23575477|NCT00062868|65838731|FG015|Dose Level 3|Lost to Follow-up|0|||
23167228|NCT03670953|64359385|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
23167229|NCT03670953|64359386|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
23167230|NCT03670953|64359387|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
23167231|NCT03670953|64359384|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
23167232|NCT03670953|64359385|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
23167233|NCT03670953|64359386|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
23167234|NCT03670953|64359387|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
23167235|NCT03670953|64359384|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
23167236|NCT03670953|64359385|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
23167237|NCT03670953|64359386|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
23167238|NCT03670953|64359387|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
23167239|NCT03670953|64359384|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
23167240|NCT03670953|64359385|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
23167241|NCT03670953|64359386|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
23167242|NCT03670953|64359387|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
23167243|NCT02699892|64359390|FG000|Overall Study|Other|36|||
23167244|NCT02347176|64359391|FG000|Overall Study|Lost to Follow-up|2|||
23167245|NCT02347176|64359392|FG001|Overall Study|Lost to Follow-up|3|||
23167246|NCT02347176|64359393|FG002|Overall Study|Lost to Follow-up|1|||
23167247|NCT02347176|64359394|FG003|Overall Study|Lost to Follow-up|1|||
23167248|NCT02347176|64359391|FG000|Overall Study|Withdrawal by Subject|9|||
23167249|NCT02347176|64359392|FG001|Overall Study|Withdrawal by Subject|5|||
23167250|NCT02347176|64359393|FG002|Overall Study|Withdrawal by Subject|5|||
23167251|NCT02347176|64359394|FG003|Overall Study|Withdrawal by Subject|3|||
23167252|NCT02347176|64359391|FG000|Overall Study|Other|1|||
23167253|NCT02347176|64359392|FG001|Overall Study|Other|2|||
23167254|NCT02347176|64359393|FG002|Overall Study|Other|2|||
23167255|NCT02347176|64359394|FG003|Overall Study|Other|0|||
23167256|NCT00713700|64359397|FG000|Overall Study|Lost to Follow-up|3|||
23167257|NCT00713700|64359397|FG000|Overall Study|Withdrawal by Subject|1|||
23167258|NCT01604265|64359398|FG000|Overall Study|Adverse Event|1|||
23167259|NCT01604265|64359399|FG001|Overall Study|Adverse Event|0|||
23167260|NCT01604265|64359398|FG000|Overall Study|Withdrawal by Subject|1|||
23167261|NCT01604265|64359399|FG001|Overall Study|Withdrawal by Subject|0|||
23167262|NCT04101331|64359401|FG000|Overall Study|Adverse Event|7|||
23167263|NCT04101331|64359401|FG000|Overall Study|Disease progression|79|||
23167264|NCT04101331|64359401|FG000|Overall Study|Withdrawal by Subject|1|||
23167265|NCT04101331|64359401|FG000|Overall Study|Investigator decision|6|||
23167266|NCT04101331|64359401|FG000|Overall Study|Death|6|||
23167267|NCT04101331|64359401|FG000|Overall Study|Allogenic transplant|1|||
23167268|NCT00267748|64359402|FG000|Non-randomized Period|Progressive disease|10|||
23167269|NCT00267748|64359403|FG001|Non-randomized Period|Progressive disease|0|||
23167270|NCT00267748|64359404|FG002|Non-randomized Period|Progressive disease|0|||
23167271|NCT00267748|64359402|FG000|Non-randomized Period|Adverse Event|8|||
23167272|NCT00267748|64359403|FG001|Non-randomized Period|Adverse Event|0|||
23167273|NCT00267748|64359404|FG002|Non-randomized Period|Adverse Event|0|||
23167274|NCT00267748|64359402|FG000|Non-randomized Period|Death|1|||
23167275|NCT00267748|64359403|FG001|Non-randomized Period|Death|0|||
23167276|NCT00267748|64359404|FG002|Non-randomized Period|Death|0|||
23167277|NCT00267748|64359402|FG000|Non-randomized Period|Participant not willing to participate|1|||
23167278|NCT00267748|64359403|FG001|Non-randomized Period|Participant not willing to participate|0|||
23167279|NCT00267748|64359404|FG002|Non-randomized Period|Participant not willing to participate|0|||
23167280|NCT00267748|64359402|FG000|Non-randomized Period|Other|3|||
23167281|NCT00267748|64359403|FG001|Non-randomized Period|Other|0|||
23167282|NCT00267748|64359404|FG002|Non-randomized Period|Other|0|||
23167283|NCT00267748|64359402|FG000|Randomized Period|Death|0|||
23167284|NCT00267748|64359403|FG001|Randomized Period|Death|2|||
23167285|NCT00267748|64359404|FG002|Randomized Period|Death|3|||
23167286|NCT00267748|64359402|FG000|Randomized Period|Adverse Event|0|||
23167287|NCT00267748|64359403|FG001|Randomized Period|Adverse Event|23|||
23167288|NCT00267748|64359404|FG002|Randomized Period|Adverse Event|25|||
23167289|NCT00267748|64359402|FG000|Randomized Period|Global deterioration of health status|0|||
23333670|NCT00113763|64962090|FG000|Overall Study|Adverse Event|5|||
23333671|NCT00113763|64962091|FG001|Overall Study|Adverse Event|2|||
23333672|NCT00113763|64962090|FG000|Overall Study|Disease Progression|28|||
23167290|NCT00267748|64359403|FG001|Randomized Period|Global deterioration of health status|6|||
23167291|NCT00267748|64359404|FG002|Randomized Period|Global deterioration of health status|7|||
23167292|NCT00267748|64359402|FG000|Randomized Period|Lost to Follow-up|0|||
23167293|NCT00267748|64359403|FG001|Randomized Period|Lost to Follow-up|1|||
23167294|NCT00267748|64359404|FG002|Randomized Period|Lost to Follow-up|0|||
23167295|NCT00267748|64359402|FG000|Randomized Period|Objective progression or relapse|0|||
23167296|NCT00267748|64359403|FG001|Randomized Period|Objective progression or relapse|77|||
23167297|NCT00267748|64359404|FG002|Randomized Period|Objective progression or relapse|86|||
23333673|NCT00113763|64962091|FG001|Overall Study|Disease Progression|14|||
23167298|NCT00267748|64359402|FG000|Randomized Period|Withdrawal by Subject|0|||
23167299|NCT00267748|64359403|FG001|Randomized Period|Withdrawal by Subject|9|||
23167300|NCT00267748|64359404|FG002|Randomized Period|Withdrawal by Subject|2|||
23167301|NCT00267748|64359402|FG000|Randomized Period|Other|0|||
23167302|NCT00267748|64359403|FG001|Randomized Period|Other|9|||
23167303|NCT00267748|64359404|FG002|Randomized Period|Other|6|||
23167304|NCT00267748|64359402|FG000|Randomized Period|randomized but not treated|0|||
23167305|NCT00267748|64359403|FG001|Randomized Period|randomized but not treated|0|||
23167306|NCT00267748|64359404|FG002|Randomized Period|randomized but not treated|3|||
23167307|NCT01411085|64359406|FG000|Overall Study|Physician Decision|1|||
23167308|NCT01411085|64359406|FG000|Overall Study|Protocol Violation|1|||
23167309|NCT01411085|64359406|FG000|Overall Study|Adverse Event|1|||
23167310|NCT01339559|64359407|FG000|Overall Study|Adverse Event|92|||
23167311|NCT01339559|64359407|FG000|Overall Study|Death|5|||
23167312|NCT01339559|64359407|FG000|Overall Study|Lack of Efficacy|164|||
23167313|NCT01339559|64359407|FG000|Overall Study|Lost to Follow-up|22|||
23167314|NCT01339559|64359407|FG000|Overall Study|Subject choice|89|||
23167315|NCT01339559|64359407|FG000|Overall Study|Protocol Violation|15|||
23167316|NCT01339559|64359407|FG000|Overall Study|Study closure at site|1|||
23167317|NCT01339559|64359407|FG000|Overall Study|Incarcerated|2|||
23167318|NCT01339559|64359407|FG000|Overall Study|Epilepsy surgery|1|||
23167319|NCT01339559|64359407|FG000|Overall Study|Pregnancy planned|2|||
23167320|NCT01339559|64359407|FG000|Overall Study|Left the country|1|||
23167321|NCT01339559|64359407|FG000|Overall Study|Investigator decision|2|||
23167322|NCT01339559|64359407|FG000|Overall Study|Patient didn't wish to continue|1|||
23167323|NCT01339559|64359407|FG000|Overall Study|PI decision|1|||
23167324|NCT03691974|64359410|FG000|Overall Study|Physician Decision|1|||
23167325|NCT03691974|64359411|FG001|Overall Study|Physician Decision|0|||
23167326|NCT03691974|64359410|FG000|Overall Study|Adverse Event|1|||
23167327|NCT03691974|64359411|FG001|Overall Study|Adverse Event|0|||
23167328|NCT03691974|64359410|FG000|Overall Study|Withdrawal by Subject|11|||
23167329|NCT03691974|64359411|FG001|Overall Study|Withdrawal by Subject|9|||
23167330|NCT03691974|64359410|FG000|Overall Study|Protocol Violation|1|||
23167331|NCT03691974|64359411|FG001|Overall Study|Protocol Violation|0|||
23167332|NCT03691974|64359410|FG000|Overall Study|Lost to Follow-up|8|||
23167333|NCT03691974|64359411|FG001|Overall Study|Lost to Follow-up|7|||
23167334|NCT00936208|64359412|FG000|Overall Study|Protocol Violation|37|||
23167335|NCT00936208|64359413|FG001|Overall Study|Protocol Violation|22|||
23167336|NCT00744874|64359417|FG000|Overall Study|Lost to Follow-up|1|||
23167337|NCT00744874|64359417|FG000|Overall Study|Withdrawal by Subject|1|||
23167338|NCT00744874|64359417|FG000|Overall Study|Study Device not available at procedure|1|||
23167339|NCT00744874|64359417|FG000|Overall Study|Unable to accomodate schedule|1|||
23167340|NCT01285908|64359424|FG000|Baseline Measurement|unable to insert catheter|1|||
23167341|NCT01285908|64359425|FG001|Baseline Measurement|unable to insert catheter|0|||
23167342|NCT01285908|64359426|FG002|Baseline Measurement|unable to insert catheter|0|||
23167343|NCT01285908|64359424|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
23167344|NCT01285908|64359425|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
23167345|NCT01285908|64359426|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
23167346|NCT01285908|64359424|FG000|Baseline Measurement|unable to tolerate procedure|1|||
23167347|NCT01285908|64359425|FG001|Baseline Measurement|unable to tolerate procedure|0|||
23167348|NCT01285908|64359426|FG002|Baseline Measurement|unable to tolerate procedure|0|||
23167349|NCT00278993|64359427|FG000|Overall Study|Adverse Event|24|||
23167350|NCT00278993|64359427|FG000|Overall Study|Withdrawal by Subject|5|||
23167351|NCT00278993|64359427|FG000|Overall Study|Progressive Disease|65|||
23167352|NCT00278993|64359427|FG000|Overall Study|Physician Decision|9|||
23167353|NCT00278993|64359427|FG000|Overall Study|Not Otherwise Specified|4|||
23167354|NCT00852995|64359428|FG000|Overall Study|Adverse Event|1|||
23167355|NCT00852995|64359429|FG001|Overall Study|Adverse Event|0|||
23167356|NCT00852995|64359430|FG002|Overall Study|Adverse Event|4|||
23167357|NCT00852995|64359431|FG003|Overall Study|Adverse Event|0|||
23167358|NCT00852995|64359432|FG004|Overall Study|Adverse Event|0|||
23167359|NCT00852995|64359428|FG000|Overall Study|Lost to Follow-up|0|||
23167360|NCT00852995|64359429|FG001|Overall Study|Lost to Follow-up|1|||
23167361|NCT00852995|64359430|FG002|Overall Study|Lost to Follow-up|1|||
23167362|NCT00852995|64359431|FG003|Overall Study|Lost to Follow-up|0|||
23167363|NCT00852995|64359432|FG004|Overall Study|Lost to Follow-up|0|||
23167364|NCT00852995|64359428|FG000|Overall Study|Withdrawal by Subject|4|||
23167365|NCT00852995|64359429|FG001|Overall Study|Withdrawal by Subject|0|||
23167366|NCT00852995|64359430|FG002|Overall Study|Withdrawal by Subject|0|||
23167367|NCT00852995|64359431|FG003|Overall Study|Withdrawal by Subject|1|||
23167368|NCT00852995|64359432|FG004|Overall Study|Withdrawal by Subject|2|||
23167369|NCT00852995|64359428|FG000|Overall Study|Non-Compliance|0|||
23167370|NCT00852995|64359429|FG001|Overall Study|Non-Compliance|0|||
23167371|NCT00852995|64359430|FG002|Overall Study|Non-Compliance|0|||
23167372|NCT00852995|64359431|FG003|Overall Study|Non-Compliance|2|||
23167373|NCT00852995|64359432|FG004|Overall Study|Non-Compliance|0|||
23167374|NCT00852995|64359428|FG000|Overall Study|Progressive Disease|1|||
23167375|NCT00852995|64359429|FG001|Overall Study|Progressive Disease|0|||
23167376|NCT00852995|64359430|FG002|Overall Study|Progressive Disease|0|||
23167377|NCT00852995|64359431|FG003|Overall Study|Progressive Disease|2|||
23167378|NCT00852995|64359432|FG004|Overall Study|Progressive Disease|1|||
23167379|NCT00852995|64359428|FG000|Overall Study|Physician Decision|1|||
23167380|NCT00852995|64359429|FG001|Overall Study|Physician Decision|0|||
23167381|NCT00852995|64359430|FG002|Overall Study|Physician Decision|0|||
23167382|NCT00852995|64359431|FG003|Overall Study|Physician Decision|0|||
23167383|NCT00852995|64359432|FG004|Overall Study|Physician Decision|0|||
23227256|NCT01997892|64575036|FG000|Overall Study|Other|3|||
23167384|NCT00852995|64359428|FG000|Overall Study|Protocol Violation|0|||
23167385|NCT00852995|64359429|FG001|Overall Study|Protocol Violation|0|||
23167386|NCT00852995|64359430|FG002|Overall Study|Protocol Violation|0|||
23575478|NCT00062868|65838732|FG016|Dose Level 3|Lost to Follow-up|0|||
23575479|NCT00062868|65838733|FG017|Dose Level 3|Lost to Follow-up|0|||
23575480|NCT00062868|65838734|FG018|Dose Level 3|Lost to Follow-up|0|||
23575481|NCT00062868|65838735|FG019|Dose Level 3|Lost to Follow-up|0|||
23575482|NCT00062868|65838736|FG020|Dose Level 3|Lost to Follow-up|0|||
23575483|NCT00062868|65838716|FG000|Dose Level 3|Withdrew|0|||
23575484|NCT00062868|65838717|FG001|Dose Level 3|Withdrew|0|||
23575485|NCT00062868|65838718|FG002|Dose Level 3|Withdrew|2|||
23575486|NCT00062868|65838719|FG003|Dose Level 3|Withdrew|0|||
23227257|NCT01997892|64575036|FG000|Overall Study|Study completion data not recorded|35|||
23575487|NCT00062868|65838720|FG004|Dose Level 3|Withdrew|0|||
23575488|NCT00062868|65838721|FG005|Dose Level 3|Withdrew|0|||
23575489|NCT00062868|65838722|FG006|Dose Level 3|Withdrew|0|||
23167387|NCT00852995|64359431|FG003|Overall Study|Protocol Violation|0|||
23167388|NCT00852995|64359432|FG004|Overall Study|Protocol Violation|1|||
23167389|NCT00852995|64359428|FG000|Overall Study|Moved Out of Area|1|||
23167390|NCT00852995|64359429|FG001|Overall Study|Moved Out of Area|0|||
23167391|NCT00852995|64359430|FG002|Overall Study|Moved Out of Area|0|||
23333674|NCT00113763|64962090|FG000|Overall Study|Lost to Follow-up|10|||
23333675|NCT00113763|64962091|FG001|Overall Study|Lost to Follow-up|0|||
23333676|NCT00113763|64962090|FG000|Overall Study|Withdrawal by Subject|1|||
23333677|NCT00113763|64962091|FG001|Overall Study|Withdrawal by Subject|4|||
23333678|NCT00113763|64962090|FG000|Overall Study|Other|27|||
23575490|NCT00062868|65838723|FG007|Dose Level 3|Withdrew|0|||
23167392|NCT00852995|64359431|FG003|Overall Study|Moved Out of Area|0|||
23227258|NCT00088595|64575047|FG000|Overall Study|Adverse Event|11|||
23227259|NCT00088595|64575047|FG000|Overall Study|Withdrawal by Subject|8|||
23575491|NCT00062868|65838724|FG008|Dose Level 3|Withdrew|0|||
23167393|NCT00852995|64359432|FG004|Overall Study|Moved Out of Area|0|||
23167394|NCT03548051|64359439|FG000|Overall Study|Death|1|||
23167395|NCT03548051|64359440|FG001|Overall Study|Death|1|||
23167396|NCT03548051|64359439|FG000|Overall Study|Withdrawal by Subject|1|||
23167397|NCT03548051|64359440|FG001|Overall Study|Withdrawal by Subject|0|||
23167398|NCT01634555|64359447|FG000|Overall Study|Adverse Event|3|||
23167399|NCT01634555|64359447|FG000|Overall Study|Physician Decision|1|||
23167400|NCT01929408|64359448|FG000|Overall Study|received HCT as initial treatment|8|||
23167401|NCT02182687|64359453|FG000|Overall Study|Withdrawal by Subject|4|||
23167402|NCT02182687|64359454|FG001|Overall Study|Withdrawal by Subject|0|||
23167403|NCT02182687|64359453|FG000|Overall Study|Adverse Event|1|||
23167404|NCT02182687|64359454|FG001|Overall Study|Adverse Event|0|||
23167405|NCT02182687|64359453|FG000|Overall Study|Lost to Follow-up|0|||
23167406|NCT02182687|64359454|FG001|Overall Study|Lost to Follow-up|1|||
23167407|NCT02239939|64359455|FG000|Overall Study|Adverse Event|1|||
23167408|NCT02239939|64359456|FG001|Overall Study|Adverse Event|0|||
23167409|NCT02239939|64359455|FG000|Overall Study|Withdrawal by Subject|1|||
23575492|NCT00062868|65838725|FG009|Dose Level 3|Withdrew|0|||
23167410|NCT02239939|64359456|FG001|Overall Study|Withdrawal by Subject|1|||
23167411|NCT02239939|64359455|FG000|Overall Study|Lost to Follow-up|0|||
23167412|NCT02239939|64359456|FG001|Overall Study|Lost to Follow-up|1|||
23227260|NCT00088595|64575047|FG000|Overall Study|Ongoing (After Core)|7|||
23227261|NCT00088595|64575047|FG000|Overall Study|New Cancer Therapy|2|||
23227262|NCT03006926|64575052|FG000|Overall Study|Adverse Event|0|||
23227263|NCT03006926|64575053|FG001|Overall Study|Adverse Event|27|||
23333679|NCT00113763|64962091|FG001|Overall Study|Other|6|||
23167413|NCT02425826|64359457|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
23167414|NCT02425826|64359458|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
23167415|NCT02425826|64359459|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
23167416|NCT02425826|64359457|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
23167417|NCT02425826|64359458|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
23227264|NCT03006926|64575052|FG000|Overall Study|Withdrawal by Subject|0|||
23575493|NCT00062868|65838726|FG010|Dose Level 3|Withdrew|0|||
23575494|NCT00062868|65838727|FG011|Dose Level 3|Withdrew|0|||
23575495|NCT00062868|65838728|FG012|Dose Level 3|Withdrew|0|||
23227265|NCT03006926|64575053|FG001|Overall Study|Withdrawal by Subject|1|||
23333680|NCT00113763|64962090|FG000|Overall Study|Non-compliance|1|||
23575496|NCT00062868|65838729|FG013|Dose Level 3|Withdrew|0|||
23167418|NCT02425826|64359459|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
23167419|NCT02425826|64359457|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
23167420|NCT02425826|64359458|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
23167421|NCT02425826|64359459|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
23167422|NCT02425826|64359457|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
23167423|NCT02425826|64359458|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
23167424|NCT02425826|64359459|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
23167425|NCT02425826|64359457|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
23167426|NCT02425826|64359458|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
23167427|NCT02425826|64359459|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
23167428|NCT02425826|64359457|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
23167429|NCT02425826|64359458|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
23167430|NCT02425826|64359459|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
23167431|NCT02425826|64359457|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
23167432|NCT02425826|64359458|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
23167433|NCT02425826|64359459|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
23167434|NCT02425826|64359457|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
23167435|NCT02425826|64359458|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
23167436|NCT02425826|64359459|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
23167437|NCT02425826|64359457|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
23167438|NCT02425826|64359458|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
23167439|NCT02425826|64359459|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
23167440|NCT02425826|64359457|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
23167441|NCT02425826|64359458|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
23167442|NCT02425826|64359459|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
23167443|NCT03699007|64359460|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
23167444|NCT03699007|64359461|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
23167445|NCT03699007|64359460|FG000|6-month Follow Up|Lost to Follow-up|2|||
23167446|NCT03699007|64359461|FG001|6-month Follow Up|Lost to Follow-up|3|||
23333681|NCT00113763|64962091|FG001|Overall Study|Non-compliance|0|||
23333682|NCT00113763|64962090|FG000|Overall Study|Ongoing|1|||
23333683|NCT00113763|64962091|FG001|Overall Study|Ongoing|0|||
23333684|NCT00686829|64962092|FG000|Overall Study|Adverse Event|5|||
23333685|NCT00686829|64962092|FG000|Overall Study|Lack of Efficacy|6|||
23333686|NCT00686829|64962092|FG000|Overall Study|Lost to Follow-up|4|||
23333687|NCT00686829|64962092|FG000|Overall Study|Withdrawal by Subject|14|||
23333688|NCT00686829|64962092|FG000|Overall Study|Protocol Violation|3|||
23333689|NCT00686829|64962092|FG000|Overall Study|Sponsor discontinued VCV|47|||
23333690|NCT02155283|64962093|FG000|Overall Study|Lost to Follow-up|3|||
23333691|NCT02155283|64962093|FG000|Overall Study|Withdrawal by Subject|1|||
23333692|NCT02155283|64962093|FG000|Overall Study|Protocol Violation|3|||
23333693|NCT01623310|64962095|FG000|Overall Study|Adverse Event|21|||
23333694|NCT01623310|64962095|FG000|Overall Study|Lost to Follow-up|18|||
23333695|NCT01623310|64962095|FG000|Overall Study|Lack of Efficacy|6|||
23333696|NCT01623310|64962095|FG000|Overall Study|Protocol Violation|6|||
23333697|NCT01623310|64962095|FG000|Overall Study|Withdrawal by Subject|25|||
23333698|NCT01623310|64962095|FG000|Overall Study|Became potentially child-bearing|1|||
23333699|NCT01623310|64962095|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
23333700|NCT01623310|64962095|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
23333701|NCT04578457|64962096|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
23333702|NCT04578457|64962096|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
23333703|NCT04578457|64962096|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
23333704|NCT04578457|64962096|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
23333705|NCT03423173|64962097|FG000|Overall Study|Randomized but not vaccinated|1|||
23333706|NCT03423173|64962098|FG001|Overall Study|Randomized but not vaccinated|0|||
23333707|NCT03423173|64962099|FG002|Overall Study|Randomized but not vaccinated|2|||
23333708|NCT03423173|64962100|FG003|Overall Study|Randomized but not vaccinated|1|||
23227266|NCT03006926|64575052|FG000|Overall Study|Radiological Disease Progression|0|||
23227267|NCT03006926|64575053|FG001|Overall Study|Radiological Disease Progression|52|||
23333709|NCT03423173|64962097|FG000|Overall Study|Adverse Event|1|||
23333710|NCT03423173|64962098|FG001|Overall Study|Adverse Event|1|||
23333711|NCT03423173|64962099|FG002|Overall Study|Adverse Event|1|||
23333712|NCT03423173|64962100|FG003|Overall Study|Adverse Event|1|||
23333713|NCT03423173|64962097|FG000|Overall Study|Lost to Follow-up|10|||
23333714|NCT03423173|64962098|FG001|Overall Study|Lost to Follow-up|19|||
23447533|NCT00717249|65380503|FG001|Overall Study|Lost to Follow-up|0|||
23333715|NCT03423173|64962099|FG002|Overall Study|Lost to Follow-up|17|||
23333716|NCT03423173|64962100|FG003|Overall Study|Lost to Follow-up|22|||
23333717|NCT03423173|64962097|FG000|Overall Study|Withdrawal of consent|4|||
23333718|NCT03423173|64962098|FG001|Overall Study|Withdrawal of consent|10|||
23447534|NCT00717249|65380502|FG000|Overall Study|Withdrawal by Subject|1|||
23167447|NCT00861744|64359464|FG000|Overall Study|Adverse Event|0|||
23167448|NCT00861744|64359465|FG001|Overall Study|Adverse Event|0|||
23167449|NCT00861744|64359466|FG002|Overall Study|Adverse Event|0|||
23167450|NCT00861744|64359467|FG003|Overall Study|Adverse Event|1|||
23167451|NCT00861744|64359464|FG000|Overall Study|Lost to Follow-up|7|||
23167452|NCT00861744|64359465|FG001|Overall Study|Lost to Follow-up|19|||
23167453|NCT00861744|64359466|FG002|Overall Study|Lost to Follow-up|17|||
23167454|NCT00861744|64359467|FG003|Overall Study|Lost to Follow-up|12|||
23333719|NCT03423173|64962099|FG002|Overall Study|Withdrawal of consent|4|||
23333720|NCT03423173|64962100|FG003|Overall Study|Withdrawal of consent|5|||
23333721|NCT03423173|64962097|FG000|Overall Study|Death|1|||
23333722|NCT03423173|64962098|FG001|Overall Study|Death|0|||
23333723|NCT03423173|64962099|FG002|Overall Study|Death|0|||
23333724|NCT03423173|64962100|FG003|Overall Study|Death|0|||
23333725|NCT03423173|64962097|FG000|Overall Study|Reason not Specified|2|||
23333726|NCT03423173|64962098|FG001|Overall Study|Reason not Specified|5|||
23333727|NCT03423173|64962099|FG002|Overall Study|Reason not Specified|3|||
23333728|NCT03423173|64962100|FG003|Overall Study|Reason not Specified|1|||
23333729|NCT00179660|64965255|FG000|Overall Study|Adverse Event|7|||
23333730|NCT00179660|64965255|FG000|Overall Study|Lack of therapeutic effect|28|||
23333731|NCT00179660|64965255|FG000|Overall Study|Withdrawal by Subject|2|||
23333732|NCT00179660|64965255|FG000|Overall Study|Lost to Follow-up|1|||
23333733|NCT00179660|64965255|FG000|Overall Study|Death|3|||
23333734|NCT00179660|64965255|FG000|Overall Study|Other - Unspecified|9|||
23333735|NCT02780713|64965266|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
23333736|NCT02780713|64965267|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
23333737|NCT02780713|64965268|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
23333738|NCT02780713|64965269|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
23333739|NCT02780713|64965270|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
23333740|NCT03645395|64965271|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
23333741|NCT03645395|64965272|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
23333742|NCT03645395|64965273|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
23333743|NCT03645395|64965274|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
23333744|NCT03645395|64965271|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
23333745|NCT03645395|64965272|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
23333746|NCT03645395|64965273|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
23333747|NCT03645395|64965274|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
23333748|NCT03645395|64965271|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
23333749|NCT03645395|64965272|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
23333750|NCT03645395|64965273|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
23333751|NCT03645395|64965274|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
23333752|NCT03645395|64965271|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
23333753|NCT03645395|64965272|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
23333754|NCT03645395|64965273|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
23575497|NCT00062868|65838730|FG014|Dose Level 3|Withdrew|0|||
23575498|NCT00062868|65838731|FG015|Dose Level 3|Withdrew|0|||
23575499|NCT00062868|65838732|FG016|Dose Level 3|Withdrew|0|||
23575500|NCT00062868|65838733|FG017|Dose Level 3|Withdrew|0|||
23167455|NCT00861744|64359464|FG000|Overall Study|Withdrawal by Subject|10|||
23167456|NCT00861744|64359465|FG001|Overall Study|Withdrawal by Subject|6|||
23167457|NCT00861744|64359466|FG002|Overall Study|Withdrawal by Subject|6|||
23167458|NCT00861744|64359467|FG003|Overall Study|Withdrawal by Subject|19|||
23167459|NCT00861744|64359464|FG000|Overall Study|Protocol Violation|0|||
23167460|NCT00861744|64359465|FG001|Overall Study|Protocol Violation|1|||
23227268|NCT03006926|64575052|FG000|Overall Study|Clinical Disease Progression|0|||
23227269|NCT03006926|64575053|FG001|Overall Study|Clinical Disease Progression|10|||
23227270|NCT03006926|64575052|FG000|Overall Study|Other|0|||
23227271|NCT03006926|64575053|FG001|Overall Study|Other|8|||
23227272|NCT03950440|64575054|FG000|Overall Study|Death|8|||
23227273|NCT03950440|64575055|FG001|Overall Study|Death|2|||
23227274|NCT03950440|64575056|FG002|Overall Study|Death|1|||
23227275|NCT02139280|64575058|FG000|Overall Study|No longer eligible|2|||
23227276|NCT02139280|64575059|FG001|Overall Study|No longer eligible|0|||
23167461|NCT00861744|64359466|FG002|Overall Study|Protocol Violation|0|||
23227277|NCT05091918|64575060|FG000|Overall Study|Adverse Event|1|||
23333755|NCT03645395|64965274|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
23333756|NCT01754129|64965276|FG000|Overall Study|Death|13|||
23333757|NCT01754129|64965276|FG000|Overall Study|Duodopa discontinuation|9|||
23333758|NCT01754129|64965276|FG000|Overall Study|Lost to Follow-up|7|||
23333759|NCT01754129|64965276|FG000|Overall Study|Withdrew consent|1|||
23333760|NCT01754129|64965276|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
23333761|NCT02147158|64965277|FG000|Treatment Course 1|Adverse Event|1|||
23333762|NCT02147158|64965278|FG001|Treatment Course 1|Adverse Event|4|||
23575501|NCT00062868|65838734|FG018|Dose Level 3|Withdrew|0|||
23227278|NCT05091918|64575060|FG000|Overall Study|Withdrawal by Subject|81|||
23575502|NCT00062868|65838735|FG019|Dose Level 3|Withdrew|0|||
23167462|NCT00861744|64359467|FG003|Overall Study|Protocol Violation|0|||
23167463|NCT00861744|64359464|FG000|Overall Study|Migration from study area|0|||
23167464|NCT00861744|64359465|FG001|Overall Study|Migration from study area|3|||
23167465|NCT00861744|64359466|FG002|Overall Study|Migration from study area|1|||
23167466|NCT00861744|64359467|FG003|Overall Study|Migration from study area|0|||
23167467|NCT00861744|64359464|FG000|Overall Study|Blood draws|0|||
23167468|NCT00861744|64359465|FG001|Overall Study|Blood draws|0|||
23167469|NCT00861744|64359466|FG002|Overall Study|Blood draws|0|||
23333763|NCT02147158|64965279|FG002|Treatment Course 1|Adverse Event|3|||
23333764|NCT02147158|64965280|FG003|Treatment Course 1|Adverse Event|4|||
23333765|NCT02147158|64965281|FG004|Treatment Course 1|Adverse Event|1|||
23333766|NCT02147158|64965282|FG005|Treatment Course 1|Adverse Event|2|||
23333767|NCT02147158|64965277|FG000|Treatment Course 1|Lost to Follow-up|2|||
23333768|NCT02147158|64965278|FG001|Treatment Course 1|Lost to Follow-up|4|||
23333769|NCT02147158|64965279|FG002|Treatment Course 1|Lost to Follow-up|3|||
23333770|NCT02147158|64965280|FG003|Treatment Course 1|Lost to Follow-up|3|||
23333771|NCT02147158|64965281|FG004|Treatment Course 1|Lost to Follow-up|2|||
23333772|NCT02147158|64965282|FG005|Treatment Course 1|Lost to Follow-up|4|||
23333773|NCT02147158|64965277|FG000|Treatment Course 1|Protocol Violation|0|||
23333774|NCT02147158|64965278|FG001|Treatment Course 1|Protocol Violation|0|||
23333775|NCT02147158|64965279|FG002|Treatment Course 1|Protocol Violation|1|||
23333776|NCT02147158|64965280|FG003|Treatment Course 1|Protocol Violation|1|||
23333777|NCT02147158|64965281|FG004|Treatment Course 1|Protocol Violation|0|||
23333778|NCT02147158|64965282|FG005|Treatment Course 1|Protocol Violation|0|||
23333779|NCT02147158|64965277|FG000|Treatment Course 1|Withdrawal of Consent|1|||
23333780|NCT02147158|64965278|FG001|Treatment Course 1|Withdrawal of Consent|1|||
23333781|NCT02147158|64965279|FG002|Treatment Course 1|Withdrawal of Consent|1|||
23333782|NCT02147158|64965280|FG003|Treatment Course 1|Withdrawal of Consent|5|||
23333783|NCT02147158|64965281|FG004|Treatment Course 1|Withdrawal of Consent|3|||
23333784|NCT02147158|64965282|FG005|Treatment Course 1|Withdrawal of Consent|2|||
23167470|NCT00861744|64359467|FG003|Overall Study|Blood draws|1|||
23333785|NCT02147158|64965277|FG000|Off-Treatment Interval 1|Adverse Event|1|||
23333786|NCT02147158|64965278|FG001|Off-Treatment Interval 1|Adverse Event|0|||
23333787|NCT02147158|64965279|FG002|Off-Treatment Interval 1|Adverse Event|0|||
23333788|NCT02147158|64965280|FG003|Off-Treatment Interval 1|Adverse Event|1|||
23333789|NCT02147158|64965281|FG004|Off-Treatment Interval 1|Adverse Event|0|||
23333790|NCT02147158|64965282|FG005|Off-Treatment Interval 1|Adverse Event|0|||
23333791|NCT02147158|64965277|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
23333792|NCT02147158|64965278|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
23333793|NCT02147158|64965279|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
23333794|NCT02147158|64965280|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
23333795|NCT02147158|64965281|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
23333796|NCT02147158|64965282|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
23333797|NCT02147158|64965277|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
23333798|NCT02147158|64965278|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
23333799|NCT02147158|64965279|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
23575503|NCT00062868|65838736|FG020|Dose Level 3|Withdrew|0|||
23167471|NCT00075504|64359470|FG000|Overall Study|Withdrawal by Subject|9|||
23167472|NCT00075504|64359471|FG001|Overall Study|Withdrawal by Subject|7|||
23167473|NCT02268058|64359472|FG000|Overall Study|Protocol Violation|1|||
23167474|NCT02268058|64359473|FG001|Overall Study|Protocol Violation|0|||
23167475|NCT02268058|64359474|FG002|Overall Study|Protocol Violation|0|||
23167476|NCT02268058|64359475|FG003|Overall Study|Protocol Violation|0|||
23167477|NCT00075023|64359477|FG000|Pilot Study|Physician Decision|1|||
23167478|NCT00075023|64359478|FG001|Pilot Study|Physician Decision|2|||
23167479|NCT00075023|64359477|FG000|Pilot Study|Withdrawal by Subject|1|||
23167480|NCT00075023|64359478|FG001|Pilot Study|Withdrawal by Subject|0|||
23167481|NCT00183274|64359480|FG000|Phase 1: Open-Label|Adverse Event|31|||
23167482|NCT00183274|64359481|FG001|Phase 1: Open-Label|Adverse Event|0|||
23167483|NCT00183274|64359482|FG002|Phase 1: Open-Label|Adverse Event|0|||
23167484|NCT00183274|64359483|FG003|Phase 1: Open-Label|Adverse Event|0|||
23167485|NCT00183274|64359484|FG004|Phase 1: Open-Label|Adverse Event|0|||
23167486|NCT00183274|64359485|FG005|Phase 1: Open-Label|Adverse Event|0|||
23167487|NCT00183274|64359480|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
23167488|NCT00183274|64359481|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
23167489|NCT00183274|64359482|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
23333800|NCT02147158|64965280|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
23333801|NCT02147158|64965281|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
23333802|NCT02147158|64965282|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
23333803|NCT02147158|64965277|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
23333804|NCT02147158|64965278|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
23167490|NCT00183274|64359483|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
23333805|NCT02147158|64965279|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
23167491|NCT00183274|64359484|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
23167492|NCT00183274|64359485|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
23167493|NCT00183274|64359480|FG000|Phase 1: Open-Label|Protocol Violation|11|||
23167494|NCT00183274|64359481|FG001|Phase 1: Open-Label|Protocol Violation|0|||
23167495|NCT00183274|64359482|FG002|Phase 1: Open-Label|Protocol Violation|0|||
23167496|NCT00183274|64359483|FG003|Phase 1: Open-Label|Protocol Violation|0|||
23167497|NCT00183274|64359484|FG004|Phase 1: Open-Label|Protocol Violation|0|||
23167498|NCT00183274|64359485|FG005|Phase 1: Open-Label|Protocol Violation|0|||
23167499|NCT00183274|64359480|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
23167500|NCT00183274|64359481|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
23167501|NCT00183274|64359482|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
23167502|NCT00183274|64359483|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
23167503|NCT00183274|64359484|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
23167504|NCT00183274|64359485|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
23167505|NCT00183274|64359480|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
23167506|NCT00183274|64359481|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
23447535|NCT00717249|65380503|FG001|Overall Study|Withdrawal by Subject|2|||
23447536|NCT00717249|65380502|FG000|Overall Study|Pregnancy|6|||
23447537|NCT00717249|65380503|FG001|Overall Study|Pregnancy|3|||
23447538|NCT00717249|65380502|FG000|Overall Study|Protocol Violation|0|||
23447539|NCT00717249|65380503|FG001|Overall Study|Protocol Violation|2|||
23447540|NCT00717249|65380502|FG000|Overall Study|Subject became Ineligible|1|||
23447541|NCT00717249|65380503|FG001|Overall Study|Subject became Ineligible|1|||
23447542|NCT00717249|65380502|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
23447543|NCT00717249|65380503|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
23447544|NCT00717249|65380502|FG000|Overall Study|Gastric Surgery|0|||
23447545|NCT00717249|65380503|FG001|Overall Study|Gastric Surgery|1|||
23447546|NCT00717249|65380502|FG000|Overall Study|Diagnosed with Diabetes|1|||
23447547|NCT00717249|65380503|FG001|Overall Study|Diagnosed with Diabetes|0|||
23447548|NCT00717249|65380502|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
23447549|NCT00717249|65380503|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
23447550|NCT00717249|65380502|FG000|Overall Study|Subject relocated|1|||
23447551|NCT00717249|65380503|FG001|Overall Study|Subject relocated|0|||
23447552|NCT00717249|65380502|FG000|Overall Study|Headaches|1|||
23447553|NCT00717249|65380503|FG001|Overall Study|Headaches|0|||
23447554|NCT02420093|65380512|FG000|Overall Study|Withdrawal by Subject|1|||
23447555|NCT02420093|65380513|FG001|Overall Study|Withdrawal by Subject|1|||
23447556|NCT02905266|65380514|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
23447557|NCT02905266|65380515|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
23447558|NCT02905266|65380514|FG000|Treatment Phase Part 1|Disease Progression|6|||
23447559|NCT02905266|65380515|FG001|Treatment Phase Part 1|Disease Progression|7|||
23447560|NCT02905266|65380514|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
23447561|NCT02905266|65380515|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
23447562|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
23447563|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
23447564|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
23447565|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
23447566|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
23447567|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
23447568|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Death|0|||
23447569|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Death|1|||
23447570|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
23447571|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
23447572|NCT02905266|65380514|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
23447573|NCT02905266|65380515|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
23167507|NCT00183274|64359482|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
23167508|NCT00183274|64359483|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
23167509|NCT00183274|64359484|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
23167510|NCT00183274|64359485|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
23167511|NCT00183274|64359480|FG000|Phase 1: Open-Label|Other|9|||
23167512|NCT00183274|64359481|FG001|Phase 1: Open-Label|Other|0|||
23167513|NCT00183274|64359482|FG002|Phase 1: Open-Label|Other|0|||
23167514|NCT00183274|64359483|FG003|Phase 1: Open-Label|Other|0|||
23167515|NCT00183274|64359484|FG004|Phase 1: Open-Label|Other|0|||
23167516|NCT00183274|64359485|FG005|Phase 1: Open-Label|Other|0|||
23447574|NCT02905266|65380514|FG000|Maintenance Phase Part 2|Disease Progression|9|||
23447575|NCT02905266|65380515|FG001|Maintenance Phase Part 2|Disease Progression|2|||
23447576|NCT02905266|65380514|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
23575504|NCT03697460|65838737|FG000|Overall Study|Withdrawal by Subject|3|||
23447577|NCT02905266|65380515|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
23167517|NCT00183274|64359480|FG000|Phase 2: Double-Blind|Relapsed|0|||
23167518|NCT00183274|64359481|FG001|Phase 2: Double-Blind|Relapsed|8|||
23167519|NCT00183274|64359482|FG002|Phase 2: Double-Blind|Relapsed|29|||
23167520|NCT00183274|64359483|FG003|Phase 2: Double-Blind|Relapsed|0|||
23167521|NCT00183274|64359484|FG004|Phase 2: Double-Blind|Relapsed|0|||
23167522|NCT00183274|64359485|FG005|Phase 2: Double-Blind|Relapsed|0|||
23447578|NCT02905266|65380514|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
23575505|NCT00372528|65838738|FG000|Overall Study|Lack of Efficacy|1|||
23447579|NCT02905266|65380515|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
23447580|NCT00890825|65380517|FG000|Overall Study|Withdrawal by Subject|1|||
23447581|NCT00890825|65380518|FG001|Overall Study|Withdrawal by Subject|0|||
23447582|NCT00890825|65380517|FG000|Overall Study|Alive at data cut off (DCO)|13|||
23447583|NCT00890825|65380518|FG001|Overall Study|Alive at data cut off (DCO)|14|||
23447584|NCT03187132|65380519|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
23447585|NCT03187132|65380520|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
23447586|NCT03187132|65380519|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
23447587|NCT03187132|65380520|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
23447588|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
23447589|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
23447590|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
23447591|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
23447592|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
23447593|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
23447594|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
23447595|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
23447596|NCT03187132|65380519|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
23447597|NCT03187132|65380520|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
23447598|NCT03187132|65380519|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
23447599|NCT03187132|65380520|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
23447600|NCT03187132|65380519|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
23447601|NCT03187132|65380520|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
23447602|NCT03187132|65380519|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
23167523|NCT00183274|64359480|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
23167524|NCT00183274|64359481|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
23167525|NCT00183274|64359482|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
23167526|NCT00183274|64359483|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
23167527|NCT00183274|64359484|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
23167528|NCT00183274|64359485|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
23167529|NCT00183274|64359480|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
23167530|NCT00183274|64359481|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
23167531|NCT00183274|64359482|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
23167532|NCT00183274|64359483|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
23167533|NCT00183274|64359484|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
23167534|NCT00183274|64359485|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
23167535|NCT00183274|64359480|FG000|Phase 3: Double-Blind|Relapsed|0|||
23167536|NCT00183274|64359481|FG001|Phase 3: Double-Blind|Relapsed|0|||
23167537|NCT00183274|64359482|FG002|Phase 3: Double-Blind|Relapsed|0|||
23167538|NCT00183274|64359483|FG003|Phase 3: Double-Blind|Relapsed|1|||
23333806|NCT02147158|64965280|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
23333807|NCT02147158|64965281|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
23333808|NCT02147158|64965282|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
23333809|NCT02147158|64965277|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
23333810|NCT02147158|64965278|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
23333811|NCT02147158|64965279|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
23333812|NCT02147158|64965280|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
23333813|NCT02147158|64965281|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
23333814|NCT02147158|64965282|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
23333815|NCT02147158|64965277|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
23333816|NCT02147158|64965278|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
23333817|NCT02147158|64965279|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
23333818|NCT02147158|64965280|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
23333819|NCT02147158|64965281|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
23333820|NCT02147158|64965282|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
23333821|NCT02147158|64965277|FG000|Treatment Course 2|Adverse Event|0|||
23333822|NCT02147158|64965278|FG001|Treatment Course 2|Adverse Event|4|||
23333823|NCT02147158|64965279|FG002|Treatment Course 2|Adverse Event|2|||
23333824|NCT02147158|64965280|FG003|Treatment Course 2|Adverse Event|1|||
23333825|NCT02147158|64965281|FG004|Treatment Course 2|Adverse Event|0|||
23333826|NCT02147158|64965282|FG005|Treatment Course 2|Adverse Event|1|||
23333827|NCT02147158|64965277|FG000|Treatment Course 2|Withdrawal of Consent|0|||
23447603|NCT03187132|65380520|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
23447604|NCT03187132|65380519|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
23575506|NCT00372528|65838738|FG000|Overall Study|Adverse Event|1|||
23575507|NCT00372528|65838738|FG000|Overall Study|Study Terminated by Sponsor|18|||
23227279|NCT00796549|64575061|FG000|Overall Study|Adverse Event|11|||
23333828|NCT02147158|64965278|FG001|Treatment Course 2|Withdrawal of Consent|1|||
23333829|NCT02147158|64965279|FG002|Treatment Course 2|Withdrawal of Consent|2|||
23333830|NCT02147158|64965280|FG003|Treatment Course 2|Withdrawal of Consent|3|||
23447605|NCT03187132|65380520|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
23447606|NCT02221674|65380523|FG000|Overall Study|Lost to Follow-up|1|||
23447607|NCT02221674|65380524|FG001|Overall Study|Lost to Follow-up|0|||
23447608|NCT02221674|65380525|FG002|Overall Study|Lost to Follow-up|0|||
23447609|NCT02730728|65380526|FG000|Overall Study|Withdrawal by Subject|0|||
23447610|NCT02730728|65380527|FG001|Overall Study|Withdrawal by Subject|1|||
23447611|NCT02730728|65380528|FG002|Overall Study|Withdrawal by Subject|0|||
23447612|NCT02730728|65380526|FG000|Overall Study|Lack of Efficacy|0|||
23447613|NCT02730728|65380527|FG001|Overall Study|Lack of Efficacy|1|||
23447614|NCT02730728|65380528|FG002|Overall Study|Lack of Efficacy|1|||
23447615|NCT00570310|65380539|FG000|Overall Study|Adverse Event|1|||
23447616|NCT00570310|65380540|FG001|Overall Study|Adverse Event|2|||
23447617|NCT00570310|65380539|FG000|Overall Study|Lack of Efficacy|1|||
23447618|NCT00570310|65380540|FG001|Overall Study|Lack of Efficacy|4|||
23447619|NCT00687804|65380547|FG000|Core Study|Adverse Event|5|||
23447620|NCT00687804|65380548|FG001|Core Study|Adverse Event|3|||
23447621|NCT00687804|65380549|FG002|Core Study|Adverse Event|3|||
23447622|NCT00687804|65380547|FG000|Core Study|Abnormal laboratory value(s)|1|||
23447623|NCT00687804|65380548|FG001|Core Study|Abnormal laboratory value(s)|0|||
23575508|NCT00372528|65838738|FG000|Overall Study|Other|1|||
23447624|NCT00687804|65380549|FG002|Core Study|Abnormal laboratory value(s)|0|||
23447625|NCT00687804|65380547|FG000|Core Study|Lack of Efficacy|1|||
23447626|NCT00687804|65380548|FG001|Core Study|Lack of Efficacy|1|||
23447627|NCT00687804|65380549|FG002|Core Study|Lack of Efficacy|1|||
23447628|NCT00687804|65380547|FG000|Core Study|Withdrawal by Subject|4|||
23447629|NCT00687804|65380548|FG001|Core Study|Withdrawal by Subject|7|||
23447630|NCT00687804|65380549|FG002|Core Study|Withdrawal by Subject|7|||
23447631|NCT00687804|65380547|FG000|Core Study|Lost to Follow-up|0|||
23447632|NCT00687804|65380548|FG001|Core Study|Lost to Follow-up|1|||
23447633|NCT00687804|65380549|FG002|Core Study|Lost to Follow-up|0|||
23447634|NCT00687804|65380547|FG000|Core Study|Death|2|||
23575509|NCT00097370|65838739|FG000|Stage 1|Adverse Event|3|||
23575510|NCT00097370|65838739|FG000|Stage 1|Withdrawal by Subject|1|||
23575511|NCT00097370|65838739|FG000|Stage 1|Lack of Efficacy|2|||
23227280|NCT00796549|64575061|FG000|Overall Study|not entered|149|||
23227281|NCT00796549|64575061|FG000|Overall Study|Other|2|||
23227282|NCT00796549|64575061|FG000|Overall Study|Progressive disease|56|||
23227283|NCT00364611|64575068|FG000|Overall Study|Did not receive study medication|0|||
23227284|NCT00364611|64575069|FG001|Overall Study|Did not receive study medication|1|||
23227285|NCT00364611|64575068|FG000|Overall Study|Adverse Event|7|||
23227286|NCT00364611|64575069|FG001|Overall Study|Adverse Event|4|||
23227287|NCT00364611|64575068|FG000|Overall Study|Participant's Request|3|||
23227288|NCT00364611|64575069|FG001|Overall Study|Participant's Request|4|||
23227289|NCT00364611|64575068|FG000|Overall Study|Disease Progression|38|||
23227290|NCT00364611|64575069|FG001|Overall Study|Disease Progression|8|||
23227291|NCT00364611|64575068|FG000|Overall Study|Investigator decision|2|||
23227292|NCT00364611|64575069|FG001|Overall Study|Investigator decision|2|||
23227293|NCT00364611|64575068|FG000|Overall Study|Found Ineligible|1|||
23227294|NCT00364611|64575069|FG001|Overall Study|Found Ineligible|0|||
23227295|NCT00364611|64575068|FG000|Overall Study|Presumed CR on Study|0|||
23227296|NCT00364611|64575069|FG001|Overall Study|Presumed CR on Study|1|||
23227297|NCT00364611|64575068|FG000|Overall Study|Receiving Liver Ablation|0|||
23227298|NCT00364611|64575069|FG001|Overall Study|Receiving Liver Ablation|1|||
23227299|NCT01947127|64575070|FG000|Overall Study|Protocol Violation|18|||
23227300|NCT01947127|64575071|FG001|Overall Study|Protocol Violation|38|||
23227301|NCT01947127|64575070|FG000|Overall Study|Withdrawal by Subject|1|||
23227302|NCT01947127|64575071|FG001|Overall Study|Withdrawal by Subject|1|||
23227303|NCT01947127|64575070|FG000|Overall Study|Data loss|4|||
23227304|NCT01947127|64575071|FG001|Overall Study|Data loss|4|||
23227305|NCT00233324|64575072|FG000|Main Study|Death|68|||
23227306|NCT00233324|64575073|FG001|Main Study|Death|60|||
23227307|NCT00233324|64575074|FG002|Main Study|Death|62|||
23227308|NCT00233324|64575075|FG003|Main Study|Death|47|||
23227309|NCT00233324|64575072|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
23227310|NCT00233324|64575073|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
23227311|NCT00233324|64575074|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
23447635|NCT00687804|65380548|FG001|Core Study|Death|2|||
23447636|NCT00687804|65380549|FG002|Core Study|Death|2|||
23575512|NCT00097370|65838739|FG000|Stage 2|Adverse Event|5|||
23227312|NCT00233324|64575075|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
23227313|NCT00233324|64575072|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
23227314|NCT00233324|64575073|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
23227315|NCT00233324|64575074|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
23227316|NCT00233324|64575075|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
23227317|NCT03935594|64575076|FG000|Overall Study|Physician Decision|3|||
23227318|NCT03662789|64575079|FG000|Overall Study|Lost to Follow-up|1|||
23227319|NCT03662789|64575080|FG001|Overall Study|Lost to Follow-up|2|||
23227320|NCT03662789|64575079|FG000|Overall Study|Could not perform treadmill test|4|||
23447637|NCT00687804|65380547|FG000|Core Study|Protocol Violation|1|||
23447638|NCT00687804|65380548|FG001|Core Study|Protocol Violation|1|||
23575513|NCT00097370|65838739|FG000|Stage 2|Withdrawal by Subject|1|||
23167539|NCT00183274|64359484|FG004|Phase 3: Double-Blind|Relapsed|11|||
23167540|NCT00183274|64359485|FG005|Phase 3: Double-Blind|Relapsed|2|||
23167541|NCT04016311|64359486|FG000|Overall Study|Withdrawal by Subject|1|||
23167542|NCT04016311|64359487|FG001|Overall Study|Withdrawal by Subject|0|||
23167543|NCT00847912|64359488|FG000|Overall Study|Protocol Violation|6|||
23167544|NCT00847912|64359489|FG001|Overall Study|Protocol Violation|7|||
23167545|NCT00847912|64359488|FG000|Overall Study|Withdrawal by Subject|3|||
23167546|NCT00847912|64359489|FG001|Overall Study|Withdrawal by Subject|6|||
23167547|NCT03002155|64359492|FG000|Overall Study|Lost to Follow-up|1|||
23167548|NCT03002155|64359493|FG001|Overall Study|Lost to Follow-up|2|||
23167549|NCT03002155|64359492|FG000|Overall Study|Withdrawal by Subject|1|||
23167550|NCT03002155|64359493|FG001|Overall Study|Withdrawal by Subject|0|||
23167551|NCT03002155|64359492|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
23167552|NCT03002155|64359493|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
23167553|NCT01414257|64359494|FG000|Overall Study|No Visit After First Day of Treatment|12|||
23167554|NCT01414257|64359494|FG000|Overall Study|Protocol Violation|10|||
23167555|NCT02135692|64359495|FG000|Overall Study|Adverse Event|3|||
23167556|NCT02135692|64359495|FG000|Overall Study|Lack of Efficacy|2|||
23167557|NCT02135692|64359495|FG000|Overall Study|Protocol Violation|2|||
23167558|NCT02135692|64359495|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
23167559|NCT02135692|64359495|FG000|Overall Study|Product commercially available|159|||
23167560|NCT02135692|64359495|FG000|Overall Study|Study closed/terminated|153|||
23167561|NCT02135692|64359495|FG000|Overall Study|Lost to Follow-up|4|||
23167562|NCT02135692|64359495|FG000|Overall Study|Withdrawal by Subject|15|||
23167563|NCT03655756|64359498|FG000|Overall Study|Death|1|||
23167564|NCT02482129|64359499|FG000|Overall Study|Adverse Event-prior to treatment|0|||
23167565|NCT02482129|64359500|FG001|Overall Study|Adverse Event-prior to treatment|1|||
23167566|NCT02482129|64359499|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
23167567|NCT02482129|64359500|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
23167568|NCT02482129|64359499|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
23167569|NCT02482129|64359500|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
23167570|NCT02482129|64359499|FG000|Overall Study|Criteria not met-prior to treatment|1|||
23167571|NCT02482129|64359500|FG001|Overall Study|Criteria not met-prior to treatment|0|||
23167572|NCT02482129|64359499|FG000|Overall Study|Adverse Event|1|||
23167573|NCT02482129|64359500|FG001|Overall Study|Adverse Event|0|||
23167574|NCT02482129|64359499|FG000|Overall Study|Withdrawal by Subject|2|||
23167575|NCT02482129|64359500|FG001|Overall Study|Withdrawal by Subject|0|||
23167576|NCT02482129|64359499|FG000|Overall Study|Criteria not met|1|||
23167577|NCT02482129|64359500|FG001|Overall Study|Criteria not met|0|||
23167578|NCT03115151|64359502|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
23167579|NCT03115151|64359503|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
23167580|NCT03115151|64359502|FG000|Overall Study|Epidural catheter removal|1|||
23167581|NCT03115151|64359503|FG001|Overall Study|Epidural catheter removal|0|||
23167582|NCT03115151|64359502|FG000|Overall Study|Withdrawal by Subject|0|||
23167583|NCT03115151|64359503|FG001|Overall Study|Withdrawal by Subject|1|||
23167584|NCT03115151|64359502|FG000|Overall Study|Intervention not received according to the protocol.|1|||
23167585|NCT03115151|64359503|FG001|Overall Study|Intervention not received according to the protocol.|1|||
23167586|NCT03115151|64359502|FG000|Overall Study|Physician Decision|1|||
23167587|NCT03115151|64359503|FG001|Overall Study|Physician Decision|0|||
23167588|NCT03115151|64359502|FG000|Overall Study|Randomization not applied|1|||
23167589|NCT03115151|64359503|FG001|Overall Study|Randomization not applied|1|||
23167590|NCT03451773|64359507|FG000|Overall Study|Death on study|1|||
23167591|NCT03451773|64359508|FG001|Overall Study|Death on study|5|||
23167592|NCT03451773|64359507|FG000|Overall Study|Death during follow-up period|0|||
23167593|NCT03451773|64359508|FG001|Overall Study|Death during follow-up period|1|||
23167594|NCT02111993|64359511|FG000|Overall Study|Physician Decision|5|||
23167595|NCT02111993|64359512|FG001|Overall Study|Physician Decision|4|||
23167596|NCT00264875|64359523|FG000|Overall Study|Adverse Event|6|||
23227321|NCT03662789|64575080|FG001|Overall Study|Could not perform treadmill test|4|||
23227322|NCT03662789|64575079|FG000|Overall Study|Death|0|||
23227323|NCT03662789|64575080|FG001|Overall Study|Death|1|||
23227324|NCT01925014|64575081|FG000|Overall Study|Inappropriate enrollment|4|||
23227325|NCT01925014|64575082|FG001|Overall Study|Inappropriate enrollment|6|||
23227326|NCT01925014|64575081|FG000|Overall Study|Withdrawal by Subject|5|||
23227327|NCT01925014|64575082|FG001|Overall Study|Withdrawal by Subject|13|||
23227328|NCT02875366|64575083|FG000|Overall Study|Adverse Event|0|||
23227329|NCT02875366|64575084|FG001|Overall Study|Adverse Event|2|||
23227330|NCT02875366|64575083|FG000|Overall Study|Noncompliance|0|||
23167597|NCT00264875|64359523|FG000|Overall Study|Lost to Follow-up|6|||
23167598|NCT00264875|64359523|FG000|Overall Study|Protocol Violation|11|||
23167599|NCT00264875|64359523|FG000|Overall Study|Withdrawal by Subject|7|||
23167600|NCT02751502|64363016|FG000|Overall Study|Lack of funding|4|||
23227331|NCT02875366|64575084|FG001|Overall Study|Noncompliance|1|||
23227332|NCT00952588|64575085|FG000|Overall Study|Death|28|||
23227333|NCT00952588|64575086|FG001|Overall Study|Death|13|||
23167601|NCT02595450|64363017|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
23167602|NCT02595450|64363017|FG000|Overall Study|Enrolled, but not treated|8|||
23167603|NCT02415712|64363018|FG000|Overall Study|Protocol Violation|16|||
23167604|NCT01632566|64363022|FG000|Overall Study|Withdrawal by Subject|0|||
23167605|NCT01632566|64363023|FG001|Overall Study|Withdrawal by Subject|1|||
23167606|NCT01632566|64363024|FG002|Overall Study|Withdrawal by Subject|0|||
23167607|NCT01632566|64363025|FG003|Overall Study|Withdrawal by Subject|0|||
23167608|NCT01632566|64363026|FG004|Overall Study|Withdrawal by Subject|0|||
23167609|NCT01632566|64363022|FG000|Overall Study|Sponsor Decision|0|||
23167610|NCT01632566|64363023|FG001|Overall Study|Sponsor Decision|2|||
23167611|NCT01632566|64363024|FG002|Overall Study|Sponsor Decision|9|||
23167612|NCT01632566|64363025|FG003|Overall Study|Sponsor Decision|2|||
23167613|NCT01632566|64363026|FG004|Overall Study|Sponsor Decision|2|||
23167614|NCT01928381|64363027|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
23167615|NCT01928381|64363028|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23167616|NCT01928381|64363029|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23167617|NCT01928381|64363030|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23167618|NCT01928381|64363031|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23167619|NCT01928381|64363032|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23167620|NCT01928381|64363033|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
23167621|NCT01928381|64363027|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
23167622|NCT01928381|64363028|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
23167623|NCT01928381|64363029|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
23167624|NCT01928381|64363030|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
23167625|NCT01928381|64363031|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
23167626|NCT01928381|64363032|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
23167627|NCT01928381|64363033|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
23167628|NCT01928381|64363027|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
23167629|NCT01928381|64363028|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
23167630|NCT01928381|64363029|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
23167631|NCT01928381|64363030|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
23167632|NCT01928381|64363031|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
23167633|NCT01928381|64363032|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
23167634|NCT01928381|64363033|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
23167635|NCT01928381|64363027|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
23167636|NCT01928381|64363028|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
23167637|NCT01928381|64363029|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
23167638|NCT01928381|64363030|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
23167639|NCT01928381|64363031|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
23167640|NCT01928381|64363032|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
23167641|NCT01928381|64363033|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
23167642|NCT01928381|64363027|FG000|Part 1 - Pain Training|Protocol Violation|1|||
23167643|NCT01928381|64363028|FG001|Part 1 - Pain Training|Protocol Violation|0|||
23167644|NCT01928381|64363029|FG002|Part 1 - Pain Training|Protocol Violation|0|||
23167645|NCT01928381|64363030|FG003|Part 1 - Pain Training|Protocol Violation|0|||
23167646|NCT01928381|64363031|FG004|Part 1 - Pain Training|Protocol Violation|0|||
23167647|NCT01928381|64363032|FG005|Part 1 - Pain Training|Protocol Violation|0|||
23167648|NCT01928381|64363033|FG006|Part 1 - Pain Training|Protocol Violation|0|||
23167649|NCT01928381|64363027|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
23167650|NCT01928381|64363028|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23167651|NCT01928381|64363029|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23167652|NCT01928381|64363030|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23167653|NCT01928381|64363031|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23167654|NCT01928381|64363032|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23167655|NCT01928381|64363033|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
23167656|NCT01928381|64363027|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
23167657|NCT01928381|64363028|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23167658|NCT01928381|64363029|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23167659|NCT01928381|64363030|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23447639|NCT00687804|65380549|FG002|Core Study|Protocol Violation|0|||
23167660|NCT01928381|64363031|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23167661|NCT01928381|64363032|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23167662|NCT01928381|64363033|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
23167663|NCT01928381|64363027|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
23167664|NCT01928381|64363028|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23167665|NCT01928381|64363029|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23167666|NCT01928381|64363030|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23167667|NCT01928381|64363031|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23167668|NCT01928381|64363032|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23167669|NCT01928381|64363033|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
23333831|NCT02147158|64965281|FG004|Treatment Course 2|Withdrawal of Consent|0|||
23333832|NCT02147158|64965282|FG005|Treatment Course 2|Withdrawal of Consent|0|||
23333833|NCT02147158|64965277|FG000|Treatment Course 2|Lost to Follow-up|1|||
23333834|NCT02147158|64965278|FG001|Treatment Course 2|Lost to Follow-up|0|||
23333835|NCT02147158|64965279|FG002|Treatment Course 2|Lost to Follow-up|1|||
23333836|NCT02147158|64965280|FG003|Treatment Course 2|Lost to Follow-up|1|||
23333837|NCT02147158|64965281|FG004|Treatment Course 2|Lost to Follow-up|0|||
23333838|NCT02147158|64965282|FG005|Treatment Course 2|Lost to Follow-up|1|||
23333839|NCT02147158|64965277|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
23333840|NCT02147158|64965278|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
23333841|NCT02147158|64965279|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
23333842|NCT02147158|64965280|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
23333843|NCT02147158|64965281|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
23333844|NCT02147158|64965282|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
23333845|NCT02147158|64965277|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
23333846|NCT02147158|64965278|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
23333847|NCT02147158|64965279|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
23333848|NCT02147158|64965280|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
23333849|NCT02147158|64965281|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
23333850|NCT02147158|64965282|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
23333851|NCT02147158|64965277|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
23333852|NCT02147158|64965278|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
23333853|NCT02147158|64965279|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
23333854|NCT02147158|64965280|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
23333855|NCT02147158|64965281|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
23333856|NCT02147158|64965282|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
23333857|NCT02147158|64965277|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
23333858|NCT02147158|64965278|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
23333859|NCT02147158|64965279|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
23333860|NCT02147158|64965280|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
23333861|NCT02147158|64965281|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
23333862|NCT02147158|64965282|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
23333863|NCT02147158|64965277|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
23333864|NCT02147158|64965278|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
23333865|NCT02147158|64965279|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
23333866|NCT02147158|64965280|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
23333867|NCT02147158|64965281|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
23333868|NCT02147158|64965282|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
23333869|NCT03515811|64965283|FG000|Overall Study|Lost to Follow-up|2|||
23333870|NCT03515811|64965284|FG001|Overall Study|Lost to Follow-up|1|||
23333871|NCT03515811|64965283|FG000|Overall Study|Protocol Violation|1|||
23167670|NCT01928381|64363027|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
23167671|NCT01928381|64363028|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23167672|NCT01928381|64363029|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23167673|NCT01928381|64363030|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23167674|NCT01928381|64363031|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23167675|NCT01928381|64363032|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23167676|NCT01928381|64363033|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
23167677|NCT01928381|64363027|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
23167678|NCT01928381|64363028|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
23167679|NCT01928381|64363029|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
23167680|NCT01928381|64363030|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
23167681|NCT01928381|64363031|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
23167682|NCT01928381|64363032|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
23167683|NCT01928381|64363033|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
23167684|NCT01928381|64363027|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23167685|NCT01928381|64363028|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23167686|NCT01928381|64363029|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
23167687|NCT01928381|64363030|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23167688|NCT01928381|64363031|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23167689|NCT01928381|64363032|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23167690|NCT01928381|64363033|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
23167691|NCT01928381|64363027|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
23167692|NCT01928381|64363028|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
23333872|NCT03515811|64965284|FG001|Overall Study|Protocol Violation|1|||
23333873|NCT03515811|64965283|FG000|Overall Study|Death|1|||
23333874|NCT03515811|64965284|FG001|Overall Study|Death|1|||
23333875|NCT03515811|64965283|FG000|Overall Study|Withdrawal by Subject|0|||
23333876|NCT03515811|64965284|FG001|Overall Study|Withdrawal by Subject|2|||
23333877|NCT03515811|64965283|FG000|Overall Study|Technical Problems|1|||
23333878|NCT03515811|64965284|FG001|Overall Study|Technical Problems|0|||
23333879|NCT03515811|64965283|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
23333880|NCT03515811|64965284|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
23333881|NCT03515811|64965283|FG000|Overall Study|COVID-19|0|||
23333882|NCT03515811|64965284|FG001|Overall Study|COVID-19|1|||
23167693|NCT01928381|64363029|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
23167694|NCT01928381|64363030|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
23167695|NCT01928381|64363031|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
23167696|NCT01928381|64363032|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
23167697|NCT01928381|64363033|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
23167698|NCT01928381|64363027|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
23167699|NCT01928381|64363028|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
23167700|NCT01928381|64363029|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
23167701|NCT01928381|64363030|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
23167702|NCT01928381|64363031|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
23167703|NCT01928381|64363032|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
23167704|NCT01928381|64363033|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
23167705|NCT01928381|64363027|FG000|Washout First Intervention|Protocol Violation|0|||
23167706|NCT01928381|64363028|FG001|Washout First Intervention|Protocol Violation|0|||
23167707|NCT01928381|64363029|FG002|Washout First Intervention|Protocol Violation|0|||
23167708|NCT01928381|64363030|FG003|Washout First Intervention|Protocol Violation|0|||
23167709|NCT01928381|64363031|FG004|Washout First Intervention|Protocol Violation|1|||
23167710|NCT01928381|64363032|FG005|Washout First Intervention|Protocol Violation|0|||
23167711|NCT01928381|64363033|FG006|Washout First Intervention|Protocol Violation|0|||
23575514|NCT00097370|65838739|FG000|Stage 2|Lack of Efficacy|3|||
23575515|NCT00097370|65838739|FG000|Stage 2|Pregnancy|1|||
23575516|NCT00097370|65838739|FG000|Stage 2|Sponsor Terminated Study|2|||
23575517|NCT00097370|65838739|FG000|Stage 2|Lost to Follow-up|1|||
23575518|NCT00097370|65838739|FG000|Stage 3|Adverse Event|2|||
23575519|NCT00097370|65838739|FG000|Stage 3|Withdrawal by Subject|3|||
23575520|NCT00097370|65838739|FG000|Stage 3|Lack of Efficacy|1|||
23575521|NCT00097370|65838739|FG000|Stage 3|Sponsor Terminated Study|52|||
23575522|NCT00097370|65838739|FG000|Stage 3|Lost to Follow-up|1|||
23575523|NCT05114590|65838745|FG000|Overall Study|Adverse Event|1|||
23575524|NCT05114590|65838745|FG000|Overall Study|Investigator decision|1|||
23575525|NCT05114590|65838745|FG000|Overall Study|Lost to Follow-up|5|||
23575526|NCT05114590|65838745|FG000|Overall Study|Withdrawal by Subject|5|||
23575527|NCT05114590|65838745|FG000|Overall Study|Other|2|||
23575528|NCT02781506|65838746|FG000|Overall Study|Adverse Event|5|||
23575529|NCT03523871|65838748|FG000|Overall Study|Death|1|||
23575530|NCT01744496|65838749|FG000|Titration Period|Adverse Event|2|||
23575531|NCT01744496|65838750|FG001|Titration Period|Adverse Event|1|||
23575532|NCT01744496|65838749|FG000|Titration Period|Personal reasons|0|||
23575533|NCT01744496|65838750|FG001|Titration Period|Personal reasons|1|||
23575534|NCT01744496|65838749|FG000|Maintenance Period|Adverse Event|1|||
23575535|NCT01744496|65838750|FG001|Maintenance Period|Adverse Event|3|||
23333883|NCT00729612|64965285|FG000|Overall Study|Non evaluable for response|10|||
23333884|NCT01091662|64965286|FG000|Overall Study|Adverse Event|1|||
23167712|NCT01928381|64363027|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
23167713|NCT01928381|64363028|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
23167714|NCT01928381|64363029|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
23167715|NCT01928381|64363030|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
23167716|NCT01928381|64363031|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
23167717|NCT01928381|64363032|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
23167718|NCT01928381|64363033|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
23167719|NCT01928381|64363027|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
23167720|NCT01928381|64363028|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
23167721|NCT01928381|64363029|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
23167722|NCT01928381|64363030|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
23167723|NCT01928381|64363031|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
23333885|NCT01091662|64965287|FG001|Overall Study|Adverse Event|9|||
23333886|NCT01091662|64965286|FG000|Overall Study|Physician Decision|1|||
23333887|NCT01091662|64965287|FG001|Overall Study|Physician Decision|1|||
23575536|NCT01744496|65838749|FG000|Maintenance Period|Protocol Violation|1|||
23575537|NCT01744496|65838750|FG001|Maintenance Period|Protocol Violation|0|||
23167724|NCT01928381|64363032|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
23167725|NCT01928381|64363033|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
23333888|NCT01091662|64965286|FG000|Overall Study|Withdrawal by Subject|7|||
23447640|NCT00687804|65380547|FG000|Open-Label Extension Study|Adverse Event|2|||
23447641|NCT00687804|65380548|FG001|Open-Label Extension Study|Adverse Event|2|||
23575538|NCT01744496|65838749|FG000|Maintenance Period|Withdrawal by Subject|1|||
23575539|NCT01744496|65838750|FG001|Maintenance Period|Withdrawal by Subject|1|||
23575540|NCT01744496|65838749|FG000|Maintenance Period|Subject left town|1|||
23167730|NCT03686397|64363038|FG000|Overall Study|Lack of Efficacy|3|||
23167731|NCT03686397|64363039|FG001|Overall Study|Lack of Efficacy|5|||
23167732|NCT03686397|64363038|FG000|Overall Study|Adverse Event|0|||
23167733|NCT03686397|64363039|FG001|Overall Study|Adverse Event|1|||
23167734|NCT03686397|64363038|FG000|Overall Study|Protocol Violation|0|||
23167735|NCT03686397|64363039|FG001|Overall Study|Protocol Violation|1|||
23167736|NCT03686397|64363038|FG000|Overall Study|Withdrawal by Subject|0|||
23167737|NCT03686397|64363039|FG001|Overall Study|Withdrawal by Subject|1|||
23167738|NCT03686397|64363038|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
23167739|NCT03686397|64363039|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
23167740|NCT00603915|64363040|FG000|Overall Study|Physician Decision|1|||
23167741|NCT02669017|64363041|FG000|Overall Study|Death|1|||
23167742|NCT02669017|64363042|FG001|Overall Study|Death|2|||
23167743|NCT02669017|64363043|FG002|Overall Study|Death|2|||
23167744|NCT02669017|64363044|FG003|Overall Study|Death|3|||
23167745|NCT02669017|64363045|FG004|Overall Study|Death|8|||
23167746|NCT02669017|64363046|FG005|Overall Study|Death|18|||
23167747|NCT02669017|64363047|FG006|Overall Study|Death|10|||
23167748|NCT02669017|64363048|FG007|Overall Study|Death|47|||
23167749|NCT02669017|64363049|FG008|Overall Study|Death|20|||
23167750|NCT02669017|64363041|FG000|Overall Study|Withdrawal by Subject|0|||
23167751|NCT02669017|64363042|FG001|Overall Study|Withdrawal by Subject|0|||
23167752|NCT02669017|64363043|FG002|Overall Study|Withdrawal by Subject|0|||
23167753|NCT02669017|64363044|FG003|Overall Study|Withdrawal by Subject|1|||
23167754|NCT02669017|64363045|FG004|Overall Study|Withdrawal by Subject|2|||
23167755|NCT02669017|64363046|FG005|Overall Study|Withdrawal by Subject|0|||
23167756|NCT02669017|64363047|FG006|Overall Study|Withdrawal by Subject|0|||
23167757|NCT02669017|64363048|FG007|Overall Study|Withdrawal by Subject|2|||
23167758|NCT02669017|64363049|FG008|Overall Study|Withdrawal by Subject|2|||
23167759|NCT02669017|64363041|FG000|Overall Study|Lost to Follow-up|0|||
23167760|NCT02669017|64363042|FG001|Overall Study|Lost to Follow-up|0|||
23167761|NCT02669017|64363043|FG002|Overall Study|Lost to Follow-up|0|||
23167762|NCT02669017|64363044|FG003|Overall Study|Lost to Follow-up|0|||
23167763|NCT02669017|64363045|FG004|Overall Study|Lost to Follow-up|0|||
23167764|NCT02669017|64363046|FG005|Overall Study|Lost to Follow-up|0|||
23167765|NCT02669017|64363047|FG006|Overall Study|Lost to Follow-up|0|||
23167766|NCT02669017|64363048|FG007|Overall Study|Lost to Follow-up|0|||
23167767|NCT02669017|64363049|FG008|Overall Study|Lost to Follow-up|1|||
23167768|NCT02669017|64363041|FG000|Overall Study|Miscellaneous|0|||
23167769|NCT02669017|64363042|FG001|Overall Study|Miscellaneous|0|||
23167770|NCT02669017|64363043|FG002|Overall Study|Miscellaneous|0|||
23333889|NCT01091662|64965287|FG001|Overall Study|Withdrawal by Subject|6|||
23333890|NCT01091662|64965286|FG000|Overall Study|met exit criteria|7|||
23333891|NCT01091662|64965287|FG001|Overall Study|met exit criteria|13|||
23167771|NCT02669017|64363044|FG003|Overall Study|Miscellaneous|0|||
23167772|NCT02669017|64363045|FG004|Overall Study|Miscellaneous|2|||
23167773|NCT02669017|64363046|FG005|Overall Study|Miscellaneous|1|||
23167774|NCT02669017|64363047|FG006|Overall Study|Miscellaneous|1|||
23167775|NCT02669017|64363048|FG007|Overall Study|Miscellaneous|13|||
23167776|NCT02669017|64363049|FG008|Overall Study|Miscellaneous|2|||
23167777|NCT02429414|64363050|FG000|Overall Study|Physician Decision|0|||
23167778|NCT02429414|64363051|FG001|Overall Study|Physician Decision|1|||
23167779|NCT01890421|64363052|FG000|Overall Study|Adverse Event|1|||
23333892|NCT01091662|64965286|FG000|Overall Study|met exclusion criteria|1|||
23333893|NCT01091662|64965287|FG001|Overall Study|met exclusion criteria|0|||
23447642|NCT00687804|65380549|FG002|Open-Label Extension Study|Adverse Event|2|||
23167780|NCT01890421|64363052|FG000|Overall Study|Other reason|10|||
23167781|NCT01834729|64363053|FG000|Overall Study|Did not return bowel diaries|0|||
23167782|NCT01834729|64363054|FG001|Overall Study|Did not return bowel diaries|0|||
23167783|NCT01834729|64363055|FG002|Overall Study|Did not return bowel diaries|3|||
23167784|NCT01834729|64363056|FG003|Overall Study|Did not return bowel diaries|0|||
23167785|NCT01834729|64363053|FG000|Overall Study|Withdrawal by Subject|1|||
23167786|NCT01834729|64363054|FG001|Overall Study|Withdrawal by Subject|1|||
23333894|NCT01091662|64965286|FG000|Overall Study|Lost to Follow-up|0|||
23447643|NCT00687804|65380547|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
23167787|NCT01834729|64363055|FG002|Overall Study|Withdrawal by Subject|0|||
23167788|NCT01834729|64363056|FG003|Overall Study|Withdrawal by Subject|0|||
23447644|NCT00687804|65380548|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
23447645|NCT00687804|65380549|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
23167789|NCT01834729|64363053|FG000|Overall Study|Adverse Event|0|||
23575541|NCT01744496|65838750|FG001|Maintenance Period|Subject left town|0|||
23167790|NCT01834729|64363054|FG001|Overall Study|Adverse Event|0|||
23167791|NCT01834729|64363055|FG002|Overall Study|Adverse Event|0|||
23167792|NCT01834729|64363056|FG003|Overall Study|Adverse Event|2|||
23167793|NCT00999908|64363057|FG000|Treatment Period 1|Subject withdrew consent|2|||
23167794|NCT00999908|64363058|FG001|Treatment Period 1|Subject withdrew consent|0|||
23167795|NCT00999908|64363059|FG002|Treatment Period 1|Subject withdrew consent|0|||
23167796|NCT00999908|64363057|FG000|Treatment Period 2|Protocol Violation|1|||
23167797|NCT00999908|64363058|FG001|Treatment Period 2|Protocol Violation|0|||
23167798|NCT00999908|64363059|FG002|Treatment Period 2|Protocol Violation|0|||
23167799|NCT00708500|64363066|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
23167800|NCT00708500|64363067|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
23167801|NCT00708500|64363068|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
23167802|NCT00708500|64363066|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
23167803|NCT00708500|64363067|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
23167804|NCT00708500|64363068|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
23167805|NCT00708500|64363066|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
23575542|NCT00107380|65838753|FG000|Overall Study|Adverse Event|7|||
23575543|NCT00107380|65838753|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
23575544|NCT00107380|65838753|FG000|Overall Study|Progression/relapse|4|||
23575545|NCT00107380|65838753|FG000|Overall Study|Death|3|||
23575546|NCT00107380|65838753|FG000|Overall Study|Other - not protocol specified|7|||
23167806|NCT00708500|64363067|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
23167807|NCT00708500|64363068|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
23167808|NCT00708500|64363066|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
23167809|NCT00708500|64363067|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
23167810|NCT00708500|64363068|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
23167811|NCT00708500|64363066|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
23167812|NCT00708500|64363067|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
23167813|NCT00708500|64363068|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
23167814|NCT00708500|64363066|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
23167815|NCT00708500|64363067|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
23167816|NCT00708500|64363068|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
23167817|NCT00708500|64363066|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
23167818|NCT00708500|64363067|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
23227334|NCT00952588|64575085|FG000|Overall Study|Withdrawal by Subject|2|||
23227335|NCT00952588|64575086|FG001|Overall Study|Withdrawal by Subject|5|||
23227336|NCT00952588|64575085|FG000|Overall Study|Adverse Event|2|||
23227337|NCT00952588|64575086|FG001|Overall Study|Adverse Event|3|||
23227338|NCT00952588|64575085|FG000|Overall Study|Lost to Follow-up|2|||
23227339|NCT00952588|64575086|FG001|Overall Study|Lost to Follow-up|0|||
23167819|NCT00708500|64363068|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
23167820|NCT00708500|64363066|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
23167821|NCT00708500|64363067|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
23167822|NCT00708500|64363068|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
23167823|NCT00708500|64363066|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
23167824|NCT00708500|64363067|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
23167825|NCT00708500|64363068|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
23167826|NCT00708500|64363066|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
23167827|NCT00708500|64363067|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
23167828|NCT00708500|64363068|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
23167829|NCT00708500|64363066|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
23167830|NCT00708500|64363067|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
23167831|NCT00708500|64363068|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
23167832|NCT00708500|64363066|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
23167833|NCT00708500|64363067|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
23167834|NCT00708500|64363068|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
23167835|NCT00708500|64363066|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
23167836|NCT00708500|64363067|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
23167837|NCT00708500|64363068|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
23167838|NCT00708500|64363066|FG000|FOLLOWUP|Adverse Event|0|||
23167839|NCT00708500|64363067|FG001|FOLLOWUP|Adverse Event|1|||
23167840|NCT00708500|64363068|FG002|FOLLOWUP|Adverse Event|0|||
23575547|NCT00107380|65838753|FG000|Overall Study|Ineligible|2|||
23167841|NCT00708500|64363066|FG000|FOLLOWUP|Lost to Follow-up|1|||
23167842|NCT00708500|64363067|FG001|FOLLOWUP|Lost to Follow-up|6|||
23227340|NCT00952588|64575085|FG000|Overall Study|Physician Decision|0|||
23227341|NCT00952588|64575086|FG001|Overall Study|Physician Decision|1|||
23167843|NCT00708500|64363068|FG002|FOLLOWUP|Lost to Follow-up|4|||
23167844|NCT00708500|64363066|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
23167845|NCT00708500|64363067|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
23167846|NCT00708500|64363068|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
23167847|NCT00708500|64363066|FG000|FOLLOWUP|Subject withdrew consent|31|||
23167848|NCT00708500|64363067|FG001|FOLLOWUP|Subject withdrew consent|4|||
23333895|NCT01091662|64965287|FG001|Overall Study|Lost to Follow-up|1|||
23333896|NCT01091662|64965286|FG000|Overall Study|Pregnancy|0|||
23333897|NCT01091662|64965287|FG001|Overall Study|Pregnancy|1|||
23333898|NCT01091662|64965286|FG000|Overall Study|Protocol Violation|0|||
23333899|NCT01091662|64965287|FG001|Overall Study|Protocol Violation|2|||
23333900|NCT01091662|64965286|FG000|Overall Study|unable to swallow capsule|0|||
23333901|NCT01091662|64965287|FG001|Overall Study|unable to swallow capsule|1|||
23333902|NCT03889418|64965288|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
23333903|NCT03889418|64965289|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23333904|NCT03889418|64965290|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23333905|NCT03889418|64965291|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23333906|NCT03889418|64965292|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23333907|NCT03889418|64965293|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23333908|NCT03889418|64965294|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23167849|NCT00708500|64363068|FG002|FOLLOWUP|Subject withdrew consent|5|||
23167850|NCT00708500|64363066|FG000|FOLLOWUP|Non-compliance with protocol|5|||
23167851|NCT00708500|64363067|FG001|FOLLOWUP|Non-compliance with protocol|0|||
23167852|NCT00708500|64363068|FG002|FOLLOWUP|Non-compliance with protocol|1|||
23167853|NCT01394939|64363069|FG000|Overall Study|Adverse Event|1|||
23167854|NCT01394939|64363070|FG001|Overall Study|Adverse Event|3|||
23167855|NCT01394939|64363071|FG002|Overall Study|Adverse Event|0|||
23167856|NCT01394939|64363072|FG003|Overall Study|Adverse Event|2|||
23167857|NCT01394939|64363069|FG000|Overall Study|Death|0|||
23167858|NCT01394939|64363070|FG001|Overall Study|Death|2|||
23167859|NCT01394939|64363071|FG002|Overall Study|Death|0|||
23167860|NCT01394939|64363072|FG003|Overall Study|Death|0|||
23167861|NCT01394939|64363069|FG000|Overall Study|Physician Decision|0|||
23167862|NCT01394939|64363070|FG001|Overall Study|Physician Decision|1|||
23167863|NCT01394939|64363071|FG002|Overall Study|Physician Decision|0|||
23167864|NCT01394939|64363072|FG003|Overall Study|Physician Decision|0|||
23167865|NCT01394939|64363069|FG000|Overall Study|Withdrawal by Subject|0|||
23167866|NCT01394939|64363070|FG001|Overall Study|Withdrawal by Subject|2|||
23167867|NCT01394939|64363071|FG002|Overall Study|Withdrawal by Subject|0|||
23167868|NCT01394939|64363072|FG003|Overall Study|Withdrawal by Subject|2|||
23167869|NCT01394939|64363069|FG000|Overall Study|Others|0|||
23167870|NCT01394939|64363070|FG001|Overall Study|Others|2|||
23167871|NCT01394939|64363071|FG002|Overall Study|Others|0|||
23167872|NCT01394939|64363072|FG003|Overall Study|Others|3|||
23167873|NCT00326898|64363073|FG000|Overall Study|Disease progression|52|||
23167874|NCT00326898|64363074|FG001|Overall Study|Disease progression|54|||
23167875|NCT00326898|64363075|FG002|Overall Study|Disease progression|102|||
23167876|NCT00326898|64363073|FG000|Overall Study|Adverse Event|124|||
23167877|NCT00326898|64363074|FG001|Overall Study|Adverse Event|128|||
23167878|NCT00326898|64363075|FG002|Overall Study|Adverse Event|33|||
23167879|NCT00326898|64363073|FG000|Overall Study|Death|2|||
23167880|NCT00326898|64363074|FG001|Overall Study|Death|0|||
23167881|NCT00326898|64363075|FG002|Overall Study|Death|0|||
23167882|NCT00326898|64363073|FG000|Overall Study|Withdrawal by Subject|134|||
23167883|NCT00326898|64363074|FG001|Overall Study|Withdrawal by Subject|128|||
23167884|NCT00326898|64363075|FG002|Overall Study|Withdrawal by Subject|32|||
23167885|NCT00326898|64363073|FG000|Overall Study|Alternative therapy|1|||
23167886|NCT00326898|64363074|FG001|Overall Study|Alternative therapy|0|||
23167887|NCT00326898|64363075|FG002|Overall Study|Alternative therapy|0|||
23167888|NCT00326898|64363073|FG000|Overall Study|Other complicating disease|5|||
23167889|NCT00326898|64363074|FG001|Overall Study|Other complicating disease|5|||
23167890|NCT00326898|64363075|FG002|Overall Study|Other complicating disease|4|||
23167891|NCT00326898|64363073|FG000|Overall Study|Other/Missing/Unknown|33|||
23167892|NCT00326898|64363074|FG001|Overall Study|Other/Missing/Unknown|28|||
23167893|NCT00326898|64363075|FG002|Overall Study|Other/Missing/Unknown|32|||
23167894|NCT01587079|64363076|FG000|Overall Study|Protocol-specified criteria|9|||
23333909|NCT03889418|64965295|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23447646|NCT00687804|65380547|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
23167895|NCT01587079|64363076|FG000|Overall Study|Protocol Violation|5|||
23167896|NCT01587079|64363076|FG000|Overall Study|Lost to Follow-up|2|||
23167897|NCT01587079|64363076|FG000|Overall Study|Physician Decision|2|||
23167898|NCT01587079|64363076|FG000|Overall Study|Withdrawal by Subject|7|||
23167899|NCT01587079|64363076|FG000|Overall Study|Adverse Event|14|||
23333910|NCT03889418|64965296|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23333911|NCT03889418|64965297|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
23333912|NCT03889418|64965288|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23167900|NCT01844895|64363077|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
23227342|NCT00952588|64575085|FG000|Overall Study|Lack of Efficacy|2|||
23167901|NCT01844895|64363077|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
23167902|NCT01844895|64363077|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
23167903|NCT01844895|64363077|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
23167904|NCT01844895|64363077|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
23167905|NCT01844895|64363077|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
23333913|NCT03889418|64965289|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
23333914|NCT03889418|64965290|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
23333915|NCT03889418|64965291|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23333916|NCT03889418|64965292|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23333917|NCT03889418|64965293|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23167906|NCT01844895|64363077|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
23333918|NCT03889418|64965294|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23333919|NCT03889418|64965295|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23333920|NCT03889418|64965296|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23333921|NCT03889418|64965297|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
23333922|NCT03889418|64965288|FG000|October-December 2019 (Month 7-9)|Death|0|||
23333923|NCT03889418|64965289|FG001|October-December 2019 (Month 7-9)|Death|0|||
23333924|NCT03889418|64965290|FG002|October-December 2019 (Month 7-9)|Death|0|||
23333925|NCT03889418|64965291|FG003|October-December 2019 (Month 7-9)|Death|0|||
23333926|NCT03889418|64965292|FG004|October-December 2019 (Month 7-9)|Death|0|||
23333927|NCT03889418|64965293|FG005|October-December 2019 (Month 7-9)|Death|0|||
23333928|NCT03889418|64965294|FG006|October-December 2019 (Month 7-9)|Death|0|||
23333929|NCT03889418|64965295|FG007|October-December 2019 (Month 7-9)|Death|0|||
23333930|NCT03889418|64965296|FG008|October-December 2019 (Month 7-9)|Death|1|||
23167907|NCT00356278|64363090|FG000|Overall Study|Withdrawal by Subject|25|||
23167908|NCT00356278|64363091|FG001|Overall Study|Withdrawal by Subject|15|||
23167909|NCT00356278|64363092|FG002|Overall Study|Withdrawal by Subject|19|||
23167910|NCT00132132|64363093|FG000|Overall Study|Lost to Follow-up|7|||
23167911|NCT00132132|64363094|FG001|Overall Study|Lost to Follow-up|2|||
23167912|NCT01665144|64363097|FG000|Core Part|Withdrawal by Subject|96|||
23167913|NCT01665144|64363098|FG001|Core Part|Withdrawal by Subject|77|||
23333931|NCT03889418|64965297|FG009|October-December 2019 (Month 7-9)|Death|0|||
23333932|NCT03889418|64965288|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23447647|NCT00687804|65380548|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
23447648|NCT00687804|65380549|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
23575548|NCT02059161|65838754|FG000|Overall Study|Pregnancy|0|||
23575549|NCT02059161|65838755|FG001|Overall Study|Pregnancy|2|||
23575550|NCT02059161|65838754|FG000|Overall Study|Adverse Event|2|||
23575551|NCT02059161|65838755|FG001|Overall Study|Adverse Event|6|||
23575552|NCT02059161|65838754|FG000|Overall Study|Lost to Follow-up|20|||
23575553|NCT02059161|65838755|FG001|Overall Study|Lost to Follow-up|12|||
23575554|NCT02059161|65838754|FG000|Overall Study|Physician Decision|4|||
23575555|NCT02059161|65838755|FG001|Overall Study|Physician Decision|4|||
23167914|NCT01665144|64363099|FG002|Core Part|Withdrawal by Subject|0|||
23167915|NCT01665144|64363097|FG000|Core Part|Adverse Event|45|||
23167916|NCT01665144|64363098|FG001|Core Part|Adverse Event|18|||
23575556|NCT02059161|65838754|FG000|Overall Study|Protocol Violation|1|||
23575557|NCT02059161|65838755|FG001|Overall Study|Protocol Violation|1|||
23167917|NCT01665144|64363099|FG002|Core Part|Adverse Event|0|||
23167918|NCT01665144|64363097|FG000|Core Part|Lack of Efficacy|16|||
23167919|NCT01665144|64363098|FG001|Core Part|Lack of Efficacy|11|||
23167920|NCT01665144|64363099|FG002|Core Part|Lack of Efficacy|0|||
23167921|NCT01665144|64363097|FG000|Core Part|Lost to Follow-up|9|||
23167922|NCT01665144|64363098|FG001|Core Part|Lost to Follow-up|8|||
23167923|NCT01665144|64363099|FG002|Core Part|Lost to Follow-up|0|||
23167924|NCT01665144|64363097|FG000|Core Part|Physician Decision|13|||
23167925|NCT01665144|64363098|FG001|Core Part|Physician Decision|1|||
23167926|NCT01665144|64363099|FG002|Core Part|Physician Decision|0|||
23167927|NCT01665144|64363097|FG000|Core Part|Progressive disease|8|||
23575558|NCT02059161|65838754|FG000|Overall Study|Withdrawal by Subject|16|||
23575559|NCT02059161|65838755|FG001|Overall Study|Withdrawal by Subject|13|||
23167928|NCT01665144|64363098|FG001|Core Part|Progressive disease|4|||
23167929|NCT01665144|64363099|FG002|Core Part|Progressive disease|0|||
23167930|NCT01665144|64363097|FG000|Core Part|Non-compliance with study treatment|5|||
23167931|NCT01665144|64363098|FG001|Core Part|Non-compliance with study treatment|0|||
23167932|NCT01665144|64363099|FG002|Core Part|Non-compliance with study treatment|0|||
23167933|NCT01665144|64363097|FG000|Core Part|Death|3|||
23333933|NCT03889418|64965289|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23333934|NCT03889418|64965290|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23333935|NCT03889418|64965291|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
23333936|NCT03889418|64965292|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23333937|NCT03889418|64965293|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23167934|NCT01665144|64363098|FG001|Core Part|Death|1|||
23167935|NCT01665144|64363099|FG002|Core Part|Death|0|||
23167936|NCT01665144|64363097|FG000|Core Part|Protocol deviation|3|||
23333938|NCT03889418|64965294|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23333939|NCT03889418|64965295|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
23333940|NCT03889418|64965296|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23227343|NCT00952588|64575086|FG001|Overall Study|Lack of Efficacy|2|||
23227344|NCT00081263|64575089|FG000|Overall Study|clerical error|1|||
23227345|NCT00081263|64575090|FG001|Overall Study|clerical error|0|||
23227346|NCT00081263|64575089|FG000|Overall Study|wrong cell type|7|||
23227347|NCT00081263|64575090|FG001|Overall Study|wrong cell type|5|||
23227348|NCT00081263|64575089|FG000|Overall Study|improper pre-protocol therapy|0|||
23227349|NCT00081263|64575090|FG001|Overall Study|improper pre-protocol therapy|1|||
23227350|NCT00081263|64575089|FG000|Overall Study|Inadequate pathology|0|||
23227351|NCT00081263|64575090|FG001|Overall Study|Inadequate pathology|1|||
23227352|NCT00081263|64575089|FG000|Overall Study|Never treated|4|||
23227353|NCT00081263|64575090|FG001|Overall Study|Never treated|5|||
23333941|NCT03889418|64965297|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
23333942|NCT03889418|64965288|FG000|April - June 2020 (Month 13-15)|Death|0|||
23333943|NCT03889418|64965289|FG001|April - June 2020 (Month 13-15)|Death|1|||
23333944|NCT03889418|64965290|FG002|April - June 2020 (Month 13-15)|Death|0|||
23333945|NCT03889418|64965291|FG003|April - June 2020 (Month 13-15)|Death|0|||
23333946|NCT03889418|64965292|FG004|April - June 2020 (Month 13-15)|Death|0|||
23333947|NCT03889418|64965293|FG005|April - June 2020 (Month 13-15)|Death|0|||
23333948|NCT03889418|64965294|FG006|April - June 2020 (Month 13-15)|Death|0|||
23333949|NCT03889418|64965295|FG007|April - June 2020 (Month 13-15)|Death|0|||
23333950|NCT03889418|64965296|FG008|April - June 2020 (Month 13-15)|Death|0|||
23333951|NCT03889418|64965297|FG009|April - June 2020 (Month 13-15)|Death|0|||
23333952|NCT03889418|64965288|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23333953|NCT03889418|64965289|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23447649|NCT00687804|65380547|FG000|Open-Label Extension Study|Administrative problems|1|||
23447650|NCT00687804|65380548|FG001|Open-Label Extension Study|Administrative problems|1|||
23447651|NCT00687804|65380549|FG002|Open-Label Extension Study|Administrative problems|0|||
23447652|NCT00687804|65380547|FG000|Open-Label Extension Study|Death|2|||
23447653|NCT00687804|65380548|FG001|Open-Label Extension Study|Death|3|||
23447654|NCT00687804|65380549|FG002|Open-Label Extension Study|Death|3|||
23447655|NCT03956550|65380550|FG000|Overall Study|Sponsor decision|65|||
23447656|NCT03956550|65380551|FG001|Overall Study|Sponsor decision|66|||
23447657|NCT03956550|65380552|FG002|Overall Study|Sponsor decision|64|||
23447658|NCT03956550|65380550|FG000|Overall Study|Adverse Event|0|||
23447659|NCT03956550|65380551|FG001|Overall Study|Adverse Event|1|||
23447660|NCT03956550|65380552|FG002|Overall Study|Adverse Event|0|||
23447661|NCT03956550|65380550|FG000|Overall Study|Withdrawal by Subject|5|||
23447662|NCT03956550|65380551|FG001|Overall Study|Withdrawal by Subject|5|||
23447663|NCT03956550|65380552|FG002|Overall Study|Withdrawal by Subject|6|||
23447664|NCT00799266|65380555|FG000|Overall Study|Adverse Event|0|||
23447665|NCT00799266|65380556|FG001|Overall Study|Adverse Event|1|||
23447666|NCT00799266|65380555|FG000|Overall Study|Subject withdrew consent|3|||
23447667|NCT00799266|65380556|FG001|Overall Study|Subject withdrew consent|0|||
23447668|NCT01426958|65380558|FG000|Overall Study|Adverse Event|2|||
23447669|NCT01546857|65380561|FG000|Overall Study|Withdrawal by Subject|2|||
23447670|NCT01546857|65380562|FG001|Overall Study|Withdrawal by Subject|3|||
23447671|NCT03649074|65380563|FG000|Overall Study|Lost to Follow-up|2|||
23447672|NCT03649074|65380564|FG001|Overall Study|Lost to Follow-up|1|||
23447673|NCT03649074|65380563|FG000|Overall Study|Adverse Event|1|||
23447674|NCT03649074|65380564|FG001|Overall Study|Adverse Event|0|||
23447675|NCT03649074|65380563|FG000|Overall Study|Physician Decision|1|||
23447676|NCT03649074|65380564|FG001|Overall Study|Physician Decision|0|||
23447677|NCT03649074|65380563|FG000|Overall Study|Withdrawal by Subject|0|||
23447678|NCT03649074|65380564|FG001|Overall Study|Withdrawal by Subject|2|||
23447679|NCT03649074|65380563|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
23227354|NCT00081263|64575089|FG000|Overall Study|Inadequate data|5|||
23227355|NCT00081263|64575090|FG001|Overall Study|Inadequate data|10|||
23227356|NCT00216086|64575091|FG000|Overall Study|Protocol Violation|1|||
23333954|NCT03889418|64965290|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23333955|NCT03889418|64965291|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
23333956|NCT03889418|64965292|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23333957|NCT03889418|64965293|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23333958|NCT03889418|64965294|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23333959|NCT03889418|64965295|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23333960|NCT03889418|64965296|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23447680|NCT03649074|65380564|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
23447681|NCT03649074|65380563|FG000|Overall Study|Other|1|||
23447682|NCT03649074|65380564|FG001|Overall Study|Other|0|||
23447683|NCT03038126|65380567|FG000|Overall Study|Death|1|||
23447684|NCT03038126|65380568|FG001|Overall Study|Death|1|||
23447685|NCT03038126|65380567|FG000|Overall Study|Withdrawal by Subject|5|||
23227357|NCT00216086|64575091|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
23447686|NCT03038126|65380568|FG001|Overall Study|Withdrawal by Subject|0|||
23447687|NCT03038126|65380567|FG000|Overall Study|Lost to Follow-up|0|||
23333961|NCT03889418|64965297|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
23333962|NCT03889418|64965288|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
23333963|NCT03889418|64965289|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
23333964|NCT03889418|64965290|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
23333965|NCT03889418|64965291|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
23333966|NCT03889418|64965292|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
23333967|NCT03889418|64965293|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
23333968|NCT03889418|64965294|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
23333969|NCT03889418|64965295|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
23333970|NCT03889418|64965296|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
23333971|NCT03889418|64965297|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
23333972|NCT03889418|64965288|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23333973|NCT03889418|64965289|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
23333974|NCT03889418|64965290|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
23333975|NCT03889418|64965291|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
23333976|NCT03889418|64965292|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23333977|NCT03889418|64965293|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23333978|NCT03889418|64965294|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23333979|NCT03889418|64965295|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
23333980|NCT03889418|64965296|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
23333981|NCT03889418|64965297|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
23333982|NCT02875613|64965300|FG000|Overall Study|Withdrawal by Subject|1|||
23333983|NCT02875613|64965300|FG000|Overall Study|Screen Failure|1|||
23333984|NCT03337113|64965301|FG000|Overall Study|Adverse Event|1|||
23333985|NCT03337113|64965302|FG001|Overall Study|Adverse Event|1|||
23333986|NCT03337113|64965303|FG002|Overall Study|Adverse Event|0|||
23333987|NCT03337113|64965304|FG003|Overall Study|Adverse Event|1|||
23333988|NCT03337113|64965301|FG000|Overall Study|Physician Decision|0|||
23333989|NCT03337113|64965302|FG001|Overall Study|Physician Decision|2|||
23333990|NCT03337113|64965303|FG002|Overall Study|Physician Decision|0|||
23333991|NCT03337113|64965304|FG003|Overall Study|Physician Decision|1|||
23333992|NCT03337113|64965301|FG000|Overall Study|Withdrawal by Subject|0|||
23333993|NCT03337113|64965302|FG001|Overall Study|Withdrawal by Subject|0|||
23333994|NCT03337113|64965303|FG002|Overall Study|Withdrawal by Subject|1|||
23333995|NCT03337113|64965304|FG003|Overall Study|Withdrawal by Subject|0|||
23333996|NCT03668119|64965310|FG000|Pre-treatment|Disease Progression|1|||
23333997|NCT03668119|64965311|FG001|Pre-treatment|Disease Progression|0|||
23333998|NCT03668119|64965310|FG000|Treatment|Disease Progression|76|||
23333999|NCT03668119|64965311|FG001|Treatment|Disease Progression|57|||
23334000|NCT03668119|64965310|FG000|Treatment|Study drug toxicity|19|||
23334001|NCT03668119|64965311|FG001|Treatment|Study drug toxicity|1|||
23334002|NCT03668119|64965310|FG000|Treatment|Death|3|||
23334003|NCT03668119|64965311|FG001|Treatment|Death|0|||
23334004|NCT03668119|64965310|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
23334005|NCT03668119|64965311|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
23334006|NCT03668119|64965310|FG000|Treatment|Withdrawal by Subject|1|||
23334007|NCT03668119|64965311|FG001|Treatment|Withdrawal by Subject|1|||
23334008|NCT03668119|64965310|FG000|Treatment|Participant request to discontinue study treatment|3|||
23334009|NCT03668119|64965311|FG001|Treatment|Participant request to discontinue study treatment|1|||
23334010|NCT03668119|64965310|FG000|Treatment|Maximum Clinical Benefit|0|||
23334011|NCT03668119|64965311|FG001|Treatment|Maximum Clinical Benefit|1|||
23334012|NCT03668119|64965310|FG000|Treatment|Participants completed treatment|27|||
23447688|NCT03038126|65380568|FG001|Overall Study|Lost to Follow-up|1|||
23447689|NCT03038126|65380567|FG000|Overall Study|Long Term Hospitalization|2|||
23447690|NCT03038126|65380568|FG001|Overall Study|Long Term Hospitalization|0|||
23575560|NCT02059161|65838754|FG000|Overall Study|Randomized in error, no study drug|0|||
23575561|NCT02059161|65838755|FG001|Overall Study|Randomized in error, no study drug|1|||
23334013|NCT03668119|64965311|FG001|Treatment|Participants completed treatment|11|||
23334014|NCT03668119|64965310|FG000|Treatment|Other reasons|2|||
23575562|NCT02059161|65838754|FG000|Overall Study|Non-compliance with study drug|6|||
23575563|NCT02059161|65838755|FG001|Overall Study|Non-compliance with study drug|2|||
23334015|NCT03668119|64965311|FG001|Treatment|Other reasons|1|||
23334016|NCT01401361|64965312|FG000|Overall Study|Withdrawal by Subject|16|||
23334017|NCT01401361|64965312|FG000|Overall Study|Lack of Efficacy|6|||
23334018|NCT01401361|64965312|FG000|Overall Study|Physician Decision|1|||
23334019|NCT01401361|64965312|FG000|Overall Study|Lost to Follow-up|3|||
23334020|NCT01401361|64965312|FG000|Overall Study|Subject/family decision post procedure|2|||
23334021|NCT00485732|64965313|FG000|Overall Study|Protocol Violation|1|||
23334022|NCT00485732|64965314|FG001|Overall Study|Protocol Violation|3|||
23334023|NCT00485732|64965313|FG000|Overall Study|Withdrawal by Subject|5|||
23334024|NCT00485732|64965314|FG001|Overall Study|Withdrawal by Subject|4|||
23334025|NCT00485732|64965313|FG000|Overall Study|Lost to Follow-up|2|||
23334026|NCT00485732|64965314|FG001|Overall Study|Lost to Follow-up|2|||
23334027|NCT02596971|64965317|FG000|Overall Study|Death|5|||
23334028|NCT02596971|64965318|FG001|Overall Study|Death|1|||
23334029|NCT02596971|64965319|FG002|Overall Study|Death|5|||
23334030|NCT02596971|64965317|FG000|Overall Study|Withdrawal by Subject|5|||
23334031|NCT02596971|64965318|FG001|Overall Study|Withdrawal by Subject|1|||
23334032|NCT02596971|64965319|FG002|Overall Study|Withdrawal by Subject|4|||
23334033|NCT04177095|64965320|FG000|Overall Study|Withdrawal by Subject|3|||
23334034|NCT04177095|64965320|FG000|Overall Study|Screen Failure|3|||
23334035|NCT04177095|64965320|FG000|Overall Study|Problems with the Trugraf assay|1|||
23334036|NCT01372995|64965322|FG000|Overall Study|Spouse withdrew participant from study|0|||
23334037|NCT01372995|64965323|FG001|Overall Study|Spouse withdrew participant from study|1|||
23334038|NCT01372995|64965324|FG002|Overall Study|Spouse withdrew participant from study|0|||
23334039|NCT01372995|64965322|FG000|Overall Study|Physician Decision|0|||
23334040|NCT01372995|64965323|FG001|Overall Study|Physician Decision|0|||
23334041|NCT01372995|64965324|FG002|Overall Study|Physician Decision|1|||
23334042|NCT03878446|64965325|FG000|Overall Study|Withdrawn by parent or guardian|1|||
23334043|NCT03878446|64965326|FG001|Overall Study|Withdrawn by parent or guardian|0|||
23334044|NCT03878446|64965327|FG002|Overall Study|Withdrawn by parent or guardian|0|||
23334045|NCT03878446|64965328|FG003|Overall Study|Withdrawn by parent or guardian|0|||
23334046|NCT03878446|64965329|FG004|Overall Study|Withdrawn by parent or guardian|0|||
23334047|NCT02729051|64965330|FG000|Overall Study|Adverse Event|21|||
23334048|NCT02729051|64965331|FG001|Overall Study|Adverse Event|11|||
23334049|NCT02729051|64965330|FG000|Overall Study|Lack of Efficacy|1|||
23334050|NCT02729051|64965331|FG001|Overall Study|Lack of Efficacy|1|||
23334051|NCT02729051|64965330|FG000|Overall Study|Lost to Follow-up|1|||
23334052|NCT02729051|64965331|FG001|Overall Study|Lost to Follow-up|2|||
23334053|NCT02729051|64965330|FG000|Overall Study|Physician Decision|1|||
23334054|NCT02729051|64965331|FG001|Overall Study|Physician Decision|1|||
23334055|NCT02729051|64965330|FG000|Overall Study|Withdrawal by Subject|6|||
23334056|NCT02729051|64965331|FG001|Overall Study|Withdrawal by Subject|17|||
23334057|NCT03482453|64965340|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334058|NCT03482453|64965341|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334059|NCT03482453|64965342|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334060|NCT03482453|64965343|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334061|NCT03482453|64965344|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334062|NCT03482453|64965345|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334063|NCT03482453|64965346|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23447691|NCT03038126|65380567|FG000|Overall Study|Too Ill to Participate|1|||
23447692|NCT03038126|65380568|FG001|Overall Study|Too Ill to Participate|2|||
23575564|NCT03101592|65838765|FG000|Overall Study|participant files could not be located|111|||
23575565|NCT03101592|65838766|FG001|Overall Study|participant files could not be located|170|||
23575566|NCT03101592|65838767|FG002|Overall Study|participant files could not be located|118|||
23575567|NCT00280293|65838768|FG000|Overall Study|Protocol Violation|3|||
23575568|NCT00280293|65838769|FG001|Overall Study|Protocol Violation|0|||
23575569|NCT00280293|65838768|FG000|Overall Study|Physician Decision|5|||
23575570|NCT00280293|65838769|FG001|Overall Study|Physician Decision|4|||
23575571|NCT00280293|65838768|FG000|Overall Study|Lost to Follow-up|14|||
23575572|NCT00280293|65838769|FG001|Overall Study|Lost to Follow-up|12|||
23575573|NCT00280293|65838768|FG000|Overall Study|Withdrawal by Subject|3|||
23575574|NCT00280293|65838769|FG001|Overall Study|Withdrawal by Subject|5|||
23575575|NCT00280293|65838768|FG000|Overall Study|Incarceration/Legal Reasons|1|||
23575576|NCT00280293|65838769|FG001|Overall Study|Incarceration/Legal Reasons|1|||
23575577|NCT00280293|65838768|FG000|Overall Study|Adverse Event|0|||
23575578|NCT00280293|65838769|FG001|Overall Study|Adverse Event|1|||
23575579|NCT02431533|65838770|FG000|Overall Study|Withdrawal by Subject|1|||
23575580|NCT02431533|65838771|FG001|Overall Study|Withdrawal by Subject|3|||
23575581|NCT02431533|65838770|FG000|Overall Study|Developed Exclusionary criteria|1|||
23575582|NCT02431533|65838771|FG001|Overall Study|Developed Exclusionary criteria|0|||
23575583|NCT00235495|65838772|FG000|Overall Study|Death|52|||
23575584|NCT00235495|65838773|FG001|Overall Study|Death|42|||
23334064|NCT03482453|64965347|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334065|NCT03482453|64965348|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334066|NCT03482453|64965349|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334067|NCT03482453|64965350|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
23447693|NCT01479868|65380569|FG000|Overall Study|Adverse Event|1|||
23334068|NCT03482453|64965351|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
23334069|NCT00997373|64965352|FG000|Overall Study|Withdrawal by Subject|5|||
23334070|NCT00997373|64965353|FG001|Overall Study|Withdrawal by Subject|0|||
23334071|NCT00997373|64965352|FG000|Overall Study|wrong tumor type|4|||
23334072|NCT00997373|64965353|FG001|Overall Study|wrong tumor type|0|||
23334073|NCT00997373|64965352|FG000|Overall Study|could not have hysterectomy|6|||
23334074|NCT00997373|64965353|FG001|Overall Study|could not have hysterectomy|0|||
23334075|NCT00125242|64965354|FG000|Overall Study|did not qualify|7|||
23334076|NCT00125242|64965355|FG001|Overall Study|did not qualify|2|||
23334077|NCT01876810|64965364|FG000|Overall Study|Physician Decision|0|||
23334078|NCT01876810|64965365|FG001|Overall Study|Physician Decision|1|||
23334079|NCT00831311|64965366|FG000|Overall Study|Definitive Contraindication|3|||
23334080|NCT00831311|64965367|FG001|Overall Study|Definitive Contraindication|3|||
23334081|NCT00831311|64965366|FG000|Overall Study|Lost to Follow-up|3|||
23334082|NCT00831311|64965367|FG001|Overall Study|Lost to Follow-up|0|||
23334083|NCT00831311|64965366|FG000|Overall Study|Physician Decision|0|||
23334084|NCT00831311|64965367|FG001|Overall Study|Physician Decision|1|||
23334085|NCT00831311|64965366|FG000|Overall Study|Withdrawal by Subject|6|||
23334086|NCT00831311|64965367|FG001|Overall Study|Withdrawal by Subject|4|||
23334087|NCT00454363|64965368|FG000|Overall Study|Adverse Event|1|||
23334088|NCT00454363|64965369|FG001|Overall Study|Adverse Event|2|||
23334089|NCT00454363|64965368|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
23334090|NCT00454363|64965369|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
23334091|NCT01430754|64965374|FG000|Run-In Phase|Circadian Period Ineligible|24|||
23334092|NCT01430754|64965375|FG001|Run-In Phase|Circadian Period Ineligible|0|||
23334093|NCT01430754|64965374|FG000|Run-In Phase|Protocol Violation|6|||
23334094|NCT01430754|64965375|FG001|Run-In Phase|Protocol Violation|0|||
23334095|NCT01430754|64965374|FG000|Run-In Phase|Adverse Event|2|||
23334096|NCT01430754|64965375|FG001|Run-In Phase|Adverse Event|0|||
23334097|NCT01430754|64965374|FG000|Run-In Phase|Other|2|||
23334098|NCT01430754|64965375|FG001|Run-In Phase|Other|0|||
23334099|NCT01430754|64965374|FG000|Run-In Phase|Withdrawal by Subject|2|||
23334100|NCT01430754|64965375|FG001|Run-In Phase|Withdrawal by Subject|0|||
23334101|NCT01430754|64965374|FG000|Run-In Phase|Lost to Follow-up|1|||
23334102|NCT01430754|64965375|FG001|Run-In Phase|Lost to Follow-up|0|||
23334103|NCT00356148|64965381|FG000|Overall Study|Reoperation within 30 days|2|||
23334104|NCT00356148|64965382|FG001|Overall Study|Reoperation within 30 days|1|||
23334105|NCT03476187|64965383|FG000|Overall Study|Protocol Violation|7|||
23334106|NCT03476187|64965383|FG000|Overall Study|Physician Decision|5|||
23334107|NCT03656068|64965385|FG000|Overall Study|Withdrawal by Subject|4|||
23334108|NCT03656068|64965385|FG000|Overall Study|Adverse Event|1|||
23334109|NCT02347774|64965387|FG000|Study Participation|Lost to Follow-up|3|||
23334110|NCT02347774|64965388|FG001|Study Participation|Lost to Follow-up|6|||
23334111|NCT02347774|64965389|FG002|Study Participation|Lost to Follow-up|2|||
23334112|NCT02347774|64965387|FG000|Study Participation|Withdrawal by Subject|8|||
23334113|NCT02347774|64965388|FG001|Study Participation|Withdrawal by Subject|9|||
23334114|NCT02347774|64965389|FG002|Study Participation|Withdrawal by Subject|15|||
23334115|NCT02347774|64965387|FG000|Study Participation|Adverse Event|1|||
23575585|NCT00235495|65838772|FG000|Overall Study|Withdrawal by Subject|5|||
23575586|NCT00235495|65838773|FG001|Overall Study|Withdrawal by Subject|3|||
23575587|NCT00235495|65838772|FG000|Overall Study|Lost to Follow-up|11|||
23575588|NCT00235495|65838773|FG001|Overall Study|Lost to Follow-up|13|||
23575589|NCT00235495|65838772|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
23575590|NCT00235495|65838773|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
23575591|NCT00848211|65838774|FG000|Overall Study|Protocol Violation|0|||
23575592|NCT00848211|65838775|FG001|Overall Study|Protocol Violation|1|||
23575593|NCT00848211|65838776|FG002|Overall Study|Protocol Violation|1|||
23575594|NCT00848211|65838777|FG003|Overall Study|Protocol Violation|0|||
23575595|NCT00848211|65838774|FG000|Overall Study|Adverse Event|0|||
23575596|NCT00848211|65838775|FG001|Overall Study|Adverse Event|0|||
23575597|NCT00848211|65838776|FG002|Overall Study|Adverse Event|0|||
23575598|NCT00848211|65838777|FG003|Overall Study|Adverse Event|0|||
23575599|NCT00057811|65838778|FG000|Overall Study|Lack of Efficacy|1|||
23575600|NCT00057811|65838779|FG001|Overall Study|Lack of Efficacy|4|||
23575601|NCT00057811|65838778|FG000|Overall Study|Physician Decision|1|||
23575602|NCT00057811|65838779|FG001|Overall Study|Physician Decision|0|||
23334116|NCT02347774|64965388|FG001|Study Participation|Adverse Event|4|||
23575603|NCT00057811|65838778|FG000|Overall Study|Withdrawal by Subject|3|||
23575604|NCT00057811|65838779|FG001|Overall Study|Withdrawal by Subject|4|||
23575605|NCT00057811|65838778|FG000|Overall Study|Ineligible|4|||
23575606|NCT00057811|65838779|FG001|Overall Study|Ineligible|2|||
23334117|NCT02347774|64965389|FG002|Study Participation|Adverse Event|6|||
23334118|NCT02347774|64965387|FG000|Study Participation|withdrew consent|1|||
23334119|NCT02347774|64965388|FG001|Study Participation|withdrew consent|1|||
23334120|NCT02347774|64965389|FG002|Study Participation|withdrew consent|1|||
23334121|NCT02347774|64965387|FG000|Study Participation|Met Prolonged QT criteria|1|||
23334122|NCT02347774|64965388|FG001|Study Participation|Met Prolonged QT criteria|0|||
23575607|NCT00057811|65838778|FG000|Overall Study|Inevaluable|1|||
23334123|NCT02347774|64965389|FG002|Study Participation|Met Prolonged QT criteria|0|||
23334124|NCT02347774|64965387|FG000|Study Participation|non-compliance with study drug|0|||
23334125|NCT02347774|64965388|FG001|Study Participation|non-compliance with study drug|1|||
23334126|NCT02347774|64965389|FG002|Study Participation|non-compliance with study drug|0|||
23334127|NCT02347774|64965387|FG000|Study Participation|incarceration|1|||
23334128|NCT02347774|64965388|FG001|Study Participation|incarceration|0|||
23334129|NCT02347774|64965389|FG002|Study Participation|incarceration|0|||
23334130|NCT02347774|64965387|FG000|Study Participation|randomized in error|0|||
23334131|NCT02347774|64965388|FG001|Study Participation|randomized in error|0|||
23334132|NCT02347774|64965389|FG002|Study Participation|randomized in error|1|||
23334133|NCT02347774|64965387|FG000|On Study Treatment|Adverse Event|9|||
23334134|NCT02347774|64965388|FG001|On Study Treatment|Adverse Event|15|||
23334135|NCT02347774|64965389|FG002|On Study Treatment|Adverse Event|19|||
23334136|NCT02347774|64965387|FG000|On Study Treatment|Lack of Efficacy|3|||
23334137|NCT02347774|64965388|FG001|On Study Treatment|Lack of Efficacy|0|||
23334138|NCT02347774|64965389|FG002|On Study Treatment|Lack of Efficacy|2|||
23334139|NCT02347774|64965387|FG000|On Study Treatment|non-complicance with study medication|0|||
23334140|NCT02347774|64965388|FG001|On Study Treatment|non-complicance with study medication|2|||
23334141|NCT02347774|64965389|FG002|On Study Treatment|non-complicance with study medication|0|||
23334142|NCT02347774|64965387|FG000|On Study Treatment|Protocol Violation|0|||
23334143|NCT02347774|64965388|FG001|On Study Treatment|Protocol Violation|0|||
23334144|NCT02347774|64965389|FG002|On Study Treatment|Protocol Violation|1|||
23334145|NCT02347774|64965387|FG000|On Study Treatment|withdrew consent|9|||
23334146|NCT02347774|64965388|FG001|On Study Treatment|withdrew consent|8|||
23334147|NCT02347774|64965389|FG002|On Study Treatment|withdrew consent|12|||
23334148|NCT02347774|64965387|FG000|On Study Treatment|Lost to Follow-up|2|||
23334149|NCT02347774|64965388|FG001|On Study Treatment|Lost to Follow-up|6|||
23334150|NCT02347774|64965389|FG002|On Study Treatment|Lost to Follow-up|1|||
23334151|NCT02347774|64965387|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
23334152|NCT02347774|64965388|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
23334153|NCT02347774|64965389|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
23334154|NCT02347774|64965387|FG000|On Study Treatment|ranomized in error|0|||
23334155|NCT02347774|64965388|FG001|On Study Treatment|ranomized in error|0|||
23334156|NCT02347774|64965389|FG002|On Study Treatment|ranomized in error|1|||
23334157|NCT03693612|64965392|FG000|Overall Study|Lost to Follow-up|0|||
23334158|NCT03693612|64965393|FG001|Overall Study|Lost to Follow-up|0|||
23334159|NCT03693612|64965394|FG002|Overall Study|Lost to Follow-up|0|||
23334160|NCT03693612|64965395|FG003|Overall Study|Lost to Follow-up|0|||
23334161|NCT03693612|64965396|FG004|Overall Study|Lost to Follow-up|1|||
23334162|NCT03693612|64965397|FG005|Overall Study|Lost to Follow-up|0|||
23334163|NCT03693612|64965398|FG006|Overall Study|Lost to Follow-up|0|||
23334164|NCT03693612|64965392|FG000|Overall Study|Withdrawal by Subject|0|||
23334165|NCT03693612|64965393|FG001|Overall Study|Withdrawal by Subject|0|||
23334166|NCT03693612|64965394|FG002|Overall Study|Withdrawal by Subject|1|||
23334167|NCT03693612|64965395|FG003|Overall Study|Withdrawal by Subject|0|||
23334168|NCT03693612|64965396|FG004|Overall Study|Withdrawal by Subject|2|||
23334169|NCT03693612|64965397|FG005|Overall Study|Withdrawal by Subject|0|||
23334170|NCT03693612|64965398|FG006|Overall Study|Withdrawal by Subject|0|||
23334171|NCT03693612|64965392|FG000|Overall Study|Study Terminated by Sponsor|0|||
23334172|NCT03693612|64965393|FG001|Overall Study|Study Terminated by Sponsor|1|||
23334173|NCT03693612|64965394|FG002|Overall Study|Study Terminated by Sponsor|0|||
23334174|NCT03693612|64965395|FG003|Overall Study|Study Terminated by Sponsor|0|||
23334175|NCT03693612|64965396|FG004|Overall Study|Study Terminated by Sponsor|3|||
23167937|NCT01665144|64363098|FG001|Core Part|Protocol deviation|1|||
23334176|NCT03693612|64965397|FG005|Overall Study|Study Terminated by Sponsor|0|||
23334177|NCT03693612|64965398|FG006|Overall Study|Study Terminated by Sponsor|0|||
23334178|NCT00591565|64965399|FG000|Overall Study|lost follow up, withdrawn|5|||
23334179|NCT02955355|64965400|FG000|Overall Study|Adverse Event|4|||
23334180|NCT02955355|64965400|FG000|Overall Study|Death|1|||
23167938|NCT01665144|64363099|FG002|Core Part|Protocol deviation|0|||
23334181|NCT02955355|64965400|FG000|Overall Study|Physician Decision|21|||
23334182|NCT02955355|64965400|FG000|Overall Study|Site Terminated by Sponsor|35|||
23334183|NCT02955355|64965400|FG000|Overall Study|Withdrawal by Subject|19|||
23334184|NCT02955355|64965400|FG000|Overall Study|Reason Not Specified|5|||
23334185|NCT03759587|64965402|FG000|Overall Study|Adverse Event|5|||
23334186|NCT03759587|64965402|FG000|Overall Study|Progressive Disease|10|||
23334187|NCT03759587|64965402|FG000|Overall Study|Site Terminated by Sponsor|3|||
23334188|NCT03759587|64965402|FG000|Overall Study|Withdrawal by Subject|1|||
23334189|NCT05107492|64965403|FG000|Overall Study|Lost to Follow-up|1|||
23334190|NCT05107492|64965404|FG001|Overall Study|Lost to Follow-up|0|||
23334191|NCT01002989|64965405|FG000|Overall Study|exclusion criteria, no consent|5|||
23334192|NCT00410813|64965406|FG000|Overall Study|Adverse Event|6|||
23334193|NCT00410813|64965407|FG001|Overall Study|Adverse Event|11|||
23334194|NCT00410813|64965406|FG000|Overall Study|Progression|32|||
23334195|NCT00410813|64965407|FG001|Overall Study|Progression|21|||
23334196|NCT00410813|64965406|FG000|Overall Study|Not protocol specified|3|||
23334197|NCT00410813|64965407|FG001|Overall Study|Not protocol specified|4|||
23334198|NCT00410813|64965406|FG000|Overall Study|Ineligible|2|||
23334199|NCT00410813|64965407|FG001|Overall Study|Ineligible|4|||
23334200|NCT00410813|64965406|FG000|Overall Study|Death|0|||
23334201|NCT00410813|64965407|FG001|Overall Study|Death|2|||
23334202|NCT03291431|64965408|FG000|Overall Study|Protocol Violation|2|||
23334203|NCT03291431|64965409|FG001|Overall Study|Protocol Violation|1|||
23334204|NCT03291431|64965408|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
23334205|NCT03291431|64965409|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
23334206|NCT03291431|64965408|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
23334207|NCT03291431|64965409|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
23334208|NCT01732640|64965410|FG000|Overall Study|Adverse Event|0|||
23334209|NCT01732640|64965411|FG001|Overall Study|Adverse Event|1|||
23334210|NCT01732640|64965410|FG000|Overall Study|Death|0|||
23334211|NCT01732640|64965411|FG001|Overall Study|Death|1|||
23334212|NCT00356122|64965413|FG000|TREATMENT|Lack of Efficacy|26|||
23334213|NCT00356122|64965413|FG000|TREATMENT|Adverse Event|10|||
23334214|NCT00356122|64965413|FG000|TREATMENT|Subject's request|4|||
23334215|NCT00356122|64965413|FG000|TREATMENT|Other|4|||
23334216|NCT00356122|64965413|FG000|TREATMENT|Did not receive study medication|1|||
23334217|NCT00356122|64965413|FG000|FOLLOW-UP|Death|37|||
23334218|NCT00356122|64965413|FG000|FOLLOW-UP|Lost to Follow-up|2|||
23334219|NCT00356122|64965413|FG000|FOLLOW-UP|Other|2|||
23334220|NCT03321968|64965414|FG000|Overall Study|Withdrawal by Subject|1|||
23334221|NCT03321968|64965415|FG001|Overall Study|Withdrawal by Subject|2|||
23334222|NCT03321968|64965416|FG002|Overall Study|Withdrawal by Subject|1|||
23334223|NCT03321968|64965414|FG000|Overall Study|Lost to Follow-up|2|||
23334224|NCT03321968|64965415|FG001|Overall Study|Lost to Follow-up|0|||
23334225|NCT03321968|64965416|FG002|Overall Study|Lost to Follow-up|1|||
23334226|NCT03321968|64965414|FG000|Overall Study|Other than specified|0|||
23334227|NCT03321968|64965415|FG001|Overall Study|Other than specified|0|||
23334228|NCT03321968|64965416|FG002|Overall Study|Other than specified|1|||
23334229|NCT02844933|64965429|FG000|Overall Study|Discontinued due to premature termination of study|3|||
23334230|NCT02844933|64965430|FG001|Overall Study|Discontinued due to premature termination of study|2|||
23334231|NCT02530125|64965437|FG000|Completed Treatment|Early termination of study|1|||
23334232|NCT02530125|64965437|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
23334233|NCT00576420|64965440|FG000|Overall Study|Death|0|||
23334234|NCT00576420|64965441|FG001|Overall Study|Death|0|||
23334235|NCT00576420|64965442|FG002|Overall Study|Death|1|||
23334236|NCT00568061|64965447|FG000|Overall Study|Inclusion / exclusion criteria|5|||
23334237|NCT00568061|64965448|FG001|Overall Study|Inclusion / exclusion criteria|1|||
23334238|NCT00568061|64965447|FG000|Overall Study|Adverse Event|0|||
23334239|NCT00568061|64965448|FG001|Overall Study|Adverse Event|1|||
23334240|NCT00740792|64965449|FG000|Overall Study|Adverse Event|3|||
23334241|NCT00740792|64965450|FG001|Overall Study|Adverse Event|1|||
23334242|NCT00740792|64965451|FG002|Overall Study|Adverse Event|1|||
23334243|NCT00740792|64965452|FG003|Overall Study|Adverse Event|3|||
23334244|NCT00740792|64965449|FG000|Overall Study|Lack of Efficacy|1|||
23334245|NCT00740792|64965450|FG001|Overall Study|Lack of Efficacy|1|||
23334246|NCT00740792|64965451|FG002|Overall Study|Lack of Efficacy|0|||
23334247|NCT00740792|64965452|FG003|Overall Study|Lack of Efficacy|3|||
23334248|NCT00740792|64965449|FG000|Overall Study|Lost to Follow-up|2|||
23334249|NCT00740792|64965450|FG001|Overall Study|Lost to Follow-up|1|||
23334250|NCT00740792|64965451|FG002|Overall Study|Lost to Follow-up|0|||
23334251|NCT00740792|64965452|FG003|Overall Study|Lost to Follow-up|0|||
23334252|NCT00740792|64965449|FG000|Overall Study|Protocol Violation|0|||
23447694|NCT01479868|65380569|FG000|Overall Study|Lost to Follow-up|4|||
23334253|NCT00740792|64965450|FG001|Overall Study|Protocol Violation|1|||
23334254|NCT00740792|64965451|FG002|Overall Study|Protocol Violation|0|||
23334255|NCT00740792|64965452|FG003|Overall Study|Protocol Violation|2|||
23334256|NCT00740792|64965449|FG000|Overall Study|Withdrawal by Subject|1|||
23334257|NCT00740792|64965450|FG001|Overall Study|Withdrawal by Subject|1|||
23334258|NCT00740792|64965451|FG002|Overall Study|Withdrawal by Subject|0|||
23334259|NCT00740792|64965452|FG003|Overall Study|Withdrawal by Subject|0|||
23334260|NCT00740792|64965449|FG000|Overall Study|administrative|3|||
23334261|NCT00740792|64965450|FG001|Overall Study|administrative|3|||
23334262|NCT00740792|64965451|FG002|Overall Study|administrative|8|||
23334263|NCT00740792|64965452|FG003|Overall Study|administrative|2|||
23334264|NCT00746564|64965453|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
23334265|NCT02343939|64965454|FG000|Overall Study|Death|0|||
23334266|NCT02343939|64965455|FG001|Overall Study|Death|15|||
23575608|NCT00057811|65838779|FG001|Overall Study|Inevaluable|2|||
23575609|NCT00329719|65838787|FG000|Overall Study|Lost to Follow-up|0|||
23575610|NCT00329719|65838788|FG001|Overall Study|Lost to Follow-up|0|||
23575611|NCT00329719|65838789|FG002|Overall Study|Lost to Follow-up|0|||
23575612|NCT00329719|65838790|FG003|Overall Study|Lost to Follow-up|1|||
23575613|NCT00136916|65838793|FG000|Overall Study|Never received study treatment|3|||
23575614|NCT00136916|65838794|FG001|Overall Study|Never received study treatment|5|||
23575615|NCT00136916|65838793|FG000|Overall Study|Death|1|||
23575616|NCT00136916|65838794|FG001|Overall Study|Death|3|||
23575617|NCT00136916|65838793|FG000|Overall Study|Adverse Event|27|||
23575618|NCT00136916|65838794|FG001|Overall Study|Adverse Event|8|||
23167939|NCT01665144|64363097|FG000|Core Part|New therapy for study indication|2|||
23167940|NCT01665144|64363098|FG001|Core Part|New therapy for study indication|1|||
23167941|NCT01665144|64363099|FG002|Core Part|New therapy for study indication|0|||
23167942|NCT01665144|64363097|FG000|Core Part|Technical problems|2|||
23167943|NCT01665144|64363098|FG001|Core Part|Technical problems|0|||
23167944|NCT01665144|64363099|FG002|Core Part|Technical problems|0|||
23575619|NCT00136916|65838793|FG000|Overall Study|Laboratory abnormality|0|||
23575620|NCT00136916|65838794|FG001|Overall Study|Laboratory abnormality|1|||
23575621|NCT00136916|65838793|FG000|Overall Study|Lack of Efficacy|13|||
23575622|NCT00136916|65838794|FG001|Overall Study|Lack of Efficacy|3|||
23575623|NCT00136916|65838793|FG000|Overall Study|Lost to Follow-up|12|||
23575624|NCT00136916|65838794|FG001|Overall Study|Lost to Follow-up|14|||
23167945|NCT01665144|64363097|FG000|Extension Part|Patient/guardian decision|180|||
23167946|NCT01665144|64363098|FG001|Extension Part|Patient/guardian decision|0|||
23167947|NCT01665144|64363099|FG002|Extension Part|Patient/guardian decision|98|||
23167948|NCT01665144|64363097|FG000|Extension Part|Adverse Event|104|||
23167949|NCT01665144|64363098|FG001|Extension Part|Adverse Event|0|||
23575625|NCT00136916|65838793|FG000|Overall Study|Withdrawal by Subject|44|||
23575626|NCT00136916|65838794|FG001|Overall Study|Withdrawal by Subject|46|||
23575627|NCT00136916|65838793|FG000|Overall Study|Other|22|||
23167950|NCT01665144|64363099|FG002|Extension Part|Adverse Event|59|||
23167951|NCT01665144|64363097|FG000|Extension Part|Study closed early|42|||
23167952|NCT01665144|64363098|FG001|Extension Part|Study closed early|0|||
23167953|NCT01665144|64363099|FG002|Extension Part|Study closed early|19|||
23167954|NCT01665144|64363097|FG000|Extension Part|Progressive disease|36|||
23167955|NCT01665144|64363098|FG001|Extension Part|Progressive disease|0|||
23167956|NCT01665144|64363099|FG002|Extension Part|Progressive disease|14|||
23167957|NCT01665144|64363097|FG000|Extension Part|Lack of Efficacy|37|||
23447695|NCT01479868|65380569|FG000|Overall Study|Protocol Violation|1|||
23447696|NCT01479868|65380569|FG000|Overall Study|Withdrawal by Subject|1|||
23167958|NCT01665144|64363098|FG001|Extension Part|Lack of Efficacy|0|||
23334267|NCT02343939|64965456|FG002|Overall Study|Death|4|||
23575628|NCT00136916|65838794|FG001|Overall Study|Other|24|||
23167959|NCT01665144|64363099|FG002|Extension Part|Lack of Efficacy|12|||
23334268|NCT02343939|64965457|FG003|Overall Study|Death|2|||
23167960|NCT01665144|64363097|FG000|Extension Part|Physician Decision|29|||
23167961|NCT01665144|64363098|FG001|Extension Part|Physician Decision|0|||
23334269|NCT02343939|64965458|FG004|Overall Study|Death|5|||
23167962|NCT01665144|64363099|FG002|Extension Part|Physician Decision|13|||
23167963|NCT01665144|64363097|FG000|Extension Part|Technical problems|20|||
23167964|NCT01665144|64363098|FG001|Extension Part|Technical problems|0|||
23167965|NCT01665144|64363099|FG002|Extension Part|Technical problems|8|||
23334270|NCT02343939|64965459|FG005|Overall Study|Death|11|||
23167966|NCT01665144|64363097|FG000|Extension Part|Death|20|||
23167967|NCT01665144|64363098|FG001|Extension Part|Death|0|||
23167968|NCT01665144|64363099|FG002|Extension Part|Death|4|||
23167969|NCT01665144|64363097|FG000|Extension Part|Missing|12|||
23167970|NCT01665144|64363098|FG001|Extension Part|Missing|0|||
23167971|NCT01665144|64363099|FG002|Extension Part|Missing|6|||
23167972|NCT01665144|64363097|FG000|Extension Part|Lost to Follow-up|9|||
23167973|NCT01665144|64363098|FG001|Extension Part|Lost to Follow-up|0|||
23167974|NCT01665144|64363099|FG002|Extension Part|Lost to Follow-up|5|||
23167975|NCT01665144|64363097|FG000|Extension Part|New therapy for study indication|3|||
23167976|NCT01665144|64363098|FG001|Extension Part|New therapy for study indication|0|||
23167977|NCT01665144|64363099|FG002|Extension Part|New therapy for study indication|2|||
23167978|NCT01665144|64363097|FG000|Extension Part|Protocol deviation|3|||
23167979|NCT01665144|64363098|FG001|Extension Part|Protocol deviation|0|||
23167980|NCT01665144|64363099|FG002|Extension Part|Protocol deviation|0|||
23167981|NCT03728309|64363100|FG000|Overall Study|Randomized but not Treated|0|||
23167982|NCT03728309|64363101|FG001|Overall Study|Randomized but not Treated|1|||
23167983|NCT03728309|64363100|FG000|Overall Study|Adverse Event|0|||
23167984|NCT03728309|64363101|FG001|Overall Study|Adverse Event|1|||
23167985|NCT03728309|64363100|FG000|Overall Study|Withdrawal by Subject|2|||
23167986|NCT03728309|64363101|FG001|Overall Study|Withdrawal by Subject|8|||
23167987|NCT03728309|64363100|FG000|Overall Study|Lost to Follow-up|9|||
23167988|NCT03728309|64363101|FG001|Overall Study|Lost to Follow-up|10|||
23167989|NCT03728309|64363100|FG000|Overall Study|Protocol Deviation|0|||
23167990|NCT03728309|64363101|FG001|Overall Study|Protocol Deviation|1|||
23167991|NCT03728309|64363100|FG000|Overall Study|Due to COVID|1|||
23167992|NCT03728309|64363101|FG001|Overall Study|Due to COVID|3|||
23167993|NCT04327388|64363108|FG000|Overall Study|Adverse Event|17|||
23167994|NCT04327388|64363109|FG001|Overall Study|Adverse Event|18|||
23167995|NCT04327388|64363110|FG002|Overall Study|Adverse Event|9|||
23167996|NCT04327388|64363108|FG000|Overall Study|Other|1|||
23167997|NCT04327388|64363109|FG001|Overall Study|Other|2|||
23167998|NCT04327388|64363110|FG002|Overall Study|Other|0|||
23167999|NCT04327388|64363108|FG000|Overall Study|Randomized and not treated|2|||
23334271|NCT02343939|64965460|FG006|Overall Study|Death|8|||
23334272|NCT02343939|64965461|FG007|Overall Study|Death|22|||
23334273|NCT02343939|64965462|FG008|Overall Study|Death|1|||
23334274|NCT02343939|64965454|FG000|Overall Study|Study terminated by sponsor|0|||
23334275|NCT02343939|64965455|FG001|Overall Study|Study terminated by sponsor|27|||
23334276|NCT02343939|64965456|FG002|Overall Study|Study terminated by sponsor|0|||
23334277|NCT02343939|64965457|FG003|Overall Study|Study terminated by sponsor|1|||
23334278|NCT02343939|64965458|FG004|Overall Study|Study terminated by sponsor|1|||
23334279|NCT02343939|64965459|FG005|Overall Study|Study terminated by sponsor|5|||
23334280|NCT02343939|64965460|FG006|Overall Study|Study terminated by sponsor|3|||
23334281|NCT02343939|64965461|FG007|Overall Study|Study terminated by sponsor|4|||
23334282|NCT02343939|64965462|FG008|Overall Study|Study terminated by sponsor|0|||
23575629|NCT00136916|65838793|FG000|Overall Study|Discontinued in follow up period|3|||
23168000|NCT04327388|64363109|FG001|Overall Study|Randomized and not treated|0|||
23575630|NCT00136916|65838794|FG001|Overall Study|Discontinued in follow up period|0|||
23575631|NCT01528709|65838795|FG000|Overall Study|Death|2|||
23575632|NCT01528709|65838796|FG001|Overall Study|Death|0|||
23575633|NCT01528709|65838795|FG000|Overall Study|Withdrawal by Subject|10|||
23575634|NCT01528709|65838796|FG001|Overall Study|Withdrawal by Subject|15|||
23575635|NCT01528709|65838795|FG000|Overall Study|allergy|1|||
23168001|NCT04327388|64363110|FG002|Overall Study|Randomized and not treated|2|||
23168002|NCT00623480|64363111|FG000|Overall Study|Lost to Follow-up|0|||
23334283|NCT02343939|64965454|FG000|Overall Study|Withdrew consent|3|||
23575636|NCT01528709|65838796|FG001|Overall Study|allergy|0|||
23168003|NCT00623480|64363112|FG001|Overall Study|Lost to Follow-up|1|||
23168004|NCT00623480|64363111|FG000|Overall Study|Withdrawal by Subject|2|||
23334284|NCT02343939|64965455|FG001|Overall Study|Withdrew consent|6|||
23168005|NCT00623480|64363112|FG001|Overall Study|Withdrawal by Subject|4|||
23168006|NCT00623480|64363111|FG000|Overall Study|Lack of Efficacy|1|||
23168007|NCT00623480|64363112|FG001|Overall Study|Lack of Efficacy|0|||
23168008|NCT00623480|64363111|FG000|Overall Study|Non-compliant with study medication|4|||
23168009|NCT00623480|64363112|FG001|Overall Study|Non-compliant with study medication|0|||
23168010|NCT00623480|64363111|FG000|Overall Study|Protocol Violation|0|||
23168011|NCT00623480|64363112|FG001|Overall Study|Protocol Violation|1|||
23168012|NCT00623480|64363111|FG000|Overall Study|Site closed by sponsor|0|||
23227358|NCT00216086|64575091|FG000|Overall Study|Social Reasons|2|||
23334285|NCT02343939|64965456|FG002|Overall Study|Withdrew consent|1|||
23334286|NCT02343939|64965457|FG003|Overall Study|Withdrew consent|2|||
23575637|NCT00958009|65838797|FG000|Overall Study|Adverse Event|1|||
23168013|NCT00623480|64363112|FG001|Overall Study|Site closed by sponsor|1|||
23168014|NCT00288080|64363117|FG000|Overall Study|Withdrawal by Subject|1|||
23227359|NCT00376675|64575092|FG000|Overall Study|Withdrawal by Subject|9|||
23227360|NCT00376675|64575093|FG001|Overall Study|Withdrawal by Subject|2|||
23227361|NCT00376675|64575092|FG000|Overall Study|Adverse Event|10|||
23227362|NCT00376675|64575093|FG001|Overall Study|Adverse Event|5|||
23168015|NCT00288080|64363118|FG001|Overall Study|Withdrawal by Subject|3|||
23168016|NCT00288080|64363117|FG000|Overall Study|Protocol Violation|25|||
23168017|NCT00288080|64363118|FG001|Overall Study|Protocol Violation|20|||
23168018|NCT02175680|64363121|FG000|Overall Study|non-compliance|1|||
23168019|NCT02175680|64363121|FG000|Overall Study|other non-medical reason|1|||
23168020|NCT00371865|64363122|FG000|Overall Study|Lack of Efficacy|0|||
23168021|NCT00371865|64363123|FG001|Overall Study|Lack of Efficacy|2|||
23168022|NCT00371865|64363122|FG000|Overall Study|Protocol Violation|3|||
23168023|NCT00371865|64363123|FG001|Overall Study|Protocol Violation|2|||
23168024|NCT00371865|64363122|FG000|Overall Study|Withdrawal by Subject|12|||
23168025|NCT00371865|64363123|FG001|Overall Study|Withdrawal by Subject|10|||
23168026|NCT01029366|64363124|FG000|Overall Study|Withdrawal by Subject|1|||
23168027|NCT01029366|64363125|FG001|Overall Study|Withdrawal by Subject|0|||
23168028|NCT01029366|64363124|FG000|Overall Study|Death|1|||
23168029|NCT01029366|64363125|FG001|Overall Study|Death|1|||
23168030|NCT01029366|64363124|FG000|Overall Study|disease progression|2|||
23168031|NCT01029366|64363125|FG001|Overall Study|disease progression|0|||
23168032|NCT01029366|64363124|FG000|Overall Study|manufacturing failure|0|||
23168033|NCT01029366|64363125|FG001|Overall Study|manufacturing failure|1|||
23168034|NCT00774345|64363128|FG000|Pre-treatment|Other reasons|2|||
23168035|NCT00774345|64363129|FG001|Pre-treatment|Other reasons|0|||
23168036|NCT00774345|64363128|FG000|Treatment|Adverse Event|61|||
23168037|NCT00774345|64363129|FG001|Treatment|Adverse Event|15|||
23168038|NCT00774345|64363128|FG000|Treatment|Progressive Disease without histologic transformation|51|||
23168039|NCT00774345|64363129|FG001|Treatment|Progressive Disease without histologic transformation|111|||
23168040|NCT00774345|64363128|FG000|Treatment|Progressive Disease with histologic transformation|4|||
23168041|NCT00774345|64363129|FG001|Treatment|Progressive Disease with histologic transformation|2|||
23168042|NCT00774345|64363128|FG000|Treatment|Withdrawal by Subject|5|||
23168043|NCT00774345|64363129|FG001|Treatment|Withdrawal by Subject|2|||
23168044|NCT00774345|64363128|FG000|Treatment|Lost to Follow-up|1|||
23168045|NCT00774345|64363129|FG001|Treatment|Lost to Follow-up|1|||
23168046|NCT00774345|64363128|FG000|Treatment|Death|4|||
23168047|NCT00774345|64363129|FG001|Treatment|Death|0|||
23227363|NCT00376675|64575092|FG000|Overall Study|Other Reason|1|||
23227364|NCT00376675|64575093|FG001|Overall Study|Other Reason|7|||
23227365|NCT01263470|64575094|FG000|Overall Study|Adverse Event|2|||
23227366|NCT01263470|64575095|FG001|Overall Study|Adverse Event|2|||
23227367|NCT01263470|64575096|FG002|Overall Study|Adverse Event|1|||
23227368|NCT01263470|64575097|FG003|Overall Study|Adverse Event|1|||
23227369|NCT01263470|64575098|FG004|Overall Study|Adverse Event|2|||
23227370|NCT01263470|64575099|FG005|Overall Study|Adverse Event|2|||
23227371|NCT01263470|64575094|FG000|Overall Study|Protocol Violation|0|||
23227372|NCT01263470|64575095|FG001|Overall Study|Protocol Violation|1|||
23227373|NCT01263470|64575096|FG002|Overall Study|Protocol Violation|0|||
23227374|NCT01263470|64575097|FG003|Overall Study|Protocol Violation|0|||
23227375|NCT01263470|64575098|FG004|Overall Study|Protocol Violation|0|||
23227376|NCT01263470|64575099|FG005|Overall Study|Protocol Violation|1|||
23227377|NCT01263470|64575094|FG000|Overall Study|Withdrawal by Subject|0|||
23227378|NCT01263470|64575095|FG001|Overall Study|Withdrawal by Subject|1|||
23227379|NCT01263470|64575096|FG002|Overall Study|Withdrawal by Subject|1|||
23227380|NCT01263470|64575097|FG003|Overall Study|Withdrawal by Subject|2|||
23227381|NCT01263470|64575098|FG004|Overall Study|Withdrawal by Subject|0|||
23227382|NCT01263470|64575099|FG005|Overall Study|Withdrawal by Subject|2|||
23227383|NCT01263470|64575094|FG000|Overall Study|Lack of Efficacy|0|||
23227384|NCT01263470|64575095|FG001|Overall Study|Lack of Efficacy|0|||
23227385|NCT01263470|64575096|FG002|Overall Study|Lack of Efficacy|2|||
23227386|NCT01263470|64575097|FG003|Overall Study|Lack of Efficacy|0|||
23227387|NCT01263470|64575098|FG004|Overall Study|Lack of Efficacy|0|||
23227388|NCT01263470|64575099|FG005|Overall Study|Lack of Efficacy|0|||
23227389|NCT01263470|64575094|FG000|Overall Study|Participant Unavailability|0|||
23227390|NCT01263470|64575095|FG001|Overall Study|Participant Unavailability|1|||
23168048|NCT00774345|64363128|FG000|Treatment|Other Reasons|32|||
23168049|NCT00774345|64363129|FG001|Treatment|Other Reasons|26|||
23168050|NCT00661531|64363130|FG000|Overall Study|Withdrawal by Subject|3|||
23168051|NCT00884273|64363131|FG000|Overall Study|Adverse Event|0|||
23168052|NCT00884273|64363132|FG001|Overall Study|Adverse Event|2|||
23168053|NCT00884273|64363131|FG000|Overall Study|Protocol Violation|1|||
23168054|NCT00884273|64363132|FG001|Overall Study|Protocol Violation|3|||
23168055|NCT00884273|64363131|FG000|Overall Study|Practical reasons|1|||
23227391|NCT01263470|64575096|FG002|Overall Study|Participant Unavailability|0|||
23227392|NCT01263470|64575097|FG003|Overall Study|Participant Unavailability|0|||
23227393|NCT01263470|64575098|FG004|Overall Study|Participant Unavailability|0|||
23334287|NCT02343939|64965458|FG004|Overall Study|Withdrew consent|2|||
23334288|NCT02343939|64965459|FG005|Overall Study|Withdrew consent|0|||
23334289|NCT02343939|64965460|FG006|Overall Study|Withdrew consent|0|||
23334290|NCT02343939|64965461|FG007|Overall Study|Withdrew consent|8|||
23334291|NCT02343939|64965462|FG008|Overall Study|Withdrew consent|6|||
23334292|NCT02343939|64965454|FG000|Overall Study|Treatment failure|0|||
23334293|NCT02343939|64965455|FG001|Overall Study|Treatment failure|0|||
23334294|NCT02343939|64965456|FG002|Overall Study|Treatment failure|0|||
23334295|NCT02343939|64965457|FG003|Overall Study|Treatment failure|0|||
23334296|NCT02343939|64965458|FG004|Overall Study|Treatment failure|0|||
23447697|NCT01479868|65380569|FG000|Overall Study|Sponsor's Decision|1|||
23447698|NCT01479868|65380569|FG000|Overall Study|Initiation of new HCV Therapy|1|||
23168056|NCT00884273|64363132|FG001|Overall Study|Practical reasons|0|||
23168057|NCT03920670|64363133|FG000|Overall Study|Protocol Violation|2|||
23168058|NCT03920670|64363134|FG001|Overall Study|Protocol Violation|2|||
23334297|NCT02343939|64965459|FG005|Overall Study|Treatment failure|0|||
23334298|NCT02343939|64965460|FG006|Overall Study|Treatment failure|2|||
23447699|NCT01473732|65380570|FG000|Overall Study|Adverse Event|1|||
23447700|NCT01473732|65380571|FG001|Overall Study|Adverse Event|0|||
23447701|NCT01473732|65380570|FG000|Overall Study|Death|1|||
23447702|NCT01473732|65380571|FG001|Overall Study|Death|0|||
23447703|NCT00836186|65380578|FG000|Overall Study|Blood could not be drawn|1|||
23447704|NCT00108862|65380587|FG000|Overall Study|Death|31|||
23447705|NCT00108862|65380588|FG001|Overall Study|Death|37|||
23447706|NCT00108862|65380587|FG000|Overall Study|Withdrawal by Subject|10|||
23447707|NCT00108862|65380588|FG001|Overall Study|Withdrawal by Subject|6|||
23447708|NCT00108862|65380587|FG000|Overall Study|Lost to Follow-up|27|||
23447709|NCT00108862|65380588|FG001|Overall Study|Lost to Follow-up|19|||
23447710|NCT00801229|65380589|FG000|Signed Consent|Withdrawal by Subject|2|||
23447711|NCT00801229|65380590|FG001|Signed Consent|Withdrawal by Subject|2|||
23447712|NCT00801229|65380589|FG000|Signed Consent|Found Ineligible|1|||
23447713|NCT00801229|65380590|FG001|Signed Consent|Found Ineligible|1|||
23447714|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
23447715|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
23334299|NCT02343939|64965461|FG007|Overall Study|Treatment failure|1|||
23334300|NCT02343939|64965462|FG008|Overall Study|Treatment failure|0|||
23334301|NCT02343939|64965454|FG000|Overall Study|Investigator's discretion|0|||
23334302|NCT02343939|64965455|FG001|Overall Study|Investigator's discretion|0|||
23334303|NCT02343939|64965456|FG002|Overall Study|Investigator's discretion|0|||
23334304|NCT02343939|64965457|FG003|Overall Study|Investigator's discretion|1|||
23334305|NCT02343939|64965458|FG004|Overall Study|Investigator's discretion|0|||
23334306|NCT02343939|64965459|FG005|Overall Study|Investigator's discretion|0|||
23334307|NCT02343939|64965460|FG006|Overall Study|Investigator's discretion|1|||
23334308|NCT02343939|64965461|FG007|Overall Study|Investigator's discretion|0|||
23334309|NCT02343939|64965462|FG008|Overall Study|Investigator's discretion|0|||
23334310|NCT02343939|64965454|FG000|Overall Study|Adverse Event|0|||
23334311|NCT02343939|64965455|FG001|Overall Study|Adverse Event|0|||
23334312|NCT02343939|64965456|FG002|Overall Study|Adverse Event|0|||
23334313|NCT02343939|64965457|FG003|Overall Study|Adverse Event|0|||
23334314|NCT02343939|64965458|FG004|Overall Study|Adverse Event|0|||
23334315|NCT02343939|64965459|FG005|Overall Study|Adverse Event|1|||
23334316|NCT02343939|64965460|FG006|Overall Study|Adverse Event|0|||
23334317|NCT02343939|64965461|FG007|Overall Study|Adverse Event|0|||
23334318|NCT02343939|64965462|FG008|Overall Study|Adverse Event|0|||
23334319|NCT02343939|64965454|FG000|Overall Study|Never Treated With ENTO|0|||
23334320|NCT02343939|64965455|FG001|Overall Study|Never Treated With ENTO|0|||
23334321|NCT02343939|64965456|FG002|Overall Study|Never Treated With ENTO|0|||
23334322|NCT02343939|64965457|FG003|Overall Study|Never Treated With ENTO|0|||
23334323|NCT02343939|64965458|FG004|Overall Study|Never Treated With ENTO|0|||
23334324|NCT02343939|64965459|FG005|Overall Study|Never Treated With ENTO|0|||
23334325|NCT02343939|64965460|FG006|Overall Study|Never Treated With ENTO|1|||
23447716|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
23447717|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
23447718|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
23575638|NCT00958009|65838797|FG000|Overall Study|Subject found device difficult to use|1|||
23575639|NCT00738530|65838800|FG000|Overall Study|Death|220|||
23575640|NCT00738530|65838801|FG001|Overall Study|Death|224|||
23575641|NCT00738530|65838800|FG000|Overall Study|Lost to Follow-up|8|||
23168059|NCT03920670|64363133|FG000|Overall Study|Adverse Event|1|||
23334326|NCT02343939|64965461|FG007|Overall Study|Never Treated With ENTO|2|||
23334327|NCT02343939|64965462|FG008|Overall Study|Never Treated With ENTO|0|||
23334328|NCT03876743|64965469|FG000|Overall Study|Lost to Follow-up|6|||
23334329|NCT03876743|64965470|FG001|Overall Study|Lost to Follow-up|4|||
23168060|NCT03920670|64363134|FG001|Overall Study|Adverse Event|0|||
23168061|NCT01064167|64363137|FG000|Overall Study|Protocol Violation|14|||
23447719|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
23334330|NCT03876743|64965471|FG002|Overall Study|Lost to Follow-up|4|||
23334331|NCT03876743|64965472|FG003|Overall Study|Lost to Follow-up|7|||
23168062|NCT01064167|64363138|FG001|Overall Study|Protocol Violation|15|||
23168063|NCT00820898|64363139|FG000|Overall Study|Inelgible - wrong primary site|1|||
23334332|NCT03793842|64965473|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
23334333|NCT03793842|64965474|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
23334334|NCT03793842|64965473|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
23334335|NCT03793842|64965474|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
23334336|NCT04478695|64965475|FG000|Overall Study|Death|1|||
23334337|NCT04478695|64965476|FG001|Overall Study|Death|0|||
23334338|NCT03809663|64965477|FG000|Overall Study|Decision by sponsor|24|||
23334339|NCT03809663|64965478|FG001|Overall Study|Decision by sponsor|18|||
23334340|NCT03809663|64965479|FG002|Overall Study|Decision by sponsor|20|||
23334341|NCT03809663|64965480|FG003|Overall Study|Decision by sponsor|20|||
23334342|NCT03809663|64965481|FG004|Overall Study|Decision by sponsor|0|||
23334343|NCT03809663|64965482|FG005|Overall Study|Decision by sponsor|0|||
23168064|NCT01780662|64363141|FG000|Overall Study|Adverse Event|1|||
23168065|NCT01780662|64363142|FG001|Overall Study|Adverse Event|0|||
23168066|NCT01780662|64363143|FG002|Overall Study|Adverse Event|2|||
23168067|NCT01780662|64363141|FG000|Overall Study|Physician Decision|0|||
23168068|NCT01780662|64363142|FG001|Overall Study|Physician Decision|5|||
23168069|NCT01780662|64363143|FG002|Overall Study|Physician Decision|7|||
23168070|NCT01780662|64363141|FG000|Overall Study|Protocol Violation|0|||
23168071|NCT01780662|64363142|FG001|Overall Study|Protocol Violation|1|||
23168072|NCT01780662|64363143|FG002|Overall Study|Protocol Violation|0|||
23168073|NCT01780662|64363141|FG000|Overall Study|Ineligible|0|||
23168074|NCT01780662|64363142|FG001|Overall Study|Ineligible|0|||
23168075|NCT01780662|64363143|FG002|Overall Study|Ineligible|1|||
23168076|NCT01902966|64363144|FG000|Overall Study|Death|1|||
23168077|NCT01902966|64363144|FG000|Overall Study|Physician Decision|1|||
23168078|NCT01902966|64363144|FG000|Overall Study|Withdrawal by Subject|1|||
23168079|NCT04942925|64363145|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
23168080|NCT04942925|64363146|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
23168081|NCT04942925|64363145|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
23168082|NCT04942925|64363146|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
23168083|NCT01562548|64363147|FG000|Overall Study|Lost to Follow-up|0|||
23168084|NCT01562548|64363148|FG001|Overall Study|Lost to Follow-up|0|||
23168085|NCT01562548|64363149|FG002|Overall Study|Lost to Follow-up|1|||
23168086|NCT01562548|64363150|FG003|Overall Study|Lost to Follow-up|0|||
23168087|NCT01870401|64363151|FG000|Overall Study|Death|48|||
23227394|NCT01263470|64575099|FG005|Overall Study|Participant Unavailability|0|||
23227395|NCT01263470|64575094|FG000|Overall Study|Study Drug Non-compliance|0|||
23227396|NCT01263470|64575095|FG001|Overall Study|Study Drug Non-compliance|0|||
23227397|NCT01263470|64575096|FG002|Overall Study|Study Drug Non-compliance|0|||
23227398|NCT01263470|64575097|FG003|Overall Study|Study Drug Non-compliance|0|||
23334344|NCT03809663|64965477|FG000|Overall Study|Withdrawal by Subject|26|||
23334345|NCT03809663|64965478|FG001|Overall Study|Withdrawal by Subject|22|||
23334346|NCT03809663|64965479|FG002|Overall Study|Withdrawal by Subject|27|||
23334347|NCT03809663|64965480|FG003|Overall Study|Withdrawal by Subject|26|||
23334348|NCT03809663|64965481|FG004|Overall Study|Withdrawal by Subject|0|||
23334349|NCT03809663|64965482|FG005|Overall Study|Withdrawal by Subject|0|||
23334350|NCT03809663|64965477|FG000|Overall Study|Lost to Follow-up|1|||
23334351|NCT03809663|64965478|FG001|Overall Study|Lost to Follow-up|4|||
23334352|NCT03809663|64965479|FG002|Overall Study|Lost to Follow-up|1|||
23334353|NCT03809663|64965480|FG003|Overall Study|Lost to Follow-up|1|||
23334354|NCT03809663|64965481|FG004|Overall Study|Lost to Follow-up|0|||
23227399|NCT01263470|64575098|FG004|Overall Study|Study Drug Non-compliance|1|||
23227400|NCT01263470|64575099|FG005|Overall Study|Study Drug Non-compliance|0|||
23334355|NCT03809663|64965482|FG005|Overall Study|Lost to Follow-up|0|||
23334356|NCT01735916|64965483|FG000|Overall Study|Subject not eligible to be randomized|11|||
23334357|NCT01735916|64965484|FG001|Overall Study|Subject not eligible to be randomized|0|||
23334358|NCT01735916|64965485|FG002|Overall Study|Subject not eligible to be randomized|0|||
23334359|NCT01735916|64965483|FG000|Overall Study|Early termination of study by sponsor|4|||
23334360|NCT01735916|64965484|FG001|Overall Study|Early termination of study by sponsor|19|||
23334361|NCT01735916|64965485|FG002|Overall Study|Early termination of study by sponsor|7|||
23334362|NCT01735916|64965483|FG000|Overall Study|Withdrawal by Subject|3|||
23334363|NCT01735916|64965484|FG001|Overall Study|Withdrawal by Subject|0|||
23334364|NCT01735916|64965485|FG002|Overall Study|Withdrawal by Subject|0|||
23334365|NCT01684943|64965487|FG000|Overall Study|Inadequate Venous Access|3|||
23334366|NCT01684943|64965488|FG001|Overall Study|Inadequate Venous Access|0|||
23334367|NCT01684943|64965489|FG002|Overall Study|Inadequate Venous Access|0|||
23168088|NCT01870401|64363152|FG001|Overall Study|Death|24|||
23168089|NCT01870401|64363151|FG000|Overall Study|Withdrawal by Subject|39|||
23168090|NCT01870401|64363152|FG001|Overall Study|Withdrawal by Subject|26|||
23168091|NCT01870401|64363151|FG000|Overall Study|Lost to Follow-up|19|||
23168092|NCT01870401|64363152|FG001|Overall Study|Lost to Follow-up|14|||
23168093|NCT01870401|64363151|FG000|Overall Study|Other|9|||
23227401|NCT02202161|64575100|FG000|Overall Study|Adverse Event|1|||
23447720|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
23447721|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
23447722|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
23447723|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
23447724|NCT00801229|65380589|FG000|Received Study Drug/Placebo|Adverse Event|1|||
23447725|NCT00801229|65380590|FG001|Received Study Drug/Placebo|Adverse Event|1|||
23447726|NCT00269919|65380591|FG000|Overall Study|Other|26|||
23447727|NCT00269919|65380591|FG000|Overall Study|Started but not treated|1|||
23447728|NCT01569841|65380592|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
23447729|NCT01569841|65380593|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
23447730|NCT04549545|65380594|FG000|Initial Period|Withdrawal by Subject|4|||
23575642|NCT00738530|65838801|FG001|Overall Study|Lost to Follow-up|6|||
23227402|NCT02202161|64575101|FG001|Overall Study|Adverse Event|1|||
23227403|NCT02202161|64575102|FG002|Overall Study|Adverse Event|0|||
23227404|NCT02202161|64575103|FG003|Overall Study|Adverse Event|0|||
23227405|NCT02202161|64575104|FG004|Overall Study|Adverse Event|0|||
23227406|NCT02202161|64575105|FG005|Overall Study|Adverse Event|1|||
23227407|NCT02202161|64575106|FG006|Overall Study|Adverse Event|0|||
23227408|NCT02202161|64575107|FG007|Overall Study|Adverse Event|0|||
23227409|NCT02202161|64575100|FG000|Overall Study|Did not meet continuation criteria|0|||
23227410|NCT02202161|64575101|FG001|Overall Study|Did not meet continuation criteria|0|||
23227411|NCT02202161|64575102|FG002|Overall Study|Did not meet continuation criteria|0|||
23227412|NCT02202161|64575103|FG003|Overall Study|Did not meet continuation criteria|0|||
23227413|NCT02202161|64575104|FG004|Overall Study|Did not meet continuation criteria|0|||
23227414|NCT02202161|64575105|FG005|Overall Study|Did not meet continuation criteria|0|||
23227415|NCT02202161|64575106|FG006|Overall Study|Did not meet continuation criteria|0|||
23227416|NCT02202161|64575107|FG007|Overall Study|Did not meet continuation criteria|3|||
23227417|NCT02202161|64575100|FG000|Overall Study|Physician Decision|0|||
23227418|NCT02202161|64575101|FG001|Overall Study|Physician Decision|0|||
23227419|NCT02202161|64575102|FG002|Overall Study|Physician Decision|0|||
23227420|NCT02202161|64575103|FG003|Overall Study|Physician Decision|0|||
23227421|NCT02202161|64575104|FG004|Overall Study|Physician Decision|0|||
23227422|NCT02202161|64575105|FG005|Overall Study|Physician Decision|0|||
23227423|NCT02202161|64575106|FG006|Overall Study|Physician Decision|0|||
23227424|NCT02202161|64575107|FG007|Overall Study|Physician Decision|3|||
23227425|NCT02202161|64575100|FG000|Overall Study|Withdrawal by Subject|0|||
23227426|NCT02202161|64575101|FG001|Overall Study|Withdrawal by Subject|0|||
23227427|NCT02202161|64575102|FG002|Overall Study|Withdrawal by Subject|0|||
23227428|NCT02202161|64575103|FG003|Overall Study|Withdrawal by Subject|0|||
23227429|NCT02202161|64575104|FG004|Overall Study|Withdrawal by Subject|1|||
23227430|NCT02202161|64575105|FG005|Overall Study|Withdrawal by Subject|0|||
23227431|NCT02202161|64575106|FG006|Overall Study|Withdrawal by Subject|0|||
23227432|NCT02202161|64575107|FG007|Overall Study|Withdrawal by Subject|0|||
23227433|NCT02038790|64575111|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
23227434|NCT02038790|64575112|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
23227435|NCT01603615|64575113|FG000|Overall Study|Did not Receive Treatment|7|||
23227436|NCT01603615|64575113|FG000|Overall Study|Lost to Follow-up|9|||
23227437|NCT01603615|64575113|FG000|Overall Study|Personal Reasons|17|||
23227438|NCT01603615|64575113|FG000|Overall Study|Other Miscellaneous|1|||
23227439|NCT02380703|64575114|FG000|Overall Study|Withdrawal by Subject|12|||
23227440|NCT02380703|64575115|FG001|Overall Study|Withdrawal by Subject|9|||
23227441|NCT02380703|64575114|FG000|Overall Study|Lost to Follow-up|12|||
23227442|NCT02380703|64575115|FG001|Overall Study|Lost to Follow-up|12|||
23227443|NCT02380703|64575114|FG000|Overall Study|Caregiver death|1|||
23227444|NCT02380703|64575115|FG001|Overall Study|Caregiver death|0|||
23227445|NCT02380703|64575114|FG000|Overall Study|Person with dementia (PWD) death|7|||
23227446|NCT02380703|64575115|FG001|Overall Study|Person with dementia (PWD) death|8|||
23227447|NCT02380703|64575114|FG000|Overall Study|Entered Long-term Care|4|||
23227448|NCT02380703|64575115|FG001|Overall Study|Entered Long-term Care|7|||
23227449|NCT03462030|64575116|FG000|Overall Study|Withdrawal by Subject|1|||
23227450|NCT03462030|64575117|FG001|Overall Study|Withdrawal by Subject|1|||
23575643|NCT00738530|65838800|FG000|Overall Study|Withdrawal by Subject|6|||
23575644|NCT00738530|65838801|FG001|Overall Study|Withdrawal by Subject|8|||
23227451|NCT01435122|64575118|FG000|Overall Study|Early withdrawal due to toxicity|8|||
23227452|NCT02531633|64575120|FG000|Part A (52 Weeks)|Sponsor request|24|||
23227453|NCT02531633|64575121|FG001|Part A (52 Weeks)|Sponsor request|24|||
23227454|NCT02531633|64575122|FG002|Part A (52 Weeks)|Sponsor request|18|||
23227455|NCT02531633|64575123|FG003|Part A (52 Weeks)|Sponsor request|18|||
23227456|NCT02531633|64575124|FG004|Part A (52 Weeks)|Sponsor request|19|||
23227457|NCT02531633|64575125|FG005|Part A (52 Weeks)|Sponsor request|0|||
23227458|NCT02531633|64575126|FG006|Part A (52 Weeks)|Sponsor request|0|||
23227459|NCT02531633|64575127|FG007|Part A (52 Weeks)|Sponsor request|0|||
23575645|NCT03930186|65838808|FG000|Weeks 0 to 16|Adverse Event|6|||
23575646|NCT03930186|65838808|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
23227460|NCT02531633|64575128|FG008|Part A (52 Weeks)|Sponsor request|0|||
23575647|NCT03930186|65838808|FG000|Weeks 16 to 32|Adverse Event|1|||
23227461|NCT02531633|64575129|FG009|Part A (52 Weeks)|Sponsor request|0|||
23334368|NCT01684943|64965487|FG000|Overall Study|Principal Investigator Determination|1|||
23334369|NCT01684943|64965488|FG001|Overall Study|Principal Investigator Determination|0|||
23334370|NCT01684943|64965489|FG002|Overall Study|Principal Investigator Determination|0|||
23334371|NCT01684943|64965487|FG000|Overall Study|Excluded from Analysis|1|||
23334372|NCT01684943|64965488|FG001|Overall Study|Excluded from Analysis|1|||
23334373|NCT01684943|64965489|FG002|Overall Study|Excluded from Analysis|1|||
23334374|NCT01684943|64965487|FG000|Overall Study|Lost to Follow-up|3|||
23334375|NCT01684943|64965488|FG001|Overall Study|Lost to Follow-up|0|||
23334376|NCT01684943|64965489|FG002|Overall Study|Lost to Follow-up|0|||
23334377|NCT01684943|64965487|FG000|Overall Study|Planning Pregnancy|1|||
23334378|NCT01684943|64965488|FG001|Overall Study|Planning Pregnancy|0|||
23334379|NCT01684943|64965489|FG002|Overall Study|Planning Pregnancy|0|||
23334380|NCT00833105|64965493|FG000|Overall Study|Withdrawal by Subject|1|||
23334381|NCT00833105|64965493|FG000|Overall Study|Adverse Event|2|||
23334382|NCT02518048|64965502|FG000|Overall Study|Withdrawal by Subject|1|||
23334383|NCT02920008|64965504|FG000|Overall Study|Death|117|||
23334384|NCT02920008|64965505|FG001|Overall Study|Death|127|||
23334385|NCT02920008|64965504|FG000|Overall Study|Withdrawal by Subject|3|||
23334386|NCT02920008|64965505|FG001|Overall Study|Withdrawal by Subject|6|||
23334387|NCT02920008|64965504|FG000|Overall Study|Lost to Follow-up|0|||
23334388|NCT02920008|64965505|FG001|Overall Study|Lost to Follow-up|1|||
23334389|NCT00333983|64965506|FG000|Overall Study|Lost to Follow-up|2|||
23334390|NCT00333983|64965507|FG001|Overall Study|Lost to Follow-up|1|||
23227462|NCT02531633|64575120|FG000|Part A (52 Weeks)|Protocol Violation|1|||
23227463|NCT02531633|64575121|FG001|Part A (52 Weeks)|Protocol Violation|0|||
23227464|NCT02531633|64575122|FG002|Part A (52 Weeks)|Protocol Violation|0|||
23227465|NCT02531633|64575123|FG003|Part A (52 Weeks)|Protocol Violation|0|||
23227466|NCT02531633|64575124|FG004|Part A (52 Weeks)|Protocol Violation|0|||
23334391|NCT00333983|64965508|FG002|Overall Study|Lost to Follow-up|0|||
23334392|NCT00333983|64965506|FG000|Overall Study|Adverse Event|1|||
23334393|NCT00333983|64965507|FG001|Overall Study|Adverse Event|1|||
23334394|NCT00333983|64965508|FG002|Overall Study|Adverse Event|1|||
23334395|NCT00333983|64965506|FG000|Overall Study|Withdrawal by Subject|0|||
23334396|NCT00333983|64965507|FG001|Overall Study|Withdrawal by Subject|3|||
23334397|NCT00333983|64965508|FG002|Overall Study|Withdrawal by Subject|1|||
23334398|NCT04112043|64965509|FG000|Overall Study|Withdrawal by Subject|1|||
23334399|NCT04112043|64965510|FG001|Overall Study|Withdrawal by Subject|1|||
23334400|NCT04112043|64965511|FG002|Overall Study|Withdrawal by Subject|1|||
23334401|NCT04112043|64965509|FG000|Overall Study|Taking NR supplement|1|||
23334402|NCT04112043|64965510|FG001|Overall Study|Taking NR supplement|0|||
23334403|NCT04112043|64965511|FG002|Overall Study|Taking NR supplement|0|||
23334404|NCT04112043|64965509|FG000|Overall Study|Adverse Event|0|||
23334405|NCT04112043|64965510|FG001|Overall Study|Adverse Event|1|||
23334406|NCT04112043|64965511|FG002|Overall Study|Adverse Event|0|||
23334407|NCT00582608|64965515|FG000|Overall Study|Not Treated|7|||
23334408|NCT00582608|64965515|FG000|Overall Study|Patient Ineligible|1|||
23334409|NCT00582608|64965515|FG000|Overall Study|Lack of accrual|4|||
23334410|NCT01996254|64965521|FG000|Overall Study|Change in Eligibility|0|||
23334411|NCT01996254|64965522|FG001|Overall Study|Change in Eligibility|2|||
23334412|NCT01996254|64965523|FG002|Overall Study|Change in Eligibility|0|||
23334413|NCT01996254|64965521|FG000|Overall Study|Withdrawal by Subject|0|||
23334414|NCT01996254|64965522|FG001|Overall Study|Withdrawal by Subject|3|||
23334415|NCT01996254|64965523|FG002|Overall Study|Withdrawal by Subject|4|||
23334416|NCT01996254|64965521|FG000|Overall Study|Lost to Follow-up|1|||
23334417|NCT01996254|64965522|FG001|Overall Study|Lost to Follow-up|0|||
23334418|NCT01996254|64965523|FG002|Overall Study|Lost to Follow-up|4|||
23334419|NCT01931475|64965524|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
23227467|NCT02531633|64575125|FG005|Part A (52 Weeks)|Protocol Violation|0|||
23227468|NCT02531633|64575126|FG006|Part A (52 Weeks)|Protocol Violation|0|||
23227469|NCT02531633|64575127|FG007|Part A (52 Weeks)|Protocol Violation|0|||
23227470|NCT02531633|64575128|FG008|Part A (52 Weeks)|Protocol Violation|0|||
23227471|NCT02531633|64575129|FG009|Part A (52 Weeks)|Protocol Violation|0|||
23227472|NCT02531633|64575120|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
23227473|NCT02531633|64575121|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
23227474|NCT02531633|64575122|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
23334420|NCT01931475|64965525|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
23334421|NCT01931475|64965524|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
23334422|NCT01931475|64965525|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
23334423|NCT01931475|64965524|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
23334424|NCT01931475|64965525|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
23334425|NCT01931475|64965524|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
23334426|NCT01931475|64965525|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
23334427|NCT01931475|64965524|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
23227475|NCT02531633|64575123|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
23227476|NCT02531633|64575124|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
23334428|NCT01931475|64965525|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
23334429|NCT01931475|64965524|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
23334430|NCT01931475|64965525|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
23334431|NCT01931475|64965524|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
23334432|NCT01931475|64965525|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
23334433|NCT01931475|64965524|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
23334434|NCT01931475|64965525|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
23334435|NCT01931475|64965524|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
23334436|NCT01931475|64965525|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
23334437|NCT01931475|64965524|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
23334438|NCT01931475|64965525|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
23334439|NCT01931475|64965524|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
23334440|NCT01931475|64965525|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
23334441|NCT00442897|64965527|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
23334442|NCT00442897|64965528|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
23334443|NCT00442897|64965527|FG000|Base Study (12 Week Follow-up)|Death|0|||
23334444|NCT00442897|64965528|FG001|Base Study (12 Week Follow-up)|Death|1|||
23334445|NCT00442897|64965527|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
23334446|NCT00442897|64965528|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
23334447|NCT00442897|64965527|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
23334448|NCT00442897|64965528|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
23334449|NCT00442897|64965527|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
23334450|NCT00442897|64965528|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
23334451|NCT00442897|64965527|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
23334452|NCT00442897|64965528|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
23334453|NCT00442897|64965527|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
23227477|NCT02531633|64575125|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
23227478|NCT02531633|64575126|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
23227479|NCT02531633|64575127|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
23334454|NCT00442897|64965528|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
23334455|NCT00442897|64965527|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
23334456|NCT00442897|64965528|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
23334457|NCT01436370|64965532|FG000|Overall Study|Lost to Follow-up|0|||
23334458|NCT01436370|64965533|FG001|Overall Study|Lost to Follow-up|0|||
23334459|NCT01436370|64965534|FG002|Overall Study|Lost to Follow-up|0|||
23334460|NCT01436370|64965535|FG003|Overall Study|Lost to Follow-up|0|||
23334461|NCT01436370|64965536|FG004|Overall Study|Lost to Follow-up|1|||
23334462|NCT01436370|64965537|FG005|Overall Study|Lost to Follow-up|0|||
23447731|NCT04549545|65380595|FG001|Initial Period|Withdrawal by Subject|0|||
23447732|NCT04549545|65380594|FG000|Initial Period|Additional ENT Procedure|3|||
23447733|NCT04549545|65380595|FG001|Initial Period|Additional ENT Procedure|0|||
23447734|NCT04549545|65380594|FG000|Initial Period|Lost to Follow-up|3|||
23447735|NCT04549545|65380595|FG001|Initial Period|Lost to Follow-up|1|||
23447736|NCT04549545|65380594|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
23447737|NCT04549545|65380595|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
23447738|NCT04549545|65380594|FG000|Crossover Period|Additional ENT Procedure|0|||
23447739|NCT04549545|65380595|FG001|Crossover Period|Additional ENT Procedure|6|||
23447740|NCT04549545|65380594|FG000|Crossover Period|Lost to Follow-up|0|||
23447741|NCT04549545|65380595|FG001|Crossover Period|Lost to Follow-up|1|||
23447742|NCT04549545|65380594|FG000|Crossover Period|Withdrawal by Subject|0|||
23447743|NCT04549545|65380595|FG001|Crossover Period|Withdrawal by Subject|4|||
23447744|NCT02587520|65380596|FG000|Overall Study|Protocol Violation|2|||
23447745|NCT02587520|65380597|FG001|Overall Study|Protocol Violation|0|||
23227480|NCT02531633|64575128|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
23227481|NCT02531633|64575129|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
23334463|NCT01436370|64965538|FG006|Overall Study|Lost to Follow-up|0|||
23334464|NCT01436370|64965539|FG007|Overall Study|Lost to Follow-up|0|||
23227482|NCT02531633|64575120|FG000|Part A (52 Weeks)|Physician Decision|1|||
23227483|NCT02531633|64575121|FG001|Part A (52 Weeks)|Physician Decision|4|||
23227484|NCT02531633|64575122|FG002|Part A (52 Weeks)|Physician Decision|3|||
23227485|NCT02531633|64575123|FG003|Part A (52 Weeks)|Physician Decision|1|||
23227486|NCT02531633|64575124|FG004|Part A (52 Weeks)|Physician Decision|0|||
23227487|NCT02531633|64575125|FG005|Part A (52 Weeks)|Physician Decision|0|||
23227488|NCT02531633|64575126|FG006|Part A (52 Weeks)|Physician Decision|0|||
23334465|NCT04164732|64965540|FG000|Treatment run-in Period|Adverse Event|4|||
23334466|NCT04164732|64965541|FG001|Treatment run-in Period|Adverse Event|0|||
23334467|NCT04164732|64965542|FG002|Treatment run-in Period|Adverse Event|0|||
23334468|NCT04164732|64965540|FG000|Treatment run-in Period|Physician Decision|1|||
23447746|NCT02587520|65380598|FG002|Overall Study|Protocol Violation|0|||
23447747|NCT02587520|65380599|FG003|Overall Study|Protocol Violation|2|||
23334469|NCT04164732|64965541|FG001|Treatment run-in Period|Physician Decision|0|||
23227489|NCT02531633|64575127|FG007|Part A (52 Weeks)|Physician Decision|0|||
23447748|NCT02587520|65380600|FG004|Overall Study|Protocol Violation|0|||
23447749|NCT02587520|65380601|FG005|Overall Study|Protocol Violation|1|||
23447750|NCT02587520|65380602|FG006|Overall Study|Protocol Violation|1|||
23447751|NCT02587520|65380603|FG007|Overall Study|Protocol Violation|1|||
23447752|NCT02587520|65380604|FG008|Overall Study|Protocol Violation|3|||
23447753|NCT02587520|65380605|FG009|Overall Study|Protocol Violation|3|||
23447754|NCT02587520|65380606|FG010|Overall Study|Protocol Violation|1|||
23447755|NCT02587520|65380607|FG011|Overall Study|Protocol Violation|2|||
23227490|NCT02531633|64575128|FG008|Part A (52 Weeks)|Physician Decision|0|||
23227491|NCT02531633|64575129|FG009|Part A (52 Weeks)|Physician Decision|0|||
23227492|NCT02531633|64575120|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
23227493|NCT02531633|64575121|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
23227494|NCT02531633|64575122|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
23227495|NCT02531633|64575123|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
23227496|NCT02531633|64575124|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
23447756|NCT02587520|65380608|FG012|Overall Study|Protocol Violation|0|||
23447757|NCT02587520|65380609|FG013|Overall Study|Protocol Violation|0|||
23447758|NCT02587520|65380610|FG014|Overall Study|Protocol Violation|0|||
23334470|NCT04164732|64965542|FG002|Treatment run-in Period|Physician Decision|0|||
23334471|NCT04164732|64965540|FG000|Treatment run-in Period|Screen Failure|1|||
23334472|NCT04164732|64965541|FG001|Treatment run-in Period|Screen Failure|0|||
23168094|NCT01870401|64363152|FG001|Overall Study|Other|7|||
23168095|NCT01870401|64363151|FG000|Overall Study|On-going in the Study|35|||
23168096|NCT01870401|64363152|FG001|Overall Study|On-going in the Study|25|||
23168097|NCT00711100|64363153|FG000|Overall Study|Lack of Efficacy|5|||
23168098|NCT00711100|64363153|FG000|Overall Study|Withdrawal by Subject|8|||
23168099|NCT00049673|64363154|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
23168100|NCT00049673|64363155|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
23168101|NCT02222207|64363157|FG000|Overall Study|Death|1|||
23168102|NCT02222207|64363157|FG000|Overall Study|Other reasons|2|||
23168103|NCT02222207|64363157|FG000|Overall Study|Adverse Event|1|||
23168104|NCT03529773|64363158|FG000|Overall Study|Adverse Event|0|||
23168105|NCT03529773|64363159|FG001|Overall Study|Adverse Event|0|||
23168106|NCT03529773|64363160|FG002|Overall Study|Adverse Event|0|||
23168107|NCT03529773|64363161|FG003|Overall Study|Adverse Event|0|||
23168108|NCT03529773|64363162|FG004|Overall Study|Adverse Event|0|||
23168109|NCT03529773|64363163|FG005|Overall Study|Adverse Event|0|||
23168110|NCT03529773|64363164|FG006|Overall Study|Adverse Event|0|||
23168111|NCT03529773|64363165|FG007|Overall Study|Adverse Event|0|||
23168112|NCT03529773|64363166|FG008|Overall Study|Adverse Event|0|||
23168113|NCT03529773|64363167|FG009|Overall Study|Adverse Event|0|||
23168114|NCT03529773|64363168|FG010|Overall Study|Adverse Event|0|||
23227497|NCT02531633|64575125|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
23334473|NCT04164732|64965542|FG002|Treatment run-in Period|Screen Failure|0|||
23334474|NCT04164732|64965540|FG000|Randomized Treatment Period|Adverse Event|0|||
23334475|NCT04164732|64965541|FG001|Randomized Treatment Period|Adverse Event|1|||
23334476|NCT04164732|64965542|FG002|Randomized Treatment Period|Adverse Event|0|||
23334477|NCT04164732|64965540|FG000|Randomized Treatment Period|Protocol Deviation|0|||
23334478|NCT04164732|64965541|FG001|Randomized Treatment Period|Protocol Deviation|1|||
23334479|NCT04164732|64965542|FG002|Randomized Treatment Period|Protocol Deviation|1|||
23334480|NCT04164732|64965540|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
23334481|NCT04164732|64965541|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
23334482|NCT04164732|64965542|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
23334483|NCT04498182|64965545|FG000|Overall Study|Adverse Event|2|||
23334484|NCT04498182|64965546|FG001|Overall Study|Adverse Event|3|||
23334485|NCT04498182|64965547|FG002|Overall Study|Adverse Event|2|||
23334486|NCT04498182|64965545|FG000|Overall Study|Withdrawal of Consent|3|||
23334487|NCT04498182|64965546|FG001|Overall Study|Withdrawal of Consent|4|||
23334488|NCT04498182|64965547|FG002|Overall Study|Withdrawal of Consent|3|||
23334489|NCT04498182|64965545|FG000|Overall Study|Non-Compliant|1|||
23334490|NCT04498182|64965546|FG001|Overall Study|Non-Compliant|0|||
23334491|NCT04498182|64965547|FG002|Overall Study|Non-Compliant|1|||
23334492|NCT04498182|64965545|FG000|Overall Study|Lost to Follow-up|0|||
23334493|NCT04498182|64965546|FG001|Overall Study|Lost to Follow-up|0|||
23334494|NCT04498182|64965547|FG002|Overall Study|Lost to Follow-up|1|||
23334495|NCT04498182|64965545|FG000|Overall Study|Investigator Decision|0|||
23227498|NCT02531633|64575126|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
23227499|NCT02531633|64575127|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
23168115|NCT03529773|64363169|FG011|Overall Study|Adverse Event|0|||
23168116|NCT03529773|64363170|FG012|Overall Study|Adverse Event|0|||
23227500|NCT02531633|64575128|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
23334496|NCT04498182|64965546|FG001|Overall Study|Investigator Decision|0|||
23334497|NCT04498182|64965547|FG002|Overall Study|Investigator Decision|1|||
23334498|NCT04498182|64965545|FG000|Overall Study|Protocol Violation|1|||
23334499|NCT04498182|64965546|FG001|Overall Study|Protocol Violation|0|||
23168117|NCT03529773|64363171|FG013|Overall Study|Adverse Event|0|||
23168118|NCT03529773|64363172|FG014|Overall Study|Adverse Event|0|||
23334500|NCT04498182|64965547|FG002|Overall Study|Protocol Violation|2|||
23334501|NCT04157296|64965551|FG000|Overall Study|Withdrawal by Subject|0|||
23334502|NCT04157296|64965552|FG001|Overall Study|Withdrawal by Subject|1|||
23334503|NCT04157296|64965551|FG000|Overall Study|Did not obtain second fMRI.|0|||
23334504|NCT04157296|64965552|FG001|Overall Study|Did not obtain second fMRI.|1|||
23334505|NCT04157296|64965551|FG000|Overall Study|MRI failed/no second fMRI|0|||
23575648|NCT03930186|65838808|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
23575649|NCT00830947|65838813|FG000|Overall Study|Lost to Follow-up|4|||
23575650|NCT00830947|65838814|FG001|Overall Study|Lost to Follow-up|4|||
23575651|NCT04545619|65838815|FG000|Overall Study|due to equipment challenges|1|||
23575652|NCT00877851|65838816|FG000|Overall Study|Lost to Follow-up|5|||
23575653|NCT00877851|65838817|FG001|Overall Study|Lost to Follow-up|5|||
23575654|NCT00877851|65838816|FG000|Overall Study|computer problem|3|||
23575655|NCT00877851|65838817|FG001|Overall Study|computer problem|0|||
23575656|NCT00877851|65838816|FG000|Overall Study|no longer interested in participating|1|||
23575657|NCT00877851|65838817|FG001|Overall Study|no longer interested in participating|0|||
23575658|NCT01318811|65838820|FG000|Overall Study|Physician Decision|1|||
23575659|NCT01318811|65838821|FG001|Overall Study|Physician Decision|1|||
23575660|NCT01318811|65838820|FG000|Overall Study|CRRT stopped for head CT|0|||
23575661|NCT01318811|65838821|FG001|Overall Study|CRRT stopped for head CT|1|||
23575662|NCT01318811|65838820|FG000|Overall Study|Death|0|||
23575663|NCT01318811|65838821|FG001|Overall Study|Death|1|||
23334506|NCT04157296|64965552|FG001|Overall Study|MRI failed/no second fMRI|1|||
23334507|NCT04537234|64969220|FG000|Overall Study|Withdrawal by Subject|2|||
23334508|NCT04537234|64969221|FG001|Overall Study|Withdrawal by Subject|0|||
23334509|NCT01948193|64969222|FG000|Overall Study|Serious event|2|||
23334510|NCT01948193|64969222|FG000|Overall Study|Lost to Follow-up|7|||
23334511|NCT02112045|64969223|FG000|Overall Study|Withdrawal by Subject|1|||
23334512|NCT02112045|64969224|FG001|Overall Study|Withdrawal by Subject|0|||
23334513|NCT00758485|64969230|FG000|Overall Study|Lost to Follow-up|0|||
23334514|NCT00758485|64969231|FG001|Overall Study|Lost to Follow-up|1|||
23334515|NCT00758485|64969230|FG000|Overall Study|Not Treated|1|||
23334516|NCT00758485|64969231|FG001|Overall Study|Not Treated|2|||
23334517|NCT03887442|64969232|FG000|Overall Study|Adverse Event|1|||
23334518|NCT03887442|64969233|FG001|Overall Study|Adverse Event|0|||
23334519|NCT00458536|64969234|FG000|Overall Study|Disease progression prior to treatment|7|||
23334520|NCT00458536|64969234|FG000|Overall Study|Unable to make vaccine|3|||
23334521|NCT00458536|64969234|FG000|Overall Study|No measurable disease after surgery|2|||
23334522|NCT00458536|64969234|FG000|Overall Study|Did not have renal cell carcinoma|2|||
23334523|NCT00458536|64969234|FG000|Overall Study|Patient did not have surgery|1|||
23334524|NCT00458536|64969234|FG000|Overall Study|Ineligible due to toxicity|1|||
23334525|NCT00458536|64969234|FG000|Overall Study|Withdrawal by Subject|1|||
23334526|NCT00458536|64969234|FG000|Overall Study|Progressive disease during treatment|2|||
23334527|NCT01355575|64969235|FG000|Overall Study|Withdrawal by Subject|2|||
23334528|NCT00984568|64969236|FG000|Overall Study|Withdrawal by Subject|1|||
23334529|NCT00984568|64969237|FG001|Overall Study|Withdrawal by Subject|2|||
23334530|NCT00984568|64969236|FG000|Overall Study|Lack of Efficacy|2|||
23334531|NCT00984568|64969237|FG001|Overall Study|Lack of Efficacy|0|||
23334532|NCT00984568|64969236|FG000|Overall Study|Adverse Event|2|||
23334533|NCT00984568|64969237|FG001|Overall Study|Adverse Event|0|||
23334534|NCT00984568|64969236|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
23334535|NCT00984568|64969237|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
23334536|NCT00984568|64969236|FG000|Overall Study|Lost to Follow-up|0|||
23334537|NCT00984568|64969237|FG001|Overall Study|Lost to Follow-up|1|||
23334538|NCT00984568|64969236|FG000|Overall Study|Opportunistic Infection|1|||
23334539|NCT00984568|64969237|FG001|Overall Study|Opportunistic Infection|0|||
23334540|NCT00984568|64969236|FG000|Overall Study|Unknown Reason|1|||
23334541|NCT00984568|64969237|FG001|Overall Study|Unknown Reason|3|||
23334542|NCT00379080|64969238|FG000|Overall Study|Withdrawal by Subject|0|||
23334543|NCT00379080|64969239|FG001|Overall Study|Withdrawal by Subject|4|||
23334544|NCT00379080|64969240|FG002|Overall Study|Withdrawal by Subject|0|||
23334545|NCT03831113|64969244|FG000|Overall Study|Withdrawal by Subject|0|||
23334546|NCT03831113|64969245|FG001|Overall Study|Withdrawal by Subject|2|||
23334547|NCT03831113|64969244|FG000|Overall Study|Protocol Violation|0|||
23334548|NCT03831113|64969245|FG001|Overall Study|Protocol Violation|9|||
23334549|NCT01560234|64969248|FG000|Overall Study|Lost to Follow-up|3|||
23575664|NCT01318811|65838820|FG000|Overall Study|CRRT stopped for head MRI|0|||
23575665|NCT01318811|65838821|FG001|Overall Study|CRRT stopped for head MRI|1|||
23227501|NCT02531633|64575129|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
23334550|NCT01560234|64969249|FG001|Overall Study|Lost to Follow-up|0|||
23334551|NCT01560234|64969250|FG002|Overall Study|Lost to Follow-up|1|||
23334552|NCT01560234|64969251|FG003|Overall Study|Lost to Follow-up|0|||
23334553|NCT01560234|64969252|FG004|Overall Study|Lost to Follow-up|0|||
23334554|NCT01560234|64969253|FG005|Overall Study|Lost to Follow-up|2|||
23334555|NCT01560234|64969254|FG006|Overall Study|Lost to Follow-up|0|||
23575666|NCT02449044|65838822|FG000|Overall Study|Lost to Follow-up|2|||
23575667|NCT02449044|65838822|FG000|Overall Study|Withdrawal by Subject|13|||
23334556|NCT01560234|64969255|FG007|Overall Study|Lost to Follow-up|2|||
23334557|NCT04087720|64969256|FG000|Overall Study|Withdrawal by Subject|2|||
23334558|NCT04087720|64969256|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
23334559|NCT02230904|64969257|FG000|Overall Study|Safety follow up could not take place|0|||
23334560|NCT02230904|64969258|FG001|Overall Study|Safety follow up could not take place|1|||
23334561|NCT02040857|64969261|FG000|Overall Study|Adverse Event|14|||
23334562|NCT02040857|64969261|FG000|Overall Study|Physician Decision|5|||
23334563|NCT02040857|64969261|FG000|Overall Study|Withdrawal by Subject|31|||
23334564|NCT02040857|64969261|FG000|Overall Study|patient non-compliance|3|||
23334565|NCT02040857|64969261|FG000|Overall Study|Lost to Follow-up|2|||
23334566|NCT02040857|64969261|FG000|Overall Study|recurrence|4|||
23334567|NCT02040857|64969261|FG000|Overall Study|ineligible|1|||
23334568|NCT00603590|64969262|FG000|Overall Study|Did not attend study clinic|39|||
23334569|NCT00603590|64969263|FG001|Overall Study|Did not attend study clinic|30|||
23334570|NCT00603590|64969262|FG000|Overall Study|Refused blood test|5|||
23334571|NCT00603590|64969263|FG001|Overall Study|Refused blood test|1|||
23334572|NCT00603590|64969262|FG000|Overall Study|Patient discontinued study drug|22|||
23334573|NCT00603590|64969263|FG001|Overall Study|Patient discontinued study drug|15|||
23334574|NCT00603590|64969262|FG000|Overall Study|Adverse Event|2|||
23334575|NCT00603590|64969263|FG001|Overall Study|Adverse Event|0|||
23334576|NCT00603590|64969262|FG000|Overall Study|Lost to Follow-up|8|||
23334577|NCT00603590|64969263|FG001|Overall Study|Lost to Follow-up|4|||
23334578|NCT00603590|64969262|FG000|Overall Study|Cardiovascular event|0|||
23334579|NCT00603590|64969263|FG001|Overall Study|Cardiovascular event|1|||
23334580|NCT02616146|64969272|FG000|Overall Study|Adverse Event|64|||
23168119|NCT03529773|64363173|FG015|Overall Study|Adverse Event|0|||
23334581|NCT02616146|64969273|FG001|Overall Study|Adverse Event|24|||
23334582|NCT02616146|64969272|FG000|Overall Study|Lost to Follow-up|23|||
23334583|NCT02616146|64969273|FG001|Overall Study|Lost to Follow-up|13|||
23334584|NCT02616146|64969272|FG000|Overall Study|Non-compliance with study protocol|2|||
23334585|NCT02616146|64969273|FG001|Overall Study|Non-compliance with study protocol|0|||
23334586|NCT02616146|64969272|FG000|Overall Study|Non-compliance with study drug|4|||
23334587|NCT02616146|64969273|FG001|Overall Study|Non-compliance with study drug|2|||
23334588|NCT02616146|64969272|FG000|Overall Study|Pregnancy|2|||
23334589|NCT02616146|64969273|FG001|Overall Study|Pregnancy|2|||
23334590|NCT02616146|64969272|FG000|Overall Study|Pregnancy wish|3|||
23334591|NCT02616146|64969273|FG001|Overall Study|Pregnancy wish|0|||
23334592|NCT02616146|64969272|FG000|Overall Study|Protocol Violation|6|||
23334593|NCT02616146|64969273|FG001|Overall Study|Protocol Violation|3|||
23334594|NCT02616146|64969272|FG000|Overall Study|Study terminated by sponsor|1372|||
23334595|NCT02616146|64969273|FG001|Overall Study|Study terminated by sponsor|432|||
23334596|NCT02616146|64969272|FG000|Overall Study|Participant moved|4|||
23334597|NCT02616146|64969273|FG001|Overall Study|Participant moved|3|||
23334598|NCT02616146|64969272|FG000|Overall Study|Withdrawal by Subject|30|||
23334599|NCT02616146|64969273|FG001|Overall Study|Withdrawal by Subject|24|||
23168120|NCT03529773|64363174|FG016|Overall Study|Adverse Event|0|||
23168121|NCT03529773|64363175|FG017|Overall Study|Adverse Event|0|||
23168122|NCT03529773|64363176|FG018|Overall Study|Adverse Event|0|||
23168123|NCT03529773|64363177|FG019|Overall Study|Adverse Event|0|||
23168124|NCT03529773|64363178|FG020|Overall Study|Adverse Event|0|||
23168125|NCT03529773|64363179|FG021|Overall Study|Adverse Event|0|||
23168126|NCT03529773|64363180|FG022|Overall Study|Adverse Event|0|||
23168127|NCT03529773|64363181|FG023|Overall Study|Adverse Event|0|||
23168128|NCT03529773|64363182|FG024|Overall Study|Adverse Event|0|||
23168129|NCT03529773|64363183|FG025|Overall Study|Adverse Event|0|||
23168130|NCT03529773|64363184|FG026|Overall Study|Adverse Event|0|||
23168131|NCT03529773|64363185|FG027|Overall Study|Adverse Event|0|||
23168132|NCT03529773|64363186|FG028|Overall Study|Adverse Event|0|||
23168133|NCT03529773|64363187|FG029|Overall Study|Adverse Event|0|||
23168134|NCT03529773|64363188|FG030|Overall Study|Adverse Event|1|||
23168135|NCT03529773|64363189|FG031|Overall Study|Adverse Event|0|||
23168136|NCT03529773|64363190|FG032|Overall Study|Adverse Event|0|||
23168137|NCT03529773|64363191|FG033|Overall Study|Adverse Event|0|||
23168138|NCT03529773|64363192|FG034|Overall Study|Adverse Event|0|||
23168139|NCT03529773|64363193|FG035|Overall Study|Adverse Event|1|||
23168140|NCT03529773|64363194|FG036|Overall Study|Adverse Event|0|||
23575668|NCT02449044|65838822|FG000|Overall Study|Adverse Event|30|||
23168141|NCT03529773|64363195|FG037|Overall Study|Adverse Event|0|||
23168142|NCT03529773|64363196|FG038|Overall Study|Adverse Event|1|||
23168143|NCT03529773|64363197|FG039|Overall Study|Adverse Event|1|||
23168144|NCT03529773|64363158|FG000|Overall Study|Death|0|||
23168145|NCT03529773|64363159|FG001|Overall Study|Death|0|||
23334600|NCT02616146|64969272|FG000|Overall Study|Physician Decision|2|||
23334601|NCT02616146|64969273|FG001|Overall Study|Physician Decision|1|||
23334602|NCT01582854|64969274|FG000|Overall Study|Death|8|||
23334603|NCT01582854|64969275|FG001|Overall Study|Death|5|||
23334604|NCT01582854|64969274|FG000|Overall Study|Adverse Event|2|||
23334605|NCT01582854|64969275|FG001|Overall Study|Adverse Event|3|||
23168146|NCT03529773|64363160|FG002|Overall Study|Death|0|||
23334606|NCT01582854|64969274|FG000|Overall Study|Withdrawal by Participant|8|||
23334607|NCT01582854|64969275|FG001|Overall Study|Withdrawal by Participant|11|||
23334608|NCT01582854|64969274|FG000|Overall Study|Lost to Follow-up|1|||
23334609|NCT01582854|64969275|FG001|Overall Study|Lost to Follow-up|2|||
23334610|NCT01582854|64969274|FG000|Overall Study|Physician Decision|0|||
23334611|NCT01582854|64969275|FG001|Overall Study|Physician Decision|1|||
23334612|NCT01582854|64969274|FG000|Overall Study|Recurrent Stroke|13|||
23334613|NCT01582854|64969275|FG001|Overall Study|Recurrent Stroke|8|||
23334614|NCT01582854|64969274|FG000|Overall Study|Disallowed Concomitant Medication|3|||
23334615|NCT01582854|64969275|FG001|Overall Study|Disallowed Concomitant Medication|2|||
23334616|NCT01582854|64969274|FG000|Overall Study|Carotid or Neurosurgery|0|||
23334617|NCT01582854|64969275|FG001|Overall Study|Carotid or Neurosurgery|1|||
23334618|NCT01582854|64969274|FG000|Overall Study|General Anaesthesia|0|||
23334619|NCT01582854|64969275|FG001|Overall Study|General Anaesthesia|1|||
23334620|NCT01582854|64969274|FG000|Overall Study|Other Miscellaneous Reason|1|||
23334621|NCT01582854|64969275|FG001|Overall Study|Other Miscellaneous Reason|0|||
23334622|NCT02654977|64969276|FG000|Overall Study|Death|1|||
23334623|NCT02654977|64969276|FG000|Overall Study|Lost to Follow-up|1|||
23334624|NCT02654977|64969276|FG000|Overall Study|Adverse Event|1|||
23334625|NCT02654977|64969276|FG000|Overall Study|Withdrawal by Subject|1|||
23334626|NCT02654977|64969276|FG000|Overall Study|Lack of Efficacy|3|||
23334627|NCT04266795|64969277|FG000|Overall Study|Adverse Event|10|||
23334628|NCT04266795|64969278|FG001|Overall Study|Adverse Event|19|||
23334629|NCT04266795|64969277|FG000|Overall Study|Death|7|||
23334630|NCT04266795|64969278|FG001|Overall Study|Death|8|||
23334631|NCT04266795|64969277|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
23334632|NCT04266795|64969278|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
23334633|NCT04266795|64969277|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
23334634|NCT04266795|64969278|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23334635|NCT04266795|64969277|FG000|Overall Study|Progressive Disease|12|||
23334636|NCT04266795|64969278|FG001|Overall Study|Progressive Disease|9|||
23334637|NCT04266795|64969277|FG000|Overall Study|Withdrawal by Patient|5|||
23334638|NCT04266795|64969278|FG001|Overall Study|Withdrawal by Patient|6|||
23334639|NCT04266795|64969277|FG000|Overall Study|Disease Relapse|3|||
23334640|NCT04266795|64969278|FG001|Overall Study|Disease Relapse|6|||
23334641|NCT04266795|64969277|FG000|Overall Study|Reason not Specified|12|||
23334642|NCT04266795|64969278|FG001|Overall Study|Reason not Specified|10|||
23334643|NCT04266795|64969277|FG000|Overall Study|Participants Ongoing on Treatment|25|||
23334644|NCT04266795|64969278|FG001|Overall Study|Participants Ongoing on Treatment|23|||
23334645|NCT00356135|64969279|FG000|Overall Study|Protocol Violation|1|||
23334646|NCT00356135|64969280|FG001|Overall Study|Protocol Violation|0|||
23334647|NCT00356135|64969281|FG002|Overall Study|Protocol Violation|0|||
23334648|NCT00356135|64969279|FG000|Overall Study|Adverse Event|1|||
23334649|NCT00356135|64969280|FG001|Overall Study|Adverse Event|0|||
23334650|NCT00356135|64969281|FG002|Overall Study|Adverse Event|0|||
23334651|NCT00356135|64969279|FG000|Overall Study|Lost to Follow-up|0|||
23334652|NCT00356135|64969280|FG001|Overall Study|Lost to Follow-up|0|||
23334653|NCT00356135|64969281|FG002|Overall Study|Lost to Follow-up|1|||
23334654|NCT00356135|64969279|FG000|Overall Study|Physician Decision|1|||
23334655|NCT00356135|64969280|FG001|Overall Study|Physician Decision|1|||
23334656|NCT00356135|64969281|FG002|Overall Study|Physician Decision|1|||
23334657|NCT00356135|64969279|FG000|Overall Study|Subject non-compliance|1|||
23334658|NCT00356135|64969280|FG001|Overall Study|Subject non-compliance|1|||
23334659|NCT00356135|64969281|FG002|Overall Study|Subject non-compliance|3|||
23334660|NCT02748356|64969282|FG000|Overall Study|Withdrawal by Subject|1|||
23334661|NCT02492984|64969288|FG000|Overall Study|Adverse Event|1|||
23334662|NCT02492984|64969289|FG001|Overall Study|Adverse Event|0|||
23334663|NCT02492984|64969288|FG000|Overall Study|Protocol Violation|1|||
23334664|NCT02492984|64969289|FG001|Overall Study|Protocol Violation|0|||
23334665|NCT02492984|64969288|FG000|Overall Study|Withdrawal by Subject|1|||
23334666|NCT02492984|64969289|FG001|Overall Study|Withdrawal by Subject|0|||
23334667|NCT01827267|64969290|FG000|Overall Study|Did not receive study drug|1|||
23334668|NCT01827267|64969291|FG001|Overall Study|Did not receive study drug|1|||
23575669|NCT02449044|65838822|FG000|Overall Study|Met Withdrawal Criteria|7|||
23575670|NCT02449044|65838822|FG000|Overall Study|Physician Decision|9|||
23575671|NCT02449044|65838822|FG000|Overall Study|Sponsor Discontinued Trial|3|||
23227502|NCT02531633|64575120|FG000|Part A (52 Weeks)|Other|2|||
23227503|NCT02531633|64575121|FG001|Part A (52 Weeks)|Other|0|||
23227504|NCT02531633|64575122|FG002|Part A (52 Weeks)|Other|0|||
23227505|NCT02531633|64575123|FG003|Part A (52 Weeks)|Other|0|||
23227506|NCT02531633|64575124|FG004|Part A (52 Weeks)|Other|0|||
23227507|NCT02531633|64575125|FG005|Part A (52 Weeks)|Other|0|||
23227508|NCT02531633|64575126|FG006|Part A (52 Weeks)|Other|0|||
23334669|NCT01827267|64969290|FG000|Overall Study|Physician Decision|1|||
23334670|NCT01827267|64969291|FG001|Overall Study|Physician Decision|0|||
23334671|NCT01827267|64969290|FG000|Overall Study|Disease Progression|1|||
23227509|NCT02531633|64575127|FG007|Part A (52 Weeks)|Other|0|||
23334672|NCT01827267|64969291|FG001|Overall Study|Disease Progression|1|||
23447759|NCT02587520|65380611|FG015|Overall Study|Protocol Violation|0|||
23168147|NCT03529773|64363161|FG003|Overall Study|Death|0|||
23168148|NCT03529773|64363162|FG004|Overall Study|Death|0|||
23334673|NCT01827267|64969290|FG000|Overall Study|Sponsor Discontinued Study|2|||
23334674|NCT01827267|64969291|FG001|Overall Study|Sponsor Discontinued Study|8|||
23334675|NCT01827267|64969290|FG000|Overall Study|Still on study|0|||
23334676|NCT01827267|64969291|FG001|Overall Study|Still on study|2|||
23334677|NCT01455597|64969292|FG000|Overall Study|Adverse Event|7|||
23334678|NCT01455597|64969293|FG001|Overall Study|Adverse Event|0|||
23334679|NCT01455597|64969294|FG002|Overall Study|Adverse Event|5|||
23334680|NCT01455597|64969295|FG003|Overall Study|Adverse Event|1|||
23334681|NCT01455597|64969292|FG000|Overall Study|Lack of Efficacy|0|||
23334682|NCT01455597|64969293|FG001|Overall Study|Lack of Efficacy|1|||
23334683|NCT01455597|64969294|FG002|Overall Study|Lack of Efficacy|2|||
23334684|NCT01455597|64969295|FG003|Overall Study|Lack of Efficacy|0|||
23334685|NCT01455597|64969292|FG000|Overall Study|Lost to Follow-up|3|||
23334686|NCT01455597|64969293|FG001|Overall Study|Lost to Follow-up|0|||
23334687|NCT01455597|64969294|FG002|Overall Study|Lost to Follow-up|2|||
23334688|NCT01455597|64969295|FG003|Overall Study|Lost to Follow-up|1|||
23334689|NCT01455597|64969292|FG000|Overall Study|Withdrew Consent|6|||
23334690|NCT01455597|64969293|FG001|Overall Study|Withdrew Consent|5|||
23334691|NCT01455597|64969294|FG002|Overall Study|Withdrew Consent|8|||
23334692|NCT01455597|64969295|FG003|Overall Study|Withdrew Consent|5|||
23334693|NCT01455597|64969292|FG000|Overall Study|Reason not Specified|1|||
23334694|NCT01455597|64969293|FG001|Overall Study|Reason not Specified|2|||
23334695|NCT01455597|64969294|FG002|Overall Study|Reason not Specified|3|||
23334696|NCT01455597|64969295|FG003|Overall Study|Reason not Specified|3|||
23334697|NCT02278939|64969296|FG000|Overall Study|lack of time|1|||
23334698|NCT02278939|64969297|FG001|Overall Study|lack of time|0|||
23334699|NCT02278939|64969296|FG000|Overall Study|Lost to Follow-up|1|||
23334700|NCT02278939|64969297|FG001|Overall Study|Lost to Follow-up|1|||
23334701|NCT02278939|64969296|FG000|Overall Study|death in family|1|||
23575672|NCT01853254|65838823|FG000|Overall Study|Abnormal Laboratory Test|1|||
23334702|NCT02278939|64969297|FG001|Overall Study|death in family|0|||
23334703|NCT02278939|64969296|FG000|Overall Study|family emergency unable to commit|2|||
23334704|NCT02278939|64969297|FG001|Overall Study|family emergency unable to commit|0|||
23334705|NCT01868022|64969298|FG000|Overall Study|Withdrawal by Subject|0|||
23334706|NCT01868022|64969299|FG001|Overall Study|Withdrawal by Subject|0|||
23334707|NCT01868022|64969300|FG002|Overall Study|Withdrawal by Subject|1|||
23334708|NCT01868022|64969301|FG003|Overall Study|Withdrawal by Subject|1|||
23575673|NCT01853254|65838823|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
23575674|NCT01853254|65838823|FG000|Overall Study|Death|1|||
23575675|NCT01853254|65838823|FG000|Overall Study|Failure to Return|43|||
23575676|NCT01853254|65838823|FG000|Overall Study|Insufficient Therapeutic Response|22|||
23575677|NCT01853254|65838823|FG000|Overall Study|Refusal of Treatment|1|||
23575678|NCT01853254|65838823|FG000|Overall Study|Other Protocol Violation|1|||
23575679|NCT01853254|65838823|FG000|Overall Study|Withdrawal of Consent|16|||
23575680|NCT01853254|65838823|FG000|Overall Study|Administrative/Other|16|||
23575681|NCT02956967|65838824|FG000|Overall Study|Adverse Event|3|||
23168149|NCT03529773|64363163|FG005|Overall Study|Death|0|||
23334709|NCT01868022|64969302|FG004|Overall Study|Withdrawal by Subject|0|||
23334710|NCT01868022|64969303|FG005|Overall Study|Withdrawal by Subject|0|||
23334711|NCT01868022|64969304|FG006|Overall Study|Withdrawal by Subject|0|||
23334712|NCT01868022|64969305|FG007|Overall Study|Withdrawal by Subject|1|||
23334713|NCT01868022|64969306|FG008|Overall Study|Withdrawal by Subject|0|||
23334714|NCT01868022|64969298|FG000|Overall Study|Adverse Event|0|||
23334715|NCT01868022|64969299|FG001|Overall Study|Adverse Event|0|||
23334716|NCT01868022|64969300|FG002|Overall Study|Adverse Event|0|||
23334717|NCT01868022|64969301|FG003|Overall Study|Adverse Event|0|||
23334718|NCT01868022|64969302|FG004|Overall Study|Adverse Event|2|||
23334719|NCT01868022|64969303|FG005|Overall Study|Adverse Event|0|||
23168150|NCT03529773|64363164|FG006|Overall Study|Death|0|||
23334720|NCT01868022|64969304|FG006|Overall Study|Adverse Event|0|||
23334721|NCT01868022|64969305|FG007|Overall Study|Adverse Event|2|||
23334722|NCT01868022|64969306|FG008|Overall Study|Adverse Event|2|||
23334723|NCT01868022|64969298|FG000|Overall Study|Physician Decision|0|||
23334724|NCT01868022|64969299|FG001|Overall Study|Physician Decision|0|||
23334725|NCT01868022|64969300|FG002|Overall Study|Physician Decision|0|||
23334726|NCT01868022|64969301|FG003|Overall Study|Physician Decision|0|||
23334727|NCT01868022|64969302|FG004|Overall Study|Physician Decision|0|||
23334728|NCT01868022|64969303|FG005|Overall Study|Physician Decision|1|||
23334729|NCT01868022|64969304|FG006|Overall Study|Physician Decision|0|||
23334730|NCT01868022|64969305|FG007|Overall Study|Physician Decision|2|||
23575682|NCT02956967|65838824|FG000|Overall Study|Reason non-related to neutropenia|10|||
23575683|NCT02956967|65838824|FG000|Overall Study|Lost to Follow-up|5|||
23575684|NCT02956967|65838824|FG000|Overall Study|Missing|1|||
23334731|NCT01868022|64969306|FG008|Overall Study|Physician Decision|0|||
23334732|NCT01868022|64969298|FG000|Overall Study|Study closed/terminated|0|||
23334733|NCT01868022|64969299|FG001|Overall Study|Study closed/terminated|0|||
23575685|NCT02956967|65838824|FG000|Overall Study|Termination of Nivestim administration|29|||
23334734|NCT01868022|64969300|FG002|Overall Study|Study closed/terminated|0|||
23334735|NCT01868022|64969301|FG003|Overall Study|Study closed/terminated|0|||
23334736|NCT01868022|64969302|FG004|Overall Study|Study closed/terminated|0|||
23334737|NCT01868022|64969303|FG005|Overall Study|Study closed/terminated|0|||
23334738|NCT01868022|64969304|FG006|Overall Study|Study closed/terminated|0|||
23334739|NCT01868022|64969305|FG007|Overall Study|Study closed/terminated|1|||
23334740|NCT01868022|64969306|FG008|Overall Study|Study closed/terminated|0|||
23334741|NCT01868022|64969298|FG000|Overall Study|Ongoing|0|||
23334742|NCT01868022|64969299|FG001|Overall Study|Ongoing|0|||
23334743|NCT01868022|64969300|FG002|Overall Study|Ongoing|0|||
23334744|NCT01868022|64969301|FG003|Overall Study|Ongoing|0|||
23334745|NCT01868022|64969302|FG004|Overall Study|Ongoing|0|||
23334746|NCT01868022|64969303|FG005|Overall Study|Ongoing|0|||
23334747|NCT01868022|64969304|FG006|Overall Study|Ongoing|0|||
23334748|NCT01868022|64969305|FG007|Overall Study|Ongoing|3|||
23168151|NCT03529773|64363165|FG007|Overall Study|Death|0|||
23334749|NCT01868022|64969306|FG008|Overall Study|Ongoing|0|||
23334750|NCT04654468|64969311|FG000|Overall Study|Death|1|||
23334751|NCT04654468|64969311|FG000|Overall Study|Ongoing in the Study|50|||
23334752|NCT01106911|64969312|FG000|Overall Study|Physician Decision|2|||
23334753|NCT01106911|64969312|FG000|Overall Study|deemed ineligible after screening|3|||
23334754|NCT00406367|64969315|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
23334755|NCT00406367|64969316|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
23334756|NCT00406367|64969315|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
23334757|NCT00406367|64969316|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
23334758|NCT00406367|64969315|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
23334759|NCT00406367|64969316|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
23334760|NCT00406367|64969315|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
23334761|NCT00406367|64969316|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
23334762|NCT00406367|64969315|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
23334763|NCT00406367|64969316|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
23334764|NCT00406367|64969315|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
23334765|NCT00406367|64969316|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
23334766|NCT00406367|64969315|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
23334767|NCT00406367|64969316|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
23334768|NCT00406367|64969315|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
23334769|NCT00406367|64969316|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
23334770|NCT00406367|64969315|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
23334771|NCT00406367|64969316|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
23334772|NCT00406367|64969315|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
23334773|NCT00406367|64969316|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
23334774|NCT00406367|64969315|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
23334775|NCT00406367|64969316|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
23334776|NCT00406367|64969315|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
23334777|NCT00406367|64969316|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
23334778|NCT04520997|64969323|FG000|Overall Study|Lost to Follow-up|1|||
23334779|NCT04520997|64969324|FG001|Overall Study|Lost to Follow-up|1|||
23334780|NCT04520997|64969323|FG000|Overall Study|Withdrawal by Subject|1|||
23334781|NCT04520997|64969324|FG001|Overall Study|Withdrawal by Subject|0|||
23334782|NCT04520997|64969323|FG000|Overall Study|Not Treated|0|||
23334783|NCT04520997|64969324|FG001|Overall Study|Not Treated|1|||
23334784|NCT03020992|64969328|FG000|Overall Study|Adverse Event|5|||
23334785|NCT03020992|64969328|FG000|Overall Study|Withdrawal by Subject|1|||
23334786|NCT02120833|64969331|FG000|Overall Study|Adverse Event|1|||
23168152|NCT03529773|64363166|FG008|Overall Study|Death|0|||
23334787|NCT02120833|64969332|FG001|Overall Study|Adverse Event|0|||
23168153|NCT03529773|64363167|FG009|Overall Study|Death|0|||
23168154|NCT03529773|64363168|FG010|Overall Study|Death|0|||
23168155|NCT03529773|64363169|FG011|Overall Study|Death|0|||
23168156|NCT03529773|64363170|FG012|Overall Study|Death|1|||
23168157|NCT03529773|64363171|FG013|Overall Study|Death|0|||
23168158|NCT03529773|64363172|FG014|Overall Study|Death|0|||
23168159|NCT03529773|64363173|FG015|Overall Study|Death|0|||
23168160|NCT03529773|64363174|FG016|Overall Study|Death|0|||
23168161|NCT03529773|64363175|FG017|Overall Study|Death|0|||
23168162|NCT03529773|64363176|FG018|Overall Study|Death|0|||
23334788|NCT02120833|64969331|FG000|Overall Study|Withdrawal by Subject|2|||
23334789|NCT02120833|64969332|FG001|Overall Study|Withdrawal by Subject|0|||
23168163|NCT03529773|64363177|FG019|Overall Study|Death|1|||
23168164|NCT03529773|64363178|FG020|Overall Study|Death|0|||
23168165|NCT03529773|64363179|FG021|Overall Study|Death|0|||
23334790|NCT02120833|64969331|FG000|Overall Study|Lost to Follow-up|1|||
23168166|NCT03529773|64363180|FG022|Overall Study|Death|1|||
23334791|NCT02120833|64969332|FG001|Overall Study|Lost to Follow-up|1|||
23334792|NCT01540487|64969334|FG000|Overall Study|Protocol Violation|1|||
23334793|NCT01540487|64969335|FG001|Overall Study|Protocol Violation|0|||
23334794|NCT02490371|64969336|FG000|Overall Study|Lost to Follow-up|1|||
23334795|NCT02490371|64969337|FG001|Overall Study|Lost to Follow-up|1|||
23334796|NCT03811093|64969338|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
23334797|NCT03811093|64969339|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
23334798|NCT03811093|64969338|FG000|Overall Study|Unable to measure body fat percentage|2|||
23334799|NCT03811093|64969339|FG001|Overall Study|Unable to measure body fat percentage|0|||
23334800|NCT01177293|64969340|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
23334801|NCT01177293|64969341|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
23334802|NCT04606394|64969342|FG000|Overall Study|Withdrawal by Subject|3|||
23334803|NCT04606394|64969342|FG000|Overall Study|Exclusion criteria screen failure|12|||
23334804|NCT03055338|64969346|FG000|Overall Study|Lost to Follow-up|9|||
23334805|NCT03055338|64969347|FG001|Overall Study|Lost to Follow-up|2|||
23334806|NCT03055338|64969348|FG002|Overall Study|Lost to Follow-up|3|||
23334807|NCT03055338|64969346|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
23227510|NCT02531633|64575128|FG008|Part A (52 Weeks)|Other|0|||
23227511|NCT02531633|64575129|FG009|Part A (52 Weeks)|Other|0|||
23227512|NCT02531633|64575120|FG000|Part B (104 Weeks)|Sponsor request|0|||
23227513|NCT02531633|64575121|FG001|Part B (104 Weeks)|Sponsor request|0|||
23227514|NCT02531633|64575122|FG002|Part B (104 Weeks)|Sponsor request|0|||
23227515|NCT02531633|64575123|FG003|Part B (104 Weeks)|Sponsor request|0|||
23227516|NCT02531633|64575124|FG004|Part B (104 Weeks)|Sponsor request|0|||
23227517|NCT02531633|64575125|FG005|Part B (104 Weeks)|Sponsor request|8|||
23334808|NCT03055338|64969347|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
23334809|NCT03055338|64969348|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
23334810|NCT03055338|64969346|FG000|Overall Study|Physician Decision|0|||
23575686|NCT00372060|65838825|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
23575687|NCT00372060|65838826|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
23575688|NCT00372060|65838825|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
23575689|NCT00372060|65838826|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
23575690|NCT00372060|65838825|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
23575691|NCT00372060|65838826|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
23575692|NCT00372060|65838825|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
23575693|NCT00372060|65838826|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
23575694|NCT00372060|65838825|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
23575695|NCT00372060|65838826|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
23575696|NCT00372060|65838825|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
23575697|NCT00372060|65838826|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
23575698|NCT01656759|65838828|FG000|Overall Study|Protocol Violation|2|||
23575699|NCT01656759|65838829|FG001|Overall Study|Protocol Violation|3|||
23575700|NCT02337361|65838830|FG000|3-month Follow-up|Lost to Follow-up|19|||
23575701|NCT02337361|65838831|FG001|3-month Follow-up|Lost to Follow-up|14|||
23575702|NCT02337361|65838830|FG000|6-month Follow-up|Lost to Follow-up|2|||
23575703|NCT02337361|65838831|FG001|6-month Follow-up|Lost to Follow-up|4|||
23575704|NCT00610675|65838832|FG000|Overall Study|Untreated|4|||
23575705|NCT00610675|65838832|FG000|Overall Study|Adverse Event|67|||
23575706|NCT00610675|65838832|FG000|Overall Study|Insufficient Effect|31|||
23575707|NCT00610675|65838832|FG000|Overall Study|Withdrawal by Subject|28|||
23575708|NCT00610675|65838832|FG000|Overall Study|Reasons unrelated to trial|27|||
23575709|NCT00610675|65838832|FG000|Overall Study|Lack of Compliance|7|||
23575710|NCT00610675|65838832|FG000|Overall Study|Lost to Follow-up|31|||
23575711|NCT00610675|65838832|FG000|Overall Study|Other reason (not specified)|25|||
23575712|NCT00801242|65838833|FG000|Overall Study|Adverse Event|10|||
23575713|NCT00801242|65838833|FG000|Overall Study|Withdrawal by Subject|13|||
23575714|NCT00801242|65838833|FG000|Overall Study|Protocol Violation|5|||
23575715|NCT00801242|65838833|FG000|Overall Study|Physician Decision|3|||
23575716|NCT00801242|65838833|FG000|Overall Study|Lost to Follow-up|1|||
23575717|NCT00801242|65838833|FG000|Overall Study|Miscellaneous reasons|20|||
23575718|NCT01628510|65838834|FG000|Overall Study|Withdrawal by Subject|0|||
23575719|NCT01628510|65838835|FG001|Overall Study|Withdrawal by Subject|4|||
23575720|NCT01628510|65838834|FG000|Overall Study|Death|3|||
23575721|NCT01628510|65838835|FG001|Overall Study|Death|1|||
23575722|NCT04285229|65838836|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23575723|NCT04285229|65838837|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23575724|NCT04285229|65838838|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23334811|NCT03055338|64969347|FG001|Overall Study|Physician Decision|0|||
23334812|NCT03055338|64969348|FG002|Overall Study|Physician Decision|2|||
23334813|NCT03055338|64969346|FG000|Overall Study|Withdrawal by Subject|9|||
23227518|NCT02531633|64575126|FG006|Part B (104 Weeks)|Sponsor request|5|||
23334814|NCT03055338|64969347|FG001|Overall Study|Withdrawal by Subject|8|||
23334815|NCT03055338|64969348|FG002|Overall Study|Withdrawal by Subject|7|||
23334816|NCT01628198|64969352|FG000|Overall Study|Lost to Follow-up|7|||
23334817|NCT01628198|64969352|FG000|Overall Study|Withdrawal by Subject|10|||
23334818|NCT01628198|64969352|FG000|Overall Study|Screen failure|1|||
23334819|NCT01986933|64969353|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
23334820|NCT01986933|64969354|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
23334821|NCT01986933|64969355|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
23334822|NCT01986933|64969356|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
23334823|NCT01986933|64969357|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
23334824|NCT01986933|64969353|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
23334825|NCT01986933|64969354|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
23334826|NCT01986933|64969355|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
23334827|NCT01986933|64969356|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
23334828|NCT01986933|64969357|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
23334829|NCT01986933|64969353|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
23334830|NCT01986933|64969354|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
23334831|NCT01986933|64969355|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
23334832|NCT01986933|64969356|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
23575725|NCT04285229|65838839|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23575726|NCT04285229|65838840|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23575727|NCT04285229|65838841|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23575728|NCT04285229|65838836|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
23575729|NCT04285229|65838837|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
23575730|NCT04285229|65838838|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
23575731|NCT04285229|65838839|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
23575732|NCT04285229|65838840|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
23575733|NCT04285229|65838841|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
23575734|NCT04285229|65838836|FG000|Extended Treatment Period|Adverse Event|0|||
23334833|NCT01986933|64969357|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
23334834|NCT01986933|64969353|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
23575735|NCT04285229|65838837|FG001|Extended Treatment Period|Adverse Event|0|||
23575736|NCT04285229|65838838|FG002|Extended Treatment Period|Adverse Event|0|||
23575737|NCT04285229|65838839|FG003|Extended Treatment Period|Adverse Event|1|||
23575738|NCT04285229|65838840|FG004|Extended Treatment Period|Adverse Event|0|||
23575739|NCT04285229|65838841|FG005|Extended Treatment Period|Adverse Event|0|||
23575740|NCT04285229|65838836|FG000|Extended Treatment Period|Physician Decision|0|||
23575741|NCT04285229|65838837|FG001|Extended Treatment Period|Physician Decision|0|||
23334835|NCT01986933|64969354|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
23334836|NCT01986933|64969355|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
23227519|NCT02531633|64575127|FG007|Part B (104 Weeks)|Sponsor request|3|||
23227520|NCT02531633|64575128|FG008|Part B (104 Weeks)|Sponsor request|5|||
23227521|NCT02531633|64575129|FG009|Part B (104 Weeks)|Sponsor request|4|||
23227522|NCT02531633|64575120|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
23227523|NCT02531633|64575121|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
23227524|NCT02531633|64575122|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
23227525|NCT02531633|64575123|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
23227526|NCT02531633|64575124|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
23227527|NCT02531633|64575125|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
23227528|NCT02531633|64575126|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
23227529|NCT02531633|64575127|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
23227530|NCT02531633|64575128|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
23227531|NCT02531633|64575129|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
23227532|NCT03227692|64575130|FG000|Overall Study|Protocol Violation|1|||
23227533|NCT03227692|64575131|FG001|Overall Study|Protocol Violation|1|||
23227534|NCT03227692|64575130|FG000|Overall Study|Lost to Follow-up|4|||
23227535|NCT03227692|64575131|FG001|Overall Study|Lost to Follow-up|2|||
23334837|NCT01986933|64969356|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
23334838|NCT01986933|64969357|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
23575742|NCT04285229|65838838|FG002|Extended Treatment Period|Physician Decision|1|||
23575743|NCT04285229|65838839|FG003|Extended Treatment Period|Physician Decision|0|||
23575744|NCT04285229|65838840|FG004|Extended Treatment Period|Physician Decision|0|||
23575745|NCT04285229|65838841|FG005|Extended Treatment Period|Physician Decision|0|||
23575746|NCT04285229|65838836|FG000|Follow-up Period|Adverse Event|0|||
23575747|NCT04285229|65838837|FG001|Follow-up Period|Adverse Event|0|||
23575748|NCT04285229|65838838|FG002|Follow-up Period|Adverse Event|0|||
23334839|NCT01986933|64969353|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
23575749|NCT04285229|65838839|FG003|Follow-up Period|Adverse Event|0|||
23575750|NCT04285229|65838840|FG004|Follow-up Period|Adverse Event|1|||
23575751|NCT04285229|65838841|FG005|Follow-up Period|Adverse Event|4|||
23575752|NCT04285229|65838836|FG000|Follow-up Period|Withdrawal by Subject|0|||
23334840|NCT01986933|64969354|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
23227536|NCT03227692|64575130|FG000|Overall Study|Adverse Event|0|||
23227537|NCT03227692|64575131|FG001|Overall Study|Adverse Event|2|||
23227538|NCT03702166|64575132|FG000|Overall Study|Lost to Follow-up|1|||
23227539|NCT03702166|64575132|FG000|Overall Study|Withdrawal by Subject|1|||
23575753|NCT04285229|65838837|FG001|Follow-up Period|Withdrawal by Subject|0|||
23575754|NCT04285229|65838838|FG002|Follow-up Period|Withdrawal by Subject|0|||
23575755|NCT04285229|65838839|FG003|Follow-up Period|Withdrawal by Subject|0|||
23575756|NCT04285229|65838840|FG004|Follow-up Period|Withdrawal by Subject|0|||
23575757|NCT04285229|65838841|FG005|Follow-up Period|Withdrawal by Subject|5|||
23575758|NCT04285229|65838836|FG000|Follow-up Period|Covid-19|0|||
23575759|NCT04285229|65838837|FG001|Follow-up Period|Covid-19|0|||
23575760|NCT04285229|65838838|FG002|Follow-up Period|Covid-19|0|||
23227540|NCT03595176|64575133|FG000|Overall Study|Death|0|||
23575761|NCT04285229|65838839|FG003|Follow-up Period|Covid-19|0|||
23575762|NCT04285229|65838840|FG004|Follow-up Period|Covid-19|0|||
23575763|NCT04285229|65838841|FG005|Follow-up Period|Covid-19|2|||
23575764|NCT04285229|65838836|FG000|Follow-up Period|Physician Decision|0|||
23575765|NCT04285229|65838837|FG001|Follow-up Period|Physician Decision|0|||
23575766|NCT04285229|65838838|FG002|Follow-up Period|Physician Decision|0|||
23575767|NCT04285229|65838839|FG003|Follow-up Period|Physician Decision|0|||
23575768|NCT04285229|65838840|FG004|Follow-up Period|Physician Decision|0|||
23575769|NCT04285229|65838841|FG005|Follow-up Period|Physician Decision|1|||
23575770|NCT00742274|65838842|FG000|Overall Study|Death|1|||
23575771|NCT00742274|65838843|FG001|Overall Study|Death|0|||
23575772|NCT00742274|65838842|FG000|Overall Study|Withdrawal by Subject|1|||
23575773|NCT00742274|65838843|FG001|Overall Study|Withdrawal by Subject|2|||
23575774|NCT00742274|65838842|FG000|Overall Study|Removed for medical reasons|1|||
23575775|NCT00742274|65838843|FG001|Overall Study|Removed for medical reasons|1|||
23575776|NCT02176928|65838846|FG000|Overall Study|Lost to Follow-up|2|||
23575777|NCT02176928|65838847|FG001|Overall Study|Lost to Follow-up|4|||
23575778|NCT00502996|65838848|FG000|Overall Study|Lost to Follow-up|9|||
23575779|NCT00502996|65838848|FG000|Overall Study|Protocol Violation|2|||
23575780|NCT00502996|65838848|FG000|Overall Study|Treatment failure|25|||
23575781|NCT00502996|65838848|FG000|Overall Study|Withdrawal Informed Consent|6|||
23575782|NCT00502996|65838848|FG000|Overall Study|Adverse Event|2|||
23575783|NCT01627340|65838850|FG000|Overall Study|Adverse Event|1|||
23575784|NCT01627340|65838851|FG001|Overall Study|Adverse Event|0|||
23168167|NCT03529773|64363181|FG023|Overall Study|Death|0|||
23168168|NCT03529773|64363182|FG024|Overall Study|Death|0|||
23168169|NCT03529773|64363183|FG025|Overall Study|Death|0|||
23168170|NCT03529773|64363184|FG026|Overall Study|Death|0|||
23168171|NCT03529773|64363185|FG027|Overall Study|Death|0|||
23168172|NCT03529773|64363186|FG028|Overall Study|Death|0|||
23168173|NCT03529773|64363187|FG029|Overall Study|Death|0|||
23227541|NCT03595176|64575134|FG001|Overall Study|Death|2|||
23227542|NCT03595176|64575133|FG000|Overall Study|Lost to Follow-up|0|||
23227543|NCT03595176|64575134|FG001|Overall Study|Lost to Follow-up|1|||
23227544|NCT00886587|64575136|FG000|Overall Study|Adverse Event|2|||
23227545|NCT00886587|64575137|FG001|Overall Study|Adverse Event|1|||
23227546|NCT00886587|64575136|FG000|Overall Study|Protocol Violation|2|||
23227547|NCT00886587|64575137|FG001|Overall Study|Protocol Violation|0|||
23227548|NCT00886587|64575136|FG000|Overall Study|Withdrawal by Subject|0|||
23168174|NCT03529773|64363188|FG030|Overall Study|Death|0|||
23168175|NCT03529773|64363189|FG031|Overall Study|Death|0|||
23168176|NCT03529773|64363190|FG032|Overall Study|Death|0|||
23168177|NCT03529773|64363191|FG033|Overall Study|Death|1|||
23168178|NCT03529773|64363192|FG034|Overall Study|Death|1|||
23227549|NCT00886587|64575137|FG001|Overall Study|Withdrawal by Subject|1|||
23227550|NCT01266070|64575138|FG000|Overall Study|Adverse Event|3|||
23227551|NCT01266070|64575138|FG000|Overall Study|Protocol Violation|1|||
23227552|NCT00537810|64575141|FG000|Overall Study|Withdrawal by Subject|4|||
23168179|NCT03529773|64363193|FG035|Overall Study|Death|0|||
23168180|NCT03529773|64363194|FG036|Overall Study|Death|1|||
23227553|NCT00537810|64575142|FG001|Overall Study|Withdrawal by Subject|11|||
23334841|NCT01986933|64969355|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
23447760|NCT02587520|65380612|FG016|Overall Study|Protocol Violation|0|||
23575785|NCT01627340|65838850|FG000|Overall Study|Lost to Follow-up|8|||
23575786|NCT01627340|65838851|FG001|Overall Study|Lost to Follow-up|4|||
23575787|NCT01627340|65838850|FG000|Overall Study|Pregnancy|1|||
23575788|NCT01627340|65838851|FG001|Overall Study|Pregnancy|0|||
23575789|NCT01627340|65838850|FG000|Overall Study|Withdrawal by Subject|2|||
23168181|NCT03529773|64363195|FG037|Overall Study|Death|0|||
23168182|NCT03529773|64363196|FG038|Overall Study|Death|0|||
23168183|NCT03529773|64363197|FG039|Overall Study|Death|0|||
23168184|NCT03529773|64363158|FG000|Overall Study|Lost to Follow-up|0|||
23168185|NCT03529773|64363159|FG001|Overall Study|Lost to Follow-up|0|||
23227554|NCT00537810|64575143|FG002|Overall Study|Withdrawal by Subject|4|||
23227555|NCT00537810|64575144|FG003|Overall Study|Withdrawal by Subject|3|||
23575790|NCT01627340|65838851|FG001|Overall Study|Withdrawal by Subject|0|||
23575791|NCT00725010|65838854|FG000|Overall Study|Toxicity|9|||
23575792|NCT00725010|65838854|FG000|Overall Study|Tumor Progression|7|||
23575793|NCT00725010|65838854|FG000|Overall Study|Withdrawal by Subject|2|||
23575794|NCT00725010|65838854|FG000|Overall Study|Death|1|||
23575795|NCT00725010|65838854|FG000|Overall Study|Lost to Follow-up|1|||
23575796|NCT00725010|65838854|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
23575797|NCT00725010|65838854|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
23575798|NCT00725010|65838854|FG000|Overall Study|No further documentation|1|||
23575799|NCT00725010|65838854|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
23168186|NCT03529773|64363160|FG002|Overall Study|Lost to Follow-up|1|||
23334842|NCT01986933|64969356|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
23447761|NCT02587520|65380613|FG017|Overall Study|Protocol Violation|0|||
23447762|NCT02587520|65380596|FG000|Overall Study|Adverse Event|0|||
23575800|NCT01755689|65838858|FG000|Overall Study|Withdrawal by Subject|1|||
23168187|NCT03529773|64363161|FG003|Overall Study|Lost to Follow-up|0|||
23334843|NCT01986933|64969357|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
23334844|NCT01986933|64969353|FG000|Active-to-active (Part B)|Adverse Event|0|||
23334845|NCT01986933|64969354|FG001|Active-to-active (Part B)|Adverse Event|2|||
23334846|NCT01986933|64969355|FG002|Active-to-active (Part B)|Adverse Event|0|||
23334847|NCT01986933|64969356|FG003|Active-to-active (Part B)|Adverse Event|1|||
23334848|NCT01986933|64969357|FG004|Active-to-active (Part B)|Adverse Event|3|||
23334849|NCT01986933|64969353|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
23334850|NCT01986933|64969354|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
23334851|NCT01986933|64969355|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
23334852|NCT01986933|64969356|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
23334853|NCT01986933|64969357|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
23334854|NCT01986933|64969353|FG000|Active-to-active (Part B)|Pregnancy|0|||
23334855|NCT01986933|64969354|FG001|Active-to-active (Part B)|Pregnancy|0|||
23334856|NCT01986933|64969355|FG002|Active-to-active (Part B)|Pregnancy|0|||
23334857|NCT01986933|64969356|FG003|Active-to-active (Part B)|Pregnancy|0|||
23334858|NCT01986933|64969357|FG004|Active-to-active (Part B)|Pregnancy|1|||
23334859|NCT01986933|64969353|FG000|Active-to-active (Part B)|Physician Decision|0|||
23334860|NCT01986933|64969354|FG001|Active-to-active (Part B)|Physician Decision|0|||
23334861|NCT01986933|64969355|FG002|Active-to-active (Part B)|Physician Decision|1|||
23334862|NCT01986933|64969356|FG003|Active-to-active (Part B)|Physician Decision|1|||
23334863|NCT01986933|64969357|FG004|Active-to-active (Part B)|Physician Decision|0|||
23334864|NCT01986933|64969353|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
23334865|NCT01986933|64969354|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
23334866|NCT01986933|64969355|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
23334867|NCT01986933|64969356|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
23334868|NCT01986933|64969357|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
23334869|NCT01986933|64969353|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
23334870|NCT01986933|64969354|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
23334871|NCT01986933|64969355|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
23334872|NCT01986933|64969356|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
23334873|NCT01986933|64969357|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
23334874|NCT01986933|64969353|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
23334875|NCT01986933|64969354|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
23447763|NCT02587520|65380597|FG001|Overall Study|Adverse Event|0|||
23447764|NCT02587520|65380598|FG002|Overall Study|Adverse Event|0|||
23447765|NCT02587520|65380599|FG003|Overall Study|Adverse Event|0|||
23168188|NCT03529773|64363162|FG004|Overall Study|Lost to Follow-up|1|||
23168189|NCT03529773|64363163|FG005|Overall Study|Lost to Follow-up|1|||
23168190|NCT03529773|64363164|FG006|Overall Study|Lost to Follow-up|0|||
23168191|NCT03529773|64363165|FG007|Overall Study|Lost to Follow-up|0|||
23168192|NCT03529773|64363166|FG008|Overall Study|Lost to Follow-up|0|||
23168193|NCT03529773|64363167|FG009|Overall Study|Lost to Follow-up|0|||
23168194|NCT03529773|64363168|FG010|Overall Study|Lost to Follow-up|0|||
23168195|NCT03529773|64363169|FG011|Overall Study|Lost to Follow-up|0|||
23168196|NCT03529773|64363170|FG012|Overall Study|Lost to Follow-up|0|||
23168197|NCT03529773|64363171|FG013|Overall Study|Lost to Follow-up|1|||
23168198|NCT03529773|64363172|FG014|Overall Study|Lost to Follow-up|4|||
23334876|NCT01986933|64969355|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
23334877|NCT01986933|64969356|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
23334878|NCT01986933|64969357|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
23334879|NCT01986933|64969353|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
23447766|NCT02587520|65380600|FG004|Overall Study|Adverse Event|0|||
23575801|NCT01755689|65838859|FG001|Overall Study|Withdrawal by Subject|3|||
23168199|NCT03529773|64363173|FG015|Overall Study|Lost to Follow-up|1|||
23168200|NCT03529773|64363174|FG016|Overall Study|Lost to Follow-up|1|||
23168201|NCT03529773|64363175|FG017|Overall Study|Lost to Follow-up|0|||
23575802|NCT01755689|65838860|FG002|Overall Study|Withdrawal by Subject|2|||
23575803|NCT01755689|65838861|FG003|Overall Study|Withdrawal by Subject|1|||
23168202|NCT03529773|64363176|FG018|Overall Study|Lost to Follow-up|1|||
23168203|NCT03529773|64363177|FG019|Overall Study|Lost to Follow-up|1|||
23334880|NCT01986933|64969354|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
23334881|NCT01986933|64969355|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
23334882|NCT01986933|64969356|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
23334883|NCT01986933|64969357|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
23334884|NCT01986933|64969353|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
23334885|NCT01986933|64969354|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
23334886|NCT01986933|64969355|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
23334887|NCT01986933|64969356|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
23334888|NCT01986933|64969357|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
23334889|NCT01986933|64969353|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
23334890|NCT01986933|64969354|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
23334891|NCT01986933|64969355|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
23334892|NCT01986933|64969356|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
23334893|NCT01986933|64969357|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
23334894|NCT01986933|64969353|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
23334895|NCT01986933|64969354|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
23334896|NCT01986933|64969355|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
23334897|NCT01986933|64969356|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
23334898|NCT01986933|64969357|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
23334899|NCT01986933|64969353|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
23334900|NCT01986933|64969354|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
23334901|NCT01986933|64969355|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
23334902|NCT01986933|64969356|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
23334903|NCT01986933|64969357|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
23334904|NCT01920958|64969358|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
23334905|NCT01262287|64969359|FG000|Overall Study|Lost to Follow-up|2|||
23334906|NCT01262287|64969360|FG001|Overall Study|Lost to Follow-up|1|||
23334907|NCT03363776|64969361|FG000|Overall Study|Progressive disease|2|||
23334908|NCT03363776|64969362|FG001|Overall Study|Progressive disease|3|||
23334909|NCT03363776|64969363|FG002|Overall Study|Progressive disease|1|||
23334910|NCT03363776|64969361|FG000|Overall Study|Study drug toxicity|0|||
23334911|NCT03363776|64969362|FG001|Overall Study|Study drug toxicity|0|||
23334912|NCT03363776|64969363|FG002|Overall Study|Study drug toxicity|1|||
23334913|NCT03363776|64969361|FG000|Overall Study|Death|1|||
23334914|NCT03363776|64969362|FG001|Overall Study|Death|0|||
23334915|NCT03363776|64969363|FG002|Overall Study|Death|0|||
23334916|NCT00996125|64969366|FG000|Overall Study|Adverse Event|0|||
23334917|NCT00996125|64969367|FG001|Overall Study|Adverse Event|2|||
23334918|NCT00996125|64969366|FG000|Overall Study|Lost to Follow-up|1|||
23334919|NCT00996125|64969367|FG001|Overall Study|Lost to Follow-up|6|||
23334920|NCT00996125|64969366|FG000|Overall Study|Withdrawal by Subject|4|||
23334921|NCT00996125|64969367|FG001|Overall Study|Withdrawal by Subject|3|||
23334922|NCT00708214|64969371|FG000|Overall Study|Other Adverse Event|3|||
23334923|NCT00708214|64969372|FG001|Overall Study|Other Adverse Event|6|||
23334924|NCT00708214|64969373|FG002|Overall Study|Other Adverse Event|2|||
23334925|NCT00708214|64969371|FG000|Overall Study|Other|0|||
23334926|NCT00708214|64969372|FG001|Overall Study|Other|1|||
23334927|NCT00708214|64969373|FG002|Overall Study|Other|1|||
23334928|NCT00708214|64969371|FG000|Overall Study|Progressive Disease|4|||
23334929|NCT00708214|64969372|FG001|Overall Study|Progressive Disease|6|||
23334930|NCT00708214|64969373|FG002|Overall Study|Progressive Disease|5|||
23334931|NCT03412734|64969377|FG000|Overall Study|Incorrect labeling of samples|2|||
23334932|NCT03412734|64969378|FG001|Overall Study|Incorrect labeling of samples|0|||
23334933|NCT03412734|64969377|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
23334934|NCT03412734|64969378|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
23334935|NCT02042950|64969382|FG000|Overall Study|Progressive Disease|4|||
23168204|NCT03529773|64363178|FG020|Overall Study|Lost to Follow-up|2|||
23168205|NCT03529773|64363179|FG021|Overall Study|Lost to Follow-up|4|||
23168206|NCT03529773|64363180|FG022|Overall Study|Lost to Follow-up|3|||
23168207|NCT03529773|64363181|FG023|Overall Study|Lost to Follow-up|4|||
23168208|NCT03529773|64363182|FG024|Overall Study|Lost to Follow-up|3|||
23334936|NCT01568034|64969385|FG000|Overall Study|Withdrawal by Subject|1|||
23334937|NCT01568034|64969386|FG001|Overall Study|Withdrawal by Subject|0|||
23334938|NCT01568034|64969387|FG002|Overall Study|Withdrawal by Subject|0|||
23334939|NCT01568034|64969388|FG003|Overall Study|Withdrawal by Subject|0|||
23334940|NCT02860130|64969389|FG000|Overall Study|Adverse Event|2|||
23334941|NCT02860130|64969390|FG001|Overall Study|Adverse Event|3|||
23334942|NCT02860130|64969389|FG000|Overall Study|Protocol Violation|1|||
23334943|NCT02860130|64969390|FG001|Overall Study|Protocol Violation|1|||
23334944|NCT02860130|64969389|FG000|Overall Study|Withdrawal by Subject|0|||
23334945|NCT02860130|64969390|FG001|Overall Study|Withdrawal by Subject|2|||
23168209|NCT03529773|64363183|FG025|Overall Study|Lost to Follow-up|5|||
23334946|NCT02860130|64969389|FG000|Overall Study|Physician Decision|2|||
23168210|NCT03529773|64363184|FG026|Overall Study|Lost to Follow-up|5|||
23334947|NCT02860130|64969390|FG001|Overall Study|Physician Decision|2|||
23334948|NCT02860130|64969389|FG000|Overall Study|Other|2|||
23334949|NCT02860130|64969390|FG001|Overall Study|Other|1|||
23334950|NCT02222545|64969391|FG000|Overall Study|Adverse Event|1|||
23334951|NCT02222545|64969392|FG001|Overall Study|Adverse Event|0|||
23334952|NCT02222545|64969393|FG002|Overall Study|Adverse Event|2|||
23575804|NCT01755689|65838862|FG004|Overall Study|Withdrawal by Subject|1|||
23575805|NCT01755689|65838858|FG000|Overall Study|Migrated/moved from study area|0|||
23334953|NCT02222545|64969391|FG000|Overall Study|Death|0|||
23334954|NCT02222545|64969392|FG001|Overall Study|Death|0|||
23334955|NCT02222545|64969393|FG002|Overall Study|Death|9|||
23334956|NCT02222545|64969391|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
23334957|NCT02222545|64969392|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
23575806|NCT01755689|65838859|FG001|Overall Study|Migrated/moved from study area|1|||
23575807|NCT01755689|65838860|FG002|Overall Study|Migrated/moved from study area|1|||
23575808|NCT01755689|65838861|FG003|Overall Study|Migrated/moved from study area|1|||
23575809|NCT01755689|65838862|FG004|Overall Study|Migrated/moved from study area|1|||
23575810|NCT01755689|65838858|FG000|Overall Study|Lost to Follow-up|1|||
23575811|NCT01755689|65838859|FG001|Overall Study|Lost to Follow-up|0|||
23575812|NCT01755689|65838860|FG002|Overall Study|Lost to Follow-up|1|||
23575813|NCT01755689|65838861|FG003|Overall Study|Lost to Follow-up|0|||
23575814|NCT01755689|65838862|FG004|Overall Study|Lost to Follow-up|2|||
23575815|NCT01755689|65838858|FG000|Overall Study|Pregnancy|1|||
23575816|NCT01755689|65838859|FG001|Overall Study|Pregnancy|1|||
23575817|NCT01755689|65838860|FG002|Overall Study|Pregnancy|2|||
23575818|NCT01755689|65838861|FG003|Overall Study|Pregnancy|4|||
23575819|NCT01755689|65838862|FG004|Overall Study|Pregnancy|2|||
23575820|NCT00388362|65838863|FG000|Enrolled|Ineligible|1|||
23575821|NCT00388362|65838863|FG000|Enrolled|Adverse Event|9|||
23575822|NCT00388362|65838863|FG000|Enrolled|Death|1|||
23168211|NCT03529773|64363185|FG027|Overall Study|Lost to Follow-up|0|||
23168212|NCT03529773|64363186|FG028|Overall Study|Lost to Follow-up|0|||
23168213|NCT03529773|64363187|FG029|Overall Study|Lost to Follow-up|0|||
23168214|NCT03529773|64363188|FG030|Overall Study|Lost to Follow-up|1|||
23575823|NCT00388362|65838863|FG000|Enrolled|Loss insurance|1|||
23575824|NCT00388362|65838863|FG000|Enrolled|Withdrawal by Subject|1|||
23575825|NCT00388362|65838863|FG000|Remained on Study Median of 514 Days|Death|2|||
23575826|NCT01661881|65838868|FG000|Overall Study|Disease Progression|1|||
23575827|NCT00663117|65838869|FG000|Overall Study|Lack of Efficacy|1|||
23575828|NCT00663117|65838870|FG001|Overall Study|Lack of Efficacy|0|||
23575829|NCT02886936|65838871|FG000|Overall Study|Lost to Follow-up|4|||
23575830|NCT02886936|65838872|FG001|Overall Study|Lost to Follow-up|3|||
23575831|NCT02886936|65838873|FG002|Overall Study|Lost to Follow-up|0|||
23168215|NCT03529773|64363189|FG031|Overall Study|Lost to Follow-up|0|||
23168216|NCT03529773|64363190|FG032|Overall Study|Lost to Follow-up|0|||
23168217|NCT03529773|64363191|FG033|Overall Study|Lost to Follow-up|1|||
23168218|NCT03529773|64363192|FG034|Overall Study|Lost to Follow-up|1|||
23168219|NCT03529773|64363193|FG035|Overall Study|Lost to Follow-up|0|||
23168220|NCT03529773|64363194|FG036|Overall Study|Lost to Follow-up|0|||
23168221|NCT03529773|64363195|FG037|Overall Study|Lost to Follow-up|3|||
23168222|NCT03529773|64363196|FG038|Overall Study|Lost to Follow-up|1|||
23168223|NCT03529773|64363197|FG039|Overall Study|Lost to Follow-up|1|||
23168224|NCT03529773|64363158|FG000|Overall Study|No longer meets eligibility criteria|0|||
23168225|NCT03529773|64363159|FG001|Overall Study|No longer meets eligibility criteria|0|||
23168226|NCT03529773|64363160|FG002|Overall Study|No longer meets eligibility criteria|0|||
23168227|NCT03529773|64363161|FG003|Overall Study|No longer meets eligibility criteria|0|||
23168228|NCT03529773|64363162|FG004|Overall Study|No longer meets eligibility criteria|0|||
23168229|NCT03529773|64363163|FG005|Overall Study|No longer meets eligibility criteria|0|||
23168230|NCT03529773|64363164|FG006|Overall Study|No longer meets eligibility criteria|0|||
23168231|NCT03529773|64363165|FG007|Overall Study|No longer meets eligibility criteria|0|||
23168232|NCT03529773|64363166|FG008|Overall Study|No longer meets eligibility criteria|0|||
23168233|NCT03529773|64363167|FG009|Overall Study|No longer meets eligibility criteria|0|||
23168234|NCT03529773|64363168|FG010|Overall Study|No longer meets eligibility criteria|0|||
23334958|NCT02222545|64969393|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
23334959|NCT02222545|64969391|FG000|Overall Study|Withdrawal by Subject|0|||
23168235|NCT03529773|64363169|FG011|Overall Study|No longer meets eligibility criteria|0|||
23168236|NCT03529773|64363170|FG012|Overall Study|No longer meets eligibility criteria|0|||
23168237|NCT03529773|64363171|FG013|Overall Study|No longer meets eligibility criteria|0|||
23334960|NCT02222545|64969392|FG001|Overall Study|Withdrawal by Subject|0|||
23227556|NCT00537810|64575141|FG000|Overall Study|Medically withdrawn|2|||
23334961|NCT02222545|64969393|FG002|Overall Study|Withdrawal by Subject|3|||
23334962|NCT02222545|64969391|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
23575832|NCT00419003|65838874|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
23575833|NCT00419003|65838875|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
23575834|NCT00419003|65838874|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
23575835|NCT00419003|65838875|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
23575836|NCT01880515|65838876|FG000|Overall Study|Lost to Follow-up|3|||
23575837|NCT01880515|65838877|FG001|Overall Study|Lost to Follow-up|2|||
23575838|NCT01880515|65838876|FG000|Overall Study|Disease Progression|5|||
23575839|NCT01880515|65838877|FG001|Overall Study|Disease Progression|7|||
23575840|NCT03499600|65838878|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
23575841|NCT03499600|65838879|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
23575842|NCT00531011|65838880|FG000|Overall Study|Withdrawal by Subject|2|||
23575843|NCT00531011|65838881|FG001|Overall Study|Withdrawal by Subject|4|||
23575844|NCT00531011|65838880|FG000|Overall Study|Death|1|||
23575845|NCT00531011|65838881|FG001|Overall Study|Death|0|||
23575846|NCT00531011|65838880|FG000|Overall Study|Lost to Follow-up|1|||
23575847|NCT00531011|65838881|FG001|Overall Study|Lost to Follow-up|0|||
23575848|NCT00531011|65838880|FG000|Overall Study|Physician Decision|0|||
23575849|NCT00531011|65838881|FG001|Overall Study|Physician Decision|3|||
23334963|NCT02222545|64969392|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
23334964|NCT02222545|64969393|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
23334965|NCT00818766|64969394|FG000|Overall Study|Could not be Contacted on Day 28|11|||
23334966|NCT00818766|64969395|FG001|Overall Study|Could not be Contacted on Day 28|10|||
23334967|NCT00818766|64969394|FG000|Overall Study|Death|1|||
23334968|NCT00818766|64969395|FG001|Overall Study|Death|0|||
23334969|NCT00818766|64969394|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
23334970|NCT00818766|64969395|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
23334971|NCT01014988|64969396|FG000|Overall Study|Adverse Event|20|||
23334972|NCT01014988|64969397|FG001|Overall Study|Adverse Event|0|||
23334973|NCT01014988|64969398|FG002|Overall Study|Adverse Event|1|||
23334974|NCT01014988|64969399|FG003|Overall Study|Adverse Event|0|||
23334975|NCT01014988|64969400|FG004|Overall Study|Adverse Event|1|||
23334976|NCT01014988|64969401|FG005|Overall Study|Adverse Event|3|||
23334977|NCT01014988|64969396|FG000|Overall Study|Lost to Follow-up|1|||
23334978|NCT01014988|64969397|FG001|Overall Study|Lost to Follow-up|0|||
23334979|NCT01014988|64969398|FG002|Overall Study|Lost to Follow-up|1|||
23334980|NCT01014988|64969399|FG003|Overall Study|Lost to Follow-up|0|||
23334981|NCT01014988|64969400|FG004|Overall Study|Lost to Follow-up|0|||
23334982|NCT01014988|64969401|FG005|Overall Study|Lost to Follow-up|0|||
23334983|NCT01014988|64969396|FG000|Overall Study|Physician Decision|1|||
23334984|NCT01014988|64969397|FG001|Overall Study|Physician Decision|0|||
23334985|NCT01014988|64969398|FG002|Overall Study|Physician Decision|0|||
23334986|NCT01014988|64969399|FG003|Overall Study|Physician Decision|0|||
23334987|NCT01014988|64969400|FG004|Overall Study|Physician Decision|0|||
23334988|NCT01014988|64969401|FG005|Overall Study|Physician Decision|0|||
23334989|NCT01014988|64969396|FG000|Overall Study|Withdrawal by Subject|1|||
23334990|NCT01014988|64969397|FG001|Overall Study|Withdrawal by Subject|0|||
23334991|NCT01014988|64969398|FG002|Overall Study|Withdrawal by Subject|0|||
23334992|NCT01014988|64969399|FG003|Overall Study|Withdrawal by Subject|0|||
23334993|NCT01014988|64969400|FG004|Overall Study|Withdrawal by Subject|0|||
23334994|NCT01014988|64969401|FG005|Overall Study|Withdrawal by Subject|0|||
23334995|NCT02159053|64969402|FG000|Overall Study|Death|2|||
23334996|NCT02159053|64969403|FG001|Overall Study|Death|0|||
23334997|NCT02159053|64969404|FG002|Overall Study|Death|1|||
23334998|NCT02159053|64969402|FG000|Overall Study|Physician Decision|0|||
23334999|NCT02159053|64969403|FG001|Overall Study|Physician Decision|1|||
23335000|NCT02159053|64969404|FG002|Overall Study|Physician Decision|1|||
23335001|NCT02159053|64969402|FG000|Overall Study|Lack of Efficacy|3|||
23335002|NCT02159053|64969403|FG001|Overall Study|Lack of Efficacy|4|||
23335003|NCT02159053|64969404|FG002|Overall Study|Lack of Efficacy|7|||
23335004|NCT02159053|64969402|FG000|Overall Study|Adverse Event|7|||
23335005|NCT02159053|64969403|FG001|Overall Study|Adverse Event|6|||
23335006|NCT02159053|64969404|FG002|Overall Study|Adverse Event|5|||
23335007|NCT02159053|64969402|FG000|Overall Study|Participants/guardian decision|8|||
23335008|NCT02159053|64969403|FG001|Overall Study|Participants/guardian decision|10|||
23335009|NCT02159053|64969404|FG002|Overall Study|Participants/guardian decision|6|||
23335010|NCT04553471|64969405|FG000|Overall Study|Did not start treatment on protocol|3|||
23335011|NCT04553471|64969405|FG000|Overall Study|Death|1|||
23335012|NCT02919969|64969408|FG000|Overall Study|Lack of Efficacy|22|||
23335013|NCT02919969|64969408|FG000|Overall Study|Death|4|||
23335014|NCT02919969|64969408|FG000|Overall Study|Physician Decision|3|||
23575850|NCT00467142|65838885|FG000|Overall Study|Withdrawal by Subject|1|||
23335015|NCT02919969|64969408|FG000|Overall Study|Withdrawal by Subject|2|||
23335016|NCT04471428|64969409|FG000|Overall Study|Withdrawal by Subject|29|||
23335017|NCT04471428|64969410|FG001|Overall Study|Withdrawal by Subject|1|||
23335018|NCT04471428|64969409|FG000|Overall Study|Physician Decision|0|||
23335019|NCT04471428|64969410|FG001|Overall Study|Physician Decision|1|||
23335020|NCT04471428|64969409|FG000|Overall Study|Reason Not Specified|0|||
23335021|NCT04471428|64969410|FG001|Overall Study|Reason Not Specified|2|||
23335022|NCT04471428|64969409|FG000|Overall Study|Death|106|||
23335023|NCT04471428|64969410|FG001|Overall Study|Death|114|||
23575851|NCT00467142|65838885|FG000|Overall Study|Adverse Event|1|||
23575852|NCT00467142|65838885|FG000|Overall Study|Protocol Violation|1|||
23335024|NCT04471428|64969409|FG000|Overall Study|Ongoing in the study|45|||
23335025|NCT04471428|64969410|FG001|Overall Study|Ongoing in the study|68|||
23335026|NCT03309943|64969411|FG000|Overall Study|Withdrawal by Subject|0|||
23335027|NCT03309943|64969412|FG001|Overall Study|Withdrawal by Subject|1|||
23335028|NCT03309943|64969411|FG000|Overall Study|Inappropriate behavior towards staff|0|||
23335029|NCT03309943|64969412|FG001|Overall Study|Inappropriate behavior towards staff|1|||
23335030|NCT01266291|64969413|FG000|Overall Study|Adverse Event|1|||
23335031|NCT02308540|64969414|FG000|Overall Study|Lost to Follow-up|0|||
23335032|NCT02308540|64969415|FG001|Overall Study|Lost to Follow-up|0|||
23335033|NCT02308540|64969416|FG002|Overall Study|Lost to Follow-up|0|||
23335034|NCT02308540|64969417|FG003|Overall Study|Lost to Follow-up|0|||
23335035|NCT02308540|64969418|FG004|Overall Study|Lost to Follow-up|0|||
23335036|NCT02308540|64969419|FG005|Overall Study|Lost to Follow-up|1|||
23335037|NCT00556933|64969420|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
23335038|NCT00556933|64969421|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
23335039|NCT00556933|64969422|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
23335040|NCT00556933|64969423|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
23335041|NCT00556933|64969420|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
23335042|NCT00556933|64969421|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
23335043|NCT00556933|64969422|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
23335044|NCT00556933|64969423|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
23335045|NCT00556933|64969420|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
23335046|NCT00556933|64969421|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
23335047|NCT00556933|64969422|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
23335048|NCT00556933|64969423|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
23335049|NCT00556933|64969420|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
23335050|NCT00556933|64969421|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
23335051|NCT00556933|64969422|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
23335052|NCT00556933|64969423|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
23335053|NCT00556933|64969420|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
23335054|NCT00556933|64969421|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
23335055|NCT00556933|64969422|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
23335056|NCT00556933|64969423|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
23335057|NCT00556933|64969420|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
23335058|NCT00556933|64969421|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
23335059|NCT00556933|64969422|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
23335060|NCT00556933|64969423|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
23335061|NCT00556933|64969420|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
23335062|NCT00556933|64969421|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
23335063|NCT00556933|64969422|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
23335064|NCT00556933|64969423|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
23335065|NCT00556933|64969420|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
23335066|NCT00556933|64969421|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
23335067|NCT00556933|64969422|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
23335068|NCT00556933|64969423|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
23335069|NCT00556933|64969420|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
23335070|NCT00556933|64969421|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
23335071|NCT00556933|64969422|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
23335072|NCT00556933|64969423|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
23335073|NCT00556933|64969420|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
23335074|NCT00556933|64969421|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
23575853|NCT01113463|65838886|FG000|Overall Study|Physician Decision|5|||
23575854|NCT02507219|65838887|FG000|Overall Study|Physician Decision|1|||
23575855|NCT02507219|65838888|FG001|Overall Study|Physician Decision|0|||
23575856|NCT02507219|65838889|FG002|Overall Study|Physician Decision|0|||
23575857|NCT02507219|65838890|FG003|Overall Study|Physician Decision|0|||
23575858|NCT02507219|65838891|FG004|Overall Study|Physician Decision|0|||
23575859|NCT02507219|65838892|FG005|Overall Study|Physician Decision|0|||
23575860|NCT02507219|65838887|FG000|Overall Study|Withdrawal by Subject|0|||
23575861|NCT02507219|65838888|FG001|Overall Study|Withdrawal by Subject|0|||
23575862|NCT02507219|65838889|FG002|Overall Study|Withdrawal by Subject|0|||
23575863|NCT02507219|65838890|FG003|Overall Study|Withdrawal by Subject|0|||
23335075|NCT00556933|64969422|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
23335076|NCT00556933|64969423|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
23575864|NCT02507219|65838891|FG004|Overall Study|Withdrawal by Subject|1|||
23335077|NCT00556933|64969420|FG000|CNI Withdrawal vs. Minimization|Death|0|||
23447767|NCT02587520|65380601|FG005|Overall Study|Adverse Event|0|||
23575865|NCT02507219|65838892|FG005|Overall Study|Withdrawal by Subject|0|||
23575866|NCT01473420|65838893|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
23335078|NCT00556933|64969421|FG001|CNI Withdrawal vs. Minimization|Death|0|||
23335079|NCT00556933|64969422|FG002|CNI Withdrawal vs. Minimization|Death|0|||
23335080|NCT00556933|64969423|FG003|CNI Withdrawal vs. Minimization|Death|1|||
23227557|NCT00537810|64575142|FG001|Overall Study|Medically withdrawn|2|||
23227558|NCT00537810|64575143|FG002|Overall Study|Medically withdrawn|0|||
23227559|NCT00537810|64575144|FG003|Overall Study|Medically withdrawn|1|||
23227560|NCT00397631|64575145|FG000|Overall Study|Adverse Event|5|||
23227561|NCT00397631|64575146|FG001|Overall Study|Adverse Event|6|||
23227562|NCT00397631|64575145|FG000|Overall Study|Lack of Efficacy|7|||
23227563|NCT00397631|64575146|FG001|Overall Study|Lack of Efficacy|10|||
23227564|NCT00397631|64575145|FG000|Overall Study|Lost to Follow-up|8|||
23227565|NCT00397631|64575146|FG001|Overall Study|Lost to Follow-up|9|||
23227566|NCT00397631|64575145|FG000|Overall Study|Physician Decision|2|||
23227567|NCT00397631|64575146|FG001|Overall Study|Physician Decision|0|||
23227568|NCT00397631|64575145|FG000|Overall Study|Protocol Violation|0|||
23227569|NCT00397631|64575146|FG001|Overall Study|Protocol Violation|1|||
23227570|NCT00397631|64575145|FG000|Overall Study|Withdrawal by Subject|7|||
23227571|NCT00397631|64575146|FG001|Overall Study|Withdrawal by Subject|14|||
23227572|NCT00397631|64575145|FG000|Overall Study|protocol discontinuation criteria|1|||
23227573|NCT00397631|64575146|FG001|Overall Study|protocol discontinuation criteria|4|||
23227574|NCT00355615|64575147|FG000|Randomized Double Blind Period|Adverse Event|1|||
23227575|NCT00355615|64575148|FG001|Randomized Double Blind Period|Adverse Event|0|||
23227576|NCT00355615|64575149|FG002|Randomized Double Blind Period|Adverse Event|0|||
23227577|NCT00355615|64575150|FG003|Randomized Double Blind Period|Adverse Event|0|||
23227578|NCT00355615|64575151|FG004|Randomized Double Blind Period|Adverse Event|0|||
23227579|NCT00355615|64575147|FG000|Randomized Double Blind Period|Protocol Violation|0|||
23227580|NCT00355615|64575148|FG001|Randomized Double Blind Period|Protocol Violation|0|||
23227581|NCT00355615|64575149|FG002|Randomized Double Blind Period|Protocol Violation|1|||
23227582|NCT00355615|64575150|FG003|Randomized Double Blind Period|Protocol Violation|1|||
23227583|NCT00355615|64575151|FG004|Randomized Double Blind Period|Protocol Violation|0|||
23227584|NCT00355615|64575147|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
23227585|NCT00355615|64575148|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
23227586|NCT00355615|64575149|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
23227587|NCT00355615|64575150|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
23227588|NCT00355615|64575151|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
23227589|NCT00355615|64575147|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
23227590|NCT00355615|64575148|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
23227591|NCT00355615|64575149|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
23227592|NCT00355615|64575150|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
23227593|NCT00355615|64575151|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
23227594|NCT00355615|64575147|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
23227595|NCT00355615|64575148|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
23227596|NCT00355615|64575149|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
23227597|NCT00355615|64575150|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
23227598|NCT00355615|64575151|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
23227599|NCT00355615|64575147|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
23227600|NCT00355615|64575148|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
23227601|NCT00355615|64575149|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
23227602|NCT00355615|64575150|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
23227603|NCT00355615|64575151|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
23227604|NCT00394654|64575152|FG000|Overall Study|Lost to Follow-up|1|||
23227605|NCT00394654|64575153|FG001|Overall Study|Lost to Follow-up|0|||
23227606|NCT00394654|64575152|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
23227607|NCT00394654|64575153|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
23227608|NCT03228836|64575158|FG000|Overall Study|Adverse Event|3|||
23227609|NCT03228836|64575158|FG000|Overall Study|Withdrawal by Subject|1|||
23227610|NCT03228836|64575158|FG000|Overall Study|Death|1|||
23227611|NCT03228836|64575158|FG000|Overall Study|Physician Decision|1|||
23227612|NCT03228836|64575158|FG000|Overall Study|Disease Progression|7|||
23227613|NCT03228836|64575158|FG000|Overall Study|Other|4|||
23227614|NCT00405275|64577826|FG000|Overall Study|Death|1|||
23227615|NCT00405275|64577827|FG001|Overall Study|Death|0|||
23227616|NCT00405275|64577826|FG000|Overall Study|Lost to Follow-up|5|||
23227617|NCT00405275|64577827|FG001|Overall Study|Lost to Follow-up|1|||
23227618|NCT00405275|64577826|FG000|Overall Study|Withdrawal by Subject|7|||
23227619|NCT00405275|64577827|FG001|Overall Study|Withdrawal by Subject|9|||
23227620|NCT00405275|64577826|FG000|Overall Study|Unwilling to continue|10|||
23227621|NCT00405275|64577827|FG001|Overall Study|Unwilling to continue|9|||
23335081|NCT00300885|64969424|FG000|Treatment|Adverse Event|134|||
23335082|NCT00300885|64969425|FG001|Treatment|Adverse Event|82|||
23227622|NCT00866606|64577832|FG000|Overall Study|Lost to Follow-up|3|||
23335083|NCT00300885|64969424|FG000|Treatment|Death|20|||
23168238|NCT03529773|64363172|FG014|Overall Study|No longer meets eligibility criteria|0|||
23335084|NCT00300885|64969425|FG001|Treatment|Death|7|||
23335085|NCT00300885|64969424|FG000|Treatment|Lack of Efficacy|1|||
23335086|NCT00300885|64969425|FG001|Treatment|Lack of Efficacy|1|||
23335087|NCT00300885|64969424|FG000|Treatment|Lost to Follow-up|3|||
23335088|NCT00300885|64969425|FG001|Treatment|Lost to Follow-up|2|||
23335089|NCT00300885|64969424|FG000|Treatment|Physician Decision|4|||
23575867|NCT01473420|65838894|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
23168239|NCT03529773|64363173|FG015|Overall Study|No longer meets eligibility criteria|0|||
23168240|NCT03529773|64363174|FG016|Overall Study|No longer meets eligibility criteria|0|||
23168241|NCT03529773|64363175|FG017|Overall Study|No longer meets eligibility criteria|0|||
23168242|NCT03529773|64363176|FG018|Overall Study|No longer meets eligibility criteria|0|||
23168243|NCT03529773|64363177|FG019|Overall Study|No longer meets eligibility criteria|0|||
23168244|NCT03529773|64363178|FG020|Overall Study|No longer meets eligibility criteria|0|||
23168245|NCT03529773|64363179|FG021|Overall Study|No longer meets eligibility criteria|0|||
23575868|NCT01473420|65838893|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
23575869|NCT01473420|65838894|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
23575870|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
23575871|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
23575872|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
23575873|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
23575874|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
23575875|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
23575876|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
23575877|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
23575878|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
23575879|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
23575880|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
23575881|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
23575882|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
23575883|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
23575884|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
23575885|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
23575886|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
23575887|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
23575888|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
23575889|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
23575890|NCT01473420|65838893|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
23575891|NCT01473420|65838894|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
23575892|NCT02400307|65838895|FG000|Overall Study|Enrolled and Never Dosed|1|||
23575893|NCT02400307|65838896|FG001|Overall Study|Enrolled and Never Dosed|0|||
23575894|NCT01767129|65838898|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
23575895|NCT01767129|65838899|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
23575896|NCT01155726|65838908|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
23575897|NCT01155726|65838909|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
23575898|NCT01155726|65838910|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
23575899|NCT01155726|65838911|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
23575900|NCT01052662|65838912|FG000|Overall Study|Lost to Follow-up|15|||
23575901|NCT01052662|65838913|FG001|Overall Study|Lost to Follow-up|13|||
23575902|NCT01052662|65838914|FG002|Overall Study|Lost to Follow-up|18|||
23575903|NCT01052662|65838912|FG000|Overall Study|Withdrawal by Subject|3|||
23575904|NCT01052662|65838913|FG001|Overall Study|Withdrawal by Subject|2|||
23575905|NCT01052662|65838914|FG002|Overall Study|Withdrawal by Subject|1|||
23575906|NCT01052662|65838912|FG000|Overall Study|Pharmacy issue|1|||
23575907|NCT01052662|65838913|FG001|Overall Study|Pharmacy issue|3|||
23575908|NCT01052662|65838914|FG002|Overall Study|Pharmacy issue|3|||
23575909|NCT01052662|65838912|FG000|Overall Study|Adverse Event|1|||
23575910|NCT01052662|65838913|FG001|Overall Study|Adverse Event|1|||
23575911|NCT01052662|65838914|FG002|Overall Study|Adverse Event|0|||
23575912|NCT01052662|65838912|FG000|Overall Study|Legal Problem|2|||
23575913|NCT01052662|65838913|FG001|Overall Study|Legal Problem|0|||
23575914|NCT01052662|65838914|FG002|Overall Study|Legal Problem|0|||
23575915|NCT01052662|65838912|FG000|Overall Study|Administrative|0|||
23575916|NCT01052662|65838913|FG001|Overall Study|Administrative|3|||
23575917|NCT01052662|65838914|FG002|Overall Study|Administrative|0|||
23335090|NCT00300885|64969425|FG001|Treatment|Physician Decision|5|||
23335091|NCT00300885|64969424|FG000|Treatment|Protocol Violation|11|||
23575918|NCT03220737|65838915|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
23335092|NCT00300885|64969425|FG001|Treatment|Protocol Violation|11|||
23335093|NCT00300885|64969424|FG000|Treatment|Withdrawal by Subject|26|||
23335094|NCT00300885|64969425|FG001|Treatment|Withdrawal by Subject|23|||
23575919|NCT03220737|65838916|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
23575920|NCT03220737|65838917|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
23168246|NCT03529773|64363180|FG022|Overall Study|No longer meets eligibility criteria|1|||
23168247|NCT03529773|64363181|FG023|Overall Study|No longer meets eligibility criteria|0|||
23168248|NCT03529773|64363182|FG024|Overall Study|No longer meets eligibility criteria|0|||
23168249|NCT03529773|64363183|FG025|Overall Study|No longer meets eligibility criteria|0|||
23168250|NCT03529773|64363184|FG026|Overall Study|No longer meets eligibility criteria|0|||
23227623|NCT00866606|64577832|FG000|Overall Study|Adverse Event|1|||
23227624|NCT00098865|64577833|FG000|Overall Study|Progressive Disease|6|||
23227625|NCT00098865|64577833|FG000|Overall Study|Adverse Event|2|||
23575921|NCT03220737|65838918|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
23575922|NCT03220737|65838919|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
23575923|NCT03220737|65838920|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
23575924|NCT03220737|65838921|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
23575925|NCT03220737|65838915|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
23575926|NCT03220737|65838916|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
23335095|NCT00300885|64969424|FG000|Treatment|Disease progression|171|||
23168251|NCT03529773|64363185|FG027|Overall Study|No longer meets eligibility criteria|0|||
23168252|NCT03529773|64363186|FG028|Overall Study|No longer meets eligibility criteria|0|||
23168253|NCT03529773|64363187|FG029|Overall Study|No longer meets eligibility criteria|0|||
23227626|NCT00098865|64577833|FG000|Overall Study|Alternative Therapy|1|||
23227627|NCT02005211|64577834|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23227628|NCT02005211|64577835|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23227629|NCT02005211|64577836|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23227630|NCT02005211|64577837|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23227631|NCT02005211|64577838|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
23227632|NCT02005211|64577839|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23227633|NCT02005211|64577840|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
23227634|NCT03523715|64577841|FG000|Overall Study|Lost to Follow-up|11|||
23227635|NCT03523715|64577842|FG001|Overall Study|Lost to Follow-up|14|||
23227636|NCT03523715|64577841|FG000|Overall Study|Did not meet inclusion criteria|1|||
23227637|NCT03523715|64577842|FG001|Overall Study|Did not meet inclusion criteria|0|||
23227638|NCT03523715|64577841|FG000|Overall Study|Internally inconsistent reporting|0|||
23227639|NCT03523715|64577842|FG001|Overall Study|Internally inconsistent reporting|2|||
23227640|NCT01291511|64577843|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
23227641|NCT01291511|64577844|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
23168254|NCT03529773|64363188|FG030|Overall Study|No longer meets eligibility criteria|0|||
23168255|NCT03529773|64363189|FG031|Overall Study|No longer meets eligibility criteria|0|||
23168256|NCT03529773|64363190|FG032|Overall Study|No longer meets eligibility criteria|0|||
23168257|NCT03529773|64363191|FG033|Overall Study|No longer meets eligibility criteria|0|||
23227642|NCT01291511|64577843|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
23227643|NCT01291511|64577844|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
23335096|NCT00300885|64969425|FG001|Treatment|Disease progression|238|||
23335097|NCT00300885|64969424|FG000|Treatment|Random code broken (subject died)|0|||
23335098|NCT00300885|64969425|FG001|Treatment|Random code broken (subject died)|1|||
23335099|NCT00300885|64969424|FG000|Treatment|Non-compliant with study medication|3|||
23335100|NCT00300885|64969425|FG001|Treatment|Non-compliant with study medication|4|||
23335101|NCT00300885|64969424|FG000|Follow-up|Death|141|||
23335102|NCT00300885|64969425|FG001|Follow-up|Death|163|||
23335103|NCT00300885|64969424|FG000|Follow-up|Lost to Follow-up|11|||
23335104|NCT00300885|64969425|FG001|Follow-up|Lost to Follow-up|7|||
23335105|NCT00300885|64969424|FG000|Follow-up|Withdrawal by Subject|26|||
23335106|NCT00300885|64969425|FG001|Follow-up|Withdrawal by Subject|25|||
23335107|NCT02142959|64969426|FG000|Overall Study|Adverse Event|1|||
23335108|NCT02142959|64969427|FG001|Overall Study|Adverse Event|0|||
23335109|NCT02142959|64969428|FG002|Overall Study|Adverse Event|0|||
23335110|NCT02142959|64969426|FG000|Overall Study|Death|0|||
23335111|NCT02142959|64969427|FG001|Overall Study|Death|1|||
23335112|NCT02142959|64969428|FG002|Overall Study|Death|0|||
23335113|NCT02142959|64969426|FG000|Overall Study|Withdrawal by Subject|3|||
23335114|NCT02142959|64969427|FG001|Overall Study|Withdrawal by Subject|1|||
23335115|NCT02142959|64969428|FG002|Overall Study|Withdrawal by Subject|3|||
23335116|NCT02142959|64969426|FG000|Overall Study|Administrative Reasons|1|||
23335117|NCT02142959|64969427|FG001|Overall Study|Administrative Reasons|0|||
23227644|NCT01291511|64577843|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
23335118|NCT02142959|64969428|FG002|Overall Study|Administrative Reasons|1|||
23335119|NCT02142959|64969426|FG000|Overall Study|Missing|0|||
23335120|NCT02142959|64969427|FG001|Overall Study|Missing|1|||
23335121|NCT02142959|64969428|FG002|Overall Study|Missing|0|||
23575927|NCT03220737|65838917|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
23227645|NCT01291511|64577844|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
23227646|NCT01291511|64577843|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
23335122|NCT02142959|64969426|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
23227647|NCT01291511|64577844|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
23227648|NCT01291511|64577843|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
23227649|NCT01291511|64577844|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
23227650|NCT01291511|64577843|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
23227651|NCT01291511|64577844|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
23227652|NCT01291511|64577843|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
23227653|NCT01291511|64577844|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
23227654|NCT01291511|64577843|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
23335123|NCT02142959|64969427|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
23335124|NCT02142959|64969428|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
23335125|NCT02142959|64969426|FG000|Overall Study|Patient didn't complete end of study visit|0|||
23335126|NCT02142959|64969427|FG001|Overall Study|Patient didn't complete end of study visit|0|||
23575928|NCT03220737|65838918|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
23575929|NCT03220737|65838919|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
23575930|NCT03220737|65838920|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
23575931|NCT03220737|65838921|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
23575932|NCT03220737|65838915|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
23575933|NCT03220737|65838916|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
23575934|NCT03220737|65838917|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
23575935|NCT03220737|65838918|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
23575936|NCT03220737|65838919|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
23575937|NCT03220737|65838920|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
23575938|NCT03220737|65838921|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
23575939|NCT03220737|65838915|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575940|NCT03220737|65838916|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575941|NCT03220737|65838917|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
23575942|NCT03220737|65838918|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575943|NCT03220737|65838919|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575944|NCT03220737|65838920|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575945|NCT03220737|65838921|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
23575946|NCT03220737|65838915|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575947|NCT03220737|65838916|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575948|NCT03220737|65838917|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575949|NCT03220737|65838918|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575950|NCT03220737|65838919|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
23575951|NCT03220737|65838920|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575952|NCT03220737|65838921|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
23575953|NCT03220737|65838915|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
23575954|NCT03220737|65838916|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575955|NCT03220737|65838917|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575956|NCT03220737|65838918|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575957|NCT03220737|65838919|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575958|NCT03220737|65838920|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575959|NCT03220737|65838921|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
23575960|NCT03220737|65838915|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
23575961|NCT03220737|65838916|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575962|NCT03220737|65838917|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575963|NCT03220737|65838918|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575964|NCT03220737|65838919|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575965|NCT03220737|65838920|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575966|NCT03220737|65838921|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
23575967|NCT03220737|65838915|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
23575968|NCT03220737|65838916|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575969|NCT03220737|65838917|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575970|NCT03220737|65838918|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23335127|NCT02142959|64969428|FG002|Overall Study|Patient didn't complete end of study visit|1|||
23335128|NCT00892151|64969437|FG000|Overall Study|Protocol Violation|1|||
23335129|NCT00813813|64969438|FG000|Overall Study|Withdrawal by Subject|1|||
23335130|NCT00813813|64969439|FG001|Overall Study|Withdrawal by Subject|1|||
23335131|NCT00813813|64969438|FG000|Overall Study|Lost to Follow-up|2|||
23335132|NCT00813813|64969439|FG001|Overall Study|Lost to Follow-up|7|||
23335133|NCT00813813|64969438|FG000|Overall Study|Other|0|||
23335134|NCT00813813|64969439|FG001|Overall Study|Other|1|||
23335135|NCT02122887|64969440|FG000|Overall Study|Withdrawal by Subject|20|||
23335136|NCT02122887|64969441|FG001|Overall Study|Withdrawal by Subject|2|||
23447768|NCT02587520|65380602|FG006|Overall Study|Adverse Event|0|||
23575971|NCT03220737|65838919|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575972|NCT03220737|65838920|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575973|NCT03220737|65838921|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
23575974|NCT00003377|65838922|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
23575975|NCT00003377|65838923|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
23575976|NCT00003377|65838924|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
23575977|NCT00003377|65838925|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
23227655|NCT01291511|64577844|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
23227656|NCT01291511|64577843|FG000|Cross-Titration and Stabilization Phase|Death|1|||
23575978|NCT00003377|65838926|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
23575979|NCT00003377|65838922|FG000|Period II|Ureteral stent complications|0|||
23575980|NCT00003377|65838923|FG001|Period II|Ureteral stent complications|0|||
23575981|NCT00003377|65838924|FG002|Period II|Ureteral stent complications|0|||
23575982|NCT00003377|65838925|FG003|Period II|Ureteral stent complications|0|||
23575983|NCT00003377|65838926|FG004|Period II|Ureteral stent complications|1|||
23575984|NCT03658811|65838927|FG000|Overall Study|Lost to Follow-up|3|||
23575985|NCT01625910|65838928|FG000|Overall Study|Lost to Follow-up|3|||
23575986|NCT01625910|65838929|FG001|Overall Study|Lost to Follow-up|4|||
23575987|NCT00885495|65838930|FG000|Overall Study|Adverse Event|1|||
23575988|NCT00885495|65838931|FG001|Overall Study|Adverse Event|2|||
23575989|NCT00885495|65838930|FG000|Overall Study|Protocol Violation|0|||
23575990|NCT00885495|65838931|FG001|Overall Study|Protocol Violation|1|||
23575991|NCT00885495|65838930|FG000|Overall Study|Withdrawal by Subject|1|||
23575992|NCT00885495|65838931|FG001|Overall Study|Withdrawal by Subject|0|||
23575993|NCT00604721|65838932|FG000|Overall Study|Physician Decision|1|||
23575994|NCT00604721|65838932|FG000|Overall Study|Withdrawal by Subject|1|||
23575995|NCT02234310|65838934|FG000|Overall Study|Physician Decision|1|||
23575996|NCT02234310|65838934|FG000|Overall Study|Adverse Event|1|||
23575997|NCT02234310|65838934|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
23575998|NCT02234310|65838934|FG000|Overall Study|Withdrawal by Subject|2|||
23575999|NCT00163215|65838935|FG000|Overall Study|Lack of Efficacy|3|||
23576000|NCT00163215|65838935|FG000|Overall Study|Withdrawal by Subject|5|||
23576001|NCT00163215|65838935|FG000|Overall Study|Other|7|||
23576002|NCT00900627|65838936|FG000|Overall Study|Condition under investigation worsened|4|||
23576003|NCT00900627|65838937|FG001|Overall Study|Condition under investigation worsened|0|||
23576004|NCT00900627|65838938|FG002|Overall Study|Condition under investigation worsened|5|||
23576005|NCT00900627|65838939|FG003|Overall Study|Condition under investigation worsened|3|||
23576006|NCT00900627|65838940|FG004|Overall Study|Condition under investigation worsened|0|||
23576007|NCT00900627|65838941|FG005|Overall Study|Condition under investigation worsened|0|||
23227657|NCT01291511|64577844|FG001|Cross-Titration and Stabilization Phase|Death|0|||
23227658|NCT01291511|64577843|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
23227659|NCT01291511|64577844|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
23227660|NCT01291511|64577843|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
23227661|NCT01291511|64577844|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
23227662|NCT01291511|64577843|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
23227663|NCT01291511|64577844|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
23227664|NCT01291511|64577843|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
23227665|NCT01291511|64577844|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
23227666|NCT01291511|64577843|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
23227667|NCT01291511|64577844|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
23576008|NCT00900627|65838936|FG000|Overall Study|Withdrawal by Subject|1|||
23576009|NCT00900627|65838937|FG001|Overall Study|Withdrawal by Subject|0|||
23576010|NCT00900627|65838938|FG002|Overall Study|Withdrawal by Subject|1|||
23576011|NCT00900627|65838939|FG003|Overall Study|Withdrawal by Subject|0|||
23227668|NCT01291511|64577843|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
23227669|NCT01291511|64577844|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
23227670|NCT01291511|64577843|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
23227671|NCT01291511|64577844|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
23227672|NCT01291511|64577843|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
23447769|NCT02587520|65380603|FG007|Overall Study|Adverse Event|0|||
23576012|NCT00900627|65838940|FG004|Overall Study|Withdrawal by Subject|1|||
23576013|NCT00900627|65838941|FG005|Overall Study|Withdrawal by Subject|2|||
23576014|NCT00900627|65838936|FG000|Overall Study|Adverse Event|1|||
23576015|NCT00900627|65838937|FG001|Overall Study|Adverse Event|2|||
23576016|NCT00900627|65838938|FG002|Overall Study|Adverse Event|0|||
23576017|NCT00900627|65838939|FG003|Overall Study|Adverse Event|3|||
23576018|NCT00900627|65838940|FG004|Overall Study|Adverse Event|0|||
23227673|NCT01291511|64577844|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
23227674|NCT01291511|64577843|FG000|Double-blind Relapse Prevention Phase|Death|1|||
23227675|NCT01291511|64577844|FG001|Double-blind Relapse Prevention Phase|Death|0|||
23227676|NCT02092324|64577845|FG000|Overall Study|Adverse Event|1|||
23227677|NCT02092324|64577845|FG000|Overall Study|Lack of Efficacy|6|||
23227678|NCT02092324|64577845|FG000|Overall Study|Proceed to Transplant|3|||
23227679|NCT02092324|64577845|FG000|Overall Study|Physician Decision|7|||
23227680|NCT02092324|64577845|FG000|Overall Study|Misdiagnosis|2|||
23227681|NCT01183104|64577846|FG000|Overall Study|Adverse Event|8|||
23227682|NCT01183104|64577847|FG001|Overall Study|Adverse Event|6|||
23227683|NCT01183104|64577846|FG000|Overall Study|Death|0|||
23227684|NCT01183104|64577847|FG001|Overall Study|Death|1|||
23227685|NCT01183104|64577846|FG000|Overall Study|Lost to Follow-up|14|||
23227686|NCT01183104|64577847|FG001|Overall Study|Lost to Follow-up|7|||
23227687|NCT01183104|64577846|FG000|Overall Study|Physician Decision|5|||
23227688|NCT01183104|64577847|FG001|Overall Study|Physician Decision|8|||
23168258|NCT03529773|64363192|FG034|Overall Study|No longer meets eligibility criteria|0|||
23168259|NCT03529773|64363193|FG035|Overall Study|No longer meets eligibility criteria|0|||
23168260|NCT03529773|64363194|FG036|Overall Study|No longer meets eligibility criteria|0|||
23168261|NCT03529773|64363195|FG037|Overall Study|No longer meets eligibility criteria|0|||
23168262|NCT03529773|64363196|FG038|Overall Study|No longer meets eligibility criteria|1|||
23168263|NCT03529773|64363197|FG039|Overall Study|No longer meets eligibility criteria|0|||
23168264|NCT03529773|64363158|FG000|Overall Study|Other|0|||
23168265|NCT03529773|64363159|FG001|Overall Study|Other|0|||
23168266|NCT03529773|64363160|FG002|Overall Study|Other|0|||
23168267|NCT03529773|64363161|FG003|Overall Study|Other|0|||
23168268|NCT03529773|64363162|FG004|Overall Study|Other|0|||
23168269|NCT03529773|64363163|FG005|Overall Study|Other|0|||
23168270|NCT03529773|64363164|FG006|Overall Study|Other|0|||
23168271|NCT03529773|64363165|FG007|Overall Study|Other|0|||
23168272|NCT03529773|64363166|FG008|Overall Study|Other|0|||
23168273|NCT03529773|64363167|FG009|Overall Study|Other|0|||
23168274|NCT03529773|64363168|FG010|Overall Study|Other|0|||
23168275|NCT03529773|64363169|FG011|Overall Study|Other|0|||
23168276|NCT03529773|64363170|FG012|Overall Study|Other|1|||
23168277|NCT03529773|64363171|FG013|Overall Study|Other|0|||
23168278|NCT03529773|64363172|FG014|Overall Study|Other|2|||
23168279|NCT03529773|64363173|FG015|Overall Study|Other|0|||
23168280|NCT03529773|64363174|FG016|Overall Study|Other|0|||
23168281|NCT03529773|64363175|FG017|Overall Study|Other|3|||
23168282|NCT03529773|64363176|FG018|Overall Study|Other|0|||
23227689|NCT01183104|64577846|FG000|Overall Study|Withdrawal by Subject|6|||
23227690|NCT01183104|64577847|FG001|Overall Study|Withdrawal by Subject|11|||
23576019|NCT00900627|65838941|FG005|Overall Study|Adverse Event|0|||
23576020|NCT00900627|65838936|FG000|Overall Study|Death|0|||
23576021|NCT00900627|65838937|FG001|Overall Study|Death|0|||
23576022|NCT00900627|65838938|FG002|Overall Study|Death|0|||
23576023|NCT00900627|65838939|FG003|Overall Study|Death|0|||
23576024|NCT00900627|65838940|FG004|Overall Study|Death|28|||
23576025|NCT00900627|65838941|FG005|Overall Study|Death|24|||
23576026|NCT01657682|65838942|FG000|Overall Study|Lost to Follow-up|1|||
23576027|NCT01657682|65838943|FG001|Overall Study|Lost to Follow-up|0|||
23576028|NCT01657682|65838944|FG002|Overall Study|Lost to Follow-up|0|||
23576029|NCT01657682|65838942|FG000|Overall Study|Withdrawal by Subject|0|||
23576030|NCT01657682|65838943|FG001|Overall Study|Withdrawal by Subject|1|||
23576031|NCT01657682|65838944|FG002|Overall Study|Withdrawal by Subject|1|||
23576032|NCT01657682|65838942|FG000|Overall Study|Adverse Event|0|||
23576033|NCT01657682|65838943|FG001|Overall Study|Adverse Event|1|||
23576034|NCT01657682|65838944|FG002|Overall Study|Adverse Event|0|||
23576035|NCT02950545|65838945|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576036|NCT02950545|65838946|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576037|NCT02950545|65838947|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576038|NCT02950545|65838948|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576039|NCT02950545|65838949|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
23576040|NCT02950545|65838950|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
23576041|NCT02950545|65838945|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
23168283|NCT03529773|64363177|FG019|Overall Study|Other|0|||
23168284|NCT03529773|64363178|FG020|Overall Study|Other|1|||
23168285|NCT03529773|64363179|FG021|Overall Study|Other|0|||
23168286|NCT03529773|64363180|FG022|Overall Study|Other|1|||
23576042|NCT02950545|65838946|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
23576043|NCT02950545|65838947|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
23576044|NCT02950545|65838948|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
23576045|NCT02950545|65838949|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
23576046|NCT02950545|65838950|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
23168287|NCT03529773|64363181|FG023|Overall Study|Other|0|||
23168288|NCT03529773|64363182|FG024|Overall Study|Other|3|||
23168289|NCT03529773|64363183|FG025|Overall Study|Other|2|||
23168290|NCT03529773|64363184|FG026|Overall Study|Other|2|||
23168291|NCT03529773|64363185|FG027|Overall Study|Other|0|||
23168292|NCT03529773|64363186|FG028|Overall Study|Other|0|||
23227691|NCT01183104|64577846|FG000|Overall Study|Nonparticipation in Extension Study|39|||
23227692|NCT01183104|64577847|FG001|Overall Study|Nonparticipation in Extension Study|50|||
23227693|NCT01183104|64577846|FG000|Overall Study|Did not receive study drug|5|||
23335137|NCT00464490|64969449|FG000|Overall Study|Physician Decision|11|||
23227694|NCT01183104|64577847|FG001|Overall Study|Did not receive study drug|9|||
23227695|NCT02881151|64577848|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
23227696|NCT01601873|64577849|FG000|Overall Study|Lost to Follow-up|2|||
23227697|NCT01601873|64577850|FG001|Overall Study|Lost to Follow-up|3|||
23227698|NCT01969565|64577855|FG000|Overall Study|Withdrawal by Subject|1|||
23227699|NCT02545049|64577856|FG000|Overall Study|Withdrawal by Subject|1|||
23227700|NCT02545049|64577857|FG001|Overall Study|Withdrawal by Subject|7|||
23227701|NCT02545049|64577856|FG000|Overall Study|Lost to Follow-up|4|||
23227702|NCT02545049|64577857|FG001|Overall Study|Lost to Follow-up|6|||
23227703|NCT02545049|64577856|FG000|Overall Study|GCP violations|37|||
23227704|NCT02545049|64577857|FG001|Overall Study|GCP violations|48|||
23227705|NCT03661983|64577858|FG000|Open Label Stabilization Phase|Adverse Event|5|||
23227706|NCT03661983|64577859|FG001|Open Label Stabilization Phase|Adverse Event|0|||
23227707|NCT03661983|64577860|FG002|Open Label Stabilization Phase|Adverse Event|0|||
23227708|NCT03661983|64577861|FG003|Open Label Stabilization Phase|Adverse Event|0|||
23227709|NCT03661983|64577858|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
23227710|NCT03661983|64577859|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
23335138|NCT00464490|64969450|FG001|Overall Study|Physician Decision|11|||
23335139|NCT00003830|64969452|FG000|Overall Study|No follow up data|3|||
23335140|NCT00003830|64969453|FG001|Overall Study|No follow up data|0|||
23335141|NCT00003830|64969452|FG000|Overall Study|Sentinel node positive patients|829|||
23335142|NCT00003830|64969453|FG001|Overall Study|Sentinel node positive patients|793|||
23335143|NCT02473250|64969454|FG000|Overall Study|Lost to Follow-up|10|||
23335144|NCT02473250|64969454|FG000|Overall Study|Physician Decision|5|||
23335145|NCT02473250|64969454|FG000|Overall Study|Did not tolerate medication washout|3|||
23335146|NCT02473250|64969454|FG000|Overall Study|Antidepressant effect of divalproex|2|||
23335147|NCT00022698|64969455|FG000|Overall Study|Adverse Event|5|||
23335148|NCT00022698|64969456|FG001|Overall Study|Adverse Event|9|||
23335149|NCT00022698|64969455|FG000|Overall Study|Death|0|||
23335150|NCT00022698|64969456|FG001|Overall Study|Death|2|||
23335151|NCT00022698|64969455|FG000|Overall Study|Failure to return|0|||
23335152|NCT00022698|64969456|FG001|Overall Study|Failure to return|1|||
23335153|NCT00022698|64969455|FG000|Overall Study|Refused treatment|0|||
23335154|NCT00022698|64969456|FG001|Overall Study|Refused treatment|2|||
23335155|NCT00022698|64969455|FG000|Overall Study|Insufficient therapeutic response|2|||
23335156|NCT00022698|64969456|FG001|Overall Study|Insufficient therapeutic response|14|||
23335157|NCT00022698|64969455|FG000|Overall Study|Administrative /other|1|||
23335158|NCT00022698|64969456|FG001|Overall Study|Administrative /other|7|||
23335159|NCT01017874|64969463|FG000|Overall Study|Withdrawal by Subject|23|||
23335160|NCT01017874|64969464|FG001|Overall Study|Withdrawal by Subject|20|||
23335161|NCT01017874|64969463|FG000|Overall Study|Sponsor decision|3|||
23335162|NCT01017874|64969464|FG001|Overall Study|Sponsor decision|1|||
23335163|NCT01017874|64969463|FG000|Overall Study|Lost to Follow-up|3|||
23335164|NCT01017874|64969464|FG001|Overall Study|Lost to Follow-up|2|||
23335165|NCT01017874|64969463|FG000|Overall Study|Physician Decision|1|||
23335166|NCT01017874|64969464|FG001|Overall Study|Physician Decision|3|||
23335167|NCT03056638|64969476|FG000|Overall Study|Death|1|||
23335168|NCT03056638|64969477|FG001|Overall Study|Death|0|||
23335169|NCT00723008|64969478|FG000|Enrollment|Lost to Follow-up|1|||
23335170|NCT00723008|64969479|FG001|Enrollment|Lost to Follow-up|0|||
23335171|NCT00723008|64969478|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
23335172|NCT00723008|64969479|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
23335173|NCT00723008|64969478|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
23335174|NCT00723008|64969479|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
23335175|NCT00723008|64969478|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
23335176|NCT00723008|64969479|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
23335177|NCT00723008|64969478|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
23335178|NCT00723008|64969479|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
23335179|NCT00723008|64969478|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
23335180|NCT00723008|64969479|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
23335181|NCT01068678|64969480|FG000|Overall Study|Lack of Efficacy|3|||
23335182|NCT01068678|64969481|FG001|Overall Study|Lack of Efficacy|2|||
23227711|NCT03661983|64577860|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
23227712|NCT03661983|64577861|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
23335183|NCT01068678|64969480|FG000|Overall Study|Protocol Violation|5|||
23335184|NCT01068678|64969481|FG001|Overall Study|Protocol Violation|1|||
23335185|NCT01068678|64969480|FG000|Overall Study|Withdrawal criteria|12|||
23335186|NCT01068678|64969481|FG001|Overall Study|Withdrawal criteria|6|||
23335187|NCT01068678|64969480|FG000|Overall Study|Unclassified|18|||
23335188|NCT01068678|64969481|FG001|Overall Study|Unclassified|15|||
23335189|NCT01732458|64969482|FG000|Overall Study|Lost to Follow-up|0|||
23335190|NCT01732458|64969483|FG001|Overall Study|Lost to Follow-up|2|||
23335191|NCT01732458|64969484|FG002|Overall Study|Lost to Follow-up|0|||
23335192|NCT01732458|64969485|FG003|Overall Study|Lost to Follow-up|0|||
23335193|NCT01732458|64969482|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23335194|NCT01732458|64969483|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23335195|NCT01732458|64969484|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23335196|NCT01732458|64969485|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23335197|NCT01732458|64969482|FG000|Overall Study|Physician Decision|1|||
23335198|NCT01732458|64969483|FG001|Overall Study|Physician Decision|2|||
23335199|NCT01732458|64969484|FG002|Overall Study|Physician Decision|2|||
23335200|NCT01732458|64969485|FG003|Overall Study|Physician Decision|0|||
23335201|NCT01732458|64969482|FG000|Overall Study|Protocol Violation|2|||
23335202|NCT01732458|64969483|FG001|Overall Study|Protocol Violation|0|||
23335203|NCT01732458|64969484|FG002|Overall Study|Protocol Violation|0|||
23335204|NCT01732458|64969485|FG003|Overall Study|Protocol Violation|2|||
23335205|NCT01732458|64969482|FG000|Overall Study|Screen Failure|0|||
23227713|NCT03661983|64577858|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
23227714|NCT03661983|64577859|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
23227715|NCT03661983|64577860|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
23227716|NCT03661983|64577861|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
23227717|NCT03661983|64577858|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
23227718|NCT03661983|64577859|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
23227719|NCT03661983|64577860|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
23227720|NCT03661983|64577861|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
23227721|NCT03661983|64577858|FG000|Double-blind Randomized Phase|Adverse Event|0|||
23227722|NCT03661983|64577859|FG001|Double-blind Randomized Phase|Adverse Event|1|||
23227723|NCT03661983|64577860|FG002|Double-blind Randomized Phase|Adverse Event|0|||
23227724|NCT03661983|64577861|FG003|Double-blind Randomized Phase|Adverse Event|0|||
23227725|NCT03661983|64577858|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
23227726|NCT03661983|64577859|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
23227727|NCT03661983|64577860|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
23227728|NCT03661983|64577861|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
23227729|NCT03661983|64577858|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
23227730|NCT03661983|64577859|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
23227731|NCT03661983|64577860|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
23227732|NCT03661983|64577861|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
23227733|NCT03661983|64577858|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
23227734|NCT03661983|64577859|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
23227735|NCT03661983|64577860|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
23227736|NCT03661983|64577861|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
23227737|NCT01332851|64577862|FG000|Overall Study|Withdrawal by Subject|4|||
23227738|NCT01332851|64577863|FG001|Overall Study|Withdrawal by Subject|2|||
23227739|NCT01332851|64577862|FG000|Overall Study|Lost to Follow-up|7|||
23227740|NCT01332851|64577863|FG001|Overall Study|Lost to Follow-up|11|||
23227741|NCT00732472|64577864|FG000|Overall Study|Adverse Event|0|||
23227742|NCT00732472|64577865|FG001|Overall Study|Adverse Event|1|||
23227743|NCT00732472|64577866|FG002|Overall Study|Adverse Event|1|||
23227744|NCT00732472|64577867|FG003|Overall Study|Adverse Event|1|||
23227745|NCT00732472|64577864|FG000|Overall Study|Protocol Violation|0|||
23335206|NCT01732458|64969483|FG001|Overall Study|Screen Failure|1|||
23335207|NCT01732458|64969484|FG002|Overall Study|Screen Failure|0|||
23335208|NCT01732458|64969485|FG003|Overall Study|Screen Failure|0|||
23335209|NCT04657198|64969486|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
23168293|NCT03529773|64363187|FG029|Overall Study|Other|0|||
23168294|NCT03529773|64363188|FG030|Overall Study|Other|0|||
23168295|NCT03529773|64363189|FG031|Overall Study|Other|0|||
23168296|NCT03529773|64363190|FG032|Overall Study|Other|0|||
23168297|NCT03529773|64363191|FG033|Overall Study|Other|0|||
23168298|NCT03529773|64363192|FG034|Overall Study|Other|1|||
23168299|NCT03529773|64363193|FG035|Overall Study|Other|1|||
23168300|NCT03529773|64363194|FG036|Overall Study|Other|0|||
23168301|NCT03529773|64363195|FG037|Overall Study|Other|0|||
23168302|NCT03529773|64363196|FG038|Overall Study|Other|0|||
23168303|NCT03529773|64363197|FG039|Overall Study|Other|0|||
23168304|NCT03529773|64363158|FG000|Overall Study|Physician Decision|0|||
23168305|NCT03529773|64363159|FG001|Overall Study|Physician Decision|0|||
23168306|NCT03529773|64363160|FG002|Overall Study|Physician Decision|0|||
23168307|NCT03529773|64363161|FG003|Overall Study|Physician Decision|0|||
23168308|NCT03529773|64363162|FG004|Overall Study|Physician Decision|0|||
23168309|NCT03529773|64363163|FG005|Overall Study|Physician Decision|0|||
23168310|NCT03529773|64363164|FG006|Overall Study|Physician Decision|0|||
23168311|NCT03529773|64363165|FG007|Overall Study|Physician Decision|0|||
23168312|NCT03529773|64363166|FG008|Overall Study|Physician Decision|0|||
23168313|NCT03529773|64363167|FG009|Overall Study|Physician Decision|0|||
23168314|NCT03529773|64363168|FG010|Overall Study|Physician Decision|0|||
23168315|NCT03529773|64363169|FG011|Overall Study|Physician Decision|0|||
23168316|NCT03529773|64363170|FG012|Overall Study|Physician Decision|0|||
23168317|NCT03529773|64363171|FG013|Overall Study|Physician Decision|0|||
23168318|NCT03529773|64363172|FG014|Overall Study|Physician Decision|0|||
23168319|NCT03529773|64363173|FG015|Overall Study|Physician Decision|0|||
23335210|NCT04657198|64969487|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
23335211|NCT04657198|64969488|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
23335212|NCT03318861|64969489|FG000|Overall Study|Death|2|||
23335213|NCT03318861|64969490|FG001|Overall Study|Death|3|||
23335214|NCT03318861|64969491|FG002|Overall Study|Death|3|||
23168320|NCT03529773|64363174|FG016|Overall Study|Physician Decision|0|||
23168321|NCT03529773|64363175|FG017|Overall Study|Physician Decision|0|||
23168322|NCT03529773|64363176|FG018|Overall Study|Physician Decision|0|||
23168323|NCT03529773|64363177|FG019|Overall Study|Physician Decision|1|||
23335215|NCT03318861|64969492|FG003|Overall Study|Death|2|||
23335216|NCT03318861|64969493|FG004|Overall Study|Death|2|||
23335217|NCT03318861|64969489|FG000|Overall Study|Enrolled But Never Treated|0|||
23335218|NCT03318861|64969490|FG001|Overall Study|Enrolled But Never Treated|1|||
23335219|NCT03318861|64969491|FG002|Overall Study|Enrolled But Never Treated|0|||
23335220|NCT03318861|64969492|FG003|Overall Study|Enrolled But Never Treated|1|||
23335221|NCT03318861|64969493|FG004|Overall Study|Enrolled But Never Treated|1|||
23335222|NCT03318861|64969489|FG000|Overall Study|Informed Consent Withdraw|0|||
23335223|NCT03318861|64969490|FG001|Overall Study|Informed Consent Withdraw|0|||
23335224|NCT03318861|64969491|FG002|Overall Study|Informed Consent Withdraw|0|||
23335225|NCT03318861|64969492|FG003|Overall Study|Informed Consent Withdraw|1|||
23335226|NCT03318861|64969493|FG004|Overall Study|Informed Consent Withdraw|0|||
23335227|NCT03318861|64969489|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
23335228|NCT03318861|64969490|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
23335229|NCT03318861|64969491|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
23335230|NCT03318861|64969492|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
23335231|NCT03318861|64969493|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
23335232|NCT00782795|64969494|FG000|Overall Study|Withdrawal by Subject|1|||
23335233|NCT00782795|64969495|FG001|Overall Study|Withdrawal by Subject|2|||
23335234|NCT01841762|64969496|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
23335235|NCT01841762|64969496|FG000|Treatment Period|Adverse Event|16|||
23335236|NCT01841762|64969496|FG000|Treatment Period|Death|1|||
23335237|NCT01841762|64969496|FG000|Treatment Period|Withdrawal by Subject|7|||
23335238|NCT01841762|64969496|FG000|Treatment Period|Lost to Follow-up|1|||
23168324|NCT03529773|64363178|FG020|Overall Study|Physician Decision|1|||
23168325|NCT03529773|64363179|FG021|Overall Study|Physician Decision|0|||
23168326|NCT03529773|64363180|FG022|Overall Study|Physician Decision|0|||
23168327|NCT03529773|64363181|FG023|Overall Study|Physician Decision|0|||
23168328|NCT03529773|64363182|FG024|Overall Study|Physician Decision|0|||
23168329|NCT03529773|64363183|FG025|Overall Study|Physician Decision|0|||
23168330|NCT03529773|64363184|FG026|Overall Study|Physician Decision|0|||
23168331|NCT03529773|64363185|FG027|Overall Study|Physician Decision|0|||
23168332|NCT03529773|64363186|FG028|Overall Study|Physician Decision|0|||
23168333|NCT03529773|64363187|FG029|Overall Study|Physician Decision|0|||
23168334|NCT03529773|64363188|FG030|Overall Study|Physician Decision|0|||
23168335|NCT03529773|64363189|FG031|Overall Study|Physician Decision|0|||
23168336|NCT03529773|64363190|FG032|Overall Study|Physician Decision|0|||
23168337|NCT03529773|64363191|FG033|Overall Study|Physician Decision|0|||
23168338|NCT03529773|64363192|FG034|Overall Study|Physician Decision|0|||
23168339|NCT03529773|64363193|FG035|Overall Study|Physician Decision|0|||
23168340|NCT03529773|64363194|FG036|Overall Study|Physician Decision|0|||
23168341|NCT03529773|64363195|FG037|Overall Study|Physician Decision|0|||
23168342|NCT03529773|64363196|FG038|Overall Study|Physician Decision|0|||
23168343|NCT03529773|64363197|FG039|Overall Study|Physician Decision|0|||
23168344|NCT03529773|64363158|FG000|Overall Study|Protocol Violation|0|||
23168345|NCT03529773|64363159|FG001|Overall Study|Protocol Violation|0|||
23168346|NCT03529773|64363160|FG002|Overall Study|Protocol Violation|0|||
23168347|NCT03529773|64363161|FG003|Overall Study|Protocol Violation|0|||
23168348|NCT03529773|64363162|FG004|Overall Study|Protocol Violation|0|||
23168349|NCT03529773|64363163|FG005|Overall Study|Protocol Violation|0|||
23168350|NCT03529773|64363164|FG006|Overall Study|Protocol Violation|0|||
23168351|NCT03529773|64363165|FG007|Overall Study|Protocol Violation|0|||
23168352|NCT03529773|64363166|FG008|Overall Study|Protocol Violation|0|||
23168353|NCT03529773|64363167|FG009|Overall Study|Protocol Violation|0|||
23168354|NCT03529773|64363168|FG010|Overall Study|Protocol Violation|0|||
23168355|NCT03529773|64363169|FG011|Overall Study|Protocol Violation|0|||
23168356|NCT03529773|64363170|FG012|Overall Study|Protocol Violation|0|||
23168357|NCT03529773|64363171|FG013|Overall Study|Protocol Violation|0|||
23168358|NCT03529773|64363172|FG014|Overall Study|Protocol Violation|0|||
23335239|NCT01841762|64969496|FG000|Treatment Period|Physician Decision|2|||
23335240|NCT01841762|64969496|FG000|Treatment Period|Other, including non-compliance|5|||
23335241|NCT01841762|64969496|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
23447770|NCT02587520|65380604|FG008|Overall Study|Adverse Event|0|||
23447771|NCT02587520|65380605|FG009|Overall Study|Adverse Event|0|||
23447772|NCT02587520|65380606|FG010|Overall Study|Adverse Event|0|||
23168359|NCT03529773|64363173|FG015|Overall Study|Protocol Violation|0|||
23168360|NCT03529773|64363174|FG016|Overall Study|Protocol Violation|0|||
23168361|NCT03529773|64363175|FG017|Overall Study|Protocol Violation|0|||
23168362|NCT03529773|64363176|FG018|Overall Study|Protocol Violation|0|||
23168363|NCT03529773|64363177|FG019|Overall Study|Protocol Violation|0|||
23168364|NCT03529773|64363178|FG020|Overall Study|Protocol Violation|0|||
23168365|NCT03529773|64363179|FG021|Overall Study|Protocol Violation|0|||
23335242|NCT01841762|64969496|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
23227746|NCT00732472|64577865|FG001|Overall Study|Protocol Violation|0|||
23227747|NCT00732472|64577866|FG002|Overall Study|Protocol Violation|0|||
23227748|NCT00732472|64577867|FG003|Overall Study|Protocol Violation|1|||
23227749|NCT00732472|64577864|FG000|Overall Study|Withdrawal by Subject|0|||
23227750|NCT00732472|64577865|FG001|Overall Study|Withdrawal by Subject|2|||
23227751|NCT00732472|64577866|FG002|Overall Study|Withdrawal by Subject|0|||
23227752|NCT00732472|64577867|FG003|Overall Study|Withdrawal by Subject|1|||
23227753|NCT03483012|64577869|FG000|Overall Study|Lack of Efficacy|6|||
23227754|NCT03049852|64577870|FG000|Overall Study|Lost to Follow-up|0|||
23335243|NCT01841762|64969496|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
23335244|NCT01841762|64969496|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
23168366|NCT03529773|64363180|FG022|Overall Study|Protocol Violation|0|||
23168367|NCT03529773|64363181|FG023|Overall Study|Protocol Violation|0|||
23168368|NCT03529773|64363182|FG024|Overall Study|Protocol Violation|0|||
23168369|NCT03529773|64363183|FG025|Overall Study|Protocol Violation|0|||
23168370|NCT03529773|64363184|FG026|Overall Study|Protocol Violation|0|||
23168371|NCT03529773|64363185|FG027|Overall Study|Protocol Violation|0|||
23168372|NCT03529773|64363186|FG028|Overall Study|Protocol Violation|0|||
23168373|NCT03529773|64363187|FG029|Overall Study|Protocol Violation|0|||
23227755|NCT03049852|64577871|FG001|Overall Study|Lost to Follow-up|1|||
23335245|NCT00665431|64969498|FG000|Overall Study|Adverse Event|16|||
23335246|NCT00665431|64969499|FG001|Overall Study|Adverse Event|22|||
23335247|NCT00665431|64969500|FG002|Overall Study|Adverse Event|6|||
23335248|NCT00665431|64969498|FG000|Overall Study|Withdrawal by Subject|17|||
23335249|NCT00665431|64969499|FG001|Overall Study|Withdrawal by Subject|25|||
23335250|NCT00665431|64969500|FG002|Overall Study|Withdrawal by Subject|15|||
23335251|NCT00665431|64969498|FG000|Overall Study|Lost to Follow-up|3|||
23335252|NCT00665431|64969499|FG001|Overall Study|Lost to Follow-up|3|||
23335253|NCT00665431|64969500|FG002|Overall Study|Lost to Follow-up|1|||
23576047|NCT02950545|65838945|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576048|NCT02950545|65838946|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576049|NCT02950545|65838947|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576050|NCT02950545|65838948|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576051|NCT02950545|65838949|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
23576052|NCT02950545|65838950|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
23576053|NCT02950545|65838945|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
23576054|NCT02950545|65838946|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576055|NCT02950545|65838947|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576056|NCT02950545|65838948|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576057|NCT02950545|65838949|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576058|NCT02950545|65838950|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
23576059|NCT02950545|65838945|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576060|NCT02950545|65838946|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576061|NCT02950545|65838947|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576062|NCT02950545|65838948|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576063|NCT02950545|65838949|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
23576064|NCT02950545|65838950|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
23576065|NCT02703532|65838951|FG000|Overall Study|Withdrawal by Subject|0|||
23576066|NCT02703532|65838952|FG001|Overall Study|Withdrawal by Subject|1|||
23576067|NCT02703532|65838953|FG002|Overall Study|Withdrawal by Subject|0|||
23576068|NCT02703532|65838954|FG003|Overall Study|Withdrawal by Subject|1|||
23576069|NCT02703532|65838951|FG000|Overall Study|Lost to Follow-up|2|||
23576070|NCT02703532|65838952|FG001|Overall Study|Lost to Follow-up|0|||
23576071|NCT02703532|65838953|FG002|Overall Study|Lost to Follow-up|2|||
23168374|NCT03529773|64363188|FG030|Overall Study|Protocol Violation|1|||
23168375|NCT03529773|64363189|FG031|Overall Study|Protocol Violation|0|||
23168376|NCT03529773|64363190|FG032|Overall Study|Protocol Violation|0|||
23227756|NCT03049852|64577872|FG002|Overall Study|Lost to Follow-up|0|||
23227757|NCT01051856|64577873|FG000|Overall Study|Withdrawal by Subject|1|||
23227758|NCT01051856|64577874|FG001|Overall Study|Withdrawal by Subject|0|||
23227759|NCT02516306|64577875|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
23227760|NCT02516306|64577876|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
23576072|NCT02703532|65838954|FG003|Overall Study|Lost to Follow-up|0|||
23576073|NCT01158378|65838956|FG000|Overall Study|Death|4|||
23576074|NCT01158378|65838957|FG001|Overall Study|Death|5|||
23576075|NCT01158378|65838956|FG000|Overall Study|Lost to Follow-up|2|||
23576076|NCT01158378|65838957|FG001|Overall Study|Lost to Follow-up|4|||
23335254|NCT00665431|64969498|FG000|Overall Study|Other|4|||
23335255|NCT00665431|64969499|FG001|Overall Study|Other|7|||
23168377|NCT03529773|64363191|FG033|Overall Study|Protocol Violation|0|||
23168378|NCT03529773|64363192|FG034|Overall Study|Protocol Violation|0|||
23227761|NCT00083616|64577877|FG000|Overall Study|Disease Progression|16|||
23335256|NCT00665431|64969500|FG002|Overall Study|Other|2|||
23335257|NCT01609010|64969504|FG000|Overall Study|Stable disease (SD)|22|||
23335258|NCT01609010|64969505|FG001|Overall Study|Stable disease (SD)|16|||
23335259|NCT01609010|64969504|FG000|Overall Study|Progressive disease (PD)|8|||
23335260|NCT01609010|64969505|FG001|Overall Study|Progressive disease (PD)|10|||
23335261|NCT01609010|64969504|FG000|Overall Study|Adverse Event|3|||
23335262|NCT01609010|64969505|FG001|Overall Study|Adverse Event|6|||
23335263|NCT01609010|64969504|FG000|Overall Study|Withdrawal by Subject|2|||
23335264|NCT01609010|64969505|FG001|Overall Study|Withdrawal by Subject|2|||
23335265|NCT01609010|64969504|FG000|Overall Study|Other|2|||
23335266|NCT01609010|64969505|FG001|Overall Study|Other|0|||
23335267|NCT01609010|64969504|FG000|Overall Study|Other malignancy|1|||
23227762|NCT00083616|64577877|FG000|Overall Study|Lost to Follow-up|1|||
23227763|NCT00083616|64577877|FG000|Overall Study|Physician Decision|2|||
23227764|NCT00083616|64577877|FG000|Overall Study|Withdrawal by Subject|3|||
23227765|NCT00083616|64577877|FG000|Overall Study|Ineligibility determined|2|||
23227766|NCT00083616|64577877|FG000|Overall Study|Non-compliance|1|||
23227767|NCT00083616|64577877|FG000|Overall Study|Other|6|||
23227768|NCT02324049|64577878|FG000|Part C|Study terminated|11|||
23227769|NCT02850276|64577879|FG000|Overall Study|screen failure|43|||
23227770|NCT02850276|64577879|FG000|Overall Study|Withdrawal by Subject|14|||
23227771|NCT02850276|64577879|FG000|Overall Study|Physician Decision|2|||
23227772|NCT02850276|64577879|FG000|Overall Study|Lost to Follow-up|2|||
23227773|NCT02140762|64577880|FG000|Overall Study|Adverse Event|1|||
23227774|NCT02140762|64577881|FG001|Overall Study|Adverse Event|1|||
23227775|NCT02140762|64577880|FG000|Overall Study|Lost to Follow-up|9|||
23227776|NCT02140762|64577881|FG001|Overall Study|Lost to Follow-up|5|||
23227777|NCT02140762|64577880|FG000|Overall Study|Protocol Violation|1|||
23227778|NCT02140762|64577881|FG001|Overall Study|Protocol Violation|1|||
23227779|NCT02140762|64577880|FG000|Overall Study|Withdrawal by Subject|6|||
23227780|NCT02140762|64577881|FG001|Overall Study|Withdrawal by Subject|4|||
23227781|NCT02140762|64577880|FG000|Overall Study|Other|0|||
23227782|NCT02140762|64577881|FG001|Overall Study|Other|1|||
23227783|NCT00266695|64577882|FG000|Overall Study|Adverse Event|1|||
23227784|NCT00266695|64577882|FG000|Overall Study|Death|9|||
23227785|NCT00266695|64577882|FG000|Overall Study|Physician Decision|1|||
23227786|NCT00266695|64577882|FG000|Overall Study|Lost to Follow-up|3|||
23227787|NCT00266695|64577882|FG000|Overall Study|Withdrawal by Subject|15|||
23227788|NCT04009824|64577887|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
23227789|NCT04009824|64577888|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
23227790|NCT04009824|64577889|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
23227791|NCT04009824|64577890|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
23227792|NCT04009824|64577891|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
23227793|NCT02010567|64577892|FG000|Overall Study|Adverse Event|0|||
23227794|NCT02010567|64577893|FG001|Overall Study|Adverse Event|0|||
23227795|NCT02010567|64577894|FG002|Overall Study|Adverse Event|1|||
23227796|NCT02010567|64577895|FG003|Overall Study|Adverse Event|0|||
23227797|NCT02010567|64577896|FG004|Overall Study|Adverse Event|1|||
23227798|NCT02933489|64577900|FG000|Overall Study|Ineligible|3|||
23227799|NCT02933489|64577901|FG001|Overall Study|Ineligible|3|||
23227800|NCT02933489|64577900|FG000|Overall Study|Withdrawal by Subject|27|||
23227801|NCT02933489|64577901|FG001|Overall Study|Withdrawal by Subject|18|||
23227802|NCT02933489|64577900|FG000|Overall Study|Unable to complete exams (other)|14|||
23227803|NCT02933489|64577901|FG001|Overall Study|Unable to complete exams (other)|7|||
23227804|NCT03756285|64577902|FG000|Overall Study|Lost to Follow-up|0|||
23227805|NCT03756285|64577903|FG001|Overall Study|Lost to Follow-up|1|||
23227806|NCT03756285|64577902|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
23227807|NCT03756285|64577903|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
23227808|NCT03756285|64577902|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
23227809|NCT03756285|64577903|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
23227810|NCT01057394|64577906|FG000|Overall Study|Not eligible|0|||
23227811|NCT01057394|64577907|FG001|Overall Study|Not eligible|2|||
23227812|NCT01675141|64577908|FG000|Overall Study|Lenalidomide outside NIH|3|||
23227813|NCT01675141|64577908|FG000|Overall Study|Withdrawal by Subject|3|||
23576077|NCT01158378|65838956|FG000|Overall Study|Withdrawal by Subject|4|||
23227814|NCT01675141|64577908|FG000|Overall Study|Physician Decision|4|||
23227815|NCT01675141|64577908|FG000|Overall Study|No treatment, per protocol|1|||
23227816|NCT03687827|64577909|FG000|Treatment Period 1|Death|0|||
23576078|NCT01158378|65838957|FG001|Overall Study|Withdrawal by Subject|0|||
23227817|NCT03687827|64577910|FG001|Treatment Period 1|Death|1|||
23227818|NCT03687827|64577909|FG000|Treatment Period 1|Lost to Follow-up|2|||
23227819|NCT03687827|64577910|FG001|Treatment Period 1|Lost to Follow-up|2|||
23335268|NCT01609010|64969505|FG001|Overall Study|Other malignancy|0|||
23335269|NCT01609010|64969504|FG000|Overall Study|Pathology review|2|||
23335270|NCT01609010|64969505|FG001|Overall Study|Pathology review|1|||
23335271|NCT01609010|64969504|FG000|Overall Study|Protocol Violation|1|||
23335272|NCT01609010|64969505|FG001|Overall Study|Protocol Violation|1|||
23335273|NCT01609010|64969504|FG000|Overall Study|New cancer|1|||
23168379|NCT03529773|64363193|FG035|Overall Study|Protocol Violation|0|||
23168380|NCT03529773|64363194|FG036|Overall Study|Protocol Violation|0|||
23168381|NCT03529773|64363195|FG037|Overall Study|Protocol Violation|0|||
23168382|NCT03529773|64363196|FG038|Overall Study|Protocol Violation|0|||
23168383|NCT03529773|64363197|FG039|Overall Study|Protocol Violation|0|||
23576079|NCT00798174|65838961|FG000|Overall Study|inability to implant azygos coil|3|||
23335274|NCT01609010|64969505|FG001|Overall Study|New cancer|0|||
23335275|NCT01609010|64969504|FG000|Overall Study|Lost to Follow-up|1|||
23335276|NCT01609010|64969505|FG001|Overall Study|Lost to Follow-up|1|||
23335277|NCT00789854|64969509|FG000|Overall Study|Adverse Event|28|||
23335278|NCT00789854|64969510|FG001|Overall Study|Adverse Event|23|||
23335279|NCT00789854|64969511|FG002|Overall Study|Adverse Event|18|||
23335280|NCT00789854|64969509|FG000|Overall Study|Lost to Follow-up|1|||
23335281|NCT00789854|64969510|FG001|Overall Study|Lost to Follow-up|1|||
23335282|NCT00789854|64969511|FG002|Overall Study|Lost to Follow-up|4|||
23335283|NCT00789854|64969509|FG000|Overall Study|Withdrawal by Subject|9|||
23335284|NCT00789854|64969510|FG001|Overall Study|Withdrawal by Subject|6|||
23335285|NCT00789854|64969511|FG002|Overall Study|Withdrawal by Subject|17|||
23335286|NCT00789854|64969509|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23447773|NCT02587520|65380607|FG011|Overall Study|Adverse Event|1|||
23576080|NCT00798174|65838962|FG001|Overall Study|inability to implant azygos coil|3|||
23576081|NCT00798174|65838961|FG000|Overall Study|Inability to sedate for DFT testing|1|||
23576082|NCT00798174|65838962|FG001|Overall Study|Inability to sedate for DFT testing|0|||
23576083|NCT04012814|65838964|FG000|Overall Study|Lost to Follow-up|4|||
23168384|NCT03529773|64363158|FG000|Overall Study|Withdrawal by Subject|0|||
23168385|NCT03529773|64363159|FG001|Overall Study|Withdrawal by Subject|0|||
23168386|NCT03529773|64363160|FG002|Overall Study|Withdrawal by Subject|0|||
23168387|NCT03529773|64363161|FG003|Overall Study|Withdrawal by Subject|0|||
23168388|NCT03529773|64363162|FG004|Overall Study|Withdrawal by Subject|0|||
23168389|NCT03529773|64363163|FG005|Overall Study|Withdrawal by Subject|0|||
23168390|NCT03529773|64363164|FG006|Overall Study|Withdrawal by Subject|0|||
23168391|NCT03529773|64363165|FG007|Overall Study|Withdrawal by Subject|1|||
23168392|NCT03529773|64363166|FG008|Overall Study|Withdrawal by Subject|0|||
23168393|NCT03529773|64363167|FG009|Overall Study|Withdrawal by Subject|1|||
23168394|NCT03529773|64363168|FG010|Overall Study|Withdrawal by Subject|1|||
23168395|NCT03529773|64363169|FG011|Overall Study|Withdrawal by Subject|0|||
23168396|NCT03529773|64363170|FG012|Overall Study|Withdrawal by Subject|0|||
23168397|NCT03529773|64363171|FG013|Overall Study|Withdrawal by Subject|0|||
23168398|NCT03529773|64363172|FG014|Overall Study|Withdrawal by Subject|0|||
23168399|NCT03529773|64363173|FG015|Overall Study|Withdrawal by Subject|3|||
23168400|NCT03529773|64363174|FG016|Overall Study|Withdrawal by Subject|0|||
23168401|NCT03529773|64363175|FG017|Overall Study|Withdrawal by Subject|2|||
23168402|NCT03529773|64363176|FG018|Overall Study|Withdrawal by Subject|3|||
23168403|NCT03529773|64363177|FG019|Overall Study|Withdrawal by Subject|1|||
23168404|NCT03529773|64363178|FG020|Overall Study|Withdrawal by Subject|3|||
23168405|NCT03529773|64363179|FG021|Overall Study|Withdrawal by Subject|1|||
23168406|NCT03529773|64363180|FG022|Overall Study|Withdrawal by Subject|1|||
23168407|NCT03529773|64363181|FG023|Overall Study|Withdrawal by Subject|2|||
23168408|NCT03529773|64363182|FG024|Overall Study|Withdrawal by Subject|2|||
23168409|NCT03529773|64363183|FG025|Overall Study|Withdrawal by Subject|4|||
23168410|NCT03529773|64363184|FG026|Overall Study|Withdrawal by Subject|2|||
23168411|NCT03529773|64363185|FG027|Overall Study|Withdrawal by Subject|1|||
23168412|NCT03529773|64363186|FG028|Overall Study|Withdrawal by Subject|1|||
23168413|NCT03529773|64363187|FG029|Overall Study|Withdrawal by Subject|0|||
23168414|NCT03529773|64363188|FG030|Overall Study|Withdrawal by Subject|0|||
23447774|NCT02587520|65380608|FG012|Overall Study|Adverse Event|0|||
23447775|NCT02587520|65380609|FG013|Overall Study|Adverse Event|0|||
23447776|NCT02587520|65380610|FG014|Overall Study|Adverse Event|0|||
23447777|NCT02587520|65380611|FG015|Overall Study|Adverse Event|0|||
23447778|NCT02587520|65380612|FG016|Overall Study|Adverse Event|0|||
23168415|NCT03529773|64363189|FG031|Overall Study|Withdrawal by Subject|0|||
23168416|NCT03529773|64363190|FG032|Overall Study|Withdrawal by Subject|0|||
23168417|NCT03529773|64363191|FG033|Overall Study|Withdrawal by Subject|0|||
23168418|NCT03529773|64363192|FG034|Overall Study|Withdrawal by Subject|1|||
23168419|NCT03529773|64363193|FG035|Overall Study|Withdrawal by Subject|2|||
23168420|NCT03529773|64363194|FG036|Overall Study|Withdrawal by Subject|0|||
23168421|NCT03529773|64363195|FG037|Overall Study|Withdrawal by Subject|2|||
23168422|NCT03529773|64363196|FG038|Overall Study|Withdrawal by Subject|1|||
23335287|NCT00789854|64969510|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
23576084|NCT04012814|65838964|FG000|Overall Study|Withdrawal by Subject|2|||
23576085|NCT04012814|65838964|FG000|Overall Study|Protocol Violation|1|||
23335288|NCT00789854|64969511|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23335289|NCT00789854|64969509|FG000|Overall Study|Severe non-compliance to the protocol|3|||
23576086|NCT04012814|65838964|FG000|Overall Study|Adverse Event|1|||
23168423|NCT03529773|64363197|FG039|Overall Study|Withdrawal by Subject|1|||
23168424|NCT03529773|64363158|FG000|Overall Study|Screen Failure|0|||
23168425|NCT03529773|64363159|FG001|Overall Study|Screen Failure|0|||
23168426|NCT03529773|64363160|FG002|Overall Study|Screen Failure|0|||
23168427|NCT03529773|64363161|FG003|Overall Study|Screen Failure|0|||
23168428|NCT03529773|64363162|FG004|Overall Study|Screen Failure|0|||
23168429|NCT03529773|64363163|FG005|Overall Study|Screen Failure|0|||
23168430|NCT03529773|64363164|FG006|Overall Study|Screen Failure|0|||
23168431|NCT03529773|64363165|FG007|Overall Study|Screen Failure|0|||
23168432|NCT03529773|64363166|FG008|Overall Study|Screen Failure|0|||
23168433|NCT03529773|64363167|FG009|Overall Study|Screen Failure|0|||
23168434|NCT03529773|64363168|FG010|Overall Study|Screen Failure|0|||
23168435|NCT03529773|64363169|FG011|Overall Study|Screen Failure|0|||
23168436|NCT03529773|64363170|FG012|Overall Study|Screen Failure|0|||
23168437|NCT03529773|64363171|FG013|Overall Study|Screen Failure|0|||
23168438|NCT03529773|64363172|FG014|Overall Study|Screen Failure|0|||
23168439|NCT03529773|64363173|FG015|Overall Study|Screen Failure|0|||
23168440|NCT03529773|64363174|FG016|Overall Study|Screen Failure|0|||
23168441|NCT03529773|64363175|FG017|Overall Study|Screen Failure|0|||
23168442|NCT03529773|64363176|FG018|Overall Study|Screen Failure|0|||
23168443|NCT03529773|64363177|FG019|Overall Study|Screen Failure|0|||
23168444|NCT03529773|64363178|FG020|Overall Study|Screen Failure|0|||
23168445|NCT03529773|64363179|FG021|Overall Study|Screen Failure|0|||
23227820|NCT03687827|64577909|FG000|Treatment Period 1|Physician Decision|5|||
23447779|NCT02587520|65380613|FG017|Overall Study|Adverse Event|0|||
23576087|NCT01994720|65838965|FG000|Overall Study|Withdrawal by Subject|46|||
23576088|NCT01994720|65838966|FG001|Overall Study|Withdrawal by Subject|56|||
23227821|NCT03687827|64577910|FG001|Treatment Period 1|Physician Decision|2|||
23576089|NCT03300817|65838967|FG000|Overall Study|Withdrawal by Subject|1|||
23576090|NCT03300817|65838967|FG000|Overall Study|Adverse Event|1|||
23576091|NCT03300817|65838967|FG000|Overall Study|Subject Found to be Ineligible|2|||
23576092|NCT00810641|65838968|FG000|Overall Study|Withdrawal by Subject|0|||
23576093|NCT00810641|65838969|FG001|Overall Study|Withdrawal by Subject|1|||
23576094|NCT00810641|65838970|FG002|Overall Study|Withdrawal by Subject|2|||
23576095|NCT04834362|65838971|FG000|Overall Study|Death|1|||
23576096|NCT04834362|65838972|FG001|Overall Study|Death|2|||
23576097|NCT02448719|65838973|FG000|Overall Study|Withdrawal by Subject|0|||
23576098|NCT02448719|65838974|FG001|Overall Study|Withdrawal by Subject|0|||
23576099|NCT02448719|65838975|FG002|Overall Study|Withdrawal by Subject|0|||
23576100|NCT02448719|65838976|FG003|Overall Study|Withdrawal by Subject|0|||
23576101|NCT02448719|65838977|FG004|Overall Study|Withdrawal by Subject|1|||
23576102|NCT02448719|65838978|FG005|Overall Study|Withdrawal by Subject|0|||
23576103|NCT02448719|65838979|FG006|Overall Study|Withdrawal by Subject|0|||
23576104|NCT02448719|65838980|FG007|Overall Study|Withdrawal by Subject|0|||
23576105|NCT02448719|65838981|FG008|Overall Study|Withdrawal by Subject|0|||
23576106|NCT02448719|65838982|FG009|Overall Study|Withdrawal by Subject|0|||
23576107|NCT02448719|65838983|FG010|Overall Study|Withdrawal by Subject|0|||
23168446|NCT03529773|64363180|FG022|Overall Study|Screen Failure|0|||
23227822|NCT03687827|64577909|FG000|Treatment Period 1|Withdrawal by Subject|7|||
23227823|NCT03687827|64577910|FG001|Treatment Period 1|Withdrawal by Subject|3|||
23227824|NCT03687827|64577909|FG000|Treatment Period 2|Physician Decision|4|||
23227825|NCT03687827|64577910|FG001|Treatment Period 2|Physician Decision|1|||
23227826|NCT03687827|64577909|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23227827|NCT03687827|64577910|FG001|Treatment Period 2|Withdrawal by Subject|2|||
23227828|NCT00703781|64577913|FG000|Overall Study|Withdrawal by Subject|1|||
23227829|NCT00703781|64577914|FG001|Overall Study|Withdrawal by Subject|2|||
23227830|NCT00703781|64577913|FG000|Overall Study|Cancelled surgery|1|||
23227831|NCT00703781|64577914|FG001|Overall Study|Cancelled surgery|0|||
23227832|NCT01289028|64577915|FG000|Overall Study|Progressive Disease|49|||
23227833|NCT01289028|64577915|FG000|Overall Study|Adverse Event|14|||
23227834|NCT01289028|64577915|FG000|Overall Study|Withdrawal by Subject|6|||
23227835|NCT01289028|64577915|FG000|Overall Study|Death|4|||
23227836|NCT01289028|64577915|FG000|Overall Study|Lack of Efficacy|2|||
23227837|NCT01289028|64577915|FG000|Overall Study|No longer required|2|||
23227838|NCT01289028|64577915|FG000|Overall Study|Lost to Follow-up|2|||
23227839|NCT01289028|64577915|FG000|Overall Study|New Cancer Therapy|2|||
23227840|NCT01289028|64577915|FG000|Overall Study|Abnormal Lab Value|1|||
23335290|NCT00789854|64969510|FG001|Overall Study|Severe non-compliance to the protocol|0|||
23576108|NCT01683994|65838985|FG000|Overall Study|Withdrawal by Subject|1|||
23168447|NCT03529773|64363181|FG023|Overall Study|Screen Failure|0|||
23168448|NCT03529773|64363182|FG024|Overall Study|Screen Failure|0|||
23576109|NCT01683994|65838986|FG001|Overall Study|Withdrawal by Subject|0|||
23168449|NCT03529773|64363183|FG025|Overall Study|Screen Failure|0|||
23227841|NCT01289028|64577915|FG000|Overall Study|Missing reason for discon|1|||
23227842|NCT02274766|64577916|FG000|Overall Study|Withdrawal by Subject|3|||
23227843|NCT02274766|64577917|FG001|Overall Study|Withdrawal by Subject|6|||
23576110|NCT01683994|65838987|FG002|Overall Study|Withdrawal by Subject|0|||
23576111|NCT01683994|65838988|FG003|Overall Study|Withdrawal by Subject|1|||
23576112|NCT01683994|65838989|FG004|Overall Study|Withdrawal by Subject|0|||
23335291|NCT00789854|64969511|FG002|Overall Study|Severe non-compliance to the protocol|0|||
23335292|NCT00789854|64969509|FG000|Overall Study|Safety reasons|0|||
23335293|NCT00789854|64969510|FG001|Overall Study|Safety reasons|0|||
23335294|NCT00789854|64969511|FG002|Overall Study|Safety reasons|2|||
23335295|NCT00789854|64969509|FG000|Overall Study|Other|6|||
23335296|NCT00789854|64969510|FG001|Overall Study|Other|0|||
23335297|NCT00789854|64969511|FG002|Overall Study|Other|5|||
23335298|NCT01842633|64969512|FG000|Overall Study|Screen Failure|1|||
23335299|NCT01842633|64969513|FG001|Overall Study|Screen Failure|0|||
23168450|NCT03529773|64363184|FG026|Overall Study|Screen Failure|0|||
23168451|NCT03529773|64363185|FG027|Overall Study|Screen Failure|0|||
23168452|NCT03529773|64363186|FG028|Overall Study|Screen Failure|0|||
23168453|NCT03529773|64363187|FG029|Overall Study|Screen Failure|0|||
23168454|NCT03529773|64363188|FG030|Overall Study|Screen Failure|0|||
23168455|NCT03529773|64363189|FG031|Overall Study|Screen Failure|0|||
23168456|NCT03529773|64363190|FG032|Overall Study|Screen Failure|0|||
23168457|NCT03529773|64363191|FG033|Overall Study|Screen Failure|0|||
23168458|NCT03529773|64363192|FG034|Overall Study|Screen Failure|0|||
23168459|NCT03529773|64363193|FG035|Overall Study|Screen Failure|0|||
23168460|NCT03529773|64363194|FG036|Overall Study|Screen Failure|1|||
23168461|NCT03529773|64363195|FG037|Overall Study|Screen Failure|1|||
23168462|NCT03529773|64363196|FG038|Overall Study|Screen Failure|0|||
23168463|NCT03529773|64363197|FG039|Overall Study|Screen Failure|1|||
23168464|NCT03529773|64363158|FG000|Overall Study|Randomized but not vaccinated|0|||
23168465|NCT03529773|64363159|FG001|Overall Study|Randomized but not vaccinated|0|||
23227844|NCT02274766|64577916|FG000|Overall Study|Did Not Receive Study Drug|1|||
23227845|NCT02274766|64577917|FG001|Overall Study|Did Not Receive Study Drug|1|||
23227846|NCT02274766|64577916|FG000|Overall Study|Subject Unwilling to Proceed|0|||
23227847|NCT02274766|64577917|FG001|Overall Study|Subject Unwilling to Proceed|1|||
23335300|NCT01842633|64969514|FG002|Overall Study|Screen Failure|0|||
23227848|NCT02274766|64577916|FG000|Overall Study|Adverse Event|0|||
23227849|NCT02274766|64577917|FG001|Overall Study|Adverse Event|1|||
23227850|NCT01625611|64577918|FG000|Overall Study|No adlib drinks Lab 1|3|||
23227851|NCT01625611|64577919|FG001|Overall Study|No adlib drinks Lab 1|0|||
23227852|NCT01625611|64577918|FG000|Overall Study|Technical issues with PET|1|||
23576113|NCT01683994|65838985|FG000|Overall Study|Intercurrent illness|0|||
23576114|NCT01683994|65838986|FG001|Overall Study|Intercurrent illness|0|||
23576115|NCT01683994|65838987|FG002|Overall Study|Intercurrent illness|0|||
23576116|NCT01683994|65838988|FG003|Overall Study|Intercurrent illness|2|||
23576117|NCT01683994|65838989|FG004|Overall Study|Intercurrent illness|1|||
23576118|NCT01782326|65838994|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
23576119|NCT01782326|65838995|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
23576120|NCT01782326|65838994|FG000|Planned Treatment Epoch|Death|29|||
23576121|NCT01782326|65838995|FG001|Planned Treatment Epoch|Death|30|||
23335301|NCT01842633|64969512|FG000|Overall Study|Adverse Event|1|||
23335302|NCT01842633|64969513|FG001|Overall Study|Adverse Event|1|||
23335303|NCT01842633|64969514|FG002|Overall Study|Adverse Event|0|||
23335304|NCT01842633|64969512|FG000|Overall Study|Withdrawal by Subject|0|||
23335305|NCT01842633|64969513|FG001|Overall Study|Withdrawal by Subject|1|||
23335306|NCT01842633|64969514|FG002|Overall Study|Withdrawal by Subject|0|||
23335307|NCT01842633|64969512|FG000|Overall Study|Technical issues|1|||
23335308|NCT01842633|64969513|FG001|Overall Study|Technical issues|0|||
23335309|NCT01842633|64969514|FG002|Overall Study|Technical issues|0|||
23335310|NCT00441129|64969518|FG000|Overall Study|Withdrawal by Subject|6|||
23335311|NCT00441129|64969519|FG001|Overall Study|Withdrawal by Subject|14|||
23335312|NCT02861586|64969520|FG000|Overall Study|Withdrawal by Subject|1|||
23335313|NCT02861586|64969521|FG001|Overall Study|Withdrawal by Subject|2|||
23335314|NCT02861586|64969522|FG002|Overall Study|Withdrawal by Subject|0|||
23335315|NCT02861586|64969523|FG003|Overall Study|Withdrawal by Subject|0|||
23335316|NCT02861586|64969524|FG004|Overall Study|Withdrawal by Subject|0|||
23335317|NCT02861586|64969525|FG005|Overall Study|Withdrawal by Subject|1|||
23335318|NCT02861586|64969526|FG006|Overall Study|Withdrawal by Subject|1|||
23335319|NCT02861586|64969527|FG007|Overall Study|Withdrawal by Subject|0|||
23576122|NCT01782326|65838994|FG000|Planned Treatment Epoch|Physician Decision|18|||
23168466|NCT03529773|64363160|FG002|Overall Study|Randomized but not vaccinated|0|||
23335320|NCT02861586|64969520|FG000|Overall Study|Lost to Follow-up|3|||
23335321|NCT02861586|64969521|FG001|Overall Study|Lost to Follow-up|1|||
23335322|NCT02861586|64969522|FG002|Overall Study|Lost to Follow-up|1|||
23168467|NCT03529773|64363161|FG003|Overall Study|Randomized but not vaccinated|0|||
23168468|NCT03529773|64363162|FG004|Overall Study|Randomized but not vaccinated|0|||
23168469|NCT03529773|64363163|FG005|Overall Study|Randomized but not vaccinated|0|||
23335323|NCT02861586|64969523|FG003|Overall Study|Lost to Follow-up|0|||
23335324|NCT02861586|64969524|FG004|Overall Study|Lost to Follow-up|0|||
23335325|NCT02861586|64969525|FG005|Overall Study|Lost to Follow-up|3|||
23335326|NCT02861586|64969526|FG006|Overall Study|Lost to Follow-up|0|||
23335327|NCT02861586|64969527|FG007|Overall Study|Lost to Follow-up|0|||
23335328|NCT02861586|64969520|FG000|Overall Study|Adverse Event|0|||
23335329|NCT02861586|64969521|FG001|Overall Study|Adverse Event|0|||
23335330|NCT02861586|64969522|FG002|Overall Study|Adverse Event|0|||
23335331|NCT02861586|64969523|FG003|Overall Study|Adverse Event|0|||
23335332|NCT02861586|64969524|FG004|Overall Study|Adverse Event|0|||
23335333|NCT02861586|64969525|FG005|Overall Study|Adverse Event|1|||
23335334|NCT02861586|64969526|FG006|Overall Study|Adverse Event|0|||
23335335|NCT02861586|64969527|FG007|Overall Study|Adverse Event|0|||
23335336|NCT04747886|64972888|FG000|Overall Study|Withdrawal by Subject|1|||
23335337|NCT04747886|64972889|FG001|Overall Study|Withdrawal by Subject|4|||
23335338|NCT00457002|64972890|FG000|Overall Study|Death|40|||
23335339|NCT00457002|64972891|FG001|Overall Study|Death|47|||
23335340|NCT00457002|64972890|FG000|Overall Study|Adverse Event|284|||
23335341|NCT00457002|64972891|FG001|Overall Study|Adverse Event|260|||
23335342|NCT00457002|64972890|FG000|Overall Study|Withdrawal by Subject|299|||
23335343|NCT00457002|64972891|FG001|Overall Study|Withdrawal by Subject|271|||
23335344|NCT00457002|64972890|FG000|Overall Study|Lost to Follow-up|72|||
23335345|NCT00457002|64972891|FG001|Overall Study|Lost to Follow-up|71|||
23447780|NCT02587520|65380596|FG000|Overall Study|Withdrawal by Subject|0|||
23447781|NCT02587520|65380597|FG001|Overall Study|Withdrawal by Subject|0|||
23447782|NCT02587520|65380598|FG002|Overall Study|Withdrawal by Subject|1|||
23447783|NCT02587520|65380599|FG003|Overall Study|Withdrawal by Subject|1|||
23447784|NCT02587520|65380600|FG004|Overall Study|Withdrawal by Subject|0|||
23447785|NCT02587520|65380601|FG005|Overall Study|Withdrawal by Subject|1|||
23447786|NCT02587520|65380602|FG006|Overall Study|Withdrawal by Subject|1|||
23447787|NCT02587520|65380603|FG007|Overall Study|Withdrawal by Subject|0|||
23447788|NCT02587520|65380604|FG008|Overall Study|Withdrawal by Subject|0|||
23447789|NCT02587520|65380605|FG009|Overall Study|Withdrawal by Subject|0|||
23447790|NCT02587520|65380606|FG010|Overall Study|Withdrawal by Subject|0|||
23447791|NCT02587520|65380607|FG011|Overall Study|Withdrawal by Subject|0|||
23447792|NCT02587520|65380608|FG012|Overall Study|Withdrawal by Subject|0|||
23447793|NCT02587520|65380609|FG013|Overall Study|Withdrawal by Subject|1|||
23447794|NCT02587520|65380610|FG014|Overall Study|Withdrawal by Subject|0|||
23447795|NCT02587520|65380611|FG015|Overall Study|Withdrawal by Subject|0|||
23447796|NCT02587520|65380612|FG016|Overall Study|Withdrawal by Subject|0|||
23447797|NCT02587520|65380613|FG017|Overall Study|Withdrawal by Subject|0|||
23447798|NCT02587520|65380596|FG000|Overall Study|Lost to Follow-up|0|||
23447799|NCT02587520|65380597|FG001|Overall Study|Lost to Follow-up|2|||
23447800|NCT02587520|65380598|FG002|Overall Study|Lost to Follow-up|0|||
23447801|NCT02587520|65380599|FG003|Overall Study|Lost to Follow-up|2|||
23447802|NCT02587520|65380600|FG004|Overall Study|Lost to Follow-up|0|||
23447803|NCT02587520|65380601|FG005|Overall Study|Lost to Follow-up|1|||
23447804|NCT02587520|65380602|FG006|Overall Study|Lost to Follow-up|1|||
23447805|NCT02587520|65380603|FG007|Overall Study|Lost to Follow-up|1|||
23227853|NCT01625611|64577919|FG001|Overall Study|Technical issues with PET|0|||
23227854|NCT01625611|64577918|FG000|Overall Study|Unable to complete study procedures|1|||
23227855|NCT01625611|64577919|FG001|Overall Study|Unable to complete study procedures|0|||
23227856|NCT01625611|64577918|FG000|Overall Study|Withdrawal by Subject|3|||
23447806|NCT02587520|65380604|FG008|Overall Study|Lost to Follow-up|0|||
23447807|NCT02587520|65380605|FG009|Overall Study|Lost to Follow-up|2|||
23447808|NCT02587520|65380606|FG010|Overall Study|Lost to Follow-up|2|||
23447809|NCT02587520|65380607|FG011|Overall Study|Lost to Follow-up|1|||
23447810|NCT02587520|65380608|FG012|Overall Study|Lost to Follow-up|0|||
23447811|NCT02587520|65380609|FG013|Overall Study|Lost to Follow-up|0|||
23447812|NCT02587520|65380610|FG014|Overall Study|Lost to Follow-up|0|||
23447813|NCT02587520|65380611|FG015|Overall Study|Lost to Follow-up|0|||
23447814|NCT02587520|65380612|FG016|Overall Study|Lost to Follow-up|0|||
23447815|NCT02587520|65380613|FG017|Overall Study|Lost to Follow-up|0|||
23447816|NCT01965704|65380614|FG000|Overall Study|Withdrawal by Subject|2|||
23447817|NCT01965704|65380615|FG001|Overall Study|Withdrawal by Subject|2|||
23447818|NCT01965704|65380616|FG002|Overall Study|Withdrawal by Subject|1|||
23447819|NCT01965704|65380617|FG003|Overall Study|Withdrawal by Subject|1|||
23447820|NCT01965704|65380614|FG000|Overall Study|Delivered at home|1|||
23447821|NCT01965704|65380615|FG001|Overall Study|Delivered at home|1|||
23447822|NCT01965704|65380616|FG002|Overall Study|Delivered at home|0|||
23227857|NCT01625611|64577919|FG001|Overall Study|Withdrawal by Subject|0|||
23227858|NCT04590963|64577920|FG000|Overall Study|Death|118|||
23227859|NCT04590963|64577921|FG001|Overall Study|Death|59|||
23227860|NCT04590963|64577920|FG000|Overall Study|Lost to Follow-up|1|||
23447823|NCT01965704|65380617|FG003|Overall Study|Delivered at home|0|||
23447824|NCT01965704|65380614|FG000|Overall Study|Experienced complications|0|||
23447825|NCT01965704|65380615|FG001|Overall Study|Experienced complications|0|||
23447826|NCT01965704|65380616|FG002|Overall Study|Experienced complications|2|||
23447827|NCT01965704|65380617|FG003|Overall Study|Experienced complications|2|||
23447828|NCT01965704|65380614|FG000|Overall Study|Adverse Event|0|||
23447829|NCT01965704|65380615|FG001|Overall Study|Adverse Event|0|||
23447830|NCT01965704|65380616|FG002|Overall Study|Adverse Event|1|||
23447831|NCT01965704|65380617|FG003|Overall Study|Adverse Event|1|||
23335346|NCT00457002|64972890|FG000|Overall Study|Poor/Non-compliance|46|||
23447832|NCT01965704|65380614|FG000|Overall Study|Did not meet inclusion criteria|0|||
23447833|NCT01965704|65380615|FG001|Overall Study|Did not meet inclusion criteria|0|||
23447834|NCT01965704|65380616|FG002|Overall Study|Did not meet inclusion criteria|1|||
23447835|NCT01965704|65380617|FG003|Overall Study|Did not meet inclusion criteria|1|||
23447836|NCT01453140|65380618|FG000|Overall Study|Adverse Event|3|||
23447837|NCT05274958|65380621|FG000|Overall Study|Only completed 1 set of PROMs|22|||
23447838|NCT05274958|65380622|FG001|Overall Study|Only completed 1 set of PROMs|35|||
23447839|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
23447840|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
23447841|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
23447842|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
23447843|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
23447844|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
23447845|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
23447846|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
23447847|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
23447848|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
23447849|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
23447850|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
23447851|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
23447852|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
23576123|NCT01782326|65838995|FG001|Planned Treatment Epoch|Physician Decision|16|||
23576124|NCT01782326|65838994|FG000|Planned Treatment Epoch|Protocol deviation|2|||
23576125|NCT01782326|65838995|FG001|Planned Treatment Epoch|Protocol deviation|3|||
23227861|NCT04590963|64577921|FG001|Overall Study|Lost to Follow-up|1|||
23168470|NCT03529773|64363164|FG006|Overall Study|Randomized but not vaccinated|0|||
23168471|NCT03529773|64363165|FG007|Overall Study|Randomized but not vaccinated|0|||
23168472|NCT03529773|64363166|FG008|Overall Study|Randomized but not vaccinated|0|||
23168473|NCT03529773|64363167|FG009|Overall Study|Randomized but not vaccinated|0|||
23168474|NCT03529773|64363168|FG010|Overall Study|Randomized but not vaccinated|0|||
23576126|NCT01782326|65838994|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
23227862|NCT04590963|64577920|FG000|Overall Study|Progressive disease|0|||
23227863|NCT04590963|64577921|FG001|Overall Study|Progressive disease|1|||
23168475|NCT03529773|64363169|FG011|Overall Study|Randomized but not vaccinated|0|||
23168476|NCT03529773|64363170|FG012|Overall Study|Randomized but not vaccinated|0|||
23168477|NCT03529773|64363171|FG013|Overall Study|Randomized but not vaccinated|0|||
23168478|NCT03529773|64363172|FG014|Overall Study|Randomized but not vaccinated|0|||
23168479|NCT03529773|64363173|FG015|Overall Study|Randomized but not vaccinated|0|||
23168480|NCT03529773|64363174|FG016|Overall Study|Randomized but not vaccinated|0|||
23168481|NCT03529773|64363175|FG017|Overall Study|Randomized but not vaccinated|1|||
23168482|NCT03529773|64363176|FG018|Overall Study|Randomized but not vaccinated|0|||
23168483|NCT03529773|64363177|FG019|Overall Study|Randomized but not vaccinated|0|||
23168484|NCT03529773|64363178|FG020|Overall Study|Randomized but not vaccinated|0|||
23168485|NCT03529773|64363179|FG021|Overall Study|Randomized but not vaccinated|0|||
23227864|NCT04590963|64577920|FG000|Overall Study|Study terminated by sponsor|103|||
23227865|NCT04590963|64577921|FG001|Overall Study|Study terminated by sponsor|50|||
23227866|NCT04590963|64577920|FG000|Overall Study|Withdrawal by Subject|15|||
23227867|NCT04590963|64577921|FG001|Overall Study|Withdrawal by Subject|8|||
23576127|NCT01782326|65838995|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
23576128|NCT01782326|65838994|FG000|Planned Treatment Epoch|Technical problems|0|||
23576129|NCT01782326|65838995|FG001|Planned Treatment Epoch|Technical problems|4|||
23576130|NCT01782326|65838994|FG000|Double-blind Treatment|Adverse Event|129|||
23227868|NCT04590963|64577920|FG000|Overall Study|Ongoing at data cut-off|9|||
23227869|NCT04590963|64577921|FG001|Overall Study|Ongoing at data cut-off|4|||
23227870|NCT04590963|64577920|FG000|Overall Study|Screen failure|1|||
23227871|NCT04590963|64577921|FG001|Overall Study|Screen failure|0|||
23227872|NCT01495689|64577923|FG000|Overall Study|Death|0|||
23227873|NCT01495689|64577924|FG001|Overall Study|Death|1|||
23227874|NCT01495689|64577923|FG000|Overall Study|Withdrawal by Subject|3|||
23227875|NCT01495689|64577924|FG001|Overall Study|Withdrawal by Subject|0|||
23447853|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
23576131|NCT01782326|65838995|FG001|Double-blind Treatment|Adverse Event|145|||
23576132|NCT01782326|65838994|FG000|Double-blind Treatment|Subject/guardian decision|111|||
23168486|NCT03529773|64363180|FG022|Overall Study|Randomized but not vaccinated|0|||
23227876|NCT01495689|64577923|FG000|Overall Study|Lost to Follow-up|7|||
23227877|NCT01495689|64577924|FG001|Overall Study|Lost to Follow-up|6|||
23168487|NCT03529773|64363181|FG023|Overall Study|Randomized but not vaccinated|0|||
23227878|NCT01241318|64577925|FG000|Overall Study|Woman: false pregnancies|27|||
23227879|NCT01241318|64577926|FG001|Overall Study|Woman: false pregnancies|15|||
23335347|NCT00457002|64972891|FG001|Overall Study|Poor/Non-compliance|33|||
23576133|NCT01782326|65838995|FG001|Double-blind Treatment|Subject/guardian decision|125|||
23576134|NCT01782326|65838994|FG000|Double-blind Treatment|Lack of Efficacy|17|||
23447854|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
23447855|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
23447856|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
23447857|NCT01910402|65380623|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
23447858|NCT01910402|65380624|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
23447859|NCT01910402|65380625|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
23447860|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
23447861|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
23447862|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
23447863|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
23447864|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
23447865|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
23168488|NCT03529773|64363182|FG024|Overall Study|Randomized but not vaccinated|0|||
23168489|NCT03529773|64363183|FG025|Overall Study|Randomized but not vaccinated|0|||
23168490|NCT03529773|64363184|FG026|Overall Study|Randomized but not vaccinated|0|||
23168491|NCT03529773|64363185|FG027|Overall Study|Randomized but not vaccinated|1|||
23168492|NCT03529773|64363186|FG028|Overall Study|Randomized but not vaccinated|0|||
23168493|NCT03529773|64363187|FG029|Overall Study|Randomized but not vaccinated|0|||
23168494|NCT03529773|64363188|FG030|Overall Study|Randomized but not vaccinated|0|||
23168495|NCT03529773|64363189|FG031|Overall Study|Randomized but not vaccinated|0|||
23168496|NCT03529773|64363190|FG032|Overall Study|Randomized but not vaccinated|0|||
23168497|NCT03529773|64363191|FG033|Overall Study|Randomized but not vaccinated|0|||
23168498|NCT03529773|64363192|FG034|Overall Study|Randomized but not vaccinated|0|||
23168499|NCT03529773|64363193|FG035|Overall Study|Randomized but not vaccinated|0|||
23168500|NCT03529773|64363194|FG036|Overall Study|Randomized but not vaccinated|0|||
23168501|NCT03529773|64363195|FG037|Overall Study|Randomized but not vaccinated|0|||
23168502|NCT03529773|64363196|FG038|Overall Study|Randomized but not vaccinated|0|||
23168503|NCT03529773|64363197|FG039|Overall Study|Randomized but not vaccinated|0|||
23168504|NCT00623428|64363198|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
23168505|NCT00623428|64363199|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
23168506|NCT00623428|64363198|FG000|Treatment Period|Death|0|||
23168507|NCT00623428|64363199|FG001|Treatment Period|Death|1|||
23168508|NCT00623428|64363198|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
23168509|NCT00623428|64363199|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
23168510|NCT00623428|64363198|FG000|Treatment Period|Insufficient therapeutic response|0|||
23168511|NCT00623428|64363199|FG001|Treatment Period|Insufficient therapeutic response|2|||
23168512|NCT00623428|64363198|FG000|Treatment Period|Other|0|||
23168513|NCT00623428|64363199|FG001|Treatment Period|Other|1|||
23168514|NCT00623428|64363198|FG000|Treatment Period|Withdrawal by Subject|0|||
23168515|NCT00623428|64363199|FG001|Treatment Period|Withdrawal by Subject|1|||
23168516|NCT00623428|64363198|FG000|Follow-up Period|Relapse post-treatment|11|||
23168517|NCT00623428|64363199|FG001|Follow-up Period|Relapse post-treatment|3|||
23168518|NCT00623428|64363198|FG000|Follow-up Period|Failure to return|10|||
23168519|NCT00623428|64363199|FG001|Follow-up Period|Failure to return|2|||
23168520|NCT00623428|64363198|FG000|Follow-up Period|Patient withdrew consent|5|||
23168521|NCT00623428|64363199|FG001|Follow-up Period|Patient withdrew consent|4|||
23168522|NCT00623428|64363198|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
23168523|NCT00623428|64363199|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
23168524|NCT00623428|64363198|FG000|Follow-up Period|Did not cooperate|0|||
23168525|NCT00623428|64363199|FG001|Follow-up Period|Did not cooperate|3|||
23168526|NCT00623428|64363198|FG000|Follow-up Period|Reason not specified|1|||
23168527|NCT00623428|64363199|FG001|Follow-up Period|Reason not specified|1|||
23168528|NCT00623428|64363198|FG000|Follow-up Period|Death|0|||
23168529|NCT00623428|64363199|FG001|Follow-up Period|Death|1|||
23168530|NCT00590590|64363200|FG000|Overall Study|Lack of Efficacy|1|||
23168531|NCT00590590|64363201|FG001|Overall Study|Lack of Efficacy|2|||
23168532|NCT00590590|64363202|FG002|Overall Study|Lack of Efficacy|0|||
23168533|NCT00590590|64363200|FG000|Overall Study|Adverse Event|1|||
23168534|NCT00590590|64363201|FG001|Overall Study|Adverse Event|0|||
23168535|NCT00590590|64363202|FG002|Overall Study|Adverse Event|0|||
23168536|NCT00590590|64363200|FG000|Overall Study|Protocol Violation|0|||
23168537|NCT00590590|64363201|FG001|Overall Study|Protocol Violation|0|||
23168538|NCT00590590|64363202|FG002|Overall Study|Protocol Violation|2|||
23168539|NCT00590590|64363200|FG000|Overall Study|Lost to Follow-up|4|||
23447866|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
23168540|NCT00590590|64363201|FG001|Overall Study|Lost to Follow-up|1|||
23168541|NCT00590590|64363202|FG002|Overall Study|Lost to Follow-up|2|||
23168542|NCT00590590|64363200|FG000|Overall Study|Withdrawal by Subject|0|||
23168543|NCT00590590|64363201|FG001|Overall Study|Withdrawal by Subject|1|||
23335348|NCT00457002|64972890|FG000|Overall Study|No longer met criteria|41|||
23168544|NCT00590590|64363202|FG002|Overall Study|Withdrawal by Subject|1|||
23227880|NCT01241318|64577925|FG000|Overall Study|Woman: miscarriage/abortion|46|||
23227881|NCT01241318|64577926|FG001|Overall Study|Woman: miscarriage/abortion|38|||
23227882|NCT01241318|64577925|FG000|Overall Study|Withdrawal by Subject|175|||
23227883|NCT01241318|64577926|FG001|Overall Study|Withdrawal by Subject|46|||
23227884|NCT01241318|64577925|FG000|Overall Study|Lost to Follow-up|740|||
23335349|NCT00457002|64972891|FG001|Overall Study|No longer met criteria|37|||
23227885|NCT01241318|64577926|FG001|Overall Study|Lost to Follow-up|455|||
23227886|NCT01241318|64577925|FG000|Overall Study|Death|2|||
23227887|NCT01241318|64577926|FG001|Overall Study|Death|4|||
23227888|NCT01241318|64577925|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
23227889|NCT01241318|64577926|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
23227890|NCT01241318|64577925|FG000|Overall Study|Woman: Stillborn infant|129|||
23227891|NCT01241318|64577926|FG001|Overall Study|Woman: Stillborn infant|146|||
23227892|NCT01021293|64577927|FG000|Overall Study|Serious Adverse Event|2|||
23227893|NCT01021293|64577928|FG001|Overall Study|Serious Adverse Event|1|||
23227894|NCT01021293|64577927|FG000|Overall Study|Adverse Event|2|||
23227895|NCT01021293|64577928|FG001|Overall Study|Adverse Event|1|||
23227896|NCT01021293|64577927|FG000|Overall Study|Withdrawal by Subject|1|||
23227897|NCT01021293|64577928|FG001|Overall Study|Withdrawal by Subject|3|||
23227898|NCT01021293|64577927|FG000|Overall Study|Migrated/moved from study area|6|||
23227899|NCT01021293|64577928|FG001|Overall Study|Migrated/moved from study area|18|||
23227900|NCT01021293|64577927|FG000|Overall Study|Lost to Follow-up|1|||
23227901|NCT01021293|64577928|FG001|Overall Study|Lost to Follow-up|1|||
23227902|NCT00715949|64577935|FG000|Overall Study|could not finish first test|4|||
23227903|NCT02045979|64577953|FG000|Overall Study|Informed Consent Withdrawn|2|||
23227904|NCT02045979|64577954|FG001|Overall Study|Informed Consent Withdrawn|0|||
23227905|NCT02045979|64577955|FG002|Overall Study|Informed Consent Withdrawn|1|||
23227906|NCT02045979|64577953|FG000|Overall Study|not specified above|0|||
23227907|NCT02045979|64577954|FG001|Overall Study|not specified above|1|||
23227908|NCT02045979|64577955|FG002|Overall Study|not specified above|0|||
23227909|NCT03083470|64577956|FG000|Overall Study|Lost to Follow-up|0|||
23227910|NCT03083470|64577957|FG001|Overall Study|Lost to Follow-up|0|||
23227911|NCT03083470|64577958|FG002|Overall Study|Lost to Follow-up|0|||
23227912|NCT03083470|64577959|FG003|Overall Study|Lost to Follow-up|0|||
23227913|NCT03083470|64577960|FG004|Overall Study|Lost to Follow-up|1|||
23335350|NCT00457002|64972890|FG000|Overall Study|Administrative reason by Sponsor|1|||
23335351|NCT00457002|64972891|FG001|Overall Study|Administrative reason by Sponsor|0|||
23335352|NCT00457002|64972890|FG000|Overall Study|non-specified|29|||
23168545|NCT00590590|64363200|FG000|Overall Study|Did not complete due to study closure|1|||
23168546|NCT00590590|64363201|FG001|Overall Study|Did not complete due to study closure|1|||
23168547|NCT00590590|64363202|FG002|Overall Study|Did not complete due to study closure|1|||
23168548|NCT00590590|64363200|FG000|Overall Study|Did not complete study|0|||
23168549|NCT00590590|64363201|FG001|Overall Study|Did not complete study|1|||
23168550|NCT00590590|64363202|FG002|Overall Study|Did not complete study|0|||
23168551|NCT02559687|64363207|FG000|Overall Study|Death|112|||
23168552|NCT02559687|64363207|FG000|Overall Study|Sponsor Decision|5|||
23168553|NCT02559687|64363207|FG000|Overall Study|Withdrawal by Subject|4|||
23168554|NCT00874120|64363208|FG000|First Intervention|Adverse Event|0|||
23168555|NCT00874120|64363209|FG001|First Intervention|Adverse Event|1|||
23227914|NCT03083470|64577956|FG000|Overall Study|Withdrawal by Subject|0|||
23227915|NCT03083470|64577957|FG001|Overall Study|Withdrawal by Subject|0|||
23227916|NCT03083470|64577958|FG002|Overall Study|Withdrawal by Subject|0|||
23227917|NCT03083470|64577959|FG003|Overall Study|Withdrawal by Subject|0|||
23227918|NCT03083470|64577960|FG004|Overall Study|Withdrawal by Subject|1|||
23227919|NCT04124952|64577961|FG000|Overall Study|Lost to Follow-up|1|||
23227920|NCT00112840|64577962|FG000|Overall Study|Physician Decision|1|||
23227921|NCT00112840|64577963|FG001|Overall Study|Physician Decision|0|||
23227922|NCT00112840|64577964|FG002|Overall Study|Physician Decision|0|||
23227923|NCT00112840|64577962|FG000|Overall Study|Withdrawal by Subject|1|||
23227924|NCT00112840|64577963|FG001|Overall Study|Withdrawal by Subject|0|||
23227925|NCT00112840|64577964|FG002|Overall Study|Withdrawal by Subject|1|||
23227926|NCT00112840|64577962|FG000|Overall Study|Protocol Violation|0|||
23576135|NCT01782326|65838995|FG001|Double-blind Treatment|Lack of Efficacy|22|||
23168556|NCT00874120|64363208|FG000|First Intervention|Withdrawal by Subject|2|||
23168557|NCT00874120|64363209|FG001|First Intervention|Withdrawal by Subject|0|||
23168558|NCT00874120|64363208|FG000|First Intervention|Lost to Follow-up|0|||
23168559|NCT00874120|64363209|FG001|First Intervention|Lost to Follow-up|1|||
23227927|NCT00112840|64577963|FG001|Overall Study|Protocol Violation|0|||
23227928|NCT00112840|64577964|FG002|Overall Study|Protocol Violation|5|||
23227929|NCT01487863|64577965|FG000|Overall Study|Death|19|||
23227930|NCT01487863|64577966|FG001|Overall Study|Death|19|||
23227931|NCT00731666|64577967|FG000|Overall Study|Adverse Event|2|||
23227932|NCT00731666|64577967|FG000|Overall Study|Lost to Follow-up|8|||
23227933|NCT00731666|64577967|FG000|Overall Study|Withdrawal by Subject|2|||
23227934|NCT00338806|64577968|FG000|Acute Phase|Withdrawal by Subject|0|||
23227935|NCT00338806|64577969|FG001|Acute Phase|Withdrawal by Subject|1|||
23576136|NCT01782326|65838994|FG000|Double-blind Treatment|Physician Decision|13|||
23168560|NCT00874120|64363208|FG000|First Intervention|Protocol Violation|3|||
23168561|NCT00874120|64363209|FG001|First Intervention|Protocol Violation|0|||
23168562|NCT00874120|64363208|FG000|First Intervention|positive drug test|1|||
23168563|NCT00874120|64363209|FG001|First Intervention|positive drug test|0|||
23168564|NCT00874120|64363208|FG000|Second Intervention|Withdrawal by Subject|1|||
23168565|NCT00874120|64363209|FG001|Second Intervention|Withdrawal by Subject|0|||
23168566|NCT00874120|64363208|FG000|Second Intervention|Protocol Violation|1|||
23168567|NCT00874120|64363209|FG001|Second Intervention|Protocol Violation|0|||
23335353|NCT00457002|64972891|FG001|Overall Study|non-specified|38|||
23335354|NCT00457002|64972890|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
23335355|NCT00457002|64972891|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
23335356|NCT02423343|64972892|FG000|Overall Study|Withdrawal by Subject|0|||
23335357|NCT02423343|64972893|FG001|Overall Study|Withdrawal by Subject|1|||
23335358|NCT02423343|64972894|FG002|Overall Study|Withdrawal by Subject|0|||
23335359|NCT02423343|64972895|FG003|Overall Study|Withdrawal by Subject|0|||
23335360|NCT02423343|64972896|FG004|Overall Study|Withdrawal by Subject|0|||
23335361|NCT02423343|64972897|FG005|Overall Study|Withdrawal by Subject|0|||
23335362|NCT02423343|64972892|FG000|Overall Study|Progressive Disease|0|||
23335363|NCT02423343|64972893|FG001|Overall Study|Progressive Disease|0|||
23335364|NCT02423343|64972894|FG002|Overall Study|Progressive Disease|0|||
23335365|NCT02423343|64972895|FG003|Overall Study|Progressive Disease|0|||
23335366|NCT02423343|64972896|FG004|Overall Study|Progressive Disease|2|||
23335367|NCT02423343|64972897|FG005|Overall Study|Progressive Disease|0|||
23335368|NCT02423343|64972892|FG000|Overall Study|Adverse Event|0|||
23335369|NCT02423343|64972893|FG001|Overall Study|Adverse Event|0|||
23335370|NCT02423343|64972894|FG002|Overall Study|Adverse Event|0|||
23335371|NCT02423343|64972895|FG003|Overall Study|Adverse Event|0|||
23335372|NCT02423343|64972896|FG004|Overall Study|Adverse Event|2|||
23335373|NCT02423343|64972897|FG005|Overall Study|Adverse Event|0|||
23335374|NCT02423343|64972892|FG000|Overall Study|Death|0|||
23335375|NCT02423343|64972893|FG001|Overall Study|Death|0|||
23335376|NCT02423343|64972894|FG002|Overall Study|Death|0|||
23576137|NCT01782326|65838995|FG001|Double-blind Treatment|Physician Decision|16|||
23576138|NCT01782326|65838994|FG000|Double-blind Treatment|Protocol deviation|8|||
23576139|NCT01782326|65838995|FG001|Double-blind Treatment|Protocol deviation|7|||
23576140|NCT01782326|65838994|FG000|Double-blind Treatment|Technical problems|0|||
23576141|NCT01782326|65838995|FG001|Double-blind Treatment|Technical problems|5|||
23576142|NCT00619151|65838996|FG000|Overall Study|Study terminated prior to followup|1|||
23576143|NCT00619151|65838997|FG001|Overall Study|Study terminated prior to followup|0|||
23576144|NCT03018106|65838998|FG000|Overall Study|Lost to Follow-up|0|||
23168568|NCT01395394|64363210|FG000|Baseline Study Visit|Protocol Violation|1|||
23168569|NCT01395394|64363211|FG001|Baseline Study Visit|Protocol Violation|0|||
23168570|NCT01395394|64363212|FG002|Baseline Study Visit|Protocol Violation|0|||
23168571|NCT00903929|64363213|FG000|Overall Study|Withdrawal by Subject|0|||
23168572|NCT00903929|64363214|FG001|Overall Study|Withdrawal by Subject|0|||
23168573|NCT00903929|64363215|FG002|Overall Study|Withdrawal by Subject|1|||
23168574|NCT00903929|64363216|FG003|Overall Study|Withdrawal by Subject|2|||
23168575|NCT00903929|64363213|FG000|Overall Study|Adverse Event|0|||
23168576|NCT00903929|64363214|FG001|Overall Study|Adverse Event|0|||
23168577|NCT00903929|64363215|FG002|Overall Study|Adverse Event|0|||
23168578|NCT00903929|64363216|FG003|Overall Study|Adverse Event|1|||
23168579|NCT01148537|64363217|FG000|Overall Study|Withdrawal by Subject|1|||
23576145|NCT03018106|65838999|FG001|Overall Study|Lost to Follow-up|1|||
23576146|NCT00262743|65839000|FG000|Overall Study|Adverse Event|0|||
23576147|NCT00262743|65839001|FG001|Overall Study|Adverse Event|9|||
23576148|NCT00262743|65839000|FG000|Overall Study|Disease progression|0|||
23576149|NCT00262743|65839001|FG001|Overall Study|Disease progression|3|||
23227936|NCT00338806|64577968|FG000|Follow-up|Lost to Follow-up|1|||
23576150|NCT03283553|65839002|FG000|Patient Participant Flow|Death|5|||
23576151|NCT03283553|65839003|FG001|Patient Participant Flow|Death|10|||
23576152|NCT03283553|65839002|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
23576153|NCT03283553|65839003|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
23576154|NCT03283553|65839002|FG000|Patient Participant Flow|Lost to Follow-up|1|||
23335377|NCT02423343|64972895|FG003|Overall Study|Death|0|||
23335378|NCT02423343|64972896|FG004|Overall Study|Death|1|||
23335379|NCT02423343|64972897|FG005|Overall Study|Death|0|||
23335380|NCT00596817|64972898|FG000|Open-label Period|Adverse Event|0|||
23335381|NCT00596817|64972899|FG001|Open-label Period|Adverse Event|49|||
23335382|NCT00596817|64972898|FG000|Open-label Period|Lack of Efficacy|0|||
23335383|NCT00596817|64972899|FG001|Open-label Period|Lack of Efficacy|33|||
23576155|NCT03283553|65839003|FG001|Patient Participant Flow|Lost to Follow-up|1|||
23168580|NCT01148537|64363218|FG001|Overall Study|Withdrawal by Subject|0|||
23168581|NCT01148537|64363219|FG002|Overall Study|Withdrawal by Subject|2|||
23227937|NCT00338806|64577969|FG001|Follow-up|Lost to Follow-up|3|||
23335384|NCT00596817|64972898|FG000|Open-label Period|Other Reasons|0|||
23335385|NCT00596817|64972899|FG001|Open-label Period|Other Reasons|65|||
23576156|NCT03283553|65839002|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
23576157|NCT03283553|65839003|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
23576158|NCT03283553|65839002|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
23576159|NCT03283553|65839003|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
23576160|NCT03283553|65839002|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
23576161|NCT03283553|65839003|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
23576162|NCT02100722|65839004|FG000|Overall Study|Withdrawal pre-procedure|4|||
23576163|NCT02100722|65839005|FG001|Overall Study|Withdrawal pre-procedure|9|||
23168582|NCT01148537|64363217|FG000|Overall Study|Adverse Event|2|||
23168583|NCT01148537|64363218|FG001|Overall Study|Adverse Event|0|||
23168584|NCT01148537|64363219|FG002|Overall Study|Adverse Event|1|||
23335386|NCT00596817|64972898|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
23335387|NCT00596817|64972899|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
23335388|NCT00596817|64972898|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
23335389|NCT00596817|64972899|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
23335390|NCT00596817|64972898|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
23335391|NCT00596817|64972899|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
23335392|NCT00596817|64972898|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
23335393|NCT00596817|64972899|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
23335394|NCT00596817|64972898|FG000|Double-blind Period|Adverse Event|5|||
23335395|NCT00596817|64972899|FG001|Double-blind Period|Adverse Event|16|||
23335396|NCT00596817|64972898|FG000|Double-blind Period|Lack of Efficacy|52|||
23335397|NCT00596817|64972899|FG001|Double-blind Period|Lack of Efficacy|28|||
23335398|NCT00596817|64972898|FG000|Double-blind Period|Non-compliance With Study Product|3|||
23335399|NCT00596817|64972899|FG001|Double-blind Period|Non-compliance With Study Product|4|||
23168585|NCT00841763|64363224|FG000|Overall Study|Withdrawal by Subject|60|||
23168586|NCT00841763|64363225|FG001|Overall Study|Withdrawal by Subject|17|||
23168587|NCT00841763|64363226|FG002|Overall Study|Withdrawal by Subject|4|||
23227938|NCT02607865|64577971|FG000|Overall Study|Lost to Follow-up|9|||
23227939|NCT02607865|64577972|FG001|Overall Study|Lost to Follow-up|7|||
23227940|NCT02607865|64577973|FG002|Overall Study|Lost to Follow-up|7|||
23227941|NCT02607865|64577974|FG003|Overall Study|Lost to Follow-up|5|||
23227942|NCT02607865|64577971|FG000|Overall Study|Withdrawal by Subject|18|||
23227943|NCT02607865|64577972|FG001|Overall Study|Withdrawal by Subject|18|||
23227944|NCT02607865|64577973|FG002|Overall Study|Withdrawal by Subject|17|||
23227945|NCT02607865|64577974|FG003|Overall Study|Withdrawal by Subject|8|||
23227946|NCT02607865|64577971|FG000|Overall Study|Death|5|||
23227947|NCT02607865|64577972|FG001|Overall Study|Death|4|||
23227948|NCT02607865|64577973|FG002|Overall Study|Death|1|||
23168588|NCT00841763|64363227|FG003|Overall Study|Withdrawal by Subject|1|||
23168589|NCT00841763|64363224|FG000|Overall Study|Adverse Event|9|||
23168590|NCT00841763|64363225|FG001|Overall Study|Adverse Event|10|||
23168591|NCT00841763|64363226|FG002|Overall Study|Adverse Event|3|||
23168592|NCT00841763|64363227|FG003|Overall Study|Adverse Event|2|||
23168593|NCT00841763|64363224|FG000|Overall Study|Lost to Follow-up|63|||
23168594|NCT00841763|64363225|FG001|Overall Study|Lost to Follow-up|25|||
23168595|NCT00841763|64363226|FG002|Overall Study|Lost to Follow-up|0|||
23168596|NCT00841763|64363227|FG003|Overall Study|Lost to Follow-up|0|||
23168597|NCT00841763|64363224|FG000|Overall Study|Protocol Violation|20|||
23168598|NCT00841763|64363225|FG001|Overall Study|Protocol Violation|3|||
23168599|NCT00841763|64363226|FG002|Overall Study|Protocol Violation|1|||
23168600|NCT00841763|64363227|FG003|Overall Study|Protocol Violation|0|||
23168601|NCT00841763|64363224|FG000|Overall Study|Administrative Reasons|3|||
23168602|NCT00841763|64363225|FG001|Overall Study|Administrative Reasons|1|||
23168603|NCT00841763|64363226|FG002|Overall Study|Administrative Reasons|0|||
23168604|NCT00841763|64363227|FG003|Overall Study|Administrative Reasons|0|||
23168605|NCT00841763|64363224|FG000|Overall Study|Unable to Classify|7|||
23168606|NCT00841763|64363225|FG001|Overall Study|Unable to Classify|1|||
23168607|NCT00841763|64363226|FG002|Overall Study|Unable to Classify|0|||
23168608|NCT00841763|64363227|FG003|Overall Study|Unable to Classify|0|||
23227949|NCT02607865|64577974|FG003|Overall Study|Death|3|||
23227950|NCT02607865|64577971|FG000|Overall Study|Unclassified|1|||
23227951|NCT02607865|64577972|FG001|Overall Study|Unclassified|1|||
23335400|NCT00596817|64972898|FG000|Double-blind Period|Protocol Violation|11|||
23335401|NCT00596817|64972899|FG001|Double-blind Period|Protocol Violation|8|||
23335402|NCT00596817|64972898|FG000|Double-blind Period|Withdrawal of Consent|7|||
23227952|NCT02607865|64577973|FG002|Overall Study|Unclassified|2|||
23227953|NCT02607865|64577974|FG003|Overall Study|Unclassified|0|||
23335403|NCT00596817|64972899|FG001|Double-blind Period|Withdrawal of Consent|3|||
23576164|NCT02100722|65839004|FG000|Overall Study|Withdrawal post-procedure|0|||
23168609|NCT00749996|64363228|FG000|Overall Study|Lost to Follow-up|7|||
23168610|NCT00749996|64363229|FG001|Overall Study|Lost to Follow-up|4|||
23168611|NCT00749996|64363228|FG000|Overall Study|Withdrawal by Subject|5|||
23168612|NCT00749996|64363229|FG001|Overall Study|Withdrawal by Subject|4|||
23335404|NCT00596817|64972898|FG000|Double-blind Period|Lost to Follow-up|0|||
23168613|NCT00749996|64363228|FG000|Overall Study|Protocol Violation|2|||
23168614|NCT00749996|64363229|FG001|Overall Study|Protocol Violation|3|||
23168615|NCT00749996|64363228|FG000|Overall Study|Physician Decision|2|||
23168616|NCT00749996|64363229|FG001|Overall Study|Physician Decision|0|||
23168617|NCT00749996|64363228|FG000|Overall Study|Pregnancy|0|||
23168618|NCT00749996|64363229|FG001|Overall Study|Pregnancy|2|||
23168619|NCT00749996|64363228|FG000|Overall Study|Adverse Event|1|||
23168620|NCT00749996|64363229|FG001|Overall Study|Adverse Event|0|||
23168621|NCT00749996|64363228|FG000|Overall Study|Death|1|||
23168622|NCT00749996|64363229|FG001|Overall Study|Death|0|||
23168623|NCT01294800|64363230|FG000|Overall Study|Adverse Event|7|||
23168624|NCT01294800|64363231|FG001|Overall Study|Adverse Event|6|||
23168625|NCT01294800|64363232|FG002|Overall Study|Adverse Event|12|||
23168626|NCT01294800|64363233|FG003|Overall Study|Adverse Event|5|||
23168627|NCT01294800|64363230|FG000|Overall Study|Subject Withdrew Consent|2|||
23168628|NCT01294800|64363231|FG001|Overall Study|Subject Withdrew Consent|2|||
23168629|NCT01294800|64363232|FG002|Overall Study|Subject Withdrew Consent|2|||
23168630|NCT01294800|64363233|FG003|Overall Study|Subject Withdrew Consent|11|||
23168631|NCT01294800|64363230|FG000|Overall Study|Lost to Follow-up|0|||
23168632|NCT01294800|64363231|FG001|Overall Study|Lost to Follow-up|0|||
23168633|NCT01294800|64363232|FG002|Overall Study|Lost to Follow-up|1|||
23168634|NCT01294800|64363233|FG003|Overall Study|Lost to Follow-up|0|||
23168635|NCT01294800|64363230|FG000|Overall Study|Non-compliance With Protocol|0|||
23168636|NCT01294800|64363231|FG001|Overall Study|Non-compliance With Protocol|1|||
23168637|NCT01294800|64363232|FG002|Overall Study|Non-compliance With Protocol|1|||
23168638|NCT01294800|64363233|FG003|Overall Study|Non-compliance With Protocol|0|||
23168639|NCT01294800|64363230|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
23168640|NCT01294800|64363231|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
23168641|NCT01294800|64363232|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
23168642|NCT01294800|64363233|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
23168643|NCT00927095|64363236|FG000|Overall Study|Adverse Event|3|||
23168644|NCT00927095|64363237|FG001|Overall Study|Adverse Event|1|||
23168645|NCT00927095|64363238|FG002|Overall Study|Adverse Event|0|||
23168646|NCT00927095|64363236|FG000|Overall Study|Withdrawal by Subject|2|||
23168647|NCT00927095|64363237|FG001|Overall Study|Withdrawal by Subject|1|||
23227954|NCT02811640|64577975|FG000|Overall Study|Technology malfunction|2|||
23227955|NCT00366444|64577976|FG000|Overall Study|Withdrawal by Subject|1|||
23227956|NCT00366444|64577977|FG001|Overall Study|Withdrawal by Subject|1|||
23227957|NCT00366444|64577976|FG000|Overall Study|Lack of Efficacy|0|||
23227958|NCT00366444|64577977|FG001|Overall Study|Lack of Efficacy|1|||
23227959|NCT05466240|64577981|FG000|Overall Study|Adverse Event|1|||
23576165|NCT02100722|65839005|FG001|Overall Study|Withdrawal post-procedure|3|||
23576166|NCT02100722|65839004|FG000|Overall Study|Lost to Follow-up|2|||
23576167|NCT02100722|65839005|FG001|Overall Study|Lost to Follow-up|2|||
23576168|NCT02100722|65839004|FG000|Overall Study|Continuing on study|751|||
23576169|NCT02100722|65839005|FG001|Overall Study|Continuing on study|729|||
23576170|NCT03699124|65839006|FG000|Overall Study|Adverse Event|6|||
23576171|NCT03699124|65839007|FG001|Overall Study|Adverse Event|5|||
23576172|NCT03699124|65839008|FG002|Overall Study|Adverse Event|2|||
23576173|NCT03699124|65839006|FG000|Overall Study|Death|0|||
23576174|NCT03699124|65839007|FG001|Overall Study|Death|2|||
23576175|NCT03699124|65839008|FG002|Overall Study|Death|0|||
23168648|NCT00927095|64363238|FG002|Overall Study|Withdrawal by Subject|1|||
23335405|NCT00596817|64972899|FG001|Double-blind Period|Lost to Follow-up|2|||
23335406|NCT00596817|64972898|FG000|Double-blind Period|Other Reasons|10|||
23447867|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
23335407|NCT00596817|64972899|FG001|Double-blind Period|Other Reasons|18|||
23335408|NCT01862250|64972901|FG000|Overall Study|Adverse Event|4|||
23335409|NCT03343704|64972902|FG000|Overall Study|Refused to complete follow up|0|||
23335410|NCT03343704|64972903|FG001|Overall Study|Refused to complete follow up|1|||
23447868|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
23447869|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
23168649|NCT00927095|64363236|FG000|Overall Study|Physician Decision|1|||
23168650|NCT00927095|64363237|FG001|Overall Study|Physician Decision|2|||
23168651|NCT00927095|64363238|FG002|Overall Study|Physician Decision|1|||
23168652|NCT03047980|64363242|FG000|Overall Study|Adverse Event|1|||
23227960|NCT05466240|64577982|FG001|Overall Study|Adverse Event|0|||
23227961|NCT05466240|64577981|FG000|Overall Study|Withdrawal by Subject|1|||
23335411|NCT03343704|64972902|FG000|Overall Study|Death|0|||
23168653|NCT02161211|64363243|FG000|Overall Study|Lost to Follow-up|21|||
23168654|NCT02161211|64363244|FG001|Overall Study|Lost to Follow-up|27|||
23168655|NCT02161211|64363245|FG002|Overall Study|Lost to Follow-up|21|||
23168656|NCT02161211|64363243|FG000|Overall Study|Dropped|12|||
23227962|NCT05466240|64577982|FG001|Overall Study|Withdrawal by Subject|0|||
23227963|NCT01058395|64577983|FG000|Overall Study|Death|2|||
23576176|NCT03699124|65839006|FG000|Overall Study|Lost to Follow-up|20|||
23576177|NCT03699124|65839007|FG001|Overall Study|Lost to Follow-up|16|||
23335412|NCT03343704|64972903|FG001|Overall Study|Death|1|||
23335413|NCT03343704|64972902|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
23335414|NCT03343704|64972903|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
23576178|NCT03699124|65839008|FG002|Overall Study|Lost to Follow-up|15|||
23168657|NCT02161211|64363244|FG001|Overall Study|Dropped|5|||
23576179|NCT03699124|65839006|FG000|Overall Study|Protocol Violation|1|||
23576180|NCT03699124|65839007|FG001|Overall Study|Protocol Violation|0|||
23576181|NCT03699124|65839008|FG002|Overall Study|Protocol Violation|0|||
23576182|NCT03699124|65839006|FG000|Overall Study|Withdrawal by Subject|13|||
23576183|NCT03699124|65839007|FG001|Overall Study|Withdrawal by Subject|14|||
23576184|NCT03699124|65839008|FG002|Overall Study|Withdrawal by Subject|13|||
23576185|NCT03699124|65839006|FG000|Overall Study|Other reasons|5|||
23576186|NCT03699124|65839007|FG001|Overall Study|Other reasons|3|||
23576187|NCT03699124|65839008|FG002|Overall Study|Other reasons|10|||
23576188|NCT02408549|65839011|FG000|Overall Study|Adverse Event|15|||
23576189|NCT02408549|65839011|FG000|Overall Study|Death|4|||
23576190|NCT02408549|65839011|FG000|Overall Study|Lack of Efficacy|17|||
23576191|NCT02408549|65839011|FG000|Overall Study|Protocol Violation|4|||
23576192|NCT02408549|65839011|FG000|Overall Study|Lost to Follow-up|6|||
23576193|NCT02408549|65839011|FG000|Overall Study|Consent withdrawn|30|||
23576194|NCT02408549|65839011|FG000|Overall Study|Neurology research program closing at site|1|||
23576195|NCT02408549|65839011|FG000|Overall Study|Site closure|1|||
23576196|NCT02408549|65839011|FG000|Overall Study|Pregnancy|1|||
23576197|NCT02408549|65839011|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
23576198|NCT02408549|65839011|FG000|Overall Study|Subject moved to another place, far from site|1|||
23576199|NCT02408549|65839011|FG000|Overall Study|Study terminated at site|1|||
23576200|NCT03029780|65839015|FG000|Overall Study|Disease Progression|20|||
23576201|NCT03029780|65839016|FG001|Overall Study|Disease Progression|22|||
23576202|NCT03029780|65839015|FG000|Overall Study|Study Drug Toxicity|15|||
23576203|NCT03029780|65839016|FG001|Overall Study|Study Drug Toxicity|11|||
23576204|NCT03029780|65839015|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23576205|NCT03029780|65839016|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23576206|NCT03029780|65839015|FG000|Overall Study|Participant request to discontinue study treatment|4|||
23576207|NCT03029780|65839016|FG001|Overall Study|Participant request to discontinue study treatment|1|||
23576208|NCT03029780|65839015|FG000|Overall Study|Maximum clinical benefit|1|||
23576209|NCT03029780|65839016|FG001|Overall Study|Maximum clinical benefit|0|||
23576210|NCT03029780|65839015|FG000|Overall Study|Participant no longer meets study criteria|0|||
23576211|NCT03029780|65839016|FG001|Overall Study|Participant no longer meets study criteria|1|||
23576212|NCT03029780|65839015|FG000|Overall Study|Other reasons|6|||
23576213|NCT03029780|65839016|FG001|Overall Study|Other reasons|6|||
23576214|NCT03029780|65839015|FG000|Overall Study|Not reported|1|||
23576215|NCT03029780|65839016|FG001|Overall Study|Not reported|1|||
23576216|NCT03029780|65839015|FG000|Overall Study|Death|2|||
23576217|NCT03029780|65839016|FG001|Overall Study|Death|6|||
23576218|NCT03055832|65839018|FG000|Week 2|Withdrawal by Subject|1|||
23576219|NCT03055832|65839019|FG001|Week 2|Withdrawal by Subject|0|||
23168658|NCT02161211|64363245|FG002|Overall Study|Dropped|9|||
23168659|NCT04315181|64363246|FG000|Overall Study|Non-responsive to drug conditions.|1|||
23168660|NCT04081363|64363247|FG000|Overall Study|Withdrawal by Subject|1|||
23168661|NCT04081363|64363248|FG001|Overall Study|Withdrawal by Subject|0|||
23168662|NCT03595553|64363251|FG000|Overall Study|Withdrawal by Subject|20|||
23168663|NCT03595553|64363252|FG001|Overall Study|Withdrawal by Subject|8|||
23168664|NCT03595553|64363251|FG000|Overall Study|Physician Decision|3|||
23168665|NCT03595553|64363252|FG001|Overall Study|Physician Decision|2|||
23168666|NCT03595553|64363251|FG000|Overall Study|Adverse Event|2|||
23168667|NCT03595553|64363252|FG001|Overall Study|Adverse Event|5|||
23168668|NCT03595553|64363251|FG000|Overall Study|Death|24|||
23168669|NCT03595553|64363252|FG001|Overall Study|Death|22|||
23168670|NCT03595553|64363251|FG000|Overall Study|Lost to Follow-up|6|||
23168671|NCT03595553|64363252|FG001|Overall Study|Lost to Follow-up|7|||
23168672|NCT03595553|64363251|FG000|Overall Study|Other as indicated in CSR|3|||
23168673|NCT03595553|64363252|FG001|Overall Study|Other as indicated in CSR|3|||
23168674|NCT03595553|64363251|FG000|Overall Study|Sponsor Decision|0|||
23227964|NCT01058395|64577984|FG001|Overall Study|Death|1|||
23576220|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
23576221|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
23576222|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
23168675|NCT03595553|64363252|FG001|Overall Study|Sponsor Decision|1|||
23576223|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
23576224|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
23576225|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
23576226|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
23576227|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
23576228|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
23168676|NCT02706873|64363253|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
23168677|NCT02706873|64363254|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
23168678|NCT02706873|64363255|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
23576229|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
23576230|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
23576231|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
23335415|NCT00178685|64972904|FG000|Overall Study|Death|3|||
23335416|NCT00178685|64972905|FG001|Overall Study|Death|3|||
23335417|NCT00178685|64972906|FG002|Overall Study|Death|6|||
23335418|NCT00178685|64972904|FG000|Overall Study|Lost to Follow-up|100|||
23335419|NCT00178685|64972905|FG001|Overall Study|Lost to Follow-up|187|||
23168679|NCT02706873|64363256|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
23168680|NCT02706873|64363253|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
23168681|NCT02706873|64363254|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
23168682|NCT02706873|64363255|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
23335420|NCT00178685|64972906|FG002|Overall Study|Lost to Follow-up|183|||
23335421|NCT00178685|64972904|FG000|Overall Study|Withdrawal by Subject|8|||
23335422|NCT00178685|64972905|FG001|Overall Study|Withdrawal by Subject|14|||
23335423|NCT00178685|64972906|FG002|Overall Study|Withdrawal by Subject|7|||
23335424|NCT03674112|64972907|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
23335425|NCT03674112|64972908|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
23335426|NCT03674112|64972907|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
23335427|NCT03674112|64972908|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
23335428|NCT03674112|64972907|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
23335429|NCT03674112|64972908|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
23335430|NCT03674112|64972907|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
23335431|NCT03674112|64972908|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
23335432|NCT03674112|64972907|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
23576232|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
23576233|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
23576234|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
23576235|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
23576236|NCT02240680|65839020|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
23576237|NCT02240680|65839021|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
23576238|NCT02240680|65839022|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
23576239|NCT02240680|65839023|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
23576240|NCT02240680|65839020|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
23576241|NCT02240680|65839021|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
23576242|NCT02240680|65839022|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
23576243|NCT02240680|65839023|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
23576244|NCT02240680|65839020|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
23576245|NCT02240680|65839021|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
23576246|NCT02240680|65839022|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
23168683|NCT02706873|64363256|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
23168684|NCT02706873|64363253|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
23168685|NCT02706873|64363254|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
23168686|NCT02706873|64363255|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
23168687|NCT02706873|64363256|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
23168688|NCT02706873|64363253|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
23168689|NCT02706873|64363254|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
23168690|NCT02706873|64363255|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
23168691|NCT02706873|64363256|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
23168692|NCT02706873|64363253|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
23168693|NCT02706873|64363254|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
23168694|NCT02706873|64363255|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
23168695|NCT02706873|64363256|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
23168696|NCT02706873|64363253|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
23168697|NCT02706873|64363254|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
23168698|NCT02706873|64363255|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
23168699|NCT02706873|64363256|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
23168700|NCT02706873|64363253|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
23168701|NCT02706873|64363254|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
23168702|NCT02706873|64363255|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
23168703|NCT02706873|64363256|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
23168704|NCT02706873|64363253|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
23335433|NCT03674112|64972908|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
23335434|NCT03674112|64972907|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
23335435|NCT03674112|64972908|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
23168705|NCT02706873|64363254|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
23335436|NCT03674112|64972907|FG000|Follow-Up Period (≥3 Years)|Death|2|||
23335437|NCT03674112|64972908|FG001|Follow-Up Period (≥3 Years)|Death|0|||
23335438|NCT03674112|64972907|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
23335439|NCT03674112|64972908|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
23335440|NCT02393950|64972910|FG000|Overall Study|Adverse Event|1|||
23335441|NCT02393950|64972911|FG001|Overall Study|Adverse Event|0|||
23335442|NCT02393950|64972910|FG000|Overall Study|Withdrawal by Subject|0|||
23335443|NCT02393950|64972911|FG001|Overall Study|Withdrawal by Subject|1|||
23335444|NCT00708552|64972914|FG000|Overall Study|Adverse Event|10|||
23335445|NCT00708552|64972915|FG001|Overall Study|Adverse Event|3|||
23335446|NCT00708552|64972916|FG002|Overall Study|Adverse Event|4|||
23335447|NCT00708552|64972917|FG003|Overall Study|Adverse Event|6|||
23335448|NCT00708552|64972914|FG000|Overall Study|Lack of Efficacy|0|||
23335449|NCT00708552|64972915|FG001|Overall Study|Lack of Efficacy|4|||
23335450|NCT00708552|64972916|FG002|Overall Study|Lack of Efficacy|1|||
23335451|NCT00708552|64972917|FG003|Overall Study|Lack of Efficacy|0|||
23335452|NCT00708552|64972914|FG000|Overall Study|Protocol Violation|0|||
23335453|NCT00708552|64972915|FG001|Overall Study|Protocol Violation|0|||
23335454|NCT00708552|64972916|FG002|Overall Study|Protocol Violation|2|||
23335455|NCT00708552|64972917|FG003|Overall Study|Protocol Violation|4|||
23335456|NCT00708552|64972914|FG000|Overall Study|Lost to Follow-up|4|||
23335457|NCT00708552|64972915|FG001|Overall Study|Lost to Follow-up|2|||
23335458|NCT00708552|64972916|FG002|Overall Study|Lost to Follow-up|0|||
23335459|NCT00708552|64972917|FG003|Overall Study|Lost to Follow-up|1|||
23335460|NCT00708552|64972914|FG000|Overall Study|Physician Decision|1|||
23335461|NCT00708552|64972915|FG001|Overall Study|Physician Decision|2|||
23335462|NCT00708552|64972916|FG002|Overall Study|Physician Decision|0|||
23335463|NCT00708552|64972917|FG003|Overall Study|Physician Decision|0|||
23335464|NCT00708552|64972914|FG000|Overall Study|Withdrawal by Subject|12|||
23335465|NCT00708552|64972915|FG001|Overall Study|Withdrawal by Subject|7|||
23335466|NCT00708552|64972916|FG002|Overall Study|Withdrawal by Subject|8|||
23335467|NCT00708552|64972917|FG003|Overall Study|Withdrawal by Subject|10|||
23335468|NCT00975611|64972918|FG000|Overall Study|Screen Fail|16|||
23335469|NCT00975611|64972918|FG000|Overall Study|Physician Decision|1|||
23335470|NCT03018080|64972919|FG000|Overall Study|Death|12|||
23335471|NCT03018080|64972920|FG001|Overall Study|Death|19|||
23335472|NCT02203721|64972921|FG000|Overall Study|Lost to Follow-up|1|||
23335473|NCT02203721|64972922|FG001|Overall Study|Lost to Follow-up|0|||
23335474|NCT02203721|64972921|FG000|Overall Study|Death|0|||
23335475|NCT02203721|64972922|FG001|Overall Study|Death|2|||
23335476|NCT02203721|64972921|FG000|Overall Study|Illness|0|||
23335477|NCT02203721|64972922|FG001|Overall Study|Illness|1|||
23335478|NCT01029782|64972924|FG000|Overall Study|Lost to Follow-up|2|||
23335479|NCT01029782|64972925|FG001|Overall Study|Lost to Follow-up|2|||
23335480|NCT01029782|64972924|FG000|Overall Study|Diagnosis changed|1|||
23335481|NCT01029782|64972925|FG001|Overall Study|Diagnosis changed|1|||
23335482|NCT01029782|64972924|FG000|Overall Study|Adverse Event|0|||
23335483|NCT01029782|64972925|FG001|Overall Study|Adverse Event|1|||
23335484|NCT01029782|64972924|FG000|Overall Study|Physician Decision|0|||
23335485|NCT01029782|64972925|FG001|Overall Study|Physician Decision|1|||
23335486|NCT01029782|64972924|FG000|Overall Study|Protocol Violation|0|||
23335487|NCT01029782|64972925|FG001|Overall Study|Protocol Violation|2|||
23447870|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
23168706|NCT02706873|64363255|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
23168707|NCT02706873|64363256|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
23168708|NCT02706873|64363253|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
23168709|NCT02706873|64363254|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
23168710|NCT02706873|64363255|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
23168711|NCT02706873|64363256|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
23168712|NCT02706873|64363253|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
23168713|NCT02706873|64363254|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
23168714|NCT02706873|64363255|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
23335488|NCT01029782|64972924|FG000|Overall Study|Withdrawal by Subject|0|||
23335489|NCT01029782|64972925|FG001|Overall Study|Withdrawal by Subject|1|||
23335490|NCT01289639|64972926|FG000|Overall Study|Lost to Follow-up|1|||
23335491|NCT01289639|64972927|FG001|Overall Study|Lost to Follow-up|0|||
23335492|NCT01289639|64972928|FG002|Overall Study|Lost to Follow-up|0|||
23335493|NCT01435018|64972931|FG000|Overall Study|Death|37|||
23335494|NCT01435018|64972932|FG001|Overall Study|Death|18|||
23335495|NCT01435018|64972933|FG002|Overall Study|Death|25|||
23335496|NCT01435018|64972931|FG000|Overall Study|Site is closing|4|||
23335497|NCT01435018|64972932|FG001|Overall Study|Site is closing|9|||
23335498|NCT01435018|64972933|FG002|Overall Study|Site is closing|7|||
23335499|NCT01435018|64972931|FG000|Overall Study|Withdrew consent|0|||
23335500|NCT01435018|64972932|FG001|Overall Study|Withdrew consent|3|||
23335501|NCT01435018|64972933|FG002|Overall Study|Withdrew consent|1|||
23168715|NCT02706873|64363256|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
23335502|NCT01435018|64972931|FG000|Overall Study|Not willing to adhere to requirements|0|||
23335503|NCT01435018|64972932|FG001|Overall Study|Not willing to adhere to requirements|2|||
23335504|NCT01435018|64972933|FG002|Overall Study|Not willing to adhere to requirements|3|||
23335505|NCT01435018|64972931|FG000|Overall Study|Not able to get to clinic|2|||
23576247|NCT02240680|65839023|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
23576248|NCT02240680|65839020|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
23168716|NCT02706873|64363253|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
23168717|NCT02706873|64363254|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
23168718|NCT02706873|64363255|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
23168719|NCT02706873|64363256|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
23576249|NCT02240680|65839021|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
23576250|NCT02240680|65839022|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
23576251|NCT02240680|65839023|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
23576252|NCT01653847|65839024|FG000|Overall Study|Withdrawal by Subject|1|||
23576253|NCT01653847|65839025|FG001|Overall Study|Withdrawal by Subject|0|||
23576254|NCT02107443|65839026|FG000|Overall Study|Death|42|||
23576255|NCT02107443|65839027|FG001|Overall Study|Death|30|||
23576256|NCT02107443|65839026|FG000|Overall Study|Study Protocol Violation|3|||
23576257|NCT02107443|65839027|FG001|Overall Study|Study Protocol Violation|1|||
23576258|NCT02107443|65839026|FG000|Overall Study|Registered but Not Eligible|0|||
23168720|NCT02706873|64363253|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
23168721|NCT02706873|64363254|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
23168722|NCT02706873|64363255|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
23168723|NCT02706873|64363256|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
23168724|NCT02706873|64363253|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
23168725|NCT02706873|64363254|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
23168726|NCT02706873|64363255|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
23168727|NCT02706873|64363256|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
23168728|NCT02104583|64363257|FG000|Overall Study|New ICD or CRT-D implanted|2|||
23168729|NCT02104583|64363258|FG001|Overall Study|New ICD or CRT-D implanted|0|||
23168730|NCT02104583|64363259|FG002|Overall Study|New ICD or CRT-D implanted|1|||
23168731|NCT02104583|64363260|FG003|Overall Study|New ICD or CRT-D implanted|0|||
23168732|NCT02104583|64363261|FG004|Overall Study|New ICD or CRT-D implanted|0|||
23168733|NCT02104583|64363257|FG000|Overall Study|Death|2|||
23168734|NCT02104583|64363258|FG001|Overall Study|Death|1|||
23168735|NCT02104583|64363259|FG002|Overall Study|Death|3|||
23168736|NCT02104583|64363260|FG003|Overall Study|Death|3|||
23168737|NCT02104583|64363261|FG004|Overall Study|Death|5|||
23168738|NCT02104583|64363257|FG000|Overall Study|Subject required cardiac ablation|6|||
23168739|NCT02104583|64363258|FG001|Overall Study|Subject required cardiac ablation|4|||
23168740|NCT02104583|64363259|FG002|Overall Study|Subject required cardiac ablation|4|||
23168741|NCT02104583|64363260|FG003|Overall Study|Subject required cardiac ablation|5|||
23168742|NCT02104583|64363261|FG004|Overall Study|Subject required cardiac ablation|4|||
23168743|NCT02104583|64363257|FG000|Overall Study|Subject required prohibited medication|0|||
23168744|NCT02104583|64363258|FG001|Overall Study|Subject required prohibited medication|1|||
23168745|NCT02104583|64363259|FG002|Overall Study|Subject required prohibited medication|1|||
23168746|NCT02104583|64363260|FG003|Overall Study|Subject required prohibited medication|0|||
23168747|NCT02104583|64363261|FG004|Overall Study|Subject required prohibited medication|1|||
23168748|NCT02104583|64363257|FG000|Overall Study|Withdrew Consent|3|||
23168749|NCT02104583|64363258|FG001|Overall Study|Withdrew Consent|2|||
23168750|NCT02104583|64363259|FG002|Overall Study|Withdrew Consent|0|||
23168751|NCT02104583|64363260|FG003|Overall Study|Withdrew Consent|2|||
23168752|NCT02104583|64363261|FG004|Overall Study|Withdrew Consent|1|||
23168753|NCT02104583|64363257|FG000|Overall Study|Investigator's Discretion|1|||
23576259|NCT02107443|65839027|FG001|Overall Study|Registered but Not Eligible|1|||
23168754|NCT02104583|64363258|FG001|Overall Study|Investigator's Discretion|0|||
23168755|NCT02104583|64363259|FG002|Overall Study|Investigator's Discretion|0|||
23168756|NCT02104583|64363260|FG003|Overall Study|Investigator's Discretion|0|||
23168757|NCT02104583|64363261|FG004|Overall Study|Investigator's Discretion|0|||
23168758|NCT02104583|64363257|FG000|Overall Study|Protocol Violation|0|||
23168759|NCT02104583|64363258|FG001|Overall Study|Protocol Violation|0|||
23168760|NCT02104583|64363259|FG002|Overall Study|Protocol Violation|1|||
23168761|NCT02104583|64363260|FG003|Overall Study|Protocol Violation|0|||
23168762|NCT02104583|64363261|FG004|Overall Study|Protocol Violation|0|||
23168763|NCT02104583|64363257|FG000|Overall Study|Adverse Event|3|||
23168764|NCT02104583|64363258|FG001|Overall Study|Adverse Event|3|||
23168765|NCT02104583|64363259|FG002|Overall Study|Adverse Event|6|||
23168766|NCT02104583|64363260|FG003|Overall Study|Adverse Event|6|||
23168767|NCT02104583|64363261|FG004|Overall Study|Adverse Event|1|||
23168768|NCT02104583|64363257|FG000|Overall Study|Lost to Follow-up|1|||
23168769|NCT02104583|64363258|FG001|Overall Study|Lost to Follow-up|0|||
23168770|NCT02104583|64363259|FG002|Overall Study|Lost to Follow-up|0|||
23168771|NCT02104583|64363260|FG003|Overall Study|Lost to Follow-up|0|||
23576260|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
23168772|NCT02104583|64363261|FG004|Overall Study|Lost to Follow-up|0|||
23168773|NCT02104583|64363257|FG000|Overall Study|Randomized but Never Treated|0|||
23168774|NCT02104583|64363258|FG001|Overall Study|Randomized but Never Treated|0|||
23227965|NCT01058395|64577983|FG000|Overall Study|Lost to Follow-up|1|||
23168775|NCT02104583|64363259|FG002|Overall Study|Randomized but Never Treated|0|||
23168776|NCT02104583|64363260|FG003|Overall Study|Randomized but Never Treated|1|||
23168777|NCT02104583|64363261|FG004|Overall Study|Randomized but Never Treated|0|||
23168778|NCT03548558|64363263|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
23168779|NCT03548558|64363264|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
23168780|NCT03548558|64363265|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
23168781|NCT03548558|64363266|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
23168782|NCT03548558|64363267|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
23168783|NCT03548558|64363268|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
23168784|NCT03548558|64363269|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
23168785|NCT03548558|64363263|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
23168786|NCT03548558|64363264|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
23168787|NCT03548558|64363265|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
23168788|NCT03548558|64363266|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
23168789|NCT03548558|64363267|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
23227966|NCT01058395|64577984|FG001|Overall Study|Lost to Follow-up|0|||
23227967|NCT00783263|64577986|FG000|Overall Study|Adverse Event|3|||
23227968|NCT00783263|64577987|FG001|Overall Study|Adverse Event|0|||
23335506|NCT01435018|64972932|FG001|Overall Study|Not able to get to clinic|0|||
23335507|NCT01435018|64972933|FG002|Overall Study|Not able to get to clinic|2|||
23227969|NCT00783263|64577988|FG002|Overall Study|Adverse Event|2|||
23227970|NCT00783263|64577989|FG003|Overall Study|Adverse Event|1|||
23227971|NCT00783263|64577986|FG000|Overall Study|Lost to Follow-up|1|||
23227972|NCT00783263|64577987|FG001|Overall Study|Lost to Follow-up|1|||
23227973|NCT00783263|64577988|FG002|Overall Study|Lost to Follow-up|0|||
23227974|NCT00783263|64577989|FG003|Overall Study|Lost to Follow-up|0|||
23227975|NCT00783263|64577986|FG000|Overall Study|Withdrawal by Subject|0|||
23227976|NCT00783263|64577987|FG001|Overall Study|Withdrawal by Subject|1|||
23227977|NCT00783263|64577988|FG002|Overall Study|Withdrawal by Subject|1|||
23335508|NCT01435018|64972931|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23335509|NCT01435018|64972932|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23335510|NCT01435018|64972933|FG002|Overall Study|Severe debilitation, unable to continue|1|||
23335511|NCT01435018|64972931|FG000|Overall Study|Unable to contact participant/parent|1|||
23335512|NCT01435018|64972932|FG001|Overall Study|Unable to contact participant/parent|1|||
23335513|NCT01435018|64972933|FG002|Overall Study|Unable to contact participant/parent|1|||
23335514|NCT01435018|64972931|FG000|Overall Study|Enrollment Violation|0|||
23335515|NCT01435018|64972932|FG001|Overall Study|Enrollment Violation|1|||
23335516|NCT01435018|64972933|FG002|Overall Study|Enrollment Violation|0|||
23335517|NCT01435018|64972931|FG000|Overall Study|Never started chemotherapy|3|||
23335518|NCT01435018|64972932|FG001|Overall Study|Never started chemotherapy|0|||
23335519|NCT01435018|64972933|FG002|Overall Study|Never started chemotherapy|1|||
23335520|NCT00652626|64972937|FG000|Initial Treatment Phase|Adverse Event|0|||
23335521|NCT00652626|64972938|FG001|Initial Treatment Phase|Adverse Event|0|||
23335522|NCT00652626|64972939|FG002|Initial Treatment Phase|Adverse Event|0|||
23335523|NCT00652626|64972940|FG003|Initial Treatment Phase|Adverse Event|0|||
23335524|NCT00652626|64972941|FG004|Initial Treatment Phase|Adverse Event|1|||
23335525|NCT00652626|64972942|FG005|Initial Treatment Phase|Adverse Event|0|||
23335526|NCT00652626|64972943|FG006|Initial Treatment Phase|Adverse Event|0|||
23335527|NCT00652626|64972937|FG000|Initial Treatment Phase|Protocol Violation|0|||
23335528|NCT00652626|64972938|FG001|Initial Treatment Phase|Protocol Violation|0|||
23335529|NCT00652626|64972939|FG002|Initial Treatment Phase|Protocol Violation|0|||
23335530|NCT00652626|64972940|FG003|Initial Treatment Phase|Protocol Violation|1|||
23335531|NCT00652626|64972941|FG004|Initial Treatment Phase|Protocol Violation|0|||
23335532|NCT00652626|64972942|FG005|Initial Treatment Phase|Protocol Violation|0|||
23335533|NCT00652626|64972943|FG006|Initial Treatment Phase|Protocol Violation|0|||
23335534|NCT00652626|64972937|FG000|Initial Treatment Phase|Physician Decision|0|||
23335535|NCT00652626|64972938|FG001|Initial Treatment Phase|Physician Decision|0|||
23335536|NCT00652626|64972939|FG002|Initial Treatment Phase|Physician Decision|0|||
23335537|NCT00652626|64972940|FG003|Initial Treatment Phase|Physician Decision|0|||
23335538|NCT00652626|64972941|FG004|Initial Treatment Phase|Physician Decision|1|||
23168790|NCT03548558|64363268|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
23227978|NCT00783263|64577989|FG003|Overall Study|Withdrawal by Subject|2|||
23227979|NCT02442765|64577990|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
23227980|NCT02442765|64577991|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
23335539|NCT00652626|64972942|FG005|Initial Treatment Phase|Physician Decision|0|||
23335540|NCT00652626|64972943|FG006|Initial Treatment Phase|Physician Decision|0|||
23335541|NCT00652626|64972937|FG000|Initial Treatment Phase|Sponsor Request|0|||
23335542|NCT00652626|64972938|FG001|Initial Treatment Phase|Sponsor Request|0|||
23335543|NCT00652626|64972939|FG002|Initial Treatment Phase|Sponsor Request|1|||
23335544|NCT00652626|64972940|FG003|Initial Treatment Phase|Sponsor Request|0|||
23335545|NCT00652626|64972941|FG004|Initial Treatment Phase|Sponsor Request|0|||
23335546|NCT00652626|64972942|FG005|Initial Treatment Phase|Sponsor Request|0|||
23168791|NCT03548558|64363269|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
23168792|NCT03548558|64363263|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
23168793|NCT03548558|64363264|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
23168794|NCT03548558|64363265|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
23168795|NCT03548558|64363266|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
23168796|NCT03548558|64363267|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
23168797|NCT03548558|64363268|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
23168798|NCT03548558|64363269|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
23168799|NCT03548558|64363263|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
23576261|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
23576262|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
23576263|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
23576264|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Changed Mind|2|||
23576265|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Changed Mind|0|||
23576266|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
23168800|NCT03548558|64363264|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
23168801|NCT03548558|64363265|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
23335547|NCT00652626|64972943|FG006|Initial Treatment Phase|Sponsor Request|0|||
23335548|NCT00652626|64972937|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
23335549|NCT00652626|64972938|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
23227981|NCT02442765|64577992|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
23227982|NCT02442765|64577993|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
23227983|NCT02442765|64577994|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
23227984|NCT02442765|64577995|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
23227985|NCT02442765|64577996|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
23227986|NCT02442765|64577997|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
23227987|NCT02442765|64577990|FG000|Stage 2- (Days 43 to 85)|Death|0|||
23227988|NCT02442765|64577991|FG001|Stage 2- (Days 43 to 85)|Death|0|||
23227989|NCT02442765|64577992|FG002|Stage 2- (Days 43 to 85)|Death|0|||
23227990|NCT02442765|64577993|FG003|Stage 2- (Days 43 to 85)|Death|1|||
23227991|NCT02442765|64577994|FG004|Stage 2- (Days 43 to 85)|Death|1|||
23227992|NCT02442765|64577995|FG005|Stage 2- (Days 43 to 85)|Death|0|||
23227993|NCT02442765|64577996|FG006|Stage 2- (Days 43 to 85)|Death|2|||
23227994|NCT02442765|64577997|FG007|Stage 2- (Days 43 to 85)|Death|0|||
23227995|NCT02442765|64577990|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23227996|NCT02442765|64577991|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23227997|NCT02442765|64577992|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23227998|NCT02442765|64577993|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
23227999|NCT02442765|64577994|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23228000|NCT02442765|64577995|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23228001|NCT02442765|64577996|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23228002|NCT02442765|64577997|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
23228003|NCT02442765|64577990|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23228004|NCT02442765|64577991|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23228005|NCT02442765|64577992|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23228006|NCT02442765|64577993|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
23228007|NCT02442765|64577994|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23228008|NCT02442765|64577995|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23228009|NCT02442765|64577996|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23228010|NCT02442765|64577997|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
23335550|NCT00652626|64972939|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
23335551|NCT00652626|64972940|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
23335552|NCT00652626|64972941|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
23335553|NCT00652626|64972942|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
23335554|NCT00652626|64972943|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
23335555|NCT00652626|64972937|FG000|Extension Phase|Withdrawal by Subject|0|||
23335556|NCT00652626|64972938|FG001|Extension Phase|Withdrawal by Subject|0|||
23335557|NCT00652626|64972939|FG002|Extension Phase|Withdrawal by Subject|0|||
23335558|NCT00652626|64972940|FG003|Extension Phase|Withdrawal by Subject|0|||
23335559|NCT00652626|64972941|FG004|Extension Phase|Withdrawal by Subject|0|||
23228011|NCT02442765|64577990|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23576267|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
23228012|NCT02442765|64577991|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23335560|NCT00652626|64972942|FG005|Extension Phase|Withdrawal by Subject|2|||
23335561|NCT00652626|64972943|FG006|Extension Phase|Withdrawal by Subject|0|||
23576268|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
23168802|NCT03548558|64363266|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
23228013|NCT02442765|64577992|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23228014|NCT02442765|64577993|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
23335562|NCT00652626|64972937|FG000|Extension Phase|Adverse Event|0|||
23335563|NCT00652626|64972938|FG001|Extension Phase|Adverse Event|0|||
23576269|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
23168803|NCT03548558|64363267|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
23168804|NCT03548558|64363268|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
23168805|NCT03548558|64363269|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
23168806|NCT03548558|64363263|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
23168807|NCT03548558|64363264|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
23168808|NCT03548558|64363265|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
23168809|NCT03548558|64363266|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
23447871|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
23447872|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
23447873|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
23447874|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
23447875|NCT01910402|65380623|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
23447876|NCT01910402|65380624|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
23447877|NCT01910402|65380625|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
23447878|NCT04854551|65380630|FG000|Overall Study|Withdrawal by Subject|1|||
23447879|NCT04854551|65380631|FG001|Overall Study|Withdrawal by Subject|1|||
23447880|NCT01594931|65380636|FG000|Overall Study|Adverse Event|3|||
23447881|NCT01594931|65380637|FG001|Overall Study|Adverse Event|1|||
23447882|NCT01594931|65380638|FG002|Overall Study|Adverse Event|1|||
23447883|NCT01594931|65380636|FG000|Overall Study|Withdrawal by Subject|2|||
23447884|NCT01594931|65380637|FG001|Overall Study|Withdrawal by Subject|1|||
23447885|NCT01594931|65380638|FG002|Overall Study|Withdrawal by Subject|1|||
23447886|NCT01594931|65380636|FG000|Overall Study|Lack of Efficacy|7|||
23447887|NCT01594931|65380637|FG001|Overall Study|Lack of Efficacy|2|||
23447888|NCT01594931|65380638|FG002|Overall Study|Lack of Efficacy|2|||
23447889|NCT01594931|65380636|FG000|Overall Study|Lost to Follow-up|4|||
23447890|NCT01594931|65380637|FG001|Overall Study|Lost to Follow-up|3|||
23447891|NCT01594931|65380638|FG002|Overall Study|Lost to Follow-up|3|||
23168810|NCT03548558|64363267|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
23168811|NCT03548558|64363268|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
23168812|NCT03548558|64363269|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
23168813|NCT03548558|64363263|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
23168814|NCT03548558|64363264|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
23168815|NCT03548558|64363265|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
23168816|NCT03548558|64363266|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
23168817|NCT03548558|64363267|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
23168818|NCT03548558|64363268|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
23168819|NCT03548558|64363269|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
23168820|NCT01324232|64363270|FG000|Overall Study|Protocol Violation|0|||
23168821|NCT01324232|64363271|FG001|Overall Study|Protocol Violation|0|||
23168822|NCT01324232|64363272|FG002|Overall Study|Protocol Violation|0|||
23168823|NCT01324232|64363273|FG003|Overall Study|Protocol Violation|2|||
23168824|NCT01324232|64363270|FG000|Overall Study|Missing|0|||
23168825|NCT01324232|64363271|FG001|Overall Study|Missing|0|||
23168826|NCT01324232|64363272|FG002|Overall Study|Missing|1|||
23168827|NCT01324232|64363273|FG003|Overall Study|Missing|0|||
23447892|NCT01594931|65380636|FG000|Overall Study|Protocol Violation|2|||
23447893|NCT01594931|65380637|FG001|Overall Study|Protocol Violation|1|||
23447894|NCT01594931|65380638|FG002|Overall Study|Protocol Violation|0|||
23447895|NCT01594931|65380636|FG000|Overall Study|No defiined|11|||
23447896|NCT01594931|65380637|FG001|Overall Study|No defiined|4|||
23447897|NCT01594931|65380638|FG002|Overall Study|No defiined|7|||
23447898|NCT04950465|65380641|FG000|Overall Study|Lost to Follow-up|1|||
23447899|NCT04950465|65380642|FG001|Overall Study|Lost to Follow-up|0|||
23447900|NCT04950465|65380643|FG002|Overall Study|Lost to Follow-up|0|||
23447901|NCT02763644|65380644|FG000|Overall Study|Patient/guardian decision|1|||
23447902|NCT02763644|65380645|FG001|Overall Study|Patient/guardian decision|0|||
23447903|NCT02763644|65380644|FG000|Overall Study|Death|1|||
23447904|NCT02763644|65380645|FG001|Overall Study|Death|1|||
23447905|NCT02763644|65380644|FG000|Overall Study|Adverse Event|1|||
23447906|NCT02763644|65380645|FG001|Overall Study|Adverse Event|1|||
23447907|NCT02222558|65380646|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
23447908|NCT02222558|65380647|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
23447909|NCT02222558|65380648|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
23447910|NCT02222558|65380649|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
23447911|NCT02222558|65380650|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
23447912|NCT02222558|65380651|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
23447913|NCT02222558|65380646|FG000|Period 3|Withdrawal by Subject|0|||
23447914|NCT02222558|65380647|FG001|Period 3|Withdrawal by Subject|0|||
23447915|NCT02222558|65380648|FG002|Period 3|Withdrawal by Subject|0|||
23447916|NCT02222558|65380649|FG003|Period 3|Withdrawal by Subject|0|||
23447917|NCT02222558|65380650|FG004|Period 3|Withdrawal by Subject|0|||
23447918|NCT02222558|65380651|FG005|Period 3|Withdrawal by Subject|1|||
23447919|NCT03191630|65380652|FG000|Overall Study|Lost to Follow-up|7|||
23447920|NCT03191630|65380653|FG001|Overall Study|Lost to Follow-up|7|||
23447921|NCT04628780|65380659|FG000|Overall Study|Death|0|||
23447922|NCT04628780|65380660|FG001|Overall Study|Death|1|||
23447923|NCT04628780|65380661|FG002|Overall Study|Death|0|||
23447924|NCT04628780|65380662|FG003|Overall Study|Death|0|||
23447925|NCT04628780|65380663|FG004|Overall Study|Death|1|||
23447926|NCT04628780|65380664|FG005|Overall Study|Death|0|||
23447927|NCT04628780|65380659|FG000|Overall Study|Physician Decision|2|||
23447928|NCT04628780|65380660|FG001|Overall Study|Physician Decision|0|||
23447929|NCT04628780|65380661|FG002|Overall Study|Physician Decision|0|||
23447930|NCT04628780|65380662|FG003|Overall Study|Physician Decision|0|||
23447931|NCT04628780|65380663|FG004|Overall Study|Physician Decision|2|||
23447932|NCT04628780|65380664|FG005|Overall Study|Physician Decision|0|||
23447933|NCT04628780|65380659|FG000|Overall Study|Progressive disease|2|||
23447934|NCT04628780|65380660|FG001|Overall Study|Progressive disease|2|||
23447935|NCT04628780|65380661|FG002|Overall Study|Progressive disease|2|||
23447936|NCT04628780|65380662|FG003|Overall Study|Progressive disease|3|||
23447937|NCT04628780|65380663|FG004|Overall Study|Progressive disease|9|||
23447938|NCT04628780|65380664|FG005|Overall Study|Progressive disease|4|||
23447939|NCT04628780|65380659|FG000|Overall Study|Withdrawal by Subject|0|||
23447940|NCT04628780|65380660|FG001|Overall Study|Withdrawal by Subject|1|||
23447941|NCT04628780|65380661|FG002|Overall Study|Withdrawal by Subject|2|||
23447942|NCT04628780|65380662|FG003|Overall Study|Withdrawal by Subject|0|||
23447943|NCT04628780|65380663|FG004|Overall Study|Withdrawal by Subject|3|||
23447944|NCT04628780|65380664|FG005|Overall Study|Withdrawal by Subject|1|||
23447945|NCT04628780|65380659|FG000|Overall Study|Global deterioration of health status|0|||
23447946|NCT04628780|65380660|FG001|Overall Study|Global deterioration of health status|0|||
23447947|NCT04628780|65380661|FG002|Overall Study|Global deterioration of health status|0|||
23447948|NCT04628780|65380662|FG003|Overall Study|Global deterioration of health status|0|||
23447949|NCT04628780|65380663|FG004|Overall Study|Global deterioration of health status|1|||
23447950|NCT04628780|65380664|FG005|Overall Study|Global deterioration of health status|1|||
23447951|NCT01367834|65380665|FG000|Overall Study|Withdrawal by Subject|2|||
23447952|NCT01367834|65380666|FG001|Overall Study|Withdrawal by Subject|2|||
23447953|NCT01367834|65380665|FG000|Overall Study|Study was ended.|0|||
23447954|NCT01367834|65380666|FG001|Overall Study|Study was ended.|1|||
23447955|NCT04023526|65384466|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
23447956|NCT04023526|65384467|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
23447957|NCT04023526|65384466|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
23447958|NCT04023526|65384467|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
23447959|NCT01855412|65384471|FG000|Overall Study|Death|77|||
23447960|NCT01855412|65384472|FG001|Overall Study|Death|123|||
23447961|NCT01855412|65384473|FG002|Overall Study|Death|30|||
23447962|NCT01855412|65384471|FG000|Overall Study|Lost to Follow-up|28|||
23447963|NCT01855412|65384472|FG001|Overall Study|Lost to Follow-up|46|||
23447964|NCT01855412|65384473|FG002|Overall Study|Lost to Follow-up|15|||
23447965|NCT01855412|65384471|FG000|Overall Study|Withdrawal by Subject|77|||
23447966|NCT01855412|65384472|FG001|Overall Study|Withdrawal by Subject|123|||
23447967|NCT01855412|65384473|FG002|Overall Study|Withdrawal by Subject|24|||
23447968|NCT01855412|65384471|FG000|Overall Study|Physician Decision|25|||
23447969|NCT01855412|65384472|FG001|Overall Study|Physician Decision|31|||
23447970|NCT01855412|65384473|FG002|Overall Study|Physician Decision|3|||
23447971|NCT01855412|65384471|FG000|Overall Study|Site Closure|4|||
23447972|NCT01855412|65384472|FG001|Overall Study|Site Closure|18|||
23447973|NCT01855412|65384473|FG002|Overall Study|Site Closure|1|||
23447974|NCT01855412|65384471|FG000|Overall Study|Reason not Specified|1|||
23447975|NCT01855412|65384472|FG001|Overall Study|Reason not Specified|2|||
23447976|NCT01855412|65384473|FG002|Overall Study|Reason not Specified|3|||
23447977|NCT01693029|65384476|FG000|Overall Study|Withdrawal by Subject|15|||
23447978|NCT01693029|65384477|FG001|Overall Study|Withdrawal by Subject|22|||
23447979|NCT01693029|65384476|FG000|Overall Study|Kidney transplantation|7|||
23447980|NCT01693029|65384477|FG001|Overall Study|Kidney transplantation|7|||
23447981|NCT01693029|65384476|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
23447982|NCT01693029|65384477|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
23447983|NCT01693029|65384476|FG000|Overall Study|Protocol Violation|6|||
23447984|NCT01693029|65384477|FG001|Overall Study|Protocol Violation|7|||
23447985|NCT01693029|65384476|FG000|Overall Study|Change in dialysis modality|2|||
23447986|NCT01693029|65384477|FG001|Overall Study|Change in dialysis modality|1|||
23447987|NCT01693029|65384476|FG000|Overall Study|Physician Decision|0|||
23447988|NCT01693029|65384477|FG001|Overall Study|Physician Decision|2|||
23447989|NCT01693029|65384476|FG000|Overall Study|Lost to Follow-up|0|||
23576270|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
23447990|NCT01693029|65384477|FG001|Overall Study|Lost to Follow-up|1|||
23447991|NCT01693029|65384476|FG000|Overall Study|Adverse Event|1|||
23447992|NCT01693029|65384477|FG001|Overall Study|Adverse Event|6|||
23576271|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
23576272|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
23447993|NCT01693029|65384476|FG000|Overall Study|Death|5|||
23447994|NCT01693029|65384477|FG001|Overall Study|Death|8|||
23447995|NCT01693029|65384476|FG000|Overall Study|Non-compliance|2|||
23447996|NCT01693029|65384477|FG001|Overall Study|Non-compliance|1|||
23447997|NCT00286442|65384478|FG000|Overall Study|Hyperglycemic Rescue|19|||
23447998|NCT00286442|65384479|FG001|Overall Study|Hyperglycemic Rescue|17|||
23447999|NCT00286442|65384480|FG002|Overall Study|Hyperglycemic Rescue|25|||
23448000|NCT00286442|65384478|FG000|Overall Study|Adverse Event|7|||
23448001|NCT00286442|65384479|FG001|Overall Study|Adverse Event|6|||
23448002|NCT00286442|65384480|FG002|Overall Study|Adverse Event|1|||
23448003|NCT00286442|65384478|FG000|Overall Study|Protocol Violation|2|||
23448004|NCT00286442|65384479|FG001|Overall Study|Protocol Violation|4|||
23448005|NCT00286442|65384480|FG002|Overall Study|Protocol Violation|2|||
23448006|NCT00286442|65384478|FG000|Overall Study|Lost to Follow-up|5|||
23448007|NCT00286442|65384479|FG001|Overall Study|Lost to Follow-up|2|||
23448008|NCT00286442|65384480|FG002|Overall Study|Lost to Follow-up|1|||
23448009|NCT00286442|65384478|FG000|Overall Study|Physician Decision|1|||
23448010|NCT00286442|65384479|FG001|Overall Study|Physician Decision|1|||
23448011|NCT00286442|65384480|FG002|Overall Study|Physician Decision|1|||
23448012|NCT00286442|65384478|FG000|Overall Study|Administrative Error|1|||
23448013|NCT00286442|65384479|FG001|Overall Study|Administrative Error|1|||
23448014|NCT00286442|65384480|FG002|Overall Study|Administrative Error|0|||
23448015|NCT00286442|65384478|FG000|Overall Study|Withdrawal by Subject|2|||
23448016|NCT00286442|65384479|FG001|Overall Study|Withdrawal by Subject|14|||
23448017|NCT00286442|65384480|FG002|Overall Study|Withdrawal by Subject|2|||
23448018|NCT00880620|65384481|FG000|Overall Study|Adverse Event|4|||
23448019|NCT00880620|65384482|FG001|Overall Study|Adverse Event|5|||
23448020|NCT00880620|65384483|FG002|Overall Study|Adverse Event|15|||
23448021|NCT00880620|65384484|FG003|Overall Study|Adverse Event|15|||
23448022|NCT00880620|65384481|FG000|Overall Study|Death|0|||
23448023|NCT00880620|65384482|FG001|Overall Study|Death|0|||
23448024|NCT00880620|65384483|FG002|Overall Study|Death|1|||
23448025|NCT00880620|65384484|FG003|Overall Study|Death|0|||
23448026|NCT00880620|65384481|FG000|Overall Study|Lack of Efficacy|12|||
23448027|NCT00880620|65384482|FG001|Overall Study|Lack of Efficacy|4|||
23448028|NCT00880620|65384483|FG002|Overall Study|Lack of Efficacy|0|||
23448029|NCT00880620|65384484|FG003|Overall Study|Lack of Efficacy|1|||
23448030|NCT00880620|65384481|FG000|Overall Study|Lost to Follow-up|0|||
23448031|NCT00880620|65384482|FG001|Overall Study|Lost to Follow-up|1|||
23448032|NCT00880620|65384483|FG002|Overall Study|Lost to Follow-up|1|||
23448033|NCT00880620|65384484|FG003|Overall Study|Lost to Follow-up|0|||
23448034|NCT00880620|65384481|FG000|Overall Study|Protocol Violation|0|||
23448035|NCT00880620|65384482|FG001|Overall Study|Protocol Violation|1|||
23448036|NCT00880620|65384483|FG002|Overall Study|Protocol Violation|0|||
23448037|NCT00880620|65384484|FG003|Overall Study|Protocol Violation|2|||
23448038|NCT00880620|65384481|FG000|Overall Study|Withdrawal by Subject|4|||
23448039|NCT00880620|65384482|FG001|Overall Study|Withdrawal by Subject|3|||
23448040|NCT00880620|65384483|FG002|Overall Study|Withdrawal by Subject|1|||
23448041|NCT00880620|65384484|FG003|Overall Study|Withdrawal by Subject|3|||
23448042|NCT00880620|65384481|FG000|Overall Study|Noncompliance|0|||
23448043|NCT00880620|65384482|FG001|Overall Study|Noncompliance|0|||
23448044|NCT00880620|65384483|FG002|Overall Study|Noncompliance|1|||
23448045|NCT00880620|65384484|FG003|Overall Study|Noncompliance|1|||
23448046|NCT00880620|65384481|FG000|Overall Study|Other|1|||
23448047|NCT00880620|65384482|FG001|Overall Study|Other|1|||
23448048|NCT00880620|65384483|FG002|Overall Study|Other|2|||
23448049|NCT00880620|65384484|FG003|Overall Study|Other|2|||
23448050|NCT01176058|65384485|FG000|Overall Study|Adverse Event|1|||
23448051|NCT01176058|65384486|FG001|Overall Study|Adverse Event|0|||
23448052|NCT01176058|65384485|FG000|Overall Study|Insufficient clinical response|2|||
23448053|NCT01176058|65384486|FG001|Overall Study|Insufficient clinical response|2|||
23448054|NCT01176058|65384485|FG000|Overall Study|Insufficient mycological response|0|||
23448055|NCT01176058|65384486|FG001|Overall Study|Insufficient mycological response|1|||
23448056|NCT01176058|65384485|FG000|Overall Study|Withdrawal by Subject|1|||
23448057|NCT01176058|65384486|FG001|Overall Study|Withdrawal by Subject|0|||
23448058|NCT03275740|65384487|FG000|Overall Study|Adverse Event|0|||
23448059|NCT03275740|65384488|FG001|Overall Study|Adverse Event|0|||
23448060|NCT03275740|65384489|FG002|Overall Study|Adverse Event|0|||
23448061|NCT03275740|65384490|FG003|Overall Study|Adverse Event|0|||
23448062|NCT03275740|65384491|FG004|Overall Study|Adverse Event|1|||
23448063|NCT03275740|65384492|FG005|Overall Study|Adverse Event|0|||
23448064|NCT03275740|65384493|FG006|Overall Study|Adverse Event|0|||
23448065|NCT03275740|65384494|FG007|Overall Study|Adverse Event|0|||
23448066|NCT03275740|65384495|FG008|Overall Study|Adverse Event|0|||
23448067|NCT03275740|65384496|FG009|Overall Study|Adverse Event|0|||
23448068|NCT03275740|65384497|FG010|Overall Study|Adverse Event|0|||
23448069|NCT03275740|65384498|FG011|Overall Study|Adverse Event|0|||
23448070|NCT03275740|65384487|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448071|NCT03275740|65384488|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448072|NCT03275740|65384489|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448073|NCT03275740|65384490|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448074|NCT03275740|65384491|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448075|NCT03275740|65384492|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
23448076|NCT03275740|65384493|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448077|NCT03275740|65384494|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448078|NCT03275740|65384495|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448079|NCT03275740|65384496|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448080|NCT03275740|65384497|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448081|NCT03275740|65384498|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
23448082|NCT03275740|65384487|FG000|Overall Study|Withdrawal by Subject|0|||
23448083|NCT03275740|65384488|FG001|Overall Study|Withdrawal by Subject|0|||
23448084|NCT03275740|65384489|FG002|Overall Study|Withdrawal by Subject|0|||
23448085|NCT03275740|65384490|FG003|Overall Study|Withdrawal by Subject|0|||
23448086|NCT03275740|65384491|FG004|Overall Study|Withdrawal by Subject|0|||
23448087|NCT03275740|65384492|FG005|Overall Study|Withdrawal by Subject|0|||
23448088|NCT03275740|65384493|FG006|Overall Study|Withdrawal by Subject|0|||
23448089|NCT03275740|65384494|FG007|Overall Study|Withdrawal by Subject|0|||
23448090|NCT03275740|65384495|FG008|Overall Study|Withdrawal by Subject|1|||
23448091|NCT03275740|65384496|FG009|Overall Study|Withdrawal by Subject|1|||
23448092|NCT03275740|65384497|FG010|Overall Study|Withdrawal by Subject|0|||
23448093|NCT03275740|65384498|FG011|Overall Study|Withdrawal by Subject|0|||
23448094|NCT01384734|65384499|FG000|Overall Study|Adverse Event|0|||
23448095|NCT01384734|65384500|FG001|Overall Study|Adverse Event|3|||
23448096|NCT01384734|65384501|FG002|Overall Study|Adverse Event|0|||
23448097|NCT01384734|65384502|FG003|Overall Study|Adverse Event|2|||
23448098|NCT01384734|65384503|FG004|Overall Study|Adverse Event|7|||
23448099|NCT01384734|65384499|FG000|Overall Study|Death|1|||
23448100|NCT01384734|65384500|FG001|Overall Study|Death|0|||
23448101|NCT01384734|65384501|FG002|Overall Study|Death|1|||
23448102|NCT01384734|65384502|FG003|Overall Study|Death|0|||
23448103|NCT01384734|65384503|FG004|Overall Study|Death|0|||
23448104|NCT01384734|65384499|FG000|Overall Study|Continuation criteria not met|0|||
23448105|NCT01384734|65384500|FG001|Overall Study|Continuation criteria not met|0|||
23448106|NCT01384734|65384501|FG002|Overall Study|Continuation criteria not met|1|||
23448107|NCT01384734|65384502|FG003|Overall Study|Continuation criteria not met|1|||
23448108|NCT01384734|65384503|FG004|Overall Study|Continuation criteria not met|0|||
23448109|NCT01384734|65384499|FG000|Overall Study|Lack of Efficacy|3|||
23448110|NCT01384734|65384500|FG001|Overall Study|Lack of Efficacy|7|||
23448111|NCT01384734|65384501|FG002|Overall Study|Lack of Efficacy|4|||
23448112|NCT01384734|65384502|FG003|Overall Study|Lack of Efficacy|4|||
23448113|NCT01384734|65384503|FG004|Overall Study|Lack of Efficacy|2|||
23448114|NCT01384734|65384499|FG000|Overall Study|Lost to Follow-up|5|||
23448115|NCT01384734|65384500|FG001|Overall Study|Lost to Follow-up|3|||
23448116|NCT01384734|65384501|FG002|Overall Study|Lost to Follow-up|3|||
23448117|NCT01384734|65384502|FG003|Overall Study|Lost to Follow-up|8|||
23448118|NCT01384734|65384503|FG004|Overall Study|Lost to Follow-up|5|||
23448119|NCT01384734|65384499|FG000|Overall Study|Non-compliance with study drug|1|||
23448120|NCT01384734|65384500|FG001|Overall Study|Non-compliance with study drug|2|||
23448121|NCT01384734|65384501|FG002|Overall Study|Non-compliance with study drug|6|||
23448122|NCT01384734|65384502|FG003|Overall Study|Non-compliance with study drug|0|||
23448123|NCT01384734|65384503|FG004|Overall Study|Non-compliance with study drug|2|||
23448124|NCT01384734|65384499|FG000|Overall Study|Pregnancy|0|||
23448125|NCT01384734|65384500|FG001|Overall Study|Pregnancy|1|||
23448126|NCT01384734|65384501|FG002|Overall Study|Pregnancy|0|||
23448127|NCT01384734|65384502|FG003|Overall Study|Pregnancy|0|||
23448128|NCT01384734|65384503|FG004|Overall Study|Pregnancy|1|||
23448129|NCT01384734|65384499|FG000|Overall Study|Sponsor terminated|0|||
23448130|NCT01384734|65384500|FG001|Overall Study|Sponsor terminated|0|||
23448131|NCT01384734|65384501|FG002|Overall Study|Sponsor terminated|0|||
23448132|NCT01384734|65384502|FG003|Overall Study|Sponsor terminated|0|||
23448133|NCT01384734|65384503|FG004|Overall Study|Sponsor terminated|1|||
23448134|NCT01384734|65384499|FG000|Overall Study|Withdrawal by Subject|5|||
23448135|NCT01384734|65384500|FG001|Overall Study|Withdrawal by Subject|5|||
23448136|NCT01384734|65384501|FG002|Overall Study|Withdrawal by Subject|6|||
23448137|NCT01384734|65384502|FG003|Overall Study|Withdrawal by Subject|7|||
23448138|NCT01384734|65384503|FG004|Overall Study|Withdrawal by Subject|9|||
23448139|NCT01384734|65384499|FG000|Overall Study|Investigator relocating|0|||
23448140|NCT01384734|65384500|FG001|Overall Study|Investigator relocating|2|||
23448141|NCT01384734|65384501|FG002|Overall Study|Investigator relocating|0|||
23448142|NCT01384734|65384502|FG003|Overall Study|Investigator relocating|3|||
23448143|NCT01384734|65384503|FG004|Overall Study|Investigator relocating|1|||
23448144|NCT01384734|65384499|FG000|Overall Study|Unable to come back for visit|1|||
23448145|NCT01384734|65384500|FG001|Overall Study|Unable to come back for visit|0|||
23448146|NCT01384734|65384501|FG002|Overall Study|Unable to come back for visit|1|||
23448147|NCT01384734|65384502|FG003|Overall Study|Unable to come back for visit|1|||
23448148|NCT01384734|65384503|FG004|Overall Study|Unable to come back for visit|0|||
23448149|NCT01384734|65384499|FG000|Overall Study|Prison|0|||
23448150|NCT01384734|65384500|FG001|Overall Study|Prison|0|||
23335564|NCT00652626|64972939|FG002|Extension Phase|Adverse Event|0|||
23335565|NCT00652626|64972940|FG003|Extension Phase|Adverse Event|0|||
23335566|NCT00652626|64972941|FG004|Extension Phase|Adverse Event|0|||
23335567|NCT00652626|64972942|FG005|Extension Phase|Adverse Event|2|||
23448151|NCT01384734|65384501|FG002|Overall Study|Prison|1|||
23448152|NCT01384734|65384502|FG003|Overall Study|Prison|0|||
23448153|NCT01384734|65384503|FG004|Overall Study|Prison|0|||
23448154|NCT01384734|65384499|FG000|Overall Study|As per Exclusion criteria|0|||
23448155|NCT01384734|65384500|FG001|Overall Study|As per Exclusion criteria|1|||
23448156|NCT01384734|65384501|FG002|Overall Study|As per Exclusion criteria|0|||
23448157|NCT01384734|65384502|FG003|Overall Study|As per Exclusion criteria|0|||
23448158|NCT01384734|65384503|FG004|Overall Study|As per Exclusion criteria|0|||
23448159|NCT01384734|65384499|FG000|Overall Study|Missed End of treatment visit|0|||
23448160|NCT01384734|65384500|FG001|Overall Study|Missed End of treatment visit|0|||
23448161|NCT01384734|65384501|FG002|Overall Study|Missed End of treatment visit|0|||
23448162|NCT01384734|65384502|FG003|Overall Study|Missed End of treatment visit|1|||
23448163|NCT01384734|65384503|FG004|Overall Study|Missed End of treatment visit|0|||
23448164|NCT01384734|65384499|FG000|Overall Study|Adhesion problem|0|||
23448165|NCT01384734|65384500|FG001|Overall Study|Adhesion problem|0|||
23448166|NCT01384734|65384501|FG002|Overall Study|Adhesion problem|0|||
23448167|NCT01384734|65384502|FG003|Overall Study|Adhesion problem|1|||
23448168|NCT01384734|65384503|FG004|Overall Study|Adhesion problem|0|||
23448169|NCT01384734|65384499|FG000|Overall Study|Early termination|0|||
23448170|NCT01384734|65384500|FG001|Overall Study|Early termination|0|||
23448171|NCT01384734|65384501|FG002|Overall Study|Early termination|0|||
23168828|NCT01324232|64363270|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
23168829|NCT01324232|64363271|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
23168830|NCT01324232|64363272|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
23168831|NCT01324232|64363273|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
23168832|NCT01324232|64363270|FG000|Overall Study|Lack of Efficacy|2|||
23168833|NCT01324232|64363271|FG001|Overall Study|Lack of Efficacy|1|||
23168834|NCT01324232|64363272|FG002|Overall Study|Lack of Efficacy|2|||
23168835|NCT01324232|64363273|FG003|Overall Study|Lack of Efficacy|2|||
23168836|NCT01324232|64363270|FG000|Overall Study|Participant Refused Medication|0|||
23168837|NCT01324232|64363271|FG001|Overall Study|Participant Refused Medication|1|||
23168838|NCT01324232|64363272|FG002|Overall Study|Participant Refused Medication|0|||
23168839|NCT01324232|64363273|FG003|Overall Study|Participant Refused Medication|0|||
23168840|NCT01324232|64363270|FG000|Overall Study|Intercurrent illness|0|||
23168841|NCT01324232|64363271|FG001|Overall Study|Intercurrent illness|0|||
23168842|NCT01324232|64363272|FG002|Overall Study|Intercurrent illness|0|||
23168843|NCT01324232|64363273|FG003|Overall Study|Intercurrent illness|1|||
23168844|NCT01324232|64363270|FG000|Overall Study|Adverse Event|2|||
23168845|NCT01324232|64363271|FG001|Overall Study|Adverse Event|5|||
23168846|NCT01324232|64363272|FG002|Overall Study|Adverse Event|6|||
23168847|NCT01324232|64363273|FG003|Overall Study|Adverse Event|6|||
23168848|NCT01324232|64363270|FG000|Overall Study|Withdrawal by Subject|0|||
23168849|NCT01324232|64363271|FG001|Overall Study|Withdrawal by Subject|3|||
23168850|NCT01324232|64363272|FG002|Overall Study|Withdrawal by Subject|4|||
23168851|NCT01324232|64363273|FG003|Overall Study|Withdrawal by Subject|0|||
23168852|NCT01324232|64363270|FG000|Overall Study|Lost to Follow-up|1|||
23168853|NCT01324232|64363271|FG001|Overall Study|Lost to Follow-up|0|||
23168854|NCT01324232|64363272|FG002|Overall Study|Lost to Follow-up|0|||
23335568|NCT00652626|64972943|FG006|Extension Phase|Adverse Event|1|||
23335569|NCT00652626|64972937|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23448172|NCT01384734|65384502|FG003|Overall Study|Early termination|0|||
23448173|NCT01384734|65384503|FG004|Overall Study|Early termination|1|||
23448174|NCT01384734|65384499|FG000|Overall Study|Physician Decision|1|||
23448175|NCT01384734|65384500|FG001|Overall Study|Physician Decision|0|||
23448176|NCT01384734|65384501|FG002|Overall Study|Physician Decision|0|||
23448177|NCT01384734|65384502|FG003|Overall Study|Physician Decision|0|||
23168855|NCT01324232|64363273|FG003|Overall Study|Lost to Follow-up|0|||
23168856|NCT02678390|64363281|FG000|AE (1 Day)|Withdrawal by Subject|0|||
23168857|NCT02678390|64363282|FG001|AE (1 Day)|Withdrawal by Subject|1|||
23335570|NCT00652626|64972938|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23335571|NCT00652626|64972939|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23448178|NCT01384734|65384503|FG004|Overall Study|Physician Decision|0|||
23448179|NCT01271725|65384516|FG000|Part A|Progressive disease according to RECIST|8|||
23448180|NCT01271725|65384517|FG001|Part A|Progressive disease according to RECIST|0|||
23448181|NCT01271725|65384516|FG000|Part A|Clinical signs/symptoms of progression|2|||
23448182|NCT01271725|65384517|FG001|Part A|Clinical signs/symptoms of progression|0|||
23448183|NCT01271725|65384516|FG000|Part A|Other Adverse Event|8|||
23448184|NCT01271725|65384517|FG001|Part A|Other Adverse Event|0|||
23448185|NCT01271725|65384516|FG000|Part A|Lost to Follow-up|1|||
23448186|NCT01271725|65384517|FG001|Part A|Lost to Follow-up|0|||
23168858|NCT01500057|64363285|FG000|Overall Study|Lost to Follow-up|6|||
23168859|NCT01500057|64363286|FG001|Overall Study|Lost to Follow-up|4|||
23448187|NCT01271725|65384516|FG000|Part A|Withdrawal by Subject|12|||
23448188|NCT01271725|65384517|FG001|Part A|Withdrawal by Subject|0|||
23448189|NCT01271725|65384516|FG000|Part A|Other than specified|3|||
23335572|NCT00652626|64972940|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23335573|NCT00652626|64972941|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23335574|NCT00652626|64972942|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
23335575|NCT00652626|64972943|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
23448190|NCT01271725|65384517|FG001|Part A|Other than specified|0|||
23448191|NCT01271725|65384516|FG000|Part A|Protocol Violation|1|||
23448192|NCT01271725|65384517|FG001|Part A|Protocol Violation|0|||
23448193|NCT01271725|65384516|FG000|Part B|Other than specified|0|||
23448194|NCT01271725|65384517|FG001|Part B|Other than specified|2|||
23335576|NCT00652626|64972937|FG000|Extension Phase|Physician Decision|0|||
23335577|NCT00652626|64972938|FG001|Extension Phase|Physician Decision|0|||
23335578|NCT00652626|64972939|FG002|Extension Phase|Physician Decision|0|||
23335579|NCT00652626|64972940|FG003|Extension Phase|Physician Decision|0|||
23448195|NCT01271725|65384516|FG000|Part B|Clinical signs/symptoms of progression|0|||
23448196|NCT01271725|65384517|FG001|Part B|Clinical signs/symptoms of progression|2|||
23448197|NCT01271725|65384516|FG000|Part B|Other Adverse Event|0|||
23448198|NCT01271725|65384517|FG001|Part B|Other Adverse Event|1|||
23448199|NCT01271725|65384516|FG000|Part B|Protocol Violation|0|||
23448200|NCT01271725|65384517|FG001|Part B|Protocol Violation|1|||
23448201|NCT01271725|65384516|FG000|Part B|Withdrawal by Subject|0|||
23448202|NCT01271725|65384517|FG001|Part B|Withdrawal by Subject|6|||
23448203|NCT02442349|65384518|FG000|Overall Study|Death|14|||
23448204|NCT02442349|65384518|FG000|Overall Study|Withdrawal by Subject|8|||
23448205|NCT02442349|65384518|FG000|Overall Study|On-going Study at Data Cut-off|149|||
23448206|NCT03571204|65384519|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
23448207|NCT03571204|65384520|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
23448208|NCT03571204|65384521|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
23448209|NCT03571204|65384519|FG000|Overall Study|Physician Decision|0|||
23448210|NCT03571204|65384520|FG001|Overall Study|Physician Decision|1|||
23448211|NCT03571204|65384521|FG002|Overall Study|Physician Decision|0|||
23448212|NCT03535974|65384526|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
23448213|NCT03535974|65384527|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
23448214|NCT03535974|65384528|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
23448215|NCT03535974|65384526|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
23448216|NCT03535974|65384527|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
23448217|NCT03535974|65384528|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
23448218|NCT01358825|65384532|FG000|Overall Study|Blood sample not drawn|0|||
23448219|NCT01358825|65384533|FG001|Overall Study|Blood sample not drawn|1|||
23168860|NCT02867761|64363287|FG000|Overall Study|Participant withdrawn by investigator|0|||
23168861|NCT02867761|64363288|FG001|Overall Study|Participant withdrawn by investigator|1|||
23168862|NCT02867761|64363287|FG000|Overall Study|Lost to Follow-up|25|||
23335580|NCT00652626|64972941|FG004|Extension Phase|Physician Decision|0|||
23335581|NCT00652626|64972942|FG005|Extension Phase|Physician Decision|1|||
23335582|NCT00652626|64972943|FG006|Extension Phase|Physician Decision|1|||
23335583|NCT00652626|64972937|FG000|Extension Phase|Death|0|||
23335584|NCT00652626|64972938|FG001|Extension Phase|Death|0|||
23335585|NCT00652626|64972939|FG002|Extension Phase|Death|0|||
23335586|NCT00652626|64972940|FG003|Extension Phase|Death|0|||
23335587|NCT00652626|64972941|FG004|Extension Phase|Death|0|||
23335588|NCT00652626|64972942|FG005|Extension Phase|Death|1|||
23335589|NCT00652626|64972943|FG006|Extension Phase|Death|1|||
23335590|NCT02411448|64972946|FG000|Overall Study|Withdrawal by Subject|1|||
23335591|NCT02411448|64972947|FG001|Overall Study|Withdrawal by Subject|14|||
23335592|NCT02411448|64972948|FG002|Overall Study|Withdrawal by Subject|9|||
23335593|NCT02411448|64972946|FG000|Overall Study|Other|0|||
23335594|NCT02411448|64972947|FG001|Overall Study|Other|2|||
23335595|NCT02411448|64972948|FG002|Overall Study|Other|0|||
23335596|NCT02411448|64972946|FG000|Overall Study|Did not receive study treatment|0|||
23335597|NCT02411448|64972947|FG001|Overall Study|Did not receive study treatment|3|||
23335598|NCT02411448|64972948|FG002|Overall Study|Did not receive study treatment|0|||
23335599|NCT02411448|64972946|FG000|Overall Study|Alive on study treatment|3|||
23335600|NCT02411448|64972947|FG001|Overall Study|Alive on study treatment|64|||
23335601|NCT02411448|64972948|FG002|Overall Study|Alive on study treatment|43|||
23335602|NCT02737930|64972949|FG000|Overall Study|Withdrawal by Subject|0|||
23335603|NCT02737930|64972950|FG001|Overall Study|Withdrawal by Subject|1|||
23335604|NCT01077154|64972951|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
23448220|NCT03649217|65384534|FG000|Overall Study|subject had severe ataxia not initially found|1|||
23448221|NCT03649217|65384534|FG000|Overall Study|subject had cognitive issues not initially found|1|||
23448222|NCT02544503|65384541|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
23335605|NCT01077154|64972952|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
23335606|NCT01077154|64972951|FG000|Overall Study|Withdrawal by Subject|369|||
23335607|NCT01077154|64972952|FG001|Overall Study|Withdrawal by Subject|385|||
23335608|NCT01077154|64972951|FG000|Overall Study|Death|215|||
23335609|NCT01077154|64972952|FG001|Overall Study|Death|214|||
23335610|NCT01077154|64972951|FG000|Overall Study|Lost to Follow-up|43|||
23335611|NCT01077154|64972952|FG001|Overall Study|Lost to Follow-up|35|||
23335612|NCT01077154|64972951|FG000|Overall Study|Noncompliance|22|||
23335613|NCT01077154|64972952|FG001|Overall Study|Noncompliance|20|||
23335614|NCT01077154|64972951|FG000|Overall Study|Disease Progression|18|||
23335615|NCT01077154|64972952|FG001|Overall Study|Disease Progression|20|||
23335616|NCT01077154|64972951|FG000|Overall Study|Ineligibility Determined|10|||
23335617|NCT01077154|64972952|FG001|Overall Study|Ineligibility Determined|14|||
23335618|NCT01077154|64972951|FG000|Overall Study|Other|14|||
23335619|NCT01077154|64972952|FG001|Overall Study|Other|11|||
23448223|NCT02544503|65384542|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
23448224|NCT02544503|65384541|FG000|Overall Study|Lost to Follow-up|9|||
23448225|NCT02544503|65384542|FG001|Overall Study|Lost to Follow-up|0|||
23335620|NCT01077154|64972951|FG000|Overall Study|Adverse Event|9|||
23335621|NCT01077154|64972952|FG001|Overall Study|Adverse Event|9|||
23335622|NCT01077154|64972951|FG000|Overall Study|Administrative Decision|1|||
23335623|NCT01077154|64972952|FG001|Overall Study|Administrative Decision|6|||
23335624|NCT01077154|64972951|FG000|Overall Study|Protocol Deviation|1|||
23335625|NCT01077154|64972952|FG001|Overall Study|Protocol Deviation|0|||
23335626|NCT03991299|64972954|FG000|Overall Study|Study closed, sponsor decision|3|||
23335627|NCT03991299|64972954|FG000|Overall Study|Withdrawal by Subject|1|||
23335628|NCT00959374|64972958|FG000|Overall Study|Withdrawal by Subject|2|||
23335629|NCT00959374|64972958|FG000|Overall Study|Lost to Follow-up|14|||
23335630|NCT00959374|64972958|FG000|Overall Study|Death|1|||
23335631|NCT00959374|64972958|FG000|Overall Study|Protocol Violation|1|||
23335632|NCT00959374|64972958|FG000|Overall Study|Implant Removed/Not Replaced|4|||
23335633|NCT00959374|64972958|FG000|Overall Study|Physician Decision|1|||
23335634|NCT00877487|64972961|FG000|Open-label Treatment Phase|Adverse Event|1|||
23335635|NCT00877487|64972962|FG001|Open-label Treatment Phase|Adverse Event|0|||
23335636|NCT00877487|64972961|FG000|Open-label Treatment Phase|Protocol Violation|3|||
23335637|NCT00877487|64972962|FG001|Open-label Treatment Phase|Protocol Violation|0|||
23335638|NCT00877487|64972961|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
23335639|NCT00877487|64972962|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
23335640|NCT00877487|64972961|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
23335641|NCT00877487|64972962|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
23335642|NCT00877487|64972961|FG000|Open-label Treatment Phase|Out of country for business|1|||
23448226|NCT02544503|65384541|FG000|Overall Study|Withdrawal by Subject|1|||
23448227|NCT02544503|65384542|FG001|Overall Study|Withdrawal by Subject|0|||
23448228|NCT00584012|65384547|FG000|Overall Study|Withdrawal by Subject|1|||
23448229|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
23448230|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
23448231|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
23448232|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
23448233|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
23448234|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
23335643|NCT00877487|64972962|FG001|Open-label Treatment Phase|Out of country for business|0|||
23335644|NCT00877487|64972961|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
23335645|NCT00877487|64972962|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
23335646|NCT00877487|64972961|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
23335647|NCT00877487|64972962|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
23335648|NCT00877487|64972961|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
23335649|NCT00877487|64972962|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
23335650|NCT00877487|64972961|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
23335651|NCT00877487|64972962|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
23335652|NCT04967885|64972966|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
23335653|NCT04967885|64972967|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
23448235|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
23448236|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
23335654|NCT04967885|64972966|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
23335655|NCT04967885|64972967|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
23335656|NCT04967885|64972966|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
23335657|NCT04967885|64972967|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
23335658|NCT04967885|64972966|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
23335659|NCT04967885|64972967|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
23335660|NCT04967885|64972966|FG000|EMI-II Intervention|Lost to Follow-up|14|||
23335661|NCT04967885|64972967|FG001|EMI-II Intervention|Lost to Follow-up|10|||
23448237|NCT01987102|65384548|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
23335662|NCT02498444|64972970|FG000|Overall Study|Withdrawal by Subject|3|||
23335663|NCT02498444|64972971|FG001|Overall Study|Withdrawal by Subject|0|||
23335664|NCT02498444|64972970|FG000|Overall Study|Physician Decision|1|||
23335665|NCT02498444|64972971|FG001|Overall Study|Physician Decision|0|||
23335666|NCT02844543|64972977|FG000|Overall Study|Withdrawal by Subject|4|||
23335667|NCT02844543|64972977|FG000|Overall Study|Did not meet eligibility criteria|1|||
23335668|NCT01136356|64972978|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
23335669|NCT01136356|64972979|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
23335670|NCT01136356|64972978|FG000|First 18-day Withdrawal|Physician Decision|1|||
23335671|NCT01136356|64972979|FG001|First 18-day Withdrawal|Physician Decision|0|||
23335672|NCT01136356|64972978|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
23335673|NCT01136356|64972979|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
23335674|NCT00977080|64972983|FG000|Overall Study|Adverse Event|2|||
23335675|NCT00977080|64972984|FG001|Overall Study|Adverse Event|7|||
23448238|NCT01987102|65384549|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
23448239|NCT01987102|65384548|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
23448240|NCT01987102|65384549|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
23448241|NCT01400698|65384551|FG000|Overall Study|Lost to Follow-up|2|||
23448242|NCT01400698|65384552|FG001|Overall Study|Lost to Follow-up|5|||
23448243|NCT01400698|65384553|FG002|Overall Study|Lost to Follow-up|2|||
23448244|NCT01400698|65384554|FG003|Overall Study|Lost to Follow-up|1|||
23448245|NCT01400698|65384555|FG004|Overall Study|Lost to Follow-up|4|||
23448246|NCT01400698|65384556|FG005|Overall Study|Lost to Follow-up|3|||
23448247|NCT01400698|65384551|FG000|Overall Study|Withdrawal by Subject|8|||
23448248|NCT01400698|65384552|FG001|Overall Study|Withdrawal by Subject|2|||
23448249|NCT01400698|65384553|FG002|Overall Study|Withdrawal by Subject|0|||
23448250|NCT01400698|65384554|FG003|Overall Study|Withdrawal by Subject|4|||
23448251|NCT01400698|65384555|FG004|Overall Study|Withdrawal by Subject|1|||
23448252|NCT01400698|65384556|FG005|Overall Study|Withdrawal by Subject|3|||
23448253|NCT01400698|65384551|FG000|Overall Study|Protocol Violation|0|||
23448254|NCT01400698|65384552|FG001|Overall Study|Protocol Violation|1|||
23448255|NCT01400698|65384553|FG002|Overall Study|Protocol Violation|0|||
23448256|NCT01400698|65384554|FG003|Overall Study|Protocol Violation|0|||
23448257|NCT01400698|65384555|FG004|Overall Study|Protocol Violation|1|||
23448258|NCT01400698|65384556|FG005|Overall Study|Protocol Violation|0|||
23448259|NCT01400698|65384551|FG000|Overall Study|Non-compliance|0|||
23448260|NCT01400698|65384552|FG001|Overall Study|Non-compliance|1|||
23448261|NCT01400698|65384553|FG002|Overall Study|Non-compliance|0|||
23448262|NCT01400698|65384554|FG003|Overall Study|Non-compliance|1|||
23448263|NCT01400698|65384555|FG004|Overall Study|Non-compliance|0|||
23448264|NCT01400698|65384556|FG005|Overall Study|Non-compliance|0|||
23448265|NCT01400698|65384551|FG000|Overall Study|Adverse Event|1|||
23448266|NCT01400698|65384552|FG001|Overall Study|Adverse Event|0|||
23448267|NCT01400698|65384553|FG002|Overall Study|Adverse Event|0|||
23448268|NCT01400698|65384554|FG003|Overall Study|Adverse Event|0|||
23448269|NCT01400698|65384555|FG004|Overall Study|Adverse Event|0|||
23448270|NCT01400698|65384556|FG005|Overall Study|Adverse Event|0|||
23448271|NCT01400698|65384551|FG000|Overall Study|Other|4|||
23448272|NCT01400698|65384552|FG001|Overall Study|Other|2|||
23448273|NCT01400698|65384553|FG002|Overall Study|Other|0|||
23448274|NCT01400698|65384554|FG003|Overall Study|Other|2|||
23448275|NCT01400698|65384555|FG004|Overall Study|Other|1|||
23448276|NCT01400698|65384556|FG005|Overall Study|Other|0|||
23448277|NCT01879683|65384557|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
23448278|NCT00255190|65384563|FG000|Overall Study|Adverse Event|17|||
23448279|NCT00255190|65384564|FG001|Overall Study|Adverse Event|36|||
23448280|NCT00255190|65384563|FG000|Overall Study|Protocol Violation|2|||
23448281|NCT00255190|65384564|FG001|Overall Study|Protocol Violation|2|||
23448282|NCT00255190|65384563|FG000|Overall Study|Lost to Follow-up|10|||
23576273|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
23576274|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Other Medical|9|||
23576275|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Other Medical|5|||
23576276|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Disease Progression|4|||
23335676|NCT00977080|64972985|FG002|Overall Study|Adverse Event|7|||
23335677|NCT00977080|64972986|FG003|Overall Study|Adverse Event|7|||
23335678|NCT00977080|64972983|FG000|Overall Study|Withdrawal by Subject|1|||
23335679|NCT00977080|64972984|FG001|Overall Study|Withdrawal by Subject|5|||
23448283|NCT00255190|65384564|FG001|Overall Study|Lost to Follow-up|27|||
23448284|NCT00255190|65384563|FG000|Overall Study|Withdrew Consent|17|||
23448285|NCT00255190|65384564|FG001|Overall Study|Withdrew Consent|48|||
23448286|NCT00255190|65384563|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
23448287|NCT00255190|65384564|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
23448288|NCT00255190|65384563|FG000|Overall Study|Erosive esophagitis not healed|0|||
23448289|NCT00255190|65384564|FG001|Overall Study|Erosive esophagitis not healed|20|||
23448290|NCT00255190|65384563|FG000|Overall Study|Various|4|||
23448291|NCT00255190|65384564|FG001|Overall Study|Various|23|||
23448292|NCT00619515|65384565|FG000|Overall Study|Study Termination by IRB|73|||
23576277|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Disease Progression|2|||
23448293|NCT00871871|65384567|FG000|Part I|Adverse Event|0|||
23448294|NCT00871871|65384568|FG001|Part I|Adverse Event|2|||
23448295|NCT00871871|65384569|FG002|Part I|Adverse Event|0|||
23448296|NCT00871871|65384570|FG003|Part I|Adverse Event|0|||
23448297|NCT00871871|65384567|FG000|Part I|Withdrawal by Subject|3|||
23448298|NCT00871871|65384568|FG001|Part I|Withdrawal by Subject|0|||
23448299|NCT00871871|65384569|FG002|Part I|Withdrawal by Subject|0|||
23448300|NCT00871871|65384570|FG003|Part I|Withdrawal by Subject|0|||
23448301|NCT00871871|65384567|FG000|Part I|Laboratory abnormality|0|||
23448302|NCT00871871|65384568|FG001|Part I|Laboratory abnormality|1|||
23448303|NCT00871871|65384569|FG002|Part I|Laboratory abnormality|0|||
23448304|NCT00871871|65384570|FG003|Part I|Laboratory abnormality|0|||
23448305|NCT00871871|65384567|FG000|Part II|Lack of Efficacy|0|||
23448306|NCT00871871|65384568|FG001|Part II|Lack of Efficacy|0|||
23448307|NCT00871871|65384569|FG002|Part II|Lack of Efficacy|1|||
23448308|NCT00871871|65384570|FG003|Part II|Lack of Efficacy|0|||
23448309|NCT00871871|65384567|FG000|Part II|Withdrawal by Subject|0|||
23448310|NCT00871871|65384568|FG001|Part II|Withdrawal by Subject|0|||
23448311|NCT00871871|65384569|FG002|Part II|Withdrawal by Subject|2|||
23448312|NCT00871871|65384570|FG003|Part II|Withdrawal by Subject|1|||
23448313|NCT00871871|65384567|FG000|Part II|Adverse Event|0|||
23448314|NCT00871871|65384568|FG001|Part II|Adverse Event|0|||
23448315|NCT00871871|65384569|FG002|Part II|Adverse Event|1|||
23448316|NCT00871871|65384570|FG003|Part II|Adverse Event|2|||
23448317|NCT00871871|65384567|FG000|Part II|Protocol Violation|0|||
23448318|NCT00871871|65384568|FG001|Part II|Protocol Violation|0|||
23448319|NCT00871871|65384569|FG002|Part II|Protocol Violation|0|||
23448320|NCT00871871|65384570|FG003|Part II|Protocol Violation|1|||
23448321|NCT02734693|65384571|FG000|Overall Study|Adverse Event|1|||
23448322|NCT02734693|65384572|FG001|Overall Study|Adverse Event|3|||
23448323|NCT02734693|65384573|FG002|Overall Study|Adverse Event|3|||
23448324|NCT02734693|65384571|FG000|Overall Study|Lack of Efficacy|1|||
23448325|NCT02734693|65384572|FG001|Overall Study|Lack of Efficacy|0|||
23335680|NCT00977080|64972985|FG002|Overall Study|Withdrawal by Subject|1|||
23335681|NCT00977080|64972986|FG003|Overall Study|Withdrawal by Subject|5|||
23335682|NCT00977080|64972983|FG000|Overall Study|Protocol Violation|7|||
23335683|NCT00977080|64972984|FG001|Overall Study|Protocol Violation|3|||
23448326|NCT02734693|65384573|FG002|Overall Study|Lack of Efficacy|0|||
23448327|NCT02734693|65384571|FG000|Overall Study|Lost to Follow-up|2|||
23448328|NCT02734693|65384572|FG001|Overall Study|Lost to Follow-up|0|||
23448329|NCT02734693|65384573|FG002|Overall Study|Lost to Follow-up|0|||
23448330|NCT02734693|65384571|FG000|Overall Study|Protocol Violation|1|||
23448331|NCT02734693|65384572|FG001|Overall Study|Protocol Violation|0|||
23448332|NCT02734693|65384573|FG002|Overall Study|Protocol Violation|0|||
23576278|NCT02107443|65839026|FG000|Overall Study|Withdrawal: Personal Issues|0|||
23576279|NCT02107443|65839027|FG001|Overall Study|Withdrawal: Personal Issues|3|||
23576280|NCT00765362|65839028|FG000|Overall Study|Death|9|||
23576281|NCT00765362|65839028|FG000|Overall Study|Adverse Event|2|||
23576282|NCT00765362|65839028|FG000|Overall Study|Protocol Violation|18|||
23576283|NCT00765362|65839028|FG000|Overall Study|Withdrawal by Subject|13|||
23576284|NCT00765362|65839028|FG000|Overall Study|Lost to Follow-up|95|||
23576285|NCT02025205|65839029|FG000|Overall Study|Withdrawal by Subject|1|||
23576286|NCT02025205|65839030|FG001|Overall Study|Withdrawal by Subject|1|||
23576287|NCT02025205|65839029|FG000|Overall Study|Protocol Violation|2|||
23576288|NCT02025205|65839030|FG001|Overall Study|Protocol Violation|1|||
23576289|NCT02025205|65839029|FG000|Overall Study|Death|0|||
23576290|NCT02025205|65839030|FG001|Overall Study|Death|1|||
23576291|NCT03000673|65839031|FG000|Overall Study|Withdrawal by Subject|1|||
23576292|NCT03000673|65839032|FG001|Overall Study|Withdrawal by Subject|0|||
23576293|NCT03000673|65839033|FG002|Overall Study|Withdrawal by Subject|0|||
23576294|NCT03000673|65839034|FG003|Overall Study|Withdrawal by Subject|0|||
23576295|NCT01290094|65843326|FG000|Overall Study|Withdrawal by Subject|1|||
23576296|NCT01290094|65843326|FG000|Overall Study|Lost to Follow-up|5|||
23576297|NCT03212365|65843342|FG000|Overall Study|Discharged prior to Xa level|12|||
23576298|NCT03212365|65843343|FG001|Overall Study|Discharged prior to Xa level|8|||
23576299|NCT03212365|65843342|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
23576300|NCT03212365|65843343|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
23168863|NCT02867761|64363288|FG001|Overall Study|Lost to Follow-up|18|||
23335684|NCT00977080|64972985|FG002|Overall Study|Protocol Violation|4|||
23448333|NCT02734693|65384571|FG000|Overall Study|Withdrawal by Subject|1|||
23448334|NCT02734693|65384572|FG001|Overall Study|Withdrawal by Subject|0|||
23448335|NCT02734693|65384573|FG002|Overall Study|Withdrawal by Subject|0|||
23448336|NCT02354235|65384577|FG000|Overall Study|Adverse Event|2|||
23448337|NCT02354235|65384578|FG001|Overall Study|Adverse Event|2|||
23448338|NCT02354235|65384577|FG000|Overall Study|Physician Decision|0|||
23448339|NCT02354235|65384578|FG001|Overall Study|Physician Decision|1|||
23448340|NCT02354235|65384577|FG000|Overall Study|Withdrawal by Subject|1|||
23448341|NCT02354235|65384578|FG001|Overall Study|Withdrawal by Subject|3|||
23448342|NCT02354235|65384577|FG000|Overall Study|Conflict with the stopping criteria|0|||
23448343|NCT02354235|65384578|FG001|Overall Study|Conflict with the stopping criteria|1|||
23335685|NCT00977080|64972986|FG003|Overall Study|Protocol Violation|3|||
23228015|NCT02442765|64577994|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23228016|NCT02442765|64577995|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
23228017|NCT02442765|64577996|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
23228018|NCT02442765|64577997|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
23228019|NCT02442765|64577990|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23228020|NCT02442765|64577991|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23228021|NCT02442765|64577992|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23228022|NCT02442765|64577993|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
23228023|NCT02442765|64577994|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23335686|NCT00977080|64972983|FG000|Overall Study|Noncompliance|0|||
23576301|NCT03212365|65843342|FG000|Overall Study|Refused study medication|3|||
23576302|NCT03212365|65843343|FG001|Overall Study|Refused study medication|0|||
23576303|NCT03212365|65843342|FG000|Overall Study|Initiated heparin infusion on floor|1|||
23576304|NCT03212365|65843343|FG001|Overall Study|Initiated heparin infusion on floor|1|||
23576305|NCT03212365|65843342|FG000|Overall Study|Unexpected return to OR|1|||
23168864|NCT02867761|64363287|FG000|Overall Study|Unable to complete protocol|3|||
23168865|NCT02867761|64363288|FG001|Overall Study|Unable to complete protocol|7|||
23168866|NCT02229552|64363289|FG000|Baseline|Withdrawal by Subject|6|||
23168867|NCT02229552|64363289|FG000|1-year Follow up|Withdrawal by Subject|7|||
23168868|NCT02229552|64363289|FG000|1-year Follow up|Lost to Follow-up|18|||
23168869|NCT02229552|64363289|FG000|2-Year Follow up|Withdrawal by Subject|9|||
23168870|NCT02229552|64363289|FG000|2-Year Follow up|Lost to Follow-up|17|||
23168871|NCT03713944|64363291|FG000|Study Treatment|Patient non-compliance|1|||
23168872|NCT03713944|64363291|FG000|Study Treatment|Alternative Cancer Therapy|3|||
23168873|NCT03713944|64363291|FG000|Study Treatment|Disease Progression|18|||
23168874|NCT03713944|64363291|FG000|Study Treatment|AE/Side Effects/Complications|2|||
23168875|NCT03713944|64363291|FG000|Study Treatment|Death|2|||
23228024|NCT02442765|64577995|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
23228025|NCT02442765|64577996|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
23576306|NCT03212365|65843343|FG001|Overall Study|Unexpected return to OR|1|||
23576307|NCT03212365|65843342|FG000|Overall Study|Medication distribution error|1|||
23335687|NCT00977080|64972984|FG001|Overall Study|Noncompliance|2|||
23335688|NCT00977080|64972985|FG002|Overall Study|Noncompliance|1|||
23335689|NCT00977080|64972986|FG003|Overall Study|Noncompliance|0|||
23335690|NCT00977080|64972983|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
23335691|NCT00977080|64972984|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
23335692|NCT00977080|64972985|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
23335693|NCT00977080|64972986|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
23335694|NCT00977080|64972983|FG000|Overall Study|Required kidney transplantation|1|||
23335695|NCT00977080|64972984|FG001|Overall Study|Required kidney transplantation|3|||
23335696|NCT00977080|64972985|FG002|Overall Study|Required kidney transplantation|3|||
23335697|NCT00977080|64972986|FG003|Overall Study|Required kidney transplantation|1|||
23335698|NCT00977080|64972983|FG000|Overall Study|Travel for family reasons|1|||
23335699|NCT00977080|64972984|FG001|Overall Study|Travel for family reasons|0|||
23335700|NCT00977080|64972985|FG002|Overall Study|Travel for family reasons|0|||
23335701|NCT00977080|64972986|FG003|Overall Study|Travel for family reasons|0|||
23335702|NCT00656292|64972987|FG000|Overall Study|Withdrawal by Subject|2|||
23335703|NCT00656292|64972988|FG001|Overall Study|Withdrawal by Subject|3|||
23335704|NCT00656292|64972987|FG000|Overall Study|Screen failure|1|||
23335705|NCT00656292|64972988|FG001|Overall Study|Screen failure|2|||
23335706|NCT01163851|64972990|FG000|Overall Study|Site Closure|0|||
23335707|NCT01163851|64972991|FG001|Overall Study|Site Closure|1|||
23335708|NCT01163851|64972990|FG000|Overall Study|Enrolled but not treated|1|||
23335709|NCT01163851|64972991|FG001|Overall Study|Enrolled but not treated|0|||
23335710|NCT00566020|64972992|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
23576308|NCT03212365|65843343|FG001|Overall Study|Medication distribution error|0|||
23576309|NCT03212365|65843342|FG000|Overall Study|Required epidural placement|1|||
23335711|NCT00566020|64972993|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
23335712|NCT00566020|64972992|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
23335713|NCT00566020|64972993|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
23335714|NCT00566020|64972992|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
23335715|NCT00566020|64972993|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
23576310|NCT03212365|65843343|FG001|Overall Study|Required epidural placement|0|||
23335716|NCT00566020|64972992|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
23335717|NCT00566020|64972993|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
23335718|NCT00566020|64972992|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
23576311|NCT03212365|65843342|FG000|Overall Study|Withdrawal by Subject|0|||
23168876|NCT03713944|64363291|FG000|Study Treatment|Withdrawal by Subject|1|||
23168877|NCT03713944|64363291|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
23335719|NCT00566020|64972993|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
23448344|NCT02366312|65384579|FG000|Overall Study|Lost to Follow-up|0|||
23576312|NCT03212365|65843343|FG001|Overall Study|Withdrawal by Subject|1|||
23576313|NCT03212365|65843342|FG000|Overall Study|developed acute renal failure|0|||
23576314|NCT03212365|65843343|FG001|Overall Study|developed acute renal failure|1|||
23576315|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23576316|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
23576317|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
23576318|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
23576319|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
23576320|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
23576321|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23576322|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23576323|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23576324|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
23335720|NCT00566020|64972992|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
23335721|NCT00566020|64972993|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
23335722|NCT03625466|64972995|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
23335723|NCT03625466|64972996|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
23335724|NCT03625466|64972997|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
23335725|NCT03625466|64972995|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
23335726|NCT03625466|64972996|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
23335727|NCT03625466|64972997|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
23335728|NCT03625466|64972995|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
23335729|NCT03625466|64972996|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
23335730|NCT03625466|64972997|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
23335731|NCT03491462|64972999|FG000|Overall Study|Lost to Follow-up|2|||
23335732|NCT03491462|64973000|FG001|Overall Study|Lost to Follow-up|0|||
23335733|NCT03491462|64972999|FG000|Overall Study|Adverse Event|11|||
23335734|NCT03491462|64973000|FG001|Overall Study|Adverse Event|1|||
23335735|NCT03491462|64972999|FG000|Overall Study|Physician Decision|3|||
23335736|NCT03491462|64973000|FG001|Overall Study|Physician Decision|0|||
23335737|NCT03491462|64972999|FG000|Overall Study|Withdrawal by Subject|22|||
23335738|NCT03491462|64973000|FG001|Overall Study|Withdrawal by Subject|15|||
23335739|NCT00267969|64973001|FG000|Controlled Period|Adverse Event|6|||
23335740|NCT00267969|64973002|FG001|Controlled Period|Adverse Event|0|||
23335741|NCT00267969|64973003|FG002|Controlled Period|Adverse Event|2|||
23335742|NCT00267969|64973004|FG003|Controlled Period|Adverse Event|0|||
23335743|NCT00267969|64973005|FG004|Controlled Period|Adverse Event|0|||
23335744|NCT00267969|64973006|FG005|Controlled Period|Adverse Event|0|||
23335745|NCT00267969|64973007|FG006|Controlled Period|Adverse Event|0|||
23335746|NCT00267969|64973001|FG000|Controlled Period|Lack of Efficacy|3|||
23335747|NCT00267969|64973002|FG001|Controlled Period|Lack of Efficacy|0|||
23335748|NCT00267969|64973003|FG002|Controlled Period|Lack of Efficacy|1|||
23335749|NCT00267969|64973004|FG003|Controlled Period|Lack of Efficacy|0|||
23335750|NCT00267969|64973005|FG004|Controlled Period|Lack of Efficacy|0|||
23335751|NCT00267969|64973006|FG005|Controlled Period|Lack of Efficacy|0|||
23335752|NCT00267969|64973007|FG006|Controlled Period|Lack of Efficacy|0|||
23335753|NCT00267969|64973001|FG000|Controlled Period|Lost to Follow-up|1|||
23335754|NCT00267969|64973002|FG001|Controlled Period|Lost to Follow-up|0|||
23335755|NCT00267969|64973003|FG002|Controlled Period|Lost to Follow-up|1|||
23335756|NCT00267969|64973004|FG003|Controlled Period|Lost to Follow-up|0|||
23335757|NCT00267969|64973005|FG004|Controlled Period|Lost to Follow-up|0|||
23335758|NCT00267969|64973006|FG005|Controlled Period|Lost to Follow-up|0|||
23335759|NCT00267969|64973007|FG006|Controlled Period|Lost to Follow-up|0|||
23335760|NCT00267969|64973001|FG000|Controlled Period|Randomized but not treated|0|||
23335761|NCT00267969|64973002|FG001|Controlled Period|Randomized but not treated|0|||
23335762|NCT00267969|64973003|FG002|Controlled Period|Randomized but not treated|1|||
23335763|NCT00267969|64973004|FG003|Controlled Period|Randomized but not treated|0|||
23335764|NCT00267969|64973005|FG004|Controlled Period|Randomized but not treated|0|||
23335765|NCT00267969|64973006|FG005|Controlled Period|Randomized but not treated|0|||
23576325|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576326|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23335766|NCT00267969|64973007|FG006|Controlled Period|Randomized but not treated|0|||
23335767|NCT00267969|64973001|FG000|Controlled Period|Other|2|||
23335768|NCT00267969|64973002|FG001|Controlled Period|Other|1|||
23335769|NCT00267969|64973003|FG002|Controlled Period|Other|6|||
23335770|NCT00267969|64973004|FG003|Controlled Period|Other|0|||
23335771|NCT00267969|64973005|FG004|Controlled Period|Other|0|||
23335772|NCT00267969|64973006|FG005|Controlled Period|Other|0|||
23335773|NCT00267969|64973007|FG006|Controlled Period|Other|0|||
23335774|NCT00267969|64973001|FG000|After Controlled Period|Adverse Event|0|||
23335775|NCT00267969|64973002|FG001|After Controlled Period|Adverse Event|0|||
23448345|NCT02366312|65384580|FG001|Overall Study|Lost to Follow-up|1|||
23335776|NCT00267969|64973003|FG002|After Controlled Period|Adverse Event|0|||
23335777|NCT00267969|64973004|FG003|After Controlled Period|Adverse Event|7|||
23335778|NCT00267969|64973005|FG004|After Controlled Period|Adverse Event|8|||
23335779|NCT00267969|64973006|FG005|After Controlled Period|Adverse Event|23|||
23335780|NCT00267969|64973007|FG006|After Controlled Period|Adverse Event|21|||
23335781|NCT00267969|64973001|FG000|After Controlled Period|Death|0|||
23335782|NCT00267969|64973002|FG001|After Controlled Period|Death|0|||
23335783|NCT00267969|64973003|FG002|After Controlled Period|Death|0|||
23335784|NCT00267969|64973004|FG003|After Controlled Period|Death|1|||
23335785|NCT00267969|64973005|FG004|After Controlled Period|Death|2|||
23335786|NCT00267969|64973006|FG005|After Controlled Period|Death|0|||
23335787|NCT00267969|64973007|FG006|After Controlled Period|Death|1|||
23335788|NCT00267969|64973001|FG000|After Controlled Period|Lack of Efficacy|0|||
23335789|NCT00267969|64973002|FG001|After Controlled Period|Lack of Efficacy|0|||
23335790|NCT00267969|64973003|FG002|After Controlled Period|Lack of Efficacy|0|||
23335791|NCT00267969|64973004|FG003|After Controlled Period|Lack of Efficacy|10|||
23335792|NCT00267969|64973005|FG004|After Controlled Period|Lack of Efficacy|6|||
23335793|NCT00267969|64973006|FG005|After Controlled Period|Lack of Efficacy|28|||
23335794|NCT00267969|64973007|FG006|After Controlled Period|Lack of Efficacy|15|||
23335795|NCT00267969|64973001|FG000|After Controlled Period|Lost to Follow-up|0|||
23335796|NCT00267969|64973002|FG001|After Controlled Period|Lost to Follow-up|0|||
23335797|NCT00267969|64973003|FG002|After Controlled Period|Lost to Follow-up|0|||
23335798|NCT00267969|64973004|FG003|After Controlled Period|Lost to Follow-up|5|||
23335799|NCT00267969|64973005|FG004|After Controlled Period|Lost to Follow-up|8|||
23335800|NCT00267969|64973006|FG005|After Controlled Period|Lost to Follow-up|9|||
23335801|NCT00267969|64973007|FG006|After Controlled Period|Lost to Follow-up|10|||
23335802|NCT00267969|64973001|FG000|After Controlled Period|Other|0|||
23335803|NCT00267969|64973002|FG001|After Controlled Period|Other|0|||
23335804|NCT00267969|64973003|FG002|After Controlled Period|Other|0|||
23335805|NCT00267969|64973004|FG003|After Controlled Period|Other|13|||
23335806|NCT00267969|64973005|FG004|After Controlled Period|Other|11|||
23335807|NCT00267969|64973006|FG005|After Controlled Period|Other|22|||
23335808|NCT00267969|64973007|FG006|After Controlled Period|Other|25|||
23335809|NCT00713258|64973008|FG000|Overall Study|Adverse Event|2|||
23335810|NCT00713258|64973009|FG001|Overall Study|Adverse Event|4|||
23335811|NCT00713258|64973008|FG000|Overall Study|Non-Compliance|2|||
23335812|NCT00713258|64973009|FG001|Overall Study|Non-Compliance|1|||
23335813|NCT00713258|64973008|FG000|Overall Study|Other|1|||
23335814|NCT00713258|64973009|FG001|Overall Study|Other|1|||
23335815|NCT02027545|64973010|FG000|Overall Study|Failed to sign HIPAA|0|||
23335816|NCT02027545|64973011|FG001|Overall Study|Failed to sign HIPAA|2|||
23335817|NCT02027545|64973010|FG000|Overall Study|Failed to attend study visit|2|||
23335818|NCT02027545|64973011|FG001|Overall Study|Failed to attend study visit|0|||
23335819|NCT02027545|64973010|FG000|Overall Study|Protocol Violation|1|||
23335820|NCT02027545|64973011|FG001|Overall Study|Protocol Violation|0|||
23335821|NCT02199795|64973012|FG000|Overall Study|no longer met inclusion criteria|1|||
23335822|NCT02199795|64973013|FG001|Overall Study|no longer met inclusion criteria|0|||
23335823|NCT02199795|64973012|FG000|Overall Study|withdrew due to shoulder pain|1|||
23335824|NCT02199795|64973013|FG001|Overall Study|withdrew due to shoulder pain|0|||
23335825|NCT01575834|64973014|FG000|Overall Study|Withdrawal by Subject|352|||
23335826|NCT01575834|64973015|FG001|Overall Study|Withdrawal by Subject|390|||
23335827|NCT01575834|64973014|FG000|Overall Study|Death|81|||
23335828|NCT01575834|64973015|FG001|Overall Study|Death|74|||
23335829|NCT01575834|64973014|FG000|Overall Study|Other|70|||
23335830|NCT01575834|64973015|FG001|Overall Study|Other|70|||
23335831|NCT01575834|64973014|FG000|Overall Study|Adverse Event|63|||
23335832|NCT01575834|64973015|FG001|Overall Study|Adverse Event|61|||
23335833|NCT01575834|64973014|FG000|Overall Study|Lost to Follow-up|55|||
23335834|NCT01575834|64973015|FG001|Overall Study|Lost to Follow-up|68|||
23168878|NCT03713944|64363291|FG000|Study Treatment|Symptomatic Deterioration|2|||
23168879|NCT03713944|64363291|FG000|Follow up|Withdrawal by Subject|2|||
23335835|NCT01575834|64973014|FG000|Overall Study|Noncompliance|52|||
23335836|NCT01575834|64973015|FG001|Overall Study|Noncompliance|27|||
23168880|NCT03713944|64363291|FG000|Follow up|Death|11|||
23168881|NCT03713944|64363291|FG000|Follow up|Study Terminated|3|||
23168882|NCT02217566|64363293|FG000|Overall Study|Lost to Follow-up|2|||
23168883|NCT02217566|64363293|FG000|Overall Study|Death|3|||
23335837|NCT01575834|64973014|FG000|Overall Study|Administrative decision|15|||
23335838|NCT01575834|64973015|FG001|Overall Study|Administrative decision|33|||
23335839|NCT01575834|64973014|FG000|Overall Study|Ineligibility Determined|5|||
23335840|NCT01575834|64973015|FG001|Overall Study|Ineligibility Determined|8|||
23335841|NCT01575834|64973014|FG000|Overall Study|Protocol Deviation|4|||
23335842|NCT01575834|64973015|FG001|Overall Study|Protocol Deviation|3|||
23168884|NCT02217566|64363293|FG000|Overall Study|Early study termination|6|||
23168885|NCT01462266|64363296|FG000|Overall Study|Adverse Event|7|||
23335843|NCT01575834|64973014|FG000|Overall Study|Requirement for Alternative Therapy|2|||
23335844|NCT01575834|64973015|FG001|Overall Study|Requirement for Alternative Therapy|4|||
23335845|NCT02282631|64973016|FG000|Overall Study|Lost to Follow-up|2|||
23335846|NCT02282631|64973017|FG001|Overall Study|Lost to Follow-up|0|||
23335847|NCT01580670|64973021|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
23335848|NCT01580670|64973021|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
23335849|NCT05020665|64973022|FG000|Overall Study|Study terminated by Sponsor|5|||
23335850|NCT05020665|64973023|FG001|Overall Study|Study terminated by Sponsor|4|||
23335851|NCT05020665|64973022|FG000|Overall Study|Death|2|||
23335852|NCT05020665|64973023|FG001|Overall Study|Death|1|||
23168886|NCT01462266|64363297|FG001|Overall Study|Adverse Event|6|||
23335853|NCT05020665|64973022|FG000|Overall Study|Physician Decision|0|||
23335854|NCT05020665|64973023|FG001|Overall Study|Physician Decision|1|||
23168887|NCT01462266|64363296|FG000|Overall Study|Death|2|||
23168888|NCT01462266|64363297|FG001|Overall Study|Death|1|||
23168889|NCT01462266|64363296|FG000|Overall Study|Lack of Efficacy|0|||
23168890|NCT01462266|64363297|FG001|Overall Study|Lack of Efficacy|2|||
23168891|NCT01462266|64363296|FG000|Overall Study|Lost to Follow-up|4|||
23335855|NCT05020665|64973022|FG000|Overall Study|Withdrawal by Subject|0|||
23335856|NCT05020665|64973023|FG001|Overall Study|Withdrawal by Subject|1|||
23335857|NCT05020665|64973022|FG000|Overall Study|Reason not specified|1|||
23335858|NCT05020665|64973023|FG001|Overall Study|Reason not specified|0|||
23335859|NCT03278613|64973032|FG000|Overall Study|Lost to Follow-up|3|||
23335860|NCT03278613|64973033|FG001|Overall Study|Lost to Follow-up|1|||
23335861|NCT00471822|64973034|FG000|Overall Study|Protocol Violation|2|||
23335862|NCT05326529|64973035|FG000|Overall Study|Lack of Efficacy|0|||
23335863|NCT05326529|64973036|FG001|Overall Study|Lack of Efficacy|1|||
23168892|NCT01462266|64363297|FG001|Overall Study|Lost to Follow-up|3|||
23168893|NCT01462266|64363296|FG000|Overall Study|Non-compliance with study drug|3|||
23576327|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576328|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
23576329|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
23576330|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576331|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576332|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576333|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576334|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
23576335|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23576336|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
23576337|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
23576338|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
23576339|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
23576340|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
23576341|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23168894|NCT01462266|64363297|FG001|Overall Study|Non-compliance with study drug|0|||
23168895|NCT01462266|64363296|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
23168896|NCT01462266|64363297|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
23168897|NCT01462266|64363296|FG000|Overall Study|Physician Decision|2|||
23168898|NCT01462266|64363297|FG001|Overall Study|Physician Decision|5|||
23168899|NCT01462266|64363296|FG000|Overall Study|Protocol Violation|1|||
23168900|NCT01462266|64363297|FG001|Overall Study|Protocol Violation|3|||
23168901|NCT01462266|64363296|FG000|Overall Study|Withdrawal by Subject|7|||
23168902|NCT01462266|64363297|FG001|Overall Study|Withdrawal by Subject|2|||
23168903|NCT01462266|64363296|FG000|Overall Study|Screen failure|1|||
23168904|NCT01462266|64363297|FG001|Overall Study|Screen failure|1|||
23168905|NCT04677712|64363298|FG000|Overall Study|Lost to Follow-up|0|||
23168906|NCT04677712|64363299|FG001|Overall Study|Lost to Follow-up|1|||
23228026|NCT02442765|64577997|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
23228027|NCT02442765|64577990|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23228028|NCT02442765|64577991|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23228029|NCT02442765|64577992|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23228030|NCT02442765|64577993|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23228031|NCT02442765|64577994|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
23228032|NCT02442765|64577995|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
23335864|NCT05326529|64973037|FG002|Overall Study|Lack of Efficacy|0|||
23576342|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23228033|NCT02442765|64577996|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
23228034|NCT02442765|64577997|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
23168907|NCT04677712|64363300|FG002|Overall Study|Lost to Follow-up|0|||
23228035|NCT02442765|64577990|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23335865|NCT05326529|64973035|FG000|Overall Study|Physician Decision|0|||
23168908|NCT04677712|64363301|FG003|Overall Study|Lost to Follow-up|0|||
23168909|NCT04677712|64363302|FG004|Overall Study|Lost to Follow-up|0|||
23168910|NCT04677712|64363303|FG005|Overall Study|Lost to Follow-up|0|||
23168911|NCT03434977|64363304|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
23168912|NCT03434977|64363305|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
23168913|NCT01780831|64363306|FG000|Overall Study|Withdrawal by Subject|0|||
23168914|NCT01780831|64363307|FG001|Overall Study|Withdrawal by Subject|0|||
23168915|NCT01780831|64363308|FG002|Overall Study|Withdrawal by Subject|4|||
23168916|NCT01780831|64363309|FG003|Overall Study|Withdrawal by Subject|0|||
23168917|NCT01780831|64363306|FG000|Overall Study|Lost to Follow-up|0|||
23168918|NCT01780831|64363307|FG001|Overall Study|Lost to Follow-up|0|||
23168919|NCT01780831|64363308|FG002|Overall Study|Lost to Follow-up|0|||
23168920|NCT01780831|64363309|FG003|Overall Study|Lost to Follow-up|1|||
23168921|NCT01659320|64363317|FG000|Overall Study|Withdrawal by Subject|2|||
23168922|NCT01659320|64363317|FG000|Overall Study|Physician Decision|1|||
23168923|NCT03310970|64363335|FG000|Overall Study|Withdrawal by Subject|0|||
23168924|NCT03310970|64363336|FG001|Overall Study|Withdrawal by Subject|1|||
23168925|NCT03988907|64363337|FG000|Overall Study|Unable to complete visit|0|||
23168926|NCT03988907|64363338|FG001|Overall Study|Unable to complete visit|1|||
23168927|NCT01543087|64363339|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
23168928|NCT01543087|64363340|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
23168929|NCT01543087|64363341|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
23168930|NCT01543087|64363342|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
23168931|NCT01543087|64363343|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
23168932|NCT01543087|64363344|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
23168933|NCT01543087|64363339|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
23168934|NCT01543087|64363340|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
23168935|NCT01543087|64363341|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
23168936|NCT01543087|64363342|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
23168937|NCT01543087|64363343|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
23168938|NCT01543087|64363344|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
23168939|NCT01543087|64363339|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
23168940|NCT01543087|64363340|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
23168941|NCT01543087|64363341|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
23168942|NCT01543087|64363342|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
23168943|NCT01543087|64363343|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
23168944|NCT01543087|64363344|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
23168945|NCT01543087|64363339|FG000|Stage 1 (48 Months)|Other than specified|5|||
23168946|NCT01543087|64363340|FG001|Stage 1 (48 Months)|Other than specified|0|||
23168947|NCT01543087|64363341|FG002|Stage 1 (48 Months)|Other than specified|9|||
23168948|NCT01543087|64363342|FG003|Stage 1 (48 Months)|Other than specified|0|||
23168949|NCT01543087|64363343|FG004|Stage 1 (48 Months)|Other than specified|0|||
23168950|NCT01543087|64363344|FG005|Stage 1 (48 Months)|Other than specified|0|||
23168951|NCT01543087|64363339|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
23168952|NCT01543087|64363340|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
23168953|NCT01543087|64363341|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
23168954|NCT01543087|64363342|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
23168955|NCT01543087|64363343|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
23168956|NCT01543087|64363344|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
23168957|NCT01543087|64363339|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
23168958|NCT01543087|64363340|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
23168959|NCT01543087|64363341|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
23168960|NCT01543087|64363342|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
23168961|NCT01543087|64363343|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
23168962|NCT01543087|64363344|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
23168963|NCT01543087|64363339|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
23168964|NCT01543087|64363340|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
23168965|NCT01543087|64363341|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
23168966|NCT01543087|64363342|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
23168967|NCT01543087|64363343|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
23168968|NCT01543087|64363344|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
23168969|NCT02831673|64363345|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
23168970|NCT02831673|64363346|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
23168971|NCT02831673|64363347|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
23168972|NCT02831673|64363348|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
23168973|NCT02831673|64363349|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
23335866|NCT05326529|64973036|FG001|Overall Study|Physician Decision|0|||
23168974|NCT02831673|64363345|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
23168975|NCT02831673|64363346|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
23168976|NCT02831673|64363347|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
23168977|NCT02831673|64363348|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
23168978|NCT02831673|64363349|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
23168979|NCT02831673|64363345|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
23168980|NCT02831673|64363346|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
23168981|NCT02831673|64363347|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
23335867|NCT05326529|64973037|FG002|Overall Study|Physician Decision|2|||
23335868|NCT00685399|64973038|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23335869|NCT00685399|64973039|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23335870|NCT00685399|64973040|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23335871|NCT00685399|64973041|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23335872|NCT00685399|64973042|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23335873|NCT00685399|64973043|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23335874|NCT00685399|64973044|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23335875|NCT00685399|64973045|FG007|Treatment Period 1|Withdrawal by Subject|0|||
23335876|NCT00685399|64973038|FG000|Treatment Period 1|Protocol Violation|1|||
23335877|NCT00685399|64973039|FG001|Treatment Period 1|Protocol Violation|0|||
23335878|NCT00685399|64973040|FG002|Treatment Period 1|Protocol Violation|0|||
23335879|NCT00685399|64973041|FG003|Treatment Period 1|Protocol Violation|0|||
23335880|NCT00685399|64973042|FG004|Treatment Period 1|Protocol Violation|0|||
23335881|NCT00685399|64973043|FG005|Treatment Period 1|Protocol Violation|0|||
23335882|NCT00685399|64973044|FG006|Treatment Period 1|Protocol Violation|0|||
23335883|NCT00685399|64973045|FG007|Treatment Period 1|Protocol Violation|0|||
23335884|NCT00685399|64973038|FG000|Treatment Period 1|Administrative|2|||
23335885|NCT00685399|64973039|FG001|Treatment Period 1|Administrative|0|||
23335886|NCT00685399|64973040|FG002|Treatment Period 1|Administrative|0|||
23335887|NCT00685399|64973041|FG003|Treatment Period 1|Administrative|0|||
23335888|NCT00685399|64973042|FG004|Treatment Period 1|Administrative|0|||
23335889|NCT00685399|64973043|FG005|Treatment Period 1|Administrative|0|||
23335890|NCT00685399|64973044|FG006|Treatment Period 1|Administrative|0|||
23335891|NCT00685399|64973045|FG007|Treatment Period 1|Administrative|0|||
23335892|NCT00685399|64973038|FG000|Treatment Period 1|Lack of Efficacy|1|||
23335893|NCT00685399|64973039|FG001|Treatment Period 1|Lack of Efficacy|0|||
23335894|NCT00685399|64973040|FG002|Treatment Period 1|Lack of Efficacy|0|||
23335895|NCT00685399|64973041|FG003|Treatment Period 1|Lack of Efficacy|0|||
23335896|NCT00685399|64973042|FG004|Treatment Period 1|Lack of Efficacy|0|||
23335897|NCT00685399|64973043|FG005|Treatment Period 1|Lack of Efficacy|0|||
23335898|NCT00685399|64973044|FG006|Treatment Period 1|Lack of Efficacy|0|||
23335899|NCT00685399|64973045|FG007|Treatment Period 1|Lack of Efficacy|0|||
23335900|NCT00685399|64973038|FG000|Treatment Period 2|Administrative Problems|0|||
23335901|NCT00685399|64973039|FG001|Treatment Period 2|Administrative Problems|2|||
23335902|NCT00685399|64973040|FG002|Treatment Period 2|Administrative Problems|1|||
23335903|NCT00685399|64973041|FG003|Treatment Period 2|Administrative Problems|0|||
23335904|NCT00685399|64973042|FG004|Treatment Period 2|Administrative Problems|0|||
23335905|NCT00685399|64973043|FG005|Treatment Period 2|Administrative Problems|0|||
23335906|NCT00685399|64973044|FG006|Treatment Period 2|Administrative Problems|0|||
23335907|NCT00685399|64973045|FG007|Treatment Period 2|Administrative Problems|0|||
23335908|NCT00685399|64973038|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23335909|NCT00685399|64973039|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23335910|NCT00685399|64973040|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23335911|NCT00685399|64973041|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23335912|NCT00685399|64973042|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23335913|NCT00685399|64973043|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23335914|NCT00685399|64973044|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23335915|NCT00685399|64973045|FG007|Treatment Period 2|Withdrawal by Subject|2|||
23335916|NCT00685399|64973038|FG000|Treatment Period 2|Adverse Event|0|||
23335917|NCT00685399|64973039|FG001|Treatment Period 2|Adverse Event|0|||
23335918|NCT00685399|64973040|FG002|Treatment Period 2|Adverse Event|0|||
23335919|NCT00685399|64973041|FG003|Treatment Period 2|Adverse Event|0|||
23335920|NCT00685399|64973042|FG004|Treatment Period 2|Adverse Event|0|||
23335921|NCT00685399|64973043|FG005|Treatment Period 2|Adverse Event|1|||
23335922|NCT00685399|64973044|FG006|Treatment Period 2|Adverse Event|0|||
23335923|NCT00685399|64973045|FG007|Treatment Period 2|Adverse Event|0|||
23335924|NCT00685399|64973038|FG000|Treatment Period 2|Lack of Efficacy|0|||
23335925|NCT00685399|64973039|FG001|Treatment Period 2|Lack of Efficacy|10|||
23335926|NCT00685399|64973040|FG002|Treatment Period 2|Lack of Efficacy|2|||
23335927|NCT00685399|64973041|FG003|Treatment Period 2|Lack of Efficacy|0|||
23335928|NCT00685399|64973042|FG004|Treatment Period 2|Lack of Efficacy|0|||
23335929|NCT00685399|64973043|FG005|Treatment Period 2|Lack of Efficacy|1|||
23335930|NCT00685399|64973044|FG006|Treatment Period 2|Lack of Efficacy|0|||
23335931|NCT00685399|64973045|FG007|Treatment Period 2|Lack of Efficacy|0|||
23335932|NCT00685399|64973038|FG000|Extension|Administrative Issues|0|||
23335933|NCT00685399|64973039|FG001|Extension|Administrative Issues|0|||
23335934|NCT00685399|64973040|FG002|Extension|Administrative Issues|0|||
23335935|NCT00685399|64973041|FG003|Extension|Administrative Issues|1|||
23335936|NCT00685399|64973042|FG004|Extension|Administrative Issues|0|||
23335937|NCT00685399|64973043|FG005|Extension|Administrative Issues|0|||
23335938|NCT00685399|64973044|FG006|Extension|Administrative Issues|0|||
23335939|NCT00685399|64973045|FG007|Extension|Administrative Issues|0|||
23335940|NCT00685399|64973038|FG000|Extension|Withdrawal by Subject|0|||
23335941|NCT00685399|64973039|FG001|Extension|Withdrawal by Subject|0|||
23335942|NCT00685399|64973040|FG002|Extension|Withdrawal by Subject|0|||
23335943|NCT00685399|64973041|FG003|Extension|Withdrawal by Subject|1|||
23335944|NCT00685399|64973042|FG004|Extension|Withdrawal by Subject|0|||
23335945|NCT00685399|64973043|FG005|Extension|Withdrawal by Subject|0|||
23335946|NCT00685399|64973044|FG006|Extension|Withdrawal by Subject|0|||
23335947|NCT00685399|64973045|FG007|Extension|Withdrawal by Subject|0|||
23335948|NCT00685399|64973038|FG000|Extension|Protocol Violation|0|||
23335949|NCT00685399|64973039|FG001|Extension|Protocol Violation|0|||
23168982|NCT02831673|64363348|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
23168983|NCT02831673|64363349|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
23335950|NCT00685399|64973040|FG002|Extension|Protocol Violation|0|||
23335951|NCT00685399|64973041|FG003|Extension|Protocol Violation|1|||
23335952|NCT00685399|64973042|FG004|Extension|Protocol Violation|0|||
23335953|NCT00685399|64973043|FG005|Extension|Protocol Violation|0|||
23335954|NCT00685399|64973044|FG006|Extension|Protocol Violation|0|||
23335955|NCT00685399|64973045|FG007|Extension|Protocol Violation|0|||
23335956|NCT00685399|64973038|FG000|Extension|Lack of Efficacy|0|||
23335957|NCT00685399|64973039|FG001|Extension|Lack of Efficacy|0|||
23335958|NCT00685399|64973040|FG002|Extension|Lack of Efficacy|0|||
23335959|NCT00685399|64973041|FG003|Extension|Lack of Efficacy|2|||
23335960|NCT00685399|64973042|FG004|Extension|Lack of Efficacy|0|||
23335961|NCT00685399|64973043|FG005|Extension|Lack of Efficacy|0|||
23335962|NCT00685399|64973044|FG006|Extension|Lack of Efficacy|0|||
23335963|NCT00685399|64973045|FG007|Extension|Lack of Efficacy|0|||
23335964|NCT00685399|64973038|FG000|Extension|Adverse Event|0|||
23335965|NCT00685399|64973039|FG001|Extension|Adverse Event|0|||
23335966|NCT00685399|64973040|FG002|Extension|Adverse Event|0|||
23335967|NCT00685399|64973041|FG003|Extension|Adverse Event|2|||
23335968|NCT00685399|64973042|FG004|Extension|Adverse Event|0|||
23335969|NCT00685399|64973043|FG005|Extension|Adverse Event|0|||
23335970|NCT00685399|64973044|FG006|Extension|Adverse Event|0|||
23335971|NCT00685399|64973045|FG007|Extension|Adverse Event|0|||
23335972|NCT02589626|64973048|FG000|Overall Study|Other than the reason specified|1|||
23335973|NCT02589626|64973049|FG001|Overall Study|Other than the reason specified|0|||
23335974|NCT02589626|64973048|FG000|Overall Study|Withdrawal by Subject|1|||
23335975|NCT02589626|64973049|FG001|Overall Study|Withdrawal by Subject|1|||
23335976|NCT02589626|64973048|FG000|Overall Study|Adverse Event|1|||
23335977|NCT02589626|64973049|FG001|Overall Study|Adverse Event|1|||
23335978|NCT02201108|64973050|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
23335979|NCT02201108|64973051|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
23335980|NCT02201108|64973050|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
23335981|NCT02201108|64973051|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
23335982|NCT02201108|64973050|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
23335983|NCT02201108|64973051|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
23335984|NCT02201108|64973050|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
23335985|NCT02201108|64973051|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
23335986|NCT02201108|64973050|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
23576343|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23576344|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
23576345|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
23576346|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576347|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576348|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
23576349|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
23576350|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576351|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23168984|NCT02831673|64363345|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
23168985|NCT02831673|64363346|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
23168986|NCT02831673|64363347|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
23168987|NCT02831673|64363348|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
23168988|NCT02831673|64363349|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
23168989|NCT02831673|64363345|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
23168990|NCT02831673|64363346|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
23168991|NCT02831673|64363347|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
23168992|NCT02831673|64363348|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
23335987|NCT02201108|64973051|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
23335988|NCT02201108|64973050|FG000|Open Label Period (up to Week 192)|Other reason|4|||
23335989|NCT02201108|64973051|FG001|Open Label Period (up to Week 192)|Other reason|7|||
23335990|NCT02201108|64973050|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
23335991|NCT02201108|64973051|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
23335992|NCT02058537|64973056|FG000|Overall Study|Withdrawal by Subject|1|||
23335993|NCT00402688|64973063|FG000|Overall Study|Adverse Event|12|||
23335994|NCT00402688|64973064|FG001|Overall Study|Adverse Event|9|||
23576352|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23335995|NCT00402688|64973065|FG002|Overall Study|Adverse Event|3|||
23335996|NCT00402688|64973063|FG000|Overall Study|Withdrawal by Subject|3|||
23335997|NCT00402688|64973064|FG001|Overall Study|Withdrawal by Subject|1|||
23335998|NCT00402688|64973065|FG002|Overall Study|Withdrawal by Subject|1|||
23335999|NCT00402688|64973063|FG000|Overall Study|Physician Decision|0|||
23336000|NCT00402688|64973064|FG001|Overall Study|Physician Decision|0|||
23336001|NCT00402688|64973065|FG002|Overall Study|Physician Decision|1|||
23336002|NCT00402688|64973063|FG000|Overall Study|Lack of Efficacy|4|||
23336003|NCT00402688|64973064|FG001|Overall Study|Lack of Efficacy|4|||
23336004|NCT00402688|64973065|FG002|Overall Study|Lack of Efficacy|5|||
23336005|NCT00402688|64973063|FG000|Overall Study|Protocol Violation|1|||
23336006|NCT00402688|64973064|FG001|Overall Study|Protocol Violation|1|||
23336007|NCT00402688|64973065|FG002|Overall Study|Protocol Violation|1|||
23168993|NCT02831673|64363349|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
23168994|NCT02831673|64363345|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
23168995|NCT02831673|64363346|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
23168996|NCT02831673|64363347|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
23168997|NCT02831673|64363348|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
23168998|NCT02831673|64363349|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
23228036|NCT02442765|64577991|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23336008|NCT00402688|64973063|FG000|Overall Study|Lost to Follow-up|1|||
23336009|NCT00402688|64973064|FG001|Overall Study|Lost to Follow-up|0|||
23336010|NCT00402688|64973065|FG002|Overall Study|Lost to Follow-up|2|||
23336011|NCT00402688|64973063|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
23336012|NCT00402688|64973064|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
23336013|NCT00402688|64973065|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
23336014|NCT00402688|64973063|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
23336015|NCT00402688|64973064|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
23336016|NCT00402688|64973065|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
23336017|NCT00402688|64973063|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
23336018|NCT00402688|64973064|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
23336019|NCT00402688|64973065|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
23336020|NCT02073929|64973066|FG000|Overall Study|Lost to Follow-up|2|||
23336021|NCT02073929|64973067|FG001|Overall Study|Lost to Follow-up|1|||
23336022|NCT02073929|64973066|FG000|Overall Study|Adverse Event|2|||
23336023|NCT02073929|64973067|FG001|Overall Study|Adverse Event|1|||
23336024|NCT02073929|64973066|FG000|Overall Study|Withdrawal by Subject|0|||
23336025|NCT02073929|64973067|FG001|Overall Study|Withdrawal by Subject|1|||
23336026|NCT02285166|64973068|FG000|Overall Study|Case Report Forms Uncollected|564|||
23336027|NCT02285166|64973068|FG000|Overall Study|Protocol Deviation|402|||
23336028|NCT00237458|64973072|FG000|Overall Study|Lack of Efficacy|1|||
23336029|NCT00237458|64973072|FG000|Overall Study|Adverse Event|1|||
23336030|NCT00237458|64973072|FG000|Overall Study|Withdrawal by Subject|1|||
23336031|NCT03003494|64973076|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
23336032|NCT00101166|64973077|FG000|Overall Study|progressive disease|10|||
23336033|NCT03192306|64973078|FG000|Overall Study|Did not treat cold sore during study|149|||
23336034|NCT03192306|64973079|FG001|Overall Study|Did not treat cold sore during study|143|||
23336035|NCT03192306|64973078|FG000|Overall Study|Withdrawal by Subject|1|||
23336036|NCT03192306|64973079|FG001|Overall Study|Withdrawal by Subject|1|||
23336037|NCT03192306|64973078|FG000|Overall Study|Lost to Follow-up|1|||
23336038|NCT03192306|64973079|FG001|Overall Study|Lost to Follow-up|0|||
23336039|NCT03192306|64973078|FG000|Overall Study|Protocol Violation|1|||
23336040|NCT03192306|64973079|FG001|Overall Study|Protocol Violation|1|||
23336041|NCT00468481|64973090|FG000|Overall Study|Adverse Event|13|||
23336042|NCT00468481|64973091|FG001|Overall Study|Adverse Event|3|||
23336043|NCT00468481|64973090|FG000|Overall Study|Lost to Follow-up|25|||
23336044|NCT00468481|64973091|FG001|Overall Study|Lost to Follow-up|8|||
23336045|NCT00468481|64973090|FG000|Overall Study|Pregnancy|2|||
23336046|NCT00468481|64973091|FG001|Overall Study|Pregnancy|0|||
23336047|NCT00468481|64973090|FG000|Overall Study|Protocol Violation|18|||
23228037|NCT02442765|64577992|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23336048|NCT00468481|64973091|FG001|Overall Study|Protocol Violation|8|||
23336049|NCT00468481|64973090|FG000|Overall Study|Withdrawal by Subject|12|||
23336050|NCT00468481|64973091|FG001|Overall Study|Withdrawal by Subject|3|||
23336051|NCT00468481|64973090|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
23336052|NCT00468481|64973091|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
23336053|NCT00468481|64973090|FG000|Overall Study|Prohibited Medication|1|||
23336054|NCT00468481|64973091|FG001|Overall Study|Prohibited Medication|1|||
23336055|NCT00468481|64973090|FG000|Overall Study|Egg Donor|1|||
23336056|NCT00468481|64973091|FG001|Overall Study|Egg Donor|0|||
23336057|NCT00468481|64973090|FG000|Overall Study|Moved out of area|4|||
23336058|NCT00468481|64973091|FG001|Overall Study|Moved out of area|1|||
23336059|NCT00468481|64973090|FG000|Overall Study|Non-Compliance|5|||
23168999|NCT02831673|64363345|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
23169000|NCT02831673|64363346|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
23169001|NCT02831673|64363347|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
23169002|NCT02831673|64363348|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
23576353|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576354|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
23576355|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576356|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576357|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
23576358|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
23576359|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576360|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576361|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576362|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576363|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576364|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
23576365|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576366|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576367|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576368|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576369|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
23576370|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576371|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576372|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23336060|NCT00468481|64973091|FG001|Overall Study|Non-Compliance|0|||
23336061|NCT00468481|64973090|FG000|Overall Study|Other|6|||
23336062|NCT00468481|64973091|FG001|Overall Study|Other|0|||
23336063|NCT01250873|64973092|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
23336064|NCT01250873|64973092|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
23336065|NCT01682226|64973095|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
23336066|NCT01682226|64973095|FG000|Overall Study|Participants did not receive treatment|2|||
23336067|NCT01682226|64973095|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
23336068|NCT01894100|64973096|FG000|Overall Study|Lost to Follow-up|0|||
23169003|NCT02831673|64363349|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
23169004|NCT02831673|64363345|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
23169005|NCT02831673|64363346|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
23169006|NCT02831673|64363347|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
23169007|NCT02831673|64363348|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
23169008|NCT02831673|64363349|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
23169009|NCT02831673|64363345|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23169010|NCT02831673|64363346|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23169011|NCT02831673|64363347|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
23169012|NCT02831673|64363348|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
23169013|NCT02831673|64363349|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23169014|NCT02831673|64363345|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23169015|NCT02831673|64363346|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23169016|NCT02831673|64363347|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
23169017|NCT02831673|64363348|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
23169018|NCT02831673|64363349|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23336069|NCT01894100|64973097|FG001|Overall Study|Lost to Follow-up|1|||
23336070|NCT01894100|64973096|FG000|Overall Study|Withdrawal by Subject|3|||
23169019|NCT02831673|64363345|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23169020|NCT02831673|64363346|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23169021|NCT02831673|64363347|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23169022|NCT02831673|64363348|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
23169023|NCT02831673|64363349|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23169024|NCT02831673|64363345|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
23169025|NCT02831673|64363346|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
23169026|NCT02831673|64363347|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
23169027|NCT02831673|64363348|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
23336071|NCT01894100|64973097|FG001|Overall Study|Withdrawal by Subject|0|||
23336072|NCT02237196|64973098|FG000|Overall Study|Adverse Event|0|||
23336073|NCT02237196|64973099|FG001|Overall Study|Adverse Event|1|||
23336074|NCT02237196|64973100|FG002|Overall Study|Adverse Event|1|||
23576373|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576374|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
23576375|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576376|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576377|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576378|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
23576379|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
23576380|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
23576381|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576382|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576383|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576384|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
23576385|NCT02018861|65843344|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23336075|NCT02237196|64973101|FG003|Overall Study|Adverse Event|0|||
23336076|NCT02237196|64973098|FG000|Overall Study|Lost to Follow-up|4|||
23336077|NCT02237196|64973099|FG001|Overall Study|Lost to Follow-up|2|||
23336078|NCT02237196|64973100|FG002|Overall Study|Lost to Follow-up|4|||
23336079|NCT02237196|64973101|FG003|Overall Study|Lost to Follow-up|6|||
23336080|NCT02237196|64973098|FG000|Overall Study|Physician Decision|2|||
23336081|NCT02237196|64973099|FG001|Overall Study|Physician Decision|0|||
23336082|NCT02237196|64973100|FG002|Overall Study|Physician Decision|0|||
23576386|NCT02018861|65843345|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576387|NCT02018861|65843346|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576388|NCT02018861|65843347|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
23576389|NCT02018861|65843348|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
23576390|NCT02018861|65843349|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576391|NCT02018861|65843350|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576392|NCT02018861|65843351|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576393|NCT02018861|65843352|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576394|NCT02018861|65843353|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
23576395|NCT02018861|65843344|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576396|NCT02018861|65843345|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576397|NCT02018861|65843346|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576398|NCT02018861|65843347|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576399|NCT02018861|65843348|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576400|NCT02018861|65843349|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576401|NCT02018861|65843350|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
23576402|NCT02018861|65843351|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
23576403|NCT02018861|65843352|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576404|NCT02018861|65843353|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
23576405|NCT02018861|65843344|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576406|NCT02018861|65843345|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576407|NCT02018861|65843346|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576408|NCT02018861|65843347|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576409|NCT02018861|65843348|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576410|NCT02018861|65843349|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576411|NCT02018861|65843350|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
23576412|NCT02018861|65843351|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
23576413|NCT02018861|65843352|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576414|NCT02018861|65843353|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
23576415|NCT02018861|65843344|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576416|NCT02018861|65843345|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576417|NCT02018861|65843346|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576418|NCT02018861|65843347|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576419|NCT02018861|65843348|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576420|NCT02018861|65843349|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576421|NCT02018861|65843350|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576422|NCT02018861|65843351|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576423|NCT02018861|65843352|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
23576424|NCT02018861|65843353|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
23576425|NCT02018861|65843344|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576426|NCT02018861|65843345|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576427|NCT02018861|65843346|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23169028|NCT02831673|64363349|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
23169029|NCT02831673|64363345|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23169030|NCT02831673|64363346|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23169031|NCT02831673|64363347|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
23169032|NCT02831673|64363348|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
23169033|NCT02831673|64363349|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23169034|NCT02831673|64363345|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23169035|NCT02831673|64363346|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23169036|NCT02831673|64363347|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
23169037|NCT02831673|64363348|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
23169038|NCT02831673|64363349|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23169039|NCT02831673|64363345|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23169040|NCT02831673|64363346|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23169041|NCT02831673|64363347|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
23169042|NCT02831673|64363348|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
23169043|NCT02831673|64363349|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23169044|NCT02831673|64363345|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
23576428|NCT02018861|65843347|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576429|NCT02018861|65843348|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23169045|NCT02831673|64363346|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
23169046|NCT02831673|64363347|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
23169047|NCT02831673|64363348|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
23169048|NCT02831673|64363349|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
23169049|NCT02831673|64363345|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23169050|NCT02831673|64363346|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23169051|NCT02831673|64363347|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23169052|NCT02831673|64363348|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23169053|NCT02831673|64363349|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
23169054|NCT02831673|64363345|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23169055|NCT02831673|64363346|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23169056|NCT02831673|64363347|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23169057|NCT02831673|64363348|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23169058|NCT02831673|64363349|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
23169059|NCT02831673|64363345|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23169060|NCT02831673|64363346|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23169061|NCT02831673|64363347|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23169062|NCT02831673|64363348|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23169063|NCT02831673|64363349|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
23169064|NCT02831673|64363345|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23228038|NCT02442765|64577993|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23228039|NCT02442765|64577994|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
23228040|NCT02442765|64577995|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23228041|NCT02442765|64577996|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
23228042|NCT02442765|64577997|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
23228043|NCT03030261|64577998|FG000|Overall Study|Still receiving continuation therapy|5|||
23228044|NCT00819052|64577999|FG000|Overall Study|Adverse Event|0|||
23228045|NCT00819052|64578000|FG001|Overall Study|Adverse Event|5|||
23448346|NCT03553758|65384581|FG000|Overall Study|Lost to Follow-up|1|||
23228046|NCT00819052|64577999|FG000|Overall Study|Protocol Violation|1|||
23228047|NCT00819052|64578000|FG001|Overall Study|Protocol Violation|2|||
23228048|NCT00819052|64577999|FG000|Overall Study|Lost to Follow-up|1|||
23448347|NCT02478463|65384583|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
23576430|NCT02018861|65843349|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576431|NCT02018861|65843350|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576432|NCT02018861|65843351|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576433|NCT02018861|65843352|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
23576434|NCT02018861|65843353|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
23576435|NCT02018861|65843344|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576436|NCT02018861|65843345|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576437|NCT02018861|65843346|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23228049|NCT00819052|64578000|FG001|Overall Study|Lost to Follow-up|2|||
23228050|NCT00819052|64577999|FG000|Overall Study|Withdrawal by Subject|1|||
23228051|NCT00819052|64578000|FG001|Overall Study|Withdrawal by Subject|2|||
23228052|NCT00819052|64577999|FG000|Overall Study|Lack of Efficacy|1|||
23448348|NCT02478463|65384583|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
23169065|NCT02831673|64363346|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23169066|NCT02831673|64363347|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23169067|NCT02831673|64363348|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23169068|NCT02831673|64363349|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
23169069|NCT01290692|64363351|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
23576438|NCT02018861|65843347|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576439|NCT02018861|65843348|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576440|NCT02018861|65843349|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576441|NCT02018861|65843350|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576442|NCT02018861|65843351|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576443|NCT02018861|65843352|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
23169070|NCT00272038|64363352|FG000|Overall Study|withdrew before they received 2 cycles|7|||
23169071|NCT03245450|64363353|FG000|Overall Study|Radiological disease progression|3|||
23169072|NCT03245450|64363354|FG001|Overall Study|Radiological disease progression|3|||
23169073|NCT03245450|64363355|FG002|Overall Study|Radiological disease progression|2|||
23169074|NCT03245450|64363356|FG003|Overall Study|Radiological disease progression|2|||
23169075|NCT03245450|64363357|FG004|Overall Study|Radiological disease progression|7|||
23169076|NCT03245450|64363358|FG005|Overall Study|Radiological disease progression|6|||
23169077|NCT03245450|64363359|FG006|Overall Study|Radiological disease progression|6|||
23169078|NCT03245450|64363353|FG000|Overall Study|Clinical disease progression|0|||
23169079|NCT03245450|64363354|FG001|Overall Study|Clinical disease progression|0|||
23169080|NCT03245450|64363355|FG002|Overall Study|Clinical disease progression|1|||
23169081|NCT03245450|64363356|FG003|Overall Study|Clinical disease progression|0|||
23169082|NCT03245450|64363357|FG004|Overall Study|Clinical disease progression|0|||
23169083|NCT03245450|64363358|FG005|Overall Study|Clinical disease progression|2|||
23169084|NCT03245450|64363359|FG006|Overall Study|Clinical disease progression|0|||
23169085|NCT03245450|64363353|FG000|Overall Study|Other|0|||
23169086|NCT03245450|64363354|FG001|Overall Study|Other|0|||
23169087|NCT03245450|64363355|FG002|Overall Study|Other|0|||
23169088|NCT03245450|64363356|FG003|Overall Study|Other|1|||
23169089|NCT03245450|64363357|FG004|Overall Study|Other|1|||
23169090|NCT03245450|64363358|FG005|Overall Study|Other|1|||
23169091|NCT03245450|64363359|FG006|Overall Study|Other|1|||
23169092|NCT03245450|64363353|FG000|Overall Study|Withdrawal by Subject|0|||
23576444|NCT02018861|65843353|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
23576445|NCT01720797|65843356|FG000|Overall Study|Withdrawal by Subject|3|||
23576446|NCT01720797|65843357|FG001|Overall Study|Withdrawal by Subject|0|||
23576447|NCT00121199|65843359|FG000|Overall Study|Adverse Event|11|||
23576448|NCT00121199|65843359|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23169093|NCT03245450|64363354|FG001|Overall Study|Withdrawal by Subject|1|||
23169094|NCT03245450|64363355|FG002|Overall Study|Withdrawal by Subject|0|||
23336083|NCT02237196|64973101|FG003|Overall Study|Physician Decision|1|||
23336084|NCT02237196|64973098|FG000|Overall Study|Pregnancy|0|||
23336085|NCT02237196|64973099|FG001|Overall Study|Pregnancy|0|||
23336086|NCT02237196|64973100|FG002|Overall Study|Pregnancy|1|||
23336087|NCT02237196|64973101|FG003|Overall Study|Pregnancy|1|||
23336088|NCT02237196|64973098|FG000|Overall Study|Withdrawal by Subject|1|||
23336089|NCT02237196|64973099|FG001|Overall Study|Withdrawal by Subject|1|||
23336090|NCT02237196|64973100|FG002|Overall Study|Withdrawal by Subject|4|||
23336091|NCT02237196|64973101|FG003|Overall Study|Withdrawal by Subject|1|||
23336092|NCT02237196|64973098|FG000|Overall Study|Site Error|1|||
23336093|NCT02237196|64973099|FG001|Overall Study|Site Error|2|||
23336094|NCT02237196|64973100|FG002|Overall Study|Site Error|0|||
23336095|NCT02237196|64973101|FG003|Overall Study|Site Error|2|||
23336096|NCT01668173|64973102|FG000|Overall Study|Adverse Event|3|||
23336097|NCT01668173|64973102|FG000|Overall Study|Trial suspension|4|||
23336098|NCT00977314|64973103|FG000|Overall Study|Withdrawal by Subject|1|||
23336099|NCT00977314|64973104|FG001|Overall Study|Withdrawal by Subject|0|||
23336100|NCT00977314|64973103|FG000|Overall Study|Physician Decision|1|||
23336101|NCT00977314|64973104|FG001|Overall Study|Physician Decision|0|||
23448349|NCT02478463|65384583|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
23448350|NCT02869633|65384588|FG000|Overall Study|Death|2|||
23169095|NCT03245450|64363356|FG003|Overall Study|Withdrawal by Subject|0|||
23169096|NCT03245450|64363357|FG004|Overall Study|Withdrawal by Subject|0|||
23169097|NCT03245450|64363358|FG005|Overall Study|Withdrawal by Subject|0|||
23336102|NCT01186692|64973105|FG000|Overall Study|Not Catheterized|11|||
23336103|NCT01186692|64973105|FG000|Overall Study|Futher testing contraindicated implant|19|||
23169098|NCT03245450|64363359|FG006|Overall Study|Withdrawal by Subject|0|||
23336104|NCT01186692|64973105|FG000|Overall Study|Adverse Event|2|||
23336105|NCT01857583|64973108|FG000|Overall Study|Adverse Event|0|||
23336106|NCT01857583|64973109|FG001|Overall Study|Adverse Event|0|||
23336107|NCT01857583|64973110|FG002|Overall Study|Adverse Event|1|||
23336108|NCT01857583|64973111|FG003|Overall Study|Adverse Event|1|||
23576449|NCT00121199|65843359|FG000|Overall Study|Progression/Relapse|1|||
23576450|NCT00121199|65843359|FG000|Overall Study|Death|3|||
23576451|NCT00121199|65843359|FG000|Overall Study|Other - Not Protocol Specified|3|||
23576452|NCT00121199|65843359|FG000|Overall Study|Ineligible|9|||
23576453|NCT02061761|65843362|FG000|Overall Study|Disease progression|2|||
23576454|NCT02061761|65843363|FG001|Overall Study|Disease progression|8|||
23576455|NCT02061761|65843364|FG002|Overall Study|Disease progression|4|||
23576456|NCT02061761|65843365|FG003|Overall Study|Disease progression|5|||
23576457|NCT02061761|65843366|FG004|Overall Study|Disease progression|9|||
23576458|NCT02061761|65843367|FG005|Overall Study|Disease progression|3|||
23576459|NCT02061761|65843368|FG006|Overall Study|Disease progression|1|||
23576460|NCT02061761|65843369|FG007|Overall Study|Disease progression|2|||
23576461|NCT02061761|65843370|FG008|Overall Study|Disease progression|28|||
23576462|NCT02061761|65843362|FG000|Overall Study|Study Drug toxicity|0|||
23576463|NCT02061761|65843363|FG001|Overall Study|Study Drug toxicity|0|||
23576464|NCT02061761|65843364|FG002|Overall Study|Study Drug toxicity|0|||
23169099|NCT03245450|64363353|FG000|Overall Study|Adverse Event|0|||
23169100|NCT03245450|64363354|FG001|Overall Study|Adverse Event|0|||
23169101|NCT03245450|64363355|FG002|Overall Study|Adverse Event|0|||
23169102|NCT03245450|64363356|FG003|Overall Study|Adverse Event|0|||
23169103|NCT03245450|64363357|FG004|Overall Study|Adverse Event|1|||
23169104|NCT03245450|64363358|FG005|Overall Study|Adverse Event|0|||
23169105|NCT03245450|64363359|FG006|Overall Study|Adverse Event|2|||
23169106|NCT00291551|64363360|FG000|Overall Study|Death|7|||
23169107|NCT00291551|64363360|FG000|Overall Study|Withdrawal by Subject|6|||
23169108|NCT01849874|64363361|FG000|Overall Study|Death|89|||
23169109|NCT01849874|64363362|FG001|Overall Study|Death|42|||
23169110|NCT01849874|64363361|FG000|Overall Study|Withdrawal by Subject|17|||
23169111|NCT01849874|64363362|FG001|Overall Study|Withdrawal by Subject|16|||
23576465|NCT02061761|65843365|FG003|Overall Study|Study Drug toxicity|0|||
23576466|NCT02061761|65843366|FG004|Overall Study|Study Drug toxicity|0|||
23576467|NCT02061761|65843367|FG005|Overall Study|Study Drug toxicity|1|||
23169112|NCT01849874|64363361|FG000|Overall Study|Lost to Follow-up|3|||
23169113|NCT01849874|64363362|FG001|Overall Study|Lost to Follow-up|2|||
23169114|NCT01849874|64363361|FG000|Overall Study|Study Termination By Sponsor|93|||
23169115|NCT01849874|64363362|FG001|Overall Study|Study Termination By Sponsor|48|||
23169116|NCT01849874|64363361|FG000|Overall Study|Completed as per protocol amendment 6|3|||
23169117|NCT01849874|64363362|FG001|Overall Study|Completed as per protocol amendment 6|0|||
23169118|NCT01849874|64363361|FG000|Overall Study|Physician Decision|7|||
23169119|NCT01849874|64363362|FG001|Overall Study|Physician Decision|1|||
23169120|NCT01849874|64363361|FG000|Overall Study|Other|16|||
23169121|NCT01849874|64363362|FG001|Overall Study|Other|4|||
23169122|NCT00606086|64363365|FG000|Overall Study|Adverse Event|1|||
23169123|NCT00606086|64363366|FG001|Overall Study|Adverse Event|1|||
23169124|NCT00606086|64363365|FG000|Overall Study|Lost to Follow-up|4|||
23169125|NCT00606086|64363366|FG001|Overall Study|Lost to Follow-up|8|||
23169126|NCT00606086|64363365|FG000|Overall Study|Protocol Violation|1|||
23169127|NCT00606086|64363366|FG001|Overall Study|Protocol Violation|0|||
23169128|NCT00606086|64363365|FG000|Overall Study|Withdrawal by Subject|5|||
23169129|NCT00606086|64363366|FG001|Overall Study|Withdrawal by Subject|3|||
23169130|NCT00606086|64363365|FG000|Overall Study|Non-compliance|0|||
23169131|NCT00606086|64363366|FG001|Overall Study|Non-compliance|1|||
23169132|NCT00606086|64363365|FG000|Overall Study|Randomized, not treated|1|||
23169133|NCT00606086|64363366|FG001|Overall Study|Randomized, not treated|2|||
23169134|NCT00209339|64363367|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
23448351|NCT02869633|65384589|FG001|Overall Study|Death|1|||
23169135|NCT00209339|64363367|FG000|At 12 Months Follow-up|Death|1|||
23169136|NCT00209339|64363367|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
23169137|NCT00209339|64363367|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
23169138|NCT00209339|64363367|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
23169139|NCT00209339|64363367|FG000|At 24 Months Follow-up|Death|1|||
23169140|NCT00209339|64363367|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
23169141|NCT00209339|64363367|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
23169142|NCT00209339|64363367|FG000|At 4 Years Follow-up|Death|1|||
23169143|NCT00209339|64363367|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
23169144|NCT00209339|64363367|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
23448352|NCT02869633|65384588|FG000|Overall Study|Patient refused follow-up|1|||
23576468|NCT02061761|65843368|FG006|Overall Study|Study Drug toxicity|0|||
23576469|NCT02061761|65843369|FG007|Overall Study|Study Drug toxicity|2|||
23576470|NCT02061761|65843370|FG008|Overall Study|Study Drug toxicity|6|||
23576471|NCT02061761|65843362|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
23169145|NCT00209339|64363367|FG000|At 5 Years Follow-up|Death|1|||
23169146|NCT00880893|64363368|FG000|Overall Study|Protocol Violation|13|||
23169147|NCT00880893|64363369|FG001|Overall Study|Protocol Violation|1|||
23169148|NCT00880893|64363368|FG000|Overall Study|Withdrawal by Subject|15|||
23169149|NCT00880893|64363369|FG001|Overall Study|Withdrawal by Subject|11|||
23169150|NCT00880893|64363368|FG000|Overall Study|Lost to Follow-up|76|||
23169151|NCT00880893|64363369|FG001|Overall Study|Lost to Follow-up|33|||
23576472|NCT02061761|65843363|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
23448353|NCT02869633|65384589|FG001|Overall Study|Patient refused follow-up|0|||
23576473|NCT02061761|65843364|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
23576474|NCT02061761|65843365|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
23576475|NCT02061761|65843366|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
23576476|NCT02061761|65843367|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
23576477|NCT02061761|65843368|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
23576478|NCT02061761|65843369|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
23576479|NCT02061761|65843370|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
23576480|NCT02061761|65843362|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23576481|NCT02061761|65843363|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23576482|NCT02061761|65843364|FG002|Overall Study|Participant request to discontinue study treatment|2|||
23576483|NCT02061761|65843365|FG003|Overall Study|Participant request to discontinue study treatment|2|||
23576484|NCT02061761|65843366|FG004|Overall Study|Participant request to discontinue study treatment|0|||
23336109|NCT01857583|64973108|FG000|Overall Study|Death|0|||
23336110|NCT01857583|64973109|FG001|Overall Study|Death|1|||
23336111|NCT01857583|64973110|FG002|Overall Study|Death|1|||
23336112|NCT01857583|64973111|FG003|Overall Study|Death|0|||
23336113|NCT01857583|64973108|FG000|Overall Study|Physician Decision|0|||
23336114|NCT01857583|64973109|FG001|Overall Study|Physician Decision|0|||
23336115|NCT01857583|64973110|FG002|Overall Study|Physician Decision|0|||
23336116|NCT01857583|64973111|FG003|Overall Study|Physician Decision|1|||
23169152|NCT00880893|64363368|FG000|Overall Study|Serious adverse event|3|||
23169153|NCT00880893|64363369|FG001|Overall Study|Serious adverse event|0|||
23336117|NCT01857583|64973108|FG000|Overall Study|Withdrawal by Subject|1|||
23336118|NCT01857583|64973109|FG001|Overall Study|Withdrawal by Subject|0|||
23336119|NCT01857583|64973110|FG002|Overall Study|Withdrawal by Subject|1|||
23336120|NCT01857583|64973111|FG003|Overall Study|Withdrawal by Subject|2|||
23336121|NCT00423332|64973113|FG000|Overall Study|Adverse Event|6|||
23336122|NCT00423332|64973114|FG001|Overall Study|Adverse Event|2|||
23336123|NCT00423332|64973113|FG000|Overall Study|Withdrawal by Subject|1|||
23336124|NCT00423332|64973114|FG001|Overall Study|Withdrawal by Subject|0|||
23336125|NCT00423332|64973113|FG000|Overall Study|Condition under investigation worsened|1|||
23336126|NCT00423332|64973114|FG001|Overall Study|Condition under investigation worsened|1|||
23336127|NCT00423332|64973113|FG000|Overall Study|Progressive at Week 6|0|||
23336128|NCT00423332|64973114|FG001|Overall Study|Progressive at Week 6|1|||
23336129|NCT00423332|64973113|FG000|Overall Study|Unblinded before 12 weeks|1|||
23336130|NCT00423332|64973114|FG001|Overall Study|Unblinded before 12 weeks|3|||
23336131|NCT01868438|64973115|FG000|First Intervention|Withdrawal by Subject|5|||
23336132|NCT01868438|64973116|FG001|First Intervention|Withdrawal by Subject|1|||
23336133|NCT01868438|64973115|FG000|First Intervention|Lost to Follow-up|2|||
23336134|NCT01868438|64973116|FG001|First Intervention|Lost to Follow-up|3|||
23336135|NCT01868438|64973115|FG000|First Intervention|Meeting the non-redosing criteria|0|||
23336136|NCT01868438|64973116|FG001|First Intervention|Meeting the non-redosing criteria|1|||
23336137|NCT01868438|64973115|FG000|Second Intervention|Adverse Event|3|||
23336138|NCT01868438|64973116|FG001|Second Intervention|Adverse Event|3|||
23336139|NCT02282813|64973117|FG000|Overall Study|Withdrawal by Subject|4|||
23336140|NCT02282813|64973118|FG001|Overall Study|Withdrawal by Subject|5|||
23169154|NCT01445678|64363372|FG000|Overall Study|Adverse Event|12|||
23169155|NCT01445678|64363373|FG001|Overall Study|Adverse Event|8|||
23169156|NCT01445678|64363372|FG000|Overall Study|Lack of Efficacy|0|||
23169157|NCT01445678|64363373|FG001|Overall Study|Lack of Efficacy|2|||
23169158|NCT01445678|64363372|FG000|Overall Study|Lost to Follow-up|8|||
23169159|NCT01445678|64363373|FG001|Overall Study|Lost to Follow-up|5|||
23169160|NCT01445678|64363372|FG000|Overall Study|Protocol Violation|1|||
23169161|NCT01445678|64363373|FG001|Overall Study|Protocol Violation|1|||
23169162|NCT01445678|64363372|FG000|Overall Study|Withdrawal by Subject|9|||
23169163|NCT01445678|64363373|FG001|Overall Study|Withdrawal by Subject|5|||
23169164|NCT04562090|64363375|FG000|Overall Study|Withdrawal by Subject|3|||
23169165|NCT04562090|64363376|FG001|Overall Study|Withdrawal by Subject|4|||
23169166|NCT04562090|64363375|FG000|Overall Study|Protocol Violation|2|||
23169167|NCT04562090|64363376|FG001|Overall Study|Protocol Violation|0|||
23169168|NCT04562090|64363375|FG000|Overall Study|Lack of Efficacy|0|||
23169169|NCT04562090|64363376|FG001|Overall Study|Lack of Efficacy|1|||
23169170|NCT04562090|64363375|FG000|Overall Study|Adverse Event|1|||
23169171|NCT04562090|64363376|FG001|Overall Study|Adverse Event|4|||
23336141|NCT02282813|64973119|FG002|Overall Study|Withdrawal by Subject|0|||
23169172|NCT04562090|64363375|FG000|Overall Study|Miscellaneous|0|||
23169173|NCT04562090|64363376|FG001|Overall Study|Miscellaneous|3|||
23169174|NCT00705783|64363378|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
23169175|NCT00705783|64363379|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
23169176|NCT00705783|64363380|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
23169177|NCT00705783|64363378|FG000|Conversion Phase|Lost to Follow-up|13|||
23169178|NCT00705783|64363379|FG001|Conversion Phase|Lost to Follow-up|0|||
23336142|NCT02282813|64973117|FG000|Overall Study|Adverse Event|3|||
23336143|NCT02282813|64973118|FG001|Overall Study|Adverse Event|10|||
23336144|NCT02282813|64973119|FG002|Overall Study|Adverse Event|1|||
23336145|NCT02282813|64973117|FG000|Overall Study|Subject non-compliance|1|||
23336146|NCT02282813|64973118|FG001|Overall Study|Subject non-compliance|4|||
23336147|NCT02282813|64973119|FG002|Overall Study|Subject non-compliance|0|||
23336148|NCT02282813|64973117|FG000|Overall Study|Physician Decision|0|||
23336149|NCT02282813|64973118|FG001|Overall Study|Physician Decision|3|||
23336150|NCT02282813|64973119|FG002|Overall Study|Physician Decision|1|||
23169179|NCT00705783|64363380|FG002|Conversion Phase|Lost to Follow-up|0|||
23169180|NCT00705783|64363378|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
23336151|NCT02282813|64973117|FG000|Overall Study|Lost to Follow-up|2|||
23336152|NCT02282813|64973118|FG001|Overall Study|Lost to Follow-up|0|||
23336153|NCT02282813|64973119|FG002|Overall Study|Lost to Follow-up|1|||
23336154|NCT02282813|64973117|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
23336155|NCT02282813|64973118|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
23336156|NCT02282813|64973119|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
23336157|NCT02282813|64973117|FG000|Overall Study|Lack of Efficacy|1|||
23336158|NCT02282813|64973118|FG001|Overall Study|Lack of Efficacy|0|||
23336159|NCT02282813|64973119|FG002|Overall Study|Lack of Efficacy|0|||
23336160|NCT02282813|64973117|FG000|Overall Study|Administrative reasons|0|||
23336161|NCT02282813|64973118|FG001|Overall Study|Administrative reasons|1|||
23336162|NCT02282813|64973119|FG002|Overall Study|Administrative reasons|0|||
23169181|NCT00705783|64363379|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
23169182|NCT00705783|64363380|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
23169183|NCT00705783|64363378|FG000|Conversion Phase|Withdrawn by Investigator|4|||
23169184|NCT00705783|64363379|FG001|Conversion Phase|Withdrawn by Investigator|0|||
23169185|NCT00705783|64363380|FG002|Conversion Phase|Withdrawn by Investigator|0|||
23169186|NCT00705783|64363378|FG000|Conversion Phase|Withdrew Consent|24|||
23336163|NCT01081769|64973120|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
23336164|NCT01081769|64973121|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
23336165|NCT01081769|64973120|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
23336166|NCT01081769|64973121|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
23336167|NCT01081769|64973120|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
23336168|NCT01081769|64973121|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
23336169|NCT01081769|64973120|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
23336170|NCT01081769|64973121|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
23336171|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Adverse Event|14|||
23336172|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Adverse Event|11|||
23336173|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Death|1|||
23336174|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Death|1|||
23336175|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
23336176|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
23336177|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
23336178|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
23336179|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Pregnancy|1|||
23336180|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Pregnancy|0|||
23336181|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
23336182|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
23336183|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
23336184|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
23228053|NCT00819052|64578000|FG001|Overall Study|Lack of Efficacy|1|||
23228054|NCT00819052|64577999|FG000|Overall Study|Pregnancy|1|||
23228055|NCT00819052|64578000|FG001|Overall Study|Pregnancy|2|||
23228056|NCT00819052|64577999|FG000|Overall Study|Death or events leading to death|1|||
23228057|NCT00819052|64578000|FG001|Overall Study|Death or events leading to death|0|||
23228058|NCT00584987|64578001|FG000|Overall Study|Protocol Violation|1|||
23228059|NCT00584987|64578002|FG001|Overall Study|Protocol Violation|1|||
23228060|NCT00584987|64578003|FG002|Overall Study|Protocol Violation|1|||
23228061|NCT00584987|64578004|FG003|Overall Study|Protocol Violation|0|||
23228062|NCT00584987|64578001|FG000|Overall Study|Adverse Event|0|||
23228063|NCT00584987|64578002|FG001|Overall Study|Adverse Event|0|||
23228064|NCT00584987|64578003|FG002|Overall Study|Adverse Event|0|||
23228065|NCT00584987|64578004|FG003|Overall Study|Adverse Event|1|||
23228066|NCT01997333|64578005|FG000|Randomization and Treatment|Disease Progression|70|||
23228067|NCT01997333|64578006|FG001|Randomization and Treatment|Disease Progression|159|||
23228068|NCT01997333|64578005|FG000|Randomization and Treatment|Adverse Event|10|||
23228069|NCT01997333|64578006|FG001|Randomization and Treatment|Adverse Event|32|||
23228070|NCT01997333|64578005|FG000|Randomization and Treatment|Physician Decision|0|||
23336185|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Other|0|||
23336186|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Other|1|||
23169187|NCT00705783|64363379|FG001|Conversion Phase|Withdrew Consent|0|||
23336187|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Ineligibility|3|||
23336188|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Ineligibility|4|||
23336189|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
23169188|NCT00705783|64363380|FG002|Conversion Phase|Withdrew Consent|0|||
23169189|NCT00705783|64363378|FG000|Conversion Phase|Protocol Deviation|2|||
23169190|NCT00705783|64363379|FG001|Conversion Phase|Protocol Deviation|0|||
23169191|NCT00705783|64363380|FG002|Conversion Phase|Protocol Deviation|0|||
23169192|NCT00705783|64363378|FG000|Conversion Phase|Adverse Event|11|||
23169193|NCT00705783|64363379|FG001|Conversion Phase|Adverse Event|0|||
23169194|NCT00705783|64363380|FG002|Conversion Phase|Adverse Event|0|||
23169195|NCT00705783|64363378|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
23169196|NCT00705783|64363379|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23169197|NCT00705783|64363380|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
23169198|NCT00705783|64363378|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
23169199|NCT00705783|64363379|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23169200|NCT00705783|64363380|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
23169201|NCT00705783|64363378|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
23169202|NCT00705783|64363379|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
23169203|NCT00705783|64363380|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
23169204|NCT00705783|64363378|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
23169205|NCT00705783|64363379|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
23169206|NCT00705783|64363380|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
23169207|NCT00705783|64363378|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
23169208|NCT00705783|64363379|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23169209|NCT00705783|64363380|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
23169210|NCT00705783|64363378|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
23169211|NCT00705783|64363379|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23169212|NCT00705783|64363380|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
23169213|NCT00705783|64363378|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
23169214|NCT00705783|64363379|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
23228071|NCT01997333|64578006|FG001|Randomization and Treatment|Physician Decision|4|||
23576485|NCT02061761|65843367|FG005|Overall Study|Participant request to discontinue study treatment|1|||
23576486|NCT02061761|65843368|FG006|Overall Study|Participant request to discontinue study treatment|0|||
23576487|NCT02061761|65843369|FG007|Overall Study|Participant request to discontinue study treatment|0|||
23576488|NCT02061761|65843370|FG008|Overall Study|Participant request to discontinue study treatment|2|||
23576489|NCT02061761|65843362|FG000|Overall Study|Withdrawal by Subject|0|||
23576490|NCT02061761|65843363|FG001|Overall Study|Withdrawal by Subject|0|||
23576491|NCT02061761|65843364|FG002|Overall Study|Withdrawal by Subject|0|||
23576492|NCT02061761|65843365|FG003|Overall Study|Withdrawal by Subject|0|||
23576493|NCT02061761|65843366|FG004|Overall Study|Withdrawal by Subject|0|||
23169215|NCT00705783|64363380|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
23169216|NCT00705783|64363378|FG000|Oral Stabilization Phase|Adverse Event|14|||
23169217|NCT00705783|64363379|FG001|Oral Stabilization Phase|Adverse Event|0|||
23169218|NCT00705783|64363380|FG002|Oral Stabilization Phase|Adverse Event|0|||
23169219|NCT00705783|64363378|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
23169220|NCT00705783|64363379|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23169221|NCT00705783|64363380|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23169222|NCT00705783|64363378|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
23169223|NCT00705783|64363379|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23169224|NCT00705783|64363380|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23169225|NCT00705783|64363378|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
23169226|NCT00705783|64363379|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
23169227|NCT00705783|64363380|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
23169228|NCT00705783|64363378|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
23169229|NCT00705783|64363379|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
23169230|NCT00705783|64363380|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
23169231|NCT00705783|64363378|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
23169232|NCT00705783|64363379|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
23169233|NCT00705783|64363380|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
23169234|NCT00705783|64363378|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
23228072|NCT01997333|64578005|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
23228073|NCT01997333|64578006|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
23228074|NCT01997333|64578005|FG000|Randomization and Treatment|Did not receive treatment|17|||
23228075|NCT01997333|64578006|FG001|Randomization and Treatment|Did not receive treatment|5|||
23228076|NCT01997333|64578005|FG000|Survival Follow up|Withdrawal by Subject|15|||
23228077|NCT01997333|64578006|FG001|Survival Follow up|Withdrawal by Subject|6|||
23228078|NCT01997333|64578005|FG000|Survival Follow up|Lost to Follow-up|0|||
23576494|NCT02061761|65843367|FG005|Overall Study|Withdrawal by Subject|0|||
23576495|NCT02061761|65843368|FG006|Overall Study|Withdrawal by Subject|0|||
23576496|NCT02061761|65843369|FG007|Overall Study|Withdrawal by Subject|0|||
23169235|NCT00705783|64363379|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
23169236|NCT00705783|64363380|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
23228079|NCT01997333|64578006|FG001|Survival Follow up|Lost to Follow-up|6|||
23576497|NCT02061761|65843370|FG008|Overall Study|Withdrawal by Subject|2|||
23169237|NCT00705783|64363378|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
23169238|NCT00705783|64363379|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
23169239|NCT00705783|64363380|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
23169240|NCT00705783|64363378|FG000|Depot Stabilization Phase|Adverse Event|17|||
23169241|NCT00705783|64363379|FG001|Depot Stabilization Phase|Adverse Event|0|||
23169242|NCT00705783|64363380|FG002|Depot Stabilization Phase|Adverse Event|0|||
23169243|NCT00705783|64363378|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
23169244|NCT00705783|64363379|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23169245|NCT00705783|64363380|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
23169246|NCT00705783|64363378|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
23169247|NCT00705783|64363379|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23169248|NCT00705783|64363380|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
23169249|NCT00705783|64363378|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
23169250|NCT00705783|64363379|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
23169251|NCT00705783|64363380|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
23169252|NCT00705783|64363378|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
23169253|NCT00705783|64363379|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
23169254|NCT00705783|64363380|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
23169255|NCT00705783|64363378|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
23169256|NCT00705783|64363379|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
23169257|NCT00705783|64363380|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
23169258|NCT00705783|64363378|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
23169259|NCT00705783|64363379|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
23169260|NCT00705783|64363380|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
23169261|NCT00705783|64363378|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
23169262|NCT00705783|64363379|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
23336190|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
23336191|NCT01081769|64973120|FG000|CORE Intent-To-Treat|Patient Moved|2|||
23336192|NCT01081769|64973121|FG001|CORE Intent-To-Treat|Patient Moved|2|||
23576498|NCT02061761|65843362|FG000|Overall Study|Maximum clinical benefit|0|||
23169263|NCT00705783|64363380|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
23169264|NCT00705783|64363378|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
23228080|NCT01997333|64578005|FG000|Survival Follow up|Various|1|||
23336193|NCT00491556|64973122|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
23336194|NCT00491556|64973123|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
23336195|NCT00491556|64973122|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
23336196|NCT00491556|64973123|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
23336197|NCT00491556|64973122|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
23336198|NCT00491556|64973123|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
23336199|NCT00491556|64973122|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
23336200|NCT00491556|64973123|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
23336201|NCT00491556|64973122|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
23448354|NCT02869633|65384588|FG000|Overall Study|Provider discretion|1|||
23228081|NCT01997333|64578006|FG001|Survival Follow up|Various|2|||
23228082|NCT02306148|64578010|FG000|Overall Study|Adverse Event|12|||
23228083|NCT02306148|64578011|FG001|Overall Study|Adverse Event|6|||
23228084|NCT02306148|64578010|FG000|Overall Study|Lost to Follow-up|1|||
23228085|NCT02306148|64578011|FG001|Overall Study|Lost to Follow-up|4|||
23228086|NCT00323479|64578012|FG000|Overall Study|Adverse Event|2|||
23228087|NCT00323479|64578012|FG000|Overall Study|Withdrawal by Subject|2|||
23228088|NCT00323479|64578012|FG000|Overall Study|Protocol Violation|3|||
23228089|NCT00323479|64578012|FG000|Overall Study|house moving|1|||
23228090|NCT03018340|64578013|FG000|Overall Study|Adverse Event|1|||
23228091|NCT03018340|64578014|FG001|Overall Study|Adverse Event|2|||
23228092|NCT03018340|64578013|FG000|Overall Study|Withdrawal by Subject|0|||
23228093|NCT03018340|64578014|FG001|Overall Study|Withdrawal by Subject|8|||
23228094|NCT03018340|64578013|FG000|Overall Study|Lack of Efficacy|0|||
23228095|NCT03018340|64578014|FG001|Overall Study|Lack of Efficacy|1|||
23228096|NCT03018340|64578013|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
23228097|NCT03018340|64578014|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
23228098|NCT03018340|64578013|FG000|Overall Study|Lost to Follow-up|1|||
23228099|NCT03018340|64578014|FG001|Overall Study|Lost to Follow-up|7|||
23228100|NCT03018340|64578013|FG000|Overall Study|Protocol Violation|3|||
23228101|NCT03018340|64578014|FG001|Overall Study|Protocol Violation|7|||
23228102|NCT03018340|64578013|FG000|Overall Study|Not further specified|0|||
23228103|NCT03018340|64578014|FG001|Overall Study|Not further specified|1|||
23228104|NCT03512028|64578015|FG000|Overall Study|Withdrawal by Subject|2|||
23228105|NCT03512028|64578016|FG001|Overall Study|Withdrawal by Subject|0|||
23228106|NCT03512028|64578015|FG000|Overall Study|Protocol Violation|2|||
23576499|NCT02061761|65843363|FG001|Overall Study|Maximum clinical benefit|0|||
23169265|NCT00705783|64363379|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
23169266|NCT00705783|64363380|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
23336202|NCT00491556|64973123|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
23336203|NCT00491556|64973122|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
23336204|NCT00491556|64973123|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
23336205|NCT00491556|64973122|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
23336206|NCT00491556|64973123|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
23336207|NCT00491556|64973122|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
23336208|NCT00491556|64973123|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
23336209|NCT00491556|64973122|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
23336210|NCT00491556|64973123|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
23336211|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
23169267|NCT00705783|64363378|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
23169268|NCT00705783|64363379|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
23169269|NCT00705783|64363380|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
23169270|NCT00705783|64363378|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
23169271|NCT00705783|64363379|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
23169272|NCT00705783|64363380|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
23336212|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
23336213|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
23336214|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
23336215|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
23336216|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
23336217|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
23336218|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
23336219|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
23336220|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
23336221|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
23336222|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
23336223|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
23336224|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
23336225|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
23336226|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
23336227|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
23336228|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
23336229|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
23336230|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
23336231|NCT00491556|64973122|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
23336232|NCT00491556|64973123|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
23336233|NCT01681212|64973126|FG000|Overall Study|No longer met study criteria|5|||
23336234|NCT01681212|64973126|FG000|Overall Study|Administrative reason by sponsor|1|||
23336235|NCT00489307|64973127|FG000|Overall Study|Death|1|||
23336236|NCT00489307|64973128|FG001|Overall Study|Death|1|||
23448355|NCT02869633|65384589|FG001|Overall Study|Provider discretion|0|||
23448356|NCT02869633|65384588|FG000|Overall Study|Investigator decision|1|||
23448357|NCT02869633|65384589|FG001|Overall Study|Investigator decision|0|||
23448358|NCT02869633|65384588|FG000|Overall Study|Lost to Follow-up|0|||
23448359|NCT02869633|65384589|FG001|Overall Study|Lost to Follow-up|1|||
23169273|NCT00705783|64363378|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
23169274|NCT00705783|64363379|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
23169275|NCT00705783|64363380|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
23169276|NCT01678144|64363381|FG000|Stage 1: MAR Classic|Adverse Event|1|||
23169277|NCT03509350|64366974|FG000|Overall Study|Withdrawal by Subject|0|||
23169278|NCT03509350|64366975|FG001|Overall Study|Withdrawal by Subject|2|||
23169279|NCT01692301|64366976|FG000|Overall Study|Adverse Event|15|||
23336237|NCT00489307|64973127|FG000|Overall Study|Lost to Follow-up|2|||
23448360|NCT02869633|65384588|FG000|Overall Study|Not eligible|6|||
23448361|NCT02869633|65384589|FG001|Overall Study|Not eligible|1|||
23448362|NCT02869633|65384588|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
23448363|NCT02869633|65384589|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
23448364|NCT02869633|65384588|FG000|Overall Study|Withdrawal by Subject|0|||
23448365|NCT02869633|65384589|FG001|Overall Study|Withdrawal by Subject|1|||
23448366|NCT00428948|65384592|FG000|Overall Study|Lost to Follow-up|15|||
23448367|NCT00428948|65384593|FG001|Overall Study|Lost to Follow-up|8|||
23448368|NCT00428948|65384592|FG000|Overall Study|Adverse Event|148|||
23448369|NCT00428948|65384593|FG001|Overall Study|Adverse Event|24|||
23448370|NCT00428948|65384592|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
23576500|NCT02061761|65843364|FG002|Overall Study|Maximum clinical benefit|0|||
23448371|NCT00428948|65384593|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
23448372|NCT00428948|65384592|FG000|Overall Study|Investigator Withdrew Subject|3|||
23169280|NCT01692301|64366977|FG001|Overall Study|Adverse Event|12|||
23448373|NCT00428948|65384593|FG001|Overall Study|Investigator Withdrew Subject|4|||
23448374|NCT00428948|65384592|FG000|Overall Study|Subject Withdrew Consent|50|||
23448375|NCT00428948|65384593|FG001|Overall Study|Subject Withdrew Consent|30|||
23448376|NCT00428948|65384592|FG000|Overall Study|Protocol Deviation|1|||
23448377|NCT00428948|65384593|FG001|Overall Study|Protocol Deviation|1|||
23448378|NCT00672555|65384594|FG000|Overall Study|Lost to Follow-up|4|||
23448379|NCT00672555|65384594|FG000|Overall Study|Did not want to answer questionnaire|2|||
23448380|NCT05051579|65384596|FG000|Overall Study|Withdrawal by Subject|3|||
23448381|NCT05051579|65384597|FG001|Overall Study|Withdrawal by Subject|5|||
23448382|NCT05051579|65384598|FG002|Overall Study|Withdrawal by Subject|2|||
23448383|NCT05051579|65384599|FG003|Overall Study|Withdrawal by Subject|1|||
23448384|NCT05051579|65384600|FG004|Overall Study|Withdrawal by Subject|4|||
23448385|NCT05051579|65384601|FG005|Overall Study|Withdrawal by Subject|0|||
23448386|NCT05051579|65384602|FG006|Overall Study|Withdrawal by Subject|4|||
23448387|NCT05051579|65384596|FG000|Overall Study|Lost to Follow-up|1|||
23448388|NCT05051579|65384597|FG001|Overall Study|Lost to Follow-up|0|||
23448389|NCT05051579|65384598|FG002|Overall Study|Lost to Follow-up|0|||
23448390|NCT05051579|65384599|FG003|Overall Study|Lost to Follow-up|0|||
23448391|NCT05051579|65384600|FG004|Overall Study|Lost to Follow-up|1|||
23448392|NCT05051579|65384601|FG005|Overall Study|Lost to Follow-up|0|||
23448393|NCT05051579|65384602|FG006|Overall Study|Lost to Follow-up|1|||
23448394|NCT05051579|65384596|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448395|NCT05051579|65384597|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448396|NCT05051579|65384598|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448397|NCT05051579|65384599|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448398|NCT05051579|65384600|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448399|NCT05051579|65384601|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
23448400|NCT05051579|65384602|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
23448401|NCT05051579|65384596|FG000|Overall Study|Adverse Event|2|||
23448402|NCT05051579|65384597|FG001|Overall Study|Adverse Event|1|||
23448403|NCT05051579|65384598|FG002|Overall Study|Adverse Event|0|||
23448404|NCT05051579|65384599|FG003|Overall Study|Adverse Event|4|||
23448405|NCT05051579|65384600|FG004|Overall Study|Adverse Event|1|||
23448406|NCT05051579|65384601|FG005|Overall Study|Adverse Event|2|||
23448407|NCT05051579|65384602|FG006|Overall Study|Adverse Event|0|||
23448408|NCT05051579|65384596|FG000|Overall Study|Inadvertent Enrollment|0|||
23448409|NCT05051579|65384597|FG001|Overall Study|Inadvertent Enrollment|0|||
23448410|NCT05051579|65384598|FG002|Overall Study|Inadvertent Enrollment|0|||
23448411|NCT05051579|65384599|FG003|Overall Study|Inadvertent Enrollment|0|||
23448412|NCT05051579|65384600|FG004|Overall Study|Inadvertent Enrollment|0|||
23448413|NCT05051579|65384601|FG005|Overall Study|Inadvertent Enrollment|0|||
23448414|NCT05051579|65384602|FG006|Overall Study|Inadvertent Enrollment|1|||
23448415|NCT05051579|65384596|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448416|NCT05051579|65384597|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
23448417|NCT05051579|65384598|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448418|NCT05051579|65384599|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448419|NCT05051579|65384600|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448420|NCT05051579|65384601|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448421|NCT05051579|65384602|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
23448422|NCT05051579|65384596|FG000|Overall Study|Sponsor Decision|0|||
23448423|NCT05051579|65384597|FG001|Overall Study|Sponsor Decision|0|||
23448424|NCT05051579|65384598|FG002|Overall Study|Sponsor Decision|0|||
23448425|NCT05051579|65384599|FG003|Overall Study|Sponsor Decision|0|||
23448426|NCT05051579|65384600|FG004|Overall Study|Sponsor Decision|1|||
23448427|NCT05051579|65384601|FG005|Overall Study|Sponsor Decision|0|||
23448428|NCT05051579|65384602|FG006|Overall Study|Sponsor Decision|0|||
23448429|NCT05051579|65384596|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448430|NCT05051579|65384597|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448431|NCT05051579|65384598|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448432|NCT05051579|65384599|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448433|NCT05051579|65384600|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
23448434|NCT05051579|65384601|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23169281|NCT01692301|64366976|FG000|Overall Study|Death|1|||
23169282|NCT01692301|64366977|FG001|Overall Study|Death|2|||
23169283|NCT01692301|64366976|FG000|Overall Study|Lack of Efficacy|0|||
23169284|NCT01692301|64366977|FG001|Overall Study|Lack of Efficacy|5|||
23336238|NCT00489307|64973128|FG001|Overall Study|Lost to Follow-up|2|||
23169285|NCT01692301|64366976|FG000|Overall Study|Non-compliance with study treatment|1|||
23169286|NCT01692301|64366977|FG001|Overall Study|Non-compliance with study treatment|2|||
23169287|NCT01692301|64366976|FG000|Overall Study|Protocol deviation|9|||
23169288|NCT01692301|64366977|FG001|Overall Study|Protocol deviation|2|||
23169289|NCT01692301|64366976|FG000|Overall Study|Patient/guardian decision|16|||
23448435|NCT05051579|65384602|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
23448436|NCT01424501|65384603|FG000|Overall Study|Withdrawal by Subject|1|||
23448437|NCT01424501|65384604|FG001|Overall Study|Withdrawal by Subject|0|||
23448438|NCT01424501|65384605|FG002|Overall Study|Withdrawal by Subject|1|||
23448439|NCT01424501|65384606|FG003|Overall Study|Withdrawal by Subject|0|||
23448440|NCT01424501|65384607|FG004|Overall Study|Withdrawal by Subject|0|||
23448441|NCT01424501|65384608|FG005|Overall Study|Withdrawal by Subject|0|||
23448442|NCT01424501|65384603|FG000|Overall Study|Lost to Follow-up|0|||
23448443|NCT01424501|65384604|FG001|Overall Study|Lost to Follow-up|1|||
23448444|NCT01424501|65384605|FG002|Overall Study|Lost to Follow-up|1|||
23448445|NCT01424501|65384606|FG003|Overall Study|Lost to Follow-up|0|||
23448446|NCT01424501|65384607|FG004|Overall Study|Lost to Follow-up|0|||
23448447|NCT01424501|65384608|FG005|Overall Study|Lost to Follow-up|0|||
23448448|NCT04073186|65384614|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
23336239|NCT00489307|64973127|FG000|Overall Study|Physician Decision|1|||
23336240|NCT00489307|64973128|FG001|Overall Study|Physician Decision|0|||
23336241|NCT00489307|64973127|FG000|Overall Study|Withdrawal by Subject|2|||
23336242|NCT00489307|64973128|FG001|Overall Study|Withdrawal by Subject|4|||
23336243|NCT00489307|64973127|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
23336244|NCT00489307|64973128|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
23336245|NCT00489307|64973127|FG000|Overall Study|Surgery after assignment|1|||
23336246|NCT00489307|64973128|FG001|Overall Study|Surgery after assignment|0|||
23336247|NCT00489307|64973127|FG000|Overall Study|Did not fill up the forms|2|||
23336248|NCT00489307|64973128|FG001|Overall Study|Did not fill up the forms|1|||
23336249|NCT00489307|64973127|FG000|Overall Study|Patient or family refusal|5|||
23336250|NCT00489307|64973128|FG001|Overall Study|Patient or family refusal|9|||
23336251|NCT01011465|64973133|FG000|Overall Study|Withdrawal by Subject|2|||
23336252|NCT01011465|64973134|FG001|Overall Study|Withdrawal by Subject|1|||
23336253|NCT01011465|64973135|FG002|Overall Study|Withdrawal by Subject|0|||
23336254|NCT01011465|64973136|FG003|Overall Study|Withdrawal by Subject|0|||
23336255|NCT01011465|64973137|FG004|Overall Study|Withdrawal by Subject|1|||
23336256|NCT01011465|64973138|FG005|Overall Study|Withdrawal by Subject|0|||
23336257|NCT01011465|64973139|FG006|Overall Study|Withdrawal by Subject|1|||
23336258|NCT01011465|64973140|FG007|Overall Study|Withdrawal by Subject|0|||
23336259|NCT02411396|64973143|FG000|Overall Study|Lost to Follow-up|31|||
23336260|NCT02411396|64973143|FG000|Overall Study|Death|10|||
23336261|NCT00443079|64973145|FG000|Overall Study|Lost to Follow-up|0|||
23336262|NCT00443079|64973146|FG001|Overall Study|Lost to Follow-up|1|||
23336263|NCT02841280|64973147|FG000|Overall Study|Adverse Event|2|||
23336264|NCT02841280|64973148|FG001|Overall Study|Adverse Event|1|||
23336265|NCT02841280|64973147|FG000|Overall Study|Death|1|||
23336266|NCT02841280|64973148|FG001|Overall Study|Death|0|||
23336267|NCT02841280|64973147|FG000|Overall Study|Lost to Follow-up|2|||
23336268|NCT02841280|64973148|FG001|Overall Study|Lost to Follow-up|2|||
23336269|NCT02841280|64973147|FG000|Overall Study|Withdrawal by Subject|7|||
23336270|NCT02841280|64973148|FG001|Overall Study|Withdrawal by Subject|3|||
23336271|NCT02841280|64973147|FG000|Overall Study|Stop Point: BP above threshold|2|||
23336272|NCT02841280|64973148|FG001|Overall Study|Stop Point: BP above threshold|0|||
23336273|NCT00474045|64973160|FG000|Overall Study|Adverse Event|18|||
23336274|NCT00474045|64973161|FG001|Overall Study|Adverse Event|8|||
23336275|NCT00474045|64973160|FG000|Overall Study|Unclassified|1|||
23336276|NCT00474045|64973161|FG001|Overall Study|Unclassified|3|||
23336277|NCT00474045|64973160|FG000|Overall Study|Lack of Efficacy|0|||
23336278|NCT00474045|64973161|FG001|Overall Study|Lack of Efficacy|9|||
23336279|NCT00474045|64973160|FG000|Overall Study|Lost to Follow-up|1|||
23336280|NCT00474045|64973161|FG001|Overall Study|Lost to Follow-up|1|||
23336281|NCT00474045|64973160|FG000|Overall Study|Protocol Violation|10|||
23336282|NCT00474045|64973161|FG001|Overall Study|Protocol Violation|12|||
23336283|NCT00474045|64973160|FG000|Overall Study|Withdrawal by Subject|16|||
23336284|NCT00474045|64973161|FG001|Overall Study|Withdrawal by Subject|18|||
23336285|NCT00474045|64973160|FG000|Overall Study|Withdrawal criteria|60|||
23336286|NCT00474045|64973161|FG001|Overall Study|Withdrawal criteria|50|||
23336287|NCT01295671|64973164|FG000|Overall Study|Lost to Follow-up|4|||
23169290|NCT01692301|64366977|FG001|Overall Study|Patient/guardian decision|15|||
23169291|NCT01692301|64366976|FG000|Overall Study|Technical problems|0|||
23169292|NCT01692301|64366977|FG001|Overall Study|Technical problems|1|||
23169293|NCT01692301|64366976|FG000|Overall Study|Physician Decision|2|||
23169294|NCT01692301|64366977|FG001|Overall Study|Physician Decision|2|||
23336288|NCT01295671|64973165|FG001|Overall Study|Lost to Follow-up|6|||
23448449|NCT04073186|65384614|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
23336289|NCT01295671|64973166|FG002|Overall Study|Lost to Follow-up|3|||
23336290|NCT01295671|64973164|FG000|Overall Study|Withdrawal by Subject|3|||
23448450|NCT04073186|65384614|FG000|First Wearing Cycle|Protocol Violation|1|||
23336291|NCT01295671|64973165|FG001|Overall Study|Withdrawal by Subject|1|||
23336292|NCT01295671|64973166|FG002|Overall Study|Withdrawal by Subject|0|||
23336293|NCT00644917|64973167|FG000|Overall Study|Withdrawal by Subject|2|||
23336294|NCT01221272|64973168|FG000|Period 1|Adverse Event|2|||
23336295|NCT01221272|64973169|FG001|Period 1|Adverse Event|0|||
23336296|NCT01221272|64973168|FG000|Period 1|Consent Withdrawal|0|||
23336297|NCT01221272|64973169|FG001|Period 1|Consent Withdrawal|1|||
23336298|NCT01221272|64973168|FG000|Period 1|Significant Dosing Noncompliance|0|||
23336299|NCT01221272|64973169|FG001|Period 1|Significant Dosing Noncompliance|1|||
23336300|NCT01221272|64973168|FG000|Period 2|Adverse Event|0|||
23336301|NCT01221272|64973169|FG001|Period 2|Adverse Event|2|||
23336302|NCT00994461|64973174|FG000|Overall Study|Adverse Event|2|||
23336303|NCT00994461|64973175|FG001|Overall Study|Adverse Event|1|||
23336304|NCT00994461|64973176|FG002|Overall Study|Adverse Event|0|||
23336305|NCT00347009|64973177|FG000|Overall Study|Death|1|||
23336306|NCT00347009|64973177|FG000|Overall Study|Adverse Event|6|||
23336307|NCT00347009|64973177|FG000|Overall Study|Withdrawal by Subject|3|||
23336308|NCT00347009|64973177|FG000|Overall Study|Physician Decision|5|||
23336309|NCT00347009|64973177|FG000|Overall Study|Lost to Follow-up|4|||
23336310|NCT00347009|64973177|FG000|Overall Study|Protocol Violation|2|||
23336311|NCT00347009|64973177|FG000|Overall Study|Adverse Laboratory Experience|1|||
23336312|NCT00347009|64973177|FG000|Overall Study|Insufficient Viral Suppression|3|||
23336313|NCT00347009|64973177|FG000|Overall Study|Increased ALT/HBV DNA|1|||
23336314|NCT00347009|64973177|FG000|Overall Study|Serious Adverse Event|1|||
23336315|NCT01075256|64976004|FG000|Overall Study|Withdrawal by Subject|1|||
23336316|NCT01075256|64976005|FG001|Overall Study|Withdrawal by Subject|0|||
23336317|NCT01075256|64976006|FG002|Overall Study|Withdrawal by Subject|0|||
23336318|NCT01339923|64976014|FG000|Overall Study|Adverse Event|1|||
23336319|NCT01339923|64976015|FG001|Overall Study|Adverse Event|1|||
23336320|NCT01339923|64976016|FG002|Overall Study|Adverse Event|1|||
23336321|NCT01339923|64976017|FG003|Overall Study|Adverse Event|0|||
23336322|NCT01339923|64976018|FG004|Overall Study|Adverse Event|0|||
23336323|NCT01339923|64976019|FG005|Overall Study|Adverse Event|0|||
23336324|NCT01339923|64976020|FG006|Overall Study|Adverse Event|1|||
23336325|NCT01339923|64976014|FG000|Overall Study|Inappropriate Enrollment|1|||
23336326|NCT01339923|64976015|FG001|Overall Study|Inappropriate Enrollment|0|||
23336327|NCT01339923|64976016|FG002|Overall Study|Inappropriate Enrollment|0|||
23336328|NCT01339923|64976017|FG003|Overall Study|Inappropriate Enrollment|0|||
23336329|NCT01339923|64976018|FG004|Overall Study|Inappropriate Enrollment|0|||
23336330|NCT01339923|64976019|FG005|Overall Study|Inappropriate Enrollment|1|||
23336331|NCT01339923|64976020|FG006|Overall Study|Inappropriate Enrollment|0|||
23336332|NCT01339923|64976014|FG000|Overall Study|Lost to Follow-up|4|||
23336333|NCT01339923|64976015|FG001|Overall Study|Lost to Follow-up|4|||
23336334|NCT01339923|64976016|FG002|Overall Study|Lost to Follow-up|0|||
23169295|NCT01692301|64366976|FG000|Overall Study|Lost to Follow-up|1|||
23169296|NCT01692301|64366977|FG001|Overall Study|Lost to Follow-up|1|||
23169297|NCT01110200|64366978|FG000|Overall Study|Adverse Event|28|||
23169298|NCT01110200|64366979|FG001|Overall Study|Adverse Event|28|||
23169299|NCT01110200|64366978|FG000|Overall Study|Withdrawal by Subject|25|||
23336335|NCT01339923|64976017|FG003|Overall Study|Lost to Follow-up|3|||
23336336|NCT01339923|64976018|FG004|Overall Study|Lost to Follow-up|1|||
23336337|NCT01339923|64976019|FG005|Overall Study|Lost to Follow-up|1|||
23336338|NCT01339923|64976020|FG006|Overall Study|Lost to Follow-up|5|||
23336339|NCT01339923|64976014|FG000|Overall Study|Protocol Violation|0|||
23336340|NCT01339923|64976015|FG001|Overall Study|Protocol Violation|0|||
23336341|NCT01339923|64976016|FG002|Overall Study|Protocol Violation|0|||
23336342|NCT01339923|64976017|FG003|Overall Study|Protocol Violation|0|||
23336343|NCT01339923|64976018|FG004|Overall Study|Protocol Violation|0|||
23336344|NCT01339923|64976019|FG005|Overall Study|Protocol Violation|3|||
23336345|NCT01339923|64976020|FG006|Overall Study|Protocol Violation|1|||
23336346|NCT01339923|64976014|FG000|Overall Study|Unable to Classify|1|||
23336347|NCT01339923|64976015|FG001|Overall Study|Unable to Classify|0|||
23169300|NCT01110200|64366979|FG001|Overall Study|Withdrawal by Subject|32|||
23336348|NCT01339923|64976016|FG002|Overall Study|Unable to Classify|1|||
23336349|NCT01339923|64976017|FG003|Overall Study|Unable to Classify|0|||
23336350|NCT01339923|64976018|FG004|Overall Study|Unable to Classify|0|||
23336351|NCT01339923|64976019|FG005|Overall Study|Unable to Classify|1|||
23336352|NCT01339923|64976020|FG006|Overall Study|Unable to Classify|5|||
23169301|NCT01110200|64366978|FG000|Overall Study|Lack of Efficacy|16|||
23169302|NCT01110200|64366979|FG001|Overall Study|Lack of Efficacy|25|||
23336353|NCT01339923|64976014|FG000|Overall Study|Withdrawal by Subject|7|||
23336354|NCT01339923|64976015|FG001|Overall Study|Withdrawal by Subject|11|||
23336355|NCT01339923|64976016|FG002|Overall Study|Withdrawal by Subject|6|||
23336356|NCT01339923|64976017|FG003|Overall Study|Withdrawal by Subject|1|||
23336357|NCT01339923|64976018|FG004|Overall Study|Withdrawal by Subject|4|||
23336358|NCT01339923|64976019|FG005|Overall Study|Withdrawal by Subject|3|||
23336359|NCT01339923|64976020|FG006|Overall Study|Withdrawal by Subject|2|||
23336360|NCT02016105|64976026|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
23336361|NCT02016105|64976027|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
23336362|NCT02016105|64976028|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
23336363|NCT02016105|64976029|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
23336364|NCT02016105|64976030|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
23336365|NCT02016105|64976031|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
23336366|NCT02016105|64976026|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
23336367|NCT02016105|64976027|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
23336368|NCT02016105|64976028|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
23336369|NCT02016105|64976029|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
23336370|NCT02016105|64976030|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
23336371|NCT02016105|64976031|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
23336372|NCT02016105|64976026|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
23336373|NCT02016105|64976027|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
23336374|NCT02016105|64976028|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
23336375|NCT02016105|64976029|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
23336376|NCT02016105|64976030|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
23336377|NCT02016105|64976031|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
23336378|NCT02016105|64976026|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
23336379|NCT02016105|64976027|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
23336380|NCT02016105|64976028|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
23336381|NCT02016105|64976029|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
23336382|NCT02016105|64976030|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
23336383|NCT02016105|64976031|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
23336384|NCT02016105|64976026|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
23336385|NCT02016105|64976027|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
23336386|NCT02016105|64976028|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
23336387|NCT02016105|64976029|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
23336388|NCT02016105|64976030|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
23336389|NCT02016105|64976031|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
23336390|NCT02016105|64976026|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
23336391|NCT02016105|64976027|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
23336392|NCT02016105|64976028|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
23336393|NCT02016105|64976029|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
23336394|NCT02016105|64976030|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
23336395|NCT02016105|64976031|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
23336396|NCT02016105|64976026|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
23336397|NCT02016105|64976027|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
23336398|NCT02016105|64976028|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
23336399|NCT02016105|64976029|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
23336400|NCT02016105|64976030|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
23336401|NCT02016105|64976031|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
23336402|NCT02016105|64976026|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
23336403|NCT02016105|64976027|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
23336404|NCT02016105|64976028|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
23336405|NCT02016105|64976029|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
23336406|NCT02016105|64976030|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
23336407|NCT02016105|64976031|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
23336408|NCT02016105|64976026|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
23336409|NCT02016105|64976027|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
23336410|NCT02016105|64976028|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
23336411|NCT02016105|64976029|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
23336412|NCT02016105|64976030|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
23336413|NCT02016105|64976031|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
23336414|NCT02016105|64976026|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
23336415|NCT02016105|64976027|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
23336416|NCT02016105|64976028|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
23336417|NCT02016105|64976029|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
23336418|NCT02016105|64976030|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
23336419|NCT02016105|64976031|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
23336420|NCT02016105|64976026|FG000|TREATMENT PERIOD 2|Death|0|||
23336421|NCT02016105|64976027|FG001|TREATMENT PERIOD 2|Death|0|||
23336422|NCT02016105|64976028|FG002|TREATMENT PERIOD 2|Death|0|||
23336423|NCT02016105|64976029|FG003|TREATMENT PERIOD 2|Death|0|||
23336424|NCT02016105|64976030|FG004|TREATMENT PERIOD 2|Death|0|||
23336425|NCT02016105|64976031|FG005|TREATMENT PERIOD 2|Death|1|||
23336426|NCT02016105|64976026|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
23336427|NCT02016105|64976027|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
23336428|NCT02016105|64976028|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
23336429|NCT02016105|64976029|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
23336430|NCT02016105|64976030|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
23336431|NCT02016105|64976031|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
23336432|NCT02016105|64976026|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
23336433|NCT02016105|64976027|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
23336434|NCT02016105|64976028|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
23336435|NCT02016105|64976029|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
23169303|NCT01110200|64366978|FG000|Overall Study|Protocol Violation|14|||
23336436|NCT02016105|64976030|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
23336437|NCT02016105|64976031|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
23336438|NCT02016105|64976026|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
23336439|NCT02016105|64976027|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
23336440|NCT02016105|64976028|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
23336441|NCT02016105|64976029|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
23336442|NCT02016105|64976030|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
23336443|NCT02016105|64976031|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
23336444|NCT02016105|64976026|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
23336445|NCT02016105|64976027|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
23336446|NCT02016105|64976028|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
23336447|NCT02016105|64976029|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
23336448|NCT02016105|64976030|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
23336449|NCT02016105|64976031|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
23336450|NCT02016105|64976026|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
23336451|NCT02016105|64976027|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
23336452|NCT02016105|64976028|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
23336453|NCT02016105|64976029|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
23169304|NCT01110200|64366979|FG001|Overall Study|Protocol Violation|12|||
23169305|NCT01110200|64366978|FG000|Overall Study|Physician Decision|13|||
23169306|NCT01110200|64366979|FG001|Overall Study|Physician Decision|17|||
23169307|NCT01110200|64366978|FG000|Overall Study|Lost to Follow-up|10|||
23169308|NCT01110200|64366979|FG001|Overall Study|Lost to Follow-up|7|||
23169309|NCT05490771|64366980|FG000|Overall Study|Disease progression|18|||
23169310|NCT05490771|64366980|FG000|Overall Study|Adverse Event|3|||
23169311|NCT05490771|64366980|FG000|Overall Study|Other complicating disease|1|||
23169312|NCT05490771|64366980|FG000|Overall Study|Withdrawal by Subject|3|||
23169313|NCT05490771|64366980|FG000|Overall Study|Physician Decision|1|||
23169314|NCT05490771|64366980|FG000|Overall Study|Still on treatment|2|||
23169315|NCT05490771|64366980|FG000|Overall Study|Never start protocol therapy|5|||
23169316|NCT05490771|64366980|FG000|Overall Study|Ineligible|2|||
23169317|NCT00691483|64366981|FG000|Overall Study|Adverse Event|14|||
23169318|NCT00691483|64366982|FG001|Overall Study|Adverse Event|6|||
23169319|NCT00691483|64366981|FG000|Overall Study|Lost to Follow-up|17|||
23169320|NCT00691483|64366982|FG001|Overall Study|Lost to Follow-up|10|||
23169321|NCT00691483|64366981|FG000|Overall Study|Withdrawal by Subject|24|||
23169322|NCT00691483|64366982|FG001|Overall Study|Withdrawal by Subject|7|||
23169323|NCT00691483|64366981|FG000|Overall Study|Other known cause|6|||
23336454|NCT02016105|64976030|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
23336455|NCT02016105|64976031|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
23336456|NCT02016105|64976026|FG000|EXTENSION PERIOD|Adverse Event|0|||
23336457|NCT02016105|64976027|FG001|EXTENSION PERIOD|Adverse Event|0|||
23169324|NCT00691483|64366982|FG001|Overall Study|Other known cause|1|||
23169325|NCT00691483|64366981|FG000|Overall Study|Randomized by not treated|7|||
23169326|NCT00691483|64366982|FG001|Overall Study|Randomized by not treated|1|||
23169327|NCT01060059|64366992|FG000|Overall Study|Adverse Event|1|||
23169328|NCT01060059|64366993|FG001|Overall Study|Adverse Event|1|||
23169329|NCT01060059|64366992|FG000|Overall Study|Death|2|||
23169330|NCT01060059|64366993|FG001|Overall Study|Death|3|||
23169331|NCT01060059|64366992|FG000|Overall Study|Lost to Follow-up|18|||
23169332|NCT01060059|64366993|FG001|Overall Study|Lost to Follow-up|34|||
23169333|NCT01060059|64366992|FG000|Overall Study|entry criteria not met|4|||
23169334|NCT01060059|64366993|FG001|Overall Study|entry criteria not met|3|||
23336458|NCT02016105|64976028|FG002|EXTENSION PERIOD|Adverse Event|2|||
23336459|NCT02016105|64976029|FG003|EXTENSION PERIOD|Adverse Event|0|||
23336460|NCT02016105|64976030|FG004|EXTENSION PERIOD|Adverse Event|1|||
23336461|NCT02016105|64976031|FG005|EXTENSION PERIOD|Adverse Event|0|||
23336462|NCT02016105|64976026|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
23336463|NCT02016105|64976027|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
23336464|NCT02016105|64976028|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
23336465|NCT02016105|64976029|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
23336466|NCT02016105|64976030|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
23336467|NCT02016105|64976031|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
23336468|NCT02016105|64976026|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
23336469|NCT02016105|64976027|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
23336470|NCT02016105|64976028|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
23336471|NCT02016105|64976029|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
23336472|NCT02016105|64976030|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
23336473|NCT02016105|64976031|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
23336474|NCT02016105|64976026|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
23336475|NCT02016105|64976027|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
23336476|NCT02016105|64976028|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
23169335|NCT01060059|64366992|FG000|Overall Study|Withdrawal by Subject|35|||
23169336|NCT01060059|64366993|FG001|Overall Study|Withdrawal by Subject|23|||
23169337|NCT01060059|64366992|FG000|Overall Study|lack of glycemic control|2|||
23169338|NCT01060059|64366993|FG001|Overall Study|lack of glycemic control|1|||
23169339|NCT01060059|64366992|FG000|Overall Study|lack of compliance|5|||
23169340|NCT01060059|64366993|FG001|Overall Study|lack of compliance|2|||
23336477|NCT02016105|64976029|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
23336478|NCT02016105|64976030|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
23336479|NCT02016105|64976031|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
23336480|NCT02418156|64976032|FG000|Overall Study|Lost to Follow-up|12|||
23336481|NCT02418156|64976032|FG000|Overall Study|Death|2|||
23336482|NCT02418156|64976032|FG000|Overall Study|Physician Decision|1|||
23336483|NCT02418156|64976032|FG000|Overall Study|Withdrawal by Subject|1|||
23336484|NCT02418156|64976032|FG000|Overall Study|Subject refused to return|1|||
23336485|NCT01609543|64976033|FG000|Overall Study|Disease Progression|28|||
23336486|NCT01609543|64976033|FG000|Overall Study|Adverse Event|5|||
23336487|NCT01609543|64976033|FG000|Overall Study|Withdrawal by Subject|1|||
23336488|NCT01609543|64976033|FG000|Overall Study|Protocol Violation|1|||
23336489|NCT01609543|64976033|FG000|Overall Study|Death|7|||
23336490|NCT02805660|64976034|FG000|Overall Study|Death|5|||
23169341|NCT00516737|64366996|FG000|Overall Study|Lost to Follow-up|2|||
23169342|NCT00516737|64366997|FG001|Overall Study|Lost to Follow-up|0|||
23169343|NCT00516737|64366996|FG000|Overall Study|Physician Decision|0|||
23169344|NCT00516737|64366997|FG001|Overall Study|Physician Decision|1|||
23169345|NCT00516737|64366996|FG000|Overall Study|Withdrawal by Subject|0|||
23169346|NCT00516737|64366997|FG001|Overall Study|Withdrawal by Subject|1|||
23169347|NCT00516737|64366996|FG000|Overall Study|Lack of Qualifying Event|9|||
23169348|NCT00516737|64366997|FG001|Overall Study|Lack of Qualifying Event|6|||
23169349|NCT01745146|64366998|FG000|Overall Study|Withdrawal by Subject|1|||
23169350|NCT01745146|64366999|FG001|Overall Study|Withdrawal by Subject|3|||
23169351|NCT01745146|64366998|FG000|Overall Study|Lost to Follow-up|2|||
23169352|NCT01745146|64366999|FG001|Overall Study|Lost to Follow-up|0|||
23169353|NCT01396005|64367000|FG000|Overall Study|Withdrawal by Subject|0|||
23169354|NCT01396005|64367001|FG001|Overall Study|Withdrawal by Subject|1|||
23169355|NCT01396005|64367000|FG000|Overall Study|Non-compliance with protocol|0|||
23169356|NCT01396005|64367001|FG001|Overall Study|Non-compliance with protocol|1|||
23169357|NCT02363686|64367003|FG000|Overall Study|Withdrawal by Subject|22|||
23169358|NCT02363686|64367003|FG000|Overall Study|incomplete FEES examinations|13|||
23169359|NCT02568046|64367004|FG000|Overall Study|Adverse Event|0|||
23169360|NCT02568046|64367005|FG001|Overall Study|Adverse Event|1|||
23169361|NCT02568046|64367004|FG000|Overall Study|Death|2|||
23169362|NCT02568046|64367005|FG001|Overall Study|Death|0|||
23169363|NCT02568046|64367004|FG000|Overall Study|Progressive Disease|1|||
23169364|NCT02568046|64367005|FG001|Overall Study|Progressive Disease|0|||
23169365|NCT02568046|64367004|FG000|Overall Study|Withdrawal by Subject|2|||
23169366|NCT02568046|64367005|FG001|Overall Study|Withdrawal by Subject|1|||
23169367|NCT02568046|64367004|FG000|Overall Study|Other Events|0|||
23169368|NCT02568046|64367005|FG001|Overall Study|Other Events|1|||
23169369|NCT01731678|64367011|FG000|Overall Study|Withdrawal by Subject|3|||
23169370|NCT01731678|64367011|FG000|Overall Study|Did not meet inclusion criteria|1|||
23169371|NCT01731678|64367011|FG000|Overall Study|RMT too high, making TMS difficult|3|||
23169372|NCT00789529|64367014|FG000|Overall Study|Withdrawal by Subject|0|||
23169373|NCT00789529|64367015|FG001|Overall Study|Withdrawal by Subject|1|||
23169374|NCT00789529|64367014|FG000|Overall Study|Other Reason|1|||
23169375|NCT00789529|64367015|FG001|Overall Study|Other Reason|0|||
23169376|NCT04660643|64367016|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
23169377|NCT04660643|64367017|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
23169378|NCT04660643|64367018|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
23169379|NCT04660643|64367016|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
23169380|NCT04660643|64367017|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
23169381|NCT04660643|64367018|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
23169382|NCT04660643|64367016|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
23169383|NCT04660643|64367017|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
23169384|NCT04660643|64367018|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
23169385|NCT04660643|64367016|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
23169386|NCT04660643|64367017|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
23169387|NCT04660643|64367018|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
23336491|NCT02805660|64976035|FG001|Overall Study|Death|2|||
23336492|NCT02805660|64976036|FG002|Overall Study|Death|9|||
23169388|NCT04660643|64367016|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
23169389|NCT04660643|64367017|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
23169390|NCT04660643|64367018|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
23169391|NCT04660643|64367016|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
23169392|NCT04660643|64367017|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
23169393|NCT04660643|64367018|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
23336493|NCT02805660|64976037|FG003|Overall Study|Death|5|||
23336494|NCT02805660|64976038|FG004|Overall Study|Death|0|||
23336495|NCT02805660|64976039|FG005|Overall Study|Death|14|||
23336496|NCT02805660|64976040|FG006|Overall Study|Death|12|||
23336497|NCT02805660|64976034|FG000|Overall Study|Lost to Follow-up|0|||
23336498|NCT02805660|64976035|FG001|Overall Study|Lost to Follow-up|1|||
23336499|NCT02805660|64976036|FG002|Overall Study|Lost to Follow-up|1|||
23336500|NCT02805660|64976037|FG003|Overall Study|Lost to Follow-up|2|||
23336501|NCT02805660|64976038|FG004|Overall Study|Lost to Follow-up|0|||
23336502|NCT02805660|64976039|FG005|Overall Study|Lost to Follow-up|0|||
23336503|NCT02805660|64976040|FG006|Overall Study|Lost to Follow-up|0|||
23336504|NCT02805660|64976034|FG000|Overall Study|Withdrawal by Subject|0|||
23336505|NCT02805660|64976035|FG001|Overall Study|Withdrawal by Subject|0|||
23336506|NCT02805660|64976036|FG002|Overall Study|Withdrawal by Subject|0|||
23336507|NCT02805660|64976037|FG003|Overall Study|Withdrawal by Subject|3|||
23336508|NCT02805660|64976038|FG004|Overall Study|Withdrawal by Subject|1|||
23336509|NCT02805660|64976039|FG005|Overall Study|Withdrawal by Subject|0|||
23336510|NCT02805660|64976040|FG006|Overall Study|Withdrawal by Subject|2|||
23336511|NCT02805660|64976034|FG000|Overall Study|Study terminated by Sponsor|0|||
23336512|NCT02805660|64976035|FG001|Overall Study|Study terminated by Sponsor|0|||
23228107|NCT03512028|64578016|FG001|Overall Study|Protocol Violation|0|||
23228108|NCT02871791|64578017|FG000|Phase 1b|Death|0|||
23228109|NCT02871791|64578018|FG001|Phase 1b|Death|1|||
23228110|NCT02871791|64578017|FG000|Phase 1b|progressive disease|6|||
23228111|NCT02871791|64578018|FG001|Phase 1b|progressive disease|2|||
23228112|NCT02871791|64578017|FG000|Phase 2|Death|1|||
23228113|NCT02871791|64578018|FG001|Phase 2|Death|0|||
23336513|NCT02805660|64976036|FG002|Overall Study|Study terminated by Sponsor|1|||
23336514|NCT02805660|64976037|FG003|Overall Study|Study terminated by Sponsor|4|||
23336515|NCT02805660|64976038|FG004|Overall Study|Study terminated by Sponsor|2|||
23336516|NCT02805660|64976039|FG005|Overall Study|Study terminated by Sponsor|3|||
23336517|NCT02805660|64976040|FG006|Overall Study|Study terminated by Sponsor|1|||
23336518|NCT02805660|64976034|FG000|Overall Study|Miscellaneous|0|||
23336519|NCT02805660|64976035|FG001|Overall Study|Miscellaneous|1|||
23336520|NCT02805660|64976036|FG002|Overall Study|Miscellaneous|0|||
23336521|NCT02805660|64976037|FG003|Overall Study|Miscellaneous|4|||
23336522|NCT02805660|64976038|FG004|Overall Study|Miscellaneous|0|||
23336523|NCT02805660|64976039|FG005|Overall Study|Miscellaneous|6|||
23336524|NCT02805660|64976040|FG006|Overall Study|Miscellaneous|4|||
23336525|NCT03656692|64976041|FG000|Overall Study|Worsening of disease activity|2|||
23336526|NCT03656692|64976041|FG000|Overall Study|Physician Decision|1|||
23336527|NCT02275546|64976044|FG000|Treatment Period 2|Withdrawal by Subject|2|||
23336528|NCT02275546|64976045|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23336529|NCT02275546|64976044|FG000|Treatment Period 2|Protocol Violation|0|||
23336530|NCT02275546|64976045|FG001|Treatment Period 2|Protocol Violation|1|||
23336531|NCT03103321|64976046|FG000|Overall Study|Protocol Violation|1|||
23336532|NCT03103321|64976047|FG001|Overall Study|Protocol Violation|1|||
23336533|NCT03103321|64976048|FG002|Overall Study|Protocol Violation|1|||
23336534|NCT03103321|64976049|FG003|Overall Study|Protocol Violation|0|||
23336535|NCT01972438|64976050|FG000|Baseline-Month 3 Crossover Period|Death|1|||
23336536|NCT01972438|64976051|FG001|Baseline-Month 3 Crossover Period|Death|0|||
23336537|NCT01972438|64976050|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
23169394|NCT04660643|64367016|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
23169395|NCT04660643|64367017|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
23169396|NCT04660643|64367018|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
23169397|NCT04660643|64367016|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
23169398|NCT04660643|64367017|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
23169399|NCT04660643|64367018|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
23169400|NCT04660643|64367016|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
23169401|NCT04660643|64367017|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
23169402|NCT04660643|64367018|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
23169403|NCT04660643|64367016|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
23169404|NCT04660643|64367017|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
23169405|NCT04660643|64367018|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
23169406|NCT04660643|64367016|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
23169407|NCT04660643|64367017|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
23169408|NCT04660643|64367018|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
23169409|NCT04660643|64367016|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
23169410|NCT04660643|64367017|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
23228114|NCT02871791|64578017|FG000|Phase 2|Lost to Follow-up|2|||
23228115|NCT02871791|64578018|FG001|Phase 2|Lost to Follow-up|0|||
23228116|NCT00784459|64578020|FG000|Overall Study|Adverse Event|0|||
23228117|NCT00784459|64578021|FG001|Overall Study|Adverse Event|2|||
23336538|NCT01972438|64976051|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
23336539|NCT01972438|64976050|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
23336540|NCT01972438|64976051|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
23336541|NCT01972438|64976050|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
23336542|NCT01972438|64976051|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
23336543|NCT01972438|64976050|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
23336544|NCT01972438|64976051|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
23336545|NCT01972438|64976050|FG000|Months 6-12 Study Period|Death|1|||
23336546|NCT01972438|64976051|FG001|Months 6-12 Study Period|Death|0|||
23336547|NCT01972438|64976050|FG000|Months 6-12 Study Period|Early Study Closure|2|||
23336548|NCT01972438|64976051|FG001|Months 6-12 Study Period|Early Study Closure|2|||
23336549|NCT01972438|64976050|FG000|Post Month 12 Study Period|Early Study Closure|3|||
23336550|NCT01972438|64976051|FG001|Post Month 12 Study Period|Early Study Closure|4|||
23336551|NCT00471081|64976052|FG000|Active Phase|Protocol Violation|1|||
23336552|NCT00471081|64976053|FG001|Active Phase|Protocol Violation|1|||
23336553|NCT00471081|64976052|FG000|Active Phase|Withdrawal by Subject|0|||
23336554|NCT00471081|64976053|FG001|Active Phase|Withdrawal by Subject|3|||
23336555|NCT00471081|64976052|FG000|Active Phase|Lost to Follow-up|0|||
23448451|NCT04073186|65384614|FG000|First Wearing Cycle|Lens Discomfort|2|||
23448452|NCT04073186|65384614|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
23448453|NCT04073186|65384614|FG000|Second Wearing Cycle|Adverse Event|1|||
23448454|NCT04024891|65384616|FG000|Overall Study|Pregnancy|0|||
23448455|NCT04024891|65384617|FG001|Overall Study|Pregnancy|1|||
23448456|NCT04112303|65384621|FG000|Overall Study|Death|1|||
23448457|NCT02518971|65384623|FG000|Overall Study|Lost to Follow-up|0|||
23448458|NCT02518971|65384624|FG001|Overall Study|Lost to Follow-up|1|||
23448459|NCT02518971|65384623|FG000|Overall Study|Physician Decision|6|||
23448460|NCT02518971|65384624|FG001|Overall Study|Physician Decision|6|||
23448461|NCT02518971|65384623|FG000|Overall Study|Protocol Violation|6|||
23448462|NCT02518971|65384624|FG001|Overall Study|Protocol Violation|4|||
23448463|NCT02518971|65384623|FG000|Overall Study|Withdrawal by Subject|4|||
23448464|NCT02518971|65384624|FG001|Overall Study|Withdrawal by Subject|5|||
23448465|NCT02518971|65384623|FG000|Overall Study|Side effects|1|||
23169411|NCT04660643|64367018|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
23169412|NCT04660643|64367016|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
23169413|NCT04660643|64367017|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
23169414|NCT04660643|64367018|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
23169415|NCT04660643|64367016|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
23169416|NCT04660643|64367017|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
23169417|NCT04660643|64367018|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
23169418|NCT04660643|64367016|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
23169419|NCT04660643|64367017|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
23169420|NCT04660643|64367018|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
23169421|NCT04660643|64367016|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
23169422|NCT04660643|64367017|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
23169423|NCT04660643|64367018|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
23169424|NCT04418765|64367021|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
23169425|NCT04418765|64367022|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
23169426|NCT04418765|64367023|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
23169427|NCT04418765|64367021|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
23169428|NCT04418765|64367022|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
23169429|NCT04418765|64367023|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
23169430|NCT04418765|64367021|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
23169431|NCT04418765|64367022|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
23169432|NCT04418765|64367023|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
23169433|NCT04418765|64367021|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
23169434|NCT04418765|64367022|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
23169435|NCT04418765|64367023|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
23169436|NCT04418765|64367021|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
23169437|NCT04418765|64367022|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
23169438|NCT04418765|64367023|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
23169439|NCT04418765|64367021|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
23169440|NCT04418765|64367022|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
23169441|NCT04418765|64367023|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
23169442|NCT04418765|64367021|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
23448466|NCT02518971|65384624|FG001|Overall Study|Side effects|0|||
23448467|NCT02518971|65384623|FG000|Overall Study|medication lost in mail|0|||
23448468|NCT02518971|65384624|FG001|Overall Study|medication lost in mail|1|||
23576501|NCT02061761|65843365|FG003|Overall Study|Maximum clinical benefit|1|||
23576502|NCT02061761|65843366|FG004|Overall Study|Maximum clinical benefit|0|||
23448469|NCT02518971|65384623|FG000|Overall Study|eligibility criteria no longer met|6|||
23448470|NCT02518971|65384624|FG001|Overall Study|eligibility criteria no longer met|3|||
23448471|NCT01521507|65384625|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
23576503|NCT02061761|65843367|FG005|Overall Study|Maximum clinical benefit|0|||
23448472|NCT01521507|65384626|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
23448473|NCT01521507|65384625|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
23448474|NCT01521507|65384626|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
23448475|NCT01521507|65384625|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
23448476|NCT01521507|65384626|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
23448477|NCT01521507|65384625|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
23448478|NCT01521507|65384626|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
23448479|NCT01521507|65384625|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
23448480|NCT01521507|65384626|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
23448481|NCT01521507|65384625|FG000|Stage 2: Observational Design|Physician Decision|1|||
23448482|NCT01521507|65384626|FG001|Stage 2: Observational Design|Physician Decision|0|||
23448483|NCT01125800|65384628|FG000|Phase I|Protocol Violation|0|||
23448484|NCT01125800|65384629|FG001|Phase I|Protocol Violation|3|||
23448485|NCT01125800|65384630|FG002|Phase I|Protocol Violation|1|||
23448486|NCT01125800|65384631|FG003|Phase I|Protocol Violation|1|||
23448487|NCT01125800|65384632|FG004|Phase I|Protocol Violation|0|||
23448488|NCT01125800|65384628|FG000|Phase I|Adverse Event|2|||
23448489|NCT01125800|65384629|FG001|Phase I|Adverse Event|2|||
23448490|NCT01125800|65384630|FG002|Phase I|Adverse Event|1|||
23448491|NCT01125800|65384631|FG003|Phase I|Adverse Event|7|||
23448492|NCT01125800|65384632|FG004|Phase I|Adverse Event|0|||
23448493|NCT01125800|65384628|FG000|Phase I|Administrative problems|1|||
23448494|NCT01125800|65384629|FG001|Phase I|Administrative problems|0|||
23448495|NCT01125800|65384630|FG002|Phase I|Administrative problems|0|||
23448496|NCT01125800|65384631|FG003|Phase I|Administrative problems|0|||
23448497|NCT01125800|65384632|FG004|Phase I|Administrative problems|0|||
23448498|NCT01125800|65384628|FG000|Phase I|Withdrawal by Subject|0|||
23448499|NCT01125800|65384629|FG001|Phase I|Withdrawal by Subject|0|||
23448500|NCT01125800|65384630|FG002|Phase I|Withdrawal by Subject|1|||
23448501|NCT01125800|65384631|FG003|Phase I|Withdrawal by Subject|0|||
23448502|NCT01125800|65384632|FG004|Phase I|Withdrawal by Subject|0|||
23448503|NCT01125800|65384628|FG000|Phase I|Disease progression|5|||
23448504|NCT01125800|65384629|FG001|Phase I|Disease progression|4|||
23448505|NCT01125800|65384630|FG002|Phase I|Disease progression|1|||
23448506|NCT01125800|65384631|FG003|Phase I|Disease progression|3|||
23448507|NCT01125800|65384632|FG004|Phase I|Disease progression|0|||
23448508|NCT01125800|65384628|FG000|Phase II|Protocol Violation|0|||
23448509|NCT01125800|65384629|FG001|Phase II|Protocol Violation|0|||
23448510|NCT01125800|65384630|FG002|Phase II|Protocol Violation|0|||
23448511|NCT01125800|65384631|FG003|Phase II|Protocol Violation|0|||
23448512|NCT01125800|65384632|FG004|Phase II|Protocol Violation|1|||
23448513|NCT01125800|65384628|FG000|Phase II|Adverse Event|0|||
23448514|NCT01125800|65384629|FG001|Phase II|Adverse Event|0|||
23448515|NCT01125800|65384630|FG002|Phase II|Adverse Event|0|||
23448516|NCT01125800|65384631|FG003|Phase II|Adverse Event|0|||
23448517|NCT01125800|65384632|FG004|Phase II|Adverse Event|2|||
23448518|NCT01125800|65384628|FG000|Phase II|Disease progression|0|||
23448519|NCT01125800|65384629|FG001|Phase II|Disease progression|0|||
23448520|NCT01125800|65384630|FG002|Phase II|Disease progression|0|||
23336556|NCT00471081|64976053|FG001|Active Phase|Lost to Follow-up|1|||
23336557|NCT00471081|64976052|FG000|Active Phase|Lost health plan/insurance|1|||
23448521|NCT01125800|65384631|FG003|Phase II|Disease progression|1|||
23448522|NCT01125800|65384632|FG004|Phase II|Disease progression|8|||
23448523|NCT00462306|65384633|FG000|Overall Study|insufficient data|0|||
23448524|NCT00462306|65384634|FG001|Overall Study|insufficient data|13|||
23448525|NCT00402168|65384635|FG000|Randomized|Lost to Follow-up|1|||
23448526|NCT00402168|65384636|FG001|Randomized|Lost to Follow-up|0|||
23448527|NCT00402168|65384635|FG000|Randomized|Withdrawal by Subject|0|||
23448528|NCT00402168|65384636|FG001|Randomized|Withdrawal by Subject|1|||
23448529|NCT00402168|65384635|FG000|Treatment (up to 12 Months)|Death|0|||
23448530|NCT00402168|65384636|FG001|Treatment (up to 12 Months)|Death|1|||
23448531|NCT00402168|65384635|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
23448532|NCT00402168|65384636|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
23448533|NCT00402168|65384635|FG000|Treatment (up to 12 Months)|non-specified|0|||
23448534|NCT00402168|65384636|FG001|Treatment (up to 12 Months)|non-specified|1|||
23448535|NCT00402168|65384635|FG000|Long Term (LT)|Adverse Event|1|||
23448536|NCT00402168|65384636|FG001|Long Term (LT)|Adverse Event|5|||
23169443|NCT04418765|64367022|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
23169444|NCT04418765|64367023|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
23448537|NCT00402168|65384635|FG000|Long Term (LT)|Withdrawal by Subject|4|||
23448538|NCT00402168|65384636|FG001|Long Term (LT)|Withdrawal by Subject|7|||
23448539|NCT00402168|65384635|FG000|Long Term (LT)|Pregnancy|0|||
23448540|NCT00402168|65384636|FG001|Long Term (LT)|Pregnancy|1|||
23448541|NCT00402168|65384635|FG000|Long Term (LT)|Lost to Follow-up|1|||
23448542|NCT00402168|65384636|FG001|Long Term (LT)|Lost to Follow-up|0|||
23448543|NCT00402168|65384635|FG000|Long Term (LT)|Death|4|||
23448544|NCT00402168|65384636|FG001|Long Term (LT)|Death|0|||
23448545|NCT00402168|65384635|FG000|Long Term (LT)|Lack of Efficacy|0|||
23448546|NCT00402168|65384636|FG001|Long Term (LT)|Lack of Efficacy|2|||
23169445|NCT04418765|64367021|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
23169446|NCT04418765|64367022|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
23169447|NCT04418765|64367023|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
23169448|NCT04418765|64367021|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
23169449|NCT04418765|64367022|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
23169450|NCT04418765|64367023|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
23169451|NCT04418765|64367021|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
23169452|NCT04418765|64367022|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
23169453|NCT04418765|64367023|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
23169454|NCT04418765|64367021|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
23169455|NCT04418765|64367022|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
23169456|NCT04418765|64367023|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
23169457|NCT04418765|64367021|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
23169458|NCT04418765|64367022|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
23169459|NCT04418765|64367023|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
23169460|NCT04418765|64367021|FG000|Extension Period (48 Weeks)|Other than specified|0|||
23169461|NCT04418765|64367022|FG001|Extension Period (48 Weeks)|Other than specified|5|||
23169462|NCT04418765|64367023|FG002|Extension Period (48 Weeks)|Other than specified|2|||
23169463|NCT01098071|64367027|FG000|Overall Study|Surgery (adenoidectomy)|2|||
23169464|NCT01098071|64367027|FG000|Overall Study|Lost to Follow-up|13|||
23169465|NCT04673786|64367029|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
23169466|NCT04673786|64367030|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
23169467|NCT04673786|64367031|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
23169468|NCT04673786|64367029|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
23169469|NCT04673786|64367030|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
23169470|NCT04673786|64367031|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
23169471|NCT04673786|64367029|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
23169472|NCT04673786|64367030|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
23169473|NCT04673786|64367031|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
23169474|NCT04673786|64367029|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
23169475|NCT04673786|64367030|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
23169476|NCT04673786|64367031|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
23336558|NCT00471081|64976053|FG001|Active Phase|Lost health plan/insurance|8|||
23448547|NCT00402168|65384635|FG000|Long Term (LT)|non-specified|1|||
23448548|NCT00402168|65384636|FG001|Long Term (LT)|non-specified|2|||
23448549|NCT00402168|65384635|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
23448550|NCT00402168|65384636|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
23448551|NCT00402168|65384635|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
23448552|NCT00402168|65384636|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
23448553|NCT00496080|65384637|FG000|Overall Study|Lost to Follow-up|9|||
23448554|NCT00496080|65384637|FG000|Overall Study|Surgical re-intervention|7|||
23448555|NCT00496080|65384637|FG000|Overall Study|Withdrawal by Subject|5|||
23448556|NCT00496080|65384637|FG000|Overall Study|Physician Decision|6|||
23448557|NCT00887549|65384638|FG000|Induction Therapy|Adverse Event|8|||
23448558|NCT00887549|65384638|FG000|Induction Therapy|Physician Decision|1|||
23448559|NCT00887549|65384638|FG000|Induction Therapy|Progressive Disease|13|||
23448560|NCT00887549|65384638|FG000|Induction Therapy|Death due to Study Disease|4|||
23448561|NCT00887549|65384638|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
23448562|NCT00887549|65384638|FG000|Maintenance Therapy|Adverse Event|16|||
23448563|NCT00887549|65384638|FG000|Maintenance Therapy|Physician Decision|1|||
23448564|NCT00887549|65384638|FG000|Maintenance Therapy|Progressive Disease|25|||
23448565|NCT00887549|65384638|FG000|Maintenance Therapy|Death due to adverse event|1|||
23228118|NCT02203916|64578022|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23228119|NCT02203916|64578023|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
23228120|NCT02203916|64578024|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
23448566|NCT01485094|65384639|FG000|Overall Study|Adverse Event|1|||
23448567|NCT01485094|65384640|FG001|Overall Study|Adverse Event|1|||
23448568|NCT01485094|65384641|FG002|Overall Study|Adverse Event|1|||
23448569|NCT01485094|65384639|FG000|Overall Study|Lost to Follow-up|1|||
23448570|NCT01485094|65384640|FG001|Overall Study|Lost to Follow-up|0|||
23448571|NCT01485094|65384641|FG002|Overall Study|Lost to Follow-up|0|||
23448572|NCT01485094|65384639|FG000|Overall Study|Withdrawal by Subject|1|||
23169477|NCT04673786|64367029|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
23169478|NCT04673786|64367030|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
23169479|NCT04673786|64367031|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
23169480|NCT04673786|64367029|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
23169481|NCT04673786|64367030|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
23169482|NCT04673786|64367031|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
23169483|NCT03557281|64367032|FG000|Overall Study|Investigator discretion|0|||
23169484|NCT03557281|64367033|FG001|Overall Study|Investigator discretion|0|||
23169485|NCT03557281|64367034|FG002|Overall Study|Investigator discretion|1|||
23169486|NCT03557281|64367035|FG003|Overall Study|Investigator discretion|0|||
23169487|NCT03557281|64367036|FG004|Overall Study|Investigator discretion|0|||
23169488|NCT03557281|64367032|FG000|Overall Study|Withdrawal by Subject|0|||
23169489|NCT03557281|64367033|FG001|Overall Study|Withdrawal by Subject|1|||
23448573|NCT01485094|65384640|FG001|Overall Study|Withdrawal by Subject|1|||
23448574|NCT01485094|65384641|FG002|Overall Study|Withdrawal by Subject|0|||
23448575|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
23448576|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
23448577|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Death|1|||
23448578|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Death|2|||
23448579|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
23448580|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
23448581|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
23448582|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
23448583|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
23448584|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
23448585|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
23448586|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
23448587|NCT01794000|65384643|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
23448588|NCT01794000|65384644|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
23448589|NCT01794000|65384643|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
23448590|NCT01794000|65384644|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23448591|NCT04014062|65384645|FG000|Period I: Dosing|Medical Grounds|4|||
23448592|NCT04014062|65384646|FG001|Period I: Dosing|Medical Grounds|5|||
23448593|NCT04014062|65384645|FG000|Period I: Dosing|Withdrawal by Subject|3|||
23448594|NCT04014062|65384646|FG001|Period I: Dosing|Withdrawal by Subject|1|||
23448595|NCT01597635|65384647|FG000|Part A|Adverse Event|3|||
23448596|NCT01597635|65384648|FG001|Part A|Adverse Event|0|||
23448597|NCT01597635|65384649|FG002|Part A|Adverse Event|0|||
23448598|NCT01597635|65384647|FG000|Part B|Adverse Event|0|||
23448599|NCT01597635|65384648|FG001|Part B|Adverse Event|0|||
23448600|NCT01597635|65384649|FG002|Part B|Adverse Event|1|||
23448601|NCT01597635|65384647|FG000|Part B|Protocol Violation|0|||
23448602|NCT01597635|65384648|FG001|Part B|Protocol Violation|1|||
23448603|NCT01597635|65384649|FG002|Part B|Protocol Violation|0|||
23448604|NCT01597635|65384647|FG000|Part B|Protocol-defined stopping criteria|0|||
23228121|NCT02203916|64578022|FG000|Overall Study|Major Protocol Deviation|1|||
23448605|NCT01597635|65384648|FG001|Part B|Protocol-defined stopping criteria|4|||
23448606|NCT01597635|65384649|FG002|Part B|Protocol-defined stopping criteria|3|||
23448607|NCT01597635|65384647|FG000|Part B|Withdrawal by Subject|0|||
23448608|NCT01597635|65384648|FG001|Part B|Withdrawal by Subject|1|||
23448609|NCT01597635|65384649|FG002|Part B|Withdrawal by Subject|0|||
23448610|NCT01061359|65384654|FG000|Overall Study|Death|32|||
23448611|NCT01061359|65384654|FG000|Overall Study|Lost to Follow-up|1072|||
23448612|NCT01061359|65384654|FG000|Overall Study|Relapse|187|||
23448613|NCT01061359|65384654|FG000|Overall Study|Secondary neoplasm|11|||
23448614|NCT04393493|65384655|FG000|First 4 Days of Intervention|Early improvement|5|||
23448615|NCT04393493|65384656|FG001|First 4 Days of Intervention|Early improvement|7|||
23448616|NCT03137992|65384657|FG000|Washout Period 1|Adverse Event|1|||
23448617|NCT03137992|65384658|FG001|Washout Period 1|Adverse Event|1|||
23448618|NCT03137992|65384659|FG002|Washout Period 1|Adverse Event|0|||
23448619|NCT03137992|65384660|FG003|Washout Period 1|Adverse Event|0|||
23448620|NCT03137992|65384661|FG004|Washout Period 1|Adverse Event|0|||
23448621|NCT03137992|65384662|FG005|Washout Period 1|Adverse Event|1|||
23448622|NCT03137992|65384657|FG000|Washout Period 1|Withdrawal by Subject|0|||
23448623|NCT03137992|65384658|FG001|Washout Period 1|Withdrawal by Subject|1|||
23448624|NCT03137992|65384659|FG002|Washout Period 1|Withdrawal by Subject|1|||
23448625|NCT03137992|65384660|FG003|Washout Period 1|Withdrawal by Subject|0|||
23448626|NCT03137992|65384661|FG004|Washout Period 1|Withdrawal by Subject|0|||
23448627|NCT03137992|65384662|FG005|Washout Period 1|Withdrawal by Subject|0|||
23448628|NCT03137992|65384657|FG000|Washout Period 1|Principal Investigator Discretion|0|||
23448629|NCT03137992|65384658|FG001|Washout Period 1|Principal Investigator Discretion|1|||
23448630|NCT03137992|65384659|FG002|Washout Period 1|Principal Investigator Discretion|0|||
23448631|NCT03137992|65384660|FG003|Washout Period 1|Principal Investigator Discretion|0|||
23448632|NCT03137992|65384661|FG004|Washout Period 1|Principal Investigator Discretion|0|||
23448633|NCT03137992|65384662|FG005|Washout Period 1|Principal Investigator Discretion|0|||
23448634|NCT03137992|65384657|FG000|Washout Period 1|COPD Exacerbation|1|||
23448635|NCT03137992|65384658|FG001|Washout Period 1|COPD Exacerbation|1|||
23448636|NCT03137992|65384659|FG002|Washout Period 1|COPD Exacerbation|1|||
23448637|NCT03137992|65384660|FG003|Washout Period 1|COPD Exacerbation|0|||
23448638|NCT03137992|65384661|FG004|Washout Period 1|COPD Exacerbation|1|||
23448639|NCT03137992|65384662|FG005|Washout Period 1|COPD Exacerbation|1|||
23448640|NCT03137992|65384657|FG000|Washout Period 1|Subject Noncompliance|1|||
23448641|NCT03137992|65384658|FG001|Washout Period 1|Subject Noncompliance|0|||
23448642|NCT03137992|65384659|FG002|Washout Period 1|Subject Noncompliance|0|||
23448643|NCT03137992|65384660|FG003|Washout Period 1|Subject Noncompliance|0|||
23448644|NCT03137992|65384661|FG004|Washout Period 1|Subject Noncompliance|1|||
23448645|NCT03137992|65384662|FG005|Washout Period 1|Subject Noncompliance|0|||
23448646|NCT03137992|65384657|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
23448647|NCT03137992|65384658|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
23448648|NCT03137992|65384659|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
23448649|NCT03137992|65384660|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
23448650|NCT03137992|65384661|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
23448651|NCT03137992|65384662|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
23448652|NCT03137992|65384657|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
23448653|NCT03137992|65384658|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
23448654|NCT03137992|65384659|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
23448655|NCT03137992|65384660|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
23448656|NCT03137992|65384661|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
23448657|NCT03137992|65384662|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
23448658|NCT03137992|65384657|FG000|Period 2 (Visit 3)|Adverse Event|0|||
23448659|NCT03137992|65384658|FG001|Period 2 (Visit 3)|Adverse Event|1|||
23448660|NCT03137992|65384659|FG002|Period 2 (Visit 3)|Adverse Event|0|||
23448661|NCT03137992|65384660|FG003|Period 2 (Visit 3)|Adverse Event|0|||
23448662|NCT03137992|65384661|FG004|Period 2 (Visit 3)|Adverse Event|0|||
23169490|NCT03557281|64367034|FG002|Overall Study|Withdrawal by Subject|1|||
23169491|NCT03557281|64367035|FG003|Overall Study|Withdrawal by Subject|1|||
23169492|NCT03557281|64367036|FG004|Overall Study|Withdrawal by Subject|2|||
23169493|NCT03557281|64367032|FG000|Overall Study|Randomized, but did not receive treatment|0|||
23448663|NCT03137992|65384662|FG005|Period 2 (Visit 3)|Adverse Event|0|||
23448664|NCT03137992|65384657|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
23448665|NCT03137992|65384658|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
23169494|NCT03557281|64367033|FG001|Overall Study|Randomized, but did not receive treatment|0|||
23169495|NCT03557281|64367034|FG002|Overall Study|Randomized, but did not receive treatment|0|||
23169496|NCT03557281|64367035|FG003|Overall Study|Randomized, but did not receive treatment|0|||
23169497|NCT03557281|64367036|FG004|Overall Study|Randomized, but did not receive treatment|1|||
23169498|NCT03605680|64367039|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
23169499|NCT03605680|64367040|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
23448666|NCT03137992|65384659|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
23448667|NCT03137992|65384660|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
23448668|NCT03137992|65384661|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
23448669|NCT03137992|65384662|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
23448670|NCT03137992|65384657|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
23448671|NCT03137992|65384658|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
23448672|NCT03137992|65384659|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
23448673|NCT03137992|65384660|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
23169500|NCT03605680|64367041|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
23448674|NCT03137992|65384661|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
23448675|NCT03137992|65384662|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
23448676|NCT03137992|65384657|FG000|Washout Period 2|COPD Exacerbation|1|||
23448677|NCT03137992|65384658|FG001|Washout Period 2|COPD Exacerbation|1|||
23448678|NCT03137992|65384659|FG002|Washout Period 2|COPD Exacerbation|0|||
23448679|NCT03137992|65384660|FG003|Washout Period 2|COPD Exacerbation|0|||
23448680|NCT03137992|65384661|FG004|Washout Period 2|COPD Exacerbation|1|||
23448681|NCT03137992|65384662|FG005|Washout Period 2|COPD Exacerbation|0|||
23448682|NCT03137992|65384657|FG000|Washout Period 2|Subject Non-compliance|0|||
23448683|NCT03137992|65384658|FG001|Washout Period 2|Subject Non-compliance|1|||
23448684|NCT03137992|65384659|FG002|Washout Period 2|Subject Non-compliance|0|||
23448685|NCT03137992|65384660|FG003|Washout Period 2|Subject Non-compliance|0|||
23448686|NCT03137992|65384661|FG004|Washout Period 2|Subject Non-compliance|0|||
23448687|NCT03137992|65384662|FG005|Washout Period 2|Subject Non-compliance|0|||
23448688|NCT03137992|65384657|FG000|Washout Period 2|Adverse Event|0|||
23448689|NCT03137992|65384658|FG001|Washout Period 2|Adverse Event|0|||
23448690|NCT03137992|65384659|FG002|Washout Period 2|Adverse Event|0|||
23448691|NCT03137992|65384660|FG003|Washout Period 2|Adverse Event|1|||
23169501|NCT03605680|64367042|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
23169502|NCT03605680|64367039|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
23169503|NCT03605680|64367040|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
23169504|NCT03605680|64367041|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
23169505|NCT03605680|64367042|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
23169506|NCT03605680|64367039|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
23169507|NCT03605680|64367040|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
23169508|NCT03605680|64367041|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
23169509|NCT03605680|64367042|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
23169510|NCT03605680|64367039|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
23169511|NCT03605680|64367040|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
23169512|NCT03605680|64367041|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
23169513|NCT03605680|64367042|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
23448692|NCT03137992|65384661|FG004|Washout Period 2|Adverse Event|1|||
23448693|NCT03137992|65384662|FG005|Washout Period 2|Adverse Event|0|||
23448694|NCT03137992|65384657|FG000|Washout Period 2|Withdrawal by Subject|1|||
23448695|NCT03137992|65384658|FG001|Washout Period 2|Withdrawal by Subject|0|||
23448696|NCT03137992|65384659|FG002|Washout Period 2|Withdrawal by Subject|0|||
23448697|NCT03137992|65384660|FG003|Washout Period 2|Withdrawal by Subject|0|||
23448698|NCT03137992|65384661|FG004|Washout Period 2|Withdrawal by Subject|1|||
23448699|NCT03137992|65384662|FG005|Washout Period 2|Withdrawal by Subject|0|||
23448700|NCT03137992|65384657|FG000|Washout Period 2|Sponsor Decision|0|||
23448701|NCT03137992|65384658|FG001|Washout Period 2|Sponsor Decision|0|||
23448702|NCT03137992|65384659|FG002|Washout Period 2|Sponsor Decision|0|||
23448703|NCT03137992|65384660|FG003|Washout Period 2|Sponsor Decision|0|||
23448704|NCT03137992|65384661|FG004|Washout Period 2|Sponsor Decision|0|||
23169514|NCT03605680|64367039|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
23228122|NCT02203916|64578023|FG001|Overall Study|Major Protocol Deviation|1|||
23228123|NCT02203916|64578024|FG002|Overall Study|Major Protocol Deviation|0|||
23448705|NCT03137992|65384662|FG005|Washout Period 2|Sponsor Decision|1|||
23448706|NCT03137992|65384657|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
23448707|NCT03137992|65384658|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
23448708|NCT03137992|65384659|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
23448709|NCT03137992|65384660|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
23448710|NCT03137992|65384661|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
23448711|NCT03137992|65384662|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
23448712|NCT03137992|65384657|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
23448713|NCT03137992|65384658|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
23448714|NCT03137992|65384659|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
23448715|NCT03137992|65384660|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
23448716|NCT03137992|65384661|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
23448717|NCT03137992|65384662|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
23448718|NCT03137992|65384657|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
23448719|NCT03137992|65384658|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
23448720|NCT03137992|65384659|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
23448721|NCT03137992|65384660|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
23448722|NCT03137992|65384661|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
23448723|NCT03137992|65384662|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
23448724|NCT03137992|65384657|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23448725|NCT03137992|65384658|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23448726|NCT03137992|65384659|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23448727|NCT03137992|65384660|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
23448728|NCT03137992|65384661|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23228124|NCT02203916|64578022|FG000|Overall Study|Lost to Follow-up|0|||
23448729|NCT03137992|65384662|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
23448730|NCT03137992|65384657|FG000|Part 2 (Open-label Extension)|Per study team|1|||
23448731|NCT03137992|65384658|FG001|Part 2 (Open-label Extension)|Per study team|0|||
23448732|NCT03137992|65384659|FG002|Part 2 (Open-label Extension)|Per study team|0|||
23448733|NCT03137992|65384660|FG003|Part 2 (Open-label Extension)|Per study team|0|||
23448734|NCT03137992|65384661|FG004|Part 2 (Open-label Extension)|Per study team|0|||
23448735|NCT03137992|65384662|FG005|Part 2 (Open-label Extension)|Per study team|0|||
23448736|NCT03137992|65384657|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448737|NCT03137992|65384658|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448738|NCT03137992|65384659|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448739|NCT03137992|65384660|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448740|NCT03137992|65384661|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
23448741|NCT03137992|65384662|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
23448742|NCT04098809|65384665|FG000|Overall Study|Withdrawal by Subject|1|||
23448743|NCT04098809|65384666|FG001|Overall Study|Withdrawal by Subject|3|||
23448744|NCT04098809|65384665|FG000|Overall Study|Physician Decision|2|||
23448745|NCT04098809|65384666|FG001|Overall Study|Physician Decision|1|||
23448746|NCT03863509|65384667|FG000|Overall Study|COVID-19 shutdown period|0|||
23448747|NCT03863509|65384668|FG001|Overall Study|COVID-19 shutdown period|4|||
23448748|NCT03863509|65384669|FG002|Overall Study|COVID-19 shutdown period|0|||
23448749|NCT03863509|65384667|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
23448750|NCT03863509|65384668|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
23448751|NCT03863509|65384669|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
23448752|NCT03863509|65384667|FG000|Overall Study|Lost to Follow-up|8|||
23448753|NCT03863509|65384668|FG001|Overall Study|Lost to Follow-up|0|||
23448754|NCT03863509|65384669|FG002|Overall Study|Lost to Follow-up|2|||
23448755|NCT03863509|65384667|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
23448756|NCT03863509|65384668|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
23448757|NCT03863509|65384669|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
23448758|NCT03863509|65384667|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
23448759|NCT03863509|65384668|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
23448760|NCT03863509|65384669|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
23448761|NCT04378270|65384670|FG000|Overall Study|Lack of Efficacy|1|||
23448762|NCT04378270|65384670|FG000|Overall Study|Withdrawal by Subject|1|||
23448763|NCT04378270|65384670|FG000|Overall Study|Screen Failure|1|||
23448764|NCT04378270|65384670|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
23448765|NCT02614729|65384671|FG000|Overall Study|Withdrawal by Subject|1|||
23448766|NCT02614729|65384672|FG001|Overall Study|Withdrawal by Subject|0|||
23448767|NCT02680665|65384673|FG000|Overall Study|No visit after the first prescription|5|||
23448768|NCT02380287|65384674|FG000|Overall Study|Adverse Event|0|||
23448769|NCT02380287|65384675|FG001|Overall Study|Adverse Event|0|||
23448770|NCT02380287|65384676|FG002|Overall Study|Adverse Event|1|||
23448771|NCT02380287|65384677|FG003|Overall Study|Adverse Event|0|||
23448772|NCT02380287|65384678|FG004|Overall Study|Adverse Event|0|||
23448773|NCT02380287|65384679|FG005|Overall Study|Adverse Event|0|||
23448774|NCT02380287|65384680|FG006|Overall Study|Adverse Event|0|||
23448775|NCT02380287|65384681|FG007|Overall Study|Adverse Event|0|||
23448776|NCT00369577|65384682|FG000|Overall Study|Withdrawal by Subject|0|||
23448777|NCT00369577|65384683|FG001|Overall Study|Withdrawal by Subject|0|||
23448778|NCT00369577|65384684|FG002|Overall Study|Withdrawal by Subject|1|||
23448779|NCT00671034|65384685|FG000|Overall Study|Adverse Event|5|||
23448780|NCT00671034|65384686|FG001|Overall Study|Adverse Event|7|||
23448781|NCT00671034|65384687|FG002|Overall Study|Adverse Event|1|||
23448782|NCT00671034|65384685|FG000|Overall Study|Death|3|||
23448783|NCT00671034|65384686|FG001|Overall Study|Death|2|||
23448784|NCT00671034|65384687|FG002|Overall Study|Death|1|||
23448785|NCT00671034|65384685|FG000|Overall Study|Physician Decision|12|||
23448786|NCT00671034|65384686|FG001|Overall Study|Physician Decision|4|||
23448787|NCT00671034|65384687|FG002|Overall Study|Physician Decision|5|||
23448788|NCT00671034|65384685|FG000|Overall Study|VHR ALL feature|8|||
23448789|NCT00671034|65384686|FG001|Overall Study|VHR ALL feature|3|||
23448790|NCT00671034|65384687|FG002|Overall Study|VHR ALL feature|5|||
23448791|NCT00671034|65384685|FG000|Overall Study|Refusal|5|||
23448792|NCT00671034|65384686|FG001|Overall Study|Refusal|3|||
23448793|NCT00671034|65384687|FG002|Overall Study|Refusal|5|||
23448794|NCT00671034|65384685|FG000|Overall Study|includes Alternative therapy, etc.|6|||
23448795|NCT00671034|65384686|FG001|Overall Study|includes Alternative therapy, etc.|1|||
23448796|NCT00671034|65384687|FG002|Overall Study|includes Alternative therapy, etc.|7|||
23448797|NCT02252146|65384690|FG000|Overall Study|Lack of Efficacy|4|||
23448798|NCT02252146|65384690|FG000|Overall Study|Entered hospice care|1|||
23448799|NCT02252146|65384690|FG000|Overall Study|Inability to travel to study site|1|||
23448800|NCT00601835|65384694|FG000|Overall Study|Withdrawal by Subject|9|||
23448801|NCT00601835|65384695|FG001|Overall Study|Withdrawal by Subject|6|||
23448802|NCT00601835|65384694|FG000|Overall Study|Physician Decision|1|||
23448803|NCT00601835|65384695|FG001|Overall Study|Physician Decision|0|||
23448804|NCT00601835|65384694|FG000|Overall Study|Lost to Follow-up|37|||
23448805|NCT00601835|65384695|FG001|Overall Study|Lost to Follow-up|5|||
23448806|NCT00601835|65384694|FG000|Overall Study|Adverse Event|1|||
23448807|NCT00601835|65384695|FG001|Overall Study|Adverse Event|1|||
23169515|NCT03605680|64367040|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
23169516|NCT03605680|64367041|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
23169517|NCT03605680|64367042|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
23169518|NCT03605680|64367039|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
23169519|NCT03605680|64367040|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
23169520|NCT03605680|64367041|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
23169521|NCT03605680|64367042|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
23448808|NCT00601835|65384694|FG000|Overall Study|Relocate|12|||
23448809|NCT00601835|65384695|FG001|Overall Study|Relocate|2|||
23448810|NCT00354679|65384696|FG000|Overall Study|Patient Not Treated|1|||
23448811|NCT03343626|65384697|FG000|Overall Study|Lost to Follow-up|4|||
23448812|NCT03343626|65384698|FG001|Overall Study|Lost to Follow-up|3|||
23448813|NCT03343626|65384699|FG002|Overall Study|Lost to Follow-up|2|||
23448814|NCT03343626|65384700|FG003|Overall Study|Lost to Follow-up|5|||
23448815|NCT03343626|65384701|FG004|Overall Study|Lost to Follow-up|4|||
23448816|NCT03343626|65384702|FG005|Overall Study|Lost to Follow-up|4|||
23448817|NCT03343626|65384703|FG006|Overall Study|Lost to Follow-up|4|||
23448818|NCT03343626|65384704|FG007|Overall Study|Lost to Follow-up|7|||
23448819|NCT03343626|65384697|FG000|Overall Study|Withdrawal of Consent|2|||
23448820|NCT03343626|65384698|FG001|Overall Study|Withdrawal of Consent|1|||
23448821|NCT03343626|65384699|FG002|Overall Study|Withdrawal of Consent|0|||
23448822|NCT03343626|65384700|FG003|Overall Study|Withdrawal of Consent|3|||
23448823|NCT03343626|65384701|FG004|Overall Study|Withdrawal of Consent|3|||
23448824|NCT03343626|65384702|FG005|Overall Study|Withdrawal of Consent|1|||
23448825|NCT03343626|65384703|FG006|Overall Study|Withdrawal of Consent|1|||
23448826|NCT03343626|65384704|FG007|Overall Study|Withdrawal of Consent|2|||
23448827|NCT03343626|65384697|FG000|Overall Study|Reason not Specified|0|||
23448828|NCT03343626|65384698|FG001|Overall Study|Reason not Specified|1|||
23448829|NCT03343626|65384699|FG002|Overall Study|Reason not Specified|0|||
23448830|NCT03343626|65384700|FG003|Overall Study|Reason not Specified|0|||
23448831|NCT03343626|65384701|FG004|Overall Study|Reason not Specified|0|||
23448832|NCT03343626|65384702|FG005|Overall Study|Reason not Specified|0|||
23448833|NCT03343626|65384703|FG006|Overall Study|Reason not Specified|0|||
23448834|NCT03343626|65384704|FG007|Overall Study|Reason not Specified|1|||
23448835|NCT03343626|65384697|FG000|Overall Study|Data Entry Error|0|||
23448836|NCT03343626|65384698|FG001|Overall Study|Data Entry Error|0|||
23448837|NCT03343626|65384699|FG002|Overall Study|Data Entry Error|0|||
23448838|NCT03343626|65384700|FG003|Overall Study|Data Entry Error|0|||
23448839|NCT03343626|65384701|FG004|Overall Study|Data Entry Error|0|||
23448840|NCT03343626|65384702|FG005|Overall Study|Data Entry Error|0|||
23448841|NCT03343626|65384703|FG006|Overall Study|Data Entry Error|0|||
23448842|NCT03343626|65384704|FG007|Overall Study|Data Entry Error|1|||
23448843|NCT04486235|65384705|FG000|Overall Study|Pregnancy|1|||
23448844|NCT04486235|65384706|FG001|Overall Study|Pregnancy|0|||
23448845|NCT04486235|65384705|FG000|Overall Study|Lost to Follow-up|1|||
23448846|NCT04486235|65384706|FG001|Overall Study|Lost to Follow-up|0|||
23448847|NCT00655629|65384707|FG000|Overall Study|Adverse Event|4|||
23448848|NCT00655629|65384708|FG001|Overall Study|Adverse Event|1|||
23448849|NCT00655629|65384707|FG000|Overall Study|Lack of Efficacy|2|||
23448850|NCT00655629|65384708|FG001|Overall Study|Lack of Efficacy|12|||
23448851|NCT00655629|65384707|FG000|Overall Study|Lost to Follow-up|4|||
23448852|NCT00655629|65384708|FG001|Overall Study|Lost to Follow-up|3|||
23169522|NCT03605680|64367039|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
23336559|NCT00471081|64976052|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
23448853|NCT00655629|65384707|FG000|Overall Study|Protocol Violation|5|||
23448854|NCT00655629|65384708|FG001|Overall Study|Protocol Violation|3|||
23448855|NCT00655629|65384707|FG000|Overall Study|consent withdrawn|6|||
23448856|NCT00655629|65384708|FG001|Overall Study|consent withdrawn|4|||
23448857|NCT02025179|65384709|FG000|Overall Study|Lost to Follow-up|0|||
23448858|NCT02025179|65384710|FG001|Overall Study|Lost to Follow-up|0|||
23448859|NCT02025179|65384711|FG002|Overall Study|Lost to Follow-up|1|||
23448860|NCT01454596|65384714|FG000|Overall Study|Death|0|||
23448861|NCT01454596|65384715|FG001|Overall Study|Death|0|||
23448862|NCT01454596|65384716|FG002|Overall Study|Death|0|||
23448863|NCT01454596|65384717|FG003|Overall Study|Death|0|||
23448864|NCT01454596|65384718|FG004|Overall Study|Death|0|||
23448865|NCT01454596|65384719|FG005|Overall Study|Death|0|||
23448866|NCT01454596|65384720|FG006|Overall Study|Death|0|||
23448867|NCT01454596|65384721|FG007|Overall Study|Death|0|||
23448868|NCT01454596|65384722|FG008|Overall Study|Death|0|||
23448869|NCT01454596|65384723|FG009|Overall Study|Death|1|||
23448870|NCT01454596|65384724|FG010|Overall Study|Death|1|||
23448871|NCT01454596|65384725|FG011|Overall Study|Death|0|||
23448872|NCT01236521|65384726|FG000|Overall Study|Withdrawal by Subject|12|||
23448873|NCT01236521|65384727|FG001|Overall Study|Withdrawal by Subject|17|||
23448874|NCT01236521|65384726|FG000|Overall Study|Death|2|||
23448875|NCT01236521|65384727|FG001|Overall Study|Death|1|||
23448876|NCT01236521|65384726|FG000|Overall Study|Lost to Follow-up|9|||
23169523|NCT03605680|64367040|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
23169524|NCT03605680|64367041|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
23169525|NCT03605680|64367042|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
23169526|NCT03605680|64367039|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
23169527|NCT03605680|64367040|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
23169528|NCT03605680|64367041|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
23169529|NCT03605680|64367042|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
23169530|NCT03605680|64367039|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
23169531|NCT03605680|64367040|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
23228125|NCT02203916|64578023|FG001|Overall Study|Lost to Follow-up|1|||
23228126|NCT02203916|64578024|FG002|Overall Study|Lost to Follow-up|0|||
23228127|NCT02203916|64578022|FG000|Overall Study|Voluntary Withdrawal|3|||
23228128|NCT02203916|64578023|FG001|Overall Study|Voluntary Withdrawal|3|||
23448877|NCT01236521|65384727|FG001|Overall Study|Lost to Follow-up|7|||
23448878|NCT01486966|65384730|FG000|Overall Study|Adverse Event|0|||
23448879|NCT01486966|65384731|FG001|Overall Study|Adverse Event|1|||
23448880|NCT01486966|65384730|FG000|Overall Study|Withdrawal by Subject|0|||
23448881|NCT01486966|65384731|FG001|Overall Study|Withdrawal by Subject|1|||
23228129|NCT02203916|64578024|FG002|Overall Study|Voluntary Withdrawal|8|||
23228130|NCT02203916|64578022|FG000|Overall Study|Lack of Efficacy|3|||
23228131|NCT02203916|64578023|FG001|Overall Study|Lack of Efficacy|0|||
23228132|NCT02203916|64578024|FG002|Overall Study|Lack of Efficacy|0|||
23228133|NCT02203916|64578022|FG000|Overall Study|Reason Not Specified|0|||
23228134|NCT02203916|64578023|FG001|Overall Study|Reason Not Specified|2|||
23228135|NCT02203916|64578024|FG002|Overall Study|Reason Not Specified|1|||
23228136|NCT03323086|64578027|FG000|Overall Study|Lost to Follow-up|3|||
23228137|NCT03323086|64578028|FG001|Overall Study|Lost to Follow-up|2|||
23228138|NCT00423267|64578029|FG000|Period A|Withdrawal by Subject|0|||
23228139|NCT00423267|64578030|FG001|Period A|Withdrawal by Subject|1|||
23228140|NCT00423267|64578029|FG000|Period A|Non-compliance with protocol|1|||
23228141|NCT00423267|64578030|FG001|Period A|Non-compliance with protocol|0|||
23228142|NCT00423267|64578029|FG000|Period A|Administrative|1|||
23228143|NCT00423267|64578030|FG001|Period A|Administrative|0|||
23228144|NCT02425891|64578032|FG000|Overall Study|Death|333|||
23228145|NCT02425891|64578033|FG001|Overall Study|Death|314|||
23228146|NCT02425891|64578032|FG000|Overall Study|Lost to Follow-up|4|||
23228147|NCT02425891|64578033|FG001|Overall Study|Lost to Follow-up|6|||
23228148|NCT02425891|64578032|FG000|Overall Study|Non-Compliance|1|||
23228149|NCT02425891|64578033|FG001|Overall Study|Non-Compliance|1|||
23228150|NCT02425891|64578032|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
23228151|NCT02425891|64578033|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
23228152|NCT02425891|64578032|FG000|Overall Study|Physician Decision|0|||
23228153|NCT02425891|64578033|FG001|Overall Study|Physician Decision|1|||
23228154|NCT02425891|64578032|FG000|Overall Study|Protocol Violation|1|||
23228155|NCT02425891|64578033|FG001|Overall Study|Protocol Violation|1|||
23228156|NCT02425891|64578032|FG000|Overall Study|Study Terminated By Sponsor|85|||
23228157|NCT02425891|64578033|FG001|Overall Study|Study Terminated By Sponsor|95|||
23228158|NCT02425891|64578032|FG000|Overall Study|Withdrawal by Subject|27|||
23228159|NCT02425891|64578033|FG001|Overall Study|Withdrawal by Subject|32|||
23228160|NCT00634751|64578034|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
23448882|NCT01799226|65384748|FG000|Overall Study|Withdrawal by Subject|1|||
23448883|NCT01799226|65384749|FG001|Overall Study|Withdrawal by Subject|0|||
23448884|NCT01799226|65384748|FG000|Overall Study|Disqualified at Day 14|1|||
23228161|NCT00634751|64578035|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
23336560|NCT00471081|64976053|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
23448885|NCT01799226|65384749|FG001|Overall Study|Disqualified at Day 14|0|||
23576504|NCT02061761|65843368|FG006|Overall Study|Maximum clinical benefit|0|||
23228162|NCT00634751|64578036|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
23576505|NCT02061761|65843369|FG007|Overall Study|Maximum clinical benefit|0|||
23228163|NCT00634751|64578037|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
23228164|NCT00634751|64578034|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
23228165|NCT00634751|64578035|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
23448886|NCT02576639|65384750|FG000|Overall Study|Withdrawal by Subject|1|||
23448887|NCT02576639|65384751|FG001|Overall Study|Withdrawal by Subject|2|||
23448888|NCT02576639|65384752|FG002|Overall Study|Withdrawal by Subject|1|||
23448889|NCT02576639|65384753|FG003|Overall Study|Withdrawal by Subject|0|||
23448890|NCT02576639|65384754|FG004|Overall Study|Withdrawal by Subject|1|||
23448891|NCT02576639|65384750|FG000|Overall Study|Adverse Event|1|||
23448892|NCT02576639|65384751|FG001|Overall Study|Adverse Event|0|||
23448893|NCT02576639|65384752|FG002|Overall Study|Adverse Event|1|||
23448894|NCT02576639|65384753|FG003|Overall Study|Adverse Event|1|||
23448895|NCT02576639|65384754|FG004|Overall Study|Adverse Event|2|||
23448896|NCT02576639|65384750|FG000|Overall Study|Physician Decision|0|||
23448897|NCT02576639|65384751|FG001|Overall Study|Physician Decision|0|||
23448898|NCT02576639|65384752|FG002|Overall Study|Physician Decision|0|||
23448899|NCT02576639|65384753|FG003|Overall Study|Physician Decision|0|||
23448900|NCT02576639|65384754|FG004|Overall Study|Physician Decision|1|||
23448901|NCT01980095|65384755|FG000|Overall Study|Lost to Follow-up|6|||
23448902|NCT01980095|65384756|FG001|Overall Study|Lost to Follow-up|7|||
23448903|NCT01980095|65384755|FG000|Overall Study|Withdrawal by Subject|2|||
23448904|NCT01980095|65384756|FG001|Overall Study|Withdrawal by Subject|3|||
23448905|NCT01980095|65384755|FG000|Overall Study|Poor compliance|5|||
23448906|NCT01980095|65384756|FG001|Overall Study|Poor compliance|0|||
23448907|NCT01980095|65384755|FG000|Overall Study|Safety issue|0|||
23448908|NCT01980095|65384756|FG001|Overall Study|Safety issue|1|||
23448909|NCT01980095|65384755|FG000|Overall Study|Study drug discontinued|1|||
23448910|NCT01980095|65384756|FG001|Overall Study|Study drug discontinued|0|||
23448911|NCT01980095|65384755|FG000|Overall Study|Randomized by mistake|1|||
23448912|NCT01980095|65384756|FG001|Overall Study|Randomized by mistake|0|||
23448913|NCT01623115|65384760|FG000|Overall Study|Randomized but not treated|0|||
23448914|NCT01623115|65384761|FG001|Overall Study|Randomized but not treated|1|||
23448915|NCT01623115|65384760|FG000|Overall Study|Physician Decision|1|||
23448916|NCT01623115|65384761|FG001|Overall Study|Physician Decision|0|||
23448917|NCT01623115|65384760|FG000|Overall Study|Participants moved|1|||
23448918|NCT01623115|65384761|FG001|Overall Study|Participants moved|5|||
23448919|NCT01623115|65384760|FG000|Overall Study|Adverse Event|10|||
23448920|NCT01623115|65384761|FG001|Overall Study|Adverse Event|13|||
23228166|NCT00634751|64578036|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
23228167|NCT00634751|64578037|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
23576506|NCT02061761|65843370|FG008|Overall Study|Maximum clinical benefit|6|||
23336561|NCT00471081|64976052|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
23336562|NCT00471081|64976053|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
23336563|NCT00471081|64976052|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
23336564|NCT00471081|64976053|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
23336565|NCT03086967|64976054|FG000|Overall Study|Screen Failure|2|||
23336566|NCT03086967|64976055|FG001|Overall Study|Screen Failure|2|||
23336567|NCT01508130|64976060|FG000|Overall Study|Adverse Event|81|||
23336568|NCT01508130|64976061|FG001|Overall Study|Adverse Event|28|||
23228168|NCT00634751|64578034|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
23228169|NCT00634751|64578035|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
23228170|NCT00634751|64578036|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
23228171|NCT00634751|64578037|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
23228172|NCT03245840|64578038|FG000|Overall Study|Adverse Event|6|||
23228173|NCT03245840|64578039|FG001|Overall Study|Adverse Event|0|||
23228174|NCT03245840|64578038|FG000|Overall Study|Death|2|||
23228175|NCT03245840|64578039|FG001|Overall Study|Death|0|||
23228176|NCT03245840|64578038|FG000|Overall Study|Withdrawal by Subject|31|||
23228177|NCT03245840|64578039|FG001|Overall Study|Withdrawal by Subject|1|||
23336569|NCT01508130|64976060|FG000|Overall Study|Death|3|||
23336570|NCT01508130|64976061|FG001|Overall Study|Death|1|||
23336571|NCT01508130|64976060|FG000|Overall Study|Protocol Violation|2|||
23336572|NCT01508130|64976061|FG001|Overall Study|Protocol Violation|0|||
23336573|NCT01508130|64976060|FG000|Overall Study|Lost to Follow-up|25|||
23336574|NCT01508130|64976061|FG001|Overall Study|Lost to Follow-up|2|||
23336575|NCT01508130|64976060|FG000|Overall Study|Withdrawal by Subject|3|||
23336576|NCT01508130|64976061|FG001|Overall Study|Withdrawal by Subject|3|||
23336577|NCT01508130|64976060|FG000|Overall Study|Subject's substantial non-compliance|25|||
23336578|NCT01508130|64976061|FG001|Overall Study|Subject's substantial non-compliance|9|||
23336579|NCT01508130|64976060|FG000|Overall Study|Insufficient therapeutic response|74|||
23448921|NCT01623115|65384760|FG000|Overall Study|Poor compliance to protocol|4|||
23576507|NCT02061761|65843362|FG000|Overall Study|Participant no longer meets study criteria|0|||
23169532|NCT03605680|64367041|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
23228178|NCT03245840|64578038|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23228179|NCT03245840|64578039|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23448922|NCT01623115|65384761|FG001|Overall Study|Poor compliance to protocol|10|||
23448923|NCT01623115|65384760|FG000|Overall Study|Consent withdrawn by participant|2|||
23448924|NCT01623115|65384761|FG001|Overall Study|Consent withdrawn by participant|6|||
23448925|NCT01623115|65384760|FG000|Overall Study|Related to study drug administration|0|||
23448926|NCT01623115|65384761|FG001|Overall Study|Related to study drug administration|2|||
23336580|NCT01508130|64976061|FG001|Overall Study|Insufficient therapeutic response|23|||
23336581|NCT01508130|64976060|FG000|Overall Study|Administrative|14|||
23336582|NCT01508130|64976061|FG001|Overall Study|Administrative|3|||
23336583|NCT02049814|64976068|FG000|Overall Study|Reason not Specified|4|||
23336584|NCT02049814|64976069|FG001|Overall Study|Reason not Specified|3|||
23336585|NCT02049814|64976068|FG000|Overall Study|Pregnancy|1|||
23336586|NCT02049814|64976069|FG001|Overall Study|Pregnancy|0|||
23336587|NCT02049814|64976068|FG000|Overall Study|Lost to Follow-up|2|||
23336588|NCT02049814|64976069|FG001|Overall Study|Lost to Follow-up|3|||
23336589|NCT02049814|64976068|FG000|Overall Study|Serious Protocol Violation|5|||
23336590|NCT02049814|64976069|FG001|Overall Study|Serious Protocol Violation|7|||
23336591|NCT02049814|64976068|FG000|Overall Study|Study Termination|0|||
23336592|NCT02049814|64976069|FG001|Overall Study|Study Termination|1|||
23336593|NCT02049814|64976068|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
23336594|NCT02049814|64976069|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
23336595|NCT02049814|64976068|FG000|Overall Study|Voluntary withdrawal|9|||
23336596|NCT02049814|64976069|FG001|Overall Study|Voluntary withdrawal|8|||
23336597|NCT01570361|64976070|FG000|Overall Study|Subject discontinued|1|||
23336598|NCT01570361|64976071|FG001|Overall Study|Subject discontinued|2|||
23336599|NCT01570361|64976070|FG000|Overall Study|Sponsor closing the study|51|||
23336600|NCT01570361|64976071|FG001|Overall Study|Sponsor closing the study|50|||
23336601|NCT01570361|64976070|FG000|Overall Study|Subject excluded|5|||
23336602|NCT01570361|64976071|FG001|Overall Study|Subject excluded|3|||
23336603|NCT01570361|64976070|FG000|Overall Study|Subject withdrew consent|14|||
23336604|NCT01570361|64976071|FG001|Overall Study|Subject withdrew consent|9|||
23336605|NCT01570361|64976070|FG000|Overall Study|Adverse Event|2|||
23336606|NCT01570361|64976071|FG001|Overall Study|Adverse Event|1|||
23336607|NCT01570361|64976070|FG000|Overall Study|Lost to Follow-up|4|||
23336608|NCT01570361|64976071|FG001|Overall Study|Lost to Follow-up|4|||
23336609|NCT01570361|64976070|FG000|Overall Study|Death|5|||
23336610|NCT01570361|64976071|FG001|Overall Study|Death|4|||
23336611|NCT01570361|64976070|FG000|Overall Study|Other|0|||
23336612|NCT01570361|64976071|FG001|Overall Study|Other|2|||
23336613|NCT00857896|64976074|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
23169533|NCT03605680|64367042|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
23169534|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
23169535|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
23169536|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
23169537|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
23169538|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
23169539|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
23169540|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
23169541|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
23169542|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23169543|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23169544|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23169545|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
23169546|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
23169547|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
23169548|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
23169549|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
23169550|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
23169551|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
23169552|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
23169553|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
23169554|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
23169555|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
23169556|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
23169557|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
23169558|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
23169559|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
23169560|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
23169561|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
23169562|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
23228180|NCT03245840|64578038|FG000|Overall Study|Physician Decision|4|||
23336614|NCT04480424|64976085|FG000|Overall Study|Withdrawal by Subject|0|||
23336615|NCT04480424|64976086|FG001|Overall Study|Withdrawal by Subject|2|||
23336616|NCT04480424|64976085|FG000|Overall Study|Lost to Follow-up|3|||
23336617|NCT04480424|64976086|FG001|Overall Study|Lost to Follow-up|3|||
23336618|NCT04480424|64976085|FG000|Overall Study|Death|14|||
23448927|NCT01623115|65384760|FG000|Overall Study|Last visit outside protocol visit window|14|||
23336619|NCT04480424|64976086|FG001|Overall Study|Death|16|||
23336620|NCT04480424|64976085|FG000|Overall Study|Reason not Specified|5|||
23169563|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
23169564|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
23169565|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
23169566|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
23169567|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
23228181|NCT03245840|64578039|FG001|Overall Study|Physician Decision|1|||
23228182|NCT03245840|64578038|FG000|Overall Study|Study Terminated by Sponsor|56|||
23169568|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
23169569|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
23169570|NCT03605680|64367039|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
23169571|NCT03605680|64367040|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
23169572|NCT03605680|64367041|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
23169573|NCT03605680|64367042|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
23169574|NCT02068547|64367044|FG000|Overall Study|Lost to Follow-up|3|||
23169575|NCT02068547|64367045|FG001|Overall Study|Lost to Follow-up|3|||
23169576|NCT02068547|64367044|FG000|Overall Study|Physician Decision|1|||
23169577|NCT02068547|64367045|FG001|Overall Study|Physician Decision|0|||
23169578|NCT01736579|64367046|FG000|Overall Study|Termination of Study by Sponsor|2|||
23169579|NCT01736579|64367047|FG001|Overall Study|Termination of Study by Sponsor|2|||
23169580|NCT02740478|64367048|FG000|Overall Study|Withdrawal by Subject|1|||
23169581|NCT01133171|64367049|FG000|Overall Study|Withdrawal by Subject|1|||
23169582|NCT01133171|64367050|FG001|Overall Study|Withdrawal by Subject|2|||
23169583|NCT01133171|64367051|FG002|Overall Study|Withdrawal by Subject|0|||
23169584|NCT00512798|64367052|FG000|Overall Study|Death|0|||
23169585|NCT00512798|64367053|FG001|Overall Study|Death|3|||
23169586|NCT00512798|64367052|FG000|Overall Study|Adverse Event|2|||
23169587|NCT00512798|64367053|FG001|Overall Study|Adverse Event|4|||
23169588|NCT00512798|64367052|FG000|Overall Study|Progression of disease|14|||
23169589|NCT00512798|64367053|FG001|Overall Study|Progression of disease|20|||
23169590|NCT00512798|64367052|FG000|Overall Study|Withdrawal by Subject|3|||
23169591|NCT00512798|64367053|FG001|Overall Study|Withdrawal by Subject|0|||
23169592|NCT00695565|64367054|FG000|Overall Study|Lost to Follow-up|4|||
23169593|NCT00695565|64367055|FG001|Overall Study|Lost to Follow-up|4|||
23169594|NCT00695565|64367054|FG000|Overall Study|Adverse Event|3|||
23169595|NCT00695565|64367055|FG001|Overall Study|Adverse Event|1|||
23169596|NCT00695565|64367054|FG000|Overall Study|Protocol Violation|3|||
23169597|NCT00695565|64367055|FG001|Overall Study|Protocol Violation|1|||
23169598|NCT00695565|64367054|FG000|Overall Study|Withdrawal by Subject|1|||
23169599|NCT00695565|64367055|FG001|Overall Study|Withdrawal by Subject|1|||
23169600|NCT00695565|64367054|FG000|Overall Study|Lack of Efficacy|1|||
23169601|NCT00695565|64367055|FG001|Overall Study|Lack of Efficacy|1|||
23169602|NCT00695565|64367054|FG000|Overall Study|Subject did not follow instructions|1|||
23169603|NCT00695565|64367055|FG001|Overall Study|Subject did not follow instructions|1|||
23169604|NCT03847987|64367061|FG000|Overall Study|Lost to Follow-up|1|||
23169605|NCT03847987|64367062|FG001|Overall Study|Lost to Follow-up|0|||
23169606|NCT03847987|64367061|FG000|Overall Study|Adverse Event|2|||
23169607|NCT03847987|64367062|FG001|Overall Study|Adverse Event|0|||
23169608|NCT01614093|64367064|FG000|Overall Study|Withdrawal by Subject|1|||
23169609|NCT01100437|64367065|FG000|Titration/Stabilization|Adverse Event|0|||
23169610|NCT01100437|64367066|FG001|Titration/Stabilization|Adverse Event|0|||
23169611|NCT01100437|64367067|FG002|Titration/Stabilization|Adverse Event|4|||
23169612|NCT01100437|64367065|FG000|Titration/Stabilization|Non-compliance|0|||
23169613|NCT01100437|64367066|FG001|Titration/Stabilization|Non-compliance|0|||
23169614|NCT01100437|64367067|FG002|Titration/Stabilization|Non-compliance|1|||
23169615|NCT01100437|64367065|FG000|Titration/Stabilization|Sponsor canceled study|0|||
23169616|NCT01100437|64367066|FG001|Titration/Stabilization|Sponsor canceled study|0|||
23169617|NCT01100437|64367067|FG002|Titration/Stabilization|Sponsor canceled study|1|||
23169618|NCT01100437|64367065|FG000|Maintenance|Withdrawal by Subject|0|||
23169619|NCT01100437|64367066|FG001|Maintenance|Withdrawal by Subject|0|||
23169620|NCT01100437|64367067|FG002|Maintenance|Withdrawal by Subject|1|||
23169621|NCT01100437|64367065|FG000|Maintenance|Sponsor termination of study|0|||
23169622|NCT01100437|64367066|FG001|Maintenance|Sponsor termination of study|0|||
23169623|NCT01100437|64367067|FG002|Maintenance|Sponsor termination of study|1|||
23169624|NCT04356183|64367068|FG000|Overall Study|Lost to Follow-up|1|||
23169625|NCT04356183|64367069|FG001|Overall Study|Lost to Follow-up|0|||
23169626|NCT04356183|64367068|FG000|Overall Study|Withdrawal by Subject|1|||
23169627|NCT04356183|64367069|FG001|Overall Study|Withdrawal by Subject|1|||
23169628|NCT00511355|64367070|FG000|Overall Study|Adverse Event|4|||
23169629|NCT00511355|64367071|FG001|Overall Study|Adverse Event|4|||
23169630|NCT00511355|64367070|FG000|Overall Study|Pregnancy Wish|1|||
23169631|NCT00511355|64367071|FG001|Overall Study|Pregnancy Wish|0|||
23169632|NCT00511355|64367070|FG000|Overall Study|Lost to Follow-up|2|||
23228183|NCT03245840|64578039|FG001|Overall Study|Study Terminated by Sponsor|6|||
23169633|NCT00511355|64367071|FG001|Overall Study|Lost to Follow-up|1|||
23169634|NCT00511355|64367070|FG000|Overall Study|Other Reason|0|||
23169635|NCT00511355|64367071|FG001|Overall Study|Other Reason|1|||
23228184|NCT03245840|64578038|FG000|Overall Study|Site Terminated by Sponsor|4|||
23228185|NCT03245840|64578039|FG001|Overall Study|Site Terminated by Sponsor|0|||
23228186|NCT03245840|64578038|FG000|Overall Study|Lost to Follow-up|12|||
23228187|NCT03245840|64578039|FG001|Overall Study|Lost to Follow-up|2|||
23228188|NCT03245840|64578038|FG000|Overall Study|Pregnancy|2|||
23228189|NCT03245840|64578039|FG001|Overall Study|Pregnancy|0|||
23228190|NCT03245840|64578038|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23576508|NCT02061761|65843363|FG001|Overall Study|Participant no longer meets study criteria|0|||
23169636|NCT00511355|64367070|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
23169637|NCT00511355|64367071|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
23169638|NCT00511355|64367070|FG000|Overall Study|Withdrawal of informed consent|0|||
23169639|NCT00511355|64367071|FG001|Overall Study|Withdrawal of informed consent|1|||
23576509|NCT02061761|65843364|FG002|Overall Study|Participant no longer meets study criteria|0|||
23576510|NCT02061761|65843365|FG003|Overall Study|Participant no longer meets study criteria|0|||
23169640|NCT00511355|64367070|FG000|Overall Study|Other reason pre-treatment|0|||
23169641|NCT00511355|64367071|FG001|Overall Study|Other reason pre-treatment|1|||
23169642|NCT01700192|64367074|FG000|Overall Study|Adverse Event|73|||
23169643|NCT01700192|64367075|FG001|Overall Study|Adverse Event|18|||
23169644|NCT01700192|64367074|FG000|Overall Study|Lack of Efficacy|1|||
23169645|NCT01700192|64367075|FG001|Overall Study|Lack of Efficacy|0|||
23169646|NCT01700192|64367074|FG000|Overall Study|Lost to Follow-up|42|||
23228191|NCT03245840|64578039|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23228192|NCT03245840|64578038|FG000|Overall Study|Not treated|1|||
23228193|NCT03245840|64578039|FG001|Overall Study|Not treated|1|||
23228194|NCT01843933|64578042|FG000|Overall Study|Data lost|6|||
23576511|NCT02061761|65843366|FG004|Overall Study|Participant no longer meets study criteria|0|||
23576512|NCT02061761|65843367|FG005|Overall Study|Participant no longer meets study criteria|0|||
23576513|NCT02061761|65843368|FG006|Overall Study|Participant no longer meets study criteria|0|||
23576514|NCT02061761|65843369|FG007|Overall Study|Participant no longer meets study criteria|0|||
23576515|NCT02061761|65843370|FG008|Overall Study|Participant no longer meets study criteria|1|||
23576516|NCT02061761|65843362|FG000|Overall Study|Other reasons|0|||
23576517|NCT02061761|65843363|FG001|Overall Study|Other reasons|0|||
23576518|NCT02061761|65843364|FG002|Overall Study|Other reasons|0|||
23576519|NCT02061761|65843365|FG003|Overall Study|Other reasons|0|||
23576520|NCT02061761|65843366|FG004|Overall Study|Other reasons|2|||
23576521|NCT02061761|65843367|FG005|Overall Study|Other reasons|0|||
23576522|NCT02061761|65843368|FG006|Overall Study|Other reasons|0|||
23576523|NCT02061761|65843369|FG007|Overall Study|Other reasons|0|||
23576524|NCT02061761|65843370|FG008|Overall Study|Other reasons|6|||
23576525|NCT01403987|65843371|FG000|Overall Study|Residents forgot their secret PIN|18|||
23576526|NCT01403987|65843372|FG001|Overall Study|Residents forgot their secret PIN|17|||
23576527|NCT01403987|65843373|FG002|Overall Study|Residents forgot their secret PIN|18|||
23576528|NCT02015663|65843377|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
23576529|NCT02015663|65843378|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
23228195|NCT01843933|64578043|FG001|Overall Study|Data lost|4|||
23228196|NCT00939094|64578044|FG000|Overall Study|Adverse Event|9|||
23228197|NCT00939094|64578045|FG001|Overall Study|Adverse Event|0|||
23228198|NCT00939094|64578044|FG000|Overall Study|Withdrawal by Subject|1|||
23228199|NCT00939094|64578045|FG001|Overall Study|Withdrawal by Subject|6|||
23228200|NCT00939094|64578044|FG000|Overall Study|Lost to Follow-up|1|||
23228201|NCT00939094|64578045|FG001|Overall Study|Lost to Follow-up|1|||
23228202|NCT00939094|64578044|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23228203|NCT00939094|64578045|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23228204|NCT00939094|64578044|FG000|Overall Study|Severe non-compliance to protocol|0|||
23228205|NCT00939094|64578045|FG001|Overall Study|Severe non-compliance to protocol|1|||
23228206|NCT00939094|64578044|FG000|Overall Study|Study stopped by sponsor|0|||
23228207|NCT00939094|64578045|FG001|Overall Study|Study stopped by sponsor|2|||
23228208|NCT00939094|64578044|FG000|Overall Study|Abnormal ECG findings|1|||
23228209|NCT00939094|64578045|FG001|Overall Study|Abnormal ECG findings|0|||
23228210|NCT03231228|64578048|FG000|Overall Study|Lost to Follow-up|2|||
23228211|NCT03231228|64578049|FG001|Overall Study|Lost to Follow-up|0|||
23228212|NCT03231228|64578048|FG000|Overall Study|Physician Decision|1|||
23576530|NCT02015663|65843377|FG000|Overall Study|Withdrawal by Subject|1|||
23576531|NCT02015663|65843378|FG001|Overall Study|Withdrawal by Subject|0|||
23576532|NCT02015663|65843377|FG000|Overall Study|Protocol Violation|0|||
23169647|NCT01700192|64367075|FG001|Overall Study|Lost to Follow-up|29|||
23169648|NCT01700192|64367074|FG000|Overall Study|Noncompliance with study drug|0|||
23169649|NCT01700192|64367075|FG001|Overall Study|Noncompliance with study drug|5|||
23228213|NCT03231228|64578049|FG001|Overall Study|Physician Decision|0|||
23228214|NCT01425528|64578050|FG000|Overall Study|Withdrawal by Subject|1|||
23228215|NCT01425528|64578051|FG001|Overall Study|Withdrawal by Subject|1|||
23228216|NCT00392210|64578052|FG000|First Voiding Trial|Physician Decision|2|||
23228217|NCT00392210|64578053|FG001|First Voiding Trial|Physician Decision|2|||
23576533|NCT02015663|65843378|FG001|Overall Study|Protocol Violation|1|||
23576534|NCT02015663|65843377|FG000|Overall Study|Adverse Event|3|||
23169650|NCT01700192|64367074|FG000|Overall Study|Physician Decision|2|||
23169651|NCT01700192|64367075|FG001|Overall Study|Physician Decision|3|||
23169652|NCT01700192|64367074|FG000|Overall Study|Pregnancy|1|||
23576535|NCT02015663|65843378|FG001|Overall Study|Adverse Event|0|||
23576536|NCT02015663|65843377|FG000|Overall Study|Administrative problems|10|||
23576537|NCT02015663|65843378|FG001|Overall Study|Administrative problems|11|||
23576538|NCT01657032|65843379|FG000|Overall Study|Lost to Follow-up|0|||
23576539|NCT01657032|65843380|FG001|Overall Study|Lost to Follow-up|7|||
23576540|NCT02451930|65843381|FG000|Overall Study|Death|0|||
23169653|NCT01700192|64367075|FG001|Overall Study|Pregnancy|4|||
23169654|NCT01700192|64367074|FG000|Overall Study|Progressive disease|1|||
23576541|NCT02451930|65843382|FG001|Overall Study|Death|15|||
23576542|NCT02451930|65843381|FG000|Overall Study|Lost to Follow-up|0|||
23576543|NCT02451930|65843382|FG001|Overall Study|Lost to Follow-up|3|||
23576544|NCT02451930|65843381|FG000|Overall Study|Sponsor Decision|2|||
23576545|NCT02451930|65843382|FG001|Overall Study|Sponsor Decision|10|||
23576546|NCT02451930|65843381|FG000|Overall Study|Withdrawal by Subject|0|||
23576547|NCT02451930|65843382|FG001|Overall Study|Withdrawal by Subject|1|||
23576548|NCT02451930|65843381|FG000|Overall Study|Other|0|||
23576549|NCT02451930|65843382|FG001|Overall Study|Other|1|||
23576550|NCT01511536|65843383|FG000|Phase 1|Other|0|||
23576551|NCT01511536|65843384|FG001|Phase 1|Other|1|||
23576552|NCT01511536|65843385|FG002|Phase 1|Other|0|||
23576553|NCT01511536|65843383|FG000|Phase 2|Other|0|||
23576554|NCT01511536|65843384|FG001|Phase 2|Other|0|||
23576555|NCT01511536|65843385|FG002|Phase 2|Other|9|||
23576556|NCT00333138|65843386|FG000|Core Study (6 Months)|Adverse Event|4|||
23576557|NCT00333138|65843387|FG001|Core Study (6 Months)|Adverse Event|5|||
23576558|NCT00333138|65843388|FG002|Core Study (6 Months)|Adverse Event|8|||
23576559|NCT00333138|65843386|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
23576560|NCT00333138|65843387|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
23576561|NCT00333138|65843388|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
23169655|NCT01700192|64367075|FG001|Overall Study|Progressive disease|0|||
23336621|NCT04480424|64976086|FG001|Overall Study|Reason not Specified|5|||
23336622|NCT02101736|64976088|FG000|Overall Study|Protocol Violation|3|||
23336623|NCT02101736|64976089|FG001|Overall Study|Protocol Violation|0|||
23336624|NCT02101736|64976088|FG000|Overall Study|Withdrawal by Subject|1|||
23336625|NCT02101736|64976089|FG001|Overall Study|Withdrawal by Subject|1|||
23336626|NCT03425396|64976090|FG000|Overall Study|Lost to Follow-up|2|||
23336627|NCT03425396|64976091|FG001|Overall Study|Lost to Follow-up|5|||
23336628|NCT03425396|64976092|FG002|Overall Study|Lost to Follow-up|2|||
23336629|NCT03425396|64976093|FG003|Overall Study|Lost to Follow-up|0|||
23336630|NCT03425396|64976094|FG004|Overall Study|Lost to Follow-up|0|||
23336631|NCT03425396|64976090|FG000|Overall Study|Withdrawal by Subject|0|||
23169656|NCT01700192|64367074|FG000|Overall Study|Protocol Violation|3|||
23169657|NCT01700192|64367075|FG001|Overall Study|Protocol Violation|4|||
23169658|NCT01700192|64367074|FG000|Overall Study|Technical problems|0|||
23169659|NCT01700192|64367075|FG001|Overall Study|Technical problems|1|||
23169660|NCT01700192|64367074|FG000|Overall Study|Withdrawal by Subject|56|||
23169661|NCT01700192|64367075|FG001|Overall Study|Withdrawal by Subject|64|||
23169662|NCT01700192|64367074|FG000|Overall Study|Never received study drug|1|||
23169663|NCT01700192|64367075|FG001|Overall Study|Never received study drug|0|||
23169664|NCT01913483|64367076|FG000|Overall Study|Withdrawal by Subject|1|||
23169665|NCT01913483|64367077|FG001|Overall Study|Withdrawal by Subject|2|||
23169666|NCT01913483|64367076|FG000|Overall Study|Lost to Follow-up|6|||
23169667|NCT01913483|64367077|FG001|Overall Study|Lost to Follow-up|3|||
23169668|NCT01913483|64367076|FG000|Overall Study|Death|14|||
23169669|NCT01913483|64367077|FG001|Overall Study|Death|17|||
23169670|NCT02926950|64367078|FG000|Overall Study|Adverse Event|4|||
23169671|NCT02926950|64367079|FG001|Overall Study|Adverse Event|6|||
23169672|NCT02926950|64367078|FG000|Overall Study|At the participant's own request|21|||
23169673|NCT02926950|64367079|FG001|Overall Study|At the participant's own request|25|||
23169674|NCT02926950|64367078|FG000|Overall Study|Reason not Specified|17|||
23169675|NCT02926950|64367079|FG001|Overall Study|Reason not Specified|9|||
23169676|NCT02926950|64367078|FG000|Overall Study|Lost to Follow-up|7|||
23169677|NCT02926950|64367079|FG001|Overall Study|Lost to Follow-up|8|||
23169678|NCT04372927|64367080|FG000|Overall Study|Death|1|||
23169679|NCT01035905|64367082|FG000|Overall Study|Lack of Efficacy|1|||
23576562|NCT00333138|65843386|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
23169680|NCT01035905|64367083|FG001|Overall Study|Lack of Efficacy|1|||
23169681|NCT00783094|64367084|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
23169682|NCT00783094|64367085|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
23228218|NCT00643851|64578056|FG000|Overall Study|Death|0|||
23336632|NCT03425396|64976091|FG001|Overall Study|Withdrawal by Subject|1|||
23336633|NCT03425396|64976092|FG002|Overall Study|Withdrawal by Subject|0|||
23576563|NCT00333138|65843387|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
23576564|NCT00333138|65843388|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
23576565|NCT00333138|65843386|FG000|Core Study (6 Months)|Protocol Violation|1|||
23576566|NCT00333138|65843387|FG001|Core Study (6 Months)|Protocol Violation|0|||
23576567|NCT00333138|65843388|FG002|Core Study (6 Months)|Protocol Violation|1|||
23169683|NCT00783094|64367086|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
23169684|NCT00783094|64367084|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
23169685|NCT00783094|64367085|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
23169686|NCT00783094|64367086|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
23169687|NCT00783094|64367084|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
23169688|NCT00783094|64367085|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
23169689|NCT00783094|64367086|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
23169690|NCT00783094|64367084|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
23169691|NCT00783094|64367085|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
23169692|NCT00783094|64367086|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
23169693|NCT00783094|64367084|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
23169694|NCT00783094|64367085|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
23169695|NCT00783094|64367086|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
23169696|NCT00783094|64367084|FG000|Open-Label Extension Period|Adverse Event|12|||
23169697|NCT00783094|64367085|FG001|Open-Label Extension Period|Adverse Event|7|||
23169698|NCT00783094|64367086|FG002|Open-Label Extension Period|Adverse Event|16|||
23169699|NCT00783094|64367084|FG000|Open-Label Extension Period|Death|0|||
23336634|NCT03425396|64976093|FG003|Overall Study|Withdrawal by Subject|1|||
23336635|NCT03425396|64976094|FG004|Overall Study|Withdrawal by Subject|0|||
23169700|NCT00783094|64367085|FG001|Open-Label Extension Period|Death|0|||
23169701|NCT00783094|64367086|FG002|Open-Label Extension Period|Death|1|||
23169702|NCT00783094|64367084|FG000|Open-Label Extension Period|Protocol Violation|4|||
23169703|NCT00783094|64367085|FG001|Open-Label Extension Period|Protocol Violation|5|||
23169704|NCT00783094|64367086|FG002|Open-Label Extension Period|Protocol Violation|7|||
23169705|NCT00783094|64367084|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
23169706|NCT00783094|64367085|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
23169707|NCT00783094|64367086|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
23169708|NCT00783094|64367084|FG000|Open-Label Extension Period|Physician Decision|4|||
23169709|NCT00783094|64367085|FG001|Open-Label Extension Period|Physician Decision|2|||
23169710|NCT00783094|64367086|FG002|Open-Label Extension Period|Physician Decision|3|||
23169711|NCT00783094|64367084|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
23169712|NCT00783094|64367085|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
23169713|NCT00783094|64367086|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
23169714|NCT03969888|64367091|FG000|Overall Study|Never Received Study Drug|0|||
23169715|NCT03969888|64367092|FG001|Overall Study|Never Received Study Drug|0|||
23169716|NCT03969888|64367093|FG002|Overall Study|Never Received Study Drug|1|||
23169717|NCT03969888|64367094|FG003|Overall Study|Never Received Study Drug|0|||
23169718|NCT03969888|64367095|FG004|Overall Study|Never Received Study Drug|0|||
23169719|NCT03969888|64367096|FG005|Overall Study|Never Received Study Drug|0|||
23169720|NCT03969888|64367097|FG006|Overall Study|Never Received Study Drug|1|||
23169721|NCT03969888|64367098|FG007|Overall Study|Never Received Study Drug|0|||
23169722|NCT03969888|64367091|FG000|Overall Study|Reason Not Specified|0|||
23169723|NCT03969888|64367092|FG001|Overall Study|Reason Not Specified|0|||
23169724|NCT03969888|64367093|FG002|Overall Study|Reason Not Specified|0|||
23169725|NCT03969888|64367094|FG003|Overall Study|Reason Not Specified|0|||
23169726|NCT03969888|64367095|FG004|Overall Study|Reason Not Specified|0|||
23169727|NCT03969888|64367096|FG005|Overall Study|Reason Not Specified|0|||
23169728|NCT03969888|64367097|FG006|Overall Study|Reason Not Specified|0|||
23169729|NCT03969888|64367098|FG007|Overall Study|Reason Not Specified|1|||
23169730|NCT01262365|64367118|FG000|Overall Study|Lack of Efficacy|35|||
23336636|NCT03425396|64976090|FG000|Overall Study|Other|0|||
23336637|NCT03425396|64976091|FG001|Overall Study|Other|1|||
23336638|NCT03425396|64976092|FG002|Overall Study|Other|1|||
23336639|NCT03425396|64976093|FG003|Overall Study|Other|0|||
23336640|NCT03425396|64976094|FG004|Overall Study|Other|1|||
23336641|NCT01102257|64976095|FG000|Overall Study|Adverse Event|1|||
23336642|NCT01102257|64976096|FG001|Overall Study|Adverse Event|0|||
23336643|NCT01102257|64976095|FG000|Overall Study|Adverse Event|1|||
23336644|NCT01102257|64976096|FG001|Overall Study|Adverse Event|0|||
23336645|NCT01340872|64976097|FG000|Double-blind Phase|Adverse Event|6|||
23336646|NCT01340872|64976098|FG001|Double-blind Phase|Adverse Event|4|||
23336647|NCT01340872|64976099|FG002|Double-blind Phase|Adverse Event|0|||
23336648|NCT01340872|64976100|FG003|Double-blind Phase|Adverse Event|0|||
23336649|NCT01340872|64976097|FG000|Double-blind Phase|Withdrawal by Subject|3|||
23336650|NCT01340872|64976098|FG001|Double-blind Phase|Withdrawal by Subject|5|||
23336651|NCT01340872|64976099|FG002|Double-blind Phase|Withdrawal by Subject|0|||
23169731|NCT01262365|64367119|FG001|Overall Study|Lack of Efficacy|30|||
23228219|NCT00643851|64578057|FG001|Overall Study|Death|1|||
23336652|NCT01340872|64976100|FG003|Double-blind Phase|Withdrawal by Subject|0|||
23336653|NCT01340872|64976097|FG000|Double-blind Phase|Lost to Follow-up|0|||
23576568|NCT00333138|65843386|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
23576569|NCT00333138|65843387|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
23336654|NCT01340872|64976098|FG001|Double-blind Phase|Lost to Follow-up|1|||
23169732|NCT01262365|64367120|FG002|Overall Study|Lack of Efficacy|47|||
23169733|NCT01262365|64367118|FG000|Overall Study|Protocol Violation|3|||
23169734|NCT01262365|64367119|FG001|Overall Study|Protocol Violation|1|||
23169735|NCT01262365|64367120|FG002|Overall Study|Protocol Violation|1|||
23169736|NCT01262365|64367118|FG000|Overall Study|Lost to Follow-up|3|||
23169737|NCT01262365|64367119|FG001|Overall Study|Lost to Follow-up|7|||
23169738|NCT01262365|64367120|FG002|Overall Study|Lost to Follow-up|6|||
23169739|NCT01262365|64367118|FG000|Overall Study|Withdrawal by Subject|17|||
23169740|NCT01262365|64367119|FG001|Overall Study|Withdrawal by Subject|22|||
23169741|NCT01262365|64367120|FG002|Overall Study|Withdrawal by Subject|22|||
23169742|NCT01262365|64367118|FG000|Overall Study|Death|1|||
23169743|NCT01262365|64367119|FG001|Overall Study|Death|2|||
23169744|NCT01262365|64367120|FG002|Overall Study|Death|1|||
23169745|NCT01262365|64367118|FG000|Overall Study|Adverse Event|26|||
23169746|NCT01262365|64367119|FG001|Overall Study|Adverse Event|16|||
23336655|NCT01340872|64976099|FG002|Double-blind Phase|Lost to Follow-up|0|||
23336656|NCT01340872|64976100|FG003|Double-blind Phase|Lost to Follow-up|0|||
23336657|NCT01340872|64976097|FG000|Double-blind Phase|Protocol Violation|0|||
23336658|NCT01340872|64976098|FG001|Double-blind Phase|Protocol Violation|1|||
23169747|NCT01262365|64367120|FG002|Overall Study|Adverse Event|11|||
23169748|NCT01262365|64367118|FG000|Overall Study|sponsor decision|1|||
23169749|NCT01262365|64367119|FG001|Overall Study|sponsor decision|1|||
23169750|NCT01262365|64367120|FG002|Overall Study|sponsor decision|0|||
23169751|NCT01262365|64367118|FG000|Overall Study|Randomization error|1|||
23169752|NCT01262365|64367119|FG001|Overall Study|Randomization error|0|||
23169753|NCT01262365|64367120|FG002|Overall Study|Randomization error|2|||
23169754|NCT01262365|64367118|FG000|Overall Study|Non-compliance|1|||
23169755|NCT01262365|64367119|FG001|Overall Study|Non-compliance|0|||
23169756|NCT01262365|64367120|FG002|Overall Study|Non-compliance|2|||
23169757|NCT01262365|64367118|FG000|Overall Study|Suspected pregnancy|1|||
23169758|NCT01262365|64367119|FG001|Overall Study|Suspected pregnancy|0|||
23169759|NCT01262365|64367120|FG002|Overall Study|Suspected pregnancy|0|||
23169760|NCT01262365|64367118|FG000|Overall Study|Patient pregnant|1|||
23169761|NCT01262365|64367119|FG001|Overall Study|Patient pregnant|0|||
23169762|NCT01262365|64367120|FG002|Overall Study|Patient pregnant|1|||
23169763|NCT01262365|64367118|FG000|Overall Study|Toxicity related to study drug|0|||
23169764|NCT01262365|64367119|FG001|Overall Study|Toxicity related to study drug|1|||
23169765|NCT01262365|64367120|FG002|Overall Study|Toxicity related to study drug|0|||
23169766|NCT01262365|64367118|FG000|Overall Study|Cannot tolerate the protocol|0|||
23169767|NCT01262365|64367119|FG001|Overall Study|Cannot tolerate the protocol|1|||
23169768|NCT01262365|64367120|FG002|Overall Study|Cannot tolerate the protocol|0|||
23169769|NCT01262365|64367118|FG000|Overall Study|Patient unavailable|0|||
23169770|NCT01262365|64367119|FG001|Overall Study|Patient unavailable|0|||
23169771|NCT01262365|64367120|FG002|Overall Study|Patient unavailable|1|||
23169772|NCT00391222|64367121|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
23169773|NCT00391222|64367122|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
23169774|NCT00391222|64367123|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
23169775|NCT00391222|64367124|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
23169776|NCT00391222|64367121|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
23169777|NCT00391222|64367122|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
23169778|NCT00391222|64367123|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
23169779|NCT00391222|64367124|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
23169780|NCT00391222|64367121|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
23169781|NCT00391222|64367122|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
23169782|NCT00391222|64367123|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
23169783|NCT00391222|64367124|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
23169784|NCT00391222|64367121|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
23169785|NCT00391222|64367122|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
23169786|NCT00391222|64367123|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
23336659|NCT01340872|64976099|FG002|Double-blind Phase|Protocol Violation|0|||
23336660|NCT01340872|64976100|FG003|Double-blind Phase|Protocol Violation|0|||
23336661|NCT01340872|64976097|FG000|Open-label Phase|Physician Decision|0|||
23336662|NCT01340872|64976098|FG001|Open-label Phase|Physician Decision|0|||
23336663|NCT01340872|64976099|FG002|Open-label Phase|Physician Decision|2|||
23169787|NCT00391222|64367124|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
23169788|NCT00391222|64367121|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
23169789|NCT00391222|64367122|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
23169790|NCT00391222|64367123|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
23169791|NCT00391222|64367124|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
23169792|NCT00391222|64367121|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
23336664|NCT01340872|64976100|FG003|Open-label Phase|Physician Decision|1|||
23169793|NCT00391222|64367122|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
23169794|NCT00391222|64367123|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
23228220|NCT00643851|64578058|FG002|Overall Study|Death|0|||
23169795|NCT00391222|64367124|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
23169796|NCT00391222|64367121|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
23169797|NCT00391222|64367122|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
23169798|NCT00391222|64367123|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
23169799|NCT00391222|64367124|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
23169800|NCT00391222|64367121|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
23169801|NCT00391222|64367122|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
23169802|NCT00391222|64367123|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
23169803|NCT00391222|64367124|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
23169804|NCT00391222|64367121|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
23169805|NCT00391222|64367122|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
23169806|NCT00391222|64367123|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
23169807|NCT00391222|64367124|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
23336665|NCT01340872|64976097|FG000|Open-label Phase|Pregnancy|0|||
23336666|NCT01340872|64976098|FG001|Open-label Phase|Pregnancy|0|||
23169808|NCT00391222|64367121|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
23169809|NCT00391222|64367122|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
23336667|NCT01340872|64976099|FG002|Open-label Phase|Pregnancy|1|||
23336668|NCT01340872|64976100|FG003|Open-label Phase|Pregnancy|0|||
23336669|NCT01340872|64976097|FG000|Open-label Phase|Adverse Event|0|||
23336670|NCT01340872|64976098|FG001|Open-label Phase|Adverse Event|0|||
23336671|NCT01340872|64976099|FG002|Open-label Phase|Adverse Event|8|||
23336672|NCT01340872|64976100|FG003|Open-label Phase|Adverse Event|4|||
23336673|NCT01340872|64976097|FG000|Open-label Phase|Withdrawal by Subject|0|||
23336674|NCT01340872|64976098|FG001|Open-label Phase|Withdrawal by Subject|0|||
23336675|NCT01340872|64976099|FG002|Open-label Phase|Withdrawal by Subject|1|||
23336676|NCT01340872|64976100|FG003|Open-label Phase|Withdrawal by Subject|6|||
23228221|NCT00643851|64578056|FG000|Overall Study|Lack of Efficacy|0|||
23228222|NCT00643851|64578057|FG001|Overall Study|Lack of Efficacy|1|||
23228223|NCT00643851|64578058|FG002|Overall Study|Lack of Efficacy|0|||
23228224|NCT00643851|64578056|FG000|Overall Study|Adverse Event|2|||
23228225|NCT00643851|64578057|FG001|Overall Study|Adverse Event|6|||
23228226|NCT00643851|64578058|FG002|Overall Study|Adverse Event|6|||
23228227|NCT00643851|64578056|FG000|Overall Study|Lost to Follow-up|4|||
23228228|NCT00643851|64578057|FG001|Overall Study|Lost to Follow-up|6|||
23228229|NCT00643851|64578058|FG002|Overall Study|Lost to Follow-up|9|||
23336677|NCT01340872|64976097|FG000|Open-label Phase|Worsening of IBD|0|||
23336678|NCT01340872|64976098|FG001|Open-label Phase|Worsening of IBD|0|||
23336679|NCT01340872|64976099|FG002|Open-label Phase|Worsening of IBD|1|||
23336680|NCT01340872|64976100|FG003|Open-label Phase|Worsening of IBD|0|||
23336681|NCT00667823|64976101|FG000|Overall Study|Lost to Follow-up|5|||
23336682|NCT00667823|64976101|FG000|Overall Study|Adverse Event|7|||
23336683|NCT00667823|64976101|FG000|Overall Study|Death|182|||
23169810|NCT00391222|64367123|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
23169811|NCT00391222|64367124|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
23169812|NCT00391222|64367121|FG000|Period III (Double-Blind Treatment)|Other|6|||
23228230|NCT00643851|64578056|FG000|Overall Study|Withdrawal by Subject|8|||
23336684|NCT00667823|64976101|FG000|Overall Study|Withdrawal by Subject|12|||
23336685|NCT00667823|64976101|FG000|Overall Study|Other|8|||
23336686|NCT00667823|64976101|FG000|Overall Study|Missing (completion page missing)|2|||
23336687|NCT01046903|64976102|FG000|Overall Study|Lost to Follow-up|16|||
23336688|NCT01046903|64976102|FG000|Overall Study|Adverse Event|4|||
23336689|NCT01046903|64976102|FG000|Overall Study|Withdrawal by Subject|3|||
23336690|NCT01046903|64976102|FG000|Overall Study|Other|5|||
23336691|NCT00887315|64976111|FG000|Overall Study|Study termination|7|||
23336692|NCT00887315|64976112|FG001|Overall Study|Study termination|4|||
23336693|NCT00529308|64976113|FG000|Overall Study|Withdrawal by Subject|1|||
23336694|NCT00529308|64976114|FG001|Overall Study|Withdrawal by Subject|1|||
23336695|NCT01814696|64976115|FG000|Overall Study|Withdrawal by Subject|1|||
23336696|NCT01814696|64976116|FG001|Overall Study|Withdrawal by Subject|0|||
23336697|NCT01814696|64976115|FG000|Overall Study|Randomized to wrong group|1|||
23336698|NCT01814696|64976116|FG001|Overall Study|Randomized to wrong group|0|||
23336699|NCT03287635|64976118|FG000|Overall Study|Lost to Follow-up|5|||
23448928|NCT01623115|65384761|FG001|Overall Study|Last visit outside protocol visit window|26|||
23228231|NCT00643851|64578057|FG001|Overall Study|Withdrawal by Subject|15|||
23228232|NCT00643851|64578058|FG002|Overall Study|Withdrawal by Subject|9|||
23336700|NCT03287635|64976118|FG000|Overall Study|Withdrawal by Subject|1|||
23336701|NCT03287635|64976118|FG000|Overall Study|Physician Decision|1|||
23336702|NCT00039871|64976119|FG000|Overall Study|Adverse Event|165|||
23336703|NCT00039871|64976119|FG000|Overall Study|Lost to Follow-up|18|||
23336704|NCT00039871|64976119|FG000|Overall Study|Protocol Violation|24|||
23336705|NCT00039871|64976119|FG000|Overall Study|Withdrawal by Subject|97|||
23336706|NCT00039871|64976119|FG000|Overall Study|Did not meet eligibility criteria|11|||
23336707|NCT00039871|64976119|FG000|Overall Study|Administrative|1|||
23169813|NCT00391222|64367122|FG001|Period III (Double-Blind Treatment)|Other|1|||
23336708|NCT00039871|64976119|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
23336709|NCT00039871|64976119|FG000|Overall Study|Never entered follow-up|7|||
23336710|NCT02609607|64976120|FG000|Overall Study|Lost to Follow-up|0|||
23336711|NCT02609607|64976121|FG001|Overall Study|Lost to Follow-up|1|||
23336712|NCT03436693|64976131|FG000|Overall Study|Adverse Event|22|||
23336713|NCT03436693|64976132|FG001|Overall Study|Adverse Event|10|||
23336714|NCT03436693|64976131|FG000|Overall Study|Physician Decision|3|||
23336715|NCT03436693|64976132|FG001|Overall Study|Physician Decision|3|||
23336716|NCT03436693|64976131|FG000|Overall Study|Withdrawal by Subject|4|||
23336717|NCT03436693|64976132|FG001|Overall Study|Withdrawal by Subject|13|||
23336718|NCT03436693|64976131|FG000|Overall Study|Progressive Disease|1|||
23336719|NCT03436693|64976132|FG001|Overall Study|Progressive Disease|1|||
23336720|NCT01417156|64976133|FG000|Overall Study|Adverse Event|12|||
23336721|NCT01417156|64976133|FG000|Overall Study|Protocol Violation|2|||
23336722|NCT00520533|64976135|FG000|Overall Study|Death|1|||
23336723|NCT00520533|64976135|FG000|Overall Study|Suspension of the study for safety reasons|1|||
23336724|NCT00520533|64976135|FG000|Overall Study|Withdrawal by Subject|1|||
23336725|NCT00520533|64976135|FG000|Overall Study|Physician Decision|1|||
23336726|NCT01068730|64976138|FG000|Period 3|Personal reason|1|||
23336727|NCT01068730|64976139|FG001|Period 3|Personal reason|0|||
23336728|NCT01068730|64976140|FG002|Period 3|Personal reason|0|||
23336729|NCT01068730|64976141|FG003|Period 3|Personal reason|0|||
23336730|NCT01068730|64976138|FG000|Period 4|Family emergency|0|||
23336731|NCT01068730|64976139|FG001|Period 4|Family emergency|1|||
23336732|NCT01068730|64976140|FG002|Period 4|Family emergency|0|||
23336733|NCT01068730|64976141|FG003|Period 4|Family emergency|0|||
23336734|NCT03226769|64976144|FG000|Overall Study|Withdrawal by Subject|0|||
23336735|NCT03226769|64976145|FG001|Overall Study|Withdrawal by Subject|1|||
23336736|NCT02582684|64976147|FG000|Overall Study|Unable to contact subject/parent|4|||
23336737|NCT02582684|64976147|FG000|Overall Study|Subject not able to get to clinic|10|||
23336738|NCT02582684|64976147|FG000|Overall Study|Subject withdrew consent|1|||
23336739|NCT02582684|64976147|FG000|Overall Study|Found to be ineligible after enrollment|2|||
23336740|NCT01500382|64976148|FG000|Washout Period|Study site went out of business|0|||
23336741|NCT01500382|64976149|FG001|Washout Period|Study site went out of business|0|||
23336742|NCT01500382|64976150|FG002|Washout Period|Study site went out of business|1|||
23336743|NCT01500382|64976151|FG003|Washout Period|Study site went out of business|0|||
23169814|NCT00391222|64367123|FG002|Period III (Double-Blind Treatment)|Other|6|||
23169815|NCT00391222|64367124|FG003|Period III (Double-Blind Treatment)|Other|0|||
23169816|NCT00978029|64367125|FG000|Overall Study|Adverse Event|1|||
23169817|NCT00978029|64367126|FG001|Overall Study|Adverse Event|2|||
23169818|NCT00978029|64367127|FG002|Overall Study|Adverse Event|5|||
23169819|NCT00978029|64367125|FG000|Overall Study|Withdrawal by Subject|0|||
23336744|NCT04109391|64976152|FG000|Overall Study|Adverse Event|2|||
23336745|NCT04109391|64976153|FG001|Overall Study|Adverse Event|2|||
23336746|NCT04109391|64976154|FG002|Overall Study|Adverse Event|0|||
23336747|NCT04109391|64976152|FG000|Overall Study|Withdrawal by Subject|2|||
23169820|NCT00978029|64367126|FG001|Overall Study|Withdrawal by Subject|0|||
23228233|NCT00643851|64578056|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
23228234|NCT00643851|64578057|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
23228235|NCT00643851|64578058|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
23228236|NCT00554840|64578060|FG000|Overall Study|Physician Decision|0|||
23228237|NCT00554840|64578061|FG001|Overall Study|Physician Decision|1|||
23228238|NCT04397757|64578062|FG000|Overall Study|Death|3|||
23228239|NCT04397757|64578063|FG001|Overall Study|Death|11|||
23228240|NCT04397757|64578062|FG000|Overall Study|Withdrawal by Subject|2|||
23228241|NCT04397757|64578063|FG001|Overall Study|Withdrawal by Subject|0|||
23228242|NCT04397757|64578062|FG000|Overall Study|Lost to Follow-up|4|||
23228243|NCT04397757|64578063|FG001|Overall Study|Lost to Follow-up|3|||
23228244|NCT00113555|64578064|FG000|Overall Study|Baseline Failure|59|||
23336748|NCT04109391|64976153|FG001|Overall Study|Withdrawal by Subject|0|||
23336749|NCT04109391|64976154|FG002|Overall Study|Withdrawal by Subject|0|||
23336750|NCT04109391|64976152|FG000|Overall Study|Pregnancy|1|||
23336751|NCT04109391|64976153|FG001|Overall Study|Pregnancy|0|||
23169821|NCT00978029|64367127|FG002|Overall Study|Withdrawal by Subject|1|||
23169822|NCT00978029|64367125|FG000|Overall Study|Protocol Violation|0|||
23169823|NCT00978029|64367126|FG001|Overall Study|Protocol Violation|1|||
23228245|NCT00113555|64578064|FG000|Overall Study|Permanently Explanted|7|||
23228246|NCT00113555|64578064|FG000|Overall Study|Death|1|||
23169824|NCT00978029|64367127|FG002|Overall Study|Protocol Violation|0|||
23228247|NCT00113555|64578064|FG000|Overall Study|Missed Followup|4|||
23336752|NCT04109391|64976154|FG002|Overall Study|Pregnancy|0|||
23336753|NCT04109391|64976152|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
23336754|NCT04109391|64976153|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
23336755|NCT04109391|64976154|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
23336756|NCT04109391|64976152|FG000|Overall Study|Lost to Follow-up|0|||
23169825|NCT01662895|64367128|FG000|Overall Study|Lost to Follow-up|0|||
23169826|NCT01662895|64367129|FG001|Overall Study|Lost to Follow-up|1|||
23169827|NCT00452699|64367130|FG000|Overall Study|Adverse Event|10|||
23169828|NCT00452699|64367131|FG001|Overall Study|Adverse Event|3|||
23169829|NCT00452699|64367130|FG000|Overall Study|Lack of Efficacy|6|||
23336757|NCT04109391|64976153|FG001|Overall Study|Lost to Follow-up|0|||
23336758|NCT04109391|64976154|FG002|Overall Study|Lost to Follow-up|1|||
23336759|NCT04109391|64976152|FG000|Overall Study|Lack of Efficacy|2|||
23336760|NCT04109391|64976153|FG001|Overall Study|Lack of Efficacy|2|||
23336761|NCT04109391|64976154|FG002|Overall Study|Lack of Efficacy|3|||
23336762|NCT03670836|64976155|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
23336763|NCT03670836|64976156|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
23336764|NCT03670836|64976155|FG000|Per Protocol Population (PP)|Physician Decision|9|||
23336765|NCT03670836|64976156|FG001|Per Protocol Population (PP)|Physician Decision|10|||
23169830|NCT00452699|64367131|FG001|Overall Study|Lack of Efficacy|4|||
23169831|NCT00452699|64367130|FG000|Overall Study|Lost to Follow-up|6|||
23169832|NCT00452699|64367131|FG001|Overall Study|Lost to Follow-up|9|||
23169833|NCT00452699|64367130|FG000|Overall Study|Protocol Violation|21|||
23169834|NCT00452699|64367131|FG001|Overall Study|Protocol Violation|25|||
23228248|NCT00113555|64578064|FG000|Overall Study|Lost to Follow-up|8|||
23228249|NCT00711412|64578065|FG000|Induction Treatment|Death|2|||
23228250|NCT00711412|64578065|FG000|Induction Treatment|Adverse Event|1|||
23336766|NCT03670836|64976155|FG000|Per Protocol Population (PP)|Physician Decision|4|||
23336767|NCT03670836|64976156|FG001|Per Protocol Population (PP)|Physician Decision|6|||
23228251|NCT00711412|64578065|FG000|Induction Treatment|Other|1|||
23228252|NCT00711412|64578065|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
23228253|NCT00711412|64578065|FG000|Evaluated for Combination Treatment|Death|1|||
23228254|NCT00711412|64578065|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
23228255|NCT00711412|64578065|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
23228256|NCT00711412|64578065|FG000|Combination Treatment|Progressive Disease|1|||
23228257|NCT00711412|64578065|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
23336768|NCT03670836|64976155|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
23336769|NCT03670836|64976156|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
23336770|NCT02964507|64976157|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
23336771|NCT02964507|64976158|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
23336772|NCT02964507|64976159|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
23336773|NCT02964507|64976160|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
23336774|NCT02964507|64976161|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
23336775|NCT02964507|64976162|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
23336776|NCT02964507|64976163|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
23336777|NCT02964507|64976164|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
23336778|NCT02964507|64976157|FG000|Overall Study|Study terminated by Sponsor|9|||
23336779|NCT02964507|64976158|FG001|Overall Study|Study terminated by Sponsor|1|||
23336780|NCT02964507|64976159|FG002|Overall Study|Study terminated by Sponsor|9|||
23336781|NCT02964507|64976160|FG003|Overall Study|Study terminated by Sponsor|3|||
23336782|NCT02964507|64976161|FG004|Overall Study|Study terminated by Sponsor|3|||
23336783|NCT02964507|64976162|FG005|Overall Study|Study terminated by Sponsor|2|||
23336784|NCT02964507|64976163|FG006|Overall Study|Study terminated by Sponsor|0|||
23336785|NCT02964507|64976164|FG007|Overall Study|Study terminated by Sponsor|0|||
23336786|NCT02964507|64976157|FG000|Overall Study|Other|3|||
23336787|NCT02964507|64976158|FG001|Overall Study|Other|0|||
23336788|NCT02964507|64976159|FG002|Overall Study|Other|0|||
23336789|NCT02964507|64976160|FG003|Overall Study|Other|0|||
23336790|NCT02964507|64976161|FG004|Overall Study|Other|1|||
23336791|NCT02964507|64976162|FG005|Overall Study|Other|0|||
23336792|NCT02964507|64976163|FG006|Overall Study|Other|0|||
23336793|NCT02964507|64976164|FG007|Overall Study|Other|0|||
23336794|NCT02964507|64976157|FG000|Overall Study|Death|11|||
23336795|NCT02964507|64976158|FG001|Overall Study|Death|9|||
23336796|NCT02964507|64976159|FG002|Overall Study|Death|12|||
23336797|NCT02964507|64976160|FG003|Overall Study|Death|2|||
23336798|NCT02964507|64976161|FG004|Overall Study|Death|10|||
23336799|NCT02964507|64976162|FG005|Overall Study|Death|5|||
23336800|NCT02964507|64976163|FG006|Overall Study|Death|0|||
23336801|NCT02964507|64976164|FG007|Overall Study|Death|0|||
23169835|NCT00452699|64367130|FG000|Overall Study|Withdrawal by Subject|26|||
23169836|NCT00452699|64367131|FG001|Overall Study|Withdrawal by Subject|25|||
23169837|NCT00452699|64367130|FG000|Overall Study|Other|12|||
23169838|NCT00452699|64367131|FG001|Overall Study|Other|7|||
23169839|NCT01784965|64367132|FG000|Overall Study|Withdrawal by Subject|6|||
23228258|NCT00711412|64578065|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
23228259|NCT00711412|64578065|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
23228260|NCT00711412|64578065|FG000|Evaluation for Response and Surgery|Death|1|||
23336802|NCT02964507|64976157|FG000|Overall Study|Withdrawal by Subject|1|||
23336803|NCT02964507|64976158|FG001|Overall Study|Withdrawal by Subject|0|||
23336804|NCT02964507|64976159|FG002|Overall Study|Withdrawal by Subject|1|||
23336805|NCT02964507|64976160|FG003|Overall Study|Withdrawal by Subject|1|||
23448929|NCT01623115|65384760|FG000|Overall Study|Site closure|1|||
23448930|NCT01623115|65384761|FG001|Overall Study|Site closure|7|||
23448931|NCT01623115|65384760|FG000|Overall Study|Death|0|||
23448932|NCT01623115|65384761|FG001|Overall Study|Death|4|||
23448933|NCT01623115|65384760|FG000|Overall Study|Other than specified above|0|||
23448934|NCT01623115|65384761|FG001|Overall Study|Other than specified above|3|||
23448935|NCT00181766|65384767|FG000|Overall Study|Lost to Follow-up|6|||
23448936|NCT00181766|65384767|FG000|Overall Study|Adverse Event|4|||
23448937|NCT00181766|65384767|FG000|Overall Study|non-compliance|2|||
23448938|NCT01508169|65384774|FG000|Overall Study|Adverse Event|1|||
23448939|NCT01508169|65384775|FG001|Overall Study|Adverse Event|0|||
23448940|NCT01508169|65384774|FG000|Overall Study|Withdrawal by Subject|1|||
23448941|NCT01508169|65384775|FG001|Overall Study|Withdrawal by Subject|0|||
23448942|NCT01508169|65384774|FG000|Overall Study|Lost to Follow-up|1|||
23448943|NCT01508169|65384775|FG001|Overall Study|Lost to Follow-up|2|||
23448944|NCT00962208|65384779|FG000|Overall Study|Could not achieve good vision|9|||
23448945|NCT00962208|65384780|FG001|Overall Study|Could not achieve good vision|0|||
23448946|NCT00962208|65384779|FG000|Overall Study|Contraindicated to continue study|5|||
23448947|NCT00962208|65384780|FG001|Overall Study|Contraindicated to continue study|1|||
23448948|NCT00962208|65384779|FG000|Overall Study|Lost to Follow-up|0|||
23448949|NCT00962208|65384780|FG001|Overall Study|Lost to Follow-up|9|||
23448950|NCT02471014|65384784|FG000|Overall Study|Lost to Follow-up|2|||
23448951|NCT02471014|65384785|FG001|Overall Study|Lost to Follow-up|2|||
23448952|NCT01370265|65384786|FG000|First Intervention|Adverse Event|1|||
23448953|NCT01370265|65384787|FG001|First Intervention|Adverse Event|1|||
23448954|NCT01962441|65384788|FG000|Randomized Period|Randomized but Never Treated|4|||
23448955|NCT01962441|65384789|FG001|Randomized Period|Randomized but Never Treated|2|||
23448956|NCT01962441|65384790|FG002|Randomized Period|Randomized but Never Treated|3|||
23448957|NCT01962441|65384788|FG000|Randomized Period|Lost to Follow-up|2|||
23448958|NCT01962441|65384789|FG001|Randomized Period|Lost to Follow-up|4|||
23448959|NCT01962441|65384790|FG002|Randomized Period|Lost to Follow-up|4|||
23448960|NCT01962441|65384788|FG000|Randomized Period|Withdrew Consent|3|||
23448961|NCT01962441|65384789|FG001|Randomized Period|Withdrew Consent|3|||
23448962|NCT01962441|65384790|FG002|Randomized Period|Withdrew Consent|2|||
23448963|NCT01962441|65384788|FG000|Randomized Period|Adverse Event|1|||
23448964|NCT01962441|65384789|FG001|Randomized Period|Adverse Event|1|||
23448965|NCT01962441|65384790|FG002|Randomized Period|Adverse Event|0|||
23448966|NCT01962441|65384788|FG000|Randomized Period|Death|0|||
23448967|NCT01962441|65384789|FG001|Randomized Period|Death|0|||
23448968|NCT01962441|65384790|FG002|Randomized Period|Death|2|||
23448969|NCT01962441|65384788|FG000|Randomized Period|Protocol Violation|0|||
23448970|NCT01962441|65384789|FG001|Randomized Period|Protocol Violation|1|||
23336806|NCT02964507|64976161|FG004|Overall Study|Withdrawal by Subject|0|||
23336807|NCT02964507|64976162|FG005|Overall Study|Withdrawal by Subject|1|||
23336808|NCT02964507|64976163|FG006|Overall Study|Withdrawal by Subject|0|||
23336809|NCT02964507|64976164|FG007|Overall Study|Withdrawal by Subject|0|||
23336810|NCT02964507|64976157|FG000|Overall Study|Physician Decision|2|||
23336811|NCT02964507|64976158|FG001|Overall Study|Physician Decision|0|||
23336812|NCT02964507|64976159|FG002|Overall Study|Physician Decision|3|||
23336813|NCT02964507|64976160|FG003|Overall Study|Physician Decision|0|||
23336814|NCT02964507|64976161|FG004|Overall Study|Physician Decision|1|||
23336815|NCT02964507|64976162|FG005|Overall Study|Physician Decision|0|||
23336816|NCT02964507|64976163|FG006|Overall Study|Physician Decision|0|||
23336817|NCT02964507|64976164|FG007|Overall Study|Physician Decision|0|||
23336818|NCT02316548|64976165|FG000|Overall Study|Protocol Violation|0|||
23336819|NCT02316548|64976166|FG001|Overall Study|Protocol Violation|1|||
23336820|NCT00570687|64976168|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336821|NCT00570687|64976169|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336822|NCT00570687|64976170|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23448971|NCT01962441|65384790|FG002|Randomized Period|Protocol Violation|0|||
23448972|NCT01962441|65384788|FG000|Retreatment Substudy|Lack of Efficacy|1|||
23448973|NCT01962441|65384789|FG001|Retreatment Substudy|Lack of Efficacy|0|||
23448974|NCT01962441|65384790|FG002|Retreatment Substudy|Lack of Efficacy|0|||
23448975|NCT01962441|65384788|FG000|Retreatment Substudy|Lost to Follow-up|1|||
23448976|NCT01962441|65384789|FG001|Retreatment Substudy|Lost to Follow-up|0|||
23448977|NCT01962441|65384790|FG002|Retreatment Substudy|Lost to Follow-up|0|||
23448978|NCT01363700|65384791|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
23448979|NCT01363700|65384792|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
23448980|NCT01363700|65384793|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
23448981|NCT01363700|65384794|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
23448982|NCT01363700|65384795|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
23448983|NCT02098746|65384798|FG000|Overall Study|Changes of Investigator|2|||
23448984|NCT02098746|65384798|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23448985|NCT02098746|65384798|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
23336823|NCT00570687|64976171|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336824|NCT00570687|64976172|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
23336825|NCT00570687|64976173|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
23336826|NCT00570687|64976174|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
23336827|NCT00570687|64976175|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
23336828|NCT00570687|64976176|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
23336829|NCT00570687|64976177|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
23336830|NCT00570687|64976168|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336831|NCT00570687|64976169|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336832|NCT00570687|64976170|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23576570|NCT00333138|65843388|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
23576571|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
23576572|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
23576573|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
23576574|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
23576575|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
23576576|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
23576577|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
23576578|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
23576579|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
23576580|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
23576581|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
23576582|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
23576583|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
23576584|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
23576585|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
23576586|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
23576587|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
23576588|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
23576589|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
23576590|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
23576591|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
23576592|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
23576593|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
23576594|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
23576595|NCT00333138|65843386|FG000|Extension Study (Month6 to End of Study)|Death|0|||
23576596|NCT00333138|65843387|FG001|Extension Study (Month6 to End of Study)|Death|1|||
23336833|NCT00570687|64976171|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336834|NCT00570687|64976172|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23169840|NCT01784965|64367133|FG001|Overall Study|Withdrawal by Subject|3|||
23228261|NCT00711412|64578065|FG000|Survival Follow up Until Death|Other|12|||
23228262|NCT04735432|64578067|FG000|Overall Study|Other - due to personal reason|1|||
23228263|NCT04735432|64578068|FG001|Overall Study|Other - due to personal reason|0|||
23228264|NCT04735432|64578067|FG000|Overall Study|Adverse Event|2|||
23228265|NCT04735432|64578068|FG001|Overall Study|Adverse Event|0|||
23228266|NCT02483611|64578069|FG000|Overall Study|Protocol Violation|0|||
23336835|NCT00570687|64976173|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23169841|NCT01784965|64367132|FG000|Overall Study|Adverse Event|0|||
23169842|NCT01784965|64367133|FG001|Overall Study|Adverse Event|8|||
23169843|NCT03718143|64367134|FG000|Overall Study|Death|1|||
23169844|NCT03718143|64367135|FG001|Overall Study|Death|0|||
23169845|NCT03718143|64367136|FG002|Overall Study|Death|0|||
23169846|NCT03718143|64367134|FG000|Overall Study|Progression of Disease|1|||
23169847|NCT03718143|64367135|FG001|Overall Study|Progression of Disease|0|||
23169848|NCT03718143|64367136|FG002|Overall Study|Progression of Disease|0|||
23169849|NCT03718143|64367134|FG000|Overall Study|Withdrawal of Informed Consent|1|||
23169850|NCT03718143|64367135|FG001|Overall Study|Withdrawal of Informed Consent|2|||
23336836|NCT00570687|64976174|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336837|NCT00570687|64976175|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23576597|NCT00333138|65843388|FG002|Extension Study (Month6 to End of Study)|Death|0|||
23576598|NCT00665561|65843391|FG000|Overall Study|Death recorded on subject summary pages|75|||
23169851|NCT03718143|64367136|FG002|Overall Study|Withdrawal of Informed Consent|1|||
23228267|NCT02483611|64578070|FG001|Overall Study|Protocol Violation|0|||
23448986|NCT02098746|65384798|FG000|Overall Study|Data Not Available After Treatment|1|||
23228268|NCT02483611|64578071|FG002|Overall Study|Protocol Violation|1|||
23336838|NCT00570687|64976176|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
23336839|NCT00570687|64976177|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336840|NCT00570687|64976168|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336841|NCT00570687|64976169|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336842|NCT00570687|64976170|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336843|NCT00570687|64976171|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336844|NCT00570687|64976172|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23576599|NCT00665561|65843392|FG001|Overall Study|Death recorded on subject summary pages|75|||
23576600|NCT00665561|65843391|FG000|Overall Study|Does not meet entrance criteria|19|||
23336845|NCT00570687|64976173|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336846|NCT00570687|64976174|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
23336847|NCT00570687|64976175|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336848|NCT00570687|64976176|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336849|NCT00570687|64976177|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
23336850|NCT02309411|64976183|FG000|Overall Study|Physician Decision|1|||
23336851|NCT02309411|64976184|FG001|Overall Study|Physician Decision|0|||
23576601|NCT00665561|65843392|FG001|Overall Study|Does not meet entrance criteria|21|||
23576602|NCT00665561|65843391|FG000|Overall Study|Lost to Follow-up|203|||
23576603|NCT00665561|65843392|FG001|Overall Study|Lost to Follow-up|264|||
23576604|NCT00665561|65843391|FG000|Overall Study|Withdrawal by Subject|74|||
23576605|NCT00665561|65843392|FG001|Overall Study|Withdrawal by Subject|65|||
23576606|NCT00665561|65843391|FG000|Overall Study|Other|123|||
23576607|NCT00665561|65843392|FG001|Overall Study|Other|108|||
23576608|NCT00665561|65843391|FG000|Overall Study|Site closed|8|||
23576609|NCT00665561|65843392|FG001|Overall Study|Site closed|0|||
23576610|NCT00665561|65843391|FG000|Overall Study|Withdrawn due to pregnancy|0|||
23576611|NCT00665561|65843392|FG001|Overall Study|Withdrawn due to pregnancy|1|||
23448987|NCT02532517|65384799|FG000|Overall Study|Did not complete 24-Month visit|4|||
23448988|NCT02532517|65384799|FG000|Overall Study|Failed Angiographic eligibility|1|||
23448989|NCT02532517|65384799|FG000|Overall Study|Lost to Follow-up|4|||
23448990|NCT02532517|65384799|FG000|Overall Study|Withdrawal by Subject|4|||
23576612|NCT03073005|65843393|FG000|Overall Study|Death|6|||
23576613|NCT03073005|65843394|FG001|Overall Study|Death|0|||
23576614|NCT03073005|65843395|FG002|Overall Study|Death|7|||
23576615|NCT03073005|65843396|FG003|Overall Study|Death|0|||
23576616|NCT03073005|65843393|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
23576617|NCT03073005|65843394|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
23576618|NCT03073005|65843395|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
23576619|NCT03073005|65843396|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
23576620|NCT03073005|65843393|FG000|Overall Study|Lost to Follow-up|2|||
23576621|NCT03073005|65843394|FG001|Overall Study|Lost to Follow-up|2|||
23576622|NCT03073005|65843395|FG002|Overall Study|Lost to Follow-up|1|||
23576623|NCT03073005|65843396|FG003|Overall Study|Lost to Follow-up|2|||
23576624|NCT03073005|65843393|FG000|Overall Study|Withdrawal by Subject|0|||
23576625|NCT03073005|65843394|FG001|Overall Study|Withdrawal by Subject|4|||
23576626|NCT03073005|65843395|FG002|Overall Study|Withdrawal by Subject|4|||
23576627|NCT03073005|65843396|FG003|Overall Study|Withdrawal by Subject|4|||
23576628|NCT01347645|65843399|FG000|Overall Study|Death|1|||
23576629|NCT01347645|65843400|FG001|Overall Study|Death|5|||
23576630|NCT01347645|65843401|FG002|Overall Study|Death|2|||
23576631|NCT01347645|65843402|FG003|Overall Study|Death|7|||
23576632|NCT01347645|65843403|FG004|Overall Study|Death|7|||
23169852|NCT00586495|64367140|FG000|Treatment Period|Adverse Event|11|||
23169853|NCT00586495|64367140|FG000|Treatment Period|Death|1|||
23169854|NCT00586495|64367140|FG000|Treatment Period|Protocol Violation|1|||
23169855|NCT00586495|64367140|FG000|Treatment Period|Withdrawal by Subject|1|||
23169856|NCT00586495|64367140|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
23169857|NCT00586495|64367140|FG000|Treatment Period|Switch to commercial drug|10|||
23448991|NCT02532517|65384799|FG000|Overall Study|Death|4|||
23576633|NCT01347645|65843399|FG000|Overall Study|Lost to Follow-up|1|||
23576634|NCT01347645|65843400|FG001|Overall Study|Lost to Follow-up|1|||
23576635|NCT01347645|65843401|FG002|Overall Study|Lost to Follow-up|0|||
23576636|NCT01347645|65843402|FG003|Overall Study|Lost to Follow-up|1|||
23576637|NCT01347645|65843403|FG004|Overall Study|Lost to Follow-up|1|||
23576638|NCT01347645|65843399|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
23576639|NCT01347645|65843400|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
23576640|NCT01347645|65843401|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
23576641|NCT01347645|65843402|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
23576642|NCT01347645|65843403|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
23576643|NCT01347645|65843399|FG000|Overall Study|Other|1|||
23576644|NCT01347645|65843400|FG001|Overall Study|Other|0|||
23576645|NCT01347645|65843401|FG002|Overall Study|Other|0|||
23336852|NCT02309411|64976185|FG002|Overall Study|Physician Decision|0|||
23336853|NCT02309411|64976183|FG000|Overall Study|Withdrawal by Subject|1|||
23336854|NCT02309411|64976184|FG001|Overall Study|Withdrawal by Subject|1|||
23336855|NCT02309411|64976185|FG002|Overall Study|Withdrawal by Subject|0|||
23336856|NCT01377922|64976186|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
23336857|NCT01377922|64976187|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
23336858|NCT02111577|64976192|FG000|Overall Study|Protocol Violation|2|||
23336859|NCT02111577|64976193|FG001|Overall Study|Protocol Violation|0|||
23336860|NCT02111577|64976192|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
23336861|NCT02111577|64976193|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
23336862|NCT02111577|64976192|FG000|Overall Study|Failure to produce study treatment|6|||
23228269|NCT02254304|64578077|FG000|Overall Study|Adverse Event|2|||
23228270|NCT02254304|64578078|FG001|Overall Study|Adverse Event|1|||
23228271|NCT02254304|64578077|FG000|Overall Study|Lost to Follow-up|2|||
23228272|NCT02254304|64578078|FG001|Overall Study|Lost to Follow-up|2|||
23228273|NCT02254304|64578077|FG000|Overall Study|Protocol Violation|1|||
23228274|NCT02254304|64578078|FG001|Overall Study|Protocol Violation|0|||
23228275|NCT02254304|64578077|FG000|Overall Study|Withdrawal by Subject|3|||
23228276|NCT02254304|64578078|FG001|Overall Study|Withdrawal by Subject|0|||
23228277|NCT02254304|64578077|FG000|Overall Study|Injection site pain and Injection fear|1|||
23228278|NCT02254304|64578078|FG001|Overall Study|Injection site pain and Injection fear|0|||
23228279|NCT02254304|64578077|FG000|Overall Study|Personal causes|4|||
23336863|NCT02111577|64976193|FG001|Overall Study|Failure to produce study treatment|0|||
23336864|NCT02111577|64976192|FG000|Overall Study|Death|518|||
23336865|NCT02111577|64976193|FG001|Overall Study|Death|254|||
23336866|NCT02111577|64976192|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
23336867|NCT02111577|64976193|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
23336868|NCT02111577|64976192|FG000|Overall Study|Adverse Event|1|||
23336869|NCT02111577|64976193|FG001|Overall Study|Adverse Event|1|||
23336870|NCT02111577|64976192|FG000|Overall Study|Withdrawal by Subject|51|||
23336871|NCT02111577|64976193|FG001|Overall Study|Withdrawal by Subject|23|||
23336872|NCT02111577|64976192|FG000|Overall Study|Disease progression|0|||
23336873|NCT02111577|64976193|FG001|Overall Study|Disease progression|1|||
23336874|NCT02111577|64976192|FG000|Overall Study|Lost to Follow-up|19|||
23336875|NCT02111577|64976193|FG001|Overall Study|Lost to Follow-up|10|||
23336876|NCT00734162|64976195|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
23336877|NCT00734162|64976196|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
23336878|NCT00734162|64976197|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
23336879|NCT00734162|64976198|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
23336880|NCT00734162|64976195|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
23336881|NCT00734162|64976196|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
23336882|NCT00734162|64976197|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
23336883|NCT00734162|64976198|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
23336884|NCT00734162|64976195|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
23336885|NCT00734162|64976196|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
23336886|NCT00734162|64976197|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
23336887|NCT00734162|64976198|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
23336888|NCT00734162|64976195|FG000|Open-Label Phase|Withdrew Consent|1|||
23336889|NCT00734162|64976196|FG001|Open-Label Phase|Withdrew Consent|0|||
23336890|NCT00734162|64976197|FG002|Open-Label Phase|Withdrew Consent|1|||
23336891|NCT00734162|64976198|FG003|Open-Label Phase|Withdrew Consent|1|||
23336892|NCT00734162|64976195|FG000|Open-Label Phase|Lost to Follow-up|1|||
23336893|NCT00734162|64976196|FG001|Open-Label Phase|Lost to Follow-up|2|||
23336894|NCT00734162|64976197|FG002|Open-Label Phase|Lost to Follow-up|0|||
23336895|NCT00734162|64976198|FG003|Open-Label Phase|Lost to Follow-up|1|||
23169858|NCT00586495|64367140|FG000|Follow-up|Death|40|||
23169859|NCT00586495|64367140|FG000|Follow-up|Lost to Follow-up|1|||
23169860|NCT00586495|64367140|FG000|Follow-up|Withdrawal by Subject|4|||
23169861|NCT00586495|64367140|FG000|Follow-up|Protocol driven decision point|37|||
23169862|NCT00586495|64367140|FG000|Follow-up|Switch to commercial drug|10|||
23169863|NCT01338415|64367141|FG000|Core + Extension|Adverse Event|8|||
23169864|NCT01338415|64367142|FG001|Core + Extension|Adverse Event|6|||
23169865|NCT01338415|64367143|FG002|Core + Extension|Adverse Event|0|||
23169866|NCT01338415|64367141|FG000|Core + Extension|Withdrawal by Subject|1|||
23169867|NCT01338415|64367142|FG001|Core + Extension|Withdrawal by Subject|1|||
23336896|NCT00734162|64976195|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23336897|NCT00734162|64976196|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23336898|NCT00734162|64976197|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23576646|NCT01347645|65843402|FG003|Overall Study|Other|0|||
23576647|NCT01347645|65843403|FG004|Overall Study|Other|1|||
23169868|NCT01338415|64367143|FG002|Core + Extension|Withdrawal by Subject|0|||
23228280|NCT02254304|64578078|FG001|Overall Study|Personal causes|1|||
23228281|NCT02254304|64578077|FG000|Overall Study|Personal decision|1|||
23228282|NCT02254304|64578078|FG001|Overall Study|Personal decision|0|||
23228283|NCT02710422|64578079|FG000|Overall Study|Termination of study|9|||
23336899|NCT00734162|64976198|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
23336900|NCT01222520|64976199|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
23336901|NCT01222520|64976200|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
23336902|NCT01222520|64976199|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
23336903|NCT01222520|64976200|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
23336904|NCT01222520|64976199|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
23336905|NCT01222520|64976200|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
23336906|NCT01222520|64976199|FG000|Double-blind Period|Adverse Event|0|||
23336907|NCT01222520|64976200|FG001|Double-blind Period|Adverse Event|1|||
23336908|NCT01222520|64976199|FG000|Double-blind Period|Lack of Efficacy|0|||
23336909|NCT01222520|64976200|FG001|Double-blind Period|Lack of Efficacy|1|||
23336910|NCT01222520|64976199|FG000|Double-blind Period|Study medication stolen|1|||
23336911|NCT01222520|64976200|FG001|Double-blind Period|Study medication stolen|0|||
23576648|NCT01347645|65843399|FG000|Overall Study|Withdrawal by Subject|0|||
23576649|NCT01347645|65843400|FG001|Overall Study|Withdrawal by Subject|0|||
23336912|NCT00247611|64976201|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
23336913|NCT00247611|64976202|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
23228284|NCT02710422|64578080|FG001|Overall Study|Termination of study|9|||
23228285|NCT01034709|64578083|FG000|Overall Study|Protocol Violation|9|||
23228286|NCT01034709|64578084|FG001|Overall Study|Protocol Violation|16|||
23336914|NCT00247611|64976201|FG000|Baselined|Completed baseline only|9|||
23336915|NCT00247611|64976202|FG001|Baselined|Completed baseline only|8|||
23336916|NCT02129777|64976203|FG000|Double-Blind Period|Adverse Event|0|||
23336917|NCT02129777|64976204|FG001|Double-Blind Period|Adverse Event|0|||
23336918|NCT02129777|64976205|FG002|Double-Blind Period|Adverse Event|0|||
23336919|NCT02129777|64976206|FG003|Double-Blind Period|Adverse Event|0|||
23336920|NCT02129777|64976207|FG004|Double-Blind Period|Adverse Event|1|||
23336921|NCT02129777|64976208|FG005|Double-Blind Period|Adverse Event|0|||
23336922|NCT02129777|64976209|FG006|Double-Blind Period|Adverse Event|0|||
23336923|NCT02129777|64976203|FG000|Double-Blind Period|Lost to Follow-up|1|||
23336924|NCT02129777|64976204|FG001|Double-Blind Period|Lost to Follow-up|1|||
23336925|NCT02129777|64976205|FG002|Double-Blind Period|Lost to Follow-up|1|||
23228287|NCT03147495|64578089|FG000|Overall Study|Physician Decision|0|||
23576650|NCT01347645|65843401|FG002|Overall Study|Withdrawal by Subject|0|||
23336926|NCT02129777|64976206|FG003|Double-Blind Period|Lost to Follow-up|2|||
23336927|NCT02129777|64976207|FG004|Double-Blind Period|Lost to Follow-up|0|||
23336928|NCT02129777|64976208|FG005|Double-Blind Period|Lost to Follow-up|0|||
23336929|NCT02129777|64976209|FG006|Double-Blind Period|Lost to Follow-up|0|||
23336930|NCT02129777|64976203|FG000|Double-Blind Period|Withdrawal by Subject|2|||
23336931|NCT02129777|64976204|FG001|Double-Blind Period|Withdrawal by Subject|4|||
23336932|NCT02129777|64976205|FG002|Double-Blind Period|Withdrawal by Subject|3|||
23336933|NCT02129777|64976206|FG003|Double-Blind Period|Withdrawal by Subject|2|||
23336934|NCT02129777|64976207|FG004|Double-Blind Period|Withdrawal by Subject|3|||
23336935|NCT02129777|64976208|FG005|Double-Blind Period|Withdrawal by Subject|0|||
23336936|NCT02129777|64976209|FG006|Double-Blind Period|Withdrawal by Subject|0|||
23169869|NCT01338415|64367141|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
23576651|NCT01347645|65843402|FG003|Overall Study|Withdrawal by Subject|3|||
23576652|NCT01347645|65843403|FG004|Overall Study|Withdrawal by Subject|3|||
23336937|NCT02129777|64976203|FG000|Double-Blind Period|Pregnancy|0|||
23169870|NCT01338415|64367142|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
23169871|NCT01338415|64367143|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
23169872|NCT01338415|64367141|FG000|Core + Extension|Other (administrative reason)|1|||
23169873|NCT01338415|64367142|FG001|Core + Extension|Other (administrative reason)|0|||
23169874|NCT01338415|64367143|FG002|Core + Extension|Other (administrative reason)|0|||
23169875|NCT01338415|64367141|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
23169876|NCT01338415|64367142|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
23576653|NCT01347645|65843399|FG000|Overall Study|Physician Decision|0|||
23576654|NCT01347645|65843400|FG001|Overall Study|Physician Decision|0|||
23576655|NCT01347645|65843401|FG002|Overall Study|Physician Decision|0|||
23169877|NCT01338415|64367143|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
23169878|NCT01338415|64367141|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
23169879|NCT01338415|64367142|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
23169880|NCT01338415|64367143|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
23228288|NCT03147495|64578090|FG001|Overall Study|Physician Decision|6|||
23336938|NCT02129777|64976204|FG001|Double-Blind Period|Pregnancy|0|||
23336939|NCT02129777|64976205|FG002|Double-Blind Period|Pregnancy|0|||
23576656|NCT01347645|65843402|FG003|Overall Study|Physician Decision|0|||
23228289|NCT01950364|64578091|FG000|Overall Study|Adverse Event|3|||
23228290|NCT01950364|64578092|FG001|Overall Study|Adverse Event|0|||
23336940|NCT02129777|64976206|FG003|Double-Blind Period|Pregnancy|0|||
23336941|NCT02129777|64976207|FG004|Double-Blind Period|Pregnancy|1|||
23336942|NCT02129777|64976208|FG005|Double-Blind Period|Pregnancy|0|||
23336943|NCT02129777|64976209|FG006|Double-Blind Period|Pregnancy|0|||
23576657|NCT01347645|65843403|FG004|Overall Study|Physician Decision|1|||
23336944|NCT02129777|64976203|FG000|Double-Blind Period|Lack of Efficacy|3|||
23336945|NCT02129777|64976204|FG001|Double-Blind Period|Lack of Efficacy|1|||
23336946|NCT02129777|64976205|FG002|Double-Blind Period|Lack of Efficacy|0|||
23336947|NCT02129777|64976206|FG003|Double-Blind Period|Lack of Efficacy|3|||
23336948|NCT02129777|64976207|FG004|Double-Blind Period|Lack of Efficacy|2|||
23336949|NCT02129777|64976208|FG005|Double-Blind Period|Lack of Efficacy|0|||
23336950|NCT02129777|64976209|FG006|Double-Blind Period|Lack of Efficacy|0|||
23336951|NCT02129777|64976203|FG000|Double-Blind Period|Other|1|||
23336952|NCT02129777|64976204|FG001|Double-Blind Period|Other|2|||
23336953|NCT02129777|64976205|FG002|Double-Blind Period|Other|0|||
23336954|NCT02129777|64976206|FG003|Double-Blind Period|Other|0|||
23336955|NCT02129777|64976207|FG004|Double-Blind Period|Other|0|||
23336956|NCT02129777|64976208|FG005|Double-Blind Period|Other|0|||
23336957|NCT02129777|64976209|FG006|Double-Blind Period|Other|0|||
23336958|NCT02129777|64976203|FG000|Open-Label Period|Lack of Efficacy|0|||
23336959|NCT02129777|64976204|FG001|Open-Label Period|Lack of Efficacy|0|||
23336960|NCT02129777|64976205|FG002|Open-Label Period|Lack of Efficacy|0|||
23336961|NCT02129777|64976206|FG003|Open-Label Period|Lack of Efficacy|0|||
23336962|NCT02129777|64976207|FG004|Open-Label Period|Lack of Efficacy|0|||
23336963|NCT02129777|64976208|FG005|Open-Label Period|Lack of Efficacy|0|||
23336964|NCT02129777|64976209|FG006|Open-Label Period|Lack of Efficacy|5|||
23169881|NCT01338415|64367141|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
23169882|NCT01338415|64367142|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
23336965|NCT02129777|64976203|FG000|Open-Label Period|Lost to Follow-up|0|||
23336966|NCT02129777|64976204|FG001|Open-Label Period|Lost to Follow-up|0|||
23336967|NCT02129777|64976205|FG002|Open-Label Period|Lost to Follow-up|0|||
23336968|NCT02129777|64976206|FG003|Open-Label Period|Lost to Follow-up|0|||
23336969|NCT02129777|64976207|FG004|Open-Label Period|Lost to Follow-up|0|||
23336970|NCT02129777|64976208|FG005|Open-Label Period|Lost to Follow-up|1|||
23336971|NCT02129777|64976209|FG006|Open-Label Period|Lost to Follow-up|1|||
23336972|NCT02129777|64976203|FG000|Open-Label Period|Withdrawal by Subject|0|||
23169883|NCT01338415|64367143|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
23169884|NCT01338415|64367141|FG000|Exceptional Use Treatment Period|Death|0|||
23169885|NCT01338415|64367142|FG001|Exceptional Use Treatment Period|Death|0|||
23169886|NCT01338415|64367143|FG002|Exceptional Use Treatment Period|Death|1|||
23169887|NCT01777152|64367144|FG000|Overall Study|Withdrawal by Subject|22|||
23169888|NCT01777152|64367145|FG001|Overall Study|Withdrawal by Subject|16|||
23169889|NCT01777152|64367144|FG000|Overall Study|Lost to Follow-up|3|||
23169890|NCT01777152|64367145|FG001|Overall Study|Lost to Follow-up|5|||
23169891|NCT01777152|64367144|FG000|Overall Study|Death|68|||
23169892|NCT01777152|64367145|FG001|Overall Study|Death|89|||
23169893|NCT01777152|64367144|FG000|Overall Study|Not eligible, no study drug received|1|||
23169894|NCT01777152|64367145|FG001|Overall Study|Not eligible, no study drug received|0|||
23169895|NCT01777152|64367144|FG000|Overall Study|Change of diagnosis|1|||
23169896|NCT01777152|64367145|FG001|Overall Study|Change of diagnosis|0|||
23169897|NCT01375764|64367147|FG000|Overall Study|Lost to Follow-up|0|||
23169898|NCT01375764|64367148|FG001|Overall Study|Lost to Follow-up|1|||
23169899|NCT01375764|64367149|FG002|Overall Study|Lost to Follow-up|0|||
23169900|NCT01375764|64367150|FG003|Overall Study|Lost to Follow-up|0|||
23169901|NCT01375764|64367151|FG004|Overall Study|Lost to Follow-up|0|||
23169902|NCT01375764|64367147|FG000|Overall Study|Withdrawal by Subject|2|||
23169903|NCT01375764|64367148|FG001|Overall Study|Withdrawal by Subject|0|||
23169904|NCT01375764|64367149|FG002|Overall Study|Withdrawal by Subject|0|||
23169905|NCT01375764|64367150|FG003|Overall Study|Withdrawal by Subject|0|||
23169906|NCT01375764|64367151|FG004|Overall Study|Withdrawal by Subject|1|||
23169907|NCT01375764|64367147|FG000|Overall Study|Other|0|||
23169908|NCT01375764|64367148|FG001|Overall Study|Other|0|||
23169909|NCT01375764|64367149|FG002|Overall Study|Other|0|||
23169910|NCT01375764|64367150|FG003|Overall Study|Other|1|||
23169911|NCT01375764|64367151|FG004|Overall Study|Other|0|||
23169912|NCT00705939|64367152|FG000|Overall Study|Protocol Violation|0|||
23169913|NCT00705939|64367153|FG001|Overall Study|Protocol Violation|0|||
23169914|NCT00705939|64367154|FG002|Overall Study|Protocol Violation|1|||
23169915|NCT00705939|64367152|FG000|Overall Study|Withdrawal by Subject|0|||
23169916|NCT00705939|64367153|FG001|Overall Study|Withdrawal by Subject|1|||
23169917|NCT00705939|64367154|FG002|Overall Study|Withdrawal by Subject|3|||
23169918|NCT00705939|64367152|FG000|Overall Study|Physician Decision|0|||
23169919|NCT00705939|64367153|FG001|Overall Study|Physician Decision|1|||
23169920|NCT00705939|64367154|FG002|Overall Study|Physician Decision|0|||
23169921|NCT01294670|64367155|FG000|Overall Study|Not treated|1|||
23169922|NCT01294670|64367156|FG001|Overall Study|Not treated|0|||
23336973|NCT02129777|64976204|FG001|Open-Label Period|Withdrawal by Subject|0|||
23336974|NCT02129777|64976205|FG002|Open-Label Period|Withdrawal by Subject|0|||
23169923|NCT01294670|64367157|FG002|Overall Study|Not treated|0|||
23169924|NCT01294670|64367158|FG003|Overall Study|Not treated|0|||
23336975|NCT02129777|64976206|FG003|Open-Label Period|Withdrawal by Subject|0|||
23169925|NCT01294670|64367159|FG004|Overall Study|Not treated|0|||
23336976|NCT02129777|64976207|FG004|Open-Label Period|Withdrawal by Subject|0|||
23336977|NCT02129777|64976208|FG005|Open-Label Period|Withdrawal by Subject|1|||
23336978|NCT02129777|64976209|FG006|Open-Label Period|Withdrawal by Subject|3|||
23336979|NCT02129777|64976203|FG000|Open-Label Period|Study Termination|0|||
23448992|NCT02362724|65384800|FG000|Overall Study|Withdrawal by Subject|3|||
23448993|NCT02362724|65384801|FG001|Overall Study|Withdrawal by Subject|1|||
23169926|NCT01823679|64367160|FG000|Overall Study|Death|1|||
23169927|NCT01514682|64367161|FG000|Overall Study|Withdrawal by Subject|2|||
23169928|NCT01514682|64367162|FG001|Overall Study|Withdrawal by Subject|3|||
23169929|NCT01514682|64367161|FG000|Overall Study|Physician Decision|4|||
23169930|NCT01514682|64367162|FG001|Overall Study|Physician Decision|3|||
23169931|NCT00523991|64367163|FG000|Overall Study|Adverse Event|6|||
23448994|NCT02362724|65384800|FG000|Overall Study|Adverse Event|3|||
23448995|NCT02362724|65384801|FG001|Overall Study|Adverse Event|0|||
23169932|NCT00523991|64367164|FG001|Overall Study|Adverse Event|5|||
23169933|NCT00523991|64367163|FG000|Overall Study|Protocol Violation|1|||
23169934|NCT00523991|64367164|FG001|Overall Study|Protocol Violation|4|||
23169935|NCT00523991|64367163|FG000|Overall Study|Lost to Follow-up|4|||
23169936|NCT00523991|64367164|FG001|Overall Study|Lost to Follow-up|1|||
23169937|NCT00523991|64367163|FG000|Overall Study|Withdrawal by Subject|7|||
23169938|NCT00523991|64367164|FG001|Overall Study|Withdrawal by Subject|17|||
23169939|NCT00523991|64367163|FG000|Overall Study|Other reason (not specified)|3|||
23169940|NCT00523991|64367164|FG001|Overall Study|Other reason (not specified)|0|||
23169941|NCT04428424|64367169|FG000|Overall Study|Does not meet entrance criteria|132|||
23169942|NCT04428424|64367169|FG000|Overall Study|Lost to Follow-up|115|||
23169943|NCT01046877|64367174|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
23228291|NCT01950364|64578091|FG000|Overall Study|Stem Cell Transplant|2|||
23228292|NCT01950364|64578092|FG001|Overall Study|Stem Cell Transplant|6|||
23228293|NCT01950364|64578091|FG000|Overall Study|Disease Progression|5|||
23228294|NCT01950364|64578092|FG001|Overall Study|Disease Progression|2|||
23228295|NCT01950364|64578091|FG000|Overall Study|Withdrawal by Subject|0|||
23448996|NCT02871635|65384802|FG000|Overall Study|Primary lack of efficacy|4|||
23228296|NCT01950364|64578092|FG001|Overall Study|Withdrawal by Subject|1|||
23228297|NCT01950364|64578091|FG000|Overall Study|Protocol Violation|0|||
23228298|NCT01950364|64578092|FG001|Overall Study|Protocol Violation|1|||
23228299|NCT02417935|64578096|FG000|Treatment Period|Adverse Event|12|||
23228300|NCT02417935|64578097|FG001|Treatment Period|Adverse Event|10|||
23228301|NCT02417935|64578096|FG000|Treatment Period|Lost to Follow-up|1|||
23228302|NCT02417935|64578097|FG001|Treatment Period|Lost to Follow-up|0|||
23228303|NCT02417935|64578096|FG000|Treatment Period|Entry Criteria not met|0|||
23228304|NCT02417935|64578097|FG001|Treatment Period|Entry Criteria not met|1|||
23228305|NCT02417935|64578096|FG000|Treatment Period|Protocol Violation|2|||
23228306|NCT02417935|64578097|FG001|Treatment Period|Protocol Violation|1|||
23228307|NCT02417935|64578096|FG000|Treatment Period|Withdrawal by Subject|3|||
23228308|NCT02417935|64578097|FG001|Treatment Period|Withdrawal by Subject|3|||
23228309|NCT02417935|64578096|FG000|Treatment Period|Physician Decision|3|||
23448997|NCT02871635|65384803|FG001|Overall Study|Primary lack of efficacy|4|||
23448998|NCT02871635|65384802|FG000|Overall Study|Protocol Violation|3|||
23448999|NCT02871635|65384803|FG001|Overall Study|Protocol Violation|1|||
23449000|NCT02871635|65384802|FG000|Overall Study|Lost to Follow-up|1|||
23449001|NCT02871635|65384803|FG001|Overall Study|Lost to Follow-up|2|||
23449002|NCT02871635|65384802|FG000|Overall Study|Pregnancy|0|||
23449003|NCT02871635|65384803|FG001|Overall Study|Pregnancy|2|||
23449004|NCT02871635|65384802|FG000|Overall Study|Physician Decision|1|||
23449005|NCT02871635|65384803|FG001|Overall Study|Physician Decision|1|||
23449006|NCT02871635|65384802|FG000|Overall Study|Withdrawal by Subject|3|||
23449007|NCT02871635|65384803|FG001|Overall Study|Withdrawal by Subject|4|||
23449008|NCT02871635|65384802|FG000|Overall Study|Adverse Event|4|||
23449009|NCT02871635|65384803|FG001|Overall Study|Adverse Event|4|||
23449010|NCT02871635|65384802|FG000|Overall Study|Secondary lack of efficacy|2|||
23169944|NCT01046877|64367174|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
23228310|NCT02417935|64578097|FG001|Treatment Period|Physician Decision|1|||
23449011|NCT02871635|65384803|FG001|Overall Study|Secondary lack of efficacy|1|||
23169945|NCT00700271|64367180|FG000|Overall Study|Adverse Event|4|||
23228311|NCT00471276|64581029|FG000|Overall Study|Death|2|||
23228312|NCT00471276|64581029|FG000|Overall Study|Adverse Event|16|||
23228313|NCT00471276|64581029|FG000|Overall Study|Protocol Violation|1|||
23228314|NCT00471276|64581029|FG000|Overall Study|Objective progression or relapse|54|||
23449012|NCT02631551|65387861|FG000|Overall Study|Adverse Event|1|||
23449013|NCT02631551|65387862|FG001|Overall Study|Adverse Event|2|||
23449014|NCT02631551|65387863|FG002|Overall Study|Adverse Event|4|||
23449015|NCT02631551|65387864|FG003|Overall Study|Adverse Event|0|||
23449016|NCT02631551|65387861|FG000|Overall Study|Lack of Efficacy|0|||
23169946|NCT00700271|64367181|FG001|Overall Study|Adverse Event|6|||
23228315|NCT00471276|64581029|FG000|Overall Study|Global deterioration of health status|1|||
23228316|NCT00471276|64581029|FG000|Overall Study|Other|3|||
23228317|NCT00471276|64581029|FG000|Overall Study|Refused treatment|6|||
23336980|NCT02129777|64976204|FG001|Open-Label Period|Study Termination|0|||
23169947|NCT00700271|64367180|FG000|Overall Study|Protocol Violation|1|||
23169948|NCT00700271|64367181|FG001|Overall Study|Protocol Violation|0|||
23169949|NCT00700271|64367180|FG000|Overall Study|Administrative Reasons|1|||
23169950|NCT00700271|64367181|FG001|Overall Study|Administrative Reasons|0|||
23169951|NCT00700271|64367180|FG000|Overall Study|Withdrawal by Subject|6|||
23169952|NCT00700271|64367181|FG001|Overall Study|Withdrawal by Subject|4|||
23169953|NCT00700271|64367180|FG000|Overall Study|Lost to Follow-up|2|||
23169954|NCT00700271|64367181|FG001|Overall Study|Lost to Follow-up|2|||
23169955|NCT02486757|64367182|FG000|Overall Study|Lost to Follow-up|1|||
23169956|NCT02828358|64367183|FG000|Overall Study|Physician Decision|7|||
23169957|NCT02828358|64367184|FG001|Overall Study|Physician Decision|1|||
23169958|NCT02828358|64367183|FG000|Overall Study|Treatment Failure|6|||
23169959|NCT02828358|64367184|FG001|Overall Study|Treatment Failure|0|||
23169960|NCT02828358|64367183|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
23169961|NCT02828358|64367184|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
23169962|NCT02828358|64367183|FG000|Overall Study|Refusal of further protocol therapy|2|||
23169963|NCT02828358|64367184|FG001|Overall Study|Refusal of further protocol therapy|0|||
23169964|NCT02828358|64367183|FG000|Overall Study|Relapse|25|||
23169965|NCT02828358|64367184|FG001|Overall Study|Relapse|0|||
23576658|NCT01347645|65843399|FG000|Overall Study|Adverse Event|0|||
23576659|NCT01347645|65843400|FG001|Overall Study|Adverse Event|0|||
23576660|NCT01347645|65843401|FG002|Overall Study|Adverse Event|0|||
23576661|NCT01347645|65843402|FG003|Overall Study|Adverse Event|1|||
23576662|NCT01347645|65843403|FG004|Overall Study|Adverse Event|1|||
23576663|NCT03738241|65843408|FG000|Overall Study|Withdrawal by Subject|0|||
23576664|NCT03738241|65843409|FG001|Overall Study|Withdrawal by Subject|0|||
23576665|NCT03738241|65843410|FG002|Overall Study|Withdrawal by Subject|0|||
23576666|NCT03738241|65843411|FG003|Overall Study|Withdrawal by Subject|0|||
23576667|NCT03738241|65843412|FG004|Overall Study|Withdrawal by Subject|0|||
23576668|NCT03738241|65843413|FG005|Overall Study|Withdrawal by Subject|0|||
23576669|NCT03738241|65843414|FG006|Overall Study|Withdrawal by Subject|0|||
23576670|NCT03738241|65843415|FG007|Overall Study|Withdrawal by Subject|0|||
23576671|NCT03738241|65843416|FG008|Overall Study|Withdrawal by Subject|0|||
23576672|NCT03738241|65843417|FG009|Overall Study|Withdrawal by Subject|1|||
23576673|NCT03738241|65843408|FG000|Overall Study|Physician Decision|0|||
23169966|NCT02828358|64367183|FG000|Overall Study|Still on therapy|5|||
23169967|NCT02828358|64367184|FG001|Overall Study|Still on therapy|0|||
23169968|NCT01580488|64367185|FG000|Overall Study|Withdrawal by Subject|1|||
23169969|NCT02447848|64367186|FG000|Overall Study|Patient discharged|3|||
23169970|NCT02447848|64367186|FG000|Overall Study|Lack of Efficacy|4|||
23169971|NCT02447848|64367186|FG000|Overall Study|Withdrawal by Subject|4|||
23169972|NCT01325428|64367187|FG000|Part A|Progressive disease according to RECIST|9|||
23169973|NCT01325428|64367187|FG000|Part A|Clinical signs, symptoms of progression|2|||
23169974|NCT01325428|64367187|FG000|Part A|Other adverse event|1|||
23169975|NCT01325428|64367187|FG000|Part A|Refused continue taking trial medication|2|||
23169976|NCT01325428|64367187|FG000|Part A|Other reason not defined above|2|||
23576674|NCT03738241|65843409|FG001|Overall Study|Physician Decision|0|||
23576675|NCT03738241|65843410|FG002|Overall Study|Physician Decision|0|||
23576676|NCT03738241|65843411|FG003|Overall Study|Physician Decision|0|||
23576677|NCT03738241|65843412|FG004|Overall Study|Physician Decision|0|||
23576678|NCT03738241|65843413|FG005|Overall Study|Physician Decision|0|||
23576679|NCT03738241|65843414|FG006|Overall Study|Physician Decision|0|||
23576680|NCT03738241|65843415|FG007|Overall Study|Physician Decision|0|||
23576681|NCT03738241|65843416|FG008|Overall Study|Physician Decision|1|||
23576682|NCT03738241|65843417|FG009|Overall Study|Physician Decision|0|||
23576683|NCT03738241|65843408|FG000|Overall Study|Adverse Event|1|||
23576684|NCT03738241|65843409|FG001|Overall Study|Adverse Event|0|||
23576685|NCT03738241|65843410|FG002|Overall Study|Adverse Event|0|||
23576686|NCT03738241|65843411|FG003|Overall Study|Adverse Event|0|||
23576687|NCT03738241|65843412|FG004|Overall Study|Adverse Event|0|||
23576688|NCT03738241|65843413|FG005|Overall Study|Adverse Event|0|||
23576689|NCT03738241|65843414|FG006|Overall Study|Adverse Event|0|||
23576690|NCT03738241|65843415|FG007|Overall Study|Adverse Event|0|||
23576691|NCT03738241|65843416|FG008|Overall Study|Adverse Event|0|||
23576692|NCT03738241|65843417|FG009|Overall Study|Adverse Event|0|||
23576693|NCT00131911|65843419|FG000|Overall Study|Withdrawal by Subject|1|||
23576694|NCT00131911|65843420|FG001|Overall Study|Withdrawal by Subject|0|||
23169977|NCT01325428|64367187|FG000|Part B|Refused continue taking trial medication|2|||
23576695|NCT02955277|65843423|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
23169978|NCT01325428|64367187|FG000|Part B|Other reason not defined above|1|||
23169979|NCT00464178|64367192|FG000|Overall Study|Protocol Violation|1|||
23169980|NCT00464178|64367192|FG000|Overall Study|Withdrawal by Subject|1|||
23169981|NCT00699907|64367193|FG000|Overall Study|Withdrawal by Subject|2|||
23169982|NCT00699907|64367194|FG001|Overall Study|Withdrawal by Subject|1|||
23169983|NCT00699907|64367195|FG002|Overall Study|Withdrawal by Subject|0|||
23576696|NCT02955277|65843424|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
23576697|NCT02955277|65843423|FG000|Post to Follow-up|Lost to Follow-up|8|||
23576698|NCT02955277|65843424|FG001|Post to Follow-up|Lost to Follow-up|11|||
23169984|NCT00699907|64367193|FG000|Overall Study|No usable sample|0|||
23576699|NCT03285711|65843428|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
23576700|NCT03285711|65843429|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
23576701|NCT03285711|65843430|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
23576702|NCT03285711|65843431|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
23576703|NCT03285711|65843428|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
23169985|NCT00699907|64367194|FG001|Overall Study|No usable sample|9|||
23169986|NCT00699907|64367195|FG002|Overall Study|No usable sample|8|||
23169987|NCT02362503|64367198|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
23169988|NCT02362503|64367199|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
23169989|NCT02362503|64367200|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
23169990|NCT02362503|64367198|FG000|Double-blind Period-Up to 8 Days|Death|1|||
23169991|NCT02362503|64367199|FG001|Double-blind Period-Up to 8 Days|Death|0|||
23169992|NCT02362503|64367200|FG002|Double-blind Period-Up to 8 Days|Death|0|||
23169993|NCT02362503|64367198|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
23169994|NCT02362503|64367199|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
23169995|NCT02362503|64367200|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
23169996|NCT02362503|64367198|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
23169997|NCT02362503|64367199|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
23169998|NCT02362503|64367200|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
23169999|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
23170000|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
23170001|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
23170002|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
23170003|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
23170004|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
23170005|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
23170006|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
23170007|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
23170008|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
23170009|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
23170010|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
23170011|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
23170012|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
23170013|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
23170014|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
23170015|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
23170016|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
23170017|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
23170018|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
23170019|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
23170020|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
23170021|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
23170022|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
23170023|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
23170024|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
23170025|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
23170026|NCT02362503|64367198|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
23170027|NCT02362503|64367199|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
23170028|NCT02362503|64367200|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
23170029|NCT04041284|64367201|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
23170030|NCT04041284|64367202|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
23170031|NCT04041284|64367201|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
23170032|NCT04041284|64367202|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
23170033|NCT04041284|64367201|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
23170034|NCT04041284|64367202|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
23170035|NCT04041284|64367201|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
23170036|NCT04041284|64367202|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
23170037|NCT04041284|64367201|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
23170038|NCT04041284|64367202|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
23170039|NCT04041284|64367201|FG000|DB Phase (12 Weeks)|Other than specified|1|||
23170040|NCT04041284|64367202|FG001|DB Phase (12 Weeks)|Other than specified|0|||
23170041|NCT04041284|64367201|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
23170042|NCT04041284|64367202|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
23170043|NCT04041284|64367201|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
23170044|NCT04041284|64367202|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
23170045|NCT04041284|64367201|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
23170046|NCT04041284|64367202|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
23576704|NCT03285711|65843429|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
23576705|NCT03285711|65843430|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
23170047|NCT04041284|64367201|FG000|OL Phase (12 Weeks)|Other than specified|6|||
23170048|NCT04041284|64367202|FG001|OL Phase (12 Weeks)|Other than specified|2|||
23170049|NCT01192022|64367203|FG000|Overall Study|Withdrawal of Consent|3|||
23170050|NCT01192022|64367204|FG001|Overall Study|Withdrawal of Consent|1|||
23170051|NCT01192022|64367205|FG002|Overall Study|Withdrawal of Consent|0|||
23170052|NCT01192022|64367206|FG003|Overall Study|Withdrawal of Consent|0|||
23170053|NCT01192022|64367207|FG004|Overall Study|Withdrawal of Consent|0|||
23170054|NCT01192022|64367203|FG000|Overall Study|Lost to Follow-up|4|||
23336981|NCT02129777|64976205|FG002|Open-Label Period|Study Termination|0|||
23336982|NCT02129777|64976206|FG003|Open-Label Period|Study Termination|0|||
23170055|NCT01192022|64367204|FG001|Overall Study|Lost to Follow-up|2|||
23170056|NCT01192022|64367205|FG002|Overall Study|Lost to Follow-up|1|||
23170057|NCT01192022|64367206|FG003|Overall Study|Lost to Follow-up|1|||
23170058|NCT01192022|64367207|FG004|Overall Study|Lost to Follow-up|0|||
23170059|NCT01192022|64367203|FG000|Overall Study|Adverse Event|1|||
23170060|NCT01192022|64367204|FG001|Overall Study|Adverse Event|0|||
23170061|NCT01192022|64367205|FG002|Overall Study|Adverse Event|0|||
23170062|NCT01192022|64367206|FG003|Overall Study|Adverse Event|0|||
23170063|NCT01192022|64367207|FG004|Overall Study|Adverse Event|0|||
23170064|NCT01192022|64367203|FG000|Overall Study|Fatal Adverse Event|4|||
23170065|NCT01192022|64367204|FG001|Overall Study|Fatal Adverse Event|6|||
23170066|NCT01192022|64367205|FG002|Overall Study|Fatal Adverse Event|0|||
23170067|NCT01192022|64367206|FG003|Overall Study|Fatal Adverse Event|0|||
23170068|NCT01192022|64367207|FG004|Overall Study|Fatal Adverse Event|1|||
23170069|NCT01192022|64367203|FG000|Overall Study|Physician withdrew-patient hardship|1|||
23170070|NCT01192022|64367204|FG001|Overall Study|Physician withdrew-patient hardship|0|||
23170071|NCT01192022|64367205|FG002|Overall Study|Physician withdrew-patient hardship|0|||
23170072|NCT01192022|64367206|FG003|Overall Study|Physician withdrew-patient hardship|0|||
23170073|NCT01192022|64367207|FG004|Overall Study|Physician withdrew-patient hardship|0|||
23170074|NCT01192022|64367203|FG000|Overall Study|Patient too sick from chemotherapy|0|||
23170075|NCT01192022|64367204|FG001|Overall Study|Patient too sick from chemotherapy|1|||
23170076|NCT01192022|64367205|FG002|Overall Study|Patient too sick from chemotherapy|0|||
23170077|NCT01192022|64367206|FG003|Overall Study|Patient too sick from chemotherapy|0|||
23170078|NCT01192022|64367207|FG004|Overall Study|Patient too sick from chemotherapy|0|||
23170079|NCT01192022|64367203|FG000|Overall Study|Patient needed surgery|0|||
23170080|NCT01192022|64367204|FG001|Overall Study|Patient needed surgery|1|||
23170081|NCT01192022|64367205|FG002|Overall Study|Patient needed surgery|0|||
23170082|NCT01192022|64367206|FG003|Overall Study|Patient needed surgery|0|||
23170083|NCT01192022|64367207|FG004|Overall Study|Patient needed surgery|0|||
23170084|NCT01192022|64367203|FG000|Overall Study|Parents did not allow all follow up|0|||
23170085|NCT01192022|64367204|FG001|Overall Study|Parents did not allow all follow up|0|||
23170086|NCT01192022|64367205|FG002|Overall Study|Parents did not allow all follow up|0|||
23170087|NCT01192022|64367206|FG003|Overall Study|Parents did not allow all follow up|1|||
23170088|NCT01192022|64367207|FG004|Overall Study|Parents did not allow all follow up|0|||
23170089|NCT02982954|64367208|FG000|Overall Study|Death|55|||
23170090|NCT02982954|64367209|FG001|Overall Study|Death|29|||
23170091|NCT02982954|64367210|FG002|Overall Study|Death|15|||
23170092|NCT02982954|64367211|FG003|Overall Study|Death|20|||
23170093|NCT02982954|64367208|FG000|Overall Study|Lost to Follow-up|2|||
23170094|NCT02982954|64367209|FG001|Overall Study|Lost to Follow-up|1|||
23170095|NCT02982954|64367210|FG002|Overall Study|Lost to Follow-up|0|||
23170096|NCT02982954|64367211|FG003|Overall Study|Lost to Follow-up|0|||
23170097|NCT02982954|64367208|FG000|Overall Study|Participant withdrew consent|7|||
23170098|NCT02982954|64367209|FG001|Overall Study|Participant withdrew consent|5|||
23170099|NCT02982954|64367210|FG002|Overall Study|Participant withdrew consent|1|||
23170100|NCT02982954|64367211|FG003|Overall Study|Participant withdrew consent|1|||
23170101|NCT02982954|64367208|FG000|Overall Study|Other reasons|42|||
23336983|NCT02129777|64976207|FG004|Open-Label Period|Study Termination|0|||
23336984|NCT02129777|64976208|FG005|Open-Label Period|Study Termination|10|||
23336985|NCT02129777|64976209|FG006|Open-Label Period|Study Termination|39|||
23336986|NCT00325156|64976212|FG000|Overall Study|Protocol Violation|8|||
23170102|NCT02982954|64367209|FG001|Overall Study|Other reasons|17|||
23170103|NCT02982954|64367210|FG002|Overall Study|Other reasons|12|||
23170104|NCT02982954|64367211|FG003|Overall Study|Other reasons|3|||
23170105|NCT02982954|64367208|FG000|Overall Study|Premature site closure|0|||
23170106|NCT02982954|64367209|FG001|Overall Study|Premature site closure|0|||
23170107|NCT02982954|64367210|FG002|Overall Study|Premature site closure|0|||
23170108|NCT02982954|64367211|FG003|Overall Study|Premature site closure|1|||
23170109|NCT01097863|64367212|FG000|Overall Study|Discomfort|1|||
23449017|NCT02631551|65387862|FG001|Overall Study|Lack of Efficacy|0|||
23170110|NCT01097863|64367213|FG001|Overall Study|Discomfort|0|||
23449018|NCT02631551|65387863|FG002|Overall Study|Lack of Efficacy|1|||
23170111|NCT01097863|64367214|FG002|Overall Study|Discomfort|1|||
23170112|NCT01097863|64367212|FG000|Overall Study|Did not return for final visit|0|||
23170113|NCT01097863|64367213|FG001|Overall Study|Did not return for final visit|0|||
23170114|NCT01097863|64367214|FG002|Overall Study|Did not return for final visit|1|||
23449019|NCT02631551|65387864|FG003|Overall Study|Lack of Efficacy|0|||
23170115|NCT02387580|64367216|FG000|Overall Study|Withdrawal by Subject|0|||
23170116|NCT02387580|64367217|FG001|Overall Study|Withdrawal by Subject|0|||
23170117|NCT02387580|64367218|FG002|Overall Study|Withdrawal by Subject|0|||
23170118|NCT02387580|64367219|FG003|Overall Study|Withdrawal by Subject|1|||
23170119|NCT02387580|64367220|FG004|Overall Study|Withdrawal by Subject|0|||
23170120|NCT02387580|64367221|FG005|Overall Study|Withdrawal by Subject|0|||
23170121|NCT03436862|64367226|FG000|Overall Study|Adverse Event|4|||
23170122|NCT03436862|64367226|FG000|Overall Study|Progressive Disease|2|||
23170123|NCT00676715|64367227|FG000|Overall Study|Withdrawal by Subject|7|||
23170124|NCT00676715|64367228|FG001|Overall Study|Withdrawal by Subject|9|||
23170125|NCT00676715|64367229|FG002|Overall Study|Withdrawal by Subject|10|||
23170126|NCT00676715|64367230|FG003|Overall Study|Withdrawal by Subject|10|||
23170127|NCT00676715|64367227|FG000|Overall Study|Other|2|||
23170128|NCT00676715|64367228|FG001|Overall Study|Other|6|||
23170129|NCT00676715|64367229|FG002|Overall Study|Other|4|||
23170130|NCT00676715|64367230|FG003|Overall Study|Other|3|||
23170131|NCT00676715|64367227|FG000|Overall Study|Lost to Follow-up|1|||
23170132|NCT00676715|64367228|FG001|Overall Study|Lost to Follow-up|1|||
23170133|NCT00676715|64367229|FG002|Overall Study|Lost to Follow-up|7|||
23170134|NCT00676715|64367230|FG003|Overall Study|Lost to Follow-up|3|||
23170135|NCT00676715|64367227|FG000|Overall Study|Death|1|||
23170136|NCT00676715|64367228|FG001|Overall Study|Death|1|||
23170137|NCT00676715|64367229|FG002|Overall Study|Death|1|||
23336987|NCT00325156|64976212|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
23336988|NCT00325156|64976212|FG000|Overall Study|Migrated/moved from study area|12|||
23336989|NCT00325156|64976212|FG000|Overall Study|Adverse event, non-fatal|3|||
23336990|NCT00325156|64976212|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
23336991|NCT00325156|64976212|FG000|Overall Study|Other|1|||
23336992|NCT00325156|64976212|FG000|Overall Study|Withdrawal by Subject|31|||
23336993|NCT00794040|64976213|FG000|Overall Study|Withdrawal by Subject|3|||
23336994|NCT00794040|64976214|FG001|Overall Study|Withdrawal by Subject|4|||
23336995|NCT00794040|64976213|FG000|Overall Study|Physician Decision|0|||
23336996|NCT00794040|64976214|FG001|Overall Study|Physician Decision|1|||
23336997|NCT01194999|64976217|FG000|Overall Study|Lost to Follow-up|17|||
23336998|NCT01672710|64976220|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
23336999|NCT01672710|64976221|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
23337000|NCT01672710|64976220|FG000|3 Month Follow up|Lost to Follow-up|2|||
23337001|NCT01672710|64976221|FG001|3 Month Follow up|Lost to Follow-up|3|||
23337002|NCT01672710|64976220|FG000|3 Month Follow up|follow up due after termination date|4|||
23337003|NCT01672710|64976221|FG001|3 Month Follow up|follow up due after termination date|1|||
23337004|NCT02424630|64976223|FG000|Overall Study|No rotator cuff tear|1|||
23337005|NCT02424630|64976224|FG001|Overall Study|No rotator cuff tear|2|||
23337006|NCT02424630|64976223|FG000|Overall Study|Open procedure|0|||
23337007|NCT02424630|64976224|FG001|Overall Study|Open procedure|1|||
23337008|NCT03508726|64976225|FG000|Overall Study|Withdrawal by Subject|0|||
23337009|NCT03508726|64976226|FG001|Overall Study|Withdrawal by Subject|1|||
23337010|NCT02993250|64976232|FG000|Overall Study|Lost to Follow-up|0|||
23337011|NCT02993250|64976233|FG001|Overall Study|Lost to Follow-up|1|||
23449020|NCT02631551|65387861|FG000|Overall Study|Lost to Follow-up|1|||
23576706|NCT03285711|65843431|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
23576707|NCT03285711|65843428|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
23576708|NCT03285711|65843429|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
23576709|NCT03285711|65843430|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
23576710|NCT03285711|65843431|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
23576711|NCT03285711|65843428|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
23576712|NCT03285711|65843429|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
23576713|NCT03285711|65843430|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
23576714|NCT03285711|65843431|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
23576715|NCT00901485|65843435|FG000|Overall Study|Lack of Efficacy|0|||
23170138|NCT00676715|64367230|FG003|Overall Study|Death|0|||
23170139|NCT00676715|64367227|FG000|Overall Study|Adverse Event|0|||
23170140|NCT00676715|64367228|FG001|Overall Study|Adverse Event|1|||
23337012|NCT03386994|64976234|FG000|Overall Study|Lung transplant|1|||
23337013|NCT03386994|64976234|FG000|Overall Study|Adverse Event|14|||
23337014|NCT03386994|64976234|FG000|Overall Study|Lost to Follow-up|4|||
23337015|NCT03386994|64976234|FG000|Overall Study|Withdrawal by Subject|3|||
23337016|NCT03386994|64976234|FG000|Overall Study|Death|16|||
23337017|NCT04740827|64976235|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
23170141|NCT00676715|64367229|FG002|Overall Study|Adverse Event|2|||
23337018|NCT04740827|64976236|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
23337019|NCT04740827|64976235|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
23170142|NCT00676715|64367230|FG003|Overall Study|Adverse Event|0|||
23170143|NCT00676715|64367227|FG000|Overall Study|Participants Ongoing|29|||
23170144|NCT00676715|64367228|FG001|Overall Study|Participants Ongoing|29|||
23449021|NCT02631551|65387862|FG001|Overall Study|Lost to Follow-up|2|||
23170145|NCT00676715|64367229|FG002|Overall Study|Participants Ongoing|17|||
23576716|NCT00901485|65843436|FG001|Overall Study|Lack of Efficacy|2|||
23576717|NCT00901485|65843435|FG000|Overall Study|Withdrawal by Subject|1|||
23576718|NCT00901485|65843436|FG001|Overall Study|Withdrawal by Subject|2|||
23576719|NCT00372567|65843440|FG000|Phase 3 Study|Adverse Event|5|||
23576720|NCT00372567|65843441|FG001|Phase 3 Study|Adverse Event|1|||
23576721|NCT00372567|65843442|FG002|Phase 3 Study|Adverse Event|1|||
23576722|NCT00372567|65843440|FG000|Phase 3 Study|Death|1|||
23576723|NCT00372567|65843441|FG001|Phase 3 Study|Death|1|||
23170146|NCT00676715|64367230|FG003|Overall Study|Participants Ongoing|24|||
23170147|NCT01816243|64367231|FG000|Overall Study|Adverse Event|6|||
23170148|NCT01816243|64367231|FG000|Overall Study|Lost to Follow-up|1|||
23170149|NCT01816243|64367231|FG000|Overall Study|Lack of Efficacy|1|||
23170150|NCT01816243|64367231|FG000|Overall Study|Not eligible for the study|1|||
23170151|NCT01816243|64367231|FG000|Overall Study|Amputation|3|||
23170152|NCT01965262|64367232|FG000|Second Intervention (7 Days)|Discontinued|0|||
23170153|NCT01965262|64367233|FG001|Second Intervention (7 Days)|Discontinued|1|||
23170154|NCT01965262|64367232|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
23170155|NCT01965262|64367233|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
23170156|NCT01965262|64367232|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
23170157|NCT01965262|64367233|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
23170158|NCT02105454|64367242|FG000|Overall Study|Withdrawal by Subject|1|||
23170159|NCT02793232|64367243|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23170160|NCT02793232|64367244|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23170161|NCT02793232|64367245|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23170162|NCT02793232|64367246|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23170163|NCT02793232|64367247|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
23170164|NCT02793232|64367248|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23170165|NCT02793232|64367249|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
23170166|NCT02793232|64367250|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23170167|NCT02793232|64367251|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
23170168|NCT00433329|64367252|FG000|Overall Study|Adverse Event|9|||
23170169|NCT00433329|64367252|FG000|Overall Study|Death|4|||
23170170|NCT00433329|64367252|FG000|Overall Study|Withdrew consent|3|||
23170171|NCT00433329|64367252|FG000|Overall Study|Discontinued sildenafil|2|||
23170172|NCT00433329|64367252|FG000|Overall Study|Moved out of state|1|||
23170173|NCT00433329|64367252|FG000|Overall Study|Lost to Follow-up|1|||
23170174|NCT00433329|64367252|FG000|Overall Study|Physician Decision|1|||
23170175|NCT01127165|64367255|FG000|Overall Study|Adverse Event|2|||
23170176|NCT01127165|64367256|FG001|Overall Study|Adverse Event|2|||
23170177|NCT01127165|64367255|FG000|Overall Study|Lack of Efficacy|10|||
23170178|NCT01127165|64367256|FG001|Overall Study|Lack of Efficacy|8|||
23170179|NCT01127165|64367255|FG000|Overall Study|Lost to Follow-up|3|||
23228318|NCT01521494|64581032|FG000|Overall Study|Adverse Event|1|||
23228319|NCT01521494|64581033|FG001|Overall Study|Adverse Event|2|||
23228320|NCT01521494|64581034|FG002|Overall Study|Adverse Event|9|||
23228321|NCT01521494|64581035|FG003|Overall Study|Adverse Event|6|||
23228322|NCT01521494|64581036|FG004|Overall Study|Adverse Event|2|||
23228323|NCT01521494|64581032|FG000|Overall Study|Lack of Efficacy|0|||
23228324|NCT01521494|64581033|FG001|Overall Study|Lack of Efficacy|0|||
23228325|NCT01521494|64581034|FG002|Overall Study|Lack of Efficacy|0|||
23228326|NCT01521494|64581035|FG003|Overall Study|Lack of Efficacy|0|||
23228327|NCT01521494|64581036|FG004|Overall Study|Lack of Efficacy|2|||
23228328|NCT01521494|64581032|FG000|Overall Study|Withdrawal by Subject|1|||
23228329|NCT01521494|64581033|FG001|Overall Study|Withdrawal by Subject|1|||
23449022|NCT02631551|65387863|FG002|Overall Study|Lost to Follow-up|0|||
23576724|NCT00372567|65843442|FG002|Phase 3 Study|Death|0|||
23576725|NCT00372567|65843440|FG000|Phase 3 Study|Protocol Violation|0|||
23576726|NCT00372567|65843441|FG001|Phase 3 Study|Protocol Violation|0|||
23576727|NCT00372567|65843442|FG002|Phase 3 Study|Protocol Violation|1|||
23576728|NCT00372567|65843440|FG000|Phase 3 Study|Objective progression or relapse|10|||
23576729|NCT00372567|65843441|FG001|Phase 3 Study|Objective progression or relapse|13|||
23576730|NCT00372567|65843442|FG002|Phase 3 Study|Objective progression or relapse|4|||
23576731|NCT00372567|65843440|FG000|Phase 3 Study|Global deterioration of health status|0|||
23576732|NCT00372567|65843441|FG001|Phase 3 Study|Global deterioration of health status|1|||
23170180|NCT01127165|64367256|FG001|Overall Study|Lost to Follow-up|5|||
23170181|NCT01127165|64367255|FG000|Overall Study|Withdrawal by Subject|1|||
23170182|NCT01127165|64367256|FG001|Overall Study|Withdrawal by Subject|3|||
23228330|NCT01521494|64581034|FG002|Overall Study|Withdrawal by Subject|0|||
23576733|NCT00372567|65843442|FG002|Phase 3 Study|Global deterioration of health status|0|||
23576734|NCT00372567|65843440|FG000|Phase 3 Study|Other|2|||
23170183|NCT01127165|64367255|FG000|Overall Study|Protocol Violation|0|||
23170184|NCT01127165|64367256|FG001|Overall Study|Protocol Violation|1|||
23228331|NCT01521494|64581035|FG003|Overall Study|Withdrawal by Subject|2|||
23228332|NCT01521494|64581036|FG004|Overall Study|Withdrawal by Subject|0|||
23576735|NCT00372567|65843441|FG001|Phase 3 Study|Other|2|||
23228333|NCT01521494|64581032|FG000|Overall Study|Decrease in serum phosphate|0|||
23228334|NCT01521494|64581033|FG001|Overall Study|Decrease in serum phosphate|2|||
23228335|NCT01521494|64581034|FG002|Overall Study|Decrease in serum phosphate|3|||
23228336|NCT01521494|64581035|FG003|Overall Study|Decrease in serum phosphate|12|||
23576736|NCT00372567|65843442|FG002|Phase 3 Study|Other|1|||
23576737|NCT00372567|65843440|FG000|Phase 3 Study|study terminated by sponsor|13|||
23576738|NCT00372567|65843441|FG001|Phase 3 Study|study terminated by sponsor|8|||
23576739|NCT00372567|65843442|FG002|Phase 3 Study|study terminated by sponsor|5|||
23576740|NCT02084082|65843445|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
23228337|NCT01521494|64581036|FG004|Overall Study|Decrease in serum phosphate|0|||
23228338|NCT01521494|64581032|FG000|Overall Study|Decrease in serum calcium|0|||
23228339|NCT01521494|64581033|FG001|Overall Study|Decrease in serum calcium|0|||
23449023|NCT02631551|65387864|FG003|Overall Study|Lost to Follow-up|3|||
23449024|NCT02631551|65387861|FG000|Overall Study|Withdrawal by Subject|2|||
23449025|NCT02631551|65387862|FG001|Overall Study|Withdrawal by Subject|2|||
23449026|NCT02631551|65387863|FG002|Overall Study|Withdrawal by Subject|0|||
23449027|NCT02631551|65387864|FG003|Overall Study|Withdrawal by Subject|5|||
23449028|NCT02631551|65387861|FG000|Overall Study|Protocol deviation|3|||
23449029|NCT02631551|65387862|FG001|Overall Study|Protocol deviation|6|||
23449030|NCT02631551|65387863|FG002|Overall Study|Protocol deviation|3|||
23449031|NCT02631551|65387864|FG003|Overall Study|Protocol deviation|0|||
23449032|NCT02631551|65387861|FG000|Overall Study|Non-compliance with study procedures|0|||
23449033|NCT02631551|65387862|FG001|Overall Study|Non-compliance with study procedures|0|||
23449034|NCT02631551|65387863|FG002|Overall Study|Non-compliance with study procedures|1|||
23449035|NCT02631551|65387864|FG003|Overall Study|Non-compliance with study procedures|1|||
23449036|NCT02631551|65387861|FG000|Overall Study|Non-compliance with study drug|1|||
23449037|NCT02631551|65387862|FG001|Overall Study|Non-compliance with study drug|0|||
23449038|NCT02631551|65387863|FG002|Overall Study|Non-compliance with study drug|0|||
23449039|NCT02631551|65387864|FG003|Overall Study|Non-compliance with study drug|0|||
23449040|NCT02631551|65387861|FG000|Overall Study|Other, specific reasons not collected|5|||
23449041|NCT02631551|65387862|FG001|Overall Study|Other, specific reasons not collected|7|||
23449042|NCT02631551|65387863|FG002|Overall Study|Other, specific reasons not collected|2|||
23449043|NCT02631551|65387864|FG003|Overall Study|Other, specific reasons not collected|2|||
23449044|NCT01702558|65387866|FG000|Overall Study|Withdrawal by Subject|0|||
23449045|NCT01702558|65387867|FG001|Overall Study|Withdrawal by Subject|0|||
23449046|NCT01702558|65387868|FG002|Overall Study|Withdrawal by Subject|0|||
23449047|NCT01702558|65387869|FG003|Overall Study|Withdrawal by Subject|12|||
23449048|NCT01702558|65387870|FG004|Overall Study|Withdrawal by Subject|4|||
23449049|NCT01702558|65387866|FG000|Overall Study|Lost to Follow-up|0|||
23449050|NCT01702558|65387867|FG001|Overall Study|Lost to Follow-up|0|||
23449051|NCT01702558|65387868|FG002|Overall Study|Lost to Follow-up|0|||
23449052|NCT01702558|65387869|FG003|Overall Study|Lost to Follow-up|3|||
23449053|NCT01702558|65387870|FG004|Overall Study|Lost to Follow-up|0|||
23449054|NCT01702558|65387866|FG000|Overall Study|Death|4|||
23449055|NCT01702558|65387867|FG001|Overall Study|Death|3|||
23449056|NCT01702558|65387868|FG002|Overall Study|Death|3|||
23449057|NCT01702558|65387869|FG003|Overall Study|Death|16|||
23449058|NCT01702558|65387870|FG004|Overall Study|Death|20|||
23228340|NCT01521494|64581034|FG002|Overall Study|Decrease in serum calcium|0|||
23228341|NCT01521494|64581035|FG003|Overall Study|Decrease in serum calcium|1|||
23228342|NCT01521494|64581036|FG004|Overall Study|Decrease in serum calcium|1|||
23228343|NCT01521494|64581032|FG000|Overall Study|Physician Decision|0|||
23228344|NCT01521494|64581033|FG001|Overall Study|Physician Decision|0|||
23228345|NCT01521494|64581034|FG002|Overall Study|Physician Decision|0|||
23228346|NCT01521494|64581035|FG003|Overall Study|Physician Decision|0|||
23228347|NCT01521494|64581036|FG004|Overall Study|Physician Decision|2|||
23228348|NCT01693562|64581039|FG000|Escalation Phase|Withdrawal by Subject|0|||
23228349|NCT01693562|64581040|FG001|Escalation Phase|Withdrawal by Subject|1|||
23228350|NCT01693562|64581041|FG002|Escalation Phase|Withdrawal by Subject|0|||
23228351|NCT01693562|64581042|FG003|Escalation Phase|Withdrawal by Subject|0|||
23228352|NCT01693562|64581043|FG004|Escalation Phase|Withdrawal by Subject|0|||
23576741|NCT02084082|65843446|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
23576742|NCT02084082|65843447|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
23576743|NCT02084082|65843448|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
23228353|NCT01693562|64581044|FG005|Escalation Phase|Withdrawal by Subject|2|||
23228354|NCT01693562|64581045|FG006|Escalation Phase|Withdrawal by Subject|0|||
23228355|NCT01693562|64581046|FG007|Escalation Phase|Withdrawal by Subject|0|||
23228356|NCT01693562|64581047|FG008|Escalation Phase|Withdrawal by Subject|0|||
23449059|NCT01702558|65387866|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
23449060|NCT01702558|65387867|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
23449061|NCT01702558|65387868|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
23449062|NCT01702558|65387869|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
23449063|NCT01702558|65387870|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
23449064|NCT01702558|65387866|FG000|Overall Study|Study Terminated by Sponsor|0|||
23576744|NCT02084082|65843445|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23449065|NCT01702558|65387867|FG001|Overall Study|Study Terminated by Sponsor|1|||
23449066|NCT01702558|65387868|FG002|Overall Study|Study Terminated by Sponsor|0|||
23449067|NCT01702558|65387869|FG003|Overall Study|Study Terminated by Sponsor|0|||
23449068|NCT01702558|65387870|FG004|Overall Study|Study Terminated by Sponsor|1|||
23449069|NCT01702558|65387866|FG000|Overall Study|Other|0|||
23449070|NCT01702558|65387867|FG001|Overall Study|Other|0|||
23449071|NCT01702558|65387868|FG002|Overall Study|Other|0|||
23449072|NCT01702558|65387869|FG003|Overall Study|Other|16|||
23449073|NCT01702558|65387870|FG004|Overall Study|Other|17|||
23449074|NCT00833040|65387871|FG000|Overall Study|Adverse Event|0|||
23449075|NCT00833040|65387872|FG001|Overall Study|Adverse Event|0|||
23449076|NCT00833040|65387873|FG002|Overall Study|Adverse Event|0|||
23449077|NCT00833040|65387874|FG003|Overall Study|Adverse Event|0|||
23449078|NCT00833040|65387875|FG004|Overall Study|Adverse Event|0|||
23449079|NCT00833040|65387876|FG005|Overall Study|Adverse Event|1|||
23449080|NCT03579940|65387877|FG000|Period 2|Withdrawal by Subject|0|||
23449081|NCT03579940|65387878|FG001|Period 2|Withdrawal by Subject|0|||
23449082|NCT03579940|65387879|FG002|Period 2|Withdrawal by Subject|1|||
23449083|NCT03579940|65387880|FG003|Period 2|Withdrawal by Subject|0|||
23449084|NCT03579940|65387881|FG004|Period 2|Withdrawal by Subject|0|||
23449085|NCT03579940|65387882|FG005|Period 2|Withdrawal by Subject|0|||
23449086|NCT03579940|65387883|FG006|Period 2|Withdrawal by Subject|0|||
23449087|NCT03579940|65387884|FG007|Period 2|Withdrawal by Subject|0|||
23449088|NCT03579940|65387885|FG008|Period 2|Withdrawal by Subject|0|||
23449089|NCT03579940|65387886|FG009|Period 2|Withdrawal by Subject|0|||
23449090|NCT03579940|65387887|FG010|Period 2|Withdrawal by Subject|0|||
23449091|NCT02451917|65387888|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
23449092|NCT02451917|65387889|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
23449093|NCT02451917|65387888|FG000|First Intervention (24 Weeks)|Death|0|||
23449094|NCT02451917|65387889|FG001|First Intervention (24 Weeks)|Death|1|||
23449095|NCT02451917|65387888|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
23449096|NCT02451917|65387889|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
23449097|NCT02562716|65387892|FG000|Overall Study|Adverse Event|7|||
23449098|NCT02562716|65387893|FG001|Overall Study|Adverse Event|14|||
23449099|NCT02562716|65387892|FG000|Overall Study|Withdrawal unrelated to AE|7|||
23449100|NCT02562716|65387893|FG001|Overall Study|Withdrawal unrelated to AE|1|||
23449101|NCT02562716|65387892|FG000|Overall Study|Progression|8|||
23449102|NCT02562716|65387893|FG001|Overall Study|Progression|10|||
23449103|NCT02562716|65387892|FG000|Overall Study|Death|2|||
23449104|NCT02562716|65387893|FG001|Overall Study|Death|1|||
23449105|NCT02562716|65387892|FG000|Overall Study|Not protocol specified|4|||
23449106|NCT02562716|65387893|FG001|Overall Study|Not protocol specified|2|||
23228357|NCT01693562|64581048|FG009|Escalation Phase|Withdrawal by Subject|0|||
23228358|NCT01693562|64581049|FG010|Escalation Phase|Withdrawal by Subject|0|||
23449107|NCT01402817|65387894|FG000|Overall Study|Withdrawal by Subject|3|||
23449108|NCT01402817|65387894|FG000|Overall Study|Study Suspended by FDA|8|||
23449109|NCT00404651|65387897|FG000|Overall Study|Serious Adverse Event|0|||
23449110|NCT00404651|65387898|FG001|Overall Study|Serious Adverse Event|0|||
23449111|NCT00404651|65387899|FG002|Overall Study|Serious Adverse Event|2|||
23449112|NCT00404651|65387900|FG003|Overall Study|Serious Adverse Event|0|||
23449113|NCT00404651|65387897|FG000|Overall Study|Protocol Violation|10|||
23449114|NCT00404651|65387898|FG001|Overall Study|Protocol Violation|5|||
23449115|NCT00404651|65387899|FG002|Overall Study|Protocol Violation|14|||
23449116|NCT00404651|65387900|FG003|Overall Study|Protocol Violation|5|||
23449117|NCT00404651|65387897|FG000|Overall Study|Lost to Follow-up|15|||
23449118|NCT00404651|65387898|FG001|Overall Study|Lost to Follow-up|11|||
23449119|NCT00404651|65387899|FG002|Overall Study|Lost to Follow-up|13|||
23449120|NCT00404651|65387900|FG003|Overall Study|Lost to Follow-up|10|||
23449121|NCT00404651|65387897|FG000|Overall Study|Withdrawal by Subject|14|||
23449122|NCT00404651|65387898|FG001|Overall Study|Withdrawal by Subject|12|||
23449123|NCT00404651|65387899|FG002|Overall Study|Withdrawal by Subject|16|||
23449124|NCT00404651|65387900|FG003|Overall Study|Withdrawal by Subject|6|||
23449125|NCT02524171|65387903|FG000|6-month Follow-up|Lost to Follow-up|53|||
23449126|NCT02524171|65387904|FG001|6-month Follow-up|Lost to Follow-up|45|||
23228359|NCT01693562|64581050|FG011|Escalation Phase|Withdrawal by Subject|0|||
23228360|NCT01693562|64581051|FG012|Escalation Phase|Withdrawal by Subject|0|||
23449127|NCT02524171|65387903|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
23449128|NCT02524171|65387904|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
23449129|NCT02913482|65387907|FG000|Overall Study|Death|0|||
23449130|NCT02913482|65387908|FG001|Overall Study|Death|2|||
23449131|NCT02913482|65387909|FG002|Overall Study|Death|2|||
23449132|NCT02913482|65387907|FG000|Overall Study|Progressive Disease|1|||
23449133|NCT02913482|65387908|FG001|Overall Study|Progressive Disease|1|||
23449134|NCT02913482|65387909|FG002|Overall Study|Progressive Disease|1|||
23449135|NCT02913482|65387907|FG000|Overall Study|Reason not specified|0|||
23449136|NCT02913482|65387908|FG001|Overall Study|Reason not specified|0|||
23449137|NCT02913482|65387909|FG002|Overall Study|Reason not specified|1|||
23449138|NCT02913482|65387907|FG000|Overall Study|Withdrawal by Subject|0|||
23449139|NCT02913482|65387908|FG001|Overall Study|Withdrawal by Subject|1|||
23449140|NCT02913482|65387909|FG002|Overall Study|Withdrawal by Subject|1|||
23449141|NCT02611817|65387913|FG000|Open-label Induction Phase|Reason not Specified|9|||
23449142|NCT02611817|65387914|FG001|Open-label Induction Phase|Reason not Specified|0|||
23449143|NCT02611817|65387915|FG002|Open-label Induction Phase|Reason not Specified|0|||
23449144|NCT02611817|65387913|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
23449145|NCT02611817|65387914|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
23449146|NCT02611817|65387915|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
23449147|NCT02611817|65387913|FG000|Open-label Induction Phase|Pregnancy|1|||
23449148|NCT02611817|65387914|FG001|Open-label Induction Phase|Pregnancy|0|||
23449149|NCT02611817|65387915|FG002|Open-label Induction Phase|Pregnancy|0|||
23449150|NCT02611817|65387913|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
23449151|NCT02611817|65387914|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
23449152|NCT02611817|65387915|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
23449153|NCT02611817|65387913|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
23449154|NCT02611817|65387914|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
23449155|NCT02611817|65387915|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
23449156|NCT02611817|65387913|FG000|Open-label Induction Phase|Protocol Violation|5|||
23449157|NCT02611817|65387914|FG001|Open-label Induction Phase|Protocol Violation|0|||
23449158|NCT02611817|65387915|FG002|Open-label Induction Phase|Protocol Violation|0|||
23449159|NCT02611817|65387913|FG000|Open-label Induction Phase|Adverse Event|16|||
23449160|NCT02611817|65387914|FG001|Open-label Induction Phase|Adverse Event|0|||
23449161|NCT02611817|65387915|FG002|Open-label Induction Phase|Adverse Event|0|||
23449162|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
23449163|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
23449164|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
23449165|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
23449166|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
23449167|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
23449168|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
23449169|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
23449170|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
23449171|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
23449172|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
23449173|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
23449174|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
23449175|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
23449176|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
23449177|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
23449178|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
23449179|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
23449180|NCT02611817|65387913|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
23449181|NCT02611817|65387914|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
23449182|NCT02611817|65387915|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
23449183|NCT00730158|65387920|FG000|Overall Study|Withdrawal by Subject|1|||
23449184|NCT00730158|65387921|FG001|Overall Study|Withdrawal by Subject|1|||
23449185|NCT01960140|65387922|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
23449186|NCT01177007|65387923|FG000|Overall Study|Lost to Follow-up|2|||
23449187|NCT01177007|65387923|FG000|Overall Study|Death|4|||
23449188|NCT01177007|65387923|FG000|Overall Study|Entered hospice care|5|||
23449189|NCT01177007|65387923|FG000|Overall Study|Required additional Y90 treatment|6|||
23228361|NCT01693562|64581052|FG013|Escalation Phase|Withdrawal by Subject|0|||
23449190|NCT01177007|65387923|FG000|Overall Study|Change in treatment modality|21|||
23449191|NCT00300755|65387924|FG000|Overall Study|Adverse Event|1|||
23449192|NCT00300755|65387925|FG001|Overall Study|Adverse Event|2|||
23449193|NCT00300755|65387926|FG002|Overall Study|Adverse Event|1|||
23449194|NCT00300755|65387924|FG000|Overall Study|Withdrawal by Subject|0|||
23449195|NCT00300755|65387925|FG001|Overall Study|Withdrawal by Subject|2|||
23449196|NCT00300755|65387926|FG002|Overall Study|Withdrawal by Subject|0|||
23228362|NCT01693562|64581053|FG014|Escalation Phase|Withdrawal by Subject|0|||
23228363|NCT01693562|64581054|FG015|Escalation Phase|Withdrawal by Subject|0|||
23228364|NCT01693562|64581055|FG016|Escalation Phase|Withdrawal by Subject|0|||
23228365|NCT01693562|64581056|FG017|Escalation Phase|Withdrawal by Subject|0|||
23228366|NCT01693562|64581057|FG018|Escalation Phase|Withdrawal by Subject|0|||
23228367|NCT01693562|64581058|FG019|Escalation Phase|Withdrawal by Subject|0|||
23228368|NCT01693562|64581059|FG020|Escalation Phase|Withdrawal by Subject|0|||
23449197|NCT00300755|65387924|FG000|Overall Study|Protocol Violation|0|||
23449198|NCT00300755|65387925|FG001|Overall Study|Protocol Violation|0|||
23449199|NCT00300755|65387926|FG002|Overall Study|Protocol Violation|1|||
23449200|NCT01096316|65387927|FG000|Overall Study|Lost to Follow-up|15|||
23228369|NCT01693562|64581060|FG021|Escalation Phase|Withdrawal by Subject|0|||
23449201|NCT01096316|65387928|FG001|Overall Study|Lost to Follow-up|9|||
23449202|NCT02753946|65387935|FG000|Overall Study|Adverse Event|7|||
23449203|NCT02753946|65387936|FG001|Overall Study|Adverse Event|6|||
23449204|NCT02753946|65387935|FG000|Overall Study|Withdrawal by Subject|6|||
23449205|NCT02753946|65387936|FG001|Overall Study|Withdrawal by Subject|1|||
23449206|NCT02753946|65387935|FG000|Overall Study|Lack of Efficacy|1|||
23449207|NCT02753946|65387936|FG001|Overall Study|Lack of Efficacy|0|||
23449208|NCT02753946|65387935|FG000|Overall Study|Physician Decision|0|||
23449209|NCT02753946|65387936|FG001|Overall Study|Physician Decision|2|||
23449210|NCT00764361|65387937|FG000|Overall Study|Withdrawal by Subject|2|||
23449211|NCT00764361|65387938|FG001|Overall Study|Withdrawal by Subject|3|||
23170185|NCT01903837|64367257|FG000|Part A|Withdrawal by Subject|4|||
23170186|NCT01903837|64367258|FG001|Part A|Withdrawal by Subject|9|||
23170187|NCT01903837|64367259|FG002|Part A|Withdrawal by Subject|8|||
23170188|NCT01903837|64367260|FG003|Part A|Withdrawal by Subject|5|||
23170189|NCT01903837|64367257|FG000|Part A|Adverse Event|3|||
23170190|NCT01903837|64367258|FG001|Part A|Adverse Event|6|||
23170191|NCT01903837|64367259|FG002|Part A|Adverse Event|9|||
23170192|NCT01903837|64367260|FG003|Part A|Adverse Event|6|||
23170193|NCT01903837|64367257|FG000|Part A|Lost to Follow-up|9|||
23170194|NCT01903837|64367258|FG001|Part A|Lost to Follow-up|7|||
23170195|NCT01903837|64367259|FG002|Part A|Lost to Follow-up|7|||
23170196|NCT01903837|64367260|FG003|Part A|Lost to Follow-up|2|||
23170197|NCT01903837|64367257|FG000|Part A|Non-compliance with study drug|1|||
23170198|NCT01903837|64367258|FG001|Part A|Non-compliance with study drug|4|||
23170199|NCT01903837|64367259|FG002|Part A|Non-compliance with study drug|4|||
23449212|NCT00764361|65387937|FG000|Overall Study|Adverse Event|0|||
23449213|NCT00764361|65387938|FG001|Overall Study|Adverse Event|1|||
23449214|NCT01469221|65387949|FG000|Double Blind Phase|Protocol Violation|1|||
23449215|NCT01469221|65387950|FG001|Double Blind Phase|Protocol Violation|0|||
23449216|NCT01469221|65387951|FG002|Double Blind Phase|Protocol Violation|0|||
23449217|NCT01469221|65387949|FG000|Double Blind Phase|Physician Decision|1|||
23449218|NCT01469221|65387950|FG001|Double Blind Phase|Physician Decision|1|||
23449219|NCT01469221|65387951|FG002|Double Blind Phase|Physician Decision|0|||
23449220|NCT01469221|65387949|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
23449221|NCT01469221|65387950|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
23449222|NCT01469221|65387951|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
23449223|NCT02741635|65387955|FG000|Overall Study|Withdrawal by Subject|1|||
23449224|NCT03827655|65387957|FG000|Overall Study|Death|0|||
23449225|NCT03827655|65387958|FG001|Overall Study|Death|0|||
23449226|NCT03827655|65387959|FG002|Overall Study|Death|0|||
23449227|NCT03827655|65387960|FG003|Overall Study|Death|0|||
23449228|NCT03827655|65387961|FG004|Overall Study|Death|1|||
23449229|NCT03827655|65387957|FG000|Overall Study|Protocol Deviation|1|||
23449230|NCT03827655|65387958|FG001|Overall Study|Protocol Deviation|0|||
23449231|NCT03827655|65387959|FG002|Overall Study|Protocol Deviation|1|||
23449232|NCT03827655|65387960|FG003|Overall Study|Protocol Deviation|1|||
23449233|NCT03827655|65387961|FG004|Overall Study|Protocol Deviation|0|||
23449234|NCT03827655|65387957|FG000|Overall Study|Withdrawal by Subject|3|||
23449235|NCT03827655|65387958|FG001|Overall Study|Withdrawal by Subject|2|||
23449236|NCT03827655|65387959|FG002|Overall Study|Withdrawal by Subject|2|||
23449237|NCT03827655|65387960|FG003|Overall Study|Withdrawal by Subject|0|||
23449238|NCT03827655|65387961|FG004|Overall Study|Withdrawal by Subject|1|||
23449239|NCT03827655|65387957|FG000|Overall Study|Reason not Specified|3|||
23449240|NCT03827655|65387958|FG001|Overall Study|Reason not Specified|1|||
23449241|NCT03827655|65387959|FG002|Overall Study|Reason not Specified|1|||
23449242|NCT03827655|65387960|FG003|Overall Study|Reason not Specified|1|||
23449243|NCT03827655|65387961|FG004|Overall Study|Reason not Specified|1|||
23449244|NCT00836589|65387962|FG000|Overall Study|Lost to Follow-up|246|||
23449245|NCT00836589|65387962|FG000|Overall Study|Death|429|||
23449246|NCT00836589|65387962|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
23449247|NCT00466440|65387963|FG000|Overall Study|Adverse Event|0|||
23449248|NCT00466440|65387964|FG001|Overall Study|Adverse Event|3|||
23449249|NCT00466440|65387965|FG002|Overall Study|Adverse Event|1|||
23449250|NCT00466440|65387963|FG000|Overall Study|Death|1|||
23449251|NCT00466440|65387964|FG001|Overall Study|Death|1|||
23449252|NCT00466440|65387965|FG002|Overall Study|Death|0|||
23449253|NCT00466440|65387963|FG000|Overall Study|Progressive disease|13|||
23449254|NCT00466440|65387964|FG001|Overall Study|Progressive disease|5|||
23449255|NCT00466440|65387965|FG002|Overall Study|Progressive disease|4|||
23449256|NCT00466440|65387963|FG000|Overall Study|Lost to Follow-up|0|||
23170200|NCT01903837|64367260|FG003|Part A|Non-compliance with study drug|0|||
23170201|NCT01903837|64367257|FG000|Part A|Physician Decision|1|||
23449257|NCT00466440|65387964|FG001|Overall Study|Lost to Follow-up|1|||
23449258|NCT00466440|65387965|FG002|Overall Study|Lost to Follow-up|0|||
23449259|NCT00466440|65387963|FG000|Overall Study|Physician Decision|0|||
23449260|NCT00466440|65387964|FG001|Overall Study|Physician Decision|1|||
23449261|NCT00466440|65387965|FG002|Overall Study|Physician Decision|2|||
23170202|NCT01903837|64367258|FG001|Part A|Physician Decision|1|||
23170203|NCT01903837|64367259|FG002|Part A|Physician Decision|0|||
23449262|NCT00466440|65387963|FG000|Overall Study|Protocol entry criteria not met|0|||
23449263|NCT00466440|65387964|FG001|Overall Study|Protocol entry criteria not met|0|||
23449264|NCT00466440|65387965|FG002|Overall Study|Protocol entry criteria not met|4|||
23449265|NCT00466440|65387963|FG000|Overall Study|Withdrawal by Subject|0|||
23449266|NCT00466440|65387964|FG001|Overall Study|Withdrawal by Subject|1|||
23449267|NCT00466440|65387965|FG002|Overall Study|Withdrawal by Subject|0|||
23449268|NCT00466440|65387963|FG000|Overall Study|Sponsor decision|0|||
23449269|NCT00466440|65387964|FG001|Overall Study|Sponsor decision|0|||
23449270|NCT00466440|65387965|FG002|Overall Study|Sponsor decision|1|||
23449271|NCT00411671|65387968|FG000|Overall Study|Adverse Event|15|||
23449272|NCT00411671|65387968|FG000|Overall Study|Death|2|||
23449273|NCT00411671|65387968|FG000|Overall Study|Lost to Follow-up|3|||
23449274|NCT01362348|65387969|FG000|Overall Study|Protocol-defined stopping criteria|9|||
23449275|NCT01362348|65387969|FG000|Overall Study|Study closed/terminated|5|||
23449276|NCT01751984|65387973|FG000|Overall Study|Adverse Event|5|||
23449277|NCT01751984|65387974|FG001|Overall Study|Adverse Event|3|||
23449278|NCT01751984|65387973|FG000|Overall Study|Withdrawal by Subject|0|||
23449279|NCT01751984|65387974|FG001|Overall Study|Withdrawal by Subject|1|||
23449280|NCT01751984|65387973|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
23449281|NCT01751984|65387974|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
23449282|NCT04612725|65387980|FG000|Overall Study|Adverse Event|1|||
23449283|NCT04612725|65387981|FG001|Overall Study|Adverse Event|3|||
23449284|NCT04612725|65387982|FG002|Overall Study|Adverse Event|1|||
23449285|NCT04612725|65387983|FG003|Overall Study|Adverse Event|0|||
23449286|NCT04612725|65387984|FG004|Overall Study|Adverse Event|1|||
23449287|NCT04612725|65387980|FG000|Overall Study|Lost to Follow-up|0|||
23449288|NCT04612725|65387981|FG001|Overall Study|Lost to Follow-up|1|||
23449289|NCT04612725|65387982|FG002|Overall Study|Lost to Follow-up|0|||
23449290|NCT04612725|65387983|FG003|Overall Study|Lost to Follow-up|0|||
23449291|NCT04612725|65387984|FG004|Overall Study|Lost to Follow-up|0|||
23449292|NCT04612725|65387980|FG000|Overall Study|Physician Decision|2|||
23449293|NCT04612725|65387981|FG001|Overall Study|Physician Decision|0|||
23449294|NCT04612725|65387982|FG002|Overall Study|Physician Decision|0|||
23449295|NCT04612725|65387983|FG003|Overall Study|Physician Decision|0|||
23449296|NCT04612725|65387984|FG004|Overall Study|Physician Decision|0|||
23449297|NCT04612725|65387980|FG000|Overall Study|Study terminated by sponsor|3|||
23449298|NCT04612725|65387981|FG001|Overall Study|Study terminated by sponsor|1|||
23449299|NCT04612725|65387982|FG002|Overall Study|Study terminated by sponsor|2|||
23449300|NCT04612725|65387983|FG003|Overall Study|Study terminated by sponsor|4|||
23449301|NCT04612725|65387984|FG004|Overall Study|Study terminated by sponsor|5|||
23449302|NCT04612725|65387980|FG000|Overall Study|Withdrawal by Subject|8|||
23449303|NCT04612725|65387981|FG001|Overall Study|Withdrawal by Subject|3|||
23449304|NCT04612725|65387982|FG002|Overall Study|Withdrawal by Subject|5|||
23449305|NCT04612725|65387983|FG003|Overall Study|Withdrawal by Subject|1|||
23449306|NCT04612725|65387984|FG004|Overall Study|Withdrawal by Subject|9|||
23449307|NCT04612725|65387980|FG000|Overall Study|Other|0|||
23449308|NCT04612725|65387981|FG001|Overall Study|Other|0|||
23449309|NCT04612725|65387982|FG002|Overall Study|Other|0|||
23449310|NCT04612725|65387983|FG003|Overall Study|Other|0|||
23449311|NCT04612725|65387984|FG004|Overall Study|Other|1|||
23449312|NCT03066193|65387986|FG000|Overall Study|Withdrawal by Subject|1|||
23449313|NCT02079038|65387987|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
23449314|NCT02079038|65387988|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
23449315|NCT02079038|65387987|FG000|Modified Intent to Treat Population|Death|1|||
23449316|NCT02079038|65387988|FG001|Modified Intent to Treat Population|Death|0|||
23449317|NCT02079038|65387987|FG000|Completed 6 Months|Lost to Follow-up|2|||
23449318|NCT02079038|65387988|FG001|Completed 6 Months|Lost to Follow-up|1|||
23449319|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
23449320|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
23449321|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
23449322|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
23449323|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
23449324|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
23449325|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
23449326|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
23449327|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
23449328|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
23449329|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
23449330|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
23449331|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
23449332|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
23449333|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
23449334|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
23449335|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
23449336|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
23449337|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
23449338|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
23449339|NCT03573323|65387989|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
23449340|NCT03573323|65387990|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
23449341|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
23449342|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
23449343|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
23449344|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
23449345|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
23449346|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
23449347|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
23449348|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
23449349|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
23449350|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
23449351|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
23449352|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
23449353|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
23449354|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
23449355|NCT03573323|65387989|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
23449356|NCT03573323|65387990|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
23449357|NCT01702025|65387991|FG000|Overall Study|Equipment failure|1|||
23449358|NCT01702025|65387992|FG001|Overall Study|Equipment failure|0|||
23449359|NCT01702025|65387993|FG002|Overall Study|Equipment failure|0|||
23449360|NCT01702025|65387994|FG003|Overall Study|Equipment failure|0|||
23449361|NCT01702025|65387991|FG000|Overall Study|Adverse Event|1|||
23449362|NCT01702025|65387992|FG001|Overall Study|Adverse Event|1|||
23449363|NCT01702025|65387993|FG002|Overall Study|Adverse Event|1|||
23449364|NCT01702025|65387994|FG003|Overall Study|Adverse Event|0|||
23449365|NCT00496015|65387995|FG000|Overall Study|Other|1|||
23449366|NCT00496015|65387996|FG001|Overall Study|Other|0|||
23449367|NCT00496015|65387997|FG002|Overall Study|Other|0|||
23449368|NCT00496015|65387998|FG003|Overall Study|Other|1|||
23449369|NCT00496015|65387999|FG004|Overall Study|Other|0|||
23449370|NCT00844844|65388000|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
23449371|NCT00844844|65388000|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
23449372|NCT00844844|65388000|FG000|Extension Treatment Period|Adverse Event|2|||
23449373|NCT00844844|65388000|FG000|Post Treatment Period|Withdrawal by Subject|1|||
23449374|NCT02055898|65388001|FG000|First Intervention (5 Days)|Physician Decision|2|||
23449375|NCT02055898|65388002|FG001|First Intervention (5 Days)|Physician Decision|0|||
23170204|NCT01903837|64367260|FG003|Part A|Physician Decision|0|||
23170205|NCT01903837|64367257|FG000|Part A|Protocol Violation|1|||
23449376|NCT02055898|65388001|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
23449377|NCT02055898|65388002|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
23449378|NCT01946139|65388005|FG000|Overall Study|Withdrawal by Subject|8|||
23449379|NCT01946139|65388005|FG000|Overall Study|ineligible|8|||
23449380|NCT01946139|65388005|FG000|Overall Study|Specimens not available|4|||
23449381|NCT01247324|65388006|FG000|Overall Study|Death|6|||
23576745|NCT02084082|65843446|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23170206|NCT01903837|64367258|FG001|Part A|Protocol Violation|1|||
23170207|NCT01903837|64367259|FG002|Part A|Protocol Violation|0|||
23170208|NCT01903837|64367260|FG003|Part A|Protocol Violation|0|||
23170209|NCT01903837|64367257|FG000|Part B|Lost to Follow-up|0|||
23170210|NCT01903837|64367258|FG001|Part B|Lost to Follow-up|3|||
23170211|NCT01903837|64367259|FG002|Part B|Lost to Follow-up|3|||
23170212|NCT01903837|64367260|FG003|Part B|Lost to Follow-up|4|||
23170213|NCT01903837|64367257|FG000|Part B|Withdrawal by Subject|1|||
23170214|NCT01903837|64367258|FG001|Part B|Withdrawal by Subject|2|||
23170215|NCT01903837|64367259|FG002|Part B|Withdrawal by Subject|0|||
23170216|NCT01903837|64367260|FG003|Part B|Withdrawal by Subject|3|||
23170217|NCT01903837|64367257|FG000|Part B|Adverse Event|3|||
23170218|NCT01903837|64367258|FG001|Part B|Adverse Event|0|||
23170219|NCT01903837|64367259|FG002|Part B|Adverse Event|2|||
23170220|NCT01903837|64367260|FG003|Part B|Adverse Event|0|||
23170221|NCT01903837|64367257|FG000|Part B|Non-compliance with study drug|2|||
23170222|NCT01903837|64367258|FG001|Part B|Non-compliance with study drug|0|||
23170223|NCT01903837|64367259|FG002|Part B|Non-compliance with study drug|0|||
23449382|NCT01247324|65388007|FG001|Overall Study|Death|10|||
23576746|NCT02084082|65843447|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
23576747|NCT02084082|65843448|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
23449383|NCT01247324|65388006|FG000|Overall Study|Physician Decision|2|||
23449384|NCT01247324|65388007|FG001|Overall Study|Physician Decision|3|||
23449385|NCT01247324|65388006|FG000|Overall Study|Non-compliance with study drug|3|||
23170224|NCT01903837|64367260|FG003|Part B|Non-compliance with study drug|1|||
23170225|NCT01903837|64367257|FG000|Part B|Incarceration|2|||
23170226|NCT01903837|64367258|FG001|Part B|Incarceration|0|||
23170227|NCT01903837|64367259|FG002|Part B|Incarceration|0|||
23170228|NCT01903837|64367260|FG003|Part B|Incarceration|1|||
23170229|NCT01903837|64367257|FG000|Part B|Physician Decision|1|||
23170230|NCT01903837|64367258|FG001|Part B|Physician Decision|0|||
23449386|NCT01247324|65388007|FG001|Overall Study|Non-compliance with study drug|0|||
23449387|NCT01247324|65388006|FG000|Overall Study|Lack of Efficacy|24|||
23449388|NCT01247324|65388007|FG001|Overall Study|Lack of Efficacy|14|||
23449389|NCT01247324|65388006|FG000|Overall Study|Non-compliance|3|||
23576748|NCT02427646|65843451|FG000|Overall Study|Lack of Efficacy|2|||
23170231|NCT01903837|64367259|FG002|Part B|Physician Decision|0|||
23170232|NCT01903837|64367260|FG003|Part B|Physician Decision|2|||
23170233|NCT01903837|64367257|FG000|Part B|Lack of Efficacy|0|||
23170234|NCT01903837|64367258|FG001|Part B|Lack of Efficacy|1|||
23170235|NCT01903837|64367259|FG002|Part B|Lack of Efficacy|0|||
23170236|NCT01903837|64367260|FG003|Part B|Lack of Efficacy|0|||
23170237|NCT01446419|64367261|FG000|Overall Study|Death|1|||
23170238|NCT01446419|64367262|FG001|Overall Study|Death|0|||
23170239|NCT01446419|64367261|FG000|Overall Study|Withdrawal by Subject|1|||
23170240|NCT01446419|64367262|FG001|Overall Study|Withdrawal by Subject|1|||
23170241|NCT01446419|64367261|FG000|Overall Study|Terminated per protocol|3|||
23170242|NCT01446419|64367262|FG001|Overall Study|Terminated per protocol|0|||
23170243|NCT00268242|64367263|FG000|Overall Study|Death|1|||
23170244|NCT02921971|64367264|FG000|Overall Study|Adverse Event|1|||
23576749|NCT02427646|65843452|FG001|Overall Study|Lack of Efficacy|3|||
23576750|NCT02427646|65843451|FG000|Overall Study|Physician Decision|1|||
23170245|NCT02921971|64367265|FG001|Overall Study|Adverse Event|2|||
23170246|NCT02921971|64367264|FG000|Overall Study|Lack of Efficacy|3|||
23228370|NCT01693562|64581061|FG022|Escalation Phase|Withdrawal by Subject|0|||
23228371|NCT01693562|64581039|FG000|Escalation Phase|Death|4|||
23228372|NCT01693562|64581040|FG001|Escalation Phase|Death|2|||
23228373|NCT01693562|64581041|FG002|Escalation Phase|Death|0|||
23228374|NCT01693562|64581042|FG003|Escalation Phase|Death|3|||
23228375|NCT01693562|64581043|FG004|Escalation Phase|Death|6|||
23228376|NCT01693562|64581044|FG005|Escalation Phase|Death|4|||
23228377|NCT01693562|64581045|FG006|Escalation Phase|Death|0|||
23228378|NCT01693562|64581046|FG007|Escalation Phase|Death|0|||
23228379|NCT01693562|64581047|FG008|Escalation Phase|Death|0|||
23228380|NCT01693562|64581048|FG009|Escalation Phase|Death|0|||
23228381|NCT01693562|64581049|FG010|Escalation Phase|Death|0|||
23228382|NCT01693562|64581050|FG011|Escalation Phase|Death|0|||
23228383|NCT01693562|64581051|FG012|Escalation Phase|Death|0|||
23228384|NCT01693562|64581052|FG013|Escalation Phase|Death|0|||
23228385|NCT01693562|64581053|FG014|Escalation Phase|Death|0|||
23228386|NCT01693562|64581054|FG015|Escalation Phase|Death|0|||
23228387|NCT01693562|64581055|FG016|Escalation Phase|Death|0|||
23228388|NCT01693562|64581056|FG017|Escalation Phase|Death|0|||
23228389|NCT01693562|64581057|FG018|Escalation Phase|Death|0|||
23228390|NCT01693562|64581058|FG019|Escalation Phase|Death|0|||
23228391|NCT01693562|64581059|FG020|Escalation Phase|Death|0|||
23228392|NCT01693562|64581060|FG021|Escalation Phase|Death|0|||
23228393|NCT01693562|64581061|FG022|Escalation Phase|Death|0|||
23228394|NCT01693562|64581039|FG000|Escalation Phase|Lost to Follow-up|0|||
23228395|NCT01693562|64581040|FG001|Escalation Phase|Lost to Follow-up|1|||
23228396|NCT01693562|64581041|FG002|Escalation Phase|Lost to Follow-up|1|||
23228397|NCT01693562|64581042|FG003|Escalation Phase|Lost to Follow-up|0|||
23228398|NCT01693562|64581043|FG004|Escalation Phase|Lost to Follow-up|0|||
23170247|NCT02921971|64367265|FG001|Overall Study|Lack of Efficacy|1|||
23228399|NCT01693562|64581044|FG005|Escalation Phase|Lost to Follow-up|0|||
23228400|NCT01693562|64581045|FG006|Escalation Phase|Lost to Follow-up|0|||
23228401|NCT01693562|64581046|FG007|Escalation Phase|Lost to Follow-up|0|||
23228402|NCT01693562|64581047|FG008|Escalation Phase|Lost to Follow-up|0|||
23228403|NCT01693562|64581048|FG009|Escalation Phase|Lost to Follow-up|0|||
23228404|NCT01693562|64581049|FG010|Escalation Phase|Lost to Follow-up|0|||
23228405|NCT01693562|64581050|FG011|Escalation Phase|Lost to Follow-up|0|||
23228406|NCT01693562|64581051|FG012|Escalation Phase|Lost to Follow-up|0|||
23228407|NCT01693562|64581052|FG013|Escalation Phase|Lost to Follow-up|0|||
23228408|NCT01693562|64581053|FG014|Escalation Phase|Lost to Follow-up|0|||
23228409|NCT01693562|64581054|FG015|Escalation Phase|Lost to Follow-up|0|||
23228410|NCT01693562|64581055|FG016|Escalation Phase|Lost to Follow-up|0|||
23228411|NCT01693562|64581056|FG017|Escalation Phase|Lost to Follow-up|0|||
23228412|NCT01693562|64581057|FG018|Escalation Phase|Lost to Follow-up|0|||
23228413|NCT01693562|64581058|FG019|Escalation Phase|Lost to Follow-up|0|||
23228414|NCT01693562|64581059|FG020|Escalation Phase|Lost to Follow-up|0|||
23228415|NCT01693562|64581060|FG021|Escalation Phase|Lost to Follow-up|0|||
23228416|NCT01693562|64581061|FG022|Escalation Phase|Lost to Follow-up|0|||
23576751|NCT02427646|65843452|FG001|Overall Study|Physician Decision|4|||
23170248|NCT02921971|64367264|FG000|Overall Study|Other than specified above|2|||
23170249|NCT02921971|64367265|FG001|Overall Study|Other than specified above|1|||
23228417|NCT01693562|64581039|FG000|Escalation Phase|Other|0|||
23228418|NCT01693562|64581040|FG001|Escalation Phase|Other|0|||
23228419|NCT01693562|64581041|FG002|Escalation Phase|Other|2|||
23228420|NCT01693562|64581042|FG003|Escalation Phase|Other|0|||
23170250|NCT01568593|64367266|FG000|Overall Study|Lack of Efficacy|4|||
23449390|NCT01247324|65388007|FG001|Overall Study|Non-compliance|2|||
23228421|NCT01693562|64581043|FG004|Escalation Phase|Other|0|||
23228422|NCT01693562|64581044|FG005|Escalation Phase|Other|1|||
23228423|NCT01693562|64581045|FG006|Escalation Phase|Other|0|||
23228424|NCT01693562|64581046|FG007|Escalation Phase|Other|0|||
23228425|NCT01693562|64581047|FG008|Escalation Phase|Other|0|||
23228426|NCT01693562|64581048|FG009|Escalation Phase|Other|0|||
23337020|NCT04740827|64976236|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
23337021|NCT04740827|64976235|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
23337022|NCT04740827|64976236|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
23337023|NCT04740827|64976235|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
23337024|NCT04740827|64976236|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
23337025|NCT04740827|64976235|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
23337026|NCT04740827|64976236|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
23337027|NCT04740827|64976235|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
23337028|NCT04740827|64976236|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
23337029|NCT01053663|64976237|FG000|Overall Study|Death|2|||
23337030|NCT01053663|64976237|FG000|Overall Study|Lost to Follow-up|1|||
23337031|NCT01053663|64976237|FG000|Overall Study|Poor IV Access|1|||
23337032|NCT01053663|64976237|FG000|Overall Study|Transferred to Another Hospital|1|||
23337033|NCT01053663|64976237|FG000|Overall Study|Negative Influenza Diagnosis|1|||
23337034|NCT01166438|64976239|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
23337035|NCT01166438|64976240|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
23337036|NCT01166438|64976239|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
23337037|NCT01166438|64976240|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
23337038|NCT01166438|64976239|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
23337039|NCT01166438|64976240|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
23337040|NCT01166438|64976239|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
23337041|NCT01166438|64976240|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
23337042|NCT01166438|64976239|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
23337043|NCT01166438|64976240|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
23337044|NCT01166438|64976239|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
23337045|NCT01166438|64976240|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
23337046|NCT02632409|64976245|FG000|Randomized|AE unrelated to study Drug|0|||
23337047|NCT02632409|64976246|FG001|Randomized|AE unrelated to study Drug|1|||
23337048|NCT02632409|64976245|FG000|Randomized|Participant withdrew consent|2|||
23576752|NCT02427646|65843451|FG000|Overall Study|Protocol Violation|3|||
23576753|NCT02427646|65843452|FG001|Overall Study|Protocol Violation|3|||
23576754|NCT02427646|65843451|FG000|Overall Study|Bothersome hand weakness|2|||
23576755|NCT02427646|65843452|FG001|Overall Study|Bothersome hand weakness|4|||
23337049|NCT02632409|64976246|FG001|Randomized|Participant withdrew consent|1|||
23337050|NCT02632409|64976245|FG000|Randomized|No Longer meets study criteria|5|||
23337051|NCT02632409|64976246|FG001|Randomized|No Longer meets study criteria|0|||
23170251|NCT01568593|64367267|FG001|Overall Study|Lack of Efficacy|1|||
23170252|NCT01568593|64367266|FG000|Overall Study|Adverse Event|3|||
23170253|NCT01568593|64367267|FG001|Overall Study|Adverse Event|2|||
23170254|NCT00412750|64367268|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23170255|NCT00412750|64367269|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23170256|NCT00412750|64367270|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23170257|NCT00412750|64367268|FG000|Overall Study|Administrative problems|21|||
23337052|NCT02632409|64976245|FG000|Randomized|other reasons|1|||
23337053|NCT02632409|64976246|FG001|Randomized|other reasons|0|||
23337054|NCT02632409|64976245|FG000|Treatment Period|Ongoing Treatment|20|||
23337055|NCT02632409|64976246|FG001|Treatment Period|Ongoing Treatment|21|||
23337056|NCT02632409|64976245|FG000|Treatment Period|Disease Recurrence|147|||
23337057|NCT02632409|64976246|FG001|Treatment Period|Disease Recurrence|90|||
23337058|NCT02632409|64976245|FG000|Treatment Period|Study Drug Toxicity|8|||
23228427|NCT01693562|64581049|FG010|Escalation Phase|Other|0|||
23228428|NCT01693562|64581050|FG011|Escalation Phase|Other|0|||
23576756|NCT00513019|65843454|FG000|Overall Study|Adverse Event|1|||
23576757|NCT00513019|65843455|FG001|Overall Study|Adverse Event|0|||
23576758|NCT00513019|65843454|FG000|Overall Study|Withdrawal by Subject|4|||
23576759|NCT00513019|65843455|FG001|Overall Study|Withdrawal by Subject|5|||
23170258|NCT00412750|64367269|FG001|Overall Study|Administrative problems|17|||
23228429|NCT01693562|64581051|FG012|Escalation Phase|Other|0|||
23228430|NCT01693562|64581052|FG013|Escalation Phase|Other|0|||
23228431|NCT01693562|64581053|FG014|Escalation Phase|Other|0|||
23337059|NCT02632409|64976246|FG001|Treatment Period|Study Drug Toxicity|49|||
23337060|NCT02632409|64976245|FG000|Treatment Period|Death|1|||
23337061|NCT02632409|64976246|FG001|Treatment Period|Death|0|||
23337062|NCT02632409|64976245|FG000|Treatment Period|AE unrelated to study drug|15|||
23576760|NCT01770860|65843456|FG000|Overall Study|Withdrawal by Subject|4|||
23576761|NCT01770860|65843456|FG000|Overall Study|Lost to Follow-up|1|||
23228432|NCT01693562|64581054|FG015|Escalation Phase|Other|0|||
23337063|NCT02632409|64976246|FG001|Treatment Period|AE unrelated to study drug|16|||
23228433|NCT01693562|64581055|FG016|Escalation Phase|Other|0|||
23576762|NCT01770860|65843456|FG000|Overall Study|Administrative decision made by the PI|1|||
23576763|NCT00605319|65843457|FG000|Overall Study|Adverse Event|6|||
23576764|NCT00983619|65843458|FG000|Overall Study|Lost to Follow-up|0|||
23576765|NCT00983619|65843459|FG001|Overall Study|Lost to Follow-up|1|||
23576766|NCT00983619|65843460|FG002|Overall Study|Lost to Follow-up|0|||
23576767|NCT00983619|65843461|FG003|Overall Study|Lost to Follow-up|0|||
23576768|NCT00983619|65843462|FG004|Overall Study|Lost to Follow-up|0|||
23576769|NCT00983619|65843463|FG005|Overall Study|Lost to Follow-up|2|||
23576770|NCT00983619|65843464|FG006|Overall Study|Lost to Follow-up|0|||
23576771|NCT00983619|65843465|FG007|Overall Study|Lost to Follow-up|0|||
23576772|NCT00983619|65843466|FG008|Overall Study|Lost to Follow-up|0|||
23576773|NCT00983619|65843467|FG009|Overall Study|Lost to Follow-up|0|||
23576774|NCT00983619|65843468|FG010|Overall Study|Lost to Follow-up|0|||
23576775|NCT00983619|65843469|FG011|Overall Study|Lost to Follow-up|2|||
23576776|NCT00983619|65843458|FG000|Overall Study|Withdrawal by Subject|2|||
23576777|NCT00983619|65843459|FG001|Overall Study|Withdrawal by Subject|1|||
23576778|NCT00983619|65843460|FG002|Overall Study|Withdrawal by Subject|1|||
23576779|NCT00983619|65843461|FG003|Overall Study|Withdrawal by Subject|3|||
23576780|NCT00983619|65843462|FG004|Overall Study|Withdrawal by Subject|1|||
23576781|NCT00983619|65843463|FG005|Overall Study|Withdrawal by Subject|23|||
23576782|NCT00983619|65843464|FG006|Overall Study|Withdrawal by Subject|0|||
23576783|NCT00983619|65843465|FG007|Overall Study|Withdrawal by Subject|0|||
23576784|NCT00983619|65843466|FG008|Overall Study|Withdrawal by Subject|0|||
23576785|NCT00983619|65843467|FG009|Overall Study|Withdrawal by Subject|0|||
23576786|NCT00983619|65843468|FG010|Overall Study|Withdrawal by Subject|1|||
23576787|NCT00983619|65843469|FG011|Overall Study|Withdrawal by Subject|1|||
23576788|NCT00983619|65843458|FG000|Overall Study|Death|0|||
23576789|NCT00983619|65843459|FG001|Overall Study|Death|2|||
23576790|NCT00983619|65843460|FG002|Overall Study|Death|2|||
23576791|NCT00983619|65843461|FG003|Overall Study|Death|1|||
23576792|NCT00983619|65843462|FG004|Overall Study|Death|2|||
23576793|NCT00983619|65843463|FG005|Overall Study|Death|30|||
23576794|NCT00983619|65843464|FG006|Overall Study|Death|1|||
23576795|NCT00983619|65843465|FG007|Overall Study|Death|0|||
23576796|NCT00983619|65843466|FG008|Overall Study|Death|1|||
23576797|NCT00983619|65843467|FG009|Overall Study|Death|2|||
23576798|NCT00983619|65843468|FG010|Overall Study|Death|9|||
23576799|NCT00983619|65843469|FG011|Overall Study|Death|8|||
23576800|NCT00983619|65843458|FG000|Overall Study|Other|1|||
23576801|NCT00983619|65843459|FG001|Overall Study|Other|0|||
23576802|NCT00983619|65843460|FG002|Overall Study|Other|0|||
23576803|NCT00983619|65843461|FG003|Overall Study|Other|1|||
23576804|NCT00983619|65843462|FG004|Overall Study|Other|0|||
23576805|NCT00983619|65843463|FG005|Overall Study|Other|12|||
23576806|NCT00983619|65843464|FG006|Overall Study|Other|2|||
23576807|NCT00983619|65843465|FG007|Overall Study|Other|2|||
23576808|NCT00983619|65843466|FG008|Overall Study|Other|0|||
23576809|NCT00983619|65843467|FG009|Overall Study|Other|1|||
23576810|NCT00983619|65843468|FG010|Overall Study|Other|1|||
23576811|NCT00983619|65843469|FG011|Overall Study|Other|0|||
23576812|NCT00691028|65843470|FG000|Open-label Period|Adverse Event|0|||
23576813|NCT00691028|65843471|FG001|Open-label Period|Adverse Event|0|||
23228434|NCT01693562|64581056|FG017|Escalation Phase|Other|0|||
23337064|NCT02632409|64976245|FG000|Treatment Period|Request to discontinue treatment|4|||
23337065|NCT02632409|64976246|FG001|Treatment Period|Request to discontinue treatment|19|||
23337066|NCT02632409|64976245|FG000|Treatment Period|Participant withdrew consent|7|||
23337067|NCT02632409|64976246|FG001|Treatment Period|Participant withdrew consent|5|||
23337068|NCT02632409|64976245|FG000|Treatment Period|Lost to Follow-up|0|||
23337069|NCT02632409|64976246|FG001|Treatment Period|Lost to Follow-up|1|||
23337070|NCT02632409|64976245|FG000|Treatment Period|Maximum clinical benefit|1|||
23337071|NCT02632409|64976246|FG001|Treatment Period|Maximum clinical benefit|0|||
23337072|NCT02632409|64976245|FG000|Treatment Period|No longer meets study criteria|3|||
23337073|NCT02632409|64976246|FG001|Treatment Period|No longer meets study criteria|0|||
23337074|NCT02632409|64976245|FG000|Treatment Period|Administrative Reason by sponsor|0|||
23337075|NCT02632409|64976246|FG001|Treatment Period|Administrative Reason by sponsor|1|||
23337076|NCT02632409|64976245|FG000|Treatment Period|Other Reasons|10|||
23337077|NCT02632409|64976246|FG001|Treatment Period|Other Reasons|6|||
23449391|NCT01247324|65388006|FG000|Overall Study|Pregnancy|5|||
23449392|NCT01247324|65388007|FG001|Overall Study|Pregnancy|10|||
23576814|NCT00691028|65843472|FG002|Open-label Period|Adverse Event|0|||
23576815|NCT00691028|65843473|FG003|Open-label Period|Adverse Event|16|||
23576816|NCT00691028|65843470|FG000|Open-label Period|Withdrawal by Subject|0|||
23576817|NCT00691028|65843471|FG001|Open-label Period|Withdrawal by Subject|0|||
23576818|NCT00691028|65843472|FG002|Open-label Period|Withdrawal by Subject|0|||
23576819|NCT00691028|65843473|FG003|Open-label Period|Withdrawal by Subject|3|||
23576820|NCT00691028|65843470|FG000|Open-label Period|not come to a hospital|0|||
23576821|NCT00691028|65843471|FG001|Open-label Period|not come to a hospital|0|||
23576822|NCT00691028|65843472|FG002|Open-label Period|not come to a hospital|0|||
23576823|NCT00691028|65843473|FG003|Open-label Period|not come to a hospital|1|||
23576824|NCT00691028|65843470|FG000|Double-blind Period|Adverse Event|8|||
23337078|NCT00931255|64976249|FG000|Overall Study|Follow up biopsy not done|2|||
23337079|NCT00931255|64976250|FG001|Overall Study|Follow up biopsy not done|3|||
23337080|NCT03039621|64976253|FG000|Overall Study|Violation of inclusion criteria|3|||
23337081|NCT03039621|64976254|FG001|Overall Study|Violation of inclusion criteria|2|||
23337082|NCT03039621|64976253|FG000|Overall Study|Non-compliance with protocol requirement|4|||
23337083|NCT03039621|64976254|FG001|Overall Study|Non-compliance with protocol requirement|5|||
23337084|NCT03039621|64976253|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
23337085|NCT03039621|64976254|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
23576825|NCT00691028|65843471|FG001|Double-blind Period|Adverse Event|9|||
23337086|NCT03039621|64976253|FG000|Overall Study|Violation of non-inclusion criteria|1|||
23337087|NCT03039621|64976254|FG001|Overall Study|Violation of non-inclusion criteria|2|||
23337088|NCT00712543|64976255|FG000|Day 8-14|Lost to Follow-up|0|||
23576826|NCT00691028|65843472|FG002|Double-blind Period|Adverse Event|6|||
23576827|NCT00691028|65843473|FG003|Double-blind Period|Adverse Event|0|||
23576828|NCT00691028|65843470|FG000|Double-blind Period|Lack of Efficacy|4|||
23576829|NCT00691028|65843471|FG001|Double-blind Period|Lack of Efficacy|3|||
23337089|NCT00712543|64976256|FG001|Day 8-14|Lost to Follow-up|2|||
23170259|NCT00412750|64367270|FG002|Overall Study|Administrative problems|14|||
23576830|NCT00691028|65843472|FG002|Double-blind Period|Lack of Efficacy|2|||
23576831|NCT00691028|65843473|FG003|Double-blind Period|Lack of Efficacy|0|||
23576832|NCT00691028|65843470|FG000|Double-blind Period|Withdrawal by Subject|1|||
23576833|NCT00691028|65843471|FG001|Double-blind Period|Withdrawal by Subject|0|||
23576834|NCT00691028|65843472|FG002|Double-blind Period|Withdrawal by Subject|1|||
23576835|NCT00691028|65843473|FG003|Double-blind Period|Withdrawal by Subject|0|||
23576836|NCT00691028|65843470|FG000|Double-blind Period|not come to a hospital.|0|||
23170260|NCT00412750|64367268|FG000|Overall Study|Adverse Event|8|||
23170261|NCT00412750|64367269|FG001|Overall Study|Adverse Event|3|||
23170262|NCT00412750|64367270|FG002|Overall Study|Adverse Event|3|||
23228435|NCT01693562|64581057|FG018|Escalation Phase|Other|0|||
23576837|NCT00691028|65843471|FG001|Double-blind Period|not come to a hospital.|1|||
23576838|NCT00691028|65843472|FG002|Double-blind Period|not come to a hospital.|0|||
23576839|NCT00691028|65843473|FG003|Double-blind Period|not come to a hospital.|0|||
23576840|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
23576841|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
23576842|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
23576843|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
23576844|NCT00335153|65843477|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
23170263|NCT00412750|64367268|FG000|Overall Study|Lost to Follow-up|1|||
23170264|NCT00412750|64367269|FG001|Overall Study|Lost to Follow-up|0|||
23337090|NCT02257489|64976257|FG000|Overall Study|Withdrawal by Subject|0|||
23576845|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
23228436|NCT01693562|64581058|FG019|Escalation Phase|Other|0|||
23228437|NCT01693562|64581059|FG020|Escalation Phase|Other|0|||
23228438|NCT01693562|64581060|FG021|Escalation Phase|Other|0|||
23228439|NCT01693562|64581061|FG022|Escalation Phase|Other|0|||
23228440|NCT01693562|64581039|FG000|Exploration Phase|Withdrawal by Subject|0|||
23228441|NCT01693562|64581040|FG001|Exploration Phase|Withdrawal by Subject|0|||
23337091|NCT02257489|64976258|FG001|Overall Study|Withdrawal by Subject|0|||
23576846|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
23170265|NCT00412750|64367270|FG002|Overall Study|Lost to Follow-up|1|||
23170266|NCT00412750|64367268|FG000|Overall Study|Withdrawal by Subject|0|||
23170267|NCT00412750|64367269|FG001|Overall Study|Withdrawal by Subject|1|||
23170268|NCT00412750|64367270|FG002|Overall Study|Withdrawal by Subject|2|||
23170269|NCT00412750|64367268|FG000|Overall Study|Lack of Efficacy|0|||
23170270|NCT00412750|64367269|FG001|Overall Study|Lack of Efficacy|0|||
23170271|NCT00412750|64367270|FG002|Overall Study|Lack of Efficacy|3|||
23170272|NCT01926782|64367275|FG000|Overall Study|Participant moved|2|||
23170273|NCT01926782|64367276|FG001|Overall Study|Participant moved|0|||
23170274|NCT01926782|64367277|FG002|Overall Study|Participant moved|1|||
23170275|NCT01926782|64367278|FG003|Overall Study|Participant moved|1|||
23170276|NCT01926782|64367279|FG004|Overall Study|Participant moved|0|||
23170277|NCT01926782|64367280|FG005|Overall Study|Participant moved|3|||
23170278|NCT01926782|64367275|FG000|Overall Study|Physician Decision|0|||
23170279|NCT01926782|64367276|FG001|Overall Study|Physician Decision|2|||
23170280|NCT01926782|64367277|FG002|Overall Study|Physician Decision|1|||
23170281|NCT01926782|64367278|FG003|Overall Study|Physician Decision|1|||
23170282|NCT01926782|64367279|FG004|Overall Study|Physician Decision|0|||
23170283|NCT01926782|64367280|FG005|Overall Study|Physician Decision|0|||
23170284|NCT01926782|64367275|FG000|Overall Study|Other than specified|2|||
23170285|NCT01926782|64367276|FG001|Overall Study|Other than specified|3|||
23170286|NCT01926782|64367277|FG002|Overall Study|Other than specified|5|||
23228442|NCT01693562|64581041|FG002|Exploration Phase|Withdrawal by Subject|0|||
23337092|NCT02257489|64976259|FG002|Overall Study|Withdrawal by Subject|0|||
23449393|NCT01247324|65388006|FG000|Overall Study|Protocol Violation|1|||
23449394|NCT01247324|65388007|FG001|Overall Study|Protocol Violation|1|||
23228443|NCT01693562|64581042|FG003|Exploration Phase|Withdrawal by Subject|0|||
23576847|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
23576848|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
23576849|NCT00335153|65843477|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
23576850|NCT04922021|65843481|FG000|Overall Study|Withdrawal by Subject|4|||
23576851|NCT04922021|65843482|FG001|Overall Study|Withdrawal by Subject|10|||
23576852|NCT04922021|65843481|FG000|Overall Study|Adverse Event|2|||
23576853|NCT04922021|65843482|FG001|Overall Study|Adverse Event|2|||
23576854|NCT04922021|65843481|FG000|Overall Study|Lack of Efficacy|0|||
23576855|NCT04922021|65843482|FG001|Overall Study|Lack of Efficacy|1|||
23576856|NCT04922021|65843481|FG000|Overall Study|Multiple reasons|1|||
23576857|NCT04922021|65843482|FG001|Overall Study|Multiple reasons|0|||
23576858|NCT03712098|65843483|FG000|Overall Study|Lost to Follow-up|3|||
23576859|NCT03712098|65843484|FG001|Overall Study|Lost to Follow-up|7|||
23576860|NCT03712098|65843483|FG000|Overall Study|Withdrawal by Subject|9|||
23576861|NCT03712098|65843484|FG001|Overall Study|Withdrawal by Subject|4|||
23576862|NCT03712098|65843483|FG000|Overall Study|Protocol Violation|2|||
23576863|NCT03712098|65843484|FG001|Overall Study|Protocol Violation|1|||
23576864|NCT02322775|65843490|FG000|Overall Study|Adverse Event|1|||
23576865|NCT02322775|65843491|FG001|Overall Study|Adverse Event|0|||
23576866|NCT02322775|65843490|FG000|Overall Study|Lost to Follow-up|0|||
23337093|NCT02257489|64976260|FG003|Overall Study|Withdrawal by Subject|1|||
23337094|NCT02257489|64976261|FG004|Overall Study|Withdrawal by Subject|0|||
23337095|NCT02257489|64976262|FG005|Overall Study|Withdrawal by Subject|0|||
23337096|NCT02257489|64976263|FG006|Overall Study|Withdrawal by Subject|0|||
23337097|NCT02257489|64976264|FG007|Overall Study|Withdrawal by Subject|0|||
23337098|NCT02257489|64976265|FG008|Overall Study|Withdrawal by Subject|0|||
23337099|NCT01515865|64976266|FG000|Part A (Open-label)|Other|3|||
23337100|NCT01515865|64976267|FG001|Part A (Open-label)|Other|0|||
23337101|NCT01515865|64976268|FG002|Part A (Open-label)|Other|0|||
23337102|NCT01515865|64976266|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
23337103|NCT01515865|64976267|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
23337104|NCT01515865|64976268|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
23337105|NCT01515865|64976266|FG000|Part B (Open-label)|Other|1|||
23337106|NCT01515865|64976267|FG001|Part B (Open-label)|Other|0|||
23337107|NCT01515865|64976268|FG002|Part B (Open-label)|Other|0|||
23337108|NCT00550745|64976269|FG000|Overall Study|Death|20|||
23337109|NCT00550745|64976270|FG001|Overall Study|Death|16|||
23337110|NCT00550745|64976269|FG000|Overall Study|Lost to Follow-up|45|||
23576867|NCT02322775|65843491|FG001|Overall Study|Lost to Follow-up|1|||
23576868|NCT02322775|65843490|FG000|Overall Study|Protocol Violation|1|||
23170287|NCT01926782|64367278|FG003|Overall Study|Other than specified|12|||
23170288|NCT01926782|64367279|FG004|Overall Study|Other than specified|4|||
23170289|NCT01926782|64367280|FG005|Overall Study|Other than specified|11|||
23170290|NCT01926782|64367275|FG000|Overall Study|Adverse Event|13|||
23170291|NCT01926782|64367276|FG001|Overall Study|Adverse Event|4|||
23170292|NCT01926782|64367277|FG002|Overall Study|Adverse Event|17|||
23170293|NCT01926782|64367278|FG003|Overall Study|Adverse Event|4|||
23170294|NCT01926782|64367279|FG004|Overall Study|Adverse Event|3|||
23170295|NCT01926782|64367280|FG005|Overall Study|Adverse Event|14|||
23170296|NCT01926782|64367275|FG000|Overall Study|Poor compliance to protocol|5|||
23170297|NCT01926782|64367276|FG001|Overall Study|Poor compliance to protocol|3|||
23170298|NCT01926782|64367277|FG002|Overall Study|Poor compliance to protocol|8|||
23170299|NCT01926782|64367278|FG003|Overall Study|Poor compliance to protocol|0|||
23170300|NCT01926782|64367279|FG004|Overall Study|Poor compliance to protocol|1|||
23228444|NCT01693562|64581043|FG004|Exploration Phase|Withdrawal by Subject|0|||
23228445|NCT01693562|64581044|FG005|Exploration Phase|Withdrawal by Subject|0|||
23228446|NCT01693562|64581045|FG006|Exploration Phase|Withdrawal by Subject|2|||
23228447|NCT01693562|64581046|FG007|Exploration Phase|Withdrawal by Subject|0|||
23228448|NCT01693562|64581047|FG008|Exploration Phase|Withdrawal by Subject|0|||
23228449|NCT01693562|64581048|FG009|Exploration Phase|Withdrawal by Subject|0|||
23228450|NCT01693562|64581049|FG010|Exploration Phase|Withdrawal by Subject|0|||
23228451|NCT01693562|64581050|FG011|Exploration Phase|Withdrawal by Subject|0|||
23228452|NCT01693562|64581051|FG012|Exploration Phase|Withdrawal by Subject|0|||
23170301|NCT01926782|64367280|FG005|Overall Study|Poor compliance to protocol|6|||
23228453|NCT01693562|64581052|FG013|Exploration Phase|Withdrawal by Subject|0|||
23170302|NCT01926782|64367275|FG000|Overall Study|Randomized and not treated|0|||
23170303|NCT01926782|64367276|FG001|Overall Study|Randomized and not treated|0|||
23170304|NCT01926782|64367277|FG002|Overall Study|Randomized and not treated|0|||
23228454|NCT01693562|64581053|FG014|Exploration Phase|Withdrawal by Subject|0|||
23576869|NCT02322775|65843491|FG001|Overall Study|Protocol Violation|0|||
23228455|NCT01693562|64581054|FG015|Exploration Phase|Withdrawal by Subject|0|||
23228456|NCT01693562|64581055|FG016|Exploration Phase|Withdrawal by Subject|0|||
23576870|NCT02322775|65843490|FG000|Overall Study|Withdrawal by Subject|3|||
23337111|NCT00550745|64976270|FG001|Overall Study|Lost to Follow-up|30|||
23337112|NCT00550745|64976269|FG000|Overall Study|Physician Decision|0|||
23337113|NCT00550745|64976270|FG001|Overall Study|Physician Decision|2|||
23576871|NCT02322775|65843491|FG001|Overall Study|Withdrawal by Subject|4|||
23576872|NCT02322775|65843490|FG000|Overall Study|Not willing to perform all FU visits|0|||
23170305|NCT01926782|64367278|FG003|Overall Study|Randomized and not treated|1|||
23170306|NCT01926782|64367279|FG004|Overall Study|Randomized and not treated|0|||
23170307|NCT01926782|64367280|FG005|Overall Study|Randomized and not treated|0|||
23170308|NCT01926782|64367275|FG000|Overall Study|Withdrawal by Subject|6|||
23170309|NCT01926782|64367276|FG001|Overall Study|Withdrawal by Subject|1|||
23170310|NCT01926782|64367277|FG002|Overall Study|Withdrawal by Subject|8|||
23170311|NCT01926782|64367278|FG003|Overall Study|Withdrawal by Subject|1|||
23170312|NCT01926782|64367279|FG004|Overall Study|Withdrawal by Subject|0|||
23170313|NCT01926782|64367280|FG005|Overall Study|Withdrawal by Subject|5|||
23170314|NCT01926782|64367275|FG000|Overall Study|Related to study drug administration|0|||
23170315|NCT01926782|64367276|FG001|Overall Study|Related to study drug administration|0|||
23170316|NCT01926782|64367277|FG002|Overall Study|Related to study drug administration|0|||
23170317|NCT01926782|64367278|FG003|Overall Study|Related to study drug administration|0|||
23170318|NCT01926782|64367279|FG004|Overall Study|Related to study drug administration|0|||
23170319|NCT01926782|64367280|FG005|Overall Study|Related to study drug administration|2|||
23170320|NCT02361216|64367281|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
23170321|NCT02361216|64367282|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
23170322|NCT02361216|64367281|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
23228457|NCT01693562|64581056|FG017|Exploration Phase|Withdrawal by Subject|0|||
23228458|NCT01693562|64581057|FG018|Exploration Phase|Withdrawal by Subject|0|||
23228459|NCT01693562|64581058|FG019|Exploration Phase|Withdrawal by Subject|0|||
23228460|NCT01693562|64581059|FG020|Exploration Phase|Withdrawal by Subject|0|||
23228461|NCT01693562|64581060|FG021|Exploration Phase|Withdrawal by Subject|0|||
23228462|NCT01693562|64581061|FG022|Exploration Phase|Withdrawal by Subject|0|||
23228463|NCT01693562|64581039|FG000|Exploration Phase|Death|0|||
23228464|NCT01693562|64581040|FG001|Exploration Phase|Death|0|||
23228465|NCT01693562|64581041|FG002|Exploration Phase|Death|0|||
23228466|NCT01693562|64581042|FG003|Exploration Phase|Death|0|||
23228467|NCT01693562|64581043|FG004|Exploration Phase|Death|0|||
23228468|NCT01693562|64581044|FG005|Exploration Phase|Death|0|||
23228469|NCT01693562|64581045|FG006|Exploration Phase|Death|17|||
23228470|NCT01693562|64581046|FG007|Exploration Phase|Death|0|||
23228471|NCT01693562|64581047|FG008|Exploration Phase|Death|0|||
23228472|NCT01693562|64581048|FG009|Exploration Phase|Death|0|||
23228473|NCT01693562|64581049|FG010|Exploration Phase|Death|0|||
23228474|NCT01693562|64581050|FG011|Exploration Phase|Death|0|||
23228475|NCT01693562|64581051|FG012|Exploration Phase|Death|0|||
23228476|NCT01693562|64581052|FG013|Exploration Phase|Death|0|||
23228477|NCT01693562|64581053|FG014|Exploration Phase|Death|0|||
23228478|NCT01693562|64581054|FG015|Exploration Phase|Death|0|||
23228479|NCT01693562|64581055|FG016|Exploration Phase|Death|0|||
23228480|NCT01693562|64581056|FG017|Exploration Phase|Death|0|||
23228481|NCT01693562|64581057|FG018|Exploration Phase|Death|0|||
23228482|NCT01693562|64581058|FG019|Exploration Phase|Death|0|||
23228483|NCT01693562|64581059|FG020|Exploration Phase|Death|0|||
23228484|NCT01693562|64581060|FG021|Exploration Phase|Death|0|||
23228485|NCT01693562|64581061|FG022|Exploration Phase|Death|0|||
23228486|NCT01693562|64581039|FG000|Exploration Phase|Other|0|||
23228487|NCT01693562|64581040|FG001|Exploration Phase|Other|0|||
23228488|NCT01693562|64581041|FG002|Exploration Phase|Other|0|||
23228489|NCT01693562|64581042|FG003|Exploration Phase|Other|0|||
23228490|NCT01693562|64581043|FG004|Exploration Phase|Other|0|||
23228491|NCT01693562|64581044|FG005|Exploration Phase|Other|0|||
23228492|NCT01693562|64581045|FG006|Exploration Phase|Other|2|||
23228493|NCT01693562|64581046|FG007|Exploration Phase|Other|0|||
23228494|NCT01693562|64581047|FG008|Exploration Phase|Other|0|||
23228495|NCT01693562|64581048|FG009|Exploration Phase|Other|0|||
23228496|NCT01693562|64581049|FG010|Exploration Phase|Other|0|||
23228497|NCT01693562|64581050|FG011|Exploration Phase|Other|0|||
23228498|NCT01693562|64581051|FG012|Exploration Phase|Other|0|||
23228499|NCT01693562|64581052|FG013|Exploration Phase|Other|0|||
23228500|NCT01693562|64581053|FG014|Exploration Phase|Other|0|||
23228501|NCT01693562|64581054|FG015|Exploration Phase|Other|0|||
23228502|NCT01693562|64581055|FG016|Exploration Phase|Other|0|||
23228503|NCT01693562|64581056|FG017|Exploration Phase|Other|0|||
23228504|NCT01693562|64581057|FG018|Exploration Phase|Other|0|||
23228505|NCT01693562|64581058|FG019|Exploration Phase|Other|0|||
23228506|NCT01693562|64581059|FG020|Exploration Phase|Other|0|||
23228507|NCT01693562|64581060|FG021|Exploration Phase|Other|0|||
23228508|NCT01693562|64581061|FG022|Exploration Phase|Other|0|||
23228509|NCT01693562|64581039|FG000|Expansion Phase|Withdrawal by Subject|0|||
23228510|NCT01693562|64581040|FG001|Expansion Phase|Withdrawal by Subject|0|||
23228511|NCT01693562|64581041|FG002|Expansion Phase|Withdrawal by Subject|0|||
23228512|NCT01693562|64581042|FG003|Expansion Phase|Withdrawal by Subject|0|||
23228513|NCT01693562|64581043|FG004|Expansion Phase|Withdrawal by Subject|0|||
23228514|NCT01693562|64581044|FG005|Expansion Phase|Withdrawal by Subject|0|||
23228515|NCT01693562|64581045|FG006|Expansion Phase|Withdrawal by Subject|0|||
23228516|NCT01693562|64581046|FG007|Expansion Phase|Withdrawal by Subject|16|||
23228517|NCT01693562|64581047|FG008|Expansion Phase|Withdrawal by Subject|2|||
23228518|NCT01693562|64581048|FG009|Expansion Phase|Withdrawal by Subject|54|||
23228519|NCT01693562|64581049|FG010|Expansion Phase|Withdrawal by Subject|2|||
23228520|NCT01693562|64581050|FG011|Expansion Phase|Withdrawal by Subject|2|||
23228521|NCT01693562|64581051|FG012|Expansion Phase|Withdrawal by Subject|3|||
23228522|NCT01693562|64581052|FG013|Expansion Phase|Withdrawal by Subject|5|||
23228523|NCT01693562|64581053|FG014|Expansion Phase|Withdrawal by Subject|16|||
23228524|NCT01693562|64581054|FG015|Expansion Phase|Withdrawal by Subject|7|||
23228525|NCT01693562|64581055|FG016|Expansion Phase|Withdrawal by Subject|40|||
23228526|NCT01693562|64581056|FG017|Expansion Phase|Withdrawal by Subject|4|||
23228527|NCT01693562|64581057|FG018|Expansion Phase|Withdrawal by Subject|8|||
23228528|NCT01693562|64581058|FG019|Expansion Phase|Withdrawal by Subject|3|||
23228529|NCT01693562|64581059|FG020|Expansion Phase|Withdrawal by Subject|1|||
23228530|NCT01693562|64581060|FG021|Expansion Phase|Withdrawal by Subject|8|||
23228531|NCT01693562|64581061|FG022|Expansion Phase|Withdrawal by Subject|1|||
23228532|NCT01693562|64581039|FG000|Expansion Phase|Death|0|||
23228533|NCT01693562|64581040|FG001|Expansion Phase|Death|0|||
23228534|NCT01693562|64581041|FG002|Expansion Phase|Death|0|||
23228535|NCT01693562|64581042|FG003|Expansion Phase|Death|0|||
23228536|NCT01693562|64581043|FG004|Expansion Phase|Death|0|||
23228537|NCT01693562|64581044|FG005|Expansion Phase|Death|0|||
23228538|NCT01693562|64581045|FG006|Expansion Phase|Death|0|||
23228539|NCT01693562|64581046|FG007|Expansion Phase|Death|42|||
23228540|NCT01693562|64581047|FG008|Expansion Phase|Death|17|||
23228541|NCT01693562|64581048|FG009|Expansion Phase|Death|208|||
23228542|NCT01693562|64581049|FG010|Expansion Phase|Death|30|||
23228543|NCT01693562|64581050|FG011|Expansion Phase|Death|8|||
23170323|NCT02361216|64367282|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
23170324|NCT02361216|64367281|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
23170325|NCT02361216|64367282|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
23170326|NCT02361216|64367281|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
23170327|NCT02361216|64367282|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
23170328|NCT02361216|64367281|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
23170329|NCT02361216|64367282|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
23170330|NCT02361216|64367281|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
23228544|NCT01693562|64581051|FG012|Expansion Phase|Death|19|||
23228545|NCT01693562|64581052|FG013|Expansion Phase|Death|42|||
23228546|NCT01693562|64581053|FG014|Expansion Phase|Death|23|||
23228547|NCT01693562|64581054|FG015|Expansion Phase|Death|23|||
23228548|NCT01693562|64581055|FG016|Expansion Phase|Death|128|||
23228549|NCT01693562|64581056|FG017|Expansion Phase|Death|16|||
23228550|NCT01693562|64581057|FG018|Expansion Phase|Death|36|||
23228551|NCT01693562|64581058|FG019|Expansion Phase|Death|16|||
23228552|NCT01693562|64581059|FG020|Expansion Phase|Death|17|||
23228553|NCT01693562|64581060|FG021|Expansion Phase|Death|35|||
23228554|NCT01693562|64581061|FG022|Expansion Phase|Death|7|||
23228555|NCT01693562|64581039|FG000|Expansion Phase|Lost to Follow-up|0|||
23228556|NCT01693562|64581040|FG001|Expansion Phase|Lost to Follow-up|0|||
23228557|NCT01693562|64581041|FG002|Expansion Phase|Lost to Follow-up|0|||
23337114|NCT00550745|64976269|FG000|Overall Study|Protocol Violation|4|||
23170331|NCT02361216|64367282|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
23170332|NCT02556255|64367283|FG000|Overall Study|Lost to Follow-up|4|||
23170333|NCT01273883|64367284|FG000|First Intervention|Adverse Event|2|||
23170334|NCT01273883|64367285|FG001|First Intervention|Adverse Event|1|||
23170335|NCT01273883|64367284|FG000|Second Intervention|Lost to Follow-up|1|||
23170336|NCT01273883|64367285|FG001|Second Intervention|Lost to Follow-up|1|||
23170337|NCT01273883|64367284|FG000|Second Intervention|Lack of Efficacy|1|||
23170338|NCT01273883|64367285|FG001|Second Intervention|Lack of Efficacy|0|||
23170339|NCT02301403|64367286|FG000|Overall Study|Withdrawal by Subject|28|||
23170340|NCT02301403|64367287|FG001|Overall Study|Withdrawal by Subject|41|||
23170341|NCT00150592|64367288|FG000|Overall Study|Adverse Event|4|||
23170342|NCT00150592|64367289|FG001|Overall Study|Adverse Event|1|||
23170343|NCT00150592|64367288|FG000|Overall Study|Protocol Violation|1|||
23170344|NCT00150592|64367289|FG001|Overall Study|Protocol Violation|0|||
23170345|NCT00150592|64367288|FG000|Overall Study|Withdrawal by Subject|1|||
23170346|NCT00150592|64367289|FG001|Overall Study|Withdrawal by Subject|2|||
23170347|NCT00150592|64367288|FG000|Overall Study|Non-compliance|1|||
23170348|NCT00150592|64367289|FG001|Overall Study|Non-compliance|0|||
23170349|NCT04849780|64367294|FG000|Period 1|Covid-19 Related|1|||
23170350|NCT04849780|64367295|FG001|Period 1|Covid-19 Related|0|||
23228558|NCT01693562|64581042|FG003|Expansion Phase|Lost to Follow-up|0|||
23228559|NCT01693562|64581043|FG004|Expansion Phase|Lost to Follow-up|0|||
23228560|NCT01693562|64581044|FG005|Expansion Phase|Lost to Follow-up|0|||
23228561|NCT01693562|64581045|FG006|Expansion Phase|Lost to Follow-up|0|||
23228562|NCT01693562|64581046|FG007|Expansion Phase|Lost to Follow-up|1|||
23228563|NCT01693562|64581047|FG008|Expansion Phase|Lost to Follow-up|2|||
23228564|NCT01693562|64581048|FG009|Expansion Phase|Lost to Follow-up|10|||
23228565|NCT01693562|64581049|FG010|Expansion Phase|Lost to Follow-up|4|||
23228566|NCT01693562|64581050|FG011|Expansion Phase|Lost to Follow-up|4|||
23228567|NCT01693562|64581051|FG012|Expansion Phase|Lost to Follow-up|1|||
23228568|NCT01693562|64581052|FG013|Expansion Phase|Lost to Follow-up|3|||
23170351|NCT04849780|64367294|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
23170352|NCT04849780|64367295|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
23170353|NCT04849780|64367294|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
23170354|NCT04849780|64367295|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
23170355|NCT00915343|64370748|FG000|Part B - Open Label Period|Treatment switch|0|||
23170356|NCT00915343|64370749|FG001|Part B - Open Label Period|Treatment switch|0|||
23170357|NCT00915343|64370750|FG002|Part B - Open Label Period|Treatment switch|1|||
23337115|NCT00550745|64976270|FG001|Overall Study|Protocol Violation|2|||
23337116|NCT00550745|64976269|FG000|Overall Study|Withdrawal by Subject|17|||
23228569|NCT01693562|64581053|FG014|Expansion Phase|Lost to Follow-up|0|||
23228570|NCT01693562|64581054|FG015|Expansion Phase|Lost to Follow-up|1|||
23228571|NCT01693562|64581055|FG016|Expansion Phase|Lost to Follow-up|1|||
23228572|NCT01693562|64581056|FG017|Expansion Phase|Lost to Follow-up|0|||
23228573|NCT01693562|64581057|FG018|Expansion Phase|Lost to Follow-up|2|||
23228574|NCT01693562|64581058|FG019|Expansion Phase|Lost to Follow-up|1|||
23228575|NCT01693562|64581059|FG020|Expansion Phase|Lost to Follow-up|2|||
23228576|NCT01693562|64581060|FG021|Expansion Phase|Lost to Follow-up|2|||
23228577|NCT01693562|64581061|FG022|Expansion Phase|Lost to Follow-up|1|||
23228578|NCT01693562|64581039|FG000|Expansion Phase|Other|0|||
23228579|NCT01693562|64581040|FG001|Expansion Phase|Other|0|||
23228580|NCT01693562|64581041|FG002|Expansion Phase|Other|0|||
23228581|NCT01693562|64581042|FG003|Expansion Phase|Other|0|||
23228582|NCT01693562|64581043|FG004|Expansion Phase|Other|0|||
23228583|NCT01693562|64581044|FG005|Expansion Phase|Other|0|||
23228584|NCT01693562|64581045|FG006|Expansion Phase|Other|0|||
23228585|NCT01693562|64581046|FG007|Expansion Phase|Other|3|||
23228586|NCT01693562|64581047|FG008|Expansion Phase|Other|1|||
23228587|NCT01693562|64581048|FG009|Expansion Phase|Other|28|||
23228588|NCT01693562|64581049|FG010|Expansion Phase|Other|4|||
23228589|NCT01693562|64581050|FG011|Expansion Phase|Other|7|||
23228590|NCT01693562|64581051|FG012|Expansion Phase|Other|0|||
23228591|NCT01693562|64581052|FG013|Expansion Phase|Other|1|||
23228592|NCT01693562|64581053|FG014|Expansion Phase|Other|1|||
23228593|NCT01693562|64581054|FG015|Expansion Phase|Other|0|||
23228594|NCT01693562|64581055|FG016|Expansion Phase|Other|28|||
23228595|NCT01693562|64581056|FG017|Expansion Phase|Other|0|||
23228596|NCT01693562|64581057|FG018|Expansion Phase|Other|1|||
23228597|NCT01693562|64581058|FG019|Expansion Phase|Other|0|||
23228598|NCT01693562|64581059|FG020|Expansion Phase|Other|1|||
23228599|NCT01693562|64581060|FG021|Expansion Phase|Other|17|||
23228600|NCT01693562|64581061|FG022|Expansion Phase|Other|1|||
23228601|NCT04490499|64581064|FG000|Overall Study|Withdrawal by Subject|2|||
23228602|NCT04048876|64581065|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
23228603|NCT04048876|64581066|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
23228604|NCT04048876|64581067|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
23228605|NCT04048876|64581068|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
23228606|NCT04048876|64581065|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
23228607|NCT04048876|64581066|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
23228608|NCT04048876|64581067|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
23228609|NCT04048876|64581068|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
23337117|NCT00550745|64976270|FG001|Overall Study|Withdrawal by Subject|10|||
23337118|NCT00550745|64976269|FG000|Overall Study|Screen failure|1|||
23337119|NCT00550745|64976270|FG001|Overall Study|Screen failure|0|||
23337120|NCT00661609|64976280|FG000|Overall Study|Adverse Event|4|||
23337121|NCT00661609|64976280|FG000|Overall Study|Death|20|||
23337122|NCT00661609|64976280|FG000|Overall Study|Withdrawal by Subject|2|||
23337123|NCT00661609|64976280|FG000|Overall Study|PI Decision|1|||
23337124|NCT00661609|64976280|FG000|Overall Study|Survival follow up stage discontinued|11|||
23576873|NCT02322775|65843491|FG001|Overall Study|Not willing to perform all FU visits|1|||
23576874|NCT00946647|65843492|FG000|Phase 1 Part|Adverse Event|2|||
23576875|NCT00946647|65843493|FG001|Phase 1 Part|Adverse Event|5|||
23576876|NCT00946647|65843494|FG002|Phase 1 Part|Adverse Event|3|||
23170358|NCT00915343|64370748|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
23228610|NCT04048876|64581065|FG000|Placebo Controlled Phase|Adverse Event|0|||
23228611|NCT04048876|64581066|FG001|Placebo Controlled Phase|Adverse Event|1|||
23337125|NCT00661609|64976280|FG000|Overall Study|Disease progression|3|||
23170359|NCT00915343|64370749|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
23228612|NCT04048876|64581067|FG002|Placebo Controlled Phase|Adverse Event|0|||
23228613|NCT04048876|64581068|FG003|Placebo Controlled Phase|Adverse Event|0|||
23228614|NCT04048876|64581065|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
23228615|NCT04048876|64581066|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
23228616|NCT04048876|64581067|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
23337126|NCT00570141|64976281|FG000|Overall Study|Adverse Event|1|||
23449395|NCT01247324|65388006|FG000|Overall Study|Reason not specified|42|||
23228617|NCT04048876|64581068|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
23228618|NCT00424099|64581071|FG000|Overall Study|Adverse Event|0|||
23337127|NCT00570141|64976281|FG000|Overall Study|Missed visits|1|||
23576877|NCT00946647|65843495|FG003|Phase 1 Part|Adverse Event|0|||
23337128|NCT00570141|64976281|FG000|Overall Study|Lost to Follow-up|1|||
23337129|NCT02035202|64976284|FG000|Overall Study|Lost to Follow-up|8|||
23337130|NCT02035202|64976285|FG001|Overall Study|Lost to Follow-up|16|||
23337131|NCT02035202|64976286|FG002|Overall Study|Lost to Follow-up|2|||
23337132|NCT02527434|64976287|FG000|Overall Study|Lost to Follow-up|2|||
23449396|NCT01247324|65388007|FG001|Overall Study|Reason not specified|32|||
23449397|NCT01247324|65388006|FG000|Overall Study|Consent withdrawn by participant|41|||
23449398|NCT01247324|65388007|FG001|Overall Study|Consent withdrawn by participant|56|||
23449399|NCT01247324|65388006|FG000|Overall Study|Adverse Event|49|||
23449400|NCT01247324|65388007|FG001|Overall Study|Adverse Event|35|||
23449401|NCT01247324|65388006|FG000|Overall Study|Lost to Follow-up|3|||
23449402|NCT01247324|65388007|FG001|Overall Study|Lost to Follow-up|6|||
23449403|NCT01247324|65388006|FG000|Overall Study|Study Terminated by Sponsor|4|||
23449404|NCT01247324|65388007|FG001|Overall Study|Study Terminated by Sponsor|1|||
23449405|NCT01247324|65388006|FG000|Overall Study|Missing|2|||
23449406|NCT01247324|65388007|FG001|Overall Study|Missing|1|||
23449407|NCT00795535|65388018|FG000|Overall Study|incomplete data and technical problems|20|||
23449408|NCT00479336|65388025|FG000|Overall Study|Adverse Event|1|||
23449409|NCT00479336|65388026|FG001|Overall Study|Adverse Event|1|||
23449410|NCT00479336|65388027|FG002|Overall Study|Adverse Event|1|||
23170360|NCT00915343|64370750|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
23170361|NCT03551743|64370751|FG000|Overall Study|Adverse Event|1|||
23170362|NCT03551743|64370752|FG001|Overall Study|Adverse Event|0|||
23170363|NCT03551743|64370753|FG002|Overall Study|Adverse Event|0|||
23170364|NCT03551743|64370754|FG003|Overall Study|Adverse Event|0|||
23170365|NCT03551743|64370751|FG000|Overall Study|Withdrawal by Subject|1|||
23337133|NCT02527434|64976288|FG001|Overall Study|Lost to Follow-up|2|||
23337134|NCT02527434|64976289|FG002|Overall Study|Lost to Follow-up|0|||
23337135|NCT02527434|64976287|FG000|Overall Study|Death|19|||
23337136|NCT02527434|64976288|FG001|Overall Study|Death|6|||
23337137|NCT02527434|64976289|FG002|Overall Study|Death|17|||
23337138|NCT02527434|64976287|FG000|Overall Study|Withdrawal by Subject|5|||
23337139|NCT02527434|64976288|FG001|Overall Study|Withdrawal by Subject|3|||
23337140|NCT02527434|64976289|FG002|Overall Study|Withdrawal by Subject|3|||
23337141|NCT02527434|64976287|FG000|Overall Study|Reason Not Specified|1|||
23337142|NCT02527434|64976288|FG001|Overall Study|Reason Not Specified|0|||
23337143|NCT02527434|64976289|FG002|Overall Study|Reason Not Specified|0|||
23337144|NCT02527434|64976287|FG000|Overall Study|Site closure|1|||
23337145|NCT02527434|64976288|FG001|Overall Study|Site closure|0|||
23337146|NCT02527434|64976289|FG002|Overall Study|Site closure|0|||
23337147|NCT01344824|64976290|FG000|Overall Study|Adverse Event|15|||
23170366|NCT03551743|64370752|FG001|Overall Study|Withdrawal by Subject|0|||
23170367|NCT03551743|64370753|FG002|Overall Study|Withdrawal by Subject|0|||
23170368|NCT03551743|64370754|FG003|Overall Study|Withdrawal by Subject|0|||
23170369|NCT00105443|64370769|FG000|Double-Blind Treatment|Adverse Event|1|||
23170370|NCT00105443|64370770|FG001|Double-Blind Treatment|Adverse Event|0|||
23170371|NCT00105443|64370771|FG002|Double-Blind Treatment|Adverse Event|0|||
23170372|NCT00105443|64370772|FG003|Double-Blind Treatment|Adverse Event|0|||
23170373|NCT00105443|64370769|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
23170374|NCT00105443|64370770|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
23170375|NCT00105443|64370771|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
23170376|NCT00105443|64370772|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
23170377|NCT00105443|64370769|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
23170378|NCT00105443|64370770|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
23170379|NCT00105443|64370771|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
23170380|NCT00105443|64370772|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
23170381|NCT00105443|64370769|FG000|Double-Blind Treatment|Physician Decision|1|||
23170382|NCT00105443|64370770|FG001|Double-Blind Treatment|Physician Decision|0|||
23170383|NCT00105443|64370771|FG002|Double-Blind Treatment|Physician Decision|2|||
23170384|NCT00105443|64370772|FG003|Double-Blind Treatment|Physician Decision|0|||
23170385|NCT00105443|64370769|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
23170386|NCT00105443|64370770|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
23170387|NCT00105443|64370771|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
23170388|NCT00105443|64370772|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
23170389|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
23170390|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
23170391|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
23170392|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
23449411|NCT00479336|65388028|FG003|Overall Study|Adverse Event|3|||
23449412|NCT00479336|65388025|FG000|Overall Study|Lack of Efficacy|1|||
23170393|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
23170394|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
23337148|NCT01344824|64976290|FG000|Overall Study|Withdrawal by Subject|6|||
23337149|NCT01344824|64976290|FG000|Overall Study|Other complicating disease|1|||
23337150|NCT01344824|64976290|FG000|Overall Study|Progression|15|||
23449413|NCT00479336|65388026|FG001|Overall Study|Lack of Efficacy|0|||
23449414|NCT00479336|65388027|FG002|Overall Study|Lack of Efficacy|0|||
23449415|NCT00479336|65388028|FG003|Overall Study|Lack of Efficacy|0|||
23449416|NCT00479336|65388025|FG000|Overall Study|Protocol Violation|0|||
23449417|NCT00479336|65388026|FG001|Overall Study|Protocol Violation|1|||
23449418|NCT00479336|65388027|FG002|Overall Study|Protocol Violation|0|||
23449419|NCT00479336|65388028|FG003|Overall Study|Protocol Violation|0|||
23449420|NCT00479336|65388025|FG000|Overall Study|Withdrawal by Subject|1|||
23449421|NCT00479336|65388026|FG001|Overall Study|Withdrawal by Subject|2|||
23449422|NCT00479336|65388027|FG002|Overall Study|Withdrawal by Subject|0|||
23449423|NCT00479336|65388028|FG003|Overall Study|Withdrawal by Subject|0|||
23449424|NCT00479336|65388025|FG000|Overall Study|Physician Decision|0|||
23449425|NCT00479336|65388026|FG001|Overall Study|Physician Decision|1|||
23449426|NCT00479336|65388027|FG002|Overall Study|Physician Decision|0|||
23449427|NCT00479336|65388028|FG003|Overall Study|Physician Decision|2|||
23449428|NCT00479336|65388025|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
23449429|NCT00479336|65388026|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
23449430|NCT00479336|65388027|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
23449431|NCT00479336|65388028|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
23449432|NCT01458639|65388036|FG000|Overall Study|Physician Decision|4|||
23449433|NCT01458639|65388036|FG000|Overall Study|Equipment issue|1|||
23449434|NCT01458639|65388036|FG000|Overall Study|Inability to obtain subject blood sample|1|||
23449435|NCT02679755|65388039|FG000|Overall Study|Death|0|||
23449436|NCT02679755|65388040|FG001|Overall Study|Death|3|||
23449437|NCT02679755|65388039|FG000|Overall Study|Global deterioration of health status|1|||
23449438|NCT02679755|65388040|FG001|Overall Study|Global deterioration of health status|8|||
23449439|NCT02679755|65388039|FG000|Overall Study|Lost to Follow-up|1|||
23449440|NCT02679755|65388040|FG001|Overall Study|Lost to Follow-up|0|||
23449441|NCT02679755|65388039|FG000|Overall Study|Objective progression or relapse|24|||
23449442|NCT02679755|65388040|FG001|Overall Study|Objective progression or relapse|83|||
23449443|NCT02679755|65388039|FG000|Overall Study|Not defined|0|||
23449444|NCT02679755|65388040|FG001|Overall Study|Not defined|2|||
23449445|NCT02679755|65388039|FG000|Overall Study|Withdrawal by participant|6|||
23449446|NCT02679755|65388040|FG001|Overall Study|Withdrawal by participant|3|||
23449447|NCT02679755|65388039|FG000|Overall Study|Adverse Event|1|||
23449448|NCT02679755|65388040|FG001|Overall Study|Adverse Event|4|||
23449449|NCT02679755|65388039|FG000|Overall Study|Adverse events not related to study drug|1|||
23449450|NCT02679755|65388040|FG001|Overall Study|Adverse events not related to study drug|2|||
23449451|NCT00796666|65388041|FG000|Overall Study|Death|2|||
23449452|NCT00796666|65388042|FG001|Overall Study|Death|4|||
23449453|NCT00796666|65388041|FG000|Overall Study|Withdrawal by Subject|2|||
23449454|NCT00796666|65388042|FG001|Overall Study|Withdrawal by Subject|0|||
23449455|NCT00796666|65388041|FG000|Overall Study|Adverse Event|7|||
23449456|NCT00796666|65388042|FG001|Overall Study|Adverse Event|5|||
23449457|NCT00796666|65388041|FG000|Overall Study|Protocol Violation|1|||
23449458|NCT00796666|65388042|FG001|Overall Study|Protocol Violation|0|||
23449459|NCT00796666|65388041|FG000|Overall Study|Other|1|||
23449460|NCT00796666|65388042|FG001|Overall Study|Other|0|||
23449461|NCT00796666|65388041|FG000|Overall Study|Terminated by sponsor|53|||
23449462|NCT00796666|65388042|FG001|Overall Study|Terminated by sponsor|55|||
23449463|NCT00796666|65388041|FG000|Overall Study|Randomized and not treated|1|||
23449464|NCT00796666|65388042|FG001|Overall Study|Randomized and not treated|0|||
23449465|NCT00961181|65388045|FG000|Overall Study|Death|2|||
23449466|NCT00961181|65388045|FG000|Overall Study|Withdrawal by Subject|2|||
23449467|NCT00961181|65388045|FG000|Overall Study|Lost to Follow-up|1|||
23449468|NCT00985465|65388046|FG000|Overall Study|Withdrawal by Subject|1|||
23449469|NCT00985465|65388047|FG001|Overall Study|Withdrawal by Subject|2|||
23449470|NCT00985465|65388046|FG000|Overall Study|Considered to be part of the other group|0|||
23449471|NCT00985465|65388047|FG001|Overall Study|Considered to be part of the other group|1|||
23449472|NCT03058692|65388048|FG000|Overall Study|Lost to Follow-up|2|||
23449473|NCT03058692|65388049|FG001|Overall Study|Lost to Follow-up|1|||
23449474|NCT03058692|65388048|FG000|Overall Study|Withdrawal by Subject|1|||
23337151|NCT00610155|64976291|FG000|Period 1|Withdrawal by Subject|0|||
23449475|NCT03058692|65388049|FG001|Overall Study|Withdrawal by Subject|1|||
23449476|NCT02090426|65388050|FG000|Overall Study|Lost to Follow-up|12|||
23449477|NCT02090426|65388051|FG001|Overall Study|Lost to Follow-up|6|||
23449478|NCT00922623|65388052|FG000|Overall Study|Other|4|||
23449479|NCT00922623|65388052|FG000|Overall Study|Lost to Follow-up|1|||
23449480|NCT00948064|65388053|FG000|Phase I|No treatment received|1|||
23449481|NCT00948064|65388054|FG001|Phase I|No treatment received|0|||
23449482|NCT00948064|65388055|FG002|Phase I|No treatment received|0|||
23449483|NCT00948064|65388053|FG000|Phase II|Physician Decision|0|||
23449484|NCT00948064|65388054|FG001|Phase II|Physician Decision|0|||
23449485|NCT00948064|65388055|FG002|Phase II|Physician Decision|1|||
23449486|NCT00948064|65388053|FG000|Phase II|Withdrawal by Subject|0|||
23449487|NCT00948064|65388054|FG001|Phase II|Withdrawal by Subject|1|||
23449488|NCT00948064|65388055|FG002|Phase II|Withdrawal by Subject|0|||
23576878|NCT00946647|65843496|FG004|Phase 1 Part|Adverse Event|0|||
23576879|NCT00946647|65843492|FG000|Phase 1 Part|Disease progression|3|||
23449489|NCT02469623|65388057|FG000|Overall Study|Not consented for long-term follow-up|4|||
23449490|NCT02469623|65388057|FG000|Overall Study|Lost to Follow-up|4|||
23449491|NCT02469623|65388057|FG000|Overall Study|Withdrawal by Subject|2|||
23449492|NCT02469623|65388057|FG000|Overall Study|Death|3|||
23449493|NCT04390243|65388058|FG000|Overall Study|Death|1|||
23449494|NCT04390243|65388058|FG000|Overall Study|Disease Progression|4|||
23449495|NCT04390243|65388058|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
23449496|NCT00556998|65388059|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
23449497|NCT00556998|65388059|FG000|Voriconazole Intravenous (IV)|Other|4|||
23449498|NCT00556998|65388059|FG000|Voriconazole Oral|Adverse Event|1|||
23449499|NCT00556998|65388059|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
23449500|NCT02936635|65388062|FG000|Overall Study|Adverse Event|43|||
23449501|NCT02936635|65388063|FG001|Overall Study|Adverse Event|25|||
23449502|NCT02936635|65388062|FG000|Overall Study|Progressive Disease|10|||
23449503|NCT02936635|65388063|FG001|Overall Study|Progressive Disease|18|||
23449504|NCT02936635|65388062|FG000|Overall Study|Sponsor Discretion|10|||
23449505|NCT02936635|65388063|FG001|Overall Study|Sponsor Discretion|16|||
23449506|NCT02936635|65388062|FG000|Overall Study|Death|9|||
23449507|NCT02936635|65388063|FG001|Overall Study|Death|15|||
23449508|NCT02936635|65388062|FG000|Overall Study|Withdrawal by Subject|8|||
23449509|NCT02936635|65388063|FG001|Overall Study|Withdrawal by Subject|15|||
23449510|NCT02936635|65388062|FG000|Overall Study|Physician Decision|2|||
23449511|NCT02936635|65388063|FG001|Overall Study|Physician Decision|9|||
23449512|NCT02936635|65388062|FG000|Overall Study|Lost to Follow-up|1|||
23449513|NCT02936635|65388063|FG001|Overall Study|Lost to Follow-up|2|||
23449514|NCT02936635|65388062|FG000|Overall Study|Protocol Violation|1|||
23449515|NCT02936635|65388063|FG001|Overall Study|Protocol Violation|0|||
23449516|NCT02936635|65388062|FG000|Overall Study|Lack of effect/Entry into other study|31|||
23449517|NCT02936635|65388063|FG001|Overall Study|Lack of effect/Entry into other study|65|||
23449518|NCT01618669|65388067|FG000|Overall Study|Lost to Follow-up|1|||
23449519|NCT01618669|65388068|FG001|Overall Study|Lost to Follow-up|1|||
23170395|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
23337152|NCT00610155|64976292|FG001|Period 1|Withdrawal by Subject|0|||
23337153|NCT00610155|64976293|FG002|Period 1|Withdrawal by Subject|1|||
23337154|NCT00610155|64976294|FG003|Period 1|Withdrawal by Subject|0|||
23337155|NCT00610155|64976295|FG004|Period 1|Withdrawal by Subject|0|||
23337156|NCT00610155|64976296|FG005|Period 1|Withdrawal by Subject|0|||
23337157|NCT00610155|64976291|FG000|Period 3|Adverse Event|1|||
23337158|NCT00610155|64976292|FG001|Period 3|Adverse Event|0|||
23337159|NCT00610155|64976293|FG002|Period 3|Adverse Event|0|||
23337160|NCT00610155|64976294|FG003|Period 3|Adverse Event|0|||
23337161|NCT00610155|64976295|FG004|Period 3|Adverse Event|0|||
23337162|NCT00610155|64976296|FG005|Period 3|Adverse Event|0|||
23337163|NCT03063086|64976301|FG000|Overall Study|technical problems|1|||
23337164|NCT03063086|64976302|FG001|Overall Study|technical problems|0|||
23337165|NCT03063086|64976303|FG002|Overall Study|technical problems|0|||
23337166|NCT03063086|64976304|FG003|Overall Study|technical problems|0|||
23337167|NCT03063086|64976305|FG004|Overall Study|technical problems|0|||
23337168|NCT03063086|64976306|FG005|Overall Study|technical problems|0|||
23337169|NCT03063086|64976301|FG000|Overall Study|Adverse Event|1|||
23337170|NCT03063086|64976302|FG001|Overall Study|Adverse Event|1|||
23337171|NCT03063086|64976303|FG002|Overall Study|Adverse Event|1|||
23337172|NCT03063086|64976304|FG003|Overall Study|Adverse Event|1|||
23170396|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
23337173|NCT03063086|64976305|FG004|Overall Study|Adverse Event|0|||
23337174|NCT03063086|64976306|FG005|Overall Study|Adverse Event|0|||
23170397|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
23170398|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
23170399|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
23170400|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
23170401|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
23170402|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
23170403|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
23337175|NCT03063086|64976301|FG000|Overall Study|subject/guardian decision|1|||
23449520|NCT01618669|65388067|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
23449521|NCT01618669|65388068|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
23449522|NCT01618669|65388067|FG000|Overall Study|Adverse Event|16|||
23449523|NCT01618669|65388068|FG001|Overall Study|Adverse Event|7|||
23449524|NCT01618669|65388067|FG000|Overall Study|Protocol Violation|5|||
23449525|NCT01618669|65388068|FG001|Overall Study|Protocol Violation|3|||
23449526|NCT01618669|65388067|FG000|Overall Study|Withdrawal by Subject|9|||
23337176|NCT03063086|64976302|FG001|Overall Study|subject/guardian decision|0|||
23337177|NCT03063086|64976303|FG002|Overall Study|subject/guardian decision|0|||
23337178|NCT03063086|64976304|FG003|Overall Study|subject/guardian decision|0|||
23337179|NCT03063086|64976305|FG004|Overall Study|subject/guardian decision|0|||
23337180|NCT03063086|64976306|FG005|Overall Study|subject/guardian decision|0|||
23449527|NCT01618669|65388068|FG001|Overall Study|Withdrawal by Subject|9|||
23449528|NCT01618669|65388067|FG000|Overall Study|Miscellaneous Reason|0|||
23449529|NCT01618669|65388068|FG001|Overall Study|Miscellaneous Reason|1|||
23449530|NCT00474955|65388069|FG000|Overall Study|Adverse Event|2|||
23449531|NCT00474955|65388069|FG000|Overall Study|Drug unavailability|1|||
23449532|NCT00474955|65388069|FG000|Overall Study|Personal reasons|5|||
23449533|NCT01290523|65388070|FG000|Overall Study|Death|3|||
23449534|NCT01156480|65388071|FG000|Overall Study|change in diagnosis|0|||
23170404|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
23170405|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
23170406|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
23170407|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
23170408|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
23170409|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
23170410|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
23170411|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
23170412|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
23170413|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
23170414|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
23170415|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
23170416|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
23170417|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
23170418|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
23170419|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
23170420|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
23170421|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
23170422|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
23228619|NCT00424099|64581072|FG001|Overall Study|Adverse Event|1|||
23449535|NCT01156480|65388072|FG001|Overall Study|change in diagnosis|1|||
23449536|NCT03642873|65388073|FG000|Third Intervention (1 Day)|Screen failure|0|||
23449537|NCT03642873|65388074|FG001|Third Intervention (1 Day)|Screen failure|0|||
23449538|NCT03642873|65388075|FG002|Third Intervention (1 Day)|Screen failure|0|||
23449539|NCT03642873|65388076|FG003|Third Intervention (1 Day)|Screen failure|0|||
23449540|NCT03642873|65388077|FG004|Third Intervention (1 Day)|Screen failure|1|||
23449541|NCT03642873|65388078|FG005|Third Intervention (1 Day)|Screen failure|0|||
23228620|NCT00424099|64581073|FG002|Overall Study|Adverse Event|1|||
23228621|NCT00424099|64581074|FG003|Overall Study|Adverse Event|0|||
23228622|NCT00424099|64581071|FG000|Overall Study|Death|0|||
23228623|NCT00424099|64581072|FG001|Overall Study|Death|1|||
23228624|NCT00424099|64581073|FG002|Overall Study|Death|0|||
23228625|NCT00424099|64581074|FG003|Overall Study|Death|0|||
23228626|NCT00424099|64581071|FG000|Overall Study|Illness|2|||
23337181|NCT03063086|64976301|FG000|Overall Study|Non-compliance with study treatment|0|||
23337182|NCT03063086|64976302|FG001|Overall Study|Non-compliance with study treatment|0|||
23337183|NCT03063086|64976303|FG002|Overall Study|Non-compliance with study treatment|0|||
23449542|NCT02510001|65388085|FG000|Overall Study|Early disease progression|0|||
23337184|NCT03063086|64976304|FG003|Overall Study|Non-compliance with study treatment|1|||
23449543|NCT02510001|65388086|FG001|Overall Study|Early disease progression|0|||
23449544|NCT02510001|65388087|FG002|Overall Study|Early disease progression|0|||
23449545|NCT02510001|65388088|FG003|Overall Study|Early disease progression|1|||
23449546|NCT02510001|65388089|FG004|Overall Study|Early disease progression|1|||
23576880|NCT00946647|65843493|FG001|Phase 1 Part|Disease progression|6|||
23576881|NCT00946647|65843494|FG002|Phase 1 Part|Disease progression|1|||
23337185|NCT03063086|64976305|FG004|Overall Study|Non-compliance with study treatment|0|||
23337186|NCT03063086|64976306|FG005|Overall Study|Non-compliance with study treatment|1|||
23337187|NCT03063086|64976301|FG000|Overall Study|Physician Decision|0|||
23337188|NCT03063086|64976302|FG001|Overall Study|Physician Decision|0|||
23449547|NCT02510001|65388090|FG005|Overall Study|Early disease progression|1|||
23449548|NCT02510001|65388091|FG006|Overall Study|Early disease progression|0|||
23449549|NCT02510001|65388092|FG007|Overall Study|Early disease progression|0|||
23449550|NCT02510001|65388085|FG000|Overall Study|Adverse Event|0|||
23449551|NCT02510001|65388086|FG001|Overall Study|Adverse Event|0|||
23449552|NCT02510001|65388087|FG002|Overall Study|Adverse Event|0|||
23449553|NCT02510001|65388088|FG003|Overall Study|Adverse Event|1|||
23576882|NCT00946647|65843495|FG003|Phase 1 Part|Disease progression|0|||
23576883|NCT00946647|65843496|FG004|Phase 1 Part|Disease progression|0|||
23576884|NCT00946647|65843492|FG000|Phase 1 Part|Withdrawal by Subject|1|||
23576885|NCT00946647|65843493|FG001|Phase 1 Part|Withdrawal by Subject|4|||
23576886|NCT00946647|65843494|FG002|Phase 1 Part|Withdrawal by Subject|3|||
23576887|NCT00946647|65843495|FG003|Phase 1 Part|Withdrawal by Subject|0|||
23228627|NCT00424099|64581072|FG001|Overall Study|Illness|0|||
23576888|NCT00946647|65843496|FG004|Phase 1 Part|Withdrawal by Subject|0|||
23576889|NCT00946647|65843492|FG000|Phase 1 Part|Abnormal values|0|||
23449554|NCT02510001|65388089|FG004|Overall Study|Adverse Event|2|||
23449555|NCT02510001|65388090|FG005|Overall Study|Adverse Event|1|||
23449556|NCT02510001|65388091|FG006|Overall Study|Adverse Event|2|||
23449557|NCT02510001|65388092|FG007|Overall Study|Adverse Event|5|||
23449558|NCT02510001|65388085|FG000|Overall Study|Physician Decision|0|||
23449559|NCT02510001|65388086|FG001|Overall Study|Physician Decision|0|||
23449560|NCT02510001|65388087|FG002|Overall Study|Physician Decision|0|||
23228628|NCT00424099|64581073|FG002|Overall Study|Illness|1|||
23228629|NCT00424099|64581074|FG003|Overall Study|Illness|4|||
23228630|NCT00424099|64581071|FG000|Overall Study|Lost to Follow-up|0|||
23337189|NCT03063086|64976303|FG002|Overall Study|Physician Decision|0|||
23337190|NCT03063086|64976304|FG003|Overall Study|Physician Decision|1|||
23337191|NCT03063086|64976305|FG004|Overall Study|Physician Decision|0|||
23337192|NCT03063086|64976306|FG005|Overall Study|Physician Decision|0|||
23337193|NCT00090493|64978923|FG000|Overall Study|Physician Decision|2|||
23337194|NCT02438826|64978924|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
23337195|NCT02438826|64978925|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
23337196|NCT02438826|64978926|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
23228631|NCT00424099|64581072|FG001|Overall Study|Lost to Follow-up|0|||
23228632|NCT00424099|64581073|FG002|Overall Study|Lost to Follow-up|3|||
23228633|NCT00424099|64581074|FG003|Overall Study|Lost to Follow-up|0|||
23228634|NCT00424099|64581071|FG000|Overall Study|Hospitalized|1|||
23228635|NCT00424099|64581072|FG001|Overall Study|Hospitalized|2|||
23228636|NCT00424099|64581073|FG002|Overall Study|Hospitalized|1|||
23228637|NCT00424099|64581074|FG003|Overall Study|Hospitalized|3|||
23228638|NCT00424099|64581071|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
23337197|NCT02438826|64978927|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23337198|NCT02438826|64978924|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
23337199|NCT02438826|64978925|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23337200|NCT02438826|64978926|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23337201|NCT02438826|64978927|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
23337202|NCT02438826|64978924|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
23337203|NCT02438826|64978925|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
23337204|NCT02438826|64978926|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23337205|NCT02438826|64978927|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
23337206|NCT02438826|64978924|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
23337207|NCT02438826|64978925|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
23337208|NCT02438826|64978926|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
23337209|NCT02438826|64978927|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
23337210|NCT02438826|64978924|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
23337211|NCT02438826|64978925|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
23337212|NCT02438826|64978926|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
23228639|NCT00424099|64581072|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
23228640|NCT00424099|64581073|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
23228641|NCT00424099|64581074|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
23228642|NCT00424099|64581071|FG000|Overall Study|Withdrawal by Subject|1|||
23228643|NCT00424099|64581072|FG001|Overall Study|Withdrawal by Subject|9|||
23228644|NCT00424099|64581073|FG002|Overall Study|Withdrawal by Subject|4|||
23228645|NCT00424099|64581074|FG003|Overall Study|Withdrawal by Subject|6|||
23228646|NCT00424099|64581071|FG000|Overall Study|Physician Decision|0|||
23228647|NCT00424099|64581072|FG001|Overall Study|Physician Decision|0|||
23228648|NCT00424099|64581073|FG002|Overall Study|Physician Decision|1|||
23228649|NCT00424099|64581074|FG003|Overall Study|Physician Decision|0|||
23228650|NCT00424099|64581071|FG000|Overall Study|Missing|0|||
23228651|NCT00424099|64581072|FG001|Overall Study|Missing|0|||
23228652|NCT00424099|64581073|FG002|Overall Study|Missing|1|||
23228653|NCT00424099|64581074|FG003|Overall Study|Missing|0|||
23228654|NCT04043416|64581077|FG000|Washout|Change in health condition|0|||
23228655|NCT04043416|64581078|FG001|Washout|Change in health condition|1|||
23337213|NCT02438826|64978927|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
23449561|NCT02510001|65388088|FG003|Overall Study|Physician Decision|0|||
23228656|NCT04474366|64581086|FG000|Overall Study|Lost to Follow-up|2|||
23228657|NCT04474366|64581087|FG001|Overall Study|Lost to Follow-up|5|||
23337214|NCT02438826|64978924|FG000|Open-Label Treatment Phase|Adverse Event|11|||
23337215|NCT02438826|64978925|FG001|Open-Label Treatment Phase|Adverse Event|6|||
23449562|NCT02510001|65388089|FG004|Overall Study|Physician Decision|1|||
23449563|NCT02510001|65388090|FG005|Overall Study|Physician Decision|0|||
23449564|NCT02510001|65388091|FG006|Overall Study|Physician Decision|0|||
23449565|NCT02510001|65388092|FG007|Overall Study|Physician Decision|0|||
23449566|NCT02510001|65388085|FG000|Overall Study|Withdrawal by Subject|0|||
23449567|NCT02510001|65388086|FG001|Overall Study|Withdrawal by Subject|0|||
23228658|NCT00606931|64581096|FG000|Overall Study|Withdrawal by Subject|3|||
23228659|NCT02060903|64581097|FG000|Overall Study|Lost to Follow-up|4|||
23228660|NCT02060903|64581098|FG001|Overall Study|Lost to Follow-up|0|||
23228661|NCT02060903|64581097|FG000|Overall Study|Withdrawal by Subject|0|||
23228662|NCT02060903|64581098|FG001|Overall Study|Withdrawal by Subject|7|||
23337216|NCT02438826|64978926|FG002|Open-Label Treatment Phase|Adverse Event|0|||
23337217|NCT02438826|64978927|FG003|Open-Label Treatment Phase|Adverse Event|0|||
23337218|NCT02438826|64978924|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
23337219|NCT02438826|64978925|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
23337220|NCT02438826|64978926|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
23337221|NCT02438826|64978927|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
23337222|NCT02438826|64978924|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
23337223|NCT02438826|64978925|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
23337224|NCT02438826|64978926|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
23337225|NCT02438826|64978927|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
23337226|NCT02438826|64978924|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
23337227|NCT02438826|64978925|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
23337228|NCT02438826|64978926|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
23337229|NCT02438826|64978927|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
23337230|NCT02438826|64978924|FG000|Post-Treatment Phase|Adverse Event|3|||
23337231|NCT02438826|64978925|FG001|Post-Treatment Phase|Adverse Event|0|||
23337232|NCT02438826|64978926|FG002|Post-Treatment Phase|Adverse Event|0|||
23337233|NCT02438826|64978927|FG003|Post-Treatment Phase|Adverse Event|0|||
23337234|NCT02438826|64978924|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
23337235|NCT02438826|64978925|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
23337236|NCT02438826|64978926|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
23337237|NCT02438826|64978927|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
23337238|NCT02438826|64978924|FG000|Post-Treatment Phase|Physician Decision|1|||
23337239|NCT02438826|64978925|FG001|Post-Treatment Phase|Physician Decision|0|||
23337240|NCT02438826|64978926|FG002|Post-Treatment Phase|Physician Decision|0|||
23337241|NCT02438826|64978927|FG003|Post-Treatment Phase|Physician Decision|0|||
23337242|NCT02438826|64978924|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
23337243|NCT02438826|64978925|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
23337244|NCT02438826|64978926|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
23337245|NCT02438826|64978927|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
23337246|NCT05140382|64978928|FG000|Overall Study|Death|3|||
23337247|NCT05140382|64978929|FG001|Overall Study|Death|0|||
23337248|NCT05140382|64978930|FG002|Overall Study|Death|0|||
23337249|NCT05140382|64978928|FG000|Overall Study|Investigator decision|1|||
23576890|NCT00946647|65843493|FG001|Phase 1 Part|Abnormal values|2|||
23576891|NCT00946647|65843494|FG002|Phase 1 Part|Abnormal values|0|||
23576892|NCT00946647|65843495|FG003|Phase 1 Part|Abnormal values|0|||
23576893|NCT00946647|65843496|FG004|Phase 1 Part|Abnormal values|0|||
23576894|NCT00946647|65843492|FG000|Phase 1 Part|Reason missing|0|||
23576895|NCT00946647|65843493|FG001|Phase 1 Part|Reason missing|1|||
23576896|NCT00946647|65843494|FG002|Phase 1 Part|Reason missing|0|||
23576897|NCT00946647|65843495|FG003|Phase 1 Part|Reason missing|0|||
23228663|NCT01512693|64581102|FG000|Overall Study|Withdrawal by Subject|0|||
23228664|NCT01512693|64581103|FG001|Overall Study|Withdrawal by Subject|1|||
23228665|NCT02828644|64581104|FG000|Overall Study|Lost to Follow-up|23|||
23228666|NCT02828644|64581105|FG001|Overall Study|Lost to Follow-up|22|||
23228667|NCT00033293|64581109|FG000|Overall Study|Death|0|||
23228668|NCT00033293|64581110|FG001|Overall Study|Death|1|||
23228669|NCT00033293|64581109|FG000|Overall Study|Lack of Efficacy|5|||
23228670|NCT00033293|64581110|FG001|Overall Study|Lack of Efficacy|8|||
23228671|NCT00033293|64581109|FG000|Overall Study|Lost to Follow-up|0|||
23228672|NCT00033293|64581110|FG001|Overall Study|Lost to Follow-up|1|||
23228673|NCT00033293|64581109|FG000|Overall Study|Physician Decision|3|||
23228674|NCT00033293|64581110|FG001|Overall Study|Physician Decision|1|||
23228675|NCT00033293|64581109|FG000|Overall Study|Withdrawal by Subject|1|||
23228676|NCT00033293|64581110|FG001|Overall Study|Withdrawal by Subject|0|||
23228677|NCT00033293|64581109|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
23228678|NCT00033293|64581110|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
23337250|NCT05140382|64978929|FG001|Overall Study|Investigator decision|0|||
23337251|NCT05140382|64978930|FG002|Overall Study|Investigator decision|0|||
23337252|NCT05140382|64978928|FG000|Overall Study|Other|4|||
23337253|NCT05140382|64978929|FG001|Overall Study|Other|0|||
23337254|NCT05140382|64978930|FG002|Overall Study|Other|1|||
23337255|NCT05140382|64978928|FG000|Overall Study|Progressive disease|20|||
23337256|NCT05140382|64978929|FG001|Overall Study|Progressive disease|1|||
23337257|NCT05140382|64978930|FG002|Overall Study|Progressive disease|12|||
23337258|NCT05140382|64978928|FG000|Overall Study|Subjective disease progression|2|||
23576898|NCT00946647|65843496|FG004|Phase 1 Part|Reason missing|0|||
23337259|NCT05140382|64978929|FG001|Overall Study|Subjective disease progression|1|||
23576899|NCT00946647|65843492|FG000|Phase ll Part|Untreated|0|||
23228679|NCT00033293|64581109|FG000|Overall Study|Treatment refused|0|||
23228680|NCT00033293|64581110|FG001|Overall Study|Treatment refused|6|||
23228681|NCT03480841|64581111|FG000|Overall Study|Lost to Follow-up|2|||
23228682|NCT00550615|64581114|FG000|Overall Study|Withdrawal by Subject|0|||
23576900|NCT00946647|65843493|FG001|Phase ll Part|Untreated|0|||
23576901|NCT00946647|65843494|FG002|Phase ll Part|Untreated|0|||
23576902|NCT00946647|65843495|FG003|Phase ll Part|Untreated|0|||
23576903|NCT00946647|65843496|FG004|Phase ll Part|Untreated|2|||
23576904|NCT00946647|65843492|FG000|Phase ll Part|Adverse Event|0|||
23576905|NCT00946647|65843493|FG001|Phase ll Part|Adverse Event|0|||
23576906|NCT00946647|65843494|FG002|Phase ll Part|Adverse Event|0|||
23576907|NCT00946647|65843495|FG003|Phase ll Part|Adverse Event|10|||
23576908|NCT00946647|65843496|FG004|Phase ll Part|Adverse Event|6|||
23576909|NCT00946647|65843492|FG000|Phase ll Part|Withdrawal by Subject|0|||
23576910|NCT00946647|65843493|FG001|Phase ll Part|Withdrawal by Subject|0|||
23576911|NCT00946647|65843494|FG002|Phase ll Part|Withdrawal by Subject|0|||
23576912|NCT00946647|65843495|FG003|Phase ll Part|Withdrawal by Subject|8|||
23576913|NCT00946647|65843496|FG004|Phase ll Part|Withdrawal by Subject|6|||
23576914|NCT00946647|65843492|FG000|Phase ll Part|Administrative problems|0|||
23576915|NCT00946647|65843493|FG001|Phase ll Part|Administrative problems|0|||
23576916|NCT00946647|65843494|FG002|Phase ll Part|Administrative problems|0|||
23576917|NCT00946647|65843495|FG003|Phase ll Part|Administrative problems|3|||
23576918|NCT00946647|65843496|FG004|Phase ll Part|Administrative problems|8|||
23576919|NCT00946647|65843492|FG000|Phase ll Part|Death|0|||
23576920|NCT00946647|65843493|FG001|Phase ll Part|Death|0|||
23576921|NCT00946647|65843494|FG002|Phase ll Part|Death|0|||
23576922|NCT00946647|65843495|FG003|Phase ll Part|Death|7|||
23576923|NCT00946647|65843496|FG004|Phase ll Part|Death|4|||
23576924|NCT00946647|65843492|FG000|Phase ll Part|Disease progression|0|||
23576925|NCT00946647|65843493|FG001|Phase ll Part|Disease progression|0|||
23576926|NCT00946647|65843494|FG002|Phase ll Part|Disease progression|0|||
23576927|NCT00946647|65843495|FG003|Phase ll Part|Disease progression|6|||
23576928|NCT00946647|65843496|FG004|Phase ll Part|Disease progression|14|||
23228683|NCT00550615|64581115|FG001|Overall Study|Withdrawal by Subject|0|||
23228684|NCT00550615|64581116|FG002|Overall Study|Withdrawal by Subject|2|||
23228685|NCT00550615|64581117|FG003|Overall Study|Withdrawal by Subject|3|||
23228686|NCT00550615|64581114|FG000|Overall Study|Not evaluable|0|||
23228687|NCT00550615|64581115|FG001|Overall Study|Not evaluable|0|||
23228688|NCT00550615|64581116|FG002|Overall Study|Not evaluable|2|||
23228689|NCT00550615|64581117|FG003|Overall Study|Not evaluable|7|||
23228690|NCT01685060|64581124|FG000|Overall Study|Rollover patients|16|||
23228691|NCT01685060|64581124|FG000|Overall Study|Adverse Event|12|||
23228692|NCT01685060|64581124|FG000|Overall Study|Progressive disease|69|||
23228693|NCT01685060|64581124|FG000|Overall Study|Physician Decision|14|||
23228694|NCT01685060|64581124|FG000|Overall Study|Subject/guardian decision|20|||
23228695|NCT01685060|64581124|FG000|Overall Study|Lost to Follow-up|1|||
23228696|NCT01685060|64581124|FG000|Overall Study|Death|8|||
23228697|NCT02405091|64581125|FG000|Overall Study|Adverse Event|16|||
23228698|NCT02405091|64581126|FG001|Overall Study|Adverse Event|10|||
23228699|NCT02405091|64581127|FG002|Overall Study|Adverse Event|0|||
23228700|NCT02405091|64581125|FG000|Overall Study|Protocol Violation|1|||
23228701|NCT02405091|64581126|FG001|Overall Study|Protocol Violation|0|||
23228702|NCT02405091|64581127|FG002|Overall Study|Protocol Violation|0|||
23228703|NCT02405091|64581125|FG000|Overall Study|Noncompliance|1|||
23228704|NCT02405091|64581126|FG001|Overall Study|Noncompliance|6|||
23228705|NCT02405091|64581127|FG002|Overall Study|Noncompliance|2|||
23228706|NCT02405091|64581125|FG000|Overall Study|Withdrawal by Subject|4|||
23228707|NCT02405091|64581126|FG001|Overall Study|Withdrawal by Subject|8|||
23228708|NCT02405091|64581127|FG002|Overall Study|Withdrawal by Subject|0|||
23228709|NCT02405091|64581125|FG000|Overall Study|Death|0|||
23228710|NCT02405091|64581126|FG001|Overall Study|Death|1|||
23228711|NCT02405091|64581127|FG002|Overall Study|Death|0|||
23228712|NCT02405091|64581125|FG000|Overall Study|Lost to Follow-up|5|||
23228713|NCT02405091|64581126|FG001|Overall Study|Lost to Follow-up|6|||
23228714|NCT02405091|64581127|FG002|Overall Study|Lost to Follow-up|0|||
23228715|NCT02405091|64581125|FG000|Overall Study|Physician Decision|2|||
23228716|NCT02405091|64581126|FG001|Overall Study|Physician Decision|2|||
23228717|NCT02405091|64581127|FG002|Overall Study|Physician Decision|0|||
23228718|NCT00736450|64581137|FG000|Overall Study|Not ABC gene eligible|19|||
23228719|NCT00736450|64581137|FG000|Overall Study|Withdrawal by Subject|5|||
23228720|NCT00736450|64581137|FG000|Overall Study|Physician Decision|1|||
23228721|NCT03322540|64581138|FG000|Overall Study|Death|21|||
23228722|NCT03322540|64581139|FG001|Overall Study|Death|28|||
23228723|NCT03322540|64581138|FG000|Overall Study|Lost to Follow-up|0|||
23228724|NCT03322540|64581139|FG001|Overall Study|Lost to Follow-up|1|||
23228725|NCT03322540|64581138|FG000|Overall Study|Physician Decision|7|||
23228726|NCT03322540|64581139|FG001|Overall Study|Physician Decision|6|||
23228727|NCT03322540|64581138|FG000|Overall Study|Withdrawal by Subject|3|||
23228728|NCT03322540|64581139|FG001|Overall Study|Withdrawal by Subject|1|||
23228729|NCT03322540|64581138|FG000|Overall Study|Study terminated by sponsor|0|||
23228730|NCT03322540|64581139|FG001|Overall Study|Study terminated by sponsor|1|||
23228731|NCT00631969|64581140|FG000|Overall Study|Adverse Event|3|||
23576929|NCT00946647|65843492|FG000|Phase ll Part|Protocol Violation|0|||
23576930|NCT00946647|65843493|FG001|Phase ll Part|Protocol Violation|0|||
23576931|NCT00946647|65843494|FG002|Phase ll Part|Protocol Violation|0|||
23576932|NCT00946647|65843495|FG003|Phase ll Part|Protocol Violation|4|||
23576933|NCT00946647|65843496|FG004|Phase ll Part|Protocol Violation|2|||
23449568|NCT02510001|65388087|FG002|Overall Study|Withdrawal by Subject|0|||
23449569|NCT02510001|65388088|FG003|Overall Study|Withdrawal by Subject|0|||
23576934|NCT00946647|65843492|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
23576935|NCT00946647|65843493|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
23576936|NCT00946647|65843494|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
23576937|NCT00946647|65843495|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
23576938|NCT00946647|65843496|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
23576939|NCT03633903|65843499|FG000|Overall Study|Withdrawal by Subject|1|||
23576940|NCT03633903|65843500|FG001|Overall Study|Withdrawal by Subject|2|||
23576941|NCT03633903|65843499|FG000|Overall Study|Lost to Follow-up|5|||
23576942|NCT03633903|65843500|FG001|Overall Study|Lost to Follow-up|5|||
23576943|NCT02478359|65843501|FG000|Overall Study|Disenrolled from health plan|106|||
23576944|NCT02478359|65843502|FG001|Overall Study|Disenrolled from health plan|65|||
23576945|NCT03660943|65843522|FG000|Overall Study|Adverse Event|5|||
23576946|NCT03660943|65843523|FG001|Overall Study|Adverse Event|3|||
23576947|NCT03660943|65843522|FG000|Overall Study|Death|0|||
23576948|NCT03660943|65843523|FG001|Overall Study|Death|2|||
23576949|NCT03660943|65843522|FG000|Overall Study|Lost to Follow-up|7|||
23576950|NCT03660943|65843523|FG001|Overall Study|Lost to Follow-up|3|||
23576951|NCT03660943|65843522|FG000|Overall Study|Protocol Violation|3|||
23576952|NCT03660943|65843523|FG001|Overall Study|Protocol Violation|5|||
23576953|NCT03660943|65843522|FG000|Overall Study|Withdrawal by Subject|8|||
23576954|NCT03660943|65843523|FG001|Overall Study|Withdrawal by Subject|15|||
23576955|NCT03660943|65843522|FG000|Overall Study|Lack of Efficacy|9|||
23576956|NCT03660943|65843523|FG001|Overall Study|Lack of Efficacy|12|||
23576957|NCT03660943|65843522|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
23576958|NCT03660943|65843523|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
23576959|NCT01871285|65843531|FG000|First Intervention (1 Day)|Adverse Event|1|||
23576960|NCT01871285|65843532|FG001|First Intervention (1 Day)|Adverse Event|0|||
23576961|NCT01871285|65843533|FG002|First Intervention (1 Day)|Adverse Event|0|||
23576962|NCT01871285|65843534|FG003|First Intervention (1 Day)|Adverse Event|0|||
23576963|NCT01871285|65843531|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
23576964|NCT01871285|65843532|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
23576965|NCT01871285|65843533|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
23576966|NCT01871285|65843534|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
23576967|NCT02391038|65843539|FG000|Overall Study|Progressive disease|3|||
23576968|NCT02391038|65843540|FG001|Overall Study|Progressive disease|3|||
23576969|NCT02391038|65843541|FG002|Overall Study|Progressive disease|6|||
23576970|NCT01115998|65843543|FG000|Overall Study|Lost to Follow-up|6|||
23576971|NCT01115998|65843544|FG001|Overall Study|Lost to Follow-up|6|||
23576972|NCT03704298|65843545|FG000|Overall Study|Death|3|||
23576973|NCT03704298|65843546|FG001|Overall Study|Death|1|||
23576974|NCT03704298|65843547|FG002|Overall Study|Death|1|||
23576975|NCT03704298|65843548|FG003|Overall Study|Death|0|||
23576976|NCT03704298|65843545|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
23576977|NCT03704298|65843546|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
23576978|NCT03704298|65843547|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
23576979|NCT03704298|65843548|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
23576980|NCT03704298|65843545|FG000|Overall Study|Withdrawal by Subject|1|||
23576981|NCT03704298|65843546|FG001|Overall Study|Withdrawal by Subject|0|||
23576982|NCT03704298|65843547|FG002|Overall Study|Withdrawal by Subject|0|||
23576983|NCT03704298|65843548|FG003|Overall Study|Withdrawal by Subject|0|||
23576984|NCT03704298|65843545|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
23576985|NCT03704298|65843546|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
23576986|NCT03704298|65843547|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
23576987|NCT03704298|65843548|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
23576988|NCT00593554|65843549|FG000|Overall Study|Death|1|||
23576989|NCT00593554|65843550|FG001|Overall Study|Death|2|||
23576990|NCT00593554|65843549|FG000|Overall Study|Physician Decision|0|||
23576991|NCT00593554|65843550|FG001|Overall Study|Physician Decision|1|||
23576992|NCT00593554|65843549|FG000|Overall Study|Withdrawal by Subject|1|||
23576993|NCT00593554|65843550|FG001|Overall Study|Withdrawal by Subject|0|||
23576994|NCT00593554|65843549|FG000|Overall Study|Disease Progression|1|||
23576995|NCT00593554|65843550|FG001|Overall Study|Disease Progression|2|||
23337260|NCT05140382|64978930|FG002|Overall Study|Subjective disease progression|0|||
23449570|NCT02510001|65388089|FG004|Overall Study|Withdrawal by Subject|0|||
23576996|NCT01256476|65843551|FG000|Overall Study|Adverse Event|2|||
23576997|NCT01256476|65843552|FG001|Overall Study|Adverse Event|1|||
23337261|NCT05140382|64978928|FG000|Overall Study|Unknown at data cut-off|0|||
23449571|NCT02510001|65388090|FG005|Overall Study|Withdrawal by Subject|0|||
23576998|NCT01256476|65843551|FG000|Overall Study|Withdrawal by Subject|2|||
23576999|NCT01256476|65843552|FG001|Overall Study|Withdrawal by Subject|1|||
23577000|NCT01256476|65843551|FG000|Overall Study|Lost to Follow-up|1|||
23577001|NCT01256476|65843552|FG001|Overall Study|Lost to Follow-up|2|||
23337262|NCT05140382|64978929|FG001|Overall Study|Unknown at data cut-off|0|||
23337263|NCT05140382|64978930|FG002|Overall Study|Unknown at data cut-off|1|||
23337264|NCT05140382|64978928|FG000|Overall Study|Withdrawal by Subject|1|||
23337265|NCT05140382|64978929|FG001|Overall Study|Withdrawal by Subject|0|||
23337266|NCT05140382|64978930|FG002|Overall Study|Withdrawal by Subject|4|||
23337267|NCT05140382|64978928|FG000|Overall Study|Withdrawal of consent|0|||
23337268|NCT05140382|64978929|FG001|Overall Study|Withdrawal of consent|0|||
23337269|NCT05140382|64978930|FG002|Overall Study|Withdrawal of consent|1|||
23337270|NCT01094301|64978931|FG000|Trial Stage|Withdrawal by Subject|1|||
23337271|NCT01094301|64978931|FG000|Implant Stage|Adverse Event|1|||
23337272|NCT01094301|64978931|FG000|Implant Stage|Protocol Violation|1|||
23337273|NCT01094301|64978931|FG000|Implant Stage|Withdrawal by Subject|2|||
23337274|NCT01094301|64978931|FG000|Implant Stage|No return of pain|4|||
23337275|NCT01683266|64978934|FG000|Overall Study|Adverse Event|5|||
23337276|NCT01683266|64978935|FG001|Overall Study|Adverse Event|4|||
23337277|NCT01683266|64978934|FG000|Overall Study|Lack of Efficacy|5|||
23337278|NCT01683266|64978935|FG001|Overall Study|Lack of Efficacy|2|||
23337279|NCT01683266|64978934|FG000|Overall Study|Protocol Violation|13|||
23337280|NCT01683266|64978935|FG001|Overall Study|Protocol Violation|6|||
23337281|NCT01683266|64978934|FG000|Overall Study|Personal Reason|17|||
23337282|NCT01683266|64978935|FG001|Overall Study|Personal Reason|25|||
23337283|NCT01683266|64978934|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
23337284|NCT01683266|64978935|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
23337285|NCT01683266|64978934|FG000|Overall Study|Lost to Follow-up|5|||
23337286|NCT01683266|64978935|FG001|Overall Study|Lost to Follow-up|0|||
23337287|NCT01683266|64978934|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
23337288|NCT01683266|64978935|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
23337289|NCT01683266|64978934|FG000|Overall Study|Nonserious Hypoglycemia|0|||
23337290|NCT01683266|64978935|FG001|Overall Study|Nonserious Hypoglycemia|3|||
23337291|NCT01683266|64978934|FG000|Overall Study|Perceived Lack of Efficacy|1|||
23337292|NCT01683266|64978935|FG001|Overall Study|Perceived Lack of Efficacy|1|||
23337293|NCT01683266|64978934|FG000|Overall Study|Possibly Hypoglycemia|1|||
23170423|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
23170424|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
23170425|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
23170426|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
23170427|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
23170428|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
23170429|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
23170430|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
23170431|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
23170432|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
23170433|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
23170434|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
23170435|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
23170436|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
23170437|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
23170438|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
23170439|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
23170440|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
23337294|NCT01683266|64978935|FG001|Overall Study|Possibly Hypoglycemia|0|||
23337295|NCT01683266|64978934|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
23337296|NCT01683266|64978935|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
23337297|NCT02981082|64978936|FG000|Overall Study|Withdrawal by Subject|2|||
23337298|NCT02981082|64978937|FG001|Overall Study|Withdrawal by Subject|0|||
23337299|NCT02981082|64978936|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
23337300|NCT02981082|64978937|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
23337301|NCT02981082|64978936|FG000|Overall Study|Adverse Event|0|||
23337302|NCT02981082|64978937|FG001|Overall Study|Adverse Event|1|||
23337303|NCT00089778|64978943|FG000|Overall Study|Protocol Violation|0|||
23337304|NCT00089778|64978944|FG001|Overall Study|Protocol Violation|0|||
23337305|NCT00089778|64978945|FG002|Overall Study|Protocol Violation|1|||
23337306|NCT01726270|64978946|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
23337307|NCT01726270|64978946|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
23337308|NCT01726270|64978946|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
23337309|NCT01726270|64978946|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
23337310|NCT01726270|64978946|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
23170441|NCT00105443|64370769|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
23170442|NCT00105443|64370770|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
23170443|NCT00105443|64370771|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
23170444|NCT00105443|64370772|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
23577002|NCT01256476|65843551|FG000|Overall Study|Persistent ALT or AST elevation|1|||
23577003|NCT01256476|65843552|FG001|Overall Study|Persistent ALT or AST elevation|0|||
23577004|NCT01256476|65843551|FG000|Overall Study|Physician Decision|0|||
23170448|NCT05779072|64370774|FG000|Overall Study|Lost to Follow-up|0|||
23170449|NCT05779072|64370775|FG001|Overall Study|Lost to Follow-up|1|||
23170450|NCT05779072|64370774|FG000|Overall Study|Withdrawal by Subject|1|||
23170451|NCT05779072|64370775|FG001|Overall Study|Withdrawal by Subject|5|||
23170452|NCT03273166|64370778|FG000|Overall Study|Withdrawn prior to Completion|31|||
23170453|NCT04142983|64370779|FG000|Overall Study|Lost to Follow-up|73|||
23170454|NCT04142983|64370779|FG000|Overall Study|Withdrawal by Subject|10|||
23170455|NCT04142983|64370779|FG000|Overall Study|Physician Decision|1|||
23170456|NCT04142983|64370779|FG000|Overall Study|Adverse Event|1|||
23170457|NCT04142983|64370779|FG000|Overall Study|No longer eligible|4|||
23170458|NCT04142983|64370779|FG000|Overall Study|Screen Failure|10|||
23170459|NCT03891901|64370782|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
23170460|NCT03891901|64370783|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23170461|NCT03891901|64370784|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23170462|NCT03891901|64370785|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23170463|NCT03891901|64370786|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23170464|NCT03891901|64370787|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23577005|NCT01256476|65843552|FG001|Overall Study|Physician Decision|1|||
23228732|NCT00631969|64581141|FG001|Overall Study|Adverse Event|1|||
23228733|NCT00631969|64581140|FG000|Overall Study|Lack of Efficacy|2|||
23228734|NCT00631969|64581141|FG001|Overall Study|Lack of Efficacy|8|||
23577006|NCT01256476|65843551|FG000|Overall Study|Subject non-compliance|0|||
23577007|NCT01256476|65843552|FG001|Overall Study|Subject non-compliance|1|||
23577008|NCT01256476|65843551|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
23577009|NCT01256476|65843552|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
23577010|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
23577011|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
23577012|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
23577013|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
23577014|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
23577015|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
23577016|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
23577017|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
23577018|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
23577019|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
23577020|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
23577021|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
23577022|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
23577023|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
23228735|NCT00631969|64581140|FG000|Overall Study|Lost to Follow-up|2|||
23228736|NCT00631969|64581141|FG001|Overall Study|Lost to Follow-up|1|||
23228737|NCT00631969|64581140|FG000|Overall Study|Protocol Violation|1|||
23228738|NCT00631969|64581141|FG001|Overall Study|Protocol Violation|1|||
23228739|NCT00631969|64581140|FG000|Overall Study|Consent Withdrawn|5|||
23228740|NCT00631969|64581141|FG001|Overall Study|Consent Withdrawn|7|||
23228741|NCT00631969|64581140|FG000|Overall Study|Noncompliant With Study Medication|0|||
23228742|NCT00631969|64581141|FG001|Overall Study|Noncompliant With Study Medication|1|||
23337311|NCT01726270|64978946|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
23337312|NCT01397825|64978948|FG000|Overall Study|Progressive Disease|10|||
23337313|NCT01397825|64978949|FG001|Overall Study|Progressive Disease|3|||
23337314|NCT01397825|64978950|FG002|Overall Study|Progressive Disease|11|||
23337315|NCT01397825|64978951|FG003|Overall Study|Progressive Disease|1|||
23337316|NCT01397825|64978952|FG004|Overall Study|Progressive Disease|0|||
23337317|NCT01397825|64978948|FG000|Overall Study|Symptomatic Deterioration|2|||
23337318|NCT01397825|64978949|FG001|Overall Study|Symptomatic Deterioration|0|||
23337319|NCT01397825|64978950|FG002|Overall Study|Symptomatic Deterioration|4|||
23337320|NCT01397825|64978951|FG003|Overall Study|Symptomatic Deterioration|0|||
23337321|NCT01397825|64978952|FG004|Overall Study|Symptomatic Deterioration|0|||
23337322|NCT01397825|64978948|FG000|Overall Study|Adverse Event|0|||
23337323|NCT01397825|64978949|FG001|Overall Study|Adverse Event|1|||
23337324|NCT01397825|64978950|FG002|Overall Study|Adverse Event|5|||
23337325|NCT01397825|64978951|FG003|Overall Study|Adverse Event|1|||
23337326|NCT01397825|64978952|FG004|Overall Study|Adverse Event|0|||
23337327|NCT01397825|64978948|FG000|Overall Study|Withdrawal by Subject|1|||
23228743|NCT00631969|64581140|FG000|Overall Study|No Drug Exposure|2|||
23228744|NCT00631969|64581141|FG001|Overall Study|No Drug Exposure|2|||
23228745|NCT00089505|64581144|FG000|Overall Study|Death|4|||
23228746|NCT00089505|64581145|FG001|Overall Study|Death|1|||
23228747|NCT00089505|64581146|FG002|Overall Study|Death|5|||
23228748|NCT00089505|64581147|FG003|Overall Study|Death|8|||
23228749|NCT00089505|64581144|FG000|Overall Study|Withdrawal by Subject|3|||
23228750|NCT00089505|64581145|FG001|Overall Study|Withdrawal by Subject|0|||
23228751|NCT00089505|64581146|FG002|Overall Study|Withdrawal by Subject|6|||
23228752|NCT00089505|64581147|FG003|Overall Study|Withdrawal by Subject|6|||
23228753|NCT00089505|64581144|FG000|Overall Study|Lost to Follow-up|1|||
23228754|NCT00089505|64581145|FG001|Overall Study|Lost to Follow-up|1|||
23228755|NCT00089505|64581146|FG002|Overall Study|Lost to Follow-up|9|||
23228756|NCT00089505|64581147|FG003|Overall Study|Lost to Follow-up|7|||
23228757|NCT00089505|64581144|FG000|Overall Study|Physician Decision|1|||
23228758|NCT00089505|64581145|FG001|Overall Study|Physician Decision|0|||
23337328|NCT01397825|64978949|FG001|Overall Study|Withdrawal by Subject|0|||
23337329|NCT01397825|64978950|FG002|Overall Study|Withdrawal by Subject|5|||
23228759|NCT00089505|64581146|FG002|Overall Study|Physician Decision|0|||
23228760|NCT00089505|64581147|FG003|Overall Study|Physician Decision|0|||
23228761|NCT00089505|64581144|FG000|Overall Study|Protocol Violation|0|||
23228762|NCT00089505|64581145|FG001|Overall Study|Protocol Violation|0|||
23228763|NCT00089505|64581146|FG002|Overall Study|Protocol Violation|1|||
23228764|NCT00089505|64581147|FG003|Overall Study|Protocol Violation|0|||
23228765|NCT05013385|64581148|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
23228766|NCT02658149|64581149|FG000|Overall Study|Physician Decision|1|||
23228767|NCT02658149|64581150|FG001|Overall Study|Physician Decision|0|||
23228768|NCT01657253|64581152|FG000|Overall Study|Lost to Follow-up|6|||
23228769|NCT01657253|64581153|FG001|Overall Study|Lost to Follow-up|5|||
23228770|NCT01657253|64581152|FG000|Overall Study|Withdrawal by Subject|11|||
23228771|NCT01657253|64581153|FG001|Overall Study|Withdrawal by Subject|12|||
23228772|NCT01657253|64581152|FG000|Overall Study|Adverse Event|0|||
23228773|NCT01657253|64581153|FG001|Overall Study|Adverse Event|1|||
23228774|NCT00443534|64581158|FG000|Overall Study|Lack of Efficacy|67|||
23337330|NCT01397825|64978951|FG003|Overall Study|Withdrawal by Subject|1|||
23337331|NCT01397825|64978952|FG004|Overall Study|Withdrawal by Subject|0|||
23337332|NCT01252563|64978955|FG000|Overall Study|Contract Deviation|41|||
23228775|NCT00443534|64581158|FG000|Overall Study|Adverse Event|16|||
23228776|NCT00443534|64581158|FG000|Overall Study|Death|9|||
23228777|NCT00443534|64581158|FG000|Overall Study|Withdrawal by Subject|8|||
23228778|NCT00443534|64581158|FG000|Overall Study|Study Terminated by Sponsor|12|||
23228779|NCT00443534|64581158|FG000|Overall Study|Other|10|||
23228780|NCT00443534|64581158|FG000|Overall Study|Enrolled, Not Treated|1|||
23228781|NCT01227252|64581165|FG000|Overall Study|Sponsor Decision|0|||
23228782|NCT01227252|64581166|FG001|Overall Study|Sponsor Decision|1|||
23228783|NCT01227252|64581167|FG002|Overall Study|Sponsor Decision|0|||
23337333|NCT01252563|64978955|FG000|Overall Study|Centralized Registration Deviation|30|||
23337334|NCT01252563|64978955|FG000|Overall Study|Lost to Follow-up|161|||
23228784|NCT01227252|64581168|FG003|Overall Study|Sponsor Decision|0|||
23228785|NCT01227252|64581165|FG000|Overall Study|Lost to Follow-up|0|||
23228786|NCT01227252|64581166|FG001|Overall Study|Lost to Follow-up|1|||
23228787|NCT01227252|64581167|FG002|Overall Study|Lost to Follow-up|0|||
23228788|NCT01227252|64581168|FG003|Overall Study|Lost to Follow-up|0|||
23228789|NCT01227252|64581165|FG000|Overall Study|Withdrawal by Subject|0|||
23228790|NCT01227252|64581166|FG001|Overall Study|Withdrawal by Subject|1|||
23228791|NCT01227252|64581167|FG002|Overall Study|Withdrawal by Subject|0|||
23228792|NCT01227252|64581168|FG003|Overall Study|Withdrawal by Subject|0|||
23228793|NCT00086385|64581170|FG000|Overall Study|Death|2|||
23228794|NCT00086385|64581171|FG001|Overall Study|Death|2|||
23228795|NCT00086385|64581172|FG002|Overall Study|Death|1|||
23228796|NCT00086385|64581173|FG003|Overall Study|Death|1|||
23228797|NCT00836953|64581174|FG000|Overall Study|Withdrawal by Subject|1|||
23228798|NCT00836953|64581174|FG000|Overall Study|Lost to Follow-up|1|||
23228799|NCT01610414|64581175|FG000|Study Start - Month 13|Serious Adverse Event|65|||
23228800|NCT01610414|64581176|FG001|Study Start - Month 13|Serious Adverse Event|67|||
23228801|NCT01610414|64581175|FG000|Study Start - Month 13|Adverse Event|14|||
23228802|NCT01610414|64581176|FG001|Study Start - Month 13|Adverse Event|14|||
23228803|NCT01610414|64581175|FG000|Study Start - Month 13|Protocol Violation|3|||
23577024|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
23577025|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
23228804|NCT01610414|64581176|FG001|Study Start - Month 13|Protocol Violation|1|||
23228805|NCT01610414|64581175|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
23228806|NCT01610414|64581176|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
23228807|NCT01610414|64581175|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
23228808|NCT01610414|64581176|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
23228809|NCT01610414|64581175|FG000|Study Start - Month 13|Lost to Follow-up|4|||
23228810|NCT01610414|64581176|FG001|Study Start - Month 13|Lost to Follow-up|6|||
23228811|NCT01610414|64581175|FG000|Study Start - Month 13|Suspected HZ episode|1|||
23228812|NCT01610414|64581176|FG001|Study Start - Month 13|Suspected HZ episode|3|||
23228813|NCT01610414|64581175|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
23228814|NCT01610414|64581176|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
23228815|NCT01610414|64581175|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
23228816|NCT01610414|64581176|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
23228817|NCT01610414|64581175|FG000|Month 13 - Month 25|Adverse Event|8|||
23228818|NCT01610414|64581176|FG001|Month 13 - Month 25|Adverse Event|4|||
23228819|NCT01610414|64581175|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
23228820|NCT01610414|64581176|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
23228821|NCT01610414|64581175|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
23228822|NCT01610414|64581176|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
23228823|NCT01610414|64581175|FG000|Month 13 - Month 25|Protocol Violation|0|||
23228824|NCT01610414|64581176|FG001|Month 13 - Month 25|Protocol Violation|2|||
23228825|NCT01610414|64581175|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
23228826|NCT01610414|64581176|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
23228827|NCT01610414|64581175|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
23228828|NCT01610414|64581176|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
23228829|NCT01610414|64581175|FG000|After Month 25|Study end not reached|48|||
23228830|NCT01610414|64581176|FG001|After Month 25|Study end not reached|53|||
23228831|NCT01320033|64581186|FG000|Overall Study|Lack of Efficacy|0|||
23228832|NCT01320033|64581187|FG001|Overall Study|Lack of Efficacy|0|||
23228833|NCT01320033|64581188|FG002|Overall Study|Lack of Efficacy|1|||
23228834|NCT01320033|64581186|FG000|Overall Study|Adverse Event|9|||
23228835|NCT01320033|64581187|FG001|Overall Study|Adverse Event|7|||
23228836|NCT01320033|64581188|FG002|Overall Study|Adverse Event|8|||
23228837|NCT01320033|64581186|FG000|Overall Study|Withdrawal by Subject|22|||
23228838|NCT01320033|64581187|FG001|Overall Study|Withdrawal by Subject|23|||
23228839|NCT01320033|64581188|FG002|Overall Study|Withdrawal by Subject|23|||
23228840|NCT01320033|64581186|FG000|Overall Study|Protocol Violation|3|||
23228841|NCT01320033|64581187|FG001|Overall Study|Protocol Violation|5|||
23228842|NCT01320033|64581188|FG002|Overall Study|Protocol Violation|3|||
23228843|NCT01320033|64581186|FG000|Overall Study|Lost to Follow-up|22|||
23228844|NCT01320033|64581187|FG001|Overall Study|Lost to Follow-up|26|||
23577026|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
23577027|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
23577028|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
23228845|NCT01320033|64581188|FG002|Overall Study|Lost to Follow-up|17|||
23228846|NCT01320033|64581186|FG000|Overall Study|Other|2|||
23228847|NCT01320033|64581187|FG001|Overall Study|Other|3|||
23228848|NCT01320033|64581188|FG002|Overall Study|Other|1|||
23228849|NCT00827112|64581189|FG000|Overall Study|Adverse Event|2|||
23228850|NCT00827112|64581190|FG001|Overall Study|Adverse Event|0|||
23228851|NCT00827112|64581189|FG000|Overall Study|Lack of Efficacy|2|||
23228852|NCT00827112|64581190|FG001|Overall Study|Lack of Efficacy|0|||
23228853|NCT00827112|64581189|FG000|Overall Study|Lost to Follow-up|3|||
23228854|NCT00827112|64581190|FG001|Overall Study|Lost to Follow-up|2|||
23228855|NCT00827112|64581189|FG000|Overall Study|Pregnancy|0|||
23228856|NCT00827112|64581190|FG001|Overall Study|Pregnancy|1|||
23228857|NCT00827112|64581189|FG000|Overall Study|Protocol Violation|0|||
23228858|NCT00827112|64581190|FG001|Overall Study|Protocol Violation|2|||
23228859|NCT00827112|64581189|FG000|Overall Study|Withdrawal by Subject|2|||
23228860|NCT00827112|64581190|FG001|Overall Study|Withdrawal by Subject|1|||
23228861|NCT00827112|64581189|FG000|Overall Study|Randomized but not treated|5|||
23228862|NCT00827112|64581190|FG001|Overall Study|Randomized but not treated|3|||
23228863|NCT00827112|64581189|FG000|Overall Study|Other|1|||
23228864|NCT00827112|64581190|FG001|Overall Study|Other|3|||
23228865|NCT01058356|64581192|FG000|Overall Study|Adverse Event|5|||
23228866|NCT01058356|64581192|FG000|Overall Study|Administration of contraindicated drugs|12|||
23228867|NCT01058356|64581192|FG000|Overall Study|Withdrawal by Subject|21|||
23228868|NCT01058356|64581192|FG000|Overall Study|Lost to Follow-up|4|||
23228869|NCT01987609|64581193|FG000|Overall Study|Adverse Event|1|||
23228870|NCT02773849|64581196|FG000|Overall Study|Lost to Follow-up|11|||
23228871|NCT02773849|64581196|FG000|Overall Study|Death|26|||
23228872|NCT02773849|64581196|FG000|Overall Study|Withdrawal by Subject|5|||
23228873|NCT02773849|64581196|FG000|Overall Study|Withdrawal of Consent|9|||
23228874|NCT02773849|64581196|FG000|Overall Study|Other: not due to lack of tolerability|11|||
23228875|NCT02178592|64581201|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
23228876|NCT02178592|64581202|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
23228877|NCT02178592|64581201|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
23228878|NCT02178592|64581202|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
23228879|NCT02178592|64581201|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
23228880|NCT02178592|64581202|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
23228881|NCT02178592|64581201|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
23228882|NCT02178592|64581202|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
23228883|NCT02178592|64581201|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
23228884|NCT02178592|64581202|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
23228885|NCT02178592|64581201|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
23228886|NCT02178592|64581202|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
23228887|NCT02178592|64581201|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
23228888|NCT02178592|64581202|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
23228889|NCT02178592|64581201|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
23228890|NCT02178592|64581202|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
23228891|NCT02178592|64581201|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
23228892|NCT02178592|64581202|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
23228893|NCT02178592|64581201|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
23228894|NCT02178592|64581202|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
23228895|NCT02178592|64581201|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
23228896|NCT02178592|64581202|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
23228897|NCT02178592|64581201|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
23228898|NCT02178592|64581202|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
23228899|NCT03233308|64581205|FG000|Overall Study|Adverse Event|1|||
23228900|NCT03233308|64581205|FG000|Overall Study|Protocol Violation|1|||
23228901|NCT03035409|64581212|FG000|Overall Study|Adverse Event|5|||
23228902|NCT03035409|64581212|FG000|Overall Study|Death|2|||
23228903|NCT03035409|64581212|FG000|Overall Study|Withdrawal by Subject|2|||
23228904|NCT03035409|64581212|FG000|Overall Study|Non compliance|4|||
23228905|NCT03035409|64581212|FG000|Overall Study|Patient was jittery|1|||
23228906|NCT03035409|64581212|FG000|Overall Study|Did not like Questionnaire|1|||
23228907|NCT03035409|64581212|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
23228908|NCT03035409|64581212|FG000|Overall Study|Did not like taking drugs|1|||
23228909|NCT00444951|64581213|FG000|Overall Study|Lost to Follow-up|1|||
23228910|NCT00444951|64581214|FG001|Overall Study|Lost to Follow-up|1|||
23228911|NCT00444951|64581215|FG002|Overall Study|Lost to Follow-up|0|||
23228912|NCT00444951|64581213|FG000|Overall Study|Withdrawal by Subject|4|||
23228913|NCT00444951|64581214|FG001|Overall Study|Withdrawal by Subject|5|||
23228914|NCT00444951|64581215|FG002|Overall Study|Withdrawal by Subject|3|||
23228915|NCT00939341|64581218|FG000|Overall Study|Adverse Event|15|||
23337335|NCT01252563|64978955|FG000|Overall Study|No visit after first day of treatment|194|||
23228916|NCT00939341|64581218|FG000|Overall Study|Pregnancy|1|||
23228917|NCT00939341|64581218|FG000|Overall Study|Lost to Follow-up|23|||
23228918|NCT00939341|64581218|FG000|Overall Study|Withdrawal by Subject|13|||
23228919|NCT00939341|64581218|FG000|Overall Study|Protocol Violation|6|||
23228920|NCT00939341|64581218|FG000|Overall Study|Incorrect enrolment|8|||
23228921|NCT00414973|64581219|FG000|Overall Study|Withdrawal by Subject|14|||
23228922|NCT00414973|64581220|FG001|Overall Study|Withdrawal by Subject|4|||
23228923|NCT00414973|64581221|FG002|Overall Study|Withdrawal by Subject|1|||
23228924|NCT00414973|64581222|FG003|Overall Study|Withdrawal by Subject|0|||
23228925|NCT00414973|64581219|FG000|Overall Study|Adverse Event|10|||
23228926|NCT00414973|64581220|FG001|Overall Study|Adverse Event|0|||
23337336|NCT01252563|64978955|FG000|Overall Study|No drug administration|6|||
23337337|NCT03502070|64978956|FG000|Overall Study|Withdrawal by Subject|1|||
23337338|NCT03502070|64978956|FG000|Overall Study|Screen Failure|1|||
23337339|NCT00285207|64978957|FG000|Overall Study|Lost to Follow-up|3|||
23337340|NCT00285207|64978958|FG001|Overall Study|Lost to Follow-up|2|||
23337341|NCT00285207|64978957|FG000|Overall Study|Withdrawal by Subject|5|||
23337342|NCT00285207|64978958|FG001|Overall Study|Withdrawal by Subject|2|||
23228927|NCT00414973|64581221|FG002|Overall Study|Adverse Event|1|||
23228928|NCT00414973|64581222|FG003|Overall Study|Adverse Event|0|||
23228929|NCT00414973|64581219|FG000|Overall Study|Protocol Violation|3|||
23228930|NCT00414973|64581220|FG001|Overall Study|Protocol Violation|4|||
23228931|NCT00414973|64581221|FG002|Overall Study|Protocol Violation|0|||
23228932|NCT00414973|64581222|FG003|Overall Study|Protocol Violation|0|||
23228933|NCT00414973|64581219|FG000|Overall Study|Lost to Follow-up|0|||
23228934|NCT00414973|64581220|FG001|Overall Study|Lost to Follow-up|2|||
23228935|NCT00414973|64581221|FG002|Overall Study|Lost to Follow-up|0|||
23228936|NCT00414973|64581222|FG003|Overall Study|Lost to Follow-up|0|||
23228937|NCT00414973|64581219|FG000|Overall Study|Sponsor Decision|1|||
23228938|NCT00414973|64581220|FG001|Overall Study|Sponsor Decision|0|||
23228939|NCT00414973|64581221|FG002|Overall Study|Sponsor Decision|0|||
23228940|NCT00414973|64581222|FG003|Overall Study|Sponsor Decision|0|||
23228941|NCT00414973|64581219|FG000|Overall Study|Death|0|||
23228942|NCT00414973|64581220|FG001|Overall Study|Death|0|||
23228943|NCT00414973|64581221|FG002|Overall Study|Death|1|||
23228944|NCT00414973|64581222|FG003|Overall Study|Death|0|||
23228945|NCT00303719|64581223|FG000|Overall Study|Not evaluable, prior therapies|0|||
23228946|NCT00303719|64581224|FG001|Overall Study|Not evaluable, prior therapies|30|||
23228947|NCT00303719|64581223|FG000|Overall Study|Lost to Follow-up|0|||
23228948|NCT00303719|64581224|FG001|Overall Study|Lost to Follow-up|7|||
23228949|NCT04905563|64581225|FG000|Overall Study|Withdrawal by Subject|1|||
23228950|NCT04905563|64581226|FG001|Overall Study|Withdrawal by Subject|0|||
23228951|NCT04905563|64581225|FG000|Overall Study|Standard of care orders entered by resident|1|||
23228952|NCT04905563|64581226|FG001|Overall Study|Standard of care orders entered by resident|0|||
23228953|NCT04905563|64581225|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
23337343|NCT00285207|64978957|FG000|Overall Study|Pregnancy|1|||
23337344|NCT00285207|64978958|FG001|Overall Study|Pregnancy|1|||
23337345|NCT00285207|64978957|FG000|Overall Study|non-compliance|0|||
23337346|NCT00285207|64978958|FG001|Overall Study|non-compliance|1|||
23337347|NCT03339726|64978959|FG000|Overall Study|Withdrawal by Subject|1|||
23337348|NCT03339726|64978960|FG001|Overall Study|Withdrawal by Subject|0|||
23337349|NCT03339726|64978961|FG002|Overall Study|Withdrawal by Subject|0|||
23337350|NCT03339726|64978959|FG000|Overall Study|Lost to Follow-up|0|||
23337351|NCT03339726|64978960|FG001|Overall Study|Lost to Follow-up|1|||
23337352|NCT03339726|64978961|FG002|Overall Study|Lost to Follow-up|0|||
23337353|NCT03706430|64978964|FG000|Overall Study|No A-Line placed|5|||
23337354|NCT03706430|64978964|FG000|Overall Study|Subject had gel nail polish|1|||
23337355|NCT03706430|64978964|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
23337356|NCT03706430|64978964|FG000|Overall Study|Cancelled Case|6|||
23337357|NCT03706430|64978964|FG000|Overall Study|Physician Decision|2|||
23337358|NCT01878149|64978965|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
23337359|NCT01878149|64978966|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
23337360|NCT02429778|64978967|FG000|Overall Study|Lost to Follow-up|2|||
23337361|NCT02429778|64978968|FG001|Overall Study|Lost to Follow-up|0|||
23337362|NCT02429778|64978967|FG000|Overall Study|Withdrawal by Subject|5|||
23337363|NCT02429778|64978968|FG001|Overall Study|Withdrawal by Subject|0|||
23337364|NCT01127451|64978978|FG000|Overall Study|Other|2|||
23337365|NCT01127451|64978979|FG001|Overall Study|Other|1|||
23337366|NCT01127451|64978978|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
23337367|NCT01127451|64978979|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
23337368|NCT01127451|64978978|FG000|Overall Study|Death|22|||
23228954|NCT04905563|64581226|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
23228955|NCT04905563|64581225|FG000|Overall Study|Withdrawal by Subject|0|||
23228956|NCT04905563|64581226|FG001|Overall Study|Withdrawal by Subject|1|||
23228957|NCT03323385|64581227|FG000|Overall Study|Withdrawal by Subject|1|||
23228958|NCT03323385|64581228|FG001|Overall Study|Withdrawal by Subject|2|||
23228959|NCT03323385|64581227|FG000|Overall Study|Noncompliance|0|||
23337369|NCT01127451|64978979|FG001|Overall Study|Death|17|||
23337370|NCT01127451|64978978|FG000|Overall Study|Lost to Follow-up|3|||
23337371|NCT01127451|64978979|FG001|Overall Study|Lost to Follow-up|0|||
23337372|NCT01127451|64978978|FG000|Overall Study|Administrative Reason by Sponsor|2|||
23337373|NCT01127451|64978979|FG001|Overall Study|Administrative Reason by Sponsor|2|||
23337374|NCT05486091|64978983|FG000|Overall Study|Withdrawal by Subject|1|||
23449572|NCT02510001|65388091|FG006|Overall Study|Withdrawal by Subject|0|||
23449573|NCT02510001|65388092|FG007|Overall Study|Withdrawal by Subject|2|||
23449574|NCT00412893|65388096|FG000|Overall Study|Adverse Event|31|||
23449575|NCT00412893|65388097|FG001|Overall Study|Adverse Event|53|||
23449576|NCT00412893|65388096|FG000|Overall Study|Death|17|||
23449577|NCT00412893|65388097|FG001|Overall Study|Death|21|||
23449578|NCT00412893|65388096|FG000|Overall Study|Insufficient Therapeutic Response|39|||
23449579|NCT00412893|65388097|FG001|Overall Study|Insufficient Therapeutic Response|23|||
23449580|NCT00412893|65388096|FG000|Overall Study|Lost to Follow-up|2|||
23449581|NCT00412893|65388097|FG001|Overall Study|Lost to Follow-up|1|||
23449582|NCT00412893|65388096|FG000|Overall Study|Violation of Selection at Entry|17|||
23449583|NCT00412893|65388097|FG001|Overall Study|Violation of Selection at Entry|10|||
23449584|NCT00412893|65388096|FG000|Overall Study|Other Protocol Violation|10|||
23449585|NCT00412893|65388097|FG001|Overall Study|Other Protocol Violation|6|||
23449586|NCT00412893|65388096|FG000|Overall Study|Did Not Cooperate|12|||
23449587|NCT00412893|65388097|FG001|Overall Study|Did Not Cooperate|9|||
23449588|NCT00412893|65388096|FG000|Overall Study|Administrative Reason|12|||
23449589|NCT00412893|65388097|FG001|Overall Study|Administrative Reason|15|||
23449590|NCT00412893|65388096|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
23449591|NCT00412893|65388097|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
23449592|NCT00088530|65388098|FG000|Overall Study|Progressive/Relapsed Disease|28|||
23449593|NCT00088530|65388099|FG001|Overall Study|Progressive/Relapsed Disease|39|||
23449594|NCT00088530|65388098|FG000|Overall Study|Adverse Event|15|||
23449595|NCT00088530|65388099|FG001|Overall Study|Adverse Event|9|||
23449596|NCT00088530|65388098|FG000|Overall Study|Withdrawal by Subject|2|||
23449597|NCT00088530|65388099|FG001|Overall Study|Withdrawal by Subject|5|||
23449598|NCT00088530|65388098|FG000|Overall Study|Lost to Follow-up|2|||
23449599|NCT00088530|65388099|FG001|Overall Study|Lost to Follow-up|0|||
23449600|NCT00088530|65388098|FG000|Overall Study|Physician Decision|2|||
23449601|NCT00088530|65388099|FG001|Overall Study|Physician Decision|0|||
23449602|NCT00088530|65388098|FG000|Overall Study|Sponsor decision|0|||
23577029|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
23577030|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
23577031|NCT02718417|65843575|FG000|Chemotherapy Phase (CP)|Other|2|||
23577032|NCT02718417|65843576|FG001|Chemotherapy Phase (CP)|Other|0|||
23577033|NCT02718417|65843577|FG002|Chemotherapy Phase (CP)|Other|1|||
23577034|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Adverse Event|21|||
23577035|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Adverse Event|26|||
23577036|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Adverse Event|0|||
23577037|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
23577038|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
23577039|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
23577040|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
23577041|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
23577042|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
23577043|NCT02718417|65843575|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
23577044|NCT02718417|65843576|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
23577045|NCT02718417|65843577|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
23577046|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Physician's decision|6|||
23577047|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Physician's decision|7|||
23577048|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Physician's decision|0|||
23577049|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Progressive disease|100|||
23577050|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Progressive disease|88|||
23577051|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Progressive disease|0|||
23577052|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Other|2|||
23577053|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Other|1|||
23577054|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Other|0|||
23577055|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
23577056|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
23577057|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
23577058|NCT02718417|65843575|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
23577059|NCT02718417|65843576|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
23577060|NCT02718417|65843577|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
23577061|NCT02718417|65843575|FG000|Observation Phase (OP)|Adverse Event|0|||
23577062|NCT02718417|65843576|FG001|Observation Phase (OP)|Adverse Event|0|||
23577063|NCT02718417|65843577|FG002|Observation Phase (OP)|Adverse Event|1|||
23577064|NCT02718417|65843575|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
23449603|NCT00088530|65388099|FG001|Overall Study|Sponsor decision|1|||
23577065|NCT02718417|65843576|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
23577066|NCT02718417|65843577|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
23170465|NCT03891901|64370788|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23449604|NCT00088530|65388098|FG000|Overall Study|Patient never treated|1|||
23449605|NCT00088530|65388099|FG001|Overall Study|Patient never treated|0|||
23337375|NCT05486091|64978983|FG000|Overall Study|Lost to Follow-up|2|||
23337376|NCT00627445|64978984|FG000|Overall Study|Adverse Event|3|||
23337377|NCT00627445|64978985|FG001|Overall Study|Adverse Event|3|||
23337378|NCT00627445|64978984|FG000|Overall Study|Lack of Efficacy|0|||
23337379|NCT00627445|64978985|FG001|Overall Study|Lack of Efficacy|1|||
23337380|NCT00627445|64978984|FG000|Overall Study|Other|6|||
23228960|NCT03323385|64581228|FG001|Overall Study|Noncompliance|1|||
23228961|NCT02471586|64581231|FG000|Overall Study|Lost to Follow-up|3|||
23228962|NCT02471586|64581232|FG001|Overall Study|Lost to Follow-up|8|||
23228963|NCT02471586|64581233|FG002|Overall Study|Lost to Follow-up|4|||
23228964|NCT02471586|64581231|FG000|Overall Study|Death|2|||
23228965|NCT02471586|64581232|FG001|Overall Study|Death|2|||
23228966|NCT02471586|64581233|FG002|Overall Study|Death|0|||
23228967|NCT03619902|64581234|FG000|Overall Study|Termination of Study by Investigator|1|||
23228968|NCT03619902|64581234|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
23228969|NCT00256204|64581235|FG000|Overall Study|Adverse Event|10|||
23228970|NCT00256204|64581236|FG001|Overall Study|Adverse Event|14|||
23449606|NCT00688259|65388105|FG000|Overall Study|Lost to Follow-up|2|||
23449607|NCT00688259|65388106|FG001|Overall Study|Lost to Follow-up|4|||
23449608|NCT00688259|65388105|FG000|Overall Study|Physician Decision|1|||
23449609|NCT00688259|65388106|FG001|Overall Study|Physician Decision|0|||
23449610|NCT00688259|65388105|FG000|Overall Study|Withdrawal by Subject|2|||
23449611|NCT00688259|65388106|FG001|Overall Study|Withdrawal by Subject|0|||
23449612|NCT00688259|65388105|FG000|Overall Study|Declined Interview|2|||
23449613|NCT00688259|65388106|FG001|Overall Study|Declined Interview|3|||
23449614|NCT00688259|65388105|FG000|Overall Study|Hospitalized at Follow-up|0|||
23449615|NCT00688259|65388106|FG001|Overall Study|Hospitalized at Follow-up|1|||
23449616|NCT00580723|65388110|FG000|Overall Study|Did not want to participate in extension|3|||
23449617|NCT00580723|65388110|FG000|Overall Study|Lost to Follow-up|5|||
23449618|NCT00628030|65388111|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
23449619|NCT00628030|65388112|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
23449620|NCT00628030|65388111|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
23449621|NCT00628030|65388112|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
23449622|NCT00628030|65388111|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
23449623|NCT00628030|65388112|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
23449624|NCT02336230|65388114|FG000|Overall Study|Adverse Event|1|||
23449625|NCT02336230|65388114|FG000|Overall Study|Withdrawal of consent|1|||
23449626|NCT02336230|65388114|FG000|Overall Study|Death|9|||
23449627|NCT02336230|65388114|FG000|Overall Study|Dose not received due to shipping delay|1|||
23449628|NCT02336230|65388114|FG000|Overall Study|Discontinuation of MSC infusion|1|||
23449629|NCT01410890|65388121|FG000|Overall Study|Withdrawal by Subject|0|||
23449630|NCT01410890|65388122|FG001|Overall Study|Withdrawal by Subject|1|||
23449631|NCT00615017|65388123|FG000|Overall Study|Adverse Event|0|||
23449632|NCT00615017|65388124|FG001|Overall Study|Adverse Event|1|||
23449633|NCT00615017|65388125|FG002|Overall Study|Adverse Event|2|||
23449634|NCT00615017|65388126|FG003|Overall Study|Adverse Event|0|||
23449635|NCT00615017|65388127|FG004|Overall Study|Adverse Event|0|||
23449636|NCT00615017|65388128|FG005|Overall Study|Adverse Event|1|||
23449637|NCT00615017|65388123|FG000|Overall Study|Death|0|||
23449638|NCT00615017|65388124|FG001|Overall Study|Death|0|||
23228971|NCT00256204|64581237|FG002|Overall Study|Adverse Event|16|||
23449639|NCT00615017|65388125|FG002|Overall Study|Death|2|||
23228972|NCT00256204|64581238|FG003|Overall Study|Adverse Event|14|||
23228973|NCT00256204|64581235|FG000|Overall Study|Death|0|||
23337381|NCT00627445|64978985|FG001|Overall Study|Other|8|||
23449640|NCT00615017|65388126|FG003|Overall Study|Death|0|||
23449641|NCT00615017|65388127|FG004|Overall Study|Death|1|||
23337382|NCT00638404|64978989|FG000|Overall Study|Physician Decision|8|||
23449642|NCT00615017|65388128|FG005|Overall Study|Death|1|||
23449643|NCT00615017|65388123|FG000|Overall Study|Sepsis resolved|0|||
23449644|NCT00615017|65388124|FG001|Overall Study|Sepsis resolved|0|||
23449645|NCT00615017|65388125|FG002|Overall Study|Sepsis resolved|1|||
23449646|NCT00615017|65388126|FG003|Overall Study|Sepsis resolved|0|||
23449647|NCT00615017|65388127|FG004|Overall Study|Sepsis resolved|0|||
23449648|NCT00615017|65388128|FG005|Overall Study|Sepsis resolved|0|||
23449649|NCT00615017|65388123|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
23449650|NCT00615017|65388124|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
23449651|NCT00615017|65388125|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
23449652|NCT00615017|65388126|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
23170466|NCT03891901|64370789|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23170467|NCT03891901|64370790|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
23170468|NCT03891901|64370782|FG000|Overall Study|Adverse Event|2|||
23170469|NCT03891901|64370783|FG001|Overall Study|Adverse Event|2|||
23170470|NCT03891901|64370784|FG002|Overall Study|Adverse Event|0|||
23170471|NCT03891901|64370785|FG003|Overall Study|Adverse Event|0|||
23170472|NCT03891901|64370786|FG004|Overall Study|Adverse Event|0|||
23170473|NCT03891901|64370787|FG005|Overall Study|Adverse Event|0|||
23170474|NCT03891901|64370788|FG006|Overall Study|Adverse Event|0|||
23170475|NCT03891901|64370789|FG007|Overall Study|Adverse Event|0|||
23170476|NCT03891901|64370790|FG008|Overall Study|Adverse Event|0|||
23170477|NCT03891901|64370782|FG000|Overall Study|Poor venous access|1|||
23170478|NCT03891901|64370783|FG001|Overall Study|Poor venous access|0|||
23170479|NCT03891901|64370784|FG002|Overall Study|Poor venous access|0|||
23170480|NCT03891901|64370785|FG003|Overall Study|Poor venous access|0|||
23170481|NCT03891901|64370786|FG004|Overall Study|Poor venous access|0|||
23170482|NCT03891901|64370787|FG005|Overall Study|Poor venous access|0|||
23170483|NCT03891901|64370788|FG006|Overall Study|Poor venous access|0|||
23170484|NCT03891901|64370789|FG007|Overall Study|Poor venous access|0|||
23170485|NCT03891901|64370790|FG008|Overall Study|Poor venous access|0|||
23170486|NCT03891901|64370782|FG000|Overall Study|Withdrawal by Subject|0|||
23170487|NCT03891901|64370783|FG001|Overall Study|Withdrawal by Subject|2|||
23170488|NCT03891901|64370784|FG002|Overall Study|Withdrawal by Subject|0|||
23228974|NCT00256204|64581236|FG001|Overall Study|Death|1|||
23228975|NCT00256204|64581237|FG002|Overall Study|Death|0|||
23228976|NCT00256204|64581238|FG003|Overall Study|Death|0|||
23228977|NCT00256204|64581235|FG000|Overall Study|Lost to Follow-up|1|||
23228978|NCT00256204|64581236|FG001|Overall Study|Lost to Follow-up|1|||
23228979|NCT00256204|64581237|FG002|Overall Study|Lost to Follow-up|1|||
23228980|NCT00256204|64581238|FG003|Overall Study|Lost to Follow-up|2|||
23228981|NCT00256204|64581235|FG000|Overall Study|Protocol Violation|1|||
23228982|NCT00256204|64581236|FG001|Overall Study|Protocol Violation|0|||
23228983|NCT00256204|64581237|FG002|Overall Study|Protocol Violation|2|||
23228984|NCT00256204|64581238|FG003|Overall Study|Protocol Violation|1|||
23228985|NCT00256204|64581235|FG000|Overall Study|Physician Decision|0|||
23228986|NCT00256204|64581236|FG001|Overall Study|Physician Decision|0|||
23228987|NCT00256204|64581237|FG002|Overall Study|Physician Decision|1|||
23228988|NCT00256204|64581238|FG003|Overall Study|Physician Decision|2|||
23228989|NCT00256204|64581235|FG000|Overall Study|Withdrawal by Subject|17|||
23228990|NCT00256204|64581236|FG001|Overall Study|Withdrawal by Subject|6|||
23228991|NCT00256204|64581237|FG002|Overall Study|Withdrawal by Subject|7|||
23228992|NCT00256204|64581238|FG003|Overall Study|Withdrawal by Subject|5|||
23228993|NCT00256204|64581235|FG000|Overall Study|Need for additional prohibited treatment|38|||
23228994|NCT00256204|64581236|FG001|Overall Study|Need for additional prohibited treatment|28|||
23228995|NCT00256204|64581237|FG002|Overall Study|Need for additional prohibited treatment|27|||
23228996|NCT00256204|64581238|FG003|Overall Study|Need for additional prohibited treatment|25|||
23228997|NCT00697255|64581239|FG000|Stage 1a|Insufficient ovarian response|1|||
23337383|NCT00638404|64978990|FG001|Overall Study|Physician Decision|0|||
23449653|NCT00615017|65388127|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
23449654|NCT00615017|65388128|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
23449655|NCT00615017|65388123|FG000|Overall Study|Physician discontinued drug|0|||
23449656|NCT00615017|65388124|FG001|Overall Study|Physician discontinued drug|0|||
23449657|NCT00615017|65388125|FG002|Overall Study|Physician discontinued drug|0|||
23449658|NCT00615017|65388126|FG003|Overall Study|Physician discontinued drug|0|||
23170489|NCT03891901|64370785|FG003|Overall Study|Withdrawal by Subject|0|||
23170490|NCT03891901|64370786|FG004|Overall Study|Withdrawal by Subject|0|||
23170491|NCT03891901|64370787|FG005|Overall Study|Withdrawal by Subject|0|||
23170492|NCT03891901|64370788|FG006|Overall Study|Withdrawal by Subject|0|||
23170493|NCT03891901|64370789|FG007|Overall Study|Withdrawal by Subject|0|||
23228998|NCT00697255|64581240|FG001|Stage 1a|Insufficient ovarian response|0|||
23228999|NCT00697255|64581239|FG000|Stage 1a|Multifollicular growth|1|||
23229000|NCT00697255|64581240|FG001|Stage 1a|Multifollicular growth|0|||
23229001|NCT00697255|64581239|FG000|Stage 1a|Not growing of dominant follicle|1|||
23229002|NCT00697255|64581240|FG001|Stage 1a|Not growing of dominant follicle|0|||
23229003|NCT00697255|64581239|FG000|Stage 1b|Not growing of dominant follicle|0|||
23229004|NCT00697255|64581240|FG001|Stage 1b|Not growing of dominant follicle|1|||
23449659|NCT00615017|65388127|FG004|Overall Study|Physician discontinued drug|0|||
23229005|NCT00697255|64581239|FG000|Stage 1b|Insufficient ovarian response|0|||
23229006|NCT00697255|64581240|FG001|Stage 1b|Insufficient ovarian response|1|||
23229007|NCT04129242|64581241|FG000|Overall Study|Physician Decision|1|||
23229008|NCT04129242|64581242|FG001|Overall Study|Physician Decision|1|||
23229009|NCT04129242|64581241|FG000|Overall Study|Protocol Violation|0|||
23229010|NCT04129242|64581242|FG001|Overall Study|Protocol Violation|1|||
23229011|NCT01594749|64581243|FG000|Overall Study|Adverse Event|2|||
23229012|NCT01594749|64581244|FG001|Overall Study|Adverse Event|1|||
23449660|NCT00615017|65388128|FG005|Overall Study|Physician discontinued drug|1|||
23229013|NCT01594749|64581243|FG000|Overall Study|Withdrawal by Subject|2|||
23337384|NCT01938430|64978991|FG000|Overall Study|Randomized but Not Treated|0|||
23337385|NCT01938430|64978992|FG001|Overall Study|Randomized but Not Treated|0|||
23337386|NCT01938430|64978993|FG002|Overall Study|Randomized but Not Treated|0|||
23337387|NCT01938430|64978994|FG003|Overall Study|Randomized but Not Treated|0|||
23337388|NCT01938430|64978995|FG004|Overall Study|Randomized but Not Treated|0|||
23337389|NCT01938430|64978996|FG005|Overall Study|Randomized but Not Treated|0|||
23337390|NCT01938430|64978997|FG006|Overall Study|Randomized but Not Treated|0|||
23337391|NCT01938430|64978998|FG007|Overall Study|Randomized but Not Treated|0|||
23337392|NCT01938430|64978999|FG008|Overall Study|Randomized but Not Treated|0|||
23337393|NCT01938430|64979000|FG009|Overall Study|Randomized but Not Treated|0|||
23337394|NCT01938430|64979001|FG010|Overall Study|Randomized but Not Treated|1|||
23337395|NCT01938430|64979002|FG011|Overall Study|Randomized but Not Treated|0|||
23337396|NCT01938430|64979003|FG012|Overall Study|Randomized but Not Treated|0|||
23449661|NCT00855959|65388129|FG000|Overall Study|Adverse Event|2|||
23577067|NCT02718417|65843575|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
23229014|NCT01594749|64581244|FG001|Overall Study|Withdrawal by Subject|2|||
23229015|NCT01594749|64581243|FG000|Overall Study|Protocol Violation|2|||
23229016|NCT01594749|64581244|FG001|Overall Study|Protocol Violation|0|||
23229017|NCT01594749|64581243|FG000|Overall Study|Physician Decision|1|||
23229018|NCT01594749|64581244|FG001|Overall Study|Physician Decision|1|||
23229019|NCT01594749|64581243|FG000|Overall Study|Non-compliance with Protocol|0|||
23229020|NCT01594749|64581244|FG001|Overall Study|Non-compliance with Protocol|1|||
23229021|NCT01594749|64581243|FG000|Overall Study|Lost to Follow-up|1|||
23229022|NCT01594749|64581244|FG001|Overall Study|Lost to Follow-up|0|||
23229023|NCT01594749|64581243|FG000|Overall Study|Death|9|||
23229024|NCT01594749|64581244|FG001|Overall Study|Death|3|||
23229025|NCT01594749|64581243|FG000|Overall Study|Not Treated|4|||
23229026|NCT01594749|64581244|FG001|Overall Study|Not Treated|10|||
23229027|NCT01594749|64581243|FG000|Overall Study|Lost Source Documentation|1|||
23229028|NCT01594749|64581244|FG001|Overall Study|Lost Source Documentation|0|||
23229029|NCT02477800|64581245|FG000|Placebo-Controlled Period|Adverse Event|16|||
23229030|NCT02477800|64581246|FG001|Placebo-Controlled Period|Adverse Event|25|||
23229031|NCT02477800|64581247|FG002|Placebo-Controlled Period|Adverse Event|28|||
23229032|NCT02477800|64581248|FG003|Placebo-Controlled Period|Adverse Event|0|||
23229033|NCT02477800|64581249|FG004|Placebo-Controlled Period|Adverse Event|0|||
23229034|NCT02477800|64581250|FG005|Placebo-Controlled Period|Adverse Event|0|||
23229035|NCT02477800|64581251|FG006|Placebo-Controlled Period|Adverse Event|0|||
23229036|NCT02477800|64581245|FG000|Placebo-Controlled Period|Change of Treatment|1|||
23229037|NCT02477800|64581246|FG001|Placebo-Controlled Period|Change of Treatment|2|||
23229038|NCT02477800|64581247|FG002|Placebo-Controlled Period|Change of Treatment|1|||
23229039|NCT02477800|64581248|FG003|Placebo-Controlled Period|Change of Treatment|0|||
23229040|NCT02477800|64581249|FG004|Placebo-Controlled Period|Change of Treatment|0|||
23229041|NCT02477800|64581250|FG005|Placebo-Controlled Period|Change of Treatment|0|||
23229042|NCT02477800|64581251|FG006|Placebo-Controlled Period|Change of Treatment|0|||
23229043|NCT02477800|64581245|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
23229044|NCT02477800|64581246|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
23229045|NCT02477800|64581247|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
23229046|NCT02477800|64581248|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
23229047|NCT02477800|64581249|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
23229048|NCT02477800|64581250|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
23229049|NCT02477800|64581251|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
23229050|NCT02477800|64581245|FG000|Placebo-Controlled Period|Death|0|||
23229051|NCT02477800|64581246|FG001|Placebo-Controlled Period|Death|3|||
23229052|NCT02477800|64581247|FG002|Placebo-Controlled Period|Death|2|||
23229053|NCT02477800|64581248|FG003|Placebo-Controlled Period|Death|0|||
23229054|NCT02477800|64581249|FG004|Placebo-Controlled Period|Death|0|||
23229055|NCT02477800|64581250|FG005|Placebo-Controlled Period|Death|0|||
23337397|NCT01938430|64979004|FG013|Overall Study|Randomized but Not Treated|1|||
23229056|NCT02477800|64581251|FG006|Placebo-Controlled Period|Death|0|||
23229057|NCT02477800|64581245|FG000|Placebo-Controlled Period|Disease Progression|1|||
23337398|NCT01938430|64978991|FG000|Overall Study|Adverse Event|0|||
23337399|NCT01938430|64978992|FG001|Overall Study|Adverse Event|0|||
23337400|NCT01938430|64978993|FG002|Overall Study|Adverse Event|0|||
23337401|NCT01938430|64978994|FG003|Overall Study|Adverse Event|0|||
23229058|NCT02477800|64581246|FG001|Placebo-Controlled Period|Disease Progression|0|||
23229059|NCT02477800|64581247|FG002|Placebo-Controlled Period|Disease Progression|1|||
23577068|NCT02718417|65843576|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
23577069|NCT02718417|65843577|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
23577070|NCT02718417|65843575|FG000|Observation Phase (OP)|Physician Decision|0|||
23577071|NCT02718417|65843576|FG001|Observation Phase (OP)|Physician Decision|0|||
23577072|NCT02718417|65843577|FG002|Observation Phase (OP)|Physician Decision|9|||
23577073|NCT02718417|65843575|FG000|Observation Phase (OP)|Progressive disease|0|||
23577074|NCT02718417|65843576|FG001|Observation Phase (OP)|Progressive disease|0|||
23577075|NCT02718417|65843577|FG002|Observation Phase (OP)|Progressive disease|92|||
23577076|NCT02718417|65843575|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
23577077|NCT02718417|65843576|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
23577078|NCT02718417|65843577|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
23577079|NCT02718417|65843575|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
23229060|NCT02477800|64581248|FG003|Placebo-Controlled Period|Disease Progression|0|||
23229061|NCT02477800|64581249|FG004|Placebo-Controlled Period|Disease Progression|0|||
23229062|NCT02477800|64581250|FG005|Placebo-Controlled Period|Disease Progression|0|||
23229063|NCT02477800|64581251|FG006|Placebo-Controlled Period|Disease Progression|0|||
23229064|NCT02477800|64581245|FG000|Placebo-Controlled Period|Investigator Decision|3|||
23337402|NCT01938430|64978995|FG004|Overall Study|Adverse Event|0|||
23229065|NCT02477800|64581246|FG001|Placebo-Controlled Period|Investigator Decision|2|||
23229066|NCT02477800|64581247|FG002|Placebo-Controlled Period|Investigator Decision|1|||
23229067|NCT02477800|64581248|FG003|Placebo-Controlled Period|Investigator Decision|0|||
23229068|NCT02477800|64581249|FG004|Placebo-Controlled Period|Investigator Decision|0|||
23229069|NCT02477800|64581250|FG005|Placebo-Controlled Period|Investigator Decision|0|||
23229070|NCT02477800|64581251|FG006|Placebo-Controlled Period|Investigator Decision|0|||
23229071|NCT02477800|64581245|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
23229072|NCT02477800|64581246|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
23229073|NCT02477800|64581247|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
23229074|NCT02477800|64581248|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
23229075|NCT02477800|64581249|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
23229076|NCT02477800|64581250|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
23229077|NCT02477800|64581251|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
23229078|NCT02477800|64581245|FG000|Placebo-Controlled Period|Relocation|2|||
23229079|NCT02477800|64581246|FG001|Placebo-Controlled Period|Relocation|0|||
23229080|NCT02477800|64581247|FG002|Placebo-Controlled Period|Relocation|0|||
23229081|NCT02477800|64581248|FG003|Placebo-Controlled Period|Relocation|0|||
23229082|NCT02477800|64581249|FG004|Placebo-Controlled Period|Relocation|0|||
23229083|NCT02477800|64581250|FG005|Placebo-Controlled Period|Relocation|0|||
23229084|NCT02477800|64581251|FG006|Placebo-Controlled Period|Relocation|0|||
23229085|NCT02477800|64581245|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
23229086|NCT02477800|64581246|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
23229087|NCT02477800|64581247|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
23229088|NCT02477800|64581248|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
23229089|NCT02477800|64581249|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
23229090|NCT02477800|64581250|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
23229091|NCT02477800|64581251|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
23229092|NCT02477800|64581245|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
23229093|NCT02477800|64581246|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
23229094|NCT02477800|64581247|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23229095|NCT02477800|64581248|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23229096|NCT02477800|64581249|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23229097|NCT02477800|64581250|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23229098|NCT02477800|64581251|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
23229099|NCT02477800|64581245|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
23229100|NCT02477800|64581246|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
23229101|NCT02477800|64581247|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
23229102|NCT02477800|64581248|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
23229103|NCT02477800|64581249|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
23229104|NCT02477800|64581250|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
23229105|NCT02477800|64581251|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
23229106|NCT02477800|64581245|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
23229107|NCT02477800|64581246|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
23229108|NCT02477800|64581247|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
23229109|NCT02477800|64581248|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23229110|NCT02477800|64581249|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23229111|NCT02477800|64581250|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23229112|NCT02477800|64581251|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23229113|NCT02477800|64581245|FG000|Placebo-Controlled Period|Reason not Specified|161|||
23229114|NCT02477800|64581246|FG001|Placebo-Controlled Period|Reason not Specified|161|||
23229115|NCT02477800|64581247|FG002|Placebo-Controlled Period|Reason not Specified|189|||
23229116|NCT02477800|64581248|FG003|Placebo-Controlled Period|Reason not Specified|0|||
23229117|NCT02477800|64581249|FG004|Placebo-Controlled Period|Reason not Specified|0|||
23229118|NCT02477800|64581250|FG005|Placebo-Controlled Period|Reason not Specified|0|||
23229119|NCT02477800|64581251|FG006|Placebo-Controlled Period|Reason not Specified|0|||
23229120|NCT02477800|64581245|FG000|Long Term Extension Period|Adverse Event|0|||
23229121|NCT02477800|64581246|FG001|Long Term Extension Period|Adverse Event|0|||
23229122|NCT02477800|64581247|FG002|Long Term Extension Period|Adverse Event|0|||
23170494|NCT03891901|64370790|FG008|Overall Study|Withdrawal by Subject|0|||
23170495|NCT00763139|64370791|FG000|Overall Study|Adverse Event|4|||
23170496|NCT00763139|64370792|FG001|Overall Study|Adverse Event|2|||
23170497|NCT00763139|64370791|FG000|Overall Study|Withdrawal by Subject|0|||
23170498|NCT00763139|64370792|FG001|Overall Study|Withdrawal by Subject|1|||
23170499|NCT00763139|64370791|FG000|Overall Study|med change not allowed by protocol|1|||
23170500|NCT00763139|64370792|FG001|Overall Study|med change not allowed by protocol|0|||
23170501|NCT01789970|64370793|FG000|Open-label Titration Period|Adverse Event|68|||
23170502|NCT01789970|64370794|FG001|Open-label Titration Period|Adverse Event|0|||
23229123|NCT02477800|64581248|FG003|Long Term Extension Period|Adverse Event|6|||
23229124|NCT02477800|64581249|FG004|Long Term Extension Period|Adverse Event|2|||
23170503|NCT01789970|64370795|FG002|Open-label Titration Period|Adverse Event|0|||
23229125|NCT02477800|64581250|FG005|Long Term Extension Period|Adverse Event|4|||
23229126|NCT02477800|64581251|FG006|Long Term Extension Period|Adverse Event|3|||
23229127|NCT02477800|64581245|FG000|Long Term Extension Period|Death|0|||
23229128|NCT02477800|64581246|FG001|Long Term Extension Period|Death|0|||
23229129|NCT02477800|64581247|FG002|Long Term Extension Period|Death|0|||
23229130|NCT02477800|64581248|FG003|Long Term Extension Period|Death|1|||
23229131|NCT02477800|64581249|FG004|Long Term Extension Period|Death|1|||
23229132|NCT02477800|64581250|FG005|Long Term Extension Period|Death|1|||
23229133|NCT02477800|64581251|FG006|Long Term Extension Period|Death|2|||
23229134|NCT02477800|64581245|FG000|Long Term Extension Period|Consent Withdrawn|0|||
23229135|NCT02477800|64581246|FG001|Long Term Extension Period|Consent Withdrawn|0|||
23229136|NCT02477800|64581247|FG002|Long Term Extension Period|Consent Withdrawn|0|||
23229137|NCT02477800|64581248|FG003|Long Term Extension Period|Consent Withdrawn|10|||
23337403|NCT01938430|64978996|FG005|Overall Study|Adverse Event|0|||
23337404|NCT01938430|64978997|FG006|Overall Study|Adverse Event|1|||
23337405|NCT01938430|64978998|FG007|Overall Study|Adverse Event|0|||
23337406|NCT01938430|64978999|FG008|Overall Study|Adverse Event|0|||
23337407|NCT01938430|64979000|FG009|Overall Study|Adverse Event|0|||
23337408|NCT01938430|64979001|FG010|Overall Study|Adverse Event|0|||
23337409|NCT01938430|64979002|FG011|Overall Study|Adverse Event|0|||
23337410|NCT01938430|64979003|FG012|Overall Study|Adverse Event|0|||
23337411|NCT01938430|64979004|FG013|Overall Study|Adverse Event|0|||
23337412|NCT01938430|64978991|FG000|Overall Study|Death|1|||
23337413|NCT01938430|64978992|FG001|Overall Study|Death|2|||
23337414|NCT01938430|64978993|FG002|Overall Study|Death|2|||
23337415|NCT01938430|64978994|FG003|Overall Study|Death|1|||
23337416|NCT01938430|64978995|FG004|Overall Study|Death|0|||
23337417|NCT01938430|64978996|FG005|Overall Study|Death|0|||
23337418|NCT01938430|64978997|FG006|Overall Study|Death|1|||
23337419|NCT01938430|64978998|FG007|Overall Study|Death|1|||
23337420|NCT01938430|64978999|FG008|Overall Study|Death|2|||
23337421|NCT01938430|64979000|FG009|Overall Study|Death|3|||
23337422|NCT01938430|64979001|FG010|Overall Study|Death|0|||
23337423|NCT01938430|64979002|FG011|Overall Study|Death|0|||
23337424|NCT01938430|64979003|FG012|Overall Study|Death|0|||
23337425|NCT01938430|64979004|FG013|Overall Study|Death|0|||
23337426|NCT01938430|64978991|FG000|Overall Study|Investigator's Discretion|0|||
23337427|NCT01938430|64978992|FG001|Overall Study|Investigator's Discretion|0|||
23337428|NCT01938430|64978993|FG002|Overall Study|Investigator's Discretion|1|||
23337429|NCT01938430|64978994|FG003|Overall Study|Investigator's Discretion|0|||
23337430|NCT01938430|64978995|FG004|Overall Study|Investigator's Discretion|0|||
23337431|NCT01938430|64978996|FG005|Overall Study|Investigator's Discretion|0|||
23337432|NCT01938430|64978997|FG006|Overall Study|Investigator's Discretion|0|||
23337433|NCT01938430|64978998|FG007|Overall Study|Investigator's Discretion|0|||
23337434|NCT01938430|64978999|FG008|Overall Study|Investigator's Discretion|0|||
23337435|NCT01938430|64979000|FG009|Overall Study|Investigator's Discretion|0|||
23337436|NCT01938430|64979001|FG010|Overall Study|Investigator's Discretion|0|||
23337437|NCT01938430|64979002|FG011|Overall Study|Investigator's Discretion|0|||
23337438|NCT01938430|64979003|FG012|Overall Study|Investigator's Discretion|0|||
23337439|NCT01938430|64979004|FG013|Overall Study|Investigator's Discretion|0|||
23337440|NCT01938430|64978991|FG000|Overall Study|Lack of Efficacy|3|||
23337441|NCT01938430|64978992|FG001|Overall Study|Lack of Efficacy|1|||
23337442|NCT01938430|64978993|FG002|Overall Study|Lack of Efficacy|1|||
23337443|NCT01938430|64978994|FG003|Overall Study|Lack of Efficacy|1|||
23337444|NCT01938430|64978995|FG004|Overall Study|Lack of Efficacy|0|||
23337445|NCT01938430|64978996|FG005|Overall Study|Lack of Efficacy|0|||
23337446|NCT01938430|64978997|FG006|Overall Study|Lack of Efficacy|0|||
23337447|NCT01938430|64978998|FG007|Overall Study|Lack of Efficacy|0|||
23337448|NCT01938430|64978999|FG008|Overall Study|Lack of Efficacy|1|||
23337449|NCT01938430|64979000|FG009|Overall Study|Lack of Efficacy|0|||
23337450|NCT01938430|64979001|FG010|Overall Study|Lack of Efficacy|2|||
23337451|NCT01938430|64979002|FG011|Overall Study|Lack of Efficacy|1|||
23229138|NCT02477800|64581249|FG004|Long Term Extension Period|Consent Withdrawn|4|||
23337452|NCT01938430|64979003|FG012|Overall Study|Lack of Efficacy|0|||
23337453|NCT01938430|64979004|FG013|Overall Study|Lack of Efficacy|0|||
23337454|NCT01938430|64978991|FG000|Overall Study|Lost to Follow-up|0|||
23337455|NCT01938430|64978992|FG001|Overall Study|Lost to Follow-up|0|||
23337456|NCT01938430|64978993|FG002|Overall Study|Lost to Follow-up|1|||
23337457|NCT01938430|64978994|FG003|Overall Study|Lost to Follow-up|0|||
23337458|NCT01938430|64978995|FG004|Overall Study|Lost to Follow-up|0|||
23337459|NCT01938430|64978996|FG005|Overall Study|Lost to Follow-up|1|||
23337460|NCT01938430|64978997|FG006|Overall Study|Lost to Follow-up|0|||
23337461|NCT01938430|64978998|FG007|Overall Study|Lost to Follow-up|0|||
23337462|NCT01938430|64978999|FG008|Overall Study|Lost to Follow-up|0|||
23337463|NCT01938430|64979000|FG009|Overall Study|Lost to Follow-up|0|||
23229139|NCT02477800|64581250|FG005|Long Term Extension Period|Consent Withdrawn|13|||
23337464|NCT01938430|64979001|FG010|Overall Study|Lost to Follow-up|0|||
23337465|NCT01938430|64979002|FG011|Overall Study|Lost to Follow-up|0|||
23337466|NCT01938430|64979003|FG012|Overall Study|Lost to Follow-up|0|||
23229140|NCT02477800|64581251|FG006|Long Term Extension Period|Consent Withdrawn|16|||
23337467|NCT01938430|64979004|FG013|Overall Study|Lost to Follow-up|0|||
23337468|NCT01938430|64978991|FG000|Overall Study|Withdrew Consent|0|||
23337469|NCT01938430|64978992|FG001|Overall Study|Withdrew Consent|0|||
23337470|NCT01938430|64978993|FG002|Overall Study|Withdrew Consent|0|||
23337471|NCT01938430|64978994|FG003|Overall Study|Withdrew Consent|0|||
23337472|NCT01938430|64978995|FG004|Overall Study|Withdrew Consent|0|||
23337473|NCT01938430|64978996|FG005|Overall Study|Withdrew Consent|0|||
23337474|NCT01938430|64978997|FG006|Overall Study|Withdrew Consent|0|||
23337475|NCT01938430|64978998|FG007|Overall Study|Withdrew Consent|0|||
23337476|NCT01938430|64978999|FG008|Overall Study|Withdrew Consent|1|||
23337477|NCT01938430|64979000|FG009|Overall Study|Withdrew Consent|0|||
23337478|NCT01938430|64979001|FG010|Overall Study|Withdrew Consent|0|||
23337479|NCT01938430|64979002|FG011|Overall Study|Withdrew Consent|0|||
23337480|NCT01938430|64979003|FG012|Overall Study|Withdrew Consent|0|||
23337481|NCT01938430|64979004|FG013|Overall Study|Withdrew Consent|0|||
23337482|NCT04468347|64979005|FG000|Overall Study|Withdrawal by Subject|0|||
23337483|NCT04468347|64979006|FG001|Overall Study|Withdrawal by Subject|1|||
23337484|NCT04468347|64979007|FG002|Overall Study|Withdrawal by Subject|3|||
23337485|NCT04468347|64979008|FG003|Overall Study|Withdrawal by Subject|3|||
23337486|NCT04468347|64979005|FG000|Overall Study|Lost to Follow-up|0|||
23337487|NCT04468347|64979006|FG001|Overall Study|Lost to Follow-up|0|||
23337488|NCT04468347|64979007|FG002|Overall Study|Lost to Follow-up|1|||
23449662|NCT00855959|65388129|FG000|Overall Study|Lost to Follow-up|2|||
23170504|NCT01789970|64370793|FG000|Open-label Titration Period|Lack of Efficacy|31|||
23170505|NCT01789970|64370794|FG001|Open-label Titration Period|Lack of Efficacy|0|||
23170506|NCT01789970|64370795|FG002|Open-label Titration Period|Lack of Efficacy|0|||
23170507|NCT01789970|64370793|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
23170508|NCT01789970|64370794|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
23170509|NCT01789970|64370795|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
23170510|NCT01789970|64370793|FG000|Open-label Titration Period|Protocol Violation|18|||
23170511|NCT01789970|64370794|FG001|Open-label Titration Period|Protocol Violation|0|||
23170512|NCT01789970|64370795|FG002|Open-label Titration Period|Protocol Violation|0|||
23170513|NCT01789970|64370793|FG000|Open-label Titration Period|Lost to Follow-up|5|||
23170514|NCT01789970|64370794|FG001|Open-label Titration Period|Lost to Follow-up|0|||
23170515|NCT01789970|64370795|FG002|Open-label Titration Period|Lost to Follow-up|0|||
23170516|NCT01789970|64370793|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
23170517|NCT01789970|64370794|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
23170518|NCT01789970|64370795|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
23170519|NCT01789970|64370793|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
23337489|NCT04468347|64979008|FG003|Overall Study|Lost to Follow-up|1|||
23337490|NCT04468347|64979005|FG000|Overall Study|Physician Decision|1|||
23337491|NCT04468347|64979006|FG001|Overall Study|Physician Decision|0|||
23337492|NCT04468347|64979007|FG002|Overall Study|Physician Decision|2|||
23337493|NCT04468347|64979008|FG003|Overall Study|Physician Decision|0|||
23337494|NCT04468347|64979005|FG000|Overall Study|Protocol Violation|1|||
23337495|NCT04468347|64979006|FG001|Overall Study|Protocol Violation|0|||
23337496|NCT04468347|64979007|FG002|Overall Study|Protocol Violation|0|||
23337497|NCT04468347|64979008|FG003|Overall Study|Protocol Violation|0|||
23337498|NCT01718535|64979013|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
23337499|NCT01718535|64979014|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
23449663|NCT00855959|65388129|FG000|Overall Study|Withdrawal by Subject|3|||
23337500|NCT01718535|64979015|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
23337501|NCT01718535|64979016|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
23337502|NCT01718535|64979017|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
23337503|NCT01718535|64979018|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
23337504|NCT01718535|64979019|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
23577080|NCT02718417|65843576|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
23577081|NCT02718417|65843577|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
23577082|NCT02718417|65843575|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
23577083|NCT02718417|65843576|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
23577084|NCT02718417|65843577|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
23577085|NCT02718417|65843575|FG000|Observation Phase (OP)|Other|0|||
23577086|NCT02718417|65843576|FG001|Observation Phase (OP)|Other|0|||
23577087|NCT02718417|65843577|FG002|Observation Phase (OP)|Other|7|||
23577088|NCT02718417|65843575|FG000|Follow-up Phase|Adverse Event|3|||
23577089|NCT02718417|65843576|FG001|Follow-up Phase|Adverse Event|1|||
23337505|NCT01718535|64979020|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
23337506|NCT01718535|64979021|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
23337507|NCT01718535|64979022|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
23337508|NCT00378508|64979030|FG000|Overall Study|Withdrawal by Subject|1|||
23337509|NCT00378508|64979031|FG001|Overall Study|Withdrawal by Subject|3|||
23337510|NCT00378508|64979030|FG000|Overall Study|Lost to Follow-up|1|||
23577090|NCT02718417|65843577|FG002|Follow-up Phase|Adverse Event|1|||
23577091|NCT02718417|65843575|FG000|Follow-up Phase|Other|4|||
23577092|NCT02718417|65843576|FG001|Follow-up Phase|Other|6|||
23577093|NCT02718417|65843577|FG002|Follow-up Phase|Other|4|||
23170520|NCT01789970|64370794|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
23170521|NCT01789970|64370795|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
23170522|NCT01789970|64370793|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
23170523|NCT01789970|64370794|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
23170524|NCT01789970|64370795|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
23170525|NCT01789970|64370793|FG000|Open-label Titration Period|Pregnancy|2|||
23170526|NCT01789970|64370794|FG001|Open-label Titration Period|Pregnancy|0|||
23577094|NCT02718417|65843575|FG000|Follow-up Phase|Withdrawal by Subject|19|||
23577095|NCT02718417|65843576|FG001|Follow-up Phase|Withdrawal by Subject|17|||
23170527|NCT01789970|64370795|FG002|Open-label Titration Period|Pregnancy|0|||
23170528|NCT01789970|64370793|FG000|Open-label Titration Period|Other|76|||
23170529|NCT01789970|64370794|FG001|Open-label Titration Period|Other|0|||
23170530|NCT01789970|64370795|FG002|Open-label Titration Period|Other|0|||
23170531|NCT01789970|64370793|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
23170532|NCT01789970|64370794|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
23170533|NCT01789970|64370795|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
23170534|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
23170535|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
23170536|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
23170537|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23170538|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
23170539|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
23170540|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23170541|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
23229141|NCT02477800|64581245|FG000|Long Term Extension Period|Disease Progression|0|||
23229142|NCT02477800|64581246|FG001|Long Term Extension Period|Disease Progression|0|||
23229143|NCT02477800|64581247|FG002|Long Term Extension Period|Disease Progression|0|||
23229144|NCT02477800|64581248|FG003|Long Term Extension Period|Disease Progression|3|||
23229145|NCT02477800|64581249|FG004|Long Term Extension Period|Disease Progression|1|||
23229146|NCT02477800|64581250|FG005|Long Term Extension Period|Disease Progression|1|||
23229147|NCT02477800|64581251|FG006|Long Term Extension Period|Disease Progression|0|||
23229148|NCT02477800|64581245|FG000|Long Term Extension Period|Investigator Decision|0|||
23229149|NCT02477800|64581246|FG001|Long Term Extension Period|Investigator Decision|0|||
23229150|NCT02477800|64581247|FG002|Long Term Extension Period|Investigator Decision|0|||
23229151|NCT02477800|64581248|FG003|Long Term Extension Period|Investigator Decision|0|||
23229152|NCT02477800|64581249|FG004|Long Term Extension Period|Investigator Decision|0|||
23229153|NCT02477800|64581250|FG005|Long Term Extension Period|Investigator Decision|0|||
23229154|NCT02477800|64581251|FG006|Long Term Extension Period|Investigator Decision|2|||
23229155|NCT02477800|64581245|FG000|Long Term Extension Period|Lost to Follow-up|0|||
23229156|NCT02477800|64581246|FG001|Long Term Extension Period|Lost to Follow-up|0|||
23229157|NCT02477800|64581247|FG002|Long Term Extension Period|Lost to Follow-up|0|||
23229158|NCT02477800|64581248|FG003|Long Term Extension Period|Lost to Follow-up|0|||
23229159|NCT02477800|64581249|FG004|Long Term Extension Period|Lost to Follow-up|1|||
23229160|NCT02477800|64581250|FG005|Long Term Extension Period|Lost to Follow-up|3|||
23577096|NCT02718417|65843577|FG002|Follow-up Phase|Withdrawal by Subject|5|||
23577097|NCT02718417|65843575|FG000|Follow-up Phase|Study terminated by sponsor|100|||
23229161|NCT02477800|64581251|FG006|Long Term Extension Period|Lost to Follow-up|0|||
23229162|NCT02477800|64581245|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
23229163|NCT02477800|64581246|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
23229164|NCT02477800|64581247|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
23229165|NCT02477800|64581248|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
23229166|NCT02477800|64581249|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
23229167|NCT02477800|64581250|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
23229168|NCT02477800|64581251|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
23229169|NCT02477800|64581245|FG000|Long Term Extension Period|Study Visit Burden|0|||
23229170|NCT02477800|64581246|FG001|Long Term Extension Period|Study Visit Burden|0|||
23229171|NCT02477800|64581247|FG002|Long Term Extension Period|Study Visit Burden|0|||
23229172|NCT02477800|64581248|FG003|Long Term Extension Period|Study Visit Burden|3|||
23229173|NCT02477800|64581249|FG004|Long Term Extension Period|Study Visit Burden|0|||
23229174|NCT02477800|64581250|FG005|Long Term Extension Period|Study Visit Burden|2|||
23229175|NCT02477800|64581251|FG006|Long Term Extension Period|Study Visit Burden|2|||
23337511|NCT00378508|64979031|FG001|Overall Study|Lost to Follow-up|0|||
23337512|NCT01737710|64979035|FG000|Overall Study|Lost to Follow-up|0|||
23337513|NCT01737710|64979036|FG001|Overall Study|Lost to Follow-up|2|||
23337514|NCT01737710|64979037|FG002|Overall Study|Lost to Follow-up|2|||
23337515|NCT01737710|64979038|FG003|Overall Study|Lost to Follow-up|0|||
23337516|NCT01737710|64979039|FG004|Overall Study|Lost to Follow-up|0|||
23449664|NCT00855959|65388129|FG000|Overall Study|Pregnancy|1|||
23449665|NCT00855959|65388129|FG000|Overall Study|Incorrect enrolment|1|||
23170542|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
23170543|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
23170544|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
23170545|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
23170546|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
23170547|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
23170548|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
23170549|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
23170550|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
23170551|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
23170552|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
23337517|NCT01737710|64979035|FG000|Overall Study|Withdrawal by Subject|1|||
23337518|NCT01737710|64979036|FG001|Overall Study|Withdrawal by Subject|1|||
23337519|NCT01737710|64979037|FG002|Overall Study|Withdrawal by Subject|1|||
23337520|NCT01737710|64979038|FG003|Overall Study|Withdrawal by Subject|0|||
23337521|NCT01737710|64979039|FG004|Overall Study|Withdrawal by Subject|0|||
23337522|NCT01737710|64979035|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
23337523|NCT01737710|64979036|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
23337524|NCT01737710|64979037|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
23337525|NCT01737710|64979038|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
23337526|NCT01737710|64979039|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
23337527|NCT04105218|64979040|FG000|Overall Study|Withdrawal by Subject|3|||
23337528|NCT04105218|64979041|FG001|Overall Study|Withdrawal by Subject|2|||
23337529|NCT04105218|64979040|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
23337530|NCT04105218|64979041|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
23337531|NCT04105218|64979040|FG000|Overall Study|Failed screening tests|2|||
23337532|NCT04105218|64979041|FG001|Overall Study|Failed screening tests|1|||
23337533|NCT02366637|64979042|FG000|First Intervention Period|Adverse Event|0|||
23337534|NCT02366637|64979043|FG001|First Intervention Period|Adverse Event|1|||
23337535|NCT02366637|64979042|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
23337536|NCT02366637|64979043|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
23337537|NCT02366637|64979042|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
23337538|NCT02366637|64979043|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
23337539|NCT01217476|64979049|FG000|Overall Study|Adverse Event|6|||
23337540|NCT01217476|64979050|FG001|Overall Study|Adverse Event|1|||
23337541|NCT01217476|64979049|FG000|Overall Study|Physician Decision|0|||
23337542|NCT01217476|64979050|FG001|Overall Study|Physician Decision|1|||
23337543|NCT01217476|64979049|FG000|Overall Study|Withdrawal by Subject|3|||
23337544|NCT01217476|64979050|FG001|Overall Study|Withdrawal by Subject|3|||
23337545|NCT01217476|64979049|FG000|Overall Study|Surgery on the Target Limb|0|||
23337546|NCT01217476|64979050|FG001|Overall Study|Surgery on the Target Limb|2|||
23337547|NCT01217476|64979049|FG000|Overall Study|Protocol Deviation|1|||
23337548|NCT01217476|64979050|FG001|Overall Study|Protocol Deviation|0|||
23337549|NCT01217476|64979049|FG000|Overall Study|Other|2|||
23337550|NCT01217476|64979050|FG001|Overall Study|Other|0|||
23337551|NCT03233529|64979055|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
23337552|NCT03233529|64979055|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
23337553|NCT00427921|64979056|FG000|Overall Study|Adverse Event|26|||
23337554|NCT00427921|64979056|FG000|Overall Study|Withdrawal by Subject|4|||
23337555|NCT00427921|64979056|FG000|Overall Study|Lost to Follow-up|2|||
23337556|NCT00427921|64979056|FG000|Overall Study|Other reason not specified|10|||
23337557|NCT00427921|64979056|FG000|Overall Study|Adverse Event + Hospitalization|1|||
23337558|NCT00427921|64979056|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
23337559|NCT00427921|64979056|FG000|Overall Study|Adverse Event + No Response|1|||
23337560|NCT00427921|64979056|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
23337561|NCT00427921|64979056|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
23170553|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
23170554|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
23170555|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
23170556|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
23170557|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
23170558|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
23170559|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
23170560|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
23170561|NCT01789970|64370793|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
23170562|NCT01789970|64370794|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
23170563|NCT01789970|64370795|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
23170564|NCT02867995|64370796|FG000|Overall Study|Withdrawal by Subject|0|||
23170565|NCT02867995|64370797|FG001|Overall Study|Withdrawal by Subject|1|||
23337562|NCT00427921|64979056|FG000|Overall Study|Adverse Event + Lost Response|1|||
23337563|NCT00427921|64979056|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
23337564|NCT00427921|64979056|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
23337565|NCT00986921|64979057|FG000|Overall Study|Physician Decision|1|||
23337566|NCT00986921|64979058|FG001|Overall Study|Physician Decision|0|||
23337567|NCT00900159|64979060|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
23337568|NCT00900159|64979061|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
23337569|NCT01942486|64979062|FG000|Overall Study|Lost to Follow-up|27|||
23337570|NCT01062113|64979068|FG000|Overall Study|Adverse Event|1|||
23337571|NCT01062113|64979069|FG001|Overall Study|Adverse Event|0|||
23337572|NCT01062113|64979070|FG002|Overall Study|Adverse Event|0|||
23337573|NCT01062113|64979068|FG000|Overall Study|Lack of Efficacy|38|||
23337574|NCT01062113|64979069|FG001|Overall Study|Lack of Efficacy|22|||
23337575|NCT01062113|64979070|FG002|Overall Study|Lack of Efficacy|31|||
23337576|NCT01062113|64979068|FG000|Overall Study|Withdrawal by Subject|1|||
23337577|NCT01062113|64979069|FG001|Overall Study|Withdrawal by Subject|0|||
23337578|NCT01062113|64979070|FG002|Overall Study|Withdrawal by Subject|0|||
23337579|NCT00932373|64979071|FG000|Overall Study|Progressive disease|3|||
23337580|NCT00932373|64979072|FG001|Overall Study|Progressive disease|1|||
23337581|NCT00932373|64979073|FG002|Overall Study|Progressive disease|0|||
23337582|NCT00932373|64979074|FG003|Overall Study|Progressive disease|0|||
23337583|NCT00932373|64979075|FG004|Overall Study|Progressive disease|10|||
23337584|NCT00932373|64979076|FG005|Overall Study|Progressive disease|1|||
23337585|NCT00932373|64979077|FG006|Overall Study|Progressive disease|0|||
23337586|NCT00932373|64979078|FG007|Overall Study|Progressive disease|2|||
23337587|NCT00932373|64979079|FG008|Overall Study|Progressive disease|1|||
23337588|NCT00932373|64979080|FG009|Overall Study|Progressive disease|9|||
23337589|NCT00932373|64979081|FG010|Overall Study|Progressive disease|2|||
23337590|NCT00932373|64979071|FG000|Overall Study|Adverse Event|0|||
23337591|NCT00932373|64979072|FG001|Overall Study|Adverse Event|0|||
23337592|NCT00932373|64979073|FG002|Overall Study|Adverse Event|0|||
23337593|NCT00932373|64979074|FG003|Overall Study|Adverse Event|0|||
23337594|NCT00932373|64979075|FG004|Overall Study|Adverse Event|2|||
23337595|NCT00932373|64979076|FG005|Overall Study|Adverse Event|1|||
23337596|NCT00932373|64979077|FG006|Overall Study|Adverse Event|0|||
23337597|NCT00932373|64979078|FG007|Overall Study|Adverse Event|1|||
23337598|NCT00932373|64979079|FG008|Overall Study|Adverse Event|0|||
23337599|NCT00932373|64979080|FG009|Overall Study|Adverse Event|2|||
23337600|NCT00932373|64979081|FG010|Overall Study|Adverse Event|1|||
23337601|NCT00932373|64979071|FG000|Overall Study|Physician Decision|0|||
23337602|NCT00932373|64979072|FG001|Overall Study|Physician Decision|0|||
23337603|NCT00932373|64979073|FG002|Overall Study|Physician Decision|1|||
23337604|NCT00932373|64979074|FG003|Overall Study|Physician Decision|0|||
23337605|NCT00932373|64979075|FG004|Overall Study|Physician Decision|2|||
23337606|NCT00932373|64979076|FG005|Overall Study|Physician Decision|0|||
23337607|NCT00932373|64979077|FG006|Overall Study|Physician Decision|0|||
23337608|NCT00932373|64979078|FG007|Overall Study|Physician Decision|0|||
23337609|NCT00932373|64979079|FG008|Overall Study|Physician Decision|0|||
23337610|NCT00932373|64979080|FG009|Overall Study|Physician Decision|1|||
23337611|NCT00932373|64979081|FG010|Overall Study|Physician Decision|0|||
23337612|NCT00932373|64979071|FG000|Overall Study|Dose limiting toxicity|0|||
23337613|NCT00932373|64979072|FG001|Overall Study|Dose limiting toxicity|0|||
23337614|NCT00932373|64979073|FG002|Overall Study|Dose limiting toxicity|0|||
23337615|NCT00932373|64979074|FG003|Overall Study|Dose limiting toxicity|0|||
23337616|NCT00932373|64979075|FG004|Overall Study|Dose limiting toxicity|0|||
23337617|NCT00932373|64979076|FG005|Overall Study|Dose limiting toxicity|1|||
23337618|NCT00932373|64979077|FG006|Overall Study|Dose limiting toxicity|0|||
23337619|NCT00932373|64979078|FG007|Overall Study|Dose limiting toxicity|0|||
23337620|NCT00932373|64979079|FG008|Overall Study|Dose limiting toxicity|0|||
23337621|NCT00932373|64979080|FG009|Overall Study|Dose limiting toxicity|0|||
23337622|NCT00932373|64979081|FG010|Overall Study|Dose limiting toxicity|0|||
23337623|NCT00932373|64979071|FG000|Overall Study|Withdrawal by Subject|0|||
23337624|NCT00932373|64979072|FG001|Overall Study|Withdrawal by Subject|0|||
23337625|NCT00932373|64979073|FG002|Overall Study|Withdrawal by Subject|0|||
23337626|NCT00932373|64979074|FG003|Overall Study|Withdrawal by Subject|0|||
23337627|NCT00932373|64979075|FG004|Overall Study|Withdrawal by Subject|0|||
23337628|NCT00932373|64979076|FG005|Overall Study|Withdrawal by Subject|0|||
23337629|NCT00932373|64979077|FG006|Overall Study|Withdrawal by Subject|0|||
23337630|NCT00932373|64979078|FG007|Overall Study|Withdrawal by Subject|0|||
23170566|NCT02867995|64370796|FG000|Overall Study|Lost to Follow-up|0|||
23337631|NCT00932373|64979079|FG008|Overall Study|Withdrawal by Subject|1|||
23337632|NCT00932373|64979080|FG009|Overall Study|Withdrawal by Subject|0|||
23337633|NCT00932373|64979081|FG010|Overall Study|Withdrawal by Subject|0|||
23337634|NCT00932373|64979071|FG000|Overall Study|Clinical progression|0|||
23337635|NCT00932373|64979072|FG001|Overall Study|Clinical progression|0|||
23337636|NCT00932373|64979073|FG002|Overall Study|Clinical progression|0|||
23337637|NCT00932373|64979074|FG003|Overall Study|Clinical progression|0|||
23337638|NCT00932373|64979075|FG004|Overall Study|Clinical progression|0|||
23337639|NCT00932373|64979076|FG005|Overall Study|Clinical progression|0|||
23337640|NCT00932373|64979077|FG006|Overall Study|Clinical progression|1|||
23337641|NCT00932373|64979078|FG007|Overall Study|Clinical progression|0|||
23337642|NCT00932373|64979079|FG008|Overall Study|Clinical progression|0|||
23337643|NCT00932373|64979080|FG009|Overall Study|Clinical progression|0|||
23337644|NCT00932373|64979081|FG010|Overall Study|Clinical progression|0|||
23337645|NCT00932373|64979071|FG000|Overall Study|Lack of Efficacy|0|||
23337646|NCT00932373|64979072|FG001|Overall Study|Lack of Efficacy|0|||
23337647|NCT00932373|64979073|FG002|Overall Study|Lack of Efficacy|0|||
23337648|NCT00932373|64979074|FG003|Overall Study|Lack of Efficacy|0|||
23337649|NCT00932373|64979075|FG004|Overall Study|Lack of Efficacy|0|||
23337650|NCT00932373|64979076|FG005|Overall Study|Lack of Efficacy|0|||
23337651|NCT00932373|64979077|FG006|Overall Study|Lack of Efficacy|0|||
23337652|NCT00932373|64979078|FG007|Overall Study|Lack of Efficacy|0|||
23337653|NCT00932373|64979079|FG008|Overall Study|Lack of Efficacy|0|||
23337654|NCT00932373|64979080|FG009|Overall Study|Lack of Efficacy|1|||
23337655|NCT00932373|64979081|FG010|Overall Study|Lack of Efficacy|0|||
23337656|NCT00930774|64979083|FG000|Overall Study|Withdrawal by Subject|1|||
23337657|NCT00930774|64979084|FG001|Overall Study|Withdrawal by Subject|9|||
23337658|NCT00930774|64979085|FG002|Overall Study|Withdrawal by Subject|2|||
23337659|NCT00930774|64979086|FG003|Overall Study|Withdrawal by Subject|0|||
23337660|NCT02477332|64979087|FG000|Overall Study|Adverse Event|0|||
23337661|NCT02477332|64979088|FG001|Overall Study|Adverse Event|1|||
23337662|NCT02477332|64979089|FG002|Overall Study|Adverse Event|1|||
23449666|NCT01392547|65388132|FG000|Overall Study|Adverse Event|2|||
23577098|NCT02718417|65843576|FG001|Follow-up Phase|Study terminated by sponsor|138|||
23577099|NCT02718417|65843577|FG002|Follow-up Phase|Study terminated by sponsor|6|||
23577100|NCT02718417|65843575|FG000|Follow-up Phase|Lost to Follow-up|2|||
23577101|NCT02718417|65843576|FG001|Follow-up Phase|Lost to Follow-up|3|||
23577102|NCT02718417|65843577|FG002|Follow-up Phase|Lost to Follow-up|0|||
23577103|NCT02718417|65843575|FG000|Follow-up Phase|Death leading to discontinuation|7|||
23577104|NCT02718417|65843576|FG001|Follow-up Phase|Death leading to discontinuation|7|||
23577105|NCT02718417|65843577|FG002|Follow-up Phase|Death leading to discontinuation|3|||
23577106|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
23577107|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
23577108|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
23577109|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
23577110|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
23577111|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
23577112|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
23577113|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
23577114|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
23577115|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
23577116|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
23577117|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
23577118|NCT02718417|65843575|FG000|Long-term Follow-up Phase|Other|0|||
23577119|NCT02718417|65843576|FG001|Long-term Follow-up Phase|Other|2|||
23577120|NCT02718417|65843577|FG002|Long-term Follow-up Phase|Other|0|||
23577121|NCT00231894|65843595|FG000|Overall Study|Withdrawal by Subject|1|||
23577122|NCT00231894|65843596|FG001|Overall Study|Withdrawal by Subject|1|||
23577123|NCT00439179|65843601|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
23577124|NCT00439179|65843602|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
23577125|NCT00439179|65843603|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
23577126|NCT00439179|65843604|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
23577127|NCT02325713|65843630|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577128|NCT02325713|65843631|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577129|NCT02325713|65843632|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577130|NCT02325713|65843633|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577131|NCT02325713|65843634|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577132|NCT02325713|65843635|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577133|NCT02325713|65843636|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577134|NCT02325713|65843637|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577135|NCT02325713|65843638|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577136|NCT02325713|65843639|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577137|NCT02325713|65843640|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
23577138|NCT02325713|65843641|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577139|NCT02325713|65843642|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577140|NCT02325713|65843643|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577141|NCT02325713|65843644|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23577142|NCT02325713|65843645|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
23170567|NCT02867995|64370797|FG001|Overall Study|Lost to Follow-up|2|||
23170568|NCT01534676|64370798|FG000|Overall Study|Study closed due to poor enrollment|2|||
23170569|NCT01534676|64370799|FG001|Overall Study|Study closed due to poor enrollment|1|||
23449667|NCT01392547|65388132|FG000|Overall Study|Non-compliance|2|||
23449668|NCT01392547|65388132|FG000|Overall Study|Withdrawal criteria|3|||
23577143|NCT02325713|65843630|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
23337663|NCT02477332|64979090|FG003|Overall Study|Adverse Event|2|||
23337664|NCT02477332|64979091|FG004|Overall Study|Adverse Event|1|||
23577144|NCT02325713|65843631|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577145|NCT02325713|65843632|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23337665|NCT02477332|64979092|FG005|Overall Study|Adverse Event|2|||
23337666|NCT02477332|64979087|FG000|Overall Study|Lack of Efficacy|1|||
23337667|NCT02477332|64979088|FG001|Overall Study|Lack of Efficacy|2|||
23337668|NCT02477332|64979089|FG002|Overall Study|Lack of Efficacy|1|||
23337669|NCT02477332|64979090|FG003|Overall Study|Lack of Efficacy|2|||
23337670|NCT02477332|64979091|FG004|Overall Study|Lack of Efficacy|1|||
23337671|NCT02477332|64979092|FG005|Overall Study|Lack of Efficacy|1|||
23337672|NCT02477332|64979087|FG000|Overall Study|Non-compliance with study treatment|0|||
23337673|NCT02477332|64979088|FG001|Overall Study|Non-compliance with study treatment|1|||
23337674|NCT02477332|64979089|FG002|Overall Study|Non-compliance with study treatment|2|||
23577146|NCT02325713|65843633|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577147|NCT02325713|65843634|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577148|NCT02325713|65843635|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577149|NCT02325713|65843636|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577150|NCT02325713|65843637|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577151|NCT02325713|65843638|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577152|NCT02325713|65843639|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577153|NCT02325713|65843640|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577154|NCT02325713|65843641|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577155|NCT02325713|65843642|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577156|NCT02325713|65843643|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577157|NCT02325713|65843644|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577158|NCT02325713|65843645|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
23577159|NCT02325713|65843630|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577160|NCT02325713|65843631|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577161|NCT02325713|65843632|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23337675|NCT02477332|64979090|FG003|Overall Study|Non-compliance with study treatment|0|||
23337676|NCT02477332|64979091|FG004|Overall Study|Non-compliance with study treatment|0|||
23337677|NCT02477332|64979092|FG005|Overall Study|Non-compliance with study treatment|0|||
23337678|NCT02477332|64979087|FG000|Overall Study|Pregnancy|0|||
23337679|NCT02477332|64979088|FG001|Overall Study|Pregnancy|0|||
23337680|NCT02477332|64979089|FG002|Overall Study|Pregnancy|0|||
23337681|NCT02477332|64979090|FG003|Overall Study|Pregnancy|1|||
23337682|NCT02477332|64979091|FG004|Overall Study|Pregnancy|0|||
23337683|NCT02477332|64979092|FG005|Overall Study|Pregnancy|0|||
23577162|NCT02325713|65843633|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577163|NCT02325713|65843634|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577164|NCT02325713|65843635|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23170570|NCT01344876|64370800|FG000|Overall Study|Adverse Event|0|||
23170571|NCT01344876|64370801|FG001|Overall Study|Adverse Event|0|||
23170572|NCT01344876|64370802|FG002|Overall Study|Adverse Event|0|||
23170573|NCT01344876|64370803|FG003|Overall Study|Adverse Event|0|||
23170574|NCT01344876|64370804|FG004|Overall Study|Adverse Event|1|||
23170575|NCT01344876|64370800|FG000|Overall Study|Withdrawal by Subject|0|||
23170576|NCT01344876|64370801|FG001|Overall Study|Withdrawal by Subject|0|||
23337684|NCT02477332|64979087|FG000|Overall Study|Protocol Violation|2|||
23337685|NCT02477332|64979088|FG001|Overall Study|Protocol Violation|0|||
23337686|NCT02477332|64979089|FG002|Overall Study|Protocol Violation|3|||
23229176|NCT02477800|64581245|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
23229177|NCT02477800|64581246|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
23229178|NCT02477800|64581247|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
23229179|NCT02477800|64581248|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
23229180|NCT02477800|64581249|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
23229181|NCT02477800|64581250|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
23229182|NCT02477800|64581251|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
23229183|NCT02477800|64581245|FG000|Long Term Extension Period|Reason not Specified|0|||
23229184|NCT02477800|64581246|FG001|Long Term Extension Period|Reason not Specified|0|||
23229185|NCT02477800|64581247|FG002|Long Term Extension Period|Reason not Specified|0|||
23229186|NCT02477800|64581248|FG003|Long Term Extension Period|Reason not Specified|126|||
23229187|NCT02477800|64581249|FG004|Long Term Extension Period|Reason not Specified|140|||
23229188|NCT02477800|64581250|FG005|Long Term Extension Period|Reason not Specified|270|||
23229189|NCT02477800|64581251|FG006|Long Term Extension Period|Reason not Specified|224|||
23229190|NCT03258762|64581252|FG000|Overall Study|Lost to Follow-up|0|||
23229191|NCT03258762|64581253|FG001|Overall Study|Lost to Follow-up|1|||
23229192|NCT01156012|64581260|FG000|Overall Study|Adverse Event|3|||
23229193|NCT01156012|64581261|FG001|Overall Study|Adverse Event|1|||
23229194|NCT01156012|64581260|FG000|Overall Study|Lost to Follow-up|1|||
23229195|NCT01156012|64581261|FG001|Overall Study|Lost to Follow-up|0|||
23229196|NCT01156012|64581260|FG000|Overall Study|Withdrawal by Subject|1|||
23229197|NCT01156012|64581261|FG001|Overall Study|Withdrawal by Subject|0|||
23229198|NCT01156012|64581260|FG000|Overall Study|use of commercial drug instead of study|0|||
23229199|NCT01156012|64581261|FG001|Overall Study|use of commercial drug instead of study|1|||
23229200|NCT01156012|64581260|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
23229201|NCT01156012|64581261|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
23229202|NCT00679354|64581262|FG000|Overall Study|Death|3|||
23229203|NCT00679354|64581262|FG000|Overall Study|Lack of Efficacy|22|||
23229204|NCT00679354|64581262|FG000|Overall Study|Physician Decision|4|||
23229205|NCT00679354|64581262|FG000|Overall Study|Ineligible|1|||
23229206|NCT02975206|64581263|FG000|Overall Study|Withdrawal by Subject|14|||
23229207|NCT02975206|64581264|FG001|Overall Study|Withdrawal by Subject|11|||
23229208|NCT02975206|64581265|FG002|Overall Study|Withdrawal by Subject|11|||
23229209|NCT02975206|64581263|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
23229210|NCT02975206|64581264|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
23229211|NCT02975206|64581265|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
23229212|NCT04652102|64581266|FG000|Overall Study|Adverse Event|14|||
23229213|NCT04652102|64581267|FG001|Overall Study|Adverse Event|13|||
23229214|NCT04652102|64581266|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
23229215|NCT04652102|64581267|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
23229216|NCT04652102|64581266|FG000|Overall Study|Physician Decision|78|||
23229217|NCT04652102|64581267|FG001|Overall Study|Physician Decision|40|||
23229218|NCT04652102|64581266|FG000|Overall Study|Study Ended by Sponsor|64|||
23229219|NCT04652102|64581267|FG001|Overall Study|Study Ended by Sponsor|17|||
23229220|NCT04652102|64581266|FG000|Overall Study|Withdrawal by Subject|4625|||
23229221|NCT04652102|64581267|FG001|Overall Study|Withdrawal by Subject|5594|||
23229222|NCT04652102|64581266|FG000|Overall Study|Lost to Follow-up|2019|||
23229223|NCT04652102|64581267|FG001|Overall Study|Lost to Follow-up|1082|||
23229224|NCT04652102|64581266|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
23229225|NCT04652102|64581267|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
23229226|NCT04652102|64581266|FG000|Overall Study|Miscellaneous|80|||
23229227|NCT04652102|64581267|FG001|Overall Study|Miscellaneous|64|||
23229228|NCT01468844|64581269|FG000|Overall Study|Adverse Event|1|||
23229229|NCT01468844|64581270|FG001|Overall Study|Adverse Event|0|||
23229230|NCT01468844|64581269|FG000|Overall Study|Withdrawal by Subject|1|||
23229231|NCT01468844|64581270|FG001|Overall Study|Withdrawal by Subject|0|||
23229232|NCT04062240|64581271|FG000|Overall Study|equipment malfunction|1|||
23229233|NCT01738594|64581273|FG000|Registration and Treatment Start|Adverse Event|0|||
23229234|NCT01738594|64581274|FG001|Registration and Treatment Start|Adverse Event|1|||
23229235|NCT01738594|64581275|FG002|Registration and Treatment Start|Adverse Event|0|||
23229236|NCT01738594|64581276|FG003|Registration and Treatment Start|Adverse Event|0|||
23229237|NCT01738594|64581277|FG004|Registration and Treatment Start|Adverse Event|0|||
23229238|NCT01738594|64581278|FG005|Registration and Treatment Start|Adverse Event|0|||
23229239|NCT01738594|64581279|FG006|Registration and Treatment Start|Adverse Event|0|||
23229240|NCT01738594|64581280|FG007|Registration and Treatment Start|Adverse Event|0|||
23229241|NCT01738594|64581273|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23229242|NCT01738594|64581274|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23229243|NCT01738594|64581275|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23229244|NCT01738594|64581276|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23229245|NCT01738594|64581277|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23337687|NCT02477332|64979090|FG003|Overall Study|Protocol Violation|3|||
23337688|NCT02477332|64979091|FG004|Overall Study|Protocol Violation|1|||
23229246|NCT01738594|64581278|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
23229247|NCT01738594|64581279|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23229248|NCT01738594|64581280|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
23229249|NCT01738594|64581273|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
23229250|NCT01738594|64581274|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
23229251|NCT01738594|64581275|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
23229252|NCT01738594|64581276|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
23229253|NCT01738594|64581277|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
23229254|NCT01738594|64581278|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
23337689|NCT02477332|64979092|FG005|Overall Study|Protocol Violation|1|||
23337690|NCT02477332|64979087|FG000|Overall Study|Technical problems|0|||
23337691|NCT02477332|64979088|FG001|Overall Study|Technical problems|0|||
23577165|NCT02325713|65843636|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577166|NCT02325713|65843637|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577167|NCT02325713|65843638|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577168|NCT02325713|65843639|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
23577169|NCT02325713|65843640|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577170|NCT02325713|65843641|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577171|NCT02325713|65843642|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577172|NCT02325713|65843643|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577173|NCT02325713|65843644|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577174|NCT02325713|65843645|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
23577175|NCT02320721|65843646|FG000|Overall Study|Adverse Event|6|||
23577176|NCT02320721|65843647|FG001|Overall Study|Adverse Event|6|||
23577177|NCT02320721|65843646|FG000|Overall Study|Lack of Efficacy|2|||
23577178|NCT02320721|65843647|FG001|Overall Study|Lack of Efficacy|0|||
23577179|NCT02320721|65843646|FG000|Overall Study|Poor compliance to protocol|3|||
23577180|NCT02320721|65843647|FG001|Overall Study|Poor compliance to protocol|7|||
23577181|NCT02320721|65843646|FG000|Overall Study|Randomized but not treated|0|||
23577182|NCT02320721|65843647|FG001|Overall Study|Randomized but not treated|1|||
23577183|NCT02320721|65843646|FG000|Overall Study|Hypoglycemia|1|||
23577184|NCT02320721|65843647|FG001|Overall Study|Hypoglycemia|0|||
23577185|NCT02320721|65843646|FG000|Overall Study|Other than specified above|15|||
23577186|NCT02320721|65843647|FG001|Overall Study|Other than specified above|20|||
23577187|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Adverse Event|5|||
23577188|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Adverse Event|13|||
23577189|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Adverse Event|0|||
23577190|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
23577191|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
23229255|NCT01738594|64581279|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
23229256|NCT01738594|64581280|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
23229257|NCT01738594|64581273|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23229258|NCT01738594|64581274|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23229259|NCT01738594|64581275|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23229260|NCT01738594|64581276|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23229261|NCT01738594|64581277|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23229262|NCT01738594|64581278|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
23229263|NCT01738594|64581279|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23229264|NCT01738594|64581280|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
23229265|NCT01738594|64581273|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23337692|NCT02477332|64979089|FG002|Overall Study|Technical problems|1|||
23337693|NCT02477332|64979090|FG003|Overall Study|Technical problems|0|||
23337694|NCT02477332|64979091|FG004|Overall Study|Technical problems|0|||
23337695|NCT02477332|64979092|FG005|Overall Study|Technical problems|0|||
23337696|NCT02477332|64979087|FG000|Overall Study|Lost to Follow-up|0|||
23337697|NCT02477332|64979088|FG001|Overall Study|Lost to Follow-up|0|||
23337698|NCT02477332|64979089|FG002|Overall Study|Lost to Follow-up|2|||
23337699|NCT02477332|64979090|FG003|Overall Study|Lost to Follow-up|0|||
23449669|NCT01392547|65388132|FG000|Overall Study|Unclassified|1|||
23449670|NCT01076959|65388136|FG000|Overall Study|Adverse Event|767|||
23449671|NCT01076959|65388136|FG000|Overall Study|Lack of Efficacy|849|||
23449672|NCT01076959|65388136|FG000|Overall Study|Non-compliance|274|||
23449673|NCT01076959|65388136|FG000|Overall Study|Lost to Follow-up|241|||
23449674|NCT01076959|65388136|FG000|Overall Study|Other|119|||
23449675|NCT02420379|65388137|FG000|Overall Study|Withdrawal by Subject|0|||
23577192|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
23577193|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
23577194|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
23577195|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
23337700|NCT02477332|64979091|FG004|Overall Study|Lost to Follow-up|0|||
23337701|NCT02477332|64979092|FG005|Overall Study|Lost to Follow-up|0|||
23577196|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
23577197|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
23577198|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
23577199|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
23577200|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
23577201|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
23577202|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
23577203|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
23577204|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
23577205|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Physician Decision|2|||
23577206|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Physician Decision|3|||
23577207|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Physician Decision|0|||
23577208|NCT01449929|65843648|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
23577209|NCT01449929|65843649|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
23577210|NCT01449929|65843650|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
23577211|NCT01449929|65843648|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
23577212|NCT01449929|65843649|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
23577213|NCT01449929|65843650|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
23577214|NCT01449929|65843648|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
23337702|NCT02477332|64979087|FG000|Overall Study|Physician Decision|0|||
23337703|NCT02477332|64979088|FG001|Overall Study|Physician Decision|0|||
23337704|NCT02477332|64979089|FG002|Overall Study|Physician Decision|1|||
23337705|NCT02477332|64979090|FG003|Overall Study|Physician Decision|3|||
23337706|NCT02477332|64979091|FG004|Overall Study|Physician Decision|0|||
23337707|NCT02477332|64979092|FG005|Overall Study|Physician Decision|1|||
23337708|NCT02477332|64979087|FG000|Overall Study|Withdrawal by Subject|0|||
23337709|NCT02477332|64979088|FG001|Overall Study|Withdrawal by Subject|3|||
23337710|NCT02477332|64979089|FG002|Overall Study|Withdrawal by Subject|1|||
23337711|NCT02477332|64979090|FG003|Overall Study|Withdrawal by Subject|2|||
23337712|NCT02477332|64979091|FG004|Overall Study|Withdrawal by Subject|1|||
23337713|NCT02477332|64979092|FG005|Overall Study|Withdrawal by Subject|0|||
23170577|NCT01344876|64370802|FG002|Overall Study|Withdrawal by Subject|1|||
23170578|NCT01344876|64370803|FG003|Overall Study|Withdrawal by Subject|0|||
23170579|NCT01344876|64370804|FG004|Overall Study|Withdrawal by Subject|0|||
23170580|NCT01344876|64370800|FG000|Overall Study|Definite progression of primary disease|1|||
23170581|NCT01344876|64370801|FG001|Overall Study|Definite progression of primary disease|0|||
23170582|NCT01344876|64370802|FG002|Overall Study|Definite progression of primary disease|0|||
23170583|NCT01344876|64370803|FG003|Overall Study|Definite progression of primary disease|3|||
23170584|NCT01344876|64370804|FG004|Overall Study|Definite progression of primary disease|0|||
23170585|NCT01106846|64370805|FG000|Overall Study|Change in surgical procedure|0|||
23229266|NCT01738594|64581274|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23229267|NCT01738594|64581275|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23229268|NCT01738594|64581276|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23229269|NCT01738594|64581277|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23337714|NCT03224598|64979093|FG000|Overall Study|Lost to Follow-up|0|||
23337715|NCT03224598|64979094|FG001|Overall Study|Lost to Follow-up|2|||
23337716|NCT03224598|64979095|FG002|Overall Study|Lost to Follow-up|0|||
23577215|NCT01449929|65843649|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
23577216|NCT01449929|65843650|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
23577217|NCT01449929|65843648|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
23577218|NCT01449929|65843649|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
23577219|NCT01449929|65843650|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
23577220|NCT02276547|65843651|FG000|Overall Study|Death|2|||
23577221|NCT02276547|65843651|FG000|Overall Study|Explant|2|||
23577222|NCT01603121|65843652|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
23577223|NCT01603121|65843653|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
23577224|NCT03619174|65843656|FG000|Overall Study|Lost to Follow-up|3|||
23577225|NCT03619174|65843657|FG001|Overall Study|Lost to Follow-up|0|||
23577226|NCT03619174|65843656|FG000|Overall Study|Withdrawal by Subject|4|||
23577227|NCT03619174|65843657|FG001|Overall Study|Withdrawal by Subject|3|||
23577228|NCT03619174|65843656|FG000|Overall Study|Pregnancy|1|||
23577229|NCT03619174|65843657|FG001|Overall Study|Pregnancy|1|||
23229270|NCT01738594|64581278|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
23229271|NCT01738594|64581279|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23229272|NCT01738594|64581280|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
23229273|NCT01738594|64581273|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23229274|NCT01738594|64581274|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23229275|NCT01738594|64581275|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23229276|NCT01738594|64581276|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23229277|NCT01738594|64581277|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
23229278|NCT01738594|64581278|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23229279|NCT01738594|64581279|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23229280|NCT01738594|64581280|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
23229281|NCT01738594|64581273|FG000|Follow up for 1 Year|Death|0|||
23229282|NCT01738594|64581274|FG001|Follow up for 1 Year|Death|0|||
23229283|NCT01738594|64581275|FG002|Follow up for 1 Year|Death|0|||
23229284|NCT01738594|64581276|FG003|Follow up for 1 Year|Death|0|||
23229285|NCT01738594|64581277|FG004|Follow up for 1 Year|Death|0|||
23229286|NCT01738594|64581278|FG005|Follow up for 1 Year|Death|1|||
23229287|NCT01738594|64581279|FG006|Follow up for 1 Year|Death|0|||
23229288|NCT01738594|64581280|FG007|Follow up for 1 Year|Death|0|||
23229289|NCT01738594|64581273|FG000|Follow up for 1 Year|Other|0|||
23229290|NCT01738594|64581274|FG001|Follow up for 1 Year|Other|0|||
23229291|NCT01738594|64581275|FG002|Follow up for 1 Year|Other|0|||
23229292|NCT01738594|64581276|FG003|Follow up for 1 Year|Other|0|||
23229293|NCT01738594|64581277|FG004|Follow up for 1 Year|Other|0|||
23229294|NCT01738594|64581278|FG005|Follow up for 1 Year|Other|2|||
23229295|NCT01738594|64581279|FG006|Follow up for 1 Year|Other|0|||
23229296|NCT01738594|64581280|FG007|Follow up for 1 Year|Other|0|||
23229297|NCT00982111|64581283|FG000|Overall Study|Adverse Event|1|||
23229298|NCT00982111|64581284|FG001|Overall Study|Adverse Event|1|||
23229299|NCT00982111|64581283|FG000|Overall Study|Progressive Disease|46|||
23229300|NCT00982111|64581284|FG001|Overall Study|Progressive Disease|39|||
23229301|NCT00982111|64581283|FG000|Overall Study|Lost to Follow-up|9|||
23229302|NCT00982111|64581284|FG001|Overall Study|Lost to Follow-up|6|||
23229303|NCT00982111|64581283|FG000|Overall Study|New Anti-Cancer Therapy|5|||
23229304|NCT00982111|64581284|FG001|Overall Study|New Anti-Cancer Therapy|5|||
23229305|NCT00982111|64581283|FG000|Overall Study|Medical Decision|1|||
23229306|NCT00982111|64581284|FG001|Overall Study|Medical Decision|0|||
23229307|NCT00982111|64581283|FG000|Overall Study|Withdrawal by Subject|17|||
23229308|NCT00982111|64581284|FG001|Overall Study|Withdrawal by Subject|19|||
23229309|NCT00982111|64581283|FG000|Overall Study|Global Study End|0|||
23229310|NCT00982111|64581284|FG001|Overall Study|Global Study End|1|||
23229311|NCT00982111|64581283|FG000|Overall Study|Sponsor's Decision|0|||
23229312|NCT00982111|64581284|FG001|Overall Study|Sponsor's Decision|1|||
23229313|NCT01196091|64581285|FG000|Overall Study|Adverse Event|22|||
23229314|NCT01196091|64581286|FG001|Overall Study|Adverse Event|27|||
23229315|NCT01196091|64581287|FG002|Overall Study|Adverse Event|26|||
23337717|NCT03224598|64979093|FG000|Overall Study|Other|0|||
23577230|NCT03619174|65843656|FG000|Overall Study|Discomfort during treatment|1|||
23229316|NCT01196091|64581285|FG000|Overall Study|Death|3|||
23229317|NCT01196091|64581286|FG001|Overall Study|Death|2|||
23229318|NCT01196091|64581287|FG002|Overall Study|Death|2|||
23229319|NCT01196091|64581285|FG000|Overall Study|Entry Criteria Not Met|11|||
23229320|NCT01196091|64581286|FG001|Overall Study|Entry Criteria Not Met|11|||
23229321|NCT01196091|64581287|FG002|Overall Study|Entry Criteria Not Met|10|||
23229322|NCT01196091|64581285|FG000|Overall Study|Lack of Efficacy|15|||
23229323|NCT01196091|64581286|FG001|Overall Study|Lack of Efficacy|12|||
23229324|NCT01196091|64581287|FG002|Overall Study|Lack of Efficacy|17|||
23577231|NCT03619174|65843657|FG001|Overall Study|Discomfort during treatment|0|||
23577232|NCT03909165|65843658|FG000|Overall Study|Physician Decision|0|||
23577233|NCT03909165|65843659|FG001|Overall Study|Physician Decision|1|||
23577234|NCT03909165|65843660|FG002|Overall Study|Physician Decision|0|||
23449676|NCT02420379|65388138|FG001|Overall Study|Withdrawal by Subject|3|||
23449677|NCT02420379|65388137|FG000|Overall Study|Unable to complete due to schooling|0|||
23449678|NCT02420379|65388138|FG001|Overall Study|Unable to complete due to schooling|1|||
23449679|NCT02420379|65388137|FG000|Overall Study|Transitioned to commercial drug|1|||
23449680|NCT02420379|65388138|FG001|Overall Study|Transitioned to commercial drug|0|||
23449681|NCT01276639|65388139|FG000|Week 0 to 16|Death|1|||
23449682|NCT01276639|65388140|FG001|Week 0 to 16|Death|0|||
23449683|NCT01276639|65388141|FG002|Week 0 to 16|Death|0|||
23449684|NCT01276639|65388142|FG003|Week 0 to 16|Death|0|||
23449685|NCT01276639|65388143|FG004|Week 0 to 16|Death|0|||
23449686|NCT01276639|65388139|FG000|Week 0 to 16|Adverse Event|11|||
23449687|NCT01276639|65388140|FG001|Week 0 to 16|Adverse Event|8|||
23449688|NCT01276639|65388141|FG002|Week 0 to 16|Adverse Event|11|||
23449689|NCT01276639|65388142|FG003|Week 0 to 16|Adverse Event|0|||
23449690|NCT01276639|65388143|FG004|Week 0 to 16|Adverse Event|0|||
23449691|NCT01276639|65388139|FG000|Week 0 to 16|Lack of Efficacy|20|||
23449692|NCT01276639|65388140|FG001|Week 0 to 16|Lack of Efficacy|15|||
23449693|NCT01276639|65388141|FG002|Week 0 to 16|Lack of Efficacy|25|||
23449694|NCT01276639|65388142|FG003|Week 0 to 16|Lack of Efficacy|0|||
23449695|NCT01276639|65388143|FG004|Week 0 to 16|Lack of Efficacy|0|||
23449696|NCT01276639|65388139|FG000|Week 0 to 16|Lost to Follow-up|3|||
23449697|NCT01276639|65388140|FG001|Week 0 to 16|Lost to Follow-up|5|||
23449698|NCT01276639|65388141|FG002|Week 0 to 16|Lost to Follow-up|3|||
23449699|NCT01276639|65388142|FG003|Week 0 to 16|Lost to Follow-up|0|||
23449700|NCT01276639|65388143|FG004|Week 0 to 16|Lost to Follow-up|0|||
23449701|NCT01276639|65388139|FG000|Week 0 to 16|Withdrawal by Subject|8|||
23449702|NCT01276639|65388140|FG001|Week 0 to 16|Withdrawal by Subject|5|||
23449703|NCT01276639|65388141|FG002|Week 0 to 16|Withdrawal by Subject|4|||
23449704|NCT01276639|65388142|FG003|Week 0 to 16|Withdrawal by Subject|0|||
23449705|NCT01276639|65388143|FG004|Week 0 to 16|Withdrawal by Subject|0|||
23449706|NCT01276639|65388139|FG000|Week 0 to 16|Other|7|||
23449707|NCT01276639|65388140|FG001|Week 0 to 16|Other|7|||
23449708|NCT01276639|65388141|FG002|Week 0 to 16|Other|2|||
23449709|NCT01276639|65388142|FG003|Week 0 to 16|Other|0|||
23449710|NCT01276639|65388143|FG004|Week 0 to 16|Other|0|||
23449711|NCT01276639|65388139|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
23449712|NCT01276639|65388140|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
23449713|NCT01276639|65388141|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
23449714|NCT01276639|65388142|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
23577235|NCT03909165|65843661|FG003|Overall Study|Physician Decision|0|||
23577236|NCT03909165|65843662|FG004|Overall Study|Physician Decision|0|||
23577237|NCT03909165|65843658|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23577238|NCT03909165|65843659|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23577239|NCT03909165|65843660|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23577240|NCT03909165|65843661|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23577241|NCT03909165|65843662|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
23170586|NCT01106846|64370806|FG001|Overall Study|Change in surgical procedure|1|||
23170587|NCT00577993|64370807|FG000|Overall Study|Adverse Event|1|||
23170588|NCT00577993|64370808|FG001|Overall Study|Adverse Event|0|||
23170589|NCT00577993|64370809|FG002|Overall Study|Adverse Event|0|||
23449715|NCT01276639|65388143|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
23170590|NCT00577993|64370807|FG000|Overall Study|Death|0|||
23449716|NCT01276639|65388139|FG000|Week 16 to 52|Death|1|||
23449717|NCT01276639|65388140|FG001|Week 16 to 52|Death|0|||
23449718|NCT01276639|65388141|FG002|Week 16 to 52|Death|0|||
23449719|NCT01276639|65388142|FG003|Week 16 to 52|Death|0|||
23577242|NCT03909165|65843658|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
23577243|NCT03909165|65843659|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
23577244|NCT03909165|65843660|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
23577245|NCT03909165|65843661|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
23577246|NCT03909165|65843662|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
23577247|NCT03909165|65843658|FG000|Overall Study|Previous Drug Exposure|0|||
23170591|NCT00577993|64370808|FG001|Overall Study|Death|1|||
23170592|NCT00577993|64370809|FG002|Overall Study|Death|1|||
23170593|NCT00577993|64370807|FG000|Overall Study|Lack of Efficacy|0|||
23170594|NCT00577993|64370808|FG001|Overall Study|Lack of Efficacy|1|||
23170595|NCT00577993|64370809|FG002|Overall Study|Lack of Efficacy|0|||
23449720|NCT01276639|65388143|FG004|Week 16 to 52|Death|0|||
23449721|NCT01276639|65388139|FG000|Week 16 to 52|Adverse Event|10|||
23449722|NCT01276639|65388140|FG001|Week 16 to 52|Adverse Event|13|||
23449723|NCT01276639|65388141|FG002|Week 16 to 52|Adverse Event|0|||
23449724|NCT01276639|65388142|FG003|Week 16 to 52|Adverse Event|1|||
23449725|NCT01276639|65388143|FG004|Week 16 to 52|Adverse Event|3|||
23170596|NCT00577993|64370807|FG000|Overall Study|Protocol Violation|2|||
23449726|NCT01276639|65388139|FG000|Week 16 to 52|Lack of Efficacy|99|||
23449727|NCT01276639|65388140|FG001|Week 16 to 52|Lack of Efficacy|71|||
23449728|NCT01276639|65388141|FG002|Week 16 to 52|Lack of Efficacy|0|||
23449729|NCT01276639|65388142|FG003|Week 16 to 52|Lack of Efficacy|14|||
23577248|NCT03909165|65843659|FG001|Overall Study|Previous Drug Exposure|0|||
23577249|NCT03909165|65843660|FG002|Overall Study|Previous Drug Exposure|1|||
23577250|NCT03909165|65843661|FG003|Overall Study|Previous Drug Exposure|0|||
23577251|NCT03909165|65843662|FG004|Overall Study|Previous Drug Exposure|0|||
23577252|NCT03909165|65843658|FG000|Overall Study|Early Discharge|1|||
23577253|NCT03909165|65843659|FG001|Overall Study|Early Discharge|0|||
23577254|NCT03909165|65843660|FG002|Overall Study|Early Discharge|0|||
23229325|NCT01196091|64581285|FG000|Overall Study|Lost to Follow-up|5|||
23229326|NCT01196091|64581286|FG001|Overall Study|Lost to Follow-up|5|||
23229327|NCT01196091|64581287|FG002|Overall Study|Lost to Follow-up|6|||
23229328|NCT01196091|64581285|FG000|Overall Study|Parent/Caregiver Decision|0|||
23577255|NCT03909165|65843661|FG003|Overall Study|Early Discharge|0|||
23577256|NCT03909165|65843662|FG004|Overall Study|Early Discharge|0|||
23577257|NCT04179461|65843663|FG000|Overall Study|Lost to Follow-up|4|||
23577258|NCT00701311|65843667|FG000|Overall Study|Lack of Efficacy|3|||
23577259|NCT00701311|65843667|FG000|Overall Study|Adverse Event|3|||
23577260|NCT00701311|65843667|FG000|Overall Study|Withdrawal by Subject|2|||
23577261|NCT03785340|65843677|FG000|Overall Study|Lost to Follow-up|2|||
23577262|NCT03785340|65843678|FG001|Overall Study|Lost to Follow-up|0|||
23577263|NCT03785340|65843677|FG000|Overall Study|Adverse Event|1|||
23577264|NCT03785340|65843678|FG001|Overall Study|Adverse Event|0|||
23577265|NCT03929302|65843682|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
23337718|NCT03224598|64979094|FG001|Overall Study|Other|1|||
23577266|NCT03929302|65843683|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
23577267|NCT03929302|65843684|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
23577268|NCT03929302|65843682|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
23577269|NCT03929302|65843683|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
23577270|NCT03929302|65843684|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
23577271|NCT03929302|65843682|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
23577272|NCT03929302|65843683|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
23577273|NCT03929302|65843684|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
23577274|NCT04707391|65843685|FG000|Overall Study|Adverse Event|5|||
23577275|NCT04707391|65843686|FG001|Overall Study|Adverse Event|8|||
23577276|NCT04707391|65843685|FG000|Overall Study|Lost to Follow-up|44|||
23577277|NCT04707391|65843686|FG001|Overall Study|Lost to Follow-up|31|||
23577278|NCT04707391|65843685|FG000|Overall Study|Protocol Violation|1|||
23229329|NCT01196091|64581286|FG001|Overall Study|Parent/Caregiver Decision|0|||
23577279|NCT04707391|65843686|FG001|Overall Study|Protocol Violation|5|||
23577280|NCT04707391|65843685|FG000|Overall Study|Withdrawal by Subject|27|||
23577281|NCT04707391|65843686|FG001|Overall Study|Withdrawal by Subject|25|||
23577282|NCT04707391|65843685|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
23577283|NCT04707391|65843686|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
23577284|NCT04707391|65843685|FG000|Overall Study|Other|0|||
23577285|NCT04707391|65843686|FG001|Overall Study|Other|2|||
23577286|NCT02501811|65843687|FG000|Overall Study|Death|1|||
23577287|NCT02501811|65843688|FG001|Overall Study|Death|3|||
23577288|NCT02501811|65843689|FG002|Overall Study|Death|2|||
23577289|NCT02501811|65843690|FG003|Overall Study|Death|3|||
23577290|NCT02501811|65843687|FG000|Overall Study|Withdrawal by Subject|3|||
23229330|NCT01196091|64581287|FG002|Overall Study|Parent/Caregiver Decision|1|||
23229331|NCT01196091|64581285|FG000|Overall Study|Withdrawal by Subject|16|||
23229332|NCT01196091|64581286|FG001|Overall Study|Withdrawal by Subject|19|||
23229333|NCT01196091|64581287|FG002|Overall Study|Withdrawal by Subject|22|||
23229334|NCT01196091|64581285|FG000|Overall Study|Physician Decision|3|||
23229335|NCT01196091|64581286|FG001|Overall Study|Physician Decision|3|||
23229336|NCT01196091|64581287|FG002|Overall Study|Physician Decision|4|||
23229337|NCT01196091|64581285|FG000|Overall Study|Protocol Violation|1|||
23229338|NCT01196091|64581286|FG001|Overall Study|Protocol Violation|3|||
23229339|NCT01196091|64581287|FG002|Overall Study|Protocol Violation|3|||
23337719|NCT03224598|64979095|FG002|Overall Study|Other|0|||
23337720|NCT02760004|64979096|FG000|Overall Study|Lost to Follow-up|13|||
23337721|NCT02760004|64979097|FG001|Overall Study|Lost to Follow-up|22|||
23577291|NCT02501811|65843688|FG001|Overall Study|Withdrawal by Subject|3|||
23577292|NCT02501811|65843689|FG002|Overall Study|Withdrawal by Subject|2|||
23577293|NCT02501811|65843690|FG003|Overall Study|Withdrawal by Subject|3|||
23577294|NCT02501811|65843687|FG000|Overall Study|Lost to Follow-up|0|||
23577295|NCT02501811|65843688|FG001|Overall Study|Lost to Follow-up|0|||
23577296|NCT02501811|65843689|FG002|Overall Study|Lost to Follow-up|2|||
23577297|NCT02501811|65843690|FG003|Overall Study|Lost to Follow-up|1|||
23577298|NCT01375959|65843691|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
23577299|NCT01375959|65843692|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
23577300|NCT01375959|65843691|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
23577301|NCT01375959|65843692|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
23229340|NCT01196091|64581285|FG000|Overall Study|Sponsor Decision|6|||
23449730|NCT01276639|65388143|FG004|Week 16 to 52|Lack of Efficacy|13|||
23577302|NCT01375959|65843691|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
23577303|NCT01375959|65843692|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
23577304|NCT00737061|65843693|FG000|Waiting Period|Lost to Follow-up|6|||
23577305|NCT00737061|65843693|FG000|Waiting Period|Withdrawal by Subject|1|||
23577306|NCT00737061|65843693|FG000|Waiting Period|Bilateral placement failure|34|||
23577307|NCT00737061|65843693|FG000|Waiting Period|Deemed patent following HSG|26|||
23577308|NCT00737061|65843693|FG000|Waiting Period|Alternative contraception failure|3|||
23577309|NCT00737061|65843693|FG000|Waiting Period|Elected surgical tubal ligation|5|||
23577310|NCT00737061|65843693|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
23577311|NCT00737061|65843693|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
23577312|NCT00737061|65843693|FG000|1 Year Wearing Period|Discontinued reilance|3|||
23577313|NCT00737061|65843693|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
23577314|NCT01232556|65843694|FG000|Overall Study|Withdrawal by Subject|21|||
23577315|NCT01232556|65843695|FG001|Overall Study|Withdrawal by Subject|17|||
23577316|NCT01232556|65843694|FG000|Overall Study|Death|97|||
23577317|NCT01232556|65843695|FG001|Overall Study|Death|97|||
23577318|NCT01232556|65843694|FG000|Overall Study|Lost to Follow-up|0|||
23577319|NCT01232556|65843695|FG001|Overall Study|Lost to Follow-up|2|||
23577320|NCT01232556|65843694|FG000|Overall Study|Terminated by Sponsor|35|||
23577321|NCT01232556|65843695|FG001|Overall Study|Terminated by Sponsor|51|||
23577322|NCT01232556|65843694|FG000|Overall Study|Other|6|||
23577323|NCT01232556|65843695|FG001|Overall Study|Other|4|||
23577324|NCT01575860|65843702|FG000|Overall Study|Withdrawal by Subject|1|||
23577325|NCT01575860|65843702|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
23577326|NCT04004208|65843705|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23577327|NCT04004208|65843706|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23577328|NCT04004208|65843705|FG000|Overall Study|Death|3|||
23577329|NCT04004208|65843706|FG001|Overall Study|Death|0|||
23577330|NCT04004208|65843705|FG000|Overall Study|COVID-19 pandemic|1|||
23577331|NCT04004208|65843706|FG001|Overall Study|COVID-19 pandemic|0|||
23577332|NCT04004208|65843705|FG000|Overall Study|Physician Decision|1|||
23577333|NCT04004208|65843706|FG001|Overall Study|Physician Decision|0|||
23577334|NCT04004208|65843705|FG000|Overall Study|Adverse Event|1|||
23577335|NCT04004208|65843706|FG001|Overall Study|Adverse Event|1|||
23577336|NCT00124982|65843707|FG000|Short-term Period|Death|1|||
23577337|NCT00124982|65843708|FG001|Short-term Period|Death|1|||
23577338|NCT00124982|65843709|FG002|Short-term Period|Death|0|||
23577339|NCT00124982|65843707|FG000|Short-term Period|Adverse Event|17|||
23577340|NCT00124982|65843708|FG001|Short-term Period|Adverse Event|22|||
23577341|NCT00124982|65843709|FG002|Short-term Period|Adverse Event|0|||
23577342|NCT00124982|65843707|FG000|Short-term Period|Lack of Efficacy|32|||
23577343|NCT00124982|65843708|FG001|Short-term Period|Lack of Efficacy|73|||
23577344|NCT00124982|65843709|FG002|Short-term Period|Lack of Efficacy|0|||
23577345|NCT00124982|65843707|FG000|Short-term Period|Lost to Follow-up|8|||
23577346|NCT00124982|65843708|FG001|Short-term Period|Lost to Follow-up|5|||
23577347|NCT00124982|65843709|FG002|Short-term Period|Lost to Follow-up|0|||
23577348|NCT00124982|65843707|FG000|Short-term Period|Withdrawal of Consent|7|||
23577349|NCT00124982|65843708|FG001|Short-term Period|Withdrawal of Consent|9|||
23577350|NCT00124982|65843709|FG002|Short-term Period|Withdrawal of Consent|0|||
23577351|NCT00124982|65843707|FG000|Short-term Period|Poor/Non-compliance|3|||
23577352|NCT00124982|65843708|FG001|Short-term Period|Poor/Non-compliance|1|||
23577353|NCT00124982|65843709|FG002|Short-term Period|Poor/Non-compliance|0|||
23577354|NCT00124982|65843707|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
23577355|NCT00124982|65843708|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
23577356|NCT00124982|65843709|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
23577357|NCT00124982|65843707|FG000|Short-term Period|Participant Decision|1|||
23577358|NCT00124982|65843708|FG001|Short-term Period|Participant Decision|0|||
23577359|NCT00124982|65843709|FG002|Short-term Period|Participant Decision|0|||
23577360|NCT00124982|65843707|FG000|Short-term Period|Participant Chose Own Doctor|0|||
23577361|NCT00124982|65843708|FG001|Short-term Period|Participant Chose Own Doctor|1|||
23170597|NCT00577993|64370808|FG001|Overall Study|Protocol Violation|3|||
23170598|NCT00577993|64370809|FG002|Overall Study|Protocol Violation|0|||
23170599|NCT00577993|64370807|FG000|Overall Study|Withdrawal by Subject|1|||
23170600|NCT00577993|64370808|FG001|Overall Study|Withdrawal by Subject|0|||
23170601|NCT00577993|64370809|FG002|Overall Study|Withdrawal by Subject|2|||
23170602|NCT00577993|64370807|FG000|Overall Study|Conversion|2|||
23577362|NCT00124982|65843709|FG002|Short-term Period|Participant Chose Own Doctor|0|||
23170603|NCT00577993|64370808|FG001|Overall Study|Conversion|5|||
23577363|NCT00124982|65843707|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
23577364|NCT00124982|65843708|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
23577365|NCT00124982|65843709|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
23170604|NCT00577993|64370809|FG002|Overall Study|Conversion|0|||
23577366|NCT00124982|65843707|FG000|Short-term Period|Participant Had Lymphopenia|1|||
23577367|NCT00124982|65843708|FG001|Short-term Period|Participant Had Lymphopenia|0|||
23577368|NCT00124982|65843709|FG002|Short-term Period|Participant Had Lymphopenia|0|||
23577369|NCT00124982|65843707|FG000|Long-term Period|Death|0|||
23449731|NCT01276639|65388139|FG000|Week 16 to 52|Lost to Follow-up|3|||
23449732|NCT01276639|65388140|FG001|Week 16 to 52|Lost to Follow-up|1|||
23449733|NCT01276639|65388141|FG002|Week 16 to 52|Lost to Follow-up|0|||
23449734|NCT01276639|65388142|FG003|Week 16 to 52|Lost to Follow-up|0|||
23449735|NCT01276639|65388143|FG004|Week 16 to 52|Lost to Follow-up|1|||
23449736|NCT01276639|65388139|FG000|Week 16 to 52|Withdrawal by Subject|4|||
23170605|NCT00577993|64370807|FG000|Overall Study|Uninsured|1|||
23170606|NCT00577993|64370808|FG001|Overall Study|Uninsured|0|||
23170607|NCT00577993|64370809|FG002|Overall Study|Uninsured|0|||
23449737|NCT01276639|65388140|FG001|Week 16 to 52|Withdrawal by Subject|4|||
23449738|NCT01276639|65388141|FG002|Week 16 to 52|Withdrawal by Subject|0|||
23449739|NCT01276639|65388142|FG003|Week 16 to 52|Withdrawal by Subject|0|||
23449740|NCT01276639|65388143|FG004|Week 16 to 52|Withdrawal by Subject|1|||
23449741|NCT01276639|65388139|FG000|Week 16 to 52|Other|10|||
23449742|NCT01276639|65388140|FG001|Week 16 to 52|Other|12|||
23449743|NCT01276639|65388141|FG002|Week 16 to 52|Other|0|||
23449744|NCT01276639|65388142|FG003|Week 16 to 52|Other|1|||
23449745|NCT01276639|65388143|FG004|Week 16 to 52|Other|3|||
23449746|NCT01620086|65388145|FG000|Overall Study|Withdrawal by Subject|3|||
23449747|NCT01620086|65388146|FG001|Overall Study|Withdrawal by Subject|3|||
23449748|NCT01620086|65388147|FG002|Overall Study|Withdrawal by Subject|0|||
23449749|NCT01620086|65388145|FG000|Overall Study|failed study criteria|1|||
23449750|NCT01620086|65388146|FG001|Overall Study|failed study criteria|4|||
23449751|NCT01620086|65388147|FG002|Overall Study|failed study criteria|0|||
23449752|NCT01620086|65388145|FG000|Overall Study|Physician Decision|1|||
23449753|NCT01620086|65388146|FG001|Overall Study|Physician Decision|0|||
23449754|NCT01620086|65388147|FG002|Overall Study|Physician Decision|0|||
23449755|NCT03683173|65388152|FG000|Completed Follow-up|Unavailable|235|||
23170608|NCT01564862|64370810|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
23170609|NCT01564862|64370811|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
23170610|NCT01564862|64370812|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
23170611|NCT01564862|64370810|FG000|Overall Study|Major Protocol Deviation|3|||
23170612|NCT01564862|64370811|FG001|Overall Study|Major Protocol Deviation|3|||
23170613|NCT01564862|64370812|FG002|Overall Study|Major Protocol Deviation|4|||
23170614|NCT01564862|64370810|FG000|Overall Study|Lost to Follow-up|10|||
23170615|NCT01564862|64370811|FG001|Overall Study|Lost to Follow-up|8|||
23170616|NCT01564862|64370812|FG002|Overall Study|Lost to Follow-up|6|||
23449756|NCT03683173|65388153|FG001|Completed Follow-up|Unavailable|217|||
23449757|NCT03683173|65388152|FG000|Completed Follow-up|Refused|69|||
23449758|NCT03683173|65388153|FG001|Completed Follow-up|Refused|59|||
23449759|NCT03683173|65388152|FG000|Completed Follow-up|Disconnected phone|65|||
23449760|NCT03683173|65388153|FG001|Completed Follow-up|Disconnected phone|95|||
23449761|NCT03683173|65388152|FG000|Completed Follow-up|Health issue/deceased|10|||
23449762|NCT03683173|65388153|FG001|Completed Follow-up|Health issue/deceased|4|||
23449763|NCT03683173|65388152|FG000|Completed Follow-up|Moved away|8|||
23449764|NCT03683173|65388153|FG001|Completed Follow-up|Moved away|1|||
23170617|NCT01564862|64370810|FG000|Overall Study|Voluntary Withdrawal|9|||
23170618|NCT01564862|64370811|FG001|Overall Study|Voluntary Withdrawal|6|||
23170619|NCT01564862|64370812|FG002|Overall Study|Voluntary Withdrawal|8|||
23170620|NCT01564862|64370810|FG000|Overall Study|Lack of Efficacy|1|||
23449765|NCT01425801|65388162|FG000|Period 1|Withdrawal by Subject|0|||
23170621|NCT01564862|64370811|FG001|Overall Study|Lack of Efficacy|5|||
23170622|NCT01564862|64370812|FG002|Overall Study|Lack of Efficacy|6|||
23449766|NCT01425801|65388163|FG001|Period 1|Withdrawal by Subject|0|||
23449767|NCT01425801|65388164|FG002|Period 1|Withdrawal by Subject|0|||
23449768|NCT01425801|65388165|FG003|Period 1|Withdrawal by Subject|0|||
23449769|NCT01425801|65388166|FG004|Period 1|Withdrawal by Subject|1|||
23229341|NCT01196091|64581286|FG001|Overall Study|Sponsor Decision|5|||
23229342|NCT01196091|64581287|FG002|Overall Study|Sponsor Decision|4|||
23229343|NCT01196091|64581285|FG000|Overall Study|Excluded Site|5|||
23229344|NCT01196091|64581286|FG001|Overall Study|Excluded Site|11|||
23577370|NCT00124982|65843708|FG001|Long-term Period|Death|0|||
23577371|NCT00124982|65843709|FG002|Long-term Period|Death|1|||
23577372|NCT00124982|65843707|FG000|Long-term Period|Adverse Event|0|||
23577373|NCT00124982|65843708|FG001|Long-term Period|Adverse Event|0|||
23577374|NCT00124982|65843709|FG002|Long-term Period|Adverse Event|17|||
23577375|NCT00124982|65843707|FG000|Long-term Period|Lack of Efficacy|0|||
23577376|NCT00124982|65843708|FG001|Long-term Period|Lack of Efficacy|0|||
23577377|NCT00124982|65843709|FG002|Long-term Period|Lack of Efficacy|46|||
23229345|NCT01196091|64581287|FG002|Overall Study|Excluded Site|8|||
23229346|NCT01196091|64581285|FG000|Overall Study|Randomized, No Study Drug Received|1|||
23229347|NCT01196091|64581286|FG001|Overall Study|Randomized, No Study Drug Received|0|||
23229348|NCT01196091|64581287|FG002|Overall Study|Randomized, No Study Drug Received|1|||
23577378|NCT00124982|65843707|FG000|Long-term Period|Lost to Follow-up|0|||
23577379|NCT00124982|65843708|FG001|Long-term Period|Lost to Follow-up|0|||
23577380|NCT00124982|65843709|FG002|Long-term Period|Lost to Follow-up|4|||
23577381|NCT00124982|65843707|FG000|Long-term Period|Withdrawal by Subject|0|||
23577382|NCT00124982|65843708|FG001|Long-term Period|Withdrawal by Subject|0|||
23229349|NCT01882439|64581293|FG000|Overall Study|Adverse event related to study drug|3|||
23229350|NCT01882439|64581294|FG001|Overall Study|Adverse event related to study drug|8|||
23229351|NCT01882439|64581295|FG002|Overall Study|Adverse event related to study drug|1|||
23229352|NCT01882439|64581296|FG003|Overall Study|Adverse event related to study drug|2|||
23229353|NCT01882439|64581293|FG000|Overall Study|Pregnancy|0|||
23229354|NCT01882439|64581294|FG001|Overall Study|Pregnancy|1|||
23229355|NCT01882439|64581295|FG002|Overall Study|Pregnancy|0|||
23229356|NCT01882439|64581296|FG003|Overall Study|Pregnancy|0|||
23229357|NCT01882439|64581293|FG000|Overall Study|Protocol Violation|2|||
23229358|NCT01882439|64581294|FG001|Overall Study|Protocol Violation|2|||
23229359|NCT01882439|64581295|FG002|Overall Study|Protocol Violation|0|||
23229360|NCT01882439|64581296|FG003|Overall Study|Protocol Violation|1|||
23229361|NCT01882439|64581293|FG000|Overall Study|No longer willing to participate|1|||
23229362|NCT01882439|64581294|FG001|Overall Study|No longer willing to participate|4|||
23229363|NCT01882439|64581295|FG002|Overall Study|No longer willing to participate|2|||
23229364|NCT01882439|64581296|FG003|Overall Study|No longer willing to participate|3|||
23229365|NCT01882439|64581293|FG000|Overall Study|Medication error with no associated AE|0|||
23229366|NCT01882439|64581294|FG001|Overall Study|Medication error with no associated AE|0|||
23229367|NCT01882439|64581295|FG002|Overall Study|Medication error with no associated AE|2|||
23229368|NCT01882439|64581296|FG003|Overall Study|Medication error with no associated AE|0|||
23229369|NCT01882439|64581293|FG000|Overall Study|Insufficient clinical response|1|||
23229370|NCT01882439|64581294|FG001|Overall Study|Insufficient clinical response|4|||
23229371|NCT01882439|64581295|FG002|Overall Study|Insufficient clinical response|4|||
23229372|NCT01882439|64581296|FG003|Overall Study|Insufficient clinical response|2|||
23577383|NCT00124982|65843709|FG002|Long-term Period|Withdrawal by Subject|16|||
23577384|NCT00124982|65843707|FG000|Long-term Period|Pregnancy|0|||
23577385|NCT00124982|65843708|FG001|Long-term Period|Pregnancy|0|||
23577386|NCT00124982|65843709|FG002|Long-term Period|Pregnancy|1|||
23577387|NCT00124982|65843707|FG000|Long-term Period|Poor/Non-compliance|0|||
23229373|NCT01882439|64581293|FG000|Overall Study|Adverse event unrelated to study drug|2|||
23229374|NCT01882439|64581294|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23577388|NCT00124982|65843708|FG001|Long-term Period|Poor/Non-compliance|0|||
23577389|NCT00124982|65843709|FG002|Long-term Period|Poor/Non-compliance|2|||
23229375|NCT01882439|64581295|FG002|Overall Study|Adverse event unrelated to study drug|1|||
23229376|NCT01882439|64581296|FG003|Overall Study|Adverse event unrelated to study drug|1|||
23229377|NCT04411472|64581300|FG000|Overall Study|Adverse Event|5|||
23229378|NCT04411472|64581301|FG001|Overall Study|Adverse Event|10|||
23229379|NCT04411472|64581302|FG002|Overall Study|Adverse Event|1|||
23229380|NCT04411472|64581303|FG003|Overall Study|Adverse Event|0|||
23229381|NCT04411472|64581304|FG004|Overall Study|Adverse Event|0|||
23449770|NCT01425801|65388167|FG005|Period 1|Withdrawal by Subject|0|||
23577390|NCT00124982|65843707|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
23229382|NCT04411472|64581305|FG005|Overall Study|Adverse Event|0|||
23229383|NCT04411472|64581300|FG000|Overall Study|Protocol Violation|1|||
23229384|NCT04411472|64581301|FG001|Overall Study|Protocol Violation|0|||
23229385|NCT04411472|64581302|FG002|Overall Study|Protocol Violation|0|||
23229386|NCT04411472|64581303|FG003|Overall Study|Protocol Violation|0|||
23577391|NCT00124982|65843708|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
23577392|NCT00124982|65843709|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
23577393|NCT00124982|65843707|FG000|Long-term Period|Neurologist Recommendation|0|||
23577394|NCT00124982|65843708|FG001|Long-term Period|Neurologist Recommendation|0|||
23337722|NCT00617890|64979098|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
23337723|NCT00617890|64979099|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
23337724|NCT00617890|64979100|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
23337725|NCT00617890|64979101|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
23337726|NCT00617890|64979098|FG000|Overall Study|Lack of Efficacy|23|||
23337727|NCT00617890|64979099|FG001|Overall Study|Lack of Efficacy|26|||
23337728|NCT00617890|64979100|FG002|Overall Study|Lack of Efficacy|30|||
23337729|NCT00617890|64979101|FG003|Overall Study|Lack of Efficacy|97|||
23337730|NCT00617890|64979098|FG000|Overall Study|Lost to Follow-up|0|||
23337731|NCT00617890|64979099|FG001|Overall Study|Lost to Follow-up|0|||
23337732|NCT00617890|64979100|FG002|Overall Study|Lost to Follow-up|1|||
23337733|NCT00617890|64979101|FG003|Overall Study|Lost to Follow-up|2|||
23337734|NCT00617890|64979098|FG000|Overall Study|Withdrawal by Subject|4|||
23337735|NCT00617890|64979099|FG001|Overall Study|Withdrawal by Subject|1|||
23337736|NCT00617890|64979100|FG002|Overall Study|Withdrawal by Subject|0|||
23337737|NCT00617890|64979101|FG003|Overall Study|Withdrawal by Subject|2|||
23337738|NCT00617890|64979098|FG000|Overall Study|Protocol Violation|2|||
23337739|NCT00617890|64979099|FG001|Overall Study|Protocol Violation|1|||
23337740|NCT00617890|64979100|FG002|Overall Study|Protocol Violation|0|||
23337741|NCT00617890|64979101|FG003|Overall Study|Protocol Violation|0|||
23337742|NCT00617890|64979098|FG000|Overall Study|Adverse Event|1|||
23337743|NCT00617890|64979099|FG001|Overall Study|Adverse Event|0|||
23337744|NCT00617890|64979100|FG002|Overall Study|Adverse Event|3|||
23337745|NCT00617890|64979101|FG003|Overall Study|Adverse Event|8|||
23337746|NCT00617890|64979098|FG000|Overall Study|Not treated|1|||
23337747|NCT00617890|64979099|FG001|Overall Study|Not treated|0|||
23170623|NCT01564862|64370810|FG000|Overall Study|Other reason(s)|1|||
23170624|NCT01564862|64370811|FG001|Overall Study|Other reason(s)|0|||
23170625|NCT01564862|64370812|FG002|Overall Study|Other reason(s)|0|||
23337748|NCT00617890|64979100|FG002|Overall Study|Not treated|1|||
23337749|NCT00617890|64979101|FG003|Overall Study|Not treated|1|||
23337750|NCT01866111|64979102|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
23337751|NCT01866111|64979103|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
23337752|NCT01866111|64979104|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
23337753|NCT01866111|64979105|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
23337754|NCT01866111|64979102|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
23170626|NCT02627495|64370813|FG000|Overall Study|Withdrawal by Subject|4|||
23170627|NCT00797732|64370816|FG000|Overall Study|Withdrawal by Subject|3|||
23170628|NCT00797732|64370817|FG001|Overall Study|Withdrawal by Subject|3|||
23170629|NCT00797732|64370818|FG002|Overall Study|Withdrawal by Subject|0|||
23170630|NCT00797732|64370816|FG000|Overall Study|Lost to Follow-up|1|||
23170631|NCT00797732|64370817|FG001|Overall Study|Lost to Follow-up|0|||
23170632|NCT00797732|64370818|FG002|Overall Study|Lost to Follow-up|0|||
23170633|NCT00797732|64370816|FG000|Overall Study|Death|1|||
23170634|NCT00797732|64370817|FG001|Overall Study|Death|0|||
23170635|NCT00797732|64370818|FG002|Overall Study|Death|0|||
23170636|NCT00797732|64370816|FG000|Overall Study|Not meet inclusion criteria|0|||
23170637|NCT00797732|64370817|FG001|Overall Study|Not meet inclusion criteria|0|||
23170638|NCT00797732|64370818|FG002|Overall Study|Not meet inclusion criteria|7|||
23170639|NCT00797732|64370816|FG000|Overall Study|Excluded due to time constraints|0|||
23170640|NCT00797732|64370817|FG001|Overall Study|Excluded due to time constraints|0|||
23170641|NCT00797732|64370818|FG002|Overall Study|Excluded due to time constraints|24|||
23170642|NCT00797732|64370816|FG000|Overall Study|Refused to Participate|0|||
23170643|NCT00797732|64370817|FG001|Overall Study|Refused to Participate|0|||
23170644|NCT00797732|64370818|FG002|Overall Study|Refused to Participate|123|||
23170645|NCT02599961|64370819|FG000|Overall Study|Withdrawal by Subject|1|||
23170646|NCT02599961|64370819|FG000|Overall Study|Subject Non-Compliance|2|||
23170647|NCT02599961|64370819|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
23170648|NCT02599961|64370819|FG000|Overall Study|Other, Not Specified|3|||
23170649|NCT03665285|64370820|FG000|Overall Study|Started New Anticancer Treatment|1|||
23170650|NCT03665285|64370821|FG001|Overall Study|Started New Anticancer Treatment|1|||
23170651|NCT03665285|64370822|FG002|Overall Study|Started New Anticancer Treatment|2|||
23170652|NCT03665285|64370823|FG003|Overall Study|Started New Anticancer Treatment|4|||
23170653|NCT03665285|64370824|FG004|Overall Study|Started New Anticancer Treatment|1|||
23229387|NCT04411472|64581304|FG004|Overall Study|Protocol Violation|0|||
23337755|NCT01866111|64979103|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
23337756|NCT01866111|64979104|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
23337757|NCT01866111|64979105|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
23337758|NCT03070002|64979106|FG000|Follow up for 2 Years|Death|1|||
23449771|NCT01425801|65388162|FG000|Period 2|Withdrawal by Subject|0|||
23449772|NCT01425801|65388163|FG001|Period 2|Withdrawal by Subject|0|||
23449773|NCT01425801|65388164|FG002|Period 2|Withdrawal by Subject|0|||
23449774|NCT01425801|65388165|FG003|Period 2|Withdrawal by Subject|0|||
23449775|NCT01425801|65388166|FG004|Period 2|Withdrawal by Subject|1|||
23449776|NCT01425801|65388167|FG005|Period 2|Withdrawal by Subject|0|||
23449777|NCT01425801|65388162|FG000|Period 3|Stability criteria not fullfilled|0|||
23449778|NCT01425801|65388163|FG001|Period 3|Stability criteria not fullfilled|0|||
23449779|NCT01425801|65388164|FG002|Period 3|Stability criteria not fullfilled|1|||
23449780|NCT01425801|65388165|FG003|Period 3|Stability criteria not fullfilled|0|||
23449781|NCT01425801|65388166|FG004|Period 3|Stability criteria not fullfilled|0|||
23449782|NCT01425801|65388167|FG005|Period 3|Stability criteria not fullfilled|0|||
23449783|NCT01425801|65388162|FG000|Period 4|Not able to maintain visit schedule|0|||
23449784|NCT01425801|65388163|FG001|Period 4|Not able to maintain visit schedule|0|||
23449785|NCT01425801|65388164|FG002|Period 4|Not able to maintain visit schedule|1|||
23449786|NCT01425801|65388165|FG003|Period 4|Not able to maintain visit schedule|0|||
23449787|NCT01425801|65388166|FG004|Period 4|Not able to maintain visit schedule|0|||
23449788|NCT01425801|65388167|FG005|Period 4|Not able to maintain visit schedule|0|||
23449789|NCT01745367|65388168|FG000|Overall Study|Death|1|||
23170654|NCT03665285|64370825|FG005|Overall Study|Started New Anticancer Treatment|1|||
23170655|NCT03665285|64370826|FG006|Overall Study|Started New Anticancer Treatment|2|||
23170656|NCT03665285|64370827|FG007|Overall Study|Started New Anticancer Treatment|15|||
23170657|NCT03665285|64370828|FG008|Overall Study|Started New Anticancer Treatment|1|||
23170658|NCT03665285|64370820|FG000|Overall Study|Disease Progression|0|||
23170659|NCT03665285|64370821|FG001|Overall Study|Disease Progression|0|||
23170660|NCT03665285|64370822|FG002|Overall Study|Disease Progression|3|||
23170661|NCT03665285|64370823|FG003|Overall Study|Disease Progression|1|||
23170662|NCT03665285|64370824|FG004|Overall Study|Disease Progression|0|||
23170663|NCT03665285|64370825|FG005|Overall Study|Disease Progression|0|||
23170664|NCT03665285|64370826|FG006|Overall Study|Disease Progression|0|||
23170665|NCT03665285|64370827|FG007|Overall Study|Disease Progression|7|||
23170666|NCT03665285|64370828|FG008|Overall Study|Disease Progression|1|||
23170667|NCT03665285|64370820|FG000|Overall Study|Hospice|0|||
23170668|NCT03665285|64370821|FG001|Overall Study|Hospice|0|||
23229388|NCT04411472|64581305|FG005|Overall Study|Protocol Violation|0|||
23449790|NCT01745367|65388169|FG001|Overall Study|Death|0|||
23449791|NCT01745367|65388168|FG000|Overall Study|Withdrawal by Subject|1|||
23449792|NCT01745367|65388169|FG001|Overall Study|Withdrawal by Subject|2|||
23449793|NCT01745367|65388168|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
23229389|NCT04411472|64581300|FG000|Overall Study|Withdrawal by Subject|0|||
23229390|NCT04411472|64581301|FG001|Overall Study|Withdrawal by Subject|1|||
23170669|NCT03665285|64370822|FG002|Overall Study|Hospice|0|||
23337759|NCT02693002|64979107|FG000|Overall Study|Withdrawal by Subject|1|||
23337760|NCT02693002|64979108|FG001|Overall Study|Withdrawal by Subject|0|||
23337761|NCT04439214|64979117|FG000|Overall Study|Adverse Event|13|||
23337762|NCT04439214|64979117|FG000|Overall Study|Disease progression|16|||
23337763|NCT04439214|64979117|FG000|Overall Study|Death|1|||
23337764|NCT04439214|64979117|FG000|Overall Study|Withdrawal by Subject|2|||
23337765|NCT04439214|64979117|FG000|Overall Study|Declining health|1|||
23337766|NCT04439214|64979117|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
23337767|NCT04439214|64979117|FG000|Overall Study|Ineligible|5|||
23337768|NCT02702388|64979120|FG000|Overall Study|Disease Progression|18|||
23337769|NCT02702388|64979121|FG001|Overall Study|Disease Progression|25|||
23337770|NCT02702388|64979120|FG000|Overall Study|Withdrawal by Subject|9|||
23337771|NCT02702388|64979121|FG001|Overall Study|Withdrawal by Subject|7|||
23337772|NCT02702388|64979120|FG000|Overall Study|Adverse Event|11|||
23337773|NCT02702388|64979121|FG001|Overall Study|Adverse Event|15|||
23449794|NCT01745367|65388169|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
23449795|NCT01745367|65388168|FG000|Overall Study|Other Reasons Unspecified|0|||
23449796|NCT01745367|65388169|FG001|Overall Study|Other Reasons Unspecified|2|||
23449797|NCT00718510|65388170|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
23449798|NCT00718510|65388171|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23449799|NCT00718510|65388170|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
23449800|NCT00718510|65388171|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23449801|NCT00743249|65388172|FG000|Overall Study|Adverse Event|0|||
23449802|NCT00743249|65388173|FG001|Overall Study|Adverse Event|4|||
23449803|NCT00743249|65388172|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
23449804|NCT00743249|65388173|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
23449805|NCT00743249|65388172|FG000|Overall Study|Unsuccessful insertion of stent|2|||
23449806|NCT00743249|65388173|FG001|Overall Study|Unsuccessful insertion of stent|1|||
23449807|NCT01272232|65388182|FG000|Weeks 0-56|Adverse Event|39|||
23449808|NCT01272232|65388183|FG001|Weeks 0-56|Adverse Event|18|||
23337774|NCT02702388|64979120|FG000|Overall Study|Other|2|||
23449809|NCT01272232|65388184|FG002|Weeks 0-56|Adverse Event|7|||
23449810|NCT01272232|65388182|FG000|Weeks 0-56|Lack of Efficacy|0|||
23170670|NCT03665285|64370823|FG003|Overall Study|Hospice|0|||
23229391|NCT04411472|64581302|FG002|Overall Study|Withdrawal by Subject|0|||
23229392|NCT04411472|64581303|FG003|Overall Study|Withdrawal by Subject|1|||
23229393|NCT04411472|64581304|FG004|Overall Study|Withdrawal by Subject|0|||
23229394|NCT04411472|64581305|FG005|Overall Study|Withdrawal by Subject|0|||
23170671|NCT03665285|64370824|FG004|Overall Study|Hospice|0|||
23170672|NCT03665285|64370825|FG005|Overall Study|Hospice|0|||
23170673|NCT03665285|64370826|FG006|Overall Study|Hospice|0|||
23170674|NCT03665285|64370827|FG007|Overall Study|Hospice|2|||
23170675|NCT03665285|64370828|FG008|Overall Study|Hospice|0|||
23170676|NCT03665285|64370820|FG000|Overall Study|Withdrawal by Subject|0|||
23170677|NCT03665285|64370821|FG001|Overall Study|Withdrawal by Subject|0|||
23170678|NCT03665285|64370822|FG002|Overall Study|Withdrawal by Subject|0|||
23170679|NCT03665285|64370823|FG003|Overall Study|Withdrawal by Subject|0|||
23170680|NCT03665285|64370824|FG004|Overall Study|Withdrawal by Subject|1|||
23170681|NCT03665285|64370825|FG005|Overall Study|Withdrawal by Subject|0|||
23229395|NCT04411472|64581300|FG000|Overall Study|Physician Decision|1|||
23229396|NCT04411472|64581301|FG001|Overall Study|Physician Decision|0|||
23337775|NCT02702388|64979121|FG001|Overall Study|Other|4|||
23170682|NCT03665285|64370826|FG006|Overall Study|Withdrawal by Subject|0|||
23337776|NCT01264081|64979127|FG000|Participants Screened|Screening failures|30|||
23337777|NCT01264081|64979127|FG000|Started Treatment|Withdrawal by Subject|1|||
23337778|NCT01264081|64979127|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
23337779|NCT03728426|64979130|FG000|Overall Study|Death|3|||
23449811|NCT01272232|65388183|FG001|Weeks 0-56|Lack of Efficacy|0|||
23337780|NCT01750697|64979131|FG000|Overall Study|Transferred Back to Local Hospital|1|||
23337781|NCT01750697|64979131|FG000|Overall Study|Physician and Family Decision|1|||
23337782|NCT01750697|64979131|FG000|Overall Study|Transferred to Adult Services|5|||
23337783|NCT01750697|64979131|FG000|Overall Study|Physician Decision|1|||
23337784|NCT01750697|64979131|FG000|Overall Study|Withdrawal by Subject|1|||
23337785|NCT02048826|64979134|FG000|Overall Study|Withdrawal by Subject|1|||
23337786|NCT02048826|64979135|FG001|Overall Study|Withdrawal by Subject|0|||
23337787|NCT00280397|64979136|FG000|Overall Study|Adverse Event|1|||
23170683|NCT03665285|64370827|FG007|Overall Study|Withdrawal by Subject|2|||
23170684|NCT03665285|64370828|FG008|Overall Study|Withdrawal by Subject|0|||
23170685|NCT03665285|64370820|FG000|Overall Study|Physician Decision|0|||
23170686|NCT03665285|64370821|FG001|Overall Study|Physician Decision|0|||
23337788|NCT02126579|64979137|FG000|Overall Study|disease progression|0|||
23337789|NCT02126579|64979138|FG001|Overall Study|disease progression|0|||
23337790|NCT02126579|64979139|FG002|Overall Study|disease progression|0|||
23337791|NCT02126579|64979140|FG003|Overall Study|disease progression|1|||
23337792|NCT02126579|64979141|FG004|Overall Study|disease progression|0|||
23337793|NCT02126579|64979142|FG005|Overall Study|disease progression|0|||
23337794|NCT02126579|64979143|FG006|Overall Study|disease progression|1|||
23337795|NCT02649439|64979144|FG000|Overall Study|Switched to alternative treatment|6|||
23337796|NCT02649439|64979145|FG001|Overall Study|Switched to alternative treatment|4|||
23337797|NCT02649439|64979144|FG000|Overall Study|Patient decision|1|||
23337798|NCT02649439|64979145|FG001|Overall Study|Patient decision|0|||
23337799|NCT02649439|64979144|FG000|Overall Study|Patient going out of country|1|||
23337800|NCT02649439|64979145|FG001|Overall Study|Patient going out of country|0|||
23337801|NCT02649439|64979144|FG000|Overall Study|To start finasteride|1|||
23170687|NCT03665285|64370822|FG002|Overall Study|Physician Decision|0|||
23170688|NCT03665285|64370823|FG003|Overall Study|Physician Decision|0|||
23170689|NCT03665285|64370824|FG004|Overall Study|Physician Decision|0|||
23229397|NCT04411472|64581302|FG002|Overall Study|Physician Decision|0|||
23229398|NCT04411472|64581303|FG003|Overall Study|Physician Decision|0|||
23229399|NCT04411472|64581304|FG004|Overall Study|Physician Decision|0|||
23229400|NCT04411472|64581305|FG005|Overall Study|Physician Decision|0|||
23229401|NCT04411472|64581300|FG000|Overall Study|Study terminated by sponsor|17|||
23229402|NCT04411472|64581301|FG001|Overall Study|Study terminated by sponsor|20|||
23170690|NCT03665285|64370825|FG005|Overall Study|Physician Decision|0|||
23170691|NCT03665285|64370826|FG006|Overall Study|Physician Decision|0|||
23170692|NCT03665285|64370827|FG007|Overall Study|Physician Decision|2|||
23170693|NCT03665285|64370828|FG008|Overall Study|Physician Decision|0|||
23170694|NCT01073566|64370829|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
23170695|NCT01073566|64370830|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
23170696|NCT02275338|64370831|FG000|Overall Study|Adverse Event|15|||
23170697|NCT02275338|64370831|FG000|Overall Study|Lack of Efficacy|3|||
23170698|NCT02275338|64370831|FG000|Overall Study|Withdrawal by Subject|4|||
23170699|NCT02275338|64370831|FG000|Overall Study|Disease progression (death)|1|||
23170700|NCT02275338|64370831|FG000|Overall Study|Ineligible to start Phase 2|4|||
23170701|NCT02275338|64370831|FG000|Overall Study|Reason not specified|5|||
23170702|NCT02275338|64370831|FG000|Overall Study|Does not meet entry criteria|1|||
23170703|NCT02682901|64370832|FG000|Overall Study|Adverse Event|10|||
23170704|NCT02682901|64370833|FG001|Overall Study|Adverse Event|3|||
23170705|NCT02682901|64370832|FG000|Overall Study|Lack of Efficacy|0|||
23170706|NCT02682901|64370833|FG001|Overall Study|Lack of Efficacy|1|||
23229403|NCT04411472|64581302|FG002|Overall Study|Study terminated by sponsor|3|||
23229404|NCT04411472|64581303|FG003|Overall Study|Study terminated by sponsor|0|||
23229405|NCT04411472|64581304|FG004|Overall Study|Study terminated by sponsor|0|||
23337802|NCT02649439|64979145|FG001|Overall Study|To start finasteride|0|||
23337803|NCT02649439|64979144|FG000|Overall Study|Physician Decision|1|||
23449812|NCT01272232|65388184|FG002|Weeks 0-56|Lack of Efficacy|3|||
23337804|NCT02649439|64979145|FG001|Overall Study|Physician Decision|0|||
23337805|NCT02649439|64979144|FG000|Overall Study|Disease progression on study|12|||
23337806|NCT02649439|64979145|FG001|Overall Study|Disease progression on study|13|||
23337807|NCT02649439|64979144|FG000|Overall Study|Refused further treatment|1|||
23337808|NCT02649439|64979145|FG001|Overall Study|Refused further treatment|0|||
23337809|NCT02649439|64979144|FG000|Overall Study|Refused further follow up|2|||
23337810|NCT02649439|64979145|FG001|Overall Study|Refused further follow up|7|||
23337811|NCT02649439|64979144|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
23337812|NCT02649439|64979145|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
23337813|NCT02649439|64979144|FG000|Overall Study|No treatment, per protocol|1|||
23337814|NCT02649439|64979145|FG001|Overall Study|No treatment, per protocol|0|||
23337815|NCT02649439|64979144|FG000|Overall Study|PSA DT makes ineligible|0|||
23337816|NCT02649439|64979145|FG001|Overall Study|PSA DT makes ineligible|1|||
23337817|NCT02649439|64979144|FG000|Overall Study|Rising PSA No Mets|0|||
23337818|NCT02649439|64979145|FG001|Overall Study|Rising PSA No Mets|1|||
23337819|NCT02649439|64979144|FG000|Overall Study|Rising PSA|0|||
23229406|NCT04411472|64581305|FG005|Overall Study|Study terminated by sponsor|0|||
23229407|NCT04815291|64581308|FG000|Overall Study|Lost to Follow-up|1|||
23229408|NCT04815291|64581308|FG000|Overall Study|Physician Decision|4|||
23229409|NCT04815291|64581308|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
23229410|NCT05158244|64581310|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
23229411|NCT05158244|64581311|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
23229412|NCT05158244|64581312|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
23229413|NCT05158244|64581313|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
23229414|NCT05158244|64581314|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
23229415|NCT05158244|64581310|FG000|Overall Study|Withdrawal by Subject|0|||
23577395|NCT00124982|65843709|FG002|Long-term Period|Neurologist Recommendation|1|||
23337820|NCT02649439|64979145|FG001|Overall Study|Rising PSA|1|||
23337821|NCT02649439|64979144|FG000|Overall Study|Signed follow up protocol|0|||
23337822|NCT02649439|64979145|FG001|Overall Study|Signed follow up protocol|1|||
23337823|NCT00596687|64979146|FG000|Overall Study|< 24 hours of insulin treatment|8|||
23337824|NCT00596687|64979147|FG001|Overall Study|< 24 hours of insulin treatment|6|||
23337825|NCT00596687|64979146|FG000|Overall Study|continuous insulin infusion during TPN|2|||
23337826|NCT00596687|64979147|FG001|Overall Study|continuous insulin infusion during TPN|1|||
23337827|NCT00596687|64979146|FG000|Overall Study|Withdrawal by Subject|3|||
23337828|NCT00596687|64979147|FG001|Overall Study|Withdrawal by Subject|1|||
23337829|NCT00596687|64979146|FG000|Overall Study|cancelled surgery|1|||
23337830|NCT00596687|64979147|FG001|Overall Study|cancelled surgery|1|||
23337831|NCT02235077|64979158|FG000|Overall Study|Death|5|||
23337832|NCT02235077|64979159|FG001|Overall Study|Death|7|||
23337833|NCT02235077|64979158|FG000|Overall Study|Lost to Follow-up|5|||
23577396|NCT01101165|65843710|FG000|Period 1|Adverse Event|1|||
23577397|NCT01101165|65843711|FG001|Period 1|Adverse Event|2|||
23577398|NCT01101165|65843710|FG000|Period 1|Withdrawal by Subject|0|||
23577399|NCT01101165|65843711|FG001|Period 1|Withdrawal by Subject|2|||
23577400|NCT01101165|65843710|FG000|Period 1|Positive Drug Screen|0|||
23577401|NCT01101165|65843711|FG001|Period 1|Positive Drug Screen|1|||
23577402|NCT01101165|65843710|FG000|Period 1|Lost to Follow-up|1|||
23577403|NCT01101165|65843711|FG001|Period 1|Lost to Follow-up|0|||
23577404|NCT01101165|65843710|FG000|Period 2|Withdrawal by Subject|3|||
23577405|NCT01101165|65843711|FG001|Period 2|Withdrawal by Subject|1|||
23577406|NCT01101165|65843710|FG000|Period 2|Adverse Event|1|||
23577407|NCT01101165|65843711|FG001|Period 2|Adverse Event|0|||
23577408|NCT03005288|65843712|FG000|Overall Study|Withdrawal by Subject|7|||
23577409|NCT03005288|65843713|FG001|Overall Study|Withdrawal by Subject|5|||
23577410|NCT03005288|65843712|FG000|Overall Study|Lost to Follow-up|0|||
23229416|NCT05158244|64581311|FG001|Overall Study|Withdrawal by Subject|0|||
23337834|NCT02235077|64979159|FG001|Overall Study|Lost to Follow-up|6|||
23229417|NCT05158244|64581312|FG002|Overall Study|Withdrawal by Subject|1|||
23229418|NCT05158244|64581313|FG003|Overall Study|Withdrawal by Subject|0|||
23229419|NCT05158244|64581314|FG004|Overall Study|Withdrawal by Subject|0|||
23229420|NCT03590613|64581315|FG000|Period 2, 4 Days|Physician Decision|0|||
23229421|NCT03590613|64581316|FG001|Period 2, 4 Days|Physician Decision|0|||
23229422|NCT03590613|64581317|FG002|Period 2, 4 Days|Physician Decision|0|||
23229423|NCT03590613|64581318|FG003|Period 2, 4 Days|Physician Decision|1|||
23229424|NCT01775995|64581321|FG000|Overall Study|Lost to Follow-up|1|||
23229425|NCT01775995|64581322|FG001|Overall Study|Lost to Follow-up|1|||
23337835|NCT02235077|64979158|FG000|Overall Study|Withdrawal by Subject|8|||
23577411|NCT03005288|65843713|FG001|Overall Study|Lost to Follow-up|1|||
23577412|NCT03005288|65843712|FG000|Overall Study|Adverse Event|5|||
23229426|NCT00877890|64581325|FG000|Overall Study|Adverse Event|6|||
23337836|NCT02235077|64979159|FG001|Overall Study|Withdrawal by Subject|5|||
23337837|NCT02235077|64979158|FG000|Overall Study|Physician Decision|0|||
23337838|NCT02235077|64979159|FG001|Overall Study|Physician Decision|1|||
23337839|NCT00533702|64979160|FG000|Overall Study|Withdrawal by Subject|3|||
23337840|NCT00533702|64979161|FG001|Overall Study|Withdrawal by Subject|1|||
23577413|NCT03005288|65843713|FG001|Overall Study|Adverse Event|0|||
23577414|NCT03005288|65843712|FG000|Overall Study|Protocol deviation|0|||
23577415|NCT03005288|65843713|FG001|Overall Study|Protocol deviation|1|||
23337841|NCT00533702|64979160|FG000|Overall Study|Found ineligible after randomization|2|||
23337842|NCT00533702|64979161|FG001|Overall Study|Found ineligible after randomization|1|||
23337843|NCT00507819|64979162|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
23337844|NCT00507819|64979163|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
23337845|NCT00582816|64979167|FG000|Overall Study|Engraftment Failure|3|||
23337846|NCT00820248|64979168|FG000|Overall Study|No treated|4|||
23337847|NCT00820248|64979169|FG001|Overall Study|No treated|1|||
23337848|NCT03865316|64979174|FG000|Overall Study|Procedure Cancelled|4|||
23337849|NCT03865316|64979174|FG000|Overall Study|Equipment failure|4|||
23337850|NCT02055365|64979175|FG000|Overall Study|Prematurely Withdrawn|1|||
23337851|NCT01680861|64979178|FG000|Early Post-transplant Period|Protocol Violation|1|||
23337852|NCT01680861|64979179|FG001|Early Post-transplant Period|Protocol Violation|1|||
23337853|NCT02907892|64979180|FG000|Overall Study|Lost to Follow-up|27|||
23337854|NCT02907892|64979181|FG001|Overall Study|Lost to Follow-up|40|||
23337855|NCT04666259|64979184|FG000|Overall Study|ongoing at data cut-off|6|||
23337856|NCT04666259|64979185|FG001|Overall Study|ongoing at data cut-off|14|||
23337857|NCT04666259|64979186|FG002|Overall Study|ongoing at data cut-off|0|||
23337858|NCT04666259|64979184|FG000|Overall Study|Progressive Disease|0|||
23337859|NCT04666259|64979185|FG001|Overall Study|Progressive Disease|1|||
23337860|NCT04666259|64979186|FG002|Overall Study|Progressive Disease|0|||
23337861|NCT04666259|64979184|FG000|Overall Study|Physician Decision|9|||
23337862|NCT04666259|64979185|FG001|Overall Study|Physician Decision|3|||
23577416|NCT03005288|65843712|FG000|Overall Study|Physician Decision|0|||
23577417|NCT03005288|65843713|FG001|Overall Study|Physician Decision|1|||
23582229|NCT03441984|65862402|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23337863|NCT04666259|64979186|FG002|Overall Study|Physician Decision|3|||
23337864|NCT04666259|64979184|FG000|Overall Study|Adverse Event|3|||
23337865|NCT04666259|64979185|FG001|Overall Study|Adverse Event|1|||
23337866|NCT04666259|64979186|FG002|Overall Study|Adverse Event|0|||
23337867|NCT04666259|64979184|FG000|Overall Study|Withdrawal by Subject|1|||
23337868|NCT04666259|64979185|FG001|Overall Study|Withdrawal by Subject|2|||
23337869|NCT04666259|64979186|FG002|Overall Study|Withdrawal by Subject|0|||
23337870|NCT04666259|64979184|FG000|Overall Study|Enrolled but not treated and discontinued|1|||
23337871|NCT04666259|64979185|FG001|Overall Study|Enrolled but not treated and discontinued|0|||
23337872|NCT04666259|64979186|FG002|Overall Study|Enrolled but not treated and discontinued|0|||
23337873|NCT01696929|64979187|FG000|Overall Study|Physician Decision|1|||
23337874|NCT00754234|64979188|FG000|Overall Study|Withdrawal by Subject|3|||
23337875|NCT02865499|64979189|FG000|Baseline|Adverse Event|1|||
23337876|NCT02865499|64979189|FG000|Baseline|Withdrawal by Subject|1|||
23337877|NCT00526669|64979194|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
23337878|NCT00526669|64979195|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
23337879|NCT00526669|64979194|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
23337880|NCT00526669|64979195|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
23337881|NCT00526669|64979194|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
23337882|NCT00526669|64979195|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
23337883|NCT00526669|64979194|FG000|Combined Treatment Phase|Death|0|||
23337884|NCT00526669|64979195|FG001|Combined Treatment Phase|Death|2|||
23337885|NCT00619892|64979200|FG000|Overall Study|Adverse Event|3|||
23337886|NCT00619892|64979201|FG001|Overall Study|Adverse Event|0|||
23337887|NCT00619892|64979200|FG000|Overall Study|Lost to Follow-up|0|||
23337888|NCT00619892|64979201|FG001|Overall Study|Lost to Follow-up|1|||
23337889|NCT00619892|64979200|FG000|Overall Study|Intercurrent illness|0|||
23337890|NCT00619892|64979201|FG001|Overall Study|Intercurrent illness|1|||
23582230|NCT03441984|65862403|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582231|NCT03441984|65862404|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582232|NCT03441984|65862405|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582233|NCT03441984|65862406|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582234|NCT03441984|65862407|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582235|NCT03441984|65862408|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582236|NCT03441984|65862409|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
23582237|NCT00567879|65862410|FG000|Overall Study|Adverse Event|2|||
23582238|NCT00567879|65862411|FG001|Overall Study|Adverse Event|0|||
23582239|NCT00567879|65862412|FG002|Overall Study|Adverse Event|1|||
23582240|NCT00567879|65862413|FG003|Overall Study|Adverse Event|0|||
23170707|NCT02721355|64370836|FG000|Overall Study|Lost to Follow-up|6|||
23582241|NCT00567879|65862414|FG004|Overall Study|Adverse Event|1|||
23337891|NCT00886743|64979202|FG000|Overall Study|Adverse Event|3|||
23337892|NCT00886743|64979202|FG000|Overall Study|Other|1|||
23337893|NCT01736397|64979203|FG000|Overall Study|Lack of Efficacy|1|||
23337894|NCT01736397|64979204|FG001|Overall Study|Lack of Efficacy|11|||
23582242|NCT00567879|65862415|FG005|Overall Study|Adverse Event|0|||
23337895|NCT01736397|64979203|FG000|Overall Study|Withdrawal by Subject|6|||
23337896|NCT01736397|64979204|FG001|Overall Study|Withdrawal by Subject|5|||
23337897|NCT01736397|64979203|FG000|Overall Study|Lost to Follow-up|0|||
23337898|NCT01736397|64979204|FG001|Overall Study|Lost to Follow-up|1|||
23337899|NCT01736397|64979203|FG000|Overall Study|Adverse Event|6|||
23337900|NCT01736397|64979204|FG001|Overall Study|Adverse Event|3|||
23337901|NCT01736397|64979203|FG000|Overall Study|Not stated|1|||
23337902|NCT01736397|64979204|FG001|Overall Study|Not stated|4|||
23337903|NCT02693171|64979210|FG000|Overall Study|Adverse Event|1|||
23337904|NCT02693171|64979210|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
23337905|NCT02107859|64979211|FG000|Overall Study|Withdrawal by Subject|14|||
23337906|NCT02107859|64979211|FG000|Overall Study|Adverse Event|3|||
23337907|NCT02107859|64979211|FG000|Overall Study|Study closure|41|||
23337908|NCT02107859|64979211|FG000|Overall Study|Other than specified|3|||
23337909|NCT01387516|64979216|FG000|Overall Study|Lost to Follow-up|4|||
23337910|NCT01387516|64979217|FG001|Overall Study|Lost to Follow-up|4|||
23337911|NCT01387516|64979218|FG002|Overall Study|Lost to Follow-up|2|||
23337912|NCT01387516|64979219|FG003|Overall Study|Lost to Follow-up|3|||
23337913|NCT01387516|64979216|FG000|Overall Study|Withdrawal by Subject|1|||
23337914|NCT01387516|64979217|FG001|Overall Study|Withdrawal by Subject|1|||
23337915|NCT01387516|64979218|FG002|Overall Study|Withdrawal by Subject|2|||
23337916|NCT01387516|64979219|FG003|Overall Study|Withdrawal by Subject|0|||
23337917|NCT01387516|64979216|FG000|Overall Study|Death|0|||
23337918|NCT01387516|64979217|FG001|Overall Study|Death|0|||
23337919|NCT01387516|64979218|FG002|Overall Study|Death|0|||
23337920|NCT01387516|64979219|FG003|Overall Study|Death|1|||
23337921|NCT02211638|64979220|FG000|Overall Study|Case Report Forms Uncollected|291|||
23337922|NCT02211638|64979220|FG000|Overall Study|Protocol Violation|692|||
23337923|NCT02640950|64982872|FG000|Overall Study|Adverse Event|1|||
23337924|NCT02640950|64982872|FG000|Overall Study|Withdrawal by Subject|1|||
23337925|NCT02811861|64982875|FG000|Overall Study|Radiological Disease Progression|123|||
23337926|NCT02811861|64982876|FG001|Overall Study|Radiological Disease Progression|97|||
23337927|NCT02811861|64982877|FG002|Overall Study|Radiological Disease Progression|174|||
23229427|NCT00877890|64581326|FG001|Overall Study|Adverse Event|6|||
23229428|NCT00877890|64581325|FG000|Overall Study|Lost to Follow-up|5|||
23229429|NCT00877890|64581326|FG001|Overall Study|Lost to Follow-up|5|||
23229430|NCT00877890|64581325|FG000|Overall Study|Protocol Violation|0|||
23229431|NCT00877890|64581326|FG001|Overall Study|Protocol Violation|1|||
23229432|NCT00877890|64581325|FG000|Overall Study|Withdrawal of Consent|6|||
23229433|NCT00877890|64581326|FG001|Overall Study|Withdrawal of Consent|12|||
23229434|NCT00877890|64581325|FG000|Overall Study|Investigator Decision|0|||
23337928|NCT02811861|64982875|FG000|Overall Study|Clinical Disease Progression|20|||
23337929|NCT02811861|64982876|FG001|Overall Study|Clinical Disease Progression|19|||
23337930|NCT02811861|64982877|FG002|Overall Study|Clinical Disease Progression|22|||
23337931|NCT02811861|64982875|FG000|Overall Study|Adverse Event|63|||
23337932|NCT02811861|64982876|FG001|Overall Study|Adverse Event|60|||
23337933|NCT02811861|64982877|FG002|Overall Study|Adverse Event|41|||
23337934|NCT02811861|64982875|FG000|Overall Study|Lost to Follow-up|0|||
23337935|NCT02811861|64982876|FG001|Overall Study|Lost to Follow-up|0|||
23229435|NCT00877890|64581326|FG001|Overall Study|Investigator Decision|2|||
23229436|NCT00877890|64581325|FG000|Overall Study|Loss of Glucose Control|3|||
23229437|NCT00877890|64581326|FG001|Overall Study|Loss of Glucose Control|4|||
23229438|NCT01191190|64581327|FG000|Overall Study|Withdrawal by Subject|1|||
23229439|NCT00934791|64581328|FG000|Overall Study|Withdrawal by Subject|1|||
23229440|NCT00934791|64581329|FG001|Overall Study|Withdrawal by Subject|0|||
23229441|NCT03347279|64581330|FG000|Overall Study|Withdrawal by Subject|8|||
23229442|NCT03347279|64581331|FG001|Overall Study|Withdrawal by Subject|15|||
23229443|NCT03347279|64581330|FG000|Overall Study|Death|0|||
23337936|NCT02811861|64982877|FG002|Overall Study|Lost to Follow-up|1|||
23337937|NCT02811861|64982875|FG000|Overall Study|Subject Choice|29|||
23337938|NCT02811861|64982876|FG001|Overall Study|Subject Choice|17|||
23229444|NCT03347279|64581331|FG001|Overall Study|Death|2|||
23229445|NCT03347279|64581330|FG000|Overall Study|Lost to Follow-up|5|||
23229446|NCT03347279|64581331|FG001|Overall Study|Lost to Follow-up|2|||
23229447|NCT03347279|64581330|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
23229448|NCT03347279|64581331|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
23229449|NCT00508820|64581332|FG000|Overall Study|Adverse Event|6|||
23337939|NCT02811861|64982877|FG002|Overall Study|Subject Choice|23|||
23337940|NCT02811861|64982875|FG000|Overall Study|Withdrawal by Subject|4|||
23337941|NCT02811861|64982876|FG001|Overall Study|Withdrawal by Subject|4|||
23229450|NCT00508820|64581333|FG001|Overall Study|Adverse Event|10|||
23229451|NCT00508820|64581332|FG000|Overall Study|Death|6|||
23229452|NCT00508820|64581333|FG001|Overall Study|Death|8|||
23229453|NCT00508820|64581332|FG000|Overall Study|Lost to Follow-up|1|||
23229454|NCT00508820|64581333|FG001|Overall Study|Lost to Follow-up|1|||
23229455|NCT00508820|64581332|FG000|Overall Study|Physician Decision|8|||
23337942|NCT02811861|64982877|FG002|Overall Study|Withdrawal by Subject|9|||
23337943|NCT02811861|64982875|FG000|Overall Study|Other|4|||
23337944|NCT02811861|64982876|FG001|Overall Study|Other|13|||
23337945|NCT02811861|64982877|FG002|Overall Study|Other|3|||
23337946|NCT02811861|64982875|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
23229456|NCT00508820|64581333|FG001|Overall Study|Physician Decision|2|||
23229457|NCT00508820|64581332|FG000|Overall Study|Pregnancy|0|||
23229458|NCT00508820|64581333|FG001|Overall Study|Pregnancy|2|||
23229459|NCT00508820|64581332|FG000|Overall Study|Protocol Violation|2|||
23229460|NCT00508820|64581333|FG001|Overall Study|Protocol Violation|0|||
23337947|NCT02811861|64982876|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
23337948|NCT02811861|64982877|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
23337949|NCT02811861|64982875|FG000|Overall Study|Randomized but not treated|2|||
23337950|NCT02811861|64982876|FG001|Overall Study|Randomized but not treated|3|||
23337951|NCT02811861|64982877|FG002|Overall Study|Randomized but not treated|17|||
23337952|NCT00869999|64982878|FG000|Overall Study|Withdrawal by Subject|1|||
23337953|NCT00869999|64982878|FG000|Overall Study|removed prior to starting therapy|1|||
23577418|NCT02264574|65846804|FG000|Overall Study|Death|21|||
23229461|NCT00508820|64581332|FG000|Overall Study|Withdrawal by Subject|10|||
23229462|NCT00508820|64581333|FG001|Overall Study|Withdrawal by Subject|12|||
23229463|NCT00508820|64581332|FG000|Overall Study|Other|11|||
23229464|NCT00508820|64581333|FG001|Overall Study|Other|2|||
23229465|NCT00508820|64581332|FG000|Overall Study|Noncompliance|1|||
23229466|NCT00508820|64581333|FG001|Overall Study|Noncompliance|0|||
23229467|NCT00508820|64581332|FG000|Overall Study|Requirement for alternative therapy|7|||
23229468|NCT00508820|64581333|FG001|Overall Study|Requirement for alternative therapy|15|||
23577419|NCT02264574|65846805|FG001|Overall Study|Death|21|||
23577420|NCT02264574|65846804|FG000|Overall Study|Withdrawal by Subject|8|||
23577421|NCT02264574|65846805|FG001|Overall Study|Withdrawal by Subject|6|||
23229469|NCT00508820|64581332|FG000|Overall Study|Protocol-specified Criteria|3|||
23229470|NCT00508820|64581333|FG001|Overall Study|Protocol-specified Criteria|12|||
23229471|NCT03267511|64581334|FG000|Overall Study|Lost to Follow-up|0|||
23229472|NCT03267511|64581335|FG001|Overall Study|Lost to Follow-up|0|||
23229473|NCT03267511|64581336|FG002|Overall Study|Lost to Follow-up|0|||
23229474|NCT03267511|64581337|FG003|Overall Study|Lost to Follow-up|1|||
23229475|NCT00775138|64581340|FG000|Overall Study|Withdrawal by Subject|0|||
23229476|NCT00775138|64581341|FG001|Overall Study|Withdrawal by Subject|0|||
23229477|NCT00775138|64581342|FG002|Overall Study|Withdrawal by Subject|2|||
23229478|NCT00775138|64581343|FG003|Overall Study|Withdrawal by Subject|2|||
23229479|NCT00775138|64581340|FG000|Overall Study|Adverse Event|0|||
23229480|NCT00775138|64581341|FG001|Overall Study|Adverse Event|0|||
23229481|NCT00775138|64581342|FG002|Overall Study|Adverse Event|1|||
23229482|NCT00775138|64581343|FG003|Overall Study|Adverse Event|0|||
23229483|NCT04005885|64584026|FG000|First Intervention|Withdrawal by Subject|1|||
23229484|NCT04005885|64584027|FG001|First Intervention|Withdrawal by Subject|1|||
23229485|NCT04005885|64584026|FG000|Second Intervention|Withdrawal by Subject|0|||
23229486|NCT04005885|64584027|FG001|Second Intervention|Withdrawal by Subject|2|||
23229487|NCT02087241|64584028|FG000|Overall Study|Death|2|||
23229488|NCT02087241|64584029|FG001|Overall Study|Death|1|||
23577422|NCT02264574|65846804|FG000|Overall Study|Other, Not Specified|0|||
23577423|NCT02264574|65846805|FG001|Overall Study|Other, Not Specified|3|||
23229489|NCT02087241|64584030|FG002|Overall Study|Death|1|||
23229490|NCT02087241|64584031|FG003|Overall Study|Death|1|||
23229491|NCT02087241|64584028|FG000|Overall Study|Withdrawal by Subject|1|||
23229492|NCT02087241|64584029|FG001|Overall Study|Withdrawal by Subject|0|||
23229493|NCT02087241|64584030|FG002|Overall Study|Withdrawal by Subject|0|||
23229494|NCT02087241|64584031|FG003|Overall Study|Withdrawal by Subject|1|||
23229495|NCT02087241|64584028|FG000|Overall Study|Progressive Disease|0|||
23229496|NCT02087241|64584029|FG001|Overall Study|Progressive Disease|0|||
23229497|NCT02087241|64584030|FG002|Overall Study|Progressive Disease|0|||
23229498|NCT02087241|64584031|FG003|Overall Study|Progressive Disease|1|||
23229499|NCT02087241|64584028|FG000|Overall Study|Study Terminated by Sponsor|0|||
23577424|NCT05177848|65846806|FG000|Overall Study|Lost to Follow-up|1|||
23577425|NCT05177848|65846807|FG001|Overall Study|Lost to Follow-up|4|||
23577426|NCT05177848|65846806|FG000|Overall Study|Discontinued|2|||
23577427|NCT05177848|65846807|FG001|Overall Study|Discontinued|1|||
23577428|NCT04668144|65846808|FG000|Overall Study|Protocol Violation|0|||
23337954|NCT02361346|64982883|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
23229500|NCT02087241|64584029|FG001|Overall Study|Study Terminated by Sponsor|2|||
23229501|NCT02087241|64584030|FG002|Overall Study|Study Terminated by Sponsor|0|||
23229502|NCT02087241|64584031|FG003|Overall Study|Study Terminated by Sponsor|4|||
23229503|NCT00542425|64584037|FG000|Initial 24 Weeks|Administrative reasons|0|||
23337955|NCT02361346|64982884|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
23577429|NCT04668144|65846809|FG001|Overall Study|Protocol Violation|1|||
23577430|NCT04668144|65846810|FG002|Overall Study|Protocol Violation|2|||
23229504|NCT00542425|64584038|FG001|Initial 24 Weeks|Administrative reasons|0|||
23337956|NCT02361346|64982885|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
23229505|NCT00542425|64584039|FG002|Initial 24 Weeks|Administrative reasons|1|||
23229506|NCT00542425|64584040|FG003|Initial 24 Weeks|Administrative reasons|1|||
23229507|NCT00542425|64584041|FG004|Initial 24 Weeks|Administrative reasons|0|||
23229508|NCT00542425|64584037|FG000|Initial 24 Weeks|Adverse Event|0|||
23229509|NCT00542425|64584038|FG001|Initial 24 Weeks|Adverse Event|1|||
23229510|NCT00542425|64584039|FG002|Initial 24 Weeks|Adverse Event|1|||
23577431|NCT00843882|65846811|FG000|Step 1|Lack of Efficacy|14|||
23577432|NCT00843882|65846812|FG001|Step 1|Lack of Efficacy|10|||
23577433|NCT00843882|65846813|FG002|Step 1|Lack of Efficacy|21|||
23577434|NCT00843882|65846811|FG000|Step 1|Adverse Event|8|||
23577435|NCT00843882|65846812|FG001|Step 1|Adverse Event|17|||
23577436|NCT00843882|65846813|FG002|Step 1|Adverse Event|20|||
23577437|NCT00843882|65846811|FG000|Step 1|Death|1|||
23577438|NCT00843882|65846812|FG001|Step 1|Death|2|||
23577439|NCT00843882|65846813|FG002|Step 1|Death|4|||
23577440|NCT00843882|65846811|FG000|Step 1|Withdrawal by Subject|6|||
23170708|NCT02721355|64370837|FG001|Overall Study|Lost to Follow-up|1|||
23170709|NCT01400451|64370840|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
23170710|NCT01400451|64370841|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
23170711|NCT01400451|64370842|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
23170712|NCT01400451|64370840|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
23170713|NCT01400451|64370841|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
23170714|NCT01400451|64370842|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
23170715|NCT01400451|64370840|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
23170716|NCT01400451|64370841|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
23170717|NCT01400451|64370842|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
23170718|NCT01400451|64370840|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
23170719|NCT01400451|64370841|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
23170720|NCT01400451|64370842|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
23170721|NCT01400451|64370840|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
23170722|NCT01400451|64370841|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
23170723|NCT01400451|64370842|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
23170724|NCT02307370|64370843|FG000|Overall Study|Death|5|||
23170725|NCT02307370|64370843|FG000|Overall Study|Lost to Follow-up|1|||
23170726|NCT02307370|64370843|FG000|Overall Study|Withdrawal by Subject|1|||
23170727|NCT02307370|64370843|FG000|Overall Study|Declined Addendum ICF|6|||
23170728|NCT02307370|64370843|FG000|Overall Study|No response during telephone contact|5|||
23170729|NCT02307370|64370843|FG000|Overall Study|Protocol Violation|1|||
23170730|NCT00781456|64370844|FG000|Overall Study|Adverse Event|3|||
23170731|NCT00781456|64370845|FG001|Overall Study|Adverse Event|3|||
23170732|NCT00781456|64370844|FG000|Overall Study|Withdrawal by Subject|3|||
23170733|NCT00781456|64370845|FG001|Overall Study|Withdrawal by Subject|5|||
23170734|NCT00781456|64370844|FG000|Overall Study|Protocol Violation|4|||
23170735|NCT00781456|64370845|FG001|Overall Study|Protocol Violation|1|||
23170736|NCT00781456|64370844|FG000|Overall Study|Noncompliance With Protocol|1|||
23170737|NCT00781456|64370845|FG001|Overall Study|Noncompliance With Protocol|1|||
23170738|NCT00781456|64370844|FG000|Overall Study|Lost to Follow-up|10|||
23170739|NCT00781456|64370845|FG001|Overall Study|Lost to Follow-up|5|||
23170740|NCT00781456|64370844|FG000|Overall Study|Other Reason, Unknown|0|||
23170741|NCT00781456|64370845|FG001|Overall Study|Other Reason, Unknown|1|||
23170742|NCT00323557|64370846|FG000|Overall Study|Physician Decision|1|||
23170743|NCT00323557|64370847|FG001|Overall Study|Physician Decision|0|||
23170744|NCT01609842|64370850|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
23170745|NCT01609842|64370851|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
23170746|NCT03403205|64370852|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
23170747|NCT03403205|64370853|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
23170748|NCT03403205|64370854|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
23170749|NCT03403205|64370855|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
23170750|NCT03403205|64370856|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23170751|NCT03403205|64370857|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23170752|NCT03403205|64370852|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
23170753|NCT03403205|64370853|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23170754|NCT03403205|64370854|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
23170755|NCT03403205|64370855|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23170756|NCT03403205|64370856|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23170757|NCT03403205|64370857|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23170758|NCT03403205|64370852|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
23170759|NCT03403205|64370853|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
23170760|NCT03403205|64370854|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
23170761|NCT03403205|64370855|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
23170762|NCT03403205|64370856|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
23229511|NCT00542425|64584040|FG003|Initial 24 Weeks|Adverse Event|3|||
23577441|NCT00843882|65846812|FG001|Step 1|Withdrawal by Subject|12|||
23577442|NCT00843882|65846813|FG002|Step 1|Withdrawal by Subject|9|||
23577443|NCT00843882|65846811|FG000|Step 1|Physician Decision|0|||
23577444|NCT00843882|65846812|FG001|Step 1|Physician Decision|5|||
23577445|NCT00843882|65846813|FG002|Step 1|Physician Decision|1|||
23577446|NCT00843882|65846811|FG000|Step 1|Patient and physician's decision|0|||
23577447|NCT00843882|65846812|FG001|Step 1|Patient and physician's decision|0|||
23229512|NCT00542425|64584041|FG004|Initial 24 Weeks|Adverse Event|2|||
23229513|NCT00542425|64584037|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
23229514|NCT00542425|64584038|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
23229515|NCT00542425|64584039|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
23229516|NCT00542425|64584040|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
23229517|NCT00542425|64584041|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
23229518|NCT00542425|64584037|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
23229519|NCT00542425|64584038|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
23229520|NCT00542425|64584039|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
23229521|NCT00542425|64584040|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
23229522|NCT00542425|64584041|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
23229523|NCT00542425|64584037|FG000|Initial 24 Weeks|Non-compliance|0|||
23229524|NCT00542425|64584038|FG001|Initial 24 Weeks|Non-compliance|0|||
23229525|NCT00542425|64584039|FG002|Initial 24 Weeks|Non-compliance|0|||
23229526|NCT00542425|64584040|FG003|Initial 24 Weeks|Non-compliance|1|||
23229527|NCT00542425|64584041|FG004|Initial 24 Weeks|Non-compliance|1|||
23229528|NCT00542425|64584037|FG000|Initial 24 Weeks|Protocol Violation|0|||
23229529|NCT00542425|64584038|FG001|Initial 24 Weeks|Protocol Violation|0|||
23229530|NCT00542425|64584039|FG002|Initial 24 Weeks|Protocol Violation|0|||
23229531|NCT00542425|64584040|FG003|Initial 24 Weeks|Protocol Violation|1|||
23229532|NCT00542425|64584041|FG004|Initial 24 Weeks|Protocol Violation|0|||
23229533|NCT00542425|64584037|FG000|Initial 24 Weeks|Refusal of treatment|2|||
23229534|NCT00542425|64584038|FG001|Initial 24 Weeks|Refusal of treatment|2|||
23229535|NCT00542425|64584039|FG002|Initial 24 Weeks|Refusal of treatment|1|||
23229536|NCT00542425|64584040|FG003|Initial 24 Weeks|Refusal of treatment|4|||
23229537|NCT00542425|64584041|FG004|Initial 24 Weeks|Refusal of treatment|1|||
23229538|NCT00542425|64584037|FG000|Initial 24 Weeks|Other|0|||
23229539|NCT00542425|64584038|FG001|Initial 24 Weeks|Other|2|||
23229540|NCT00542425|64584039|FG002|Initial 24 Weeks|Other|1|||
23229541|NCT00542425|64584040|FG003|Initial 24 Weeks|Other|0|||
23229542|NCT00542425|64584041|FG004|Initial 24 Weeks|Other|0|||
23229543|NCT00542425|64584037|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
23229544|NCT00542425|64584038|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
23229545|NCT00542425|64584039|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
23229546|NCT00542425|64584040|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
23229547|NCT00542425|64584041|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
23229548|NCT00542425|64584037|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
23229549|NCT00542425|64584038|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
23229550|NCT00542425|64584039|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
23229551|NCT00542425|64584040|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
23229552|NCT00542425|64584041|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
23229553|NCT00542425|64584037|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
23229554|NCT00542425|64584038|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
23229555|NCT00542425|64584039|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
23229556|NCT00542425|64584040|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
23229557|NCT00542425|64584041|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
23229558|NCT00542425|64584037|FG000|Extended 24 Weeks of Treatment|Other|1|||
23229559|NCT00542425|64584038|FG001|Extended 24 Weeks of Treatment|Other|1|||
23229560|NCT00542425|64584039|FG002|Extended 24 Weeks of Treatment|Other|0|||
23229561|NCT00542425|64584040|FG003|Extended 24 Weeks of Treatment|Other|0|||
23229562|NCT00542425|64584041|FG004|Extended 24 Weeks of Treatment|Other|1|||
23229563|NCT00303329|64584044|FG000|Overall Study|Adverse Event|7|||
23229564|NCT00303329|64584045|FG001|Overall Study|Adverse Event|14|||
23577448|NCT00843882|65846813|FG002|Step 1|Patient and physician's decision|1|||
23577449|NCT00843882|65846811|FG000|Step 1|Other complicating disease|1|||
23577450|NCT00843882|65846812|FG001|Step 1|Other complicating disease|3|||
23577451|NCT00843882|65846813|FG002|Step 1|Other complicating disease|4|||
23577452|NCT00843882|65846811|FG000|Step 1|Alternative therapy|0|||
23577453|NCT00843882|65846812|FG001|Step 1|Alternative therapy|1|||
23577454|NCT00843882|65846813|FG002|Step 1|Alternative therapy|1|||
23577455|NCT00843882|65846811|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
23577456|NCT00843882|65846812|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
23229565|NCT00303329|64584044|FG000|Overall Study|Abnormal Laboratory Values|0|||
23229566|NCT00303329|64584045|FG001|Overall Study|Abnormal Laboratory Values|1|||
23229567|NCT00303329|64584044|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
23577457|NCT00843882|65846813|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
23577458|NCT00843882|65846811|FG000|Step 1|Off treatment reason unknown|0|||
23577459|NCT00843882|65846812|FG001|Step 1|Off treatment reason unknown|1|||
23577460|NCT00843882|65846813|FG002|Step 1|Off treatment reason unknown|4|||
23577461|NCT00843882|65846811|FG000|Step 1|Never started treatment|2|||
23229568|NCT00303329|64584045|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23229569|NCT00303329|64584044|FG000|Overall Study|Condition no longer requires study drug|0|||
23229570|NCT00303329|64584045|FG001|Overall Study|Condition no longer requires study drug|8|||
23229571|NCT00303329|64584044|FG000|Overall Study|Protocol Violation|3|||
23577462|NCT00843882|65846812|FG001|Step 1|Never started treatment|0|||
23577463|NCT00843882|65846813|FG002|Step 1|Never started treatment|0|||
23577464|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
23229572|NCT00303329|64584045|FG001|Overall Study|Protocol Violation|0|||
23229573|NCT00303329|64584044|FG000|Overall Study|Withdrawal by Subject|9|||
23229574|NCT00303329|64584045|FG001|Overall Study|Withdrawal by Subject|15|||
23229575|NCT00303329|64584044|FG000|Overall Study|Lost to Follow-up|0|||
23229576|NCT00303329|64584045|FG001|Overall Study|Lost to Follow-up|1|||
23229577|NCT00303329|64584044|FG000|Overall Study|Administrative problems|1|||
23229578|NCT00303329|64584045|FG001|Overall Study|Administrative problems|0|||
23229579|NCT00303329|64584044|FG000|Overall Study|Death|2|||
23229580|NCT00303329|64584045|FG001|Overall Study|Death|12|||
23229581|NCT00303329|64584044|FG000|Overall Study|Stopped at end of core|3|||
23229582|NCT00303329|64584045|FG001|Overall Study|Stopped at end of core|9|||
23229583|NCT00303329|64584044|FG000|Overall Study|Stopped at end of extension 1|1|||
23229584|NCT00303329|64584045|FG001|Overall Study|Stopped at end of extension 1|0|||
23229585|NCT04554394|64584056|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
23229586|NCT04554394|64584057|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
23229587|NCT04554394|64584056|FG000|Overall Study|Withdrawal by Subject|2|||
23229588|NCT04554394|64584057|FG001|Overall Study|Withdrawal by Subject|2|||
23229589|NCT04554394|64584056|FG000|Overall Study|Lost to Follow-up|2|||
23229590|NCT04554394|64584057|FG001|Overall Study|Lost to Follow-up|2|||
23229591|NCT04554394|64584056|FG000|Overall Study|Physician Decision|1|||
23229592|NCT04554394|64584057|FG001|Overall Study|Physician Decision|1|||
23229593|NCT00137267|64584058|FG000|Overall Study|Lost to Follow-up|15|||
23229594|NCT00137267|64584059|FG001|Overall Study|Lost to Follow-up|21|||
23229595|NCT02504424|64584064|FG000|Overall Study|Withdrawal by Subject|2|||
23229596|NCT01970540|64584067|FG000|Overall Study|Non-treatment-related AE|0|||
23229597|NCT01970540|64584068|FG001|Overall Study|Non-treatment-related AE|0|||
23229598|NCT01970540|64584069|FG002|Overall Study|Non-treatment-related AE|1|||
23229599|NCT01970540|64584067|FG000|Overall Study|Progressive disease|55|||
23229600|NCT01970540|64584068|FG001|Overall Study|Progressive disease|23|||
23229601|NCT01970540|64584069|FG002|Overall Study|Progressive disease|10|||
23229602|NCT01970540|64584067|FG000|Overall Study|Treatment delay over protocol|0|||
23229603|NCT01970540|64584068|FG001|Overall Study|Treatment delay over protocol|0|||
23229604|NCT01970540|64584069|FG002|Overall Study|Treatment delay over protocol|1|||
23229605|NCT01970540|64584067|FG000|Overall Study|Physician Decision|7|||
23229606|NCT01970540|64584068|FG001|Overall Study|Physician Decision|2|||
23229607|NCT01970540|64584069|FG002|Overall Study|Physician Decision|0|||
23229608|NCT01970540|64584067|FG000|Overall Study|Clinical progression|0|||
23229609|NCT01970540|64584068|FG001|Overall Study|Clinical progression|1|||
23229610|NCT01970540|64584069|FG002|Overall Study|Clinical progression|1|||
23577465|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
23577466|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
23577467|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
23577468|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
23577469|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
23577470|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
23577471|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
23577472|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
23577473|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
23229611|NCT01970540|64584067|FG000|Overall Study|End of study|2|||
23229612|NCT01970540|64584068|FG001|Overall Study|End of study|0|||
23229613|NCT01970540|64584069|FG002|Overall Study|End of study|2|||
23229614|NCT01970540|64584067|FG000|Overall Study|Adverse Event|0|||
23229615|NCT01970540|64584068|FG001|Overall Study|Adverse Event|2|||
23229616|NCT01970540|64584069|FG002|Overall Study|Adverse Event|1|||
23229617|NCT01970540|64584067|FG000|Overall Study|Treatment-related AE|4|||
23229618|NCT01970540|64584068|FG001|Overall Study|Treatment-related AE|0|||
23577474|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
23577475|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
23577476|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
23229619|NCT01970540|64584069|FG002|Overall Study|Treatment-related AE|2|||
23229620|NCT01970540|64584067|FG000|Overall Study|Withdrawal by Subject|4|||
23229621|NCT01970540|64584068|FG001|Overall Study|Withdrawal by Subject|0|||
23229622|NCT01970540|64584069|FG002|Overall Study|Withdrawal by Subject|1|||
23229623|NCT01970540|64584067|FG000|Overall Study|Clinical deterioration|1|||
23229624|NCT01970540|64584068|FG001|Overall Study|Clinical deterioration|0|||
23229625|NCT01970540|64584069|FG002|Overall Study|Clinical deterioration|0|||
23229626|NCT00661362|64584072|FG000|Overall Study|Adverse Event|5|||
23229627|NCT00661362|64584073|FG001|Overall Study|Adverse Event|4|||
23229628|NCT00661362|64584072|FG000|Overall Study|Incorrect enrollment|2|||
23449813|NCT01272232|65388182|FG000|Weeks 0-56|Protocol Violation|12|||
23577477|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
23229629|NCT00661362|64584073|FG001|Overall Study|Incorrect enrollment|0|||
23229630|NCT00661362|64584072|FG000|Overall Study|Study specific discontinuation criteria|4|||
23229631|NCT00661362|64584073|FG001|Overall Study|Study specific discontinuation criteria|11|||
23229632|NCT00661362|64584072|FG000|Overall Study|Withdrawal by Subject|13|||
23229633|NCT00661362|64584073|FG001|Overall Study|Withdrawal by Subject|23|||
23229634|NCT00661362|64584072|FG000|Overall Study|Lost to Follow-up|3|||
23229635|NCT00661362|64584073|FG001|Overall Study|Lost to Follow-up|1|||
23229636|NCT00661362|64584072|FG000|Overall Study|Severe non-compliance to protocol|0|||
23229637|NCT00661362|64584073|FG001|Overall Study|Severe non-compliance to protocol|1|||
23229638|NCT00661362|64584072|FG000|Overall Study|Safety reasons|1|||
23229639|NCT00661362|64584073|FG001|Overall Study|Safety reasons|0|||
23229640|NCT00661362|64584072|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
23229641|NCT00661362|64584073|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
23229642|NCT02757768|64584074|FG000|Overall Study|Randomized Never Received Study Drug|3|||
23229643|NCT02757768|64584075|FG001|Overall Study|Randomized Never Received Study Drug|4|||
23229644|NCT02757768|64584074|FG000|Overall Study|Adverse Event|5|||
23229645|NCT02757768|64584075|FG001|Overall Study|Adverse Event|3|||
23229646|NCT02757768|64584074|FG000|Overall Study|Lack of Efficacy|2|||
23229647|NCT02757768|64584075|FG001|Overall Study|Lack of Efficacy|1|||
23229648|NCT02757768|64584074|FG000|Overall Study|Lost to Follow-up|1|||
23229649|NCT02757768|64584075|FG001|Overall Study|Lost to Follow-up|0|||
23229650|NCT02757768|64584074|FG000|Overall Study|Protocol Deviation|2|||
23229651|NCT02757768|64584075|FG001|Overall Study|Protocol Deviation|9|||
23229652|NCT02757768|64584074|FG000|Overall Study|Withdrawal by Subject|16|||
23229653|NCT02757768|64584075|FG001|Overall Study|Withdrawal by Subject|9|||
23229654|NCT02757768|64584074|FG000|Overall Study|Miscellaneous|4|||
23229655|NCT02757768|64584075|FG001|Overall Study|Miscellaneous|2|||
23229656|NCT00462488|64584077|FG000|Overall Study|Protocol Violation|1|||
23229657|NCT00462488|64584078|FG001|Overall Study|Protocol Violation|0|||
23229658|NCT00462488|64584077|FG000|Overall Study|Lack of Efficacy|19|||
23229659|NCT00462488|64584078|FG001|Overall Study|Lack of Efficacy|17|||
23229660|NCT03419741|64584079|FG000|Overall Study|Adverse Event|1|||
23229661|NCT03419741|64584080|FG001|Overall Study|Adverse Event|0|||
23229662|NCT03419741|64584079|FG000|Overall Study|Withdrawal by Subject|1|||
23229663|NCT03419741|64584080|FG001|Overall Study|Withdrawal by Subject|2|||
23229664|NCT01696396|64584086|FG000|Overall Study|Withdrawal by Subject|19|||
23229665|NCT01696396|64584087|FG001|Overall Study|Withdrawal by Subject|5|||
23229666|NCT01696396|64584088|FG002|Overall Study|Withdrawal by Subject|19|||
23229667|NCT01696396|64584089|FG003|Overall Study|Withdrawal by Subject|11|||
23229668|NCT01696396|64584086|FG000|Overall Study|Decision by Sponsor|3|||
23229669|NCT01696396|64584087|FG001|Overall Study|Decision by Sponsor|1|||
23229670|NCT01696396|64584088|FG002|Overall Study|Decision by Sponsor|2|||
23229671|NCT01696396|64584089|FG003|Overall Study|Decision by Sponsor|2|||
23229672|NCT01696396|64584086|FG000|Overall Study|Lost to Follow-up|9|||
23229673|NCT01696396|64584087|FG001|Overall Study|Lost to Follow-up|1|||
23229674|NCT01696396|64584088|FG002|Overall Study|Lost to Follow-up|4|||
23229675|NCT01696396|64584089|FG003|Overall Study|Lost to Follow-up|1|||
23229676|NCT01696396|64584086|FG000|Overall Study|Death|0|||
23229677|NCT01696396|64584087|FG001|Overall Study|Death|0|||
23229678|NCT01696396|64584088|FG002|Overall Study|Death|1|||
23229679|NCT01696396|64584089|FG003|Overall Study|Death|0|||
23229680|NCT00736385|64584090|FG000|Overall Study|Withdrawal by Subject|2|||
23229681|NCT00736385|64584091|FG001|Overall Study|Withdrawal by Subject|2|||
23229682|NCT00736385|64584090|FG000|Overall Study|Adverse Event|0|||
23229683|NCT00736385|64584091|FG001|Overall Study|Adverse Event|1|||
23229684|NCT01603628|64584092|FG000|Overall Study|Personal Reasons|1|||
23229685|NCT01603628|64584093|FG001|Overall Study|Personal Reasons|1|||
23229686|NCT01603628|64584094|FG002|Overall Study|Personal Reasons|2|||
23229687|NCT01603628|64584092|FG000|Overall Study|Protocol Violation|1|||
23229688|NCT01603628|64584093|FG001|Overall Study|Protocol Violation|1|||
23229689|NCT01603628|64584094|FG002|Overall Study|Protocol Violation|0|||
23229690|NCT01603628|64584092|FG000|Overall Study|Lost to Follow-up|0|||
23229691|NCT01603628|64584093|FG001|Overall Study|Lost to Follow-up|1|||
23229692|NCT01603628|64584094|FG002|Overall Study|Lost to Follow-up|0|||
23229693|NCT01603628|64584092|FG000|Overall Study|Other Miscellaneous Reason|1|||
23229694|NCT01603628|64584093|FG001|Overall Study|Other Miscellaneous Reason|0|||
23229695|NCT01603628|64584094|FG002|Overall Study|Other Miscellaneous Reason|0|||
23229696|NCT03824704|64584095|FG000|Overall Study|Study Terminated by Sponsor|1|||
23229697|NCT00434876|64584096|FG000|Overall Study|Lost to Follow-up|1|||
23577478|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
23229698|NCT00434876|64584097|FG001|Overall Study|Lost to Follow-up|1|||
23229699|NCT01195636|64584098|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
23229700|NCT01195636|64584099|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
23229701|NCT01195636|64584098|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
23229702|NCT01195636|64584099|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
23229703|NCT01195636|64584098|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23229704|NCT01195636|64584099|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
23229705|NCT01195636|64584098|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
23229706|NCT01195636|64584099|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
23229707|NCT01195636|64584098|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
23229708|NCT01195636|64584099|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
23229709|NCT01195636|64584098|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
23229710|NCT01195636|64584099|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
23229711|NCT01195636|64584098|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
23229712|NCT01195636|64584099|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
23229713|NCT01195636|64584098|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23229714|NCT01195636|64584099|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
23229715|NCT02853318|64584100|FG000|Overall Study|Withdrawal by Subject|1|||
23229716|NCT01938391|64584101|FG000|6 Month Follow up|Withdrawal by Subject|1|||
23229717|NCT01938391|64584101|FG000|12 Month Follow up|Physician Decision|1|||
23229718|NCT01938391|64584101|FG000|12 Month Follow up|Withdrawal by Subject|1|||
23229719|NCT05049122|64584102|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
23229720|NCT05049122|64584102|FG000|Overall Study|Participant moved|1|||
23229721|NCT05049122|64584102|FG000|Overall Study|At the direction of the doctor|1|||
23229722|NCT04610827|64584104|FG000|Overall Study|Withdrawal by Subject|1|||
23229723|NCT04610827|64584105|FG001|Overall Study|Withdrawal by Subject|1|||
23229724|NCT04610827|64584106|FG002|Overall Study|Withdrawal by Subject|0|||
23229725|NCT01904760|64584109|FG000|Overall Study|Protocol Violation|1|||
23229726|NCT01904760|64584110|FG001|Overall Study|Protocol Violation|0|||
23229727|NCT04604015|64584111|FG000|Overall Study|Incomplete Data Collection|33|||
23229728|NCT01326481|64584112|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
23229729|NCT04430036|64584117|FG000|Safety Run in Phase|Progression of disease|2|||
23229730|NCT03598140|64584118|FG000|Overall Study|enrolled but didn't start|1|||
23229731|NCT03598140|64584119|FG001|Overall Study|enrolled but didn't start|0|||
23229732|NCT03432819|64584122|FG000|Overall Study|Lost to Follow-up|2|||
23229733|NCT03432819|64584123|FG001|Overall Study|Lost to Follow-up|2|||
23577479|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
23577480|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
23577481|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
23577482|NCT00843882|65846811|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
23577483|NCT00843882|65846812|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
23577484|NCT00843882|65846813|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
23577485|NCT02790606|65846815|FG000|Overall Study|Death|27|||
23577486|NCT02790606|65846815|FG000|Overall Study|Lost to Follow-up|4|||
23577487|NCT02790606|65846815|FG000|Overall Study|Physician Decision|3|||
23577488|NCT02790606|65846815|FG000|Overall Study|Withdrawal by Subject|1|||
23577489|NCT04796935|65846816|FG000|Overall Study|Withdrawal by Subject|0|||
23577490|NCT04796935|65846817|FG001|Overall Study|Withdrawal by Subject|1|||
23577491|NCT04796935|65846816|FG000|Overall Study|Physician Decision|0|||
23577492|NCT04796935|65846817|FG001|Overall Study|Physician Decision|1|||
23229734|NCT03432819|64584122|FG000|Overall Study|Withdrawal by Subject|5|||
23229735|NCT03432819|64584123|FG001|Overall Study|Withdrawal by Subject|3|||
23229736|NCT00545740|64584124|FG000|Overall Study|Lack of Efficacy|34|||
23229737|NCT00545740|64584125|FG001|Overall Study|Lack of Efficacy|35|||
23229738|NCT00545740|64584126|FG002|Overall Study|Lack of Efficacy|47|||
23229739|NCT00545740|64584127|FG003|Overall Study|Lack of Efficacy|36|||
23229740|NCT00545740|64584124|FG000|Overall Study|Withdrawal by Subject|17|||
23229741|NCT00545740|64584125|FG001|Overall Study|Withdrawal by Subject|15|||
23229742|NCT00545740|64584126|FG002|Overall Study|Withdrawal by Subject|16|||
23229743|NCT00545740|64584127|FG003|Overall Study|Withdrawal by Subject|18|||
23229744|NCT00545740|64584124|FG000|Overall Study|Adverse Event|10|||
23577493|NCT04796935|65846816|FG000|Overall Study|Device not available|1|||
23577494|NCT04796935|65846817|FG001|Overall Study|Device not available|0|||
23577495|NCT04796935|65846816|FG000|Overall Study|Trained provider not available|1|||
23577496|NCT04796935|65846817|FG001|Overall Study|Trained provider not available|0|||
23577497|NCT02711995|65846818|FG000|Washout (90 Days)|Conflicting medication|1|||
23577498|NCT00504348|65846819|FG000|Overall Study|Adverse Event|3|||
23577499|NCT00504348|65846819|FG000|Overall Study|Lack of Efficacy|4|||
23577500|NCT00504348|65846819|FG000|Overall Study|Physician Decision|1|||
23577501|NCT02487446|65846820|FG000|Period 1|Physician Decision|0|||
23229745|NCT00545740|64584125|FG001|Overall Study|Adverse Event|18|||
23229746|NCT00545740|64584126|FG002|Overall Study|Adverse Event|19|||
23229747|NCT00545740|64584127|FG003|Overall Study|Adverse Event|9|||
23229748|NCT00545740|64584124|FG000|Overall Study|Lost to Follow-up|7|||
23229749|NCT00545740|64584125|FG001|Overall Study|Lost to Follow-up|5|||
23229750|NCT00545740|64584126|FG002|Overall Study|Lost to Follow-up|5|||
23229751|NCT00545740|64584127|FG003|Overall Study|Lost to Follow-up|6|||
23229752|NCT00545740|64584124|FG000|Overall Study|Protocol Violation|1|||
23577502|NCT02487446|65846821|FG001|Period 1|Physician Decision|1|||
23577503|NCT02487446|65846820|FG000|Period 1|Lack of Efficacy|1|||
23577504|NCT02487446|65846821|FG001|Period 1|Lack of Efficacy|0|||
23577505|NCT02487446|65846820|FG000|Period 1|Protocol deviation|3|||
23577506|NCT02487446|65846821|FG001|Period 1|Protocol deviation|2|||
23577507|NCT02487446|65846820|FG000|Period 1|Lost to Follow-up|2|||
23577508|NCT02487446|65846821|FG001|Period 1|Lost to Follow-up|0|||
23577509|NCT02487446|65846820|FG000|Period 1|Withdrawal by Subject|2|||
23577510|NCT02487446|65846821|FG001|Period 1|Withdrawal by Subject|0|||
23577511|NCT02487446|65846820|FG000|Period 1|Adverse Event|5|||
23577512|NCT02487446|65846821|FG001|Period 1|Adverse Event|5|||
23577513|NCT02487446|65846820|FG000|Washout|Lost to Follow-up|0|||
23577514|NCT02487446|65846821|FG001|Washout|Lost to Follow-up|2|||
23577515|NCT02487446|65846820|FG000|Washout|Withdrawal by Subject|1|||
23577516|NCT02487446|65846821|FG001|Washout|Withdrawal by Subject|4|||
23577517|NCT02487446|65846820|FG000|Washout|Adverse Event|2|||
23577518|NCT02487446|65846821|FG001|Washout|Adverse Event|2|||
23577519|NCT02487446|65846820|FG000|Period 2|Protocol deviation|0|||
23577520|NCT02487446|65846821|FG001|Period 2|Protocol deviation|1|||
23577521|NCT02487446|65846820|FG000|Period 2|Lost to Follow-up|1|||
23577522|NCT02487446|65846821|FG001|Period 2|Lost to Follow-up|1|||
23577523|NCT02487446|65846820|FG000|Period 2|Withdrawal by Subject|1|||
23577524|NCT02487446|65846821|FG001|Period 2|Withdrawal by Subject|1|||
23577525|NCT02487446|65846820|FG000|Period 2|Adverse Event|6|||
23577526|NCT02487446|65846821|FG001|Period 2|Adverse Event|2|||
23577527|NCT00445692|65846823|FG000|Overall Study|Adverse Event|11|||
23577528|NCT00445692|65846823|FG000|Overall Study|Lack of Efficacy|5|||
23577529|NCT01272011|65846824|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
23577530|NCT01272011|65846825|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
23577531|NCT01272011|65846826|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
23449814|NCT01272232|65388183|FG001|Weeks 0-56|Protocol Violation|8|||
23449815|NCT01272232|65388184|FG002|Weeks 0-56|Protocol Violation|13|||
23449816|NCT01272232|65388182|FG000|Weeks 0-56|Withdrawal criteria|32|||
23449817|NCT01272232|65388183|FG001|Weeks 0-56|Withdrawal criteria|14|||
23449818|NCT01272232|65388184|FG002|Weeks 0-56|Withdrawal criteria|37|||
23449819|NCT01272232|65388182|FG000|Weeks 0-56|Unclassified|16|||
23449820|NCT01272232|65388183|FG001|Weeks 0-56|Unclassified|7|||
23449821|NCT01272232|65388184|FG002|Weeks 0-56|Unclassified|12|||
23449822|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
23449823|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
23449824|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
23449825|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
23449826|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
23449827|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
23449828|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
23449829|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
23449830|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
23449831|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
23449832|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
23449833|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
23449834|NCT01272232|65388182|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
23449835|NCT01272232|65388183|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
23449836|NCT01272232|65388184|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
23449837|NCT00657540|65391310|FG000|Overall Study|Lost to Follow-up|1|||
23449838|NCT00657540|65391311|FG001|Overall Study|Lost to Follow-up|4|||
23449839|NCT03836625|65391314|FG000|Overall Study|Lost to Follow-up|9|||
23449840|NCT03836625|65391315|FG001|Overall Study|Lost to Follow-up|9|||
23449841|NCT03836625|65391314|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
23449842|NCT03836625|65391315|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
23577532|NCT03726879|65846835|FG000|Overall Study|Death|6|||
23449843|NCT03836625|65391314|FG000|Overall Study|Death|0|||
23577533|NCT03726879|65846836|FG001|Overall Study|Death|4|||
23577534|NCT03726879|65846835|FG000|Overall Study|Physician Decision|0|||
23577535|NCT03726879|65846836|FG001|Overall Study|Physician Decision|2|||
23577536|NCT03726879|65846835|FG000|Overall Study|Protocol Violation|0|||
23577537|NCT03726879|65846836|FG001|Overall Study|Protocol Violation|1|||
23337957|NCT02361346|64982886|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
23449844|NCT03836625|65391315|FG001|Overall Study|Death|1|||
23449845|NCT03836625|65391314|FG000|Overall Study|Refused follow-up|0|||
23449846|NCT03836625|65391315|FG001|Overall Study|Refused follow-up|1|||
23577538|NCT03726879|65846835|FG000|Overall Study|Withdrawal by Subject|5|||
23337958|NCT02361346|64982887|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
23337959|NCT02361346|64982888|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
23449847|NCT01050634|65391316|FG000|Overall Study|Enrolled, but Not Treated|56|||
23449848|NCT01050634|65391316|FG000|Overall Study|Death|2|||
23577539|NCT03726879|65846836|FG001|Overall Study|Withdrawal by Subject|5|||
23577540|NCT03726879|65846835|FG000|Overall Study|TSH result is unstable|0|||
23577541|NCT03726879|65846836|FG001|Overall Study|TSH result is unstable|1|||
23577542|NCT03726879|65846835|FG000|Overall Study|Continuing on Study|215|||
23577543|NCT03726879|65846836|FG001|Overall Study|Continuing on Study|215|||
23577544|NCT01400893|65846837|FG000|Overall Study|Death|27|||
23577545|NCT01400893|65846838|FG001|Overall Study|Death|21|||
23577546|NCT01400893|65846837|FG000|Overall Study|Lost to Follow-up|0|||
23337960|NCT02361346|64982889|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
23337961|NCT02361346|64982890|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
23337962|NCT02361346|64982891|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
23337963|NCT02361346|64982883|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23337964|NCT02361346|64982884|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23337965|NCT02361346|64982885|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23337966|NCT02361346|64982886|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23337967|NCT02361346|64982887|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
23337968|NCT02361346|64982888|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23337969|NCT02361346|64982889|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23337970|NCT02361346|64982890|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23337971|NCT02361346|64982891|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
23337972|NCT02361346|64982883|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
23337973|NCT02361346|64982884|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
23337974|NCT02361346|64982885|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
23337975|NCT02361346|64982886|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
23337976|NCT02361346|64982887|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
23337977|NCT02361346|64982888|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
23337978|NCT02361346|64982889|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
23337979|NCT02361346|64982890|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
23337980|NCT02361346|64982891|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
23337981|NCT02361346|64982883|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23337982|NCT02361346|64982884|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23337983|NCT02361346|64982885|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23337984|NCT02361346|64982886|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23337985|NCT02361346|64982887|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23337986|NCT02361346|64982888|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23337987|NCT02361346|64982889|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23170763|NCT03403205|64370857|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
23170764|NCT03403205|64370852|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
23170765|NCT03403205|64370853|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
23170766|NCT03403205|64370854|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
23170767|NCT03403205|64370855|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
23170768|NCT03403205|64370856|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
23170769|NCT03403205|64370857|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
23170770|NCT03403205|64370852|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
23170771|NCT03403205|64370853|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23170772|NCT03403205|64370854|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23170773|NCT03403205|64370855|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23170774|NCT03403205|64370856|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23170775|NCT03403205|64370857|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
23170776|NCT03403205|64370852|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23170777|NCT03403205|64370853|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
23170778|NCT03403205|64370854|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23170779|NCT03403205|64370855|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23170780|NCT03403205|64370856|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23170781|NCT03403205|64370857|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
23170782|NCT03403205|64370852|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
23170783|NCT03403205|64370853|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
23170784|NCT03403205|64370854|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
23170785|NCT03403205|64370855|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
23170786|NCT03403205|64370856|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
23170787|NCT03403205|64370857|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
23170788|NCT03403205|64370852|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
23337988|NCT02361346|64982890|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
23337989|NCT02361346|64982891|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
23337990|NCT02361346|64982883|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23337991|NCT02361346|64982884|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23337992|NCT02361346|64982885|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23337993|NCT02361346|64982886|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23337994|NCT02361346|64982887|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23229753|NCT00545740|64584125|FG001|Overall Study|Protocol Violation|3|||
23229754|NCT00545740|64584126|FG002|Overall Study|Protocol Violation|1|||
23229755|NCT00545740|64584127|FG003|Overall Study|Protocol Violation|0|||
23229756|NCT00545740|64584124|FG000|Overall Study|Non-compliance|0|||
23229757|NCT00545740|64584125|FG001|Overall Study|Non-compliance|2|||
23229758|NCT00545740|64584126|FG002|Overall Study|Non-compliance|1|||
23229759|NCT00545740|64584127|FG003|Overall Study|Non-compliance|0|||
23229760|NCT00545740|64584124|FG000|Overall Study|Moved|2|||
23229761|NCT00545740|64584125|FG001|Overall Study|Moved|0|||
23229762|NCT00545740|64584126|FG002|Overall Study|Moved|1|||
23229763|NCT00545740|64584127|FG003|Overall Study|Moved|0|||
23229764|NCT00545740|64584124|FG000|Overall Study|Diverticulitis attack|0|||
23229765|NCT00545740|64584125|FG001|Overall Study|Diverticulitis attack|0|||
23229766|NCT00545740|64584126|FG002|Overall Study|Diverticulitis attack|1|||
23229767|NCT00545740|64584127|FG003|Overall Study|Diverticulitis attack|1|||
23229768|NCT00545740|64584124|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
23229769|NCT00545740|64584125|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
23229770|NCT00545740|64584126|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
23229771|NCT00545740|64584127|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
23229772|NCT00545740|64584124|FG000|Overall Study|Site closure|1|||
23229773|NCT00545740|64584125|FG001|Overall Study|Site closure|0|||
23229774|NCT00545740|64584126|FG002|Overall Study|Site closure|0|||
23229775|NCT00545740|64584127|FG003|Overall Study|Site closure|0|||
23229776|NCT00545740|64584124|FG000|Overall Study|Missed visit|1|||
23229777|NCT00545740|64584125|FG001|Overall Study|Missed visit|0|||
23229778|NCT00545740|64584126|FG002|Overall Study|Missed visit|0|||
23229779|NCT00545740|64584127|FG003|Overall Study|Missed visit|0|||
23229780|NCT00545740|64584124|FG000|Overall Study|Physician Decision|0|||
23229781|NCT00545740|64584125|FG001|Overall Study|Physician Decision|0|||
23229782|NCT00545740|64584126|FG002|Overall Study|Physician Decision|3|||
23229783|NCT00545740|64584127|FG003|Overall Study|Physician Decision|0|||
23229784|NCT00545740|64584124|FG000|Overall Study|Accepted only monthly telephone calls|1|||
23229785|NCT00545740|64584125|FG001|Overall Study|Accepted only monthly telephone calls|0|||
23229786|NCT00545740|64584126|FG002|Overall Study|Accepted only monthly telephone calls|0|||
23229787|NCT00545740|64584127|FG003|Overall Study|Accepted only monthly telephone calls|0|||
23229788|NCT00545740|64584124|FG000|Overall Study|Sponsor decision|0|||
23229789|NCT00545740|64584125|FG001|Overall Study|Sponsor decision|1|||
23229790|NCT00545740|64584126|FG002|Overall Study|Sponsor decision|0|||
23229791|NCT00545740|64584127|FG003|Overall Study|Sponsor decision|0|||
23229792|NCT00545740|64584124|FG000|Overall Study|Lack of time|0|||
23229793|NCT00545740|64584125|FG001|Overall Study|Lack of time|1|||
23229794|NCT00545740|64584126|FG002|Overall Study|Lack of time|0|||
23229795|NCT00545740|64584127|FG003|Overall Study|Lack of time|0|||
23229796|NCT00545740|64584124|FG000|Overall Study|Non-adherence to visits|0|||
23229797|NCT00545740|64584125|FG001|Overall Study|Non-adherence to visits|1|||
23229798|NCT00545740|64584126|FG002|Overall Study|Non-adherence to visits|0|||
23229799|NCT00545740|64584127|FG003|Overall Study|Non-adherence to visits|0|||
23229800|NCT00545740|64584124|FG000|Overall Study|Patient difficulties|0|||
23229801|NCT00545740|64584125|FG001|Overall Study|Patient difficulties|1|||
23229802|NCT00545740|64584126|FG002|Overall Study|Patient difficulties|0|||
23229803|NCT00545740|64584127|FG003|Overall Study|Patient difficulties|0|||
23229804|NCT00545740|64584124|FG000|Overall Study|Husband against study|0|||
23229805|NCT00545740|64584125|FG001|Overall Study|Husband against study|0|||
23229806|NCT00545740|64584126|FG002|Overall Study|Husband against study|1|||
23229807|NCT00545740|64584127|FG003|Overall Study|Husband against study|0|||
23229808|NCT01021553|64584128|FG000|Overall Study|Adverse Event|1|||
23229809|NCT01021553|64584129|FG001|Overall Study|Adverse Event|0|||
23229810|NCT01021553|64584130|FG002|Overall Study|Adverse Event|0|||
23337995|NCT02361346|64982888|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23229811|NCT01021553|64584128|FG000|Overall Study|Lack of Efficacy|2|||
23229812|NCT01021553|64584129|FG001|Overall Study|Lack of Efficacy|2|||
23449849|NCT01050634|65391316|FG000|Overall Study|Adverse Event|42|||
23229813|NCT01021553|64584130|FG002|Overall Study|Lack of Efficacy|0|||
23229814|NCT01021553|64584128|FG000|Overall Study|Protocol Violation|0|||
23229815|NCT01021553|64584129|FG001|Overall Study|Protocol Violation|2|||
23229816|NCT01021553|64584130|FG002|Overall Study|Protocol Violation|2|||
23229817|NCT01021553|64584128|FG000|Overall Study|Lost to Follow-up|0|||
23337996|NCT02361346|64982889|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23337997|NCT02361346|64982890|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
23337998|NCT02361346|64982891|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
23337999|NCT02361346|64982883|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23338000|NCT02361346|64982884|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23338001|NCT02361346|64982885|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23338002|NCT02361346|64982886|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23338003|NCT02361346|64982887|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23338004|NCT02361346|64982888|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23338005|NCT02361346|64982889|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23338006|NCT02361346|64982890|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
23338007|NCT02361346|64982891|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
23338008|NCT02797080|64982894|FG000|Overall Study|Lost to Follow-up|1|||
23338009|NCT02797080|64982894|FG000|Overall Study|Withdrawal by Subject|1|||
23338010|NCT01437995|64982898|FG000|Overall Study|Lost to Follow-up|11|||
23338011|NCT01437995|64982899|FG001|Overall Study|Lost to Follow-up|18|||
23338012|NCT01437995|64982900|FG002|Overall Study|Lost to Follow-up|20|||
23338013|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
23338014|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
23338015|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
23338016|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
23338017|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
23338018|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
23170789|NCT03403205|64370853|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
23229818|NCT01021553|64584129|FG001|Overall Study|Lost to Follow-up|0|||
23229819|NCT01021553|64584130|FG002|Overall Study|Lost to Follow-up|1|||
23229820|NCT01021553|64584128|FG000|Overall Study|Withdrawal by Subject|1|||
23229821|NCT01021553|64584129|FG001|Overall Study|Withdrawal by Subject|1|||
23229822|NCT01021553|64584130|FG002|Overall Study|Withdrawal by Subject|0|||
23229823|NCT01535638|64584138|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
23229824|NCT01535638|64584139|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
23229825|NCT01535638|64584140|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
23229826|NCT01535638|64584141|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
23229827|NCT01535638|64584142|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
23229828|NCT01535638|64584143|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
23229829|NCT01535638|64584138|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
23229830|NCT01535638|64584139|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
23229831|NCT01535638|64584140|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
23229832|NCT01535638|64584141|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
23229833|NCT01535638|64584142|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
23229834|NCT01535638|64584143|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
23229835|NCT04035473|64584144|FG000|Screening/Baseline|Death|0|||
23229836|NCT04035473|64584145|FG001|Screening/Baseline|Death|1|||
23229837|NCT04035473|64584144|FG000|Screening/Baseline|Adverse Event|0|||
23229838|NCT04035473|64584145|FG001|Screening/Baseline|Adverse Event|1|||
23229839|NCT04035473|64584144|FG000|Follow-up Period|Adverse Event|2|||
23229840|NCT04035473|64584145|FG001|Follow-up Period|Adverse Event|0|||
23229841|NCT00286234|64584146|FG000|Overall Study|Protocol Violation|1|||
23229842|NCT00286234|64584147|FG001|Overall Study|Protocol Violation|2|||
23229843|NCT00286234|64584148|FG002|Overall Study|Protocol Violation|0|||
23229844|NCT00286234|64584149|FG003|Overall Study|Protocol Violation|1|||
23229845|NCT00286234|64584146|FG000|Overall Study|Physician Decision|1|||
23229846|NCT00286234|64584147|FG001|Overall Study|Physician Decision|0|||
23229847|NCT00286234|64584148|FG002|Overall Study|Physician Decision|0|||
23229848|NCT00286234|64584149|FG003|Overall Study|Physician Decision|1|||
23449850|NCT01050634|65391316|FG000|Overall Study|Lost to Follow-up|2|||
23170790|NCT03403205|64370854|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
23170791|NCT03403205|64370855|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
23170792|NCT03403205|64370856|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
23170793|NCT03403205|64370857|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
23170794|NCT03403205|64370852|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
23170795|NCT03403205|64370853|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
23170796|NCT03403205|64370854|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
23170797|NCT03403205|64370855|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
23170798|NCT03403205|64370856|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
23170799|NCT03403205|64370857|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
23170800|NCT03403205|64370852|FG000|Extension Period (Up to 60 Months)|Death|1|||
23229849|NCT00286234|64584146|FG000|Overall Study|Adverse Event|0|||
23229850|NCT00286234|64584147|FG001|Overall Study|Adverse Event|0|||
23229851|NCT00286234|64584148|FG002|Overall Study|Adverse Event|0|||
23229852|NCT00286234|64584149|FG003|Overall Study|Adverse Event|1|||
23229853|NCT00286234|64584146|FG000|Overall Study|Adverse Event|0|||
23229854|NCT00286234|64584147|FG001|Overall Study|Adverse Event|0|||
23338019|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
23229855|NCT00286234|64584148|FG002|Overall Study|Adverse Event|0|||
23229856|NCT00286234|64584149|FG003|Overall Study|Adverse Event|1|||
23229857|NCT00129376|64584150|FG000|Overall Study|Adverse Event|1|||
23229858|NCT00129376|64584150|FG000|Overall Study|Lack of Efficacy|1|||
23229859|NCT02407236|64584151|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
23229860|NCT02407236|64584152|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
23229861|NCT02407236|64584153|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
23338020|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
23338021|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
23338022|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
23338023|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
23338024|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
23338025|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
23338026|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
23338027|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
23338028|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
23338029|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
23338030|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
23338031|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
23338032|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
23338033|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
23338034|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
23170801|NCT03403205|64370853|FG001|Extension Period (Up to 60 Months)|Death|0|||
23338035|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
23338036|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
23338037|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
23338038|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
23338039|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
23338040|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
23449851|NCT01050634|65391316|FG000|Overall Study|Other|21|||
23449852|NCT01050634|65391316|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
23449853|NCT01927497|65391317|FG000|Overall Study|Death|0|||
23170802|NCT03403205|64370854|FG002|Extension Period (Up to 60 Months)|Death|0|||
23170803|NCT03403205|64370855|FG003|Extension Period (Up to 60 Months)|Death|0|||
23170804|NCT03403205|64370856|FG004|Extension Period (Up to 60 Months)|Death|0|||
23170805|NCT03403205|64370857|FG005|Extension Period (Up to 60 Months)|Death|0|||
23170806|NCT03403205|64370852|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
23170807|NCT03403205|64370853|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23170808|NCT03403205|64370854|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23170809|NCT03403205|64370855|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23170810|NCT03403205|64370856|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23170811|NCT03403205|64370857|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
23170812|NCT03403205|64370852|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
23170813|NCT03403205|64370853|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
23170814|NCT03403205|64370854|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
23170815|NCT03403205|64370855|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
23170816|NCT03403205|64370856|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
23170817|NCT03403205|64370857|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
23170818|NCT03403205|64370852|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
23170819|NCT03403205|64370853|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23170820|NCT03403205|64370854|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23170821|NCT03403205|64370855|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23170822|NCT03403205|64370856|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23170823|NCT03403205|64370857|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
23170824|NCT03403205|64370852|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
23170825|NCT03403205|64370853|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
23170826|NCT03403205|64370854|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
23170827|NCT03403205|64370855|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
23170828|NCT03403205|64370856|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
23170829|NCT03403205|64370857|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
23229862|NCT02407236|64584154|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
23338041|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
23338042|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
23338043|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
23338044|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
23338045|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
23338046|NCT00839527|64982901|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
23338047|NCT00839527|64982902|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
23577547|NCT01400893|65846838|FG001|Overall Study|Lost to Follow-up|6|||
23577548|NCT03169361|65846842|FG000|Overall Study|Protocol Violation|32|||
23338048|NCT00839527|64982903|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
23338049|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
23338050|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
23338051|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
23338052|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
23338053|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
23338054|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
23338055|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
23338056|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
23338057|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
23338058|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
23338059|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
23577549|NCT00178256|65846843|FG000|Overall Study|Adverse Event|2|||
23577550|NCT00178256|65846844|FG001|Overall Study|Adverse Event|0|||
23577551|NCT00178256|65846845|FG002|Overall Study|Adverse Event|0|||
23577552|NCT00178256|65846846|FG003|Overall Study|Adverse Event|0|||
23577553|NCT00178256|65846843|FG000|Overall Study|Death|0|||
23577554|NCT00178256|65846844|FG001|Overall Study|Death|1|||
23577555|NCT00178256|65846845|FG002|Overall Study|Death|0|||
23577556|NCT00178256|65846846|FG003|Overall Study|Death|1|||
23229863|NCT02407236|64584155|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
23229864|NCT02407236|64584156|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
23338060|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
23338061|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
23338062|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
23338063|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
23338064|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
23338065|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
23338066|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
23577557|NCT00178256|65846843|FG000|Overall Study|Cancer progression|2|||
23577558|NCT00178256|65846844|FG001|Overall Study|Cancer progression|0|||
23577559|NCT00178256|65846845|FG002|Overall Study|Cancer progression|0|||
23577560|NCT00178256|65846846|FG003|Overall Study|Cancer progression|1|||
23229865|NCT02407236|64584157|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
23229866|NCT02407236|64584158|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
23229867|NCT02407236|64584159|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
23229868|NCT02407236|64584160|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
23229869|NCT02407236|64584161|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
23229870|NCT02407236|64584162|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
23229871|NCT02407236|64584163|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
23229872|NCT02407236|64584151|FG000|Induction Study (8 Weeks)|Death|0|||
23229873|NCT02407236|64584152|FG001|Induction Study (8 Weeks)|Death|0|||
23229874|NCT02407236|64584153|FG002|Induction Study (8 Weeks)|Death|1|||
23229875|NCT02407236|64584154|FG003|Induction Study (8 Weeks)|Death|0|||
23229876|NCT02407236|64584155|FG004|Induction Study (8 Weeks)|Death|0|||
23229877|NCT02407236|64584156|FG005|Induction Study (8 Weeks)|Death|0|||
23229878|NCT02407236|64584157|FG006|Induction Study (8 Weeks)|Death|0|||
23229879|NCT02407236|64584158|FG007|Induction Study (8 Weeks)|Death|0|||
23229880|NCT02407236|64584159|FG008|Induction Study (8 Weeks)|Death|0|||
23229881|NCT02407236|64584160|FG009|Induction Study (8 Weeks)|Death|0|||
23229882|NCT02407236|64584161|FG010|Induction Study (8 Weeks)|Death|0|||
23229883|NCT02407236|64584162|FG011|Induction Study (8 Weeks)|Death|0|||
23229884|NCT02407236|64584163|FG012|Induction Study (8 Weeks)|Death|0|||
23229885|NCT02407236|64584151|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
23577561|NCT00590980|65846847|FG000|Overall Study|Did not meet all inclusion criteria|10|||
23577562|NCT04990440|65846852|FG000|Overall Study|Sponsor's Decision|0|||
23577563|NCT04990440|65846853|FG001|Overall Study|Sponsor's Decision|0|||
23577564|NCT04990440|65846854|FG002|Overall Study|Sponsor's Decision|1|||
23577565|NCT00670540|65846858|FG000|Overall Study|ineligible|17|||
23577566|NCT00670540|65846858|FG000|Overall Study|not living in France|348|||
23577567|NCT00670540|65846858|FG000|Overall Study|refused to participate|189|||
23577568|NCT00670540|65846858|FG000|Overall Study|controls randomised for no follow up|2770|||
23577569|NCT00670540|65846858|FG000|Overall Study|missing information inclusion criteria|1|||
23577570|NCT01536262|65846859|FG000|Overall Study|Adverse Event|6|||
23229886|NCT02407236|64584152|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
23229887|NCT02407236|64584153|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
23229888|NCT02407236|64584154|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23229889|NCT02407236|64584155|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23229890|NCT02407236|64584156|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23338067|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
23338068|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
23338069|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
23338070|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
23338071|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
23338072|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
23338073|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
23338074|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
23338075|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
23338076|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
23338077|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
23338078|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
23338079|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
23577571|NCT01536262|65846860|FG001|Overall Study|Adverse Event|1|||
23577572|NCT01536262|65846861|FG002|Overall Study|Adverse Event|2|||
23577573|NCT01536262|65846859|FG000|Overall Study|Withdrawal by Subject|1|||
23577574|NCT01536262|65846860|FG001|Overall Study|Withdrawal by Subject|1|||
23577575|NCT01536262|65846861|FG002|Overall Study|Withdrawal by Subject|0|||
23577576|NCT01536262|65846859|FG000|Overall Study|Other than stated above|1|||
23577577|NCT01536262|65846860|FG001|Overall Study|Other than stated above|0|||
23338080|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
23338081|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
23338082|NCT00839527|64982901|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
23338083|NCT00839527|64982902|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
23338084|NCT00839527|64982903|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
23338085|NCT01322490|64982904|FG000|Treatment Period|Adverse Event|12|||
23338086|NCT01322490|64982905|FG001|Treatment Period|Adverse Event|18|||
23338087|NCT01322490|64982906|FG002|Treatment Period|Adverse Event|15|||
23338088|NCT01322490|64982904|FG000|Treatment Period|Death|5|||
23338089|NCT01322490|64982905|FG001|Treatment Period|Death|7|||
23338090|NCT01322490|64982906|FG002|Treatment Period|Death|3|||
23338091|NCT01322490|64982904|FG000|Treatment Period|Lack of Efficacy|89|||
23338092|NCT01322490|64982905|FG001|Treatment Period|Lack of Efficacy|100|||
23338093|NCT01322490|64982906|FG002|Treatment Period|Lack of Efficacy|112|||
23338094|NCT01322490|64982904|FG000|Treatment Period|Physician Decision|0|||
23577578|NCT01536262|65846861|FG002|Overall Study|Other than stated above|0|||
23577579|NCT02414828|65846864|FG000|Overall Study|Lost to Follow-up|0|||
23577580|NCT02414828|65846865|FG001|Overall Study|Lost to Follow-up|1|||
23577581|NCT02414828|65846866|FG002|Overall Study|Lost to Follow-up|1|||
23577582|NCT02414828|65846867|FG003|Overall Study|Lost to Follow-up|2|||
23577583|NCT01244984|65846870|FG000|Overall Study|Adverse Event|2|||
23577584|NCT01244984|65846871|FG001|Overall Study|Adverse Event|11|||
23577585|NCT01244984|65846872|FG002|Overall Study|Adverse Event|2|||
23577586|NCT01244984|65846870|FG000|Overall Study|Protocol Violation|1|||
23577587|NCT01244984|65846871|FG001|Overall Study|Protocol Violation|0|||
23577588|NCT01244984|65846872|FG002|Overall Study|Protocol Violation|0|||
23170830|NCT03403205|64370852|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
23170831|NCT03403205|64370853|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
23170832|NCT03403205|64370854|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
23170833|NCT03403205|64370855|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
23170834|NCT03403205|64370856|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
23170835|NCT03403205|64370857|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
23170836|NCT03403205|64370852|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
23170837|NCT03403205|64370853|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
23170838|NCT03403205|64370854|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
23170839|NCT03403205|64370855|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
23170840|NCT03403205|64370856|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
23170841|NCT03403205|64370857|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
23170842|NCT04312009|64370864|FG000|Overall Study|Withdrawal by Subject|2|||
23170843|NCT04312009|64370865|FG001|Overall Study|Withdrawal by Subject|1|||
23338095|NCT01322490|64982905|FG001|Treatment Period|Physician Decision|2|||
23577589|NCT01244984|65846870|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
23577590|NCT01244984|65846871|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
23577591|NCT01244984|65846872|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
23170844|NCT02615990|64370866|FG000|Overall Study|study terminated|1|||
23170845|NCT02615990|64370867|FG001|Overall Study|study terminated|1|||
23577592|NCT01244984|65846870|FG000|Overall Study|Withdrawal by Subject|1|||
23577593|NCT01244984|65846871|FG001|Overall Study|Withdrawal by Subject|2|||
23577594|NCT01244984|65846872|FG002|Overall Study|Withdrawal by Subject|2|||
23338096|NCT01322490|64982906|FG002|Treatment Period|Physician Decision|1|||
23338097|NCT01322490|64982904|FG000|Treatment Period|Protocol Violation|7|||
23338098|NCT01322490|64982905|FG001|Treatment Period|Protocol Violation|5|||
23338099|NCT01322490|64982906|FG002|Treatment Period|Protocol Violation|4|||
23338100|NCT01322490|64982904|FG000|Treatment Period|Withdrawal by Subject|14|||
23338101|NCT01322490|64982905|FG001|Treatment Period|Withdrawal by Subject|16|||
23577595|NCT00965484|65846873|FG000|Overall Study|Protocol Violation|1|||
23577596|NCT00965484|65846873|FG000|Overall Study|Withdrawal by Subject|1|||
23338102|NCT01322490|64982906|FG002|Treatment Period|Withdrawal by Subject|11|||
23338103|NCT01322490|64982904|FG000|Treatment Period|Non-compliance with study drug|0|||
23338104|NCT01322490|64982905|FG001|Treatment Period|Non-compliance with study drug|0|||
23338105|NCT01322490|64982906|FG002|Treatment Period|Non-compliance with study drug|1|||
23338106|NCT01322490|64982904|FG000|Treatment Period|Other per report|2|||
23338107|NCT01322490|64982905|FG001|Treatment Period|Other per report|2|||
23577597|NCT02926937|65846874|FG000|Overall Study|Adverse Event|0|||
23577598|NCT02926937|65846875|FG001|Overall Study|Adverse Event|1|||
23577599|NCT02926937|65846876|FG002|Overall Study|Adverse Event|1|||
23577600|NCT02926937|65846874|FG000|Overall Study|Poor Compliance to Protocol|1|||
23577601|NCT02926937|65846875|FG001|Overall Study|Poor Compliance to Protocol|0|||
23338108|NCT01322490|64982906|FG002|Treatment Period|Other per report|1|||
23338109|NCT01322490|64982904|FG000|Treatment Period|Randomized but Not Treated|3|||
23338110|NCT01322490|64982905|FG001|Treatment Period|Randomized but Not Treated|3|||
23338111|NCT01322490|64982906|FG002|Treatment Period|Randomized but Not Treated|5|||
23338112|NCT01322490|64982904|FG000|Long Term Follow-up Period|Death|235|||
23338113|NCT01322490|64982905|FG001|Long Term Follow-up Period|Death|239|||
23338114|NCT01322490|64982906|FG002|Long Term Follow-up Period|Death|236|||
23338115|NCT01322490|64982904|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
23338116|NCT01322490|64982905|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
23338117|NCT01322490|64982906|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
23338118|NCT01322490|64982904|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
23338119|NCT01322490|64982905|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
23338120|NCT01322490|64982906|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
23338121|NCT01322490|64982904|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
23338122|NCT01322490|64982905|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
23338123|NCT01322490|64982906|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
23338124|NCT01322490|64982904|FG000|Long Term Follow-up Period|Other per report|3|||
23338125|NCT01322490|64982905|FG001|Long Term Follow-up Period|Other per report|2|||
23338126|NCT01322490|64982906|FG002|Long Term Follow-up Period|Other per report|2|||
23338127|NCT01322490|64982904|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
23338128|NCT01322490|64982905|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
23338129|NCT01322490|64982906|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
23338130|NCT01258998|64982907|FG000|Overall Study|Ineligible|1|||
23338131|NCT02778074|64982908|FG000|Overall Study|Lost to Follow-up|7|||
23338132|NCT02778074|64982909|FG001|Overall Study|Lost to Follow-up|10|||
23338133|NCT02291601|64982912|FG000|Abdomen|Did not qualify|333|||
23338134|NCT02291601|64982913|FG001|Abdomen|Did not qualify|54|||
23338135|NCT02291601|64982914|FG002|Abdomen|Did not qualify|339|||
23338136|NCT02291601|64982912|FG000|Groin|Did not qualify|183|||
23338137|NCT02291601|64982913|FG001|Groin|Did not qualify|30|||
23338138|NCT02291601|64982914|FG002|Groin|Did not qualify|177|||
23170846|NCT01978093|64370872|FG000|Overall Study|Death|1|||
23170847|NCT01978093|64370873|FG001|Overall Study|Death|0|||
23170848|NCT01978093|64370872|FG000|Overall Study|Adverse Event|0|||
23170849|NCT01978093|64370873|FG001|Overall Study|Adverse Event|5|||
23338139|NCT00793624|64982917|FG000|Overall Study|Adverse Event|18|||
23338140|NCT00793624|64982918|FG001|Overall Study|Adverse Event|16|||
23338141|NCT00793624|64982919|FG002|Overall Study|Adverse Event|15|||
23338142|NCT00793624|64982920|FG003|Overall Study|Adverse Event|20|||
23338143|NCT00793624|64982917|FG000|Overall Study|Lost to Follow-up|2|||
23170850|NCT01978093|64370872|FG000|Overall Study|Protocol Violation|8|||
23170851|NCT01978093|64370873|FG001|Overall Study|Protocol Violation|2|||
23170852|NCT01978093|64370872|FG000|Overall Study|Withdrawal by Subject|29|||
23170853|NCT01978093|64370873|FG001|Overall Study|Withdrawal by Subject|25|||
23170854|NCT01978093|64370872|FG000|Overall Study|Lost to Follow-up|11|||
23170855|NCT01978093|64370873|FG001|Overall Study|Lost to Follow-up|15|||
23170856|NCT01978093|64370872|FG000|Overall Study|Migrated/moved from study area|11|||
23338144|NCT00793624|64982918|FG001|Overall Study|Lost to Follow-up|2|||
23577602|NCT02926937|65846876|FG002|Overall Study|Poor Compliance to Protocol|0|||
23170857|NCT01978093|64370873|FG001|Overall Study|Migrated/moved from study area|13|||
23170858|NCT01978093|64370872|FG000|Overall Study|Loss of kaiser coverage|4|||
23170859|NCT01978093|64370873|FG001|Overall Study|Loss of kaiser coverage|10|||
23229891|NCT02407236|64584157|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23338145|NCT00793624|64982919|FG002|Overall Study|Lost to Follow-up|4|||
23229892|NCT02407236|64584158|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23229893|NCT02407236|64584159|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23229894|NCT02407236|64584160|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23229895|NCT02407236|64584161|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23229896|NCT02407236|64584162|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23229897|NCT02407236|64584163|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
23338146|NCT00793624|64982920|FG003|Overall Study|Lost to Follow-up|0|||
23229898|NCT02407236|64584151|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23338147|NCT00793624|64982917|FG000|Overall Study|Withdrawal by Subject|20|||
23338148|NCT00793624|64982918|FG001|Overall Study|Withdrawal by Subject|9|||
23338149|NCT00793624|64982919|FG002|Overall Study|Withdrawal by Subject|11|||
23338150|NCT00793624|64982920|FG003|Overall Study|Withdrawal by Subject|14|||
23338151|NCT00793624|64982917|FG000|Overall Study|Lack of Efficacy|9|||
23338152|NCT00793624|64982918|FG001|Overall Study|Lack of Efficacy|2|||
23338153|NCT00793624|64982919|FG002|Overall Study|Lack of Efficacy|1|||
23229899|NCT02407236|64584152|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229900|NCT02407236|64584153|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
23229901|NCT02407236|64584154|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229902|NCT02407236|64584155|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229903|NCT02407236|64584156|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229904|NCT02407236|64584157|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229905|NCT02407236|64584158|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229906|NCT02407236|64584159|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229907|NCT02407236|64584160|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229908|NCT02407236|64584161|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229909|NCT02407236|64584162|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229910|NCT02407236|64584163|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
23229911|NCT02407236|64584151|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
23229912|NCT02407236|64584152|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
23229913|NCT02407236|64584153|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
23229914|NCT02407236|64584154|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
23229915|NCT02407236|64584155|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
23229916|NCT02407236|64584156|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
23229917|NCT02407236|64584157|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
23229918|NCT02407236|64584158|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
23229919|NCT02407236|64584159|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
23229920|NCT02407236|64584160|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
23229921|NCT02407236|64584161|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
23229922|NCT02407236|64584162|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
23229923|NCT02407236|64584163|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
23229924|NCT02407236|64584151|FG000|Induction Study (8 Weeks)|Other|2|||
23229925|NCT02407236|64584152|FG001|Induction Study (8 Weeks)|Other|1|||
23229926|NCT02407236|64584153|FG002|Induction Study (8 Weeks)|Other|5|||
23229927|NCT02407236|64584154|FG003|Induction Study (8 Weeks)|Other|0|||
23229928|NCT02407236|64584155|FG004|Induction Study (8 Weeks)|Other|0|||
23229929|NCT02407236|64584156|FG005|Induction Study (8 Weeks)|Other|0|||
23229930|NCT02407236|64584157|FG006|Induction Study (8 Weeks)|Other|0|||
23229931|NCT02407236|64584158|FG007|Induction Study (8 Weeks)|Other|0|||
23229932|NCT02407236|64584159|FG008|Induction Study (8 Weeks)|Other|0|||
23229933|NCT02407236|64584160|FG009|Induction Study (8 Weeks)|Other|0|||
23229934|NCT02407236|64584161|FG010|Induction Study (8 Weeks)|Other|0|||
23229935|NCT02407236|64584162|FG011|Induction Study (8 Weeks)|Other|0|||
23229936|NCT02407236|64584163|FG012|Induction Study (8 Weeks)|Other|0|||
23229937|NCT02407236|64584151|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
23229938|NCT02407236|64584152|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
23229939|NCT02407236|64584153|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
23229940|NCT02407236|64584154|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
23229941|NCT02407236|64584155|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
23229942|NCT02407236|64584156|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
23229943|NCT02407236|64584157|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
23229944|NCT02407236|64584158|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
23229945|NCT02407236|64584159|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
23229946|NCT02407236|64584160|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
23229947|NCT02407236|64584161|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
23229948|NCT02407236|64584162|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
23338154|NCT00793624|64982920|FG003|Overall Study|Lack of Efficacy|3|||
23229949|NCT02407236|64584163|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
23229950|NCT02407236|64584151|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23229951|NCT02407236|64584152|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23338155|NCT00793624|64982917|FG000|Overall Study|Non compliance with protocol|2|||
23338156|NCT00793624|64982918|FG001|Overall Study|Non compliance with protocol|3|||
23449854|NCT01927497|65391318|FG001|Overall Study|Death|1|||
23449855|NCT01927497|65391317|FG000|Overall Study|Protocol Violation|2|||
23449856|NCT01927497|65391318|FG001|Overall Study|Protocol Violation|0|||
23449857|NCT01339689|65391319|FG000|Overall Study|Adverse Event|1|||
23449858|NCT01339689|65391320|FG001|Overall Study|Adverse Event|2|||
23449859|NCT01339689|65391319|FG000|Overall Study|Lost to Follow-up|9|||
23449860|NCT01339689|65391320|FG001|Overall Study|Lost to Follow-up|3|||
23449861|NCT01339689|65391319|FG000|Overall Study|Withdrawal by Subject|3|||
23338157|NCT00793624|64982919|FG002|Overall Study|Non compliance with protocol|2|||
23338158|NCT00793624|64982920|FG003|Overall Study|Non compliance with protocol|3|||
23338159|NCT00793624|64982917|FG000|Overall Study|Other reason not described above|6|||
23338160|NCT00793624|64982918|FG001|Overall Study|Other reason not described above|4|||
23338161|NCT00793624|64982919|FG002|Overall Study|Other reason not described above|6|||
23338162|NCT00793624|64982920|FG003|Overall Study|Other reason not described above|3|||
23338163|NCT02782923|64982921|FG000|Overall Study|Lost to Follow-up|15|||
23338164|NCT01738503|64982924|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
23338165|NCT01738503|64982925|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
23338166|NCT01738503|64982926|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
23338167|NCT01738503|64982927|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
23338168|NCT01738503|64982928|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
23338169|NCT01738503|64982929|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
23338170|NCT01738503|64982930|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
23338171|NCT01738503|64982924|FG000|Treatment Period|Adverse Event|0|||
23338172|NCT01738503|64982925|FG001|Treatment Period|Adverse Event|1|||
23338173|NCT01738503|64982926|FG002|Treatment Period|Adverse Event|0|||
23338174|NCT01738503|64982927|FG003|Treatment Period|Adverse Event|1|||
23338175|NCT01738503|64982928|FG004|Treatment Period|Adverse Event|2|||
23338176|NCT01738503|64982929|FG005|Treatment Period|Adverse Event|2|||
23338177|NCT01738503|64982930|FG006|Treatment Period|Adverse Event|2|||
23338178|NCT01738503|64982924|FG000|Treatment Period|Lost to Follow-up|0|||
23338179|NCT01738503|64982925|FG001|Treatment Period|Lost to Follow-up|0|||
23338180|NCT01738503|64982926|FG002|Treatment Period|Lost to Follow-up|3|||
23338181|NCT01738503|64982927|FG003|Treatment Period|Lost to Follow-up|4|||
23338182|NCT01738503|64982928|FG004|Treatment Period|Lost to Follow-up|1|||
23449862|NCT01339689|65391320|FG001|Overall Study|Withdrawal by Subject|0|||
23449863|NCT01339689|65391319|FG000|Overall Study|Noncompliance|1|||
23170860|NCT01978093|64370872|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
23170861|NCT01978093|64370873|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
23170862|NCT01978093|64370872|FG000|Overall Study|Mother lost custody of child|0|||
23170863|NCT01978093|64370873|FG001|Overall Study|Mother lost custody of child|1|||
23170864|NCT01978093|64370872|FG000|Overall Study|Child was in care of grandmother|0|||
23170865|NCT01978093|64370873|FG001|Overall Study|Child was in care of grandmother|1|||
23170866|NCT01978093|64370872|FG000|Overall Study|N/A for vaccine administration|0|||
23170867|NCT01978093|64370873|FG001|Overall Study|N/A for vaccine administration|1|||
23170868|NCT02531646|64370874|FG000|Overall Study|equip. image processing issue|5|||
23170869|NCT02531646|64370875|FG001|Overall Study|equip. image processing issue|1|||
23170870|NCT02531646|64370876|FG002|Overall Study|equip. image processing issue|0|||
23170871|NCT01049035|64370877|FG000|Overall Study|Serious adverse event|0|||
23170872|NCT01049035|64370878|FG001|Overall Study|Serious adverse event|1|||
23170873|NCT01049035|64370879|FG002|Overall Study|Serious adverse event|1|||
23170874|NCT01049035|64370880|FG003|Overall Study|Serious adverse event|2|||
23170875|NCT01049035|64370881|FG004|Overall Study|Serious adverse event|0|||
23170876|NCT01049035|64370882|FG005|Overall Study|Serious adverse event|0|||
23170877|NCT01049035|64370883|FG006|Overall Study|Serious adverse event|0|||
23170878|NCT01049035|64370877|FG000|Overall Study|Other adverse event (AE)|0|||
23170879|NCT01049035|64370878|FG001|Overall Study|Other adverse event (AE)|0|||
23170880|NCT01049035|64370879|FG002|Overall Study|Other adverse event (AE)|0|||
23170881|NCT01049035|64370880|FG003|Overall Study|Other adverse event (AE)|1|||
23170882|NCT01049035|64370881|FG004|Overall Study|Other adverse event (AE)|0|||
23170883|NCT01049035|64370882|FG005|Overall Study|Other adverse event (AE)|0|||
23170884|NCT01049035|64370883|FG006|Overall Study|Other adverse event (AE)|0|||
23170885|NCT01049035|64370877|FG000|Overall Study|Non-compliance with the protocol|12|||
23170886|NCT01049035|64370878|FG001|Overall Study|Non-compliance with the protocol|6|||
23170887|NCT01049035|64370879|FG002|Overall Study|Non-compliance with the protocol|14|||
23170888|NCT01049035|64370880|FG003|Overall Study|Non-compliance with the protocol|5|||
23170889|NCT01049035|64370881|FG004|Overall Study|Non-compliance with the protocol|3|||
23170890|NCT01049035|64370882|FG005|Overall Study|Non-compliance with the protocol|4|||
23338183|NCT01738503|64982929|FG005|Treatment Period|Lost to Follow-up|1|||
23338184|NCT01738503|64982930|FG006|Treatment Period|Lost to Follow-up|5|||
23449864|NCT01339689|65391320|FG001|Overall Study|Noncompliance|0|||
23449865|NCT01339689|65391319|FG000|Overall Study|Relocated out of area|0|||
23338185|NCT01738503|64982924|FG000|Treatment Period|Withdrawal by Subject|0|||
23338186|NCT01738503|64982925|FG001|Treatment Period|Withdrawal by Subject|1|||
23449866|NCT01339689|65391320|FG001|Overall Study|Relocated out of area|1|||
23229952|NCT02407236|64584153|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23229953|NCT02407236|64584154|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
23229954|NCT02407236|64584155|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
23229955|NCT02407236|64584156|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
23229956|NCT02407236|64584157|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
23229957|NCT02407236|64584158|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
23229958|NCT02407236|64584159|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23229959|NCT02407236|64584160|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23229960|NCT02407236|64584161|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23229961|NCT02407236|64584162|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23229962|NCT02407236|64584163|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
23229963|NCT02407236|64584151|FG000|Maintenance Study (44 Weeks)|Other|0|||
23229964|NCT02407236|64584152|FG001|Maintenance Study (44 Weeks)|Other|0|||
23229965|NCT02407236|64584153|FG002|Maintenance Study (44 Weeks)|Other|0|||
23229966|NCT02407236|64584154|FG003|Maintenance Study (44 Weeks)|Other|5|||
23229967|NCT02407236|64584155|FG004|Maintenance Study (44 Weeks)|Other|7|||
23229968|NCT02407236|64584156|FG005|Maintenance Study (44 Weeks)|Other|8|||
23229969|NCT02407236|64584157|FG006|Maintenance Study (44 Weeks)|Other|4|||
23229970|NCT02407236|64584158|FG007|Maintenance Study (44 Weeks)|Other|6|||
23229971|NCT02407236|64584159|FG008|Maintenance Study (44 Weeks)|Other|0|||
23229972|NCT02407236|64584160|FG009|Maintenance Study (44 Weeks)|Other|0|||
23229973|NCT02407236|64584161|FG010|Maintenance Study (44 Weeks)|Other|0|||
23229974|NCT02407236|64584162|FG011|Maintenance Study (44 Weeks)|Other|0|||
23229975|NCT02407236|64584163|FG012|Maintenance Study (44 Weeks)|Other|0|||
23229976|NCT02407236|64584151|FG000|Maintenance Study (44 Weeks)|Death|0|||
23229977|NCT02407236|64584152|FG001|Maintenance Study (44 Weeks)|Death|0|||
23229978|NCT02407236|64584153|FG002|Maintenance Study (44 Weeks)|Death|0|||
23229979|NCT02407236|64584154|FG003|Maintenance Study (44 Weeks)|Death|0|||
23229980|NCT02407236|64584155|FG004|Maintenance Study (44 Weeks)|Death|0|||
23229981|NCT02407236|64584156|FG005|Maintenance Study (44 Weeks)|Death|0|||
23229982|NCT02407236|64584157|FG006|Maintenance Study (44 Weeks)|Death|0|||
23229983|NCT02407236|64584158|FG007|Maintenance Study (44 Weeks)|Death|1|||
23229984|NCT02407236|64584159|FG008|Maintenance Study (44 Weeks)|Death|0|||
23229985|NCT02407236|64584160|FG009|Maintenance Study (44 Weeks)|Death|0|||
23229986|NCT02407236|64584161|FG010|Maintenance Study (44 Weeks)|Death|0|||
23229987|NCT02407236|64584162|FG011|Maintenance Study (44 Weeks)|Death|0|||
23229988|NCT02407236|64584163|FG012|Maintenance Study (44 Weeks)|Death|0|||
23229989|NCT02407236|64584151|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23229990|NCT02407236|64584152|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23229991|NCT02407236|64584153|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23229992|NCT02407236|64584154|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23229993|NCT02407236|64584155|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23229994|NCT02407236|64584156|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23229995|NCT02407236|64584157|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23229996|NCT02407236|64584158|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
23229997|NCT02407236|64584159|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
23229998|NCT02407236|64584160|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
23229999|NCT02407236|64584161|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
23230000|NCT02407236|64584162|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
23230001|NCT02407236|64584163|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
23230002|NCT02407236|64584151|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230003|NCT02407236|64584152|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230004|NCT02407236|64584153|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230005|NCT02407236|64584154|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230006|NCT02407236|64584155|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230007|NCT02407236|64584156|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230008|NCT02407236|64584157|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230009|NCT02407236|64584158|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230010|NCT02407236|64584159|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230011|NCT02407236|64584160|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230012|NCT02407236|64584161|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
23230013|NCT02407236|64584162|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230014|NCT02407236|64584163|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
23230015|NCT02407236|64584151|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23230016|NCT02407236|64584152|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23230017|NCT02407236|64584153|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23230018|NCT02407236|64584154|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23230019|NCT02407236|64584155|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23230020|NCT02407236|64584156|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23449867|NCT01339689|65391319|FG000|Overall Study|Other|2|||
23230021|NCT02407236|64584157|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23230022|NCT02407236|64584158|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
23230023|NCT02407236|64584159|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
23230024|NCT02407236|64584160|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
23230025|NCT02407236|64584161|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
23230026|NCT02407236|64584162|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
23230027|NCT02407236|64584163|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
23230028|NCT02407236|64584151|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
23230029|NCT02407236|64584152|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
23230030|NCT02407236|64584153|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
23230031|NCT02407236|64584154|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
23230032|NCT02407236|64584155|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
23230033|NCT02407236|64584156|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
23230034|NCT02407236|64584157|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
23230035|NCT02407236|64584158|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
23230036|NCT02407236|64584159|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
23230037|NCT02407236|64584160|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
23230038|NCT02407236|64584161|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
23230039|NCT02407236|64584162|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
23230040|NCT02407236|64584163|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
23230041|NCT03289676|64584164|FG000|Overall Study|Withdrawal by Subject|2|||
23230042|NCT03289676|64584165|FG001|Overall Study|Withdrawal by Subject|0|||
23577603|NCT02926937|65846874|FG000|Overall Study|Lost to Follow-up|4|||
23577604|NCT02926937|65846875|FG001|Overall Study|Lost to Follow-up|5|||
23577605|NCT02926937|65846876|FG002|Overall Study|Lost to Follow-up|0|||
23577606|NCT02926937|65846874|FG000|Overall Study|At the Participant's own Request|11|||
23577607|NCT02926937|65846875|FG001|Overall Study|At the Participant's own Request|5|||
23577608|NCT02926937|65846876|FG002|Overall Study|At the Participant's own Request|8|||
23577609|NCT02926937|65846874|FG000|Overall Study|Reason not Specified|3|||
23230043|NCT03289676|64584164|FG000|Overall Study|Protocol Violation|2|||
23230044|NCT03289676|64584165|FG001|Overall Study|Protocol Violation|0|||
23230045|NCT03289676|64584164|FG000|Overall Study|Lost to Follow-up|0|||
23230046|NCT03289676|64584165|FG001|Overall Study|Lost to Follow-up|1|||
23230047|NCT01029691|64584166|FG000|Continued APAP to Delivery|Death|0|||
23230048|NCT01029691|64584167|FG001|Continued APAP to Delivery|Death|0|||
23230049|NCT01029691|64584168|FG002|Continued APAP to Delivery|Death|1|||
23230050|NCT01351415|64584169|FG000|Overall Study|Withdrawal by Subject|15|||
23230051|NCT01351415|64584170|FG001|Overall Study|Withdrawal by Subject|17|||
23230052|NCT01351415|64584169|FG000|Overall Study|Trial termination by the Sponsor|28|||
23230053|NCT01351415|64584170|FG001|Overall Study|Trial termination by the Sponsor|19|||
23230054|NCT01351415|64584169|FG000|Overall Study|Lost to Follow-up|5|||
23230055|NCT01351415|64584170|FG001|Overall Study|Lost to Follow-up|7|||
23230056|NCT01351415|64584169|FG000|Overall Study|Death|190|||
23230057|NCT01351415|64584170|FG001|Overall Study|Death|187|||
23230058|NCT01351415|64584169|FG000|Overall Study|Physician Decision|2|||
23230059|NCT01351415|64584170|FG001|Overall Study|Physician Decision|3|||
23230060|NCT01351415|64584169|FG000|Overall Study|Reason unknown|0|||
23230061|NCT01351415|64584170|FG001|Overall Study|Reason unknown|2|||
23230062|NCT01351415|64584169|FG000|Overall Study|Never Started|5|||
23230063|NCT01351415|64584170|FG001|Overall Study|Never Started|5|||
23230064|NCT00901394|64584171|FG000|Overall Study|Physician Decision|1|||
23577610|NCT02926937|65846875|FG001|Overall Study|Reason not Specified|4|||
23577611|NCT02926937|65846876|FG002|Overall Study|Reason not Specified|2|||
23577612|NCT02748512|65846878|FG000|Overall Study|Lost to Follow-up|1|||
23577613|NCT02748512|65846879|FG001|Overall Study|Lost to Follow-up|1|||
23170891|NCT01049035|64370883|FG006|Overall Study|Non-compliance with the protocol|10|||
23170892|NCT01049035|64370877|FG000|Overall Study|Lost to Follow-up|5|||
23170893|NCT01049035|64370878|FG001|Overall Study|Lost to Follow-up|4|||
23170894|NCT01049035|64370879|FG002|Overall Study|Lost to Follow-up|4|||
23170895|NCT01049035|64370880|FG003|Overall Study|Lost to Follow-up|1|||
23170896|NCT01049035|64370881|FG004|Overall Study|Lost to Follow-up|0|||
23170897|NCT01049035|64370882|FG005|Overall Study|Lost to Follow-up|3|||
23170898|NCT01049035|64370883|FG006|Overall Study|Lost to Follow-up|3|||
23170899|NCT01049035|64370877|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
23170900|NCT01049035|64370878|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
23170901|NCT01049035|64370879|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
23170902|NCT01049035|64370880|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
23170903|NCT01049035|64370881|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
23170904|NCT01049035|64370882|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
23230065|NCT00901394|64584172|FG001|Overall Study|Physician Decision|1|||
23577614|NCT01077024|65846880|FG000|Overall Study|Lost to Follow-up|20|||
23577615|NCT01077024|65846881|FG001|Overall Study|Lost to Follow-up|14|||
23577616|NCT01077024|65846880|FG000|Overall Study|Withdrawal by Subject|0|||
23230066|NCT00901394|64584173|FG002|Overall Study|Physician Decision|2|||
23230067|NCT01512108|64584174|FG000|Overall Study|Adverse Event|9|||
23230068|NCT01512108|64584175|FG001|Overall Study|Adverse Event|4|||
23230069|NCT01512108|64584174|FG000|Overall Study|Protocol Violation|1|||
23230070|NCT01512108|64584175|FG001|Overall Study|Protocol Violation|2|||
23230071|NCT01512108|64584174|FG000|Overall Study|Withdrawal Criteria|1|||
23230072|NCT01512108|64584175|FG001|Overall Study|Withdrawal Criteria|0|||
23230073|NCT01512108|64584174|FG000|Overall Study|Unclassified|11|||
23230074|NCT01512108|64584175|FG001|Overall Study|Unclassified|3|||
23230075|NCT02177942|64584176|FG000|Overall Study|Adverse Event|1|||
23230076|NCT02177942|64584177|FG001|Overall Study|Adverse Event|0|||
23230077|NCT02177942|64584176|FG000|Overall Study|Lost to Follow-up|1|||
23230078|NCT02177942|64584177|FG001|Overall Study|Lost to Follow-up|1|||
23230079|NCT02177942|64584176|FG000|Overall Study|Protocol Violation|4|||
23230080|NCT02177942|64584177|FG001|Overall Study|Protocol Violation|6|||
23230081|NCT02177942|64584176|FG000|Overall Study|Withdrawal by Subject|71|||
23230082|NCT02177942|64584177|FG001|Overall Study|Withdrawal by Subject|81|||
23230083|NCT01279954|64584180|FG000|Overall Study|Lack of Efficacy|3|||
23230084|NCT01279954|64584181|FG001|Overall Study|Lack of Efficacy|4|||
23230085|NCT01809327|64584182|FG000|Overall Study|Lost to Follow-up|5|||
23230086|NCT01809327|64584183|FG001|Overall Study|Lost to Follow-up|2|||
23230087|NCT01809327|64584184|FG002|Overall Study|Lost to Follow-up|4|||
23230088|NCT01809327|64584185|FG003|Overall Study|Lost to Follow-up|2|||
23230089|NCT01809327|64584186|FG004|Overall Study|Lost to Follow-up|3|||
23230090|NCT01809327|64584182|FG000|Overall Study|Withdrawal by Subject|6|||
23230091|NCT01809327|64584183|FG001|Overall Study|Withdrawal by Subject|4|||
23230092|NCT01809327|64584184|FG002|Overall Study|Withdrawal by Subject|4|||
23230093|NCT01809327|64584185|FG003|Overall Study|Withdrawal by Subject|2|||
23230094|NCT01809327|64584186|FG004|Overall Study|Withdrawal by Subject|5|||
23230095|NCT01809327|64584182|FG000|Overall Study|Adverse Event|4|||
23230096|NCT01809327|64584183|FG001|Overall Study|Adverse Event|3|||
23230097|NCT01809327|64584184|FG002|Overall Study|Adverse Event|7|||
23230098|NCT01809327|64584185|FG003|Overall Study|Adverse Event|4|||
23230099|NCT01809327|64584186|FG004|Overall Study|Adverse Event|8|||
23230100|NCT01809327|64584182|FG000|Overall Study|Death|1|||
23230101|NCT01809327|64584183|FG001|Overall Study|Death|0|||
23230102|NCT01809327|64584184|FG002|Overall Study|Death|0|||
23230103|NCT01809327|64584185|FG003|Overall Study|Death|0|||
23230104|NCT01809327|64584186|FG004|Overall Study|Death|0|||
23230105|NCT01809327|64584182|FG000|Overall Study|Protocol Violation|0|||
23230106|NCT01809327|64584183|FG001|Overall Study|Protocol Violation|1|||
23230107|NCT01809327|64584184|FG002|Overall Study|Protocol Violation|0|||
23230108|NCT01809327|64584185|FG003|Overall Study|Protocol Violation|0|||
23230109|NCT01809327|64584186|FG004|Overall Study|Protocol Violation|0|||
23230110|NCT01809327|64584182|FG000|Overall Study|Physician Decision|1|||
23230111|NCT01809327|64584183|FG001|Overall Study|Physician Decision|1|||
23230112|NCT01809327|64584184|FG002|Overall Study|Physician Decision|0|||
23230113|NCT01809327|64584185|FG003|Overall Study|Physician Decision|0|||
23230114|NCT01809327|64584186|FG004|Overall Study|Physician Decision|0|||
23230115|NCT01809327|64584182|FG000|Overall Study|Pregnancy|1|||
23230116|NCT01809327|64584183|FG001|Overall Study|Pregnancy|0|||
23230117|NCT01809327|64584184|FG002|Overall Study|Pregnancy|0|||
23230118|NCT01809327|64584185|FG003|Overall Study|Pregnancy|0|||
23230119|NCT01809327|64584186|FG004|Overall Study|Pregnancy|0|||
23230120|NCT01809327|64584182|FG000|Overall Study|Other|14|||
23230121|NCT01809327|64584183|FG001|Overall Study|Other|15|||
23230122|NCT01809327|64584184|FG002|Overall Study|Other|7|||
23230123|NCT01809327|64584185|FG003|Overall Study|Other|4|||
23230124|NCT01809327|64584186|FG004|Overall Study|Other|9|||
23230125|NCT01981096|64584194|FG000|Overall Study|Parent illness|1|||
23230126|NCT01981096|64584195|FG001|Overall Study|Parent illness|0|||
23230127|NCT01981096|64584194|FG000|Overall Study|Withdrawal by Subject|0|||
23230128|NCT01981096|64584195|FG001|Overall Study|Withdrawal by Subject|1|||
23230129|NCT01981096|64584194|FG000|Overall Study|Lost to Follow-up|2|||
23230130|NCT01981096|64584195|FG001|Overall Study|Lost to Follow-up|0|||
23230131|NCT00397891|64584202|FG000|Overall Study|Withdrawal by Subject|1|||
23230132|NCT00397891|64584203|FG001|Overall Study|Withdrawal by Subject|0|||
23230133|NCT00397891|64584204|FG002|Overall Study|Withdrawal by Subject|0|||
23230134|NCT00397891|64584205|FG003|Overall Study|Withdrawal by Subject|0|||
23230135|NCT00397891|64584206|FG004|Overall Study|Withdrawal by Subject|1|||
23230136|NCT01682759|64584208|FG000|Overall Study|Death|2|||
23230137|NCT01682759|64584209|FG001|Overall Study|Death|1|||
23230138|NCT01682759|64584208|FG000|Overall Study|Lost to Follow-up|10|||
23230139|NCT01682759|64584209|FG001|Overall Study|Lost to Follow-up|13|||
23230140|NCT01682759|64584208|FG000|Overall Study|Physician Decision|1|||
23230141|NCT01682759|64584209|FG001|Overall Study|Physician Decision|1|||
23230142|NCT01682759|64584208|FG000|Overall Study|Withdrawal by Subject|56|||
23230143|NCT01682759|64584209|FG001|Overall Study|Withdrawal by Subject|55|||
23230144|NCT01108263|64584210|FG000|Overall Study|Adverse Event|0|||
23230145|NCT01108263|64584211|FG001|Overall Study|Adverse Event|1|||
23230146|NCT01731600|64584212|FG000|Overall Study|Adverse Event|2|||
23230147|NCT01731600|64584213|FG001|Overall Study|Adverse Event|0|||
23230148|NCT01731600|64584212|FG000|Overall Study|Withdrawal criteria|1|||
23230149|NCT01731600|64584213|FG001|Overall Study|Withdrawal criteria|0|||
23230150|NCT01731600|64584212|FG000|Overall Study|Other reasons|3|||
23338187|NCT01738503|64982926|FG002|Treatment Period|Withdrawal by Subject|0|||
23338188|NCT01738503|64982927|FG003|Treatment Period|Withdrawal by Subject|1|||
23338189|NCT01738503|64982928|FG004|Treatment Period|Withdrawal by Subject|1|||
23338190|NCT01738503|64982929|FG005|Treatment Period|Withdrawal by Subject|1|||
23338191|NCT01738503|64982930|FG006|Treatment Period|Withdrawal by Subject|1|||
23338192|NCT01738503|64982924|FG000|Treatment Period|Protocol Violation|0|||
23230151|NCT01731600|64584213|FG001|Overall Study|Other reasons|0|||
23230152|NCT00908895|64584214|FG000|Overall Study|Lost to Follow-up|1|||
23230153|NCT00908895|64584215|FG001|Overall Study|Lost to Follow-up|3|||
23230154|NCT00908895|64584214|FG000|Overall Study|algodystrophy|2|||
23230155|NCT00908895|64584215|FG001|Overall Study|algodystrophy|2|||
23230156|NCT00908895|64584214|FG000|Overall Study|Adverse Event|1|||
23230157|NCT00908895|64584215|FG001|Overall Study|Adverse Event|1|||
23230158|NCT02061540|64584216|FG000|Overall Study|Adverse Event|2|||
23338193|NCT01738503|64982925|FG001|Treatment Period|Protocol Violation|3|||
23338194|NCT01738503|64982926|FG002|Treatment Period|Protocol Violation|1|||
23338195|NCT01738503|64982927|FG003|Treatment Period|Protocol Violation|0|||
23338196|NCT01738503|64982928|FG004|Treatment Period|Protocol Violation|4|||
23338197|NCT01738503|64982929|FG005|Treatment Period|Protocol Violation|2|||
23449868|NCT01339689|65391320|FG001|Overall Study|Other|2|||
23577617|NCT01077024|65846881|FG001|Overall Study|Withdrawal by Subject|2|||
23577618|NCT01077024|65846880|FG000|Overall Study|Incarcerated|7|||
23230159|NCT02061540|64584216|FG000|Overall Study|Withdrawal by Subject|2|||
23230160|NCT02639182|64584217|FG000|Overall Study|Disease Progression|50|||
23230161|NCT02639182|64584218|FG001|Overall Study|Disease Progression|49|||
23230162|NCT02639182|64584217|FG000|Overall Study|Adverse Event|7|||
23230163|NCT02639182|64584218|FG001|Overall Study|Adverse Event|5|||
23230164|NCT02639182|64584217|FG000|Overall Study|Physician Decision|3|||
23230165|NCT02639182|64584218|FG001|Overall Study|Physician Decision|3|||
23230166|NCT02639182|64584217|FG000|Overall Study|Withdrew Consent|5|||
23230167|NCT02639182|64584218|FG001|Overall Study|Withdrew Consent|4|||
23230168|NCT02639182|64584217|FG000|Overall Study|Lost to Follow-up|0|||
23577619|NCT01077024|65846881|FG001|Overall Study|Incarcerated|8|||
23577620|NCT01077024|65846880|FG000|Overall Study|Other|4|||
23230169|NCT02639182|64584218|FG001|Overall Study|Lost to Follow-up|1|||
23230170|NCT02639182|64584217|FG000|Overall Study|Study Closure|1|||
23230171|NCT02639182|64584218|FG001|Overall Study|Study Closure|2|||
23230172|NCT02639182|64584217|FG000|Overall Study|Sponsor Ended Study|0|||
23230173|NCT02639182|64584218|FG001|Overall Study|Sponsor Ended Study|1|||
23230174|NCT02639182|64584217|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
23230175|NCT02639182|64584218|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
23230176|NCT02918006|64584226|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
23230177|NCT02918006|64584227|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
23577621|NCT01077024|65846881|FG001|Overall Study|Other|4|||
23577622|NCT00322868|65846883|FG000|Overall Study|disease progression|1|||
23577623|NCT01982760|65846886|FG000|Overall Study|Physician Decision|1|||
23577624|NCT01982760|65846887|FG001|Overall Study|Physician Decision|0|||
23230178|NCT02918006|64584228|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
23230179|NCT02918006|64584226|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
23230180|NCT02918006|64584227|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
23230181|NCT02918006|64584228|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
23230182|NCT02918006|64584226|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
23230183|NCT02918006|64584227|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
23230184|NCT02918006|64584228|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
23230185|NCT02918006|64584226|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
23230186|NCT02918006|64584227|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
23230187|NCT02918006|64584228|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
23230188|NCT02918006|64584226|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
23230189|NCT02918006|64584227|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
23230190|NCT02918006|64584228|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
23230191|NCT02918006|64584226|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
23230192|NCT02918006|64584227|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
23230193|NCT02918006|64584228|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
23338198|NCT01738503|64982930|FG006|Treatment Period|Protocol Violation|0|||
23449869|NCT01339689|65391319|FG000|Overall Study|multiple reasons|1|||
23230194|NCT02918006|64584226|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
23577625|NCT02554513|65846889|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
23577626|NCT02554513|65846890|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
23230195|NCT02918006|64584227|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
23230196|NCT02918006|64584228|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
23230197|NCT02918006|64584226|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
23338199|NCT01738503|64982924|FG000|Treatment Period|Other|0|||
23338200|NCT01738503|64982925|FG001|Treatment Period|Other|0|||
23230198|NCT02918006|64584227|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
23230199|NCT02918006|64584228|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
23230200|NCT02918006|64584226|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
23230201|NCT02918006|64584227|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
23230202|NCT02918006|64584228|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
23230203|NCT01333865|64584229|FG000|Overall Study|Adverse Event|2|||
23230204|NCT02260791|64584230|FG000|Overall Study|Lost to Follow-up|4|||
23230205|NCT02260791|64584231|FG001|Overall Study|Lost to Follow-up|4|||
23230206|NCT02260791|64584230|FG000|Overall Study|Lack of Efficacy|2|||
23230207|NCT02260791|64584231|FG001|Overall Study|Lack of Efficacy|1|||
23230208|NCT02260791|64584230|FG000|Overall Study|Adverse Event|13|||
23230209|NCT02260791|64584231|FG001|Overall Study|Adverse Event|9|||
23230210|NCT02260791|64584230|FG000|Overall Study|Death|1|||
23230211|NCT02260791|64584231|FG001|Overall Study|Death|0|||
23230212|NCT02260791|64584230|FG000|Overall Study|Withdrawal by Subject|11|||
23230213|NCT02260791|64584231|FG001|Overall Study|Withdrawal by Subject|16|||
23230214|NCT02260791|64584230|FG000|Overall Study|Screen failure|0|||
23230215|NCT02260791|64584231|FG001|Overall Study|Screen failure|1|||
23230216|NCT02260791|64584230|FG000|Overall Study|Protocol deviation|2|||
23230217|NCT02260791|64584231|FG001|Overall Study|Protocol deviation|3|||
23230218|NCT00281528|64584232|FG000|Overall Study|Progressive Disease|28|||
23230219|NCT00281528|64584233|FG001|Overall Study|Progressive Disease|18|||
23230220|NCT00281528|64584234|FG002|Overall Study|Progressive Disease|27|||
23230221|NCT00281528|64584232|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
23230222|NCT00281528|64584233|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
23230223|NCT00281528|64584234|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
23230224|NCT00281528|64584232|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
23230225|NCT00281528|64584233|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
23230226|NCT00281528|64584234|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
23230227|NCT00281528|64584232|FG000|Overall Study|Physician Decision|11|||
23230228|NCT00281528|64584233|FG001|Overall Study|Physician Decision|4|||
23230229|NCT00281528|64584234|FG002|Overall Study|Physician Decision|5|||
23230230|NCT00281528|64584232|FG000|Overall Study|Protocol Violation|1|||
23577627|NCT01932996|65846892|FG000|Overall Study|Protocol Violation|2|||
23577628|NCT01932996|65846893|FG001|Overall Study|Protocol Violation|0|||
23230231|NCT00281528|64584233|FG001|Overall Study|Protocol Violation|0|||
23230232|NCT00281528|64584234|FG002|Overall Study|Protocol Violation|1|||
23230233|NCT00281528|64584232|FG000|Overall Study|Withdrawal by Subject|5|||
23230234|NCT00281528|64584233|FG001|Overall Study|Withdrawal by Subject|5|||
23230235|NCT00281528|64584234|FG002|Overall Study|Withdrawal by Subject|7|||
23230236|NCT00281528|64584232|FG000|Overall Study|Other|6|||
23230237|NCT00281528|64584233|FG001|Overall Study|Other|3|||
23230238|NCT00281528|64584234|FG002|Overall Study|Other|5|||
23230239|NCT02646332|64584241|FG000|Overall Study|Lost to Follow-up|0|||
23230240|NCT02646332|64584242|FG001|Overall Study|Lost to Follow-up|3|||
23230241|NCT02382276|64584243|FG000|Overall Study|Withdrawal by Subject|4|||
23230242|NCT02382276|64584244|FG001|Overall Study|Withdrawal by Subject|8|||
23230243|NCT02382276|64584245|FG002|Overall Study|Withdrawal by Subject|5|||
23230244|NCT02382276|64584243|FG000|Overall Study|Adverse Event|7|||
23230245|NCT02382276|64584244|FG001|Overall Study|Adverse Event|2|||
23230246|NCT02382276|64584245|FG002|Overall Study|Adverse Event|32|||
23230247|NCT02382276|64584243|FG000|Overall Study|Physician Decision|0|||
23230248|NCT02382276|64584244|FG001|Overall Study|Physician Decision|0|||
23230249|NCT02382276|64584245|FG002|Overall Study|Physician Decision|2|||
23230250|NCT04439266|64584246|FG000|Overall Study|Ineligible|1|||
23230251|NCT04439266|64584246|FG000|Overall Study|Adverse Event|1|||
23449870|NCT01339689|65391320|FG001|Overall Study|multiple reasons|1|||
23577629|NCT02687919|65846897|FG000|Overall Study|Withdrawal by Subject|6|||
23577630|NCT02687919|65846898|FG001|Overall Study|Withdrawal by Subject|6|||
23577631|NCT02687919|65846897|FG000|Overall Study|Protocol Violation|2|||
23577632|NCT02687919|65846898|FG001|Overall Study|Protocol Violation|0|||
23577633|NCT00783692|65846903|FG000|Induction Phase|Adverse Event|7|||
23577634|NCT00783692|65846904|FG001|Induction Phase|Adverse Event|9|||
23577635|NCT00783692|65846905|FG002|Induction Phase|Adverse Event|24|||
23577636|NCT00783692|65846906|FG003|Induction Phase|Adverse Event|0|||
23230252|NCT04439266|64584246|FG000|Overall Study|Death|1|||
23230253|NCT04439266|64584246|FG000|Overall Study|Disease progression|1|||
23230254|NCT04439266|64584246|FG000|Overall Study|Still on treatment|1|||
23230255|NCT01957111|64584249|FG000|Overall Study|Withdrawal by Subject|1|||
23230256|NCT01957111|64584250|FG001|Overall Study|Withdrawal by Subject|1|||
23230257|NCT00125268|64584251|FG000|Overall Study|Withdrawal by Subject|1|||
23230258|NCT00125268|64584252|FG001|Overall Study|Withdrawal by Subject|1|||
23230259|NCT00372905|64584253|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
23230260|NCT00372905|64584254|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
23230261|NCT00372905|64584255|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
23230262|NCT00372905|64584256|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
23230263|NCT00372905|64584253|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
23577637|NCT00783692|65846907|FG004|Induction Phase|Adverse Event|0|||
23338201|NCT01738503|64982926|FG002|Treatment Period|Other|1|||
23338202|NCT01738503|64982927|FG003|Treatment Period|Other|0|||
23338203|NCT01738503|64982928|FG004|Treatment Period|Other|0|||
23338204|NCT01738503|64982929|FG005|Treatment Period|Other|0|||
23338205|NCT01738503|64982930|FG006|Treatment Period|Other|0|||
23338206|NCT01738503|64982924|FG000|PET Imaging Sub-study|Adverse Event|0|||
23338207|NCT01738503|64982925|FG001|PET Imaging Sub-study|Adverse Event|0|||
23338208|NCT01738503|64982926|FG002|PET Imaging Sub-study|Adverse Event|0|||
23338209|NCT01738503|64982927|FG003|PET Imaging Sub-study|Adverse Event|0|||
23338210|NCT01738503|64982928|FG004|PET Imaging Sub-study|Adverse Event|0|||
23338211|NCT01738503|64982929|FG005|PET Imaging Sub-study|Adverse Event|1|||
23338212|NCT01738503|64982930|FG006|PET Imaging Sub-study|Adverse Event|0|||
23338213|NCT01738503|64982924|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23338214|NCT01738503|64982925|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23338215|NCT01738503|64982926|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23338216|NCT01738503|64982927|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23338217|NCT01738503|64982928|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
23577638|NCT00783692|65846908|FG005|Induction Phase|Adverse Event|0|||
23577639|NCT00783692|65846909|FG006|Induction Phase|Adverse Event|0|||
23577640|NCT00783692|65846903|FG000|Induction Phase|Protocol Violation|0|||
23577641|NCT00783692|65846904|FG001|Induction Phase|Protocol Violation|0|||
23170905|NCT01049035|64370883|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
23338218|NCT01738503|64982929|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
23338219|NCT01738503|64982930|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
23338220|NCT03089697|64982933|FG000|Overall Study|Adverse Event|1|||
23338221|NCT03089697|64982934|FG001|Overall Study|Adverse Event|2|||
23577642|NCT00783692|65846905|FG002|Induction Phase|Protocol Violation|1|||
23577643|NCT00783692|65846906|FG003|Induction Phase|Protocol Violation|0|||
23577644|NCT00783692|65846907|FG004|Induction Phase|Protocol Violation|0|||
23170906|NCT04599062|64370884|FG000|Overall Study|Physician Decision|1|||
23170907|NCT04599062|64370885|FG001|Overall Study|Physician Decision|0|||
23170908|NCT00848354|64370894|FG000|Phase 1|Adverse Event|5|||
23170909|NCT00848354|64370895|FG001|Phase 1|Adverse Event|4|||
23170910|NCT00848354|64370894|FG000|Phase 1|Discontinuation of study by sponsor|2|||
23170911|NCT00848354|64370895|FG001|Phase 1|Discontinuation of study by sponsor|1|||
23170912|NCT00848354|64370894|FG000|Phase 1|Failed to return|0|||
23170913|NCT00848354|64370895|FG001|Phase 1|Failed to return|1|||
23170914|NCT00848354|64370894|FG000|Phase 1|Lost to Follow-up|1|||
23170915|NCT00848354|64370895|FG001|Phase 1|Lost to Follow-up|1|||
23170916|NCT00848354|64370894|FG000|Phase 1|Unspecified Reason|1|||
23170917|NCT00848354|64370895|FG001|Phase 1|Unspecified Reason|1|||
23170918|NCT00848354|64370894|FG000|Phase 1|Protocol Violation|1|||
23170919|NCT00848354|64370895|FG001|Phase 1|Protocol Violation|1|||
23170920|NCT00848354|64370894|FG000|Phase 1|Withdrawal by Subject|2|||
23170921|NCT00848354|64370895|FG001|Phase 1|Withdrawal by Subject|4|||
23170922|NCT00848354|64370894|FG000|Phase 1|Lack of Efficacy|0|||
23170923|NCT00848354|64370895|FG001|Phase 1|Lack of Efficacy|1|||
23170924|NCT00848354|64370894|FG000|Phase 2 Year 1|Adverse Event|7|||
23170925|NCT00848354|64370895|FG001|Phase 2 Year 1|Adverse Event|2|||
23170926|NCT00848354|64370894|FG000|Phase 2 Year 1|Death|1|||
23230264|NCT00372905|64584254|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
23230265|NCT00372905|64584255|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
23230266|NCT00372905|64584256|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
23230267|NCT00372905|64584253|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
23230268|NCT00372905|64584254|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
23230269|NCT00372905|64584255|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
23230270|NCT00372905|64584256|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
23230271|NCT00372905|64584253|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
23230272|NCT00372905|64584254|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
23230273|NCT00372905|64584255|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
23230274|NCT00372905|64584256|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
23230275|NCT00372905|64584253|FG000|Follow up Until Relapse or Progression|Study closed|0|||
23230276|NCT00372905|64584254|FG001|Follow up Until Relapse or Progression|Study closed|0|||
23338222|NCT03089697|64982933|FG000|Overall Study|Withdrawal by Subject|1|||
23338223|NCT03089697|64982934|FG001|Overall Study|Withdrawal by Subject|0|||
23338224|NCT04236141|64982935|FG000|Overall Study|Death|18|||
23338225|NCT04236141|64982936|FG001|Overall Study|Death|10|||
23577645|NCT00783692|65846908|FG005|Induction Phase|Protocol Violation|0|||
23577646|NCT00783692|65846909|FG006|Induction Phase|Protocol Violation|0|||
23170927|NCT00848354|64370895|FG001|Phase 2 Year 1|Death|0|||
23170928|NCT00848354|64370894|FG000|Phase 2 Year 1|Failed to Return|1|||
23230277|NCT00372905|64584255|FG002|Follow up Until Relapse or Progression|Study closed|0|||
23230278|NCT00372905|64584256|FG003|Follow up Until Relapse or Progression|Study closed|3|||
23338226|NCT04236141|64982935|FG000|Overall Study|Withdrawal by Participant|1|||
23338227|NCT04236141|64982936|FG001|Overall Study|Withdrawal by Participant|0|||
23449871|NCT00880698|65391321|FG000|Overall Study|Death|0|||
23449872|NCT00880698|65391322|FG001|Overall Study|Death|0|||
23449873|NCT00880698|65391323|FG002|Overall Study|Death|1|||
23449874|NCT00880698|65391324|FG003|Overall Study|Death|2|||
23449875|NCT00880698|65391321|FG000|Overall Study|Lost to Follow-up|1|||
23449876|NCT00880698|65391322|FG001|Overall Study|Lost to Follow-up|3|||
23449877|NCT00880698|65391323|FG002|Overall Study|Lost to Follow-up|0|||
23449878|NCT00880698|65391324|FG003|Overall Study|Lost to Follow-up|1|||
23449879|NCT02738801|65391325|FG000|Overall Study|Adverse Event|1|||
23449880|NCT02738801|65391326|FG001|Overall Study|Adverse Event|1|||
23449881|NCT02738801|65391325|FG000|Overall Study|Withdrawal by Subject|0|||
23449882|NCT02738801|65391326|FG001|Overall Study|Withdrawal by Subject|1|||
23449883|NCT03259555|65391327|FG000|Overall Study|Adverse Event|6|||
23230279|NCT00372905|64584253|FG000|Follow up Until Relapse or Progression|Other|0|||
23230280|NCT00372905|64584254|FG001|Follow up Until Relapse or Progression|Other|1|||
23230281|NCT00372905|64584255|FG002|Follow up Until Relapse or Progression|Other|0|||
23230282|NCT00372905|64584256|FG003|Follow up Until Relapse or Progression|Other|0|||
23230283|NCT00826540|64584257|FG000|Overall Study|ineligible|3|||
23230284|NCT00826540|64584257|FG000|Overall Study|Withdrawal by Subject|1|||
23449884|NCT03259555|65391328|FG001|Overall Study|Adverse Event|4|||
23449885|NCT03259555|65391327|FG000|Overall Study|Lack of Efficacy|6|||
23170929|NCT00848354|64370895|FG001|Phase 2 Year 1|Failed to Return|1|||
23230285|NCT02630459|64584259|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23230286|NCT02630459|64584260|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
23230287|NCT02630459|64584261|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23449886|NCT03259555|65391328|FG001|Overall Study|Lack of Efficacy|4|||
23449887|NCT03259555|65391327|FG000|Overall Study|Lost to Follow-up|0|||
23449888|NCT03259555|65391328|FG001|Overall Study|Lost to Follow-up|2|||
23170930|NCT00848354|64370894|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
23170931|NCT00848354|64370895|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
23170932|NCT00848354|64370894|FG000|Phase 2 Year 1|Unspecified Reason|3|||
23170933|NCT00848354|64370895|FG001|Phase 2 Year 1|Unspecified Reason|0|||
23170934|NCT00848354|64370894|FG000|Phase 2 Year 1|Protocol Violation|4|||
23170935|NCT00848354|64370895|FG001|Phase 2 Year 1|Protocol Violation|1|||
23170936|NCT00848354|64370894|FG000|Phase 2 Year 1|Subject Request|1|||
23170937|NCT00848354|64370895|FG001|Phase 2 Year 1|Subject Request|2|||
23170938|NCT00848354|64370894|FG000|Phase 2 Year 2|Adverse Event|12|||
23170939|NCT00848354|64370895|FG001|Phase 2 Year 2|Adverse Event|2|||
23170940|NCT00848354|64370894|FG000|Phase 2 Year 2|Death|2|||
23170941|NCT00848354|64370895|FG001|Phase 2 Year 2|Death|0|||
23170942|NCT00848354|64370894|FG000|Phase 2 Year 2|Failed to return|3|||
23170943|NCT00848354|64370895|FG001|Phase 2 Year 2|Failed to return|0|||
23170944|NCT00848354|64370894|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
23170945|NCT00848354|64370895|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
23170946|NCT00848354|64370894|FG000|Phase 2 Year 2|Unspecified Reason|1|||
23170947|NCT00848354|64370895|FG001|Phase 2 Year 2|Unspecified Reason|0|||
23170948|NCT00848354|64370894|FG000|Phase 2 Year 2|Protocol Violation|1|||
23170949|NCT00848354|64370895|FG001|Phase 2 Year 2|Protocol Violation|1|||
23170950|NCT00848354|64370894|FG000|Phase 2 Year 2|Subject Request|1|||
23170951|NCT00848354|64370895|FG001|Phase 2 Year 2|Subject Request|1|||
23170952|NCT00848354|64370894|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
23170953|NCT00848354|64370895|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
23170954|NCT02437162|64370896|FG000|Overall Study|Protocol Violation|0|||
23170955|NCT02437162|64370897|FG001|Overall Study|Protocol Violation|1|||
23170956|NCT02437162|64370898|FG002|Overall Study|Protocol Violation|0|||
23170957|NCT02437162|64370896|FG000|Overall Study|Randomized but not treated|0|||
23170958|NCT02437162|64370897|FG001|Overall Study|Randomized but not treated|0|||
23170959|NCT02437162|64370898|FG002|Overall Study|Randomized but not treated|1|||
23170960|NCT02437162|64370896|FG000|Overall Study|Study discontinued by Sponsor|93|||
23170961|NCT02437162|64370897|FG001|Overall Study|Study discontinued by Sponsor|98|||
23170962|NCT02437162|64370898|FG002|Overall Study|Study discontinued by Sponsor|97|||
23170963|NCT02437162|64370896|FG000|Overall Study|Withdrawal by Subject|13|||
23170964|NCT02437162|64370897|FG001|Overall Study|Withdrawal by Subject|7|||
23170965|NCT02437162|64370898|FG002|Overall Study|Withdrawal by Subject|9|||
23170966|NCT02437162|64370896|FG000|Overall Study|Adverse Event|0|||
23170967|NCT02437162|64370897|FG001|Overall Study|Adverse Event|1|||
23170968|NCT02437162|64370898|FG002|Overall Study|Adverse Event|0|||
23170969|NCT02437162|64370896|FG000|Overall Study|Lost to Follow-up|1|||
23230288|NCT02630459|64584262|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
23230289|NCT02630459|64584263|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23449889|NCT03259555|65391327|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23449890|NCT03259555|65391328|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23449891|NCT03259555|65391327|FG000|Overall Study|Progressive Disease|0|||
23449892|NCT03259555|65391328|FG001|Overall Study|Progressive Disease|2|||
23449893|NCT03259555|65391327|FG000|Overall Study|Withdrawal by Subject|19|||
23170970|NCT02437162|64370897|FG001|Overall Study|Lost to Follow-up|0|||
23170971|NCT02437162|64370898|FG002|Overall Study|Lost to Follow-up|1|||
23170972|NCT02437162|64370896|FG000|Overall Study|Death|0|||
23230290|NCT02630459|64584264|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23230291|NCT02630459|64584265|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23230292|NCT02630459|64584266|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
23230293|NCT02630459|64584259|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23230294|NCT02630459|64584260|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23230295|NCT02630459|64584261|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
23230296|NCT02630459|64584262|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23230297|NCT02630459|64584263|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23230298|NCT02630459|64584264|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23230299|NCT02630459|64584265|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23230300|NCT02630459|64584266|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
23230301|NCT02630459|64584259|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
23338228|NCT04236141|64982935|FG000|Overall Study|Reason not Specified|1|||
23338229|NCT04236141|64982936|FG001|Overall Study|Reason not Specified|0|||
23449894|NCT03259555|65391328|FG001|Overall Study|Withdrawal by Subject|16|||
23449895|NCT03259555|65391327|FG000|Overall Study|Physician Decision|1|||
23449896|NCT03259555|65391328|FG001|Overall Study|Physician Decision|2|||
23449897|NCT03259555|65391327|FG000|Overall Study|Other|1|||
23449898|NCT03259555|65391328|FG001|Overall Study|Other|0|||
23449899|NCT02294396|65391329|FG000|Overall Study|Adverse Event|26|||
23449900|NCT02294396|65391330|FG001|Overall Study|Adverse Event|25|||
23449901|NCT02294396|65391331|FG002|Overall Study|Adverse Event|21|||
23449902|NCT02294396|65391332|FG003|Overall Study|Adverse Event|24|||
23449903|NCT02294396|65391329|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
23449904|NCT02294396|65391330|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
23449905|NCT02294396|65391331|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
23449906|NCT02294396|65391332|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
23449907|NCT02294396|65391329|FG000|Overall Study|Withdrawal by Subject|8|||
23449908|NCT02294396|65391330|FG001|Overall Study|Withdrawal by Subject|6|||
23170973|NCT02437162|64370897|FG001|Overall Study|Death|1|||
23170974|NCT02437162|64370898|FG002|Overall Study|Death|0|||
23170975|NCT02437162|64370896|FG000|Overall Study|Other|0|||
23170976|NCT02437162|64370897|FG001|Overall Study|Other|0|||
23449909|NCT02294396|65391331|FG002|Overall Study|Withdrawal by Subject|6|||
23449910|NCT02294396|65391332|FG003|Overall Study|Withdrawal by Subject|8|||
23170977|NCT02437162|64370898|FG002|Overall Study|Other|1|||
23170978|NCT00911989|64370899|FG000|Overall Study|Adverse Event|1|||
23170979|NCT00803179|64370902|FG000|Overall Study|Lost to Follow-up|3|||
23170980|NCT03984305|64370903|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
23170981|NCT03984305|64370904|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
23170982|NCT03984305|64370903|FG000|Overall Study|Withdrawal by Subject|3|||
23170983|NCT03984305|64370904|FG001|Overall Study|Withdrawal by Subject|3|||
23170984|NCT03984305|64370903|FG000|Overall Study|Lost to Follow-up|1|||
23170985|NCT03984305|64370904|FG001|Overall Study|Lost to Follow-up|0|||
23170986|NCT01738971|64370908|FG000|Overall Study|Lost to Follow-up|19|||
23170987|NCT01738971|64370909|FG001|Overall Study|Lost to Follow-up|30|||
23170988|NCT01738971|64370910|FG002|Overall Study|Lost to Follow-up|17|||
23170989|NCT01425203|64370912|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
23170990|NCT01425203|64370913|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
23170991|NCT01425203|64370914|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
23170992|NCT01425203|64370912|FG000|Treatment Phase|Failure at futility timepoint|8|||
23170993|NCT01425203|64370913|FG001|Treatment Phase|Failure at futility timepoint|27|||
23170994|NCT01425203|64370914|FG002|Treatment Phase|Failure at futility timepoint|0|||
23170995|NCT01425203|64370912|FG000|Treatment Phase|Other virologic failure criteria|5|||
23170996|NCT01425203|64370913|FG001|Treatment Phase|Other virologic failure criteria|3|||
23170997|NCT01425203|64370914|FG002|Treatment Phase|Other virologic failure criteria|0|||
23170998|NCT01425203|64370912|FG000|Treatment Phase|Unidentified reasons|11|||
23170999|NCT01425203|64370913|FG001|Treatment Phase|Unidentified reasons|5|||
23171000|NCT01425203|64370914|FG002|Treatment Phase|Unidentified reasons|0|||
23171001|NCT01425203|64370912|FG000|Treatment Phase|Did not receive treatment|0|||
23171002|NCT01425203|64370913|FG001|Treatment Phase|Did not receive treatment|1|||
23449911|NCT02294396|65391329|FG000|Overall Study|Lost to Follow-up|0|||
23171003|NCT01425203|64370914|FG002|Treatment Phase|Did not receive treatment|0|||
23171004|NCT01425203|64370912|FG000|Crossover Phase|Failure at futility timepoint|0|||
23171005|NCT01425203|64370913|FG001|Crossover Phase|Failure at futility timepoint|0|||
23171006|NCT01425203|64370914|FG002|Crossover Phase|Failure at futility timepoint|3|||
23171007|NCT01425203|64370912|FG000|Crossover Phase|Other virologic failure criteria|0|||
23230302|NCT02630459|64584260|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
23230303|NCT02630459|64584261|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
23449912|NCT02294396|65391330|FG001|Overall Study|Lost to Follow-up|0|||
23171008|NCT01425203|64370913|FG001|Crossover Phase|Other virologic failure criteria|0|||
23171009|NCT01425203|64370914|FG002|Crossover Phase|Other virologic failure criteria|3|||
23171010|NCT00666458|64370923|FG000|Overall Study|Adverse Event|8|||
23449913|NCT02294396|65391331|FG002|Overall Study|Lost to Follow-up|1|||
23449914|NCT02294396|65391332|FG003|Overall Study|Lost to Follow-up|1|||
23449915|NCT02294396|65391329|FG000|Overall Study|Protocol Deviation|3|||
23449916|NCT02294396|65391330|FG001|Overall Study|Protocol Deviation|2|||
23449917|NCT02294396|65391331|FG002|Overall Study|Protocol Deviation|2|||
23449918|NCT02294396|65391332|FG003|Overall Study|Protocol Deviation|1|||
23449919|NCT02294396|65391329|FG000|Overall Study|Miscellaneous|2|||
23449920|NCT02294396|65391330|FG001|Overall Study|Miscellaneous|0|||
23449921|NCT02294396|65391331|FG002|Overall Study|Miscellaneous|5|||
23449922|NCT02294396|65391332|FG003|Overall Study|Miscellaneous|2|||
23449923|NCT01135134|65391333|FG000|Overall Study|Adverse Event|1|||
23449924|NCT01135134|65391334|FG001|Overall Study|Adverse Event|1|||
23449925|NCT01135134|65391333|FG000|Overall Study|Did not meet protocol eligibility|1|||
23449926|NCT01135134|65391334|FG001|Overall Study|Did not meet protocol eligibility|0|||
23449927|NCT03546621|65391335|FG000|Overall Study|Withdrawal by Subject|0|||
23449928|NCT03546621|65391336|FG001|Overall Study|Withdrawal by Subject|1|||
23449929|NCT03546621|65391337|FG002|Overall Study|Withdrawal by Subject|2|||
23449930|NCT03546621|65391338|FG003|Overall Study|Withdrawal by Subject|1|||
23449931|NCT03546621|65391335|FG000|Overall Study|Lost to Follow-up|0|||
23449932|NCT03546621|65391336|FG001|Overall Study|Lost to Follow-up|1|||
23449933|NCT03546621|65391337|FG002|Overall Study|Lost to Follow-up|0|||
23449934|NCT03546621|65391338|FG003|Overall Study|Lost to Follow-up|0|||
23449935|NCT03546621|65391335|FG000|Overall Study|Adverse Event|0|||
23449936|NCT03546621|65391336|FG001|Overall Study|Adverse Event|1|||
23449937|NCT03546621|65391337|FG002|Overall Study|Adverse Event|0|||
23449938|NCT03546621|65391338|FG003|Overall Study|Adverse Event|1|||
23449939|NCT03546621|65391335|FG000|Overall Study|Progressive disease|0|||
23449940|NCT03546621|65391336|FG001|Overall Study|Progressive disease|0|||
23449941|NCT03546621|65391337|FG002|Overall Study|Progressive disease|0|||
23449942|NCT03546621|65391338|FG003|Overall Study|Progressive disease|1|||
23449943|NCT03016312|65391340|FG000|Overall Study|discontinued before the treatment started|0|||
23449944|NCT03016312|65391341|FG001|Overall Study|discontinued before the treatment started|1|||
23449945|NCT03016312|65391340|FG000|Overall Study|Withdrawal by Subject|37|||
23449946|NCT03016312|65391341|FG001|Overall Study|Withdrawal by Subject|44|||
23449947|NCT03016312|65391340|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
23449948|NCT03016312|65391341|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
23449949|NCT03016312|65391340|FG000|Overall Study|Physician Decision|1|||
23449950|NCT03016312|65391341|FG001|Overall Study|Physician Decision|3|||
23449951|NCT03016312|65391340|FG000|Overall Study|Lost to Follow-up|12|||
23449952|NCT03016312|65391341|FG001|Overall Study|Lost to Follow-up|12|||
23449953|NCT03016312|65391340|FG000|Overall Study|Death|210|||
23449954|NCT03016312|65391341|FG001|Overall Study|Death|184|||
23449955|NCT03016312|65391340|FG000|Overall Study|loss to contact|1|||
23449956|NCT03016312|65391341|FG001|Overall Study|loss to contact|0|||
23449957|NCT03016312|65391340|FG000|Overall Study|started a new cancer therapy|1|||
23449958|NCT03016312|65391341|FG001|Overall Study|started a new cancer therapy|0|||
23449959|NCT02836652|65391342|FG000|Overall Study|Death|3|||
23449960|NCT02836652|65391343|FG001|Overall Study|Death|3|||
23449961|NCT02836652|65391342|FG000|Overall Study|Transplant/Explant|3|||
23449962|NCT02836652|65391343|FG001|Overall Study|Transplant/Explant|4|||
23449963|NCT02836652|65391342|FG000|Overall Study|Withdrawn|9|||
23449964|NCT02836652|65391343|FG001|Overall Study|Withdrawn|9|||
23449965|NCT02836652|65391342|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
23449966|NCT02836652|65391343|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
23449967|NCT00539994|65391344|FG000|Overall Study|Lost to Follow-up|2|||
23449968|NCT00539994|65391345|FG001|Overall Study|Lost to Follow-up|1|||
23449969|NCT00539994|65391346|FG002|Overall Study|Lost to Follow-up|0|||
23449970|NCT00539994|65391344|FG000|Overall Study|Withdrawal by Subject|1|||
23449971|NCT00539994|65391345|FG001|Overall Study|Withdrawal by Subject|0|||
23449972|NCT00539994|65391346|FG002|Overall Study|Withdrawal by Subject|1|||
23449973|NCT00539994|65391344|FG000|Overall Study|Physician Decision|0|||
23449974|NCT00539994|65391345|FG001|Overall Study|Physician Decision|0|||
23449975|NCT00539994|65391346|FG002|Overall Study|Physician Decision|1|||
23449976|NCT02336607|65391348|FG000|Overall Study|Physician Decision|1|||
23449977|NCT02336607|65391349|FG001|Overall Study|Physician Decision|4|||
23449978|NCT02336607|65391350|FG002|Overall Study|Physician Decision|3|||
23449979|NCT02336607|65391351|FG003|Overall Study|Physician Decision|15|||
23171011|NCT00666458|64370924|FG001|Overall Study|Adverse Event|7|||
23171012|NCT00666458|64370923|FG000|Overall Study|Withdrawal by Subject|5|||
23449980|NCT02336607|65391348|FG000|Overall Study|Lack of Efficacy|1|||
23449981|NCT02336607|65391349|FG001|Overall Study|Lack of Efficacy|0|||
23449982|NCT02336607|65391350|FG002|Overall Study|Lack of Efficacy|0|||
23449983|NCT02336607|65391351|FG003|Overall Study|Lack of Efficacy|2|||
23449984|NCT02336607|65391348|FG000|Overall Study|Lost to Follow-up|2|||
23171013|NCT00666458|64370924|FG001|Overall Study|Withdrawal by Subject|4|||
23449985|NCT02336607|65391349|FG001|Overall Study|Lost to Follow-up|1|||
23449986|NCT02336607|65391350|FG002|Overall Study|Lost to Follow-up|0|||
23449987|NCT02336607|65391351|FG003|Overall Study|Lost to Follow-up|21|||
23449988|NCT02336607|65391348|FG000|Overall Study|Protocol Violation|0|||
23449989|NCT02336607|65391349|FG001|Overall Study|Protocol Violation|1|||
23449990|NCT02336607|65391350|FG002|Overall Study|Protocol Violation|1|||
23449991|NCT02336607|65391351|FG003|Overall Study|Protocol Violation|3|||
23449992|NCT02336607|65391348|FG000|Overall Study|Adverse Event|0|||
23449993|NCT02336607|65391349|FG001|Overall Study|Adverse Event|2|||
23449994|NCT02336607|65391350|FG002|Overall Study|Adverse Event|2|||
23449995|NCT02336607|65391351|FG003|Overall Study|Adverse Event|26|||
23449996|NCT02336607|65391348|FG000|Overall Study|Withdrawal by Subject|0|||
23449997|NCT02336607|65391349|FG001|Overall Study|Withdrawal by Subject|2|||
23449998|NCT02336607|65391350|FG002|Overall Study|Withdrawal by Subject|0|||
23449999|NCT02336607|65391351|FG003|Overall Study|Withdrawal by Subject|20|||
23450000|NCT03914417|65391352|FG000|Overall Study|Withdrawal by Subject|2|||
23450001|NCT01620060|65391358|FG000|Overall Study|Adverse Event|9|||
23450002|NCT01620060|65391358|FG000|Overall Study|Protocol Violation|1|||
23450003|NCT01620060|65391358|FG000|Overall Study|Withdrawal by Subject|1|||
23230304|NCT02630459|64584262|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
23230305|NCT02630459|64584263|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
23230306|NCT02630459|64584264|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
23230307|NCT02630459|64584265|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
23230308|NCT02630459|64584266|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
23230309|NCT02630459|64584259|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
23230310|NCT02630459|64584260|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23230311|NCT02630459|64584261|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23230312|NCT02630459|64584262|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23230313|NCT02630459|64584263|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23230314|NCT02630459|64584264|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23230315|NCT02630459|64584265|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23230316|NCT02630459|64584266|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
23230317|NCT02630459|64584259|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23230318|NCT02630459|64584260|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23230319|NCT02630459|64584261|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23450004|NCT01620060|65391358|FG000|Overall Study|Did not comply with Study Produre|1|||
23450005|NCT01620060|65391358|FG000|Overall Study|Family emergency|1|||
23450006|NCT01620060|65391358|FG000|Overall Study|Per Sponsor Decision|2|||
23450007|NCT04033367|65391359|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
23450008|NCT04033367|65391360|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
23450009|NCT04033367|65391359|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
23450010|NCT04033367|65391360|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
23450011|NCT04033367|65391359|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
23450012|NCT04033367|65391360|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
23450013|NCT04033367|65391359|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
23450014|NCT04033367|65391360|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
23450015|NCT04664153|65391361|FG000|Overall Study|Lack of Efficacy|0|||
23450016|NCT04664153|65391362|FG001|Overall Study|Lack of Efficacy|0|||
23450017|NCT04664153|65391363|FG002|Overall Study|Lack of Efficacy|1|||
23450018|NCT04664153|65391364|FG003|Overall Study|Lack of Efficacy|0|||
23450019|NCT04664153|65391361|FG000|Overall Study|Physician Decision|0|||
23450020|NCT04664153|65391362|FG001|Overall Study|Physician Decision|0|||
23450021|NCT04664153|65391363|FG002|Overall Study|Physician Decision|1|||
23450022|NCT04664153|65391364|FG003|Overall Study|Physician Decision|0|||
23450023|NCT04664153|65391361|FG000|Overall Study|Withdrawal by Subject|3|||
23450024|NCT04664153|65391362|FG001|Overall Study|Withdrawal by Subject|2|||
23450025|NCT04664153|65391363|FG002|Overall Study|Withdrawal by Subject|1|||
23450026|NCT04664153|65391364|FG003|Overall Study|Withdrawal by Subject|2|||
23450027|NCT04664153|65391361|FG000|Overall Study|Other|0|||
23450028|NCT04664153|65391362|FG001|Overall Study|Other|1|||
23450029|NCT04664153|65391363|FG002|Overall Study|Other|0|||
23450030|NCT04664153|65391364|FG003|Overall Study|Other|0|||
23450031|NCT04664153|65391361|FG000|Overall Study|Adverse Event|4|||
23450032|NCT04664153|65391362|FG001|Overall Study|Adverse Event|0|||
23450033|NCT04664153|65391363|FG002|Overall Study|Adverse Event|1|||
23450034|NCT04664153|65391364|FG003|Overall Study|Adverse Event|0|||
23450035|NCT00763386|65391369|FG000|Overall Study|Adverse Event|43|||
23450036|NCT00763386|65391370|FG001|Overall Study|Adverse Event|33|||
23450037|NCT00763386|65391369|FG000|Overall Study|Death|1|||
23450038|NCT00763386|65391370|FG001|Overall Study|Death|2|||
23450039|NCT00763386|65391369|FG000|Overall Study|Lost to Follow-up|3|||
23450040|NCT00763386|65391370|FG001|Overall Study|Lost to Follow-up|3|||
23450041|NCT00763386|65391369|FG000|Overall Study|Withdrawal by Subject|0|||
23450042|NCT00763386|65391370|FG001|Overall Study|Withdrawal by Subject|1|||
23450043|NCT00763386|65391369|FG000|Overall Study|CRF missing|0|||
23450044|NCT00763386|65391370|FG001|Overall Study|CRF missing|1|||
23450045|NCT00763386|65391369|FG000|Overall Study|Study Prosthesis Removed|1|||
23450046|NCT00763386|65391370|FG001|Overall Study|Study Prosthesis Removed|0|||
23450047|NCT00165672|65391371|FG000|Overall Study|Adverse Event|0|||
23450048|NCT00165672|65391372|FG001|Overall Study|Adverse Event|1|||
23450049|NCT03431441|65391378|FG000|Overall Study|Withdrawal by Subject|2|||
23450050|NCT03431441|65391378|FG000|Overall Study|Adverse Event|2|||
23450051|NCT03431441|65391378|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
23450052|NCT00499681|65391381|FG000|Overall Study|toxicity|0|||
23450053|NCT00499681|65391382|FG001|Overall Study|toxicity|1|||
23450054|NCT00499681|65391381|FG000|Overall Study|disease progression|0|||
23450055|NCT00499681|65391382|FG001|Overall Study|disease progression|1|||
23450056|NCT00999544|65391383|FG000|Overall Study|Withdrawal by Subject|1|||
23450057|NCT00667888|65391389|FG000|Overall Study|Death|1|||
23450058|NCT00667888|65391390|FG001|Overall Study|Death|1|||
23450059|NCT00667888|65391389|FG000|Overall Study|Withdrawal by Subject|6|||
23450060|NCT00667888|65391390|FG001|Overall Study|Withdrawal by Subject|3|||
23450061|NCT00667888|65391389|FG000|Overall Study|Proceed with other treatment|3|||
23450062|NCT00667888|65391390|FG001|Overall Study|Proceed with other treatment|3|||
23450063|NCT00667888|65391389|FG000|Overall Study|Ineligible after SIM|0|||
23450064|NCT00667888|65391390|FG001|Overall Study|Ineligible after SIM|2|||
23450065|NCT00330759|65391400|FG000|Overall Study|Death|316|||
23450066|NCT00330759|65391401|FG001|Overall Study|Death|310|||
23450067|NCT00330759|65391400|FG000|Overall Study|Disease progression|104|||
23450068|NCT00330759|65391401|FG001|Overall Study|Disease progression|126|||
23450069|NCT00330759|65391400|FG000|Overall Study|Withdrawal by Subject|143|||
23450070|NCT00330759|65391401|FG001|Overall Study|Withdrawal by Subject|124|||
23450071|NCT00330759|65391400|FG000|Overall Study|Adverse Event|48|||
23450072|NCT00330759|65391401|FG001|Overall Study|Adverse Event|36|||
23450073|NCT00330759|65391400|FG000|Overall Study|Participant request|31|||
23450074|NCT00330759|65391401|FG001|Overall Study|Participant request|22|||
23450075|NCT00330759|65391400|FG000|Overall Study|Lost to Follow-up|16|||
23450076|NCT00330759|65391401|FG001|Overall Study|Lost to Follow-up|22|||
23450077|NCT00330759|65391400|FG000|Overall Study|Noncompliance|15|||
23450078|NCT00330759|65391401|FG001|Overall Study|Noncompliance|17|||
23450079|NCT00330759|65391400|FG000|Overall Study|Physician Decision|1|||
23450080|NCT00330759|65391401|FG001|Overall Study|Physician Decision|2|||
23450081|NCT00330759|65391400|FG000|Overall Study|Protocol deviation|0|||
23450082|NCT00330759|65391401|FG001|Overall Study|Protocol deviation|2|||
23450083|NCT00330759|65391400|FG000|Overall Study|Ineligibility determined|2|||
23450084|NCT00330759|65391401|FG001|Overall Study|Ineligibility determined|1|||
23450085|NCT00330759|65391400|FG000|Overall Study|Other|36|||
23450086|NCT00330759|65391401|FG001|Overall Study|Other|44|||
23450087|NCT00859547|65391406|FG000|Overall Study|Lost to Follow-up|1|||
23450088|NCT00859547|65391406|FG000|Overall Study|Parent withdrew consent|1|||
23450089|NCT03071263|65391407|FG000|Overall Study|Adverse Event|1|||
23450090|NCT03071263|65391408|FG001|Overall Study|Adverse Event|3|||
23450091|NCT03071263|65391407|FG000|Overall Study|Withdrawal by Subject|1|||
23450092|NCT03071263|65391408|FG001|Overall Study|Withdrawal by Subject|3|||
23450093|NCT03071263|65391407|FG000|Overall Study|Physician Decision|1|||
23171014|NCT00666458|64370923|FG000|Overall Study|Lost to Follow-up|0|||
23171015|NCT00666458|64370924|FG001|Overall Study|Lost to Follow-up|3|||
23171016|NCT00666458|64370923|FG000|Overall Study|Administrative reason by sponsor|1|||
23171017|NCT00666458|64370924|FG001|Overall Study|Administrative reason by sponsor|1|||
23171018|NCT00666458|64370923|FG000|Overall Study|Incorrect enrollment|7|||
23171019|NCT00666458|64370924|FG001|Overall Study|Incorrect enrollment|1|||
23171020|NCT00666458|64370923|FG000|Overall Study|Study specific discontinuation criteria|14|||
23171021|NCT00666458|64370924|FG001|Overall Study|Study specific discontinuation criteria|7|||
23171022|NCT00666458|64370923|FG000|Overall Study|Severe non-compliance to the protocol|1|||
23171023|NCT00666458|64370924|FG001|Overall Study|Severe non-compliance to the protocol|1|||
23171024|NCT00666458|64370923|FG000|Overall Study|Safety reasons|1|||
23171025|NCT00666458|64370924|FG001|Overall Study|Safety reasons|0|||
23450094|NCT03071263|65391408|FG001|Overall Study|Physician Decision|0|||
23450095|NCT03071263|65391407|FG000|Overall Study|Participant moved to another city|0|||
23450096|NCT03071263|65391408|FG001|Overall Study|Participant moved to another city|1|||
23450097|NCT02800863|65391409|FG000|Overall Study|Adverse Event|14|||
23450098|NCT02800863|65391409|FG000|Overall Study|Another Device Implanted|1|||
23450099|NCT02800863|65391409|FG000|Overall Study|Device Explanted|1|||
23450100|NCT02800863|65391409|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
23450101|NCT02800863|65391409|FG000|Overall Study|Health Issues|1|||
23450102|NCT02800863|65391409|FG000|Overall Study|Insurance Denial|8|||
23171026|NCT00666458|64370923|FG000|Overall Study|Medical history of anemia|1|||
23171027|NCT00666458|64370924|FG001|Overall Study|Medical history of anemia|0|||
23450103|NCT02800863|65391409|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
23450104|NCT02800863|65391409|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
23171028|NCT01145066|64370925|FG000|Overall Study|To resume NSAIDs|2|||
23171029|NCT01145066|64370926|FG001|Overall Study|To resume NSAIDs|2|||
23450105|NCT02800863|65391409|FG000|Overall Study|Screen Failure|1|||
23450106|NCT02800863|65391409|FG000|Overall Study|Sponsor Request|6|||
23450107|NCT02800863|65391409|FG000|Overall Study|Death|3|||
23577647|NCT00783692|65846903|FG000|Induction Phase|Lack of Efficacy|1|||
23171030|NCT01145066|64370927|FG002|Overall Study|To resume NSAIDs|1|||
23171031|NCT01145066|64370925|FG000|Overall Study|Non-related surgery|0|||
23171032|NCT01145066|64370926|FG001|Overall Study|Non-related surgery|0|||
23171033|NCT01145066|64370927|FG002|Overall Study|Non-related surgery|1|||
23171034|NCT01145066|64370925|FG000|Overall Study|Withdrawal by Subject|0|||
23171035|NCT01145066|64370926|FG001|Overall Study|Withdrawal by Subject|0|||
23171036|NCT01145066|64370927|FG002|Overall Study|Withdrawal by Subject|2|||
23171037|NCT01145066|64370925|FG000|Overall Study|To start new med|1|||
23171038|NCT01145066|64370926|FG001|Overall Study|To start new med|0|||
23171039|NCT01145066|64370927|FG002|Overall Study|To start new med|0|||
23230320|NCT02630459|64584262|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23230321|NCT02630459|64584263|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
23230322|NCT02630459|64584264|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
23230323|NCT02630459|64584265|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23230324|NCT02630459|64584266|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
23230325|NCT02630459|64584259|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23171040|NCT01145066|64370925|FG000|Overall Study|problems swallowing capsule|1|||
23171041|NCT01145066|64370926|FG001|Overall Study|problems swallowing capsule|0|||
23171042|NCT01145066|64370927|FG002|Overall Study|problems swallowing capsule|0|||
23171043|NCT01145066|64370925|FG000|Overall Study|Abdominal discomfort|0|||
23171044|NCT01145066|64370926|FG001|Overall Study|Abdominal discomfort|1|||
23171045|NCT01145066|64370927|FG002|Overall Study|Abdominal discomfort|0|||
23230326|NCT02630459|64584260|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23230327|NCT02630459|64584261|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23230328|NCT02630459|64584262|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23171046|NCT01145066|64370925|FG000|Overall Study|Low platelet count|0|||
23171047|NCT01145066|64370926|FG001|Overall Study|Low platelet count|1|||
23171048|NCT01145066|64370927|FG002|Overall Study|Low platelet count|0|||
23171049|NCT01857869|64370928|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
23171050|NCT01857869|64370929|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
23171051|NCT01857869|64370930|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
23171052|NCT01857869|64370931|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
23171053|NCT01857869|64370932|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
23171054|NCT01857869|64370933|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
23171055|NCT01857869|64370934|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
23171056|NCT01857869|64370935|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
23171057|NCT01857869|64370936|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
23171058|NCT01857869|64370937|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
23171059|NCT01857869|64370928|FG000|Primary/Challenge Phase|Pregnancy|1|||
23171060|NCT01857869|64370929|FG001|Primary/Challenge Phase|Pregnancy|0|||
23171061|NCT01857869|64370930|FG002|Primary/Challenge Phase|Pregnancy|0|||
23171062|NCT01857869|64370931|FG003|Primary/Challenge Phase|Pregnancy|0|||
23230329|NCT02630459|64584263|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
23230330|NCT02630459|64584264|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
23230331|NCT02630459|64584265|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23230332|NCT02630459|64584266|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
23230333|NCT02630459|64584259|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23230334|NCT02630459|64584260|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23230335|NCT02630459|64584261|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23450108|NCT02800863|65391409|FG000|Overall Study|Subject Implant at Another Facility|1|||
23450109|NCT02800863|65391409|FG000|Overall Study|Lost to Follow-up|26|||
23450110|NCT02800863|65391409|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
23230336|NCT02630459|64584262|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23230337|NCT02630459|64584263|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
23230338|NCT02630459|64584264|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23230339|NCT02630459|64584265|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23230340|NCT02630459|64584266|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
23230341|NCT01426009|64584267|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
23230342|NCT01426009|64584267|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
23230343|NCT01426009|64584267|FG000|Washout 1|Withdrawal by Subject|1|||
23230344|NCT01426009|64584267|FG000|Washout 1|Personal Reasons|1|||
23230345|NCT01426009|64584267|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
23230346|NCT01426009|64584267|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
23171063|NCT01857869|64370932|FG004|Primary/Challenge Phase|Pregnancy|0|||
23171064|NCT01857869|64370933|FG005|Primary/Challenge Phase|Pregnancy|0|||
23171065|NCT01857869|64370934|FG006|Primary/Challenge Phase|Pregnancy|0|||
23171066|NCT01857869|64370935|FG007|Primary/Challenge Phase|Pregnancy|0|||
23171067|NCT01857869|64370936|FG008|Primary/Challenge Phase|Pregnancy|0|||
23171068|NCT01857869|64370937|FG009|Primary/Challenge Phase|Pregnancy|0|||
23171069|NCT01857869|64370928|FG000|Primary/Challenge Phase|Protocol Violation|1|||
23171070|NCT01857869|64370929|FG001|Primary/Challenge Phase|Protocol Violation|0|||
23171071|NCT01857869|64370930|FG002|Primary/Challenge Phase|Protocol Violation|0|||
23230347|NCT01426009|64584267|FG000|Washout 2|electrive surgery|1|||
23577648|NCT00783692|65846904|FG001|Induction Phase|Lack of Efficacy|3|||
23577649|NCT00783692|65846905|FG002|Induction Phase|Lack of Efficacy|28|||
23577650|NCT00783692|65846906|FG003|Induction Phase|Lack of Efficacy|0|||
23577651|NCT00783692|65846907|FG004|Induction Phase|Lack of Efficacy|0|||
23577652|NCT00783692|65846908|FG005|Induction Phase|Lack of Efficacy|0|||
23577653|NCT00783692|65846909|FG006|Induction Phase|Lack of Efficacy|0|||
23577654|NCT00783692|65846903|FG000|Induction Phase|Withdrawal by Subject|3|||
23577655|NCT00783692|65846904|FG001|Induction Phase|Withdrawal by Subject|9|||
23577656|NCT00783692|65846905|FG002|Induction Phase|Withdrawal by Subject|16|||
23577657|NCT00783692|65846906|FG003|Induction Phase|Withdrawal by Subject|0|||
23577658|NCT00783692|65846907|FG004|Induction Phase|Withdrawal by Subject|0|||
23577659|NCT00783692|65846908|FG005|Induction Phase|Withdrawal by Subject|0|||
23577660|NCT00783692|65846909|FG006|Induction Phase|Withdrawal by Subject|0|||
23577661|NCT00783692|65846903|FG000|Induction Phase|Lost to Follow-up|0|||
23577662|NCT00783692|65846904|FG001|Induction Phase|Lost to Follow-up|0|||
23577663|NCT00783692|65846905|FG002|Induction Phase|Lost to Follow-up|3|||
23577664|NCT00783692|65846906|FG003|Induction Phase|Lost to Follow-up|0|||
23577665|NCT00783692|65846907|FG004|Induction Phase|Lost to Follow-up|0|||
23577666|NCT00783692|65846908|FG005|Induction Phase|Lost to Follow-up|0|||
23577667|NCT00783692|65846909|FG006|Induction Phase|Lost to Follow-up|0|||
23577668|NCT00783692|65846903|FG000|Induction Phase|Other|0|||
23577669|NCT00783692|65846904|FG001|Induction Phase|Other|0|||
23577670|NCT00783692|65846905|FG002|Induction Phase|Other|2|||
23577671|NCT00783692|65846906|FG003|Induction Phase|Other|0|||
23577672|NCT00783692|65846907|FG004|Induction Phase|Other|0|||
23577673|NCT00783692|65846908|FG005|Induction Phase|Other|0|||
23577674|NCT00783692|65846909|FG006|Induction Phase|Other|0|||
23577675|NCT00783692|65846903|FG000|Maintenance Phase|Adverse Event|7|||
23577676|NCT00783692|65846904|FG001|Maintenance Phase|Adverse Event|0|||
23577677|NCT00783692|65846905|FG002|Maintenance Phase|Adverse Event|0|||
23577678|NCT00783692|65846906|FG003|Maintenance Phase|Adverse Event|15|||
23577679|NCT00783692|65846907|FG004|Maintenance Phase|Adverse Event|12|||
23577680|NCT00783692|65846908|FG005|Maintenance Phase|Adverse Event|9|||
23577681|NCT00783692|65846909|FG006|Maintenance Phase|Adverse Event|38|||
23577682|NCT00783692|65846903|FG000|Maintenance Phase|Protocol Violation|0|||
23577683|NCT00783692|65846904|FG001|Maintenance Phase|Protocol Violation|0|||
23577684|NCT00783692|65846905|FG002|Maintenance Phase|Protocol Violation|0|||
23577685|NCT00783692|65846906|FG003|Maintenance Phase|Protocol Violation|1|||
23577686|NCT00783692|65846907|FG004|Maintenance Phase|Protocol Violation|2|||
23577687|NCT00783692|65846908|FG005|Maintenance Phase|Protocol Violation|3|||
23577688|NCT00783692|65846909|FG006|Maintenance Phase|Protocol Violation|4|||
23577689|NCT00783692|65846903|FG000|Maintenance Phase|Lack of Efficacy|79|||
23577690|NCT00783692|65846904|FG001|Maintenance Phase|Lack of Efficacy|0|||
23577691|NCT00783692|65846905|FG002|Maintenance Phase|Lack of Efficacy|0|||
23577692|NCT00783692|65846906|FG003|Maintenance Phase|Lack of Efficacy|64|||
23577693|NCT00783692|65846907|FG004|Maintenance Phase|Lack of Efficacy|58|||
23577694|NCT00783692|65846908|FG005|Maintenance Phase|Lack of Efficacy|48|||
23577695|NCT00783692|65846909|FG006|Maintenance Phase|Lack of Efficacy|177|||
23577696|NCT00783692|65846903|FG000|Maintenance Phase|Withdrawal by Subject|7|||
23577697|NCT00783692|65846904|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23577698|NCT00783692|65846905|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23577699|NCT00783692|65846906|FG003|Maintenance Phase|Withdrawal by Subject|7|||
23577700|NCT00783692|65846907|FG004|Maintenance Phase|Withdrawal by Subject|6|||
23577701|NCT00783692|65846908|FG005|Maintenance Phase|Withdrawal by Subject|9|||
23577702|NCT00783692|65846909|FG006|Maintenance Phase|Withdrawal by Subject|24|||
23577703|NCT00783692|65846903|FG000|Maintenance Phase|Lost to Follow-up|2|||
23577704|NCT00783692|65846904|FG001|Maintenance Phase|Lost to Follow-up|0|||
23577705|NCT00783692|65846905|FG002|Maintenance Phase|Lost to Follow-up|0|||
23577706|NCT00783692|65846906|FG003|Maintenance Phase|Lost to Follow-up|1|||
23577707|NCT00783692|65846907|FG004|Maintenance Phase|Lost to Follow-up|3|||
23577708|NCT00783692|65846908|FG005|Maintenance Phase|Lost to Follow-up|2|||
23577709|NCT00783692|65846909|FG006|Maintenance Phase|Lost to Follow-up|5|||
23577710|NCT00783692|65846903|FG000|Maintenance Phase|Other|0|||
23577711|NCT00783692|65846904|FG001|Maintenance Phase|Other|0|||
23577712|NCT00783692|65846905|FG002|Maintenance Phase|Other|0|||
23577713|NCT00783692|65846906|FG003|Maintenance Phase|Other|1|||
23577714|NCT00783692|65846907|FG004|Maintenance Phase|Other|0|||
23577715|NCT00783692|65846908|FG005|Maintenance Phase|Other|1|||
23577716|NCT00783692|65846909|FG006|Maintenance Phase|Other|1|||
23577717|NCT01004263|65846910|FG000|Overall Study|Adverse Event|15|||
23577718|NCT01004263|65846910|FG000|Overall Study|Withdrawal by Subject|58|||
23577719|NCT01004263|65846910|FG000|Overall Study|Protocol Violation|10|||
23577720|NCT01004263|65846910|FG000|Overall Study|Lost to Follow-up|64|||
23577721|NCT01004263|65846910|FG000|Overall Study|Lack of Efficacy|13|||
23577722|NCT01004263|65846910|FG000|Overall Study|Pregnancy|2|||
23577723|NCT01004263|65846910|FG000|Overall Study|Physician Decision|15|||
23577724|NCT01004263|65846910|FG000|Overall Study|Lack of Qualifying Event|2|||
23230348|NCT01426009|64584267|FG000|Washout 3|personal reasons|1|||
23230349|NCT01426009|64584267|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
23230350|NCT01426009|64584267|FG000|Washout 4|Lost to Follow-up|1|||
23230351|NCT00312728|64584270|FG000|Overall Study|Progressive disease|53|||
23230352|NCT00312728|64584270|FG000|Overall Study|Adverse Event|32|||
23230353|NCT00312728|64584270|FG000|Overall Study|Withdrawal by Subject|10|||
23230354|NCT00312728|64584270|FG000|Overall Study|Required non-protocol cancer treatment|2|||
23230355|NCT00312728|64584270|FG000|Overall Study|Protocol Violation|2|||
23230356|NCT00312728|64584270|FG000|Overall Study|Other|10|||
23230357|NCT00312728|64584270|FG000|Overall Study|Other|1|||
23230358|NCT03345849|64584271|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
23230359|NCT03345849|64584272|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
23230360|NCT03345849|64584273|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
23230361|NCT03345849|64584274|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
23230362|NCT03345849|64584271|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
23230363|NCT03345849|64584272|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
23230364|NCT03345849|64584273|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
23230365|NCT03345849|64584274|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
23230366|NCT03345849|64584271|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
23230367|NCT03345849|64584272|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
23230368|NCT03345849|64584273|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
23230369|NCT03345849|64584274|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
23230370|NCT03345849|64584271|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
23230371|NCT03345849|64584272|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
23230372|NCT03345849|64584273|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
23230373|NCT03345849|64584274|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
23230374|NCT03345849|64584271|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
23230375|NCT03345849|64584272|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
23230376|NCT03345849|64584273|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
23230377|NCT03345849|64584274|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
23230378|NCT03345849|64584271|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
23230379|NCT03345849|64584272|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
23230380|NCT03345849|64584273|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
23230381|NCT03345849|64584274|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
23230382|NCT03345849|64584271|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
23230383|NCT03345849|64584272|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
23230384|NCT03345849|64584273|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
23230385|NCT03345849|64584274|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
23230386|NCT03345849|64584271|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
23230387|NCT03345849|64584272|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
23230388|NCT03345849|64584273|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
23230389|NCT03345849|64584274|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
23230390|NCT03345849|64584271|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23230391|NCT03345849|64584272|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23450111|NCT02800863|65391409|FG000|Overall Study|Subject and/or Family Request|64|||
23450112|NCT02800863|65391409|FG000|Overall Study|Trial Failure|81|||
23450113|NCT02800863|65391409|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
23450114|NCT01601535|65391410|FG000|Phase 1|Adverse Event|1|||
23450115|NCT01601535|65391411|FG001|Phase 1|Adverse Event|0|||
23450116|NCT01601535|65391412|FG002|Phase 1|Adverse Event|2|||
23450117|NCT01601535|65391413|FG003|Phase 1|Adverse Event|1|||
23450118|NCT01601535|65391414|FG004|Phase 1|Adverse Event|0|||
23450119|NCT01601535|65391415|FG005|Phase 1|Adverse Event|0|||
23450120|NCT01601535|65391410|FG000|Phase 1|Withdrawal by Subject|2|||
23450121|NCT01601535|65391411|FG001|Phase 1|Withdrawal by Subject|1|||
23450122|NCT01601535|65391412|FG002|Phase 1|Withdrawal by Subject|1|||
23450123|NCT01601535|65391413|FG003|Phase 1|Withdrawal by Subject|2|||
23450124|NCT01601535|65391414|FG004|Phase 1|Withdrawal by Subject|0|||
23450125|NCT01601535|65391415|FG005|Phase 1|Withdrawal by Subject|0|||
23230392|NCT03345849|64584273|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
23230393|NCT03345849|64584274|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
23230394|NCT03345849|64584271|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
23230395|NCT03345849|64584272|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
23450126|NCT01601535|65391410|FG000|Phase 1|Progressive Disease|2|||
23450127|NCT01601535|65391411|FG001|Phase 1|Progressive Disease|3|||
23450128|NCT01601535|65391412|FG002|Phase 1|Progressive Disease|2|||
23450129|NCT01601535|65391413|FG003|Phase 1|Progressive Disease|1|||
23450130|NCT01601535|65391414|FG004|Phase 1|Progressive Disease|0|||
23450131|NCT01601535|65391415|FG005|Phase 1|Progressive Disease|0|||
23450132|NCT01601535|65391410|FG000|Phase 1|Started Another Treatment|1|||
23230396|NCT03345849|64584273|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
23338230|NCT04236141|64982935|FG000|Overall Study|Study terminated by Sponsor|8|||
23338231|NCT04236141|64982936|FG001|Overall Study|Study terminated by Sponsor|4|||
23338232|NCT01015131|64982941|FG000|Overall Study|Physician Decision|1|||
23338233|NCT01015131|64982941|FG000|Overall Study|Protocol Violation|1|||
23338234|NCT01015131|64982941|FG000|Overall Study|Withdrawal by Subject|2|||
23338235|NCT01015131|64982941|FG000|Overall Study|Other Protocol Specified Criteria|4|||
23338236|NCT01960907|64982942|FG000|Overall Study|Death|4|||
23338237|NCT01960907|64982943|FG001|Overall Study|Death|3|||
23338238|NCT01960907|64982942|FG000|Overall Study|Withdrawal by Subject|32|||
23338239|NCT01960907|64982943|FG001|Overall Study|Withdrawal by Subject|42|||
23338240|NCT02295020|64982947|FG000|Overall Study|Adverse Event|0|||
23338241|NCT02295020|64982948|FG001|Overall Study|Adverse Event|1|||
23338242|NCT02295020|64982947|FG000|Overall Study|Withdrawal by Subject|3|||
23338243|NCT02295020|64982948|FG001|Overall Study|Withdrawal by Subject|2|||
23338244|NCT00384839|64982949|FG000|Overall Study|Adverse Event|4|||
23338245|NCT00384839|64982949|FG000|Overall Study|Investigator Request|1|||
23338246|NCT00384839|64982949|FG000|Overall Study|Patient Request|1|||
23338247|NCT00384839|64982949|FG000|Overall Study|Ineligible|2|||
23338248|NCT03379753|64982952|FG000|Overall Study|Withdrawal by Subject|2|||
23338249|NCT03379753|64982953|FG001|Overall Study|Withdrawal by Subject|1|||
23338250|NCT03379753|64982952|FG000|Overall Study|not having correct procedure|1|||
23338251|NCT03379753|64982953|FG001|Overall Study|not having correct procedure|2|||
23338252|NCT03379753|64982952|FG000|Overall Study|No primary outcome|12|||
23338253|NCT03379753|64982953|FG001|Overall Study|No primary outcome|22|||
23338254|NCT03485495|64982954|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
23338255|NCT03485495|64982955|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
23338256|NCT01475851|64982956|FG000|Overall Study|Protocol defined stopping criteria|1|||
23338257|NCT01475851|64982957|FG001|Overall Study|Protocol defined stopping criteria|0|||
23338258|NCT01482065|64982958|FG000|Overall Study|Withdrawal by Subject|0|||
23338259|NCT01482065|64982959|FG001|Overall Study|Withdrawal by Subject|1|||
23338260|NCT01282372|64982963|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
23338261|NCT01282372|64982963|FG000|Overall Study|Lost to Follow-up|23|||
23338262|NCT01282372|64982963|FG000|Overall Study|Withdrawal by Subject|11|||
23338263|NCT01282372|64982963|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
23338264|NCT01282372|64982963|FG000|Overall Study|Death|1|||
23338265|NCT01282372|64982963|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
23338266|NCT01282372|64982963|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
23338267|NCT01282372|64982963|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
23338268|NCT01282372|64982963|FG000|Overall Study|Adverse Event|12|||
23338269|NCT02029989|64982964|FG000|Overall Study|Withdrawal by Subject|1|||
23338270|NCT02029989|64982965|FG001|Overall Study|Withdrawal by Subject|0|||
23338271|NCT02029989|64982964|FG000|Overall Study|Withdrawal: Fear of needles|1|||
23338272|NCT02029989|64982965|FG001|Overall Study|Withdrawal: Fear of needles|0|||
23338273|NCT02029989|64982964|FG000|Overall Study|Change of location|2|||
23338274|NCT02029989|64982965|FG001|Overall Study|Change of location|3|||
23338275|NCT02029989|64982964|FG000|Overall Study|Physician Decision|2|||
23338276|NCT02029989|64982965|FG001|Overall Study|Physician Decision|0|||
23338277|NCT02029989|64982964|FG000|Overall Study|Lost to Follow-up|9|||
23338278|NCT02029989|64982965|FG001|Overall Study|Lost to Follow-up|7|||
23338279|NCT02029989|64982964|FG000|Overall Study|Death|0|||
23230397|NCT03345849|64584274|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
23338280|NCT02029989|64982965|FG001|Overall Study|Death|1|||
23338281|NCT02029989|64982964|FG000|Overall Study|Protocol Violation|1|||
23338282|NCT02029989|64982965|FG001|Overall Study|Protocol Violation|0|||
23338283|NCT03640559|64982969|FG000|Overall Study|Physician Decision|1|||
23338284|NCT03640559|64982970|FG001|Overall Study|Physician Decision|1|||
23338285|NCT03640559|64982969|FG000|Overall Study|Withdrawal by Subject|1|||
23338286|NCT03640559|64982970|FG001|Overall Study|Withdrawal by Subject|0|||
23338287|NCT00812981|64982977|FG000|Overall Study|Other|0|||
23338288|NCT00812981|64982978|FG001|Overall Study|Other|1|||
23338289|NCT02009397|64982979|FG000|Overall Study|Protocol Violation|6|||
23338290|NCT02009397|64982979|FG000|Overall Study|Death|8|||
23338291|NCT02009397|64982979|FG000|Overall Study|Lost to Follow-up|6|||
23338292|NCT00090220|64982980|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
23338293|NCT00090220|64982981|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
23338294|NCT00090220|64982982|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23338295|NCT00090220|64982983|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23338296|NCT00090220|64982984|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23338297|NCT00090220|64982985|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
23450133|NCT01601535|65391411|FG001|Phase 1|Started Another Treatment|2|||
23230398|NCT03345849|64584271|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
23230399|NCT03345849|64584272|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
23230400|NCT03345849|64584273|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
23577725|NCT00557505|65846913|FG000|Overall Study|Death|0|||
23577726|NCT00557505|65846914|FG001|Overall Study|Death|0|||
23577727|NCT00557505|65846915|FG002|Overall Study|Death|0|||
23577728|NCT00557505|65846916|FG003|Overall Study|Death|0|||
23577729|NCT00557505|65846917|FG004|Overall Study|Death|0|||
23577730|NCT00557505|65846918|FG005|Overall Study|Death|0|||
23577731|NCT00557505|65846919|FG006|Overall Study|Death|0|||
23230401|NCT03345849|64584274|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
23230402|NCT00529152|64584275|FG000|Overall Study|Adverse Event|2|||
23230403|NCT00529152|64584275|FG000|Overall Study|Withdrawal by Subject|2|||
23230404|NCT00529152|64584275|FG000|Overall Study|Lost to Follow-up|1|||
23230405|NCT02802735|64584276|FG000|Overall Study|Withdrawal by Subject|0|||
23230406|NCT02802735|64584277|FG001|Overall Study|Withdrawal by Subject|1|||
23230407|NCT02802735|64584278|FG002|Overall Study|Withdrawal by Subject|0|||
23230408|NCT02802735|64584279|FG003|Overall Study|Withdrawal by Subject|0|||
23230409|NCT02802735|64584280|FG004|Overall Study|Withdrawal by Subject|0|||
23450134|NCT01601535|65391412|FG002|Phase 1|Started Another Treatment|0|||
23577732|NCT00557505|65846920|FG007|Overall Study|Death|0|||
23577733|NCT00557505|65846921|FG008|Overall Study|Death|1|||
23577734|NCT00557505|65846913|FG000|Overall Study|Adverse Event|0|||
23577735|NCT00557505|65846914|FG001|Overall Study|Adverse Event|0|||
23577736|NCT00557505|65846915|FG002|Overall Study|Adverse Event|1|||
23171072|NCT01857869|64370931|FG003|Primary/Challenge Phase|Protocol Violation|0|||
23171073|NCT01857869|64370932|FG004|Primary/Challenge Phase|Protocol Violation|0|||
23171074|NCT01857869|64370933|FG005|Primary/Challenge Phase|Protocol Violation|0|||
23171075|NCT01857869|64370934|FG006|Primary/Challenge Phase|Protocol Violation|0|||
23171076|NCT01857869|64370935|FG007|Primary/Challenge Phase|Protocol Violation|0|||
23171077|NCT01857869|64370936|FG008|Primary/Challenge Phase|Protocol Violation|0|||
23171078|NCT01857869|64370937|FG009|Primary/Challenge Phase|Protocol Violation|0|||
23171079|NCT01857869|64370928|FG000|Primary/Challenge Phase|Other|1|||
23171080|NCT01857869|64370929|FG001|Primary/Challenge Phase|Other|1|||
23171081|NCT01857869|64370930|FG002|Primary/Challenge Phase|Other|0|||
23171082|NCT01857869|64370931|FG003|Primary/Challenge Phase|Other|0|||
23171083|NCT01857869|64370932|FG004|Primary/Challenge Phase|Other|0|||
23171084|NCT01857869|64370933|FG005|Primary/Challenge Phase|Other|0|||
23171085|NCT01857869|64370934|FG006|Primary/Challenge Phase|Other|0|||
23171086|NCT01857869|64370935|FG007|Primary/Challenge Phase|Other|0|||
23171087|NCT01857869|64370936|FG008|Primary/Challenge Phase|Other|0|||
23171088|NCT01857869|64370937|FG009|Primary/Challenge Phase|Other|0|||
23171089|NCT01857869|64370928|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23171090|NCT01857869|64370929|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23171091|NCT01857869|64370930|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23171092|NCT01857869|64370931|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
23171093|NCT01857869|64370932|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23171094|NCT01857869|64370933|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23171095|NCT01857869|64370934|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23171096|NCT01857869|64370935|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23171097|NCT01857869|64370936|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23171098|NCT01857869|64370937|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
23171099|NCT01857869|64370928|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23171100|NCT01857869|64370929|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23171101|NCT01857869|64370930|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23171102|NCT01857869|64370931|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
23171103|NCT01857869|64370932|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23171104|NCT01857869|64370933|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23171105|NCT01857869|64370934|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23171106|NCT01857869|64370935|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23171107|NCT01857869|64370936|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23171108|NCT01857869|64370937|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
23171109|NCT04506294|64370946|FG000|Overall Study|Lost to Follow-up|70|||
23171110|NCT04506294|64370947|FG001|Overall Study|Lost to Follow-up|20|||
23171111|NCT04506294|64370946|FG000|Overall Study|Withdrawal by Subject|16|||
23171112|NCT04506294|64370947|FG001|Overall Study|Withdrawal by Subject|2|||
23230410|NCT01948791|64584281|FG000|Overall Study|Adverse Event|12|||
23230411|NCT01948791|64584281|FG000|Overall Study|Lack of Efficacy|3|||
23230412|NCT01948791|64584281|FG000|Overall Study|Protocol Violation|2|||
23230413|NCT01948791|64584281|FG000|Overall Study|Withdrawal by Subject|5|||
23230414|NCT01948791|64584281|FG000|Overall Study|Lost to Follow-up|6|||
23577737|NCT00557505|65846916|FG003|Overall Study|Adverse Event|0|||
23577738|NCT00557505|65846917|FG004|Overall Study|Adverse Event|0|||
23577739|NCT00557505|65846918|FG005|Overall Study|Adverse Event|0|||
23577740|NCT00557505|65846919|FG006|Overall Study|Adverse Event|1|||
23230415|NCT01948791|64584281|FG000|Overall Study|Management issues|1|||
23338298|NCT00090220|64982980|FG000|Base Study Vaccination Period|Adverse Event|6|||
23338299|NCT00090220|64982981|FG001|Base Study Vaccination Period|Adverse Event|1|||
23230416|NCT01948791|64584281|FG000|Overall Study|Others|7|||
23338300|NCT00090220|64982982|FG002|Base Study Vaccination Period|Adverse Event|0|||
23338301|NCT00090220|64982983|FG003|Base Study Vaccination Period|Adverse Event|0|||
23338302|NCT00090220|64982984|FG004|Base Study Vaccination Period|Adverse Event|0|||
23338303|NCT00090220|64982985|FG005|Base Study Vaccination Period|Adverse Event|0|||
23338304|NCT00090220|64982980|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
23338305|NCT00090220|64982981|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
23338306|NCT00090220|64982982|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
23338307|NCT00090220|64982983|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
23338308|NCT00090220|64982984|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
23338309|NCT00090220|64982985|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
23338310|NCT00090220|64982980|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
23338311|NCT00090220|64982981|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
23338312|NCT00090220|64982982|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
23338313|NCT00090220|64982983|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
23338314|NCT00090220|64982984|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
23338315|NCT00090220|64982985|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
23338316|NCT00090220|64982980|FG000|Base Study Vaccination Period|Patient Moved|6|||
23338317|NCT00090220|64982981|FG001|Base Study Vaccination Period|Patient Moved|2|||
23338318|NCT00090220|64982982|FG002|Base Study Vaccination Period|Patient Moved|0|||
23338319|NCT00090220|64982983|FG003|Base Study Vaccination Period|Patient Moved|0|||
23338320|NCT00090220|64982984|FG004|Base Study Vaccination Period|Patient Moved|0|||
23171113|NCT00159861|64370948|FG000|Core Study - 16 Weeks|Death|3|||
23171114|NCT00159861|64370949|FG001|Core Study - 16 Weeks|Death|0|||
23171115|NCT00159861|64370948|FG000|Core Study - 16 Weeks|Adverse Event|12|||
23171116|NCT00159861|64370949|FG001|Core Study - 16 Weeks|Adverse Event|6|||
23171117|NCT00159861|64370948|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
23171118|NCT00159861|64370949|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
23171119|NCT00159861|64370948|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
23171120|NCT00159861|64370949|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
23171121|NCT00159861|64370948|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
23171122|NCT00159861|64370949|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
23171123|NCT00159861|64370948|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
23171124|NCT00159861|64370949|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
23171125|NCT00159861|64370948|FG000|Extension Study - up to 3 Years|Death|24|||
23171126|NCT00159861|64370949|FG001|Extension Study - up to 3 Years|Death|28|||
23171127|NCT00159861|64370948|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
23171128|NCT00159861|64370949|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
23171129|NCT00159861|64370948|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
23171130|NCT00159861|64370949|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
23171131|NCT00159861|64370948|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
23171132|NCT00159861|64370949|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
23171133|NCT00159861|64370948|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
23171134|NCT00159861|64370949|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
23171135|NCT02810964|64370956|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
23171136|NCT02810964|64370957|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
23171137|NCT02810964|64370956|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
23171138|NCT02810964|64370957|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
23171139|NCT02810964|64370956|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
23171140|NCT02810964|64370957|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
23171141|NCT02810964|64370956|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
23171142|NCT02810964|64370957|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
23230417|NCT01948791|64584281|FG000|Overall Study|Screening failure|35|||
23230418|NCT02390362|64584282|FG000|Overall Study|Withdrawal by Subject|0|||
23230419|NCT02390362|64584283|FG001|Overall Study|Withdrawal by Subject|1|||
23230420|NCT01815099|64584286|FG000|Overall Study|Lack of Efficacy|1|||
23230421|NCT01815099|64584286|FG000|Overall Study|unable to attend study visits|1|||
23230422|NCT00638989|64584287|FG000|Overall Study|Lost to Follow-up|0|||
23338321|NCT00090220|64982985|FG005|Base Study Vaccination Period|Patient Moved|0|||
23171143|NCT03806127|64370958|FG000|Overall Study|Withdrawal by Subject|4|||
23171144|NCT03806127|64370959|FG001|Overall Study|Withdrawal by Subject|5|||
23171145|NCT03806127|64370958|FG000|Overall Study|Protocol Violation|3|||
23171146|NCT03806127|64370959|FG001|Overall Study|Protocol Violation|1|||
23171147|NCT03806127|64370958|FG000|Overall Study|Adverse Event|3|||
23230423|NCT00638989|64584288|FG001|Overall Study|Lost to Follow-up|0|||
23230424|NCT00638989|64584289|FG002|Overall Study|Lost to Follow-up|1|||
23230425|NCT00850135|64584290|FG000|Overall Study|Physician Decision|1|||
23338322|NCT00090220|64982980|FG000|Base Study Vaccination Period|Other|4|||
23338323|NCT00090220|64982981|FG001|Base Study Vaccination Period|Other|4|||
23577741|NCT00557505|65846920|FG007|Overall Study|Adverse Event|0|||
23577742|NCT00557505|65846921|FG008|Overall Study|Adverse Event|0|||
23577743|NCT00557505|65846913|FG000|Overall Study|Global deterioration of health|1|||
23171148|NCT03806127|64370959|FG001|Overall Study|Adverse Event|0|||
23171149|NCT03806127|64370958|FG000|Overall Study|Unable to Complete Procedures|0|||
23171150|NCT03806127|64370959|FG001|Overall Study|Unable to Complete Procedures|1|||
23577744|NCT00557505|65846914|FG001|Overall Study|Global deterioration of health|0|||
23577745|NCT00557505|65846915|FG002|Overall Study|Global deterioration of health|0|||
23577746|NCT00557505|65846916|FG003|Overall Study|Global deterioration of health|0|||
23577747|NCT00557505|65846917|FG004|Overall Study|Global deterioration of health|0|||
23577748|NCT00557505|65846918|FG005|Overall Study|Global deterioration of health|0|||
23577749|NCT00557505|65846919|FG006|Overall Study|Global deterioration of health|0|||
23577750|NCT00557505|65846920|FG007|Overall Study|Global deterioration of health|0|||
23577751|NCT00557505|65846921|FG008|Overall Study|Global deterioration of health|0|||
23577752|NCT00557505|65846913|FG000|Overall Study|Objective progression or relapse|2|||
23577753|NCT00557505|65846914|FG001|Overall Study|Objective progression or relapse|3|||
23577754|NCT00557505|65846915|FG002|Overall Study|Objective progression or relapse|3|||
23577755|NCT00557505|65846916|FG003|Overall Study|Objective progression or relapse|2|||
23577756|NCT00557505|65846917|FG004|Overall Study|Objective progression or relapse|2|||
23171151|NCT03806127|64370958|FG000|Overall Study|Pregnancy|0|||
23171152|NCT03806127|64370959|FG001|Overall Study|Pregnancy|1|||
23171153|NCT03806127|64370958|FG000|Overall Study|Lost to Follow-up|5|||
23171154|NCT03806127|64370959|FG001|Overall Study|Lost to Follow-up|1|||
23171155|NCT03806127|64370958|FG000|Overall Study|Physician Decision|1|||
23171156|NCT03806127|64370959|FG001|Overall Study|Physician Decision|1|||
23171157|NCT03806127|64370958|FG000|Overall Study|Could Not Come Due to Covid|1|||
23171158|NCT03806127|64370959|FG001|Overall Study|Could Not Come Due to Covid|0|||
23171159|NCT03806127|64370958|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
23171160|NCT03806127|64370959|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
23171161|NCT03806127|64370958|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
23171162|NCT03806127|64370959|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
23171163|NCT03806127|64370958|FG000|Overall Study|Covid 19 Restrictions|2|||
23171164|NCT03806127|64370959|FG001|Overall Study|Covid 19 Restrictions|0|||
23171165|NCT03806127|64370958|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
23171166|NCT03806127|64370959|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
23171167|NCT03806127|64370958|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
23171168|NCT03806127|64370959|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
23171169|NCT00772629|64370963|FG000|Overall Study|Subject was not vaccinated|1|||
23171170|NCT00772629|64370964|FG001|Overall Study|Subject was not vaccinated|0|||
23171171|NCT00993031|64370965|FG000|Overall Study|Death|0|||
23171172|NCT00993031|64370966|FG001|Overall Study|Death|1|||
23171173|NCT00993031|64370965|FG000|Overall Study|Physician Decision|0|||
23171174|NCT00993031|64370966|FG001|Overall Study|Physician Decision|2|||
23171175|NCT00993031|64370965|FG000|Overall Study|Withdrawal by Subject|3|||
23171176|NCT00993031|64370966|FG001|Overall Study|Withdrawal by Subject|3|||
23171177|NCT00993031|64370965|FG000|Overall Study|Lost to Follow-up|19|||
23171178|NCT00993031|64370966|FG001|Overall Study|Lost to Follow-up|13|||
23171179|NCT01877083|64370967|FG000|Treatment Phase|Disease Progression|10|||
23171180|NCT01877083|64370967|FG000|Treatment Phase|Clinical Progression|1|||
23171181|NCT01877083|64370967|FG000|Treatment Phase|Adverse Event|6|||
23171182|NCT01877083|64370967|FG000|Treatment Phase|Withdrawal by Subject|2|||
23171183|NCT01877083|64370967|FG000|Treatment Phase|Lost to Follow-up|1|||
23171184|NCT01877083|64370967|FG000|Extension Phase|Disease Progression|3|||
23171185|NCT01877083|64370967|FG000|Extension Phase|Adverse Event|2|||
23171186|NCT03064841|64370973|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
23171187|NCT03064841|64370973|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
23171188|NCT03064841|64370973|FG000|Overall Study|Screen failure|2|||
23171189|NCT02432235|64370974|FG000|Overall Study|Death|1|||
23171190|NCT02432235|64370975|FG001|Overall Study|Death|1|||
23171191|NCT02432235|64370976|FG002|Overall Study|Death|2|||
23171192|NCT02432235|64370977|FG003|Overall Study|Death|2|||
23577757|NCT00557505|65846918|FG005|Overall Study|Objective progression or relapse|3|||
23171193|NCT02432235|64370978|FG004|Overall Study|Death|1|||
23171194|NCT02432235|64370979|FG005|Overall Study|Death|3|||
23171195|NCT02432235|64370980|FG006|Overall Study|Death|11|||
23171196|NCT02432235|64370981|FG007|Overall Study|Death|15|||
23171197|NCT02432235|64370982|FG008|Overall Study|Death|15|||
23171198|NCT02432235|64370983|FG009|Overall Study|Death|3|||
23450135|NCT01601535|65391413|FG003|Phase 1|Started Another Treatment|0|||
23171199|NCT02432235|64370984|FG010|Overall Study|Death|1|||
23171200|NCT02432235|64370985|FG011|Overall Study|Death|0|||
23171201|NCT02432235|64370974|FG000|Overall Study|Withdrawal by Subject|0|||
23577758|NCT00557505|65846919|FG006|Overall Study|Objective progression or relapse|2|||
23577759|NCT00557505|65846920|FG007|Overall Study|Objective progression or relapse|5|||
23230426|NCT00942422|64584291|FG000|Overall Study|Withdrawal by Subject|1|||
23230427|NCT00942422|64584291|FG000|Overall Study|Death|1|||
23230428|NCT00942422|64584291|FG000|Overall Study|Progressive diease|1|||
23230429|NCT00764322|64584292|FG000|Overall Study|Withdrawal by Subject|11|||
23230430|NCT00764322|64584292|FG000|Overall Study|No CYP2D6 genotyping|9|||
23230431|NCT00626795|64584300|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
23230432|NCT00626795|64584301|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
23230433|NCT00626795|64584302|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
23230434|NCT00626795|64584300|FG000|Blinded Treatment|Lack of Efficacy|2|||
23230435|NCT00626795|64584301|FG001|Blinded Treatment|Lack of Efficacy|0|||
23230436|NCT00626795|64584302|FG002|Blinded Treatment|Lack of Efficacy|0|||
23230437|NCT00626795|64584300|FG000|Blinded Treatment|Unacceptable adverse event|0|||
23230438|NCT00626795|64584301|FG001|Blinded Treatment|Unacceptable adverse event|0|||
23230439|NCT00626795|64584302|FG002|Blinded Treatment|Unacceptable adverse event|1|||
23230440|NCT00626795|64584300|FG000|Blinded Treatment|Protocol Violation|0|||
23230441|NCT00626795|64584301|FG001|Blinded Treatment|Protocol Violation|1|||
23230442|NCT00626795|64584302|FG002|Blinded Treatment|Protocol Violation|1|||
23230443|NCT00626795|64584300|FG000|Blinded Treatment|Withdrawal by Subject|1|||
23230444|NCT00626795|64584301|FG001|Blinded Treatment|Withdrawal by Subject|1|||
23230445|NCT00626795|64584302|FG002|Blinded Treatment|Withdrawal by Subject|0|||
23230446|NCT00626795|64584300|FG000|Blinded Treatment|Other reasons|2|||
23230447|NCT00626795|64584301|FG001|Blinded Treatment|Other reasons|0|||
23230448|NCT00626795|64584302|FG002|Blinded Treatment|Other reasons|2|||
23230449|NCT00626795|64584300|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
23230450|NCT00626795|64584301|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
23230451|NCT00626795|64584302|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
23230452|NCT00887913|64584311|FG000|Overall Study|Withdrawal by Subject|6|||
23230453|NCT02117024|64588044|FG000|Overall Study|Progressive Disease|26|||
23230454|NCT02117024|64588045|FG001|Overall Study|Progressive Disease|9|||
23230455|NCT02117024|64588044|FG000|Overall Study|Significant Clinical Progression|7|||
23230456|NCT02117024|64588045|FG001|Overall Study|Significant Clinical Progression|4|||
23230457|NCT02117024|64588044|FG000|Overall Study|Death|5|||
23230458|NCT02117024|64588045|FG001|Overall Study|Death|0|||
23230459|NCT02117024|64588044|FG000|Overall Study|Withdrawal by Subject|3|||
23230460|NCT02117024|64588045|FG001|Overall Study|Withdrawal by Subject|1|||
23338324|NCT00090220|64982982|FG002|Base Study Vaccination Period|Other|0|||
23338325|NCT00090220|64982983|FG003|Base Study Vaccination Period|Other|0|||
23338326|NCT00090220|64982984|FG004|Base Study Vaccination Period|Other|0|||
23338327|NCT00090220|64982985|FG005|Base Study Vaccination Period|Other|0|||
23338328|NCT00090220|64982980|FG000|Base Study Follow-up Period|Adverse Event|6|||
23338329|NCT00090220|64982981|FG001|Base Study Follow-up Period|Adverse Event|1|||
23338330|NCT00090220|64982982|FG002|Base Study Follow-up Period|Adverse Event|0|||
23577760|NCT00557505|65846921|FG008|Overall Study|Objective progression or relapse|15|||
23577761|NCT00557505|65846913|FG000|Overall Study|Withdrawal by Subject|0|||
23230461|NCT02117024|64588044|FG000|Overall Study|Protocol Violation|1|||
23230462|NCT02117024|64588045|FG001|Overall Study|Protocol Violation|0|||
23230463|NCT02117024|64588044|FG000|Overall Study|Adverse Event|1|||
23230464|NCT02117024|64588045|FG001|Overall Study|Adverse Event|2|||
23230465|NCT02117024|64588044|FG000|Overall Study|Randomized in Error|1|||
23230466|NCT02117024|64588045|FG001|Overall Study|Randomized in Error|0|||
23230467|NCT02117024|64588044|FG000|Overall Study|Patient returned to primary oncologist|0|||
23230468|NCT02117024|64588045|FG001|Overall Study|Patient returned to primary oncologist|1|||
23338331|NCT00090220|64982983|FG003|Base Study Follow-up Period|Adverse Event|0|||
23338332|NCT00090220|64982984|FG004|Base Study Follow-up Period|Adverse Event|0|||
23577762|NCT00557505|65846914|FG001|Overall Study|Withdrawal by Subject|0|||
23577763|NCT00557505|65846915|FG002|Overall Study|Withdrawal by Subject|0|||
23577764|NCT00557505|65846916|FG003|Overall Study|Withdrawal by Subject|1|||
23577765|NCT00557505|65846917|FG004|Overall Study|Withdrawal by Subject|0|||
23577766|NCT00557505|65846918|FG005|Overall Study|Withdrawal by Subject|0|||
23577767|NCT00557505|65846919|FG006|Overall Study|Withdrawal by Subject|0|||
23577768|NCT00557505|65846920|FG007|Overall Study|Withdrawal by Subject|0|||
23577769|NCT00557505|65846921|FG008|Overall Study|Withdrawal by Subject|1|||
23577770|NCT02303574|65846922|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577771|NCT02303574|65846923|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577772|NCT02303574|65846924|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
23577773|NCT02303574|65846925|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577774|NCT02303574|65846926|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577775|NCT02303574|65846927|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577776|NCT02303574|65846928|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577777|NCT02303574|65846929|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23230469|NCT02117024|64588044|FG000|Overall Study|Patient took treatment break|0|||
23230470|NCT02117024|64588045|FG001|Overall Study|Patient took treatment break|1|||
23338333|NCT00090220|64982985|FG005|Base Study Follow-up Period|Adverse Event|0|||
23338334|NCT00090220|64982980|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
23171202|NCT02432235|64370975|FG001|Overall Study|Withdrawal by Subject|1|||
23171203|NCT02432235|64370976|FG002|Overall Study|Withdrawal by Subject|0|||
23171204|NCT02432235|64370977|FG003|Overall Study|Withdrawal by Subject|0|||
23171205|NCT02432235|64370978|FG004|Overall Study|Withdrawal by Subject|0|||
23171206|NCT02432235|64370979|FG005|Overall Study|Withdrawal by Subject|2|||
23171207|NCT02432235|64370980|FG006|Overall Study|Withdrawal by Subject|5|||
23171208|NCT02432235|64370981|FG007|Overall Study|Withdrawal by Subject|3|||
23171209|NCT02432235|64370982|FG008|Overall Study|Withdrawal by Subject|1|||
23171210|NCT02432235|64370983|FG009|Overall Study|Withdrawal by Subject|0|||
23171211|NCT02432235|64370984|FG010|Overall Study|Withdrawal by Subject|0|||
23171212|NCT02432235|64370985|FG011|Overall Study|Withdrawal by Subject|0|||
23171213|NCT02432235|64370974|FG000|Overall Study|Lost to Follow-up|0|||
23171214|NCT02432235|64370975|FG001|Overall Study|Lost to Follow-up|0|||
23171215|NCT02432235|64370976|FG002|Overall Study|Lost to Follow-up|0|||
23171216|NCT02432235|64370977|FG003|Overall Study|Lost to Follow-up|0|||
23171217|NCT02432235|64370978|FG004|Overall Study|Lost to Follow-up|0|||
23450136|NCT01601535|65391414|FG004|Phase 1|Started Another Treatment|0|||
23450137|NCT01601535|65391415|FG005|Phase 1|Started Another Treatment|0|||
23450138|NCT01601535|65391410|FG000|Phase 2|Adverse Event|0|||
23450139|NCT01601535|65391411|FG001|Phase 2|Adverse Event|0|||
23450140|NCT01601535|65391412|FG002|Phase 2|Adverse Event|0|||
23450141|NCT01601535|65391413|FG003|Phase 2|Adverse Event|0|||
23450142|NCT01601535|65391414|FG004|Phase 2|Adverse Event|5|||
23450143|NCT01601535|65391415|FG005|Phase 2|Adverse Event|1|||
23450144|NCT01601535|65391410|FG000|Phase 2|Withdrawal by Subject|0|||
23577778|NCT02303574|65846930|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577779|NCT02303574|65846931|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
23577780|NCT02303574|65846922|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577781|NCT02303574|65846923|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577782|NCT02303574|65846924|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577783|NCT02303574|65846925|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577784|NCT02303574|65846926|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577785|NCT02303574|65846927|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577786|NCT02303574|65846928|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577787|NCT02303574|65846929|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
23577788|NCT02303574|65846930|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577789|NCT02303574|65846931|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
23577790|NCT01152554|65846932|FG000|Overall Study|Withdrawal by Subject|73|||
23577791|NCT01152554|65846933|FG001|Overall Study|Withdrawal by Subject|28|||
23577792|NCT01152554|65846932|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
23577793|NCT01152554|65846933|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
23577794|NCT01152554|65846932|FG000|Overall Study|Adverse Event|67|||
23577795|NCT01152554|65846933|FG001|Overall Study|Adverse Event|14|||
23577796|NCT01152554|65846932|FG000|Overall Study|Severe non-compliance to protocol|36|||
23577797|NCT01152554|65846933|FG001|Overall Study|Severe non-compliance to protocol|14|||
23577798|NCT01152554|65846932|FG000|Overall Study|Condition under investigation worsened|5|||
23577799|NCT01152554|65846933|FG001|Overall Study|Condition under investigation worsened|2|||
23577800|NCT01152554|65846932|FG000|Overall Study|Lack of Efficacy|20|||
23577801|NCT01152554|65846933|FG001|Overall Study|Lack of Efficacy|3|||
23577802|NCT01152554|65846932|FG000|Overall Study|Study-specific withdrawal criteria|17|||
23577803|NCT01152554|65846933|FG001|Overall Study|Study-specific withdrawal criteria|8|||
23577804|NCT01152554|65846932|FG000|Overall Study|Lost to Follow-up|87|||
23577805|NCT01152554|65846933|FG001|Overall Study|Lost to Follow-up|32|||
23577806|NCT01152554|65846932|FG000|Overall Study|Other|28|||
23577807|NCT01152554|65846933|FG001|Overall Study|Other|8|||
23577808|NCT01152554|65846932|FG000|Overall Study|Death|1|||
23577809|NCT01152554|65846933|FG001|Overall Study|Death|1|||
23577810|NCT02761629|65846939|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
23577811|NCT02761629|65846940|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
23577812|NCT02761629|65846939|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23577813|NCT02761629|65846940|FG001|Overall Study|Insufficient Therapeutic Response|7|||
23577814|NCT02761629|65846939|FG000|Overall Study|Failure to Return|2|||
23577815|NCT02761629|65846940|FG001|Overall Study|Failure to Return|4|||
23577816|NCT02761629|65846939|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
23577817|NCT02761629|65846940|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
23577818|NCT02761629|65846939|FG000|Overall Study|Protocol Violation|2|||
23577819|NCT02761629|65846940|FG001|Overall Study|Protocol Violation|2|||
23171218|NCT02432235|64370979|FG005|Overall Study|Lost to Follow-up|1|||
23171219|NCT02432235|64370980|FG006|Overall Study|Lost to Follow-up|0|||
23450145|NCT01601535|65391411|FG001|Phase 2|Withdrawal by Subject|0|||
23450146|NCT01601535|65391412|FG002|Phase 2|Withdrawal by Subject|0|||
23171220|NCT02432235|64370981|FG007|Overall Study|Lost to Follow-up|0|||
23450147|NCT01601535|65391413|FG003|Phase 2|Withdrawal by Subject|0|||
23171221|NCT02432235|64370982|FG008|Overall Study|Lost to Follow-up|1|||
23450148|NCT01601535|65391414|FG004|Phase 2|Withdrawal by Subject|8|||
23577820|NCT02761629|65846939|FG000|Overall Study|Withdrawal by Subject|0|||
23577821|NCT02761629|65846940|FG001|Overall Study|Withdrawal by Subject|3|||
23577822|NCT02761629|65846939|FG000|Overall Study|Other|0|||
23577823|NCT02761629|65846940|FG001|Overall Study|Other|2|||
23577824|NCT02761629|65846939|FG000|Overall Study|Lost to Follow-up|4|||
23577825|NCT02761629|65846940|FG001|Overall Study|Lost to Follow-up|1|||
23577826|NCT02761629|65846939|FG000|Overall Study|Randomized But Not Treated|8|||
23577827|NCT02761629|65846940|FG001|Overall Study|Randomized But Not Treated|4|||
23577828|NCT01822821|65846943|FG000|Overall Study|Eligible surgery cancelled|1|||
23577829|NCT01822821|65846944|FG001|Overall Study|Eligible surgery cancelled|1|||
23577830|NCT01822821|65846943|FG000|Overall Study|Other reasons|1|||
23577831|NCT01822821|65846944|FG001|Overall Study|Other reasons|0|||
23577832|NCT03639675|65846945|FG000|Overall Study|Withdrawal by Subject|1|||
23577833|NCT01154036|65846948|FG000|Phase I|Physician Decision|0|||
23577834|NCT01154036|65846949|FG001|Phase I|Physician Decision|1|||
23577835|NCT01154036|65846950|FG002|Phase I|Physician Decision|0|||
23577836|NCT01154036|65846951|FG003|Phase I|Physician Decision|0|||
23577837|NCT01154036|65846952|FG004|Phase I|Physician Decision|0|||
23577838|NCT01154036|65846953|FG005|Phase I|Physician Decision|0|||
23577839|NCT01154036|65846954|FG006|Phase I|Physician Decision|0|||
23577840|NCT01154036|65846955|FG007|Phase I|Physician Decision|0|||
23577841|NCT01154036|65846948|FG000|Phase I|Lost to Follow-up|0|||
23577842|NCT01154036|65846949|FG001|Phase I|Lost to Follow-up|3|||
23577843|NCT01154036|65846950|FG002|Phase I|Lost to Follow-up|6|||
23577844|NCT01154036|65846951|FG003|Phase I|Lost to Follow-up|0|||
23577845|NCT01154036|65846952|FG004|Phase I|Lost to Follow-up|0|||
23577846|NCT01154036|65846953|FG005|Phase I|Lost to Follow-up|0|||
23577847|NCT01154036|65846954|FG006|Phase I|Lost to Follow-up|0|||
23577848|NCT01154036|65846955|FG007|Phase I|Lost to Follow-up|0|||
23577849|NCT01154036|65846948|FG000|Phase I|Protocol Violation|0|||
23577850|NCT01154036|65846949|FG001|Phase I|Protocol Violation|3|||
23577851|NCT01154036|65846950|FG002|Phase I|Protocol Violation|9|||
23577852|NCT01154036|65846951|FG003|Phase I|Protocol Violation|0|||
23577853|NCT01154036|65846952|FG004|Phase I|Protocol Violation|0|||
23577854|NCT01154036|65846953|FG005|Phase I|Protocol Violation|0|||
23577855|NCT01154036|65846954|FG006|Phase I|Protocol Violation|0|||
23577856|NCT01154036|65846955|FG007|Phase I|Protocol Violation|0|||
23577857|NCT01154036|65846948|FG000|Phase I|Withdrawal by Subject|2|||
23577858|NCT01154036|65846949|FG001|Phase I|Withdrawal by Subject|10|||
23577859|NCT01154036|65846950|FG002|Phase I|Withdrawal by Subject|29|||
23577860|NCT01154036|65846951|FG003|Phase I|Withdrawal by Subject|0|||
23577861|NCT01154036|65846952|FG004|Phase I|Withdrawal by Subject|0|||
23577862|NCT01154036|65846953|FG005|Phase I|Withdrawal by Subject|0|||
23577863|NCT01154036|65846954|FG006|Phase I|Withdrawal by Subject|0|||
23577864|NCT01154036|65846955|FG007|Phase I|Withdrawal by Subject|0|||
23577865|NCT01154036|65846948|FG000|Phase I|Adverse Event|1|||
23577866|NCT01154036|65846949|FG001|Phase I|Adverse Event|11|||
23577867|NCT01154036|65846950|FG002|Phase I|Adverse Event|12|||
23577868|NCT01154036|65846951|FG003|Phase I|Adverse Event|0|||
23577869|NCT01154036|65846952|FG004|Phase I|Adverse Event|0|||
23577870|NCT01154036|65846953|FG005|Phase I|Adverse Event|0|||
23577871|NCT01154036|65846954|FG006|Phase I|Adverse Event|0|||
23577872|NCT01154036|65846955|FG007|Phase I|Adverse Event|0|||
23577873|NCT01154036|65846948|FG000|Phase II|Adverse Event|0|||
23577874|NCT01154036|65846949|FG001|Phase II|Adverse Event|0|||
23171222|NCT02432235|64370983|FG009|Overall Study|Lost to Follow-up|0|||
23171223|NCT02432235|64370984|FG010|Overall Study|Lost to Follow-up|0|||
23577875|NCT01154036|65846950|FG002|Phase II|Adverse Event|0|||
23577876|NCT01154036|65846951|FG003|Phase II|Adverse Event|0|||
23171224|NCT02432235|64370985|FG011|Overall Study|Lost to Follow-up|0|||
23171225|NCT02432235|64370974|FG000|Overall Study|Miscellaneous|0|||
23171226|NCT02432235|64370975|FG001|Overall Study|Miscellaneous|0|||
23171227|NCT02432235|64370976|FG002|Overall Study|Miscellaneous|0|||
23577877|NCT01154036|65846952|FG004|Phase II|Adverse Event|1|||
23577878|NCT01154036|65846953|FG005|Phase II|Adverse Event|1|||
23171228|NCT02432235|64370977|FG003|Overall Study|Miscellaneous|0|||
23171229|NCT02432235|64370978|FG004|Overall Study|Miscellaneous|1|||
23171230|NCT02432235|64370979|FG005|Overall Study|Miscellaneous|6|||
23171231|NCT02432235|64370980|FG006|Overall Study|Miscellaneous|2|||
23171232|NCT02432235|64370981|FG007|Overall Study|Miscellaneous|2|||
23338335|NCT00090220|64982981|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
23577879|NCT01154036|65846954|FG006|Phase II|Adverse Event|1|||
23577880|NCT01154036|65846955|FG007|Phase II|Adverse Event|1|||
23577881|NCT01154036|65846948|FG000|Phase II|Physician Decision|0|||
23577882|NCT01154036|65846949|FG001|Phase II|Physician Decision|0|||
23577883|NCT01154036|65846950|FG002|Phase II|Physician Decision|0|||
23577884|NCT01154036|65846951|FG003|Phase II|Physician Decision|0|||
23577885|NCT01154036|65846952|FG004|Phase II|Physician Decision|0|||
23577886|NCT01154036|65846953|FG005|Phase II|Physician Decision|0|||
23577887|NCT01154036|65846954|FG006|Phase II|Physician Decision|1|||
23577888|NCT01154036|65846955|FG007|Phase II|Physician Decision|0|||
23577889|NCT01154036|65846948|FG000|Phase II|Lost to Follow-up|0|||
23577890|NCT01154036|65846949|FG001|Phase II|Lost to Follow-up|0|||
23577891|NCT01154036|65846950|FG002|Phase II|Lost to Follow-up|0|||
23577892|NCT01154036|65846951|FG003|Phase II|Lost to Follow-up|1|||
23577893|NCT01154036|65846952|FG004|Phase II|Lost to Follow-up|2|||
23577894|NCT01154036|65846953|FG005|Phase II|Lost to Follow-up|0|||
23577895|NCT01154036|65846954|FG006|Phase II|Lost to Follow-up|2|||
23577896|NCT01154036|65846955|FG007|Phase II|Lost to Follow-up|1|||
23577897|NCT01154036|65846948|FG000|Phase II|Protocol Violation|0|||
23577898|NCT01154036|65846949|FG001|Phase II|Protocol Violation|0|||
23577899|NCT01154036|65846950|FG002|Phase II|Protocol Violation|0|||
23577900|NCT01154036|65846951|FG003|Phase II|Protocol Violation|0|||
23577901|NCT01154036|65846952|FG004|Phase II|Protocol Violation|1|||
23577902|NCT01154036|65846953|FG005|Phase II|Protocol Violation|2|||
23577903|NCT01154036|65846954|FG006|Phase II|Protocol Violation|0|||
23577904|NCT01154036|65846955|FG007|Phase II|Protocol Violation|0|||
23577905|NCT01154036|65846948|FG000|Phase II|Withdrawal by Subject|0|||
23577906|NCT01154036|65846949|FG001|Phase II|Withdrawal by Subject|0|||
23577907|NCT01154036|65846950|FG002|Phase II|Withdrawal by Subject|0|||
23577908|NCT01154036|65846951|FG003|Phase II|Withdrawal by Subject|0|||
23577909|NCT01154036|65846952|FG004|Phase II|Withdrawal by Subject|4|||
23171233|NCT02432235|64370982|FG008|Overall Study|Miscellaneous|4|||
23171234|NCT02432235|64370983|FG009|Overall Study|Miscellaneous|0|||
23171235|NCT02432235|64370984|FG010|Overall Study|Miscellaneous|0|||
23338336|NCT00090220|64982982|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
23338337|NCT00090220|64982983|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
23338338|NCT00090220|64982984|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
23338339|NCT00090220|64982985|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
23338340|NCT00090220|64982980|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
23338341|NCT00090220|64982981|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
23577910|NCT01154036|65846953|FG005|Phase II|Withdrawal by Subject|2|||
23577911|NCT01154036|65846954|FG006|Phase II|Withdrawal by Subject|5|||
23577912|NCT01154036|65846955|FG007|Phase II|Withdrawal by Subject|4|||
23577913|NCT01764386|65846956|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
23577914|NCT01764386|65846957|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
23577915|NCT01764386|65846956|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
23577916|NCT01764386|65846957|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
23577917|NCT01764386|65846956|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
23577918|NCT01764386|65846957|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
23577919|NCT01764386|65846956|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
23577920|NCT01764386|65846957|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
23577921|NCT01764386|65846956|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
23577922|NCT01764386|65846957|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
23577923|NCT01764386|65846956|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
23577924|NCT01764386|65846957|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
23577925|NCT01764386|65846956|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
23577926|NCT01764386|65846957|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
23577927|NCT01764386|65846956|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
23577928|NCT01764386|65846957|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
23577929|NCT02559817|65846958|FG000|Treatment Period|Adverse Event|1|||
23577930|NCT02559817|65846959|FG001|Treatment Period|Adverse Event|0|||
23577931|NCT02559817|65846960|FG002|Treatment Period|Adverse Event|1|||
23577932|NCT02559817|65846961|FG003|Treatment Period|Adverse Event|0|||
23577933|NCT02559817|65846962|FG004|Treatment Period|Adverse Event|0|||
23577934|NCT02559817|65846958|FG000|Treatment Period|Lack of Efficacy|0|||
23577935|NCT02559817|65846959|FG001|Treatment Period|Lack of Efficacy|1|||
23577936|NCT02559817|65846960|FG002|Treatment Period|Lack of Efficacy|0|||
23577937|NCT02559817|65846961|FG003|Treatment Period|Lack of Efficacy|0|||
23577938|NCT02559817|65846962|FG004|Treatment Period|Lack of Efficacy|0|||
23577939|NCT02559817|65846958|FG000|Treatment Period|Lost to Follow-up|0|||
23577940|NCT02559817|65846959|FG001|Treatment Period|Lost to Follow-up|1|||
23577941|NCT02559817|65846960|FG002|Treatment Period|Lost to Follow-up|0|||
23577942|NCT02559817|65846961|FG003|Treatment Period|Lost to Follow-up|1|||
23577943|NCT02559817|65846962|FG004|Treatment Period|Lost to Follow-up|0|||
23171236|NCT02432235|64370985|FG011|Overall Study|Miscellaneous|1|||
23171237|NCT01463098|64370996|FG000|Part A (11 Days)|Participant Choice|2|||
23171238|NCT01463098|64370997|FG001|Part A (11 Days)|Participant Choice|0|||
23171239|NCT01463098|64370998|FG002|Part A (11 Days)|Participant Choice|0|||
23171240|NCT01463098|64370999|FG003|Part A (11 Days)|Participant Choice|0|||
23171241|NCT01463098|64371000|FG004|Part A (11 Days)|Participant Choice|0|||
23338342|NCT00090220|64982982|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
23577944|NCT02559817|65846958|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
23577945|NCT02559817|65846959|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
23577946|NCT02559817|65846960|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
23338343|NCT00090220|64982983|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
23338344|NCT00090220|64982984|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
23338345|NCT00090220|64982985|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
23338346|NCT00090220|64982980|FG000|Base Study Follow-up Period|Patient Moved|20|||
23338347|NCT00090220|64982981|FG001|Base Study Follow-up Period|Patient Moved|28|||
23338348|NCT00090220|64982982|FG002|Base Study Follow-up Period|Patient Moved|0|||
23338349|NCT00090220|64982983|FG003|Base Study Follow-up Period|Patient Moved|0|||
23338350|NCT00090220|64982984|FG004|Base Study Follow-up Period|Patient Moved|0|||
23338351|NCT00090220|64982985|FG005|Base Study Follow-up Period|Patient Moved|0|||
23338352|NCT00090220|64982980|FG000|Base Study Follow-up Period|Other|19|||
23338353|NCT00090220|64982981|FG001|Base Study Follow-up Period|Other|21|||
23338354|NCT00090220|64982982|FG002|Base Study Follow-up Period|Other|0|||
23338355|NCT00090220|64982983|FG003|Base Study Follow-up Period|Other|0|||
23338356|NCT00090220|64982984|FG004|Base Study Follow-up Period|Other|0|||
23338357|NCT00090220|64982985|FG005|Base Study Follow-up Period|Other|0|||
23338358|NCT00090220|64982980|FG000|Extension 1 (EXT1)|Adverse Event|0|||
23338359|NCT00090220|64982981|FG001|Extension 1 (EXT1)|Adverse Event|0|||
23338360|NCT00090220|64982982|FG002|Extension 1 (EXT1)|Adverse Event|4|||
23338361|NCT00090220|64982983|FG003|Extension 1 (EXT1)|Adverse Event|0|||
23338362|NCT00090220|64982984|FG004|Extension 1 (EXT1)|Adverse Event|0|||
23338363|NCT00090220|64982985|FG005|Extension 1 (EXT1)|Adverse Event|0|||
23338364|NCT00090220|64982980|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
23230471|NCT02117024|64588044|FG000|Overall Study|Physician Decision|0|||
23230472|NCT02117024|64588045|FG001|Overall Study|Physician Decision|2|||
23577947|NCT02559817|65846961|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
23577948|NCT02559817|65846962|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
23577949|NCT02559817|65846958|FG000|Treatment Period|Protocol Violation|0|||
23230473|NCT03330106|64588046|FG000|Part A|Withdrawal by Subject|1|||
23230474|NCT03330106|64588047|FG001|Part A|Withdrawal by Subject|1|||
23230475|NCT03330106|64588048|FG002|Part A|Withdrawal by Subject|0|||
23230476|NCT03330106|64588049|FG003|Part A|Withdrawal by Subject|0|||
23230477|NCT03330106|64588046|FG000|Part A|Death|2|||
23230478|NCT03330106|64588047|FG001|Part A|Death|1|||
23230479|NCT03330106|64588048|FG002|Part A|Death|0|||
23338365|NCT00090220|64982981|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
23450149|NCT01601535|65391415|FG005|Phase 2|Withdrawal by Subject|2|||
23450150|NCT01601535|65391410|FG000|Phase 2|Progressive Disease|0|||
23450151|NCT01601535|65391411|FG001|Phase 2|Progressive Disease|0|||
23450152|NCT01601535|65391412|FG002|Phase 2|Progressive Disease|0|||
23450153|NCT01601535|65391413|FG003|Phase 2|Progressive Disease|0|||
23450154|NCT01601535|65391414|FG004|Phase 2|Progressive Disease|5|||
23450155|NCT01601535|65391415|FG005|Phase 2|Progressive Disease|7|||
23450156|NCT01601535|65391410|FG000|Phase 2|Started Another Treatment|0|||
23577950|NCT02559817|65846959|FG001|Treatment Period|Protocol Violation|0|||
23577951|NCT02559817|65846960|FG002|Treatment Period|Protocol Violation|0|||
23577952|NCT02559817|65846961|FG003|Treatment Period|Protocol Violation|1|||
23577953|NCT02559817|65846962|FG004|Treatment Period|Protocol Violation|0|||
23577954|NCT02034435|65846963|FG000|Overall Study|Withdrawal by Subject|1|||
23577955|NCT02034435|65846964|FG001|Overall Study|Withdrawal by Subject|0|||
23577956|NCT02034435|65846965|FG002|Overall Study|Withdrawal by Subject|0|||
23577957|NCT02034435|65846966|FG003|Overall Study|Withdrawal by Subject|0|||
23577958|NCT02034435|65846963|FG000|Overall Study|Illness|0|||
23577959|NCT02034435|65846964|FG001|Overall Study|Illness|2|||
23338366|NCT00090220|64982982|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
23338367|NCT00090220|64982983|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
23338368|NCT00090220|64982984|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
23338369|NCT00090220|64982985|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
23338370|NCT00090220|64982980|FG000|Extension 1 (EXT1)|Moved|0|||
23338371|NCT00090220|64982981|FG001|Extension 1 (EXT1)|Moved|0|||
23338372|NCT00090220|64982982|FG002|Extension 1 (EXT1)|Moved|2|||
23338373|NCT00090220|64982983|FG003|Extension 1 (EXT1)|Moved|1|||
23450157|NCT01601535|65391411|FG001|Phase 2|Started Another Treatment|0|||
23450158|NCT01601535|65391412|FG002|Phase 2|Started Another Treatment|0|||
23577960|NCT02034435|65846965|FG002|Overall Study|Illness|0|||
23450159|NCT01601535|65391413|FG003|Phase 2|Started Another Treatment|0|||
23230480|NCT03330106|64588049|FG003|Part A|Death|0|||
23338374|NCT00090220|64982984|FG004|Extension 1 (EXT1)|Moved|0|||
23450160|NCT01601535|65391414|FG004|Phase 2|Started Another Treatment|1|||
23230481|NCT03330106|64588046|FG000|Part A|Adverse Event|0|||
23230482|NCT03330106|64588047|FG001|Part A|Adverse Event|1|||
23338375|NCT00090220|64982985|FG005|Extension 1 (EXT1)|Moved|0|||
23338376|NCT00090220|64982980|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23338377|NCT00090220|64982981|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23338378|NCT00090220|64982982|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
23338379|NCT00090220|64982983|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23338380|NCT00090220|64982984|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23577961|NCT02034435|65846966|FG003|Overall Study|Illness|0|||
23577962|NCT02034435|65846963|FG000|Overall Study|Inadequate IV access|1|||
23338381|NCT00090220|64982985|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
23338382|NCT00090220|64982980|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
23338383|NCT00090220|64982981|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
23338384|NCT00090220|64982982|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
23338385|NCT00090220|64982983|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
23338386|NCT00090220|64982984|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
23338387|NCT00090220|64982985|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
23338388|NCT00090220|64982980|FG000|Extension 1 (EXT1)|Other reason|0|||
23338389|NCT00090220|64982981|FG001|Extension 1 (EXT1)|Other reason|0|||
23338390|NCT00090220|64982982|FG002|Extension 1 (EXT1)|Other reason|2|||
23338391|NCT00090220|64982983|FG003|Extension 1 (EXT1)|Other reason|0|||
23338392|NCT00090220|64982984|FG004|Extension 1 (EXT1)|Other reason|0|||
23338393|NCT00090220|64982985|FG005|Extension 1 (EXT1)|Other reason|0|||
23338394|NCT00090220|64982980|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23338395|NCT00090220|64982981|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23338396|NCT00090220|64982982|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23338397|NCT00090220|64982983|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23577963|NCT02034435|65846964|FG001|Overall Study|Inadequate IV access|0|||
23577964|NCT02034435|65846965|FG002|Overall Study|Inadequate IV access|0|||
23577965|NCT02034435|65846966|FG003|Overall Study|Inadequate IV access|1|||
23577966|NCT00373295|65846967|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23577967|NCT00373295|65846968|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
23577968|NCT00373295|65846969|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23577969|NCT00373295|65846970|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23577970|NCT00373295|65846971|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
23577971|NCT00373295|65846972|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23577972|NCT04212169|65846973|FG000|Overall Study|Adverse Event|0|||
23577973|NCT04212169|65846974|FG001|Overall Study|Adverse Event|0|||
23577974|NCT04212169|65846975|FG002|Overall Study|Adverse Event|0|||
23577975|NCT04212169|65846976|FG003|Overall Study|Adverse Event|2|||
23577976|NCT04212169|65846973|FG000|Overall Study|Lost to Follow-up|1|||
23577977|NCT04212169|65846974|FG001|Overall Study|Lost to Follow-up|0|||
23577978|NCT04212169|65846975|FG002|Overall Study|Lost to Follow-up|0|||
23577979|NCT04212169|65846976|FG003|Overall Study|Lost to Follow-up|2|||
23577980|NCT04212169|65846973|FG000|Overall Study|Withdrawal by Subject|10|||
23577981|NCT04212169|65846974|FG001|Overall Study|Withdrawal by Subject|2|||
23577982|NCT04212169|65846975|FG002|Overall Study|Withdrawal by Subject|5|||
23577983|NCT04212169|65846976|FG003|Overall Study|Withdrawal by Subject|7|||
23577984|NCT04212169|65846973|FG000|Overall Study|Other reason, unspecified|3|||
23577985|NCT04212169|65846974|FG001|Overall Study|Other reason, unspecified|1|||
23577986|NCT04212169|65846975|FG002|Overall Study|Other reason, unspecified|0|||
23450161|NCT01601535|65391415|FG005|Phase 2|Started Another Treatment|2|||
23450162|NCT01290757|65391416|FG000|Overall Study|Adverse Event|1|||
23450163|NCT01290757|65391417|FG001|Overall Study|Adverse Event|0|||
23450164|NCT01290757|65391416|FG000|Overall Study|Protocol Violation|1|||
23450165|NCT01290757|65391417|FG001|Overall Study|Protocol Violation|1|||
23577987|NCT04212169|65846976|FG003|Overall Study|Other reason, unspecified|2|||
23577988|NCT02013687|65846977|FG000|Overall Study|Lost to Follow-up|0|||
23338398|NCT00090220|64982984|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
23338399|NCT00090220|64982985|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
23338400|NCT00090220|64982980|FG000|Long-term Follow-up (EXT2)|Death|0|||
23338401|NCT00090220|64982981|FG001|Long-term Follow-up (EXT2)|Death|0|||
23577989|NCT02013687|65846978|FG001|Overall Study|Lost to Follow-up|0|||
23577990|NCT02013687|65846979|FG002|Overall Study|Lost to Follow-up|1|||
23577991|NCT02013687|65846980|FG003|Overall Study|Lost to Follow-up|0|||
23577992|NCT02013687|65846977|FG000|Overall Study|Protocol Violation|0|||
23577993|NCT02013687|65846978|FG001|Overall Study|Protocol Violation|0|||
23171242|NCT01463098|64371001|FG005|Part A (11 Days)|Participant Choice|0|||
23171243|NCT01463098|64371002|FG006|Part A (11 Days)|Participant Choice|0|||
23171244|NCT01463098|64371003|FG007|Part A (11 Days)|Participant Choice|0|||
23171245|NCT01463098|64371004|FG008|Part A (11 Days)|Participant Choice|1|||
23171246|NCT01463098|64371005|FG009|Part A (11 Days)|Participant Choice|0|||
23171247|NCT01463098|64371006|FG010|Part A (11 Days)|Participant Choice|0|||
23171248|NCT01463098|64371007|FG011|Part A (11 Days)|Participant Choice|0|||
23338402|NCT00090220|64982982|FG002|Long-term Follow-up (EXT2)|Death|0|||
23338403|NCT00090220|64982983|FG003|Long-term Follow-up (EXT2)|Death|0|||
23338404|NCT00090220|64982984|FG004|Long-term Follow-up (EXT2)|Death|1|||
23338405|NCT00090220|64982985|FG005|Long-term Follow-up (EXT2)|Death|1|||
23338406|NCT00090220|64982980|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23577994|NCT02013687|65846979|FG002|Overall Study|Protocol Violation|0|||
23577995|NCT02013687|65846980|FG003|Overall Study|Protocol Violation|1|||
23577996|NCT02013687|65846977|FG000|Overall Study|Withdrawal by Subject|0|||
23577997|NCT02013687|65846978|FG001|Overall Study|Withdrawal by Subject|0|||
23577998|NCT02013687|65846979|FG002|Overall Study|Withdrawal by Subject|0|||
23577999|NCT02013687|65846980|FG003|Overall Study|Withdrawal by Subject|1|||
23578000|NCT02013687|65846977|FG000|Overall Study|Missed visits due to patient travel|0|||
23230483|NCT03330106|64588048|FG002|Part A|Adverse Event|0|||
23230484|NCT03330106|64588049|FG003|Part A|Adverse Event|0|||
23230485|NCT03330106|64588046|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
23230486|NCT03330106|64588047|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
23230487|NCT03330106|64588048|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
23578001|NCT02013687|65846978|FG001|Overall Study|Missed visits due to patient travel|0|||
23578002|NCT02013687|65846979|FG002|Overall Study|Missed visits due to patient travel|1|||
23578003|NCT02013687|65846980|FG003|Overall Study|Missed visits due to patient travel|0|||
23578004|NCT03290079|65846981|FG000|Overall Study|Death|2|||
23578005|NCT00813488|65846982|FG000|Titration Period 1|Adverse Event|6|||
23578006|NCT00813488|65846983|FG001|Titration Period 1|Adverse Event|1|||
23578007|NCT00813488|65846982|FG000|Titration Period 1|Lack of Efficacy|9|||
23578008|NCT00813488|65846983|FG001|Titration Period 1|Lack of Efficacy|7|||
23578009|NCT00813488|65846982|FG000|Titration Period 1|Withdrawal by Subject|2|||
23578010|NCT00813488|65846983|FG001|Titration Period 1|Withdrawal by Subject|2|||
23578011|NCT00813488|65846982|FG000|Titration Period 1|Protocol Violation|4|||
23578012|NCT00813488|65846983|FG001|Titration Period 1|Protocol Violation|3|||
23578013|NCT00813488|65846982|FG000|Titration Period 1|Non-compliance to study medication|4|||
23578014|NCT00813488|65846983|FG001|Titration Period 1|Non-compliance to study medication|1|||
23578015|NCT00813488|65846982|FG000|Titration Period 1|Non-compliance to study procedures|2|||
23578016|NCT00813488|65846983|FG001|Titration Period 1|Non-compliance to study procedures|2|||
23578017|NCT00813488|65846982|FG000|Titration Period 1|Technical Difficulties|0|||
23578018|NCT00813488|65846983|FG001|Titration Period 1|Technical Difficulties|1|||
23578019|NCT00813488|65846982|FG000|Titration Period 2|Adverse Event|2|||
23578020|NCT00813488|65846983|FG001|Titration Period 2|Adverse Event|3|||
23578021|NCT00813488|65846982|FG000|Titration Period 2|Lack of Efficacy|8|||
23578022|NCT00813488|65846983|FG001|Titration Period 2|Lack of Efficacy|4|||
23578023|NCT00813488|65846982|FG000|Titration Period 2|Protocol Violation|3|||
23578024|NCT00813488|65846983|FG001|Titration Period 2|Protocol Violation|2|||
23578025|NCT00813488|65846982|FG000|Titration Period 2|Lost to Follow-up|1|||
23230488|NCT03330106|64588049|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
23230489|NCT03330106|64588046|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
23230490|NCT03330106|64588047|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
23230491|NCT03330106|64588048|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
23230492|NCT03330106|64588049|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
23230493|NCT03330106|64588046|FG000|Part A|Progressive Disease|0|||
23230494|NCT03330106|64588047|FG001|Part A|Progressive Disease|1|||
23230495|NCT03330106|64588048|FG002|Part A|Progressive Disease|0|||
23230496|NCT03330106|64588049|FG003|Part A|Progressive Disease|0|||
23230497|NCT03330106|64588046|FG000|Part B|Lost to Follow-up|0|||
23230498|NCT03330106|64588047|FG001|Part B|Lost to Follow-up|0|||
23230499|NCT03330106|64588048|FG002|Part B|Lost to Follow-up|0|||
23230500|NCT03330106|64588049|FG003|Part B|Lost to Follow-up|1|||
23230501|NCT03330106|64588046|FG000|Part B|Withdrawal by Subject|0|||
23450166|NCT01290757|65391416|FG000|Overall Study|Other|0|||
23450167|NCT01290757|65391417|FG001|Overall Study|Other|1|||
23450168|NCT00113841|65391424|FG000|Overall Study|Disease progression|0|||
23450169|NCT00113841|65391425|FG001|Overall Study|Disease progression|2|||
23450170|NCT00113841|65391424|FG000|Overall Study|Non-compliant|1|||
23450171|NCT00113841|65391425|FG001|Overall Study|Non-compliant|0|||
23450172|NCT01643668|65391426|FG000|Overall Study|Death|1|||
23450173|NCT02807623|65391431|FG000|Overall Study|Lost to Follow-up|23|||
23450174|NCT02807623|65391432|FG001|Overall Study|Lost to Follow-up|18|||
23450175|NCT02807623|65391433|FG002|Overall Study|Lost to Follow-up|22|||
23450176|NCT02807623|65391431|FG000|Overall Study|Drug intolerance|0|||
23450177|NCT02807623|65391432|FG001|Overall Study|Drug intolerance|1|||
23450178|NCT02807623|65391433|FG002|Overall Study|Drug intolerance|0|||
23450179|NCT02807623|65391431|FG000|Overall Study|incomplete blood draw|0|||
23450180|NCT02807623|65391432|FG001|Overall Study|incomplete blood draw|2|||
23450181|NCT02807623|65391433|FG002|Overall Study|incomplete blood draw|1|||
23450182|NCT01176032|65391436|FG000|Overall Study|Adverse Event|1|||
23578026|NCT00813488|65846983|FG001|Titration Period 2|Lost to Follow-up|0|||
23578027|NCT00813488|65846982|FG000|Titration Period 2|Non-compliance with study procedures|2|||
23578028|NCT00813488|65846983|FG001|Titration Period 2|Non-compliance with study procedures|1|||
23578029|NCT00813488|65846982|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
23230502|NCT03330106|64588047|FG001|Part B|Withdrawal by Subject|0|||
23230503|NCT03330106|64588048|FG002|Part B|Withdrawal by Subject|4|||
23230504|NCT03330106|64588049|FG003|Part B|Withdrawal by Subject|0|||
23450183|NCT01176032|65391437|FG001|Overall Study|Adverse Event|0|||
23450184|NCT01176032|65391436|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23450185|NCT01176032|65391437|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23578030|NCT00813488|65846983|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
23338407|NCT00090220|64982981|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23338408|NCT00090220|64982982|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23338409|NCT00090220|64982983|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23338410|NCT00090220|64982984|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
23338411|NCT00090220|64982985|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
23338412|NCT00090220|64982980|FG000|Long-term Follow-up (EXT2)|Other|0|||
23338413|NCT00090220|64982981|FG001|Long-term Follow-up (EXT2)|Other|0|||
23338414|NCT00090220|64982982|FG002|Long-term Follow-up (EXT2)|Other|0|||
23338415|NCT00090220|64982983|FG003|Long-term Follow-up (EXT2)|Other|0|||
23338416|NCT00090220|64982984|FG004|Long-term Follow-up (EXT2)|Other|1|||
23338417|NCT00090220|64982985|FG005|Long-term Follow-up (EXT2)|Other|0|||
23338418|NCT01399047|64982986|FG000|Overall Study|Withdrawal by Subject|0|||
23338419|NCT01399047|64982987|FG001|Overall Study|Withdrawal by Subject|1|||
23338420|NCT01031836|64982990|FG000|Stage I|Adverse Event|1|||
23338421|NCT01031836|64982991|FG001|Stage I|Adverse Event|1|||
23338422|NCT01031836|64982992|FG002|Stage I|Adverse Event|0|||
23338423|NCT01031836|64982993|FG003|Stage I|Adverse Event|0|||
23338424|NCT01031836|64982994|FG004|Stage I|Adverse Event|0|||
23338425|NCT01031836|64982995|FG005|Stage I|Adverse Event|0|||
23338426|NCT01031836|64982990|FG000|Stage I|Other|0|||
23338427|NCT01031836|64982991|FG001|Stage I|Other|1|||
23338428|NCT01031836|64982992|FG002|Stage I|Other|0|||
23578031|NCT00813488|65846982|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
23578032|NCT00813488|65846983|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
23578033|NCT00813488|65846982|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
23578034|NCT00813488|65846983|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
23578035|NCT00813488|65846982|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
23578036|NCT00813488|65846983|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
23578037|NCT00813488|65846982|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
23578038|NCT00813488|65846983|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
23578039|NCT00813488|65846982|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
23578040|NCT00813488|65846983|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
23338429|NCT01031836|64982993|FG003|Stage I|Other|0|||
23450186|NCT01176032|65391436|FG000|Overall Study|Protocol Violation|1|||
23450187|NCT01176032|65391437|FG001|Overall Study|Protocol Violation|0|||
23450188|NCT01176032|65391436|FG000|Overall Study|Informed consent withdrawn|3|||
23450189|NCT01176032|65391437|FG001|Overall Study|Informed consent withdrawn|0|||
23338430|NCT01031836|64982994|FG004|Stage I|Other|0|||
23338431|NCT01031836|64982995|FG005|Stage I|Other|1|||
23338432|NCT01031836|64982990|FG000|Stage II|Adverse Event|0|||
23338433|NCT01031836|64982991|FG001|Stage II|Adverse Event|0|||
23450190|NCT01176032|65391436|FG000|Overall Study|Other|1|||
23578041|NCT00813488|65846982|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
23338434|NCT01031836|64982992|FG002|Stage II|Adverse Event|2|||
23338435|NCT01031836|64982993|FG003|Stage II|Adverse Event|2|||
23450191|NCT01176032|65391437|FG001|Overall Study|Other|0|||
23578042|NCT00813488|65846983|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
23338436|NCT01031836|64982994|FG004|Stage II|Adverse Event|1|||
23338437|NCT01031836|64982995|FG005|Stage II|Adverse Event|1|||
23338438|NCT01031836|64982990|FG000|Stage II|Other|2|||
23338439|NCT01031836|64982991|FG001|Stage II|Other|0|||
23338440|NCT01031836|64982992|FG002|Stage II|Other|0|||
23338441|NCT01031836|64982993|FG003|Stage II|Other|1|||
23450192|NCT02920892|65391438|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
23450193|NCT02920892|65391439|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
23450194|NCT02920892|65391440|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
23450195|NCT02920892|65391438|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
23450196|NCT02920892|65391439|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
23450197|NCT02920892|65391440|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
23450198|NCT02920892|65391438|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
23450199|NCT02920892|65391439|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
23450200|NCT02920892|65391440|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
23450201|NCT02920892|65391438|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
23450202|NCT02920892|65391439|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
23450203|NCT02920892|65391440|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
23450204|NCT02920892|65391438|FG000|Placebo-Controlled Period|Physician Decision|0|||
23450205|NCT02920892|65391439|FG001|Placebo-Controlled Period|Physician Decision|0|||
23450206|NCT02920892|65391440|FG002|Placebo-Controlled Period|Physician Decision|1|||
23450207|NCT02920892|65391438|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
23450208|NCT02920892|65391439|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
23450209|NCT02920892|65391440|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
23450210|NCT02920892|65391438|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
23450211|NCT02920892|65391439|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
23450212|NCT02920892|65391440|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
23450213|NCT02920892|65391438|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
23450214|NCT02920892|65391439|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
23450215|NCT02920892|65391440|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
23450216|NCT01759420|65391441|FG000|Overall Study|Screen failure|5|||
23450217|NCT01759420|65391441|FG000|Overall Study|Inaccurate EKG machine readings|1|||
23450218|NCT01631435|65391442|FG000|Overall Study|Adverse Event|2|||
23450219|NCT01631435|65391442|FG000|Overall Study|Withdrawal by Subject|2|||
23450220|NCT01631435|65391442|FG000|Overall Study|incomplete study procedure|5|||
23450221|NCT01100320|65391443|FG000|Period 1|Withdrawal by Subject|2|||
23450222|NCT01100320|65391444|FG001|Period 1|Withdrawal by Subject|4|||
23450223|NCT01100320|65391443|FG000|Period 1|Positive Drug Screen|1|||
23450224|NCT01100320|65391444|FG001|Period 1|Positive Drug Screen|1|||
23450225|NCT01100320|65391443|FG000|Period 1|Adverse Event|2|||
23450226|NCT01100320|65391444|FG001|Period 1|Adverse Event|2|||
23450227|NCT01100320|65391443|FG000|Period 2|Withdrawal by Subject|1|||
23450228|NCT01100320|65391444|FG001|Period 2|Withdrawal by Subject|1|||
23450229|NCT02542865|65391447|FG000|Overall Study|Identified as screen failure|1|||
23450230|NCT02542865|65391448|FG001|Overall Study|Identified as screen failure|0|||
23450231|NCT02542865|65391447|FG000|Overall Study|Withdrawal by Subject|16|||
23450232|NCT02542865|65391448|FG001|Overall Study|Withdrawal by Subject|0|||
23450233|NCT00604565|65391449|FG000|Overall Study|Study terminated|0|||
23450234|NCT00604565|65391450|FG001|Overall Study|Study terminated|3|||
23450235|NCT00556075|65391456|FG000|Overall Study|Lost to Follow-up|3|||
23450236|NCT00556075|65391457|FG001|Overall Study|Lost to Follow-up|0|||
23450237|NCT00556075|65391458|FG002|Overall Study|Lost to Follow-up|3|||
23450238|NCT00556075|65391456|FG000|Overall Study|Withdrawal by Subject|3|||
23450239|NCT00556075|65391457|FG001|Overall Study|Withdrawal by Subject|3|||
23450240|NCT00556075|65391458|FG002|Overall Study|Withdrawal by Subject|0|||
23450241|NCT00556075|65391456|FG000|Overall Study|Protocol Violation|1|||
23450242|NCT00556075|65391457|FG001|Overall Study|Protocol Violation|1|||
23450243|NCT00556075|65391458|FG002|Overall Study|Protocol Violation|3|||
23450244|NCT00556075|65391456|FG000|Overall Study|Not eligible|1|||
23450245|NCT00556075|65391457|FG001|Overall Study|Not eligible|1|||
23450246|NCT00556075|65391458|FG002|Overall Study|Not eligible|2|||
23450247|NCT00556075|65391456|FG000|Overall Study|Adverse Event|1|||
23450248|NCT00556075|65391457|FG001|Overall Study|Adverse Event|2|||
23450249|NCT00556075|65391458|FG002|Overall Study|Adverse Event|0|||
23450250|NCT00556075|65391456|FG000|Overall Study|Personal issues|4|||
23578043|NCT00813488|65846982|FG000|Double-blind Treatment Period 2|Other|1|||
23338442|NCT01031836|64982994|FG004|Stage II|Other|1|||
23338443|NCT01031836|64982995|FG005|Stage II|Other|0|||
23338444|NCT01270464|64983002|FG000|Overall Study|Protocol Violation|4|||
23450251|NCT00556075|65391457|FG001|Overall Study|Personal issues|1|||
23450252|NCT00556075|65391458|FG002|Overall Study|Personal issues|0|||
23450253|NCT00556075|65391456|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
23450254|NCT00556075|65391457|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
23450255|NCT00556075|65391458|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
23450256|NCT01255423|65391459|FG000|Overall Study|Abnormal Laboratory value|3|||
23450257|NCT01255423|65391460|FG001|Overall Study|Abnormal Laboratory value|2|||
23450258|NCT01255423|65391459|FG000|Overall Study|Use of prohibited medications|0|||
23450259|NCT01255423|65391460|FG001|Overall Study|Use of prohibited medications|1|||
23450260|NCT04864639|65391461|FG000|Overall Study|Death|1|||
23450261|NCT04864639|65391461|FG000|Overall Study|Lost to Follow-up|1|||
23578044|NCT00813488|65846983|FG001|Double-blind Treatment Period 2|Other|0|||
23450262|NCT04590014|65391463|FG000|Overall Study|Withdrawal by Subject|1|||
23450263|NCT04590014|65391464|FG001|Overall Study|Withdrawal by Subject|0|||
23450264|NCT01488045|65391470|FG000|Overall Study|Withdrawal by Subject|6|||
23450265|NCT01488045|65391471|FG001|Overall Study|Withdrawal by Subject|11|||
23450266|NCT01488045|65391470|FG000|Overall Study|Failure to present for colonoscopy|3|||
23450267|NCT01488045|65391471|FG001|Overall Study|Failure to present for colonoscopy|6|||
23450268|NCT01488045|65391470|FG000|Overall Study|Failure to report exclusion criteria|0|||
23450269|NCT01488045|65391471|FG001|Overall Study|Failure to report exclusion criteria|1|||
23450270|NCT00614575|65391474|FG000|Overall Study|Adverse Event|106|||
23450271|NCT00614575|65391474|FG000|Overall Study|Lost to Follow-up|55|||
23450272|NCT00614575|65391474|FG000|Overall Study|Lack of Efficacy|14|||
23450273|NCT00614575|65391474|FG000|Overall Study|Withdrawal by Subject|6|||
23450274|NCT00614575|65391474|FG000|Overall Study|Death|3|||
23450275|NCT00614575|65391474|FG000|Overall Study|Physician Decision|2|||
23450276|NCT00614575|65391474|FG000|Overall Study|No data were collected.|18|||
23450277|NCT00614575|65391474|FG000|Overall Study|Irregularly enrolled patients|23|||
23450278|NCT00614575|65391474|FG000|Overall Study|No treatment|1|||
23450279|NCT00681629|65391475|FG000|Overall Study|Study termination|4|||
23450280|NCT00681629|65391476|FG001|Overall Study|Study termination|2|||
23450281|NCT00681629|65391475|FG000|Overall Study|Adverse Event|1|||
23450282|NCT00681629|65391476|FG001|Overall Study|Adverse Event|0|||
23450283|NCT00614380|65391479|FG000|Overall Study|Adverse Event|14|||
23450284|NCT00614380|65391480|FG001|Overall Study|Adverse Event|4|||
23450285|NCT00614380|65391481|FG002|Overall Study|Adverse Event|0|||
23450286|NCT00614380|65391482|FG003|Overall Study|Adverse Event|0|||
23450287|NCT00614380|65391479|FG000|Overall Study|Lost to Follow-up|6|||
23450288|NCT00614380|65391480|FG001|Overall Study|Lost to Follow-up|1|||
23450289|NCT00614380|65391481|FG002|Overall Study|Lost to Follow-up|0|||
23450290|NCT00614380|65391482|FG003|Overall Study|Lost to Follow-up|0|||
23450291|NCT00614380|65391479|FG000|Overall Study|Non compliant with the protocol|12|||
23450292|NCT00614380|65391480|FG001|Overall Study|Non compliant with the protocol|2|||
23450293|NCT00614380|65391481|FG002|Overall Study|Non compliant with the protocol|1|||
23450294|NCT00614380|65391482|FG003|Overall Study|Non compliant with the protocol|2|||
23450295|NCT00614380|65391479|FG000|Overall Study|Consent withdrawn|3|||
23450296|NCT00614380|65391480|FG001|Overall Study|Consent withdrawn|1|||
23450297|NCT00614380|65391481|FG002|Overall Study|Consent withdrawn|0|||
23450298|NCT00614380|65391482|FG003|Overall Study|Consent withdrawn|0|||
23450299|NCT05135871|65391483|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
23450300|NCT05135871|65391484|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
23450301|NCT05135871|65391485|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
23450302|NCT05135871|65391486|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
23450303|NCT02519439|65391487|FG000|Overall Study|Study Termination|19|||
23450304|NCT02519439|65391487|FG000|Overall Study|Withdrawal by Subject|1|||
23450305|NCT02519439|65391487|FG000|Overall Study|Adverse Event|1|||
23450306|NCT04737278|65391494|FG000|Overall Study|Lost to Follow-up|1|||
23450307|NCT04737278|65391495|FG001|Overall Study|Lost to Follow-up|1|||
23450308|NCT04737278|65391494|FG000|Overall Study|Withdrawal by Subject|1|||
23450309|NCT04737278|65391495|FG001|Overall Study|Withdrawal by Subject|0|||
23450310|NCT04737278|65391494|FG000|Overall Study|Protocol Violation|1|||
23578045|NCT00813488|65846982|FG000|Open-label Extension|Adverse Event|1|||
23578046|NCT00813488|65846983|FG001|Open-label Extension|Adverse Event|2|||
23578047|NCT00813488|65846982|FG000|Open-label Extension|Lack of Efficacy|3|||
23578048|NCT00813488|65846983|FG001|Open-label Extension|Lack of Efficacy|0|||
23578049|NCT00813488|65846982|FG000|Open-label Extension|Withdrawal by Subject|0|||
23578050|NCT00813488|65846983|FG001|Open-label Extension|Withdrawal by Subject|2|||
23578051|NCT00813488|65846982|FG000|Open-label Extension|Protocol Violation|1|||
23578052|NCT00813488|65846983|FG001|Open-label Extension|Protocol Violation|2|||
23578053|NCT00813488|65846982|FG000|Open-label Extension|Non-compliance study medication|4|||
23578054|NCT00813488|65846983|FG001|Open-label Extension|Non-compliance study medication|0|||
23171249|NCT01463098|64371008|FG012|Part A (11 Days)|Participant Choice|0|||
23171250|NCT01463098|64371009|FG013|Part A (11 Days)|Participant Choice|0|||
23171251|NCT01463098|64370996|FG000|Part A (11 Days)|Lost to Follow-up|0|||
23450311|NCT04737278|65391495|FG001|Overall Study|Protocol Violation|1|||
23450312|NCT04737278|65391494|FG000|Overall Study|failure to complete questionnaire|1|||
23450313|NCT04737278|65391495|FG001|Overall Study|failure to complete questionnaire|1|||
23450314|NCT00531284|65391496|FG000|Overall Study|Progressive Disease|1|||
23450315|NCT00531284|65391497|FG001|Overall Study|Progressive Disease|3|||
23450316|NCT00531284|65391498|FG002|Overall Study|Progressive Disease|5|||
23450317|NCT00531284|65391499|FG003|Overall Study|Progressive Disease|42|||
23450318|NCT00531284|65391500|FG004|Overall Study|Progressive Disease|4|||
23450319|NCT00531284|65391501|FG005|Overall Study|Progressive Disease|4|||
23450320|NCT00531284|65391502|FG006|Overall Study|Progressive Disease|3|||
23450321|NCT00531284|65391503|FG007|Overall Study|Progressive Disease|8|||
23578055|NCT00813488|65846982|FG000|Open-label Extension|Non-compliance study procedures|2|||
23338445|NCT01270464|64983003|FG001|Overall Study|Protocol Violation|3|||
23338446|NCT01270464|64983004|FG002|Overall Study|Protocol Violation|2|||
23578056|NCT00813488|65846983|FG001|Open-label Extension|Non-compliance study procedures|1|||
23578057|NCT00813488|65846982|FG000|Open-label Extension|Other|1|||
23230505|NCT03330106|64588046|FG000|Part B|Death|0|||
23230506|NCT03330106|64588047|FG001|Part B|Death|0|||
23230507|NCT03330106|64588048|FG002|Part B|Death|2|||
23230508|NCT03330106|64588049|FG003|Part B|Death|0|||
23230509|NCT03330106|64588046|FG000|Part B|Clinical Progression|0|||
23338447|NCT01270464|64983002|FG000|Overall Study|Lack of Efficacy|2|||
23338448|NCT01270464|64983003|FG001|Overall Study|Lack of Efficacy|3|||
23338449|NCT01270464|64983004|FG002|Overall Study|Lack of Efficacy|1|||
23578058|NCT00813488|65846983|FG001|Open-label Extension|Other|0|||
23578059|NCT01719861|65846990|FG000|Cycle 1|Death|4|||
23578060|NCT01719861|65846990|FG000|Cycle 2|Death|1|||
23578061|NCT04714216|65846994|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
23578062|NCT04714216|65846994|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
23578063|NCT01543685|65846995|FG000|Overall Study|Lack of Efficacy|1|||
23578064|NCT01543685|65846996|FG001|Overall Study|Lack of Efficacy|2|||
23578065|NCT01543685|65846997|FG002|Overall Study|Lack of Efficacy|2|||
23578066|NCT01543685|65846998|FG003|Overall Study|Lack of Efficacy|0|||
23578067|NCT01543685|65846999|FG004|Overall Study|Lack of Efficacy|2|||
23578068|NCT01543685|65846995|FG000|Overall Study|Adverse Event|2|||
23578069|NCT01543685|65846996|FG001|Overall Study|Adverse Event|1|||
23578070|NCT01543685|65846997|FG002|Overall Study|Adverse Event|0|||
23578071|NCT01543685|65846998|FG003|Overall Study|Adverse Event|0|||
23578072|NCT01543685|65846999|FG004|Overall Study|Adverse Event|2|||
23171252|NCT01463098|64370997|FG001|Part A (11 Days)|Lost to Follow-up|0|||
23171253|NCT01463098|64370998|FG002|Part A (11 Days)|Lost to Follow-up|0|||
23171254|NCT01463098|64370999|FG003|Part A (11 Days)|Lost to Follow-up|0|||
23171255|NCT01463098|64371000|FG004|Part A (11 Days)|Lost to Follow-up|1|||
23338450|NCT01270464|64983002|FG000|Overall Study|Adverse Event|9|||
23338451|NCT01270464|64983003|FG001|Overall Study|Adverse Event|1|||
23338452|NCT01270464|64983004|FG002|Overall Study|Adverse Event|7|||
23338453|NCT01270464|64983002|FG000|Overall Study|Withdrawal by Subject|2|||
23338454|NCT01270464|64983003|FG001|Overall Study|Withdrawal by Subject|1|||
23338455|NCT01270464|64983004|FG002|Overall Study|Withdrawal by Subject|4|||
23338456|NCT01270464|64983002|FG000|Overall Study|Lost to Follow-up|2|||
23338457|NCT01270464|64983003|FG001|Overall Study|Lost to Follow-up|3|||
23338458|NCT01270464|64983004|FG002|Overall Study|Lost to Follow-up|1|||
23338459|NCT01270464|64983002|FG000|Overall Study|Other|1|||
23338460|NCT01270464|64983003|FG001|Overall Study|Other|1|||
23338461|NCT01270464|64983004|FG002|Overall Study|Other|3|||
23338462|NCT00814333|64983005|FG000|Enrollment|Lost to Follow-up|1|||
23338463|NCT00814333|64983006|FG001|Enrollment|Lost to Follow-up|0|||
23338464|NCT00601172|64983019|FG000|Overall Study|Adverse Event|43|||
23338465|NCT00601172|64983020|FG001|Overall Study|Adverse Event|32|||
23338466|NCT00601172|64983019|FG000|Overall Study|Lack of Efficacy|11|||
23338467|NCT00601172|64983020|FG001|Overall Study|Lack of Efficacy|12|||
23171256|NCT01463098|64371001|FG005|Part A (11 Days)|Lost to Follow-up|0|||
23171257|NCT01463098|64371002|FG006|Part A (11 Days)|Lost to Follow-up|0|||
23171258|NCT01463098|64371003|FG007|Part A (11 Days)|Lost to Follow-up|0|||
23171259|NCT01463098|64371004|FG008|Part A (11 Days)|Lost to Follow-up|0|||
23171260|NCT01463098|64371005|FG009|Part A (11 Days)|Lost to Follow-up|0|||
23171261|NCT01463098|64371006|FG010|Part A (11 Days)|Lost to Follow-up|0|||
23171262|NCT01463098|64371007|FG011|Part A (11 Days)|Lost to Follow-up|0|||
23171263|NCT01463098|64371008|FG012|Part A (11 Days)|Lost to Follow-up|0|||
23171264|NCT01463098|64371009|FG013|Part A (11 Days)|Lost to Follow-up|0|||
23171265|NCT01463098|64370996|FG000|Part B (11 Days)|Participant Choice|0|||
23171266|NCT01463098|64370997|FG001|Part B (11 Days)|Participant Choice|0|||
23171267|NCT01463098|64370998|FG002|Part B (11 Days)|Participant Choice|0|||
23171268|NCT01463098|64370999|FG003|Part B (11 Days)|Participant Choice|0|||
23171269|NCT01463098|64371000|FG004|Part B (11 Days)|Participant Choice|0|||
23338468|NCT00601172|64983019|FG000|Overall Study|Protocol Violation|2|||
23578073|NCT04822298|65847000|FG000|Overall Study|Death|3|||
23578074|NCT03759366|65847001|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
23578075|NCT03759366|65847001|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
23578076|NCT01636362|65847002|FG000|Overall Study|Physician Decision|6|||
23578077|NCT01636362|65847002|FG000|Overall Study|Subject healed, not returning|1|||
23171270|NCT01463098|64371001|FG005|Part B (11 Days)|Participant Choice|0|||
23171271|NCT01463098|64371002|FG006|Part B (11 Days)|Participant Choice|0|||
23171272|NCT01463098|64371003|FG007|Part B (11 Days)|Participant Choice|0|||
23171273|NCT01463098|64371004|FG008|Part B (11 Days)|Participant Choice|0|||
23171274|NCT01463098|64371005|FG009|Part B (11 Days)|Participant Choice|0|||
23230510|NCT03330106|64588047|FG001|Part B|Clinical Progression|0|||
23230511|NCT03330106|64588048|FG002|Part B|Clinical Progression|1|||
23338469|NCT00601172|64983020|FG001|Overall Study|Protocol Violation|5|||
23338470|NCT00601172|64983019|FG000|Overall Study|Lost to Follow-up|4|||
23338471|NCT00601172|64983020|FG001|Overall Study|Lost to Follow-up|3|||
23338472|NCT00601172|64983019|FG000|Overall Study|Physician Decision|27|||
23338473|NCT00601172|64983020|FG001|Overall Study|Physician Decision|28|||
23338474|NCT00601172|64983019|FG000|Overall Study|Withdrawal by Subject|35|||
23338475|NCT00601172|64983020|FG001|Overall Study|Withdrawal by Subject|27|||
23338476|NCT00601172|64983019|FG000|Overall Study|Did not meet continuation criteria|19|||
23338477|NCT00601172|64983020|FG001|Overall Study|Did not meet continuation criteria|20|||
23338478|NCT01684423|64983022|FG000|Overall Study|Withdrawal by Subject|0|||
23171275|NCT01463098|64371006|FG010|Part B (11 Days)|Participant Choice|0|||
23171276|NCT01463098|64371007|FG011|Part B (11 Days)|Participant Choice|1|||
23171277|NCT01463098|64371008|FG012|Part B (11 Days)|Participant Choice|0|||
23171278|NCT01463098|64371009|FG013|Part B (11 Days)|Participant Choice|0|||
23171279|NCT03847610|64371013|FG000|Overall Study|Withdrawal by Subject|1|||
23171280|NCT03107793|64371014|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
23171281|NCT03107793|64371015|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
23171282|NCT03107793|64371016|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
23171283|NCT03107793|64371017|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
23171284|NCT03107793|64371018|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
23171285|NCT03107793|64371014|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
23171286|NCT03107793|64371015|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
23171287|NCT03107793|64371016|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
23171288|NCT03107793|64371017|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
23171289|NCT03107793|64371018|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
23338479|NCT01684423|64983023|FG001|Overall Study|Withdrawal by Subject|0|||
23338480|NCT01684423|64983024|FG002|Overall Study|Withdrawal by Subject|1|||
23338481|NCT01684423|64983025|FG003|Overall Study|Withdrawal by Subject|0|||
23338482|NCT01684423|64983026|FG004|Overall Study|Withdrawal by Subject|0|||
23338483|NCT02135107|64983027|FG000|Treatment Period|Withdrawal by Subject|11|||
23338484|NCT02135107|64983028|FG001|Treatment Period|Withdrawal by Subject|0|||
23338485|NCT02135107|64983029|FG002|Treatment Period|Withdrawal by Subject|0|||
23338486|NCT02135107|64983030|FG003|Treatment Period|Withdrawal by Subject|0|||
23338487|NCT02135107|64983027|FG000|Treatment Period|Adverse Event|5|||
23338488|NCT02135107|64983028|FG001|Treatment Period|Adverse Event|2|||
23338489|NCT02135107|64983029|FG002|Treatment Period|Adverse Event|0|||
23450322|NCT00531284|65391504|FG008|Overall Study|Progressive Disease|6|||
23578078|NCT01636362|65847002|FG000|Overall Study|Withdrawal by Subject|1|||
23171290|NCT03107793|64371014|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
23171291|NCT03107793|64371015|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
23171292|NCT03107793|64371016|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
23171293|NCT03107793|64371017|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
23338490|NCT02135107|64983030|FG003|Treatment Period|Adverse Event|0|||
23338491|NCT02135107|64983027|FG000|Treatment Period|Pregnancy|1|||
23450323|NCT00531284|65391505|FG009|Overall Study|Progressive Disease|3|||
23578079|NCT03459729|65847004|FG000|Overall Study|Physician Decision|2|||
23578080|NCT02081391|65847005|FG000|12-hour Treatment|Withdrawal by Subject|3|||
23578081|NCT02081391|65847006|FG001|12-hour Treatment|Withdrawal by Subject|2|||
23578082|NCT02081391|65847007|FG002|12-hour Treatment|Withdrawal by Subject|0|||
23578083|NCT02081391|65847008|FG003|12-hour Treatment|Withdrawal by Subject|0|||
23578084|NCT02081391|65847005|FG000|12-hour Treatment|Physician Decision|4|||
23578085|NCT02081391|65847006|FG001|12-hour Treatment|Physician Decision|1|||
23578086|NCT02081391|65847007|FG002|12-hour Treatment|Physician Decision|0|||
23578087|NCT02081391|65847008|FG003|12-hour Treatment|Physician Decision|0|||
23578088|NCT02081391|65847005|FG000|12-hour Treatment|Lack of Efficacy|3|||
23578089|NCT02081391|65847006|FG001|12-hour Treatment|Lack of Efficacy|0|||
23578090|NCT02081391|65847007|FG002|12-hour Treatment|Lack of Efficacy|0|||
23578091|NCT02081391|65847008|FG003|12-hour Treatment|Lack of Efficacy|0|||
23578092|NCT02081391|65847005|FG000|12-hour Treatment|Adverse Event|4|||
23578093|NCT02081391|65847006|FG001|12-hour Treatment|Adverse Event|2|||
23578094|NCT02081391|65847007|FG002|12-hour Treatment|Adverse Event|0|||
23578095|NCT02081391|65847008|FG003|12-hour Treatment|Adverse Event|0|||
23578096|NCT02081391|65847005|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
23578097|NCT02081391|65847006|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
23578098|NCT02081391|65847007|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
23578099|NCT02081391|65847008|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
23578100|NCT02081391|65847005|FG000|12-hour Treatment|Further reasons|2|||
23578101|NCT02081391|65847006|FG001|12-hour Treatment|Further reasons|1|||
23578102|NCT02081391|65847007|FG002|12-hour Treatment|Further reasons|0|||
23171294|NCT03107793|64371018|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
23338492|NCT02135107|64983028|FG001|Treatment Period|Pregnancy|0|||
23338493|NCT02135107|64983029|FG002|Treatment Period|Pregnancy|0|||
23578103|NCT02081391|65847008|FG003|12-hour Treatment|Further reasons|0|||
23578104|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
23338494|NCT02135107|64983030|FG003|Treatment Period|Pregnancy|0|||
23230512|NCT03330106|64588049|FG003|Part B|Clinical Progression|1|||
23230513|NCT03330106|64588046|FG000|Part B|Symptomatic Deterioration|0|||
23230514|NCT03330106|64588047|FG001|Part B|Symptomatic Deterioration|0|||
23230515|NCT03330106|64588048|FG002|Part B|Symptomatic Deterioration|0|||
23338495|NCT02135107|64983027|FG000|Treatment Period|Other|115|||
23338496|NCT02135107|64983028|FG001|Treatment Period|Other|24|||
23338497|NCT02135107|64983029|FG002|Treatment Period|Other|0|||
23338498|NCT02135107|64983030|FG003|Treatment Period|Other|0|||
23450324|NCT00531284|65391506|FG010|Overall Study|Progressive Disease|3|||
23450325|NCT00531284|65391507|FG011|Overall Study|Progressive Disease|14|||
23450326|NCT00531284|65391508|FG012|Overall Study|Progressive Disease|2|||
23450327|NCT00531284|65391509|FG013|Overall Study|Progressive Disease|1|||
23338499|NCT02135107|64983027|FG000|Maintenance Therapy Period|Adverse Event|0|||
23338500|NCT02135107|64983028|FG001|Maintenance Therapy Period|Adverse Event|0|||
23338501|NCT02135107|64983029|FG002|Maintenance Therapy Period|Adverse Event|3|||
23338502|NCT02135107|64983030|FG003|Maintenance Therapy Period|Adverse Event|7|||
23338503|NCT02135107|64983027|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
23338504|NCT02135107|64983028|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
23338505|NCT02135107|64983029|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
23338506|NCT02135107|64983030|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
23338507|NCT02135107|64983027|FG000|Maintenance Therapy Period|Pregnancy|0|||
23338508|NCT02135107|64983028|FG001|Maintenance Therapy Period|Pregnancy|0|||
23338509|NCT02135107|64983029|FG002|Maintenance Therapy Period|Pregnancy|0|||
23338510|NCT02135107|64983030|FG003|Maintenance Therapy Period|Pregnancy|1|||
23338511|NCT02135107|64983027|FG000|Maintenance Therapy Period|Other|0|||
23338512|NCT02135107|64983028|FG001|Maintenance Therapy Period|Other|0|||
23338513|NCT02135107|64983029|FG002|Maintenance Therapy Period|Other|7|||
23338514|NCT02135107|64983030|FG003|Maintenance Therapy Period|Other|8|||
23338515|NCT00507728|64983031|FG000|Randomization to Month 3|Lost to Follow-up|15|||
23338516|NCT00507728|64983032|FG001|Randomization to Month 3|Lost to Follow-up|14|||
23338517|NCT00507728|64983033|FG002|Randomization to Month 3|Lost to Follow-up|20|||
23338518|NCT00507728|64983031|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
23338519|NCT00507728|64983032|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
23338520|NCT00507728|64983033|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
23338521|NCT01769508|64983035|FG000|Overall Study|Death|3|||
23338522|NCT01769508|64983035|FG000|Overall Study|Withdrawal by Subject|1|||
23338523|NCT01769508|64983035|FG000|Overall Study|Adverse Event|1|||
23338524|NCT01769508|64983035|FG000|Overall Study|Lost to Follow-up|1|||
23338525|NCT00803790|64983038|FG000|Period 1|Adverse Event|0|||
23338526|NCT00803790|64983039|FG001|Period 1|Adverse Event|1|||
23338527|NCT00803790|64983040|FG002|Period 1|Adverse Event|0|||
23338528|NCT00803790|64983041|FG003|Period 1|Adverse Event|0|||
23338529|NCT00803790|64983038|FG000|Period 1|Lost to Follow-up|1|||
23338530|NCT00803790|64983039|FG001|Period 1|Lost to Follow-up|2|||
23338531|NCT00803790|64983040|FG002|Period 1|Lost to Follow-up|0|||
23338532|NCT00803790|64983041|FG003|Period 1|Lost to Follow-up|0|||
23338533|NCT00803790|64983038|FG000|Period 1|Withdrawal by Subject|8|||
23338534|NCT00803790|64983039|FG001|Period 1|Withdrawal by Subject|6|||
23338535|NCT00803790|64983040|FG002|Period 1|Withdrawal by Subject|0|||
23338536|NCT00803790|64983041|FG003|Period 1|Withdrawal by Subject|0|||
23338537|NCT00803790|64983038|FG000|Period 1|positive drug screen or personal reasons|0|||
23338538|NCT00803790|64983039|FG001|Period 1|positive drug screen or personal reasons|3|||
23450328|NCT00531284|65391510|FG014|Overall Study|Progressive Disease|2|||
23450329|NCT00531284|65391511|FG015|Overall Study|Progressive Disease|11|||
23230516|NCT03330106|64588049|FG003|Part B|Symptomatic Deterioration|1|||
23230517|NCT03330106|64588046|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
23338539|NCT00803790|64983040|FG002|Period 1|positive drug screen or personal reasons|0|||
23338540|NCT00803790|64983041|FG003|Period 1|positive drug screen or personal reasons|4|||
23338541|NCT00803790|64983038|FG000|Period 1|Protocol Violation|0|||
23338542|NCT00803790|64983039|FG001|Period 1|Protocol Violation|0|||
23338543|NCT00803790|64983040|FG002|Period 1|Protocol Violation|1|||
23450330|NCT00531284|65391512|FG016|Overall Study|Progressive Disease|5|||
23230518|NCT03330106|64588047|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
23230519|NCT03330106|64588048|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
23230520|NCT03330106|64588049|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
23230521|NCT03330106|64588046|FG000|Part B|Progressive Disease|0|||
23230522|NCT03330106|64588047|FG001|Part B|Progressive Disease|0|||
23230523|NCT03330106|64588048|FG002|Part B|Progressive Disease|11|||
23230524|NCT03330106|64588049|FG003|Part B|Progressive Disease|4|||
23230525|NCT00735072|64588056|FG000|Overall Study|interrupted study med during ARV change|1|||
23230526|NCT00735072|64588057|FG001|Overall Study|interrupted study med during ARV change|0|||
23450331|NCT00531284|65391496|FG000|Overall Study|Adverse Event|0|||
23450332|NCT00531284|65391497|FG001|Overall Study|Adverse Event|1|||
23450333|NCT00531284|65391498|FG002|Overall Study|Adverse Event|1|||
23450334|NCT00531284|65391499|FG003|Overall Study|Adverse Event|7|||
23450335|NCT00531284|65391500|FG004|Overall Study|Adverse Event|0|||
23450336|NCT00531284|65391501|FG005|Overall Study|Adverse Event|2|||
23450337|NCT00531284|65391502|FG006|Overall Study|Adverse Event|3|||
23230527|NCT00735072|64588056|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
23230528|NCT00735072|64588057|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
23230529|NCT01077193|64588064|FG000|Overall Study|Lost to Follow-up|1|||
23230530|NCT01077193|64588064|FG000|Overall Study|Withdrawal by Subject|2|||
23230531|NCT01077193|64588064|FG000|Overall Study|Lack of Efficacy|1|||
23230532|NCT01077193|64588064|FG000|Overall Study|Study Terminated by Sponsor|40|||
23230533|NCT03969589|64588065|FG000|Overall Study|Lost to Follow-up|3|||
23230534|NCT03969589|64588066|FG001|Overall Study|Lost to Follow-up|2|||
23230535|NCT03969589|64588065|FG000|Overall Study|Declined Follow-Up|0|||
23230536|NCT03969589|64588066|FG001|Overall Study|Declined Follow-Up|1|||
23230537|NCT03500419|64588067|FG000|Overall Study|Withdrawal by Subject|2|||
23230538|NCT03500419|64588068|FG001|Overall Study|Withdrawal by Subject|25|||
23230539|NCT02394028|64588069|FG000|Induction Phase|Adverse Event|2|||
23338544|NCT00803790|64983041|FG003|Period 1|Protocol Violation|0|||
23450338|NCT00531284|65391503|FG007|Overall Study|Adverse Event|2|||
23338545|NCT00803790|64983038|FG000|Period 2|Adverse Event|0|||
23338546|NCT00803790|64983039|FG001|Period 2|Adverse Event|0|||
23578105|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
23578106|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
23578107|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
23578108|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
23578109|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
23578110|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
23578111|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
23578112|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
23578113|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
23578114|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
23578115|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
23578116|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
23578117|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
23578118|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
23578119|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
23578120|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
23578121|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
23578122|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
23578123|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
23578124|NCT02081391|65847005|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
23578125|NCT02081391|65847006|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
23578126|NCT02081391|65847007|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
23578127|NCT02081391|65847008|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
23230540|NCT02394028|64588070|FG001|Induction Phase|Adverse Event|4|||
23230541|NCT02394028|64588071|FG002|Induction Phase|Adverse Event|1|||
23450339|NCT00531284|65391504|FG008|Overall Study|Adverse Event|3|||
23578128|NCT02531438|65847009|FG000|Overall Study|Adverse Event|7|||
23578129|NCT02531438|65847010|FG001|Overall Study|Adverse Event|9|||
23338547|NCT00803790|64983040|FG002|Period 2|Adverse Event|1|||
23450340|NCT00531284|65391505|FG009|Overall Study|Adverse Event|0|||
23230542|NCT02394028|64588072|FG003|Induction Phase|Adverse Event|2|||
23230543|NCT02394028|64588073|FG004|Induction Phase|Adverse Event|5|||
23338548|NCT00803790|64983041|FG003|Period 2|Adverse Event|1|||
23338549|NCT00803790|64983038|FG000|Period 2|Withdrawal by Subject|1|||
23338550|NCT00803790|64983039|FG001|Period 2|Withdrawal by Subject|0|||
23338551|NCT00803790|64983040|FG002|Period 2|Withdrawal by Subject|0|||
23338552|NCT00803790|64983041|FG003|Period 2|Withdrawal by Subject|0|||
23338553|NCT00803790|64983038|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
23171295|NCT03107793|64371014|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
23171296|NCT03107793|64371015|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23171297|NCT03107793|64371016|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23171298|NCT03107793|64371017|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23171299|NCT03107793|64371018|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23171300|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23171301|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
23171302|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
23171303|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23171304|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
23171305|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23171306|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
23338554|NCT00803790|64983039|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
23338555|NCT00803790|64983040|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
23450341|NCT00531284|65391506|FG010|Overall Study|Adverse Event|0|||
23578130|NCT02531438|65847009|FG000|Overall Study|Lost to Follow-up|0|||
23578131|NCT02531438|65847010|FG001|Overall Study|Lost to Follow-up|3|||
23578132|NCT02531438|65847009|FG000|Overall Study|Withdrawal by Subject|7|||
23578133|NCT02531438|65847010|FG001|Overall Study|Withdrawal by Subject|8|||
23578134|NCT02531438|65847009|FG000|Overall Study|Physician Decision|0|||
23578135|NCT02531438|65847010|FG001|Overall Study|Physician Decision|1|||
23578136|NCT02531438|65847009|FG000|Overall Study|Death|6|||
23578137|NCT02531438|65847010|FG001|Overall Study|Death|3|||
23578138|NCT02531438|65847009|FG000|Overall Study|Randomized, but Not Treated|4|||
23578139|NCT02531438|65847010|FG001|Overall Study|Randomized, but Not Treated|0|||
23578140|NCT02531438|65847009|FG000|Overall Study|Missed EOT/PTE Visit|5|||
23578141|NCT02531438|65847010|FG001|Overall Study|Missed EOT/PTE Visit|2|||
23578142|NCT02531438|65847009|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
23578143|NCT02531438|65847010|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
23578144|NCT01866917|65847013|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
23578145|NCT01866917|65847014|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
23578146|NCT00031447|65847035|FG000|Overall Study|Lost to Follow-up|0|||
23171307|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
23171308|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23171309|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
23171310|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
23171311|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
23171312|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
23171313|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
23171314|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
23171315|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23171316|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
23171317|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
23171318|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23171319|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
23171320|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
23171321|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
23171322|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
23171323|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
23171324|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
23171325|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
23171326|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
23171327|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
23171328|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
23171329|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
23171330|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23171331|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
23171332|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23171333|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23171334|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
23171335|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
23171336|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
23171337|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
23171338|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
23171339|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
23171340|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
23171341|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
23171342|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
23171343|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
23171344|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
23171345|NCT03107793|64371014|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23171346|NCT03107793|64371015|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
23171347|NCT03107793|64371016|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
23171348|NCT03107793|64371017|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23171349|NCT03107793|64371018|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
23171350|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
23171351|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
23171352|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
23171353|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
23171354|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
23578147|NCT00031447|65847036|FG001|Overall Study|Lost to Follow-up|1|||
23578148|NCT00031447|65847035|FG000|Overall Study|Non-compliant|1|||
23578149|NCT00031447|65847036|FG001|Overall Study|Non-compliant|1|||
23230544|NCT02394028|64588074|FG005|Induction Phase|Adverse Event|2|||
23230545|NCT02394028|64588075|FG006|Induction Phase|Adverse Event|0|||
23230546|NCT02394028|64588076|FG007|Induction Phase|Adverse Event|0|||
23230547|NCT02394028|64588077|FG008|Induction Phase|Adverse Event|0|||
23230548|NCT02394028|64588078|FG009|Induction Phase|Adverse Event|0|||
23230549|NCT02394028|64588079|FG010|Induction Phase|Adverse Event|0|||
23230550|NCT02394028|64588069|FG000|Induction Phase|Lack of Efficacy|3|||
23230551|NCT02394028|64588070|FG001|Induction Phase|Lack of Efficacy|6|||
23230552|NCT02394028|64588071|FG002|Induction Phase|Lack of Efficacy|2|||
23230553|NCT02394028|64588072|FG003|Induction Phase|Lack of Efficacy|17|||
23230554|NCT02394028|64588073|FG004|Induction Phase|Lack of Efficacy|14|||
23230555|NCT02394028|64588074|FG005|Induction Phase|Lack of Efficacy|8|||
23230556|NCT02394028|64588075|FG006|Induction Phase|Lack of Efficacy|17|||
23230557|NCT02394028|64588076|FG007|Induction Phase|Lack of Efficacy|23|||
23578150|NCT00031447|65847035|FG000|Overall Study|Re-activation of Disease|2|||
23578151|NCT00031447|65847036|FG001|Overall Study|Re-activation of Disease|1|||
23230558|NCT02394028|64588077|FG008|Induction Phase|Lack of Efficacy|0|||
23230559|NCT02394028|64588078|FG009|Induction Phase|Lack of Efficacy|0|||
23230560|NCT02394028|64588079|FG010|Induction Phase|Lack of Efficacy|0|||
23230561|NCT02394028|64588069|FG000|Induction Phase|Lost to Follow-up|1|||
23230562|NCT02394028|64588070|FG001|Induction Phase|Lost to Follow-up|0|||
23230563|NCT02394028|64588071|FG002|Induction Phase|Lost to Follow-up|0|||
23230564|NCT02394028|64588072|FG003|Induction Phase|Lost to Follow-up|1|||
23230565|NCT02394028|64588073|FG004|Induction Phase|Lost to Follow-up|0|||
23230566|NCT02394028|64588074|FG005|Induction Phase|Lost to Follow-up|0|||
23230567|NCT02394028|64588075|FG006|Induction Phase|Lost to Follow-up|1|||
23230568|NCT02394028|64588076|FG007|Induction Phase|Lost to Follow-up|0|||
23230569|NCT02394028|64588077|FG008|Induction Phase|Lost to Follow-up|0|||
23230570|NCT02394028|64588078|FG009|Induction Phase|Lost to Follow-up|0|||
23230571|NCT02394028|64588079|FG010|Induction Phase|Lost to Follow-up|0|||
23230572|NCT02394028|64588069|FG000|Induction Phase|Non-compliance|0|||
23230573|NCT02394028|64588070|FG001|Induction Phase|Non-compliance|1|||
23230574|NCT02394028|64588071|FG002|Induction Phase|Non-compliance|3|||
23230575|NCT02394028|64588072|FG003|Induction Phase|Non-compliance|1|||
23230576|NCT02394028|64588073|FG004|Induction Phase|Non-compliance|3|||
23230577|NCT02394028|64588074|FG005|Induction Phase|Non-compliance|0|||
23230578|NCT02394028|64588075|FG006|Induction Phase|Non-compliance|1|||
23230579|NCT02394028|64588076|FG007|Induction Phase|Non-compliance|1|||
23230580|NCT02394028|64588077|FG008|Induction Phase|Non-compliance|0|||
23230581|NCT02394028|64588078|FG009|Induction Phase|Non-compliance|0|||
23230582|NCT02394028|64588079|FG010|Induction Phase|Non-compliance|0|||
23230583|NCT02394028|64588069|FG000|Induction Phase|Physician Decision|0|||
23230584|NCT02394028|64588070|FG001|Induction Phase|Physician Decision|0|||
23230585|NCT02394028|64588071|FG002|Induction Phase|Physician Decision|1|||
23230586|NCT02394028|64588072|FG003|Induction Phase|Physician Decision|4|||
23578152|NCT00031447|65847035|FG000|Overall Study|Disruption of blinded study drug supply|7|||
23230587|NCT02394028|64588073|FG004|Induction Phase|Physician Decision|0|||
23230588|NCT02394028|64588074|FG005|Induction Phase|Physician Decision|2|||
23230589|NCT02394028|64588075|FG006|Induction Phase|Physician Decision|1|||
23230590|NCT02394028|64588076|FG007|Induction Phase|Physician Decision|0|||
23230591|NCT02394028|64588077|FG008|Induction Phase|Physician Decision|0|||
23230592|NCT02394028|64588078|FG009|Induction Phase|Physician Decision|0|||
23230593|NCT02394028|64588079|FG010|Induction Phase|Physician Decision|0|||
23230594|NCT02394028|64588069|FG000|Induction Phase|Protocol Violation|0|||
23230595|NCT02394028|64588070|FG001|Induction Phase|Protocol Violation|2|||
23230596|NCT02394028|64588071|FG002|Induction Phase|Protocol Violation|0|||
23230597|NCT02394028|64588072|FG003|Induction Phase|Protocol Violation|3|||
23230598|NCT02394028|64588073|FG004|Induction Phase|Protocol Violation|0|||
23230599|NCT02394028|64588074|FG005|Induction Phase|Protocol Violation|1|||
23578153|NCT00031447|65847036|FG001|Overall Study|Disruption of blinded study drug supply|4|||
23230600|NCT02394028|64588075|FG006|Induction Phase|Protocol Violation|1|||
23230601|NCT02394028|64588076|FG007|Induction Phase|Protocol Violation|0|||
23230602|NCT02394028|64588077|FG008|Induction Phase|Protocol Violation|0|||
23230603|NCT02394028|64588078|FG009|Induction Phase|Protocol Violation|0|||
23450342|NCT00531284|65391507|FG011|Overall Study|Adverse Event|5|||
23450343|NCT00531284|65391508|FG012|Overall Study|Adverse Event|0|||
23230604|NCT02394028|64588079|FG010|Induction Phase|Protocol Violation|0|||
23450344|NCT00531284|65391509|FG013|Overall Study|Adverse Event|1|||
23450345|NCT00531284|65391510|FG014|Overall Study|Adverse Event|1|||
23230605|NCT02394028|64588069|FG000|Induction Phase|Withdrawal by Subject|1|||
23230606|NCT02394028|64588070|FG001|Induction Phase|Withdrawal by Subject|2|||
23230607|NCT02394028|64588071|FG002|Induction Phase|Withdrawal by Subject|4|||
23230608|NCT02394028|64588072|FG003|Induction Phase|Withdrawal by Subject|6|||
23230609|NCT02394028|64588073|FG004|Induction Phase|Withdrawal by Subject|7|||
23230610|NCT02394028|64588074|FG005|Induction Phase|Withdrawal by Subject|4|||
23230611|NCT02394028|64588075|FG006|Induction Phase|Withdrawal by Subject|3|||
23230612|NCT02394028|64588076|FG007|Induction Phase|Withdrawal by Subject|6|||
23450346|NCT00531284|65391511|FG015|Overall Study|Adverse Event|0|||
23230613|NCT02394028|64588077|FG008|Induction Phase|Withdrawal by Subject|0|||
23230614|NCT02394028|64588078|FG009|Induction Phase|Withdrawal by Subject|0|||
23230615|NCT02394028|64588079|FG010|Induction Phase|Withdrawal by Subject|0|||
23230616|NCT02394028|64588069|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230617|NCT02394028|64588070|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230618|NCT02394028|64588071|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230619|NCT02394028|64588072|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230620|NCT02394028|64588073|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230621|NCT02394028|64588074|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230622|NCT02394028|64588075|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
23230623|NCT02394028|64588076|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230624|NCT02394028|64588077|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230625|NCT02394028|64588078|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230626|NCT02394028|64588079|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
23230627|NCT02394028|64588069|FG000|Induction Phase|Sponsor decision|0|||
23230628|NCT02394028|64588070|FG001|Induction Phase|Sponsor decision|1|||
23230629|NCT02394028|64588071|FG002|Induction Phase|Sponsor decision|2|||
23230630|NCT02394028|64588072|FG003|Induction Phase|Sponsor decision|0|||
23230631|NCT02394028|64588073|FG004|Induction Phase|Sponsor decision|0|||
23578154|NCT02300311|65847037|FG000|Overall Study|Other than the reason specified|1|||
23578155|NCT02300311|65847038|FG001|Overall Study|Other than the reason specified|0|||
23230632|NCT02394028|64588074|FG005|Induction Phase|Sponsor decision|0|||
23230633|NCT02394028|64588075|FG006|Induction Phase|Sponsor decision|0|||
23230634|NCT02394028|64588076|FG007|Induction Phase|Sponsor decision|0|||
23230635|NCT02394028|64588077|FG008|Induction Phase|Sponsor decision|0|||
23230636|NCT02394028|64588078|FG009|Induction Phase|Sponsor decision|0|||
23230637|NCT02394028|64588079|FG010|Induction Phase|Sponsor decision|0|||
23230638|NCT02394028|64588069|FG000|Induction Phase|Technical reason|0|||
23230639|NCT02394028|64588070|FG001|Induction Phase|Technical reason|0|||
23230640|NCT02394028|64588071|FG002|Induction Phase|Technical reason|0|||
23230641|NCT02394028|64588072|FG003|Induction Phase|Technical reason|1|||
23230642|NCT02394028|64588073|FG004|Induction Phase|Technical reason|0|||
23230643|NCT02394028|64588074|FG005|Induction Phase|Technical reason|0|||
23230644|NCT02394028|64588075|FG006|Induction Phase|Technical reason|0|||
23230645|NCT02394028|64588076|FG007|Induction Phase|Technical reason|0|||
23230646|NCT02394028|64588077|FG008|Induction Phase|Technical reason|0|||
23230647|NCT02394028|64588078|FG009|Induction Phase|Technical reason|0|||
23230648|NCT02394028|64588079|FG010|Induction Phase|Technical reason|0|||
23230649|NCT02394028|64588069|FG000|Induction Phase|:ack of calculation|0|||
23230650|NCT02394028|64588070|FG001|Induction Phase|:ack of calculation|0|||
23230651|NCT02394028|64588071|FG002|Induction Phase|:ack of calculation|0|||
23230652|NCT02394028|64588072|FG003|Induction Phase|:ack of calculation|0|||
23230653|NCT02394028|64588073|FG004|Induction Phase|:ack of calculation|0|||
23230654|NCT02394028|64588074|FG005|Induction Phase|:ack of calculation|0|||
23230655|NCT02394028|64588075|FG006|Induction Phase|:ack of calculation|0|||
23230656|NCT02394028|64588076|FG007|Induction Phase|:ack of calculation|1|||
23230657|NCT02394028|64588077|FG008|Induction Phase|:ack of calculation|0|||
23230658|NCT02394028|64588078|FG009|Induction Phase|:ack of calculation|0|||
23230659|NCT02394028|64588079|FG010|Induction Phase|:ack of calculation|0|||
23230660|NCT02394028|64588069|FG000|Maintenance Phase|Protocol Violation|0|||
23230661|NCT02394028|64588070|FG001|Maintenance Phase|Protocol Violation|0|||
23230662|NCT02394028|64588071|FG002|Maintenance Phase|Protocol Violation|0|||
23230663|NCT02394028|64588072|FG003|Maintenance Phase|Protocol Violation|0|||
23230664|NCT02394028|64588073|FG004|Maintenance Phase|Protocol Violation|0|||
23230665|NCT02394028|64588074|FG005|Maintenance Phase|Protocol Violation|0|||
23338556|NCT00803790|64983041|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
23338557|NCT02730377|64983049|FG000|Overall Study|Other|5|||
23338558|NCT02730377|64983050|FG001|Overall Study|Other|4|||
23578156|NCT02300311|65847037|FG000|Overall Study|Refused to continue taking medication|18|||
23578157|NCT02300311|65847038|FG001|Overall Study|Refused to continue taking medication|0|||
23578158|NCT02819479|65847044|FG000|Overall Study|Adverse Event|2|||
23230666|NCT02394028|64588075|FG006|Maintenance Phase|Protocol Violation|0|||
23230667|NCT02394028|64588076|FG007|Maintenance Phase|Protocol Violation|0|||
23230668|NCT02394028|64588077|FG008|Maintenance Phase|Protocol Violation|0|||
23230669|NCT02394028|64588078|FG009|Maintenance Phase|Protocol Violation|0|||
23230670|NCT02394028|64588079|FG010|Maintenance Phase|Protocol Violation|1|||
23230671|NCT02394028|64588069|FG000|Maintenance Phase|Physician Decision|0|||
23230672|NCT02394028|64588070|FG001|Maintenance Phase|Physician Decision|0|||
23578159|NCT00114959|65847047|FG000|Overall Study|Lack of Efficacy|6|||
23230673|NCT02394028|64588071|FG002|Maintenance Phase|Physician Decision|0|||
23338559|NCT02730377|64983049|FG000|Overall Study|Death|1|||
23338560|NCT02730377|64983050|FG001|Overall Study|Death|8|||
23450347|NCT00531284|65391512|FG016|Overall Study|Adverse Event|2|||
23578160|NCT00114959|65847047|FG000|Overall Study|Physician Decision|1|||
23230674|NCT02394028|64588072|FG003|Maintenance Phase|Physician Decision|0|||
23230675|NCT02394028|64588073|FG004|Maintenance Phase|Physician Decision|0|||
23230676|NCT02394028|64588074|FG005|Maintenance Phase|Physician Decision|0|||
23230677|NCT02394028|64588075|FG006|Maintenance Phase|Physician Decision|0|||
23230678|NCT02394028|64588076|FG007|Maintenance Phase|Physician Decision|0|||
23230679|NCT02394028|64588077|FG008|Maintenance Phase|Physician Decision|1|||
23230680|NCT02394028|64588078|FG009|Maintenance Phase|Physician Decision|3|||
23230681|NCT02394028|64588079|FG010|Maintenance Phase|Physician Decision|2|||
23230682|NCT02394028|64588069|FG000|Maintenance Phase|Lack of Efficacy|0|||
23230683|NCT02394028|64588070|FG001|Maintenance Phase|Lack of Efficacy|0|||
23338561|NCT02730377|64983049|FG000|Overall Study|Inadequate glycaemic control|368|||
23338562|NCT02730377|64983050|FG001|Overall Study|Inadequate glycaemic control|473|||
23338563|NCT02730377|64983049|FG000|Overall Study|Adverse Event|79|||
23338564|NCT02730377|64983050|FG001|Overall Study|Adverse Event|41|||
23338565|NCT02730377|64983049|FG000|Overall Study|Protocol Violation|23|||
23338566|NCT02730377|64983050|FG001|Overall Study|Protocol Violation|30|||
23338567|NCT02730377|64983049|FG000|Overall Study|Lack of Efficacy|4|||
23338568|NCT02730377|64983050|FG001|Overall Study|Lack of Efficacy|13|||
23338569|NCT02730377|64983049|FG000|Overall Study|Pregnancy|0|||
23230684|NCT02394028|64588071|FG002|Maintenance Phase|Lack of Efficacy|0|||
23230685|NCT02394028|64588072|FG003|Maintenance Phase|Lack of Efficacy|0|||
23230686|NCT02394028|64588073|FG004|Maintenance Phase|Lack of Efficacy|0|||
23230687|NCT02394028|64588074|FG005|Maintenance Phase|Lack of Efficacy|0|||
23230688|NCT02394028|64588075|FG006|Maintenance Phase|Lack of Efficacy|0|||
23230689|NCT02394028|64588076|FG007|Maintenance Phase|Lack of Efficacy|0|||
23230690|NCT02394028|64588077|FG008|Maintenance Phase|Lack of Efficacy|7|||
23230691|NCT02394028|64588078|FG009|Maintenance Phase|Lack of Efficacy|25|||
23230692|NCT02394028|64588079|FG010|Maintenance Phase|Lack of Efficacy|33|||
23230693|NCT02394028|64588069|FG000|Maintenance Phase|Death|0|||
23230694|NCT02394028|64588070|FG001|Maintenance Phase|Death|0|||
23230695|NCT02394028|64588071|FG002|Maintenance Phase|Death|0|||
23230696|NCT02394028|64588072|FG003|Maintenance Phase|Death|0|||
23230697|NCT02394028|64588073|FG004|Maintenance Phase|Death|0|||
23230698|NCT02394028|64588074|FG005|Maintenance Phase|Death|0|||
23230699|NCT02394028|64588075|FG006|Maintenance Phase|Death|0|||
23230700|NCT02394028|64588076|FG007|Maintenance Phase|Death|0|||
23230701|NCT02394028|64588077|FG008|Maintenance Phase|Death|0|||
23230702|NCT02394028|64588078|FG009|Maintenance Phase|Death|0|||
23230703|NCT02394028|64588079|FG010|Maintenance Phase|Death|1|||
23230704|NCT02394028|64588069|FG000|Maintenance Phase|Adverse Event|0|||
23230705|NCT02394028|64588070|FG001|Maintenance Phase|Adverse Event|0|||
23230706|NCT02394028|64588071|FG002|Maintenance Phase|Adverse Event|0|||
23230707|NCT02394028|64588072|FG003|Maintenance Phase|Adverse Event|0|||
23230708|NCT02394028|64588073|FG004|Maintenance Phase|Adverse Event|0|||
23230709|NCT02394028|64588074|FG005|Maintenance Phase|Adverse Event|0|||
23230710|NCT02394028|64588075|FG006|Maintenance Phase|Adverse Event|0|||
23230711|NCT02394028|64588076|FG007|Maintenance Phase|Adverse Event|0|||
23230712|NCT02394028|64588077|FG008|Maintenance Phase|Adverse Event|1|||
23230713|NCT02394028|64588078|FG009|Maintenance Phase|Adverse Event|1|||
23230714|NCT02394028|64588079|FG010|Maintenance Phase|Adverse Event|3|||
23230715|NCT02394028|64588069|FG000|Maintenance Phase|Site closure|0|||
23230716|NCT02394028|64588070|FG001|Maintenance Phase|Site closure|0|||
23230717|NCT02394028|64588071|FG002|Maintenance Phase|Site closure|0|||
23230718|NCT02394028|64588072|FG003|Maintenance Phase|Site closure|0|||
23230719|NCT02394028|64588073|FG004|Maintenance Phase|Site closure|0|||
23230720|NCT02394028|64588074|FG005|Maintenance Phase|Site closure|0|||
23230721|NCT02394028|64588075|FG006|Maintenance Phase|Site closure|0|||
23230722|NCT02394028|64588076|FG007|Maintenance Phase|Site closure|0|||
23230723|NCT02394028|64588077|FG008|Maintenance Phase|Site closure|0|||
23230724|NCT02394028|64588078|FG009|Maintenance Phase|Site closure|1|||
23230725|NCT02394028|64588079|FG010|Maintenance Phase|Site closure|0|||
23230726|NCT02394028|64588069|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23230727|NCT02394028|64588070|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23230728|NCT02394028|64588071|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23338570|NCT02730377|64983050|FG001|Overall Study|Pregnancy|1|||
23338571|NCT02730377|64983049|FG000|Overall Study|Withdrawal by Subject|45|||
23338572|NCT02730377|64983050|FG001|Overall Study|Withdrawal by Subject|42|||
23230729|NCT02394028|64588072|FG003|Maintenance Phase|Withdrawal by Subject|0|||
23230730|NCT02394028|64588073|FG004|Maintenance Phase|Withdrawal by Subject|0|||
23230731|NCT02394028|64588074|FG005|Maintenance Phase|Withdrawal by Subject|0|||
23338573|NCT02730377|64983049|FG000|Overall Study|Lost to Follow-up|25|||
23338574|NCT02730377|64983050|FG001|Overall Study|Lost to Follow-up|21|||
23230732|NCT02394028|64588075|FG006|Maintenance Phase|Withdrawal by Subject|0|||
23230733|NCT02394028|64588076|FG007|Maintenance Phase|Withdrawal by Subject|0|||
23230734|NCT02394028|64588077|FG008|Maintenance Phase|Withdrawal by Subject|3|||
23230735|NCT02394028|64588078|FG009|Maintenance Phase|Withdrawal by Subject|12|||
23230736|NCT02394028|64588079|FG010|Maintenance Phase|Withdrawal by Subject|12|||
23230737|NCT03091920|64588084|FG000|Overall Study|Adverse Event|0|||
23230738|NCT03091920|64588085|FG001|Overall Study|Adverse Event|1|||
23230739|NCT03091920|64588086|FG002|Overall Study|Adverse Event|0|||
23230740|NCT02576652|64588091|FG000|Overall Study|Withdrawal by Subject|2|||
23230741|NCT02813681|64588092|FG000|Overall Study|Physician Decision|5|||
23230742|NCT02813681|64588093|FG001|Overall Study|Physician Decision|5|||
23230743|NCT02813681|64588094|FG002|Overall Study|Physician Decision|0|||
23230744|NCT02813681|64588092|FG000|Overall Study|Lost to Follow-up|0|||
23230745|NCT02813681|64588093|FG001|Overall Study|Lost to Follow-up|1|||
23230746|NCT02813681|64588094|FG002|Overall Study|Lost to Follow-up|0|||
23230747|NCT01234337|64588095|FG000|Overall Study|Adverse Event|58|||
23230748|NCT01234337|64588096|FG001|Overall Study|Adverse Event|21|||
23230749|NCT01234337|64588095|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
23230750|NCT01234337|64588096|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
23230751|NCT01234337|64588095|FG000|Overall Study|Investi. decision not protocol driven|5|||
23230752|NCT01234337|64588096|FG001|Overall Study|Investi. decision not protocol driven|6|||
23230753|NCT01234337|64588095|FG000|Overall Study|Non-compliant with study medication|3|||
23230754|NCT01234337|64588096|FG001|Overall Study|Non-compliant with study medication|2|||
23230755|NCT01234337|64588095|FG000|Overall Study|Randomized but not treated|6|||
23230756|NCT01234337|64588096|FG001|Overall Study|Randomized but not treated|4|||
23230757|NCT01234337|64588095|FG000|Overall Study|Lost to Follow-up|0|||
23230758|NCT01234337|64588096|FG001|Overall Study|Lost to Follow-up|1|||
23230759|NCT01234337|64588095|FG000|Overall Study|Protocol Violation|2|||
23230760|NCT01234337|64588096|FG001|Overall Study|Protocol Violation|3|||
23230761|NCT01234337|64588095|FG000|Overall Study|Withdrawal by Subject|11|||
23230762|NCT01234337|64588096|FG001|Overall Study|Withdrawal by Subject|9|||
23230763|NCT01234337|64588095|FG000|Overall Study|Death|0|||
23230764|NCT01234337|64588096|FG001|Overall Study|Death|1|||
23230765|NCT01234337|64588095|FG000|Overall Study|Switch to commercial drug|0|||
23230766|NCT01234337|64588096|FG001|Overall Study|Switch to commercial drug|1|||
23230767|NCT00474539|64588097|FG000|Infant Series|Withdrawal by Subject|3|||
23230768|NCT00474539|64588098|FG001|Infant Series|Withdrawal by Subject|4|||
23230769|NCT00474539|64588097|FG000|Infant Series|Randomization error|5|||
23230770|NCT00474539|64588098|FG001|Infant Series|Randomization error|0|||
23230771|NCT00474539|64588097|FG000|Infant Series|Lost to Follow-up|2|||
23230772|NCT00474539|64588098|FG001|Infant Series|Lost to Follow-up|1|||
23230773|NCT00474539|64588097|FG000|Infant Series|Protocol Violation|0|||
23230774|NCT00474539|64588098|FG001|Infant Series|Protocol Violation|1|||
23230775|NCT00474539|64588097|FG000|After Infant Series|Lost to Follow-up|3|||
23230776|NCT00474539|64588098|FG001|After Infant Series|Lost to Follow-up|0|||
23230777|NCT00474539|64588097|FG000|After Infant Series|Withdrawal by Subject|1|||
23230778|NCT00474539|64588098|FG001|After Infant Series|Withdrawal by Subject|0|||
23230779|NCT00474539|64588097|FG000|Toddler Dose|Protocol Violation|1|||
23230780|NCT00474539|64588098|FG001|Toddler Dose|Protocol Violation|0|||
23230781|NCT01566981|64588109|FG000|Overall Study|Lost to Follow-up|5|||
23230782|NCT01566981|64588110|FG001|Overall Study|Lost to Follow-up|8|||
23230783|NCT01038635|64588119|FG000|Overall Study|Disease Progression|2|||
23230784|NCT01038635|64588120|FG001|Overall Study|Disease Progression|0|||
23230785|NCT01038635|64588121|FG002|Overall Study|Disease Progression|0|||
23230786|NCT01038635|64588122|FG003|Overall Study|Disease Progression|0|||
23230787|NCT01038635|64588123|FG004|Overall Study|Disease Progression|0|||
23230788|NCT01038635|64588124|FG005|Overall Study|Disease Progression|0|||
23230789|NCT01038635|64588125|FG006|Overall Study|Disease Progression|1|||
23230790|NCT01038635|64588126|FG007|Overall Study|Disease Progression|4|||
23230791|NCT01038635|64588127|FG008|Overall Study|Disease Progression|0|||
23230792|NCT01038635|64588119|FG000|Overall Study|Death|0|||
23230793|NCT01038635|64588120|FG001|Overall Study|Death|0|||
23230794|NCT01038635|64588121|FG002|Overall Study|Death|0|||
23230795|NCT01038635|64588122|FG003|Overall Study|Death|0|||
23230796|NCT01038635|64588123|FG004|Overall Study|Death|1|||
23230797|NCT01038635|64588124|FG005|Overall Study|Death|0|||
23230798|NCT01038635|64588125|FG006|Overall Study|Death|1|||
23230799|NCT01038635|64588126|FG007|Overall Study|Death|1|||
23230800|NCT01038635|64588127|FG008|Overall Study|Death|2|||
23230801|NCT03267576|64588128|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
23450348|NCT00531284|65391496|FG000|Overall Study|Withdrawal by Subject|1|||
23230802|NCT03267576|64588129|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
23230803|NCT03267576|64588128|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
23230804|NCT03267576|64588129|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
23230805|NCT01230489|64588130|FG000|Overall Study|Death|2|||
23230806|NCT01230489|64588130|FG000|Overall Study|Adverse Event|2|||
23230807|NCT01230489|64588130|FG000|Overall Study|Treatment modality changed|1|||
23230808|NCT01683058|64588131|FG000|Overall Study|Lost to Follow-up|9|||
23230809|NCT01683058|64588131|FG000|Overall Study|Adverse Event|6|||
23230810|NCT01683058|64588131|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
23230811|NCT01683058|64588131|FG000|Overall Study|Withdrawal by Subject|7|||
23230812|NCT01683058|64588131|FG000|Overall Study|Lack of Efficacy|2|||
23230813|NCT05643170|64588132|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
23230814|NCT05643170|64588132|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
23230815|NCT00381706|64588137|FG000|Overall Study|Never treated|7|||
23230816|NCT00381706|64588138|FG001|Overall Study|Never treated|2|||
23230817|NCT00381706|64588139|FG002|Overall Study|Never treated|1|||
23230818|NCT00579527|64588140|FG000|Overall Study|Death|4|||
23230819|NCT01657903|64588141|FG000|Overall Study|Lost to Follow-up|1|||
23230820|NCT01657903|64588141|FG000|Overall Study|Withdrawal by Subject|1|||
23230821|NCT02155660|64588142|FG000|Overall Study|Other Reason|8|||
23230822|NCT02155660|64588143|FG001|Overall Study|Other Reason|6|||
23230823|NCT02155660|64588144|FG002|Overall Study|Other Reason|10|||
23230824|NCT02155660|64588145|FG003|Overall Study|Other Reason|10|||
23230825|NCT02155660|64588142|FG000|Overall Study|Study-specific withdrawal criteria|0|||
23230826|NCT02155660|64588143|FG001|Overall Study|Study-specific withdrawal criteria|1|||
23230827|NCT02155660|64588144|FG002|Overall Study|Study-specific withdrawal criteria|1|||
23230828|NCT02155660|64588145|FG003|Overall Study|Study-specific withdrawal criteria|1|||
23230829|NCT02155660|64588142|FG000|Overall Study|Severe non-compliance|0|||
23230830|NCT02155660|64588143|FG001|Overall Study|Severe non-compliance|4|||
23230831|NCT02155660|64588144|FG002|Overall Study|Severe non-compliance|0|||
23230832|NCT02155660|64588145|FG003|Overall Study|Severe non-compliance|1|||
23230833|NCT02155660|64588142|FG000|Overall Study|Adverse Event|2|||
23230834|NCT02155660|64588143|FG001|Overall Study|Adverse Event|6|||
23230835|NCT02155660|64588144|FG002|Overall Study|Adverse Event|3|||
23230836|NCT02155660|64588145|FG003|Overall Study|Adverse Event|1|||
23230837|NCT02155660|64588142|FG000|Overall Study|Lost to Follow-up|3|||
23230838|NCT02155660|64588143|FG001|Overall Study|Lost to Follow-up|6|||
23230839|NCT02155660|64588144|FG002|Overall Study|Lost to Follow-up|5|||
23230840|NCT02155660|64588145|FG003|Overall Study|Lost to Follow-up|8|||
23230841|NCT02155660|64588142|FG000|Overall Study|Death|17|||
23230842|NCT02155660|64588143|FG001|Overall Study|Death|19|||
23230843|NCT02155660|64588144|FG002|Overall Study|Death|17|||
23230844|NCT02155660|64588145|FG003|Overall Study|Death|19|||
23230845|NCT02155660|64588142|FG000|Overall Study|Withdrawal by Subject|28|||
23230846|NCT02155660|64588143|FG001|Overall Study|Withdrawal by Subject|31|||
23230847|NCT02155660|64588144|FG002|Overall Study|Withdrawal by Subject|24|||
23230848|NCT02155660|64588145|FG003|Overall Study|Withdrawal by Subject|21|||
23230849|NCT01488994|64588147|FG000|Overall Study|Withdrawal by Subject|0|||
23230850|NCT01488994|64588148|FG001|Overall Study|Withdrawal by Subject|1|||
23230851|NCT03377452|64588149|FG000|Overall Study|Refused assessment|0|||
23230852|NCT03377452|64588150|FG001|Overall Study|Refused assessment|2|||
23230853|NCT03377452|64588149|FG000|Overall Study|Lost to Follow-up|5|||
23230854|NCT03377452|64588150|FG001|Overall Study|Lost to Follow-up|4|||
23230855|NCT00750867|64588153|FG000|Overall Study|Adverse Event|2|||
23230856|NCT00890201|64588154|FG000|Overall Study|Protocol Violation|5|||
23230857|NCT00890201|64588155|FG001|Overall Study|Protocol Violation|56|||
23230858|NCT00805142|64588158|FG000|Titration Period|Adverse Event|3|||
23230859|NCT00805142|64588159|FG001|Titration Period|Adverse Event|3|||
23230860|NCT00805142|64588158|FG000|Titration Period|Lack of Efficacy|1|||
23230861|NCT00805142|64588159|FG001|Titration Period|Lack of Efficacy|1|||
23230862|NCT00805142|64588158|FG000|Titration Period|Lost to Follow-up|0|||
23230863|NCT00805142|64588159|FG001|Titration Period|Lost to Follow-up|1|||
23230864|NCT00805142|64588158|FG000|Titration Period|Disease Progression|2|||
23230865|NCT00805142|64588159|FG001|Titration Period|Disease Progression|1|||
23230866|NCT00805142|64588158|FG000|Titration Period|Withdrawal of consent|0|||
23230867|NCT00805142|64588159|FG001|Titration Period|Withdrawal of consent|1|||
23338575|NCT00679029|64983051|FG000|Overall Study|Adverse Event|3|||
23450349|NCT00531284|65391497|FG001|Overall Study|Withdrawal by Subject|0|||
23450350|NCT00531284|65391498|FG002|Overall Study|Withdrawal by Subject|0|||
23450351|NCT00531284|65391499|FG003|Overall Study|Withdrawal by Subject|4|||
23450352|NCT00531284|65391500|FG004|Overall Study|Withdrawal by Subject|0|||
23450353|NCT00531284|65391501|FG005|Overall Study|Withdrawal by Subject|0|||
23450354|NCT00531284|65391502|FG006|Overall Study|Withdrawal by Subject|0|||
23450355|NCT00531284|65391503|FG007|Overall Study|Withdrawal by Subject|0|||
23450356|NCT00531284|65391504|FG008|Overall Study|Withdrawal by Subject|0|||
23450357|NCT00531284|65391505|FG009|Overall Study|Withdrawal by Subject|0|||
23230868|NCT00805142|64588158|FG000|Titration Period|Other|0|||
23230869|NCT00805142|64588159|FG001|Titration Period|Other|3|||
23230870|NCT00805142|64588158|FG000|Maintenance Period|Adverse Event|0|||
23230871|NCT00805142|64588159|FG001|Maintenance Period|Adverse Event|1|||
23230872|NCT00805142|64588158|FG000|Maintenance Period|Other|0|||
23230873|NCT00805142|64588159|FG001|Maintenance Period|Other|1|||
23230874|NCT03793010|64588160|FG000|Overall Study|Withdrawal by Subject|5|||
23230875|NCT03793010|64588161|FG001|Overall Study|Withdrawal by Subject|7|||
23450358|NCT00531284|65391506|FG010|Overall Study|Withdrawal by Subject|0|||
23450359|NCT00531284|65391507|FG011|Overall Study|Withdrawal by Subject|3|||
23230876|NCT03793010|64588160|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
23230877|NCT03793010|64588161|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
23230878|NCT03793010|64588160|FG000|Overall Study|Lost to Follow-up|1|||
23230879|NCT03793010|64588161|FG001|Overall Study|Lost to Follow-up|2|||
23230880|NCT03793010|64588160|FG000|Overall Study|Patient couldn't sit still for injection|1|||
23450360|NCT00531284|65391508|FG012|Overall Study|Withdrawal by Subject|0|||
23450361|NCT00531284|65391509|FG013|Overall Study|Withdrawal by Subject|1|||
23450362|NCT00531284|65391510|FG014|Overall Study|Withdrawal by Subject|0|||
23450363|NCT00531284|65391511|FG015|Overall Study|Withdrawal by Subject|1|||
23450364|NCT00531284|65391512|FG016|Overall Study|Withdrawal by Subject|1|||
23450365|NCT00531284|65391496|FG000|Overall Study|Other|1|||
23450366|NCT00531284|65391497|FG001|Overall Study|Other|0|||
23450367|NCT00531284|65391498|FG002|Overall Study|Other|0|||
23450368|NCT00531284|65391499|FG003|Overall Study|Other|10|||
23450369|NCT00531284|65391500|FG004|Overall Study|Other|2|||
23450370|NCT00531284|65391501|FG005|Overall Study|Other|1|||
23450371|NCT00531284|65391502|FG006|Overall Study|Other|0|||
23230881|NCT03793010|64588161|FG001|Overall Study|Patient couldn't sit still for injection|0|||
23230882|NCT03793010|64588160|FG000|Overall Study|Withdrew to pursue other treatment|1|||
23230883|NCT03793010|64588161|FG001|Overall Study|Withdrew to pursue other treatment|0|||
23230884|NCT03793010|64588160|FG000|Overall Study|Did not meet eligibility criteria|1|||
23230885|NCT03793010|64588161|FG001|Overall Study|Did not meet eligibility criteria|0|||
23230886|NCT00590031|64588162|FG000|Overall Study|Adverse Event|3|||
23230887|NCT00590031|64588162|FG000|Overall Study|Withdrawal by Subject|1|||
23230888|NCT00590031|64588162|FG000|Overall Study|Metastatic Disease|1|||
23230889|NCT00590031|64588162|FG000|Overall Study|Admin Hold|1|||
23230890|NCT03395704|64588163|FG000|Overall Study|Adverse Event|2|||
23230891|NCT03395704|64588164|FG001|Overall Study|Adverse Event|1|||
23230892|NCT03395704|64588163|FG000|Overall Study|Withdrawal by Subject|2|||
23230893|NCT03395704|64588164|FG001|Overall Study|Withdrawal by Subject|1|||
23230894|NCT03395704|64588163|FG000|Overall Study|Physician Decision|0|||
23230895|NCT03395704|64588164|FG001|Overall Study|Physician Decision|1|||
23230896|NCT00959192|64588169|FG000|Overall Study|Adverse Event|1|||
23230897|NCT00959192|64588170|FG001|Overall Study|Adverse Event|1|||
23230898|NCT00959192|64588171|FG002|Overall Study|Adverse Event|1|||
23230899|NCT00959192|64588172|FG003|Overall Study|Adverse Event|0|||
23230900|NCT00959192|64588169|FG000|Overall Study|Investigator Request|1|||
23230901|NCT00959192|64588170|FG001|Overall Study|Investigator Request|0|||
23230902|NCT00959192|64588171|FG002|Overall Study|Investigator Request|0|||
23230903|NCT00959192|64588172|FG003|Overall Study|Investigator Request|0|||
23230904|NCT00959192|64588169|FG000|Overall Study|Caregiver Request|0|||
23230905|NCT00959192|64588170|FG001|Overall Study|Caregiver Request|0|||
23450372|NCT00531284|65391503|FG007|Overall Study|Other|0|||
23450373|NCT00531284|65391504|FG008|Overall Study|Other|2|||
23450374|NCT00531284|65391505|FG009|Overall Study|Other|1|||
23450375|NCT00531284|65391506|FG010|Overall Study|Other|0|||
23450376|NCT00531284|65391507|FG011|Overall Study|Other|2|||
23450377|NCT00531284|65391508|FG012|Overall Study|Other|0|||
23450378|NCT00531284|65391509|FG013|Overall Study|Other|0|||
23450379|NCT00531284|65391510|FG014|Overall Study|Other|1|||
23450380|NCT00531284|65391511|FG015|Overall Study|Other|0|||
23450381|NCT00531284|65391512|FG016|Overall Study|Other|0|||
23578161|NCT00114959|65847047|FG000|Overall Study|Death|1|||
23578162|NCT01852162|65847050|FG000|Overall Study|Adverse Event|1|||
23171355|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
23171356|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
23171357|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
23171358|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
23171359|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
23171360|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
23171361|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
23171362|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
23171363|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
23171364|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
23171365|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Death|0|||
23171366|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Death|0|||
23171367|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Death|0|||
23230906|NCT00959192|64588171|FG002|Overall Study|Caregiver Request|2|||
23450382|NCT01602224|65391513|FG000|Overall Study|Adverse Event|0|||
23450383|NCT01602224|65391514|FG001|Overall Study|Adverse Event|1|||
23450384|NCT01602224|65391515|FG002|Overall Study|Adverse Event|0|||
23450385|NCT01602224|65391513|FG000|Overall Study|Investigator Decison|1|||
23171368|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Death|0|||
23230907|NCT00959192|64588172|FG003|Overall Study|Caregiver Request|1|||
23230908|NCT03557801|64588173|FG000|Overall Study|Protocol Violation|1|||
23230909|NCT03557801|64588174|FG001|Overall Study|Protocol Violation|0|||
23230910|NCT03557801|64588175|FG002|Overall Study|Protocol Violation|0|||
23230911|NCT03557801|64588173|FG000|Overall Study|Withdrawal by Subject|1|||
23230912|NCT03557801|64588174|FG001|Overall Study|Withdrawal by Subject|0|||
23450386|NCT01602224|65391514|FG001|Overall Study|Investigator Decison|0|||
23450387|NCT01602224|65391515|FG002|Overall Study|Investigator Decison|0|||
23578163|NCT01852162|65847051|FG001|Overall Study|Adverse Event|0|||
23450388|NCT01602224|65391513|FG000|Overall Study|Lost to Follow-up|0|||
23450389|NCT01602224|65391514|FG001|Overall Study|Lost to Follow-up|0|||
23450390|NCT01602224|65391515|FG002|Overall Study|Lost to Follow-up|1|||
23450391|NCT01602224|65391513|FG000|Overall Study|Protocol Violation|0|||
23450392|NCT01602224|65391514|FG001|Overall Study|Protocol Violation|1|||
23450393|NCT01602224|65391515|FG002|Overall Study|Protocol Violation|0|||
23450394|NCT01602224|65391513|FG000|Overall Study|Sponsor Decision|2|||
23450395|NCT01602224|65391514|FG001|Overall Study|Sponsor Decision|3|||
23450396|NCT01602224|65391515|FG002|Overall Study|Sponsor Decision|2|||
23450397|NCT01602224|65391513|FG000|Overall Study|Withdrawal by Subject|5|||
23450398|NCT01602224|65391514|FG001|Overall Study|Withdrawal by Subject|3|||
23450399|NCT01602224|65391515|FG002|Overall Study|Withdrawal by Subject|3|||
23450400|NCT01650558|65391516|FG000|Overall Study|Migration out of study area|61|||
23450401|NCT01650558|65391517|FG001|Overall Study|Migration out of study area|71|||
23450402|NCT01650558|65391518|FG002|Overall Study|Migration out of study area|56|||
23450403|NCT01650558|65391516|FG000|Overall Study|Lost to Follow-up|10|||
23450404|NCT01650558|65391517|FG001|Overall Study|Lost to Follow-up|13|||
23450405|NCT01650558|65391518|FG002|Overall Study|Lost to Follow-up|6|||
23450406|NCT01650558|65391516|FG000|Overall Study|Death|10|||
23450407|NCT01650558|65391517|FG001|Overall Study|Death|6|||
23450408|NCT01650558|65391518|FG002|Overall Study|Death|8|||
23450409|NCT01650558|65391516|FG000|Overall Study|Withdrawal by Subject|1|||
23450410|NCT01650558|65391517|FG001|Overall Study|Withdrawal by Subject|1|||
23450411|NCT01650558|65391518|FG002|Overall Study|Withdrawal by Subject|3|||
23450412|NCT01650558|65391516|FG000|Overall Study|Non-compliant participant|1|||
23450413|NCT01650558|65391517|FG001|Overall Study|Non-compliant participant|0|||
23450414|NCT01650558|65391518|FG002|Overall Study|Non-compliant participant|2|||
23450415|NCT01650558|65391516|FG000|Overall Study|Physician Decision|0|||
23450416|NCT01650558|65391517|FG001|Overall Study|Physician Decision|1|||
23450417|NCT01650558|65391518|FG002|Overall Study|Physician Decision|0|||
23450418|NCT01307319|65391519|FG000|Overall Study|Adverse Event|2|||
23450419|NCT01307319|65391520|FG001|Overall Study|Adverse Event|2|||
23450420|NCT01307319|65391521|FG002|Overall Study|Adverse Event|1|||
23450421|NCT01307319|65391519|FG000|Overall Study|Lost to Follow-up|1|||
23450422|NCT01307319|65391520|FG001|Overall Study|Lost to Follow-up|0|||
23450423|NCT01307319|65391521|FG002|Overall Study|Lost to Follow-up|1|||
23450424|NCT01307319|65391519|FG000|Overall Study|Protocol Violation|1|||
23450425|NCT01307319|65391520|FG001|Overall Study|Protocol Violation|1|||
23450426|NCT01307319|65391521|FG002|Overall Study|Protocol Violation|0|||
23450427|NCT01307319|65391519|FG000|Overall Study|Withdrawal by Subject|0|||
23450428|NCT01307319|65391520|FG001|Overall Study|Withdrawal by Subject|1|||
23450429|NCT01307319|65391521|FG002|Overall Study|Withdrawal by Subject|2|||
23450430|NCT01307319|65391519|FG000|Overall Study|Other|0|||
23450431|NCT01307319|65391520|FG001|Overall Study|Other|4|||
23450432|NCT01307319|65391521|FG002|Overall Study|Other|3|||
23450433|NCT02210000|65391524|FG000|Overall Study|Study Terminated|11|||
23450434|NCT02210000|65391525|FG001|Overall Study|Study Terminated|12|||
23450435|NCT02210000|65391524|FG000|Overall Study|Withdrawal by Subject|7|||
23450436|NCT02210000|65391525|FG001|Overall Study|Withdrawal by Subject|1|||
23450437|NCT02210000|65391524|FG000|Overall Study|Adverse Event|1|||
23450438|NCT02210000|65391525|FG001|Overall Study|Adverse Event|5|||
23450439|NCT02210000|65391524|FG000|Overall Study|Lost to Follow-up|0|||
23450440|NCT02210000|65391525|FG001|Overall Study|Lost to Follow-up|2|||
23450441|NCT02210000|65391524|FG000|Overall Study|Physician Decision|0|||
23450442|NCT02210000|65391525|FG001|Overall Study|Physician Decision|1|||
23450443|NCT03480152|65391526|FG000|Phase I|Signed consent. Died before treatment.|1|||
23578164|NCT01852162|65847050|FG000|Overall Study|Withdrawal by Subject|3|||
23171369|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Death|1|||
23171370|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
23171371|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
23171372|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
23171373|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
23171374|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
23171375|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
23450444|NCT03480152|65391527|FG001|Phase I|Signed consent. Died before treatment.|0|||
23450445|NCT03480152|65391528|FG002|Phase I|Signed consent. Died before treatment.|0|||
23450446|NCT03883581|65391529|FG000|Overall Study|Withdrawal by Subject|4|||
23450447|NCT01421017|65391530|FG000|Overall Study|Withdrawal by Subject|2|||
23450448|NCT01421017|65391531|FG001|Overall Study|Withdrawal by Subject|0|||
23450449|NCT01421017|65391532|FG002|Overall Study|Withdrawal by Subject|0|||
23450450|NCT01421017|65391530|FG000|Overall Study|POD|0|||
23450451|NCT01421017|65391531|FG001|Overall Study|POD|6|||
23450452|NCT01421017|65391532|FG002|Overall Study|POD|3|||
23450453|NCT01121146|65391533|FG000|Overall Study|Death|17|||
23450454|NCT01121146|65391534|FG001|Overall Study|Death|15|||
23450455|NCT01121146|65391533|FG000|Overall Study|Adverse Event|2|||
23450456|NCT01121146|65391534|FG001|Overall Study|Adverse Event|11|||
23450457|NCT01121146|65391533|FG000|Overall Study|Lost to Follow-up|7|||
23450458|NCT01121146|65391534|FG001|Overall Study|Lost to Follow-up|16|||
23450459|NCT04292535|65391541|FG000|Overall Study|Withdrawal by Subject|0|||
23450460|NCT04292535|65391542|FG001|Overall Study|Withdrawal by Subject|0|||
23450461|NCT04292535|65391543|FG002|Overall Study|Withdrawal by Subject|0|||
23450462|NCT04292535|65391544|FG003|Overall Study|Withdrawal by Subject|0|||
23450463|NCT04292535|65391545|FG004|Overall Study|Withdrawal by Subject|0|||
23450464|NCT04292535|65391546|FG005|Overall Study|Withdrawal by Subject|0|||
23450465|NCT04292535|65391547|FG006|Overall Study|Withdrawal by Subject|0|||
23450466|NCT04292535|65391548|FG007|Overall Study|Withdrawal by Subject|1|||
23450467|NCT04292535|65391549|FG008|Overall Study|Withdrawal by Subject|0|||
23450468|NCT04292535|65391550|FG009|Overall Study|Withdrawal by Subject|0|||
23450469|NCT04292535|65391551|FG010|Overall Study|Withdrawal by Subject|0|||
23450470|NCT04292535|65391552|FG011|Overall Study|Withdrawal by Subject|0|||
23450471|NCT04292535|65391553|FG012|Overall Study|Withdrawal by Subject|0|||
23450472|NCT04292535|65391554|FG013|Overall Study|Withdrawal by Subject|0|||
23450473|NCT04292535|65391541|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450474|NCT04292535|65391542|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450475|NCT04292535|65391543|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450476|NCT04292535|65391544|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450477|NCT04292535|65391545|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450478|NCT04292535|65391546|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450479|NCT04292535|65391547|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450480|NCT04292535|65391548|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
23450481|NCT04292535|65391549|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450482|NCT04292535|65391550|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450483|NCT04292535|65391551|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450484|NCT04292535|65391552|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
23450485|NCT04292535|65391553|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
23450486|NCT04292535|65391554|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
23450487|NCT04292535|65391541|FG000|Overall Study|Report of Dizziness|0|||
23450488|NCT04292535|65391542|FG001|Overall Study|Report of Dizziness|0|||
23450489|NCT04292535|65391543|FG002|Overall Study|Report of Dizziness|0|||
23450490|NCT04292535|65391544|FG003|Overall Study|Report of Dizziness|0|||
23450491|NCT04292535|65391545|FG004|Overall Study|Report of Dizziness|0|||
23450492|NCT04292535|65391546|FG005|Overall Study|Report of Dizziness|0|||
23450493|NCT04292535|65391547|FG006|Overall Study|Report of Dizziness|0|||
23450494|NCT04292535|65391548|FG007|Overall Study|Report of Dizziness|0|||
23450495|NCT04292535|65391549|FG008|Overall Study|Report of Dizziness|0|||
23450496|NCT04292535|65391550|FG009|Overall Study|Report of Dizziness|0|||
23450497|NCT04292535|65391551|FG010|Overall Study|Report of Dizziness|0|||
23450498|NCT04292535|65391552|FG011|Overall Study|Report of Dizziness|0|||
23450499|NCT04292535|65391553|FG012|Overall Study|Report of Dizziness|0|||
23450500|NCT04292535|65391554|FG013|Overall Study|Report of Dizziness|1|||
23450501|NCT04292535|65391541|FG000|Overall Study|Equipment Failure|0|||
23450502|NCT04292535|65391542|FG001|Overall Study|Equipment Failure|0|||
23450503|NCT04292535|65391543|FG002|Overall Study|Equipment Failure|0|||
23450504|NCT04292535|65391544|FG003|Overall Study|Equipment Failure|0|||
23450505|NCT04292535|65391545|FG004|Overall Study|Equipment Failure|0|||
23450506|NCT04292535|65391546|FG005|Overall Study|Equipment Failure|0|||
23450507|NCT04292535|65391547|FG006|Overall Study|Equipment Failure|0|||
23450508|NCT04292535|65391548|FG007|Overall Study|Equipment Failure|0|||
23450509|NCT04292535|65391549|FG008|Overall Study|Equipment Failure|0|||
23450510|NCT04292535|65391550|FG009|Overall Study|Equipment Failure|0|||
23450511|NCT04292535|65391551|FG010|Overall Study|Equipment Failure|0|||
23450512|NCT04292535|65391552|FG011|Overall Study|Equipment Failure|1|||
23450513|NCT04292535|65391553|FG012|Overall Study|Equipment Failure|0|||
23450514|NCT04292535|65391554|FG013|Overall Study|Equipment Failure|0|||
23450515|NCT01929226|65391556|FG000|Overall Study|Lost to Follow-up|4|||
23450516|NCT01929226|65391557|FG001|Overall Study|Lost to Follow-up|0|||
23450517|NCT01929226|65391556|FG000|Overall Study|Withdrawal by Subject|1|||
23450518|NCT01929226|65391557|FG001|Overall Study|Withdrawal by Subject|1|||
23450519|NCT00419393|65391558|FG000|Overall Study|Adverse Event|5|||
23450520|NCT00419393|65391558|FG000|Overall Study|Protocol Violation|5|||
23450521|NCT00419393|65391558|FG000|Overall Study|Withdrawal by Subject|7|||
23450522|NCT00419393|65391558|FG000|Overall Study|Other: Sponsor request|3|||
23450523|NCT00419393|65391558|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
23450524|NCT00419393|65391558|FG000|Overall Study|Other: Site closure|1|||
23450525|NCT00419393|65391558|FG000|Overall Study|Other: Other health problems|1|||
23450526|NCT00419393|65391558|FG000|Overall Study|Other: Investigator decision|1|||
23450527|NCT00100789|65391559|FG000|Overall Study|Adverse Event|10|||
23450528|NCT00100789|65391559|FG000|Overall Study|Withdrawal by Subject|1|||
23450529|NCT00100789|65391559|FG000|Overall Study|Progression/relapse|42|||
23450530|NCT00100789|65391559|FG000|Overall Study|Death|2|||
23450531|NCT00100789|65391559|FG000|Overall Study|Not protocol specified|5|||
23450532|NCT00100789|65391559|FG000|Overall Study|Ineligible|3|||
23450533|NCT00100789|65391559|FG000|Overall Study|Never received treatment|1|||
23450534|NCT01894607|65391561|FG000|Overall Study|Ineligible|1|||
23450535|NCT03309878|65391568|FG000|Overall Study|Adverse Event|1|||
23450536|NCT03309878|65391569|FG001|Overall Study|Adverse Event|0|||
23450537|NCT03309878|65391570|FG002|Overall Study|Adverse Event|0|||
23450538|NCT03309878|65391571|FG003|Overall Study|Adverse Event|0|||
23450539|NCT03309878|65391568|FG000|Overall Study|Did not maintain eligibility|2|||
23450540|NCT03309878|65391569|FG001|Overall Study|Did not maintain eligibility|1|||
23450541|NCT03309878|65391570|FG002|Overall Study|Did not maintain eligibility|0|||
23450542|NCT03309878|65391571|FG003|Overall Study|Did not maintain eligibility|0|||
23450543|NCT03309878|65391568|FG000|Overall Study|Withdrawal by Subject|0|||
23450544|NCT03309878|65391569|FG001|Overall Study|Withdrawal by Subject|1|||
23450545|NCT03309878|65391570|FG002|Overall Study|Withdrawal by Subject|0|||
23450546|NCT03309878|65391571|FG003|Overall Study|Withdrawal by Subject|0|||
23450547|NCT04332107|65391573|FG000|Day 3|Lost to Follow-up|23|||
23450548|NCT04332107|65391574|FG001|Day 3|Lost to Follow-up|14|||
23450549|NCT04332107|65391573|FG000|Day 3|Missing outcome data|3|||
23578165|NCT01852162|65847051|FG001|Overall Study|Withdrawal by Subject|1|||
23578166|NCT00708097|65847058|FG000|Period 1|Protocol Violation|0|||
23171376|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
23171377|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
23171378|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
23171379|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
23171380|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
23171381|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
23171382|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
23171383|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
23171384|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
23171385|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
23171386|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
23171387|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
23578167|NCT00708097|65847059|FG001|Period 1|Protocol Violation|1|||
23578168|NCT00708097|65847060|FG002|Period 1|Protocol Violation|0|||
23578169|NCT00708097|65847061|FG003|Period 1|Protocol Violation|2|||
23578170|NCT00708097|65847062|FG004|Period 1|Protocol Violation|0|||
23578171|NCT00708097|65847058|FG000|Period 1|Other Reason|0|||
23578172|NCT00708097|65847059|FG001|Period 1|Other Reason|0|||
23578173|NCT00708097|65847060|FG002|Period 1|Other Reason|0|||
23578174|NCT00708097|65847061|FG003|Period 1|Other Reason|0|||
23578175|NCT00708097|65847062|FG004|Period 1|Other Reason|1|||
23578176|NCT00708097|65847058|FG000|Period 2|Protocol Violation|0|||
23578177|NCT00708097|65847059|FG001|Period 2|Protocol Violation|1|||
23578178|NCT00708097|65847060|FG002|Period 2|Protocol Violation|1|||
23578179|NCT00708097|65847061|FG003|Period 2|Protocol Violation|1|||
23578180|NCT00708097|65847062|FG004|Period 2|Protocol Violation|0|||
23578181|NCT03432533|65847064|FG000|Overall Study|Lost to Follow-up|1|||
23171388|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
23171389|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
23171390|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
23230913|NCT03557801|64588175|FG002|Overall Study|Withdrawal by Subject|3|||
23338576|NCT00679029|64983051|FG000|Overall Study|Withdrawal by Subject|1|||
23338577|NCT00679029|64983051|FG000|Overall Study|Lost to Follow-up|1|||
23338578|NCT02651155|64983052|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23338579|NCT02651155|64983053|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
23338580|NCT02651155|64983052|FG000|Overall Study|Voluntary Withdrawal|5|||
23338581|NCT02651155|64983053|FG001|Overall Study|Voluntary Withdrawal|0|||
23450550|NCT04332107|65391574|FG001|Day 3|Missing outcome data|6|||
23578182|NCT03432533|65847065|FG001|Overall Study|Lost to Follow-up|2|||
23450551|NCT04332107|65391573|FG000|Day 14|Lost to Follow-up|13|||
23450552|NCT04332107|65391574|FG001|Day 14|Lost to Follow-up|4|||
23450553|NCT04332107|65391573|FG000|Day 14|Missing outcome data|4|||
23450554|NCT04332107|65391574|FG001|Day 14|Missing outcome data|4|||
23578183|NCT03432533|65847064|FG000|Overall Study|Withdrawal by Subject|14|||
23578184|NCT03432533|65847065|FG001|Overall Study|Withdrawal by Subject|9|||
23578185|NCT01833065|65847066|FG000|Overall Study|Adverse Event|6|||
23578186|NCT01833065|65847067|FG001|Overall Study|Adverse Event|1|||
23338582|NCT03615144|64983054|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
23338583|NCT03615144|64983055|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
23338584|NCT01334918|64983063|FG000|Overall Study|Did not receive study drug|6|||
23338585|NCT01334918|64983064|FG001|Overall Study|Did not receive study drug|0|||
23338586|NCT01334918|64983063|FG000|Overall Study|Adverse Event|2|||
23338587|NCT01334918|64983064|FG001|Overall Study|Adverse Event|0|||
23171391|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
23171392|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
23450555|NCT04332107|65391573|FG000|Day 21|Lost to Follow-up|10|||
23450556|NCT04332107|65391574|FG001|Day 21|Lost to Follow-up|2|||
23450557|NCT00360412|65391575|FG000|Overall Study|Adverse Event|37|||
23450558|NCT00360412|65391576|FG001|Overall Study|Adverse Event|65|||
23450559|NCT00360412|65391575|FG000|Overall Study|Protocol Violation|2|||
23450560|NCT00360412|65391576|FG001|Overall Study|Protocol Violation|5|||
23450561|NCT00360412|65391575|FG000|Overall Study|Patient withdrew consent|27|||
23450562|NCT00360412|65391576|FG001|Overall Study|Patient withdrew consent|52|||
23450563|NCT00360412|65391575|FG000|Overall Study|Lack of therapeutic efficacy|46|||
23450564|NCT00360412|65391576|FG001|Overall Study|Lack of therapeutic efficacy|61|||
23450565|NCT00360412|65391575|FG000|Overall Study|Physician Decision|2|||
23450566|NCT00360412|65391576|FG001|Overall Study|Physician Decision|4|||
23450567|NCT00360412|65391575|FG000|Overall Study|Other|5|||
23578187|NCT01833065|65847068|FG002|Overall Study|Adverse Event|0|||
23578188|NCT01833065|65847069|FG003|Overall Study|Adverse Event|2|||
23578189|NCT01833065|65847070|FG004|Overall Study|Adverse Event|3|||
23578190|NCT01833065|65847066|FG000|Overall Study|Protocol Violation|1|||
23578191|NCT01833065|65847067|FG001|Overall Study|Protocol Violation|0|||
23578192|NCT01833065|65847068|FG002|Overall Study|Protocol Violation|0|||
23578193|NCT01833065|65847069|FG003|Overall Study|Protocol Violation|0|||
23578194|NCT01833065|65847070|FG004|Overall Study|Protocol Violation|2|||
23578195|NCT01833065|65847066|FG000|Overall Study|Lost to Follow-up|1|||
23578196|NCT01833065|65847067|FG001|Overall Study|Lost to Follow-up|0|||
23578197|NCT01833065|65847068|FG002|Overall Study|Lost to Follow-up|0|||
23578198|NCT01833065|65847069|FG003|Overall Study|Lost to Follow-up|0|||
23578199|NCT01833065|65847070|FG004|Overall Study|Lost to Follow-up|3|||
23578200|NCT01833065|65847066|FG000|Overall Study|Withdrawal by Subject|6|||
23171393|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
23171394|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
23171395|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Other|0|||
23171396|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Other|0|||
23171397|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Other|0|||
23171398|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Other|1|||
23171399|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Other|3|||
23171400|NCT03107793|64371014|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
23578201|NCT01833065|65847067|FG001|Overall Study|Withdrawal by Subject|2|||
23578202|NCT01833065|65847068|FG002|Overall Study|Withdrawal by Subject|4|||
23171401|NCT03107793|64371015|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
23171402|NCT03107793|64371016|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
23171403|NCT03107793|64371017|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
23171404|NCT03107793|64371018|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
23171405|NCT03298022|64371019|FG000|Overall Study|Lack of Efficacy|4|||
23171406|NCT03298022|64371019|FG000|Overall Study|Withdrawal by Subject|7|||
23171407|NCT03298022|64371019|FG000|Overall Study|Adverse Event|1|||
23171408|NCT03298022|64371019|FG000|Overall Study|disease relapse|1|||
23171409|NCT01637142|64371020|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
23171410|NCT01297270|64371023|FG000|Overall Study|Adverse Event|19|||
23171411|NCT01297270|64371024|FG001|Overall Study|Adverse Event|32|||
23171412|NCT01297270|64371025|FG002|Overall Study|Adverse Event|5|||
23171413|NCT01297270|64371023|FG000|Overall Study|Lack of Efficacy|15|||
23171414|NCT01297270|64371024|FG001|Overall Study|Lack of Efficacy|17|||
23171415|NCT01297270|64371025|FG002|Overall Study|Lack of Efficacy|15|||
23338588|NCT01334918|64983063|FG000|Overall Study|Withdrawal by Subject|0|||
23338589|NCT01334918|64983064|FG001|Overall Study|Withdrawal by Subject|1|||
23338590|NCT03617770|64983066|FG000|Overall Study|Lost to Follow-up|1|||
23578203|NCT01833065|65847069|FG003|Overall Study|Withdrawal by Subject|3|||
23338591|NCT03617770|64983067|FG001|Overall Study|Lost to Follow-up|0|||
23338592|NCT00459290|64983070|FG000|Overall Study|Adverse Event|3|||
23450568|NCT00360412|65391576|FG001|Overall Study|Other|6|||
23450569|NCT00360412|65391575|FG000|Overall Study|Study termination by Sponsor|214|||
23450570|NCT00360412|65391576|FG001|Overall Study|Study termination by Sponsor|469|||
23450571|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
23171416|NCT01297270|64371023|FG000|Overall Study|Lost to Follow-up|1|||
23171417|NCT01297270|64371024|FG001|Overall Study|Lost to Follow-up|2|||
23338593|NCT00459290|64983070|FG000|Overall Study|Ineligible|2|||
23578204|NCT01833065|65847070|FG004|Overall Study|Withdrawal by Subject|11|||
23578205|NCT01833065|65847066|FG000|Overall Study|Subject's substantial non-compliance|0|||
23171418|NCT01297270|64371025|FG002|Overall Study|Lost to Follow-up|1|||
23171419|NCT01297270|64371023|FG000|Overall Study|Protocol Violation|0|||
23171420|NCT01297270|64371024|FG001|Overall Study|Protocol Violation|2|||
23578206|NCT01833065|65847067|FG001|Overall Study|Subject's substantial non-compliance|1|||
23578207|NCT01833065|65847068|FG002|Overall Study|Subject's substantial non-compliance|0|||
23171421|NCT01297270|64371025|FG002|Overall Study|Protocol Violation|0|||
23578208|NCT01833065|65847069|FG003|Overall Study|Subject's substantial non-compliance|0|||
23578209|NCT01833065|65847070|FG004|Overall Study|Subject's substantial non-compliance|0|||
23578210|NCT01833065|65847066|FG000|Overall Study|Trial terminated by sponsor|8|||
23578211|NCT01833065|65847067|FG001|Overall Study|Trial terminated by sponsor|8|||
23578212|NCT01833065|65847068|FG002|Overall Study|Trial terminated by sponsor|7|||
23578213|NCT01833065|65847069|FG003|Overall Study|Trial terminated by sponsor|3|||
23578214|NCT01833065|65847070|FG004|Overall Study|Trial terminated by sponsor|13|||
23578215|NCT01833065|65847066|FG000|Overall Study|Others|2|||
23578216|NCT01833065|65847067|FG001|Overall Study|Others|1|||
23578217|NCT01833065|65847068|FG002|Overall Study|Others|1|||
23578218|NCT01833065|65847069|FG003|Overall Study|Others|1|||
23578219|NCT01833065|65847070|FG004|Overall Study|Others|4|||
23578220|NCT02652130|65847071|FG000|Overall Study|Death|1|||
23578221|NCT01668147|65847072|FG000|Overall Study|Withdrawal by Subject|6|||
23578222|NCT04296942|65847073|FG000|Overall Study|Study closure by sponsor|1|||
23578223|NCT04296942|65847074|FG001|Overall Study|Study closure by sponsor|0|||
23578224|NCT04296942|65847075|FG002|Overall Study|Study closure by sponsor|0|||
23578225|NCT03677375|65847076|FG000|Overall Study|Incomplete procedure|8|||
23578226|NCT03677375|65847076|FG000|Overall Study|Adverse Event|3|||
23578227|NCT03677375|65847076|FG000|Overall Study|Physician Decision|1|||
23578228|NCT02800928|65847077|FG000|Overall Study|Withdrawal by Subject|1|||
23578229|NCT02800928|65847078|FG001|Overall Study|Withdrawal by Subject|1|||
23578230|NCT02800928|65847077|FG000|Overall Study|Protocol Violation|1|||
23578231|NCT02800928|65847078|FG001|Overall Study|Protocol Violation|1|||
23578232|NCT00231179|65847079|FG000|Overall Study|Lost to Follow-up|21|||
23578233|NCT00231179|65847080|FG001|Overall Study|Lost to Follow-up|21|||
23578234|NCT00231179|65847079|FG000|Overall Study|Withdrawal by Subject|3|||
23578235|NCT00231179|65847080|FG001|Overall Study|Withdrawal by Subject|3|||
23578236|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
23578237|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
23578238|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
23578239|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
23578240|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
23578241|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
23171422|NCT01297270|64371023|FG000|Overall Study|Withdrawal by Subject|7|||
23171423|NCT01297270|64371024|FG001|Overall Study|Withdrawal by Subject|15|||
23171424|NCT01297270|64371025|FG002|Overall Study|Withdrawal by Subject|7|||
23171425|NCT01297270|64371023|FG000|Overall Study|Other reason not defined above|3|||
23171426|NCT01297270|64371024|FG001|Overall Study|Other reason not defined above|3|||
23171427|NCT01297270|64371025|FG002|Overall Study|Other reason not defined above|1|||
23171428|NCT01297270|64371023|FG000|Overall Study|Not treated|0|||
23171429|NCT01297270|64371024|FG001|Overall Study|Not treated|1|||
23171430|NCT01297270|64371025|FG002|Overall Study|Not treated|0|||
23171431|NCT02356562|64371026|FG000|Overall Study|Withdrawal by Subject|0|||
23171432|NCT02356562|64371027|FG001|Overall Study|Withdrawal by Subject|1|||
23171433|NCT02356562|64371026|FG000|Overall Study|Re-entered treatment in a previous study|1|||
23171434|NCT02356562|64371027|FG001|Overall Study|Re-entered treatment in a previous study|0|||
23171435|NCT02356562|64371026|FG000|Overall Study|site closure|1|||
23171436|NCT02356562|64371027|FG001|Overall Study|site closure|0|||
23171437|NCT01783678|64371030|FG000|Overall Study|Randomized but Not Treated|0|||
23171438|NCT01783678|64371031|FG001|Overall Study|Randomized but Not Treated|0|||
23171439|NCT01783678|64371032|FG002|Overall Study|Randomized but Not Treated|0|||
23171440|NCT01783678|64371033|FG003|Overall Study|Randomized but Not Treated|1|||
23171441|NCT01783678|64371034|FG004|Overall Study|Randomized but Not Treated|0|||
23171442|NCT01783678|64371035|FG005|Overall Study|Randomized but Not Treated|0|||
23171443|NCT01783678|64371030|FG000|Overall Study|Lack of Efficacy|1|||
23171444|NCT01783678|64371031|FG001|Overall Study|Lack of Efficacy|13|||
23171445|NCT01783678|64371032|FG002|Overall Study|Lack of Efficacy|1|||
23171446|NCT01783678|64371033|FG003|Overall Study|Lack of Efficacy|3|||
23450572|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
23171447|NCT01783678|64371034|FG004|Overall Study|Lack of Efficacy|6|||
23171448|NCT01783678|64371035|FG005|Overall Study|Lack of Efficacy|5|||
23578242|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
23578243|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
23578244|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
23578245|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
23578246|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
23171449|NCT01783678|64371030|FG000|Overall Study|Lost to Follow-up|0|||
23578247|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
23578248|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
23338594|NCT02727777|64983071|FG000|Overall Study|Screen Failure|2|||
23338595|NCT02727777|64983072|FG001|Overall Study|Screen Failure|0|||
23338596|NCT02727777|64983073|FG002|Overall Study|Screen Failure|0|||
23338597|NCT02727777|64983071|FG000|Overall Study|Progressive disease|2|||
23338598|NCT02727777|64983072|FG001|Overall Study|Progressive disease|0|||
23338599|NCT02727777|64983073|FG002|Overall Study|Progressive disease|0|||
23338600|NCT02217410|64983074|FG000|Overall Study|Graft Loss|0|||
23338601|NCT02217410|64983075|FG001|Overall Study|Graft Loss|0|||
23338602|NCT02217410|64983076|FG002|Overall Study|Graft Loss|2|||
23338603|NCT02217410|64983074|FG000|Overall Study|Withdrawal by Subject|0|||
23338604|NCT02217410|64983075|FG001|Overall Study|Withdrawal by Subject|0|||
23338605|NCT02217410|64983076|FG002|Overall Study|Withdrawal by Subject|2|||
23230914|NCT03557801|64588173|FG000|Overall Study|Lost to Follow-up|0|||
23230915|NCT03557801|64588174|FG001|Overall Study|Lost to Follow-up|1|||
23230916|NCT03557801|64588175|FG002|Overall Study|Lost to Follow-up|0|||
23230917|NCT02129192|64588176|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
23450573|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
23450574|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
23450575|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
23171450|NCT01783678|64371031|FG001|Overall Study|Lost to Follow-up|4|||
23171451|NCT01783678|64371032|FG002|Overall Study|Lost to Follow-up|0|||
23171452|NCT01783678|64371033|FG003|Overall Study|Lost to Follow-up|2|||
23171453|NCT01783678|64371034|FG004|Overall Study|Lost to Follow-up|1|||
23171454|NCT01783678|64371035|FG005|Overall Study|Lost to Follow-up|0|||
23171455|NCT01783678|64371030|FG000|Overall Study|Withdrew Consent|1|||
23450576|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
23450577|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
23450578|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
23450579|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
23578249|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
23578250|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
23171456|NCT01783678|64371031|FG001|Overall Study|Withdrew Consent|1|||
23338606|NCT02217410|64983074|FG000|Overall Study|Lost to Follow-up|0|||
23338607|NCT02217410|64983075|FG001|Overall Study|Lost to Follow-up|0|||
23338608|NCT02217410|64983076|FG002|Overall Study|Lost to Follow-up|1|||
23338609|NCT02217410|64983074|FG000|Overall Study|Lack of Efficacy|0|||
23338610|NCT02217410|64983075|FG001|Overall Study|Lack of Efficacy|1|||
23338611|NCT02217410|64983076|FG002|Overall Study|Lack of Efficacy|0|||
23338612|NCT02217410|64983074|FG000|Overall Study|Physician Decision|1|||
23338613|NCT02217410|64983075|FG001|Overall Study|Physician Decision|3|||
23338614|NCT02217410|64983076|FG002|Overall Study|Physician Decision|0|||
23338615|NCT02231879|64983077|FG000|Overall Study|Adverse Event|2|||
23338616|NCT02231879|64983078|FG001|Overall Study|Adverse Event|1|||
23338617|NCT02231879|64983077|FG000|Overall Study|Lack of Efficacy|0|||
23338618|NCT02231879|64983078|FG001|Overall Study|Lack of Efficacy|1|||
23338619|NCT00623935|64983079|FG000|Overall Study|Death|1|||
23338620|NCT00623935|64983079|FG000|Overall Study|Patient Declined Transplant|1|||
23338621|NCT02977572|64983085|FG000|Overall Study|Exclusion criterion|2|||
23171457|NCT01783678|64371032|FG002|Overall Study|Withdrew Consent|0|||
23171458|NCT01783678|64371033|FG003|Overall Study|Withdrew Consent|2|||
23171459|NCT01783678|64371034|FG004|Overall Study|Withdrew Consent|0|||
23171460|NCT01783678|64371035|FG005|Overall Study|Withdrew Consent|0|||
23171461|NCT01182428|64371036|FG000|Overall Study|Physician Decision|1|||
23230918|NCT02129192|64588177|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
23230919|NCT02943577|64588182|FG000|Overall Study|Protocol Violation|0|||
23338622|NCT02977572|64983086|FG001|Overall Study|Exclusion criterion|2|||
23338623|NCT02276560|64983091|FG000|Overall Study|Adverse Event|1|||
23338624|NCT02276560|64983092|FG001|Overall Study|Adverse Event|0|||
23338625|NCT02276560|64983093|FG002|Overall Study|Adverse Event|0|||
23338626|NCT02792192|64983094|FG000|Overall Study|Death|1|||
23338627|NCT02792192|64983095|FG001|Overall Study|Death|0|||
23338628|NCT02792192|64983096|FG002|Overall Study|Death|0|||
23338629|NCT02792192|64983097|FG003|Overall Study|Death|0|||
23338630|NCT02792192|64983094|FG000|Overall Study|Informed Consent Withdrawn|4|||
23338631|NCT02792192|64983095|FG001|Overall Study|Informed Consent Withdrawn|0|||
23338632|NCT02792192|64983096|FG002|Overall Study|Informed Consent Withdrawn|0|||
23338633|NCT02792192|64983097|FG003|Overall Study|Informed Consent Withdrawn|0|||
23450580|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
23171462|NCT01182428|64371037|FG001|Overall Study|Physician Decision|0|||
23171463|NCT01182428|64371036|FG000|Overall Study|Lost to Follow-up|9|||
23171464|NCT01182428|64371037|FG001|Overall Study|Lost to Follow-up|1|||
23171465|NCT01182428|64371036|FG000|Overall Study|Withdrawal by Subject|1|||
23338634|NCT02792192|64983094|FG000|Overall Study|Physician Decision|1|||
23338635|NCT02792192|64983095|FG001|Overall Study|Physician Decision|0|||
23338636|NCT02792192|64983096|FG002|Overall Study|Physician Decision|0|||
23230920|NCT02943577|64588183|FG001|Overall Study|Protocol Violation|1|||
23338637|NCT02792192|64983097|FG003|Overall Study|Physician Decision|0|||
23338638|NCT02792192|64983094|FG000|Overall Study|Progressive Disease|0|||
23338639|NCT02792192|64983095|FG001|Overall Study|Progressive Disease|1|||
23338640|NCT02792192|64983096|FG002|Overall Study|Progressive Disease|0|||
23338641|NCT02792192|64983097|FG003|Overall Study|Progressive Disease|0|||
23338642|NCT02792192|64983094|FG000|Overall Study|Study Terminated By Sponsor|6|||
23338643|NCT02792192|64983095|FG001|Overall Study|Study Terminated By Sponsor|10|||
23338644|NCT02792192|64983096|FG002|Overall Study|Study Terminated By Sponsor|0|||
23338645|NCT02792192|64983097|FG003|Overall Study|Study Terminated By Sponsor|0|||
23338646|NCT01085630|64983098|FG000|Overall Study|Insufficient data|1|||
23338647|NCT01085630|64983099|FG001|Overall Study|Insufficient data|0|||
23338648|NCT01085630|64983098|FG000|Overall Study|Ineligible|3|||
23338649|NCT01085630|64983099|FG001|Overall Study|Ineligible|0|||
23338650|NCT02640677|64983100|FG000|Overall Study|Lost to Follow-up|1|||
23338651|NCT02640677|64983100|FG000|Overall Study|Withdrawal by Subject|1|||
23338652|NCT02887248|64983107|FG000|Overall Study|Withdrawal by Subject|1|||
23338653|NCT02887248|64983107|FG000|Overall Study|Adverse Event|1|||
23338654|NCT02887248|64983107|FG000|Overall Study|Progressive Disease|1|||
23338655|NCT00761280|64983112|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
23338656|NCT00761280|64983113|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
23338657|NCT00761280|64983112|FG000|Randomization to First Dose|Sponsor decision|1|||
23338658|NCT00761280|64983113|FG001|Randomization to First Dose|Sponsor decision|0|||
23338659|NCT00761280|64983112|FG000|Randomization to First Dose|Other|1|||
23338660|NCT00761280|64983113|FG001|Randomization to First Dose|Other|0|||
23338661|NCT00761280|64983112|FG000|First Dose to End of Study|End of trial|5|||
23338662|NCT00761280|64983113|FG001|First Dose to End of Study|End of trial|5|||
23338663|NCT00761280|64983112|FG000|First Dose to End of Study|Progressive disease|5|||
23338664|NCT00761280|64983113|FG001|First Dose to End of Study|Progressive disease|3|||
23338665|NCT00761280|64983112|FG000|First Dose to End of Study|Sponsor decision|1|||
23338666|NCT00761280|64983113|FG001|First Dose to End of Study|Sponsor decision|2|||
23338667|NCT00761280|64983112|FG000|First Dose to End of Study|Death|1|||
23578251|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
23578252|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
23578253|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
23578254|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578255|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
23578256|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578257|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578258|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578259|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
23578260|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
23578261|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578262|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578263|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578264|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578265|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
23578266|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
23578267|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
23578268|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
23578269|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
23578270|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
23578271|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
23578272|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
23578273|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
23578274|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
23578275|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
23578276|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
23578277|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
23578278|NCT01089556|65847084|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
23578279|NCT01089556|65847085|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
23578280|NCT01089556|65847086|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
23578281|NCT01089556|65847087|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
23578282|NCT01089556|65847088|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
23578283|NCT01089556|65847089|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
23578284|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
23338668|NCT00761280|64983113|FG001|First Dose to End of Study|Death|0|||
23338669|NCT00761280|64983112|FG000|First Dose to End of Study|Lost to Follow-up|0|||
23578285|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
23578286|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
23578287|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
23578288|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
23338670|NCT00761280|64983113|FG001|First Dose to End of Study|Lost to Follow-up|1|||
23338671|NCT02453334|64983119|FG000|Overall Study|Death|15|||
23338672|NCT02453334|64983120|FG001|Overall Study|Death|13|||
23338673|NCT02453334|64983119|FG000|Overall Study|Adverse Event|2|||
23338674|NCT02453334|64983120|FG001|Overall Study|Adverse Event|1|||
23338675|NCT02453334|64983119|FG000|Overall Study|Lost to Follow-up|5|||
23338676|NCT02453334|64983120|FG001|Overall Study|Lost to Follow-up|9|||
23338677|NCT02453334|64983119|FG000|Overall Study|Physician Decision|1|||
23338678|NCT02453334|64983120|FG001|Overall Study|Physician Decision|0|||
23338679|NCT02453334|64983119|FG000|Overall Study|Withdrawal by Subject|17|||
23338680|NCT02453334|64983120|FG001|Overall Study|Withdrawal by Subject|13|||
23338681|NCT02453334|64983119|FG000|Overall Study|Other reason|1|||
23338682|NCT02453334|64983120|FG001|Overall Study|Other reason|4|||
23338683|NCT00957268|64983121|FG000|Overall Study|Voluntary Withdrawal|0|||
23338684|NCT00957268|64983122|FG001|Overall Study|Voluntary Withdrawal|0|||
23338685|NCT00957268|64983123|FG002|Overall Study|Voluntary Withdrawal|1|||
23338686|NCT00957268|64983124|FG003|Overall Study|Voluntary Withdrawal|0|||
23338687|NCT00957268|64983125|FG004|Overall Study|Voluntary Withdrawal|0|||
23338688|NCT04590586|64983126|FG000|Overall Study|Death|7|||
23338689|NCT04590586|64983127|FG001|Overall Study|Death|1|||
23338690|NCT04590586|64983128|FG002|Overall Study|Death|37|||
23338691|NCT04590586|64983129|FG003|Overall Study|Death|34|||
23338692|NCT04590586|64983130|FG004|Overall Study|Death|19|||
23338693|NCT04590586|64983131|FG005|Overall Study|Death|3|||
23338694|NCT04590586|64983126|FG000|Overall Study|Lost to Follow-up|3|||
23338695|NCT04590586|64983127|FG001|Overall Study|Lost to Follow-up|0|||
23338696|NCT04590586|64983128|FG002|Overall Study|Lost to Follow-up|11|||
23338697|NCT04590586|64983129|FG003|Overall Study|Lost to Follow-up|11|||
23338698|NCT04590586|64983130|FG004|Overall Study|Lost to Follow-up|6|||
23338699|NCT04590586|64983131|FG005|Overall Study|Lost to Follow-up|0|||
23338700|NCT04590586|64983126|FG000|Overall Study|Withdrawal by Subject|0|||
23338701|NCT04590586|64983127|FG001|Overall Study|Withdrawal by Subject|0|||
23338702|NCT04590586|64983128|FG002|Overall Study|Withdrawal by Subject|6|||
23338703|NCT04590586|64983129|FG003|Overall Study|Withdrawal by Subject|0|||
23338704|NCT04590586|64983130|FG004|Overall Study|Withdrawal by Subject|3|||
23338705|NCT04590586|64983131|FG005|Overall Study|Withdrawal by Subject|0|||
23338706|NCT04590586|64983126|FG000|Overall Study|Other|3|||
23338707|NCT04590586|64983127|FG001|Overall Study|Other|0|||
23338708|NCT04590586|64983128|FG002|Overall Study|Other|1|||
23338709|NCT04590586|64983129|FG003|Overall Study|Other|1|||
23338710|NCT04590586|64983130|FG004|Overall Study|Other|2|||
23338711|NCT04590586|64983131|FG005|Overall Study|Other|1|||
23338712|NCT00915876|64983134|FG000|Overall Study|Adverse Event|0|||
23338713|NCT00915876|64983135|FG001|Overall Study|Adverse Event|1|||
23338714|NCT02582242|64983136|FG000|Overall Study|Adverse Event|4|||
23338715|NCT02582242|64983137|FG001|Overall Study|Adverse Event|3|||
23338716|NCT02582242|64983136|FG000|Overall Study|Protocol Violation|3|||
23338717|NCT02582242|64983137|FG001|Overall Study|Protocol Violation|1|||
23338718|NCT02582242|64983136|FG000|Overall Study|Lost to Follow-up|0|||
23338719|NCT02582242|64983137|FG001|Overall Study|Lost to Follow-up|1|||
23338720|NCT02582242|64983136|FG000|Overall Study|Withdrawal by Subject|11|||
23338721|NCT02582242|64983137|FG001|Overall Study|Withdrawal by Subject|11|||
23338722|NCT02582242|64983136|FG000|Overall Study|Unclassified|2|||
23338723|NCT02582242|64983137|FG001|Overall Study|Unclassified|1|||
23338724|NCT01122394|64983138|FG000|Overall Study|Withdrawal by Subject|1|||
23338725|NCT01122394|64983139|FG001|Overall Study|Withdrawal by Subject|1|||
23338726|NCT01122394|64983138|FG000|Overall Study|Lost to Follow-up|2|||
23578289|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
23578290|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
23578291|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
23578292|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
23578293|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
23578294|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
23578295|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
23578296|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
23578297|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
23578298|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
23578299|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
23578300|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
23338727|NCT01122394|64983139|FG001|Overall Study|Lost to Follow-up|2|||
23338728|NCT01122394|64983138|FG000|Overall Study|Adverse Event|0|||
23578301|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
23230921|NCT02943577|64588182|FG000|Overall Study|Adverse Event|3|||
23230922|NCT02943577|64588183|FG001|Overall Study|Adverse Event|2|||
23338729|NCT01122394|64983139|FG001|Overall Study|Adverse Event|1|||
23338730|NCT04382755|64983146|FG000|Overall Study|Withdrawal by Subject|1|||
23338731|NCT04382755|64983147|FG001|Overall Study|Withdrawal by Subject|0|||
23338732|NCT04382755|64983146|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
23338733|NCT04382755|64983147|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
23340866|NCT01936181|64992871|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
23578302|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23578303|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23338734|NCT04382755|64983146|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
23338735|NCT04382755|64983147|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
23338736|NCT00095238|64983148|FG000|Overall Study|Lack of Efficacy|9|||
23338737|NCT00095238|64983149|FG001|Overall Study|Lack of Efficacy|9|||
23338738|NCT00095238|64983148|FG000|Overall Study|Adverse Event|331|||
23338739|NCT00095238|64983149|FG001|Overall Study|Adverse Event|287|||
23338740|NCT00095238|64983148|FG000|Overall Study|Subject Withdrew Consent|208|||
23338741|NCT00095238|64983149|FG001|Overall Study|Subject Withdrew Consent|223|||
23338742|NCT00095238|64983148|FG000|Overall Study|Death|154|||
23338743|NCT00095238|64983149|FG001|Overall Study|Death|170|||
23338744|NCT00095238|64983148|FG000|Overall Study|Lost to Follow-up|19|||
23230923|NCT02943577|64588182|FG000|Overall Study|Lost to Follow-up|0|||
23230924|NCT02943577|64588183|FG001|Overall Study|Lost to Follow-up|1|||
23230925|NCT02943577|64588182|FG000|Overall Study|Withdrawal by Subject|1|||
23230926|NCT02943577|64588183|FG001|Overall Study|Withdrawal by Subject|1|||
23230927|NCT02943577|64588182|FG000|Overall Study|Pregnancy|1|||
23230928|NCT02943577|64588183|FG001|Overall Study|Pregnancy|0|||
23230929|NCT01284127|64588185|FG000|Overall Study|Adverse Event|2|||
23230930|NCT01284127|64588185|FG000|Overall Study|Withdrawal by Subject|4|||
23230931|NCT01284127|64588185|FG000|Overall Study|Physician Decision|1|||
23230932|NCT00307736|64588188|FG000|Overall Study|Adverse Event|0|||
23230933|NCT00307736|64588189|FG001|Overall Study|Adverse Event|0|||
23230934|NCT00307736|64588190|FG002|Overall Study|Adverse Event|1|||
23230935|NCT00307736|64588191|FG003|Overall Study|Adverse Event|3|||
23230936|NCT00307736|64588188|FG000|Overall Study|Withdrawal by Subject|0|||
23230937|NCT00307736|64588189|FG001|Overall Study|Withdrawal by Subject|0|||
23230938|NCT00307736|64588190|FG002|Overall Study|Withdrawal by Subject|2|||
23230939|NCT00307736|64588191|FG003|Overall Study|Withdrawal by Subject|0|||
23230940|NCT00718887|64588192|FG000|Overall Study|Withdrawal by Subject|3|||
23230941|NCT00718887|64588193|FG001|Overall Study|Withdrawal by Subject|2|||
23230942|NCT00718887|64588192|FG000|Overall Study|Not identified|2|||
23230943|NCT00718887|64588193|FG001|Overall Study|Not identified|7|||
23230944|NCT01728454|64588205|FG000|Stage 1 and 2|Pregnancy|1|||
23230945|NCT01728454|64588206|FG001|Stage 1 and 2|Pregnancy|0|||
23230946|NCT01728454|64588207|FG002|Stage 1 and 2|Pregnancy|0|||
23230947|NCT01728454|64588205|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
23230948|NCT01728454|64588206|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
23230949|NCT01728454|64588207|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
23230950|NCT01728454|64588205|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
23230951|NCT01728454|64588206|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
23230952|NCT01728454|64588207|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
23230953|NCT01728454|64588205|FG000|Stage 1 and 2|Lost to Follow-up|1|||
23230954|NCT01728454|64588206|FG001|Stage 1 and 2|Lost to Follow-up|1|||
23230955|NCT01728454|64588207|FG002|Stage 1 and 2|Lost to Follow-up|0|||
23230956|NCT01728454|64588205|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
23230957|NCT01728454|64588206|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
23230958|NCT01728454|64588207|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
23230959|NCT01728454|64588205|FG000|Stage 3|Reason Missing|0|||
23338745|NCT00095238|64983149|FG001|Overall Study|Lost to Follow-up|24|||
23338746|NCT00095238|64983148|FG000|Overall Study|Noncompliance|44|||
23338747|NCT00095238|64983149|FG001|Overall Study|Noncompliance|45|||
23578304|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
23578305|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23578306|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23578307|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
23578308|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
23578309|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
23578310|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
23578311|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
23578312|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
23578313|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
23578314|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
23578315|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
23578316|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
23578317|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
23230960|NCT01728454|64588206|FG001|Stage 3|Reason Missing|0|||
23230961|NCT01728454|64588207|FG002|Stage 3|Reason Missing|1|||
23230962|NCT01728454|64588205|FG000|Stage 3|Subject Required Other Treatment|0|||
23230963|NCT01728454|64588206|FG001|Stage 3|Subject Required Other Treatment|1|||
23230964|NCT01728454|64588207|FG002|Stage 3|Subject Required Other Treatment|0|||
23230965|NCT01728454|64588205|FG000|Stage 3|Pregnancy|1|||
23230966|NCT01728454|64588206|FG001|Stage 3|Pregnancy|0|||
23230967|NCT01728454|64588207|FG002|Stage 3|Pregnancy|0|||
23230968|NCT01728454|64588205|FG000|Stage 3|Withdrew Consent|1|||
23230969|NCT01728454|64588206|FG001|Stage 3|Withdrew Consent|0|||
23230970|NCT01728454|64588207|FG002|Stage 3|Withdrew Consent|1|||
23230971|NCT01728454|64588205|FG000|Stage 3|Non-compliance with Protocol|0|||
23230972|NCT01728454|64588206|FG001|Stage 3|Non-compliance with Protocol|0|||
23230973|NCT01728454|64588207|FG002|Stage 3|Non-compliance with Protocol|1|||
23230974|NCT01728454|64588205|FG000|Stage 3|Lost to Follow-up|0|||
23230975|NCT01728454|64588206|FG001|Stage 3|Lost to Follow-up|3|||
23230976|NCT01728454|64588207|FG002|Stage 3|Lost to Follow-up|1|||
23230977|NCT01728454|64588205|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
23230978|NCT01728454|64588206|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
23230979|NCT01728454|64588207|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
23230980|NCT00634933|64588208|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
23230981|NCT00634933|64588209|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
23230982|NCT00634933|64588210|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
23230983|NCT00634933|64588211|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
23230984|NCT00634933|64588212|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
23230985|NCT00634933|64588208|FG000|Part A: Baseline to Week 24|Death|1|||
23230986|NCT00634933|64588209|FG001|Part A: Baseline to Week 24|Death|0|||
23230987|NCT00634933|64588210|FG002|Part A: Baseline to Week 24|Death|0|||
23230988|NCT00634933|64588211|FG003|Part A: Baseline to Week 24|Death|0|||
23230989|NCT00634933|64588212|FG004|Part A: Baseline to Week 24|Death|0|||
23230990|NCT00634933|64588208|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
23230991|NCT00634933|64588209|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
23230992|NCT00634933|64588210|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
23230993|NCT00634933|64588211|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
23578318|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
23578319|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
23578320|NCT01089556|65847084|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
23578321|NCT01089556|65847085|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
23578322|NCT01089556|65847086|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
23578323|NCT01089556|65847087|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
23230994|NCT00634933|64588212|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
23230995|NCT00634933|64588208|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
23230996|NCT00634933|64588209|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
23230997|NCT00634933|64588210|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
23230998|NCT00634933|64588211|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
23230999|NCT00634933|64588212|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
23231000|NCT00634933|64588208|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
23231001|NCT00634933|64588209|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
23231002|NCT00634933|64588210|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
23231003|NCT00634933|64588211|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
23231004|NCT00634933|64588212|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
23231005|NCT00634933|64588208|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
23231006|NCT00634933|64588209|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
23231007|NCT00634933|64588210|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
23231008|NCT00634933|64588211|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
23231009|NCT00634933|64588212|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
23231010|NCT00634933|64588208|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
23338748|NCT00095238|64983148|FG000|Overall Study|No longer met study criteria|4|||
23578324|NCT01089556|65847088|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
23578325|NCT01089556|65847089|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
23231011|NCT00634933|64588209|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
23231012|NCT00634933|64588210|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
23231013|NCT00634933|64588211|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
23231014|NCT00634933|64588212|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
23231015|NCT00634933|64588208|FG000|Part A: Baseline to Week 24|Other|1|||
23231016|NCT00634933|64588209|FG001|Part A: Baseline to Week 24|Other|8|||
23231017|NCT00634933|64588210|FG002|Part A: Baseline to Week 24|Other|5|||
23231018|NCT00634933|64588211|FG003|Part A: Baseline to Week 24|Other|0|||
23231019|NCT00634933|64588212|FG004|Part A: Baseline to Week 24|Other|0|||
23231020|NCT00634933|64588208|FG000|Between Part A and Part B|Physician Decision|0|||
23231021|NCT00634933|64588209|FG001|Between Part A and Part B|Physician Decision|1|||
23231022|NCT00634933|64588210|FG002|Between Part A and Part B|Physician Decision|0|||
23231023|NCT00634933|64588211|FG003|Between Part A and Part B|Physician Decision|0|||
23231024|NCT00634933|64588212|FG004|Between Part A and Part B|Physician Decision|0|||
23231025|NCT00634933|64588208|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
23231026|NCT00634933|64588209|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
23578326|NCT02056119|65847090|FG000|Overall Study|Death|1|||
23231027|NCT00634933|64588210|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
23231028|NCT00634933|64588211|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
23231029|NCT00634933|64588212|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
23338749|NCT00095238|64983149|FG001|Overall Study|No longer met study criteria|5|||
23231030|NCT00634933|64588208|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
23231031|NCT00634933|64588209|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
23231032|NCT00634933|64588210|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
23231033|NCT00634933|64588211|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
23231034|NCT00634933|64588212|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
23231035|NCT00634933|64588208|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
23231036|NCT00634933|64588209|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
23231037|NCT00634933|64588210|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
23231038|NCT00634933|64588211|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
23231039|NCT00634933|64588212|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
23231040|NCT00634933|64588208|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
23231041|NCT00634933|64588209|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
23231042|NCT00634933|64588210|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
23231043|NCT00634933|64588211|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
23231044|NCT00634933|64588212|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
23231045|NCT00634933|64588208|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
23231046|NCT00634933|64588209|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
23231047|NCT00634933|64588210|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
23231048|NCT00634933|64588211|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
23231049|NCT00634933|64588212|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
23231050|NCT00634933|64588208|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
23231051|NCT00634933|64588209|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
23231052|NCT00634933|64588210|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
23231053|NCT00634933|64588211|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
23231054|NCT00634933|64588212|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
23231055|NCT00634933|64588208|FG000|Part B: Week 24 to Week 52|Other|0|||
23231056|NCT00634933|64588209|FG001|Part B: Week 24 to Week 52|Other|0|||
23231057|NCT00634933|64588210|FG002|Part B: Week 24 to Week 52|Other|5|||
23231058|NCT00634933|64588211|FG003|Part B: Week 24 to Week 52|Other|0|||
23231059|NCT00634933|64588212|FG004|Part B: Week 24 to Week 52|Other|1|||
23231060|NCT03125902|64588213|FG000|Overall Study|Adverse Event|0|||
23231061|NCT03125902|64588214|FG001|Overall Study|Adverse Event|1|||
23231062|NCT03125902|64588213|FG000|Overall Study|Death|119|||
23231063|NCT03125902|64588214|FG001|Overall Study|Death|229|||
23578327|NCT02056119|65847091|FG001|Overall Study|Death|2|||
23578328|NCT02056119|65847090|FG000|Overall Study|Intubated for less than 24 hrs|2|||
23578329|NCT02056119|65847091|FG001|Overall Study|Intubated for less than 24 hrs|7|||
23578330|NCT02056119|65847090|FG000|Overall Study|No aerosol treatments were given.|3|||
23578331|NCT02056119|65847091|FG001|Overall Study|No aerosol treatments were given.|2|||
23578332|NCT02056119|65847090|FG000|Overall Study|Received Metaneb treatment|0|||
23578333|NCT02056119|65847091|FG001|Overall Study|Received Metaneb treatment|2|||
23231064|NCT03125902|64588213|FG000|Overall Study|Lost to Follow-up|4|||
23231065|NCT03125902|64588214|FG001|Overall Study|Lost to Follow-up|13|||
23231066|NCT03125902|64588213|FG000|Overall Study|Other|0|||
23231067|NCT03125902|64588214|FG001|Overall Study|Other|4|||
23231068|NCT03125902|64588213|FG000|Overall Study|Physician Decision|2|||
23231069|NCT03125902|64588214|FG001|Overall Study|Physician Decision|1|||
23231070|NCT03125902|64588213|FG000|Overall Study|Progressive Disease|0|||
23231071|NCT03125902|64588214|FG001|Overall Study|Progressive Disease|3|||
23231072|NCT03125902|64588213|FG000|Overall Study|Study Terminated By Sponsor|74|||
23231073|NCT03125902|64588214|FG001|Overall Study|Study Terminated By Sponsor|143|||
23231074|NCT03125902|64588213|FG000|Overall Study|Withdrawal by Subject|21|||
23231075|NCT03125902|64588214|FG001|Overall Study|Withdrawal by Subject|37|||
23231076|NCT01728194|64588215|FG000|Overall Study|Lost to Follow-up|4|||
23231077|NCT01728194|64588216|FG001|Overall Study|Lost to Follow-up|3|||
23231078|NCT01728194|64588215|FG000|Overall Study|Physician Decision|4|||
23231079|NCT01728194|64588216|FG001|Overall Study|Physician Decision|0|||
23231080|NCT01728194|64588215|FG000|Overall Study|Withdrawal by Subject|7|||
23231081|NCT01728194|64588216|FG001|Overall Study|Withdrawal by Subject|3|||
23231082|NCT01728194|64588215|FG000|Overall Study|Perceived Medication Side Effects|4|||
23231083|NCT01728194|64588216|FG001|Overall Study|Perceived Medication Side Effects|0|||
23231084|NCT01728194|64588215|FG000|Overall Study|Family Member Request|1|||
23231085|NCT01728194|64588216|FG001|Overall Study|Family Member Request|0|||
23231086|NCT00684073|64588217|FG000|Selection|Selection/non-selection criteria|3|||
23231087|NCT00684073|64588217|FG000|Selection|Death|1|||
23231088|NCT00684073|64588217|FG000|Selection|noncompliance|1|||
23338750|NCT00095238|64983148|FG000|Overall Study|Study terminated by sponsor|0|||
23231089|NCT00684073|64588217|FG000|Selection|Lost to Follow-up|1|||
23231090|NCT00684073|64588217|FG000|Selection|request of the sponsor|1|||
23231091|NCT00684073|64588217|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
23231092|NCT02141854|64588219|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
23578334|NCT02056119|65847090|FG000|Overall Study|Protocol Violation|4|||
23578335|NCT02056119|65847091|FG001|Overall Study|Protocol Violation|7|||
23231093|NCT02141854|64588220|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23231094|NCT02141854|64588221|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23231095|NCT02141854|64588222|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23231096|NCT02141854|64588223|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23231097|NCT02141854|64588224|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
23231098|NCT02141854|64588219|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
23231099|NCT02141854|64588220|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23578336|NCT00051311|65847092|FG000|Overall Study|Starting new study|0|||
23578337|NCT00051311|65847093|FG001|Overall Study|Starting new study|1|||
23578338|NCT00051311|65847092|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
23578339|NCT00051311|65847093|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
23578340|NCT00051311|65847092|FG000|Overall Study|Death of recipient|8|||
23578341|NCT00051311|65847093|FG001|Overall Study|Death of recipient|8|||
23578342|NCT00051311|65847092|FG000|Overall Study|Recipient taken off study|4|||
23578343|NCT00051311|65847093|FG001|Overall Study|Recipient taken off study|4|||
23578344|NCT02162732|65847094|FG000|Overall Study|Biopsy not performed.|18|||
23578345|NCT02696785|65847095|FG000|Blinded Treatment Period|Adverse Event|0|||
23578346|NCT02696785|65847096|FG001|Blinded Treatment Period|Adverse Event|1|||
23578347|NCT02696785|65847097|FG002|Blinded Treatment Period|Adverse Event|3|||
23578348|NCT02696785|65847098|FG003|Blinded Treatment Period|Adverse Event|0|||
23578349|NCT02696785|65847095|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
23578350|NCT02696785|65847096|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
23578351|NCT02696785|65847097|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
23578352|NCT02696785|65847098|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
23578353|NCT02696785|65847095|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
23578354|NCT02696785|65847096|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
23578355|NCT02696785|65847097|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
23578356|NCT02696785|65847098|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
23578357|NCT02696785|65847095|FG000|Blinded Treatment Period|Screen Failure|1|||
23578358|NCT02696785|65847096|FG001|Blinded Treatment Period|Screen Failure|0|||
23338751|NCT00095238|64983149|FG001|Overall Study|Study terminated by sponsor|1|||
23338752|NCT00095238|64983148|FG000|Overall Study|Missing|1|||
23338753|NCT00095238|64983149|FG001|Overall Study|Missing|0|||
23338754|NCT00095238|64983148|FG000|Overall Study|Other Reasons|87|||
23578359|NCT02696785|65847097|FG002|Blinded Treatment Period|Screen Failure|0|||
23231100|NCT02141854|64588221|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23231101|NCT02141854|64588222|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23231102|NCT02141854|64588223|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23231103|NCT02141854|64588224|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
23578360|NCT02696785|65847098|FG003|Blinded Treatment Period|Screen Failure|0|||
23338755|NCT00095238|64983149|FG001|Overall Study|Other Reasons|88|||
23338756|NCT02880865|64983157|FG000|Overall Study|Adverse Event|1|||
23338757|NCT02880865|64983158|FG001|Overall Study|Adverse Event|0|||
23338758|NCT02880865|64983157|FG000|Overall Study|Withdrawal by Subject|0|||
23338759|NCT02880865|64983158|FG001|Overall Study|Withdrawal by Subject|2|||
23338760|NCT02880865|64983157|FG000|Overall Study|Physician Decision|0|||
23338761|NCT02880865|64983158|FG001|Overall Study|Physician Decision|1|||
23338762|NCT01263782|64983162|FG000|Overall Study|Death|0|||
23338763|NCT01263782|64983163|FG001|Overall Study|Death|0|||
23338764|NCT01263782|64983164|FG002|Overall Study|Death|1|||
23338765|NCT01263782|64983165|FG003|Overall Study|Death|0|||
23338766|NCT01263782|64983162|FG000|Overall Study|Progressive disease|0|||
23578361|NCT02696785|65847095|FG000|Washout Period|Withdrawal by Subject|0|||
23578362|NCT02696785|65847096|FG001|Washout Period|Withdrawal by Subject|1|||
23578363|NCT02696785|65847097|FG002|Washout Period|Withdrawal by Subject|0|||
23231104|NCT02141854|64588219|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
23231105|NCT02141854|64588220|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23231106|NCT02141854|64588221|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23231107|NCT02141854|64588222|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23231108|NCT02141854|64588223|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23231109|NCT02141854|64588224|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
23231110|NCT02141854|64588219|FG000|Run-In Period (Pre-assignment)|Other|14|||
23231111|NCT02141854|64588220|FG001|Run-In Period (Pre-assignment)|Other|0|||
23338767|NCT01263782|64983163|FG001|Overall Study|Progressive disease|0|||
23338768|NCT01263782|64983164|FG002|Overall Study|Progressive disease|0|||
23338769|NCT01263782|64983165|FG003|Overall Study|Progressive disease|1|||
23450581|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
23578364|NCT02696785|65847098|FG003|Washout Period|Withdrawal by Subject|0|||
23578365|NCT02696785|65847095|FG000|Washout Period|Lack of Efficacy|0|||
23578366|NCT02696785|65847096|FG001|Washout Period|Lack of Efficacy|1|||
23578367|NCT02696785|65847097|FG002|Washout Period|Lack of Efficacy|0|||
23338770|NCT01263782|64983162|FG000|Overall Study|Too early|0|||
23578368|NCT02696785|65847098|FG003|Washout Period|Lack of Efficacy|0|||
23578369|NCT02696785|65847095|FG000|Extended Treatment Period|Adverse Event|2|||
23231112|NCT02141854|64588221|FG002|Run-In Period (Pre-assignment)|Other|0|||
23231113|NCT02141854|64588222|FG003|Run-In Period (Pre-assignment)|Other|0|||
23231114|NCT02141854|64588223|FG004|Run-In Period (Pre-assignment)|Other|0|||
23231115|NCT02141854|64588224|FG005|Run-In Period (Pre-assignment)|Other|0|||
23231116|NCT02141854|64588219|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
23231117|NCT02141854|64588220|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
23231118|NCT02141854|64588221|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
23231119|NCT02141854|64588222|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
23231120|NCT02141854|64588223|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
23231121|NCT02141854|64588224|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
23231122|NCT02141854|64588219|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
23231123|NCT02141854|64588220|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23231124|NCT02141854|64588221|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23231125|NCT02141854|64588222|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23231126|NCT02141854|64588223|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23231127|NCT02141854|64588224|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
23231128|NCT02141854|64588219|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
23231129|NCT02141854|64588220|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23231130|NCT02141854|64588221|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23231131|NCT02141854|64588222|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23231132|NCT02141854|64588223|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23231133|NCT02141854|64588224|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
23578370|NCT02696785|65847096|FG001|Extended Treatment Period|Adverse Event|3|||
23578371|NCT02696785|65847097|FG002|Extended Treatment Period|Adverse Event|2|||
23231134|NCT02141854|64588219|FG000|Treatment Period|Protocol Violation|0|||
23231135|NCT02141854|64588220|FG001|Treatment Period|Protocol Violation|1|||
23231136|NCT02141854|64588221|FG002|Treatment Period|Protocol Violation|0|||
23231137|NCT02141854|64588222|FG003|Treatment Period|Protocol Violation|2|||
23231138|NCT02141854|64588223|FG004|Treatment Period|Protocol Violation|2|||
23231139|NCT02141854|64588224|FG005|Treatment Period|Protocol Violation|1|||
23231140|NCT02141854|64588219|FG000|Treatment Period|Noncompliance|0|||
23231141|NCT02141854|64588220|FG001|Treatment Period|Noncompliance|0|||
23231142|NCT02141854|64588221|FG002|Treatment Period|Noncompliance|0|||
23231143|NCT02141854|64588222|FG003|Treatment Period|Noncompliance|1|||
23231144|NCT02141854|64588223|FG004|Treatment Period|Noncompliance|0|||
23231145|NCT02141854|64588224|FG005|Treatment Period|Noncompliance|0|||
23231146|NCT02141854|64588219|FG000|Treatment Period|Lack of Efficacy|0|||
23338771|NCT01263782|64983163|FG001|Overall Study|Too early|0|||
23338772|NCT01263782|64983164|FG002|Overall Study|Too early|1|||
23338773|NCT01263782|64983165|FG003|Overall Study|Too early|0|||
23338774|NCT01263782|64983162|FG000|Overall Study|Inevaluable|0|||
23338775|NCT01263782|64983163|FG001|Overall Study|Inevaluable|0|||
23338776|NCT01263782|64983164|FG002|Overall Study|Inevaluable|1|||
23231147|NCT02141854|64588220|FG001|Treatment Period|Lack of Efficacy|0|||
23231148|NCT02141854|64588221|FG002|Treatment Period|Lack of Efficacy|0|||
23231149|NCT02141854|64588222|FG003|Treatment Period|Lack of Efficacy|1|||
23231150|NCT02141854|64588223|FG004|Treatment Period|Lack of Efficacy|1|||
23231151|NCT02141854|64588224|FG005|Treatment Period|Lack of Efficacy|7|||
23231152|NCT02141854|64588219|FG000|Treatment Period|Pregnancy|0|||
23231153|NCT02141854|64588220|FG001|Treatment Period|Pregnancy|1|||
23231154|NCT02141854|64588221|FG002|Treatment Period|Pregnancy|0|||
23231155|NCT02141854|64588222|FG003|Treatment Period|Pregnancy|0|||
23231156|NCT02141854|64588223|FG004|Treatment Period|Pregnancy|0|||
23231157|NCT02141854|64588224|FG005|Treatment Period|Pregnancy|0|||
23578372|NCT02696785|65847098|FG003|Extended Treatment Period|Adverse Event|1|||
23578373|NCT02696785|65847095|FG000|Extended Treatment Period|Lack of Efficacy|0|||
23578374|NCT02696785|65847096|FG001|Extended Treatment Period|Lack of Efficacy|1|||
23578375|NCT02696785|65847097|FG002|Extended Treatment Period|Lack of Efficacy|0|||
23578376|NCT02696785|65847098|FG003|Extended Treatment Period|Lack of Efficacy|0|||
23578377|NCT02696785|65847095|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
23578378|NCT02696785|65847096|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
23578379|NCT02696785|65847097|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
23578380|NCT02696785|65847098|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
23338777|NCT01263782|64983165|FG003|Overall Study|Inevaluable|0|||
23578381|NCT02696785|65847095|FG000|Follow-up Period|Adverse Event|0|||
23578382|NCT02696785|65847096|FG001|Follow-up Period|Adverse Event|0|||
23231158|NCT02141854|64588219|FG000|Treatment Period|Other|0|||
23231159|NCT02141854|64588220|FG001|Treatment Period|Other|1|||
23231160|NCT02141854|64588221|FG002|Treatment Period|Other|2|||
23231161|NCT02141854|64588222|FG003|Treatment Period|Other|0|||
23231162|NCT02141854|64588223|FG004|Treatment Period|Other|1|||
23231163|NCT02141854|64588224|FG005|Treatment Period|Other|2|||
23338778|NCT01866657|64983166|FG000|Overall Study|Surgery canceled|2|||
23338779|NCT01866657|64983167|FG001|Overall Study|Surgery canceled|0|||
23338780|NCT04481789|64983168|FG000|Period 1|Withdrawal by Subject|1|||
23578383|NCT02696785|65847097|FG002|Follow-up Period|Adverse Event|8|||
23578384|NCT02696785|65847098|FG003|Follow-up Period|Adverse Event|2|||
23578385|NCT02696785|65847095|FG000|Follow-up Period|Lost to Follow-up|0|||
23578386|NCT02696785|65847096|FG001|Follow-up Period|Lost to Follow-up|0|||
23578387|NCT02696785|65847097|FG002|Follow-up Period|Lost to Follow-up|0|||
23578388|NCT02696785|65847098|FG003|Follow-up Period|Lost to Follow-up|1|||
23578389|NCT02696785|65847095|FG000|Follow-up Period|Lack of Efficacy|0|||
23578390|NCT02696785|65847096|FG001|Follow-up Period|Lack of Efficacy|0|||
23578391|NCT02696785|65847097|FG002|Follow-up Period|Lack of Efficacy|0|||
23578392|NCT02696785|65847098|FG003|Follow-up Period|Lack of Efficacy|1|||
23171466|NCT01182428|64371037|FG001|Overall Study|Withdrawal by Subject|0|||
23338781|NCT04481789|64983169|FG001|Period 1|Withdrawal by Subject|0|||
23338782|NCT04481789|64983170|FG002|Period 1|Withdrawal by Subject|0|||
23338783|NCT04481789|64983171|FG003|Period 1|Withdrawal by Subject|0|||
23338784|NCT04481789|64983172|FG004|Period 1|Withdrawal by Subject|0|||
23450582|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
23450583|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
23450584|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
23450585|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
23450586|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
23450587|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
23450588|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
23450589|NCT03605667|65391577|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
23450590|NCT03605667|65391578|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
23450591|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
23450592|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
23450593|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Other|6|||
23450594|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Other|8|||
23450595|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
23450596|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
23450597|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
23450598|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
23450599|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
23171467|NCT00191451|64371042|FG000|Overall Study|Withdrawal by Subject|2|||
23171468|NCT00191451|64371043|FG001|Overall Study|Withdrawal by Subject|3|||
23171469|NCT00191451|64371044|FG002|Overall Study|Withdrawal by Subject|5|||
23171470|NCT00191451|64371042|FG000|Overall Study|Physician Decision|2|||
23171471|NCT00191451|64371043|FG001|Overall Study|Physician Decision|9|||
23450600|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
23450601|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
23450602|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
23450603|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
23450604|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
23450605|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
23450606|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
23450607|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Death|0|||
23450608|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Death|2|||
23450609|NCT03605667|65391577|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
23450610|NCT03605667|65391578|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
23450611|NCT00687401|65391579|FG000|Overall Study|Protocol Violation|7|||
23450612|NCT00687401|65391579|FG000|Overall Study|Adverse Event|6|||
23450613|NCT00687401|65391579|FG000|Overall Study|Lack of Efficacy|6|||
23450614|NCT00687401|65391579|FG000|Overall Study|Withdrawal by Subject|4|||
23450615|NCT00687401|65391579|FG000|Overall Study|Did not return for visit|3|||
23450616|NCT00687401|65391579|FG000|Overall Study|For reasons different from those above|4|||
23578393|NCT02696785|65847095|FG000|Follow-up Period|Withdrawal by Subject|1|||
23171472|NCT00191451|64371044|FG002|Overall Study|Physician Decision|6|||
23171473|NCT00191451|64371042|FG000|Overall Study|Sponsor Decision|1|||
23171474|NCT00191451|64371043|FG001|Overall Study|Sponsor Decision|0|||
23171475|NCT00191451|64371044|FG002|Overall Study|Sponsor Decision|0|||
23171476|NCT00191451|64371042|FG000|Overall Study|Ineligible|0|||
23171477|NCT00191451|64371043|FG001|Overall Study|Ineligible|1|||
23171478|NCT00191451|64371044|FG002|Overall Study|Ineligible|0|||
23171479|NCT00191451|64371042|FG000|Overall Study|Reason Not Specified|2|||
23171480|NCT00191451|64371043|FG001|Overall Study|Reason Not Specified|1|||
23171481|NCT00191451|64371044|FG002|Overall Study|Reason Not Specified|3|||
23338785|NCT04481789|64983173|FG005|Period 1|Withdrawal by Subject|0|||
23450617|NCT01903460|65391581|FG000|Overall Study|Adverse Event|0|||
23450618|NCT01903460|65391582|FG001|Overall Study|Adverse Event|0|||
23578394|NCT02696785|65847096|FG001|Follow-up Period|Withdrawal by Subject|0|||
23171482|NCT03948178|64371047|FG000|Overall Study|Protocol Violation|1|||
23171483|NCT03948178|64371047|FG000|Overall Study|Lost to Follow-up|2|||
23171484|NCT03948178|64371047|FG000|Overall Study|Withdrawal by Subject|2|||
23171485|NCT03948178|64371047|FG000|Overall Study|Reason not known|2|||
23171486|NCT03948178|64371047|FG000|Overall Study|Personal reason|14|||
23338786|NCT03503370|64983180|FG000|Overall Study|Death|3|||
23450619|NCT01903460|65391583|FG002|Overall Study|Adverse Event|0|||
23450620|NCT01903460|65391584|FG003|Overall Study|Adverse Event|1|||
23450621|NCT00286494|65391585|FG000|Overall Study|Hyperglycemic rescue|12|||
23231164|NCT02141854|64588219|FG000|Treatment Period|Adverse Event|0|||
23231165|NCT02141854|64588220|FG001|Treatment Period|Adverse Event|2|||
23231166|NCT02141854|64588221|FG002|Treatment Period|Adverse Event|2|||
23231167|NCT02141854|64588222|FG003|Treatment Period|Adverse Event|0|||
23231168|NCT02141854|64588223|FG004|Treatment Period|Adverse Event|2|||
23231169|NCT02141854|64588224|FG005|Treatment Period|Adverse Event|2|||
23231170|NCT02141854|64588219|FG000|Treatment Period|Withdrawal by Subject|0|||
23231171|NCT02141854|64588220|FG001|Treatment Period|Withdrawal by Subject|2|||
23231172|NCT02141854|64588221|FG002|Treatment Period|Withdrawal by Subject|3|||
23231173|NCT02141854|64588222|FG003|Treatment Period|Withdrawal by Subject|3|||
23231174|NCT02141854|64588223|FG004|Treatment Period|Withdrawal by Subject|4|||
23231175|NCT02141854|64588224|FG005|Treatment Period|Withdrawal by Subject|7|||
23231176|NCT02141854|64588219|FG000|Treatment Period|Disease progression|0|||
23231177|NCT02141854|64588220|FG001|Treatment Period|Disease progression|2|||
23231178|NCT02141854|64588221|FG002|Treatment Period|Disease progression|1|||
23231179|NCT02141854|64588222|FG003|Treatment Period|Disease progression|3|||
23231180|NCT02141854|64588223|FG004|Treatment Period|Disease progression|0|||
23231181|NCT02141854|64588224|FG005|Treatment Period|Disease progression|18|||
23231182|NCT02141854|64588219|FG000|Treatment Period|Lost to Follow-up|0|||
23231183|NCT02141854|64588220|FG001|Treatment Period|Lost to Follow-up|1|||
23231184|NCT02141854|64588221|FG002|Treatment Period|Lost to Follow-up|1|||
23231185|NCT02141854|64588222|FG003|Treatment Period|Lost to Follow-up|1|||
23231186|NCT02141854|64588223|FG004|Treatment Period|Lost to Follow-up|0|||
23231187|NCT02141854|64588224|FG005|Treatment Period|Lost to Follow-up|1|||
23231188|NCT00540228|64588225|FG000|Overall Study|Adverse Event|2|||
23231189|NCT00540228|64588226|FG001|Overall Study|Adverse Event|0|||
23231190|NCT00540228|64588227|FG002|Overall Study|Adverse Event|0|||
23231191|NCT00540228|64588228|FG003|Overall Study|Adverse Event|0|||
23231192|NCT00540228|64588229|FG004|Overall Study|Adverse Event|0|||
23231193|NCT00540228|64588225|FG000|Overall Study|Lost to Follow-up|1|||
23231194|NCT00540228|64588226|FG001|Overall Study|Lost to Follow-up|1|||
23231195|NCT00540228|64588227|FG002|Overall Study|Lost to Follow-up|0|||
23231196|NCT00540228|64588228|FG003|Overall Study|Lost to Follow-up|0|||
23231197|NCT00540228|64588229|FG004|Overall Study|Lost to Follow-up|0|||
23231198|NCT00095836|64588230|FG000|Overall Study|Lost to Follow-up|1|||
23231199|NCT00095836|64588230|FG000|Overall Study|Adverse Event|1|||
23231200|NCT00095836|64588230|FG000|Overall Study|Death|2|||
23231201|NCT01888367|64588231|FG000|Overall Study|Physician Decision|3|||
23231202|NCT01888367|64588232|FG001|Overall Study|Physician Decision|4|||
23231203|NCT01888367|64588233|FG002|Overall Study|Physician Decision|2|||
23231204|NCT01888367|64588231|FG000|Overall Study|Death|2|||
23231205|NCT01888367|64588232|FG001|Overall Study|Death|0|||
23231206|NCT01888367|64588233|FG002|Overall Study|Death|1|||
23231207|NCT01888367|64588231|FG000|Overall Study|Withdrawal by Subject|1|||
23231208|NCT01888367|64588232|FG001|Overall Study|Withdrawal by Subject|0|||
23231209|NCT01888367|64588233|FG002|Overall Study|Withdrawal by Subject|1|||
23231210|NCT01888367|64588231|FG000|Overall Study|Lost to Follow-up|1|||
23231211|NCT01888367|64588232|FG001|Overall Study|Lost to Follow-up|1|||
23231212|NCT01888367|64588233|FG002|Overall Study|Lost to Follow-up|0|||
23231213|NCT01888367|64588231|FG000|Overall Study|Protocol Violation|0|||
23231214|NCT01888367|64588232|FG001|Overall Study|Protocol Violation|0|||
23231215|NCT01888367|64588233|FG002|Overall Study|Protocol Violation|1|||
23231216|NCT01888367|64588231|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
23231217|NCT01888367|64588232|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
23231218|NCT01888367|64588233|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
23450622|NCT00286494|65391586|FG001|Overall Study|Hyperglycemic rescue|19|||
23231219|NCT00951912|64588236|FG000|Overall Study|Lack of Efficacy|1|||
23231220|NCT00951912|64588237|FG001|Overall Study|Lack of Efficacy|0|||
23231221|NCT00951912|64588238|FG002|Overall Study|Lack of Efficacy|0|||
23231222|NCT00951912|64588236|FG000|Overall Study|Adverse Event|0|||
23231223|NCT00951912|64588237|FG001|Overall Study|Adverse Event|1|||
23231224|NCT00951912|64588238|FG002|Overall Study|Adverse Event|1|||
23231225|NCT00951912|64588236|FG000|Overall Study|Lost to Follow-up|2|||
23231226|NCT00951912|64588237|FG001|Overall Study|Lost to Follow-up|2|||
23450623|NCT00286494|65391587|FG002|Overall Study|Hyperglycemic rescue|18|||
23450624|NCT00286494|65391585|FG000|Overall Study|Withdrawal by Subject|2|||
23231227|NCT00951912|64588238|FG002|Overall Study|Lost to Follow-up|0|||
23578395|NCT02696785|65847097|FG002|Follow-up Period|Withdrawal by Subject|5|||
23578396|NCT02696785|65847098|FG003|Follow-up Period|Withdrawal by Subject|4|||
23231228|NCT00951912|64588236|FG000|Overall Study|Physician Decision|1|||
23231229|NCT00951912|64588237|FG001|Overall Study|Physician Decision|0|||
23231230|NCT00951912|64588238|FG002|Overall Study|Physician Decision|1|||
23231231|NCT00951912|64588236|FG000|Overall Study|Withdrawal by Subject|1|||
23231232|NCT00951912|64588237|FG001|Overall Study|Withdrawal by Subject|1|||
23231233|NCT00951912|64588238|FG002|Overall Study|Withdrawal by Subject|0|||
23231234|NCT00951912|64588236|FG000|Overall Study|Other:Depression|1|||
23231235|NCT00951912|64588237|FG001|Overall Study|Other:Depression|0|||
23231236|NCT00951912|64588238|FG002|Overall Study|Other:Depression|0|||
23231237|NCT00951912|64588236|FG000|Overall Study|Other: Colon cancer|1|||
23231238|NCT00951912|64588237|FG001|Overall Study|Other: Colon cancer|0|||
23231239|NCT00951912|64588238|FG002|Overall Study|Other: Colon cancer|0|||
23231240|NCT00951912|64588236|FG000|Overall Study|Other: Stroke|0|||
23231241|NCT00951912|64588237|FG001|Overall Study|Other: Stroke|1|||
23231242|NCT00951912|64588238|FG002|Overall Study|Other: Stroke|0|||
23231243|NCT04107935|64588239|FG000|Overall Study|Death|1|||
23231244|NCT04107935|64588240|FG001|Overall Study|Death|0|||
23231245|NCT03812224|64588241|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
23231246|NCT03812224|64588242|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
23231247|NCT03812224|64588241|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
23231248|NCT03812224|64588242|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
23231249|NCT03812224|64588241|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
23231250|NCT03812224|64588242|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
23578397|NCT01712685|65847102|FG000|Overall Study|pt declined to participate before trmt|1|||
23578398|NCT00506285|65847103|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
23578399|NCT00506285|65847104|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
23578400|NCT00506285|65847103|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
23578401|NCT00506285|65847104|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
23578402|NCT00506285|65847103|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
23578403|NCT00506285|65847104|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
23578404|NCT00506285|65847103|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
23578405|NCT00506285|65847104|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
23578406|NCT00506285|65847103|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
23578407|NCT00506285|65847104|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
23578408|NCT01394991|65847108|FG000|Overall Study|Adverse Event|0|||
23578409|NCT01394991|65847109|FG001|Overall Study|Adverse Event|4|||
23578410|NCT01394991|65847108|FG000|Overall Study|Lack of Efficacy|5|||
23578411|NCT01394991|65847109|FG001|Overall Study|Lack of Efficacy|7|||
23578412|NCT01394991|65847108|FG000|Overall Study|Lost to Follow-up|6|||
23578413|NCT01394991|65847109|FG001|Overall Study|Lost to Follow-up|8|||
23578414|NCT01394991|65847108|FG000|Overall Study|Physician Decision|1|||
23578415|NCT01394991|65847109|FG001|Overall Study|Physician Decision|3|||
23578416|NCT01394991|65847108|FG000|Overall Study|Protocol Violation|1|||
23578417|NCT01394991|65847109|FG001|Overall Study|Protocol Violation|1|||
23578418|NCT01394991|65847108|FG000|Overall Study|Withdrawal by Subject|20|||
23578419|NCT01394991|65847109|FG001|Overall Study|Withdrawal by Subject|17|||
23578420|NCT01394991|65847108|FG000|Overall Study|Chemotherapy Termination|10|||
23578421|NCT01394991|65847109|FG001|Overall Study|Chemotherapy Termination|15|||
23578422|NCT01394991|65847108|FG000|Overall Study|Disease Progression|7|||
23578423|NCT01394991|65847109|FG001|Overall Study|Disease Progression|7|||
23578424|NCT01394991|65847108|FG000|Overall Study|Prematurely Termination of Trial|9|||
23578425|NCT01394991|65847109|FG001|Overall Study|Prematurely Termination of Trial|10|||
23578426|NCT04562779|65847110|FG000|Overall Study|Lost to Follow-up|7|||
23578427|NCT04562779|65847111|FG001|Overall Study|Lost to Follow-up|5|||
23578428|NCT04562779|65847112|FG002|Overall Study|Lost to Follow-up|10|||
23578429|NCT04562779|65847110|FG000|Overall Study|Protocol Violation|2|||
23578430|NCT04562779|65847111|FG001|Overall Study|Protocol Violation|2|||
23578431|NCT04562779|65847112|FG002|Overall Study|Protocol Violation|0|||
23578432|NCT00087490|65847113|FG000|Overall Study|Death|6|||
23578433|NCT00087490|65847114|FG001|Overall Study|Death|4|||
23578434|NCT00087490|65847113|FG000|Overall Study|Adverse Event|3|||
23231251|NCT03812224|64588241|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
23231252|NCT03812224|64588242|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
23231253|NCT02436915|64588243|FG000|Overall Study|Withdrawal by Subject|0|||
23578435|NCT00087490|65847114|FG001|Overall Study|Adverse Event|8|||
23578436|NCT00087490|65847113|FG000|Overall Study|Lack of Efficacy|0|||
23578437|NCT00087490|65847114|FG001|Overall Study|Lack of Efficacy|2|||
23578438|NCT00087490|65847113|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
23578439|NCT00087490|65847114|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
23578440|NCT00087490|65847113|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
23578441|NCT00087490|65847114|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
23578442|NCT00087490|65847113|FG000|Overall Study|Randomized but not treated|7|||
23578443|NCT00087490|65847114|FG001|Overall Study|Randomized but not treated|18|||
23171487|NCT03948178|64371047|FG000|Overall Study|Disease progression|30|||
23171488|NCT03948178|64371047|FG000|Overall Study|Adverse Event|12|||
23171489|NCT03948178|64371047|FG000|Overall Study|Sponsor terminated study|164|||
23171490|NCT02971670|64371054|FG000|Overall Study|Withdrawal by Subject|4|||
23171491|NCT02971670|64371055|FG001|Overall Study|Withdrawal by Subject|1|||
23171492|NCT02971670|64371056|FG002|Overall Study|Withdrawal by Subject|1|||
23171493|NCT02971670|64371057|FG003|Overall Study|Withdrawal by Subject|2|||
23450625|NCT00286494|65391586|FG001|Overall Study|Withdrawal by Subject|10|||
23450626|NCT00286494|65391587|FG002|Overall Study|Withdrawal by Subject|9|||
23450627|NCT00286494|65391585|FG000|Overall Study|Adverse Event|3|||
23450628|NCT00286494|65391586|FG001|Overall Study|Adverse Event|8|||
23450629|NCT00286494|65391587|FG002|Overall Study|Adverse Event|6|||
23450630|NCT00286494|65391585|FG000|Overall Study|Physician Decision|5|||
23450631|NCT00286494|65391586|FG001|Overall Study|Physician Decision|5|||
23450632|NCT00286494|65391587|FG002|Overall Study|Physician Decision|1|||
23450633|NCT00286494|65391585|FG000|Overall Study|Lost to Follow-up|3|||
23450634|NCT00286494|65391586|FG001|Overall Study|Lost to Follow-up|1|||
23450635|NCT00286494|65391587|FG002|Overall Study|Lost to Follow-up|3|||
23450636|NCT00286494|65391585|FG000|Overall Study|Protocol Violation|1|||
23450637|NCT00286494|65391586|FG001|Overall Study|Protocol Violation|1|||
23450638|NCT00286494|65391587|FG002|Overall Study|Protocol Violation|2|||
23450639|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Progressive disease|50|||
23450640|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Progressive disease|110|||
23450641|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Progressive disease|0|||
23450642|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Progressive disease|0|||
23450643|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
23450644|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
23450645|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23450646|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23450647|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Adverse Event|7|||
23450648|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Adverse Event|7|||
23450649|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Adverse Event|0|||
23450650|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Adverse Event|0|||
23578444|NCT00681811|65847115|FG000|Overall Study|Adverse Event|1|||
23578445|NCT00681811|65847116|FG001|Overall Study|Adverse Event|1|||
23231254|NCT02436915|64588244|FG001|Overall Study|Withdrawal by Subject|1|||
23231255|NCT03529162|64588245|FG000|Overall Study|Lost to Follow-up|2|||
23578446|NCT00681811|65847115|FG000|Overall Study|Withdrawal by Subject|2|||
23578447|NCT00681811|65847116|FG001|Overall Study|Withdrawal by Subject|2|||
23578448|NCT00681811|65847115|FG000|Overall Study|Non-compliance|0|||
23578449|NCT00681811|65847116|FG001|Overall Study|Non-compliance|1|||
23578450|NCT01101542|65847118|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
23578451|NCT01101542|65847118|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
23171494|NCT02532855|64371061|FG000|Overall Study|Lost to Follow-up|4|||
23171495|NCT02532855|64371062|FG001|Overall Study|Lost to Follow-up|3|||
23171496|NCT02532855|64371061|FG000|Overall Study|Withdrawal by Subject|4|||
23171497|NCT02532855|64371062|FG001|Overall Study|Withdrawal by Subject|8|||
23171498|NCT00506883|64371063|FG000|Overall Study|Lost to Follow-up|1|||
23171499|NCT00506883|64371064|FG001|Overall Study|Lost to Follow-up|1|||
23171500|NCT00506883|64371065|FG002|Overall Study|Lost to Follow-up|1|||
23171501|NCT00506883|64371063|FG000|Overall Study|Withdrawal by Subject|1|||
23171502|NCT00506883|64371064|FG001|Overall Study|Withdrawal by Subject|0|||
23171503|NCT00506883|64371065|FG002|Overall Study|Withdrawal by Subject|1|||
23231256|NCT03529162|64588246|FG001|Overall Study|Lost to Follow-up|2|||
23231257|NCT01875731|64588247|FG000|Overall Study|Fail to obtain lab sample|1|||
23231258|NCT01875731|64588248|FG001|Overall Study|Fail to obtain lab sample|0|||
23231259|NCT05060003|64588251|FG000|Overall Study|ctDNA negative|7|||
23231260|NCT04051944|64588252|FG000|Overall Study|Study ending|1|||
23231261|NCT04051944|64588253|FG001|Overall Study|Study ending|1|||
23231262|NCT04051944|64588252|FG000|Overall Study|Early study termination by participant|1|||
23231263|NCT04051944|64588253|FG001|Overall Study|Early study termination by participant|0|||
23578452|NCT01101542|65847118|FG000|Year 4 Surveillance Period|Other|287|||
23171504|NCT00506883|64371063|FG000|Overall Study|Lack of Efficacy|0|||
23231264|NCT04051944|64588252|FG000|Overall Study|Withdrawal by Subject|2|||
23338787|NCT03503370|64983181|FG001|Overall Study|Death|1|||
23450651|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Other|1|||
23450652|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Other|3|||
23450653|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Other|0|||
23171505|NCT00506883|64371064|FG001|Overall Study|Lack of Efficacy|1|||
23171506|NCT00506883|64371065|FG002|Overall Study|Lack of Efficacy|1|||
23171507|NCT00506883|64371063|FG000|Overall Study|Other|5|||
23171508|NCT00506883|64371064|FG001|Overall Study|Other|1|||
23450654|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Other|0|||
23578453|NCT01101542|65847118|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
23578454|NCT01101542|65847118|FG000|Year 5 Surveillance Period|Pregnancy|1|||
23578455|NCT01101542|65847118|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
23231265|NCT04051944|64588253|FG001|Overall Study|Withdrawal by Subject|2|||
23231266|NCT04051944|64588252|FG000|Overall Study|Lack of Efficacy|3|||
23231267|NCT04051944|64588253|FG001|Overall Study|Lack of Efficacy|0|||
23171509|NCT00506883|64371065|FG002|Overall Study|Other|1|||
23171510|NCT02469090|64371074|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
23171511|NCT02469090|64371075|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
23171512|NCT02469090|64371076|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
23171513|NCT02469090|64371074|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
23171514|NCT02469090|64371075|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
23171515|NCT02469090|64371076|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
23171516|NCT02469090|64371074|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
23171517|NCT02469090|64371075|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
23171518|NCT02469090|64371076|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
23171519|NCT02469090|64371074|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
23171520|NCT02469090|64371075|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
23231268|NCT04051944|64588252|FG000|Overall Study|Adverse event, non- fatal|1|||
23231269|NCT04051944|64588253|FG001|Overall Study|Adverse event, non- fatal|1|||
23231270|NCT02608099|64588256|FG000|Overall Study|Ablation procedure not initiated|3|||
23231271|NCT02608099|64588257|FG001|Overall Study|Ablation procedure not initiated|2|||
23338788|NCT00002931|64983182|FG000|Overall Study|rapidly progressing disease during|2|||
23450655|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Physician Decision|6|||
23450656|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Physician Decision|3|||
23450657|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Physician Decision|0|||
23338789|NCT02714595|64983183|FG000|Overall Study|Lost to Follow-up|1|||
23338790|NCT02714595|64983184|FG001|Overall Study|Lost to Follow-up|0|||
23338791|NCT02714595|64983183|FG000|Overall Study|Withdrawal by Subject|1|||
23338792|NCT02714595|64983184|FG001|Overall Study|Withdrawal by Subject|2|||
23338793|NCT02714595|64983183|FG000|Overall Study|Lack of Efficacy|0|||
23338794|NCT02714595|64983184|FG001|Overall Study|Lack of Efficacy|1|||
23338795|NCT02714595|64983183|FG000|Overall Study|Death|30|||
23338796|NCT02714595|64983184|FG001|Overall Study|Death|9|||
23338797|NCT02714595|64983183|FG000|Overall Study|Other-Miscellaneous|0|||
23338798|NCT02714595|64983184|FG001|Overall Study|Other-Miscellaneous|1|||
23338799|NCT00594100|64985966|FG000|Procedure|Technical Failure|9|||
23338800|NCT00594100|64985966|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
23338801|NCT00594100|64985966|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
23338802|NCT00594100|64985966|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
23338803|NCT03689374|64985970|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
23338804|NCT03689374|64985971|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
23338805|NCT03689374|64985972|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
23338806|NCT03689374|64985970|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
23338807|NCT03689374|64985971|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
23338808|NCT03689374|64985972|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
23338809|NCT03689374|64985970|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
23338810|NCT03689374|64985971|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
23338811|NCT03689374|64985972|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
23338812|NCT03689374|64985970|FG000|Treatment Period (Week 0 to 52)|Death|0|||
23450658|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Physician Decision|0|||
23338813|NCT03689374|64985971|FG001|Treatment Period (Week 0 to 52)|Death|11|||
23338814|NCT03689374|64985972|FG002|Treatment Period (Week 0 to 52)|Death|1|||
23338815|NCT00688701|64985978|FG000|Overall Study|Adverse Event|1|||
23338816|NCT00688701|64985979|FG001|Overall Study|Adverse Event|0|||
23338817|NCT00688701|64985980|FG002|Overall Study|Adverse Event|5|||
23338818|NCT00688701|64985981|FG003|Overall Study|Adverse Event|3|||
23338819|NCT00688701|64985978|FG000|Overall Study|Lack of Efficacy|0|||
23338820|NCT00688701|64985979|FG001|Overall Study|Lack of Efficacy|1|||
23338821|NCT00688701|64985980|FG002|Overall Study|Lack of Efficacy|0|||
23338822|NCT00688701|64985981|FG003|Overall Study|Lack of Efficacy|0|||
23338823|NCT00688701|64985978|FG000|Overall Study|Withdrawal by Subject|3|||
23338824|NCT00688701|64985979|FG001|Overall Study|Withdrawal by Subject|3|||
23338825|NCT00688701|64985980|FG002|Overall Study|Withdrawal by Subject|4|||
23338826|NCT00688701|64985981|FG003|Overall Study|Withdrawal by Subject|8|||
23338827|NCT00688701|64985978|FG000|Overall Study|Poor compliance to protocol|0|||
23338828|NCT00688701|64985979|FG001|Overall Study|Poor compliance to protocol|1|||
23578456|NCT01101542|65847118|FG000|Year 6 Surveillance Period|Pregnancy|1|||
23171521|NCT02469090|64371076|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
23171522|NCT02469090|64371074|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
23171523|NCT02469090|64371075|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
23338829|NCT00688701|64985980|FG002|Overall Study|Poor compliance to protocol|1|||
23338830|NCT00688701|64985981|FG003|Overall Study|Poor compliance to protocol|0|||
23338831|NCT00355147|64985985|FG000|Overall Study|Lost to Follow-up|10|||
23338832|NCT00355147|64985986|FG001|Overall Study|Lost to Follow-up|8|||
23338833|NCT00355147|64985985|FG000|Overall Study|Withdrawal by Subject|8|||
23338834|NCT00355147|64985986|FG001|Overall Study|Withdrawal by Subject|12|||
23338835|NCT05113979|64985987|FG000|Overall Study|Death|2|||
23338836|NCT05113979|64985987|FG000|Overall Study|Lost to Follow-up|1|||
23338837|NCT01421225|64985988|FG000|Overall Study|Withdrawal by Subject|0|||
23338838|NCT01421225|64985989|FG001|Overall Study|Withdrawal by Subject|1|||
23338839|NCT02752165|64985995|FG000|Overall Study|Withdrawal by Subject|6|||
23338840|NCT02752165|64985996|FG001|Overall Study|Withdrawal by Subject|6|||
23338841|NCT02752165|64985995|FG000|Overall Study|Protocol Violation|6|||
23338842|NCT02752165|64985996|FG001|Overall Study|Protocol Violation|5|||
23338843|NCT02752165|64985995|FG000|Overall Study|Lost to Follow-up|33|||
23338844|NCT02752165|64985996|FG001|Overall Study|Lost to Follow-up|38|||
23338845|NCT01817582|64985997|FG000|Overall Study|Withdrawal by Subject|0|||
23338846|NCT01817582|64985998|FG001|Overall Study|Withdrawal by Subject|1|||
23450659|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Death|1|||
23450660|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Death|1|||
23450661|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Death|0|||
23338847|NCT01817582|64985999|FG002|Overall Study|Withdrawal by Subject|0|||
23338848|NCT01817582|64985997|FG000|Overall Study|Participant revealed masked treatment|1|||
23338849|NCT01817582|64985998|FG001|Overall Study|Participant revealed masked treatment|0|||
23338850|NCT01817582|64985999|FG002|Overall Study|Participant revealed masked treatment|0|||
23338851|NCT01817582|64985997|FG000|Overall Study|Randomized but exclusion criteria met|1|||
23338852|NCT01817582|64985998|FG001|Overall Study|Randomized but exclusion criteria met|0|||
23338853|NCT01817582|64985999|FG002|Overall Study|Randomized but exclusion criteria met|0|||
23338854|NCT01108341|64986001|FG000|Overall Study|Death|2|||
23338855|NCT01108341|64986001|FG000|Overall Study|Withdrawal by Subject|1|||
23338856|NCT01108341|64986001|FG000|Overall Study|Lost to Follow-up|1|||
23338857|NCT01108341|64986001|FG000|Overall Study|Other|1|||
23338858|NCT00960986|64986002|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
23338859|NCT00960986|64986003|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
23338860|NCT00960986|64986004|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
23338861|NCT00960986|64986005|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
23338862|NCT00960986|64986002|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
23338863|NCT00960986|64986003|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
23338864|NCT00960986|64986004|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
23338865|NCT00960986|64986005|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
23338866|NCT00960986|64986002|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
23338867|NCT00960986|64986003|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
23338868|NCT00960986|64986004|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
23338869|NCT00960986|64986005|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
23338870|NCT00960986|64986002|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
23338871|NCT00960986|64986003|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
23338872|NCT00960986|64986004|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
23338873|NCT00960986|64986005|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
23338874|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
23338875|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
23450662|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Death|0|||
23450663|NCT01695135|65391588|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
23231272|NCT00925522|64588258|FG000|Overall Study|study closed -- business decision|20|||
23231273|NCT04880642|64588266|FG000|Randomization|Withdrawal by Subject|2|||
23231274|NCT04880642|64588267|FG001|Randomization|Withdrawal by Subject|3|||
23231275|NCT04880642|64588266|FG000|Treatment Period|Adverse Event|0|||
23231276|NCT04880642|64588267|FG001|Treatment Period|Adverse Event|1|||
23231277|NCT04880642|64588266|FG000|Treatment Period|Death|6|||
23231278|NCT04880642|64588267|FG001|Treatment Period|Death|6|||
23231279|NCT04880642|64588266|FG000|Treatment Period|Lost to Follow-up|1|||
23231280|NCT04880642|64588267|FG001|Treatment Period|Lost to Follow-up|0|||
23231281|NCT04880642|64588266|FG000|Treatment Period|Protocol Violation|0|||
23231282|NCT04880642|64588267|FG001|Treatment Period|Protocol Violation|1|||
23231283|NCT04880642|64588266|FG000|Treatment Period|Withdrawal by Subject|5|||
23231284|NCT04880642|64588267|FG001|Treatment Period|Withdrawal by Subject|3|||
23231285|NCT04880642|64588266|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
23231286|NCT04880642|64588267|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
23231287|NCT04880642|64588266|FG000|Follow-up|Death|4|||
23231288|NCT04880642|64588267|FG001|Follow-up|Death|3|||
23231289|NCT04880642|64588266|FG000|Follow-up|Withdrawal by Subject|1|||
23231290|NCT04880642|64588267|FG001|Follow-up|Withdrawal by Subject|0|||
23231291|NCT02176226|64588272|FG000|Overall Study|Lost to Follow-up|3|||
23231292|NCT02176226|64588272|FG000|Overall Study|Withdrew prior to treatment|6|||
23231293|NCT02607735|64588274|FG000|Primary Study|Randomized but Never Treated|1|||
23338876|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
23338877|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
23338878|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Death|0|||
23338879|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Death|0|||
23338880|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Death|1|||
23338881|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Death|0|||
23338882|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
23338883|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
23338884|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
23338885|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
23338886|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
23338887|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
23338888|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
23338889|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
23578457|NCT01101542|65847118|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
23578458|NCT00997243|65847121|FG000|Overall Study|Early termination of study by sponsor|7|||
23578459|NCT01734811|65850197|FG000|Overall Study|Lost to Follow-up|2|||
23578460|NCT01734811|65850198|FG001|Overall Study|Lost to Follow-up|3|||
23578461|NCT01734811|65850197|FG000|Overall Study|Withdrawal by Subject|2|||
23338890|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
23338891|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
23578462|NCT01734811|65850198|FG001|Overall Study|Withdrawal by Subject|0|||
23578463|NCT01390857|65850199|FG000|Overall Study|Protocol Violation|2|||
23578464|NCT01390857|65850199|FG000|Overall Study|Lost to Follow-up|1|||
23578465|NCT01390857|65850199|FG000|Overall Study|No Visit after the First Visit|7|||
23578466|NCT02068885|65850205|FG000|Overall Study|Withdrew|3|||
23578467|NCT02068885|65850206|FG001|Overall Study|Withdrew|5|||
23578468|NCT02068885|65850207|FG002|Overall Study|Withdrew|8|||
23578469|NCT01118962|65850208|FG000|Overall Study|Adverse Event|2|||
23578470|NCT01118962|65850208|FG000|Overall Study|Lack of Efficacy|1|||
23578471|NCT01118962|65850208|FG000|Overall Study|Protocol Violation|1|||
23578472|NCT01118962|65850208|FG000|Overall Study|Withdrawal by Subject|4|||
23171524|NCT02469090|64371076|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
23171525|NCT02469090|64371074|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
23338892|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
23338893|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
23338894|NCT00960986|64986002|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
23171526|NCT02469090|64371075|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
23171527|NCT02469090|64371076|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
23171528|NCT02469090|64371074|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
23171529|NCT02469090|64371075|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
23171530|NCT02469090|64371076|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
23171531|NCT02469090|64371074|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
23171532|NCT02469090|64371075|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
23171533|NCT02469090|64371076|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
23171534|NCT00684957|64371079|FG000|Overall Study|Withdrawal by Subject|1|||
23171535|NCT00684957|64371080|FG001|Overall Study|Withdrawal by Subject|1|||
23171536|NCT00684957|64371079|FG000|Overall Study|Lost to Follow-up|1|||
23171537|NCT00684957|64371080|FG001|Overall Study|Lost to Follow-up|0|||
23171538|NCT02863809|64371082|FG000|Overall Study|Adverse Event|8|||
23171539|NCT02863809|64371083|FG001|Overall Study|Adverse Event|8|||
23171540|NCT02863809|64371082|FG000|Overall Study|Withdrawal by Subject|0|||
23171541|NCT02863809|64371083|FG001|Overall Study|Withdrawal by Subject|1|||
23171542|NCT02863809|64371082|FG000|Overall Study|Lost to Follow-up|1|||
23171543|NCT02863809|64371083|FG001|Overall Study|Lost to Follow-up|1|||
23171544|NCT02863809|64371082|FG000|Overall Study|Death|1|||
23171545|NCT02863809|64371083|FG001|Overall Study|Death|0|||
23171546|NCT01353703|64371085|FG000|Overall Study|Migrated/moved from study area|1|||
23171547|NCT01353703|64371086|FG001|Overall Study|Migrated/moved from study area|0|||
23171548|NCT03804684|64371087|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
23171549|NCT03804684|64371088|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
23171550|NCT02302963|64371089|FG000|Overall Study|Withdrawal by Subject|2|||
23171551|NCT02302963|64371090|FG001|Overall Study|Withdrawal by Subject|1|||
23171552|NCT02302963|64371089|FG000|Overall Study|Steroid injection|0|||
23171553|NCT02302963|64371090|FG001|Overall Study|Steroid injection|1|||
23171554|NCT02302963|64371089|FG000|Overall Study|Physician Decision|1|||
23171555|NCT02302963|64371090|FG001|Overall Study|Physician Decision|0|||
23171556|NCT01192347|64375449|FG000|Overall Study|Death|3|||
23171557|NCT01192347|64375449|FG000|Overall Study|Lost to Follow-up|3|||
23578473|NCT01118962|65850208|FG000|Overall Study|Pregnancy|1|||
23171558|NCT01192347|64375449|FG000|Overall Study|Withdrawal by Subject|1|||
23171559|NCT01192347|64375449|FG000|Overall Study|Adverse Event|1|||
23171560|NCT01192347|64375449|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
23338895|NCT00960986|64986003|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
23578474|NCT01118962|65850208|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
23578475|NCT00530777|65850209|FG000|Overall Study|Lost to Follow-up|0|||
23231294|NCT02607735|64588275|FG001|Primary Study|Randomized but Never Treated|0|||
23231295|NCT02607735|64588276|FG002|Primary Study|Randomized but Never Treated|0|||
23231296|NCT02607735|64588274|FG000|Primary Study|Lost to Follow-up|4|||
23231297|NCT02607735|64588275|FG001|Primary Study|Lost to Follow-up|0|||
23231298|NCT02607735|64588276|FG002|Primary Study|Lost to Follow-up|0|||
23231299|NCT02607735|64588274|FG000|Primary Study|Withdrew Consent|2|||
23231300|NCT02607735|64588275|FG001|Primary Study|Withdrew Consent|0|||
23231301|NCT02607735|64588276|FG002|Primary Study|Withdrew Consent|0|||
23231302|NCT02607735|64588274|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
23231303|NCT02607735|64588275|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
23231304|NCT02607735|64588276|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
23231305|NCT02607735|64588274|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
23231306|NCT02607735|64588275|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
23231307|NCT02607735|64588276|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
23231308|NCT00413231|64588277|FG000|0 to 30-day Post Treatment|Death|5|||
23231309|NCT00413231|64588277|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
23231310|NCT00413231|64588277|FG000|30-day to 365-day Post Treatment|Death|13|||
23231311|NCT00413231|64588277|FG000|365-day to 60-month Post Treatment|Death|36|||
23231312|NCT00413231|64588277|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
23231313|NCT00413231|64588277|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
23231314|NCT00413231|64588277|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
23231315|NCT02358863|64588281|FG000|Overall Study|Physician Decision|3|||
23231316|NCT02994927|64588289|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23231317|NCT02994927|64588290|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23231318|NCT02994927|64588289|FG000|Overall Study|Did not meet eligibility criteria|0|||
23231319|NCT02994927|64588290|FG001|Overall Study|Did not meet eligibility criteria|1|||
23231320|NCT02994927|64588289|FG000|Overall Study|Physician Decision|4|||
23231321|NCT02994927|64588290|FG001|Overall Study|Physician Decision|3|||
23231322|NCT02994927|64588289|FG000|Overall Study|Death|4|||
23231323|NCT02994927|64588290|FG001|Overall Study|Death|2|||
23231324|NCT02994927|64588289|FG000|Overall Study|Adverse Event|2|||
23231325|NCT02994927|64588290|FG001|Overall Study|Adverse Event|1|||
23231326|NCT02994927|64588289|FG000|Overall Study|Withdrawal by Subject|3|||
23231327|NCT02994927|64588290|FG001|Overall Study|Withdrawal by Subject|6|||
23231328|NCT02994927|64588289|FG000|Overall Study|Lost to Follow-up|2|||
23231329|NCT02994927|64588290|FG001|Overall Study|Lost to Follow-up|1|||
23231330|NCT03818399|64588293|FG000|Overall Study|Lost to Follow-up|11|||
23231331|NCT03818399|64588293|FG000|Overall Study|Withdrawal by Subject|1|||
23231332|NCT03818399|64588293|FG000|Overall Study|Protocol Violation|2|||
23231333|NCT01790633|64588299|FG000|Overall Study|Protocol Violation|1|||
23231334|NCT01790633|64588300|FG001|Overall Study|Protocol Violation|2|||
23231335|NCT01790633|64588299|FG000|Overall Study|Did not have serology performed|47|||
23231336|NCT01790633|64588300|FG001|Overall Study|Did not have serology performed|0|||
23231337|NCT01790633|64588299|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
23231338|NCT01790633|64588300|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
23231339|NCT00362297|64588303|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
23231340|NCT00362297|64588304|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
23231341|NCT01982942|64588305|FG000|Overall Study|Adverse Event|10|||
23231342|NCT01982942|64588306|FG001|Overall Study|Adverse Event|5|||
23231343|NCT01982942|64588305|FG000|Overall Study|Lost to Follow-up|4|||
23231344|NCT01982942|64588306|FG001|Overall Study|Lost to Follow-up|3|||
23231345|NCT01982942|64588305|FG000|Overall Study|Multiple sclerosis progression|3|||
23231346|NCT01982942|64588306|FG001|Overall Study|Multiple sclerosis progression|2|||
23231347|NCT01982942|64588305|FG000|Overall Study|Wanted to try therapy not permitted|1|||
23231348|NCT01982942|64588306|FG001|Overall Study|Wanted to try therapy not permitted|0|||
23231349|NCT01982942|64588305|FG000|Overall Study|Subject declined future visits|0|||
23231350|NCT01982942|64588306|FG001|Overall Study|Subject declined future visits|1|||
23231351|NCT01982942|64588305|FG000|Overall Study|Left geographical area|2|||
23231352|NCT01982942|64588306|FG001|Overall Study|Left geographical area|0|||
23231353|NCT01982942|64588305|FG000|Overall Study|Too many pills|1|||
23231354|NCT01982942|64588306|FG001|Overall Study|Too many pills|0|||
23578476|NCT00530777|65850210|FG001|Overall Study|Lost to Follow-up|1|||
23231355|NCT01982942|64588305|FG000|Overall Study|MS Relapse|0|||
23231356|NCT01982942|64588306|FG001|Overall Study|MS Relapse|1|||
23578477|NCT00530777|65850209|FG000|Overall Study|Death|1|||
23231357|NCT01982942|64588305|FG000|Overall Study|Chose to join a stem cell trial|0|||
23231358|NCT01982942|64588306|FG001|Overall Study|Chose to join a stem cell trial|1|||
23231359|NCT01982942|64588305|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
23231360|NCT01982942|64588306|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
23231361|NCT01005875|64588307|FG000|Overall Study|Death|3|||
23231362|NCT00758394|64588308|FG000|2nd Intervention Order|Lost to Follow-up|0|||
23231363|NCT00758394|64588309|FG001|2nd Intervention Order|Lost to Follow-up|1|||
23231364|NCT00758394|64588310|FG002|2nd Intervention Order|Lost to Follow-up|0|||
23231365|NCT00758394|64588311|FG003|2nd Intervention Order|Lost to Follow-up|0|||
23231366|NCT00758394|64588308|FG000|3rd Intervention|Lost to Follow-up|1|||
23231367|NCT00758394|64588309|FG001|3rd Intervention|Lost to Follow-up|0|||
23231368|NCT00758394|64588310|FG002|3rd Intervention|Lost to Follow-up|0|||
23231369|NCT00758394|64588311|FG003|3rd Intervention|Lost to Follow-up|1|||
23231370|NCT02807376|64588312|FG000|Overall Study|Intra-operative exclusion criteria|3|||
23231371|NCT02807376|64588313|FG001|Overall Study|Intra-operative exclusion criteria|0|||
23231372|NCT02807376|64588312|FG000|Overall Study|Lost to Follow-up|0|||
23231373|NCT02807376|64588313|FG001|Overall Study|Lost to Follow-up|1|||
23231374|NCT00962780|64588314|FG000|Overall Study|Death|0|||
23231375|NCT00962780|64588315|FG001|Overall Study|Death|1|||
23338896|NCT00960986|64986004|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
23338897|NCT00960986|64986005|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
23338898|NCT03053063|64986008|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
23338899|NCT03053063|64986009|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
23231376|NCT00962780|64588314|FG000|Overall Study|Protocol Violation|9|||
23231377|NCT00962780|64588315|FG001|Overall Study|Protocol Violation|4|||
23338900|NCT03053063|64986010|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
23338901|NCT03053063|64986011|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
23338902|NCT03053063|64986008|FG000|Randomized Phase|Withdrew consent|8|||
23338903|NCT03053063|64986009|FG001|Randomized Phase|Withdrew consent|11|||
23338904|NCT03053063|64986010|FG002|Randomized Phase|Withdrew consent|5|||
23338905|NCT03053063|64986011|FG003|Randomized Phase|Withdrew consent|0|||
23338906|NCT03053063|64986008|FG000|Randomized Phase|Investigator's Discretion|8|||
23338907|NCT03053063|64986009|FG001|Randomized Phase|Investigator's Discretion|6|||
23338908|NCT03053063|64986010|FG002|Randomized Phase|Investigator's Discretion|2|||
23338909|NCT03053063|64986011|FG003|Randomized Phase|Investigator's Discretion|0|||
23231378|NCT00962780|64588314|FG000|Overall Study|Withdrawal by Subject|1|||
23231379|NCT00962780|64588315|FG001|Overall Study|Withdrawal by Subject|8|||
23338910|NCT03053063|64986008|FG000|Randomized Phase|Lost to Follow-up|3|||
23338911|NCT03053063|64986009|FG001|Randomized Phase|Lost to Follow-up|5|||
23338912|NCT03053063|64986010|FG002|Randomized Phase|Lost to Follow-up|1|||
23338913|NCT03053063|64986011|FG003|Randomized Phase|Lost to Follow-up|0|||
23338914|NCT03053063|64986008|FG000|Randomized Phase|Adverse Event|0|||
23338915|NCT03053063|64986009|FG001|Randomized Phase|Adverse Event|1|||
23338916|NCT03053063|64986010|FG002|Randomized Phase|Adverse Event|0|||
23338917|NCT03053063|64986011|FG003|Randomized Phase|Adverse Event|0|||
23338918|NCT03053063|64986008|FG000|Randomized Phase|Randomized but Never Treated|1|||
23338919|NCT03053063|64986009|FG001|Randomized Phase|Randomized but Never Treated|3|||
23338920|NCT03053063|64986010|FG002|Randomized Phase|Randomized but Never Treated|2|||
23338921|NCT03053063|64986011|FG003|Randomized Phase|Randomized but Never Treated|0|||
23231380|NCT00962780|64588314|FG000|Overall Study|Other|0|||
23231381|NCT00962780|64588315|FG001|Overall Study|Other|1|||
23338922|NCT03053063|64986008|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
23338923|NCT03053063|64986009|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
23338924|NCT03053063|64986010|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
23338925|NCT03053063|64986011|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
23338926|NCT03053063|64986008|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
23338927|NCT03053063|64986009|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
23338928|NCT03053063|64986010|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
23338929|NCT03053063|64986011|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
23338930|NCT03053063|64986008|FG000|Open-Label Phase|Death|0|||
23338931|NCT03053063|64986009|FG001|Open-Label Phase|Death|0|||
23338932|NCT03053063|64986010|FG002|Open-Label Phase|Death|0|||
23338933|NCT03053063|64986011|FG003|Open-Label Phase|Death|2|||
23338934|NCT03053063|64986008|FG000|Open-Label Phase|Investigator's discretion|0|||
23231382|NCT01064622|64588318|FG000|Randomized Phase II|Withdrawal by Subject|2|||
23231383|NCT01064622|64588319|FG001|Randomized Phase II|Withdrawal by Subject|2|||
23231384|NCT01064622|64588318|FG000|Randomized Phase II|Protocol Violation|0|||
23231385|NCT01064622|64588319|FG001|Randomized Phase II|Protocol Violation|1|||
23231386|NCT01853397|64588322|FG000|Overall Study|Withdrawal by Subject|0|||
23231387|NCT01853397|64588323|FG001|Overall Study|Withdrawal by Subject|0|||
23231388|NCT01853397|64588324|FG002|Overall Study|Withdrawal by Subject|0|||
23231389|NCT01853397|64588325|FG003|Overall Study|Withdrawal by Subject|1|||
23231390|NCT01853397|64588322|FG000|Overall Study|Subject Noncompliance|0|||
23231391|NCT01853397|64588323|FG001|Overall Study|Subject Noncompliance|0|||
23231392|NCT01853397|64588324|FG002|Overall Study|Subject Noncompliance|0|||
23231393|NCT01853397|64588325|FG003|Overall Study|Subject Noncompliance|1|||
23338935|NCT03053063|64986009|FG001|Open-Label Phase|Investigator's discretion|0|||
23578478|NCT00530777|65850210|FG001|Overall Study|Death|2|||
23578479|NCT00530777|65850209|FG000|Overall Study|Physician Decision|1|||
23231394|NCT02795182|64588326|FG000|Overall Study|Death|5|||
23231395|NCT02795182|64588327|FG001|Overall Study|Death|4|||
23231396|NCT02795182|64588328|FG002|Overall Study|Death|4|||
23231397|NCT02795182|64588329|FG003|Overall Study|Death|18|||
23231398|NCT02795182|64588326|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
23338936|NCT03053063|64986010|FG002|Open-Label Phase|Investigator's discretion|0|||
23338937|NCT03053063|64986011|FG003|Open-Label Phase|Investigator's discretion|2|||
23578480|NCT00530777|65850210|FG001|Overall Study|Physician Decision|0|||
23578481|NCT00530777|65850209|FG000|Overall Study|Withdrawal by Subject|0|||
23578482|NCT00530777|65850210|FG001|Overall Study|Withdrawal by Subject|1|||
23578483|NCT00530777|65850209|FG000|Overall Study|Unable to adhere to visit schedule|5|||
23578484|NCT00530777|65850210|FG001|Overall Study|Unable to adhere to visit schedule|1|||
23578485|NCT00764868|65850215|FG000|Overall Study|Adverse Event|18|||
23578486|NCT00764868|65850215|FG000|Overall Study|Withdrawal by Subject|31|||
23578487|NCT00764868|65850215|FG000|Overall Study|Non-compliance|16|||
23578488|NCT00764868|65850215|FG000|Overall Study|Lost to Follow-up|25|||
23578489|NCT00764868|65850215|FG000|Overall Study|Lack of Efficacy|5|||
23578490|NCT00764868|65850215|FG000|Overall Study|Subject moved|7|||
23578491|NCT00764868|65850215|FG000|Overall Study|Pregnancy|3|||
23578492|NCT00764868|65850215|FG000|Overall Study|Prohibited medication|1|||
23578493|NCT00764868|65850215|FG000|Overall Study|Out of town|1|||
23578494|NCT00764868|65850215|FG000|Overall Study|Misuse and compliance of study drug|1|||
23578495|NCT00764868|65850215|FG000|Overall Study|Subject sent to boarding school|1|||
23578496|NCT00764868|65850215|FG000|Overall Study|Met an exclusion criteria|1|||
23578497|NCT00764868|65850215|FG000|Overall Study|Positive drug screen|2|||
23578498|NCT00764868|65850215|FG000|Overall Study|Sponsor requested withdrawal|1|||
23578499|NCT01348854|65850216|FG000|Overall Study|Lost to Follow-up|2|||
23578500|NCT01348854|65850217|FG001|Overall Study|Lost to Follow-up|1|||
23578501|NCT01348854|65850216|FG000|Overall Study|Withdrawal by Subject|1|||
23578502|NCT01348854|65850217|FG001|Overall Study|Withdrawal by Subject|0|||
23578503|NCT00724061|65850218|FG000|Dose Escalation Phase|Adverse Event|2|||
23578504|NCT00724061|65850218|FG000|Dose Escalation Phase|Disease Progression|3|||
23578505|NCT03670602|65850224|FG000|Overall Study|Lost to Follow-up|1|||
23578506|NCT03670602|65850225|FG001|Overall Study|Lost to Follow-up|0|||
23578507|NCT03670602|65850224|FG000|Overall Study|Withdrawal by Subject|0|||
23578508|NCT03670602|65850225|FG001|Overall Study|Withdrawal by Subject|3|||
23578509|NCT01561079|65850227|FG000|Overall Study|Physician Decision|17|||
23578510|NCT01561079|65850227|FG000|Overall Study|Withdrawal by Subject|59|||
23578511|NCT01561079|65850227|FG000|Overall Study|Protocol Violation|2|||
23578512|NCT03424239|65850228|FG000|Overall Study|Withdrawal by Subject|2|||
23171561|NCT01192347|64375449|FG000|Overall Study|Patient seen in different hospital|1|||
23171562|NCT01192347|64375449|FG000|Overall Study|Patient not visiting hospital regularly|1|||
23171563|NCT01192347|64375449|FG000|Overall Study|Patient did not show up for visits|1|||
23338938|NCT02720744|64986022|FG000|Overall Study|Protocol Violation|0|||
23338939|NCT02720744|64986023|FG001|Overall Study|Protocol Violation|2|||
23338940|NCT02720744|64986022|FG000|Overall Study|Pregnancy|2|||
23338941|NCT02720744|64986023|FG001|Overall Study|Pregnancy|0|||
23338942|NCT02720744|64986022|FG000|Overall Study|Lack of Efficacy|2|||
23338943|NCT02720744|64986023|FG001|Overall Study|Lack of Efficacy|8|||
23338944|NCT02720744|64986022|FG000|Overall Study|Adverse Event|21|||
23338945|NCT02720744|64986023|FG001|Overall Study|Adverse Event|3|||
23338946|NCT02720744|64986022|FG000|Overall Study|Withdrawal by Subject|11|||
23338947|NCT02720744|64986023|FG001|Overall Study|Withdrawal by Subject|11|||
23338948|NCT02720744|64986022|FG000|Overall Study|Lost to follow up|2|||
23171564|NCT00419380|64375450|FG000|Overall Study|Lack of Efficacy|1|||
23171565|NCT00419380|64375451|FG001|Overall Study|Lack of Efficacy|7|||
23171566|NCT00419380|64375450|FG000|Overall Study|Physician Decision|0|||
23171567|NCT00419380|64375451|FG001|Overall Study|Physician Decision|1|||
23171568|NCT00419380|64375450|FG000|Overall Study|Lost to Follow-up|0|||
23171569|NCT00419380|64375451|FG001|Overall Study|Lost to Follow-up|1|||
23171570|NCT00419380|64375450|FG000|Overall Study|Withdrawal by Subject|0|||
23171571|NCT00419380|64375451|FG001|Overall Study|Withdrawal by Subject|1|||
23171572|NCT01017952|64375453|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
23171573|NCT01017952|64375454|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23171574|NCT01017952|64375455|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23171575|NCT01017952|64375456|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23171576|NCT01017952|64375457|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23171577|NCT01017952|64375453|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
23171578|NCT01017952|64375454|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
23171579|NCT01017952|64375455|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
23171580|NCT01017952|64375456|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
23338949|NCT02720744|64986023|FG001|Overall Study|Lost to follow up|0|||
23578513|NCT01143077|65850229|FG000|Overall Study|Lack of Efficacy|0|||
23578514|NCT01143077|65850230|FG001|Overall Study|Lack of Efficacy|2|||
23578515|NCT01143077|65850231|FG002|Overall Study|Lack of Efficacy|1|||
23578516|NCT01143077|65850229|FG000|Overall Study|Adverse Event|5|||
23338950|NCT02720744|64986022|FG000|Overall Study|Non Compliance with Investigational Product|0|||
23578517|NCT01143077|65850230|FG001|Overall Study|Adverse Event|6|||
23578518|NCT01143077|65850231|FG002|Overall Study|Adverse Event|5|||
23578519|NCT01143077|65850229|FG000|Overall Study|Lost to Follow-up|2|||
23338951|NCT02720744|64986023|FG001|Overall Study|Non Compliance with Investigational Product|1|||
23338952|NCT02720744|64986022|FG000|Overall Study|Excluded Concomitant Medication|0|||
23578520|NCT01143077|65850230|FG001|Overall Study|Lost to Follow-up|3|||
23578521|NCT01143077|65850231|FG002|Overall Study|Lost to Follow-up|4|||
23578522|NCT01143077|65850229|FG000|Overall Study|Protocol Violation|2|||
23578523|NCT01143077|65850230|FG001|Overall Study|Protocol Violation|0|||
23578524|NCT01143077|65850231|FG002|Overall Study|Protocol Violation|0|||
23578525|NCT01143077|65850229|FG000|Overall Study|Withdrawal by Subject|4|||
23578526|NCT01143077|65850230|FG001|Overall Study|Withdrawal by Subject|3|||
23578527|NCT01143077|65850231|FG002|Overall Study|Withdrawal by Subject|3|||
23578528|NCT01143077|65850229|FG000|Overall Study|Non-compliance with study drug|0|||
23578529|NCT01143077|65850230|FG001|Overall Study|Non-compliance with study drug|1|||
23231399|NCT02795182|64588327|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
23231400|NCT02795182|64588328|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
23231401|NCT02795182|64588329|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
23231402|NCT02795182|64588326|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
23231403|NCT02795182|64588327|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
23231404|NCT02795182|64588328|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
23338953|NCT02720744|64986023|FG001|Overall Study|Excluded Concomitant Medication|1|||
23338954|NCT02656290|64986024|FG000|Overall Study|Lost to Follow-up|1|||
23338955|NCT02656290|64986024|FG000|Overall Study|Reintervention|3|||
23338956|NCT03505593|64986025|FG000|Overall Study|Withdrawal by Subject|1|||
23338957|NCT03505593|64986025|FG000|Overall Study|Died before procedure|1|||
23338958|NCT03505593|64986025|FG000|Overall Study|Anatomical abnormality|1|||
23338959|NCT03505593|64986025|FG000|Overall Study|Unable to pass through esophagus|1|||
23338960|NCT03505593|64986025|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
23338961|NCT00721279|64986027|FG000|Overall Study|Lack of Efficacy|6|||
23338962|NCT00721279|64986028|FG001|Overall Study|Lack of Efficacy|3|||
23338963|NCT00721279|64986027|FG000|Overall Study|Tolerability insufficient|5|||
23338964|NCT00721279|64986028|FG001|Overall Study|Tolerability insufficient|2|||
23338965|NCT00721279|64986027|FG000|Overall Study|Withdrawal by Subject|13|||
23578530|NCT01143077|65850231|FG002|Overall Study|Non-compliance with study drug|1|||
23171581|NCT01017952|64375457|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
23171582|NCT01017952|64375453|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
23171583|NCT01017952|64375454|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
23171584|NCT01017952|64375455|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
23171585|NCT01017952|64375456|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
23171586|NCT01017952|64375457|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
23171587|NCT01017952|64375453|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
23171588|NCT01017952|64375454|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23171589|NCT01017952|64375455|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23171590|NCT01017952|64375456|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23171591|NCT01017952|64375457|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23171592|NCT01017952|64375453|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
23171593|NCT01017952|64375454|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
23171594|NCT01017952|64375455|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
23171595|NCT01017952|64375456|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
23171596|NCT01017952|64375457|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
23171597|NCT01017952|64375453|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
23171598|NCT01017952|64375454|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23171599|NCT01017952|64375455|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23171600|NCT01017952|64375456|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23171601|NCT01017952|64375457|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23171602|NCT01017952|64375453|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
23171603|NCT01017952|64375454|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
23171604|NCT01017952|64375455|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
23171605|NCT01017952|64375456|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
23171606|NCT01017952|64375457|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
23171607|NCT01017952|64375453|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23171608|NCT01017952|64375454|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
23171609|NCT01017952|64375455|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
23171610|NCT01017952|64375456|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
23171611|NCT01017952|64375457|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
23171612|NCT01017952|64375453|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
23171613|NCT01017952|64375454|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
23171614|NCT01017952|64375455|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
23171615|NCT01017952|64375456|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
23171616|NCT01017952|64375457|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
23171617|NCT01017952|64375453|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
23171618|NCT01017952|64375454|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
23171619|NCT01017952|64375455|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
23171620|NCT01017952|64375456|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
23171621|NCT01017952|64375457|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
23171622|NCT01017952|64375453|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23171623|NCT01017952|64375454|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
23171624|NCT01017952|64375455|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
23171625|NCT01017952|64375456|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
23231405|NCT02795182|64588329|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
23231406|NCT02795182|64588326|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
23231407|NCT02795182|64588327|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
23231408|NCT02795182|64588328|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
23231409|NCT02795182|64588329|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
23231410|NCT02795182|64588326|FG000|Overall Study|Withdrawal by Subject|4|||
23338966|NCT00721279|64986028|FG001|Overall Study|Withdrawal by Subject|3|||
23338967|NCT00721279|64986027|FG000|Overall Study|Other|12|||
23338968|NCT00721279|64986028|FG001|Overall Study|Other|16|||
23338969|NCT02288091|64986030|FG000|Overall Study|Lost to Follow-up|1|||
23338970|NCT02288091|64986030|FG000|Overall Study|Screen fail|7|||
23338971|NCT01895270|64986035|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
23338972|NCT01895270|64986036|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
23338973|NCT01895270|64986035|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
23338974|NCT01895270|64986036|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
23450664|NCT01695135|65391589|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
23231411|NCT02795182|64588327|FG001|Overall Study|Withdrawal by Subject|0|||
23231412|NCT02795182|64588328|FG002|Overall Study|Withdrawal by Subject|0|||
23231413|NCT02795182|64588329|FG003|Overall Study|Withdrawal by Subject|3|||
23231414|NCT02795182|64588326|FG000|Overall Study|Lost to Follow-up|0|||
23231415|NCT02795182|64588327|FG001|Overall Study|Lost to Follow-up|0|||
23231416|NCT02795182|64588328|FG002|Overall Study|Lost to Follow-up|1|||
23231417|NCT02795182|64588329|FG003|Overall Study|Lost to Follow-up|1|||
23231418|NCT02795182|64588326|FG000|Overall Study|Roll Over to Long Term Extension|3|||
23231419|NCT02795182|64588327|FG001|Overall Study|Roll Over to Long Term Extension|3|||
23231420|NCT02795182|64588328|FG002|Overall Study|Roll Over to Long Term Extension|2|||
23231421|NCT02795182|64588329|FG003|Overall Study|Roll Over to Long Term Extension|5|||
23231422|NCT02795182|64588326|FG000|Overall Study|Progressive Disease|0|||
23231423|NCT02795182|64588327|FG001|Overall Study|Progressive Disease|1|||
23231424|NCT02795182|64588328|FG002|Overall Study|Progressive Disease|0|||
23231425|NCT02795182|64588329|FG003|Overall Study|Progressive Disease|4|||
23231426|NCT02795182|64588326|FG000|Overall Study|Physician Decision|0|||
23231427|NCT02795182|64588327|FG001|Overall Study|Physician Decision|0|||
23231428|NCT02795182|64588328|FG002|Overall Study|Physician Decision|0|||
23231429|NCT02795182|64588329|FG003|Overall Study|Physician Decision|1|||
23231430|NCT04109066|64588330|FG000|Pre-treatment|Participant withdrew consent|2|||
23231431|NCT04109066|64588331|FG001|Pre-treatment|Participant withdrew consent|0|||
23231432|NCT04109066|64588330|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
23231433|NCT04109066|64588331|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
23231434|NCT04109066|64588330|FG000|Treatment|Lack of Efficacy|2|||
23231435|NCT04109066|64588331|FG001|Treatment|Lack of Efficacy|3|||
23231436|NCT04109066|64588330|FG000|Treatment|Adverse Event|19|||
23231437|NCT04109066|64588331|FG001|Treatment|Adverse Event|6|||
23231438|NCT04109066|64588330|FG000|Treatment|Participant request to discontinue Study treatment|12|||
23231439|NCT04109066|64588331|FG001|Treatment|Participant request to discontinue Study treatment|14|||
23231440|NCT04109066|64588330|FG000|Treatment|Withdrawal by Subject|7|||
23231441|NCT04109066|64588331|FG001|Treatment|Withdrawal by Subject|8|||
23231442|NCT04109066|64588330|FG000|Treatment|Death|3|||
23231443|NCT04109066|64588331|FG001|Treatment|Death|0|||
23231444|NCT04109066|64588330|FG000|Treatment|Participant no longer meets study criteria|3|||
23231445|NCT04109066|64588331|FG001|Treatment|Participant no longer meets study criteria|1|||
23231446|NCT04109066|64588330|FG000|Treatment|Administrative reasons by sponsor|2|||
23450665|NCT01695135|65391590|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
23450666|NCT01695135|65391591|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
23231447|NCT04109066|64588331|FG001|Treatment|Administrative reasons by sponsor|3|||
23231448|NCT04109066|64588330|FG000|Treatment|Other reasons|17|||
23231449|NCT04109066|64588331|FG001|Treatment|Other reasons|23|||
23231450|NCT04109066|64588330|FG000|Treatment|Disease Progression|4|||
23231451|NCT04109066|64588331|FG001|Treatment|Disease Progression|7|||
23231452|NCT04109066|64588330|FG000|Treatment|Study drug toxicity|13|||
23231453|NCT04109066|64588331|FG001|Treatment|Study drug toxicity|5|||
23578531|NCT01143077|65850229|FG000|Overall Study|Administrative|1|||
23578532|NCT01143077|65850230|FG001|Overall Study|Administrative|0|||
23231454|NCT04109066|64588330|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
23231455|NCT04109066|64588331|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
23450667|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
23450668|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
23171626|NCT01017952|64375457|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
23171627|NCT01017952|64375453|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23171628|NCT01017952|64375454|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
23171629|NCT01017952|64375455|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
23171630|NCT01017952|64375456|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23171631|NCT01017952|64375457|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23171632|NCT01017952|64375453|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23171633|NCT01017952|64375454|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
23171634|NCT01017952|64375455|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
23231456|NCT04109066|64588330|FG000|Treatment|Disease Recurrence|0|||
23171635|NCT01017952|64375456|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
23171636|NCT01017952|64375457|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
23171637|NCT01017952|64375453|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
23171638|NCT01017952|64375454|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
23171639|NCT01017952|64375455|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
23171640|NCT01017952|64375456|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
23171641|NCT01017952|64375457|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
23171642|NCT02902120|64375458|FG000|Overall Study|Lack of Efficacy|1|||
23171643|NCT02296242|64375462|FG000|Overall Study|Death|1|||
23171644|NCT02296242|64375463|FG001|Overall Study|Death|1|||
23171645|NCT02296242|64375464|FG002|Overall Study|Death|1|||
23171646|NCT02296242|64375465|FG003|Overall Study|Death|1|||
23171647|NCT02296242|64375466|FG004|Overall Study|Death|1|||
23171648|NCT02296242|64375462|FG000|Overall Study|Withdrawal by Subject|0|||
23171649|NCT02296242|64375463|FG001|Overall Study|Withdrawal by Subject|0|||
23171650|NCT02296242|64375464|FG002|Overall Study|Withdrawal by Subject|1|||
23231457|NCT04109066|64588331|FG001|Treatment|Disease Recurrence|2|||
23450669|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
23450670|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
23450671|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
23578533|NCT01143077|65850231|FG002|Overall Study|Administrative|0|||
23338975|NCT01895270|64986035|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
23338976|NCT01895270|64986036|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
23338977|NCT01895270|64986035|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
23338978|NCT01895270|64986036|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
23338979|NCT01895270|64986035|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
23171651|NCT02296242|64375465|FG003|Overall Study|Withdrawal by Subject|1|||
23171652|NCT02296242|64375466|FG004|Overall Study|Withdrawal by Subject|3|||
23231458|NCT04109066|64588330|FG000|Treatment|Not reported|6|||
23231459|NCT04109066|64588331|FG001|Treatment|Not reported|8|||
23231460|NCT04109066|64588330|FG000|Treatment|On-going treatment|48|||
23231461|NCT04109066|64588331|FG001|Treatment|On-going treatment|52|||
23231462|NCT01497899|64588333|FG000|Double-Blind Phase|Randomized but not Treated|1|||
23231463|NCT01497899|64588334|FG001|Double-Blind Phase|Randomized but not Treated|0|||
23231464|NCT01497899|64588335|FG002|Double-Blind Phase|Randomized but not Treated|0|||
23231465|NCT01497899|64588336|FG003|Double-Blind Phase|Randomized but not Treated|0|||
23231466|NCT01497899|64588333|FG000|Double-Blind Phase|Adverse Event|1|||
23231467|NCT01497899|64588334|FG001|Double-Blind Phase|Adverse Event|0|||
23231468|NCT01497899|64588335|FG002|Double-Blind Phase|Adverse Event|0|||
23231469|NCT01497899|64588336|FG003|Double-Blind Phase|Adverse Event|0|||
23231470|NCT01497899|64588333|FG000|Double-Blind Phase|Lack of Efficacy|0|||
23231471|NCT01497899|64588334|FG001|Double-Blind Phase|Lack of Efficacy|1|||
23231472|NCT01497899|64588335|FG002|Double-Blind Phase|Lack of Efficacy|0|||
23231473|NCT01497899|64588336|FG003|Double-Blind Phase|Lack of Efficacy|0|||
23231474|NCT01497899|64588333|FG000|Double-Blind Phase|Investigator's Discretion|1|||
23231475|NCT01497899|64588334|FG001|Double-Blind Phase|Investigator's Discretion|0|||
23231476|NCT01497899|64588335|FG002|Double-Blind Phase|Investigator's Discretion|0|||
23231477|NCT01497899|64588336|FG003|Double-Blind Phase|Investigator's Discretion|0|||
23231478|NCT01497899|64588333|FG000|Double-Blind Phase|Withdrew Consent|0|||
23231479|NCT01497899|64588334|FG001|Double-Blind Phase|Withdrew Consent|1|||
23450672|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
23578534|NCT01143077|65850229|FG000|Overall Study|Principal Investigator Decision|2|||
23231480|NCT01497899|64588335|FG002|Double-Blind Phase|Withdrew Consent|0|||
23231481|NCT01497899|64588336|FG003|Double-Blind Phase|Withdrew Consent|0|||
23231482|NCT01497899|64588333|FG000|Double-Blind Phase|Lost to Follow-up|3|||
23231483|NCT01497899|64588334|FG001|Double-Blind Phase|Lost to Follow-up|2|||
23231484|NCT01497899|64588335|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23450673|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
23450674|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
23450675|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
23450676|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
23450677|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
23450678|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
23450679|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Other|0|||
23450680|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Other|0|||
23450681|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Other|4|||
23450682|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Other|7|||
23450683|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
23450684|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
23450685|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
23450686|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
23450687|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Death|0|||
23450688|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Death|0|||
23450689|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Death|2|||
23450690|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Death|7|||
23450691|NCT01695135|65391588|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
23450692|NCT01695135|65391589|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
23450693|NCT01695135|65391590|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
23450694|NCT01695135|65391591|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
23450695|NCT02201524|65391594|FG000|Overall Study|Adverse Event|0|||
23450696|NCT02201524|65391595|FG001|Overall Study|Adverse Event|2|||
23450697|NCT02201524|65391596|FG002|Overall Study|Adverse Event|1|||
23450698|NCT02201524|65391597|FG003|Overall Study|Adverse Event|0|||
23450699|NCT02201524|65391594|FG000|Overall Study|Insufficient clinical response|1|||
23450700|NCT02201524|65391595|FG001|Overall Study|Insufficient clinical response|0|||
23450701|NCT02201524|65391596|FG002|Overall Study|Insufficient clinical response|0|||
23450702|NCT02201524|65391597|FG003|Overall Study|Insufficient clinical response|0|||
23450703|NCT02201524|65391594|FG000|Overall Study|Lost to Follow-up|0|||
23450704|NCT02201524|65391595|FG001|Overall Study|Lost to Follow-up|0|||
23450705|NCT02201524|65391596|FG002|Overall Study|Lost to Follow-up|2|||
23450706|NCT02201524|65391597|FG003|Overall Study|Lost to Follow-up|0|||
23171653|NCT02296242|64375462|FG000|Overall Study|Disease Progression|1|||
23171654|NCT02296242|64375463|FG001|Overall Study|Disease Progression|3|||
23171655|NCT02296242|64375464|FG002|Overall Study|Disease Progression|2|||
23171656|NCT02296242|64375465|FG003|Overall Study|Disease Progression|8|||
23171657|NCT02296242|64375466|FG004|Overall Study|Disease Progression|11|||
23171658|NCT02296242|64375462|FG000|Overall Study|Unacceptable Toxicity|0|||
23338980|NCT01895270|64986036|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
23338981|NCT01895270|64986035|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
23338982|NCT01895270|64986036|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
23338983|NCT01895270|64986035|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
23338984|NCT01895270|64986036|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
23171659|NCT02296242|64375463|FG001|Overall Study|Unacceptable Toxicity|0|||
23171660|NCT02296242|64375464|FG002|Overall Study|Unacceptable Toxicity|0|||
23338985|NCT03030989|64986040|FG000|Overall Study|Fever|2|||
23171661|NCT02296242|64375465|FG003|Overall Study|Unacceptable Toxicity|0|||
23171662|NCT02296242|64375466|FG004|Overall Study|Unacceptable Toxicity|1|||
23171663|NCT02296242|64375462|FG000|Overall Study|Patient Condition Changed|0|||
23171664|NCT02296242|64375463|FG001|Overall Study|Patient Condition Changed|0|||
23171665|NCT02296242|64375464|FG002|Overall Study|Patient Condition Changed|2|||
23171666|NCT02296242|64375465|FG003|Overall Study|Patient Condition Changed|0|||
23171667|NCT02296242|64375466|FG004|Overall Study|Patient Condition Changed|1|||
23171668|NCT02296242|64375462|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
23171669|NCT02296242|64375463|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
23171670|NCT02296242|64375464|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
23171671|NCT02296242|64375465|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
23171672|NCT02296242|64375466|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
23171673|NCT02296242|64375462|FG000|Overall Study|Lost to Follow-up|1|||
23171674|NCT02296242|64375463|FG001|Overall Study|Lost to Follow-up|0|||
23171675|NCT02296242|64375464|FG002|Overall Study|Lost to Follow-up|0|||
23171676|NCT02296242|64375465|FG003|Overall Study|Lost to Follow-up|0|||
23338986|NCT03030989|64986041|FG001|Overall Study|Fever|2|||
23338987|NCT03030989|64986040|FG000|Overall Study|Rash|2|||
23338988|NCT03030989|64986041|FG001|Overall Study|Rash|1|||
23338989|NCT03030989|64986040|FG000|Overall Study|Fatigue/Overwhelmed|1|||
23450707|NCT02201524|65391594|FG000|Overall Study|No longer meets eligibility criteria|0|||
23171677|NCT02296242|64375466|FG004|Overall Study|Lost to Follow-up|0|||
23171678|NCT02296242|64375462|FG000|Overall Study|Need for Hydroxyurea|2|||
23338990|NCT03030989|64986041|FG001|Overall Study|Fatigue/Overwhelmed|5|||
23171679|NCT02296242|64375463|FG001|Overall Study|Need for Hydroxyurea|0|||
23338991|NCT03030989|64986040|FG000|Overall Study|Positive Blood Cultures|2|||
23338992|NCT03030989|64986041|FG001|Overall Study|Positive Blood Cultures|1|||
23338993|NCT03030989|64986040|FG000|Overall Study|Line Removed|0|||
23338994|NCT03030989|64986041|FG001|Overall Study|Line Removed|2|||
23338995|NCT03030989|64986040|FG000|Overall Study|No longer interested|5|||
23338996|NCT03030989|64986041|FG001|Overall Study|No longer interested|3|||
23171680|NCT02296242|64375464|FG002|Overall Study|Need for Hydroxyurea|0|||
23171681|NCT02296242|64375465|FG003|Overall Study|Need for Hydroxyurea|0|||
23171682|NCT02296242|64375466|FG004|Overall Study|Need for Hydroxyurea|0|||
23171683|NCT02296242|64375462|FG000|Overall Study|Screened for Other Protocol|0|||
23171684|NCT02296242|64375463|FG001|Overall Study|Screened for Other Protocol|1|||
23171685|NCT02296242|64375464|FG002|Overall Study|Screened for Other Protocol|0|||
23171686|NCT02296242|64375465|FG003|Overall Study|Screened for Other Protocol|0|||
23171687|NCT02296242|64375466|FG004|Overall Study|Screened for Other Protocol|0|||
23171688|NCT02296242|64375462|FG000|Overall Study|Physician Decision|0|||
23171689|NCT02296242|64375463|FG001|Overall Study|Physician Decision|1|||
23171690|NCT02296242|64375464|FG002|Overall Study|Physician Decision|0|||
23171691|NCT02296242|64375465|FG003|Overall Study|Physician Decision|1|||
23171692|NCT02296242|64375466|FG004|Overall Study|Physician Decision|0|||
23171693|NCT02296242|64375462|FG000|Overall Study|Alternative Treatment|0|||
23171694|NCT02296242|64375463|FG001|Overall Study|Alternative Treatment|0|||
23171695|NCT02296242|64375464|FG002|Overall Study|Alternative Treatment|0|||
23171696|NCT02296242|64375465|FG003|Overall Study|Alternative Treatment|1|||
23171697|NCT02296242|64375466|FG004|Overall Study|Alternative Treatment|0|||
23171698|NCT02296242|64375462|FG000|Overall Study|Adverse Event|0|||
23171699|NCT02296242|64375463|FG001|Overall Study|Adverse Event|0|||
23171700|NCT02296242|64375464|FG002|Overall Study|Adverse Event|0|||
23171701|NCT02296242|64375465|FG003|Overall Study|Adverse Event|1|||
23171702|NCT02296242|64375466|FG004|Overall Study|Adverse Event|0|||
23171703|NCT02296242|64375462|FG000|Overall Study|Lack of Efficacy|0|||
23171704|NCT02296242|64375463|FG001|Overall Study|Lack of Efficacy|0|||
23171705|NCT02296242|64375464|FG002|Overall Study|Lack of Efficacy|0|||
23171706|NCT02296242|64375465|FG003|Overall Study|Lack of Efficacy|0|||
23171707|NCT02296242|64375466|FG004|Overall Study|Lack of Efficacy|3|||
23171708|NCT00684515|64375467|FG000|Overall Study|Adverse Event|3|||
23171709|NCT00684515|64375468|FG001|Overall Study|Adverse Event|3|||
23171710|NCT00684515|64375469|FG002|Overall Study|Adverse Event|1|||
23171711|NCT00684515|64375467|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
23171712|NCT00684515|64375468|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
23171713|NCT00684515|64375469|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
23171714|NCT02340663|64375474|FG000|Overall Study|Lost to Follow-up|1|||
23171715|NCT02340663|64375475|FG001|Overall Study|Lost to Follow-up|0|||
23171716|NCT02340663|64375474|FG000|Overall Study|Protocol Violation|1|||
23171717|NCT02340663|64375475|FG001|Overall Study|Protocol Violation|0|||
23171718|NCT02340663|64375474|FG000|Overall Study|Withdrawal by Subject|3|||
23171719|NCT02340663|64375475|FG001|Overall Study|Withdrawal by Subject|1|||
23339009|NCT00281632|64986051|FG000|Overall Study|Adverse Event|7|||
23339010|NCT00281632|64986051|FG000|Overall Study|Withdrawal by Subject|2|||
23339011|NCT00281632|64986051|FG000|Overall Study|Disease Progression|22|||
23339012|NCT00281632|64986051|FG000|Overall Study|Death|1|||
23171720|NCT01668654|64375476|FG000|Overall Study|Study Closed/Terminated|3|||
23171721|NCT01668654|64375476|FG000|Overall Study|Withdrawal by Subject|1|||
23171722|NCT01298492|64375477|FG000|Overall Study|Death|2|||
23171723|NCT01298492|64375477|FG000|Overall Study|Insufficient Clinical Response|22|||
23339013|NCT00281632|64986051|FG000|Overall Study|Physician Decision|1|||
23171724|NCT01298492|64375477|FG000|Overall Study|Lost to Follow-up|12|||
23171725|NCT01298492|64375477|FG000|Overall Study|Withdrawal by Subject|47|||
23171726|NCT01298492|64375477|FG000|Overall Study|Other (Unspecified)|7|||
23171727|NCT01298492|64375477|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
23339014|NCT00281632|64986051|FG000|Overall Study|Ongoing|3|||
23171728|NCT01298492|64375477|FG000|Overall Study|Protocol Violation|2|||
23171729|NCT01298492|64375477|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
23171730|NCT01298492|64375477|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
23339015|NCT00319592|64986052|FG000|Overall Study|Protocol Violation|1|||
23339016|NCT00319592|64986053|FG001|Overall Study|Protocol Violation|0|||
23339017|NCT00319592|64986052|FG000|Overall Study|Physician Decision|0|||
23339018|NCT00319592|64986053|FG001|Overall Study|Physician Decision|1|||
23339019|NCT00968981|64986056|FG000|Overall Study|Adverse Event|2|||
23339020|NCT00968981|64986057|FG001|Overall Study|Adverse Event|0|||
23339021|NCT00968981|64986058|FG002|Overall Study|Adverse Event|0|||
23339022|NCT00968981|64986056|FG000|Overall Study|Disease Progression|14|||
23339023|NCT00968981|64986057|FG001|Overall Study|Disease Progression|16|||
23339024|NCT00968981|64986058|FG002|Overall Study|Disease Progression|13|||
23339025|NCT00968981|64986056|FG000|Overall Study|Lost to Follow-up|0|||
23339026|NCT00968981|64986057|FG001|Overall Study|Lost to Follow-up|0|||
23339027|NCT00968981|64986058|FG002|Overall Study|Lost to Follow-up|1|||
23339028|NCT00968981|64986056|FG000|Overall Study|Physician Decision|5|||
23339029|NCT00968981|64986057|FG001|Overall Study|Physician Decision|3|||
23339030|NCT00968981|64986058|FG002|Overall Study|Physician Decision|5|||
23339031|NCT00968981|64986056|FG000|Overall Study|Withdrawal by Subject|1|||
23339032|NCT00968981|64986057|FG001|Overall Study|Withdrawal by Subject|3|||
23339033|NCT00968981|64986058|FG002|Overall Study|Withdrawal by Subject|3|||
23339034|NCT01273623|64986059|FG000|Overall Study|did not meet IVUS criteria|29|||
23339035|NCT05723328|64986062|FG000|Overall Study|Investigator's Decision|5|||
23339036|NCT05723328|64986063|FG001|Overall Study|Investigator's Decision|2|||
23339037|NCT03521115|64986068|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
23339038|NCT03521115|64986069|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
23339039|NCT03521115|64986068|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
23339040|NCT03521115|64986069|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
23339041|NCT01190267|64986072|FG000|Overall Study|Adverse Event|10|||
23339042|NCT01190267|64986073|FG001|Overall Study|Adverse Event|0|||
23339043|NCT01190267|64986072|FG000|Overall Study|Treatment Failure|8|||
23231485|NCT01497899|64588336|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23231486|NCT01497899|64588333|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
23231487|NCT01497899|64588334|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
23231488|NCT01497899|64588335|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
23231489|NCT01497899|64588336|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
23231490|NCT01497899|64588333|FG000|Open-Label Extension Phase|Adverse Event|1|||
23231491|NCT01497899|64588334|FG001|Open-Label Extension Phase|Adverse Event|0|||
23231492|NCT01497899|64588335|FG002|Open-Label Extension Phase|Adverse Event|0|||
23231493|NCT01497899|64588336|FG003|Open-Label Extension Phase|Adverse Event|0|||
23231494|NCT01497899|64588333|FG000|Open-Label Extension Phase|Death|1|||
23231495|NCT01497899|64588334|FG001|Open-Label Extension Phase|Death|0|||
23231496|NCT01497899|64588335|FG002|Open-Label Extension Phase|Death|0|||
23231497|NCT01497899|64588336|FG003|Open-Label Extension Phase|Death|0|||
23339044|NCT01190267|64986073|FG001|Overall Study|Treatment Failure|2|||
23339045|NCT01190267|64986072|FG000|Overall Study|Lost to Follow-up|2|||
23578535|NCT01143077|65850230|FG001|Overall Study|Principal Investigator Decision|0|||
23578536|NCT01143077|65850231|FG002|Overall Study|Principal Investigator Decision|1|||
23578537|NCT01929993|65850232|FG000|Overall Study|Protocol Violation|4|||
23578538|NCT01929993|65850233|FG001|Overall Study|Protocol Violation|6|||
23578539|NCT01929993|65850232|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
23578540|NCT01929993|65850233|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
23578541|NCT01268059|65850234|FG000|Overall Study|Lost to Follow-up|0|||
23578542|NCT01268059|65850235|FG001|Overall Study|Lost to Follow-up|1|||
23578543|NCT01268059|65850236|FG002|Overall Study|Lost to Follow-up|0|||
23578544|NCT01268059|65850237|FG003|Overall Study|Lost to Follow-up|0|||
23578545|NCT01268059|65850234|FG000|Overall Study|Withdrawal by Subject|7|||
23578546|NCT01268059|65850235|FG001|Overall Study|Withdrawal by Subject|4|||
23578547|NCT01268059|65850236|FG002|Overall Study|Withdrawal by Subject|0|||
23578548|NCT01268059|65850237|FG003|Overall Study|Withdrawal by Subject|0|||
23578549|NCT01268059|65850234|FG000|Overall Study|Death|20|||
23578550|NCT01268059|65850235|FG001|Overall Study|Death|30|||
23578551|NCT01268059|65850236|FG002|Overall Study|Death|3|||
23578552|NCT01268059|65850237|FG003|Overall Study|Death|5|||
23578553|NCT01268059|65850234|FG000|Overall Study|Progression of disease|1|||
23578554|NCT01268059|65850235|FG001|Overall Study|Progression of disease|0|||
23231498|NCT01497899|64588333|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
23339046|NCT01190267|64986073|FG001|Overall Study|Lost to Follow-up|0|||
23339047|NCT01190267|64986072|FG000|Overall Study|Withdrawal by Subject|13|||
23578555|NCT01268059|65850236|FG002|Overall Study|Progression of disease|0|||
23578556|NCT01268059|65850237|FG003|Overall Study|Progression of disease|0|||
23578557|NCT00772928|65850239|FG000|Overall Study|Lost to Follow-up|9|||
23231499|NCT01497899|64588334|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
23578558|NCT00772928|65850240|FG001|Overall Study|Lost to Follow-up|6|||
23339048|NCT01190267|64986073|FG001|Overall Study|Withdrawal by Subject|1|||
23339049|NCT01190267|64986072|FG000|Overall Study|Protocol Violation|8|||
23339050|NCT01190267|64986073|FG001|Overall Study|Protocol Violation|1|||
23339051|NCT04016779|64986074|FG000|Overall Study|Adverse Event|9|||
23339052|NCT04016779|64986075|FG001|Overall Study|Adverse Event|17|||
23339053|NCT04016779|64986074|FG000|Overall Study|Lack of Efficacy|4|||
23339054|NCT04016779|64986075|FG001|Overall Study|Lack of Efficacy|1|||
23339055|NCT04016779|64986074|FG000|Overall Study|Lost to Follow-up|5|||
23339056|NCT04016779|64986075|FG001|Overall Study|Lost to Follow-up|14|||
23339057|NCT04016779|64986074|FG000|Overall Study|Physician Decision|1|||
23339058|NCT04016779|64986075|FG001|Overall Study|Physician Decision|3|||
23339059|NCT04016779|64986074|FG000|Overall Study|Withdrawal by Subject|6|||
23339060|NCT04016779|64986075|FG001|Overall Study|Withdrawal by Subject|8|||
23339061|NCT04016779|64986074|FG000|Overall Study|Non-compliance with Study Drug|2|||
23339062|NCT04016779|64986075|FG001|Overall Study|Non-compliance with Study Drug|3|||
23339063|NCT04016779|64986074|FG000|Overall Study|Other, Multiple categories|17|||
23339064|NCT04016779|64986075|FG001|Overall Study|Other, Multiple categories|17|||
23339065|NCT04484142|64986076|FG000|Overall Study|Adverse Event|13|||
23339066|NCT04484142|64986076|FG000|Overall Study|Progressive Disease|87|||
23339067|NCT04484142|64986076|FG000|Overall Study|Clinical Progression|10|||
23171731|NCT02706730|64375478|FG000|Overall Study|Adverse Event|3|||
23339068|NCT04484142|64986076|FG000|Overall Study|Withdrawal by Subject|6|||
23578559|NCT00772928|65850239|FG000|Overall Study|Protocol Violation|10|||
23578560|NCT00772928|65850240|FG001|Overall Study|Protocol Violation|12|||
23578561|NCT00772928|65850239|FG000|Overall Study|Withdrawal by Subject|25|||
23171732|NCT02706730|64375478|FG000|Overall Study|Lack of Efficacy|5|||
23171733|NCT02706730|64375478|FG000|Overall Study|Withdrawal by Subject|11|||
23171734|NCT02706730|64375478|FG000|Overall Study|Study Terminated by Sponsor|11|||
23171735|NCT02706730|64375478|FG000|Overall Study|Subject chose not to receive injection|3|||
23171736|NCT01765673|64375480|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
23578562|NCT00772928|65850240|FG001|Overall Study|Withdrawal by Subject|22|||
23578563|NCT00772928|65850239|FG000|Overall Study|Did not receive vaccine|0|||
23578564|NCT00772928|65850240|FG001|Overall Study|Did not receive vaccine|1|||
23578565|NCT00811187|65850241|FG000|Overall Study|Unable to place device / procedure abort|3|||
23578566|NCT00811187|65850242|FG001|Overall Study|Unable to place device / procedure abort|3|||
23171737|NCT00493870|64375489|FG000|Overall Study|Lost to Follow-up|12|||
23171738|NCT00493870|64375490|FG001|Overall Study|Lost to Follow-up|15|||
23171739|NCT01583374|64375491|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
23171740|NCT01583374|64375492|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
23171741|NCT01583374|64375493|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
23171742|NCT01583374|64375494|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23171743|NCT01583374|64375495|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23171744|NCT01583374|64375496|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23171745|NCT01583374|64375497|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23171746|NCT01583374|64375498|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23171747|NCT01583374|64375499|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
23171748|NCT01583374|64375491|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
23171749|NCT01583374|64375492|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
23171750|NCT01583374|64375493|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
23171751|NCT01583374|64375494|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23578567|NCT00224133|65850243|FG000|Overall Study|Adverse Event|93|||
23578568|NCT00224133|65850243|FG000|Overall Study|Protocol Violation|6|||
23578569|NCT00224133|65850243|FG000|Overall Study|Withdrawal by Subject|33|||
23171752|NCT01583374|64375495|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23171753|NCT01583374|64375496|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23339069|NCT04484142|64986076|FG000|Overall Study|Physician Decision|1|||
23339070|NCT02549287|64986077|FG000|Overall Study|Lost to Follow-up|65|||
23578570|NCT00224133|65850243|FG000|Overall Study|Lack of Efficacy|58|||
23578571|NCT00224133|65850243|FG000|Overall Study|Lost to Follow-up|21|||
23231500|NCT01497899|64588335|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
23231501|NCT01497899|64588336|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
23231502|NCT01497899|64588333|FG000|Open-Label Extension Phase|Pregnancy|0|||
23231503|NCT01497899|64588334|FG001|Open-Label Extension Phase|Pregnancy|1|||
23231504|NCT01497899|64588335|FG002|Open-Label Extension Phase|Pregnancy|1|||
23231505|NCT01497899|64588336|FG003|Open-Label Extension Phase|Pregnancy|0|||
23231506|NCT01497899|64588333|FG000|Open-Label Extension Phase|Protocol Violation|0|||
23231507|NCT01497899|64588334|FG001|Open-Label Extension Phase|Protocol Violation|0|||
23231508|NCT01497899|64588335|FG002|Open-Label Extension Phase|Protocol Violation|1|||
23231509|NCT01497899|64588336|FG003|Open-Label Extension Phase|Protocol Violation|0|||
23231510|NCT01497899|64588333|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
23231511|NCT01497899|64588334|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
23231512|NCT01497899|64588335|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
23231513|NCT01497899|64588336|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
23231514|NCT03524664|64588343|FG000|Overall Study|Withdrawal by Subject|1|||
23231515|NCT03524664|64588344|FG001|Overall Study|Withdrawal by Subject|2|||
23231516|NCT03524664|64588343|FG000|Overall Study|Lost to Follow-up|4|||
23231517|NCT03524664|64588344|FG001|Overall Study|Lost to Follow-up|13|||
23578572|NCT00224133|65850243|FG000|Overall Study|Physician Decision|1|||
23578573|NCT00224133|65850243|FG000|Overall Study|Other|14|||
23578574|NCT02065245|65850244|FG000|Infusion 1|Lost to Follow-up|0|||
23578575|NCT02065245|65850245|FG001|Infusion 1|Lost to Follow-up|0|||
23578576|NCT02065245|65850246|FG002|Infusion 1|Lost to Follow-up|0|||
23578577|NCT02065245|65850247|FG003|Infusion 1|Lost to Follow-up|0|||
23578578|NCT02065245|65850248|FG004|Infusion 1|Lost to Follow-up|0|||
23578579|NCT02065245|65850249|FG005|Infusion 1|Lost to Follow-up|0|||
23578580|NCT02065245|65850250|FG006|Infusion 1|Lost to Follow-up|1|||
23578581|NCT02065245|65850244|FG000|Infusion 1|Death|0|||
23578582|NCT02065245|65850245|FG001|Infusion 1|Death|0|||
23578583|NCT02065245|65850246|FG002|Infusion 1|Death|1|||
23578584|NCT02065245|65850247|FG003|Infusion 1|Death|0|||
23578585|NCT02065245|65850248|FG004|Infusion 1|Death|1|||
23578586|NCT02065245|65850249|FG005|Infusion 1|Death|0|||
23578587|NCT02065245|65850250|FG006|Infusion 1|Death|0|||
23578588|NCT02065245|65850244|FG000|Infusion 2|Death|0|||
23578589|NCT02065245|65850245|FG001|Infusion 2|Death|0|||
23578590|NCT02065245|65850246|FG002|Infusion 2|Death|0|||
23578591|NCT02065245|65850247|FG003|Infusion 2|Death|0|||
23578592|NCT02065245|65850248|FG004|Infusion 2|Death|0|||
23578593|NCT02065245|65850249|FG005|Infusion 2|Death|0|||
23578594|NCT02065245|65850250|FG006|Infusion 2|Death|1|||
23578595|NCT02065245|65850244|FG000|Infusion 3|Lost to Follow-up|1|||
23578596|NCT02065245|65850245|FG001|Infusion 3|Lost to Follow-up|1|||
23578597|NCT02065245|65850246|FG002|Infusion 3|Lost to Follow-up|0|||
23578598|NCT02065245|65850247|FG003|Infusion 3|Lost to Follow-up|0|||
23578599|NCT02065245|65850248|FG004|Infusion 3|Lost to Follow-up|0|||
23578600|NCT02065245|65850249|FG005|Infusion 3|Lost to Follow-up|0|||
23578601|NCT02065245|65850250|FG006|Infusion 3|Lost to Follow-up|0|||
23578602|NCT04088409|65850251|FG000|Part A|Withdrawal by Subject|2|||
23578603|NCT04088409|65850252|FG001|Part A|Withdrawal by Subject|1|||
23578604|NCT04088409|65850251|FG000|Part A|Did Not Meet Randomization Criteria|2|||
23578605|NCT04088409|65850252|FG001|Part A|Did Not Meet Randomization Criteria|0|||
23578606|NCT04088409|65850251|FG000|Part A|Lack of Efficacy|9|||
23578607|NCT04088409|65850252|FG001|Part A|Lack of Efficacy|0|||
23578608|NCT04088409|65850251|FG000|Part A|Lost to Follow-up|1|||
23578609|NCT04088409|65850252|FG001|Part A|Lost to Follow-up|0|||
23578610|NCT04088409|65850251|FG000|Part A|Adverse Event|1|||
23578611|NCT04088409|65850252|FG001|Part A|Adverse Event|0|||
23578612|NCT04088409|65850251|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
23578613|NCT04088409|65850252|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
23578614|NCT04088409|65850251|FG000|Part B|Ongoing Treatment|10|||
23578615|NCT04088409|65850252|FG001|Part B|Ongoing Treatment|0|||
23578616|NCT00783718|65850260|FG000|Induction Phase|Adverse Event|4|||
23231518|NCT00554229|64588349|FG000|Overall Study|Lost to Follow-up|3|||
23231519|NCT00554229|64588350|FG001|Overall Study|Lost to Follow-up|6|||
23231520|NCT00554229|64588349|FG000|Overall Study|Withdrawal by Subject|29|||
23231521|NCT00554229|64588350|FG001|Overall Study|Withdrawal by Subject|37|||
23578617|NCT00783718|65850261|FG001|Induction Phase|Adverse Event|0|||
23578618|NCT00783718|65850262|FG002|Induction Phase|Adverse Event|7|||
23578619|NCT00783718|65850263|FG003|Induction Phase|Adverse Event|0|||
23578620|NCT00783718|65850264|FG004|Induction Phase|Adverse Event|0|||
23231522|NCT00554229|64588349|FG000|Overall Study|Adverse Event|71|||
23578621|NCT00783718|65850265|FG005|Induction Phase|Adverse Event|0|||
23578622|NCT00783718|65850266|FG006|Induction Phase|Adverse Event|0|||
23578623|NCT00783718|65850260|FG000|Induction Phase|Protocol Violation|1|||
23578624|NCT00783718|65850261|FG001|Induction Phase|Protocol Violation|1|||
23578625|NCT00783718|65850262|FG002|Induction Phase|Protocol Violation|6|||
23578626|NCT00783718|65850263|FG003|Induction Phase|Protocol Violation|0|||
23231523|NCT00554229|64588350|FG001|Overall Study|Adverse Event|39|||
23231524|NCT00554229|64588349|FG000|Overall Study|Protocol Violation|3|||
23231525|NCT00554229|64588350|FG001|Overall Study|Protocol Violation|3|||
23231526|NCT00554229|64588349|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
23231527|NCT00554229|64588350|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
23231528|NCT00554229|64588349|FG000|Overall Study|Randomised but no treatment received|1|||
23231529|NCT00554229|64588350|FG001|Overall Study|Randomised but no treatment received|0|||
23231530|NCT01412333|64588351|FG000|Overall Study|Adverse Event|40|||
23231531|NCT01412333|64588352|FG001|Overall Study|Adverse Event|42|||
23231532|NCT01412333|64588351|FG000|Overall Study|Death|5|||
23231533|NCT01412333|64588352|FG001|Overall Study|Death|6|||
23231534|NCT01412333|64588351|FG000|Overall Study|Lack of Efficacy|22|||
23231535|NCT01412333|64588352|FG001|Overall Study|Lack of Efficacy|10|||
23231536|NCT01412333|64588351|FG000|Overall Study|Lost to Follow-up|15|||
23231537|NCT01412333|64588352|FG001|Overall Study|Lost to Follow-up|12|||
23231538|NCT01412333|64588351|FG000|Overall Study|Non-Compliance|3|||
23578627|NCT00783718|65850264|FG004|Induction Phase|Protocol Violation|0|||
23578628|NCT00783718|65850265|FG005|Induction Phase|Protocol Violation|0|||
23578629|NCT00783718|65850266|FG006|Induction Phase|Protocol Violation|0|||
23578630|NCT00783718|65850260|FG000|Induction Phase|Lack of Efficacy|5|||
23578631|NCT00783718|65850261|FG001|Induction Phase|Lack of Efficacy|2|||
23578632|NCT00783718|65850262|FG002|Induction Phase|Lack of Efficacy|14|||
23578633|NCT00783718|65850263|FG003|Induction Phase|Lack of Efficacy|0|||
23231539|NCT01412333|64588352|FG001|Overall Study|Non-Compliance|7|||
23339071|NCT02549287|64986078|FG001|Overall Study|Lost to Follow-up|26|||
23578634|NCT00783718|65850264|FG004|Induction Phase|Lack of Efficacy|0|||
23231540|NCT01412333|64588351|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23231541|NCT01412333|64588352|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23231542|NCT01412333|64588351|FG000|Overall Study|Other|30|||
23231543|NCT01412333|64588352|FG001|Overall Study|Other|33|||
23231544|NCT01412333|64588351|FG000|Overall Study|Physician Decision|11|||
23231545|NCT01412333|64588352|FG001|Overall Study|Physician Decision|16|||
23231546|NCT01412333|64588351|FG000|Overall Study|Pregnancy|6|||
23231547|NCT01412333|64588352|FG001|Overall Study|Pregnancy|4|||
23231548|NCT01412333|64588351|FG000|Overall Study|Protocol Violation|1|||
23231549|NCT01412333|64588352|FG001|Overall Study|Protocol Violation|2|||
23231550|NCT01412333|64588351|FG000|Overall Study|Study Terminated By Sponsor|3|||
23339072|NCT02549287|64986077|FG000|Overall Study|Withdrawal by Subject|15|||
23339073|NCT02549287|64986078|FG001|Overall Study|Withdrawal by Subject|6|||
23171754|NCT01583374|64375497|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23171755|NCT01583374|64375498|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23171756|NCT01583374|64375499|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
23171757|NCT01583374|64375491|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
23171758|NCT01583374|64375492|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
23171759|NCT01583374|64375493|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23171760|NCT01583374|64375494|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23171761|NCT01583374|64375495|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23171762|NCT01583374|64375496|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23171763|NCT01583374|64375497|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23171764|NCT01583374|64375498|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23171765|NCT01583374|64375499|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
23171766|NCT01583374|64375491|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
23171767|NCT01583374|64375492|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
23171768|NCT01583374|64375493|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
23171769|NCT01583374|64375494|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23171770|NCT01583374|64375495|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23171771|NCT01583374|64375496|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23171772|NCT01583374|64375497|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23171773|NCT01583374|64375498|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23171774|NCT01583374|64375499|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
23171775|NCT01583374|64375491|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
23171776|NCT01583374|64375492|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
23171777|NCT01583374|64375493|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23171778|NCT01583374|64375494|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23231551|NCT01412333|64588352|FG001|Overall Study|Study Terminated By Sponsor|2|||
23231552|NCT01412333|64588351|FG000|Overall Study|Withdrawal by Subject|51|||
23231553|NCT01412333|64588352|FG001|Overall Study|Withdrawal by Subject|54|||
23231554|NCT01412333|64588351|FG000|Overall Study|Missing|1|||
23231555|NCT01412333|64588352|FG001|Overall Study|Missing|3|||
23231556|NCT04450394|64588353|FG000|Overall Study|Adverse Event|2|||
23578635|NCT00783718|65850265|FG005|Induction Phase|Lack of Efficacy|0|||
23578636|NCT00783718|65850266|FG006|Induction Phase|Lack of Efficacy|0|||
23231557|NCT04450394|64588354|FG001|Overall Study|Adverse Event|0|||
23231558|NCT04450394|64588355|FG002|Overall Study|Adverse Event|0|||
23231559|NCT04450394|64588353|FG000|Overall Study|Death|0|||
23231560|NCT04450394|64588354|FG001|Overall Study|Death|1|||
23231561|NCT04450394|64588355|FG002|Overall Study|Death|0|||
23231562|NCT04450394|64588353|FG000|Overall Study|Lost to Follow-up|0|||
23231563|NCT04450394|64588354|FG001|Overall Study|Lost to Follow-up|3|||
23231564|NCT04450394|64588355|FG002|Overall Study|Lost to Follow-up|0|||
23231565|NCT04450394|64588353|FG000|Overall Study|Physician Decision|0|||
23231566|NCT04450394|64588354|FG001|Overall Study|Physician Decision|1|||
23231567|NCT04450394|64588355|FG002|Overall Study|Physician Decision|0|||
23231568|NCT04450394|64588353|FG000|Overall Study|Protocol Violation|2|||
23231569|NCT04450394|64588354|FG001|Overall Study|Protocol Violation|0|||
23231570|NCT04450394|64588355|FG002|Overall Study|Protocol Violation|0|||
23231571|NCT04450394|64588353|FG000|Overall Study|Withdrawal by Subject|6|||
23231572|NCT04450394|64588354|FG001|Overall Study|Withdrawal by Subject|9|||
23231573|NCT04450394|64588355|FG002|Overall Study|Withdrawal by Subject|0|||
23231574|NCT00504595|64588356|FG000|Overall Study|Lack of Efficacy|1|||
23231575|NCT00504595|64588357|FG001|Overall Study|Lack of Efficacy|0|||
23231576|NCT00504595|64588358|FG002|Overall Study|Lack of Efficacy|0|||
23231577|NCT00504595|64588359|FG003|Overall Study|Lack of Efficacy|0|||
23231578|NCT00504595|64588356|FG000|Overall Study|Other|0|||
23231579|NCT00504595|64588357|FG001|Overall Study|Other|0|||
23231580|NCT00504595|64588358|FG002|Overall Study|Other|2|||
23231581|NCT00504595|64588359|FG003|Overall Study|Other|0|||
23231582|NCT02543801|64588360|FG000|Overall Study|Protocol Violation|1|||
23231583|NCT02543801|64588361|FG001|Overall Study|Protocol Violation|2|||
23231584|NCT02543801|64588362|FG002|Overall Study|Protocol Violation|0|||
23231585|NCT02543801|64588363|FG003|Overall Study|Protocol Violation|0|||
23231586|NCT00621764|64588364|FG000|Overall Study|Protocol Violation|0|||
23231587|NCT00621764|64588365|FG001|Overall Study|Protocol Violation|0|||
23231588|NCT00621764|64588366|FG002|Overall Study|Protocol Violation|0|||
23231589|NCT00621764|64588367|FG003|Overall Study|Protocol Violation|1|||
23231590|NCT00626327|64588368|FG000|Overall Study|Withdrawal by Subject|21|||
23231591|NCT00626327|64588369|FG001|Overall Study|Withdrawal by Subject|29|||
23231592|NCT00626327|64588370|FG002|Overall Study|Withdrawal by Subject|30|||
23231593|NCT00626327|64588368|FG000|Overall Study|Adverse Event|1|||
23231594|NCT00626327|64588369|FG001|Overall Study|Adverse Event|0|||
23231595|NCT00626327|64588370|FG002|Overall Study|Adverse Event|0|||
23578637|NCT00783718|65850260|FG000|Induction Phase|Withdrawal by Subject|3|||
23578638|NCT00783718|65850261|FG001|Induction Phase|Withdrawal by Subject|4|||
23578639|NCT00783718|65850262|FG002|Induction Phase|Withdrawal by Subject|8|||
23578640|NCT00783718|65850263|FG003|Induction Phase|Withdrawal by Subject|0|||
23578641|NCT00783718|65850264|FG004|Induction Phase|Withdrawal by Subject|0|||
23578642|NCT00783718|65850265|FG005|Induction Phase|Withdrawal by Subject|0|||
23578643|NCT00783718|65850266|FG006|Induction Phase|Withdrawal by Subject|0|||
23578644|NCT00783718|65850260|FG000|Induction Phase|Lost to Follow-up|1|||
23578645|NCT00783718|65850261|FG001|Induction Phase|Lost to Follow-up|0|||
23578646|NCT00783718|65850262|FG002|Induction Phase|Lost to Follow-up|1|||
23578647|NCT00783718|65850263|FG003|Induction Phase|Lost to Follow-up|0|||
23578648|NCT00783718|65850264|FG004|Induction Phase|Lost to Follow-up|0|||
23578649|NCT00783718|65850265|FG005|Induction Phase|Lost to Follow-up|0|||
23578650|NCT00783718|65850266|FG006|Induction Phase|Lost to Follow-up|0|||
23578651|NCT00783718|65850260|FG000|Maintenance Phase|Adverse Event|12|||
23578652|NCT00783718|65850261|FG001|Maintenance Phase|Adverse Event|0|||
23578653|NCT00783718|65850262|FG002|Maintenance Phase|Adverse Event|0|||
23578654|NCT00783718|65850263|FG003|Maintenance Phase|Adverse Event|15|||
23578655|NCT00783718|65850264|FG004|Maintenance Phase|Adverse Event|7|||
23578656|NCT00783718|65850265|FG005|Maintenance Phase|Adverse Event|6|||
23231596|NCT00626327|64588368|FG000|Overall Study|Lost to Follow-up|24|||
23231597|NCT00626327|64588369|FG001|Overall Study|Lost to Follow-up|21|||
23231598|NCT00626327|64588370|FG002|Overall Study|Lost to Follow-up|23|||
23231599|NCT00626327|64588368|FG000|Overall Study|Inappropriate enrollment|4|||
23231600|NCT00626327|64588369|FG001|Overall Study|Inappropriate enrollment|5|||
23231601|NCT00626327|64588370|FG002|Overall Study|Inappropriate enrollment|3|||
23231602|NCT00626327|64588368|FG000|Overall Study|Administrative Reason|2|||
23231603|NCT00626327|64588369|FG001|Overall Study|Administrative Reason|0|||
23231604|NCT00626327|64588370|FG002|Overall Study|Administrative Reason|6|||
23231605|NCT00626327|64588368|FG000|Overall Study|Protocol Violation|26|||
23231606|NCT00626327|64588369|FG001|Overall Study|Protocol Violation|4|||
23231607|NCT00626327|64588370|FG002|Overall Study|Protocol Violation|26|||
23578657|NCT00783718|65850266|FG006|Maintenance Phase|Adverse Event|16|||
23231608|NCT01899729|64588371|FG000|Overall Study|Adverse Event|1|||
23231609|NCT01899729|64588372|FG001|Overall Study|Adverse Event|0|||
23231610|NCT01899729|64588373|FG002|Overall Study|Adverse Event|0|||
23231611|NCT01899729|64588374|FG003|Overall Study|Adverse Event|0|||
23578658|NCT00783718|65850260|FG000|Maintenance Phase|Protocol Violation|1|||
23578659|NCT00783718|65850261|FG001|Maintenance Phase|Protocol Violation|0|||
23171779|NCT01583374|64375495|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23171780|NCT01583374|64375496|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23171781|NCT01583374|64375497|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23171782|NCT01583374|64375498|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23171783|NCT01583374|64375499|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
23171784|NCT01583374|64375491|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23171785|NCT01583374|64375492|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23171786|NCT01583374|64375493|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
23171787|NCT01583374|64375494|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23171788|NCT01583374|64375495|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23171789|NCT01583374|64375496|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23171790|NCT01583374|64375497|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23171791|NCT01583374|64375498|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23171792|NCT01583374|64375499|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
23171793|NCT01583374|64375491|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
23171794|NCT01583374|64375492|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
23171795|NCT01583374|64375493|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
23171796|NCT01583374|64375494|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
23171797|NCT01583374|64375495|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
23171798|NCT01583374|64375496|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
23171799|NCT01583374|64375497|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
23171800|NCT01583374|64375498|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
23171801|NCT01583374|64375499|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
23171802|NCT01583374|64375491|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23171803|NCT01583374|64375492|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23171804|NCT01583374|64375493|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23171805|NCT01583374|64375494|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23171806|NCT01583374|64375495|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23171807|NCT01583374|64375496|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23171808|NCT01583374|64375497|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23171809|NCT01583374|64375498|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
23171810|NCT01583374|64375499|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
23171811|NCT01583374|64375491|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
23171812|NCT01583374|64375492|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23171813|NCT01583374|64375493|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
23171814|NCT01583374|64375494|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
23171815|NCT01583374|64375495|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23171816|NCT01583374|64375496|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23171817|NCT01583374|64375497|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
23171818|NCT01583374|64375498|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
23171819|NCT01583374|64375499|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
23171820|NCT01583374|64375491|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
23171821|NCT01583374|64375492|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
23171822|NCT01583374|64375493|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
23171823|NCT01583374|64375494|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
23171824|NCT01583374|64375495|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
23171825|NCT01583374|64375496|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
23171826|NCT01583374|64375497|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
23171827|NCT01583374|64375498|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
23171828|NCT01583374|64375499|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
23171829|NCT01583374|64375491|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23171830|NCT01583374|64375492|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
23171831|NCT01583374|64375493|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
23171832|NCT01583374|64375494|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23171833|NCT01583374|64375495|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
23171834|NCT01583374|64375496|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23171835|NCT01583374|64375497|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23171836|NCT01583374|64375498|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23578660|NCT00783718|65850262|FG002|Maintenance Phase|Protocol Violation|0|||
23578661|NCT00783718|65850263|FG003|Maintenance Phase|Protocol Violation|0|||
23578662|NCT00783718|65850264|FG004|Maintenance Phase|Protocol Violation|0|||
23578663|NCT00783718|65850265|FG005|Maintenance Phase|Protocol Violation|0|||
23578664|NCT00783718|65850266|FG006|Maintenance Phase|Protocol Violation|2|||
23578665|NCT00783718|65850260|FG000|Maintenance Phase|Lack of Efficacy|83|||
23578666|NCT00783718|65850261|FG001|Maintenance Phase|Lack of Efficacy|0|||
23578667|NCT00783718|65850262|FG002|Maintenance Phase|Lack of Efficacy|0|||
23231612|NCT01899729|64588375|FG004|Overall Study|Adverse Event|1|||
23231613|NCT01899729|64588371|FG000|Overall Study|Withdrawal by Subject|1|||
23231614|NCT01899729|64588372|FG001|Overall Study|Withdrawal by Subject|2|||
23231615|NCT01899729|64588373|FG002|Overall Study|Withdrawal by Subject|0|||
23231616|NCT01899729|64588374|FG003|Overall Study|Withdrawal by Subject|0|||
23231617|NCT01899729|64588375|FG004|Overall Study|Withdrawal by Subject|0|||
23231618|NCT01899729|64588371|FG000|Overall Study|Lack of Efficacy|0|||
23231619|NCT01899729|64588372|FG001|Overall Study|Lack of Efficacy|0|||
23231620|NCT01899729|64588373|FG002|Overall Study|Lack of Efficacy|2|||
23231621|NCT01899729|64588374|FG003|Overall Study|Lack of Efficacy|0|||
23231622|NCT01899729|64588375|FG004|Overall Study|Lack of Efficacy|1|||
23231623|NCT03961529|64588383|FG000|Overall Study|Adverse Event|13|||
23231624|NCT03961529|64588384|FG001|Overall Study|Adverse Event|5|||
23231625|NCT03961529|64588385|FG002|Overall Study|Adverse Event|2|||
23231626|NCT03961529|64588383|FG000|Overall Study|Withdrawal by Subject|17|||
23231627|NCT03961529|64588384|FG001|Overall Study|Withdrawal by Subject|2|||
23231628|NCT03961529|64588385|FG002|Overall Study|Withdrawal by Subject|1|||
23231629|NCT03961529|64588383|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23231630|NCT03961529|64588384|FG001|Overall Study|Withdrawal by parent/guardian|7|||
23231631|NCT03961529|64588385|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23231632|NCT03961529|64588383|FG000|Overall Study|Physician Decision|2|||
23231633|NCT03961529|64588384|FG001|Overall Study|Physician Decision|1|||
23231634|NCT03961529|64588385|FG002|Overall Study|Physician Decision|1|||
23231635|NCT03961529|64588383|FG000|Overall Study|Lost to Follow-up|2|||
23231636|NCT03961529|64588384|FG001|Overall Study|Lost to Follow-up|1|||
23231637|NCT03961529|64588385|FG002|Overall Study|Lost to Follow-up|0|||
23231638|NCT03961529|64588383|FG000|Overall Study|Lack of Efficacy|2|||
23231639|NCT03961529|64588384|FG001|Overall Study|Lack of Efficacy|0|||
23231640|NCT03961529|64588385|FG002|Overall Study|Lack of Efficacy|1|||
23231641|NCT03961529|64588383|FG000|Overall Study|Other|6|||
23231642|NCT03961529|64588384|FG001|Overall Study|Other|1|||
23231643|NCT03961529|64588385|FG002|Overall Study|Other|0|||
23231644|NCT00523744|64588392|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
23231645|NCT00523744|64588392|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
23231646|NCT00523744|64588392|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
23231647|NCT00523744|64588392|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
23231648|NCT00523744|64588392|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
23231649|NCT00523744|64588392|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
23231650|NCT01766401|64588394|FG000|Overall Study|Adverse Event|7|||
23231651|NCT01766401|64588395|FG001|Overall Study|Adverse Event|22|||
23231652|NCT01766401|64588394|FG000|Overall Study|Lack of Efficacy|1|||
23231653|NCT01766401|64588395|FG001|Overall Study|Lack of Efficacy|2|||
23231654|NCT01766401|64588394|FG000|Overall Study|Protocol Violation|3|||
23231655|NCT01766401|64588395|FG001|Overall Study|Protocol Violation|8|||
23231656|NCT01766401|64588394|FG000|Overall Study|Withdrawal by Subject|15|||
23231657|NCT01766401|64588395|FG001|Overall Study|Withdrawal by Subject|12|||
23231658|NCT01766401|64588394|FG000|Overall Study|Lost to Follow-up|10|||
23231659|NCT01766401|64588395|FG001|Overall Study|Lost to Follow-up|11|||
23231660|NCT01766401|64588394|FG000|Overall Study|Pregnancy|1|||
23231661|NCT01766401|64588395|FG001|Overall Study|Pregnancy|1|||
23231662|NCT04097925|64588401|FG000|Overall Study|Withdrawal by Subject|1|||
23231663|NCT00740116|64588407|FG000|Overall Study|Withdrawal by Subject|1|||
23231664|NCT00740116|64588408|FG001|Overall Study|Withdrawal by Subject|1|||
23231665|NCT00740116|64588407|FG000|Overall Study|Protocol Violation|1|||
23231666|NCT00740116|64588408|FG001|Overall Study|Protocol Violation|4|||
23231667|NCT01265511|64591703|FG000|Overall Study|Lack of Efficacy|2|||
23231668|NCT01265511|64591704|FG001|Overall Study|Lack of Efficacy|1|||
23231669|NCT01265511|64591703|FG000|Overall Study|Met stopping rules|0|||
23231670|NCT01265511|64591704|FG001|Overall Study|Met stopping rules|2|||
23231671|NCT01097057|64591714|FG000|Overall Study|Physician Decision|3|||
23231672|NCT00842829|64591715|FG000|Dose Titration Period|Adverse Event|11|||
23231673|NCT00842829|64591716|FG001|Dose Titration Period|Adverse Event|10|||
23231674|NCT00842829|64591717|FG002|Dose Titration Period|Adverse Event|0|||
23231675|NCT00842829|64591715|FG000|Dose Titration Period|Lack of Efficacy|4|||
23231676|NCT00842829|64591716|FG001|Dose Titration Period|Lack of Efficacy|1|||
23231677|NCT00842829|64591717|FG002|Dose Titration Period|Lack of Efficacy|0|||
23339074|NCT02496091|64986082|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23339075|NCT03843541|64986083|FG000|Overall Study|Adverse Event|4|||
23231678|NCT00842829|64591715|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
23231679|NCT00842829|64591716|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
23231680|NCT00842829|64591717|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
23231681|NCT00842829|64591715|FG000|Dose Titration Period|Withdrawal by Subject|2|||
23231682|NCT00842829|64591716|FG001|Dose Titration Period|Withdrawal by Subject|6|||
23231683|NCT00842829|64591717|FG002|Dose Titration Period|Withdrawal by Subject|0|||
23231684|NCT00842829|64591715|FG000|Dose Titration Period|Other|5|||
23231685|NCT00842829|64591716|FG001|Dose Titration Period|Other|4|||
23231686|NCT00842829|64591717|FG002|Dose Titration Period|Other|0|||
23231687|NCT00842829|64591715|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
23231688|NCT00842829|64591716|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
23339076|NCT03843541|64986084|FG001|Overall Study|Adverse Event|2|||
23339077|NCT03843541|64986085|FG002|Overall Study|Adverse Event|3|||
23339078|NCT03843541|64986083|FG000|Overall Study|Death|1|||
23339079|NCT03843541|64986084|FG001|Overall Study|Death|0|||
23339080|NCT03843541|64986085|FG002|Overall Study|Death|0|||
23339081|NCT03843541|64986083|FG000|Overall Study|Lack of adherence to study medication|0|||
23339082|NCT03843541|64986084|FG001|Overall Study|Lack of adherence to study medication|0|||
23339083|NCT03843541|64986085|FG002|Overall Study|Lack of adherence to study medication|1|||
23339084|NCT03843541|64986083|FG000|Overall Study|Physician Decision|1|||
23231689|NCT00842829|64591717|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
23339085|NCT03843541|64986084|FG001|Overall Study|Physician Decision|2|||
23339086|NCT03843541|64986085|FG002|Overall Study|Physician Decision|2|||
23450708|NCT02201524|65391595|FG001|Overall Study|No longer meets eligibility criteria|0|||
23450709|NCT02201524|65391596|FG002|Overall Study|No longer meets eligibility criteria|0|||
23231690|NCT00842829|64591715|FG000|Dose Titration Period|Non-compliance to study drug|2|||
23231691|NCT00842829|64591716|FG001|Dose Titration Period|Non-compliance to study drug|1|||
23231692|NCT00842829|64591717|FG002|Dose Titration Period|Non-compliance to study drug|0|||
23231693|NCT00842829|64591715|FG000|Treatment Period|Adverse Event|0|||
23231694|NCT00842829|64591716|FG001|Treatment Period|Adverse Event|0|||
23231695|NCT00842829|64591717|FG002|Treatment Period|Adverse Event|15|||
23231696|NCT00842829|64591715|FG000|Treatment Period|Lack of Efficacy|0|||
23231697|NCT00842829|64591716|FG001|Treatment Period|Lack of Efficacy|0|||
23231698|NCT00842829|64591717|FG002|Treatment Period|Lack of Efficacy|6|||
23231699|NCT00842829|64591715|FG000|Treatment Period|Unstable persistent cancer pain|0|||
23231700|NCT00842829|64591716|FG001|Treatment Period|Unstable persistent cancer pain|0|||
23231701|NCT00842829|64591717|FG002|Treatment Period|Unstable persistent cancer pain|5|||
23231702|NCT00842829|64591715|FG000|Treatment Period|Withdrawal by Subject|0|||
23231703|NCT00842829|64591716|FG001|Treatment Period|Withdrawal by Subject|0|||
23231704|NCT00842829|64591717|FG002|Treatment Period|Withdrawal by Subject|11|||
23231705|NCT00842829|64591715|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
23231706|NCT00842829|64591716|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
23231707|NCT00842829|64591717|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
23231708|NCT00842829|64591715|FG000|Treatment Period|Protocol Violation|0|||
23231709|NCT00842829|64591716|FG001|Treatment Period|Protocol Violation|0|||
23231710|NCT00842829|64591717|FG002|Treatment Period|Protocol Violation|2|||
23231711|NCT00842829|64591715|FG000|Treatment Period|Other|0|||
23231712|NCT00842829|64591716|FG001|Treatment Period|Other|0|||
23231713|NCT00842829|64591717|FG002|Treatment Period|Other|18|||
23339087|NCT03843541|64986083|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
23339088|NCT03843541|64986084|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
23339089|NCT03843541|64986085|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
23450710|NCT02201524|65391597|FG003|Overall Study|No longer meets eligibility criteria|2|||
23450711|NCT02201524|65391594|FG000|Overall Study|Protocol Violation|0|||
23450712|NCT02201524|65391595|FG001|Overall Study|Protocol Violation|0|||
23450713|NCT02201524|65391596|FG002|Overall Study|Protocol Violation|0|||
23450714|NCT02201524|65391597|FG003|Overall Study|Protocol Violation|1|||
23450715|NCT02201524|65391594|FG000|Overall Study|Withdrawal by Subject|0|||
23450716|NCT02201524|65391595|FG001|Overall Study|Withdrawal by Subject|0|||
23450717|NCT02201524|65391596|FG002|Overall Study|Withdrawal by Subject|1|||
23450718|NCT02201524|65391597|FG003|Overall Study|Withdrawal by Subject|1|||
23450719|NCT02201524|65391594|FG000|Overall Study|Other|1|||
23450720|NCT02201524|65391595|FG001|Overall Study|Other|1|||
23450721|NCT02201524|65391596|FG002|Overall Study|Other|0|||
23450722|NCT02201524|65391597|FG003|Overall Study|Other|0|||
23450723|NCT01721161|65391598|FG000|Overall Study|Adverse Event|2|||
23450724|NCT01721161|65391599|FG001|Overall Study|Adverse Event|3|||
23450725|NCT01721161|65391598|FG000|Overall Study|Lost to Follow-up|1|||
23450726|NCT01721161|65391599|FG001|Overall Study|Lost to Follow-up|2|||
23450727|NCT01721161|65391598|FG000|Overall Study|Withdrawal by Subject|1|||
23450728|NCT01721161|65391599|FG001|Overall Study|Withdrawal by Subject|1|||
23450729|NCT01721161|65391598|FG000|Overall Study|Other|0|||
23450730|NCT01721161|65391599|FG001|Overall Study|Other|1|||
23453640|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
23453641|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
23453642|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23453643|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23339090|NCT03843541|64986083|FG000|Overall Study|Withdrawal by Subject|6|||
23453644|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23453645|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23231714|NCT00842829|64591715|FG000|Treatment Period|Non-compliance to study procedures|0|||
23231715|NCT00842829|64591716|FG001|Treatment Period|Non-compliance to study procedures|0|||
23231716|NCT00842829|64591717|FG002|Treatment Period|Non-compliance to study procedures|4|||
23450731|NCT00757237|65394984|FG000|Overall Study|Lost to Follow-up|0|||
23231717|NCT00842829|64591715|FG000|Treatment Period|Unclear completion status|0|||
23231718|NCT00842829|64591716|FG001|Treatment Period|Unclear completion status|0|||
23231719|NCT00842829|64591717|FG002|Treatment Period|Unclear completion status|1|||
23231720|NCT00842829|64591715|FG000|Continuation Period|Adverse Event|0|||
23231721|NCT00842829|64591716|FG001|Continuation Period|Adverse Event|0|||
23231722|NCT00842829|64591717|FG002|Continuation Period|Adverse Event|32|||
23231723|NCT00842829|64591715|FG000|Continuation Period|Lack of Efficacy|0|||
23231724|NCT00842829|64591716|FG001|Continuation Period|Lack of Efficacy|0|||
23231725|NCT00842829|64591717|FG002|Continuation Period|Lack of Efficacy|6|||
23450732|NCT00757237|65394985|FG001|Overall Study|Lost to Follow-up|1|||
23450733|NCT00757237|65394984|FG000|Overall Study|Protocol Violation|0|||
23450734|NCT00757237|65394985|FG001|Overall Study|Protocol Violation|2|||
23450735|NCT00757237|65394984|FG000|Overall Study|Physician Decision|2|||
23450736|NCT00757237|65394985|FG001|Overall Study|Physician Decision|3|||
23450737|NCT00757237|65394984|FG000|Overall Study|Withdrawal by Subject|8|||
23450738|NCT00757237|65394985|FG001|Overall Study|Withdrawal by Subject|12|||
23450739|NCT00757237|65394984|FG000|Overall Study|Safety or Tolerability|3|||
23450740|NCT00757237|65394985|FG001|Overall Study|Safety or Tolerability|5|||
23450741|NCT00757237|65394984|FG000|Overall Study|Other|0|||
23450742|NCT00757237|65394985|FG001|Overall Study|Other|2|||
23450743|NCT00148759|65394987|FG000|Overall Study|Withdrawal by Subject|1|||
23450744|NCT00148759|65394988|FG001|Overall Study|Withdrawal by Subject|1|||
23450745|NCT00148759|65394987|FG000|Overall Study|Lost to Follow-up|1|||
23450746|NCT00148759|65394988|FG001|Overall Study|Lost to Follow-up|0|||
23450747|NCT01664910|65394989|FG000|Overall Study|Adverse Event|0|||
23450748|NCT01664910|65394990|FG001|Overall Study|Adverse Event|0|||
23450749|NCT01664910|65394991|FG002|Overall Study|Adverse Event|1|||
23450750|NCT00721396|65394995|FG000|Overall Study|Adverse Event|4|||
23450751|NCT00721396|65394996|FG001|Overall Study|Adverse Event|7|||
23450752|NCT00721396|65394997|FG002|Overall Study|Adverse Event|2|||
23450753|NCT00721396|65394998|FG003|Overall Study|Adverse Event|0|||
23450754|NCT00721396|65394995|FG000|Overall Study|Withdrawal by Subject|12|||
23450755|NCT00721396|65394996|FG001|Overall Study|Withdrawal by Subject|15|||
23450756|NCT00721396|65394997|FG002|Overall Study|Withdrawal by Subject|3|||
23450757|NCT00721396|65394998|FG003|Overall Study|Withdrawal by Subject|7|||
23450758|NCT00721396|65394995|FG000|Overall Study|Lost to Follow-up|7|||
23450759|NCT00721396|65394996|FG001|Overall Study|Lost to Follow-up|9|||
23450760|NCT00721396|65394997|FG002|Overall Study|Lost to Follow-up|3|||
23450761|NCT00721396|65394998|FG003|Overall Study|Lost to Follow-up|3|||
23450762|NCT00721396|65394995|FG000|Overall Study|Protocol Violation|4|||
23450763|NCT00721396|65394996|FG001|Overall Study|Protocol Violation|3|||
23450764|NCT00721396|65394997|FG002|Overall Study|Protocol Violation|1|||
23450765|NCT00721396|65394998|FG003|Overall Study|Protocol Violation|0|||
23450766|NCT00721396|65394995|FG000|Overall Study|Inappropriate enrollment|0|||
23450767|NCT00721396|65394996|FG001|Overall Study|Inappropriate enrollment|2|||
23171837|NCT01583374|64375499|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
23171838|NCT01583374|64375491|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23171839|NCT01583374|64375492|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23171840|NCT01583374|64375493|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
23171841|NCT01583374|64375494|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23171842|NCT01583374|64375495|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
23171843|NCT01583374|64375496|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
23171844|NCT01583374|64375497|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23171845|NCT01583374|64375498|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23171846|NCT01583374|64375499|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
23171847|NCT01583374|64375491|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
23171848|NCT01583374|64375492|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
23171849|NCT01583374|64375493|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
23171850|NCT01583374|64375494|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
23171851|NCT01583374|64375495|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
23171852|NCT01583374|64375496|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
23171853|NCT01583374|64375497|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
23171854|NCT01583374|64375498|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
23231726|NCT00842829|64591715|FG000|Continuation Period|Unstable persistent cancer pain|0|||
23231727|NCT00842829|64591716|FG001|Continuation Period|Unstable persistent cancer pain|0|||
23450768|NCT00721396|65394997|FG002|Overall Study|Inappropriate enrollment|0|||
23450769|NCT00721396|65394998|FG003|Overall Study|Inappropriate enrollment|0|||
23450770|NCT00721396|65394995|FG000|Overall Study|Administrative reason|3|||
23450771|NCT00721396|65394996|FG001|Overall Study|Administrative reason|0|||
23450772|NCT00721396|65394997|FG002|Overall Study|Administrative reason|1|||
23450773|NCT00721396|65394998|FG003|Overall Study|Administrative reason|0|||
23231728|NCT00842829|64591717|FG002|Continuation Period|Unstable persistent cancer pain|3|||
23231729|NCT00842829|64591715|FG000|Continuation Period|Withdrawal by Subject|0|||
23171855|NCT01583374|64375499|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
23171856|NCT01583374|64375491|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
23171857|NCT01583374|64375492|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
23171858|NCT01583374|64375493|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
23171859|NCT01583374|64375494|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
23171860|NCT01583374|64375495|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
23171861|NCT01583374|64375496|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
23171862|NCT01583374|64375497|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
23171863|NCT01583374|64375498|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
23171864|NCT01583374|64375499|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
23171865|NCT01583374|64375491|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23171866|NCT01583374|64375492|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23171867|NCT01583374|64375493|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23171868|NCT01583374|64375494|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23171869|NCT01583374|64375495|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
23171870|NCT01583374|64375496|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23171871|NCT01583374|64375497|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
23171872|NCT01583374|64375498|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
23171873|NCT01583374|64375499|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
23171874|NCT01583374|64375491|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
23171875|NCT01583374|64375492|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
23171876|NCT01583374|64375493|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
23450774|NCT00416624|65394999|FG000|Overall Study|Withdrawal by Subject|1|||
23231730|NCT00842829|64591716|FG001|Continuation Period|Withdrawal by Subject|0|||
23339091|NCT03843541|64986084|FG001|Overall Study|Withdrawal by Subject|9|||
23450775|NCT00416624|65395000|FG001|Overall Study|Withdrawal by Subject|6|||
23450776|NCT00416624|65395001|FG002|Overall Study|Withdrawal by Subject|4|||
23171877|NCT01583374|64375494|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
23171878|NCT01583374|64375495|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
23450777|NCT00416624|65395002|FG003|Overall Study|Withdrawal by Subject|9|||
23450778|NCT00416624|65394999|FG000|Overall Study|Death|4|||
23450779|NCT00416624|65395000|FG001|Overall Study|Death|7|||
23450780|NCT00416624|65395001|FG002|Overall Study|Death|7|||
23450781|NCT00416624|65395002|FG003|Overall Study|Death|1|||
23450782|NCT00416624|65394999|FG000|Overall Study|Adverse Event|8|||
23450783|NCT00416624|65395000|FG001|Overall Study|Adverse Event|3|||
23450784|NCT00416624|65395001|FG002|Overall Study|Adverse Event|2|||
23450785|NCT00416624|65395002|FG003|Overall Study|Adverse Event|2|||
23450786|NCT00416624|65394999|FG000|Overall Study|Other|8|||
23450787|NCT00416624|65395000|FG001|Overall Study|Other|11|||
23450788|NCT00416624|65395001|FG002|Overall Study|Other|5|||
23450789|NCT00416624|65395002|FG003|Overall Study|Other|5|||
23450790|NCT00416624|65394999|FG000|Overall Study|Cancel|1|||
23450791|NCT00416624|65395000|FG001|Overall Study|Cancel|0|||
23450792|NCT00416624|65395001|FG002|Overall Study|Cancel|0|||
23450793|NCT00416624|65395002|FG003|Overall Study|Cancel|0|||
23450794|NCT02653326|65395005|FG000|Overall Study|Lost to Follow-up|10|||
23450795|NCT02653326|65395006|FG001|Overall Study|Lost to Follow-up|7|||
23450796|NCT01329263|65395007|FG000|Overall Study|Lost to Follow-up|4|||
23450797|NCT01329263|65395008|FG001|Overall Study|Lost to Follow-up|21|||
23450798|NCT01329263|65395007|FG000|Overall Study|Withdrawal by Subject|1|||
23450799|NCT01329263|65395008|FG001|Overall Study|Withdrawal by Subject|2|||
23450800|NCT01141712|65395009|FG000|Overall Study|Disease progression|3|||
23450801|NCT01092728|65395019|FG000|Overall Study|Withdrawal by Subject|2|||
23450802|NCT01092728|65395020|FG001|Overall Study|Withdrawal by Subject|0|||
23450803|NCT01092728|65395019|FG000|Overall Study|Adverse Event|0|||
23450804|NCT01092728|65395020|FG001|Overall Study|Adverse Event|1|||
23450805|NCT01092728|65395019|FG000|Overall Study|Disease Progression|1|||
23450806|NCT01092728|65395020|FG001|Overall Study|Disease Progression|13|||
23450807|NCT01092728|65395019|FG000|Overall Study|Prohibited Concomitant Medications|1|||
23450808|NCT01092728|65395020|FG001|Overall Study|Prohibited Concomitant Medications|0|||
23171879|NCT01583374|64375496|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
23171880|NCT01583374|64375497|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
23450809|NCT00308139|65395022|FG000|Overall Study|Adverse Event|20|||
23450810|NCT00308139|65395023|FG001|Overall Study|Adverse Event|14|||
23450811|NCT00308139|65395022|FG000|Overall Study|Lost to Follow-up|13|||
23450812|NCT00308139|65395023|FG001|Overall Study|Lost to Follow-up|8|||
23450813|NCT00308139|65395022|FG000|Overall Study|Protocol Violation|3|||
23450814|NCT00308139|65395023|FG001|Overall Study|Protocol Violation|2|||
23450815|NCT00308139|65395022|FG000|Overall Study|Withdrawal of Consent|40|||
23450816|NCT00308139|65395023|FG001|Overall Study|Withdrawal of Consent|42|||
23450817|NCT00308139|65395022|FG000|Overall Study|Investigator Decision|11|||
23450818|NCT00308139|65395023|FG001|Overall Study|Investigator Decision|10|||
23450819|NCT00308139|65395022|FG000|Overall Study|Loss of Glucose Control|5|||
23450820|NCT00308139|65395023|FG001|Overall Study|Loss of Glucose Control|7|||
23450821|NCT00308139|65395022|FG000|Overall Study|Administrative|1|||
23450822|NCT00308139|65395023|FG001|Overall Study|Administrative|4|||
23450823|NCT00308139|65395022|FG000|Overall Study|Other|1|||
23450824|NCT00308139|65395023|FG001|Overall Study|Other|0|||
23450825|NCT01216202|65395027|FG000|Overall Study|Withdrawal by Subject|8|||
23231731|NCT00842829|64591717|FG002|Continuation Period|Withdrawal by Subject|10|||
23231732|NCT00842829|64591715|FG000|Continuation Period|Other|0|||
23231733|NCT00842829|64591716|FG001|Continuation Period|Other|0|||
23231734|NCT00842829|64591717|FG002|Continuation Period|Other|7|||
23231735|NCT00842829|64591715|FG000|Continuation Period|Non-compliance to study procedures|0|||
23339092|NCT03843541|64986085|FG002|Overall Study|Withdrawal by Subject|7|||
23450826|NCT01216202|65395028|FG001|Overall Study|Withdrawal by Subject|0|||
23578668|NCT00783718|65850263|FG003|Maintenance Phase|Lack of Efficacy|61|||
23578669|NCT00783718|65850264|FG004|Maintenance Phase|Lack of Efficacy|31|||
23171881|NCT01583374|64375498|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
23171882|NCT01583374|64375499|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
23171883|NCT01583374|64375491|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
23578670|NCT00783718|65850265|FG005|Maintenance Phase|Lack of Efficacy|33|||
23171884|NCT01583374|64375492|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
23171885|NCT01583374|64375493|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
23171886|NCT01583374|64375494|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
23171887|NCT01583374|64375495|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
23171888|NCT01583374|64375496|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
23171889|NCT01583374|64375497|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
23171890|NCT01583374|64375498|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
23171891|NCT01583374|64375499|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
23171892|NCT01583374|64375491|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23171893|NCT01583374|64375492|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
23171894|NCT01583374|64375493|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23171895|NCT01583374|64375494|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
23171896|NCT01583374|64375495|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
23171897|NCT01583374|64375496|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23171898|NCT01583374|64375497|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
23171899|NCT01583374|64375498|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23171900|NCT01583374|64375499|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
23171901|NCT01583374|64375491|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
23171902|NCT01583374|64375492|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
23171903|NCT01583374|64375493|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
23171904|NCT01583374|64375494|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
23171905|NCT01583374|64375495|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
23171906|NCT01583374|64375496|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
23171907|NCT01583374|64375497|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
23171908|NCT01583374|64375498|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
23171909|NCT01583374|64375499|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
23171910|NCT03434379|64375503|FG000|Global Period|Lost to Follow-up|3|||
23171911|NCT03434379|64375504|FG001|Global Period|Lost to Follow-up|6|||
23171912|NCT03434379|64375505|FG002|Global Period|Lost to Follow-up|0|||
23171913|NCT03434379|64375506|FG003|Global Period|Lost to Follow-up|0|||
23171914|NCT03434379|64375503|FG000|Global Period|Death|115|||
23171915|NCT03434379|64375504|FG001|Global Period|Death|228|||
23171916|NCT03434379|64375505|FG002|Global Period|Death|0|||
23171917|NCT03434379|64375506|FG003|Global Period|Death|0|||
23171918|NCT03434379|64375503|FG000|Global Period|Withdrawal by Subject|20|||
23171919|NCT03434379|64375504|FG001|Global Period|Withdrawal by Subject|21|||
23171920|NCT03434379|64375505|FG002|Global Period|Withdrawal by Subject|0|||
23171921|NCT03434379|64375506|FG003|Global Period|Withdrawal by Subject|0|||
23171922|NCT03434379|64375503|FG000|Global Period|Reason Unspecified|0|||
23171923|NCT03434379|64375504|FG001|Global Period|Reason Unspecified|1|||
23339093|NCT03843541|64986083|FG000|Overall Study|Administration of rescue mucolytic|0|||
23450827|NCT01216202|65395027|FG000|Overall Study|Death|0|||
23450828|NCT01216202|65395028|FG001|Overall Study|Death|2|||
23171924|NCT03434379|64375505|FG002|Global Period|Reason Unspecified|0|||
23171925|NCT03434379|64375506|FG003|Global Period|Reason Unspecified|0|||
23171926|NCT03434379|64375503|FG000|Global Period|Study Ended by Sponsor|26|||
23171927|NCT03434379|64375504|FG001|Global Period|Study Ended by Sponsor|80|||
23171928|NCT03434379|64375505|FG002|Global Period|Study Ended by Sponsor|0|||
23171929|NCT03434379|64375506|FG003|Global Period|Study Ended by Sponsor|0|||
23231736|NCT00842829|64591716|FG001|Continuation Period|Non-compliance to study procedures|0|||
23450829|NCT01216202|65395027|FG000|Overall Study|Lost to Follow-up|14|||
23450830|NCT01216202|65395028|FG001|Overall Study|Lost to Follow-up|0|||
23171930|NCT03434379|64375503|FG000|Global Period|Physician Decision|1|||
23171931|NCT03434379|64375504|FG001|Global Period|Physician Decision|0|||
23171932|NCT03434379|64375505|FG002|Global Period|Physician Decision|0|||
23171933|NCT03434379|64375506|FG003|Global Period|Physician Decision|0|||
23171934|NCT03434379|64375503|FG000|China Extension Period|Lost to Follow-up|0|||
23171935|NCT03434379|64375504|FG001|China Extension Period|Lost to Follow-up|0|||
23171936|NCT03434379|64375505|FG002|China Extension Period|Lost to Follow-up|2|||
23171937|NCT03434379|64375506|FG003|China Extension Period|Lost to Follow-up|3|||
23450831|NCT03310723|65395029|FG000|Overall Study|Withdrawal by Subject|0|||
23450832|NCT03310723|65395030|FG001|Overall Study|Withdrawal by Subject|1|||
23450833|NCT03310723|65395029|FG000|Overall Study|Protocol Violation|0|||
23450834|NCT03310723|65395030|FG001|Overall Study|Protocol Violation|2|||
23450835|NCT00468299|65395033|FG000|Overall Study|Withdrawal by Subject|0|||
23450836|NCT00468299|65395034|FG001|Overall Study|Withdrawal by Subject|1|||
23171938|NCT03434379|64375503|FG000|China Extension Period|Death|0|||
23171939|NCT03434379|64375504|FG001|China Extension Period|Death|0|||
23450837|NCT02138890|65395039|FG000|Overall Study|Adverse Event|1|||
23171940|NCT03434379|64375505|FG002|China Extension Period|Death|46|||
23450838|NCT02138890|65395040|FG001|Overall Study|Adverse Event|0|||
23450839|NCT03007966|65395041|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
23450840|NCT03007966|65395042|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
23450841|NCT03951077|65395049|FG000|Overall Study|Adverse Event|1|||
23450842|NCT03951077|65395050|FG001|Overall Study|Adverse Event|0|||
23450843|NCT03951077|65395051|FG002|Overall Study|Adverse Event|0|||
23450844|NCT03951077|65395052|FG003|Overall Study|Adverse Event|0|||
23450845|NCT03951077|65395053|FG004|Overall Study|Adverse Event|0|||
23450846|NCT03951077|65395054|FG005|Overall Study|Adverse Event|0|||
23450847|NCT03951077|65395049|FG000|Overall Study|Withdrawal by Subject|3|||
23450848|NCT03951077|65395050|FG001|Overall Study|Withdrawal by Subject|3|||
23450849|NCT03951077|65395051|FG002|Overall Study|Withdrawal by Subject|0|||
23450850|NCT03951077|65395052|FG003|Overall Study|Withdrawal by Subject|3|||
23171941|NCT03434379|64375506|FG003|China Extension Period|Death|88|||
23171942|NCT03434379|64375503|FG000|China Extension Period|Withdrawal by Subject|0|||
23171943|NCT03434379|64375504|FG001|China Extension Period|Withdrawal by Subject|0|||
23171944|NCT03434379|64375505|FG002|China Extension Period|Withdrawal by Subject|8|||
23171945|NCT03434379|64375506|FG003|China Extension Period|Withdrawal by Subject|6|||
23171946|NCT03434379|64375503|FG000|China Extension Period|Study Ended by Sponsor|0|||
23171947|NCT03434379|64375504|FG001|China Extension Period|Study Ended by Sponsor|0|||
23171948|NCT03434379|64375505|FG002|China Extension Period|Study Ended by Sponsor|5|||
23171949|NCT03434379|64375506|FG003|China Extension Period|Study Ended by Sponsor|36|||
23171950|NCT02792842|64375507|FG000|Overall Study|Adverse Event|4|||
23171951|NCT02792842|64375508|FG001|Overall Study|Adverse Event|2|||
23171952|NCT02792842|64375509|FG002|Overall Study|Adverse Event|3|||
23171953|NCT02792842|64375507|FG000|Overall Study|Withdrawal by Subject|0|||
23171954|NCT02792842|64375508|FG001|Overall Study|Withdrawal by Subject|1|||
23171955|NCT02792842|64375509|FG002|Overall Study|Withdrawal by Subject|2|||
23171956|NCT02792842|64375507|FG000|Overall Study|Lost to Follow-up|0|||
23171957|NCT02792842|64375508|FG001|Overall Study|Lost to Follow-up|0|||
23171958|NCT02792842|64375509|FG002|Overall Study|Lost to Follow-up|1|||
23171959|NCT02792842|64375507|FG000|Overall Study|Schedule delay|0|||
23171960|NCT02792842|64375508|FG001|Overall Study|Schedule delay|1|||
23171961|NCT02792842|64375509|FG002|Overall Study|Schedule delay|1|||
23171962|NCT00527605|64375510|FG000|Overall Study|Adverse Event|3|||
23171963|NCT00527605|64375511|FG001|Overall Study|Adverse Event|0|||
23171964|NCT00527605|64375510|FG000|Overall Study|Withdrawal by Subject|3|||
23171965|NCT00527605|64375511|FG001|Overall Study|Withdrawal by Subject|7|||
23171966|NCT00527605|64375510|FG000|Overall Study|Lost to Follow-up|6|||
23171967|NCT00527605|64375511|FG001|Overall Study|Lost to Follow-up|2|||
23171968|NCT00527605|64375510|FG000|Overall Study|Protocol Violation|1|||
23171969|NCT00527605|64375511|FG001|Overall Study|Protocol Violation|2|||
23171970|NCT01512264|64375520|FG000|Overall Study|Lost to Follow-up|0|||
23171971|NCT01512264|64375521|FG001|Overall Study|Lost to Follow-up|0|||
23171972|NCT01512264|64375522|FG002|Overall Study|Lost to Follow-up|0|||
23171973|NCT01512264|64375523|FG003|Overall Study|Lost to Follow-up|1|||
23171974|NCT00074958|64375524|FG000|Overall Study|Adverse Event|1|||
23171975|NCT05594173|64375525|FG000|Overall Study|Adverse Event|1|||
23171976|NCT05594173|64375525|FG000|Overall Study|COVID-19 Pandemic|2|||
23450851|NCT03951077|65395053|FG004|Overall Study|Withdrawal by Subject|3|||
23450852|NCT03951077|65395054|FG005|Overall Study|Withdrawal by Subject|2|||
23578671|NCT00783718|65850266|FG006|Maintenance Phase|Lack of Efficacy|155|||
23171977|NCT03694925|64375526|FG000|Overall Study|Inadequate laboratory testing|0|||
23171978|NCT03694925|64375527|FG001|Overall Study|Inadequate laboratory testing|3|||
23171979|NCT03694925|64375528|FG002|Overall Study|Inadequate laboratory testing|0|||
23171980|NCT04002310|64375561|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
23171981|NCT04002310|64375562|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
23450853|NCT03951077|65395049|FG000|Overall Study|Lost to Follow-up|1|||
23450854|NCT03951077|65395050|FG001|Overall Study|Lost to Follow-up|1|||
23450855|NCT03951077|65395051|FG002|Overall Study|Lost to Follow-up|2|||
23450856|NCT03951077|65395052|FG003|Overall Study|Lost to Follow-up|3|||
23450857|NCT03951077|65395053|FG004|Overall Study|Lost to Follow-up|2|||
23450858|NCT03951077|65395054|FG005|Overall Study|Lost to Follow-up|3|||
23450859|NCT03951077|65395049|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
23450860|NCT03951077|65395050|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
23578672|NCT00783718|65850260|FG000|Maintenance Phase|Withdrawal by Subject|6|||
23578673|NCT00783718|65850261|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23578674|NCT00783718|65850262|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23578675|NCT00783718|65850263|FG003|Maintenance Phase|Withdrawal by Subject|2|||
23578676|NCT00783718|65850264|FG004|Maintenance Phase|Withdrawal by Subject|5|||
23578677|NCT00783718|65850265|FG005|Maintenance Phase|Withdrawal by Subject|2|||
23578678|NCT00783718|65850266|FG006|Maintenance Phase|Withdrawal by Subject|20|||
23578679|NCT00783718|65850260|FG000|Maintenance Phase|Lost to Follow-up|3|||
23578680|NCT00783718|65850261|FG001|Maintenance Phase|Lost to Follow-up|0|||
23578681|NCT00783718|65850262|FG002|Maintenance Phase|Lost to Follow-up|0|||
23578682|NCT00783718|65850263|FG003|Maintenance Phase|Lost to Follow-up|0|||
23578683|NCT00783718|65850264|FG004|Maintenance Phase|Lost to Follow-up|2|||
23578684|NCT00783718|65850265|FG005|Maintenance Phase|Lost to Follow-up|0|||
23578685|NCT00783718|65850266|FG006|Maintenance Phase|Lost to Follow-up|2|||
23578686|NCT02271594|65850267|FG000|Overall Study|Study closed; recruiting failure|19|||
23450861|NCT03951077|65395051|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
23450862|NCT03951077|65395052|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
23578687|NCT02271594|65850268|FG001|Overall Study|Study closed; recruiting failure|12|||
23578688|NCT03033576|65850269|FG000|Overall Study|Ineligible|1|||
23578689|NCT03033576|65850270|FG001|Overall Study|Ineligible|1|||
23578690|NCT03033576|65850269|FG000|Overall Study|Adverse Event|4|||
23578691|NCT03033576|65850270|FG001|Overall Study|Adverse Event|20|||
23578692|NCT03033576|65850269|FG000|Overall Study|Progression/relapse|9|||
23578693|NCT03033576|65850270|FG001|Overall Study|Progression/relapse|36|||
23578694|NCT03033576|65850269|FG000|Overall Study|Death|1|||
23171982|NCT04002310|64375563|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
23171983|NCT04002310|64375564|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
23171984|NCT04002310|64375565|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
23171985|NCT02634580|64375566|FG000|Double-blind Treatment Period|Subject Request|1|||
23171986|NCT02634580|64375567|FG001|Double-blind Treatment Period|Subject Request|0|||
23171987|NCT02634580|64375568|FG002|Double-blind Treatment Period|Subject Request|1|||
23171988|NCT02634580|64375569|FG003|Double-blind Treatment Period|Subject Request|1|||
23231737|NCT00842829|64591717|FG002|Continuation Period|Non-compliance to study procedures|2|||
23231738|NCT00842829|64591715|FG000|Continuation Period|Non-compliance to study drug|0|||
23231739|NCT00842829|64591716|FG001|Continuation Period|Non-compliance to study drug|0|||
23231740|NCT00842829|64591717|FG002|Continuation Period|Non-compliance to study drug|1|||
23231741|NCT02041533|64591718|FG000|Pre-Treatment Period|Disease Progression|1|||
23231742|NCT02041533|64591719|FG001|Pre-Treatment Period|Disease Progression|1|||
23450863|NCT03951077|65395053|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
23450864|NCT03951077|65395054|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
23450865|NCT03951077|65395049|FG000|Overall Study|Other, Not Specified|12|||
23450866|NCT03951077|65395050|FG001|Overall Study|Other, Not Specified|10|||
23450867|NCT03951077|65395051|FG002|Overall Study|Other, Not Specified|10|||
23450868|NCT03951077|65395052|FG003|Overall Study|Other, Not Specified|5|||
23231743|NCT02041533|64591718|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
23231744|NCT02041533|64591719|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
23231745|NCT02041533|64591718|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
23231746|NCT02041533|64591719|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
23231747|NCT02041533|64591718|FG000|Treatment Period|Disease progression|189|||
23231748|NCT02041533|64591719|FG001|Treatment Period|Disease progression|146|||
23231749|NCT02041533|64591718|FG000|Treatment Period|Study drug toxicity|30|||
23231750|NCT02041533|64591719|FG001|Treatment Period|Study drug toxicity|34|||
23231751|NCT02041533|64591718|FG000|Treatment Period|Death|1|||
23231752|NCT02041533|64591719|FG001|Treatment Period|Death|0|||
23450869|NCT03951077|65395053|FG004|Overall Study|Other, Not Specified|9|||
23578695|NCT03033576|65850270|FG001|Overall Study|Death|1|||
23231753|NCT02041533|64591718|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
23231754|NCT02041533|64591719|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
23231755|NCT02041533|64591718|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
23578696|NCT03033576|65850269|FG000|Overall Study|Patient refusal|1|||
23578697|NCT03033576|65850270|FG001|Overall Study|Patient refusal|6|||
23578698|NCT03033576|65850269|FG000|Overall Study|Other, unspecified reasons|0|||
23578699|NCT03033576|65850270|FG001|Overall Study|Other, unspecified reasons|4|||
23578700|NCT03033576|65850269|FG000|Overall Study|Currently on protocol therapy|0|||
23231756|NCT02041533|64591719|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
23231757|NCT02041533|64591718|FG000|Treatment Period|Participant withdrew consent|2|||
23450870|NCT03951077|65395054|FG005|Overall Study|Other, Not Specified|6|||
23231758|NCT02041533|64591719|FG001|Treatment Period|Participant withdrew consent|2|||
23231759|NCT02041533|64591718|FG000|Treatment Period|Maximum clinical benefit|0|||
23578701|NCT03033576|65850270|FG001|Overall Study|Currently on protocol therapy|2|||
23231760|NCT02041533|64591719|FG001|Treatment Period|Maximum clinical benefit|18|||
23231761|NCT02041533|64591718|FG000|Treatment Period|Poor/Non-compliance|1|||
23231762|NCT02041533|64591719|FG001|Treatment Period|Poor/Non-compliance|0|||
23231763|NCT02041533|64591718|FG000|Treatment Period|Administrative reason by sponsor|1|||
23231764|NCT02041533|64591719|FG001|Treatment Period|Administrative reason by sponsor|0|||
23231765|NCT02041533|64591718|FG000|Treatment Period|Other reasons|9|||
23231766|NCT02041533|64591719|FG001|Treatment Period|Other reasons|2|||
23231767|NCT02041533|64591718|FG000|Treatment Period|Not Reported|0|||
23231768|NCT02041533|64591719|FG001|Treatment Period|Not Reported|1|||
23231769|NCT00963820|64591725|FG000|Dose Escalation Phase|Progressive Disease|3|||
23231770|NCT00963820|64591726|FG001|Dose Escalation Phase|Progressive Disease|3|||
23231771|NCT00963820|64591727|FG002|Dose Escalation Phase|Progressive Disease|3|||
23231772|NCT00963820|64591728|FG003|Dose Escalation Phase|Progressive Disease|3|||
23231773|NCT00963820|64591729|FG004|Dose Escalation Phase|Progressive Disease|4|||
23231774|NCT00963820|64591730|FG005|Dose Escalation Phase|Progressive Disease|3|||
23231775|NCT00963820|64591731|FG006|Dose Escalation Phase|Progressive Disease|3|||
23231776|NCT00963820|64591732|FG007|Dose Escalation Phase|Progressive Disease|2|||
23231777|NCT00963820|64591733|FG008|Dose Escalation Phase|Progressive Disease|0|||
23171989|NCT02634580|64375566|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
23171990|NCT02634580|64375567|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
23171991|NCT02634580|64375568|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
23171992|NCT02634580|64375569|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
23171993|NCT04607733|64375570|FG000|Overall Study|Lost to Follow-up|1|||
23171994|NCT04607733|64375571|FG001|Overall Study|Lost to Follow-up|0|||
23171995|NCT04607733|64375572|FG002|Overall Study|Lost to Follow-up|0|||
23171996|NCT04607733|64375573|FG003|Overall Study|Lost to Follow-up|1|||
23231778|NCT00963820|64591734|FG009|Dose Escalation Phase|Progressive Disease|0|||
23231779|NCT00963820|64591735|FG010|Dose Escalation Phase|Progressive Disease|0|||
23231780|NCT00963820|64591736|FG011|Dose Escalation Phase|Progressive Disease|0|||
23171997|NCT04607733|64375574|FG004|Overall Study|Lost to Follow-up|1|||
23231781|NCT00963820|64591725|FG000|Dose Escalation Phase|Adverse Event|0|||
23231782|NCT00963820|64591726|FG001|Dose Escalation Phase|Adverse Event|0|||
23231783|NCT00963820|64591727|FG002|Dose Escalation Phase|Adverse Event|0|||
23231784|NCT00963820|64591728|FG003|Dose Escalation Phase|Adverse Event|0|||
23231785|NCT00963820|64591729|FG004|Dose Escalation Phase|Adverse Event|0|||
23231786|NCT00963820|64591730|FG005|Dose Escalation Phase|Adverse Event|0|||
23231787|NCT00963820|64591731|FG006|Dose Escalation Phase|Adverse Event|3|||
23578702|NCT00551213|65850271|FG000|Overall Study|Adverse Event|6|||
23578703|NCT00551213|65850272|FG001|Overall Study|Adverse Event|3|||
23578704|NCT00551213|65850271|FG000|Overall Study|Progressive Disease|41|||
23578705|NCT00551213|65850272|FG001|Overall Study|Progressive Disease|12|||
23578706|NCT00551213|65850271|FG000|Overall Study|Withdrawal by Subject|2|||
23578707|NCT00551213|65850272|FG001|Overall Study|Withdrawal by Subject|0|||
23578708|NCT00551213|65850271|FG000|Overall Study|Not Treated|1|||
23578709|NCT00551213|65850272|FG001|Overall Study|Not Treated|2|||
23578710|NCT05576662|65850273|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
23578711|NCT05576662|65850274|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
23578712|NCT05576662|65850273|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
23578713|NCT05576662|65850274|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
23578714|NCT05576662|65850273|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
23578715|NCT05576662|65850274|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
23578716|NCT05576662|65850273|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
23578717|NCT05576662|65850274|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
23578718|NCT01813422|65850275|FG000|Overall Study|Withdrawal by Subject|14|||
23578719|NCT01813422|65850276|FG001|Overall Study|Withdrawal by Subject|8|||
23578720|NCT01813422|65850275|FG000|Overall Study|Death|2|||
23171998|NCT04607733|64375575|FG005|Overall Study|Lost to Follow-up|0|||
23231788|NCT00963820|64591732|FG007|Dose Escalation Phase|Adverse Event|1|||
23231789|NCT00963820|64591733|FG008|Dose Escalation Phase|Adverse Event|0|||
23231790|NCT00963820|64591734|FG009|Dose Escalation Phase|Adverse Event|0|||
23231791|NCT00963820|64591735|FG010|Dose Escalation Phase|Adverse Event|0|||
23578721|NCT01813422|65850276|FG001|Overall Study|Death|3|||
23171999|NCT04607733|64375570|FG000|Overall Study|Withdrawal by Subject|0|||
23172000|NCT04607733|64375571|FG001|Overall Study|Withdrawal by Subject|0|||
23172001|NCT04607733|64375572|FG002|Overall Study|Withdrawal by Subject|0|||
23231792|NCT00963820|64591736|FG011|Dose Escalation Phase|Adverse Event|0|||
23231793|NCT00963820|64591725|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23231794|NCT00963820|64591726|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23231795|NCT00963820|64591727|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23231796|NCT00963820|64591728|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23231797|NCT00963820|64591729|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
23172002|NCT04607733|64375573|FG003|Overall Study|Withdrawal by Subject|0|||
23450871|NCT03951077|65395049|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
23578722|NCT01813422|65850275|FG000|Overall Study|Sponsor Decision|2|||
23578723|NCT01813422|65850276|FG001|Overall Study|Sponsor Decision|1|||
23578724|NCT01813422|65850275|FG000|Overall Study|Lost to Follow-up|2|||
23578725|NCT01813422|65850276|FG001|Overall Study|Lost to Follow-up|4|||
23578726|NCT01017120|65850281|FG000|Overall Study|Adverse Event|9|||
23578727|NCT01017120|65850282|FG001|Overall Study|Adverse Event|0|||
23578728|NCT01017120|65850281|FG000|Overall Study|Lost to Follow-up|13|||
23172003|NCT04607733|64375574|FG004|Overall Study|Withdrawal by Subject|1|||
23172004|NCT04607733|64375575|FG005|Overall Study|Withdrawal by Subject|0|||
23172005|NCT04161131|64375576|FG000|Overall Study|Ineligible|2|||
23172006|NCT04161131|64375576|FG000|Overall Study|Lost to Follow-up|4|||
23172007|NCT04429061|64375578|FG000|Overall Study|Lost to Follow-up|62|||
23172008|NCT04429061|64375579|FG001|Overall Study|Lost to Follow-up|87|||
23172009|NCT04429061|64375578|FG000|Overall Study|Withdrawal by Subject|3|||
23172010|NCT04429061|64375579|FG001|Overall Study|Withdrawal by Subject|4|||
23172011|NCT02918019|64375581|FG000|Overall Study|Death|0|||
23172012|NCT02918019|64375582|FG001|Overall Study|Death|0|||
23172013|NCT02918019|64375583|FG002|Overall Study|Death|1|||
23172014|NCT02918019|64375584|FG003|Overall Study|Death|0|||
23172015|NCT02918019|64375581|FG000|Overall Study|Lost to Follow-up|1|||
23172016|NCT02918019|64375582|FG001|Overall Study|Lost to Follow-up|1|||
23172017|NCT02918019|64375583|FG002|Overall Study|Lost to Follow-up|0|||
23172018|NCT02918019|64375584|FG003|Overall Study|Lost to Follow-up|1|||
23172019|NCT02918019|64375581|FG000|Overall Study|Principal investigator request|0|||
23172020|NCT02918019|64375582|FG001|Overall Study|Principal investigator request|0|||
23578729|NCT01017120|65850282|FG001|Overall Study|Lost to Follow-up|11|||
23578730|NCT01017120|65850281|FG000|Overall Study|Lack of Efficacy|1|||
23172021|NCT02918019|64375583|FG002|Overall Study|Principal investigator request|0|||
23172022|NCT02918019|64375584|FG003|Overall Study|Principal investigator request|1|||
23172023|NCT02918019|64375581|FG000|Overall Study|Physician Decision|1|||
23172024|NCT02918019|64375582|FG001|Overall Study|Physician Decision|3|||
23172025|NCT02918019|64375583|FG002|Overall Study|Physician Decision|2|||
23578731|NCT01017120|65850282|FG001|Overall Study|Lack of Efficacy|0|||
23578732|NCT01017120|65850281|FG000|Overall Study|Withdrawal by Subject|39|||
23578733|NCT01017120|65850282|FG001|Overall Study|Withdrawal by Subject|21|||
23578734|NCT01017120|65850281|FG000|Overall Study|Pregnancy|1|||
23578735|NCT01017120|65850282|FG001|Overall Study|Pregnancy|1|||
23578736|NCT01017120|65850281|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
23578737|NCT01017120|65850282|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
23578738|NCT01017120|65850281|FG000|Overall Study|Relocated Out of Town|0|||
23578739|NCT01017120|65850282|FG001|Overall Study|Relocated Out of Town|2|||
23578740|NCT01017120|65850281|FG000|Overall Study|Protocol Violation|1|||
23172026|NCT02918019|64375584|FG003|Overall Study|Physician Decision|0|||
23172027|NCT02918019|64375581|FG000|Overall Study|Protocol deviation|1|||
23172028|NCT02918019|64375582|FG001|Overall Study|Protocol deviation|1|||
23172029|NCT02918019|64375583|FG002|Overall Study|Protocol deviation|0|||
23172030|NCT02918019|64375584|FG003|Overall Study|Protocol deviation|2|||
23172031|NCT02918019|64375581|FG000|Overall Study|Withdrawal by Subject|3|||
23172032|NCT02918019|64375582|FG001|Overall Study|Withdrawal by Subject|4|||
23172033|NCT02918019|64375583|FG002|Overall Study|Withdrawal by Subject|6|||
23172034|NCT02918019|64375584|FG003|Overall Study|Withdrawal by Subject|4|||
23172035|NCT02918019|64375581|FG000|Overall Study|Adverse Event|0|||
23172036|NCT02918019|64375582|FG001|Overall Study|Adverse Event|1|||
23172037|NCT02918019|64375583|FG002|Overall Study|Adverse Event|0|||
23172038|NCT02918019|64375584|FG003|Overall Study|Adverse Event|1|||
23172039|NCT00883337|64375585|FG000|Core Treatment Period|Adverse Event|9|||
23172040|NCT00883337|64375586|FG001|Core Treatment Period|Adverse Event|12|||
23172041|NCT00883337|64375587|FG002|Core Treatment Period|Adverse Event|22|||
23172042|NCT00883337|64375585|FG000|Core Treatment Period|Lack of Efficacy|7|||
23172043|NCT00883337|64375586|FG001|Core Treatment Period|Lack of Efficacy|4|||
23172044|NCT00883337|64375587|FG002|Core Treatment Period|Lack of Efficacy|2|||
23578741|NCT01017120|65850282|FG001|Overall Study|Protocol Violation|0|||
23172045|NCT00883337|64375585|FG000|Core Treatment Period|Lost to Follow-up|1|||
23172046|NCT00883337|64375586|FG001|Core Treatment Period|Lost to Follow-up|1|||
23450872|NCT03951077|65395050|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
23172047|NCT00883337|64375587|FG002|Core Treatment Period|Lost to Follow-up|0|||
23172048|NCT00883337|64375585|FG000|Core Treatment Period|Withdrawal by Subject|2|||
23578742|NCT01017120|65850281|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
23231798|NCT00963820|64591730|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
23231799|NCT00963820|64591731|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
23231800|NCT00963820|64591732|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
23231801|NCT00963820|64591733|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
23231802|NCT00963820|64591734|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
23231803|NCT00963820|64591735|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
23231804|NCT00963820|64591736|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
23231805|NCT00963820|64591725|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23578743|NCT01017120|65850282|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
23231806|NCT00963820|64591726|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23231807|NCT00963820|64591727|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23231808|NCT00963820|64591728|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23231809|NCT00963820|64591729|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23231810|NCT00963820|64591730|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23231811|NCT00963820|64591731|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
23231812|NCT00963820|64591732|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23231813|NCT00963820|64591733|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23231814|NCT00963820|64591734|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23231815|NCT00963820|64591735|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23339094|NCT03843541|64986084|FG001|Overall Study|Administration of rescue mucolytic|0|||
23339095|NCT03843541|64986085|FG002|Overall Study|Administration of rescue mucolytic|1|||
23578744|NCT00432159|65850283|FG000|Overall Study|Death|0|||
23578745|NCT00432159|65850284|FG001|Overall Study|Death|1|||
23578746|NCT00432159|65850285|FG002|Overall Study|Death|0|||
23578747|NCT00432159|65850286|FG003|Overall Study|Death|0|||
23578748|NCT00432159|65850287|FG004|Overall Study|Death|0|||
23578749|NCT00432159|65850283|FG000|Overall Study|Failure|9|||
23578750|NCT00432159|65850284|FG001|Overall Study|Failure|5|||
23578751|NCT00432159|65850285|FG002|Overall Study|Failure|3|||
23578752|NCT00432159|65850286|FG003|Overall Study|Failure|2|||
23578753|NCT00432159|65850287|FG004|Overall Study|Failure|3|||
23578754|NCT00432159|65850283|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
23578755|NCT00432159|65850284|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
23578756|NCT00432159|65850285|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
23578757|NCT00432159|65850286|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
23578758|NCT00432159|65850287|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
23578759|NCT00329303|65850288|FG000|Overall Study|Lack of Efficacy|1|||
23578760|NCT00329303|65850289|FG001|Overall Study|Lack of Efficacy|0|||
23578761|NCT00329303|65850288|FG000|Overall Study|Decision of the sponsor|0|||
23578762|NCT00329303|65850289|FG001|Overall Study|Decision of the sponsor|1|||
23578763|NCT00329303|65850288|FG000|Overall Study|Patient no longer available|1|||
23578764|NCT00329303|65850289|FG001|Overall Study|Patient no longer available|0|||
23578765|NCT00329303|65850288|FG000|Overall Study|Patient relocated|0|||
23578766|NCT00329303|65850289|FG001|Overall Study|Patient relocated|1|||
23578767|NCT01515319|65850290|FG000|Overall Study|Withdrawal by Subject|0|||
23578768|NCT01515319|65850291|FG001|Overall Study|Withdrawal by Subject|0|||
23578769|NCT01515319|65850292|FG002|Overall Study|Withdrawal by Subject|0|||
23578770|NCT01515319|65850293|FG003|Overall Study|Withdrawal by Subject|0|||
23578771|NCT01515319|65850294|FG004|Overall Study|Withdrawal by Subject|0|||
23578772|NCT01515319|65850295|FG005|Overall Study|Withdrawal by Subject|0|||
23172049|NCT00883337|64375586|FG001|Core Treatment Period|Withdrawal by Subject|2|||
23172050|NCT00883337|64375587|FG002|Core Treatment Period|Withdrawal by Subject|6|||
23172051|NCT00883337|64375585|FG000|Core Treatment Period|Wish to be pregnant|1|||
23172052|NCT00883337|64375586|FG001|Core Treatment Period|Wish to be pregnant|2|||
23172053|NCT00883337|64375587|FG002|Core Treatment Period|Wish to be pregnant|1|||
23172054|NCT00883337|64375585|FG000|Core Treatment Period|Poor compliance to protocol|0|||
23172055|NCT00883337|64375586|FG001|Core Treatment Period|Poor compliance to protocol|0|||
23172056|NCT00883337|64375587|FG002|Core Treatment Period|Poor compliance to protocol|1|||
23172057|NCT00883337|64375585|FG000|Core Treatment Period|Other than above|0|||
23172058|NCT00883337|64375586|FG001|Core Treatment Period|Other than above|1|||
23172059|NCT00883337|64375587|FG002|Core Treatment Period|Other than above|1|||
23231816|NCT00963820|64591736|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
23231817|NCT00963820|64591725|FG000|Expansion Phase|Progressive Disease|0|||
23231818|NCT00963820|64591726|FG001|Expansion Phase|Progressive Disease|0|||
23578773|NCT01515319|65850296|FG006|Overall Study|Withdrawal by Subject|1|||
23231819|NCT00963820|64591727|FG002|Expansion Phase|Progressive Disease|0|||
23231820|NCT00963820|64591728|FG003|Expansion Phase|Progressive Disease|0|||
23231821|NCT00963820|64591729|FG004|Expansion Phase|Progressive Disease|0|||
23578774|NCT01515319|65850297|FG007|Overall Study|Withdrawal by Subject|0|||
23578775|NCT01515319|65850298|FG008|Overall Study|Withdrawal by Subject|0|||
23578776|NCT01515319|65850299|FG009|Overall Study|Withdrawal by Subject|0|||
23172060|NCT00883337|64375585|FG000|Extension Treatment Period|Adverse Event|8|||
23578777|NCT01515319|65850290|FG000|Overall Study|Adverse Event|0|||
23578778|NCT01515319|65850291|FG001|Overall Study|Adverse Event|0|||
23578779|NCT01515319|65850292|FG002|Overall Study|Adverse Event|0|||
23578780|NCT01515319|65850293|FG003|Overall Study|Adverse Event|0|||
23578781|NCT01515319|65850294|FG004|Overall Study|Adverse Event|0|||
23578782|NCT01515319|65850295|FG005|Overall Study|Adverse Event|0|||
23578783|NCT01515319|65850296|FG006|Overall Study|Adverse Event|0|||
23578784|NCT01515319|65850297|FG007|Overall Study|Adverse Event|0|||
23578785|NCT01515319|65850298|FG008|Overall Study|Adverse Event|3|||
23578786|NCT01515319|65850299|FG009|Overall Study|Adverse Event|0|||
23578787|NCT01515319|65850290|FG000|Overall Study|Protocol Violation|0|||
23578788|NCT01515319|65850291|FG001|Overall Study|Protocol Violation|0|||
23578789|NCT01515319|65850292|FG002|Overall Study|Protocol Violation|0|||
23578790|NCT01515319|65850293|FG003|Overall Study|Protocol Violation|0|||
23578791|NCT01515319|65850294|FG004|Overall Study|Protocol Violation|0|||
23578792|NCT01515319|65850295|FG005|Overall Study|Protocol Violation|0|||
23578793|NCT01515319|65850296|FG006|Overall Study|Protocol Violation|0|||
23578794|NCT01515319|65850297|FG007|Overall Study|Protocol Violation|0|||
23578795|NCT01515319|65850298|FG008|Overall Study|Protocol Violation|2|||
23172061|NCT00883337|64375586|FG001|Extension Treatment Period|Adverse Event|5|||
23172062|NCT00883337|64375587|FG002|Extension Treatment Period|Adverse Event|5|||
23172063|NCT00883337|64375585|FG000|Extension Treatment Period|Lack of Efficacy|8|||
23172064|NCT00883337|64375586|FG001|Extension Treatment Period|Lack of Efficacy|8|||
23172065|NCT00883337|64375587|FG002|Extension Treatment Period|Lack of Efficacy|8|||
23172066|NCT00883337|64375585|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
23172067|NCT00883337|64375586|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
23172068|NCT00883337|64375587|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
23172069|NCT00883337|64375585|FG000|Extension Treatment Period|Lost to Follow-up|1|||
23172070|NCT00883337|64375586|FG001|Extension Treatment Period|Lost to Follow-up|0|||
23172071|NCT00883337|64375587|FG002|Extension Treatment Period|Lost to Follow-up|0|||
23172072|NCT00883337|64375585|FG000|Extension Treatment Period|Other than above|10|||
23172073|NCT00883337|64375586|FG001|Extension Treatment Period|Other than above|9|||
23172074|NCT00883337|64375587|FG002|Extension Treatment Period|Other than above|5|||
23172075|NCT00626093|64375588|FG000|Overall Study|Lost to Follow-up|5|||
23172076|NCT00626093|64375588|FG000|Overall Study|Death|1|||
23172077|NCT00626093|64375588|FG000|Overall Study|Physician Decision|4|||
23172078|NCT00626093|64375588|FG000|Overall Study|Withdrawal by Subject|6|||
23172079|NCT00626093|64375588|FG000|Overall Study|Protocol Violation|1|||
23172080|NCT00626093|64375588|FG000|Overall Study|One of the required devices not implante|6|||
23172081|NCT01496885|64375596|FG000|Overall Study|Lost to Follow-up|13|||
23578796|NCT01515319|65850299|FG009|Overall Study|Protocol Violation|0|||
23578797|NCT02401529|65850300|FG000|Overall Study|Lost to Follow-up|2|||
23578798|NCT02401529|65850301|FG001|Overall Study|Lost to Follow-up|1|||
23578799|NCT02401529|65850300|FG000|Overall Study|Physician Decision|2|||
23578800|NCT02401529|65850301|FG001|Overall Study|Physician Decision|6|||
23578801|NCT02401529|65850300|FG000|Overall Study|Protocol Violation|5|||
23578802|NCT02401529|65850301|FG001|Overall Study|Protocol Violation|0|||
23578803|NCT04523181|65850306|FG000|Overall Study|Withdrawal by Subject|4|||
23578804|NCT04523181|65850307|FG001|Overall Study|Withdrawal by Subject|5|||
23578805|NCT04523181|65850306|FG000|Overall Study|Lost to Follow-up|2|||
23578806|NCT04523181|65850307|FG001|Overall Study|Lost to Follow-up|3|||
23578807|NCT04523181|65850306|FG000|Overall Study|Physician Decision|1|||
23578808|NCT04523181|65850307|FG001|Overall Study|Physician Decision|0|||
23172082|NCT01496885|64375596|FG000|Overall Study|Withdrawal by Subject|7|||
23172083|NCT01496885|64375596|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
23172084|NCT01496885|64375596|FG000|Overall Study|Death|1|||
23172085|NCT01870739|64375597|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
23172086|NCT01870739|64375598|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
23172087|NCT01870739|64375597|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
23172088|NCT01870739|64375598|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
23172089|NCT01870739|64375597|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
23172090|NCT01870739|64375598|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
23172091|NCT01870739|64375597|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
23172092|NCT01870739|64375598|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
23172093|NCT01870739|64375597|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
23172094|NCT01870739|64375598|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
23172095|NCT01870739|64375597|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
23172096|NCT01870739|64375598|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
23172097|NCT01870739|64375597|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
23172098|NCT01870739|64375598|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
23172099|NCT00429585|64375599|FG000|Overall Study|Death|1|||
23172100|NCT00429585|64375600|FG001|Overall Study|Death|0|||
23172101|NCT00429585|64375599|FG000|Overall Study|Lost to Follow-up|27|||
23172102|NCT00429585|64375600|FG001|Overall Study|Lost to Follow-up|20|||
23172103|NCT00429585|64375599|FG000|Overall Study|Physician Decision|2|||
23172104|NCT00429585|64375600|FG001|Overall Study|Physician Decision|0|||
23172105|NCT01641939|64375601|FG000|Overall Study|Death|90|||
23172106|NCT01641939|64375602|FG001|Overall Study|Death|187|||
23172107|NCT01641939|64375603|FG002|Overall Study|Death|61|||
23172108|NCT01641939|64375601|FG000|Overall Study|Lost to Follow-up|3|||
23172109|NCT01641939|64375602|FG001|Overall Study|Lost to Follow-up|2|||
23172110|NCT01641939|64375603|FG002|Overall Study|Lost to Follow-up|1|||
23172111|NCT01641939|64375601|FG000|Overall Study|Withdrawal by Subject|14|||
23172112|NCT01641939|64375602|FG001|Overall Study|Withdrawal by Subject|11|||
23172113|NCT01641939|64375603|FG002|Overall Study|Withdrawal by Subject|5|||
23172114|NCT01641939|64375601|FG000|Overall Study|Study Terminated by Sponsor|10|||
23172115|NCT01641939|64375602|FG001|Overall Study|Study Terminated by Sponsor|28|||
23172116|NCT01641939|64375603|FG002|Overall Study|Study Terminated by Sponsor|3|||
23172117|NCT01363986|64375604|FG000|Overall Study|Disease progression|1|||
23172118|NCT00704964|64375605|FG000|Overall Study|Not completed on time|328|||
23172119|NCT02684981|64375608|FG000|Overall Study|Permanently discontinued the treatment|157|||
23578809|NCT04523181|65850306|FG000|Overall Study|Transferred to external facility.|1|||
23172120|NCT02684981|64375609|FG001|Overall Study|Permanently discontinued the treatment|161|||
23578810|NCT04523181|65850307|FG001|Overall Study|Transferred to external facility.|1|||
23578811|NCT01354938|65850313|FG000|Overall Study|Lost to Follow-up|1|||
23578812|NCT01446003|65850314|FG000|Period 1|Protocol Violation|2|||
23578813|NCT01446003|65850315|FG001|Period 1|Protocol Violation|0|||
23578814|NCT01446003|65850314|FG000|Period 2|Adverse Event|1|||
23578815|NCT01446003|65850315|FG001|Period 2|Adverse Event|0|||
23578816|NCT00953160|65850316|FG000|Overall Study|Lost to Follow-up|23|||
23578817|NCT00953160|65850316|FG000|Overall Study|Withdrawal by Subject|4|||
23578818|NCT02939183|65850317|FG000|Overall Study|Death|0|||
23578819|NCT02939183|65850318|FG001|Overall Study|Death|0|||
23578820|NCT02939183|65850319|FG002|Overall Study|Death|1|||
23578821|NCT02939183|65850320|FG003|Overall Study|Death|0|||
23578822|NCT02939183|65850321|FG004|Overall Study|Death|0|||
23578823|NCT02939183|65850322|FG005|Overall Study|Death|2|||
23578824|NCT02939183|65850323|FG006|Overall Study|Death|1|||
23578825|NCT02939183|65850324|FG007|Overall Study|Death|0|||
23578826|NCT02939183|65850325|FG008|Overall Study|Death|0|||
23578827|NCT02939183|65850317|FG000|Overall Study|Sponsor decision|0|||
23578828|NCT02939183|65850318|FG001|Overall Study|Sponsor decision|1|||
23578829|NCT02939183|65850319|FG002|Overall Study|Sponsor decision|0|||
23578830|NCT02939183|65850320|FG003|Overall Study|Sponsor decision|1|||
23578831|NCT02939183|65850321|FG004|Overall Study|Sponsor decision|2|||
23578832|NCT02939183|65850322|FG005|Overall Study|Sponsor decision|0|||
23578833|NCT02939183|65850323|FG006|Overall Study|Sponsor decision|3|||
23578834|NCT02939183|65850324|FG007|Overall Study|Sponsor decision|1|||
23578835|NCT02939183|65850325|FG008|Overall Study|Sponsor decision|4|||
23578836|NCT02939183|65850317|FG000|Overall Study|Withdrawal by Subject|0|||
23578837|NCT02939183|65850318|FG001|Overall Study|Withdrawal by Subject|2|||
23578838|NCT02939183|65850319|FG002|Overall Study|Withdrawal by Subject|0|||
23578839|NCT02939183|65850320|FG003|Overall Study|Withdrawal by Subject|1|||
23578840|NCT02939183|65850321|FG004|Overall Study|Withdrawal by Subject|0|||
23578841|NCT02939183|65850322|FG005|Overall Study|Withdrawal by Subject|0|||
23578842|NCT02939183|65850323|FG006|Overall Study|Withdrawal by Subject|2|||
23578843|NCT02939183|65850324|FG007|Overall Study|Withdrawal by Subject|2|||
23578844|NCT02939183|65850325|FG008|Overall Study|Withdrawal by Subject|2|||
23578845|NCT02939183|65850317|FG000|Overall Study|Not treated due to adverse event|0|||
23578846|NCT02939183|65850318|FG001|Overall Study|Not treated due to adverse event|0|||
23578847|NCT02939183|65850319|FG002|Overall Study|Not treated due to adverse event|0|||
23578848|NCT02939183|65850320|FG003|Overall Study|Not treated due to adverse event|1|||
23578849|NCT02939183|65850321|FG004|Overall Study|Not treated due to adverse event|0|||
23578850|NCT02939183|65850322|FG005|Overall Study|Not treated due to adverse event|0|||
23578851|NCT02939183|65850323|FG006|Overall Study|Not treated due to adverse event|1|||
23578852|NCT02939183|65850324|FG007|Overall Study|Not treated due to adverse event|0|||
23578853|NCT02939183|65850325|FG008|Overall Study|Not treated due to adverse event|0|||
23578854|NCT03673098|65850328|FG000|Overall Study|Lost to Follow-up|2|||
23578855|NCT03673098|65850329|FG001|Overall Study|Lost to Follow-up|3|||
23578856|NCT03673098|65850328|FG000|Overall Study|Withdrawal by Subject|6|||
23578857|NCT03673098|65850329|FG001|Overall Study|Withdrawal by Subject|1|||
23578858|NCT03673098|65850328|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
23578859|NCT03673098|65850329|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
23578860|NCT02412761|65850330|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23578861|NCT02412761|65850331|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23578862|NCT02412761|65850332|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23578863|NCT02412761|65850333|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23578864|NCT02412761|65850334|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23578865|NCT02412761|65850335|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23578866|NCT00814489|65850340|FG000|Overall Study|Other|2|||
23578867|NCT00814489|65850341|FG001|Overall Study|Other|0|||
23578868|NCT00814489|65850342|FG002|Overall Study|Other|1|||
23578869|NCT00318656|65850346|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
23578870|NCT00318656|65850347|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
23578871|NCT00318656|65850346|FG000|Overall Study|Did not receive any treatment|0|||
23578872|NCT00318656|65850347|FG001|Overall Study|Did not receive any treatment|1|||
23578873|NCT02099539|65850354|FG000|Overall Study|Progressive Disease|3|||
23578874|NCT02099539|65850355|FG001|Overall Study|Progressive Disease|2|||
23172121|NCT02684981|64375610|FG002|Overall Study|Permanently discontinued the treatment|110|||
23172122|NCT02684981|64375608|FG000|Overall Study|Other|83|||
23172123|NCT02684981|64375609|FG001|Overall Study|Other|49|||
23172124|NCT02684981|64375610|FG002|Overall Study|Other|17|||
23578875|NCT02099539|65850356|FG002|Overall Study|Progressive Disease|2|||
23578876|NCT02099539|65850357|FG003|Overall Study|Progressive Disease|1|||
23578877|NCT02099539|65850358|FG004|Overall Study|Progressive Disease|4|||
23578878|NCT02099539|65850359|FG005|Overall Study|Progressive Disease|2|||
23578879|NCT02099539|65850360|FG006|Overall Study|Progressive Disease|0|||
23578880|NCT02099539|65850354|FG000|Overall Study|Adverse Event|0|||
23578881|NCT02099539|65850355|FG001|Overall Study|Adverse Event|0|||
23578882|NCT02099539|65850356|FG002|Overall Study|Adverse Event|1|||
23578883|NCT02099539|65850357|FG003|Overall Study|Adverse Event|1|||
23578884|NCT02099539|65850358|FG004|Overall Study|Adverse Event|0|||
23578885|NCT02099539|65850359|FG005|Overall Study|Adverse Event|0|||
23578886|NCT02099539|65850360|FG006|Overall Study|Adverse Event|0|||
23578887|NCT02099539|65850354|FG000|Overall Study|Physician Decision|0|||
23578888|NCT02099539|65850355|FG001|Overall Study|Physician Decision|0|||
23578889|NCT02099539|65850356|FG002|Overall Study|Physician Decision|0|||
23578890|NCT02099539|65850357|FG003|Overall Study|Physician Decision|0|||
23578891|NCT02099539|65850358|FG004|Overall Study|Physician Decision|0|||
23578892|NCT02099539|65850359|FG005|Overall Study|Physician Decision|1|||
23578893|NCT02099539|65850360|FG006|Overall Study|Physician Decision|0|||
23578894|NCT01222247|65850361|FG000|Overall Study|Lost to Follow-up|2|||
23578895|NCT01222247|65850362|FG001|Overall Study|Lost to Follow-up|2|||
23578896|NCT00924664|65850363|FG000|Overall Study|Adverse Event|23|||
23578897|NCT00924664|65850364|FG001|Overall Study|Adverse Event|39|||
23578898|NCT00924664|65850363|FG000|Overall Study|Lack of Efficacy|10|||
23578899|NCT00924664|65850364|FG001|Overall Study|Lack of Efficacy|15|||
23578900|NCT00924664|65850363|FG000|Overall Study|Lost to Follow-up|10|||
23578901|NCT00924664|65850364|FG001|Overall Study|Lost to Follow-up|12|||
23578902|NCT00924664|65850363|FG000|Overall Study|Withdrawal by Subject|47|||
23578903|NCT00924664|65850364|FG001|Overall Study|Withdrawal by Subject|71|||
23578904|NCT00924664|65850363|FG000|Overall Study|Protocol Violation|2|||
23578905|NCT00924664|65850364|FG001|Overall Study|Protocol Violation|5|||
23578906|NCT00924664|65850363|FG000|Overall Study|Pregnancy|1|||
23578907|NCT00924664|65850364|FG001|Overall Study|Pregnancy|1|||
23578908|NCT00924664|65850363|FG000|Overall Study|Death|0|||
23578909|NCT00924664|65850364|FG001|Overall Study|Death|2|||
23578910|NCT00924664|65850363|FG000|Overall Study|Study terminated by sponsor|199|||
23578911|NCT00924664|65850364|FG001|Overall Study|Study terminated by sponsor|330|||
23578912|NCT00924664|65850363|FG000|Overall Study|Other|29|||
23578913|NCT00924664|65850364|FG001|Overall Study|Other|52|||
23578914|NCT00924664|65850363|FG000|Overall Study|Randomized but not Treated|1|||
23578915|NCT00924664|65850364|FG001|Overall Study|Randomized but not Treated|0|||
23578916|NCT04305912|65850365|FG000|First Intervention|COVID-19 Suspension|2|||
23578917|NCT04305912|65850366|FG001|First Intervention|COVID-19 Suspension|0|||
23578918|NCT04305912|65850365|FG000|First Intervention|Withdrawal by Subject|0|||
23578919|NCT04305912|65850366|FG001|First Intervention|Withdrawal by Subject|1|||
23578920|NCT04305912|65850365|FG000|Second Intervention|Adverse Event|0|||
23578921|NCT04305912|65850366|FG001|Second Intervention|Adverse Event|1|||
23578922|NCT04776213|65850368|FG000|Overall Study|Other|1|||
23578923|NCT04776213|65850368|FG000|Overall Study|Withdrawal by Subject|7|||
23578924|NCT04776213|65850368|FG000|Overall Study|Protocol Violation|1|||
23339096|NCT03843541|64986083|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
23339097|NCT03843541|64986084|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
23231822|NCT00963820|64591730|FG005|Expansion Phase|Progressive Disease|0|||
23231823|NCT00963820|64591731|FG006|Expansion Phase|Progressive Disease|0|||
23231824|NCT00963820|64591732|FG007|Expansion Phase|Progressive Disease|0|||
23231825|NCT00963820|64591733|FG008|Expansion Phase|Progressive Disease|8|||
23339098|NCT03843541|64986085|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
23339099|NCT04545567|64986086|FG000|Overall Study|tested positive for SARS-co-V2|1|||
23578925|NCT04776213|65850368|FG000|Overall Study|Lost to Follow-up|2|||
23231826|NCT00963820|64591734|FG009|Expansion Phase|Progressive Disease|6|||
23231827|NCT00963820|64591735|FG010|Expansion Phase|Progressive Disease|4|||
23231828|NCT00963820|64591736|FG011|Expansion Phase|Progressive Disease|2|||
23231829|NCT00963820|64591725|FG000|Expansion Phase|Adverse Event|0|||
23578926|NCT01642186|65850369|FG000|Overall Study|Death|0|||
23578927|NCT01642186|65850370|FG001|Overall Study|Death|2|||
23578928|NCT01642186|65850371|FG002|Overall Study|Death|2|||
23578929|NCT01642186|65850369|FG000|Overall Study|Lost to Follow-up|0|||
23578930|NCT01642186|65850370|FG001|Overall Study|Lost to Follow-up|0|||
23578931|NCT01642186|65850371|FG002|Overall Study|Lost to Follow-up|1|||
23578932|NCT01559090|65850372|FG000|Stage I|Withdrawal by Subject|2|||
23578933|NCT01559090|65850373|FG001|Stage I|Withdrawal by Subject|2|||
23578934|NCT01559090|65850374|FG002|Stage I|Withdrawal by Subject|3|||
23578935|NCT01559090|65850372|FG000|Stage II|Withdrawal by Subject|1|||
23578936|NCT01559090|65850373|FG001|Stage II|Withdrawal by Subject|0|||
23578937|NCT01559090|65850374|FG002|Stage II|Withdrawal by Subject|0|||
23231830|NCT00963820|64591726|FG001|Expansion Phase|Adverse Event|0|||
23231831|NCT00963820|64591727|FG002|Expansion Phase|Adverse Event|0|||
23578938|NCT03379233|65850375|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
23578939|NCT03379233|65850376|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
23578940|NCT03168438|65850377|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
23578941|NCT03168438|65850378|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
23578942|NCT03523585|65850379|FG000|Overall Study|Progressive Disease|174|||
23578943|NCT03523585|65850380|FG001|Overall Study|Progressive Disease|64|||
23578944|NCT03523585|65850381|FG002|Overall Study|Progressive Disease|77|||
23578945|NCT03523585|65850379|FG000|Overall Study|Adverse Event|74|||
23578946|NCT03523585|65850380|FG001|Overall Study|Adverse Event|5|||
23578947|NCT03523585|65850381|FG002|Overall Study|Adverse Event|9|||
23578948|NCT03523585|65850379|FG000|Overall Study|Withdrawal by Subject|30|||
23578949|NCT03523585|65850380|FG001|Overall Study|Withdrawal by Subject|11|||
23578950|NCT03523585|65850381|FG002|Overall Study|Withdrawal by Subject|6|||
23578951|NCT03523585|65850379|FG000|Overall Study|Clinical Progression|23|||
23578952|NCT03523585|65850380|FG001|Overall Study|Clinical Progression|5|||
23578953|NCT03523585|65850381|FG002|Overall Study|Clinical Progression|10|||
23578954|NCT03523585|65850379|FG000|Overall Study|Death|4|||
23578955|NCT03523585|65850380|FG001|Overall Study|Death|0|||
23578956|NCT03523585|65850381|FG002|Overall Study|Death|1|||
23578957|NCT03523585|65850379|FG000|Overall Study|Physician Decision|2|||
23578958|NCT03523585|65850380|FG001|Overall Study|Physician Decision|1|||
23578959|NCT03523585|65850381|FG002|Overall Study|Physician Decision|0|||
23578960|NCT03523585|65850379|FG000|Overall Study|Lost to Follow-up|1|||
23578961|NCT03523585|65850380|FG001|Overall Study|Lost to Follow-up|0|||
23578962|NCT03523585|65850381|FG002|Overall Study|Lost to Follow-up|0|||
23578963|NCT03523585|65850379|FG000|Overall Study|Miscellaneous|1|||
23578964|NCT03523585|65850380|FG001|Overall Study|Miscellaneous|0|||
23578965|NCT03523585|65850381|FG002|Overall Study|Miscellaneous|0|||
23578966|NCT03523585|65850379|FG000|Overall Study|Protocol Deviation|1|||
23578967|NCT03523585|65850380|FG001|Overall Study|Protocol Deviation|0|||
23578968|NCT03523585|65850381|FG002|Overall Study|Protocol Deviation|1|||
23578969|NCT03523585|65850379|FG000|Overall Study|Randomized But Not Treated|2|||
23578970|NCT03523585|65850380|FG001|Overall Study|Randomized But Not Treated|4|||
23578971|NCT03523585|65850381|FG002|Overall Study|Randomized But Not Treated|3|||
23578972|NCT02015195|65850386|FG000|Overall Study|Adverse Event|0|||
23578973|NCT02015195|65850387|FG001|Overall Study|Adverse Event|0|||
23578974|NCT02015195|65850388|FG002|Overall Study|Adverse Event|0|||
23578975|NCT02015195|65850389|FG003|Overall Study|Adverse Event|1|||
23578976|NCT02015195|65850390|FG004|Overall Study|Adverse Event|0|||
23578977|NCT02015195|65850391|FG005|Overall Study|Adverse Event|0|||
23578978|NCT02015195|65850392|FG006|Overall Study|Adverse Event|0|||
23578979|NCT00945477|65850393|FG000|Overall Study|Adverse Event|3|||
23578980|NCT00945477|65850393|FG000|Overall Study|Lack of Efficacy|2|||
23578981|NCT00945477|65850393|FG000|Overall Study|Withdrawal by Subject|1|||
23578982|NCT01023308|65850394|FG000|Overall Study|Abnormal test proceedure results|3|||
23578983|NCT01023308|65850395|FG001|Overall Study|Abnormal test proceedure results|8|||
23578984|NCT01023308|65850394|FG000|Overall Study|Administrative problems|2|||
23578985|NCT01023308|65850395|FG001|Overall Study|Administrative problems|1|||
23578986|NCT01023308|65850394|FG000|Overall Study|Adverse Event|130|||
23578987|NCT01023308|65850395|FG001|Overall Study|Adverse Event|66|||
23578988|NCT01023308|65850394|FG000|Overall Study|Death|21|||
23578989|NCT01023308|65850395|FG001|Overall Study|Death|17|||
23578990|NCT01023308|65850394|FG000|Overall Study|Disease progression|82|||
23578991|NCT01023308|65850395|FG001|Overall Study|Disease progression|153|||
23578992|NCT01023308|65850394|FG000|Overall Study|New Cancer therapy|4|||
23578993|NCT01023308|65850395|FG001|Overall Study|New Cancer therapy|7|||
23578994|NCT01023308|65850394|FG000|Overall Study|Protocol Violation|3|||
23578995|NCT01023308|65850395|FG001|Overall Study|Protocol Violation|4|||
23578996|NCT01023308|65850394|FG000|Overall Study|Untreated|5|||
23578997|NCT01023308|65850395|FG001|Overall Study|Untreated|5|||
23578998|NCT01023308|65850394|FG000|Overall Study|Lost to Follow-up|1|||
23578999|NCT01023308|65850395|FG001|Overall Study|Lost to Follow-up|0|||
23579000|NCT01023308|65850394|FG000|Overall Study|Withdrawal by Subject|34|||
23579001|NCT01023308|65850395|FG001|Overall Study|Withdrawal by Subject|18|||
23579002|NCT01036087|65850396|FG000|Overall Study|Adverse Event|2|||
23579003|NCT01036087|65850396|FG000|Overall Study|Lack of Efficacy|1|||
23231832|NCT00963820|64591728|FG003|Expansion Phase|Adverse Event|0|||
23231833|NCT00963820|64591729|FG004|Expansion Phase|Adverse Event|0|||
23231834|NCT00963820|64591730|FG005|Expansion Phase|Adverse Event|0|||
23231835|NCT00963820|64591731|FG006|Expansion Phase|Adverse Event|0|||
23579004|NCT01616563|65850400|FG000|Overall Study|Lost to Follow-up|40|||
23579005|NCT04541186|65850404|FG000|Main Study|Adverse Event|0|||
23579006|NCT04541186|65850405|FG001|Main Study|Adverse Event|0|||
23579007|NCT04541186|65850406|FG002|Main Study|Adverse Event|4|||
23579008|NCT04541186|65850407|FG003|Main Study|Adverse Event|0|||
23579009|NCT04541186|65850408|FG004|Main Study|Adverse Event|0|||
23579010|NCT04541186|65850404|FG000|Main Study|Investigator Decision|0|||
23579011|NCT04541186|65850405|FG001|Main Study|Investigator Decision|0|||
23579012|NCT04541186|65850406|FG002|Main Study|Investigator Decision|1|||
23579013|NCT04541186|65850407|FG003|Main Study|Investigator Decision|1|||
23579014|NCT04541186|65850408|FG004|Main Study|Investigator Decision|0|||
23231836|NCT00963820|64591732|FG007|Expansion Phase|Adverse Event|0|||
23579015|NCT04541186|65850404|FG000|Main Study|Withdrawal by Subject|1|||
23579016|NCT04541186|65850405|FG001|Main Study|Withdrawal by Subject|1|||
23579017|NCT04541186|65850406|FG002|Main Study|Withdrawal by Subject|0|||
23579018|NCT04541186|65850407|FG003|Main Study|Withdrawal by Subject|0|||
23231837|NCT00963820|64591733|FG008|Expansion Phase|Adverse Event|1|||
23231838|NCT00963820|64591734|FG009|Expansion Phase|Adverse Event|3|||
23231839|NCT00963820|64591735|FG010|Expansion Phase|Adverse Event|0|||
23579019|NCT04541186|65850408|FG004|Main Study|Withdrawal by Subject|0|||
23579020|NCT04541186|65850404|FG000|Main Study|COVID-19-related Dose Interruption|0|||
23579021|NCT04541186|65850405|FG001|Main Study|COVID-19-related Dose Interruption|0|||
23339100|NCT04545567|64986087|FG001|Overall Study|tested positive for SARS-co-V2|1|||
23339101|NCT04545567|64986086|FG000|Overall Study|Withdrawal by Subject|0|||
23339102|NCT04545567|64986087|FG001|Overall Study|Withdrawal by Subject|1|||
23339103|NCT00626821|64986090|FG000|Overall Study|Adverse Event|44|||
23339104|NCT00626821|64986090|FG000|Overall Study|Protocol Violation|33|||
23339105|NCT00626821|64986090|FG000|Overall Study|Withdrawal by Subject|10|||
23339106|NCT00626821|64986090|FG000|Overall Study|Physician Decision|9|||
23579022|NCT04541186|65850406|FG002|Main Study|COVID-19-related Dose Interruption|0|||
23231840|NCT00963820|64591736|FG011|Expansion Phase|Adverse Event|0|||
23231841|NCT00963820|64591725|FG000|Expansion Phase|Withdrawal by Subject|0|||
23579023|NCT04541186|65850407|FG003|Main Study|COVID-19-related Dose Interruption|0|||
23579024|NCT04541186|65850408|FG004|Main Study|COVID-19-related Dose Interruption|1|||
23579025|NCT04541186|65850404|FG000|Main Study|Randomized in Error Not Treated|0|||
23579026|NCT04541186|65850405|FG001|Main Study|Randomized in Error Not Treated|0|||
23579027|NCT04541186|65850406|FG002|Main Study|Randomized in Error Not Treated|1|||
23579028|NCT04541186|65850407|FG003|Main Study|Randomized in Error Not Treated|0|||
23579029|NCT04541186|65850408|FG004|Main Study|Randomized in Error Not Treated|0|||
23579030|NCT04541186|65850404|FG000|Fibrate Expansion Study|Other than Specified|0|||
23579031|NCT04541186|65850405|FG001|Fibrate Expansion Study|Other than Specified|0|||
23579032|NCT04541186|65850406|FG002|Fibrate Expansion Study|Other than Specified|0|||
23579033|NCT04541186|65850407|FG003|Fibrate Expansion Study|Other than Specified|0|||
23579034|NCT04541186|65850408|FG004|Fibrate Expansion Study|Other than Specified|1|||
23579035|NCT03772314|65850409|FG000|Overall Study|Adverse Event|7|||
23579036|NCT03772314|65850410|FG001|Overall Study|Adverse Event|2|||
23172125|NCT02435849|64375611|FG000|Overall Study|Death|23|||
23172126|NCT02435849|64375612|FG001|Overall Study|Death|0|||
23172127|NCT02435849|64375611|FG000|Overall Study|Lack of Efficacy|10|||
23172128|NCT02435849|64375612|FG001|Overall Study|Lack of Efficacy|0|||
23231842|NCT00963820|64591726|FG001|Expansion Phase|Withdrawal by Subject|0|||
23231843|NCT00963820|64591727|FG002|Expansion Phase|Withdrawal by Subject|0|||
23231844|NCT00963820|64591728|FG003|Expansion Phase|Withdrawal by Subject|0|||
23231845|NCT00963820|64591729|FG004|Expansion Phase|Withdrawal by Subject|0|||
23231846|NCT00963820|64591730|FG005|Expansion Phase|Withdrawal by Subject|0|||
23231847|NCT00963820|64591731|FG006|Expansion Phase|Withdrawal by Subject|0|||
23231848|NCT00963820|64591732|FG007|Expansion Phase|Withdrawal by Subject|0|||
23231849|NCT00963820|64591733|FG008|Expansion Phase|Withdrawal by Subject|1|||
23231850|NCT00963820|64591734|FG009|Expansion Phase|Withdrawal by Subject|0|||
23339107|NCT00626821|64986090|FG000|Overall Study|Product dysfunction|21|||
23339108|NCT00626821|64986090|FG000|Overall Study|other/unknown reason|104|||
23450873|NCT03951077|65395051|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
23579037|NCT05550337|65850411|FG000|Overall Study|Lack of Efficacy|0|||
23579038|NCT05550337|65850412|FG001|Overall Study|Lack of Efficacy|0|||
23172129|NCT02435849|64375611|FG000|Overall Study|New therapy for study indication|8|||
23172130|NCT02435849|64375612|FG001|Overall Study|New therapy for study indication|0|||
23172131|NCT02435849|64375611|FG000|Overall Study|Subject/guardian decision|5|||
23172132|NCT02435849|64375612|FG001|Overall Study|Subject/guardian decision|1|||
23172133|NCT02435849|64375611|FG000|Overall Study|Lost to Follow-up|1|||
23172134|NCT02435849|64375612|FG001|Overall Study|Lost to Follow-up|0|||
23172135|NCT02435849|64375611|FG000|Overall Study|Physician Decision|1|||
23172136|NCT02435849|64375612|FG001|Overall Study|Physician Decision|0|||
23172137|NCT01703858|64375621|FG000|Overall Study|Withdrawal by Subject|0|||
23172138|NCT01703858|64375622|FG001|Overall Study|Withdrawal by Subject|1|||
23172139|NCT01703858|64375623|FG002|Overall Study|Withdrawal by Subject|0|||
23172140|NCT03733392|64375629|FG000|Overall Study|Withdrawal by Subject|11|||
23172141|NCT03733392|64375630|FG001|Overall Study|Withdrawal by Subject|1|||
23172142|NCT03733392|64375629|FG000|Overall Study|Death|1|||
23172143|NCT03733392|64375630|FG001|Overall Study|Death|0|||
23172144|NCT03733392|64375629|FG000|Overall Study|Lost to Follow-up|5|||
23172145|NCT03733392|64375630|FG001|Overall Study|Lost to Follow-up|0|||
23172146|NCT03733392|64375629|FG000|Overall Study|Protocol Violation|0|||
23172147|NCT03733392|64375630|FG001|Overall Study|Protocol Violation|1|||
23172148|NCT03733392|64375629|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
23579039|NCT05550337|65850413|FG002|Overall Study|Lack of Efficacy|1|||
23579040|NCT05550337|65850411|FG000|Overall Study|Adverse Event|1|||
23579041|NCT05550337|65850412|FG001|Overall Study|Adverse Event|5|||
23231851|NCT00963820|64591735|FG010|Expansion Phase|Withdrawal by Subject|1|||
23231852|NCT00963820|64591736|FG011|Expansion Phase|Withdrawal by Subject|1|||
23231853|NCT00963820|64591725|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23579042|NCT05550337|65850413|FG002|Overall Study|Adverse Event|0|||
23579043|NCT05550337|65850411|FG000|Overall Study|Withdrawal by Subject|8|||
23579044|NCT05550337|65850412|FG001|Overall Study|Withdrawal by Subject|14|||
23579045|NCT05550337|65850413|FG002|Overall Study|Withdrawal by Subject|10|||
23579046|NCT05550337|65850411|FG000|Overall Study|Pregnancy|0|||
23579047|NCT05550337|65850412|FG001|Overall Study|Pregnancy|0|||
23579048|NCT05550337|65850413|FG002|Overall Study|Pregnancy|1|||
23579049|NCT05550337|65850411|FG000|Overall Study|Protocol Violation|1|||
23579050|NCT05550337|65850412|FG001|Overall Study|Protocol Violation|3|||
23579051|NCT05550337|65850413|FG002|Overall Study|Protocol Violation|4|||
23579052|NCT05550337|65850411|FG000|Overall Study|Physician Decision|2|||
23579053|NCT05550337|65850412|FG001|Overall Study|Physician Decision|1|||
23579054|NCT05550337|65850413|FG002|Overall Study|Physician Decision|1|||
23579055|NCT05550337|65850411|FG000|Overall Study|Lost to Follow-up|16|||
23579056|NCT05550337|65850412|FG001|Overall Study|Lost to Follow-up|11|||
23579057|NCT05550337|65850413|FG002|Overall Study|Lost to Follow-up|11|||
23579058|NCT02692235|65850415|FG000|Overall Study|Withdrawal by Subject|2|||
23579059|NCT02692235|65850416|FG001|Overall Study|Withdrawal by Subject|1|||
23579060|NCT02692235|65850415|FG000|Overall Study|Adverse Event|1|||
23579061|NCT02692235|65850416|FG001|Overall Study|Adverse Event|2|||
23579062|NCT00986102|65850417|FG000|Overall Study|Lost to Follow-up|0|||
23579063|NCT00986102|65850418|FG001|Overall Study|Lost to Follow-up|1|||
23579064|NCT00986102|65850419|FG002|Overall Study|Lost to Follow-up|0|||
23579065|NCT00986102|65850420|FG003|Overall Study|Lost to Follow-up|1|||
23579066|NCT00986102|65850417|FG000|Overall Study|Withdrawal by Subject|1|||
23579067|NCT00986102|65850418|FG001|Overall Study|Withdrawal by Subject|1|||
23579068|NCT00986102|65850419|FG002|Overall Study|Withdrawal by Subject|0|||
23579069|NCT00986102|65850420|FG003|Overall Study|Withdrawal by Subject|0|||
23579070|NCT00409708|65850421|FG000|Treatment|Abnormal test procedure result(s)|1|||
23579071|NCT00409708|65850422|FG001|Treatment|Abnormal test procedure result(s)|0|||
23579072|NCT00409708|65850421|FG000|Treatment|Lack of Efficacy|0|||
23579073|NCT00409708|65850422|FG001|Treatment|Lack of Efficacy|1|||
23579074|NCT00409708|65850421|FG000|Treatment|Protocol Violation|6|||
23579075|NCT00409708|65850422|FG001|Treatment|Protocol Violation|2|||
23579076|NCT00409708|65850421|FG000|Treatment|Withdrawal by Subject|3|||
23579077|NCT00409708|65850422|FG001|Treatment|Withdrawal by Subject|8|||
23579078|NCT00409708|65850421|FG000|Treatment|Lost to Follow-up|0|||
23579079|NCT00409708|65850422|FG001|Treatment|Lost to Follow-up|6|||
23579080|NCT00409708|65850421|FG000|Treatment|Administrative problems|5|||
23579081|NCT00409708|65850422|FG001|Treatment|Administrative problems|0|||
23579082|NCT00409708|65850421|FG000|Washout|Lack of Efficacy|9|||
23172149|NCT03733392|64375630|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
23172150|NCT03733392|64375629|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
23172151|NCT03733392|64375630|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
23172152|NCT03733392|64375629|FG000|Overall Study|Patient Non-Compliance|2|||
23172153|NCT03733392|64375630|FG001|Overall Study|Patient Non-Compliance|1|||
23172154|NCT03733392|64375629|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
23172155|NCT03733392|64375630|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
23172156|NCT03733392|64375629|FG000|Overall Study|Withdrawal prior to procedure|5|||
23172157|NCT03733392|64375630|FG001|Overall Study|Withdrawal prior to procedure|2|||
23172158|NCT02526550|64375631|FG000|Overall Study|Lost to Follow-up|1|||
23172159|NCT01537211|64375634|FG000|Overall Study|Lost to Follow-up|0|||
23172160|NCT01537211|64375635|FG001|Overall Study|Lost to Follow-up|1|||
23172161|NCT02631538|64375637|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
23172162|NCT02631538|64375638|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
23172163|NCT02631538|64375639|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
23172164|NCT02631538|64375640|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
23172165|NCT02631538|64375637|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
23172166|NCT02631538|64375638|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
23172167|NCT02631538|64375639|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
23172168|NCT02631538|64375640|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
23172169|NCT02631538|64375637|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
23172170|NCT02631538|64375638|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
23172171|NCT02631538|64375639|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
23172172|NCT02631538|64375640|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
23339109|NCT02640404|64986091|FG000|Overall Study|Protocol Violation|1|||
23579083|NCT00409708|65850422|FG001|Washout|Lack of Efficacy|1|||
23579084|NCT00409708|65850421|FG000|Washout|Protocol Violation|0|||
23579085|NCT00409708|65850422|FG001|Washout|Protocol Violation|1|||
23579086|NCT00409708|65850421|FG000|Washout|Withdrawal by Subject|11|||
23579087|NCT00409708|65850422|FG001|Washout|Withdrawal by Subject|5|||
23579088|NCT00409708|65850421|FG000|Washout|Lost to Follow-up|1|||
23579089|NCT00409708|65850422|FG001|Washout|Lost to Follow-up|3|||
23579090|NCT01094743|65850423|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
23231854|NCT00963820|64591726|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23231855|NCT00963820|64591727|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23231856|NCT00963820|64591728|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23450874|NCT03951077|65395052|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
23450875|NCT03951077|65395053|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
23450876|NCT03951077|65395054|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
23450877|NCT02738008|65395058|FG000|Overall Study|Study Terminated by Sponsor|1|||
23450878|NCT02738008|65395059|FG001|Overall Study|Study Terminated by Sponsor|5|||
23450879|NCT02738008|65395060|FG002|Overall Study|Study Terminated by Sponsor|3|||
23450880|NCT02738008|65395058|FG000|Overall Study|Adverse Event|0|||
23450881|NCT02738008|65395059|FG001|Overall Study|Adverse Event|1|||
23579091|NCT00940017|65850424|FG000|Overall Study|did not meet entrance criteria|3|||
23579092|NCT00940017|65850424|FG000|Overall Study|Adverse Event|1|||
23579093|NCT00999661|65850425|FG000|Overall Study|Lost to Follow-up|59|||
23579094|NCT00999661|65850425|FG000|Overall Study|Adverse Event|1|||
23579095|NCT00999661|65850425|FG000|Overall Study|Withdrawal by Subject|1|||
23579096|NCT00999661|65850425|FG000|Overall Study|Not meeting eligibility criteria|9|||
23450882|NCT02738008|65395060|FG002|Overall Study|Adverse Event|2|||
23450883|NCT05579977|65395061|FG000|Treatment Phase|Other|0|||
23450884|NCT05579977|65395062|FG001|Treatment Phase|Other|0|||
23450885|NCT05579977|65395063|FG002|Treatment Phase|Other|0|||
23579097|NCT01167023|65850435|FG000|Overall Study|Lost to Follow-up|0|||
23579098|NCT01167023|65850436|FG001|Overall Study|Lost to Follow-up|1|||
23579099|NCT01167023|65850437|FG002|Overall Study|Lost to Follow-up|1|||
23579100|NCT01167023|65850435|FG000|Overall Study|Screen Failure|0|||
23172173|NCT02631538|64375637|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
23172174|NCT02631538|64375638|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
23172175|NCT02631538|64375639|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
23450886|NCT05579977|65395064|FG003|Treatment Phase|Other|2|||
23172176|NCT02631538|64375640|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
23172177|NCT02631538|64375637|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
23172178|NCT02631538|64375638|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
23172179|NCT02631538|64375639|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
23450887|NCT05579977|65395065|FG004|Treatment Phase|Other|1|||
23450888|NCT05579977|65395066|FG005|Treatment Phase|Other|2|||
23450889|NCT05579977|65395067|FG006|Treatment Phase|Other|1|||
23450890|NCT05579977|65395068|FG007|Treatment Phase|Other|2|||
23450891|NCT05579977|65395069|FG008|Treatment Phase|Other|2|||
23450892|NCT05579977|65395070|FG009|Treatment Phase|Other|1|||
23450893|NCT05579977|65395071|FG010|Treatment Phase|Other|0|||
23450894|NCT05579977|65395072|FG011|Treatment Phase|Other|0|||
23450895|NCT05579977|65395073|FG012|Treatment Phase|Other|3|||
23450896|NCT05579977|65395061|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
23450897|NCT05579977|65395062|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
23450898|NCT05579977|65395063|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
23450899|NCT05579977|65395064|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
23450900|NCT05579977|65395065|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
23450901|NCT05579977|65395066|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
23450902|NCT05579977|65395067|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
23172180|NCT02631538|64375640|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
23172181|NCT02631538|64375637|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
23172182|NCT02631538|64375638|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
23172183|NCT02631538|64375639|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
23172184|NCT02631538|64375640|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
23172185|NCT01777581|64375641|FG000|Overall Study|Lost to Follow-up|1|||
23172186|NCT01777581|64375642|FG001|Overall Study|Lost to Follow-up|1|||
23231857|NCT00963820|64591729|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23231858|NCT00963820|64591730|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23231859|NCT00963820|64591731|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23231860|NCT00963820|64591732|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23231861|NCT00963820|64591733|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23231862|NCT00963820|64591734|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23450903|NCT05579977|65395068|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
23450904|NCT05579977|65395069|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
23450905|NCT05579977|65395070|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
23172187|NCT01777581|64375641|FG000|Overall Study|Adverse Event|2|||
23172188|NCT01777581|64375642|FG001|Overall Study|Adverse Event|0|||
23231863|NCT00963820|64591735|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
23339110|NCT02640404|64986092|FG001|Overall Study|Protocol Violation|0|||
23450906|NCT05579977|65395071|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
23579101|NCT01167023|65850436|FG001|Overall Study|Screen Failure|1|||
23579102|NCT01167023|65850437|FG002|Overall Study|Screen Failure|0|||
23339111|NCT02640404|64986091|FG000|Overall Study|Withdrawal by Subject|1|||
23339112|NCT02640404|64986092|FG001|Overall Study|Withdrawal by Subject|0|||
23339113|NCT01637922|64986102|FG000|Overall Study|Adverse Event|0|||
23339114|NCT01637922|64986103|FG001|Overall Study|Adverse Event|1|||
23339115|NCT01637922|64986102|FG000|Overall Study|Protocol Violation|0|||
23339116|NCT01637922|64986103|FG001|Overall Study|Protocol Violation|1|||
23339117|NCT01637922|64986102|FG000|Overall Study|Withdrawal by Subject|0|||
23579103|NCT01167023|65850435|FG000|Overall Study|Sponsor Decision|0|||
23579104|NCT01167023|65850436|FG001|Overall Study|Sponsor Decision|1|||
23579105|NCT01167023|65850437|FG002|Overall Study|Sponsor Decision|0|||
23579106|NCT01167023|65850435|FG000|Overall Study|Withdrawal by Subject|0|||
23579107|NCT01167023|65850436|FG001|Overall Study|Withdrawal by Subject|0|||
23579108|NCT01167023|65850437|FG002|Overall Study|Withdrawal by Subject|1|||
23579109|NCT00495469|65850438|FG000|Overall Study|Adverse Event|0|||
23579110|NCT00495469|65850439|FG001|Overall Study|Adverse Event|1|||
23579111|NCT00495469|65850440|FG002|Overall Study|Adverse Event|3|||
23579112|NCT00495469|65850441|FG003|Overall Study|Adverse Event|0|||
23339118|NCT01637922|64986103|FG001|Overall Study|Withdrawal by Subject|3|||
23339119|NCT01637922|64986102|FG000|Overall Study|Lost to Follow-up|2|||
23339120|NCT01637922|64986103|FG001|Overall Study|Lost to Follow-up|0|||
23339121|NCT00890084|64986108|FG000|Overall Study|Adverse Event|16|||
23339122|NCT00890084|64986108|FG000|Overall Study|Lost to Follow-up|126|||
23339123|NCT02759055|64986110|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
23339124|NCT02759055|64986111|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
23339125|NCT02537431|64986114|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
23339126|NCT01867710|64986115|FG000|Overall Study|Death|25|||
23339127|NCT01867710|64986116|FG001|Overall Study|Death|15|||
23339128|NCT01867710|64986117|FG002|Overall Study|Death|27|||
23339129|NCT01867710|64986118|FG003|Overall Study|Death|20|||
23339130|NCT01867710|64986115|FG000|Overall Study|Lost to Follow-up|3|||
23339131|NCT01867710|64986116|FG001|Overall Study|Lost to Follow-up|4|||
23339132|NCT01867710|64986117|FG002|Overall Study|Lost to Follow-up|3|||
23339133|NCT01867710|64986118|FG003|Overall Study|Lost to Follow-up|2|||
23339134|NCT01867710|64986115|FG000|Overall Study|Withdrawal of consent|2|||
23339135|NCT01867710|64986116|FG001|Overall Study|Withdrawal of consent|5|||
23339136|NCT01867710|64986117|FG002|Overall Study|Withdrawal of consent|1|||
23339137|NCT01867710|64986118|FG003|Overall Study|Withdrawal of consent|2|||
23339138|NCT01867710|64986115|FG000|Overall Study|Study Terminated by Sponsor|9|||
23339139|NCT01867710|64986116|FG001|Overall Study|Study Terminated by Sponsor|13|||
23450907|NCT05579977|65395072|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
23450908|NCT05579977|65395073|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
23450909|NCT05579977|65395061|FG000|Treatment Phase|Withdrawal by Subject|2|||
23450910|NCT05579977|65395062|FG001|Treatment Phase|Withdrawal by Subject|0|||
23172189|NCT01777581|64375641|FG000|Overall Study|Lack of Efficacy|0|||
23172190|NCT01777581|64375642|FG001|Overall Study|Lack of Efficacy|1|||
23339140|NCT01867710|64986117|FG002|Overall Study|Study Terminated by Sponsor|8|||
23339141|NCT01867710|64986118|FG003|Overall Study|Study Terminated by Sponsor|16|||
23339142|NCT01867710|64986115|FG000|Overall Study|Biochemical progression|0|||
23339143|NCT01867710|64986116|FG001|Overall Study|Biochemical progression|1|||
23339144|NCT01867710|64986117|FG002|Overall Study|Biochemical progression|0|||
23339145|NCT01867710|64986118|FG003|Overall Study|Biochemical progression|0|||
23579113|NCT00495469|65850442|FG004|Overall Study|Adverse Event|1|||
23339146|NCT01867710|64986115|FG000|Overall Study|Clinical progression|0|||
23339147|NCT01867710|64986116|FG001|Overall Study|Clinical progression|0|||
23579114|NCT00495469|65850443|FG005|Overall Study|Adverse Event|1|||
23579115|NCT00495469|65850444|FG006|Overall Study|Adverse Event|1|||
23450911|NCT05579977|65395063|FG002|Treatment Phase|Withdrawal by Subject|0|||
23450912|NCT05579977|65395064|FG003|Treatment Phase|Withdrawal by Subject|1|||
23450913|NCT05579977|65395065|FG004|Treatment Phase|Withdrawal by Subject|2|||
23450914|NCT05579977|65395066|FG005|Treatment Phase|Withdrawal by Subject|0|||
23450915|NCT05579977|65395067|FG006|Treatment Phase|Withdrawal by Subject|1|||
23450916|NCT05579977|65395068|FG007|Treatment Phase|Withdrawal by Subject|8|||
23450917|NCT05579977|65395069|FG008|Treatment Phase|Withdrawal by Subject|3|||
23450918|NCT05579977|65395070|FG009|Treatment Phase|Withdrawal by Subject|3|||
23450919|NCT05579977|65395071|FG010|Treatment Phase|Withdrawal by Subject|5|||
23450920|NCT05579977|65395072|FG011|Treatment Phase|Withdrawal by Subject|1|||
23450921|NCT05579977|65395073|FG012|Treatment Phase|Withdrawal by Subject|3|||
23339148|NCT01867710|64986117|FG002|Overall Study|Clinical progression|1|||
23339149|NCT01867710|64986118|FG003|Overall Study|Clinical progression|0|||
23339150|NCT01867710|64986115|FG000|Overall Study|Disease progression|1|||
23339151|NCT01867710|64986116|FG001|Overall Study|Disease progression|0|||
23339152|NCT01867710|64986117|FG002|Overall Study|Disease progression|0|||
23339153|NCT01867710|64986118|FG003|Overall Study|Disease progression|0|||
23450922|NCT05579977|65395061|FG000|Treatment Phase|Study terminated by sponsor|70|||
23450923|NCT05579977|65395062|FG001|Treatment Phase|Study terminated by sponsor|70|||
23450924|NCT05579977|65395063|FG002|Treatment Phase|Study terminated by sponsor|61|||
23450925|NCT05579977|65395064|FG003|Treatment Phase|Study terminated by sponsor|59|||
23450926|NCT05579977|65395065|FG004|Treatment Phase|Study terminated by sponsor|63|||
23450927|NCT05579977|65395066|FG005|Treatment Phase|Study terminated by sponsor|53|||
23450928|NCT05579977|65395067|FG006|Treatment Phase|Study terminated by sponsor|66|||
23450929|NCT05579977|65395068|FG007|Treatment Phase|Study terminated by sponsor|48|||
23339154|NCT01867710|64986115|FG000|Overall Study|Patient decision|0|||
23339155|NCT01867710|64986116|FG001|Overall Study|Patient decision|0|||
23339156|NCT01867710|64986117|FG002|Overall Study|Patient decision|0|||
23339157|NCT01867710|64986118|FG003|Overall Study|Patient decision|1|||
23450930|NCT05579977|65395069|FG008|Treatment Phase|Study terminated by sponsor|47|||
23450931|NCT05579977|65395070|FG009|Treatment Phase|Study terminated by sponsor|37|||
23450932|NCT05579977|65395071|FG010|Treatment Phase|Study terminated by sponsor|44|||
23450933|NCT05579977|65395072|FG011|Treatment Phase|Study terminated by sponsor|36|||
23450934|NCT05579977|65395073|FG012|Treatment Phase|Study terminated by sponsor|32|||
23450935|NCT05579977|65395061|FG000|Treatment Phase|Pregnancy|0|||
23450936|NCT05579977|65395062|FG001|Treatment Phase|Pregnancy|0|||
23339158|NCT01867710|64986115|FG000|Overall Study|Patient to follow subsequent treatment|0|||
23339159|NCT01867710|64986116|FG001|Overall Study|Patient to follow subsequent treatment|1|||
23339160|NCT01867710|64986117|FG002|Overall Study|Patient to follow subsequent treatment|0|||
23339161|NCT01867710|64986118|FG003|Overall Study|Patient to follow subsequent treatment|0|||
23450937|NCT05579977|65395063|FG002|Treatment Phase|Pregnancy|0|||
23450938|NCT05579977|65395064|FG003|Treatment Phase|Pregnancy|0|||
23450939|NCT05579977|65395065|FG004|Treatment Phase|Pregnancy|0|||
23450940|NCT05579977|65395066|FG005|Treatment Phase|Pregnancy|0|||
23450941|NCT05579977|65395067|FG006|Treatment Phase|Pregnancy|0|||
23172191|NCT00494091|64375643|FG000|Overall Study|Death|5|||
23172192|NCT00494091|64375644|FG001|Overall Study|Death|54|||
23450942|NCT05579977|65395068|FG007|Treatment Phase|Pregnancy|0|||
23450943|NCT05579977|65395069|FG008|Treatment Phase|Pregnancy|0|||
23450944|NCT05579977|65395070|FG009|Treatment Phase|Pregnancy|1|||
23450945|NCT05579977|65395071|FG010|Treatment Phase|Pregnancy|0|||
23579116|NCT00495469|65850438|FG000|Overall Study|Lost to Follow-up|1|||
23579117|NCT00495469|65850439|FG001|Overall Study|Lost to Follow-up|1|||
23172193|NCT00494091|64375643|FG000|Overall Study|Lost to Follow-up|0|||
23172194|NCT00494091|64375644|FG001|Overall Study|Lost to Follow-up|4|||
23339162|NCT01867710|64986115|FG000|Overall Study|Progressive disease|1|||
23339163|NCT01867710|64986116|FG001|Overall Study|Progressive disease|0|||
23339164|NCT01867710|64986117|FG002|Overall Study|Progressive disease|0|||
23579118|NCT00495469|65850440|FG002|Overall Study|Lost to Follow-up|3|||
23579119|NCT00495469|65850441|FG003|Overall Study|Lost to Follow-up|1|||
23579120|NCT00495469|65850442|FG004|Overall Study|Lost to Follow-up|0|||
23172195|NCT00494091|64375643|FG000|Overall Study|Other|1|||
23172196|NCT00494091|64375644|FG001|Overall Study|Other|11|||
23172197|NCT00494091|64375643|FG000|Overall Study|Withdrawal by Subject|0|||
23339165|NCT01867710|64986118|FG003|Overall Study|Progressive disease|0|||
23339166|NCT01867710|64986115|FG000|Overall Study|Protocol Violation|0|||
23172198|NCT00494091|64375644|FG001|Overall Study|Withdrawal by Subject|7|||
23339167|NCT01867710|64986116|FG001|Overall Study|Protocol Violation|0|||
23450946|NCT05579977|65395072|FG011|Treatment Phase|Pregnancy|0|||
23450947|NCT05579977|65395073|FG012|Treatment Phase|Pregnancy|0|||
23450948|NCT05579977|65395061|FG000|Treatment Phase|Physician Decision|0|||
23450949|NCT05579977|65395062|FG001|Treatment Phase|Physician Decision|0|||
23450950|NCT05579977|65395063|FG002|Treatment Phase|Physician Decision|0|||
23450951|NCT05579977|65395064|FG003|Treatment Phase|Physician Decision|0|||
23339168|NCT01867710|64986117|FG002|Overall Study|Protocol Violation|0|||
23579121|NCT00495469|65850443|FG005|Overall Study|Lost to Follow-up|0|||
23579122|NCT00495469|65850444|FG006|Overall Study|Lost to Follow-up|0|||
23579123|NCT00495469|65850438|FG000|Overall Study|Protocol Violation|0|||
23450952|NCT05579977|65395065|FG004|Treatment Phase|Physician Decision|0|||
23450953|NCT05579977|65395066|FG005|Treatment Phase|Physician Decision|0|||
23450954|NCT05579977|65395067|FG006|Treatment Phase|Physician Decision|0|||
23450955|NCT05579977|65395068|FG007|Treatment Phase|Physician Decision|0|||
23450956|NCT05579977|65395069|FG008|Treatment Phase|Physician Decision|0|||
23450957|NCT05579977|65395070|FG009|Treatment Phase|Physician Decision|0|||
23450958|NCT05579977|65395071|FG010|Treatment Phase|Physician Decision|0|||
23450959|NCT05579977|65395072|FG011|Treatment Phase|Physician Decision|1|||
23450960|NCT05579977|65395073|FG012|Treatment Phase|Physician Decision|0|||
23450961|NCT05579977|65395061|FG000|Treatment Phase|Lost to Follow-up|0|||
23450962|NCT05579977|65395062|FG001|Treatment Phase|Lost to Follow-up|0|||
23450963|NCT05579977|65395063|FG002|Treatment Phase|Lost to Follow-up|0|||
23450964|NCT05579977|65395064|FG003|Treatment Phase|Lost to Follow-up|1|||
23450965|NCT05579977|65395065|FG004|Treatment Phase|Lost to Follow-up|1|||
23450966|NCT05579977|65395066|FG005|Treatment Phase|Lost to Follow-up|1|||
23450967|NCT05579977|65395067|FG006|Treatment Phase|Lost to Follow-up|0|||
23450968|NCT05579977|65395068|FG007|Treatment Phase|Lost to Follow-up|1|||
23450969|NCT05579977|65395069|FG008|Treatment Phase|Lost to Follow-up|2|||
23450970|NCT05579977|65395070|FG009|Treatment Phase|Lost to Follow-up|2|||
23450971|NCT05579977|65395071|FG010|Treatment Phase|Lost to Follow-up|1|||
23450972|NCT05579977|65395072|FG011|Treatment Phase|Lost to Follow-up|4|||
23450973|NCT05579977|65395073|FG012|Treatment Phase|Lost to Follow-up|3|||
23450974|NCT05579977|65395061|FG000|Treatment Phase|Death|1|||
23450975|NCT05579977|65395062|FG001|Treatment Phase|Death|0|||
23450976|NCT05579977|65395063|FG002|Treatment Phase|Death|0|||
23450977|NCT05579977|65395064|FG003|Treatment Phase|Death|0|||
23450978|NCT05579977|65395065|FG004|Treatment Phase|Death|0|||
23450979|NCT05579977|65395066|FG005|Treatment Phase|Death|0|||
23450980|NCT05579977|65395067|FG006|Treatment Phase|Death|0|||
23450981|NCT05579977|65395068|FG007|Treatment Phase|Death|0|||
23450982|NCT05579977|65395069|FG008|Treatment Phase|Death|0|||
23450983|NCT05579977|65395070|FG009|Treatment Phase|Death|0|||
23450984|NCT05579977|65395071|FG010|Treatment Phase|Death|0|||
23450985|NCT05579977|65395072|FG011|Treatment Phase|Death|0|||
23450986|NCT05579977|65395073|FG012|Treatment Phase|Death|0|||
23450987|NCT05579977|65395061|FG000|Treatment Phase|Adverse Event|0|||
23450988|NCT05579977|65395062|FG001|Treatment Phase|Adverse Event|3|||
23450989|NCT05579977|65395063|FG002|Treatment Phase|Adverse Event|11|||
23450990|NCT05579977|65395064|FG003|Treatment Phase|Adverse Event|10|||
23450991|NCT05579977|65395065|FG004|Treatment Phase|Adverse Event|5|||
23450992|NCT05579977|65395066|FG005|Treatment Phase|Adverse Event|17|||
23450993|NCT05579977|65395067|FG006|Treatment Phase|Adverse Event|5|||
23450994|NCT05579977|65395068|FG007|Treatment Phase|Adverse Event|5|||
23450995|NCT05579977|65395069|FG008|Treatment Phase|Adverse Event|12|||
23450996|NCT05579977|65395070|FG009|Treatment Phase|Adverse Event|20|||
23450997|NCT05579977|65395071|FG010|Treatment Phase|Adverse Event|15|||
23450998|NCT05579977|65395072|FG011|Treatment Phase|Adverse Event|24|||
23450999|NCT05579977|65395073|FG012|Treatment Phase|Adverse Event|23|||
23451000|NCT05579977|65395061|FG000|Treatment Phase|Randomized not treated|0|||
23451001|NCT05579977|65395062|FG001|Treatment Phase|Randomized not treated|0|||
23451002|NCT05579977|65395063|FG002|Treatment Phase|Randomized not treated|0|||
23451003|NCT05579977|65395064|FG003|Treatment Phase|Randomized not treated|0|||
23451004|NCT05579977|65395065|FG004|Treatment Phase|Randomized not treated|1|||
23451005|NCT05579977|65395066|FG005|Treatment Phase|Randomized not treated|0|||
23451006|NCT05579977|65395067|FG006|Treatment Phase|Randomized not treated|0|||
23451007|NCT05579977|65395068|FG007|Treatment Phase|Randomized not treated|0|||
23451008|NCT05579977|65395069|FG008|Treatment Phase|Randomized not treated|0|||
23451009|NCT05579977|65395070|FG009|Treatment Phase|Randomized not treated|0|||
23451010|NCT05579977|65395071|FG010|Treatment Phase|Randomized not treated|0|||
23451011|NCT05579977|65395072|FG011|Treatment Phase|Randomized not treated|0|||
23451012|NCT05579977|65395073|FG012|Treatment Phase|Randomized not treated|0|||
23451013|NCT05579977|65395061|FG000|Follow up|Death|1|||
23451014|NCT05579977|65395062|FG001|Follow up|Death|0|||
23451015|NCT05579977|65395063|FG002|Follow up|Death|0|||
23451016|NCT05579977|65395064|FG003|Follow up|Death|0|||
23451017|NCT05579977|65395065|FG004|Follow up|Death|0|||
23451018|NCT05579977|65395066|FG005|Follow up|Death|0|||
23451019|NCT05579977|65395067|FG006|Follow up|Death|0|||
23451020|NCT05579977|65395068|FG007|Follow up|Death|0|||
23451021|NCT05579977|65395069|FG008|Follow up|Death|0|||
23451022|NCT05579977|65395070|FG009|Follow up|Death|0|||
23451023|NCT05579977|65395071|FG010|Follow up|Death|0|||
23451024|NCT05579977|65395072|FG011|Follow up|Death|0|||
23451025|NCT05579977|65395073|FG012|Follow up|Death|0|||
23451026|NCT05579977|65395061|FG000|Follow up|Lost to Follow-up|0|||
23451027|NCT05579977|65395062|FG001|Follow up|Lost to Follow-up|0|||
23451028|NCT05579977|65395063|FG002|Follow up|Lost to Follow-up|0|||
23451029|NCT05579977|65395064|FG003|Follow up|Lost to Follow-up|1|||
23451030|NCT05579977|65395065|FG004|Follow up|Lost to Follow-up|1|||
23451031|NCT05579977|65395066|FG005|Follow up|Lost to Follow-up|2|||
23451032|NCT05579977|65395067|FG006|Follow up|Lost to Follow-up|1|||
23451033|NCT05579977|65395068|FG007|Follow up|Lost to Follow-up|1|||
23451034|NCT05579977|65395069|FG008|Follow up|Lost to Follow-up|3|||
23451035|NCT05579977|65395070|FG009|Follow up|Lost to Follow-up|2|||
23451036|NCT05579977|65395071|FG010|Follow up|Lost to Follow-up|2|||
23451037|NCT05579977|65395072|FG011|Follow up|Lost to Follow-up|4|||
23451038|NCT05579977|65395073|FG012|Follow up|Lost to Follow-up|4|||
23451039|NCT05579977|65395061|FG000|Follow up|Withdrawal by Subject|2|||
23451040|NCT05579977|65395062|FG001|Follow up|Withdrawal by Subject|0|||
23451041|NCT05579977|65395063|FG002|Follow up|Withdrawal by Subject|0|||
23451042|NCT05579977|65395064|FG003|Follow up|Withdrawal by Subject|0|||
23451043|NCT05579977|65395065|FG004|Follow up|Withdrawal by Subject|1|||
23451044|NCT05579977|65395066|FG005|Follow up|Withdrawal by Subject|0|||
23451045|NCT05579977|65395067|FG006|Follow up|Withdrawal by Subject|1|||
23451046|NCT05579977|65395068|FG007|Follow up|Withdrawal by Subject|4|||
23451047|NCT05579977|65395069|FG008|Follow up|Withdrawal by Subject|2|||
23451048|NCT05579977|65395070|FG009|Follow up|Withdrawal by Subject|3|||
23451049|NCT05579977|65395071|FG010|Follow up|Withdrawal by Subject|3|||
23451050|NCT05579977|65395072|FG011|Follow up|Withdrawal by Subject|1|||
23451051|NCT05579977|65395073|FG012|Follow up|Withdrawal by Subject|3|||
23451052|NCT04999839|65395074|FG000|Overall Study|Adverse Event|1|||
23451053|NCT04999839|65395075|FG001|Overall Study|Adverse Event|1|||
23451054|NCT04999839|65395076|FG002|Overall Study|Adverse Event|1|||
23451055|NCT04999839|65395077|FG003|Overall Study|Adverse Event|1|||
23451056|NCT04999839|65395078|FG004|Overall Study|Adverse Event|1|||
23451057|NCT04999839|65395074|FG000|Overall Study|Lost to Follow-up|2|||
23451058|NCT04999839|65395075|FG001|Overall Study|Lost to Follow-up|0|||
23451059|NCT04999839|65395076|FG002|Overall Study|Lost to Follow-up|2|||
23451060|NCT04999839|65395077|FG003|Overall Study|Lost to Follow-up|4|||
23451061|NCT04999839|65395078|FG004|Overall Study|Lost to Follow-up|1|||
23451062|NCT04999839|65395074|FG000|Overall Study|Withdrawal by Subject|6|||
23451063|NCT04999839|65395075|FG001|Overall Study|Withdrawal by Subject|5|||
23451064|NCT04999839|65395076|FG002|Overall Study|Withdrawal by Subject|3|||
23451065|NCT04999839|65395077|FG003|Overall Study|Withdrawal by Subject|2|||
23451066|NCT04999839|65395078|FG004|Overall Study|Withdrawal by Subject|2|||
23451067|NCT04999839|65395074|FG000|Overall Study|Lack of Efficacy|0|||
23451068|NCT04999839|65395075|FG001|Overall Study|Lack of Efficacy|1|||
23451069|NCT04999839|65395076|FG002|Overall Study|Lack of Efficacy|0|||
23451070|NCT04999839|65395077|FG003|Overall Study|Lack of Efficacy|0|||
23339169|NCT01867710|64986118|FG003|Overall Study|Protocol Violation|1|||
23339170|NCT01867710|64986115|FG000|Overall Study|PSA-progression|0|||
23339171|NCT01867710|64986116|FG001|Overall Study|PSA-progression|1|||
23339172|NCT01867710|64986117|FG002|Overall Study|PSA-progression|0|||
23339173|NCT01867710|64986118|FG003|Overall Study|PSA-progression|0|||
23451071|NCT04999839|65395078|FG004|Overall Study|Lack of Efficacy|0|||
23451072|NCT04999839|65395074|FG000|Overall Study|Physician Decision|0|||
23579124|NCT00495469|65850439|FG001|Overall Study|Protocol Violation|0|||
23579125|NCT00495469|65850440|FG002|Overall Study|Protocol Violation|0|||
23579126|NCT00495469|65850441|FG003|Overall Study|Protocol Violation|0|||
23579127|NCT00495469|65850442|FG004|Overall Study|Protocol Violation|1|||
23579128|NCT00495469|65850443|FG005|Overall Study|Protocol Violation|2|||
23579129|NCT00495469|65850444|FG006|Overall Study|Protocol Violation|0|||
23579130|NCT00495469|65850438|FG000|Overall Study|Withdrawal by Subject|5|||
23579131|NCT00495469|65850439|FG001|Overall Study|Withdrawal by Subject|3|||
23579132|NCT00495469|65850440|FG002|Overall Study|Withdrawal by Subject|1|||
23579133|NCT00495469|65850441|FG003|Overall Study|Withdrawal by Subject|3|||
23579134|NCT00495469|65850442|FG004|Overall Study|Withdrawal by Subject|3|||
23579135|NCT00495469|65850443|FG005|Overall Study|Withdrawal by Subject|2|||
23579136|NCT00495469|65850444|FG006|Overall Study|Withdrawal by Subject|3|||
23579137|NCT00495469|65850438|FG000|Overall Study|Lack of Efficacy|0|||
23579138|NCT00495469|65850439|FG001|Overall Study|Lack of Efficacy|0|||
23579139|NCT00495469|65850440|FG002|Overall Study|Lack of Efficacy|0|||
23451073|NCT04999839|65395075|FG001|Overall Study|Physician Decision|0|||
23451074|NCT04999839|65395076|FG002|Overall Study|Physician Decision|0|||
23451075|NCT04999839|65395077|FG003|Overall Study|Physician Decision|0|||
23451076|NCT04999839|65395078|FG004|Overall Study|Physician Decision|1|||
23579140|NCT00495469|65850441|FG003|Overall Study|Lack of Efficacy|0|||
23579141|NCT00495469|65850442|FG004|Overall Study|Lack of Efficacy|0|||
23451077|NCT04999839|65395074|FG000|Overall Study|Sponsor request|0|||
23451078|NCT04999839|65395075|FG001|Overall Study|Sponsor request|1|||
23579142|NCT00495469|65850443|FG005|Overall Study|Lack of Efficacy|0|||
23579143|NCT00495469|65850444|FG006|Overall Study|Lack of Efficacy|1|||
23579144|NCT00495469|65850438|FG000|Overall Study|Liver function test abnormality|0|||
23579145|NCT00495469|65850439|FG001|Overall Study|Liver function test abnormality|1|||
23579146|NCT00495469|65850440|FG002|Overall Study|Liver function test abnormality|0|||
23579147|NCT00495469|65850441|FG003|Overall Study|Liver function test abnormality|0|||
23451079|NCT04999839|65395076|FG002|Overall Study|Sponsor request|0|||
23451080|NCT04999839|65395077|FG003|Overall Study|Sponsor request|0|||
23451081|NCT04999839|65395078|FG004|Overall Study|Sponsor request|0|||
23451082|NCT04999839|65395074|FG000|Overall Study|Other|0|||
23451083|NCT04999839|65395075|FG001|Overall Study|Other|0|||
23451084|NCT04999839|65395076|FG002|Overall Study|Other|1|||
23451085|NCT04999839|65395077|FG003|Overall Study|Other|0|||
23451086|NCT04999839|65395078|FG004|Overall Study|Other|0|||
23451087|NCT01300728|65395085|FG000|Overall Study|Withdrawal by Subject|1|||
23451088|NCT01300728|65395086|FG001|Overall Study|Withdrawal by Subject|1|||
23451089|NCT01300728|65395085|FG000|Overall Study|Physician Decision|1|||
23451090|NCT01300728|65395086|FG001|Overall Study|Physician Decision|0|||
23451091|NCT01046565|65395089|FG000|Overall Study|Adverse Event|2|||
23451092|NCT01046565|65395089|FG000|Overall Study|Withdrawal by Subject|7|||
23451093|NCT00960063|65395090|FG000|Overall Study|Adverse Event|1|||
23451094|NCT00960063|65395091|FG001|Overall Study|Adverse Event|0|||
23451095|NCT00960063|65395092|FG002|Overall Study|Adverse Event|0|||
23451096|NCT00960063|65395090|FG000|Overall Study|Progression of Disease|0|||
23451097|NCT00960063|65395091|FG001|Overall Study|Progression of Disease|0|||
23451098|NCT00960063|65395092|FG002|Overall Study|Progression of Disease|3|||
23451099|NCT02610777|65395093|FG000|Overall Study|Lost to Follow-up|1|||
23451100|NCT02610777|65395094|FG001|Overall Study|Lost to Follow-up|0|||
23451101|NCT02610777|65395093|FG000|Overall Study|Site Terminated by Sponsor|9|||
23451102|NCT02610777|65395094|FG001|Overall Study|Site Terminated by Sponsor|8|||
23451103|NCT02610777|65395093|FG000|Overall Study|Withdrawal by Subject|2|||
23451104|NCT02610777|65395094|FG001|Overall Study|Withdrawal by Subject|2|||
23451105|NCT02610777|65395093|FG000|Overall Study|Reason not Specified|0|||
23451106|NCT02610777|65395094|FG001|Overall Study|Reason not Specified|1|||
23451107|NCT02610777|65395093|FG000|Overall Study|Death|50|||
23451108|NCT02610777|65395094|FG001|Overall Study|Death|47|||
23451109|NCT00292942|65395099|FG000|Overall Study|Withdrawal by Subject|0|||
23451110|NCT00292942|65395100|FG001|Overall Study|Withdrawal by Subject|0|||
23451111|NCT00292942|65395101|FG002|Overall Study|Withdrawal by Subject|1|||
23451112|NCT00292942|65395102|FG003|Overall Study|Withdrawal by Subject|0|||
23451113|NCT00292942|65395099|FG000|Overall Study|Adverse Event|0|||
23451114|NCT00292942|65395100|FG001|Overall Study|Adverse Event|0|||
23451115|NCT00292942|65395101|FG002|Overall Study|Adverse Event|0|||
23451116|NCT00292942|65395102|FG003|Overall Study|Adverse Event|1|||
23451117|NCT00527735|65395103|FG000|Overall Study|Disease progression|47|||
23451118|NCT00527735|65395104|FG001|Overall Study|Disease progression|61|||
23451119|NCT00527735|65395105|FG002|Overall Study|Disease progression|53|||
23451120|NCT00527735|65395103|FG000|Overall Study|Death|23|||
23451121|NCT00527735|65395104|FG001|Overall Study|Death|13|||
23451122|NCT00527735|65395105|FG002|Overall Study|Death|15|||
23451123|NCT00527735|65395103|FG000|Overall Study|Completed treatment in treatment phase|14|||
23451124|NCT00527735|65395104|FG001|Overall Study|Completed treatment in treatment phase|13|||
23451125|NCT00527735|65395105|FG002|Overall Study|Completed treatment in treatment phase|18|||
23451126|NCT00527735|65395103|FG000|Overall Study|Adverse Event|10|||
23451127|NCT00527735|65395104|FG001|Overall Study|Adverse Event|6|||
23451128|NCT00527735|65395105|FG002|Overall Study|Adverse Event|7|||
23451129|NCT00527735|65395103|FG000|Overall Study|Not identified|5|||
23451130|NCT00527735|65395104|FG001|Overall Study|Not identified|5|||
23451131|NCT00527735|65395105|FG002|Overall Study|Not identified|5|||
23451132|NCT00527735|65395103|FG000|Overall Study|Withdrawal by Subject|5|||
23451133|NCT00527735|65395104|FG001|Overall Study|Withdrawal by Subject|4|||
23451134|NCT00527735|65395105|FG002|Overall Study|Withdrawal by Subject|3|||
23451135|NCT00527735|65395103|FG000|Overall Study|No longer met study criteria|2|||
23451136|NCT00527735|65395104|FG001|Overall Study|No longer met study criteria|2|||
23451137|NCT00527735|65395105|FG002|Overall Study|No longer met study criteria|1|||
23451138|NCT00527735|65395103|FG000|Overall Study|Lost to Follow-up|0|||
23451139|NCT00527735|65395104|FG001|Overall Study|Lost to Follow-up|0|||
23451140|NCT00527735|65395105|FG002|Overall Study|Lost to Follow-up|3|||
23451141|NCT00527735|65395103|FG000|Overall Study|Poor compliance or noncompliance|0|||
23451142|NCT00527735|65395104|FG001|Overall Study|Poor compliance or noncompliance|1|||
23451143|NCT00527735|65395105|FG002|Overall Study|Poor compliance or noncompliance|1|||
23451144|NCT00527735|65395103|FG000|Overall Study|Completed treatment during maintenance|2|||
23172199|NCT00343512|64375649|FG000|Overall Study|Withdrawal by Subject|2|||
23451145|NCT00527735|65395104|FG001|Overall Study|Completed treatment during maintenance|2|||
23451146|NCT00527735|65395105|FG002|Overall Study|Completed treatment during maintenance|1|||
23451147|NCT02994108|65395108|FG000|Intervention Messages|Withdrawal by Subject|2|||
23451148|NCT02994108|65395109|FG001|Intervention Messages|Withdrawal by Subject|0|||
23451149|NCT02994108|65395108|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
23451150|NCT02994108|65395109|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
23231864|NCT00963820|64591736|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
23231865|NCT01365468|64591737|FG000|Overall Study|Physician Decision|1|||
23231866|NCT01365468|64591738|FG001|Overall Study|Physician Decision|0|||
23231867|NCT01365468|64591737|FG000|Overall Study|Disease progression|1|||
23231868|NCT01365468|64591738|FG001|Overall Study|Disease progression|0|||
23231869|NCT01365468|64591737|FG000|Overall Study|Lost to Follow-up|2|||
23231870|NCT01365468|64591738|FG001|Overall Study|Lost to Follow-up|0|||
23231871|NCT00984009|64591739|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
23231872|NCT01797302|64591744|FG000|Overall Study|Lost to Follow-up|16|||
23231873|NCT01797302|64591745|FG001|Overall Study|Lost to Follow-up|23|||
23231874|NCT01797302|64591746|FG002|Overall Study|Lost to Follow-up|22|||
23231875|NCT01797302|64591744|FG000|Overall Study|Withdrawal by Subject|1|||
23231876|NCT01797302|64591745|FG001|Overall Study|Withdrawal by Subject|3|||
23231877|NCT01797302|64591746|FG002|Overall Study|Withdrawal by Subject|4|||
23231878|NCT00170846|64591749|FG000|Overall Study|Subject withdrew Informed Consent|5|||
23231879|NCT00170846|64591750|FG001|Overall Study|Subject withdrew Informed Consent|12|||
23231880|NCT00170846|64591751|FG002|Overall Study|Subject withdrew Informed Consent|8|||
23231881|NCT00170846|64591749|FG000|Overall Study|Lost to Follow-up|6|||
23231882|NCT00170846|64591750|FG001|Overall Study|Lost to Follow-up|3|||
23231883|NCT00170846|64591751|FG002|Overall Study|Lost to Follow-up|2|||
23231884|NCT00170846|64591749|FG000|Overall Study|Death|0|||
23231885|NCT00170846|64591750|FG001|Overall Study|Death|3|||
23231886|NCT00170846|64591751|FG002|Overall Study|Death|3|||
23231887|NCT00170846|64591749|FG000|Overall Study|Reason Missing|0|||
23231888|NCT00170846|64591750|FG001|Overall Study|Reason Missing|1|||
23231889|NCT00170846|64591751|FG002|Overall Study|Reason Missing|0|||
23231890|NCT00695318|64591752|FG000|Overall Study|Lost to Follow-up|1|||
23231891|NCT00695318|64591753|FG001|Overall Study|Lost to Follow-up|0|||
23231892|NCT00695318|64591752|FG000|Overall Study|Withdrawal by Subject|2|||
23231893|NCT00695318|64591753|FG001|Overall Study|Withdrawal by Subject|0|||
23231894|NCT00695318|64591752|FG000|Overall Study|Death|1|||
23339174|NCT01867710|64986115|FG000|Overall Study|Study medication no longer effective|0|||
23339175|NCT01867710|64986116|FG001|Overall Study|Study medication no longer effective|1|||
23339176|NCT01867710|64986117|FG002|Overall Study|Study medication no longer effective|0|||
23231895|NCT00695318|64591753|FG001|Overall Study|Death|1|||
23231896|NCT00695318|64591752|FG000|Overall Study|Study Terminated|1|||
23231897|NCT00695318|64591753|FG001|Overall Study|Study Terminated|0|||
23231898|NCT01072500|64591755|FG000|Overall Study|Death|2|||
23231899|NCT01072500|64591756|FG001|Overall Study|Death|2|||
23231900|NCT01072500|64591755|FG000|Overall Study|Lost to Follow-up|5|||
23231901|NCT01072500|64591756|FG001|Overall Study|Lost to Follow-up|2|||
23231902|NCT01072500|64591755|FG000|Overall Study|Withdrawal by Subject|17|||
23231903|NCT01072500|64591756|FG001|Overall Study|Withdrawal by Subject|10|||
23231904|NCT02127970|64591760|FG000|Overall Study|Adverse Event|2|||
23231905|NCT02127970|64591761|FG001|Overall Study|Adverse Event|1|||
23231906|NCT02127970|64591760|FG000|Overall Study|Death|1|||
23231907|NCT02127970|64591761|FG001|Overall Study|Death|1|||
23231908|NCT02127970|64591760|FG000|Overall Study|Lost to Follow-up|14|||
23231909|NCT02127970|64591761|FG001|Overall Study|Lost to Follow-up|14|||
23231910|NCT02127970|64591760|FG000|Overall Study|Reason not Specified|4|||
23231911|NCT02127970|64591761|FG001|Overall Study|Reason not Specified|7|||
23231912|NCT02127970|64591760|FG000|Overall Study|Pregnancy|0|||
23231913|NCT02127970|64591761|FG001|Overall Study|Pregnancy|1|||
23339177|NCT01867710|64986118|FG003|Overall Study|Study medication no longer effective|0|||
23579148|NCT00495469|65850442|FG004|Overall Study|Liver function test abnormality|0|||
23579149|NCT00495469|65850443|FG005|Overall Study|Liver function test abnormality|0|||
23579150|NCT00495469|65850444|FG006|Overall Study|Liver function test abnormality|0|||
23579151|NCT00495469|65850438|FG000|Overall Study|ST depression at randomisation in ECG|0|||
23579152|NCT00495469|65850439|FG001|Overall Study|ST depression at randomisation in ECG|1|||
23579153|NCT00495469|65850440|FG002|Overall Study|ST depression at randomisation in ECG|0|||
23579154|NCT00495469|65850441|FG003|Overall Study|ST depression at randomisation in ECG|0|||
23579155|NCT00495469|65850442|FG004|Overall Study|ST depression at randomisation in ECG|0|||
23579156|NCT00495469|65850443|FG005|Overall Study|ST depression at randomisation in ECG|0|||
23579157|NCT00495469|65850444|FG006|Overall Study|ST depression at randomisation in ECG|0|||
23579158|NCT00664521|65850445|FG000|Overall Study|Adverse Event|4|||
23579159|NCT00664521|65850446|FG001|Overall Study|Adverse Event|1|||
23579160|NCT00664521|65850445|FG000|Overall Study|Lost to Follow-up|1|||
23579161|NCT00664521|65850446|FG001|Overall Study|Lost to Follow-up|0|||
23579162|NCT00664521|65850445|FG000|Overall Study|Other|1|||
23579163|NCT00664521|65850446|FG001|Overall Study|Other|0|||
23579164|NCT04096365|65850447|FG000|Overall Study|Adverse Event|1|||
23579165|NCT02688621|65850451|FG000|Overall Study|Pregnancy|1|||
23579166|NCT02688621|65850452|FG001|Overall Study|Pregnancy|3|||
23579167|NCT02688621|65850451|FG000|Overall Study|Lost to Follow-up|38|||
23579168|NCT02688621|65850452|FG001|Overall Study|Lost to Follow-up|15|||
23579169|NCT02688621|65850451|FG000|Overall Study|Withdrawal by Subject|1|||
23579170|NCT02688621|65850452|FG001|Overall Study|Withdrawal by Subject|0|||
23579171|NCT02825043|65850453|FG000|Overall Study|Lost to Follow-up|4|||
23579172|NCT01700530|65850457|FG000|Overall Study|Withdrawal by Subject|0|||
23579173|NCT01700530|65850458|FG001|Overall Study|Withdrawal by Subject|3|||
23579174|NCT01700530|65850459|FG002|Overall Study|Withdrawal by Subject|1|||
23339178|NCT02244463|64986121|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
23339179|NCT02244463|64986122|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339180|NCT02244463|64986123|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339181|NCT02244463|64986124|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339182|NCT02244463|64986125|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339183|NCT02244463|64986126|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
23339184|NCT02244463|64986121|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
23339185|NCT02244463|64986122|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
23339186|NCT02244463|64986123|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
23339187|NCT02244463|64986124|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
23339188|NCT02244463|64986125|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
23339189|NCT02244463|64986126|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
23339190|NCT02244463|64986121|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339191|NCT02244463|64986122|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
23339192|NCT02244463|64986123|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339193|NCT02244463|64986124|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339194|NCT02244463|64986125|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339195|NCT02244463|64986126|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
23339196|NCT02244463|64986121|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23339197|NCT02244463|64986122|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23579175|NCT01729871|65850460|FG000|Overall Study|Adverse Event|7|||
23579176|NCT01729871|65850461|FG001|Overall Study|Adverse Event|7|||
23339198|NCT02244463|64986123|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
23339199|NCT02244463|64986124|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23339200|NCT02244463|64986125|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23579177|NCT01729871|65850460|FG000|Overall Study|Death|0|||
23579178|NCT01729871|65850461|FG001|Overall Study|Death|1|||
23579179|NCT01729871|65850460|FG000|Overall Study|Lack of Efficacy|0|||
23579180|NCT01729871|65850461|FG001|Overall Study|Lack of Efficacy|1|||
23579181|NCT01729871|65850460|FG000|Overall Study|Physician Decision|0|||
23579182|NCT01729871|65850461|FG001|Overall Study|Physician Decision|2|||
23579183|NCT01729871|65850460|FG000|Overall Study|Protocol Violation|1|||
23231914|NCT02127970|64591760|FG000|Overall Study|Subject Withdrew Consent|5|||
23231915|NCT02127970|64591761|FG001|Overall Study|Subject Withdrew Consent|3|||
23231916|NCT00413777|64591762|FG000|Fixed-dose Period|Lost to Follow-up|1|||
23231917|NCT00413777|64591763|FG001|Fixed-dose Period|Lost to Follow-up|1|||
23339201|NCT02244463|64986126|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
23339202|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339203|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339204|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339205|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
23339206|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339207|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
23339208|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339209|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339210|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339211|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
23339212|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339213|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
23339214|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339215|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339216|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339217|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
23339218|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339219|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
23339220|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339221|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339222|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339223|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
23339224|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339225|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
23339226|NCT02244463|64986121|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339227|NCT02244463|64986122|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339228|NCT02244463|64986123|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339229|NCT02244463|64986124|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
23339230|NCT02244463|64986125|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339231|NCT02244463|64986126|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
23339232|NCT02244463|64986121|FG000|Period 5: Phase II|Disease Progression|0|||
23339233|NCT02244463|64986122|FG001|Period 5: Phase II|Disease Progression|0|||
23339234|NCT02244463|64986123|FG002|Period 5: Phase II|Disease Progression|0|||
23339235|NCT02244463|64986124|FG003|Period 5: Phase II|Disease Progression|0|||
23339236|NCT02244463|64986125|FG004|Period 5: Phase II|Disease Progression|10|||
23339237|NCT02244463|64986126|FG005|Period 5: Phase II|Disease Progression|11|||
23339238|NCT02244463|64986121|FG000|Period 5: Phase II|Physician Decision|0|||
23339239|NCT02244463|64986122|FG001|Period 5: Phase II|Physician Decision|0|||
23339240|NCT02244463|64986123|FG002|Period 5: Phase II|Physician Decision|0|||
23339241|NCT02244463|64986124|FG003|Period 5: Phase II|Physician Decision|0|||
23231918|NCT00413777|64591762|FG000|Fixed-dose Period|Adverse Event|2|||
23231919|NCT00413777|64591763|FG001|Fixed-dose Period|Adverse Event|1|||
23231920|NCT00413777|64591762|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
23231921|NCT00413777|64591763|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
23231922|NCT00413777|64591762|FG000|Fixed-dose Period|Withdrew Consent|0|||
23231923|NCT00413777|64591763|FG001|Fixed-dose Period|Withdrew Consent|1|||
23231924|NCT00656799|64591764|FG000|Overall Study|Death|2|||
23231925|NCT00535236|64591767|FG000|Overall Study|Adverse Event|1|||
23231926|NCT00535236|64591768|FG001|Overall Study|Adverse Event|0|||
23231927|NCT00535236|64591769|FG002|Overall Study|Adverse Event|9|||
23231928|NCT00535236|64591770|FG003|Overall Study|Adverse Event|3|||
23231929|NCT00535236|64591771|FG004|Overall Study|Adverse Event|3|||
23231930|NCT00535236|64591772|FG005|Overall Study|Adverse Event|0|||
23231931|NCT00535236|64591773|FG006|Overall Study|Adverse Event|5|||
23231932|NCT00535236|64591774|FG007|Overall Study|Adverse Event|1|||
23231933|NCT00535236|64591775|FG008|Overall Study|Adverse Event|2|||
23231934|NCT00535236|64591776|FG009|Overall Study|Adverse Event|1|||
23231935|NCT00535236|64591767|FG000|Overall Study|Lost to Follow-up|1|||
23231936|NCT00535236|64591768|FG001|Overall Study|Lost to Follow-up|2|||
23231937|NCT00535236|64591769|FG002|Overall Study|Lost to Follow-up|0|||
23339242|NCT02244463|64986125|FG004|Period 5: Phase II|Physician Decision|3|||
23339243|NCT02244463|64986126|FG005|Period 5: Phase II|Physician Decision|2|||
23339244|NCT02244463|64986121|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
23339245|NCT02244463|64986122|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
23339246|NCT02244463|64986123|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
23231938|NCT00535236|64591770|FG003|Overall Study|Lost to Follow-up|0|||
23231939|NCT00535236|64591771|FG004|Overall Study|Lost to Follow-up|2|||
23231940|NCT00535236|64591772|FG005|Overall Study|Lost to Follow-up|0|||
23231941|NCT00535236|64591773|FG006|Overall Study|Lost to Follow-up|0|||
23231942|NCT00535236|64591774|FG007|Overall Study|Lost to Follow-up|0|||
23231943|NCT00535236|64591775|FG008|Overall Study|Lost to Follow-up|6|||
23339247|NCT02244463|64986124|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
23339248|NCT02244463|64986125|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
23339249|NCT02244463|64986126|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
23339250|NCT02244463|64986121|FG000|Period 5: Phase II|Intercurrent Illness|0|||
23339251|NCT02244463|64986122|FG001|Period 5: Phase II|Intercurrent Illness|0|||
23339252|NCT02244463|64986123|FG002|Period 5: Phase II|Intercurrent Illness|0|||
23339253|NCT02244463|64986124|FG003|Period 5: Phase II|Intercurrent Illness|0|||
23339254|NCT02244463|64986125|FG004|Period 5: Phase II|Intercurrent Illness|2|||
23339255|NCT02244463|64986126|FG005|Period 5: Phase II|Intercurrent Illness|0|||
23339256|NCT02244463|64986121|FG000|Period 5: Phase II|Adverse Event|0|||
23339257|NCT02244463|64986122|FG001|Period 5: Phase II|Adverse Event|0|||
23339258|NCT02244463|64986123|FG002|Period 5: Phase II|Adverse Event|0|||
23339259|NCT02244463|64986124|FG003|Period 5: Phase II|Adverse Event|0|||
23339260|NCT02244463|64986125|FG004|Period 5: Phase II|Adverse Event|0|||
23339261|NCT02244463|64986126|FG005|Period 5: Phase II|Adverse Event|2|||
23339262|NCT02244463|64986121|FG000|Period 5: Phase II|Still On treatment|0|||
23339263|NCT02244463|64986122|FG001|Period 5: Phase II|Still On treatment|0|||
23339264|NCT02244463|64986123|FG002|Period 5: Phase II|Still On treatment|0|||
23339265|NCT02244463|64986124|FG003|Period 5: Phase II|Still On treatment|0|||
23339266|NCT02244463|64986125|FG004|Period 5: Phase II|Still On treatment|0|||
23339267|NCT02244463|64986126|FG005|Period 5: Phase II|Still On treatment|3|||
23339268|NCT01758731|64986130|FG000|Overall Study|Physician Decision|1|||
23339269|NCT01860040|64986131|FG000|Overall Study|Withdrawal by Subject|1|||
23339270|NCT01860040|64986132|FG001|Overall Study|Withdrawal by Subject|0|||
23339271|NCT00729157|64986133|FG000|Overall Study|Withdrawal by Subject|1|||
23339272|NCT01290679|64986136|FG000|Overall Study|Adverse Event|2|||
23339273|NCT01290679|64986137|FG001|Overall Study|Adverse Event|0|||
23339274|NCT01290679|64986136|FG000|Overall Study|Lost to Follow-up|8|||
23339275|NCT01290679|64986137|FG001|Overall Study|Lost to Follow-up|10|||
23339276|NCT01290679|64986136|FG000|Overall Study|Protocol Violation|0|||
23339277|NCT01290679|64986137|FG001|Overall Study|Protocol Violation|1|||
23339278|NCT01290679|64986136|FG000|Overall Study|Withdrawal by Subject|6|||
23339279|NCT01290679|64986137|FG001|Overall Study|Withdrawal by Subject|5|||
23339280|NCT01290679|64986136|FG000|Overall Study|Subject Entered Another Trial|0|||
23339281|NCT01290679|64986137|FG001|Overall Study|Subject Entered Another Trial|5|||
23339282|NCT04672252|64986138|FG000|Overall Study|Protocol Violation|1|||
23339283|NCT04672252|64986139|FG001|Overall Study|Protocol Violation|0|||
23579184|NCT01729871|65850461|FG001|Overall Study|Protocol Violation|0|||
23579185|NCT01729871|65850460|FG000|Overall Study|Withdrawal by Subject|0|||
23579186|NCT01729871|65850461|FG001|Overall Study|Withdrawal by Subject|3|||
23579187|NCT01729871|65850460|FG000|Overall Study|Other|4|||
23579188|NCT01729871|65850461|FG001|Overall Study|Other|9|||
23231944|NCT00535236|64591776|FG009|Overall Study|Lost to Follow-up|1|||
23231945|NCT00535236|64591767|FG000|Overall Study|Physician Decision|0|||
23231946|NCT00535236|64591768|FG001|Overall Study|Physician Decision|0|||
23231947|NCT00535236|64591769|FG002|Overall Study|Physician Decision|0|||
23231948|NCT00535236|64591770|FG003|Overall Study|Physician Decision|0|||
23231949|NCT00535236|64591771|FG004|Overall Study|Physician Decision|1|||
23231950|NCT00535236|64591772|FG005|Overall Study|Physician Decision|0|||
23231951|NCT00535236|64591773|FG006|Overall Study|Physician Decision|1|||
23231952|NCT00535236|64591774|FG007|Overall Study|Physician Decision|0|||
23231953|NCT00535236|64591775|FG008|Overall Study|Physician Decision|0|||
23231954|NCT00535236|64591776|FG009|Overall Study|Physician Decision|0|||
23231955|NCT00535236|64591767|FG000|Overall Study|Protocol Violation|2|||
23231956|NCT00535236|64591768|FG001|Overall Study|Protocol Violation|0|||
23231957|NCT00535236|64591769|FG002|Overall Study|Protocol Violation|1|||
23231958|NCT00535236|64591770|FG003|Overall Study|Protocol Violation|0|||
23231959|NCT00535236|64591771|FG004|Overall Study|Protocol Violation|0|||
23231960|NCT00535236|64591772|FG005|Overall Study|Protocol Violation|0|||
23231961|NCT00535236|64591773|FG006|Overall Study|Protocol Violation|0|||
23231962|NCT00535236|64591774|FG007|Overall Study|Protocol Violation|0|||
23339284|NCT01613222|64986140|FG000|Overall Study|Physician Decision|1|||
23339285|NCT01613222|64986140|FG000|Overall Study|Unable to place arterial line|1|||
23339286|NCT01613222|64986140|FG000|Overall Study|Reused disposable sensors|10|||
23339287|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
23339288|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
23339289|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
23339290|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
23339291|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
23339292|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
23339293|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
23579189|NCT00821236|65850462|FG000|Overall Study|Lost to Follow-up|3|||
23231963|NCT00535236|64591775|FG008|Overall Study|Protocol Violation|1|||
23231964|NCT00535236|64591776|FG009|Overall Study|Protocol Violation|0|||
23231965|NCT00535236|64591767|FG000|Overall Study|Withdrawal by Subject|3|||
23231966|NCT00535236|64591768|FG001|Overall Study|Withdrawal by Subject|0|||
23231967|NCT00535236|64591769|FG002|Overall Study|Withdrawal by Subject|2|||
23231968|NCT00535236|64591770|FG003|Overall Study|Withdrawal by Subject|1|||
23231969|NCT00535236|64591771|FG004|Overall Study|Withdrawal by Subject|6|||
23231970|NCT00535236|64591772|FG005|Overall Study|Withdrawal by Subject|1|||
23231971|NCT00535236|64591773|FG006|Overall Study|Withdrawal by Subject|5|||
23231972|NCT00535236|64591774|FG007|Overall Study|Withdrawal by Subject|0|||
23231973|NCT00535236|64591775|FG008|Overall Study|Withdrawal by Subject|4|||
23231974|NCT00535236|64591776|FG009|Overall Study|Withdrawal by Subject|2|||
23231975|NCT00591786|64591777|FG000|Overall Study|Withdrawal of Informed Consent|0|||
23231976|NCT00591786|64591778|FG001|Overall Study|Withdrawal of Informed Consent|0|||
23231977|NCT00591786|64591779|FG002|Overall Study|Withdrawal of Informed Consent|1|||
23231978|NCT00591786|64591780|FG003|Overall Study|Withdrawal of Informed Consent|0|||
23231979|NCT00591786|64591781|FG004|Overall Study|Withdrawal of Informed Consent|0|||
23231980|NCT00591786|64591782|FG005|Overall Study|Withdrawal of Informed Consent|0|||
23231981|NCT00591786|64591783|FG006|Overall Study|Withdrawal of Informed Consent|0|||
23231982|NCT00591786|64591784|FG007|Overall Study|Withdrawal of Informed Consent|0|||
23231983|NCT00591786|64591785|FG008|Overall Study|Withdrawal of Informed Consent|0|||
23231984|NCT00591786|64591786|FG009|Overall Study|Withdrawal of Informed Consent|0|||
23231985|NCT02058966|64591787|FG000|Open-Label Methamphetamine|Adverse Event|1|||
23231986|NCT02058966|64591787|FG000|First Intervention|Withdrawal by Subject|1|||
23231987|NCT03018028|64591788|FG000|Overall Study|Withdrawal by Subject|3|||
23231988|NCT03018028|64591789|FG001|Overall Study|Withdrawal by Subject|0|||
23339294|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
23339295|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
23231989|NCT03018028|64591790|FG002|Overall Study|Withdrawal by Subject|1|||
23231990|NCT03018028|64591791|FG003|Overall Study|Withdrawal by Subject|2|||
23231991|NCT03018028|64591792|FG004|Overall Study|Withdrawal by Subject|0|||
23231992|NCT01024946|64591801|FG000|Overall Study|Screen Failure|3|||
23231993|NCT01024946|64591801|FG000|Overall Study|Withdrawal by Subject|1|||
23231994|NCT01024946|64591801|FG000|Overall Study|Adverse Event|1|||
23231995|NCT02371980|64591803|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
23231996|NCT02371980|64591804|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
23231997|NCT02371980|64591805|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
23231998|NCT02371980|64591806|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
23231999|NCT02371980|64591807|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
23232000|NCT02371980|64591803|FG000|Open-label Period|Significant Protocol Deviation|19|||
23232001|NCT02371980|64591804|FG001|Open-label Period|Significant Protocol Deviation|0|||
23232002|NCT02371980|64591805|FG002|Open-label Period|Significant Protocol Deviation|0|||
23232003|NCT02371980|64591806|FG003|Open-label Period|Significant Protocol Deviation|0|||
23232004|NCT02371980|64591807|FG004|Open-label Period|Significant Protocol Deviation|0|||
23232005|NCT02371980|64591803|FG000|Open-label Period|Noncompliance with Study Drug|10|||
23232006|NCT02371980|64591804|FG001|Open-label Period|Noncompliance with Study Drug|0|||
23232007|NCT02371980|64591805|FG002|Open-label Period|Noncompliance with Study Drug|0|||
23232008|NCT02371980|64591806|FG003|Open-label Period|Noncompliance with Study Drug|0|||
23232009|NCT02371980|64591807|FG004|Open-label Period|Noncompliance with Study Drug|0|||
23232010|NCT02371980|64591803|FG000|Open-label Period|Lost to Follow-up|55|||
23232011|NCT02371980|64591804|FG001|Open-label Period|Lost to Follow-up|0|||
23232012|NCT02371980|64591805|FG002|Open-label Period|Lost to Follow-up|0|||
23339296|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
23172200|NCT02499029|64375650|FG000|Overall Study|Lost to Follow-up|2|||
23232013|NCT02371980|64591806|FG003|Open-label Period|Lost to Follow-up|0|||
23232014|NCT02371980|64591807|FG004|Open-label Period|Lost to Follow-up|0|||
23232015|NCT02371980|64591803|FG000|Open-label Period|Voluntary Withdrawal|91|||
23232016|NCT02371980|64591804|FG001|Open-label Period|Voluntary Withdrawal|0|||
23232017|NCT02371980|64591805|FG002|Open-label Period|Voluntary Withdrawal|0|||
23232018|NCT02371980|64591806|FG003|Open-label Period|Voluntary Withdrawal|0|||
23232019|NCT02371980|64591807|FG004|Open-label Period|Voluntary Withdrawal|0|||
23232020|NCT02371980|64591803|FG000|Open-label Period|Pregnancy|1|||
23232021|NCT02371980|64591804|FG001|Open-label Period|Pregnancy|0|||
23232022|NCT02371980|64591805|FG002|Open-label Period|Pregnancy|0|||
23232023|NCT02371980|64591806|FG003|Open-label Period|Pregnancy|0|||
23232024|NCT02371980|64591807|FG004|Open-label Period|Pregnancy|0|||
23232025|NCT02371980|64591803|FG000|Open-label Period|Lack of Efficacy|116|||
23339297|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
23339298|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
23232026|NCT02371980|64591804|FG001|Open-label Period|Lack of Efficacy|0|||
23232027|NCT02371980|64591805|FG002|Open-label Period|Lack of Efficacy|0|||
23232028|NCT02371980|64591806|FG003|Open-label Period|Lack of Efficacy|0|||
23232029|NCT02371980|64591807|FG004|Open-label Period|Lack of Efficacy|0|||
23232030|NCT02371980|64591803|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
23232031|NCT02371980|64591804|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
23232032|NCT02371980|64591805|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
23232033|NCT02371980|64591806|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
23232034|NCT02371980|64591807|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
23232035|NCT02371980|64591803|FG000|Open-label Period|Reason not Specified|9|||
23232036|NCT02371980|64591804|FG001|Open-label Period|Reason not Specified|0|||
23232037|NCT02371980|64591805|FG002|Open-label Period|Reason not Specified|0|||
23232038|NCT02371980|64591806|FG003|Open-label Period|Reason not Specified|0|||
23232039|NCT02371980|64591807|FG004|Open-label Period|Reason not Specified|0|||
23232040|NCT02371980|64591803|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
23232041|NCT02371980|64591804|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
23232042|NCT02371980|64591805|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
23232043|NCT02371980|64591806|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
23232044|NCT02371980|64591807|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
23232045|NCT02371980|64591803|FG000|Double-blind Period|Significant Protocol Deviation|0|||
23579190|NCT01124617|65850463|FG000|Overall Study|Adverse Event|5|||
23579191|NCT01124617|65850464|FG001|Overall Study|Adverse Event|2|||
23579192|NCT01124617|65850463|FG000|Overall Study|Lack of Efficacy|2|||
23579193|NCT01124617|65850464|FG001|Overall Study|Lack of Efficacy|1|||
23579194|NCT01124617|65850463|FG000|Overall Study|Protocol Violation|1|||
23579195|NCT01124617|65850464|FG001|Overall Study|Protocol Violation|1|||
23579196|NCT01124617|65850463|FG000|Overall Study|Withdrawal by Subject|9|||
23579197|NCT01124617|65850464|FG001|Overall Study|Withdrawal by Subject|1|||
23579198|NCT01124617|65850463|FG000|Overall Study|Other|2|||
23579199|NCT01124617|65850464|FG001|Overall Study|Other|1|||
23579200|NCT02491411|65850467|FG000|Overall Study|Physician Decision|4|||
23579201|NCT03019458|65850468|FG000|Overall Study|Death|0|||
23579202|NCT03019458|65850469|FG001|Overall Study|Death|1|||
23579203|NCT00209027|65850470|FG000|Overall Study|study terminated|10|||
23579204|NCT00209027|65850471|FG001|Overall Study|study terminated|0|||
23579205|NCT02906683|65853291|FG000|Overall Study|Adverse Event|0|||
23579206|NCT02906683|65853292|FG001|Overall Study|Adverse Event|1|||
23579207|NCT02906683|65853293|FG002|Overall Study|Adverse Event|0|||
23579208|NCT02906683|65853291|FG000|Overall Study|Physician Decision|0|||
23172201|NCT02499029|64375651|FG001|Overall Study|Lost to Follow-up|2|||
23172202|NCT02499029|64375650|FG000|Overall Study|Physician Decision|2|||
23172203|NCT02499029|64375651|FG001|Overall Study|Physician Decision|1|||
23172204|NCT02499029|64375650|FG000|Overall Study|Death|1|||
23172205|NCT02499029|64375651|FG001|Overall Study|Death|0|||
23172206|NCT00328627|64375653|FG000|Overall Study|Hyperglycemic Rescue|41|||
23172207|NCT00328627|64375654|FG001|Overall Study|Hyperglycemic Rescue|18|||
23232046|NCT02371980|64591804|FG001|Double-blind Period|Significant Protocol Deviation|2|||
23451151|NCT02994108|65395108|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
23451152|NCT02994108|65395109|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
23579209|NCT02906683|65853292|FG001|Overall Study|Physician Decision|1|||
23579210|NCT02906683|65853293|FG002|Overall Study|Physician Decision|1|||
23579211|NCT02906683|65853291|FG000|Overall Study|Withdrawal by Subject|0|||
23579212|NCT02906683|65853292|FG001|Overall Study|Withdrawal by Subject|2|||
23579213|NCT02906683|65853293|FG002|Overall Study|Withdrawal by Subject|1|||
23579214|NCT02906683|65853291|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
23579215|NCT02906683|65853292|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
23579216|NCT02906683|65853293|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
23579217|NCT02906683|65853291|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
23579218|NCT02906683|65853292|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
23579219|NCT02906683|65853293|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
23579220|NCT01641861|65853295|FG000|Overall Study|Lost to Follow-up|21|||
23579221|NCT01641861|65853296|FG001|Overall Study|Lost to Follow-up|16|||
23579222|NCT01641861|65853295|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
23579223|NCT01641861|65853296|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
23579224|NCT01641861|65853295|FG000|Overall Study|Died due to drowning|0|||
23579225|NCT01641861|65853296|FG001|Overall Study|Died due to drowning|1|||
23579226|NCT02459587|65853299|FG000|3-Month Follow-up Assessment|Death|0|||
23579227|NCT02459587|65853300|FG001|3-Month Follow-up Assessment|Death|2|||
23579228|NCT02459587|65853299|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
23579229|NCT02459587|65853300|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
23579230|NCT02459587|65853299|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
23579231|NCT02459587|65853300|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
23579232|NCT02459587|65853299|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
23579233|NCT02459587|65853300|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
23579234|NCT02459587|65853299|FG000|6-month Follow-up Assessment|Death|2|||
23579235|NCT02459587|65853300|FG001|6-month Follow-up Assessment|Death|1|||
23579236|NCT02459587|65853299|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
23579237|NCT02459587|65853300|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
23172208|NCT00328627|64375655|FG002|Overall Study|Hyperglycemic Rescue|16|||
23172209|NCT00328627|64375656|FG003|Overall Study|Hyperglycemic Rescue|13|||
23451153|NCT02994108|65395108|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
23232047|NCT02371980|64591805|FG002|Double-blind Period|Significant Protocol Deviation|7|||
23232048|NCT02371980|64591806|FG003|Double-blind Period|Significant Protocol Deviation|3|||
23232049|NCT02371980|64591807|FG004|Double-blind Period|Significant Protocol Deviation|3|||
23232050|NCT02371980|64591803|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
23232051|NCT02371980|64591804|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
23232052|NCT02371980|64591805|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
23232053|NCT02371980|64591806|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
23232054|NCT02371980|64591807|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
23232055|NCT02371980|64591803|FG000|Double-blind Period|Lost to Follow-up|0|||
23232056|NCT02371980|64591804|FG001|Double-blind Period|Lost to Follow-up|8|||
23232057|NCT02371980|64591805|FG002|Double-blind Period|Lost to Follow-up|8|||
23232058|NCT02371980|64591806|FG003|Double-blind Period|Lost to Follow-up|6|||
23232059|NCT02371980|64591807|FG004|Double-blind Period|Lost to Follow-up|5|||
23232060|NCT02371980|64591803|FG000|Double-blind Period|Voluntary Withdrawal|0|||
23232061|NCT02371980|64591804|FG001|Double-blind Period|Voluntary Withdrawal|12|||
23232062|NCT02371980|64591805|FG002|Double-blind Period|Voluntary Withdrawal|8|||
23232063|NCT02371980|64591806|FG003|Double-blind Period|Voluntary Withdrawal|9|||
23232064|NCT02371980|64591807|FG004|Double-blind Period|Voluntary Withdrawal|11|||
23232065|NCT02371980|64591803|FG000|Double-blind Period|Relapse|0|||
23232066|NCT02371980|64591804|FG001|Double-blind Period|Relapse|50|||
23232067|NCT02371980|64591805|FG002|Double-blind Period|Relapse|25|||
23339299|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
23339300|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
23232068|NCT02371980|64591806|FG003|Double-blind Period|Relapse|25|||
23232069|NCT02371980|64591807|FG004|Double-blind Period|Relapse|26|||
23232070|NCT02371980|64591803|FG000|Double-blind Period|Reason not Specified|0|||
23232071|NCT02371980|64591804|FG001|Double-blind Period|Reason not Specified|3|||
23232072|NCT02371980|64591805|FG002|Double-blind Period|Reason not Specified|3|||
23232073|NCT02371980|64591806|FG003|Double-blind Period|Reason not Specified|2|||
23232074|NCT02371980|64591807|FG004|Double-blind Period|Reason not Specified|1|||
23232075|NCT02371980|64591803|FG000|Double-blind Period|Missing|0|||
23232076|NCT02371980|64591804|FG001|Double-blind Period|Missing|1|||
23232077|NCT02371980|64591805|FG002|Double-blind Period|Missing|0|||
23232078|NCT02371980|64591806|FG003|Double-blind Period|Missing|0|||
23232079|NCT02371980|64591807|FG004|Double-blind Period|Missing|0|||
23232080|NCT00935701|64591811|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
23232081|NCT00286156|64591817|FG000|Overall Study|Missed 12 month visit|0|||
23232082|NCT00286156|64591818|FG001|Overall Study|Missed 12 month visit|0|||
23339301|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
23339302|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Death|0|||
23232083|NCT00286156|64591819|FG002|Overall Study|Missed 12 month visit|1|||
23232084|NCT00286156|64591817|FG000|Overall Study|AE: pulmonary embolus|0|||
23232085|NCT00286156|64591818|FG001|Overall Study|AE: pulmonary embolus|1|||
23232086|NCT00286156|64591819|FG002|Overall Study|AE: pulmonary embolus|0|||
23232087|NCT00286156|64591817|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
23232088|NCT00286156|64591818|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
23339303|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Death|0|||
23339304|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Death|1|||
23339305|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Death|2|||
23339306|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Death|7|||
23339307|NCT00941863|64986141|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
23339308|NCT00941863|64986142|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
23339309|NCT00941863|64986143|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
23339310|NCT00941863|64986144|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
23339311|NCT00941863|64986145|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
23339312|NCT00941863|64986141|FG000|Continued After PCD|Withdrawal by Subject|0|||
23339313|NCT00941863|64986142|FG001|Continued After PCD|Withdrawal by Subject|0|||
23339314|NCT00941863|64986143|FG002|Continued After PCD|Withdrawal by Subject|0|||
23339315|NCT00941863|64986144|FG003|Continued After PCD|Withdrawal by Subject|0|||
23339316|NCT00941863|64986145|FG004|Continued After PCD|Withdrawal by Subject|1|||
23339317|NCT00941863|64986141|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
23339318|NCT00941863|64986142|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
23339319|NCT00941863|64986143|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
23339320|NCT00941863|64986144|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
23232089|NCT00286156|64591819|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
23232090|NCT00286156|64591817|FG000|Overall Study|AE: pneumonia|1|||
23232091|NCT00286156|64591818|FG001|Overall Study|AE: pneumonia|0|||
23232092|NCT00286156|64591819|FG002|Overall Study|AE: pneumonia|0|||
23232093|NCT02059174|64591823|FG000|Period 1|Withdrawal by Subject|0|||
23232094|NCT02059174|64591824|FG001|Period 1|Withdrawal by Subject|2|||
23232095|NCT02059174|64591823|FG000|Period 2|Withdrawal by Subject|0|||
23232096|NCT02059174|64591824|FG001|Period 2|Withdrawal by Subject|2|||
23232097|NCT02059174|64591823|FG000|Period 2|Protocol Violation|1|||
23232098|NCT02059174|64591824|FG001|Period 2|Protocol Violation|0|||
23232099|NCT02059174|64591823|FG000|Period 3|Physician Decision|1|||
23232100|NCT02059174|64591824|FG001|Period 3|Physician Decision|0|||
23232101|NCT02681094|64591827|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
23232102|NCT02681094|64591828|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
23232103|NCT02681094|64591829|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
23232104|NCT02681094|64591827|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
23232105|NCT02681094|64591828|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
23232106|NCT02681094|64591829|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
23232107|NCT02681094|64591827|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
23232108|NCT02681094|64591828|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
23232109|NCT02681094|64591829|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
23232110|NCT02681094|64591827|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
23232111|NCT02681094|64591828|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
23232112|NCT02681094|64591829|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
23232113|NCT02681094|64591827|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
23232114|NCT02681094|64591828|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
23232115|NCT02681094|64591829|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
23232116|NCT02681094|64591827|FG000|1 -Modified Enrolled Participants Set|Other|6|||
23232117|NCT02681094|64591828|FG001|1 -Modified Enrolled Participants Set|Other|6|||
23232118|NCT02681094|64591829|FG002|1 -Modified Enrolled Participants Set|Other|7|||
23232119|NCT02681094|64591827|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
23232120|NCT02681094|64591828|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
23232121|NCT02681094|64591829|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
23232122|NCT02681094|64591827|FG000|2 - Enrolled Participants Set|Participant decision|7|||
23232123|NCT02681094|64591828|FG001|2 - Enrolled Participants Set|Participant decision|10|||
23232124|NCT02681094|64591829|FG002|2 - Enrolled Participants Set|Participant decision|9|||
23232125|NCT02681094|64591827|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
23232126|NCT02681094|64591828|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
23232127|NCT02681094|64591829|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
23232128|NCT02681094|64591827|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
23232129|NCT02681094|64591828|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
23232130|NCT02681094|64591829|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
23232131|NCT02681094|64591827|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
23232132|NCT02681094|64591828|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
23232133|NCT02681094|64591829|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
23232134|NCT02681094|64591827|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
23232135|NCT02681094|64591828|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
23232136|NCT02681094|64591829|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
23232137|NCT02681094|64591827|FG000|2 - Enrolled Participants Set|Other|6|||
23339321|NCT00941863|64986145|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
23339322|NCT04533412|64986146|FG000|Overall Study|Withdrawal by Subject|1|||
23339323|NCT04533412|64986147|FG001|Overall Study|Withdrawal by Subject|1|||
23232138|NCT02681094|64591828|FG001|2 - Enrolled Participants Set|Other|6|||
23232139|NCT02681094|64591829|FG002|2 - Enrolled Participants Set|Other|7|||
23232140|NCT02681094|64591827|FG000|2 - Enrolled Participants Set|No treatment given|0|||
23232141|NCT02681094|64591828|FG001|2 - Enrolled Participants Set|No treatment given|1|||
23232142|NCT02681094|64591829|FG002|2 - Enrolled Participants Set|No treatment given|1|||
23232143|NCT02500706|64591835|FG000|Overall Study|Adverse Event|0|||
23232144|NCT02500706|64591836|FG001|Overall Study|Adverse Event|0|||
23232145|NCT02500706|64591837|FG002|Overall Study|Adverse Event|1|||
23232146|NCT02500706|64591835|FG000|Overall Study|Lost to Follow-up|0|||
23232147|NCT02500706|64591836|FG001|Overall Study|Lost to Follow-up|1|||
23232148|NCT02500706|64591837|FG002|Overall Study|Lost to Follow-up|1|||
23232149|NCT02500706|64591835|FG000|Overall Study|Withdrawal by Subject|4|||
23232150|NCT02500706|64591836|FG001|Overall Study|Withdrawal by Subject|6|||
23232151|NCT02500706|64591837|FG002|Overall Study|Withdrawal by Subject|4|||
23579238|NCT02459587|65853299|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
23579239|NCT02459587|65853300|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
23232152|NCT02500706|64591835|FG000|Overall Study|Unclassified|0|||
23232153|NCT02500706|64591836|FG001|Overall Study|Unclassified|0|||
23232154|NCT02500706|64591837|FG002|Overall Study|Unclassified|1|||
23232155|NCT01990339|64591838|FG000|Overall Study|Data Not Available|49|||
23232156|NCT01990339|64591838|FG000|Overall Study|Voluntary Withdrawal|1402|||
23232157|NCT01990339|64591838|FG000|Overall Study|Lost to Follow-up|861|||
23339324|NCT04533412|64986146|FG000|Overall Study|Lost to Follow-up|1|||
23232158|NCT00495794|64591839|FG000|Overall Study|Pharmacist did not activate patient|522|||
23579240|NCT02459587|65853299|FG000|12-month Follow-up Assessment|Death|2|||
23339325|NCT04533412|64986147|FG001|Overall Study|Lost to Follow-up|4|||
23339326|NCT05483686|64986148|FG000|Overall Study|Lost to Follow-up|5|||
23339327|NCT05483686|64986149|FG001|Overall Study|Lost to Follow-up|7|||
23339328|NCT01163318|64986153|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
23339329|NCT01163318|64986153|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
23339330|NCT01163318|64986153|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
23339331|NCT01163318|64986153|FG000|Overall Study|Participants Without Case Report Form|7|||
23339332|NCT01163318|64986153|FG000|Overall Study|Multiple Reasons Per Participant|224|||
23339333|NCT03301844|64986154|FG000|Overall Study|suspected colon cancer|1|||
23339334|NCT03301844|64986155|FG001|Overall Study|suspected colon cancer|1|||
23339335|NCT01343277|64986156|FG000|Overall Study|Other|3|||
23339336|NCT01343277|64986157|FG001|Overall Study|Other|3|||
23339337|NCT01343277|64986156|FG000|Overall Study|Withdrawal by Subject|18|||
23339338|NCT01343277|64986157|FG001|Overall Study|Withdrawal by Subject|13|||
23339339|NCT01343277|64986156|FG000|Overall Study|Physician Decision|1|||
23451154|NCT02994108|65395109|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
23451155|NCT02300259|65395112|FG000|Period 1|Adverse Event|0|||
23451156|NCT02300259|65395113|FG001|Period 1|Adverse Event|0|||
23451157|NCT02300259|65395114|FG002|Period 1|Adverse Event|1|||
23579241|NCT02459587|65853300|FG001|12-month Follow-up Assessment|Death|0|||
23579242|NCT02459587|65853299|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
23451158|NCT02300259|65395112|FG000|Period 1|Withdrawal by Subject|0|||
23451159|NCT02300259|65395113|FG001|Period 1|Withdrawal by Subject|0|||
23451160|NCT02300259|65395114|FG002|Period 1|Withdrawal by Subject|1|||
23451161|NCT02300259|65395112|FG000|Period 2|Adverse Event|1|||
23451162|NCT02300259|65395113|FG001|Period 2|Adverse Event|0|||
23451163|NCT02300259|65395114|FG002|Period 2|Adverse Event|0|||
23579243|NCT02459587|65853300|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
23579244|NCT02459587|65853299|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
23579245|NCT02459587|65853300|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
23579246|NCT02459587|65853299|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
23579247|NCT02459587|65853300|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
23579248|NCT03176134|65853304|FG000|Overall Study|Lost to Follow-up|0|||
23579249|NCT03176134|65853305|FG001|Overall Study|Lost to Follow-up|2|||
23579250|NCT03176134|65853306|FG002|Overall Study|Lost to Follow-up|0|||
23579251|NCT03176134|65853307|FG003|Overall Study|Lost to Follow-up|0|||
23172210|NCT00328627|64375657|FG004|Overall Study|Hyperglycemic Rescue|6|||
23172211|NCT00328627|64375658|FG005|Overall Study|Hyperglycemic Rescue|5|||
23172212|NCT00328627|64375659|FG006|Overall Study|Hyperglycemic Rescue|19|||
23172213|NCT00328627|64375660|FG007|Overall Study|Hyperglycemic Rescue|6|||
23172214|NCT00328627|64375661|FG008|Overall Study|Hyperglycemic Rescue|6|||
23172215|NCT00328627|64375662|FG009|Overall Study|Hyperglycemic Rescue|11|||
23172216|NCT00328627|64375663|FG010|Overall Study|Hyperglycemic Rescue|3|||
23172217|NCT00328627|64375664|FG011|Overall Study|Hyperglycemic Rescue|2|||
23172218|NCT00328627|64375653|FG000|Overall Study|Adverse Event|3|||
23172219|NCT00328627|64375654|FG001|Overall Study|Adverse Event|1|||
23172220|NCT00328627|64375655|FG002|Overall Study|Adverse Event|2|||
23172221|NCT00328627|64375656|FG003|Overall Study|Adverse Event|3|||
23172222|NCT00328627|64375657|FG004|Overall Study|Adverse Event|1|||
23172223|NCT00328627|64375658|FG005|Overall Study|Adverse Event|2|||
23172224|NCT00328627|64375659|FG006|Overall Study|Adverse Event|1|||
23172225|NCT00328627|64375660|FG007|Overall Study|Adverse Event|2|||
23172226|NCT00328627|64375661|FG008|Overall Study|Adverse Event|0|||
23172227|NCT00328627|64375662|FG009|Overall Study|Adverse Event|7|||
23172228|NCT00328627|64375663|FG010|Overall Study|Adverse Event|5|||
23172229|NCT00328627|64375664|FG011|Overall Study|Adverse Event|4|||
23172230|NCT00328627|64375653|FG000|Overall Study|Protocol Violation|2|||
23172231|NCT00328627|64375654|FG001|Overall Study|Protocol Violation|2|||
23172232|NCT00328627|64375655|FG002|Overall Study|Protocol Violation|2|||
23172233|NCT00328627|64375656|FG003|Overall Study|Protocol Violation|8|||
23172234|NCT00328627|64375657|FG004|Overall Study|Protocol Violation|5|||
23172235|NCT00328627|64375658|FG005|Overall Study|Protocol Violation|5|||
23172236|NCT00328627|64375659|FG006|Overall Study|Protocol Violation|6|||
23172237|NCT00328627|64375660|FG007|Overall Study|Protocol Violation|2|||
23172238|NCT00328627|64375661|FG008|Overall Study|Protocol Violation|1|||
23172239|NCT00328627|64375662|FG009|Overall Study|Protocol Violation|4|||
23172240|NCT00328627|64375663|FG010|Overall Study|Protocol Violation|6|||
23339340|NCT01343277|64986157|FG001|Overall Study|Physician Decision|2|||
23451164|NCT02300259|65395112|FG000|Period 2|Withdrawal by Subject|0|||
23579252|NCT03176134|65853308|FG004|Overall Study|Lost to Follow-up|0|||
23579253|NCT03176134|65853309|FG005|Overall Study|Lost to Follow-up|0|||
23172241|NCT00328627|64375664|FG011|Overall Study|Protocol Violation|2|||
23172242|NCT00328627|64375653|FG000|Overall Study|Lost to Follow-up|4|||
23172243|NCT00328627|64375654|FG001|Overall Study|Lost to Follow-up|2|||
23451165|NCT02300259|65395113|FG001|Period 2|Withdrawal by Subject|0|||
23451166|NCT02300259|65395114|FG002|Period 2|Withdrawal by Subject|1|||
23451167|NCT00659061|65395115|FG000|Overall Study|Migration due to political unrest|21|||
23232159|NCT00495794|64591840|FG001|Overall Study|Pharmacist did not activate patient|0|||
23232160|NCT02363322|64591841|FG000|Overall Study|Lost to Follow-up|1|||
23232161|NCT02363322|64591842|FG001|Overall Study|Lost to Follow-up|0|||
23232162|NCT00760994|64591843|FG000|Overall Study|Lost to Follow-up|4|||
23232163|NCT00760994|64591844|FG001|Overall Study|Lost to Follow-up|4|||
23232164|NCT00760994|64591845|FG002|Overall Study|Lost to Follow-up|3|||
23451168|NCT00659061|65395116|FG001|Overall Study|Migration due to political unrest|15|||
23451169|NCT00866177|65395123|FG000|Overall Study|Withdrawal by Subject|1|||
23451170|NCT00866177|65395123|FG000|Overall Study|Not Treated|151|||
23579254|NCT03176134|65853310|FG006|Overall Study|Lost to Follow-up|0|||
23232165|NCT01117428|64591846|FG000|Overall Study|Lack of Efficacy|1|||
23232166|NCT01117428|64591847|FG001|Overall Study|Lack of Efficacy|0|||
23232167|NCT01117428|64591848|FG002|Overall Study|Lack of Efficacy|0|||
23232168|NCT01117428|64591849|FG003|Overall Study|Lack of Efficacy|0|||
23232169|NCT01117428|64591850|FG004|Overall Study|Lack of Efficacy|0|||
23232170|NCT01117428|64591851|FG005|Overall Study|Lack of Efficacy|0|||
23232171|NCT01117428|64591846|FG000|Overall Study|Adverse Event|4|||
23232172|NCT01117428|64591847|FG001|Overall Study|Adverse Event|0|||
23232173|NCT01117428|64591848|FG002|Overall Study|Adverse Event|0|||
23232174|NCT01117428|64591849|FG003|Overall Study|Adverse Event|0|||
23232175|NCT01117428|64591850|FG004|Overall Study|Adverse Event|1|||
23232176|NCT01117428|64591851|FG005|Overall Study|Adverse Event|2|||
23232177|NCT01117428|64591846|FG000|Overall Study|Death|0|||
23232178|NCT01117428|64591847|FG001|Overall Study|Death|1|||
23232179|NCT01117428|64591848|FG002|Overall Study|Death|2|||
23232180|NCT01117428|64591849|FG003|Overall Study|Death|0|||
23232181|NCT01117428|64591850|FG004|Overall Study|Death|0|||
23232182|NCT01117428|64591851|FG005|Overall Study|Death|1|||
23232183|NCT01117428|64591846|FG000|Overall Study|Physician Decision|0|||
23232184|NCT01117428|64591847|FG001|Overall Study|Physician Decision|1|||
23232185|NCT01117428|64591848|FG002|Overall Study|Physician Decision|0|||
23232186|NCT01117428|64591849|FG003|Overall Study|Physician Decision|0|||
23232187|NCT01117428|64591850|FG004|Overall Study|Physician Decision|0|||
23232188|NCT01117428|64591851|FG005|Overall Study|Physician Decision|0|||
23232189|NCT01117428|64591846|FG000|Overall Study|Withdrawal by Subject|0|||
23232190|NCT01117428|64591847|FG001|Overall Study|Withdrawal by Subject|0|||
23232191|NCT01117428|64591848|FG002|Overall Study|Withdrawal by Subject|1|||
23232192|NCT01117428|64591849|FG003|Overall Study|Withdrawal by Subject|0|||
23232193|NCT01117428|64591850|FG004|Overall Study|Withdrawal by Subject|0|||
23579255|NCT03176134|65853311|FG007|Overall Study|Lost to Follow-up|0|||
23579256|NCT03176134|65853304|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23579257|NCT03176134|65853305|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23579258|NCT03176134|65853306|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
23579259|NCT03176134|65853307|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23579260|NCT03176134|65853308|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23579261|NCT03176134|65853309|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23579262|NCT03176134|65853310|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
23579263|NCT03176134|65853311|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
23579264|NCT01417000|65853312|FG000|Overall Study|Death|59|||
23579265|NCT01417000|65853313|FG001|Overall Study|Death|28|||
23579266|NCT01417000|65853312|FG000|Overall Study|Lost to Follow-up|1|||
23579267|NCT01417000|65853313|FG001|Overall Study|Lost to Follow-up|0|||
23579268|NCT01417000|65853312|FG000|Overall Study|Study Terminated by Sponsor|1|||
23579269|NCT01417000|65853313|FG001|Overall Study|Study Terminated by Sponsor|1|||
23579270|NCT02851511|65853331|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
23579271|NCT02851511|65853332|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
23579272|NCT02851511|65853333|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
23579273|NCT02851511|65853334|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
23579274|NCT02851511|65853331|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
23579275|NCT02851511|65853332|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
23579276|NCT02851511|65853333|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
23579277|NCT02851511|65853334|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
23579278|NCT02851511|65853331|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
23232194|NCT01117428|64591851|FG005|Overall Study|Withdrawal by Subject|0|||
23232195|NCT01117428|64591846|FG000|Overall Study|Progressive disease|15|||
23232196|NCT01117428|64591847|FG001|Overall Study|Progressive disease|27|||
23232197|NCT01117428|64591848|FG002|Overall Study|Progressive disease|10|||
23232198|NCT01117428|64591849|FG003|Overall Study|Progressive disease|12|||
23232199|NCT01117428|64591850|FG004|Overall Study|Progressive disease|16|||
23232200|NCT01117428|64591851|FG005|Overall Study|Progressive disease|17|||
23232201|NCT01977040|64591852|FG000|Overall Study|Vasa previa not confirmed|2|||
23232202|NCT01277666|64591853|FG000|Overall Study|Adverse Event|26|||
23579279|NCT02851511|65853332|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
23579280|NCT02851511|65853333|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
23579281|NCT02851511|65853334|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
23232203|NCT01277666|64591854|FG001|Overall Study|Adverse Event|25|||
23232204|NCT01277666|64591855|FG002|Overall Study|Adverse Event|20|||
23232205|NCT01277666|64591853|FG000|Overall Study|Lack of Efficacy|8|||
23232206|NCT01277666|64591854|FG001|Overall Study|Lack of Efficacy|20|||
23232207|NCT01277666|64591855|FG002|Overall Study|Lack of Efficacy|12|||
23579282|NCT02851511|65853331|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
23579283|NCT02851511|65853332|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
23579284|NCT02851511|65853333|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
23579285|NCT02851511|65853334|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
23579286|NCT02851511|65853331|FG000|Phase I|Physician Decision|0|||
23579287|NCT02851511|65853332|FG001|Phase I|Physician Decision|0|||
23579288|NCT02851511|65853333|FG002|Phase I|Physician Decision|0|||
23579289|NCT02851511|65853334|FG003|Phase I|Physician Decision|1|||
23579290|NCT02851511|65853331|FG000|Phase I|Withdrawal by Subject|2|||
23579291|NCT02851511|65853332|FG001|Phase I|Withdrawal by Subject|1|||
23579292|NCT02851511|65853333|FG002|Phase I|Withdrawal by Subject|0|||
23579293|NCT02851511|65853334|FG003|Phase I|Withdrawal by Subject|3|||
23579294|NCT02851511|65853331|FG000|Phase II|Physician Decision|18|||
23232208|NCT01277666|64591853|FG000|Overall Study|Protocol Violation|2|||
23579295|NCT02851511|65853332|FG001|Phase II|Physician Decision|16|||
23579296|NCT02851511|65853333|FG002|Phase II|Physician Decision|0|||
23579297|NCT02851511|65853334|FG003|Phase II|Physician Decision|0|||
23232209|NCT01277666|64591854|FG001|Overall Study|Protocol Violation|3|||
23579298|NCT02851511|65853331|FG000|Phase II|Withdrawal by Subject|18|||
23579299|NCT02851511|65853332|FG001|Phase II|Withdrawal by Subject|16|||
23579300|NCT02851511|65853333|FG002|Phase II|Withdrawal by Subject|0|||
23172244|NCT00328627|64375655|FG002|Overall Study|Lost to Follow-up|2|||
23579301|NCT02851511|65853334|FG003|Phase II|Withdrawal by Subject|0|||
23172245|NCT00328627|64375656|FG003|Overall Study|Lost to Follow-up|4|||
23579302|NCT02851511|65853331|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
23579303|NCT02851511|65853332|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
23579304|NCT02851511|65853333|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
23579305|NCT02851511|65853334|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
23172246|NCT00328627|64375657|FG004|Overall Study|Lost to Follow-up|0|||
23172247|NCT00328627|64375658|FG005|Overall Study|Lost to Follow-up|2|||
23172248|NCT00328627|64375659|FG006|Overall Study|Lost to Follow-up|3|||
23172249|NCT00328627|64375660|FG007|Overall Study|Lost to Follow-up|0|||
23172250|NCT00328627|64375661|FG008|Overall Study|Lost to Follow-up|3|||
23172251|NCT00328627|64375662|FG009|Overall Study|Lost to Follow-up|2|||
23172252|NCT00328627|64375663|FG010|Overall Study|Lost to Follow-up|0|||
23172253|NCT00328627|64375664|FG011|Overall Study|Lost to Follow-up|1|||
23172254|NCT00328627|64375653|FG000|Overall Study|Withdrawal by Subject|5|||
23172255|NCT00328627|64375654|FG001|Overall Study|Withdrawal by Subject|4|||
23172256|NCT00328627|64375655|FG002|Overall Study|Withdrawal by Subject|5|||
23172257|NCT00328627|64375656|FG003|Overall Study|Withdrawal by Subject|6|||
23172258|NCT00328627|64375657|FG004|Overall Study|Withdrawal by Subject|2|||
23172259|NCT00328627|64375658|FG005|Overall Study|Withdrawal by Subject|5|||
23172260|NCT00328627|64375659|FG006|Overall Study|Withdrawal by Subject|4|||
23172261|NCT00328627|64375660|FG007|Overall Study|Withdrawal by Subject|4|||
23172262|NCT00328627|64375661|FG008|Overall Study|Withdrawal by Subject|4|||
23172263|NCT00328627|64375662|FG009|Overall Study|Withdrawal by Subject|5|||
23172264|NCT00328627|64375663|FG010|Overall Study|Withdrawal by Subject|2|||
23172265|NCT00328627|64375664|FG011|Overall Study|Withdrawal by Subject|7|||
23172266|NCT00328627|64375653|FG000|Overall Study|Pregnancy|0|||
23172267|NCT00328627|64375654|FG001|Overall Study|Pregnancy|1|||
23172268|NCT00328627|64375655|FG002|Overall Study|Pregnancy|0|||
23172269|NCT00328627|64375656|FG003|Overall Study|Pregnancy|0|||
23172270|NCT00328627|64375657|FG004|Overall Study|Pregnancy|0|||
23172271|NCT00328627|64375658|FG005|Overall Study|Pregnancy|0|||
23172272|NCT00328627|64375659|FG006|Overall Study|Pregnancy|0|||
23172273|NCT00328627|64375660|FG007|Overall Study|Pregnancy|0|||
23172274|NCT00328627|64375661|FG008|Overall Study|Pregnancy|0|||
23172275|NCT00328627|64375662|FG009|Overall Study|Pregnancy|0|||
23172276|NCT00328627|64375663|FG010|Overall Study|Pregnancy|0|||
23172277|NCT00328627|64375664|FG011|Overall Study|Pregnancy|0|||
23172278|NCT00328627|64375653|FG000|Overall Study|Physician Decision|4|||
23172279|NCT00328627|64375654|FG001|Overall Study|Physician Decision|3|||
23579306|NCT02851511|65853331|FG000|Phase II|Lost to Follow-up|0|||
23172280|NCT00328627|64375655|FG002|Overall Study|Physician Decision|1|||
23172281|NCT00328627|64375656|FG003|Overall Study|Physician Decision|2|||
23579307|NCT02851511|65853332|FG001|Phase II|Lost to Follow-up|1|||
23579308|NCT02851511|65853333|FG002|Phase II|Lost to Follow-up|0|||
23579309|NCT02851511|65853334|FG003|Phase II|Lost to Follow-up|0|||
23579310|NCT00871429|65853335|FG000|Overall Study|Lost to Follow-up|6|||
23579311|NCT00871429|65853335|FG000|Overall Study|Withdrawal by Subject|17|||
23579312|NCT00871429|65853335|FG000|Overall Study|Questionnaire not completed|1|||
23579313|NCT02373813|65853336|FG000|Run-In Period|Other, Not Specified|5|||
23579314|NCT02373813|65853337|FG001|Run-In Period|Other, Not Specified|0|||
23579315|NCT02373813|65853338|FG002|Run-In Period|Other, Not Specified|0|||
23579316|NCT02373813|65853339|FG003|Run-In Period|Other, Not Specified|0|||
23579317|NCT02373813|65853336|FG000|Run-In Period|Withdrawal by Subject|16|||
23232210|NCT01277666|64591855|FG002|Overall Study|Protocol Violation|2|||
23232211|NCT01277666|64591853|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
23172282|NCT00328627|64375657|FG004|Overall Study|Physician Decision|1|||
23172283|NCT00328627|64375658|FG005|Overall Study|Physician Decision|1|||
23172284|NCT00328627|64375659|FG006|Overall Study|Physician Decision|1|||
23172285|NCT00328627|64375660|FG007|Overall Study|Physician Decision|0|||
23172286|NCT00328627|64375661|FG008|Overall Study|Physician Decision|3|||
23172287|NCT00328627|64375662|FG009|Overall Study|Physician Decision|2|||
23172288|NCT00328627|64375663|FG010|Overall Study|Physician Decision|1|||
23172289|NCT00328627|64375664|FG011|Overall Study|Physician Decision|0|||
23172290|NCT00328627|64375653|FG000|Overall Study|Other|0|||
23172291|NCT00328627|64375654|FG001|Overall Study|Other|0|||
23172292|NCT00328627|64375655|FG002|Overall Study|Other|0|||
23172293|NCT00328627|64375656|FG003|Overall Study|Other|1|||
23172294|NCT00328627|64375657|FG004|Overall Study|Other|0|||
23172295|NCT00328627|64375658|FG005|Overall Study|Other|0|||
23172296|NCT00328627|64375659|FG006|Overall Study|Other|1|||
23172297|NCT00328627|64375660|FG007|Overall Study|Other|0|||
23232212|NCT01277666|64591854|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
23579318|NCT02373813|65853337|FG001|Run-In Period|Withdrawal by Subject|0|||
23579319|NCT02373813|65853338|FG002|Run-In Period|Withdrawal by Subject|0|||
23579320|NCT02373813|65853339|FG003|Run-In Period|Withdrawal by Subject|0|||
23172298|NCT00328627|64375661|FG008|Overall Study|Other|0|||
23172299|NCT00328627|64375662|FG009|Overall Study|Other|1|||
23172300|NCT00328627|64375663|FG010|Overall Study|Other|1|||
23172301|NCT00328627|64375664|FG011|Overall Study|Other|0|||
23172302|NCT02543528|64375665|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
23232213|NCT01277666|64591855|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
23232214|NCT01277666|64591853|FG000|Overall Study|Lost to Follow-up|1|||
23232215|NCT01277666|64591854|FG001|Overall Study|Lost to Follow-up|1|||
23232216|NCT01277666|64591855|FG002|Overall Study|Lost to Follow-up|2|||
23232217|NCT01277666|64591853|FG000|Overall Study|Withdrawal by Subject|7|||
23232218|NCT01277666|64591854|FG001|Overall Study|Withdrawal by Subject|8|||
23232219|NCT01277666|64591855|FG002|Overall Study|Withdrawal by Subject|6|||
23232220|NCT01277666|64591853|FG000|Overall Study|Death|0|||
23232221|NCT01277666|64591854|FG001|Overall Study|Death|0|||
23232222|NCT01277666|64591855|FG002|Overall Study|Death|1|||
23232223|NCT02354690|64591864|FG000|Overall Study|Physician Decision|1|||
23232224|NCT00829010|64591865|FG000|Overall Study|Adverse Event|1|||
23232225|NCT00829010|64591866|FG001|Overall Study|Adverse Event|0|||
23232226|NCT00829010|64591867|FG002|Overall Study|Adverse Event|0|||
23232227|NCT00829010|64591868|FG003|Overall Study|Adverse Event|0|||
23232228|NCT00829010|64591869|FG004|Overall Study|Adverse Event|0|||
23232229|NCT00829010|64591865|FG000|Overall Study|Withdrawal by Subject|0|||
23232230|NCT00829010|64591866|FG001|Overall Study|Withdrawal by Subject|1|||
23232231|NCT00829010|64591867|FG002|Overall Study|Withdrawal by Subject|1|||
23232232|NCT00829010|64591868|FG003|Overall Study|Withdrawal by Subject|0|||
23232233|NCT00829010|64591869|FG004|Overall Study|Withdrawal by Subject|2|||
23232234|NCT00829010|64591865|FG000|Overall Study|Lost to Follow-up|1|||
23232235|NCT00829010|64591866|FG001|Overall Study|Lost to Follow-up|0|||
23232236|NCT00829010|64591867|FG002|Overall Study|Lost to Follow-up|2|||
23232237|NCT00829010|64591868|FG003|Overall Study|Lost to Follow-up|0|||
23232238|NCT00829010|64591869|FG004|Overall Study|Lost to Follow-up|0|||
23232239|NCT00829010|64591865|FG000|Overall Study|Fatality|5|||
23232240|NCT00829010|64591866|FG001|Overall Study|Fatality|4|||
23232241|NCT00829010|64591867|FG002|Overall Study|Fatality|0|||
23232242|NCT00829010|64591868|FG003|Overall Study|Fatality|3|||
23232243|NCT00829010|64591869|FG004|Overall Study|Fatality|0|||
23232244|NCT00829010|64591865|FG000|Overall Study|Migrated/Moved from study area|3|||
23232245|NCT00829010|64591866|FG001|Overall Study|Migrated/Moved from study area|4|||
23232246|NCT00829010|64591867|FG002|Overall Study|Migrated/Moved from study area|0|||
23232247|NCT00829010|64591868|FG003|Overall Study|Migrated/Moved from study area|5|||
23232248|NCT00829010|64591869|FG004|Overall Study|Migrated/Moved from study area|0|||
23232249|NCT00305773|64591874|FG000|Overall Study|Death|3|||
23232250|NCT00305773|64591875|FG001|Overall Study|Death|2|||
23232251|NCT00305773|64591874|FG000|Overall Study|Adverse Event|1|||
23232252|NCT00305773|64591875|FG001|Overall Study|Adverse Event|2|||
23339341|NCT01343277|64986156|FG000|Overall Study|Death|10|||
23339342|NCT01343277|64986157|FG001|Overall Study|Death|1|||
23339343|NCT01343277|64986156|FG000|Overall Study|Adverse Event|67|||
23339344|NCT01343277|64986157|FG001|Overall Study|Adverse Event|13|||
23339345|NCT01343277|64986156|FG000|Overall Study|Disease progression|270|||
23339346|NCT01343277|64986157|FG001|Overall Study|Disease progression|138|||
23339347|NCT01343277|64986156|FG000|Overall Study|Randomized not treated|6|||
23339348|NCT01343277|64986157|FG001|Overall Study|Randomized not treated|21|||
23339349|NCT01343277|64986156|FG000|Overall Study|Treatment ongoing|8|||
23339350|NCT01343277|64986157|FG001|Overall Study|Treatment ongoing|2|||
23339351|NCT01343277|64986156|FG000|Overall Study|Subsequent anticancer therapy|1|||
23339352|NCT01343277|64986157|FG001|Overall Study|Subsequent anticancer therapy|0|||
23339353|NCT02833844|64986165|FG000|Double-Blind Period|Withdrawal by Subject|2|||
23339354|NCT02833844|64986166|FG001|Double-Blind Period|Withdrawal by Subject|3|||
23339355|NCT02833844|64986165|FG000|Double-Blind Period|Protocol Violation|0|||
23339356|NCT02833844|64986166|FG001|Double-Blind Period|Protocol Violation|4|||
23339357|NCT02833844|64986165|FG000|Open-Label Period|Death|0|||
23579321|NCT02373813|65853336|FG000|Run-In Period|Decision by Sponsor|11|||
23232253|NCT00305773|64591874|FG000|Overall Study|Alternative Treatment|4|||
23232254|NCT00305773|64591875|FG001|Overall Study|Alternative Treatment|4|||
23232255|NCT00305773|64591874|FG000|Overall Study|Physician Decision|1|||
23232256|NCT00305773|64591875|FG001|Overall Study|Physician Decision|1|||
23232257|NCT00305773|64591874|FG000|Overall Study|Withdrawal by Subject|1|||
23232258|NCT00305773|64591875|FG001|Overall Study|Withdrawal by Subject|4|||
23232259|NCT00305773|64591874|FG000|Overall Study|Disease Progression|1|||
23232260|NCT00305773|64591875|FG001|Overall Study|Disease Progression|3|||
23232261|NCT00305773|64591874|FG000|Overall Study|All other reasons|3|||
23232262|NCT00305773|64591875|FG001|Overall Study|All other reasons|2|||
23232263|NCT01562327|64591876|FG000|Overall Study|Adverse Event|2|||
23232264|NCT01562327|64591876|FG000|Overall Study|Lack of Efficacy|1|||
23232265|NCT01562327|64591876|FG000|Overall Study|Participant drop-out|1|||
23339358|NCT02833844|64986166|FG001|Open-Label Period|Death|2|||
23339359|NCT02833844|64986165|FG000|Open-Label Period|Lost to Follow-up|1|||
23232266|NCT01562327|64591876|FG000|Overall Study|Infusion not received at 6 month window|4|||
23232267|NCT02646891|64591877|FG000|Overall Study|Adverse Event|0|||
23232268|NCT02646891|64591878|FG001|Overall Study|Adverse Event|1|||
23232269|NCT02646891|64591879|FG002|Overall Study|Adverse Event|0|||
23339360|NCT02833844|64986166|FG001|Open-Label Period|Lost to Follow-up|0|||
23579322|NCT02373813|65853337|FG001|Run-In Period|Decision by Sponsor|0|||
23232270|NCT02646891|64591880|FG003|Overall Study|Adverse Event|0|||
23232271|NCT02646891|64591881|FG004|Overall Study|Adverse Event|0|||
23232272|NCT02646891|64591882|FG005|Overall Study|Adverse Event|0|||
23232273|NCT02646891|64591883|FG006|Overall Study|Adverse Event|0|||
23232274|NCT02646891|64591884|FG007|Overall Study|Adverse Event|0|||
23232275|NCT02646891|64591885|FG008|Overall Study|Adverse Event|0|||
23232276|NCT02646891|64591886|FG009|Overall Study|Adverse Event|0|||
23232277|NCT02646891|64591877|FG000|Overall Study|Lost to Follow-up|0|||
23232278|NCT02646891|64591878|FG001|Overall Study|Lost to Follow-up|0|||
23232279|NCT02646891|64591879|FG002|Overall Study|Lost to Follow-up|0|||
23232280|NCT02646891|64591880|FG003|Overall Study|Lost to Follow-up|0|||
23232281|NCT02646891|64591881|FG004|Overall Study|Lost to Follow-up|0|||
23232282|NCT02646891|64591882|FG005|Overall Study|Lost to Follow-up|0|||
23232283|NCT02646891|64591883|FG006|Overall Study|Lost to Follow-up|2|||
23232284|NCT02646891|64591884|FG007|Overall Study|Lost to Follow-up|2|||
23232285|NCT02646891|64591885|FG008|Overall Study|Lost to Follow-up|2|||
23232286|NCT02646891|64591886|FG009|Overall Study|Lost to Follow-up|2|||
23232287|NCT02646891|64591877|FG000|Overall Study|Protocol Violation|0|||
23232288|NCT02646891|64591878|FG001|Overall Study|Protocol Violation|0|||
23232289|NCT02646891|64591879|FG002|Overall Study|Protocol Violation|0|||
23232290|NCT02646891|64591880|FG003|Overall Study|Protocol Violation|0|||
23232291|NCT02646891|64591881|FG004|Overall Study|Protocol Violation|0|||
23232292|NCT02646891|64591882|FG005|Overall Study|Protocol Violation|0|||
23232293|NCT02646891|64591883|FG006|Overall Study|Protocol Violation|1|||
23232294|NCT02646891|64591884|FG007|Overall Study|Protocol Violation|1|||
23232295|NCT02646891|64591885|FG008|Overall Study|Protocol Violation|0|||
23232296|NCT02646891|64591886|FG009|Overall Study|Protocol Violation|0|||
23232297|NCT02646891|64591877|FG000|Overall Study|Withdrawal by Subject|2|||
23232298|NCT02646891|64591878|FG001|Overall Study|Withdrawal by Subject|0|||
23232299|NCT02646891|64591879|FG002|Overall Study|Withdrawal by Subject|1|||
23232300|NCT02646891|64591880|FG003|Overall Study|Withdrawal by Subject|0|||
23232301|NCT02646891|64591881|FG004|Overall Study|Withdrawal by Subject|0|||
23232302|NCT02646891|64591882|FG005|Overall Study|Withdrawal by Subject|0|||
23232303|NCT02646891|64591883|FG006|Overall Study|Withdrawal by Subject|5|||
23232304|NCT02646891|64591884|FG007|Overall Study|Withdrawal by Subject|9|||
23232305|NCT02646891|64591885|FG008|Overall Study|Withdrawal by Subject|7|||
23232306|NCT02646891|64591886|FG009|Overall Study|Withdrawal by Subject|3|||
23232307|NCT02646891|64591877|FG000|Overall Study|Death|0|||
23232308|NCT02646891|64591878|FG001|Overall Study|Death|0|||
23232309|NCT02646891|64591879|FG002|Overall Study|Death|0|||
23232310|NCT02646891|64591880|FG003|Overall Study|Death|0|||
23232311|NCT02646891|64591881|FG004|Overall Study|Death|0|||
23232312|NCT02646891|64591882|FG005|Overall Study|Death|0|||
23232313|NCT02646891|64591883|FG006|Overall Study|Death|1|||
23232314|NCT02646891|64591884|FG007|Overall Study|Death|1|||
23232315|NCT02646891|64591885|FG008|Overall Study|Death|1|||
23232316|NCT02646891|64591886|FG009|Overall Study|Death|0|||
23232317|NCT02499172|64591892|FG000|Overall Study|Financial reason|0|||
23232318|NCT02499172|64591893|FG001|Overall Study|Financial reason|0|||
23232319|NCT02499172|64591894|FG002|Overall Study|Financial reason|523|||
23232320|NCT02499172|64591895|FG003|Overall Study|Financial reason|436|||
23232321|NCT02499172|64591892|FG000|Overall Study|Lost to Follow-up|65|||
23232322|NCT02499172|64591893|FG001|Overall Study|Lost to Follow-up|64|||
23232323|NCT02499172|64591894|FG002|Overall Study|Lost to Follow-up|0|||
23232324|NCT02499172|64591895|FG003|Overall Study|Lost to Follow-up|0|||
23232325|NCT03055806|64591904|FG000|Overall Study|Adverse Event|0|||
23232326|NCT03055806|64591905|FG001|Overall Study|Adverse Event|0|||
23339361|NCT02833844|64986165|FG000|Open-Label Period|Withdrawal by Subject|1|||
23232327|NCT03055806|64591906|FG002|Overall Study|Adverse Event|1|||
23232328|NCT03055806|64591907|FG003|Overall Study|Adverse Event|1|||
23232329|NCT03055806|64591904|FG000|Overall Study|Lost to Follow-up|0|||
23232330|NCT03055806|64591905|FG001|Overall Study|Lost to Follow-up|3|||
23232331|NCT03055806|64591906|FG002|Overall Study|Lost to Follow-up|6|||
23232332|NCT03055806|64591907|FG003|Overall Study|Lost to Follow-up|7|||
23232333|NCT03055806|64591904|FG000|Overall Study|Physician Decision|1|||
23232334|NCT03055806|64591905|FG001|Overall Study|Physician Decision|0|||
23232335|NCT03055806|64591906|FG002|Overall Study|Physician Decision|0|||
23232336|NCT03055806|64591907|FG003|Overall Study|Physician Decision|1|||
23232337|NCT03055806|64591904|FG000|Overall Study|Protocol Violation|1|||
23232338|NCT03055806|64591905|FG001|Overall Study|Protocol Violation|0|||
23232339|NCT03055806|64591906|FG002|Overall Study|Protocol Violation|0|||
23232340|NCT03055806|64591907|FG003|Overall Study|Protocol Violation|0|||
23232341|NCT03055806|64591904|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
23339362|NCT02833844|64986166|FG001|Open-Label Period|Withdrawal by Subject|0|||
23579323|NCT02373813|65853338|FG002|Run-In Period|Decision by Sponsor|0|||
23232342|NCT03055806|64591905|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
23232343|NCT03055806|64591906|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
23232344|NCT03055806|64591907|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
23232345|NCT03055806|64591904|FG000|Overall Study|Withdrawal of consent to continue study|2|||
23232346|NCT03055806|64591905|FG001|Overall Study|Withdrawal of consent to continue study|3|||
23232347|NCT03055806|64591906|FG002|Overall Study|Withdrawal of consent to continue study|4|||
23232348|NCT03055806|64591907|FG003|Overall Study|Withdrawal of consent to continue study|6|||
23232349|NCT03055806|64591904|FG000|Overall Study|Partner not willing to try intercourse|1|||
23232350|NCT03055806|64591905|FG001|Overall Study|Partner not willing to try intercourse|0|||
23232351|NCT03055806|64591906|FG002|Overall Study|Partner not willing to try intercourse|0|||
23232352|NCT03055806|64591907|FG003|Overall Study|Partner not willing to try intercourse|0|||
23232353|NCT00917553|64591908|FG000|Overall Study|Lost to Follow-up|2|||
23232354|NCT00917553|64591909|FG001|Overall Study|Lost to Follow-up|1|||
23232355|NCT00606021|64591912|FG000|Induction Phase|Death|73|||
23232356|NCT00606021|64591913|FG001|Induction Phase|Death|0|||
23232357|NCT00606021|64591914|FG002|Induction Phase|Death|0|||
23232358|NCT00606021|64591912|FG000|Induction Phase|Physician Decision|2|||
23232359|NCT00606021|64591913|FG001|Induction Phase|Physician Decision|0|||
23232360|NCT00606021|64591914|FG002|Induction Phase|Physician Decision|0|||
23232361|NCT00606021|64591912|FG000|Induction Phase|Withdrawal by Subject|2|||
23232362|NCT00606021|64591913|FG001|Induction Phase|Withdrawal by Subject|0|||
23232363|NCT00606021|64591914|FG002|Induction Phase|Withdrawal by Subject|0|||
23232364|NCT00606021|64591912|FG000|Induction Phase|Lost to Follow-up|10|||
23232365|NCT00606021|64591913|FG001|Induction Phase|Lost to Follow-up|0|||
23232366|NCT00606021|64591914|FG002|Induction Phase|Lost to Follow-up|0|||
23232367|NCT00606021|64591912|FG000|Maintenance Phase|Death|0|||
23232368|NCT00606021|64591913|FG001|Maintenance Phase|Death|17|||
23232369|NCT00606021|64591914|FG002|Maintenance Phase|Death|15|||
23232370|NCT00606021|64591912|FG000|Maintenance Phase|Physician Decision|0|||
23232371|NCT00606021|64591913|FG001|Maintenance Phase|Physician Decision|1|||
23232372|NCT00606021|64591914|FG002|Maintenance Phase|Physician Decision|0|||
23232373|NCT00606021|64591912|FG000|Maintenance Phase|Lost to Follow-up|0|||
23232374|NCT00606021|64591913|FG001|Maintenance Phase|Lost to Follow-up|5|||
23232375|NCT00606021|64591914|FG002|Maintenance Phase|Lost to Follow-up|2|||
23232376|NCT02611037|64591915|FG000|Overall Study|Withdrawal prior to treatment|2|||
23232377|NCT02611037|64591916|FG001|Overall Study|Withdrawal prior to treatment|0|||
23232378|NCT00440232|64591917|FG000|Overall Study|Lost to Follow-up|1|||
23232379|NCT00440232|64591918|FG001|Overall Study|Lost to Follow-up|1|||
23232380|NCT00440232|64591917|FG000|Overall Study|Unable to treat within allowed time|0|||
23232381|NCT00440232|64591918|FG001|Overall Study|Unable to treat within allowed time|1|||
23232382|NCT00440232|64591917|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
23339363|NCT01953601|64986167|FG000|Part 1 (Base Study)|Adverse Event|24|||
23339364|NCT01953601|64986168|FG001|Part 1 (Base Study)|Adverse Event|37|||
23339365|NCT01953601|64986169|FG002|Part 1 (Base Study)|Adverse Event|15|||
23339366|NCT01953601|64986167|FG000|Part 1 (Base Study)|Death|2|||
23339367|NCT01953601|64986168|FG001|Part 1 (Base Study)|Death|0|||
23339368|NCT01953601|64986169|FG002|Part 1 (Base Study)|Death|3|||
23339369|NCT01953601|64986167|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
23339370|NCT01953601|64986168|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
23339371|NCT01953601|64986169|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
23339372|NCT01953601|64986167|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
23339373|NCT01953601|64986168|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
23339374|NCT01953601|64986169|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
23339375|NCT01953601|64986167|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
23339376|NCT01953601|64986168|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
23339377|NCT01953601|64986169|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
23339378|NCT01953601|64986167|FG000|Part 1 (Base Study)|Physician Decision|3|||
23339379|NCT01953601|64986168|FG001|Part 1 (Base Study)|Physician Decision|7|||
23339380|NCT01953601|64986169|FG002|Part 1 (Base Study)|Physician Decision|4|||
23232383|NCT00440232|64591918|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
23232384|NCT01796106|64591919|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
23232385|NCT01796106|64591920|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
23232386|NCT01078974|64591921|FG000|Overall Study|Adverse Event|3|||
23232387|NCT02993731|64591923|FG000|Overall Study|Study Termination|101|||
23232388|NCT02993731|64591924|FG001|Overall Study|Study Termination|105|||
23232389|NCT02364999|64591929|FG000|Overall Study|Death|136|||
23232390|NCT02364999|64591930|FG001|Overall Study|Death|138|||
23232391|NCT02364999|64591929|FG000|Overall Study|Lost to Follow-up|10|||
23232392|NCT02364999|64591930|FG001|Overall Study|Lost to Follow-up|15|||
23232393|NCT02364999|64591929|FG000|Overall Study|Protocol Violation|3|||
23232394|NCT02364999|64591930|FG001|Overall Study|Protocol Violation|2|||
23232395|NCT02364999|64591929|FG000|Overall Study|Withdrawal by Subject|14|||
23232396|NCT02364999|64591930|FG001|Overall Study|Withdrawal by Subject|14|||
23339381|NCT01953601|64986167|FG000|Part 1 (Base Study)|Screen failure|1|||
23339382|NCT01953601|64986168|FG001|Part 1 (Base Study)|Screen failure|0|||
23339383|NCT01953601|64986169|FG002|Part 1 (Base Study)|Screen failure|1|||
23232397|NCT02364999|64591929|FG000|Overall Study|Other|0|||
23232398|NCT02364999|64591930|FG001|Overall Study|Other|1|||
23339384|NCT01953601|64986167|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
23579324|NCT02373813|65853339|FG003|Run-In Period|Decision by Sponsor|0|||
23579325|NCT02373813|65853336|FG000|Run-In Period|Protocol Violation|75|||
23579326|NCT02373813|65853337|FG001|Run-In Period|Protocol Violation|0|||
23579327|NCT02373813|65853338|FG002|Run-In Period|Protocol Violation|0|||
23579328|NCT02373813|65853339|FG003|Run-In Period|Protocol Violation|0|||
23579329|NCT02373813|65853336|FG000|Run-In Period|Lost to Follow-up|2|||
23579330|NCT02373813|65853337|FG001|Run-In Period|Lost to Follow-up|0|||
23579331|NCT02373813|65853338|FG002|Run-In Period|Lost to Follow-up|0|||
23579332|NCT02373813|65853339|FG003|Run-In Period|Lost to Follow-up|0|||
23579333|NCT02373813|65853336|FG000|Run-In Period|Adverse Event|3|||
23172303|NCT02543528|64375666|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
23172304|NCT02543528|64375667|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
23172305|NCT02543528|64375668|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
23172306|NCT02543528|64375669|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
23172307|NCT02543528|64375665|FG000|Adaptation Period|Lens Handling Difficultes|0|||
23172308|NCT02543528|64375666|FG001|Adaptation Period|Lens Handling Difficultes|0|||
23172309|NCT02543528|64375667|FG002|Adaptation Period|Lens Handling Difficultes|0|||
23172310|NCT02543528|64375668|FG003|Adaptation Period|Lens Handling Difficultes|0|||
23172311|NCT02543528|64375669|FG004|Adaptation Period|Lens Handling Difficultes|8|||
23172312|NCT02543528|64375665|FG000|Adaptation Period|Lost to Follow-up|0|||
23172313|NCT02543528|64375666|FG001|Adaptation Period|Lost to Follow-up|0|||
23172314|NCT02543528|64375667|FG002|Adaptation Period|Lost to Follow-up|0|||
23172315|NCT02543528|64375668|FG003|Adaptation Period|Lost to Follow-up|0|||
23172316|NCT02543528|64375669|FG004|Adaptation Period|Lost to Follow-up|14|||
23172317|NCT02543528|64375665|FG000|Adaptation Period|Adverse Event|0|||
23172318|NCT02543528|64375666|FG001|Adaptation Period|Adverse Event|0|||
23172319|NCT02543528|64375667|FG002|Adaptation Period|Adverse Event|0|||
23172320|NCT02543528|64375668|FG003|Adaptation Period|Adverse Event|0|||
23172321|NCT02543528|64375669|FG004|Adaptation Period|Adverse Event|2|||
23172322|NCT02543528|64375665|FG000|Extended Wear Period|Adverse Event|17|||
23172323|NCT02543528|64375666|FG001|Extended Wear Period|Adverse Event|11|||
23172324|NCT02543528|64375667|FG002|Extended Wear Period|Adverse Event|16|||
23172325|NCT02543528|64375668|FG003|Extended Wear Period|Adverse Event|3|||
23172326|NCT02543528|64375669|FG004|Extended Wear Period|Adverse Event|0|||
23172327|NCT02543528|64375665|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
23172328|NCT02543528|64375666|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
23172329|NCT02543528|64375667|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
23172330|NCT02543528|64375668|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
23172331|NCT02543528|64375669|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
23172332|NCT02543528|64375665|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
23172333|NCT02543528|64375666|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
23172334|NCT02543528|64375667|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
23172335|NCT02543528|64375668|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
23172336|NCT02543528|64375669|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
23172337|NCT02543528|64375665|FG000|Extended Wear Period|Lost to Follow-up|0|||
23172338|NCT02543528|64375666|FG001|Extended Wear Period|Lost to Follow-up|1|||
23172339|NCT02543528|64375667|FG002|Extended Wear Period|Lost to Follow-up|2|||
23172340|NCT02543528|64375668|FG003|Extended Wear Period|Lost to Follow-up|1|||
23172341|NCT02543528|64375669|FG004|Extended Wear Period|Lost to Follow-up|0|||
23172342|NCT02543528|64375665|FG000|Extended Wear Period|Withdrawal by Subject|10|||
23172343|NCT02543528|64375666|FG001|Extended Wear Period|Withdrawal by Subject|9|||
23172344|NCT02543528|64375667|FG002|Extended Wear Period|Withdrawal by Subject|4|||
23172345|NCT02543528|64375668|FG003|Extended Wear Period|Withdrawal by Subject|5|||
23172346|NCT02543528|64375669|FG004|Extended Wear Period|Withdrawal by Subject|0|||
23172347|NCT00382993|64375672|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
23172348|NCT00382993|64375673|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
23172349|NCT00382993|64375672|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
23172350|NCT00382993|64375673|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
23172351|NCT00382993|64375672|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
23232399|NCT02364999|64591929|FG000|Overall Study|Randomized but did not receive treatment|2|||
23232400|NCT02364999|64591930|FG001|Overall Study|Randomized but did not receive treatment|3|||
23232401|NCT02909504|64591931|FG000|Overall Study|Adverse Event|2|||
23172352|NCT00382993|64375673|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
23172353|NCT00382993|64375672|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
23172354|NCT00382993|64375673|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
23172355|NCT00382993|64375672|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
23232402|NCT02909504|64591931|FG000|Overall Study|Lack of Efficacy|3|||
23232403|NCT02909504|64591931|FG000|Overall Study|Withdrawal by Subject|4|||
23232404|NCT02909504|64591931|FG000|Overall Study|Pregnancy|1|||
23579334|NCT02373813|65853337|FG001|Run-In Period|Adverse Event|0|||
23579335|NCT02373813|65853338|FG002|Run-In Period|Adverse Event|0|||
23579336|NCT02373813|65853339|FG003|Run-In Period|Adverse Event|0|||
23579337|NCT02373813|65853336|FG000|Run-In Period|Noncompliance|1|||
23232405|NCT02909504|64591931|FG000|Overall Study|Subject moved|1|||
23339385|NCT01953601|64986168|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
23339386|NCT01953601|64986169|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
23339387|NCT01953601|64986167|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
23339388|NCT01953601|64986168|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
23339389|NCT01953601|64986169|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
23339390|NCT01953601|64986167|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
23339391|NCT01953601|64986168|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
23339392|NCT01953601|64986169|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
23339393|NCT01953601|64986167|FG000|Part 1 (Base Study)|Subject moved|2|||
23339394|NCT01953601|64986168|FG001|Part 1 (Base Study)|Subject moved|2|||
23579338|NCT02373813|65853337|FG001|Run-In Period|Noncompliance|0|||
23579339|NCT02373813|65853338|FG002|Run-In Period|Noncompliance|0|||
23339395|NCT01953601|64986169|FG002|Part 1 (Base Study)|Subject moved|1|||
23339396|NCT01953601|64986167|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
23579340|NCT02373813|65853339|FG003|Run-In Period|Noncompliance|0|||
23579341|NCT02373813|65853336|FG000|Run-In Period|Ineligibility Determined|3|||
23339397|NCT01953601|64986168|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
23339398|NCT01953601|64986169|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
23339399|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Adverse Event|1|||
23339400|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Adverse Event|1|||
23339401|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Adverse Event|10|||
23339402|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Death|0|||
23339403|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Death|3|||
23339404|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Death|0|||
23339405|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
23339406|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
23451171|NCT02485691|65395124|FG000|Overall Study|Adverse Event|25|||
23172356|NCT00382993|64375673|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
23172357|NCT00382993|64375672|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
23172358|NCT00382993|64375673|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
23172359|NCT00382993|64375672|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
23172360|NCT00382993|64375673|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
23172361|NCT00382993|64375672|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
23172362|NCT00382993|64375673|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
23172363|NCT00382993|64375672|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
23172364|NCT00382993|64375673|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
23172365|NCT00382993|64375672|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
23172366|NCT00382993|64375673|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
23172367|NCT00608985|64375674|FG000|Overall Study|Adverse Event|2|||
23172368|NCT00608985|64375675|FG001|Overall Study|Adverse Event|7|||
23172369|NCT00608985|64375676|FG002|Overall Study|Adverse Event|4|||
23172370|NCT00608985|64375677|FG003|Overall Study|Adverse Event|6|||
23172371|NCT00608985|64375674|FG000|Overall Study|Administrative/Other|7|||
23172372|NCT00608985|64375675|FG001|Overall Study|Administrative/Other|4|||
23172373|NCT00608985|64375676|FG002|Overall Study|Administrative/Other|1|||
23172374|NCT00608985|64375677|FG003|Overall Study|Administrative/Other|2|||
23172375|NCT00608985|64375674|FG000|Overall Study|Withdrawal of Consent|5|||
23172376|NCT00608985|64375675|FG001|Overall Study|Withdrawal of Consent|1|||
23172377|NCT00608985|64375676|FG002|Overall Study|Withdrawal of Consent|1|||
23172378|NCT00608985|64375677|FG003|Overall Study|Withdrawal of Consent|1|||
23172379|NCT00608985|64375674|FG000|Overall Study|Lost to Follow-up|2|||
23172380|NCT00608985|64375675|FG001|Overall Study|Lost to Follow-up|1|||
23172381|NCT00608985|64375676|FG002|Overall Study|Lost to Follow-up|0|||
23172382|NCT00608985|64375677|FG003|Overall Study|Lost to Follow-up|0|||
23172383|NCT00293579|64375678|FG000|Overall Study|Withdrawal by Subject|1|||
23172384|NCT00573794|64375680|FG000|Overall Study|Adverse Event|81|||
23172385|NCT00573794|64375680|FG000|Overall Study|Withdrew Consent|90|||
23172386|NCT00573794|64375680|FG000|Overall Study|Lost to Follow-up|13|||
23172387|NCT00573794|64375680|FG000|Overall Study|Protocol Violation|6|||
23172388|NCT00573794|64375680|FG000|Overall Study|Lack of Efficacy|94|||
23172389|NCT00573794|64375680|FG000|Overall Study|Other|46|||
23172390|NCT03213366|64375681|FG000|Overall Study|Lost to Follow-up|9|||
23172391|NCT03213366|64375682|FG001|Overall Study|Lost to Follow-up|4|||
23172392|NCT01707693|64375683|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
23172393|NCT01707693|64375684|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
23579342|NCT02373813|65853337|FG001|Run-In Period|Ineligibility Determined|0|||
23172394|NCT01707693|64375683|FG000|Overall Study Allocation|Protocol Violation|4|||
23172395|NCT01707693|64375684|FG001|Overall Study Allocation|Protocol Violation|3|||
23172396|NCT01707693|64375683|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
23172397|NCT01707693|64375684|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
23172398|NCT01707693|64375683|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
23339407|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
23451172|NCT02485691|65395125|FG001|Overall Study|Adverse Event|11|||
23339408|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
23339409|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
23339410|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
23339411|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Physician Decision|2|||
23339412|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Physician Decision|0|||
23339413|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Physician Decision|2|||
23339414|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
23339415|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
23339416|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
23339417|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
23339418|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
23339419|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
23339420|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
23339421|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
23339422|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
23339423|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Subject moved|0|||
23339424|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Subject moved|0|||
23339425|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Subject moved|1|||
23339426|NCT01953601|64986167|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
23339427|NCT01953601|64986168|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
23339428|NCT01953601|64986169|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
23339429|NCT01893281|64986172|FG000|Overall Study|Adverse Event|1|||
23579343|NCT02373813|65853338|FG002|Run-In Period|Ineligibility Determined|0|||
23579344|NCT02373813|65853339|FG003|Run-In Period|Ineligibility Determined|0|||
23579345|NCT02373813|65853336|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
23172399|NCT01707693|64375684|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
23172400|NCT01847885|64375687|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
23172401|NCT01847885|64375688|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
23172402|NCT01847885|64375689|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
23172403|NCT01847885|64375687|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
23172404|NCT01847885|64375688|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
23172405|NCT01847885|64375689|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
23172406|NCT01847885|64375687|FG000|Initial Enrollment (Consented)|Screen failure|39|||
23172407|NCT01847885|64375688|FG001|Initial Enrollment (Consented)|Screen failure|0|||
23172408|NCT01847885|64375689|FG002|Initial Enrollment (Consented)|Screen failure|0|||
23172409|NCT01847885|64375687|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
23172410|NCT01847885|64375688|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
23172411|NCT01847885|64375689|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
23172412|NCT01847885|64375687|FG000|Randomization|Protocol Violation|0|||
23172413|NCT01847885|64375688|FG001|Randomization|Protocol Violation|1|||
23172414|NCT01847885|64375689|FG002|Randomization|Protocol Violation|0|||
23172415|NCT01847885|64375687|FG000|Randomization|Withdrawal by Subject|0|||
23172416|NCT01847885|64375688|FG001|Randomization|Withdrawal by Subject|0|||
23172417|NCT01847885|64375689|FG002|Randomization|Withdrawal by Subject|2|||
23172418|NCT01847885|64375687|FG000|Randomization|Screen Failure|0|||
23172419|NCT01847885|64375688|FG001|Randomization|Screen Failure|3|||
23172420|NCT01847885|64375689|FG002|Randomization|Screen Failure|0|||
23172421|NCT00725075|64375690|FG000|Overall Study|Use of Excluded Medication|0|||
23172422|NCT00725075|64375691|FG001|Overall Study|Use of Excluded Medication|1|||
23172423|NCT00725075|64375692|FG002|Overall Study|Use of Excluded Medication|0|||
23172424|NCT00725075|64375690|FG000|Overall Study|Protocol Violation|0|||
23172425|NCT00725075|64375691|FG001|Overall Study|Protocol Violation|0|||
23172426|NCT00725075|64375692|FG002|Overall Study|Protocol Violation|1|||
23172427|NCT00725075|64375690|FG000|Overall Study|Lost to Follow-up|1|||
23172428|NCT00725075|64375691|FG001|Overall Study|Lost to Follow-up|0|||
23172429|NCT00725075|64375692|FG002|Overall Study|Lost to Follow-up|0|||
23172430|NCT00725075|64375690|FG000|Overall Study|Withdrawal by Subject|4|||
23172431|NCT00725075|64375691|FG001|Overall Study|Withdrawal by Subject|5|||
23172432|NCT00725075|64375692|FG002|Overall Study|Withdrawal by Subject|4|||
23172433|NCT00725075|64375690|FG000|Overall Study|Adverse Event|2|||
23172434|NCT00725075|64375691|FG001|Overall Study|Adverse Event|1|||
23172435|NCT00725075|64375692|FG002|Overall Study|Adverse Event|1|||
23172436|NCT00725075|64375690|FG000|Overall Study|Worsening of Disease|2|||
23172437|NCT00725075|64375691|FG001|Overall Study|Worsening of Disease|1|||
23172438|NCT00725075|64375692|FG002|Overall Study|Worsening of Disease|2|||
23172439|NCT00725075|64375690|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
23172440|NCT00725075|64375691|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
23172441|NCT00725075|64375692|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
23172442|NCT00725075|64375690|FG000|Overall Study|Other|1|||
23172443|NCT00725075|64375691|FG001|Overall Study|Other|0|||
23172444|NCT00725075|64375692|FG002|Overall Study|Other|0|||
23172445|NCT01784861|64375693|FG000|Overall Study|Adverse Event|0|||
23339430|NCT01893281|64986172|FG000|Overall Study|Protocol Violation|1|||
23451173|NCT02485691|65395124|FG000|Overall Study|Poor compliance to protocol|0|||
23451174|NCT02485691|65395125|FG001|Overall Study|Poor compliance to protocol|1|||
23451175|NCT02485691|65395124|FG000|Overall Study|Disease progression|57|||
23451176|NCT02485691|65395125|FG001|Overall Study|Disease progression|92|||
23451177|NCT02485691|65395124|FG000|Overall Study|Investigator's decision|23|||
23451178|NCT02485691|65395125|FG001|Overall Study|Investigator's decision|5|||
23451179|NCT02485691|65395124|FG000|Overall Study|Participant's request|13|||
23451180|NCT02485691|65395125|FG001|Overall Study|Participant's request|6|||
23451181|NCT02485691|65395124|FG000|Overall Study|Other reason|8|||
23451182|NCT02485691|65395125|FG001|Overall Study|Other reason|9|||
23451183|NCT02485691|65395124|FG000|Overall Study|Randomized and not treated|3|||
23451184|NCT02485691|65395125|FG001|Overall Study|Randomized and not treated|2|||
23451185|NCT00346216|65395127|FG000|Overall Study|Other|181|||
23451186|NCT00346216|65395128|FG001|Overall Study|Other|231|||
23451187|NCT00346216|65395129|FG002|Overall Study|Other|205|||
23451188|NCT00346216|65395127|FG000|Overall Study|No longer willing to participate|600|||
23451189|NCT00346216|65395128|FG001|Overall Study|No longer willing to participate|606|||
23451190|NCT00346216|65395129|FG002|Overall Study|No longer willing to participate|585|||
23451191|NCT00346216|65395127|FG000|Overall Study|Withdrawal by Subject|661|||
23451192|NCT00346216|65395128|FG001|Overall Study|Withdrawal by Subject|692|||
23451193|NCT00346216|65395129|FG002|Overall Study|Withdrawal by Subject|651|||
23451194|NCT00346216|65395127|FG000|Overall Study|Lost to Follow-up|611|||
23451195|NCT00346216|65395128|FG001|Overall Study|Lost to Follow-up|588|||
23451196|NCT00346216|65395129|FG002|Overall Study|Lost to Follow-up|542|||
23451197|NCT00346216|65395127|FG000|Overall Study|Physician Decision|80|||
23451198|NCT00346216|65395128|FG001|Overall Study|Physician Decision|76|||
23451199|NCT00346216|65395129|FG002|Overall Study|Physician Decision|59|||
23451200|NCT00346216|65395127|FG000|Overall Study|Does not meet entrance criteria|13|||
23451201|NCT00346216|65395128|FG001|Overall Study|Does not meet entrance criteria|10|||
23451202|NCT00346216|65395129|FG002|Overall Study|Does not meet entrance criteria|8|||
23451203|NCT00346216|65395127|FG000|Overall Study|Death|189|||
23451204|NCT00346216|65395128|FG001|Overall Study|Death|192|||
23451205|NCT00346216|65395129|FG002|Overall Study|Death|228|||
23451206|NCT00346216|65395127|FG000|Overall Study|Study terminated by sponsor|11|||
23451207|NCT00346216|65395128|FG001|Overall Study|Study terminated by sponsor|4|||
23451208|NCT00346216|65395129|FG002|Overall Study|Study terminated by sponsor|8|||
23451209|NCT00346216|65395127|FG000|Overall Study|Missing Subject Summary Status|62|||
23451210|NCT00346216|65395128|FG001|Overall Study|Missing Subject Summary Status|61|||
23451211|NCT00346216|65395129|FG002|Overall Study|Missing Subject Summary Status|62|||
23451212|NCT02978417|65395132|FG000|Overall Study|Lost to Follow-up|2|||
23451213|NCT02978417|65395133|FG001|Overall Study|Lost to Follow-up|2|||
23451214|NCT01033240|65395134|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
23451215|NCT01033240|65395135|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
23451216|NCT01033240|65395136|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
23451217|NCT01033240|65395134|FG000|Overall Study|Death|2|||
23451218|NCT01033240|65395135|FG001|Overall Study|Death|0|||
23451219|NCT01033240|65395136|FG002|Overall Study|Death|0|||
23451220|NCT01033240|65395134|FG000|Overall Study|Withdrew Consent|2|||
23451221|NCT01033240|65395135|FG001|Overall Study|Withdrew Consent|9|||
23451222|NCT01033240|65395136|FG002|Overall Study|Withdrew Consent|2|||
23451223|NCT01033240|65395134|FG000|Overall Study|Disease Progression|35|||
23451224|NCT01033240|65395135|FG001|Overall Study|Disease Progression|32|||
23451225|NCT01033240|65395136|FG002|Overall Study|Disease Progression|41|||
23451226|NCT01033240|65395134|FG000|Overall Study|Investigator Discretion|0|||
23451227|NCT01033240|65395135|FG001|Overall Study|Investigator Discretion|0|||
23451228|NCT01033240|65395136|FG002|Overall Study|Investigator Discretion|2|||
23451229|NCT01033240|65395134|FG000|Overall Study|Other|0|||
23172446|NCT01784861|64375694|FG001|Overall Study|Adverse Event|0|||
23172447|NCT01784861|64375695|FG002|Overall Study|Adverse Event|1|||
23172448|NCT01784861|64375696|FG003|Overall Study|Adverse Event|2|||
23172449|NCT01784861|64375697|FG004|Overall Study|Adverse Event|1|||
23172450|NCT01784861|64375698|FG005|Overall Study|Adverse Event|0|||
23172451|NCT01784861|64375693|FG000|Overall Study|Withdrawal by Subject|0|||
23172452|NCT01784861|64375694|FG001|Overall Study|Withdrawal by Subject|0|||
23172453|NCT01784861|64375695|FG002|Overall Study|Withdrawal by Subject|0|||
23172454|NCT01784861|64375696|FG003|Overall Study|Withdrawal by Subject|1|||
23172455|NCT01784861|64375697|FG004|Overall Study|Withdrawal by Subject|0|||
23172456|NCT01784861|64375698|FG005|Overall Study|Withdrawal by Subject|0|||
23172457|NCT01784861|64375693|FG000|Overall Study|Physician Decision|0|||
23451230|NCT01033240|65395135|FG001|Overall Study|Other|1|||
23451231|NCT01033240|65395136|FG002|Overall Study|Other|2|||
23451232|NCT02922725|65395137|FG000|Overall Study|Withdrawal by Subject|1|||
23451233|NCT02922725|65395138|FG001|Overall Study|Withdrawal by Subject|0|||
23451234|NCT02922725|65395139|FG002|Overall Study|Withdrawal by Subject|0|||
23451235|NCT02675907|65395140|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
23451236|NCT02675907|65395141|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
23451237|NCT02675907|65395140|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
23451238|NCT02675907|65395141|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
23451239|NCT02675907|65395140|FG000|Study Overall|Lack of Efficacy|1|||
23451240|NCT02675907|65395141|FG001|Study Overall|Lack of Efficacy|0|||
23451241|NCT02675907|65395140|FG000|Study Overall|Withdrawal by Subject|2|||
23451242|NCT02675907|65395141|FG001|Study Overall|Withdrawal by Subject|2|||
23451243|NCT02675907|65395140|FG000|Study Overall|Lost to Follow-up|0|||
23451244|NCT02675907|65395141|FG001|Study Overall|Lost to Follow-up|2|||
23451245|NCT00057863|65395142|FG000|Overall Study|Death|1|||
23451246|NCT00057863|65395142|FG000|Overall Study|Withdrawal by Subject|2|||
23451247|NCT01535807|65395146|FG000|Overall Study|Withdrawal by Subject|1|||
23451248|NCT01535807|65395147|FG001|Overall Study|Withdrawal by Subject|1|||
23451249|NCT01535807|65395146|FG000|Overall Study|Data collection error|1|||
23451250|NCT01535807|65395147|FG001|Overall Study|Data collection error|1|||
23451251|NCT00703924|65395148|FG000|Overall Study|Withdrawal by Subject|1|||
23451252|NCT00703924|65395149|FG001|Overall Study|Withdrawal by Subject|1|||
23451253|NCT00117637|65395150|FG000|First Intervention (Period 1)|Adverse Event|11|||
23451254|NCT00117637|65395151|FG001|First Intervention (Period 1)|Adverse Event|16|||
23451255|NCT00117637|65395150|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
23451256|NCT00117637|65395151|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
23451257|NCT00117637|65395150|FG000|First Intervention (Period 1)|Protocol Violation|1|||
23451258|NCT00117637|65395151|FG001|First Intervention (Period 1)|Protocol Violation|0|||
23451259|NCT00117637|65395150|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
23451260|NCT00117637|65395151|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
23451261|NCT00117637|65395150|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
23451262|NCT00117637|65395151|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
23451263|NCT00117637|65395150|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
23451264|NCT00117637|65395151|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
23451265|NCT00117637|65395150|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
23451266|NCT00117637|65395151|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
23451267|NCT00117637|65395150|FG000|First Intervention (Period 1)|reason not reported|0|||
23451268|NCT00117637|65395151|FG001|First Intervention (Period 1)|reason not reported|1|||
23451269|NCT00117637|65395150|FG000|Second Intervention (Period 2)|Adverse Event|0|||
23451270|NCT00117637|65395151|FG001|Second Intervention (Period 2)|Adverse Event|9|||
23451271|NCT00117637|65395150|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
23451272|NCT00117637|65395151|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
23451273|NCT00117637|65395150|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
23451274|NCT00117637|65395151|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
23451275|NCT00117637|65395150|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
23451276|NCT00117637|65395151|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
23451277|NCT00117637|65395150|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
23451278|NCT00117637|65395151|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
23451279|NCT00117637|65395150|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
23172458|NCT01784861|64375694|FG001|Overall Study|Physician Decision|0|||
23172459|NCT01784861|64375695|FG002|Overall Study|Physician Decision|0|||
23172460|NCT01784861|64375696|FG003|Overall Study|Physician Decision|2|||
23172461|NCT01784861|64375697|FG004|Overall Study|Physician Decision|0|||
23172462|NCT01784861|64375698|FG005|Overall Study|Physician Decision|1|||
23172463|NCT01239160|64375699|FG000|Overall Study|Lost to Follow-up|3|||
23172464|NCT01239160|64375700|FG001|Overall Study|Lost to Follow-up|5|||
23172465|NCT01239160|64375701|FG002|Overall Study|Lost to Follow-up|0|||
23172466|NCT01239160|64375699|FG000|Overall Study|Withdrawal by Subject|17|||
23172467|NCT01239160|64375700|FG001|Overall Study|Withdrawal by Subject|6|||
23451280|NCT00117637|65395151|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
23579346|NCT02373813|65853337|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
23579347|NCT02373813|65853338|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
23579348|NCT02373813|65853339|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
23579349|NCT02373813|65853336|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23579350|NCT02373813|65853337|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
23579351|NCT02373813|65853338|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
23579352|NCT02373813|65853339|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
23579353|NCT02373813|65853336|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23579354|NCT02373813|65853337|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
23579355|NCT02373813|65853338|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
23579356|NCT02373813|65853339|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
23579357|NCT02373813|65853336|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23172468|NCT01239160|64375701|FG002|Overall Study|Withdrawal by Subject|2|||
23451281|NCT00117637|65395150|FG000|Second Intervention (Period 2)|reason not reported|1|||
23172469|NCT01239160|64375699|FG000|Overall Study|Physician Decision|5|||
23172470|NCT01239160|64375700|FG001|Overall Study|Physician Decision|7|||
23579358|NCT02373813|65853337|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
23579359|NCT02373813|65853338|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
23579360|NCT02373813|65853339|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
23579361|NCT01838551|65853348|FG000|Overall Study|Adverse Event|16|||
23579362|NCT01838551|65853348|FG000|Overall Study|Death|1|||
23579363|NCT01838551|65853348|FG000|Overall Study|Lack of Efficacy|10|||
23579364|NCT01838551|65853348|FG000|Overall Study|Physician Decision|4|||
23579365|NCT01838551|65853348|FG000|Overall Study|Withdrawal by Subject|10|||
23579366|NCT01838551|65853348|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
23172471|NCT01239160|64375701|FG002|Overall Study|Physician Decision|2|||
23579367|NCT03850444|65853349|FG000|Overall Study|Adverse Event|16|||
23579368|NCT03850444|65853350|FG001|Overall Study|Adverse Event|10|||
23579369|NCT03850444|65853349|FG000|Overall Study|Death|87|||
23232406|NCT02909504|64591931|FG000|Overall Study|Lost to Follow-up|1|||
23232407|NCT00702949|64591933|FG000|Overall Study|Refusal|3|||
23579370|NCT03850444|65853350|FG001|Overall Study|Death|107|||
23579371|NCT03850444|65853349|FG000|Overall Study|Lost to Follow-up|1|||
23579372|NCT03850444|65853350|FG001|Overall Study|Lost to Follow-up|1|||
23579373|NCT03850444|65853349|FG000|Overall Study|Withdrawal by Subject|1|||
23579374|NCT03850444|65853350|FG001|Overall Study|Withdrawal by Subject|5|||
23579375|NCT03850444|65853349|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
23579376|NCT03850444|65853350|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
23579377|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
23579378|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
23579379|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
23579380|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
23579381|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
23579382|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
23579383|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
23579384|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
23579385|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
23579386|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
23579387|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
23579388|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
23579389|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
23579390|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
23579391|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
23579392|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
23579393|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
23579394|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
23579395|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579396|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
23579397|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
23579398|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579399|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579400|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
23579401|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579402|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579403|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
23579404|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
23579405|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
23579406|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
23579407|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
23579408|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
23579409|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
23579410|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
23579411|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
23579412|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
23579413|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
23579414|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
23579415|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
23579416|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
23579417|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
23579418|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
23579419|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
23579420|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
23579421|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
23579422|NCT01369355|65853351|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
23579423|NCT01369355|65853352|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
23579424|NCT01369355|65853353|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
23579425|NCT01369355|65853354|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
23579426|NCT01369355|65853355|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
23579427|NCT01369355|65853356|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
23579428|NCT01369355|65853357|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
23579429|NCT01369355|65853358|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
23579430|NCT01369355|65853359|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
23579431|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
23579432|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
23579433|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
23579434|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
23579435|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
23232408|NCT00702949|64591934|FG001|Overall Study|Refusal|2|||
23339431|NCT01893281|64986172|FG000|Overall Study|Withdrawal by Subject|1|||
23339432|NCT02693106|64986179|FG000|Overall Study|No time|3|||
23339433|NCT00102531|64986182|FG000|Overall Study|Adverse Event|0|||
23339434|NCT00102531|64986183|FG001|Overall Study|Adverse Event|1|||
23339435|NCT00102531|64986182|FG000|Overall Study|Disease Progression|5|||
23339436|NCT00102531|64986183|FG001|Overall Study|Disease Progression|9|||
23339437|NCT00102531|64986182|FG000|Overall Study|Physician Decision|0|||
23339438|NCT00102531|64986183|FG001|Overall Study|Physician Decision|1|||
23232409|NCT00702949|64591935|FG002|Overall Study|Refusal|2|||
23232410|NCT00702949|64591933|FG000|Overall Study|Adverse Event|1|||
23232411|NCT00702949|64591934|FG001|Overall Study|Adverse Event|6|||
23339439|NCT01082211|64986185|FG000|Overall Study|Protocol Violation|4|||
23339440|NCT01082211|64986185|FG000|Overall Study|No protocol treatment received|3|||
23339441|NCT00675428|64986187|FG000|Overall Study|Disease Progression|2|||
23339442|NCT00675428|64986188|FG001|Overall Study|Disease Progression|2|||
23339443|NCT00675428|64986187|FG000|Overall Study|No Disease Response After Cycle 6|0|||
23232412|NCT00702949|64591935|FG002|Overall Study|Adverse Event|3|||
23232413|NCT00702949|64591933|FG000|Overall Study|Other Medical Reason/unknown|1|||
23232414|NCT00702949|64591934|FG001|Overall Study|Other Medical Reason/unknown|1|||
23232415|NCT00702949|64591935|FG002|Overall Study|Other Medical Reason/unknown|3|||
23232416|NCT01716585|64591936|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
23232417|NCT01716585|64591937|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
23232418|NCT01716585|64591936|FG000|Double-blind Treatment|Adverse Event|2|||
23232419|NCT01716585|64591937|FG001|Double-blind Treatment|Adverse Event|1|||
23232420|NCT01716585|64591936|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
23232421|NCT01716585|64591937|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
23232422|NCT01716585|64591936|FG000|Double-blind Treatment|Lost to Follow-up|2|||
23232423|NCT01716585|64591937|FG001|Double-blind Treatment|Lost to Follow-up|0|||
23232424|NCT01716585|64591936|FG000|Double-blind Treatment|Subject Noncompliant|1|||
23232425|NCT01716585|64591937|FG001|Double-blind Treatment|Subject Noncompliant|0|||
23232426|NCT01716585|64591936|FG000|Double-blind Treatment|Other|1|||
23232427|NCT01716585|64591937|FG001|Double-blind Treatment|Other|0|||
23232428|NCT01716585|64591936|FG000|Open-label Treatment|Adverse Event|0|||
23232429|NCT01716585|64591937|FG001|Open-label Treatment|Adverse Event|2|||
23232430|NCT01716585|64591936|FG000|Open-label Treatment|Virologic Failure|0|||
23232431|NCT01716585|64591937|FG001|Open-label Treatment|Virologic Failure|2|||
23339444|NCT00675428|64986188|FG001|Overall Study|No Disease Response After Cycle 6|1|||
23339445|NCT00675428|64986187|FG000|Overall Study|Physician Decision|1|||
23339446|NCT00675428|64986188|FG001|Overall Study|Physician Decision|0|||
23339447|NCT03180684|64986195|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
23339448|NCT03180684|64986196|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
23339449|NCT03180684|64986195|FG000|Overall Study|Physician Decision|1|||
23232432|NCT01716585|64591936|FG000|Open-label Treatment|Withdrawal by Subject|0|||
23232433|NCT01716585|64591937|FG001|Open-label Treatment|Withdrawal by Subject|3|||
23232434|NCT02728804|64591938|FG000|Overall Study|Ineligible|3|||
23232435|NCT02728804|64591938|FG000|Overall Study|Did not complete baseline questionnaire|9|||
23232436|NCT02728804|64591938|FG000|Overall Study|Death|99|||
23339450|NCT03180684|64986196|FG001|Overall Study|Physician Decision|0|||
23339451|NCT03180684|64986195|FG000|Overall Study|Lost to Follow-up|1|||
23339452|NCT03180684|64986196|FG001|Overall Study|Lost to Follow-up|0|||
23451282|NCT00117637|65395151|FG001|Second Intervention (Period 2)|reason not reported|0|||
23451283|NCT00587158|65395158|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
23451284|NCT00587158|65395159|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
23451285|NCT00587158|65395158|FG000|Overall Study|Physician Decision|0|||
23451286|NCT00587158|65395159|FG001|Overall Study|Physician Decision|1|||
23451287|NCT00587158|65395158|FG000|Overall Study|Lost to Follow-up|1|||
23451288|NCT00587158|65395159|FG001|Overall Study|Lost to Follow-up|2|||
23451289|NCT00587158|65395158|FG000|Overall Study|Death|0|||
23451290|NCT00587158|65395159|FG001|Overall Study|Death|1|||
23451291|NCT00587158|65395158|FG000|Overall Study|Subject did not want to take study med|0|||
23451292|NCT00587158|65395159|FG001|Overall Study|Subject did not want to take study med|1|||
23172472|NCT01239160|64375699|FG000|Overall Study|Early Termination Due to Study Closure|0|||
23172473|NCT01239160|64375700|FG001|Overall Study|Early Termination Due to Study Closure|1|||
23232437|NCT01259388|64591952|FG000|Overall Study|Adverse Event|3|||
23172474|NCT01239160|64375701|FG002|Overall Study|Early Termination Due to Study Closure|6|||
23172475|NCT00500682|64375707|FG000|Overall Study|Adverse Event|37|||
23172476|NCT00500682|64375708|FG001|Overall Study|Adverse Event|29|||
23172477|NCT00500682|64375707|FG000|Overall Study|Death|25|||
23172478|NCT00500682|64375708|FG001|Overall Study|Death|16|||
23172479|NCT00500682|64375707|FG000|Overall Study|Lost to Follow-up|11|||
23172480|NCT00500682|64375708|FG001|Overall Study|Lost to Follow-up|11|||
23172481|NCT00500682|64375707|FG000|Overall Study|Physician Decision|6|||
23172482|NCT00500682|64375708|FG001|Overall Study|Physician Decision|10|||
23172483|NCT00500682|64375707|FG000|Overall Study|Pregnancy|2|||
23172484|NCT00500682|64375708|FG001|Overall Study|Pregnancy|0|||
23172485|NCT00500682|64375707|FG000|Overall Study|Protocol Violation|1|||
23172486|NCT00500682|64375708|FG001|Overall Study|Protocol Violation|3|||
23172487|NCT00500682|64375707|FG000|Overall Study|Withdrawal by Subject|80|||
23172488|NCT00500682|64375708|FG001|Overall Study|Withdrawal by Subject|74|||
23172489|NCT00500682|64375707|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
23172490|NCT00500682|64375708|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
23172491|NCT03175549|64375709|FG000|Overall Study|Lost to Follow-up|2|||
23172492|NCT03175549|64375710|FG001|Overall Study|Lost to Follow-up|2|||
23172493|NCT03175549|64375709|FG000|Overall Study|Medication non-compliance|2|||
23172494|NCT03175549|64375710|FG001|Overall Study|Medication non-compliance|2|||
23172495|NCT01582308|64375715|FG000|Period 1|Withdrawal by Subject|0|||
23172496|NCT01582308|64375716|FG001|Period 1|Withdrawal by Subject|0|||
23172497|NCT01582308|64375717|FG002|Period 1|Withdrawal by Subject|0|||
23172498|NCT01582308|64375718|FG003|Period 1|Withdrawal by Subject|0|||
23172499|NCT01582308|64375719|FG004|Period 1|Withdrawal by Subject|0|||
23172500|NCT01582308|64375720|FG005|Period 1|Withdrawal by Subject|0|||
23172501|NCT01582308|64375721|FG006|Period 1|Withdrawal by Subject|1|||
23172502|NCT01582308|64375722|FG007|Period 1|Withdrawal by Subject|0|||
23172503|NCT01582308|64375723|FG008|Period 1|Withdrawal by Subject|0|||
23172504|NCT01582308|64375724|FG009|Period 1|Withdrawal by Subject|0|||
23172505|NCT01582308|64375715|FG000|10-day Washout Following Period 1|Physician Decision|0|||
23172506|NCT01582308|64375716|FG001|10-day Washout Following Period 1|Physician Decision|0|||
23232438|NCT01259388|64591953|FG001|Overall Study|Adverse Event|0|||
23232439|NCT01259388|64591952|FG000|Overall Study|Withdrawal by Subject|1|||
23451293|NCT00296816|65395160|FG000|Overall Study|Disease Progression|37|||
23451294|NCT00296816|65395160|FG000|Overall Study|Adverse Event|18|||
23451295|NCT00296816|65395160|FG000|Overall Study|Investigator/Participant request|5|||
23172507|NCT01582308|64375717|FG002|10-day Washout Following Period 1|Physician Decision|0|||
23172508|NCT01582308|64375718|FG003|10-day Washout Following Period 1|Physician Decision|0|||
23172509|NCT01582308|64375719|FG004|10-day Washout Following Period 1|Physician Decision|1|||
23172510|NCT01582308|64375720|FG005|10-day Washout Following Period 1|Physician Decision|0|||
23172511|NCT01582308|64375721|FG006|10-day Washout Following Period 1|Physician Decision|0|||
23172512|NCT01582308|64375722|FG007|10-day Washout Following Period 1|Physician Decision|0|||
23232440|NCT01259388|64591953|FG001|Overall Study|Withdrawal by Subject|1|||
23451296|NCT00296816|65395160|FG000|Overall Study|Non-compliance|1|||
23339453|NCT03180684|64986195|FG000|Overall Study|Progressive Disease|1|||
23339454|NCT03180684|64986196|FG001|Overall Study|Progressive Disease|0|||
23339455|NCT05088603|64986211|FG000|Overall Study|Protocol Violation|6|||
23339456|NCT05088603|64986212|FG001|Overall Study|Protocol Violation|1|||
23339457|NCT03348930|64986213|FG000|Washout (1 Week)|Lost to Follow-up|1|||
23339458|NCT03348930|64986214|FG001|Washout (1 Week)|Lost to Follow-up|1|||
23232441|NCT01259388|64591952|FG000|Overall Study|Physician Decision|1|||
23232442|NCT01259388|64591953|FG001|Overall Study|Physician Decision|0|||
23232443|NCT00963469|64591959|FG000|Overall Study|Adverse Event|15|||
23232444|NCT00963469|64591960|FG001|Overall Study|Adverse Event|11|||
23232445|NCT00963469|64591961|FG002|Overall Study|Adverse Event|1|||
23232446|NCT00963469|64591959|FG000|Overall Study|Lack of Efficacy|10|||
23232447|NCT00963469|64591960|FG001|Overall Study|Lack of Efficacy|7|||
23339459|NCT02587598|64986215|FG000|Overall Study|Death|4|||
23339460|NCT02587598|64986216|FG001|Overall Study|Death|8|||
23339461|NCT02587598|64986217|FG002|Overall Study|Death|4|||
23339462|NCT02587598|64986218|FG003|Overall Study|Death|16|||
23339463|NCT02587598|64986219|FG004|Overall Study|Death|9|||
23339464|NCT02587598|64986220|FG005|Overall Study|Death|4|||
23339465|NCT02587598|64986221|FG006|Overall Study|Death|6|||
23339466|NCT02587598|64986222|FG007|Overall Study|Death|7|||
23339467|NCT02587598|64986223|FG008|Overall Study|Death|9|||
23339468|NCT02587598|64986224|FG009|Overall Study|Death|1|||
23339469|NCT02587598|64986225|FG010|Overall Study|Death|3|||
23339470|NCT02587598|64986215|FG000|Overall Study|Study Terminated by the Sponsor|0|||
23339471|NCT02587598|64986216|FG001|Overall Study|Study Terminated by the Sponsor|1|||
23339472|NCT02587598|64986217|FG002|Overall Study|Study Terminated by the Sponsor|0|||
23339473|NCT02587598|64986218|FG003|Overall Study|Study Terminated by the Sponsor|3|||
23339474|NCT02587598|64986219|FG004|Overall Study|Study Terminated by the Sponsor|0|||
23339475|NCT02587598|64986220|FG005|Overall Study|Study Terminated by the Sponsor|1|||
23339476|NCT02587598|64986221|FG006|Overall Study|Study Terminated by the Sponsor|0|||
23339477|NCT02587598|64986222|FG007|Overall Study|Study Terminated by the Sponsor|0|||
23339478|NCT02587598|64986223|FG008|Overall Study|Study Terminated by the Sponsor|0|||
23339479|NCT02587598|64986224|FG009|Overall Study|Study Terminated by the Sponsor|1|||
23339480|NCT02587598|64986225|FG010|Overall Study|Study Terminated by the Sponsor|6|||
23339481|NCT02587598|64986215|FG000|Overall Study|Reason for study withdrawal not specified|0|||
23339482|NCT02587598|64986216|FG001|Overall Study|Reason for study withdrawal not specified|1|||
23339483|NCT02587598|64986217|FG002|Overall Study|Reason for study withdrawal not specified|0|||
23339484|NCT02587598|64986218|FG003|Overall Study|Reason for study withdrawal not specified|0|||
23339485|NCT02587598|64986219|FG004|Overall Study|Reason for study withdrawal not specified|0|||
23339486|NCT02587598|64986220|FG005|Overall Study|Reason for study withdrawal not specified|0|||
23339487|NCT02587598|64986221|FG006|Overall Study|Reason for study withdrawal not specified|0|||
23339488|NCT02587598|64986222|FG007|Overall Study|Reason for study withdrawal not specified|0|||
23339489|NCT02587598|64986223|FG008|Overall Study|Reason for study withdrawal not specified|0|||
23339490|NCT02587598|64986224|FG009|Overall Study|Reason for study withdrawal not specified|0|||
23339491|NCT02587598|64986225|FG010|Overall Study|Reason for study withdrawal not specified|0|||
23339492|NCT02587598|64986215|FG000|Overall Study|Withdrawal by Subject|0|||
23339493|NCT02587598|64986216|FG001|Overall Study|Withdrawal by Subject|1|||
23339494|NCT02587598|64986217|FG002|Overall Study|Withdrawal by Subject|0|||
23339495|NCT02587598|64986218|FG003|Overall Study|Withdrawal by Subject|2|||
23339496|NCT02587598|64986219|FG004|Overall Study|Withdrawal by Subject|3|||
23339497|NCT02587598|64986220|FG005|Overall Study|Withdrawal by Subject|1|||
23339498|NCT02587598|64986221|FG006|Overall Study|Withdrawal by Subject|0|||
23339499|NCT02587598|64986222|FG007|Overall Study|Withdrawal by Subject|0|||
23339500|NCT02587598|64986223|FG008|Overall Study|Withdrawal by Subject|0|||
23339501|NCT02587598|64986224|FG009|Overall Study|Withdrawal by Subject|1|||
23339502|NCT02587598|64986225|FG010|Overall Study|Withdrawal by Subject|2|||
23172513|NCT01582308|64375723|FG008|10-day Washout Following Period 1|Physician Decision|0|||
23172514|NCT01582308|64375724|FG009|10-day Washout Following Period 1|Physician Decision|0|||
23172515|NCT01582308|64375715|FG000|Period 4|Physician Decision|1|||
23172516|NCT01582308|64375716|FG001|Period 4|Physician Decision|0|||
23172517|NCT01582308|64375717|FG002|Period 4|Physician Decision|0|||
23172518|NCT01582308|64375718|FG003|Period 4|Physician Decision|0|||
23172519|NCT01582308|64375719|FG004|Period 4|Physician Decision|0|||
23172520|NCT01582308|64375720|FG005|Period 4|Physician Decision|1|||
23172521|NCT01582308|64375721|FG006|Period 4|Physician Decision|0|||
23172522|NCT01582308|64375722|FG007|Period 4|Physician Decision|0|||
23172523|NCT01582308|64375723|FG008|Period 4|Physician Decision|0|||
23172524|NCT01582308|64375724|FG009|Period 4|Physician Decision|1|||
23232448|NCT00963469|64591961|FG002|Overall Study|Lack of Efficacy|2|||
23339503|NCT02587598|64986215|FG000|Overall Study|Physician Decision|0|||
23172525|NCT02317562|64375729|FG000|Overall Study|Physician Decision|1|||
23232449|NCT00963469|64591959|FG000|Overall Study|Lost to Follow-up|1|||
23339504|NCT02587598|64986216|FG001|Overall Study|Physician Decision|0|||
23339505|NCT02587598|64986217|FG002|Overall Study|Physician Decision|0|||
23172526|NCT02317562|64375729|FG000|Overall Study|early termination of the study|8|||
23172527|NCT02317562|64375729|FG000|Overall Study|Lack of Efficacy|4|||
23172528|NCT02317562|64375729|FG000|Overall Study|Withdrawal by Subject|1|||
23172529|NCT00044512|64375730|FG000|Follow Up|Lost to Follow-up|2|||
23172530|NCT02452762|64375731|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
23172531|NCT02452762|64375732|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
23172532|NCT02452762|64375731|FG000|Overall Study|Withdrawal by Subject|1|||
23172533|NCT02452762|64375732|FG001|Overall Study|Withdrawal by Subject|0|||
23172534|NCT02450578|64375733|FG000|Overall Study|ECG abnormality so not treated|1|||
23172535|NCT02450578|64375734|FG001|Overall Study|ECG abnormality so not treated|0|||
23172536|NCT02450578|64375735|FG002|Overall Study|ECG abnormality so not treated|0|||
23172537|NCT02450578|64375736|FG003|Overall Study|ECG abnormality so not treated|0|||
23172538|NCT00354601|64375737|FG000|Overall Study|Protocol Violation|1|||
23172539|NCT00354601|64375737|FG000|Overall Study|progression|1|||
23172540|NCT02513329|64375738|FG000|Overall Study|Lost to Follow-up|5|||
23172541|NCT02513329|64375739|FG001|Overall Study|Lost to Follow-up|2|||
23172542|NCT01292057|64375740|FG000|Overall Study|Protocol Violation|1|||
23232450|NCT00963469|64591960|FG001|Overall Study|Lost to Follow-up|1|||
23172543|NCT01292057|64375741|FG001|Overall Study|Protocol Violation|1|||
23172544|NCT01292057|64375740|FG000|Overall Study|Lost to Follow-up|1|||
23172545|NCT01292057|64375741|FG001|Overall Study|Lost to Follow-up|1|||
23172546|NCT02285114|64375750|FG000|Overall Study|Investigator's Discretion|0|||
23172547|NCT02285114|64375751|FG001|Overall Study|Investigator's Discretion|2|||
23172548|NCT02285114|64375752|FG002|Overall Study|Investigator's Discretion|0|||
23172549|NCT02285114|64375750|FG000|Overall Study|Withdrew Consent|0|||
23172550|NCT02285114|64375751|FG001|Overall Study|Withdrew Consent|0|||
23172551|NCT02285114|64375752|FG002|Overall Study|Withdrew Consent|1|||
23172552|NCT02285114|64375750|FG000|Overall Study|Enrolled but not treated|1|||
23172553|NCT02285114|64375751|FG001|Overall Study|Enrolled but not treated|0|||
23172554|NCT02285114|64375752|FG002|Overall Study|Enrolled but not treated|0|||
23172555|NCT02285114|64375750|FG000|Overall Study|Still on study|21|||
23172556|NCT02285114|64375751|FG001|Overall Study|Still on study|5|||
23232451|NCT00963469|64591961|FG002|Overall Study|Lost to Follow-up|0|||
23232452|NCT00963469|64591959|FG000|Overall Study|Protocol Violation|5|||
23232453|NCT00963469|64591960|FG001|Overall Study|Protocol Violation|5|||
23232454|NCT00963469|64591961|FG002|Overall Study|Protocol Violation|3|||
23232455|NCT00963469|64591959|FG000|Overall Study|Withdrawal by Subject|4|||
23232456|NCT00963469|64591960|FG001|Overall Study|Withdrawal by Subject|1|||
23232457|NCT00963469|64591961|FG002|Overall Study|Withdrawal by Subject|1|||
23232458|NCT00963469|64591959|FG000|Overall Study|Pre-randomization Adverse Event|1|||
23232459|NCT00963469|64591960|FG001|Overall Study|Pre-randomization Adverse Event|2|||
23232460|NCT00963469|64591961|FG002|Overall Study|Pre-randomization Adverse Event|0|||
23232461|NCT00963469|64591959|FG000|Overall Study|Moved|1|||
23339506|NCT02587598|64986218|FG003|Overall Study|Physician Decision|0|||
23339507|NCT02587598|64986219|FG004|Overall Study|Physician Decision|0|||
23172557|NCT02285114|64375752|FG002|Overall Study|Still on study|2|||
23172558|NCT03538743|64375758|FG000|Overall Study|Adverse Event|0|||
23172559|NCT03538743|64375759|FG001|Overall Study|Adverse Event|0|||
23172560|NCT03538743|64375760|FG002|Overall Study|Adverse Event|1|||
23232462|NCT00963469|64591960|FG001|Overall Study|Moved|0|||
23232463|NCT00963469|64591961|FG002|Overall Study|Moved|0|||
23232464|NCT00963469|64591959|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
23232465|NCT00963469|64591960|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
23232466|NCT00963469|64591961|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
23232467|NCT03137433|64591962|FG000|Overall Study|Withdrawal by Subject|11|||
23232468|NCT03137433|64591963|FG001|Overall Study|Withdrawal by Subject|11|||
23232469|NCT03137433|64591962|FG000|Overall Study|Lost to Follow-up|5|||
23232470|NCT03137433|64591963|FG001|Overall Study|Lost to Follow-up|6|||
23232471|NCT03137433|64591962|FG000|Overall Study|Physician Decision|2|||
23232472|NCT03137433|64591963|FG001|Overall Study|Physician Decision|0|||
23232473|NCT03137433|64591962|FG000|Overall Study|Moved out of study area|1|||
23232474|NCT03137433|64591963|FG001|Overall Study|Moved out of study area|0|||
23232475|NCT03137433|64591962|FG000|Overall Study|Too far out of window due to COVID|0|||
23232476|NCT03137433|64591963|FG001|Overall Study|Too far out of window due to COVID|1|||
23232477|NCT01524900|64591973|FG000|Overall Study|Lost to Follow-up|3|||
23232478|NCT01524900|64591974|FG001|Overall Study|Lost to Follow-up|12|||
23232479|NCT01524900|64591975|FG002|Overall Study|Lost to Follow-up|1|||
23232480|NCT01524900|64591976|FG003|Overall Study|Lost to Follow-up|0|||
23232481|NCT01524900|64591977|FG004|Overall Study|Lost to Follow-up|0|||
23232482|NCT01524900|64591973|FG000|Overall Study|Other reason than stated above|1|||
23232483|NCT01524900|64591974|FG001|Overall Study|Other reason than stated above|1|||
23232484|NCT01524900|64591975|FG002|Overall Study|Other reason than stated above|0|||
23232485|NCT01524900|64591976|FG003|Overall Study|Other reason than stated above|0|||
23232486|NCT01524900|64591977|FG004|Overall Study|Other reason than stated above|0|||
23232487|NCT01524900|64591973|FG000|Overall Study|No reason documented|2|||
23232488|NCT01524900|64591974|FG001|Overall Study|No reason documented|1|||
23232489|NCT01524900|64591975|FG002|Overall Study|No reason documented|0|||
23232490|NCT01524900|64591976|FG003|Overall Study|No reason documented|1|||
23579436|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
23579437|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
23579438|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
23579439|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
23579440|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Death|0|||
23579441|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Death|0|||
23579442|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Death|0|||
23579443|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Death|0|||
23579444|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Death|0|||
23579445|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Death|0|||
23579446|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Death|0|||
23579447|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Death|1|||
23579448|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Death|3|||
23579449|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23579450|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23579451|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23579452|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23579453|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23232491|NCT01524900|64591977|FG004|Overall Study|No reason documented|0|||
23232492|NCT02712008|64591978|FG000|Baseline (Day 1) up to Week 12|Death|3|||
23232493|NCT02712008|64591979|FG001|Baseline (Day 1) up to Week 12|Death|0|||
23232494|NCT02712008|64591980|FG002|Baseline (Day 1) up to Week 12|Death|0|||
23232495|NCT02712008|64591981|FG003|Baseline (Day 1) up to Week 12|Death|0|||
23232496|NCT02712008|64591982|FG004|Baseline (Day 1) up to Week 12|Death|0|||
23232497|NCT02712008|64591983|FG005|Baseline (Day 1) up to Week 12|Death|0|||
23232498|NCT02712008|64591984|FG006|Baseline (Day 1) up to Week 12|Death|0|||
23232499|NCT02712008|64591985|FG007|Baseline (Day 1) up to Week 12|Death|0|||
23232500|NCT02712008|64591978|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23232501|NCT02712008|64591979|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
23232502|NCT02712008|64591980|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
23232503|NCT02712008|64591981|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23232504|NCT02712008|64591982|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23232505|NCT02712008|64591983|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23232506|NCT02712008|64591984|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23232507|NCT02712008|64591985|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23232508|NCT02712008|64591978|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
23232509|NCT02712008|64591979|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23232510|NCT02712008|64591980|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
23232511|NCT02712008|64591981|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23579454|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
23232512|NCT02712008|64591982|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23232513|NCT02712008|64591983|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23232514|NCT02712008|64591984|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23232515|NCT02712008|64591985|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23232516|NCT02712008|64591978|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23232517|NCT02712008|64591979|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23232518|NCT02712008|64591980|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
23232519|NCT02712008|64591981|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23232520|NCT02712008|64591982|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23232521|NCT02712008|64591983|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23232522|NCT02712008|64591984|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23232523|NCT02712008|64591985|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
23232524|NCT02712008|64591978|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23232525|NCT02712008|64591979|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
23232526|NCT02712008|64591980|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23232527|NCT02712008|64591981|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23232528|NCT02712008|64591982|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23232529|NCT02712008|64591983|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23232530|NCT02712008|64591984|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23232531|NCT02712008|64591985|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
23232532|NCT02712008|64591978|FG000|From Week 12 up to Week 36|Adverse Event|0|||
23232533|NCT02712008|64591979|FG001|From Week 12 up to Week 36|Adverse Event|0|||
23232534|NCT02712008|64591980|FG002|From Week 12 up to Week 36|Adverse Event|0|||
23232535|NCT02712008|64591981|FG003|From Week 12 up to Week 36|Adverse Event|0|||
23232536|NCT02712008|64591982|FG004|From Week 12 up to Week 36|Adverse Event|1|||
23232537|NCT02712008|64591983|FG005|From Week 12 up to Week 36|Adverse Event|0|||
23232538|NCT02712008|64591984|FG006|From Week 12 up to Week 36|Adverse Event|0|||
23232539|NCT02712008|64591985|FG007|From Week 12 up to Week 36|Adverse Event|2|||
23232540|NCT02712008|64591978|FG000|From Week 12 up to Week 36|Death|1|||
23232541|NCT02712008|64591979|FG001|From Week 12 up to Week 36|Death|0|||
23232542|NCT02712008|64591980|FG002|From Week 12 up to Week 36|Death|0|||
23232543|NCT02712008|64591981|FG003|From Week 12 up to Week 36|Death|0|||
23232544|NCT02712008|64591982|FG004|From Week 12 up to Week 36|Death|0|||
23232545|NCT02712008|64591983|FG005|From Week 12 up to Week 36|Death|0|||
23232546|NCT02712008|64591984|FG006|From Week 12 up to Week 36|Death|1|||
23232547|NCT02712008|64591985|FG007|From Week 12 up to Week 36|Death|0|||
23232548|NCT02712008|64591978|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
23232549|NCT02712008|64591979|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
23232550|NCT02712008|64591980|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
23232551|NCT02712008|64591981|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
23232552|NCT02712008|64591982|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
23232553|NCT02712008|64591983|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
23232554|NCT02712008|64591984|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
23232555|NCT02712008|64591985|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
23232556|NCT02712008|64591978|FG000|From Week 12 up to Week 36|Physician Decision|0|||
23232557|NCT02712008|64591979|FG001|From Week 12 up to Week 36|Physician Decision|0|||
23232558|NCT02712008|64591980|FG002|From Week 12 up to Week 36|Physician Decision|0|||
23232559|NCT02712008|64591981|FG003|From Week 12 up to Week 36|Physician Decision|1|||
23232560|NCT02712008|64591982|FG004|From Week 12 up to Week 36|Physician Decision|1|||
23232561|NCT02712008|64591983|FG005|From Week 12 up to Week 36|Physician Decision|0|||
23232562|NCT02712008|64591984|FG006|From Week 12 up to Week 36|Physician Decision|0|||
23232563|NCT02712008|64591985|FG007|From Week 12 up to Week 36|Physician Decision|0|||
23232564|NCT02712008|64591978|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23232565|NCT02712008|64591979|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23172561|NCT03538743|64375761|FG003|Overall Study|Adverse Event|1|||
23172562|NCT03538743|64375762|FG004|Overall Study|Adverse Event|0|||
23172563|NCT03538743|64375763|FG005|Overall Study|Adverse Event|0|||
23172564|NCT03538743|64375764|FG006|Overall Study|Adverse Event|0|||
23232566|NCT02712008|64591980|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23232567|NCT02712008|64591981|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23232568|NCT02712008|64591982|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23232569|NCT02712008|64591983|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
23232570|NCT02712008|64591984|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
23232571|NCT02712008|64591985|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
23232572|NCT04021706|64591995|FG000|Overall Study|Adverse Event|2|||
23232573|NCT04021706|64591996|FG001|Overall Study|Adverse Event|0|||
23232574|NCT04021706|64591995|FG000|Overall Study|Withdrawal by Subject|1|||
23232575|NCT04021706|64591996|FG001|Overall Study|Withdrawal by Subject|2|||
23232576|NCT04021706|64591995|FG000|Overall Study|Physician Decision|1|||
23232577|NCT04021706|64591996|FG001|Overall Study|Physician Decision|0|||
23232578|NCT00298766|64591997|FG000|Overall Study|Adverse Event|18|||
23232579|NCT00298766|64591997|FG000|Overall Study|Death|2|||
23232580|NCT00298766|64591997|FG000|Overall Study|Withdrawal by Subject|9|||
23232581|NCT00298766|64591997|FG000|Overall Study|Treatment ongoing|4|||
23232582|NCT00298766|64591997|FG000|Overall Study|Progression of amyloid markers|4|||
23232583|NCT00298766|64591997|FG000|Overall Study|Deterioration in KPS and organ function|1|||
23232584|NCT00298766|64591997|FG000|Overall Study|Subjects overall condition deterioration|4|||
23232585|NCT00298766|64591997|FG000|Overall Study|Other|4|||
23232586|NCT01849289|64591998|FG000|Overall Study|Adverse Event|3|||
23232587|NCT01849289|64591999|FG001|Overall Study|Adverse Event|3|||
23232588|NCT01849289|64591998|FG000|Overall Study|Protocol Violation|3|||
23232589|NCT01849289|64591999|FG001|Overall Study|Protocol Violation|3|||
23232590|NCT01849289|64591998|FG000|Overall Study|Withdrawal criteria|1|||
23232591|NCT01849289|64591999|FG001|Overall Study|Withdrawal criteria|0|||
23232592|NCT01849289|64591998|FG000|Overall Study|Unclassified|25|||
23172565|NCT03538743|64375765|FG007|Overall Study|Adverse Event|0|||
23232593|NCT01849289|64591999|FG001|Overall Study|Unclassified|18|||
23232594|NCT02381795|64592000|FG000|Overall Study|Withdrawal by Subject|1|||
23232595|NCT02381795|64592000|FG000|Overall Study|Study Terminated|2|||
23232596|NCT03696576|64592005|FG000|Overall Study|Soreness of throat after therapy|1|||
23232597|NCT03696576|64592006|FG001|Overall Study|Soreness of throat after therapy|1|||
23232598|NCT03696576|64592005|FG000|Overall Study|Lost to Follow-up|2|||
23232599|NCT03696576|64592006|FG001|Overall Study|Lost to Follow-up|4|||
23232600|NCT02098733|64592007|FG000|Overall Study|Data Not Available|5|||
23232601|NCT02098733|64592007|FG000|Overall Study|Lost to Follow-up|5|||
23232602|NCT00805194|64592008|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
23172566|NCT03538743|64375766|FG008|Overall Study|Adverse Event|0|||
23172567|NCT03538743|64375758|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
23172568|NCT03538743|64375759|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
23172569|NCT03538743|64375760|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
23232603|NCT00805194|64592009|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
23232604|NCT00805194|64592008|FG000|Overall Study|Worsening or AE of underlying disease|64|||
23232605|NCT00805194|64592009|FG001|Overall Study|Worsening or AE of underlying disease|70|||
23232606|NCT00805194|64592008|FG000|Overall Study|Other AE|84|||
23232607|NCT00805194|64592009|FG001|Overall Study|Other AE|73|||
23232608|NCT00805194|64592008|FG000|Overall Study|Protocol Violation|9|||
23232609|NCT00805194|64592009|FG001|Overall Study|Protocol Violation|9|||
23232610|NCT00805194|64592008|FG000|Overall Study|Lost to Follow-up|5|||
23172570|NCT03538743|64375761|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
23172571|NCT03538743|64375762|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
23232611|NCT00805194|64592009|FG001|Overall Study|Lost to Follow-up|5|||
23232612|NCT00805194|64592008|FG000|Overall Study|Withdrawal by Subject|60|||
23232613|NCT00805194|64592009|FG001|Overall Study|Withdrawal by Subject|42|||
23232614|NCT00805194|64592008|FG000|Overall Study|Not treated|3|||
23232615|NCT00805194|64592009|FG001|Overall Study|Not treated|4|||
23232616|NCT00805194|64592008|FG000|Overall Study|Reasons other than stated above|20|||
23232617|NCT00805194|64592009|FG001|Overall Study|Reasons other than stated above|16|||
23232618|NCT04657003|64592010|FG000|Overall Study|Adverse Event|5|||
23232619|NCT04657003|64592011|FG001|Overall Study|Adverse Event|1|||
23232620|NCT04657003|64592012|FG002|Overall Study|Adverse Event|5|||
23232621|NCT04657003|64592010|FG000|Overall Study|Death|0|||
23232622|NCT04657003|64592011|FG001|Overall Study|Death|2|||
23232623|NCT04657003|64592012|FG002|Overall Study|Death|0|||
23232624|NCT04657003|64592010|FG000|Overall Study|Lost to Follow-up|8|||
23232625|NCT04657003|64592011|FG001|Overall Study|Lost to Follow-up|4|||
23232626|NCT04657003|64592012|FG002|Overall Study|Lost to Follow-up|10|||
23232627|NCT04657003|64592010|FG000|Overall Study|Other - As Reported by Investigator|3|||
23232628|NCT04657003|64592011|FG001|Overall Study|Other - As Reported by Investigator|2|||
23232629|NCT04657003|64592012|FG002|Overall Study|Other - As Reported by Investigator|2|||
23232630|NCT04657003|64592010|FG000|Overall Study|Pregnancy|2|||
23232631|NCT04657003|64592011|FG001|Overall Study|Pregnancy|0|||
23172572|NCT03538743|64375763|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
23172573|NCT03538743|64375764|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
23232632|NCT04657003|64592012|FG002|Overall Study|Pregnancy|2|||
23232633|NCT04657003|64592010|FG000|Overall Study|Withdrawal by Subject|16|||
23232634|NCT04657003|64592011|FG001|Overall Study|Withdrawal by Subject|7|||
23232635|NCT04657003|64592012|FG002|Overall Study|Withdrawal by Subject|10|||
23232636|NCT00082628|64592014|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
23232637|NCT00082628|64592015|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
23232638|NCT00082628|64592016|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
23232639|NCT00082628|64592017|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
23232640|NCT00082628|64592018|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
23232641|NCT00082628|64592014|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
23232642|NCT00082628|64592015|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
23232643|NCT00082628|64592016|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
23232644|NCT00082628|64592017|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
23232645|NCT00082628|64592018|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
23232646|NCT00082628|64592014|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
23232647|NCT00082628|64592015|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
23232648|NCT00082628|64592016|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
23232649|NCT00082628|64592017|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
23232650|NCT00082628|64592018|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
23232651|NCT00082628|64592014|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
23232652|NCT00082628|64592015|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
23232653|NCT00082628|64592016|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
23232654|NCT00082628|64592017|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
23232655|NCT00082628|64592018|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
23232656|NCT00082628|64592014|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
23232657|NCT00082628|64592015|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
23232658|NCT00082628|64592016|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
23232659|NCT00082628|64592017|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
23232660|NCT00082628|64592018|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
23232661|NCT00082628|64592014|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
23232662|NCT00082628|64592015|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
23232663|NCT00082628|64592016|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
23232664|NCT00082628|64592017|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
23232665|NCT00082628|64592018|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
23339508|NCT02587598|64986220|FG005|Overall Study|Physician Decision|0|||
23339509|NCT02587598|64986221|FG006|Overall Study|Physician Decision|0|||
23172574|NCT03538743|64375765|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
23172575|NCT03538743|64375766|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
23172576|NCT03538743|64375758|FG000|Overall Study|Withdrawal by Subject|0|||
23172577|NCT03538743|64375759|FG001|Overall Study|Withdrawal by Subject|0|||
23172578|NCT03538743|64375760|FG002|Overall Study|Withdrawal by Subject|0|||
23172579|NCT03538743|64375761|FG003|Overall Study|Withdrawal by Subject|1|||
23172580|NCT03538743|64375762|FG004|Overall Study|Withdrawal by Subject|0|||
23172581|NCT03538743|64375763|FG005|Overall Study|Withdrawal by Subject|0|||
23172582|NCT03538743|64375764|FG006|Overall Study|Withdrawal by Subject|0|||
23232666|NCT00082628|64592014|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
23232667|NCT00082628|64592015|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
23232668|NCT00082628|64592016|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
23232669|NCT00082628|64592017|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
23232670|NCT00082628|64592018|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
23579455|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
23579456|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
23579457|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
23579458|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579459|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579460|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579461|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579462|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579463|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579464|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
23579465|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
23579466|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
23579467|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579468|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579469|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579470|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579471|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579472|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
23579473|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
23579474|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
23579475|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
23579476|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579477|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579478|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579479|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579480|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579481|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
23579482|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
23579483|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
23579484|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
23579485|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579486|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579487|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579488|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579489|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579490|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
23579491|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
23579492|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
23579493|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
23579494|NCT01369355|65853351|FG000|Long-term Extension (Week 44-272)|Other|0|||
23579495|NCT01369355|65853352|FG001|Long-term Extension (Week 44-272)|Other|0|||
23579496|NCT01369355|65853353|FG002|Long-term Extension (Week 44-272)|Other|0|||
23579497|NCT01369355|65853354|FG003|Long-term Extension (Week 44-272)|Other|0|||
23579498|NCT01369355|65853355|FG004|Long-term Extension (Week 44-272)|Other|0|||
23579499|NCT01369355|65853356|FG005|Long-term Extension (Week 44-272)|Other|0|||
23579500|NCT01369355|65853357|FG006|Long-term Extension (Week 44-272)|Other|110|||
23579501|NCT01369355|65853358|FG007|Long-term Extension (Week 44-272)|Other|9|||
23579502|NCT01369355|65853359|FG008|Long-term Extension (Week 44-272)|Other|17|||
23579503|NCT01474512|65853360|FG000|Induction Period|Adverse Event|6|||
23579504|NCT01474512|65853361|FG001|Induction Period|Adverse Event|10|||
23579505|NCT01474512|65853362|FG002|Induction Period|Adverse Event|10|||
23579506|NCT01474512|65853363|FG003|Induction Period|Adverse Event|0|||
23232671|NCT01266876|64595865|FG000|Overall Study|Adverse Event|0|||
23232672|NCT01266876|64595866|FG001|Overall Study|Adverse Event|0|||
23232673|NCT01266876|64595867|FG002|Overall Study|Adverse Event|0|||
23232674|NCT01266876|64595868|FG003|Overall Study|Adverse Event|1|||
23232675|NCT01266876|64595869|FG004|Overall Study|Adverse Event|0|||
23232676|NCT03490734|64595870|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
23232677|NCT03490734|64595871|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
23339510|NCT02587598|64986222|FG007|Overall Study|Physician Decision|0|||
23339511|NCT02587598|64986223|FG008|Overall Study|Physician Decision|0|||
23579507|NCT01474512|65853364|FG004|Induction Period|Adverse Event|0|||
23579508|NCT01474512|65853365|FG005|Induction Period|Adverse Event|0|||
23579509|NCT01474512|65853366|FG006|Induction Period|Adverse Event|0|||
23451297|NCT00296816|65395160|FG000|Overall Study|Missing for end of treatment|4|||
23579510|NCT01474512|65853367|FG007|Induction Period|Adverse Event|0|||
23172583|NCT03538743|64375765|FG007|Overall Study|Withdrawal by Subject|0|||
23172584|NCT03538743|64375766|FG008|Overall Study|Withdrawal by Subject|0|||
23172585|NCT01323478|64375768|FG000|Overall Study|Adverse Event|7|||
23172586|NCT01323478|64375768|FG000|Overall Study|Lack of Efficacy|4|||
23172587|NCT01323478|64375768|FG000|Overall Study|Non-compliance With Study Product|3|||
23172588|NCT01323478|64375768|FG000|Overall Study|Protocol Violation|1|||
23172589|NCT01323478|64375768|FG000|Overall Study|Withdrawal of Consent|1|||
23172590|NCT01323478|64375768|FG000|Overall Study|Administrative or Other Reasons|8|||
23172591|NCT05162066|64375769|FG000|Overall Study|Adverse Event|1|||
23172592|NCT05162066|64375770|FG001|Overall Study|Adverse Event|0|||
23172593|NCT05162066|64375771|FG002|Overall Study|Adverse Event|0|||
23172594|NCT05162066|64375769|FG000|Overall Study|Perceived lack of efficacy|1|||
23172595|NCT05162066|64375770|FG001|Overall Study|Perceived lack of efficacy|0|||
23172596|NCT05162066|64375771|FG002|Overall Study|Perceived lack of efficacy|0|||
23172597|NCT03742037|64375772|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23172598|NCT03742037|64375773|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
23172599|NCT03742037|64375774|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23172600|NCT03742037|64375775|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23172601|NCT03742037|64375776|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23172602|NCT03742037|64375777|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23172603|NCT03742037|64375778|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
23172604|NCT03742037|64375772|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
23172605|NCT03742037|64375773|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
23172606|NCT03742037|64375774|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
23172607|NCT03742037|64375775|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
23172608|NCT03742037|64375776|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
23172609|NCT03742037|64375777|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
23172610|NCT03742037|64375778|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
23172611|NCT03742037|64375772|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
23172612|NCT03742037|64375773|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
23172613|NCT03742037|64375774|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
23172614|NCT03742037|64375775|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
23172615|NCT03742037|64375776|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
23172616|NCT03742037|64375777|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
23172617|NCT03742037|64375778|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
23172618|NCT03742037|64375772|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23172619|NCT03742037|64375773|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
23172620|NCT03742037|64375774|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23172621|NCT03742037|64375775|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23172622|NCT03742037|64375776|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23172623|NCT03742037|64375777|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
23172624|NCT03742037|64375778|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
23172625|NCT03742037|64375772|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
23172626|NCT03742037|64375773|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
23172627|NCT03742037|64375774|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
23172628|NCT03742037|64375775|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
23172629|NCT03742037|64375776|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
23172630|NCT03742037|64375777|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
23172631|NCT03742037|64375778|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
23172632|NCT03742037|64375772|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23172633|NCT03742037|64375773|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23172634|NCT03742037|64375774|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23172635|NCT03742037|64375775|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23172636|NCT03742037|64375776|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23172637|NCT03742037|64375777|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
23172638|NCT03742037|64375778|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
23172639|NCT03742037|64375772|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
23172640|NCT03742037|64375773|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
23172641|NCT03742037|64375774|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
23172642|NCT03742037|64375775|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
23172643|NCT03742037|64375776|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
23172644|NCT03742037|64375777|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
23172645|NCT03742037|64375778|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
23579511|NCT01474512|65853368|FG008|Induction Period|Adverse Event|0|||
23232678|NCT03490734|64595872|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
23232679|NCT03490734|64595873|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
23232680|NCT03490734|64595870|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
23232681|NCT03490734|64595871|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
23232682|NCT03490734|64595872|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
23579512|NCT01474512|65853369|FG009|Induction Period|Adverse Event|0|||
23579513|NCT01474512|65853370|FG010|Induction Period|Adverse Event|0|||
23579514|NCT01474512|65853371|FG011|Induction Period|Adverse Event|0|||
23579515|NCT01474512|65853372|FG012|Induction Period|Adverse Event|0|||
23579516|NCT01474512|65853373|FG013|Induction Period|Adverse Event|0|||
23579517|NCT01474512|65853374|FG014|Induction Period|Adverse Event|0|||
23579518|NCT01474512|65853375|FG015|Induction Period|Adverse Event|0|||
23579519|NCT01474512|65853376|FG016|Induction Period|Adverse Event|0|||
23232683|NCT03490734|64595873|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
23232684|NCT03490734|64595870|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
23232685|NCT03490734|64595871|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
23232686|NCT03490734|64595872|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
23232687|NCT03490734|64595873|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
23232688|NCT03490734|64595870|FG000|Post-intervention Scan Visit|Adverse Event|2|||
23232689|NCT03490734|64595871|FG001|Post-intervention Scan Visit|Adverse Event|0|||
23232690|NCT03490734|64595872|FG002|Post-intervention Scan Visit|Adverse Event|0|||
23232691|NCT03490734|64595873|FG003|Post-intervention Scan Visit|Adverse Event|0|||
23232692|NCT03490734|64595870|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
23232693|NCT03490734|64595871|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
23232694|NCT03490734|64595872|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
23232695|NCT03490734|64595873|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
23232696|NCT03490734|64595870|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
23232697|NCT03490734|64595871|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
23232698|NCT03490734|64595872|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
23232699|NCT03490734|64595873|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
23232700|NCT02828982|64595874|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23232701|NCT02828982|64595875|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23232702|NCT01539720|64595879|FG000|Overall Study|Screen Fail|15|||
23232703|NCT01539720|64595880|FG001|Overall Study|Screen Fail|3|||
23232704|NCT01539720|64595879|FG000|Overall Study|Lost to Follow-up|14|||
23232705|NCT01539720|64595880|FG001|Overall Study|Lost to Follow-up|7|||
23232706|NCT00129220|64595881|FG000|Study Period II|Adverse Event|9|||
23232707|NCT00129220|64595882|FG001|Study Period II|Adverse Event|5|||
23232708|NCT00129220|64595883|FG002|Study Period II|Adverse Event|7|||
23232709|NCT00129220|64595881|FG000|Study Period II|Lack of Efficacy|15|||
23232710|NCT00129220|64595882|FG001|Study Period II|Lack of Efficacy|1|||
23232711|NCT00129220|64595883|FG002|Study Period II|Lack of Efficacy|28|||
23232712|NCT00129220|64595881|FG000|Study Period II|Entry Criteria Not Met|2|||
23579520|NCT01474512|65853377|FG017|Induction Period|Adverse Event|0|||
23579521|NCT01474512|65853360|FG000|Induction Period|Lack of Efficacy|7|||
23579522|NCT01474512|65853361|FG001|Induction Period|Lack of Efficacy|1|||
23579523|NCT01474512|65853362|FG002|Induction Period|Lack of Efficacy|0|||
23172646|NCT03742037|64375772|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23172647|NCT03742037|64375773|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23172648|NCT03742037|64375774|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23172649|NCT03742037|64375775|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23172650|NCT03742037|64375776|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23172651|NCT03742037|64375777|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
23172652|NCT03742037|64375778|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
23172653|NCT03742037|64375772|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
23172654|NCT03742037|64375773|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
23172655|NCT03742037|64375774|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
23172656|NCT03742037|64375775|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
23172657|NCT03742037|64375776|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
23172658|NCT03742037|64375777|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
23172659|NCT03742037|64375778|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
23172660|NCT03742037|64375772|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
23232713|NCT00129220|64595882|FG001|Study Period II|Entry Criteria Not Met|0|||
23451298|NCT00296816|65395160|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
23579524|NCT01474512|65853363|FG003|Induction Period|Lack of Efficacy|0|||
23579525|NCT01474512|65853364|FG004|Induction Period|Lack of Efficacy|0|||
23579526|NCT01474512|65853365|FG005|Induction Period|Lack of Efficacy|0|||
23579527|NCT01474512|65853366|FG006|Induction Period|Lack of Efficacy|0|||
23579528|NCT01474512|65853367|FG007|Induction Period|Lack of Efficacy|0|||
23232714|NCT00129220|64595883|FG002|Study Period II|Entry Criteria Not Met|2|||
23579529|NCT01474512|65853368|FG008|Induction Period|Lack of Efficacy|0|||
23579530|NCT01474512|65853369|FG009|Induction Period|Lack of Efficacy|0|||
23579531|NCT01474512|65853370|FG010|Induction Period|Lack of Efficacy|0|||
23579532|NCT01474512|65853371|FG011|Induction Period|Lack of Efficacy|0|||
23579533|NCT01474512|65853372|FG012|Induction Period|Lack of Efficacy|0|||
23579534|NCT01474512|65853373|FG013|Induction Period|Lack of Efficacy|0|||
23579535|NCT01474512|65853374|FG014|Induction Period|Lack of Efficacy|0|||
23579536|NCT01474512|65853375|FG015|Induction Period|Lack of Efficacy|0|||
23579537|NCT01474512|65853376|FG016|Induction Period|Lack of Efficacy|0|||
23579538|NCT01474512|65853377|FG017|Induction Period|Lack of Efficacy|0|||
23579539|NCT01474512|65853360|FG000|Induction Period|Withdrawal by Subject|6|||
23579540|NCT01474512|65853361|FG001|Induction Period|Withdrawal by Subject|6|||
23579541|NCT01474512|65853362|FG002|Induction Period|Withdrawal by Subject|5|||
23579542|NCT01474512|65853363|FG003|Induction Period|Withdrawal by Subject|0|||
23579543|NCT01474512|65853364|FG004|Induction Period|Withdrawal by Subject|0|||
23579544|NCT01474512|65853365|FG005|Induction Period|Withdrawal by Subject|0|||
23579545|NCT01474512|65853366|FG006|Induction Period|Withdrawal by Subject|0|||
23579546|NCT01474512|65853367|FG007|Induction Period|Withdrawal by Subject|0|||
23579547|NCT01474512|65853368|FG008|Induction Period|Withdrawal by Subject|0|||
23579548|NCT01474512|65853369|FG009|Induction Period|Withdrawal by Subject|0|||
23579549|NCT01474512|65853370|FG010|Induction Period|Withdrawal by Subject|0|||
23579550|NCT01474512|65853371|FG011|Induction Period|Withdrawal by Subject|0|||
23579551|NCT01474512|65853372|FG012|Induction Period|Withdrawal by Subject|0|||
23579552|NCT01474512|65853373|FG013|Induction Period|Withdrawal by Subject|0|||
23579553|NCT01474512|65853374|FG014|Induction Period|Withdrawal by Subject|0|||
23579554|NCT01474512|65853375|FG015|Induction Period|Withdrawal by Subject|0|||
23579555|NCT01474512|65853376|FG016|Induction Period|Withdrawal by Subject|0|||
23579556|NCT01474512|65853377|FG017|Induction Period|Withdrawal by Subject|0|||
23579557|NCT01474512|65853360|FG000|Induction Period|Protocol Violation|3|||
23579558|NCT01474512|65853361|FG001|Induction Period|Protocol Violation|6|||
23579559|NCT01474512|65853362|FG002|Induction Period|Protocol Violation|0|||
23579560|NCT01474512|65853363|FG003|Induction Period|Protocol Violation|0|||
23579561|NCT01474512|65853364|FG004|Induction Period|Protocol Violation|0|||
23579562|NCT01474512|65853365|FG005|Induction Period|Protocol Violation|0|||
23579563|NCT01474512|65853366|FG006|Induction Period|Protocol Violation|0|||
23579564|NCT01474512|65853367|FG007|Induction Period|Protocol Violation|0|||
23579565|NCT01474512|65853368|FG008|Induction Period|Protocol Violation|0|||
23579566|NCT01474512|65853369|FG009|Induction Period|Protocol Violation|0|||
23579567|NCT01474512|65853370|FG010|Induction Period|Protocol Violation|0|||
23579568|NCT01474512|65853371|FG011|Induction Period|Protocol Violation|0|||
23579569|NCT01474512|65853372|FG012|Induction Period|Protocol Violation|0|||
23579570|NCT01474512|65853373|FG013|Induction Period|Protocol Violation|0|||
23579571|NCT01474512|65853374|FG014|Induction Period|Protocol Violation|0|||
23579572|NCT01474512|65853375|FG015|Induction Period|Protocol Violation|0|||
23579573|NCT01474512|65853376|FG016|Induction Period|Protocol Violation|0|||
23579574|NCT01474512|65853377|FG017|Induction Period|Protocol Violation|0|||
23579575|NCT01474512|65853360|FG000|Induction Period|Sponsor Decision|1|||
23579576|NCT01474512|65853361|FG001|Induction Period|Sponsor Decision|1|||
23579577|NCT01474512|65853362|FG002|Induction Period|Sponsor Decision|1|||
23579578|NCT01474512|65853363|FG003|Induction Period|Sponsor Decision|0|||
23579579|NCT01474512|65853364|FG004|Induction Period|Sponsor Decision|0|||
23579580|NCT01474512|65853365|FG005|Induction Period|Sponsor Decision|0|||
23579581|NCT01474512|65853366|FG006|Induction Period|Sponsor Decision|0|||
23579582|NCT01474512|65853367|FG007|Induction Period|Sponsor Decision|0|||
23579583|NCT01474512|65853368|FG008|Induction Period|Sponsor Decision|0|||
23579584|NCT01474512|65853369|FG009|Induction Period|Sponsor Decision|0|||
23579585|NCT01474512|65853370|FG010|Induction Period|Sponsor Decision|0|||
23579586|NCT01474512|65853371|FG011|Induction Period|Sponsor Decision|0|||
23579587|NCT01474512|65853372|FG012|Induction Period|Sponsor Decision|0|||
23579588|NCT01474512|65853373|FG013|Induction Period|Sponsor Decision|0|||
23579589|NCT01474512|65853374|FG014|Induction Period|Sponsor Decision|0|||
23579590|NCT01474512|65853375|FG015|Induction Period|Sponsor Decision|0|||
23579591|NCT01474512|65853376|FG016|Induction Period|Sponsor Decision|0|||
23579592|NCT01474512|65853377|FG017|Induction Period|Sponsor Decision|0|||
23579593|NCT01474512|65853360|FG000|Induction Period|Lost to Follow-up|1|||
23579594|NCT01474512|65853361|FG001|Induction Period|Lost to Follow-up|0|||
23579595|NCT01474512|65853362|FG002|Induction Period|Lost to Follow-up|2|||
23579596|NCT01474512|65853363|FG003|Induction Period|Lost to Follow-up|0|||
23579597|NCT01474512|65853364|FG004|Induction Period|Lost to Follow-up|0|||
23579598|NCT01474512|65853365|FG005|Induction Period|Lost to Follow-up|0|||
23579599|NCT01474512|65853366|FG006|Induction Period|Lost to Follow-up|0|||
23579600|NCT01474512|65853367|FG007|Induction Period|Lost to Follow-up|0|||
23579601|NCT01474512|65853368|FG008|Induction Period|Lost to Follow-up|0|||
23579602|NCT01474512|65853369|FG009|Induction Period|Lost to Follow-up|0|||
23579603|NCT01474512|65853370|FG010|Induction Period|Lost to Follow-up|0|||
23579604|NCT01474512|65853371|FG011|Induction Period|Lost to Follow-up|0|||
23579605|NCT01474512|65853372|FG012|Induction Period|Lost to Follow-up|0|||
23579606|NCT01474512|65853373|FG013|Induction Period|Lost to Follow-up|0|||
23579607|NCT01474512|65853374|FG014|Induction Period|Lost to Follow-up|0|||
23579608|NCT01474512|65853375|FG015|Induction Period|Lost to Follow-up|0|||
23579609|NCT01474512|65853376|FG016|Induction Period|Lost to Follow-up|0|||
23579610|NCT01474512|65853377|FG017|Induction Period|Lost to Follow-up|0|||
23579611|NCT01474512|65853360|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579612|NCT01474512|65853361|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579613|NCT01474512|65853362|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579614|NCT01474512|65853363|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
23579615|NCT01474512|65853364|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
23579616|NCT01474512|65853365|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
23579617|NCT01474512|65853366|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
23579618|NCT01474512|65853367|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579619|NCT01474512|65853368|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579620|NCT01474512|65853369|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579621|NCT01474512|65853370|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579622|NCT01474512|65853371|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579623|NCT01474512|65853372|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579624|NCT01474512|65853373|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579625|NCT01474512|65853374|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579626|NCT01474512|65853375|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579627|NCT01474512|65853376|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579628|NCT01474512|65853377|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
23579629|NCT01474512|65853360|FG000|Maintenance Period|Adverse Event|0|||
23579630|NCT01474512|65853361|FG001|Maintenance Period|Adverse Event|0|||
23579631|NCT01474512|65853362|FG002|Maintenance Period|Adverse Event|0|||
23579632|NCT01474512|65853363|FG003|Maintenance Period|Adverse Event|4|||
23579633|NCT01474512|65853364|FG004|Maintenance Period|Adverse Event|2|||
23579634|NCT01474512|65853365|FG005|Maintenance Period|Adverse Event|7|||
23579635|NCT01474512|65853366|FG006|Maintenance Period|Adverse Event|0|||
23579636|NCT01474512|65853367|FG007|Maintenance Period|Adverse Event|19|||
23579637|NCT01474512|65853368|FG008|Maintenance Period|Adverse Event|1|||
23579638|NCT01474512|65853369|FG009|Maintenance Period|Adverse Event|3|||
23579639|NCT01474512|65853370|FG010|Maintenance Period|Adverse Event|0|||
23579640|NCT01474512|65853371|FG011|Maintenance Period|Adverse Event|0|||
23579641|NCT01474512|65853372|FG012|Maintenance Period|Adverse Event|0|||
23579642|NCT01474512|65853373|FG013|Maintenance Period|Adverse Event|0|||
23579643|NCT01474512|65853374|FG014|Maintenance Period|Adverse Event|0|||
23579644|NCT01474512|65853375|FG015|Maintenance Period|Adverse Event|0|||
23579645|NCT01474512|65853376|FG016|Maintenance Period|Adverse Event|0|||
23579646|NCT01474512|65853377|FG017|Maintenance Period|Adverse Event|0|||
23579647|NCT01474512|65853360|FG000|Maintenance Period|Withdrawal by Subject|0|||
23579648|NCT01474512|65853361|FG001|Maintenance Period|Withdrawal by Subject|0|||
23579649|NCT01474512|65853362|FG002|Maintenance Period|Withdrawal by Subject|0|||
23579650|NCT01474512|65853363|FG003|Maintenance Period|Withdrawal by Subject|6|||
23172661|NCT03742037|64375773|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
23172662|NCT03742037|64375774|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
23579651|NCT01474512|65853364|FG004|Maintenance Period|Withdrawal by Subject|2|||
23579652|NCT01474512|65853365|FG005|Maintenance Period|Withdrawal by Subject|3|||
23579653|NCT01474512|65853366|FG006|Maintenance Period|Withdrawal by Subject|1|||
23579654|NCT01474512|65853367|FG007|Maintenance Period|Withdrawal by Subject|6|||
23579655|NCT01474512|65853368|FG008|Maintenance Period|Withdrawal by Subject|3|||
23579656|NCT01474512|65853369|FG009|Maintenance Period|Withdrawal by Subject|1|||
23579657|NCT01474512|65853370|FG010|Maintenance Period|Withdrawal by Subject|0|||
23579658|NCT01474512|65853371|FG011|Maintenance Period|Withdrawal by Subject|0|||
23579659|NCT01474512|65853372|FG012|Maintenance Period|Withdrawal by Subject|0|||
23579660|NCT01474512|65853373|FG013|Maintenance Period|Withdrawal by Subject|0|||
23579661|NCT01474512|65853374|FG014|Maintenance Period|Withdrawal by Subject|0|||
23579662|NCT01474512|65853375|FG015|Maintenance Period|Withdrawal by Subject|0|||
23579663|NCT01474512|65853376|FG016|Maintenance Period|Withdrawal by Subject|0|||
23579664|NCT01474512|65853377|FG017|Maintenance Period|Withdrawal by Subject|0|||
23579665|NCT01474512|65853360|FG000|Maintenance Period|Lost to Follow-up|0|||
23579666|NCT01474512|65853361|FG001|Maintenance Period|Lost to Follow-up|0|||
23579667|NCT01474512|65853362|FG002|Maintenance Period|Lost to Follow-up|0|||
23579668|NCT01474512|65853363|FG003|Maintenance Period|Lost to Follow-up|3|||
23579669|NCT01474512|65853364|FG004|Maintenance Period|Lost to Follow-up|3|||
23579670|NCT01474512|65853365|FG005|Maintenance Period|Lost to Follow-up|0|||
23339512|NCT02587598|64986224|FG009|Overall Study|Physician Decision|0|||
23579671|NCT01474512|65853366|FG006|Maintenance Period|Lost to Follow-up|0|||
23579672|NCT01474512|65853367|FG007|Maintenance Period|Lost to Follow-up|2|||
23579673|NCT01474512|65853368|FG008|Maintenance Period|Lost to Follow-up|1|||
23579674|NCT01474512|65853369|FG009|Maintenance Period|Lost to Follow-up|1|||
23579675|NCT01474512|65853370|FG010|Maintenance Period|Lost to Follow-up|0|||
23579676|NCT01474512|65853371|FG011|Maintenance Period|Lost to Follow-up|0|||
23579677|NCT01474512|65853372|FG012|Maintenance Period|Lost to Follow-up|0|||
23579678|NCT01474512|65853373|FG013|Maintenance Period|Lost to Follow-up|0|||
23579679|NCT01474512|65853374|FG014|Maintenance Period|Lost to Follow-up|0|||
23579680|NCT01474512|65853375|FG015|Maintenance Period|Lost to Follow-up|0|||
23579681|NCT01474512|65853376|FG016|Maintenance Period|Lost to Follow-up|0|||
23579682|NCT01474512|65853377|FG017|Maintenance Period|Lost to Follow-up|0|||
23579683|NCT01474512|65853360|FG000|Maintenance Period|Death|0|||
23579684|NCT01474512|65853361|FG001|Maintenance Period|Death|0|||
23579685|NCT01474512|65853362|FG002|Maintenance Period|Death|0|||
23579686|NCT01474512|65853363|FG003|Maintenance Period|Death|0|||
23579687|NCT01474512|65853364|FG004|Maintenance Period|Death|0|||
23579688|NCT01474512|65853365|FG005|Maintenance Period|Death|2|||
23579689|NCT01474512|65853366|FG006|Maintenance Period|Death|0|||
23579690|NCT01474512|65853367|FG007|Maintenance Period|Death|0|||
23579691|NCT01474512|65853368|FG008|Maintenance Period|Death|0|||
23579692|NCT01474512|65853369|FG009|Maintenance Period|Death|0|||
23579693|NCT01474512|65853370|FG010|Maintenance Period|Death|0|||
23579694|NCT01474512|65853371|FG011|Maintenance Period|Death|0|||
23579695|NCT01474512|65853372|FG012|Maintenance Period|Death|0|||
23579696|NCT01474512|65853373|FG013|Maintenance Period|Death|0|||
23579697|NCT01474512|65853374|FG014|Maintenance Period|Death|0|||
23579698|NCT01474512|65853375|FG015|Maintenance Period|Death|0|||
23579699|NCT01474512|65853376|FG016|Maintenance Period|Death|0|||
23579700|NCT01474512|65853377|FG017|Maintenance Period|Death|0|||
23579701|NCT01474512|65853360|FG000|Maintenance Period|Physician Decision|0|||
23579702|NCT01474512|65853361|FG001|Maintenance Period|Physician Decision|0|||
23579703|NCT01474512|65853362|FG002|Maintenance Period|Physician Decision|0|||
23579704|NCT01474512|65853363|FG003|Maintenance Period|Physician Decision|0|||
23579705|NCT01474512|65853364|FG004|Maintenance Period|Physician Decision|0|||
23579706|NCT01474512|65853365|FG005|Maintenance Period|Physician Decision|1|||
23172663|NCT03742037|64375775|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
23172664|NCT03742037|64375776|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
23172665|NCT03742037|64375777|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
23172666|NCT03742037|64375778|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
23172667|NCT03742037|64375772|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23172668|NCT03742037|64375773|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
23172669|NCT03742037|64375774|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
23172670|NCT03742037|64375775|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23172671|NCT03742037|64375776|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23172672|NCT03742037|64375777|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23172673|NCT03742037|64375778|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
23172674|NCT03742037|64375772|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
23172675|NCT03742037|64375773|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23172676|NCT03742037|64375774|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23172677|NCT03742037|64375775|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23232715|NCT00129220|64595881|FG000|Study Period II|Protocol Violation|4|||
23232716|NCT00129220|64595882|FG001|Study Period II|Protocol Violation|2|||
23232717|NCT00129220|64595883|FG002|Study Period II|Protocol Violation|1|||
23232718|NCT00129220|64595881|FG000|Study Period II|Physician Decision|0|||
23232719|NCT00129220|64595882|FG001|Study Period II|Physician Decision|1|||
23232720|NCT00129220|64595883|FG002|Study Period II|Physician Decision|0|||
23232721|NCT00129220|64595881|FG000|Study Period II|Withdrawal by Subject|1|||
23232722|NCT00129220|64595882|FG001|Study Period II|Withdrawal by Subject|3|||
23232723|NCT00129220|64595883|FG002|Study Period II|Withdrawal by Subject|4|||
23232724|NCT00129220|64595881|FG000|Study Period II|Reason Not Specified|2|||
23232725|NCT00129220|64595882|FG001|Study Period II|Reason Not Specified|0|||
23232726|NCT00129220|64595883|FG002|Study Period II|Reason Not Specified|5|||
23232727|NCT00129220|64595881|FG000|Study Period III|Adverse Event|1|||
23579707|NCT01474512|65853366|FG006|Maintenance Period|Physician Decision|0|||
23579708|NCT01474512|65853367|FG007|Maintenance Period|Physician Decision|2|||
23579709|NCT01474512|65853368|FG008|Maintenance Period|Physician Decision|0|||
23579710|NCT01474512|65853369|FG009|Maintenance Period|Physician Decision|0|||
23579711|NCT01474512|65853370|FG010|Maintenance Period|Physician Decision|0|||
23172678|NCT03742037|64375776|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23172679|NCT03742037|64375777|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
23232728|NCT00129220|64595882|FG001|Study Period III|Adverse Event|0|||
23232729|NCT00129220|64595883|FG002|Study Period III|Adverse Event|3|||
23232730|NCT00129220|64595881|FG000|Study Period III|Protocol Violation|1|||
23232731|NCT00129220|64595882|FG001|Study Period III|Protocol Violation|1|||
23232732|NCT00129220|64595883|FG002|Study Period III|Protocol Violation|2|||
23232733|NCT00129220|64595881|FG000|Study Period III|Withdrawal by Subject|1|||
23579712|NCT01474512|65853371|FG011|Maintenance Period|Physician Decision|0|||
23172680|NCT03742037|64375778|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
23172681|NCT03742037|64375772|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
23172682|NCT03742037|64375773|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
23172683|NCT03742037|64375774|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
23172684|NCT03742037|64375775|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
23172685|NCT03742037|64375776|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
23172686|NCT03742037|64375777|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
23172687|NCT03742037|64375778|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
23172688|NCT03742037|64375772|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
23172689|NCT03742037|64375773|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
23172690|NCT03742037|64375774|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
23172691|NCT03742037|64375775|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
23172692|NCT03742037|64375776|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
23232734|NCT00129220|64595882|FG001|Study Period III|Withdrawal by Subject|0|||
23232735|NCT00129220|64595883|FG002|Study Period III|Withdrawal by Subject|3|||
23232736|NCT00129220|64595881|FG000|Study Period III|Sponsor Decision|1|||
23232737|NCT00129220|64595882|FG001|Study Period III|Sponsor Decision|0|||
23232738|NCT00129220|64595883|FG002|Study Period III|Sponsor Decision|0|||
23172693|NCT03742037|64375777|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
23172694|NCT03742037|64375778|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
23172695|NCT03742037|64375772|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23172696|NCT03742037|64375773|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23451299|NCT00296816|65395160|FG000|Overall Study|Poor performance status|1|||
23451300|NCT00296816|65395160|FG000|Overall Study|Relocation to Florida|1|||
23451301|NCT00296816|65395160|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
23451302|NCT00296816|65395160|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
23451303|NCT00296816|65395160|FG000|Overall Study|Neuropathy/patient preference|1|||
23451304|NCT00296816|65395160|FG000|Overall Study|Proteinuria|1|||
23451305|NCT00296816|65395160|FG000|Overall Study|ineligibility due to radiation treatment|1|||
23451306|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
23451307|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
23451308|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
23451309|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
23451310|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
23451311|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
23451312|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
23451313|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
23451314|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
23451315|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
23451316|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
23175851|NCT01506882|64386592|FG001|Overall Study|Withdrawal by Subject|3|||
23451317|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
23451318|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
23451319|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
23451320|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
23232739|NCT00129220|64595881|FG000|Study Period III|Reason Not Specified|9|||
23451321|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
23451322|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
23451323|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
23232740|NCT00129220|64595882|FG001|Study Period III|Reason Not Specified|0|||
23232741|NCT00129220|64595883|FG002|Study Period III|Reason Not Specified|2|||
23451324|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
23451325|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
23451326|NCT01329978|65395163|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
23451327|NCT01329978|65395164|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
23451328|NCT01329978|65395165|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
23451329|NCT01329978|65395166|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
23451330|NCT01329978|65395167|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
23451331|NCT01329978|65395163|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
23451332|NCT01329978|65395164|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
23451333|NCT01329978|65395165|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
23451334|NCT01329978|65395166|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
23451335|NCT01329978|65395167|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
23451336|NCT01329978|65395163|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
23172697|NCT03742037|64375774|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
23232742|NCT01362062|64595884|FG000|Overall Study|Adverse Event|1|||
23451337|NCT01329978|65395164|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
23451338|NCT01329978|65395165|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
23451339|NCT01329978|65395166|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
23451340|NCT01329978|65395167|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
23451341|NCT02796677|65395169|FG000|Overall Study|Adverse Event|11|||
23451342|NCT02796677|65395170|FG001|Overall Study|Adverse Event|22|||
23451343|NCT02796677|65395171|FG002|Overall Study|Adverse Event|14|||
23451344|NCT02796677|65395172|FG003|Overall Study|Adverse Event|14|||
23451345|NCT02796677|65395169|FG000|Overall Study|Protocol Violation|7|||
23451346|NCT02796677|65395170|FG001|Overall Study|Protocol Violation|5|||
23451347|NCT02796677|65395171|FG002|Overall Study|Protocol Violation|4|||
23451348|NCT02796677|65395172|FG003|Overall Study|Protocol Violation|8|||
23172698|NCT03742037|64375775|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23172699|NCT03742037|64375776|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23172700|NCT03742037|64375777|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23172701|NCT03742037|64375778|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
23172702|NCT01995071|64375781|FG000|Overall Study|Adverse Event|0|||
23172703|NCT01995071|64375782|FG001|Overall Study|Adverse Event|0|||
23232743|NCT01362062|64595885|FG001|Overall Study|Adverse Event|0|||
23232744|NCT01362062|64595884|FG000|Overall Study|Lost to Follow-up|11|||
23451349|NCT02796677|65395169|FG000|Overall Study|Lost to Follow-up|1|||
23451350|NCT02796677|65395170|FG001|Overall Study|Lost to Follow-up|5|||
23451351|NCT02796677|65395171|FG002|Overall Study|Lost to Follow-up|2|||
23172704|NCT01995071|64375783|FG002|Overall Study|Adverse Event|0|||
23172705|NCT01995071|64375784|FG003|Overall Study|Adverse Event|0|||
23172706|NCT01995071|64375785|FG004|Overall Study|Adverse Event|0|||
23172707|NCT01995071|64375786|FG005|Overall Study|Adverse Event|0|||
23172708|NCT01995071|64375787|FG006|Overall Study|Adverse Event|1|||
23172709|NCT01995071|64375788|FG007|Overall Study|Adverse Event|0|||
23172710|NCT01995071|64375789|FG008|Overall Study|Adverse Event|0|||
23172711|NCT01995071|64375790|FG009|Overall Study|Adverse Event|0|||
23172712|NCT01995071|64375791|FG010|Overall Study|Adverse Event|0|||
23172713|NCT01995071|64375792|FG011|Overall Study|Adverse Event|0|||
23172714|NCT01995071|64375781|FG000|Overall Study|Moved|0|||
23172715|NCT01995071|64375782|FG001|Overall Study|Moved|0|||
23172716|NCT01995071|64375783|FG002|Overall Study|Moved|1|||
23172717|NCT01995071|64375784|FG003|Overall Study|Moved|0|||
23172718|NCT01995071|64375785|FG004|Overall Study|Moved|1|||
23172719|NCT01995071|64375786|FG005|Overall Study|Moved|0|||
23172720|NCT01995071|64375787|FG006|Overall Study|Moved|0|||
23172721|NCT01995071|64375788|FG007|Overall Study|Moved|0|||
23172722|NCT01995071|64375789|FG008|Overall Study|Moved|0|||
23172723|NCT01995071|64375790|FG009|Overall Study|Moved|0|||
23172724|NCT01995071|64375791|FG010|Overall Study|Moved|1|||
23172725|NCT01995071|64375792|FG011|Overall Study|Moved|0|||
23172726|NCT01995071|64375781|FG000|Overall Study|Lost to Follow-up|1|||
23172727|NCT01995071|64375782|FG001|Overall Study|Lost to Follow-up|0|||
23172728|NCT01995071|64375783|FG002|Overall Study|Lost to Follow-up|0|||
23172729|NCT01995071|64375784|FG003|Overall Study|Lost to Follow-up|0|||
23172730|NCT01995071|64375785|FG004|Overall Study|Lost to Follow-up|0|||
23172731|NCT01995071|64375786|FG005|Overall Study|Lost to Follow-up|0|||
23232745|NCT01362062|64595885|FG001|Overall Study|Lost to Follow-up|0|||
23232746|NCT01362062|64595884|FG000|Overall Study|Withdrawal by Subject|2|||
23232747|NCT01362062|64595885|FG001|Overall Study|Withdrawal by Subject|0|||
23232748|NCT01362062|64595884|FG000|Overall Study|Non-compliant participant|2|||
23232749|NCT01362062|64595885|FG001|Overall Study|Non-compliant participant|0|||
23232750|NCT01362062|64595884|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
23232751|NCT01362062|64595885|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
23232752|NCT01362062|64595884|FG000|Overall Study|Had significant improvement|9|||
23232753|NCT01362062|64595885|FG001|Overall Study|Had significant improvement|0|||
23232754|NCT05047601|64595887|FG000|Overall Study|Lost to Follow-up|9|||
23232755|NCT05047601|64595888|FG001|Overall Study|Lost to Follow-up|11|||
23172732|NCT01995071|64375787|FG006|Overall Study|Lost to Follow-up|0|||
23339513|NCT02587598|64986225|FG010|Overall Study|Physician Decision|3|||
23451352|NCT02796677|65395172|FG003|Overall Study|Lost to Follow-up|2|||
23451353|NCT02796677|65395169|FG000|Overall Study|Lack of Efficacy|7|||
23451354|NCT02796677|65395170|FG001|Overall Study|Lack of Efficacy|9|||
23451355|NCT02796677|65395171|FG002|Overall Study|Lack of Efficacy|14|||
23451356|NCT02796677|65395172|FG003|Overall Study|Lack of Efficacy|20|||
23172733|NCT01995071|64375788|FG007|Overall Study|Lost to Follow-up|1|||
23232756|NCT05047601|64595889|FG002|Overall Study|Lost to Follow-up|7|||
23232757|NCT05047601|64595887|FG000|Overall Study|Withdrawal by Subject|25|||
23232758|NCT05047601|64595888|FG001|Overall Study|Withdrawal by Subject|36|||
23232759|NCT05047601|64595889|FG002|Overall Study|Withdrawal by Subject|23|||
23232760|NCT05047601|64595887|FG000|Overall Study|Other|10|||
23232761|NCT05047601|64595888|FG001|Overall Study|Other|6|||
23232762|NCT05047601|64595889|FG002|Overall Study|Other|5|||
23232763|NCT01397409|64595894|FG000|Stage 2|Adverse Event|0|||
23232764|NCT01397409|64595895|FG001|Stage 2|Adverse Event|0|||
23232765|NCT01397409|64595896|FG002|Stage 2|Adverse Event|0|||
23232766|NCT01397409|64595897|FG003|Stage 2|Adverse Event|0|||
23232767|NCT01397409|64595898|FG004|Stage 2|Adverse Event|6|||
23232768|NCT01397409|64595899|FG005|Stage 2|Adverse Event|3|||
23232769|NCT01397409|64595900|FG006|Stage 2|Adverse Event|0|||
23232770|NCT01397409|64595901|FG007|Stage 2|Adverse Event|0|||
23232771|NCT01397409|64595902|FG008|Stage 2|Adverse Event|0|||
23232772|NCT01397409|64595903|FG009|Stage 2|Adverse Event|0|||
23232773|NCT01397409|64595894|FG000|Stage 2|Personal Reasons|0|||
23232774|NCT01397409|64595895|FG001|Stage 2|Personal Reasons|0|||
23232775|NCT01397409|64595896|FG002|Stage 2|Personal Reasons|0|||
23339514|NCT00435487|64986226|FG000|Overall Study|Death|3|||
23339515|NCT00435487|64986227|FG001|Overall Study|Death|4|||
23339516|NCT00435487|64986226|FG000|Overall Study|Adverse Event|0|||
23339517|NCT00435487|64986227|FG001|Overall Study|Adverse Event|3|||
23339518|NCT00435487|64986226|FG000|Overall Study|Lost to Follow-up|2|||
23339519|NCT00435487|64986227|FG001|Overall Study|Lost to Follow-up|2|||
23339520|NCT00435487|64986226|FG000|Overall Study|Other|5|||
23579713|NCT01474512|65853372|FG012|Maintenance Period|Physician Decision|0|||
23579714|NCT01474512|65853373|FG013|Maintenance Period|Physician Decision|0|||
23579715|NCT01474512|65853374|FG014|Maintenance Period|Physician Decision|0|||
23579716|NCT01474512|65853375|FG015|Maintenance Period|Physician Decision|0|||
23579717|NCT01474512|65853376|FG016|Maintenance Period|Physician Decision|0|||
23579718|NCT01474512|65853377|FG017|Maintenance Period|Physician Decision|0|||
23339521|NCT00435487|64986227|FG001|Overall Study|Other|2|||
23339522|NCT00435487|64986226|FG000|Overall Study|Withdrawal by Subject|2|||
23339523|NCT00435487|64986227|FG001|Overall Study|Withdrawal by Subject|1|||
23339524|NCT00435487|64986226|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
23451357|NCT02796677|65395169|FG000|Overall Study|Withdrawal by Subject|4|||
23579719|NCT01474512|65853360|FG000|Maintenance Period|Clinical Relapse|0|||
23579720|NCT01474512|65853361|FG001|Maintenance Period|Clinical Relapse|0|||
23579721|NCT01474512|65853362|FG002|Maintenance Period|Clinical Relapse|0|||
23579722|NCT01474512|65853363|FG003|Maintenance Period|Clinical Relapse|1|||
23579723|NCT01474512|65853364|FG004|Maintenance Period|Clinical Relapse|0|||
23579724|NCT01474512|65853365|FG005|Maintenance Period|Clinical Relapse|0|||
23579725|NCT01474512|65853366|FG006|Maintenance Period|Clinical Relapse|0|||
23579726|NCT01474512|65853367|FG007|Maintenance Period|Clinical Relapse|0|||
23232776|NCT01397409|64595897|FG003|Stage 2|Personal Reasons|0|||
23339525|NCT00435487|64986227|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
23339526|NCT00435487|64986226|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
23451358|NCT02796677|65395170|FG001|Overall Study|Withdrawal by Subject|14|||
23451359|NCT02796677|65395171|FG002|Overall Study|Withdrawal by Subject|6|||
23579727|NCT01474512|65853368|FG008|Maintenance Period|Clinical Relapse|0|||
23172734|NCT01995071|64375789|FG008|Overall Study|Lost to Follow-up|1|||
23232777|NCT01397409|64595898|FG004|Stage 2|Personal Reasons|1|||
23232778|NCT01397409|64595899|FG005|Stage 2|Personal Reasons|0|||
23232779|NCT01397409|64595900|FG006|Stage 2|Personal Reasons|0|||
23232780|NCT01397409|64595901|FG007|Stage 2|Personal Reasons|0|||
23232781|NCT01397409|64595902|FG008|Stage 2|Personal Reasons|0|||
23232782|NCT01397409|64595903|FG009|Stage 2|Personal Reasons|0|||
23339527|NCT00435487|64986227|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
23339528|NCT00330343|64986232|FG000|Overall Study|Lost to Follow-up|5|||
23339529|NCT02475265|64986235|FG000|Overall Study|Physician Decision|1|||
23339530|NCT02475265|64986235|FG000|Overall Study|Withdrawal by Subject|2|||
23339531|NCT03875482|64986238|FG000|Overall Study|Adverse Event|0|||
23339532|NCT03875482|64986239|FG001|Overall Study|Adverse Event|1|||
23339533|NCT03875482|64986238|FG000|Overall Study|Withdrew consent|5|||
23339534|NCT03875482|64986239|FG001|Overall Study|Withdrew consent|6|||
23339535|NCT03875482|64986238|FG000|Overall Study|Lost to Follow-up|8|||
23339536|NCT03875482|64986239|FG001|Overall Study|Lost to Follow-up|2|||
23339537|NCT03875482|64986238|FG000|Overall Study|Lack of Efficacy|0|||
23339538|NCT03875482|64986239|FG001|Overall Study|Lack of Efficacy|11|||
23339539|NCT01931995|64986240|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
23339540|NCT01931995|64986241|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
23172735|NCT01995071|64375790|FG009|Overall Study|Lost to Follow-up|0|||
23172736|NCT01995071|64375791|FG010|Overall Study|Lost to Follow-up|0|||
23172737|NCT01995071|64375792|FG011|Overall Study|Lost to Follow-up|0|||
23172738|NCT01995071|64375781|FG000|Overall Study|Incarcerated|0|||
23172739|NCT01995071|64375782|FG001|Overall Study|Incarcerated|0|||
23339541|NCT01931995|64986240|FG000|First Intervention (1 Day)|Physician Decision|1|||
23339542|NCT01931995|64986241|FG001|First Intervention (1 Day)|Physician Decision|1|||
23339543|NCT01931995|64986240|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
23579728|NCT01474512|65853369|FG009|Maintenance Period|Clinical Relapse|0|||
23579729|NCT01474512|65853370|FG010|Maintenance Period|Clinical Relapse|0|||
23579730|NCT01474512|65853371|FG011|Maintenance Period|Clinical Relapse|0|||
23579731|NCT01474512|65853372|FG012|Maintenance Period|Clinical Relapse|0|||
23579732|NCT01474512|65853373|FG013|Maintenance Period|Clinical Relapse|0|||
23579733|NCT01474512|65853374|FG014|Maintenance Period|Clinical Relapse|0|||
23579734|NCT01474512|65853375|FG015|Maintenance Period|Clinical Relapse|0|||
23579735|NCT01474512|65853376|FG016|Maintenance Period|Clinical Relapse|0|||
23579736|NCT01474512|65853377|FG017|Maintenance Period|Clinical Relapse|0|||
23579737|NCT01474512|65853360|FG000|Maintenance Period|Lack of Efficacy|0|||
23579738|NCT01474512|65853361|FG001|Maintenance Period|Lack of Efficacy|0|||
23579739|NCT01474512|65853362|FG002|Maintenance Period|Lack of Efficacy|0|||
23579740|NCT01474512|65853363|FG003|Maintenance Period|Lack of Efficacy|1|||
23579741|NCT01474512|65853364|FG004|Maintenance Period|Lack of Efficacy|0|||
23579742|NCT01474512|65853365|FG005|Maintenance Period|Lack of Efficacy|0|||
23579743|NCT01474512|65853366|FG006|Maintenance Period|Lack of Efficacy|0|||
23579744|NCT01474512|65853367|FG007|Maintenance Period|Lack of Efficacy|11|||
23579745|NCT01474512|65853368|FG008|Maintenance Period|Lack of Efficacy|11|||
23579746|NCT01474512|65853369|FG009|Maintenance Period|Lack of Efficacy|12|||
23579747|NCT01474512|65853370|FG010|Maintenance Period|Lack of Efficacy|0|||
23579748|NCT01474512|65853371|FG011|Maintenance Period|Lack of Efficacy|0|||
23579749|NCT01474512|65853372|FG012|Maintenance Period|Lack of Efficacy|0|||
23579750|NCT01474512|65853373|FG013|Maintenance Period|Lack of Efficacy|0|||
23579751|NCT01474512|65853374|FG014|Maintenance Period|Lack of Efficacy|0|||
23579752|NCT01474512|65853375|FG015|Maintenance Period|Lack of Efficacy|0|||
23579753|NCT01474512|65853376|FG016|Maintenance Period|Lack of Efficacy|0|||
23579754|NCT01474512|65853377|FG017|Maintenance Period|Lack of Efficacy|0|||
23579755|NCT01474512|65853360|FG000|Maintenance Period|Protocol Violation|0|||
23579756|NCT01474512|65853361|FG001|Maintenance Period|Protocol Violation|0|||
23579757|NCT01474512|65853362|FG002|Maintenance Period|Protocol Violation|0|||
23579758|NCT01474512|65853363|FG003|Maintenance Period|Protocol Violation|1|||
23579759|NCT01474512|65853364|FG004|Maintenance Period|Protocol Violation|0|||
23579760|NCT01474512|65853365|FG005|Maintenance Period|Protocol Violation|0|||
23579761|NCT01474512|65853366|FG006|Maintenance Period|Protocol Violation|0|||
23579762|NCT01474512|65853367|FG007|Maintenance Period|Protocol Violation|1|||
23579763|NCT01474512|65853368|FG008|Maintenance Period|Protocol Violation|0|||
23172740|NCT01995071|64375783|FG002|Overall Study|Incarcerated|0|||
23172741|NCT01995071|64375784|FG003|Overall Study|Incarcerated|0|||
23172742|NCT01995071|64375785|FG004|Overall Study|Incarcerated|0|||
23172743|NCT01995071|64375786|FG005|Overall Study|Incarcerated|0|||
23172744|NCT01995071|64375787|FG006|Overall Study|Incarcerated|0|||
23172745|NCT01995071|64375788|FG007|Overall Study|Incarcerated|1|||
23339544|NCT01931995|64986241|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
23339545|NCT04713592|64986250|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
23579764|NCT01474512|65853369|FG009|Maintenance Period|Protocol Violation|1|||
23579765|NCT01474512|65853370|FG010|Maintenance Period|Protocol Violation|0|||
23579766|NCT01474512|65853371|FG011|Maintenance Period|Protocol Violation|0|||
23172746|NCT01995071|64375789|FG008|Overall Study|Incarcerated|0|||
23339546|NCT04713592|64986251|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
23579767|NCT01474512|65853372|FG012|Maintenance Period|Protocol Violation|0|||
23172747|NCT01995071|64375790|FG009|Overall Study|Incarcerated|0|||
23339547|NCT04713592|64986252|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
23339548|NCT04713592|64986253|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
23339549|NCT04713592|64986250|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
23339550|NCT04713592|64986251|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
23339551|NCT04713592|64986252|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
23339552|NCT04713592|64986253|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
23579768|NCT01474512|65853373|FG013|Maintenance Period|Protocol Violation|0|||
23579769|NCT01474512|65853374|FG014|Maintenance Period|Protocol Violation|0|||
23579770|NCT01474512|65853375|FG015|Maintenance Period|Protocol Violation|0|||
23579771|NCT01474512|65853376|FG016|Maintenance Period|Protocol Violation|0|||
23579772|NCT01474512|65853377|FG017|Maintenance Period|Protocol Violation|0|||
23579773|NCT01474512|65853360|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
23579774|NCT01474512|65853361|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
23579775|NCT01474512|65853362|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
23579776|NCT01474512|65853363|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
23579777|NCT01474512|65853364|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
23579778|NCT01474512|65853365|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
23579779|NCT01474512|65853366|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
23579780|NCT01474512|65853367|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
23579781|NCT01474512|65853368|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
23579782|NCT01474512|65853369|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
23579783|NCT01474512|65853370|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
23579784|NCT01474512|65853371|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
23579785|NCT01474512|65853372|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
23579786|NCT01474512|65853373|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
23579787|NCT01474512|65853374|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
23579788|NCT01474512|65853375|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
23579789|NCT01474512|65853376|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
23579790|NCT01474512|65853377|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
23579791|NCT01474512|65853360|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
23579792|NCT01474512|65853361|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
23579793|NCT01474512|65853362|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
23579794|NCT01474512|65853363|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
23579795|NCT01474512|65853364|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
23579796|NCT01474512|65853365|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
23579797|NCT01474512|65853366|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
23579798|NCT01474512|65853367|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
23579799|NCT01474512|65853368|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
23579800|NCT01474512|65853369|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
23579801|NCT01474512|65853370|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
23579802|NCT01474512|65853371|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
23579803|NCT01474512|65853372|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
23579804|NCT01474512|65853373|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
23579805|NCT01474512|65853374|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
23579806|NCT01474512|65853375|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
23579807|NCT01474512|65853376|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
23579808|NCT01474512|65853377|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
23579809|NCT01474512|65853360|FG000|Long-Term Extension Period|Adverse Event|0|||
23579810|NCT01474512|65853361|FG001|Long-Term Extension Period|Adverse Event|0|||
23579811|NCT01474512|65853362|FG002|Long-Term Extension Period|Adverse Event|0|||
23579812|NCT01474512|65853363|FG003|Long-Term Extension Period|Adverse Event|0|||
23579813|NCT01474512|65853364|FG004|Long-Term Extension Period|Adverse Event|0|||
23579814|NCT01474512|65853365|FG005|Long-Term Extension Period|Adverse Event|0|||
23579815|NCT01474512|65853366|FG006|Long-Term Extension Period|Adverse Event|0|||
23579816|NCT01474512|65853367|FG007|Long-Term Extension Period|Adverse Event|0|||
23579817|NCT01474512|65853368|FG008|Long-Term Extension Period|Adverse Event|0|||
23579818|NCT01474512|65853369|FG009|Long-Term Extension Period|Adverse Event|0|||
23579819|NCT01474512|65853370|FG010|Long-Term Extension Period|Adverse Event|0|||
23579820|NCT01474512|65853371|FG011|Long-Term Extension Period|Adverse Event|1|||
23579821|NCT01474512|65853372|FG012|Long-Term Extension Period|Adverse Event|57|||
23579822|NCT01474512|65853373|FG013|Long-Term Extension Period|Adverse Event|58|||
23579823|NCT01474512|65853374|FG014|Long-Term Extension Period|Adverse Event|0|||
23579824|NCT01474512|65853375|FG015|Long-Term Extension Period|Adverse Event|0|||
23579825|NCT01474512|65853376|FG016|Long-Term Extension Period|Adverse Event|0|||
23579826|NCT01474512|65853377|FG017|Long-Term Extension Period|Adverse Event|0|||
23579827|NCT01474512|65853360|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
23579828|NCT01474512|65853361|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
23579829|NCT01474512|65853362|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
23579830|NCT01474512|65853363|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
23579831|NCT01474512|65853364|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
23579832|NCT01474512|65853365|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
23451360|NCT02796677|65395172|FG003|Overall Study|Withdrawal by Subject|7|||
23451361|NCT02796677|65395169|FG000|Overall Study|Progressive disease|6|||
23451362|NCT02796677|65395170|FG001|Overall Study|Progressive disease|15|||
23579833|NCT01474512|65853366|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
23579834|NCT01474512|65853367|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
23579835|NCT01474512|65853368|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
23579836|NCT01474512|65853369|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
23579837|NCT01474512|65853370|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
23579838|NCT01474512|65853371|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
23579839|NCT01474512|65853372|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
23579840|NCT01474512|65853373|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
23579841|NCT01474512|65853374|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
23579842|NCT01474512|65853375|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
23579843|NCT01474512|65853376|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
23579844|NCT01474512|65853377|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
23579845|NCT01474512|65853360|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
23579846|NCT01474512|65853361|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
23579847|NCT01474512|65853362|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
23172748|NCT01995071|64375791|FG010|Overall Study|Incarcerated|0|||
23172749|NCT01995071|64375792|FG011|Overall Study|Incarcerated|0|||
23172750|NCT00364689|64375793|FG000|Overall Study|Lost to Follow-up|1|||
23172751|NCT01042600|64375794|FG000|Overall Study|Ineligible|1|||
23172752|NCT01042600|64375795|FG001|Overall Study|Ineligible|0|||
23172753|NCT00493038|64375796|FG000|Treatment|Adverse Event|8|||
23172754|NCT00493038|64375797|FG001|Treatment|Adverse Event|4|||
23172755|NCT00493038|64375796|FG000|Treatment|Lost to Follow-up|5|||
23172756|NCT00493038|64375797|FG001|Treatment|Lost to Follow-up|3|||
23172757|NCT00493038|64375796|FG000|Treatment|Withdrawal by Subject|11|||
23172758|NCT00493038|64375797|FG001|Treatment|Withdrawal by Subject|12|||
23172759|NCT00493038|64375796|FG000|Treatment|Other|0|||
23172760|NCT00493038|64375797|FG001|Treatment|Other|1|||
23232783|NCT01397409|64595894|FG000|Stage 2|Other Miscellaneous Reasons|0|||
23172761|NCT00493038|64375796|FG000|Follow-up|Lost to Follow-up|1|||
23451363|NCT02796677|65395171|FG002|Overall Study|Progressive disease|13|||
23232784|NCT01397409|64595895|FG001|Stage 2|Other Miscellaneous Reasons|0|||
23232785|NCT01397409|64595896|FG002|Stage 2|Other Miscellaneous Reasons|0|||
23232786|NCT01397409|64595897|FG003|Stage 2|Other Miscellaneous Reasons|0|||
23232787|NCT01397409|64595898|FG004|Stage 2|Other Miscellaneous Reasons|1|||
23232788|NCT01397409|64595899|FG005|Stage 2|Other Miscellaneous Reasons|1|||
23232789|NCT01397409|64595900|FG006|Stage 2|Other Miscellaneous Reasons|0|||
23232790|NCT01397409|64595901|FG007|Stage 2|Other Miscellaneous Reasons|0|||
23232791|NCT01397409|64595902|FG008|Stage 2|Other Miscellaneous Reasons|0|||
23232792|NCT01397409|64595903|FG009|Stage 2|Other Miscellaneous Reasons|0|||
23232793|NCT01397409|64595894|FG000|Stage 3|Adverse Event|0|||
23232794|NCT01397409|64595895|FG001|Stage 3|Adverse Event|0|||
23232795|NCT01397409|64595896|FG002|Stage 3|Adverse Event|0|||
23232796|NCT01397409|64595897|FG003|Stage 3|Adverse Event|0|||
23232797|NCT01397409|64595898|FG004|Stage 3|Adverse Event|0|||
23232798|NCT01397409|64595899|FG005|Stage 3|Adverse Event|0|||
23232799|NCT01397409|64595900|FG006|Stage 3|Adverse Event|0|||
23579848|NCT01474512|65853363|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
23579849|NCT01474512|65853364|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
23232800|NCT01397409|64595901|FG007|Stage 3|Adverse Event|1|||
23579850|NCT01474512|65853365|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
23579851|NCT01474512|65853366|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
23579852|NCT01474512|65853367|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
23579853|NCT01474512|65853368|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
23579854|NCT01474512|65853369|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
23579855|NCT01474512|65853370|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
23579856|NCT01474512|65853371|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
23579857|NCT01474512|65853372|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
23579858|NCT01474512|65853373|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
23579859|NCT01474512|65853374|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
23579860|NCT01474512|65853375|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
23579861|NCT01474512|65853376|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
23579862|NCT01474512|65853377|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
23579863|NCT01474512|65853360|FG000|Long-Term Extension Period|Physician Decision|0|||
23579864|NCT01474512|65853361|FG001|Long-Term Extension Period|Physician Decision|0|||
23579865|NCT01474512|65853362|FG002|Long-Term Extension Period|Physician Decision|0|||
23579866|NCT01474512|65853363|FG003|Long-Term Extension Period|Physician Decision|0|||
23579867|NCT01474512|65853364|FG004|Long-Term Extension Period|Physician Decision|0|||
23579868|NCT01474512|65853365|FG005|Long-Term Extension Period|Physician Decision|0|||
23579869|NCT01474512|65853366|FG006|Long-Term Extension Period|Physician Decision|0|||
23579870|NCT01474512|65853367|FG007|Long-Term Extension Period|Physician Decision|0|||
23579871|NCT01474512|65853368|FG008|Long-Term Extension Period|Physician Decision|0|||
23579872|NCT01474512|65853369|FG009|Long-Term Extension Period|Physician Decision|0|||
23579873|NCT01474512|65853370|FG010|Long-Term Extension Period|Physician Decision|0|||
23579874|NCT01474512|65853371|FG011|Long-Term Extension Period|Physician Decision|0|||
23579875|NCT01474512|65853372|FG012|Long-Term Extension Period|Physician Decision|21|||
23579876|NCT01474512|65853373|FG013|Long-Term Extension Period|Physician Decision|21|||
23579877|NCT01474512|65853374|FG014|Long-Term Extension Period|Physician Decision|0|||
23579878|NCT01474512|65853375|FG015|Long-Term Extension Period|Physician Decision|0|||
23579879|NCT01474512|65853376|FG016|Long-Term Extension Period|Physician Decision|0|||
23579880|NCT01474512|65853377|FG017|Long-Term Extension Period|Physician Decision|0|||
23579881|NCT01474512|65853360|FG000|Long-Term Extension Period|Clinical Relapse|0|||
23579882|NCT01474512|65853361|FG001|Long-Term Extension Period|Clinical Relapse|0|||
23579883|NCT01474512|65853362|FG002|Long-Term Extension Period|Clinical Relapse|0|||
23579884|NCT01474512|65853363|FG003|Long-Term Extension Period|Clinical Relapse|0|||
23579885|NCT01474512|65853364|FG004|Long-Term Extension Period|Clinical Relapse|0|||
23579886|NCT01474512|65853365|FG005|Long-Term Extension Period|Clinical Relapse|0|||
23579887|NCT01474512|65853366|FG006|Long-Term Extension Period|Clinical Relapse|0|||
23579888|NCT01474512|65853367|FG007|Long-Term Extension Period|Clinical Relapse|0|||
23579889|NCT01474512|65853368|FG008|Long-Term Extension Period|Clinical Relapse|0|||
23579890|NCT01474512|65853369|FG009|Long-Term Extension Period|Clinical Relapse|0|||
23579891|NCT01474512|65853370|FG010|Long-Term Extension Period|Clinical Relapse|0|||
23579892|NCT01474512|65853371|FG011|Long-Term Extension Period|Clinical Relapse|0|||
23579893|NCT01474512|65853372|FG012|Long-Term Extension Period|Clinical Relapse|9|||
23579894|NCT01474512|65853373|FG013|Long-Term Extension Period|Clinical Relapse|9|||
23579895|NCT01474512|65853374|FG014|Long-Term Extension Period|Clinical Relapse|0|||
23579896|NCT01474512|65853375|FG015|Long-Term Extension Period|Clinical Relapse|0|||
23579897|NCT01474512|65853376|FG016|Long-Term Extension Period|Clinical Relapse|0|||
23579898|NCT01474512|65853377|FG017|Long-Term Extension Period|Clinical Relapse|0|||
23232801|NCT01397409|64595902|FG008|Stage 3|Adverse Event|0|||
23232802|NCT01397409|64595903|FG009|Stage 3|Adverse Event|0|||
23232803|NCT01397409|64595894|FG000|Stage 3|Other Miscellaneous Reasons|0|||
23339553|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
23339554|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
23339555|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
23339556|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
23339557|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23339558|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23579899|NCT01474512|65853360|FG000|Long-Term Extension Period|Death|0|||
23579900|NCT01474512|65853361|FG001|Long-Term Extension Period|Death|0|||
23172762|NCT00493038|64375797|FG001|Follow-up|Lost to Follow-up|0|||
23172763|NCT00763321|64375798|FG000|Open-label Period|Adverse Event|24|||
23579901|NCT01474512|65853362|FG002|Long-Term Extension Period|Death|0|||
23579902|NCT01474512|65853363|FG003|Long-Term Extension Period|Death|0|||
23579903|NCT01474512|65853364|FG004|Long-Term Extension Period|Death|0|||
23579904|NCT01474512|65853365|FG005|Long-Term Extension Period|Death|0|||
23579905|NCT01474512|65853366|FG006|Long-Term Extension Period|Death|0|||
23579906|NCT01474512|65853367|FG007|Long-Term Extension Period|Death|0|||
23579907|NCT01474512|65853368|FG008|Long-Term Extension Period|Death|0|||
23579908|NCT01474512|65853369|FG009|Long-Term Extension Period|Death|0|||
23172764|NCT00763321|64375799|FG001|Open-label Period|Adverse Event|0|||
23172765|NCT00763321|64375800|FG002|Open-label Period|Adverse Event|0|||
23339559|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
23339560|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
23339561|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
23451364|NCT02796677|65395172|FG003|Overall Study|Progressive disease|18|||
23451365|NCT02796677|65395169|FG000|Overall Study|Reason not mentioned|2|||
23451366|NCT02796677|65395170|FG001|Overall Study|Reason not mentioned|3|||
23579909|NCT01474512|65853370|FG010|Long-Term Extension Period|Death|0|||
23172766|NCT00763321|64375798|FG000|Open-label Period|Lost to Follow-up|14|||
23172767|NCT00763321|64375799|FG001|Open-label Period|Lost to Follow-up|0|||
23172768|NCT00763321|64375800|FG002|Open-label Period|Lost to Follow-up|0|||
23172769|NCT00763321|64375798|FG000|Open-label Period|Withdrawal by Subject|7|||
23172770|NCT00763321|64375799|FG001|Open-label Period|Withdrawal by Subject|0|||
23172771|NCT00763321|64375800|FG002|Open-label Period|Withdrawal by Subject|0|||
23172772|NCT00763321|64375798|FG000|Open-label Period|Subject noncompliant|7|||
23172773|NCT00763321|64375799|FG001|Open-label Period|Subject noncompliant|0|||
23172774|NCT00763321|64375800|FG002|Open-label Period|Subject noncompliant|0|||
23451367|NCT02796677|65395171|FG002|Overall Study|Reason not mentioned|0|||
23579910|NCT01474512|65853371|FG011|Long-Term Extension Period|Death|0|||
23579911|NCT01474512|65853372|FG012|Long-Term Extension Period|Death|9|||
23579912|NCT01474512|65853373|FG013|Long-Term Extension Period|Death|9|||
23579913|NCT01474512|65853374|FG014|Long-Term Extension Period|Death|0|||
23172775|NCT00763321|64375798|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
23172776|NCT00763321|64375799|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
23172777|NCT00763321|64375800|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
23172778|NCT00763321|64375798|FG000|Open-label Period|Lack of Efficacy|2|||
23172779|NCT00763321|64375799|FG001|Open-label Period|Lack of Efficacy|0|||
23172780|NCT00763321|64375800|FG002|Open-label Period|Lack of Efficacy|0|||
23172781|NCT00763321|64375798|FG000|Open-label Period|Other|4|||
23172782|NCT00763321|64375799|FG001|Open-label Period|Other|0|||
23172783|NCT00763321|64375800|FG002|Open-label Period|Other|0|||
23172784|NCT00763321|64375798|FG000|Double-blind Period|Lack of Efficacy|0|||
23172785|NCT00763321|64375799|FG001|Double-blind Period|Lack of Efficacy|9|||
23172786|NCT00763321|64375800|FG002|Double-blind Period|Lack of Efficacy|17|||
23172787|NCT00763321|64375798|FG000|Double-blind Period|Adverse Event|0|||
23172788|NCT00763321|64375799|FG001|Double-blind Period|Adverse Event|4|||
23172789|NCT00763321|64375800|FG002|Double-blind Period|Adverse Event|4|||
23172790|NCT00763321|64375798|FG000|Double-blind Period|Lost to Follow-up|0|||
23172791|NCT00763321|64375799|FG001|Double-blind Period|Lost to Follow-up|4|||
23172792|NCT00763321|64375800|FG002|Double-blind Period|Lost to Follow-up|2|||
23172793|NCT00763321|64375798|FG000|Double-blind Period|Withdrawal by Subject|0|||
23232804|NCT01397409|64595895|FG001|Stage 3|Other Miscellaneous Reasons|0|||
23232805|NCT01397409|64595896|FG002|Stage 3|Other Miscellaneous Reasons|0|||
23232806|NCT01397409|64595897|FG003|Stage 3|Other Miscellaneous Reasons|0|||
23232807|NCT01397409|64595898|FG004|Stage 3|Other Miscellaneous Reasons|0|||
23232808|NCT01397409|64595899|FG005|Stage 3|Other Miscellaneous Reasons|0|||
23232809|NCT01397409|64595900|FG006|Stage 3|Other Miscellaneous Reasons|0|||
23232810|NCT01397409|64595901|FG007|Stage 3|Other Miscellaneous Reasons|1|||
23232811|NCT01397409|64595902|FG008|Stage 3|Other Miscellaneous Reasons|0|||
23232812|NCT01397409|64595903|FG009|Stage 3|Other Miscellaneous Reasons|0|||
23232813|NCT02477215|64595904|FG000|Dose Escalation Phase|Physician Decision|1|||
23232814|NCT02477215|64595905|FG001|Dose Escalation Phase|Physician Decision|2|||
23232815|NCT02477215|64595906|FG002|Dose Escalation Phase|Physician Decision|0|||
23232816|NCT02477215|64595904|FG000|Fixed Dose Phase|Physician Decision|0|||
23232817|NCT02477215|64595905|FG001|Fixed Dose Phase|Physician Decision|7|||
23232818|NCT02477215|64595906|FG002|Fixed Dose Phase|Physician Decision|0|||
23232819|NCT01736176|64595909|FG000|Overall Study|Adverse Event|3|||
23232820|NCT01736176|64595909|FG000|Overall Study|Withdrawal by Subject|4|||
23232821|NCT01736176|64595909|FG000|Overall Study|Lack of Efficacy|3|||
23232822|NCT01736176|64595909|FG000|Overall Study|Unable to Complete PEG Placement|1|||
23232823|NCT00526227|64595910|FG000|Overall Study|Device not implanted|1|||
23232824|NCT00526227|64595910|FG000|Overall Study|Death|1|||
23232825|NCT00983827|64595911|FG000|Overall Study|Withdrawal by Subject|1|||
23232826|NCT00508001|64595912|FG000|Overall Study|Adverse Event|2|||
23232827|NCT00508001|64595913|FG001|Overall Study|Adverse Event|0|||
23232828|NCT00508001|64595914|FG002|Overall Study|Adverse Event|4|||
23232829|NCT00508001|64595912|FG000|Overall Study|condition under investigation worsened|13|||
23232830|NCT00508001|64595913|FG001|Overall Study|condition under investigation worsened|7|||
23232831|NCT00508001|64595914|FG002|Overall Study|condition under investigation worsened|1|||
23232832|NCT00508001|64595912|FG000|Overall Study|Death|0|||
23232833|NCT00508001|64595913|FG001|Overall Study|Death|1|||
23232834|NCT00508001|64595914|FG002|Overall Study|Death|1|||
23232835|NCT00508001|64595912|FG000|Overall Study|Withdrawal by Subject|4|||
23232836|NCT00508001|64595913|FG001|Overall Study|Withdrawal by Subject|4|||
23232837|NCT00508001|64595914|FG002|Overall Study|Withdrawal by Subject|1|||
23232838|NCT02709889|64595915|FG000|Overall Study|Withdrawal by Subject|11|||
23232839|NCT02709889|64595916|FG001|Overall Study|Withdrawal by Subject|10|||
23232840|NCT02709889|64595917|FG002|Overall Study|Withdrawal by Subject|2|||
23232841|NCT02709889|64595918|FG003|Overall Study|Withdrawal by Subject|12|||
23232842|NCT02709889|64595915|FG000|Overall Study|Death|25|||
23232843|NCT02709889|64595916|FG001|Overall Study|Death|38|||
23232844|NCT02709889|64595917|FG002|Overall Study|Death|4|||
23232845|NCT02709889|64595918|FG003|Overall Study|Death|44|||
23232846|NCT02709889|64595915|FG000|Overall Study|Physician Decision|1|||
23232847|NCT02709889|64595916|FG001|Overall Study|Physician Decision|2|||
23232848|NCT02709889|64595917|FG002|Overall Study|Physician Decision|3|||
23232849|NCT02709889|64595918|FG003|Overall Study|Physician Decision|5|||
23172794|NCT00763321|64375799|FG001|Double-blind Period|Withdrawal by Subject|2|||
23172795|NCT00763321|64375800|FG002|Double-blind Period|Withdrawal by Subject|3|||
23172796|NCT00763321|64375798|FG000|Double-blind Period|Other|0|||
23232850|NCT02709889|64595915|FG000|Overall Study|Lost to Follow-up|2|||
23232851|NCT02709889|64595916|FG001|Overall Study|Lost to Follow-up|0|||
23232852|NCT02709889|64595917|FG002|Overall Study|Lost to Follow-up|0|||
23232853|NCT02709889|64595918|FG003|Overall Study|Lost to Follow-up|4|||
23232854|NCT02709889|64595915|FG000|Overall Study|Study Terminated by Sponsor|4|||
23232855|NCT02709889|64595916|FG001|Overall Study|Study Terminated by Sponsor|6|||
23232856|NCT02709889|64595917|FG002|Overall Study|Study Terminated by Sponsor|2|||
23232857|NCT02709889|64595918|FG003|Overall Study|Study Terminated by Sponsor|17|||
23232858|NCT02709889|64595915|FG000|Overall Study|Other, Not Specified|0|||
23232859|NCT02709889|64595916|FG001|Overall Study|Other, Not Specified|1|||
23232860|NCT02709889|64595917|FG002|Overall Study|Other, Not Specified|1|||
23232861|NCT02709889|64595918|FG003|Overall Study|Other, Not Specified|6|||
23232862|NCT00779506|64595924|FG000|Overall Study|Screening Failed|2|||
23339562|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
23339563|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
23339564|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
23339565|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23339566|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23232863|NCT00779506|64595924|FG000|Overall Study|Adverse Event|4|||
23232864|NCT00779506|64595924|FG000|Overall Study|Lack of Efficacy|11|||
23232865|NCT00779506|64595924|FG000|Overall Study|Protocol Violation|5|||
23232866|NCT00779506|64595924|FG000|Overall Study|Withdrawal by Subject|6|||
23232867|NCT00779506|64595924|FG000|Overall Study|Lost to Follow-up|1|||
23232868|NCT01552408|64595934|FG000|Overall Study|Lost to Follow-up|2|||
23232869|NCT01552408|64595935|FG001|Overall Study|Lost to Follow-up|0|||
23232870|NCT01552408|64595934|FG000|Overall Study|Relocation|0|||
23339567|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
23339568|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
23339569|NCT04713592|64986250|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
23339570|NCT04713592|64986251|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
23339571|NCT04713592|64986252|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
23339572|NCT04713592|64986253|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
23339573|NCT01899742|64986257|FG000|Overall Study|Adverse Event|5|||
23339574|NCT01899742|64986258|FG001|Overall Study|Adverse Event|4|||
23339575|NCT01899742|64986257|FG000|Overall Study|Lack of Efficacy|1|||
23339576|NCT01899742|64986258|FG001|Overall Study|Lack of Efficacy|5|||
23339577|NCT01899742|64986257|FG000|Overall Study|Protocol Violation|2|||
23339578|NCT01899742|64986258|FG001|Overall Study|Protocol Violation|2|||
23339579|NCT01899742|64986257|FG000|Overall Study|Withdrawal by Subject|9|||
23339580|NCT01899742|64986258|FG001|Overall Study|Withdrawal by Subject|5|||
23339581|NCT02225366|64986259|FG000|Overall Study|Lack of Efficacy|1|||
23232871|NCT01552408|64595935|FG001|Overall Study|Relocation|1|||
23232872|NCT01552408|64595934|FG000|Overall Study|Withdrawal by Subject|2|||
23232873|NCT01552408|64595935|FG001|Overall Study|Withdrawal by Subject|1|||
23232874|NCT01049360|64595938|FG000|Period 1|Adverse Event|0|||
23232875|NCT01049360|64595939|FG001|Period 1|Adverse Event|1|||
23232876|NCT01049360|64595940|FG002|Period 1|Adverse Event|0|||
23232877|NCT01049360|64595941|FG003|Period 1|Adverse Event|1|||
23232878|NCT01049360|64595942|FG004|Period 1|Adverse Event|0|||
23232879|NCT01049360|64595943|FG005|Period 1|Adverse Event|0|||
23232880|NCT01049360|64595944|FG006|Period 1|Adverse Event|0|||
23232881|NCT01049360|64595945|FG007|Period 1|Adverse Event|1|||
23232882|NCT01049360|64595946|FG008|Period 1|Adverse Event|0|||
23232883|NCT01049360|64595947|FG009|Period 1|Adverse Event|0|||
23232884|NCT01049360|64595948|FG010|Period 1|Adverse Event|0|||
23232885|NCT01049360|64595949|FG011|Period 1|Adverse Event|0|||
23232886|NCT01049360|64595950|FG012|Period 1|Adverse Event|1|||
23232887|NCT01049360|64595951|FG013|Period 1|Adverse Event|1|||
23232888|NCT01049360|64595952|FG014|Period 1|Adverse Event|0|||
23232889|NCT01049360|64595953|FG015|Period 1|Adverse Event|0|||
23232890|NCT01049360|64595954|FG016|Period 1|Adverse Event|1|||
23232891|NCT01049360|64595955|FG017|Period 1|Adverse Event|0|||
23232892|NCT01049360|64595956|FG018|Period 1|Adverse Event|1|||
23232893|NCT01049360|64595957|FG019|Period 1|Adverse Event|0|||
23232894|NCT01049360|64595938|FG000|Period 1|Did not meet inc/exc criteria|0|||
23232895|NCT01049360|64595939|FG001|Period 1|Did not meet inc/exc criteria|0|||
23232896|NCT01049360|64595940|FG002|Period 1|Did not meet inc/exc criteria|0|||
23232897|NCT01049360|64595941|FG003|Period 1|Did not meet inc/exc criteria|0|||
23232898|NCT01049360|64595942|FG004|Period 1|Did not meet inc/exc criteria|0|||
23232899|NCT01049360|64595943|FG005|Period 1|Did not meet inc/exc criteria|0|||
23232900|NCT01049360|64595944|FG006|Period 1|Did not meet inc/exc criteria|0|||
23339582|NCT02225366|64986260|FG001|Overall Study|Lack of Efficacy|0|||
23339583|NCT00954512|64986263|FG000|Overall Study|Withdrawal by Subject|0|||
23451368|NCT02796677|65395172|FG003|Overall Study|Reason not mentioned|5|||
23451369|NCT02748863|65395173|FG000|Treatment Period 1|Adverse Event|0|||
23451370|NCT02748863|65395174|FG001|Treatment Period 1|Adverse Event|1|||
23232901|NCT01049360|64595945|FG007|Period 1|Did not meet inc/exc criteria|1|||
23232902|NCT01049360|64595946|FG008|Period 1|Did not meet inc/exc criteria|1|||
23451371|NCT02748863|65395175|FG002|Treatment Period 1|Adverse Event|0|||
23451372|NCT02748863|65395176|FG003|Treatment Period 1|Adverse Event|0|||
23232903|NCT01049360|64595947|FG009|Period 1|Did not meet inc/exc criteria|0|||
23232904|NCT01049360|64595948|FG010|Period 1|Did not meet inc/exc criteria|0|||
23232905|NCT01049360|64595949|FG011|Period 1|Did not meet inc/exc criteria|0|||
23232906|NCT01049360|64595950|FG012|Period 1|Did not meet inc/exc criteria|0|||
23232907|NCT01049360|64595951|FG013|Period 1|Did not meet inc/exc criteria|0|||
23232908|NCT01049360|64595952|FG014|Period 1|Did not meet inc/exc criteria|0|||
23232909|NCT01049360|64595953|FG015|Period 1|Did not meet inc/exc criteria|0|||
23232910|NCT01049360|64595954|FG016|Period 1|Did not meet inc/exc criteria|0|||
23232911|NCT01049360|64595955|FG017|Period 1|Did not meet inc/exc criteria|0|||
23232912|NCT01049360|64595956|FG018|Period 1|Did not meet inc/exc criteria|0|||
23232913|NCT01049360|64595957|FG019|Period 1|Did not meet inc/exc criteria|0|||
23232914|NCT01049360|64595938|FG000|Period 1|Withdrawal by Subject|0|||
23232915|NCT01049360|64595939|FG001|Period 1|Withdrawal by Subject|0|||
23232916|NCT01049360|64595940|FG002|Period 1|Withdrawal by Subject|0|||
23232917|NCT01049360|64595941|FG003|Period 1|Withdrawal by Subject|0|||
23232918|NCT01049360|64595942|FG004|Period 1|Withdrawal by Subject|0|||
23232919|NCT01049360|64595943|FG005|Period 1|Withdrawal by Subject|0|||
23232920|NCT01049360|64595944|FG006|Period 1|Withdrawal by Subject|0|||
23232921|NCT01049360|64595945|FG007|Period 1|Withdrawal by Subject|0|||
23232922|NCT01049360|64595946|FG008|Period 1|Withdrawal by Subject|1|||
23232923|NCT01049360|64595947|FG009|Period 1|Withdrawal by Subject|0|||
23232924|NCT01049360|64595948|FG010|Period 1|Withdrawal by Subject|1|||
23232925|NCT01049360|64595949|FG011|Period 1|Withdrawal by Subject|0|||
23232926|NCT01049360|64595950|FG012|Period 1|Withdrawal by Subject|1|||
23232927|NCT01049360|64595951|FG013|Period 1|Withdrawal by Subject|0|||
23232928|NCT01049360|64595952|FG014|Period 1|Withdrawal by Subject|0|||
23232929|NCT01049360|64595953|FG015|Period 1|Withdrawal by Subject|0|||
23232930|NCT01049360|64595954|FG016|Period 1|Withdrawal by Subject|0|||
23232931|NCT01049360|64595955|FG017|Period 1|Withdrawal by Subject|0|||
23232932|NCT01049360|64595956|FG018|Period 1|Withdrawal by Subject|0|||
23232933|NCT01049360|64595957|FG019|Period 1|Withdrawal by Subject|0|||
23232934|NCT01049360|64595938|FG000|Period 2|Protocol Violation|0|||
23232935|NCT01049360|64595939|FG001|Period 2|Protocol Violation|0|||
23232936|NCT01049360|64595940|FG002|Period 2|Protocol Violation|0|||
23232937|NCT01049360|64595941|FG003|Period 2|Protocol Violation|1|||
23232938|NCT01049360|64595942|FG004|Period 2|Protocol Violation|0|||
23232939|NCT01049360|64595943|FG005|Period 2|Protocol Violation|0|||
23232940|NCT01049360|64595944|FG006|Period 2|Protocol Violation|0|||
23232941|NCT01049360|64595945|FG007|Period 2|Protocol Violation|0|||
23232942|NCT01049360|64595946|FG008|Period 2|Protocol Violation|0|||
23172797|NCT00763321|64375799|FG001|Double-blind Period|Other|2|||
23172798|NCT00763321|64375800|FG002|Double-blind Period|Other|3|||
23175852|NCT01506882|64386591|FG000|Overall Study|SAE, non-fatal|2|||
23175853|NCT01506882|64386592|FG001|Overall Study|SAE, non-fatal|0|||
23175854|NCT01506882|64386591|FG000|Overall Study|AE, non-serious non-fatal|3|||
23175855|NCT01506882|64386592|FG001|Overall Study|AE, non-serious non-fatal|1|||
23175856|NCT01506882|64386591|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
23175857|NCT01506882|64386592|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23175858|NCT01506882|64386591|FG000|Overall Study|Other Reason|2|||
23175859|NCT01506882|64386592|FG001|Overall Study|Other Reason|0|||
23175860|NCT01276236|64386593|FG000|Overall Study|Lack of Efficacy|2|||
23175861|NCT01276236|64386593|FG000|Overall Study|Withdrawal by Subject|4|||
23175862|NCT03433781|64386594|FG000|Overall Study|Progression of Disease|1|||
23175863|NCT03433781|64386595|FG001|Overall Study|Progression of Disease|0|||
23175864|NCT03433781|64386596|FG002|Overall Study|Progression of Disease|0|||
23175865|NCT03433781|64386594|FG000|Overall Study|Physician Decision|0|||
23175866|NCT03433781|64386595|FG001|Overall Study|Physician Decision|1|||
23175867|NCT03433781|64386596|FG002|Overall Study|Physician Decision|0|||
23175868|NCT04162210|64386597|FG000|Overall Study|Lost to Follow-up|4|||
23232943|NCT01049360|64595947|FG009|Period 2|Protocol Violation|0|||
23232944|NCT01049360|64595948|FG010|Period 2|Protocol Violation|0|||
23232945|NCT01049360|64595949|FG011|Period 2|Protocol Violation|0|||
23339584|NCT00954512|64986264|FG001|Overall Study|Withdrawal by Subject|0|||
23339585|NCT00954512|64986265|FG002|Overall Study|Withdrawal by Subject|0|||
23339586|NCT00954512|64986266|FG003|Overall Study|Withdrawal by Subject|0|||
23339587|NCT00954512|64986267|FG004|Overall Study|Withdrawal by Subject|0|||
23451373|NCT02748863|65395177|FG004|Treatment Period 1|Adverse Event|0|||
23451374|NCT02748863|65395173|FG000|Treatment Period 1|Lack of Efficacy|0|||
23579914|NCT01474512|65853375|FG015|Long-Term Extension Period|Death|0|||
23175869|NCT04162210|64386598|FG001|Overall Study|Lost to Follow-up|1|||
23175870|NCT04162210|64386597|FG000|Overall Study|Withdrawal by Subject|17|||
23175871|NCT04162210|64386598|FG001|Overall Study|Withdrawal by Subject|9|||
23232946|NCT01049360|64595950|FG012|Period 2|Protocol Violation|0|||
23232947|NCT01049360|64595951|FG013|Period 2|Protocol Violation|0|||
23232948|NCT01049360|64595952|FG014|Period 2|Protocol Violation|1|||
23232949|NCT01049360|64595953|FG015|Period 2|Protocol Violation|1|||
23232950|NCT01049360|64595954|FG016|Period 2|Protocol Violation|0|||
23232951|NCT01049360|64595955|FG017|Period 2|Protocol Violation|0|||
23232952|NCT01049360|64595956|FG018|Period 2|Protocol Violation|0|||
23175872|NCT04162210|64386597|FG000|Overall Study|Ongoing|113|||
23175873|NCT04162210|64386598|FG001|Overall Study|Ongoing|59|||
23232953|NCT01049360|64595957|FG019|Period 2|Protocol Violation|0|||
23232954|NCT01049360|64595938|FG000|Period 2|Adverse Event|0|||
23232955|NCT01049360|64595939|FG001|Period 2|Adverse Event|1|||
23232956|NCT01049360|64595940|FG002|Period 2|Adverse Event|0|||
23232957|NCT01049360|64595941|FG003|Period 2|Adverse Event|0|||
23451375|NCT02748863|65395174|FG001|Treatment Period 1|Lack of Efficacy|0|||
23339588|NCT00954512|64986268|FG005|Overall Study|Withdrawal by Subject|1|||
23339589|NCT00954512|64986263|FG000|Overall Study|Adverse Event|0|||
23339590|NCT00954512|64986264|FG001|Overall Study|Adverse Event|0|||
23339591|NCT00954512|64986265|FG002|Overall Study|Adverse Event|0|||
23339592|NCT00954512|64986266|FG003|Overall Study|Adverse Event|0|||
23339593|NCT00954512|64986267|FG004|Overall Study|Adverse Event|1|||
23339594|NCT00954512|64986268|FG005|Overall Study|Adverse Event|2|||
23339595|NCT00954512|64986263|FG000|Overall Study|Physician Decision|0|||
23339596|NCT00954512|64986264|FG001|Overall Study|Physician Decision|1|||
23339597|NCT00954512|64986265|FG002|Overall Study|Physician Decision|0|||
23339598|NCT00954512|64986266|FG003|Overall Study|Physician Decision|1|||
23339599|NCT00954512|64986267|FG004|Overall Study|Physician Decision|0|||
23339600|NCT00954512|64986268|FG005|Overall Study|Physician Decision|0|||
23339601|NCT00954512|64986263|FG000|Overall Study|Symptomatic Deterioration|0|||
23339602|NCT00954512|64986264|FG001|Overall Study|Symptomatic Deterioration|1|||
23339603|NCT00954512|64986265|FG002|Overall Study|Symptomatic Deterioration|0|||
23339604|NCT00954512|64986266|FG003|Overall Study|Symptomatic Deterioration|0|||
23339605|NCT00954512|64986267|FG004|Overall Study|Symptomatic Deterioration|2|||
23339606|NCT00954512|64986268|FG005|Overall Study|Symptomatic Deterioration|0|||
23339607|NCT00954512|64986263|FG000|Overall Study|Progression of Disease|2|||
23339608|NCT00954512|64986264|FG001|Overall Study|Progression of Disease|1|||
23339609|NCT00954512|64986265|FG002|Overall Study|Progression of Disease|0|||
23339610|NCT00954512|64986266|FG003|Overall Study|Progression of Disease|1|||
23339611|NCT00954512|64986267|FG004|Overall Study|Progression of Disease|1|||
23339612|NCT00954512|64986268|FG005|Overall Study|Progression of Disease|1|||
23339613|NCT00562302|64986270|FG000|Overall Study|Lost to Follow-up|3|||
23339614|NCT00562302|64986271|FG001|Overall Study|Lost to Follow-up|3|||
23339615|NCT00562302|64986270|FG000|Overall Study|Adverse Event|0|||
23339616|NCT00562302|64986271|FG001|Overall Study|Adverse Event|6|||
23339617|NCT00562302|64986270|FG000|Overall Study|Non-compliance|1|||
23339618|NCT00562302|64986271|FG001|Overall Study|Non-compliance|2|||
23579915|NCT01474512|65853376|FG016|Long-Term Extension Period|Death|0|||
23579916|NCT01474512|65853377|FG017|Long-Term Extension Period|Death|0|||
23232958|NCT01049360|64595942|FG004|Period 2|Adverse Event|0|||
23232959|NCT01049360|64595943|FG005|Period 2|Adverse Event|0|||
23232960|NCT01049360|64595944|FG006|Period 2|Adverse Event|0|||
23232961|NCT01049360|64595945|FG007|Period 2|Adverse Event|0|||
23232962|NCT01049360|64595946|FG008|Period 2|Adverse Event|1|||
23232963|NCT01049360|64595947|FG009|Period 2|Adverse Event|0|||
23232964|NCT01049360|64595948|FG010|Period 2|Adverse Event|0|||
23232965|NCT01049360|64595949|FG011|Period 2|Adverse Event|0|||
23232966|NCT01049360|64595950|FG012|Period 2|Adverse Event|0|||
23232967|NCT01049360|64595951|FG013|Period 2|Adverse Event|0|||
23232968|NCT01049360|64595952|FG014|Period 2|Adverse Event|0|||
23232969|NCT01049360|64595953|FG015|Period 2|Adverse Event|0|||
23232970|NCT01049360|64595954|FG016|Period 2|Adverse Event|0|||
23232971|NCT01049360|64595955|FG017|Period 2|Adverse Event|0|||
23232972|NCT01049360|64595956|FG018|Period 2|Adverse Event|0|||
23232973|NCT01049360|64595957|FG019|Period 2|Adverse Event|1|||
23232974|NCT01049360|64595938|FG000|Period 2|Withdrawal by Subject|0|||
23232975|NCT01049360|64595939|FG001|Period 2|Withdrawal by Subject|0|||
23232976|NCT01049360|64595940|FG002|Period 2|Withdrawal by Subject|0|||
23232977|NCT01049360|64595941|FG003|Period 2|Withdrawal by Subject|1|||
23232978|NCT01049360|64595942|FG004|Period 2|Withdrawal by Subject|0|||
23232979|NCT01049360|64595943|FG005|Period 2|Withdrawal by Subject|0|||
23232980|NCT01049360|64595944|FG006|Period 2|Withdrawal by Subject|0|||
23232981|NCT01049360|64595945|FG007|Period 2|Withdrawal by Subject|0|||
23232982|NCT01049360|64595946|FG008|Period 2|Withdrawal by Subject|0|||
23232983|NCT01049360|64595947|FG009|Period 2|Withdrawal by Subject|0|||
23232984|NCT01049360|64595948|FG010|Period 2|Withdrawal by Subject|0|||
23232985|NCT01049360|64595949|FG011|Period 2|Withdrawal by Subject|0|||
23232986|NCT01049360|64595950|FG012|Period 2|Withdrawal by Subject|0|||
23232987|NCT01049360|64595951|FG013|Period 2|Withdrawal by Subject|0|||
23232988|NCT01049360|64595952|FG014|Period 2|Withdrawal by Subject|1|||
23339619|NCT00562302|64986270|FG000|Overall Study|Withdrawal by Subject|7|||
23339620|NCT00562302|64986271|FG001|Overall Study|Withdrawal by Subject|8|||
23339621|NCT00562302|64986270|FG000|Overall Study|Death|1|||
23339622|NCT00562302|64986271|FG001|Overall Study|Death|2|||
23232989|NCT01049360|64595953|FG015|Period 2|Withdrawal by Subject|0|||
23339623|NCT00562302|64986270|FG000|Overall Study|Lung resection prior to study completion|7|||
23232990|NCT01049360|64595954|FG016|Period 2|Withdrawal by Subject|0|||
23232991|NCT01049360|64595955|FG017|Period 2|Withdrawal by Subject|0|||
23232992|NCT01049360|64595956|FG018|Period 2|Withdrawal by Subject|0|||
23232993|NCT01049360|64595957|FG019|Period 2|Withdrawal by Subject|1|||
23232994|NCT01049360|64595938|FG000|Period 2|Lack of Efficacy|0|||
23232995|NCT01049360|64595939|FG001|Period 2|Lack of Efficacy|0|||
23232996|NCT01049360|64595940|FG002|Period 2|Lack of Efficacy|0|||
23232997|NCT01049360|64595941|FG003|Period 2|Lack of Efficacy|0|||
23232998|NCT01049360|64595942|FG004|Period 2|Lack of Efficacy|0|||
23339624|NCT00562302|64986271|FG001|Overall Study|Lung resection prior to study completion|7|||
23339625|NCT00562302|64986270|FG000|Overall Study|Not stated|1|||
23232999|NCT01049360|64595943|FG005|Period 2|Lack of Efficacy|1|||
23233000|NCT01049360|64595944|FG006|Period 2|Lack of Efficacy|0|||
23233001|NCT01049360|64595945|FG007|Period 2|Lack of Efficacy|0|||
23233002|NCT01049360|64595946|FG008|Period 2|Lack of Efficacy|0|||
23579917|NCT01474512|65853360|FG000|Long-Term Extension Period|Sponsor Decision|0|||
23579918|NCT01474512|65853361|FG001|Long-Term Extension Period|Sponsor Decision|0|||
23579919|NCT01474512|65853362|FG002|Long-Term Extension Period|Sponsor Decision|0|||
23172799|NCT01848145|64379024|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
23172800|NCT01848145|64379024|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
23172801|NCT01848145|64379024|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
23172802|NCT01848145|64379024|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
23172803|NCT01848145|64379024|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
23172804|NCT01848145|64379024|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
23172805|NCT01848145|64379024|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
23172806|NCT00796315|64379025|FG000|Overall Study|Protocol Violation|0|||
23172807|NCT00796315|64379026|FG001|Overall Study|Protocol Violation|1|||
23172808|NCT00796315|64379027|FG002|Overall Study|Protocol Violation|0|||
23172809|NCT01623271|64379029|FG000|Overall Study|Withdrawal by Subject|2|||
23172810|NCT02319044|64379030|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
23172811|NCT02319044|64379031|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
23172812|NCT02319044|64379032|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
23172813|NCT02319044|64379030|FG000|Overall Study|Withdrawal by Subject|3|||
23172814|NCT02319044|64379031|FG001|Overall Study|Withdrawal by Subject|3|||
23172815|NCT02319044|64379032|FG002|Overall Study|Withdrawal by Subject|6|||
23172816|NCT02319044|64379030|FG000|Overall Study|Condition under investigation worsened|100|||
23172817|NCT02319044|64379031|FG001|Overall Study|Condition under investigation worsened|50|||
23172818|NCT02319044|64379032|FG002|Overall Study|Condition under investigation worsened|46|||
23172819|NCT02319044|64379030|FG000|Overall Study|Adverse Event|17|||
23172820|NCT02319044|64379031|FG001|Overall Study|Adverse Event|2|||
23172821|NCT02319044|64379032|FG002|Overall Study|Adverse Event|8|||
23172822|NCT02319044|64379030|FG000|Overall Study|Study specific discontinuation criteria|2|||
23172823|NCT02319044|64379031|FG001|Overall Study|Study specific discontinuation criteria|2|||
23172824|NCT02319044|64379032|FG002|Overall Study|Study specific discontinuation criteria|1|||
23172825|NCT02319044|64379030|FG000|Overall Study|Not treated|0|||
23172826|NCT02319044|64379031|FG001|Overall Study|Not treated|2|||
23172827|NCT02319044|64379032|FG002|Overall Study|Not treated|2|||
23172828|NCT01920711|64379037|FG000|Overall Study|Death|347|||
23172829|NCT01920711|64379038|FG001|Overall Study|Death|356|||
23172830|NCT01920711|64379037|FG000|Overall Study|Lost to Follow-up|13|||
23172831|NCT01920711|64379038|FG001|Overall Study|Lost to Follow-up|14|||
23172832|NCT01920711|64379037|FG000|Overall Study|Withdrawal by Subject|4|||
23172833|NCT01920711|64379038|FG001|Overall Study|Withdrawal by Subject|3|||
23172834|NCT02658812|64379039|FG000|Overall Study|Disease Progression|7|||
23172835|NCT02658812|64379039|FG000|Overall Study|Unrelated to study treatment|1|||
23172836|NCT02658812|64379039|FG000|Overall Study|Adverse Event|1|||
23172837|NCT03683394|64379040|FG000|Overall Study|Withdrawal by Subject|4|||
23172838|NCT03683394|64379041|FG001|Overall Study|Withdrawal by Subject|8|||
23172839|NCT03683394|64379040|FG000|Overall Study|Lost to Follow-up|7|||
23172840|NCT03683394|64379041|FG001|Overall Study|Lost to Follow-up|0|||
23172841|NCT03683394|64379040|FG000|Overall Study|Death|3|||
23172842|NCT03683394|64379041|FG001|Overall Study|Death|1|||
23172843|NCT02894840|64379042|FG000|Overall Study|Lost to Follow-up|1|||
23172844|NCT02894840|64379043|FG001|Overall Study|Lost to Follow-up|0|||
23172845|NCT02894840|64379044|FG002|Overall Study|Lost to Follow-up|3|||
23172846|NCT02894840|64379045|FG003|Overall Study|Lost to Follow-up|0|||
23172847|NCT00482014|64379046|FG000|Overall Study|Withdrawal by Subject|1|||
23172848|NCT00482014|64379047|FG001|Overall Study|Withdrawal by Subject|2|||
23172849|NCT00482014|64379048|FG002|Overall Study|Withdrawal by Subject|3|||
23172850|NCT00482014|64379049|FG003|Overall Study|Withdrawal by Subject|4|||
23172851|NCT00482014|64379046|FG000|Overall Study|Adverse Event|3|||
23172852|NCT00482014|64379047|FG001|Overall Study|Adverse Event|0|||
23172853|NCT00482014|64379048|FG002|Overall Study|Adverse Event|2|||
23172854|NCT00482014|64379049|FG003|Overall Study|Adverse Event|8|||
23172855|NCT00482014|64379046|FG000|Overall Study|Death|1|||
23172856|NCT00482014|64379047|FG001|Overall Study|Death|2|||
23172857|NCT00482014|64379048|FG002|Overall Study|Death|1|||
23233003|NCT01049360|64595947|FG009|Period 2|Lack of Efficacy|0|||
23172858|NCT00482014|64379049|FG003|Overall Study|Death|4|||
23172859|NCT00482014|64379046|FG000|Overall Study|Lack of Efficacy|1|||
23172860|NCT00482014|64379047|FG001|Overall Study|Lack of Efficacy|0|||
23172861|NCT00482014|64379048|FG002|Overall Study|Lack of Efficacy|4|||
23172862|NCT00482014|64379049|FG003|Overall Study|Lack of Efficacy|6|||
23172863|NCT00482014|64379046|FG000|Overall Study|Sponsor Decision|1|||
23172864|NCT00482014|64379047|FG001|Overall Study|Sponsor Decision|2|||
23172865|NCT00482014|64379048|FG002|Overall Study|Sponsor Decision|1|||
23172866|NCT00482014|64379049|FG003|Overall Study|Sponsor Decision|1|||
23233004|NCT01049360|64595948|FG010|Period 2|Lack of Efficacy|0|||
23233005|NCT01049360|64595949|FG011|Period 2|Lack of Efficacy|0|||
23233006|NCT01049360|64595950|FG012|Period 2|Lack of Efficacy|0|||
23233007|NCT01049360|64595951|FG013|Period 2|Lack of Efficacy|0|||
23233008|NCT01049360|64595952|FG014|Period 2|Lack of Efficacy|0|||
23233009|NCT01049360|64595953|FG015|Period 2|Lack of Efficacy|0|||
23233010|NCT01049360|64595954|FG016|Period 2|Lack of Efficacy|0|||
23233011|NCT01049360|64595955|FG017|Period 2|Lack of Efficacy|0|||
23233012|NCT01049360|64595956|FG018|Period 2|Lack of Efficacy|0|||
23233013|NCT01049360|64595957|FG019|Period 2|Lack of Efficacy|0|||
23233014|NCT01049360|64595938|FG000|Period 4|Protocol Violation|0|||
23233015|NCT01049360|64595939|FG001|Period 4|Protocol Violation|0|||
23233016|NCT01049360|64595940|FG002|Period 4|Protocol Violation|0|||
23233017|NCT01049360|64595941|FG003|Period 4|Protocol Violation|0|||
23233018|NCT01049360|64595942|FG004|Period 4|Protocol Violation|0|||
23233019|NCT01049360|64595943|FG005|Period 4|Protocol Violation|0|||
23233020|NCT01049360|64595944|FG006|Period 4|Protocol Violation|0|||
23233021|NCT01049360|64595945|FG007|Period 4|Protocol Violation|0|||
23233022|NCT01049360|64595946|FG008|Period 4|Protocol Violation|0|||
23233023|NCT01049360|64595947|FG009|Period 4|Protocol Violation|0|||
23233024|NCT01049360|64595948|FG010|Period 4|Protocol Violation|0|||
23233025|NCT01049360|64595949|FG011|Period 4|Protocol Violation|0|||
23233026|NCT01049360|64595950|FG012|Period 4|Protocol Violation|0|||
23233027|NCT01049360|64595951|FG013|Period 4|Protocol Violation|0|||
23233028|NCT01049360|64595952|FG014|Period 4|Protocol Violation|0|||
23233029|NCT01049360|64595953|FG015|Period 4|Protocol Violation|0|||
23233030|NCT01049360|64595954|FG016|Period 4|Protocol Violation|0|||
23233031|NCT01049360|64595955|FG017|Period 4|Protocol Violation|1|||
23233032|NCT01049360|64595956|FG018|Period 4|Protocol Violation|0|||
23233033|NCT01049360|64595957|FG019|Period 4|Protocol Violation|0|||
23233034|NCT01049360|64595938|FG000|Period 4|Withdrawal by Subject|0|||
23233035|NCT01049360|64595939|FG001|Period 4|Withdrawal by Subject|0|||
23233036|NCT01049360|64595940|FG002|Period 4|Withdrawal by Subject|0|||
23233037|NCT01049360|64595941|FG003|Period 4|Withdrawal by Subject|1|||
23233038|NCT01049360|64595942|FG004|Period 4|Withdrawal by Subject|0|||
23233039|NCT01049360|64595943|FG005|Period 4|Withdrawal by Subject|0|||
23233040|NCT01049360|64595944|FG006|Period 4|Withdrawal by Subject|0|||
23233041|NCT01049360|64595945|FG007|Period 4|Withdrawal by Subject|0|||
23233042|NCT01049360|64595946|FG008|Period 4|Withdrawal by Subject|0|||
23233043|NCT01049360|64595947|FG009|Period 4|Withdrawal by Subject|0|||
23233044|NCT01049360|64595948|FG010|Period 4|Withdrawal by Subject|0|||
23233045|NCT01049360|64595949|FG011|Period 4|Withdrawal by Subject|0|||
23233046|NCT01049360|64595950|FG012|Period 4|Withdrawal by Subject|0|||
23233047|NCT01049360|64595951|FG013|Period 4|Withdrawal by Subject|0|||
23233048|NCT01049360|64595952|FG014|Period 4|Withdrawal by Subject|0|||
23233049|NCT01049360|64595953|FG015|Period 4|Withdrawal by Subject|0|||
23339626|NCT00562302|64986271|FG001|Overall Study|Not stated|4|||
23451376|NCT02748863|65395175|FG002|Treatment Period 1|Lack of Efficacy|1|||
23579920|NCT01474512|65853363|FG003|Long-Term Extension Period|Sponsor Decision|0|||
23579921|NCT01474512|65853364|FG004|Long-Term Extension Period|Sponsor Decision|0|||
23579922|NCT01474512|65853365|FG005|Long-Term Extension Period|Sponsor Decision|0|||
23579923|NCT01474512|65853366|FG006|Long-Term Extension Period|Sponsor Decision|0|||
23579924|NCT01474512|65853367|FG007|Long-Term Extension Period|Sponsor Decision|0|||
23579925|NCT01474512|65853368|FG008|Long-Term Extension Period|Sponsor Decision|0|||
23579926|NCT01474512|65853369|FG009|Long-Term Extension Period|Sponsor Decision|0|||
23579927|NCT01474512|65853370|FG010|Long-Term Extension Period|Sponsor Decision|0|||
23579928|NCT01474512|65853371|FG011|Long-Term Extension Period|Sponsor Decision|0|||
23579929|NCT01474512|65853372|FG012|Long-Term Extension Period|Sponsor Decision|6|||
23579930|NCT01474512|65853373|FG013|Long-Term Extension Period|Sponsor Decision|6|||
23579931|NCT01474512|65853374|FG014|Long-Term Extension Period|Sponsor Decision|0|||
23579932|NCT01474512|65853375|FG015|Long-Term Extension Period|Sponsor Decision|0|||
23579933|NCT01474512|65853376|FG016|Long-Term Extension Period|Sponsor Decision|0|||
23579934|NCT01474512|65853377|FG017|Long-Term Extension Period|Sponsor Decision|0|||
23579935|NCT01474512|65853360|FG000|Long-Term Extension Period|Protocol Violation|0|||
23579936|NCT01474512|65853361|FG001|Long-Term Extension Period|Protocol Violation|0|||
23233050|NCT01049360|64595954|FG016|Period 4|Withdrawal by Subject|0|||
23233051|NCT01049360|64595955|FG017|Period 4|Withdrawal by Subject|0|||
23233052|NCT01049360|64595956|FG018|Period 4|Withdrawal by Subject|0|||
23233053|NCT01049360|64595957|FG019|Period 4|Withdrawal by Subject|0|||
23233054|NCT01906489|64595958|FG000|Overall Study|Adverse Event|10|||
23233055|NCT01906489|64595959|FG001|Overall Study|Adverse Event|3|||
23233056|NCT01906489|64595958|FG000|Overall Study|Worsening of CKD|6|||
23233057|NCT01906489|64595959|FG001|Overall Study|Worsening of CKD|4|||
23233058|NCT01906489|64595958|FG000|Overall Study|Withdrawal by Subject|5|||
23233059|NCT01906489|64595959|FG001|Overall Study|Withdrawal by Subject|0|||
23233060|NCT01906489|64595958|FG000|Overall Study|Worsening of Anemia|1|||
23233061|NCT01906489|64595959|FG001|Overall Study|Worsening of Anemia|0|||
23233062|NCT01906489|64595958|FG000|Overall Study|Protocol Violation|0|||
23233063|NCT01906489|64595959|FG001|Overall Study|Protocol Violation|1|||
23451377|NCT02748863|65395176|FG003|Treatment Period 1|Lack of Efficacy|0|||
23451378|NCT02748863|65395177|FG004|Treatment Period 1|Lack of Efficacy|0|||
23451379|NCT02748863|65395173|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23451380|NCT02748863|65395174|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23451381|NCT02748863|65395175|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23451382|NCT02748863|65395176|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23451383|NCT02748863|65395177|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23451384|NCT02748863|65395173|FG000|Treatment Period 2|Lost to Follow-up|2|||
23451385|NCT02748863|65395174|FG001|Treatment Period 2|Lost to Follow-up|0|||
23451386|NCT02748863|65395175|FG002|Treatment Period 2|Lost to Follow-up|0|||
23451387|NCT02748863|65395176|FG003|Treatment Period 2|Lost to Follow-up|0|||
23451388|NCT02748863|65395177|FG004|Treatment Period 2|Lost to Follow-up|0|||
23451389|NCT02748863|65395173|FG000|Treatment Period 2|Adverse Event|3|||
23451390|NCT02748863|65395174|FG001|Treatment Period 2|Adverse Event|2|||
23451391|NCT02748863|65395175|FG002|Treatment Period 2|Adverse Event|0|||
23451392|NCT02748863|65395176|FG003|Treatment Period 2|Adverse Event|2|||
23451393|NCT02748863|65395177|FG004|Treatment Period 2|Adverse Event|0|||
23451394|NCT02748863|65395173|FG000|Treatment Period 2|Lack of Efficacy|0|||
23451395|NCT02748863|65395174|FG001|Treatment Period 2|Lack of Efficacy|1|||
23451396|NCT02748863|65395175|FG002|Treatment Period 2|Lack of Efficacy|0|||
23451397|NCT02748863|65395176|FG003|Treatment Period 2|Lack of Efficacy|0|||
23451398|NCT02748863|65395177|FG004|Treatment Period 2|Lack of Efficacy|0|||
23451399|NCT02748863|65395173|FG000|Treatment Period 2|Pregnancy|0|||
23451400|NCT02748863|65395174|FG001|Treatment Period 2|Pregnancy|0|||
23451401|NCT02748863|65395175|FG002|Treatment Period 2|Pregnancy|0|||
23451402|NCT02748863|65395176|FG003|Treatment Period 2|Pregnancy|0|||
23451403|NCT02748863|65395177|FG004|Treatment Period 2|Pregnancy|1|||
23451404|NCT03449758|65395178|FG000|Overall Study|Major protocol deviation|1|||
23451405|NCT03449758|65395178|FG000|Overall Study|Treatment inefficacy|5|||
23451406|NCT03449758|65395178|FG000|Overall Study|Adverse Event|9|||
23451407|NCT03449758|65395178|FG000|Overall Study|Consent withdrawal|1|||
23451408|NCT03449758|65395178|FG000|Overall Study|Other unspecified reason|3|||
23451409|NCT00506350|65395181|FG000|Overall Study|Serious Adverse Event|1|||
23451410|NCT00506350|65395182|FG001|Overall Study|Serious Adverse Event|0|||
23451411|NCT00506350|65395183|FG002|Overall Study|Serious Adverse Event|0|||
23451412|NCT00506350|65395184|FG003|Overall Study|Serious Adverse Event|0|||
23451413|NCT00506350|65395185|FG004|Overall Study|Serious Adverse Event|0|||
23451414|NCT00506350|65395186|FG005|Overall Study|Serious Adverse Event|0|||
23451415|NCT00506350|65395187|FG006|Overall Study|Serious Adverse Event|0|||
23451416|NCT00506350|65395188|FG007|Overall Study|Serious Adverse Event|0|||
23451417|NCT00506350|65395189|FG008|Overall Study|Serious Adverse Event|0|||
23451418|NCT00506350|65395181|FG000|Overall Study|Adverse Event|0|||
23579937|NCT01474512|65853362|FG002|Long-Term Extension Period|Protocol Violation|0|||
23579938|NCT01474512|65853363|FG003|Long-Term Extension Period|Protocol Violation|0|||
23579939|NCT01474512|65853364|FG004|Long-Term Extension Period|Protocol Violation|0|||
23579940|NCT01474512|65853365|FG005|Long-Term Extension Period|Protocol Violation|0|||
23579941|NCT01474512|65853366|FG006|Long-Term Extension Period|Protocol Violation|0|||
23579942|NCT01474512|65853367|FG007|Long-Term Extension Period|Protocol Violation|0|||
23579943|NCT01474512|65853368|FG008|Long-Term Extension Period|Protocol Violation|0|||
23579944|NCT01474512|65853369|FG009|Long-Term Extension Period|Protocol Violation|0|||
23579945|NCT01474512|65853370|FG010|Long-Term Extension Period|Protocol Violation|0|||
23579946|NCT01474512|65853371|FG011|Long-Term Extension Period|Protocol Violation|0|||
23579947|NCT01474512|65853372|FG012|Long-Term Extension Period|Protocol Violation|5|||
23451419|NCT00506350|65395182|FG001|Overall Study|Adverse Event|0|||
23579948|NCT01474512|65853373|FG013|Long-Term Extension Period|Protocol Violation|5|||
23451420|NCT00506350|65395183|FG002|Overall Study|Adverse Event|0|||
23451421|NCT00506350|65395184|FG003|Overall Study|Adverse Event|0|||
23451422|NCT00506350|65395185|FG004|Overall Study|Adverse Event|0|||
23451423|NCT00506350|65395186|FG005|Overall Study|Adverse Event|0|||
23451424|NCT00506350|65395187|FG006|Overall Study|Adverse Event|0|||
23451425|NCT00506350|65395188|FG007|Overall Study|Adverse Event|1|||
23451426|NCT00506350|65395189|FG008|Overall Study|Adverse Event|1|||
23451427|NCT00506350|65395181|FG000|Overall Study|Protocol Violation|0|||
23451428|NCT00506350|65395182|FG001|Overall Study|Protocol Violation|0|||
23451429|NCT00506350|65395183|FG002|Overall Study|Protocol Violation|1|||
23579949|NCT01474512|65853374|FG014|Long-Term Extension Period|Protocol Violation|0|||
23172867|NCT01157078|64379050|FG000|Overall Study|Withdrawal by Subject|12|||
23172868|NCT01157078|64379051|FG001|Overall Study|Withdrawal by Subject|14|||
23172869|NCT01157078|64379050|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23172870|NCT01157078|64379051|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23172871|NCT01157078|64379050|FG000|Overall Study|Adverse Event|6|||
23172872|NCT01157078|64379051|FG001|Overall Study|Adverse Event|6|||
23172873|NCT01157078|64379050|FG000|Overall Study|Severe non-compliance to protocol|2|||
23172874|NCT01157078|64379051|FG001|Overall Study|Severe non-compliance to protocol|4|||
23172875|NCT01157078|64379050|FG000|Overall Study|Condition under investigation worsened|0|||
23172876|NCT01157078|64379051|FG001|Overall Study|Condition under investigation worsened|1|||
23172877|NCT01157078|64379050|FG000|Overall Study|Lack of Efficacy|2|||
23172878|NCT01157078|64379051|FG001|Overall Study|Lack of Efficacy|0|||
23172879|NCT01157078|64379050|FG000|Overall Study|Study-specific withdrawal criteria|2|||
23172880|NCT01157078|64379051|FG001|Overall Study|Study-specific withdrawal criteria|2|||
23233064|NCT01906489|64595958|FG000|Overall Study|Non- Compliance|1|||
23233065|NCT01906489|64595959|FG001|Overall Study|Non- Compliance|0|||
23233066|NCT01906489|64595958|FG000|Overall Study|Sponsor Decision|1|||
23233067|NCT01906489|64595959|FG001|Overall Study|Sponsor Decision|0|||
23233068|NCT01906489|64595958|FG000|Overall Study|Lost to Follow-up|1|||
23233069|NCT01906489|64595959|FG001|Overall Study|Lost to Follow-up|1|||
23233070|NCT01906489|64595958|FG000|Overall Study|Other|1|||
23233071|NCT01906489|64595959|FG001|Overall Study|Other|0|||
23233072|NCT01852591|64595960|FG000|Overall Study|Withdrawal by Subject|2|||
23579950|NCT01474512|65853375|FG015|Long-Term Extension Period|Protocol Violation|0|||
23579951|NCT01474512|65853376|FG016|Long-Term Extension Period|Protocol Violation|0|||
23579952|NCT01474512|65853377|FG017|Long-Term Extension Period|Protocol Violation|0|||
23233073|NCT01852591|64595960|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
23233074|NCT02561273|64595962|FG000|Overall Study|Protocol Violation|1|||
23233075|NCT02561273|64595963|FG001|Overall Study|Protocol Violation|0|||
23233076|NCT01757821|64595964|FG000|Overall Study|Adverse Event|1|||
23233077|NCT02185040|64595965|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
23339627|NCT01878084|64986272|FG000|Overall Study|Physician Decision|2|||
23339628|NCT02572076|64986273|FG000|Overall Study|Protocol Violation|1|||
23339629|NCT00877071|64986274|FG000|Overall Study|disease progression|2|||
23339630|NCT01023256|64986275|FG000|Overall Study|Protocol Violation|2|||
23339631|NCT01023256|64986276|FG001|Overall Study|Protocol Violation|3|||
23339632|NCT01023256|64986277|FG002|Overall Study|Protocol Violation|0|||
23339633|NCT01023256|64986278|FG003|Overall Study|Protocol Violation|0|||
23339634|NCT01023256|64986275|FG000|Overall Study|Randomized but not treated|1|||
23339635|NCT01023256|64986276|FG001|Overall Study|Randomized but not treated|0|||
23339636|NCT01023256|64986277|FG002|Overall Study|Randomized but not treated|1|||
23451430|NCT00506350|65395184|FG003|Overall Study|Protocol Violation|0|||
23579953|NCT01474512|65853360|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579954|NCT01474512|65853361|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579955|NCT01474512|65853362|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579956|NCT01474512|65853363|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579957|NCT01474512|65853364|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579958|NCT01474512|65853365|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579959|NCT01474512|65853366|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579960|NCT01474512|65853367|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579961|NCT01474512|65853368|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579962|NCT01474512|65853369|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579963|NCT01474512|65853370|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579964|NCT01474512|65853371|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579965|NCT01474512|65853372|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
23579966|NCT01474512|65853373|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
23579967|NCT01474512|65853374|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23172881|NCT01157078|64379050|FG000|Overall Study|Lost to Follow-up|7|||
23172882|NCT01157078|64379051|FG001|Overall Study|Lost to Follow-up|5|||
23172883|NCT01157078|64379050|FG000|Overall Study|Other|2|||
23172884|NCT01157078|64379051|FG001|Overall Study|Other|4|||
23233078|NCT02185040|64595966|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
23233079|NCT02185040|64595967|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
23233080|NCT02185040|64595968|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
23233081|NCT02185040|64595969|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
23339637|NCT01023256|64986278|FG003|Overall Study|Randomized but not treated|0|||
23339638|NCT01023256|64986275|FG000|Overall Study|Other|1|||
23339639|NCT01023256|64986276|FG001|Overall Study|Other|0|||
23339640|NCT01023256|64986277|FG002|Overall Study|Other|0|||
23451431|NCT00506350|65395185|FG004|Overall Study|Protocol Violation|0|||
23451432|NCT00506350|65395186|FG005|Overall Study|Protocol Violation|0|||
23451433|NCT00506350|65395187|FG006|Overall Study|Protocol Violation|1|||
23451434|NCT00506350|65395188|FG007|Overall Study|Protocol Violation|0|||
23451435|NCT00506350|65395189|FG008|Overall Study|Protocol Violation|0|||
23451436|NCT00506350|65395181|FG000|Overall Study|Withdrawal by Subject|0|||
23451437|NCT00506350|65395182|FG001|Overall Study|Withdrawal by Subject|1|||
23451438|NCT00506350|65395183|FG002|Overall Study|Withdrawal by Subject|1|||
23451439|NCT00506350|65395184|FG003|Overall Study|Withdrawal by Subject|1|||
23451440|NCT00506350|65395185|FG004|Overall Study|Withdrawal by Subject|4|||
23451441|NCT00506350|65395186|FG005|Overall Study|Withdrawal by Subject|1|||
23451442|NCT00506350|65395187|FG006|Overall Study|Withdrawal by Subject|1|||
23451443|NCT00506350|65395188|FG007|Overall Study|Withdrawal by Subject|2|||
23451444|NCT00506350|65395189|FG008|Overall Study|Withdrawal by Subject|0|||
23451445|NCT00506350|65395181|FG000|Overall Study|Lost to Follow-up|1|||
23451446|NCT00506350|65395182|FG001|Overall Study|Lost to Follow-up|1|||
23451447|NCT00506350|65395183|FG002|Overall Study|Lost to Follow-up|1|||
23451448|NCT00506350|65395184|FG003|Overall Study|Lost to Follow-up|1|||
23451449|NCT00506350|65395185|FG004|Overall Study|Lost to Follow-up|2|||
23451450|NCT00506350|65395186|FG005|Overall Study|Lost to Follow-up|1|||
23451451|NCT00506350|65395187|FG006|Overall Study|Lost to Follow-up|0|||
23451452|NCT00506350|65395188|FG007|Overall Study|Lost to Follow-up|0|||
23451453|NCT00506350|65395189|FG008|Overall Study|Lost to Follow-up|2|||
23451454|NCT00506350|65395181|FG000|Overall Study|Medical Reason|0|||
23451455|NCT00506350|65395182|FG001|Overall Study|Medical Reason|0|||
23451456|NCT00506350|65395183|FG002|Overall Study|Medical Reason|0|||
23451457|NCT00506350|65395184|FG003|Overall Study|Medical Reason|0|||
23451458|NCT00506350|65395185|FG004|Overall Study|Medical Reason|1|||
23451459|NCT00506350|65395186|FG005|Overall Study|Medical Reason|0|||
23451460|NCT00506350|65395187|FG006|Overall Study|Medical Reason|0|||
23451461|NCT00506350|65395188|FG007|Overall Study|Medical Reason|0|||
23451462|NCT00506350|65395189|FG008|Overall Study|Medical Reason|0|||
23451463|NCT00506350|65395181|FG000|Overall Study|Other|1|||
23451464|NCT00506350|65395182|FG001|Overall Study|Other|1|||
23451465|NCT00506350|65395183|FG002|Overall Study|Other|3|||
23451466|NCT00506350|65395184|FG003|Overall Study|Other|0|||
23451467|NCT00506350|65395185|FG004|Overall Study|Other|3|||
23451468|NCT00506350|65395186|FG005|Overall Study|Other|0|||
23451469|NCT00506350|65395187|FG006|Overall Study|Other|0|||
23451470|NCT00506350|65395188|FG007|Overall Study|Other|2|||
23451471|NCT00506350|65395189|FG008|Overall Study|Other|2|||
23451472|NCT02888106|65395190|FG000|Overall Study|Withdrawal by Subject|1|||
23579968|NCT01474512|65853375|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579969|NCT01474512|65853376|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579970|NCT01474512|65853377|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
23579971|NCT01474512|65853360|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579972|NCT01474512|65853361|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579973|NCT01474512|65853362|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579974|NCT01474512|65853363|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579975|NCT01474512|65853364|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579976|NCT01474512|65853365|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579977|NCT01474512|65853366|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579978|NCT01474512|65853367|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23172885|NCT01445769|64379053|FG000|Overall Study|Consent Withdrawn|2|||
23172886|NCT01445769|64379053|FG000|Overall Study|Disease Progression|1|||
23172887|NCT01445769|64379053|FG000|Overall Study|Lost to Follow-up|5|||
23172888|NCT01639833|64379054|FG000|Overall Study|Death|4|||
23172889|NCT01639833|64379055|FG001|Overall Study|Death|2|||
23172890|NCT01639833|64379054|FG000|Overall Study|Withdrawal by Subject|2|||
23172891|NCT01639833|64379055|FG001|Overall Study|Withdrawal by Subject|2|||
23172892|NCT02161562|64379056|FG000|Overall Study|Withdrawal by Subject|5|||
23172893|NCT02161562|64379057|FG001|Overall Study|Withdrawal by Subject|8|||
23172894|NCT02161562|64379056|FG000|Overall Study|Protocol Violation|9|||
23172895|NCT02161562|64379057|FG001|Overall Study|Protocol Violation|4|||
23172896|NCT02161562|64379056|FG000|Overall Study|Pregnancy|1|||
23172897|NCT02161562|64379057|FG001|Overall Study|Pregnancy|2|||
23172898|NCT02161562|64379056|FG000|Overall Study|Lost to Follow-up|3|||
23172899|NCT02161562|64379057|FG001|Overall Study|Lost to Follow-up|1|||
23172900|NCT02161562|64379056|FG000|Overall Study|Lack of Efficacy|4|||
23172901|NCT02161562|64379057|FG001|Overall Study|Lack of Efficacy|1|||
23172902|NCT02161562|64379056|FG000|Overall Study|Adverse Event|1|||
23172903|NCT02161562|64379057|FG001|Overall Study|Adverse Event|1|||
23172904|NCT02161562|64379056|FG000|Overall Study|Participant moved back to home country|1|||
23172905|NCT02161562|64379057|FG001|Overall Study|Participant moved back to home country|0|||
23451473|NCT02888106|65395191|FG001|Overall Study|Withdrawal by Subject|2|||
23451474|NCT02888106|65395192|FG002|Overall Study|Withdrawal by Subject|0|||
23451475|NCT02888106|65395193|FG003|Overall Study|Withdrawal by Subject|1|||
23579979|NCT01474512|65853368|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23451476|NCT02888106|65395194|FG004|Overall Study|Withdrawal by Subject|0|||
23451477|NCT02888106|65395195|FG005|Overall Study|Withdrawal by Subject|0|||
23451478|NCT02888106|65395190|FG000|Overall Study|Lost to Follow-up|1|||
23451479|NCT02888106|65395191|FG001|Overall Study|Lost to Follow-up|0|||
23451480|NCT02888106|65395192|FG002|Overall Study|Lost to Follow-up|0|||
23451481|NCT02888106|65395193|FG003|Overall Study|Lost to Follow-up|1|||
23451482|NCT02888106|65395194|FG004|Overall Study|Lost to Follow-up|0|||
23451483|NCT02888106|65395195|FG005|Overall Study|Lost to Follow-up|1|||
23451484|NCT02888106|65395190|FG000|Overall Study|Adverse Event|2|||
23451485|NCT02888106|65395191|FG001|Overall Study|Adverse Event|0|||
23451486|NCT02888106|65395192|FG002|Overall Study|Adverse Event|0|||
23451487|NCT02888106|65395193|FG003|Overall Study|Adverse Event|0|||
23451488|NCT02888106|65395194|FG004|Overall Study|Adverse Event|0|||
23451489|NCT02888106|65395195|FG005|Overall Study|Adverse Event|0|||
23172906|NCT02161562|64379056|FG000|Overall Study|Withdrew due to being out of the country|1|||
23172907|NCT02161562|64379057|FG001|Overall Study|Withdrew due to being out of the country|0|||
23172908|NCT02161562|64379056|FG000|Overall Study|Participant moved out of province|1|||
23172909|NCT02161562|64379057|FG001|Overall Study|Participant moved out of province|0|||
23172910|NCT00666926|64379059|FG000|Overall Study|Adverse Event|0|||
23172911|NCT00666926|64379060|FG001|Overall Study|Adverse Event|0|||
23172912|NCT00666926|64379061|FG002|Overall Study|Adverse Event|0|||
23172913|NCT00666926|64379062|FG003|Overall Study|Adverse Event|0|||
23172914|NCT00666926|64379063|FG004|Overall Study|Adverse Event|0|||
23172915|NCT00666926|64379064|FG005|Overall Study|Adverse Event|0|||
23172916|NCT00666926|64379065|FG006|Overall Study|Adverse Event|0|||
23172917|NCT00666926|64379066|FG007|Overall Study|Adverse Event|0|||
23172918|NCT00666926|64379067|FG008|Overall Study|Adverse Event|0|||
23172919|NCT00666926|64379068|FG009|Overall Study|Adverse Event|2|||
23172920|NCT00666926|64379069|FG010|Overall Study|Adverse Event|2|||
23172921|NCT00666926|64379070|FG011|Overall Study|Adverse Event|2|||
23172922|NCT00666926|64379071|FG012|Overall Study|Adverse Event|0|||
23172923|NCT00666926|64379072|FG013|Overall Study|Adverse Event|1|||
23172924|NCT00666926|64379073|FG014|Overall Study|Adverse Event|0|||
23172925|NCT00666926|64379074|FG015|Overall Study|Adverse Event|0|||
23172926|NCT00666926|64379059|FG000|Overall Study|Laboratory abnormality|0|||
23172927|NCT00666926|64379060|FG001|Overall Study|Laboratory abnormality|0|||
23172928|NCT00666926|64379061|FG002|Overall Study|Laboratory abnormality|0|||
23172929|NCT00666926|64379062|FG003|Overall Study|Laboratory abnormality|0|||
23172930|NCT00666926|64379063|FG004|Overall Study|Laboratory abnormality|0|||
23172931|NCT00666926|64379064|FG005|Overall Study|Laboratory abnormality|0|||
23172932|NCT00666926|64379065|FG006|Overall Study|Laboratory abnormality|0|||
23172933|NCT00666926|64379066|FG007|Overall Study|Laboratory abnormality|0|||
23172934|NCT00666926|64379067|FG008|Overall Study|Laboratory abnormality|0|||
23172935|NCT00666926|64379068|FG009|Overall Study|Laboratory abnormality|0|||
23172936|NCT00666926|64379069|FG010|Overall Study|Laboratory abnormality|1|||
23172937|NCT00666926|64379070|FG011|Overall Study|Laboratory abnormality|0|||
23172938|NCT00666926|64379071|FG012|Overall Study|Laboratory abnormality|0|||
23451490|NCT02888106|65395190|FG000|Overall Study|Withdrawal of consent|0|||
23451491|NCT02888106|65395191|FG001|Overall Study|Withdrawal of consent|0|||
23451492|NCT02888106|65395192|FG002|Overall Study|Withdrawal of consent|0|||
23451493|NCT02888106|65395193|FG003|Overall Study|Withdrawal of consent|0|||
23451494|NCT02888106|65395194|FG004|Overall Study|Withdrawal of consent|1|||
23451495|NCT02888106|65395195|FG005|Overall Study|Withdrawal of consent|0|||
23451496|NCT02888106|65395190|FG000|Overall Study|Pregnancy|1|||
23451497|NCT02888106|65395191|FG001|Overall Study|Pregnancy|0|||
23451498|NCT02888106|65395192|FG002|Overall Study|Pregnancy|0|||
23451499|NCT02888106|65395193|FG003|Overall Study|Pregnancy|0|||
23451500|NCT02888106|65395194|FG004|Overall Study|Pregnancy|0|||
23451501|NCT02888106|65395195|FG005|Overall Study|Pregnancy|0|||
23451502|NCT00430716|65395196|FG000|Double Blind Phase|Death|1|||
23451503|NCT00430716|65395197|FG001|Double Blind Phase|Death|0|||
23451504|NCT00430716|65395198|FG002|Double Blind Phase|Death|0|||
23172939|NCT00666926|64379072|FG013|Overall Study|Laboratory abnormality|0|||
23172940|NCT00666926|64379073|FG014|Overall Study|Laboratory abnormality|0|||
23172941|NCT00666926|64379074|FG015|Overall Study|Laboratory abnormality|1|||
23172942|NCT00666926|64379059|FG000|Overall Study|Lack of Efficacy|0|||
23172943|NCT00666926|64379060|FG001|Overall Study|Lack of Efficacy|0|||
23172944|NCT00666926|64379061|FG002|Overall Study|Lack of Efficacy|0|||
23172945|NCT00666926|64379062|FG003|Overall Study|Lack of Efficacy|0|||
23172946|NCT00666926|64379063|FG004|Overall Study|Lack of Efficacy|0|||
23172947|NCT00666926|64379064|FG005|Overall Study|Lack of Efficacy|1|||
23172948|NCT00666926|64379065|FG006|Overall Study|Lack of Efficacy|0|||
23172949|NCT00666926|64379066|FG007|Overall Study|Lack of Efficacy|0|||
23172950|NCT00666926|64379067|FG008|Overall Study|Lack of Efficacy|0|||
23172951|NCT00666926|64379068|FG009|Overall Study|Lack of Efficacy|0|||
23451505|NCT00430716|65395196|FG000|Double Blind Phase|No longer willing to participate|2|||
23451506|NCT00430716|65395197|FG001|Double Blind Phase|No longer willing to participate|1|||
23451507|NCT00430716|65395198|FG002|Double Blind Phase|No longer willing to participate|1|||
23451508|NCT00430716|65395196|FG000|Double Blind Phase|Other|0|||
23451509|NCT00430716|65395197|FG001|Double Blind Phase|Other|2|||
23451510|NCT00430716|65395198|FG002|Double Blind Phase|Other|0|||
23451511|NCT00430716|65395196|FG000|Double Blind Phase|Study terminated by sponsor|1|||
23172952|NCT00666926|64379069|FG010|Overall Study|Lack of Efficacy|0|||
23172953|NCT00666926|64379070|FG011|Overall Study|Lack of Efficacy|1|||
23172954|NCT00666926|64379071|FG012|Overall Study|Lack of Efficacy|0|||
23172955|NCT00666926|64379072|FG013|Overall Study|Lack of Efficacy|0|||
23172956|NCT00666926|64379073|FG014|Overall Study|Lack of Efficacy|0|||
23172957|NCT00666926|64379074|FG015|Overall Study|Lack of Efficacy|0|||
23172958|NCT00666926|64379059|FG000|Overall Study|Lost to Follow-up|0|||
23172959|NCT00666926|64379060|FG001|Overall Study|Lost to Follow-up|0|||
23172960|NCT00666926|64379061|FG002|Overall Study|Lost to Follow-up|0|||
23172961|NCT00666926|64379062|FG003|Overall Study|Lost to Follow-up|1|||
23172962|NCT00666926|64379063|FG004|Overall Study|Lost to Follow-up|0|||
23172963|NCT00666926|64379064|FG005|Overall Study|Lost to Follow-up|0|||
23172964|NCT00666926|64379065|FG006|Overall Study|Lost to Follow-up|0|||
23172965|NCT00666926|64379066|FG007|Overall Study|Lost to Follow-up|0|||
23172966|NCT00666926|64379067|FG008|Overall Study|Lost to Follow-up|0|||
23172967|NCT00666926|64379068|FG009|Overall Study|Lost to Follow-up|0|||
23172968|NCT00666926|64379069|FG010|Overall Study|Lost to Follow-up|0|||
23172969|NCT00666926|64379070|FG011|Overall Study|Lost to Follow-up|0|||
23172970|NCT00666926|64379071|FG012|Overall Study|Lost to Follow-up|0|||
23172971|NCT00666926|64379072|FG013|Overall Study|Lost to Follow-up|0|||
23172972|NCT00666926|64379073|FG014|Overall Study|Lost to Follow-up|0|||
23172973|NCT00666926|64379074|FG015|Overall Study|Lost to Follow-up|0|||
23172974|NCT00666926|64379059|FG000|Overall Study|Other|2|||
23172975|NCT00666926|64379060|FG001|Overall Study|Other|4|||
23172976|NCT00666926|64379061|FG002|Overall Study|Other|3|||
23172977|NCT00666926|64379062|FG003|Overall Study|Other|3|||
23172978|NCT00666926|64379063|FG004|Overall Study|Other|3|||
23172979|NCT00666926|64379064|FG005|Overall Study|Other|3|||
23172980|NCT00666926|64379065|FG006|Overall Study|Other|4|||
23172981|NCT00666926|64379066|FG007|Overall Study|Other|0|||
23172982|NCT00666926|64379067|FG008|Overall Study|Other|3|||
23172983|NCT00666926|64379068|FG009|Overall Study|Other|5|||
23172984|NCT00666926|64379069|FG010|Overall Study|Other|3|||
23172985|NCT00666926|64379070|FG011|Overall Study|Other|26|||
23172986|NCT00666926|64379071|FG012|Overall Study|Other|3|||
23172987|NCT00666926|64379072|FG013|Overall Study|Other|2|||
23172988|NCT00666926|64379073|FG014|Overall Study|Other|4|||
23172989|NCT00666926|64379074|FG015|Overall Study|Other|4|||
23172990|NCT00666926|64379059|FG000|Overall Study|Withdrawal by Subject|0|||
23172991|NCT00666926|64379060|FG001|Overall Study|Withdrawal by Subject|0|||
23172992|NCT00666926|64379061|FG002|Overall Study|Withdrawal by Subject|0|||
23172993|NCT00666926|64379062|FG003|Overall Study|Withdrawal by Subject|0|||
23172994|NCT00666926|64379063|FG004|Overall Study|Withdrawal by Subject|0|||
23172995|NCT00666926|64379064|FG005|Overall Study|Withdrawal by Subject|0|||
23172996|NCT00666926|64379065|FG006|Overall Study|Withdrawal by Subject|0|||
23172997|NCT00666926|64379066|FG007|Overall Study|Withdrawal by Subject|1|||
23172998|NCT00666926|64379067|FG008|Overall Study|Withdrawal by Subject|0|||
23172999|NCT00666926|64379068|FG009|Overall Study|Withdrawal by Subject|3|||
23173000|NCT00666926|64379069|FG010|Overall Study|Withdrawal by Subject|0|||
23173001|NCT00666926|64379070|FG011|Overall Study|Withdrawal by Subject|3|||
23173002|NCT00666926|64379071|FG012|Overall Study|Withdrawal by Subject|0|||
23173003|NCT00666926|64379072|FG013|Overall Study|Withdrawal by Subject|1|||
23173004|NCT00666926|64379073|FG014|Overall Study|Withdrawal by Subject|3|||
23173005|NCT00666926|64379074|FG015|Overall Study|Withdrawal by Subject|3|||
23233082|NCT02185040|64595970|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
23233083|NCT02185040|64595971|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
23233084|NCT02185040|64595965|FG000|Part 1 Treatment Phase|Adverse Event|1|||
23233085|NCT02185040|64595966|FG001|Part 1 Treatment Phase|Adverse Event|0|||
23233086|NCT02185040|64595967|FG002|Part 1 Treatment Phase|Adverse Event|0|||
23233087|NCT02185040|64595968|FG003|Part 1 Treatment Phase|Adverse Event|2|||
23233088|NCT02185040|64595969|FG004|Part 1 Treatment Phase|Adverse Event|3|||
23233089|NCT02185040|64595970|FG005|Part 1 Treatment Phase|Adverse Event|0|||
23233090|NCT02185040|64595971|FG006|Part 1 Treatment Phase|Adverse Event|0|||
23233091|NCT02185040|64595965|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23233092|NCT02185040|64595966|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
23173006|NCT00666926|64379059|FG000|Overall Study|Death|0|||
23451512|NCT00430716|65395197|FG001|Double Blind Phase|Study terminated by sponsor|1|||
23451513|NCT00430716|65395198|FG002|Double Blind Phase|Study terminated by sponsor|2|||
23173007|NCT00666926|64379060|FG001|Overall Study|Death|0|||
23173008|NCT00666926|64379061|FG002|Overall Study|Death|0|||
23233093|NCT02185040|64595967|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23451514|NCT00430716|65395196|FG000|Double Blind Phase|Adverse Event|1|||
23173009|NCT00666926|64379062|FG003|Overall Study|Death|0|||
23173010|NCT00666926|64379063|FG004|Overall Study|Death|0|||
23173011|NCT00666926|64379064|FG005|Overall Study|Death|0|||
23173012|NCT00666926|64379065|FG006|Overall Study|Death|0|||
23173013|NCT00666926|64379066|FG007|Overall Study|Death|0|||
23339641|NCT01023256|64986278|FG003|Overall Study|Other|2|||
23339642|NCT01023256|64986275|FG000|Overall Study|Adverse Event|0|||
23339643|NCT01023256|64986276|FG001|Overall Study|Adverse Event|0|||
23339644|NCT01023256|64986277|FG002|Overall Study|Adverse Event|0|||
23339645|NCT01023256|64986278|FG003|Overall Study|Adverse Event|1|||
23339646|NCT01023256|64986275|FG000|Overall Study|Withdrawal by Subject|0|||
23339647|NCT01023256|64986276|FG001|Overall Study|Withdrawal by Subject|0|||
23339648|NCT01023256|64986277|FG002|Overall Study|Withdrawal by Subject|0|||
23451515|NCT00430716|65395197|FG001|Double Blind Phase|Adverse Event|1|||
23451516|NCT00430716|65395198|FG002|Double Blind Phase|Adverse Event|3|||
23451517|NCT00430716|65395196|FG000|Double Blind Phase|Not treated|1|||
23173014|NCT00666926|64379067|FG008|Overall Study|Death|0|||
23173015|NCT00666926|64379068|FG009|Overall Study|Death|0|||
23451518|NCT00430716|65395197|FG001|Double Blind Phase|Not treated|0|||
23451519|NCT00430716|65395198|FG002|Double Blind Phase|Not treated|0|||
23173016|NCT00666926|64379069|FG010|Overall Study|Death|0|||
23173017|NCT00666926|64379070|FG011|Overall Study|Death|1|||
23173018|NCT00666926|64379071|FG012|Overall Study|Death|0|||
23173019|NCT00666926|64379072|FG013|Overall Study|Death|0|||
23173020|NCT00666926|64379073|FG014|Overall Study|Death|0|||
23339649|NCT01023256|64986278|FG003|Overall Study|Withdrawal by Subject|2|||
23339650|NCT04531462|64986281|FG000|Overall Study|Withdrawal by Subject|3|||
23339651|NCT04531462|64986282|FG001|Overall Study|Withdrawal by Subject|1|||
23339652|NCT04531462|64986281|FG000|Overall Study|Adverse Event|3|||
23339653|NCT04531462|64986282|FG001|Overall Study|Adverse Event|3|||
23339654|NCT00471718|64989227|FG000|Overall Study|Adverse Event|3|||
23339655|NCT00471718|64989227|FG000|Overall Study|other complicating disease|1|||
23339656|NCT00471718|64989227|FG000|Overall Study|disease progression|22|||
23339657|NCT00471718|64989227|FG000|Overall Study|Withdrawal by Subject|1|||
23339658|NCT01489254|64989228|FG000|Double-blind Part|Adverse Event|7|||
23339659|NCT01489254|64989229|FG001|Double-blind Part|Adverse Event|2|||
23339660|NCT01489254|64989230|FG002|Double-blind Part|Adverse Event|2|||
23451520|NCT00430716|65395196|FG000|Open Label Phase|Lost to Follow-up|1|||
23173021|NCT00666926|64379074|FG015|Overall Study|Death|0|||
23173022|NCT01441063|64379077|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
23173023|NCT01441063|64379077|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
23173024|NCT03980938|64379080|FG000|Treatment Period 1|Study Terminated|1|||
23173025|NCT03980938|64379081|FG001|Treatment Period 1|Study Terminated|1|||
23173026|NCT03980938|64379080|FG000|Treatment Period 2|Study Terminated|2|||
23173027|NCT03980938|64379081|FG001|Treatment Period 2|Study Terminated|2|||
23173028|NCT01972074|64379082|FG000|Overall Study|Adverse Event|4|||
23173029|NCT01972074|64379083|FG001|Overall Study|Adverse Event|1|||
23173030|NCT01972074|64379084|FG002|Overall Study|Adverse Event|0|||
23173031|NCT01972074|64379082|FG000|Overall Study|Lack of Efficacy|1|||
23173032|NCT01972074|64379083|FG001|Overall Study|Lack of Efficacy|1|||
23173033|NCT01972074|64379084|FG002|Overall Study|Lack of Efficacy|0|||
23173034|NCT01972074|64379082|FG000|Overall Study|Lost to Follow-up|0|||
23173035|NCT01972074|64379083|FG001|Overall Study|Lost to Follow-up|1|||
23173036|NCT01972074|64379084|FG002|Overall Study|Lost to Follow-up|1|||
23173037|NCT01972074|64379082|FG000|Overall Study|Withdrawal by Subject|1|||
23173038|NCT01972074|64379083|FG001|Overall Study|Withdrawal by Subject|1|||
23173039|NCT01972074|64379084|FG002|Overall Study|Withdrawal by Subject|1|||
23173040|NCT01972074|64379082|FG000|Overall Study|Scanner Unavailable|0|||
23173041|NCT01972074|64379083|FG001|Overall Study|Scanner Unavailable|0|||
23173042|NCT01972074|64379084|FG002|Overall Study|Scanner Unavailable|1|||
23173043|NCT03705793|64379086|FG000|Overall Study|Lost to Follow-up|3|||
23173044|NCT03705793|64379087|FG001|Overall Study|Lost to Follow-up|4|||
23173045|NCT03705793|64379086|FG000|Overall Study|Withdrawal by Subject|2|||
23233094|NCT02185040|64595968|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23233095|NCT02185040|64595969|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23233096|NCT02185040|64595970|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23233097|NCT02185040|64595971|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
23233098|NCT02185040|64595965|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
23233099|NCT02185040|64595966|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
23233100|NCT02185040|64595967|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
23233101|NCT02185040|64595968|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
23233102|NCT02185040|64595969|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
23233103|NCT02185040|64595970|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
23173046|NCT03705793|64379087|FG001|Overall Study|Withdrawal by Subject|1|||
23233104|NCT02185040|64595971|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
23173047|NCT00090545|64379088|FG000|Overall Study|Disease progression on study|21|||
23173048|NCT00090545|64379089|FG001|Overall Study|Disease progression on study|17|||
23339661|NCT01489254|64989231|FG003|Double-blind Part|Adverse Event|0|||
23339662|NCT01489254|64989228|FG000|Double-blind Part|Pregnancy|1|||
23339663|NCT01489254|64989229|FG001|Double-blind Part|Pregnancy|3|||
23339664|NCT01489254|64989230|FG002|Double-blind Part|Pregnancy|0|||
23339665|NCT01489254|64989231|FG003|Double-blind Part|Pregnancy|0|||
23339666|NCT01489254|64989228|FG000|Double-blind Part|Withdrawal by Subject|12|||
23339667|NCT01489254|64989229|FG001|Double-blind Part|Withdrawal by Subject|20|||
23339668|NCT01489254|64989230|FG002|Double-blind Part|Withdrawal by Subject|1|||
23339669|NCT01489254|64989231|FG003|Double-blind Part|Withdrawal by Subject|0|||
23339670|NCT01489254|64989228|FG000|Double-blind Part|Lost to Follow-up|1|||
23339671|NCT01489254|64989229|FG001|Double-blind Part|Lost to Follow-up|2|||
23339672|NCT01489254|64989230|FG002|Double-blind Part|Lost to Follow-up|0|||
23339673|NCT01489254|64989231|FG003|Double-blind Part|Lost to Follow-up|0|||
23339674|NCT01489254|64989228|FG000|Double-blind Part|Other reasons for not completing study|4|||
23339675|NCT01489254|64989229|FG001|Double-blind Part|Other reasons for not completing study|6|||
23339676|NCT01489254|64989230|FG002|Double-blind Part|Other reasons for not completing study|0|||
23339677|NCT01489254|64989231|FG003|Double-blind Part|Other reasons for not completing study|0|||
23339678|NCT01489254|64989228|FG000|Open-label Extension Part|Adverse Event|0|||
23339679|NCT01489254|64989229|FG001|Open-label Extension Part|Adverse Event|0|||
23339680|NCT01489254|64989230|FG002|Open-label Extension Part|Adverse Event|0|||
23339681|NCT01489254|64989231|FG003|Open-label Extension Part|Adverse Event|10|||
23339682|NCT01489254|64989228|FG000|Open-label Extension Part|Pregnancy|0|||
23339683|NCT01489254|64989229|FG001|Open-label Extension Part|Pregnancy|0|||
23339684|NCT01489254|64989230|FG002|Open-label Extension Part|Pregnancy|0|||
23339685|NCT01489254|64989231|FG003|Open-label Extension Part|Pregnancy|3|||
23173049|NCT00090545|64379088|FG000|Overall Study|Refused further treatment|1|||
23173050|NCT00090545|64379089|FG001|Overall Study|Refused further treatment|4|||
23173051|NCT00090545|64379088|FG000|Overall Study|Death|0|||
23173052|NCT00090545|64379089|FG001|Overall Study|Death|1|||
23173053|NCT00090545|64379088|FG000|Overall Study|Adverse Event|0|||
23173054|NCT00090545|64379089|FG001|Overall Study|Adverse Event|2|||
23173055|NCT05019131|64379093|FG000|Overall Study|Lost to Follow-up|0|||
23173056|NCT05019131|64379094|FG001|Overall Study|Lost to Follow-up|3|||
23173057|NCT00272987|64379095|FG000|Overall Study|Adverse Event|1|||
23173058|NCT00272987|64379096|FG001|Overall Study|Adverse Event|0|||
23173059|NCT00272987|64379097|FG002|Overall Study|Adverse Event|0|||
23173060|NCT00272987|64379095|FG000|Overall Study|Lost to Follow-up|3|||
23173061|NCT00272987|64379096|FG001|Overall Study|Lost to Follow-up|1|||
23173062|NCT00272987|64379097|FG002|Overall Study|Lost to Follow-up|1|||
23173063|NCT00272987|64379095|FG000|Overall Study|Withdrawal by Subject|1|||
23173064|NCT00272987|64379096|FG001|Overall Study|Withdrawal by Subject|0|||
23173065|NCT00272987|64379097|FG002|Overall Study|Withdrawal by Subject|3|||
23173066|NCT00272987|64379095|FG000|Overall Study|Sponsor Terminated study|0|||
23173067|NCT00272987|64379096|FG001|Overall Study|Sponsor Terminated study|1|||
23173068|NCT00272987|64379097|FG002|Overall Study|Sponsor Terminated study|1|||
23173069|NCT00272987|64379095|FG000|Overall Study|Disease progression|1|||
23173070|NCT00272987|64379096|FG001|Overall Study|Disease progression|1|||
23173071|NCT00272987|64379097|FG002|Overall Study|Disease progression|2|||
23173072|NCT00272987|64379095|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
23173073|NCT00272987|64379096|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
23173074|NCT00272987|64379097|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
23173075|NCT00272987|64379095|FG000|Overall Study|Death|1|||
23173076|NCT00272987|64379096|FG001|Overall Study|Death|0|||
23173077|NCT00272987|64379097|FG002|Overall Study|Death|0|||
23173078|NCT00768898|64379098|FG000|Overall Study|Unrelated injury|1|||
23173079|NCT00768898|64379098|FG000|Overall Study|Headache|1|||
23173080|NCT02154087|64379099|FG000|Overall Study|Study Termination|1|||
23173081|NCT00217087|64379102|FG000|Overall Study|decided to have esophagectomy|1|||
23173082|NCT00217087|64379103|FG001|Overall Study|decided to have esophagectomy|2|||
23173083|NCT00217087|64379102|FG000|Overall Study|completed less than 12 months return|10|||
23173084|NCT00217087|64379103|FG001|Overall Study|completed less than 12 months return|18|||
23173085|NCT01699087|64379105|FG000|Overall Study|Lost to Follow-up|7|||
23173086|NCT01699087|64379105|FG000|Overall Study|Screen failure (prior to treatment)|15|||
23173087|NCT01699087|64379105|FG000|Overall Study|Unable to make future visits|2|||
23173088|NCT02167945|64379109|FG000|Overall Study|Adverse Event|16|||
23173089|NCT02167945|64379109|FG000|Overall Study|Withdrew Consent|42|||
23173090|NCT02167945|64379109|FG000|Overall Study|Lost to Follow-up|122|||
23173091|NCT02167945|64379109|FG000|Overall Study|COVID-19 logistical restrictions|6|||
23173092|NCT02167945|64379109|FG000|Overall Study|Other, not specified|63|||
23339686|NCT01489254|64989228|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
23339687|NCT01489254|64989229|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
23173093|NCT05098041|64379114|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
23173094|NCT03604445|64379115|FG000|Overall Study|Death|0|||
23173095|NCT03604445|64379116|FG001|Overall Study|Death|0|||
23173096|NCT03604445|64379117|FG002|Overall Study|Death|0|||
23173097|NCT03604445|64379118|FG003|Overall Study|Death|0|||
23173098|NCT03604445|64379119|FG004|Overall Study|Death|0|||
23339688|NCT01489254|64989230|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
23339689|NCT01489254|64989231|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
23233105|NCT02185040|64595965|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
23233106|NCT02185040|64595966|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
23233107|NCT02185040|64595967|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
23233108|NCT02185040|64595968|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
23233109|NCT02185040|64595969|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
23233110|NCT02185040|64595970|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
23233111|NCT02185040|64595971|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
23233112|NCT02185040|64595965|FG000|Active Treatment Extension Phase|Adverse Event|0|||
23233113|NCT02185040|64595966|FG001|Active Treatment Extension Phase|Adverse Event|0|||
23233114|NCT02185040|64595967|FG002|Active Treatment Extension Phase|Adverse Event|0|||
23233115|NCT02185040|64595968|FG003|Active Treatment Extension Phase|Adverse Event|0|||
23233116|NCT02185040|64595969|FG004|Active Treatment Extension Phase|Adverse Event|0|||
23233117|NCT02185040|64595970|FG005|Active Treatment Extension Phase|Adverse Event|1|||
23233118|NCT02185040|64595971|FG006|Active Treatment Extension Phase|Adverse Event|4|||
23233119|NCT02185040|64595965|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23233120|NCT02185040|64595966|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23233121|NCT02185040|64595967|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23233122|NCT02185040|64595968|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23233123|NCT02185040|64595969|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
23233124|NCT02185040|64595970|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
23233125|NCT02185040|64595971|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
23339690|NCT01489254|64989228|FG000|Open-label Extension Part|Protocol Violation|0|||
23339691|NCT01489254|64989229|FG001|Open-label Extension Part|Protocol Violation|0|||
23339692|NCT01489254|64989230|FG002|Open-label Extension Part|Protocol Violation|0|||
23173099|NCT03604445|64379120|FG005|Overall Study|Death|0|||
23173100|NCT03604445|64379121|FG006|Overall Study|Death|0|||
23173101|NCT03604445|64379122|FG007|Overall Study|Death|0|||
23173102|NCT03604445|64379123|FG008|Overall Study|Death|1|||
23173103|NCT03604445|64379115|FG000|Overall Study|Withdrawal by Subject|0|||
23173104|NCT03604445|64379116|FG001|Overall Study|Withdrawal by Subject|0|||
23173105|NCT03604445|64379117|FG002|Overall Study|Withdrawal by Subject|0|||
23173106|NCT03604445|64379118|FG003|Overall Study|Withdrawal by Subject|0|||
23173107|NCT03604445|64379119|FG004|Overall Study|Withdrawal by Subject|0|||
23173108|NCT03604445|64379120|FG005|Overall Study|Withdrawal by Subject|0|||
23173109|NCT03604445|64379121|FG006|Overall Study|Withdrawal by Subject|1|||
23173110|NCT03604445|64379122|FG007|Overall Study|Withdrawal by Subject|0|||
23173111|NCT03604445|64379123|FG008|Overall Study|Withdrawal by Subject|0|||
23173112|NCT03604445|64379115|FG000|Overall Study|Missing visit|0|||
23173113|NCT03604445|64379116|FG001|Overall Study|Missing visit|0|||
23173114|NCT03604445|64379117|FG002|Overall Study|Missing visit|0|||
23173115|NCT03604445|64379118|FG003|Overall Study|Missing visit|0|||
23173116|NCT03604445|64379119|FG004|Overall Study|Missing visit|0|||
23173117|NCT03604445|64379120|FG005|Overall Study|Missing visit|1|||
23173118|NCT03604445|64379121|FG006|Overall Study|Missing visit|0|||
23173119|NCT03604445|64379122|FG007|Overall Study|Missing visit|1|||
23173120|NCT03604445|64379123|FG008|Overall Study|Missing visit|0|||
23173121|NCT03604445|64379115|FG000|Overall Study|Adverse Event|0|||
23173122|NCT03604445|64379116|FG001|Overall Study|Adverse Event|0|||
23173123|NCT03604445|64379117|FG002|Overall Study|Adverse Event|0|||
23173124|NCT03604445|64379118|FG003|Overall Study|Adverse Event|1|||
23173125|NCT03604445|64379119|FG004|Overall Study|Adverse Event|0|||
23173126|NCT03604445|64379120|FG005|Overall Study|Adverse Event|0|||
23173127|NCT03604445|64379121|FG006|Overall Study|Adverse Event|0|||
23173128|NCT03604445|64379122|FG007|Overall Study|Adverse Event|0|||
23173129|NCT03604445|64379123|FG008|Overall Study|Adverse Event|1|||
23173130|NCT01764633|64379129|FG000|Overall Study|Withdrawal by Subject|105|||
23173131|NCT01764633|64379130|FG001|Overall Study|Withdrawal by Subject|88|||
23173132|NCT01764633|64379129|FG000|Overall Study|Lost to Follow-up|13|||
23173133|NCT01764633|64379130|FG001|Overall Study|Lost to Follow-up|5|||
23173134|NCT01100944|64379136|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
23173135|NCT01100944|64379137|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
23173136|NCT01100944|64379138|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
23173137|NCT01100944|64379136|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
23173138|NCT01100944|64379137|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
23173139|NCT01100944|64379138|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
23173140|NCT01100944|64379136|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
23173141|NCT01100944|64379137|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
23173142|NCT01100944|64379138|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
23173143|NCT01100944|64379136|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
23173144|NCT01100944|64379137|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
23173145|NCT01100944|64379138|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
23233126|NCT02185040|64595965|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
23233127|NCT02185040|64595966|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
23233128|NCT02185040|64595967|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
23233129|NCT02185040|64595968|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
23233130|NCT02185040|64595969|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
23233131|NCT02185040|64595970|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
23233132|NCT02185040|64595971|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
23233133|NCT01060150|64595972|FG000|Overall Study|Adverse Event|6|||
23233134|NCT01060150|64595972|FG000|Overall Study|Lost to Follow-up|1|||
23233135|NCT01060150|64595972|FG000|Overall Study|Protocol Violation|6|||
23233136|NCT01060150|64595972|FG000|Overall Study|Withdrawal by Subject|8|||
23233137|NCT01060150|64595972|FG000|Overall Study|Enrolled, but not treated|2|||
23233138|NCT04524507|64595978|FG000|Overall Study|Lost to Follow-up|2|||
23233139|NCT04524507|64595979|FG001|Overall Study|Lost to Follow-up|4|||
23233140|NCT04524507|64595978|FG000|Overall Study|Withdrawal by Subject|2|||
23233141|NCT04524507|64595979|FG001|Overall Study|Withdrawal by Subject|9|||
23233142|NCT04524507|64595978|FG000|Overall Study|Death|2|||
23233143|NCT04524507|64595979|FG001|Overall Study|Death|10|||
23233144|NCT00808132|64595984|FG000|Overall Study|Adverse Event|34|||
23233145|NCT00808132|64595985|FG001|Overall Study|Adverse Event|33|||
23233146|NCT00808132|64595986|FG002|Overall Study|Adverse Event|16|||
23233147|NCT00808132|64595987|FG003|Overall Study|Adverse Event|31|||
23233148|NCT00808132|64595988|FG004|Overall Study|Adverse Event|33|||
23233149|NCT00808132|64595984|FG000|Overall Study|Death|0|||
23233150|NCT00808132|64595985|FG001|Overall Study|Death|0|||
23233151|NCT00808132|64595986|FG002|Overall Study|Death|0|||
23233152|NCT00808132|64595987|FG003|Overall Study|Death|0|||
23233153|NCT00808132|64595988|FG004|Overall Study|Death|1|||
23233154|NCT00808132|64595984|FG000|Overall Study|Physician Decision|0|||
23233155|NCT00808132|64595985|FG001|Overall Study|Physician Decision|1|||
23233156|NCT00808132|64595986|FG002|Overall Study|Physician Decision|0|||
23233157|NCT00808132|64595987|FG003|Overall Study|Physician Decision|0|||
23233158|NCT00808132|64595988|FG004|Overall Study|Physician Decision|0|||
23233159|NCT00808132|64595984|FG000|Overall Study|Lost to Follow-up|8|||
23233160|NCT00808132|64595985|FG001|Overall Study|Lost to Follow-up|10|||
23233161|NCT00808132|64595986|FG002|Overall Study|Lost to Follow-up|11|||
23233162|NCT00808132|64595987|FG003|Overall Study|Lost to Follow-up|8|||
23233163|NCT00808132|64595988|FG004|Overall Study|Lost to Follow-up|9|||
23233164|NCT00808132|64595984|FG000|Overall Study|Protocol Violation|8|||
23233165|NCT00808132|64595985|FG001|Overall Study|Protocol Violation|9|||
23233166|NCT00808132|64595986|FG002|Overall Study|Protocol Violation|4|||
23233167|NCT00808132|64595987|FG003|Overall Study|Protocol Violation|9|||
23233168|NCT00808132|64595988|FG004|Overall Study|Protocol Violation|5|||
23233169|NCT00808132|64595984|FG000|Overall Study|Withdrawal by Subject|27|||
23233170|NCT00808132|64595985|FG001|Overall Study|Withdrawal by Subject|18|||
23233171|NCT00808132|64595986|FG002|Overall Study|Withdrawal by Subject|2|||
23233172|NCT00808132|64595987|FG003|Overall Study|Withdrawal by Subject|7|||
23233173|NCT00808132|64595988|FG004|Overall Study|Withdrawal by Subject|16|||
23233174|NCT00808132|64595984|FG000|Overall Study|Other|6|||
23233175|NCT00808132|64595985|FG001|Overall Study|Other|4|||
23233176|NCT00808132|64595986|FG002|Overall Study|Other|6|||
23233177|NCT00808132|64595987|FG003|Overall Study|Other|2|||
23233178|NCT00808132|64595988|FG004|Overall Study|Other|15|||
23233179|NCT00808132|64595984|FG000|Overall Study|Randomized, but not treated|10|||
23233180|NCT00808132|64595985|FG001|Overall Study|Randomized, but not treated|7|||
23233181|NCT00808132|64595986|FG002|Overall Study|Randomized, but not treated|9|||
23233182|NCT00808132|64595987|FG003|Overall Study|Randomized, but not treated|8|||
23233183|NCT00808132|64595988|FG004|Overall Study|Randomized, but not treated|9|||
23233184|NCT00808132|64595984|FG000|Overall Study|Unsatisfactory response|5|||
23233185|NCT00808132|64595985|FG001|Overall Study|Unsatisfactory response|6|||
23233186|NCT00808132|64595986|FG002|Overall Study|Unsatisfactory response|6|||
23233187|NCT00808132|64595987|FG003|Overall Study|Unsatisfactory response|4|||
23233188|NCT00808132|64595988|FG004|Overall Study|Unsatisfactory response|12|||
23233189|NCT01231620|64595989|FG000|Overall Study|Physician Decision|3|||
23233190|NCT01231620|64595990|FG001|Overall Study|Physician Decision|5|||
23233191|NCT01231620|64595991|FG002|Overall Study|Physician Decision|10|||
23233192|NCT01231620|64595989|FG000|Overall Study|Death|12|||
23233193|NCT01231620|64595990|FG001|Overall Study|Death|14|||
23233194|NCT01231620|64595991|FG002|Overall Study|Death|11|||
23233195|NCT01231620|64595989|FG000|Overall Study|Adverse Event|2|||
23233196|NCT01231620|64595990|FG001|Overall Study|Adverse Event|2|||
23233197|NCT01231620|64595991|FG002|Overall Study|Adverse Event|1|||
23233198|NCT01231620|64595989|FG000|Overall Study|Withdrawal by Subject|6|||
23233199|NCT01231620|64595990|FG001|Overall Study|Withdrawal by Subject|6|||
23233200|NCT01231620|64595991|FG002|Overall Study|Withdrawal by Subject|8|||
23233201|NCT01231620|64595989|FG000|Overall Study|Lost to Follow-up|3|||
23233202|NCT01231620|64595990|FG001|Overall Study|Lost to Follow-up|4|||
23233203|NCT01231620|64595991|FG002|Overall Study|Lost to Follow-up|9|||
23233204|NCT02242305|64595992|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
23233205|NCT02242305|64595993|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
23233206|NCT02242305|64595992|FG000|Overall Study|Adverse Event|1|||
23233207|NCT02242305|64595993|FG001|Overall Study|Adverse Event|0|||
23233208|NCT02242305|64595992|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
23233209|NCT02242305|64595993|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
23233210|NCT02242305|64595992|FG000|Overall Study|Subject withdraws inform consent|0|||
23233211|NCT02242305|64595993|FG001|Overall Study|Subject withdraws inform consent|4|||
23233212|NCT02242305|64595992|FG000|Overall Study|Lost to Follow-up|2|||
23233213|NCT02242305|64595993|FG001|Overall Study|Lost to Follow-up|0|||
23233214|NCT02146274|64595994|FG000|Overall Study|Protocol Violation|73|||
23233215|NCT00247962|64595996|FG000|Overall Study|Adverse Event|15|||
23233216|NCT00247962|64595997|FG001|Overall Study|Adverse Event|12|||
23233217|NCT00247962|64595996|FG000|Overall Study|Lost to Follow-up|3|||
23233218|NCT00247962|64595997|FG001|Overall Study|Lost to Follow-up|1|||
23233219|NCT00247962|64595996|FG000|Overall Study|Physician Decision|0|||
23233220|NCT00247962|64595997|FG001|Overall Study|Physician Decision|1|||
23233221|NCT00247962|64595996|FG000|Overall Study|Protocol Violation|1|||
23233222|NCT00247962|64595997|FG001|Overall Study|Protocol Violation|1|||
23233223|NCT00247962|64595996|FG000|Overall Study|Withdrawal by Subject|3|||
23233224|NCT00247962|64595997|FG001|Overall Study|Withdrawal by Subject|2|||
23233225|NCT00247962|64595996|FG000|Overall Study|Lack of Efficacy|4|||
23233226|NCT00247962|64595997|FG001|Overall Study|Lack of Efficacy|2|||
23233227|NCT02698176|64595998|FG000|Overall Study|Progressive disease|4|||
23233228|NCT02698176|64595999|FG001|Overall Study|Progressive disease|3|||
23233229|NCT02698176|64596000|FG002|Overall Study|Progressive disease|1|||
23233230|NCT02698176|64596001|FG003|Overall Study|Progressive disease|0|||
23233231|NCT02698176|64595998|FG000|Overall Study|Adverse Event|2|||
23233232|NCT02698176|64595999|FG001|Overall Study|Adverse Event|0|||
23233233|NCT02698176|64596000|FG002|Overall Study|Adverse Event|0|||
23233234|NCT02698176|64596001|FG003|Overall Study|Adverse Event|0|||
23233235|NCT02698176|64595998|FG000|Overall Study|Clinical progression|3|||
23233236|NCT02698176|64595999|FG001|Overall Study|Clinical progression|0|||
23233237|NCT02698176|64596000|FG002|Overall Study|Clinical progression|0|||
23233238|NCT02698176|64596001|FG003|Overall Study|Clinical progression|0|||
23233239|NCT00412360|64596004|FG000|Overall Study|Lost to Follow-up|0|||
23233240|NCT00412360|64596005|FG001|Overall Study|Lost to Follow-up|1|||
23233241|NCT00412360|64596004|FG000|Overall Study|Not Transplanted|1|||
23233242|NCT00412360|64596005|FG001|Overall Study|Not Transplanted|2|||
23233243|NCT01287403|64596006|FG000|1st Intervention (1 Day)|Adverse Event|1|||
23233244|NCT02987205|64596014|FG000|Overall Study|Adverse Event|1|||
23233245|NCT02987205|64596014|FG000|Overall Study|Withdrawal by Subject|3|||
23233246|NCT00203294|64596015|FG000|Overall Study|Withdrawal by Subject|8|||
23233247|NCT00203294|64596016|FG001|Overall Study|Withdrawal by Subject|13|||
23233248|NCT00426842|64596017|FG000|Overall Study|Lost to Follow-up|1|||
23233249|NCT00087685|64596023|FG000|Overall Study|Adverse Event|5|||
23233250|NCT00087685|64596023|FG000|Overall Study|Non-Compliance|1|||
23233251|NCT00087685|64596023|FG000|Overall Study|Progressive Disease|5|||
23233252|NCT00087685|64596023|FG000|Overall Study|Withdrawal by Subject|3|||
23233253|NCT02475564|64596024|FG000|Overall Study|Withdrawal by Subject|1|||
23233254|NCT02475564|64596025|FG001|Overall Study|Withdrawal by Subject|0|||
23233255|NCT02475564|64596024|FG000|Overall Study|Lost to Follow-up|2|||
23233256|NCT02475564|64596025|FG001|Overall Study|Lost to Follow-up|1|||
23233257|NCT02475564|64596024|FG000|Overall Study|Intense Menstrual bleeding|1|||
23233258|NCT02475564|64596025|FG001|Overall Study|Intense Menstrual bleeding|0|||
23233259|NCT02087085|64596026|FG000|Overall Study|Adverse Event|10|||
23233260|NCT02087085|64596027|FG001|Overall Study|Adverse Event|14|||
23233261|NCT02087085|64596026|FG000|Overall Study|Lack of Efficacy|4|||
23233262|NCT02087085|64596027|FG001|Overall Study|Lack of Efficacy|3|||
23233263|NCT02087085|64596026|FG000|Overall Study|Lost to Follow-up|6|||
23233264|NCT02087085|64596027|FG001|Overall Study|Lost to Follow-up|4|||
23233265|NCT02087085|64596026|FG000|Overall Study|Withdrawal by Subject|9|||
23233266|NCT02087085|64596027|FG001|Overall Study|Withdrawal by Subject|11|||
23233267|NCT02087085|64596026|FG000|Overall Study|Protocol Violation|1|||
23233268|NCT02087085|64596027|FG001|Overall Study|Protocol Violation|0|||
23233269|NCT02087085|64596026|FG000|Overall Study|Study Terminated by Sponsor|87|||
23233270|NCT02087085|64596027|FG001|Overall Study|Study Terminated by Sponsor|80|||
23233271|NCT02087085|64596026|FG000|Overall Study|Other Miscellaneous Reasons|3|||
23233272|NCT02087085|64596027|FG001|Overall Study|Other Miscellaneous Reasons|4|||
23233273|NCT00948389|64596029|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
23233274|NCT00948389|64596030|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
23233275|NCT00948389|64596031|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
23233276|NCT00948389|64596032|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
23233277|NCT00948389|64596033|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
23233278|NCT00948389|64596029|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
23233279|NCT00948389|64596030|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
23233280|NCT00948389|64596031|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
23233281|NCT00948389|64596032|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
23233282|NCT00948389|64596033|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
23233283|NCT00948389|64596029|FG000|Overall Study|Both Progression and Toxicity|1|||
23233284|NCT00948389|64596030|FG001|Overall Study|Both Progression and Toxicity|0|||
23233285|NCT00948389|64596031|FG002|Overall Study|Both Progression and Toxicity|0|||
23233286|NCT00948389|64596032|FG003|Overall Study|Both Progression and Toxicity|0|||
23233287|NCT00948389|64596033|FG004|Overall Study|Both Progression and Toxicity|0|||
23233288|NCT02519777|64596034|FG000|Overall Study|Death|1|||
23233289|NCT02519777|64596035|FG001|Overall Study|Death|0|||
23233290|NCT02519777|64596036|FG002|Overall Study|Death|0|||
23233291|NCT02519777|64596034|FG000|Overall Study|Lost to Follow-up|0|||
23233292|NCT02519777|64596035|FG001|Overall Study|Lost to Follow-up|4|||
23233293|NCT02519777|64596036|FG002|Overall Study|Lost to Follow-up|2|||
23233294|NCT02519777|64596034|FG000|Overall Study|Withdrawal by Subject|3|||
23233295|NCT02519777|64596035|FG001|Overall Study|Withdrawal by Subject|1|||
23233296|NCT02519777|64596036|FG002|Overall Study|Withdrawal by Subject|0|||
23233297|NCT02519777|64596034|FG000|Overall Study|Severe Debilitation|1|||
23233298|NCT02519777|64596035|FG001|Overall Study|Severe Debilitation|1|||
23233299|NCT02519777|64596036|FG002|Overall Study|Severe Debilitation|1|||
23233300|NCT02519777|64596034|FG000|Overall Study|Not able to get to clinic|1|||
23233301|NCT02519777|64596035|FG001|Overall Study|Not able to get to clinic|2|||
23233302|NCT02519777|64596036|FG002|Overall Study|Not able to get to clinic|1|||
23233303|NCT01711359|64596037|FG000|Treatment Period|Withdrawal by Subject|18|||
23233304|NCT01711359|64596038|FG001|Treatment Period|Withdrawal by Subject|7|||
23233305|NCT01711359|64596039|FG002|Treatment Period|Withdrawal by Subject|13|||
23233306|NCT01711359|64596037|FG000|Treatment Period|Lack of Efficacy|13|||
23233307|NCT01711359|64596038|FG001|Treatment Period|Lack of Efficacy|2|||
23233308|NCT01711359|64596039|FG002|Treatment Period|Lack of Efficacy|2|||
23233309|NCT01711359|64596037|FG000|Treatment Period|Adverse Event|8|||
23233310|NCT01711359|64596038|FG001|Treatment Period|Adverse Event|10|||
23233311|NCT01711359|64596039|FG002|Treatment Period|Adverse Event|24|||
23233312|NCT01711359|64596037|FG000|Treatment Period|Physician Decision|4|||
23233313|NCT01711359|64596038|FG001|Treatment Period|Physician Decision|3|||
23233314|NCT01711359|64596039|FG002|Treatment Period|Physician Decision|2|||
23233315|NCT01711359|64596037|FG000|Treatment Period|Death|3|||
23233316|NCT01711359|64596038|FG001|Treatment Period|Death|0|||
23233317|NCT01711359|64596039|FG002|Treatment Period|Death|0|||
23233318|NCT01711359|64596037|FG000|Treatment Period|Entry Criteria Not Met|1|||
23233319|NCT01711359|64596038|FG001|Treatment Period|Entry Criteria Not Met|0|||
23233320|NCT01711359|64596039|FG002|Treatment Period|Entry Criteria Not Met|0|||
23233321|NCT01711359|64596037|FG000|Treatment Period|Sponsor Decision|1|||
23233322|NCT01711359|64596038|FG001|Treatment Period|Sponsor Decision|0|||
23233323|NCT01711359|64596039|FG002|Treatment Period|Sponsor Decision|0|||
23233324|NCT01711359|64596037|FG000|Treatment Period|Lost to Follow-up|1|||
23233325|NCT01711359|64596038|FG001|Treatment Period|Lost to Follow-up|1|||
23233326|NCT01711359|64596039|FG002|Treatment Period|Lost to Follow-up|1|||
23233327|NCT01711359|64596037|FG000|Treatment Period|Randomized, Not Treated|3|||
23233328|NCT01711359|64596038|FG001|Treatment Period|Randomized, Not Treated|1|||
23233329|NCT01711359|64596039|FG002|Treatment Period|Randomized, Not Treated|0|||
23233330|NCT02694562|64596040|FG000|Overall Study|Death|8|||
23233331|NCT02694562|64596040|FG000|Overall Study|Protocol Violation|4|||
23233332|NCT02694562|64596040|FG000|Overall Study|Lost to Follow-up|3|||
23233333|NCT02694562|64596040|FG000|Overall Study|Screen Failure|2|||
23233334|NCT02694562|64596040|FG000|Overall Study|Physician Decision|1|||
23233335|NCT00784836|64596044|FG000|Overall Study|Early Study Termination|3|||
23233336|NCT03287830|64596045|FG000|Overall Study|Withdrawal by Subject|1|||
23233337|NCT03287830|64596046|FG001|Overall Study|Withdrawal by Subject|1|||
23233338|NCT03287830|64596045|FG000|Overall Study|not meeting inclusion criteria|5|||
23233339|NCT03287830|64596046|FG001|Overall Study|not meeting inclusion criteria|12|||
23233340|NCT01654224|64596047|FG000|Overall Study|Lost to Follow-up|2|||
23233341|NCT01654224|64596048|FG001|Overall Study|Lost to Follow-up|2|||
23233342|NCT01654224|64596047|FG000|Overall Study|Did not receive allocation|1|||
23233343|NCT01654224|64596048|FG001|Overall Study|Did not receive allocation|8|||
23233344|NCT01654224|64596047|FG000|Overall Study|Insufficient blood sample|3|||
23233345|NCT01654224|64596048|FG001|Overall Study|Insufficient blood sample|2|||
23233346|NCT01944462|64596049|FG000|PPPP Educational Program|Lost to Follow-up|60|||
23233347|NCT02074059|64596052|FG000|Overall Study|Death|0|||
23233348|NCT02074059|64596053|FG001|Overall Study|Death|0|||
23233349|NCT02074059|64596054|FG002|Overall Study|Death|0|||
23233350|NCT02074059|64596055|FG003|Overall Study|Death|0|||
23233351|NCT02074059|64596056|FG004|Overall Study|Death|1|||
23233352|NCT02074059|64596057|FG005|Overall Study|Death|1|||
23233353|NCT00157157|64596058|FG000|Overall Study|Withdrawal by Subject|6|||
23233354|NCT00157157|64596058|FG000|Overall Study|Physician Decision|1|||
23233355|NCT00157157|64596058|FG000|Overall Study|Lost to Follow-up|1|||
23233356|NCT00157157|64596058|FG000|Overall Study|Enrolled in another study|1|||
23233357|NCT00157157|64596058|FG000|Overall Study|Met exclusion criteria|1|||
23233358|NCT00157157|64596058|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
23233359|NCT00931515|64596059|FG000|Overall Study|Lost to Follow-up|2|||
23233360|NCT00931515|64596060|FG001|Overall Study|Lost to Follow-up|5|||
23233361|NCT04601194|64596061|FG000|Overall Study|Lost to Follow-up|7|||
23233362|NCT02192190|64596064|FG000|Overall Study|Adverse Event|1|||
23233363|NCT02192190|64596065|FG001|Overall Study|Adverse Event|1|||
23233364|NCT02192190|64596066|FG002|Overall Study|Adverse Event|0|||
23233365|NCT02192190|64596067|FG003|Overall Study|Adverse Event|0|||
23233366|NCT02192190|64596068|FG004|Overall Study|Adverse Event|0|||
23233367|NCT02192190|64596069|FG005|Overall Study|Adverse Event|0|||
23233368|NCT02192190|64596064|FG000|Overall Study|Lost to Follow-up|3|||
23233369|NCT02192190|64596065|FG001|Overall Study|Lost to Follow-up|3|||
23233370|NCT02192190|64596066|FG002|Overall Study|Lost to Follow-up|2|||
23233371|NCT02192190|64596067|FG003|Overall Study|Lost to Follow-up|1|||
23233372|NCT02192190|64596068|FG004|Overall Study|Lost to Follow-up|4|||
23233373|NCT02192190|64596069|FG005|Overall Study|Lost to Follow-up|3|||
23233374|NCT02192190|64596064|FG000|Overall Study|Physician Decision|2|||
23233375|NCT02192190|64596065|FG001|Overall Study|Physician Decision|0|||
23233376|NCT02192190|64596066|FG002|Overall Study|Physician Decision|0|||
23233377|NCT02192190|64596067|FG003|Overall Study|Physician Decision|0|||
23233378|NCT02192190|64596068|FG004|Overall Study|Physician Decision|0|||
23233379|NCT02192190|64596069|FG005|Overall Study|Physician Decision|0|||
23233380|NCT02192190|64596064|FG000|Overall Study|Terminated by Sponsor|43|||
23233381|NCT02192190|64596065|FG001|Overall Study|Terminated by Sponsor|23|||
23233382|NCT02192190|64596066|FG002|Overall Study|Terminated by Sponsor|20|||
23233383|NCT02192190|64596067|FG003|Overall Study|Terminated by Sponsor|23|||
23233384|NCT02192190|64596068|FG004|Overall Study|Terminated by Sponsor|21|||
23233385|NCT02192190|64596069|FG005|Overall Study|Terminated by Sponsor|23|||
23233386|NCT02192190|64596064|FG000|Overall Study|Withdrawal by Subject|4|||
23233387|NCT02192190|64596065|FG001|Overall Study|Withdrawal by Subject|1|||
23233388|NCT02192190|64596066|FG002|Overall Study|Withdrawal by Subject|2|||
23233389|NCT02192190|64596067|FG003|Overall Study|Withdrawal by Subject|1|||
23233390|NCT02192190|64596068|FG004|Overall Study|Withdrawal by Subject|5|||
23233391|NCT02192190|64596069|FG005|Overall Study|Withdrawal by Subject|3|||
23233392|NCT02192190|64596064|FG000|Overall Study|Could not Keep Visit Schedule|1|||
23233393|NCT02192190|64596065|FG001|Overall Study|Could not Keep Visit Schedule|0|||
23233394|NCT02192190|64596066|FG002|Overall Study|Could not Keep Visit Schedule|0|||
23233395|NCT02192190|64596067|FG003|Overall Study|Could not Keep Visit Schedule|0|||
23233396|NCT02192190|64596068|FG004|Overall Study|Could not Keep Visit Schedule|0|||
23233397|NCT02192190|64596069|FG005|Overall Study|Could not Keep Visit Schedule|0|||
23233398|NCT02192190|64596064|FG000|Overall Study|Positive Drug Screen|0|||
23233399|NCT02192190|64596065|FG001|Overall Study|Positive Drug Screen|0|||
23233400|NCT02192190|64596066|FG002|Overall Study|Positive Drug Screen|0|||
23233401|NCT02192190|64596067|FG003|Overall Study|Positive Drug Screen|1|||
23233402|NCT02192190|64596068|FG004|Overall Study|Positive Drug Screen|0|||
23233403|NCT02192190|64596069|FG005|Overall Study|Positive Drug Screen|0|||
23233404|NCT02192190|64596064|FG000|Overall Study|Inadequate Pain Relief|0|||
23233405|NCT02192190|64596065|FG001|Overall Study|Inadequate Pain Relief|1|||
23233406|NCT02192190|64596066|FG002|Overall Study|Inadequate Pain Relief|1|||
23233407|NCT02192190|64596067|FG003|Overall Study|Inadequate Pain Relief|0|||
23233408|NCT02192190|64596068|FG004|Overall Study|Inadequate Pain Relief|0|||
23233409|NCT02192190|64596069|FG005|Overall Study|Inadequate Pain Relief|0|||
23233410|NCT01293123|64596076|FG000|Overall Study|Lost to Follow-up|0|||
23233411|NCT01293123|64596077|FG001|Overall Study|Lost to Follow-up|1|||
23233412|NCT02679222|64596078|FG000|Overall Study|No time for project|1|||
23233413|NCT00087594|64596079|FG000|Overall Study|Adverse Event|2|||
23233414|NCT00087594|64596080|FG001|Overall Study|Adverse Event|3|||
23233415|NCT00087594|64596079|FG000|Overall Study|Lost to Follow-up|0|||
23233416|NCT00087594|64596080|FG001|Overall Study|Lost to Follow-up|2|||
23233417|NCT00087594|64596079|FG000|Overall Study|Withdrawal by Subject|4|||
23233418|NCT00087594|64596080|FG001|Overall Study|Withdrawal by Subject|2|||
23233419|NCT00087594|64596079|FG000|Overall Study|Lack of Efficacy|2|||
23233420|NCT00087594|64596080|FG001|Overall Study|Lack of Efficacy|5|||
23233421|NCT03958149|64596081|FG000|Overall Study|Withdrawal by Subject|0|||
23233422|NCT03958149|64596082|FG001|Overall Study|Withdrawal by Subject|1|||
23233423|NCT02067104|64596083|FG000|Overall Study|Study termination due to low accrual|4|||
23233424|NCT02067104|64596084|FG001|Overall Study|Study termination due to low accrual|5|||
23233425|NCT04369742|64596091|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
23233426|NCT04369742|64596092|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
23233427|NCT04369742|64596091|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
23233428|NCT04369742|64596092|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
23233429|NCT00465894|64596095|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
23233430|NCT00465894|64596096|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
23233431|NCT00465894|64596095|FG000|Treatment For 12 Weeks|Family Issues|1|||
23233432|NCT00465894|64596096|FG001|Treatment For 12 Weeks|Family Issues|1|||
23233433|NCT00465894|64596095|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
23233434|NCT00465894|64596096|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
23233435|NCT00352027|64596098|FG000|Overall Study|Progressive disease|3|||
23233436|NCT03225833|64596099|FG000|Overall Study|Adverse Event|0|||
23233437|NCT03225833|64596100|FG001|Overall Study|Adverse Event|1|||
23233438|NCT03225833|64596101|FG002|Overall Study|Adverse Event|2|||
23233439|NCT03225833|64596102|FG003|Overall Study|Adverse Event|0|||
23233440|NCT03225833|64596103|FG004|Overall Study|Adverse Event|0|||
23233441|NCT03225833|64596104|FG005|Overall Study|Adverse Event|2|||
23233442|NCT03225833|64596099|FG000|Overall Study|Withdrawal by Subject|1|||
23233443|NCT03225833|64596100|FG001|Overall Study|Withdrawal by Subject|0|||
23233444|NCT03225833|64596101|FG002|Overall Study|Withdrawal by Subject|0|||
23233445|NCT03225833|64596102|FG003|Overall Study|Withdrawal by Subject|0|||
23233446|NCT03225833|64596103|FG004|Overall Study|Withdrawal by Subject|1|||
23233447|NCT03225833|64596104|FG005|Overall Study|Withdrawal by Subject|0|||
23233448|NCT03225833|64596099|FG000|Overall Study|Termination of Study by Sponsor|4|||
23233449|NCT03225833|64596100|FG001|Overall Study|Termination of Study by Sponsor|0|||
23233450|NCT03225833|64596101|FG002|Overall Study|Termination of Study by Sponsor|0|||
23233451|NCT03225833|64596102|FG003|Overall Study|Termination of Study by Sponsor|0|||
23233452|NCT03225833|64596103|FG004|Overall Study|Termination of Study by Sponsor|0|||
23233453|NCT03225833|64596104|FG005|Overall Study|Termination of Study by Sponsor|7|||
23233454|NCT03225833|64596099|FG000|Overall Study|Sponsor Decision|0|||
23233455|NCT03225833|64596100|FG001|Overall Study|Sponsor Decision|0|||
23233456|NCT03225833|64596101|FG002|Overall Study|Sponsor Decision|0|||
23233457|NCT03225833|64596102|FG003|Overall Study|Sponsor Decision|0|||
23233458|NCT03225833|64596103|FG004|Overall Study|Sponsor Decision|0|||
23233459|NCT03225833|64596104|FG005|Overall Study|Sponsor Decision|1|||
23233460|NCT00851721|64596105|FG000|Overall Study|planned surgery|1|||
23233461|NCT00851721|64596106|FG001|Overall Study|planned surgery|0|||
23233462|NCT00851721|64596105|FG000|Overall Study|Death|1|||
23233463|NCT00851721|64596106|FG001|Overall Study|Death|0|||
23233464|NCT00851721|64596105|FG000|Overall Study|Adverse Event|0|||
23233465|NCT00851721|64596106|FG001|Overall Study|Adverse Event|1|||
23233466|NCT02759939|64596107|FG000|Overall Study|Missing data on first outcome assessed|11|||
23233467|NCT02759939|64596108|FG001|Overall Study|Missing data on first outcome assessed|2|||
23233468|NCT02759939|64596109|FG002|Overall Study|Missing data on first outcome assessed|5|||
23233469|NCT02759939|64596110|FG003|Overall Study|Missing data on first outcome assessed|2|||
23233470|NCT02759939|64596107|FG000|Overall Study|Ineligible for T2 and T3|310|||
23233471|NCT02759939|64596108|FG001|Overall Study|Ineligible for T2 and T3|179|||
23233472|NCT02759939|64596109|FG002|Overall Study|Ineligible for T2 and T3|366|||
23233473|NCT02759939|64596110|FG003|Overall Study|Ineligible for T2 and T3|391|||
23233474|NCT02759939|64596107|FG000|Overall Study|Lost to Follow-up|735|||
23233475|NCT02759939|64596108|FG001|Overall Study|Lost to Follow-up|791|||
23233476|NCT02759939|64596109|FG002|Overall Study|Lost to Follow-up|783|||
23233477|NCT02759939|64596110|FG003|Overall Study|Lost to Follow-up|650|||
23233478|NCT03188991|64596111|FG000|Overall Study|Withdrawal by Subject|0|||
23233479|NCT03188991|64596112|FG001|Overall Study|Withdrawal by Subject|0|||
23233480|NCT03188991|64596113|FG002|Overall Study|Withdrawal by Subject|0|||
23233481|NCT03188991|64596114|FG003|Overall Study|Withdrawal by Subject|1|||
23233482|NCT01108068|64596115|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
23233483|NCT01108068|64596116|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
23233484|NCT03763942|64596117|FG000|Overall Study|Lost to Follow-up|114|||
23233485|NCT03763942|64596118|FG001|Overall Study|Lost to Follow-up|54|||
23233486|NCT03763942|64596117|FG000|Overall Study|Protocol Violation|1|||
23233487|NCT03763942|64596118|FG001|Overall Study|Protocol Violation|0|||
23233488|NCT03763942|64596117|FG000|Overall Study|Withdrawal by Subject|2|||
23233489|NCT03763942|64596118|FG001|Overall Study|Withdrawal by Subject|0|||
23233490|NCT03763942|64596117|FG000|Overall Study|Other|2|||
23233491|NCT03763942|64596118|FG001|Overall Study|Other|3|||
23233492|NCT00417248|64596123|FG000|Overall Study|Study Terminated|6|||
23233493|NCT00417248|64596123|FG000|Overall Study|Death|1|||
23233494|NCT00417248|64596123|FG000|Overall Study|Lack of Efficacy|1|||
23233495|NCT01371721|64596125|FG000|Overall Study|Adverse Event|5|||
23233496|NCT01371721|64596126|FG001|Overall Study|Adverse Event|4|||
23233497|NCT01371721|64596127|FG002|Overall Study|Adverse Event|5|||
23233498|NCT01371721|64596125|FG000|Overall Study|Protocol Violation|6|||
23233499|NCT01371721|64596126|FG001|Overall Study|Protocol Violation|4|||
23233500|NCT01371721|64596127|FG002|Overall Study|Protocol Violation|5|||
23233501|NCT01371721|64596125|FG000|Overall Study|Lost to Follow-up|8|||
23233502|NCT01371721|64596126|FG001|Overall Study|Lost to Follow-up|2|||
23233503|NCT01371721|64596127|FG002|Overall Study|Lost to Follow-up|6|||
23233504|NCT01371721|64596125|FG000|Overall Study|Withdrawal by Subject|5|||
23233505|NCT01371721|64596126|FG001|Overall Study|Withdrawal by Subject|7|||
23233506|NCT01371721|64596127|FG002|Overall Study|Withdrawal by Subject|11|||
23233507|NCT01371721|64596125|FG000|Overall Study|Other|2|||
23233508|NCT01371721|64596126|FG001|Overall Study|Other|3|||
23233509|NCT01371721|64596127|FG002|Overall Study|Other|0|||
23233510|NCT01371721|64596125|FG000|Overall Study|Lack of Efficacy|2|||
23233511|NCT01371721|64596126|FG001|Overall Study|Lack of Efficacy|4|||
23233512|NCT01371721|64596127|FG002|Overall Study|Lack of Efficacy|3|||
23233513|NCT01371721|64596125|FG000|Overall Study|Randomized but not treated|1|||
23233514|NCT01371721|64596126|FG001|Overall Study|Randomized but not treated|0|||
23233515|NCT01371721|64596127|FG002|Overall Study|Randomized but not treated|0|||
23233516|NCT01842334|64596131|FG000|Overall Study|Withdrawal by Subject|3|||
23233517|NCT01842334|64596132|FG001|Overall Study|Withdrawal by Subject|3|||
23233518|NCT01842334|64596131|FG000|Overall Study|Moved away mid-study|0|||
23233519|NCT01842334|64596132|FG001|Overall Study|Moved away mid-study|1|||
23233520|NCT01526928|64596142|FG000|Overall Study|Progressive Disease|35|||
23233521|NCT01526928|64596143|FG001|Overall Study|Progressive Disease|17|||
23233522|NCT01526928|64596144|FG002|Overall Study|Progressive Disease|150|||
23233523|NCT01526928|64596145|FG003|Overall Study|Progressive Disease|182|||
23233524|NCT01526928|64596146|FG004|Overall Study|Progressive Disease|76|||
23233525|NCT01526928|64596147|FG005|Overall Study|Progressive Disease|4|||
23233526|NCT01526928|64596142|FG000|Overall Study|Adverse Event|2|||
23233527|NCT01526928|64596143|FG001|Overall Study|Adverse Event|1|||
23233528|NCT01526928|64596144|FG002|Overall Study|Adverse Event|29|||
23233529|NCT01526928|64596145|FG003|Overall Study|Adverse Event|40|||
23233530|NCT01526928|64596146|FG004|Overall Study|Adverse Event|13|||
23233531|NCT01526928|64596147|FG005|Overall Study|Adverse Event|2|||
23233532|NCT01526928|64596142|FG000|Overall Study|Death|0|||
23233533|NCT01526928|64596143|FG001|Overall Study|Death|0|||
23233534|NCT01526928|64596144|FG002|Overall Study|Death|3|||
23233535|NCT01526928|64596145|FG003|Overall Study|Death|0|||
23233536|NCT01526928|64596146|FG004|Overall Study|Death|0|||
23233537|NCT01526928|64596147|FG005|Overall Study|Death|0|||
23233538|NCT01526928|64596142|FG000|Overall Study|Withdrawal by Subject|1|||
23233539|NCT01526928|64596143|FG001|Overall Study|Withdrawal by Subject|0|||
23233540|NCT01526928|64596144|FG002|Overall Study|Withdrawal by Subject|13|||
23233541|NCT01526928|64596145|FG003|Overall Study|Withdrawal by Subject|11|||
23233542|NCT01526928|64596146|FG004|Overall Study|Withdrawal by Subject|3|||
23233543|NCT01526928|64596147|FG005|Overall Study|Withdrawal by Subject|0|||
23233544|NCT01526928|64596142|FG000|Overall Study|Physician Decision|0|||
23233545|NCT01526928|64596143|FG001|Overall Study|Physician Decision|0|||
23233546|NCT01526928|64596144|FG002|Overall Study|Physician Decision|2|||
23233547|NCT01526928|64596145|FG003|Overall Study|Physician Decision|5|||
23233548|NCT01526928|64596146|FG004|Overall Study|Physician Decision|0|||
23233549|NCT01526928|64596147|FG005|Overall Study|Physician Decision|0|||
23233550|NCT01526928|64596142|FG000|Overall Study|Other Reason|0|||
23233551|NCT01526928|64596143|FG001|Overall Study|Other Reason|1|||
23233552|NCT01526928|64596144|FG002|Overall Study|Other Reason|11|||
23233553|NCT01526928|64596145|FG003|Overall Study|Other Reason|4|||
23233554|NCT01526928|64596146|FG004|Overall Study|Other Reason|1|||
23233555|NCT01526928|64596147|FG005|Overall Study|Other Reason|0|||
23233556|NCT01526928|64596142|FG000|Overall Study|Lost to Follow-up|0|||
23233557|NCT01526928|64596143|FG001|Overall Study|Lost to Follow-up|0|||
23233558|NCT01526928|64596144|FG002|Overall Study|Lost to Follow-up|0|||
23233559|NCT01526928|64596145|FG003|Overall Study|Lost to Follow-up|1|||
23233560|NCT01526928|64596146|FG004|Overall Study|Lost to Follow-up|0|||
23233561|NCT01526928|64596147|FG005|Overall Study|Lost to Follow-up|0|||
23233562|NCT01526928|64596142|FG000|Overall Study|Protocol Deviation|0|||
23233563|NCT01526928|64596143|FG001|Overall Study|Protocol Deviation|0|||
23233564|NCT01526928|64596144|FG002|Overall Study|Protocol Deviation|0|||
23233565|NCT01526928|64596145|FG003|Overall Study|Protocol Deviation|2|||
23233566|NCT01526928|64596146|FG004|Overall Study|Protocol Deviation|0|||
23233567|NCT01526928|64596147|FG005|Overall Study|Protocol Deviation|0|||
23233568|NCT01526928|64596142|FG000|Overall Study|Missing|0|||
23233569|NCT01526928|64596143|FG001|Overall Study|Missing|0|||
23233570|NCT01526928|64596144|FG002|Overall Study|Missing|1|||
23233571|NCT01526928|64596145|FG003|Overall Study|Missing|0|||
23233572|NCT01526928|64596146|FG004|Overall Study|Missing|2|||
23233573|NCT01526928|64596147|FG005|Overall Study|Missing|0|||
23233574|NCT00620815|64596148|FG000|Overall Study|Adverse Event|1|||
23233575|NCT00620815|64596149|FG001|Overall Study|Adverse Event|1|||
23233576|NCT00620815|64596150|FG002|Overall Study|Adverse Event|2|||
23233577|NCT00620815|64596148|FG000|Overall Study|Withdrawal by Subject|1|||
23233578|NCT00620815|64596149|FG001|Overall Study|Withdrawal by Subject|2|||
23173146|NCT04557384|64379143|FG000|Overall Study|Study Terminated by Sponsor|1|||
23173147|NCT04557384|64379143|FG000|Overall Study|Death|1|||
23173148|NCT01656434|64379146|FG000|Overall Study|Adverse Event|199|||
23173149|NCT01656434|64379147|FG001|Overall Study|Adverse Event|63|||
23233579|NCT00620815|64596150|FG002|Overall Study|Withdrawal by Subject|0|||
23233580|NCT00620815|64596148|FG000|Overall Study|Lost to Follow-up|1|||
23233581|NCT00620815|64596149|FG001|Overall Study|Lost to Follow-up|6|||
23233582|NCT00620815|64596150|FG002|Overall Study|Lost to Follow-up|3|||
23233583|NCT00620815|64596148|FG000|Overall Study|Inappropriate enrolment|0|||
23233584|NCT00620815|64596149|FG001|Overall Study|Inappropriate enrolment|0|||
23233585|NCT00620815|64596150|FG002|Overall Study|Inappropriate enrolment|1|||
23233586|NCT00620815|64596148|FG000|Overall Study|Protocol Violation|1|||
23233587|NCT00620815|64596149|FG001|Overall Study|Protocol Violation|2|||
23233588|NCT00620815|64596150|FG002|Overall Study|Protocol Violation|1|||
23233589|NCT01542632|64596152|FG000|Overall Study|Withdrawal of Consent|0|||
23233590|NCT01542632|64596153|FG001|Overall Study|Withdrawal of Consent|0|||
23233591|NCT01542632|64596154|FG002|Overall Study|Withdrawal of Consent|0|||
23233592|NCT01542632|64596155|FG003|Overall Study|Withdrawal of Consent|2|||
23233593|NCT01542632|64596156|FG004|Overall Study|Withdrawal of Consent|3|||
23233594|NCT01542632|64596157|FG005|Overall Study|Withdrawal of Consent|0|||
23233595|NCT01542632|64596152|FG000|Overall Study|Adverse Event|0|||
23233596|NCT01542632|64596153|FG001|Overall Study|Adverse Event|0|||
23233597|NCT01542632|64596154|FG002|Overall Study|Adverse Event|1|||
23233598|NCT01542632|64596155|FG003|Overall Study|Adverse Event|0|||
23233599|NCT01542632|64596156|FG004|Overall Study|Adverse Event|0|||
23233600|NCT01542632|64596157|FG005|Overall Study|Adverse Event|0|||
23173150|NCT01656434|64379146|FG000|Overall Study|Enrollment terminated at trial site|2|||
23173151|NCT01656434|64379147|FG001|Overall Study|Enrollment terminated at trial site|0|||
23233601|NCT01542632|64596152|FG000|Overall Study|Lost to Follow-up|0|||
23233602|NCT01542632|64596153|FG001|Overall Study|Lost to Follow-up|1|||
23579980|NCT01474512|65853369|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579981|NCT01474512|65853370|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579982|NCT01474512|65853371|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
23579983|NCT01474512|65853372|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23233603|NCT01542632|64596154|FG002|Overall Study|Lost to Follow-up|0|||
23233604|NCT01542632|64596155|FG003|Overall Study|Lost to Follow-up|0|||
23233605|NCT01542632|64596156|FG004|Overall Study|Lost to Follow-up|0|||
23233606|NCT01542632|64596157|FG005|Overall Study|Lost to Follow-up|0|||
23233607|NCT01542632|64596152|FG000|Overall Study|Sponsor/Investigator Decision|0|||
23233608|NCT01542632|64596153|FG001|Overall Study|Sponsor/Investigator Decision|0|||
23233609|NCT01542632|64596154|FG002|Overall Study|Sponsor/Investigator Decision|0|||
23233610|NCT01542632|64596155|FG003|Overall Study|Sponsor/Investigator Decision|0|||
23233611|NCT01542632|64596156|FG004|Overall Study|Sponsor/Investigator Decision|1|||
23233612|NCT01542632|64596157|FG005|Overall Study|Sponsor/Investigator Decision|0|||
23233613|NCT02168816|64596164|FG000|Overall Study|Lost to Follow-up|2|||
23233614|NCT02168816|64596165|FG001|Overall Study|Lost to Follow-up|2|||
23233615|NCT01611558|64596166|FG000|Induction Phase|Study drug toxicity|15|||
23233616|NCT01611558|64596166|FG000|Induction Phase|Disease progression|18|||
23233617|NCT01611558|64596166|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
23233618|NCT01611558|64596166|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
23233619|NCT01611558|64596166|FG000|Induction Phase|Death|1|||
23233620|NCT01611558|64596166|FG000|Maintenance Phase|Withdrawal by Subject|1|||
23233621|NCT01611558|64596166|FG000|Maintenance Phase|Elevated Uric acid|1|||
23233622|NCT01747655|64596167|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
23579984|NCT01474512|65853373|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579985|NCT01474512|65853374|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579986|NCT01474512|65853375|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23173152|NCT01656434|64379146|FG000|Overall Study|Lost to Follow-up|309|||
23173153|NCT01656434|64379147|FG001|Overall Study|Lost to Follow-up|76|||
23173154|NCT01656434|64379146|FG000|Overall Study|Site discontinued study participation|24|||
23173155|NCT01656434|64379147|FG001|Overall Study|Site discontinued study participation|9|||
23173156|NCT01656434|64379146|FG000|Overall Study|Screen failure|2|||
23173157|NCT01656434|64379147|FG001|Overall Study|Screen failure|0|||
23173158|NCT01656434|64379146|FG000|Overall Study|Protocol Violation|7|||
23173159|NCT01656434|64379147|FG001|Overall Study|Protocol Violation|0|||
23173160|NCT01656434|64379146|FG000|Overall Study|Pregnancy wish|18|||
23173161|NCT01656434|64379147|FG001|Overall Study|Pregnancy wish|6|||
23173162|NCT01656434|64379146|FG000|Overall Study|Pregnancy|45|||
23173163|NCT01656434|64379147|FG001|Overall Study|Pregnancy|10|||
23173164|NCT01656434|64379146|FG000|Overall Study|Physician Decision|7|||
23173165|NCT01656434|64379147|FG001|Overall Study|Physician Decision|2|||
23173166|NCT01656434|64379146|FG000|Overall Study|Non-compliance with study drug|48|||
23173167|NCT01656434|64379147|FG001|Overall Study|Non-compliance with study drug|9|||
23173168|NCT01656434|64379146|FG000|Overall Study|Study terminated by sponsor|1501|||
23173169|NCT01656434|64379147|FG001|Overall Study|Study terminated by sponsor|348|||
23233623|NCT01747655|64596168|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
23233624|NCT01747655|64596167|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
23233625|NCT01747655|64596168|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
23233626|NCT01747655|64596167|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
23233627|NCT01747655|64596168|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
23233628|NCT01432756|64596169|FG000|Overall Study|Lost to Follow-up|1|||
23233629|NCT01432756|64596170|FG001|Overall Study|Lost to Follow-up|0|||
23233630|NCT01432756|64596171|FG002|Overall Study|Lost to Follow-up|2|||
23233631|NCT01432756|64596172|FG003|Overall Study|Lost to Follow-up|1|||
23233632|NCT02400281|64596173|FG000|Overall Study|Adverse Event|0|||
23233633|NCT02400281|64596174|FG001|Overall Study|Adverse Event|0|||
23233634|NCT02400281|64596175|FG002|Overall Study|Adverse Event|1|||
23233635|NCT02400281|64596176|FG003|Overall Study|Adverse Event|0|||
23233636|NCT02400281|64596177|FG004|Overall Study|Adverse Event|1|||
23233637|NCT02400281|64596178|FG005|Overall Study|Adverse Event|0|||
23233638|NCT02400281|64596173|FG000|Overall Study|Physician Decision|0|||
23233639|NCT02400281|64596174|FG001|Overall Study|Physician Decision|0|||
23233640|NCT02400281|64596175|FG002|Overall Study|Physician Decision|1|||
23233641|NCT02400281|64596176|FG003|Overall Study|Physician Decision|0|||
23233642|NCT02400281|64596177|FG004|Overall Study|Physician Decision|0|||
23233643|NCT02400281|64596178|FG005|Overall Study|Physician Decision|0|||
23233644|NCT02132312|64596182|FG000|Overall Study|Adverse Event|2|||
23233645|NCT02132312|64596183|FG001|Overall Study|Adverse Event|0|||
23233646|NCT02132312|64596182|FG000|Overall Study|Physician Decision|1|||
23233647|NCT02132312|64596183|FG001|Overall Study|Physician Decision|1|||
23233648|NCT02132312|64596182|FG000|Overall Study|Protocol Violation|0|||
23233649|NCT02132312|64596183|FG001|Overall Study|Protocol Violation|1|||
23233650|NCT02132312|64596182|FG000|Overall Study|Withdrawal by Subject|1|||
23233651|NCT02132312|64596183|FG001|Overall Study|Withdrawal by Subject|0|||
23233652|NCT02132312|64596182|FG000|Overall Study|Lost to Follow-up|2|||
23233653|NCT02132312|64596183|FG001|Overall Study|Lost to Follow-up|1|||
23233654|NCT01207427|64596197|FG000|Double-blind Treatment Period|Adverse Event|0|||
23233655|NCT01207427|64596198|FG001|Double-blind Treatment Period|Adverse Event|1|||
23233656|NCT01207427|64596199|FG002|Double-blind Treatment Period|Adverse Event|0|||
23233657|NCT01207427|64596197|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23233658|NCT01207427|64596198|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23339693|NCT01489254|64989231|FG003|Open-label Extension Part|Protocol Violation|1|||
23339694|NCT01489254|64989228|FG000|Open-label Extension Part|Lost to Follow-up|0|||
23339695|NCT01489254|64989229|FG001|Open-label Extension Part|Lost to Follow-up|0|||
23339696|NCT01489254|64989230|FG002|Open-label Extension Part|Lost to Follow-up|0|||
23339697|NCT01489254|64989231|FG003|Open-label Extension Part|Lost to Follow-up|9|||
23451521|NCT00430716|65395197|FG001|Open Label Phase|Lost to Follow-up|0|||
23451522|NCT00430716|65395198|FG002|Open Label Phase|Lost to Follow-up|1|||
23173170|NCT01656434|64379146|FG000|Overall Study|Participant discontinued; drug related|13|||
23173171|NCT01656434|64379147|FG001|Overall Study|Participant discontinued; drug related|4|||
23173172|NCT01656434|64379146|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
23173173|NCT01656434|64379147|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
23173174|NCT01656434|64379146|FG000|Overall Study|Non-compliance with protocol|39|||
23173175|NCT01656434|64379147|FG001|Overall Study|Non-compliance with protocol|15|||
23173176|NCT01656434|64379146|FG000|Overall Study|Participant moved|40|||
23173177|NCT01656434|64379147|FG001|Overall Study|Participant moved|12|||
23173178|NCT01656434|64379146|FG000|Overall Study|Participant withdrew consent|28|||
23173179|NCT01656434|64379147|FG001|Overall Study|Participant withdrew consent|9|||
23173180|NCT01656434|64379146|FG000|Overall Study|Withdrawal by Subject|64|||
23173181|NCT01656434|64379147|FG001|Overall Study|Withdrawal by Subject|7|||
23451523|NCT00430716|65395196|FG000|Open Label Phase|No longer willing to participate|0|||
23579987|NCT01474512|65853376|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23173182|NCT01142726|64379148|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
23173183|NCT01142726|64379149|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
23173184|NCT01142726|64379150|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
23339698|NCT01489254|64989228|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
23339699|NCT01489254|64989229|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
23451524|NCT00430716|65395197|FG001|Open Label Phase|No longer willing to participate|1|||
23579988|NCT01474512|65853377|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
23579989|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
23579990|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
23233659|NCT01207427|64596199|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
23233660|NCT01207427|64596197|FG000|Double-blind Treatment Period|Protocol Violation|2|||
23233661|NCT01207427|64596198|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23233662|NCT01207427|64596199|FG002|Double-blind Treatment Period|Protocol Violation|1|||
23233663|NCT01207427|64596197|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23339700|NCT01489254|64989230|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
23579991|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
23579992|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
23579993|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
23579994|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
23173185|NCT01142726|64379148|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
23173186|NCT01142726|64379149|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
23173187|NCT01142726|64379150|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
23579995|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
23579996|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
23579997|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
23579998|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
23579999|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
23580000|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
23580001|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
23580002|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
23580003|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
23580004|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
23580005|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
23580006|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
23580007|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23173188|NCT01142726|64379148|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
23173189|NCT01142726|64379149|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
23173190|NCT01142726|64379150|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
23173191|NCT01142726|64379148|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
23173192|NCT01142726|64379149|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
23173193|NCT01142726|64379150|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
23173194|NCT01142726|64379148|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
23173195|NCT01142726|64379149|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
23173196|NCT01142726|64379150|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
23173197|NCT01142726|64379148|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
23173198|NCT01142726|64379149|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
23173199|NCT01142726|64379150|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
23173200|NCT01142726|64379148|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
23173201|NCT01142726|64379149|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
23173202|NCT01142726|64379150|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
23173203|NCT01142726|64379148|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
23173204|NCT01142726|64379149|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
23173205|NCT01142726|64379150|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
23173206|NCT01142726|64379148|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
23173207|NCT01142726|64379149|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
23173208|NCT01142726|64379150|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
23173209|NCT01142726|64379148|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
23173210|NCT01142726|64379149|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
23173211|NCT01142726|64379150|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
23173212|NCT01142726|64379148|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
23173213|NCT01142726|64379149|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
23173214|NCT01142726|64379150|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
23173215|NCT01142726|64379148|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
23173216|NCT01142726|64379149|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
23233664|NCT01207427|64596198|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23173217|NCT01142726|64379150|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
23173218|NCT01142726|64379148|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
23173219|NCT01142726|64379149|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
23173220|NCT01142726|64379150|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
23339701|NCT01489254|64989231|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
23580008|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580009|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580010|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580011|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23233665|NCT01207427|64596199|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23233666|NCT00186121|64596200|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
23233667|NCT00186121|64596200|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
23233668|NCT00186121|64596200|FG000|Overall Study|Not eligible (no treatment)|1|||
23233669|NCT02200510|64596201|FG000|Overall Study|Death|1|||
23233670|NCT02200510|64596202|FG001|Overall Study|Death|1|||
23233671|NCT02200510|64596201|FG000|Overall Study|Protocol Violation|0|||
23233672|NCT02200510|64596202|FG001|Overall Study|Protocol Violation|1|||
23233673|NCT02200510|64596201|FG000|Overall Study|Lost to Follow-up|7|||
23233674|NCT02200510|64596202|FG001|Overall Study|Lost to Follow-up|1|||
23233675|NCT02200510|64596201|FG000|Overall Study|potential COI - joined study team|1|||
23233676|NCT02200510|64596202|FG001|Overall Study|potential COI - joined study team|0|||
23233677|NCT00104299|64596203|FG000|Overall Study|Adverse Event|3|||
23233678|NCT00104299|64596204|FG001|Overall Study|Adverse Event|1|||
23233679|NCT00104299|64596203|FG000|Overall Study|Death|2|||
23233680|NCT00104299|64596204|FG001|Overall Study|Death|2|||
23233681|NCT00104299|64596203|FG000|Overall Study|Withdrawal by Subject|2|||
23233682|NCT00104299|64596204|FG001|Overall Study|Withdrawal by Subject|6|||
23233683|NCT00104299|64596203|FG000|Overall Study|Physician Decision|1|||
23233684|NCT00104299|64596204|FG001|Overall Study|Physician Decision|1|||
23233685|NCT00104299|64596203|FG000|Overall Study|To have renal transplant|1|||
23233686|NCT00104299|64596204|FG001|Overall Study|To have renal transplant|0|||
23233687|NCT01632345|64596214|FG000|Treatment: Part I|Adverse Event|1|||
23233688|NCT01632345|64596215|FG001|Treatment: Part I|Adverse Event|4|||
23233689|NCT01632345|64596216|FG002|Treatment: Part I|Adverse Event|2|||
23233690|NCT01632345|64596217|FG003|Treatment: Part I|Adverse Event|1|||
23233691|NCT01632345|64596218|FG004|Treatment: Part I|Adverse Event|3|||
23233692|NCT01632345|64596219|FG005|Treatment: Part I|Adverse Event|0|||
23233693|NCT01632345|64596220|FG006|Treatment: Part I|Adverse Event|0|||
23233694|NCT01632345|64596214|FG000|Treatment: Part I|Lack of Efficacy|0|||
23233695|NCT01632345|64596215|FG001|Treatment: Part I|Lack of Efficacy|1|||
23233696|NCT01632345|64596216|FG002|Treatment: Part I|Lack of Efficacy|0|||
23233697|NCT01632345|64596217|FG003|Treatment: Part I|Lack of Efficacy|1|||
23233698|NCT01632345|64596218|FG004|Treatment: Part I|Lack of Efficacy|1|||
23233699|NCT01632345|64596219|FG005|Treatment: Part I|Lack of Efficacy|0|||
23233700|NCT01632345|64596220|FG006|Treatment: Part I|Lack of Efficacy|0|||
23233701|NCT01632345|64596214|FG000|Treatment: Part I|Lost to Follow-up|3|||
23233702|NCT01632345|64596215|FG001|Treatment: Part I|Lost to Follow-up|2|||
23233703|NCT01632345|64596216|FG002|Treatment: Part I|Lost to Follow-up|1|||
23233704|NCT01632345|64596217|FG003|Treatment: Part I|Lost to Follow-up|3|||
23233705|NCT01632345|64596218|FG004|Treatment: Part I|Lost to Follow-up|4|||
23233706|NCT01632345|64596219|FG005|Treatment: Part I|Lost to Follow-up|0|||
23233707|NCT01632345|64596220|FG006|Treatment: Part I|Lost to Follow-up|0|||
23233708|NCT01632345|64596214|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
23233709|NCT01632345|64596215|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
23233710|NCT01632345|64596216|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
23233711|NCT01632345|64596217|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
23233712|NCT01632345|64596218|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
23233713|NCT01632345|64596219|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
23233714|NCT01632345|64596220|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
23233715|NCT01632345|64596214|FG000|Treatment: Part I|Physician Decision|2|||
23233716|NCT01632345|64596215|FG001|Treatment: Part I|Physician Decision|1|||
23233717|NCT01632345|64596216|FG002|Treatment: Part I|Physician Decision|0|||
23233718|NCT01632345|64596217|FG003|Treatment: Part I|Physician Decision|0|||
23233719|NCT01632345|64596218|FG004|Treatment: Part I|Physician Decision|1|||
23233720|NCT01632345|64596219|FG005|Treatment: Part I|Physician Decision|0|||
23233721|NCT01632345|64596220|FG006|Treatment: Part I|Physician Decision|0|||
23233722|NCT01632345|64596214|FG000|Treatment: Part I|Pregnancy|0|||
23233723|NCT01632345|64596215|FG001|Treatment: Part I|Pregnancy|1|||
23233724|NCT01632345|64596216|FG002|Treatment: Part I|Pregnancy|0|||
23233725|NCT01632345|64596217|FG003|Treatment: Part I|Pregnancy|0|||
23233726|NCT01632345|64596218|FG004|Treatment: Part I|Pregnancy|0|||
23233727|NCT01632345|64596219|FG005|Treatment: Part I|Pregnancy|0|||
23233728|NCT01632345|64596220|FG006|Treatment: Part I|Pregnancy|0|||
23233729|NCT01632345|64596214|FG000|Treatment: Part I|Protocol Deviation|0|||
23233730|NCT01632345|64596215|FG001|Treatment: Part I|Protocol Deviation|0|||
23233731|NCT01632345|64596216|FG002|Treatment: Part I|Protocol Deviation|1|||
23233732|NCT01632345|64596217|FG003|Treatment: Part I|Protocol Deviation|1|||
23233733|NCT01632345|64596218|FG004|Treatment: Part I|Protocol Deviation|0|||
23233734|NCT01632345|64596219|FG005|Treatment: Part I|Protocol Deviation|0|||
23233735|NCT01632345|64596220|FG006|Treatment: Part I|Protocol Deviation|0|||
23233736|NCT01632345|64596214|FG000|Treatment: Part I|Withdrawal by Subject|3|||
23233737|NCT01632345|64596215|FG001|Treatment: Part I|Withdrawal by Subject|4|||
23233738|NCT01632345|64596216|FG002|Treatment: Part I|Withdrawal by Subject|4|||
23233739|NCT01632345|64596217|FG003|Treatment: Part I|Withdrawal by Subject|1|||
23233740|NCT01632345|64596218|FG004|Treatment: Part I|Withdrawal by Subject|4|||
23233741|NCT01632345|64596219|FG005|Treatment: Part I|Withdrawal by Subject|0|||
23233742|NCT01632345|64596220|FG006|Treatment: Part I|Withdrawal by Subject|0|||
23233743|NCT01632345|64596214|FG000|Treatment: Part II|Adverse Event|0|||
23233744|NCT01632345|64596215|FG001|Treatment: Part II|Adverse Event|0|||
23233745|NCT01632345|64596216|FG002|Treatment: Part II|Adverse Event|0|||
23233746|NCT01632345|64596217|FG003|Treatment: Part II|Adverse Event|0|||
23580012|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580013|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580014|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580015|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23233747|NCT01632345|64596218|FG004|Treatment: Part II|Adverse Event|0|||
23233748|NCT01632345|64596219|FG005|Treatment: Part II|Adverse Event|3|||
23233749|NCT01632345|64596220|FG006|Treatment: Part II|Adverse Event|8|||
23233750|NCT01632345|64596214|FG000|Treatment: Part II|Lost to Follow-up|0|||
23451525|NCT00430716|65395198|FG002|Open Label Phase|No longer willing to participate|1|||
23580016|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580017|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580018|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580019|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580020|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
23580021|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
23580022|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
23580023|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
23173221|NCT01142726|64379148|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
23173222|NCT01142726|64379149|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
23173223|NCT01142726|64379150|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
23173224|NCT01142726|64379148|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
23173225|NCT01142726|64379149|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
23173226|NCT01142726|64379150|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
23173227|NCT01142726|64379148|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
23173228|NCT01142726|64379149|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
23173229|NCT01142726|64379150|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
23173230|NCT02475655|64379151|FG000|Overall Study|Lost to Follow-up|0|||
23233751|NCT01632345|64596215|FG001|Treatment: Part II|Lost to Follow-up|0|||
23233752|NCT01632345|64596216|FG002|Treatment: Part II|Lost to Follow-up|0|||
23233753|NCT01632345|64596217|FG003|Treatment: Part II|Lost to Follow-up|0|||
23451526|NCT00430716|65395196|FG000|Open Label Phase|Other|3|||
23580024|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
23580025|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23173231|NCT02475655|64379152|FG001|Overall Study|Lost to Follow-up|1|||
23173232|NCT00706030|64379153|FG000|Overall Study|Disease Progression|4|||
23173233|NCT00706030|64379154|FG001|Overall Study|Disease Progression|6|||
23173234|NCT00706030|64379155|FG002|Overall Study|Disease Progression|46|||
23173235|NCT00706030|64379156|FG003|Overall Study|Disease Progression|12|||
23233754|NCT01632345|64596218|FG004|Treatment: Part II|Lost to Follow-up|0|||
23233755|NCT01632345|64596219|FG005|Treatment: Part II|Lost to Follow-up|3|||
23233756|NCT01632345|64596220|FG006|Treatment: Part II|Lost to Follow-up|1|||
23233757|NCT01632345|64596214|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
23233758|NCT01632345|64596215|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
23233759|NCT01632345|64596216|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
23580026|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580027|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580028|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580029|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580030|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580031|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580032|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580033|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580034|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580035|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580036|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580037|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580038|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
23580039|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
23580040|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
23580041|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
23580042|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
23580043|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580044|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580045|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580046|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580047|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580048|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580049|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580050|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580051|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580052|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580053|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580054|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580055|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580056|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580057|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580058|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
23580059|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
23580060|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
23580061|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
23580062|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
23580063|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
23580064|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
23580065|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
23580066|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
23580067|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
23580068|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
23580069|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
23580070|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
23580071|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
23580072|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
23580073|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
23580074|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
23580075|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
23580076|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
23173236|NCT00706030|64379153|FG000|Overall Study|Adverse Event|1|||
23233760|NCT01632345|64596217|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
23233761|NCT01632345|64596218|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
23580077|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
23580078|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
23580079|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580080|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580081|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
23173237|NCT00706030|64379154|FG001|Overall Study|Adverse Event|0|||
23173238|NCT00706030|64379155|FG002|Overall Study|Adverse Event|4|||
23173239|NCT00706030|64379156|FG003|Overall Study|Adverse Event|2|||
23173240|NCT00706030|64379153|FG000|Overall Study|Withdrawal by Subject|1|||
23173241|NCT00706030|64379154|FG001|Overall Study|Withdrawal by Subject|0|||
23173242|NCT00706030|64379155|FG002|Overall Study|Withdrawal by Subject|2|||
23173243|NCT00706030|64379156|FG003|Overall Study|Withdrawal by Subject|0|||
23173244|NCT00706030|64379153|FG000|Overall Study|Physician Decision|0|||
23173245|NCT00706030|64379154|FG001|Overall Study|Physician Decision|0|||
23173246|NCT00706030|64379155|FG002|Overall Study|Physician Decision|2|||
23173247|NCT00706030|64379156|FG003|Overall Study|Physician Decision|0|||
23173248|NCT00706030|64379153|FG000|Overall Study|Not recorded|0|||
23173249|NCT00706030|64379154|FG001|Overall Study|Not recorded|0|||
23173250|NCT00706030|64379155|FG002|Overall Study|Not recorded|2|||
23173251|NCT00706030|64379156|FG003|Overall Study|Not recorded|0|||
23173252|NCT00706030|64379153|FG000|Overall Study|Protocol Violation|0|||
23173253|NCT00706030|64379154|FG001|Overall Study|Protocol Violation|0|||
23173254|NCT00706030|64379155|FG002|Overall Study|Protocol Violation|1|||
23173255|NCT00706030|64379156|FG003|Overall Study|Protocol Violation|1|||
23173256|NCT00706030|64379153|FG000|Overall Study|Failed to return|0|||
23173257|NCT00706030|64379154|FG001|Overall Study|Failed to return|0|||
23580082|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580083|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580084|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580085|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580086|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580087|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580088|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580089|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580090|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580091|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580092|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580093|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580094|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
23580095|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
23580096|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
23580097|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
23580098|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
23580099|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
23580100|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
23580101|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
23580102|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
23580103|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
23580104|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
23580105|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
23580106|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
23580107|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
23580108|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
23580109|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
23580110|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
23173258|NCT00706030|64379155|FG002|Overall Study|Failed to return|1|||
23173259|NCT00706030|64379156|FG003|Overall Study|Failed to return|0|||
23173260|NCT00706030|64379153|FG000|Overall Study|Symptomatic Deterioration|0|||
23580111|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
23173261|NCT00706030|64379154|FG001|Overall Study|Symptomatic Deterioration|0|||
23173262|NCT00706030|64379155|FG002|Overall Study|Symptomatic Deterioration|1|||
23580112|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
23580113|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
23580114|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
23173263|NCT00706030|64379156|FG003|Overall Study|Symptomatic Deterioration|0|||
23173264|NCT00706030|64379153|FG000|Overall Study|No treatment received|0|||
23173265|NCT00706030|64379154|FG001|Overall Study|No treatment received|0|||
23233762|NCT01632345|64596219|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
23233763|NCT01632345|64596220|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
23233764|NCT01632345|64596214|FG000|Treatment: Part II|Withdrawal by Subject|0|||
23233765|NCT01632345|64596215|FG001|Treatment: Part II|Withdrawal by Subject|0|||
23233766|NCT01632345|64596216|FG002|Treatment: Part II|Withdrawal by Subject|0|||
23233767|NCT01632345|64596217|FG003|Treatment: Part II|Withdrawal by Subject|0|||
23173266|NCT00706030|64379155|FG002|Overall Study|No treatment received|0|||
23173267|NCT00706030|64379156|FG003|Overall Study|No treatment received|1|||
23173268|NCT00706030|64379153|FG000|Overall Study|Death|0|||
23173269|NCT00706030|64379154|FG001|Overall Study|Death|0|||
23173270|NCT00706030|64379155|FG002|Overall Study|Death|1|||
23173271|NCT00706030|64379156|FG003|Overall Study|Death|0|||
23173272|NCT01580397|64379159|FG000|Overall Study|Lack of Efficacy|14|||
23173273|NCT02083380|64379162|FG000|Overall Study|Lack of Efficacy|68|||
23173274|NCT02083380|64379163|FG001|Overall Study|Lack of Efficacy|79|||
23173275|NCT02083380|64379164|FG002|Overall Study|Lack of Efficacy|64|||
23173276|NCT02083380|64379162|FG000|Overall Study|Withdrawal by Subject|9|||
23173277|NCT02083380|64379163|FG001|Overall Study|Withdrawal by Subject|3|||
23173278|NCT02083380|64379164|FG002|Overall Study|Withdrawal by Subject|7|||
23173279|NCT02083380|64379162|FG000|Overall Study|Physician Decision|1|||
23173280|NCT02083380|64379163|FG001|Overall Study|Physician Decision|6|||
23173281|NCT02083380|64379164|FG002|Overall Study|Physician Decision|3|||
23173282|NCT02083380|64379162|FG000|Overall Study|Adverse Event|0|||
23339702|NCT00833482|64989236|FG000|Days 11-20|Adverse Event|0|||
23580115|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580116|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580117|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580118|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580119|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580120|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580121|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580122|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580123|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580124|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580125|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580126|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580127|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580128|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580129|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
23580130|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580131|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
23580132|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
23580133|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580134|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580135|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580136|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580137|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580138|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580139|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580140|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580141|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580142|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580143|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580144|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580145|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580146|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580147|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
23580148|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580149|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
23580150|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
23580151|NCT01474512|65853360|FG000|Post-Treatment Follow-Up|Death|0|||
23173283|NCT02083380|64379163|FG001|Overall Study|Adverse Event|0|||
23173284|NCT02083380|64379164|FG002|Overall Study|Adverse Event|1|||
23173285|NCT02083380|64379162|FG000|Overall Study|Lost to Follow-up|5|||
23173286|NCT02083380|64379163|FG001|Overall Study|Lost to Follow-up|3|||
23580152|NCT01474512|65853361|FG001|Post-Treatment Follow-Up|Death|0|||
23580153|NCT01474512|65853362|FG002|Post-Treatment Follow-Up|Death|0|||
23173287|NCT02083380|64379164|FG002|Overall Study|Lost to Follow-up|3|||
23580154|NCT01474512|65853363|FG003|Post-Treatment Follow-Up|Death|0|||
23580155|NCT01474512|65853364|FG004|Post-Treatment Follow-Up|Death|0|||
23580156|NCT01474512|65853365|FG005|Post-Treatment Follow-Up|Death|0|||
23580157|NCT01474512|65853366|FG006|Post-Treatment Follow-Up|Death|0|||
23580158|NCT01474512|65853367|FG007|Post-Treatment Follow-Up|Death|0|||
23173288|NCT02083380|64379162|FG000|Overall Study|Other|8|||
23173289|NCT02083380|64379163|FG001|Overall Study|Other|4|||
23580159|NCT01474512|65853368|FG008|Post-Treatment Follow-Up|Death|0|||
23580160|NCT01474512|65853369|FG009|Post-Treatment Follow-Up|Death|0|||
23580161|NCT01474512|65853370|FG010|Post-Treatment Follow-Up|Death|0|||
23580162|NCT01474512|65853371|FG011|Post-Treatment Follow-Up|Death|0|||
23580163|NCT01474512|65853372|FG012|Post-Treatment Follow-Up|Death|0|||
23580164|NCT01474512|65853373|FG013|Post-Treatment Follow-Up|Death|0|||
23580165|NCT01474512|65853374|FG014|Post-Treatment Follow-Up|Death|0|||
23580166|NCT01474512|65853375|FG015|Post-Treatment Follow-Up|Death|0|||
23580167|NCT01474512|65853376|FG016|Post-Treatment Follow-Up|Death|1|||
23580168|NCT01474512|65853377|FG017|Post-Treatment Follow-Up|Death|0|||
23580169|NCT01653743|65853381|FG000|Overall Study|Withdrawal by Subject|1|||
23580170|NCT01653743|65853382|FG001|Overall Study|Withdrawal by Subject|0|||
23580171|NCT01653743|65853381|FG000|Overall Study|Investigator discretion|3|||
23580172|NCT01653743|65853382|FG001|Overall Study|Investigator discretion|0|||
23580173|NCT02485353|65853385|FG000|Overall Study|Death|1|||
23580174|NCT02485353|65853385|FG000|Overall Study|Disease Progression|1|||
23173290|NCT02083380|64379164|FG002|Overall Study|Other|6|||
23173291|NCT01422239|64379165|FG000|Overall Study|Lost to Follow-up|4|||
23173292|NCT01422239|64379166|FG001|Overall Study|Lost to Follow-up|3|||
23173293|NCT03870555|64379168|FG000|Period 3 (2 Days)|Adverse Event|1|||
23173294|NCT03870555|64379169|FG001|Period 3 (2 Days)|Adverse Event|0|||
23173295|NCT03870555|64379170|FG002|Period 3 (2 Days)|Adverse Event|0|||
23173296|NCT03222349|64379171|FG000|Overall Study|Treatment B not done|5|||
23173297|NCT03222349|64379172|FG001|Overall Study|Treatment B not done|0|||
23173298|NCT03222349|64379171|FG000|Overall Study|Lost to Follow-up|1|||
23173299|NCT03222349|64379172|FG001|Overall Study|Lost to Follow-up|2|||
23173300|NCT03222349|64379171|FG000|Overall Study|Withdrawal by Subject|1|||
23173301|NCT03222349|64379172|FG001|Overall Study|Withdrawal by Subject|0|||
23173302|NCT03222349|64379171|FG000|Overall Study|Treatment A not done|0|||
23173303|NCT03222349|64379172|FG001|Overall Study|Treatment A not done|5|||
23173304|NCT03222349|64379171|FG000|Overall Study|Study terminated by sponsor|1|||
23173305|NCT03222349|64379172|FG001|Overall Study|Study terminated by sponsor|0|||
23173306|NCT00413959|64379173|FG000|Overall Study|Pt had only one cycle.|1|||
23173307|NCT00331409|64379174|FG000|Overall Study|Lack of Efficacy|4|||
23173308|NCT00854828|64379175|FG000|Overall Study|Death|1|||
23173309|NCT00854828|64379176|FG001|Overall Study|Death|0|||
23173310|NCT00854828|64379177|FG002|Overall Study|Death|0|||
23173311|NCT00854828|64379178|FG003|Overall Study|Death|0|||
23173312|NCT00854828|64379175|FG000|Overall Study|Withdrawal by Subject|1|||
23339703|NCT00833482|64989237|FG001|Days 11-20|Adverse Event|2|||
23173313|NCT00854828|64379176|FG001|Overall Study|Withdrawal by Subject|1|||
23173314|NCT00854828|64379177|FG002|Overall Study|Withdrawal by Subject|0|||
23580175|NCT04155424|65853389|FG000|Overall Study|Other than specified|3|||
23173315|NCT00854828|64379178|FG003|Overall Study|Withdrawal by Subject|9|||
23580176|NCT04155424|65853389|FG000|Overall Study|Withdrawal by Subject|1|||
23580177|NCT04155424|65853389|FG000|Overall Study|Adverse Event|1|||
23580178|NCT04034238|65853390|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
23173316|NCT00854828|64379175|FG000|Overall Study|Missed 24mo visit|1|||
23173317|NCT00854828|64379176|FG001|Overall Study|Missed 24mo visit|1|||
23233768|NCT01632345|64596218|FG004|Treatment: Part II|Withdrawal by Subject|0|||
23173318|NCT00854828|64379177|FG002|Overall Study|Missed 24mo visit|8|||
23173319|NCT00854828|64379178|FG003|Overall Study|Missed 24mo visit|8|||
23173320|NCT02004873|64379179|FG000|Overall Study|Implant unsuccessful|6|||
23233769|NCT01632345|64596219|FG005|Treatment: Part II|Withdrawal by Subject|2|||
23233770|NCT01632345|64596220|FG006|Treatment: Part II|Withdrawal by Subject|2|||
23233771|NCT00612456|64596221|FG000|Overall Study|Adverse Event|1|||
23233772|NCT00612456|64596222|FG001|Overall Study|Adverse Event|0|||
23233773|NCT00612456|64596223|FG002|Overall Study|Adverse Event|0|||
23233774|NCT00612456|64596221|FG000|Overall Study|Lack of Efficacy|1|||
23233775|NCT00612456|64596222|FG001|Overall Study|Lack of Efficacy|1|||
23233776|NCT00612456|64596223|FG002|Overall Study|Lack of Efficacy|0|||
23233777|NCT00612456|64596221|FG000|Overall Study|Withdrawal by Subject|0|||
23173321|NCT02004873|64379179|FG000|Overall Study|Awaiting 6-month visit|390|||
23173322|NCT02004873|64379179|FG000|Overall Study|Missed 6-month visit|4|||
23173323|NCT02004873|64379179|FG000|Overall Study|Death|23|||
23173324|NCT02004873|64379179|FG000|Overall Study|Withdrawal by Subject|1|||
23173325|NCT00584870|64379180|FG000|Overall Study|Adverse Event|4|||
23173326|NCT00584870|64379181|FG001|Overall Study|Adverse Event|3|||
23173327|NCT00584870|64379182|FG002|Overall Study|Adverse Event|2|||
23173328|NCT00584870|64379180|FG000|Overall Study|Lost to Follow-up|4|||
23173329|NCT00584870|64379181|FG001|Overall Study|Lost to Follow-up|1|||
23173330|NCT00584870|64379182|FG002|Overall Study|Lost to Follow-up|1|||
23173331|NCT00584870|64379180|FG000|Overall Study|Lack of Efficacy|7|||
23173332|NCT00584870|64379181|FG001|Overall Study|Lack of Efficacy|14|||
23173333|NCT00584870|64379182|FG002|Overall Study|Lack of Efficacy|8|||
23173334|NCT00584870|64379180|FG000|Overall Study|Withdrawal by Subject|10|||
23173335|NCT00584870|64379181|FG001|Overall Study|Withdrawal by Subject|5|||
23173336|NCT00584870|64379182|FG002|Overall Study|Withdrawal by Subject|3|||
23173337|NCT00584870|64379180|FG000|Overall Study|Protocol Violation|1|||
23233778|NCT00612456|64596222|FG001|Overall Study|Withdrawal by Subject|1|||
23233779|NCT00612456|64596223|FG002|Overall Study|Withdrawal by Subject|0|||
23233780|NCT03604159|64596224|FG000|Overall Study|Lost to Follow-up|6|||
23233781|NCT03604159|64596225|FG001|Overall Study|Lost to Follow-up|7|||
23233782|NCT02269709|64596234|FG000|Time of Enrollment|Withdrawal by Subject|3|||
23233783|NCT02269709|64596234|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
23233784|NCT02269709|64596234|FG000|Six Month Follow-up|Lost to Follow-up|12|||
23233785|NCT03575975|64596236|FG000|Overall Study|Lost to Follow-up|1|||
23173338|NCT00584870|64379181|FG001|Overall Study|Protocol Violation|1|||
23173339|NCT00584870|64379182|FG002|Overall Study|Protocol Violation|2|||
23173340|NCT00584870|64379180|FG000|Overall Study|Did not met entrance criteria|1|||
23233786|NCT03575975|64596237|FG001|Overall Study|Lost to Follow-up|0|||
23233787|NCT03575975|64596238|FG002|Overall Study|Lost to Follow-up|0|||
23233788|NCT02612194|64596239|FG000|Overall Study|Death|5|||
23173341|NCT00584870|64379181|FG001|Overall Study|Did not met entrance criteria|0|||
23173342|NCT00584870|64379182|FG002|Overall Study|Did not met entrance criteria|0|||
23173343|NCT00584870|64379180|FG000|Overall Study|Other|2|||
23173344|NCT00584870|64379181|FG001|Overall Study|Other|0|||
23173345|NCT00584870|64379182|FG002|Overall Study|Other|0|||
23173346|NCT00584870|64379180|FG000|Overall Study|Randomized but not treated|0|||
23173347|NCT00584870|64379181|FG001|Overall Study|Randomized but not treated|1|||
23173348|NCT00584870|64379182|FG002|Overall Study|Randomized but not treated|2|||
23173349|NCT01405053|64379185|FG000|Overall Study|Adverse Event|3|||
23173350|NCT01405053|64379186|FG001|Overall Study|Adverse Event|0|||
23173351|NCT01405053|64379185|FG000|Overall Study|Lost to Follow-up|0|||
23173352|NCT01405053|64379186|FG001|Overall Study|Lost to Follow-up|1|||
23173353|NCT01405053|64379185|FG000|Overall Study|Participant choice|2|||
23173354|NCT01405053|64379186|FG001|Overall Study|Participant choice|1|||
23173355|NCT01405053|64379185|FG000|Overall Study|Inadequate therapeutic effect|2|||
23233789|NCT02612194|64596240|FG001|Overall Study|Death|0|||
23233790|NCT02612194|64596241|FG002|Overall Study|Death|2|||
23233791|NCT02612194|64596239|FG000|Overall Study|Early Study Termination|1|||
23233792|NCT02612194|64596240|FG001|Overall Study|Early Study Termination|0|||
23233793|NCT02612194|64596241|FG002|Overall Study|Early Study Termination|0|||
23233794|NCT03558503|64596243|FG000|Overall Study|Adverse Event|1|||
23233795|NCT03558503|64596243|FG000|Overall Study|Death|1|||
23233796|NCT03558503|64596243|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
23233797|NCT02500901|64600567|FG000|Overall Study|Disease ProgressionDD|2|||
23233798|NCT02554721|64600568|FG000|Overall Study|Adverse Event|1|||
23233799|NCT02554721|64600569|FG001|Overall Study|Adverse Event|0|||
23233800|NCT02554721|64600570|FG002|Overall Study|Adverse Event|0|||
23233801|NCT02554721|64600571|FG003|Overall Study|Adverse Event|0|||
23233802|NCT02554721|64600572|FG004|Overall Study|Adverse Event|1|||
23233803|NCT02554721|64600568|FG000|Overall Study|Noncompliance|0|||
23233804|NCT02554721|64600569|FG001|Overall Study|Noncompliance|0|||
23233805|NCT02554721|64600570|FG002|Overall Study|Noncompliance|0|||
23233806|NCT02554721|64600571|FG003|Overall Study|Noncompliance|0|||
23233807|NCT02554721|64600572|FG004|Overall Study|Noncompliance|1|||
23233808|NCT00211536|64600573|FG000|Overall Study|Withdrawal by Subject|2|||
23233809|NCT00211536|64600574|FG001|Overall Study|Withdrawal by Subject|2|||
23233810|NCT00211536|64600573|FG000|Overall Study|Physician Decision|0|||
23233811|NCT00211536|64600574|FG001|Overall Study|Physician Decision|5|||
23233812|NCT00211536|64600573|FG000|Overall Study|Adverse Event|2|||
23233813|NCT00211536|64600574|FG001|Overall Study|Adverse Event|0|||
23233814|NCT01087944|64600575|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
23233815|NCT01087944|64600576|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
23233816|NCT01087944|64600575|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
23233817|NCT01087944|64600576|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
23233818|NCT02516605|64600578|FG000|Overall Study|Protocol Violation|0|||
23233819|NCT02516605|64600579|FG001|Overall Study|Protocol Violation|0|||
23233820|NCT02516605|64600580|FG002|Overall Study|Protocol Violation|0|||
23233821|NCT02516605|64600581|FG003|Overall Study|Protocol Violation|0|||
23233822|NCT02516605|64600582|FG004|Overall Study|Protocol Violation|1|||
23233823|NCT02516605|64600578|FG000|Overall Study|Withdrawal by Subject|0|||
23233824|NCT02516605|64600579|FG001|Overall Study|Withdrawal by Subject|0|||
23233825|NCT02516605|64600580|FG002|Overall Study|Withdrawal by Subject|0|||
23233826|NCT02516605|64600581|FG003|Overall Study|Withdrawal by Subject|1|||
23233827|NCT02516605|64600582|FG004|Overall Study|Withdrawal by Subject|0|||
23233828|NCT03143855|64600583|FG000|Overall Study|Withdrawal by Subject|4|||
23233829|NCT03143855|64600584|FG001|Overall Study|Withdrawal by Subject|3|||
23233830|NCT03143855|64600583|FG000|Overall Study|Protocol Violation|1|||
23233831|NCT03143855|64600584|FG001|Overall Study|Protocol Violation|0|||
23233832|NCT03143855|64600583|FG000|Overall Study|Participant experienced withdrawal|0|||
23233833|NCT03143855|64600584|FG001|Overall Study|Participant experienced withdrawal|1|||
23233834|NCT01854918|64600587|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
23233835|NCT01854918|64600588|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
23233836|NCT01854918|64600587|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
23233837|NCT01854918|64600588|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
23233838|NCT01854918|64600587|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
23173356|NCT01405053|64379186|FG001|Overall Study|Inadequate therapeutic effect|1|||
23173357|NCT01405053|64379185|FG000|Overall Study|Withdrawal by Subject|3|||
23173358|NCT01405053|64379186|FG001|Overall Study|Withdrawal by Subject|4|||
23173359|NCT01405053|64379185|FG000|Overall Study|Other|0|||
23233839|NCT01854918|64600588|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
23233840|NCT01854918|64600587|FG000|SOC-controlled Period (Year 1)|Death|5|||
23233841|NCT01854918|64600588|FG001|SOC-controlled Period (Year 1)|Death|5|||
23451527|NCT00430716|65395197|FG001|Open Label Phase|Other|1|||
23451528|NCT00430716|65395198|FG002|Open Label Phase|Other|1|||
23451529|NCT00430716|65395196|FG000|Open Label Phase|Protocol Violation|1|||
23173360|NCT01405053|64379186|FG001|Overall Study|Other|1|||
23173361|NCT01430442|64379190|FG000|Overall Study|Subject Withdrew Consent|3|||
23451530|NCT00430716|65395197|FG001|Open Label Phase|Protocol Violation|0|||
23451531|NCT00430716|65395198|FG002|Open Label Phase|Protocol Violation|0|||
23173362|NCT01430442|64379191|FG001|Overall Study|Subject Withdrew Consent|0|||
23173363|NCT01430442|64379192|FG002|Overall Study|Subject Withdrew Consent|1|||
23173364|NCT01430442|64379193|FG003|Overall Study|Subject Withdrew Consent|0|||
23173365|NCT01430442|64379194|FG004|Overall Study|Subject Withdrew Consent|2|||
23173366|NCT01430442|64379195|FG005|Overall Study|Subject Withdrew Consent|1|||
23173367|NCT01430442|64379196|FG006|Overall Study|Subject Withdrew Consent|5|||
23173368|NCT01430442|64379197|FG007|Overall Study|Subject Withdrew Consent|2|||
23173369|NCT01430442|64379190|FG000|Overall Study|Lost to Follow-up|2|||
23173370|NCT01430442|64379191|FG001|Overall Study|Lost to Follow-up|0|||
23173371|NCT01430442|64379192|FG002|Overall Study|Lost to Follow-up|1|||
23173372|NCT01430442|64379193|FG003|Overall Study|Lost to Follow-up|2|||
23173373|NCT01430442|64379194|FG004|Overall Study|Lost to Follow-up|2|||
23173374|NCT01430442|64379195|FG005|Overall Study|Lost to Follow-up|1|||
23173375|NCT01430442|64379196|FG006|Overall Study|Lost to Follow-up|5|||
23173376|NCT01430442|64379197|FG007|Overall Study|Lost to Follow-up|1|||
23173377|NCT01430442|64379190|FG000|Overall Study|Pregnancy|1|||
23173378|NCT01430442|64379191|FG001|Overall Study|Pregnancy|0|||
23173379|NCT01430442|64379192|FG002|Overall Study|Pregnancy|0|||
23173380|NCT01430442|64379193|FG003|Overall Study|Pregnancy|0|||
23173381|NCT01430442|64379194|FG004|Overall Study|Pregnancy|0|||
23173382|NCT01430442|64379195|FG005|Overall Study|Pregnancy|1|||
23173383|NCT01430442|64379196|FG006|Overall Study|Pregnancy|0|||
23173384|NCT01430442|64379197|FG007|Overall Study|Pregnancy|0|||
23173385|NCT01430442|64379190|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
23173386|NCT01430442|64379191|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
23173387|NCT01430442|64379192|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
23173388|NCT01430442|64379193|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
23173389|NCT01430442|64379194|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
23173390|NCT01430442|64379195|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
23173391|NCT01430442|64379196|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
23173392|NCT01430442|64379197|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
23173393|NCT00700180|64379202|FG000|Overall Study|Death|99|||
23173394|NCT00700180|64379203|FG001|Overall Study|Death|114|||
23173395|NCT00700180|64379202|FG000|Overall Study|Alive on treatment|5|||
23173396|NCT00700180|64379203|FG001|Overall Study|Alive on treatment|3|||
23173397|NCT00700180|64379202|FG000|Overall Study|Alive in follow-up|46|||
23173398|NCT00700180|64379203|FG001|Overall Study|Alive in follow-up|27|||
23173399|NCT00700180|64379202|FG000|Overall Study|Lost to Follow-up|4|||
23173400|NCT00700180|64379203|FG001|Overall Study|Lost to Follow-up|5|||
23173401|NCT01031446|64379204|FG000|Overall Study|Disease Progression|38|||
23173402|NCT01031446|64379204|FG000|Overall Study|Adverse Event|9|||
23173403|NCT01031446|64379204|FG000|Overall Study|Physician Decision|4|||
23173404|NCT01031446|64379204|FG000|Overall Study|Withdrawal by Subject|3|||
23173405|NCT01031446|64379204|FG000|Overall Study|Still on treatment|1|||
23173406|NCT01465659|64379210|FG000|Completed 1 Cycle of Treatment|Death|0|||
23173407|NCT01465659|64379211|FG001|Completed 1 Cycle of Treatment|Death|1|||
23173408|NCT01465659|64379212|FG002|Completed 1 Cycle of Treatment|Death|0|||
23173409|NCT01465659|64379213|FG003|Completed 1 Cycle of Treatment|Death|0|||
23173410|NCT01465659|64379210|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
23173411|NCT01465659|64379211|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
23173412|NCT01465659|64379212|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
23173413|NCT01465659|64379213|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
23173414|NCT01465659|64379210|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
23173415|NCT01465659|64379211|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
23173416|NCT01465659|64379212|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
23173417|NCT01465659|64379213|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
23173418|NCT01465659|64379210|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
23173419|NCT01465659|64379211|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
23173420|NCT01465659|64379212|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
23173421|NCT01465659|64379213|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
23173422|NCT01465659|64379210|FG000|Completed Follow for 1 Year|Death|6|||
23173423|NCT01465659|64379211|FG001|Completed Follow for 1 Year|Death|3|||
23173424|NCT01465659|64379212|FG002|Completed Follow for 1 Year|Death|2|||
23451532|NCT00430716|65395196|FG000|Open Label Phase|Study terminated by sponsor|4|||
23173425|NCT01465659|64379213|FG003|Completed Follow for 1 Year|Death|4|||
23173426|NCT02049944|64379214|FG000|Overall Study|Protocol Violation|2|||
23173427|NCT02883244|64379218|FG000|Overall Study|Lost to Follow-up|0|||
23173428|NCT02883244|64379219|FG001|Overall Study|Lost to Follow-up|1|||
23173429|NCT00687362|64379222|FG000|Overall Study|Protocol Violation|2|||
23451533|NCT00430716|65395197|FG001|Open Label Phase|Study terminated by sponsor|5|||
23233842|NCT01854918|64600587|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
23233843|NCT01854918|64600588|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
23233844|NCT01854918|64600587|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
23233845|NCT01854918|64600588|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
23233846|NCT01854918|64600587|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
23233847|NCT01854918|64600588|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
23233848|NCT01854918|64600587|FG000|All-IP Period (Years 2 and 3)|Death|5|||
23233849|NCT01854918|64600588|FG001|All-IP Period (Years 2 and 3)|Death|16|||
23233850|NCT00364351|64600589|FG000|Overall Study|Adverse Event|90|||
23233851|NCT00364351|64600590|FG001|Overall Study|Adverse Event|44|||
23233852|NCT00364351|64600589|FG000|Overall Study|Condition under investigation worsened|469|||
23173430|NCT00687362|64379222|FG000|Overall Study|Withdrawal by Subject|1|||
23173431|NCT00662792|64379223|FG000|Period 1|Personal Reasons|0|||
23173432|NCT00662792|64379224|FG001|Period 1|Personal Reasons|0|||
23173433|NCT00662792|64379225|FG002|Period 1|Personal Reasons|1|||
23173434|NCT00662792|64379226|FG003|Period 1|Personal Reasons|0|||
23173435|NCT00662792|64379223|FG000|Period 1|Refused continuing medication|0|||
23173436|NCT00662792|64379224|FG001|Period 1|Refused continuing medication|1|||
23173437|NCT00662792|64379225|FG002|Period 1|Refused continuing medication|1|||
23173438|NCT00662792|64379226|FG003|Period 1|Refused continuing medication|0|||
23173439|NCT00662792|64379223|FG000|Period 1|Lost to Follow-up|1|||
23173440|NCT00662792|64379224|FG001|Period 1|Lost to Follow-up|0|||
23173441|NCT00662792|64379225|FG002|Period 1|Lost to Follow-up|0|||
23173442|NCT00662792|64379226|FG003|Period 1|Lost to Follow-up|0|||
23173443|NCT00662792|64379223|FG000|Period 1|Other adverse event (AE)|0|||
23173444|NCT00662792|64379224|FG001|Period 1|Other adverse event (AE)|2|||
23173445|NCT00662792|64379225|FG002|Period 1|Other adverse event (AE)|0|||
23173446|NCT00662792|64379226|FG003|Period 1|Other adverse event (AE)|0|||
23173447|NCT00662792|64379223|FG000|Period 1|Worsening of disease under study (AE)|1|||
23173448|NCT00662792|64379224|FG001|Period 1|Worsening of disease under study (AE)|3|||
23173449|NCT00662792|64379225|FG002|Period 1|Worsening of disease under study (AE)|2|||
23173450|NCT00662792|64379226|FG003|Period 1|Worsening of disease under study (AE)|0|||
23173451|NCT00662792|64379223|FG000|Period 1|Not treated|0|||
23173452|NCT00662792|64379224|FG001|Period 1|Not treated|1|||
23173453|NCT00662792|64379225|FG002|Period 1|Not treated|0|||
23173454|NCT00662792|64379226|FG003|Period 1|Not treated|0|||
23173455|NCT00662792|64379223|FG000|Period 2|Worsening of disease under study|1|||
23173456|NCT00662792|64379224|FG001|Period 2|Worsening of disease under study|0|||
23173457|NCT00662792|64379225|FG002|Period 2|Worsening of disease under study|0|||
23173458|NCT00662792|64379226|FG003|Period 2|Worsening of disease under study|3|||
23173459|NCT00662792|64379223|FG000|Period 3|Refused continuing medication|1|||
23173460|NCT00662792|64379224|FG001|Period 3|Refused continuing medication|0|||
23173461|NCT00662792|64379225|FG002|Period 3|Refused continuing medication|1|||
23173462|NCT00662792|64379226|FG003|Period 3|Refused continuing medication|0|||
23173463|NCT00662792|64379223|FG000|Period 3|Other adverse event (AE)|0|||
23173464|NCT00662792|64379224|FG001|Period 3|Other adverse event (AE)|0|||
23173465|NCT00662792|64379225|FG002|Period 3|Other adverse event (AE)|1|||
23173466|NCT00662792|64379226|FG003|Period 3|Other adverse event (AE)|1|||
23173467|NCT00662792|64379223|FG000|Period 4|Refused continuing medication|0|||
23173468|NCT00662792|64379224|FG001|Period 4|Refused continuing medication|1|||
23173469|NCT00662792|64379225|FG002|Period 4|Refused continuing medication|0|||
23173470|NCT00662792|64379226|FG003|Period 4|Refused continuing medication|0|||
23173471|NCT00662792|64379223|FG000|Period 4|Other adverse event (AE)|1|||
23173472|NCT00662792|64379224|FG001|Period 4|Other adverse event (AE)|0|||
23173473|NCT00662792|64379225|FG002|Period 4|Other adverse event (AE)|0|||
23173474|NCT00662792|64379226|FG003|Period 4|Other adverse event (AE)|0|||
23173475|NCT00662792|64379223|FG000|Period 4|Worsening of disease under study (AE)|0|||
23173476|NCT00662792|64379224|FG001|Period 4|Worsening of disease under study (AE)|0|||
23173477|NCT00662792|64379225|FG002|Period 4|Worsening of disease under study (AE)|0|||
23173478|NCT00662792|64379226|FG003|Period 4|Worsening of disease under study (AE)|1|||
23173479|NCT01931059|64379232|FG000|Day 1|Pregnancy|0|||
23173480|NCT01931059|64379233|FG001|Day 1|Pregnancy|1|||
23173481|NCT01931059|64379232|FG000|Day3|Lost to Follow-up|1|||
23173482|NCT01931059|64379233|FG001|Day3|Lost to Follow-up|0|||
23173483|NCT02623335|64379234|FG000|Overall Study|Death|8|||
23233853|NCT00364351|64600590|FG001|Overall Study|Condition under investigation worsened|497|||
23173484|NCT02623335|64379235|FG001|Overall Study|Death|7|||
23173485|NCT02623335|64379234|FG000|Overall Study|Lost to Follow-up|15|||
23233854|NCT00364351|64600589|FG000|Overall Study|Prohibited concomitant medication|0|||
23451534|NCT00430716|65395198|FG002|Open Label Phase|Study terminated by sponsor|4|||
23173486|NCT02623335|64379235|FG001|Overall Study|Lost to Follow-up|23|||
23173487|NCT02623335|64379234|FG000|Overall Study|Withdrawal by Subject|2|||
23173488|NCT02623335|64379235|FG001|Overall Study|Withdrawal by Subject|5|||
23173489|NCT02623335|64379234|FG000|Overall Study|Protocol Violation|2|||
23173490|NCT02623335|64379235|FG001|Overall Study|Protocol Violation|1|||
23173491|NCT04428411|64379236|FG000|Overall Study|Lost to Follow-up|114|||
23580179|NCT04034238|65853391|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23580180|NCT04034238|65853392|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
23580181|NCT04034238|65853393|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23580182|NCT04034238|65853390|FG000|Dose Escalation Phase|Screen failures|0|||
23580183|NCT04034238|65853391|FG001|Dose Escalation Phase|Screen failures|0|||
23580184|NCT04034238|65853392|FG002|Dose Escalation Phase|Screen failures|0|||
23580185|NCT04034238|65853393|FG003|Dose Escalation Phase|Screen failures|2|||
23580186|NCT04034238|65853390|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
23580187|NCT04034238|65853391|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
23580188|NCT04034238|65853392|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
23580189|NCT04034238|65853393|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
23580190|NCT04034238|65853390|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
23580191|NCT04034238|65853391|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
23580192|NCT04034238|65853392|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
23580193|NCT04034238|65853393|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
23580194|NCT03289455|65853394|FG000|Overall Study|Death|1|||
23580195|NCT03289455|65853395|FG001|Overall Study|Death|0|||
23580196|NCT03289455|65853396|FG002|Overall Study|Death|0|||
23580197|NCT03289455|65853394|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
23173492|NCT02062658|64379238|FG000|Overall Study|Withdrawal by Subject|1|||
23173493|NCT02062658|64379238|FG000|Overall Study|Lack of Efficacy|1|||
23173494|NCT02363478|64379240|FG000|Overall Study|Lost to Follow-up|4|||
23173495|NCT02363478|64379240|FG000|Overall Study|Adverse Event|4|||
23173496|NCT01986062|64379241|FG000|Overall Study|Lost to Follow-up|1|||
23173497|NCT01986062|64379242|FG001|Overall Study|Lost to Follow-up|0|||
23173498|NCT01986062|64379241|FG000|Overall Study|Withdrawal by Subject|0|||
23173499|NCT01986062|64379242|FG001|Overall Study|Withdrawal by Subject|1|||
23173500|NCT01602341|64379247|FG000|Overall Study|Adverse Event|0|||
23173501|NCT01602341|64379248|FG001|Overall Study|Adverse Event|1|||
23173502|NCT02979431|64379249|FG000|Overall Study|Parent/guardian withdrew consent|2|||
23173503|NCT02979431|64379250|FG001|Overall Study|Parent/guardian withdrew consent|1|||
23173504|NCT02979431|64379251|FG002|Overall Study|Parent/guardian withdrew consent|1|||
23173505|NCT02979431|64379252|FG003|Overall Study|Parent/guardian withdrew consent|1|||
23173506|NCT02979431|64379249|FG000|Overall Study|Randomized but received no study drug|1|||
23173507|NCT02979431|64379250|FG001|Overall Study|Randomized but received no study drug|1|||
23173508|NCT02979431|64379251|FG002|Overall Study|Randomized but received no study drug|0|||
23173509|NCT02979431|64379252|FG003|Overall Study|Randomized but received no study drug|0|||
23173510|NCT02979431|64379249|FG000|Overall Study|Adverse Event|0|||
23580198|NCT03289455|65853395|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
23580199|NCT03289455|65853396|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
23173511|NCT02979431|64379250|FG001|Overall Study|Adverse Event|0|||
23173512|NCT02979431|64379251|FG002|Overall Study|Adverse Event|1|||
23173513|NCT02979431|64379252|FG003|Overall Study|Adverse Event|0|||
23173514|NCT02979431|64379249|FG000|Overall Study|Subject left country after Day14|1|||
23173515|NCT02979431|64379250|FG001|Overall Study|Subject left country after Day14|0|||
23173516|NCT02979431|64379251|FG002|Overall Study|Subject left country after Day14|0|||
23173517|NCT02979431|64379252|FG003|Overall Study|Subject left country after Day14|0|||
23173518|NCT00686647|64379253|FG000|Overall Study|Lost to Follow-up|1|||
23173519|NCT00686647|64379253|FG000|Overall Study|Death|1|||
23173520|NCT04316585|64379257|FG000|Overall Study|Adverse Event|2|||
23173521|NCT04316585|64379258|FG001|Overall Study|Adverse Event|1|||
23173522|NCT04316585|64379257|FG000|Overall Study|Lost to Follow-up|1|||
23173523|NCT04316585|64379258|FG001|Overall Study|Lost to Follow-up|0|||
23173524|NCT04316585|64379257|FG000|Overall Study|Withdrawal by Subject|2|||
23173525|NCT04316585|64379258|FG001|Overall Study|Withdrawal by Subject|3|||
23173526|NCT04316585|64379257|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
23173527|NCT04316585|64379258|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
23173528|NCT04316585|64379257|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
23173529|NCT04316585|64379258|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
23173530|NCT03595280|64379259|FG000|Overall Study|Lost to Follow-up|6|||
23173531|NCT03595280|64379260|FG001|Overall Study|Lost to Follow-up|9|||
23173532|NCT03595280|64379261|FG002|Overall Study|Lost to Follow-up|15|||
23173533|NCT01486199|64379263|FG000|Two Year Period Between Study Days|Physician Decision|1|||
23173534|NCT01486199|64379264|FG001|Two Year Period Between Study Days|Physician Decision|0|||
23173535|NCT01459614|64379265|FG000|Overall Study|Adverse Event|1|||
23173536|NCT01459614|64379266|FG001|Overall Study|Adverse Event|0|||
23173537|NCT02799069|64379270|FG000|Overall Study|Adverse Event|0|||
23173538|NCT02799069|64379271|FG001|Overall Study|Adverse Event|2|||
23173539|NCT02799069|64379272|FG002|Overall Study|Adverse Event|2|||
23173540|NCT02799069|64379270|FG000|Overall Study|Lack of Efficacy|2|||
23173541|NCT02799069|64379271|FG001|Overall Study|Lack of Efficacy|0|||
23173542|NCT02799069|64379272|FG002|Overall Study|Lack of Efficacy|0|||
23173543|NCT02799069|64379270|FG000|Overall Study|Lost to Follow-up|1|||
23173544|NCT02799069|64379271|FG001|Overall Study|Lost to Follow-up|1|||
23173545|NCT02799069|64379272|FG002|Overall Study|Lost to Follow-up|0|||
23173546|NCT02799069|64379270|FG000|Overall Study|Withdrawal by Subject|4|||
23173547|NCT02799069|64379271|FG001|Overall Study|Withdrawal by Subject|4|||
23173548|NCT02799069|64379272|FG002|Overall Study|Withdrawal by Subject|3|||
23173549|NCT02799069|64379270|FG000|Overall Study|Protocol Violation|1|||
23173550|NCT02799069|64379271|FG001|Overall Study|Protocol Violation|0|||
23173551|NCT02799069|64379272|FG002|Overall Study|Protocol Violation|2|||
23173552|NCT02508194|64379273|FG000|Overall Study|Death|5|||
23173553|NCT02508194|64379274|FG001|Overall Study|Death|3|||
23173554|NCT02508194|64379273|FG000|Overall Study|Lost to Follow-up|25|||
23173555|NCT02508194|64379274|FG001|Overall Study|Lost to Follow-up|18|||
23173556|NCT02508194|64379273|FG000|Overall Study|Withdrawal by Subject|20|||
23173557|NCT02508194|64379274|FG001|Overall Study|Withdrawal by Subject|18|||
23173558|NCT02508194|64379273|FG000|Overall Study|Error in Randomization|1|||
23173559|NCT02508194|64379274|FG001|Overall Study|Error in Randomization|3|||
23173560|NCT02508194|64379273|FG000|Overall Study|Principal Investigator Decision|1|||
23173561|NCT02508194|64379274|FG001|Overall Study|Principal Investigator Decision|2|||
23173562|NCT02574637|64379276|FG000|Double-blind Period|Adverse Event|1|||
23173563|NCT02574637|64379277|FG001|Double-blind Period|Adverse Event|0|||
23173564|NCT02574637|64379278|FG002|Double-blind Period|Adverse Event|0|||
23173565|NCT02574637|64379279|FG003|Double-blind Period|Adverse Event|0|||
23173566|NCT02574637|64379280|FG004|Double-blind Period|Adverse Event|0|||
23173567|NCT02574637|64379281|FG005|Double-blind Period|Adverse Event|0|||
23173568|NCT02574637|64379282|FG006|Double-blind Period|Adverse Event|0|||
23173569|NCT02574637|64379283|FG007|Double-blind Period|Adverse Event|0|||
23173570|NCT02574637|64379284|FG008|Double-blind Period|Adverse Event|0|||
23173571|NCT02574637|64379285|FG009|Double-blind Period|Adverse Event|0|||
23173572|NCT02574637|64379276|FG000|Double-blind Period|Lack of Efficacy|0|||
23173573|NCT02574637|64379277|FG001|Double-blind Period|Lack of Efficacy|0|||
23173574|NCT02574637|64379278|FG002|Double-blind Period|Lack of Efficacy|2|||
23173575|NCT02574637|64379279|FG003|Double-blind Period|Lack of Efficacy|0|||
23173576|NCT02574637|64379280|FG004|Double-blind Period|Lack of Efficacy|0|||
23173577|NCT02574637|64379281|FG005|Double-blind Period|Lack of Efficacy|0|||
23173578|NCT02574637|64379282|FG006|Double-blind Period|Lack of Efficacy|0|||
23173579|NCT02574637|64379283|FG007|Double-blind Period|Lack of Efficacy|0|||
23173580|NCT02574637|64379284|FG008|Double-blind Period|Lack of Efficacy|0|||
23173581|NCT02574637|64379285|FG009|Double-blind Period|Lack of Efficacy|0|||
23173582|NCT02574637|64379276|FG000|Double-blind Period|Protocol Deviation|1|||
23173583|NCT02574637|64379277|FG001|Double-blind Period|Protocol Deviation|0|||
23173584|NCT02574637|64379278|FG002|Double-blind Period|Protocol Deviation|0|||
23173585|NCT02574637|64379279|FG003|Double-blind Period|Protocol Deviation|0|||
23173586|NCT02574637|64379280|FG004|Double-blind Period|Protocol Deviation|0|||
23173587|NCT02574637|64379281|FG005|Double-blind Period|Protocol Deviation|0|||
23173588|NCT02574637|64379282|FG006|Double-blind Period|Protocol Deviation|0|||
23173589|NCT02574637|64379283|FG007|Double-blind Period|Protocol Deviation|0|||
23173590|NCT02574637|64379284|FG008|Double-blind Period|Protocol Deviation|0|||
23173591|NCT02574637|64379285|FG009|Double-blind Period|Protocol Deviation|0|||
23173592|NCT02574637|64379276|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
23173593|NCT02574637|64379277|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
23173594|NCT02574637|64379278|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
23173595|NCT02574637|64379279|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
23173596|NCT02574637|64379280|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
23173597|NCT02574637|64379281|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
23173598|NCT02574637|64379282|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
23173599|NCT02574637|64379283|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
23173600|NCT02574637|64379284|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
23451535|NCT00849940|65395203|FG000|Overall Study|Physician Decision|4|||
23451536|NCT03798717|65395218|FG000|Overall Study|Failed Screening|0|||
23451537|NCT03798717|65395219|FG001|Overall Study|Failed Screening|0|||
23451538|NCT03798717|65395220|FG002|Overall Study|Failed Screening|0|||
23451539|NCT03798717|65395221|FG003|Overall Study|Failed Screening|0|||
23451540|NCT03798717|65395222|FG004|Overall Study|Failed Screening|0|||
23451541|NCT03798717|65395223|FG005|Overall Study|Failed Screening|1|||
23451542|NCT03798717|65395218|FG000|Overall Study|Physician Decision|1|||
23451543|NCT03798717|65395219|FG001|Overall Study|Physician Decision|0|||
23451544|NCT03798717|65395220|FG002|Overall Study|Physician Decision|1|||
23451545|NCT03798717|65395221|FG003|Overall Study|Physician Decision|0|||
23451546|NCT03798717|65395222|FG004|Overall Study|Physician Decision|0|||
23451547|NCT03798717|65395223|FG005|Overall Study|Physician Decision|0|||
23451548|NCT03798717|65395218|FG000|Overall Study|Withdrawal by Subject|0|||
23451549|NCT03798717|65395219|FG001|Overall Study|Withdrawal by Subject|0|||
23451550|NCT03798717|65395220|FG002|Overall Study|Withdrawal by Subject|0|||
23451551|NCT03798717|65395221|FG003|Overall Study|Withdrawal by Subject|1|||
23451552|NCT03798717|65395222|FG004|Overall Study|Withdrawal by Subject|0|||
23451553|NCT03798717|65395223|FG005|Overall Study|Withdrawal by Subject|0|||
23451554|NCT03798717|65395218|FG000|Overall Study|Lost to Follow-up|1|||
23451555|NCT03798717|65395219|FG001|Overall Study|Lost to Follow-up|0|||
23451556|NCT03798717|65395220|FG002|Overall Study|Lost to Follow-up|0|||
23451557|NCT03798717|65395221|FG003|Overall Study|Lost to Follow-up|1|||
23451558|NCT03798717|65395222|FG004|Overall Study|Lost to Follow-up|0|||
23451559|NCT03798717|65395223|FG005|Overall Study|Lost to Follow-up|0|||
23451560|NCT03798717|65395218|FG000|Overall Study|Adverse Event|0|||
23451561|NCT03798717|65395219|FG001|Overall Study|Adverse Event|1|||
23451562|NCT03798717|65395220|FG002|Overall Study|Adverse Event|0|||
23451563|NCT03798717|65395221|FG003|Overall Study|Adverse Event|0|||
23451564|NCT03798717|65395222|FG004|Overall Study|Adverse Event|0|||
23451565|NCT03798717|65395223|FG005|Overall Study|Adverse Event|0|||
23451566|NCT03798717|65395218|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23173601|NCT02574637|64379285|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
23451567|NCT03798717|65395219|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23451568|NCT03798717|65395220|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23451569|NCT03798717|65395221|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23451570|NCT03798717|65395222|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
23451571|NCT03798717|65395223|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
23451572|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
23451573|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23451574|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23451575|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23451576|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
23451577|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
23451578|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23451579|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23451580|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23451581|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
23451582|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
23451583|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23451584|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23451585|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23451586|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
23173602|NCT02574637|64379276|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
23173603|NCT02574637|64379277|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
23451587|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
23451588|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23451589|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23451590|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23451591|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
23451592|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
23339704|NCT00833482|64989238|FG002|Days 11-20|Adverse Event|0|||
23173604|NCT02574637|64379278|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
23173605|NCT02574637|64379279|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
23173606|NCT02574637|64379280|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
23173607|NCT02574637|64379281|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
23173608|NCT02574637|64379282|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
23173609|NCT02574637|64379283|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
23173610|NCT02574637|64379284|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
23173611|NCT02574637|64379285|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
23173612|NCT02574637|64379276|FG000|Double-blind Period|Reason Not Specified|0|||
23580200|NCT03289455|65853394|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
23580201|NCT03289455|65853395|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
23173613|NCT02574637|64379277|FG001|Double-blind Period|Reason Not Specified|0|||
23173614|NCT02574637|64379278|FG002|Double-blind Period|Reason Not Specified|0|||
23173615|NCT02574637|64379279|FG003|Double-blind Period|Reason Not Specified|1|||
23173616|NCT02574637|64379280|FG004|Double-blind Period|Reason Not Specified|0|||
23173617|NCT02574637|64379281|FG005|Double-blind Period|Reason Not Specified|0|||
23173618|NCT02574637|64379282|FG006|Double-blind Period|Reason Not Specified|0|||
23173619|NCT02574637|64379283|FG007|Double-blind Period|Reason Not Specified|0|||
23173620|NCT02574637|64379284|FG008|Double-blind Period|Reason Not Specified|0|||
23173621|NCT02574637|64379285|FG009|Double-blind Period|Reason Not Specified|0|||
23173622|NCT02574637|64379276|FG000|Open-label (OL) Period|Adverse Event|0|||
23173623|NCT02574637|64379277|FG001|Open-label (OL) Period|Adverse Event|0|||
23173624|NCT02574637|64379278|FG002|Open-label (OL) Period|Adverse Event|0|||
23173625|NCT02574637|64379279|FG003|Open-label (OL) Period|Adverse Event|0|||
23173626|NCT02574637|64379280|FG004|Open-label (OL) Period|Adverse Event|0|||
23173627|NCT02574637|64379281|FG005|Open-label (OL) Period|Adverse Event|0|||
23173628|NCT02574637|64379282|FG006|Open-label (OL) Period|Adverse Event|0|||
23173629|NCT02574637|64379283|FG007|Open-label (OL) Period|Adverse Event|0|||
23173630|NCT02574637|64379284|FG008|Open-label (OL) Period|Adverse Event|1|||
23173631|NCT02574637|64379285|FG009|Open-label (OL) Period|Adverse Event|0|||
23173632|NCT02574637|64379276|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
23451593|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23173633|NCT02574637|64379277|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
23173634|NCT02574637|64379278|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
23173635|NCT02574637|64379279|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
23173636|NCT02574637|64379280|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
23173637|NCT02574637|64379281|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
23173638|NCT02574637|64379282|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
23173639|NCT02574637|64379283|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
23173640|NCT02574637|64379284|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
23173641|NCT02574637|64379285|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
23173642|NCT02574637|64379276|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23173643|NCT02574637|64379277|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23173644|NCT02574637|64379278|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23451594|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23451595|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23451596|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
23451597|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
23451598|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23451599|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23451600|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23451601|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
23451602|NCT01173601|65395227|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
23451603|NCT01173601|65395228|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23451604|NCT01173601|65395229|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23451605|NCT01173601|65395230|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23451606|NCT01173601|65395231|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
23451607|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
23451608|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
23451609|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
23451610|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
23451611|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
23451612|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
23451613|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
23451614|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
23451615|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
23173645|NCT02574637|64379279|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23451616|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
23451617|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
23580202|NCT03289455|65853396|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
23173646|NCT02574637|64379280|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23173647|NCT02574637|64379281|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
23173648|NCT02574637|64379282|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
23173649|NCT02574637|64379283|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
23173650|NCT02574637|64379284|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
23173651|NCT02574637|64379285|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
23173652|NCT01235962|64379286|FG000|Overall Study|Withdrawal by Subject|20|||
23173653|NCT01235962|64379287|FG001|Overall Study|Withdrawal by Subject|19|||
23173654|NCT01235962|64379288|FG002|Overall Study|Withdrawal by Subject|62|||
23173655|NCT01235962|64379289|FG003|Overall Study|Withdrawal by Subject|49|||
23173656|NCT01235962|64379286|FG000|Overall Study|Lost to Follow-up|21|||
23173657|NCT01235962|64379287|FG001|Overall Study|Lost to Follow-up|16|||
23173658|NCT01235962|64379288|FG002|Overall Study|Lost to Follow-up|47|||
23173659|NCT01235962|64379289|FG003|Overall Study|Lost to Follow-up|32|||
23173660|NCT01235962|64379286|FG000|Overall Study|Physician Decision|5|||
23173661|NCT01235962|64379287|FG001|Overall Study|Physician Decision|0|||
23580203|NCT03289455|65853394|FG000|Overall Study|Progressive disease|3|||
23580204|NCT03289455|65853395|FG001|Overall Study|Progressive disease|4|||
23580205|NCT03289455|65853396|FG002|Overall Study|Progressive disease|5|||
23580206|NCT04697069|65853399|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
23580207|NCT04697069|65853400|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
23580208|NCT04697069|65853399|FG000|Overall Study|Study termination|2|||
23580209|NCT04697069|65853400|FG001|Overall Study|Study termination|1|||
23580210|NCT00770211|65853401|FG000|Overall Study|Lost to Follow-up|1|||
23580211|NCT00770211|65853402|FG001|Overall Study|Lost to Follow-up|0|||
23580212|NCT00770211|65853401|FG000|Overall Study|Withdrawal by Subject|0|||
23580213|NCT00770211|65853402|FG001|Overall Study|Withdrawal by Subject|2|||
23580214|NCT04236986|65853405|FG000|Overall Study|Withdrawal by Subject|3|||
23580215|NCT04236986|65853406|FG001|Overall Study|Withdrawal by Subject|1|||
23580216|NCT01606189|65853411|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580217|NCT01606189|65853412|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580218|NCT01606189|65853413|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580219|NCT01606189|65853414|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580220|NCT01606189|65853415|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
23580221|NCT01606189|65853416|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
23580222|NCT01606189|65853411|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23173662|NCT01235962|64379288|FG002|Overall Study|Physician Decision|9|||
23173663|NCT01235962|64379289|FG003|Overall Study|Physician Decision|5|||
23173664|NCT01665807|64379290|FG000|Overall Study|Withdrawal by Subject|2|||
23173665|NCT01665807|64379291|FG001|Overall Study|Withdrawal by Subject|0|||
23173666|NCT01665807|64379292|FG002|Overall Study|Withdrawal by Subject|1|||
23173667|NCT01171820|64379293|FG000|Overall Study|Death|3|||
23173668|NCT01171820|64379294|FG001|Overall Study|Death|3|||
23173669|NCT01171820|64379293|FG000|Overall Study|Lost to Follow-up|0|||
23173670|NCT01171820|64379294|FG001|Overall Study|Lost to Follow-up|1|||
23173671|NCT01171820|64379293|FG000|Overall Study|Withdrawal by Subject|2|||
23173672|NCT01171820|64379294|FG001|Overall Study|Withdrawal by Subject|0|||
23173673|NCT01171820|64379293|FG000|Overall Study|Physician Decision|0|||
23173674|NCT01171820|64379294|FG001|Overall Study|Physician Decision|1|||
23173675|NCT01171820|64379293|FG000|Overall Study|1-Year Missed Visit|1|||
23173676|NCT01171820|64379294|FG001|Overall Study|1-Year Missed Visit|1|||
23173677|NCT00648167|64379295|FG000|Overall Study|Adverse Event|6|||
23173678|NCT00648167|64379295|FG000|Overall Study|unable to swallow tablets|1|||
23173679|NCT00634569|64379300|FG000|Overall Study|Withdrawal by Subject|0|||
23173680|NCT00634569|64379301|FG001|Overall Study|Withdrawal by Subject|4|||
23173681|NCT00634569|64379300|FG000|Overall Study|Physician Decision|0|||
23173682|NCT00634569|64379301|FG001|Overall Study|Physician Decision|1|||
23173683|NCT00070941|64382266|FG000|Overall Study|Adverse Event|10|||
23173684|NCT00070941|64382267|FG001|Overall Study|Adverse Event|8|||
23173685|NCT00070941|64382268|FG002|Overall Study|Adverse Event|4|||
23173686|NCT00605085|64382274|FG000|Overall Study|Withdrawal by Subject|8|||
23173687|NCT00605085|64382275|FG001|Overall Study|Withdrawal by Subject|5|||
23173688|NCT00605085|64382274|FG000|Overall Study|Adverse Event|9|||
23580223|NCT01606189|65853412|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23580224|NCT01606189|65853413|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23173689|NCT00605085|64382275|FG001|Overall Study|Adverse Event|5|||
23173690|NCT00605085|64382274|FG000|Overall Study|Pregnancy|2|||
23173691|NCT00605085|64382275|FG001|Overall Study|Pregnancy|0|||
23173692|NCT00605085|64382274|FG000|Overall Study|Protocol Violation|3|||
23173693|NCT00605085|64382275|FG001|Overall Study|Protocol Violation|2|||
23173694|NCT00605085|64382274|FG000|Overall Study|Lost to Follow-up|10|||
23173695|NCT00605085|64382275|FG001|Overall Study|Lost to Follow-up|5|||
23173696|NCT00605085|64382274|FG000|Overall Study|administrative reasons|18|||
23451618|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
23451619|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
23451620|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
23451621|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
23173697|NCT00605085|64382275|FG001|Overall Study|administrative reasons|8|||
23233855|NCT00364351|64600590|FG001|Overall Study|Prohibited concomitant medication|2|||
23451622|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23451623|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
23451624|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
23451625|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
23451626|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
23451627|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
23451628|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
23451629|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23451630|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
23451631|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
23451632|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
23451633|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
23451634|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
23451635|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
23451636|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
23451637|NCT01173601|65395227|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23451638|NCT01173601|65395228|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23451639|NCT01173601|65395229|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
23451640|NCT01173601|65395230|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
23451641|NCT01173601|65395231|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
23451642|NCT02422498|65395232|FG000|Overall Study|Inevaluable|4|||
23451643|NCT01078441|65395233|FG000|Overall Study|Withdrawal by Subject|1|||
23451644|NCT00217425|65395235|FG000|Overall Study|Never started treatment|2|||
23451645|NCT00217425|65395235|FG000|Overall Study|Patient ineligible|5|||
23451646|NCT00217425|65395235|FG000|Overall Study|Lack of Efficacy|13|||
23451647|NCT00217425|65395235|FG000|Overall Study|Adverse Event|8|||
23451648|NCT00217425|65395235|FG000|Overall Study|Withdrawal by Subject|4|||
23451649|NCT00217425|65395235|FG000|Overall Study|Other complicating disease|1|||
23451650|NCT00217425|65395235|FG000|Overall Study|Other|4|||
23451651|NCT00965081|65395236|FG000|Overall Study|Adverse Event|14|||
23451652|NCT00965081|65395237|FG001|Overall Study|Adverse Event|9|||
23451653|NCT00965081|65395236|FG000|Overall Study|Lack of Efficacy|2|||
23451654|NCT00965081|65395237|FG001|Overall Study|Lack of Efficacy|5|||
23451655|NCT00965081|65395236|FG000|Overall Study|Lost to Follow-up|4|||
23451656|NCT00965081|65395237|FG001|Overall Study|Lost to Follow-up|5|||
23451657|NCT00965081|65395236|FG000|Overall Study|Physician Decision|2|||
23451658|NCT00965081|65395237|FG001|Overall Study|Physician Decision|0|||
23451659|NCT00965081|65395236|FG000|Overall Study|Protocol Violation|2|||
23451660|NCT00965081|65395237|FG001|Overall Study|Protocol Violation|5|||
23451661|NCT00965081|65395236|FG000|Overall Study|Sponsor Decision|1|||
23173698|NCT00448708|64382276|FG000|Overall Study|Death|21|||
23173699|NCT00448708|64382277|FG001|Overall Study|Death|17|||
23173700|NCT00448708|64382276|FG000|Overall Study|Withdrawal by Subject|8|||
23173701|NCT00448708|64382277|FG001|Overall Study|Withdrawal by Subject|4|||
23173702|NCT00448708|64382276|FG000|Overall Study|Lost to Follow-up|6|||
23173703|NCT00448708|64382277|FG001|Overall Study|Lost to Follow-up|8|||
23173704|NCT00448708|64382276|FG000|Overall Study|not listed|0|||
23173705|NCT00448708|64382277|FG001|Overall Study|not listed|2|||
23173706|NCT00428597|64382278|FG000|Overall Study|Randomized but not treated|3|||
23173707|NCT00428597|64382279|FG001|Overall Study|Randomized but not treated|3|||
23173708|NCT00428597|64382278|FG000|Overall Study|Objective Progression or Relapse|19|||
23173709|NCT00428597|64382279|FG001|Overall Study|Objective Progression or Relapse|47|||
23233856|NCT00364351|64600589|FG000|Overall Study|Lost to Follow-up|1|||
23451662|NCT00965081|65395237|FG001|Overall Study|Sponsor Decision|0|||
23451663|NCT00965081|65395236|FG000|Overall Study|Withdrawal by Subject|4|||
23451664|NCT00965081|65395237|FG001|Overall Study|Withdrawal by Subject|7|||
23451665|NCT00965081|65395236|FG000|Overall Study|Switched to Rescue Arm|5|||
23451666|NCT00965081|65395237|FG001|Overall Study|Switched to Rescue Arm|12|||
23451667|NCT00227721|65395239|FG000|Overall Study|On study, but never treated.|1|||
23173710|NCT00428597|64382278|FG000|Overall Study|Study Terminated by Sponsor|41|||
23173711|NCT00428597|64382279|FG001|Overall Study|Study Terminated by Sponsor|16|||
23173712|NCT00428597|64382278|FG000|Overall Study|Adverse Event|15|||
23173713|NCT00428597|64382279|FG001|Overall Study|Adverse Event|7|||
23173714|NCT00428597|64382278|FG000|Overall Study|Global Deterioration of Health Status|1|||
23173715|NCT00428597|64382279|FG001|Overall Study|Global Deterioration of Health Status|5|||
23173716|NCT00428597|64382278|FG000|Overall Study|Protocol Violation|2|||
23173717|NCT00428597|64382279|FG001|Overall Study|Protocol Violation|1|||
23173718|NCT00428597|64382278|FG000|Overall Study|Withdrawal by Subject|2|||
23173719|NCT00428597|64382279|FG001|Overall Study|Withdrawal by Subject|1|||
23451668|NCT01467505|65395240|FG000|Overall Study|Adverse Event|1|||
23451669|NCT01467505|65395241|FG001|Overall Study|Adverse Event|0|||
23451670|NCT01467505|65395240|FG000|Overall Study|Withdrawal by Subject|4|||
23451671|NCT01467505|65395241|FG001|Overall Study|Withdrawal by Subject|0|||
23451672|NCT01467505|65395240|FG000|Overall Study|Study Terminated by Sponsor|28|||
23451673|NCT01467505|65395241|FG001|Overall Study|Study Terminated by Sponsor|3|||
23451674|NCT00423657|65395248|FG000|Overall Study|Withdrew consent|10|||
23451675|NCT00423657|65395249|FG001|Overall Study|Withdrew consent|8|||
23451676|NCT00423657|65395248|FG000|Overall Study|Non-compliance|0|||
23451677|NCT00423657|65395249|FG001|Overall Study|Non-compliance|1|||
23451678|NCT00423657|65395248|FG000|Overall Study|Other|15|||
23451679|NCT00423657|65395249|FG001|Overall Study|Other|16|||
23451680|NCT00423657|65395248|FG000|Overall Study|Request of sponsor/investigator|1|||
23451681|NCT00423657|65395249|FG001|Overall Study|Request of sponsor/investigator|0|||
23451682|NCT00702702|65395253|FG000|Overall Study|Study prematurely terminated|56|||
23451683|NCT00443040|65395254|FG000|Overall Study|Withdrawal by Subject|1|||
23451684|NCT00443040|65395255|FG001|Overall Study|Withdrawal by Subject|0|||
23451685|NCT00443040|65395256|FG002|Overall Study|Withdrawal by Subject|0|||
23451686|NCT00443040|65395254|FG000|Overall Study|Converted to an open laparotomy|3|||
23173720|NCT00428597|64382278|FG000|Overall Study|Other|1|||
23173721|NCT00428597|64382279|FG001|Overall Study|Other|1|||
23173722|NCT00428597|64382278|FG000|Overall Study|Lost to Follow-up|0|||
23173723|NCT00428597|64382279|FG001|Overall Study|Lost to Follow-up|1|||
23173724|NCT00428597|64382278|FG000|Overall Study|Pregnancy|1|||
23173725|NCT00428597|64382279|FG001|Overall Study|Pregnancy|0|||
23173726|NCT00428597|64382278|FG000|Overall Study|Death|1|||
23173727|NCT00428597|64382279|FG001|Overall Study|Death|3|||
23173728|NCT01469000|64382280|FG000|Overall Study|Withdrawal by Subject|16|||
23173729|NCT01469000|64382281|FG001|Overall Study|Withdrawal by Subject|3|||
23173730|NCT01469000|64382280|FG000|Overall Study|Sponsor Decision|4|||
23173731|NCT01469000|64382281|FG001|Overall Study|Sponsor Decision|1|||
23173732|NCT00661271|64382284|FG000|Overall Study|Lost to Follow-up|28|||
23173733|NCT00661271|64382285|FG001|Overall Study|Lost to Follow-up|25|||
23451687|NCT00443040|65395255|FG001|Overall Study|Converted to an open laparotomy|0|||
23451688|NCT00443040|65395256|FG002|Overall Study|Converted to an open laparotomy|1|||
23173734|NCT03167073|64382286|FG000|Overall Study|Stillbirth|1|||
23173735|NCT03167073|64382287|FG001|Overall Study|Stillbirth|0|||
23233857|NCT00364351|64600590|FG001|Overall Study|Lost to Follow-up|1|||
23233858|NCT00364351|64600589|FG000|Overall Study|Withdrawal by Subject|30|||
23451689|NCT01814527|65395259|FG000|Overall Study|RTP greater than 30 days|6|||
23451690|NCT01814527|65395260|FG001|Overall Study|RTP greater than 30 days|1|||
23451691|NCT00467740|65395263|FG000|Overall Study|Adverse Event|0|||
23339705|NCT00833482|64989239|FG003|Days 11-20|Adverse Event|0|||
23339706|NCT00833482|64989240|FG004|Days 11-20|Adverse Event|0|||
23339707|NCT00833482|64989241|FG005|Days 11-20|Adverse Event|0|||
23339708|NCT00833482|64989236|FG000|Days 11-20|Withdrawal by Subject|0|||
23339709|NCT00833482|64989237|FG001|Days 11-20|Withdrawal by Subject|1|||
23339710|NCT00833482|64989238|FG002|Days 11-20|Withdrawal by Subject|0|||
23339711|NCT00833482|64989239|FG003|Days 11-20|Withdrawal by Subject|0|||
23339712|NCT00833482|64989240|FG004|Days 11-20|Withdrawal by Subject|0|||
23339713|NCT00833482|64989241|FG005|Days 11-20|Withdrawal by Subject|0|||
23339714|NCT00833482|64989236|FG000|Days 21-30|Adverse Event|0|||
23339715|NCT00833482|64989237|FG001|Days 21-30|Adverse Event|0|||
23451692|NCT00467740|65395264|FG001|Overall Study|Adverse Event|0|||
23173736|NCT03634800|64382288|FG000|Overall Study|Adverse Event|1|||
23173737|NCT03634800|64382288|FG000|Overall Study|Disease Progression|4|||
23173738|NCT03634800|64382288|FG000|Overall Study|Withdrawal by Subject|1|||
23173739|NCT02847598|64382289|FG000|Overall Study|Adverse Event|0|||
23173740|NCT02847598|64382290|FG001|Overall Study|Adverse Event|0|||
23173741|NCT02847598|64382291|FG002|Overall Study|Adverse Event|0|||
23173742|NCT02847598|64382292|FG003|Overall Study|Adverse Event|0|||
23173743|NCT02847598|64382293|FG004|Overall Study|Adverse Event|0|||
23233859|NCT00364351|64600590|FG001|Overall Study|Withdrawal by Subject|29|||
23339716|NCT00833482|64989238|FG002|Days 21-30|Adverse Event|1|||
23339717|NCT00833482|64989239|FG003|Days 21-30|Adverse Event|0|||
23451693|NCT00467740|65395265|FG002|Overall Study|Adverse Event|1|||
23451694|NCT00467740|65395266|FG003|Overall Study|Adverse Event|0|||
23339718|NCT00833482|64989240|FG004|Days 21-30|Adverse Event|0|||
23173744|NCT02847598|64382294|FG005|Overall Study|Adverse Event|0|||
23339719|NCT00833482|64989241|FG005|Days 21-30|Adverse Event|0|||
23339720|NCT00833482|64989236|FG000|Days 21-30|Withdrawal by Subject|0|||
23339721|NCT00833482|64989237|FG001|Days 21-30|Withdrawal by Subject|0|||
23339722|NCT00833482|64989238|FG002|Days 21-30|Withdrawal by Subject|0|||
23339723|NCT00833482|64989239|FG003|Days 21-30|Withdrawal by Subject|0|||
23339724|NCT00833482|64989240|FG004|Days 21-30|Withdrawal by Subject|1|||
23339725|NCT00833482|64989241|FG005|Days 21-30|Withdrawal by Subject|0|||
23451695|NCT00467740|65395267|FG004|Overall Study|Adverse Event|0|||
23173745|NCT02847598|64382295|FG006|Overall Study|Adverse Event|0|||
23173746|NCT02847598|64382296|FG007|Overall Study|Adverse Event|1|||
23173747|NCT02847598|64382289|FG000|Overall Study|Consent withdrawn|2|||
23173748|NCT02847598|64382290|FG001|Overall Study|Consent withdrawn|0|||
23173749|NCT02847598|64382291|FG002|Overall Study|Consent withdrawn|0|||
23173750|NCT02847598|64382292|FG003|Overall Study|Consent withdrawn|4|||
23173751|NCT02847598|64382293|FG004|Overall Study|Consent withdrawn|3|||
23173752|NCT02847598|64382294|FG005|Overall Study|Consent withdrawn|2|||
23173753|NCT02847598|64382295|FG006|Overall Study|Consent withdrawn|1|||
23173754|NCT02847598|64382296|FG007|Overall Study|Consent withdrawn|3|||
23173755|NCT02847598|64382289|FG000|Overall Study|Death|3|||
23173756|NCT02847598|64382290|FG001|Overall Study|Death|0|||
23173757|NCT02847598|64382291|FG002|Overall Study|Death|0|||
23173758|NCT02847598|64382292|FG003|Overall Study|Death|0|||
23173759|NCT02847598|64382293|FG004|Overall Study|Death|0|||
23173760|NCT02847598|64382294|FG005|Overall Study|Death|0|||
23173761|NCT02847598|64382295|FG006|Overall Study|Death|0|||
23173762|NCT02847598|64382296|FG007|Overall Study|Death|0|||
23173763|NCT02847598|64382289|FG000|Overall Study|Lost to Follow-up|0|||
23173764|NCT02847598|64382290|FG001|Overall Study|Lost to Follow-up|0|||
23173765|NCT02847598|64382291|FG002|Overall Study|Lost to Follow-up|0|||
23173766|NCT02847598|64382292|FG003|Overall Study|Lost to Follow-up|0|||
23173767|NCT02847598|64382293|FG004|Overall Study|Lost to Follow-up|0|||
23173768|NCT02847598|64382294|FG005|Overall Study|Lost to Follow-up|1|||
23173769|NCT02847598|64382295|FG006|Overall Study|Lost to Follow-up|1|||
23173770|NCT02847598|64382296|FG007|Overall Study|Lost to Follow-up|0|||
23173771|NCT03686969|64382299|FG000|Overall Study|Study terminated|1|||
23173772|NCT03686969|64382300|FG001|Overall Study|Study terminated|0|||
23173773|NCT02675075|64382302|FG000|Overall Study|Lost to Follow-up|3|||
23173774|NCT02675075|64382303|FG001|Overall Study|Lost to Follow-up|0|||
23173775|NCT02322710|64382304|FG000|Overall Study|No efficacy assessment post-baseline|0|||
23173776|NCT02322710|64382305|FG001|Overall Study|No efficacy assessment post-baseline|1|||
23173777|NCT02322710|64382304|FG000|Overall Study|Protocol Violation|20|||
23173778|NCT02322710|64382305|FG001|Overall Study|Protocol Violation|25|||
23173779|NCT01761266|64382309|FG000|Overall Study|Death|415|||
23173780|NCT01761266|64382310|FG001|Overall Study|Death|402|||
23173781|NCT01761266|64382309|FG000|Overall Study|Lost to Follow-up|8|||
23173782|NCT01761266|64382310|FG001|Overall Study|Lost to Follow-up|12|||
23173783|NCT01761266|64382309|FG000|Overall Study|Withdrawal by Subject|14|||
23173784|NCT01761266|64382310|FG001|Overall Study|Withdrawal by Subject|10|||
23173785|NCT01761266|64382309|FG000|Overall Study|Sponsor Decision|41|||
23173786|NCT01761266|64382310|FG001|Overall Study|Sponsor Decision|52|||
23173787|NCT01084551|64382311|FG000|Overall Study|Adverse Event|2|||
23173788|NCT01084551|64382312|FG001|Overall Study|Adverse Event|9|||
23173789|NCT01084551|64382313|FG002|Overall Study|Adverse Event|4|||
23173790|NCT01084551|64382311|FG000|Overall Study|Lack of Efficacy|2|||
23173791|NCT01084551|64382312|FG001|Overall Study|Lack of Efficacy|0|||
23173792|NCT01084551|64382313|FG002|Overall Study|Lack of Efficacy|1|||
23173793|NCT01084551|64382311|FG000|Overall Study|Withdrawal by Subject|2|||
23173794|NCT01084551|64382312|FG001|Overall Study|Withdrawal by Subject|1|||
23173795|NCT01084551|64382313|FG002|Overall Study|Withdrawal by Subject|0|||
23173796|NCT01084551|64382311|FG000|Overall Study|Protocol Violation|2|||
23173797|NCT01084551|64382312|FG001|Overall Study|Protocol Violation|4|||
23339726|NCT02278120|64989242|FG000|Treatment Period|Progressive disease|234|||
23451696|NCT00467740|65395263|FG000|Overall Study|Protocol Violation|0|||
23173798|NCT01084551|64382313|FG002|Overall Study|Protocol Violation|0|||
23173799|NCT01084551|64382311|FG000|Overall Study|Lost to Follow-up|0|||
23173800|NCT01084551|64382312|FG001|Overall Study|Lost to Follow-up|0|||
23173801|NCT01084551|64382313|FG002|Overall Study|Lost to Follow-up|3|||
23173802|NCT01084551|64382311|FG000|Overall Study|Physician Decision|1|||
23173803|NCT01084551|64382312|FG001|Overall Study|Physician Decision|0|||
23173804|NCT01084551|64382313|FG002|Overall Study|Physician Decision|0|||
23173805|NCT00197054|64382314|FG000|Overall Study|Withdrawal by Subject|9|||
23173806|NCT00197054|64382315|FG001|Overall Study|Withdrawal by Subject|3|||
23451697|NCT00467740|65395264|FG001|Overall Study|Protocol Violation|0|||
23173807|NCT00197054|64382316|FG002|Overall Study|Withdrawal by Subject|3|||
23173808|NCT00197054|64382314|FG000|Overall Study|Moved from area|7|||
23173809|NCT00197054|64382315|FG001|Overall Study|Moved from area|14|||
23173810|NCT00197054|64382316|FG002|Overall Study|Moved from area|9|||
23173811|NCT00197054|64382314|FG000|Overall Study|Lost to Follow-up|1|||
23173812|NCT00197054|64382315|FG001|Overall Study|Lost to Follow-up|4|||
23173813|NCT00197054|64382316|FG002|Overall Study|Lost to Follow-up|0|||
23173814|NCT00332709|64382317|FG000|Overall Study|Adverse Event|11|||
23173815|NCT00332709|64382318|FG001|Overall Study|Adverse Event|14|||
23173816|NCT00332709|64382317|FG000|Overall Study|Withdrawal by Subject|2|||
23173817|NCT00332709|64382318|FG001|Overall Study|Withdrawal by Subject|3|||
23173818|NCT00332709|64382317|FG000|Overall Study|Lost to Follow-up|2|||
23173819|NCT00332709|64382318|FG001|Overall Study|Lost to Follow-up|0|||
23173820|NCT00332709|64382317|FG000|Overall Study|Administrative Problems|0|||
23173821|NCT00332709|64382318|FG001|Overall Study|Administrative Problems|3|||
23173822|NCT00332709|64382317|FG000|Overall Study|Abnormal test procedure result|1|||
23173823|NCT00332709|64382318|FG001|Overall Study|Abnormal test procedure result|0|||
23173824|NCT03902080|64382319|FG000|Overall Study|Adverse Event|17|||
23173825|NCT03902080|64382320|FG001|Overall Study|Adverse Event|15|||
23173826|NCT03902080|64382319|FG000|Overall Study|Withdrawal by Subject|28|||
23173827|NCT03902080|64382320|FG001|Overall Study|Withdrawal by Subject|35|||
23173828|NCT03902080|64382319|FG000|Overall Study|Lost to Follow-up|6|||
23173829|NCT03902080|64382320|FG001|Overall Study|Lost to Follow-up|7|||
23173830|NCT03902080|64382319|FG000|Overall Study|Other|3|||
23173831|NCT03902080|64382320|FG001|Overall Study|Other|5|||
23173832|NCT03902080|64382319|FG000|Overall Study|Non compliance|4|||
23173833|NCT03902080|64382320|FG001|Overall Study|Non compliance|3|||
23173834|NCT03902080|64382319|FG000|Overall Study|Physician Decision|5|||
23173835|NCT03902080|64382320|FG001|Overall Study|Physician Decision|1|||
23173836|NCT03902080|64382319|FG000|Overall Study|Protocol Violation|3|||
23173837|NCT03902080|64382320|FG001|Overall Study|Protocol Violation|3|||
23339727|NCT02278120|64989243|FG001|Treatment Period|Progressive disease|260|||
23339728|NCT02278120|64989242|FG000|Treatment Period|Subject/guardian decision|23|||
23339729|NCT02278120|64989243|FG001|Treatment Period|Subject/guardian decision|20|||
23339730|NCT02278120|64989242|FG000|Treatment Period|Adverse Event|16|||
23339731|NCT02278120|64989243|FG001|Treatment Period|Adverse Event|14|||
23339732|NCT02278120|64989242|FG000|Treatment Period|Physician Decision|14|||
23339733|NCT02278120|64989243|FG001|Treatment Period|Physician Decision|27|||
23339734|NCT02278120|64989242|FG000|Treatment Period|Death|3|||
23339735|NCT02278120|64989243|FG001|Treatment Period|Death|3|||
23339736|NCT02278120|64989242|FG000|Treatment Period|Lost to Follow-up|2|||
23339737|NCT02278120|64989243|FG001|Treatment Period|Lost to Follow-up|0|||
23339738|NCT02278120|64989242|FG000|Treatment Period|Protocol deviation|0|||
23339739|NCT02278120|64989243|FG001|Treatment Period|Protocol deviation|2|||
23339740|NCT02278120|64989242|FG000|Treatment Period|Study terminated as per protocol|43|||
23339741|NCT02278120|64989243|FG001|Treatment Period|Study terminated as per protocol|11|||
23339742|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Death|0|||
23339743|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Death|1|||
23173838|NCT03902080|64382319|FG000|Overall Study|Lack of Efficacy|1|||
23173839|NCT03902080|64382320|FG001|Overall Study|Lack of Efficacy|3|||
23173840|NCT03902080|64382319|FG000|Overall Study|Withdrawn prior to dosing|0|||
23173841|NCT03902080|64382320|FG001|Overall Study|Withdrawn prior to dosing|1|||
23173842|NCT04082663|64382321|FG000|Overall Study|Adverse Event|6|||
23339744|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
23339745|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23340867|NCT01936181|64992872|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
23339746|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
23339747|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
23339748|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
23339749|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
23339750|NCT02278120|64989242|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23339751|NCT02278120|64989243|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23339752|NCT00231114|64989244|FG000|Randomized|Withdrawal by Subject|6|||
23339753|NCT00231114|64989245|FG001|Randomized|Withdrawal by Subject|3|||
23339754|NCT00231114|64989244|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
23339755|NCT00231114|64989245|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
23339756|NCT00231114|64989244|FG000|Post-Treatment Period|Lost to Follow-up|6|||
23339757|NCT00231114|64989245|FG001|Post-Treatment Period|Lost to Follow-up|1|||
23339758|NCT00231114|64989244|FG000|Post-Treatment Period|Physician Decision|1|||
23339759|NCT00231114|64989245|FG001|Post-Treatment Period|Physician Decision|0|||
23339760|NCT00231114|64989244|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
23339761|NCT00231114|64989245|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
23173843|NCT04082663|64382321|FG000|Overall Study|Lost to Follow-up|1|||
23173844|NCT01827384|64382324|FG000|Overall Study|Switched to alternative treatment|0|||
23173845|NCT01827384|64382325|FG001|Overall Study|Switched to alternative treatment|0|||
23173846|NCT01827384|64382326|FG002|Overall Study|Switched to alternative treatment|0|||
23173847|NCT01827384|64382327|FG003|Overall Study|Switched to alternative treatment|0|||
23173848|NCT01827384|64382328|FG004|Overall Study|Switched to alternative treatment|0|||
23173849|NCT01827384|64382329|FG005|Overall Study|Switched to alternative treatment|0|||
23173850|NCT01827384|64382330|FG006|Overall Study|Switched to alternative treatment|0|||
23339762|NCT02949843|64989246|FG000|Overall Study|Withdrawal by Subject|0|||
23339763|NCT02949843|64989247|FG001|Overall Study|Withdrawal by Subject|1|||
23339764|NCT02949843|64989248|FG002|Overall Study|Withdrawal by Subject|1|||
23339765|NCT00068393|64989250|FG000|Overall Study|Adverse Event|2|||
23339766|NCT00068393|64989250|FG000|Overall Study|Death|3|||
23339767|NCT00068393|64989250|FG000|Overall Study|Withdrawal by Subject|3|||
23339768|NCT00068393|64989250|FG000|Overall Study|Alternative treatment|1|||
23339769|NCT00068393|64989250|FG000|Overall Study|Quality of life worsening|1|||
23339770|NCT03429244|64989253|FG000|Overall Study|Withdrawal by Subject|2|||
23339771|NCT03429244|64989254|FG001|Overall Study|Withdrawal by Subject|1|||
23339772|NCT03429244|64989255|FG002|Overall Study|Withdrawal by Subject|1|||
23339773|NCT00138073|64989256|FG000|Overall Study|lack of resources|55|||
23339774|NCT03075891|64989257|FG000|Overall Study|Withdrawal by Subject|3|||
23339775|NCT03075891|64989258|FG001|Overall Study|Withdrawal by Subject|6|||
23339776|NCT03075891|64989257|FG000|Overall Study|Lost to Follow-up|1|||
23339777|NCT03075891|64989258|FG001|Overall Study|Lost to Follow-up|0|||
23339778|NCT03075891|64989257|FG000|Overall Study|Pregnancy|3|||
23339779|NCT03075891|64989258|FG001|Overall Study|Pregnancy|1|||
23339780|NCT03075891|64989257|FG000|Overall Study|visits not performed (no time)|1|||
23339781|NCT03075891|64989258|FG001|Overall Study|visits not performed (no time)|0|||
23339782|NCT03075891|64989257|FG000|Overall Study|Drug abuse relapse issue|0|||
23339783|NCT03075891|64989258|FG001|Overall Study|Drug abuse relapse issue|1|||
23339784|NCT03075891|64989257|FG000|Overall Study|Participant requiring study withdrawal|0|||
23339785|NCT03075891|64989258|FG001|Overall Study|Participant requiring study withdrawal|1|||
23339786|NCT03075891|64989257|FG000|Overall Study|Adverse event, non-fatal|1|||
23339787|NCT03075891|64989258|FG001|Overall Study|Adverse event, non-fatal|4|||
23339788|NCT01190410|64989259|FG000|Overall Study|Adverse Event|0|||
23339789|NCT01190410|64989260|FG001|Overall Study|Adverse Event|3|||
23339790|NCT01190410|64989259|FG000|Overall Study|Lack of Efficacy|0|||
23339791|NCT01190410|64989260|FG001|Overall Study|Lack of Efficacy|2|||
23339792|NCT01190410|64989259|FG000|Overall Study|Withdrawal by Subject|0|||
23339793|NCT01190410|64989260|FG001|Overall Study|Withdrawal by Subject|2|||
23339794|NCT01190410|64989259|FG000|Overall Study|Administrative decision|1|||
23339795|NCT01190410|64989260|FG001|Overall Study|Administrative decision|0|||
23339796|NCT01190410|64989259|FG000|Overall Study|PI discretion|0|||
23580225|NCT01606189|65853414|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23580226|NCT01606189|65853415|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
23580227|NCT01606189|65853416|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
23173851|NCT01827384|64382331|FG007|Overall Study|Switched to alternative treatment|0|||
23173852|NCT01827384|64382332|FG008|Overall Study|Switched to alternative treatment|0|||
23173853|NCT01827384|64382333|FG009|Overall Study|Switched to alternative treatment|0|||
23339797|NCT01190410|64989260|FG001|Overall Study|PI discretion|2|||
23339798|NCT00747474|64989261|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339799|NCT00747474|64989262|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339800|NCT00747474|64989263|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339801|NCT00747474|64989264|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339802|NCT00747474|64989265|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339803|NCT00747474|64989266|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23173854|NCT01827384|64382334|FG010|Overall Study|Switched to alternative treatment|0|||
23173855|NCT01827384|64382335|FG011|Overall Study|Switched to alternative treatment|0|||
23173856|NCT01827384|64382336|FG012|Overall Study|Switched to alternative treatment|0|||
23173857|NCT01827384|64382337|FG013|Overall Study|Switched to alternative treatment|2|||
23173858|NCT01827384|64382324|FG000|Overall Study|Disease progression before treatment|0|||
23173859|NCT01827384|64382325|FG001|Overall Study|Disease progression before treatment|0|||
23173860|NCT01827384|64382326|FG002|Overall Study|Disease progression before treatment|0|||
23173861|NCT01827384|64382327|FG003|Overall Study|Disease progression before treatment|0|||
23173862|NCT01827384|64382328|FG004|Overall Study|Disease progression before treatment|0|||
23173863|NCT01827384|64382329|FG005|Overall Study|Disease progression before treatment|0|||
23173864|NCT01827384|64382330|FG006|Overall Study|Disease progression before treatment|0|||
23173865|NCT01827384|64382331|FG007|Overall Study|Disease progression before treatment|0|||
23173866|NCT01827384|64382332|FG008|Overall Study|Disease progression before treatment|0|||
23173867|NCT01827384|64382333|FG009|Overall Study|Disease progression before treatment|0|||
23173868|NCT01827384|64382334|FG010|Overall Study|Disease progression before treatment|0|||
23173869|NCT01827384|64382335|FG011|Overall Study|Disease progression before treatment|0|||
23173870|NCT01827384|64382336|FG012|Overall Study|Disease progression before treatment|0|||
23173871|NCT01827384|64382337|FG013|Overall Study|Disease progression before treatment|4|||
23339804|NCT00747474|64989267|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339805|NCT00747474|64989268|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
23339806|NCT00747474|64989269|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339807|NCT00747474|64989270|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23173872|NCT01827384|64382324|FG000|Overall Study|Ineligible|0|||
23173873|NCT01827384|64382325|FG001|Overall Study|Ineligible|0|||
23173874|NCT01827384|64382326|FG002|Overall Study|Ineligible|0|||
23173875|NCT01827384|64382327|FG003|Overall Study|Ineligible|0|||
23173876|NCT01827384|64382328|FG004|Overall Study|Ineligible|0|||
23173877|NCT01827384|64382329|FG005|Overall Study|Ineligible|0|||
23173878|NCT01827384|64382330|FG006|Overall Study|Ineligible|0|||
23173879|NCT01827384|64382331|FG007|Overall Study|Ineligible|0|||
23173880|NCT01827384|64382332|FG008|Overall Study|Ineligible|0|||
23173881|NCT01827384|64382333|FG009|Overall Study|Ineligible|0|||
23173882|NCT01827384|64382334|FG010|Overall Study|Ineligible|0|||
23173883|NCT01827384|64382335|FG011|Overall Study|Ineligible|0|||
23173884|NCT01827384|64382336|FG012|Overall Study|Ineligible|0|||
23173885|NCT01827384|64382337|FG013|Overall Study|Ineligible|19|||
23173886|NCT01827384|64382324|FG000|Overall Study|Participant died before treatment|0|||
23173887|NCT01827384|64382325|FG001|Overall Study|Participant died before treatment|0|||
23173888|NCT01827384|64382326|FG002|Overall Study|Participant died before treatment|0|||
23173889|NCT01827384|64382327|FG003|Overall Study|Participant died before treatment|0|||
23173890|NCT01827384|64382328|FG004|Overall Study|Participant died before treatment|0|||
23173891|NCT01827384|64382329|FG005|Overall Study|Participant died before treatment|0|||
23173892|NCT01827384|64382330|FG006|Overall Study|Participant died before treatment|0|||
23173893|NCT01827384|64382331|FG007|Overall Study|Participant died before treatment|0|||
23173894|NCT01827384|64382332|FG008|Overall Study|Participant died before treatment|0|||
23173895|NCT01827384|64382333|FG009|Overall Study|Participant died before treatment|0|||
23173896|NCT01827384|64382334|FG010|Overall Study|Participant died before treatment|0|||
23173897|NCT01827384|64382335|FG011|Overall Study|Participant died before treatment|0|||
23173898|NCT01827384|64382336|FG012|Overall Study|Participant died before treatment|0|||
23173899|NCT01827384|64382337|FG013|Overall Study|Participant died before treatment|5|||
23173900|NCT01827384|64382324|FG000|Overall Study|Insufficient tumor cells|0|||
23173901|NCT01827384|64382325|FG001|Overall Study|Insufficient tumor cells|0|||
23173902|NCT01827384|64382326|FG002|Overall Study|Insufficient tumor cells|0|||
23173903|NCT01827384|64382327|FG003|Overall Study|Insufficient tumor cells|0|||
23173904|NCT01827384|64382328|FG004|Overall Study|Insufficient tumor cells|0|||
23173905|NCT01827384|64382329|FG005|Overall Study|Insufficient tumor cells|0|||
23173906|NCT01827384|64382330|FG006|Overall Study|Insufficient tumor cells|0|||
23173907|NCT01827384|64382331|FG007|Overall Study|Insufficient tumor cells|0|||
23173908|NCT01827384|64382332|FG008|Overall Study|Insufficient tumor cells|0|||
23173909|NCT01827384|64382333|FG009|Overall Study|Insufficient tumor cells|0|||
23173910|NCT01827384|64382334|FG010|Overall Study|Insufficient tumor cells|0|||
23173911|NCT01827384|64382335|FG011|Overall Study|Insufficient tumor cells|0|||
23173912|NCT01827384|64382336|FG012|Overall Study|Insufficient tumor cells|0|||
23173913|NCT01827384|64382337|FG013|Overall Study|Insufficient tumor cells|13|||
23173914|NCT01827384|64382324|FG000|Overall Study|No actionable mutation|0|||
23339808|NCT00747474|64989271|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339809|NCT00747474|64989272|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
23339810|NCT00073983|64989273|FG000|Overall Study|not evaluable|1|||
23339811|NCT02004886|64989274|FG000|Overall Study|Adverse Event|0|||
23339812|NCT02004886|64989275|FG001|Overall Study|Adverse Event|1|||
23339813|NCT02004886|64989276|FG002|Overall Study|Adverse Event|0|||
23339814|NCT02004886|64989277|FG003|Overall Study|Adverse Event|0|||
23173915|NCT01827384|64382325|FG001|Overall Study|No actionable mutation|0|||
23451698|NCT00467740|65395265|FG002|Overall Study|Protocol Violation|1|||
23451699|NCT00467740|65395266|FG003|Overall Study|Protocol Violation|0|||
23451700|NCT00467740|65395267|FG004|Overall Study|Protocol Violation|0|||
23451701|NCT00467740|65395263|FG000|Overall Study|Lost to Follow-up|0|||
23451702|NCT00467740|65395264|FG001|Overall Study|Lost to Follow-up|1|||
23451703|NCT00467740|65395265|FG002|Overall Study|Lost to Follow-up|0|||
23451704|NCT00467740|65395266|FG003|Overall Study|Lost to Follow-up|0|||
23451705|NCT00467740|65395267|FG004|Overall Study|Lost to Follow-up|0|||
23451706|NCT00467740|65395263|FG000|Overall Study|Withdrawal by Subject|1|||
23451707|NCT00467740|65395264|FG001|Overall Study|Withdrawal by Subject|1|||
23451708|NCT00467740|65395265|FG002|Overall Study|Withdrawal by Subject|0|||
23451709|NCT00467740|65395266|FG003|Overall Study|Withdrawal by Subject|1|||
23451710|NCT00467740|65395267|FG004|Overall Study|Withdrawal by Subject|0|||
23173916|NCT01827384|64382326|FG002|Overall Study|No actionable mutation|0|||
23173917|NCT01827384|64382327|FG003|Overall Study|No actionable mutation|0|||
23451711|NCT00467740|65395263|FG000|Overall Study|Lack of Efficacy|0|||
23451712|NCT00467740|65395264|FG001|Overall Study|Lack of Efficacy|1|||
23173918|NCT01827384|64382328|FG004|Overall Study|No actionable mutation|0|||
23173919|NCT01827384|64382329|FG005|Overall Study|No actionable mutation|0|||
23173920|NCT01827384|64382330|FG006|Overall Study|No actionable mutation|0|||
23451713|NCT00467740|65395265|FG002|Overall Study|Lack of Efficacy|0|||
23451714|NCT00467740|65395266|FG003|Overall Study|Lack of Efficacy|0|||
23451715|NCT00467740|65395267|FG004|Overall Study|Lack of Efficacy|0|||
23173921|NCT01827384|64382331|FG007|Overall Study|No actionable mutation|0|||
23173922|NCT01827384|64382332|FG008|Overall Study|No actionable mutation|0|||
23173923|NCT01827384|64382333|FG009|Overall Study|No actionable mutation|0|||
23173924|NCT01827384|64382334|FG010|Overall Study|No actionable mutation|0|||
23173925|NCT01827384|64382335|FG011|Overall Study|No actionable mutation|0|||
23173926|NCT01827384|64382336|FG012|Overall Study|No actionable mutation|0|||
23173927|NCT01827384|64382337|FG013|Overall Study|No actionable mutation|73|||
23451716|NCT00079040|65395268|FG000|Overall Study|Withdrew before treatment|1|||
23451717|NCT00079040|65395268|FG000|Overall Study|Ineligible|1|||
23451718|NCT01451723|65395270|FG000|Overall Study|study halted|6|||
23451719|NCT01451723|65395271|FG001|Overall Study|study halted|5|||
23451720|NCT01791244|65395272|FG000|Overall Study|Adverse Event|5|||
23451721|NCT01791244|65395273|FG001|Overall Study|Adverse Event|7|||
23451722|NCT01791244|65395272|FG000|Overall Study|Insufficient clinical response|10|||
23451723|NCT01791244|65395273|FG001|Overall Study|Insufficient clinical response|10|||
23451724|NCT01791244|65395272|FG000|Overall Study|Laboratory Abnormality|0|||
23451725|NCT01791244|65395273|FG001|Overall Study|Laboratory Abnormality|1|||
23451726|NCT00857285|65395274|FG000|Overall Study|Adverse Event|4|||
23451727|NCT00857285|65395275|FG001|Overall Study|Adverse Event|2|||
23451728|NCT00857285|65395274|FG000|Overall Study|Lack of Efficacy|0|||
23451729|NCT00857285|65395275|FG001|Overall Study|Lack of Efficacy|2|||
23451730|NCT00857285|65395274|FG000|Overall Study|Protocol Violation|3|||
23451731|NCT00857285|65395275|FG001|Overall Study|Protocol Violation|1|||
23451732|NCT00857285|65395274|FG000|Overall Study|Withdrawal by Subject|4|||
23451733|NCT00857285|65395275|FG001|Overall Study|Withdrawal by Subject|0|||
23451734|NCT00857285|65395274|FG000|Overall Study|Randomization criteria not met|1|||
23451735|NCT00857285|65395275|FG001|Overall Study|Randomization criteria not met|1|||
23451736|NCT02193776|65395276|FG000|Overall Study|Consent withdrawn|1|||
23451737|NCT02193776|65395277|FG001|Overall Study|Consent withdrawn|0|||
23451738|NCT02193776|65395278|FG002|Overall Study|Consent withdrawn|0|||
23451739|NCT02193776|65395279|FG003|Overall Study|Consent withdrawn|0|||
23451740|NCT02193776|65395276|FG000|Overall Study|Failure to comply with protocol|0|||
23451741|NCT02193776|65395277|FG001|Overall Study|Failure to comply with protocol|1|||
23451742|NCT02193776|65395278|FG002|Overall Study|Failure to comply with protocol|0|||
23451743|NCT02193776|65395279|FG003|Overall Study|Failure to comply with protocol|0|||
23580228|NCT00797225|65853418|FG000|Weeks 1 to 12|Adverse Event|0|||
23580229|NCT00797225|65853419|FG001|Weeks 1 to 12|Adverse Event|0|||
23580230|NCT00797225|65853420|FG002|Weeks 1 to 12|Adverse Event|1|||
23580231|NCT00797225|65853421|FG003|Weeks 1 to 12|Adverse Event|0|||
23580232|NCT00797225|65853422|FG004|Weeks 1 to 12|Adverse Event|0|||
23173928|NCT01827384|64382324|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
23451744|NCT02193776|65395276|FG000|Overall Study|Investigator/Sponsor decision|1|||
23451745|NCT02193776|65395277|FG001|Overall Study|Investigator/Sponsor decision|1|||
23451746|NCT02193776|65395278|FG002|Overall Study|Investigator/Sponsor decision|0|||
23451747|NCT02193776|65395279|FG003|Overall Study|Investigator/Sponsor decision|0|||
23451748|NCT02193776|65395276|FG000|Overall Study|Death|1|||
23451749|NCT02193776|65395277|FG001|Overall Study|Death|0|||
23451750|NCT02193776|65395278|FG002|Overall Study|Death|0|||
23451751|NCT02193776|65395279|FG003|Overall Study|Death|0|||
23451752|NCT02193776|65395276|FG000|Overall Study|Adverse event/Specific toxicity|5|||
23451753|NCT02193776|65395277|FG001|Overall Study|Adverse event/Specific toxicity|5|||
23451754|NCT02193776|65395278|FG002|Overall Study|Adverse event/Specific toxicity|2|||
23451755|NCT02193776|65395279|FG003|Overall Study|Adverse event/Specific toxicity|2|||
23580233|NCT00797225|65853423|FG005|Weeks 1 to 12|Adverse Event|0|||
23451756|NCT01788566|65395280|FG000|Overall Study|Death|4|||
23451757|NCT01788566|65395280|FG000|Overall Study|Adverse Event|1|||
23451758|NCT01788566|65395280|FG000|Overall Study|Clinical Progressive Disease|3|||
23451759|NCT01884077|65395284|FG000|Overall Study|screen fail|0|||
23451760|NCT01884077|65395285|FG001|Overall Study|screen fail|2|||
23451761|NCT01884077|65395284|FG000|Overall Study|canceled surgery|2|||
23451762|NCT01884077|65395285|FG001|Overall Study|canceled surgery|0|||
23451763|NCT01884077|65395284|FG000|Overall Study|Lost to Follow-up|0|||
23451764|NCT01884077|65395285|FG001|Overall Study|Lost to Follow-up|4|||
23451765|NCT01884077|65395284|FG000|Overall Study|study closed|6|||
23451766|NCT01884077|65395285|FG001|Overall Study|study closed|4|||
23451767|NCT04516746|65395292|FG000|Overall Study|Randomized but not Treated|51|||
23451768|NCT04516746|65395293|FG001|Overall Study|Randomized but not Treated|19|||
23173929|NCT01827384|64382325|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
23173930|NCT01827384|64382326|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
23173931|NCT01827384|64382327|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
23173932|NCT01827384|64382328|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
23173933|NCT01827384|64382329|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
23173934|NCT01827384|64382330|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
23173935|NCT01827384|64382331|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
23173936|NCT01827384|64382332|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
23173937|NCT01827384|64382333|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
23173938|NCT01827384|64382334|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
23173939|NCT01827384|64382335|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
23173940|NCT01827384|64382336|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
23173941|NCT01827384|64382337|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
23173942|NCT03757988|64382338|FG000|Overall Study|Withdrawal by Subject|1|||
23173943|NCT01337973|64382345|FG000|Overall Study|Lost to Follow-up|2|||
23173944|NCT01337973|64382346|FG001|Overall Study|Lost to Follow-up|4|||
23173945|NCT01337973|64382347|FG002|Overall Study|Lost to Follow-up|3|||
23173946|NCT01337973|64382345|FG000|Overall Study|Death|1|||
23173947|NCT01337973|64382346|FG001|Overall Study|Death|2|||
23173948|NCT01337973|64382347|FG002|Overall Study|Death|1|||
23173949|NCT01337973|64382345|FG000|Overall Study|Withdrawal by Subject|10|||
23173950|NCT01337973|64382346|FG001|Overall Study|Withdrawal by Subject|8|||
23173951|NCT01337973|64382347|FG002|Overall Study|Withdrawal by Subject|4|||
23173952|NCT01337973|64382345|FG000|Overall Study|missing data on primary outcome|3|||
23173953|NCT01337973|64382346|FG001|Overall Study|missing data on primary outcome|1|||
23173954|NCT01337973|64382347|FG002|Overall Study|missing data on primary outcome|3|||
23173955|NCT00763009|64382348|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
23173956|NCT00820755|64382349|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
23173957|NCT00820755|64382350|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
23173958|NCT00820755|64382351|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
23173959|NCT00820755|64382349|FG000|Period 1: Combination Therapy Phase|Death|28|||
23173960|NCT00820755|64382350|FG001|Period 1: Combination Therapy Phase|Death|0|||
23173961|NCT00820755|64382351|FG002|Period 1: Combination Therapy Phase|Death|0|||
23173962|NCT00820755|64382349|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
23173963|NCT00820755|64382350|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
23173964|NCT00820755|64382351|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
23173965|NCT00820755|64382349|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
23173966|NCT00820755|64382350|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
23173967|NCT00820755|64382351|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
23173968|NCT00820755|64382349|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
23173969|NCT00820755|64382350|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
23173970|NCT00820755|64382351|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
23173971|NCT00820755|64382349|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
23173972|NCT00820755|64382350|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
23173973|NCT00820755|64382351|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
23173974|NCT00820755|64382349|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
23173975|NCT00820755|64382350|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
23173976|NCT00820755|64382351|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
23173977|NCT00820755|64382349|FG000|Period 1: Combination Therapy Phase|Other|11|||
23173978|NCT00820755|64382350|FG001|Period 1: Combination Therapy Phase|Other|0|||
23451769|NCT04516746|65395292|FG000|Overall Study|Adverse Event|0|||
23451770|NCT04516746|65395293|FG001|Overall Study|Adverse Event|1|||
23451771|NCT04516746|65395292|FG000|Overall Study|Death|62|||
23451772|NCT04516746|65395293|FG001|Overall Study|Death|32|||
23451773|NCT04516746|65395292|FG000|Overall Study|Lost to Follow-up|3431|||
23451774|NCT04516746|65395293|FG001|Overall Study|Lost to Follow-up|1831|||
23173979|NCT00820755|64382351|FG002|Period 1: Combination Therapy Phase|Other|0|||
23173980|NCT00820755|64382349|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
23173981|NCT00820755|64382350|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
23173982|NCT00820755|64382351|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
23173983|NCT00087646|64382352|FG000|Overall Study|Adverse Event|37|||
23173984|NCT00087646|64382353|FG001|Overall Study|Adverse Event|6|||
23173985|NCT00087646|64382354|FG002|Overall Study|Adverse Event|18|||
23173986|NCT00087646|64382355|FG003|Overall Study|Adverse Event|20|||
23173987|NCT00087646|64382352|FG000|Overall Study|Death|0|||
23173988|NCT00087646|64382353|FG001|Overall Study|Death|1|||
23173989|NCT00087646|64382354|FG002|Overall Study|Death|0|||
23173990|NCT00087646|64382355|FG003|Overall Study|Death|0|||
23451775|NCT04516746|65395292|FG000|Overall Study|Withdrawal by Subject|1946|||
23451776|NCT04516746|65395293|FG001|Overall Study|Withdrawal by Subject|1696|||
23451777|NCT04516746|65395292|FG000|Overall Study|Physician Decision|10|||
23173991|NCT00087646|64382352|FG000|Overall Study|Withdrawal by Subject|6|||
23173992|NCT00087646|64382353|FG001|Overall Study|Withdrawal by Subject|1|||
23173993|NCT00087646|64382354|FG002|Overall Study|Withdrawal by Subject|2|||
23173994|NCT00087646|64382355|FG003|Overall Study|Withdrawal by Subject|2|||
23173995|NCT00087646|64382352|FG000|Overall Study|Insufficient therapeutic response|64|||
23173996|NCT00087646|64382353|FG001|Overall Study|Insufficient therapeutic response|24|||
23451778|NCT04516746|65395293|FG001|Overall Study|Physician Decision|8|||
23451779|NCT04516746|65395292|FG000|Overall Study|Other|35|||
23451780|NCT04516746|65395293|FG001|Overall Study|Other|16|||
23451781|NCT02544321|65395305|FG000|Overall Study|Withdrawal by Subject|1|||
23451782|NCT02544321|65395306|FG001|Overall Study|Withdrawal by Subject|2|||
23451783|NCT02544321|65395305|FG000|Overall Study|Adverse Event|1|||
23451784|NCT02544321|65395306|FG001|Overall Study|Adverse Event|1|||
23451785|NCT02544321|65395305|FG000|Overall Study|Protocol Violation|0|||
23451786|NCT02544321|65395306|FG001|Overall Study|Protocol Violation|1|||
23451787|NCT00550953|65395307|FG000|Overall Study|Adverse Event|4|||
23451788|NCT00550953|65395308|FG001|Overall Study|Adverse Event|3|||
23451789|NCT00550953|65395307|FG000|Overall Study|Not able to visit the site|2|||
23451790|NCT00550953|65395308|FG001|Overall Study|Not able to visit the site|3|||
23451791|NCT04537793|65395309|FG000|Part B (24 Weeks)|Adverse Event|0|||
23451792|NCT04537793|65395310|FG001|Part B (24 Weeks)|Adverse Event|1|||
23451793|NCT03206216|65395311|FG000|Overall Study|Withdrawal by Subject|0|||
23451794|NCT03206216|65395312|FG001|Overall Study|Withdrawal by Subject|1|||
23451795|NCT02407223|65395315|FG000|Overall Study|Adverse Event|1|||
23451796|NCT02407223|65395316|FG001|Overall Study|Adverse Event|0|||
23451797|NCT02407223|65395317|FG002|Overall Study|Adverse Event|1|||
23451798|NCT02407223|65395315|FG000|Overall Study|Lack of Efficacy|6|||
23451799|NCT02407223|65395316|FG001|Overall Study|Lack of Efficacy|6|||
23451800|NCT02407223|65395317|FG002|Overall Study|Lack of Efficacy|4|||
23451801|NCT02407223|65395315|FG000|Overall Study|Lost to Follow-up|1|||
23451802|NCT02407223|65395316|FG001|Overall Study|Lost to Follow-up|0|||
23451803|NCT02407223|65395317|FG002|Overall Study|Lost to Follow-up|2|||
23451804|NCT02407223|65395315|FG000|Overall Study|Withdrawal by Subject|2|||
23451805|NCT02407223|65395316|FG001|Overall Study|Withdrawal by Subject|4|||
23451806|NCT02407223|65395317|FG002|Overall Study|Withdrawal by Subject|4|||
23451807|NCT02407223|65395315|FG000|Overall Study|Study Terminated by Sponsor|77|||
23451808|NCT02407223|65395316|FG001|Overall Study|Study Terminated by Sponsor|80|||
23451809|NCT02407223|65395317|FG002|Overall Study|Study Terminated by Sponsor|86|||
23451810|NCT02407223|65395315|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
23451811|NCT02407223|65395316|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
23451812|NCT02407223|65395317|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
23451813|NCT02407223|65395315|FG000|Overall Study|Other|29|||
23451814|NCT02407223|65395316|FG001|Overall Study|Other|27|||
23173997|NCT00087646|64382354|FG002|Overall Study|Insufficient therapeutic response|38|||
23173998|NCT00087646|64382355|FG003|Overall Study|Insufficient therapeutic response|51|||
23173999|NCT00087646|64382352|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
23174000|NCT00087646|64382353|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
23174001|NCT00087646|64382354|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
23174002|NCT00087646|64382355|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
23174003|NCT00087646|64382352|FG000|Overall Study|Failure to Return|5|||
23174004|NCT00087646|64382353|FG001|Overall Study|Failure to Return|2|||
23451815|NCT02407223|65395317|FG002|Overall Study|Other|25|||
23451816|NCT00377520|65395318|FG000|Overall Study|Ineligible (Prior radiation)|1|||
23451817|NCT02269124|65395319|FG000|Overall Study|Lost to Follow-up|1|||
23451818|NCT02269124|65395320|FG001|Overall Study|Lost to Follow-up|0|||
23451819|NCT02269124|65395319|FG000|Overall Study|Withdrawal by Subject|0|||
23451820|NCT02269124|65395320|FG001|Overall Study|Withdrawal by Subject|2|||
23451821|NCT00399516|65395323|FG000|Overall Study|Lost to Follow-up|2|||
23451822|NCT03550378|65395324|FG000|Overall Study|Death|0|||
23451823|NCT03550378|65395325|FG001|Overall Study|Death|1|||
23451824|NCT01420861|65395330|FG000|Overall Study|Adverse Event|2|||
23451825|NCT01420861|65395330|FG000|Overall Study|Study terminated by Sponsor|7|||
23174005|NCT00087646|64382354|FG002|Overall Study|Failure to Return|2|||
23174006|NCT00087646|64382355|FG003|Overall Study|Failure to Return|3|||
23174007|NCT00087646|64382352|FG000|Overall Study|Administrative/Other|6|||
23174008|NCT00087646|64382353|FG001|Overall Study|Administrative/Other|1|||
23174009|NCT00087646|64382354|FG002|Overall Study|Administrative/Other|1|||
23174010|NCT00087646|64382355|FG003|Overall Study|Administrative/Other|2|||
23174011|NCT00087646|64382352|FG000|Overall Study|Other Protocol Violation|3|||
23174012|NCT00087646|64382353|FG001|Overall Study|Other Protocol Violation|1|||
23174013|NCT00087646|64382354|FG002|Overall Study|Other Protocol Violation|0|||
23174014|NCT00087646|64382355|FG003|Overall Study|Other Protocol Violation|0|||
23174015|NCT00087646|64382352|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23174016|NCT00087646|64382353|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
23174017|NCT00087646|64382354|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
23174018|NCT00087646|64382355|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
23174019|NCT01818297|64382356|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
23174020|NCT01818297|64382357|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
23174021|NCT01818297|64382356|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
23174022|NCT01818297|64382357|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
23174023|NCT01818297|64382356|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
23174024|NCT01818297|64382357|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
23174025|NCT03603652|64382358|FG000|Overall Study|Death|2|||
23174026|NCT01592760|64382359|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
23174027|NCT01592760|64382360|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
23174028|NCT01592760|64382361|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
23174029|NCT00477165|64382362|FG000|Overall Study|Adverse Event|7|||
23174030|NCT00477165|64382363|FG001|Overall Study|Adverse Event|2|||
23174031|NCT00130832|64382364|FG000|Overall Study|Adverse Event|1|||
23174032|NCT00130832|64382365|FG001|Overall Study|Adverse Event|1|||
23174033|NCT00130832|64382364|FG000|Overall Study|Lost to Follow-up|1|||
23174034|NCT00130832|64382365|FG001|Overall Study|Lost to Follow-up|2|||
23174035|NCT00130832|64382364|FG000|Overall Study|Protocol Violation|6|||
23174036|NCT00130832|64382365|FG001|Overall Study|Protocol Violation|8|||
23174037|NCT00130832|64382364|FG000|Overall Study|Withdrawal by Subject|6|||
23174038|NCT00130832|64382365|FG001|Overall Study|Withdrawal by Subject|1|||
23174039|NCT00130832|64382364|FG000|Overall Study|Moved|2|||
23174040|NCT00130832|64382365|FG001|Overall Study|Moved|2|||
23174041|NCT00130832|64382364|FG000|Overall Study|Other|0|||
23174042|NCT00130832|64382365|FG001|Overall Study|Other|3|||
23174043|NCT02292771|64382366|FG000|Overall Study|Withdrawal by Subject|2|||
23174044|NCT02292771|64382367|FG001|Overall Study|Withdrawal by Subject|1|||
23174045|NCT02292771|64382366|FG000|Overall Study|Lost to Follow-up|2|||
23174046|NCT02292771|64382367|FG001|Overall Study|Lost to Follow-up|1|||
23174047|NCT01725750|64382368|FG000|Overall Study|Adverse Event|1|||
23174048|NCT01725750|64382369|FG001|Overall Study|Adverse Event|0|||
23174049|NCT01725750|64382368|FG000|Overall Study|Lost to Follow-up|1|||
23174050|NCT01725750|64382369|FG001|Overall Study|Lost to Follow-up|1|||
23174051|NCT01725750|64382368|FG000|Overall Study|Withdrawal by Subject|0|||
23174052|NCT01725750|64382369|FG001|Overall Study|Withdrawal by Subject|9|||
23174053|NCT03261531|64382370|FG000|Overall Study|Withdrawal by Subject|4|||
23174054|NCT02078219|64382375|FG000|Overall Study|Other|2|||
23174055|NCT02078219|64382376|FG001|Overall Study|Other|2|||
23174056|NCT02078219|64382377|FG002|Overall Study|Other|3|||
23174057|NCT02078219|64382378|FG003|Overall Study|Other|0|||
23174058|NCT02078219|64382379|FG004|Overall Study|Other|1|||
23174059|NCT02078219|64382375|FG000|Overall Study|Withdrawal by Subject|0|||
23174060|NCT02078219|64382376|FG001|Overall Study|Withdrawal by Subject|1|||
23174061|NCT02078219|64382377|FG002|Overall Study|Withdrawal by Subject|0|||
23174062|NCT02078219|64382378|FG003|Overall Study|Withdrawal by Subject|1|||
23174063|NCT02078219|64382379|FG004|Overall Study|Withdrawal by Subject|1|||
23174064|NCT02078219|64382375|FG000|Overall Study|Protocol Violation|0|||
23174065|NCT02078219|64382376|FG001|Overall Study|Protocol Violation|0|||
23174066|NCT02078219|64382377|FG002|Overall Study|Protocol Violation|0|||
23174067|NCT02078219|64382378|FG003|Overall Study|Protocol Violation|1|||
23174068|NCT02078219|64382379|FG004|Overall Study|Protocol Violation|0|||
23174069|NCT02078219|64382375|FG000|Overall Study|Death|0|||
23174070|NCT02078219|64382376|FG001|Overall Study|Death|0|||
23174071|NCT02078219|64382377|FG002|Overall Study|Death|0|||
23174072|NCT02078219|64382378|FG003|Overall Study|Death|1|||
23174073|NCT02078219|64382379|FG004|Overall Study|Death|0|||
23580234|NCT00797225|65853424|FG006|Weeks 1 to 12|Adverse Event|0|||
23174074|NCT02078219|64382375|FG000|Overall Study|Adverse Event|1|||
23174075|NCT02078219|64382376|FG001|Overall Study|Adverse Event|1|||
23174076|NCT02078219|64382377|FG002|Overall Study|Adverse Event|3|||
23174077|NCT02078219|64382378|FG003|Overall Study|Adverse Event|1|||
23174078|NCT02078219|64382379|FG004|Overall Study|Adverse Event|0|||
23174079|NCT03099707|64382382|FG000|Overall Study|Withdrawal by Subject|0|||
23174080|NCT03099707|64382383|FG001|Overall Study|Withdrawal by Subject|3|||
23174081|NCT03099707|64382382|FG000|Overall Study|Lost to Follow-up|0|||
23451826|NCT01420861|65395330|FG000|Overall Study|Screen failure|7|||
23451827|NCT01420861|65395330|FG000|Overall Study|Randomized not Treated|2|||
23451828|NCT00395746|65398836|FG000|Overall Study|Adverse Event|5|||
23451829|NCT00395746|65398837|FG001|Overall Study|Adverse Event|2|||
23451830|NCT00395746|65398838|FG002|Overall Study|Adverse Event|2|||
23451831|NCT00395746|65398836|FG000|Overall Study|Protocol Violation|0|||
23451832|NCT00395746|65398837|FG001|Overall Study|Protocol Violation|1|||
23451833|NCT00395746|65398838|FG002|Overall Study|Protocol Violation|0|||
23451834|NCT00395746|65398836|FG000|Overall Study|Lack of Efficacy|2|||
23451835|NCT00395746|65398837|FG001|Overall Study|Lack of Efficacy|0|||
23451836|NCT00395746|65398838|FG002|Overall Study|Lack of Efficacy|17|||
23451837|NCT00395746|65398836|FG000|Overall Study|Hypoglycaemia|2|||
23451838|NCT00395746|65398837|FG001|Overall Study|Hypoglycaemia|1|||
23451839|NCT00395746|65398838|FG002|Overall Study|Hypoglycaemia|0|||
23451840|NCT00395746|65398836|FG000|Overall Study|Subject decision|0|||
23451841|NCT00395746|65398837|FG001|Overall Study|Subject decision|0|||
23451842|NCT00395746|65398838|FG002|Overall Study|Subject decision|1|||
23451843|NCT00395746|65398836|FG000|Overall Study|Withdrawal of consent|0|||
23451844|NCT00395746|65398837|FG001|Overall Study|Withdrawal of consent|0|||
23174082|NCT03099707|64382383|FG001|Overall Study|Lost to Follow-up|1|||
23174083|NCT01360645|64382384|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
23174084|NCT01360645|64382385|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
23174085|NCT01360645|64382386|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
23174086|NCT01360645|64382387|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
23174087|NCT01360645|64382384|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
23174088|NCT01360645|64382385|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
23174089|NCT01360645|64382386|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
23174090|NCT01360645|64382387|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
23174091|NCT01360645|64382384|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
23174092|NCT01360645|64382385|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
23174093|NCT01360645|64382386|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
23174094|NCT01360645|64382387|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
23174095|NCT01360645|64382384|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
23174096|NCT01360645|64382385|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
23174097|NCT01360645|64382386|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
23174098|NCT01360645|64382387|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
23174099|NCT01360645|64382384|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
23174100|NCT01360645|64382385|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
23174101|NCT01360645|64382386|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
23174102|NCT01360645|64382387|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
23451845|NCT00395746|65398838|FG002|Overall Study|Withdrawal of consent|1|||
23451846|NCT00395746|65398836|FG000|Overall Study|Difficultulty in use of device|0|||
23451847|NCT00395746|65398837|FG001|Overall Study|Difficultulty in use of device|0|||
23451848|NCT00395746|65398838|FG002|Overall Study|Difficultulty in use of device|1|||
23451849|NCT00395746|65398836|FG000|Overall Study|Unable to visit site on schedule|1|||
23174103|NCT01360645|64382384|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
23174104|NCT01360645|64382385|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
23174105|NCT01360645|64382386|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
23174106|NCT01360645|64382387|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
23174107|NCT01360645|64382384|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
23174108|NCT01360645|64382385|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
23451850|NCT00395746|65398837|FG001|Overall Study|Unable to visit site on schedule|0|||
23174109|NCT01360645|64382386|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
23174110|NCT01360645|64382387|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
23174111|NCT01360645|64382384|FG000|Phase B (6 Weeks)|Adverse Event|0|||
23174112|NCT01360645|64382385|FG001|Phase B (6 Weeks)|Adverse Event|6|||
23174113|NCT01360645|64382386|FG002|Phase B (6 Weeks)|Adverse Event|0|||
23174114|NCT01360645|64382387|FG003|Phase B (6 Weeks)|Adverse Event|0|||
23174115|NCT01360645|64382384|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23174116|NCT01360645|64382385|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
23174117|NCT01360645|64382386|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
23174118|NCT01360645|64382387|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23174119|NCT01360645|64382384|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
23174120|NCT01360645|64382385|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
23174121|NCT01360645|64382386|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
23451851|NCT00395746|65398838|FG002|Overall Study|Unable to visit site on schedule|0|||
23451852|NCT01535040|65398839|FG000|Overall Study|Physician Decision|0|||
23451853|NCT01535040|65398840|FG001|Overall Study|Physician Decision|1|||
23451854|NCT01535040|65398839|FG000|Overall Study|Withdrawal by Subject|13|||
23451855|NCT01535040|65398840|FG001|Overall Study|Withdrawal by Subject|10|||
23451856|NCT01535040|65398839|FG000|Overall Study|Never Started|9|||
23174122|NCT01360645|64382387|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
23174123|NCT01360645|64382384|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
23174124|NCT01360645|64382385|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
23174125|NCT01360645|64382386|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
23174126|NCT01360645|64382387|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
23174127|NCT01360645|64382384|FG000|Phase A+|Lost to Follow-up|0|||
23174128|NCT01360645|64382385|FG001|Phase A+|Lost to Follow-up|0|||
23451857|NCT01535040|65398840|FG001|Overall Study|Never Started|4|||
23451858|NCT01535040|65398839|FG000|Overall Study|Toxicity|7|||
23451859|NCT01535040|65398840|FG001|Overall Study|Toxicity|5|||
23451860|NCT01535040|65398839|FG000|Overall Study|Multiple Reasons|1|||
23451861|NCT01535040|65398840|FG001|Overall Study|Multiple Reasons|1|||
23451862|NCT00551759|65398841|FG000|Overall Study|Adverse Event|7|||
23451863|NCT00551759|65398841|FG000|Overall Study|Death|5|||
23451864|NCT00551759|65398841|FG000|Overall Study|Ineligible|1|||
23451865|NCT01005251|65398842|FG000|Overall Study|Withdrawal by Subject|2|||
23451866|NCT01005251|65398843|FG001|Overall Study|Withdrawal by Subject|5|||
23451867|NCT01005251|65398844|FG002|Overall Study|Withdrawal by Subject|3|||
23451868|NCT01005251|65398845|FG003|Overall Study|Withdrawal by Subject|4|||
23451869|NCT01005251|65398846|FG004|Overall Study|Withdrawal by Subject|9|||
23451870|NCT01005251|65398842|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
23451871|NCT01005251|65398843|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23451872|NCT01005251|65398844|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
23451873|NCT01005251|65398845|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
23451874|NCT01005251|65398846|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
23451875|NCT01005251|65398842|FG000|Overall Study|Adverse Event|2|||
23451876|NCT01005251|65398843|FG001|Overall Study|Adverse Event|6|||
23451877|NCT01005251|65398844|FG002|Overall Study|Adverse Event|8|||
23451878|NCT01005251|65398845|FG003|Overall Study|Adverse Event|5|||
23451879|NCT01005251|65398846|FG004|Overall Study|Adverse Event|4|||
23451880|NCT01005251|65398842|FG000|Overall Study|Protocol Violation|1|||
23451881|NCT01005251|65398843|FG001|Overall Study|Protocol Violation|0|||
23451882|NCT01005251|65398844|FG002|Overall Study|Protocol Violation|0|||
23451883|NCT01005251|65398845|FG003|Overall Study|Protocol Violation|0|||
23451884|NCT01005251|65398846|FG004|Overall Study|Protocol Violation|2|||
23451885|NCT01005251|65398842|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
23451886|NCT01005251|65398843|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
23451887|NCT01005251|65398844|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
23451888|NCT01005251|65398845|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
23451889|NCT01005251|65398846|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
23451890|NCT01005251|65398842|FG000|Overall Study|Lost to Follow-up|1|||
23451891|NCT01005251|65398843|FG001|Overall Study|Lost to Follow-up|4|||
23451892|NCT01005251|65398844|FG002|Overall Study|Lost to Follow-up|2|||
23451893|NCT01005251|65398845|FG003|Overall Study|Lost to Follow-up|0|||
23451894|NCT01005251|65398846|FG004|Overall Study|Lost to Follow-up|0|||
23451895|NCT01005251|65398842|FG000|Overall Study|Physician Decision|0|||
23451896|NCT01005251|65398843|FG001|Overall Study|Physician Decision|0|||
23451897|NCT01005251|65398844|FG002|Overall Study|Physician Decision|0|||
23451898|NCT01005251|65398845|FG003|Overall Study|Physician Decision|0|||
23451899|NCT01005251|65398846|FG004|Overall Study|Physician Decision|2|||
23451900|NCT01005251|65398842|FG000|Overall Study|Patient moved|1|||
23451901|NCT01005251|65398843|FG001|Overall Study|Patient moved|0|||
23451902|NCT01005251|65398844|FG002|Overall Study|Patient moved|0|||
23451903|NCT01005251|65398845|FG003|Overall Study|Patient moved|0|||
23451904|NCT01005251|65398846|FG004|Overall Study|Patient moved|0|||
23451905|NCT01005251|65398842|FG000|Overall Study|Wrong drug dispensed|0|||
23451906|NCT01005251|65398843|FG001|Overall Study|Wrong drug dispensed|1|||
23451907|NCT01005251|65398844|FG002|Overall Study|Wrong drug dispensed|0|||
23451908|NCT01005251|65398845|FG003|Overall Study|Wrong drug dispensed|0|||
23451909|NCT01005251|65398846|FG004|Overall Study|Wrong drug dispensed|0|||
23451910|NCT01005251|65398842|FG000|Overall Study|Randomized in error|0|||
23451911|NCT01005251|65398843|FG001|Overall Study|Randomized in error|0|||
23451912|NCT01005251|65398844|FG002|Overall Study|Randomized in error|1|||
23174129|NCT01360645|64382386|FG002|Phase A+|Lost to Follow-up|0|||
23174130|NCT01360645|64382387|FG003|Phase A+|Lost to Follow-up|7|||
23451913|NCT01005251|65398845|FG003|Overall Study|Randomized in error|1|||
23451914|NCT01005251|65398846|FG004|Overall Study|Randomized in error|0|||
23451915|NCT01005251|65398842|FG000|Overall Study|Lack of Efficacy|0|||
23451916|NCT01005251|65398843|FG001|Overall Study|Lack of Efficacy|0|||
23451917|NCT01005251|65398844|FG002|Overall Study|Lack of Efficacy|1|||
23451918|NCT01005251|65398845|FG003|Overall Study|Lack of Efficacy|1|||
23451919|NCT01005251|65398846|FG004|Overall Study|Lack of Efficacy|0|||
23451920|NCT00647296|65398847|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451921|NCT00647296|65398848|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451922|NCT00647296|65398849|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451923|NCT00647296|65398850|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
23451924|NCT00647296|65398847|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
23451925|NCT00647296|65398848|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
23451926|NCT00647296|65398849|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
23451927|NCT00647296|65398850|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
23451928|NCT00647296|65398847|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
23451929|NCT00647296|65398848|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
23451930|NCT00647296|65398849|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
23451931|NCT00647296|65398850|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
23451932|NCT00647296|65398847|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
23451933|NCT00647296|65398848|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
23451934|NCT00647296|65398849|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
23451935|NCT00647296|65398850|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
23451936|NCT00647296|65398847|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
23451937|NCT00647296|65398848|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
23451938|NCT00647296|65398849|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
23451939|NCT00647296|65398850|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
23451940|NCT00647296|65398847|FG000|Part 2: 4-week Placebo Washout|Death|3|||
23451941|NCT00647296|65398848|FG001|Part 2: 4-week Placebo Washout|Death|0|||
23451942|NCT00647296|65398849|FG002|Part 2: 4-week Placebo Washout|Death|0|||
23451943|NCT00647296|65398850|FG003|Part 2: 4-week Placebo Washout|Death|0|||
23451944|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451945|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
23451946|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
23451947|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
23451948|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
23451949|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
23451950|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
23451951|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
23451952|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
23451953|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
23451954|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
23451955|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
23451956|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
23451957|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
23451958|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
23451959|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
23451960|NCT00647296|65398847|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
23451961|NCT00647296|65398848|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
23451962|NCT00647296|65398849|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
23451963|NCT00647296|65398850|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
23451964|NCT00591006|65398856|FG000|Overall Study|Withdrawal by Subject|0|||
23451965|NCT00591006|65398857|FG001|Overall Study|Withdrawal by Subject|0|||
23451966|NCT00591006|65398858|FG002|Overall Study|Withdrawal by Subject|0|||
23451967|NCT00591006|65398859|FG003|Overall Study|Withdrawal by Subject|0|||
23451968|NCT00591006|65398860|FG004|Overall Study|Withdrawal by Subject|0|||
23451969|NCT00591006|65398861|FG005|Overall Study|Withdrawal by Subject|0|||
23451970|NCT00591006|65398862|FG006|Overall Study|Withdrawal by Subject|0|||
23451971|NCT00591006|65398863|FG007|Overall Study|Withdrawal by Subject|0|||
23451972|NCT00591006|65398864|FG008|Overall Study|Withdrawal by Subject|0|||
23451973|NCT00591006|65398865|FG009|Overall Study|Withdrawal by Subject|0|||
23451974|NCT00591006|65398866|FG010|Overall Study|Withdrawal by Subject|0|||
23451975|NCT00591006|65398867|FG011|Overall Study|Withdrawal by Subject|0|||
23451976|NCT00591006|65398868|FG012|Overall Study|Withdrawal by Subject|0|||
23451977|NCT00591006|65398869|FG013|Overall Study|Withdrawal by Subject|0|||
23451978|NCT00591006|65398870|FG014|Overall Study|Withdrawal by Subject|0|||
23451979|NCT00591006|65398871|FG015|Overall Study|Withdrawal by Subject|1|||
23451980|NCT00591006|65398872|FG016|Overall Study|Withdrawal by Subject|0|||
23451981|NCT00591006|65398873|FG017|Overall Study|Withdrawal by Subject|0|||
23451982|NCT00591006|65398874|FG018|Overall Study|Withdrawal by Subject|0|||
23451983|NCT00591006|65398875|FG019|Overall Study|Withdrawal by Subject|0|||
23451984|NCT00591006|65398876|FG020|Overall Study|Withdrawal by Subject|0|||
23451985|NCT00591006|65398877|FG021|Overall Study|Withdrawal by Subject|0|||
23174131|NCT01360645|64382384|FG000|Phase A+|Adverse Event|0|||
23174132|NCT01360645|64382385|FG001|Phase A+|Adverse Event|0|||
23451986|NCT00591006|65398878|FG022|Overall Study|Withdrawal by Subject|0|||
23451987|NCT00591006|65398879|FG023|Overall Study|Withdrawal by Subject|1|||
23451988|NCT00591006|65398856|FG000|Overall Study|Adverse Event|0|||
23451989|NCT00591006|65398857|FG001|Overall Study|Adverse Event|0|||
23451990|NCT00591006|65398858|FG002|Overall Study|Adverse Event|0|||
23451991|NCT00591006|65398859|FG003|Overall Study|Adverse Event|0|||
23451992|NCT00591006|65398860|FG004|Overall Study|Adverse Event|0|||
23451993|NCT00591006|65398861|FG005|Overall Study|Adverse Event|0|||
23451994|NCT00591006|65398862|FG006|Overall Study|Adverse Event|0|||
23451995|NCT00591006|65398863|FG007|Overall Study|Adverse Event|0|||
23451996|NCT00591006|65398864|FG008|Overall Study|Adverse Event|0|||
23451997|NCT00591006|65398865|FG009|Overall Study|Adverse Event|0|||
23451998|NCT00591006|65398866|FG010|Overall Study|Adverse Event|0|||
23451999|NCT00591006|65398867|FG011|Overall Study|Adverse Event|0|||
23580235|NCT00797225|65853425|FG007|Weeks 1 to 12|Adverse Event|0|||
23580236|NCT00797225|65853418|FG000|Weeks 1 to 12|Non-compliance|0|||
23174133|NCT01360645|64382386|FG002|Phase A+|Adverse Event|0|||
23174134|NCT01360645|64382387|FG003|Phase A+|Adverse Event|2|||
23174135|NCT01360645|64382384|FG000|Phase A+|Met Withdrawal Criteria|0|||
23174136|NCT01360645|64382385|FG001|Phase A+|Met Withdrawal Criteria|0|||
23174137|NCT01360645|64382386|FG002|Phase A+|Met Withdrawal Criteria|0|||
23174138|NCT01360645|64382387|FG003|Phase A+|Met Withdrawal Criteria|4|||
23174139|NCT01360645|64382384|FG000|Phase A+|Physician Decision|0|||
23174140|NCT01360645|64382385|FG001|Phase A+|Physician Decision|0|||
23174141|NCT01360645|64382386|FG002|Phase A+|Physician Decision|0|||
23174142|NCT01360645|64382387|FG003|Phase A+|Physician Decision|2|||
23174143|NCT01360645|64382384|FG000|Phase A+|Withdrawal by Subject|0|||
23174144|NCT01360645|64382385|FG001|Phase A+|Withdrawal by Subject|0|||
23174145|NCT01360645|64382386|FG002|Phase A+|Withdrawal by Subject|0|||
23174146|NCT01360645|64382387|FG003|Phase A+|Withdrawal by Subject|5|||
23174147|NCT01360645|64382384|FG000|Phase A+|Protocol Deviation|0|||
23174148|NCT01360645|64382385|FG001|Phase A+|Protocol Deviation|0|||
23174149|NCT01360645|64382386|FG002|Phase A+|Protocol Deviation|0|||
23174150|NCT01360645|64382387|FG003|Phase A+|Protocol Deviation|4|||
23174151|NCT03093155|64382388|FG000|Overall Study|Not Eligible|1|||
23174152|NCT03093155|64382389|FG001|Overall Study|Not Eligible|0|||
23174153|NCT03093155|64382388|FG000|Overall Study|Withdrawal by Subject|0|||
23174154|NCT03093155|64382389|FG001|Overall Study|Withdrawal by Subject|1|||
23174155|NCT01557166|64382390|FG000|Overall Study|Adverse Event|20|||
23174156|NCT01557166|64382391|FG001|Overall Study|Adverse Event|6|||
23174157|NCT01557166|64382390|FG000|Overall Study|Lack of Efficacy|2|||
23174158|NCT01557166|64382391|FG001|Overall Study|Lack of Efficacy|1|||
23174159|NCT01557166|64382390|FG000|Overall Study|Protocol Violation|8|||
23174160|NCT01557166|64382391|FG001|Overall Study|Protocol Violation|5|||
23174161|NCT01557166|64382390|FG000|Overall Study|Withdrawn consent|12|||
23174162|NCT01557166|64382391|FG001|Overall Study|Withdrawn consent|20|||
23174163|NCT01557166|64382390|FG000|Overall Study|Target dose not tolerated|1|||
23580237|NCT00797225|65853419|FG001|Weeks 1 to 12|Non-compliance|1|||
23580238|NCT00797225|65853420|FG002|Weeks 1 to 12|Non-compliance|0|||
23580239|NCT00797225|65853421|FG003|Weeks 1 to 12|Non-compliance|0|||
23580240|NCT00797225|65853422|FG004|Weeks 1 to 12|Non-compliance|0|||
23580241|NCT00797225|65853423|FG005|Weeks 1 to 12|Non-compliance|0|||
23580242|NCT00797225|65853424|FG006|Weeks 1 to 12|Non-compliance|0|||
23580243|NCT00797225|65853425|FG007|Weeks 1 to 12|Non-compliance|0|||
23580244|NCT00797225|65853418|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
23580245|NCT00797225|65853419|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
23580246|NCT00797225|65853420|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
23580247|NCT00797225|65853421|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
23580248|NCT00797225|65853422|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
23580249|NCT00797225|65853423|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
23580250|NCT00797225|65853424|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
23174164|NCT01557166|64382391|FG001|Overall Study|Target dose not tolerated|0|||
23174165|NCT01557166|64382390|FG000|Overall Study|Psychiatric disorder|1|||
23174166|NCT01557166|64382391|FG001|Overall Study|Psychiatric disorder|0|||
23174167|NCT01557166|64382390|FG000|Overall Study|Unclassified|2|||
23174168|NCT01557166|64382391|FG001|Overall Study|Unclassified|5|||
23174169|NCT01078805|64382392|FG000|Overall Study|Clinically significant abnormal lab|5|||
23174170|NCT01078805|64382392|FG000|Overall Study|Death|134|||
23174171|NCT01078805|64382392|FG000|Overall Study|Lost to Follow-up|676|||
23174172|NCT01078805|64382392|FG000|Overall Study|Physician Decision|169|||
23174173|NCT01078805|64382392|FG000|Overall Study|Serious adverse event|26|||
23174174|NCT01078805|64382392|FG000|Overall Study|Sponsor decision|46|||
23174175|NCT01078805|64382392|FG000|Overall Study|Withdrawal by Subject|739|||
23174176|NCT01078805|64382392|FG000|Overall Study|Other|173|||
23174177|NCT01078805|64382392|FG000|Overall Study|Didn't take study drug|82|||
23174178|NCT00848120|64382395|FG000|Overall Study|Adverse Event|1|||
23174179|NCT00865020|64382400|FG000|Overall Study|Withdrawal by Subject|22|||
23174180|NCT00865020|64382401|FG001|Overall Study|Withdrawal by Subject|16|||
23174181|NCT00865020|64382400|FG000|Overall Study|Adverse Event|9|||
23233860|NCT00364351|64600589|FG000|Overall Study|Incorrect enrollment|1|||
23339815|NCT02004886|64989274|FG000|Overall Study|Unable to attend future visits|1|||
23580251|NCT00797225|65853425|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
23580252|NCT00797225|65853418|FG000|Weeks 1 to 12|Sponsor Decision|1|||
23580253|NCT00797225|65853419|FG001|Weeks 1 to 12|Sponsor Decision|0|||
23174182|NCT00865020|64382401|FG001|Overall Study|Adverse Event|14|||
23452000|NCT00591006|65398868|FG012|Overall Study|Adverse Event|0|||
23580254|NCT00797225|65853420|FG002|Weeks 1 to 12|Sponsor Decision|0|||
23174183|NCT00865020|64382400|FG000|Overall Study|Abnormal test procedure result(s)|6|||
23174184|NCT00865020|64382401|FG001|Overall Study|Abnormal test procedure result(s)|8|||
23174185|NCT00865020|64382400|FG000|Overall Study|Lost to Follow-up|6|||
23174186|NCT00865020|64382401|FG001|Overall Study|Lost to Follow-up|4|||
23174187|NCT00865020|64382400|FG000|Overall Study|Protocol deviation|4|||
23580255|NCT00797225|65853421|FG003|Weeks 1 to 12|Sponsor Decision|0|||
23580256|NCT00797225|65853422|FG004|Weeks 1 to 12|Sponsor Decision|0|||
23580257|NCT00797225|65853423|FG005|Weeks 1 to 12|Sponsor Decision|0|||
23580258|NCT00797225|65853424|FG006|Weeks 1 to 12|Sponsor Decision|0|||
23580259|NCT00797225|65853425|FG007|Weeks 1 to 12|Sponsor Decision|0|||
23580260|NCT00797225|65853418|FG000|Weeks 13 to 24|Non-compliance|0|||
23580261|NCT00797225|65853419|FG001|Weeks 13 to 24|Non-compliance|2|||
23580262|NCT00797225|65853420|FG002|Weeks 13 to 24|Non-compliance|0|||
23580263|NCT00797225|65853421|FG003|Weeks 13 to 24|Non-compliance|0|||
23580264|NCT00797225|65853422|FG004|Weeks 13 to 24|Non-compliance|0|||
23580265|NCT00797225|65853423|FG005|Weeks 13 to 24|Non-compliance|0|||
23580266|NCT00797225|65853424|FG006|Weeks 13 to 24|Non-compliance|0|||
23580267|NCT00797225|65853425|FG007|Weeks 13 to 24|Non-compliance|0|||
23580268|NCT00797225|65853418|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
23580269|NCT00797225|65853419|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
23580270|NCT00797225|65853420|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
23580271|NCT00797225|65853421|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
23580272|NCT00797225|65853422|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
23580273|NCT00797225|65853423|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
23580274|NCT00797225|65853424|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
23580275|NCT00797225|65853425|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
23580276|NCT00797225|65853418|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
23580277|NCT00797225|65853419|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
23580278|NCT00797225|65853420|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
23580279|NCT00797225|65853421|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
23580280|NCT00797225|65853422|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
23580281|NCT00797225|65853423|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
23580282|NCT00797225|65853424|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
23580283|NCT00797225|65853425|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
23174188|NCT00865020|64382401|FG001|Overall Study|Protocol deviation|1|||
23174189|NCT00865020|64382400|FG000|Overall Study|Administrative problems|0|||
23174190|NCT00865020|64382401|FG001|Overall Study|Administrative problems|2|||
23174191|NCT00865020|64382400|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23174192|NCT00865020|64382401|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23174193|NCT00865020|64382400|FG000|Overall Study|Death|0|||
23174194|NCT00865020|64382401|FG001|Overall Study|Death|1|||
23174195|NCT00865020|64382400|FG000|Overall Study|Randomized but discontinued|2|||
23174196|NCT00865020|64382401|FG001|Overall Study|Randomized but discontinued|4|||
23174197|NCT00643994|64382406|FG000|Overall Study|Death|24|||
23174198|NCT00643994|64382406|FG000|Overall Study|Lost to Follow-up|72|||
23174199|NCT00946309|64382407|FG000|Overall Study|Protocol Violation|1|||
23174200|NCT00946309|64382408|FG001|Overall Study|Protocol Violation|0|||
23174201|NCT00946309|64382407|FG000|Overall Study|Lost to Follow-up|0|||
23174202|NCT00946309|64382408|FG001|Overall Study|Lost to Follow-up|1|||
23174203|NCT00946309|64382407|FG000|Overall Study|Procedure cancelled/discontinued|0|||
23174204|NCT00946309|64382408|FG001|Overall Study|Procedure cancelled/discontinued|3|||
23174205|NCT02787850|64382410|FG000|Overall Study|Withdrawal by Subject|0|||
23580284|NCT00797225|65853418|FG000|Weeks 13 to 24|Adverse Event|0|||
23174206|NCT02787850|64382411|FG001|Overall Study|Withdrawal by Subject|1|||
23174207|NCT01408147|64382415|FG000|Overall Study|Withdrawal by Subject|0|||
23174208|NCT01408147|64382416|FG001|Overall Study|Withdrawal by Subject|1|||
23174209|NCT01015833|64382417|FG000|Overall Study|Death|1|||
23174210|NCT01015833|64382418|FG001|Overall Study|Death|0|||
23174211|NCT01015833|64382417|FG000|Overall Study|Withdrawal by Subject|3|||
23174212|NCT01015833|64382418|FG001|Overall Study|Withdrawal by Subject|2|||
23174213|NCT01015833|64382417|FG000|Overall Study|Adverse Event|0|||
23174214|NCT01015833|64382418|FG001|Overall Study|Adverse Event|1|||
23174215|NCT01015833|64382417|FG000|Overall Study|Physician Decision|2|||
23174216|NCT01015833|64382418|FG001|Overall Study|Physician Decision|0|||
23174217|NCT01015833|64382417|FG000|Overall Study|Symptomatic deterioration|0|||
23174218|NCT01015833|64382418|FG001|Overall Study|Symptomatic deterioration|1|||
23174219|NCT01015833|64382417|FG000|Overall Study|Other|5|||
23174220|NCT01015833|64382418|FG001|Overall Study|Other|1|||
23174221|NCT01015833|64382417|FG000|Overall Study|Motor Vehicle Accidents|1|||
23174222|NCT01015833|64382418|FG001|Overall Study|Motor Vehicle Accidents|0|||
23580285|NCT00797225|65853419|FG001|Weeks 13 to 24|Adverse Event|1|||
23580286|NCT00797225|65853420|FG002|Weeks 13 to 24|Adverse Event|0|||
23580287|NCT00797225|65853421|FG003|Weeks 13 to 24|Adverse Event|0|||
23580288|NCT00797225|65853422|FG004|Weeks 13 to 24|Adverse Event|0|||
23580289|NCT00797225|65853423|FG005|Weeks 13 to 24|Adverse Event|0|||
23580290|NCT00797225|65853424|FG006|Weeks 13 to 24|Adverse Event|1|||
23580291|NCT00797225|65853425|FG007|Weeks 13 to 24|Adverse Event|0|||
23174223|NCT01015833|64382417|FG000|Overall Study|Did not start treatment|1|||
23174224|NCT01015833|64382418|FG001|Overall Study|Did not start treatment|0|||
23174225|NCT04823949|64382419|FG000|Overall Study|Withdrawal by Subject|0|||
23174226|NCT04823949|64382420|FG001|Overall Study|Withdrawal by Subject|4|||
23174227|NCT04823949|64382419|FG000|Overall Study|Physician Decision|0|||
23174228|NCT04823949|64382420|FG001|Overall Study|Physician Decision|1|||
23174229|NCT00440726|64382428|FG000|Phase 1|Dose-Limiting Toxicity|0|||
23174230|NCT00440726|64382429|FG001|Phase 1|Dose-Limiting Toxicity|1|||
23174231|NCT00440726|64382430|FG002|Phase 1|Dose-Limiting Toxicity|0|||
23174232|NCT00440726|64382428|FG000|Phase 1|Physician Decision|1|||
23174233|NCT00440726|64382429|FG001|Phase 1|Physician Decision|0|||
23174234|NCT00440726|64382430|FG002|Phase 1|Physician Decision|0|||
23174235|NCT00440726|64382428|FG000|Phase 2|Death|0|||
23174236|NCT00440726|64382429|FG001|Phase 2|Death|0|||
23174237|NCT00440726|64382430|FG002|Phase 2|Death|1|||
23174238|NCT00440726|64382428|FG000|Phase 2|Adverse Event|0|||
23174239|NCT00440726|64382429|FG001|Phase 2|Adverse Event|0|||
23174240|NCT00440726|64382430|FG002|Phase 2|Adverse Event|1|||
23174241|NCT00756938|64382433|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
23174242|NCT00756938|64382434|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
23174243|NCT00756938|64382435|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
23174244|NCT00756938|64382436|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
23174245|NCT00756938|64382433|FG000|12-week Base Study|Protocol Violation|0|||
23174246|NCT00756938|64382434|FG001|12-week Base Study|Protocol Violation|0|||
23174247|NCT00756938|64382435|FG002|12-week Base Study|Protocol Violation|1|||
23174248|NCT00756938|64382436|FG003|12-week Base Study|Protocol Violation|0|||
23174249|NCT00756938|64382433|FG000|12-week Base Study|Lost to Follow-up|1|||
23174250|NCT00756938|64382434|FG001|12-week Base Study|Lost to Follow-up|0|||
23174251|NCT00756938|64382435|FG002|12-week Base Study|Lost to Follow-up|0|||
23174252|NCT00756938|64382436|FG003|12-week Base Study|Lost to Follow-up|0|||
23174253|NCT00756938|64382433|FG000|Optional Extension|Lack of Efficacy|0|||
23174254|NCT00756938|64382434|FG001|Optional Extension|Lack of Efficacy|0|||
23174255|NCT00756938|64382435|FG002|Optional Extension|Lack of Efficacy|0|||
23174256|NCT00756938|64382436|FG003|Optional Extension|Lack of Efficacy|1|||
23174257|NCT00756938|64382433|FG000|Optional Extension|End of Study|0|||
23174258|NCT00756938|64382434|FG001|Optional Extension|End of Study|0|||
23174259|NCT00756938|64382435|FG002|Optional Extension|End of Study|0|||
23174260|NCT00756938|64382436|FG003|Optional Extension|End of Study|11|||
23580292|NCT00797225|65853418|FG000|Weeks 13 to 24|Sponsor Decision|0|||
23580293|NCT00797225|65853419|FG001|Weeks 13 to 24|Sponsor Decision|0|||
23580294|NCT00797225|65853420|FG002|Weeks 13 to 24|Sponsor Decision|0|||
23580295|NCT00797225|65853421|FG003|Weeks 13 to 24|Sponsor Decision|0|||
23580296|NCT00797225|65853422|FG004|Weeks 13 to 24|Sponsor Decision|0|||
23580297|NCT00797225|65853423|FG005|Weeks 13 to 24|Sponsor Decision|0|||
23580298|NCT00797225|65853424|FG006|Weeks 13 to 24|Sponsor Decision|1|||
23580299|NCT00797225|65853425|FG007|Weeks 13 to 24|Sponsor Decision|0|||
23580300|NCT00795132|65853427|FG000|Overall Study|Death|1|||
23580301|NCT00795132|65853427|FG000|Overall Study|Relapse|2|||
23580302|NCT01304147|65853429|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
23580303|NCT01304147|65853430|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
23580304|NCT04226495|65853431|FG000|Overall Study|Withdrawal by Subject|3|||
23580305|NCT04226495|65853432|FG001|Overall Study|Withdrawal by Subject|3|||
23580306|NCT04226495|65853431|FG000|Overall Study|PI discretion|2|||
23580307|NCT04226495|65853432|FG001|Overall Study|PI discretion|4|||
23580308|NCT04939428|65853433|FG000|Overall Study|Death|0|||
23580309|NCT04939428|65853434|FG001|Overall Study|Death|1|||
23580310|NCT04939428|65853435|FG002|Overall Study|Death|0|||
23580311|NCT04939428|65853433|FG000|Overall Study|Lost to Follow-up|0|||
23174261|NCT00756938|64382433|FG000|Optional Extension|Protocol-specific criteria met|0|||
23174262|NCT00756938|64382434|FG001|Optional Extension|Protocol-specific criteria met|0|||
23174263|NCT00756938|64382435|FG002|Optional Extension|Protocol-specific criteria met|0|||
23174264|NCT00756938|64382436|FG003|Optional Extension|Protocol-specific criteria met|9|||
23174265|NCT00756938|64382433|FG000|Optional Extension|Physician Decision|0|||
23174266|NCT00756938|64382434|FG001|Optional Extension|Physician Decision|0|||
23174267|NCT00756938|64382435|FG002|Optional Extension|Physician Decision|0|||
23174268|NCT00756938|64382436|FG003|Optional Extension|Physician Decision|3|||
23174269|NCT00756938|64382433|FG000|Optional Extension|Lost to Follow-up|0|||
23174270|NCT00756938|64382434|FG001|Optional Extension|Lost to Follow-up|0|||
23174271|NCT00756938|64382435|FG002|Optional Extension|Lost to Follow-up|0|||
23174272|NCT00756938|64382436|FG003|Optional Extension|Lost to Follow-up|1|||
23174273|NCT00756938|64382433|FG000|Optional Extension|Protocol Violation|0|||
23339816|NCT02004886|64989275|FG001|Overall Study|Unable to attend future visits|0|||
23580312|NCT04939428|65853434|FG001|Overall Study|Lost to Follow-up|5|||
23580313|NCT04939428|65853435|FG002|Overall Study|Lost to Follow-up|0|||
23580314|NCT04939428|65853433|FG000|Overall Study|Physician Decision|1|||
23580315|NCT04939428|65853434|FG001|Overall Study|Physician Decision|0|||
23580316|NCT04939428|65853435|FG002|Overall Study|Physician Decision|0|||
23174274|NCT00756938|64382434|FG001|Optional Extension|Protocol Violation|0|||
23174275|NCT00756938|64382435|FG002|Optional Extension|Protocol Violation|0|||
23174276|NCT00756938|64382436|FG003|Optional Extension|Protocol Violation|1|||
23580317|NCT04939428|65853433|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
23580318|NCT04939428|65853434|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23580319|NCT04939428|65853435|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23580320|NCT04939428|65853433|FG000|Overall Study|Withdrawal by Subject|10|||
23580321|NCT04939428|65853434|FG001|Overall Study|Withdrawal by Subject|11|||
23580322|NCT04939428|65853435|FG002|Overall Study|Withdrawal by Subject|0|||
23174277|NCT00756938|64382433|FG000|Optional Extension|Withdrawal by Subject|0|||
23174278|NCT00756938|64382434|FG001|Optional Extension|Withdrawal by Subject|0|||
23174279|NCT00756938|64382435|FG002|Optional Extension|Withdrawal by Subject|0|||
23174280|NCT00756938|64382436|FG003|Optional Extension|Withdrawal by Subject|10|||
23174281|NCT00756938|64382433|FG000|Optional Extension|Adverse Event|0|||
23174282|NCT00756938|64382434|FG001|Optional Extension|Adverse Event|0|||
23174283|NCT00756938|64382435|FG002|Optional Extension|Adverse Event|0|||
23174284|NCT00756938|64382436|FG003|Optional Extension|Adverse Event|1|||
23174285|NCT02026063|64382442|FG000|Overall Study|Physician Decision|0|||
23174286|NCT02026063|64382443|FG001|Overall Study|Physician Decision|10|||
23580323|NCT04939428|65853433|FG000|Overall Study|Unkown|6|||
23174287|NCT02026063|64382442|FG000|Overall Study|Noncompliance with Study Drug|1|||
23174288|NCT02026063|64382443|FG001|Overall Study|Noncompliance with Study Drug|1|||
23174289|NCT02026063|64382442|FG000|Overall Study|Withdrawal of Consent|1|||
23174290|NCT02026063|64382443|FG001|Overall Study|Withdrawal of Consent|6|||
23174291|NCT02026063|64382442|FG000|Overall Study|Adverse Event|5|||
23174292|NCT02026063|64382443|FG001|Overall Study|Adverse Event|20|||
23174293|NCT02026063|64382442|FG000|Overall Study|Lack of Efficacy|0|||
23174294|NCT02026063|64382443|FG001|Overall Study|Lack of Efficacy|4|||
23174295|NCT02026063|64382442|FG000|Overall Study|Lost to Follow-up|0|||
23174296|NCT02026063|64382443|FG001|Overall Study|Lost to Follow-up|1|||
23174297|NCT02026063|64382442|FG000|Overall Study|Reason not Specified|2|||
23174298|NCT02026063|64382443|FG001|Overall Study|Reason not Specified|7|||
23174299|NCT01613326|64382446|FG000|Overall Study|Adverse Event|7|||
23174300|NCT01613326|64382447|FG001|Overall Study|Adverse Event|5|||
23174301|NCT01613326|64382446|FG000|Overall Study|Withdrawal by Subject|3|||
23174302|NCT01613326|64382447|FG001|Overall Study|Withdrawal by Subject|4|||
23174303|NCT01613326|64382446|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23174304|NCT01613326|64382447|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23174305|NCT01613326|64382446|FG000|Overall Study|inability to use device|1|||
23174306|NCT01613326|64382447|FG001|Overall Study|inability to use device|0|||
23174307|NCT01613326|64382446|FG000|Overall Study|Lack of Efficacy|0|||
23174308|NCT01613326|64382447|FG001|Overall Study|Lack of Efficacy|1|||
23174309|NCT01613326|64382446|FG000|Overall Study|Lost to Follow-up|0|||
23174310|NCT01613326|64382447|FG001|Overall Study|Lost to Follow-up|1|||
23174311|NCT01613326|64382446|FG000|Overall Study|Administrative|0|||
23174312|NCT01613326|64382447|FG001|Overall Study|Administrative|2|||
23174313|NCT01613326|64382446|FG000|Overall Study|Protocol Violation|0|||
23174314|NCT01613326|64382447|FG001|Overall Study|Protocol Violation|1|||
23174315|NCT00132041|64382448|FG000|Baseline|Ineligible|6|||
23174316|NCT00132041|64382448|FG000|3 Months Post Ablation|Transplant|1|||
23174317|NCT00132041|64382448|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
23174318|NCT00132041|64382448|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
23174319|NCT00132041|64382448|FG000|6 Months Post Ablation|Death|2|||
23174320|NCT00132041|64382448|FG000|6 Months Post Ablation|Transplant|6|||
23174321|NCT00132041|64382448|FG000|9 Months Post Ablation|Death|1|||
23174322|NCT00132041|64382448|FG000|9 Months Post Ablation|Transplant|1|||
23174323|NCT00132041|64382448|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
23174324|NCT00132041|64382448|FG000|12 Months Post Ablation|Death|1|||
23174325|NCT00132041|64382448|FG000|12 Months Post Ablation|Transplant|1|||
23174326|NCT00132041|64382448|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
23174327|NCT00132041|64382448|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
23233861|NCT00364351|64600590|FG001|Overall Study|Incorrect enrollment|1|||
23233862|NCT00364351|64600589|FG000|Overall Study|Sponsor decision|1|||
23233863|NCT00364351|64600590|FG001|Overall Study|Sponsor decision|0|||
23233864|NCT00364351|64600589|FG000|Overall Study|Poor treatment compliance|0|||
23580324|NCT04939428|65853434|FG001|Overall Study|Unkown|3|||
23580325|NCT04939428|65853435|FG002|Overall Study|Unkown|0|||
23580326|NCT04939428|65853433|FG000|Overall Study|Discotinued per protocol|0|||
23580327|NCT04939428|65853434|FG001|Overall Study|Discotinued per protocol|0|||
23174328|NCT00132041|64382448|FG000|15 Months Post Ablation|Death|1|||
23174329|NCT00132041|64382448|FG000|15 Months Post Ablation|Transplant|5|||
23174330|NCT00132041|64382448|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
23174331|NCT00132041|64382448|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
23174332|NCT00132041|64382448|FG000|18 Months Post Ablation|Transplant|1|||
23174333|NCT00132041|64382448|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
23233865|NCT00364351|64600590|FG001|Overall Study|Poor treatment compliance|3|||
23174334|NCT00132041|64382448|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
23174335|NCT00379795|64382449|FG000|Overall Study|Death|31|||
23174336|NCT00379795|64382450|FG001|Overall Study|Death|8|||
23580328|NCT04939428|65853435|FG002|Overall Study|Discotinued per protocol|902|||
23174337|NCT00379795|64382451|FG002|Overall Study|Death|6|||
23233866|NCT00364351|64600589|FG000|Overall Study|Investigator error|0|||
23233867|NCT00364351|64600590|FG001|Overall Study|Investigator error|2|||
23233868|NCT00364351|64600589|FG000|Overall Study|Patient could not travel to site|0|||
23233869|NCT00364351|64600590|FG001|Overall Study|Patient could not travel to site|1|||
23233870|NCT00364351|64600589|FG000|Overall Study|Randomised treatment not started|0|||
23233871|NCT00364351|64600590|FG001|Overall Study|Randomised treatment not started|3|||
23580329|NCT03085017|65853438|FG000|Overall Study|Death|0|||
23580330|NCT03085017|65853439|FG001|Overall Study|Death|3|||
23580331|NCT00498186|65853440|FG000|Overall Study|Protocol Violation|10|||
23580332|NCT00498186|65853440|FG000|Overall Study|Lack of Efficacy|31|||
23580333|NCT00498186|65853440|FG000|Overall Study|Adverse Event|89|||
23580334|NCT00498186|65853440|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
23580335|NCT00498186|65853440|FG000|Overall Study|Withdrawal by Subject|18|||
23580336|NCT00498186|65853440|FG000|Overall Study|Lost to Follow-up|3|||
23580337|NCT00498186|65853440|FG000|Overall Study|Other|10|||
23580338|NCT05349084|65853441|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
23580339|NCT00630539|65853442|FG000|Overall Study|Adverse Event|1|||
23174338|NCT00379795|64382452|FG003|Overall Study|Death|4|||
23174339|NCT00379795|64382453|FG004|Overall Study|Death|7|||
23174340|NCT00379795|64382449|FG000|Overall Study|Adverse Event|17|||
23174341|NCT00379795|64382450|FG001|Overall Study|Adverse Event|3|||
23174342|NCT00379795|64382451|FG002|Overall Study|Adverse Event|3|||
23174343|NCT00379795|64382452|FG003|Overall Study|Adverse Event|1|||
23174344|NCT00379795|64382453|FG004|Overall Study|Adverse Event|4|||
23174345|NCT00379795|64382449|FG000|Overall Study|Lost to Follow-up|8|||
23174346|NCT00379795|64382450|FG001|Overall Study|Lost to Follow-up|1|||
23174347|NCT00379795|64382451|FG002|Overall Study|Lost to Follow-up|2|||
23174348|NCT00379795|64382452|FG003|Overall Study|Lost to Follow-up|1|||
23174349|NCT00379795|64382453|FG004|Overall Study|Lost to Follow-up|4|||
23174350|NCT00379795|64382449|FG000|Overall Study|Physician Decision|25|||
23174351|NCT00379795|64382450|FG001|Overall Study|Physician Decision|0|||
23174352|NCT00379795|64382451|FG002|Overall Study|Physician Decision|2|||
23174353|NCT00379795|64382452|FG003|Overall Study|Physician Decision|2|||
23174354|NCT00379795|64382453|FG004|Overall Study|Physician Decision|2|||
23174355|NCT00379795|64382449|FG000|Overall Study|Withdrawal by Subject|94|||
23174356|NCT00379795|64382450|FG001|Overall Study|Withdrawal by Subject|11|||
23174357|NCT00379795|64382451|FG002|Overall Study|Withdrawal by Subject|19|||
23174358|NCT00379795|64382452|FG003|Overall Study|Withdrawal by Subject|7|||
23174359|NCT00379795|64382453|FG004|Overall Study|Withdrawal by Subject|14|||
23174360|NCT00379795|64382449|FG000|Overall Study|Subject non-compliance|7|||
23174361|NCT00379795|64382450|FG001|Overall Study|Subject non-compliance|2|||
23174362|NCT00379795|64382451|FG002|Overall Study|Subject non-compliance|0|||
23174363|NCT00379795|64382452|FG003|Overall Study|Subject non-compliance|0|||
23174364|NCT00379795|64382453|FG004|Overall Study|Subject non-compliance|1|||
23174365|NCT00379795|64382449|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
23174366|NCT00379795|64382450|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
23174367|NCT00379795|64382451|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
23174368|NCT00379795|64382452|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
23174369|NCT00379795|64382453|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
23174370|NCT00379795|64382449|FG000|Overall Study|Subjects condition mandated intervention|34|||
23174371|NCT00379795|64382450|FG001|Overall Study|Subjects condition mandated intervention|9|||
23174372|NCT00379795|64382451|FG002|Overall Study|Subjects condition mandated intervention|7|||
23174373|NCT00379795|64382452|FG003|Overall Study|Subjects condition mandated intervention|5|||
23174374|NCT00379795|64382453|FG004|Overall Study|Subjects condition mandated intervention|7|||
23174375|NCT00379795|64382449|FG000|Overall Study|Sponsor's decision|257|||
23174376|NCT00379795|64382450|FG001|Overall Study|Sponsor's decision|17|||
23174377|NCT00379795|64382451|FG002|Overall Study|Sponsor's decision|54|||
23174378|NCT00379795|64382452|FG003|Overall Study|Sponsor's decision|47|||
23174379|NCT00379795|64382453|FG004|Overall Study|Sponsor's decision|10|||
23174380|NCT01791855|64382455|FG000|Overall Study|Adverse Event|0|||
23174381|NCT01791855|64382456|FG001|Overall Study|Adverse Event|0|||
23174382|NCT01791855|64382457|FG002|Overall Study|Adverse Event|0|||
23174383|NCT01791855|64382458|FG003|Overall Study|Adverse Event|1|||
23174384|NCT01791855|64382455|FG000|Overall Study|Randomized, not treated|0|||
23233872|NCT00106626|64600591|FG000|Overall Study|Adverse Event|5|||
23339817|NCT02004886|64989276|FG002|Overall Study|Unable to attend future visits|0|||
23174385|NCT01791855|64382456|FG001|Overall Study|Randomized, not treated|1|||
23174386|NCT01791855|64382457|FG002|Overall Study|Randomized, not treated|0|||
23174387|NCT01791855|64382458|FG003|Overall Study|Randomized, not treated|0|||
23174388|NCT03682120|64382459|FG000|Overall Study|Lost to Follow-up|11|||
23174389|NCT03682120|64382460|FG001|Overall Study|Lost to Follow-up|4|||
23174390|NCT03682120|64382461|FG002|Overall Study|Lost to Follow-up|5|||
23174391|NCT03682120|64382462|FG003|Overall Study|Lost to Follow-up|2|||
23580340|NCT00630539|65853443|FG001|Overall Study|Adverse Event|3|||
23233873|NCT00106626|64600592|FG001|Overall Study|Adverse Event|4|||
23339818|NCT02004886|64989277|FG003|Overall Study|Unable to attend future visits|0|||
23339819|NCT01598090|64989279|FG000|Treatment Period|Poor/non-compliance|0|||
23339820|NCT01598090|64989280|FG001|Treatment Period|Poor/non-compliance|2|||
23339821|NCT01598090|64989281|FG002|Treatment Period|Poor/non-compliance|0|||
23339822|NCT01598090|64989279|FG000|Treatment Period|No longer meet study criteria|0|||
23339823|NCT01598090|64989280|FG001|Treatment Period|No longer meet study criteria|1|||
23174392|NCT03682120|64382459|FG000|Overall Study|Physician Decision|1|||
23174393|NCT03682120|64382460|FG001|Overall Study|Physician Decision|0|||
23174394|NCT03682120|64382461|FG002|Overall Study|Physician Decision|0|||
23174395|NCT03682120|64382462|FG003|Overall Study|Physician Decision|0|||
23174396|NCT03682120|64382459|FG000|Overall Study|Withdrawal by Subject|1|||
23174397|NCT03682120|64382460|FG001|Overall Study|Withdrawal by Subject|2|||
23174398|NCT03682120|64382461|FG002|Overall Study|Withdrawal by Subject|3|||
23174399|NCT03682120|64382462|FG003|Overall Study|Withdrawal by Subject|0|||
23233874|NCT00106626|64600593|FG002|Overall Study|Adverse Event|3|||
23233875|NCT00106626|64600594|FG003|Overall Study|Adverse Event|3|||
23233876|NCT00106626|64600591|FG000|Overall Study|Progressive Disease|4|||
23339824|NCT01598090|64989281|FG002|Treatment Period|No longer meet study criteria|0|||
23339825|NCT01598090|64989279|FG000|Treatment Period|Lack of Efficacy|5|||
23339826|NCT01598090|64989280|FG001|Treatment Period|Lack of Efficacy|14|||
23452001|NCT00591006|65398869|FG013|Overall Study|Adverse Event|0|||
23339827|NCT01598090|64989281|FG002|Treatment Period|Lack of Efficacy|6|||
23339828|NCT01598090|64989279|FG000|Treatment Period|Adverse Event|2|||
23339829|NCT01598090|64989280|FG001|Treatment Period|Adverse Event|33|||
23339830|NCT01598090|64989281|FG002|Treatment Period|Adverse Event|17|||
23339831|NCT01598090|64989279|FG000|Treatment Period|Other reasons|0|||
23339832|NCT01598090|64989280|FG001|Treatment Period|Other reasons|4|||
23339833|NCT01598090|64989281|FG002|Treatment Period|Other reasons|1|||
23339834|NCT01598090|64989279|FG000|Treatment Period|Withdrawal by Subject|3|||
23339835|NCT01598090|64989280|FG001|Treatment Period|Withdrawal by Subject|13|||
23339836|NCT01598090|64989281|FG002|Treatment Period|Withdrawal by Subject|10|||
23339837|NCT01598090|64989279|FG000|Treatment Period|Lost to Follow-up|1|||
23339838|NCT01598090|64989280|FG001|Treatment Period|Lost to Follow-up|5|||
23339839|NCT01598090|64989281|FG002|Treatment Period|Lost to Follow-up|1|||
23339840|NCT01598090|64989279|FG000|Follow-up Period|Death|0|||
23339841|NCT01598090|64989280|FG001|Follow-up Period|Death|1|||
23339842|NCT01598090|64989281|FG002|Follow-up Period|Death|0|||
23339843|NCT01598090|64989279|FG000|Follow-up Period|No longer required per protocol|1|||
23339844|NCT01598090|64989280|FG001|Follow-up Period|No longer required per protocol|3|||
23339845|NCT01598090|64989281|FG002|Follow-up Period|No longer required per protocol|2|||
23339846|NCT01598090|64989279|FG000|Follow-up Period|Not reported|0|||
23339847|NCT01598090|64989280|FG001|Follow-up Period|Not reported|10|||
23339848|NCT01598090|64989281|FG002|Follow-up Period|Not reported|4|||
23339849|NCT01598090|64989279|FG000|Follow-up Period|Withdrawal by Subject|0|||
23339850|NCT01598090|64989280|FG001|Follow-up Period|Withdrawal by Subject|3|||
23339851|NCT01598090|64989281|FG002|Follow-up Period|Withdrawal by Subject|2|||
23339852|NCT01598090|64989279|FG000|Follow-up Period|Other reasons|2|||
23339853|NCT01598090|64989280|FG001|Follow-up Period|Other reasons|8|||
23339854|NCT01598090|64989281|FG002|Follow-up Period|Other reasons|8|||
23339855|NCT01598090|64989279|FG000|Follow-up Period|Lost to Follow-up|2|||
23339856|NCT01598090|64989280|FG001|Follow-up Period|Lost to Follow-up|10|||
23339857|NCT01598090|64989281|FG002|Follow-up Period|Lost to Follow-up|12|||
23339858|NCT02163447|64989296|FG000|Overall Study|Withdrawal by Subject|2|||
23339859|NCT02163447|64989297|FG001|Overall Study|Withdrawal by Subject|0|||
23339860|NCT02163447|64989298|FG002|Overall Study|Withdrawal by Subject|1|||
23339861|NCT02163447|64989296|FG000|Overall Study|Lost to Follow-up|1|||
23339862|NCT02163447|64989297|FG001|Overall Study|Lost to Follow-up|3|||
23452002|NCT00591006|65398870|FG014|Overall Study|Adverse Event|0|||
23233877|NCT00106626|64600592|FG001|Overall Study|Progressive Disease|1|||
23233878|NCT00106626|64600593|FG002|Overall Study|Progressive Disease|9|||
23233879|NCT00106626|64600594|FG003|Overall Study|Progressive Disease|10|||
23233880|NCT00106626|64600591|FG000|Overall Study|Received radiation on new therapy|1|||
23233881|NCT00106626|64600592|FG001|Overall Study|Received radiation on new therapy|0|||
23233882|NCT00106626|64600593|FG002|Overall Study|Received radiation on new therapy|0|||
23233883|NCT00106626|64600594|FG003|Overall Study|Received radiation on new therapy|0|||
23233884|NCT00106626|64600591|FG000|Overall Study|> 14 day delay in therapy start|0|||
23233885|NCT00106626|64600592|FG001|Overall Study|> 14 day delay in therapy start|1|||
23452003|NCT00591006|65398871|FG015|Overall Study|Adverse Event|0|||
23452004|NCT00591006|65398872|FG016|Overall Study|Adverse Event|0|||
23174400|NCT03682120|64382459|FG000|Overall Study|Death|0|||
23233886|NCT00106626|64600593|FG002|Overall Study|> 14 day delay in therapy start|0|||
23233887|NCT00106626|64600594|FG003|Overall Study|> 14 day delay in therapy start|0|||
23233888|NCT00422942|64600598|FG000|Overall Study|Study terminated by Sponsor|3|||
23339863|NCT02163447|64989298|FG002|Overall Study|Lost to Follow-up|0|||
23339864|NCT02163447|64989296|FG000|Overall Study|Moved out of study area|2|||
23339865|NCT02163447|64989297|FG001|Overall Study|Moved out of study area|3|||
23174401|NCT03682120|64382460|FG001|Overall Study|Death|1|||
23339866|NCT02163447|64989298|FG002|Overall Study|Moved out of study area|2|||
23339867|NCT02163447|64989296|FG000|Overall Study|Became HIV infected at time of delivery|1|||
23339868|NCT02163447|64989297|FG001|Overall Study|Became HIV infected at time of delivery|0|||
23339869|NCT02163447|64989298|FG002|Overall Study|Became HIV infected at time of delivery|0|||
23339870|NCT02751450|64989302|FG000|Overall Study|Adverse Event|1|||
23339871|NCT02751450|64989303|FG001|Overall Study|Adverse Event|0|||
23339872|NCT01704651|64989305|FG000|Overall Study|Pre-op withdrawal by subject|1|||
23339873|NCT01704651|64989306|FG001|Overall Study|Pre-op withdrawal by subject|1|||
23339874|NCT01704651|64989305|FG000|Overall Study|Pre-op change in treatment plan|1|||
23339875|NCT01704651|64989306|FG001|Overall Study|Pre-op change in treatment plan|4|||
23339876|NCT01704651|64989305|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
23339877|NCT01704651|64989306|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
23339878|NCT01704651|64989305|FG000|Overall Study|Post-op did not have laparotomy|2|||
23339879|NCT01704651|64989306|FG001|Overall Study|Post-op did not have laparotomy|1|||
23339880|NCT02828124|64989307|FG000|Overall Study|Disease Progression|1|||
23339881|NCT02828124|64989308|FG001|Overall Study|Disease Progression|2|||
23339882|NCT02828124|64989309|FG002|Overall Study|Disease Progression|1|||
23339883|NCT02828124|64989310|FG003|Overall Study|Disease Progression|4|||
23339884|NCT02828124|64989307|FG000|Overall Study|AE Unrelated to Study Drug|0|||
23339885|NCT02828124|64989308|FG001|Overall Study|AE Unrelated to Study Drug|0|||
23339886|NCT02828124|64989309|FG002|Overall Study|AE Unrelated to Study Drug|0|||
23339887|NCT02828124|64989310|FG003|Overall Study|AE Unrelated to Study Drug|1|||
23339888|NCT02828124|64989307|FG000|Overall Study|Subject Withdrew Consent|0|||
23339889|NCT02828124|64989308|FG001|Overall Study|Subject Withdrew Consent|0|||
23339890|NCT02828124|64989309|FG002|Overall Study|Subject Withdrew Consent|0|||
23339891|NCT02828124|64989310|FG003|Overall Study|Subject Withdrew Consent|1|||
23339892|NCT01438294|64989313|FG000|Overall Study|Lost to Follow-up|3|||
23339893|NCT01438294|64989314|FG001|Overall Study|Lost to Follow-up|7|||
23339894|NCT00956592|64989323|FG000|Overall Study|Protocol Violation|1|||
23339895|NCT00956592|64989324|FG001|Overall Study|Protocol Violation|3|||
23339896|NCT02005692|64989332|FG000|Overall Study|Protocol Violation|1|||
23339897|NCT02005692|64989332|FG000|Overall Study|Withdrawal by Subject|1|||
23339898|NCT02005692|64989332|FG000|Overall Study|Discharged earlier than anticipated|5|||
23339899|NCT04413552|64989333|FG000|Overall Study|Adverse Event|0|||
23339900|NCT04413552|64989334|FG001|Overall Study|Adverse Event|0|||
23339901|NCT04413552|64989335|FG002|Overall Study|Adverse Event|0|||
23339902|NCT04413552|64989336|FG003|Overall Study|Adverse Event|0|||
23339903|NCT04413552|64989337|FG004|Overall Study|Adverse Event|0|||
23339904|NCT04413552|64989338|FG005|Overall Study|Adverse Event|0|||
23339905|NCT04413552|64989339|FG006|Overall Study|Adverse Event|1|||
23339906|NCT04413552|64989340|FG007|Overall Study|Adverse Event|0|||
23339907|NCT04413552|64989341|FG008|Overall Study|Adverse Event|0|||
23339908|NCT04413552|64989342|FG009|Overall Study|Adverse Event|0|||
23339909|NCT01925131|64989345|FG000|Overall Study|Death|0|||
23339910|NCT01925131|64989346|FG001|Overall Study|Death|0|||
23339911|NCT01925131|64989347|FG002|Overall Study|Death|1|||
23339912|NCT01925131|64989348|FG003|Overall Study|Death|0|||
23339913|NCT01925131|64989349|FG004|Overall Study|Death|0|||
23339914|NCT01925131|64989350|FG005|Overall Study|Death|0|||
23339915|NCT01925131|64989345|FG000|Overall Study|Progression/Relapse|1|||
23339916|NCT01925131|64989346|FG001|Overall Study|Progression/Relapse|1|||
23339917|NCT01925131|64989347|FG002|Overall Study|Progression/Relapse|4|||
23339918|NCT01925131|64989348|FG003|Overall Study|Progression/Relapse|0|||
23339919|NCT01925131|64989349|FG004|Overall Study|Progression/Relapse|0|||
23339920|NCT01925131|64989350|FG005|Overall Study|Progression/Relapse|1|||
23339921|NCT01925131|64989345|FG000|Overall Study|Patient Refusal|1|||
23339922|NCT01925131|64989346|FG001|Overall Study|Patient Refusal|0|||
23339923|NCT01925131|64989347|FG002|Overall Study|Patient Refusal|0|||
23339924|NCT01925131|64989348|FG003|Overall Study|Patient Refusal|0|||
23452005|NCT00591006|65398873|FG017|Overall Study|Adverse Event|0|||
23580341|NCT00630539|65853444|FG002|Overall Study|Adverse Event|1|||
23580342|NCT00630539|65853445|FG003|Overall Study|Adverse Event|2|||
23580343|NCT00630539|65853442|FG000|Overall Study|Withdrawal by Subject|0|||
23339925|NCT01925131|64989349|FG004|Overall Study|Patient Refusal|0|||
23339926|NCT01925131|64989350|FG005|Overall Study|Patient Refusal|0|||
23339927|NCT01925131|64989345|FG000|Overall Study|Adverse Event|0|||
23339928|NCT01925131|64989346|FG001|Overall Study|Adverse Event|0|||
23339929|NCT01925131|64989347|FG002|Overall Study|Adverse Event|2|||
23339930|NCT01925131|64989348|FG003|Overall Study|Adverse Event|0|||
23580344|NCT00630539|65853443|FG001|Overall Study|Withdrawal by Subject|1|||
23339931|NCT01925131|64989349|FG004|Overall Study|Adverse Event|1|||
23339932|NCT01925131|64989350|FG005|Overall Study|Adverse Event|3|||
23339933|NCT01925131|64989345|FG000|Overall Study|Other - Not Protocol Specified|3|||
23339934|NCT01925131|64989346|FG001|Overall Study|Other - Not Protocol Specified|1|||
23339935|NCT01925131|64989347|FG002|Overall Study|Other - Not Protocol Specified|2|||
23339936|NCT01925131|64989348|FG003|Overall Study|Other - Not Protocol Specified|5|||
23339937|NCT01925131|64989349|FG004|Overall Study|Other - Not Protocol Specified|10|||
23580345|NCT00630539|65853444|FG002|Overall Study|Withdrawal by Subject|0|||
23339938|NCT01925131|64989350|FG005|Overall Study|Other - Not Protocol Specified|6|||
23339939|NCT03919695|64989352|FG000|3-month Follow-up|Death|1|||
23339940|NCT03919695|64989353|FG001|3-month Follow-up|Death|1|||
23339941|NCT03919695|64989352|FG000|3-month Follow-up|unable to contact|0|||
23339942|NCT03919695|64989353|FG001|3-month Follow-up|unable to contact|3|||
23339943|NCT03919695|64989352|FG000|3-month Follow-up|in prison|0|||
23339944|NCT03919695|64989353|FG001|3-month Follow-up|in prison|1|||
23339945|NCT03919695|64989352|FG000|6-month Follow-up|Death|0|||
23339946|NCT03919695|64989353|FG001|6-month Follow-up|Death|1|||
23339947|NCT03919695|64989352|FG000|6-month Follow-up|Lost to Follow-up|1|||
23339948|NCT03919695|64989353|FG001|6-month Follow-up|Lost to Follow-up|2|||
23339949|NCT03919695|64989352|FG000|6-month Follow-up|in prison|0|||
23339950|NCT03919695|64989353|FG001|6-month Follow-up|in prison|2|||
23339951|NCT03919695|64989352|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
23339952|NCT03919695|64989353|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
23339953|NCT03919695|64989352|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
23339954|NCT03919695|64989353|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
23339955|NCT02320058|64989363|FG000|Overall Study|Death|25|||
23339956|NCT02320058|64989364|FG001|Overall Study|Death|10|||
23339957|NCT02320058|64989363|FG000|Overall Study|Lost to Follow-up|4|||
23339958|NCT02320058|64989364|FG001|Overall Study|Lost to Follow-up|0|||
23339959|NCT02320058|64989363|FG000|Overall Study|Other reasons|4|||
23339960|NCT02320058|64989364|FG001|Overall Study|Other reasons|1|||
23339961|NCT02320058|64989363|FG000|Overall Study|Withdrawal by Subject|8|||
23339962|NCT02320058|64989364|FG001|Overall Study|Withdrawal by Subject|2|||
23339963|NCT02320058|64989363|FG000|Overall Study|Not reported|1|||
23339964|NCT02320058|64989364|FG001|Overall Study|Not reported|0|||
23339965|NCT03033602|64989367|FG000|Overall Study|Withdrawal by Subject|11|||
23339966|NCT03033602|64989368|FG001|Overall Study|Withdrawal by Subject|21|||
23339967|NCT03033602|64989367|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
23339968|NCT03033602|64989368|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
23339969|NCT02659514|64989369|FG000|Overall Study|Adverse Event|3|||
23339970|NCT02659514|64989370|FG001|Overall Study|Adverse Event|12|||
23339971|NCT02659514|64989369|FG000|Overall Study|Disease Progression|23|||
23339972|NCT02659514|64989370|FG001|Overall Study|Disease Progression|13|||
23339973|NCT02659514|64989369|FG000|Overall Study|Withdrawal by Subject|0|||
23339974|NCT02659514|64989370|FG001|Overall Study|Withdrawal by Subject|4|||
23339975|NCT02659514|64989369|FG000|Overall Study|Lost to Follow-up|0|||
23339976|NCT02659514|64989370|FG001|Overall Study|Lost to Follow-up|1|||
23339977|NCT02659514|64989369|FG000|Overall Study|Death|6|||
23339978|NCT02659514|64989370|FG001|Overall Study|Death|1|||
23339979|NCT02659514|64989369|FG000|Overall Study|Reason Unspecified|0|||
23339980|NCT02659514|64989370|FG001|Overall Study|Reason Unspecified|3|||
23339981|NCT00160706|64989373|FG000|Overall Study|Adverse Event|53|||
23339982|NCT00160706|64989373|FG000|Overall Study|Adverse Event and Other Reason|105|||
23339983|NCT00160706|64989373|FG000|Overall Study|Protocol Violation|3|||
23339984|NCT00160706|64989373|FG000|Overall Study|Withdrawal by Subject|41|||
23339985|NCT00160706|64989373|FG000|Overall Study|Withdrawal by Subject and Other|12|||
23339986|NCT00160706|64989373|FG000|Overall Study|Physician Decision|10|||
23339987|NCT00160706|64989373|FG000|Overall Study|Physician Decision and Other|3|||
23339988|NCT00160706|64989373|FG000|Overall Study|Lost to Follow-up|4|||
23339989|NCT00160706|64989373|FG000|Overall Study|Lost to Follow-up and Other|1|||
23339990|NCT00160706|64989373|FG000|Overall Study|Lack of Efficacy|42|||
23339991|NCT00160706|64989373|FG000|Overall Study|Lack of Efficacy and Other|1|||
23339992|NCT00160706|64989373|FG000|Overall Study|Other Reason|11|||
23339993|NCT05033262|64989374|FG000|Overall Study|Lost to Follow-up|1|||
23339994|NCT05033262|64989375|FG001|Overall Study|Lost to Follow-up|0|||
23339995|NCT05033262|64989376|FG002|Overall Study|Lost to Follow-up|0|||
23339996|NCT05033262|64989377|FG003|Overall Study|Lost to Follow-up|1|||
23339997|NCT00750139|64989378|FG000|Overall Study|Adverse Event|1|||
23339998|NCT00750139|64989379|FG001|Overall Study|Adverse Event|2|||
23339999|NCT00750139|64989380|FG002|Overall Study|Adverse Event|0|||
23340000|NCT00750139|64989381|FG003|Overall Study|Adverse Event|1|||
23340001|NCT00750139|64989378|FG000|Overall Study|Lost to Follow-up|17|||
23340002|NCT00750139|64989379|FG001|Overall Study|Lost to Follow-up|12|||
23340003|NCT00750139|64989380|FG002|Overall Study|Lost to Follow-up|15|||
23340004|NCT00750139|64989381|FG003|Overall Study|Lost to Follow-up|6|||
23340005|NCT00750139|64989378|FG000|Overall Study|Withdrawal by Subject|3|||
23340006|NCT00750139|64989379|FG001|Overall Study|Withdrawal by Subject|2|||
23340007|NCT00750139|64989380|FG002|Overall Study|Withdrawal by Subject|6|||
23340008|NCT00750139|64989381|FG003|Overall Study|Withdrawal by Subject|2|||
23340009|NCT00750139|64989378|FG000|Overall Study|Physician Decision|1|||
23340010|NCT00750139|64989379|FG001|Overall Study|Physician Decision|1|||
23340011|NCT00750139|64989380|FG002|Overall Study|Physician Decision|0|||
23340012|NCT00750139|64989381|FG003|Overall Study|Physician Decision|0|||
23340013|NCT00750139|64989378|FG000|Overall Study|Non-compliance|1|||
23340014|NCT00750139|64989379|FG001|Overall Study|Non-compliance|0|||
23340015|NCT00750139|64989380|FG002|Overall Study|Non-compliance|1|||
23233889|NCT01314261|64600605|FG000|Overall Study|Adverse Event|1|||
23233890|NCT01314261|64600606|FG001|Overall Study|Adverse Event|0|||
23233891|NCT01314261|64600607|FG002|Overall Study|Adverse Event|0|||
23233892|NCT01314261|64600608|FG003|Overall Study|Adverse Event|0|||
23233893|NCT01314261|64600605|FG000|Overall Study|Withdrawal by Subject|0|||
23233894|NCT01314261|64600606|FG001|Overall Study|Withdrawal by Subject|3|||
23233895|NCT01314261|64600607|FG002|Overall Study|Withdrawal by Subject|1|||
23233896|NCT01314261|64600608|FG003|Overall Study|Withdrawal by Subject|0|||
23233897|NCT01314261|64600605|FG000|Overall Study|Lost to Follow-up|1|||
23233898|NCT01314261|64600606|FG001|Overall Study|Lost to Follow-up|0|||
23233899|NCT01314261|64600607|FG002|Overall Study|Lost to Follow-up|2|||
23233900|NCT01314261|64600608|FG003|Overall Study|Lost to Follow-up|2|||
23233901|NCT01314261|64600605|FG000|Overall Study|Virologic Failure|0|||
23233902|NCT01314261|64600606|FG001|Overall Study|Virologic Failure|1|||
23233903|NCT01314261|64600607|FG002|Overall Study|Virologic Failure|0|||
23233904|NCT01314261|64600608|FG003|Overall Study|Virologic Failure|1|||
23233905|NCT00669240|64600609|FG000|Overall Study|Lack of Efficacy|33|||
23233906|NCT00669240|64600609|FG000|Overall Study|Withdrawal by Subject|42|||
23233907|NCT00669240|64600609|FG000|Overall Study|Lost to Follow-up|34|||
23233908|NCT00669240|64600609|FG000|Overall Study|Adverse Event|21|||
23233909|NCT00669240|64600609|FG000|Overall Study|Other|19|||
23233910|NCT00669240|64600609|FG000|Overall Study|Enrolled but not treated|15|||
23233911|NCT00669240|64600609|FG000|Overall Study|Enrolled but no dosing record|1|||
23233912|NCT02155712|64600610|FG000|Overall Study|Death|12|||
23233913|NCT02155712|64600611|FG001|Overall Study|Death|0|||
23233914|NCT02155712|64600610|FG000|Overall Study|Lost to Follow-up|37|||
23233915|NCT02155712|64600611|FG001|Overall Study|Lost to Follow-up|22|||
23233916|NCT02155712|64600610|FG000|Overall Study|Revision of device|4|||
23233917|NCT02155712|64600611|FG001|Overall Study|Revision of device|3|||
23233918|NCT02155712|64600610|FG000|Overall Study|Withdrawal by Subject|39|||
23233919|NCT02155712|64600611|FG001|Overall Study|Withdrawal by Subject|21|||
23233920|NCT02155712|64600610|FG000|Overall Study|Site termination|77|||
23233921|NCT02155712|64600611|FG001|Overall Study|Site termination|19|||
23233922|NCT02155712|64600610|FG000|Overall Study|Sponsor terminated study early|150|||
23233923|NCT02155712|64600611|FG001|Overall Study|Sponsor terminated study early|0|||
23233924|NCT02155712|64600610|FG000|Overall Study|Missed final 5-year protocol visit|0|||
23233925|NCT02155712|64600611|FG001|Overall Study|Missed final 5-year protocol visit|32|||
23233926|NCT02155712|64600610|FG000|Overall Study|Censored because surgery cancelled|6|||
23233927|NCT02155712|64600611|FG001|Overall Study|Censored because surgery cancelled|10|||
23233928|NCT02155712|64600610|FG000|Overall Study|Censored because study device was not implanted|61|||
23233929|NCT02155712|64600611|FG001|Overall Study|Censored because study device was not implanted|66|||
23233930|NCT02155712|64600610|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
23233931|NCT02155712|64600611|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
23233932|NCT02926833|64600612|FG000|Overall Study|Death|1|||
23233933|NCT02926833|64600613|FG001|Overall Study|Death|1|||
23233934|NCT02926833|64600614|FG002|Overall Study|Death|2|||
23233935|NCT02926833|64600615|FG003|Overall Study|Death|13|||
23233936|NCT02926833|64600612|FG000|Overall Study|Lost to Follow-up|1|||
23233937|NCT02926833|64600613|FG001|Overall Study|Lost to Follow-up|2|||
23233938|NCT02926833|64600614|FG002|Overall Study|Lost to Follow-up|0|||
23233939|NCT02926833|64600615|FG003|Overall Study|Lost to Follow-up|3|||
23233940|NCT02926833|64600612|FG000|Overall Study|Full Consent Withdrawal|0|||
23233941|NCT02926833|64600613|FG001|Overall Study|Full Consent Withdrawal|0|||
23233942|NCT02926833|64600614|FG002|Overall Study|Full Consent Withdrawal|0|||
23233943|NCT02926833|64600615|FG003|Overall Study|Full Consent Withdrawal|2|||
23233944|NCT02926833|64600612|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
23233945|NCT02926833|64600613|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
23233946|NCT02926833|64600614|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
23233947|NCT02926833|64600615|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
23233948|NCT02926833|64600612|FG000|Overall Study|Investigator Decision|0|||
23233949|NCT02926833|64600613|FG001|Overall Study|Investigator Decision|1|||
23233950|NCT02926833|64600614|FG002|Overall Study|Investigator Decision|0|||
23233951|NCT02926833|64600615|FG003|Overall Study|Investigator Decision|0|||
23233952|NCT02926833|64600612|FG000|Overall Study|Adverse Event|0|||
23233953|NCT02926833|64600613|FG001|Overall Study|Adverse Event|0|||
23233954|NCT02926833|64600614|FG002|Overall Study|Adverse Event|1|||
23233955|NCT02926833|64600615|FG003|Overall Study|Adverse Event|0|||
23233956|NCT02926833|64600612|FG000|Overall Study|Partial Withdrawal of Consent|0|||
23233957|NCT02926833|64600613|FG001|Overall Study|Partial Withdrawal of Consent|0|||
23233958|NCT02926833|64600614|FG002|Overall Study|Partial Withdrawal of Consent|0|||
23233959|NCT02926833|64600615|FG003|Overall Study|Partial Withdrawal of Consent|1|||
23233960|NCT00686894|64600616|FG000|Overall Study|Relapse|2|||
23233961|NCT00686894|64600616|FG000|Overall Study|Protocol Violation|4|||
23233962|NCT00960323|64600618|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
23233963|NCT00121485|64600619|FG000|Overall Study|Not implanted|1|||
23233964|NCT00121485|64600620|FG001|Overall Study|Not implanted|5|||
23233965|NCT00121485|64600619|FG000|Overall Study|Crossover|0|||
23340016|NCT00750139|64989381|FG003|Overall Study|Non-compliance|3|||
23340017|NCT00750139|64989378|FG000|Overall Study|Termination by sponsor|4|||
23340018|NCT00750139|64989379|FG001|Overall Study|Termination by sponsor|0|||
23340019|NCT00750139|64989380|FG002|Overall Study|Termination by sponsor|0|||
23340020|NCT00750139|64989381|FG003|Overall Study|Termination by sponsor|1|||
23340021|NCT00750139|64989378|FG000|Overall Study|Non-specific|62|||
23340022|NCT00750139|64989379|FG001|Overall Study|Non-specific|42|||
23340023|NCT00750139|64989380|FG002|Overall Study|Non-specific|79|||
23340024|NCT00750139|64989381|FG003|Overall Study|Non-specific|33|||
23340025|NCT01880086|64989382|FG000|Overall Study|Lost to Follow-up|1|||
23340026|NCT01880086|64989383|FG001|Overall Study|Lost to Follow-up|1|||
23340027|NCT00631410|64989384|FG000|Overall Study|Adverse Event|1|||
23340028|NCT00631410|64989385|FG001|Overall Study|Adverse Event|3|||
23340029|NCT00631410|64989384|FG000|Overall Study|Objective Progression or Relapse|4|||
23340030|NCT00631410|64989385|FG001|Overall Study|Objective Progression or Relapse|3|||
23340031|NCT00631410|64989384|FG000|Overall Study|Surgery|1|||
23340032|NCT00631410|64989385|FG001|Overall Study|Surgery|0|||
23340033|NCT03483961|64989388|FG000|Overall Study|Lost to Follow-up|7|||
23340034|NCT03483961|64989389|FG001|Overall Study|Lost to Follow-up|6|||
23340035|NCT03483961|64989390|FG002|Overall Study|Lost to Follow-up|6|||
23452006|NCT00591006|65398874|FG018|Overall Study|Adverse Event|0|||
23580346|NCT00630539|65853445|FG003|Overall Study|Withdrawal by Subject|1|||
23580347|NCT01598987|65853448|FG000|Baseline to Month 12|Administrative problems|2|||
23174402|NCT03682120|64382461|FG002|Overall Study|Death|0|||
23174403|NCT03682120|64382462|FG003|Overall Study|Death|0|||
23174404|NCT03682120|64382459|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
23174405|NCT03682120|64382460|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
23174406|NCT03682120|64382461|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
23174407|NCT03682120|64382462|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
23174408|NCT02908880|64382463|FG000|Overall Study|Lost to Follow-up|4|||
23174409|NCT02908880|64382463|FG000|Overall Study|Explantation of the device|1|||
23174410|NCT02908880|64382463|FG000|Overall Study|Withdrawal by Subject|17|||
23174411|NCT02908880|64382463|FG000|Overall Study|Death|5|||
23174412|NCT01688050|64382471|FG000|Overall Study|Death|7|||
23174413|NCT01688050|64382471|FG000|Overall Study|Conversion to open repair|1|||
23174414|NCT01688050|64382471|FG000|Overall Study|Lost to Follow-up|13|||
23174415|NCT01688050|64382471|FG000|Overall Study|Withdrawal by Subject|10|||
23174416|NCT03056573|64382472|FG000|Overall Study|Death|2|||
23174417|NCT03056573|64382473|FG001|Overall Study|Death|4|||
23174418|NCT03056573|64382472|FG000|Overall Study|Withdrawal by Subject|2|||
23174419|NCT03056573|64382473|FG001|Overall Study|Withdrawal by Subject|0|||
23174420|NCT03056573|64382472|FG000|Overall Study|Lost to Follow-up|1|||
23174421|NCT03056573|64382473|FG001|Overall Study|Lost to Follow-up|1|||
23174422|NCT01565980|64382474|FG000|Overall Study|Death|1|||
23174423|NCT01565980|64382475|FG001|Overall Study|Death|0|||
23174424|NCT01565980|64382474|FG000|Overall Study|Lost to Follow-up|1|||
23174425|NCT01565980|64382475|FG001|Overall Study|Lost to Follow-up|0|||
23174426|NCT01565980|64382474|FG000|Overall Study|health complications|1|||
23174427|NCT01565980|64382475|FG001|Overall Study|health complications|1|||
23174428|NCT01565980|64382474|FG000|Overall Study|stopped medical treatment|1|||
23174429|NCT01565980|64382475|FG001|Overall Study|stopped medical treatment|0|||
23174430|NCT01565980|64382474|FG000|Overall Study|Withdrawal by Subject|0|||
23174431|NCT01565980|64382475|FG001|Overall Study|Withdrawal by Subject|3|||
23174432|NCT01627860|64382477|FG000|Overall Study|Adverse Event|9|||
23174433|NCT01627860|64382478|FG001|Overall Study|Adverse Event|4|||
23174434|NCT01627860|64382477|FG000|Overall Study|Withdrawal by Subject|2|||
23174435|NCT01627860|64382478|FG001|Overall Study|Withdrawal by Subject|1|||
23174436|NCT01627860|64382477|FG000|Overall Study|Seizure frequency doubled|0|||
23340036|NCT03483961|64989391|FG003|Overall Study|Lost to Follow-up|6|||
23580348|NCT01598987|65853448|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
23580349|NCT01598987|65853448|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
23580350|NCT01598987|65853448|FG000|Baseline to 24 Month|Administrative problems|2|||
23580351|NCT01598987|65853448|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
23580352|NCT03976375|65853453|FG000|Overall Study|Death|147|||
23580353|NCT03976375|65853454|FG001|Overall Study|Death|150|||
23580354|NCT03976375|65853455|FG002|Overall Study|Death|38|||
23580355|NCT03976375|65853453|FG000|Overall Study|Lost to Follow-up|1|||
23452007|NCT00591006|65398875|FG019|Overall Study|Adverse Event|0|||
23174437|NCT01627860|64382478|FG001|Overall Study|Seizure frequency doubled|1|||
23174438|NCT01627860|64382477|FG000|Overall Study|Protocol Violation|1|||
23174439|NCT01627860|64382478|FG001|Overall Study|Protocol Violation|0|||
23580356|NCT03976375|65853454|FG001|Overall Study|Lost to Follow-up|1|||
23580357|NCT03976375|65853455|FG002|Overall Study|Lost to Follow-up|1|||
23174440|NCT04682405|64382479|FG000|Overall Study|Adverse Event|0|||
23340037|NCT03483961|64989392|FG004|Overall Study|Lost to Follow-up|6|||
23340038|NCT03483961|64989393|FG005|Overall Study|Lost to Follow-up|4|||
23340039|NCT03483961|64989394|FG006|Overall Study|Lost to Follow-up|4|||
23340040|NCT03483961|64989395|FG007|Overall Study|Lost to Follow-up|11|||
23340041|NCT03483961|64989396|FG008|Overall Study|Lost to Follow-up|1|||
23340042|NCT03483961|64989397|FG009|Overall Study|Lost to Follow-up|0|||
23340043|NCT03483961|64989388|FG000|Overall Study|Withdrawal by Subject|3|||
23340044|NCT03483961|64989389|FG001|Overall Study|Withdrawal by Subject|4|||
23340045|NCT03483961|64989390|FG002|Overall Study|Withdrawal by Subject|5|||
23340046|NCT03483961|64989391|FG003|Overall Study|Withdrawal by Subject|3|||
23340047|NCT03483961|64989392|FG004|Overall Study|Withdrawal by Subject|4|||
23340048|NCT03483961|64989393|FG005|Overall Study|Withdrawal by Subject|2|||
23340049|NCT03483961|64989394|FG006|Overall Study|Withdrawal by Subject|1|||
23174441|NCT04682405|64382480|FG001|Overall Study|Adverse Event|1|||
23174442|NCT02614079|64382481|FG000|Overall Study|Withdrawal by Subject|1|||
23174443|NCT00578643|64382482|FG000|Overall Study|Death|1|||
23174444|NCT00578643|64382482|FG000|Overall Study|Lost to Follow-up|1|||
23174445|NCT01481896|64382483|FG000|Overall Study|Lost to Follow-up|12|||
23174446|NCT01116544|64382484|FG000|Overall Study|Protocol Violation|1|||
23174447|NCT01116544|64382485|FG001|Overall Study|Protocol Violation|0|||
23174448|NCT01116544|64382484|FG000|Overall Study|Withdrawal by Subject|1|||
23174449|NCT01116544|64382485|FG001|Overall Study|Withdrawal by Subject|1|||
23174450|NCT01737931|64382486|FG000|Overall Study|Withdrawal by Subject|0|||
23174451|NCT01737931|64382487|FG001|Overall Study|Withdrawal by Subject|1|||
23174452|NCT01737931|64382488|FG002|Overall Study|Withdrawal by Subject|1|||
23452008|NCT00591006|65398876|FG020|Overall Study|Adverse Event|0|||
23452009|NCT00591006|65398877|FG021|Overall Study|Adverse Event|0|||
23174453|NCT01737931|64382486|FG000|Overall Study|Physician Decision|0|||
23174454|NCT01737931|64382487|FG001|Overall Study|Physician Decision|1|||
23174455|NCT01737931|64382488|FG002|Overall Study|Physician Decision|0|||
23340050|NCT03483961|64989395|FG007|Overall Study|Withdrawal by Subject|2|||
23452010|NCT00591006|65398878|FG022|Overall Study|Adverse Event|1|||
23233966|NCT00121485|64600620|FG001|Overall Study|Crossover|2|||
23233967|NCT03145207|64600622|FG000|Overall Study|volunteer started taking allergy shots|1|||
23233968|NCT03145207|64600622|FG000|Overall Study|baseline blood pressure high|1|||
23233969|NCT00302731|64600623|FG000|Overall Study|Lost to Follow-up|1|||
23233970|NCT00302731|64600624|FG001|Overall Study|Lost to Follow-up|2|||
23233971|NCT00302731|64600625|FG002|Overall Study|Lost to Follow-up|0|||
23233972|NCT00302731|64600626|FG003|Overall Study|Lost to Follow-up|0|||
23340051|NCT03483961|64989396|FG008|Overall Study|Withdrawal by Subject|1|||
23340052|NCT03483961|64989397|FG009|Overall Study|Withdrawal by Subject|0|||
23340053|NCT03483961|64989388|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
23340054|NCT03483961|64989389|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23233973|NCT00302731|64600623|FG000|Overall Study|Adverse Event|0|||
23233974|NCT00302731|64600624|FG001|Overall Study|Adverse Event|2|||
23233975|NCT00302731|64600625|FG002|Overall Study|Adverse Event|2|||
23233976|NCT00302731|64600626|FG003|Overall Study|Adverse Event|0|||
23233977|NCT00302731|64600623|FG000|Overall Study|Withdrawal by Subject|1|||
23233978|NCT00302731|64600624|FG001|Overall Study|Withdrawal by Subject|1|||
23233979|NCT00302731|64600625|FG002|Overall Study|Withdrawal by Subject|0|||
23233980|NCT00302731|64600626|FG003|Overall Study|Withdrawal by Subject|0|||
23233981|NCT00302731|64600623|FG000|Overall Study|Protocol Violation|1|||
23233982|NCT00302731|64600624|FG001|Overall Study|Protocol Violation|0|||
23233983|NCT00302731|64600625|FG002|Overall Study|Protocol Violation|0|||
23233984|NCT00302731|64600626|FG003|Overall Study|Protocol Violation|0|||
23233985|NCT00302731|64600623|FG000|Overall Study|cancer unrelated to study discovered|1|||
23233986|NCT00302731|64600624|FG001|Overall Study|cancer unrelated to study discovered|0|||
23233987|NCT00302731|64600625|FG002|Overall Study|cancer unrelated to study discovered|1|||
23233988|NCT00302731|64600626|FG003|Overall Study|cancer unrelated to study discovered|0|||
23233989|NCT02785588|64600627|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
23233990|NCT02785588|64600627|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
23233991|NCT01883362|64600628|FG000|Treatment|Adverse Event|1|||
23233992|NCT01883362|64600629|FG001|Treatment|Adverse Event|8|||
23233993|NCT01883362|64600628|FG000|Treatment|Withdrawal by Subject|6|||
23233994|NCT01883362|64600629|FG001|Treatment|Withdrawal by Subject|2|||
23233995|NCT01883362|64600628|FG000|Treatment|Administrative problems|4|||
23233996|NCT01883362|64600629|FG001|Treatment|Administrative problems|1|||
23233997|NCT01883362|64600628|FG000|Treatment|Relapse|4|||
23233998|NCT01883362|64600629|FG001|Treatment|Relapse|2|||
23233999|NCT01883362|64600628|FG000|Treatment|Randomized, not treated|1|||
23234000|NCT01883362|64600629|FG001|Treatment|Randomized, not treated|1|||
23234001|NCT01883362|64600628|FG000|Post Treatment Follow-up|Protocol Violation|0|||
23234002|NCT01883362|64600629|FG001|Post Treatment Follow-up|Protocol Violation|1|||
23234003|NCT01883362|64600628|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
23234004|NCT01883362|64600629|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
23234005|NCT01883362|64600628|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
23234006|NCT01883362|64600629|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
23234007|NCT01883362|64600628|FG000|Post Treatment Follow-up|Administrative problems|2|||
23234008|NCT01883362|64600629|FG001|Post Treatment Follow-up|Administrative problems|0|||
23234009|NCT01883362|64600628|FG000|Post Treatment Follow-up|Death|8|||
23234010|NCT01883362|64600629|FG001|Post Treatment Follow-up|Death|4|||
23234011|NCT01883362|64600628|FG000|Post Treatment Follow-up|Relapse|1|||
23234012|NCT01883362|64600629|FG001|Post Treatment Follow-up|Relapse|2|||
23234013|NCT02906644|64600630|FG000|First 2 Weeks|Withdrawal by Subject|0|||
23234014|NCT02906644|64600631|FG001|First 2 Weeks|Withdrawal by Subject|2|||
23234015|NCT02906644|64600630|FG000|First 2 Weeks|Physician Decision|1|||
23234016|NCT02906644|64600631|FG001|First 2 Weeks|Physician Decision|1|||
23234017|NCT02906644|64600630|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
23234018|NCT02906644|64600631|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
23234019|NCT02906644|64600630|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
23234020|NCT02906644|64600631|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
23234021|NCT04594213|64600632|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
23234022|NCT04594213|64600633|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
23234023|NCT04594213|64600634|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
23234024|NCT04594213|64600635|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23234025|NCT04594213|64600636|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23234026|NCT04594213|64600637|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
23234027|NCT04594213|64600632|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23234028|NCT04594213|64600633|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
23234029|NCT04594213|64600634|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23234030|NCT04594213|64600635|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23234031|NCT04594213|64600636|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23234032|NCT04594213|64600637|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
23234033|NCT04594213|64600632|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
23234034|NCT04594213|64600633|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23174456|NCT02814565|64382489|FG000|Overall Study|Lack of Efficacy|0|||
23174457|NCT02814565|64382490|FG001|Overall Study|Lack of Efficacy|1|||
23174458|NCT02814565|64382489|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
23174459|NCT02814565|64382490|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
23174460|NCT01652287|64382492|FG000|Overall Study|Withdrawal by Subject|2|||
23174461|NCT01652287|64382493|FG001|Overall Study|Withdrawal by Subject|0|||
23174462|NCT03887130|64382494|FG000|Overall Study|Progressive disease|23|||
23174463|NCT03887130|64382495|FG001|Overall Study|Progressive disease|14|||
23174464|NCT03887130|64382496|FG002|Overall Study|Progressive disease|7|||
23174465|NCT03887130|64382494|FG000|Overall Study|Protocol Violation|3|||
23174466|NCT03887130|64382495|FG001|Overall Study|Protocol Violation|1|||
23174467|NCT03887130|64382496|FG002|Overall Study|Protocol Violation|2|||
23174468|NCT03887130|64382494|FG000|Overall Study|Drug related toxicity|7|||
23174469|NCT03887130|64382495|FG001|Overall Study|Drug related toxicity|7|||
23174470|NCT03887130|64382496|FG002|Overall Study|Drug related toxicity|13|||
23174471|NCT03887130|64382494|FG000|Overall Study|Non drug related toxicity|3|||
23174472|NCT03887130|64382495|FG001|Overall Study|Non drug related toxicity|0|||
23174473|NCT03887130|64382496|FG002|Overall Study|Non drug related toxicity|0|||
23174474|NCT03887130|64382494|FG000|Overall Study|Death|2|||
23174475|NCT03887130|64382495|FG001|Overall Study|Death|2|||
23174476|NCT03887130|64382496|FG002|Overall Study|Death|1|||
23174477|NCT03887130|64382494|FG000|Overall Study|Withdrawal by Subject|7|||
23174478|NCT03887130|64382495|FG001|Overall Study|Withdrawal by Subject|6|||
23174479|NCT03887130|64382496|FG002|Overall Study|Withdrawal by Subject|11|||
23174480|NCT03887130|64382494|FG000|Overall Study|other reason|6|||
23174481|NCT03887130|64382495|FG001|Overall Study|other reason|20|||
23234035|NCT04594213|64600634|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
23234036|NCT04594213|64600635|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23234037|NCT04594213|64600636|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23234038|NCT04594213|64600637|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
23234039|NCT04594213|64600632|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23234040|NCT04594213|64600633|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23234041|NCT04594213|64600634|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23234042|NCT04594213|64600635|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23234043|NCT04594213|64600636|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
23234044|NCT04594213|64600637|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
23234045|NCT04594213|64600632|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23234046|NCT04594213|64600633|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23234047|NCT04594213|64600634|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
23234048|NCT04594213|64600635|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
23234049|NCT04594213|64600636|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
23234050|NCT04594213|64600637|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
23234051|NCT04594213|64600632|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23234052|NCT04594213|64600633|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23234053|NCT04594213|64600634|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23234054|NCT04594213|64600635|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23234055|NCT04594213|64600636|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
23234056|NCT04594213|64600637|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
23234057|NCT04594213|64600632|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23234058|NCT04594213|64600633|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23234059|NCT04594213|64600634|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23234060|NCT04594213|64600635|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
23234061|NCT04594213|64600636|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23234062|NCT04594213|64600637|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
23234063|NCT04594213|64600632|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23234064|NCT04594213|64600633|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23234065|NCT04594213|64600634|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23234066|NCT04594213|64600635|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
23234067|NCT04594213|64600636|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23234068|NCT04594213|64600637|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
23234069|NCT04594213|64600632|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23234070|NCT04594213|64600633|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23234071|NCT04594213|64600634|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
23234072|NCT04594213|64600635|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
23234073|NCT04594213|64600636|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
23234074|NCT04594213|64600637|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
23234075|NCT04594213|64600632|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23234076|NCT04594213|64600633|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23234077|NCT04594213|64600634|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
23234078|NCT04594213|64600635|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
23234079|NCT04594213|64600636|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
23234080|NCT04594213|64600637|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
23234081|NCT04594213|64600632|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
23234082|NCT04594213|64600633|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
23234083|NCT04594213|64600634|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
23234084|NCT04594213|64600635|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
23234085|NCT04594213|64600636|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
23234086|NCT04594213|64600637|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
23234087|NCT01684930|64600641|FG000|Overall Study|Withdrawal by Subject|3|||
23234088|NCT01684930|64600642|FG001|Overall Study|Withdrawal by Subject|1|||
23234089|NCT00660829|64600643|FG000|Overall Study|Adverse Event|3|||
23234090|NCT00660829|64600644|FG001|Overall Study|Adverse Event|4|||
23234091|NCT00660829|64600643|FG000|Overall Study|Lack of Efficacy|2|||
23234092|NCT00660829|64600644|FG001|Overall Study|Lack of Efficacy|3|||
23234093|NCT00660829|64600643|FG000|Overall Study|Non-Compliance|0|||
23234094|NCT00660829|64600644|FG001|Overall Study|Non-Compliance|4|||
23234095|NCT00660829|64600643|FG000|Overall Study|Withdrawal by Subject|1|||
23234096|NCT00660829|64600644|FG001|Overall Study|Withdrawal by Subject|2|||
23234097|NCT00660829|64600643|FG000|Overall Study|Lost to Follow-up|3|||
23580358|NCT03976375|65853453|FG000|Overall Study|Withdrawal by Subject|4|||
23580359|NCT03976375|65853454|FG001|Overall Study|Withdrawal by Subject|9|||
23234098|NCT00660829|64600644|FG001|Overall Study|Lost to Follow-up|2|||
23234099|NCT00660829|64600643|FG000|Overall Study|Other|9|||
23234100|NCT00660829|64600644|FG001|Overall Study|Other|4|||
23234101|NCT05102734|64600655|FG000|Overall Study|Did not require vasopressors|1|||
23234102|NCT05102734|64600656|FG001|Overall Study|Did not require vasopressors|0|||
23234103|NCT05102734|64600655|FG000|Overall Study|Did not have functioning PA catheter|1|||
23234104|NCT05102734|64600656|FG001|Overall Study|Did not have functioning PA catheter|0|||
23234105|NCT05102734|64600655|FG000|Overall Study|Inadequate video quality|2|||
23234106|NCT05102734|64600656|FG001|Overall Study|Inadequate video quality|0|||
23580360|NCT03976375|65853455|FG002|Overall Study|Withdrawal by Subject|4|||
23580361|NCT03976375|65853453|FG000|Overall Study|Ongoing|33|||
23580362|NCT03976375|65853454|FG001|Overall Study|Ongoing|29|||
23580363|NCT03976375|65853455|FG002|Overall Study|Ongoing|5|||
23580364|NCT00490555|65853458|FG000|Overall Study|noncompliant with drug administration|0|||
23580365|NCT00490555|65853459|FG001|Overall Study|noncompliant with drug administration|0|||
23580366|NCT00490555|65853460|FG002|Overall Study|noncompliant with drug administration|2|||
23580367|NCT00490555|65853461|FG003|Overall Study|noncompliant with drug administration|0|||
23580368|NCT02153788|65853464|FG000|Overall Study|Physician Decision|2|||
23580369|NCT02153788|65853465|FG001|Overall Study|Physician Decision|1|||
23580370|NCT00859014|65853469|FG000|Overall Study|Death|4|||
23580371|NCT00859014|65853469|FG000|Overall Study|Lost to Follow-up|1|||
23580372|NCT01686932|65853475|FG000|Period 1|Adverse Event|1|||
23580373|NCT01686932|65853476|FG001|Period 1|Adverse Event|1|||
23580374|NCT02938442|65853477|FG000|Overall Study|Death|0|||
23580375|NCT02938442|65853478|FG001|Overall Study|Death|1|||
23580376|NCT02938442|65853477|FG000|Overall Study|Lost to Follow-up|0|||
23580377|NCT02938442|65853478|FG001|Overall Study|Lost to Follow-up|1|||
23234107|NCT02055976|64600657|FG000|Overall Study|Other|0|||
23234108|NCT02055976|64600658|FG001|Overall Study|Other|0|||
23234109|NCT02055976|64600659|FG002|Overall Study|Other|1|||
23234110|NCT02055976|64600660|FG003|Overall Study|Other|0|||
23234111|NCT02055976|64600661|FG004|Overall Study|Other|0|||
23234112|NCT02055976|64600662|FG005|Overall Study|Other|0|||
23234113|NCT02055976|64600663|FG006|Overall Study|Other|0|||
23234114|NCT02055976|64600664|FG007|Overall Study|Other|0|||
23234115|NCT02055976|64600665|FG008|Overall Study|Other|0|||
23234116|NCT02055976|64600657|FG000|Overall Study|Adverse Event|0|||
23234117|NCT02055976|64600658|FG001|Overall Study|Adverse Event|0|||
23234118|NCT02055976|64600659|FG002|Overall Study|Adverse Event|0|||
23234119|NCT02055976|64600660|FG003|Overall Study|Adverse Event|0|||
23234120|NCT02055976|64600661|FG004|Overall Study|Adverse Event|0|||
23234121|NCT02055976|64600662|FG005|Overall Study|Adverse Event|1|||
23234122|NCT02055976|64600663|FG006|Overall Study|Adverse Event|1|||
23234123|NCT02055976|64600664|FG007|Overall Study|Adverse Event|0|||
23234124|NCT02055976|64600665|FG008|Overall Study|Adverse Event|0|||
23234125|NCT02055976|64600657|FG000|Overall Study|Does not meet entrance criteria|0|||
23234126|NCT02055976|64600658|FG001|Overall Study|Does not meet entrance criteria|0|||
23234127|NCT02055976|64600659|FG002|Overall Study|Does not meet entrance criteria|0|||
23580378|NCT02938442|65853477|FG000|Overall Study|Physician Decision|0|||
23234128|NCT02055976|64600660|FG003|Overall Study|Does not meet entrance criteria|0|||
23234129|NCT02055976|64600661|FG004|Overall Study|Does not meet entrance criteria|0|||
23234130|NCT02055976|64600662|FG005|Overall Study|Does not meet entrance criteria|0|||
23234131|NCT02055976|64600663|FG006|Overall Study|Does not meet entrance criteria|1|||
23234132|NCT02055976|64600664|FG007|Overall Study|Does not meet entrance criteria|0|||
23234133|NCT02055976|64600665|FG008|Overall Study|Does not meet entrance criteria|0|||
23234134|NCT02055976|64600657|FG000|Overall Study|Lost to Follow-up|0|||
23234135|NCT02055976|64600658|FG001|Overall Study|Lost to Follow-up|0|||
23234136|NCT02055976|64600659|FG002|Overall Study|Lost to Follow-up|0|||
23234137|NCT02055976|64600660|FG003|Overall Study|Lost to Follow-up|1|||
23234138|NCT02055976|64600661|FG004|Overall Study|Lost to Follow-up|0|||
23234139|NCT02055976|64600662|FG005|Overall Study|Lost to Follow-up|0|||
23234140|NCT02055976|64600663|FG006|Overall Study|Lost to Follow-up|0|||
23452011|NCT00591006|65398879|FG023|Overall Study|Adverse Event|0|||
23580379|NCT02938442|65853478|FG001|Overall Study|Physician Decision|1|||
23580380|NCT02938442|65853477|FG000|Overall Study|Withdrawal by Subject|2|||
23580381|NCT02938442|65853478|FG001|Overall Study|Withdrawal by Subject|0|||
23234141|NCT02055976|64600664|FG007|Overall Study|Lost to Follow-up|0|||
23234142|NCT02055976|64600665|FG008|Overall Study|Lost to Follow-up|0|||
23234143|NCT02624713|64600666|FG000|Overall Study|Lost to Follow-up|14|||
23234144|NCT02624713|64600667|FG001|Overall Study|Lost to Follow-up|0|||
23234145|NCT01277757|64600679|FG000|Overall Study|Disease Progression|1|||
23234146|NCT01277757|64600679|FG000|Overall Study|Withdrawal by Subject|1|||
23234147|NCT00242658|64600681|FG000|Overall Study|Lost to Follow-up|22|||
23234148|NCT00242658|64600682|FG001|Overall Study|Lost to Follow-up|19|||
23234149|NCT00424463|64600683|FG000|Overall Study|Adverse Event|2|||
23580382|NCT01556243|65853479|FG000|Overall Study|Ineligible|34|||
23234150|NCT00424463|64600684|FG001|Overall Study|Adverse Event|3|||
23452012|NCT03149055|65398880|FG000|Overall Study|Not treated|4|||
23580383|NCT01556243|65853479|FG000|Overall Study|Converted to mastectomy|14|||
23580384|NCT01556243|65853479|FG000|Overall Study|Unable to achieve negative margins|2|||
23234151|NCT00424463|64600685|FG002|Overall Study|Adverse Event|2|||
23234152|NCT00424463|64600683|FG000|Overall Study|Physician Decision|0|||
23234153|NCT00424463|64600684|FG001|Overall Study|Physician Decision|2|||
23234154|NCT00424463|64600685|FG002|Overall Study|Physician Decision|2|||
23234155|NCT00424463|64600683|FG000|Overall Study|Withdrawal by Subject|4|||
23234156|NCT00424463|64600684|FG001|Overall Study|Withdrawal by Subject|2|||
23234157|NCT00424463|64600685|FG002|Overall Study|Withdrawal by Subject|5|||
23234158|NCT00424463|64600683|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
23234159|NCT00424463|64600684|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
23234160|NCT00424463|64600685|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
23234161|NCT00424463|64600683|FG000|Overall Study|Patient's convenience|0|||
23234162|NCT00424463|64600684|FG001|Overall Study|Patient's convenience|0|||
23234163|NCT00424463|64600685|FG002|Overall Study|Patient's convenience|1|||
23234164|NCT01513460|64600686|FG000|Overall Study|Death|0|||
23234165|NCT01513460|64600687|FG001|Overall Study|Death|0|||
23234166|NCT01513460|64600688|FG002|Overall Study|Death|1|||
23234167|NCT01513460|64600686|FG000|Overall Study|Lost to Follow-up|0|||
23234168|NCT01513460|64600687|FG001|Overall Study|Lost to Follow-up|0|||
23234169|NCT01513460|64600688|FG002|Overall Study|Lost to Follow-up|2|||
23234170|NCT01513460|64600686|FG000|Overall Study|Abnormal laboratory value|1|||
23234171|NCT01513460|64600687|FG001|Overall Study|Abnormal laboratory value|0|||
23234172|NCT01513460|64600688|FG002|Overall Study|Abnormal laboratory value|1|||
23234173|NCT01513460|64600686|FG000|Overall Study|Lack of Efficacy|1|||
23234174|NCT01513460|64600687|FG001|Overall Study|Lack of Efficacy|2|||
23234175|NCT01513460|64600688|FG002|Overall Study|Lack of Efficacy|5|||
23234176|NCT01513460|64600686|FG000|Overall Study|Protocol deviations|3|||
23580385|NCT01556243|65853479|FG000|Overall Study|Withdrawal by Subject|16|||
23234177|NCT01513460|64600687|FG001|Overall Study|Protocol deviations|4|||
23234178|NCT01513460|64600688|FG002|Overall Study|Protocol deviations|3|||
23234179|NCT01513460|64600686|FG000|Overall Study|Withdrawal by Subject|7|||
23234180|NCT01513460|64600687|FG001|Overall Study|Withdrawal by Subject|8|||
23234181|NCT01513460|64600688|FG002|Overall Study|Withdrawal by Subject|21|||
23234182|NCT01513460|64600686|FG000|Overall Study|Adverse Event|16|||
23234183|NCT01513460|64600687|FG001|Overall Study|Adverse Event|18|||
23234184|NCT01513460|64600688|FG002|Overall Study|Adverse Event|23|||
23234185|NCT01513460|64600686|FG000|Overall Study|Abnormal test procedure|1|||
23234186|NCT01513460|64600687|FG001|Overall Study|Abnormal test procedure|0|||
23234187|NCT01513460|64600688|FG002|Overall Study|Abnormal test procedure|0|||
23234188|NCT01681004|64600689|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
23234189|NCT01681004|64600690|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
23234190|NCT01681004|64600689|FG000|Study Completion|Lost to Follow-up|8|||
23234191|NCT01681004|64600690|FG001|Study Completion|Lost to Follow-up|3|||
23234192|NCT01681004|64600689|FG000|Study Completion|Physician Decision|1|||
23234193|NCT01681004|64600690|FG001|Study Completion|Physician Decision|3|||
23234194|NCT01681004|64600689|FG000|Study Completion|Site Termination|2|||
23234195|NCT01681004|64600690|FG001|Study Completion|Site Termination|1|||
23234196|NCT01681004|64600689|FG000|Study Completion|Death|1|||
23234197|NCT01681004|64600690|FG001|Study Completion|Death|1|||
23234198|NCT04419558|64600691|FG000|DB Period (48 Weeks)|Adverse Event|6|||
23234199|NCT04419558|64600692|FG001|DB Period (48 Weeks)|Adverse Event|6|||
23234200|NCT04419558|64600691|FG000|DB Period (48 Weeks)|Death|14|||
23234201|NCT04419558|64600692|FG001|DB Period (48 Weeks)|Death|11|||
23234202|NCT04419558|64600691|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
23234203|NCT04419558|64600692|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
23234204|NCT04419558|64600691|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
23234205|NCT04419558|64600692|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
23234206|NCT04419558|64600691|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
23234207|NCT04419558|64600692|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
23234208|NCT04419558|64600691|FG000|DB Period (48 Weeks)|Disease Progression|1|||
23234209|NCT04419558|64600692|FG001|DB Period (48 Weeks)|Disease Progression|0|||
23234210|NCT04419558|64600691|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
23580386|NCT00994279|65853482|FG000|Overall Study|Withdrawal by Subject|2|||
23580387|NCT00994279|65853483|FG001|Overall Study|Withdrawal by Subject|2|||
23580388|NCT00994279|65853482|FG000|Overall Study|Toxicity|1|||
23580389|NCT00994279|65853483|FG001|Overall Study|Toxicity|0|||
23580390|NCT00994279|65853482|FG000|Overall Study|Multiple reasons|1|||
23580391|NCT00994279|65853483|FG001|Overall Study|Multiple reasons|3|||
23580392|NCT01192295|65853484|FG000|Overall Study|Adverse Event|3|||
23580393|NCT01192295|65853485|FG001|Overall Study|Adverse Event|7|||
23580394|NCT01192295|65853484|FG000|Overall Study|Withdrawal by Subject|3|||
23580395|NCT01192295|65853485|FG001|Overall Study|Withdrawal by Subject|4|||
23580396|NCT01192295|65853484|FG000|Overall Study|Lost to Follow-up|0|||
23580397|NCT01192295|65853485|FG001|Overall Study|Lost to Follow-up|1|||
23580398|NCT01192295|65853484|FG000|Overall Study|Lack of Efficacy|0|||
23580399|NCT01192295|65853485|FG001|Overall Study|Lack of Efficacy|5|||
23580400|NCT01192295|65853484|FG000|Overall Study|Administrative|4|||
23580401|NCT01192295|65853485|FG001|Overall Study|Administrative|6|||
23580402|NCT02501629|65853486|FG000|Overall Study|Death|0|||
23234211|NCT04419558|64600692|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
23234212|NCT04419558|64600691|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
23580403|NCT02501629|65853487|FG001|Overall Study|Death|1|||
23234213|NCT04419558|64600692|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
23452013|NCT02714569|65398891|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
23452014|NCT02714569|65398892|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
23452015|NCT02714569|65398893|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
23452016|NCT02714569|65398894|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
23452017|NCT02714569|65398895|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
23452018|NCT02714569|65398896|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
23452019|NCT02714569|65398897|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
23452020|NCT02714569|65398898|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
23452021|NCT02714569|65398899|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
23452022|NCT02714569|65398900|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
23452023|NCT02714569|65398901|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
23452024|NCT02714569|65398891|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452025|NCT02714569|65398892|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452026|NCT02714569|65398893|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452027|NCT02714569|65398894|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
23452028|NCT02714569|65398895|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452029|NCT02714569|65398896|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23580404|NCT02501629|65853486|FG000|Overall Study|Withdrawn from study by sponsor|1|||
23580405|NCT02501629|65853487|FG001|Overall Study|Withdrawn from study by sponsor|0|||
23580406|NCT02501629|65853486|FG000|Overall Study|Early termination by sponsor|1|||
23580407|NCT02501629|65853487|FG001|Overall Study|Early termination by sponsor|0|||
23580408|NCT02501629|65853486|FG000|Overall Study|Withdrawal by Subject|3|||
23580409|NCT02501629|65853487|FG001|Overall Study|Withdrawal by Subject|5|||
23580410|NCT02501629|65853486|FG000|Overall Study|Subject did not return to site|0|||
23580411|NCT02501629|65853487|FG001|Overall Study|Subject did not return to site|1|||
23580412|NCT02498613|65853488|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
23580413|NCT02498613|65853489|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
23580414|NCT02498613|65853490|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
23580415|NCT02498613|65853491|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
23580416|NCT02498613|65853488|FG000|Overall Study|Withdrawal by Subject|3|||
23580417|NCT02498613|65853489|FG001|Overall Study|Withdrawal by Subject|1|||
23580418|NCT02498613|65853490|FG002|Overall Study|Withdrawal by Subject|0|||
23580419|NCT02498613|65853491|FG003|Overall Study|Withdrawal by Subject|0|||
23580420|NCT00630864|65853492|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
23580421|NCT00630864|65853492|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
23580422|NCT00448864|65853493|FG000|Overall Study|Death|1|||
23580423|NCT00448864|65853494|FG001|Overall Study|Death|0|||
23580424|NCT00448864|65853495|FG002|Overall Study|Death|0|||
23580425|NCT00448864|65853493|FG000|Overall Study|Lost to Follow-up|3|||
23580426|NCT00448864|65853494|FG001|Overall Study|Lost to Follow-up|1|||
23580427|NCT00448864|65853495|FG002|Overall Study|Lost to Follow-up|0|||
23580428|NCT00448864|65853493|FG000|Overall Study|Physician Decision|1|||
23580429|NCT00448864|65853494|FG001|Overall Study|Physician Decision|0|||
23580430|NCT00448864|65853495|FG002|Overall Study|Physician Decision|1|||
23580431|NCT00448864|65853493|FG000|Overall Study|Withdrawal by Subject|0|||
23580432|NCT00448864|65853494|FG001|Overall Study|Withdrawal by Subject|2|||
23580433|NCT00448864|65853495|FG002|Overall Study|Withdrawal by Subject|0|||
23580434|NCT00448864|65853493|FG000|Overall Study|Protocol Violation|0|||
23580435|NCT00448864|65853494|FG001|Overall Study|Protocol Violation|2|||
23580436|NCT00448864|65853495|FG002|Overall Study|Protocol Violation|0|||
23580437|NCT03382821|65853498|FG000|Overall Study|Did not receive allocated intervention.|0|||
23580438|NCT03382821|65853499|FG001|Overall Study|Did not receive allocated intervention.|3|||
23174482|NCT03887130|64382496|FG002|Overall Study|other reason|17|||
23174483|NCT03183128|64382499|FG000|Overall Study|Adverse Event|1|||
23174484|NCT03183128|64382500|FG001|Overall Study|Adverse Event|2|||
23174485|NCT03183128|64382499|FG000|Overall Study|Withdrawal by Subject|1|||
23174486|NCT03183128|64382500|FG001|Overall Study|Withdrawal by Subject|8|||
23174487|NCT03183128|64382499|FG000|Overall Study|Protocol Violation|2|||
23174488|NCT03183128|64382500|FG001|Overall Study|Protocol Violation|0|||
23174489|NCT03183128|64382499|FG000|Overall Study|Lack of Efficacy|4|||
23174490|NCT03183128|64382500|FG001|Overall Study|Lack of Efficacy|27|||
23580439|NCT04610684|65853505|FG000|Study Treatment|Withdrawal by Subject|1|||
23580440|NCT04610684|65853505|FG000|Study Treatment|Disease Progression|2|||
23340055|NCT03483961|64989390|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340056|NCT03483961|64989391|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340057|NCT03483961|64989392|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340058|NCT03483961|64989393|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340059|NCT03483961|64989394|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340060|NCT03483961|64989395|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340061|NCT03483961|64989396|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340062|NCT03483961|64989397|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
23340063|NCT03483961|64989388|FG000|Overall Study|Adverse Event|0|||
23340064|NCT03483961|64989389|FG001|Overall Study|Adverse Event|0|||
23452030|NCT02714569|65398897|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23234214|NCT04419558|64600691|FG000|DB Period (48 Weeks)|Participant Decision|4|||
23234215|NCT04419558|64600692|FG001|DB Period (48 Weeks)|Participant Decision|3|||
23234216|NCT04419558|64600691|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
23234217|NCT04419558|64600692|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
23234218|NCT04419558|64600691|FG000|OLE Period (48 Weeks)|Death|4|||
23234219|NCT04419558|64600692|FG001|OLE Period (48 Weeks)|Death|6|||
23234220|NCT04419558|64600691|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
23234221|NCT04419558|64600692|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
23234222|NCT04419558|64600691|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
23234223|NCT04419558|64600692|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
23234224|NCT04118127|64600693|FG000|Overall Study|Trial terminated by sponsor|0|||
23234225|NCT04118127|64600694|FG001|Overall Study|Trial terminated by sponsor|12|||
23234226|NCT04118127|64600693|FG000|Overall Study|Adverse Event|1|||
23234227|NCT04118127|64600694|FG001|Overall Study|Adverse Event|2|||
23234228|NCT04118127|64600693|FG000|Overall Study|Physician Decision|0|||
23234229|NCT04118127|64600694|FG001|Overall Study|Physician Decision|1|||
23234230|NCT04118127|64600693|FG000|Overall Study|Withdrawal by Subject|2|||
23234231|NCT04118127|64600694|FG001|Overall Study|Withdrawal by Subject|1|||
23234232|NCT00967343|64600695|FG000|Overall Study|Study termination by sponsor|12|||
23234233|NCT00967343|64600695|FG000|Overall Study|Death|24|||
23234234|NCT00967343|64600695|FG000|Overall Study|Relapse|1|||
23234235|NCT00967343|64600695|FG000|Overall Study|Lost to Follow-up|1|||
23234236|NCT00945945|64600696|FG000|Overall Study|Adverse Event|15|||
23234237|NCT00945945|64600697|FG001|Overall Study|Adverse Event|35|||
23234238|NCT00945945|64600696|FG000|Overall Study|Withdrawal by Subject|7|||
23234239|NCT00945945|64600697|FG001|Overall Study|Withdrawal by Subject|10|||
23234240|NCT00945945|64600696|FG000|Overall Study|Lost to Follow-up|4|||
23234241|NCT00945945|64600697|FG001|Overall Study|Lost to Follow-up|5|||
23234242|NCT00945945|64600696|FG000|Overall Study|Lack of Efficacy|6|||
23234243|NCT00945945|64600697|FG001|Overall Study|Lack of Efficacy|2|||
23234244|NCT00945945|64600696|FG000|Overall Study|Protocol Violation|4|||
23234245|NCT00945945|64600697|FG001|Overall Study|Protocol Violation|2|||
23234246|NCT00945945|64600696|FG000|Overall Study|Entry Criteria Not Met|0|||
23234247|NCT00945945|64600697|FG001|Overall Study|Entry Criteria Not Met|1|||
23234248|NCT02555722|64600699|FG000|Week 2|Adverse Event|0|||
23234249|NCT02555722|64600700|FG001|Week 2|Adverse Event|1|||
23234250|NCT02555722|64600699|FG000|Week 2|Withdrawal by Subject|1|||
23234251|NCT02555722|64600700|FG001|Week 2|Withdrawal by Subject|0|||
23234252|NCT02555722|64600699|FG000|Month 1|Lens Discomfort|1|||
23234253|NCT02555722|64600700|FG001|Month 1|Lens Discomfort|0|||
23234254|NCT02555722|64600699|FG000|Month 2|Withdrawal by Subject|3|||
23234255|NCT02555722|64600700|FG001|Month 2|Withdrawal by Subject|0|||
23234256|NCT02555722|64600699|FG000|Month 2|Lost to Follow-up|1|||
23234257|NCT02555722|64600700|FG001|Month 2|Lost to Follow-up|0|||
23234258|NCT01298661|64600701|FG000|Overall Study|Withdrawal by Subject|2|||
23234259|NCT01298661|64600702|FG001|Overall Study|Withdrawal by Subject|0|||
23234260|NCT01298661|64600703|FG002|Overall Study|Withdrawal by Subject|2|||
23234261|NCT00361504|64600706|FG000|Overall Study|Withdrawal by Subject|94|||
23234262|NCT00361504|64600707|FG001|Overall Study|Withdrawal by Subject|31|||
23234263|NCT00361504|64600706|FG000|Overall Study|Lost to Follow-up|40|||
23234264|NCT00361504|64600707|FG001|Overall Study|Lost to Follow-up|7|||
23234265|NCT00361504|64600706|FG000|Overall Study|Adverse Event|203|||
23234266|NCT00361504|64600707|FG001|Overall Study|Adverse Event|82|||
23234267|NCT00361504|64600706|FG000|Overall Study|Lack of Efficacy|72|||
23234268|NCT00361504|64600707|FG001|Overall Study|Lack of Efficacy|7|||
23234269|NCT00361504|64600706|FG000|Overall Study|Resolution of Pain|2|||
23234270|NCT00361504|64600707|FG001|Overall Study|Resolution of Pain|0|||
23340065|NCT03483961|64989390|FG002|Overall Study|Adverse Event|1|||
23340066|NCT03483961|64989391|FG003|Overall Study|Adverse Event|0|||
23340067|NCT03483961|64989392|FG004|Overall Study|Adverse Event|0|||
23340068|NCT03483961|64989393|FG005|Overall Study|Adverse Event|0|||
23340069|NCT03483961|64989394|FG006|Overall Study|Adverse Event|0|||
23340070|NCT03483961|64989395|FG007|Overall Study|Adverse Event|0|||
23340071|NCT03483961|64989396|FG008|Overall Study|Adverse Event|0|||
23340072|NCT03483961|64989397|FG009|Overall Study|Adverse Event|0|||
23340073|NCT02541669|64989402|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
23340074|NCT02541669|64989403|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
23340075|NCT02541669|64989404|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
23340076|NCT02541669|64989405|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
23580441|NCT04610684|65853505|FG000|Follow up|Death|2|||
23340077|NCT02541669|64989406|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
23340078|NCT01089608|64989407|FG000|Overall Study|Adverse Event|0|||
23340079|NCT01089608|64989408|FG001|Overall Study|Adverse Event|4|||
23580442|NCT04610684|65853505|FG000|Follow up|Withdrawal by Subject|1|||
23580443|NCT00335556|65853506|FG000|Overall Study|Death|0|||
23580444|NCT00335556|65853507|FG001|Overall Study|Death|5|||
23580445|NCT00335556|65853508|FG002|Overall Study|Death|0|||
23580446|NCT00335556|65853509|FG003|Overall Study|Death|0|||
23580447|NCT00335556|65853510|FG004|Overall Study|Death|1|||
23580448|NCT00335556|65853511|FG005|Overall Study|Death|0|||
23580449|NCT00335556|65853506|FG000|Overall Study|Lack of Efficacy|0|||
23580450|NCT00335556|65853507|FG001|Overall Study|Lack of Efficacy|19|||
23580451|NCT00335556|65853508|FG002|Overall Study|Lack of Efficacy|3|||
23340080|NCT01089608|64989407|FG000|Overall Study|Lost to Follow-up|0|||
23580452|NCT00335556|65853509|FG003|Overall Study|Lack of Efficacy|3|||
23580453|NCT00335556|65853510|FG004|Overall Study|Lack of Efficacy|0|||
23580454|NCT00335556|65853511|FG005|Overall Study|Lack of Efficacy|1|||
23174491|NCT03183128|64382499|FG000|Overall Study|Lost to Follow-up|1|||
23234271|NCT00361504|64600706|FG000|Overall Study|Study medication non compliant|42|||
23234272|NCT00361504|64600707|FG001|Overall Study|Study medication non compliant|15|||
23580455|NCT00335556|65853506|FG000|Overall Study|Physician Decision|0|||
23580456|NCT00335556|65853507|FG001|Overall Study|Physician Decision|6|||
23580457|NCT00335556|65853508|FG002|Overall Study|Physician Decision|2|||
23580458|NCT00335556|65853509|FG003|Overall Study|Physician Decision|1|||
23580459|NCT00335556|65853510|FG004|Overall Study|Physician Decision|0|||
23580460|NCT00335556|65853511|FG005|Overall Study|Physician Decision|0|||
23580461|NCT00335556|65853506|FG000|Overall Study|Ineligible|2|||
23580462|NCT00335556|65853507|FG001|Overall Study|Ineligible|0|||
23580463|NCT00335556|65853508|FG002|Overall Study|Ineligible|0|||
23580464|NCT00335556|65853509|FG003|Overall Study|Ineligible|0|||
23580465|NCT00335556|65853510|FG004|Overall Study|Ineligible|0|||
23580466|NCT00335556|65853511|FG005|Overall Study|Ineligible|0|||
23580467|NCT00335556|65853506|FG000|Overall Study|Refusal of further protocol therapy|0|||
23580468|NCT00335556|65853507|FG001|Overall Study|Refusal of further protocol therapy|4|||
23580469|NCT00335556|65853508|FG002|Overall Study|Refusal of further protocol therapy|0|||
23580470|NCT00335556|65853509|FG003|Overall Study|Refusal of further protocol therapy|1|||
23234273|NCT00361504|64600706|FG000|Overall Study|All other|28|||
23234274|NCT00361504|64600707|FG001|Overall Study|All other|3|||
23234275|NCT04806334|64600708|FG000|Overall Study|Withdrawal by Subject|1|||
23234276|NCT01724021|64600709|FG000|Overall Study|Adverse Event|11|||
23234277|NCT01724021|64600710|FG001|Overall Study|Adverse Event|6|||
23234278|NCT01724021|64600709|FG000|Overall Study|Death|46|||
23580471|NCT00335556|65853510|FG004|Overall Study|Refusal of further protocol therapy|0|||
23580472|NCT00335556|65853511|FG005|Overall Study|Refusal of further protocol therapy|0|||
23580473|NCT00761774|65853514|FG000|Overall Study|Adverse Event|17|||
23580474|NCT00761774|65853514|FG000|Overall Study|Lack of Efficacy|37|||
23580475|NCT00761774|65853514|FG000|Overall Study|Lost to Follow-up|2|||
23580476|NCT00761774|65853514|FG000|Overall Study|Withdrawal by Subject|9|||
23580477|NCT00761774|65853514|FG000|Overall Study|Non-compliance|4|||
23580478|NCT00761774|65853514|FG000|Overall Study|End of study|2|||
23580479|NCT00761774|65853514|FG000|Overall Study|Reclassification of seizures|1|||
23580480|NCT00761774|65853514|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
23580481|NCT00761774|65853514|FG000|Overall Study|Sponsor decision|1|||
23580482|NCT00761774|65853514|FG000|Overall Study|Investigator clinical judgement|1|||
23580483|NCT00761774|65853514|FG000|Overall Study|Patient moved out of study area|1|||
23580484|NCT00761774|65853514|FG000|Overall Study|Coordinator leaving site|1|||
23580485|NCT00761774|65853514|FG000|Overall Study|Subject IP non-compliance|1|||
23580486|NCT00761774|65853514|FG000|Overall Study|IP stopped by hospital physician|1|||
23234279|NCT01724021|64600710|FG001|Overall Study|Death|58|||
23234280|NCT01724021|64600709|FG000|Overall Study|Participant request/ Withdrew consent|18|||
23234281|NCT01724021|64600710|FG001|Overall Study|Participant request/ Withdrew consent|14|||
23234282|NCT01724021|64600709|FG000|Overall Study|Lost to Follow-up|15|||
23234283|NCT01724021|64600710|FG001|Overall Study|Lost to Follow-up|15|||
23234284|NCT01724021|64600709|FG000|Overall Study|Reason Not Specified|36|||
23234285|NCT01724021|64600710|FG001|Overall Study|Reason Not Specified|39|||
23234286|NCT01724021|64600709|FG000|Overall Study|Missing|1|||
23234287|NCT01724021|64600710|FG001|Overall Study|Missing|1|||
23234288|NCT00732199|64600711|FG000|Overall Study|Withdrawal by Subject|25|||
23452031|NCT02714569|65398898|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23580487|NCT01555762|65853515|FG000|Overall Study|No information on Bevacizumab intake|11|||
23580488|NCT01555762|65853515|FG000|Overall Study|Missing start date of infusion|8|||
23580489|NCT01555762|65853515|FG000|Overall Study|75 years old or more ticked No|1|||
23580490|NCT01555762|65853515|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
23580491|NCT01555762|65853515|FG000|Overall Study|Death linked to progression of disease|165|||
23580492|NCT01555762|65853515|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
23580493|NCT01555762|65853515|FG000|Overall Study|Investigator's decision|10|||
23580494|NCT01555762|65853515|FG000|Overall Study|Participant not wishing to continue|5|||
23580495|NCT01555762|65853515|FG000|Overall Study|Missing data|1|||
23580496|NCT01555762|65853515|FG000|Overall Study|Death linked to an adverse event|14|||
23234289|NCT00732199|64600712|FG001|Overall Study|Withdrawal by Subject|18|||
23234290|NCT00732199|64600711|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
23234291|NCT00732199|64600712|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
23234292|NCT02036476|64600715|FG000|Overall Study|Withdrawal by Subject|2|||
23234293|NCT02036476|64600715|FG000|Overall Study|Progressive Disease|4|||
23234294|NCT02036476|64600715|FG000|Overall Study|Unacceptable Toxicity|2|||
23234295|NCT02561572|64600716|FG000|Overall Study|Inadequate time before surgery|2|||
23340081|NCT01089608|64989408|FG001|Overall Study|Lost to Follow-up|2|||
23234296|NCT02561572|64600717|FG001|Overall Study|Inadequate time before surgery|1|||
23234297|NCT02561572|64600716|FG000|Overall Study|Protocol Violation|0|||
23234298|NCT02561572|64600717|FG001|Overall Study|Protocol Violation|1|||
23234299|NCT01454531|64600718|FG000|Overall Study|Adverse Event|14|||
23234300|NCT01454531|64600718|FG000|Overall Study|Withdrawal by Subject|5|||
23234301|NCT01454531|64600718|FG000|Overall Study|Lost to Follow-up|1|||
23234302|NCT01454531|64600718|FG000|Overall Study|Physician Decision|1|||
23234303|NCT01454531|64600718|FG000|Overall Study|Delay in IMP administration|1|||
23234304|NCT01454531|64600718|FG000|Overall Study|Other|1|||
23234305|NCT04511533|64600720|FG000|Treatment|Other|2|||
23580497|NCT01140347|65853518|FG000|Overall Study|Lost to Follow-up|5|||
23580498|NCT01140347|65853519|FG001|Overall Study|Lost to Follow-up|6|||
23580499|NCT01140347|65853518|FG000|Overall Study|Withdrawal by Subject|13|||
23580500|NCT01140347|65853519|FG001|Overall Study|Withdrawal by Subject|8|||
23580501|NCT03115346|65853522|FG000|Overall Study|Did not have AAA surgery|28|||
23580502|NCT03115346|65853523|FG001|Overall Study|Did not have AAA surgery|15|||
23580503|NCT03115346|65853522|FG000|Overall Study|Death|3|||
23580504|NCT03115346|65853523|FG001|Overall Study|Death|1|||
23580505|NCT03115346|65853522|FG000|Overall Study|Withdrawal by Subject|0|||
23580506|NCT03115346|65853523|FG001|Overall Study|Withdrawal by Subject|3|||
23580507|NCT03115346|65853522|FG000|Overall Study|Lost to Follow-up|0|||
23580508|NCT03115346|65853523|FG001|Overall Study|Lost to Follow-up|3|||
23580509|NCT03251378|65853524|FG000|Overall Study|Death|3|||
23580510|NCT03251378|65853525|FG001|Overall Study|Death|2|||
23580511|NCT03251378|65853526|FG002|Overall Study|Death|3|||
23580512|NCT03251378|65853527|FG003|Overall Study|Death|30|||
23580513|NCT03251378|65853528|FG004|Overall Study|Death|24|||
23234306|NCT04511533|64600720|FG000|Treatment|Withdrawal by Subject|11|||
23234307|NCT04511533|64600720|FG000|Treatment|Death|5|||
23234308|NCT04511533|64600720|FG000|Treatment|Physician Decision|1|||
23234309|NCT04511533|64600720|FG000|Treatment|Progressive Disease|61|||
23234310|NCT04511533|64600720|FG000|Follow-Up|Other|7|||
23234311|NCT04511533|64600720|FG000|Follow-Up|Withdrawal by Subject|5|||
23340082|NCT01790828|64989417|FG000|Overall Study|Other|34|||
23340083|NCT02691013|64989418|FG000|Overall Study|Withdrawal by Subject|3|||
23340084|NCT02691013|64989419|FG001|Overall Study|Withdrawal by Subject|0|||
23234312|NCT04511533|64600720|FG000|Follow-Up|Lost to Follow-up|2|||
23234313|NCT04511533|64600720|FG000|Follow-Up|Death|4|||
23234314|NCT00134563|64600721|FG000|Overall Study|Not treated due to protocol violation|0|||
23234315|NCT00134563|64600722|FG001|Overall Study|Not treated due to protocol violation|1|||
23234316|NCT00134563|64600723|FG002|Overall Study|Not treated due to protocol violation|1|||
23234317|NCT00134563|64600721|FG000|Overall Study|Adverse Event|29|||
23234318|NCT00134563|64600722|FG001|Overall Study|Adverse Event|37|||
23234319|NCT00134563|64600723|FG002|Overall Study|Adverse Event|38|||
23234320|NCT00134563|64600721|FG000|Overall Study|Lack of Efficacy|24|||
23234321|NCT00134563|64600722|FG001|Overall Study|Lack of Efficacy|14|||
23234322|NCT00134563|64600723|FG002|Overall Study|Lack of Efficacy|17|||
23234323|NCT00134563|64600721|FG000|Overall Study|Protocol Violation|3|||
23234324|NCT00134563|64600722|FG001|Overall Study|Protocol Violation|2|||
23234325|NCT00134563|64600723|FG002|Overall Study|Protocol Violation|5|||
23340085|NCT01931956|64989428|FG000|Overall Study|Death|42|||
23580514|NCT03251378|65853529|FG005|Overall Study|Death|12|||
23580515|NCT03251378|65853530|FG006|Overall Study|Death|12|||
23580516|NCT03251378|65853524|FG000|Overall Study|Lost to Follow-up|0|||
23580517|NCT03251378|65853525|FG001|Overall Study|Lost to Follow-up|0|||
23234326|NCT00134563|64600721|FG000|Overall Study|Lost to Follow-up|4|||
23234327|NCT00134563|64600722|FG001|Overall Study|Lost to Follow-up|0|||
23234328|NCT00134563|64600723|FG002|Overall Study|Lost to Follow-up|2|||
23234329|NCT00134563|64600721|FG000|Overall Study|progressive disease|11|||
23234330|NCT00134563|64600722|FG001|Overall Study|progressive disease|4|||
23234331|NCT00134563|64600723|FG002|Overall Study|progressive disease|2|||
23234332|NCT00134563|64600721|FG000|Overall Study|did not wish to continue|33|||
23234333|NCT00134563|64600722|FG001|Overall Study|did not wish to continue|32|||
23234334|NCT00134563|64600723|FG002|Overall Study|did not wish to continue|26|||
23234335|NCT00134563|64600721|FG000|Overall Study|Reason other than above|0|||
23340086|NCT01931956|64989429|FG001|Overall Study|Death|7|||
23234336|NCT00134563|64600722|FG001|Overall Study|Reason other than above|2|||
23580518|NCT03251378|65853526|FG002|Overall Study|Lost to Follow-up|1|||
23580519|NCT03251378|65853527|FG003|Overall Study|Lost to Follow-up|3|||
23580520|NCT03251378|65853528|FG004|Overall Study|Lost to Follow-up|0|||
23580521|NCT03251378|65853529|FG005|Overall Study|Lost to Follow-up|0|||
23234337|NCT00134563|64600723|FG002|Overall Study|Reason other than above|5|||
23234338|NCT03481634|64600737|FG000|Overall Study|Withdrawal by Subject|16|||
23340087|NCT01931956|64989430|FG002|Overall Study|Death|379|||
23580522|NCT03251378|65853530|FG006|Overall Study|Lost to Follow-up|0|||
23234339|NCT03481634|64600738|FG001|Overall Study|Withdrawal by Subject|19|||
23234340|NCT03481634|64600739|FG002|Overall Study|Withdrawal by Subject|14|||
23234341|NCT03481634|64600737|FG000|Overall Study|Protocol Violation|1|||
23234342|NCT03481634|64600738|FG001|Overall Study|Protocol Violation|0|||
23234343|NCT03481634|64600739|FG002|Overall Study|Protocol Violation|1|||
23234344|NCT03481634|64600737|FG000|Overall Study|Progressive disease|0|||
23234345|NCT03481634|64600738|FG001|Overall Study|Progressive disease|1|||
23234346|NCT03481634|64600739|FG002|Overall Study|Progressive disease|0|||
23234347|NCT03481634|64600737|FG000|Overall Study|Physician Decision|3|||
23234348|NCT03481634|64600738|FG001|Overall Study|Physician Decision|0|||
23234349|NCT03481634|64600739|FG002|Overall Study|Physician Decision|1|||
23234350|NCT03481634|64600737|FG000|Overall Study|Lost to Follow-up|3|||
23234351|NCT03481634|64600738|FG001|Overall Study|Lost to Follow-up|4|||
23234352|NCT03481634|64600739|FG002|Overall Study|Lost to Follow-up|4|||
23234353|NCT03481634|64600737|FG000|Overall Study|Death|4|||
23234354|NCT03481634|64600738|FG001|Overall Study|Death|8|||
23234355|NCT03481634|64600739|FG002|Overall Study|Death|7|||
23234356|NCT03481634|64600737|FG000|Overall Study|Adverse Event|6|||
23234357|NCT03481634|64600738|FG001|Overall Study|Adverse Event|3|||
23234358|NCT03481634|64600739|FG002|Overall Study|Adverse Event|7|||
23234359|NCT02062385|64600740|FG000|Overall Study|Adverse Event|19|||
23234360|NCT02062385|64600741|FG001|Overall Study|Adverse Event|13|||
23234361|NCT02062385|64600742|FG002|Overall Study|Adverse Event|1|||
23234362|NCT02062385|64600743|FG003|Overall Study|Adverse Event|0|||
23234363|NCT02062385|64600740|FG000|Overall Study|Protocol Violation|1|||
23234364|NCT02062385|64600741|FG001|Overall Study|Protocol Violation|0|||
23452032|NCT02714569|65398899|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23174492|NCT03183128|64382500|FG001|Overall Study|Lost to Follow-up|0|||
23174493|NCT03183128|64382499|FG000|Overall Study|Death|2|||
23174494|NCT03183128|64382500|FG001|Overall Study|Death|0|||
23174495|NCT03183128|64382499|FG000|Overall Study|Physician Decision|1|||
23174496|NCT03183128|64382500|FG001|Overall Study|Physician Decision|0|||
23174497|NCT00880256|64382503|FG000|Overall Study|Lost to Follow-up|28|||
23174498|NCT03555266|64382504|FG000|Overall Study|Protocol Violation|6|||
23174499|NCT03555266|64382505|FG001|Overall Study|Protocol Violation|4|||
23174500|NCT03345472|64382508|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
23174501|NCT03345472|64382508|FG000|Implant to 3 Months|Physician Decision|1|||
23174502|NCT03345472|64382508|FG000|Implant to 3 Months|Adverse Event|1|||
23174503|NCT03345472|64382508|FG000|3 Months to 12 Months|Physician Decision|3|||
23174504|NCT03345472|64382508|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
23174505|NCT03345472|64382508|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
23174506|NCT03345472|64382508|FG000|3 Months to 12 Months|Adverse Event|1|||
23174507|NCT03345472|64382508|FG000|3 Months to 12 Months|Death|1|||
23174508|NCT02445586|64382511|FG000|Overall Study|Death|14|||
23174509|NCT02445586|64382511|FG000|Overall Study|Withdrawal by Subject|13|||
23174510|NCT02445586|64382511|FG000|Overall Study|Disease Progression|10|||
23174511|NCT02445586|64382511|FG000|Overall Study|Protocol Violation|1|||
23174512|NCT02445586|64382511|FG000|Overall Study|Medical Condition|1|||
23174513|NCT04067518|64382514|FG000|Overall Study|Adverse Event|1|||
23174514|NCT04067518|64382515|FG001|Overall Study|Adverse Event|3|||
23174515|NCT04067518|64382514|FG000|Overall Study|Screen failures|0|||
23174516|NCT04067518|64382515|FG001|Overall Study|Screen failures|1|||
23174517|NCT04067518|64382514|FG000|Overall Study|Enrolled but not treated|0|||
23174518|NCT04067518|64382515|FG001|Overall Study|Enrolled but not treated|1|||
23174519|NCT01318122|64382521|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23174520|NCT01318122|64382522|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23174521|NCT01318122|64382523|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
23174522|NCT01318122|64382524|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
23174523|NCT01318122|64382521|FG000|Enrolled - Long-Term Extension Study|Other|1|||
23174524|NCT01318122|64382522|FG001|Enrolled - Long-Term Extension Study|Other|0|||
23174525|NCT01318122|64382523|FG002|Enrolled - Long-Term Extension Study|Other|0|||
23174526|NCT01318122|64382524|FG003|Enrolled - Long-Term Extension Study|Other|0|||
23174527|NCT01318122|64382521|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
23174528|NCT01318122|64382522|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
23174529|NCT01318122|64382523|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
23174530|NCT01318122|64382524|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
23174531|NCT01318122|64382521|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
23174532|NCT01318122|64382522|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23174533|NCT01318122|64382523|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23174534|NCT01318122|64382524|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23174535|NCT01318122|64382521|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23174536|NCT01318122|64382522|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
23234365|NCT02062385|64600742|FG002|Overall Study|Protocol Violation|0|||
23234366|NCT02062385|64600743|FG003|Overall Study|Protocol Violation|0|||
23234367|NCT02062385|64600740|FG000|Overall Study|Incomplete EPI by database lock|2|||
23340088|NCT01931956|64989431|FG003|Overall Study|Death|96|||
23340089|NCT01931956|64989428|FG000|Overall Study|Withdrawal by Subject|5|||
23340090|NCT01931956|64989429|FG001|Overall Study|Withdrawal by Subject|0|||
23340091|NCT01931956|64989430|FG002|Overall Study|Withdrawal by Subject|70|||
23340092|NCT01931956|64989431|FG003|Overall Study|Withdrawal by Subject|30|||
23580523|NCT03251378|65853524|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
23580524|NCT03251378|65853525|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
23580525|NCT03251378|65853526|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
23580526|NCT03251378|65853527|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
23174537|NCT01318122|64382523|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23174538|NCT01318122|64382524|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23174539|NCT01318122|64382521|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23174540|NCT01318122|64382522|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
23174541|NCT01318122|64382523|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
23174542|NCT01318122|64382524|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23174543|NCT03118297|64382530|FG000|Overall Study|Lost to Follow-up|0|||
23174544|NCT03118297|64382531|FG001|Overall Study|Lost to Follow-up|2|||
23174545|NCT02239263|64382532|FG000|Overall Study|Protocol Violation|6|||
23174546|NCT02024971|64382533|FG000|Overall Study|Data Not Available|30|||
23174547|NCT02024971|64382533|FG000|Overall Study|Lost to Follow-up|6|||
23174548|NCT00400400|64382534|FG000|Overall Study|Adverse Event|9|||
23174549|NCT00400400|64382535|FG001|Overall Study|Adverse Event|8|||
23174550|NCT00400400|64382534|FG000|Overall Study|Protocol Violation|2|||
23174551|NCT00400400|64382535|FG001|Overall Study|Protocol Violation|0|||
23174552|NCT00400400|64382534|FG000|Overall Study|Withdrawal by Subject|1|||
23174553|NCT00400400|64382535|FG001|Overall Study|Withdrawal by Subject|3|||
23174554|NCT00400400|64382534|FG000|Overall Study|Administrative Problem|1|||
23174555|NCT00400400|64382535|FG001|Overall Study|Administrative Problem|0|||
23174556|NCT00400400|64382534|FG000|Overall Study|Lost to Follow-up|0|||
23174557|NCT00400400|64382535|FG001|Overall Study|Lost to Follow-up|1|||
23174558|NCT00400400|64382534|FG000|Overall Study|Did not receive study drug|1|||
23174559|NCT00400400|64382535|FG001|Overall Study|Did not receive study drug|3|||
23174560|NCT01282229|64382541|FG000|Overall Study|Protocol Violation|2|||
23174561|NCT01482910|64382542|FG000|Overall Study|Adverse Event|6|||
23174562|NCT01482910|64382543|FG001|Overall Study|Adverse Event|5|||
23174563|NCT01482910|64382542|FG000|Overall Study|Lost to Follow-up|0|||
23174564|NCT01482910|64382543|FG001|Overall Study|Lost to Follow-up|1|||
23174565|NCT01482910|64382542|FG000|Overall Study|Protocol Violation|1|||
23174566|NCT01482910|64382543|FG001|Overall Study|Protocol Violation|1|||
23174567|NCT01482910|64382542|FG000|Overall Study|Withdrawal by Subject|7|||
23174568|NCT01482910|64382543|FG001|Overall Study|Withdrawal by Subject|2|||
23174569|NCT01482910|64382542|FG000|Overall Study|Death|1|||
23174570|NCT01482910|64382543|FG001|Overall Study|Death|0|||
23174571|NCT00529958|64382544|FG000|2-Year Follow-up|Lost to Follow-up|1|||
23174572|NCT00529958|64382545|FG001|2-Year Follow-up|Lost to Follow-up|2|||
23174573|NCT00529958|64382546|FG002|2-Year Follow-up|Lost to Follow-up|2|||
23174574|NCT00529958|64382544|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
23174575|NCT00529958|64382545|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
23174576|NCT00529958|64382546|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
23174577|NCT00529958|64382544|FG000|5-Year Follow-up|Lost to Follow-up|2|||
23174578|NCT00529958|64382545|FG001|5-Year Follow-up|Lost to Follow-up|3|||
23174579|NCT00529958|64382546|FG002|5-Year Follow-up|Lost to Follow-up|1|||
23174580|NCT00529958|64382544|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
23174581|NCT00529958|64382545|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
23174582|NCT00529958|64382546|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
23174583|NCT00234039|64382547|FG000|Overall Study|Adverse Event|2|||
23174584|NCT00234039|64382547|FG000|Overall Study|Progression/relapse|34|||
23174585|NCT00234039|64382547|FG000|Overall Study|Other - Not Protocol Specified|3|||
23174586|NCT00234039|64382547|FG000|Overall Study|Ineligible|9|||
23174587|NCT00234039|64382547|FG000|Overall Study|No Protocol Treatment Received|2|||
23174588|NCT02404103|64382548|FG000|Overall Study|Adverse Event|1|||
23174589|NCT02404103|64382549|FG001|Overall Study|Adverse Event|0|||
23174590|NCT02404103|64382548|FG000|Overall Study|Lost to Follow-up|3|||
23174591|NCT02404103|64382549|FG001|Overall Study|Lost to Follow-up|3|||
23174592|NCT05048719|64382550|FG000|Overall Study|Withdrawal by Subject|2|||
23174593|NCT05048719|64382551|FG001|Overall Study|Withdrawal by Subject|1|||
23174594|NCT05048719|64382552|FG002|Overall Study|Withdrawal by Subject|3|||
23174595|NCT05048719|64382553|FG003|Overall Study|Withdrawal by Subject|1|||
23174596|NCT05048719|64382554|FG004|Overall Study|Withdrawal by Subject|0|||
23340093|NCT01931956|64989428|FG000|Overall Study|Lost to Follow-up|2|||
23340094|NCT01931956|64989429|FG001|Overall Study|Lost to Follow-up|0|||
23174597|NCT05048719|64382555|FG005|Overall Study|Withdrawal by Subject|2|||
23174598|NCT05048719|64382556|FG006|Overall Study|Withdrawal by Subject|1|||
23174599|NCT05048719|64382557|FG007|Overall Study|Withdrawal by Subject|1|||
23174600|NCT05048719|64382558|FG008|Overall Study|Withdrawal by Subject|0|||
23174601|NCT05048719|64382550|FG000|Overall Study|Death|1|||
23234368|NCT02062385|64600741|FG001|Overall Study|Incomplete EPI by database lock|0|||
23234369|NCT02062385|64600742|FG002|Overall Study|Incomplete EPI by database lock|0|||
23234370|NCT02062385|64600743|FG003|Overall Study|Incomplete EPI by database lock|0|||
23234371|NCT02062385|64600740|FG000|Overall Study|Moved|10|||
23234372|NCT02062385|64600741|FG001|Overall Study|Moved|11|||
23234373|NCT02062385|64600742|FG002|Overall Study|Moved|1|||
23234374|NCT02062385|64600743|FG003|Overall Study|Moved|0|||
23234375|NCT02062385|64600740|FG000|Overall Study|Withdrawn by parent/guardian|46|||
23234376|NCT02062385|64600741|FG001|Overall Study|Withdrawn by parent/guardian|41|||
23234377|NCT02062385|64600742|FG002|Overall Study|Withdrawn by parent/guardian|9|||
23234378|NCT02062385|64600743|FG003|Overall Study|Withdrawn by parent/guardian|8|||
23234379|NCT02062385|64600740|FG000|Overall Study|Death|0|||
23234380|NCT02062385|64600741|FG001|Overall Study|Death|0|||
23580527|NCT03251378|65853528|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
23580528|NCT03251378|65853529|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
23580529|NCT03251378|65853530|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
23234381|NCT02062385|64600742|FG002|Overall Study|Death|0|||
23234382|NCT02062385|64600743|FG003|Overall Study|Death|1|||
23234383|NCT02062385|64600740|FG000|Overall Study|Lost to Follow-up|0|||
23234384|NCT02062385|64600741|FG001|Overall Study|Lost to Follow-up|0|||
23234385|NCT02062385|64600742|FG002|Overall Study|Lost to Follow-up|1|||
23234386|NCT02062385|64600743|FG003|Overall Study|Lost to Follow-up|0|||
23234387|NCT02207413|64600744|FG000|Overall Study|Withdrawal by Subject|1|||
23234388|NCT02207413|64600745|FG001|Overall Study|Withdrawal by Subject|0|||
23580530|NCT03251378|65853524|FG000|Overall Study|Progressive disease|2|||
23580531|NCT03251378|65853525|FG001|Overall Study|Progressive disease|0|||
23580532|NCT03251378|65853526|FG002|Overall Study|Progressive disease|0|||
23580533|NCT03251378|65853527|FG003|Overall Study|Progressive disease|1|||
23234389|NCT02207413|64600746|FG002|Overall Study|Withdrawal by Subject|0|||
23234390|NCT02207413|64600747|FG003|Overall Study|Withdrawal by Subject|0|||
23234391|NCT02207413|64600748|FG004|Overall Study|Withdrawal by Subject|3|||
23234392|NCT02207413|64600749|FG005|Overall Study|Withdrawal by Subject|7|||
23234393|NCT02207413|64600744|FG000|Overall Study|Lost to Follow-up|0|||
23234394|NCT02207413|64600745|FG001|Overall Study|Lost to Follow-up|0|||
23234395|NCT02207413|64600746|FG002|Overall Study|Lost to Follow-up|0|||
23234396|NCT02207413|64600747|FG003|Overall Study|Lost to Follow-up|1|||
23234397|NCT02207413|64600748|FG004|Overall Study|Lost to Follow-up|1|||
23234398|NCT02207413|64600749|FG005|Overall Study|Lost to Follow-up|5|||
23234399|NCT02207413|64600744|FG000|Overall Study|Adverse Event|0|||
23234400|NCT02207413|64600745|FG001|Overall Study|Adverse Event|0|||
23234401|NCT02207413|64600746|FG002|Overall Study|Adverse Event|0|||
23234402|NCT02207413|64600747|FG003|Overall Study|Adverse Event|0|||
23234403|NCT02207413|64600748|FG004|Overall Study|Adverse Event|2|||
23234404|NCT02207413|64600749|FG005|Overall Study|Adverse Event|1|||
23234405|NCT02207413|64600744|FG000|Overall Study|Migrated/moved from study area|0|||
23234406|NCT02207413|64600745|FG001|Overall Study|Migrated/moved from study area|0|||
23234407|NCT02207413|64600746|FG002|Overall Study|Migrated/moved from study area|0|||
23234408|NCT02207413|64600747|FG003|Overall Study|Migrated/moved from study area|0|||
23234409|NCT02207413|64600748|FG004|Overall Study|Migrated/moved from study area|1|||
23234410|NCT02207413|64600749|FG005|Overall Study|Migrated/moved from study area|0|||
23234411|NCT04249076|64600750|FG000|Overall Study|Adverse Event|1|||
23234412|NCT04249076|64600751|FG001|Overall Study|Adverse Event|1|||
23234413|NCT04249076|64600750|FG000|Overall Study|Protocol Violation|1|||
23234414|NCT04249076|64600751|FG001|Overall Study|Protocol Violation|2|||
23234415|NCT04249076|64600750|FG000|Overall Study|Lack of Efficacy|0|||
23234416|NCT04249076|64600751|FG001|Overall Study|Lack of Efficacy|1|||
23234417|NCT04249076|64600750|FG000|Overall Study|Withdrawal by Subject|0|||
23234418|NCT04249076|64600751|FG001|Overall Study|Withdrawal by Subject|1|||
23234419|NCT00656136|64600754|FG000|Overall Study|Progressive disease|177|||
23234420|NCT00656136|64600755|FG001|Overall Study|Progressive disease|322|||
23234421|NCT00656136|64600754|FG000|Overall Study|Other Adverse Event|5|||
23234422|NCT00656136|64600755|FG001|Overall Study|Other Adverse Event|51|||
23234423|NCT00656136|64600754|FG000|Overall Study|Protocol Violation|2|||
23452033|NCT02714569|65398900|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452034|NCT02714569|65398901|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
23452035|NCT02714569|65398891|FG000|Part A Third Intervention|Adverse Event|0|||
23580534|NCT03251378|65853528|FG004|Overall Study|Progressive disease|0|||
23580535|NCT03251378|65853529|FG005|Overall Study|Progressive disease|0|||
23580536|NCT03251378|65853530|FG006|Overall Study|Progressive disease|0|||
23580537|NCT03251378|65853524|FG000|Overall Study|Physician Decision|0|||
23234424|NCT00656136|64600755|FG001|Overall Study|Protocol Violation|3|||
23234425|NCT00656136|64600754|FG000|Overall Study|Patient refused to take study medication|7|||
23340095|NCT01931956|64989430|FG002|Overall Study|Lost to Follow-up|11|||
23580538|NCT03251378|65853525|FG001|Overall Study|Physician Decision|2|||
23234426|NCT00656136|64600755|FG001|Overall Study|Patient refused to take study medication|10|||
23234427|NCT00656136|64600754|FG000|Overall Study|Unknown and others|4|||
23340096|NCT01931956|64989431|FG003|Overall Study|Lost to Follow-up|7|||
23340097|NCT01931956|64989428|FG000|Overall Study|Expected|2|||
23340098|NCT01931956|64989429|FG001|Overall Study|Expected|0|||
23340099|NCT01931956|64989430|FG002|Overall Study|Expected|6|||
23340100|NCT01931956|64989431|FG003|Overall Study|Expected|0|||
23174602|NCT05048719|64382551|FG001|Overall Study|Death|0|||
23174603|NCT05048719|64382552|FG002|Overall Study|Death|0|||
23174604|NCT05048719|64382553|FG003|Overall Study|Death|0|||
23174605|NCT05048719|64382554|FG004|Overall Study|Death|0|||
23174606|NCT05048719|64382555|FG005|Overall Study|Death|0|||
23174607|NCT05048719|64382556|FG006|Overall Study|Death|0|||
23174608|NCT05048719|64382557|FG007|Overall Study|Death|0|||
23174609|NCT05048719|64382558|FG008|Overall Study|Death|0|||
23174610|NCT05048719|64382550|FG000|Overall Study|Adverse Event|0|||
23174611|NCT05048719|64382551|FG001|Overall Study|Adverse Event|1|||
23174612|NCT05048719|64382552|FG002|Overall Study|Adverse Event|2|||
23174613|NCT05048719|64382553|FG003|Overall Study|Adverse Event|0|||
23174614|NCT05048719|64382554|FG004|Overall Study|Adverse Event|1|||
23174615|NCT05048719|64382555|FG005|Overall Study|Adverse Event|0|||
23174616|NCT05048719|64382556|FG006|Overall Study|Adverse Event|0|||
23174617|NCT05048719|64382557|FG007|Overall Study|Adverse Event|0|||
23174618|NCT05048719|64382558|FG008|Overall Study|Adverse Event|0|||
23174619|NCT05048719|64382550|FG000|Overall Study|Lost to Follow-up|0|||
23174620|NCT05048719|64382551|FG001|Overall Study|Lost to Follow-up|0|||
23174621|NCT05048719|64382552|FG002|Overall Study|Lost to Follow-up|1|||
23174622|NCT05048719|64382553|FG003|Overall Study|Lost to Follow-up|3|||
23174623|NCT05048719|64382554|FG004|Overall Study|Lost to Follow-up|1|||
23174624|NCT05048719|64382555|FG005|Overall Study|Lost to Follow-up|1|||
23174625|NCT05048719|64382556|FG006|Overall Study|Lost to Follow-up|1|||
23174626|NCT05048719|64382557|FG007|Overall Study|Lost to Follow-up|1|||
23174627|NCT05048719|64382558|FG008|Overall Study|Lost to Follow-up|0|||
23174628|NCT05048719|64382550|FG000|Overall Study|Physician Decision|0|||
23174629|NCT05048719|64382551|FG001|Overall Study|Physician Decision|0|||
23174630|NCT05048719|64382552|FG002|Overall Study|Physician Decision|0|||
23174631|NCT05048719|64382553|FG003|Overall Study|Physician Decision|0|||
23174632|NCT05048719|64382554|FG004|Overall Study|Physician Decision|0|||
23174633|NCT05048719|64382555|FG005|Overall Study|Physician Decision|0|||
23174634|NCT05048719|64382556|FG006|Overall Study|Physician Decision|0|||
23174635|NCT05048719|64382557|FG007|Overall Study|Physician Decision|1|||
23174636|NCT05048719|64382558|FG008|Overall Study|Physician Decision|1|||
23174637|NCT05048719|64382550|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
23174638|NCT05048719|64382551|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23174639|NCT05048719|64382552|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23174640|NCT05048719|64382553|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23174641|NCT05048719|64382554|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23174642|NCT05048719|64382555|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23174643|NCT05048719|64382556|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23174644|NCT05048719|64382557|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23174645|NCT05048719|64382558|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
23174646|NCT05048719|64382550|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23174647|NCT05048719|64382551|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
23174648|NCT05048719|64382552|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23174649|NCT05048719|64382553|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23174650|NCT05048719|64382554|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23174651|NCT05048719|64382555|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23174652|NCT05048719|64382556|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23174653|NCT05048719|64382557|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23175874|NCT04303000|64386599|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
23340101|NCT01931956|64989428|FG000|Overall Study|Not due|0|||
23340102|NCT01931956|64989429|FG001|Overall Study|Not due|0|||
23340103|NCT01931956|64989430|FG002|Overall Study|Not due|21|||
23340104|NCT01931956|64989431|FG003|Overall Study|Not due|0|||
23340105|NCT01167881|64989432|FG000|Overall Study|Adverse Event|47|||
23340106|NCT01167881|64989433|FG001|Overall Study|Adverse Event|51|||
23340107|NCT01167881|64989432|FG000|Overall Study|Lack of Efficacy|4|||
23340108|NCT01167881|64989433|FG001|Overall Study|Lack of Efficacy|7|||
23340109|NCT01167881|64989432|FG000|Overall Study|Non compliant with protocol|9|||
23340110|NCT01167881|64989433|FG001|Overall Study|Non compliant with protocol|18|||
23340111|NCT01167881|64989432|FG000|Overall Study|Lost to Follow-up|19|||
23340112|NCT01167881|64989433|FG001|Overall Study|Lost to Follow-up|20|||
23340113|NCT01167881|64989432|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
23340114|NCT01167881|64989433|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
23340115|NCT01167881|64989432|FG000|Overall Study|Not treated|4|||
23340116|NCT01167881|64989433|FG001|Overall Study|Not treated|0|||
23340117|NCT01167881|64989432|FG000|Overall Study|Other not defined above|31|||
23340118|NCT01167881|64989433|FG001|Overall Study|Other not defined above|55|||
23340119|NCT05318092|64989434|FG000|Overall Study|Lost to Follow-up|3|||
23340120|NCT05318092|64989434|FG000|Overall Study|Withdrawal by Subject|1|||
23340121|NCT03315286|64989437|FG000|Overall Study|Lost to Follow-up|0|||
23340122|NCT03315286|64989438|FG001|Overall Study|Lost to Follow-up|3|||
23340123|NCT03315286|64989437|FG000|Overall Study|Withdrawal by Subject|1|||
23340124|NCT03315286|64989438|FG001|Overall Study|Withdrawal by Subject|0|||
23340125|NCT03315286|64989437|FG000|Overall Study|Protocol Violation|0|||
23340126|NCT03315286|64989438|FG001|Overall Study|Protocol Violation|1|||
23340127|NCT01275755|64989439|FG000|Double-blind Treatment Period|Adverse Event|0|||
23340128|NCT01275755|64989440|FG001|Double-blind Treatment Period|Adverse Event|2|||
23340129|NCT01275755|64989439|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
23340130|NCT01275755|64989440|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
23340131|NCT01275755|64989439|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
23340132|NCT01275755|64989440|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23340133|NCT01275755|64989439|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
23340134|NCT01275755|64989440|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
23340135|NCT02162719|64989444|FG000|Overall Study|Death|41|||
23340136|NCT02162719|64989445|FG001|Overall Study|Death|46|||
23340137|NCT02162719|64989444|FG000|Overall Study|Lost to Follow-up|1|||
23340138|NCT02162719|64989445|FG001|Overall Study|Lost to Follow-up|3|||
23340139|NCT02162719|64989444|FG000|Overall Study|Disease Progression|2|||
23340140|NCT02162719|64989445|FG001|Overall Study|Disease Progression|1|||
23340141|NCT02162719|64989444|FG000|Overall Study|Withdrawal by Subject|8|||
23340142|NCT02162719|64989445|FG001|Overall Study|Withdrawal by Subject|2|||
23340143|NCT02162719|64989444|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
23340144|NCT02162719|64989445|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
23340145|NCT03589976|64989448|FG000|Overall Study|Death|5|||
23340146|NCT03589976|64989449|FG001|Overall Study|Death|1|||
23340147|NCT03589976|64989448|FG000|Overall Study|Adverse Event|5|||
23340148|NCT03589976|64989449|FG001|Overall Study|Adverse Event|1|||
23452036|NCT02714569|65398892|FG001|Part A Third Intervention|Adverse Event|0|||
23452037|NCT02714569|65398893|FG002|Part A Third Intervention|Adverse Event|1|||
23452038|NCT02714569|65398894|FG003|Part A Third Intervention|Adverse Event|0|||
23452039|NCT02714569|65398895|FG004|Part A Third Intervention|Adverse Event|0|||
23452040|NCT02714569|65398896|FG005|Part A Third Intervention|Adverse Event|0|||
23452041|NCT02714569|65398897|FG006|Part A Third Intervention|Adverse Event|0|||
23452042|NCT02714569|65398898|FG007|Part A Third Intervention|Adverse Event|0|||
23234428|NCT00656136|64600755|FG001|Overall Study|Unknown and others|4|||
23234429|NCT02908841|64600758|FG000|Overall Study|Physician Decision|4|||
23234430|NCT02908841|64600759|FG001|Overall Study|Physician Decision|0|||
23234431|NCT01354964|64600764|FG000|Overall Study|Lost to Follow-up|2|||
23234432|NCT01354964|64600765|FG001|Overall Study|Lost to Follow-up|0|||
23234433|NCT01354964|64600764|FG000|Overall Study|IV access issues|1|||
23234434|NCT01354964|64600765|FG001|Overall Study|IV access issues|1|||
23340149|NCT03589976|64989448|FG000|Overall Study|Withdrawal by Subject|4|||
23340150|NCT03589976|64989449|FG001|Overall Study|Withdrawal by Subject|1|||
23340151|NCT03589976|64989448|FG000|Overall Study|Lost to Follow-up|1|||
23340152|NCT03589976|64989449|FG001|Overall Study|Lost to Follow-up|0|||
23452043|NCT02714569|65398899|FG008|Part A Third Intervention|Adverse Event|0|||
23580539|NCT03251378|65853526|FG002|Overall Study|Physician Decision|0|||
23340153|NCT03589976|64989448|FG000|Overall Study|Other|4|||
23452044|NCT02714569|65398900|FG009|Part A Third Intervention|Adverse Event|0|||
23234435|NCT01354964|64600764|FG000|Overall Study|Physician Decision|1|||
23452045|NCT02714569|65398901|FG010|Part A Third Intervention|Adverse Event|0|||
23234436|NCT01354964|64600765|FG001|Overall Study|Physician Decision|0|||
23340154|NCT03589976|64989449|FG001|Overall Study|Other|3|||
23340155|NCT00150800|64989451|FG000|Overall Study|Adverse Event|89|||
23340156|NCT00150800|64989451|FG000|Overall Study|Death|18|||
23340157|NCT00150800|64989451|FG000|Overall Study|Lack of Efficacy|166|||
23340158|NCT00150800|64989451|FG000|Overall Study|Lost to Follow-up|58|||
23452046|NCT02714569|65398891|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
23452047|NCT02714569|65398892|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452048|NCT02714569|65398893|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452049|NCT02714569|65398894|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452050|NCT02714569|65398895|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452051|NCT02714569|65398896|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
23452052|NCT02714569|65398897|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452053|NCT02714569|65398898|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23580540|NCT03251378|65853527|FG003|Overall Study|Physician Decision|0|||
23580541|NCT03251378|65853528|FG004|Overall Study|Physician Decision|0|||
23234437|NCT00285857|64600766|FG000|Overall Study|Withdrawal by Subject|2|||
23234438|NCT00285857|64600766|FG000|Overall Study|Inadequate initial breast cytology|1|||
23234439|NCT00285857|64600766|FG000|Overall Study|Adverse Event|1|||
23234440|NCT00723489|64600773|FG000|Overall Study|Physician Decision|0|||
23234441|NCT00723489|64600774|FG001|Overall Study|Physician Decision|1|||
23234442|NCT00723489|64600775|FG002|Overall Study|Physician Decision|0|||
23234443|NCT00723489|64600776|FG003|Overall Study|Physician Decision|0|||
23234444|NCT00723489|64600773|FG000|Overall Study|Pregnancy|0|||
23234445|NCT00723489|64600774|FG001|Overall Study|Pregnancy|0|||
23234446|NCT00723489|64600775|FG002|Overall Study|Pregnancy|0|||
23234447|NCT00723489|64600776|FG003|Overall Study|Pregnancy|1|||
23234448|NCT00723489|64600773|FG000|Overall Study|Withdrawal by Subject|0|||
23234449|NCT00723489|64600774|FG001|Overall Study|Withdrawal by Subject|0|||
23234450|NCT00723489|64600775|FG002|Overall Study|Withdrawal by Subject|0|||
23234451|NCT00723489|64600776|FG003|Overall Study|Withdrawal by Subject|1|||
23234452|NCT00723489|64600773|FG000|Overall Study|Seropositive at baseline|1|||
23234453|NCT00723489|64600774|FG001|Overall Study|Seropositive at baseline|0|||
23234454|NCT00723489|64600775|FG002|Overall Study|Seropositive at baseline|0|||
23580542|NCT03251378|65853529|FG005|Overall Study|Physician Decision|0|||
23580543|NCT03251378|65853530|FG006|Overall Study|Physician Decision|0|||
23234455|NCT00723489|64600776|FG003|Overall Study|Seropositive at baseline|0|||
23234456|NCT00723489|64600773|FG000|Overall Study|Prohibited Medication|0|||
23234457|NCT00723489|64600774|FG001|Overall Study|Prohibited Medication|0|||
23234458|NCT00723489|64600775|FG002|Overall Study|Prohibited Medication|0|||
23234459|NCT00723489|64600776|FG003|Overall Study|Prohibited Medication|1|||
23234460|NCT00723489|64600773|FG000|Overall Study|Samples Collected Out of Window|0|||
23234461|NCT00723489|64600774|FG001|Overall Study|Samples Collected Out of Window|3|||
23234462|NCT00723489|64600775|FG002|Overall Study|Samples Collected Out of Window|0|||
23234463|NCT00723489|64600776|FG003|Overall Study|Samples Collected Out of Window|0|||
23234464|NCT03730987|64600777|FG000|Overall Study|Lost to Follow-up|2|||
23234465|NCT03730987|64600778|FG001|Overall Study|Lost to Follow-up|0|||
23234466|NCT03730987|64600779|FG002|Overall Study|Lost to Follow-up|2|||
23234467|NCT03730987|64600780|FG003|Overall Study|Lost to Follow-up|0|||
23234468|NCT01218477|64600781|FG000|Overall Study|Disease progression|2|||
23234469|NCT01218477|64600782|FG001|Overall Study|Disease progression|3|||
23234470|NCT01218477|64600783|FG002|Overall Study|Disease progression|6|||
23234471|NCT01218477|64600784|FG003|Overall Study|Disease progression|2|||
23234472|NCT01218477|64600781|FG000|Overall Study|Study drug toxicity|0|||
23234473|NCT01218477|64600782|FG001|Overall Study|Study drug toxicity|2|||
23234474|NCT01218477|64600783|FG002|Overall Study|Study drug toxicity|5|||
23234475|NCT01218477|64600784|FG003|Overall Study|Study drug toxicity|0|||
23234476|NCT01218477|64600781|FG000|Overall Study|No longer meets study criteria|1|||
23234477|NCT01218477|64600782|FG001|Overall Study|No longer meets study criteria|0|||
23234478|NCT01218477|64600783|FG002|Overall Study|No longer meets study criteria|0|||
23234479|NCT01218477|64600784|FG003|Overall Study|No longer meets study criteria|0|||
23234480|NCT01218477|64600781|FG000|Overall Study|Withdrawal by Subject|0|||
23234481|NCT01218477|64600782|FG001|Overall Study|Withdrawal by Subject|0|||
23234482|NCT01218477|64600783|FG002|Overall Study|Withdrawal by Subject|1|||
23234483|NCT01218477|64600784|FG003|Overall Study|Withdrawal by Subject|0|||
23234484|NCT01218477|64600781|FG000|Overall Study|Prepared for cell transplantation|0|||
23234485|NCT01218477|64600782|FG001|Overall Study|Prepared for cell transplantation|1|||
23234486|NCT01218477|64600783|FG002|Overall Study|Prepared for cell transplantation|1|||
23234487|NCT01218477|64600784|FG003|Overall Study|Prepared for cell transplantation|0|||
23234488|NCT01218477|64600781|FG000|Overall Study|Administrative reason by sponsor|0|||
23234489|NCT01218477|64600782|FG001|Overall Study|Administrative reason by sponsor|0|||
23580544|NCT03251378|65853524|FG000|Overall Study|Other|2|||
23580545|NCT03251378|65853525|FG001|Overall Study|Other|3|||
23580546|NCT03251378|65853526|FG002|Overall Study|Other|2|||
23234490|NCT01218477|64600783|FG002|Overall Study|Administrative reason by sponsor|1|||
23234491|NCT01218477|64600784|FG003|Overall Study|Administrative reason by sponsor|0|||
23234492|NCT01218477|64600781|FG000|Overall Study|Maximum clinical benefit|0|||
23234493|NCT01218477|64600782|FG001|Overall Study|Maximum clinical benefit|2|||
23234494|NCT01218477|64600783|FG002|Overall Study|Maximum clinical benefit|0|||
23340159|NCT00150800|64989451|FG000|Overall Study|Subject's choice|90|||
23580547|NCT03251378|65853527|FG003|Overall Study|Other|0|||
23234495|NCT01218477|64600784|FG003|Overall Study|Maximum clinical benefit|0|||
23234496|NCT04335929|64600785|FG000|Overall Study|Lost to Follow-up|10|||
23234497|NCT00490815|64600786|FG000|Overall Study|Adverse Event|2|||
23234498|NCT00490815|64600787|FG001|Overall Study|Adverse Event|3|||
23234499|NCT00490815|64600786|FG000|Overall Study|Withdrawal by Subject|4|||
23234500|NCT00490815|64600787|FG001|Overall Study|Withdrawal by Subject|0|||
23234501|NCT00490815|64600786|FG000|Overall Study|Lost to Follow-up|1|||
23234502|NCT00490815|64600787|FG001|Overall Study|Lost to Follow-up|3|||
23234503|NCT00490815|64600786|FG000|Overall Study|Death|1|||
23234504|NCT00490815|64600787|FG001|Overall Study|Death|3|||
23340160|NCT00150800|64989451|FG000|Overall Study|No compliance|18|||
23340161|NCT00150800|64989451|FG000|Overall Study|IP misshandling|1|||
23340162|NCT00150800|64989451|FG000|Overall Study|Site closure|24|||
23340163|NCT00150800|64989451|FG000|Overall Study|Protocol non-adherence|2|||
23340164|NCT00150800|64989451|FG000|Overall Study|Nobody to accompany patient|1|||
23340165|NCT00150800|64989451|FG000|Overall Study|Distance too long for patient|1|||
23340166|NCT00150800|64989451|FG000|Overall Study|Neurosurgery|2|||
23234505|NCT02743494|64600797|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
23234506|NCT02743494|64600798|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
23234507|NCT02743494|64600797|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
23234508|NCT02743494|64600798|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
23234509|NCT02743494|64600797|FG000|Treatment Period|Completed treatment|229|||
23234510|NCT02743494|64600798|FG001|Treatment Period|Completed treatment|99|||
23234511|NCT02743494|64600797|FG000|Treatment Period|Disease recurrence|149|||
23234512|NCT02743494|64600798|FG001|Treatment Period|Disease recurrence|113|||
23234513|NCT02743494|64600797|FG000|Treatment Period|Study drug toxicity|57|||
23234514|NCT02743494|64600798|FG001|Treatment Period|Study drug toxicity|8|||
23234515|NCT02743494|64600797|FG000|Treatment Period|Death|1|||
23234516|NCT02743494|64600798|FG001|Treatment Period|Death|0|||
23234517|NCT02743494|64600797|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
23234518|NCT02743494|64600798|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
23234519|NCT02743494|64600797|FG000|Treatment Period|Participant request to discontinue treatment|30|||
23234520|NCT02743494|64600798|FG001|Treatment Period|Participant request to discontinue treatment|5|||
23234521|NCT02743494|64600797|FG000|Treatment Period|Participant withdrew consent|12|||
23234522|NCT02743494|64600798|FG001|Treatment Period|Participant withdrew consent|4|||
23234523|NCT02743494|64600797|FG000|Treatment Period|Lost to Follow-up|0|||
23234524|NCT02743494|64600798|FG001|Treatment Period|Lost to Follow-up|1|||
23234525|NCT02743494|64600797|FG000|Treatment Period|Poor/Non-compliance|1|||
23340167|NCT00150800|64989451|FG000|Overall Study|BRV monotherapy|1|||
23340168|NCT00150800|64989451|FG000|Overall Study|Visit refusal|3|||
23340169|NCT00150800|64989451|FG000|Overall Study|Sponsor's request|2|||
23340170|NCT00150800|64989451|FG000|Overall Study|Generalized Epilepsy|1|||
23340171|NCT00150800|64989451|FG000|Overall Study|Moved from area/country|8|||
23340172|NCT00150800|64989451|FG000|Overall Study|PI retiring|2|||
23340173|NCT00150800|64989451|FG000|Overall Study|PI leaving site|2|||
23340174|NCT00150800|64989451|FG000|Overall Study|Patient insurance|1|||
23340175|NCT00150800|64989451|FG000|Overall Study|Surgical intervention|4|||
23340176|NCT00150800|64989451|FG000|Overall Study|Pregnancy planned|1|||
23340177|NCT00150800|64989451|FG000|Overall Study|PI discontinuation request|1|||
23340178|NCT02111785|64989453|FG000|Overall Study|Death|0|||
23340179|NCT02111785|64989454|FG001|Overall Study|Death|1|||
23340180|NCT02111785|64989455|FG002|Overall Study|Death|0|||
23340181|NCT02111785|64989456|FG003|Overall Study|Death|0|||
23340182|NCT00076752|64989462|FG000|Overall Study|Death|2|||
23340183|NCT00076752|64989462|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
23340184|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
23340185|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340186|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340187|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340188|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340189|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23340190|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
23452054|NCT02714569|65398899|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23452055|NCT02714569|65398900|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23580548|NCT03251378|65853528|FG004|Overall Study|Other|1|||
23580549|NCT03251378|65853529|FG005|Overall Study|Other|1|||
23580550|NCT03251378|65853530|FG006|Overall Study|Other|1|||
23234526|NCT02743494|64600798|FG001|Treatment Period|Poor/Non-compliance|0|||
23340191|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
23340192|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340868|NCT01936181|64992873|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
23234527|NCT02743494|64600797|FG000|Treatment Period|Other reasons|7|||
23234528|NCT02743494|64600798|FG001|Treatment Period|Other reasons|2|||
23234529|NCT01667731|64600799|FG000|Overall Study|Enrolled but not treated|0|||
23174654|NCT05048719|64382558|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
23174655|NCT05048719|64382550|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23174656|NCT05048719|64382551|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
23174657|NCT05048719|64382552|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23174658|NCT05048719|64382553|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23174659|NCT05048719|64382554|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23174660|NCT05048719|64382555|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23174661|NCT05048719|64382556|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23174662|NCT05048719|64382557|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23174663|NCT05048719|64382558|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
23174664|NCT05048719|64382550|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23174665|NCT05048719|64382551|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23174666|NCT05048719|64382552|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23174667|NCT05048719|64382553|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
23174668|NCT05048719|64382554|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23174669|NCT05048719|64382555|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23174670|NCT05048719|64382556|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23174671|NCT05048719|64382557|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23234530|NCT01667731|64600800|FG001|Overall Study|Enrolled but not treated|0|||
23234531|NCT01667731|64600801|FG002|Overall Study|Enrolled but not treated|0|||
23234532|NCT01667731|64600802|FG003|Overall Study|Enrolled but not treated|0|||
23234533|NCT01667731|64600803|FG004|Overall Study|Enrolled but not treated|1|||
23234534|NCT01667731|64600799|FG000|Overall Study|Efficacy Failure|1|||
23234535|NCT01667731|64600800|FG001|Overall Study|Efficacy Failure|12|||
23234536|NCT01667731|64600801|FG002|Overall Study|Efficacy Failure|0|||
23234537|NCT01667731|64600802|FG003|Overall Study|Efficacy Failure|1|||
23234538|NCT01667731|64600803|FG004|Overall Study|Efficacy Failure|24|||
23234539|NCT01667731|64600799|FG000|Overall Study|Lost to Follow-up|2|||
23234540|NCT01667731|64600800|FG001|Overall Study|Lost to Follow-up|3|||
23234541|NCT01667731|64600801|FG002|Overall Study|Lost to Follow-up|1|||
23234542|NCT01667731|64600802|FG003|Overall Study|Lost to Follow-up|1|||
23234543|NCT01667731|64600803|FG004|Overall Study|Lost to Follow-up|2|||
23234544|NCT01667731|64600799|FG000|Overall Study|Subject Withdrew Consent|2|||
23234545|NCT01667731|64600800|FG001|Overall Study|Subject Withdrew Consent|0|||
23234546|NCT01667731|64600801|FG002|Overall Study|Subject Withdrew Consent|1|||
23234547|NCT01667731|64600802|FG003|Overall Study|Subject Withdrew Consent|0|||
23234548|NCT01667731|64600803|FG004|Overall Study|Subject Withdrew Consent|1|||
23234549|NCT01667731|64600799|FG000|Overall Study|Death|0|||
23234550|NCT01667731|64600800|FG001|Overall Study|Death|1|||
23234551|NCT01667731|64600801|FG002|Overall Study|Death|0|||
23234552|NCT01667731|64600802|FG003|Overall Study|Death|0|||
23234553|NCT01667731|64600803|FG004|Overall Study|Death|0|||
23580551|NCT03251378|65853524|FG000|Overall Study|Other|0|||
23580552|NCT03251378|65853525|FG001|Overall Study|Other|0|||
23580553|NCT03251378|65853526|FG002|Overall Study|Other|0|||
23580554|NCT03251378|65853527|FG003|Overall Study|Other|4|||
23580555|NCT03251378|65853528|FG004|Overall Study|Other|13|||
23580556|NCT03251378|65853529|FG005|Overall Study|Other|0|||
23580557|NCT03251378|65853530|FG006|Overall Study|Other|0|||
23580558|NCT01251614|65853531|FG000|Overall Study|Adverse Event|1|||
23580559|NCT01251614|65853532|FG001|Overall Study|Adverse Event|0|||
23580560|NCT01251614|65853533|FG002|Overall Study|Adverse Event|1|||
23580561|NCT01251614|65853531|FG000|Overall Study|Lack of Efficacy|1|||
23580562|NCT01251614|65853532|FG001|Overall Study|Lack of Efficacy|9|||
23580563|NCT01251614|65853533|FG002|Overall Study|Lack of Efficacy|4|||
23580564|NCT01251614|65853531|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
23580565|NCT01251614|65853532|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
23580566|NCT01251614|65853533|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
23580567|NCT01251614|65853531|FG000|Overall Study|Pregnancy|0|||
23580568|NCT01251614|65853532|FG001|Overall Study|Pregnancy|0|||
23580569|NCT01251614|65853533|FG002|Overall Study|Pregnancy|2|||
23580570|NCT01251614|65853531|FG000|Overall Study|Loss of Disease Control|0|||
23580571|NCT01251614|65853532|FG001|Overall Study|Loss of Disease Control|1|||
23580572|NCT01251614|65853533|FG002|Overall Study|Loss of Disease Control|0|||
23580573|NCT01251614|65853531|FG000|Overall Study|Withdrawal by Subject|0|||
23580574|NCT01251614|65853532|FG001|Overall Study|Withdrawal by Subject|2|||
23580575|NCT01251614|65853533|FG002|Overall Study|Withdrawal by Subject|1|||
23580576|NCT01251614|65853531|FG000|Overall Study|Lost to Follow-up|0|||
23580577|NCT01251614|65853532|FG001|Overall Study|Lost to Follow-up|1|||
23580578|NCT01251614|65853533|FG002|Overall Study|Lost to Follow-up|0|||
23580579|NCT02049437|65853537|FG000|Period 1|Adverse Event|1|||
23580580|NCT02049437|65853538|FG001|Period 1|Adverse Event|1|||
23580581|NCT02049437|65853537|FG000|Period 1|Adverse Event|1|||
23580582|NCT02049437|65853538|FG001|Period 1|Adverse Event|0|||
23580583|NCT02846415|65853539|FG000|Overall Study|Lost to Follow-up|2|||
23580584|NCT02846415|65853540|FG001|Overall Study|Lost to Follow-up|0|||
23580585|NCT02846415|65853539|FG000|Overall Study|Withdrawal by Subject|1|||
23580586|NCT02846415|65853540|FG001|Overall Study|Withdrawal by Subject|1|||
23580587|NCT00430677|65853541|FG000|Short-term Period|Death|1|||
23580588|NCT00430677|65853542|FG001|Short-term Period|Death|1|||
23580589|NCT00430677|65853543|FG002|Short-term Period|Death|5|||
23580590|NCT00430677|65853541|FG000|Short-term Period|Adverse Event|15|||
23580591|NCT00430677|65853542|FG001|Short-term Period|Adverse Event|13|||
23580592|NCT00430677|65853543|FG002|Short-term Period|Adverse Event|9|||
23580593|NCT00430677|65853541|FG000|Short-term Period|Lack of Efficacy|5|||
23580594|NCT00430677|65853542|FG001|Short-term Period|Lack of Efficacy|6|||
23580595|NCT00430677|65853543|FG002|Short-term Period|Lack of Efficacy|4|||
23580596|NCT00430677|65853541|FG000|Short-term Period|Withdrawal by Subject|1|||
23580597|NCT00430677|65853542|FG001|Short-term Period|Withdrawal by Subject|1|||
23234554|NCT02463097|64600804|FG000|Overall Study|Withdrawal by Subject|1|||
23234555|NCT01823991|64600805|FG000|Overall Study|Withdrawal by Subject|8|||
23234556|NCT01823991|64600806|FG001|Overall Study|Withdrawal by Subject|5|||
23234557|NCT00635804|64600807|FG000|Overall Study|Adverse Event|0|||
23234558|NCT00635804|64600808|FG001|Overall Study|Adverse Event|0|||
23234559|NCT00635804|64600809|FG002|Overall Study|Adverse Event|0|||
23234560|NCT00635804|64600810|FG003|Overall Study|Adverse Event|0|||
23234561|NCT00635804|64600811|FG004|Overall Study|Adverse Event|0|||
23580598|NCT00430677|65853543|FG002|Short-term Period|Withdrawal by Subject|2|||
23580599|NCT00430677|65853541|FG000|Short-term Period|Participant no longer met study criteria|1|||
23234562|NCT00635804|64600812|FG005|Overall Study|Adverse Event|1|||
23234563|NCT00635804|64600813|FG006|Overall Study|Adverse Event|0|||
23234564|NCT00635804|64600814|FG007|Overall Study|Adverse Event|0|||
23580600|NCT00430677|65853542|FG001|Short-term Period|Participant no longer met study criteria|1|||
23580601|NCT00430677|65853543|FG002|Short-term Period|Participant no longer met study criteria|2|||
23580602|NCT00430677|65853541|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
23580603|NCT00430677|65853542|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
23580604|NCT00430677|65853543|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
23580605|NCT00430677|65853541|FG000|Short-term Period|Pregnancy|0|||
23580606|NCT00430677|65853542|FG001|Short-term Period|Pregnancy|2|||
23580607|NCT00430677|65853543|FG002|Short-term Period|Pregnancy|0|||
23580608|NCT00430677|65853541|FG000|Long-term Extension Period|Death|1|||
23580609|NCT00430677|65853542|FG001|Long-term Extension Period|Death|0|||
23580610|NCT00430677|65853543|FG002|Long-term Extension Period|Death|0|||
23234565|NCT00635804|64600807|FG000|Overall Study|Withdrawal by Subject|1|||
23234566|NCT00635804|64600808|FG001|Overall Study|Withdrawal by Subject|0|||
23234567|NCT00635804|64600809|FG002|Overall Study|Withdrawal by Subject|0|||
23234568|NCT00635804|64600810|FG003|Overall Study|Withdrawal by Subject|0|||
23234569|NCT00635804|64600811|FG004|Overall Study|Withdrawal by Subject|0|||
23234570|NCT00635804|64600812|FG005|Overall Study|Withdrawal by Subject|0|||
23234571|NCT00635804|64600813|FG006|Overall Study|Withdrawal by Subject|0|||
23234572|NCT00635804|64600814|FG007|Overall Study|Withdrawal by Subject|0|||
23234573|NCT01599585|64600817|FG000|Overall Study|Withdrawal by Subject|16|||
23234574|NCT01599585|64600818|FG001|Overall Study|Withdrawal by Subject|9|||
23234575|NCT01599585|64600817|FG000|Overall Study|Lost to Follow-up|3|||
23234576|NCT01599585|64600818|FG001|Overall Study|Lost to Follow-up|5|||
23234577|NCT01599585|64600817|FG000|Overall Study|randomized did not start treatment|3|||
23234578|NCT01599585|64600818|FG001|Overall Study|randomized did not start treatment|3|||
23234579|NCT02505945|64600819|FG000|Overall Study|Withdrawal by Subject|13|||
23234580|NCT02505945|64600820|FG001|Overall Study|Withdrawal by Subject|2|||
23234581|NCT02505945|64600819|FG000|Overall Study|Adverse Event|1|||
23234582|NCT02505945|64600820|FG001|Overall Study|Adverse Event|0|||
23234583|NCT02505945|64600819|FG000|Overall Study|Physician Decision|2|||
23234584|NCT02505945|64600820|FG001|Overall Study|Physician Decision|1|||
23234585|NCT02505945|64600819|FG000|Overall Study|Lost to Follow-up|6|||
23234586|NCT02505945|64600820|FG001|Overall Study|Lost to Follow-up|1|||
23234587|NCT00696774|64600822|FG000|Period II|Adverse Event|0|||
23234588|NCT00696774|64600823|FG001|Period II|Adverse Event|0|||
23234589|NCT00696774|64600824|FG002|Period II|Adverse Event|15|||
23234590|NCT00696774|64600822|FG000|Period II|Lost to Follow-up|0|||
23234591|NCT00696774|64600823|FG001|Period II|Lost to Follow-up|0|||
23234592|NCT00696774|64600824|FG002|Period II|Lost to Follow-up|4|||
23234593|NCT00696774|64600822|FG000|Period II|Protocol Violation|0|||
23234594|NCT00696774|64600823|FG001|Period II|Protocol Violation|0|||
23234595|NCT00696774|64600824|FG002|Period II|Protocol Violation|11|||
23234596|NCT00696774|64600822|FG000|Period II|Withdrawal by Subject|0|||
23234597|NCT00696774|64600823|FG001|Period II|Withdrawal by Subject|0|||
23234598|NCT00696774|64600824|FG002|Period II|Withdrawal by Subject|4|||
23234599|NCT00696774|64600822|FG000|Period II|Sponsor Decision|0|||
23234600|NCT00696774|64600823|FG001|Period II|Sponsor Decision|0|||
23234601|NCT00696774|64600824|FG002|Period II|Sponsor Decision|0|||
23234602|NCT00696774|64600822|FG000|Period II|Lack of Efficacy|0|||
23234603|NCT00696774|64600823|FG001|Period II|Lack of Efficacy|0|||
23234604|NCT00696774|64600824|FG002|Period II|Lack of Efficacy|2|||
23234605|NCT00696774|64600822|FG000|Period III|Adverse Event|1|||
23234606|NCT00696774|64600823|FG001|Period III|Adverse Event|1|||
23234607|NCT00696774|64600824|FG002|Period III|Adverse Event|0|||
23234608|NCT00696774|64600822|FG000|Period III|Lost to Follow-up|2|||
23234609|NCT00696774|64600823|FG001|Period III|Lost to Follow-up|1|||
23234610|NCT00696774|64600824|FG002|Period III|Lost to Follow-up|0|||
23234611|NCT00696774|64600822|FG000|Period III|Protocol Violation|1|||
23234612|NCT00696774|64600823|FG001|Period III|Protocol Violation|1|||
23234613|NCT00696774|64600824|FG002|Period III|Protocol Violation|0|||
23234614|NCT00696774|64600822|FG000|Period III|Withdrawal by Subject|1|||
23234615|NCT00696774|64600823|FG001|Period III|Withdrawal by Subject|2|||
23234616|NCT00696774|64600824|FG002|Period III|Withdrawal by Subject|0|||
23234617|NCT00696774|64600822|FG000|Period III|Sponsor Decision|2|||
23234618|NCT00696774|64600823|FG001|Period III|Sponsor Decision|0|||
23234619|NCT00696774|64600824|FG002|Period III|Sponsor Decision|0|||
23234620|NCT00696774|64600822|FG000|Period III|Lack of Efficacy|0|||
23234621|NCT00696774|64600823|FG001|Period III|Lack of Efficacy|2|||
23234622|NCT00696774|64600824|FG002|Period III|Lack of Efficacy|0|||
23234623|NCT03039699|64600828|FG000|Overall Study|Incorrect inclusion|5|||
23234624|NCT03039699|64600829|FG001|Overall Study|Incorrect inclusion|4|||
23234625|NCT03039699|64600828|FG000|Overall Study|Lack of data to assess study endpoint|5|||
23234626|NCT03039699|64600829|FG001|Overall Study|Lack of data to assess study endpoint|3|||
23234627|NCT03039699|64600828|FG000|Overall Study|Bacterial infection|12|||
23234628|NCT03039699|64600829|FG001|Overall Study|Bacterial infection|28|||
23234629|NCT02583399|64600833|FG000|Overall Study|Able to be discharged|3|||
23234630|NCT02583399|64600833|FG000|Overall Study|Wanted to use a restricted medication|3|||
23234631|NCT00568399|64600834|FG000|Overall Study|Death|2|||
23234632|NCT00568399|64600834|FG000|Overall Study|Adverse Event|5|||
23234633|NCT00568399|64600834|FG000|Overall Study|Withdrawal by Subject|8|||
23234634|NCT00724243|64600839|FG000|Overall Study|Lack of Efficacy|10|||
23234635|NCT00724243|64600839|FG000|Overall Study|Adverse Event|5|||
23234636|NCT01385098|64600840|FG000|Overall Study|Adverse Event|10|||
23234637|NCT01385098|64600840|FG000|Overall Study|Lost to Follow-up|4|||
23234638|NCT02718131|64600841|FG000|Overall Study|Withdrawal by Subject|1|||
23234639|NCT02718131|64600842|FG001|Overall Study|Withdrawal by Subject|0|||
23234640|NCT02718131|64600841|FG000|Overall Study|Adverse Event|1|||
23234641|NCT02718131|64600842|FG001|Overall Study|Adverse Event|0|||
23234642|NCT02718131|64600841|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
23234643|NCT02718131|64600842|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
23234644|NCT04794491|64600849|FG000|Overall Study|Adverse Event|1|||
23234645|NCT04794491|64600849|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
23234646|NCT04794491|64600849|FG000|Overall Study|Noncompliance With Study Intervention|1|||
23234647|NCT04794491|64600849|FG000|Overall Study|Withdrawal by Subject|2|||
23234648|NCT01373294|64600851|FG000|Overall Study|Adverse Event|1|||
23234649|NCT01373294|64600852|FG001|Overall Study|Adverse Event|0|||
23234650|NCT02610231|64600853|FG000|Overall Study|Withdrawal by Subject|27|||
23340193|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23580611|NCT00430677|65853541|FG000|Long-term Extension Period|Adverse Event|3|||
23234651|NCT02610231|64600853|FG000|Overall Study|Adverse Event|20|||
23580612|NCT00430677|65853542|FG001|Long-term Extension Period|Adverse Event|2|||
23234652|NCT02610231|64600853|FG000|Overall Study|Death|5|||
23234653|NCT02610231|64600853|FG000|Overall Study|Surgery|2|||
23234654|NCT02610231|64600853|FG000|Overall Study|Physician Decision|1|||
23234655|NCT02610231|64600853|FG000|Overall Study|Non Compliance|2|||
23234656|NCT02610231|64600853|FG000|Overall Study|Other|3|||
23234657|NCT00027846|64600854|FG000|Overall Study|Lost to Follow-up|0|||
23234658|NCT00027846|64600855|FG001|Overall Study|Lost to Follow-up|41|||
23234659|NCT00027846|64600856|FG002|Overall Study|Lost to Follow-up|9|||
23234660|NCT00027846|64600854|FG000|Overall Study|Withdrawal by Subject|0|||
23234661|NCT00027846|64600855|FG001|Overall Study|Withdrawal by Subject|14|||
23234662|NCT00027846|64600856|FG002|Overall Study|Withdrawal by Subject|7|||
23234663|NCT00027846|64600854|FG000|Overall Study|Ineligible for study|2|||
23234664|NCT00027846|64600855|FG001|Overall Study|Ineligible for study|6|||
23234665|NCT00027846|64600856|FG002|Overall Study|Ineligible for study|14|||
23234666|NCT00027846|64600854|FG000|Overall Study|Entry into another COG therapeutic study|0|||
23234667|NCT00027846|64600855|FG001|Overall Study|Entry into another COG therapeutic study|5|||
23234668|NCT00027846|64600856|FG002|Overall Study|Entry into another COG therapeutic study|2|||
23234669|NCT00027846|64600854|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
23234670|NCT00027846|64600855|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
23234671|NCT00027846|64600856|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
23234672|NCT00795717|64600857|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
23234673|NCT00795717|64600858|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
23234674|NCT00795717|64600857|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
23234675|NCT00795717|64600858|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
23234676|NCT00795717|64600857|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
23234677|NCT00795717|64600858|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
23234678|NCT00795717|64600857|FG000|Phase II|too busy|0|||
23234679|NCT00795717|64600858|FG001|Phase II|too busy|1|||
23234680|NCT01952041|64600860|FG000|Overall Study|Lost to Follow-up|9|||
23234681|NCT01952041|64600861|FG001|Overall Study|Lost to Follow-up|16|||
23234682|NCT01952041|64600860|FG000|Overall Study|Withdrawal by Subject|7|||
23234683|NCT01952041|64600861|FG001|Overall Study|Withdrawal by Subject|5|||
23234684|NCT01952041|64600860|FG000|Overall Study|Death|1|||
23234685|NCT01952041|64600861|FG001|Overall Study|Death|0|||
23234686|NCT03650387|64600866|FG000|Overall Study|Withdrawal by Subject|13|||
23234687|NCT03650387|64600866|FG000|Overall Study|Lost to Follow-up|12|||
23234688|NCT03650387|64600866|FG000|Overall Study|Adverse Event (Not related)|1|||
23234689|NCT03650387|64600866|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
23234690|NCT03525613|64600867|FG000|Overall Study|Adverse Event|11|||
23234691|NCT03525613|64600868|FG001|Overall Study|Adverse Event|8|||
23234692|NCT03525613|64600869|FG002|Overall Study|Adverse Event|3|||
23234693|NCT03525613|64600870|FG003|Overall Study|Adverse Event|3|||
23234694|NCT03525613|64600867|FG000|Overall Study|Lost to Follow-up|4|||
23234695|NCT03525613|64600868|FG001|Overall Study|Lost to Follow-up|5|||
23234696|NCT03525613|64600869|FG002|Overall Study|Lost to Follow-up|3|||
23234697|NCT03525613|64600870|FG003|Overall Study|Lost to Follow-up|2|||
23234698|NCT03525613|64600867|FG000|Overall Study|Physician Decision|0|||
23234699|NCT03525613|64600868|FG001|Overall Study|Physician Decision|1|||
23234700|NCT03525613|64600869|FG002|Overall Study|Physician Decision|0|||
23580613|NCT00430677|65853543|FG002|Long-term Extension Period|Adverse Event|5|||
23234701|NCT03525613|64600870|FG003|Overall Study|Physician Decision|1|||
23234702|NCT03525613|64600867|FG000|Overall Study|Consent Withdrawal|25|||
23580614|NCT00430677|65853541|FG000|Long-term Extension Period|Lack of Efficacy|5|||
23174672|NCT05048719|64382558|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
23234703|NCT03525613|64600868|FG001|Overall Study|Consent Withdrawal|16|||
23234704|NCT03525613|64600869|FG002|Overall Study|Consent Withdrawal|12|||
23234705|NCT03525613|64600870|FG003|Overall Study|Consent Withdrawal|9|||
23234706|NCT03525613|64600867|FG000|Overall Study|Death|20|||
23234707|NCT03525613|64600868|FG001|Overall Study|Death|9|||
23234708|NCT03525613|64600869|FG002|Overall Study|Death|7|||
23234709|NCT03525613|64600870|FG003|Overall Study|Death|1|||
23234710|NCT03525613|64600867|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
23174673|NCT05048719|64382550|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23174674|NCT05048719|64382551|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23234711|NCT03525613|64600868|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
23234712|NCT03525613|64600869|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
23234713|NCT03525613|64600870|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
23234714|NCT00141297|64600876|FG000|Overall Study|Adverse Event|0|||
23234715|NCT00141297|64600877|FG001|Overall Study|Adverse Event|0|||
23234716|NCT00141297|64600878|FG002|Overall Study|Adverse Event|1|||
23234717|NCT00141297|64600879|FG003|Overall Study|Adverse Event|0|||
23234718|NCT00141297|64600880|FG004|Overall Study|Adverse Event|1|||
23234719|NCT00141297|64600881|FG005|Overall Study|Adverse Event|1|||
23234720|NCT00141297|64600882|FG006|Overall Study|Adverse Event|0|||
23234721|NCT00141297|64600883|FG007|Overall Study|Adverse Event|1|||
23234722|NCT00141297|64600884|FG008|Overall Study|Adverse Event|1|||
23234723|NCT00141297|64600885|FG009|Overall Study|Adverse Event|0|||
23234724|NCT00141297|64600876|FG000|Overall Study|Death|1|||
23234725|NCT00141297|64600877|FG001|Overall Study|Death|0|||
23234726|NCT00141297|64600878|FG002|Overall Study|Death|0|||
23234727|NCT00141297|64600879|FG003|Overall Study|Death|0|||
23234728|NCT00141297|64600880|FG004|Overall Study|Death|0|||
23234729|NCT00141297|64600881|FG005|Overall Study|Death|0|||
23234730|NCT00141297|64600882|FG006|Overall Study|Death|0|||
23234731|NCT00141297|64600883|FG007|Overall Study|Death|0|||
23234732|NCT00141297|64600884|FG008|Overall Study|Death|1|||
23340194|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340195|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340196|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340197|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
23340198|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
23340199|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340200|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340201|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340202|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340203|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23580615|NCT00430677|65853542|FG001|Long-term Extension Period|Lack of Efficacy|3|||
23580616|NCT00430677|65853543|FG002|Long-term Extension Period|Lack of Efficacy|8|||
23580617|NCT00430677|65853541|FG000|Long-term Extension Period|Lost to Follow-up|1|||
23580618|NCT00430677|65853542|FG001|Long-term Extension Period|Lost to Follow-up|1|||
23580619|NCT00430677|65853543|FG002|Long-term Extension Period|Lost to Follow-up|1|||
23234733|NCT00141297|64600885|FG009|Overall Study|Death|0|||
23234734|NCT00141297|64600876|FG000|Overall Study|Withdrawal by Subject|0|||
23234735|NCT00141297|64600877|FG001|Overall Study|Withdrawal by Subject|0|||
23234736|NCT00141297|64600878|FG002|Overall Study|Withdrawal by Subject|0|||
23580620|NCT00430677|65853541|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
23580621|NCT00430677|65853542|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
23580622|NCT00430677|65853543|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
23580623|NCT00430677|65853541|FG000|Long-term Extension Period|Pregnancy|1|||
23580624|NCT00430677|65853542|FG001|Long-term Extension Period|Pregnancy|1|||
23580625|NCT00430677|65853543|FG002|Long-term Extension Period|Pregnancy|0|||
23580626|NCT00430677|65853541|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
23580627|NCT00430677|65853542|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
23580628|NCT00430677|65853543|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
23580629|NCT00430677|65853541|FG000|Long-term Extension Period|Other|2|||
23580630|NCT00430677|65853542|FG001|Long-term Extension Period|Other|1|||
23580631|NCT00430677|65853543|FG002|Long-term Extension Period|Other|1|||
23580632|NCT00430677|65853541|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
23580633|NCT00430677|65853542|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
23580634|NCT00430677|65853543|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
23580635|NCT00519779|65853548|FG000|Overall Study|Withdrawal by Subject|0|||
23580636|NCT00519779|65853549|FG001|Overall Study|Withdrawal by Subject|1|||
23580637|NCT01878890|65853551|FG000|Overall Study|Protocol Violation|0|||
23580638|NCT01878890|65853552|FG001|Overall Study|Protocol Violation|1|||
23580639|NCT01878890|65853553|FG002|Overall Study|Protocol Violation|0|||
23580640|NCT01878890|65853554|FG003|Overall Study|Protocol Violation|0|||
23234737|NCT00141297|64600879|FG003|Overall Study|Withdrawal by Subject|0|||
23234738|NCT00141297|64600880|FG004|Overall Study|Withdrawal by Subject|0|||
23234739|NCT00141297|64600881|FG005|Overall Study|Withdrawal by Subject|0|||
23234740|NCT00141297|64600882|FG006|Overall Study|Withdrawal by Subject|0|||
23234741|NCT00141297|64600883|FG007|Overall Study|Withdrawal by Subject|0|||
23340204|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
23340205|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
23340206|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340207|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340208|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340209|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23234742|NCT00141297|64600884|FG008|Overall Study|Withdrawal by Subject|1|||
23234743|NCT00141297|64600885|FG009|Overall Study|Withdrawal by Subject|0|||
23234744|NCT00141297|64600876|FG000|Overall Study|Other|0|||
23234745|NCT00141297|64600877|FG001|Overall Study|Other|0|||
23340210|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340211|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
23340212|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
23340213|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340214|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340215|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340216|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340217|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340218|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
23340219|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
23340220|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340221|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340222|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340223|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340224|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340225|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
23340226|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
23340227|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340228|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340229|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340230|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340231|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340232|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
23340233|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
23234746|NCT00141297|64600878|FG002|Overall Study|Other|0|||
23234747|NCT00141297|64600879|FG003|Overall Study|Other|1|||
23234748|NCT00141297|64600880|FG004|Overall Study|Other|5|||
23234749|NCT00141297|64600881|FG005|Overall Study|Other|0|||
23234750|NCT00141297|64600882|FG006|Overall Study|Other|0|||
23234751|NCT00141297|64600883|FG007|Overall Study|Other|0|||
23234752|NCT00141297|64600884|FG008|Overall Study|Other|2|||
23234753|NCT00141297|64600885|FG009|Overall Study|Other|0|||
23234754|NCT00141297|64600876|FG000|Overall Study|Progressive Disease|2|||
23234755|NCT00141297|64600877|FG001|Overall Study|Progressive Disease|3|||
23234756|NCT00141297|64600878|FG002|Overall Study|Progressive Disease|6|||
23234757|NCT00141297|64600879|FG003|Overall Study|Progressive Disease|2|||
23234758|NCT00141297|64600880|FG004|Overall Study|Progressive Disease|15|||
23234759|NCT00141297|64600881|FG005|Overall Study|Progressive Disease|2|||
23234760|NCT00141297|64600882|FG006|Overall Study|Progressive Disease|3|||
23234761|NCT00141297|64600883|FG007|Overall Study|Progressive Disease|3|||
23234762|NCT00141297|64600884|FG008|Overall Study|Progressive Disease|15|||
23234763|NCT00141297|64600885|FG009|Overall Study|Progressive Disease|6|||
23234764|NCT00141297|64600876|FG000|Overall Study|Transitioned|0|||
23234765|NCT00141297|64600877|FG001|Overall Study|Transitioned|0|||
23234766|NCT00141297|64600878|FG002|Overall Study|Transitioned|0|||
23234767|NCT00141297|64600879|FG003|Overall Study|Transitioned|0|||
23234768|NCT00141297|64600880|FG004|Overall Study|Transitioned|1|||
23234769|NCT00141297|64600881|FG005|Overall Study|Transitioned|0|||
23234770|NCT00141297|64600882|FG006|Overall Study|Transitioned|0|||
23234771|NCT00141297|64600883|FG007|Overall Study|Transitioned|0|||
23234772|NCT00141297|64600884|FG008|Overall Study|Transitioned|0|||
23234773|NCT00141297|64600885|FG009|Overall Study|Transitioned|0|||
23234774|NCT03907072|64600898|FG000|Overall Study|Study Terminated by Sponsor|2|||
23234775|NCT03907072|64600899|FG001|Overall Study|Study Terminated by Sponsor|2|||
23234776|NCT03907072|64600900|FG002|Overall Study|Study Terminated by Sponsor|2|||
23234777|NCT01222767|64600901|FG000|Overall Study|Progressive disease|13|||
23234778|NCT01222767|64600901|FG000|Overall Study|Adverse Event|2|||
23234779|NCT01222767|64600901|FG000|Overall Study|Surgical resection|1|||
23234780|NCT01222767|64600901|FG000|Overall Study|Never treated|1|||
23234781|NCT01731951|64600902|FG000|Overall Study|Documented Disease Progression|1|||
23234782|NCT01731951|64600903|FG001|Overall Study|Documented Disease Progression|0|||
23234783|NCT01731951|64600904|FG002|Overall Study|Documented Disease Progression|0|||
23234784|NCT01731951|64600905|FG003|Overall Study|Documented Disease Progression|0|||
23234785|NCT01731951|64600906|FG004|Overall Study|Documented Disease Progression|0|||
23234786|NCT01731951|64600907|FG005|Overall Study|Documented Disease Progression|0|||
23234787|NCT01731951|64600902|FG000|Overall Study|Lost to Follow-up|2|||
23234788|NCT01731951|64600903|FG001|Overall Study|Lost to Follow-up|0|||
23234789|NCT01731951|64600904|FG002|Overall Study|Lost to Follow-up|0|||
23234790|NCT01731951|64600905|FG003|Overall Study|Lost to Follow-up|1|||
23234791|NCT01731951|64600906|FG004|Overall Study|Lost to Follow-up|3|||
23234792|NCT01731951|64600907|FG005|Overall Study|Lost to Follow-up|1|||
23234793|NCT01731951|64600902|FG000|Overall Study|Withdrawal of Consent|1|||
23234794|NCT01731951|64600903|FG001|Overall Study|Withdrawal of Consent|0|||
23234795|NCT01731951|64600904|FG002|Overall Study|Withdrawal of Consent|0|||
23234796|NCT01731951|64600905|FG003|Overall Study|Withdrawal of Consent|0|||
23234797|NCT01731951|64600906|FG004|Overall Study|Withdrawal of Consent|0|||
23234798|NCT01731951|64600907|FG005|Overall Study|Withdrawal of Consent|2|||
23234799|NCT01731951|64600902|FG000|Overall Study|Death|13|||
23234800|NCT01731951|64600903|FG001|Overall Study|Death|15|||
23234801|NCT01731951|64600904|FG002|Overall Study|Death|9|||
23234802|NCT01731951|64600905|FG003|Overall Study|Death|8|||
23234803|NCT01731951|64600906|FG004|Overall Study|Death|9|||
23234804|NCT01731951|64600907|FG005|Overall Study|Death|6|||
23234805|NCT01791543|64600911|FG000|Overall Study|Lost to Follow-up|1|||
23234806|NCT01791543|64600911|FG000|Overall Study|Adverse Event|1|||
23234807|NCT01928758|64604530|FG000|Overall Study|Lost to Follow-up|14|||
23234808|NCT01928758|64604531|FG001|Overall Study|Lost to Follow-up|9|||
23234809|NCT01928758|64604530|FG000|Overall Study|Withdrawal by Subject|5|||
23234810|NCT01928758|64604531|FG001|Overall Study|Withdrawal by Subject|2|||
23234811|NCT01928758|64604530|FG000|Overall Study|Adverse Event|3|||
23234812|NCT01928758|64604531|FG001|Overall Study|Adverse Event|5|||
23234813|NCT01928758|64604530|FG000|Overall Study|Protocol Violation|3|||
23234814|NCT01928758|64604531|FG001|Overall Study|Protocol Violation|4|||
23234815|NCT02194699|64604532|FG000|Randomised|Did not receive treatment|1|||
23234816|NCT02194699|64604533|FG001|Randomised|Did not receive treatment|5|||
23234817|NCT02194699|64604532|FG000|Randomised|Without potential for 52 weeks of IP|5|||
23234818|NCT02194699|64604533|FG001|Randomised|Without potential for 52 weeks of IP|5|||
23234819|NCT02194699|64604532|FG000|Randomised|Duplicate patient|2|||
23234820|NCT02194699|64604533|FG001|Randomised|Duplicate patient|1|||
23234821|NCT02194699|64604532|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
23234822|NCT02194699|64604533|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
23234823|NCT02194699|64604532|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
23234824|NCT02194699|64604533|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
23234825|NCT02194699|64604532|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
23234826|NCT02194699|64604533|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
23234827|NCT02194699|64604532|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
23234828|NCT02194699|64604533|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
23234829|NCT02194699|64604532|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
23234830|NCT02194699|64604533|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
23234831|NCT02194699|64604532|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
23234832|NCT02194699|64604533|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
23234833|NCT01398176|64604534|FG000|Overall Study|Lost to Follow-up|1|||
23234834|NCT01398176|64604535|FG001|Overall Study|Lost to Follow-up|3|||
23234835|NCT01398176|64604534|FG000|Overall Study|Physician Decision|2|||
23580641|NCT04978363|65853555|FG000|Overall Study|Other medical issues unrelated to the study|0|||
23580642|NCT04978363|65853556|FG001|Overall Study|Other medical issues unrelated to the study|0|||
23580643|NCT04978363|65853557|FG002|Overall Study|Other medical issues unrelated to the study|0|||
23234836|NCT01398176|64604535|FG001|Overall Study|Physician Decision|3|||
23234837|NCT03172026|64604536|FG000|Overall Study|Withdrawal by Subject|1|||
23234838|NCT03172026|64604537|FG001|Overall Study|Withdrawal by Subject|0|||
23234839|NCT03172026|64604536|FG000|Overall Study|COVID restrictions|1|||
23234840|NCT03172026|64604537|FG001|Overall Study|COVID restrictions|0|||
23234841|NCT01920061|64604539|FG000|Overall Study|Death|1|||
23234842|NCT01920061|64604540|FG001|Overall Study|Death|1|||
23234843|NCT01920061|64604541|FG002|Overall Study|Death|0|||
23234844|NCT01920061|64604542|FG003|Overall Study|Death|1|||
23234845|NCT01920061|64604543|FG004|Overall Study|Death|1|||
23234846|NCT01920061|64604544|FG005|Overall Study|Death|0|||
23234847|NCT01920061|64604545|FG006|Overall Study|Death|0|||
23234848|NCT01920061|64604546|FG007|Overall Study|Death|1|||
23234849|NCT01920061|64604547|FG008|Overall Study|Death|0|||
23234850|NCT01920061|64604548|FG009|Overall Study|Death|1|||
23234851|NCT01920061|64604549|FG010|Overall Study|Death|0|||
23234852|NCT01920061|64604550|FG011|Overall Study|Death|1|||
23234853|NCT01920061|64604551|FG012|Overall Study|Death|0|||
23234854|NCT01920061|64604552|FG013|Overall Study|Death|2|||
23234855|NCT01920061|64604553|FG014|Overall Study|Death|0|||
23234856|NCT01920061|64604554|FG015|Overall Study|Death|0|||
23234857|NCT01920061|64604555|FG016|Overall Study|Death|0|||
23234858|NCT01920061|64604556|FG017|Overall Study|Death|0|||
23234859|NCT01920061|64604557|FG018|Overall Study|Death|1|||
23234860|NCT01920061|64604558|FG019|Overall Study|Death|0|||
23234861|NCT01920061|64604539|FG000|Overall Study|Lost to Follow-up|0|||
23234862|NCT01920061|64604540|FG001|Overall Study|Lost to Follow-up|2|||
23234863|NCT01920061|64604541|FG002|Overall Study|Lost to Follow-up|0|||
23234864|NCT01920061|64604542|FG003|Overall Study|Lost to Follow-up|0|||
23234865|NCT01920061|64604543|FG004|Overall Study|Lost to Follow-up|0|||
23234866|NCT01920061|64604544|FG005|Overall Study|Lost to Follow-up|0|||
23234867|NCT01920061|64604545|FG006|Overall Study|Lost to Follow-up|1|||
23234868|NCT01920061|64604546|FG007|Overall Study|Lost to Follow-up|0|||
23234869|NCT01920061|64604547|FG008|Overall Study|Lost to Follow-up|0|||
23234870|NCT01920061|64604548|FG009|Overall Study|Lost to Follow-up|0|||
23234871|NCT01920061|64604549|FG010|Overall Study|Lost to Follow-up|3|||
23234872|NCT01920061|64604550|FG011|Overall Study|Lost to Follow-up|0|||
23234873|NCT01920061|64604551|FG012|Overall Study|Lost to Follow-up|0|||
23234874|NCT01920061|64604552|FG013|Overall Study|Lost to Follow-up|0|||
23234875|NCT01920061|64604553|FG014|Overall Study|Lost to Follow-up|0|||
23234876|NCT01920061|64604554|FG015|Overall Study|Lost to Follow-up|0|||
23234877|NCT01920061|64604555|FG016|Overall Study|Lost to Follow-up|0|||
23234878|NCT01920061|64604556|FG017|Overall Study|Lost to Follow-up|1|||
23234879|NCT01920061|64604557|FG018|Overall Study|Lost to Follow-up|4|||
23234880|NCT01920061|64604558|FG019|Overall Study|Lost to Follow-up|3|||
23234881|NCT01920061|64604539|FG000|Overall Study|Other|1|||
23234882|NCT01920061|64604540|FG001|Overall Study|Other|1|||
23234883|NCT01920061|64604541|FG002|Overall Study|Other|2|||
23234884|NCT01920061|64604542|FG003|Overall Study|Other|1|||
23234885|NCT01920061|64604543|FG004|Overall Study|Other|0|||
23234886|NCT01920061|64604544|FG005|Overall Study|Other|1|||
23234887|NCT01920061|64604545|FG006|Overall Study|Other|0|||
23234888|NCT01920061|64604546|FG007|Overall Study|Other|0|||
23234889|NCT01920061|64604547|FG008|Overall Study|Other|0|||
23234890|NCT01920061|64604548|FG009|Overall Study|Other|1|||
23234891|NCT01920061|64604549|FG010|Overall Study|Other|1|||
23234892|NCT01920061|64604550|FG011|Overall Study|Other|2|||
23234893|NCT01920061|64604551|FG012|Overall Study|Other|1|||
23234894|NCT01920061|64604552|FG013|Overall Study|Other|4|||
23234895|NCT01920061|64604553|FG014|Overall Study|Other|0|||
23234896|NCT01920061|64604554|FG015|Overall Study|Other|1|||
23234897|NCT01920061|64604555|FG016|Overall Study|Other|1|||
23234898|NCT01920061|64604556|FG017|Overall Study|Other|0|||
23234899|NCT01920061|64604557|FG018|Overall Study|Other|1|||
23234900|NCT01920061|64604558|FG019|Overall Study|Other|1|||
23340234|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340235|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340236|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340237|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340869|NCT01936181|64992870|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
23234901|NCT01920061|64604539|FG000|Overall Study|Participant refused further follow-up|0|||
23234902|NCT01920061|64604540|FG001|Overall Study|Participant refused further follow-up|0|||
23234903|NCT01920061|64604541|FG002|Overall Study|Participant refused further follow-up|0|||
23234904|NCT01920061|64604542|FG003|Overall Study|Participant refused further follow-up|0|||
23234905|NCT01920061|64604543|FG004|Overall Study|Participant refused further follow-up|1|||
23234906|NCT01920061|64604544|FG005|Overall Study|Participant refused further follow-up|1|||
23234907|NCT01920061|64604545|FG006|Overall Study|Participant refused further follow-up|0|||
23234908|NCT01920061|64604546|FG007|Overall Study|Participant refused further follow-up|0|||
23234909|NCT01920061|64604547|FG008|Overall Study|Participant refused further follow-up|1|||
23234910|NCT01920061|64604548|FG009|Overall Study|Participant refused further follow-up|0|||
23234911|NCT01920061|64604549|FG010|Overall Study|Participant refused further follow-up|1|||
23234912|NCT01920061|64604550|FG011|Overall Study|Participant refused further follow-up|0|||
23234913|NCT01920061|64604551|FG012|Overall Study|Participant refused further follow-up|1|||
23234914|NCT01920061|64604552|FG013|Overall Study|Participant refused further follow-up|0|||
23234915|NCT01920061|64604553|FG014|Overall Study|Participant refused further follow-up|1|||
23174675|NCT05048719|64382552|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23174676|NCT05048719|64382553|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23174677|NCT05048719|64382554|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23174678|NCT05048719|64382555|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
23174679|NCT05048719|64382556|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23174680|NCT05048719|64382557|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23174681|NCT05048719|64382558|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
23174682|NCT02751931|64382559|FG000|Overall Study|Adverse Event|3|||
23174683|NCT02751931|64382560|FG001|Overall Study|Adverse Event|0|||
23174684|NCT02751931|64382559|FG000|Overall Study|Other: Miscelleneous|10|||
23234916|NCT01920061|64604554|FG015|Overall Study|Participant refused further follow-up|2|||
23234917|NCT01920061|64604555|FG016|Overall Study|Participant refused further follow-up|1|||
23234918|NCT01920061|64604556|FG017|Overall Study|Participant refused further follow-up|1|||
23234919|NCT01920061|64604557|FG018|Overall Study|Participant refused further follow-up|0|||
23174685|NCT02751931|64382560|FG001|Overall Study|Other: Miscelleneous|8|||
23174686|NCT00559507|64382561|FG000|Overall Study|Not treated, patient ineligible|3|||
23174687|NCT03446885|64382562|FG000|Overall Study|Lost to Follow-up|1|||
23174688|NCT03446885|64382563|FG001|Overall Study|Lost to Follow-up|0|||
23174689|NCT03446885|64382562|FG000|Overall Study|Did not complete entire visit|1|||
23174690|NCT03446885|64382563|FG001|Overall Study|Did not complete entire visit|0|||
23174691|NCT00818259|64386360|FG000|Part I|Withdrawal by Subject|1|||
23174692|NCT00818259|64386361|FG001|Part I|Withdrawal by Subject|0|||
23174693|NCT00818259|64386362|FG002|Part I|Withdrawal by Subject|0|||
23174694|NCT00818259|64386363|FG003|Part I|Withdrawal by Subject|0|||
23174695|NCT00818259|64386364|FG004|Part I|Withdrawal by Subject|0|||
23452056|NCT02714569|65398901|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
23174696|NCT00818259|64386365|FG005|Part I|Withdrawal by Subject|0|||
23174697|NCT00818259|64386366|FG006|Part I|Withdrawal by Subject|0|||
23174698|NCT00818259|64386367|FG007|Part I|Withdrawal by Subject|0|||
23174699|NCT00818259|64386368|FG008|Part I|Withdrawal by Subject|0|||
23174700|NCT00818259|64386360|FG000|Part II|Physician Decision|0|||
23234920|NCT01920061|64604558|FG019|Overall Study|Participant refused further follow-up|0|||
23234921|NCT03037489|64604559|FG000|Overall Study|Adverse Event|4|||
23234922|NCT03037489|64604560|FG001|Overall Study|Adverse Event|0|||
23234923|NCT03037489|64604559|FG000|Overall Study|Withdrawal by Subject|3|||
23234924|NCT03037489|64604560|FG001|Overall Study|Withdrawal by Subject|0|||
23234925|NCT02985541|64604562|FG000|Overall Study|Withdrawal by Subject|33|||
23234926|NCT02985541|64604562|FG000|Overall Study|Lost to Follow-up|26|||
23234927|NCT02985541|64604562|FG000|Overall Study|Adverse Event|27|||
23234928|NCT02985541|64604562|FG000|Overall Study|Physician Decision|2|||
23234929|NCT02985541|64604562|FG000|Overall Study|Pregnancy|2|||
23234930|NCT02985541|64604562|FG000|Overall Study|Wish for pregnancy|44|||
23234931|NCT02985541|64604562|FG000|Overall Study|Other reason|5|||
23234932|NCT02985541|64604562|FG000|Overall Study|Not valid for analysis|2|||
23234933|NCT01066819|64604563|FG000|Overall Study|Adverse Event|18|||
23234934|NCT01066819|64604564|FG001|Overall Study|Adverse Event|1|||
23234935|NCT01066819|64604565|FG002|Overall Study|Adverse Event|6|||
23234936|NCT01066819|64604566|FG003|Overall Study|Adverse Event|0|||
23174701|NCT00818259|64386361|FG001|Part II|Physician Decision|0|||
23174702|NCT00818259|64386362|FG002|Part II|Physician Decision|1|||
23174703|NCT00818259|64386363|FG003|Part II|Physician Decision|0|||
23234937|NCT01066819|64604567|FG004|Overall Study|Adverse Event|0|||
23234938|NCT01066819|64604568|FG005|Overall Study|Adverse Event|0|||
23234939|NCT01066819|64604563|FG000|Overall Study|Death|5|||
23452057|NCT02714569|65398891|FG000|Part B (Overall)|Lost to Follow-up|0|||
23452058|NCT02714569|65398892|FG001|Part B (Overall)|Lost to Follow-up|0|||
23452059|NCT02714569|65398893|FG002|Part B (Overall)|Lost to Follow-up|0|||
23452060|NCT02714569|65398894|FG003|Part B (Overall)|Lost to Follow-up|0|||
23452061|NCT02714569|65398895|FG004|Part B (Overall)|Lost to Follow-up|0|||
23452062|NCT02714569|65398896|FG005|Part B (Overall)|Lost to Follow-up|0|||
23452063|NCT02714569|65398897|FG006|Part B (Overall)|Lost to Follow-up|1|||
23452064|NCT02714569|65398898|FG007|Part B (Overall)|Lost to Follow-up|0|||
23452065|NCT02714569|65398899|FG008|Part B (Overall)|Lost to Follow-up|0|||
23452066|NCT02714569|65398900|FG009|Part B (Overall)|Lost to Follow-up|0|||
23452067|NCT02714569|65398901|FG010|Part B (Overall)|Lost to Follow-up|0|||
23452068|NCT02714569|65398891|FG000|Part B (Overall)|Withdrawal by Subject|0|||
23452069|NCT02714569|65398892|FG001|Part B (Overall)|Withdrawal by Subject|0|||
23452070|NCT02714569|65398893|FG002|Part B (Overall)|Withdrawal by Subject|0|||
23452071|NCT02714569|65398894|FG003|Part B (Overall)|Withdrawal by Subject|0|||
23452072|NCT02714569|65398895|FG004|Part B (Overall)|Withdrawal by Subject|0|||
23452073|NCT02714569|65398896|FG005|Part B (Overall)|Withdrawal by Subject|0|||
23452074|NCT02714569|65398897|FG006|Part B (Overall)|Withdrawal by Subject|0|||
23452075|NCT02714569|65398898|FG007|Part B (Overall)|Withdrawal by Subject|1|||
23452076|NCT02714569|65398899|FG008|Part B (Overall)|Withdrawal by Subject|0|||
23452077|NCT02714569|65398900|FG009|Part B (Overall)|Withdrawal by Subject|1|||
23452078|NCT02714569|65398901|FG010|Part B (Overall)|Withdrawal by Subject|0|||
23452079|NCT02714569|65398891|FG000|Part B (Overall)|Adverse Event|0|||
23452080|NCT02714569|65398892|FG001|Part B (Overall)|Adverse Event|0|||
23452081|NCT02714569|65398893|FG002|Part B (Overall)|Adverse Event|0|||
23452082|NCT02714569|65398894|FG003|Part B (Overall)|Adverse Event|0|||
23452083|NCT02714569|65398895|FG004|Part B (Overall)|Adverse Event|0|||
23452084|NCT02714569|65398896|FG005|Part B (Overall)|Adverse Event|0|||
23452085|NCT02714569|65398897|FG006|Part B (Overall)|Adverse Event|0|||
23452086|NCT02714569|65398898|FG007|Part B (Overall)|Adverse Event|0|||
23452087|NCT02714569|65398899|FG008|Part B (Overall)|Adverse Event|0|||
23452088|NCT02714569|65398900|FG009|Part B (Overall)|Adverse Event|1|||
23452089|NCT02714569|65398901|FG010|Part B (Overall)|Adverse Event|0|||
23452090|NCT01338818|65398912|FG000|Overall Study|Adverse Event|8|||
23452091|NCT01338818|65398912|FG000|Overall Study|Lack of Efficacy|5|||
23452092|NCT01338818|65398912|FG000|Overall Study|no longer require study drug|1|||
23452093|NCT01338818|65398912|FG000|Overall Study|Withdrawal by Subject|11|||
23452094|NCT01338818|65398912|FG000|Overall Study|Lost to Follow-up|4|||
23452095|NCT01338818|65398912|FG000|Overall Study|Administrative problems|3|||
23452096|NCT01338818|65398912|FG000|Overall Study|Protocol Deviation|4|||
23452097|NCT00248495|65398913|FG000|Overall Study|Withdrawal by Subject|1|||
23174704|NCT00818259|64386364|FG004|Part II|Physician Decision|0|||
23174705|NCT00818259|64386365|FG005|Part II|Physician Decision|0|||
23452098|NCT01574274|65398914|FG000|Overall Study|Ineligible|0|||
23452099|NCT01574274|65398915|FG001|Overall Study|Ineligible|1|||
23452100|NCT01574274|65398914|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
23452101|NCT01574274|65398915|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
23452102|NCT01574274|65398914|FG000|Overall Study|Ph+ B-ALL|3|||
23452103|NCT01574274|65398915|FG001|Overall Study|Ph+ B-ALL|4|||
23452104|NCT01574274|65398914|FG000|Overall Study|Induction Death|2|||
23452105|NCT01574274|65398915|FG001|Overall Study|Induction Death|0|||
23452106|NCT01574274|65398914|FG000|Overall Study|Induction Failure|4|||
23452107|NCT01574274|65398915|FG001|Overall Study|Induction Failure|1|||
23452108|NCT01574274|65398914|FG000|Overall Study|Adverse Event|16|||
23452109|NCT01574274|65398915|FG001|Overall Study|Adverse Event|13|||
23452110|NCT01574274|65398914|FG000|Overall Study|Remission Death|1|||
23452111|NCT01574274|65398915|FG001|Overall Study|Remission Death|0|||
23452112|NCT01574274|65398914|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
23452113|NCT01574274|65398915|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
23452114|NCT01574274|65398914|FG000|Overall Study|Other, unknown|3|||
23452115|NCT01574274|65398915|FG001|Overall Study|Other, unknown|2|||
23452116|NCT02903160|65398916|FG000|Overall Study|Adverse Event|2|||
23452117|NCT02903160|65398916|FG000|Overall Study|Death|1|||
23452118|NCT02903160|65398916|FG000|Overall Study|Lost to Follow-up|2|||
23452119|NCT02903160|65398916|FG000|Overall Study|Withdrawal by Subject|1|||
23452120|NCT02903160|65398916|FG000|Overall Study|Medical Insurance Barriers|1|||
23580644|NCT04978363|65853558|FG003|Overall Study|Other medical issues unrelated to the study|0|||
23580645|NCT04978363|65853559|FG004|Overall Study|Other medical issues unrelated to the study|1|||
23452121|NCT01724866|65398917|FG000|Overall Study|Adverse Event|0|||
23452122|NCT01724866|65398918|FG001|Overall Study|Adverse Event|0|||
23452123|NCT01724866|65398919|FG002|Overall Study|Adverse Event|1|||
23452124|NCT01724866|65398920|FG003|Overall Study|Adverse Event|1|||
23452125|NCT01724866|65398917|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
23452126|NCT01724866|65398918|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
23580646|NCT04978363|65853560|FG005|Overall Study|Other medical issues unrelated to the study|0|||
23580647|NCT04978363|65853561|FG006|Overall Study|Other medical issues unrelated to the study|0|||
23452127|NCT01724866|65398919|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
23452128|NCT01724866|65398920|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
23452129|NCT01724866|65398917|FG000|Overall Study|Investigator's Discretion|0|||
23452130|NCT01724866|65398918|FG001|Overall Study|Investigator's Discretion|1|||
23452131|NCT01724866|65398919|FG002|Overall Study|Investigator's Discretion|1|||
23452132|NCT01724866|65398920|FG003|Overall Study|Investigator's Discretion|0|||
23452133|NCT01724866|65398917|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
23452134|NCT01724866|65398918|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
23452135|NCT01724866|65398919|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
23452136|NCT01724866|65398920|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
23452137|NCT01724866|65398917|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
23452138|NCT01724866|65398918|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
23452139|NCT01724866|65398919|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
23452140|NCT01724866|65398920|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
23452141|NCT01917747|65398921|FG000|Overall Study|Withdrawal by Subject|1|||
23452142|NCT01917747|65398922|FG001|Overall Study|Withdrawal by Subject|2|||
23452143|NCT01917747|65398921|FG000|Overall Study|Lost to Follow-up|18|||
23452144|NCT01917747|65398922|FG001|Overall Study|Lost to Follow-up|9|||
23452145|NCT00791388|65398925|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
23452146|NCT00791388|65398926|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
23452147|NCT00791388|65398927|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
23452148|NCT00791388|65398928|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
23452149|NCT00791388|65398929|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
23452150|NCT00791388|65398925|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
23452151|NCT00791388|65398926|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
23452152|NCT00791388|65398927|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
23452153|NCT00791388|65398928|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
23452154|NCT00791388|65398929|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
23452155|NCT00791388|65398925|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
23452156|NCT00791388|65398926|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
23452157|NCT00791388|65398927|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
23452158|NCT00791388|65398928|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
23452159|NCT00791388|65398929|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
23452160|NCT00668148|65398932|FG000|Overall Study|Adverse Event|5|||
23452161|NCT00668148|65398932|FG000|Overall Study|Subject Non-compliance|1|||
23452162|NCT00668148|65398932|FG000|Overall Study|Progressive Disease Before Treatment|2|||
23452163|NCT00668148|65398932|FG000|Overall Study|Withdrawal of Consent|2|||
23452164|NCT02349633|65398935|FG000|Overall Study|Death|0|||
23452165|NCT02349633|65398936|FG001|Overall Study|Death|1|||
23452166|NCT02349633|65398937|FG002|Overall Study|Death|0|||
23452167|NCT02349633|65398938|FG003|Overall Study|Death|0|||
23452168|NCT02349633|65398939|FG004|Overall Study|Death|0|||
23452169|NCT02349633|65398940|FG005|Overall Study|Death|1|||
23452170|NCT02349633|65398941|FG006|Overall Study|Death|1|||
23452171|NCT02349633|65398942|FG007|Overall Study|Death|1|||
23452172|NCT02349633|65398943|FG008|Overall Study|Death|0|||
23452173|NCT02349633|65398944|FG009|Overall Study|Death|1|||
23452174|NCT02349633|65398945|FG010|Overall Study|Death|0|||
23452175|NCT02349633|65398946|FG011|Overall Study|Death|0|||
23452176|NCT02349633|65398947|FG012|Overall Study|Death|0|||
23234940|NCT01066819|64604564|FG001|Overall Study|Death|0|||
23452177|NCT02349633|65398948|FG013|Overall Study|Death|0|||
23452178|NCT02349633|65398935|FG000|Overall Study|Withdrawal by Subject|0|||
23580648|NCT04978363|65853562|FG007|Overall Study|Other medical issues unrelated to the study|0|||
23580649|NCT04978363|65853563|FG008|Overall Study|Other medical issues unrelated to the study|0|||
23580650|NCT04978363|65853564|FG009|Overall Study|Other medical issues unrelated to the study|0|||
23580651|NCT04978363|65853565|FG010|Overall Study|Other medical issues unrelated to the study|0|||
23580652|NCT04978363|65853555|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
23580653|NCT04978363|65853556|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
23580654|NCT04978363|65853557|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
23580655|NCT04978363|65853558|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
23580656|NCT04978363|65853559|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
23580657|NCT04978363|65853560|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
23580658|NCT04978363|65853561|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
23580659|NCT04978363|65853562|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
23580660|NCT04978363|65853563|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
23580661|NCT04978363|65853564|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
23580662|NCT04978363|65853565|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
23580663|NCT04978363|65853555|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580664|NCT04978363|65853556|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
23580665|NCT04978363|65853557|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580666|NCT04978363|65853558|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580667|NCT04978363|65853559|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580668|NCT04978363|65853560|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580669|NCT04978363|65853561|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580670|NCT04978363|65853562|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580671|NCT04978363|65853563|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580672|NCT04978363|65853564|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580673|NCT04978363|65853565|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
23580674|NCT00561574|65853571|FG000|Overall Study|Adverse Event|21|||
23580675|NCT00561574|65853572|FG001|Overall Study|Adverse Event|24|||
23580676|NCT00561574|65853571|FG000|Overall Study|Lack of Efficacy|11|||
23580677|NCT00561574|65853572|FG001|Overall Study|Lack of Efficacy|21|||
23580678|NCT00561574|65853571|FG000|Overall Study|Withdrawal by Subject|4|||
23580679|NCT00561574|65853572|FG001|Overall Study|Withdrawal by Subject|4|||
23580680|NCT00561574|65853571|FG000|Overall Study|Reason Unrelated to Trial|6|||
23580681|NCT00561574|65853572|FG001|Overall Study|Reason Unrelated to Trial|2|||
23580682|NCT00561574|65853571|FG000|Overall Study|Lost to Follow-up|1|||
23580683|NCT00561574|65853572|FG001|Overall Study|Lost to Follow-up|0|||
23580684|NCT00561574|65853571|FG000|Overall Study|Other|5|||
23580685|NCT00561574|65853572|FG001|Overall Study|Other|7|||
23580686|NCT01253200|65853575|FG000|Overall Study|Death|1|||
23580687|NCT01253200|65853576|FG001|Overall Study|Death|0|||
23580688|NCT01253200|65853577|FG002|Overall Study|Death|0|||
23580689|NCT01253200|65853578|FG003|Overall Study|Death|0|||
23580690|NCT01253200|65853579|FG004|Overall Study|Death|0|||
23580691|NCT01253200|65853575|FG000|Overall Study|Lost to Follow-up|1|||
23580692|NCT01253200|65853576|FG001|Overall Study|Lost to Follow-up|1|||
23580693|NCT01253200|65853577|FG002|Overall Study|Lost to Follow-up|0|||
23580694|NCT01253200|65853578|FG003|Overall Study|Lost to Follow-up|0|||
23580695|NCT01253200|65853579|FG004|Overall Study|Lost to Follow-up|0|||
23580696|NCT01253200|65853575|FG000|Overall Study|Withdrawal by Subject|2|||
23580697|NCT01253200|65853576|FG001|Overall Study|Withdrawal by Subject|0|||
23580698|NCT01253200|65853577|FG002|Overall Study|Withdrawal by Subject|0|||
23580699|NCT01253200|65853578|FG003|Overall Study|Withdrawal by Subject|0|||
23580700|NCT01253200|65853579|FG004|Overall Study|Withdrawal by Subject|0|||
23580701|NCT01253200|65853575|FG000|Overall Study|Protocol Violation|1|||
23580702|NCT01253200|65853576|FG001|Overall Study|Protocol Violation|4|||
23580703|NCT01253200|65853577|FG002|Overall Study|Protocol Violation|0|||
23580704|NCT01253200|65853578|FG003|Overall Study|Protocol Violation|0|||
23580705|NCT01253200|65853579|FG004|Overall Study|Protocol Violation|5|||
23580706|NCT01253200|65853575|FG000|Overall Study|intents|10|||
23580707|NCT01253200|65853576|FG001|Overall Study|intents|10|||
23580708|NCT01253200|65853577|FG002|Overall Study|intents|1|||
23580709|NCT01253200|65853578|FG003|Overall Study|intents|3|||
23580710|NCT01253200|65853579|FG004|Overall Study|intents|0|||
23174706|NCT00818259|64386366|FG006|Part II|Physician Decision|0|||
23174707|NCT00818259|64386367|FG007|Part II|Physician Decision|0|||
23580711|NCT01253200|65853575|FG000|Overall Study|Attempts|6|||
23580712|NCT01253200|65853576|FG001|Overall Study|Attempts|4|||
23580713|NCT01253200|65853577|FG002|Overall Study|Attempts|1|||
23580714|NCT01253200|65853578|FG003|Overall Study|Attempts|2|||
23580715|NCT01253200|65853579|FG004|Overall Study|Attempts|0|||
23580716|NCT00601640|65853580|FG000|Overall Study|Withdrawal by Subject|3|||
23580717|NCT00601640|65853581|FG001|Overall Study|Withdrawal by Subject|0|||
23580718|NCT00601640|65853582|FG002|Overall Study|Withdrawal by Subject|7|||
23174708|NCT00818259|64386368|FG008|Part II|Physician Decision|0|||
23174709|NCT00818259|64386360|FG000|Part II|Lack of Efficacy|0|||
23174710|NCT00818259|64386361|FG001|Part II|Lack of Efficacy|0|||
23580719|NCT00601640|65853580|FG000|Overall Study|Death|1|||
23580720|NCT00601640|65853581|FG001|Overall Study|Death|0|||
23580721|NCT00601640|65853582|FG002|Overall Study|Death|0|||
23580722|NCT00601640|65853580|FG000|Overall Study|Adverse Event|0|||
23580723|NCT00601640|65853581|FG001|Overall Study|Adverse Event|4|||
23580724|NCT00601640|65853582|FG002|Overall Study|Adverse Event|2|||
23580725|NCT00601640|65853580|FG000|Overall Study|intercurrent illness|1|||
23580726|NCT00601640|65853581|FG001|Overall Study|intercurrent illness|0|||
23580727|NCT00601640|65853582|FG002|Overall Study|intercurrent illness|0|||
23580728|NCT00601640|65853580|FG000|Overall Study|change in eligibility status|0|||
23580729|NCT00601640|65853581|FG001|Overall Study|change in eligibility status|1|||
23580730|NCT00601640|65853582|FG002|Overall Study|change in eligibility status|1|||
23580731|NCT00367237|65853583|FG000|Overall Study|Adverse Event|7|||
23580732|NCT00367237|65853584|FG001|Overall Study|Adverse Event|2|||
23580733|NCT00367237|65853583|FG000|Overall Study|Lost to Follow-up|1|||
23580734|NCT00367237|65853584|FG001|Overall Study|Lost to Follow-up|0|||
23580735|NCT00367237|65853583|FG000|Overall Study|Withdrawal by Subject|0|||
23580736|NCT00367237|65853584|FG001|Overall Study|Withdrawal by Subject|4|||
23580737|NCT00367237|65853583|FG000|Overall Study|Protocol Violation|2|||
23580738|NCT00367237|65853584|FG001|Overall Study|Protocol Violation|5|||
23580739|NCT00558753|65853585|FG000|Overall Study|Lost to Follow-up|5|||
23580740|NCT00558753|65853586|FG001|Overall Study|Lost to Follow-up|7|||
23580741|NCT02757885|65853589|FG000|Overall Study|Screen Failures|4|||
23580742|NCT04730947|65853595|FG000|Overall Study|Withdrawal by Subject|0|||
23580743|NCT04730947|65853596|FG001|Overall Study|Withdrawal by Subject|1|||
23580744|NCT01021878|65853597|FG000|Overall Study|Lost to Follow-up|4|||
23580745|NCT01021878|65853598|FG001|Overall Study|Lost to Follow-up|3|||
23580746|NCT01021878|65853597|FG000|Overall Study|Death|0|||
23580747|NCT01021878|65853598|FG001|Overall Study|Death|1|||
23580748|NCT01021878|65853597|FG000|Overall Study|Adverse Event|6|||
23580749|NCT01021878|65853598|FG001|Overall Study|Adverse Event|5|||
23580750|NCT01021878|65853597|FG000|Overall Study|Transplantation|6|||
23580751|NCT01021878|65853598|FG001|Overall Study|Transplantation|1|||
23580752|NCT01268566|65853602|FG000|Overall Study|Lost to Follow-up|1|||
23580753|NCT01268566|65853602|FG000|Overall Study|Withdrawal by Subject|12|||
23580754|NCT01268566|65853602|FG000|Overall Study|Death|30|||
23580755|NCT00162942|65853607|FG000|Overall Study|Adverse Event|10|||
23580756|NCT00162942|65853608|FG001|Overall Study|Adverse Event|6|||
23580757|NCT00162942|65853607|FG000|Overall Study|Death|1|||
23580758|NCT00162942|65853608|FG001|Overall Study|Death|0|||
23580759|NCT00162942|65853607|FG000|Overall Study|Withdrawal by Subject|3|||
23174711|NCT00818259|64386362|FG002|Part II|Lack of Efficacy|0|||
23174712|NCT00818259|64386363|FG003|Part II|Lack of Efficacy|1|||
23174713|NCT00818259|64386364|FG004|Part II|Lack of Efficacy|0|||
23174714|NCT00818259|64386365|FG005|Part II|Lack of Efficacy|0|||
23174715|NCT00818259|64386366|FG006|Part II|Lack of Efficacy|0|||
23174716|NCT00818259|64386367|FG007|Part II|Lack of Efficacy|0|||
23174717|NCT00818259|64386368|FG008|Part II|Lack of Efficacy|0|||
23174718|NCT00818259|64386360|FG000|Part II|Not Treated|0|||
23174719|NCT00818259|64386361|FG001|Part II|Not Treated|0|||
23174720|NCT00818259|64386362|FG002|Part II|Not Treated|0|||
23174721|NCT00818259|64386363|FG003|Part II|Not Treated|1|||
23234941|NCT01066819|64604565|FG002|Overall Study|Death|1|||
23234942|NCT01066819|64604566|FG003|Overall Study|Death|0|||
23580760|NCT00162942|65853608|FG001|Overall Study|Withdrawal by Subject|6|||
23580761|NCT00162942|65853607|FG000|Overall Study|Physician Decision|1|||
23580762|NCT00162942|65853608|FG001|Overall Study|Physician Decision|0|||
23580763|NCT00162942|65853607|FG000|Overall Study|Enter Open-Label Study|76|||
23580764|NCT00162942|65853608|FG001|Overall Study|Enter Open-Label Study|35|||
23580765|NCT00162942|65853607|FG000|Overall Study|Alternate Therapy|6|||
23580766|NCT00162942|65853608|FG001|Overall Study|Alternate Therapy|2|||
23580767|NCT00162942|65853607|FG000|Overall Study|Lack of Efficacy|1|||
23580768|NCT00162942|65853608|FG001|Overall Study|Lack of Efficacy|0|||
23580769|NCT00162942|65853607|FG000|Overall Study|Flare During Active Treatment|7|||
23580770|NCT00162942|65853608|FG001|Overall Study|Flare During Active Treatment|3|||
23580771|NCT00162942|65853607|FG000|Overall Study|2 or more consecutive treatments missed|1|||
23580772|NCT00162942|65853608|FG001|Overall Study|2 or more consecutive treatments missed|0|||
23580773|NCT02424344|65853609|FG000|Overall Study|Lack of Efficacy|0|||
23580774|NCT02424344|65853610|FG001|Overall Study|Lack of Efficacy|1|||
23580775|NCT02424344|65853609|FG000|Overall Study|Withdrawal by Subject|2|||
23580776|NCT02424344|65853610|FG001|Overall Study|Withdrawal by Subject|1|||
23580777|NCT02424344|65853609|FG000|Overall Study|Lost to Follow-up|1|||
23234943|NCT01066819|64604567|FG004|Overall Study|Death|0|||
23234944|NCT01066819|64604568|FG005|Overall Study|Death|0|||
23234945|NCT01066819|64604563|FG000|Overall Study|Lack of Efficacy|22|||
23234946|NCT01066819|64604564|FG001|Overall Study|Lack of Efficacy|1|||
23234947|NCT01066819|64604565|FG002|Overall Study|Lack of Efficacy|2|||
23234948|NCT01066819|64604566|FG003|Overall Study|Lack of Efficacy|1|||
23234949|NCT01066819|64604567|FG004|Overall Study|Lack of Efficacy|0|||
23580778|NCT02424344|65853610|FG001|Overall Study|Lost to Follow-up|0|||
23580779|NCT02424344|65853609|FG000|Overall Study|Adverse Event|4|||
23580780|NCT02424344|65853610|FG001|Overall Study|Adverse Event|8|||
23580781|NCT01890967|65853611|FG000|Overall Study|Adverse Event|3|||
23234950|NCT01066819|64604568|FG005|Overall Study|Lack of Efficacy|0|||
23234951|NCT01066819|64604563|FG000|Overall Study|Physician Decision|6|||
23234952|NCT01066819|64604564|FG001|Overall Study|Physician Decision|2|||
23234953|NCT01066819|64604565|FG002|Overall Study|Physician Decision|3|||
23234954|NCT01066819|64604566|FG003|Overall Study|Physician Decision|0|||
23234955|NCT01066819|64604567|FG004|Overall Study|Physician Decision|0|||
23234956|NCT01066819|64604568|FG005|Overall Study|Physician Decision|0|||
23234957|NCT01066819|64604563|FG000|Overall Study|Protocol Violation|12|||
23234958|NCT01066819|64604564|FG001|Overall Study|Protocol Violation|6|||
23234959|NCT01066819|64604565|FG002|Overall Study|Protocol Violation|0|||
23580782|NCT01890967|65853612|FG001|Overall Study|Adverse Event|3|||
23580783|NCT01890967|65853613|FG002|Overall Study|Adverse Event|3|||
23580784|NCT01890967|65853614|FG003|Overall Study|Adverse Event|2|||
23580785|NCT01890967|65853615|FG004|Overall Study|Adverse Event|1|||
23174722|NCT00818259|64386364|FG004|Part II|Not Treated|0|||
23234960|NCT01066819|64604566|FG003|Overall Study|Protocol Violation|0|||
23234961|NCT01066819|64604567|FG004|Overall Study|Protocol Violation|0|||
23234962|NCT01066819|64604568|FG005|Overall Study|Protocol Violation|0|||
23234963|NCT01066819|64604563|FG000|Overall Study|Withdrawal by Subject|29|||
23234964|NCT01066819|64604564|FG001|Overall Study|Withdrawal by Subject|11|||
23580786|NCT01890967|65853616|FG005|Overall Study|Adverse Event|7|||
23580787|NCT01890967|65853611|FG000|Overall Study|Death|1|||
23174723|NCT00818259|64386365|FG005|Part II|Not Treated|0|||
23174724|NCT00818259|64386366|FG006|Part II|Not Treated|0|||
23234965|NCT01066819|64604565|FG002|Overall Study|Withdrawal by Subject|6|||
23452179|NCT02349633|65398936|FG001|Overall Study|Withdrawal by Subject|0|||
23452180|NCT02349633|65398937|FG002|Overall Study|Withdrawal by Subject|0|||
23452181|NCT02349633|65398938|FG003|Overall Study|Withdrawal by Subject|1|||
23452182|NCT02349633|65398939|FG004|Overall Study|Withdrawal by Subject|0|||
23452183|NCT02349633|65398940|FG005|Overall Study|Withdrawal by Subject|0|||
23452184|NCT02349633|65398941|FG006|Overall Study|Withdrawal by Subject|0|||
23452185|NCT02349633|65398942|FG007|Overall Study|Withdrawal by Subject|2|||
23452186|NCT02349633|65398943|FG008|Overall Study|Withdrawal by Subject|2|||
23452187|NCT02349633|65398944|FG009|Overall Study|Withdrawal by Subject|1|||
23452188|NCT02349633|65398945|FG010|Overall Study|Withdrawal by Subject|0|||
23452189|NCT02349633|65398946|FG011|Overall Study|Withdrawal by Subject|0|||
23452190|NCT02349633|65398947|FG012|Overall Study|Withdrawal by Subject|0|||
23452191|NCT02349633|65398948|FG013|Overall Study|Withdrawal by Subject|0|||
23452192|NCT02349633|65398935|FG000|Overall Study|Withdrawal of informed consent|0|||
23452193|NCT02349633|65398936|FG001|Overall Study|Withdrawal of informed consent|0|||
23452194|NCT02349633|65398937|FG002|Overall Study|Withdrawal of informed consent|0|||
23452195|NCT02349633|65398938|FG003|Overall Study|Withdrawal of informed consent|1|||
23452196|NCT02349633|65398939|FG004|Overall Study|Withdrawal of informed consent|1|||
23452197|NCT02349633|65398940|FG005|Overall Study|Withdrawal of informed consent|0|||
23452198|NCT02349633|65398941|FG006|Overall Study|Withdrawal of informed consent|0|||
23452199|NCT02349633|65398942|FG007|Overall Study|Withdrawal of informed consent|3|||
23452200|NCT02349633|65398943|FG008|Overall Study|Withdrawal of informed consent|0|||
23452201|NCT02349633|65398944|FG009|Overall Study|Withdrawal of informed consent|0|||
23452202|NCT02349633|65398945|FG010|Overall Study|Withdrawal of informed consent|0|||
23452203|NCT02349633|65398946|FG011|Overall Study|Withdrawal of informed consent|0|||
23452204|NCT02349633|65398947|FG012|Overall Study|Withdrawal of informed consent|0|||
23452205|NCT02349633|65398948|FG013|Overall Study|Withdrawal of informed consent|0|||
23452206|NCT02349633|65398935|FG000|Overall Study|Transition to compassionate use|0|||
23452207|NCT02349633|65398936|FG001|Overall Study|Transition to compassionate use|0|||
23452208|NCT02349633|65398937|FG002|Overall Study|Transition to compassionate use|0|||
23174725|NCT00818259|64386367|FG007|Part II|Not Treated|0|||
23174726|NCT00818259|64386368|FG008|Part II|Not Treated|0|||
23234966|NCT01066819|64604566|FG003|Overall Study|Withdrawal by Subject|0|||
23234967|NCT01066819|64604567|FG004|Overall Study|Withdrawal by Subject|0|||
23234968|NCT01066819|64604568|FG005|Overall Study|Withdrawal by Subject|0|||
23234969|NCT01066819|64604563|FG000|Overall Study|Administrative|6|||
23234970|NCT01066819|64604564|FG001|Overall Study|Administrative|4|||
23234971|NCT01066819|64604565|FG002|Overall Study|Administrative|2|||
23234972|NCT01066819|64604566|FG003|Overall Study|Administrative|0|||
23234973|NCT01066819|64604567|FG004|Overall Study|Administrative|0|||
23234974|NCT01066819|64604568|FG005|Overall Study|Administrative|0|||
23234975|NCT01066819|64604563|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
23234976|NCT01066819|64604564|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
23234977|NCT01066819|64604565|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
23234978|NCT01066819|64604566|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
23234979|NCT01066819|64604567|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
23234980|NCT01066819|64604568|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
23174727|NCT00818259|64386360|FG000|Part IV|Physician Decision|0|||
23174728|NCT00818259|64386361|FG001|Part IV|Physician Decision|0|||
23174729|NCT00818259|64386362|FG002|Part IV|Physician Decision|0|||
23174730|NCT00818259|64386363|FG003|Part IV|Physician Decision|0|||
23174731|NCT00818259|64386364|FG004|Part IV|Physician Decision|0|||
23174732|NCT00818259|64386365|FG005|Part IV|Physician Decision|1|||
23174733|NCT00818259|64386366|FG006|Part IV|Physician Decision|0|||
23174734|NCT00818259|64386367|FG007|Part IV|Physician Decision|0|||
23174735|NCT00818259|64386368|FG008|Part IV|Physician Decision|0|||
23174736|NCT00818259|64386360|FG000|Part V|Adverse Event|0|||
23174737|NCT00818259|64386361|FG001|Part V|Adverse Event|0|||
23174738|NCT00818259|64386362|FG002|Part V|Adverse Event|0|||
23174739|NCT00818259|64386363|FG003|Part V|Adverse Event|0|||
23234981|NCT01066819|64604563|FG000|Overall Study|Early termination|2|||
23234982|NCT01066819|64604564|FG001|Overall Study|Early termination|0|||
23234983|NCT01066819|64604565|FG002|Overall Study|Early termination|0|||
23234984|NCT01066819|64604566|FG003|Overall Study|Early termination|0|||
23452209|NCT02349633|65398938|FG003|Overall Study|Transition to compassionate use|0|||
23452210|NCT02349633|65398939|FG004|Overall Study|Transition to compassionate use|1|||
23452211|NCT02349633|65398940|FG005|Overall Study|Transition to compassionate use|0|||
23452212|NCT02349633|65398941|FG006|Overall Study|Transition to compassionate use|0|||
23452213|NCT02349633|65398942|FG007|Overall Study|Transition to compassionate use|3|||
23452214|NCT02349633|65398943|FG008|Overall Study|Transition to compassionate use|0|||
23452215|NCT02349633|65398944|FG009|Overall Study|Transition to compassionate use|1|||
23174740|NCT00818259|64386364|FG004|Part V|Adverse Event|0|||
23174741|NCT00818259|64386365|FG005|Part V|Adverse Event|0|||
23174742|NCT00818259|64386366|FG006|Part V|Adverse Event|0|||
23174743|NCT00818259|64386367|FG007|Part V|Adverse Event|1|||
23234985|NCT01066819|64604567|FG004|Overall Study|Early termination|0|||
23234986|NCT01066819|64604568|FG005|Overall Study|Early termination|0|||
23234987|NCT01066819|64604563|FG000|Overall Study|Failed to return|298|||
23234988|NCT01066819|64604564|FG001|Overall Study|Failed to return|107|||
23234989|NCT01066819|64604565|FG002|Overall Study|Failed to return|68|||
23234990|NCT01066819|64604566|FG003|Overall Study|Failed to return|7|||
23234991|NCT01066819|64604567|FG004|Overall Study|Failed to return|2|||
23234992|NCT01066819|64604568|FG005|Overall Study|Failed to return|3|||
23234993|NCT01066819|64604563|FG000|Overall Study|Lab test not done|9|||
23234994|NCT01066819|64604564|FG001|Overall Study|Lab test not done|0|||
23234995|NCT01066819|64604565|FG002|Overall Study|Lab test not done|2|||
23234996|NCT01066819|64604566|FG003|Overall Study|Lab test not done|1|||
23234997|NCT01066819|64604567|FG004|Overall Study|Lab test not done|0|||
23234998|NCT01066819|64604568|FG005|Overall Study|Lab test not done|0|||
23234999|NCT01066819|64604563|FG000|Overall Study|Miscellaneous|28|||
23174744|NCT00818259|64386368|FG008|Part V|Adverse Event|0|||
23174745|NCT02769624|64386369|FG000|Overall Study|Lost to Follow-up|0|||
23174746|NCT02769624|64386370|FG001|Overall Study|Lost to Follow-up|1|||
23174747|NCT01960855|64386372|FG000|Overall Study|Subject noncompliant|1|||
23580788|NCT01890967|65853612|FG001|Overall Study|Death|0|||
23580789|NCT01890967|65853613|FG002|Overall Study|Death|0|||
23580790|NCT01890967|65853614|FG003|Overall Study|Death|0|||
23580791|NCT01890967|65853615|FG004|Overall Study|Death|0|||
23580792|NCT01890967|65853616|FG005|Overall Study|Death|0|||
23580793|NCT01890967|65853611|FG000|Overall Study|Lost to Follow-up|1|||
23580794|NCT01890967|65853612|FG001|Overall Study|Lost to Follow-up|1|||
23580795|NCT01890967|65853613|FG002|Overall Study|Lost to Follow-up|1|||
23235000|NCT01066819|64604564|FG001|Overall Study|Miscellaneous|10|||
23235001|NCT01066819|64604565|FG002|Overall Study|Miscellaneous|18|||
23235002|NCT01066819|64604566|FG003|Overall Study|Miscellaneous|1|||
23235003|NCT01066819|64604567|FG004|Overall Study|Miscellaneous|0|||
23235004|NCT01066819|64604568|FG005|Overall Study|Miscellaneous|0|||
23235005|NCT01066819|64604563|FG000|Overall Study|Non responders|123|||
23235006|NCT01066819|64604564|FG001|Overall Study|Non responders|2|||
23235007|NCT01066819|64604565|FG002|Overall Study|Non responders|7|||
23235008|NCT01066819|64604566|FG003|Overall Study|Non responders|2|||
23235009|NCT01066819|64604567|FG004|Overall Study|Non responders|0|||
23235010|NCT01066819|64604568|FG005|Overall Study|Non responders|1|||
23235011|NCT01066819|64604563|FG000|Overall Study|Not categorised|9|||
23235012|NCT01066819|64604564|FG001|Overall Study|Not categorised|2|||
23235013|NCT01066819|64604565|FG002|Overall Study|Not categorised|6|||
23235014|NCT01066819|64604566|FG003|Overall Study|Not categorised|1|||
23235015|NCT01066819|64604567|FG004|Overall Study|Not categorised|0|||
23235016|NCT01066819|64604568|FG005|Overall Study|Not categorised|0|||
23235017|NCT01066819|64604563|FG000|Overall Study|Relapse|16|||
23235018|NCT01066819|64604564|FG001|Overall Study|Relapse|4|||
23235019|NCT01066819|64604565|FG002|Overall Study|Relapse|3|||
23580796|NCT01890967|65853614|FG003|Overall Study|Lost to Follow-up|1|||
23580797|NCT01890967|65853615|FG004|Overall Study|Lost to Follow-up|0|||
23174748|NCT01960855|64386373|FG001|Overall Study|Subject noncompliant|0|||
23174749|NCT01960855|64386374|FG002|Overall Study|Subject noncompliant|0|||
23174750|NCT01960855|64386375|FG003|Overall Study|Subject noncompliant|0|||
23174751|NCT01960855|64386376|FG004|Overall Study|Subject noncompliant|0|||
23174752|NCT01960855|64386372|FG000|Overall Study|Adverse Event|2|||
23174753|NCT01960855|64386373|FG001|Overall Study|Adverse Event|0|||
23174754|NCT01960855|64386374|FG002|Overall Study|Adverse Event|6|||
23174755|NCT01960855|64386375|FG003|Overall Study|Adverse Event|2|||
23174756|NCT01960855|64386376|FG004|Overall Study|Adverse Event|2|||
23174757|NCT01960855|64386372|FG000|Overall Study|Lack of Efficacy|1|||
23174758|NCT01960855|64386373|FG001|Overall Study|Lack of Efficacy|1|||
23174759|NCT01960855|64386374|FG002|Overall Study|Lack of Efficacy|0|||
23174760|NCT01960855|64386375|FG003|Overall Study|Lack of Efficacy|0|||
23235020|NCT01066819|64604566|FG003|Overall Study|Relapse|0|||
23235021|NCT01066819|64604567|FG004|Overall Study|Relapse|0|||
23235022|NCT01066819|64604568|FG005|Overall Study|Relapse|0|||
23235023|NCT01066819|64604563|FG000|Overall Study|Results not available|1|||
23235024|NCT01066819|64604564|FG001|Overall Study|Results not available|0|||
23580798|NCT01890967|65853616|FG005|Overall Study|Lost to Follow-up|1|||
23235025|NCT01066819|64604565|FG002|Overall Study|Results not available|0|||
23235026|NCT01066819|64604566|FG003|Overall Study|Results not available|0|||
23235027|NCT01066819|64604567|FG004|Overall Study|Results not available|0|||
23235028|NCT01066819|64604568|FG005|Overall Study|Results not available|0|||
23235029|NCT01066819|64604563|FG000|Overall Study|Screen failure|1|||
23174761|NCT01960855|64386376|FG004|Overall Study|Lack of Efficacy|0|||
23174762|NCT01960855|64386372|FG000|Overall Study|Other|2|||
23174763|NCT01960855|64386373|FG001|Overall Study|Other|1|||
23174764|NCT01960855|64386374|FG002|Overall Study|Other|1|||
23235030|NCT01066819|64604564|FG001|Overall Study|Screen failure|0|||
23235031|NCT01066819|64604565|FG002|Overall Study|Screen failure|0|||
23235032|NCT01066819|64604566|FG003|Overall Study|Screen failure|0|||
23235033|NCT01066819|64604567|FG004|Overall Study|Screen failure|0|||
23235034|NCT01066819|64604568|FG005|Overall Study|Screen failure|0|||
23235035|NCT01066819|64604563|FG000|Overall Study|Spontaneous cure|1|||
23235036|NCT01066819|64604564|FG001|Overall Study|Spontaneous cure|0|||
23235037|NCT01066819|64604565|FG002|Overall Study|Spontaneous cure|0|||
23235038|NCT01066819|64604566|FG003|Overall Study|Spontaneous cure|0|||
23235039|NCT01066819|64604567|FG004|Overall Study|Spontaneous cure|0|||
23235040|NCT01066819|64604568|FG005|Overall Study|Spontaneous cure|0|||
23235041|NCT01066819|64604563|FG000|Overall Study|Treatment never started|85|||
23235042|NCT01066819|64604564|FG001|Overall Study|Treatment never started|19|||
23235043|NCT01066819|64604565|FG002|Overall Study|Treatment never started|19|||
23235044|NCT01066819|64604566|FG003|Overall Study|Treatment never started|3|||
23235045|NCT01066819|64604567|FG004|Overall Study|Treatment never started|2|||
23235046|NCT01066819|64604568|FG005|Overall Study|Treatment never started|2|||
23235047|NCT01066819|64604563|FG000|Overall Study|Treatment stopped|12|||
23235048|NCT01066819|64604564|FG001|Overall Study|Treatment stopped|1|||
23235049|NCT01066819|64604565|FG002|Overall Study|Treatment stopped|2|||
23235050|NCT01066819|64604566|FG003|Overall Study|Treatment stopped|1|||
23235051|NCT01066819|64604567|FG004|Overall Study|Treatment stopped|0|||
23235052|NCT01066819|64604568|FG005|Overall Study|Treatment stopped|0|||
23235053|NCT01066819|64604563|FG000|Overall Study|Other|5|||
23235054|NCT01066819|64604564|FG001|Overall Study|Other|1|||
23235055|NCT01066819|64604565|FG002|Overall Study|Other|1|||
23235056|NCT01066819|64604566|FG003|Overall Study|Other|0|||
23235057|NCT01066819|64604567|FG004|Overall Study|Other|0|||
23235058|NCT01066819|64604568|FG005|Overall Study|Other|0|||
23235059|NCT00283062|64604575|FG000|Overall Study|Did not receive any study medication|5|||
23235060|NCT00283062|64604576|FG001|Overall Study|Did not receive any study medication|4|||
23235061|NCT00283062|64604577|FG002|Overall Study|Did not receive any study medication|36|||
23235062|NCT00283062|64604578|FG003|Overall Study|Did not receive any study medication|45|||
23235063|NCT00283062|64604575|FG000|Overall Study|Adverse Event|2|||
23235064|NCT00283062|64604576|FG001|Overall Study|Adverse Event|0|||
23235065|NCT00283062|64604577|FG002|Overall Study|Adverse Event|1|||
23235066|NCT00283062|64604578|FG003|Overall Study|Adverse Event|0|||
23235067|NCT00283062|64604575|FG000|Overall Study|Lost to Follow-up|1|||
23235068|NCT00283062|64604576|FG001|Overall Study|Lost to Follow-up|0|||
23452216|NCT02349633|65398945|FG010|Overall Study|Transition to compassionate use|0|||
23452217|NCT02349633|65398946|FG011|Overall Study|Transition to compassionate use|0|||
23452218|NCT02349633|65398947|FG012|Overall Study|Transition to compassionate use|0|||
23452219|NCT02349633|65398948|FG013|Overall Study|Transition to compassionate use|0|||
23452220|NCT02349633|65398935|FG000|Overall Study|Early termination of survival follow-up|0|||
23452221|NCT02349633|65398936|FG001|Overall Study|Early termination of survival follow-up|0|||
23452222|NCT02349633|65398937|FG002|Overall Study|Early termination of survival follow-up|0|||
23452223|NCT02349633|65398938|FG003|Overall Study|Early termination of survival follow-up|0|||
23452224|NCT02349633|65398939|FG004|Overall Study|Early termination of survival follow-up|0|||
23580799|NCT01890967|65853611|FG000|Overall Study|Protocol Violation|0|||
23580800|NCT01890967|65853612|FG001|Overall Study|Protocol Violation|3|||
23580801|NCT01890967|65853613|FG002|Overall Study|Protocol Violation|3|||
23580802|NCT01890967|65853614|FG003|Overall Study|Protocol Violation|2|||
23580803|NCT01890967|65853615|FG004|Overall Study|Protocol Violation|4|||
23580804|NCT01890967|65853616|FG005|Overall Study|Protocol Violation|1|||
23580805|NCT01890967|65853611|FG000|Overall Study|Sponsor Decision|2|||
23580806|NCT01890967|65853612|FG001|Overall Study|Sponsor Decision|0|||
23580807|NCT01890967|65853613|FG002|Overall Study|Sponsor Decision|1|||
23580808|NCT01890967|65853614|FG003|Overall Study|Sponsor Decision|3|||
23580809|NCT01890967|65853615|FG004|Overall Study|Sponsor Decision|2|||
23580810|NCT01890967|65853616|FG005|Overall Study|Sponsor Decision|3|||
23580811|NCT01890967|65853611|FG000|Overall Study|Withdrawal by Subject|3|||
23580812|NCT01890967|65853612|FG001|Overall Study|Withdrawal by Subject|4|||
23580813|NCT01890967|65853613|FG002|Overall Study|Withdrawal by Subject|2|||
23580814|NCT01890967|65853614|FG003|Overall Study|Withdrawal by Subject|3|||
23580815|NCT01890967|65853615|FG004|Overall Study|Withdrawal by Subject|3|||
23580816|NCT01890967|65853616|FG005|Overall Study|Withdrawal by Subject|1|||
23580817|NCT04476043|65853619|FG000|Overall Study|Withdrawal by Subject|1|||
23580818|NCT04476043|65853620|FG001|Overall Study|Withdrawal by Subject|3|||
23580819|NCT04476043|65853621|FG002|Overall Study|Withdrawal by Subject|4|||
23580820|NCT04476043|65853622|FG003|Overall Study|Withdrawal by Subject|1|||
23580821|NCT04476043|65853619|FG000|Overall Study|Lost to Follow-up|1|||
23580822|NCT04476043|65853620|FG001|Overall Study|Lost to Follow-up|1|||
23580823|NCT04476043|65853621|FG002|Overall Study|Lost to Follow-up|2|||
23235069|NCT00283062|64604577|FG002|Overall Study|Lost to Follow-up|1|||
23235070|NCT00283062|64604578|FG003|Overall Study|Lost to Follow-up|0|||
23235071|NCT00283062|64604575|FG000|Overall Study|Progressive disease|0|||
23235072|NCT00283062|64604576|FG001|Overall Study|Progressive disease|0|||
23235073|NCT00283062|64604577|FG002|Overall Study|Progressive disease|1|||
23235074|NCT00283062|64604578|FG003|Overall Study|Progressive disease|0|||
23235075|NCT00283062|64604575|FG000|Overall Study|Participant did not wish to continue|3|||
23452225|NCT02349633|65398940|FG005|Overall Study|Early termination of survival follow-up|0|||
23452226|NCT02349633|65398941|FG006|Overall Study|Early termination of survival follow-up|0|||
23452227|NCT02349633|65398942|FG007|Overall Study|Early termination of survival follow-up|4|||
23452228|NCT02349633|65398943|FG008|Overall Study|Early termination of survival follow-up|0|||
23452229|NCT02349633|65398944|FG009|Overall Study|Early termination of survival follow-up|0|||
23452230|NCT02349633|65398945|FG010|Overall Study|Early termination of survival follow-up|0|||
23452231|NCT02349633|65398946|FG011|Overall Study|Early termination of survival follow-up|0|||
23452232|NCT02349633|65398947|FG012|Overall Study|Early termination of survival follow-up|0|||
23452233|NCT02349633|65398948|FG013|Overall Study|Early termination of survival follow-up|0|||
23452234|NCT02349633|65398935|FG000|Overall Study|Termination by sponsor|0|||
23452235|NCT02349633|65398936|FG001|Overall Study|Termination by sponsor|0|||
23452236|NCT02349633|65398937|FG002|Overall Study|Termination by sponsor|0|||
23452237|NCT02349633|65398938|FG003|Overall Study|Termination by sponsor|0|||
23452238|NCT02349633|65398939|FG004|Overall Study|Termination by sponsor|0|||
23452239|NCT02349633|65398940|FG005|Overall Study|Termination by sponsor|0|||
23580824|NCT04476043|65853622|FG003|Overall Study|Lost to Follow-up|1|||
23580825|NCT04476043|65853619|FG000|Overall Study|Adverse Event|2|||
23580826|NCT04476043|65853620|FG001|Overall Study|Adverse Event|0|||
23580827|NCT04476043|65853621|FG002|Overall Study|Adverse Event|1|||
23580828|NCT04476043|65853622|FG003|Overall Study|Adverse Event|0|||
23580829|NCT04476043|65853619|FG000|Overall Study|Protocol Violation|0|||
23580830|NCT04476043|65853620|FG001|Overall Study|Protocol Violation|1|||
23580831|NCT04476043|65853621|FG002|Overall Study|Protocol Violation|0|||
23580832|NCT04476043|65853622|FG003|Overall Study|Protocol Violation|0|||
23580833|NCT00582790|65853629|FG000|Overall Study|Rapid progression of disease|1|||
23174765|NCT01960855|64386375|FG003|Overall Study|Other|1|||
23174766|NCT01960855|64386376|FG004|Overall Study|Other|0|||
23174767|NCT01960855|64386372|FG000|Overall Study|Consent withdrawn by subject|3|||
23340238|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23174768|NCT01960855|64386373|FG001|Overall Study|Consent withdrawn by subject|1|||
23340239|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
23340240|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
23340241|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340242|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340243|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340870|NCT01936181|64992871|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
23452240|NCT02349633|65398941|FG006|Overall Study|Termination by sponsor|0|||
23580834|NCT00480441|65853630|FG000|Screening|Not Eligible|37|||
23580835|NCT00480441|65853631|FG001|Screening|Not Eligible|0|||
23580836|NCT00480441|65853632|FG002|Screening|Not Eligible|0|||
23174769|NCT01960855|64386374|FG002|Overall Study|Consent withdrawn by subject|2|||
23174770|NCT01960855|64386375|FG003|Overall Study|Consent withdrawn by subject|1|||
23174771|NCT01960855|64386376|FG004|Overall Study|Consent withdrawn by subject|1|||
23174772|NCT01960855|64386372|FG000|Overall Study|Lost to Follow-up|2|||
23174773|NCT01960855|64386373|FG001|Overall Study|Lost to Follow-up|1|||
23174774|NCT01960855|64386374|FG002|Overall Study|Lost to Follow-up|0|||
23174775|NCT01960855|64386375|FG003|Overall Study|Lost to Follow-up|0|||
23174776|NCT01960855|64386376|FG004|Overall Study|Lost to Follow-up|2|||
23174777|NCT02723201|64386379|FG000|Second Intervention Period|Protocol Violation|1|||
23174778|NCT02723201|64386380|FG001|Second Intervention Period|Protocol Violation|0|||
23174779|NCT02723201|64386381|FG002|Second Intervention Period|Protocol Violation|0|||
23174780|NCT02723201|64386379|FG000|Second Intervention Period|Adverse Event|1|||
23174781|NCT02723201|64386380|FG001|Second Intervention Period|Adverse Event|0|||
23174782|NCT02723201|64386381|FG002|Second Intervention Period|Adverse Event|0|||
23174783|NCT02817087|64386382|FG000|Overall Study|Withdrawal by Subject|2|||
23174784|NCT02817087|64386383|FG001|Overall Study|Withdrawal by Subject|0|||
23174785|NCT00112905|64386386|FG000|Overall Study|Adverse Event|4|||
23174786|NCT00112905|64386386|FG000|Overall Study|Death|1|||
23580837|NCT00480441|65853630|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
23580838|NCT00480441|65853631|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
23174787|NCT00112905|64386386|FG000|Overall Study|Ineligibility|5|||
23174788|NCT00112905|64386386|FG000|Overall Study|Alternative treatment|1|||
23174789|NCT00112905|64386386|FG000|Overall Study|performance status was deteiorating|1|||
23174790|NCT00352105|64386393|FG000|Overall Study|Death|5|||
23174791|NCT00352105|64386393|FG000|Overall Study|Withdrawal by Subject|5|||
23174792|NCT00352105|64386393|FG000|Overall Study|Lack of Efficacy|9|||
23174793|NCT00352105|64386393|FG000|Overall Study|Adverse Event|19|||
23174794|NCT00352105|64386393|FG000|Overall Study|Protocol Violation|2|||
23174795|NCT03313050|64386396|FG000|Stage 2: 12 Months|Adverse Event|0|||
23174796|NCT03313050|64386397|FG001|Stage 2: 12 Months|Adverse Event|0|||
23174797|NCT03313050|64386398|FG002|Stage 2: 12 Months|Adverse Event|0|||
23235076|NCT00283062|64604576|FG001|Overall Study|Participant did not wish to continue|2|||
23235077|NCT00283062|64604577|FG002|Overall Study|Participant did not wish to continue|1|||
23235078|NCT00283062|64604578|FG003|Overall Study|Participant did not wish to continue|0|||
23235079|NCT00283062|64604575|FG000|Overall Study|Undefined|0|||
23235080|NCT00283062|64604576|FG001|Overall Study|Undefined|1|||
23235081|NCT00283062|64604577|FG002|Overall Study|Undefined|1|||
23174798|NCT03313050|64386399|FG003|Stage 2: 12 Months|Adverse Event|1|||
23174799|NCT03313050|64386396|FG000|Stage 2: 12 Months|Death|0|||
23174800|NCT03313050|64386397|FG001|Stage 2: 12 Months|Death|0|||
23174801|NCT03313050|64386398|FG002|Stage 2: 12 Months|Death|3|||
23174802|NCT03313050|64386399|FG003|Stage 2: 12 Months|Death|0|||
23174803|NCT03313050|64386396|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
23174804|NCT03313050|64386397|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
23174805|NCT03313050|64386398|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
23174806|NCT03313050|64386399|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
23174807|NCT03313050|64386396|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
23174808|NCT03313050|64386397|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
23174809|NCT03313050|64386398|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
23174810|NCT03313050|64386399|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
23174811|NCT03313050|64386396|FG000|Stage 2: 12 Months|Protocol deviation|0|||
23174812|NCT03313050|64386397|FG001|Stage 2: 12 Months|Protocol deviation|0|||
23174813|NCT03313050|64386398|FG002|Stage 2: 12 Months|Protocol deviation|7|||
23174814|NCT03313050|64386399|FG003|Stage 2: 12 Months|Protocol deviation|7|||
23174815|NCT03313050|64386396|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
23174816|NCT03313050|64386397|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
23174817|NCT03313050|64386398|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
23174818|NCT03313050|64386399|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
23174819|NCT03313050|64386396|FG000|Stage 2: 12 Months|Other|0|||
23174820|NCT03313050|64386397|FG001|Stage 2: 12 Months|Other|0|||
23174821|NCT03313050|64386398|FG002|Stage 2: 12 Months|Other|0|||
23174822|NCT03313050|64386399|FG003|Stage 2: 12 Months|Other|1|||
23174823|NCT02154425|64386400|FG000|Screening Period|Adverse Event|1|||
23174824|NCT00647556|64386402|FG000|Overall Study|Adverse Event|0|||
23174825|NCT00647556|64386403|FG001|Overall Study|Adverse Event|1|||
23174826|NCT00647556|64386402|FG000|Overall Study|Lost to Follow-up|1|||
23174827|NCT00647556|64386403|FG001|Overall Study|Lost to Follow-up|0|||
23174828|NCT00647556|64386402|FG000|Overall Study|Protocol Violation|0|||
23174829|NCT00647556|64386403|FG001|Overall Study|Protocol Violation|1|||
23174830|NCT00647556|64386402|FG000|Overall Study|Withdrawal by Subject|1|||
23174831|NCT00647556|64386403|FG001|Overall Study|Withdrawal by Subject|0|||
23174832|NCT00647556|64386402|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
23174833|NCT00647556|64386403|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
23174834|NCT00168831|64386404|FG000|Overall Study|Adverse Event|36|||
23174835|NCT00168831|64386405|FG001|Overall Study|Adverse Event|47|||
23174836|NCT00168831|64386406|FG002|Overall Study|Adverse Event|74|||
23174837|NCT00168831|64386404|FG000|Overall Study|Lost to Follow-up|5|||
23174838|NCT00168831|64386405|FG001|Overall Study|Lost to Follow-up|6|||
23174839|NCT00168831|64386406|FG002|Overall Study|Lost to Follow-up|4|||
23174840|NCT00168831|64386404|FG000|Overall Study|Withdrawal by Subject|7|||
23174841|NCT00168831|64386405|FG001|Overall Study|Withdrawal by Subject|14|||
23174842|NCT00168831|64386406|FG002|Overall Study|Withdrawal by Subject|19|||
23174843|NCT00168831|64386404|FG000|Overall Study|Protocol Violation|6|||
23174844|NCT00168831|64386405|FG001|Overall Study|Protocol Violation|11|||
23174845|NCT00168831|64386406|FG002|Overall Study|Protocol Violation|11|||
23174846|NCT00168831|64386404|FG000|Overall Study|Other|6|||
23174847|NCT00168831|64386405|FG001|Overall Study|Other|3|||
23174848|NCT00168831|64386406|FG002|Overall Study|Other|6|||
23174849|NCT01273064|64386407|FG000|Overall Study|Adverse Event|5|||
23174850|NCT01273064|64386408|FG001|Overall Study|Adverse Event|1|||
23174851|NCT01273064|64386409|FG002|Overall Study|Adverse Event|3|||
23174852|NCT01273064|64386410|FG003|Overall Study|Adverse Event|2|||
23174853|NCT01273064|64386411|FG004|Overall Study|Adverse Event|1|||
23174854|NCT01273064|64386407|FG000|Overall Study|Withdrawal by Subject|4|||
23174855|NCT01273064|64386408|FG001|Overall Study|Withdrawal by Subject|2|||
23174856|NCT01273064|64386409|FG002|Overall Study|Withdrawal by Subject|2|||
23174857|NCT01273064|64386410|FG003|Overall Study|Withdrawal by Subject|2|||
23235082|NCT00283062|64604578|FG003|Overall Study|Undefined|4|||
23174858|NCT01273064|64386411|FG004|Overall Study|Withdrawal by Subject|0|||
23174859|NCT01273064|64386407|FG000|Overall Study|Study Termination|13|||
23174860|NCT01273064|64386408|FG001|Overall Study|Study Termination|27|||
23174861|NCT01273064|64386409|FG002|Overall Study|Study Termination|26|||
23174862|NCT01273064|64386410|FG003|Overall Study|Study Termination|16|||
23174863|NCT01273064|64386411|FG004|Overall Study|Study Termination|8|||
23174864|NCT01273064|64386407|FG000|Overall Study|Lost to Follow-up|1|||
23174865|NCT01273064|64386408|FG001|Overall Study|Lost to Follow-up|0|||
23174866|NCT01273064|64386409|FG002|Overall Study|Lost to Follow-up|0|||
23174867|NCT01273064|64386410|FG003|Overall Study|Lost to Follow-up|0|||
23174868|NCT01273064|64386411|FG004|Overall Study|Lost to Follow-up|0|||
23235083|NCT00283062|64604575|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
23235084|NCT00283062|64604576|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
23235085|NCT00283062|64604577|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
23235086|NCT00283062|64604578|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
23235087|NCT00103207|64604592|FG000|Overall Study|Adverse Event|3|||
23235088|NCT00103207|64604592|FG000|Overall Study|Death|1|||
23235089|NCT00103207|64604592|FG000|Overall Study|Withdrawal by Subject|2|||
23235090|NCT00103207|64604592|FG000|Overall Study|Other complicating disease|1|||
23235091|NCT00103207|64604592|FG000|Overall Study|Ineligible|4|||
23235092|NCT00103207|64604592|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
23235093|NCT02911285|64604601|FG000|Overall Study|Lost to Follow-up|8|||
23235094|NCT02911285|64604602|FG001|Overall Study|Lost to Follow-up|5|||
23235095|NCT02911285|64604601|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
23235096|NCT02911285|64604602|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
23235097|NCT01345162|64604603|FG000|Overall Study|Protocol Violation|2|||
23235098|NCT01345162|64604604|FG001|Overall Study|Protocol Violation|4|||
23235099|NCT03798366|64604607|FG000|Overall Study|Lost to Follow-up|0|||
23235100|NCT03798366|64604608|FG001|Overall Study|Lost to Follow-up|1|||
23235101|NCT00689299|64604609|FG000|Overall Study|Adverse Event|2|||
23235102|NCT00689299|64604610|FG001|Overall Study|Adverse Event|1|||
23235103|NCT00689299|64604611|FG002|Overall Study|Adverse Event|1|||
23235104|NCT00689299|64604609|FG000|Overall Study|Lost to Follow-up|0|||
23235105|NCT00689299|64604610|FG001|Overall Study|Lost to Follow-up|1|||
23235106|NCT00689299|64604611|FG002|Overall Study|Lost to Follow-up|1|||
23235107|NCT00689299|64604609|FG000|Overall Study|Withdrawal by Subject|4|||
23235108|NCT00689299|64604610|FG001|Overall Study|Withdrawal by Subject|1|||
23235109|NCT00689299|64604611|FG002|Overall Study|Withdrawal by Subject|3|||
23235110|NCT00689299|64604609|FG000|Overall Study|Protocol Violation|1|||
23235111|NCT00689299|64604610|FG001|Overall Study|Protocol Violation|0|||
23235112|NCT00689299|64604611|FG002|Overall Study|Protocol Violation|0|||
23235113|NCT00911508|64604612|FG000|Overall Study|Lost to Follow-up|27|||
23235114|NCT00911508|64604613|FG001|Overall Study|Lost to Follow-up|18|||
23235115|NCT00911508|64604612|FG000|Overall Study|Withdrawal by Subject|79|||
23235116|NCT00911508|64604613|FG001|Overall Study|Withdrawal by Subject|112|||
23235117|NCT01592773|64604617|FG000|Overall Study|Study Terminated by Sponsor|582|||
23235118|NCT01592773|64604617|FG000|Overall Study|Withdrawal by Subject|35|||
23235119|NCT01592773|64604617|FG000|Overall Study|Lost to Follow-up|19|||
23235120|NCT01592773|64604617|FG000|Overall Study|Adverse Event|17|||
23235121|NCT01592773|64604617|FG000|Overall Study|Lack of Efficacy|9|||
23235122|NCT01592773|64604617|FG000|Overall Study|Protocol Violation|2|||
23235123|NCT01592773|64604617|FG000|Overall Study|Inclusion/exclusion not meet|1|||
23235124|NCT01592773|64604617|FG000|Overall Study|Other Reason|1|||
23235125|NCT01977573|64604618|FG000|Overall Study|Adverse Event|7|||
23235126|NCT01977573|64604619|FG001|Overall Study|Adverse Event|0|||
23235127|NCT01977573|64604620|FG002|Overall Study|Adverse Event|2|||
23235128|NCT01977573|64604621|FG003|Overall Study|Adverse Event|1|||
23235129|NCT01977573|64604618|FG000|Overall Study|Lost to Follow-up|1|||
23235130|NCT01977573|64604619|FG001|Overall Study|Lost to Follow-up|0|||
23235131|NCT01977573|64604620|FG002|Overall Study|Lost to Follow-up|0|||
23235132|NCT01977573|64604621|FG003|Overall Study|Lost to Follow-up|1|||
23235133|NCT01977573|64604618|FG000|Overall Study|Physician Decision|1|||
23235134|NCT01977573|64604619|FG001|Overall Study|Physician Decision|0|||
23235135|NCT01977573|64604620|FG002|Overall Study|Physician Decision|0|||
23235136|NCT01977573|64604621|FG003|Overall Study|Physician Decision|0|||
23235137|NCT01977573|64604618|FG000|Overall Study|Protocol Violation|3|||
23235138|NCT01977573|64604619|FG001|Overall Study|Protocol Violation|1|||
23235139|NCT01977573|64604620|FG002|Overall Study|Protocol Violation|0|||
23235140|NCT01977573|64604621|FG003|Overall Study|Protocol Violation|0|||
23235141|NCT01977573|64604618|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
23235142|NCT01977573|64604619|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
23235143|NCT01977573|64604620|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
23235144|NCT01977573|64604621|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
23235145|NCT01977573|64604618|FG000|Overall Study|Withdrawal by Subject|6|||
23235146|NCT01977573|64604619|FG001|Overall Study|Withdrawal by Subject|1|||
23235147|NCT01977573|64604620|FG002|Overall Study|Withdrawal by Subject|1|||
23235148|NCT01977573|64604621|FG003|Overall Study|Withdrawal by Subject|1|||
23235149|NCT03417102|64604622|FG000|Overall Study|Adverse Event|0|||
23235150|NCT03417102|64604623|FG001|Overall Study|Adverse Event|1|||
23235151|NCT03417102|64604622|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
23235152|NCT03417102|64604623|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
23235153|NCT03417102|64604622|FG000|Overall Study|Other|0|||
23235154|NCT03417102|64604623|FG001|Overall Study|Other|1|||
23235155|NCT00699582|64604624|FG000|Overall Study|Adverse Event|4|||
23235156|NCT00699582|64604625|FG001|Overall Study|Adverse Event|11|||
23235157|NCT00699582|64604626|FG002|Overall Study|Adverse Event|23|||
23235158|NCT00699582|64604624|FG000|Overall Study|Withdrawal by Subject|6|||
23235159|NCT00699582|64604625|FG001|Overall Study|Withdrawal by Subject|7|||
23235160|NCT00699582|64604626|FG002|Overall Study|Withdrawal by Subject|4|||
23235161|NCT00699582|64604624|FG000|Overall Study|Lack of Efficacy|1|||
23235162|NCT00699582|64604625|FG001|Overall Study|Lack of Efficacy|0|||
23235163|NCT00699582|64604626|FG002|Overall Study|Lack of Efficacy|1|||
23235164|NCT00699582|64604624|FG000|Overall Study|Progressive Disease|1|||
23235165|NCT00699582|64604625|FG001|Overall Study|Progressive Disease|0|||
23235166|NCT00699582|64604626|FG002|Overall Study|Progressive Disease|0|||
23235167|NCT00699582|64604624|FG000|Overall Study|Administrative/Other|4|||
23235168|NCT00699582|64604625|FG001|Overall Study|Administrative/Other|3|||
23235169|NCT00699582|64604626|FG002|Overall Study|Administrative/Other|0|||
23235170|NCT00699582|64604624|FG000|Overall Study|Randomized, Not Treated|2|||
23235171|NCT00699582|64604625|FG001|Overall Study|Randomized, Not Treated|1|||
23235172|NCT00699582|64604626|FG002|Overall Study|Randomized, Not Treated|0|||
23235173|NCT00570492|64604627|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
23235174|NCT00570492|64604628|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
23235175|NCT00570492|64604629|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
23235176|NCT00570492|64604627|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
23235177|NCT00570492|64604628|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
23235178|NCT00570492|64604629|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
23235179|NCT00570492|64604627|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
23235180|NCT00570492|64604628|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
23340244|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340245|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23340246|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
23174869|NCT01273064|64386407|FG000|Overall Study|Physician Decision|0|||
23174870|NCT01273064|64386408|FG001|Overall Study|Physician Decision|0|||
23174871|NCT01273064|64386409|FG002|Overall Study|Physician Decision|0|||
23174872|NCT01273064|64386410|FG003|Overall Study|Physician Decision|0|||
23174873|NCT01273064|64386411|FG004|Overall Study|Physician Decision|1|||
23174874|NCT01467492|64386414|FG000|Overall Study|Withdrawal by Subject|6|||
23174875|NCT01467492|64386415|FG001|Overall Study|Withdrawal by Subject|4|||
23174876|NCT01467492|64386414|FG000|Overall Study|Study Terminated by Sponsor|6|||
23174877|NCT01467492|64386415|FG001|Overall Study|Study Terminated by Sponsor|4|||
23174878|NCT01467492|64386414|FG000|Overall Study|Adverse Event|4|||
23174879|NCT01467492|64386415|FG001|Overall Study|Adverse Event|3|||
23174880|NCT01467492|64386414|FG000|Overall Study|Lost to Follow-up|3|||
23174881|NCT01467492|64386415|FG001|Overall Study|Lost to Follow-up|2|||
23174882|NCT01467492|64386414|FG000|Overall Study|Undefined|2|||
23174883|NCT01467492|64386415|FG001|Overall Study|Undefined|0|||
23174884|NCT01467492|64386414|FG000|Overall Study|Enrolled But Not Treated|1|||
23174885|NCT01467492|64386415|FG001|Overall Study|Enrolled But Not Treated|0|||
23174886|NCT00257010|64386420|FG000|Overall Study|Lack of Efficacy|11|||
23174887|NCT00257010|64386420|FG000|Overall Study|Lost to Follow-up|53|||
23174888|NCT00257010|64386420|FG000|Overall Study|Withdrawal by Subject|34|||
23174889|NCT00257010|64386420|FG000|Overall Study|Adverse Event|10|||
23174890|NCT00257010|64386420|FG000|Overall Study|various|11|||
23174891|NCT00257010|64386420|FG000|Overall Study|no headache reported|9|||
23174892|NCT03575104|64386422|FG000|Overall Study|Adverse Event|4|||
23174893|NCT03575104|64386423|FG001|Overall Study|Adverse Event|3|||
23174894|NCT03575104|64386424|FG002|Overall Study|Adverse Event|4|||
23174895|NCT03575104|64386422|FG000|Overall Study|Withdrawal by Subject|13|||
23174896|NCT03575104|64386423|FG001|Overall Study|Withdrawal by Subject|16|||
23174897|NCT03575104|64386424|FG002|Overall Study|Withdrawal by Subject|11|||
23174898|NCT03575104|64386422|FG000|Overall Study|Other reasons|6|||
23174899|NCT03575104|64386423|FG001|Overall Study|Other reasons|8|||
23174900|NCT03575104|64386424|FG002|Overall Study|Other reasons|6|||
23174901|NCT03575104|64386422|FG000|Overall Study|Lost to Follow-up|1|||
23174902|NCT03575104|64386423|FG001|Overall Study|Lost to Follow-up|2|||
23174903|NCT03575104|64386424|FG002|Overall Study|Lost to Follow-up|1|||
23174904|NCT00896532|64386425|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174905|NCT00896532|64386426|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174906|NCT00896532|64386427|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174907|NCT00896532|64386428|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
23174908|NCT00896532|64386429|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174909|NCT00896532|64386430|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
23174910|NCT00896532|64386431|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174911|NCT00896532|64386432|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23235181|NCT00570492|64604629|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
23235182|NCT00570492|64604627|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
23174912|NCT00896532|64386433|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23235183|NCT00570492|64604628|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
23235184|NCT00570492|64604629|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
23235185|NCT00570492|64604627|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
23235186|NCT00570492|64604628|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
23235187|NCT00570492|64604629|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
23235188|NCT00570492|64604627|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
23580839|NCT00480441|65853632|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
23580840|NCT00480441|65853630|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
23580841|NCT00480441|65853631|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
23580842|NCT00480441|65853632|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
23580843|NCT00480441|65853630|FG000|Baseline Functional MRI|physical contraindication|4|||
23580844|NCT00480441|65853631|FG001|Baseline Functional MRI|physical contraindication|0|||
23580845|NCT00480441|65853632|FG002|Baseline Functional MRI|physical contraindication|0|||
23580846|NCT00480441|65853630|FG000|Randomization|Lost to Follow-up|0|||
23580847|NCT00480441|65853631|FG001|Randomization|Lost to Follow-up|7|||
23580848|NCT00480441|65853632|FG002|Randomization|Lost to Follow-up|2|||
23174913|NCT00896532|64386434|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174914|NCT00896532|64386435|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174915|NCT00896532|64386436|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174916|NCT00896532|64386437|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174917|NCT00896532|64386438|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23580849|NCT01582243|65853633|FG000|Overall Study|Withdrawal by Subject|1|||
23580850|NCT01582243|65853633|FG000|Overall Study|Adverse Event|1|||
23580851|NCT01582243|65853633|FG000|Overall Study|Lost to Follow-up|1|||
23580852|NCT02788656|65856733|FG000|Overall Study|Withdrawal by Subject|1|||
23174918|NCT00896532|64386439|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174919|NCT00896532|64386440|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174920|NCT00896532|64386441|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23235189|NCT00570492|64604628|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
23235190|NCT00570492|64604629|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
23235191|NCT00570492|64604627|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
23235192|NCT00570492|64604628|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
23235193|NCT00570492|64604629|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
23235194|NCT00570492|64604627|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23235195|NCT00570492|64604628|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
23235196|NCT00570492|64604629|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
23235197|NCT00570492|64604627|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
23235198|NCT00570492|64604628|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
23235199|NCT00570492|64604629|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
23235200|NCT00570492|64604627|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
23235201|NCT00570492|64604628|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
23235202|NCT00570492|64604629|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
23235203|NCT00570492|64604627|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
23580853|NCT02788656|65856734|FG001|Overall Study|Withdrawal by Subject|0|||
23580854|NCT01096056|65856735|FG000|Overall Study|Lost to Follow-up|0|||
23580855|NCT01096056|65856736|FG001|Overall Study|Lost to Follow-up|1|||
23580856|NCT00672256|65856739|FG000|Overall Study|PI dropped, bad data|44|||
23580857|NCT04531540|65856756|FG000|Overall Study|Adverse Event|1|||
23580858|NCT04531540|65856756|FG000|Overall Study|Protocol Violation|3|||
23452241|NCT02349633|65398942|FG007|Overall Study|Termination by sponsor|1|||
23452242|NCT02349633|65398943|FG008|Overall Study|Termination by sponsor|0|||
23452243|NCT02349633|65398944|FG009|Overall Study|Termination by sponsor|2|||
23452244|NCT02349633|65398945|FG010|Overall Study|Termination by sponsor|0|||
23452245|NCT02349633|65398946|FG011|Overall Study|Termination by sponsor|0|||
23452246|NCT02349633|65398947|FG012|Overall Study|Termination by sponsor|0|||
23452247|NCT02349633|65398948|FG013|Overall Study|Termination by sponsor|0|||
23452248|NCT02349633|65398935|FG000|Overall Study|Other|0|||
23452249|NCT02349633|65398936|FG001|Overall Study|Other|0|||
23452250|NCT02349633|65398937|FG002|Overall Study|Other|0|||
23452251|NCT02349633|65398938|FG003|Overall Study|Other|0|||
23452252|NCT02349633|65398939|FG004|Overall Study|Other|0|||
23452253|NCT02349633|65398940|FG005|Overall Study|Other|0|||
23452254|NCT02349633|65398941|FG006|Overall Study|Other|0|||
23452255|NCT02349633|65398942|FG007|Overall Study|Other|2|||
23452256|NCT02349633|65398943|FG008|Overall Study|Other|0|||
23452257|NCT02349633|65398944|FG009|Overall Study|Other|0|||
23452258|NCT02349633|65398945|FG010|Overall Study|Other|0|||
23452259|NCT02349633|65398946|FG011|Overall Study|Other|0|||
23452260|NCT02349633|65398947|FG012|Overall Study|Other|0|||
23452261|NCT02349633|65398948|FG013|Overall Study|Other|0|||
23452262|NCT03623243|65398954|FG000|Overall Study|Adverse Event|15|||
23452263|NCT03623243|65398954|FG000|Overall Study|Guardian Decision|1|||
23452264|NCT03623243|65398954|FG000|Overall Study|New Therapy for Study Indication|1|||
23452265|NCT03623243|65398954|FG000|Overall Study|Protocol Deviation|3|||
23452266|NCT03623243|65398954|FG000|Overall Study|Physician Decision|4|||
23452267|NCT03623243|65398954|FG000|Overall Study|Patient Decision|15|||
23452268|NCT02552966|65398961|FG000|Overall Study|Lost to Follow-up|2|||
23452269|NCT02552966|65398961|FG000|Overall Study|Withdrawal by Subject|3|||
23452270|NCT00660192|65398962|FG000|Overall Study|Lost to Follow-up|2|||
23452271|NCT00660192|65398963|FG001|Overall Study|Lost to Follow-up|3|||
23452272|NCT03084796|65398964|FG000|Overall Study|Adverse Event|4|||
23452273|NCT03084796|65398965|FG001|Overall Study|Adverse Event|5|||
23452274|NCT03084796|65398966|FG002|Overall Study|Adverse Event|6|||
23452275|NCT03084796|65398967|FG003|Overall Study|Adverse Event|2|||
23452276|NCT03084796|65398968|FG004|Overall Study|Adverse Event|3|||
23452277|NCT03084796|65398969|FG005|Overall Study|Adverse Event|5|||
23452278|NCT03084796|65398964|FG000|Overall Study|Withdrawal by Subject|3|||
23452279|NCT03084796|65398965|FG001|Overall Study|Withdrawal by Subject|5|||
23452280|NCT03084796|65398966|FG002|Overall Study|Withdrawal by Subject|2|||
23452281|NCT03084796|65398967|FG003|Overall Study|Withdrawal by Subject|1|||
23452282|NCT03084796|65398968|FG004|Overall Study|Withdrawal by Subject|3|||
23452283|NCT03084796|65398969|FG005|Overall Study|Withdrawal by Subject|0|||
23452284|NCT03084796|65398964|FG000|Overall Study|Protocol Violation|0|||
23452285|NCT03084796|65398965|FG001|Overall Study|Protocol Violation|0|||
23452286|NCT03084796|65398966|FG002|Overall Study|Protocol Violation|1|||
23452287|NCT03084796|65398967|FG003|Overall Study|Protocol Violation|0|||
23452288|NCT03084796|65398968|FG004|Overall Study|Protocol Violation|1|||
23452289|NCT03084796|65398969|FG005|Overall Study|Protocol Violation|1|||
23452290|NCT03084796|65398964|FG000|Overall Study|Lack of Efficacy|0|||
23580859|NCT04531540|65856756|FG000|Overall Study|Withdrawal by Subject|4|||
23580860|NCT04531540|65856756|FG000|Overall Study|Found to be Ineligible|1|||
23580861|NCT00462943|65856757|FG000|Overall Study|Failure to achieve a response|5|||
23580862|NCT00462943|65856758|FG001|Overall Study|Failure to achieve a response|5|||
23580863|NCT00462943|65856759|FG002|Overall Study|Failure to achieve a response|1|||
23580864|NCT00462943|65856757|FG000|Overall Study|Adverse Event|6|||
23580865|NCT00462943|65856758|FG001|Overall Study|Adverse Event|4|||
23580866|NCT00462943|65856759|FG002|Overall Study|Adverse Event|1|||
23580867|NCT00462943|65856757|FG000|Overall Study|Protocol Violation|1|||
23580868|NCT00462943|65856758|FG001|Overall Study|Protocol Violation|0|||
23580869|NCT00462943|65856759|FG002|Overall Study|Protocol Violation|0|||
23580870|NCT00462943|65856757|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
23580871|NCT00462943|65856758|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
23452291|NCT03084796|65398965|FG001|Overall Study|Lack of Efficacy|0|||
23452292|NCT03084796|65398966|FG002|Overall Study|Lack of Efficacy|1|||
23452293|NCT03084796|65398967|FG003|Overall Study|Lack of Efficacy|0|||
23452294|NCT03084796|65398968|FG004|Overall Study|Lack of Efficacy|1|||
23452295|NCT03084796|65398969|FG005|Overall Study|Lack of Efficacy|0|||
23452296|NCT03084796|65398964|FG000|Overall Study|Lost to Follow-up|0|||
23452297|NCT03084796|65398965|FG001|Overall Study|Lost to Follow-up|0|||
23452298|NCT03084796|65398966|FG002|Overall Study|Lost to Follow-up|1|||
23452299|NCT03084796|65398967|FG003|Overall Study|Lost to Follow-up|1|||
23452300|NCT03084796|65398968|FG004|Overall Study|Lost to Follow-up|3|||
23452301|NCT03084796|65398969|FG005|Overall Study|Lost to Follow-up|1|||
23452302|NCT03084796|65398964|FG000|Overall Study|Randomization error|0|||
23452303|NCT03084796|65398965|FG001|Overall Study|Randomization error|0|||
23452304|NCT03084796|65398966|FG002|Overall Study|Randomization error|1|||
23235204|NCT00570492|64604628|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
23235205|NCT00570492|64604629|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
23235206|NCT00570492|64604627|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
23235207|NCT00570492|64604628|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
23235208|NCT00570492|64604629|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
23235209|NCT00570492|64604627|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
23235210|NCT00570492|64604628|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
23235211|NCT00570492|64604629|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
23340247|NCT04526509|64989469|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
23340248|NCT04526509|64989470|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340249|NCT04526509|64989471|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340250|NCT04526509|64989472|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340251|NCT04526509|64989473|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340252|NCT04526509|64989474|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340253|NCT04526509|64989475|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
23340254|NCT04526509|64989469|FG000|Enrolled|Study Terminated by Sponsor|0|||
23340255|NCT04526509|64989470|FG001|Enrolled|Study Terminated by Sponsor|0|||
23340256|NCT04526509|64989471|FG002|Enrolled|Study Terminated by Sponsor|0|||
23340257|NCT04526509|64989472|FG003|Enrolled|Study Terminated by Sponsor|0|||
23340258|NCT04526509|64989473|FG004|Enrolled|Study Terminated by Sponsor|0|||
23340259|NCT04526509|64989474|FG005|Enrolled|Study Terminated by Sponsor|0|||
23340260|NCT04526509|64989475|FG006|Enrolled|Study Terminated by Sponsor|1|||
23340261|NCT04526509|64989469|FG000|Enrolled|Death prior to lymphodepletion|0|||
23340262|NCT04526509|64989470|FG001|Enrolled|Death prior to lymphodepletion|0|||
23340263|NCT04526509|64989471|FG002|Enrolled|Death prior to lymphodepletion|0|||
23340264|NCT04526509|64989472|FG003|Enrolled|Death prior to lymphodepletion|1|||
23340265|NCT04526509|64989473|FG004|Enrolled|Death prior to lymphodepletion|0|||
23340266|NCT04526509|64989474|FG005|Enrolled|Death prior to lymphodepletion|0|||
23340267|NCT04526509|64989475|FG006|Enrolled|Death prior to lymphodepletion|0|||
23340268|NCT04526509|64989469|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340269|NCT04526509|64989470|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340270|NCT04526509|64989471|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340271|NCT04526509|64989472|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
23340272|NCT04526509|64989473|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340273|NCT04526509|64989474|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340274|NCT04526509|64989475|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
23340275|NCT04526509|64989469|FG000|Enrolled|Physician Decision|0|||
23340276|NCT04526509|64989470|FG001|Enrolled|Physician Decision|1|||
23340277|NCT04526509|64989471|FG002|Enrolled|Physician Decision|0|||
23340278|NCT04526509|64989472|FG003|Enrolled|Physician Decision|0|||
23340279|NCT04526509|64989473|FG004|Enrolled|Physician Decision|0|||
23340280|NCT04526509|64989474|FG005|Enrolled|Physician Decision|0|||
23340281|NCT04526509|64989475|FG006|Enrolled|Physician Decision|0|||
23340282|NCT05174949|64989476|FG000|Overall Study|Physician Decision|1|||
23340283|NCT05174949|64989477|FG001|Overall Study|Physician Decision|2|||
23340284|NCT05174949|64989478|FG002|Overall Study|Physician Decision|0|||
23340285|NCT05174949|64989479|FG003|Overall Study|Physician Decision|1|||
23340286|NCT05174949|64989480|FG004|Overall Study|Physician Decision|0|||
23340287|NCT05174949|64989481|FG005|Overall Study|Physician Decision|0|||
23340288|NCT05174949|64989476|FG000|Overall Study|Withdrawal by Subject|0|||
23340289|NCT05174949|64989477|FG001|Overall Study|Withdrawal by Subject|1|||
23340290|NCT05174949|64989478|FG002|Overall Study|Withdrawal by Subject|0|||
23340291|NCT05174949|64989479|FG003|Overall Study|Withdrawal by Subject|0|||
23340292|NCT05174949|64989480|FG004|Overall Study|Withdrawal by Subject|0|||
23340293|NCT05174949|64989481|FG005|Overall Study|Withdrawal by Subject|0|||
23340294|NCT05174949|64989476|FG000|Overall Study|Lost to Follow-up|0|||
23340295|NCT05174949|64989477|FG001|Overall Study|Lost to Follow-up|0|||
23340296|NCT05174949|64989478|FG002|Overall Study|Lost to Follow-up|0|||
23340297|NCT05174949|64989479|FG003|Overall Study|Lost to Follow-up|1|||
23235212|NCT00570492|64604627|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
23235213|NCT00570492|64604628|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
23340298|NCT05174949|64989480|FG004|Overall Study|Lost to Follow-up|0|||
23340299|NCT05174949|64989481|FG005|Overall Study|Lost to Follow-up|0|||
23340300|NCT00727844|64989488|FG000|Initial Randomization|Physician Decision|2|||
23340301|NCT00727844|64989489|FG001|Initial Randomization|Physician Decision|0|||
23452305|NCT03084796|65398967|FG003|Overall Study|Randomization error|0|||
23340302|NCT00727844|64989490|FG002|Initial Randomization|Physician Decision|0|||
23340303|NCT00727844|64989491|FG003|Initial Randomization|Physician Decision|0|||
23452306|NCT03084796|65398968|FG004|Overall Study|Randomization error|0|||
23452307|NCT03084796|65398969|FG005|Overall Study|Randomization error|0|||
23452308|NCT01018030|65398970|FG000|Overall Study|Adverse Event|10|||
23452309|NCT01018030|65398971|FG001|Overall Study|Adverse Event|5|||
23452310|NCT01018030|65398972|FG002|Overall Study|Adverse Event|5|||
23452311|NCT01018030|65398970|FG000|Overall Study|Withdrawal by Subject|2|||
23452312|NCT01018030|65398971|FG001|Overall Study|Withdrawal by Subject|2|||
23452313|NCT01018030|65398972|FG002|Overall Study|Withdrawal by Subject|4|||
23452314|NCT01018030|65398970|FG000|Overall Study|Lost to Follow-up|2|||
23452315|NCT01018030|65398971|FG001|Overall Study|Lost to Follow-up|0|||
23452316|NCT01018030|65398972|FG002|Overall Study|Lost to Follow-up|3|||
23452317|NCT01018030|65398970|FG000|Overall Study|Protocol Violation|2|||
23452318|NCT01018030|65398971|FG001|Overall Study|Protocol Violation|1|||
23452319|NCT01018030|65398972|FG002|Overall Study|Protocol Violation|0|||
23452320|NCT01018030|65398970|FG000|Overall Study|Physician Decision|1|||
23452321|NCT01018030|65398971|FG001|Overall Study|Physician Decision|0|||
23452322|NCT01018030|65398972|FG002|Overall Study|Physician Decision|1|||
23452323|NCT01018030|65398970|FG000|Overall Study|Lack of Efficacy|1|||
23452324|NCT01018030|65398971|FG001|Overall Study|Lack of Efficacy|0|||
23452325|NCT01018030|65398972|FG002|Overall Study|Lack of Efficacy|0|||
23452326|NCT01018030|65398970|FG000|Overall Study|Did Not Receive Study Drug|1|||
23452327|NCT01018030|65398971|FG001|Overall Study|Did Not Receive Study Drug|3|||
23452328|NCT01018030|65398972|FG002|Overall Study|Did Not Receive Study Drug|0|||
23452329|NCT00333775|65398973|FG000|Overall Study|Death|144|||
23452330|NCT00333775|65398974|FG001|Overall Study|Death|149|||
23452331|NCT00333775|65398975|FG002|Overall Study|Death|143|||
23452332|NCT00333775|65398973|FG000|Overall Study|In Follow-up When Study Stopped|87|||
23452333|NCT00333775|65398974|FG001|Overall Study|In Follow-up When Study Stopped|92|||
23452334|NCT00333775|65398975|FG002|Overall Study|In Follow-up When Study Stopped|96|||
23452335|NCT00333775|65398973|FG000|Overall Study|Lost to Follow-up|10|||
23452336|NCT00333775|65398974|FG001|Overall Study|Lost to Follow-up|7|||
23452337|NCT00333775|65398975|FG002|Overall Study|Lost to Follow-up|8|||
23452338|NCT01300234|65398983|FG000|Overall Study|Adverse Event|1|||
23452339|NCT01300234|65398984|FG001|Overall Study|Adverse Event|1|||
23452340|NCT01300234|65398983|FG000|Overall Study|Protocol Violation|2|||
23580872|NCT00462943|65856759|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
23580873|NCT00462943|65856757|FG000|Overall Study|Disease Progression|15|||
23580874|NCT00462943|65856758|FG001|Overall Study|Disease Progression|15|||
23580875|NCT00462943|65856759|FG002|Overall Study|Disease Progression|9|||
23580876|NCT00462943|65856757|FG000|Overall Study|Death|5|||
23580877|NCT00462943|65856758|FG001|Overall Study|Death|2|||
23580878|NCT00462943|65856759|FG002|Overall Study|Death|7|||
23580879|NCT00462943|65856757|FG000|Overall Study|Stem Cell Transplant|1|||
23580880|NCT00462943|65856758|FG001|Overall Study|Stem Cell Transplant|1|||
23580881|NCT00462943|65856759|FG002|Overall Study|Stem Cell Transplant|0|||
23580882|NCT00462943|65856757|FG000|Overall Study|Bone Marrow Transplant|1|||
23580883|NCT00462943|65856758|FG001|Overall Study|Bone Marrow Transplant|0|||
23580884|NCT00462943|65856759|FG002|Overall Study|Bone Marrow Transplant|0|||
23580885|NCT00462943|65856757|FG000|Overall Study|Required Lymphocyte Infusion|1|||
23580886|NCT00462943|65856758|FG001|Overall Study|Required Lymphocyte Infusion|0|||
23580887|NCT00462943|65856759|FG002|Overall Study|Required Lymphocyte Infusion|0|||
23580888|NCT00462943|65856757|FG000|Overall Study|Transplant - not specified|1|||
23580889|NCT00462943|65856758|FG001|Overall Study|Transplant - not specified|0|||
23580890|NCT00462943|65856759|FG002|Overall Study|Transplant - not specified|1|||
23580891|NCT00462943|65856757|FG000|Overall Study|Physician Decision|1|||
23580892|NCT00462943|65856758|FG001|Overall Study|Physician Decision|0|||
23580893|NCT00462943|65856759|FG002|Overall Study|Physician Decision|0|||
23580894|NCT00462943|65856757|FG000|Overall Study|Withdrawal by Subject|0|||
23580895|NCT00462943|65856758|FG001|Overall Study|Withdrawal by Subject|1|||
23580896|NCT00462943|65856759|FG002|Overall Study|Withdrawal by Subject|0|||
23452341|NCT01300234|65398984|FG001|Overall Study|Protocol Violation|3|||
23452342|NCT01300234|65398983|FG000|Overall Study|Withdrawal by Subject|5|||
23452343|NCT01300234|65398984|FG001|Overall Study|Withdrawal by Subject|9|||
23452344|NCT01300234|65398983|FG000|Overall Study|Lost to Follow-up|14|||
23452345|NCT01300234|65398984|FG001|Overall Study|Lost to Follow-up|12|||
23452346|NCT01300234|65398983|FG000|Overall Study|Pregnancy|2|||
23452347|NCT01300234|65398984|FG001|Overall Study|Pregnancy|1|||
23452348|NCT01300234|65398983|FG000|Overall Study|Participant reached stopping critera|2|||
23452349|NCT01300234|65398984|FG001|Overall Study|Participant reached stopping critera|0|||
23452350|NCT01300234|65398983|FG000|Overall Study|Participant stopped medication|1|||
23580897|NCT02347943|65856760|FG000|Overall Study|Study was cancelled|140|||
23580898|NCT02347943|65856761|FG001|Overall Study|Study was cancelled|67|||
23580899|NCT02347943|65856762|FG002|Overall Study|Study was cancelled|45|||
23580900|NCT02335268|65856763|FG000|Overall Study|Physician Decision|5|||
23580901|NCT02335268|65856764|FG001|Overall Study|Physician Decision|1|||
23452351|NCT01300234|65398984|FG001|Overall Study|Participant stopped medication|1|||
23580902|NCT02335268|65856763|FG000|Overall Study|Lack of Efficacy|2|||
23235214|NCT00570492|64604629|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
23235215|NCT02972658|64604630|FG000|Overall Study|Adverse Event|0|||
23580903|NCT02335268|65856764|FG001|Overall Study|Lack of Efficacy|1|||
23580904|NCT02335268|65856763|FG000|Overall Study|Adverse Event|5|||
23580905|NCT02335268|65856764|FG001|Overall Study|Adverse Event|2|||
23580906|NCT02335268|65856763|FG000|Overall Study|increase blasts|2|||
23580907|NCT02335268|65856764|FG001|Overall Study|increase blasts|0|||
23580908|NCT02335268|65856763|FG000|Overall Study|Withdrawal by Subject|3|||
23580909|NCT02335268|65856764|FG001|Overall Study|Withdrawal by Subject|2|||
23580910|NCT05355805|65856765|FG000|Overall Study|Lost to Follow-up|6|||
23580911|NCT05355805|65856766|FG001|Overall Study|Lost to Follow-up|5|||
23580912|NCT05355805|65856767|FG002|Overall Study|Lost to Follow-up|6|||
23580913|NCT05355805|65856768|FG003|Overall Study|Lost to Follow-up|2|||
23580914|NCT05355805|65856765|FG000|Overall Study|Decision by Sponsor|0|||
23580915|NCT05355805|65856766|FG001|Overall Study|Decision by Sponsor|0|||
23580916|NCT05355805|65856767|FG002|Overall Study|Decision by Sponsor|0|||
23580917|NCT05355805|65856768|FG003|Overall Study|Decision by Sponsor|1|||
23580918|NCT05355805|65856765|FG000|Overall Study|Withdrawal by Subject|7|||
23580919|NCT05355805|65856766|FG001|Overall Study|Withdrawal by Subject|10|||
23580920|NCT05355805|65856767|FG002|Overall Study|Withdrawal by Subject|9|||
23580921|NCT05355805|65856768|FG003|Overall Study|Withdrawal by Subject|2|||
23580922|NCT05355805|65856765|FG000|Overall Study|Missing|0|||
23580923|NCT05355805|65856766|FG001|Overall Study|Missing|0|||
23580924|NCT05355805|65856767|FG002|Overall Study|Missing|1|||
23580925|NCT05355805|65856768|FG003|Overall Study|Missing|0|||
23580926|NCT05355805|65856765|FG000|Overall Study|Ongoing|0|||
23580927|NCT05355805|65856766|FG001|Overall Study|Ongoing|41|||
23580928|NCT05355805|65856767|FG002|Overall Study|Ongoing|38|||
23580929|NCT05355805|65856768|FG003|Overall Study|Ongoing|48|||
23580930|NCT04159506|65856769|FG000|Overall Study|Lost to Follow-up|2|||
23580931|NCT04159506|65856770|FG001|Overall Study|Lost to Follow-up|5|||
23580932|NCT01141660|65856772|FG000|Overall Study|Physician Decision|0|||
23580933|NCT01141660|65856773|FG001|Overall Study|Physician Decision|12|||
23580934|NCT00410384|65856774|FG000|Overall Study|Withdrawal by Subject|28|||
23580935|NCT00410384|65856775|FG001|Overall Study|Withdrawal by Subject|17|||
23580936|NCT00410384|65856776|FG002|Overall Study|Withdrawal by Subject|20|||
23580937|NCT00410384|65856774|FG000|Overall Study|Adverse Event|23|||
23580938|NCT00410384|65856775|FG001|Overall Study|Adverse Event|18|||
23580939|NCT00410384|65856776|FG002|Overall Study|Adverse Event|23|||
23580940|NCT00410384|65856774|FG000|Overall Study|Lack of Efficacy|20|||
23580941|NCT00410384|65856775|FG001|Overall Study|Lack of Efficacy|12|||
23580942|NCT00410384|65856776|FG002|Overall Study|Lack of Efficacy|17|||
23580943|NCT00410384|65856774|FG000|Overall Study|Lack of Compliance|2|||
23580944|NCT00410384|65856775|FG001|Overall Study|Lack of Compliance|2|||
23580945|NCT00410384|65856776|FG002|Overall Study|Lack of Compliance|2|||
23580946|NCT00410384|65856774|FG000|Overall Study|Lost to Follow-up|4|||
23580947|NCT00410384|65856775|FG001|Overall Study|Lost to Follow-up|6|||
23580948|NCT00410384|65856776|FG002|Overall Study|Lost to Follow-up|6|||
23580949|NCT00410384|65856774|FG000|Overall Study|Protocol Violation|6|||
23580950|NCT00410384|65856775|FG001|Overall Study|Protocol Violation|6|||
23580951|NCT00410384|65856776|FG002|Overall Study|Protocol Violation|6|||
23580952|NCT00410384|65856774|FG000|Overall Study|Physician Decision|3|||
23580953|NCT00410384|65856775|FG001|Overall Study|Physician Decision|3|||
23580954|NCT00410384|65856776|FG002|Overall Study|Physician Decision|4|||
23580955|NCT00410384|65856774|FG000|Overall Study|Other|3|||
23580956|NCT00410384|65856775|FG001|Overall Study|Other|8|||
23235216|NCT02972658|64604631|FG001|Overall Study|Adverse Event|3|||
23235217|NCT02972658|64604632|FG002|Overall Study|Adverse Event|0|||
23235218|NCT02972658|64604633|FG003|Overall Study|Adverse Event|2|||
23235219|NCT02972658|64604630|FG000|Overall Study|Other-determined by Investigator|1|||
23235220|NCT02972658|64604631|FG001|Overall Study|Other-determined by Investigator|1|||
23235221|NCT02972658|64604632|FG002|Overall Study|Other-determined by Investigator|0|||
23580957|NCT00410384|65856776|FG002|Overall Study|Other|4|||
23580958|NCT00079937|65856777|FG000|Overall Study|Adverse Event|2|||
23580959|NCT00079937|65856778|FG001|Overall Study|Adverse Event|1|||
23580960|NCT00079937|65856777|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23580961|NCT00079937|65856778|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23580962|NCT00079937|65856777|FG000|Overall Study|Subject no longer requires study drug|3|||
23580963|NCT00079937|65856778|FG001|Overall Study|Subject no longer requires study drug|0|||
23580964|NCT00079937|65856777|FG000|Overall Study|Protocol Violation|8|||
23580965|NCT00079937|65856778|FG001|Overall Study|Protocol Violation|6|||
23580966|NCT00079937|65856777|FG000|Overall Study|Withdrawal by Subject|21|||
23580967|NCT00079937|65856778|FG001|Overall Study|Withdrawal by Subject|7|||
23580968|NCT00079937|65856777|FG000|Overall Study|Lost to Follow-up|12|||
23580969|NCT00079937|65856778|FG001|Overall Study|Lost to Follow-up|5|||
23580970|NCT00079937|65856777|FG000|Overall Study|Administrative problems|22|||
23580971|NCT00079937|65856778|FG001|Overall Study|Administrative problems|11|||
23580972|NCT00832780|65856779|FG000|Overall Study|Death|16|||
23235222|NCT02972658|64604633|FG003|Overall Study|Other-determined by Investigator|0|||
23235223|NCT02972658|64604630|FG000|Overall Study|Death|0|||
23235224|NCT02972658|64604631|FG001|Overall Study|Death|0|||
23235225|NCT02972658|64604632|FG002|Overall Study|Death|0|||
23235226|NCT02972658|64604633|FG003|Overall Study|Death|1|||
23235227|NCT02972658|64604630|FG000|Overall Study|Lost to Follow-up|0|||
23235228|NCT02972658|64604631|FG001|Overall Study|Lost to Follow-up|1|||
23235229|NCT02972658|64604632|FG002|Overall Study|Lost to Follow-up|1|||
23235230|NCT02972658|64604633|FG003|Overall Study|Lost to Follow-up|2|||
23452352|NCT01300234|65398983|FG000|Overall Study|Participant refused return to hospital|1|||
23235231|NCT02972658|64604630|FG000|Overall Study|Progressive Disease|0|||
23235232|NCT02972658|64604631|FG001|Overall Study|Progressive Disease|1|||
23235233|NCT02972658|64604632|FG002|Overall Study|Progressive Disease|0|||
23235234|NCT02972658|64604633|FG003|Overall Study|Progressive Disease|1|||
23340304|NCT00174967|64989492|FG000|Overall Study|Adverse Event|1|||
23340305|NCT00174967|64989493|FG001|Overall Study|Adverse Event|2|||
23340306|NCT00174967|64989494|FG002|Overall Study|Adverse Event|2|||
23580973|NCT00832780|65856779|FG000|Overall Study|Lost to Follow-up|4|||
23580974|NCT00832780|65856779|FG000|Overall Study|no reason given|2|||
23580975|NCT00832780|65856779|FG000|Overall Study|other complicating condition|2|||
23580976|NCT00832780|65856779|FG000|Overall Study|Physician Decision|1|||
23580977|NCT02107274|65856781|FG000|Treatment vs. Placebo|Adverse Event|3|||
23580978|NCT02107274|65856782|FG001|Treatment vs. Placebo|Adverse Event|0|||
23580979|NCT02107274|65856781|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
23580980|NCT02107274|65856782|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
23580981|NCT02107274|65856781|FG000|Control Phase|Lost to Follow-up|1|||
23580982|NCT02107274|65856782|FG001|Control Phase|Lost to Follow-up|1|||
23580983|NCT02107274|65856781|FG000|Control Phase|Death|2|||
23580984|NCT02107274|65856782|FG001|Control Phase|Death|0|||
23580985|NCT02107274|65856781|FG000|Control Phase|Adverse Event|0|||
23580986|NCT02107274|65856782|FG001|Control Phase|Adverse Event|1|||
23580987|NCT03582137|65856787|FG000|Overall Study|Adverse Event|1|||
23580988|NCT03582137|65856788|FG001|Overall Study|Adverse Event|0|||
23235235|NCT02972658|64604630|FG000|Overall Study|Withdrawal by Subject|4|||
23235236|NCT02972658|64604631|FG001|Overall Study|Withdrawal by Subject|4|||
23340307|NCT00174967|64989495|FG003|Overall Study|Adverse Event|1|||
23340308|NCT00174967|64989492|FG000|Overall Study|Gout Flare|0|||
23340309|NCT00174967|64989493|FG001|Overall Study|Gout Flare|0|||
23340310|NCT00174967|64989494|FG002|Overall Study|Gout Flare|0|||
23340311|NCT00174967|64989495|FG003|Overall Study|Gout Flare|1|||
23340312|NCT00174967|64989492|FG000|Overall Study|Other|0|||
23340313|NCT00174967|64989493|FG001|Overall Study|Other|1|||
23340314|NCT00174967|64989494|FG002|Overall Study|Other|0|||
23340315|NCT00174967|64989495|FG003|Overall Study|Other|0|||
23340316|NCT01075646|64989498|FG000|Overall Study|Lost to Follow-up|4|||
23340317|NCT01075646|64989499|FG001|Overall Study|Lost to Follow-up|3|||
23340318|NCT01075646|64989500|FG002|Overall Study|Lost to Follow-up|1|||
23340319|NCT01075646|64989501|FG003|Overall Study|Lost to Follow-up|2|||
23340320|NCT03385304|64989502|FG000|Overall Study|Death|19|||
23340321|NCT03385304|64989503|FG001|Overall Study|Death|7|||
23340322|NCT03385304|64989502|FG000|Overall Study|Lost to Follow-up|17|||
23340323|NCT03385304|64989503|FG001|Overall Study|Lost to Follow-up|14|||
23340324|NCT03385304|64989502|FG000|Overall Study|Withdrawal by Subject|3|||
23340325|NCT03385304|64989503|FG001|Overall Study|Withdrawal by Subject|2|||
23340326|NCT03385304|64989502|FG000|Overall Study|Incarceration|2|||
23340327|NCT03385304|64989503|FG001|Overall Study|Incarceration|3|||
23340328|NCT03782298|64989506|FG000|Overall Study|Protocol Deviation|4|||
23340329|NCT02247440|64989511|FG000|Overall Study|Withdrawal by Subject|1|||
23340330|NCT02247440|64989511|FG000|Overall Study|Lack of Efficacy|3|||
23340331|NCT00809471|64989516|FG000|Overall Study|Protocol non-compliance|15|||
23452353|NCT01300234|65398984|FG001|Overall Study|Participant refused return to hospital|0|||
23340332|NCT00809471|64989517|FG001|Overall Study|Protocol non-compliance|15|||
23340333|NCT00809471|64989518|FG002|Overall Study|Protocol non-compliance|6|||
23340334|NCT00809471|64989516|FG000|Overall Study|Lost to Follow-up|4|||
23340335|NCT00809471|64989517|FG001|Overall Study|Lost to Follow-up|2|||
23340336|NCT00809471|64989518|FG002|Overall Study|Lost to Follow-up|9|||
23340337|NCT00809471|64989516|FG000|Overall Study|Adverse Event|0|||
23340338|NCT00809471|64989517|FG001|Overall Study|Adverse Event|2|||
23340339|NCT00809471|64989518|FG002|Overall Study|Adverse Event|2|||
23340340|NCT00809471|64989516|FG000|Overall Study|Requirement for restricted medication|1|||
23452354|NCT02868554|65399002|FG000|Overall Study|Lost to Follow-up|3|||
23580989|NCT03246672|65856789|FG000|Overall Study|Lost to Follow-up|2|||
23580990|NCT04011384|65856790|FG000|Overall Study|Withdrawal by Subject|2|||
23580991|NCT04011384|65856791|FG001|Overall Study|Withdrawal by Subject|0|||
23580992|NCT00088465|65856792|FG000|Overall Study|Withdrawal by Subject|290|||
23580993|NCT00088465|65856792|FG000|Overall Study|Adverse Event|77|||
23580994|NCT00088465|65856792|FG000|Overall Study|Lost to Follow-up|57|||
23235237|NCT02972658|64604632|FG002|Overall Study|Withdrawal by Subject|1|||
23235238|NCT02972658|64604633|FG003|Overall Study|Withdrawal by Subject|6|||
23235239|NCT02972658|64604630|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
23452355|NCT02868554|65399003|FG001|Overall Study|Lost to Follow-up|0|||
23452356|NCT02868554|65399004|FG002|Overall Study|Lost to Follow-up|1|||
23452357|NCT02313766|65399005|FG000|Overall Study|surgery cancelled|1|||
23452358|NCT02313766|65399006|FG001|Overall Study|surgery cancelled|0|||
23452359|NCT02313766|65399007|FG002|Overall Study|surgery cancelled|0|||
23452360|NCT02313766|65399005|FG000|Overall Study|Lost to Follow-up|0|||
23452361|NCT02313766|65399006|FG001|Overall Study|Lost to Follow-up|2|||
23452362|NCT02313766|65399007|FG002|Overall Study|Lost to Follow-up|0|||
23452363|NCT02313766|65399005|FG000|Overall Study|Adverse Event|0|||
23340341|NCT00809471|64989517|FG001|Overall Study|Requirement for restricted medication|1|||
23340342|NCT00809471|64989518|FG002|Overall Study|Requirement for restricted medication|0|||
23340343|NCT02548351|64989519|FG000|Overall Study|Withdrawal by Subject|149|||
23340344|NCT02548351|64989520|FG001|Overall Study|Withdrawal by Subject|154|||
23340345|NCT02548351|64989521|FG002|Overall Study|Withdrawal by Subject|152|||
23340346|NCT02548351|64989519|FG000|Overall Study|Death|11|||
23340347|NCT02548351|64989520|FG001|Overall Study|Death|15|||
23340348|NCT02548351|64989521|FG002|Overall Study|Death|12|||
23340349|NCT02548351|64989519|FG000|Overall Study|Adverse Event|22|||
23340350|NCT02548351|64989520|FG001|Overall Study|Adverse Event|56|||
23340351|NCT02548351|64989521|FG002|Overall Study|Adverse Event|36|||
23340352|NCT02548351|64989519|FG000|Overall Study|Study Terminated by Sponsor|549|||
23340353|NCT02548351|64989520|FG001|Overall Study|Study Terminated by Sponsor|509|||
23340354|NCT02548351|64989521|FG002|Overall Study|Study Terminated by Sponsor|528|||
23340355|NCT02548351|64989519|FG000|Overall Study|Site Closure|14|||
23340356|NCT02548351|64989520|FG001|Overall Study|Site Closure|5|||
23340357|NCT02548351|64989521|FG002|Overall Study|Site Closure|7|||
23340358|NCT02548351|64989519|FG000|Overall Study|Non-compliance with Study Drug|4|||
23340359|NCT02548351|64989520|FG001|Overall Study|Non-compliance with Study Drug|2|||
23340360|NCT02548351|64989521|FG002|Overall Study|Non-compliance with Study Drug|0|||
23340361|NCT02548351|64989519|FG000|Overall Study|Protocol Violation|2|||
23340362|NCT02548351|64989520|FG001|Overall Study|Protocol Violation|1|||
23340363|NCT02548351|64989521|FG002|Overall Study|Protocol Violation|2|||
23340364|NCT02548351|64989519|FG000|Overall Study|Physician Decision|11|||
23340365|NCT02548351|64989520|FG001|Overall Study|Physician Decision|18|||
23340366|NCT02548351|64989521|FG002|Overall Study|Physician Decision|11|||
23340367|NCT02548351|64989519|FG000|Overall Study|Lost to Follow-up|43|||
23340368|NCT02548351|64989520|FG001|Overall Study|Lost to Follow-up|50|||
23340369|NCT02548351|64989521|FG002|Overall Study|Lost to Follow-up|57|||
23340370|NCT02548351|64989519|FG000|Overall Study|Other|19|||
23340371|NCT02548351|64989520|FG001|Overall Study|Other|16|||
23340372|NCT02548351|64989521|FG002|Overall Study|Other|20|||
23340373|NCT02548351|64989519|FG000|Overall Study|Missing|1|||
23340374|NCT02548351|64989520|FG001|Overall Study|Missing|1|||
23340375|NCT02548351|64989521|FG002|Overall Study|Missing|0|||
23340376|NCT04696354|64989524|FG000|Overall Study|Study termination|6|||
23340377|NCT04696354|64989525|FG001|Overall Study|Study termination|6|||
23340378|NCT01680159|64989531|FG000|Screening Period|Not meet criteria for dose-up period|7|||
23340379|NCT01680159|64989531|FG000|Increased Dose Period|Adverse Event|6|||
23340380|NCT01680159|64989531|FG000|Increased Dose Period|Withdrawal by Subject|2|||
23340381|NCT00256854|64989532|FG000|Overall Study|Withdrawal by Subject|2|||
23340382|NCT00256854|64989533|FG001|Overall Study|Withdrawal by Subject|3|||
23340383|NCT00256854|64989534|FG002|Overall Study|Withdrawal by Subject|0|||
23340384|NCT00256854|64989535|FG003|Overall Study|Withdrawal by Subject|0|||
23340385|NCT00256854|64989536|FG004|Overall Study|Withdrawal by Subject|0|||
23340386|NCT00256854|64989537|FG005|Overall Study|Withdrawal by Subject|0|||
23340387|NCT00256854|64989532|FG000|Overall Study|Lack of Efficacy|1|||
23340388|NCT00256854|64989533|FG001|Overall Study|Lack of Efficacy|0|||
23340389|NCT00256854|64989534|FG002|Overall Study|Lack of Efficacy|0|||
23340390|NCT00256854|64989535|FG003|Overall Study|Lack of Efficacy|0|||
23340391|NCT00256854|64989536|FG004|Overall Study|Lack of Efficacy|0|||
23340392|NCT00256854|64989537|FG005|Overall Study|Lack of Efficacy|0|||
23452364|NCT02313766|65399006|FG001|Overall Study|Adverse Event|1|||
23340393|NCT00256854|64989532|FG000|Overall Study|Protocol Violation|0|||
23340394|NCT00256854|64989533|FG001|Overall Study|Protocol Violation|1|||
23340395|NCT00256854|64989534|FG002|Overall Study|Protocol Violation|1|||
23340396|NCT00256854|64989535|FG003|Overall Study|Protocol Violation|1|||
23340397|NCT00256854|64989536|FG004|Overall Study|Protocol Violation|0|||
23340398|NCT00256854|64989537|FG005|Overall Study|Protocol Violation|0|||
23340399|NCT00256854|64989532|FG000|Overall Study|Adverse Event|0|||
23340400|NCT00256854|64989533|FG001|Overall Study|Adverse Event|0|||
23340401|NCT00256854|64989534|FG002|Overall Study|Adverse Event|2|||
23340402|NCT00256854|64989535|FG003|Overall Study|Adverse Event|2|||
23340403|NCT00256854|64989536|FG004|Overall Study|Adverse Event|0|||
23340404|NCT00256854|64989537|FG005|Overall Study|Adverse Event|1|||
23340405|NCT00256854|64989532|FG000|Overall Study|Not compliant with the study drug|0|||
23340406|NCT00256854|64989533|FG001|Overall Study|Not compliant with the study drug|0|||
23174921|NCT00896532|64386442|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174922|NCT00896532|64386443|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174923|NCT00896532|64386444|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174924|NCT00896532|64386445|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174925|NCT00896532|64386446|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174926|NCT00896532|64386447|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
23174927|NCT00896532|64386425|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23174928|NCT00896532|64386426|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
23174929|NCT00896532|64386427|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23174930|NCT00896532|64386428|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
23174931|NCT00896532|64386429|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23174932|NCT00896532|64386430|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23340407|NCT00256854|64989534|FG002|Overall Study|Not compliant with the study drug|0|||
23340408|NCT00256854|64989535|FG003|Overall Study|Not compliant with the study drug|0|||
23340409|NCT00256854|64989536|FG004|Overall Study|Not compliant with the study drug|1|||
23340410|NCT00256854|64989537|FG005|Overall Study|Not compliant with the study drug|0|||
23340411|NCT00191282|64992748|FG000|Overall Study|Adverse Event|5|||
23340412|NCT00191282|64992749|FG001|Overall Study|Adverse Event|6|||
23340413|NCT00191282|64992748|FG000|Overall Study|Death|51|||
23340414|NCT00191282|64992749|FG001|Overall Study|Death|51|||
23340415|NCT00191282|64992748|FG000|Overall Study|Lack of Efficacy|11|||
23340416|NCT00191282|64992749|FG001|Overall Study|Lack of Efficacy|6|||
23340417|NCT00191282|64992748|FG000|Overall Study|Noncompliance|14|||
23340418|NCT00191282|64992749|FG001|Overall Study|Noncompliance|17|||
23340419|NCT00191282|64992748|FG000|Overall Study|Patient moved|11|||
23340420|NCT00191282|64992749|FG001|Overall Study|Patient moved|14|||
23580995|NCT00088465|65856792|FG000|Overall Study|Physician Decision|45|||
23580996|NCT00088465|65856792|FG000|Overall Study|Sponsor Decision|37|||
23580997|NCT00088465|65856792|FG000|Overall Study|Lack of Efficacy|27|||
23580998|NCT00088465|65856792|FG000|Overall Study|Protocol Violation|17|||
23580999|NCT00088465|65856792|FG000|Overall Study|Death|11|||
23581000|NCT04438785|65856793|FG000|Overall Study|change of weight, give up intervention|2|||
23581001|NCT04438785|65856794|FG001|Overall Study|change of weight, give up intervention|10|||
23581002|NCT00578227|65856795|FG000|Overall Study|Lost to Follow-up|0|||
23581003|NCT00578227|65856796|FG001|Overall Study|Lost to Follow-up|1|||
23581004|NCT00578227|65856797|FG002|Overall Study|Lost to Follow-up|1|||
23581005|NCT00578227|65856795|FG000|Overall Study|Withdrawal by Subject|5|||
23581006|NCT00578227|65856796|FG001|Overall Study|Withdrawal by Subject|1|||
23581007|NCT00578227|65856797|FG002|Overall Study|Withdrawal by Subject|3|||
23581008|NCT00819234|65856798|FG000|Overall Study|Withdrawal by Subject|8|||
23581009|NCT00819234|65856799|FG001|Overall Study|Withdrawal by Subject|13|||
23581010|NCT00819234|65856800|FG002|Overall Study|Withdrawal by Subject|6|||
23581011|NCT00819234|65856801|FG003|Overall Study|Withdrawal by Subject|3|||
23581012|NCT00819234|65856802|FG004|Overall Study|Withdrawal by Subject|0|||
23581013|NCT00819234|65856803|FG005|Overall Study|Withdrawal by Subject|4|||
23581014|NCT00819234|65856804|FG006|Overall Study|Withdrawal by Subject|4|||
23581015|NCT00819234|65856805|FG007|Overall Study|Withdrawal by Subject|8|||
23581016|NCT00819234|65856806|FG008|Overall Study|Withdrawal by Subject|5|||
23581017|NCT00819234|65856807|FG009|Overall Study|Withdrawal by Subject|3|||
23581018|NCT00819234|65856798|FG000|Overall Study|Adverse Event|0|||
23581019|NCT00819234|65856799|FG001|Overall Study|Adverse Event|0|||
23581020|NCT00819234|65856800|FG002|Overall Study|Adverse Event|1|||
23581021|NCT00819234|65856801|FG003|Overall Study|Adverse Event|0|||
23581022|NCT00819234|65856802|FG004|Overall Study|Adverse Event|0|||
23581023|NCT00819234|65856803|FG005|Overall Study|Adverse Event|2|||
23581024|NCT00819234|65856804|FG006|Overall Study|Adverse Event|0|||
23581025|NCT00819234|65856805|FG007|Overall Study|Adverse Event|0|||
23581026|NCT00819234|65856806|FG008|Overall Study|Adverse Event|0|||
23581027|NCT00819234|65856807|FG009|Overall Study|Adverse Event|0|||
23581028|NCT00819234|65856798|FG000|Overall Study|Physician Decision|0|||
23581029|NCT00819234|65856799|FG001|Overall Study|Physician Decision|0|||
23581030|NCT00819234|65856800|FG002|Overall Study|Physician Decision|0|||
23581031|NCT00819234|65856801|FG003|Overall Study|Physician Decision|1|||
23581032|NCT00819234|65856802|FG004|Overall Study|Physician Decision|0|||
23581033|NCT00819234|65856803|FG005|Overall Study|Physician Decision|0|||
23581034|NCT00819234|65856804|FG006|Overall Study|Physician Decision|0|||
23581035|NCT00819234|65856805|FG007|Overall Study|Physician Decision|0|||
23581036|NCT00819234|65856806|FG008|Overall Study|Physician Decision|0|||
23581037|NCT00819234|65856807|FG009|Overall Study|Physician Decision|2|||
23581038|NCT00819234|65856798|FG000|Overall Study|Protocol Violation|0|||
23581039|NCT00819234|65856799|FG001|Overall Study|Protocol Violation|0|||
23581040|NCT00819234|65856800|FG002|Overall Study|Protocol Violation|1|||
23581041|NCT00819234|65856801|FG003|Overall Study|Protocol Violation|0|||
23340421|NCT00191282|64992748|FG000|Overall Study|Withdrawal by Subject|59|||
23581042|NCT00819234|65856802|FG004|Overall Study|Protocol Violation|0|||
23235240|NCT02972658|64604631|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
23235241|NCT02972658|64604632|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
23235242|NCT02972658|64604633|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
23235243|NCT02972658|64604630|FG000|Overall Study|Sponsor Decision|70|||
23235244|NCT02972658|64604631|FG001|Overall Study|Sponsor Decision|127|||
23235245|NCT02972658|64604632|FG002|Overall Study|Sponsor Decision|72|||
23340422|NCT00191282|64992749|FG001|Overall Study|Withdrawal by Subject|44|||
23340423|NCT00191282|64992748|FG000|Overall Study|Physician Decision|18|||
23340424|NCT00191282|64992749|FG001|Overall Study|Physician Decision|15|||
23340425|NCT00191282|64992748|FG000|Overall Study|Protocol entry criteria not met|14|||
23235246|NCT02972658|64604633|FG003|Overall Study|Sponsor Decision|119|||
23235247|NCT03982069|64604634|FG000|Overall Study|Lost to Follow-up|5|||
23235248|NCT03982069|64604635|FG001|Overall Study|Lost to Follow-up|5|||
23235249|NCT03982069|64604636|FG002|Overall Study|Lost to Follow-up|3|||
23235250|NCT03982069|64604637|FG003|Overall Study|Lost to Follow-up|5|||
23235251|NCT03982069|64604634|FG000|Overall Study|Physician Decision|0|||
23235252|NCT03982069|64604635|FG001|Overall Study|Physician Decision|1|||
23235253|NCT03982069|64604636|FG002|Overall Study|Physician Decision|0|||
23235254|NCT03982069|64604637|FG003|Overall Study|Physician Decision|0|||
23235255|NCT03982069|64604634|FG000|Overall Study|Withdrawal by Subject|2|||
23340426|NCT00191282|64992749|FG001|Overall Study|Protocol entry criteria not met|9|||
23581043|NCT00819234|65856803|FG005|Overall Study|Protocol Violation|0|||
23581044|NCT00819234|65856804|FG006|Overall Study|Protocol Violation|0|||
23340427|NCT00191282|64992748|FG000|Overall Study|Protocol Violation|9|||
23340428|NCT00191282|64992749|FG001|Overall Study|Protocol Violation|12|||
23340429|NCT00191282|64992748|FG000|Overall Study|Severity of outcome|2|||
23340430|NCT00191282|64992749|FG001|Overall Study|Severity of outcome|5|||
23581045|NCT00819234|65856805|FG007|Overall Study|Protocol Violation|0|||
23581046|NCT00819234|65856806|FG008|Overall Study|Protocol Violation|0|||
23581047|NCT00819234|65856807|FG009|Overall Study|Protocol Violation|0|||
23581048|NCT00819234|65856798|FG000|Overall Study|Lost to Follow-up|2|||
23581049|NCT00819234|65856799|FG001|Overall Study|Lost to Follow-up|2|||
23581050|NCT00819234|65856800|FG002|Overall Study|Lost to Follow-up|0|||
23581051|NCT00819234|65856801|FG003|Overall Study|Lost to Follow-up|2|||
23581052|NCT00819234|65856802|FG004|Overall Study|Lost to Follow-up|1|||
23581053|NCT00819234|65856803|FG005|Overall Study|Lost to Follow-up|1|||
23581054|NCT00819234|65856804|FG006|Overall Study|Lost to Follow-up|1|||
23581055|NCT00819234|65856805|FG007|Overall Study|Lost to Follow-up|1|||
23581056|NCT00819234|65856806|FG008|Overall Study|Lost to Follow-up|1|||
23581057|NCT00819234|65856807|FG009|Overall Study|Lost to Follow-up|2|||
23581058|NCT00389519|65856808|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
23174933|NCT00896532|64386431|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
23174934|NCT00896532|64386432|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174935|NCT00896532|64386433|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174936|NCT00896532|64386434|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174937|NCT00896532|64386435|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174938|NCT00896532|64386436|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174939|NCT00896532|64386437|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174940|NCT00896532|64386438|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174941|NCT00896532|64386439|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174942|NCT00896532|64386440|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174943|NCT00896532|64386441|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174944|NCT00896532|64386442|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174945|NCT00896532|64386443|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174946|NCT00896532|64386444|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174947|NCT00896532|64386445|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174948|NCT00896532|64386446|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174949|NCT00896532|64386447|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
23174950|NCT00896532|64386425|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
23174951|NCT00896532|64386426|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
23174952|NCT00896532|64386427|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
23174953|NCT00896532|64386428|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
23174954|NCT00896532|64386429|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
23174955|NCT00896532|64386430|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
23235256|NCT03982069|64604635|FG001|Overall Study|Withdrawal by Subject|1|||
23235257|NCT03982069|64604636|FG002|Overall Study|Withdrawal by Subject|5|||
23235258|NCT03982069|64604637|FG003|Overall Study|Withdrawal by Subject|2|||
23581059|NCT00389519|65856809|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
23235259|NCT03982069|64604634|FG000|Overall Study|Specimen loss|3|||
23235260|NCT03982069|64604635|FG001|Overall Study|Specimen loss|3|||
23235261|NCT03982069|64604636|FG002|Overall Study|Specimen loss|1|||
23581060|NCT00389519|65856810|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
23235262|NCT03982069|64604637|FG003|Overall Study|Specimen loss|1|||
23235263|NCT03922945|64604638|FG000|Overall Study|Adverse Event|1|||
23235264|NCT03922945|64604639|FG001|Overall Study|Adverse Event|1|||
23235265|NCT03922945|64604640|FG002|Overall Study|Adverse Event|2|||
23235266|NCT03922945|64604638|FG000|Overall Study|Lost to Follow-up|13|||
23235267|NCT03922945|64604639|FG001|Overall Study|Lost to Follow-up|9|||
23235268|NCT03922945|64604640|FG002|Overall Study|Lost to Follow-up|20|||
23235269|NCT03922945|64604638|FG000|Overall Study|Lack of Efficacy|2|||
23235270|NCT03922945|64604639|FG001|Overall Study|Lack of Efficacy|0|||
23235271|NCT03922945|64604640|FG002|Overall Study|Lack of Efficacy|1|||
23235272|NCT03922945|64604638|FG000|Overall Study|Protocol Non-Compliance|0|||
23235273|NCT03922945|64604639|FG001|Overall Study|Protocol Non-Compliance|0|||
23235274|NCT03922945|64604640|FG002|Overall Study|Protocol Non-Compliance|1|||
23235275|NCT03922945|64604638|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
23235276|NCT03922945|64604639|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
23235277|NCT03922945|64604640|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
23235278|NCT03922945|64604638|FG000|Overall Study|All Other Personal Reasons|1|||
23340431|NCT00191282|64992748|FG000|Overall Study|Sponsor's decision|2|||
23340432|NCT00191282|64992749|FG001|Overall Study|Sponsor's decision|2|||
23235279|NCT03922945|64604639|FG001|Overall Study|All Other Personal Reasons|1|||
23235280|NCT03922945|64604640|FG002|Overall Study|All Other Personal Reasons|2|||
23235281|NCT00608426|64604641|FG000|Overall Study|Death|32|||
23235282|NCT00608426|64604642|FG001|Overall Study|Death|36|||
23235283|NCT00608426|64604641|FG000|Overall Study|Lost to Follow-up|485|||
23235284|NCT00608426|64604642|FG001|Overall Study|Lost to Follow-up|521|||
23235285|NCT00608426|64604641|FG000|Overall Study|refused, health issues, wrong address|319|||
23235286|NCT00608426|64604642|FG001|Overall Study|refused, health issues, wrong address|348|||
23235287|NCT02930889|64604643|FG000|Overall Study|Lost to Follow-up|2|||
23235288|NCT02930889|64604643|FG000|Overall Study|Withdrawal by Subject|6|||
23235289|NCT02930889|64604643|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
23235290|NCT00489216|64604644|FG000|Overall Study|Adverse Event|1|||
23235291|NCT00553319|64604645|FG000|Overall Study|Lost to Follow-up|10|||
23235292|NCT00553319|64604646|FG001|Overall Study|Lost to Follow-up|9|||
23235293|NCT00553319|64604647|FG002|Overall Study|Lost to Follow-up|5|||
23235294|NCT00553319|64604645|FG000|Overall Study|wanted treatment elsewhere|2|||
23235295|NCT00553319|64604646|FG001|Overall Study|wanted treatment elsewhere|1|||
23235296|NCT00553319|64604647|FG002|Overall Study|wanted treatment elsewhere|1|||
23235297|NCT00553319|64604645|FG000|Overall Study|non-compliance|0|||
23235298|NCT00553319|64604646|FG001|Overall Study|non-compliance|0|||
23235299|NCT00553319|64604647|FG002|Overall Study|non-compliance|2|||
23235300|NCT00553319|64604645|FG000|Overall Study|incarceration|1|||
23235301|NCT00553319|64604646|FG001|Overall Study|incarceration|0|||
23235302|NCT00553319|64604647|FG002|Overall Study|incarceration|0|||
23235303|NCT00553319|64604645|FG000|Overall Study|moved|1|||
23235304|NCT00553319|64604646|FG001|Overall Study|moved|0|||
23340433|NCT00191282|64992748|FG000|Overall Study|Lost to Follow-up|24|||
23340434|NCT00191282|64992749|FG001|Overall Study|Lost to Follow-up|31|||
23340435|NCT01493284|64992750|FG000|Overall Study|Death|29|||
23340436|NCT01493284|64992750|FG000|Overall Study|Withdrawal by Subject|32|||
23340437|NCT00381238|64992764|FG000|Overall Study|Adverse Event|3|||
23340438|NCT00381238|64992764|FG000|Overall Study|Protocol Violation|1|||
23340439|NCT00381238|64992764|FG000|Overall Study|Withdrawal by Subject|4|||
23340440|NCT00381238|64992764|FG000|Overall Study|Lack of Efficacy|2|||
23340441|NCT00381238|64992764|FG000|Overall Study|Withdrew by physician|1|||
23340442|NCT00381238|64992764|FG000|Overall Study|Disease progression|1|||
23340443|NCT01701193|64992765|FG000|Overall Study|Withdrawal by Subject|2|||
23340444|NCT01701193|64992766|FG001|Overall Study|Withdrawal by Subject|2|||
23340445|NCT01701193|64992767|FG002|Overall Study|Withdrawal by Subject|1|||
23340446|NCT01701193|64992768|FG003|Overall Study|Withdrawal by Subject|2|||
23340447|NCT01701193|64992765|FG000|Overall Study|Adverse Event|1|||
23340448|NCT01701193|64992766|FG001|Overall Study|Adverse Event|0|||
23340449|NCT01701193|64992767|FG002|Overall Study|Adverse Event|0|||
23340450|NCT01701193|64992768|FG003|Overall Study|Adverse Event|0|||
23340451|NCT03702010|64992771|FG000|Follow-up (30days)|Lack of Efficacy|2|||
23340452|NCT03702010|64992772|FG001|Follow-up (30days)|Lack of Efficacy|2|||
23340453|NCT00157248|64992782|FG000|Overall Study|Adverse Event|36|||
23235305|NCT00553319|64604647|FG002|Overall Study|moved|1|||
23235306|NCT00933543|64604648|FG000|Overall Study|Adverse Event|2|||
23340454|NCT00157248|64992783|FG001|Overall Study|Adverse Event|25|||
23340455|NCT00157248|64992784|FG002|Overall Study|Adverse Event|13|||
23340456|NCT00157248|64992785|FG003|Overall Study|Adverse Event|33|||
23340457|NCT00157248|64992782|FG000|Overall Study|Protocol Violation|4|||
23235307|NCT00933543|64604649|FG001|Overall Study|Adverse Event|1|||
23235308|NCT00933543|64604648|FG000|Overall Study|Lost to Follow-up|0|||
23235309|NCT00933543|64604649|FG001|Overall Study|Lost to Follow-up|1|||
23235310|NCT00933543|64604648|FG000|Overall Study|Withdrawal by Subject|0|||
23235311|NCT00933543|64604649|FG001|Overall Study|Withdrawal by Subject|1|||
23235312|NCT00933543|64604648|FG000|Overall Study|Lack of Efficacy|0|||
23235313|NCT00933543|64604649|FG001|Overall Study|Lack of Efficacy|3|||
23340458|NCT00157248|64992783|FG001|Overall Study|Protocol Violation|0|||
23340459|NCT00157248|64992784|FG002|Overall Study|Protocol Violation|2|||
23340460|NCT00157248|64992785|FG003|Overall Study|Protocol Violation|2|||
23235314|NCT00933543|64604648|FG000|Overall Study|Other|1|||
23235315|NCT00933543|64604649|FG001|Overall Study|Other|1|||
23235316|NCT02079077|64604654|FG000|Overall Study|Lost to Follow-up|5|||
23235317|NCT02079077|64604655|FG001|Overall Study|Lost to Follow-up|7|||
23235318|NCT02079077|64604654|FG000|Overall Study|Became STIs Positive|1|||
23235319|NCT02079077|64604655|FG001|Overall Study|Became STIs Positive|2|||
23235320|NCT01474993|64604656|FG000|Overall Study|Lost to Follow-up|1|||
23235321|NCT01474993|64604657|FG001|Overall Study|Lost to Follow-up|2|||
23235322|NCT01474993|64604656|FG000|Overall Study|Adverse Event|0|||
23235323|NCT01474993|64604657|FG001|Overall Study|Adverse Event|1|||
23235324|NCT00027027|64604662|FG000|Overall Study|Adverse Event|0|||
23235325|NCT00027027|64604663|FG001|Overall Study|Adverse Event|0|||
23235326|NCT00027027|64604664|FG002|Overall Study|Adverse Event|1|||
23235327|NCT00027027|64604665|FG003|Overall Study|Adverse Event|0|||
23235328|NCT00027027|64604666|FG004|Overall Study|Adverse Event|1|||
23235329|NCT00027027|64604662|FG000|Overall Study|Admitted for Signs of PD|0|||
23235330|NCT00027027|64604663|FG001|Overall Study|Admitted for Signs of PD|0|||
23235331|NCT00027027|64604664|FG002|Overall Study|Admitted for Signs of PD|0|||
23235332|NCT00027027|64604665|FG003|Overall Study|Admitted for Signs of PD|0|||
23235333|NCT00027027|64604666|FG004|Overall Study|Admitted for Signs of PD|1|||
23235334|NCT00027027|64604662|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
23235335|NCT00027027|64604663|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
23235336|NCT00027027|64604664|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
23235337|NCT00027027|64604665|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
23235338|NCT00027027|64604666|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
23235339|NCT00027027|64604662|FG000|Overall Study|PD Requiring Surgery|0|||
23235340|NCT00027027|64604663|FG001|Overall Study|PD Requiring Surgery|0|||
23235341|NCT00027027|64604664|FG002|Overall Study|PD Requiring Surgery|1|||
23235342|NCT00027027|64604665|FG003|Overall Study|PD Requiring Surgery|0|||
23235343|NCT00027027|64604666|FG004|Overall Study|PD Requiring Surgery|0|||
23235344|NCT00027027|64604662|FG000|Overall Study|Physician Decision Due To PD|2|||
23235345|NCT00027027|64604663|FG001|Overall Study|Physician Decision Due To PD|3|||
23235346|NCT00027027|64604664|FG002|Overall Study|Physician Decision Due To PD|2|||
23235347|NCT00027027|64604665|FG003|Overall Study|Physician Decision Due To PD|3|||
23235348|NCT00027027|64604666|FG004|Overall Study|Physician Decision Due To PD|5|||
23235349|NCT00027027|64604662|FG000|Overall Study|Withdrawal by Subject|0|||
23235350|NCT00027027|64604663|FG001|Overall Study|Withdrawal by Subject|0|||
23235351|NCT00027027|64604664|FG002|Overall Study|Withdrawal by Subject|0|||
23235352|NCT00027027|64604665|FG003|Overall Study|Withdrawal by Subject|0|||
23340461|NCT00157248|64992782|FG000|Overall Study|Lost to Follow-up|0|||
23340462|NCT00157248|64992783|FG001|Overall Study|Lost to Follow-up|1|||
23340463|NCT00157248|64992784|FG002|Overall Study|Lost to Follow-up|0|||
23452365|NCT02313766|65399007|FG002|Overall Study|Adverse Event|0|||
23452366|NCT00644358|65399009|FG000|Overall Study|Adverse Event|124|||
23452367|NCT00644358|65399009|FG000|Overall Study|Lost to Follow-up|105|||
23452368|NCT00644358|65399009|FG000|Overall Study|Consent Withdrawal|64|||
23452369|NCT00644358|65399009|FG000|Overall Study|Lack of Effectiveness|39|||
23452370|NCT00644358|65399009|FG000|Overall Study|Protocol Violation|5|||
23452371|NCT00644358|65399009|FG000|Overall Study|Noncompliance|14|||
23452372|NCT00644358|65399009|FG000|Overall Study|Other Unspecified|11|||
23452373|NCT00083889|65399011|FG000|Overall Study|Adverse Event|76|||
23452374|NCT00083889|65399012|FG001|Overall Study|Adverse Event|86|||
23452375|NCT00083889|65399011|FG000|Overall Study|Protocol Violation|2|||
23452376|NCT00083889|65399012|FG001|Overall Study|Protocol Violation|2|||
23235353|NCT00027027|64604666|FG004|Overall Study|Withdrawal by Subject|1|||
23235354|NCT02708524|64604671|FG000|Overall Study|Adverse Event|0|||
23235355|NCT02708524|64604672|FG001|Overall Study|Adverse Event|1|||
23235356|NCT02708524|64604673|FG002|Overall Study|Adverse Event|0|||
23235357|NCT02708524|64604674|FG003|Overall Study|Adverse Event|0|||
23235358|NCT02708524|64604671|FG000|Overall Study|Lens Discomfort|1|||
23235359|NCT02708524|64604672|FG001|Overall Study|Lens Discomfort|0|||
23235360|NCT02708524|64604673|FG002|Overall Study|Lens Discomfort|1|||
23235361|NCT02708524|64604674|FG003|Overall Study|Lens Discomfort|0|||
23235362|NCT02708524|64604671|FG000|Overall Study|Lost to Follow-up|1|||
23235363|NCT02708524|64604672|FG001|Overall Study|Lost to Follow-up|1|||
23235364|NCT02708524|64604673|FG002|Overall Study|Lost to Follow-up|1|||
23235365|NCT02708524|64604674|FG003|Overall Study|Lost to Follow-up|0|||
23235366|NCT02708524|64604671|FG000|Overall Study|Protocol Violation|0|||
23235367|NCT02708524|64604672|FG001|Overall Study|Protocol Violation|1|||
23235368|NCT02708524|64604673|FG002|Overall Study|Protocol Violation|0|||
23235369|NCT02708524|64604674|FG003|Overall Study|Protocol Violation|0|||
23452377|NCT00083889|65399011|FG000|Overall Study|Withdrawal by Subject|22|||
23452378|NCT00083889|65399012|FG001|Overall Study|Withdrawal by Subject|24|||
23452379|NCT00083889|65399011|FG000|Overall Study|Lack of Efficacy|240|||
23452380|NCT00083889|65399012|FG001|Overall Study|Lack of Efficacy|219|||
23452381|NCT00083889|65399011|FG000|Overall Study|Decision of sponsor|32|||
23452382|NCT00083889|65399012|FG001|Overall Study|Decision of sponsor|4|||
23452383|NCT00083889|65399011|FG000|Overall Study|Randomized: did not take study drug|0|||
23452384|NCT00083889|65399012|FG001|Overall Study|Randomized: did not take study drug|15|||
23452385|NCT00083889|65399011|FG000|Overall Study|Completed on marketed sunitinub|3|||
23452386|NCT00083889|65399012|FG001|Overall Study|Completed on marketed sunitinub|0|||
23452387|NCT00083889|65399011|FG000|Overall Study|Crossover to SU011248|0|||
23452388|NCT00083889|65399012|FG001|Overall Study|Crossover to SU011248|25|||
23452389|NCT01352117|65399013|FG000|Overall Study|Death|15|||
23452390|NCT01352117|65399014|FG001|Overall Study|Death|16|||
23452391|NCT01352117|65399013|FG000|Overall Study|Withdrawal by Subject|1|||
23452392|NCT01352117|65399014|FG001|Overall Study|Withdrawal by Subject|0|||
23452393|NCT01352117|65399013|FG000|Overall Study|Lost to Follow-up|2|||
23452394|NCT01352117|65399014|FG001|Overall Study|Lost to Follow-up|7|||
23452395|NCT01352117|65399013|FG000|Overall Study|Non-adherent to study requirements|1|||
23452396|NCT01352117|65399014|FG001|Overall Study|Non-adherent to study requirements|1|||
23452397|NCT01352117|65399013|FG000|Overall Study|Did not initiate study treatment|1|||
23452398|NCT01352117|65399014|FG001|Overall Study|Did not initiate study treatment|0|||
23452399|NCT01352117|65399013|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
23452400|NCT01352117|65399014|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
23452401|NCT01702844|65399016|FG000|Overall Study|Adverse Event|9|||
23452402|NCT01702844|65399016|FG000|Overall Study|Death|1|||
23452403|NCT01702844|65399016|FG000|Overall Study|Withdrawal by Subject|3|||
23452404|NCT01702844|65399016|FG000|Overall Study|Physician Decision|6|||
23452405|NCT01332994|65399017|FG000|Overall Study|Adverse Event|34|||
23452406|NCT01332994|65399017|FG000|Overall Study|Death|1|||
23452407|NCT01332994|65399017|FG000|Overall Study|Lack of Efficacy|1|||
23452408|NCT01332994|65399017|FG000|Overall Study|Lost to Follow-up|4|||
23452409|NCT01332994|65399017|FG000|Overall Study|Protocol Violation|6|||
23452410|NCT01332994|65399017|FG000|Overall Study|Withdrawal by Subject|15|||
23452411|NCT01332994|65399017|FG000|Overall Study|Administrative Problem|2|||
23452412|NCT01332994|65399017|FG000|Overall Study|Other|8|||
23452413|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
23452414|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
23452415|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
23452416|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
23452417|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
23452418|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
23452419|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
23452420|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
23452421|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
23452422|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
23452423|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
23452424|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
23452425|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
23452426|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
23452427|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
23452428|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
23452429|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
23452430|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
23452431|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
23452432|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
23452433|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
23452434|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
23452435|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
23452436|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
23452437|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
23235370|NCT02708524|64604671|FG000|Overall Study|Withdrawal by Subject|1|||
23235371|NCT02708524|64604672|FG001|Overall Study|Withdrawal by Subject|1|||
23235372|NCT02708524|64604673|FG002|Overall Study|Withdrawal by Subject|0|||
23235373|NCT02708524|64604674|FG003|Overall Study|Withdrawal by Subject|0|||
23452438|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
23452439|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
23452440|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
23452441|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
23340464|NCT00157248|64992785|FG003|Overall Study|Lost to Follow-up|0|||
23452442|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
23235374|NCT02708524|64604671|FG000|Overall Study|Dispensed incorrect study lens|0|||
23452443|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
23452444|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
23452445|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
23452446|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
23452447|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
23452448|NCT02831764|65399018|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
23452449|NCT02831764|65399019|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
23452450|NCT02831764|65399020|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
23452451|NCT02831764|65399021|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
23452452|NCT02831764|65399022|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
23452453|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23452454|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23452455|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
23452456|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
23452457|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
23452458|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23452459|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23452460|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
23452461|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23452462|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
23452463|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23452464|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23452465|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
23452466|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
23452467|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
23452468|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
23452469|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
23235375|NCT02708524|64604672|FG001|Overall Study|Dispensed incorrect study lens|1|||
23235376|NCT02708524|64604673|FG002|Overall Study|Dispensed incorrect study lens|1|||
23235377|NCT02708524|64604674|FG003|Overall Study|Dispensed incorrect study lens|0|||
23235378|NCT02708524|64604671|FG000|Overall Study|Did not wear lens at final visit|0|||
23235379|NCT02708524|64604672|FG001|Overall Study|Did not wear lens at final visit|1|||
23235380|NCT02708524|64604673|FG002|Overall Study|Did not wear lens at final visit|0|||
23235381|NCT02708524|64604674|FG003|Overall Study|Did not wear lens at final visit|0|||
23235382|NCT02708524|64604671|FG000|Overall Study|Subject lost study lens|1|||
23235383|NCT02708524|64604672|FG001|Overall Study|Subject lost study lens|0|||
23235384|NCT02708524|64604673|FG002|Overall Study|Subject lost study lens|0|||
23235385|NCT02708524|64604674|FG003|Overall Study|Subject lost study lens|0|||
23235386|NCT01070381|64604675|FG000|Period 2, 1 Week of Wear|Handling|0|||
23235387|NCT01070381|64604676|FG001|Period 2, 1 Week of Wear|Handling|1|||
23235388|NCT01070381|64604675|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
23235389|NCT01070381|64604676|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
23235390|NCT02452034|64604680|FG000|Overall Study|Adverse Event|0|||
23235391|NCT02452034|64604681|FG001|Overall Study|Adverse Event|0|||
23235392|NCT02452034|64604682|FG002|Overall Study|Adverse Event|0|||
23235393|NCT02452034|64604683|FG003|Overall Study|Adverse Event|0|||
23235394|NCT02452034|64604684|FG004|Overall Study|Adverse Event|0|||
23235395|NCT02452034|64604685|FG005|Overall Study|Adverse Event|1|||
23235396|NCT02452034|64604680|FG000|Overall Study|Death|0|||
23235397|NCT02452034|64604681|FG001|Overall Study|Death|0|||
23235398|NCT02452034|64604682|FG002|Overall Study|Death|0|||
23235399|NCT02452034|64604683|FG003|Overall Study|Death|0|||
23235400|NCT02452034|64604684|FG004|Overall Study|Death|1|||
23235401|NCT02452034|64604685|FG005|Overall Study|Death|1|||
23235402|NCT02452034|64604680|FG000|Overall Study|Physician Decision|0|||
23235403|NCT02452034|64604681|FG001|Overall Study|Physician Decision|1|||
23235404|NCT02452034|64604682|FG002|Overall Study|Physician Decision|1|||
23235405|NCT02452034|64604683|FG003|Overall Study|Physician Decision|0|||
23235406|NCT02452034|64604684|FG004|Overall Study|Physician Decision|0|||
23235407|NCT02452034|64604685|FG005|Overall Study|Physician Decision|0|||
23235408|NCT02452034|64604680|FG000|Overall Study|Protocol Violation|0|||
23235409|NCT02452034|64604681|FG001|Overall Study|Protocol Violation|0|||
23235410|NCT02452034|64604682|FG002|Overall Study|Protocol Violation|0|||
23235411|NCT02452034|64604683|FG003|Overall Study|Protocol Violation|0|||
23235412|NCT02452034|64604684|FG004|Overall Study|Protocol Violation|0|||
23235413|NCT02452034|64604685|FG005|Overall Study|Protocol Violation|1|||
23235414|NCT02452034|64604680|FG000|Overall Study|Screen Failure|1|||
23235415|NCT02452034|64604681|FG001|Overall Study|Screen Failure|0|||
23235416|NCT02452034|64604682|FG002|Overall Study|Screen Failure|0|||
23452470|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
23452471|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
23452472|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
23452473|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23452474|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23452475|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
23452476|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
23452477|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
23235417|NCT02452034|64604683|FG003|Overall Study|Screen Failure|1|||
23235418|NCT02452034|64604684|FG004|Overall Study|Screen Failure|0|||
23235419|NCT02452034|64604685|FG005|Overall Study|Screen Failure|0|||
23452478|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23581061|NCT00389519|65856811|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
23581062|NCT00389519|65856808|FG000|Placebo Run-In|Withdrawal by Subject|19|||
23581063|NCT00389519|65856809|FG001|Placebo Run-In|Withdrawal by Subject|0|||
23581064|NCT00389519|65856810|FG002|Placebo Run-In|Withdrawal by Subject|0|||
23581065|NCT00389519|65856811|FG003|Placebo Run-In|Withdrawal by Subject|0|||
23581066|NCT00389519|65856808|FG000|Placebo Run-In|Reason not specified|40|||
23581067|NCT00389519|65856809|FG001|Placebo Run-In|Reason not specified|0|||
23174956|NCT00896532|64386431|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
23174957|NCT00896532|64386432|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
23174958|NCT00896532|64386433|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174959|NCT00896532|64386434|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174960|NCT00896532|64386435|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174961|NCT00896532|64386436|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174962|NCT00896532|64386437|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174963|NCT00896532|64386438|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23581068|NCT00389519|65856810|FG002|Placebo Run-In|Reason not specified|0|||
23581069|NCT00389519|65856811|FG003|Placebo Run-In|Reason not specified|0|||
23174964|NCT00896532|64386439|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174965|NCT00896532|64386440|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174966|NCT00896532|64386441|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174967|NCT00896532|64386442|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174968|NCT00896532|64386443|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174969|NCT00896532|64386444|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23174970|NCT00896532|64386445|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23452479|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23452480|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
23452481|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
23452482|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
23452483|NCT02831764|65399018|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23452484|NCT02831764|65399019|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23452485|NCT02831764|65399020|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
23452486|NCT02831764|65399021|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
23452487|NCT02831764|65399022|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
23581070|NCT00389519|65856808|FG000|Randomized|Did not receive study drug|2|||
23581071|NCT00389519|65856809|FG001|Randomized|Did not receive study drug|0|||
23174971|NCT00896532|64386446|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23235420|NCT02452034|64604680|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
23452488|NCT02831764|65399018|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23452489|NCT02831764|65399019|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23452490|NCT02831764|65399020|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23452491|NCT02831764|65399021|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
23452492|NCT02831764|65399022|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
23452493|NCT02831764|65399018|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23581072|NCT00389519|65856810|FG002|Randomized|Did not receive study drug|0|||
23581073|NCT00389519|65856811|FG003|Randomized|Did not receive study drug|0|||
23581074|NCT00389519|65856808|FG000|Treated|Adverse Event|1|||
23581075|NCT00389519|65856809|FG001|Treated|Adverse Event|0|||
23581076|NCT00389519|65856810|FG002|Treated|Adverse Event|0|||
23581077|NCT00389519|65856811|FG003|Treated|Adverse Event|2|||
23581078|NCT00389519|65856808|FG000|Treated|Reason not specified|1|||
23581079|NCT00389519|65856809|FG001|Treated|Reason not specified|1|||
23581080|NCT00389519|65856810|FG002|Treated|Reason not specified|0|||
23581081|NCT00389519|65856811|FG003|Treated|Reason not specified|2|||
23581082|NCT01562743|65856812|FG000|Overall Study|Adverse Event|29|||
23581083|NCT01562743|65856812|FG000|Overall Study|Lack of Efficacy|3|||
23581084|NCT01562743|65856812|FG000|Overall Study|Withdrawal by Subject|13|||
23452494|NCT02831764|65399019|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23581085|NCT01562743|65856812|FG000|Overall Study|Protocol Violation|1|||
23581086|NCT01562743|65856812|FG000|Overall Study|Discontinuation criteria|2|||
23581087|NCT01562743|65856812|FG000|Overall Study|Lost to Follow-up|2|||
23581088|NCT01562743|65856812|FG000|Overall Study|Physician Decision|2|||
23581089|NCT00562965|65856813|FG000|Overall Study|Withdrawal by Subject|0|||
23235421|NCT02452034|64604681|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
23235422|NCT02452034|64604682|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
23581090|NCT00562965|65856814|FG001|Overall Study|Withdrawal by Subject|1|||
23581091|NCT00562965|65856813|FG000|Overall Study|Death|2|||
23581092|NCT00562965|65856814|FG001|Overall Study|Death|4|||
23581093|NCT00562965|65856813|FG000|Overall Study|Lost to Follow-up|1|||
23581094|NCT00562965|65856814|FG001|Overall Study|Lost to Follow-up|0|||
23581095|NCT00562965|65856813|FG000|Overall Study|Other|0|||
23581096|NCT00562965|65856814|FG001|Overall Study|Other|1|||
23581097|NCT01238575|65856815|FG000|Overall Study|Lack of Efficacy|2|||
23581098|NCT01238575|65856816|FG001|Overall Study|Lack of Efficacy|4|||
23581099|NCT01238575|65856815|FG000|Overall Study|Adverse Event|2|||
23581100|NCT01238575|65856816|FG001|Overall Study|Adverse Event|0|||
23452495|NCT02831764|65399020|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23581101|NCT01772719|65856817|FG000|Overall Study|Withdrawal by Subject|3|||
23581102|NCT01772719|65856817|FG000|Overall Study|Adverse Event|2|||
23581103|NCT01772719|65856817|FG000|Overall Study|Protocol Violation|1|||
23581104|NCT01772719|65856817|FG000|Overall Study|Lost to Follow-up|1|||
23581105|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
23581106|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
23581107|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
23581108|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
23581109|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
23340465|NCT00157248|64992782|FG000|Overall Study|Withdrawal by Subject|1|||
23340466|NCT00157248|64992783|FG001|Overall Study|Withdrawal by Subject|4|||
23340467|NCT00157248|64992784|FG002|Overall Study|Withdrawal by Subject|3|||
23340468|NCT00157248|64992785|FG003|Overall Study|Withdrawal by Subject|3|||
23340469|NCT00157248|64992782|FG000|Overall Study|site closures, subject moving|7|||
23340470|NCT00157248|64992783|FG001|Overall Study|site closures, subject moving|7|||
23340471|NCT00157248|64992784|FG002|Overall Study|site closures, subject moving|3|||
23340472|NCT00157248|64992785|FG003|Overall Study|site closures, subject moving|9|||
23452496|NCT02831764|65399021|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
23235423|NCT02452034|64604683|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
23235424|NCT02452034|64604684|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
23235425|NCT02452034|64604685|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
23235426|NCT04585789|64604698|FG000|Overall Study|Withdrawal by Subject|1|||
23235427|NCT04585789|64604699|FG001|Overall Study|Withdrawal by Subject|0|||
23235428|NCT04585789|64604698|FG000|Overall Study|Ongoing|9|||
23452497|NCT02831764|65399022|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
23452498|NCT02831764|65399018|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23452499|NCT02831764|65399019|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23452500|NCT02831764|65399020|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23581110|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
23581111|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
23235429|NCT04585789|64604699|FG001|Overall Study|Ongoing|10|||
23581112|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
23581113|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
23581114|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
23581115|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
23581116|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
23581117|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
23235430|NCT02719028|64604700|FG000|Overall Study|Adverse Event|2|||
23235431|NCT02719028|64604701|FG001|Overall Study|Adverse Event|1|||
23235432|NCT02719028|64604702|FG002|Overall Study|Adverse Event|4|||
23235433|NCT02719028|64604703|FG003|Overall Study|Adverse Event|8|||
23235434|NCT02719028|64604700|FG000|Overall Study|Physician Decision|0|||
23235435|NCT02719028|64604701|FG001|Overall Study|Physician Decision|1|||
23235436|NCT02719028|64604702|FG002|Overall Study|Physician Decision|1|||
23235437|NCT02719028|64604703|FG003|Overall Study|Physician Decision|1|||
23235438|NCT02719028|64604700|FG000|Overall Study|Use of prohibited medication|0|||
23235439|NCT02719028|64604701|FG001|Overall Study|Use of prohibited medication|0|||
23235440|NCT02719028|64604702|FG002|Overall Study|Use of prohibited medication|1|||
23235441|NCT02719028|64604703|FG003|Overall Study|Use of prohibited medication|0|||
23235442|NCT02719028|64604700|FG000|Overall Study|Protocol Violation|0|||
23235443|NCT02719028|64604701|FG001|Overall Study|Protocol Violation|0|||
23235444|NCT02719028|64604702|FG002|Overall Study|Protocol Violation|0|||
23235445|NCT02719028|64604703|FG003|Overall Study|Protocol Violation|1|||
23235446|NCT03328325|64604704|FG000|Overall Study|Lost to Follow-up|4|||
23235447|NCT03328325|64604704|FG000|Overall Study|Physician Decision|1|||
23235448|NCT03328325|64604704|FG000|Overall Study|Withdrawal by Subject|3|||
23235449|NCT03328325|64604704|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
23235450|NCT01140646|64604713|FG000|Overall Study|Adverse Event|4|||
23235451|NCT01140646|64604713|FG000|Overall Study|Refused Further Treatment|5|||
23235452|NCT00337935|64604716|FG000|Overall Study|Adverse Event|2|||
23235453|NCT00337935|64604717|FG001|Overall Study|Adverse Event|5|||
23235454|NCT00337935|64604716|FG000|Overall Study|Death|2|||
23235455|NCT00337935|64604717|FG001|Overall Study|Death|8|||
23581118|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
23581119|NCT04672460|65856818|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
23581120|NCT04672460|65856819|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
23581121|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
23581122|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
23581123|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
23581124|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
23581125|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
23581126|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
23581127|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
23581128|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
23581129|NCT04672460|65856818|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
23581130|NCT04672460|65856819|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
23235456|NCT00337935|64604716|FG000|Overall Study|Physician Decision|1|||
23235457|NCT00337935|64604717|FG001|Overall Study|Physician Decision|1|||
23235458|NCT00337935|64604716|FG000|Overall Study|Lost to Follow-up|0|||
23235459|NCT00337935|64604717|FG001|Overall Study|Lost to Follow-up|1|||
23235460|NCT00337935|64604716|FG000|Overall Study|Protocol Violation|4|||
23235461|NCT00337935|64604717|FG001|Overall Study|Protocol Violation|3|||
23235462|NCT00337935|64604716|FG000|Overall Study|Withdrawal by Subject|1|||
23235463|NCT00337935|64604717|FG001|Overall Study|Withdrawal by Subject|7|||
23235464|NCT00337935|64604716|FG000|Overall Study|Other|0|||
23235465|NCT00337935|64604717|FG001|Overall Study|Other|1|||
23235466|NCT00337935|64604716|FG000|Overall Study|Lack of Efficacy|0|||
23235467|NCT00337935|64604717|FG001|Overall Study|Lack of Efficacy|1|||
23235468|NCT02335411|64604718|FG000|Overall Study|Death|223|||
23235469|NCT02335411|64604719|FG001|Overall Study|Death|22|||
23235470|NCT02335411|64604720|FG002|Overall Study|Death|26|||
23235471|NCT02335411|64604718|FG000|Overall Study|Physician Decision|3|||
23235472|NCT02335411|64604719|FG001|Overall Study|Physician Decision|0|||
23235473|NCT02335411|64604720|FG002|Overall Study|Physician Decision|0|||
23235474|NCT02335411|64604718|FG000|Overall Study|Protocol Violation|1|||
23235475|NCT02335411|64604719|FG001|Overall Study|Protocol Violation|0|||
23235476|NCT02335411|64604720|FG002|Overall Study|Protocol Violation|0|||
23581131|NCT04672460|65856818|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
23235477|NCT02335411|64604718|FG000|Overall Study|Withdrawal by Subject|11|||
23235478|NCT02335411|64604719|FG001|Overall Study|Withdrawal by Subject|0|||
23235479|NCT02335411|64604720|FG002|Overall Study|Withdrawal by Subject|3|||
23235480|NCT02335411|64604718|FG000|Overall Study|Sponsor Decision|12|||
23235481|NCT02335411|64604719|FG001|Overall Study|Sponsor Decision|3|||
23235482|NCT02335411|64604720|FG002|Overall Study|Sponsor Decision|2|||
23235483|NCT02335411|64604718|FG000|Overall Study|Adverse Event|9|||
23235484|NCT02335411|64604719|FG001|Overall Study|Adverse Event|0|||
23235485|NCT02335411|64604720|FG002|Overall Study|Adverse Event|0|||
23235486|NCT00565721|64604722|FG000|Overall Study|Screen Failure|2|||
23581132|NCT04672460|65856819|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
23581133|NCT04672460|65856818|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
23235487|NCT00565721|64604722|FG000|Overall Study|Lost to Follow-up|6|||
23235488|NCT00565721|64604722|FG000|Overall Study|Technical Problems|1|||
23235489|NCT00565721|64604722|FG000|Overall Study|Physician Decision|2|||
23235490|NCT00565721|64604722|FG000|Overall Study|Other reasons|6|||
23581134|NCT04672460|65856819|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
23581135|NCT04672460|65856818|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
23581136|NCT04672460|65856819|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
23581137|NCT04672460|65856818|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
23581138|NCT04672460|65856819|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
23581139|NCT02338609|65856820|FG000|Overall Study|Physician Decision|1|||
23581140|NCT02338609|65856820|FG000|Overall Study|Death|1|||
23581141|NCT03201809|65856821|FG000|Overall Study|Lost to Follow-up|2|||
23581142|NCT03201809|65856822|FG001|Overall Study|Lost to Follow-up|0|||
23581143|NCT00465361|65856823|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
23581144|NCT02368886|65856824|FG000|Overall Study|Cancel|1|||
23581145|NCT02368886|65856825|FG001|Overall Study|Cancel|1|||
23581146|NCT02368886|65856826|FG002|Overall Study|Cancel|1|||
23581147|NCT02368886|65856827|FG003|Overall Study|Cancel|3|||
23581148|NCT02368886|65856824|FG000|Overall Study|Ineligible|0|||
23581149|NCT02368886|65856825|FG001|Overall Study|Ineligible|0|||
23581150|NCT02368886|65856826|FG002|Overall Study|Ineligible|0|||
23581151|NCT02368886|65856827|FG003|Overall Study|Ineligible|1|||
23581152|NCT00797862|65856830|FG000|Overall Study|Adverse Event|86|||
23581153|NCT00797862|65856831|FG001|Overall Study|Adverse Event|44|||
23581154|NCT00797862|65856832|FG002|Overall Study|Adverse Event|58|||
23581155|NCT00797862|65856830|FG000|Overall Study|Abnormal Test Procedure Result|0|||
23581156|NCT00797862|65856831|FG001|Overall Study|Abnormal Test Procedure Result|1|||
23581157|NCT00797862|65856832|FG002|Overall Study|Abnormal Test Procedure Result|1|||
23581158|NCT00797862|65856830|FG000|Overall Study|Lack of Efficacy|1|||
23581159|NCT00797862|65856831|FG001|Overall Study|Lack of Efficacy|7|||
23581160|NCT00797862|65856832|FG002|Overall Study|Lack of Efficacy|6|||
23581161|NCT00797862|65856830|FG000|Overall Study|No longer required study medication|1|||
23581162|NCT00797862|65856831|FG001|Overall Study|No longer required study medication|0|||
23581163|NCT00797862|65856832|FG002|Overall Study|No longer required study medication|0|||
23581164|NCT00797862|65856830|FG000|Overall Study|Withdrawal by Subject|14|||
23581165|NCT00797862|65856831|FG001|Overall Study|Withdrawal by Subject|7|||
23581166|NCT00797862|65856832|FG002|Overall Study|Withdrawal by Subject|7|||
23581167|NCT00797862|65856830|FG000|Overall Study|Lost to Follow-up|11|||
23581168|NCT00797862|65856831|FG001|Overall Study|Lost to Follow-up|0|||
23581169|NCT00797862|65856832|FG002|Overall Study|Lost to Follow-up|5|||
23581170|NCT00797862|65856830|FG000|Overall Study|Administrative Problem|4|||
23581171|NCT00797862|65856831|FG001|Overall Study|Administrative Problem|0|||
23581172|NCT00797862|65856832|FG002|Overall Study|Administrative Problem|0|||
23581173|NCT00797862|65856830|FG000|Overall Study|Protocol Violation|4|||
23581174|NCT00797862|65856831|FG001|Overall Study|Protocol Violation|6|||
23235491|NCT03417999|64604723|FG000|Overall Study|Withdrawal by Subject|1|||
23581175|NCT00797862|65856832|FG002|Overall Study|Protocol Violation|8|||
23581176|NCT00797862|65856830|FG000|Overall Study|Mis-randomized|3|||
23581177|NCT00797862|65856831|FG001|Overall Study|Mis-randomized|3|||
23235492|NCT03417999|64604724|FG001|Overall Study|Withdrawal by Subject|0|||
23235493|NCT03417999|64604725|FG002|Overall Study|Withdrawal by Subject|0|||
23235494|NCT03417999|64604723|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
23235495|NCT03417999|64604724|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
23235496|NCT03417999|64604725|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
23235497|NCT03417999|64604723|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
23235498|NCT03417999|64604724|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
23235499|NCT03417999|64604725|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
23235500|NCT03417999|64604723|FG000|Overall Study|Inadequate study staff available to process samples|0|||
23581178|NCT00797862|65856832|FG002|Overall Study|Mis-randomized|1|||
23581179|NCT01244828|65856835|FG000|Overall Study|Adverse Event|37|||
23581180|NCT01244828|65856835|FG000|Overall Study|Withdrawal by Subject|31|||
23235501|NCT03417999|64604724|FG001|Overall Study|Inadequate study staff available to process samples|0|||
23581181|NCT01244828|65856835|FG000|Overall Study|Lack of Efficacy|7|||
23581182|NCT01244828|65856835|FG000|Overall Study|Lost to Follow-up|2|||
23581183|NCT01244828|65856835|FG000|Overall Study|Other reason (not specified)|1|||
23581184|NCT04530344|65856838|FG000|Overall Study|Lost to Follow-up|3|||
23581185|NCT04530344|65856839|FG001|Overall Study|Lost to Follow-up|3|||
23581186|NCT04530344|65856840|FG002|Overall Study|Lost to Follow-up|3|||
23581187|NCT04530344|65856841|FG003|Overall Study|Lost to Follow-up|10|||
23581188|NCT04530344|65856838|FG000|Overall Study|Withdrawal by Subject|14|||
23581189|NCT04530344|65856839|FG001|Overall Study|Withdrawal by Subject|5|||
23581190|NCT04530344|65856840|FG002|Overall Study|Withdrawal by Subject|18|||
23581191|NCT04530344|65856841|FG003|Overall Study|Withdrawal by Subject|33|||
23581192|NCT04530344|65856838|FG000|Overall Study|Adverse Event|0|||
23581193|NCT04530344|65856839|FG001|Overall Study|Adverse Event|0|||
23581194|NCT04530344|65856840|FG002|Overall Study|Adverse Event|0|||
23581195|NCT04530344|65856841|FG003|Overall Study|Adverse Event|1|||
23581196|NCT04530344|65856838|FG000|Overall Study|Lack of Efficacy|0|||
23581197|NCT04530344|65856839|FG001|Overall Study|Lack of Efficacy|0|||
23581198|NCT04530344|65856840|FG002|Overall Study|Lack of Efficacy|0|||
23581199|NCT04530344|65856841|FG003|Overall Study|Lack of Efficacy|1|||
23581200|NCT04530344|65856838|FG000|Overall Study|Physician Decision|0|||
23340473|NCT02989649|64992790|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
23340474|NCT02989649|64992790|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
23340475|NCT02989649|64992790|FG000|Overall Study|Lost For Observation During Study|3|||
23340476|NCT02989649|64992790|FG000|Overall Study|Reason Not Specified|13|||
23340477|NCT01597375|64992791|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
23340478|NCT01597375|64992792|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
23340479|NCT01597375|64992791|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
23340480|NCT01597375|64992792|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
23340481|NCT01597375|64992791|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
23340482|NCT01597375|64992792|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
23340483|NCT01597375|64992791|FG000|Washout (2 Weeks)|Adverse Event|1|||
23340484|NCT01597375|64992792|FG001|Washout (2 Weeks)|Adverse Event|0|||
23340485|NCT01597375|64992791|FG000|Second Intervention|Failed to react at both Aspirin|1|||
23340486|NCT01597375|64992792|FG001|Second Intervention|Failed to react at both Aspirin|1|||
23581201|NCT04530344|65856839|FG001|Overall Study|Physician Decision|0|||
23581202|NCT04530344|65856840|FG002|Overall Study|Physician Decision|1|||
23581203|NCT04530344|65856841|FG003|Overall Study|Physician Decision|1|||
23581204|NCT04530344|65856838|FG000|Overall Study|Pregnancy|0|||
23174972|NCT00896532|64386447|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
23340487|NCT01346189|64992793|FG000|Overall Study|Withdrawal by Subject|7|||
23340488|NCT01346189|64992794|FG001|Overall Study|Withdrawal by Subject|5|||
23581205|NCT04530344|65856839|FG001|Overall Study|Pregnancy|0|||
23581206|NCT04530344|65856840|FG002|Overall Study|Pregnancy|2|||
23581207|NCT04530344|65856841|FG003|Overall Study|Pregnancy|1|||
23581208|NCT04530344|65856838|FG000|Overall Study|Protocol Violation|0|||
23581209|NCT04530344|65856839|FG001|Overall Study|Protocol Violation|0|||
23581210|NCT04530344|65856840|FG002|Overall Study|Protocol Violation|0|||
23581211|NCT04530344|65856841|FG003|Overall Study|Protocol Violation|1|||
23581212|NCT04530344|65856838|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
23581213|NCT04530344|65856839|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
23581214|NCT04530344|65856840|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
23581215|NCT04530344|65856841|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
23581216|NCT04530344|65856838|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
23581217|NCT04530344|65856839|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
23581218|NCT04530344|65856840|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
23581219|NCT04530344|65856841|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
23581220|NCT04530344|65856838|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
23581221|NCT04530344|65856839|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
23581222|NCT04530344|65856840|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
23581223|NCT04530344|65856841|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
23235502|NCT03417999|64604725|FG002|Overall Study|Inadequate study staff available to process samples|1|||
23235503|NCT05604781|64604726|FG000|Overall Study|Lost to Follow-up|3|||
23235504|NCT05604781|64604726|FG000|Overall Study|Adverse Event|1|||
23235505|NCT01224171|64604727|FG000|Overall Study|Adverse Event|8|||
23235506|NCT01224171|64604728|FG001|Overall Study|Adverse Event|4|||
23235507|NCT01224171|64604727|FG000|Overall Study|Protocol Violation|0|||
23235508|NCT01224171|64604728|FG001|Overall Study|Protocol Violation|1|||
23235509|NCT01224171|64604727|FG000|Overall Study|Lack of Efficacy|5|||
23235510|NCT01224171|64604728|FG001|Overall Study|Lack of Efficacy|1|||
23235511|NCT01224171|64604727|FG000|Overall Study|Withdrawal of Consent|2|||
23235512|NCT01224171|64604728|FG001|Overall Study|Withdrawal of Consent|4|||
23235513|NCT01224171|64604727|FG000|Overall Study|Lost to Follow-up|0|||
23235514|NCT01224171|64604728|FG001|Overall Study|Lost to Follow-up|3|||
23235515|NCT01475214|64604729|FG000|Overall Study|Lost to Follow-up|1|||
23235516|NCT01475214|64604730|FG001|Overall Study|Lost to Follow-up|0|||
23235517|NCT01475214|64604731|FG002|Overall Study|Lost to Follow-up|1|||
23235518|NCT01475214|64604729|FG000|Overall Study|Physician Decision|2|||
23235519|NCT01475214|64604730|FG001|Overall Study|Physician Decision|0|||
23235520|NCT01475214|64604731|FG002|Overall Study|Physician Decision|0|||
23235521|NCT01475214|64604729|FG000|Overall Study|Withdrawal by Subject|2|||
23235522|NCT01475214|64604730|FG001|Overall Study|Withdrawal by Subject|4|||
23235523|NCT01475214|64604731|FG002|Overall Study|Withdrawal by Subject|1|||
23235524|NCT03480360|64604739|FG000|Overall Study|Death|2|||
23235525|NCT04863898|64604740|FG000|Overall Study|Away from study clinic during intervention training period|2|||
23235526|NCT04863898|64604740|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
23235527|NCT04863898|64604740|FG000|Overall Study|Lost to Follow-up|3|||
23581224|NCT04530344|65856838|FG000|Overall Study|Personal Reasons|0|||
23581225|NCT04530344|65856839|FG001|Overall Study|Personal Reasons|0|||
23581226|NCT04530344|65856840|FG002|Overall Study|Personal Reasons|0|||
23581227|NCT04530344|65856841|FG003|Overall Study|Personal Reasons|1|||
23581228|NCT04530344|65856838|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
23581229|NCT04530344|65856839|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
23581230|NCT04530344|65856840|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
23581231|NCT04530344|65856841|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
23581232|NCT02321540|65856842|FG000|Overall Study|Death|0|||
23581233|NCT02321540|65856843|FG001|Overall Study|Death|1|||
23581234|NCT02321540|65856842|FG000|Overall Study|Progression|3|||
23581235|NCT02321540|65856843|FG001|Overall Study|Progression|9|||
23581236|NCT03971357|65856846|FG000|Overall Study|Lack of Efficacy|0|||
23581237|NCT03971357|65856847|FG001|Overall Study|Lack of Efficacy|1|||
23581238|NCT00852475|65856849|FG000|Overall Study|Lost to Follow-up|3|||
23581239|NCT00852475|65856850|FG001|Overall Study|Lost to Follow-up|4|||
23581240|NCT03836664|65856851|FG000|Overall Study|Didn't complete forms and lost drug|3|||
23581241|NCT03836664|65856852|FG001|Overall Study|Didn't complete forms and lost drug|3|||
23581242|NCT01687270|65856853|FG000|Overall Study|Lack of Efficacy|11|||
23581243|NCT01687270|65856853|FG000|Overall Study|Lost to Follow-up|1|||
23235528|NCT04863898|64604740|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
23581244|NCT05233085|65856855|FG000|Overall Study|Adverse Event|1|||
23581245|NCT05233085|65856856|FG001|Overall Study|Adverse Event|0|||
23581246|NCT05233085|65856857|FG002|Overall Study|Adverse Event|0|||
23235529|NCT04863898|64604740|FG000|Overall Study|No longer employed at clinic|3|||
23235530|NCT03287089|64604741|FG000|Overall Study|Lost to Follow-up|0|||
23235531|NCT03287089|64604742|FG001|Overall Study|Lost to Follow-up|2|||
23235532|NCT03287089|64604741|FG000|Overall Study|Physician Decision|0|||
23581247|NCT05233085|65856858|FG003|Overall Study|Adverse Event|0|||
23581248|NCT05780047|65856861|FG000|Overall Study|Did not submit baseline urine test kit|226|||
23581249|NCT05780047|65856861|FG000|Overall Study|Lost to Follow-up|34|||
23235533|NCT03287089|64604742|FG001|Overall Study|Physician Decision|2|||
23581250|NCT05780047|65856861|FG000|Overall Study|Did not submit second urine test kit|124|||
23581251|NCT05310084|65856862|FG000|Overall Study|Withdrawal by Subject|2|||
23581252|NCT05310084|65856863|FG001|Overall Study|Withdrawal by Subject|3|||
23581253|NCT05310084|65856862|FG000|Overall Study|Participant availability|0|||
23581254|NCT05310084|65856863|FG001|Overall Study|Participant availability|4|||
23581255|NCT05310084|65856862|FG000|Overall Study|Lost to Follow-up|1|||
23581256|NCT05310084|65856863|FG001|Overall Study|Lost to Follow-up|1|||
23581257|NCT05310084|65856862|FG000|Overall Study|Adverse Event|1|||
23581258|NCT05310084|65856863|FG001|Overall Study|Adverse Event|1|||
23581259|NCT05310084|65856862|FG000|Overall Study|Randomized but not vaccinated|4|||
23581260|NCT05310084|65856863|FG001|Overall Study|Randomized but not vaccinated|2|||
23581261|NCT04550039|65856865|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
23581262|NCT04550039|65856866|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
23581263|NCT04550039|65856865|FG000|Overall Study|patient self-withdrew from study|0|||
23581264|NCT04550039|65856866|FG001|Overall Study|patient self-withdrew from study|1|||
23581265|NCT00751790|65856872|FG000|Overall Study|Lost to Follow-up|1|||
23581266|NCT00751790|65856872|FG000|Overall Study|Death|3|||
23581267|NCT00751790|65856872|FG000|Overall Study|Withdrawal by Subject|1|||
23581268|NCT01645111|65856879|FG000|Overall Study|Did not require Clevidipine|15|||
23581269|NCT00531479|65856884|FG000|Overall Study|Death|68|||
23581270|NCT00531479|65856885|FG001|Overall Study|Death|71|||
23340489|NCT01346189|64992795|FG002|Overall Study|Withdrawal by Subject|3|||
23340490|NCT01346189|64992796|FG003|Overall Study|Withdrawal by Subject|5|||
23340491|NCT01346189|64992793|FG000|Overall Study|Physician Decision|4|||
23340492|NCT01346189|64992794|FG001|Overall Study|Physician Decision|0|||
23340493|NCT01346189|64992795|FG002|Overall Study|Physician Decision|0|||
23340494|NCT01346189|64992796|FG003|Overall Study|Physician Decision|0|||
23581271|NCT00531479|65856884|FG000|Overall Study|Lost to Follow-up|0|||
23581272|NCT00531479|65856885|FG001|Overall Study|Lost to Follow-up|2|||
23581273|NCT00531479|65856884|FG000|Overall Study|Other|0|||
23581274|NCT00531479|65856885|FG001|Overall Study|Other|1|||
23581275|NCT00531479|65856884|FG000|Overall Study|Withdrawal by Subject|6|||
23581276|NCT00531479|65856885|FG001|Overall Study|Withdrawal by Subject|6|||
23581277|NCT00531479|65856884|FG000|Overall Study|Did not receive treatment|2|||
23581278|NCT00531479|65856885|FG001|Overall Study|Did not receive treatment|3|||
23581279|NCT01518257|65856888|FG000|Overall Study|Lost to Follow-up|1|||
23581280|NCT01518257|65856889|FG001|Overall Study|Lost to Follow-up|0|||
23581281|NCT01518257|65856888|FG000|Overall Study|Other Miscellaneous Reason|1|||
23581282|NCT01518257|65856889|FG001|Overall Study|Other Miscellaneous Reason|0|||
23581283|NCT04213846|65856890|FG000|Overall Study|Withdrawal by Subject|7|||
23235534|NCT03287089|64604741|FG000|Overall Study|Withdrawal by Subject|0|||
23235535|NCT03287089|64604742|FG001|Overall Study|Withdrawal by Subject|2|||
23235536|NCT00348686|64604743|FG000|Overall Study|Withdrawal by Subject|45|||
23235537|NCT00348686|64604743|FG000|Overall Study|Adverse Event|5|||
23235538|NCT00348686|64604743|FG000|Overall Study|Protocol Violation|6|||
23235539|NCT00348686|64604743|FG000|Overall Study|Lost to Follow-up|2|||
23235540|NCT00348686|64604743|FG000|Overall Study|Multiple Reasons|8|||
23235541|NCT01177943|64604744|FG000|First Intervention|Withdrawal by Subject|2|||
23235542|NCT01177943|64604745|FG001|First Intervention|Withdrawal by Subject|0|||
23235543|NCT00950755|64604754|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
23235544|NCT00950755|64604754|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
23235545|NCT00950755|64604754|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
23581284|NCT04213846|65856891|FG001|Overall Study|Withdrawal by Subject|6|||
23581285|NCT04213846|65856890|FG000|Overall Study|Lost to Follow-up|15|||
23581286|NCT04213846|65856891|FG001|Overall Study|Lost to Follow-up|21|||
23581287|NCT02775851|65856894|FG000|Overall Study|Adverse Event|1|||
23340495|NCT01346189|64992793|FG000|Overall Study|Moved|3|||
23340496|NCT01346189|64992794|FG001|Overall Study|Moved|0|||
23340497|NCT01346189|64992795|FG002|Overall Study|Moved|4|||
23340498|NCT01346189|64992796|FG003|Overall Study|Moved|0|||
23340499|NCT01346189|64992793|FG000|Overall Study|Other|2|||
23340500|NCT01346189|64992794|FG001|Overall Study|Other|4|||
23581288|NCT02775851|65856895|FG001|Overall Study|Adverse Event|10|||
23581289|NCT02775851|65856894|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
23340501|NCT01346189|64992795|FG002|Overall Study|Other|7|||
23581290|NCT02775851|65856895|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
23581291|NCT02775851|65856894|FG000|Overall Study|Progression/Relapse|0|||
23581292|NCT02775851|65856895|FG001|Overall Study|Progression/Relapse|4|||
23581293|NCT02775851|65856894|FG000|Overall Study|Other - Not Protocol Specified|0|||
23235546|NCT00950755|64604754|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
23235547|NCT00950755|64604754|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
23340502|NCT01346189|64992796|FG003|Overall Study|Other|3|||
23340503|NCT01346189|64992793|FG000|Overall Study|Death|0|||
23340504|NCT01346189|64992794|FG001|Overall Study|Death|3|||
23581294|NCT02775851|65856895|FG001|Overall Study|Other - Not Protocol Specified|7|||
23581295|NCT02775851|65856894|FG000|Overall Study|Withdrawal by Subject|1|||
23581296|NCT02775851|65856895|FG001|Overall Study|Withdrawal by Subject|0|||
23235548|NCT00950755|64604754|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
23235549|NCT00950755|64604754|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
23235550|NCT00950755|64604754|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
23235551|NCT00950755|64604754|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
23235552|NCT00950755|64604754|FG000|Long-Term Follow-Up|Death|8|||
23235553|NCT02146352|64604755|FG000|Overall Study|Death|1|||
23235554|NCT02146352|64604755|FG000|Overall Study|Patient entered hospice care|1|||
23235555|NCT01233284|64604760|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
23235556|NCT01233284|64604761|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23235557|NCT01233284|64604762|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23235558|NCT01233284|64604763|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23581297|NCT00577629|65856896|FG000|Treatment Period|Death|1|||
23581298|NCT00577629|65856896|FG000|Long Term Follow-Up|Death|15|||
23581299|NCT00577629|65856896|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
23581300|NCT00577629|65856896|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
23581301|NCT00577629|65856896|FG000|Long Term Follow-Up|Physician Decision|1|||
23581302|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
23581303|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
23581304|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
23581305|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
23581306|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
23581307|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
23581308|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
23581309|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
23581310|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
23581311|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
23581312|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
23581313|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
23581314|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
23581315|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
23581316|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
23581317|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
23581318|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
23581319|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
23581320|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
23581321|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
23581322|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
23581323|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
23581324|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
23581325|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
23581326|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
23581327|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
23581328|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
23581329|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
23581330|NCT00241644|65856897|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
23581331|NCT00241644|65856898|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
23235559|NCT01233284|64604764|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23581332|NCT00241644|65856899|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
23581333|NCT00241644|65856900|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
23174973|NCT00896532|64386425|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174974|NCT00896532|64386426|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174975|NCT00896532|64386427|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
23174976|NCT00896532|64386428|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174977|NCT00896532|64386429|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
23340505|NCT01346189|64992795|FG002|Overall Study|Death|0|||
23340506|NCT01346189|64992796|FG003|Overall Study|Death|0|||
23340507|NCT01346189|64992793|FG000|Overall Study|Non-health system primary care physician|0|||
23340508|NCT01346189|64992794|FG001|Overall Study|Non-health system primary care physician|5|||
23340509|NCT01346189|64992795|FG002|Overall Study|Non-health system primary care physician|0|||
23340510|NCT01346189|64992796|FG003|Overall Study|Non-health system primary care physician|0|||
23340511|NCT01346189|64992793|FG000|Overall Study|Travel|0|||
23340512|NCT01346189|64992794|FG001|Overall Study|Travel|0|||
23340513|NCT01346189|64992795|FG002|Overall Study|Travel|0|||
23340514|NCT01346189|64992796|FG003|Overall Study|Travel|3|||
23340515|NCT02968433|64992797|FG000|Overall Study|Withdrawal by Subject|1|||
23340516|NCT03852628|64992802|FG000|Overall Study|Lost to Follow-up|7|||
23340517|NCT03852628|64992803|FG001|Overall Study|Lost to Follow-up|6|||
23340518|NCT03852628|64992802|FG000|Overall Study|Lack of Efficacy|6|||
23340519|NCT03852628|64992803|FG001|Overall Study|Lack of Efficacy|6|||
23340520|NCT03937908|64992805|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
23340521|NCT03937908|64992806|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
23340522|NCT02847494|64992807|FG000|Overall Study|Lost to Follow-up|8|||
23174978|NCT00896532|64386430|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174979|NCT00896532|64386431|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174980|NCT00896532|64386432|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174981|NCT00896532|64386433|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23340523|NCT02847494|64992808|FG001|Overall Study|Lost to Follow-up|5|||
23340524|NCT01967706|64992814|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
23340525|NCT01967706|64992815|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
23340526|NCT01967706|64992816|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
23452501|NCT02831764|65399021|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
23452502|NCT02831764|65399022|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
23581334|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
23581335|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
23581336|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
23581337|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
23581338|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
23581339|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
23581340|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
23581341|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
23581342|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
23581343|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
23581344|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
23581345|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
23581346|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
23581347|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
23581348|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
23581349|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
23581350|NCT00241644|65856897|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
23581351|NCT00241644|65856898|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
23581352|NCT00241644|65856899|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
23581353|NCT00241644|65856900|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
23581354|NCT02263885|65856902|FG000|Overall Study|Withdrawal by Subject|7|||
23581355|NCT02263885|65856902|FG000|Overall Study|Alternative Treatment|3|||
23581356|NCT02724020|65856906|FG000|Overall Study|Death|16|||
23581357|NCT02724020|65856907|FG001|Overall Study|Death|18|||
23581358|NCT02724020|65856908|FG002|Overall Study|Death|19|||
23581359|NCT02724020|65856906|FG000|Overall Study|Lost to Follow-up|0|||
23581360|NCT02724020|65856907|FG001|Overall Study|Lost to Follow-up|3|||
23581361|NCT02724020|65856908|FG002|Overall Study|Lost to Follow-up|0|||
23581362|NCT02724020|65856906|FG000|Overall Study|Site Terminated by Sponsor|15|||
23581363|NCT02724020|65856907|FG001|Overall Study|Site Terminated by Sponsor|8|||
23581364|NCT02724020|65856908|FG002|Overall Study|Site Terminated by Sponsor|8|||
23581365|NCT02724020|65856906|FG000|Overall Study|Withdrawal by Subject|1|||
23581366|NCT02724020|65856907|FG001|Overall Study|Withdrawal by Subject|3|||
23581367|NCT02724020|65856908|FG002|Overall Study|Withdrawal by Subject|5|||
23581368|NCT01940887|65856911|FG000|Year 1|Protocol Violation|0|||
23581369|NCT01940887|65856912|FG001|Year 1|Protocol Violation|1|||
23581370|NCT01940887|65856911|FG000|Year 1|Physician Decision|7|||
23581371|NCT01940887|65856912|FG001|Year 1|Physician Decision|3|||
23581372|NCT01940887|65856911|FG000|Year 1|Death|5|||
23581373|NCT01940887|65856912|FG001|Year 1|Death|3|||
23581374|NCT01940887|65856911|FG000|Year 1|Adverse Event|7|||
23581375|NCT01940887|65856912|FG001|Year 1|Adverse Event|6|||
23581376|NCT01940887|65856911|FG000|Year 1|Withdrawal by Subject|18|||
23581377|NCT01940887|65856912|FG001|Year 1|Withdrawal by Subject|9|||
23581378|NCT01940887|65856911|FG000|Year 1|Lost to Follow-up|2|||
23581379|NCT01940887|65856912|FG001|Year 1|Lost to Follow-up|1|||
23581380|NCT01940887|65856911|FG000|Year 2|Physician Decision|8|||
23581381|NCT01940887|65856912|FG001|Year 2|Physician Decision|1|||
23581382|NCT01940887|65856911|FG000|Year 2|Death|0|||
23581383|NCT01940887|65856912|FG001|Year 2|Death|2|||
23581384|NCT01940887|65856911|FG000|Year 2|Sponsor Decision, early termination|192|||
23174982|NCT00896532|64386434|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174983|NCT00896532|64386435|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174984|NCT00896532|64386436|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174985|NCT00896532|64386437|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174986|NCT00896532|64386438|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174987|NCT00896532|64386439|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174988|NCT00896532|64386440|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23581385|NCT01940887|65856912|FG001|Year 2|Sponsor Decision, early termination|203|||
23581386|NCT01940887|65856911|FG000|Year 2|Adverse Event|8|||
23581387|NCT01940887|65856912|FG001|Year 2|Adverse Event|2|||
23581388|NCT01940887|65856911|FG000|Year 2|Withdrawal by Subject|8|||
23581389|NCT01940887|65856912|FG001|Year 2|Withdrawal by Subject|8|||
23581390|NCT01940887|65856911|FG000|Year 2|Lost to Follow-up|1|||
23581391|NCT01940887|65856912|FG001|Year 2|Lost to Follow-up|6|||
23581392|NCT01388543|65856913|FG000|Day 14|Adverse Event|1|||
23581393|NCT01388543|65856914|FG001|Day 14|Adverse Event|4|||
23581394|NCT02365298|65856917|FG000|Period 2|incorrect Rx dispensed|1|||
23581395|NCT02365298|65856918|FG001|Period 2|incorrect Rx dispensed|0|||
23581396|NCT02365298|65856917|FG000|Period 2|Discontinued at request of Sponsor|1|||
23581397|NCT02365298|65856918|FG001|Period 2|Discontinued at request of Sponsor|0|||
23581398|NCT02365298|65856917|FG000|Period 2|Test Article longer available|0|||
23581399|NCT02365298|65856918|FG001|Period 2|Test Article longer available|1|||
23581400|NCT02365298|65856917|FG000|Period 2|Protocol Violation|0|||
23581401|NCT02365298|65856918|FG001|Period 2|Protocol Violation|1|||
23581402|NCT00184028|65856919|FG000|Overall Study|Death|1|||
23581403|NCT00184028|65856919|FG000|Overall Study|Lack of Efficacy|4|||
23581404|NCT00184028|65856919|FG000|Overall Study|Adverse Event|2|||
23581405|NCT00184028|65856919|FG000|Overall Study|Withdrawal by Subject|1|||
23581406|NCT00184028|65856919|FG000|Overall Study|Non-compliance|2|||
23581407|NCT00594932|65856922|FG000|First 3 Months|Withdrawal by Subject|1|||
23581408|NCT00594932|65856923|FG001|First 3 Months|Withdrawal by Subject|3|||
23581409|NCT00594932|65856922|FG000|Final 3 Months|Withdrawal by Subject|4|||
23581410|NCT00594932|65856923|FG001|Final 3 Months|Withdrawal by Subject|3|||
23581411|NCT02952261|65856928|FG000|Overall Study|Withdrawal by Subject|4|||
23581412|NCT02952261|65856929|FG001|Overall Study|Withdrawal by Subject|5|||
23581413|NCT02952261|65856928|FG000|Overall Study|Protocol Violation|1|||
23581414|NCT02952261|65856929|FG001|Overall Study|Protocol Violation|0|||
23581415|NCT00836810|65856930|FG000|Overall Study|New diagnosis|1|||
23581416|NCT00836810|65856931|FG001|Overall Study|New diagnosis|0|||
23581417|NCT02320253|65856935|FG000|Overall Study|Withdrawal by Subject|3|||
23581418|NCT02320253|65856936|FG001|Overall Study|Withdrawal by Subject|0|||
23581419|NCT02320253|65856937|FG002|Overall Study|Withdrawal by Subject|0|||
23581420|NCT02320253|65856935|FG000|Overall Study|Lost to Follow-up|2|||
23581421|NCT02320253|65856936|FG001|Overall Study|Lost to Follow-up|2|||
23581422|NCT02320253|65856937|FG002|Overall Study|Lost to Follow-up|1|||
23581423|NCT02320253|65856935|FG000|Overall Study|Death|1|||
23340527|NCT01967706|64992817|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
23340528|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
23340529|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
23340530|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
23340531|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
23452503|NCT02831764|65399018|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23581424|NCT02320253|65856936|FG001|Overall Study|Death|0|||
23581425|NCT02320253|65856937|FG002|Overall Study|Death|1|||
23581426|NCT01072929|65856938|FG000|Overall Study|Adverse Event|8|||
23581427|NCT01072929|65856939|FG001|Overall Study|Adverse Event|11|||
23581428|NCT01072929|65856940|FG002|Overall Study|Adverse Event|2|||
23581429|NCT01072929|65856938|FG000|Overall Study|Lack of Efficacy|7|||
23581430|NCT01072929|65856939|FG001|Overall Study|Lack of Efficacy|4|||
23581431|NCT01072929|65856940|FG002|Overall Study|Lack of Efficacy|0|||
23581432|NCT01072929|65856938|FG000|Overall Study|Withdrawal by Subject|7|||
23581433|NCT01072929|65856939|FG001|Overall Study|Withdrawal by Subject|15|||
23581434|NCT01072929|65856940|FG002|Overall Study|Withdrawal by Subject|3|||
23581435|NCT01072929|65856938|FG000|Overall Study|Protocol Violation|13|||
23581436|NCT01072929|65856939|FG001|Overall Study|Protocol Violation|11|||
23581437|NCT01072929|65856940|FG002|Overall Study|Protocol Violation|2|||
23581438|NCT01072929|65856938|FG000|Overall Study|Lost to Follow-up|8|||
23581439|NCT01072929|65856939|FG001|Overall Study|Lost to Follow-up|4|||
23581440|NCT01072929|65856940|FG002|Overall Study|Lost to Follow-up|1|||
23581441|NCT01072929|65856938|FG000|Overall Study|Noncompliance with study medication|0|||
23581442|NCT01072929|65856939|FG001|Overall Study|Noncompliance with study medication|3|||
23581443|NCT01072929|65856940|FG002|Overall Study|Noncompliance with study medication|0|||
23581444|NCT01072929|65856938|FG000|Overall Study|Noncompliance with study procedures|1|||
23235560|NCT01233284|64604760|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23235561|NCT01233284|64604761|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
23235562|NCT01233284|64604762|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23235563|NCT01233284|64604763|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23235564|NCT01233284|64604764|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
23235565|NCT01233284|64604760|FG000|Period 1 (4 Weeks)|Other|0|||
23235566|NCT01233284|64604761|FG001|Period 1 (4 Weeks)|Other|0|||
23235567|NCT01233284|64604762|FG002|Period 1 (4 Weeks)|Other|1|||
23235568|NCT01233284|64604763|FG003|Period 1 (4 Weeks)|Other|0|||
23581445|NCT01072929|65856939|FG001|Overall Study|Noncompliance with study procedures|0|||
23235569|NCT01233284|64604764|FG004|Period 1 (4 Weeks)|Other|0|||
23235570|NCT01233284|64604760|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23235571|NCT01233284|64604761|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23235572|NCT01233284|64604762|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
23340532|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23581446|NCT01072929|65856940|FG002|Overall Study|Noncompliance with study procedures|1|||
23581447|NCT01072929|65856938|FG000|Overall Study|Other|0|||
23581448|NCT01072929|65856939|FG001|Overall Study|Other|3|||
23581449|NCT01072929|65856940|FG002|Overall Study|Other|0|||
23581450|NCT02179918|65856947|FG000|Overall Study|Death|0|||
23581451|NCT02179918|65856948|FG001|Overall Study|Death|0|||
23581452|NCT02179918|65856949|FG002|Overall Study|Death|0|||
23581453|NCT02179918|65856950|FG003|Overall Study|Death|1|||
23581454|NCT02179918|65856951|FG004|Overall Study|Death|0|||
23581455|NCT02179918|65856947|FG000|Overall Study|Lost to Follow-up|0|||
23581456|NCT02179918|65856948|FG001|Overall Study|Lost to Follow-up|0|||
23581457|NCT02179918|65856949|FG002|Overall Study|Lost to Follow-up|1|||
23581458|NCT02179918|65856950|FG003|Overall Study|Lost to Follow-up|0|||
23581459|NCT02179918|65856951|FG004|Overall Study|Lost to Follow-up|0|||
23581460|NCT02179918|65856947|FG000|Overall Study|Progressive Disease|4|||
23581461|NCT02179918|65856948|FG001|Overall Study|Progressive Disease|1|||
23581462|NCT02179918|65856949|FG002|Overall Study|Progressive Disease|1|||
23581463|NCT02179918|65856950|FG003|Overall Study|Progressive Disease|2|||
23581464|NCT02179918|65856951|FG004|Overall Study|Progressive Disease|6|||
23581465|NCT02179918|65856947|FG000|Overall Study|Other|0|||
23581466|NCT02179918|65856948|FG001|Overall Study|Other|1|||
23581467|NCT02179918|65856949|FG002|Overall Study|Other|0|||
23581468|NCT02179918|65856950|FG003|Overall Study|Other|0|||
23581469|NCT02179918|65856951|FG004|Overall Study|Other|1|||
23581470|NCT02179918|65856947|FG000|Overall Study|Subject refused further follow-up|0|||
23581471|NCT02179918|65856948|FG001|Overall Study|Subject refused further follow-up|1|||
23581472|NCT02179918|65856949|FG002|Overall Study|Subject refused further follow-up|0|||
23581473|NCT02179918|65856950|FG003|Overall Study|Subject refused further follow-up|0|||
23581474|NCT02179918|65856951|FG004|Overall Study|Subject refused further follow-up|1|||
23581475|NCT01648283|65856955|FG000|Overall Study|Withdrawal by Subject|14|||
23581476|NCT02397889|65856956|FG000|Overall Study|Physician Decision|1|||
23581477|NCT02397889|65856957|FG001|Overall Study|Physician Decision|0|||
23581478|NCT01304706|65856958|FG000|Overall Study|Adverse Event|2|||
23174989|NCT00896532|64386441|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174990|NCT00896532|64386442|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174991|NCT00896532|64386443|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174992|NCT00896532|64386444|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174993|NCT00896532|64386445|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174994|NCT00896532|64386446|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174995|NCT00896532|64386447|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
23174996|NCT00896532|64386425|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
23174997|NCT00896532|64386426|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23174998|NCT00896532|64386427|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23174999|NCT00896532|64386428|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
23175000|NCT00896532|64386429|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175001|NCT00896532|64386430|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175002|NCT00896532|64386431|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175003|NCT00896532|64386432|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175004|NCT00896532|64386433|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175005|NCT00896532|64386434|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175006|NCT00896532|64386435|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175007|NCT00896532|64386436|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175008|NCT00896532|64386437|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175009|NCT00896532|64386438|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175010|NCT00896532|64386439|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175011|NCT00896532|64386440|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175012|NCT00896532|64386441|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175013|NCT00896532|64386442|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23581479|NCT01304706|65856958|FG000|Overall Study|Lack of Efficacy|1|||
23581480|NCT01304706|65856958|FG000|Overall Study|Death|3|||
23581481|NCT01304706|65856958|FG000|Overall Study|Withdrawal by Subject|3|||
23581482|NCT01304706|65856958|FG000|Overall Study|Lost to Follow-up|7|||
23581483|NCT01304706|65856958|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
23581484|NCT02459964|65856960|FG000|Overall Study|Withdrawal by Subject|0|||
23581485|NCT02459964|65856961|FG001|Overall Study|Withdrawal by Subject|0|||
23581486|NCT02459964|65856962|FG002|Overall Study|Withdrawal by Subject|1|||
23581487|NCT02459964|65856960|FG000|Overall Study|Abnormal EKG changes|0|||
23581488|NCT02459964|65856961|FG001|Overall Study|Abnormal EKG changes|0|||
23581489|NCT02459964|65856962|FG002|Overall Study|Abnormal EKG changes|1|||
23581490|NCT01033643|65856965|FG000|Overall Study|Withdrew Consent|0|||
23581491|NCT01033643|65856966|FG001|Overall Study|Withdrew Consent|3|||
23581492|NCT01033643|65856967|FG002|Overall Study|Withdrew Consent|0|||
23581493|NCT01033643|65856968|FG003|Overall Study|Withdrew Consent|0|||
23581494|NCT01033643|65856969|FG004|Overall Study|Withdrew Consent|0|||
23581495|NCT01033643|65856970|FG005|Overall Study|Withdrew Consent|1|||
23581496|NCT04391309|65856977|FG000|Overall Study|Death|1|||
23581497|NCT04391309|65856978|FG001|Overall Study|Death|1|||
23581498|NCT04391309|65856977|FG000|Overall Study|Lost to Follow-up|3|||
23581499|NCT04391309|65856978|FG001|Overall Study|Lost to Follow-up|2|||
23581500|NCT04391309|65856977|FG000|Overall Study|Withdrawal by Subject|2|||
23581501|NCT04391309|65856978|FG001|Overall Study|Withdrawal by Subject|2|||
23581502|NCT02138916|65856979|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
23581503|NCT02138916|65856980|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
23581504|NCT02138916|65856981|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
23581505|NCT02138916|65856979|FG000|Overall Study|Death|14|||
23581506|NCT02138916|65856980|FG001|Overall Study|Death|11|||
23581507|NCT02138916|65856981|FG002|Overall Study|Death|12|||
23581508|NCT02138916|65856979|FG000|Overall Study|Withdrawal by Subject|27|||
23581509|NCT02138916|65856980|FG001|Overall Study|Withdrawal by Subject|31|||
23581510|NCT02138916|65856981|FG002|Overall Study|Withdrawal by Subject|32|||
23581511|NCT02138916|65856979|FG000|Overall Study|Study specific withdrawal criteria|0|||
23581512|NCT02138916|65856980|FG001|Overall Study|Study specific withdrawal criteria|0|||
23581513|NCT02138916|65856981|FG002|Overall Study|Study specific withdrawal criteria|1|||
23581514|NCT02138916|65856979|FG000|Overall Study|incorrect enrolment|1|||
23581515|NCT02138916|65856980|FG001|Overall Study|incorrect enrolment|1|||
23581516|NCT02138916|65856981|FG002|Overall Study|incorrect enrolment|0|||
23581517|NCT02138916|65856979|FG000|Overall Study|Severe non-compliance|1|||
23581518|NCT02138916|65856980|FG001|Overall Study|Severe non-compliance|2|||
23581519|NCT02138916|65856981|FG002|Overall Study|Severe non-compliance|1|||
23581520|NCT02138916|65856979|FG000|Overall Study|Lost to Follow-up|4|||
23581521|NCT02138916|65856980|FG001|Overall Study|Lost to Follow-up|2|||
23581522|NCT02138916|65856981|FG002|Overall Study|Lost to Follow-up|3|||
23581523|NCT02138916|65856979|FG000|Overall Study|Adverse Event|4|||
23581524|NCT02138916|65856980|FG001|Overall Study|Adverse Event|4|||
23581525|NCT02138916|65856981|FG002|Overall Study|Adverse Event|3|||
23581526|NCT01872611|65856984|FG000|Overall Study|Adverse Event|3|||
23581527|NCT01872611|65856985|FG001|Overall Study|Adverse Event|1|||
23581528|NCT01872611|65856984|FG000|Overall Study|Adverse Event, prior to treatment|0|||
23581529|NCT01872611|65856985|FG001|Overall Study|Adverse Event, prior to treatment|1|||
23581530|NCT01872611|65856984|FG000|Overall Study|Death|0|||
23581531|NCT01872611|65856985|FG001|Overall Study|Death|1|||
23581532|NCT01872611|65856984|FG000|Overall Study|Death, prior to treatment|0|||
23581533|NCT01872611|65856985|FG001|Overall Study|Death, prior to treatment|1|||
23235573|NCT01233284|64604763|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23235574|NCT01233284|64604764|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
23235575|NCT01233284|64604760|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23235576|NCT01233284|64604761|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23235577|NCT01233284|64604762|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
23235578|NCT01233284|64604763|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23235579|NCT01233284|64604764|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23235580|NCT01233284|64604760|FG000|Period 3 (4 Weeks)|Other|0|||
23235581|NCT01233284|64604761|FG001|Period 3 (4 Weeks)|Other|0|||
23235582|NCT01233284|64604762|FG002|Period 3 (4 Weeks)|Other|0|||
23235583|NCT01233284|64604763|FG003|Period 3 (4 Weeks)|Other|1|||
23235584|NCT01233284|64604764|FG004|Period 3 (4 Weeks)|Other|0|||
23235585|NCT01233284|64604760|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
23235586|NCT01233284|64604761|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
23235587|NCT01233284|64604762|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
23340533|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340534|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340535|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23581534|NCT01872611|65856984|FG000|Overall Study|Lost to Follow-up|8|||
23581535|NCT01872611|65856985|FG001|Overall Study|Lost to Follow-up|1|||
23581536|NCT01872611|65856984|FG000|Overall Study|Physician Decision|1|||
23581537|NCT01872611|65856985|FG001|Overall Study|Physician Decision|0|||
23581538|NCT01872611|65856984|FG000|Overall Study|Withdrawal by Subject|6|||
23581539|NCT01872611|65856985|FG001|Overall Study|Withdrawal by Subject|1|||
23581540|NCT01872611|65856984|FG000|Overall Study|Reason not provided|6|||
23581541|NCT01872611|65856985|FG001|Overall Study|Reason not provided|6|||
23581542|NCT01876043|65856990|FG000|Overall Study|Death|1|||
23581543|NCT01876043|65856990|FG000|Overall Study|Withdrawal by Subject|1|||
23581544|NCT01656304|65856991|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
23581545|NCT00881335|65858946|FG000|Overall Study|Lost to Follow-up|3|||
23581546|NCT00881335|65858947|FG001|Overall Study|Lost to Follow-up|2|||
23581547|NCT03201757|65858948|FG000|Overall Study|Withdrawal by Subject|133|||
23581548|NCT03201757|65858948|FG000|Overall Study|Adverse Event|44|||
23581549|NCT03201757|65858948|FG000|Overall Study|Lost to Follow-up|37|||
23581550|NCT03201757|65858948|FG000|Overall Study|Pregnancy|2|||
23581551|NCT03201757|65858948|FG000|Overall Study|Lack of Efficacy|1|||
23581552|NCT03201757|65858948|FG000|Overall Study|Protocol Violation|20|||
23581553|NCT03201757|65858948|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
23581554|NCT03201757|65858948|FG000|Overall Study|Not Yet Determined|5|||
23581555|NCT03201757|65858948|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
23581556|NCT03201757|65858948|FG000|Overall Study|Other|20|||
23581557|NCT01240356|65858950|FG000|Overall Study|Withdrawal by Subject|2|||
23581558|NCT01240356|65858951|FG001|Overall Study|Withdrawal by Subject|0|||
23581559|NCT01240356|65858950|FG000|Overall Study|MRI contraindication|1|||
23581560|NCT01240356|65858951|FG001|Overall Study|MRI contraindication|0|||
23581561|NCT02206685|65858952|FG000|Overall Study|Surgery cancelled/changed|2|||
23581562|NCT02206685|65858953|FG001|Overall Study|Surgery cancelled/changed|3|||
23581563|NCT02206685|65858952|FG000|Overall Study|Withdrawal by Subject|1|||
23581564|NCT02206685|65858953|FG001|Overall Study|Withdrawal by Subject|2|||
23581565|NCT02206685|65858952|FG000|Overall Study|Protocol Violation|2|||
23581566|NCT02206685|65858953|FG001|Overall Study|Protocol Violation|2|||
23581567|NCT03771898|65858954|FG000|Overall Study|Adverse Event|1|||
23581568|NCT03771898|65858955|FG001|Overall Study|Adverse Event|0|||
23340536|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340537|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340538|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
23340539|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
23340540|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340541|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
23340542|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
23581569|NCT03771898|65858956|FG002|Overall Study|Adverse Event|0|||
23581570|NCT03771898|65858957|FG003|Overall Study|Adverse Event|0|||
23581571|NCT03771898|65858958|FG004|Overall Study|Adverse Event|0|||
23581572|NCT03771898|65858954|FG000|Overall Study|Lost to Follow-up|1|||
23581573|NCT03771898|65858955|FG001|Overall Study|Lost to Follow-up|1|||
23581574|NCT03771898|65858956|FG002|Overall Study|Lost to Follow-up|1|||
23581575|NCT03771898|65858957|FG003|Overall Study|Lost to Follow-up|0|||
23581576|NCT03771898|65858958|FG004|Overall Study|Lost to Follow-up|0|||
23581577|NCT03771898|65858954|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23235588|NCT01233284|64604763|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
23235589|NCT01233284|64604764|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
23235590|NCT01233284|64604760|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
23235591|NCT01233284|64604761|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
23235592|NCT01233284|64604762|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
23340543|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340544|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340545|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340546|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340547|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340548|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23175014|NCT00896532|64386443|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175015|NCT00896532|64386444|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23340549|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
23340550|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
23340551|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
23581578|NCT03771898|65858955|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23581579|NCT03771898|65858956|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23581580|NCT03771898|65858957|FG003|Overall Study|Withdrawal by parent/guardian|0|||
23581581|NCT03771898|65858958|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23581582|NCT03771898|65858954|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
23581583|NCT03771898|65858955|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
23581584|NCT03771898|65858956|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
23581585|NCT03771898|65858957|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
23581586|NCT03771898|65858958|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
23581587|NCT03905135|65858959|FG000|Dose Escalation|Adverse Event|1|||
23581588|NCT03905135|65858960|FG001|Dose Escalation|Adverse Event|1|||
23581589|NCT03905135|65858959|FG000|Dose Escalation|Progressive disease|3|||
23581590|NCT03905135|65858960|FG001|Dose Escalation|Progressive disease|1|||
23581591|NCT03905135|65858959|FG000|Dose Escalation|Intercurrent illness|1|||
23581592|NCT03905135|65858960|FG001|Dose Escalation|Intercurrent illness|0|||
23581593|NCT03178201|65858974|FG000|Overall Study|Off study|5|||
23581594|NCT02042443|65858975|FG000|Overall Study|Adverse Event|2|||
23581595|NCT02042443|65858976|FG001|Overall Study|Adverse Event|1|||
23581596|NCT02042443|65858975|FG000|Overall Study|Withdrawal by Subject|0|||
23581597|NCT02042443|65858976|FG001|Overall Study|Withdrawal by Subject|1|||
23581598|NCT02042443|65858975|FG000|Overall Study|Progression|21|||
23581599|NCT02042443|65858976|FG001|Overall Study|Progression|17|||
23581600|NCT02042443|65858975|FG000|Overall Study|not protocol specified|1|||
23581601|NCT02042443|65858976|FG001|Overall Study|not protocol specified|1|||
23581602|NCT02042443|65858975|FG000|Overall Study|Not eligible/not analyzable|3|||
23581603|NCT02042443|65858976|FG001|Overall Study|Not eligible/not analyzable|6|||
23581604|NCT04091672|65858978|FG000|Overall Study|Death|6|||
23581605|NCT04091672|65858979|FG001|Overall Study|Death|6|||
23581606|NCT04091672|65858978|FG000|Overall Study|Lost to Follow-up|7|||
23581607|NCT04091672|65858979|FG001|Overall Study|Lost to Follow-up|7|||
23581608|NCT04091672|65858978|FG000|Overall Study|Withdrawal by Subject|3|||
23581609|NCT04091672|65858979|FG001|Overall Study|Withdrawal by Subject|3|||
23581610|NCT04091672|65858978|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
23581611|NCT04091672|65858979|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
23581612|NCT00359619|65858980|FG000|Overall Study|Adverse Event|0|||
23581613|NCT00359619|65858981|FG001|Overall Study|Adverse Event|0|||
23581614|NCT00359619|65858982|FG002|Overall Study|Adverse Event|1|||
23581615|NCT00359619|65858983|FG003|Overall Study|Adverse Event|0|||
23581616|NCT00359619|65858984|FG004|Overall Study|Adverse Event|0|||
23581617|NCT00359619|65858985|FG005|Overall Study|Adverse Event|0|||
23581618|NCT00359619|65858986|FG006|Overall Study|Adverse Event|1|||
23175016|NCT00896532|64386445|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175017|NCT00896532|64386446|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175018|NCT00896532|64386447|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
23175019|NCT00896532|64386425|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175020|NCT00896532|64386426|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175021|NCT00896532|64386427|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
23175022|NCT00896532|64386428|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23581619|NCT00359619|65858980|FG000|Overall Study|Withdrawal by Subject|3|||
23581620|NCT00359619|65858981|FG001|Overall Study|Withdrawal by Subject|1|||
23581621|NCT00359619|65858982|FG002|Overall Study|Withdrawal by Subject|4|||
23581622|NCT00359619|65858983|FG003|Overall Study|Withdrawal by Subject|2|||
23581623|NCT00359619|65858984|FG004|Overall Study|Withdrawal by Subject|2|||
23581624|NCT00359619|65858985|FG005|Overall Study|Withdrawal by Subject|0|||
23581625|NCT00359619|65858986|FG006|Overall Study|Withdrawal by Subject|3|||
23235593|NCT01233284|64604763|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
23235594|NCT01233284|64604764|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
23235595|NCT04298229|64604769|FG000|Overall Study|Physician Decision|1|||
23235596|NCT04298229|64604770|FG001|Overall Study|Physician Decision|1|||
23235597|NCT04298229|64604769|FG000|Overall Study|Withdrawal by Subject|1|||
23235598|NCT04298229|64604770|FG001|Overall Study|Withdrawal by Subject|1|||
23235599|NCT04298229|64604769|FG000|Overall Study|Did not receive IV loop diuretics|2|||
23235600|NCT04298229|64604770|FG001|Overall Study|Did not receive IV loop diuretics|0|||
23235601|NCT00421928|64604777|FG000|Overall Study|Adverse Event|61|||
23235602|NCT00421928|64604778|FG001|Overall Study|Adverse Event|140|||
23235603|NCT00421928|64604779|FG002|Overall Study|Adverse Event|22|||
23235604|NCT00421928|64604777|FG000|Overall Study|Lost to Follow-up|5|||
23235605|NCT00421928|64604778|FG001|Overall Study|Lost to Follow-up|0|||
23235606|NCT00421928|64604779|FG002|Overall Study|Lost to Follow-up|3|||
23235607|NCT00421928|64604777|FG000|Overall Study|Withdrawal by Subject|50|||
23235608|NCT00421928|64604778|FG001|Overall Study|Withdrawal by Subject|48|||
23235609|NCT00421928|64604779|FG002|Overall Study|Withdrawal by Subject|43|||
23235610|NCT00421928|64604777|FG000|Overall Study|Lack of Efficacy|15|||
23235611|NCT00421928|64604778|FG001|Overall Study|Lack of Efficacy|7|||
23235612|NCT00421928|64604779|FG002|Overall Study|Lack of Efficacy|35|||
23235613|NCT00421928|64604777|FG000|Overall Study|Study drug non-compliant|6|||
23235614|NCT00421928|64604778|FG001|Overall Study|Study drug non-compliant|7|||
23235615|NCT00421928|64604779|FG002|Overall Study|Study drug non-compliant|4|||
23235616|NCT00421928|64604777|FG000|Overall Study|All other|26|||
23235617|NCT00421928|64604778|FG001|Overall Study|All other|21|||
23235618|NCT00421928|64604779|FG002|Overall Study|All other|27|||
23235619|NCT00421928|64604777|FG000|Overall Study|Death|0|||
23235620|NCT00421928|64604778|FG001|Overall Study|Death|1|||
23235621|NCT00421928|64604779|FG002|Overall Study|Death|0|||
23235622|NCT02711306|64604780|FG000|Overall Study|Withdrawal by Subject|2|||
23235623|NCT02711306|64604781|FG001|Overall Study|Withdrawal by Subject|2|||
23340552|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
23340553|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
23340554|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340555|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340556|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23235624|NCT00768040|64604783|FG000|Overall Study|Adverse Event|3|||
23235625|NCT00768040|64604784|FG001|Overall Study|Adverse Event|2|||
23235626|NCT00768040|64604783|FG000|Overall Study|Abnormal laboratory value|1|||
23235627|NCT00768040|64604784|FG001|Overall Study|Abnormal laboratory value|1|||
23235628|NCT01004159|64604785|FG000|Overall Study|Adverse Event|2|||
23235629|NCT01004159|64604785|FG000|Overall Study|Disease Progression|18|||
23235630|NCT00972309|64604787|FG000|Overall Study|Switched to alternative treatment|0|||
23235631|NCT00972309|64604788|FG001|Overall Study|Switched to alternative treatment|2|||
23235632|NCT00972309|64604787|FG000|Overall Study|Refused further treatment|0|||
23235633|NCT00972309|64604788|FG001|Overall Study|Refused further treatment|1|||
23235634|NCT00972309|64604787|FG000|Overall Study|Late determination of ineligibility|0|||
23235635|NCT00972309|64604788|FG001|Overall Study|Late determination of ineligibility|1|||
23235636|NCT00972309|64604787|FG000|Overall Study|Second malignancy|1|||
23235637|NCT00972309|64604788|FG001|Overall Study|Second malignancy|1|||
23235638|NCT00972309|64604787|FG000|Overall Study|Visa issues|0|||
23235639|NCT00972309|64604788|FG001|Overall Study|Visa issues|1|||
23235640|NCT00972309|64604787|FG000|Overall Study|Secondary cancer (SCC)|0|||
23235641|NCT00972309|64604788|FG001|Overall Study|Secondary cancer (SCC)|1|||
23235642|NCT00972309|64604787|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
23235643|NCT00972309|64604788|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
23235644|NCT00972309|64604787|FG000|Overall Study|Lost to Follow-up|1|||
23235645|NCT00972309|64604788|FG001|Overall Study|Lost to Follow-up|1|||
23340557|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340558|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340559|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340560|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
23340561|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
23340562|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
23340563|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
23235646|NCT00972309|64604787|FG000|Overall Study|Disease progression on study|10|||
23235647|NCT00972309|64604788|FG001|Overall Study|Disease progression on study|4|||
23235648|NCT00665002|64604789|FG000|Overall Study|Progression/relapse during treatment|11|||
23235649|NCT00665002|64604789|FG000|Overall Study|Cytogenetic resistance|1|||
23235650|NCT04354870|64604792|FG000|Overall Study|Lost to Follow-up|32|||
23235651|NCT04354870|64604793|FG001|Overall Study|Lost to Follow-up|12|||
23235652|NCT04354870|64604792|FG000|Overall Study|Withdrawal by Subject|10|||
23235653|NCT04354870|64604793|FG001|Overall Study|Withdrawal by Subject|16|||
23235654|NCT04354870|64604792|FG000|Overall Study|Did not complete all study visits|6|||
23235655|NCT04354870|64604793|FG001|Overall Study|Did not complete all study visits|5|||
23452504|NCT02831764|65399019|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23452505|NCT02831764|65399020|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23452506|NCT02831764|65399021|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
23452507|NCT02831764|65399022|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
23452508|NCT04842747|65399023|FG000|Overall Study|Withdrawal by Subject|6|||
23452509|NCT04842747|65399024|FG001|Overall Study|Withdrawal by Subject|2|||
23452510|NCT04842747|65399023|FG000|Overall Study|Lost to Follow-up|1|||
23452511|NCT04842747|65399024|FG001|Overall Study|Lost to Follow-up|2|||
23452512|NCT04842747|65399023|FG000|Overall Study|Physician Decision|1|||
23452513|NCT04842747|65399024|FG001|Overall Study|Physician Decision|0|||
23452514|NCT04842747|65399023|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
23452515|NCT04842747|65399024|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
23452516|NCT00475670|65399025|FG000|Overall Study|Death|0|||
23452517|NCT00475670|65399026|FG001|Overall Study|Death|1|||
23452518|NCT00475670|65399025|FG000|Overall Study|Lack of Efficacy|3|||
23452519|NCT00475670|65399026|FG001|Overall Study|Lack of Efficacy|34|||
23452520|NCT00475670|65399025|FG000|Overall Study|Refused treatment|0|||
23452521|NCT00475670|65399026|FG001|Overall Study|Refused treatment|2|||
23452522|NCT00475670|65399025|FG000|Overall Study|Failure to Return|0|||
23452523|NCT00475670|65399026|FG001|Overall Study|Failure to Return|1|||
23452524|NCT00475670|65399025|FG000|Overall Study|Other|0|||
23452525|NCT00475670|65399026|FG001|Overall Study|Other|3|||
23452526|NCT03901144|65399031|FG000|Overall Study|Lost to Follow-up|1|||
23452527|NCT03901144|65399032|FG001|Overall Study|Lost to Follow-up|1|||
23452528|NCT03901144|65399033|FG002|Overall Study|Lost to Follow-up|1|||
23452529|NCT03901144|65399034|FG003|Overall Study|Lost to Follow-up|1|||
23235656|NCT03487549|64604794|FG000|Overall Study|Protocol Violation|0|||
23235657|NCT03487549|64604795|FG001|Overall Study|Protocol Violation|1|||
23235658|NCT03487549|64604794|FG000|Overall Study|Lost to Follow-up|2|||
23452530|NCT03353675|65399037|FG000|Overall Study|Adverse Event|4|||
23452531|NCT02539797|65399039|FG000|Overall Study|Lost to Follow-up|0|||
23452532|NCT02539797|65399040|FG001|Overall Study|Lost to Follow-up|1|||
23452533|NCT02539797|65399041|FG002|Overall Study|Lost to Follow-up|0|||
23452534|NCT00539981|65399044|FG000|Overall Study|Adverse events (AE)|3|||
23452535|NCT00539981|65399045|FG001|Overall Study|Adverse events (AE)|3|||
23452536|NCT00539981|65399044|FG000|Overall Study|Lost to Follow-up|260|||
23452537|NCT00539981|65399045|FG001|Overall Study|Lost to Follow-up|251|||
23452538|NCT00539981|65399044|FG000|Overall Study|Withdrew consent|22|||
23452539|NCT00539981|65399045|FG001|Overall Study|Withdrew consent|14|||
23452540|NCT00539981|65399044|FG000|Overall Study|Death|1|||
23452541|NCT00539981|65399045|FG001|Overall Study|Death|1|||
23452542|NCT00539981|65399044|FG000|Overall Study|Other reason-unspecified|9|||
23452543|NCT00539981|65399045|FG001|Overall Study|Other reason-unspecified|13|||
23452544|NCT01277744|65399046|FG000|Overall Study|Physician Decision|2|||
23452545|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
23452546|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
23452547|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
23452548|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
23452549|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
23452550|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
23452551|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
23452552|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
23452553|NCT02960217|65399050|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
23452554|NCT02960217|65399051|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
23452555|NCT02960217|65399050|FG000|Open-Label Extension Phase|Adverse Event|1|||
23452556|NCT02960217|65399051|FG001|Open-Label Extension Phase|Adverse Event|0|||
23452557|NCT02960217|65399050|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
23452558|NCT02960217|65399051|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
23452559|NCT02960217|65399050|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
23452560|NCT02960217|65399051|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
23581626|NCT00359619|65858980|FG000|Overall Study|Other|1|||
23581627|NCT00359619|65858981|FG001|Overall Study|Other|0|||
23235659|NCT03487549|64604795|FG001|Overall Study|Lost to Follow-up|1|||
23581628|NCT00359619|65858982|FG002|Overall Study|Other|0|||
23581629|NCT00359619|65858983|FG003|Overall Study|Other|0|||
23452561|NCT02960217|65399050|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
23452562|NCT02960217|65399051|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
23452563|NCT02178995|65399052|FG000|Double Blind|Adverse Event|0|||
23452564|NCT02178995|65399053|FG001|Double Blind|Adverse Event|0|||
23452565|NCT02178995|65399054|FG002|Double Blind|Adverse Event|0|||
23452566|NCT02178995|65399055|FG003|Double Blind|Adverse Event|0|||
23452567|NCT02178995|65399056|FG004|Double Blind|Adverse Event|0|||
23452568|NCT02178995|65399057|FG005|Double Blind|Adverse Event|1|||
23452569|NCT02178995|65399058|FG006|Double Blind|Adverse Event|0|||
23452570|NCT02178995|65399059|FG007|Double Blind|Adverse Event|1|||
23452571|NCT02178995|65399060|FG008|Double Blind|Adverse Event|1|||
23452572|NCT02178995|65399052|FG000|Double Blind|Lost to Follow-up|0|||
23452573|NCT02178995|65399053|FG001|Double Blind|Lost to Follow-up|1|||
23452574|NCT02178995|65399054|FG002|Double Blind|Lost to Follow-up|0|||
23452575|NCT02178995|65399055|FG003|Double Blind|Lost to Follow-up|0|||
23452576|NCT02178995|65399056|FG004|Double Blind|Lost to Follow-up|0|||
23452577|NCT02178995|65399057|FG005|Double Blind|Lost to Follow-up|0|||
23452578|NCT02178995|65399058|FG006|Double Blind|Lost to Follow-up|0|||
23452579|NCT02178995|65399059|FG007|Double Blind|Lost to Follow-up|1|||
23452580|NCT02178995|65399060|FG008|Double Blind|Lost to Follow-up|0|||
23452581|NCT02178995|65399052|FG000|Open Label|Adverse Event|2|||
23452582|NCT02178995|65399053|FG001|Open Label|Adverse Event|0|||
23452583|NCT02178995|65399054|FG002|Open Label|Adverse Event|0|||
23452584|NCT02178995|65399055|FG003|Open Label|Adverse Event|0|||
23452585|NCT02178995|65399056|FG004|Open Label|Adverse Event|0|||
23452586|NCT02178995|65399057|FG005|Open Label|Adverse Event|0|||
23452587|NCT02178995|65399058|FG006|Open Label|Adverse Event|0|||
23452588|NCT02178995|65399059|FG007|Open Label|Adverse Event|0|||
23452589|NCT02178995|65399060|FG008|Open Label|Adverse Event|0|||
23452590|NCT02721875|65399062|FG000|Overall Study|Progressive disease/relapse|1|||
23452591|NCT02721875|65399063|FG001|Overall Study|Progressive disease/relapse|0|||
23452592|NCT05470387|65399073|FG000|Overall Study|Protocol Violation|0|||
23452593|NCT05470387|65399074|FG001|Overall Study|Protocol Violation|3|||
23452594|NCT00362648|65399080|FG000|Overall Study|Adverse Event|12|||
23452595|NCT00362648|65399081|FG001|Overall Study|Adverse Event|21|||
23452596|NCT00362648|65399082|FG002|Overall Study|Adverse Event|1|||
23452597|NCT00362648|65399083|FG003|Overall Study|Adverse Event|0|||
23452598|NCT00362648|65399080|FG000|Overall Study|Lost to Follow-up|62|||
23452599|NCT00362648|65399081|FG001|Overall Study|Lost to Follow-up|69|||
23452600|NCT00362648|65399082|FG002|Overall Study|Lost to Follow-up|4|||
23452601|NCT00362648|65399083|FG003|Overall Study|Lost to Follow-up|3|||
23452602|NCT00362648|65399080|FG000|Overall Study|Protocol Violation|4|||
23452603|NCT00362648|65399081|FG001|Overall Study|Protocol Violation|2|||
23452604|NCT00362648|65399082|FG002|Overall Study|Protocol Violation|2|||
23452605|NCT00362648|65399083|FG003|Overall Study|Protocol Violation|2|||
23452606|NCT00362648|65399080|FG000|Overall Study|Withdrawal by Subject|48|||
23452607|NCT00362648|65399081|FG001|Overall Study|Withdrawal by Subject|42|||
23452608|NCT00362648|65399082|FG002|Overall Study|Withdrawal by Subject|2|||
23452609|NCT00362648|65399083|FG003|Overall Study|Withdrawal by Subject|6|||
23452610|NCT00449696|65399084|FG000|Overall Study|Other Treatment Required|6|||
23452611|NCT00449696|65399085|FG001|Overall Study|Other Treatment Required|1|||
23452612|NCT00449696|65399084|FG000|Overall Study|Withdrawal by Subject|5|||
23452613|NCT00449696|65399085|FG001|Overall Study|Withdrawal by Subject|5|||
23452614|NCT00449696|65399084|FG000|Overall Study|Lost to Follow-up|2|||
23452615|NCT00449696|65399085|FG001|Overall Study|Lost to Follow-up|3|||
23452616|NCT00449696|65399084|FG000|Overall Study|Others|7|||
23452617|NCT00449696|65399085|FG001|Overall Study|Others|0|||
23452618|NCT00988598|65399086|FG000|Overall Study|Withdrawal by Subject|2|||
23452619|NCT00988598|65399087|FG001|Overall Study|Withdrawal by Subject|0|||
23452620|NCT01132807|65399088|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
23452621|NCT01132807|65399089|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
23452622|NCT01132807|65399090|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
23452623|NCT01132807|65399088|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
23452624|NCT01132807|65399089|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
23452625|NCT01132807|65399090|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
23452626|NCT02813889|65399091|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
23235660|NCT03487549|64604794|FG000|Overall Study|Withdrawal by Subject|2|||
23235661|NCT03487549|64604795|FG001|Overall Study|Withdrawal by Subject|0|||
23235662|NCT02198040|64604796|FG000|Overall Study|Work reasons|0|||
23235663|NCT02198040|64604797|FG001|Overall Study|Work reasons|1|||
23235664|NCT02198040|64604798|FG002|Overall Study|Work reasons|0|||
23452627|NCT02813889|65399092|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
23452628|NCT04583280|65399093|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
23452629|NCT04583280|65399094|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
23452630|NCT01389882|65399095|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
23452631|NCT01389882|65399096|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
23452632|NCT01389882|65399095|FG000|Overall Study|Withdrawal by Subject|0|||
23452633|NCT01389882|65399096|FG001|Overall Study|Withdrawal by Subject|1|||
23452634|NCT00990106|65399097|FG000|Overall Study|"too busy to continue"|1|||
23452635|NCT00990106|65399098|FG001|Overall Study|"too busy to continue"|2|||
23452636|NCT00990106|65399097|FG000|Overall Study|Lost to Follow-up|1|||
23452637|NCT00990106|65399098|FG001|Overall Study|Lost to Follow-up|3|||
23235665|NCT02198040|64604796|FG000|Overall Study|Withdrawal by Subject|0|||
23235666|NCT02198040|64604797|FG001|Overall Study|Withdrawal by Subject|0|||
23235667|NCT02198040|64604798|FG002|Overall Study|Withdrawal by Subject|1|||
23235668|NCT02612129|64604799|FG000|Single Dose Treatment Period|Screening Failure|1|||
23235669|NCT02612129|64604800|FG001|Single Dose Treatment Period|Screening Failure|0|||
23235670|NCT02612129|64604801|FG002|Single Dose Treatment Period|Screening Failure|0|||
23235671|NCT02612129|64604799|FG000|Continuous Treatment Period|Early Escape|0|||
23235672|NCT02612129|64604800|FG001|Continuous Treatment Period|Early Escape|2|||
23340564|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
23581630|NCT00359619|65858984|FG004|Overall Study|Other|0|||
23581631|NCT00359619|65858985|FG005|Overall Study|Other|0|||
23340565|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340566|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340567|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340568|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340569|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340570|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340571|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
23340572|NCT04791319|64992818|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340573|NCT04791319|64992819|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340574|NCT04791319|64992820|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340575|NCT04791319|64992821|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
23340576|NCT04791319|64992822|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340577|NCT04791319|64992823|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340578|NCT04791319|64992824|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340579|NCT04791319|64992825|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340580|NCT04791319|64992826|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340581|NCT04791319|64992827|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340582|NCT04791319|64992828|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
23340583|NCT04791319|64992818|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340584|NCT04791319|64992819|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340585|NCT04791319|64992820|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340586|NCT04791319|64992821|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340587|NCT04791319|64992822|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
23340588|NCT04791319|64992823|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
23340589|NCT04791319|64992824|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
23340590|NCT04791319|64992825|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340591|NCT04791319|64992826|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340592|NCT04791319|64992827|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
23340593|NCT04791319|64992828|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
23340594|NCT04791319|64992818|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340595|NCT04791319|64992819|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340596|NCT04791319|64992820|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340597|NCT04791319|64992821|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340598|NCT04791319|64992822|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340599|NCT04791319|64992823|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340600|NCT04791319|64992824|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340601|NCT04791319|64992825|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340602|NCT04791319|64992826|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340603|NCT04791319|64992827|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
23340604|NCT04791319|64992828|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
23340605|NCT04791319|64992818|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340606|NCT04791319|64992819|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340607|NCT04791319|64992820|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340608|NCT04791319|64992821|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340609|NCT04791319|64992822|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
23340610|NCT04791319|64992823|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
23340611|NCT04791319|64992824|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
23340612|NCT04791319|64992825|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
23340613|NCT04791319|64992826|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
23581632|NCT00359619|65858986|FG006|Overall Study|Other|0|||
23235673|NCT02612129|64604801|FG002|Continuous Treatment Period|Early Escape|0|||
23340614|NCT04791319|64992827|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
23340615|NCT04791319|64992828|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
23340616|NCT04791319|64992818|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
23340617|NCT04791319|64992819|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
23340618|NCT04791319|64992820|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
23340619|NCT04791319|64992821|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
23235674|NCT02612129|64604799|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
23235675|NCT02612129|64604800|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
23235676|NCT02612129|64604801|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
23235677|NCT02612129|64604799|FG000|Continuous Treatment Period|Safety Reasons|0|||
23235678|NCT02612129|64604800|FG001|Continuous Treatment Period|Safety Reasons|3|||
23235679|NCT02612129|64604801|FG002|Continuous Treatment Period|Safety Reasons|0|||
23235680|NCT02612129|64604799|FG000|Continuous Treatment Period|Death|0|||
23235681|NCT02612129|64604800|FG001|Continuous Treatment Period|Death|1|||
23235682|NCT02612129|64604801|FG002|Continuous Treatment Period|Death|0|||
23235683|NCT02612129|64604799|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
23235684|NCT02612129|64604800|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
23235685|NCT02612129|64604801|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
23235686|NCT03044730|64604802|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
23235687|NCT03044730|64604802|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
23235688|NCT03044730|64604802|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
23235689|NCT03044730|64604802|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
23235690|NCT03044730|64604802|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
23235691|NCT03044730|64604802|FG000|Cycles 4 and Beyond|Adverse Event|1|||
23235692|NCT03044730|64604802|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
23235693|NCT03044730|64604802|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
23235694|NCT03044730|64604802|FG000|On Follow-up for 2 Years|Death|17|||
23235695|NCT02033369|64604808|FG000|Overall Study|Physician Decision|1|||
23235696|NCT02033369|64604809|FG001|Overall Study|Physician Decision|2|||
23235697|NCT02033369|64604808|FG000|Overall Study|Not a good demographic match|0|||
23235698|NCT02033369|64604809|FG001|Overall Study|Not a good demographic match|2|||
23235699|NCT02033369|64604808|FG000|Overall Study|Withdrawal by Subject|1|||
23235700|NCT02033369|64604809|FG001|Overall Study|Withdrawal by Subject|1|||
23235701|NCT02033369|64604808|FG000|Overall Study|Lost to Follow-up|1|||
23235702|NCT02033369|64604809|FG001|Overall Study|Lost to Follow-up|0|||
23235703|NCT02033369|64604808|FG000|Overall Study|Protocol Violation|2|||
23235704|NCT02033369|64604809|FG001|Overall Study|Protocol Violation|0|||
23235705|NCT01083121|64604810|FG000|Overall Study|Use of Humira outside the approved label|81|||
23581633|NCT00359619|65858980|FG000|Overall Study|Lost to Follow-up|4|||
23581634|NCT00359619|65858981|FG001|Overall Study|Lost to Follow-up|4|||
23340620|NCT04791319|64992822|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
23340621|NCT04791319|64992823|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
23340622|NCT04791319|64992824|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
23340623|NCT04791319|64992825|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
23340624|NCT04791319|64992826|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
23340625|NCT04791319|64992827|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
23340626|NCT04791319|64992828|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
23340627|NCT04064411|64992830|FG000|Overall Study|Adverse Event|29|||
23340628|NCT04064411|64992831|FG001|Overall Study|Adverse Event|19|||
23340629|NCT04064411|64992830|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
23340630|NCT04064411|64992831|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
23340631|NCT04064411|64992830|FG000|Overall Study|Protocol Deviation|0|||
23340632|NCT04064411|64992831|FG001|Overall Study|Protocol Deviation|2|||
23340633|NCT04064411|64992830|FG000|Overall Study|Withdrawal by Subject|25|||
23340634|NCT04064411|64992831|FG001|Overall Study|Withdrawal by Subject|29|||
23340635|NCT04064411|64992830|FG000|Overall Study|Lost to Follow-up|5|||
23452638|NCT00990106|65399097|FG000|Overall Study|Withdrawal by Subject|2|||
23452639|NCT00990106|65399098|FG001|Overall Study|Withdrawal by Subject|1|||
23452640|NCT00990106|65399097|FG000|Overall Study|opted for open label prazosin|1|||
23581635|NCT00359619|65858982|FG002|Overall Study|Lost to Follow-up|2|||
23235706|NCT02924129|64604811|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
23581636|NCT00359619|65858983|FG003|Overall Study|Lost to Follow-up|1|||
23581637|NCT00359619|65858984|FG004|Overall Study|Lost to Follow-up|1|||
23581638|NCT00359619|65858985|FG005|Overall Study|Lost to Follow-up|5|||
23581639|NCT00359619|65858986|FG006|Overall Study|Lost to Follow-up|0|||
23581640|NCT00603447|65859000|FG000|Overall Study|Adverse Event|0|||
23235707|NCT02924129|64604812|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
23235708|NCT02924129|64604811|FG000|Overall Study|Withdrawal by Subject|2|||
23235709|NCT02924129|64604812|FG001|Overall Study|Withdrawal by Subject|2|||
23235710|NCT02924129|64604811|FG000|Overall Study|Physician Decision|1|||
23235711|NCT02924129|64604812|FG001|Overall Study|Physician Decision|0|||
23235712|NCT02924129|64604811|FG000|Overall Study|Missed Visit|0|||
23235713|NCT02924129|64604812|FG001|Overall Study|Missed Visit|1|||
23235714|NCT00386152|64604817|FG000|Overall Study|Adverse Event|6|||
23235715|NCT00386152|64604818|FG001|Overall Study|Adverse Event|5|||
23235716|NCT00386152|64604819|FG002|Overall Study|Adverse Event|4|||
23235717|NCT00386152|64604817|FG000|Overall Study|Chang from original chemo stratification|4|||
23235718|NCT00386152|64604818|FG001|Overall Study|Chang from original chemo stratification|5|||
23235719|NCT00386152|64604819|FG002|Overall Study|Chang from original chemo stratification|6|||
23235720|NCT00386152|64604817|FG000|Overall Study|Death|3|||
23235721|NCT00386152|64604818|FG001|Overall Study|Death|0|||
23235722|NCT00386152|64604819|FG002|Overall Study|Death|1|||
23235723|NCT00386152|64604817|FG000|Overall Study|Disease progression|7|||
23235724|NCT00386152|64604818|FG001|Overall Study|Disease progression|4|||
23235725|NCT00386152|64604819|FG002|Overall Study|Disease progression|5|||
23235726|NCT00386152|64604817|FG000|Overall Study|Physician Decision|13|||
23235727|NCT00386152|64604818|FG001|Overall Study|Physician Decision|10|||
23235728|NCT00386152|64604819|FG002|Overall Study|Physician Decision|4|||
23235729|NCT00386152|64604817|FG000|Overall Study|Lost to Follow-up|1|||
23235730|NCT00386152|64604818|FG001|Overall Study|Lost to Follow-up|0|||
23235731|NCT00386152|64604819|FG002|Overall Study|Lost to Follow-up|0|||
23235732|NCT00386152|64604817|FG000|Overall Study|Completed chemotherapy|4|||
23235733|NCT00386152|64604818|FG001|Overall Study|Completed chemotherapy|5|||
23235734|NCT00386152|64604819|FG002|Overall Study|Completed chemotherapy|1|||
23235735|NCT00386152|64604817|FG000|Overall Study|Protocol Violation|3|||
23235736|NCT00386152|64604818|FG001|Overall Study|Protocol Violation|5|||
23235737|NCT00386152|64604819|FG002|Overall Study|Protocol Violation|2|||
23235738|NCT00386152|64604817|FG000|Overall Study|Withdrawal by Subject|3|||
23235739|NCT00386152|64604818|FG001|Overall Study|Withdrawal by Subject|6|||
23235740|NCT00386152|64604819|FG002|Overall Study|Withdrawal by Subject|10|||
23581641|NCT00603447|65859001|FG001|Overall Study|Adverse Event|1|||
23581642|NCT00603447|65859002|FG002|Overall Study|Adverse Event|1|||
23581643|NCT00603447|65859003|FG003|Overall Study|Adverse Event|2|||
23581644|NCT00603447|65859004|FG004|Overall Study|Adverse Event|1|||
23235741|NCT00003389|64604820|FG000|Overall Study|Disease progression|6|||
23235742|NCT00003389|64604821|FG001|Overall Study|Disease progression|1|||
23235743|NCT00003389|64604820|FG000|Overall Study|Adverse Event|13|||
23235744|NCT00003389|64604821|FG001|Overall Study|Adverse Event|2|||
23235745|NCT00003389|64604820|FG000|Overall Study|Death|0|||
23235746|NCT00003389|64604821|FG001|Overall Study|Death|3|||
23235747|NCT00003389|64604820|FG000|Overall Study|Withdrawal by Subject|12|||
23235748|NCT00003389|64604821|FG001|Overall Study|Withdrawal by Subject|5|||
23235749|NCT00003389|64604820|FG000|Overall Study|Alternative therapy|2|||
23235750|NCT00003389|64604821|FG001|Overall Study|Alternative therapy|1|||
23235751|NCT00003389|64604820|FG000|Overall Study|Complicating disease|1|||
23235752|NCT00003389|64604821|FG001|Overall Study|Complicating disease|0|||
23581645|NCT00603447|65859005|FG005|Overall Study|Adverse Event|2|||
23581646|NCT00603447|65859006|FG006|Overall Study|Adverse Event|10|||
23581647|NCT00603447|65859000|FG000|Overall Study|Other|0|||
23581648|NCT00603447|65859001|FG001|Overall Study|Other|0|||
23581649|NCT00603447|65859002|FG002|Overall Study|Other|1|||
23581650|NCT00603447|65859003|FG003|Overall Study|Other|0|||
23581651|NCT00603447|65859004|FG004|Overall Study|Other|3|||
23581652|NCT00603447|65859005|FG005|Overall Study|Other|0|||
23581653|NCT00603447|65859006|FG006|Overall Study|Other|13|||
23581654|NCT00603447|65859000|FG000|Overall Study|Withdrew Consent|0|||
23581655|NCT00603447|65859001|FG001|Overall Study|Withdrew Consent|2|||
23581656|NCT00603447|65859002|FG002|Overall Study|Withdrew Consent|0|||
23581657|NCT00603447|65859003|FG003|Overall Study|Withdrew Consent|0|||
23581658|NCT00603447|65859004|FG004|Overall Study|Withdrew Consent|1|||
23581659|NCT00603447|65859005|FG005|Overall Study|Withdrew Consent|0|||
23581660|NCT00603447|65859006|FG006|Overall Study|Withdrew Consent|1|||
23581661|NCT00052962|65859010|FG000|Overall Study|Not evaluable|0|||
23235753|NCT00003389|64604820|FG000|Overall Study|Off-treatment reason missing|31|||
23235754|NCT00003389|64604821|FG001|Overall Study|Off-treatment reason missing|21|||
23581662|NCT00052962|65859011|FG001|Overall Study|Not evaluable|2|||
23235755|NCT00003389|64604820|FG000|Overall Study|Ineligible|33|||
23235756|NCT00003389|64604821|FG001|Overall Study|Ineligible|27|||
23235757|NCT02275052|64604822|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23235758|NCT02275052|64604823|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23235759|NCT02275052|64604824|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23581663|NCT00052962|65859010|FG000|Overall Study|Not randomized/not evaluable|1|||
23581664|NCT00052962|65859011|FG001|Overall Study|Not randomized/not evaluable|0|||
23581665|NCT00072475|65859014|FG000|Overall Study|Adverse Event|44|||
23581666|NCT00072475|65859014|FG000|Overall Study|Death|3|||
23235760|NCT02275052|64604825|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23235761|NCT02275052|64604822|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
23235762|NCT02275052|64604823|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
23235763|NCT02275052|64604824|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
23235764|NCT02275052|64604825|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
23235765|NCT02275052|64604822|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
23235766|NCT02275052|64604823|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
23235767|NCT02275052|64604824|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23235768|NCT02275052|64604825|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23235769|NCT02275052|64604822|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
23235770|NCT02275052|64604823|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
23340636|NCT04064411|64992831|FG001|Overall Study|Lost to Follow-up|2|||
23340637|NCT04064411|64992830|FG000|Overall Study|Other than Specified|4|||
23340638|NCT04064411|64992831|FG001|Overall Study|Other than Specified|1|||
23340639|NCT04064411|64992830|FG000|Overall Study|Death|1|||
23340640|NCT04064411|64992831|FG001|Overall Study|Death|0|||
23340641|NCT02345889|64992832|FG000|Overall Study|Inadequate Bowel Prep|17|||
23340642|NCT02345889|64992833|FG001|Overall Study|Inadequate Bowel Prep|16|||
23340643|NCT02345889|64992834|FG002|Overall Study|Inadequate Bowel Prep|18|||
23340644|NCT02345889|64992835|FG003|Overall Study|Inadequate Bowel Prep|14|||
23340645|NCT02345889|64992832|FG000|Overall Study|Polyposis identified during procedure|1|||
23340646|NCT02345889|64992833|FG001|Overall Study|Polyposis identified during procedure|1|||
23340647|NCT02345889|64992834|FG002|Overall Study|Polyposis identified during procedure|0|||
23340648|NCT02345889|64992835|FG003|Overall Study|Polyposis identified during procedure|1|||
23235771|NCT02275052|64604824|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
23235772|NCT02275052|64604825|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
23235773|NCT02275052|64604822|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
23235774|NCT02275052|64604823|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
23235775|NCT02275052|64604824|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
23235776|NCT02275052|64604825|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
23235777|NCT02275052|64604822|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
23235778|NCT02275052|64604823|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
23235779|NCT02275052|64604824|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
23235780|NCT02275052|64604825|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
23235781|NCT02275052|64604822|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
23235782|NCT02275052|64604823|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
23235783|NCT02275052|64604824|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
23235784|NCT02275052|64604825|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
23235785|NCT02275052|64604822|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23235786|NCT02275052|64604823|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23235787|NCT02275052|64604824|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
23235788|NCT02275052|64604825|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
23235789|NCT02275052|64604822|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23235790|NCT02275052|64604823|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23235791|NCT02275052|64604824|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23235792|NCT02275052|64604825|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
23340649|NCT02345889|64992832|FG000|Overall Study|Recognized ineligible post-randomization|1|||
23340650|NCT02345889|64992833|FG001|Overall Study|Recognized ineligible post-randomization|0|||
23340651|NCT02345889|64992834|FG002|Overall Study|Recognized ineligible post-randomization|2|||
23340652|NCT02345889|64992835|FG003|Overall Study|Recognized ineligible post-randomization|1|||
23452641|NCT00990106|65399098|FG001|Overall Study|opted for open label prazosin|1|||
23452642|NCT00990106|65399097|FG000|Overall Study|relocation/deployment|4|||
23235793|NCT02275052|64604822|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
23235794|NCT02275052|64604823|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
23235795|NCT02275052|64604824|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
23235796|NCT02275052|64604825|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
23235797|NCT02275052|64604822|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23235798|NCT02275052|64604823|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23235799|NCT02275052|64604824|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23235800|NCT02275052|64604825|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
23452643|NCT00990106|65399098|FG001|Overall Study|relocation/deployment|1|||
23235801|NCT01370499|64604826|FG000|Overall Study|Adverse Event|38|||
23235802|NCT01370499|64604827|FG001|Overall Study|Adverse Event|12|||
23235803|NCT01370499|64604826|FG000|Overall Study|Lack of Efficacy|4|||
23235804|NCT01370499|64604827|FG001|Overall Study|Lack of Efficacy|2|||
23235805|NCT01370499|64604826|FG000|Overall Study|Lost to Follow-up|2|||
23235806|NCT01370499|64604827|FG001|Overall Study|Lost to Follow-up|1|||
23235807|NCT01370499|64604826|FG000|Overall Study|Physician Decision|3|||
23235808|NCT01370499|64604827|FG001|Overall Study|Physician Decision|3|||
23235809|NCT01370499|64604826|FG000|Overall Study|Protocol Violation|5|||
23235810|NCT01370499|64604827|FG001|Overall Study|Protocol Violation|4|||
23235811|NCT01370499|64604826|FG000|Overall Study|Withdrawal by Subject|18|||
23235812|NCT01370499|64604827|FG001|Overall Study|Withdrawal by Subject|7|||
23235813|NCT01370499|64604826|FG000|Overall Study|Sponsor Decision|41|||
23581667|NCT00072475|65859014|FG000|Overall Study|Withdrawal by Subject|46|||
23581668|NCT00072475|65859014|FG000|Overall Study|Patient/Investigator Decision|4|||
23581669|NCT00550732|65859015|FG000|Overall Study|Death|4|||
23581670|NCT00550732|65859015|FG000|Overall Study|Withdrawal by Subject|2|||
23581671|NCT00550732|65859015|FG000|Overall Study|Physician Decision|2|||
23581672|NCT00550732|65859015|FG000|Overall Study|Lost to Follow-up|1|||
23581673|NCT00550732|65859015|FG000|Overall Study|Palliative care|1|||
23581674|NCT00550732|65859015|FG000|Overall Study|Adverse Event|1|||
23581675|NCT01939158|65859020|FG000|Overall Study|Adverse Event|1|||
23581676|NCT01939158|65859021|FG001|Overall Study|Adverse Event|0|||
23581677|NCT01939158|65859022|FG002|Overall Study|Adverse Event|0|||
23581678|NCT01939158|65859023|FG003|Overall Study|Adverse Event|0|||
23581679|NCT01939158|65859020|FG000|Overall Study|Withdrawal by Subject|22|||
23581680|NCT01939158|65859021|FG001|Overall Study|Withdrawal by Subject|25|||
23581681|NCT01939158|65859022|FG002|Overall Study|Withdrawal by Subject|15|||
23581682|NCT01939158|65859023|FG003|Overall Study|Withdrawal by Subject|17|||
23581683|NCT01939158|65859020|FG000|Overall Study|Migrated/moved from study area|5|||
23581684|NCT01939158|65859021|FG001|Overall Study|Migrated/moved from study area|7|||
23581685|NCT01939158|65859022|FG002|Overall Study|Migrated/moved from study area|3|||
23581686|NCT01939158|65859023|FG003|Overall Study|Migrated/moved from study area|6|||
23581687|NCT01939158|65859020|FG000|Overall Study|Lost to Follow-up|18|||
23581688|NCT01939158|65859021|FG001|Overall Study|Lost to Follow-up|17|||
23581689|NCT01939158|65859022|FG002|Overall Study|Lost to Follow-up|17|||
23581690|NCT01939158|65859023|FG003|Overall Study|Lost to Follow-up|17|||
23235814|NCT01370499|64604827|FG001|Overall Study|Sponsor Decision|15|||
23235815|NCT02584660|64604828|FG000|Overall Study|Adverse Event|4|||
23235816|NCT02584660|64604829|FG001|Overall Study|Adverse Event|0|||
23235817|NCT02584660|64604828|FG000|Overall Study|Lost to Follow-up|3|||
23235818|NCT02584660|64604829|FG001|Overall Study|Lost to Follow-up|4|||
23235819|NCT02584660|64604828|FG000|Overall Study|Protocol Violation|0|||
23235820|NCT02584660|64604829|FG001|Overall Study|Protocol Violation|1|||
23235821|NCT02584660|64604828|FG000|Overall Study|Withdrawal by Subject|0|||
23235822|NCT02584660|64604829|FG001|Overall Study|Withdrawal by Subject|2|||
23235823|NCT02584660|64604828|FG000|Overall Study|Other|0|||
23452644|NCT00990106|65399097|FG000|Overall Study|started exclusionary medication|0|||
23235824|NCT02584660|64604829|FG001|Overall Study|Other|1|||
23452645|NCT00990106|65399098|FG001|Overall Study|started exclusionary medication|1|||
23581691|NCT01939158|65859020|FG000|Overall Study|Death|0|||
23235825|NCT01130831|64604830|FG000|Overall Study|Withdrawal by Subject|7|||
23235826|NCT01130831|64604830|FG000|Overall Study|Death|4|||
23235827|NCT01130831|64604830|FG000|Overall Study|Information was missing|3|||
23235828|NCT04034225|64604834|FG000|Overall Study|Death|3|||
23235829|NCT04034225|64604834|FG000|Overall Study|Withdrawal by Subject|2|||
23235830|NCT04034225|64604834|FG000|Overall Study|Study termination by Sponsor|18|||
23581692|NCT01939158|65859021|FG001|Overall Study|Death|0|||
23581693|NCT01939158|65859022|FG002|Overall Study|Death|1|||
23581694|NCT01939158|65859023|FG003|Overall Study|Death|1|||
23581695|NCT01939158|65859020|FG000|Overall Study|No longer meets eligibility criteria|0|||
23340653|NCT02345889|64992832|FG000|Overall Study|Ulcerative Colitis identified|1|||
23340654|NCT02345889|64992833|FG001|Overall Study|Ulcerative Colitis identified|0|||
23340655|NCT02345889|64992834|FG002|Overall Study|Ulcerative Colitis identified|0|||
23340656|NCT02345889|64992835|FG003|Overall Study|Ulcerative Colitis identified|0|||
23340657|NCT02345889|64992832|FG000|Overall Study|Cecum not intubated|1|||
23340658|NCT02345889|64992833|FG001|Overall Study|Cecum not intubated|0|||
23340659|NCT02345889|64992834|FG002|Overall Study|Cecum not intubated|0|||
23340660|NCT02345889|64992835|FG003|Overall Study|Cecum not intubated|0|||
23340661|NCT02419612|64992836|FG000|Short-term Treatment Period|Adverse Event|1|||
23235831|NCT04034225|64604834|FG000|Overall Study|Physician Decision|1|||
23235832|NCT04034225|64604834|FG000|Overall Study|Lack of Efficacy|1|||
23235833|NCT01365182|64604835|FG000|Overall Study|Withdrawal by Subject|10|||
23340662|NCT02419612|64992837|FG001|Short-term Treatment Period|Adverse Event|1|||
23340663|NCT02419612|64992836|FG000|Short-term Treatment Period|Death|0|||
23340664|NCT02419612|64992837|FG001|Short-term Treatment Period|Death|2|||
23340665|NCT02419612|64992836|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
23340666|NCT02419612|64992837|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
23340667|NCT02419612|64992836|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
23340668|NCT02419612|64992837|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
23340669|NCT02419612|64992836|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
23340670|NCT02419612|64992837|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
23340671|NCT02419612|64992836|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
23340672|NCT02419612|64992837|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
23340673|NCT02419612|64992836|FG000|Short-term Treatment Period|Worsening of liver function|0|||
23340674|NCT02419612|64992837|FG001|Short-term Treatment Period|Worsening of liver function|1|||
23340675|NCT02419612|64992836|FG000|Short-term Treatment Period|Subject moved out of state|0|||
23340676|NCT02419612|64992837|FG001|Short-term Treatment Period|Subject moved out of state|1|||
23340677|NCT02419612|64992836|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
23340678|NCT02419612|64992837|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
23340679|NCT02419612|64992836|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
23340680|NCT02419612|64992837|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
23340681|NCT02419612|64992836|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
23340682|NCT02419612|64992837|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
23340683|NCT02419612|64992836|FG000|Long-term Treatment Period|Death|0|||
23340684|NCT02419612|64992837|FG001|Long-term Treatment Period|Death|1|||
23340685|NCT02419612|64992836|FG000|Long-term Treatment Period|Adverse Event|0|||
23340686|NCT02419612|64992837|FG001|Long-term Treatment Period|Adverse Event|5|||
23175023|NCT00896532|64386429|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175024|NCT00896532|64386430|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175025|NCT00896532|64386431|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175026|NCT00896532|64386432|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175027|NCT00896532|64386433|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175028|NCT00896532|64386434|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175029|NCT00896532|64386435|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175030|NCT00896532|64386436|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175031|NCT00896532|64386437|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175032|NCT00896532|64386438|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175033|NCT00896532|64386439|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175034|NCT00896532|64386440|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175035|NCT00896532|64386441|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175036|NCT00896532|64386442|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175037|NCT00896532|64386443|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175038|NCT00896532|64386444|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175039|NCT00896532|64386445|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175040|NCT00896532|64386446|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175041|NCT00896532|64386447|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
23175042|NCT00896532|64386425|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175043|NCT00896532|64386426|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175044|NCT00896532|64386427|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
23175045|NCT00896532|64386428|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175046|NCT00896532|64386429|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175047|NCT00896532|64386430|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175048|NCT00896532|64386431|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175049|NCT00896532|64386432|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175050|NCT00896532|64386433|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23235834|NCT01365182|64604836|FG001|Overall Study|Withdrawal by Subject|13|||
23340687|NCT02419612|64992836|FG000|Long-term Treatment Period|Other|4|||
23340688|NCT02419612|64992837|FG001|Long-term Treatment Period|Other|4|||
23452646|NCT00990106|65399097|FG000|Overall Study|planned major surgery|0|||
23452647|NCT00990106|65399098|FG001|Overall Study|planned major surgery|1|||
23452648|NCT00990106|65399097|FG000|Overall Study|scheduling conflicts|0|||
23452649|NCT00990106|65399098|FG001|Overall Study|scheduling conflicts|2|||
23452650|NCT02735239|65399099|FG000|Overall Study|Adverse Event|0|||
23452651|NCT02735239|65399100|FG001|Overall Study|Adverse Event|0|||
23452652|NCT02735239|65399101|FG002|Overall Study|Adverse Event|4|||
23452653|NCT02735239|65399102|FG003|Overall Study|Adverse Event|0|||
23175051|NCT00896532|64386434|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175052|NCT00896532|64386435|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175053|NCT00896532|64386436|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23235835|NCT01365182|64604837|FG002|Overall Study|Withdrawal by Subject|12|||
23235836|NCT00701064|64604838|FG000|Overall Study|Protocol Violation|1|||
23235837|NCT00701064|64604839|FG001|Overall Study|Protocol Violation|1|||
23235838|NCT00701064|64604838|FG000|Overall Study|Withdrawal by Subject|1|||
23235839|NCT00701064|64604839|FG001|Overall Study|Withdrawal by Subject|1|||
23235840|NCT00701064|64604838|FG000|Overall Study|initiated other PTSD treatment|2|||
23235841|NCT00701064|64604839|FG001|Overall Study|initiated other PTSD treatment|2|||
23235842|NCT03384316|64604842|FG000|Overall Study|Screen failure|0|||
23235843|NCT03384316|64604843|FG001|Overall Study|Screen failure|1|||
23581696|NCT01939158|65859021|FG001|Overall Study|No longer meets eligibility criteria|0|||
23581697|NCT01939158|65859022|FG002|Overall Study|No longer meets eligibility criteria|1|||
23235844|NCT01078389|64604844|FG000|Overall Study|Adverse Event|10|||
23235845|NCT01078389|64604845|FG001|Overall Study|Adverse Event|6|||
23235846|NCT01078389|64604844|FG000|Overall Study|Major Protocol Deviation|2|||
23235847|NCT01078389|64604845|FG001|Overall Study|Major Protocol Deviation|0|||
23235848|NCT01078389|64604844|FG000|Overall Study|Lost to Follow-up|23|||
23235849|NCT01078389|64604845|FG001|Overall Study|Lost to Follow-up|23|||
23452654|NCT02735239|65399103|FG004|Overall Study|Adverse Event|0|||
23452655|NCT02735239|65399104|FG005|Overall Study|Adverse Event|0|||
23452656|NCT02735239|65399099|FG000|Overall Study|Death|1|||
23452657|NCT02735239|65399100|FG001|Overall Study|Death|1|||
23452658|NCT02735239|65399101|FG002|Overall Study|Death|0|||
23452659|NCT02735239|65399102|FG003|Overall Study|Death|0|||
23452660|NCT02735239|65399103|FG004|Overall Study|Death|0|||
23452661|NCT02735239|65399104|FG005|Overall Study|Death|0|||
23452662|NCT02735239|65399099|FG000|Overall Study|Physician Decision|0|||
23452663|NCT02735239|65399100|FG001|Overall Study|Physician Decision|0|||
23452664|NCT02735239|65399101|FG002|Overall Study|Physician Decision|1|||
23452665|NCT02735239|65399102|FG003|Overall Study|Physician Decision|0|||
23452666|NCT02735239|65399103|FG004|Overall Study|Physician Decision|0|||
23452667|NCT02735239|65399104|FG005|Overall Study|Physician Decision|0|||
23452668|NCT02735239|65399099|FG000|Overall Study|Progressive disease|3|||
23175054|NCT00896532|64386437|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175055|NCT00896532|64386438|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23452669|NCT02735239|65399100|FG001|Overall Study|Progressive disease|1|||
23581698|NCT01939158|65859023|FG003|Overall Study|No longer meets eligibility criteria|0|||
23581699|NCT01939158|65859020|FG000|Overall Study|Other|1|||
23581700|NCT01939158|65859021|FG001|Overall Study|Other|3|||
23581701|NCT01939158|65859022|FG002|Overall Study|Other|4|||
23581702|NCT01939158|65859023|FG003|Overall Study|Other|3|||
23581703|NCT00058058|65859025|FG000|Overall Study|Withdrawal by Subject|4|||
23175056|NCT00896532|64386439|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175057|NCT00896532|64386440|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175058|NCT00896532|64386441|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175059|NCT00896532|64386442|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175060|NCT00896532|64386443|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175061|NCT00896532|64386444|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23235850|NCT01078389|64604844|FG000|Overall Study|Voluntary Withdrawal|20|||
23175062|NCT00896532|64386445|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175063|NCT00896532|64386446|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23235851|NCT01078389|64604845|FG001|Overall Study|Voluntary Withdrawal|36|||
23235852|NCT01078389|64604844|FG000|Overall Study|Other|9|||
23452670|NCT02735239|65399101|FG002|Overall Study|Progressive disease|3|||
23452671|NCT02735239|65399102|FG003|Overall Study|Progressive disease|0|||
23452672|NCT02735239|65399103|FG004|Overall Study|Progressive disease|0|||
23452673|NCT02735239|65399104|FG005|Overall Study|Progressive disease|2|||
23581704|NCT00058058|65859025|FG000|Overall Study|Ineligible|20|||
23452674|NCT02735239|65399099|FG000|Overall Study|Withdrawal by Subject|0|||
23452675|NCT02735239|65399100|FG001|Overall Study|Withdrawal by Subject|1|||
23452676|NCT02735239|65399101|FG002|Overall Study|Withdrawal by Subject|0|||
23581705|NCT00058058|65859025|FG000|Overall Study|Claustrophobic|5|||
23452677|NCT02735239|65399102|FG003|Overall Study|Withdrawal by Subject|0|||
23452678|NCT02735239|65399103|FG004|Overall Study|Withdrawal by Subject|0|||
23452679|NCT02735239|65399104|FG005|Overall Study|Withdrawal by Subject|0|||
23452680|NCT01476722|65399107|FG000|Overall Study|Adverse Event|1|||
23452681|NCT00097500|65399109|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
23452682|NCT00097500|65399110|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
23452683|NCT00097500|65399109|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
23452684|NCT00097500|65399110|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
23452685|NCT00097500|65399109|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
23452686|NCT00097500|65399110|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
23452687|NCT00097500|65399109|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23452688|NCT00097500|65399110|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
23452689|NCT00097500|65399109|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
23452690|NCT00097500|65399110|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
23452691|NCT00097500|65399109|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
23235853|NCT01078389|64604845|FG001|Overall Study|Other|2|||
23235854|NCT02576951|64608017|FG000|Overall Study|Lost to Follow-up|0|||
23235855|NCT02576951|64608018|FG001|Overall Study|Lost to Follow-up|0|||
23452692|NCT00097500|65399110|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
23452693|NCT00097500|65399109|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
23452694|NCT00097500|65399110|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
23452695|NCT00321789|65399112|FG000|Overall Study|Lost to Follow-up|4|||
23452696|NCT00321789|65399113|FG001|Overall Study|Lost to Follow-up|7|||
23452697|NCT00321789|65399112|FG000|Overall Study|Withdrawal by Subject|6|||
23452698|NCT00321789|65399113|FG001|Overall Study|Withdrawal by Subject|6|||
23452699|NCT00321789|65399112|FG000|Overall Study|Protocol Violation|5|||
23452700|NCT00321789|65399113|FG001|Overall Study|Protocol Violation|3|||
23452701|NCT03557970|65399114|FG000|Overall Study|Study closure|1|||
23452702|NCT03557970|65399115|FG001|Overall Study|Study closure|0|||
23452703|NCT03557970|65399114|FG000|Overall Study|Physician Decision|0|||
23452704|NCT03557970|65399115|FG001|Overall Study|Physician Decision|1|||
23452705|NCT03557970|65399114|FG000|Overall Study|Death|0|||
23452706|NCT03557970|65399115|FG001|Overall Study|Death|1|||
23452707|NCT01020786|65399116|FG000|Induction Period|Entry Criteria Not Met|2|||
23452708|NCT01020786|65399116|FG000|Induction Period|Adverse Event|10|||
23452709|NCT01020786|65399116|FG000|Induction Period|Progressive Disease|31|||
23452710|NCT01020786|65399116|FG000|Induction Period|Investigator Decision|3|||
23452711|NCT01020786|65399116|FG000|Induction Period|Withdrawal by Subject|3|||
23452712|NCT01020786|65399116|FG000|Maintenance Period|Adverse Event|8|||
23452713|NCT01020786|65399116|FG000|Maintenance Period|Progressive Disease|43|||
23452714|NCT01020786|65399116|FG000|Maintenance Period|Withdrawal by Subject|8|||
23452715|NCT01020786|65399116|FG000|Maintenance Period|Sponsor Decision|1|||
23452716|NCT02159066|65399117|FG000|Part I|Adverse Event|7|||
23452717|NCT02159066|65399118|FG001|Part I|Adverse Event|5|||
23452718|NCT02159066|65399119|FG002|Part I|Adverse Event|0|||
23452719|NCT02159066|65399120|FG003|Part I|Adverse Event|0|||
23452720|NCT02159066|65399121|FG004|Part I|Adverse Event|0|||
23452721|NCT02159066|65399122|FG005|Part I|Adverse Event|0|||
23452722|NCT02159066|65399117|FG000|Part I|Death|11|||
23452723|NCT02159066|65399118|FG001|Part I|Death|9|||
23452724|NCT02159066|65399119|FG002|Part I|Death|0|||
23452725|NCT02159066|65399120|FG003|Part I|Death|0|||
23452726|NCT02159066|65399121|FG004|Part I|Death|0|||
23452727|NCT02159066|65399122|FG005|Part I|Death|0|||
23452728|NCT02159066|65399117|FG000|Part I|Progressive Disease|37|||
23452729|NCT02159066|65399118|FG001|Part I|Progressive Disease|46|||
23235856|NCT02576951|64608019|FG002|Overall Study|Lost to Follow-up|2|||
23452730|NCT02159066|65399119|FG002|Part I|Progressive Disease|0|||
23452731|NCT02159066|65399120|FG003|Part I|Progressive Disease|0|||
23452732|NCT02159066|65399121|FG004|Part I|Progressive Disease|0|||
23452733|NCT02159066|65399122|FG005|Part I|Progressive Disease|0|||
23452734|NCT02159066|65399117|FG000|Part I|New Therapy for Study Indication|5|||
23452735|NCT02159066|65399118|FG001|Part I|New Therapy for Study Indication|4|||
23452736|NCT02159066|65399119|FG002|Part I|New Therapy for Study Indication|0|||
23452737|NCT02159066|65399120|FG003|Part I|New Therapy for Study Indication|0|||
23235857|NCT02576951|64608020|FG003|Overall Study|Lost to Follow-up|2|||
23340689|NCT02419612|64992836|FG000|Long-term Treatment Period|Subject Decision|2|||
23235858|NCT02576951|64608017|FG000|Overall Study|Withdrawal by Subject|1|||
23452738|NCT02159066|65399121|FG004|Part I|New Therapy for Study Indication|0|||
23452739|NCT02159066|65399122|FG005|Part I|New Therapy for Study Indication|0|||
23452740|NCT02159066|65399117|FG000|Part I|Termination of participants from the study|3|||
23452741|NCT02159066|65399118|FG001|Part I|Termination of participants from the study|3|||
23452742|NCT02159066|65399119|FG002|Part I|Termination of participants from the study|0|||
23452743|NCT02159066|65399120|FG003|Part I|Termination of participants from the study|0|||
23452744|NCT02159066|65399121|FG004|Part I|Termination of participants from the study|0|||
23452745|NCT02159066|65399122|FG005|Part I|Termination of participants from the study|0|||
23452746|NCT02159066|65399117|FG000|Part I|Physician Decision|2|||
23452747|NCT02159066|65399118|FG001|Part I|Physician Decision|9|||
23452748|NCT02159066|65399119|FG002|Part I|Physician Decision|0|||
23452749|NCT02159066|65399120|FG003|Part I|Physician Decision|0|||
23452750|NCT02159066|65399121|FG004|Part I|Physician Decision|0|||
23452751|NCT02159066|65399122|FG005|Part I|Physician Decision|0|||
23452752|NCT02159066|65399117|FG000|Part I|Participant/Guardian Decision|9|||
23452753|NCT02159066|65399118|FG001|Part I|Participant/Guardian Decision|3|||
23452754|NCT02159066|65399119|FG002|Part I|Participant/Guardian Decision|0|||
23452755|NCT02159066|65399120|FG003|Part I|Participant/Guardian Decision|0|||
23452756|NCT02159066|65399121|FG004|Part I|Participant/Guardian Decision|0|||
23452757|NCT02159066|65399122|FG005|Part I|Participant/Guardian Decision|0|||
23452758|NCT02159066|65399117|FG000|Part I|Missing Data|1|||
23452759|NCT02159066|65399118|FG001|Part I|Missing Data|0|||
23452760|NCT02159066|65399119|FG002|Part I|Missing Data|0|||
23452761|NCT02159066|65399120|FG003|Part I|Missing Data|0|||
23452762|NCT02159066|65399121|FG004|Part I|Missing Data|0|||
23452763|NCT02159066|65399122|FG005|Part I|Missing Data|0|||
23452764|NCT02159066|65399117|FG000|Part II|Adverse Event|0|||
23452765|NCT02159066|65399118|FG001|Part II|Adverse Event|0|||
23452766|NCT02159066|65399119|FG002|Part II|Adverse Event|1|||
23452767|NCT02159066|65399120|FG003|Part II|Adverse Event|0|||
23452768|NCT02159066|65399121|FG004|Part II|Adverse Event|1|||
23452769|NCT02159066|65399122|FG005|Part II|Adverse Event|1|||
23452770|NCT02159066|65399117|FG000|Part II|Death|0|||
23452771|NCT02159066|65399118|FG001|Part II|Death|0|||
23452772|NCT02159066|65399119|FG002|Part II|Death|1|||
23452773|NCT02159066|65399120|FG003|Part II|Death|0|||
23452774|NCT02159066|65399121|FG004|Part II|Death|2|||
23452775|NCT02159066|65399122|FG005|Part II|Death|1|||
23452776|NCT02159066|65399117|FG000|Part II|Progressive Disease|0|||
23452777|NCT02159066|65399118|FG001|Part II|Progressive Disease|0|||
23452778|NCT02159066|65399119|FG002|Part II|Progressive Disease|35|||
23452779|NCT02159066|65399120|FG003|Part II|Progressive Disease|1|||
23452780|NCT02159066|65399121|FG004|Part II|Progressive Disease|7|||
23452781|NCT02159066|65399122|FG005|Part II|Progressive Disease|4|||
23452782|NCT02159066|65399117|FG000|Part II|New Therapy for Study Indication|0|||
23452783|NCT02159066|65399118|FG001|Part II|New Therapy for Study Indication|0|||
23452784|NCT02159066|65399119|FG002|Part II|New Therapy for Study Indication|0|||
23452785|NCT02159066|65399120|FG003|Part II|New Therapy for Study Indication|0|||
23581706|NCT00058058|65859025|FG000|Overall Study|technical issues|6|||
23235859|NCT02576951|64608018|FG001|Overall Study|Withdrawal by Subject|0|||
23235860|NCT02576951|64608019|FG002|Overall Study|Withdrawal by Subject|0|||
23581707|NCT00058058|65859025|FG000|Overall Study|Poor positioning, illness,pain|3|||
23581708|NCT01008748|65859026|FG000|Overall Study|Lost to Follow-up|80|||
23581709|NCT01008748|65859026|FG000|Overall Study|Other|1|||
23581710|NCT02317705|65859027|FG000|Overall Study|Withdrawal by Subject|3|||
23581711|NCT02317705|65859027|FG000|Overall Study|Physician Decision|1|||
23581712|NCT02317705|65859027|FG000|Overall Study|Drug not usable|1|||
23581713|NCT02256969|65859028|FG000|Overall Study|Screenfailed or withdrew|2|||
23581714|NCT02256969|65859029|FG001|Overall Study|Screenfailed or withdrew|1|||
23581715|NCT02256969|65859030|FG002|Overall Study|Screenfailed or withdrew|1|||
23581716|NCT00093795|65859036|FG000|Overall Study|No follow up data|20|||
23581717|NCT00093795|65859037|FG001|Overall Study|No follow up data|16|||
23581718|NCT00093795|65859038|FG002|Overall Study|No follow up data|17|||
23581719|NCT00477412|65859039|FG000|Overall Study|Death|0|||
23581720|NCT00477412|65859040|FG001|Overall Study|Death|0|||
23235861|NCT02576951|64608020|FG003|Overall Study|Withdrawal by Subject|2|||
23235862|NCT02576951|64608017|FG000|Overall Study|Protocol Violation|0|||
23452786|NCT02159066|65399121|FG004|Part II|New Therapy for Study Indication|1|||
23452787|NCT02159066|65399122|FG005|Part II|New Therapy for Study Indication|0|||
23452788|NCT02159066|65399117|FG000|Part II|Physician Decision|0|||
23452789|NCT02159066|65399118|FG001|Part II|Physician Decision|0|||
23452790|NCT02159066|65399119|FG002|Part II|Physician Decision|1|||
23452791|NCT02159066|65399120|FG003|Part II|Physician Decision|0|||
23452792|NCT02159066|65399121|FG004|Part II|Physician Decision|0|||
23452793|NCT02159066|65399122|FG005|Part II|Physician Decision|0|||
23452794|NCT02159066|65399117|FG000|Part II|Participant/Guardian Decision|0|||
23452795|NCT02159066|65399118|FG001|Part II|Participant/Guardian Decision|0|||
23452796|NCT02159066|65399119|FG002|Part II|Participant/Guardian Decision|0|||
23452797|NCT02159066|65399120|FG003|Part II|Participant/Guardian Decision|0|||
23581721|NCT00477412|65859041|FG002|Overall Study|Death|0|||
23452798|NCT02159066|65399121|FG004|Part II|Participant/Guardian Decision|2|||
23452799|NCT02159066|65399122|FG005|Part II|Participant/Guardian Decision|0|||
23452800|NCT02123134|65399125|FG000|Overall Study|Withdrawal of consent|3|||
23452801|NCT02123134|65399126|FG001|Overall Study|Withdrawal of consent|2|||
23452802|NCT02123134|65399125|FG000|Overall Study|Administrative decision|0|||
23452803|NCT02123134|65399126|FG001|Overall Study|Administrative decision|1|||
23452804|NCT02914639|65399127|FG000|Overall Study|Withdrawal by Subject|0|||
23452805|NCT02914639|65399128|FG001|Overall Study|Withdrawal by Subject|2|||
23452806|NCT00101686|65399131|FG000|Overall Study|Progressive Disease|37|||
23452807|NCT00101686|65399132|FG001|Overall Study|Progressive Disease|28|||
23452808|NCT00101686|65399133|FG002|Overall Study|Progressive Disease|37|||
23452809|NCT00101686|65399134|FG003|Overall Study|Progressive Disease|38|||
23452810|NCT00101686|65399135|FG004|Overall Study|Progressive Disease|28|||
23452811|NCT00101686|65399136|FG005|Overall Study|Progressive Disease|25|||
23452812|NCT00101686|65399137|FG006|Overall Study|Progressive Disease|5|||
23452813|NCT00101686|65399138|FG007|Overall Study|Progressive Disease|7|||
23452814|NCT00101686|65399139|FG008|Overall Study|Progressive Disease|10|||
23452815|NCT00101686|65399140|FG009|Overall Study|Progressive Disease|8|||
23452816|NCT00101686|65399131|FG000|Overall Study|initiation other anti-cancer treatment|4|||
23452817|NCT00101686|65399132|FG001|Overall Study|initiation other anti-cancer treatment|3|||
23452818|NCT00101686|65399133|FG002|Overall Study|initiation other anti-cancer treatment|4|||
23452819|NCT00101686|65399134|FG003|Overall Study|initiation other anti-cancer treatment|3|||
23235863|NCT02576951|64608018|FG001|Overall Study|Protocol Violation|0|||
23235864|NCT02576951|64608019|FG002|Overall Study|Protocol Violation|0|||
23235865|NCT02576951|64608020|FG003|Overall Study|Protocol Violation|1|||
23235866|NCT00174460|64608021|FG000|Overall Study|Withdrawal by Subject|0|||
23235867|NCT00174460|64608022|FG001|Overall Study|Withdrawal by Subject|1|||
23235868|NCT01453439|64608023|FG000|Treatment Phase|Withdrawal by Subject|13|||
23235869|NCT01453439|64608024|FG001|Treatment Phase|Withdrawal by Subject|10|||
23235870|NCT01453439|64608023|FG000|Treatment Phase|Suicidal Ideation|2|||
23235871|NCT01453439|64608024|FG001|Treatment Phase|Suicidal Ideation|0|||
23235872|NCT01453439|64608023|FG000|Treatment Phase|Need for higher level of care|1|||
23235873|NCT01453439|64608024|FG001|Treatment Phase|Need for higher level of care|1|||
23235874|NCT01453439|64608023|FG000|Treatment Phase|Therapist conflict of interest|1|||
23235875|NCT01453439|64608024|FG001|Treatment Phase|Therapist conflict of interest|0|||
23235876|NCT01453439|64608023|FG000|Follow-up|Withdrawal by Subject|0|||
23235877|NCT01453439|64608024|FG001|Follow-up|Withdrawal by Subject|1|||
23235878|NCT01453439|64608023|FG000|Follow-up|Lost to Follow-up|5|||
23235879|NCT01453439|64608024|FG001|Follow-up|Lost to Follow-up|10|||
23235880|NCT00877929|64608025|FG000|Overall Study|Adverse Event|11|||
23235881|NCT00877929|64608026|FG001|Overall Study|Adverse Event|20|||
23235882|NCT00877929|64608025|FG000|Overall Study|Protocol Violation|3|||
23235883|NCT00877929|64608026|FG001|Overall Study|Protocol Violation|3|||
23235884|NCT00877929|64608025|FG000|Overall Study|Lost to Follow-up|0|||
23235885|NCT00877929|64608026|FG001|Overall Study|Lost to Follow-up|1|||
23235886|NCT00877929|64608025|FG000|Overall Study|Withdrawal by Subject|4|||
23235887|NCT00877929|64608026|FG001|Overall Study|Withdrawal by Subject|4|||
23235888|NCT00877929|64608025|FG000|Overall Study|Lack of Efficacy|0|||
23340690|NCT02419612|64992837|FG001|Long-term Treatment Period|Subject Decision|4|||
23340691|NCT02419612|64992836|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
23235889|NCT00877929|64608026|FG001|Overall Study|Lack of Efficacy|1|||
23235890|NCT00877929|64608025|FG000|Overall Study|Other reason (not specified)|2|||
23235891|NCT00877929|64608026|FG001|Overall Study|Other reason (not specified)|6|||
23235892|NCT01605370|64608027|FG000|Overall Study|Adverse Event|1|||
23235893|NCT01605370|64608028|FG001|Overall Study|Adverse Event|0|||
23235894|NCT00848965|64608029|FG000|Overall Study|Adverse Event|1|||
23235895|NCT00848965|64608029|FG000|Overall Study|Withdrawal by Subject|1|||
23235896|NCT03868059|64608030|FG000|Overall Study|Adverse Event|3|||
23452820|NCT00101686|65399135|FG004|Overall Study|initiation other anti-cancer treatment|1|||
23452821|NCT00101686|65399136|FG005|Overall Study|initiation other anti-cancer treatment|1|||
23452822|NCT00101686|65399137|FG006|Overall Study|initiation other anti-cancer treatment|2|||
23452823|NCT00101686|65399138|FG007|Overall Study|initiation other anti-cancer treatment|2|||
23235897|NCT03868059|64608030|FG000|Overall Study|Lost to Follow-up|3|||
23235898|NCT03868059|64608030|FG000|Overall Study|Withdrawal by Subject|6|||
23235899|NCT01038609|64608031|FG000|Overall Study|Adverse Event|0|||
23235900|NCT01038609|64608032|FG001|Overall Study|Adverse Event|0|||
23235901|NCT01038609|64608033|FG002|Overall Study|Adverse Event|1|||
23235902|NCT01038609|64608034|FG003|Overall Study|Adverse Event|0|||
23235903|NCT01038609|64608035|FG004|Overall Study|Adverse Event|0|||
23235904|NCT01038609|64608031|FG000|Overall Study|Dosing Error|0|||
23235905|NCT01038609|64608032|FG001|Overall Study|Dosing Error|0|||
23235906|NCT01038609|64608033|FG002|Overall Study|Dosing Error|0|||
23235907|NCT01038609|64608034|FG003|Overall Study|Dosing Error|1|||
23235908|NCT01038609|64608035|FG004|Overall Study|Dosing Error|1|||
23235909|NCT01038609|64608031|FG000|Overall Study|Death in the Family|1|||
23235910|NCT01038609|64608032|FG001|Overall Study|Death in the Family|0|||
23235911|NCT01038609|64608033|FG002|Overall Study|Death in the Family|0|||
23235912|NCT01038609|64608034|FG003|Overall Study|Death in the Family|0|||
23340692|NCT02419612|64992837|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
23235913|NCT01038609|64608035|FG004|Overall Study|Death in the Family|0|||
23235914|NCT01038609|64608031|FG000|Overall Study|Refusal of Blood Draws|0|||
23235915|NCT01038609|64608032|FG001|Overall Study|Refusal of Blood Draws|1|||
23235916|NCT01038609|64608033|FG002|Overall Study|Refusal of Blood Draws|0|||
23235917|NCT01038609|64608034|FG003|Overall Study|Refusal of Blood Draws|0|||
23340693|NCT02256982|64992838|FG000|Overall Study|Disease Progression|0|||
23340694|NCT02256982|64992839|FG001|Overall Study|Disease Progression|1|||
23175064|NCT00896532|64386447|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
23175065|NCT00896532|64386425|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175066|NCT00896532|64386426|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175067|NCT00896532|64386427|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175068|NCT00896532|64386428|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
23175069|NCT00896532|64386429|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175070|NCT00896532|64386430|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23235918|NCT01038609|64608035|FG004|Overall Study|Refusal of Blood Draws|0|||
23340695|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
23340696|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
23340697|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
23340698|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
23452824|NCT00101686|65399139|FG008|Overall Study|initiation other anti-cancer treatment|3|||
23452825|NCT00101686|65399140|FG009|Overall Study|initiation other anti-cancer treatment|3|||
23452826|NCT00101686|65399131|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
23235919|NCT00166504|64608037|FG000|Overall Study|Adverse Event|3|||
23235920|NCT00166504|64608038|FG001|Overall Study|Adverse Event|3|||
23235921|NCT00166504|64608037|FG000|Overall Study|Lost to Follow-up|1|||
23235922|NCT00166504|64608038|FG001|Overall Study|Lost to Follow-up|1|||
23235923|NCT00166504|64608037|FG000|Overall Study|Withdrawal by Subject|1|||
23235924|NCT00166504|64608038|FG001|Overall Study|Withdrawal by Subject|0|||
23340699|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Death|0|||
23235925|NCT01569568|64608039|FG000|Overall Study|Physician Decision|0|||
23235926|NCT01569568|64608040|FG001|Overall Study|Physician Decision|2|||
23235927|NCT02577107|64608043|FG000|Overall Study|Protocol deviation|0|||
23235928|NCT02577107|64608044|FG001|Overall Study|Protocol deviation|1|||
23235929|NCT01230827|64608045|FG000|Overall Study|Lost to Follow-up|0|||
23235930|NCT01230827|64608046|FG001|Overall Study|Lost to Follow-up|0|||
23235931|NCT01230827|64608047|FG002|Overall Study|Lost to Follow-up|1|||
23340700|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Death|0|||
23340701|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Death|1|||
23235932|NCT01230827|64608048|FG003|Overall Study|Lost to Follow-up|3|||
23235933|NCT01230827|64608045|FG000|Overall Study|Withdrawal by Subject|1|||
23235934|NCT01230827|64608046|FG001|Overall Study|Withdrawal by Subject|0|||
23235935|NCT01230827|64608047|FG002|Overall Study|Withdrawal by Subject|3|||
23235936|NCT01230827|64608048|FG003|Overall Study|Withdrawal by Subject|2|||
23235937|NCT01230827|64608045|FG000|Overall Study|Lack of Efficacy|14|||
23235938|NCT01230827|64608046|FG001|Overall Study|Lack of Efficacy|1|||
23235939|NCT01230827|64608047|FG002|Overall Study|Lack of Efficacy|2|||
23235940|NCT01230827|64608048|FG003|Overall Study|Lack of Efficacy|3|||
23235941|NCT01230827|64608045|FG000|Overall Study|Adverse Event|4|||
23235942|NCT01230827|64608046|FG001|Overall Study|Adverse Event|2|||
23235943|NCT01230827|64608047|FG002|Overall Study|Adverse Event|3|||
23235944|NCT01230827|64608048|FG003|Overall Study|Adverse Event|7|||
23235945|NCT01230827|64608045|FG000|Overall Study|Recovery|0|||
23235946|NCT01230827|64608046|FG001|Overall Study|Recovery|6|||
23235947|NCT01230827|64608047|FG002|Overall Study|Recovery|0|||
23235948|NCT01230827|64608048|FG003|Overall Study|Recovery|0|||
23235949|NCT01230827|64608045|FG000|Overall Study|Study terminated by Sponsor|0|||
23235950|NCT01230827|64608046|FG001|Overall Study|Study terminated by Sponsor|2|||
23235951|NCT01230827|64608047|FG002|Overall Study|Study terminated by Sponsor|56|||
23235952|NCT01230827|64608048|FG003|Overall Study|Study terminated by Sponsor|63|||
23235953|NCT01482598|64608049|FG000|Overall Study|Death|7|||
23235954|NCT01482598|64608050|FG001|Overall Study|Death|10|||
23235955|NCT01482598|64608049|FG000|Overall Study|Physician Decision|0|||
23235956|NCT01482598|64608050|FG001|Overall Study|Physician Decision|3|||
23175071|NCT00896532|64386431|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175072|NCT00896532|64386432|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175073|NCT00896532|64386433|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175074|NCT00896532|64386434|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175075|NCT00896532|64386435|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175076|NCT00896532|64386436|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175077|NCT00896532|64386437|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175078|NCT00896532|64386438|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175079|NCT00896532|64386439|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175080|NCT00896532|64386440|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175081|NCT00896532|64386441|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175082|NCT00896532|64386442|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175083|NCT00896532|64386443|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175084|NCT00896532|64386444|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175085|NCT00896532|64386445|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175086|NCT00896532|64386446|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23175087|NCT00896532|64386447|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
23235957|NCT01482598|64608049|FG000|Overall Study|Withdrawal by Subject|4|||
23235958|NCT01482598|64608050|FG001|Overall Study|Withdrawal by Subject|5|||
23235959|NCT01482598|64608049|FG000|Overall Study|Lost to Follow-up|5|||
23235960|NCT01482598|64608050|FG001|Overall Study|Lost to Follow-up|4|||
23235961|NCT02506101|64608054|FG000|Overall Study|Transportation issues|1|||
23235962|NCT02506101|64608055|FG001|Overall Study|Transportation issues|0|||
23452827|NCT00101686|65399132|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
23581722|NCT00477412|65859042|FG003|Overall Study|Death|4|||
23175088|NCT00896532|64386425|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175089|NCT00896532|64386426|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
23175090|NCT00896532|64386427|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175091|NCT00896532|64386428|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
23175092|NCT00896532|64386429|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
23175093|NCT00896532|64386430|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175094|NCT00896532|64386431|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175095|NCT00896532|64386432|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175096|NCT00896532|64386433|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175097|NCT00896532|64386434|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175098|NCT00896532|64386435|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175099|NCT00896532|64386436|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23235963|NCT02506101|64608054|FG000|Overall Study|No enrollment and staff unavailability|1|||
23235964|NCT02506101|64608055|FG001|Overall Study|No enrollment and staff unavailability|0|||
23235965|NCT00953576|64608057|FG000|Overall Study|Adverse Event|0|||
23235966|NCT00953576|64608058|FG001|Overall Study|Adverse Event|1|||
23235967|NCT00953576|64608057|FG000|Overall Study|Ineligible after Consent|2|||
23235968|NCT00953576|64608058|FG001|Overall Study|Ineligible after Consent|0|||
23235969|NCT00475657|64608061|FG000|Overall Study|Death|1|||
23235970|NCT00475657|64608061|FG000|Overall Study|Sponsor's Decision|3|||
23235971|NCT03691831|64608062|FG000|Overall Study|Lost to Follow-up|16|||
23581723|NCT00477412|65859039|FG000|Overall Study|Lost to Follow-up|0|||
23581724|NCT00477412|65859040|FG001|Overall Study|Lost to Follow-up|0|||
23581725|NCT00477412|65859041|FG002|Overall Study|Lost to Follow-up|0|||
23581726|NCT00477412|65859042|FG003|Overall Study|Lost to Follow-up|1|||
23581727|NCT00477412|65859039|FG000|Overall Study|Withdrawal by Subject|0|||
23581728|NCT00477412|65859040|FG001|Overall Study|Withdrawal by Subject|0|||
23581729|NCT00477412|65859041|FG002|Overall Study|Withdrawal by Subject|0|||
23581730|NCT00477412|65859042|FG003|Overall Study|Withdrawal by Subject|2|||
23581731|NCT00477412|65859039|FG000|Overall Study|Second Malignancy|0|||
23581732|NCT00477412|65859040|FG001|Overall Study|Second Malignancy|0|||
23581733|NCT00477412|65859041|FG002|Overall Study|Second Malignancy|0|||
23581734|NCT00477412|65859042|FG003|Overall Study|Second Malignancy|1|||
23581735|NCT00477412|65859039|FG000|Overall Study|Adverse Event|1|||
23581736|NCT00477412|65859040|FG001|Overall Study|Adverse Event|0|||
23581737|NCT00477412|65859041|FG002|Overall Study|Adverse Event|1|||
23581738|NCT00477412|65859042|FG003|Overall Study|Adverse Event|0|||
23581739|NCT01311648|65859048|FG000|Main Study|Protocol Violation|0|||
23581740|NCT01311648|65859049|FG001|Main Study|Protocol Violation|1|||
23235972|NCT03691831|64608063|FG001|Overall Study|Lost to Follow-up|12|||
23235973|NCT03691831|64608062|FG000|Overall Study|Withdrawal by Subject|9|||
23235974|NCT03691831|64608063|FG001|Overall Study|Withdrawal by Subject|17|||
23235975|NCT03691831|64608062|FG000|Overall Study|Investigator Decision|2|||
23235976|NCT03691831|64608063|FG001|Overall Study|Investigator Decision|2|||
23235977|NCT04409262|64608071|FG000|Overall Study|Adverse Event|0|||
23235978|NCT04409262|64608072|FG001|Overall Study|Adverse Event|2|||
23235979|NCT04409262|64608071|FG000|Overall Study|Death|55|||
23235980|NCT04409262|64608072|FG001|Overall Study|Death|97|||
23235981|NCT04409262|64608071|FG000|Overall Study|Lost to Follow-up|12|||
23235982|NCT04409262|64608072|FG001|Overall Study|Lost to Follow-up|23|||
23581741|NCT01311648|65859048|FG000|Main Study|Adverse Event|0|||
23581742|NCT01311648|65859049|FG001|Main Study|Adverse Event|1|||
23581743|NCT01311648|65859048|FG000|Main Study|Inhibitor management|0|||
23581744|NCT01311648|65859049|FG001|Main Study|Inhibitor management|17|||
23581745|NCT01311648|65859048|FG000|Main Study|Withdrawal by Subject|0|||
23581746|NCT01311648|65859049|FG001|Main Study|Withdrawal by Subject|2|||
23581747|NCT01311648|65859048|FG000|Extension Study|Physician Decision|0|||
23581748|NCT01311648|65859049|FG001|Extension Study|Physician Decision|1|||
23581749|NCT01311648|65859048|FG000|Extension Study|ITI therapy with marketed product|0|||
23581750|NCT01311648|65859049|FG001|Extension Study|ITI therapy with marketed product|1|||
23581751|NCT01311648|65859048|FG000|Extension Study|Incorrect visit planning|0|||
23175100|NCT00896532|64386437|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175101|NCT00896532|64386438|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175102|NCT00896532|64386439|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23235983|NCT04409262|64608071|FG000|Overall Study|Lack of Staff|0|||
23235984|NCT04409262|64608072|FG001|Overall Study|Lack of Staff|1|||
23581752|NCT01311648|65859049|FG001|Extension Study|Incorrect visit planning|1|||
23581753|NCT01311648|65859048|FG000|Extension Study|Family's decision|0|||
23581754|NCT01311648|65859049|FG001|Extension Study|Family's decision|1|||
23235985|NCT04409262|64608071|FG000|Overall Study|Protocol Violation|3|||
23581755|NCT01311648|65859048|FG000|Extension Study|Failure of ITI therapy|0|||
23581756|NCT01311648|65859049|FG001|Extension Study|Failure of ITI therapy|3|||
23235986|NCT04409262|64608072|FG001|Overall Study|Protocol Violation|1|||
23235987|NCT04409262|64608071|FG000|Overall Study|Withdrawal by Subject|5|||
23581757|NCT01311648|65859048|FG000|Extension Study|Long travel|0|||
23235988|NCT04409262|64608072|FG001|Overall Study|Withdrawal by Subject|10|||
23235989|NCT03795233|64608073|FG000|Overall Study|Withdrawal by Subject|2|||
23235990|NCT03795233|64608074|FG001|Overall Study|Withdrawal by Subject|1|||
23581758|NCT01311648|65859049|FG001|Extension Study|Long travel|1|||
23581759|NCT01311648|65859048|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
23581760|NCT01311648|65859049|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
23581761|NCT01311648|65859048|FG000|Extension Study|Withdrawal by Subject|0|||
23581762|NCT01311648|65859049|FG001|Extension Study|Withdrawal by Subject|1|||
23581763|NCT01311648|65859048|FG000|Extension Study|Inhibitor management|0|||
23581764|NCT01311648|65859049|FG001|Extension Study|Inhibitor management|2|||
23581765|NCT04172987|65859055|FG000|Lead In Period|Adverse Event|1|||
23581766|NCT04172987|65859055|FG000|Lead In Period|Protocol Violation|1|||
23235991|NCT03795233|64608073|FG000|Overall Study|Lost to Follow-up|1|||
23235992|NCT03795233|64608074|FG001|Overall Study|Lost to Follow-up|0|||
23235993|NCT03795233|64608073|FG000|Overall Study|Death|1|||
23235994|NCT03795233|64608074|FG001|Overall Study|Death|0|||
23235995|NCT03911401|64608075|FG000|Overall Study|Adverse Event|1|||
23235996|NCT03911401|64608076|FG001|Overall Study|Adverse Event|2|||
23235997|NCT03911401|64608077|FG002|Overall Study|Adverse Event|5|||
23235998|NCT03911401|64608075|FG000|Overall Study|Lack of Efficacy|1|||
23235999|NCT03911401|64608076|FG001|Overall Study|Lack of Efficacy|1|||
23236000|NCT03911401|64608077|FG002|Overall Study|Lack of Efficacy|8|||
23236001|NCT03911401|64608075|FG000|Overall Study|Physician Decision|0|||
23236002|NCT03911401|64608076|FG001|Overall Study|Physician Decision|0|||
23236003|NCT03911401|64608077|FG002|Overall Study|Physician Decision|1|||
23236004|NCT03911401|64608075|FG000|Overall Study|Withdrawal by Subject|1|||
23236005|NCT03911401|64608076|FG001|Overall Study|Withdrawal by Subject|2|||
23581767|NCT04172987|65859055|FG000|Period 1|Physician Decision|1|||
23581768|NCT04172987|65859055|FG000|Period 2|Adverse Event|5|||
23581769|NCT04172987|65859055|FG000|Period 2|Dosing Termination by Sponsor|4|||
23581770|NCT00256308|65859063|FG000|Overall Study|Death|2|||
23581771|NCT03095508|65859064|FG000|Overall Study|Adverse Event|0|||
23581772|NCT03095508|65859065|FG001|Overall Study|Adverse Event|1|||
23581773|NCT01941316|65859066|FG000|Overall Study|Adverse Event|0|||
23581774|NCT01941316|65859067|FG001|Overall Study|Adverse Event|1|||
23581775|NCT01941316|65859068|FG002|Overall Study|Adverse Event|0|||
23581776|NCT01941316|65859069|FG003|Overall Study|Adverse Event|7|||
23581777|NCT01941316|65859066|FG000|Overall Study|Progressive Disease|3|||
23581778|NCT01941316|65859067|FG001|Overall Study|Progressive Disease|6|||
23581779|NCT01941316|65859068|FG002|Overall Study|Progressive Disease|2|||
23236006|NCT03911401|64608077|FG002|Overall Study|Withdrawal by Subject|0|||
23581780|NCT01941316|65859069|FG003|Overall Study|Progressive Disease|29|||
23581781|NCT01941316|65859066|FG000|Overall Study|Withdrawal by Subject|0|||
23581782|NCT01941316|65859067|FG001|Overall Study|Withdrawal by Subject|2|||
23581783|NCT01941316|65859068|FG002|Overall Study|Withdrawal by Subject|1|||
23236007|NCT03911401|64608075|FG000|Overall Study|Withdrawal by parent/guardian|4|||
23236008|NCT03911401|64608076|FG001|Overall Study|Withdrawal by parent/guardian|4|||
23581784|NCT01941316|65859069|FG003|Overall Study|Withdrawal by Subject|8|||
23236009|NCT03911401|64608077|FG002|Overall Study|Withdrawal by parent/guardian|11|||
23236010|NCT02889861|64608078|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
23236011|NCT01638546|64608086|FG000|Overall Study|Adverse Event|1|||
23236012|NCT01638546|64608087|FG001|Overall Study|Adverse Event|3|||
23236013|NCT04246996|64608088|FG000|Overall Study|Physician Decision|1|||
23236014|NCT04246996|64608089|FG001|Overall Study|Physician Decision|1|||
23236015|NCT04246996|64608088|FG000|Overall Study|Did not meet eligibility criteria|1|||
23236016|NCT04246996|64608089|FG001|Overall Study|Did not meet eligibility criteria|4|||
23236017|NCT01012765|64608090|FG000|Treatment Period 1|Adverse Event|1|||
23236018|NCT01012765|64608091|FG001|Treatment Period 1|Adverse Event|0|||
23236019|NCT01012765|64608092|FG002|Treatment Period 1|Adverse Event|1|||
23236020|NCT01012765|64608093|FG003|Treatment Period 1|Adverse Event|0|||
23236021|NCT01012765|64608094|FG004|Treatment Period 1|Adverse Event|0|||
23236022|NCT01012765|64608095|FG005|Treatment Period 1|Adverse Event|0|||
23581785|NCT01941316|65859066|FG000|Overall Study|Death|0|||
23581786|NCT01941316|65859067|FG001|Overall Study|Death|0|||
23581787|NCT01941316|65859068|FG002|Overall Study|Death|0|||
23581788|NCT01941316|65859069|FG003|Overall Study|Death|3|||
23581789|NCT01941316|65859066|FG000|Overall Study|Physician Decision|0|||
23581790|NCT01941316|65859067|FG001|Overall Study|Physician Decision|0|||
23581791|NCT01941316|65859068|FG002|Overall Study|Physician Decision|0|||
23581792|NCT01941316|65859069|FG003|Overall Study|Physician Decision|3|||
23581793|NCT01941316|65859066|FG000|Overall Study|Protocol Violation|0|||
23581794|NCT01941316|65859067|FG001|Overall Study|Protocol Violation|0|||
23581795|NCT01941316|65859068|FG002|Overall Study|Protocol Violation|0|||
23581796|NCT01941316|65859069|FG003|Overall Study|Protocol Violation|3|||
23581797|NCT01941316|65859066|FG000|Overall Study|Intercurrent illness|0|||
23581798|NCT01941316|65859067|FG001|Overall Study|Intercurrent illness|0|||
23581799|NCT01941316|65859068|FG002|Overall Study|Intercurrent illness|0|||
23581800|NCT01941316|65859069|FG003|Overall Study|Intercurrent illness|1|||
23175103|NCT00896532|64386440|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175104|NCT00896532|64386441|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175105|NCT00896532|64386442|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175106|NCT00896532|64386443|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175107|NCT00896532|64386444|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175108|NCT00896532|64386445|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175109|NCT00896532|64386446|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175110|NCT00896532|64386447|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
23175111|NCT00896532|64386425|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175112|NCT00896532|64386426|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175113|NCT00896532|64386427|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175114|NCT00896532|64386428|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175115|NCT00896532|64386429|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175116|NCT00896532|64386430|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175117|NCT00896532|64386431|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175118|NCT00896532|64386432|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175119|NCT00896532|64386433|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
23175120|NCT00896532|64386434|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175121|NCT00896532|64386435|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175122|NCT00896532|64386436|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175123|NCT00896532|64386437|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175124|NCT00896532|64386438|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175125|NCT00896532|64386439|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175126|NCT00896532|64386440|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175127|NCT00896532|64386441|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175128|NCT00896532|64386442|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175129|NCT00896532|64386443|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175130|NCT00896532|64386444|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175131|NCT00896532|64386445|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175132|NCT00896532|64386446|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23175133|NCT00896532|64386447|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
23236023|NCT01012765|64608090|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23236024|NCT01012765|64608091|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23236025|NCT01012765|64608092|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23581801|NCT01941316|65859066|FG000|Overall Study|Other, not specified|0|||
23581802|NCT01941316|65859067|FG001|Overall Study|Other, not specified|0|||
23581803|NCT01941316|65859068|FG002|Overall Study|Other, not specified|0|||
23581804|NCT01941316|65859069|FG003|Overall Study|Other, not specified|1|||
23581805|NCT03415022|65859070|FG000|Overall Study|Withdrawal by Subject|1|||
23236026|NCT01012765|64608093|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23236027|NCT01012765|64608094|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23236028|NCT01012765|64608095|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23236029|NCT01012765|64608090|FG000|Treatment Period 1|Administrative problems|0|||
23236030|NCT01012765|64608091|FG001|Treatment Period 1|Administrative problems|0|||
23236031|NCT01012765|64608092|FG002|Treatment Period 1|Administrative problems|1|||
23236032|NCT01012765|64608093|FG003|Treatment Period 1|Administrative problems|1|||
23236033|NCT01012765|64608094|FG004|Treatment Period 1|Administrative problems|1|||
23236034|NCT01012765|64608095|FG005|Treatment Period 1|Administrative problems|0|||
23236035|NCT01012765|64608090|FG000|Treatment Period 1|Protocol Violation|0|||
23236036|NCT01012765|64608091|FG001|Treatment Period 1|Protocol Violation|0|||
23236037|NCT01012765|64608092|FG002|Treatment Period 1|Protocol Violation|0|||
23236038|NCT01012765|64608093|FG003|Treatment Period 1|Protocol Violation|2|||
23236039|NCT01012765|64608094|FG004|Treatment Period 1|Protocol Violation|1|||
23236040|NCT01012765|64608095|FG005|Treatment Period 1|Protocol Violation|0|||
23236041|NCT01012765|64608090|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23236042|NCT01012765|64608091|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23236043|NCT01012765|64608092|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23236044|NCT01012765|64608093|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23236045|NCT01012765|64608094|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
23236046|NCT01012765|64608095|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
23236047|NCT01012765|64608090|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23236048|NCT01012765|64608091|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23236049|NCT01012765|64608092|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23236050|NCT01012765|64608093|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23236051|NCT01012765|64608094|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23236052|NCT01012765|64608095|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23236053|NCT01012765|64608090|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
23236054|NCT01012765|64608091|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
23236055|NCT01012765|64608092|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
23236056|NCT01012765|64608093|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
23236057|NCT01012765|64608094|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
23236058|NCT01012765|64608095|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
23236059|NCT01012765|64608090|FG000|Treatment Period 2|Adverse Event|0|||
23236060|NCT01012765|64608091|FG001|Treatment Period 2|Adverse Event|1|||
23236061|NCT01012765|64608092|FG002|Treatment Period 2|Adverse Event|1|||
23236062|NCT01012765|64608093|FG003|Treatment Period 2|Adverse Event|0|||
23236063|NCT01012765|64608094|FG004|Treatment Period 2|Adverse Event|0|||
23236064|NCT01012765|64608095|FG005|Treatment Period 2|Adverse Event|0|||
23236065|NCT01012765|64608090|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
23236066|NCT01012765|64608091|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
23236067|NCT01012765|64608092|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
23236068|NCT01012765|64608093|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
23236069|NCT01012765|64608094|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
23236070|NCT01012765|64608095|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
23236071|NCT04557189|64608096|FG000|Overall Study|Adverse Event|0|||
23581806|NCT03415022|65859071|FG001|Overall Study|Withdrawal by Subject|2|||
23581807|NCT03415022|65859070|FG000|Overall Study|COVID-19 Suspension|2|||
23581808|NCT03415022|65859071|FG001|Overall Study|COVID-19 Suspension|3|||
23581809|NCT03415022|65859070|FG000|Overall Study|Lost to Follow-up|2|||
23581810|NCT03415022|65859071|FG001|Overall Study|Lost to Follow-up|0|||
23581811|NCT03566680|65859072|FG000|Overall Study|Pregnancy|1|||
23581812|NCT03566680|65859072|FG000|Overall Study|Lost to Follow-up|13|||
23581813|NCT03566680|65859072|FG000|Overall Study|Withdrawal by Subject|3|||
23236072|NCT04557189|64608097|FG001|Overall Study|Adverse Event|1|||
23236073|NCT04557189|64608096|FG000|Overall Study|Lost to Follow-up|1|||
23236074|NCT04557189|64608097|FG001|Overall Study|Lost to Follow-up|1|||
23236075|NCT04557189|64608096|FG000|Overall Study|Withdrawal by Subject|2|||
23236076|NCT04557189|64608097|FG001|Overall Study|Withdrawal by Subject|1|||
23236077|NCT04557189|64608096|FG000|Overall Study|Reason not Specified|3|||
23581814|NCT00149630|65859080|FG000|Overall Study|Incarceration|2|||
23581815|NCT00149630|65859081|FG001|Overall Study|Incarceration|0|||
23581816|NCT00149630|65859080|FG000|Overall Study|Treatment Programs|4|||
23581817|NCT00149630|65859081|FG001|Overall Study|Treatment Programs|5|||
23581818|NCT00149630|65859080|FG000|Overall Study|Adverse Event|2|||
23581819|NCT00149630|65859081|FG001|Overall Study|Adverse Event|0|||
23581820|NCT02724878|65859086|FG000|Overall Study|Still on Active Therapy|15|||
23581821|NCT02724878|65859086|FG000|Overall Study|Disease Progression|31|||
23581822|NCT02724878|65859086|FG000|Overall Study|Toxicity|5|||
23581823|NCT02724878|65859086|FG000|Overall Study|Death|1|||
23581824|NCT02724878|65859086|FG000|Overall Study|Withdrawal by Subject|4|||
23581825|NCT02724878|65859086|FG000|Overall Study|Lost to Follow-up|2|||
23581826|NCT02724878|65859086|FG000|Overall Study|Protocol Violation|1|||
23581827|NCT02724878|65859086|FG000|Overall Study|Ineligible for Study Drug|5|||
23581828|NCT02724878|65859086|FG000|Overall Study|not started|1|||
23581829|NCT01773122|65859091|FG000|Overall Study|Due to amended age eligibility criteria|3|||
23236078|NCT04557189|64608097|FG001|Overall Study|Reason not Specified|6|||
23581830|NCT01773122|65859092|FG001|Overall Study|Due to amended age eligibility criteria|1|||
23581831|NCT01773122|65859093|FG002|Overall Study|Due to amended age eligibility criteria|0|||
23581832|NCT01773122|65859094|FG003|Overall Study|Due to amended age eligibility criteria|1|||
23581833|NCT00515086|65859100|FG000|Overall Study|Adverse Event|1|||
23581834|NCT00515086|65859101|FG001|Overall Study|Adverse Event|1|||
23236079|NCT00453349|64608099|FG000|Randomized|Adverse Event|12|||
23236080|NCT00453349|64608100|FG001|Randomized|Adverse Event|11|||
23236081|NCT00453349|64608099|FG000|Randomized|Lack of Efficacy|2|||
23236082|NCT00453349|64608100|FG001|Randomized|Lack of Efficacy|1|||
23236083|NCT00453349|64608099|FG000|Randomized|Lost to Follow-up|7|||
23236084|NCT00453349|64608100|FG001|Randomized|Lost to Follow-up|5|||
23236085|NCT00453349|64608099|FG000|Randomized|Protocol Violation|1|||
23236086|NCT00453349|64608100|FG001|Randomized|Protocol Violation|1|||
23236087|NCT00453349|64608099|FG000|Randomized|Withdrawal by Subject|3|||
23236088|NCT00453349|64608100|FG001|Randomized|Withdrawal by Subject|5|||
23236089|NCT00453349|64608099|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
23236090|NCT00453349|64608100|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
23236091|NCT00453349|64608099|FG000|Completed Study|Adverse Event|12|||
23236092|NCT00453349|64608100|FG001|Completed Study|Adverse Event|11|||
23236093|NCT00453349|64608099|FG000|Completed Study|Lack of Efficacy|2|||
23236094|NCT00453349|64608100|FG001|Completed Study|Lack of Efficacy|1|||
23236095|NCT00453349|64608099|FG000|Completed Study|Lost to Follow-up|7|||
23236096|NCT00453349|64608100|FG001|Completed Study|Lost to Follow-up|5|||
23236097|NCT00453349|64608099|FG000|Completed Study|Protocol Violation|1|||
23236098|NCT00453349|64608100|FG001|Completed Study|Protocol Violation|1|||
23581835|NCT00515086|65859102|FG002|Overall Study|Adverse Event|2|||
23581836|NCT00515086|65859103|FG003|Overall Study|Adverse Event|3|||
23581837|NCT00515086|65859100|FG000|Overall Study|Administrative|1|||
23581838|NCT00515086|65859101|FG001|Overall Study|Administrative|1|||
23581839|NCT00515086|65859102|FG002|Overall Study|Administrative|0|||
23236099|NCT00453349|64608099|FG000|Completed Study|Withdrawal by Subject|3|||
23236100|NCT00453349|64608100|FG001|Completed Study|Withdrawal by Subject|5|||
23236101|NCT00453349|64608099|FG000|Completed Study|Lost to follow up after study treatment|2|||
23236102|NCT00453349|64608100|FG001|Completed Study|Lost to follow up after study treatment|11|||
23236103|NCT00422227|64608101|FG000|Overall Study|Adverse Event|3|||
23236104|NCT00422227|64608102|FG001|Overall Study|Adverse Event|8|||
23236105|NCT00422227|64608101|FG000|Overall Study|Lost to Follow-up|1|||
23236106|NCT00422227|64608102|FG001|Overall Study|Lost to Follow-up|3|||
23236107|NCT00422227|64608101|FG000|Overall Study|Withdrawal by Subject|0|||
23236108|NCT00422227|64608102|FG001|Overall Study|Withdrawal by Subject|4|||
23236109|NCT02354599|64608105|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23581840|NCT00515086|65859103|FG003|Overall Study|Administrative|0|||
23581841|NCT00515086|65859100|FG000|Overall Study|Withdrawal by Subject|1|||
23581842|NCT00515086|65859101|FG001|Overall Study|Withdrawal by Subject|0|||
23581843|NCT00515086|65859102|FG002|Overall Study|Withdrawal by Subject|0|||
23236110|NCT02354599|64608106|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23236111|NCT02354599|64608107|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23581844|NCT00515086|65859103|FG003|Overall Study|Withdrawal by Subject|1|||
23581845|NCT00515086|65859100|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
23581846|NCT00515086|65859101|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23581847|NCT00515086|65859102|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
23581848|NCT00515086|65859103|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
23581849|NCT00515086|65859100|FG000|Overall Study|Lost to Follow-up|1|||
23581850|NCT00515086|65859101|FG001|Overall Study|Lost to Follow-up|0|||
23581851|NCT00515086|65859102|FG002|Overall Study|Lost to Follow-up|0|||
23581852|NCT00515086|65859103|FG003|Overall Study|Lost to Follow-up|0|||
23581853|NCT00515086|65859100|FG000|Overall Study|Study drug no longer required|0|||
23581854|NCT00515086|65859101|FG001|Overall Study|Study drug no longer required|1|||
23581855|NCT00515086|65859102|FG002|Overall Study|Study drug no longer required|0|||
23581856|NCT00515086|65859103|FG003|Overall Study|Study drug no longer required|0|||
23581857|NCT00515086|65859100|FG000|Overall Study|Death|2|||
23236112|NCT02354599|64608108|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
23236113|NCT02354599|64608109|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
23236114|NCT02354599|64608110|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
23236115|NCT02354599|64608105|FG000|Overall Study|Withdrawal by Subject|1|||
23236116|NCT02354599|64608106|FG001|Overall Study|Withdrawal by Subject|1|||
23236117|NCT02354599|64608107|FG002|Overall Study|Withdrawal by Subject|0|||
23236118|NCT02354599|64608108|FG003|Overall Study|Withdrawal by Subject|0|||
23236119|NCT02354599|64608109|FG004|Overall Study|Withdrawal by Subject|0|||
23236120|NCT02354599|64608110|FG005|Overall Study|Withdrawal by Subject|0|||
23236121|NCT00765726|64608111|FG000|Overall Study|Withdrawal by Subject|1|||
23236122|NCT00765726|64608111|FG000|Overall Study|Discontinuation of study by sponsor|8|||
23236123|NCT03759340|64608112|FG000|Overall Study|Adverse Event|2|||
23236124|NCT03759340|64608112|FG000|Overall Study|Lost to Follow-up|1|||
23236125|NCT03759340|64608112|FG000|Overall Study|Withdrawal by Subject|15|||
23236126|NCT03759340|64608112|FG000|Overall Study|Study Terminated by Sponsor|38|||
23236127|NCT00461552|64608115|FG000|Overall Study|Drug Dispensing error|0|||
23236128|NCT00461552|64608116|FG001|Overall Study|Drug Dispensing error|2|||
23236129|NCT01710709|64608128|FG000|Overall Study|Lost to Follow-up|29|||
23236130|NCT01710709|64608128|FG000|Overall Study|Adverse Event|48|||
23236131|NCT01710709|64608128|FG000|Overall Study|Participant met withdrawal criteria|33|||
23236132|NCT01710709|64608128|FG000|Overall Study|Participant withdrawn by investigator|2|||
23236133|NCT01710709|64608128|FG000|Overall Study|Withdrawal by Subject|53|||
23236134|NCT01710709|64608128|FG000|Overall Study|Protocol Violation|5|||
23236135|NCT01710709|64608128|FG000|Overall Study|Lack of Efficacy|3|||
23236136|NCT01349816|64608132|FG000|Overall Study|Withdrawal by Subject|4|||
23236137|NCT01349816|64608132|FG000|Overall Study|Physician Decision|1|||
23236138|NCT01349816|64608132|FG000|Overall Study|Adverse Event|14|||
23236139|NCT01349816|64608132|FG000|Overall Study|Lost to Follow-up|2|||
23236140|NCT01349816|64608132|FG000|Overall Study|Protocol Violation|1|||
23236141|NCT01349816|64608132|FG000|Overall Study|Protocol-specified criteria|8|||
23236142|NCT00682539|64608133|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
23236143|NCT00682539|64608134|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
23236144|NCT00682539|64608135|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
23236145|NCT00682539|64608133|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
23236146|NCT00682539|64608134|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
23236147|NCT00682539|64608135|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
23236148|NCT02213666|64608144|FG000|Overall Study|Withdrawal by Subject|1|||
23236149|NCT00985114|64608146|FG000|Overall Study|Adverse Event|1|||
23236150|NCT00985114|64608147|FG001|Overall Study|Adverse Event|0|||
23236151|NCT00985114|64608146|FG000|Overall Study|Withdrawal by Subject|0|||
23236152|NCT00985114|64608147|FG001|Overall Study|Withdrawal by Subject|2|||
23236153|NCT03418727|64608148|FG000|Overall Study|Adverse Event|1|||
23236154|NCT03418727|64608149|FG001|Overall Study|Adverse Event|2|||
23581858|NCT00515086|65859101|FG001|Overall Study|Death|0|||
23581859|NCT00515086|65859102|FG002|Overall Study|Death|0|||
23581860|NCT00515086|65859103|FG003|Overall Study|Death|0|||
23581861|NCT01720043|65859104|FG000|Overall Study|Withdrawal by Subject|1|||
23581862|NCT04337489|65859105|FG000|Overall Study|Withdrawal by Subject|1|||
23236155|NCT03418727|64608150|FG002|Overall Study|Adverse Event|0|||
23236156|NCT03418727|64608148|FG000|Overall Study|Withdrawal by Subject|0|||
23340702|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Death|0|||
23340703|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
23340704|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
23340705|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
23340706|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
23340707|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
23340708|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
23340709|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
23340710|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
23340711|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
23340712|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
23340713|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
23340714|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
23340715|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
23340716|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
23340717|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
23340718|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
23340719|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
23581863|NCT03782727|65859108|FG000|Overall Study|Lost to Follow-up|32|||
23236157|NCT03418727|64608149|FG001|Overall Study|Withdrawal by Subject|0|||
23236158|NCT03418727|64608150|FG002|Overall Study|Withdrawal by Subject|2|||
23236159|NCT01955005|64608154|FG000|Overall Study|Withdrawal by Subject|3|||
23236160|NCT01955005|64608155|FG001|Overall Study|Withdrawal by Subject|5|||
23236161|NCT00303602|64608156|FG000|Overall Study|Adverse Event|2|||
23236162|NCT00303602|64608157|FG001|Overall Study|Adverse Event|2|||
23236163|NCT00303602|64608156|FG000|Overall Study|Withdrawal by Subject|5|||
23236164|NCT00303602|64608157|FG001|Overall Study|Withdrawal by Subject|6|||
23236165|NCT00303602|64608156|FG000|Overall Study|Lost to Follow-up|5|||
23236166|NCT00303602|64608157|FG001|Overall Study|Lost to Follow-up|2|||
23236167|NCT00303602|64608156|FG000|Overall Study|Protocol entry criteria not met|2|||
23236168|NCT00303602|64608157|FG001|Overall Study|Protocol entry criteria not met|2|||
23236169|NCT00303602|64608156|FG000|Overall Study|Physician Decision|2|||
23236170|NCT00303602|64608157|FG001|Overall Study|Physician Decision|1|||
23236171|NCT00303602|64608156|FG000|Overall Study|Noncompliance|2|||
23236172|NCT00303602|64608157|FG001|Overall Study|Noncompliance|2|||
23236173|NCT00303602|64608156|FG000|Overall Study|Protocol Violation|1|||
23236174|NCT00303602|64608157|FG001|Overall Study|Protocol Violation|0|||
23236175|NCT00955682|64608158|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
23236176|NCT00955682|64608159|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
23236177|NCT00265109|64608162|FG000|Overall Study|Withdrawal by Subject|5|||
23236178|NCT00265109|64608162|FG000|Overall Study|Adverse Event|1|||
23236179|NCT00401726|64608164|FG000|Overall Study|Adverse Event|34|||
23236180|NCT00401726|64608165|FG001|Overall Study|Adverse Event|45|||
23236181|NCT00401726|64608164|FG000|Overall Study|Death|0|||
23236182|NCT00401726|64608165|FG001|Overall Study|Death|3|||
23236183|NCT00401726|64608164|FG000|Overall Study|Sponsor Request|0|||
23236184|NCT00401726|64608165|FG001|Overall Study|Sponsor Request|1|||
23236185|NCT00401726|64608164|FG000|Overall Study|Physician Decision|3|||
23236186|NCT00401726|64608165|FG001|Overall Study|Physician Decision|6|||
23236187|NCT00401726|64608164|FG000|Overall Study|Lost to Follow-up|23|||
23236188|NCT00401726|64608165|FG001|Overall Study|Lost to Follow-up|20|||
23236189|NCT00401726|64608164|FG000|Overall Study|Protocol Violation|6|||
23236190|NCT00401726|64608165|FG001|Overall Study|Protocol Violation|3|||
23236191|NCT00401726|64608164|FG000|Overall Study|Withdrawal by Subject|18|||
23236192|NCT00401726|64608165|FG001|Overall Study|Withdrawal by Subject|24|||
23236193|NCT00401726|64608164|FG000|Overall Study|Lack of Efficacy|4|||
23236194|NCT00401726|64608165|FG001|Overall Study|Lack of Efficacy|6|||
23236195|NCT00401726|64608164|FG000|Overall Study|Protocol Deviation|9|||
23236196|NCT00401726|64608165|FG001|Overall Study|Protocol Deviation|4|||
23236197|NCT01453296|64608166|FG000|Treatment Period 1|Adverse Event|0|||
23236198|NCT01453296|64608167|FG001|Treatment Period 1|Adverse Event|1|||
23236199|NCT01453296|64608166|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
23236200|NCT01453296|64608167|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
23236201|NCT01453296|64608166|FG000|Treatment Period 2|Adverse Event|1|||
23236202|NCT01453296|64608167|FG001|Treatment Period 2|Adverse Event|0|||
23581864|NCT03120676|65859110|FG000|Overall Study|Not treated|1|||
23236203|NCT01453296|64608166|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23236204|NCT01453296|64608167|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23236205|NCT04212221|64608168|FG000|Overall Study|Remained on Treatment|0|||
23236206|NCT04212221|64608169|FG001|Overall Study|Remained on Treatment|0|||
23340720|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
23581865|NCT00354029|65859113|FG000|Overall Study|Protocol Violation|4|||
23236207|NCT04212221|64608170|FG002|Overall Study|Remained on Treatment|0|||
23236208|NCT04212221|64608171|FG003|Overall Study|Remained on Treatment|1|||
23340721|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
23340722|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
23340723|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
23340724|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
23340725|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
23340726|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
23340727|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23340728|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
23340729|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23452828|NCT00101686|65399133|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
23175134|NCT00896532|64386425|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175135|NCT00896532|64386426|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175136|NCT00896532|64386427|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175137|NCT00896532|64386428|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175138|NCT00896532|64386429|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175139|NCT00896532|64386430|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175140|NCT00896532|64386431|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175141|NCT00896532|64386432|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175142|NCT00896532|64386433|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175143|NCT00896532|64386434|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175144|NCT00896532|64386435|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175145|NCT00896532|64386436|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175146|NCT00896532|64386437|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
23175147|NCT00896532|64386438|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175148|NCT00896532|64386439|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175149|NCT00896532|64386440|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175150|NCT00896532|64386441|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175151|NCT00896532|64386442|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175152|NCT00896532|64386443|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175153|NCT00896532|64386444|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175154|NCT00896532|64386445|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175155|NCT00896532|64386446|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175156|NCT00896532|64386447|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
23175157|NCT00896532|64386425|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175158|NCT00896532|64386426|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175159|NCT00896532|64386427|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175160|NCT00896532|64386428|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175161|NCT00896532|64386429|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175162|NCT00896532|64386430|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175163|NCT00896532|64386431|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175164|NCT00896532|64386432|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175165|NCT00896532|64386433|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175166|NCT00896532|64386434|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175167|NCT00896532|64386435|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
23175168|NCT00896532|64386436|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175169|NCT00896532|64386437|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
23175170|NCT00896532|64386438|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175171|NCT00896532|64386439|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175172|NCT00896532|64386440|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175173|NCT00896532|64386441|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175174|NCT00896532|64386442|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175175|NCT00896532|64386443|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175176|NCT00896532|64386444|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175177|NCT00896532|64386445|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175178|NCT00896532|64386446|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175179|NCT00896532|64386447|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
23175180|NCT00896532|64386425|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175181|NCT00896532|64386426|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175182|NCT00896532|64386427|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175183|NCT00896532|64386428|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175184|NCT00896532|64386429|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175185|NCT00896532|64386430|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175186|NCT00896532|64386431|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23236209|NCT04212221|64608172|FG004|Overall Study|Remained on Treatment|0|||
23236210|NCT04212221|64608173|FG005|Overall Study|Remained on Treatment|0|||
23340730|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23581866|NCT00354029|65859114|FG001|Overall Study|Protocol Violation|2|||
23581867|NCT03303105|65859117|FG000|Overall Study|Adverse Event|0|||
23581868|NCT03303105|65859118|FG001|Overall Study|Adverse Event|2|||
23581869|NCT03303105|65859117|FG000|Overall Study|Lack of Efficacy|1|||
23581870|NCT03303105|65859118|FG001|Overall Study|Lack of Efficacy|0|||
23581871|NCT03303105|65859117|FG000|Overall Study|Protocol Violation|1|||
23581872|NCT03303105|65859118|FG001|Overall Study|Protocol Violation|0|||
23581873|NCT03303105|65859117|FG000|Overall Study|Withdrawal by Subject|0|||
23581874|NCT03303105|65859118|FG001|Overall Study|Withdrawal by Subject|2|||
23581875|NCT05074498|65859123|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581876|NCT05074498|65859124|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581877|NCT05074498|65859125|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581878|NCT05074498|65859126|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
23581879|NCT05074498|65859127|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581880|NCT05074498|65859128|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
23581881|NCT05074498|65859123|FG000|Part 1 (Upto Day 104)|Other|1|||
23581882|NCT05074498|65859124|FG001|Part 1 (Upto Day 104)|Other|0|||
23581883|NCT05074498|65859125|FG002|Part 1 (Upto Day 104)|Other|0|||
23581884|NCT05074498|65859126|FG003|Part 1 (Upto Day 104)|Other|0|||
23581885|NCT05074498|65859127|FG004|Part 1 (Upto Day 104)|Other|0|||
23581886|NCT05074498|65859128|FG005|Part 1 (Upto Day 104)|Other|0|||
23581887|NCT05074498|65859123|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23581888|NCT05074498|65859124|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23581889|NCT05074498|65859125|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23581890|NCT05074498|65859126|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23581891|NCT05074498|65859127|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
23581892|NCT05074498|65859128|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
23175187|NCT00896532|64386432|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175188|NCT00896532|64386433|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175189|NCT00896532|64386434|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175190|NCT00896532|64386435|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175191|NCT00896532|64386436|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175192|NCT00896532|64386437|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
23175193|NCT00896532|64386438|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
23175194|NCT00896532|64386439|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175195|NCT00896532|64386440|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175196|NCT00896532|64386441|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175197|NCT00896532|64386442|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175198|NCT00896532|64386443|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175199|NCT00896532|64386444|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175200|NCT00896532|64386445|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175201|NCT00896532|64386446|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175202|NCT00896532|64386447|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
23175203|NCT00896532|64386425|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
23175204|NCT00896532|64386426|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
23175205|NCT00896532|64386427|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
23175206|NCT00896532|64386428|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
23175207|NCT00896532|64386429|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
23175208|NCT00896532|64386430|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
23175209|NCT00896532|64386431|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
23175210|NCT00896532|64386432|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
23175211|NCT00896532|64386433|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
23175212|NCT00896532|64386434|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
23175213|NCT00896532|64386435|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
23175214|NCT00896532|64386436|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
23175215|NCT00896532|64386437|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
23175216|NCT00896532|64386438|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
23175217|NCT00896532|64386439|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
23175218|NCT00896532|64386440|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
23175219|NCT00896532|64386441|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
23340731|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
23581893|NCT05074498|65859123|FG000|Part 2 (Upto Day 104)|Death|0|||
23581894|NCT05074498|65859124|FG001|Part 2 (Upto Day 104)|Death|0|||
23581895|NCT05074498|65859125|FG002|Part 2 (Upto Day 104)|Death|0|||
23581896|NCT05074498|65859126|FG003|Part 2 (Upto Day 104)|Death|0|||
23581897|NCT05074498|65859127|FG004|Part 2 (Upto Day 104)|Death|1|||
23581898|NCT05074498|65859128|FG005|Part 2 (Upto Day 104)|Death|0|||
23581899|NCT05074498|65859123|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
23236211|NCT04212221|64608174|FG006|Overall Study|Remained on Treatment|3|||
23236212|NCT04212221|64608175|FG007|Overall Study|Remained on Treatment|9|||
23236213|NCT04212221|64608168|FG000|Overall Study|Adverse Event|0|||
23236214|NCT04212221|64608169|FG001|Overall Study|Adverse Event|0|||
23236215|NCT04212221|64608170|FG002|Overall Study|Adverse Event|0|||
23236216|NCT04212221|64608171|FG003|Overall Study|Adverse Event|0|||
23236217|NCT04212221|64608172|FG004|Overall Study|Adverse Event|0|||
23236218|NCT04212221|64608173|FG005|Overall Study|Adverse Event|0|||
23236219|NCT04212221|64608174|FG006|Overall Study|Adverse Event|2|||
23236220|NCT04212221|64608175|FG007|Overall Study|Adverse Event|3|||
23236221|NCT04212221|64608168|FG000|Overall Study|Death|0|||
23236222|NCT04212221|64608169|FG001|Overall Study|Death|0|||
23236223|NCT04212221|64608170|FG002|Overall Study|Death|0|||
23236224|NCT04212221|64608171|FG003|Overall Study|Death|0|||
23236225|NCT04212221|64608172|FG004|Overall Study|Death|0|||
23236226|NCT04212221|64608173|FG005|Overall Study|Death|0|||
23236227|NCT04212221|64608174|FG006|Overall Study|Death|0|||
23236228|NCT04212221|64608175|FG007|Overall Study|Death|2|||
23236229|NCT04212221|64608168|FG000|Overall Study|Disease progression according to irRECIST|1|||
23236230|NCT04212221|64608169|FG001|Overall Study|Disease progression according to irRECIST|2|||
23175220|NCT00896532|64386442|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
23175221|NCT00896532|64386443|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
23175222|NCT00896532|64386444|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
23175223|NCT00896532|64386445|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
23175224|NCT00896532|64386446|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
23175225|NCT00896532|64386447|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
23175226|NCT00896532|64386425|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175227|NCT00896532|64386426|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175228|NCT00896532|64386427|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175229|NCT00896532|64386428|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175230|NCT00896532|64386429|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175231|NCT00896532|64386430|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175232|NCT00896532|64386431|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175233|NCT00896532|64386432|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175234|NCT00896532|64386433|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175235|NCT00896532|64386434|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175236|NCT00896532|64386435|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175237|NCT00896532|64386436|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175238|NCT00896532|64386437|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175239|NCT00896532|64386438|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175240|NCT00896532|64386439|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175241|NCT00896532|64386440|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
23175242|NCT00896532|64386441|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
23175243|NCT00896532|64386442|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175244|NCT00896532|64386443|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175245|NCT00896532|64386444|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175246|NCT00896532|64386445|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175247|NCT00896532|64386446|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175248|NCT00896532|64386447|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
23175249|NCT00896532|64386425|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175250|NCT00896532|64386426|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175251|NCT00896532|64386427|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175252|NCT00896532|64386428|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175253|NCT00896532|64386429|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175254|NCT00896532|64386430|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175255|NCT00896532|64386431|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175256|NCT00896532|64386432|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175257|NCT00896532|64386433|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175258|NCT00896532|64386434|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175259|NCT00896532|64386435|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175260|NCT00896532|64386436|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175261|NCT00896532|64386437|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23236231|NCT04212221|64608170|FG002|Overall Study|Disease progression according to irRECIST|3|||
23236232|NCT04212221|64608171|FG003|Overall Study|Disease progression according to irRECIST|3|||
23236233|NCT04212221|64608172|FG004|Overall Study|Disease progression according to irRECIST|2|||
23236234|NCT04212221|64608173|FG005|Overall Study|Disease progression according to irRECIST|2|||
23236235|NCT04212221|64608174|FG006|Overall Study|Disease progression according to irRECIST|21|||
23175262|NCT00896532|64386438|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175263|NCT00896532|64386439|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175264|NCT00896532|64386440|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
23175265|NCT00896532|64386441|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
23175266|NCT00896532|64386442|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
23175267|NCT00896532|64386443|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175268|NCT00896532|64386444|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175269|NCT00896532|64386445|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175270|NCT00896532|64386446|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175271|NCT00896532|64386447|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
23175272|NCT00896532|64386425|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175273|NCT00896532|64386426|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175274|NCT00896532|64386427|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175275|NCT00896532|64386428|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175276|NCT00896532|64386429|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175277|NCT00896532|64386430|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175278|NCT00896532|64386431|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175279|NCT00896532|64386432|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175280|NCT00896532|64386433|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175281|NCT00896532|64386434|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175282|NCT00896532|64386435|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175283|NCT00896532|64386436|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175284|NCT00896532|64386437|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175285|NCT00896532|64386438|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175286|NCT00896532|64386439|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175287|NCT00896532|64386440|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175288|NCT00896532|64386441|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
23175289|NCT00896532|64386442|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175290|NCT00896532|64386443|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175291|NCT00896532|64386444|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175292|NCT00896532|64386445|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175293|NCT00896532|64386446|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175294|NCT00896532|64386447|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
23175295|NCT00896532|64386425|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
23175296|NCT00896532|64386426|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
23175297|NCT00896532|64386427|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
23175298|NCT00896532|64386428|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
23175299|NCT00896532|64386429|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
23175300|NCT00896532|64386430|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
23175301|NCT00896532|64386431|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
23175302|NCT00896532|64386432|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
23175303|NCT00896532|64386433|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
23175304|NCT00896532|64386434|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
23175305|NCT00896532|64386435|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
23175306|NCT00896532|64386436|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
23175307|NCT00896532|64386437|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
23175308|NCT00896532|64386438|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
23175309|NCT00896532|64386439|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
23175310|NCT00896532|64386440|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
23175311|NCT00896532|64386441|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
23175312|NCT00896532|64386442|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
23175313|NCT00896532|64386443|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
23175314|NCT00896532|64386444|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
23175315|NCT00896532|64386445|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
23175316|NCT00896532|64386446|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
23175317|NCT00896532|64386447|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
23175318|NCT00896532|64386425|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175319|NCT00896532|64386426|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175320|NCT00896532|64386427|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175321|NCT00896532|64386428|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175322|NCT00896532|64386429|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175323|NCT00896532|64386430|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175324|NCT00896532|64386431|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23452829|NCT00101686|65399134|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
23452830|NCT00101686|65399135|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
23452831|NCT00101686|65399136|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
23452832|NCT00101686|65399137|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
23452833|NCT00101686|65399138|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
23452834|NCT00101686|65399139|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
23581900|NCT05074498|65859124|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
23581901|NCT05074498|65859125|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
23452835|NCT00101686|65399140|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
23452836|NCT00101686|65399131|FG000|Overall Study|unacceptable toxicity|3|||
23452837|NCT00101686|65399132|FG001|Overall Study|unacceptable toxicity|9|||
23452838|NCT00101686|65399133|FG002|Overall Study|unacceptable toxicity|10|||
23452839|NCT00101686|65399134|FG003|Overall Study|unacceptable toxicity|6|||
23452840|NCT00101686|65399135|FG004|Overall Study|unacceptable toxicity|16|||
23452841|NCT00101686|65399136|FG005|Overall Study|unacceptable toxicity|10|||
23452842|NCT00101686|65399137|FG006|Overall Study|unacceptable toxicity|4|||
23452843|NCT00101686|65399138|FG007|Overall Study|unacceptable toxicity|2|||
23452844|NCT00101686|65399139|FG008|Overall Study|unacceptable toxicity|1|||
23452845|NCT00101686|65399140|FG009|Overall Study|unacceptable toxicity|4|||
23452846|NCT00101686|65399131|FG000|Overall Study|Randomized but did not receive treament|1|||
23452847|NCT00101686|65399132|FG001|Overall Study|Randomized but did not receive treament|6|||
23452848|NCT00101686|65399133|FG002|Overall Study|Randomized but did not receive treament|2|||
23452849|NCT00101686|65399134|FG003|Overall Study|Randomized but did not receive treament|2|||
23452850|NCT00101686|65399135|FG004|Overall Study|Randomized but did not receive treament|2|||
23452851|NCT00101686|65399136|FG005|Overall Study|Randomized but did not receive treament|2|||
23452852|NCT00101686|65399137|FG006|Overall Study|Randomized but did not receive treament|0|||
23175325|NCT00896532|64386432|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175326|NCT00896532|64386433|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175327|NCT00896532|64386434|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175328|NCT00896532|64386435|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175329|NCT00896532|64386436|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175330|NCT00896532|64386437|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175331|NCT00896532|64386438|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23452853|NCT00101686|65399138|FG007|Overall Study|Randomized but did not receive treament|1|||
23452854|NCT00101686|65399139|FG008|Overall Study|Randomized but did not receive treament|0|||
23452855|NCT00101686|65399140|FG009|Overall Study|Randomized but did not receive treament|1|||
23452856|NCT00101686|65399131|FG000|Overall Study|intercurrent non-cancer related illness|0|||
23581902|NCT05074498|65859126|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
23175332|NCT00896532|64386439|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175333|NCT00896532|64386440|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175334|NCT00896532|64386441|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
23175335|NCT00896532|64386442|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175336|NCT00896532|64386443|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175337|NCT00896532|64386444|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175338|NCT00896532|64386445|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175339|NCT00896532|64386446|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175340|NCT00896532|64386447|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
23175341|NCT00896532|64386425|FG000|Months 48-72: Follow-on Phase|Death|0|||
23175342|NCT00896532|64386426|FG001|Months 48-72: Follow-on Phase|Death|0|||
23175343|NCT00896532|64386427|FG002|Months 48-72: Follow-on Phase|Death|0|||
23175344|NCT00896532|64386428|FG003|Months 48-72: Follow-on Phase|Death|0|||
23175345|NCT00896532|64386429|FG004|Months 48-72: Follow-on Phase|Death|0|||
23175346|NCT00896532|64386430|FG005|Months 48-72: Follow-on Phase|Death|0|||
23175347|NCT00896532|64386431|FG006|Months 48-72: Follow-on Phase|Death|0|||
23175348|NCT00896532|64386432|FG007|Months 48-72: Follow-on Phase|Death|0|||
23175349|NCT00896532|64386433|FG008|Months 48-72: Follow-on Phase|Death|0|||
23175350|NCT00896532|64386434|FG009|Months 48-72: Follow-on Phase|Death|0|||
23175351|NCT00896532|64386435|FG010|Months 48-72: Follow-on Phase|Death|0|||
23175352|NCT00896532|64386436|FG011|Months 48-72: Follow-on Phase|Death|0|||
23175353|NCT00896532|64386437|FG012|Months 48-72: Follow-on Phase|Death|0|||
23236236|NCT04212221|64608175|FG007|Overall Study|Disease progression according to irRECIST|17|||
23236237|NCT04212221|64608168|FG000|Overall Study|Global Deterioration of Health Status|0|||
23452857|NCT00101686|65399132|FG001|Overall Study|intercurrent non-cancer related illness|0|||
23452858|NCT00101686|65399133|FG002|Overall Study|intercurrent non-cancer related illness|2|||
23452859|NCT00101686|65399134|FG003|Overall Study|intercurrent non-cancer related illness|0|||
23452860|NCT00101686|65399135|FG004|Overall Study|intercurrent non-cancer related illness|1|||
23581903|NCT05074498|65859127|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
23452861|NCT00101686|65399136|FG005|Overall Study|intercurrent non-cancer related illness|3|||
23452862|NCT00101686|65399137|FG006|Overall Study|intercurrent non-cancer related illness|1|||
23452863|NCT00101686|65399138|FG007|Overall Study|intercurrent non-cancer related illness|0|||
23452864|NCT00101686|65399139|FG008|Overall Study|intercurrent non-cancer related illness|1|||
23452865|NCT00101686|65399140|FG009|Overall Study|intercurrent non-cancer related illness|1|||
23452866|NCT00101686|65399131|FG000|Overall Study|Physician Decision|10|||
23452867|NCT00101686|65399132|FG001|Overall Study|Physician Decision|13|||
23452868|NCT00101686|65399133|FG002|Overall Study|Physician Decision|6|||
23452869|NCT00101686|65399134|FG003|Overall Study|Physician Decision|7|||
23452870|NCT00101686|65399135|FG004|Overall Study|Physician Decision|8|||
23452871|NCT00101686|65399136|FG005|Overall Study|Physician Decision|9|||
23452872|NCT00101686|65399137|FG006|Overall Study|Physician Decision|5|||
23452873|NCT00101686|65399138|FG007|Overall Study|Physician Decision|5|||
23452874|NCT00101686|65399139|FG008|Overall Study|Physician Decision|1|||
23452875|NCT00101686|65399140|FG009|Overall Study|Physician Decision|1|||
23452876|NCT00101686|65399131|FG000|Overall Study|Other|1|||
23452877|NCT00101686|65399132|FG001|Overall Study|Other|4|||
23452878|NCT00101686|65399133|FG002|Overall Study|Other|1|||
23452879|NCT00101686|65399134|FG003|Overall Study|Other|6|||
23452880|NCT00101686|65399135|FG004|Overall Study|Other|2|||
23452881|NCT00101686|65399136|FG005|Overall Study|Other|12|||
23452882|NCT00101686|65399137|FG006|Overall Study|Other|1|||
23452883|NCT00101686|65399138|FG007|Overall Study|Other|5|||
23452884|NCT00101686|65399139|FG008|Overall Study|Other|3|||
23452885|NCT00101686|65399140|FG009|Overall Study|Other|3|||
23452886|NCT00101686|65399131|FG000|Overall Study|Withdrawal by Subject|9|||
23452887|NCT00101686|65399132|FG001|Overall Study|Withdrawal by Subject|8|||
23452888|NCT00101686|65399133|FG002|Overall Study|Withdrawal by Subject|6|||
23452889|NCT00101686|65399134|FG003|Overall Study|Withdrawal by Subject|8|||
23452890|NCT00101686|65399135|FG004|Overall Study|Withdrawal by Subject|8|||
23452891|NCT00101686|65399136|FG005|Overall Study|Withdrawal by Subject|7|||
23452892|NCT00101686|65399137|FG006|Overall Study|Withdrawal by Subject|7|||
23452893|NCT00101686|65399138|FG007|Overall Study|Withdrawal by Subject|7|||
23452894|NCT00101686|65399139|FG008|Overall Study|Withdrawal by Subject|8|||
23452895|NCT00101686|65399140|FG009|Overall Study|Withdrawal by Subject|9|||
23452896|NCT02719171|65399141|FG000|Overall Study|Adverse Event|1|||
23452897|NCT02719171|65399142|FG001|Overall Study|Adverse Event|2|||
23452898|NCT02719171|65399143|FG002|Overall Study|Adverse Event|0|||
23452899|NCT02719171|65399144|FG003|Overall Study|Adverse Event|0|||
23452900|NCT02719171|65399145|FG004|Overall Study|Adverse Event|2|||
23452901|NCT02719171|65399141|FG000|Overall Study|Lost to Follow-up|0|||
23452902|NCT02719171|65399142|FG001|Overall Study|Lost to Follow-up|0|||
23452903|NCT02719171|65399143|FG002|Overall Study|Lost to Follow-up|1|||
23452904|NCT02719171|65399144|FG003|Overall Study|Lost to Follow-up|0|||
23452905|NCT02719171|65399145|FG004|Overall Study|Lost to Follow-up|0|||
23452906|NCT02719171|65399141|FG000|Overall Study|Subject Withdrawal|0|||
23452907|NCT02719171|65399142|FG001|Overall Study|Subject Withdrawal|2|||
23452908|NCT02719171|65399143|FG002|Overall Study|Subject Withdrawal|2|||
23452909|NCT02719171|65399144|FG003|Overall Study|Subject Withdrawal|1|||
23452910|NCT02719171|65399145|FG004|Overall Study|Subject Withdrawal|0|||
23452911|NCT02719171|65399141|FG000|Overall Study|Other|0|||
23452912|NCT02719171|65399142|FG001|Overall Study|Other|0|||
23452913|NCT02719171|65399143|FG002|Overall Study|Other|0|||
23452914|NCT02719171|65399144|FG003|Overall Study|Other|1|||
23452915|NCT02719171|65399145|FG004|Overall Study|Other|0|||
23236238|NCT04212221|64608169|FG001|Overall Study|Global Deterioration of Health Status|0|||
23236239|NCT04212221|64608170|FG002|Overall Study|Global Deterioration of Health Status|0|||
23452916|NCT01945021|65399146|FG000|Overall Study|Adverse Event|1|||
23236240|NCT04212221|64608171|FG003|Overall Study|Global Deterioration of Health Status|0|||
23236241|NCT04212221|64608172|FG004|Overall Study|Global Deterioration of Health Status|0|||
23236242|NCT04212221|64608173|FG005|Overall Study|Global Deterioration of Health Status|0|||
23236243|NCT04212221|64608174|FG006|Overall Study|Global Deterioration of Health Status|0|||
23452917|NCT01945021|65399146|FG000|Overall Study|Withdrawal of consent|12|||
23452918|NCT01945021|65399146|FG000|Overall Study|Lost to Follow-up|5|||
23452919|NCT01945021|65399146|FG000|Overall Study|Death|65|||
23452920|NCT02898454|65399151|FG000|Overall Study|Adverse Event|4|||
23452921|NCT02898454|65399152|FG001|Overall Study|Adverse Event|1|||
23452922|NCT02898454|65399153|FG002|Overall Study|Adverse Event|2|||
23452923|NCT02898454|65399151|FG000|Overall Study|Protocol Violation|1|||
23452924|NCT02898454|65399152|FG001|Overall Study|Protocol Violation|0|||
23452925|NCT02898454|65399153|FG002|Overall Study|Protocol Violation|1|||
23452926|NCT02898454|65399151|FG000|Overall Study|Lack of Efficacy|4|||
23452927|NCT02898454|65399152|FG001|Overall Study|Lack of Efficacy|1|||
23452928|NCT02898454|65399153|FG002|Overall Study|Lack of Efficacy|0|||
23452929|NCT02898454|65399151|FG000|Overall Study|Withdrawal by Subject|6|||
23452930|NCT02898454|65399152|FG001|Overall Study|Withdrawal by Subject|3|||
23452931|NCT02898454|65399153|FG002|Overall Study|Withdrawal by Subject|3|||
23452932|NCT02898454|65399151|FG000|Overall Study|Lost to Follow-up|1|||
23452933|NCT02898454|65399152|FG001|Overall Study|Lost to Follow-up|0|||
23452934|NCT02898454|65399153|FG002|Overall Study|Lost to Follow-up|0|||
23452935|NCT02898454|65399151|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
23452936|NCT02898454|65399152|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
23452937|NCT02898454|65399153|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
23452938|NCT00960375|65399154|FG000|Overall Study|Lost to Follow-up|20|||
23452939|NCT00960375|65399155|FG001|Overall Study|Lost to Follow-up|22|||
23452940|NCT03186209|65399156|FG000|Overall Study|Withdrawal by Subject|11|||
23452941|NCT03186209|65399157|FG001|Overall Study|Withdrawal by Subject|22|||
23452942|NCT03186209|65399156|FG000|Overall Study|Pregnancy|1|||
23452943|NCT03186209|65399157|FG001|Overall Study|Pregnancy|0|||
23452944|NCT03186209|65399156|FG000|Overall Study|Adverse Event|4|||
23452945|NCT03186209|65399157|FG001|Overall Study|Adverse Event|0|||
23452946|NCT03186209|65399156|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
23452947|NCT03186209|65399157|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
23452948|NCT03186209|65399156|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
23452949|NCT03186209|65399157|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
23452950|NCT03186209|65399156|FG000|Overall Study|Fail to meet randomization criteria|0|||
23452951|NCT03186209|65399157|FG001|Overall Study|Fail to meet randomization criteria|1|||
23452952|NCT03186209|65399156|FG000|Overall Study|Lost to Follow-up|0|||
23452953|NCT03186209|65399157|FG001|Overall Study|Lost to Follow-up|1|||
23452954|NCT00772538|65403176|FG000|Overall Study|Adverse Event|6|||
23452955|NCT00772538|65403177|FG001|Overall Study|Adverse Event|6|||
23452956|NCT00772538|65403176|FG000|Overall Study|Protocol Violation|3|||
23452957|NCT00772538|65403177|FG001|Overall Study|Protocol Violation|3|||
23452958|NCT00772538|65403176|FG000|Overall Study|Lost to Follow-up|1|||
23452959|NCT00772538|65403177|FG001|Overall Study|Lost to Follow-up|1|||
23452960|NCT00772538|65403176|FG000|Overall Study|Withdrawal by Subject|3|||
23452961|NCT00772538|65403177|FG001|Overall Study|Withdrawal by Subject|8|||
23452962|NCT00772538|65403176|FG000|Overall Study|Lack of Efficacy|0|||
23452963|NCT00772538|65403177|FG001|Overall Study|Lack of Efficacy|1|||
23452964|NCT00772538|65403176|FG000|Overall Study|Other|7|||
23452965|NCT00772538|65403177|FG001|Overall Study|Other|7|||
23452966|NCT01924845|65403178|FG000|Overall Study|Adverse Event|3|||
23452967|NCT01924845|65403178|FG000|Overall Study|Withdrawal by Subject|2|||
23452968|NCT01924845|65403178|FG000|Overall Study|Protocol Violation|1|||
23452969|NCT02399215|65403179|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
23452970|NCT02399215|65403179|FG000|Overall Study|Withdrawal by Subject|1|||
23452971|NCT01052493|65403180|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
23452972|NCT01052493|65403181|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
23452973|NCT01052493|65403182|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
23452974|NCT00686777|65403183|FG000|Overall Study|Adverse Event|2|||
23452975|NCT00686777|65403183|FG000|Overall Study|Pregnancy|1|||
23452976|NCT00686777|65403183|FG000|Overall Study|Withdrawal by Subject|2|||
23452977|NCT00686777|65403183|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
23452978|NCT00686777|65403183|FG000|Overall Study|No Visit|1|||
23452979|NCT00774046|65403185|FG000|Screening|Not eligible|56|||
23452980|NCT00774046|65403185|FG000|Enrollment|Desired other therapy/refused|28|||
23452981|NCT00774046|65403185|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
23236244|NCT04212221|64608175|FG007|Overall Study|Global Deterioration of Health Status|2|||
23452982|NCT01232868|65403186|FG000|Overall Study|Lost to Follow-up|2|||
23452983|NCT01232868|65403187|FG001|Overall Study|Lost to Follow-up|4|||
23452984|NCT03473236|65403188|FG000|Overall Study|Withdrawal by Subject|0|||
23452985|NCT03473236|65403189|FG001|Overall Study|Withdrawal by Subject|0|||
23452986|NCT03473236|65403190|FG002|Overall Study|Withdrawal by Subject|0|||
23452987|NCT03473236|65403191|FG003|Overall Study|Withdrawal by Subject|0|||
23452988|NCT03473236|65403192|FG004|Overall Study|Withdrawal by Subject|0|||
23452989|NCT03473236|65403193|FG005|Overall Study|Withdrawal by Subject|1|||
23452990|NCT03473236|65403194|FG006|Overall Study|Withdrawal by Subject|0|||
23452991|NCT03473236|65403195|FG007|Overall Study|Withdrawal by Subject|0|||
23452992|NCT03473236|65403196|FG008|Overall Study|Withdrawal by Subject|1|||
23452993|NCT03473236|65403197|FG009|Overall Study|Withdrawal by Subject|0|||
23452994|NCT02173769|65403198|FG000|Overall Study|Protocol Violation|4|||
23452995|NCT01405768|65403199|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
23452996|NCT01405768|65403200|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
23452997|NCT01582061|65403204|FG000|Overall Study|Lack of Efficacy|3|||
23452998|NCT01582061|65403205|FG001|Overall Study|Lack of Efficacy|23|||
23452999|NCT01582061|65403204|FG000|Overall Study|Adverse Event|12|||
23453000|NCT01582061|65403205|FG001|Overall Study|Adverse Event|8|||
23453001|NCT01582061|65403204|FG000|Overall Study|Withdrawal by Subject|10|||
23453002|NCT01582061|65403205|FG001|Overall Study|Withdrawal by Subject|4|||
23236245|NCT04212221|64608168|FG000|Overall Study|Investigator's Decision|0|||
23236246|NCT04212221|64608169|FG001|Overall Study|Investigator's Decision|0|||
23236247|NCT04212221|64608170|FG002|Overall Study|Investigator's Decision|0|||
23236248|NCT04212221|64608171|FG003|Overall Study|Investigator's Decision|1|||
23453003|NCT01582061|65403204|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23453004|NCT01582061|65403205|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23236249|NCT04212221|64608172|FG004|Overall Study|Investigator's Decision|0|||
23236250|NCT04212221|64608173|FG005|Overall Study|Investigator's Decision|0|||
23236251|NCT04212221|64608174|FG006|Overall Study|Investigator's Decision|3|||
23236252|NCT04212221|64608175|FG007|Overall Study|Investigator's Decision|0|||
23236253|NCT04212221|64608168|FG000|Overall Study|Participant refused to continue treatment|0|||
23236254|NCT04212221|64608169|FG001|Overall Study|Participant refused to continue treatment|1|||
23453005|NCT01582061|65403204|FG000|Overall Study|Death|0|||
23453006|NCT01582061|65403205|FG001|Overall Study|Death|1|||
23453007|NCT01582061|65403204|FG000|Overall Study|condition no longer requires study drug|1|||
23453008|NCT01582061|65403205|FG001|Overall Study|condition no longer requires study drug|0|||
23453009|NCT01582061|65403204|FG000|Overall Study|Lost to Follow-up|1|||
23453010|NCT01582061|65403205|FG001|Overall Study|Lost to Follow-up|0|||
23453011|NCT01576341|65403206|FG000|Overall Study|Withdrawal by Subject|24|||
23453012|NCT01576341|65403206|FG000|Overall Study|Adverse Event|10|||
23453013|NCT01576341|65403206|FG000|Overall Study|Death|21|||
23453014|NCT01576341|65403206|FG000|Overall Study|Physician Decision|2|||
23453015|NCT01576341|65403206|FG000|Overall Study|Lost to Follow-up|2|||
23453016|NCT01576341|65403206|FG000|Overall Study|Kidney transplantation|10|||
23453017|NCT01576341|65403206|FG000|Overall Study|Protocol Violation|12|||
23453018|NCT01576341|65403206|FG000|Overall Study|Other|12|||
23453019|NCT04481243|65403207|FG000|Overall Study|Withdrawal by Subject|4|||
23453020|NCT01129622|65403208|FG000|Overall Study|Withdrawal by Subject|2|||
23453021|NCT00525512|65403214|FG000|Double-Blind Phase|Adverse Event|48|||
23453022|NCT00525512|65403215|FG001|Double-Blind Phase|Adverse Event|28|||
23453023|NCT00525512|65403216|FG002|Double-Blind Phase|Adverse Event|0|||
23453024|NCT00525512|65403217|FG003|Double-Blind Phase|Adverse Event|0|||
23453025|NCT00525512|65403214|FG000|Double-Blind Phase|Protocol Violation|3|||
23453026|NCT00525512|65403215|FG001|Double-Blind Phase|Protocol Violation|1|||
23453027|NCT00525512|65403216|FG002|Double-Blind Phase|Protocol Violation|0|||
23453028|NCT00525512|65403217|FG003|Double-Blind Phase|Protocol Violation|0|||
23453029|NCT00525512|65403214|FG000|Double-Blind Phase|Lost to Follow-up|3|||
23236255|NCT04212221|64608170|FG002|Overall Study|Participant refused to continue treatment|0|||
23453030|NCT00525512|65403215|FG001|Double-Blind Phase|Lost to Follow-up|7|||
23453031|NCT00525512|65403216|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23236256|NCT04212221|64608171|FG003|Overall Study|Participant refused to continue treatment|1|||
23236257|NCT04212221|64608172|FG004|Overall Study|Participant refused to continue treatment|1|||
23236258|NCT04212221|64608173|FG005|Overall Study|Participant refused to continue treatment|2|||
23236259|NCT04212221|64608174|FG006|Overall Study|Participant refused to continue treatment|4|||
23236260|NCT04212221|64608175|FG007|Overall Study|Participant refused to continue treatment|2|||
23236261|NCT04212221|64608168|FG000|Overall Study|Protocol Violation|0|||
23236262|NCT04212221|64608169|FG001|Overall Study|Protocol Violation|0|||
23236263|NCT04212221|64608170|FG002|Overall Study|Protocol Violation|0|||
23236264|NCT04212221|64608171|FG003|Overall Study|Protocol Violation|0|||
23236265|NCT04212221|64608172|FG004|Overall Study|Protocol Violation|0|||
23236266|NCT04212221|64608173|FG005|Overall Study|Protocol Violation|0|||
23236267|NCT04212221|64608174|FG006|Overall Study|Protocol Violation|0|||
23236268|NCT04212221|64608175|FG007|Overall Study|Protocol Violation|1|||
23236269|NCT01855919|64608176|FG000|Overall Study|Adverse Event|16|||
23236270|NCT01855919|64608177|FG001|Overall Study|Adverse Event|8|||
23236271|NCT01855919|64608176|FG000|Overall Study|Lack of Efficacy|1|||
23236272|NCT01855919|64608177|FG001|Overall Study|Lack of Efficacy|3|||
23236273|NCT01855919|64608176|FG000|Overall Study|Withdrawal by Subject|4|||
23236274|NCT01855919|64608177|FG001|Overall Study|Withdrawal by Subject|10|||
23236275|NCT01855919|64608176|FG000|Overall Study|Entry Criteria Not Met|1|||
23236276|NCT01855919|64608177|FG001|Overall Study|Entry Criteria Not Met|1|||
23236277|NCT01855919|64608176|FG000|Overall Study|Protocol Violation|1|||
23236278|NCT01855919|64608177|FG001|Overall Study|Protocol Violation|4|||
23236279|NCT02127931|64608181|FG000|Overall Study|Glitch in Game|1|||
23236280|NCT02390167|64608182|FG000|Overall Study|Lost to Follow-up|1|||
23236281|NCT01377194|64608185|FG000|Overall Study|Adverse Event|3|||
23581904|NCT05074498|65859128|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
23581905|NCT05074498|65859123|FG000|Part 2 (Upto Day 104)|Other|0|||
23236282|NCT01377194|64608186|FG001|Overall Study|Adverse Event|12|||
23236283|NCT01377194|64608187|FG002|Overall Study|Adverse Event|19|||
23236284|NCT01377194|64608185|FG000|Overall Study|Lack of Efficacy|3|||
23236285|NCT01377194|64608186|FG001|Overall Study|Lack of Efficacy|3|||
23236286|NCT01377194|64608187|FG002|Overall Study|Lack of Efficacy|3|||
23236287|NCT01377194|64608185|FG000|Overall Study|Protocol Violation|4|||
23236288|NCT01377194|64608186|FG001|Overall Study|Protocol Violation|10|||
23236289|NCT01377194|64608187|FG002|Overall Study|Protocol Violation|6|||
23236290|NCT01377194|64608185|FG000|Overall Study|Withdrawal by Subject|8|||
23236291|NCT01377194|64608186|FG001|Overall Study|Withdrawal by Subject|10|||
23236292|NCT01377194|64608187|FG002|Overall Study|Withdrawal by Subject|7|||
23236293|NCT01377194|64608185|FG000|Overall Study|Lost to Follow-up|14|||
23581906|NCT05074498|65859124|FG001|Part 2 (Upto Day 104)|Other|0|||
23581907|NCT05074498|65859125|FG002|Part 2 (Upto Day 104)|Other|0|||
23581908|NCT05074498|65859126|FG003|Part 2 (Upto Day 104)|Other|0|||
23581909|NCT05074498|65859127|FG004|Part 2 (Upto Day 104)|Other|1|||
23581910|NCT05074498|65859128|FG005|Part 2 (Upto Day 104)|Other|0|||
23581911|NCT00748969|65859131|FG000|Overall Study|Withdrawal by Subject|1|||
23581912|NCT00748969|65859132|FG001|Overall Study|Withdrawal by Subject|0|||
23581913|NCT00748969|65859131|FG000|Overall Study|Withdrawal by Subject|0|||
23581914|NCT00748969|65859132|FG001|Overall Study|Withdrawal by Subject|1|||
23581915|NCT04536077|65859133|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
23581916|NCT04536077|65859134|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
23581917|NCT04536077|65859133|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
23581918|NCT04536077|65859134|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
23581919|NCT01414166|65859135|FG000|Overall Study|Adverse Event|10|||
23581920|NCT01414166|65859136|FG001|Overall Study|Adverse Event|2|||
23581921|NCT01414166|65859135|FG000|Overall Study|Lost to Follow-up|4|||
23581922|NCT01414166|65859136|FG001|Overall Study|Lost to Follow-up|1|||
23581923|NCT01414166|65859135|FG000|Overall Study|Non-compliance with study drug|2|||
23581924|NCT01414166|65859136|FG001|Overall Study|Non-compliance with study drug|0|||
23581925|NCT01414166|65859135|FG000|Overall Study|Physician Decision|2|||
23581926|NCT01414166|65859136|FG001|Overall Study|Physician Decision|0|||
23581927|NCT01414166|65859135|FG000|Overall Study|Protocol Violation|2|||
23581928|NCT01414166|65859136|FG001|Overall Study|Protocol Violation|0|||
23581929|NCT01414166|65859135|FG000|Overall Study|Study terminated by Sponsor|68|||
23581930|NCT01414166|65859136|FG001|Overall Study|Study terminated by Sponsor|75|||
23581931|NCT01414166|65859135|FG000|Overall Study|Withdrawal by Subject|3|||
23581932|NCT01414166|65859136|FG001|Overall Study|Withdrawal by Subject|5|||
23236294|NCT01377194|64608186|FG001|Overall Study|Lost to Follow-up|8|||
23236295|NCT01377194|64608187|FG002|Overall Study|Lost to Follow-up|11|||
23236296|NCT01101321|64608192|FG000|Period 1|Withdrawal by Subject|1|||
23236297|NCT01101321|64608193|FG001|Period 1|Withdrawal by Subject|1|||
23236298|NCT01101321|64608192|FG000|Period 1|Adverse Event|3|||
23236299|NCT01101321|64608193|FG001|Period 1|Adverse Event|3|||
23236300|NCT03258710|64608195|FG000|Overall Study|Adverse Event|1|||
23236301|NCT03258710|64608195|FG000|Overall Study|Protocol-defined stopping criteria|1|||
23236302|NCT03258710|64608195|FG000|Overall Study|Physician Decision|1|||
23175354|NCT00896532|64386438|FG013|Months 48-72: Follow-on Phase|Death|0|||
23175355|NCT00896532|64386439|FG014|Months 48-72: Follow-on Phase|Death|0|||
23175356|NCT00896532|64386440|FG015|Months 48-72: Follow-on Phase|Death|0|||
23175357|NCT00896532|64386441|FG016|Months 48-72: Follow-on Phase|Death|0|||
23175358|NCT00896532|64386442|FG017|Months 48-72: Follow-on Phase|Death|0|||
23175359|NCT00896532|64386443|FG018|Months 48-72: Follow-on Phase|Death|1|||
23175360|NCT00896532|64386444|FG019|Months 48-72: Follow-on Phase|Death|0|||
23175361|NCT00896532|64386445|FG020|Months 48-72: Follow-on Phase|Death|0|||
23175362|NCT00896532|64386446|FG021|Months 48-72: Follow-on Phase|Death|0|||
23175363|NCT00896532|64386447|FG022|Months 48-72: Follow-on Phase|Death|0|||
23175364|NCT00896532|64386425|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23453032|NCT00525512|65403217|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23453033|NCT00525512|65403214|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
23453034|NCT00525512|65403215|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
23453035|NCT00525512|65403216|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23453036|NCT00525512|65403217|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23453037|NCT00525512|65403214|FG000|Double-Blind Phase|Lack of Efficacy|13|||
23453038|NCT00525512|65403215|FG001|Double-Blind Phase|Lack of Efficacy|5|||
23453039|NCT00525512|65403216|FG002|Double-Blind Phase|Lack of Efficacy|0|||
23453040|NCT00525512|65403217|FG003|Double-Blind Phase|Lack of Efficacy|0|||
23453041|NCT00525512|65403214|FG000|Double-Blind Phase|Other reason (not specified)|12|||
23453042|NCT00525512|65403215|FG001|Double-Blind Phase|Other reason (not specified)|13|||
23453043|NCT00525512|65403216|FG002|Double-Blind Phase|Other reason (not specified)|0|||
23453044|NCT00525512|65403217|FG003|Double-Blind Phase|Other reason (not specified)|0|||
23453045|NCT00525512|65403214|FG000|Open-Label Phase|Adverse Event|0|||
23453046|NCT00525512|65403215|FG001|Open-Label Phase|Adverse Event|0|||
23453047|NCT00525512|65403216|FG002|Open-Label Phase|Adverse Event|1|||
23453048|NCT00525512|65403217|FG003|Open-Label Phase|Adverse Event|0|||
23453049|NCT00525512|65403214|FG000|Open-Label Phase|Lost to Follow-up|0|||
23453050|NCT00525512|65403215|FG001|Open-Label Phase|Lost to Follow-up|0|||
23453051|NCT00525512|65403216|FG002|Open-Label Phase|Lost to Follow-up|1|||
23453052|NCT00525512|65403217|FG003|Open-Label Phase|Lost to Follow-up|0|||
23453053|NCT00525512|65403214|FG000|Open-Label Phase|Other reason (not specified)|0|||
23581933|NCT01460381|65859139|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
23581934|NCT01460381|65859140|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
23581935|NCT01649427|65859141|FG000|Overall Study|Adverse Event|1|||
23581936|NCT01649427|65859142|FG001|Overall Study|Adverse Event|1|||
23581937|NCT01649427|65859141|FG000|Overall Study|Withdrawal by Subject|8|||
23581938|NCT01649427|65859142|FG001|Overall Study|Withdrawal by Subject|7|||
23581939|NCT01649427|65859141|FG000|Overall Study|Lost to Follow-up|0|||
23581940|NCT01649427|65859142|FG001|Overall Study|Lost to Follow-up|1|||
23581941|NCT01649427|65859141|FG000|Overall Study|Graft loss|0|||
23581942|NCT01649427|65859142|FG001|Overall Study|Graft loss|1|||
23581943|NCT01649427|65859141|FG000|Overall Study|Surgical problems during nephrectomy|2|||
23581944|NCT01649427|65859142|FG001|Overall Study|Surgical problems during nephrectomy|2|||
23581945|NCT04639947|65859143|FG000|Overall Study|Screen fail|1|||
23581946|NCT01257503|65859148|FG000|Overall Study|Lost to Follow-up|7|||
23581947|NCT01257503|65859149|FG001|Overall Study|Lost to Follow-up|10|||
23581948|NCT01257503|65859148|FG000|Overall Study|Over 5 years old at enrollment|0|||
23581949|NCT01257503|65859149|FG001|Overall Study|Over 5 years old at enrollment|1|||
23581950|NCT01257503|65859148|FG000|Overall Study|strep culture positive at enrollment|1|||
23581951|NCT01257503|65859149|FG001|Overall Study|strep culture positive at enrollment|0|||
23581952|NCT01427907|65859150|FG000|Overall Study|Withdrawal by Subject|3|||
23581953|NCT01427907|65859151|FG001|Overall Study|Withdrawal by Subject|4|||
23581954|NCT01744691|65859152|FG000|Overall Study|Progressive Disease|18|||
23581955|NCT01744691|65859152|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
23581956|NCT01744691|65859152|FG000|Overall Study|Withdrawal of consent for treatment|3|||
23581957|NCT01744691|65859152|FG000|Overall Study|Physician Decision|4|||
23581958|NCT03686683|65859153|FG000|Overall Study|Withdrawal by Subject|52|||
23581959|NCT03686683|65859154|FG001|Overall Study|Withdrawal by Subject|32|||
23581960|NCT03686683|65859153|FG000|Overall Study|Lost to Follow-up|23|||
23581961|NCT03686683|65859154|FG001|Overall Study|Lost to Follow-up|19|||
23581962|NCT03686683|65859153|FG000|Overall Study|Adverse Event|1|||
23581963|NCT03686683|65859154|FG001|Overall Study|Adverse Event|0|||
23581964|NCT03686683|65859153|FG000|Overall Study|Death|10|||
23581965|NCT03686683|65859154|FG001|Overall Study|Death|5|||
23581966|NCT03686683|65859153|FG000|Overall Study|Progressive Disease|1|||
23581967|NCT03686683|65859154|FG001|Overall Study|Progressive Disease|1|||
23581968|NCT03686683|65859153|FG000|Overall Study|Noncompliance|1|||
23581969|NCT03686683|65859154|FG001|Overall Study|Noncompliance|0|||
23581970|NCT03686683|65859153|FG000|Overall Study|Physician Decision|1|||
23453054|NCT00525512|65403215|FG001|Open-Label Phase|Other reason (not specified)|0|||
23581971|NCT03686683|65859154|FG001|Overall Study|Physician Decision|1|||
23581972|NCT03686683|65859153|FG000|Overall Study|Screen fail post-randomization|1|||
23581973|NCT03686683|65859154|FG001|Overall Study|Screen fail post-randomization|0|||
23175365|NCT00896532|64386426|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23453055|NCT00525512|65403216|FG002|Open-Label Phase|Other reason (not specified)|4|||
23453056|NCT00525512|65403217|FG003|Open-Label Phase|Other reason (not specified)|5|||
23453057|NCT04011540|65403220|FG000|Overall Study|Lost to Follow-up|9|||
23453058|NCT04011540|65403221|FG001|Overall Study|Lost to Follow-up|6|||
23453059|NCT02021565|65403222|FG000|Baseline Through Intervention|Death|0|||
23453060|NCT02021565|65403223|FG001|Baseline Through Intervention|Death|1|||
23453061|NCT02021565|65403222|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
23453062|NCT02021565|65403223|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
23453063|NCT02021565|65403222|FG000|Baseline Through Intervention|Protocol Violation|0|||
23453064|NCT02021565|65403223|FG001|Baseline Through Intervention|Protocol Violation|7|||
23453065|NCT02021565|65403222|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
23453066|NCT02021565|65403223|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
23453067|NCT02021565|65403222|FG000|3-month Follow-up|Death|3|||
23453068|NCT02021565|65403223|FG001|3-month Follow-up|Death|0|||
23453069|NCT02021565|65403222|FG000|3-month Follow-up|Withdrawal by Subject|4|||
23453070|NCT02021565|65403223|FG001|3-month Follow-up|Withdrawal by Subject|0|||
23453071|NCT02021565|65403222|FG000|3-month Follow-up|Protocol Violation|3|||
23453072|NCT02021565|65403223|FG001|3-month Follow-up|Protocol Violation|2|||
23453073|NCT02314052|65403224|FG000|Cycle One|Adverse Event|0|||
23453074|NCT02314052|65403225|FG001|Cycle One|Adverse Event|0|||
23453075|NCT02314052|65403226|FG002|Cycle One|Adverse Event|0|||
23453076|NCT02314052|65403227|FG003|Cycle One|Adverse Event|1|||
23453077|NCT02314052|65403228|FG004|Cycle One|Adverse Event|0|||
23453078|NCT02314052|65403229|FG005|Cycle One|Adverse Event|0|||
23453079|NCT02872116|65403230|FG000|Pre-Treatment|Disease Progression|0|||
23453080|NCT02872116|65403231|FG001|Pre-Treatment|Disease Progression|1|||
23453081|NCT02872116|65403232|FG002|Pre-Treatment|Disease Progression|0|||
23453082|NCT02872116|65403230|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
23453083|NCT02872116|65403231|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
23453084|NCT02872116|65403232|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
23453085|NCT02872116|65403230|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
23453086|NCT02872116|65403231|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
23453087|NCT02872116|65403232|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
23453088|NCT02872116|65403230|FG000|Pre-Treatment|Participant withdrew consent|2|||
23453089|NCT02872116|65403231|FG001|Pre-Treatment|Participant withdrew consent|20|||
23453090|NCT02872116|65403232|FG002|Pre-Treatment|Participant withdrew consent|3|||
23453091|NCT02872116|65403230|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
23453092|NCT02872116|65403231|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
23453093|NCT02872116|65403232|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
23453094|NCT02872116|65403230|FG000|Pre-Treatment|Other reasons|1|||
23453095|NCT02872116|65403231|FG001|Pre-Treatment|Other reasons|2|||
23453096|NCT02872116|65403232|FG002|Pre-Treatment|Other reasons|2|||
23236303|NCT03633461|64608196|FG000|Overall Study|Lost to Follow-up|0|||
23236304|NCT03633461|64608197|FG001|Overall Study|Lost to Follow-up|1|||
23236305|NCT02546193|64608198|FG000|Overall Study|Withdrawal by Subject|2|||
23236306|NCT02546193|64608199|FG001|Overall Study|Withdrawal by Subject|0|||
23236307|NCT02546193|64608200|FG002|Overall Study|Withdrawal by Subject|1|||
23236308|NCT02546193|64608201|FG003|Overall Study|Withdrawal by Subject|0|||
23236309|NCT02546193|64608198|FG000|Overall Study|Not eligible at time of induction|4|||
23236310|NCT02546193|64608199|FG001|Overall Study|Not eligible at time of induction|6|||
23236311|NCT02546193|64608200|FG002|Overall Study|Not eligible at time of induction|1|||
23236312|NCT02546193|64608201|FG003|Overall Study|Not eligible at time of induction|0|||
23236313|NCT02493712|64608202|FG000|Overall Study|Withdrawal by Subject|1|||
23236314|NCT02493712|64608203|FG001|Overall Study|Withdrawal by Subject|0|||
23236315|NCT02493712|64608204|FG002|Overall Study|Withdrawal by Subject|2|||
23236316|NCT02493712|64608202|FG000|Overall Study|Protocol Violation|0|||
23236317|NCT02493712|64608203|FG001|Overall Study|Protocol Violation|0|||
23236318|NCT02493712|64608204|FG002|Overall Study|Protocol Violation|1|||
23236319|NCT02493712|64608202|FG000|Overall Study|Lost to Follow-up|1|||
23236320|NCT02493712|64608203|FG001|Overall Study|Lost to Follow-up|0|||
23236321|NCT02493712|64608204|FG002|Overall Study|Lost to Follow-up|0|||
23236322|NCT02493712|64608202|FG000|Overall Study|Physician Decision|0|||
23236323|NCT02493712|64608203|FG001|Overall Study|Physician Decision|1|||
23236324|NCT02493712|64608204|FG002|Overall Study|Physician Decision|0|||
23236325|NCT02493712|64608202|FG000|Overall Study|Lack of Efficacy|0|||
23236326|NCT02493712|64608203|FG001|Overall Study|Lack of Efficacy|5|||
23453097|NCT02872116|65403230|FG000|Treatment|Death|122|||
23453098|NCT02872116|65403231|FG001|Treatment|Death|94|||
23453099|NCT02872116|65403232|FG002|Treatment|Death|68|||
23236327|NCT02493712|64608204|FG002|Overall Study|Lack of Efficacy|3|||
23236328|NCT01430559|64608205|FG000|Overall Study|Adverse Event|7|||
23236329|NCT01430559|64608206|FG001|Overall Study|Adverse Event|3|||
23236330|NCT01430559|64608205|FG000|Overall Study|Entry criteria not met|1|||
23236331|NCT01430559|64608206|FG001|Overall Study|Entry criteria not met|1|||
23236332|NCT01430559|64608205|FG000|Overall Study|Lost to Follow-up|1|||
23236333|NCT01430559|64608206|FG001|Overall Study|Lost to Follow-up|0|||
23236334|NCT01430559|64608205|FG000|Overall Study|Medication error|1|||
23236335|NCT01430559|64608206|FG001|Overall Study|Medication error|0|||
23236336|NCT01430559|64608205|FG000|Overall Study|Withdrawal by Subject|3|||
23236337|NCT01430559|64608206|FG001|Overall Study|Withdrawal by Subject|2|||
23236338|NCT01430559|64608205|FG000|Overall Study|Protocol Violation|1|||
23236339|NCT01430559|64608206|FG001|Overall Study|Protocol Violation|0|||
23236340|NCT01430559|64608205|FG000|Overall Study|Other|3|||
23236341|NCT01430559|64608206|FG001|Overall Study|Other|3|||
23236342|NCT01430559|64608205|FG000|Overall Study|Randomized, Not Treated|3|||
23236343|NCT01430559|64608206|FG001|Overall Study|Randomized, Not Treated|3|||
23236344|NCT02418000|64608211|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
23236345|NCT02418000|64608212|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
23236346|NCT02418000|64608213|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
23236347|NCT02418000|64608214|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
23236348|NCT02418000|64608215|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
23236349|NCT02418000|64608211|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
23236350|NCT02418000|64608212|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
23340732|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
23175366|NCT00896532|64386427|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23340733|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
23340734|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
23340735|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
23453100|NCT02872116|65403230|FG000|Treatment|Lost to Follow-up|5|||
23453101|NCT02872116|65403231|FG001|Treatment|Lost to Follow-up|7|||
23453102|NCT02872116|65403232|FG002|Treatment|Lost to Follow-up|3|||
23453103|NCT02872116|65403230|FG000|Treatment|Participant withdrew consent|20|||
23453104|NCT02872116|65403231|FG001|Treatment|Participant withdrew consent|40|||
23453105|NCT02872116|65403232|FG002|Treatment|Participant withdrew consent|8|||
23453106|NCT02872116|65403230|FG000|Treatment|Other reasons|12|||
23453107|NCT02872116|65403231|FG001|Treatment|Other reasons|12|||
23453108|NCT02872116|65403232|FG002|Treatment|Other reasons|5|||
23453109|NCT00141102|65403233|FG000|Overall Study|Adverse Event|233|||
23453110|NCT00141102|65403234|FG001|Overall Study|Adverse Event|305|||
23453111|NCT00141102|65403233|FG000|Overall Study|Laboratory Abnormality|9|||
23453112|NCT00141102|65403234|FG001|Overall Study|Laboratory Abnormality|33|||
23453113|NCT00141102|65403233|FG000|Overall Study|Lack of Efficacy|21|||
23453114|NCT00141102|65403234|FG001|Overall Study|Lack of Efficacy|26|||
23453115|NCT00141102|65403233|FG000|Overall Study|Lost to Follow-up|29|||
23453116|NCT00141102|65403234|FG001|Overall Study|Lost to Follow-up|32|||
23453117|NCT00141102|65403233|FG000|Overall Study|Other|87|||
23453118|NCT00141102|65403234|FG001|Overall Study|Other|76|||
23453119|NCT00141102|65403233|FG000|Overall Study|Withdrawal by Subject|112|||
23453120|NCT00141102|65403234|FG001|Overall Study|Withdrawal by Subject|142|||
23453121|NCT00141102|65403233|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
23453122|NCT00141102|65403234|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
23175367|NCT00896532|64386428|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175368|NCT00896532|64386429|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175369|NCT00896532|64386430|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175370|NCT00896532|64386431|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175371|NCT00896532|64386432|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175372|NCT00896532|64386433|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175373|NCT00896532|64386434|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175374|NCT00896532|64386435|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175375|NCT00896532|64386436|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175376|NCT00896532|64386437|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175377|NCT00896532|64386438|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175378|NCT00896532|64386439|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175379|NCT00896532|64386440|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175380|NCT00896532|64386441|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175381|NCT00896532|64386442|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175382|NCT00896532|64386443|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175383|NCT00896532|64386444|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175384|NCT00896532|64386445|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23175385|NCT00896532|64386446|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
23236351|NCT02418000|64608213|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
23236352|NCT02418000|64608214|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
23236353|NCT02418000|64608215|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
23236354|NCT02418000|64608211|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
23236355|NCT02418000|64608212|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
23236356|NCT02418000|64608213|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
23236357|NCT02418000|64608214|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
23453123|NCT00141102|65403233|FG000|Overall Study|Death|2|||
23453124|NCT00141102|65403234|FG001|Overall Study|Death|2|||
23453125|NCT00112736|65403235|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
23453126|NCT00112736|65403236|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
23453127|NCT02051764|65403237|FG000|Overall Study|Study terminated by sponsor|0|||
23340736|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
23340737|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
23340738|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
23340739|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Other|8|||
23340740|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Other|14|||
23340741|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Other|8|||
23340742|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Other|23|||
23340743|NCT01106677|64992840|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
23340744|NCT01106677|64992841|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
23340745|NCT01106677|64992842|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
23340746|NCT01106677|64992843|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
23340747|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23340748|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23581974|NCT03686683|65859153|FG000|Overall Study|Protocol Violation|3|||
23581975|NCT03686683|65859154|FG001|Overall Study|Protocol Violation|0|||
23175386|NCT00896532|64386447|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
23581976|NCT03686683|65859153|FG000|Overall Study|No data available|1|||
23175387|NCT00896532|64386425|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175388|NCT00896532|64386426|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175389|NCT00896532|64386427|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175390|NCT00896532|64386428|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175391|NCT00896532|64386429|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175392|NCT00896532|64386430|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175393|NCT00896532|64386431|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175394|NCT00896532|64386432|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175395|NCT00896532|64386433|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175396|NCT00896532|64386434|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175397|NCT00896532|64386435|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175398|NCT00896532|64386436|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175399|NCT00896532|64386437|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175400|NCT00896532|64386438|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175401|NCT00896532|64386439|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175402|NCT00896532|64386440|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175403|NCT00896532|64386441|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175404|NCT00896532|64386442|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175405|NCT00896532|64386443|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175406|NCT00896532|64386444|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175407|NCT00896532|64386445|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175408|NCT00896532|64386446|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
23175409|NCT00896532|64386447|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
23175410|NCT01014585|64386454|FG000|Overall Study|Adverse Event|0|||
23175411|NCT01014585|64386455|FG001|Overall Study|Adverse Event|2|||
23175412|NCT01014585|64386456|FG002|Overall Study|Adverse Event|0|||
23175413|NCT01014585|64386457|FG003|Overall Study|Adverse Event|3|||
23175414|NCT01014585|64386454|FG000|Overall Study|Withdrawal by Subject|2|||
23175415|NCT01014585|64386455|FG001|Overall Study|Withdrawal by Subject|0|||
23175416|NCT01014585|64386456|FG002|Overall Study|Withdrawal by Subject|1|||
23175417|NCT01014585|64386457|FG003|Overall Study|Withdrawal by Subject|3|||
23175418|NCT01014585|64386454|FG000|Overall Study|Lost to Follow-up|0|||
23175419|NCT01014585|64386455|FG001|Overall Study|Lost to Follow-up|0|||
23175420|NCT01014585|64386456|FG002|Overall Study|Lost to Follow-up|0|||
23175421|NCT01014585|64386457|FG003|Overall Study|Lost to Follow-up|2|||
23175422|NCT01014585|64386454|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
23175423|NCT01014585|64386455|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
23175424|NCT01014585|64386456|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
23175425|NCT01014585|64386457|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
23175426|NCT02542072|64386458|FG000|First Intervention (1 Month)|Adverse Event|1|||
23175427|NCT02542072|64386459|FG001|First Intervention (1 Month)|Adverse Event|1|||
23175428|NCT02542072|64386458|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
23175429|NCT02542072|64386459|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
23175430|NCT02542072|64386458|FG000|First Intervention (1 Month)|Lens discomfort|1|||
23175431|NCT02542072|64386459|FG001|First Intervention (1 Month)|Lens discomfort|2|||
23175432|NCT02542072|64386458|FG000|First Intervention (1 Month)|Protocol Violation|1|||
23175433|NCT02542072|64386459|FG001|First Intervention (1 Month)|Protocol Violation|0|||
23340749|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
23340750|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
23340751|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Death|0|||
23175434|NCT02542072|64386458|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
23175435|NCT02542072|64386459|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
23340752|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Death|0|||
23340753|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Death|0|||
23340754|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Death|1|||
23340755|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
23340756|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
23340757|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
23340758|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
23340759|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23340760|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
23340761|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
23340762|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
23340763|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23340764|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
23340765|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23340766|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
23340767|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23340768|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23340769|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23340770|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
23340771|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23340772|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
23340773|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
23340774|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23340775|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
23340776|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
23340777|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
23340778|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
23340779|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23340780|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23340781|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23340782|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23340783|NCT01106677|64992840|FG000|Extension Period: Week 26 to Week 52|Other|6|||
23340784|NCT01106677|64992841|FG001|Extension Period: Week 26 to Week 52|Other|5|||
23340785|NCT01106677|64992842|FG002|Extension Period: Week 26 to Week 52|Other|8|||
23340786|NCT01106677|64992843|FG003|Extension Period: Week 26 to Week 52|Other|5|||
23340787|NCT00679289|64992844|FG000|Overall Study|Progressive disease|4|||
23340788|NCT00679289|64992845|FG001|Overall Study|Progressive disease|5|||
23453128|NCT02051764|65403238|FG001|Overall Study|Study terminated by sponsor|7|||
23453129|NCT00953667|65403239|FG000|Overall Study|Lost to Follow-up|11|||
23453130|NCT00953667|65403239|FG000|Overall Study|Physician Decision|35|||
23453131|NCT00953667|65403239|FG000|Overall Study|Withdrawal by Subject|63|||
23453132|NCT00953667|65403239|FG000|Overall Study|Adverse Event|10|||
23453133|NCT00953667|65403239|FG000|Overall Study|poor venous access,unable to draw blood|4|||
23453134|NCT01790594|65403240|FG000|Overall Study|Death|1|||
23453135|NCT01790594|65403241|FG001|Overall Study|Death|0|||
23453136|NCT01790594|65403242|FG002|Overall Study|Death|0|||
23453137|NCT01790594|65403240|FG000|Overall Study|Physician Decision|2|||
23453138|NCT01790594|65403241|FG001|Overall Study|Physician Decision|1|||
23453139|NCT01790594|65403242|FG002|Overall Study|Physician Decision|0|||
23453140|NCT01790594|65403240|FG000|Overall Study|Withdrawal by Subject|2|||
23453141|NCT01790594|65403241|FG001|Overall Study|Withdrawal by Subject|0|||
23453142|NCT01790594|65403242|FG002|Overall Study|Withdrawal by Subject|0|||
23453143|NCT01790594|65403240|FG000|Overall Study|Transplant was not done|0|||
23453144|NCT01790594|65403241|FG001|Overall Study|Transplant was not done|0|||
23453145|NCT01790594|65403242|FG002|Overall Study|Transplant was not done|3|||
23453146|NCT01790594|65403240|FG000|Overall Study|Terminated prior to week 76|0|||
23453147|NCT01790594|65403241|FG001|Overall Study|Terminated prior to week 76|2|||
23453148|NCT01790594|65403242|FG002|Overall Study|Terminated prior to week 76|0|||
23453149|NCT01217944|65403243|FG000|Overall Study|Protocol Violation|1|||
23453150|NCT01217944|65403244|FG001|Overall Study|Protocol Violation|1|||
23453151|NCT01217944|65403245|FG002|Overall Study|Protocol Violation|0|||
23453152|NCT01217944|65403243|FG000|Overall Study|Lost to Follow-up|3|||
23340789|NCT00679289|64992846|FG002|Overall Study|Progressive disease|18|||
23340790|NCT00679289|64992844|FG000|Overall Study|Withdrawal by Subject|0|||
23453153|NCT01217944|65403244|FG001|Overall Study|Lost to Follow-up|1|||
23453154|NCT01217944|65403245|FG002|Overall Study|Lost to Follow-up|0|||
23453155|NCT01217944|65403243|FG000|Overall Study|Withdrawal by Subject|1|||
23453156|NCT01217944|65403244|FG001|Overall Study|Withdrawal by Subject|2|||
23453157|NCT01217944|65403245|FG002|Overall Study|Withdrawal by Subject|0|||
23453158|NCT01217944|65403243|FG000|Overall Study|Lack of Efficacy|1|||
23340791|NCT00679289|64992845|FG001|Overall Study|Withdrawal by Subject|1|||
23340792|NCT00679289|64992846|FG002|Overall Study|Withdrawal by Subject|1|||
23340793|NCT00679289|64992844|FG000|Overall Study|Adverse Event|0|||
23340794|NCT00679289|64992845|FG001|Overall Study|Adverse Event|0|||
23340795|NCT00679289|64992846|FG002|Overall Study|Adverse Event|3|||
23340796|NCT00679289|64992844|FG000|Overall Study|Physician Decision|1|||
23340797|NCT00679289|64992845|FG001|Overall Study|Physician Decision|0|||
23340798|NCT00679289|64992846|FG002|Overall Study|Physician Decision|1|||
23340799|NCT01083186|64992847|FG000|Overall Study|Lost to Follow-up|48|||
23340800|NCT01083186|64992847|FG000|Overall Study|Consent Withdrawal|7|||
23340801|NCT01083186|64992847|FG000|Overall Study|Death|3|||
23175436|NCT02542072|64386458|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
23175437|NCT02542072|64386459|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
23175438|NCT03094195|64386460|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
23175439|NCT03094195|64386461|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
23175440|NCT03094195|64386462|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
23175441|NCT03094195|64386463|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23175442|NCT03094195|64386464|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23175443|NCT03094195|64386465|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23175444|NCT03094195|64386466|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23175445|NCT03094195|64386467|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23175446|NCT03094195|64386460|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
23175447|NCT03094195|64386461|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
23175448|NCT03094195|64386462|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
23175449|NCT03094195|64386463|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23175450|NCT03094195|64386464|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23175451|NCT03094195|64386465|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23175452|NCT03094195|64386466|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23175453|NCT03094195|64386467|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23175454|NCT03094195|64386460|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23175455|NCT03094195|64386461|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23175456|NCT03094195|64386462|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
23175457|NCT03094195|64386463|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23175458|NCT03094195|64386464|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23175459|NCT03094195|64386465|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23175460|NCT03094195|64386466|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23175461|NCT03094195|64386467|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23175462|NCT03094195|64386460|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23175463|NCT03094195|64386461|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
23175464|NCT03094195|64386462|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
23175465|NCT03094195|64386463|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23175466|NCT03094195|64386464|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23175467|NCT03094195|64386465|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23175468|NCT03094195|64386466|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23175469|NCT03094195|64386467|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23175470|NCT04957290|64386475|FG000|Overall Study|Progressive disease|3|||
23175471|NCT04957290|64386476|FG001|Overall Study|Progressive disease|3|||
23175472|NCT04957290|64386477|FG002|Overall Study|Progressive disease|2|||
23175473|NCT04957290|64386478|FG003|Overall Study|Progressive disease|0|||
23175474|NCT04957290|64386479|FG004|Overall Study|Progressive disease|0|||
23175475|NCT04957290|64386480|FG005|Overall Study|Progressive disease|0|||
23175476|NCT04957290|64386475|FG000|Overall Study|Withdrawal by Subject|1|||
23175477|NCT04957290|64386476|FG001|Overall Study|Withdrawal by Subject|0|||
23175478|NCT04957290|64386477|FG002|Overall Study|Withdrawal by Subject|1|||
23175479|NCT04957290|64386478|FG003|Overall Study|Withdrawal by Subject|0|||
23175480|NCT04957290|64386479|FG004|Overall Study|Withdrawal by Subject|0|||
23175481|NCT04957290|64386480|FG005|Overall Study|Withdrawal by Subject|0|||
23175482|NCT04957290|64386475|FG000|Overall Study|Death|0|||
23175483|NCT04957290|64386476|FG001|Overall Study|Death|2|||
23340802|NCT01083186|64992847|FG000|Overall Study|Adverse Event|3|||
23581977|NCT03686683|65859154|FG001|Overall Study|No data available|0|||
23581978|NCT02123966|65859158|FG000|Overall Study|Intercurrent Illness|1|||
23340803|NCT01083186|64992847|FG000|Overall Study|Lack of Efficacy|2|||
23581979|NCT01027871|65859159|FG000|Overall Study|Physician Decision|1|||
23581980|NCT01027871|65859160|FG001|Overall Study|Physician Decision|5|||
23581981|NCT01027871|65859161|FG002|Overall Study|Physician Decision|0|||
23581982|NCT01027871|65859159|FG000|Overall Study|Protocol Violation|0|||
23581983|NCT01027871|65859160|FG001|Overall Study|Protocol Violation|2|||
23175484|NCT04957290|64386477|FG002|Overall Study|Death|1|||
23175485|NCT04957290|64386478|FG003|Overall Study|Death|0|||
23175486|NCT04957290|64386479|FG004|Overall Study|Death|0|||
23175487|NCT04957290|64386480|FG005|Overall Study|Death|0|||
23175488|NCT04957290|64386475|FG000|Overall Study|non compliance with study drug|0|||
23340804|NCT01083186|64992847|FG000|Overall Study|Hemodialysis Initiation|28|||
23453159|NCT01217944|65403244|FG001|Overall Study|Lack of Efficacy|0|||
23453160|NCT01217944|65403245|FG002|Overall Study|Lack of Efficacy|0|||
23581984|NCT01027871|65859161|FG002|Overall Study|Protocol Violation|2|||
23581985|NCT01027871|65859159|FG000|Overall Study|Withdrawal by Subject|1|||
23581986|NCT01027871|65859160|FG001|Overall Study|Withdrawal by Subject|2|||
23581987|NCT01027871|65859161|FG002|Overall Study|Withdrawal by Subject|2|||
23581988|NCT01027871|65859159|FG000|Overall Study|Adverse Event|0|||
23581989|NCT01027871|65859160|FG001|Overall Study|Adverse Event|2|||
23581990|NCT01027871|65859161|FG002|Overall Study|Adverse Event|2|||
23581991|NCT01027871|65859159|FG000|Overall Study|Sponsor Decision|0|||
23581992|NCT01027871|65859160|FG001|Overall Study|Sponsor Decision|2|||
23581993|NCT01027871|65859161|FG002|Overall Study|Sponsor Decision|0|||
23581994|NCT01027871|65859159|FG000|Overall Study|Discontinued Prior to Treatment|0|||
23581995|NCT01027871|65859160|FG001|Overall Study|Discontinued Prior to Treatment|0|||
23581996|NCT01027871|65859161|FG002|Overall Study|Discontinued Prior to Treatment|1|||
23175489|NCT04957290|64386476|FG001|Overall Study|non compliance with study drug|1|||
23175490|NCT04957290|64386477|FG002|Overall Study|non compliance with study drug|0|||
23175491|NCT04957290|64386478|FG003|Overall Study|non compliance with study drug|0|||
23175492|NCT04957290|64386479|FG004|Overall Study|non compliance with study drug|0|||
23175493|NCT04957290|64386480|FG005|Overall Study|non compliance with study drug|0|||
23175494|NCT04957290|64386475|FG000|Overall Study|none specified.|0|||
23175495|NCT04957290|64386476|FG001|Overall Study|none specified.|1|||
23175496|NCT04957290|64386477|FG002|Overall Study|none specified.|2|||
23175497|NCT04957290|64386478|FG003|Overall Study|none specified.|0|||
23175498|NCT04957290|64386479|FG004|Overall Study|none specified.|0|||
23175499|NCT04957290|64386480|FG005|Overall Study|none specified.|0|||
23175500|NCT04957290|64386475|FG000|Overall Study|unacceptable toxicity|0|||
23175501|NCT04957290|64386476|FG001|Overall Study|unacceptable toxicity|0|||
23175502|NCT04957290|64386477|FG002|Overall Study|unacceptable toxicity|1|||
23175503|NCT04957290|64386478|FG003|Overall Study|unacceptable toxicity|0|||
23175504|NCT04957290|64386479|FG004|Overall Study|unacceptable toxicity|0|||
23175505|NCT04957290|64386480|FG005|Overall Study|unacceptable toxicity|0|||
23175506|NCT04957290|64386475|FG000|Overall Study|Adverse Event|0|||
23175507|NCT04957290|64386476|FG001|Overall Study|Adverse Event|0|||
23175508|NCT04957290|64386477|FG002|Overall Study|Adverse Event|1|||
23175509|NCT04957290|64386478|FG003|Overall Study|Adverse Event|0|||
23175510|NCT04957290|64386479|FG004|Overall Study|Adverse Event|0|||
23175511|NCT04957290|64386480|FG005|Overall Study|Adverse Event|0|||
23175512|NCT04957290|64386475|FG000|Overall Study|study terminated by sponsor|0|||
23175513|NCT04957290|64386476|FG001|Overall Study|study terminated by sponsor|0|||
23175514|NCT04957290|64386477|FG002|Overall Study|study terminated by sponsor|2|||
23175515|NCT04957290|64386478|FG003|Overall Study|study terminated by sponsor|0|||
23581997|NCT02289560|65859162|FG000|Overall Study|Lost to Follow-up|6|||
23581998|NCT02289560|65859162|FG000|Overall Study|Alternative Treatment|4|||
23581999|NCT02289560|65859162|FG000|Overall Study|Inadequate Treatment|2|||
23175516|NCT04957290|64386479|FG004|Overall Study|study terminated by sponsor|0|||
23175517|NCT04957290|64386480|FG005|Overall Study|study terminated by sponsor|0|||
23175518|NCT00849667|64386485|FG000|Overall Study|Withdrawal by Subject|16|||
23175519|NCT00849667|64386486|FG001|Overall Study|Withdrawal by Subject|33|||
23175520|NCT00849667|64386487|FG002|Overall Study|Withdrawal by Subject|35|||
23175521|NCT00849667|64386485|FG000|Overall Study|Lost to Follow-up|8|||
23582000|NCT02289560|65859162|FG000|Overall Study|Withdrawal by Subject|23|||
23582001|NCT01684046|65859163|FG000|Period 1, First 30 Days|Adverse Event|0|||
23582002|NCT01684046|65859164|FG001|Period 1, First 30 Days|Adverse Event|2|||
23236358|NCT02418000|64608215|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
23236359|NCT02418000|64608211|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
23236360|NCT02418000|64608212|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
23582003|NCT00819910|65859165|FG000|Overall Study|Adverse Event|0|||
23236361|NCT02418000|64608213|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
23236362|NCT02418000|64608214|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
23236363|NCT02418000|64608215|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
23236364|NCT02418000|64608211|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
23236365|NCT02418000|64608212|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
23236366|NCT02418000|64608213|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
23236367|NCT02418000|64608214|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
23236368|NCT02418000|64608215|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
23236369|NCT02418000|64608211|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236370|NCT02418000|64608212|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236371|NCT02418000|64608213|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
23236372|NCT02418000|64608214|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236373|NCT02418000|64608215|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236374|NCT02418000|64608211|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236375|NCT02418000|64608212|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236376|NCT02418000|64608213|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236377|NCT02418000|64608214|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
23236378|NCT02418000|64608215|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236379|NCT02418000|64608211|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
23236380|NCT02418000|64608212|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
23236381|NCT02418000|64608213|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
23236382|NCT02418000|64608214|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
23236383|NCT02418000|64608215|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
23236384|NCT02418000|64608211|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236385|NCT02418000|64608212|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236386|NCT02418000|64608213|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23582004|NCT00819910|65859166|FG001|Overall Study|Adverse Event|0|||
23582005|NCT00819910|65859167|FG002|Overall Study|Adverse Event|2|||
23582006|NCT00819910|65859168|FG003|Overall Study|Adverse Event|1|||
23582007|NCT00819910|65859165|FG000|Overall Study|Withdrawal by Subject|1|||
23582008|NCT00819910|65859166|FG001|Overall Study|Withdrawal by Subject|1|||
23582009|NCT00819910|65859167|FG002|Overall Study|Withdrawal by Subject|1|||
23582010|NCT00819910|65859168|FG003|Overall Study|Withdrawal by Subject|0|||
23582011|NCT00819910|65859165|FG000|Overall Study|Lost to Follow-up|1|||
23582012|NCT00819910|65859166|FG001|Overall Study|Lost to Follow-up|0|||
23582013|NCT00819910|65859167|FG002|Overall Study|Lost to Follow-up|0|||
23582014|NCT00819910|65859168|FG003|Overall Study|Lost to Follow-up|0|||
23582015|NCT04454567|65859170|FG000|Overall Study|Study Terminated by Sponsor|1|||
23582016|NCT04454567|65859171|FG001|Overall Study|Study Terminated by Sponsor|1|||
23582017|NCT01106287|65859172|FG000|Overall Study|Adverse Event|1|||
23582018|NCT01106287|65859173|FG001|Overall Study|Adverse Event|0|||
23582019|NCT01106287|65859174|FG002|Overall Study|Adverse Event|0|||
23582020|NCT01106287|65859175|FG003|Overall Study|Adverse Event|0|||
23582021|NCT01264718|65862278|FG000|Overall Study|Lost to Follow-up|3|||
23582022|NCT01264718|65862279|FG001|Overall Study|Lost to Follow-up|2|||
23582023|NCT01264718|65862278|FG000|Overall Study|Withdrawal by Subject|9|||
23236387|NCT02418000|64608214|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
23236388|NCT02418000|64608215|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
23236389|NCT00383292|64608216|FG000|Overall Study|Adverse Event|4|||
23236390|NCT00383292|64608217|FG001|Overall Study|Adverse Event|1|||
23236391|NCT00383292|64608218|FG002|Overall Study|Adverse Event|2|||
23582024|NCT01264718|65862279|FG001|Overall Study|Withdrawal by Subject|15|||
23582025|NCT01264718|65862278|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
23582026|NCT01264718|65862279|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
23582027|NCT01928940|65862280|FG000|Overall Study|Adverse Event|0|||
23582028|NCT01928940|65862281|FG001|Overall Study|Adverse Event|1|||
23236392|NCT00383292|64608216|FG000|Overall Study|Death|3|||
23236393|NCT00383292|64608217|FG001|Overall Study|Death|3|||
23236394|NCT00383292|64608218|FG002|Overall Study|Death|3|||
23236395|NCT00383292|64608216|FG000|Overall Study|Physician Decision|4|||
23236396|NCT00383292|64608217|FG001|Overall Study|Physician Decision|0|||
23236397|NCT00383292|64608218|FG002|Overall Study|Physician Decision|1|||
23236398|NCT00383292|64608216|FG000|Overall Study|Withdrawal by Subject|3|||
23236399|NCT00383292|64608217|FG001|Overall Study|Withdrawal by Subject|2|||
23236400|NCT00383292|64608218|FG002|Overall Study|Withdrawal by Subject|2|||
23236401|NCT00383292|64608216|FG000|Overall Study|Other|1|||
23236402|NCT00383292|64608217|FG001|Overall Study|Other|0|||
23236403|NCT00383292|64608218|FG002|Overall Study|Other|0|||
23236404|NCT00223990|64608221|FG000|Overall Study|Moved from area|2|||
23236405|NCT00223990|64608222|FG001|Overall Study|Moved from area|1|||
23236406|NCT00223990|64608221|FG000|Overall Study|Withdrawal by Subject|4|||
23236407|NCT00223990|64608222|FG001|Overall Study|Withdrawal by Subject|8|||
23236408|NCT00223990|64608221|FG000|Overall Study|Lost to Follow-up|1|||
23236409|NCT00223990|64608222|FG001|Overall Study|Lost to Follow-up|0|||
23236410|NCT00039377|64608226|FG000|Initial Registration|Adverse Event|2|||
23236411|NCT00039377|64608227|FG001|Initial Registration|Adverse Event|0|||
23236412|NCT00039377|64608228|FG002|Initial Registration|Adverse Event|0|||
23236413|NCT00039377|64608229|FG003|Initial Registration|Adverse Event|0|||
23236414|NCT00039377|64608226|FG000|Initial Registration|Relapsed|6|||
23236415|NCT00039377|64608227|FG001|Initial Registration|Relapsed|0|||
23236416|NCT00039377|64608228|FG002|Initial Registration|Relapsed|0|||
23236417|NCT00039377|64608229|FG003|Initial Registration|Relapsed|0|||
23236418|NCT00039377|64608226|FG000|Initial Registration|Received non-protocol therapy|11|||
23236419|NCT00039377|64608227|FG001|Initial Registration|Received non-protocol therapy|0|||
23175522|NCT00849667|64386486|FG001|Overall Study|Lost to Follow-up|8|||
23175523|NCT00849667|64386487|FG002|Overall Study|Lost to Follow-up|8|||
23175524|NCT00849667|64386485|FG000|Overall Study|Adverse Event|1|||
23175525|NCT00849667|64386486|FG001|Overall Study|Adverse Event|2|||
23175526|NCT00849667|64386487|FG002|Overall Study|Adverse Event|0|||
23175527|NCT00849667|64386485|FG000|Overall Study|Other|18|||
23175528|NCT00849667|64386486|FG001|Overall Study|Other|19|||
23175529|NCT00849667|64386487|FG002|Overall Study|Other|18|||
23582029|NCT02374957|65862282|FG000|Overall Study|Patient did not complete forms correctly|1|||
23582030|NCT02374957|65862283|FG001|Overall Study|Patient did not complete forms correctly|0|||
23582031|NCT01119703|65862284|FG000|Overall Study|Adverse Event|0|||
23582032|NCT01119703|65862285|FG001|Overall Study|Adverse Event|1|||
23582033|NCT03531905|65862286|FG000|Overall Study|Withdrawal by Subject|3|||
23582034|NCT03531905|65862287|FG001|Overall Study|Withdrawal by Subject|3|||
23582035|NCT03531905|65862288|FG002|Overall Study|Withdrawal by Subject|2|||
23582036|NCT03531905|65862286|FG000|Overall Study|Lost to Follow-up|2|||
23582037|NCT03531905|65862287|FG001|Overall Study|Lost to Follow-up|2|||
23582038|NCT03531905|65862288|FG002|Overall Study|Lost to Follow-up|1|||
23582039|NCT03531905|65862286|FG000|Overall Study|Participant was out of town|1|||
23582040|NCT03531905|65862287|FG001|Overall Study|Participant was out of town|0|||
23582041|NCT03531905|65862288|FG002|Overall Study|Participant was out of town|0|||
23582042|NCT03531905|65862286|FG000|Overall Study|Could not speak with the participant|1|||
23582043|NCT03531905|65862287|FG001|Overall Study|Could not speak with the participant|0|||
23582044|NCT03531905|65862288|FG002|Overall Study|Could not speak with the participant|0|||
23582045|NCT01250002|65862289|FG000|Overall Study|Change to open surgical procedure|4|||
23582046|NCT01250002|65862290|FG001|Overall Study|Change to open surgical procedure|3|||
23582047|NCT02540213|65862291|FG000|Overall Study|Death/adverse event|18|||
23582048|NCT02540213|65862291|FG000|Overall Study|Administrative reasons|3|||
23582049|NCT02540213|65862291|FG000|Overall Study|Kidney transplant|3|||
23175530|NCT00849667|64386485|FG000|Overall Study|Progressive disease|119|||
23175531|NCT00849667|64386486|FG001|Overall Study|Progressive disease|100|||
23175532|NCT00849667|64386487|FG002|Overall Study|Progressive disease|112|||
23453161|NCT03811340|65403248|FG000|Overall Study|subjects did not complete the survey.|90|||
23453162|NCT00001959|65403251|FG000|Overall Study|newly diagnosed colon cancer|1|||
23453163|NCT00001959|65403251|FG000|Overall Study|disabling sedation|1|||
23582050|NCT02540213|65862291|FG000|Overall Study|Lack of Efficacy|6|||
23582051|NCT02540213|65862291|FG000|Overall Study|Consent withdrawn|7|||
23582052|NCT02540213|65862291|FG000|Overall Study|Enrolled but not treated|2|||
23582053|NCT02322216|65862297|FG000|Overall Study|Adverse Event|1|||
23582054|NCT02322216|65862298|FG001|Overall Study|Adverse Event|0|||
23582055|NCT02322216|65862297|FG000|Overall Study|Withdrawal by Subject|1|||
23582056|NCT02322216|65862298|FG001|Overall Study|Withdrawal by Subject|4|||
23582057|NCT02735915|65862299|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
23582058|NCT02735915|65862299|FG000|Overall Study|Withdrawal following SAE|2|||
23582059|NCT02735915|65862299|FG000|Overall Study|Withdrawal by Subject|1|||
23582060|NCT04133363|65862300|FG000|Overall Study|Lost to Follow-up|2|||
23582061|NCT04133363|65862301|FG001|Overall Study|Lost to Follow-up|1|||
23582062|NCT04133363|65862302|FG002|Overall Study|Lost to Follow-up|4|||
23582063|NCT00926393|65862305|FG000|Overall Study|Withdrawal by Subject|1|||
23582064|NCT00926393|65862306|FG001|Overall Study|Withdrawal by Subject|2|||
23582065|NCT00926393|65862305|FG000|Overall Study|Adverse Event|1|||
23582066|NCT00926393|65862306|FG001|Overall Study|Adverse Event|1|||
23582067|NCT00823979|65862308|FG000|Overall Study|Lack of Efficacy|13|||
23175533|NCT00849667|64386485|FG000|Overall Study|Sponsor decision|208|||
23175534|NCT00849667|64386486|FG001|Overall Study|Sponsor decision|204|||
23175535|NCT00849667|64386487|FG002|Overall Study|Sponsor decision|190|||
23175536|NCT00849667|64386485|FG000|Overall Study|Investigator discretion|0|||
23175537|NCT00849667|64386486|FG001|Overall Study|Investigator discretion|0|||
23175538|NCT00849667|64386487|FG002|Overall Study|Investigator discretion|1|||
23175539|NCT00454779|64386488|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
23175540|NCT00454779|64386489|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
23175541|NCT00454779|64386488|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
23175542|NCT00454779|64386489|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
23175543|NCT00454779|64386488|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
23175544|NCT00454779|64386489|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
23175545|NCT00454779|64386488|FG000|First-line Treatment Phase|Protocol Violation|0|||
23175546|NCT00454779|64386489|FG001|First-line Treatment Phase|Protocol Violation|1|||
23175547|NCT00454779|64386488|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
23175548|NCT00454779|64386489|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
23175549|NCT00454779|64386488|FG000|First-line Treatment Phase|Ongoing|1|||
23175550|NCT00454779|64386489|FG001|First-line Treatment Phase|Ongoing|0|||
23175551|NCT00454779|64386488|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
23175552|NCT00454779|64386489|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
23175553|NCT00454779|64386488|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
23175554|NCT00454779|64386489|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
23175555|NCT00454779|64386488|FG000|Second-line Treatment Phase|Ongoing|0|||
23175556|NCT00454779|64386489|FG001|Second-line Treatment Phase|Ongoing|1|||
23175557|NCT01046695|64386500|FG000|Overall Study|Subject had a pacemaker|0|||
23175558|NCT01046695|64386501|FG001|Overall Study|Subject had a pacemaker|1|||
23175559|NCT01046695|64386500|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
23175560|NCT01046695|64386501|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
23175561|NCT01231555|64386502|FG000|Overall Study|Study terminated|8|||
23175562|NCT01231555|64386503|FG001|Overall Study|Study terminated|5|||
23175563|NCT01231555|64386504|FG002|Overall Study|Study terminated|8|||
23175564|NCT01231555|64386502|FG000|Overall Study|Withdrawal by Subject|0|||
23175565|NCT01231555|64386503|FG001|Overall Study|Withdrawal by Subject|2|||
23175566|NCT01231555|64386504|FG002|Overall Study|Withdrawal by Subject|0|||
23175567|NCT02542267|64386505|FG000|Overall Study|Withdrawal by Subject|10|||
23175568|NCT02542267|64386505|FG000|Overall Study|Physician Decision|6|||
23175569|NCT02542267|64386505|FG000|Overall Study|Lost to Follow-up|4|||
23175570|NCT02542267|64386505|FG000|Overall Study|Death|13|||
23175571|NCT02542267|64386505|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
23175572|NCT02542267|64386505|FG000|Overall Study|Other|9|||
23175573|NCT00705263|64386507|FG000|Overall Study|Withdrawal by Subject|2|||
23175574|NCT00132730|64386508|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
23175575|NCT00132730|64386509|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
23175576|NCT00132730|64386510|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
23175577|NCT00132730|64386511|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
23175578|NCT00132730|64386512|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
23175579|NCT00132730|64386513|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
23175580|NCT00132730|64386508|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
23453164|NCT00001959|65403251|FG000|Overall Study|non-compliance|1|||
23582068|NCT00823979|65862309|FG001|Overall Study|Lack of Efficacy|16|||
23582069|NCT00823979|65862310|FG002|Overall Study|Lack of Efficacy|9|||
23175581|NCT00132730|64386509|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
23236420|NCT00039377|64608228|FG002|Initial Registration|Received non-protocol therapy|0|||
23453165|NCT03057496|65403254|FG000|Overall Study|Withdrawal by Subject|8|||
23453166|NCT03057496|65403254|FG000|Overall Study|Lost to Follow-up|5|||
23453167|NCT03057496|65403254|FG000|Overall Study|Did not use device during home trial|3|||
23453168|NCT03057496|65403254|FG000|Overall Study|Device failure|2|||
23453169|NCT01188772|65403255|FG000|Overall Study|Randomized but Not Treated|0|||
23453170|NCT01188772|65403256|FG001|Overall Study|Randomized but Not Treated|1|||
23453171|NCT01188772|65403257|FG002|Overall Study|Randomized but Not Treated|0|||
23453172|NCT01188772|65403258|FG003|Overall Study|Randomized but Not Treated|0|||
23453173|NCT01188772|65403255|FG000|Overall Study|Adverse Event|0|||
23453174|NCT01188772|65403256|FG001|Overall Study|Adverse Event|1|||
23453175|NCT01188772|65403257|FG002|Overall Study|Adverse Event|2|||
23453176|NCT01188772|65403258|FG003|Overall Study|Adverse Event|0|||
23453177|NCT01188772|65403255|FG000|Overall Study|Lost to Follow-up|4|||
23453178|NCT01188772|65403256|FG001|Overall Study|Lost to Follow-up|1|||
23453179|NCT01188772|65403257|FG002|Overall Study|Lost to Follow-up|1|||
23453180|NCT01188772|65403258|FG003|Overall Study|Lost to Follow-up|1|||
23453181|NCT01188772|65403255|FG000|Overall Study|Non-responder|0|||
23453182|NCT01188772|65403256|FG001|Overall Study|Non-responder|0|||
23453183|NCT01188772|65403257|FG002|Overall Study|Non-responder|3|||
23175582|NCT00132730|64386510|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
23175583|NCT00132730|64386511|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
23175584|NCT00132730|64386512|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
23175585|NCT00132730|64386513|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
23175586|NCT00132730|64386508|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
23175587|NCT00132730|64386509|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
23175588|NCT00132730|64386510|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
23453184|NCT01188772|65403258|FG003|Overall Study|Non-responder|0|||
23453185|NCT01188772|65403255|FG000|Overall Study|Physician Decision|0|||
23453186|NCT01188772|65403256|FG001|Overall Study|Physician Decision|0|||
23175589|NCT00132730|64386511|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
23175590|NCT00132730|64386512|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
23175591|NCT00132730|64386513|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
23236421|NCT00039377|64608229|FG003|Initial Registration|Received non-protocol therapy|0|||
23236422|NCT00039377|64608226|FG000|Initial Registration|Withdrawal by Subject|3|||
23453187|NCT01188772|65403257|FG002|Overall Study|Physician Decision|1|||
23175592|NCT00132730|64386508|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
23175593|NCT00132730|64386509|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
23175594|NCT00132730|64386510|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
23236423|NCT00039377|64608227|FG001|Initial Registration|Withdrawal by Subject|0|||
23453188|NCT01188772|65403258|FG003|Overall Study|Physician Decision|0|||
23453189|NCT01188772|65403255|FG000|Overall Study|Terminated by Sponsor|0|||
23453190|NCT01188772|65403256|FG001|Overall Study|Terminated by Sponsor|0|||
23582070|NCT00823979|65862308|FG000|Overall Study|Lost to Follow-up|2|||
23582071|NCT00823979|65862309|FG001|Overall Study|Lost to Follow-up|1|||
23582072|NCT00823979|65862310|FG002|Overall Study|Lost to Follow-up|0|||
23582073|NCT00823979|65862308|FG000|Overall Study|Withdrawal by Subject|2|||
23582074|NCT00823979|65862309|FG001|Overall Study|Withdrawal by Subject|3|||
23582075|NCT00823979|65862310|FG002|Overall Study|Withdrawal by Subject|2|||
23582076|NCT00823979|65862308|FG000|Overall Study|Protocol Violation|1|||
23582077|NCT00823979|65862309|FG001|Overall Study|Protocol Violation|1|||
23582078|NCT00823979|65862310|FG002|Overall Study|Protocol Violation|0|||
23582079|NCT00823979|65862308|FG000|Overall Study|Pregnancy|0|||
23582080|NCT00823979|65862309|FG001|Overall Study|Pregnancy|1|||
23582081|NCT00823979|65862310|FG002|Overall Study|Pregnancy|0|||
23582082|NCT00823979|65862308|FG000|Overall Study|Adverse Event|0|||
23582083|NCT00823979|65862309|FG001|Overall Study|Adverse Event|2|||
23582084|NCT00823979|65862310|FG002|Overall Study|Adverse Event|4|||
23582085|NCT00823979|65862308|FG000|Overall Study|Other|2|||
23582086|NCT00823979|65862309|FG001|Overall Study|Other|0|||
23175595|NCT00132730|64386511|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
23453191|NCT01188772|65403257|FG002|Overall Study|Terminated by Sponsor|1|||
23453192|NCT01188772|65403258|FG003|Overall Study|Terminated by Sponsor|0|||
23453193|NCT01188772|65403255|FG000|Overall Study|Treatment Failure|0|||
23453194|NCT01188772|65403256|FG001|Overall Study|Treatment Failure|0|||
23453195|NCT01188772|65403257|FG002|Overall Study|Treatment Failure|1|||
23453196|NCT01188772|65403258|FG003|Overall Study|Treatment Failure|0|||
23453197|NCT01188772|65403255|FG000|Overall Study|Virologic Failure|1|||
23453198|NCT01188772|65403256|FG001|Overall Study|Virologic Failure|0|||
23453199|NCT01188772|65403257|FG002|Overall Study|Virologic Failure|0|||
23453200|NCT01188772|65403258|FG003|Overall Study|Virologic Failure|0|||
23453201|NCT01188772|65403255|FG000|Overall Study|Withdrawal by Subject|0|||
23453202|NCT01188772|65403256|FG001|Overall Study|Withdrawal by Subject|0|||
23453203|NCT01188772|65403257|FG002|Overall Study|Withdrawal by Subject|2|||
23453204|NCT01188772|65403258|FG003|Overall Study|Withdrawal by Subject|0|||
23453205|NCT01731912|65403269|FG000|Overall Study|noncompliance|2|||
23453206|NCT00985673|65403272|FG000|Overall Study|Lost to Follow-up|6|||
23453207|NCT00985673|65403273|FG001|Overall Study|Lost to Follow-up|7|||
23453208|NCT00985673|65403274|FG002|Overall Study|Lost to Follow-up|6|||
23453209|NCT00985673|65403275|FG003|Overall Study|Lost to Follow-up|10|||
23453210|NCT00985673|65403276|FG004|Overall Study|Lost to Follow-up|5|||
23453211|NCT00985673|65403277|FG005|Overall Study|Lost to Follow-up|3|||
23453212|NCT00985673|65403272|FG000|Overall Study|Withdrawal by Subject|0|||
23175596|NCT00132730|64386512|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
23175597|NCT00132730|64386513|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
23175598|NCT00132730|64386508|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
23175599|NCT00132730|64386509|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
23453213|NCT00985673|65403273|FG001|Overall Study|Withdrawal by Subject|4|||
23453214|NCT00985673|65403274|FG002|Overall Study|Withdrawal by Subject|5|||
23453215|NCT00985673|65403275|FG003|Overall Study|Withdrawal by Subject|2|||
23453216|NCT00985673|65403276|FG004|Overall Study|Withdrawal by Subject|2|||
23453217|NCT00985673|65403277|FG005|Overall Study|Withdrawal by Subject|3|||
23175600|NCT00132730|64386510|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
23175601|NCT00132730|64386511|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
23175602|NCT00132730|64386512|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
23175603|NCT00132730|64386513|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
23175604|NCT00132730|64386508|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23175605|NCT00132730|64386509|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23175606|NCT00132730|64386510|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23175607|NCT00132730|64386511|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
23175608|NCT00132730|64386512|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23175609|NCT00132730|64386513|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
23175610|NCT00132730|64386508|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
23175611|NCT00132730|64386509|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
23175612|NCT00132730|64386510|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
23175613|NCT00132730|64386511|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
23175614|NCT00132730|64386512|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
23175615|NCT00132730|64386513|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
23175616|NCT00132730|64386508|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
23453218|NCT00985673|65403272|FG000|Overall Study|Other|1|||
23453219|NCT00985673|65403273|FG001|Overall Study|Other|0|||
23453220|NCT00985673|65403274|FG002|Overall Study|Other|1|||
23582087|NCT00823979|65862310|FG002|Overall Study|Other|1|||
23582088|NCT00823979|65862308|FG000|Overall Study|Randomized but not Treated|4|||
23582089|NCT00823979|65862309|FG001|Overall Study|Randomized but not Treated|3|||
23582090|NCT00823979|65862310|FG002|Overall Study|Randomized but not Treated|1|||
23582091|NCT00823979|65862308|FG000|Overall Study|Study Terminated by Sponsor|5|||
23582092|NCT00823979|65862309|FG001|Overall Study|Study Terminated by Sponsor|5|||
23582093|NCT00823979|65862310|FG002|Overall Study|Study Terminated by Sponsor|7|||
23582094|NCT02824432|65862311|FG000|Overall Study|Major Protocol Deviation|1|||
23582095|NCT02824432|65862312|FG001|Overall Study|Major Protocol Deviation|0|||
23582096|NCT05349864|65862313|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
23582097|NCT05349864|65862314|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
23582098|NCT02908464|65862321|FG000|Overall Study|Withdrawal by Subject|2|||
23582099|NCT02908464|65862322|FG001|Overall Study|Withdrawal by Subject|1|||
23582100|NCT02908464|65862321|FG000|Overall Study|Found ineligible after randomization|0|||
23582101|NCT02908464|65862322|FG001|Overall Study|Found ineligible after randomization|2|||
23582102|NCT00916006|65862323|FG000|Overall Study|Adverse Event|1|||
23582103|NCT00916006|65862324|FG001|Overall Study|Adverse Event|1|||
23582104|NCT00916006|65862323|FG000|Overall Study|Withdrawal by Subject|2|||
23236424|NCT00039377|64608228|FG002|Initial Registration|Withdrawal by Subject|0|||
23236425|NCT00039377|64608229|FG003|Initial Registration|Withdrawal by Subject|0|||
23236426|NCT04382066|64608230|FG000|Overall Study|Adverse Event|1|||
23236427|NCT04382066|64608231|FG001|Overall Study|Adverse Event|0|||
23236428|NCT04382066|64608232|FG002|Overall Study|Adverse Event|0|||
23236429|NCT04382066|64608230|FG000|Overall Study|Death|1|||
23236430|NCT04382066|64608231|FG001|Overall Study|Death|0|||
23236431|NCT04382066|64608232|FG002|Overall Study|Death|1|||
23236432|NCT01616173|64608233|FG000|Overall Study|Lost to Follow-up|0|||
23236433|NCT01616173|64608234|FG001|Overall Study|Lost to Follow-up|2|||
23236434|NCT01616173|64608235|FG002|Overall Study|Lost to Follow-up|0|||
23236435|NCT01673373|64608238|FG000|Overall Study|Death|2|||
23236436|NCT01393444|64608240|FG000|Overall Study|Withdrawal by Subject|1|||
23236437|NCT01393444|64608240|FG000|Overall Study|Determined ineligible during screening.|2|||
23236438|NCT03370133|64608241|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
23236439|NCT03370133|64608242|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
23236440|NCT03370133|64608243|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
23236441|NCT03370133|64608244|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
23236442|NCT03370133|64608245|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
23236443|NCT03370133|64608246|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
23236444|NCT03370133|64608241|FG000|Initial Treatment Period (WK 16)|Death|1|||
23236445|NCT03370133|64608242|FG001|Initial Treatment Period (WK 16)|Death|1|||
23236446|NCT03370133|64608243|FG002|Initial Treatment Period (WK 16)|Death|1|||
23236447|NCT03370133|64608244|FG003|Initial Treatment Period (WK 16)|Death|0|||
23236448|NCT03370133|64608245|FG004|Initial Treatment Period (WK 16)|Death|0|||
23236449|NCT03370133|64608246|FG005|Initial Treatment Period (WK 16)|Death|0|||
23236450|NCT03370133|64608241|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
23236451|NCT03370133|64608242|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
23236452|NCT03370133|64608243|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
23236453|NCT03370133|64608244|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
23236454|NCT03370133|64608245|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
23236455|NCT03370133|64608246|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
23236456|NCT03370133|64608241|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23236457|NCT03370133|64608242|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23236458|NCT03370133|64608243|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
23236459|NCT03370133|64608244|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23236460|NCT03370133|64608245|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23236461|NCT03370133|64608246|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
23236462|NCT03370133|64608241|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23236463|NCT03370133|64608242|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
23236464|NCT03370133|64608243|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23236465|NCT03370133|64608244|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23236466|NCT03370133|64608245|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23236467|NCT03370133|64608246|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
23236468|NCT03370133|64608241|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
23236469|NCT03370133|64608242|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
23236470|NCT03370133|64608243|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
23236471|NCT03370133|64608244|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
23236472|NCT03370133|64608245|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
23453221|NCT00985673|65403275|FG003|Overall Study|Other|0|||
23453222|NCT00985673|65403276|FG004|Overall Study|Other|1|||
23453223|NCT00985673|65403277|FG005|Overall Study|Other|0|||
23236473|NCT03370133|64608246|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
23236474|NCT03370133|64608241|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
23236475|NCT03370133|64608242|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
23236476|NCT03370133|64608243|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
23236477|NCT03370133|64608244|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
23236478|NCT03370133|64608245|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
23236479|NCT03370133|64608246|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
23236480|NCT03370133|64608241|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
23236481|NCT03370133|64608242|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
23236482|NCT03370133|64608243|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
23453224|NCT02322281|65403300|FG000|Overall Study|Progressive Disease|42|||
23175617|NCT00132730|64386509|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
23236483|NCT03370133|64608244|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
23236484|NCT03370133|64608245|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
23236485|NCT03370133|64608246|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
23453225|NCT02322281|65403301|FG001|Overall Study|Progressive Disease|14|||
23175618|NCT00132730|64386510|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
23175619|NCT00132730|64386511|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
23175620|NCT00132730|64386512|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
23175621|NCT00132730|64386513|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
23236486|NCT03370133|64608241|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
23236487|NCT03370133|64608242|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
23236488|NCT03370133|64608243|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
23175622|NCT00132730|64386508|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23175623|NCT00132730|64386509|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23175624|NCT00132730|64386510|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23175625|NCT00132730|64386511|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23175626|NCT00132730|64386512|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
23175627|NCT00132730|64386513|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
23175628|NCT00132730|64386508|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23175629|NCT00132730|64386509|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23175630|NCT00132730|64386510|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23175631|NCT00132730|64386511|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23175632|NCT00132730|64386512|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
23175633|NCT00132730|64386513|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
23175634|NCT00132730|64386508|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23175635|NCT00132730|64386509|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23175636|NCT00132730|64386510|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23175637|NCT00132730|64386511|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23175638|NCT00132730|64386512|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
23175639|NCT00132730|64386513|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
23175640|NCT00132730|64386508|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
23175641|NCT00132730|64386509|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
23175642|NCT00132730|64386510|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
23175643|NCT00132730|64386511|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
23175644|NCT00132730|64386512|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
23175645|NCT00132730|64386513|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
23175646|NCT01724528|64386519|FG000|Overall Study|Death|3|||
23175647|NCT01724528|64386520|FG001|Overall Study|Death|0|||
23175648|NCT01724528|64386519|FG000|Overall Study|Withdrawal by Subject|0|||
23175649|NCT01724528|64386520|FG001|Overall Study|Withdrawal by Subject|2|||
23175650|NCT01724528|64386519|FG000|Overall Study|Protocol Violation|0|||
23175651|NCT01724528|64386520|FG001|Overall Study|Protocol Violation|1|||
23175652|NCT01724528|64386519|FG000|Overall Study|Patient refused to attend last visit|1|||
23175653|NCT01724528|64386520|FG001|Overall Study|Patient refused to attend last visit|0|||
23175654|NCT01959165|64386527|FG000|Overall Study|Adverse Event|0|||
23175655|NCT01959165|64386528|FG001|Overall Study|Adverse Event|0|||
23175656|NCT01959165|64386529|FG002|Overall Study|Adverse Event|0|||
23175657|NCT01959165|64386530|FG003|Overall Study|Adverse Event|1|||
23175658|NCT01959165|64386527|FG000|Overall Study|Lack of Efficacy|1|||
23175659|NCT01959165|64386528|FG001|Overall Study|Lack of Efficacy|0|||
23175660|NCT01959165|64386529|FG002|Overall Study|Lack of Efficacy|0|||
23175661|NCT01959165|64386530|FG003|Overall Study|Lack of Efficacy|0|||
23175662|NCT01959165|64386527|FG000|Overall Study|overdose|0|||
23175663|NCT01959165|64386528|FG001|Overall Study|overdose|0|||
23175664|NCT01959165|64386529|FG002|Overall Study|overdose|0|||
23175665|NCT01959165|64386530|FG003|Overall Study|overdose|1|||
23175666|NCT01959165|64386527|FG000|Overall Study|Welfare recipient|0|||
23175667|NCT01959165|64386528|FG001|Overall Study|Welfare recipient|1|||
23175668|NCT01959165|64386529|FG002|Overall Study|Welfare recipient|0|||
23175669|NCT01959165|64386530|FG003|Overall Study|Welfare recipient|0|||
23175670|NCT00454805|64386531|FG000|Overall Study|Withdrawal by Subject|9|||
23175671|NCT00454805|64386532|FG001|Overall Study|Withdrawal by Subject|2|||
23175672|NCT00454805|64386531|FG000|Overall Study|Death|0|||
23236489|NCT03370133|64608244|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
23236490|NCT03370133|64608245|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
23236491|NCT03370133|64608246|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
23236492|NCT03370133|64608241|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
23236493|NCT03370133|64608242|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
23236494|NCT03370133|64608243|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
23453226|NCT02322281|65403302|FG002|Overall Study|Progressive Disease|49|||
23175673|NCT00454805|64386532|FG001|Overall Study|Death|2|||
23175674|NCT00454805|64386531|FG000|Overall Study|Disease progression|16|||
23175675|NCT00454805|64386532|FG001|Overall Study|Disease progression|19|||
23175676|NCT00454805|64386531|FG000|Overall Study|In order to begin radiotherapy|1|||
23236495|NCT03370133|64608244|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
23340805|NCT01083186|64992847|FG000|Overall Study|Administrative Reasons|2|||
23340806|NCT01083186|64992847|FG000|Overall Study|Non-compliance to Study Treatment|1|||
23340807|NCT03155178|64992850|FG000|Overall Study|Did not meet treatment day baseline|7|||
23340808|NCT03155178|64992851|FG001|Overall Study|Did not meet treatment day baseline|7|||
23340809|NCT03155178|64992852|FG002|Overall Study|Did not meet treatment day baseline|7|||
23340810|NCT03155178|64992853|FG003|Overall Study|Did not meet treatment day baseline|7|||
23340811|NCT01194531|64992854|FG000|Overall Study|Withdrawal by Subject|1|||
23340812|NCT01194531|64992855|FG001|Overall Study|Withdrawal by Subject|0|||
23340813|NCT01194531|64992854|FG000|Overall Study|Protocol Violation|4|||
23340814|NCT01194531|64992855|FG001|Overall Study|Protocol Violation|1|||
23340815|NCT01194531|64992854|FG000|Overall Study|Physician Decision|0|||
23340816|NCT01194531|64992855|FG001|Overall Study|Physician Decision|2|||
23340817|NCT03499899|64992856|FG000|Overall Study|Adverse Event|2|||
23340818|NCT03499899|64992857|FG001|Overall Study|Adverse Event|3|||
23340819|NCT03499899|64992858|FG002|Overall Study|Adverse Event|3|||
23175677|NCT00454805|64386532|FG001|Overall Study|In order to begin radiotherapy|0|||
23175678|NCT02419508|64386533|FG000|Overall Study|Adverse Event|9|||
23175679|NCT02419508|64386534|FG001|Overall Study|Adverse Event|3|||
23175680|NCT02419508|64386533|FG000|Overall Study|Withdrawal by Subject|1|||
23175681|NCT02419508|64386534|FG001|Overall Study|Withdrawal by Subject|0|||
23175682|NCT02419508|64386533|FG000|Overall Study|Other - Reason not specified|0|||
23175683|NCT02419508|64386534|FG001|Overall Study|Other - Reason not specified|1|||
23175684|NCT02117687|64386535|FG000|Overall Study|Lost to Follow-up|0|||
23175685|NCT02117687|64386536|FG001|Overall Study|Lost to Follow-up|1|||
23175686|NCT02117687|64386535|FG000|Overall Study|Adverse Event|0|||
23175687|NCT02117687|64386536|FG001|Overall Study|Adverse Event|2|||
23175688|NCT02117687|64386535|FG000|Overall Study|Other Reasons|1|||
23175689|NCT02117687|64386536|FG001|Overall Study|Other Reasons|1|||
23175690|NCT01790503|64386540|FG000|Overall Study|Adverse Event|1|||
23175691|NCT01790503|64386541|FG001|Overall Study|Adverse Event|0|||
23175692|NCT01790503|64386542|FG002|Overall Study|Adverse Event|0|||
23175693|NCT01790503|64386543|FG003|Overall Study|Adverse Event|0|||
23175694|NCT01790503|64386544|FG004|Overall Study|Adverse Event|0|||
23175695|NCT01790503|64386545|FG005|Overall Study|Adverse Event|2|||
23175696|NCT01790503|64386546|FG006|Overall Study|Adverse Event|0|||
23175697|NCT01790503|64386547|FG007|Overall Study|Adverse Event|0|||
23175698|NCT01790503|64386548|FG008|Overall Study|Adverse Event|2|||
23175699|NCT01790503|64386549|FG009|Overall Study|Adverse Event|4|||
23175700|NCT01790503|64386550|FG010|Overall Study|Adverse Event|7|||
23175701|NCT01790503|64386540|FG000|Overall Study|Withdrawal by Subject|0|||
23175702|NCT01790503|64386541|FG001|Overall Study|Withdrawal by Subject|0|||
23340820|NCT03499899|64992856|FG000|Overall Study|Death|0|||
23175703|NCT01790503|64386542|FG002|Overall Study|Withdrawal by Subject|1|||
23175704|NCT01790503|64386543|FG003|Overall Study|Withdrawal by Subject|1|||
23236496|NCT03370133|64608245|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
23236497|NCT03370133|64608246|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
23236498|NCT03370133|64608241|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
23236499|NCT03370133|64608242|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
23236500|NCT03370133|64608243|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
23236501|NCT03370133|64608244|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
23236502|NCT03370133|64608245|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
23236503|NCT03370133|64608246|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
23236504|NCT03370133|64608241|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
23236505|NCT03370133|64608242|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
23236506|NCT03370133|64608243|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
23236507|NCT03370133|64608244|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
23236508|NCT03370133|64608245|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
23236509|NCT03370133|64608246|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
23236510|NCT03370133|64608241|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
23236511|NCT03370133|64608242|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
23236512|NCT03370133|64608243|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
23236513|NCT03370133|64608244|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
23236514|NCT03370133|64608245|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
23236515|NCT03370133|64608246|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
23236516|NCT03370133|64608241|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23236517|NCT03370133|64608242|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23236518|NCT03370133|64608243|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23236519|NCT03370133|64608244|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23236520|NCT03370133|64608245|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
23236521|NCT03370133|64608246|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
23236522|NCT03370133|64608241|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23236523|NCT03370133|64608242|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23236524|NCT03370133|64608243|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23236525|NCT03370133|64608244|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23236526|NCT03370133|64608245|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
23236527|NCT03370133|64608246|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
23236528|NCT01383317|64608247|FG000|Overall Study|Lost to Follow-up|2|||
23236529|NCT01383317|64608248|FG001|Overall Study|Lost to Follow-up|1|||
23236530|NCT01383317|64608247|FG000|Overall Study|Death|1|||
23236531|NCT01383317|64608248|FG001|Overall Study|Death|0|||
23236532|NCT01383317|64608247|FG000|Overall Study|Adverse Event|0|||
23236533|NCT01383317|64608248|FG001|Overall Study|Adverse Event|1|||
23236534|NCT03764813|64608249|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
23236535|NCT03764813|64608250|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
23236536|NCT03764813|64608251|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
23236537|NCT03764813|64608252|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
23236538|NCT03556202|64608253|FG000|Extension Treatment Period|Adverse Event|18|||
23236539|NCT03556202|64608254|FG001|Extension Treatment Period|Adverse Event|14|||
23236540|NCT03556202|64608255|FG002|Extension Treatment Period|Adverse Event|9|||
23236541|NCT03556202|64608253|FG000|Extension Treatment Period|Death|2|||
23236542|NCT03556202|64608254|FG001|Extension Treatment Period|Death|6|||
23236543|NCT03556202|64608255|FG002|Extension Treatment Period|Death|0|||
23236544|NCT03556202|64608253|FG000|Extension Treatment Period|Lack of Efficacy|5|||
23582105|NCT00916006|65862324|FG001|Overall Study|Withdrawal by Subject|5|||
23582106|NCT00916006|65862323|FG000|Overall Study|Protocol Violation|0|||
23582107|NCT00916006|65862324|FG001|Overall Study|Protocol Violation|1|||
23582108|NCT01704846|65862325|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23582109|NCT01704846|65862326|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23582110|NCT00946192|65862330|FG000|Overall Study|Lost to Follow-up|6|||
23582111|NCT00946192|65862331|FG001|Overall Study|Lost to Follow-up|11|||
23582112|NCT00946192|65862332|FG002|Overall Study|Lost to Follow-up|9|||
23582113|NCT00946192|65862330|FG000|Overall Study|Withdrawal by Subject|10|||
23582114|NCT00946192|65862331|FG001|Overall Study|Withdrawal by Subject|7|||
23236545|NCT03556202|64608254|FG001|Extension Treatment Period|Lack of Efficacy|12|||
23236546|NCT03556202|64608255|FG002|Extension Treatment Period|Lack of Efficacy|18|||
23236547|NCT03556202|64608253|FG000|Extension Treatment Period|Lost to Follow-up|9|||
23582115|NCT00946192|65862332|FG002|Overall Study|Withdrawal by Subject|3|||
23582116|NCT00946192|65862330|FG000|Overall Study|Did not start medication|2|||
23582117|NCT00946192|65862331|FG001|Overall Study|Did not start medication|0|||
23582118|NCT00946192|65862332|FG002|Overall Study|Did not start medication|0|||
23582119|NCT02028884|65862333|FG000|Double-blind Period|Adverse Event|5|||
23582120|NCT02028884|65862334|FG001|Double-blind Period|Adverse Event|3|||
23582121|NCT02028884|65862335|FG002|Double-blind Period|Adverse Event|0|||
23236548|NCT03556202|64608254|FG001|Extension Treatment Period|Lost to Follow-up|20|||
23236549|NCT03556202|64608255|FG002|Extension Treatment Period|Lost to Follow-up|2|||
23236550|NCT03556202|64608253|FG000|Extension Treatment Period|Pregnancy|2|||
23340821|NCT03499899|64992857|FG001|Overall Study|Death|0|||
23340822|NCT03499899|64992858|FG002|Overall Study|Death|1|||
23340823|NCT03499899|64992856|FG000|Overall Study|Physician Decision|3|||
23340824|NCT03499899|64992857|FG001|Overall Study|Physician Decision|6|||
23340825|NCT03499899|64992858|FG002|Overall Study|Physician Decision|6|||
23340826|NCT03499899|64992856|FG000|Overall Study|Progressive disease|15|||
23236551|NCT03556202|64608254|FG001|Extension Treatment Period|Pregnancy|4|||
23236552|NCT03556202|64608255|FG002|Extension Treatment Period|Pregnancy|3|||
23236553|NCT03556202|64608253|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
23236554|NCT03556202|64608254|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
23236555|NCT03556202|64608255|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
23453227|NCT02322281|65403300|FG000|Overall Study|Adverse Event|3|||
23453228|NCT02322281|65403301|FG001|Overall Study|Adverse Event|4|||
23453229|NCT02322281|65403302|FG002|Overall Study|Adverse Event|6|||
23453230|NCT02322281|65403300|FG000|Overall Study|Death|3|||
23453231|NCT02322281|65403301|FG001|Overall Study|Death|3|||
23453232|NCT02322281|65403302|FG002|Overall Study|Death|3|||
23453233|NCT02322281|65403300|FG000|Overall Study|Withdrawal by Subject|1|||
23453234|NCT02322281|65403301|FG001|Overall Study|Withdrawal by Subject|1|||
23453235|NCT02322281|65403302|FG002|Overall Study|Withdrawal by Subject|6|||
23453236|NCT02322281|65403300|FG000|Overall Study|Physician Decision|2|||
23453237|NCT02322281|65403301|FG001|Overall Study|Physician Decision|0|||
23453238|NCT02322281|65403302|FG002|Overall Study|Physician Decision|5|||
23453239|NCT02322281|65403300|FG000|Overall Study|Study Terminated by Sponsor|2|||
23453240|NCT02322281|65403301|FG001|Overall Study|Study Terminated by Sponsor|0|||
23453241|NCT02322281|65403302|FG002|Overall Study|Study Terminated by Sponsor|0|||
23453242|NCT02322281|65403300|FG000|Overall Study|Missing|0|||
23453243|NCT02322281|65403301|FG001|Overall Study|Missing|0|||
23453244|NCT02322281|65403302|FG002|Overall Study|Missing|1|||
23453245|NCT02322281|65403300|FG000|Overall Study|Miscellaneous|0|||
23453246|NCT02322281|65403301|FG001|Overall Study|Miscellaneous|0|||
23453247|NCT02322281|65403302|FG002|Overall Study|Miscellaneous|4|||
23453248|NCT01428258|65403308|FG000|Intervention 1|Withdrawal by Subject|2|||
23453249|NCT01428258|65403309|FG001|Intervention 1|Withdrawal by Subject|0|||
23453250|NCT00979901|65403310|FG000|Overall Study|Adverse Event|1|||
23453251|NCT00979901|65403311|FG001|Overall Study|Adverse Event|3|||
23453252|NCT00979901|65403312|FG002|Overall Study|Adverse Event|9|||
23453253|NCT00979901|65403313|FG003|Overall Study|Adverse Event|2|||
23453254|NCT00979901|65403310|FG000|Overall Study|Lack of Efficacy|8|||
23453255|NCT00979901|65403311|FG001|Overall Study|Lack of Efficacy|4|||
23453256|NCT00979901|65403312|FG002|Overall Study|Lack of Efficacy|9|||
23453257|NCT00979901|65403313|FG003|Overall Study|Lack of Efficacy|0|||
23453258|NCT00979901|65403310|FG000|Overall Study|Lost to Follow-up|1|||
23453259|NCT00979901|65403311|FG001|Overall Study|Lost to Follow-up|1|||
23453260|NCT00979901|65403312|FG002|Overall Study|Lost to Follow-up|2|||
23453261|NCT00979901|65403313|FG003|Overall Study|Lost to Follow-up|0|||
23453262|NCT00979901|65403310|FG000|Overall Study|Protocol Violation|2|||
23453263|NCT00979901|65403311|FG001|Overall Study|Protocol Violation|2|||
23453264|NCT00979901|65403312|FG002|Overall Study|Protocol Violation|7|||
23453265|NCT00979901|65403313|FG003|Overall Study|Protocol Violation|1|||
23236556|NCT03556202|64608253|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
23236557|NCT03556202|64608254|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
23236558|NCT03556202|64608255|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
23236559|NCT03556202|64608253|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
23236560|NCT03556202|64608254|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
23236561|NCT03556202|64608255|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
23453266|NCT00979901|65403310|FG000|Overall Study|Withdrawal by Subject|2|||
23453267|NCT00979901|65403311|FG001|Overall Study|Withdrawal by Subject|1|||
23340827|NCT03499899|64992857|FG001|Overall Study|Progressive disease|23|||
23340828|NCT03499899|64992858|FG002|Overall Study|Progressive disease|23|||
23340829|NCT03499899|64992856|FG000|Overall Study|Patient decision|0|||
23453268|NCT00979901|65403312|FG002|Overall Study|Withdrawal by Subject|1|||
23453269|NCT00979901|65403313|FG003|Overall Study|Withdrawal by Subject|1|||
23453270|NCT00979901|65403310|FG000|Overall Study|Noncompliance|1|||
23453271|NCT00979901|65403311|FG001|Overall Study|Noncompliance|0|||
23453272|NCT00979901|65403312|FG002|Overall Study|Noncompliance|0|||
23340830|NCT03499899|64992857|FG001|Overall Study|Patient decision|1|||
23453273|NCT00979901|65403313|FG003|Overall Study|Noncompliance|0|||
23453274|NCT00979901|65403310|FG000|Overall Study|out-of-state|1|||
23453275|NCT00979901|65403311|FG001|Overall Study|out-of-state|0|||
23453276|NCT00979901|65403312|FG002|Overall Study|out-of-state|0|||
23453277|NCT00979901|65403313|FG003|Overall Study|out-of-state|0|||
23453278|NCT00979901|65403310|FG000|Overall Study|vacation|1|||
23453279|NCT00979901|65403311|FG001|Overall Study|vacation|0|||
23453280|NCT00979901|65403312|FG002|Overall Study|vacation|0|||
23340831|NCT03499899|64992858|FG002|Overall Study|Patient decision|1|||
23340832|NCT03499899|64992856|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
23340833|NCT03499899|64992857|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
23340834|NCT03499899|64992858|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
23236562|NCT03556202|64608253|FG000|Extension Treatment Period|Physician Decision|0|||
23236563|NCT03556202|64608254|FG001|Extension Treatment Period|Physician Decision|8|||
23236564|NCT03556202|64608255|FG002|Extension Treatment Period|Physician Decision|2|||
23236565|NCT03556202|64608253|FG000|Extension Treatment Period|Protocol Violation|0|||
23236566|NCT03556202|64608254|FG001|Extension Treatment Period|Protocol Violation|1|||
23236567|NCT03556202|64608255|FG002|Extension Treatment Period|Protocol Violation|1|||
23236568|NCT03556202|64608253|FG000|Extension Treatment Period|Sponsor Decision|0|||
23236569|NCT03556202|64608254|FG001|Extension Treatment Period|Sponsor Decision|1|||
23236570|NCT03556202|64608255|FG002|Extension Treatment Period|Sponsor Decision|0|||
23236571|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
23236572|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
23236573|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
23236574|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Death|1|||
23236575|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Death|0|||
23236576|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Death|0|||
23236577|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
23236578|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
23236579|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
23236580|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
23340835|NCT04114357|64992865|FG000|Baseline-Randomization|Adverse Event|2|||
23340836|NCT04114357|64992866|FG001|Baseline-Randomization|Adverse Event|1|||
23453281|NCT00979901|65403313|FG003|Overall Study|vacation|0|||
23453282|NCT00979901|65403310|FG000|Overall Study|elevated lab values pre-randomization|1|||
23582122|NCT02028884|65862333|FG000|Double-blind Period|Eligibility Violation|1|||
23236581|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
23236582|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
23236583|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
23236584|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
23236585|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
23236586|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
23236587|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
23236588|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
23236589|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
23236590|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
23236591|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
23236592|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
23236593|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
23236594|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
23236595|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
23236596|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
23236597|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
23236598|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
23236599|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
23236600|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
23236601|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
23236602|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
23236603|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
23236604|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
23236605|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
23236606|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
23340837|NCT04114357|64992865|FG000|Baseline-Randomization|Lost to Follow-up|1|||
23340838|NCT04114357|64992866|FG001|Baseline-Randomization|Lost to Follow-up|1|||
23453283|NCT00979901|65403311|FG001|Overall Study|elevated lab values pre-randomization|0|||
23582123|NCT02028884|65862334|FG001|Double-blind Period|Eligibility Violation|0|||
23175705|NCT01790503|64386544|FG004|Overall Study|Withdrawal by Subject|1|||
23175706|NCT01790503|64386545|FG005|Overall Study|Withdrawal by Subject|2|||
23175707|NCT01790503|64386546|FG006|Overall Study|Withdrawal by Subject|1|||
23175708|NCT01790503|64386547|FG007|Overall Study|Withdrawal by Subject|0|||
23175709|NCT01790503|64386548|FG008|Overall Study|Withdrawal by Subject|0|||
23175710|NCT01790503|64386549|FG009|Overall Study|Withdrawal by Subject|0|||
23175711|NCT01790503|64386550|FG010|Overall Study|Withdrawal by Subject|1|||
23175712|NCT01790503|64386540|FG000|Overall Study|Disease progression|2|||
23175713|NCT01790503|64386541|FG001|Overall Study|Disease progression|1|||
23175714|NCT01790503|64386542|FG002|Overall Study|Disease progression|0|||
23175715|NCT01790503|64386543|FG003|Overall Study|Disease progression|1|||
23175716|NCT01790503|64386544|FG004|Overall Study|Disease progression|2|||
23453284|NCT00979901|65403312|FG002|Overall Study|elevated lab values pre-randomization|0|||
23453285|NCT00979901|65403313|FG003|Overall Study|elevated lab values pre-randomization|0|||
23453286|NCT00979901|65403310|FG000|Overall Study|Discontinued in Error|0|||
23453287|NCT00979901|65403311|FG001|Overall Study|Discontinued in Error|1|||
23453288|NCT00979901|65403312|FG002|Overall Study|Discontinued in Error|0|||
23453289|NCT00979901|65403313|FG003|Overall Study|Discontinued in Error|0|||
23453290|NCT00979901|65403310|FG000|Overall Study|Left Country|0|||
23453291|NCT00979901|65403311|FG001|Overall Study|Left Country|0|||
23453292|NCT00979901|65403312|FG002|Overall Study|Left Country|1|||
23453293|NCT00979901|65403313|FG003|Overall Study|Left Country|0|||
23453294|NCT00979901|65403310|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
23453295|NCT00979901|65403311|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
23453296|NCT00979901|65403312|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
23453297|NCT00979901|65403313|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
23453298|NCT04906499|65403316|FG000|Overall Study|Lack of time|1|||
23453299|NCT01517750|65403320|FG000|Overall Study|Lost to Follow-up|1|||
23453300|NCT01517750|65403321|FG001|Overall Study|Lost to Follow-up|2|||
23453301|NCT01517750|65403322|FG002|Overall Study|Lost to Follow-up|4|||
23453302|NCT01517750|65403323|FG003|Overall Study|Lost to Follow-up|1|||
23453303|NCT01308736|65403324|FG000|Overall Study|Did not attend a single session|6|||
23453304|NCT01308736|65403325|FG001|Overall Study|Did not attend a single session|5|||
23453305|NCT02525471|65403326|FG000|Overall Study|Screen Failure|6|||
23453306|NCT02525471|65403326|FG000|Overall Study|Withdrawal by Subject|4|||
23453307|NCT02525471|65403326|FG000|Overall Study|Death|1|||
23453308|NCT02366195|65403327|FG000|Overall Study|Protocol-specified criteria|3|||
23453309|NCT02366195|65403327|FG000|Overall Study|Withdrawal by Subject|9|||
23453310|NCT02366195|65403327|FG000|Overall Study|Lost to Follow-up|1|||
23453311|NCT02366195|65403327|FG000|Overall Study|Death|41|||
23453312|NCT03935126|65403330|FG000|Overall Study|Study termination by sponsor|3|||
23453313|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
23453314|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
23453315|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
23453316|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453317|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453318|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453319|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453320|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453321|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453322|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453323|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453324|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453325|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
23453326|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453327|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
23453328|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453329|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
23453330|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453331|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453332|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
23453333|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
23453334|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
23453335|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
23453336|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453337|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
23453338|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453339|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453340|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
23453341|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
23453342|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
23453343|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
23453344|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
23453345|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
23453346|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
23453347|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
23453348|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
23453349|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
23453350|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
23453351|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
23582124|NCT02028884|65862335|FG002|Double-blind Period|Eligibility Violation|0|||
23582125|NCT02028884|65862333|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
23453352|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
23453353|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
23453354|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
23453355|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
23453356|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
23453357|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
23453358|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
23453359|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453360|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23340839|NCT04114357|64992865|FG000|Cross-over|Adverse Event|0|||
23340840|NCT04114357|64992866|FG001|Cross-over|Adverse Event|1|||
23340841|NCT01936181|64992870|FG000|Randomised, Double-blind|Adverse Event|27|||
23340842|NCT01936181|64992871|FG001|Randomised, Double-blind|Adverse Event|21|||
23340843|NCT01936181|64992872|FG002|Randomised, Double-blind|Adverse Event|0|||
23453361|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
23453362|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453363|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453364|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453365|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453366|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453367|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453368|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
23453369|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453370|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453371|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453372|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
23453373|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453374|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453375|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453376|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453377|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453378|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453379|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453380|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453381|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453382|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453383|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453384|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453385|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453386|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
23453387|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
23453388|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453389|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453390|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453391|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
23453392|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453393|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453394|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453395|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453396|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453397|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453398|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
23453399|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453400|NCT01147666|65403343|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453401|NCT01147666|65403344|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23453402|NCT01147666|65403345|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
23340844|NCT01936181|64992873|FG003|Randomised, Double-blind|Adverse Event|0|||
23340845|NCT01936181|64992870|FG000|Randomised, Double-blind|Protocol Violation|1|||
23340846|NCT01936181|64992871|FG001|Randomised, Double-blind|Protocol Violation|5|||
23340847|NCT01936181|64992872|FG002|Randomised, Double-blind|Protocol Violation|0|||
23453403|NCT01147666|65403331|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453404|NCT01147666|65403332|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23340848|NCT01936181|64992873|FG003|Randomised, Double-blind|Protocol Violation|0|||
23453405|NCT01147666|65403333|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453406|NCT01147666|65403334|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453407|NCT01147666|65403335|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23175717|NCT01790503|64386545|FG005|Overall Study|Disease progression|1|||
23175718|NCT01790503|64386546|FG006|Overall Study|Disease progression|0|||
23453408|NCT01147666|65403336|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453409|NCT01147666|65403337|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453410|NCT01147666|65403338|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453411|NCT01147666|65403339|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453412|NCT01147666|65403340|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453413|NCT01147666|65403341|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
23453414|NCT01147666|65403342|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
23175719|NCT01790503|64386547|FG007|Overall Study|Disease progression|1|||
23175720|NCT01790503|64386548|FG008|Overall Study|Disease progression|0|||
23175721|NCT01790503|64386549|FG009|Overall Study|Disease progression|17|||
23175722|NCT01790503|64386550|FG010|Overall Study|Disease progression|7|||
23175723|NCT01790503|64386540|FG000|Overall Study|Protocol Violation|0|||
23175724|NCT01790503|64386541|FG001|Overall Study|Protocol Violation|0|||
23175725|NCT01790503|64386542|FG002|Overall Study|Protocol Violation|0|||
23175726|NCT01790503|64386543|FG003|Overall Study|Protocol Violation|0|||
23175727|NCT01790503|64386544|FG004|Overall Study|Protocol Violation|0|||
23175728|NCT01790503|64386545|FG005|Overall Study|Protocol Violation|0|||
23175729|NCT01790503|64386546|FG006|Overall Study|Protocol Violation|0|||
23175730|NCT01790503|64386547|FG007|Overall Study|Protocol Violation|0|||
23175731|NCT01790503|64386548|FG008|Overall Study|Protocol Violation|0|||
23175732|NCT01790503|64386549|FG009|Overall Study|Protocol Violation|1|||
23175733|NCT01790503|64386550|FG010|Overall Study|Protocol Violation|0|||
23175734|NCT01790503|64386540|FG000|Overall Study|Physician Decision|0|||
23175735|NCT01790503|64386541|FG001|Overall Study|Physician Decision|0|||
23175736|NCT01790503|64386542|FG002|Overall Study|Physician Decision|0|||
23175737|NCT01790503|64386543|FG003|Overall Study|Physician Decision|0|||
23175738|NCT01790503|64386544|FG004|Overall Study|Physician Decision|0|||
23175739|NCT01790503|64386545|FG005|Overall Study|Physician Decision|0|||
23175740|NCT01790503|64386546|FG006|Overall Study|Physician Decision|0|||
23236607|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
23236608|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
23236609|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
23236610|NCT03556202|64608253|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
23236611|NCT03556202|64608254|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
23236612|NCT03556202|64608255|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
23236613|NCT02569398|64608256|FG000|Overall Study|Adverse Event|0|||
23236614|NCT02569398|64608257|FG001|Overall Study|Adverse Event|1|||
23236615|NCT02569398|64608258|FG002|Overall Study|Adverse Event|6|||
23236616|NCT02569398|64608256|FG000|Overall Study|Withdrawal by Subject|43|||
23236617|NCT02569398|64608257|FG001|Overall Study|Withdrawal by Subject|43|||
23236618|NCT02569398|64608258|FG002|Overall Study|Withdrawal by Subject|30|||
23236619|NCT02569398|64608256|FG000|Overall Study|Study terminated by sponsor|130|||
23236620|NCT02569398|64608257|FG001|Overall Study|Study terminated by sponsor|131|||
23236621|NCT02569398|64608258|FG002|Overall Study|Study terminated by sponsor|134|||
23175741|NCT01790503|64386547|FG007|Overall Study|Physician Decision|0|||
23175742|NCT01790503|64386548|FG008|Overall Study|Physician Decision|0|||
23175743|NCT01790503|64386549|FG009|Overall Study|Physician Decision|1|||
23175744|NCT01790503|64386550|FG010|Overall Study|Physician Decision|1|||
23175745|NCT01790503|64386540|FG000|Overall Study|Death|0|||
23175746|NCT01790503|64386541|FG001|Overall Study|Death|0|||
23175747|NCT01790503|64386542|FG002|Overall Study|Death|0|||
23175748|NCT01790503|64386543|FG003|Overall Study|Death|0|||
23175749|NCT01790503|64386544|FG004|Overall Study|Death|0|||
23175750|NCT01790503|64386545|FG005|Overall Study|Death|0|||
23175751|NCT01790503|64386546|FG006|Overall Study|Death|0|||
23175752|NCT01790503|64386547|FG007|Overall Study|Death|0|||
23175753|NCT01790503|64386548|FG008|Overall Study|Death|0|||
23175754|NCT01790503|64386549|FG009|Overall Study|Death|1|||
23175755|NCT01790503|64386550|FG010|Overall Study|Death|0|||
23175756|NCT01790503|64386540|FG000|Overall Study|Non Compliance|0|||
23175757|NCT01790503|64386541|FG001|Overall Study|Non Compliance|0|||
23175758|NCT01790503|64386542|FG002|Overall Study|Non Compliance|0|||
23175759|NCT01790503|64386543|FG003|Overall Study|Non Compliance|0|||
23175760|NCT01790503|64386544|FG004|Overall Study|Non Compliance|1|||
23175761|NCT01790503|64386545|FG005|Overall Study|Non Compliance|0|||
23175762|NCT01790503|64386546|FG006|Overall Study|Non Compliance|0|||
23175763|NCT01790503|64386547|FG007|Overall Study|Non Compliance|0|||
23175764|NCT01790503|64386548|FG008|Overall Study|Non Compliance|0|||
23175765|NCT01790503|64386549|FG009|Overall Study|Non Compliance|0|||
23236622|NCT02569398|64608256|FG000|Overall Study|Other|12|||
23236623|NCT02569398|64608257|FG001|Overall Study|Other|14|||
23236624|NCT02569398|64608258|FG002|Overall Study|Other|13|||
23236625|NCT00280059|64608259|FG000|Efficacy Assessment Phase|Death|2|||
23236626|NCT00280059|64608260|FG001|Efficacy Assessment Phase|Death|0|||
23236627|NCT00280059|64608259|FG000|Efficacy Assessment Phase|Adverse Event|33|||
23236628|NCT00280059|64608260|FG001|Efficacy Assessment Phase|Adverse Event|31|||
23236629|NCT00280059|64608259|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
23236630|NCT00280059|64608260|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
23236631|NCT00280059|64608259|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
23236632|NCT00280059|64608260|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
23175766|NCT01790503|64386550|FG010|Overall Study|Non Compliance|0|||
23175767|NCT01790503|64386540|FG000|Overall Study|Other|0|||
23175768|NCT01790503|64386541|FG001|Overall Study|Other|0|||
23236633|NCT00280059|64608259|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
23236634|NCT00280059|64608260|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
23175769|NCT01790503|64386542|FG002|Overall Study|Other|0|||
23175770|NCT01790503|64386543|FG003|Overall Study|Other|0|||
23175771|NCT01790503|64386544|FG004|Overall Study|Other|1|||
23175772|NCT01790503|64386545|FG005|Overall Study|Other|0|||
23175773|NCT01790503|64386546|FG006|Overall Study|Other|0|||
23175875|NCT04303000|64386600|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
23175876|NCT04303000|64386601|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
23175877|NCT00630331|64386604|FG000|Overall Study|Death|2|||
23175878|NCT00630331|64386605|FG001|Overall Study|Death|1|||
23175879|NCT00630331|64386606|FG002|Overall Study|Death|1|||
23175880|NCT00630331|64386604|FG000|Overall Study|Adverse Event|1|||
23175881|NCT00630331|64386605|FG001|Overall Study|Adverse Event|0|||
23175882|NCT00630331|64386606|FG002|Overall Study|Adverse Event|0|||
23175883|NCT00630331|64386604|FG000|Overall Study|Withdrawal by Subject|12|||
23175884|NCT00630331|64386605|FG001|Overall Study|Withdrawal by Subject|7|||
23175885|NCT00630331|64386606|FG002|Overall Study|Withdrawal by Subject|5|||
23175886|NCT00630331|64386604|FG000|Overall Study|Lost to Follow-up|175|||
23175887|NCT00630331|64386605|FG001|Overall Study|Lost to Follow-up|143|||
23175888|NCT00630331|64386606|FG002|Overall Study|Lost to Follow-up|170|||
23175889|NCT00630331|64386604|FG000|Overall Study|Inappropriate enrollment|3|||
23175890|NCT00630331|64386605|FG001|Overall Study|Inappropriate enrollment|6|||
23175891|NCT00630331|64386606|FG002|Overall Study|Inappropriate enrollment|3|||
23175892|NCT00630331|64386604|FG000|Overall Study|Unable to classify|9|||
23175893|NCT00630331|64386605|FG001|Overall Study|Unable to classify|4|||
23175894|NCT00630331|64386606|FG002|Overall Study|Unable to classify|3|||
23175895|NCT00630331|64386604|FG000|Overall Study|Protocol Violation|4|||
23175896|NCT00630331|64386605|FG001|Overall Study|Protocol Violation|5|||
23175897|NCT00630331|64386606|FG002|Overall Study|Protocol Violation|6|||
23175898|NCT00802360|64386607|FG000|Overall Study|Stimulation failure|4|||
23175899|NCT00802360|64386608|FG001|Overall Study|Stimulation failure|0|||
23175900|NCT00802360|64386609|FG002|Overall Study|Stimulation failure|3|||
23175901|NCT00802360|64386610|FG003|Overall Study|Stimulation failure|3|||
23175902|NCT00802360|64386607|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
23175903|NCT00802360|64386608|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
23175904|NCT00802360|64386609|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
23175905|NCT00802360|64386610|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
23453646|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23453647|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
23453648|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
23453649|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
23453650|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
23453651|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
23453652|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453653|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453654|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453655|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453656|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453657|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453658|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
23453659|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
23453660|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
23453661|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
23453662|NCT02365649|65403362|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453663|NCT02365649|65403363|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453664|NCT02365649|65403364|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453665|NCT02365649|65403365|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453666|NCT02365649|65403366|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453667|NCT02365649|65403367|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453668|NCT02365649|65403368|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
23453669|NCT02365649|65403369|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453670|NCT02365649|65403370|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
23453671|NCT02365649|65403371|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
23453672|NCT00473434|65403372|FG000|Overall Study|Physician Decision|3|||
23453673|NCT00473434|65403372|FG000|Overall Study|Withdrawal by Subject|9|||
23453674|NCT00473434|65403372|FG000|Overall Study|Compliance|3|||
23453675|NCT00473434|65403372|FG000|Overall Study|Lack of Efficacy|3|||
23453676|NCT00473434|65403372|FG000|Overall Study|Adverse Event|3|||
23453677|NCT00473434|65403372|FG000|Overall Study|Patient was selling medication to others|1|||
23175906|NCT00802360|64386607|FG000|Overall Study|Cycle cancelled|0|||
23175907|NCT00802360|64386608|FG001|Overall Study|Cycle cancelled|1|||
23175908|NCT00802360|64386609|FG002|Overall Study|Cycle cancelled|1|||
23175909|NCT00802360|64386610|FG003|Overall Study|Cycle cancelled|1|||
23453678|NCT00473434|65403372|FG000|Overall Study|Safety evaluation|1|||
23453679|NCT00473434|65403372|FG000|Overall Study|Reason not specified|6|||
23175910|NCT00802360|64386607|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
23175911|NCT00802360|64386608|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
23175912|NCT00802360|64386609|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
23175913|NCT00802360|64386610|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
23175914|NCT00802360|64386607|FG000|Overall Study|No positive serum pregnancy|17|||
23340871|NCT01936181|64992872|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
23175915|NCT00802360|64386608|FG001|Overall Study|No positive serum pregnancy|20|||
23175916|NCT00802360|64386609|FG002|Overall Study|No positive serum pregnancy|14|||
23175917|NCT00802360|64386610|FG003|Overall Study|No positive serum pregnancy|10|||
23175918|NCT00802360|64386607|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
23175919|NCT00802360|64386608|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23340872|NCT01936181|64992873|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
23340873|NCT01936181|64992870|FG000|Transition-extension|Adverse Event|3|||
23453680|NCT00473434|65403372|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
23453681|NCT00473434|65403372|FG000|Overall Study|Switching to trial medication|1|||
23453682|NCT00473434|65403372|FG000|Overall Study|No longer required|1|||
23453683|NCT00265564|65403373|FG000|Overall Study|Lost to Follow-up|5|||
23453684|NCT00265564|65403374|FG001|Overall Study|Lost to Follow-up|7|||
23453685|NCT00265564|65403373|FG000|Overall Study|met exclusion criteria|5|||
23453686|NCT00265564|65403374|FG001|Overall Study|met exclusion criteria|2|||
23453687|NCT00982735|65403375|FG000|Overall Study|Lost to Follow-up|6|||
23453688|NCT00982735|65403375|FG000|Overall Study|Patient ineligible for trial|224|||
23453689|NCT03489863|65403376|FG000|Overall Study|Withdrawal by Subject|0|||
23453690|NCT03489863|65403377|FG001|Overall Study|Withdrawal by Subject|1|||
23453691|NCT00216671|65403381|FG000|Overall Study|Adverse Event|4|||
23453692|NCT00216671|65403382|FG001|Overall Study|Adverse Event|9|||
23453693|NCT00216671|65403381|FG000|Overall Study|Pregnancy|0|||
23340874|NCT01936181|64992871|FG001|Transition-extension|Adverse Event|0|||
23340875|NCT01936181|64992872|FG002|Transition-extension|Adverse Event|3|||
23340876|NCT01936181|64992873|FG003|Transition-extension|Adverse Event|1|||
23340877|NCT01936181|64992870|FG000|Transition-extension|Lost to Follow-up|3|||
23340878|NCT01936181|64992871|FG001|Transition-extension|Lost to Follow-up|0|||
23340879|NCT01936181|64992872|FG002|Transition-extension|Lost to Follow-up|1|||
23340880|NCT01936181|64992873|FG003|Transition-extension|Lost to Follow-up|2|||
23340881|NCT01936181|64992870|FG000|Transition-extension|Physician Decision|2|||
23340882|NCT01936181|64992871|FG001|Transition-extension|Physician Decision|0|||
23340883|NCT01936181|64992872|FG002|Transition-extension|Physician Decision|0|||
23340884|NCT01936181|64992873|FG003|Transition-extension|Physician Decision|1|||
23340885|NCT01936181|64992870|FG000|Transition-extension|Withdrawal by Subject|7|||
23340886|NCT01936181|64992871|FG001|Transition-extension|Withdrawal by Subject|0|||
23340887|NCT01936181|64992872|FG002|Transition-extension|Withdrawal by Subject|2|||
23340888|NCT01936181|64992873|FG003|Transition-extension|Withdrawal by Subject|1|||
23340889|NCT00519428|64992875|FG000|Overall Study|Adverse Event|5|||
23340890|NCT00519428|64992876|FG001|Overall Study|Adverse Event|2|||
23340891|NCT00519428|64992877|FG002|Overall Study|Adverse Event|10|||
23340892|NCT00519428|64992875|FG000|Overall Study|Lost to Follow-up|7|||
23340893|NCT00519428|64992876|FG001|Overall Study|Lost to Follow-up|7|||
23340894|NCT00519428|64992877|FG002|Overall Study|Lost to Follow-up|6|||
23340895|NCT00519428|64992875|FG000|Overall Study|Withdrawal by Subject|8|||
23340896|NCT00519428|64992876|FG001|Overall Study|Withdrawal by Subject|3|||
23340897|NCT00519428|64992877|FG002|Overall Study|Withdrawal by Subject|7|||
23340898|NCT00519428|64992875|FG000|Overall Study|unstated|1|||
23340899|NCT00519428|64992876|FG001|Overall Study|unstated|3|||
23340900|NCT00519428|64992877|FG002|Overall Study|unstated|2|||
23340901|NCT02163226|64992878|FG000|Overall Study|Death|2|||
23340902|NCT02163226|64992879|FG001|Overall Study|Death|1|||
23340903|NCT02163226|64992878|FG000|Overall Study|Withdrawal by Subject|5|||
23340904|NCT02163226|64992879|FG001|Overall Study|Withdrawal by Subject|2|||
23340905|NCT02163226|64992878|FG000|Overall Study|Returned home, local radiotherapy|3|||
23340906|NCT02163226|64992879|FG001|Overall Study|Returned home, local radiotherapy|0|||
23340907|NCT02163226|64992878|FG000|Overall Study|Repeat imaging showed no disease|2|||
23340908|NCT02163226|64992879|FG001|Overall Study|Repeat imaging showed no disease|0|||
23340909|NCT02163226|64992878|FG000|Overall Study|Incomplete radiotherapy|3|||
23340910|NCT02163226|64992879|FG001|Overall Study|Incomplete radiotherapy|0|||
23340911|NCT02163226|64992878|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
23340912|NCT02163226|64992879|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
23340913|NCT02163226|64992878|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
23340914|NCT02163226|64992879|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
23340915|NCT02163226|64992878|FG000|Overall Study|ineligible|0|||
23340916|NCT02163226|64992879|FG001|Overall Study|ineligible|3|||
23453694|NCT00216671|65403382|FG001|Overall Study|Pregnancy|1|||
23340917|NCT02394340|64992880|FG000|Overall Study|Failed drug screen test|1|||
23340918|NCT02394340|64992880|FG000|Overall Study|Adverse Event|1|||
23340919|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
23340920|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
23453695|NCT00216671|65403381|FG000|Overall Study|Withdrawal by Subject|4|||
23453696|NCT00216671|65403382|FG001|Overall Study|Withdrawal by Subject|2|||
23175920|NCT00802360|64386609|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
23175921|NCT00802360|64386610|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
23175922|NCT00802360|64386607|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
23175923|NCT00802360|64386608|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
23175924|NCT00802360|64386609|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
23175925|NCT00802360|64386610|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
23175926|NCT00802360|64386607|FG000|Overall Study|Other|2|||
23175927|NCT00802360|64386608|FG001|Overall Study|Other|3|||
23340921|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
23175928|NCT00802360|64386609|FG002|Overall Study|Other|6|||
23175929|NCT00802360|64386610|FG003|Overall Study|Other|3|||
23175930|NCT05655377|64386611|FG000|Overall Study|Withdrawal by Subject|2|||
23175931|NCT02971202|64386612|FG000|Overall Study|Pregnancy|1|||
23175932|NCT02971202|64386613|FG001|Overall Study|Pregnancy|0|||
23175933|NCT02971202|64386614|FG002|Overall Study|Pregnancy|0|||
23175934|NCT02971202|64386612|FG000|Overall Study|screen fail after consent|1|||
23175935|NCT02971202|64386613|FG001|Overall Study|screen fail after consent|0|||
23340922|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
23453697|NCT00216671|65403381|FG000|Overall Study|Refused Injections|3|||
23453698|NCT00216671|65403382|FG001|Overall Study|Refused Injections|13|||
23582247|NCT00567879|65862414|FG004|Overall Study|Abnormal test procedure(s)|0|||
23582248|NCT00567879|65862415|FG005|Overall Study|Abnormal test procedure(s)|0|||
23175936|NCT02971202|64386614|FG002|Overall Study|screen fail after consent|1|||
23175937|NCT02479802|64386618|FG000|Overall Study|Lost to Follow-up|1|||
23175938|NCT02479802|64386618|FG000|Overall Study|Adverse Event|1|||
23175939|NCT00821678|64386621|FG000|Overall Study|Withdrawal by Subject|8|||
23175940|NCT00821678|64386622|FG001|Overall Study|Withdrawal by Subject|0|||
23175941|NCT00821678|64386621|FG000|Overall Study|Lost to Follow-up|13|||
23175942|NCT00821678|64386622|FG001|Overall Study|Lost to Follow-up|12|||
23175943|NCT00821678|64386621|FG000|Overall Study|Death|0|||
23175944|NCT00821678|64386622|FG001|Overall Study|Death|2|||
23175945|NCT00481065|64386624|FG000|Overall Study|Adverse event or death|1|||
23175946|NCT00481065|64386625|FG001|Overall Study|Adverse event or death|1|||
23175947|NCT00481065|64386626|FG002|Overall Study|Adverse event or death|3|||
23175948|NCT00481065|64386627|FG003|Overall Study|Adverse event or death|0|||
23175949|NCT00481065|64386628|FG004|Overall Study|Adverse event or death|2|||
23175950|NCT00481065|64386629|FG005|Overall Study|Adverse event or death|0|||
23175951|NCT00481065|64386630|FG006|Overall Study|Adverse event or death|1|||
23175952|NCT00481065|64386631|FG007|Overall Study|Adverse event or death|1|||
23175953|NCT00481065|64386624|FG000|Overall Study|Withdrawal by Subject|11|||
23175954|NCT00481065|64386625|FG001|Overall Study|Withdrawal by Subject|12|||
23175955|NCT00481065|64386626|FG002|Overall Study|Withdrawal by Subject|7|||
23175956|NCT00481065|64386627|FG003|Overall Study|Withdrawal by Subject|11|||
23175957|NCT00481065|64386628|FG004|Overall Study|Withdrawal by Subject|13|||
23175958|NCT00481065|64386629|FG005|Overall Study|Withdrawal by Subject|12|||
23175959|NCT00481065|64386630|FG006|Overall Study|Withdrawal by Subject|9|||
23175960|NCT00481065|64386631|FG007|Overall Study|Withdrawal by Subject|10|||
23340923|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
23340924|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
23340925|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
23340926|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
23340927|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
23340928|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
23340929|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
23340930|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
23340931|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
23175961|NCT00481065|64386624|FG000|Overall Study|Lost to Follow-up|4|||
23175962|NCT00481065|64386625|FG001|Overall Study|Lost to Follow-up|2|||
23175963|NCT00481065|64386626|FG002|Overall Study|Lost to Follow-up|4|||
23175964|NCT00481065|64386627|FG003|Overall Study|Lost to Follow-up|3|||
23175965|NCT00481065|64386628|FG004|Overall Study|Lost to Follow-up|3|||
23175966|NCT00481065|64386629|FG005|Overall Study|Lost to Follow-up|3|||
23175967|NCT00481065|64386630|FG006|Overall Study|Lost to Follow-up|2|||
23340932|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
23582249|NCT00567879|65862410|FG000|Overall Study|Withdrawal by Subject|0|||
23582250|NCT00567879|65862411|FG001|Overall Study|Withdrawal by Subject|0|||
23582251|NCT00567879|65862412|FG002|Overall Study|Withdrawal by Subject|3|||
23582252|NCT00567879|65862413|FG003|Overall Study|Withdrawal by Subject|1|||
23582253|NCT00567879|65862414|FG004|Overall Study|Withdrawal by Subject|0|||
23582254|NCT00567879|65862415|FG005|Overall Study|Withdrawal by Subject|0|||
23175968|NCT00481065|64386631|FG007|Overall Study|Lost to Follow-up|5|||
23175969|NCT00481065|64386624|FG000|Overall Study|Inappropriate enrollment|4|||
23175970|NCT00481065|64386625|FG001|Overall Study|Inappropriate enrollment|0|||
23175971|NCT00481065|64386626|FG002|Overall Study|Inappropriate enrollment|2|||
23175972|NCT00481065|64386627|FG003|Overall Study|Inappropriate enrollment|0|||
23175973|NCT00481065|64386628|FG004|Overall Study|Inappropriate enrollment|2|||
23175974|NCT00481065|64386629|FG005|Overall Study|Inappropriate enrollment|1|||
23175975|NCT00481065|64386630|FG006|Overall Study|Inappropriate enrollment|0|||
23175976|NCT00481065|64386631|FG007|Overall Study|Inappropriate enrollment|1|||
23175977|NCT00481065|64386624|FG000|Overall Study|Administrative reason|0|||
23175978|NCT00481065|64386625|FG001|Overall Study|Administrative reason|0|||
23175979|NCT00481065|64386626|FG002|Overall Study|Administrative reason|0|||
23175980|NCT00481065|64386627|FG003|Overall Study|Administrative reason|0|||
23175981|NCT00481065|64386628|FG004|Overall Study|Administrative reason|0|||
23175982|NCT00481065|64386629|FG005|Overall Study|Administrative reason|2|||
23175983|NCT00481065|64386630|FG006|Overall Study|Administrative reason|1|||
23175984|NCT00481065|64386631|FG007|Overall Study|Administrative reason|0|||
23175985|NCT00481065|64386624|FG000|Overall Study|Protocol Violation|2|||
23175986|NCT00481065|64386625|FG001|Overall Study|Protocol Violation|1|||
23175987|NCT00481065|64386626|FG002|Overall Study|Protocol Violation|1|||
23175988|NCT00481065|64386627|FG003|Overall Study|Protocol Violation|1|||
23175989|NCT00481065|64386628|FG004|Overall Study|Protocol Violation|2|||
23175990|NCT00481065|64386629|FG005|Overall Study|Protocol Violation|6|||
23175991|NCT00481065|64386630|FG006|Overall Study|Protocol Violation|3|||
23175992|NCT00481065|64386631|FG007|Overall Study|Protocol Violation|2|||
23175993|NCT00481065|64386624|FG000|Overall Study|Unable to classify|0|||
23175994|NCT00481065|64386625|FG001|Overall Study|Unable to classify|1|||
23175995|NCT00481065|64386626|FG002|Overall Study|Unable to classify|2|||
23175996|NCT00481065|64386627|FG003|Overall Study|Unable to classify|0|||
23175997|NCT00481065|64386628|FG004|Overall Study|Unable to classify|1|||
23175998|NCT00481065|64386629|FG005|Overall Study|Unable to classify|0|||
23175999|NCT00481065|64386630|FG006|Overall Study|Unable to classify|0|||
23176000|NCT00481065|64386631|FG007|Overall Study|Unable to classify|0|||
23176001|NCT02307682|64386632|FG000|Overall Study|Adverse Event|9|||
23176002|NCT02307682|64386633|FG001|Overall Study|Adverse Event|8|||
23176003|NCT02307682|64386634|FG002|Overall Study|Adverse Event|12|||
23176004|NCT02307682|64386632|FG000|Overall Study|Lack of Efficacy|1|||
23176005|NCT02307682|64386633|FG001|Overall Study|Lack of Efficacy|0|||
23176006|NCT02307682|64386634|FG002|Overall Study|Lack of Efficacy|1|||
23176007|NCT02307682|64386632|FG000|Overall Study|Physician Decision|2|||
23176008|NCT02307682|64386633|FG001|Overall Study|Physician Decision|2|||
23176009|NCT02307682|64386634|FG002|Overall Study|Physician Decision|8|||
23176010|NCT02307682|64386632|FG000|Overall Study|Progressive Disease|1|||
23176011|NCT02307682|64386633|FG001|Overall Study|Progressive Disease|0|||
23176012|NCT02307682|64386634|FG002|Overall Study|Progressive Disease|0|||
23176013|NCT02307682|64386632|FG000|Overall Study|Withdrawal by Subject|26|||
23176014|NCT02307682|64386633|FG001|Overall Study|Withdrawal by Subject|34|||
23176015|NCT02307682|64386634|FG002|Overall Study|Withdrawal by Subject|23|||
23176016|NCT02307682|64386632|FG000|Overall Study|Death|9|||
23176017|NCT02307682|64386633|FG001|Overall Study|Death|7|||
23176018|NCT02307682|64386634|FG002|Overall Study|Death|12|||
23176019|NCT02307682|64386632|FG000|Overall Study|Lost to Follow-up|1|||
23176020|NCT02307682|64386633|FG001|Overall Study|Lost to Follow-up|5|||
23176021|NCT02307682|64386634|FG002|Overall Study|Lost to Follow-up|6|||
23176022|NCT02307682|64386632|FG000|Overall Study|Protocol Deviation|0|||
23176023|NCT02307682|64386633|FG001|Overall Study|Protocol Deviation|0|||
23176024|NCT02307682|64386634|FG002|Overall Study|Protocol Deviation|2|||
23176025|NCT02307682|64386632|FG000|Overall Study|Other|1|||
23176026|NCT02307682|64386633|FG001|Overall Study|Other|1|||
23176027|NCT02307682|64386634|FG002|Overall Study|Other|0|||
23176028|NCT00930059|64386635|FG000|Overall Study|Death|1|||
23176029|NCT00930059|64386636|FG001|Overall Study|Death|0|||
23176030|NCT00930059|64386635|FG000|Overall Study|Did not meet entrance criteria|1|||
23176031|NCT00930059|64386636|FG001|Overall Study|Did not meet entrance criteria|1|||
23176032|NCT00930059|64386635|FG000|Overall Study|Withdrawal by Subject|3|||
23176033|NCT00930059|64386636|FG001|Overall Study|Withdrawal by Subject|4|||
23176034|NCT00930059|64386635|FG000|Overall Study|Other|1|||
23176035|NCT00930059|64386636|FG001|Overall Study|Other|0|||
23176036|NCT00930059|64386635|FG000|Overall Study|1 site terminated by sponsor|1|||
23176037|NCT00930059|64386636|FG001|Overall Study|1 site terminated by sponsor|1|||
23176038|NCT00930059|64386635|FG000|Overall Study|Adverse Event|1|||
23176039|NCT00930059|64386636|FG001|Overall Study|Adverse Event|6|||
23176040|NCT04541004|64386637|FG000|Overall Study|Adverse Event|2|||
23340933|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
23340934|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
23340935|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
23402702|NCT03289143|65219984|FG001|Overall Study|Protocol Deviation|1|||
23176041|NCT00469612|64386639|FG000|Overall Study|Study terminated before data collected|2|||
23176042|NCT00469612|64386640|FG001|Overall Study|Study terminated before data collected|0|||
23176043|NCT05020899|64386647|FG000|8 Week Follow-up|Lost to Follow-up|3|||
23176044|NCT05020899|64386648|FG001|8 Week Follow-up|Lost to Follow-up|6|||
23176045|NCT05020899|64386647|FG000|12 Week Follow-up|Lost to Follow-up|1|||
23176046|NCT05020899|64386648|FG001|12 Week Follow-up|Lost to Follow-up|0|||
23176047|NCT05020899|64386647|FG000|12 Week Follow-up|Death|0|||
23176048|NCT05020899|64386648|FG001|12 Week Follow-up|Death|1|||
23176049|NCT02624492|64386649|FG000|Overall Study|Adverse Event|2|||
23176050|NCT02624492|64386650|FG001|Overall Study|Adverse Event|2|||
23176051|NCT02624492|64386651|FG002|Overall Study|Adverse Event|2|||
23176052|NCT02624492|64386649|FG000|Overall Study|Progressive disease|0|||
23176053|NCT02624492|64386650|FG001|Overall Study|Progressive disease|2|||
23176054|NCT02624492|64386651|FG002|Overall Study|Progressive disease|3|||
23176055|NCT00772447|64386652|FG000|Overall Study|Withdrawal by Subject|9|||
23176056|NCT00772447|64386653|FG001|Overall Study|Withdrawal by Subject|5|||
23340936|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
23340937|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
23340938|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
23340939|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
23340940|NCT04505722|64992881|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
23340941|NCT04505722|64992882|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
23340942|NCT04505722|64992883|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
23340943|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
23340944|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
23340945|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
23340946|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
23340947|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
23176057|NCT00772447|64386652|FG000|Overall Study|Physician Decision|4|||
23176058|NCT00772447|64386653|FG001|Overall Study|Physician Decision|8|||
23176059|NCT00772447|64386652|FG000|Overall Study|Lost to Follow-up|2|||
23176060|NCT00772447|64386653|FG001|Overall Study|Lost to Follow-up|4|||
23176061|NCT00772447|64386652|FG000|Overall Study|incorrect enrolment|3|||
23176062|NCT00772447|64386653|FG001|Overall Study|incorrect enrolment|4|||
23176063|NCT00772447|64386652|FG000|Overall Study|Protocol Violation|0|||
23176064|NCT00772447|64386653|FG001|Overall Study|Protocol Violation|1|||
23176065|NCT00772447|64386652|FG000|Overall Study|all others|2|||
23340948|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
23340949|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
23340950|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
23340951|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
23340952|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
23340953|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
23340954|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
23340955|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
23340956|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
23340957|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
23340958|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
23340959|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
23340960|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
23340961|NCT04505722|64992881|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
23340962|NCT04505722|64992882|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
23340963|NCT04505722|64992883|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
23340964|NCT02448537|64992884|FG000|Overall Study|Withdrawal by Subject|1|||
23340965|NCT02448537|64992885|FG001|Overall Study|Withdrawal by Subject|1|||
23340966|NCT02448537|64992886|FG002|Overall Study|Withdrawal by Subject|1|||
23340967|NCT01447446|64992891|FG000|Overall Study|Death|6|||
23340968|NCT01447446|64992892|FG001|Overall Study|Death|3|||
23340969|NCT01447446|64992893|FG002|Overall Study|Death|2|||
23340970|NCT01447446|64992894|FG003|Overall Study|Death|1|||
23340971|NCT01447446|64992895|FG004|Overall Study|Death|7|||
23340972|NCT01447446|64992896|FG005|Overall Study|Death|0|||
23340973|NCT01447446|64992891|FG000|Overall Study|Adverse Event|3|||
23340974|NCT01447446|64992892|FG001|Overall Study|Adverse Event|0|||
23340975|NCT01447446|64992893|FG002|Overall Study|Adverse Event|1|||
23340976|NCT01447446|64992894|FG003|Overall Study|Adverse Event|0|||
23340977|NCT01447446|64992895|FG004|Overall Study|Adverse Event|2|||
23340978|NCT01447446|64992896|FG005|Overall Study|Adverse Event|0|||
23340979|NCT01447446|64992891|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
23340980|NCT01447446|64992892|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
23340981|NCT01447446|64992893|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
23340982|NCT01447446|64992894|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
23340983|NCT01447446|64992895|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
23340984|NCT01447446|64992896|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
23340985|NCT01447446|64992891|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
23340986|NCT01447446|64992892|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
23340987|NCT01447446|64992893|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
23402703|NCT03289143|65219985|FG002|Overall Study|Protocol Deviation|3|||
23176066|NCT00772447|64386653|FG001|Overall Study|all others|2|||
23176067|NCT00631137|64386654|FG000|Overall Study|Withdrawal by Subject|1|||
23176068|NCT00631137|64386655|FG001|Overall Study|Withdrawal by Subject|0|||
23176069|NCT02429856|64386656|FG000|Overall Study|Death|12|||
23176070|NCT02429856|64386657|FG001|Overall Study|Death|13|||
23453699|NCT00216671|65403381|FG000|Overall Study|No Need to Continue Medication|1|||
23453700|NCT00216671|65403382|FG001|Overall Study|No Need to Continue Medication|1|||
23453701|NCT00216671|65403381|FG000|Overall Study|Insufficient Response|9|||
23453702|NCT00216671|65403382|FG001|Overall Study|Insufficient Response|4|||
23453703|NCT00216671|65403381|FG000|Overall Study|Lost to Follow-up|3|||
23453704|NCT00216671|65403382|FG001|Overall Study|Lost to Follow-up|5|||
23453705|NCT00216671|65403381|FG000|Overall Study|Non compliant|2|||
23453706|NCT00216671|65403382|FG001|Overall Study|Non compliant|2|||
23453707|NCT00216671|65403381|FG000|Overall Study|Ineligible|0|||
23453708|NCT00216671|65403382|FG001|Overall Study|Ineligible|2|||
23453709|NCT00216671|65403381|FG000|Overall Study|Physician Decision|1|||
23453710|NCT00216671|65403382|FG001|Overall Study|Physician Decision|1|||
23453711|NCT00216671|65403381|FG000|Overall Study|Protocol Violation|3|||
23453712|NCT00216671|65403382|FG001|Overall Study|Protocol Violation|5|||
23453713|NCT00216671|65403381|FG000|Overall Study|Relapse|1|||
23453714|NCT00216671|65403382|FG001|Overall Study|Relapse|0|||
23453715|NCT00216671|65403381|FG000|Overall Study|Investigator Illness|0|||
23453716|NCT00216671|65403382|FG001|Overall Study|Investigator Illness|1|||
23453717|NCT00216671|65403381|FG000|Overall Study|Patient Moved|0|||
23453718|NCT00216671|65403382|FG001|Overall Study|Patient Moved|1|||
23453719|NCT00216671|65403381|FG000|Overall Study|Ineligible, no efficacy data|2|||
23453720|NCT00216671|65403382|FG001|Overall Study|Ineligible, no efficacy data|2|||
23453721|NCT00216671|65403381|FG000|Overall Study|Insufficient Response Adverse Event|2|||
23453722|NCT00216671|65403382|FG001|Overall Study|Insufficient Response Adverse Event|1|||
23453723|NCT02694744|65403383|FG000|Overall Study|Adverse Event|2|||
23453724|NCT02694744|65403384|FG001|Overall Study|Adverse Event|1|||
23453725|NCT02694744|65403383|FG000|Overall Study|Withdrawal by Subject|2|||
23453726|NCT02694744|65403384|FG001|Overall Study|Withdrawal by Subject|1|||
23453727|NCT02694744|65403383|FG000|Overall Study|Physician Decision|1|||
23453728|NCT02694744|65403384|FG001|Overall Study|Physician Decision|2|||
23453729|NCT02694744|65403383|FG000|Overall Study|Lost to Follow-up|1|||
23453730|NCT02694744|65403384|FG001|Overall Study|Lost to Follow-up|0|||
23453731|NCT02694744|65403383|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
23453732|NCT02694744|65403384|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
23453733|NCT00768989|65403385|FG000|Prior to Week 24|Withdrawal by Subject|1|||
23453734|NCT00768989|65403386|FG001|Prior to Week 24|Withdrawal by Subject|0|||
23453735|NCT00768989|65403385|FG000|Prior to Week 24|Adverse Event|3|||
23453736|NCT00768989|65403386|FG001|Prior to Week 24|Adverse Event|0|||
23453737|NCT00768989|65403385|FG000|Prior to Week 24|Lost to Follow-up|0|||
23453738|NCT00768989|65403386|FG001|Prior to Week 24|Lost to Follow-up|1|||
23453739|NCT00768989|65403385|FG000|Prior to Week 24|Protocol Violation|0|||
23453740|NCT00768989|65403386|FG001|Prior to Week 24|Protocol Violation|2|||
23453741|NCT00768989|65403385|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
23453742|NCT00768989|65403386|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
23453743|NCT00768989|65403385|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
23453744|NCT00768989|65403386|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
23453745|NCT00768989|65403385|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
23453746|NCT00768989|65403386|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
23176071|NCT02429856|64386656|FG000|Overall Study|Lost to Follow-up|6|||
23176072|NCT02429856|64386657|FG001|Overall Study|Lost to Follow-up|5|||
23176073|NCT02429856|64386656|FG000|Overall Study|Withdrawal by Subject|1|||
23176074|NCT02429856|64386657|FG001|Overall Study|Withdrawal by Subject|1|||
23176075|NCT03653390|64386658|FG000|Overall Study|Lost to Follow-up|12|||
23176076|NCT03653390|64386659|FG001|Overall Study|Lost to Follow-up|8|||
23176077|NCT03653390|64386660|FG002|Overall Study|Lost to Follow-up|7|||
23176078|NCT03653390|64386658|FG000|Overall Study|Withdrawal by Subject|6|||
23176079|NCT03653390|64386659|FG001|Overall Study|Withdrawal by Subject|1|||
23176080|NCT03653390|64386660|FG002|Overall Study|Withdrawal by Subject|1|||
23176081|NCT03653390|64386658|FG000|Overall Study|Death|1|||
23340988|NCT01447446|64992894|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
23340989|NCT01447446|64992895|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
23453747|NCT00768989|65403385|FG000|On or After Week 36|Lack of Efficacy|1|||
23176082|NCT03653390|64386659|FG001|Overall Study|Death|0|||
23453748|NCT00768989|65403386|FG001|On or After Week 36|Lack of Efficacy|0|||
23453749|NCT00768989|65403385|FG000|On or After Week 36|Adverse Event|0|||
23453750|NCT00768989|65403386|FG001|On or After Week 36|Adverse Event|1|||
23453751|NCT00768989|65403385|FG000|On or After Week 36|Lost to Follow-up|1|||
23453752|NCT00768989|65403386|FG001|On or After Week 36|Lost to Follow-up|0|||
23176083|NCT03653390|64386660|FG002|Overall Study|Death|0|||
23176084|NCT03653390|64386658|FG000|Overall Study|Paper Survey Lost|1|||
23176085|NCT03653390|64386659|FG001|Overall Study|Paper Survey Lost|0|||
23453753|NCT00768989|65403385|FG000|On or After Week 36|Poor Compliance|1|||
23453754|NCT00768989|65403386|FG001|On or After Week 36|Poor Compliance|0|||
23453755|NCT00768989|65403385|FG000|On or After Week 36|Protocol Violation|1|||
23453756|NCT00768989|65403386|FG001|On or After Week 36|Protocol Violation|0|||
23176086|NCT03653390|64386660|FG002|Overall Study|Paper Survey Lost|0|||
23176087|NCT00675597|64386663|FG000|Overall Study|Withdrawal by Subject|3|||
23176088|NCT01164722|64386664|FG000|Overall Study|Adverse Event|0|||
23176089|NCT01164722|64386665|FG001|Overall Study|Adverse Event|1|||
23176090|NCT01164722|64386664|FG000|Overall Study|Withdrawal by Subject|3|||
23176091|NCT01164722|64386665|FG001|Overall Study|Withdrawal by Subject|4|||
23176092|NCT01164722|64386664|FG000|Overall Study|Lost to Follow-up|3|||
23176093|NCT01164722|64386665|FG001|Overall Study|Lost to Follow-up|6|||
23176094|NCT01164722|64386664|FG000|Overall Study|met protocol criteria for non-treatment|11|||
23176095|NCT01164722|64386665|FG001|Overall Study|met protocol criteria for non-treatment|1|||
23176096|NCT01164722|64386664|FG000|Overall Study|enrolled on other study, concomitant med|1|||
23176097|NCT01164722|64386665|FG001|Overall Study|enrolled on other study, concomitant med|3|||
23176098|NCT02944448|64386666|FG000|Overall Study|Adverse Event|37|||
23176099|NCT02944448|64386667|FG001|Overall Study|Adverse Event|6|||
23176100|NCT02944448|64386666|FG000|Overall Study|Lack of Efficacy|8|||
23176101|NCT02944448|64386667|FG001|Overall Study|Lack of Efficacy|5|||
23176102|NCT02944448|64386666|FG000|Overall Study|Lost to Follow-up|3|||
23176103|NCT02944448|64386667|FG001|Overall Study|Lost to Follow-up|1|||
23176104|NCT02944448|64386666|FG000|Overall Study|Protocol Violation|25|||
23176105|NCT02944448|64386667|FG001|Overall Study|Protocol Violation|7|||
23176106|NCT02944448|64386666|FG000|Overall Study|Withdrawal by Subject|14|||
23176107|NCT02944448|64386667|FG001|Overall Study|Withdrawal by Subject|4|||
23176108|NCT02944448|64386666|FG000|Overall Study|Sponsor did not supply drug in time|0|||
23176109|NCT02944448|64386667|FG001|Overall Study|Sponsor did not supply drug in time|1|||
23176110|NCT02944448|64386666|FG000|Overall Study|Noncompliant with dosing|1|||
23176111|NCT02944448|64386667|FG001|Overall Study|Noncompliant with dosing|0|||
23176112|NCT02944448|64386666|FG000|Overall Study|Abnormal laboratory values|1|||
23176113|NCT02944448|64386667|FG001|Overall Study|Abnormal laboratory values|0|||
23176114|NCT01651780|64386668|FG000|Overall Study|Physician decision: No 30-day visit|2|||
23176115|NCT01651780|64386669|FG001|Overall Study|Physician decision: No 30-day visit|1|||
23176116|NCT01651780|64386668|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
23176117|NCT01651780|64386669|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
23176118|NCT01651780|64386668|FG000|Overall Study|Withdrawal by Subject|2|||
23176119|NCT01651780|64386669|FG001|Overall Study|Withdrawal by Subject|0|||
23176120|NCT01651780|64386668|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
23176121|NCT01651780|64386669|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23176122|NCT01651780|64386668|FG000|Overall Study|Lost to Follow-up|1|||
23176123|NCT01651780|64386669|FG001|Overall Study|Lost to Follow-up|2|||
23176124|NCT01651780|64386668|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
23176125|NCT01651780|64386669|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
23176126|NCT00624520|64386670|FG000|Overall Study|Withdrawal by Subject|12|||
23176127|NCT00624520|64386671|FG001|Overall Study|Withdrawal by Subject|7|||
23176128|NCT00624520|64386670|FG000|Overall Study|Death|0|||
23176129|NCT00624520|64386671|FG001|Overall Study|Death|1|||
23176130|NCT02058147|64386672|FG000|Overall Study|Randomized but not treated|0|||
23176131|NCT02058147|64386673|FG001|Overall Study|Randomized but not treated|0|||
23176132|NCT02058147|64386674|FG002|Overall Study|Randomized but not treated|1|||
23176133|NCT02058147|64386672|FG000|Overall Study|Adverse Event|12|||
23176134|NCT02058147|64386673|FG001|Overall Study|Adverse Event|9|||
23176135|NCT02058147|64386674|FG002|Overall Study|Adverse Event|21|||
23176136|NCT02058147|64386672|FG000|Overall Study|Lack of Efficacy|1|||
23176137|NCT02058147|64386673|FG001|Overall Study|Lack of Efficacy|0|||
23176138|NCT02058147|64386674|FG002|Overall Study|Lack of Efficacy|3|||
23176139|NCT02058147|64386672|FG000|Overall Study|Poor compliance to protocol|8|||
23176140|NCT02058147|64386673|FG001|Overall Study|Poor compliance to protocol|9|||
23176141|NCT02058147|64386674|FG002|Overall Study|Poor compliance to protocol|4|||
23176142|NCT02058147|64386672|FG000|Overall Study|Other than specified|8|||
23176143|NCT02058147|64386673|FG001|Overall Study|Other than specified|9|||
23176144|NCT02058147|64386674|FG002|Overall Study|Other than specified|0|||
23176145|NCT05425563|64386675|FG000|Overall Study|Withdrawal by Subject|17|||
23176146|NCT03543410|64386676|FG000|Overall Study|Adverse Event|10|||
23176147|NCT03543410|64386677|FG001|Overall Study|Adverse Event|8|||
23176148|NCT03543410|64386678|FG002|Overall Study|Adverse Event|2|||
23340990|NCT01447446|64992896|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
23176149|NCT03543410|64386676|FG000|Overall Study|Lack of Efficacy|0|||
23176150|NCT03543410|64386677|FG001|Overall Study|Lack of Efficacy|1|||
23453757|NCT00768989|65403385|FG000|On or After Week 36|Did not attend termination visit|2|||
23453758|NCT00768989|65403386|FG001|On or After Week 36|Did not attend termination visit|0|||
23453759|NCT00768989|65403385|FG000|On or After Week 36|Sponsor Termination|45|||
23453760|NCT00768989|65403386|FG001|On or After Week 36|Sponsor Termination|26|||
23453761|NCT00837434|65403387|FG000|Overall Study|Physician Decision|3|||
23453762|NCT00837434|65403388|FG001|Overall Study|Physician Decision|0|||
23453763|NCT00837434|65403387|FG000|Overall Study|Lost to Follow-up|1|||
23453764|NCT00837434|65403388|FG001|Overall Study|Lost to Follow-up|1|||
23453765|NCT00837434|65403387|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
23453766|NCT00837434|65403388|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
23453767|NCT00837434|65403387|FG000|Overall Study|Noncompliant|2|||
23453768|NCT00837434|65403388|FG001|Overall Study|Noncompliant|0|||
23453769|NCT00837434|65403387|FG000|Overall Study|Baseline assessments not done in time|1|||
23453770|NCT00837434|65403388|FG001|Overall Study|Baseline assessments not done in time|0|||
23453771|NCT00837434|65403387|FG000|Overall Study|Unable to obtain study drug|1|||
23453772|NCT00837434|65403388|FG001|Overall Study|Unable to obtain study drug|0|||
23453773|NCT05196828|65403389|FG000|Overall Study|Withdrawal by Subject|2|||
23453774|NCT05196828|65403390|FG001|Overall Study|Withdrawal by Subject|0|||
23453775|NCT05196828|65403389|FG000|Overall Study|Lost to Follow-up|0|||
23453776|NCT05196828|65403390|FG001|Overall Study|Lost to Follow-up|4|||
23453777|NCT05196828|65403389|FG000|Overall Study|Adverse Event|1|||
23176151|NCT03543410|64386678|FG002|Overall Study|Lack of Efficacy|0|||
23176152|NCT03543410|64386676|FG000|Overall Study|Lost to Follow-up|0|||
23176153|NCT03543410|64386677|FG001|Overall Study|Lost to Follow-up|1|||
23176154|NCT03543410|64386678|FG002|Overall Study|Lost to Follow-up|0|||
23176155|NCT03543410|64386676|FG000|Overall Study|Withdrawal by Subject|5|||
23176156|NCT03543410|64386677|FG001|Overall Study|Withdrawal by Subject|2|||
23176157|NCT03543410|64386678|FG002|Overall Study|Withdrawal by Subject|8|||
23176158|NCT03543410|64386676|FG000|Overall Study|Protocol Violation|0|||
23176159|NCT03543410|64386677|FG001|Overall Study|Protocol Violation|1|||
23176160|NCT03543410|64386678|FG002|Overall Study|Protocol Violation|0|||
23176161|NCT03543410|64386676|FG000|Overall Study|Due to COVID-19|4|||
23176162|NCT03543410|64386677|FG001|Overall Study|Due to COVID-19|0|||
23176163|NCT03543410|64386678|FG002|Overall Study|Due to COVID-19|2|||
23176164|NCT03543410|64386676|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
23176165|NCT03543410|64386677|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
23176166|NCT03543410|64386678|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
23176167|NCT03543410|64386676|FG000|Overall Study|Not Due to COVID-19|2|||
23176168|NCT03543410|64386677|FG001|Overall Study|Not Due to COVID-19|0|||
23176169|NCT03543410|64386678|FG002|Overall Study|Not Due to COVID-19|1|||
23176170|NCT02600507|64386680|FG000|Overall Study|Adverse Event|3|||
23176171|NCT02600507|64386681|FG001|Overall Study|Adverse Event|15|||
23176172|NCT02600507|64386682|FG002|Overall Study|Adverse Event|5|||
23176173|NCT02600507|64386680|FG000|Overall Study|Lack of Efficacy|3|||
23176174|NCT02600507|64386681|FG001|Overall Study|Lack of Efficacy|8|||
23176175|NCT02600507|64386682|FG002|Overall Study|Lack of Efficacy|5|||
23176176|NCT02600507|64386680|FG000|Overall Study|Lost to Follow-up|3|||
23176177|NCT02600507|64386681|FG001|Overall Study|Lost to Follow-up|5|||
23176178|NCT02600507|64386682|FG002|Overall Study|Lost to Follow-up|2|||
23176179|NCT02600507|64386680|FG000|Overall Study|Protocol Violation|12|||
23176180|NCT02600507|64386681|FG001|Overall Study|Protocol Violation|4|||
23176181|NCT02600507|64386682|FG002|Overall Study|Protocol Violation|4|||
23176182|NCT02600507|64386680|FG000|Overall Study|Physician Decision|1|||
23176183|NCT02600507|64386681|FG001|Overall Study|Physician Decision|0|||
23176184|NCT02600507|64386682|FG002|Overall Study|Physician Decision|1|||
23176185|NCT02600507|64386680|FG000|Overall Study|Withdrawal by Subject|7|||
23453778|NCT05196828|65403390|FG001|Overall Study|Adverse Event|0|||
23176186|NCT02600507|64386681|FG001|Overall Study|Withdrawal by Subject|11|||
23176187|NCT02600507|64386682|FG002|Overall Study|Withdrawal by Subject|7|||
23176188|NCT02600507|64386680|FG000|Overall Study|Other|0|||
23176189|NCT02600507|64386681|FG001|Overall Study|Other|1|||
23176190|NCT02600507|64386682|FG002|Overall Study|Other|1|||
23176191|NCT05099640|64386683|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
23176192|NCT05099640|64386684|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
23176193|NCT05099640|64386685|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
23176194|NCT05099640|64386683|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
23453779|NCT01342913|65403392|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
23453780|NCT01342913|65403393|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23453781|NCT01342913|65403394|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23176195|NCT05099640|64386684|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
23176196|NCT05099640|64386685|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
23176197|NCT05099640|64386683|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
23176198|NCT05099640|64386684|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
23176199|NCT05099640|64386685|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
23453782|NCT01342913|65403392|FG000|2-week Run-in Period|Physician Decision|6|||
23453783|NCT01342913|65403393|FG001|2-week Run-in Period|Physician Decision|0|||
23453784|NCT01342913|65403394|FG002|2-week Run-in Period|Physician Decision|0|||
23453785|NCT01342913|65403392|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
23453786|NCT01342913|65403393|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23453787|NCT01342913|65403394|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23453788|NCT01342913|65403392|FG000|2-week Run-in Period|Adverse Event|2|||
23453789|NCT01342913|65403393|FG001|2-week Run-in Period|Adverse Event|0|||
23453790|NCT01342913|65403394|FG002|2-week Run-in Period|Adverse Event|0|||
23453791|NCT01342913|65403392|FG000|2-week Run-in Period|Protocol Violation|5|||
23453792|NCT01342913|65403393|FG001|2-week Run-in Period|Protocol Violation|0|||
23453793|NCT01342913|65403394|FG002|2-week Run-in Period|Protocol Violation|0|||
23453794|NCT01342913|65403392|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
23453795|NCT01342913|65403393|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
23453796|NCT01342913|65403394|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
23453797|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23176200|NCT05099640|64386683|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
23176201|NCT05099640|64386684|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
23453798|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Adverse Event|3|||
23453799|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Adverse Event|6|||
23453800|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23453801|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
23453802|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
23453803|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23453804|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
23453805|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
23453806|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23453807|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23453808|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
23453809|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Physician Decision|0|||
23453810|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Physician Decision|2|||
23453811|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Physician Decision|0|||
23453812|NCT01342913|65403392|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23453813|NCT01342913|65403393|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23453814|NCT01342913|65403394|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23453815|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
23453816|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
23453817|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Disease progression|75|||
23453818|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Disease progression|59|||
23453819|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Adverse Event|16|||
23453820|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Adverse Event|16|||
23453821|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Death|2|||
23453822|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Death|3|||
23453823|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
23453824|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
23453825|NCT00883779|65403397|FG000|Primary Study Treatment Phase|Other|3|||
23453826|NCT00883779|65403398|FG001|Primary Study Treatment Phase|Other|0|||
23453827|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Adverse Event|2|||
23453828|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Adverse Event|3|||
23453829|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Death|1|||
23453830|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Death|3|||
23453831|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
23453832|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
23453833|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
23453834|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
23453835|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Disease progression|103|||
23453836|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Disease progression|122|||
23176202|NCT05099640|64386685|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
23176203|NCT05099640|64386683|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
23176204|NCT05099640|64386684|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
23176205|NCT05099640|64386685|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
23176206|NCT05099640|64386683|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
23176207|NCT05099640|64386684|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
23176208|NCT05099640|64386685|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
23176209|NCT02183519|64386691|FG000|Overall Study|computer error|3|||
23176210|NCT02183519|64386692|FG001|Overall Study|computer error|0|||
23453837|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Other|3|||
23176211|NCT02183519|64386691|FG000|Overall Study|Did not respond to cough inducter|0|||
23453838|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Other|0|||
23453839|NCT00883779|65403397|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
23453840|NCT00883779|65403398|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
23453841|NCT00883779|65403397|FG000|Off-study Phase|Death|185|||
23453842|NCT00883779|65403398|FG001|Off-study Phase|Death|174|||
23176212|NCT02183519|64386692|FG001|Overall Study|Did not respond to cough inducter|3|||
23176213|NCT00568555|64386693|FG000|Overall Study|Withdrawal by Subject|1|||
23176214|NCT00568555|64386694|FG001|Overall Study|Withdrawal by Subject|1|||
23176215|NCT00130286|64386696|FG000|Overall Study|Withdrawal by Subject|0|||
23176216|NCT00130286|64386697|FG001|Overall Study|Withdrawal by Subject|1|||
23176217|NCT00130286|64386698|FG002|Overall Study|Withdrawal by Subject|2|||
23176218|NCT00130286|64386699|FG003|Overall Study|Withdrawal by Subject|2|||
23176219|NCT00130286|64386696|FG000|Overall Study|Adverse Event|0|||
23176220|NCT00130286|64386697|FG001|Overall Study|Adverse Event|0|||
23340991|NCT01447446|64992891|FG000|Overall Study|Administrative/Other|34|||
23340992|NCT01447446|64992892|FG001|Overall Study|Administrative/Other|9|||
23340993|NCT01447446|64992893|FG002|Overall Study|Administrative/Other|10|||
23340994|NCT01447446|64992894|FG003|Overall Study|Administrative/Other|2|||
23340995|NCT01447446|64992895|FG004|Overall Study|Administrative/Other|33|||
23340996|NCT01447446|64992896|FG005|Overall Study|Administrative/Other|4|||
23340997|NCT01447446|64992891|FG000|Overall Study|SVR12 Assessment|13|||
23340998|NCT01447446|64992892|FG001|Overall Study|SVR12 Assessment|1|||
23340999|NCT01447446|64992893|FG002|Overall Study|SVR12 Assessment|2|||
23341000|NCT01447446|64992894|FG003|Overall Study|SVR12 Assessment|1|||
23341001|NCT01447446|64992895|FG004|Overall Study|SVR12 Assessment|5|||
23341002|NCT01447446|64992896|FG005|Overall Study|SVR12 Assessment|5|||
23341003|NCT01447446|64992891|FG000|Overall Study|New Treatment Started|8|||
23341004|NCT01447446|64992892|FG001|Overall Study|New Treatment Started|2|||
23341005|NCT01447446|64992893|FG002|Overall Study|New Treatment Started|1|||
23341006|NCT01447446|64992894|FG003|Overall Study|New Treatment Started|0|||
23341007|NCT01447446|64992895|FG004|Overall Study|New Treatment Started|2|||
23341008|NCT01447446|64992896|FG005|Overall Study|New Treatment Started|0|||
23341009|NCT01447446|64992891|FG000|Overall Study|Reason not Specified|1|||
23341010|NCT01447446|64992892|FG001|Overall Study|Reason not Specified|1|||
23341011|NCT01447446|64992893|FG002|Overall Study|Reason not Specified|1|||
23341012|NCT01447446|64992894|FG003|Overall Study|Reason not Specified|1|||
23341013|NCT01447446|64992895|FG004|Overall Study|Reason not Specified|1|||
23341014|NCT01447446|64992896|FG005|Overall Study|Reason not Specified|0|||
23341015|NCT00638443|64992897|FG000|First Intervention|Adverse Event|2|||
23341016|NCT00638443|64992898|FG001|First Intervention|Adverse Event|1|||
23341017|NCT04434469|64992899|FG000|Overall Study|Death|2|||
23341018|NCT04434469|64992900|FG001|Overall Study|Death|3|||
23341019|NCT04434469|64992901|FG002|Overall Study|Death|2|||
23341020|NCT04434469|64992902|FG003|Overall Study|Death|2|||
23341021|NCT04434469|64992903|FG004|Overall Study|Death|2|||
23341022|NCT04434469|64992904|FG005|Overall Study|Death|0|||
23341023|NCT04434469|64992899|FG000|Overall Study|Lost to Follow-up|0|||
23341024|NCT04434469|64992900|FG001|Overall Study|Lost to Follow-up|0|||
23341025|NCT04434469|64992901|FG002|Overall Study|Lost to Follow-up|0|||
23341026|NCT04434469|64992902|FG003|Overall Study|Lost to Follow-up|1|||
23341027|NCT04434469|64992903|FG004|Overall Study|Lost to Follow-up|1|||
23341028|NCT04434469|64992904|FG005|Overall Study|Lost to Follow-up|0|||
23341029|NCT04434469|64992899|FG000|Overall Study|Study terminated by sponsor|1|||
23341030|NCT04434469|64992900|FG001|Overall Study|Study terminated by sponsor|1|||
23341031|NCT04434469|64992901|FG002|Overall Study|Study terminated by sponsor|1|||
23341032|NCT04434469|64992902|FG003|Overall Study|Study terminated by sponsor|2|||
23341033|NCT04434469|64992903|FG004|Overall Study|Study terminated by sponsor|3|||
23341034|NCT04434469|64992904|FG005|Overall Study|Study terminated by sponsor|3|||
23341035|NCT04434469|64992899|FG000|Overall Study|Withdrawal by Subject|0|||
23341036|NCT04434469|64992900|FG001|Overall Study|Withdrawal by Subject|0|||
23341037|NCT04434469|64992901|FG002|Overall Study|Withdrawal by Subject|1|||
23341038|NCT04434469|64992902|FG003|Overall Study|Withdrawal by Subject|0|||
23341039|NCT04434469|64992903|FG004|Overall Study|Withdrawal by Subject|0|||
23341040|NCT04434469|64992904|FG005|Overall Study|Withdrawal by Subject|0|||
23341041|NCT01646021|64992905|FG000|Overall Study|Death|77|||
23341042|NCT01646021|64992906|FG001|Overall Study|Death|83|||
23341043|NCT01646021|64992905|FG000|Overall Study|Study Terminated by Sponsor|50|||
23341044|NCT01646021|64992906|FG001|Overall Study|Study Terminated by Sponsor|41|||
23341045|NCT01646021|64992905|FG000|Overall Study|Lost to Follow-up|2|||
23341046|NCT01646021|64992906|FG001|Overall Study|Lost to Follow-up|2|||
23341047|NCT01646021|64992905|FG000|Overall Study|Withdrawal by Subject|10|||
23341048|NCT01646021|64992906|FG001|Overall Study|Withdrawal by Subject|15|||
23453843|NCT00883779|65403397|FG000|Off-study Phase|Refused treatment|1|||
23341049|NCT03813147|64992907|FG000|Overall Study|Lack of Efficacy|4|||
23341050|NCT03813147|64992908|FG001|Overall Study|Lack of Efficacy|4|||
23341051|NCT03813147|64992907|FG000|Overall Study|Physician Decision|2|||
23582255|NCT00567879|65862410|FG000|Overall Study|New cancer therapy|0|||
23176221|NCT00130286|64386698|FG002|Overall Study|Adverse Event|2|||
23341052|NCT03813147|64992908|FG001|Overall Study|Physician Decision|1|||
23341053|NCT02353442|64992909|FG000|Overall Study|Withdrawal by Subject|3|||
23341054|NCT02353442|64992910|FG001|Overall Study|Withdrawal by Subject|4|||
23341055|NCT01430403|64992911|FG000|Overall Study|Lost to Follow-up|5|||
23341056|NCT01430403|64992912|FG001|Overall Study|Lost to Follow-up|5|||
23176222|NCT00130286|64386699|FG003|Overall Study|Adverse Event|0|||
23176223|NCT00130286|64386696|FG000|Overall Study|Missing lab specimens|0|||
23176224|NCT00130286|64386697|FG001|Overall Study|Missing lab specimens|2|||
23176225|NCT00130286|64386698|FG002|Overall Study|Missing lab specimens|0|||
23176226|NCT00130286|64386699|FG003|Overall Study|Missing lab specimens|0|||
23176227|NCT02809833|64386700|FG000|Overall Study|Death|3|||
23176228|NCT02809833|64386700|FG000|Overall Study|Intolerance|54|||
23176229|NCT02809833|64386700|FG000|Overall Study|Lack of Efficacy|89|||
23582256|NCT00567879|65862411|FG001|Overall Study|New cancer therapy|0|||
23582257|NCT00567879|65862412|FG002|Overall Study|New cancer therapy|1|||
23582258|NCT00567879|65862413|FG003|Overall Study|New cancer therapy|0|||
23453844|NCT00883779|65403398|FG001|Off-study Phase|Refused treatment|1|||
23453845|NCT00883779|65403397|FG000|Off-study Phase|Failure to return|5|||
23453846|NCT00883779|65403398|FG001|Off-study Phase|Failure to return|6|||
23453847|NCT00883779|65403397|FG000|Off-study Phase|Other|18|||
23453848|NCT00883779|65403398|FG001|Off-study Phase|Other|21|||
23453849|NCT03812380|65403399|FG000|Overall Study|Protocol Violation|3|||
23453850|NCT03812380|65403400|FG001|Overall Study|Protocol Violation|3|||
23453851|NCT03812380|65403399|FG000|Overall Study|Withdrawal by Subject|5|||
23453852|NCT03812380|65403400|FG001|Overall Study|Withdrawal by Subject|4|||
23453853|NCT03812380|65403399|FG000|Overall Study|Early termination of study|14|||
23453854|NCT03812380|65403400|FG001|Overall Study|Early termination of study|14|||
23453855|NCT01089504|65403402|FG000|Overall Study|Lost to Follow-up|1|||
23453856|NCT01089504|65403403|FG001|Overall Study|Lost to Follow-up|1|||
23453857|NCT01089504|65403402|FG000|Overall Study|Withdrawal by Subject|2|||
23453858|NCT01089504|65403403|FG001|Overall Study|Withdrawal by Subject|0|||
23453859|NCT01667900|65403404|FG000|Part B|Death|0|||
23453860|NCT01667900|65403405|FG001|Part B|Death|0|||
23453861|NCT01667900|65403406|FG002|Part B|Death|0|||
23453862|NCT01667900|65403407|FG003|Part B|Death|0|||
23453863|NCT01667900|65403408|FG004|Part B|Death|0|||
23453864|NCT01667900|65403409|FG005|Part B|Death|0|||
23453865|NCT01667900|65403410|FG006|Part B|Death|0|||
23453866|NCT01667900|65403411|FG007|Part B|Death|0|||
23453867|NCT01667900|65403412|FG008|Part B|Death|0|||
23582259|NCT00567879|65862414|FG004|Overall Study|New cancer therapy|0|||
23582260|NCT00567879|65862415|FG005|Overall Study|New cancer therapy|0|||
23582261|NCT00567879|65862410|FG000|Overall Study|Disease progression|5|||
23582262|NCT00567879|65862411|FG001|Overall Study|Disease progression|7|||
23582263|NCT00567879|65862412|FG002|Overall Study|Disease progression|15|||
23582264|NCT00567879|65862413|FG003|Overall Study|Disease progression|5|||
23582265|NCT00567879|65862414|FG004|Overall Study|Disease progression|11|||
23582266|NCT00567879|65862415|FG005|Overall Study|Disease progression|3|||
23582267|NCT03383887|65862421|FG000|Overall Study|Lost to Follow-up|0|||
23582268|NCT03383887|65862422|FG001|Overall Study|Lost to Follow-up|1|||
23582269|NCT00282438|65862425|FG000|Overall Study|Lack of Efficacy|1|||
23582270|NCT00282438|65862426|FG001|Overall Study|Lack of Efficacy|0|||
23582271|NCT00282438|65862425|FG000|Overall Study|Death|0|||
23582272|NCT00282438|65862426|FG001|Overall Study|Death|1|||
23582273|NCT00349908|65862427|FG000|Overall Study|Withdrawal by Subject|0|||
23582274|NCT00349908|65862428|FG001|Overall Study|Withdrawal by Subject|4|||
23582275|NCT00569946|65862429|FG000|Overall Study|Adverse Event|16|||
23582276|NCT00569946|65862429|FG000|Overall Study|Objective Progression or Relapse|42|||
23582277|NCT00569946|65862429|FG000|Overall Study|Global Deterioration of Health Status|1|||
23582278|NCT01027286|65862431|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
23582279|NCT01027286|65862432|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
23582280|NCT01027286|65862431|FG000|Overall Study|Lost to Follow-up|0|||
23582281|NCT01027286|65862432|FG001|Overall Study|Lost to Follow-up|1|||
23582282|NCT01348087|65862442|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
23582283|NCT01348087|65862442|FG000|Overall Study|Administrative problems|79|||
23582284|NCT01348087|65862442|FG000|Overall Study|protocol deviation|1|||
23582285|NCT01348087|65862442|FG000|Overall Study|Lost to Follow-up|1|||
23582286|NCT01348087|65862442|FG000|Overall Study|Subject withdrew consent|7|||
23582287|NCT01348087|65862442|FG000|Overall Study|Adverse Event|25|||
23582288|NCT00543725|65862443|FG000|Overall Study|Adverse Event|18|||
23582289|NCT00543725|65862444|FG001|Overall Study|Adverse Event|27|||
23176230|NCT02809833|64386700|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
23176231|NCT02809833|64386700|FG000|Overall Study|Noncompliance|1|||
23176232|NCT02809833|64386700|FG000|Overall Study|Withdrawal by Subject|34|||
23582290|NCT00543725|65862443|FG000|Overall Study|Sponsor's Decision|0|||
23582291|NCT00543725|65862444|FG001|Overall Study|Sponsor's Decision|1|||
23582292|NCT00543725|65862443|FG000|Overall Study|Subject Non-Compliant|4|||
23582293|NCT00543725|65862444|FG001|Overall Study|Subject Non-Compliant|4|||
23453868|NCT01667900|65403413|FG009|Part B|Death|0|||
23453869|NCT01667900|65403414|FG010|Part B|Death|0|||
23453870|NCT01667900|65403415|FG011|Part B|Death|0|||
23453871|NCT01667900|65403416|FG012|Part B|Death|0|||
23453872|NCT01667900|65403417|FG013|Part B|Death|0|||
23453873|NCT01667900|65403418|FG014|Part B|Death|0|||
23453874|NCT01667900|65403419|FG015|Part B|Death|0|||
23453875|NCT01667900|65403420|FG016|Part B|Death|1|||
23341057|NCT01430403|64992913|FG002|Overall Study|Lost to Follow-up|3|||
23341058|NCT01430403|64992911|FG000|Overall Study|Physician Decision|1|||
23341059|NCT01430403|64992912|FG001|Overall Study|Physician Decision|0|||
23341060|NCT01430403|64992913|FG002|Overall Study|Physician Decision|0|||
23341061|NCT01430403|64992911|FG000|Overall Study|Protocol Violation|2|||
23341062|NCT01430403|64992912|FG001|Overall Study|Protocol Violation|3|||
23341063|NCT01430403|64992913|FG002|Overall Study|Protocol Violation|2|||
23341064|NCT01430403|64992911|FG000|Overall Study|Withdrawal by Subject|9|||
23341065|NCT01430403|64992912|FG001|Overall Study|Withdrawal by Subject|1|||
23341066|NCT01430403|64992913|FG002|Overall Study|Withdrawal by Subject|3|||
23341067|NCT03200704|64992914|FG000|Overall Study|Withdrawal by Subject|1|||
23341068|NCT04505540|64992915|FG000|Baseline|Protocol Violation|10|||
23341069|NCT04505540|64992915|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
23341070|NCT04505540|64992915|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
23341071|NCT04505540|64992915|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
23341072|NCT04505540|64992915|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
23341073|NCT04505540|64992915|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
23341074|NCT04505540|64992915|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
23341075|NCT04505540|64992915|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
23341076|NCT04505540|64992915|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
23341077|NCT04505540|64992915|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
23341078|NCT04505540|64992915|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
23341079|NCT04505540|64992915|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
23341080|NCT04505540|64992915|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
23341081|NCT04021121|64992916|FG000|Overall Study|Death|3|||
23341082|NCT04021121|64992917|FG001|Overall Study|Death|3|||
23341083|NCT04021121|64992918|FG002|Overall Study|Death|5|||
23341084|NCT04021121|64992919|FG003|Overall Study|Death|4|||
23341085|NCT00976820|64992920|FG000|Overall Study|Lost to Follow-up|5|||
23341086|NCT00976820|64992921|FG001|Overall Study|Lost to Follow-up|16|||
23341087|NCT00976820|64992922|FG002|Overall Study|Lost to Follow-up|2|||
23341088|NCT00976820|64992923|FG003|Overall Study|Lost to Follow-up|3|||
23341089|NCT00976820|64992920|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
23341090|NCT00976820|64992921|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
23341091|NCT00976820|64992922|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
23341092|NCT00976820|64992923|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
23341093|NCT00976820|64992920|FG000|Overall Study|Withdrawal by Subject|2|||
23341094|NCT00976820|64992921|FG001|Overall Study|Withdrawal by Subject|4|||
23341095|NCT00976820|64992922|FG002|Overall Study|Withdrawal by Subject|1|||
23341096|NCT00976820|64992923|FG003|Overall Study|Withdrawal by Subject|4|||
23341097|NCT02892422|64992924|FG000|Overall Study|Enrolled not treated|4|||
23341098|NCT02892422|64992924|FG000|Overall Study|Adverse Event|38|||
23341099|NCT02892422|64992924|FG000|Overall Study|Lack of Efficacy|32|||
23341100|NCT02892422|64992924|FG000|Overall Study|Non-compliance with study drug|11|||
23341101|NCT02892422|64992924|FG000|Overall Study|Protocol Violation|4|||
23341102|NCT02892422|64992924|FG000|Overall Study|Withdrawal by Subject|56|||
23341103|NCT02892422|64992924|FG000|Overall Study|Lost to Follow-up|5|||
23341104|NCT02892422|64992924|FG000|Overall Study|sponsor information 16159A results|21|||
23341105|NCT02892422|64992924|FG000|Overall Study|withdrawal of consent|13|||
23341106|NCT02892422|64992924|FG000|Overall Study|exclusion criteria met|3|||
23341107|NCT02892422|64992924|FG000|Overall Study|moving elsewhere|4|||
23341108|NCT02892422|64992924|FG000|Overall Study|non-compliance|10|||
23341109|NCT02892422|64992924|FG000|Overall Study|patient legally incapable|1|||
23341110|NCT02892422|64992924|FG000|Overall Study|patient decision|7|||
23341111|NCT02892422|64992924|FG000|Overall Study|Investigator decision|1|||
23341112|NCT03843632|64992925|FG000|Overall Study|Withdrawal by Subject|1|||
23341113|NCT03843632|64992926|FG001|Overall Study|Withdrawal by Subject|0|||
23341114|NCT03843632|64992927|FG002|Overall Study|Withdrawal by Subject|0|||
23341115|NCT03843632|64992928|FG003|Overall Study|Withdrawal by Subject|0|||
23341116|NCT04712019|64992929|FG000|Overall Study|Withdrawal by Subject|2|||
23341117|NCT04712019|64992930|FG001|Overall Study|Withdrawal by Subject|2|||
23341118|NCT04712019|64992929|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
23341119|NCT04712019|64992930|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
23341120|NCT05343364|64992931|FG000|Overall Study|Miscellaneous|0|||
23341121|NCT05343364|64992932|FG001|Overall Study|Miscellaneous|1|||
23341122|NCT02031640|64992933|FG000|Screening Period|Adverse Event|1|||
23176233|NCT02809833|64386700|FG000|Overall Study|Lost to Follow-up|35|||
23341123|NCT02031640|64992934|FG001|Screening Period|Adverse Event|0|||
23341124|NCT02031640|64992935|FG002|Screening Period|Adverse Event|0|||
23341125|NCT02031640|64992936|FG003|Screening Period|Adverse Event|0|||
23341126|NCT02031640|64992937|FG004|Screening Period|Adverse Event|0|||
23341127|NCT02031640|64992938|FG005|Screening Period|Adverse Event|0|||
23341128|NCT02031640|64992933|FG000|Screening Period|Withdrawal by Subject|29|||
23341129|NCT02031640|64992934|FG001|Screening Period|Withdrawal by Subject|0|||
23453876|NCT01667900|65403421|FG017|Part B|Death|0|||
23453877|NCT01667900|65403422|FG018|Part B|Death|0|||
23453878|NCT01667900|65403423|FG019|Part B|Death|0|||
23453879|NCT03050801|65403425|FG000|Experiment 1|Lost to Follow-up|0|||
23453880|NCT03050801|65403426|FG001|Experiment 1|Lost to Follow-up|1|||
23453881|NCT03050801|65403427|FG002|Experiment 1|Lost to Follow-up|0|||
23453882|NCT03050801|65403428|FG003|Experiment 1|Lost to Follow-up|0|||
23453883|NCT03050801|65403429|FG004|Experiment 1|Lost to Follow-up|0|||
23453884|NCT03050801|65403430|FG005|Experiment 1|Lost to Follow-up|0|||
23453885|NCT03050801|65403425|FG000|Experiment 1|Physician Decision|0|||
23453886|NCT03050801|65403426|FG001|Experiment 1|Physician Decision|3|||
23453887|NCT03050801|65403427|FG002|Experiment 1|Physician Decision|0|||
23453888|NCT03050801|65403428|FG003|Experiment 1|Physician Decision|0|||
23453889|NCT03050801|65403429|FG004|Experiment 1|Physician Decision|0|||
23453890|NCT03050801|65403430|FG005|Experiment 1|Physician Decision|0|||
23453891|NCT03050801|65403425|FG000|Experiment 1|Change of experimental design|0|||
23453892|NCT03050801|65403426|FG001|Experiment 1|Change of experimental design|3|||
23453893|NCT03050801|65403427|FG002|Experiment 1|Change of experimental design|0|||
23453894|NCT03050801|65403428|FG003|Experiment 1|Change of experimental design|0|||
23453895|NCT03050801|65403429|FG004|Experiment 1|Change of experimental design|0|||
23453896|NCT03050801|65403430|FG005|Experiment 1|Change of experimental design|0|||
23453897|NCT03050801|65403425|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453898|NCT03050801|65403426|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453899|NCT03050801|65403427|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
23453900|NCT03050801|65403428|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453901|NCT03050801|65403429|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453902|NCT03050801|65403430|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
23453903|NCT03050801|65403425|FG000|Experiment 2|Lost to Follow-up|0|||
23453904|NCT03050801|65403426|FG001|Experiment 2|Lost to Follow-up|0|||
23453905|NCT03050801|65403427|FG002|Experiment 2|Lost to Follow-up|0|||
23453906|NCT03050801|65403428|FG003|Experiment 2|Lost to Follow-up|1|||
23453907|NCT03050801|65403429|FG004|Experiment 2|Lost to Follow-up|1|||
23453908|NCT03050801|65403430|FG005|Experiment 2|Lost to Follow-up|0|||
23453909|NCT03050801|65403425|FG000|Experiment 2|Physician Decision|0|||
23453910|NCT03050801|65403426|FG001|Experiment 2|Physician Decision|0|||
23453911|NCT03050801|65403427|FG002|Experiment 2|Physician Decision|0|||
23453912|NCT03050801|65403428|FG003|Experiment 2|Physician Decision|0|||
23453913|NCT03050801|65403429|FG004|Experiment 2|Physician Decision|1|||
23453914|NCT03050801|65403430|FG005|Experiment 2|Physician Decision|0|||
23453915|NCT03050801|65403425|FG000|Experiment 2|Pregnancy|0|||
23453916|NCT03050801|65403426|FG001|Experiment 2|Pregnancy|0|||
23453917|NCT03050801|65403427|FG002|Experiment 2|Pregnancy|0|||
23453918|NCT03050801|65403428|FG003|Experiment 2|Pregnancy|0|||
23453919|NCT03050801|65403429|FG004|Experiment 2|Pregnancy|1|||
23176234|NCT02809833|64386700|FG000|Overall Study|Adverse Event (AE)|24|||
23176235|NCT02809833|64386700|FG000|Overall Study|Other|5|||
23453920|NCT03050801|65403430|FG005|Experiment 2|Pregnancy|0|||
23453921|NCT03050801|65403425|FG000|Experiment 2|Withdrawal by Subject|0|||
23453922|NCT03050801|65403426|FG001|Experiment 2|Withdrawal by Subject|0|||
23453923|NCT03050801|65403427|FG002|Experiment 2|Withdrawal by Subject|0|||
23453924|NCT03050801|65403428|FG003|Experiment 2|Withdrawal by Subject|1|||
23453925|NCT03050801|65403429|FG004|Experiment 2|Withdrawal by Subject|0|||
23453926|NCT03050801|65403430|FG005|Experiment 2|Withdrawal by Subject|0|||
23453927|NCT03050801|65403425|FG000|Experiment 2|Poor data quality|0|||
23453928|NCT03050801|65403426|FG001|Experiment 2|Poor data quality|0|||
23582294|NCT00543725|65862443|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
23582295|NCT00543725|65862444|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
23582296|NCT00543725|65862443|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
23176236|NCT02809833|64386700|FG000|Overall Study|Missing Information|52|||
23176237|NCT00463476|64386702|FG000|Overall Study|Withdrawal by Subject|1|||
23176238|NCT00463476|64386703|FG001|Overall Study|Withdrawal by Subject|2|||
23176239|NCT00463476|64386702|FG000|Overall Study|Lost to Follow-up|1|||
23176240|NCT00463476|64386703|FG001|Overall Study|Lost to Follow-up|1|||
23176241|NCT00486278|64386704|FG000|Overall Study|Adverse Event|5|||
23453929|NCT03050801|65403427|FG002|Experiment 2|Poor data quality|0|||
23453930|NCT03050801|65403428|FG003|Experiment 2|Poor data quality|4|||
23453931|NCT03050801|65403429|FG004|Experiment 2|Poor data quality|1|||
23453932|NCT03050801|65403430|FG005|Experiment 2|Poor data quality|0|||
23176242|NCT00486278|64386704|FG000|Overall Study|Withdrawal by Subject|2|||
23176243|NCT00486278|64386704|FG000|Overall Study|Physician Decision|2|||
23402704|NCT03289143|65219986|FG003|Overall Study|Protocol Deviation|1|||
23453933|NCT03050801|65403425|FG000|Experiment 2|Discomfort during stimulation|0|||
23453934|NCT03050801|65403426|FG001|Experiment 2|Discomfort during stimulation|0|||
23453935|NCT03050801|65403427|FG002|Experiment 2|Discomfort during stimulation|0|||
23453936|NCT03050801|65403428|FG003|Experiment 2|Discomfort during stimulation|0|||
23453937|NCT03050801|65403429|FG004|Experiment 2|Discomfort during stimulation|0|||
23453938|NCT03050801|65403430|FG005|Experiment 2|Discomfort during stimulation|2|||
23582297|NCT00543725|65862444|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
23582298|NCT00543725|65862443|FG000|Overall Study|Protocol Violation|0|||
23453939|NCT01349959|65403431|FG000|Overall Study|Adverse Event|7|||
23453940|NCT00657046|65403432|FG000|Overall Study|Adverse Event|1|||
23453941|NCT00657046|65403433|FG001|Overall Study|Adverse Event|1|||
23453942|NCT00657046|65403434|FG002|Overall Study|Adverse Event|0|||
23453943|NCT00657046|65403432|FG000|Overall Study|Protocol Violation|2|||
23453944|NCT00657046|65403433|FG001|Overall Study|Protocol Violation|2|||
23453945|NCT00657046|65403434|FG002|Overall Study|Protocol Violation|0|||
23453946|NCT00657046|65403432|FG000|Overall Study|Withdrawal by Subject|1|||
23453947|NCT00657046|65403433|FG001|Overall Study|Withdrawal by Subject|0|||
23453948|NCT00657046|65403434|FG002|Overall Study|Withdrawal by Subject|0|||
23453949|NCT00657046|65403432|FG000|Overall Study|Death|0|||
23453950|NCT00657046|65403433|FG001|Overall Study|Death|0|||
23453951|NCT00657046|65403434|FG002|Overall Study|Death|1|||
23453952|NCT00657046|65403432|FG000|Overall Study|Surgery|0|||
23453953|NCT00657046|65403433|FG001|Overall Study|Surgery|0|||
23453954|NCT00657046|65403434|FG002|Overall Study|Surgery|1|||
23453955|NCT01091675|65403437|FG000|Overall Study|Adverse Event|7|||
23453956|NCT01091675|65403437|FG000|Overall Study|Lack of Efficacy|27|||
23453957|NCT02718898|65403438|FG000|Blinded Treatment Period|Adverse Event|5|||
23453958|NCT02718898|65403439|FG001|Blinded Treatment Period|Adverse Event|1|||
23453959|NCT02718898|65403440|FG002|Blinded Treatment Period|Adverse Event|0|||
23453960|NCT02718898|65403441|FG003|Blinded Treatment Period|Adverse Event|0|||
23453961|NCT02718898|65403442|FG004|Blinded Treatment Period|Adverse Event|0|||
23453962|NCT02718898|65403443|FG005|Blinded Treatment Period|Adverse Event|0|||
23453963|NCT02718898|65403444|FG006|Blinded Treatment Period|Adverse Event|0|||
23453964|NCT02718898|65403438|FG000|Blinded Treatment Period|Physician Decision|1|||
23453965|NCT02718898|65403439|FG001|Blinded Treatment Period|Physician Decision|0|||
23453966|NCT02718898|65403440|FG002|Blinded Treatment Period|Physician Decision|0|||
23582299|NCT00543725|65862444|FG001|Overall Study|Protocol Violation|1|||
23582300|NCT00543725|65862443|FG000|Overall Study|Withdrawal by Subject|4|||
23582301|NCT00543725|65862444|FG001|Overall Study|Withdrawal by Subject|13|||
23582302|NCT00543725|65862443|FG000|Overall Study|Lost to Follow-up|15|||
23582303|NCT00543725|65862444|FG001|Overall Study|Lost to Follow-up|11|||
23582304|NCT00543725|65862443|FG000|Overall Study|Other|3|||
23582305|NCT00543725|65862444|FG001|Overall Study|Other|3|||
23582306|NCT02096003|65862446|FG000|Overall Study|Protocol Violation|0|||
23582307|NCT02096003|65862447|FG001|Overall Study|Protocol Violation|2|||
23582308|NCT02096003|65862446|FG000|Overall Study|additional surgery|2|||
23582309|NCT02096003|65862447|FG001|Overall Study|additional surgery|1|||
23582310|NCT03646669|65862449|FG000|Overall Study|Withdrawal by Subject|5|||
23582311|NCT03646669|65862450|FG001|Overall Study|Withdrawal by Subject|0|||
23582312|NCT03055013|65862453|FG000|Overall Study|Adverse Event|78|||
23582313|NCT03055013|65862454|FG001|Overall Study|Adverse Event|0|||
23582314|NCT03055013|65862453|FG000|Overall Study|Death|6|||
23582315|NCT03055013|65862454|FG001|Overall Study|Death|0|||
23582316|NCT03055013|65862453|FG000|Overall Study|Disease relapse|33|||
23582317|NCT03055013|65862454|FG001|Overall Study|Disease relapse|0|||
23582318|NCT03055013|65862453|FG000|Overall Study|Withdrawal by Subject|28|||
23582319|NCT03055013|65862454|FG001|Overall Study|Withdrawal by Subject|0|||
23582320|NCT03055013|65862453|FG000|Overall Study|Other complicating disease|5|||
23582321|NCT03055013|65862454|FG001|Overall Study|Other complicating disease|0|||
23582322|NCT03055013|65862453|FG000|Overall Study|Physician Decision|1|||
23582323|NCT03055013|65862454|FG001|Overall Study|Physician Decision|0|||
23582324|NCT03055013|65862453|FG000|Overall Study|Benign mass/non-RCC|4|||
23582325|NCT03055013|65862454|FG001|Overall Study|Benign mass/non-RCC|0|||
23582326|NCT03055013|65862453|FG000|Overall Study|Enrolled in another trial|1|||
23582327|NCT03055013|65862454|FG001|Overall Study|Enrolled in another trial|0|||
23582328|NCT03055013|65862453|FG000|Overall Study|Non-protocol therapy|1|||
23582329|NCT03055013|65862454|FG001|Overall Study|Non-protocol therapy|0|||
23582330|NCT03055013|65862453|FG000|Overall Study|Incompliance|1|||
23582331|NCT03055013|65862454|FG001|Overall Study|Incompliance|0|||
23582332|NCT03055013|65862453|FG000|Overall Study|Insurance issues|1|||
23582333|NCT03055013|65862454|FG001|Overall Study|Insurance issues|0|||
23582334|NCT03055013|65862453|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
23582335|NCT03055013|65862454|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
23582336|NCT03055013|65862453|FG000|Overall Study|Did not receive nivolumab|10|||
23582337|NCT03055013|65862454|FG001|Overall Study|Did not receive nivolumab|0|||
23582338|NCT03055013|65862453|FG000|Overall Study|Did not receive surgery|0|||
23582339|NCT03055013|65862454|FG001|Overall Study|Did not receive surgery|28|||
23582340|NCT01511250|65862455|FG000|Overall Study|Withdrawal of Consent|1|||
23582341|NCT01511250|65862456|FG001|Overall Study|Withdrawal of Consent|0|||
23582342|NCT01511250|65862457|FG002|Overall Study|Withdrawal of Consent|0|||
23453967|NCT02718898|65403441|FG003|Blinded Treatment Period|Physician Decision|0|||
23453968|NCT02718898|65403442|FG004|Blinded Treatment Period|Physician Decision|0|||
23453969|NCT02718898|65403443|FG005|Blinded Treatment Period|Physician Decision|0|||
23453970|NCT02718898|65403444|FG006|Blinded Treatment Period|Physician Decision|0|||
23176244|NCT01671280|64386709|FG000|Overall Study|Withdrawal by Subject|2|||
23176245|NCT00769119|64386710|FG000|Overall Study|Voluntary discontinuation|0|||
23176246|NCT00769119|64386711|FG001|Overall Study|Voluntary discontinuation|2|||
23176247|NCT00769119|64386710|FG000|Overall Study|Adverse Event|1|||
23176248|NCT00769119|64386711|FG001|Overall Study|Adverse Event|1|||
23453971|NCT02718898|65403438|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
23453972|NCT02718898|65403439|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
23176249|NCT00769119|64386710|FG000|Overall Study|Disallowed medication|1|||
23176250|NCT00769119|64386711|FG001|Overall Study|Disallowed medication|0|||
23176251|NCT01001702|64386712|FG000|Overall Study|Lost to Follow-up|7|||
23176252|NCT01001702|64386712|FG000|Overall Study|Adverse Event|7|||
23176253|NCT01001702|64386712|FG000|Overall Study|Sponsor Discontinued Study|4|||
23176254|NCT01001702|64386712|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
23176255|NCT01001702|64386712|FG000|Overall Study|Investigator withdrew Subject|10|||
23176256|NCT01001702|64386712|FG000|Overall Study|Withdrawal by Subject|19|||
23176257|NCT01001702|64386712|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
23176258|NCT01988090|64386713|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
23176259|NCT01988090|64386714|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
23176260|NCT01988090|64386713|FG000|Start Treament After Randomization|Protocol Violation|0|||
23176261|NCT01988090|64386714|FG001|Start Treament After Randomization|Protocol Violation|1|||
23176262|NCT01988090|64386713|FG000|Complete Study After Start|Withdrawal by Subject|2|||
23176263|NCT01988090|64386714|FG001|Complete Study After Start|Withdrawal by Subject|0|||
23176264|NCT01988090|64386713|FG000|Complete Study After Start|Protocol Violation|1|||
23176265|NCT01988090|64386714|FG001|Complete Study After Start|Protocol Violation|1|||
23176266|NCT02400255|64386715|FG000|Overall Study|Relapse|4|||
23176267|NCT02400255|64386716|FG001|Overall Study|Relapse|1|||
23176268|NCT02400255|64386717|FG002|Overall Study|Relapse|1|||
23176269|NCT02400255|64386718|FG003|Overall Study|Relapse|2|||
23176270|NCT02400255|64386715|FG000|Overall Study|Adverse Event|6|||
23176271|NCT02400255|64386716|FG001|Overall Study|Adverse Event|3|||
23176272|NCT02400255|64386717|FG002|Overall Study|Adverse Event|0|||
23176273|NCT02400255|64386718|FG003|Overall Study|Adverse Event|0|||
23176274|NCT02400255|64386715|FG000|Overall Study|Physician Decision|6|||
23176275|NCT02400255|64386716|FG001|Overall Study|Physician Decision|0|||
23176276|NCT02400255|64386717|FG002|Overall Study|Physician Decision|0|||
23176277|NCT02400255|64386718|FG003|Overall Study|Physician Decision|0|||
23176278|NCT02400255|64386715|FG000|Overall Study|Loss of insurance|1|||
23176279|NCT02400255|64386716|FG001|Overall Study|Loss of insurance|0|||
23176280|NCT02400255|64386717|FG002|Overall Study|Loss of insurance|0|||
23176281|NCT02400255|64386718|FG003|Overall Study|Loss of insurance|0|||
23176282|NCT03609619|64386719|FG000|Overall Study|Adverse Event|1|||
23176283|NCT03609619|64386720|FG001|Overall Study|Adverse Event|0|||
23176284|NCT03609619|64386719|FG000|Overall Study|Lack of Efficacy|1|||
23176285|NCT03609619|64386720|FG001|Overall Study|Lack of Efficacy|2|||
23176286|NCT03609619|64386719|FG000|Overall Study|Protocol Violation|5|||
23176287|NCT03609619|64386720|FG001|Overall Study|Protocol Violation|0|||
23176288|NCT03609619|64386719|FG000|Overall Study|Withdrawal by Subject|2|||
23176289|NCT03609619|64386720|FG001|Overall Study|Withdrawal by Subject|3|||
23176290|NCT03609619|64386719|FG000|Overall Study|Lost to Follow-up|1|||
23176291|NCT03609619|64386720|FG001|Overall Study|Lost to Follow-up|1|||
23176292|NCT00809328|64386721|FG000|Overall Study|Lack of Efficacy|18|||
23176293|NCT00809328|64386721|FG000|Overall Study|Adverse Event|6|||
23176294|NCT00809328|64386721|FG000|Overall Study|Protocol Violation|3|||
23176295|NCT00809328|64386721|FG000|Overall Study|Withdrawal by Subject|2|||
23176296|NCT01671345|64386727|FG000|Overall Study|Lost to Follow-up|10|||
23176297|NCT01671345|64386728|FG001|Overall Study|Lost to Follow-up|6|||
23453973|NCT02718898|65403440|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
23453974|NCT02718898|65403441|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
23176298|NCT01671345|64386727|FG000|Overall Study|visit with non-participating physician|3|||
23453975|NCT02718898|65403442|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
23341130|NCT02031640|64992935|FG002|Screening Period|Withdrawal by Subject|0|||
23341131|NCT02031640|64992936|FG003|Screening Period|Withdrawal by Subject|0|||
23341132|NCT02031640|64992937|FG004|Screening Period|Withdrawal by Subject|0|||
23341133|NCT02031640|64992938|FG005|Screening Period|Withdrawal by Subject|0|||
23341134|NCT02031640|64992933|FG000|Screening Period|Inclusion criteria not met|312|||
23341135|NCT02031640|64992934|FG001|Screening Period|Inclusion criteria not met|0|||
23341136|NCT02031640|64992935|FG002|Screening Period|Inclusion criteria not met|0|||
23341137|NCT02031640|64992936|FG003|Screening Period|Inclusion criteria not met|0|||
23341138|NCT02031640|64992937|FG004|Screening Period|Inclusion criteria not met|0|||
23341139|NCT02031640|64992938|FG005|Screening Period|Inclusion criteria not met|0|||
23341140|NCT02031640|64992933|FG000|Screening Period|Exclusion criteria met|30|||
23341141|NCT02031640|64992934|FG001|Screening Period|Exclusion criteria met|0|||
23341142|NCT02031640|64992935|FG002|Screening Period|Exclusion criteria met|0|||
23341143|NCT02031640|64992936|FG003|Screening Period|Exclusion criteria met|0|||
23341144|NCT02031640|64992937|FG004|Screening Period|Exclusion criteria met|0|||
23341145|NCT02031640|64992938|FG005|Screening Period|Exclusion criteria met|0|||
23341146|NCT02031640|64992933|FG000|Screening Period|Lost to Follow-up|14|||
23341147|NCT02031640|64992934|FG001|Screening Period|Lost to Follow-up|0|||
23341148|NCT02031640|64992935|FG002|Screening Period|Lost to Follow-up|0|||
23341149|NCT02031640|64992936|FG003|Screening Period|Lost to Follow-up|0|||
23341150|NCT02031640|64992937|FG004|Screening Period|Lost to Follow-up|0|||
23341151|NCT02031640|64992938|FG005|Screening Period|Lost to Follow-up|0|||
23341152|NCT02031640|64992933|FG000|Screening Period|Enrollment closed|26|||
23341153|NCT02031640|64992934|FG001|Screening Period|Enrollment closed|0|||
23341154|NCT02031640|64992935|FG002|Screening Period|Enrollment closed|0|||
23341155|NCT02031640|64992936|FG003|Screening Period|Enrollment closed|0|||
23341156|NCT02031640|64992937|FG004|Screening Period|Enrollment closed|0|||
23341157|NCT02031640|64992938|FG005|Screening Period|Enrollment closed|0|||
23341158|NCT02031640|64992933|FG000|Run-In Period|Adverse Event|4|||
23341159|NCT02031640|64992934|FG001|Run-In Period|Adverse Event|0|||
23341160|NCT02031640|64992935|FG002|Run-In Period|Adverse Event|0|||
23341161|NCT02031640|64992936|FG003|Run-In Period|Adverse Event|0|||
23341162|NCT02031640|64992937|FG004|Run-In Period|Adverse Event|0|||
23341163|NCT02031640|64992938|FG005|Run-In Period|Adverse Event|0|||
23341164|NCT02031640|64992933|FG000|Run-In Period|Withdrawal by Subject|17|||
23341165|NCT02031640|64992934|FG001|Run-In Period|Withdrawal by Subject|0|||
23341166|NCT02031640|64992935|FG002|Run-In Period|Withdrawal by Subject|0|||
23341167|NCT02031640|64992936|FG003|Run-In Period|Withdrawal by Subject|0|||
23341168|NCT02031640|64992937|FG004|Run-In Period|Withdrawal by Subject|0|||
23341169|NCT02031640|64992938|FG005|Run-In Period|Withdrawal by Subject|0|||
23341170|NCT02031640|64992933|FG000|Run-In Period|Inclusion criteria not met|38|||
23341171|NCT02031640|64992934|FG001|Run-In Period|Inclusion criteria not met|0|||
23341172|NCT02031640|64992935|FG002|Run-In Period|Inclusion criteria not met|0|||
23341173|NCT02031640|64992936|FG003|Run-In Period|Inclusion criteria not met|0|||
23341174|NCT02031640|64992937|FG004|Run-In Period|Inclusion criteria not met|0|||
23176299|NCT01671345|64386728|FG001|Overall Study|visit with non-participating physician|3|||
23176300|NCT01813890|64386729|FG000|Overall Study|Adverse Event|0|||
23176301|NCT01813890|64386730|FG001|Overall Study|Adverse Event|3|||
23341175|NCT02031640|64992938|FG005|Run-In Period|Inclusion criteria not met|0|||
23341176|NCT02031640|64992933|FG000|Run-In Period|Exclusion criteria met|8|||
23341177|NCT02031640|64992934|FG001|Run-In Period|Exclusion criteria met|0|||
23341178|NCT02031640|64992935|FG002|Run-In Period|Exclusion criteria met|0|||
23341179|NCT02031640|64992936|FG003|Run-In Period|Exclusion criteria met|0|||
23341180|NCT02031640|64992937|FG004|Run-In Period|Exclusion criteria met|0|||
23341181|NCT02031640|64992938|FG005|Run-In Period|Exclusion criteria met|0|||
23341182|NCT02031640|64992933|FG000|Run-In Period|Randomization criteria not met|85|||
23341183|NCT02031640|64992934|FG001|Run-In Period|Randomization criteria not met|0|||
23341184|NCT02031640|64992935|FG002|Run-In Period|Randomization criteria not met|0|||
23341185|NCT02031640|64992936|FG003|Run-In Period|Randomization criteria not met|0|||
23341186|NCT02031640|64992937|FG004|Run-In Period|Randomization criteria not met|0|||
23341187|NCT02031640|64992938|FG005|Run-In Period|Randomization criteria not met|0|||
23453976|NCT02718898|65403443|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
23341188|NCT02031640|64992933|FG000|Run-In Period|Various administrative reasons|17|||
23341189|NCT02031640|64992934|FG001|Run-In Period|Various administrative reasons|0|||
23341190|NCT02031640|64992935|FG002|Run-In Period|Various administrative reasons|0|||
23341191|NCT02031640|64992936|FG003|Run-In Period|Various administrative reasons|0|||
23341192|NCT02031640|64992937|FG004|Run-In Period|Various administrative reasons|0|||
23341193|NCT02031640|64992938|FG005|Run-In Period|Various administrative reasons|0|||
23582343|NCT01511250|65862458|FG003|Overall Study|Withdrawal of Consent|0|||
23582344|NCT01511250|65862459|FG004|Overall Study|Withdrawal of Consent|0|||
23176302|NCT01813890|64386731|FG002|Overall Study|Adverse Event|4|||
23341194|NCT02031640|64992933|FG000|Double-blind Treatment Period|Protocol deviation|0|||
23341195|NCT02031640|64992934|FG001|Double-blind Treatment Period|Protocol deviation|2|||
23341196|NCT02031640|64992935|FG002|Double-blind Treatment Period|Protocol deviation|0|||
23341197|NCT02031640|64992936|FG003|Double-blind Treatment Period|Protocol deviation|1|||
23341198|NCT02031640|64992937|FG004|Double-blind Treatment Period|Protocol deviation|3|||
23341199|NCT02031640|64992938|FG005|Double-blind Treatment Period|Protocol deviation|1|||
23341200|NCT02031640|64992933|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23341201|NCT02031640|64992934|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
23341202|NCT02031640|64992935|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
23341203|NCT02031640|64992936|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
23341204|NCT02031640|64992937|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
23341205|NCT02031640|64992938|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
23341206|NCT02031640|64992933|FG000|Double-blind Treatment Period|Non-compliance|0|||
23341207|NCT02031640|64992934|FG001|Double-blind Treatment Period|Non-compliance|1|||
23341208|NCT02031640|64992935|FG002|Double-blind Treatment Period|Non-compliance|0|||
23341209|NCT02031640|64992936|FG003|Double-blind Treatment Period|Non-compliance|1|||
23341210|NCT02031640|64992937|FG004|Double-blind Treatment Period|Non-compliance|1|||
23341211|NCT02031640|64992938|FG005|Double-blind Treatment Period|Non-compliance|0|||
23341212|NCT02031640|64992933|FG000|Double-blind Treatment Period|Adverse Event|0|||
23341213|NCT02031640|64992934|FG001|Double-blind Treatment Period|Adverse Event|0|||
23341214|NCT02031640|64992935|FG002|Double-blind Treatment Period|Adverse Event|0|||
23341215|NCT02031640|64992936|FG003|Double-blind Treatment Period|Adverse Event|2|||
23341216|NCT02031640|64992937|FG004|Double-blind Treatment Period|Adverse Event|0|||
23341217|NCT02031640|64992938|FG005|Double-blind Treatment Period|Adverse Event|0|||
23341218|NCT02031640|64992933|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
23341219|NCT02031640|64992934|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
23341220|NCT02031640|64992935|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
23341221|NCT02031640|64992936|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
23341222|NCT02031640|64992937|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
23341223|NCT02031640|64992938|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
23341224|NCT02031640|64992933|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23341225|NCT02031640|64992934|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
23341226|NCT02031640|64992935|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23341227|NCT02031640|64992936|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23341228|NCT02031640|64992937|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
23341229|NCT02031640|64992938|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
23341230|NCT03214380|64992939|FG000|Lead-in|Adverse Event|3|||
23341231|NCT03214380|64992940|FG001|Lead-in|Adverse Event|0|||
23341232|NCT03214380|64992941|FG002|Lead-in|Adverse Event|0|||
23341233|NCT03214380|64992942|FG003|Lead-in|Adverse Event|1|||
23341234|NCT03214380|64992943|FG004|Lead-in|Adverse Event|0|||
23341235|NCT03214380|64992944|FG005|Lead-in|Adverse Event|0|||
23341236|NCT03214380|64992939|FG000|Lead-in|Lost to Follow-up|4|||
23341237|NCT03214380|64992940|FG001|Lead-in|Lost to Follow-up|0|||
23341238|NCT03214380|64992941|FG002|Lead-in|Lost to Follow-up|0|||
23341239|NCT03214380|64992942|FG003|Lead-in|Lost to Follow-up|1|||
23341240|NCT03214380|64992943|FG004|Lead-in|Lost to Follow-up|0|||
23341241|NCT03214380|64992944|FG005|Lead-in|Lost to Follow-up|0|||
23341242|NCT03214380|64992939|FG000|Lead-in|Eligibility Criteria|3|||
23341243|NCT03214380|64992940|FG001|Lead-in|Eligibility Criteria|0|||
23341244|NCT03214380|64992941|FG002|Lead-in|Eligibility Criteria|0|||
23341245|NCT03214380|64992942|FG003|Lead-in|Eligibility Criteria|0|||
23341246|NCT03214380|64992943|FG004|Lead-in|Eligibility Criteria|0|||
23341247|NCT03214380|64992944|FG005|Lead-in|Eligibility Criteria|0|||
23341248|NCT03214380|64992939|FG000|Lead-in|Physician Decision|6|||
23341249|NCT03214380|64992940|FG001|Lead-in|Physician Decision|0|||
23341250|NCT03214380|64992941|FG002|Lead-in|Physician Decision|0|||
23341251|NCT03214380|64992942|FG003|Lead-in|Physician Decision|0|||
23341252|NCT03214380|64992943|FG004|Lead-in|Physician Decision|0|||
23341253|NCT03214380|64992944|FG005|Lead-in|Physician Decision|0|||
23341254|NCT03214380|64992939|FG000|Lead-in|Protocol Deviation|7|||
23341255|NCT03214380|64992940|FG001|Lead-in|Protocol Deviation|0|||
23341256|NCT03214380|64992941|FG002|Lead-in|Protocol Deviation|0|||
23341257|NCT03214380|64992942|FG003|Lead-in|Protocol Deviation|3|||
23341258|NCT03214380|64992943|FG004|Lead-in|Protocol Deviation|0|||
23341259|NCT03214380|64992944|FG005|Lead-in|Protocol Deviation|0|||
23341260|NCT03214380|64992939|FG000|Lead-in|Withdrawal by Subject|41|||
23341261|NCT03214380|64992940|FG001|Lead-in|Withdrawal by Subject|0|||
23341262|NCT03214380|64992941|FG002|Lead-in|Withdrawal by Subject|0|||
23341263|NCT03214380|64992942|FG003|Lead-in|Withdrawal by Subject|14|||
23341264|NCT03214380|64992943|FG004|Lead-in|Withdrawal by Subject|0|||
23341265|NCT03214380|64992944|FG005|Lead-in|Withdrawal by Subject|0|||
23341266|NCT03214380|64992939|FG000|Lead-in|Family Emergency|1|||
23341267|NCT03214380|64992940|FG001|Lead-in|Family Emergency|0|||
23341268|NCT03214380|64992941|FG002|Lead-in|Family Emergency|0|||
23341269|NCT03214380|64992942|FG003|Lead-in|Family Emergency|0|||
23341270|NCT03214380|64992943|FG004|Lead-in|Family Emergency|0|||
23341271|NCT03214380|64992944|FG005|Lead-in|Family Emergency|0|||
23341272|NCT03214380|64992939|FG000|Lead-in|Natural Disaster|9|||
23341273|NCT03214380|64992940|FG001|Lead-in|Natural Disaster|0|||
23341274|NCT03214380|64992941|FG002|Lead-in|Natural Disaster|0|||
23341275|NCT03214380|64992942|FG003|Lead-in|Natural Disaster|0|||
23341276|NCT03214380|64992943|FG004|Lead-in|Natural Disaster|0|||
23341277|NCT03214380|64992944|FG005|Lead-in|Natural Disaster|0|||
23341278|NCT03214380|64992939|FG000|Lead-in|Non Compliance|1|||
23341279|NCT03214380|64992940|FG001|Lead-in|Non Compliance|0|||
23341280|NCT03214380|64992941|FG002|Lead-in|Non Compliance|0|||
23341281|NCT03214380|64992942|FG003|Lead-in|Non Compliance|0|||
23341282|NCT03214380|64992943|FG004|Lead-in|Non Compliance|0|||
23341283|NCT03214380|64992944|FG005|Lead-in|Non Compliance|0|||
23341284|NCT03214380|64992939|FG000|Lead-in|Participant Schedule|2|||
23341285|NCT03214380|64992940|FG001|Lead-in|Participant Schedule|0|||
23341286|NCT03214380|64992941|FG002|Lead-in|Participant Schedule|0|||
23341287|NCT03214380|64992942|FG003|Lead-in|Participant Schedule|0|||
23341288|NCT03214380|64992943|FG004|Lead-in|Participant Schedule|0|||
23341289|NCT03214380|64992944|FG005|Lead-in|Participant Schedule|0|||
23341290|NCT03214380|64992939|FG000|Treatment Period|Adverse Event|0|||
23341291|NCT03214380|64992940|FG001|Treatment Period|Adverse Event|1|||
23341292|NCT03214380|64992941|FG002|Treatment Period|Adverse Event|1|||
23341293|NCT03214380|64992942|FG003|Treatment Period|Adverse Event|0|||
23341294|NCT03214380|64992943|FG004|Treatment Period|Adverse Event|1|||
23341295|NCT03214380|64992944|FG005|Treatment Period|Adverse Event|0|||
23341296|NCT03214380|64992939|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
23341297|NCT03214380|64992940|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
23341298|NCT03214380|64992941|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
23341299|NCT03214380|64992942|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
23341300|NCT03214380|64992943|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
23341301|NCT03214380|64992944|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
23341302|NCT03214380|64992939|FG000|Treatment Period|Withdrawal by Subject|0|||
23341303|NCT03214380|64992940|FG001|Treatment Period|Withdrawal by Subject|10|||
23341304|NCT03214380|64992941|FG002|Treatment Period|Withdrawal by Subject|8|||
23341305|NCT03214380|64992942|FG003|Treatment Period|Withdrawal by Subject|0|||
23341306|NCT03214380|64992943|FG004|Treatment Period|Withdrawal by Subject|7|||
23341307|NCT03214380|64992944|FG005|Treatment Period|Withdrawal by Subject|11|||
23341308|NCT03214380|64992939|FG000|Treatment Period|Death|0|||
23341309|NCT03214380|64992940|FG001|Treatment Period|Death|1|||
23341310|NCT03214380|64992941|FG002|Treatment Period|Death|2|||
23341311|NCT03214380|64992942|FG003|Treatment Period|Death|0|||
23341312|NCT03214380|64992943|FG004|Treatment Period|Death|0|||
23341313|NCT03214380|64992944|FG005|Treatment Period|Death|0|||
23341314|NCT03214380|64992939|FG000|Treatment Period|Lost to Follow-up|0|||
23341315|NCT03214380|64992940|FG001|Treatment Period|Lost to Follow-up|6|||
23341316|NCT03214380|64992941|FG002|Treatment Period|Lost to Follow-up|3|||
23341317|NCT03214380|64992942|FG003|Treatment Period|Lost to Follow-up|0|||
23341318|NCT03214380|64992943|FG004|Treatment Period|Lost to Follow-up|0|||
23341319|NCT03214380|64992944|FG005|Treatment Period|Lost to Follow-up|0|||
23341320|NCT03214380|64992939|FG000|Treatment Period|Participant schedule|0|||
23341321|NCT03214380|64992940|FG001|Treatment Period|Participant schedule|0|||
23341322|NCT03214380|64992941|FG002|Treatment Period|Participant schedule|1|||
23341323|NCT03214380|64992942|FG003|Treatment Period|Participant schedule|0|||
23341324|NCT03214380|64992943|FG004|Treatment Period|Participant schedule|0|||
23341325|NCT03214380|64992944|FG005|Treatment Period|Participant schedule|0|||
23341326|NCT03214380|64992939|FG000|Treatment Period|Treatment Interruption|0|||
23341327|NCT03214380|64992940|FG001|Treatment Period|Treatment Interruption|0|||
23341328|NCT03214380|64992941|FG002|Treatment Period|Treatment Interruption|1|||
23341329|NCT03214380|64992942|FG003|Treatment Period|Treatment Interruption|0|||
23341330|NCT03214380|64992943|FG004|Treatment Period|Treatment Interruption|0|||
23341331|NCT03214380|64992944|FG005|Treatment Period|Treatment Interruption|0|||
23341332|NCT03452488|64992945|FG000|Overall Study|Adverse Event|4|||
23341333|NCT03452488|64992946|FG001|Overall Study|Adverse Event|6|||
23341334|NCT03452488|64992947|FG002|Overall Study|Adverse Event|1|||
23582345|NCT01511250|65862460|FG005|Overall Study|Withdrawal of Consent|0|||
23176303|NCT01813890|64386729|FG000|Overall Study|Lack of Efficacy|9|||
23341335|NCT03452488|64992945|FG000|Overall Study|Death|0|||
23341336|NCT03452488|64992946|FG001|Overall Study|Death|0|||
23341337|NCT03452488|64992947|FG002|Overall Study|Death|1|||
23341338|NCT03452488|64992945|FG000|Overall Study|Lost to Follow-up|1|||
23341339|NCT03452488|64992946|FG001|Overall Study|Lost to Follow-up|2|||
23341340|NCT03452488|64992947|FG002|Overall Study|Lost to Follow-up|0|||
23341341|NCT03452488|64992945|FG000|Overall Study|PI Decision|1|||
23341342|NCT03452488|64992946|FG001|Overall Study|PI Decision|0|||
23341343|NCT03452488|64992947|FG002|Overall Study|PI Decision|0|||
23341344|NCT03452488|64992945|FG000|Overall Study|Withdrew consent|4|||
23341345|NCT03452488|64992946|FG001|Overall Study|Withdrew consent|2|||
23341346|NCT03452488|64992947|FG002|Overall Study|Withdrew consent|2|||
23341347|NCT03452488|64992945|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
23341348|NCT03452488|64992946|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
23341349|NCT03452488|64992947|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
23341350|NCT03452488|64992945|FG000|Overall Study|Other|0|||
23341351|NCT03452488|64992946|FG001|Overall Study|Other|2|||
23341352|NCT03452488|64992947|FG002|Overall Study|Other|2|||
23341353|NCT02272842|64992948|FG000|Overall Study|Lost to Follow-up|8|||
23453977|NCT02718898|65403444|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
23453978|NCT02718898|65403438|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
23582346|NCT01511250|65862461|FG006|Overall Study|Withdrawal of Consent|0|||
23582347|NCT01511250|65862462|FG007|Overall Study|Withdrawal of Consent|1|||
23582348|NCT01511250|65862463|FG008|Overall Study|Withdrawal of Consent|1|||
23582349|NCT01511250|65862464|FG009|Overall Study|Withdrawal of Consent|0|||
23176304|NCT01813890|64386730|FG001|Overall Study|Lack of Efficacy|1|||
23176305|NCT01813890|64386731|FG002|Overall Study|Lack of Efficacy|2|||
23176306|NCT01439945|64386737|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
23176307|NCT01439945|64386738|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
23176308|NCT01439945|64386739|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
23176309|NCT01439945|64386740|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
23176310|NCT01439945|64386737|FG000|Double-Blind Treatment Phase|Ineligible|1|||
23176311|NCT01439945|64386738|FG001|Double-Blind Treatment Phase|Ineligible|2|||
23176312|NCT01439945|64386739|FG002|Double-Blind Treatment Phase|Ineligible|0|||
23176313|NCT01439945|64386740|FG003|Double-Blind Treatment Phase|Ineligible|1|||
23176314|NCT01407926|64386743|FG000|Overall Study|Lost to Follow-up|55|||
23176315|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
23176316|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
23176317|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
23176318|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
23176319|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
23176320|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
23176321|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
23176322|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
23176323|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
23176324|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
23176325|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
23176326|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
23176327|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
23176328|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
23176329|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
23582350|NCT01511250|65862455|FG000|Overall Study|Sponsor/Investigator Decision|1|||
23582351|NCT01511250|65862456|FG001|Overall Study|Sponsor/Investigator Decision|0|||
23582352|NCT01511250|65862457|FG002|Overall Study|Sponsor/Investigator Decision|0|||
23582353|NCT01511250|65862458|FG003|Overall Study|Sponsor/Investigator Decision|0|||
23582354|NCT01511250|65862459|FG004|Overall Study|Sponsor/Investigator Decision|0|||
23582355|NCT01511250|65862460|FG005|Overall Study|Sponsor/Investigator Decision|0|||
23582356|NCT01511250|65862461|FG006|Overall Study|Sponsor/Investigator Decision|0|||
23582357|NCT01511250|65862462|FG007|Overall Study|Sponsor/Investigator Decision|0|||
23582358|NCT01511250|65862463|FG008|Overall Study|Sponsor/Investigator Decision|0|||
23582359|NCT01511250|65862464|FG009|Overall Study|Sponsor/Investigator Decision|0|||
23582360|NCT01511250|65862455|FG000|Overall Study|Lost to Follow-up|7|||
23582361|NCT01511250|65862456|FG001|Overall Study|Lost to Follow-up|3|||
23582362|NCT01511250|65862457|FG002|Overall Study|Lost to Follow-up|3|||
23582363|NCT01511250|65862458|FG003|Overall Study|Lost to Follow-up|3|||
23582364|NCT01511250|65862459|FG004|Overall Study|Lost to Follow-up|0|||
23582365|NCT01511250|65862460|FG005|Overall Study|Lost to Follow-up|0|||
23582366|NCT01511250|65862461|FG006|Overall Study|Lost to Follow-up|2|||
23582367|NCT01511250|65862462|FG007|Overall Study|Lost to Follow-up|3|||
23582368|NCT01511250|65862463|FG008|Overall Study|Lost to Follow-up|13|||
23582369|NCT01511250|65862464|FG009|Overall Study|Lost to Follow-up|5|||
23582370|NCT01511250|65862455|FG000|Overall Study|Protocol Violation|0|||
23582371|NCT01511250|65862456|FG001|Overall Study|Protocol Violation|2|||
23582372|NCT01511250|65862457|FG002|Overall Study|Protocol Violation|1|||
23582373|NCT01511250|65862458|FG003|Overall Study|Protocol Violation|0|||
23176330|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
23341354|NCT02272842|64992949|FG001|Overall Study|Lost to Follow-up|8|||
23341355|NCT02272842|64992948|FG000|Overall Study|Withdrawal by Subject|8|||
23341356|NCT02272842|64992949|FG001|Overall Study|Withdrawal by Subject|2|||
23582374|NCT01511250|65862459|FG004|Overall Study|Protocol Violation|0|||
23582375|NCT01511250|65862460|FG005|Overall Study|Protocol Violation|0|||
23582376|NCT01511250|65862461|FG006|Overall Study|Protocol Violation|0|||
23341357|NCT01820572|64992952|FG000|Randomization|Not Treated|2|||
23341358|NCT01820572|64992953|FG001|Randomization|Not Treated|1|||
23341359|NCT01820572|64992952|FG000|Treatment Period|Adverse Event|12|||
23341360|NCT01820572|64992953|FG001|Treatment Period|Adverse Event|7|||
23341361|NCT01820572|64992952|FG000|Treatment Period|Death|3|||
23341362|NCT01820572|64992953|FG001|Treatment Period|Death|3|||
23341363|NCT01820572|64992952|FG000|Treatment Period|Lack of Efficacy|1|||
23341364|NCT01820572|64992953|FG001|Treatment Period|Lack of Efficacy|0|||
23341365|NCT01820572|64992952|FG000|Treatment Period|poor/non compliance|0|||
23341366|NCT01820572|64992953|FG001|Treatment Period|poor/non compliance|3|||
23341367|NCT01820572|64992952|FG000|Treatment Period|request to discontinue|6|||
23341368|NCT01820572|64992953|FG001|Treatment Period|request to discontinue|11|||
23341369|NCT01820572|64992952|FG000|Treatment Period|No longer meets study criteria|3|||
23341370|NCT01820572|64992953|FG001|Treatment Period|No longer meets study criteria|10|||
23341371|NCT01820572|64992952|FG000|Treatment Period|withdrew consent|1|||
23341372|NCT01820572|64992953|FG001|Treatment Period|withdrew consent|2|||
23341373|NCT01084668|64992957|FG000|Overall Study|Lack of Efficacy|5|||
23341374|NCT01084668|64992957|FG000|Overall Study|Withdrawal by Subject|2|||
23341375|NCT01084668|64992957|FG000|Overall Study|Pregnancy|1|||
23341376|NCT01084668|64992957|FG000|Overall Study|Non-compliance|1|||
23341377|NCT05087966|64992959|FG000|Overall Study|Lost to Follow-up|1|||
23341378|NCT05087966|64992959|FG000|Overall Study|Withdrawal by Subject|5|||
23341379|NCT03613649|64992960|FG000|Second Treatment|Lost to Follow-up|0|||
23341380|NCT03613649|64992961|FG001|Second Treatment|Lost to Follow-up|0|||
23341381|NCT03613649|64992962|FG002|Second Treatment|Lost to Follow-up|1|||
23341382|NCT03613649|64992963|FG003|Second Treatment|Lost to Follow-up|0|||
23341383|NCT03613649|64992964|FG004|Second Treatment|Lost to Follow-up|0|||
23341384|NCT03613649|64992965|FG005|Second Treatment|Lost to Follow-up|0|||
23341385|NCT03613649|64992966|FG006|Second Treatment|Lost to Follow-up|0|||
23176331|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
23176332|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
23176333|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
23176334|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
23176335|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
23176336|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
23176337|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
23176338|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
23176339|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Death|2|||
23176340|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Death|1|||
23176341|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Death|2|||
23176342|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Graft loss|0|||
23176343|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Graft loss|2|||
23176344|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Graft loss|0|||
23176345|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
23176346|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
23176347|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
23176348|NCT01114529|64386746|FG000|Completed Study Medication at Month 24|Missing|2|||
23176349|NCT01114529|64386747|FG001|Completed Study Medication at Month 24|Missing|0|||
23176350|NCT01114529|64386748|FG002|Completed Study Medication at Month 24|Missing|0|||
23176351|NCT01114529|64386746|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
23176352|NCT01114529|64386747|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
23176353|NCT01114529|64386748|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
23176354|NCT01114529|64386746|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
23176355|NCT01114529|64386747|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
23176356|NCT01114529|64386748|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
23176357|NCT01114529|64386746|FG000|Completed Study Phase at Month 24|Death|8|||
23176358|NCT01114529|64386747|FG001|Completed Study Phase at Month 24|Death|5|||
23176359|NCT01114529|64386748|FG002|Completed Study Phase at Month 24|Death|4|||
23176360|NCT01114529|64386746|FG000|Completed Study Phase at Month 24|Other|2|||
23176361|NCT01114529|64386747|FG001|Completed Study Phase at Month 24|Other|0|||
23176362|NCT01114529|64386748|FG002|Completed Study Phase at Month 24|Other|0|||
23176363|NCT01114529|64386746|FG000|Completed Study Phase at Month 24|Missing|2|||
23176364|NCT01114529|64386747|FG001|Completed Study Phase at Month 24|Missing|0|||
23176365|NCT01114529|64386748|FG002|Completed Study Phase at Month 24|Missing|0|||
23176366|NCT00491179|64386749|FG000|Overall Study|Adverse Event|5|||
23176367|NCT00491179|64386750|FG001|Overall Study|Adverse Event|1|||
23341386|NCT03613649|64992967|FG007|Second Treatment|Lost to Follow-up|0|||
23341387|NCT03613649|64992968|FG008|Second Treatment|Lost to Follow-up|0|||
23176368|NCT00491179|64386749|FG000|Overall Study|Withdrawal by Subject|2|||
23341388|NCT03613649|64992969|FG009|Second Treatment|Lost to Follow-up|0|||
23341389|NCT03613649|64992970|FG010|Second Treatment|Lost to Follow-up|0|||
23341390|NCT03613649|64992971|FG011|Second Treatment|Lost to Follow-up|0|||
23341391|NCT03613649|64992960|FG000|Second Treatment|Withdrawal by Subject|0|||
23341392|NCT03613649|64992961|FG001|Second Treatment|Withdrawal by Subject|0|||
23341393|NCT03613649|64992962|FG002|Second Treatment|Withdrawal by Subject|0|||
23341394|NCT03613649|64992963|FG003|Second Treatment|Withdrawal by Subject|0|||
23341395|NCT03613649|64992964|FG004|Second Treatment|Withdrawal by Subject|1|||
23341396|NCT03613649|64992965|FG005|Second Treatment|Withdrawal by Subject|0|||
23341397|NCT03613649|64992966|FG006|Second Treatment|Withdrawal by Subject|0|||
23341398|NCT03613649|64992967|FG007|Second Treatment|Withdrawal by Subject|0|||
23341399|NCT03613649|64992968|FG008|Second Treatment|Withdrawal by Subject|0|||
23341400|NCT03613649|64992969|FG009|Second Treatment|Withdrawal by Subject|0|||
23341401|NCT03613649|64992970|FG010|Second Treatment|Withdrawal by Subject|0|||
23341402|NCT03613649|64992971|FG011|Second Treatment|Withdrawal by Subject|0|||
23341403|NCT03613649|64992960|FG000|Third Treatment|Lost to Follow-up|0|||
23341404|NCT03613649|64992961|FG001|Third Treatment|Lost to Follow-up|0|||
23341405|NCT03613649|64992962|FG002|Third Treatment|Lost to Follow-up|0|||
23341406|NCT03613649|64992963|FG003|Third Treatment|Lost to Follow-up|0|||
23341407|NCT03613649|64992964|FG004|Third Treatment|Lost to Follow-up|1|||
23341408|NCT03613649|64992965|FG005|Third Treatment|Lost to Follow-up|0|||
23341409|NCT03613649|64992966|FG006|Third Treatment|Lost to Follow-up|0|||
23341410|NCT03613649|64992967|FG007|Third Treatment|Lost to Follow-up|0|||
23341411|NCT03613649|64992968|FG008|Third Treatment|Lost to Follow-up|0|||
23341412|NCT03613649|64992969|FG009|Third Treatment|Lost to Follow-up|0|||
23341413|NCT03613649|64992970|FG010|Third Treatment|Lost to Follow-up|0|||
23341414|NCT03613649|64992971|FG011|Third Treatment|Lost to Follow-up|1|||
23341415|NCT03613649|64992960|FG000|Third Treatment|Protocol Violation|0|||
23341416|NCT03613649|64992961|FG001|Third Treatment|Protocol Violation|0|||
23341417|NCT03613649|64992962|FG002|Third Treatment|Protocol Violation|0|||
23341418|NCT03613649|64992963|FG003|Third Treatment|Protocol Violation|0|||
23341419|NCT03613649|64992964|FG004|Third Treatment|Protocol Violation|0|||
23341420|NCT03613649|64992965|FG005|Third Treatment|Protocol Violation|0|||
23341421|NCT03613649|64992966|FG006|Third Treatment|Protocol Violation|1|||
23341422|NCT03613649|64992967|FG007|Third Treatment|Protocol Violation|0|||
23341423|NCT03613649|64992968|FG008|Third Treatment|Protocol Violation|0|||
23341424|NCT03613649|64992969|FG009|Third Treatment|Protocol Violation|0|||
23341425|NCT03613649|64992970|FG010|Third Treatment|Protocol Violation|0|||
23341426|NCT03613649|64992971|FG011|Third Treatment|Protocol Violation|1|||
23341427|NCT03613649|64992960|FG000|Fourth Treatment|Protocol Violation|1|||
23341428|NCT03613649|64992961|FG001|Fourth Treatment|Protocol Violation|0|||
23341429|NCT03613649|64992962|FG002|Fourth Treatment|Protocol Violation|0|||
23341430|NCT03613649|64992963|FG003|Fourth Treatment|Protocol Violation|0|||
23341431|NCT03613649|64992964|FG004|Fourth Treatment|Protocol Violation|1|||
23341432|NCT03613649|64992965|FG005|Fourth Treatment|Protocol Violation|0|||
23341433|NCT03613649|64992966|FG006|Fourth Treatment|Protocol Violation|0|||
23341434|NCT03613649|64992967|FG007|Fourth Treatment|Protocol Violation|0|||
23341435|NCT03613649|64992968|FG008|Fourth Treatment|Protocol Violation|0|||
23341436|NCT03613649|64992969|FG009|Fourth Treatment|Protocol Violation|0|||
23341437|NCT03613649|64992970|FG010|Fourth Treatment|Protocol Violation|0|||
23341438|NCT03613649|64992971|FG011|Fourth Treatment|Protocol Violation|0|||
23341439|NCT03613649|64992960|FG000|Fourth Treatment|Physician Decision|0|||
23341440|NCT03613649|64992961|FG001|Fourth Treatment|Physician Decision|0|||
23341441|NCT03613649|64992962|FG002|Fourth Treatment|Physician Decision|0|||
23341442|NCT03613649|64992963|FG003|Fourth Treatment|Physician Decision|0|||
23341443|NCT03613649|64992964|FG004|Fourth Treatment|Physician Decision|0|||
23341444|NCT03613649|64992965|FG005|Fourth Treatment|Physician Decision|0|||
23341445|NCT03613649|64992966|FG006|Fourth Treatment|Physician Decision|1|||
23341446|NCT03613649|64992967|FG007|Fourth Treatment|Physician Decision|0|||
23341447|NCT03613649|64992968|FG008|Fourth Treatment|Physician Decision|0|||
23341448|NCT03613649|64992969|FG009|Fourth Treatment|Physician Decision|0|||
23341449|NCT03613649|64992970|FG010|Fourth Treatment|Physician Decision|0|||
23341450|NCT03613649|64992971|FG011|Fourth Treatment|Physician Decision|0|||
23341451|NCT03467217|64992974|FG000|Overall Study|Trial stopped early|5|||
23341452|NCT03467217|64992975|FG001|Overall Study|Trial stopped early|2|||
23341453|NCT03467217|64992974|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
23341454|NCT03467217|64992975|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
23341455|NCT03467217|64992974|FG000|Overall Study|Lost to Follow-up|0|||
23341456|NCT03467217|64992975|FG001|Overall Study|Lost to Follow-up|2|||
23341457|NCT00689104|64992976|FG000|Overall Study|Eligibility criterion not met|5|||
23453979|NCT02718898|65403439|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
23453980|NCT02718898|65403440|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
23341458|NCT00689104|64992977|FG001|Overall Study|Eligibility criterion not met|8|||
23341459|NCT00689104|64992978|FG002|Overall Study|Eligibility criterion not met|0|||
23341460|NCT00689104|64992979|FG003|Overall Study|Eligibility criterion not met|4|||
23341461|NCT00689104|64992976|FG000|Overall Study|Adverse Event|13|||
23341462|NCT00689104|64992977|FG001|Overall Study|Adverse Event|25|||
23341463|NCT00689104|64992978|FG002|Overall Study|Adverse Event|16|||
23341464|NCT00689104|64992979|FG003|Overall Study|Adverse Event|24|||
23341465|NCT00689104|64992976|FG000|Overall Study|Lack of Efficacy|5|||
23341466|NCT00689104|64992977|FG001|Overall Study|Lack of Efficacy|6|||
23341467|NCT00689104|64992978|FG002|Overall Study|Lack of Efficacy|2|||
23341468|NCT00689104|64992979|FG003|Overall Study|Lack of Efficacy|3|||
23341469|NCT00689104|64992976|FG000|Overall Study|Withdrawal by Subject|12|||
23341470|NCT00689104|64992977|FG001|Overall Study|Withdrawal by Subject|11|||
23341471|NCT00689104|64992978|FG002|Overall Study|Withdrawal by Subject|18|||
23341472|NCT00689104|64992979|FG003|Overall Study|Withdrawal by Subject|11|||
23341473|NCT00689104|64992976|FG000|Overall Study|Lost to Follow-up|4|||
23341474|NCT00689104|64992977|FG001|Overall Study|Lost to Follow-up|3|||
23341475|NCT00689104|64992978|FG002|Overall Study|Lost to Follow-up|2|||
23341476|NCT00689104|64992979|FG003|Overall Study|Lost to Follow-up|5|||
23341477|NCT00689104|64992976|FG000|Overall Study|Protocol Violation|2|||
23341478|NCT00689104|64992977|FG001|Overall Study|Protocol Violation|3|||
23341479|NCT00689104|64992978|FG002|Overall Study|Protocol Violation|5|||
23341480|NCT00689104|64992979|FG003|Overall Study|Protocol Violation|3|||
23341481|NCT00689104|64992976|FG000|Overall Study|Randomized but never received study drug|2|||
23341482|NCT00689104|64992977|FG001|Overall Study|Randomized but never received study drug|1|||
23341483|NCT00689104|64992978|FG002|Overall Study|Randomized but never received study drug|1|||
23341484|NCT00689104|64992979|FG003|Overall Study|Randomized but never received study drug|0|||
23341485|NCT00689104|64992976|FG000|Overall Study|Physician Decision|1|||
23341486|NCT00689104|64992977|FG001|Overall Study|Physician Decision|0|||
23341487|NCT00689104|64992978|FG002|Overall Study|Physician Decision|0|||
23341488|NCT00689104|64992979|FG003|Overall Study|Physician Decision|0|||
23341489|NCT00689104|64992976|FG000|Overall Study|Non-compliance with study procedures|0|||
23341490|NCT00689104|64992977|FG001|Overall Study|Non-compliance with study procedures|0|||
23341491|NCT00689104|64992978|FG002|Overall Study|Non-compliance with study procedures|1|||
23341492|NCT00689104|64992979|FG003|Overall Study|Non-compliance with study procedures|0|||
23341493|NCT01669174|64992980|FG000|Overall Study|Subject withdrew consent|2|||
23341494|NCT01669174|64992981|FG001|Overall Study|Subject withdrew consent|2|||
23341495|NCT01669174|64992980|FG000|Overall Study|Lost to Follow-up|1|||
23341496|NCT01669174|64992981|FG001|Overall Study|Lost to Follow-up|0|||
23341497|NCT01669174|64992980|FG000|Overall Study|Adverse Event|2|||
23341498|NCT01669174|64992981|FG001|Overall Study|Adverse Event|2|||
23341499|NCT01669174|64992980|FG000|Overall Study|Administrative problems|1|||
23341500|NCT01669174|64992981|FG001|Overall Study|Administrative problems|2|||
23341501|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
23341502|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
23341503|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
23341504|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
23341505|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
23341506|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
23341507|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
23341508|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
23341509|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
23341510|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
23341511|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Death|1|||
23341512|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Death|0|||
23341513|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
23341514|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
23341515|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
23341516|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
23341517|NCT01876784|64992982|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
23341518|NCT01876784|64992983|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
23341519|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
23341520|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
23341521|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Adverse Event|2|||
23582377|NCT01511250|65862462|FG007|Overall Study|Protocol Violation|0|||
23582378|NCT01511250|65862463|FG008|Overall Study|Protocol Violation|0|||
23582379|NCT01511250|65862464|FG009|Overall Study|Protocol Violation|0|||
23582380|NCT01120275|65862467|FG000|Overall Study|Adverse Event|3|||
23176369|NCT00491179|64386750|FG001|Overall Study|Withdrawal by Subject|1|||
23176370|NCT01262976|64386751|FG000|Up to Month 2|Serious Adverse Event|0|||
23176371|NCT01262976|64386752|FG001|Up to Month 2|Serious Adverse Event|0|||
23176372|NCT01262976|64386753|FG002|Up to Month 2|Serious Adverse Event|1|||
23176373|NCT01262976|64386754|FG003|Up to Month 2|Serious Adverse Event|0|||
23176374|NCT01262976|64386755|FG004|Up to Month 2|Serious Adverse Event|0|||
23176375|NCT01262976|64386756|FG005|Up to Month 2|Serious Adverse Event|0|||
23176376|NCT01262976|64386751|FG000|Up to Month 2|Withdrawal by Subject|1|||
23176377|NCT01262976|64386752|FG001|Up to Month 2|Withdrawal by Subject|0|||
23176378|NCT01262976|64386753|FG002|Up to Month 2|Withdrawal by Subject|0|||
23176379|NCT01262976|64386754|FG003|Up to Month 2|Withdrawal by Subject|0|||
23341522|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Adverse Event|6|||
23341523|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
23341524|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
23341525|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Progressive disease|4|||
23341526|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Progressive disease|35|||
23341527|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
23341528|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
23341529|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
23341530|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
23341531|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Death|0|||
23341532|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Death|1|||
23341533|NCT01876784|64992982|FG000|Open-label Period (31 Months)|Other than specified above|9|||
23341534|NCT01876784|64992983|FG001|Open-label Period (31 Months)|Other than specified above|18|||
23341535|NCT01154088|64992984|FG000|Overall Study|Lost to Follow-up|4|||
23341536|NCT01154088|64992985|FG001|Overall Study|Lost to Follow-up|6|||
23341537|NCT01154088|64992986|FG002|Overall Study|Lost to Follow-up|7|||
23341538|NCT02218736|64992987|FG000|Overall Study|Withdrawal by Subject|10|||
23341539|NCT02218736|64992988|FG001|Overall Study|Withdrawal by Subject|9|||
23341540|NCT02218736|64992987|FG000|Overall Study|Protocol Violation|2|||
23341541|NCT02218736|64992988|FG001|Overall Study|Protocol Violation|0|||
23341542|NCT00725608|64992990|FG000|Overall Study|Lost to Follow-up|60|||
23341543|NCT00725608|64992990|FG000|Overall Study|Adverse Event|14|||
23341544|NCT00725608|64992990|FG000|Overall Study|Individual reasons|86|||
23341545|NCT00725608|64992990|FG000|Overall Study|Other|7|||
23341546|NCT02279745|64992991|FG000|Overall Study|Adverse Event|7|||
23341547|NCT02279745|64992991|FG000|Overall Study|Death|6|||
23341548|NCT02279745|64992991|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
23341549|NCT02279745|64992991|FG000|Overall Study|Withdrawal by Subject|2|||
23341550|NCT02279745|64992991|FG000|Overall Study|Pregnancy|1|||
23341551|NCT02279745|64992991|FG000|Overall Study|Study Non-compliance|1|||
23341552|NCT02279745|64992991|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
23341553|NCT01855243|64992993|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
23341554|NCT01855243|64992994|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
23341555|NCT01855243|64992995|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
23341556|NCT00748189|64992996|FG000|Overall Study|Death|99|||
23341557|NCT00748189|64992997|FG001|Overall Study|Death|84|||
23341558|NCT00748189|64992996|FG000|Overall Study|Withdrawal by Subject|23|||
23341559|NCT00748189|64992997|FG001|Overall Study|Withdrawal by Subject|29|||
23341560|NCT00748189|64992996|FG000|Overall Study|Physician Decision|16|||
23341561|NCT00748189|64992997|FG001|Overall Study|Physician Decision|5|||
23341562|NCT00748189|64992996|FG000|Overall Study|Lost to Follow-up|8|||
23341563|NCT00748189|64992997|FG001|Overall Study|Lost to Follow-up|15|||
23341564|NCT00748189|64992996|FG000|Overall Study|Study terminated by Sponsor|70|||
23341565|NCT00748189|64992997|FG001|Overall Study|Study terminated by Sponsor|79|||
23341566|NCT00656851|64992998|FG000|Overall Study|Withdrawal by Subject|0|||
23341567|NCT00656851|64992999|FG001|Overall Study|Withdrawal by Subject|4|||
23341568|NCT00824382|64993008|FG000|Overall Study|Adverse Event|4|||
23341569|NCT00824382|64993009|FG001|Overall Study|Adverse Event|1|||
23341570|NCT00824382|64993010|FG002|Overall Study|Adverse Event|1|||
23341571|NCT00824382|64993011|FG003|Overall Study|Adverse Event|4|||
23341572|NCT00824382|64993008|FG000|Overall Study|Protocol Violation|1|||
23341573|NCT00824382|64993009|FG001|Overall Study|Protocol Violation|0|||
23341574|NCT00824382|64993010|FG002|Overall Study|Protocol Violation|0|||
23341575|NCT00824382|64993011|FG003|Overall Study|Protocol Violation|1|||
23341576|NCT00824382|64993008|FG000|Overall Study|Investigator's decision|0|||
23341577|NCT00824382|64993009|FG001|Overall Study|Investigator's decision|1|||
23341578|NCT00824382|64993010|FG002|Overall Study|Investigator's decision|2|||
23341579|NCT00824382|64993011|FG003|Overall Study|Investigator's decision|0|||
23341580|NCT02738879|64993012|FG000|Overall Study|Adverse Event|1|||
23341581|NCT02738879|64993013|FG001|Overall Study|Adverse Event|1|||
23341582|NCT02738879|64993012|FG000|Overall Study|Death|0|||
23341583|NCT02738879|64993013|FG001|Overall Study|Death|2|||
23341584|NCT02738879|64993012|FG000|Overall Study|Lost to Follow-up|1|||
23341585|NCT02738879|64993013|FG001|Overall Study|Lost to Follow-up|5|||
23341586|NCT02738879|64993012|FG000|Overall Study|Protocol Violation|1|||
23341587|NCT02738879|64993013|FG001|Overall Study|Protocol Violation|3|||
23341588|NCT02738879|64993012|FG000|Overall Study|Physician Decision|3|||
23341589|NCT02738879|64993013|FG001|Overall Study|Physician Decision|4|||
23341590|NCT02738879|64993012|FG000|Overall Study|Pregnancy|0|||
23341591|NCT02738879|64993013|FG001|Overall Study|Pregnancy|1|||
23341592|NCT02738879|64993012|FG000|Overall Study|Screen Failure|1|||
23341593|NCT02738879|64993013|FG001|Overall Study|Screen Failure|2|||
23341594|NCT02738879|64993012|FG000|Overall Study|Site Discontinued Study Participation|1|||
23341595|NCT02738879|64993013|FG001|Overall Study|Site Discontinued Study Participation|0|||
23341596|NCT02738879|64993012|FG000|Overall Study|Withdrawal by Subject|5|||
23341597|NCT02738879|64993013|FG001|Overall Study|Withdrawal by Subject|7|||
23341598|NCT00537316|64993017|FG000|Part 1|Adverse Event|7|||
23341599|NCT00537316|64993018|FG001|Part 1|Adverse Event|11|||
23341600|NCT00537316|64993019|FG002|Part 1|Adverse Event|8|||
23341601|NCT00537316|64993020|FG003|Part 1|Adverse Event|0|||
23341602|NCT00537316|64993021|FG004|Part 1|Adverse Event|0|||
23341603|NCT00537316|64993022|FG005|Part 1|Adverse Event|0|||
23341604|NCT00537316|64993023|FG006|Part 1|Adverse Event|0|||
23341605|NCT00537316|64993017|FG000|Part 1|Protocol defined clinical event|1|||
23341606|NCT00537316|64993018|FG001|Part 1|Protocol defined clinical event|0|||
23341607|NCT00537316|64993019|FG002|Part 1|Protocol defined clinical event|0|||
23341608|NCT00537316|64993020|FG003|Part 1|Protocol defined clinical event|0|||
23341609|NCT00537316|64993021|FG004|Part 1|Protocol defined clinical event|0|||
23341610|NCT00537316|64993022|FG005|Part 1|Protocol defined clinical event|0|||
23341611|NCT00537316|64993023|FG006|Part 1|Protocol defined clinical event|0|||
23341612|NCT00537316|64993017|FG000|Part 1|Lost to Follow-up|1|||
23341613|NCT00537316|64993018|FG001|Part 1|Lost to Follow-up|0|||
23341614|NCT00537316|64993019|FG002|Part 1|Lost to Follow-up|0|||
23341615|NCT00537316|64993020|FG003|Part 1|Lost to Follow-up|0|||
23341616|NCT00537316|64993021|FG004|Part 1|Lost to Follow-up|0|||
23341617|NCT00537316|64993022|FG005|Part 1|Lost to Follow-up|0|||
23341618|NCT00537316|64993023|FG006|Part 1|Lost to Follow-up|0|||
23341619|NCT00537316|64993017|FG000|Part 1|Withdrawal by Subject|3|||
23341620|NCT00537316|64993018|FG001|Part 1|Withdrawal by Subject|8|||
23341621|NCT00537316|64993019|FG002|Part 1|Withdrawal by Subject|4|||
23341622|NCT00537316|64993020|FG003|Part 1|Withdrawal by Subject|0|||
23341623|NCT00537316|64993021|FG004|Part 1|Withdrawal by Subject|0|||
23341624|NCT00537316|64993022|FG005|Part 1|Withdrawal by Subject|0|||
23341625|NCT00537316|64993023|FG006|Part 1|Withdrawal by Subject|0|||
23341626|NCT00537316|64993017|FG000|Part 1|Protocol Violation|1|||
23341627|NCT00537316|64993018|FG001|Part 1|Protocol Violation|5|||
23341628|NCT00537316|64993019|FG002|Part 1|Protocol Violation|1|||
23341629|NCT00537316|64993020|FG003|Part 1|Protocol Violation|0|||
23341630|NCT00537316|64993021|FG004|Part 1|Protocol Violation|0|||
23341631|NCT00537316|64993022|FG005|Part 1|Protocol Violation|0|||
23341632|NCT00537316|64993023|FG006|Part 1|Protocol Violation|0|||
23341633|NCT00537316|64993017|FG000|Part 1|Did not meet protocol eligibility|1|||
23341634|NCT00537316|64993018|FG001|Part 1|Did not meet protocol eligibility|3|||
23341635|NCT00537316|64993019|FG002|Part 1|Did not meet protocol eligibility|2|||
23341636|NCT00537316|64993020|FG003|Part 1|Did not meet protocol eligibility|0|||
23341637|NCT00537316|64993021|FG004|Part 1|Did not meet protocol eligibility|0|||
23341638|NCT00537316|64993022|FG005|Part 1|Did not meet protocol eligibility|0|||
23341639|NCT00537316|64993023|FG006|Part 1|Did not meet protocol eligibility|0|||
23341640|NCT00537316|64993017|FG000|Part 1|Administrative|0|||
23341641|NCT00537316|64993018|FG001|Part 1|Administrative|0|||
23341642|NCT00537316|64993019|FG002|Part 1|Administrative|2|||
23341643|NCT00537316|64993020|FG003|Part 1|Administrative|0|||
23341644|NCT00537316|64993021|FG004|Part 1|Administrative|0|||
23341645|NCT00537316|64993022|FG005|Part 1|Administrative|0|||
23341646|NCT00537316|64993023|FG006|Part 1|Administrative|0|||
23341647|NCT00537316|64993017|FG000|Part 2|Never entered follow-up|0|||
23341648|NCT00537316|64993018|FG001|Part 2|Never entered follow-up|0|||
23341649|NCT00537316|64993019|FG002|Part 2|Never entered follow-up|0|||
23341650|NCT00537316|64993020|FG003|Part 2|Never entered follow-up|0|||
23341651|NCT00537316|64993021|FG004|Part 2|Never entered follow-up|0|||
23341652|NCT00537316|64993022|FG005|Part 2|Never entered follow-up|0|||
23341653|NCT00537316|64993023|FG006|Part 2|Never entered follow-up|1|||
23341654|NCT00537316|64993017|FG000|Part 2|Adverse Event|4|||
23341655|NCT00537316|64993018|FG001|Part 2|Adverse Event|0|||
23341656|NCT00537316|64993019|FG002|Part 2|Adverse Event|2|||
23341657|NCT00537316|64993020|FG003|Part 2|Adverse Event|0|||
23341658|NCT00537316|64993021|FG004|Part 2|Adverse Event|0|||
23341659|NCT00537316|64993022|FG005|Part 2|Adverse Event|0|||
23341660|NCT00537316|64993023|FG006|Part 2|Adverse Event|0|||
23341661|NCT00537316|64993017|FG000|Part 2|Lost to Follow-up|1|||
23341662|NCT00537316|64993018|FG001|Part 2|Lost to Follow-up|0|||
23453981|NCT02718898|65403441|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
23453982|NCT02718898|65403442|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
23453983|NCT02718898|65403443|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
23341663|NCT00537316|64993019|FG002|Part 2|Lost to Follow-up|2|||
23341664|NCT00537316|64993020|FG003|Part 2|Lost to Follow-up|0|||
23341665|NCT00537316|64993021|FG004|Part 2|Lost to Follow-up|0|||
23341666|NCT00537316|64993022|FG005|Part 2|Lost to Follow-up|0|||
23341667|NCT00537316|64993023|FG006|Part 2|Lost to Follow-up|0|||
23341668|NCT00537316|64993017|FG000|Part 2|Withdrawal by Subject|5|||
23341669|NCT00537316|64993018|FG001|Part 2|Withdrawal by Subject|1|||
23341670|NCT00537316|64993019|FG002|Part 2|Withdrawal by Subject|4|||
23341671|NCT00537316|64993020|FG003|Part 2|Withdrawal by Subject|0|||
23341672|NCT00537316|64993021|FG004|Part 2|Withdrawal by Subject|0|||
23341673|NCT00537316|64993022|FG005|Part 2|Withdrawal by Subject|0|||
23341674|NCT00537316|64993023|FG006|Part 2|Withdrawal by Subject|0|||
23341675|NCT00537316|64993017|FG000|Part 2|Administrative|16|||
23341676|NCT00537316|64993018|FG001|Part 2|Administrative|8|||
23341677|NCT00537316|64993019|FG002|Part 2|Administrative|24|||
23453984|NCT02718898|65403444|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
23453985|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23453986|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23453987|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
23453988|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
23176380|NCT01262976|64386755|FG004|Up to Month 2|Withdrawal by Subject|0|||
23176381|NCT01262976|64386756|FG005|Up to Month 2|Withdrawal by Subject|0|||
23176382|NCT01262976|64386751|FG000|Up to Month 2|Migrated/moved from study area|0|||
23176383|NCT01262976|64386752|FG001|Up to Month 2|Migrated/moved from study area|1|||
23176384|NCT01262976|64386753|FG002|Up to Month 2|Migrated/moved from study area|0|||
23453989|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23453990|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23453991|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
23582381|NCT01120275|65862467|FG000|Overall Study|Progression|27|||
23582382|NCT01120275|65862467|FG000|Overall Study|Ineligible|3|||
23582383|NCT01120275|65862467|FG000|Overall Study|Withdrawal by Subject|1|||
23582384|NCT01120275|65862467|FG000|Overall Study|Refusal|1|||
23582385|NCT01120275|65862467|FG000|Overall Study|Not specific|1|||
23582386|NCT01674569|65862469|FG000|Overall Study|Adverse Event|0|||
23582387|NCT01674569|65862470|FG001|Overall Study|Adverse Event|2|||
23582388|NCT01674569|65862471|FG002|Overall Study|Adverse Event|0|||
23582389|NCT01674569|65862472|FG003|Overall Study|Adverse Event|1|||
23582390|NCT01674569|65862473|FG004|Overall Study|Adverse Event|2|||
23582391|NCT01674569|65862474|FG005|Overall Study|Adverse Event|2|||
23582392|NCT01674569|65862469|FG000|Overall Study|Protocol Violation|0|||
23582393|NCT01674569|65862470|FG001|Overall Study|Protocol Violation|1|||
23582394|NCT01674569|65862471|FG002|Overall Study|Protocol Violation|1|||
23582395|NCT01674569|65862472|FG003|Overall Study|Protocol Violation|0|||
23582396|NCT01674569|65862473|FG004|Overall Study|Protocol Violation|0|||
23582397|NCT01674569|65862474|FG005|Overall Study|Protocol Violation|0|||
23341678|NCT00537316|64993020|FG003|Part 2|Administrative|3|||
23341679|NCT00537316|64993021|FG004|Part 2|Administrative|1|||
23341680|NCT00537316|64993022|FG005|Part 2|Administrative|4|||
23341681|NCT00537316|64993023|FG006|Part 2|Administrative|1|||
23341682|NCT05845567|64993029|FG000|Overall Study|Withdrawal by Subject|1|||
23341683|NCT03193801|64993030|FG000|Overall Study|Physician Decision|2|||
23341684|NCT03193801|64993030|FG000|Overall Study|Withdrawal by Subject|1|||
23341685|NCT05148234|64993031|FG000|Phase I|Ineligible|0|||
23341686|NCT05148234|64993032|FG001|Phase I|Ineligible|0|||
23341687|NCT05148234|64993033|FG002|Phase I|Ineligible|0|||
23341688|NCT05148234|64993034|FG003|Phase I|Ineligible|0|||
23341689|NCT05148234|64993035|FG004|Phase I|Ineligible|0|||
23341690|NCT05148234|64993036|FG005|Phase I|Ineligible|0|||
23341691|NCT05148234|64993037|FG006|Phase I|Ineligible|0|||
23341692|NCT05148234|64993038|FG007|Phase I|Ineligible|1|||
23341693|NCT05148234|64993031|FG000|Phase I|Company closed the trial.|0|||
23341694|NCT05148234|64993032|FG001|Phase I|Company closed the trial.|1|||
23341695|NCT05148234|64993033|FG002|Phase I|Company closed the trial.|0|||
23341696|NCT05148234|64993034|FG003|Phase I|Company closed the trial.|0|||
23341697|NCT05148234|64993035|FG004|Phase I|Company closed the trial.|0|||
23341698|NCT05148234|64993036|FG005|Phase I|Company closed the trial.|0|||
23341699|NCT05148234|64993037|FG006|Phase I|Company closed the trial.|0|||
23341700|NCT05148234|64993038|FG007|Phase I|Company closed the trial.|0|||
23341701|NCT02655016|64993039|FG000|Overall Study|Disease progression|6|||
23341702|NCT02655016|64993040|FG001|Overall Study|Disease progression|4|||
23341703|NCT02655016|64993039|FG000|Overall Study|Site closed|0|||
23341704|NCT02655016|64993040|FG001|Overall Study|Site closed|1|||
23341705|NCT02655016|64993039|FG000|Overall Study|Death|30|||
23341706|NCT02655016|64993040|FG001|Overall Study|Death|48|||
23341707|NCT02655016|64993039|FG000|Overall Study|Lost to Follow-up|1|||
23341708|NCT02655016|64993040|FG001|Overall Study|Lost to Follow-up|1|||
23341709|NCT02655016|64993039|FG000|Overall Study|Withdrawal by Subject|18|||
23341710|NCT02655016|64993040|FG001|Overall Study|Withdrawal by Subject|36|||
23341711|NCT05239494|64995898|FG000|Overall Study|Lost to Follow-up|1|||
23341712|NCT02855359|64995899|FG000|Overall Study|Death|2|||
23341713|NCT02855359|64995900|FG001|Overall Study|Death|2|||
23341714|NCT02855359|64995901|FG002|Overall Study|Death|0|||
23341715|NCT02855359|64995902|FG003|Overall Study|Death|0|||
23341716|NCT02855359|64995899|FG000|Overall Study|Study Termination by Sponsor|9|||
23341717|NCT02855359|64995900|FG001|Overall Study|Study Termination by Sponsor|11|||
23341718|NCT02855359|64995901|FG002|Overall Study|Study Termination by Sponsor|0|||
23341719|NCT02855359|64995902|FG003|Overall Study|Study Termination by Sponsor|0|||
23341720|NCT03721835|64995903|FG000|Overall Study|Participant not able to return|1|||
23341721|NCT03721835|64995903|FG000|Overall Study|Lost to Follow-up|1|||
23341722|NCT03721835|64995903|FG000|Overall Study|Revision of the components of the study device|2|||
23341723|NCT03721835|64995903|FG000|Overall Study|Sponsor terminated study|6|||
23341724|NCT03721835|64995903|FG000|Overall Study|Death|1|||
23341725|NCT03721835|64995903|FG000|Overall Study|Sponsor decision|1|||
23341726|NCT01676896|64995904|FG000|Overall Study|Withdrawal by Subject|12|||
23341727|NCT01676896|64995905|FG001|Overall Study|Withdrawal by Subject|7|||
23341728|NCT01676896|64995906|FG002|Overall Study|Withdrawal by Subject|19|||
23341729|NCT02234596|64995907|FG000|Overall Study|Participant not treated|2|||
23341730|NCT03020199|64995910|FG000|Treatment Period|Adverse Event|0|||
23341731|NCT03020199|64995911|FG001|Treatment Period|Adverse Event|2|||
23341732|NCT03020199|64995910|FG000|Treatment Period|Lack of Efficacy|1|||
23341733|NCT03020199|64995911|FG001|Treatment Period|Lack of Efficacy|6|||
23341734|NCT03020199|64995910|FG000|Treatment Period|Lost to Follow-up|1|||
23341735|NCT03020199|64995911|FG001|Treatment Period|Lost to Follow-up|6|||
23341736|NCT03020199|64995910|FG000|Treatment Period|Physician Decision|0|||
23341737|NCT03020199|64995911|FG001|Treatment Period|Physician Decision|1|||
23341738|NCT03020199|64995910|FG000|Treatment Period|Subject/guardian decision|8|||
23341739|NCT03020199|64995911|FG001|Treatment Period|Subject/guardian decision|15|||
23341740|NCT03020199|64995910|FG000|Treatment Period|Subjects not treated|3|||
23341741|NCT03020199|64995911|FG001|Treatment Period|Subjects not treated|4|||
23341742|NCT03020199|64995910|FG000|Follow-up Period|Disease relapse|32|||
23341743|NCT03020199|64995911|FG001|Follow-up Period|Disease relapse|7|||
23582398|NCT01674569|65862469|FG000|Overall Study|Withdrawal by Subject|0|||
23341744|NCT03020199|64995910|FG000|Follow-up Period|Lack of Efficacy|1|||
23341745|NCT03020199|64995911|FG001|Follow-up Period|Lack of Efficacy|2|||
23341746|NCT03020199|64995910|FG000|Follow-up Period|Lost to Follow-up|4|||
23341747|NCT03020199|64995911|FG001|Follow-up Period|Lost to Follow-up|6|||
23341748|NCT03020199|64995910|FG000|Follow-up Period|Physician Decision|2|||
23453992|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23341749|NCT03020199|64995911|FG001|Follow-up Period|Physician Decision|2|||
23341750|NCT03020199|64995910|FG000|Follow-up Period|Protocol Violation|1|||
23341751|NCT03020199|64995911|FG001|Follow-up Period|Protocol Violation|2|||
23341752|NCT03020199|64995910|FG000|Follow-up Period|Study terminated by Sponsor|6|||
23341753|NCT03020199|64995911|FG001|Follow-up Period|Study terminated by Sponsor|3|||
23341754|NCT03020199|64995910|FG000|Follow-up Period|Subject/guardian decision|14|||
23341755|NCT03020199|64995911|FG001|Follow-up Period|Subject/guardian decision|9|||
23341756|NCT04083235|64995912|FG000|Overall Study|Death|252|||
23341757|NCT04083235|64995913|FG001|Overall Study|Death|277|||
23341758|NCT04083235|64995912|FG000|Overall Study|Withdrawal by Subject|13|||
23341759|NCT04083235|64995913|FG001|Overall Study|Withdrawal by Subject|17|||
23341760|NCT04083235|64995912|FG000|Overall Study|Lost to Follow-up|1|||
23341761|NCT04083235|64995913|FG001|Overall Study|Lost to Follow-up|1|||
23341762|NCT04083235|64995912|FG000|Overall Study|Does not meet entry criteria|1|||
23341763|NCT04083235|64995913|FG001|Overall Study|Does not meet entry criteria|0|||
23341764|NCT04083235|64995912|FG000|Overall Study|Did not receive treatment|13|||
23341765|NCT04083235|64995913|FG001|Overall Study|Did not receive treatment|8|||
23341766|NCT04083235|64995912|FG000|Overall Study|Ongoing at the time of DCO|44|||
23341767|NCT04083235|64995913|FG001|Overall Study|Ongoing at the time of DCO|7|||
23341768|NCT00380081|64995914|FG000|Overall Study|Withdrawal by Subject|0|||
23341769|NCT00380081|64995915|FG001|Overall Study|Withdrawal by Subject|0|||
23341770|NCT00380081|64995916|FG002|Overall Study|Withdrawal by Subject|0|||
23341771|NCT00380081|64995917|FG003|Overall Study|Withdrawal by Subject|0|||
23341772|NCT00380081|64995918|FG004|Overall Study|Withdrawal by Subject|1|||
23341773|NCT00380081|64995919|FG005|Overall Study|Withdrawal by Subject|0|||
23341774|NCT00380081|64995914|FG000|Overall Study|Family Emergency|0|||
23341775|NCT00380081|64995915|FG001|Overall Study|Family Emergency|0|||
23341776|NCT00380081|64995916|FG002|Overall Study|Family Emergency|0|||
23341777|NCT00380081|64995917|FG003|Overall Study|Family Emergency|0|||
23341778|NCT00380081|64995918|FG004|Overall Study|Family Emergency|0|||
23341779|NCT00380081|64995919|FG005|Overall Study|Family Emergency|1|||
23341780|NCT03201874|64995920|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
23341781|NCT03201874|64995921|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
23341782|NCT03201874|64995920|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
23341783|NCT03201874|64995921|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
23341784|NCT01869699|64995924|FG000|Overall Study|Withdrawal by Subject|1|||
23341785|NCT01869699|64995925|FG001|Overall Study|Withdrawal by Subject|0|||
23341786|NCT02253316|64995928|FG000|Consolidation|Progression|4|||
23341787|NCT02253316|64995929|FG001|Consolidation|Progression|0|||
23341788|NCT02253316|64995930|FG002|Consolidation|Progression|0|||
23341789|NCT02253316|64995928|FG000|Consolidation|Non-Compliance|1|||
23341790|NCT02253316|64995929|FG001|Consolidation|Non-Compliance|0|||
23341791|NCT02253316|64995930|FG002|Consolidation|Non-Compliance|0|||
23341792|NCT02253316|64995928|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
23341793|NCT02253316|64995929|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
23341794|NCT02253316|64995930|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
23341795|NCT02253316|64995928|FG000|Consolidation|Secondary Malignancy|2|||
23341796|NCT02253316|64995929|FG001|Consolidation|Secondary Malignancy|0|||
23341797|NCT02253316|64995930|FG002|Consolidation|Secondary Malignancy|0|||
23341798|NCT02253316|64995928|FG000|Consolidation|Adverse Event|7|||
23341799|NCT02253316|64995929|FG001|Consolidation|Adverse Event|0|||
23341800|NCT02253316|64995930|FG002|Consolidation|Adverse Event|0|||
23341801|NCT02253316|64995928|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
23341802|NCT02253316|64995929|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
23341803|NCT02253316|64995930|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
23341804|NCT02253316|64995928|FG000|Maintenance|Physician Decision|0|||
23341805|NCT02253316|64995929|FG001|Maintenance|Physician Decision|7|||
23341806|NCT02253316|64995930|FG002|Maintenance|Physician Decision|16|||
23341807|NCT02253316|64995928|FG000|Maintenance|Non-Compliance|0|||
23341808|NCT02253316|64995929|FG001|Maintenance|Non-Compliance|1|||
23341809|NCT02253316|64995930|FG002|Maintenance|Non-Compliance|1|||
23453993|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23453994|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23453995|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
23341810|NCT02253316|64995928|FG000|Maintenance|Secondary Malignancy|0|||
23341811|NCT02253316|64995929|FG001|Maintenance|Secondary Malignancy|2|||
23341812|NCT02253316|64995930|FG002|Maintenance|Secondary Malignancy|6|||
23341813|NCT02253316|64995928|FG000|Maintenance|Adverse Event|0|||
23341814|NCT02253316|64995929|FG001|Maintenance|Adverse Event|8|||
23341815|NCT02253316|64995930|FG002|Maintenance|Adverse Event|12|||
23341816|NCT02253316|64995928|FG000|Maintenance|Still receiving active treatment|0|||
23341817|NCT02253316|64995929|FG001|Maintenance|Still receiving active treatment|5|||
23341818|NCT02253316|64995930|FG002|Maintenance|Still receiving active treatment|0|||
23453996|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23341819|NCT00546117|64995931|FG000|Overall Study|Withdrawal by Subject|3|||
23341820|NCT00546117|64995932|FG001|Overall Study|Withdrawal by Subject|0|||
23341821|NCT00546117|64995931|FG000|Overall Study|Inability to schedule follow-up visit|1|||
23341822|NCT00546117|64995932|FG001|Overall Study|Inability to schedule follow-up visit|0|||
23341823|NCT01123941|64995936|FG000|Overall Study|Lost to Follow-up|2|||
23341824|NCT01123941|64995937|FG001|Overall Study|Lost to Follow-up|1|||
23341825|NCT02836236|64995938|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
23341826|NCT02836236|64995939|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
23341827|NCT02836236|64995940|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
23341828|NCT02836236|64995941|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
23341829|NCT02836236|64995938|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
23341830|NCT02836236|64995939|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
23341831|NCT02836236|64995940|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
23341832|NCT02836236|64995941|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
23341833|NCT02836236|64995938|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
23341834|NCT02836236|64995939|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
23341835|NCT02836236|64995940|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
23341836|NCT02836236|64995941|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23341837|NCT02836236|64995938|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
23341838|NCT02836236|64995939|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23341839|NCT02836236|64995940|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23341840|NCT02836236|64995941|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23341841|NCT02836236|64995938|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
23341842|NCT02836236|64995939|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
23341843|NCT02836236|64995940|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
23341844|NCT02836236|64995941|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
23341845|NCT02836236|64995938|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
23341846|NCT02836236|64995939|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
23341847|NCT02836236|64995940|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
23341848|NCT02836236|64995941|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
23341849|NCT02836236|64995938|FG000|Open-Label TAF Treatment Phase|Death|0|||
23341850|NCT02836236|64995939|FG001|Open-Label TAF Treatment Phase|Death|0|||
23341851|NCT02836236|64995940|FG002|Open-Label TAF Treatment Phase|Death|1|||
23341852|NCT02836236|64995941|FG003|Open-Label TAF Treatment Phase|Death|1|||
23341853|NCT02836236|64995938|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
23341854|NCT02836236|64995939|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
23341855|NCT02836236|64995940|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
23341856|NCT02836236|64995941|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
23341857|NCT00614120|64995944|FG000|Overall Study|Adverse Event|9|||
23341858|NCT00614120|64995945|FG001|Overall Study|Adverse Event|22|||
23341859|NCT00614120|64995946|FG002|Overall Study|Adverse Event|30|||
23341860|NCT00614120|64995947|FG003|Overall Study|Adverse Event|3|||
23341861|NCT00614120|64995944|FG000|Overall Study|Lack of Efficacy|3|||
23341862|NCT00614120|64995945|FG001|Overall Study|Lack of Efficacy|3|||
23341863|NCT00614120|64995946|FG002|Overall Study|Lack of Efficacy|2|||
23341864|NCT00614120|64995947|FG003|Overall Study|Lack of Efficacy|2|||
23341865|NCT00614120|64995944|FG000|Overall Study|Protocol Violation|2|||
23341866|NCT00614120|64995945|FG001|Overall Study|Protocol Violation|5|||
23341867|NCT00614120|64995946|FG002|Overall Study|Protocol Violation|3|||
23341868|NCT00614120|64995947|FG003|Overall Study|Protocol Violation|1|||
23341869|NCT00614120|64995944|FG000|Overall Study|Withdrawal criteria|1|||
23341870|NCT00614120|64995945|FG001|Overall Study|Withdrawal criteria|0|||
23341871|NCT00614120|64995946|FG002|Overall Study|Withdrawal criteria|0|||
23341872|NCT00614120|64995947|FG003|Overall Study|Withdrawal criteria|0|||
23341873|NCT00614120|64995944|FG000|Overall Study|Withdrawal by Subject|9|||
23341874|NCT00614120|64995945|FG001|Overall Study|Withdrawal by Subject|10|||
23341875|NCT00614120|64995946|FG002|Overall Study|Withdrawal by Subject|16|||
23341876|NCT00614120|64995947|FG003|Overall Study|Withdrawal by Subject|3|||
23453997|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23453998|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
23341877|NCT00614120|64995944|FG000|Overall Study|Did not meet trial criteria|0|||
23341878|NCT00614120|64995945|FG001|Overall Study|Did not meet trial criteria|1|||
23341879|NCT00614120|64995946|FG002|Overall Study|Did not meet trial criteria|1|||
23341880|NCT00614120|64995947|FG003|Overall Study|Did not meet trial criteria|1|||
23341881|NCT00614120|64995944|FG000|Overall Study|hCG positive (not pregnant)|0|||
23341882|NCT00614120|64995945|FG001|Overall Study|hCG positive (not pregnant)|0|||
23341883|NCT00614120|64995946|FG002|Overall Study|hCG positive (not pregnant)|1|||
23341884|NCT00614120|64995947|FG003|Overall Study|hCG positive (not pregnant)|0|||
23341885|NCT00614120|64995944|FG000|Overall Study|Hypoglycaemia|0|||
23341886|NCT00614120|64995945|FG001|Overall Study|Hypoglycaemia|0|||
23341887|NCT00614120|64995946|FG002|Overall Study|Hypoglycaemia|0|||
23341888|NCT00614120|64995947|FG003|Overall Study|Hypoglycaemia|1|||
23341889|NCT00614120|64995944|FG000|Overall Study|Lack of trial product|3|||
23341890|NCT00614120|64995945|FG001|Overall Study|Lack of trial product|3|||
23341891|NCT00614120|64995946|FG002|Overall Study|Lack of trial product|2|||
23341892|NCT00614120|64995947|FG003|Overall Study|Lack of trial product|0|||
23341893|NCT00614120|64995944|FG000|Overall Study|Late syphilis, latent|1|||
23341894|NCT00614120|64995945|FG001|Overall Study|Late syphilis, latent|0|||
23341895|NCT00614120|64995946|FG002|Overall Study|Late syphilis, latent|0|||
23341896|NCT00614120|64995947|FG003|Overall Study|Late syphilis, latent|0|||
23341897|NCT00614120|64995944|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
23341898|NCT00614120|64995945|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
23341899|NCT00614120|64995946|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
23341900|NCT00614120|64995947|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
23341901|NCT00614120|64995944|FG000|Overall Study|Lost to Follow-up|1|||
23341902|NCT00614120|64995945|FG001|Overall Study|Lost to Follow-up|2|||
23341903|NCT00614120|64995946|FG002|Overall Study|Lost to Follow-up|3|||
23341904|NCT00614120|64995947|FG003|Overall Study|Lost to Follow-up|4|||
23341905|NCT01137110|64995948|FG000|Overall Study|Protocol Violation|1|||
23341906|NCT01137110|64995949|FG001|Overall Study|Protocol Violation|0|||
23341907|NCT00808639|64995955|FG000|Overall Study|Disease progression before surgery.|1|||
23341908|NCT02662764|64995957|FG000|Overall Study|Adverse Event|6|||
23341909|NCT02662764|64995957|FG000|Overall Study|Lack of Efficacy|8|||
23341910|NCT02662764|64995957|FG000|Overall Study|Protocol Violation|1|||
23341911|NCT02662764|64995957|FG000|Overall Study|Withdrawal by Subject|5|||
23341912|NCT02662764|64995957|FG000|Overall Study|Device failure|4|||
23341913|NCT02662764|64995957|FG000|Overall Study|Patient changed treatment|1|||
23341914|NCT02662764|64995957|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
23341915|NCT00759785|64995960|FG000|Overall Study|Participant sample not evaluable|11|||
23341916|NCT00759785|64995961|FG001|Overall Study|Participant sample not evaluable|2|||
23341917|NCT00759785|64995960|FG000|Overall Study|Participant sample lost|0|||
23341918|NCT00759785|64995961|FG001|Overall Study|Participant sample lost|1|||
23341919|NCT00759785|64995960|FG000|Overall Study|Protocol Violation|1|||
23341920|NCT00759785|64995961|FG001|Overall Study|Protocol Violation|0|||
23341921|NCT00759785|64995960|FG000|Overall Study|Physician Decision|0|||
23341922|NCT00759785|64995961|FG001|Overall Study|Physician Decision|1|||
23341923|NCT00759785|64995960|FG000|Overall Study|Withdrawal by Subject|0|||
23341924|NCT00759785|64995961|FG001|Overall Study|Withdrawal by Subject|1|||
23341925|NCT01901653|64995964|FG000|Overall Study|Death|2|||
23341926|NCT01901653|64995965|FG001|Overall Study|Death|1|||
23341927|NCT01901653|64995966|FG002|Overall Study|Death|8|||
23341928|NCT01901653|64995967|FG003|Overall Study|Death|3|||
23341929|NCT01901653|64995968|FG004|Overall Study|Death|2|||
23341930|NCT01901653|64995969|FG005|Overall Study|Death|2|||
23341931|NCT01901653|64995970|FG006|Overall Study|Death|6|||
23341932|NCT01901653|64995971|FG007|Overall Study|Death|9|||
23341933|NCT01901653|64995972|FG008|Overall Study|Death|1|||
23341934|NCT01901653|64995973|FG009|Overall Study|Death|16|||
23341935|NCT01901653|64995974|FG010|Overall Study|Death|2|||
23341936|NCT01901653|64995975|FG011|Overall Study|Death|15|||
23341937|NCT01901653|64995976|FG012|Overall Study|Death|4|||
23341938|NCT01901653|64995964|FG000|Overall Study|Lost to Follow-up|1|||
23341939|NCT01901653|64995965|FG001|Overall Study|Lost to Follow-up|0|||
23341940|NCT01901653|64995966|FG002|Overall Study|Lost to Follow-up|2|||
23341941|NCT01901653|64995967|FG003|Overall Study|Lost to Follow-up|0|||
23341942|NCT01901653|64995968|FG004|Overall Study|Lost to Follow-up|0|||
23341943|NCT01901653|64995969|FG005|Overall Study|Lost to Follow-up|1|||
23341944|NCT01901653|64995970|FG006|Overall Study|Lost to Follow-up|0|||
23341945|NCT01901653|64995971|FG007|Overall Study|Lost to Follow-up|1|||
23341946|NCT01901653|64995972|FG008|Overall Study|Lost to Follow-up|0|||
23341947|NCT01901653|64995973|FG009|Overall Study|Lost to Follow-up|0|||
23341948|NCT01901653|64995974|FG010|Overall Study|Lost to Follow-up|0|||
23341949|NCT01901653|64995975|FG011|Overall Study|Lost to Follow-up|0|||
23341950|NCT01901653|64995976|FG012|Overall Study|Lost to Follow-up|0|||
23341951|NCT01901653|64995964|FG000|Overall Study|Withdrawal by Subject|0|||
23341952|NCT01901653|64995965|FG001|Overall Study|Withdrawal by Subject|0|||
23341953|NCT01901653|64995966|FG002|Overall Study|Withdrawal by Subject|0|||
23341954|NCT01901653|64995967|FG003|Overall Study|Withdrawal by Subject|0|||
23341955|NCT01901653|64995968|FG004|Overall Study|Withdrawal by Subject|0|||
23341956|NCT01901653|64995969|FG005|Overall Study|Withdrawal by Subject|0|||
23341957|NCT01901653|64995970|FG006|Overall Study|Withdrawal by Subject|1|||
23341958|NCT01901653|64995971|FG007|Overall Study|Withdrawal by Subject|0|||
23341959|NCT01901653|64995972|FG008|Overall Study|Withdrawal by Subject|0|||
23341960|NCT01901653|64995973|FG009|Overall Study|Withdrawal by Subject|0|||
23341961|NCT01901653|64995974|FG010|Overall Study|Withdrawal by Subject|0|||
23341962|NCT01901653|64995975|FG011|Overall Study|Withdrawal by Subject|0|||
23341963|NCT01901653|64995976|FG012|Overall Study|Withdrawal by Subject|0|||
23341964|NCT01901653|64995964|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
23341965|NCT01901653|64995965|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
23341966|NCT01901653|64995966|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
23341967|NCT01901653|64995967|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
23341968|NCT01901653|64995968|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
23341969|NCT01901653|64995969|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
23341970|NCT01901653|64995970|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
23341971|NCT01901653|64995971|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
23341972|NCT01901653|64995972|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
23341973|NCT01901653|64995973|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
23341974|NCT01901653|64995974|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
23341975|NCT01901653|64995975|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
23341976|NCT01901653|64995976|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
23341977|NCT04439123|64995978|FG000|Overall Study|Adverse Event|11|||
23341978|NCT04439123|64995978|FG000|Overall Study|Death|1|||
23341979|NCT04439123|64995978|FG000|Overall Study|Disease progression|19|||
23341980|NCT04439123|64995978|FG000|Overall Study|Withdrawal by Subject|2|||
23341981|NCT04439123|64995978|FG000|Overall Study|Still on treatment|2|||
23341982|NCT03533114|64995979|FG000|Overall|Adverse Event|16|||
23341983|NCT03533114|64995980|FG001|Overall|Adverse Event|11|||
23341984|NCT03533114|64995979|FG000|Overall|Consent Withdrawal by Participant|7|||
23341985|NCT03533114|64995980|FG001|Overall|Consent Withdrawal by Participant|6|||
23341986|NCT03533114|64995979|FG000|Overall|Lack of Efficacy|5|||
23341987|NCT03533114|64995980|FG001|Overall|Lack of Efficacy|3|||
23341988|NCT03533114|64995979|FG000|Overall|Lost to Follow-up|1|||
23341989|NCT03533114|64995980|FG001|Overall|Lost to Follow-up|1|||
23341990|NCT03533114|64995979|FG000|Overall|Physician Decision|0|||
23341991|NCT03533114|64995980|FG001|Overall|Physician Decision|2|||
23341992|NCT03533114|64995979|FG000|Overall|Protocol deviation|1|||
23341993|NCT03533114|64995980|FG001|Overall|Protocol deviation|1|||
23341994|NCT03533114|64995979|FG000|Overall|Failure to meet randomization criteria|1|||
23341995|NCT03533114|64995980|FG001|Overall|Failure to meet randomization criteria|2|||
23341996|NCT03533114|64995979|FG000|Overall|Non-Compliance with study drug|0|||
23341997|NCT03533114|64995980|FG001|Overall|Non-Compliance with study drug|1|||
23341998|NCT03533114|64995979|FG000|Overall|Other|0|||
23341999|NCT03533114|64995980|FG001|Overall|Other|1|||
23342000|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Adverse Event|11|||
23342001|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Adverse Event|8|||
23342002|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
23342003|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
23342004|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
23342005|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
23342006|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
23342007|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
23342008|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
23342009|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
23342010|NCT03533114|64995979|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
23342011|NCT03533114|64995980|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
23342012|NCT03533114|64995979|FG000|Stable Dose|Adverse Event|0|||
23342013|NCT03533114|64995980|FG001|Stable Dose|Adverse Event|2|||
23342014|NCT03533114|64995979|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
23342015|NCT03533114|64995980|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
23342016|NCT03533114|64995979|FG000|Stable Dose|Lack of Efficacy|1|||
23453999|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454000|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454001|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
23454002|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
23454003|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454004|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454005|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23454006|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454007|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454008|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
23454009|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
23454010|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454011|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454012|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
23454013|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454014|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454015|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454016|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
23342017|NCT03533114|64995980|FG001|Stable Dose|Lack of Efficacy|0|||
23342018|NCT03533114|64995979|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
23342019|NCT03533114|64995980|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
23342020|NCT03533114|64995979|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
23342021|NCT03533114|64995980|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
23342022|NCT03533114|64995979|FG000|Open-Label Safety Extension|Adverse Event|3|||
23342023|NCT03533114|64995980|FG001|Open-Label Safety Extension|Adverse Event|0|||
23342024|NCT03533114|64995979|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
23454017|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454018|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23454019|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
23342025|NCT03533114|64995980|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
23454020|NCT02718898|65403438|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454021|NCT02718898|65403439|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454022|NCT02718898|65403440|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454023|NCT02718898|65403441|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
23454024|NCT02718898|65403442|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454025|NCT02718898|65403443|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454026|NCT02718898|65403444|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
23454027|NCT02718898|65403438|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
23454028|NCT02718898|65403439|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
23454029|NCT02718898|65403440|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
23454030|NCT02718898|65403441|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
23454031|NCT02718898|65403442|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
23454032|NCT02718898|65403443|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
23454033|NCT02718898|65403444|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
23454034|NCT02718898|65403438|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
23454035|NCT02718898|65403439|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
23454036|NCT02718898|65403440|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
23454037|NCT02718898|65403441|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
23454038|NCT02718898|65403442|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
23454039|NCT02718898|65403443|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
23342026|NCT03533114|64995979|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
23342027|NCT03533114|64995980|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
23342028|NCT03533114|64995979|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
23342029|NCT03533114|64995980|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
23342030|NCT03533114|64995979|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
23342031|NCT03533114|64995980|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
23342032|NCT00782184|64995981|FG000|Overall Study|Adverse Event|1|||
23342033|NCT00782184|64995982|FG001|Overall Study|Adverse Event|2|||
23342034|NCT00782184|64995981|FG000|Overall Study|Protocol Violation|0|||
23342035|NCT00782184|64995982|FG001|Overall Study|Protocol Violation|1|||
23342036|NCT00782184|64995981|FG000|Overall Study|Withdrawal by Subject|3|||
23342037|NCT00782184|64995982|FG001|Overall Study|Withdrawal by Subject|2|||
23454040|NCT02718898|65403444|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
23454041|NCT02718898|65403438|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23454042|NCT02718898|65403439|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23176385|NCT01262976|64386754|FG003|Up to Month 2|Migrated/moved from study area|0|||
23176386|NCT01262976|64386755|FG004|Up to Month 2|Migrated/moved from study area|1|||
23176387|NCT01262976|64386756|FG005|Up to Month 2|Migrated/moved from study area|1|||
23176388|NCT01262976|64386751|FG000|Up to Month 2|Lost to Follow-up|1|||
23176389|NCT01262976|64386752|FG001|Up to Month 2|Lost to Follow-up|0|||
23176390|NCT01262976|64386753|FG002|Up to Month 2|Lost to Follow-up|0|||
23176391|NCT01262976|64386754|FG003|Up to Month 2|Lost to Follow-up|1|||
23176392|NCT01262976|64386755|FG004|Up to Month 2|Lost to Follow-up|1|||
23176393|NCT01262976|64386756|FG005|Up to Month 2|Lost to Follow-up|1|||
23176394|NCT01262976|64386751|FG000|Up to Month 2|Other|1|||
23176395|NCT01262976|64386752|FG001|Up to Month 2|Other|0|||
23176396|NCT01262976|64386753|FG002|Up to Month 2|Other|0|||
23176397|NCT01262976|64386754|FG003|Up to Month 2|Other|1|||
23176398|NCT01262976|64386755|FG004|Up to Month 2|Other|0|||
23176399|NCT01262976|64386756|FG005|Up to Month 2|Other|2|||
23176400|NCT01262976|64386751|FG000|Up to Month 7|Serious Adverse Event|0|||
23176401|NCT01262976|64386752|FG001|Up to Month 7|Serious Adverse Event|0|||
23176402|NCT01262976|64386753|FG002|Up to Month 7|Serious Adverse Event|2|||
23176403|NCT01262976|64386754|FG003|Up to Month 7|Serious Adverse Event|0|||
23176404|NCT01262976|64386755|FG004|Up to Month 7|Serious Adverse Event|0|||
23454043|NCT02718898|65403440|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23176405|NCT01262976|64386756|FG005|Up to Month 7|Serious Adverse Event|0|||
23176406|NCT01262976|64386751|FG000|Up to Month 7|Withdrawal by Subject|1|||
23176407|NCT01262976|64386752|FG001|Up to Month 7|Withdrawal by Subject|0|||
23342038|NCT01053962|64995983|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
23342039|NCT01053962|64995984|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
23342040|NCT01053962|64995985|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
23176408|NCT01262976|64386753|FG002|Up to Month 7|Withdrawal by Subject|0|||
23176409|NCT01262976|64386754|FG003|Up to Month 7|Withdrawal by Subject|0|||
23176410|NCT01262976|64386755|FG004|Up to Month 7|Withdrawal by Subject|0|||
23342041|NCT01053962|64995986|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
23342042|NCT01053962|64995987|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
23454044|NCT02718898|65403441|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23454045|NCT02718898|65403442|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
23454046|NCT02718898|65403443|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
23454047|NCT02718898|65403444|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
23454048|NCT03253393|65403445|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
23454049|NCT03253393|65403446|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
23454050|NCT03253393|65403447|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
23454051|NCT05236270|65403451|FG000|Overall Study|Lost to Follow-up|3|||
23454052|NCT05236270|65403452|FG001|Overall Study|Lost to Follow-up|2|||
23454053|NCT05236270|65403453|FG002|Overall Study|Lost to Follow-up|0|||
23454054|NCT05236270|65403454|FG003|Overall Study|Lost to Follow-up|0|||
23454055|NCT05236270|65403455|FG004|Overall Study|Lost to Follow-up|2|||
23454056|NCT05236270|65403456|FG005|Overall Study|Lost to Follow-up|0|||
23454057|NCT05236270|65403457|FG006|Overall Study|Lost to Follow-up|1|||
23454058|NCT05236270|65403458|FG007|Overall Study|Lost to Follow-up|3|||
23176411|NCT01262976|64386756|FG005|Up to Month 7|Withdrawal by Subject|0|||
23176412|NCT01262976|64386751|FG000|Up to Month 7|Migrated/moved from study area|0|||
23176413|NCT01262976|64386752|FG001|Up to Month 7|Migrated/moved from study area|0|||
23176414|NCT01262976|64386753|FG002|Up to Month 7|Migrated/moved from study area|1|||
23454059|NCT00499486|65403459|FG000|Overall Study|Withdrawal by Subject|16|||
23454060|NCT02587221|65403460|FG000|Overall Study|Adverse Event|3|||
23454061|NCT02587221|65403461|FG001|Overall Study|Adverse Event|3|||
23342043|NCT01053962|64995983|FG000|Pretreatment Period|Venipuncture Failure|0|||
23342044|NCT01053962|64995984|FG001|Pretreatment Period|Venipuncture Failure|0|||
23342045|NCT01053962|64995985|FG002|Pretreatment Period|Venipuncture Failure|1|||
23342046|NCT01053962|64995986|FG003|Pretreatment Period|Venipuncture Failure|0|||
23454062|NCT02587221|65403460|FG000|Overall Study|Death|33|||
23454063|NCT02587221|65403461|FG001|Overall Study|Death|34|||
23454064|NCT02587221|65403460|FG000|Overall Study|Withdrawal by Subject|66|||
23176415|NCT01262976|64386754|FG003|Up to Month 7|Migrated/moved from study area|3|||
23176416|NCT01262976|64386755|FG004|Up to Month 7|Migrated/moved from study area|1|||
23176417|NCT01262976|64386756|FG005|Up to Month 7|Migrated/moved from study area|1|||
23176418|NCT01262976|64386751|FG000|Up to Month 7|Lost to Follow-up|1|||
23176419|NCT01262976|64386752|FG001|Up to Month 7|Lost to Follow-up|0|||
23176420|NCT01262976|64386753|FG002|Up to Month 7|Lost to Follow-up|1|||
23176421|NCT01262976|64386754|FG003|Up to Month 7|Lost to Follow-up|3|||
23176422|NCT01262976|64386755|FG004|Up to Month 7|Lost to Follow-up|1|||
23176423|NCT01262976|64386756|FG005|Up to Month 7|Lost to Follow-up|3|||
23176424|NCT01262976|64386751|FG000|Up to Month 7|Other|3|||
23176425|NCT01262976|64386752|FG001|Up to Month 7|Other|0|||
23176426|NCT01262976|64386753|FG002|Up to Month 7|Other|2|||
23176427|NCT01262976|64386754|FG003|Up to Month 7|Other|0|||
23176428|NCT01262976|64386755|FG004|Up to Month 7|Other|0|||
23176429|NCT01262976|64386756|FG005|Up to Month 7|Other|0|||
23176430|NCT01262976|64386751|FG000|Up to Year 1|Serious Adverse Event|0|||
23176431|NCT01262976|64386752|FG001|Up to Year 1|Serious Adverse Event|0|||
23176432|NCT01262976|64386753|FG002|Up to Year 1|Serious Adverse Event|2|||
23176433|NCT01262976|64386754|FG003|Up to Year 1|Serious Adverse Event|0|||
23176434|NCT01262976|64386755|FG004|Up to Year 1|Serious Adverse Event|0|||
23454065|NCT02587221|65403461|FG001|Overall Study|Withdrawal by Subject|61|||
23454066|NCT02587221|65403460|FG000|Overall Study|Lost to Follow-up|21|||
23454067|NCT02587221|65403461|FG001|Overall Study|Lost to Follow-up|19|||
23176435|NCT01262976|64386756|FG005|Up to Year 1|Serious Adverse Event|0|||
23176436|NCT01262976|64386751|FG000|Up to Year 1|Withdrawal by Subject|1|||
23176437|NCT01262976|64386752|FG001|Up to Year 1|Withdrawal by Subject|0|||
23176438|NCT01262976|64386753|FG002|Up to Year 1|Withdrawal by Subject|0|||
23176439|NCT01262976|64386754|FG003|Up to Year 1|Withdrawal by Subject|0|||
23176440|NCT01262976|64386755|FG004|Up to Year 1|Withdrawal by Subject|0|||
23176441|NCT01262976|64386756|FG005|Up to Year 1|Withdrawal by Subject|0|||
23176442|NCT01262976|64386751|FG000|Up to Year 1|Migrated/moved from study area|1|||
23176443|NCT01262976|64386752|FG001|Up to Year 1|Migrated/moved from study area|0|||
23176444|NCT01262976|64386753|FG002|Up to Year 1|Migrated/moved from study area|0|||
23176445|NCT01262976|64386754|FG003|Up to Year 1|Migrated/moved from study area|3|||
23176446|NCT01262976|64386755|FG004|Up to Year 1|Migrated/moved from study area|3|||
23176447|NCT01262976|64386756|FG005|Up to Year 1|Migrated/moved from study area|2|||
23176448|NCT01262976|64386751|FG000|Up to Year 1|Lost to Follow-up|4|||
23176449|NCT01262976|64386752|FG001|Up to Year 1|Lost to Follow-up|0|||
23454068|NCT02587221|65403460|FG000|Overall Study|Protocol Violation|6|||
23176450|NCT01262976|64386753|FG002|Up to Year 1|Lost to Follow-up|0|||
23176451|NCT01262976|64386754|FG003|Up to Year 1|Lost to Follow-up|1|||
23176452|NCT01262976|64386755|FG004|Up to Year 1|Lost to Follow-up|6|||
23454069|NCT02587221|65403461|FG001|Overall Study|Protocol Violation|5|||
23454070|NCT02587221|65403460|FG000|Overall Study|Other Reason or Unspecified|2|||
23454071|NCT02587221|65403461|FG001|Overall Study|Other Reason or Unspecified|1|||
23454072|NCT00322881|65403462|FG000|Overall Study|Death|2|||
23342047|NCT01053962|64995987|FG004|Pretreatment Period|Venipuncture Failure|0|||
23342048|NCT01053962|64995983|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
23342049|NCT01053962|64995984|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
23342050|NCT01053962|64995985|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
23342051|NCT01053962|64995986|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
23342052|NCT01053962|64995987|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
23342053|NCT01053962|64995983|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
23342054|NCT01053962|64995984|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
23342055|NCT01053962|64995985|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
23342056|NCT01053962|64995986|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
23342057|NCT01053962|64995987|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
23176453|NCT01262976|64386756|FG005|Up to Year 1|Lost to Follow-up|5|||
23342058|NCT01053962|64995983|FG000|Treatment Period|Lack of Efficacy|0|||
23342059|NCT01053962|64995984|FG001|Treatment Period|Lack of Efficacy|0|||
23342060|NCT01053962|64995985|FG002|Treatment Period|Lack of Efficacy|0|||
23342061|NCT01053962|64995986|FG003|Treatment Period|Lack of Efficacy|0|||
23342062|NCT01053962|64995987|FG004|Treatment Period|Lack of Efficacy|1|||
23342063|NCT01053962|64995983|FG000|Treatment Period|Adverse Event|0|||
23342064|NCT01053962|64995984|FG001|Treatment Period|Adverse Event|0|||
23342065|NCT01053962|64995985|FG002|Treatment Period|Adverse Event|0|||
23342066|NCT01053962|64995986|FG003|Treatment Period|Adverse Event|0|||
23342067|NCT01053962|64995987|FG004|Treatment Period|Adverse Event|1|||
23342068|NCT01053962|64995983|FG000|Treatment Period|Withdrawal by Subject|0|||
23342069|NCT01053962|64995984|FG001|Treatment Period|Withdrawal by Subject|0|||
23342070|NCT01053962|64995985|FG002|Treatment Period|Withdrawal by Subject|0|||
23342071|NCT01053962|64995986|FG003|Treatment Period|Withdrawal by Subject|0|||
23342072|NCT01053962|64995987|FG004|Treatment Period|Withdrawal by Subject|1|||
23342073|NCT01053962|64995983|FG000|Treatment Period|Noncompliance with protocol|1|||
23342074|NCT01053962|64995984|FG001|Treatment Period|Noncompliance with protocol|0|||
23342075|NCT01053962|64995985|FG002|Treatment Period|Noncompliance with protocol|0|||
23342076|NCT01053962|64995986|FG003|Treatment Period|Noncompliance with protocol|0|||
23342077|NCT01053962|64995987|FG004|Treatment Period|Noncompliance with protocol|0|||
23342078|NCT01698879|64995989|FG000|Overall Study|Withdrawal by Subject|1|||
23342079|NCT01698879|64995990|FG001|Overall Study|Withdrawal by Subject|0|||
23342080|NCT01698879|64995991|FG002|Overall Study|Withdrawal by Subject|0|||
23582399|NCT01674569|65862470|FG001|Overall Study|Withdrawal by Subject|0|||
23582400|NCT01674569|65862471|FG002|Overall Study|Withdrawal by Subject|1|||
23582401|NCT01674569|65862472|FG003|Overall Study|Withdrawal by Subject|0|||
23582402|NCT01674569|65862473|FG004|Overall Study|Withdrawal by Subject|0|||
23582403|NCT01674569|65862474|FG005|Overall Study|Withdrawal by Subject|0|||
23582404|NCT02246621|65862475|FG000|Overall Study|Withdrawal by Subject|28|||
23582405|NCT02246621|65862476|FG001|Overall Study|Withdrawal by Subject|16|||
23582406|NCT02246621|65862475|FG000|Overall Study|Lost to Follow-up|1|||
23582407|NCT02246621|65862476|FG001|Overall Study|Lost to Follow-up|0|||
23582408|NCT02246621|65862475|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
23582409|NCT02246621|65862476|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
23582410|NCT03736785|65862477|FG000|Overall Study|Adverse Event|1|||
23582411|NCT03736785|65862478|FG001|Overall Study|Adverse Event|1|||
23582412|NCT03736785|65862479|FG002|Overall Study|Adverse Event|1|||
23582413|NCT03736785|65862477|FG000|Overall Study|Death|1|||
23582414|NCT03736785|65862478|FG001|Overall Study|Death|0|||
23582415|NCT03736785|65862479|FG002|Overall Study|Death|1|||
23582416|NCT03736785|65862477|FG000|Overall Study|Lost to Follow-up|0|||
23582417|NCT03736785|65862478|FG001|Overall Study|Lost to Follow-up|2|||
23582418|NCT03736785|65862479|FG002|Overall Study|Lost to Follow-up|3|||
23582419|NCT03736785|65862477|FG000|Overall Study|Non compliance with study drug|1|||
23176454|NCT01262976|64386751|FG000|Up to Year 1|Other|3|||
23176455|NCT01262976|64386752|FG001|Up to Year 1|Other|1|||
23342081|NCT04351373|64995992|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
23342082|NCT02779855|64995993|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
23582420|NCT03736785|65862478|FG001|Overall Study|Non compliance with study drug|1|||
23582421|NCT03736785|65862479|FG002|Overall Study|Non compliance with study drug|0|||
23176456|NCT01262976|64386753|FG002|Up to Year 1|Other|0|||
23342083|NCT02779855|64995994|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
23342084|NCT02779855|64995995|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
23342085|NCT00658775|64995999|FG000|Overall Study|Adverse Event|4|||
23342086|NCT00658775|64996000|FG001|Overall Study|Adverse Event|6|||
23342087|NCT00658775|64995999|FG000|Overall Study|Lost to Follow-up|17|||
23342088|NCT00658775|64996000|FG001|Overall Study|Lost to Follow-up|18|||
23582422|NCT03736785|65862477|FG000|Overall Study|Physician Decision|0|||
23582423|NCT03736785|65862478|FG001|Overall Study|Physician Decision|1|||
23342089|NCT00658775|64995999|FG000|Overall Study|Withdrawal by Subject|6|||
23342090|NCT00658775|64996000|FG001|Overall Study|Withdrawal by Subject|4|||
23342091|NCT00658775|64995999|FG000|Overall Study|Withdrawal of consent|8|||
23342092|NCT00658775|64996000|FG001|Overall Study|Withdrawal of consent|7|||
23342093|NCT00658775|64995999|FG000|Overall Study|Other|7|||
23342094|NCT00658775|64996000|FG001|Overall Study|Other|8|||
23342095|NCT05397171|64996001|FG000|Overall Study|Death|2|||
23342096|NCT05397171|64996002|FG001|Overall Study|Death|3|||
23342097|NCT05397171|64996003|FG002|Overall Study|Death|3|||
23342098|NCT05397171|64996001|FG000|Overall Study|Study Terminated By Sponsor|1|||
23342099|NCT05397171|64996002|FG001|Overall Study|Study Terminated By Sponsor|2|||
23342100|NCT05397171|64996003|FG002|Overall Study|Study Terminated By Sponsor|3|||
23342101|NCT05397171|64996001|FG000|Overall Study|Withdrawal by Subject|0|||
23342102|NCT05397171|64996002|FG001|Overall Study|Withdrawal by Subject|1|||
23342103|NCT05397171|64996003|FG002|Overall Study|Withdrawal by Subject|1|||
23342104|NCT01645891|64996004|FG000|Overall Study|Adverse Event|6|||
23342105|NCT01645891|64996005|FG001|Overall Study|Adverse Event|10|||
23342106|NCT01645891|64996004|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
23342107|NCT01645891|64996005|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
23342108|NCT01645891|64996004|FG000|Overall Study|Withdrawal by Subject|3|||
23342109|NCT01645891|64996005|FG001|Overall Study|Withdrawal by Subject|3|||
23342110|NCT01645891|64996004|FG000|Overall Study|Protocol Violation|4|||
23342111|NCT01645891|64996005|FG001|Overall Study|Protocol Violation|0|||
23342112|NCT01645891|64996004|FG000|Overall Study|Lost to Follow-up|4|||
23342113|NCT01645891|64996005|FG001|Overall Study|Lost to Follow-up|1|||
23342114|NCT01645891|64996004|FG000|Overall Study|Death|0|||
23342115|NCT01645891|64996005|FG001|Overall Study|Death|2|||
23342116|NCT00474786|64996006|FG000|Overall Study|Not Meeting Study Criteria|0|||
23342117|NCT00474786|64996007|FG001|Overall Study|Not Meeting Study Criteria|1|||
23342118|NCT00474786|64996006|FG000|Overall Study|Investigator Request|2|||
23342119|NCT00474786|64996007|FG001|Overall Study|Investigator Request|1|||
23342120|NCT00474786|64996006|FG000|Overall Study|Death|189|||
23342121|NCT00474786|64996007|FG001|Overall Study|Death|170|||
23342122|NCT00474786|64996006|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
23342123|NCT00474786|64996007|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
23342124|NCT00474786|64996006|FG000|Overall Study|Lost to Follow-up|4|||
23342125|NCT00474786|64996007|FG001|Overall Study|Lost to Follow-up|7|||
23342126|NCT00474786|64996006|FG000|Overall Study|Protocol Violation|2|||
23342127|NCT00474786|64996007|FG001|Overall Study|Protocol Violation|0|||
23342128|NCT00474786|64996006|FG000|Overall Study|Withdrawal by Subject|15|||
23342129|NCT00474786|64996007|FG001|Overall Study|Withdrawal by Subject|15|||
23342130|NCT00474786|64996006|FG000|Overall Study|Other|5|||
23342131|NCT00474786|64996007|FG001|Overall Study|Other|0|||
23582424|NCT03736785|65862479|FG002|Overall Study|Physician Decision|1|||
23582425|NCT03736785|65862477|FG000|Overall Study|Protocol Violation|1|||
23582426|NCT03736785|65862478|FG001|Overall Study|Protocol Violation|4|||
23582427|NCT03736785|65862479|FG002|Overall Study|Protocol Violation|3|||
23582428|NCT03736785|65862477|FG000|Overall Study|Sponsor Decision|1|||
23582429|NCT03736785|65862478|FG001|Overall Study|Sponsor Decision|0|||
23582430|NCT03736785|65862479|FG002|Overall Study|Sponsor Decision|0|||
23176457|NCT01262976|64386754|FG003|Up to Year 1|Other|0|||
23176458|NCT01262976|64386755|FG004|Up to Year 1|Other|2|||
23176459|NCT01262976|64386756|FG005|Up to Year 1|Other|1|||
23176460|NCT01262976|64386751|FG000|Up to Year 1|Subjects with unknown completion status|0|||
23176461|NCT01262976|64386752|FG001|Up to Year 1|Subjects with unknown completion status|0|||
23176462|NCT01262976|64386753|FG002|Up to Year 1|Subjects with unknown completion status|1|||
23176463|NCT01262976|64386754|FG003|Up to Year 1|Subjects with unknown completion status|0|||
23342132|NCT03057054|64996013|FG000|Overall Study|Death|4|||
23342133|NCT03057054|64996014|FG001|Overall Study|Death|4|||
23342134|NCT03057054|64996013|FG000|Overall Study|Withdrawal by Subject|6|||
23342135|NCT03057054|64996014|FG001|Overall Study|Withdrawal by Subject|3|||
23342136|NCT03057054|64996013|FG000|Overall Study|Ineligible|1|||
23342137|NCT03057054|64996014|FG001|Overall Study|Ineligible|1|||
23342138|NCT01608087|64996015|FG000|Overall Study|Lost to Follow-up|0|||
23342139|NCT01608087|64996016|FG001|Overall Study|Lost to Follow-up|1|||
23342140|NCT01608087|64996017|FG002|Overall Study|Lost to Follow-up|0|||
23342141|NCT01608087|64996015|FG000|Overall Study|Other Reason|0|||
23342142|NCT01608087|64996016|FG001|Overall Study|Other Reason|1|||
23342143|NCT01608087|64996017|FG002|Overall Study|Other Reason|0|||
23582431|NCT03736785|65862477|FG000|Overall Study|Unknown/Missing data|3|||
23342144|NCT03164564|64996018|FG000|Overall Study|Death|3|||
23342145|NCT03164564|64996019|FG001|Overall Study|Death|0|||
23342146|NCT03164564|64996018|FG000|Overall Study|Withdrawal by Subject|20|||
23582432|NCT03736785|65862478|FG001|Overall Study|Unknown/Missing data|2|||
23342147|NCT03164564|64996019|FG001|Overall Study|Withdrawal by Subject|15|||
23342148|NCT03164564|64996018|FG000|Overall Study|Lost to Follow-up|2|||
23342149|NCT03164564|64996019|FG001|Overall Study|Lost to Follow-up|0|||
23342150|NCT03164564|64996018|FG000|Overall Study|Physician Decision|0|||
23342151|NCT03164564|64996019|FG001|Overall Study|Physician Decision|1|||
23342152|NCT03164564|64996018|FG000|Overall Study|Adverse Event|0|||
23342153|NCT03164564|64996019|FG001|Overall Study|Adverse Event|1|||
23342154|NCT03164564|64996018|FG000|Overall Study|Ongoing|1586|||
23342155|NCT03164564|64996019|FG001|Overall Study|Ongoing|1586|||
23342156|NCT03430895|64996020|FG000|Overall Study|Not Treated|2|||
23342157|NCT01794793|64996021|FG000|Treatment Period|Withdrawal by Subject|24|||
23176464|NCT01262976|64386755|FG004|Up to Year 1|Subjects with unknown completion status|0|||
23176465|NCT01262976|64386756|FG005|Up to Year 1|Subjects with unknown completion status|1|||
23342158|NCT01794793|64996021|FG000|Treatment Period|Lack of Efficacy|22|||
23342159|NCT01794793|64996021|FG000|Treatment Period|Adverse Event|17|||
23342160|NCT01794793|64996021|FG000|Treatment Period|Physician Decision|14|||
23342161|NCT01794793|64996021|FG000|Treatment Period|Lost to Follow-up|7|||
23342162|NCT01794793|64996021|FG000|Treatment Period|Death|6|||
23342163|NCT01794793|64996021|FG000|Treatment Period|Protocol Violation|5|||
23176466|NCT01262976|64386751|FG000|Up to Year 2|Serious Adverse Event|0|||
23176467|NCT01262976|64386752|FG001|Up to Year 2|Serious Adverse Event|0|||
23176468|NCT01262976|64386753|FG002|Up to Year 2|Serious Adverse Event|2|||
23176469|NCT01262976|64386754|FG003|Up to Year 2|Serious Adverse Event|0|||
23176470|NCT01262976|64386755|FG004|Up to Year 2|Serious Adverse Event|0|||
23176471|NCT01262976|64386756|FG005|Up to Year 2|Serious Adverse Event|0|||
23454073|NCT00322881|65403462|FG000|Overall Study|Adverse Event|1|||
23454074|NCT00322881|65403462|FG000|Overall Study|Disease Progression|2|||
23176472|NCT01262976|64386751|FG000|Up to Year 2|Withdrawal by Subject|1|||
23176473|NCT01262976|64386752|FG001|Up to Year 2|Withdrawal by Subject|0|||
23176474|NCT01262976|64386753|FG002|Up to Year 2|Withdrawal by Subject|0|||
23176475|NCT01262976|64386754|FG003|Up to Year 2|Withdrawal by Subject|0|||
23176476|NCT01262976|64386755|FG004|Up to Year 2|Withdrawal by Subject|0|||
23176477|NCT01262976|64386756|FG005|Up to Year 2|Withdrawal by Subject|0|||
23176478|NCT01262976|64386751|FG000|Up to Year 2|Migrated/moved from study area|0|||
23176479|NCT01262976|64386752|FG001|Up to Year 2|Migrated/moved from study area|0|||
23176480|NCT01262976|64386753|FG002|Up to Year 2|Migrated/moved from study area|0|||
23176481|NCT01262976|64386754|FG003|Up to Year 2|Migrated/moved from study area|2|||
23176482|NCT01262976|64386755|FG004|Up to Year 2|Migrated/moved from study area|1|||
23176483|NCT01262976|64386756|FG005|Up to Year 2|Migrated/moved from study area|2|||
23176484|NCT01262976|64386751|FG000|Up to Year 2|Lost to Follow-up|1|||
23454075|NCT00189540|65403463|FG000|Overall Study|Withdrawal by Subject|3|||
23454076|NCT00189540|65403464|FG001|Overall Study|Withdrawal by Subject|0|||
23454077|NCT00189540|65403463|FG000|Overall Study|Death|4|||
23454078|NCT00189540|65403464|FG001|Overall Study|Death|1|||
23454079|NCT02240485|65403465|FG000|3 Months Post-admission|Lost to Follow-up|1|||
23454080|NCT02240485|65403466|FG001|3 Months Post-admission|Lost to Follow-up|5|||
23454081|NCT02240485|65403465|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
23454082|NCT02240485|65403466|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
23454083|NCT02240485|65403465|FG000|9 Months Post-admission|Lost to Follow-up|3|||
23454084|NCT02240485|65403466|FG001|9 Months Post-admission|Lost to Follow-up|1|||
23176485|NCT01262976|64386752|FG001|Up to Year 2|Lost to Follow-up|1|||
23176486|NCT01262976|64386753|FG002|Up to Year 2|Lost to Follow-up|2|||
23176487|NCT01262976|64386754|FG003|Up to Year 2|Lost to Follow-up|2|||
23176488|NCT01262976|64386755|FG004|Up to Year 2|Lost to Follow-up|3|||
23176489|NCT01262976|64386756|FG005|Up to Year 2|Lost to Follow-up|3|||
23176490|NCT01262976|64386751|FG000|Up to Year 2|Subjects with unknown completion status|0|||
23176491|NCT01262976|64386752|FG001|Up to Year 2|Subjects with unknown completion status|0|||
23176492|NCT01262976|64386753|FG002|Up to Year 2|Subjects with unknown completion status|1|||
23176493|NCT01262976|64386754|FG003|Up to Year 2|Subjects with unknown completion status|0|||
23176494|NCT01262976|64386755|FG004|Up to Year 2|Subjects with unknown completion status|0|||
23176495|NCT01262976|64386756|FG005|Up to Year 2|Subjects with unknown completion status|0|||
23176496|NCT01262976|64386751|FG000|Up to Year 2|Other|3|||
23176497|NCT01262976|64386752|FG001|Up to Year 2|Other|0|||
23176498|NCT01262976|64386753|FG002|Up to Year 2|Other|0|||
23342164|NCT01794793|64996021|FG000|Treatment Period|administrative problem|3|||
23342165|NCT01794793|64996021|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
23342166|NCT01794793|64996021|FG000|Post-treatment Follow-up|Adverse Event|8|||
23342167|NCT01794793|64996021|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
23342168|NCT01794793|64996021|FG000|Post-treatment Follow-up|administrative problem|5|||
23342169|NCT01794793|64996021|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
23454085|NCT02240485|65403465|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
23454086|NCT02240485|65403466|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
23342170|NCT01794793|64996021|FG000|Post-treatment Follow-up|Protocol Violation|3|||
23176499|NCT01262976|64386754|FG003|Up to Year 2|Other|0|||
23176500|NCT01262976|64386755|FG004|Up to Year 2|Other|0|||
23176501|NCT01262976|64386756|FG005|Up to Year 2|Other|0|||
23176502|NCT01262976|64386751|FG000|Up to Year 3|Serious Adverse Event|0|||
23176503|NCT01262976|64386752|FG001|Up to Year 3|Serious Adverse Event|0|||
23176504|NCT01262976|64386753|FG002|Up to Year 3|Serious Adverse Event|2|||
23342171|NCT05036668|64996025|FG000|Overall Study|lost to follow Up|0|||
23342172|NCT05036668|64996026|FG001|Overall Study|lost to follow Up|0|||
23342173|NCT05036668|64996027|FG002|Overall Study|lost to follow Up|1|||
23342174|NCT03891862|64996028|FG000|Open-label Period|Adverse Event|2|||
23342175|NCT03891862|64996029|FG001|Open-label Period|Adverse Event|0|||
23342176|NCT03891862|64996030|FG002|Open-label Period|Adverse Event|0|||
23342177|NCT03891862|64996028|FG000|Open-label Period|Protocol Violation|5|||
23342178|NCT03891862|64996029|FG001|Open-label Period|Protocol Violation|0|||
23342179|NCT03891862|64996030|FG002|Open-label Period|Protocol Violation|0|||
23342180|NCT03891862|64996028|FG000|Open-label Period|Withdrawal by Subject|6|||
23342181|NCT03891862|64996029|FG001|Open-label Period|Withdrawal by Subject|0|||
23342182|NCT03891862|64996030|FG002|Open-label Period|Withdrawal by Subject|0|||
23342183|NCT03891862|64996028|FG000|Open-label Period|Death|1|||
23342184|NCT03891862|64996029|FG001|Open-label Period|Death|0|||
23342185|NCT03891862|64996030|FG002|Open-label Period|Death|0|||
23342186|NCT03891862|64996028|FG000|Open-label Period|Lost to Follow-up|2|||
23342187|NCT03891862|64996029|FG001|Open-label Period|Lost to Follow-up|0|||
23342188|NCT03891862|64996030|FG002|Open-label Period|Lost to Follow-up|0|||
23342189|NCT03891862|64996028|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
23342190|NCT03891862|64996029|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
23342191|NCT03891862|64996030|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
23342192|NCT03891862|64996028|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
23342193|NCT03891862|64996029|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
23342194|NCT03891862|64996030|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
23342195|NCT03891862|64996028|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
23342196|NCT03891862|64996029|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
23342197|NCT03891862|64996030|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
23342198|NCT03891862|64996028|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
23342199|NCT03891862|64996029|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
23342200|NCT03891862|64996030|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
23342201|NCT03962790|64996031|FG000|Period 1|Adverse Event|0|||
23342202|NCT03962790|64996032|FG001|Period 1|Adverse Event|1|||
23342203|NCT03962790|64996031|FG000|Period 1|Failed to meet all eligibility criteria|1|||
23342204|NCT03962790|64996032|FG001|Period 1|Failed to meet all eligibility criteria|1|||
23342205|NCT03962790|64996031|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
23342206|NCT03962790|64996032|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
23342207|NCT03962790|64996031|FG000|Period 1|Withdrawal by Subject|1|||
23342208|NCT03962790|64996032|FG001|Period 1|Withdrawal by Subject|0|||
23342209|NCT02850016|64996033|FG000|Overall Study|Withdrawal by Subject|1|||
23342210|NCT02850016|64996034|FG001|Overall Study|Withdrawal by Subject|2|||
23342211|NCT04739722|64996037|FG000|Overall Study|Lost to Follow-up|5301|||
23342212|NCT04739722|64996037|FG000|Overall Study|Withdrawal by Subject|42|||
23342213|NCT04739722|64996037|FG000|Overall Study|Non Average-risk|1157|||
23342214|NCT04725812|64996038|FG000|Overall Study|Withdrawal by Subject|1|||
23342215|NCT01032239|64996041|FG000|Overall Study|Lost to Follow-up|3|||
23342216|NCT01032239|64996042|FG001|Overall Study|Lost to Follow-up|2|||
23342217|NCT01032239|64996041|FG000|Overall Study|Withdrawal by Subject|2|||
23342218|NCT01032239|64996042|FG001|Overall Study|Withdrawal by Subject|3|||
23342219|NCT01032239|64996041|FG000|Overall Study|Death|1|||
23342220|NCT01032239|64996042|FG001|Overall Study|Death|0|||
23342221|NCT01032239|64996041|FG000|Overall Study|Protocol Violation|1|||
23342222|NCT01032239|64996042|FG001|Overall Study|Protocol Violation|0|||
23342223|NCT04143594|64996052|FG000|Overall Study|Withdrew consent|3|||
23342224|NCT04143594|64996053|FG001|Overall Study|Withdrew consent|10|||
23342225|NCT04143594|64996054|FG002|Overall Study|Withdrew consent|3|||
23342226|NCT04143594|64996055|FG003|Overall Study|Withdrew consent|1|||
23342227|NCT04143594|64996052|FG000|Overall Study|Lost to Follow-up|3|||
23342228|NCT04143594|64996053|FG001|Overall Study|Lost to Follow-up|5|||
23342229|NCT04143594|64996054|FG002|Overall Study|Lost to Follow-up|11|||
23342230|NCT04143594|64996055|FG003|Overall Study|Lost to Follow-up|0|||
23342231|NCT04143594|64996052|FG000|Overall Study|Investigator's discretion|2|||
23342232|NCT04143594|64996053|FG001|Overall Study|Investigator's discretion|2|||
23342233|NCT04143594|64996054|FG002|Overall Study|Investigator's discretion|0|||
23342234|NCT04143594|64996055|FG003|Overall Study|Investigator's discretion|0|||
23342235|NCT04143594|64996052|FG000|Overall Study|Randomized but never treated|0|||
23342236|NCT04143594|64996053|FG001|Overall Study|Randomized but never treated|0|||
23342237|NCT04143594|64996054|FG002|Overall Study|Randomized but never treated|0|||
23342238|NCT04143594|64996055|FG003|Overall Study|Randomized but never treated|1|||
23342239|NCT04143594|64996052|FG000|Overall Study|Death|1|||
23176505|NCT01262976|64386754|FG003|Up to Year 3|Serious Adverse Event|0|||
23342240|NCT04143594|64996053|FG001|Overall Study|Death|0|||
23342241|NCT04143594|64996054|FG002|Overall Study|Death|1|||
23342242|NCT04143594|64996055|FG003|Overall Study|Death|0|||
23342243|NCT04143594|64996052|FG000|Overall Study|Adverse Event|1|||
23342244|NCT04143594|64996053|FG001|Overall Study|Adverse Event|0|||
23342245|NCT04143594|64996054|FG002|Overall Study|Adverse Event|0|||
23342246|NCT04143594|64996055|FG003|Overall Study|Adverse Event|0|||
23342247|NCT04143594|64996052|FG000|Overall Study|Pregnancy|0|||
23342248|NCT04143594|64996053|FG001|Overall Study|Pregnancy|0|||
23342249|NCT04143594|64996054|FG002|Overall Study|Pregnancy|1|||
23176506|NCT01262976|64386755|FG004|Up to Year 3|Serious Adverse Event|0|||
23342250|NCT04143594|64996055|FG003|Overall Study|Pregnancy|0|||
23342251|NCT04143594|64996052|FG000|Overall Study|Lack of Efficacy|1|||
23342252|NCT04143594|64996053|FG001|Overall Study|Lack of Efficacy|1|||
23176507|NCT01262976|64386756|FG005|Up to Year 3|Serious Adverse Event|0|||
23176508|NCT01262976|64386751|FG000|Up to Year 3|Withdrawal by Subject|1|||
23176509|NCT01262976|64386752|FG001|Up to Year 3|Withdrawal by Subject|0|||
23176510|NCT01262976|64386753|FG002|Up to Year 3|Withdrawal by Subject|0|||
23176511|NCT01262976|64386754|FG003|Up to Year 3|Withdrawal by Subject|0|||
23176512|NCT01262976|64386755|FG004|Up to Year 3|Withdrawal by Subject|0|||
23176513|NCT01262976|64386756|FG005|Up to Year 3|Withdrawal by Subject|0|||
23176514|NCT01262976|64386751|FG000|Up to Year 3|Migrated/moved from study area|0|||
23176515|NCT01262976|64386752|FG001|Up to Year 3|Migrated/moved from study area|0|||
23176516|NCT01262976|64386753|FG002|Up to Year 3|Migrated/moved from study area|0|||
23176517|NCT01262976|64386754|FG003|Up to Year 3|Migrated/moved from study area|2|||
23176518|NCT01262976|64386755|FG004|Up to Year 3|Migrated/moved from study area|1|||
23176519|NCT01262976|64386756|FG005|Up to Year 3|Migrated/moved from study area|1|||
23176520|NCT01262976|64386751|FG000|Up to Year 3|Lost to Follow-up|2|||
23176521|NCT01262976|64386752|FG001|Up to Year 3|Lost to Follow-up|2|||
23176522|NCT01262976|64386753|FG002|Up to Year 3|Lost to Follow-up|4|||
23176523|NCT01262976|64386754|FG003|Up to Year 3|Lost to Follow-up|3|||
23176524|NCT01262976|64386755|FG004|Up to Year 3|Lost to Follow-up|1|||
23176525|NCT01262976|64386756|FG005|Up to Year 3|Lost to Follow-up|3|||
23176526|NCT01262976|64386751|FG000|Up to Year 3|Subjects with unknown completion status|0|||
23176527|NCT01262976|64386752|FG001|Up to Year 3|Subjects with unknown completion status|0|||
23176528|NCT01262976|64386753|FG002|Up to Year 3|Subjects with unknown completion status|1|||
23176529|NCT01262976|64386754|FG003|Up to Year 3|Subjects with unknown completion status|0|||
23176530|NCT01262976|64386755|FG004|Up to Year 3|Subjects with unknown completion status|0|||
23176531|NCT01262976|64386756|FG005|Up to Year 3|Subjects with unknown completion status|0|||
23176532|NCT01262976|64386751|FG000|Up to Year 3|Other|3|||
23176533|NCT01262976|64386752|FG001|Up to Year 3|Other|0|||
23176534|NCT01262976|64386753|FG002|Up to Year 3|Other|0|||
23176535|NCT01262976|64386754|FG003|Up to Year 3|Other|0|||
23176536|NCT01262976|64386755|FG004|Up to Year 3|Other|0|||
23176537|NCT01262976|64386756|FG005|Up to Year 3|Other|0|||
23176538|NCT02292212|64386757|FG000|ViE Phase|Withdrawal by Subject|1|||
23176539|NCT02292212|64386757|FG000|ViE Phase|Protocol Violation|2|||
23176540|NCT02631200|64386759|FG000|First Period|Death|1|||
23176541|NCT02631200|64386760|FG001|First Period|Death|2|||
23176542|NCT02631200|64386759|FG000|First Period|Patient ill-health|2|||
23176543|NCT02631200|64386760|FG001|First Period|Patient ill-health|4|||
23176544|NCT02631200|64386759|FG000|First Period|Withdrawal by Subject|4|||
23176545|NCT02631200|64386760|FG001|First Period|Withdrawal by Subject|1|||
23176546|NCT02631200|64386759|FG000|Deferred Period|Death|0|||
23176547|NCT02631200|64386760|FG001|Deferred Period|Death|1|||
23176548|NCT02631200|64386759|FG000|Deferred Period|Received kidney transplant|0|||
23176549|NCT02631200|64386760|FG001|Deferred Period|Received kidney transplant|1|||
23176550|NCT02631200|64386759|FG000|Deferred Period|Withdrawal by Subject|0|||
23176551|NCT02631200|64386760|FG001|Deferred Period|Withdrawal by Subject|2|||
23176552|NCT02631200|64386759|FG000|Deferred Period|Lost to Follow-up|0|||
23176553|NCT02631200|64386760|FG001|Deferred Period|Lost to Follow-up|1|||
23176554|NCT02450487|64386764|FG000|Overall Study|Lost to Follow-up|3|||
23176555|NCT02597062|64390110|FG000|Overall Study|Ineligible|1|||
23176556|NCT01194440|64390117|FG000|Baseline (First Dose)|Reason not specified|4|||
23176557|NCT01194440|64390117|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
23176558|NCT01194440|64390117|FG000|Baseline (First Dose)|Change in therapy|1|||
23342253|NCT04143594|64996054|FG002|Overall Study|Lack of Efficacy|0|||
23176559|NCT01194440|64390117|FG000|Baseline (First Dose)|Adverse Event|1|||
23176560|NCT01194440|64390117|FG000|6-months (2nd Dose)|Change in therapy|4|||
23342254|NCT04143594|64996055|FG003|Overall Study|Lack of Efficacy|0|||
23342255|NCT04526665|64996056|FG000|Overall Study|Withdrawal by Subject|6|||
23176561|NCT02324270|64390120|FG000|Overall Study|Withdrawal by Subject|0|||
23176562|NCT02324270|64390121|FG001|Overall Study|Withdrawal by Subject|1|||
23176563|NCT02324270|64390122|FG002|Overall Study|Withdrawal by Subject|0|||
23342256|NCT04526665|64996057|FG001|Overall Study|Withdrawal by Subject|3|||
23176564|NCT02324270|64390120|FG000|Overall Study|Lost to Follow-up|4|||
23342257|NCT04526665|64996056|FG000|Overall Study|Adverse Event|4|||
23342258|NCT04526665|64996057|FG001|Overall Study|Adverse Event|1|||
23342259|NCT04526665|64996056|FG000|Overall Study|Physician Decision|2|||
23342260|NCT04526665|64996057|FG001|Overall Study|Physician Decision|2|||
23342261|NCT04526665|64996056|FG000|Overall Study|Death|2|||
23342262|NCT04526665|64996057|FG001|Overall Study|Death|0|||
23342263|NCT04526665|64996056|FG000|Overall Study|Other|0|||
23342264|NCT04526665|64996057|FG001|Overall Study|Other|1|||
23342265|NCT03555565|64996058|FG000|Overall Study|Case Report Forms Uncollected|2|||
23342266|NCT03555565|64996058|FG000|Overall Study|Protocol Deviation|13|||
23342267|NCT01095978|64996059|FG000|Overall Study|Did not take Klacid SR|2|||
23342268|NCT01095978|64996059|FG000|Overall Study|Adverse Event|1|||
23342269|NCT02682823|64996065|FG000|Overall Study|Withdrawal by Subject|0|||
23342270|NCT02682823|64996066|FG001|Overall Study|Withdrawal by Subject|0|||
23342271|NCT02682823|64996067|FG002|Overall Study|Withdrawal by Subject|1|||
23342272|NCT02682823|64996068|FG003|Overall Study|Withdrawal by Subject|0|||
23342273|NCT02682823|64996069|FG004|Overall Study|Withdrawal by Subject|1|||
23342274|NCT02682823|64996065|FG000|Overall Study|Protocol Deviation|0|||
23342275|NCT02682823|64996066|FG001|Overall Study|Protocol Deviation|1|||
23342276|NCT02682823|64996067|FG002|Overall Study|Protocol Deviation|0|||
23342277|NCT02682823|64996068|FG003|Overall Study|Protocol Deviation|0|||
23342278|NCT02682823|64996069|FG004|Overall Study|Protocol Deviation|0|||
23342279|NCT02682823|64996065|FG000|Overall Study|Adverse Event|0|||
23176565|NCT02324270|64390121|FG001|Overall Study|Lost to Follow-up|3|||
23176566|NCT02324270|64390122|FG002|Overall Study|Lost to Follow-up|4|||
23176567|NCT02324270|64390120|FG000|Overall Study|Protocol Violation|0|||
23176568|NCT02324270|64390121|FG001|Overall Study|Protocol Violation|1|||
23176569|NCT02324270|64390122|FG002|Overall Study|Protocol Violation|1|||
23176570|NCT02324270|64390120|FG000|Overall Study|Non Compliance with Study Drug|1|||
23176571|NCT02324270|64390121|FG001|Overall Study|Non Compliance with Study Drug|2|||
23176572|NCT02324270|64390122|FG002|Overall Study|Non Compliance with Study Drug|0|||
23176573|NCT03905863|64390130|FG000|Overall Study|Adverse Event|2|||
23176574|NCT03905863|64390131|FG001|Overall Study|Adverse Event|4|||
23176575|NCT03905863|64390130|FG000|Overall Study|Withdrawal by Subject|2|||
23176576|NCT03905863|64390131|FG001|Overall Study|Withdrawal by Subject|2|||
23176577|NCT03905863|64390130|FG000|Overall Study|Physician Decision|0|||
23176578|NCT03905863|64390131|FG001|Overall Study|Physician Decision|3|||
23176579|NCT03905863|64390130|FG000|Overall Study|Lost to Follow-up|1|||
23176580|NCT03905863|64390131|FG001|Overall Study|Lost to Follow-up|0|||
23176581|NCT03905863|64390130|FG000|Overall Study|Protocol Violation|0|||
23176582|NCT03905863|64390131|FG001|Overall Study|Protocol Violation|2|||
23176583|NCT03905863|64390130|FG000|Overall Study|Death|0|||
23176584|NCT03905863|64390131|FG001|Overall Study|Death|1|||
23176585|NCT00598975|64390132|FG000|Overall Study|Adverse Event|1|||
23176586|NCT00598975|64390133|FG001|Overall Study|Adverse Event|1|||
23176587|NCT00598975|64390132|FG000|Overall Study|Brain metastases|1|||
23176588|NCT00598975|64390133|FG001|Overall Study|Brain metastases|0|||
23176589|NCT00598975|64390132|FG000|Overall Study|Withdrawal by Subject|1|||
23342280|NCT02682823|64996066|FG001|Overall Study|Adverse Event|0|||
23176590|NCT00598975|64390133|FG001|Overall Study|Withdrawal by Subject|1|||
23176591|NCT00598975|64390132|FG000|Overall Study|Withdrawal of consent|0|||
23176592|NCT00598975|64390133|FG001|Overall Study|Withdrawal of consent|1|||
23342281|NCT02682823|64996067|FG002|Overall Study|Adverse Event|0|||
23342282|NCT02682823|64996068|FG003|Overall Study|Adverse Event|1|||
23342283|NCT02682823|64996069|FG004|Overall Study|Adverse Event|0|||
23454087|NCT02240485|65403465|FG000|18 Months Post-admission|Lost to Follow-up|1|||
23454088|NCT02240485|65403466|FG001|18 Months Post-admission|Lost to Follow-up|1|||
23454089|NCT02240485|65403465|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
23176593|NCT00598975|64390132|FG000|Overall Study|Disease progression|8|||
23176594|NCT00598975|64390133|FG001|Overall Study|Disease progression|3|||
23176595|NCT00598975|64390132|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
23176596|NCT00598975|64390133|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
23176597|NCT02009878|64390146|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
23176598|NCT02009878|64390147|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
23176599|NCT02009878|64390148|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
23176600|NCT01670994|64390149|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
23176601|NCT01670994|64390150|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
23176602|NCT01670994|64390149|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
23176603|NCT01670994|64390150|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
23176604|NCT01670994|64390149|FG000|Overall Study|Patient experienced DLT|0|||
23176605|NCT01670994|64390150|FG001|Overall Study|Patient experienced DLT|1|||
23176606|NCT01583179|64390151|FG000|Overall Study|Screen failure|1|||
23176607|NCT01583179|64390152|FG001|Overall Study|Screen failure|2|||
23176608|NCT00544869|64390153|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
23176609|NCT00544869|64390154|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
23176610|NCT00544869|64390155|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
23176611|NCT00544869|64390153|FG000|Overall Study|Adverse Event|6|||
23176612|NCT00544869|64390154|FG001|Overall Study|Adverse Event|1|||
23176613|NCT00544869|64390155|FG002|Overall Study|Adverse Event|0|||
23176614|NCT00544869|64390153|FG000|Overall Study|Lack of Efficacy|1|||
23176615|NCT00544869|64390154|FG001|Overall Study|Lack of Efficacy|1|||
23176616|NCT00544869|64390155|FG002|Overall Study|Lack of Efficacy|0|||
23176617|NCT00544869|64390153|FG000|Overall Study|Physician Decision|2|||
23176618|NCT00544869|64390154|FG001|Overall Study|Physician Decision|0|||
23176619|NCT00544869|64390155|FG002|Overall Study|Physician Decision|0|||
23176620|NCT01178138|64390156|FG000|Overall Study|Lost to Follow-up|8|||
23176621|NCT01178138|64390156|FG000|Overall Study|Withdrawal by Subject|7|||
23176622|NCT01178138|64390156|FG000|Overall Study|Physician Decision|8|||
23176623|NCT03896295|64390161|FG000|Overall Study|Adverse Event|0|||
23176624|NCT03896295|64390162|FG001|Overall Study|Adverse Event|1|||
23176625|NCT03896295|64390161|FG000|Overall Study|COVID-19|7|||
23176626|NCT03896295|64390162|FG001|Overall Study|COVID-19|29|||
23176627|NCT01552681|64390163|FG000|Overall Study|Withdrawal by Subject|4|||
23176628|NCT01552681|64390164|FG001|Overall Study|Withdrawal by Subject|0|||
23176629|NCT01552681|64390163|FG000|Overall Study|Physician Decision|1|||
23176630|NCT01552681|64390164|FG001|Overall Study|Physician Decision|0|||
23176631|NCT01552681|64390163|FG000|Overall Study|Subject moved away|0|||
23176632|NCT01552681|64390164|FG001|Overall Study|Subject moved away|1|||
23176633|NCT00256295|64390165|FG000|Overall Study|Withdrawal by Subject|3|||
23176634|NCT00256295|64390165|FG000|Overall Study|Death|1|||
23176635|NCT00713219|64390166|FG000|Overall Study|Death|1|||
23176636|NCT00713219|64390166|FG000|Overall Study|Protocol Violation|1|||
23176637|NCT04684420|64390167|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23176638|NCT04684420|64390168|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23176639|NCT04684420|64390169|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
23176640|NCT04684420|64390170|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
23176641|NCT04684420|64390167|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
23176642|NCT04684420|64390168|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
23176643|NCT04684420|64390169|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
23176644|NCT04684420|64390170|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
23176645|NCT03372941|64390180|FG000|Overall Study|Lost to Follow-up|2|||
23176646|NCT03372941|64390181|FG001|Overall Study|Lost to Follow-up|4|||
23176647|NCT02796755|64390182|FG000|Overall Study|Adverse Event|2|||
23176648|NCT02796755|64390183|FG001|Overall Study|Adverse Event|0|||
23176649|NCT02211261|64390184|FG000|Overall Study|Withdrawal by Subject|0|||
23176650|NCT02211261|64390185|FG001|Overall Study|Withdrawal by Subject|0|||
23176651|NCT02211261|64390186|FG002|Overall Study|Withdrawal by Subject|1|||
23176652|NCT02211261|64390187|FG003|Overall Study|Withdrawal by Subject|0|||
23176653|NCT02211261|64390188|FG004|Overall Study|Withdrawal by Subject|2|||
23176654|NCT02211261|64390189|FG005|Overall Study|Withdrawal by Subject|0|||
23176655|NCT02211261|64390190|FG006|Overall Study|Withdrawal by Subject|0|||
23176656|NCT02211261|64390191|FG007|Overall Study|Withdrawal by Subject|0|||
23176657|NCT02211261|64390192|FG008|Overall Study|Withdrawal by Subject|0|||
23454090|NCT02240485|65403466|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
23454091|NCT03740048|65403469|FG000|Overall Study|Withdrawal by Subject|1|||
23176658|NCT02211261|64390193|FG009|Overall Study|Withdrawal by Subject|0|||
23176659|NCT02211261|64390194|FG010|Overall Study|Withdrawal by Subject|0|||
23176660|NCT02211261|64390184|FG000|Overall Study|Other|0|||
23176661|NCT02211261|64390185|FG001|Overall Study|Other|0|||
23176662|NCT02211261|64390186|FG002|Overall Study|Other|0|||
23176663|NCT02211261|64390187|FG003|Overall Study|Other|0|||
23176664|NCT02211261|64390188|FG004|Overall Study|Other|0|||
23176665|NCT02211261|64390189|FG005|Overall Study|Other|1|||
23176666|NCT02211261|64390190|FG006|Overall Study|Other|0|||
23176667|NCT02211261|64390191|FG007|Overall Study|Other|0|||
23176668|NCT02211261|64390192|FG008|Overall Study|Other|0|||
23176669|NCT02211261|64390193|FG009|Overall Study|Other|2|||
23176670|NCT02211261|64390194|FG010|Overall Study|Other|0|||
23176671|NCT02211261|64390184|FG000|Overall Study|Lost to Follow-up|0|||
23176672|NCT02211261|64390185|FG001|Overall Study|Lost to Follow-up|0|||
23176673|NCT02211261|64390186|FG002|Overall Study|Lost to Follow-up|0|||
23176674|NCT02211261|64390187|FG003|Overall Study|Lost to Follow-up|0|||
23176675|NCT02211261|64390188|FG004|Overall Study|Lost to Follow-up|0|||
23176676|NCT02211261|64390189|FG005|Overall Study|Lost to Follow-up|0|||
23176677|NCT02211261|64390190|FG006|Overall Study|Lost to Follow-up|0|||
23176678|NCT02211261|64390191|FG007|Overall Study|Lost to Follow-up|1|||
23176679|NCT02211261|64390192|FG008|Overall Study|Lost to Follow-up|0|||
23176680|NCT02211261|64390193|FG009|Overall Study|Lost to Follow-up|0|||
23176681|NCT02211261|64390194|FG010|Overall Study|Lost to Follow-up|0|||
23176682|NCT00382967|64390195|FG000|Overall Study|Protocol Violation|1|||
23176683|NCT00382967|64390196|FG001|Overall Study|Protocol Violation|1|||
23176684|NCT03786432|64390197|FG000|Overall Study|Screen Failure after consent|1|||
23176685|NCT03786432|64390197|FG000|Overall Study|Lost to Follow-up|4|||
23176686|NCT03786432|64390197|FG000|Overall Study|did not complete 12 month CT scan|1|||
23176687|NCT00787787|64390201|FG000|Overall Study|Lack of Efficacy|4|||
23176688|NCT00787787|64390201|FG000|Overall Study|Adverse Event|3|||
23176689|NCT00236080|64390202|FG000|Overall Study|Adverse Event|0|||
23176690|NCT00236080|64390203|FG001|Overall Study|Adverse Event|0|||
23176691|NCT00236080|64390204|FG002|Overall Study|Adverse Event|3|||
23176692|NCT00236080|64390205|FG003|Overall Study|Adverse Event|1|||
23176693|NCT00236080|64390206|FG004|Overall Study|Adverse Event|0|||
23176694|NCT00236080|64390202|FG000|Overall Study|Lost to Follow-up|0|||
23176695|NCT00236080|64390203|FG001|Overall Study|Lost to Follow-up|1|||
23176696|NCT00236080|64390204|FG002|Overall Study|Lost to Follow-up|0|||
23176697|NCT00236080|64390205|FG003|Overall Study|Lost to Follow-up|0|||
23176698|NCT00236080|64390206|FG004|Overall Study|Lost to Follow-up|0|||
23176699|NCT00236080|64390202|FG000|Overall Study|Physician Decision|1|||
23176700|NCT00236080|64390203|FG001|Overall Study|Physician Decision|0|||
23176701|NCT00236080|64390204|FG002|Overall Study|Physician Decision|1|||
23176702|NCT00236080|64390205|FG003|Overall Study|Physician Decision|1|||
23176703|NCT00236080|64390206|FG004|Overall Study|Physician Decision|1|||
23176704|NCT00236080|64390202|FG000|Overall Study|Withdrawal by Subject|1|||
23176705|NCT00236080|64390203|FG001|Overall Study|Withdrawal by Subject|0|||
23236679|NCT01190839|64608288|FG001|Overall Study|Trial stopped by Sponsor|68|||
23236680|NCT01190839|64608287|FG000|Overall Study|Undefined|35|||
23236681|NCT01190839|64608288|FG001|Overall Study|Undefined|31|||
23236682|NCT01190839|64608287|FG000|Overall Study|Randomized but not treated|2|||
23236683|NCT01190839|64608288|FG001|Overall Study|Randomized but not treated|4|||
23236684|NCT02361307|64608291|FG000|Overall Study|Unstable medical condition.|0|||
23236685|NCT02361307|64608292|FG001|Overall Study|Unstable medical condition.|1|||
23236686|NCT00808665|64608293|FG000|Overall Study|Withdrawal by Subject|1|||
23236687|NCT00808665|64608294|FG001|Overall Study|Withdrawal by Subject|0|||
23236688|NCT00808665|64608293|FG000|Overall Study|only required minimally invasive surgery|1|||
23236689|NCT00808665|64608294|FG001|Overall Study|only required minimally invasive surgery|0|||
23236690|NCT00808665|64608293|FG000|Overall Study|surgery cancelled|1|||
23236691|NCT00808665|64608294|FG001|Overall Study|surgery cancelled|0|||
23236692|NCT00808665|64608293|FG000|Overall Study|required an additional procedure|0|||
23236693|NCT00808665|64608294|FG001|Overall Study|required an additional procedure|1|||
23236694|NCT00808665|64608293|FG000|Overall Study|Physician Decision|3|||
23236695|NCT00808665|64608294|FG001|Overall Study|Physician Decision|1|||
23236696|NCT00808665|64608293|FG000|Overall Study|Medication stopped by resident|0|||
23236697|NCT00808665|64608294|FG001|Overall Study|Medication stopped by resident|1|||
23236698|NCT01004861|64608298|FG000|Overall Study|Disease progression|3|||
23236699|NCT01004861|64608299|FG001|Overall Study|Disease progression|4|||
23236700|NCT01004861|64608300|FG002|Overall Study|Disease progression|5|||
23236701|NCT01004861|64608301|FG003|Overall Study|Disease progression|4|||
23236702|NCT01004861|64608302|FG004|Overall Study|Disease progression|4|||
23342284|NCT01905553|64996075|FG000|Period 2|Adverse Event|1|||
23176706|NCT00236080|64390204|FG002|Overall Study|Withdrawal by Subject|0|||
23176707|NCT00236080|64390205|FG003|Overall Study|Withdrawal by Subject|0|||
23176708|NCT00236080|64390206|FG004|Overall Study|Withdrawal by Subject|0|||
23236703|NCT01004861|64608303|FG005|Overall Study|Disease progression|4|||
23236704|NCT01004861|64608304|FG006|Overall Study|Disease progression|5|||
23236705|NCT01004861|64608305|FG007|Overall Study|Disease progression|1|||
23236706|NCT01004861|64608306|FG008|Overall Study|Disease progression|4|||
23176709|NCT00236080|64390202|FG000|Overall Study|Miscellaneous|0|||
23176710|NCT00236080|64390203|FG001|Overall Study|Miscellaneous|0|||
23176711|NCT00236080|64390204|FG002|Overall Study|Miscellaneous|1|||
23236707|NCT01004861|64608307|FG009|Overall Study|Disease progression|7|||
23342285|NCT01905553|64996076|FG001|Period 2|Adverse Event|0|||
23342286|NCT02166463|64996077|FG000|Overall Study|Lost to Follow-up|0|||
23342287|NCT02166463|64996078|FG001|Overall Study|Lost to Follow-up|1|||
23342288|NCT02166463|64996077|FG000|Overall Study|Physician Decision|10|||
23342289|NCT02166463|64996078|FG001|Overall Study|Physician Decision|10|||
23342290|NCT02166463|64996077|FG000|Overall Study|Ineligible|11|||
23342291|NCT02166463|64996078|FG001|Overall Study|Ineligible|2|||
23454092|NCT03740048|65403470|FG001|Overall Study|Withdrawal by Subject|1|||
23454093|NCT03740048|65403469|FG000|Overall Study|Death|1|||
23454094|NCT03740048|65403470|FG001|Overall Study|Death|6|||
23454095|NCT03740048|65403469|FG000|Overall Study|Switched to thrice-weekly HD|2|||
23454096|NCT03740048|65403470|FG001|Overall Study|Switched to thrice-weekly HD|0|||
23454097|NCT03740048|65403469|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
23342292|NCT02166463|64996077|FG000|Overall Study|Progressive Disease|9|||
23342293|NCT02166463|64996078|FG001|Overall Study|Progressive Disease|6|||
23342294|NCT02166463|64996077|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
23342295|NCT02166463|64996078|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
23342296|NCT02166463|64996077|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
23342297|NCT02166463|64996078|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
23454098|NCT03740048|65403470|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
23454099|NCT03740048|65403469|FG000|Overall Study|Lost to Follow-up|0|||
23454100|NCT03740048|65403470|FG001|Overall Study|Lost to Follow-up|1|||
23454101|NCT03740048|65403469|FG000|Overall Study|Non-compliance with HD|0|||
23454102|NCT03740048|65403470|FG001|Overall Study|Non-compliance with HD|1|||
23454103|NCT04191616|65403471|FG000|Overall Study|Death|26|||
23582433|NCT03736785|65862479|FG002|Overall Study|Unknown/Missing data|1|||
23582434|NCT03736785|65862477|FG000|Overall Study|Withdrawal by Subject|9|||
23582435|NCT03736785|65862478|FG001|Overall Study|Withdrawal by Subject|6|||
23582436|NCT03736785|65862479|FG002|Overall Study|Withdrawal by Subject|4|||
23342298|NCT02166463|64996077|FG000|Overall Study|Refusal of further protocol therapy|5|||
23454104|NCT04191616|65403471|FG000|Overall Study|Withdrawal by Subject|1|||
23454105|NCT04191616|65403471|FG000|Overall Study|Sponsor decision|2|||
23582437|NCT05489224|65862480|FG000|Treatment Period I|Withdrawal by Subject|6|||
23582438|NCT05489224|65862481|FG001|Treatment Period I|Withdrawal by Subject|5|||
23582439|NCT05489224|65862482|FG002|Treatment Period I|Withdrawal by Subject|0|||
23582440|NCT05489224|65862480|FG000|Treatment Period I|Adverse Event|3|||
23582441|NCT05489224|65862481|FG001|Treatment Period I|Adverse Event|11|||
23582442|NCT05489224|65862482|FG002|Treatment Period I|Adverse Event|0|||
23582443|NCT05489224|65862480|FG000|Treatment Period I|Lost to Follow-up|0|||
23582444|NCT05489224|65862481|FG001|Treatment Period I|Lost to Follow-up|1|||
23582445|NCT05489224|65862482|FG002|Treatment Period I|Lost to Follow-up|0|||
23582446|NCT05489224|65862480|FG000|Treatment Period I|Physician Decision|0|||
23582447|NCT05489224|65862481|FG001|Treatment Period I|Physician Decision|1|||
23582448|NCT05489224|65862482|FG002|Treatment Period I|Physician Decision|0|||
23582449|NCT05489224|65862480|FG000|Treatment Period II up to Week 32|Ongoing|222|||
23582450|NCT05489224|65862481|FG001|Treatment Period II up to Week 32|Ongoing|107|||
23582451|NCT05489224|65862482|FG002|Treatment Period II up to Week 32|Ongoing|107|||
23176712|NCT00236080|64390205|FG003|Overall Study|Miscellaneous|0|||
23176713|NCT00236080|64390206|FG004|Overall Study|Miscellaneous|0|||
23176714|NCT02899156|64390207|FG000|Overall Study|Death|1|||
23176715|NCT02899156|64390208|FG001|Overall Study|Death|0|||
23176716|NCT02899156|64390207|FG000|Overall Study|Physician Decision|0|||
23176717|NCT02899156|64390208|FG001|Overall Study|Physician Decision|1|||
23176718|NCT01824979|64390209|FG000|Overall Study|Withdrawal by Subject|5|||
23176719|NCT01824979|64390210|FG001|Overall Study|Withdrawal by Subject|0|||
23176720|NCT01824979|64390209|FG000|Overall Study|Physician Decision|2|||
23176721|NCT01824979|64390210|FG001|Overall Study|Physician Decision|0|||
23176722|NCT01824979|64390209|FG000|Overall Study|Protocol Violation|6|||
23176723|NCT01824979|64390210|FG001|Overall Study|Protocol Violation|13|||
23176724|NCT02367521|64390211|FG000|Overall Study|severe headache after intervention|2|||
23176725|NCT02367521|64390212|FG001|Overall Study|severe headache after intervention|0|||
23176726|NCT02367521|64390211|FG000|Overall Study|unable to find transportation|2|||
23176727|NCT02367521|64390212|FG001|Overall Study|unable to find transportation|0|||
23176728|NCT01879410|64390218|FG000|Overall Study|Adverse Event|9|||
23176729|NCT01879410|64390219|FG001|Overall Study|Adverse Event|14|||
23176730|NCT01879410|64390218|FG000|Overall Study|Lack of Efficacy|4|||
23176731|NCT01879410|64390219|FG001|Overall Study|Lack of Efficacy|6|||
23176732|NCT01879410|64390218|FG000|Overall Study|Protocol Violation|1|||
23176733|NCT01879410|64390219|FG001|Overall Study|Protocol Violation|7|||
23176734|NCT01879410|64390218|FG000|Overall Study|Lost to Follow-up|2|||
23176735|NCT01879410|64390219|FG001|Overall Study|Lost to Follow-up|1|||
23176736|NCT01879410|64390218|FG000|Overall Study|Withdrawal by Subject|7|||
23176737|NCT01879410|64390219|FG001|Overall Study|Withdrawal by Subject|8|||
23342299|NCT02166463|64996078|FG001|Overall Study|Refusal of further protocol therapy|6|||
23454106|NCT04191616|65403471|FG000|Overall Study|Continuing study|25|||
23454107|NCT01172535|65403472|FG000|Overall Study|Death|3|||
23454108|NCT01172535|65403472|FG000|Overall Study|Withdrawal by Subject|2|||
23454109|NCT01172535|65403472|FG000|Overall Study|Lost to Follow-up|1|||
23454110|NCT01172535|65403472|FG000|Overall Study|Ineligible at study entry|1|||
23454111|NCT01172535|65403472|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
23454112|NCT01706458|65403475|FG000|Overall Study|Physician Decision|3|||
23454113|NCT01706458|65403476|FG001|Overall Study|Physician Decision|4|||
23454114|NCT04258423|65403477|FG000|Overall Study|Study Closure|2|||
23454115|NCT04258423|65403478|FG001|Overall Study|Study Closure|2|||
23454116|NCT02859246|65403479|FG000|Overall Study|Screen fails|3|||
23454117|NCT02859246|65403479|FG000|Overall Study|Adverse Event|1|||
23454118|NCT02859246|65403479|FG000|Overall Study|Withdrawal by Subject|1|||
23454119|NCT01600885|65403480|FG000|First Period|Adverse Event|1|||
23454120|NCT01600885|65403481|FG001|First Period|Adverse Event|1|||
23454121|NCT01600885|65403480|FG000|First Period|moved out of area|1|||
23454122|NCT01600885|65403481|FG001|First Period|moved out of area|0|||
23454123|NCT01921205|65403486|FG000|Overall Study|Adverse Event|12|||
23454124|NCT01921205|65403487|FG001|Overall Study|Adverse Event|7|||
23454125|NCT01921205|65403486|FG000|Overall Study|Lack of Efficacy|1|||
23236708|NCT01004861|64608308|FG010|Overall Study|Disease progression|6|||
23236709|NCT01004861|64608309|FG011|Overall Study|Disease progression|3|||
23236710|NCT01004861|64608310|FG012|Overall Study|Disease progression|8|||
23454126|NCT01921205|65403487|FG001|Overall Study|Lack of Efficacy|0|||
23454127|NCT01921205|65403486|FG000|Overall Study|Protocol Violation|1|||
23454128|NCT01921205|65403487|FG001|Overall Study|Protocol Violation|3|||
23454129|NCT01921205|65403486|FG000|Overall Study|Lost to Follow-up|1|||
23454130|NCT01921205|65403487|FG001|Overall Study|Lost to Follow-up|1|||
23454131|NCT01921205|65403486|FG000|Overall Study|Withdrawal by Subject|6|||
23454132|NCT01921205|65403487|FG001|Overall Study|Withdrawal by Subject|5|||
23454133|NCT01921205|65403486|FG000|Overall Study|Use Of Prohibited Medication|0|||
23454134|NCT01921205|65403487|FG001|Overall Study|Use Of Prohibited Medication|1|||
23454135|NCT01921205|65403486|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
23454136|NCT01921205|65403487|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
23454137|NCT01921205|65403486|FG000|Overall Study|Non Compliance Of The Parent|0|||
23454138|NCT01921205|65403487|FG001|Overall Study|Non Compliance Of The Parent|1|||
23454139|NCT01921205|65403486|FG000|Overall Study|Non Compliance Of Child|0|||
23454140|NCT01921205|65403487|FG001|Overall Study|Non Compliance Of Child|1|||
23236711|NCT01004861|64608298|FG000|Overall Study|Physician Decision|0|||
23236712|NCT01004861|64608299|FG001|Overall Study|Physician Decision|2|||
23236713|NCT01004861|64608300|FG002|Overall Study|Physician Decision|1|||
23236714|NCT01004861|64608301|FG003|Overall Study|Physician Decision|1|||
23236715|NCT01004861|64608302|FG004|Overall Study|Physician Decision|1|||
23236716|NCT01004861|64608303|FG005|Overall Study|Physician Decision|0|||
23236717|NCT01004861|64608304|FG006|Overall Study|Physician Decision|0|||
23236718|NCT01004861|64608305|FG007|Overall Study|Physician Decision|1|||
23236719|NCT01004861|64608306|FG008|Overall Study|Physician Decision|0|||
23236720|NCT01004861|64608307|FG009|Overall Study|Physician Decision|0|||
23236721|NCT01004861|64608308|FG010|Overall Study|Physician Decision|0|||
23236722|NCT01004861|64608309|FG011|Overall Study|Physician Decision|0|||
23236723|NCT01004861|64608310|FG012|Overall Study|Physician Decision|3|||
23236724|NCT01004861|64608298|FG000|Overall Study|Adverse Event|0|||
23236725|NCT01004861|64608299|FG001|Overall Study|Adverse Event|0|||
23236726|NCT01004861|64608300|FG002|Overall Study|Adverse Event|0|||
23236727|NCT01004861|64608301|FG003|Overall Study|Adverse Event|1|||
23236728|NCT01004861|64608302|FG004|Overall Study|Adverse Event|0|||
23236729|NCT01004861|64608303|FG005|Overall Study|Adverse Event|2|||
23454141|NCT01069484|65403493|FG000|Overall Study|Death-in-near-family|1|||
23454142|NCT01069484|65403494|FG001|Overall Study|Death-in-near-family|0|||
23454143|NCT01069484|65403493|FG000|Overall Study|No specific reason|8|||
23454144|NCT01069484|65403494|FG001|Overall Study|No specific reason|2|||
23454145|NCT01069484|65403493|FG000|Overall Study|Illness mother or child|3|||
23454146|NCT01069484|65403494|FG001|Overall Study|Illness mother or child|1|||
23454147|NCT01506271|65403495|FG000|Overall Study|Progressive disease|0|||
23454148|NCT01506271|65403496|FG001|Overall Study|Progressive disease|1|||
23454149|NCT01506271|65403497|FG002|Overall Study|Progressive disease|0|||
23454150|NCT01506271|65403495|FG000|Overall Study|Protocol Violation|3|||
23454151|NCT01506271|65403496|FG001|Overall Study|Protocol Violation|1|||
23582452|NCT05489224|65862480|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
23454152|NCT01506271|65403497|FG002|Overall Study|Protocol Violation|0|||
23236730|NCT01004861|64608304|FG006|Overall Study|Adverse Event|1|||
23236731|NCT01004861|64608305|FG007|Overall Study|Adverse Event|1|||
23236732|NCT01004861|64608306|FG008|Overall Study|Adverse Event|13|||
23236733|NCT01004861|64608307|FG009|Overall Study|Adverse Event|1|||
23236734|NCT01004861|64608308|FG010|Overall Study|Adverse Event|1|||
23236735|NCT01004861|64608309|FG011|Overall Study|Adverse Event|0|||
23454153|NCT01506271|65403495|FG000|Overall Study|Death|0|||
23454154|NCT01506271|65403496|FG001|Overall Study|Death|1|||
23454155|NCT01506271|65403497|FG002|Overall Study|Death|0|||
23454156|NCT01506271|65403495|FG000|Overall Study|Adverse Event|0|||
23454157|NCT01506271|65403496|FG001|Overall Study|Adverse Event|2|||
23454158|NCT01506271|65403497|FG002|Overall Study|Adverse Event|0|||
23454159|NCT01506271|65403495|FG000|Overall Study|Insufficient supply of study drug|1|||
23454160|NCT01506271|65403496|FG001|Overall Study|Insufficient supply of study drug|0|||
23454161|NCT01506271|65403497|FG002|Overall Study|Insufficient supply of study drug|0|||
23454162|NCT01506271|65403495|FG000|Overall Study|Withdrawal by Subject|0|||
23454163|NCT01506271|65403496|FG001|Overall Study|Withdrawal by Subject|1|||
23454164|NCT01506271|65403497|FG002|Overall Study|Withdrawal by Subject|1|||
23454165|NCT01506271|65403495|FG000|Overall Study|Lost to Follow-up|0|||
23454166|NCT01506271|65403496|FG001|Overall Study|Lost to Follow-up|1|||
23454167|NCT01506271|65403497|FG002|Overall Study|Lost to Follow-up|2|||
23454168|NCT03261336|65403511|FG000|Overall Study|Adverse Event|1|||
23454169|NCT02559622|65403513|FG000|Overall Study|Progressive disease|0|||
23454170|NCT02559622|65403514|FG001|Overall Study|Progressive disease|1|||
23454171|NCT02559622|65403515|FG002|Overall Study|Progressive disease|0|||
23454172|NCT02559622|65403516|FG003|Overall Study|Progressive disease|0|||
23454173|NCT02559622|65403513|FG000|Overall Study|Adverse Event|0|||
23454174|NCT02559622|65403514|FG001|Overall Study|Adverse Event|2|||
23454175|NCT02559622|65403515|FG002|Overall Study|Adverse Event|2|||
23454176|NCT02559622|65403516|FG003|Overall Study|Adverse Event|2|||
23454177|NCT02559622|65403513|FG000|Overall Study|Patient/guardian decision|1|||
23454178|NCT02559622|65403514|FG001|Overall Study|Patient/guardian decision|2|||
23454179|NCT02559622|65403515|FG002|Overall Study|Patient/guardian decision|0|||
23454180|NCT02559622|65403516|FG003|Overall Study|Patient/guardian decision|1|||
23454181|NCT01446159|65407050|FG000|Overall Study|Withdrawal by Subject|1|||
23454182|NCT01446159|65407051|FG001|Overall Study|Withdrawal by Subject|0|||
23454183|NCT01446159|65407052|FG002|Overall Study|Withdrawal by Subject|14|||
23454184|NCT01446159|65407053|FG003|Overall Study|Withdrawal by Subject|11|||
23454185|NCT01446159|65407050|FG000|Overall Study|Lost to Follow-up|0|||
23454186|NCT01446159|65407051|FG001|Overall Study|Lost to Follow-up|0|||
23454187|NCT01446159|65407052|FG002|Overall Study|Lost to Follow-up|1|||
23454188|NCT01446159|65407053|FG003|Overall Study|Lost to Follow-up|2|||
23454189|NCT01446159|65407050|FG000|Overall Study|Death|2|||
23454190|NCT01446159|65407051|FG001|Overall Study|Death|3|||
23454191|NCT01446159|65407052|FG002|Overall Study|Death|43|||
23454192|NCT01446159|65407053|FG003|Overall Study|Death|36|||
23454193|NCT01446159|65407050|FG000|Overall Study|Other|0|||
23342300|NCT01253174|64996080|FG000|Period 1|Randomized but not treated|0|||
23454194|NCT01446159|65407051|FG001|Overall Study|Other|0|||
23454195|NCT01446159|65407052|FG002|Overall Study|Other|13|||
23454196|NCT01446159|65407053|FG003|Overall Study|Other|13|||
23454197|NCT00671658|65407054|FG000|Overall Study|Physician Decision|5|||
23454198|NCT03600909|65407055|FG000|Overall Study|Not treated|0|||
23454199|NCT03600909|65407056|FG001|Overall Study|Not treated|3|||
23454200|NCT03600909|65407057|FG002|Overall Study|Not treated|0|||
23454201|NCT02421172|65407058|FG000|Period 1|Adverse Event|1|||
23454202|NCT02421172|65407059|FG001|Period 1|Adverse Event|0|||
23454203|NCT02421172|65407060|FG002|Period 1|Adverse Event|0|||
23454204|NCT02421172|65407061|FG003|Period 1|Adverse Event|0|||
23454205|NCT02421172|65407062|FG004|Period 1|Adverse Event|0|||
23454206|NCT02421172|65407058|FG000|Period 1|Lost to Follow-up|3|||
23454207|NCT02421172|65407059|FG001|Period 1|Lost to Follow-up|1|||
23454208|NCT02421172|65407060|FG002|Period 1|Lost to Follow-up|0|||
23454209|NCT02421172|65407061|FG003|Period 1|Lost to Follow-up|0|||
23454210|NCT02421172|65407062|FG004|Period 1|Lost to Follow-up|0|||
23454211|NCT02421172|65407058|FG000|Period 1|Patient/guardian decision|0|||
23454212|NCT02421172|65407059|FG001|Period 1|Patient/guardian decision|1|||
23454213|NCT02421172|65407060|FG002|Period 1|Patient/guardian decision|0|||
23454214|NCT02421172|65407061|FG003|Period 1|Patient/guardian decision|0|||
23454215|NCT02421172|65407062|FG004|Period 1|Patient/guardian decision|0|||
23454216|NCT02421172|65407058|FG000|Period 2|Adverse Event|0|||
23454217|NCT02421172|65407059|FG001|Period 2|Adverse Event|0|||
23454218|NCT02421172|65407060|FG002|Period 2|Adverse Event|4|||
23454219|NCT02421172|65407061|FG003|Period 2|Adverse Event|0|||
23454220|NCT02421172|65407062|FG004|Period 2|Adverse Event|0|||
23454221|NCT02421172|65407058|FG000|Period 2|Lost to Follow-up|0|||
23454222|NCT02421172|65407059|FG001|Period 2|Lost to Follow-up|0|||
23454223|NCT02421172|65407060|FG002|Period 2|Lost to Follow-up|0|||
23454224|NCT02421172|65407061|FG003|Period 2|Lost to Follow-up|1|||
23454225|NCT02421172|65407062|FG004|Period 2|Lost to Follow-up|0|||
23454226|NCT02421172|65407058|FG000|Period 2|Patient/guardian decision|0|||
23454227|NCT02421172|65407059|FG001|Period 2|Patient/guardian decision|0|||
23454228|NCT02421172|65407060|FG002|Period 2|Patient/guardian decision|3|||
23454229|NCT02421172|65407061|FG003|Period 2|Patient/guardian decision|2|||
23454230|NCT02421172|65407062|FG004|Period 2|Patient/guardian decision|1|||
23454231|NCT03289208|65407065|FG000|Overall Study|Adverse Event|1|||
23454232|NCT03289208|65407066|FG001|Overall Study|Adverse Event|0|||
23454233|NCT03289208|65407067|FG002|Overall Study|Adverse Event|0|||
23454234|NCT01075243|65407068|FG000|Overall Study|Lost to Follow-up|5|||
23454235|NCT01075243|65407069|FG001|Overall Study|Lost to Follow-up|2|||
23454236|NCT01075243|65407070|FG002|Overall Study|Lost to Follow-up|0|||
23454237|NCT01075243|65407068|FG000|Overall Study|Withdrawal by Subject|1|||
23454238|NCT01075243|65407069|FG001|Overall Study|Withdrawal by Subject|1|||
23454239|NCT01075243|65407070|FG002|Overall Study|Withdrawal by Subject|0|||
23454240|NCT01710345|65407074|FG000|Overall Study|Adverse Event|0|||
23454241|NCT01710345|65407075|FG001|Overall Study|Adverse Event|2|||
23454242|NCT01710345|65407076|FG002|Overall Study|Adverse Event|0|||
23454243|NCT01710345|65407074|FG000|Overall Study|Lack of Efficacy|2|||
23454244|NCT01710345|65407075|FG001|Overall Study|Lack of Efficacy|3|||
23454245|NCT01710345|65407076|FG002|Overall Study|Lack of Efficacy|1|||
23454246|NCT01710345|65407074|FG000|Overall Study|Drug Dosing Error|1|||
23454247|NCT01710345|65407075|FG001|Overall Study|Drug Dosing Error|0|||
23454248|NCT01710345|65407076|FG002|Overall Study|Drug Dosing Error|0|||
23454249|NCT00472108|65407077|FG000|Overall Study|Lost to Follow-up|0|||
23454250|NCT00472108|65407078|FG001|Overall Study|Lost to Follow-up|1|||
23454251|NCT04564846|65407083|FG000|Overall Study|Withdrawal by Subject|2|||
23454252|NCT04564846|65407084|FG001|Overall Study|Withdrawal by Subject|1|||
23454253|NCT04564846|65407083|FG000|Overall Study|Physician Decision|0|||
23454254|NCT04564846|65407084|FG001|Overall Study|Physician Decision|1|||
23454255|NCT04564846|65407083|FG000|Overall Study|Lost to Follow-up|0|||
23454256|NCT04564846|65407084|FG001|Overall Study|Lost to Follow-up|1|||
23454257|NCT04564846|65407083|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
23454258|NCT04564846|65407084|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
23454259|NCT04564846|65407083|FG000|Overall Study|Subject non-compliance|1|||
23454260|NCT04564846|65407084|FG001|Overall Study|Subject non-compliance|0|||
23454261|NCT03760029|65407087|FG000|Overall Study|Death|1|||
23236736|NCT01004861|64608310|FG012|Overall Study|Adverse Event|2|||
23236737|NCT01004861|64608298|FG000|Overall Study|Protocol Violation|0|||
23236738|NCT01004861|64608299|FG001|Overall Study|Protocol Violation|0|||
23236739|NCT01004861|64608300|FG002|Overall Study|Protocol Violation|0|||
23236740|NCT01004861|64608301|FG003|Overall Study|Protocol Violation|0|||
23236741|NCT01004861|64608302|FG004|Overall Study|Protocol Violation|1|||
23236742|NCT01004861|64608303|FG005|Overall Study|Protocol Violation|0|||
23236743|NCT01004861|64608304|FG006|Overall Study|Protocol Violation|0|||
23342301|NCT01253174|64996081|FG001|Period 1|Randomized but not treated|1|||
23342302|NCT01253174|64996082|FG002|Period 1|Randomized but not treated|1|||
23342303|NCT01253174|64996083|FG003|Period 1|Randomized but not treated|0|||
23342304|NCT01253174|64996084|FG004|Period 1|Randomized but not treated|1|||
23342305|NCT01253174|64996085|FG005|Period 1|Randomized but not treated|0|||
23342306|NCT01253174|64996080|FG000|Period 2|Adverse Event|0|||
23342307|NCT01253174|64996081|FG001|Period 2|Adverse Event|0|||
23342308|NCT01253174|64996082|FG002|Period 2|Adverse Event|1|||
23342309|NCT01253174|64996083|FG003|Period 2|Adverse Event|0|||
23342310|NCT01253174|64996084|FG004|Period 2|Adverse Event|0|||
23342311|NCT01253174|64996085|FG005|Period 2|Adverse Event|0|||
23236744|NCT01004861|64608305|FG007|Overall Study|Protocol Violation|0|||
23236745|NCT01004861|64608306|FG008|Overall Study|Protocol Violation|0|||
23236746|NCT01004861|64608307|FG009|Overall Study|Protocol Violation|0|||
23236747|NCT01004861|64608308|FG010|Overall Study|Protocol Violation|0|||
23236748|NCT01004861|64608309|FG011|Overall Study|Protocol Violation|0|||
23236749|NCT01004861|64608310|FG012|Overall Study|Protocol Violation|0|||
23342312|NCT01253174|64996080|FG000|Period 3|Withdrawal by Subject|0|||
23454262|NCT03760029|65407088|FG001|Overall Study|Death|0|||
23236750|NCT01004861|64608298|FG000|Overall Study|Lost to Follow-up|0|||
23454263|NCT03760029|65407089|FG002|Overall Study|Death|0|||
23454264|NCT03760029|65407087|FG000|Overall Study|Lost to Follow-up|0|||
23454265|NCT03760029|65407088|FG001|Overall Study|Lost to Follow-up|2|||
23454266|NCT03760029|65407089|FG002|Overall Study|Lost to Follow-up|1|||
23454267|NCT03760029|65407087|FG000|Overall Study|Withdrawal by Subject|1|||
23454268|NCT03760029|65407088|FG001|Overall Study|Withdrawal by Subject|4|||
23236751|NCT01004861|64608299|FG001|Overall Study|Lost to Follow-up|0|||
23236752|NCT01004861|64608300|FG002|Overall Study|Lost to Follow-up|0|||
23236753|NCT01004861|64608301|FG003|Overall Study|Lost to Follow-up|0|||
23342313|NCT01253174|64996081|FG001|Period 3|Withdrawal by Subject|1|||
23342314|NCT01253174|64996082|FG002|Period 3|Withdrawal by Subject|0|||
23342315|NCT01253174|64996083|FG003|Period 3|Withdrawal by Subject|0|||
23236754|NCT01004861|64608302|FG004|Overall Study|Lost to Follow-up|0|||
23236755|NCT01004861|64608303|FG005|Overall Study|Lost to Follow-up|0|||
23236756|NCT01004861|64608304|FG006|Overall Study|Lost to Follow-up|0|||
23236757|NCT01004861|64608305|FG007|Overall Study|Lost to Follow-up|1|||
23236758|NCT01004861|64608306|FG008|Overall Study|Lost to Follow-up|3|||
23236759|NCT01004861|64608307|FG009|Overall Study|Lost to Follow-up|0|||
23236760|NCT01004861|64608308|FG010|Overall Study|Lost to Follow-up|0|||
23236761|NCT01004861|64608309|FG011|Overall Study|Lost to Follow-up|1|||
23236762|NCT01004861|64608310|FG012|Overall Study|Lost to Follow-up|0|||
23236763|NCT01004861|64608298|FG000|Overall Study|Non-compliance|0|||
23236764|NCT01004861|64608299|FG001|Overall Study|Non-compliance|0|||
23236765|NCT01004861|64608300|FG002|Overall Study|Non-compliance|0|||
23236766|NCT01004861|64608301|FG003|Overall Study|Non-compliance|0|||
23236767|NCT01004861|64608302|FG004|Overall Study|Non-compliance|0|||
23236768|NCT01004861|64608303|FG005|Overall Study|Non-compliance|0|||
23236769|NCT01004861|64608304|FG006|Overall Study|Non-compliance|0|||
23236770|NCT01004861|64608305|FG007|Overall Study|Non-compliance|0|||
23236771|NCT01004861|64608306|FG008|Overall Study|Non-compliance|5|||
23236772|NCT01004861|64608307|FG009|Overall Study|Non-compliance|0|||
23236773|NCT01004861|64608308|FG010|Overall Study|Non-compliance|0|||
23236774|NCT01004861|64608309|FG011|Overall Study|Non-compliance|0|||
23236775|NCT01004861|64608310|FG012|Overall Study|Non-compliance|1|||
23236776|NCT01004861|64608298|FG000|Overall Study|Other|0|||
23236777|NCT01004861|64608299|FG001|Overall Study|Other|0|||
23236778|NCT01004861|64608300|FG002|Overall Study|Other|0|||
23236779|NCT01004861|64608301|FG003|Overall Study|Other|0|||
23236780|NCT01004861|64608302|FG004|Overall Study|Other|0|||
23236781|NCT01004861|64608303|FG005|Overall Study|Other|0|||
23236782|NCT01004861|64608304|FG006|Overall Study|Other|0|||
23454269|NCT03760029|65407089|FG002|Overall Study|Withdrawal by Subject|1|||
23454270|NCT03760029|65407087|FG000|Overall Study|Withdrawal by parent/guardian|4|||
23454271|NCT03760029|65407088|FG001|Overall Study|Withdrawal by parent/guardian|4|||
23454272|NCT03760029|65407089|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23454273|NCT03760029|65407087|FG000|Overall Study|Other|2|||
23176738|NCT01879410|64390218|FG000|Overall Study|Randomised in Error|1|||
23176739|NCT01879410|64390219|FG001|Overall Study|Randomised in Error|2|||
23176740|NCT03336502|64390220|FG000|Overall Study|Physician Decision|0|||
23176741|NCT03336502|64390221|FG001|Overall Study|Physician Decision|1|||
23176742|NCT03336502|64390220|FG000|Overall Study|Prohibited Drugs|1|||
23176743|NCT03336502|64390221|FG001|Overall Study|Prohibited Drugs|1|||
23176744|NCT03336502|64390220|FG000|Overall Study|Death|1|||
23176745|NCT03336502|64390221|FG001|Overall Study|Death|2|||
23176746|NCT03336502|64390220|FG000|Overall Study|Adverse Event|2|||
23176747|NCT03336502|64390221|FG001|Overall Study|Adverse Event|5|||
23176748|NCT02789657|64390222|FG000|Overall Study|Withdrawal by Subject|2|||
23176749|NCT02789657|64390223|FG001|Overall Study|Withdrawal by Subject|0|||
23176750|NCT02789657|64390224|FG002|Overall Study|Withdrawal by Subject|0|||
23176751|NCT02789657|64390225|FG003|Overall Study|Withdrawal by Subject|0|||
23176752|NCT01528787|64390226|FG000|Overall Study|Withdrawal by Subject|0|||
23176753|NCT01528787|64390227|FG001|Overall Study|Withdrawal by Subject|0|||
23176754|NCT01528787|64390228|FG002|Overall Study|Withdrawal by Subject|0|||
23176755|NCT01528787|64390229|FG003|Overall Study|Withdrawal by Subject|1|||
23176756|NCT01528787|64390226|FG000|Overall Study|Family Emergency|0|||
23176757|NCT01528787|64390227|FG001|Overall Study|Family Emergency|0|||
23176758|NCT01528787|64390228|FG002|Overall Study|Family Emergency|1|||
23176759|NCT01528787|64390229|FG003|Overall Study|Family Emergency|0|||
23176760|NCT01163786|64390230|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
23176761|NCT01163786|64390230|FG000|Treatment With Bortezomib|Adverse Event|2|||
23176762|NCT01163786|64390230|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
23176763|NCT00330187|64390232|FG000|Overall Study|Lost to Follow-up|12|||
23176764|NCT00330187|64390233|FG001|Overall Study|Lost to Follow-up|13|||
23176765|NCT00330187|64390234|FG002|Overall Study|Lost to Follow-up|14|||
23176766|NCT00330187|64390235|FG003|Overall Study|Lost to Follow-up|10|||
23176767|NCT00330187|64390232|FG000|Overall Study|Withdrawal by Subject|8|||
23176768|NCT00330187|64390233|FG001|Overall Study|Withdrawal by Subject|5|||
23176769|NCT00330187|64390234|FG002|Overall Study|Withdrawal by Subject|4|||
23176770|NCT00330187|64390235|FG003|Overall Study|Withdrawal by Subject|4|||
23176771|NCT01551693|64390236|FG000|Overall Study|Disease Progression|1|||
23176772|NCT01551693|64390237|FG001|Overall Study|Disease Progression|0|||
23176773|NCT01551693|64390236|FG000|Overall Study|Adverse Event|0|||
23176774|NCT01551693|64390237|FG001|Overall Study|Adverse Event|1|||
23176775|NCT01551693|64390236|FG000|Overall Study|Withdrawal by Subject|0|||
23176776|NCT01551693|64390237|FG001|Overall Study|Withdrawal by Subject|1|||
23236783|NCT01004861|64608305|FG007|Overall Study|Other|0|||
23454274|NCT03760029|65407088|FG001|Overall Study|Other|1|||
23454275|NCT03760029|65407089|FG002|Overall Study|Other|0|||
23176777|NCT00888238|64390238|FG000|Washout Period After Period 2|Adverse Event|0|||
23236784|NCT01004861|64608306|FG008|Overall Study|Other|0|||
23236785|NCT01004861|64608307|FG009|Overall Study|Other|2|||
23236786|NCT01004861|64608308|FG010|Overall Study|Other|1|||
23236787|NCT01004861|64608309|FG011|Overall Study|Other|2|||
23236788|NCT01004861|64608310|FG012|Overall Study|Other|3|||
23236789|NCT01004861|64608298|FG000|Overall Study|Patient decision|0|||
23236790|NCT01004861|64608299|FG001|Overall Study|Patient decision|0|||
23236791|NCT01004861|64608300|FG002|Overall Study|Patient decision|0|||
23236792|NCT01004861|64608301|FG003|Overall Study|Patient decision|0|||
23236793|NCT01004861|64608302|FG004|Overall Study|Patient decision|1|||
23236794|NCT01004861|64608303|FG005|Overall Study|Patient decision|0|||
23236795|NCT01004861|64608304|FG006|Overall Study|Patient decision|1|||
23236796|NCT01004861|64608305|FG007|Overall Study|Patient decision|0|||
23236797|NCT01004861|64608306|FG008|Overall Study|Patient decision|7|||
23236798|NCT01004861|64608307|FG009|Overall Study|Patient decision|1|||
23236799|NCT01004861|64608308|FG010|Overall Study|Patient decision|1|||
23236800|NCT01004861|64608309|FG011|Overall Study|Patient decision|2|||
23236801|NCT01004861|64608310|FG012|Overall Study|Patient decision|3|||
23236802|NCT01004861|64608298|FG000|Overall Study|Transitioned to Phase 4 study|0|||
23236803|NCT01004861|64608299|FG001|Overall Study|Transitioned to Phase 4 study|0|||
23236804|NCT01004861|64608300|FG002|Overall Study|Transitioned to Phase 4 study|0|||
23236805|NCT01004861|64608301|FG003|Overall Study|Transitioned to Phase 4 study|0|||
23236806|NCT01004861|64608302|FG004|Overall Study|Transitioned to Phase 4 study|0|||
23236807|NCT01004861|64608303|FG005|Overall Study|Transitioned to Phase 4 study|0|||
23236808|NCT01004861|64608304|FG006|Overall Study|Transitioned to Phase 4 study|0|||
23236809|NCT01004861|64608305|FG007|Overall Study|Transitioned to Phase 4 study|0|||
23236810|NCT01004861|64608306|FG008|Overall Study|Transitioned to Phase 4 study|2|||
23236811|NCT01004861|64608307|FG009|Overall Study|Transitioned to Phase 4 study|0|||
23236812|NCT01004861|64608308|FG010|Overall Study|Transitioned to Phase 4 study|0|||
23236813|NCT01004861|64608309|FG011|Overall Study|Transitioned to Phase 4 study|0|||
23236814|NCT01004861|64608310|FG012|Overall Study|Transitioned to Phase 4 study|0|||
23236815|NCT01004861|64608298|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236816|NCT01004861|64608299|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236817|NCT01004861|64608300|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236818|NCT01004861|64608301|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236819|NCT01004861|64608302|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236820|NCT01004861|64608303|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236821|NCT01004861|64608304|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236822|NCT01004861|64608305|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236823|NCT01004861|64608306|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
23236824|NCT01004861|64608307|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236825|NCT01004861|64608308|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236826|NCT01004861|64608309|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236827|NCT01004861|64608310|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
23236828|NCT01004861|64608298|FG000|Overall Study|Patient withdrew|0|||
23236829|NCT01004861|64608299|FG001|Overall Study|Patient withdrew|0|||
23236830|NCT01004861|64608300|FG002|Overall Study|Patient withdrew|0|||
23236831|NCT01004861|64608301|FG003|Overall Study|Patient withdrew|0|||
23236832|NCT01004861|64608302|FG004|Overall Study|Patient withdrew|0|||
23236833|NCT01004861|64608303|FG005|Overall Study|Patient withdrew|0|||
23236834|NCT01004861|64608304|FG006|Overall Study|Patient withdrew|0|||
23236835|NCT01004861|64608305|FG007|Overall Study|Patient withdrew|0|||
23236836|NCT01004861|64608306|FG008|Overall Study|Patient withdrew|1|||
23236837|NCT01004861|64608307|FG009|Overall Study|Patient withdrew|0|||
23236838|NCT01004861|64608308|FG010|Overall Study|Patient withdrew|0|||
23236839|NCT01004861|64608309|FG011|Overall Study|Patient withdrew|0|||
23236840|NCT01004861|64608310|FG012|Overall Study|Patient withdrew|0|||
23236841|NCT01004861|64608298|FG000|Overall Study|Surgical resection|0|||
23236842|NCT01004861|64608299|FG001|Overall Study|Surgical resection|0|||
23236843|NCT01004861|64608300|FG002|Overall Study|Surgical resection|0|||
23236844|NCT01004861|64608301|FG003|Overall Study|Surgical resection|0|||
23236845|NCT01004861|64608302|FG004|Overall Study|Surgical resection|0|||
23236846|NCT01004861|64608303|FG005|Overall Study|Surgical resection|0|||
23236847|NCT01004861|64608304|FG006|Overall Study|Surgical resection|0|||
23236848|NCT01004861|64608305|FG007|Overall Study|Surgical resection|0|||
23236849|NCT01004861|64608306|FG008|Overall Study|Surgical resection|1|||
23236850|NCT01004861|64608307|FG009|Overall Study|Surgical resection|0|||
23236851|NCT01004861|64608308|FG010|Overall Study|Surgical resection|0|||
23236852|NCT01004861|64608309|FG011|Overall Study|Surgical resection|0|||
23236853|NCT01004861|64608310|FG012|Overall Study|Surgical resection|0|||
23236854|NCT01004861|64608298|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236855|NCT01004861|64608299|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236856|NCT01004861|64608300|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23342316|NCT01253174|64996084|FG004|Period 3|Withdrawal by Subject|1|||
23342317|NCT01253174|64996085|FG005|Period 3|Withdrawal by Subject|0|||
23342318|NCT01253174|64996080|FG000|Period 3|Pregnancy|0|||
23342319|NCT01253174|64996081|FG001|Period 3|Pregnancy|0|||
23342320|NCT01253174|64996082|FG002|Period 3|Pregnancy|1|||
23342321|NCT01253174|64996083|FG003|Period 3|Pregnancy|0|||
23342322|NCT01253174|64996084|FG004|Period 3|Pregnancy|0|||
23342323|NCT01253174|64996085|FG005|Period 3|Pregnancy|0|||
23342324|NCT00567489|64996086|FG000|Overall Study|Adverse Event|6|||
23342325|NCT00567489|64996087|FG001|Overall Study|Adverse Event|14|||
23342326|NCT00567489|64996086|FG000|Overall Study|Physician Decision|0|||
23342327|NCT00567489|64996087|FG001|Overall Study|Physician Decision|4|||
23342328|NCT00567489|64996086|FG000|Overall Study|Withdrawal by Subject|0|||
23342329|NCT00567489|64996087|FG001|Overall Study|Withdrawal by Subject|2|||
23342330|NCT00567489|64996086|FG000|Overall Study|Renal Transplantation|0|||
23342331|NCT00567489|64996087|FG001|Overall Study|Renal Transplantation|3|||
23342332|NCT00567489|64996086|FG000|Overall Study|Other|1|||
23342333|NCT00567489|64996087|FG001|Overall Study|Other|0|||
23342334|NCT03197324|64996088|FG000|Overall Study|Adverse Event|0|||
23342335|NCT03197324|64996089|FG001|Overall Study|Adverse Event|1|||
23342336|NCT01254318|64996098|FG000|Overall Study|Lost to Follow-up|5|||
23342337|NCT01254318|64996098|FG000|Overall Study|Death|47|||
23342338|NCT00348790|64996099|FG000|Completed Treatment|Withdrawal by Subject|4|||
23342339|NCT00348790|64996099|FG000|Completed Treatment|Disease progression|14|||
23342340|NCT00348790|64996099|FG000|Completed Treatment|Adverse Event|4|||
23342341|NCT00348790|64996099|FG000|Completed Treatment|Required surgery|2|||
23342342|NCT00348790|64996099|FG000|Completed Treatment|Unable to travel to study site|1|||
23342343|NCT03687372|64996102|FG000|Overall Study|Lost to Follow-up|12|||
23342344|NCT03687372|64996103|FG001|Overall Study|Lost to Follow-up|21|||
23342345|NCT03687372|64996102|FG000|Overall Study|Withdrawal by Subject|4|||
23342346|NCT03687372|64996103|FG001|Overall Study|Withdrawal by Subject|17|||
23342347|NCT03687372|64996102|FG000|Overall Study|Investigator Decision|1|||
23342348|NCT03687372|64996103|FG001|Overall Study|Investigator Decision|1|||
23342349|NCT04050124|64996104|FG000|Overall Study|Death|1|||
23342350|NCT04050124|64996105|FG001|Overall Study|Death|0|||
23342351|NCT02832375|64996108|FG000|Overall Study|Lost to Follow-up|1|||
23342352|NCT02832375|64996109|FG001|Overall Study|Lost to Follow-up|0|||
23342353|NCT02832375|64996108|FG000|Overall Study|Withdrawal of Consent|1|||
23342354|NCT02832375|64996109|FG001|Overall Study|Withdrawal of Consent|0|||
23342355|NCT01943851|64996112|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342356|NCT01943851|64996113|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342357|NCT01943851|64996114|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342358|NCT01943851|64996115|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
23342359|NCT01943851|64996116|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342360|NCT01943851|64996117|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342361|NCT01943851|64996118|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
23342362|NCT01943851|64996119|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
23342363|NCT01943851|64996120|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
23342364|NCT01943851|64996121|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342365|NCT01943851|64996122|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342366|NCT01943851|64996123|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342367|NCT01943851|64996124|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342368|NCT01943851|64996125|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342369|NCT01943851|64996126|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342370|NCT01943851|64996127|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23236857|NCT01004861|64608301|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236858|NCT01004861|64608302|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236859|NCT01004861|64608303|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236860|NCT01004861|64608304|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236861|NCT01004861|64608305|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236862|NCT01004861|64608306|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
23236863|NCT01004861|64608307|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236864|NCT01004861|64608308|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236865|NCT01004861|64608309|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236866|NCT01004861|64608310|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
23236867|NCT01004861|64608298|FG000|Overall Study|Study termination by Sponsor|0|||
23236868|NCT01004861|64608299|FG001|Overall Study|Study termination by Sponsor|0|||
23236869|NCT01004861|64608300|FG002|Overall Study|Study termination by Sponsor|0|||
23236870|NCT01004861|64608301|FG003|Overall Study|Study termination by Sponsor|0|||
23236871|NCT01004861|64608302|FG004|Overall Study|Study termination by Sponsor|0|||
23236872|NCT01004861|64608303|FG005|Overall Study|Study termination by Sponsor|0|||
23236873|NCT01004861|64608304|FG006|Overall Study|Study termination by Sponsor|0|||
23236874|NCT01004861|64608305|FG007|Overall Study|Study termination by Sponsor|0|||
23236875|NCT01004861|64608306|FG008|Overall Study|Study termination by Sponsor|1|||
23236876|NCT01004861|64608307|FG009|Overall Study|Study termination by Sponsor|0|||
23236877|NCT01004861|64608308|FG010|Overall Study|Study termination by Sponsor|0|||
23236878|NCT01004861|64608309|FG011|Overall Study|Study termination by Sponsor|0|||
23236879|NCT01004861|64608310|FG012|Overall Study|Study termination by Sponsor|0|||
23236880|NCT03382639|64608311|FG000|Overall Study|Adverse Event|2|||
23236881|NCT03382639|64608312|FG001|Overall Study|Adverse Event|0|||
23236882|NCT03382639|64608313|FG002|Overall Study|Adverse Event|1|||
23236883|NCT03382639|64608314|FG003|Overall Study|Adverse Event|1|||
23236884|NCT03382639|64608311|FG000|Overall Study|Lost to Follow-up|1|||
23236885|NCT03382639|64608312|FG001|Overall Study|Lost to Follow-up|0|||
23236886|NCT03382639|64608313|FG002|Overall Study|Lost to Follow-up|0|||
23236887|NCT03382639|64608314|FG003|Overall Study|Lost to Follow-up|0|||
23236888|NCT03382639|64608311|FG000|Overall Study|Withdrawal by Subject|4|||
23236889|NCT03382639|64608312|FG001|Overall Study|Withdrawal by Subject|3|||
23236890|NCT03382639|64608313|FG002|Overall Study|Withdrawal by Subject|2|||
23236891|NCT03382639|64608314|FG003|Overall Study|Withdrawal by Subject|3|||
23236892|NCT03382639|64608311|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
23236893|NCT03382639|64608312|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
23236894|NCT03382639|64608313|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
23236895|NCT03382639|64608314|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
23236896|NCT03382639|64608311|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
23236897|NCT03382639|64608312|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
23342371|NCT01943851|64996128|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342372|NCT01943851|64996129|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
23342373|NCT01943851|64996112|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342374|NCT01943851|64996113|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342375|NCT01943851|64996114|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342376|NCT01943851|64996115|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342377|NCT01943851|64996116|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
23342378|NCT01943851|64996117|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342379|NCT01943851|64996118|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342380|NCT01943851|64996119|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
23342381|NCT01943851|64996120|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342382|NCT01943851|64996121|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23236898|NCT03382639|64608313|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
23236899|NCT03382639|64608314|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
23236900|NCT03382639|64608311|FG000|Overall Study|Other|2|||
23236901|NCT03382639|64608312|FG001|Overall Study|Other|0|||
23236902|NCT03382639|64608313|FG002|Overall Study|Other|0|||
23236903|NCT03382639|64608314|FG003|Overall Study|Other|3|||
23454276|NCT01519323|65407094|FG000|Overall Study|Death|3|||
23236904|NCT00545584|64608315|FG000|Overall Study|Only one reason for discontinuation|62|||
23236905|NCT00545584|64608316|FG001|Overall Study|Only one reason for discontinuation|61|||
23236906|NCT00545584|64608317|FG002|Overall Study|Only one reason for discontinuation|48|||
23236907|NCT00545584|64608315|FG000|Overall Study|Two or more reasons for discontinuation|17|||
23342383|NCT01943851|64996122|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342384|NCT01943851|64996123|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342385|NCT01943851|64996124|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23236908|NCT00545584|64608316|FG001|Overall Study|Two or more reasons for discontinuation|19|||
23342386|NCT01943851|64996125|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23236909|NCT00545584|64608317|FG002|Overall Study|Two or more reasons for discontinuation|8|||
23236910|NCT01258803|64611316|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
23236911|NCT01258803|64611317|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
23236912|NCT01258803|64611318|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
23236913|NCT01258803|64611319|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
23236914|NCT01258803|64611320|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
23236915|NCT01258803|64611321|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
23236916|NCT01258803|64611316|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23236917|NCT01258803|64611317|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
23236918|NCT01258803|64611318|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23236919|NCT01258803|64611319|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23236920|NCT01258803|64611320|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23236921|NCT01258803|64611321|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
23236922|NCT01258803|64611316|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23236923|NCT01258803|64611317|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23236924|NCT01258803|64611318|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
23236925|NCT01258803|64611319|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23236926|NCT01258803|64611320|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23342387|NCT01943851|64996126|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342388|NCT01943851|64996127|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342389|NCT01943851|64996128|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342390|NCT01943851|64996129|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
23342391|NCT01943851|64996112|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342392|NCT01943851|64996113|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342393|NCT01943851|64996114|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342394|NCT01943851|64996115|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342395|NCT01943851|64996116|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342396|NCT01943851|64996117|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342397|NCT01943851|64996118|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342398|NCT01943851|64996119|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342399|NCT01943851|64996120|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342400|NCT01943851|64996121|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342401|NCT01943851|64996122|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342402|NCT01943851|64996123|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342403|NCT01943851|64996124|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342404|NCT01943851|64996125|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
23342405|NCT01943851|64996126|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342406|NCT01943851|64996127|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342407|NCT01943851|64996128|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23454277|NCT01519323|65407095|FG001|Overall Study|Death|2|||
23176778|NCT00888238|64390239|FG001|Washout Period After Period 2|Adverse Event|0|||
23176779|NCT00888238|64390240|FG002|Washout Period After Period 2|Adverse Event|1|||
23176780|NCT01497262|64390241|FG000|Overall Study|Abnormal Lab Values|4|||
23176781|NCT01497262|64390241|FG000|Overall Study|Abnormal Test Procedure Result|1|||
23176782|NCT01497262|64390241|FG000|Overall Study|Physician Decision|1|||
23176783|NCT01497262|64390241|FG000|Overall Study|Withdrawal by Subject|2|||
23176784|NCT01497262|64390241|FG000|Overall Study|Adverse Event|2|||
23176785|NCT01497262|64390241|FG000|Overall Study|Protocol Violation|1|||
23236927|NCT01258803|64611321|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
23454278|NCT01519323|65407094|FG000|Overall Study|Study terminated by sponsor|0|||
23454279|NCT01519323|65407095|FG001|Overall Study|Study terminated by sponsor|1|||
23236928|NCT00496782|64611326|FG000|Overall Study|Protocol Violation|1|||
23236929|NCT00496782|64611327|FG001|Overall Study|Protocol Violation|2|||
23342408|NCT01943851|64996129|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
23342409|NCT01943851|64996112|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342410|NCT01943851|64996113|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342411|NCT01943851|64996114|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342412|NCT01943851|64996115|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23454280|NCT02234843|65407096|FG000|Overall Study|Death|1|||
23582453|NCT05489224|65862481|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
23582454|NCT05489224|65862482|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
23582455|NCT05489224|65862480|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
23582456|NCT05489224|65862481|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
23582457|NCT05489224|65862482|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
23582458|NCT00991276|65862483|FG000|First Intervention Period|Adverse Event|0|||
23582459|NCT00991276|65862484|FG001|First Intervention Period|Adverse Event|1|||
23582460|NCT00991276|65862485|FG002|First Intervention Period|Adverse Event|0|||
23582461|NCT00991276|65862486|FG003|First Intervention Period|Adverse Event|1|||
23236930|NCT03672006|64611329|FG000|Overall Study|exclusion criteria met|0|||
23342413|NCT01943851|64996116|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342414|NCT01943851|64996117|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342415|NCT01943851|64996118|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342416|NCT01943851|64996119|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342417|NCT01943851|64996120|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342418|NCT01943851|64996121|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342419|NCT01943851|64996122|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342420|NCT01943851|64996123|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342421|NCT01943851|64996124|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342422|NCT01943851|64996125|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342423|NCT01943851|64996126|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342424|NCT01943851|64996127|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
23342425|NCT01943851|64996128|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342426|NCT01943851|64996129|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
23342427|NCT01943851|64996112|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342428|NCT01943851|64996113|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342429|NCT01943851|64996114|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342430|NCT01943851|64996115|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342431|NCT01943851|64996116|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342432|NCT01943851|64996117|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342433|NCT01943851|64996118|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342434|NCT01943851|64996119|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342435|NCT01943851|64996120|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342436|NCT01943851|64996121|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342437|NCT01943851|64996122|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342438|NCT01943851|64996123|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342439|NCT01943851|64996124|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342440|NCT01943851|64996125|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342441|NCT01943851|64996126|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
23342442|NCT01943851|64996127|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
23342443|NCT01943851|64996128|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
23342444|NCT01943851|64996129|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
23342445|NCT01740128|64996130|FG000|Overall Study|Pregnancy|0|||
23342446|NCT01740128|64996131|FG001|Overall Study|Pregnancy|1|||
23342447|NCT01740128|64996130|FG000|Overall Study|Protocol Violation|1|||
23342448|NCT01740128|64996131|FG001|Overall Study|Protocol Violation|2|||
23342449|NCT01740128|64996130|FG000|Overall Study|Lost to Follow-up|2|||
23342450|NCT01740128|64996131|FG001|Overall Study|Lost to Follow-up|2|||
23342451|NCT01740128|64996130|FG000|Overall Study|Withdrawal by Subject|1|||
23342452|NCT01740128|64996131|FG001|Overall Study|Withdrawal by Subject|0|||
23342453|NCT01740128|64996130|FG000|Overall Study|Insufficient protocol compliance|2|||
23342454|NCT01740128|64996131|FG001|Overall Study|Insufficient protocol compliance|2|||
23342455|NCT00655733|64996135|FG000|Overall Study|Lost to Follow-up|2|||
23342456|NCT00655733|64996136|FG001|Overall Study|Lost to Follow-up|2|||
23342457|NCT00655733|64996135|FG000|Overall Study|Adverse Event|2|||
23342458|NCT00655733|64996136|FG001|Overall Study|Adverse Event|2|||
23342459|NCT00655733|64996135|FG000|Overall Study|Withdrawal by Subject|3|||
23342460|NCT00655733|64996136|FG001|Overall Study|Withdrawal by Subject|3|||
23342461|NCT00655733|64996135|FG000|Overall Study|Physician Decision|0|||
23342462|NCT00655733|64996136|FG001|Overall Study|Physician Decision|1|||
23342463|NCT02347891|64996137|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
23236931|NCT03672006|64611330|FG001|Overall Study|exclusion criteria met|1|||
23236932|NCT02528331|64611331|FG000|Overall Study|Withdrawal by Subject|2|||
23236933|NCT00125138|64611332|FG000|Overall Study|Adverse Event|1|||
23236934|NCT00125138|64611333|FG001|Overall Study|Adverse Event|0|||
23236935|NCT00125138|64611334|FG002|Overall Study|Adverse Event|3|||
23236936|NCT00125138|64611335|FG003|Overall Study|Adverse Event|2|||
23236937|NCT00125138|64611332|FG000|Overall Study|Withdrawal by Subject|2|||
23236938|NCT00125138|64611333|FG001|Overall Study|Withdrawal by Subject|3|||
23236939|NCT00125138|64611334|FG002|Overall Study|Withdrawal by Subject|1|||
23236940|NCT00125138|64611335|FG003|Overall Study|Withdrawal by Subject|1|||
23236941|NCT00125138|64611332|FG000|Overall Study|Lack of Efficacy|0|||
23236942|NCT00125138|64611333|FG001|Overall Study|Lack of Efficacy|0|||
23236943|NCT00125138|64611334|FG002|Overall Study|Lack of Efficacy|0|||
23236944|NCT00125138|64611335|FG003|Overall Study|Lack of Efficacy|1|||
23236945|NCT00125138|64611332|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
23236946|NCT00125138|64611333|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
23236947|NCT00125138|64611334|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
23342464|NCT02347891|64996138|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
23342465|NCT02347891|64996137|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
23342466|NCT02347891|64996138|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
23342467|NCT03361865|64996139|FG000|Overall Study|Death|17|||
23342468|NCT03361865|64996140|FG001|Overall Study|Death|18|||
23342469|NCT03361865|64996139|FG000|Overall Study|Physician Decision|1|||
23236948|NCT00125138|64611335|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
23236949|NCT01967134|64611336|FG000|Overall Study|Lost to Follow-up|0|||
23236950|NCT01967134|64611337|FG001|Overall Study|Lost to Follow-up|1|||
23236951|NCT01967134|64611338|FG002|Overall Study|Lost to Follow-up|0|||
23236952|NCT00267202|64611339|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
23236953|NCT00267202|64611340|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23236954|NCT00267202|64611339|FG000|Overall Study|Withdrawal by Subject|12|||
23236955|NCT00267202|64611340|FG001|Overall Study|Withdrawal by Subject|15|||
23236956|NCT00267202|64611339|FG000|Overall Study|Adverse Event|13|||
23236957|NCT00267202|64611340|FG001|Overall Study|Adverse Event|7|||
23342470|NCT03361865|64996140|FG001|Overall Study|Physician Decision|9|||
23342471|NCT03361865|64996139|FG000|Overall Study|Withdrawal by Subject|1|||
23342472|NCT03361865|64996140|FG001|Overall Study|Withdrawal by Subject|0|||
23342473|NCT03814720|64996141|FG000|Overall Study|Lost to Follow-up|0|||
23342474|NCT03814720|64996142|FG001|Overall Study|Lost to Follow-up|1|||
23342475|NCT03814720|64996143|FG002|Overall Study|Lost to Follow-up|0|||
23342476|NCT03814720|64996144|FG003|Overall Study|Lost to Follow-up|0|||
23342477|NCT03814720|64996145|FG004|Overall Study|Lost to Follow-up|0|||
23342478|NCT00965341|64996146|FG000|Overall Study|Withdrew consent|1|||
23342479|NCT00965341|64996147|FG001|Overall Study|Withdrew consent|5|||
23342480|NCT00965341|64996146|FG000|Overall Study|Lost to Follow-up|1|||
23342481|NCT00965341|64996147|FG001|Overall Study|Lost to Follow-up|0|||
23342482|NCT00965341|64996146|FG000|Overall Study|Transportation issues|4|||
23342483|NCT00965341|64996147|FG001|Overall Study|Transportation issues|3|||
23342484|NCT02375555|64996148|FG000|Induction Period|Adverse Event|7|||
23342485|NCT02375555|64996148|FG000|Induction Period|Withdrawal by Subject|2|||
23342486|NCT02375555|64996148|FG000|Induction Period|Other|1|||
23342487|NCT02375555|64996148|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
23342488|NCT02375555|64996148|FG000|Maintenance Period|Adverse Event|2|||
23342489|NCT02375555|64996148|FG000|Maintenance Period|Withdrawal by Subject|4|||
23342490|NCT02375555|64996148|FG000|Maintenance Period|Death|1|||
23342491|NCT02375555|64996148|FG000|Maintenance Period|Disease Progression|5|||
23342492|NCT02375555|64996148|FG000|Maintenance Period|Patient Non-compliance|1|||
23342493|NCT02375555|64996148|FG000|Maintenance Period|Still on maintenance|16|||
23342494|NCT01968707|64996149|FG000|Overall Study|Did not meet treatment day baseline|49|||
23342495|NCT01968707|64996150|FG001|Overall Study|Did not meet treatment day baseline|12|||
23342496|NCT01968707|64996151|FG002|Overall Study|Did not meet treatment day baseline|41|||
23342497|NCT01968707|64996152|FG003|Overall Study|Did not meet treatment day baseline|44|||
23342498|NCT01968707|64996153|FG004|Overall Study|Did not meet treatment day baseline|36|||
23342499|NCT01968707|64996154|FG005|Overall Study|Did not meet treatment day baseline|11|||
23342500|NCT01968707|64996155|FG006|Overall Study|Did not meet treatment day baseline|34|||
23342501|NCT01968707|64996156|FG007|Overall Study|Did not meet treatment day baseline|35|||
23342502|NCT01424514|64996164|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
23342503|NCT01424514|64996165|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
23342504|NCT01424514|64996164|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
23342505|NCT01424514|64996165|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
23342506|NCT03602391|64999626|FG000|Overall Study|COVID-19|7|||
23342507|NCT03602391|64999627|FG001|Overall Study|COVID-19|6|||
23342508|NCT03981900|64999638|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
23342509|NCT03981900|64999638|FG000|Overall Study|Adverse Event|5|||
23342510|NCT03981900|64999638|FG000|Overall Study|Protocol Violation|1|||
23342511|NCT03981900|64999638|FG000|Overall Study|Withdrawal by Subject|7|||
23342512|NCT03981900|64999638|FG000|Overall Study|Lost to Follow-up|46|||
23342513|NCT03981900|64999638|FG000|Overall Study|Decision of the researcher|3|||
23342514|NCT03981900|64999638|FG000|Overall Study|Death|3|||
23342515|NCT03981900|64999638|FG000|Overall Study|Other|5|||
23342516|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342517|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342518|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342519|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342520|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
23342521|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
23342522|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342523|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342524|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342525|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342526|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
23342527|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
23342528|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Adverse Event|0|||
23236958|NCT00267202|64611339|FG000|Overall Study|Protocol Violation|2|||
23236959|NCT00267202|64611340|FG001|Overall Study|Protocol Violation|3|||
23236960|NCT00267202|64611339|FG000|Overall Study|Administrative problems|2|||
23454281|NCT02234843|65407097|FG001|Overall Study|Death|0|||
23236961|NCT00267202|64611340|FG001|Overall Study|Administrative problems|1|||
23342529|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Adverse Event|0|||
23342530|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Adverse Event|0|||
23342531|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Adverse Event|0|||
23342532|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Adverse Event|0|||
23342533|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Adverse Event|2|||
23342534|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342535|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342536|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342537|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342538|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
23342539|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
23342540|NCT03191864|64999639|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23342541|NCT03191864|64999640|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23342542|NCT03191864|64999641|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23342543|NCT03191864|64999642|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23176786|NCT00167245|64390244|FG000|Overall Study|Lost to Follow-up|20|||
23176787|NCT00167245|64390245|FG001|Overall Study|Lost to Follow-up|31|||
23176788|NCT00167245|64390244|FG000|Overall Study|Withdrawal by Subject|5|||
23176789|NCT00167245|64390245|FG001|Overall Study|Withdrawal by Subject|8|||
23176790|NCT00167245|64390244|FG000|Overall Study|Incarcerated|3|||
23176791|NCT00167245|64390245|FG001|Overall Study|Incarcerated|2|||
23176792|NCT00167245|64390244|FG000|Overall Study|Drowsy|1|||
23176793|NCT00167245|64390245|FG001|Overall Study|Drowsy|0|||
23176794|NCT00939692|64390252|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
23454282|NCT02234843|65407098|FG002|Overall Study|Death|0|||
23454283|NCT02234843|65407099|FG003|Overall Study|Death|0|||
23454284|NCT02234843|65407100|FG004|Overall Study|Death|0|||
23454285|NCT02234843|65407101|FG005|Overall Study|Death|0|||
23454286|NCT02234843|65407102|FG006|Overall Study|Death|0|||
23454287|NCT02234843|65407103|FG007|Overall Study|Death|0|||
23454288|NCT02234843|65407104|FG008|Overall Study|Death|0|||
23454289|NCT02234843|65407105|FG009|Overall Study|Death|0|||
23342544|NCT03191864|64999643|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
23342545|NCT03191864|64999644|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
23342546|NCT03191864|64999639|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
23342547|NCT03191864|64999640|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
23342548|NCT03191864|64999641|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
23342549|NCT03191864|64999642|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
23342550|NCT03191864|64999643|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
23342551|NCT03191864|64999644|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
23342552|NCT03191864|64999639|FG000|Part 1 - Induction|Adverse Event|0|||
23342553|NCT03191864|64999640|FG001|Part 1 - Induction|Adverse Event|2|||
23342554|NCT03191864|64999641|FG002|Part 1 - Induction|Adverse Event|0|||
23342555|NCT03191864|64999642|FG003|Part 1 - Induction|Adverse Event|1|||
23342556|NCT03191864|64999643|FG004|Part 1 - Induction|Adverse Event|0|||
23342557|NCT03191864|64999644|FG005|Part 1 - Induction|Adverse Event|2|||
23342558|NCT03191864|64999639|FG000|Part 1 - Induction|Randomized but never dosed|0|||
23342559|NCT03191864|64999640|FG001|Part 1 - Induction|Randomized but never dosed|0|||
23454290|NCT02234843|65407096|FG000|Overall Study|Protocol Violation|1|||
23454291|NCT02234843|65407097|FG001|Overall Study|Protocol Violation|0|||
23176795|NCT00939692|64390253|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
23176796|NCT00939692|64390252|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
23176797|NCT00939692|64390253|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
23176798|NCT01808612|64390254|FG000|Treatment Period|Adverse Event|8|||
23176799|NCT01808612|64390255|FG001|Treatment Period|Adverse Event|4|||
23176800|NCT01808612|64390256|FG002|Treatment Period|Adverse Event|3|||
23176801|NCT01808612|64390254|FG000|Treatment Period|Lost to Follow-up|2|||
23176802|NCT01808612|64390255|FG001|Treatment Period|Lost to Follow-up|2|||
23176803|NCT01808612|64390256|FG002|Treatment Period|Lost to Follow-up|1|||
23176804|NCT01808612|64390254|FG000|Treatment Period|Protocol Violation|1|||
23176805|NCT01808612|64390255|FG001|Treatment Period|Protocol Violation|0|||
23342560|NCT03191864|64999641|FG002|Part 1 - Induction|Randomized but never dosed|1|||
23454292|NCT02234843|65407098|FG002|Overall Study|Protocol Violation|1|||
23454293|NCT02234843|65407099|FG003|Overall Study|Protocol Violation|0|||
23454294|NCT02234843|65407100|FG004|Overall Study|Protocol Violation|0|||
23454295|NCT02234843|65407101|FG005|Overall Study|Protocol Violation|0|||
23176806|NCT01808612|64390256|FG002|Treatment Period|Protocol Violation|0|||
23176807|NCT01808612|64390254|FG000|Treatment Period|Withdrawal by Subject|1|||
23176808|NCT01808612|64390255|FG001|Treatment Period|Withdrawal by Subject|0|||
23176809|NCT01808612|64390256|FG002|Treatment Period|Withdrawal by Subject|4|||
23176810|NCT01808612|64390254|FG000|Treatment Period|Physician Decision|1|||
23176811|NCT01808612|64390255|FG001|Treatment Period|Physician Decision|0|||
23342561|NCT03191864|64999642|FG003|Part 1 - Induction|Randomized but never dosed|0|||
23342562|NCT03191864|64999643|FG004|Part 1 - Induction|Randomized but never dosed|0|||
23342563|NCT03191864|64999644|FG005|Part 1 - Induction|Randomized but never dosed|0|||
23342564|NCT03191864|64999639|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
23342565|NCT03191864|64999640|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
23342566|NCT03191864|64999641|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
23342567|NCT03191864|64999642|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
23342568|NCT03191864|64999643|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
23342569|NCT03191864|64999644|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
23342570|NCT03191864|64999639|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342571|NCT03191864|64999640|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342572|NCT03191864|64999641|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
23342573|NCT03191864|64999642|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342574|NCT03191864|64999643|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342575|NCT03191864|64999644|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
23342576|NCT03191864|64999639|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
23342577|NCT03191864|64999640|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342578|NCT03191864|64999641|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342579|NCT03191864|64999642|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342580|NCT03191864|64999643|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342581|NCT03191864|64999644|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
23342582|NCT03191864|64999639|FG000|Part 2 - Maintenance|Physician Decision|1|||
23342583|NCT03191864|64999640|FG001|Part 2 - Maintenance|Physician Decision|0|||
23342584|NCT03191864|64999641|FG002|Part 2 - Maintenance|Physician Decision|0|||
23342585|NCT03191864|64999642|FG003|Part 2 - Maintenance|Physician Decision|0|||
23342586|NCT03191864|64999643|FG004|Part 2 - Maintenance|Physician Decision|0|||
23342587|NCT03191864|64999644|FG005|Part 2 - Maintenance|Physician Decision|0|||
23342588|NCT03191864|64999639|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
23342589|NCT03191864|64999640|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
23342590|NCT03191864|64999641|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
23342591|NCT03191864|64999642|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
23342592|NCT03191864|64999643|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
23342593|NCT03191864|64999644|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
23342594|NCT03191864|64999639|FG000|Part 2 - Maintenance|Adverse Event|0|||
23342595|NCT03191864|64999640|FG001|Part 2 - Maintenance|Adverse Event|0|||
23342596|NCT03191864|64999641|FG002|Part 2 - Maintenance|Adverse Event|0|||
23342597|NCT03191864|64999642|FG003|Part 2 - Maintenance|Adverse Event|0|||
23342598|NCT03191864|64999643|FG004|Part 2 - Maintenance|Adverse Event|1|||
23342599|NCT03191864|64999644|FG005|Part 2 - Maintenance|Adverse Event|0|||
23342600|NCT03191864|64999639|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
23342601|NCT03191864|64999640|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
23342602|NCT03191864|64999641|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
23342603|NCT03191864|64999642|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
23342604|NCT03191864|64999643|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
23342605|NCT03191864|64999644|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
23342606|NCT03191864|64999639|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342607|NCT03191864|64999640|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342608|NCT03191864|64999641|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342609|NCT03191864|64999642|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342610|NCT03191864|64999643|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
23342611|NCT03191864|64999644|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
23342612|NCT05178641|64999647|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
23342613|NCT05178641|64999648|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
23342614|NCT05178641|64999647|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
23342615|NCT05178641|64999648|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
23342616|NCT03315754|64999652|FG000|Overall Study|COVID-19 complications leading to death|1|||
23176812|NCT01808612|64390256|FG002|Treatment Period|Physician Decision|4|||
23342617|NCT03315754|64999652|FG000|Overall Study|insurance coverage issue|1|||
23342618|NCT04161079|64999653|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
23342619|NCT00459706|64999654|FG000|Overall Study|Adverse Event|19|||
23342620|NCT00459706|64999655|FG001|Overall Study|Adverse Event|13|||
23342621|NCT00459706|64999654|FG000|Overall Study|Withdrawal by Subject|1|||
23342622|NCT00459706|64999655|FG001|Overall Study|Withdrawal by Subject|6|||
23342623|NCT00459706|64999654|FG000|Overall Study|Physician Decision|2|||
23342624|NCT00459706|64999655|FG001|Overall Study|Physician Decision|0|||
23342625|NCT00459706|64999654|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
23342626|NCT00459706|64999655|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23342627|NCT00459706|64999654|FG000|Overall Study|Protocol Violation|2|||
23454296|NCT02234843|65407102|FG006|Overall Study|Protocol Violation|0|||
23454297|NCT02234843|65407103|FG007|Overall Study|Protocol Violation|0|||
23236962|NCT00267202|64611339|FG000|Overall Study|Lost to Follow-up|3|||
23236963|NCT00267202|64611340|FG001|Overall Study|Lost to Follow-up|0|||
23236964|NCT02028182|64611341|FG000|Overall Study|Protocol Violation|2|||
23236965|NCT00451191|64611342|FG000|Overall Study|withdrawal or received alternate tx|15|||
23236966|NCT00451191|64611343|FG001|Overall Study|withdrawal or received alternate tx|11|||
23236967|NCT00643006|64611347|FG000|Overall Study|Lost to Follow-up|5|||
23236968|NCT00643006|64611348|FG001|Overall Study|Lost to Follow-up|4|||
23236969|NCT01020812|64611349|FG000|Overall Study|Physician Decision|1|||
23236970|NCT01020812|64611349|FG000|Overall Study|Withdrawal by Subject|1|||
23236971|NCT01020812|64611349|FG000|Overall Study|Protocol Violation|1|||
23236972|NCT04115488|64611352|FG000|Overall Study|Adverse Event|8|||
23236973|NCT04115488|64611353|FG001|Overall Study|Adverse Event|4|||
23236974|NCT04115488|64611352|FG000|Overall Study|Withdrawal by Subject|3|||
23236975|NCT04115488|64611353|FG001|Overall Study|Withdrawal by Subject|6|||
23236976|NCT04115488|64611352|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
23236977|NCT04115488|64611353|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
23236978|NCT04115488|64611352|FG000|Overall Study|Patient 's location change|1|||
23236979|NCT04115488|64611353|FG001|Overall Study|Patient 's location change|0|||
23236980|NCT04115488|64611352|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
23236981|NCT04115488|64611353|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
23236982|NCT00752895|64611356|FG000|Overall Study|Withdrawal by Subject|8|||
23236983|NCT00752895|64611357|FG001|Overall Study|Withdrawal by Subject|3|||
23236984|NCT00405756|64611363|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
23236985|NCT00405756|64611364|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
23236986|NCT00405756|64611365|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
23236987|NCT00405756|64611363|FG000|Double-blind Treatment|Adverse Event|31|||
23236988|NCT00405756|64611364|FG001|Double-blind Treatment|Adverse Event|27|||
23236989|NCT00405756|64611365|FG002|Double-blind Treatment|Adverse Event|12|||
23236990|NCT00405756|64611363|FG000|Double-blind Treatment|Disease Progression|47|||
23236991|NCT00405756|64611364|FG001|Double-blind Treatment|Disease Progression|81|||
23236992|NCT00405756|64611365|FG002|Double-blind Treatment|Disease Progression|102|||
23236993|NCT00405756|64611363|FG000|Double-blind Treatment|Lack of Efficacy|1|||
23236994|NCT00405756|64611364|FG001|Double-blind Treatment|Lack of Efficacy|4|||
23236995|NCT00405756|64611365|FG002|Double-blind Treatment|Lack of Efficacy|2|||
23236996|NCT00405756|64611363|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
23236997|NCT00405756|64611364|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
23236998|NCT00405756|64611365|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
23236999|NCT00405756|64611363|FG000|Double-blind Treatment|Lost to Follow-up|1|||
23237000|NCT00405756|64611364|FG001|Double-blind Treatment|Lost to Follow-up|0|||
23237001|NCT00405756|64611365|FG002|Double-blind Treatment|Lost to Follow-up|0|||
23237002|NCT00405756|64611363|FG000|Double-blind Treatment|Death|4|||
23237003|NCT00405756|64611364|FG001|Double-blind Treatment|Death|4|||
23237004|NCT00405756|64611365|FG002|Double-blind Treatment|Death|4|||
23237005|NCT00405756|64611363|FG000|Double-blind Treatment|Protocol Violation|1|||
23237006|NCT00405756|64611364|FG001|Double-blind Treatment|Protocol Violation|0|||
23237007|NCT00405756|64611365|FG002|Double-blind Treatment|Protocol Violation|2|||
23237008|NCT00405756|64611363|FG000|Double-blind Treatment|Other|7|||
23237009|NCT00405756|64611364|FG001|Double-blind Treatment|Other|4|||
23237010|NCT00405756|64611365|FG002|Double-blind Treatment|Other|4|||
23237011|NCT00405756|64611363|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
23237012|NCT00405756|64611364|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
23237013|NCT00405756|64611365|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
23237014|NCT00405756|64611363|FG000|Open-label Extension|Adverse Event|1|||
23237015|NCT00405756|64611364|FG001|Open-label Extension|Adverse Event|3|||
23237016|NCT00405756|64611365|FG002|Open-label Extension|Adverse Event|7|||
23237017|NCT00405756|64611363|FG000|Open-label Extension|Disease Progression|8|||
23237018|NCT00405756|64611364|FG001|Open-label Extension|Disease Progression|23|||
23237019|NCT00405756|64611365|FG002|Open-label Extension|Disease Progression|26|||
23237020|NCT00405756|64611363|FG000|Open-label Extension|Withdrawal by Subject|2|||
23237021|NCT00405756|64611364|FG001|Open-label Extension|Withdrawal by Subject|3|||
23237022|NCT00405756|64611365|FG002|Open-label Extension|Withdrawal by Subject|3|||
23237023|NCT00405756|64611363|FG000|Open-label Extension|Death|1|||
23237024|NCT00405756|64611364|FG001|Open-label Extension|Death|2|||
23237025|NCT00405756|64611365|FG002|Open-label Extension|Death|4|||
23237026|NCT00405756|64611363|FG000|Open-label Extension|Other|0|||
23237027|NCT00405756|64611364|FG001|Open-label Extension|Other|1|||
23237028|NCT00405756|64611365|FG002|Open-label Extension|Other|7|||
23342628|NCT00459706|64999655|FG001|Overall Study|Protocol Violation|1|||
23237029|NCT00405756|64611363|FG000|Follow-up|Ongoing in Follow-up Period|52|||
23237030|NCT00405756|64611364|FG001|Follow-up|Ongoing in Follow-up Period|51|||
23237031|NCT00405756|64611365|FG002|Follow-up|Ongoing in Follow-up Period|60|||
23237032|NCT00405756|64611363|FG000|Follow-up|Death|21|||
23237033|NCT00405756|64611364|FG001|Follow-up|Death|31|||
23237034|NCT00405756|64611365|FG002|Follow-up|Death|24|||
23237035|NCT00405756|64611363|FG000|Follow-up|Lost to Follow-up|2|||
23342629|NCT00459706|64999654|FG000|Overall Study|Failed to Return|1|||
23342630|NCT00459706|64999655|FG001|Overall Study|Failed to Return|0|||
23342631|NCT00459706|64999654|FG000|Overall Study|Other|0|||
23342632|NCT00459706|64999655|FG001|Overall Study|Other|1|||
23342633|NCT03155997|64999656|FG000|Overall Study|Withdrawal by Subject|119|||
23342634|NCT03155997|64999657|FG001|Overall Study|Withdrawal by Subject|134|||
23342635|NCT03155997|64999656|FG000|Overall Study|Lost to Follow-up|12|||
23342636|NCT03155997|64999657|FG001|Overall Study|Lost to Follow-up|13|||
23342637|NCT03155997|64999656|FG000|Overall Study|Missing disposition data|0|||
23342638|NCT03155997|64999657|FG001|Overall Study|Missing disposition data|1|||
23342639|NCT03155997|64999656|FG000|Overall Study|On study treatment|2027|||
23342640|NCT03155997|64999657|FG001|Overall Study|On study treatment|2074|||
23342641|NCT00834639|64999658|FG000|Second Intervention|Physician Decision|0|||
23342642|NCT00834639|64999659|FG001|Second Intervention|Physician Decision|2|||
23342667|NCT01565668|64999666|FG000|Overall Study|Death|2|||
23342668|NCT01565668|64999667|FG001|Overall Study|Death|1|||
23342669|NCT01565668|64999666|FG000|Overall Study|Lack of Efficacy|4|||
23342670|NCT01565668|64999667|FG001|Overall Study|Lack of Efficacy|2|||
23342671|NCT01565668|64999666|FG000|Overall Study|Participant went on Hospice Care|1|||
23342672|NCT01565668|64999667|FG001|Overall Study|Participant went on Hospice Care|0|||
23342673|NCT01565668|64999666|FG000|Overall Study|Adverse Event|6|||
23342674|NCT01565668|64999667|FG001|Overall Study|Adverse Event|1|||
23342675|NCT01565668|64999666|FG000|Overall Study|Randomized, but never received drug|0|||
23342676|NCT01565668|64999667|FG001|Overall Study|Randomized, but never received drug|2|||
23342677|NCT01565668|64999666|FG000|Overall Study|Progressive disease|13|||
23342678|NCT01565668|64999667|FG001|Overall Study|Progressive disease|14|||
23342679|NCT01565668|64999666|FG000|Overall Study|Withdrawal by Subject|1|||
23342680|NCT01565668|64999667|FG001|Overall Study|Withdrawal by Subject|3|||
23342681|NCT01565668|64999666|FG000|Overall Study|HSCT Transplant|11|||
23342682|NCT01565668|64999667|FG001|Overall Study|HSCT Transplant|15|||
23342683|NCT01054300|64999668|FG000|Period 1|Adverse Event|1|||
23342684|NCT01054300|64999669|FG001|Period 1|Adverse Event|0|||
23342685|NCT01054300|64999670|FG002|Period 1|Adverse Event|0|||
23342686|NCT01054300|64999671|FG003|Period 1|Adverse Event|0|||
23342687|NCT01054300|64999668|FG000|Period 2|Withdrawal by Subject|0|||
23342688|NCT01054300|64999669|FG001|Period 2|Withdrawal by Subject|0|||
23454298|NCT02234843|65407104|FG008|Overall Study|Protocol Violation|0|||
23454299|NCT02234843|65407105|FG009|Overall Study|Protocol Violation|0|||
23454300|NCT02234843|65407096|FG000|Overall Study|Efficacy outcome reached|2|||
23454301|NCT02234843|65407097|FG001|Overall Study|Efficacy outcome reached|0|||
23176813|NCT01808612|64390254|FG000|Treatment Period|Sponsor Decision|1|||
23342689|NCT01054300|64999670|FG002|Period 2|Withdrawal by Subject|1|||
23342690|NCT01054300|64999671|FG003|Period 2|Withdrawal by Subject|0|||
23342691|NCT04450407|64999672|FG000|Overall Study|Withdrawal by Subject|10|||
23342692|NCT04450407|64999673|FG001|Overall Study|Withdrawal by Subject|1|||
23342693|NCT04450407|64999674|FG002|Overall Study|Withdrawal by Subject|4|||
23342694|NCT04450407|64999672|FG000|Overall Study|Adverse Event|0|||
23342695|NCT04450407|64999673|FG001|Overall Study|Adverse Event|0|||
23342696|NCT04450407|64999674|FG002|Overall Study|Adverse Event|1|||
23342697|NCT04450407|64999672|FG000|Overall Study|Lost to Follow-up|1|||
23342698|NCT04450407|64999673|FG001|Overall Study|Lost to Follow-up|0|||
23342699|NCT04450407|64999674|FG002|Overall Study|Lost to Follow-up|0|||
23342700|NCT04450407|64999672|FG000|Overall Study|Physician Decision|0|||
23454302|NCT02234843|65407098|FG002|Overall Study|Efficacy outcome reached|0|||
23454303|NCT02234843|65407099|FG003|Overall Study|Efficacy outcome reached|0|||
23454304|NCT02234843|65407100|FG004|Overall Study|Efficacy outcome reached|0|||
23454305|NCT02234843|65407101|FG005|Overall Study|Efficacy outcome reached|2|||
23454306|NCT02234843|65407102|FG006|Overall Study|Efficacy outcome reached|0|||
23454307|NCT02234843|65407103|FG007|Overall Study|Efficacy outcome reached|0|||
23454308|NCT02234843|65407104|FG008|Overall Study|Efficacy outcome reached|0|||
23454309|NCT02234843|65407105|FG009|Overall Study|Efficacy outcome reached|0|||
23454310|NCT02234843|65407096|FG000|Overall Study|Patient convenience|2|||
23454311|NCT02234843|65407097|FG001|Overall Study|Patient convenience|0|||
23454312|NCT02234843|65407098|FG002|Overall Study|Patient convenience|0|||
23454313|NCT02234843|65407099|FG003|Overall Study|Patient convenience|0|||
23454314|NCT02234843|65407100|FG004|Overall Study|Patient convenience|0|||
23454315|NCT02234843|65407101|FG005|Overall Study|Patient convenience|1|||
23454316|NCT02234843|65407102|FG006|Overall Study|Patient convenience|0|||
23454317|NCT02234843|65407103|FG007|Overall Study|Patient convenience|0|||
23454318|NCT02234843|65407104|FG008|Overall Study|Patient convenience|0|||
23454319|NCT02234843|65407105|FG009|Overall Study|Patient convenience|0|||
23454320|NCT02234843|65407096|FG000|Overall Study|Withdrawal by Subject|5|||
23454321|NCT02234843|65407097|FG001|Overall Study|Withdrawal by Subject|1|||
23454322|NCT02234843|65407098|FG002|Overall Study|Withdrawal by Subject|1|||
23454323|NCT02234843|65407099|FG003|Overall Study|Withdrawal by Subject|0|||
23454324|NCT02234843|65407100|FG004|Overall Study|Withdrawal by Subject|0|||
23454325|NCT02234843|65407101|FG005|Overall Study|Withdrawal by Subject|7|||
23454326|NCT02234843|65407102|FG006|Overall Study|Withdrawal by Subject|0|||
23237036|NCT00405756|64611364|FG001|Follow-up|Lost to Follow-up|8|||
23237037|NCT00405756|64611365|FG002|Follow-up|Lost to Follow-up|4|||
23237038|NCT00672490|64611370|FG000|Overall Study|Withdrawal by Subject|8|||
23237039|NCT00672490|64611371|FG001|Overall Study|Withdrawal by Subject|8|||
23237040|NCT00672490|64611370|FG000|Overall Study|Lack of Compliance|2|||
23237041|NCT00672490|64611371|FG001|Overall Study|Lack of Compliance|7|||
23237042|NCT00672490|64611370|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
23237043|NCT00672490|64611371|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
23237044|NCT00672490|64611370|FG000|Overall Study|Adverse Event|5|||
23237045|NCT00672490|64611371|FG001|Overall Study|Adverse Event|8|||
23237046|NCT00672490|64611370|FG000|Overall Study|Violation of Concomitant Medicine|1|||
23237047|NCT00672490|64611371|FG001|Overall Study|Violation of Concomitant Medicine|0|||
23237048|NCT00672490|64611370|FG000|Overall Study|Intolerance|0|||
23237049|NCT00672490|64611371|FG001|Overall Study|Intolerance|2|||
23237050|NCT00672490|64611370|FG000|Overall Study|Lost to Follow-up|1|||
23237051|NCT00672490|64611371|FG001|Overall Study|Lost to Follow-up|5|||
23237052|NCT00672490|64611370|FG000|Overall Study|No reason was provided|6|||
23237053|NCT00672490|64611371|FG001|Overall Study|No reason was provided|2|||
23237054|NCT01856920|64611372|FG000|Overall Study|Disease Progression On Study|3|||
23237055|NCT01856920|64611373|FG001|Overall Study|Disease Progression On Study|4|||
23237056|NCT01856920|64611372|FG000|Overall Study|Disease Progression before Treatment|1|||
23237057|NCT01856920|64611373|FG001|Overall Study|Disease Progression before Treatment|0|||
23237058|NCT01856920|64611372|FG000|Overall Study|Ineligible|0|||
23237059|NCT01856920|64611373|FG001|Overall Study|Ineligible|1|||
23237060|NCT01856920|64611372|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
23237061|NCT01856920|64611373|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
23237062|NCT01856920|64611372|FG000|Overall Study|Refused further Treatment|5|||
23237063|NCT01856920|64611373|FG001|Overall Study|Refused further Treatment|1|||
23237064|NCT01856920|64611372|FG000|Overall Study|Other Reasons|0|||
23237065|NCT01856920|64611373|FG001|Overall Study|Other Reasons|1|||
23237066|NCT01856920|64611372|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
23237067|NCT01856920|64611373|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
23237068|NCT03655951|64611374|FG000|Overall Study|Lost to Follow-up|39|||
23237069|NCT03655951|64611375|FG001|Overall Study|Lost to Follow-up|20|||
23237070|NCT03655951|64611374|FG000|Overall Study|Withdrawal by Subject|0|||
23237071|NCT03655951|64611375|FG001|Overall Study|Withdrawal by Subject|1|||
23237072|NCT03737812|64611376|FG000|Overall Study|Withdrawal by Subject|1|||
23237073|NCT03737812|64611377|FG001|Overall Study|Withdrawal by Subject|2|||
23237074|NCT03737812|64611378|FG002|Overall Study|Withdrawal by Subject|1|||
23237075|NCT03737812|64611376|FG000|Overall Study|Sponsor Discontinued the Study|4|||
23237076|NCT03737812|64611377|FG001|Overall Study|Sponsor Discontinued the Study|3|||
23237077|NCT03737812|64611378|FG002|Overall Study|Sponsor Discontinued the Study|2|||
23237078|NCT03737812|64611376|FG000|Overall Study|Adverse Event|0|||
23237079|NCT03737812|64611377|FG001|Overall Study|Adverse Event|1|||
23237080|NCT03737812|64611378|FG002|Overall Study|Adverse Event|0|||
23237081|NCT03737812|64611376|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
23237082|NCT03737812|64611377|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
23237083|NCT03737812|64611378|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
23237084|NCT03339999|64611384|FG000|Overall Study|Adverse Event|1|||
23237085|NCT03339999|64611385|FG001|Overall Study|Adverse Event|2|||
23237086|NCT03339999|64611386|FG002|Overall Study|Adverse Event|2|||
23237087|NCT03339999|64611387|FG003|Overall Study|Adverse Event|1|||
23237088|NCT03339999|64611384|FG000|Overall Study|Lack of Efficacy|0|||
23237089|NCT03339999|64611385|FG001|Overall Study|Lack of Efficacy|1|||
23237090|NCT03339999|64611386|FG002|Overall Study|Lack of Efficacy|0|||
23237091|NCT03339999|64611387|FG003|Overall Study|Lack of Efficacy|0|||
23237092|NCT03339999|64611384|FG000|Overall Study|Lost to Follow-up|0|||
23237093|NCT03339999|64611385|FG001|Overall Study|Lost to Follow-up|0|||
23237094|NCT03339999|64611386|FG002|Overall Study|Lost to Follow-up|0|||
23237095|NCT03339999|64611387|FG003|Overall Study|Lost to Follow-up|1|||
23237096|NCT03339999|64611384|FG000|Overall Study|Study Terminated by Sponsor|6|||
23237097|NCT03339999|64611385|FG001|Overall Study|Study Terminated by Sponsor|3|||
23237098|NCT03339999|64611386|FG002|Overall Study|Study Terminated by Sponsor|4|||
23237099|NCT03339999|64611387|FG003|Overall Study|Study Terminated by Sponsor|3|||
23237100|NCT00736840|64611388|FG000|Overall Study|Lost to Follow-up|13|||
23342701|NCT04450407|64999673|FG001|Overall Study|Physician Decision|0|||
23342702|NCT04450407|64999674|FG002|Overall Study|Physician Decision|1|||
23342703|NCT04450407|64999672|FG000|Overall Study|Pregnancy|1|||
23237101|NCT00450814|64611389|FG000|Overall Study|Failed to complete the initial therapy|0|||
23237102|NCT00450814|64611390|FG001|Overall Study|Failed to complete the initial therapy|0|||
23237103|NCT00450814|64611391|FG002|Overall Study|Failed to complete the initial therapy|0|||
23237104|NCT00450814|64611392|FG003|Overall Study|Failed to complete the initial therapy|1|||
23237105|NCT00450814|64611393|FG004|Overall Study|Failed to complete the initial therapy|1|||
23237106|NCT00450814|64611394|FG005|Overall Study|Failed to complete the initial therapy|1|||
23342704|NCT04450407|64999673|FG001|Overall Study|Pregnancy|0|||
23454327|NCT02234843|65407103|FG007|Overall Study|Withdrawal by Subject|0|||
23454328|NCT02234843|65407104|FG008|Overall Study|Withdrawal by Subject|0|||
23454329|NCT02234843|65407105|FG009|Overall Study|Withdrawal by Subject|0|||
23454330|NCT02234843|65407096|FG000|Overall Study|Recovery|1|||
23454331|NCT02234843|65407097|FG001|Overall Study|Recovery|0|||
23237107|NCT00450814|64611395|FG006|Overall Study|Failed to complete the initial therapy|0|||
23237108|NCT00450814|64611396|FG007|Overall Study|Failed to complete the initial therapy|0|||
23237109|NCT00450814|64611397|FG008|Overall Study|Failed to complete the initial therapy|0|||
23237110|NCT00450814|64611398|FG009|Overall Study|Failed to complete the initial therapy|0|||
23237111|NCT00450814|64611399|FG010|Overall Study|Failed to complete the initial therapy|0|||
23237112|NCT00450814|64611389|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
23237113|NCT00450814|64611390|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
23237114|NCT00450814|64611391|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
23237115|NCT00450814|64611392|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
23237116|NCT00450814|64611393|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
23237117|NCT00450814|64611394|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
23237118|NCT00450814|64611395|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
23237119|NCT00450814|64611396|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
23237120|NCT00450814|64611397|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
23237121|NCT00450814|64611398|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
23237122|NCT00450814|64611399|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
23237123|NCT03198559|64611403|FG000|Overall Study|Adverse Event|2|||
23237124|NCT02370173|64611406|FG000|Overall Study|Protocol Violation|1|||
23237125|NCT02370173|64611407|FG001|Overall Study|Protocol Violation|1|||
23237126|NCT02370173|64611406|FG000|Overall Study|Withdrawal by Subject|2|||
23237127|NCT02370173|64611407|FG001|Overall Study|Withdrawal by Subject|2|||
23237128|NCT01003691|64611408|FG000|Overall Study|Adverse Event|0|||
23237129|NCT01003691|64611409|FG001|Overall Study|Adverse Event|0|||
23237130|NCT01003691|64611410|FG002|Overall Study|Adverse Event|0|||
23237131|NCT01003691|64611411|FG003|Overall Study|Adverse Event|1|||
23237132|NCT01200758|64611416|FG000|Stage I|Death|0|||
23237133|NCT01200758|64611417|FG001|Stage I|Death|1|||
23237134|NCT01200758|64611418|FG002|Stage I|Death|0|||
23237135|NCT01200758|64611419|FG003|Stage I|Death|0|||
23237136|NCT01200758|64611416|FG000|Stage I|Physician Decision|1|||
23237137|NCT01200758|64611417|FG001|Stage I|Physician Decision|1|||
23237138|NCT01200758|64611418|FG002|Stage I|Physician Decision|0|||
23237139|NCT01200758|64611419|FG003|Stage I|Physician Decision|0|||
23237140|NCT01200758|64611416|FG000|Stage I|Lack of Efficacy|2|||
23237141|NCT01200758|64611417|FG001|Stage I|Lack of Efficacy|1|||
23237142|NCT01200758|64611418|FG002|Stage I|Lack of Efficacy|0|||
23237143|NCT01200758|64611419|FG003|Stage I|Lack of Efficacy|0|||
23237144|NCT01200758|64611416|FG000|Stage I|Adverse Event|5|||
23237145|NCT01200758|64611417|FG001|Stage I|Adverse Event|5|||
23237146|NCT01200758|64611418|FG002|Stage I|Adverse Event|0|||
23237147|NCT01200758|64611419|FG003|Stage I|Adverse Event|0|||
23237148|NCT01200758|64611416|FG000|Stage I|Withdrawal by Subject|1|||
23237149|NCT01200758|64611417|FG001|Stage I|Withdrawal by Subject|2|||
23237150|NCT01200758|64611418|FG002|Stage I|Withdrawal by Subject|0|||
23237151|NCT01200758|64611419|FG003|Stage I|Withdrawal by Subject|0|||
23237152|NCT01200758|64611416|FG000|Stage I|Disease Progression|9|||
23237153|NCT01200758|64611417|FG001|Stage I|Disease Progression|7|||
23237154|NCT01200758|64611418|FG002|Stage I|Disease Progression|0|||
23237155|NCT01200758|64611419|FG003|Stage I|Disease Progression|0|||
23237156|NCT01200758|64611416|FG000|Stage 2|Disease Progression|0|||
23237157|NCT01200758|64611417|FG001|Stage 2|Disease Progression|0|||
23237158|NCT01200758|64611418|FG002|Stage 2|Disease Progression|16|||
23237159|NCT01200758|64611419|FG003|Stage 2|Disease Progression|21|||
23237160|NCT01200758|64611416|FG000|Stage 2|Lack of Efficacy|0|||
23237161|NCT01200758|64611417|FG001|Stage 2|Lack of Efficacy|0|||
23237162|NCT01200758|64611418|FG002|Stage 2|Lack of Efficacy|4|||
23237163|NCT01200758|64611419|FG003|Stage 2|Lack of Efficacy|2|||
23237164|NCT01200758|64611416|FG000|Stage 2|Physician Decision|0|||
23237165|NCT01200758|64611417|FG001|Stage 2|Physician Decision|0|||
23237166|NCT01200758|64611418|FG002|Stage 2|Physician Decision|5|||
23454332|NCT02234843|65407098|FG002|Overall Study|Recovery|0|||
23454333|NCT02234843|65407099|FG003|Overall Study|Recovery|0|||
23454334|NCT02234843|65407100|FG004|Overall Study|Recovery|0|||
23454335|NCT02234843|65407101|FG005|Overall Study|Recovery|0|||
23237167|NCT01200758|64611419|FG003|Stage 2|Physician Decision|7|||
23237168|NCT01200758|64611416|FG000|Stage 2|Adverse Event|0|||
23237169|NCT01200758|64611417|FG001|Stage 2|Adverse Event|0|||
23237170|NCT01200758|64611418|FG002|Stage 2|Adverse Event|5|||
23237171|NCT01200758|64611419|FG003|Stage 2|Adverse Event|9|||
23237172|NCT01200758|64611416|FG000|Stage 2|Withdrawal by Subject|0|||
23237173|NCT01200758|64611417|FG001|Stage 2|Withdrawal by Subject|0|||
23237174|NCT01200758|64611418|FG002|Stage 2|Withdrawal by Subject|4|||
23237175|NCT01200758|64611419|FG003|Stage 2|Withdrawal by Subject|1|||
23237176|NCT01200758|64611416|FG000|Stage 2|Lost to Follow-up|0|||
23342705|NCT04450407|64999674|FG002|Overall Study|Pregnancy|0|||
23342706|NCT04450407|64999672|FG000|Overall Study|Protocol Violation|2|||
23342707|NCT04450407|64999673|FG001|Overall Study|Protocol Violation|0|||
23342708|NCT04450407|64999674|FG002|Overall Study|Protocol Violation|0|||
23342709|NCT04450407|64999672|FG000|Overall Study|Investigational site terminated by sponsor|3|||
23342710|NCT04450407|64999673|FG001|Overall Study|Investigational site terminated by sponsor|0|||
23342711|NCT04450407|64999674|FG002|Overall Study|Investigational site terminated by sponsor|2|||
23342712|NCT02499146|64999677|FG000|Overall Study|Lost to Follow-up|1|||
23342713|NCT02499146|64999677|FG000|Overall Study|Withdrawal by Subject|1|||
23342714|NCT02499146|64999677|FG000|Overall Study|Other|2|||
23342715|NCT02499146|64999677|FG000|Overall Study|Ongoing at date of cut-off|9|||
23342716|NCT02499146|64999677|FG000|Overall Study|Began other treatment/therapy|13|||
23342717|NCT03917472|64999679|FG000|Overall Study|Physician Decision|4|||
23342718|NCT03917472|64999680|FG001|Overall Study|Physician Decision|0|||
23342719|NCT03917472|64999679|FG000|Overall Study|Adverse Event|3|||
23342720|NCT03917472|64999680|FG001|Overall Study|Adverse Event|1|||
23342721|NCT03917472|64999679|FG000|Overall Study|Death|7|||
23342722|NCT03917472|64999680|FG001|Overall Study|Death|5|||
23342723|NCT03917472|64999679|FG000|Overall Study|Withdrawal by Subject|11|||
23342724|NCT03917472|64999680|FG001|Overall Study|Withdrawal by Subject|4|||
23342725|NCT03917472|64999679|FG000|Overall Study|Lost to Follow-up|10|||
23342726|NCT03917472|64999680|FG001|Overall Study|Lost to Follow-up|5|||
23342727|NCT02000622|64999681|FG000|Overall Study|Withdrawal by Subject|5|||
23342728|NCT02000622|64999682|FG001|Overall Study|Withdrawal by Subject|7|||
23454336|NCT02234843|65407102|FG006|Overall Study|Recovery|0|||
23454337|NCT02234843|65407103|FG007|Overall Study|Recovery|0|||
23454338|NCT02234843|65407104|FG008|Overall Study|Recovery|0|||
23454339|NCT02234843|65407105|FG009|Overall Study|Recovery|0|||
23454340|NCT02234843|65407096|FG000|Overall Study|Other|0|||
23454341|NCT02234843|65407097|FG001|Overall Study|Other|2|||
23454342|NCT02234843|65407098|FG002|Overall Study|Other|0|||
23454343|NCT02234843|65407099|FG003|Overall Study|Other|1|||
23454344|NCT02234843|65407100|FG004|Overall Study|Other|0|||
23454345|NCT02234843|65407101|FG005|Overall Study|Other|1|||
23454346|NCT02234843|65407102|FG006|Overall Study|Other|0|||
23454347|NCT02234843|65407103|FG007|Overall Study|Other|1|||
23454348|NCT02234843|65407104|FG008|Overall Study|Other|0|||
23454349|NCT02234843|65407105|FG009|Overall Study|Other|0|||
23454350|NCT02234843|65407096|FG000|Overall Study|Physician Decision|4|||
23454351|NCT02234843|65407097|FG001|Overall Study|Physician Decision|1|||
23454352|NCT02234843|65407098|FG002|Overall Study|Physician Decision|0|||
23454353|NCT02234843|65407099|FG003|Overall Study|Physician Decision|1|||
23454354|NCT02234843|65407100|FG004|Overall Study|Physician Decision|0|||
23454355|NCT02234843|65407101|FG005|Overall Study|Physician Decision|0|||
23454356|NCT02234843|65407102|FG006|Overall Study|Physician Decision|0|||
23454357|NCT02234843|65407103|FG007|Overall Study|Physician Decision|1|||
23454358|NCT02234843|65407104|FG008|Overall Study|Physician Decision|0|||
23454359|NCT02234843|65407105|FG009|Overall Study|Physician Decision|0|||
23454360|NCT02234843|65407096|FG000|Overall Study|Adverse Event|5|||
23454361|NCT02234843|65407097|FG001|Overall Study|Adverse Event|1|||
23237177|NCT01200758|64611417|FG001|Stage 2|Lost to Follow-up|0|||
23237178|NCT01200758|64611418|FG002|Stage 2|Lost to Follow-up|3|||
23237179|NCT01200758|64611419|FG003|Stage 2|Lost to Follow-up|1|||
23237180|NCT01200758|64611416|FG000|Stage 2|Protocol Violation|0|||
23237181|NCT01200758|64611417|FG001|Stage 2|Protocol Violation|0|||
23237182|NCT01200758|64611418|FG002|Stage 2|Protocol Violation|1|||
23237183|NCT01200758|64611419|FG003|Stage 2|Protocol Violation|4|||
23237184|NCT01200758|64611416|FG000|Stage 2|Death|0|||
23237185|NCT01200758|64611417|FG001|Stage 2|Death|0|||
23237186|NCT01200758|64611418|FG002|Stage 2|Death|3|||
23342729|NCT02000622|64999681|FG000|Overall Study|Lost to Follow-up|4|||
23342730|NCT02000622|64999682|FG001|Overall Study|Lost to Follow-up|0|||
23342731|NCT02000622|64999681|FG000|Overall Study|Death|159|||
23342732|NCT02000622|64999682|FG001|Overall Study|Death|73|||
23342733|NCT02000622|64999681|FG000|Overall Study|Withdrawn due to site closure|1|||
23342734|NCT02000622|64999682|FG001|Overall Study|Withdrawn due to site closure|0|||
23342735|NCT01661933|64999684|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
23342736|NCT01661933|64999684|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
23342737|NCT01154296|64999685|FG000|Randomization and Intervention|Decided to decline|1|||
23454362|NCT02234843|65407098|FG002|Overall Study|Adverse Event|1|||
23454363|NCT02234843|65407099|FG003|Overall Study|Adverse Event|3|||
23454364|NCT02234843|65407100|FG004|Overall Study|Adverse Event|2|||
23454365|NCT02234843|65407101|FG005|Overall Study|Adverse Event|1|||
23454366|NCT02234843|65407102|FG006|Overall Study|Adverse Event|0|||
23454367|NCT02234843|65407103|FG007|Overall Study|Adverse Event|0|||
23454368|NCT02234843|65407104|FG008|Overall Study|Adverse Event|1|||
23454369|NCT02234843|65407105|FG009|Overall Study|Adverse Event|0|||
23237187|NCT01200758|64611419|FG003|Stage 2|Death|5|||
23237188|NCT00598442|64611420|FG000|Overall Study|Adverse Event|3|||
23237189|NCT00598442|64611421|FG001|Overall Study|Adverse Event|0|||
23237190|NCT00598442|64611422|FG002|Overall Study|Adverse Event|0|||
23454370|NCT02234843|65407096|FG000|Overall Study|Non-compliance with study drug|1|||
23454371|NCT02234843|65407097|FG001|Overall Study|Non-compliance with study drug|0|||
23454372|NCT02234843|65407098|FG002|Overall Study|Non-compliance with study drug|0|||
23454373|NCT02234843|65407099|FG003|Overall Study|Non-compliance with study drug|0|||
23454374|NCT02234843|65407100|FG004|Overall Study|Non-compliance with study drug|0|||
23454375|NCT02234843|65407101|FG005|Overall Study|Non-compliance with study drug|1|||
23454376|NCT02234843|65407102|FG006|Overall Study|Non-compliance with study drug|1|||
23454377|NCT02234843|65407103|FG007|Overall Study|Non-compliance with study drug|0|||
23454378|NCT02234843|65407104|FG008|Overall Study|Non-compliance with study drug|0|||
23454379|NCT02234843|65407105|FG009|Overall Study|Non-compliance with study drug|0|||
23454380|NCT02234843|65407096|FG000|Overall Study|Lost to Follow-up|0|||
23454381|NCT02234843|65407097|FG001|Overall Study|Lost to Follow-up|1|||
23454382|NCT02234843|65407098|FG002|Overall Study|Lost to Follow-up|0|||
23454383|NCT02234843|65407099|FG003|Overall Study|Lost to Follow-up|0|||
23454384|NCT02234843|65407100|FG004|Overall Study|Lost to Follow-up|0|||
23454385|NCT02234843|65407101|FG005|Overall Study|Lost to Follow-up|0|||
23454386|NCT02234843|65407102|FG006|Overall Study|Lost to Follow-up|1|||
23454387|NCT02234843|65407103|FG007|Overall Study|Lost to Follow-up|0|||
23454388|NCT02234843|65407104|FG008|Overall Study|Lost to Follow-up|0|||
23454389|NCT02234843|65407105|FG009|Overall Study|Lost to Follow-up|0|||
23454390|NCT01584232|65407108|FG000|Overall Study|Adverse Event|3|||
23454391|NCT01584232|65407109|FG001|Overall Study|Adverse Event|1|||
23454392|NCT01584232|65407108|FG000|Overall Study|Withdrawal by Subject|2|||
23454393|NCT01584232|65407109|FG001|Overall Study|Withdrawal by Subject|1|||
23454394|NCT01584232|65407108|FG000|Overall Study|Physician Decision|2|||
23454395|NCT01584232|65407109|FG001|Overall Study|Physician Decision|1|||
23454396|NCT01584232|65407108|FG000|Overall Study|Lost to Follow-up|1|||
23454397|NCT01584232|65407109|FG001|Overall Study|Lost to Follow-up|0|||
23454398|NCT02520726|65407110|FG000|Overall Study|Lost to Follow-up|3|||
23454399|NCT02520726|65407111|FG001|Overall Study|Lost to Follow-up|2|||
23454400|NCT03634085|65407112|FG000|Overall Study|Adverse Event|1|||
23454401|NCT03634085|65407113|FG001|Overall Study|Adverse Event|0|||
23454402|NCT03634085|65407112|FG000|Overall Study|Withdrawal by Subject|0|||
23454403|NCT03634085|65407113|FG001|Overall Study|Withdrawal by Subject|2|||
23454404|NCT01323582|65407114|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
23454405|NCT01323582|65407115|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
23454406|NCT01323582|65407114|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
23454407|NCT01323582|65407115|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
23454408|NCT01323582|65407114|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
23454409|NCT01323582|65407115|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
23454410|NCT03582215|65407116|FG000|Overall Study|Adverse Event|1|||
23454411|NCT03582215|65407117|FG001|Overall Study|Adverse Event|0|||
23454412|NCT03582215|65407118|FG002|Overall Study|Adverse Event|0|||
23454413|NCT03582215|65407119|FG003|Overall Study|Adverse Event|0|||
23454414|NCT03582215|65407120|FG004|Overall Study|Adverse Event|0|||
23454415|NCT03582215|65407121|FG005|Overall Study|Adverse Event|0|||
23454416|NCT03582215|65407122|FG006|Overall Study|Adverse Event|2|||
23454417|NCT03582215|65407123|FG007|Overall Study|Adverse Event|2|||
23454418|NCT00781768|65407124|FG000|Overall Study|Not transplanted.|0|||
23454419|NCT00781768|65407125|FG001|Overall Study|Not transplanted.|2|||
23454420|NCT00528112|65407126|FG000|Treatment up to 3 Years|Adverse Event|313|||
23454421|NCT00528112|65407127|FG001|Treatment up to 3 Years|Adverse Event|278|||
23454422|NCT00528112|65407126|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
23454423|NCT00528112|65407127|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
23454424|NCT00528112|65407126|FG000|Treatment up to 3 Years|Protocol Violation|16|||
23454425|NCT00528112|65407127|FG001|Treatment up to 3 Years|Protocol Violation|16|||
23454426|NCT00528112|65407126|FG000|Treatment up to 3 Years|Death|0|||
23454427|NCT00528112|65407127|FG001|Treatment up to 3 Years|Death|1|||
23454428|NCT00528112|65407126|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
23454429|NCT00528112|65407127|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
23454430|NCT00528112|65407126|FG000|Treatment up to 3 Years|Pregnancy|9|||
23454431|NCT00528112|65407127|FG001|Treatment up to 3 Years|Pregnancy|10|||
23454432|NCT00528112|65407126|FG000|Treatment up to 3 Years|Other reasons|186|||
23454433|NCT00528112|65407127|FG001|Treatment up to 3 Years|Other reasons|186|||
23454434|NCT00528112|65407126|FG000|Extension Phase|Withdrawal by Subject|0|||
23454435|NCT00528112|65407127|FG001|Extension Phase|Withdrawal by Subject|3|||
23454436|NCT00528112|65407126|FG000|Extension Phase|Other reasons|0|||
23454437|NCT00528112|65407127|FG001|Extension Phase|Other reasons|100|||
23454438|NCT00528112|65407126|FG000|Extension Phase|Pregnancy|0|||
23454439|NCT00528112|65407127|FG001|Extension Phase|Pregnancy|3|||
23454440|NCT00528112|65407126|FG000|Extension Phase|Lost to Follow-up|0|||
23454441|NCT00528112|65407127|FG001|Extension Phase|Lost to Follow-up|12|||
23454442|NCT00528112|65407126|FG000|Extension Phase|Death|0|||
23454443|NCT00528112|65407127|FG001|Extension Phase|Death|1|||
23454444|NCT00528112|65407126|FG000|Extension Phase|Adverse Event|0|||
23454445|NCT00528112|65407127|FG001|Extension Phase|Adverse Event|36|||
23454446|NCT00528112|65407126|FG000|Extension Phase|Protocol Violation|0|||
23454447|NCT00528112|65407127|FG001|Extension Phase|Protocol Violation|2|||
23454448|NCT01453049|65407128|FG000|Overall Study|Protocol Violation|2|||
23454449|NCT01453049|65407129|FG001|Overall Study|Protocol Violation|5|||
23454450|NCT01453049|65407128|FG000|Overall Study|Lost to Follow-up|2|||
23454451|NCT01453049|65407129|FG001|Overall Study|Lost to Follow-up|1|||
23454452|NCT01453049|65407128|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
23454453|NCT01453049|65407129|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
23454454|NCT01453049|65407128|FG000|Overall Study|Withdrawal by Subject|1|||
23454455|NCT01453049|65407129|FG001|Overall Study|Withdrawal by Subject|0|||
23454456|NCT01453049|65407128|FG000|Overall Study|Randomized in Error|1|||
23454457|NCT01453049|65407129|FG001|Overall Study|Randomized in Error|0|||
23454458|NCT00683878|65407130|FG000|Overall Study|Lack of Efficacy|3|||
23454459|NCT00683878|65407131|FG001|Overall Study|Lack of Efficacy|0|||
23454460|NCT00683878|65407132|FG002|Overall Study|Lack of Efficacy|1|||
23454461|NCT00683878|65407130|FG000|Overall Study|Adverse Event|4|||
23454462|NCT00683878|65407131|FG001|Overall Study|Adverse Event|3|||
23454463|NCT00683878|65407132|FG002|Overall Study|Adverse Event|3|||
23454464|NCT00683878|65407130|FG000|Overall Study|Withdrawal by Subject|9|||
23454465|NCT00683878|65407131|FG001|Overall Study|Withdrawal by Subject|8|||
23454466|NCT00683878|65407132|FG002|Overall Study|Withdrawal by Subject|6|||
23454467|NCT00683878|65407130|FG000|Overall Study|Death|0|||
23454468|NCT00683878|65407131|FG001|Overall Study|Death|1|||
23454469|NCT00683878|65407132|FG002|Overall Study|Death|0|||
23454470|NCT00683878|65407130|FG000|Overall Study|Lost to Follow-up|4|||
23454471|NCT00683878|65407131|FG001|Overall Study|Lost to Follow-up|2|||
23454472|NCT00683878|65407132|FG002|Overall Study|Lost to Follow-up|4|||
23454473|NCT00683878|65407130|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
23454474|NCT00683878|65407131|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
23454475|NCT00683878|65407132|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
23454476|NCT00074711|65407136|FG000|Overall Study|Withdrawal by Subject|1|||
23454477|NCT00074711|65407137|FG001|Overall Study|Withdrawal by Subject|1|||
23454478|NCT00074711|65407136|FG000|Overall Study|Lost to Follow-up|10|||
23454479|NCT00074711|65407137|FG001|Overall Study|Lost to Follow-up|8|||
23454480|NCT00074711|65407136|FG000|Overall Study|Participant stopped study drug|4|||
23454481|NCT00074711|65407137|FG001|Overall Study|Participant stopped study drug|6|||
23454482|NCT00510835|65407138|FG000|Overall Study|Withdrawal by Subject|6|||
23454483|NCT00510835|65407139|FG001|Overall Study|Withdrawal by Subject|2|||
23454484|NCT00510835|65407140|FG002|Overall Study|Withdrawal by Subject|2|||
23454485|NCT03790111|65407141|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
23454486|NCT00317473|65407144|FG000|Overall Study|Withdrawal by Subject|2|||
23454487|NCT00317473|65407145|FG001|Overall Study|Withdrawal by Subject|1|||
23454488|NCT00317473|65407146|FG002|Overall Study|Withdrawal by Subject|2|||
23454489|NCT00317473|65407147|FG003|Overall Study|Withdrawal by Subject|1|||
23237191|NCT00598442|64611420|FG000|Overall Study|Death|19|||
23237192|NCT00598442|64611421|FG001|Overall Study|Death|11|||
23454490|NCT00317473|65407148|FG004|Overall Study|Withdrawal by Subject|3|||
23454491|NCT00317473|65407149|FG005|Overall Study|Withdrawal by Subject|1|||
23454492|NCT00317473|65407144|FG000|Overall Study|Relocation|1|||
23454493|NCT00317473|65407145|FG001|Overall Study|Relocation|0|||
23454494|NCT00317473|65407146|FG002|Overall Study|Relocation|1|||
23454495|NCT00317473|65407147|FG003|Overall Study|Relocation|1|||
23454496|NCT00317473|65407148|FG004|Overall Study|Relocation|5|||
23454497|NCT00317473|65407149|FG005|Overall Study|Relocation|2|||
23454498|NCT00317473|65407144|FG000|Overall Study|Death|1|||
23454499|NCT00317473|65407145|FG001|Overall Study|Death|0|||
23454500|NCT00317473|65407146|FG002|Overall Study|Death|0|||
23454501|NCT00317473|65407147|FG003|Overall Study|Death|0|||
23454502|NCT00317473|65407148|FG004|Overall Study|Death|0|||
23454503|NCT00317473|65407149|FG005|Overall Study|Death|0|||
23454504|NCT00317473|65407144|FG000|Overall Study|Other|0|||
23454505|NCT00317473|65407145|FG001|Overall Study|Other|2|||
23454506|NCT00317473|65407146|FG002|Overall Study|Other|0|||
23454507|NCT00317473|65407147|FG003|Overall Study|Other|0|||
23454508|NCT00317473|65407148|FG004|Overall Study|Other|0|||
23454509|NCT00317473|65407149|FG005|Overall Study|Other|0|||
23454510|NCT04002960|65407150|FG000|Overall Study|Withdrawn prior to Completion|2|||
23454511|NCT00651924|65407155|FG000|Overall Study|Withdrawal by PI|0|||
23454512|NCT00651924|65407156|FG001|Overall Study|Withdrawal by PI|2|||
23454513|NCT00651924|65407155|FG000|Overall Study|Withdrawal by Subject|0|||
23454514|NCT00651924|65407156|FG001|Overall Study|Withdrawal by Subject|5|||
23454515|NCT01539759|65407157|FG000|Overall Study|Lost to Follow-up|6|||
23454516|NCT01539759|65407158|FG001|Overall Study|Lost to Follow-up|8|||
23454517|NCT04349072|65407159|FG000|Randomization Period|Found ineligible post enrollment|0|||
23237193|NCT00598442|64611422|FG002|Overall Study|Death|11|||
23454518|NCT04349072|65407160|FG001|Randomization Period|Found ineligible post enrollment|1|||
23454519|NCT04349072|65407159|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
23454520|NCT04349072|65407160|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
23454521|NCT04349072|65407159|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
23454522|NCT04349072|65407160|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
23454523|NCT04349072|65407159|FG000|Treatment Period|Physician Decision|0|||
23454524|NCT04349072|65407160|FG001|Treatment Period|Physician Decision|1|||
23454525|NCT04349072|65407159|FG000|Treatment Period|Protocol Violation|0|||
23454526|NCT04349072|65407160|FG001|Treatment Period|Protocol Violation|1|||
23454527|NCT04349072|65407159|FG000|Treatment Period|Withdrawal by Subject|1|||
23454528|NCT04349072|65407160|FG001|Treatment Period|Withdrawal by Subject|1|||
23454529|NCT00517296|65407161|FG000|Overall Study|Withdrawal by Subject|1|||
23454530|NCT00517296|65407162|FG001|Overall Study|Withdrawal by Subject|0|||
23454531|NCT00168844|65407164|FG000|Overall Study|Adverse Event|31|||
23454532|NCT00168844|65407165|FG001|Overall Study|Adverse Event|32|||
23454533|NCT00168844|65407166|FG002|Overall Study|Adverse Event|48|||
23454534|NCT00168844|65407164|FG000|Overall Study|Lost to Follow-up|4|||
23454535|NCT00168844|65407165|FG001|Overall Study|Lost to Follow-up|5|||
23454536|NCT00168844|65407166|FG002|Overall Study|Lost to Follow-up|11|||
23454537|NCT00168844|65407164|FG000|Overall Study|Withdrawal by Subject|12|||
23454538|NCT00168844|65407165|FG001|Overall Study|Withdrawal by Subject|9|||
23454539|NCT00168844|65407166|FG002|Overall Study|Withdrawal by Subject|19|||
23454540|NCT00168844|65407164|FG000|Overall Study|Protocol Violation|2|||
23454541|NCT00168844|65407165|FG001|Overall Study|Protocol Violation|2|||
23454542|NCT00168844|65407166|FG002|Overall Study|Protocol Violation|4|||
23454543|NCT00168844|65407164|FG000|Overall Study|Other|6|||
23454544|NCT00168844|65407165|FG001|Overall Study|Other|7|||
23454545|NCT00168844|65407166|FG002|Overall Study|Other|9|||
23454546|NCT00383786|65407177|FG000|Overall Study|Protocol Violation|2|||
23454547|NCT00383786|65407178|FG001|Overall Study|Protocol Violation|6|||
23454548|NCT00383786|65407177|FG000|Overall Study|Withdrawal by Subject|2|||
23454549|NCT00383786|65407178|FG001|Overall Study|Withdrawal by Subject|5|||
23454550|NCT00383786|65407177|FG000|Overall Study|Physician Decision|0|||
23454551|NCT00383786|65407178|FG001|Overall Study|Physician Decision|1|||
23454552|NCT03224130|65407179|FG000|Overall Study|consent issue|0|||
23454553|NCT03224130|65407180|FG001|Overall Study|consent issue|1|||
23237194|NCT00598442|64611420|FG000|Overall Study|Lost to Follow-up|4|||
23237195|NCT00598442|64611421|FG001|Overall Study|Lost to Follow-up|3|||
23237196|NCT00598442|64611422|FG002|Overall Study|Lost to Follow-up|3|||
23237197|NCT00598442|64611420|FG000|Overall Study|Physician Decision|2|||
23237198|NCT00598442|64611421|FG001|Overall Study|Physician Decision|1|||
23237199|NCT00598442|64611422|FG002|Overall Study|Physician Decision|1|||
23237200|NCT00598442|64611420|FG000|Overall Study|Withdrawal by Subject|8|||
23237201|NCT00598442|64611421|FG001|Overall Study|Withdrawal by Subject|16|||
23237202|NCT00598442|64611422|FG002|Overall Study|Withdrawal by Subject|6|||
23237203|NCT00598442|64611420|FG000|Overall Study|Noncompliance|0|||
23454554|NCT00918385|65407181|FG000|Monotherapy|Adverse Event|1|||
23454555|NCT00918385|65407182|FG001|Monotherapy|Adverse Event|6|||
23342738|NCT01154296|64999686|FG001|Randomization and Intervention|Decided to decline|1|||
23342739|NCT01154296|64999685|FG000|Randomization and Intervention|Declined by staff|1|||
23342740|NCT01154296|64999686|FG001|Randomization and Intervention|Declined by staff|0|||
23342741|NCT01154296|64999685|FG000|Randomization and Intervention|Did not return|1|||
23342742|NCT01154296|64999686|FG001|Randomization and Intervention|Did not return|0|||
23342743|NCT01154296|64999685|FG000|Randomization and Intervention|Left before test|0|||
23342744|NCT01154296|64999686|FG001|Randomization and Intervention|Left before test|1|||
23342745|NCT01154296|64999685|FG000|Randomization and Intervention|Left clinic early|2|||
23342746|NCT01154296|64999686|FG001|Randomization and Intervention|Left clinic early|0|||
23342747|NCT01154296|64999685|FG000|6-month Follow-up|Lost contact|269|||
23342748|NCT01154296|64999686|FG001|6-month Follow-up|Lost contact|275|||
23342749|NCT01154296|64999685|FG000|6-month Follow-up|Incarcerated|37|||
23342750|NCT01154296|64999686|FG001|6-month Follow-up|Incarcerated|32|||
23342751|NCT01154296|64999685|FG000|6-month Follow-up|Withdrew consent|14|||
23342752|NCT01154296|64999686|FG001|6-month Follow-up|Withdrew consent|15|||
23342753|NCT01154296|64999685|FG000|6-month Follow-up|Death|3|||
23342754|NCT01154296|64999686|FG001|6-month Follow-up|Death|2|||
23342755|NCT01154296|64999685|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
23342756|NCT01154296|64999686|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
23342757|NCT03403751|64999687|FG000|Overall Study|Death|5|||
23342758|NCT03403751|64999688|FG001|Overall Study|Death|6|||
23454556|NCT00918385|65407181|FG000|Monotherapy|Complicating illness|1|||
23582462|NCT00991276|65862487|FG004|First Intervention Period|Adverse Event|0|||
23237204|NCT00598442|64611421|FG001|Overall Study|Noncompliance|2|||
23237205|NCT00598442|64611422|FG002|Overall Study|Noncompliance|1|||
23342759|NCT03403751|64999687|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
23454557|NCT00918385|65407182|FG001|Monotherapy|Complicating illness|0|||
23454558|NCT00918385|65407181|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
23454559|NCT00918385|65407182|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
23454560|NCT00918385|65407181|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
23237206|NCT00598442|64611420|FG000|Overall Study|Relocation|1|||
23237207|NCT00598442|64611421|FG001|Overall Study|Relocation|4|||
23237208|NCT00598442|64611422|FG002|Overall Study|Relocation|0|||
23237209|NCT00598442|64611420|FG000|Overall Study|Renal transplant|0|||
23237210|NCT00598442|64611421|FG001|Overall Study|Renal transplant|0|||
23237211|NCT00598442|64611422|FG002|Overall Study|Renal transplant|1|||
23237212|NCT00598442|64611420|FG000|Overall Study|Site closed by sponsor|5|||
23237213|NCT00598442|64611421|FG001|Overall Study|Site closed by sponsor|2|||
23237214|NCT00598442|64611422|FG002|Overall Study|Site closed by sponsor|1|||
23237215|NCT00598442|64611420|FG000|Overall Study|Started dialysis|1|||
23237216|NCT00598442|64611421|FG001|Overall Study|Started dialysis|0|||
23342760|NCT03403751|64999688|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
23342761|NCT04017832|64999689|FG000|Overall Study|Withdrawal by Subject|13|||
23454561|NCT00918385|65407182|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
23454562|NCT00918385|65407181|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
23454563|NCT00918385|65407182|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
23454564|NCT00918385|65407181|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
23454565|NCT00918385|65407182|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
23454566|NCT00001832|65407183|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
23454567|NCT00001832|65407184|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
23454568|NCT00001832|65407185|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
23454569|NCT00001832|65407186|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
23454570|NCT00001832|65407187|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
23454571|NCT00001832|65407188|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
23454572|NCT00001832|65407189|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
23454573|NCT00001832|65407190|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
23454574|NCT00001832|65407191|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
23454575|NCT00001832|65407192|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
23454576|NCT00001832|65407193|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
23454577|NCT00001832|65407194|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
23454578|NCT00001832|65407195|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
23454579|NCT00001832|65407196|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
23454580|NCT00001832|65407197|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
23454581|NCT00001832|65407183|FG000|Treatment Period|Death during treatment|0|||
23454582|NCT00001832|65407184|FG001|Treatment Period|Death during treatment|0|||
23454583|NCT00001832|65407185|FG002|Treatment Period|Death during treatment|0|||
23454584|NCT00001832|65407186|FG003|Treatment Period|Death during treatment|0|||
23454585|NCT00001832|65407187|FG004|Treatment Period|Death during treatment|0|||
23454586|NCT00001832|65407188|FG005|Treatment Period|Death during treatment|1|||
23454587|NCT00001832|65407189|FG006|Treatment Period|Death during treatment|0|||
23454588|NCT00001832|65407190|FG007|Treatment Period|Death during treatment|0|||
23454589|NCT00001832|65407191|FG008|Treatment Period|Death during treatment|0|||
23454590|NCT00001832|65407192|FG009|Treatment Period|Death during treatment|0|||
23454591|NCT00001832|65407193|FG010|Treatment Period|Death during treatment|0|||
23454592|NCT00001832|65407194|FG011|Treatment Period|Death during treatment|0|||
23454593|NCT00001832|65407195|FG012|Treatment Period|Death during treatment|0|||
23454594|NCT00001832|65407196|FG013|Treatment Period|Death during treatment|0|||
23454595|NCT00001832|65407197|FG014|Treatment Period|Death during treatment|0|||
23454596|NCT00001832|65407183|FG000|Treatment Period|Not treated|0|||
23454597|NCT00001832|65407184|FG001|Treatment Period|Not treated|0|||
23454598|NCT00001832|65407185|FG002|Treatment Period|Not treated|0|||
23454599|NCT00001832|65407186|FG003|Treatment Period|Not treated|0|||
23454600|NCT00001832|65407187|FG004|Treatment Period|Not treated|0|||
23454601|NCT00001832|65407188|FG005|Treatment Period|Not treated|0|||
23454602|NCT00001832|65407189|FG006|Treatment Period|Not treated|0|||
23454603|NCT00001832|65407190|FG007|Treatment Period|Not treated|1|||
23176814|NCT01808612|64390255|FG001|Treatment Period|Sponsor Decision|0|||
23176815|NCT01808612|64390256|FG002|Treatment Period|Sponsor Decision|0|||
23176816|NCT01808612|64390254|FG000|Treatment Period|Lack of Efficacy|1|||
23176817|NCT01808612|64390255|FG001|Treatment Period|Lack of Efficacy|1|||
23176818|NCT01808612|64390256|FG002|Treatment Period|Lack of Efficacy|2|||
23176819|NCT01808612|64390254|FG000|Discontinuation Period|Adverse Event|1|||
23176820|NCT01808612|64390255|FG001|Discontinuation Period|Adverse Event|0|||
23176821|NCT01808612|64390256|FG002|Discontinuation Period|Adverse Event|0|||
23176822|NCT01808612|64390254|FG000|Discontinuation Period|Physician Decision|1|||
23176823|NCT01808612|64390255|FG001|Discontinuation Period|Physician Decision|0|||
23176824|NCT01808612|64390256|FG002|Discontinuation Period|Physician Decision|0|||
23176825|NCT01808612|64390254|FG000|Discontinuation Period|Lost to Follow-up|0|||
23176826|NCT01808612|64390255|FG001|Discontinuation Period|Lost to Follow-up|1|||
23176827|NCT01808612|64390256|FG002|Discontinuation Period|Lost to Follow-up|0|||
23176828|NCT01885000|64390263|FG000|Overall Study|Adverse Event|1|||
23176829|NCT01885000|64390264|FG001|Overall Study|Adverse Event|0|||
23176830|NCT01885000|64390263|FG000|Overall Study|Withdrawal by Subject|1|||
23176831|NCT01885000|64390264|FG001|Overall Study|Withdrawal by Subject|1|||
23176832|NCT01885000|64390263|FG000|Overall Study|Protocol Violation|0|||
23176833|NCT01885000|64390264|FG001|Overall Study|Protocol Violation|1|||
23454604|NCT00001832|65407191|FG008|Treatment Period|Not treated|0|||
23454605|NCT00001832|65407192|FG009|Treatment Period|Not treated|0|||
23454606|NCT00001832|65407193|FG010|Treatment Period|Not treated|0|||
23454607|NCT00001832|65407194|FG011|Treatment Period|Not treated|0|||
23454608|NCT00001832|65407195|FG012|Treatment Period|Not treated|0|||
23454609|NCT00001832|65407196|FG013|Treatment Period|Not treated|0|||
23454610|NCT00001832|65407197|FG014|Treatment Period|Not treated|0|||
23176834|NCT01987908|64390266|FG000|Placebo Lead-in Period|Adverse Event|2|||
23176835|NCT01987908|64390267|FG001|Placebo Lead-in Period|Adverse Event|0|||
23176836|NCT01987908|64390268|FG002|Placebo Lead-in Period|Adverse Event|0|||
23176837|NCT01987908|64390266|FG000|Placebo Lead-in Period|Physician Decision|2|||
23176838|NCT01987908|64390267|FG001|Placebo Lead-in Period|Physician Decision|0|||
23176839|NCT01987908|64390268|FG002|Placebo Lead-in Period|Physician Decision|0|||
23176840|NCT01987908|64390266|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
23176841|NCT01987908|64390267|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
23176842|NCT01987908|64390268|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
23176843|NCT01987908|64390266|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
23176844|NCT01987908|64390267|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
23176845|NCT01987908|64390268|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
23176846|NCT01987908|64390266|FG000|Treatment Period|Adverse Event|0|||
23176847|NCT01987908|64390267|FG001|Treatment Period|Adverse Event|1|||
23176848|NCT01987908|64390268|FG002|Treatment Period|Adverse Event|1|||
23176849|NCT01987908|64390266|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
23176850|NCT01987908|64390267|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
23176851|NCT01987908|64390268|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
23176852|NCT01987908|64390266|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
23176853|NCT01987908|64390267|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
23176854|NCT01987908|64390268|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
23176855|NCT03687502|64390274|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
23176856|NCT03687502|64390274|FG000|Overall Study|Lumason not available|1|||
23176857|NCT01327651|64390275|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
23176858|NCT01327651|64390276|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
23176859|NCT01327651|64390277|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
23176860|NCT01327651|64390278|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
23176861|NCT01327651|64390279|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
23176862|NCT01327651|64390280|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
23176863|NCT01327651|64390281|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
23176864|NCT01327651|64390282|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
23176865|NCT01327651|64390283|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
23176866|NCT01327651|64390275|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
23176867|NCT01327651|64390276|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23176868|NCT01327651|64390277|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23176869|NCT01327651|64390278|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23176870|NCT01327651|64390279|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23176871|NCT01327651|64390280|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23176872|NCT01327651|64390281|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23237217|NCT00598442|64611422|FG002|Overall Study|Started dialysis|0|||
23237218|NCT02713490|64611423|FG000|Overall Study|Withdrawal by Subject|2|||
23237219|NCT02713490|64611424|FG001|Overall Study|Withdrawal by Subject|1|||
23237220|NCT02713490|64611423|FG000|Overall Study|Did not receive study drug|1|||
23237221|NCT02713490|64611424|FG001|Overall Study|Did not receive study drug|0|||
23237222|NCT02713490|64611423|FG000|Overall Study|Met exclusion criteria|0|||
23237223|NCT02713490|64611424|FG001|Overall Study|Met exclusion criteria|1|||
23237224|NCT03077646|64611425|FG000|Overall Study|Lost to Follow-up|29|||
23237225|NCT03077646|64611426|FG001|Overall Study|Lost to Follow-up|30|||
23237226|NCT03077646|64611427|FG002|Overall Study|Lost to Follow-up|31|||
23237227|NCT02452892|64611428|FG000|Week 1 Initial Randommization|Adverse Event|1|||
23237228|NCT02452892|64611429|FG001|Week 1 Initial Randommization|Adverse Event|0|||
23237229|NCT02452892|64611430|FG002|Week 1 Initial Randommization|Adverse Event|0|||
23237230|NCT02452892|64611431|FG003|Week 1 Initial Randommization|Adverse Event|0|||
23237231|NCT02452892|64611428|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
23237232|NCT02452892|64611429|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
23237233|NCT02452892|64611430|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
23237234|NCT02452892|64611431|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
23237235|NCT02452892|64611428|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
23237236|NCT02452892|64611429|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
23454611|NCT00762359|65407202|FG000|Overall Study|Adverse Event|20|||
23454612|NCT00762359|65407203|FG001|Overall Study|Adverse Event|23|||
23237237|NCT02452892|64611430|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
23454613|NCT00762359|65407202|FG000|Overall Study|Protocol Violation|21|||
23176873|NCT01327651|64390282|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23176874|NCT01327651|64390283|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
23176875|NCT01327651|64390275|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
23176876|NCT01327651|64390276|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
23176877|NCT01327651|64390277|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
23176878|NCT01327651|64390278|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
23237238|NCT02452892|64611431|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
23176879|NCT01327651|64390279|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
23176880|NCT01327651|64390280|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
23176881|NCT01327651|64390281|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
23176882|NCT01327651|64390282|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
23176883|NCT01327651|64390283|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
23176884|NCT01327651|64390275|FG000|Post Study Follow-up|Lost to Follow-up|0|||
23176885|NCT01327651|64390276|FG001|Post Study Follow-up|Lost to Follow-up|1|||
23176886|NCT01327651|64390277|FG002|Post Study Follow-up|Lost to Follow-up|1|||
23176887|NCT01327651|64390278|FG003|Post Study Follow-up|Lost to Follow-up|0|||
23176888|NCT01327651|64390279|FG004|Post Study Follow-up|Lost to Follow-up|0|||
23176889|NCT01327651|64390280|FG005|Post Study Follow-up|Lost to Follow-up|0|||
23176890|NCT01327651|64390281|FG006|Post Study Follow-up|Lost to Follow-up|4|||
23237239|NCT02452892|64611428|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
23237240|NCT02452892|64611429|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
23237241|NCT02452892|64611430|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
23237242|NCT02452892|64611431|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
23582463|NCT00991276|65862488|FG005|First Intervention Period|Adverse Event|0|||
23237243|NCT02452892|64611428|FG000|Follow-up|Withdrawal by Subject|0|||
23237244|NCT02452892|64611429|FG001|Follow-up|Withdrawal by Subject|0|||
23582464|NCT00991276|65862483|FG000|First Intervention Period|Protocol Violation|0|||
23582465|NCT00991276|65862484|FG001|First Intervention Period|Protocol Violation|0|||
23582466|NCT00991276|65862485|FG002|First Intervention Period|Protocol Violation|0|||
23237245|NCT02452892|64611430|FG002|Follow-up|Withdrawal by Subject|0|||
23237246|NCT02452892|64611431|FG003|Follow-up|Withdrawal by Subject|1|||
23237247|NCT02452892|64611428|FG000|Follow-up|Subject left town on Day 42|1|||
23237248|NCT02452892|64611429|FG001|Follow-up|Subject left town on Day 42|0|||
23237249|NCT02452892|64611430|FG002|Follow-up|Subject left town on Day 42|0|||
23237250|NCT02452892|64611431|FG003|Follow-up|Subject left town on Day 42|0|||
23237251|NCT02147132|64611435|FG000|Overall Study|Lost to Follow-up|1|||
23237252|NCT02147132|64611436|FG001|Overall Study|Lost to Follow-up|0|||
23237253|NCT02147132|64611437|FG002|Overall Study|Lost to Follow-up|0|||
23237254|NCT02147132|64611438|FG003|Overall Study|Lost to Follow-up|0|||
23237255|NCT00706901|64611442|FG000|Overall Study|Lost to Follow-up|2|||
23237256|NCT00706901|64611443|FG001|Overall Study|Lost to Follow-up|3|||
23237257|NCT00706901|64611444|FG002|Overall Study|Lost to Follow-up|2|||
23237258|NCT00706901|64611442|FG000|Overall Study|Withdrawal by Subject|4|||
23237259|NCT00706901|64611443|FG001|Overall Study|Withdrawal by Subject|2|||
23237260|NCT00706901|64611444|FG002|Overall Study|Withdrawal by Subject|5|||
23237261|NCT00706901|64611442|FG000|Overall Study|In Jail|1|||
23237262|NCT00706901|64611443|FG001|Overall Study|In Jail|0|||
23237263|NCT00706901|64611444|FG002|Overall Study|In Jail|1|||
23237264|NCT00706901|64611442|FG000|Overall Study|Death|1|||
23237265|NCT00706901|64611443|FG001|Overall Study|Death|0|||
23237266|NCT00706901|64611444|FG002|Overall Study|Death|0|||
23237267|NCT04391894|64611445|FG000|Overall Study|Adverse Event|1|||
23237268|NCT04391894|64611446|FG001|Overall Study|Adverse Event|1|||
23237269|NCT04391894|64611447|FG002|Overall Study|Adverse Event|1|||
23237270|NCT04391894|64611448|FG003|Overall Study|Adverse Event|1|||
23582467|NCT00991276|65862486|FG003|First Intervention Period|Protocol Violation|0|||
23582468|NCT00991276|65862487|FG004|First Intervention Period|Protocol Violation|2|||
23582469|NCT00991276|65862488|FG005|First Intervention Period|Protocol Violation|0|||
23582470|NCT00991276|65862483|FG000|First Intervention Period|Insufficient clinical response|0|||
23582471|NCT00991276|65862484|FG001|First Intervention Period|Insufficient clinical response|0|||
23582472|NCT00991276|65862485|FG002|First Intervention Period|Insufficient clinical response|0|||
23176891|NCT01327651|64390282|FG007|Post Study Follow-up|Lost to Follow-up|1|||
23237271|NCT04391894|64611449|FG004|Overall Study|Adverse Event|1|||
23237272|NCT04391894|64611445|FG000|Overall Study|Lost to Follow-up|1|||
23237273|NCT04391894|64611446|FG001|Overall Study|Lost to Follow-up|0|||
23237274|NCT04391894|64611447|FG002|Overall Study|Lost to Follow-up|0|||
23237275|NCT04391894|64611448|FG003|Overall Study|Lost to Follow-up|0|||
23237276|NCT04391894|64611449|FG004|Overall Study|Lost to Follow-up|0|||
23237277|NCT04391894|64611445|FG000|Overall Study|Protocol Violation|0|||
23237278|NCT04391894|64611446|FG001|Overall Study|Protocol Violation|0|||
23237279|NCT04391894|64611447|FG002|Overall Study|Protocol Violation|0|||
23582473|NCT00991276|65862486|FG003|First Intervention Period|Insufficient clinical response|0|||
23237280|NCT04391894|64611448|FG003|Overall Study|Protocol Violation|1|||
23237281|NCT04391894|64611449|FG004|Overall Study|Protocol Violation|0|||
23176892|NCT01327651|64390283|FG008|Post Study Follow-up|Lost to Follow-up|2|||
23176893|NCT02527707|64390284|FG000|Overall Study|Adverse Event|1|||
23176894|NCT02527707|64390284|FG000|Overall Study|Adverse Event|1|||
23176895|NCT01072344|64390285|FG000|Overall Study|Relasped-reached end point|7|||
23176896|NCT01072344|64390286|FG001|Overall Study|Relasped-reached end point|12|||
23176897|NCT01072344|64390285|FG000|Overall Study|Protocol Violation|1|||
23176898|NCT01072344|64390286|FG001|Overall Study|Protocol Violation|2|||
23176899|NCT01072344|64390285|FG000|Overall Study|Lost to Follow-up|3|||
23176900|NCT01072344|64390286|FG001|Overall Study|Lost to Follow-up|4|||
23176901|NCT02688647|64390287|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
23176902|NCT02688647|64390288|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
23176903|NCT02688647|64390287|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
23176904|NCT02688647|64390288|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
23176905|NCT02688647|64390287|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
23176906|NCT02688647|64390288|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
23176907|NCT02688647|64390287|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
23176908|NCT02688647|64390288|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
23176909|NCT02688647|64390287|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
23176910|NCT02688647|64390288|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
23176911|NCT02688647|64390287|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
23176912|NCT02688647|64390288|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
23176913|NCT02688647|64390287|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
23176914|NCT02688647|64390288|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
23176915|NCT02421887|64390289|FG000|Overall Study|Lost to Follow-up|5|||
23176916|NCT02421887|64390290|FG001|Overall Study|Lost to Follow-up|0|||
23176917|NCT02421887|64390289|FG000|Overall Study|Withdrawal by Subject|8|||
23176918|NCT02421887|64390290|FG001|Overall Study|Withdrawal by Subject|5|||
23176919|NCT02421887|64390289|FG000|Overall Study|Physician Decision|2|||
23176920|NCT02421887|64390290|FG001|Overall Study|Physician Decision|4|||
23176921|NCT02421887|64390289|FG000|Overall Study|Adverse Event|2|||
23176922|NCT02421887|64390290|FG001|Overall Study|Adverse Event|0|||
23176923|NCT03739528|64390292|FG000|Overall Study|Not treated|8|||
23176924|NCT03739528|64390293|FG001|Overall Study|Not treated|12|||
23176925|NCT03739528|64390292|FG000|Overall Study|Treatment and study discontinued|6|||
23176926|NCT03739528|64390293|FG001|Overall Study|Treatment and study discontinued|2|||
23176927|NCT03739528|64390292|FG000|Overall Study|Treatment discontinued + study completed|1|||
23176928|NCT03739528|64390293|FG001|Overall Study|Treatment discontinued + study completed|3|||
23176929|NCT00441545|64390294|FG000|First Intervention|Adverse Event|6|||
23176930|NCT00441545|64390295|FG001|First Intervention|Adverse Event|5|||
23176931|NCT00441545|64390294|FG000|First Intervention|Protocol Violation|2|||
23176932|NCT00441545|64390295|FG001|First Intervention|Protocol Violation|2|||
23237282|NCT04391894|64611445|FG000|Overall Study|Withdrawal by Subject|2|||
23237283|NCT04391894|64611446|FG001|Overall Study|Withdrawal by Subject|0|||
23237284|NCT04391894|64611447|FG002|Overall Study|Withdrawal by Subject|3|||
23237285|NCT04391894|64611448|FG003|Overall Study|Withdrawal by Subject|0|||
23237286|NCT04391894|64611449|FG004|Overall Study|Withdrawal by Subject|1|||
23342762|NCT04017832|64999690|FG001|Overall Study|Withdrawal by Subject|12|||
23582474|NCT00991276|65862487|FG004|First Intervention Period|Insufficient clinical response|1|||
23582475|NCT00991276|65862488|FG005|First Intervention Period|Insufficient clinical response|0|||
23176933|NCT00441545|64390294|FG000|First Intervention|Withdrawal by Subject|3|||
23176934|NCT00441545|64390295|FG001|First Intervention|Withdrawal by Subject|3|||
23176935|NCT00441545|64390294|FG000|First Intervention|Kidney transplant|1|||
23176936|NCT00441545|64390295|FG001|First Intervention|Kidney transplant|1|||
23176937|NCT00441545|64390294|FG000|First Intervention|Lack of Efficacy|2|||
23176938|NCT00441545|64390295|FG001|First Intervention|Lack of Efficacy|0|||
23237287|NCT04391894|64611445|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
23342763|NCT04017832|64999691|FG002|Overall Study|Withdrawal by Subject|21|||
23342764|NCT04017832|64999692|FG003|Overall Study|Withdrawal by Subject|7|||
23582476|NCT00991276|65862483|FG000|First Intervention Period|Other|0|||
23582477|NCT00991276|65862484|FG001|First Intervention Period|Other|0|||
23582478|NCT00991276|65862485|FG002|First Intervention Period|Other|0|||
23582479|NCT00991276|65862486|FG003|First Intervention Period|Other|1|||
23582480|NCT00991276|65862487|FG004|First Intervention Period|Other|1|||
23582481|NCT00991276|65862488|FG005|First Intervention Period|Other|0|||
23582482|NCT00991276|65862483|FG000|First Intervention Period|Withdrawal by Subject|0|||
23582483|NCT00991276|65862484|FG001|First Intervention Period|Withdrawal by Subject|1|||
23582484|NCT00991276|65862485|FG002|First Intervention Period|Withdrawal by Subject|0|||
23176939|NCT00441545|64390294|FG000|First Intervention|Subject exceeded safety criteria|0|||
23176940|NCT00441545|64390295|FG001|First Intervention|Subject exceeded safety criteria|1|||
23342765|NCT04017832|64999689|FG000|Overall Study|Lost to Follow-up|0|||
23342766|NCT04017832|64999690|FG001|Overall Study|Lost to Follow-up|3|||
23582485|NCT00991276|65862486|FG003|First Intervention Period|Withdrawal by Subject|1|||
23582486|NCT00991276|65862487|FG004|First Intervention Period|Withdrawal by Subject|0|||
23176941|NCT00441545|64390294|FG000|First Intervention|Subject met an exclusionary criteria|1|||
23176942|NCT00441545|64390295|FG001|First Intervention|Subject met an exclusionary criteria|0|||
23176943|NCT00441545|64390294|FG000|First Intervention|Extended hospitalization|1|||
23176944|NCT00441545|64390295|FG001|First Intervention|Extended hospitalization|0|||
23342767|NCT04017832|64999691|FG002|Overall Study|Lost to Follow-up|3|||
23342768|NCT04017832|64999692|FG003|Overall Study|Lost to Follow-up|1|||
23342769|NCT04017832|64999689|FG000|Overall Study|Physician Decision|1|||
23342770|NCT04017832|64999690|FG001|Overall Study|Physician Decision|1|||
23342771|NCT04017832|64999691|FG002|Overall Study|Physician Decision|1|||
23342772|NCT04017832|64999692|FG003|Overall Study|Physician Decision|1|||
23342773|NCT04017832|64999689|FG000|Overall Study|Death|2|||
23342774|NCT04017832|64999690|FG001|Overall Study|Death|2|||
23342775|NCT04017832|64999691|FG002|Overall Study|Death|1|||
23582487|NCT00991276|65862488|FG005|First Intervention Period|Withdrawal by Subject|1|||
23582488|NCT00991276|65862483|FG000|First Intervention Period|Lost to Follow-up|0|||
23582489|NCT00991276|65862484|FG001|First Intervention Period|Lost to Follow-up|1|||
23582490|NCT00991276|65862485|FG002|First Intervention Period|Lost to Follow-up|0|||
23582491|NCT00991276|65862486|FG003|First Intervention Period|Lost to Follow-up|1|||
23582492|NCT00991276|65862487|FG004|First Intervention Period|Lost to Follow-up|0|||
23582493|NCT00991276|65862488|FG005|First Intervention Period|Lost to Follow-up|0|||
23582494|NCT00991276|65862483|FG000|Second Intervention Period|Adverse Event|0|||
23582495|NCT00991276|65862484|FG001|Second Intervention Period|Adverse Event|2|||
23582496|NCT00991276|65862485|FG002|Second Intervention Period|Adverse Event|0|||
23582497|NCT00991276|65862486|FG003|Second Intervention Period|Adverse Event|1|||
23582498|NCT00991276|65862487|FG004|Second Intervention Period|Adverse Event|1|||
23582499|NCT00991276|65862488|FG005|Second Intervention Period|Adverse Event|0|||
23582500|NCT00991276|65862483|FG000|Second Intervention Period|Protocol Violation|1|||
23582501|NCT00991276|65862484|FG001|Second Intervention Period|Protocol Violation|0|||
23582502|NCT00991276|65862485|FG002|Second Intervention Period|Protocol Violation|0|||
23582503|NCT00991276|65862486|FG003|Second Intervention Period|Protocol Violation|0|||
23582504|NCT00991276|65862487|FG004|Second Intervention Period|Protocol Violation|0|||
23582505|NCT00991276|65862488|FG005|Second Intervention Period|Protocol Violation|0|||
23582506|NCT00991276|65862483|FG000|Second Intervention Period|Other|0|||
23342776|NCT04017832|64999692|FG003|Overall Study|Death|0|||
23342777|NCT05835011|64999693|FG000|Overall Study|Study Terminated by the Sponsor|1|||
23342778|NCT05835011|64999693|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
23342779|NCT02567435|64999695|FG000|Overall Study|Death|1|||
23342780|NCT02567435|64999696|FG001|Overall Study|Death|1|||
23342781|NCT02567435|64999697|FG002|Overall Study|Death|0|||
23342782|NCT02567435|64999698|FG003|Overall Study|Death|0|||
23342783|NCT02567435|64999695|FG000|Overall Study|Ineligible|1|||
23342784|NCT02567435|64999696|FG001|Overall Study|Ineligible|3|||
23342785|NCT02567435|64999697|FG002|Overall Study|Ineligible|0|||
23342786|NCT02567435|64999698|FG003|Overall Study|Ineligible|0|||
23342787|NCT02567435|64999695|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
23342788|NCT02567435|64999696|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
23342789|NCT02567435|64999697|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
23342790|NCT02567435|64999698|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
23342791|NCT00738881|64999699|FG000|Overall Study|Withdrawal by Subject|0|||
23342792|NCT00738881|64999700|FG001|Overall Study|Withdrawal by Subject|2|||
23342793|NCT04852679|64999701|FG000|Main Intervention Period|Withdrawal by Subject|3|||
23582507|NCT00991276|65862484|FG001|Second Intervention Period|Other|0|||
23582508|NCT00991276|65862485|FG002|Second Intervention Period|Other|0|||
23176945|NCT00441545|64390294|FG000|First Intervention|Site error|1|||
23176946|NCT00441545|64390295|FG001|First Intervention|Site error|0|||
23582509|NCT00991276|65862486|FG003|Second Intervention Period|Other|1|||
23237288|NCT04391894|64611446|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
23342794|NCT04852679|64999701|FG000|Main Intervention Period|Adverse Event|1|||
23342795|NCT04852679|64999701|FG000|Main Intervention Period|Progressive Disease|16|||
23582510|NCT00991276|65862487|FG004|Second Intervention Period|Other|0|||
23342796|NCT04852679|64999701|FG000|Main Intervention Period|Refused study visit|1|||
23342797|NCT04852679|64999701|FG000|Independent Injection Period|Missed study visit|1|||
23582511|NCT00991276|65862488|FG005|Second Intervention Period|Other|1|||
23237289|NCT04391894|64611447|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
23237290|NCT04391894|64611448|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
23237291|NCT04391894|64611449|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
23237292|NCT01005966|64611450|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
23237293|NCT01005966|64611451|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
23237294|NCT01005966|64611452|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
23237295|NCT01005966|64611453|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
23237296|NCT01005966|64611454|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
23237297|NCT01005966|64611450|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
23237298|NCT01005966|64611451|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
23237299|NCT01005966|64611452|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
23237300|NCT01005966|64611453|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
23237301|NCT01005966|64611454|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
23237302|NCT01005966|64611450|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
23237303|NCT01005966|64611451|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
23237304|NCT01005966|64611452|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
23237305|NCT01005966|64611453|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
23237306|NCT01005966|64611454|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
23237307|NCT01005966|64611450|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
23237308|NCT01005966|64611451|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
23237309|NCT01005966|64611452|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
23237310|NCT01005966|64611453|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
23237311|NCT01005966|64611454|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
23237312|NCT01005966|64611450|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23237313|NCT01005966|64611451|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23237314|NCT01005966|64611452|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23237315|NCT01005966|64611453|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23237316|NCT01005966|64611454|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23237317|NCT01005966|64611450|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23237318|NCT01005966|64611451|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23237319|NCT01005966|64611452|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
23237320|NCT01005966|64611453|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23237321|NCT01005966|64611454|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
23237322|NCT01005966|64611450|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
23237323|NCT01005966|64611451|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
23237324|NCT01005966|64611452|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
23237325|NCT01005966|64611453|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
23237326|NCT01005966|64611454|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
23237327|NCT01005966|64611450|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
23237328|NCT01005966|64611451|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
23237329|NCT01005966|64611452|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
23237330|NCT01005966|64611453|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
23237331|NCT01005966|64611454|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
23237332|NCT01005966|64611450|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
23237333|NCT01005966|64611451|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
23237334|NCT01005966|64611452|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
23237335|NCT01005966|64611453|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
23237336|NCT01005966|64611454|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
23237337|NCT04225026|64611458|FG000|Overall Study|Withdrawal by Subject|4|||
23237338|NCT04225026|64611458|FG000|Overall Study|Adverse Event|1|||
23237339|NCT04225026|64611458|FG000|Overall Study|Other|1|||
23237340|NCT04225026|64611458|FG000|Overall Study|Death|11|||
23237341|NCT04225026|64611458|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
23237342|NCT01016912|64611461|FG000|End of Treatment Period|Lack of Efficacy|0|||
23237343|NCT01016912|64611462|FG001|End of Treatment Period|Lack of Efficacy|1|||
23237344|NCT01016912|64611463|FG002|End of Treatment Period|Lack of Efficacy|0|||
23237345|NCT01016912|64611464|FG003|End of Treatment Period|Lack of Efficacy|4|||
23237346|NCT01016912|64611465|FG004|End of Treatment Period|Lack of Efficacy|4|||
23237347|NCT01016912|64611461|FG000|End of Treatment Period|Adverse Event|0|||
23237348|NCT01016912|64611462|FG001|End of Treatment Period|Adverse Event|1|||
23237349|NCT01016912|64611463|FG002|End of Treatment Period|Adverse Event|1|||
23237350|NCT01016912|64611464|FG003|End of Treatment Period|Adverse Event|0|||
23237351|NCT01016912|64611465|FG004|End of Treatment Period|Adverse Event|0|||
23237352|NCT01016912|64611461|FG000|End of Treatment Period|Completed double-blind period only|0|||
23237353|NCT01016912|64611462|FG001|End of Treatment Period|Completed double-blind period only|1|||
23237354|NCT01016912|64611463|FG002|End of Treatment Period|Completed double-blind period only|0|||
23237355|NCT01016912|64611464|FG003|End of Treatment Period|Completed double-blind period only|0|||
23237356|NCT01016912|64611465|FG004|End of Treatment Period|Completed double-blind period only|0|||
23237357|NCT01016912|64611461|FG000|Follow-up Period|Other reason|0|||
23237358|NCT01016912|64611462|FG001|Follow-up Period|Other reason|0|||
23237359|NCT01016912|64611463|FG002|Follow-up Period|Other reason|1|||
23342798|NCT02733185|64999704|FG000|Overall Study|Withdrawal by Subject|12|||
23342799|NCT02733185|64999705|FG001|Overall Study|Withdrawal by Subject|10|||
23342800|NCT02733185|64999706|FG002|Overall Study|Withdrawal by Subject|17|||
23342801|NCT02733185|64999707|FG003|Overall Study|Withdrawal by Subject|21|||
23342802|NCT02733185|64999704|FG000|Overall Study|Death|46|||
23342803|NCT02733185|64999705|FG001|Overall Study|Death|34|||
23342804|NCT02733185|64999706|FG002|Overall Study|Death|35|||
23342805|NCT02733185|64999707|FG003|Overall Study|Death|43|||
23342806|NCT02733185|64999704|FG000|Overall Study|Lost to Follow-up|17|||
23342807|NCT02733185|64999705|FG001|Overall Study|Lost to Follow-up|18|||
23342808|NCT02733185|64999706|FG002|Overall Study|Lost to Follow-up|16|||
23342809|NCT02733185|64999707|FG003|Overall Study|Lost to Follow-up|11|||
23342810|NCT03526250|64999708|FG000|Overall Study|Adverse Event|4|||
23342811|NCT03526250|64999708|FG000|Overall Study|Progressive Disease|16|||
23342812|NCT03526250|64999708|FG000|Overall Study|No Treatment|3|||
23342813|NCT02680834|64999709|FG000|Overall Study|Physician Decision|5|||
23342814|NCT02680834|64999710|FG001|Overall Study|Physician Decision|2|||
23342815|NCT02680834|64999709|FG000|Overall Study|Withdrawal by Subject|6|||
23342816|NCT02680834|64999710|FG001|Overall Study|Withdrawal by Subject|0|||
23342817|NCT02680834|64999709|FG000|Overall Study|Lost to Follow-up|0|||
23342818|NCT02680834|64999710|FG001|Overall Study|Lost to Follow-up|1|||
23342819|NCT01500187|64999711|FG000|Overall Study|Lost to Follow-up|6|||
23342820|NCT01500187|64999712|FG001|Overall Study|Lost to Follow-up|0|||
23342821|NCT01992653|64999713|FG000|Overall Study|Death|0|||
23342822|NCT01992653|64999714|FG001|Overall Study|Death|0|||
23342823|NCT01992653|64999715|FG002|Overall Study|Death|1|||
23342824|NCT01992653|64999716|FG003|Overall Study|Death|0|||
23342825|NCT01992653|64999717|FG004|Overall Study|Death|1|||
23342826|NCT01992653|64999718|FG005|Overall Study|Death|0|||
23342827|NCT01992653|64999719|FG006|Overall Study|Death|4|||
23342828|NCT01992653|64999720|FG007|Overall Study|Death|2|||
23342829|NCT01992653|64999713|FG000|Overall Study|Lost to Follow-up|0|||
23342830|NCT01992653|64999714|FG001|Overall Study|Lost to Follow-up|0|||
23342831|NCT01992653|64999715|FG002|Overall Study|Lost to Follow-up|0|||
23342832|NCT01992653|64999716|FG003|Overall Study|Lost to Follow-up|0|||
23342833|NCT01992653|64999717|FG004|Overall Study|Lost to Follow-up|0|||
23342834|NCT01992653|64999718|FG005|Overall Study|Lost to Follow-up|0|||
23342835|NCT01992653|64999719|FG006|Overall Study|Lost to Follow-up|0|||
23342836|NCT01992653|64999720|FG007|Overall Study|Lost to Follow-up|1|||
23342837|NCT01992653|64999713|FG000|Overall Study|Study Completed|0|||
23342838|NCT01992653|64999714|FG001|Overall Study|Study Completed|0|||
23342839|NCT01992653|64999715|FG002|Overall Study|Study Completed|0|||
23342840|NCT01992653|64999716|FG003|Overall Study|Study Completed|0|||
23342841|NCT01992653|64999717|FG004|Overall Study|Study Completed|0|||
23342842|NCT01992653|64999718|FG005|Overall Study|Study Completed|0|||
23342843|NCT01992653|64999719|FG006|Overall Study|Study Completed|0|||
23342844|NCT01992653|64999720|FG007|Overall Study|Study Completed|1|||
23342845|NCT01992653|64999713|FG000|Overall Study|Disease Progression|0|||
23342846|NCT01992653|64999714|FG001|Overall Study|Disease Progression|0|||
23342847|NCT01992653|64999715|FG002|Overall Study|Disease Progression|0|||
23176947|NCT00441545|64390294|FG000|First Intervention|Sponsor's request|1|||
23176948|NCT00441545|64390295|FG001|First Intervention|Sponsor's request|0|||
23176949|NCT00441545|64390294|FG000|Second Intervention|Adverse Event|5|||
23176950|NCT00441545|64390295|FG001|Second Intervention|Adverse Event|2|||
23176951|NCT00441545|64390294|FG000|Second Intervention|Protocol Violation|4|||
23176952|NCT00441545|64390295|FG001|Second Intervention|Protocol Violation|1|||
23176953|NCT00441545|64390294|FG000|Second Intervention|Withdrawal by Subject|1|||
23176954|NCT00441545|64390295|FG001|Second Intervention|Withdrawal by Subject|1|||
23176955|NCT00441545|64390294|FG000|Second Intervention|Kidney Transplant|1|||
23176956|NCT00441545|64390295|FG001|Second Intervention|Kidney Transplant|1|||
23176957|NCT00441545|64390294|FG000|Second Intervention|Lack of Efficacy|0|||
23176958|NCT00441545|64390295|FG001|Second Intervention|Lack of Efficacy|1|||
23176959|NCT00441545|64390294|FG000|Second Intervention|Subject exceeded safety criteria|1|||
23176960|NCT00441545|64390295|FG001|Second Intervention|Subject exceeded safety criteria|0|||
23176961|NCT00441545|64390294|FG000|Second Intervention|Subject moved|0|||
23176962|NCT00441545|64390295|FG001|Second Intervention|Subject moved|1|||
23342848|NCT01992653|64999716|FG003|Overall Study|Disease Progression|0|||
23342849|NCT01992653|64999717|FG004|Overall Study|Disease Progression|0|||
23342850|NCT01992653|64999718|FG005|Overall Study|Disease Progression|0|||
23176963|NCT03472560|64390296|FG000|Overall Study|Subject transfer to continuation protocol|0|||
23176964|NCT03472560|64390297|FG001|Overall Study|Subject transfer to continuation protocol|1|||
23342851|NCT01992653|64999719|FG006|Overall Study|Disease Progression|4|||
23342852|NCT01992653|64999720|FG007|Overall Study|Disease Progression|0|||
23342853|NCT03467763|64999725|FG000|Overall Study|Lost to Follow-up|1|||
23342854|NCT03467763|64999725|FG000|Overall Study|Protocol Violation|2|||
23342855|NCT04934189|64999726|FG000|Overall Study|Lost to Follow-up|4|||
23342856|NCT04934189|64999726|FG000|Overall Study|Withdrawal by Subject|17|||
23342857|NCT02783729|64999727|FG000|Overall Study|Lack of Efficacy|1|||
23342858|NCT02783729|64999728|FG001|Overall Study|Lack of Efficacy|0|||
23342859|NCT02783729|64999729|FG002|Overall Study|Lack of Efficacy|0|||
23176965|NCT03472560|64390296|FG000|Overall Study|Withdrawal by Subject|4|||
23176966|NCT03472560|64390297|FG001|Overall Study|Withdrawal by Subject|0|||
23176967|NCT03472560|64390296|FG000|Overall Study|Progressive disease|24|||
23176968|NCT03472560|64390297|FG001|Overall Study|Progressive disease|8|||
23176969|NCT03472560|64390296|FG000|Overall Study|Physician Decision|1|||
23176970|NCT03472560|64390297|FG001|Overall Study|Physician Decision|0|||
23176971|NCT03472560|64390296|FG000|Overall Study|Death|7|||
23176972|NCT03472560|64390297|FG001|Overall Study|Death|4|||
23176973|NCT03472560|64390296|FG000|Overall Study|Adverse Event|5|||
23176974|NCT03472560|64390297|FG001|Overall Study|Adverse Event|3|||
23454614|NCT00762359|65407203|FG001|Overall Study|Protocol Violation|13|||
23176975|NCT03472560|64390296|FG000|Overall Study|Global deterioration of health status|0|||
23176976|NCT03472560|64390297|FG001|Overall Study|Global deterioration of health status|4|||
23176977|NCT01679002|64390298|FG000|Overall Study|Adverse Event|1|||
23176978|NCT01679002|64390299|FG001|Overall Study|Adverse Event|1|||
23176979|NCT01679002|64390300|FG002|Overall Study|Adverse Event|0|||
23176980|NCT01662440|64390301|FG000|Overall Study|Adverse Event|1|||
23176981|NCT01662440|64390302|FG001|Overall Study|Adverse Event|0|||
23176982|NCT01662440|64390303|FG002|Overall Study|Adverse Event|0|||
23176983|NCT01662440|64390304|FG003|Overall Study|Adverse Event|1|||
23176984|NCT01662440|64390301|FG000|Overall Study|Death|0|||
23176985|NCT01662440|64390302|FG001|Overall Study|Death|1|||
23176986|NCT01662440|64390303|FG002|Overall Study|Death|0|||
23176987|NCT01662440|64390304|FG003|Overall Study|Death|0|||
23176988|NCT01662440|64390301|FG000|Overall Study|Lost to Follow-up|2|||
23176989|NCT01662440|64390302|FG001|Overall Study|Lost to Follow-up|2|||
23176990|NCT01662440|64390303|FG002|Overall Study|Lost to Follow-up|4|||
23176991|NCT01662440|64390304|FG003|Overall Study|Lost to Follow-up|1|||
23176992|NCT01662440|64390301|FG000|Overall Study|Subject moved to another country.|0|||
23176993|NCT01662440|64390302|FG001|Overall Study|Subject moved to another country.|1|||
23176994|NCT01662440|64390303|FG002|Overall Study|Subject moved to another country.|0|||
23176995|NCT01662440|64390304|FG003|Overall Study|Subject moved to another country.|0|||
23176996|NCT01662440|64390301|FG000|Overall Study|Protocol Violation|1|||
23176997|NCT01662440|64390302|FG001|Overall Study|Protocol Violation|0|||
23176998|NCT01662440|64390303|FG002|Overall Study|Protocol Violation|0|||
23176999|NCT01662440|64390304|FG003|Overall Study|Protocol Violation|0|||
23177000|NCT01662440|64390301|FG000|Overall Study|Withdrawal by Subject|5|||
23177001|NCT01662440|64390302|FG001|Overall Study|Withdrawal by Subject|2|||
23177002|NCT01662440|64390303|FG002|Overall Study|Withdrawal by Subject|2|||
23177003|NCT01662440|64390304|FG003|Overall Study|Withdrawal by Subject|2|||
23237360|NCT01016912|64611464|FG003|Follow-up Period|Other reason|1|||
23237361|NCT01016912|64611465|FG004|Follow-up Period|Other reason|0|||
23237362|NCT03726320|64611466|FG000|Overall Study|Lost to Follow-up|2|||
23237363|NCT03726320|64611467|FG001|Overall Study|Lost to Follow-up|4|||
23237364|NCT03726320|64611468|FG002|Overall Study|Lost to Follow-up|0|||
23237365|NCT03726320|64611466|FG000|Overall Study|Time Constraints|4|||
23237366|NCT03726320|64611467|FG001|Overall Study|Time Constraints|1|||
23237367|NCT03726320|64611468|FG002|Overall Study|Time Constraints|0|||
23237368|NCT03726320|64611466|FG000|Overall Study|Ineligible after enrollment|3|||
23237369|NCT03726320|64611467|FG001|Overall Study|Ineligible after enrollment|3|||
23237370|NCT03726320|64611468|FG002|Overall Study|Ineligible after enrollment|0|||
23237371|NCT03726320|64611466|FG000|Overall Study|Clinic / insurance issue|2|||
23237372|NCT03726320|64611467|FG001|Overall Study|Clinic / insurance issue|0|||
23237373|NCT03726320|64611468|FG002|Overall Study|Clinic / insurance issue|0|||
23237374|NCT03726320|64611466|FG000|Overall Study|Language barrier|1|||
23237375|NCT03726320|64611467|FG001|Overall Study|Language barrier|0|||
23237376|NCT03726320|64611468|FG002|Overall Study|Language barrier|0|||
23237377|NCT03726320|64611466|FG000|Overall Study|Provider left the clinic|0|||
23237378|NCT03726320|64611467|FG001|Overall Study|Provider left the clinic|0|||
23237379|NCT03726320|64611468|FG002|Overall Study|Provider left the clinic|1|||
23237380|NCT01640353|64611469|FG000|Overall Study|Withdrew prior to treatment|10|||
23237381|NCT01640353|64611469|FG000|Overall Study|Withdrawn from analysis at term site|12|||
23237382|NCT01640353|64611469|FG000|Overall Study|Withdrawal by Subject|5|||
23454615|NCT00762359|65407202|FG000|Overall Study|Withdrawal by Subject|13|||
23454616|NCT00762359|65407203|FG001|Overall Study|Withdrawal by Subject|10|||
23454617|NCT00762359|65407202|FG000|Overall Study|Lack of Efficacy|0|||
23454618|NCT00762359|65407203|FG001|Overall Study|Lack of Efficacy|4|||
23177004|NCT00094757|64390305|FG000|Overall Study|Adverse Event|11|||
23177005|NCT00094757|64390306|FG001|Overall Study|Adverse Event|9|||
23237383|NCT01640353|64611469|FG000|Overall Study|Death|2|||
23342860|NCT02783729|64999730|FG003|Overall Study|Lack of Efficacy|0|||
23582512|NCT00991276|65862483|FG000|Third Intervention Period|Protocol Violation|1|||
23177006|NCT00094757|64390307|FG002|Overall Study|Adverse Event|6|||
23177007|NCT00094757|64390305|FG000|Overall Study|Lack of Efficacy|11|||
23177008|NCT00094757|64390306|FG001|Overall Study|Lack of Efficacy|15|||
23177009|NCT00094757|64390307|FG002|Overall Study|Lack of Efficacy|8|||
23177010|NCT00094757|64390305|FG000|Overall Study|Lost to Follow-up|3|||
23342861|NCT02783729|64999727|FG000|Overall Study|Adverse Event|2|||
23177011|NCT00094757|64390306|FG001|Overall Study|Lost to Follow-up|5|||
23177012|NCT00094757|64390307|FG002|Overall Study|Lost to Follow-up|6|||
23177013|NCT00094757|64390305|FG000|Overall Study|Patient Moved|2|||
23177014|NCT00094757|64390306|FG001|Overall Study|Patient Moved|1|||
23177015|NCT00094757|64390307|FG002|Overall Study|Patient Moved|1|||
23177016|NCT00094757|64390305|FG000|Overall Study|Protocol Violation|8|||
23177017|NCT00094757|64390306|FG001|Overall Study|Protocol Violation|5|||
23177018|NCT00094757|64390307|FG002|Overall Study|Protocol Violation|3|||
23177019|NCT00094757|64390305|FG000|Overall Study|Withdrawal by Subject|14|||
23177020|NCT00094757|64390306|FG001|Overall Study|Withdrawal by Subject|21|||
23177021|NCT00094757|64390307|FG002|Overall Study|Withdrawal by Subject|5|||
23177022|NCT00094757|64390305|FG000|Overall Study|Other|3|||
23177023|NCT00094757|64390306|FG001|Overall Study|Other|3|||
23177024|NCT00094757|64390307|FG002|Overall Study|Other|1|||
23177025|NCT00094757|64390305|FG000|Overall Study|Protocol specified discontinuation|1|||
23177026|NCT00094757|64390306|FG001|Overall Study|Protocol specified discontinuation|3|||
23177027|NCT00094757|64390307|FG002|Overall Study|Protocol specified discontinuation|0|||
23177028|NCT00110994|64390308|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
23177029|NCT00110994|64390309|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
23177030|NCT00110994|64390308|FG000|Double-blind (DB) Treatment|Death|1|||
23177031|NCT00110994|64390309|FG001|Double-blind (DB) Treatment|Death|0|||
23177032|NCT00110994|64390308|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
23177033|NCT00110994|64390309|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
23177034|NCT00110994|64390308|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
23454619|NCT00762359|65407202|FG000|Overall Study|Institution closed|2|||
23454620|NCT00762359|65407203|FG001|Overall Study|Institution closed|3|||
23454621|NCT00762359|65407202|FG000|Overall Study|Physician Decision|2|||
23454622|NCT00762359|65407203|FG001|Overall Study|Physician Decision|3|||
23177035|NCT00110994|64390309|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
23177036|NCT00110994|64390308|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
23177037|NCT00110994|64390309|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
23177038|NCT00110994|64390308|FG000|Double-blind (DB) Treatment|other reasons|2|||
23177039|NCT00110994|64390309|FG001|Double-blind (DB) Treatment|other reasons|3|||
23177040|NCT00110994|64390308|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
23177041|NCT00110994|64390309|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
23454623|NCT00762359|65407202|FG000|Overall Study|Removal|0|||
23454624|NCT00762359|65407203|FG001|Overall Study|Removal|1|||
23454625|NCT00762359|65407202|FG000|Overall Study|Withdrew consent|1|||
23454626|NCT00762359|65407203|FG001|Overall Study|Withdrew consent|0|||
23454627|NCT02656017|65407204|FG000|Overall Study|Study burden|3|||
23454628|NCT02656017|65407205|FG001|Overall Study|Study burden|3|||
23454629|NCT02656017|65407204|FG000|Overall Study|Adverse Event|2|||
23454630|NCT02656017|65407205|FG001|Overall Study|Adverse Event|1|||
23454631|NCT02656017|65407204|FG000|Overall Study|Unable/unwilling to take study medication|2|||
23454632|NCT02656017|65407205|FG001|Overall Study|Unable/unwilling to take study medication|1|||
23454633|NCT02656017|65407204|FG000|Overall Study|Began Tolvaptan|1|||
23454634|NCT02656017|65407205|FG001|Overall Study|Began Tolvaptan|1|||
23237384|NCT01640353|64611469|FG000|Overall Study|Early site termination|3|||
23454635|NCT02656017|65407204|FG000|Overall Study|Withdrawal by Subject|1|||
23454636|NCT02656017|65407205|FG001|Overall Study|Withdrawal by Subject|0|||
23454637|NCT00528957|65407210|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
23454638|NCT00528957|65407211|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
23454639|NCT00528957|65407210|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
23237385|NCT01640353|64611469|FG000|Overall Study|Lost to Follow-up|12|||
23342862|NCT02783729|64999728|FG001|Overall Study|Adverse Event|6|||
23342863|NCT02783729|64999729|FG002|Overall Study|Adverse Event|2|||
23454640|NCT00528957|65407211|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
23454641|NCT00528957|65407210|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
23454642|NCT00528957|65407211|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
23454643|NCT00528957|65407210|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
23454644|NCT00528957|65407211|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
23454645|NCT00528957|65407210|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
23454646|NCT00528957|65407211|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
23454647|NCT00528957|65407210|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
23454648|NCT00528957|65407211|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
23454649|NCT00528957|65407210|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
23454650|NCT00528957|65407211|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
23177042|NCT00110994|64390308|FG000|Active Follow-up|Other reasons|0|||
23177043|NCT00110994|64390309|FG001|Active Follow-up|Other reasons|2|||
23177044|NCT00110994|64390308|FG000|Long Term Follow-up|Death|19|||
23177045|NCT00110994|64390309|FG001|Long Term Follow-up|Death|17|||
23177046|NCT02111564|64390312|FG000|Overall Study|Death|109|||
23237386|NCT01640353|64611469|FG000|Overall Study|Physician Decision|1|||
23177047|NCT02111564|64390313|FG001|Overall Study|Death|120|||
23177048|NCT02111564|64390312|FG000|Overall Study|Lost to Follow-up|2|||
23177049|NCT02111564|64390313|FG001|Overall Study|Lost to Follow-up|3|||
23177050|NCT02111564|64390312|FG000|Overall Study|Withdrawal by Subject|20|||
23177051|NCT02111564|64390313|FG001|Overall Study|Withdrawal by Subject|20|||
23454651|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
23454652|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
23454653|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
23454654|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
23582513|NCT00991276|65862484|FG001|Third Intervention Period|Protocol Violation|0|||
23582514|NCT00991276|65862485|FG002|Third Intervention Period|Protocol Violation|0|||
23582515|NCT00991276|65862486|FG003|Third Intervention Period|Protocol Violation|0|||
23454655|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
23454656|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
23454657|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
23454658|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
23454659|NCT00528957|65407210|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
23177052|NCT00741819|64390321|FG000|Overall Study|Adverse Event|3|||
23454660|NCT00528957|65407211|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
23454661|NCT00528957|65407210|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
23454662|NCT00528957|65407211|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
23454663|NCT00528957|65407210|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
23454664|NCT00528957|65407211|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
23454665|NCT00528957|65407210|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
23454666|NCT00528957|65407211|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
23454667|NCT00528957|65407210|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
23454668|NCT00528957|65407211|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
23454669|NCT00770653|65407214|FG000|Overall Study|Adverse Event|13|||
23454670|NCT00770653|65407215|FG001|Overall Study|Adverse Event|5|||
23454671|NCT00770653|65407214|FG000|Overall Study|Protocol Violation|8|||
23454672|NCT00770653|65407215|FG001|Overall Study|Protocol Violation|6|||
23454673|NCT00770653|65407214|FG000|Overall Study|Withdrawal by Subject|4|||
23454674|NCT00770653|65407215|FG001|Overall Study|Withdrawal by Subject|7|||
23454675|NCT00770653|65407214|FG000|Overall Study|Lack of Compliance|1|||
23454676|NCT00770653|65407215|FG001|Overall Study|Lack of Compliance|4|||
23454677|NCT00770653|65407214|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
23454678|NCT00770653|65407215|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
23454679|NCT00770653|65407214|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
23454680|NCT00770653|65407215|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
23454681|NCT00770653|65407214|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
23454682|NCT00770653|65407215|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
23177053|NCT00741819|64390321|FG000|Overall Study|Withdrawal by Subject|3|||
23177054|NCT00741819|64390321|FG000|Overall Study|Death|1|||
23177055|NCT00741819|64390321|FG000|Overall Study|Disease progression|1|||
23177056|NCT02848833|64390322|FG000|Overall Study|subject who are duplicated|1|||
23177057|NCT02848833|64390322|FG000|Overall Study|have not taken the study drug|11|||
23177058|NCT02848833|64390322|FG000|Overall Study|follow-up failure|6|||
23237387|NCT02988115|64611470|FG000|Overall Study|Adverse Event|6|||
23454683|NCT00770653|65407214|FG000|Overall Study|Lost to Follow-up|1|||
23454684|NCT00770653|65407215|FG001|Overall Study|Lost to Follow-up|2|||
23454685|NCT00770653|65407214|FG000|Overall Study|Physician Decision|1|||
23454686|NCT00770653|65407215|FG001|Overall Study|Physician Decision|0|||
23454687|NCT02412306|65407216|FG000|Overall Study|Lost to Follow-up|0|||
23582516|NCT00991276|65862487|FG004|Third Intervention Period|Protocol Violation|0|||
23582517|NCT00991276|65862488|FG005|Third Intervention Period|Protocol Violation|0|||
23342864|NCT02783729|64999730|FG003|Overall Study|Adverse Event|3|||
23454688|NCT02412306|65407217|FG001|Overall Study|Lost to Follow-up|1|||
23454689|NCT02412306|65407218|FG002|Overall Study|Lost to Follow-up|0|||
23454690|NCT02412306|65407219|FG003|Overall Study|Lost to Follow-up|0|||
23454691|NCT02412306|65407220|FG004|Overall Study|Lost to Follow-up|0|||
23454692|NCT02412306|65407216|FG000|Overall Study|Withdrawal by Subject|0|||
23454693|NCT02412306|65407217|FG001|Overall Study|Withdrawal by Subject|0|||
23454694|NCT02412306|65407218|FG002|Overall Study|Withdrawal by Subject|1|||
23454695|NCT02412306|65407219|FG003|Overall Study|Withdrawal by Subject|0|||
23454696|NCT02412306|65407220|FG004|Overall Study|Withdrawal by Subject|0|||
23454697|NCT02412306|65407216|FG000|Overall Study|Death|5|||
23177059|NCT02848833|64390322|FG000|Overall Study|Protocol Violation|119|||
23177060|NCT03898063|64390325|FG000|Overall Study|Withdrawal by Subject|10|||
23177061|NCT03898063|64390326|FG001|Overall Study|Withdrawal by Subject|8|||
23177062|NCT01871090|64390329|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
23237388|NCT02988115|64611471|FG001|Overall Study|Adverse Event|1|||
23582518|NCT00991276|65862483|FG000|Third Intervention Period|Other|0|||
23582519|NCT00991276|65862484|FG001|Third Intervention Period|Other|0|||
23177063|NCT01871090|64390330|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
23177064|NCT01871090|64390329|FG000|Overall Study|Interrogation not completed correctly|1|||
23177065|NCT01871090|64390330|FG001|Overall Study|Interrogation not completed correctly|0|||
23454698|NCT02412306|65407217|FG001|Overall Study|Death|7|||
23454699|NCT02412306|65407218|FG002|Overall Study|Death|15|||
23454700|NCT02412306|65407219|FG003|Overall Study|Death|0|||
23454701|NCT02412306|65407220|FG004|Overall Study|Death|2|||
23454702|NCT00689390|65407221|FG000|Overall Study|Adverse Event|19|||
23454703|NCT00689390|65407222|FG001|Overall Study|Adverse Event|0|||
23454704|NCT00689390|65407221|FG000|Overall Study|Lost to Follow-up|179|||
23454705|NCT00689390|65407222|FG001|Overall Study|Lost to Follow-up|7|||
23454706|NCT00689390|65407221|FG000|Overall Study|Withdrawal by Subject|117|||
23454707|NCT00689390|65407222|FG001|Overall Study|Withdrawal by Subject|3|||
23454708|NCT00689390|65407221|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
23454709|NCT00689390|65407222|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
23454710|NCT00689390|65407221|FG000|Overall Study|Non-Compliance With Protocol|21|||
23454711|NCT00689390|65407222|FG001|Overall Study|Non-Compliance With Protocol|0|||
23582520|NCT00991276|65862485|FG002|Third Intervention Period|Other|0|||
23582521|NCT00991276|65862486|FG003|Third Intervention Period|Other|0|||
23177066|NCT01871090|64390329|FG000|Overall Study|Subject Non-Compliance|0|||
23177067|NCT01871090|64390330|FG001|Overall Study|Subject Non-Compliance|1|||
23177068|NCT04439279|64390331|FG000|Overall Study|Adverse Event|7|||
23177069|NCT04439279|64390331|FG000|Overall Study|Death|4|||
23177070|NCT04439279|64390331|FG000|Overall Study|Disease progression|17|||
23177071|NCT04439279|64390331|FG000|Overall Study|Complicating disease|3|||
23177072|NCT04439279|64390331|FG000|Overall Study|Withdrawal by Subject|2|||
23177073|NCT04439279|64390331|FG000|Overall Study|Ineligible|1|||
23177074|NCT04439279|64390331|FG000|Overall Study|Treatment still ongoing|1|||
23177075|NCT02425098|64390343|FG000|Overall Study|Lost to Follow-up|7|||
23177076|NCT02425098|64390344|FG001|Overall Study|Lost to Follow-up|7|||
23177077|NCT02425098|64390343|FG000|Overall Study|Withdrawal by Subject|4|||
23177078|NCT02425098|64390344|FG001|Overall Study|Withdrawal by Subject|8|||
23177079|NCT02425098|64390343|FG000|Overall Study|Pregnancy|2|||
23177080|NCT02425098|64390344|FG001|Overall Study|Pregnancy|0|||
23177081|NCT02425098|64390343|FG000|Overall Study|Reason not Specified|0|||
23177082|NCT02425098|64390344|FG001|Overall Study|Reason not Specified|1|||
23177083|NCT03136107|64390359|FG000|Overall Study|Other (Not specified)|1|||
23177084|NCT00605267|64390360|FG000|Overall Study|Adverse Event|0|||
23177085|NCT00605267|64390361|FG001|Overall Study|Adverse Event|1|||
23342865|NCT02783729|64999727|FG000|Overall Study|Other|1|||
23342866|NCT02783729|64999728|FG001|Overall Study|Other|6|||
23342867|NCT02783729|64999729|FG002|Overall Study|Other|2|||
23342868|NCT02783729|64999730|FG003|Overall Study|Other|3|||
23342869|NCT02783729|64999727|FG000|Overall Study|Withdrawal by Subject|2|||
23342870|NCT02783729|64999728|FG001|Overall Study|Withdrawal by Subject|3|||
23342871|NCT02783729|64999729|FG002|Overall Study|Withdrawal by Subject|1|||
23342872|NCT02783729|64999730|FG003|Overall Study|Withdrawal by Subject|2|||
23342873|NCT02783729|64999727|FG000|Overall Study|Participant's choice|2|||
23342874|NCT02783729|64999728|FG001|Overall Study|Participant's choice|1|||
23342875|NCT02783729|64999729|FG002|Overall Study|Participant's choice|2|||
23342876|NCT02783729|64999730|FG003|Overall Study|Participant's choice|1|||
23342877|NCT02783729|64999727|FG000|Overall Study|Lost to Follow-up|2|||
23342878|NCT02783729|64999728|FG001|Overall Study|Lost to Follow-up|1|||
23342879|NCT02783729|64999729|FG002|Overall Study|Lost to Follow-up|1|||
23342880|NCT02783729|64999730|FG003|Overall Study|Lost to Follow-up|0|||
23342881|NCT00791661|64999731|FG000|7 Day Wash-out|Adverse Event|0|||
23342882|NCT00791661|64999732|FG001|7 Day Wash-out|Adverse Event|0|||
23342883|NCT00791661|64999733|FG002|7 Day Wash-out|Adverse Event|1|||
23342884|NCT00791661|64999731|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
23342885|NCT00791661|64999732|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
23342886|NCT00791661|64999733|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
23342887|NCT00381043|64999736|FG000|Overall Study|Lost to Follow-up|8|||
23342888|NCT00381043|64999737|FG001|Overall Study|Lost to Follow-up|6|||
23342889|NCT00381043|64999736|FG000|Overall Study|Withdrawal by Subject|3|||
23342890|NCT00381043|64999737|FG001|Overall Study|Withdrawal by Subject|1|||
23342891|NCT00381043|64999736|FG000|Overall Study|wanted more care|0|||
23342892|NCT00381043|64999737|FG001|Overall Study|wanted more care|1|||
23342893|NCT00381043|64999736|FG000|Overall Study|incarcerated|1|||
23342894|NCT00381043|64999737|FG001|Overall Study|incarcerated|0|||
23177086|NCT00605267|64390360|FG000|Overall Study|Lack of Efficacy|1|||
23177087|NCT00605267|64390361|FG001|Overall Study|Lack of Efficacy|5|||
23177088|NCT00605267|64390360|FG000|Overall Study|Withdrawal by Subject|2|||
23454712|NCT00689390|65407221|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
23582522|NCT00991276|65862487|FG004|Third Intervention Period|Other|0|||
23342895|NCT04778059|64999738|FG000|Overall Study|Death|2|||
23342896|NCT04778059|64999739|FG001|Overall Study|Death|2|||
23582523|NCT00991276|65862488|FG005|Third Intervention Period|Other|1|||
23582524|NCT00991276|65862483|FG000|Third Intervention Period|Adverse Event|0|||
23582525|NCT00991276|65862484|FG001|Third Intervention Period|Adverse Event|0|||
23582526|NCT00991276|65862485|FG002|Third Intervention Period|Adverse Event|1|||
23582527|NCT00991276|65862486|FG003|Third Intervention Period|Adverse Event|0|||
23582528|NCT00991276|65862487|FG004|Third Intervention Period|Adverse Event|0|||
23582529|NCT00991276|65862488|FG005|Third Intervention Period|Adverse Event|0|||
23582530|NCT00991276|65862483|FG000|Third Intervention Period|Withdrawal by Subject|0|||
23582531|NCT00991276|65862484|FG001|Third Intervention Period|Withdrawal by Subject|0|||
23454713|NCT00689390|65407222|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
23454714|NCT00689390|65407221|FG000|Overall Study|Administrative|37|||
23454715|NCT00689390|65407222|FG001|Overall Study|Administrative|0|||
23454716|NCT03525444|65407223|FG000|Overall Study|Adverse Event|0|||
23582532|NCT00991276|65862485|FG002|Third Intervention Period|Withdrawal by Subject|0|||
23582533|NCT00991276|65862486|FG003|Third Intervention Period|Withdrawal by Subject|1|||
23582534|NCT00991276|65862487|FG004|Third Intervention Period|Withdrawal by Subject|0|||
23582535|NCT00991276|65862488|FG005|Third Intervention Period|Withdrawal by Subject|0|||
23582536|NCT01456780|65862489|FG000|Overall Study|Lost to Follow-up|3|||
23454717|NCT03525444|65407224|FG001|Overall Study|Adverse Event|1|||
23237389|NCT02988115|64611470|FG000|Overall Study|Sponsor Decision|5|||
23237390|NCT02988115|64611471|FG001|Overall Study|Sponsor Decision|2|||
23237391|NCT02988115|64611470|FG000|Overall Study|Withdrawal by Subject|1|||
23237392|NCT02988115|64611471|FG001|Overall Study|Withdrawal by Subject|1|||
23237393|NCT02988115|64611470|FG000|Overall Study|Withdrawn by Mistake|1|||
23237394|NCT02988115|64611471|FG001|Overall Study|Withdrawn by Mistake|0|||
23237395|NCT02988115|64611470|FG000|Overall Study|Lost to Follow-up|1|||
23237396|NCT02988115|64611471|FG001|Overall Study|Lost to Follow-up|0|||
23454718|NCT03525444|65407223|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
23454719|NCT03525444|65407224|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
23454720|NCT03525444|65407223|FG000|Overall Study|Other|0|||
23177089|NCT00605267|64390361|FG001|Overall Study|Withdrawal by Subject|3|||
23582537|NCT01456780|65862490|FG001|Overall Study|Lost to Follow-up|3|||
23582538|NCT01456780|65862491|FG002|Overall Study|Lost to Follow-up|0|||
23582539|NCT03523091|65862492|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
23177090|NCT03624946|64390362|FG000|Overall Study|Lost to Follow-up|0|||
23177091|NCT03624946|64390363|FG001|Overall Study|Lost to Follow-up|1|||
23177092|NCT02654002|64390365|FG000|Overall Study|Adverse Event|0|||
23177093|NCT02654002|64390366|FG001|Overall Study|Adverse Event|0|||
23177094|NCT02654002|64390367|FG002|Overall Study|Adverse Event|0|||
23177095|NCT02654002|64390368|FG003|Overall Study|Adverse Event|0|||
23177096|NCT02654002|64390369|FG004|Overall Study|Adverse Event|0|||
23177097|NCT02654002|64390370|FG005|Overall Study|Adverse Event|0|||
23177098|NCT02654002|64390371|FG006|Overall Study|Adverse Event|1|||
23177099|NCT02654002|64390372|FG007|Overall Study|Adverse Event|0|||
23177100|NCT02654002|64390373|FG008|Overall Study|Adverse Event|0|||
23177101|NCT02654002|64390365|FG000|Overall Study|Withdrew Consent|0|||
23177102|NCT02654002|64390366|FG001|Overall Study|Withdrew Consent|0|||
23582540|NCT03523091|65862493|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
23177103|NCT02654002|64390367|FG002|Overall Study|Withdrew Consent|0|||
23177104|NCT02654002|64390368|FG003|Overall Study|Withdrew Consent|0|||
23177105|NCT02654002|64390369|FG004|Overall Study|Withdrew Consent|0|||
23177106|NCT02654002|64390370|FG005|Overall Study|Withdrew Consent|1|||
23237397|NCT04491591|64611476|FG000|Overall Study|Accidently randomized|3|||
23454721|NCT03525444|65407224|FG001|Overall Study|Other|1|||
23582541|NCT03523091|65862492|FG000|Overall Study|Withdrawal by Subject|0|||
23237398|NCT04491591|64611477|FG001|Overall Study|Accidently randomized|1|||
23237399|NCT04491591|64611478|FG002|Overall Study|Accidently randomized|0|||
23177107|NCT02654002|64390371|FG006|Overall Study|Withdrew Consent|0|||
23177108|NCT02654002|64390372|FG007|Overall Study|Withdrew Consent|1|||
23177109|NCT02654002|64390373|FG008|Overall Study|Withdrew Consent|0|||
23177110|NCT01162421|64390374|FG000|Overall Study|Did not receive study drug|2|||
23177111|NCT01162421|64390375|FG001|Overall Study|Did not receive study drug|1|||
23237400|NCT04491591|64611476|FG000|Overall Study|Did not complete survey|28|||
23237401|NCT04491591|64611477|FG001|Overall Study|Did not complete survey|20|||
23237402|NCT04491591|64611478|FG002|Overall Study|Did not complete survey|3|||
23237403|NCT00976989|64611482|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23237404|NCT00976989|64611483|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
23342897|NCT04778059|64999740|FG002|Overall Study|Death|1|||
23177112|NCT01162421|64390374|FG000|Overall Study|Adverse Event|2|||
23177113|NCT01162421|64390375|FG001|Overall Study|Adverse Event|5|||
23177114|NCT01162421|64390374|FG000|Overall Study|Lost to Follow-up|0|||
23177115|NCT01162421|64390375|FG001|Overall Study|Lost to Follow-up|2|||
23177116|NCT01162421|64390374|FG000|Overall Study|Lack of Efficacy|2|||
23177117|NCT01162421|64390375|FG001|Overall Study|Lack of Efficacy|2|||
23177118|NCT01162421|64390374|FG000|Overall Study|Other|2|||
23177119|NCT01162421|64390375|FG001|Overall Study|Other|3|||
23177120|NCT03033745|64390376|FG000|Overall Study|Protocol Violation|0|||
23177121|NCT03033745|64390377|FG001|Overall Study|Protocol Violation|0|||
23177122|NCT03033745|64390378|FG002|Overall Study|Protocol Violation|1|||
23177123|NCT03033745|64390376|FG000|Overall Study|Adverse Event|1|||
23177124|NCT03033745|64390377|FG001|Overall Study|Adverse Event|0|||
23177125|NCT03033745|64390378|FG002|Overall Study|Adverse Event|1|||
23177126|NCT03033745|64390376|FG000|Overall Study|Withdrawal by Subject|0|||
23177127|NCT03033745|64390377|FG001|Overall Study|Withdrawal by Subject|1|||
23177128|NCT03033745|64390378|FG002|Overall Study|Withdrawal by Subject|0|||
23177129|NCT01916980|64390384|FG000|Overall Study|Adverse Event|4|||
23177130|NCT01916980|64390385|FG001|Overall Study|Adverse Event|2|||
23177131|NCT01916980|64390384|FG000|Overall Study|Lack of Efficacy|2|||
23177132|NCT01916980|64390385|FG001|Overall Study|Lack of Efficacy|2|||
23177133|NCT01916980|64390384|FG000|Overall Study|Withdrawal by Subject|1|||
23177134|NCT01916980|64390385|FG001|Overall Study|Withdrawal by Subject|0|||
23177135|NCT04276207|64390386|FG000|Period 1|Withdrawal by Subject|0|||
23177136|NCT04276207|64390387|FG001|Period 1|Withdrawal by Subject|1|||
23177137|NCT00927368|64390389|FG000|Overall Study|enrollment in another study|1|||
23177138|NCT00927368|64390390|FG001|Overall Study|enrollment in another study|1|||
23177139|NCT00927368|64390391|FG002|Overall Study|enrollment in another study|2|||
23177140|NCT00927368|64390389|FG000|Overall Study|Lost to Follow-up|4|||
23177141|NCT00927368|64390390|FG001|Overall Study|Lost to Follow-up|0|||
23177142|NCT00927368|64390391|FG002|Overall Study|Lost to Follow-up|0|||
23177143|NCT00927368|64390389|FG000|Overall Study|equipment failure|1|||
23177144|NCT00927368|64390390|FG001|Overall Study|equipment failure|0|||
23177145|NCT00927368|64390391|FG002|Overall Study|equipment failure|0|||
23177146|NCT00927368|64390389|FG000|Overall Study|ineligible post randomization|0|||
23177147|NCT00927368|64390390|FG001|Overall Study|ineligible post randomization|3|||
23177148|NCT00927368|64390391|FG002|Overall Study|ineligible post randomization|1|||
23177149|NCT00927368|64390389|FG000|Overall Study|cancellation of surgery|0|||
23237405|NCT00976989|64611484|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
23177150|NCT00927368|64390390|FG001|Overall Study|cancellation of surgery|1|||
23177151|NCT00927368|64390391|FG002|Overall Study|cancellation of surgery|2|||
23177152|NCT00956943|64390392|FG000|Overall Study|Lost to Follow-up|9|||
23177153|NCT00956943|64390393|FG001|Overall Study|Lost to Follow-up|10|||
23177154|NCT04451330|64390394|FG000|Overall Study|Adverse Event|1|||
23177155|NCT04451330|64390395|FG001|Overall Study|Adverse Event|2|||
23237406|NCT00976989|64611482|FG000|Overall Study|Death|5|||
23237407|NCT00976989|64611483|FG001|Overall Study|Death|7|||
23237408|NCT00976989|64611484|FG002|Overall Study|Death|10|||
23237409|NCT00976989|64611482|FG000|Overall Study|Refused Treatment|4|||
23237410|NCT00976989|64611483|FG001|Overall Study|Refused Treatment|3|||
23237411|NCT00976989|64611484|FG002|Overall Study|Refused Treatment|5|||
23237412|NCT00976989|64611482|FG000|Overall Study|Failure to Return|2|||
23237413|NCT00976989|64611483|FG001|Overall Study|Failure to Return|1|||
23237414|NCT00976989|64611484|FG002|Overall Study|Failure to Return|0|||
23237415|NCT00976989|64611482|FG000|Overall Study|Recurrence of Disease|0|||
23237416|NCT00976989|64611483|FG001|Overall Study|Recurrence of Disease|1|||
23582542|NCT03523091|65862493|FG001|Overall Study|Withdrawal by Subject|3|||
23582543|NCT03523091|65862492|FG000|Overall Study|Increase Botox dose|0|||
23582544|NCT03523091|65862493|FG001|Overall Study|Increase Botox dose|1|||
23177156|NCT04451330|64390394|FG000|Overall Study|Lost to Follow-up|5|||
23177157|NCT04451330|64390395|FG001|Overall Study|Lost to Follow-up|0|||
23177158|NCT04451330|64390394|FG000|Overall Study|Withdrawal by Subject|3|||
23177159|NCT04451330|64390395|FG001|Overall Study|Withdrawal by Subject|1|||
23177160|NCT04451330|64390394|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23177161|NCT04451330|64390395|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23177162|NCT04451330|64390394|FG000|Overall Study|Other than specified|0|||
23177163|NCT04451330|64390395|FG001|Overall Study|Other than specified|1|||
23177164|NCT01291017|64390396|FG000|Overall Study|Lost to Follow-up|2|||
23342898|NCT04778059|64999741|FG003|Overall Study|Death|1|||
23582545|NCT02095158|65862494|FG000|Overall Study|Adverse Event|14|||
23582546|NCT02095158|65862494|FG000|Overall Study|Lack of Efficacy|3|||
23582547|NCT02095158|65862494|FG000|Overall Study|Pregnancy|1|||
23582548|NCT02095158|65862494|FG000|Overall Study|Lost to Follow-up|20|||
23582549|NCT02095158|65862494|FG000|Overall Study|Personal Reasons|35|||
23582550|NCT02095158|65862494|FG000|Overall Study|Protocol Violation|1|||
23582551|NCT02095158|65862494|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23177165|NCT01291017|64390396|FG000|Overall Study|Withdrawal by Subject|3|||
23237417|NCT00976989|64611484|FG002|Overall Study|Recurrence of Disease|0|||
23582552|NCT02974010|65862495|FG000|Overall Study|Lost to Follow-up|3|||
23177166|NCT01442181|64390398|FG000|Overall Study|patient refused surgery|1|||
23454722|NCT03370276|65407225|FG000|Overall Study|Death|0|||
23454723|NCT03370276|65407226|FG001|Overall Study|Death|2|||
23454724|NCT03370276|65407227|FG002|Overall Study|Death|5|||
23454725|NCT01751061|65407231|FG000|Overall Study|Death|1|||
23454726|NCT01751061|65407232|FG001|Overall Study|Death|0|||
23454727|NCT01751061|65407231|FG000|Overall Study|patient death|5|||
23454728|NCT01751061|65407232|FG001|Overall Study|patient death|0|||
23454729|NCT01751061|65407231|FG000|Overall Study|Lost to Follow-up|40|||
23454730|NCT01751061|65407232|FG001|Overall Study|Lost to Follow-up|25|||
23454731|NCT01751061|65407231|FG000|Overall Study|patient regained decisional capacity|4|||
23454732|NCT01751061|65407232|FG001|Overall Study|patient regained decisional capacity|8|||
23454733|NCT01751061|65407231|FG000|Overall Study|Withdrawal by Subject|4|||
23454734|NCT01751061|65407232|FG001|Overall Study|Withdrawal by Subject|1|||
23454735|NCT01751061|65407231|FG000|Overall Study|Physician Decision|2|||
23454736|NCT01751061|65407232|FG001|Overall Study|Physician Decision|0|||
23454737|NCT01908426|65407233|FG000|Overall Study|Adverse Event|98|||
23454738|NCT01908426|65407234|FG001|Overall Study|Adverse Event|11|||
23454739|NCT01908426|65407233|FG000|Overall Study|Clinical Deterioration|72|||
23454740|NCT01908426|65407234|FG001|Overall Study|Clinical Deterioration|38|||
23454741|NCT01908426|65407233|FG000|Overall Study|Lack of Efficacy|3|||
23454742|NCT01908426|65407234|FG001|Overall Study|Lack of Efficacy|0|||
23454743|NCT01908426|65407233|FG000|Overall Study|Lost to Follow-up|0|||
23454744|NCT01908426|65407234|FG001|Overall Study|Lost to Follow-up|1|||
23454745|NCT01908426|65407233|FG000|Overall Study|Physician Decision|3|||
23454746|NCT01908426|65407234|FG001|Overall Study|Physician Decision|3|||
23454747|NCT01908426|65407233|FG000|Overall Study|Withdrawal by Subject|11|||
23454748|NCT01908426|65407234|FG001|Overall Study|Withdrawal by Subject|6|||
23454749|NCT01908426|65407233|FG000|Overall Study|Progressive Disease|206|||
23454750|NCT01908426|65407234|FG001|Overall Study|Progressive Disease|152|||
23454751|NCT01908426|65407233|FG000|Overall Study|Protocol Violation|1|||
23454752|NCT01908426|65407234|FG001|Overall Study|Protocol Violation|0|||
23454753|NCT01908426|65407233|FG000|Overall Study|No Study Treatment Given|3|||
23454754|NCT01908426|65407234|FG001|Overall Study|No Study Treatment Given|0|||
23454755|NCT05362487|65407235|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
23454756|NCT03001557|65407236|FG000|Core Phase|Randomized but not treated|0|||
23454757|NCT03001557|65407237|FG001|Core Phase|Randomized but not treated|0|||
23454758|NCT03001557|65407238|FG002|Core Phase|Randomized but not treated|1|||
23454759|NCT03001557|65407239|FG003|Core Phase|Randomized but not treated|0|||
23177167|NCT01442181|64390399|FG001|Overall Study|patient refused surgery|0|||
23177168|NCT01442181|64390398|FG000|Overall Study|no insurance for surgery|1|||
23177169|NCT01442181|64390399|FG001|Overall Study|no insurance for surgery|0|||
23177170|NCT01442181|64390398|FG000|Overall Study|low ejection factor|0|||
23177171|NCT01442181|64390399|FG001|Overall Study|low ejection factor|1|||
23177172|NCT01442181|64390398|FG000|Overall Study|Lost to Follow-up|1|||
23177173|NCT01442181|64390399|FG001|Overall Study|Lost to Follow-up|1|||
23177174|NCT01442181|64390398|FG000|Overall Study|patient in an additional study|1|||
23177175|NCT01442181|64390399|FG001|Overall Study|patient in an additional study|0|||
23177176|NCT01442181|64390398|FG000|Overall Study|atrial fibrillation not noted|0|||
23177177|NCT01442181|64390399|FG001|Overall Study|atrial fibrillation not noted|1|||
23177178|NCT02222714|64390400|FG000|Overall Study|Death|0|||
23177179|NCT02222714|64390401|FG001|Overall Study|Death|2|||
23177180|NCT02222714|64390402|FG002|Overall Study|Death|3|||
23177181|NCT02222714|64390403|FG003|Overall Study|Death|4|||
23177182|NCT02222714|64390404|FG004|Overall Study|Death|6|||
23177183|NCT02222714|64390400|FG000|Overall Study|Withdrawal by Subject|0|||
23177184|NCT02222714|64390401|FG001|Overall Study|Withdrawal by Subject|0|||
23342899|NCT04778059|64999742|FG004|Overall Study|Death|1|||
23454760|NCT03001557|65407240|FG004|Core Phase|Randomized but not treated|0|||
23454761|NCT03001557|65407241|FG005|Core Phase|Randomized but not treated|0|||
23177185|NCT02222714|64390402|FG002|Overall Study|Withdrawal by Subject|1|||
23454762|NCT03001557|65407242|FG006|Core Phase|Randomized but not treated|0|||
23177186|NCT02222714|64390403|FG003|Overall Study|Withdrawal by Subject|0|||
23177187|NCT02222714|64390404|FG004|Overall Study|Withdrawal by Subject|1|||
23454763|NCT03001557|65407243|FG007|Core Phase|Randomized but not treated|0|||
23454764|NCT03001557|65407236|FG000|Extension Phase|Adverse Event|0|||
23342900|NCT04778059|64999738|FG000|Overall Study|Lost to Follow-up|0|||
23342901|NCT04778059|64999739|FG001|Overall Study|Lost to Follow-up|0|||
23342902|NCT04778059|64999740|FG002|Overall Study|Lost to Follow-up|0|||
23342903|NCT04778059|64999741|FG003|Overall Study|Lost to Follow-up|0|||
23342904|NCT04778059|64999742|FG004|Overall Study|Lost to Follow-up|1|||
23342905|NCT04778059|64999738|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
23342906|NCT04778059|64999739|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
23342907|NCT04778059|64999740|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
23342908|NCT04778059|64999741|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
23342909|NCT04778059|64999742|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
23237418|NCT00976989|64611482|FG000|Overall Study|Other|1|||
23237419|NCT00976989|64611483|FG001|Overall Study|Other|0|||
23582553|NCT02974010|65862496|FG001|Overall Study|Lost to Follow-up|1|||
23582554|NCT02974010|65862497|FG002|Overall Study|Lost to Follow-up|0|||
23582555|NCT02974010|65862498|FG003|Overall Study|Lost to Follow-up|0|||
23582556|NCT02974010|65862495|FG000|Overall Study|Withdrawal by Subject|2|||
23582557|NCT02974010|65862496|FG001|Overall Study|Withdrawal by Subject|1|||
23582558|NCT02974010|65862497|FG002|Overall Study|Withdrawal by Subject|0|||
23582559|NCT02974010|65862498|FG003|Overall Study|Withdrawal by Subject|0|||
23582560|NCT02974010|65862495|FG000|Overall Study|Adverse Event|0|||
23237420|NCT00976989|64611484|FG002|Overall Study|Other|1|||
23237421|NCT02743117|64611485|FG000|Overall Study|Lost to Follow-up|0|||
23237422|NCT02743117|64611486|FG001|Overall Study|Lost to Follow-up|1|||
23342910|NCT02637895|64999745|FG000|Overall Study|Lost to Follow-up|4|||
23237423|NCT02743117|64611485|FG000|Overall Study|Other|1|||
23237424|NCT02743117|64611486|FG001|Overall Study|Other|0|||
23237425|NCT00750061|64611487|FG000|Overall Study|Adverse Event|2|||
23237426|NCT00750061|64611488|FG001|Overall Study|Adverse Event|0|||
23237427|NCT00750061|64611487|FG000|Overall Study|Withdrawal by Subject|0|||
23237428|NCT00750061|64611488|FG001|Overall Study|Withdrawal by Subject|1|||
23237429|NCT00750061|64611487|FG000|Overall Study|Physician Decision|0|||
23237430|NCT00750061|64611488|FG001|Overall Study|Physician Decision|1|||
23237431|NCT03380091|64611490|FG000|Overall Study|Withdrawal by Subject|2|||
23237432|NCT03380091|64611491|FG001|Overall Study|Withdrawal by Subject|1|||
23237433|NCT00883896|64611492|FG000|Overall Study|Lost to Follow-up|0|||
23237434|NCT00883896|64611493|FG001|Overall Study|Lost to Follow-up|0|||
23237435|NCT00883896|64611494|FG002|Overall Study|Lost to Follow-up|0|||
23237436|NCT00883896|64611495|FG003|Overall Study|Lost to Follow-up|2|||
23342911|NCT02637895|64999746|FG001|Overall Study|Lost to Follow-up|0|||
23582561|NCT02974010|65862496|FG001|Overall Study|Adverse Event|1|||
23177188|NCT00508391|64390405|FG000|First Treatment|Withdrawal by Subject|6|||
23177189|NCT00508391|64390406|FG001|First Treatment|Withdrawal by Subject|3|||
23177190|NCT00508391|64390405|FG000|Second Treatment|Withdrawal by Subject|2|||
23177191|NCT00508391|64390406|FG001|Second Treatment|Withdrawal by Subject|0|||
23177192|NCT00860158|64390409|FG000|Overall Study|Study Terminated|1|||
23177193|NCT01299766|64390412|FG000|Overall Study|Death|5|||
23177194|NCT01299766|64390413|FG001|Overall Study|Death|4|||
23177195|NCT01299766|64390412|FG000|Overall Study|Withdrawal by Subject|29|||
23177196|NCT01299766|64390413|FG001|Overall Study|Withdrawal by Subject|19|||
23177197|NCT03158220|64390414|FG000|Overall Study|Screen Failure|0|||
23177198|NCT03158220|64390415|FG001|Overall Study|Screen Failure|1|||
23177199|NCT03158220|64390414|FG000|Overall Study|Withdrawal by Subject|8|||
23177200|NCT03158220|64390415|FG001|Overall Study|Withdrawal by Subject|9|||
23177201|NCT03158220|64390414|FG000|Overall Study|Status unknown|0|||
23177202|NCT03158220|64390415|FG001|Overall Study|Status unknown|1|||
23177203|NCT03158220|64390414|FG000|Overall Study|Lost to Follow-up|8|||
23177204|NCT03158220|64390415|FG001|Overall Study|Lost to Follow-up|5|||
23177205|NCT03158220|64390414|FG000|Overall Study|Physician Decision|1|||
23177206|NCT03158220|64390415|FG001|Overall Study|Physician Decision|0|||
23177207|NCT01109940|64390416|FG000|Overall Study|Administrative problems|2|||
23177208|NCT01109940|64390417|FG001|Overall Study|Administrative problems|0|||
23177209|NCT01109940|64390418|FG002|Overall Study|Administrative problems|0|||
23177210|NCT01109940|64390419|FG003|Overall Study|Administrative problems|0|||
23237437|NCT00883896|64611492|FG000|Overall Study|Withdrawal by Subject|5|||
23237438|NCT00883896|64611493|FG001|Overall Study|Withdrawal by Subject|0|||
23582562|NCT02974010|65862497|FG002|Overall Study|Adverse Event|0|||
23237439|NCT00883896|64611494|FG002|Overall Study|Withdrawal by Subject|1|||
23237440|NCT00883896|64611495|FG003|Overall Study|Withdrawal by Subject|3|||
23237441|NCT00883896|64611492|FG000|Overall Study|Lack of Efficacy|0|||
23237442|NCT00883896|64611493|FG001|Overall Study|Lack of Efficacy|0|||
23237443|NCT00883896|64611494|FG002|Overall Study|Lack of Efficacy|0|||
23237444|NCT00883896|64611495|FG003|Overall Study|Lack of Efficacy|2|||
23237445|NCT00883896|64611492|FG000|Overall Study|Other|1|||
23237446|NCT00883896|64611493|FG001|Overall Study|Other|0|||
23237447|NCT00883896|64611494|FG002|Overall Study|Other|0|||
23237448|NCT00883896|64611495|FG003|Overall Study|Other|0|||
23237449|NCT01270139|64611501|FG000|Overall Study|Adverse Event|8|||
23237450|NCT01270139|64611502|FG001|Overall Study|Adverse Event|17|||
23237451|NCT01270139|64611503|FG002|Overall Study|Adverse Event|18|||
23237452|NCT01270139|64611501|FG000|Overall Study|Lost to Follow-up|10|||
23237453|NCT01270139|64611502|FG001|Overall Study|Lost to Follow-up|9|||
23237454|NCT01270139|64611503|FG002|Overall Study|Lost to Follow-up|2|||
23237455|NCT02173158|64611504|FG000|Efficacy Phase|Adverse Event|1|||
23237456|NCT02135848|64611505|FG000|Overall Study|Adverse Event|2|||
23237457|NCT02135848|64611506|FG001|Overall Study|Adverse Event|0|||
23237458|NCT02135848|64611505|FG000|Overall Study|Withdrawal by Subject|1|||
23237459|NCT02135848|64611506|FG001|Overall Study|Withdrawal by Subject|1|||
23237460|NCT01066546|64611507|FG000|Overall Study|Study terminated by sponsor|5|||
23237461|NCT02221882|64611508|FG000|Overall Study|Withdrawal by Subject|0|||
23237462|NCT02221882|64611509|FG001|Overall Study|Withdrawal by Subject|0|||
23237463|NCT02221882|64611510|FG002|Overall Study|Withdrawal by Subject|4|||
23237464|NCT02221882|64611511|FG003|Overall Study|Withdrawal by Subject|2|||
23237465|NCT02221882|64611512|FG004|Overall Study|Withdrawal by Subject|2|||
23237466|NCT02221882|64611513|FG005|Overall Study|Withdrawal by Subject|2|||
23237467|NCT02221882|64611508|FG000|Overall Study|Death|0|||
23237468|NCT02221882|64611509|FG001|Overall Study|Death|1|||
23237469|NCT02221882|64611510|FG002|Overall Study|Death|0|||
23237470|NCT02221882|64611511|FG003|Overall Study|Death|0|||
23237471|NCT02221882|64611512|FG004|Overall Study|Death|0|||
23237472|NCT02221882|64611513|FG005|Overall Study|Death|0|||
23237473|NCT02039687|64611517|FG000|Overall Study|Adverse Event|0|||
23237474|NCT02039687|64611518|FG001|Overall Study|Adverse Event|0|||
23237475|NCT02039687|64611519|FG002|Overall Study|Adverse Event|1|||
23237476|NCT02039687|64611520|FG003|Overall Study|Adverse Event|0|||
23237477|NCT02039687|64611517|FG000|Overall Study|Withdrawal by Subject|0|||
23237478|NCT02039687|64611518|FG001|Overall Study|Withdrawal by Subject|1|||
23237479|NCT02039687|64611519|FG002|Overall Study|Withdrawal by Subject|0|||
23237480|NCT02039687|64611520|FG003|Overall Study|Withdrawal by Subject|0|||
23237481|NCT02039687|64611517|FG000|Overall Study|treatment assignment could not be confir|0|||
23237482|NCT02039687|64611518|FG001|Overall Study|treatment assignment could not be confir|0|||
23237483|NCT02039687|64611519|FG002|Overall Study|treatment assignment could not be confir|2|||
23237484|NCT02039687|64611520|FG003|Overall Study|treatment assignment could not be confir|0|||
23237485|NCT02406586|64611526|FG000|Overall Study|Lost to Follow-up|0|||
23237486|NCT02406586|64611527|FG001|Overall Study|Lost to Follow-up|4|||
23237487|NCT02406586|64611528|FG002|Overall Study|Lost to Follow-up|2|||
23237488|NCT02406586|64611526|FG000|Overall Study|Withdrawal by Subject|1|||
23237489|NCT02406586|64611527|FG001|Overall Study|Withdrawal by Subject|0|||
23237490|NCT02406586|64611528|FG002|Overall Study|Withdrawal by Subject|0|||
23237491|NCT01219959|64611529|FG000|Overall Study|Adverse Event|6|||
23237492|NCT01219959|64611530|FG001|Overall Study|Adverse Event|14|||
23237493|NCT01219959|64611529|FG000|Overall Study|Physician Decision|0|||
23237494|NCT01219959|64611530|FG001|Overall Study|Physician Decision|4|||
23237495|NCT01219959|64611529|FG000|Overall Study|Withdrawal by Subject|0|||
23237496|NCT01219959|64611530|FG001|Overall Study|Withdrawal by Subject|2|||
23237497|NCT01219959|64611529|FG000|Overall Study|Renal Transplantation|0|||
23237498|NCT01219959|64611530|FG001|Overall Study|Renal Transplantation|3|||
23237499|NCT01219959|64611529|FG000|Overall Study|Other|1|||
23237500|NCT01219959|64611530|FG001|Overall Study|Other|0|||
23237501|NCT02329834|64611531|FG000|Overall Study|Physician Decision|1|||
23237502|NCT02329834|64611532|FG001|Overall Study|Physician Decision|0|||
23237503|NCT02408016|64611535|FG000|Overall Study|Death|6|||
23237504|NCT02408016|64611536|FG001|Overall Study|Death|1|||
23237505|NCT02408016|64611537|FG002|Overall Study|Death|0|||
23237506|NCT02408016|64611535|FG000|Overall Study|Physician Decision|0|||
23582563|NCT02974010|65862498|FG003|Overall Study|Adverse Event|0|||
23237507|NCT02408016|64611536|FG001|Overall Study|Physician Decision|2|||
23237508|NCT02408016|64611537|FG002|Overall Study|Physician Decision|0|||
23237509|NCT02145429|64611538|FG000|Overall Study|Death|4|||
23237510|NCT02145429|64611539|FG001|Overall Study|Death|5|||
23237511|NCT02145429|64611538|FG000|Overall Study|Lost to Follow-up|4|||
23582564|NCT02974010|65862495|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
23237512|NCT02145429|64611539|FG001|Overall Study|Lost to Follow-up|3|||
23237513|NCT02145429|64611538|FG000|Overall Study|Withdrawal by Subject|8|||
23237514|NCT02145429|64611539|FG001|Overall Study|Withdrawal by Subject|3|||
23237515|NCT01319422|64611547|FG000|Overall Study|Withdrawal by Subject|1|||
23237516|NCT01319422|64611548|FG001|Overall Study|Withdrawal by Subject|0|||
23237517|NCT01265719|64611549|FG000|Overall Study|Does not meet entrance criteria|0|||
23237518|NCT01265719|64611550|FG001|Overall Study|Does not meet entrance criteria|3|||
23237519|NCT01265719|64611549|FG000|Overall Study|Other reasons|2|||
23237520|NCT01265719|64611550|FG001|Overall Study|Other reasons|0|||
23342912|NCT02637895|64999745|FG000|Overall Study|Protocol Violation|0|||
23342913|NCT02637895|64999746|FG001|Overall Study|Protocol Violation|1|||
23342914|NCT02637895|64999745|FG000|Overall Study|Lack of Efficacy|1|||
23342915|NCT02637895|64999746|FG001|Overall Study|Lack of Efficacy|0|||
23342916|NCT02637895|64999745|FG000|Overall Study|Withdrawal by Subject|1|||
23342917|NCT02637895|64999746|FG001|Overall Study|Withdrawal by Subject|1|||
23342918|NCT02637895|64999745|FG000|Overall Study|Abnormal baseline lab|0|||
23342919|NCT02637895|64999746|FG001|Overall Study|Abnormal baseline lab|1|||
23342920|NCT03614078|64999751|FG000|Overall Study|Withdrawal by Subject|2|||
23342921|NCT03614078|64999752|FG001|Overall Study|Withdrawal by Subject|2|||
23342922|NCT03614078|64999753|FG002|Overall Study|Withdrawal by Subject|3|||
23342923|NCT03614078|64999751|FG000|Overall Study|Participant Did Not Return for Visit|0|||
23342924|NCT03614078|64999752|FG001|Overall Study|Participant Did Not Return for Visit|1|||
23342925|NCT03614078|64999753|FG002|Overall Study|Participant Did Not Return for Visit|0|||
23342926|NCT03614078|64999751|FG000|Overall Study|High Neutrophils|0|||
23342927|NCT03614078|64999752|FG001|Overall Study|High Neutrophils|0|||
23342928|NCT03614078|64999753|FG002|Overall Study|High Neutrophils|2|||
23342929|NCT03614078|64999751|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
23342930|NCT03614078|64999752|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
23342931|NCT03614078|64999753|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
23342932|NCT03614078|64999751|FG000|Overall Study|Exacerbation of Psoriasis|0|||
23342933|NCT03614078|64999752|FG001|Overall Study|Exacerbation of Psoriasis|1|||
23342934|NCT03614078|64999753|FG002|Overall Study|Exacerbation of Psoriasis|0|||
23342935|NCT03614078|64999751|FG000|Overall Study|Adverse Event|0|||
23342936|NCT03614078|64999752|FG001|Overall Study|Adverse Event|2|||
23342937|NCT03614078|64999753|FG002|Overall Study|Adverse Event|0|||
23342938|NCT03614078|64999751|FG000|Overall Study|Dizziness and Rash|0|||
23342939|NCT03614078|64999752|FG001|Overall Study|Dizziness and Rash|1|||
23342940|NCT03614078|64999753|FG002|Overall Study|Dizziness and Rash|0|||
23582565|NCT02974010|65862496|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
23582566|NCT02974010|65862497|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
23582567|NCT02974010|65862498|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
23582568|NCT02974010|65862495|FG000|Overall Study|Lack of Efficacy|0|||
23582569|NCT02974010|65862496|FG001|Overall Study|Lack of Efficacy|0|||
23582570|NCT02974010|65862497|FG002|Overall Study|Lack of Efficacy|1|||
23342947|NCT00749684|64999761|FG000|Overall Study|Death|1|||
23342948|NCT00749684|64999761|FG000|Overall Study|Adverse Event|27|||
23342949|NCT00749684|64999761|FG000|Overall Study|Participant's Wish|10|||
23342950|NCT00749684|64999761|FG000|Overall Study|Not Documented|1|||
23342951|NCT00749684|64999761|FG000|Overall Study|Progressive Desease|31|||
23342952|NCT00749684|64999761|FG000|Overall Study|Therapy according to protocol + AE|2|||
23342953|NCT00749684|64999761|FG000|Overall Study|AE+discontinuation on participants wish|1|||
23342954|NCT00749684|64999761|FG000|Overall Study|Missing|9|||
23342955|NCT02822573|64999762|FG000|Overall Study|Lost to Follow-up|5|||
23342956|NCT02822573|64999763|FG001|Overall Study|Lost to Follow-up|3|||
23342957|NCT02822573|64999762|FG000|Overall Study|Physician Decision|1|||
23342958|NCT02822573|64999763|FG001|Overall Study|Physician Decision|1|||
23342959|NCT02822573|64999762|FG000|Overall Study|Withdrawal by Subject|9|||
23342960|NCT02822573|64999763|FG001|Overall Study|Withdrawal by Subject|5|||
23342961|NCT02822573|64999762|FG000|Overall Study|Protocol Violation|6|||
23342962|NCT02822573|64999763|FG001|Overall Study|Protocol Violation|4|||
23342963|NCT02822573|64999762|FG000|Overall Study|Too sick or ill|2|||
23342964|NCT02822573|64999763|FG001|Overall Study|Too sick or ill|1|||
23342965|NCT02822573|64999762|FG000|Overall Study|Disease Progression|1|||
23454765|NCT03001557|65407237|FG001|Extension Phase|Adverse Event|0|||
23454766|NCT03001557|65407238|FG002|Extension Phase|Adverse Event|0|||
23454767|NCT03001557|65407239|FG003|Extension Phase|Adverse Event|0|||
23454768|NCT03001557|65407240|FG004|Extension Phase|Adverse Event|0|||
23454769|NCT03001557|65407241|FG005|Extension Phase|Adverse Event|2|||
23454770|NCT03001557|65407242|FG006|Extension Phase|Adverse Event|0|||
23454771|NCT03001557|65407243|FG007|Extension Phase|Adverse Event|0|||
23342966|NCT02822573|64999763|FG001|Overall Study|Disease Progression|1|||
23342967|NCT02822573|64999762|FG000|Overall Study|No reason given|6|||
23342968|NCT02822573|64999763|FG001|Overall Study|No reason given|4|||
23342969|NCT01096589|64999764|FG000|Overall Study|Adverse Event|2|||
23342970|NCT01096589|64999765|FG001|Overall Study|Adverse Event|1|||
23342971|NCT01096589|64999766|FG002|Overall Study|Adverse Event|2|||
23342972|NCT01096589|64999767|FG003|Overall Study|Adverse Event|1|||
23342973|NCT01096589|64999764|FG000|Overall Study|Withdrawal by Subject|2|||
23342974|NCT01096589|64999765|FG001|Overall Study|Withdrawal by Subject|1|||
23342975|NCT01096589|64999766|FG002|Overall Study|Withdrawal by Subject|1|||
23342976|NCT01096589|64999767|FG003|Overall Study|Withdrawal by Subject|1|||
23342977|NCT01096589|64999764|FG000|Overall Study|Compliance with protocol|0|||
23342978|NCT01096589|64999765|FG001|Overall Study|Compliance with protocol|0|||
23342979|NCT01096589|64999766|FG002|Overall Study|Compliance with protocol|1|||
23454772|NCT03001557|65407236|FG000|Extension Phase|Withdrawal by Subject|0|||
23454773|NCT03001557|65407237|FG001|Extension Phase|Withdrawal by Subject|0|||
23454774|NCT03001557|65407238|FG002|Extension Phase|Withdrawal by Subject|0|||
23454775|NCT03001557|65407239|FG003|Extension Phase|Withdrawal by Subject|0|||
23342980|NCT01096589|64999767|FG003|Overall Study|Compliance with protocol|0|||
23342981|NCT01096589|64999764|FG000|Overall Study|found treatment exhausting|0|||
23342982|NCT01096589|64999765|FG001|Overall Study|found treatment exhausting|0|||
23342983|NCT01096589|64999766|FG002|Overall Study|found treatment exhausting|0|||
23342984|NCT01096589|64999767|FG003|Overall Study|found treatment exhausting|1|||
23342985|NCT04756154|64999768|FG000|Overall Study|Did not meet treatment day baseline|30|||
23342986|NCT04756154|64999769|FG001|Overall Study|Did not meet treatment day baseline|28|||
23342987|NCT04756154|64999770|FG002|Overall Study|Did not meet treatment day baseline|7|||
23342988|NCT04756154|64999768|FG000|Overall Study|Did not return for final sample collection|1|||
23342989|NCT04756154|64999769|FG001|Overall Study|Did not return for final sample collection|1|||
23342990|NCT04756154|64999770|FG002|Overall Study|Did not return for final sample collection|0|||
23342991|NCT02017912|64999771|FG000|Overall Study|Withdrawal by Subject|2|||
23342992|NCT02017912|64999772|FG001|Overall Study|Withdrawal by Subject|1|||
23342993|NCT02017912|64999771|FG000|Overall Study|miscellaneous|1|||
23342994|NCT02017912|64999772|FG001|Overall Study|miscellaneous|1|||
23342995|NCT00723255|64999779|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
23342996|NCT00723255|64999779|FG000|Overall Study|Ineligible: Second primary|1|||
23342997|NCT00723255|64999779|FG000|Overall Study|Ineligible: Wrong Primary|2|||
23342998|NCT02520427|64999780|FG000|Overall Study|Decision by sponsor|0|||
23342999|NCT02520427|64999781|FG001|Overall Study|Decision by sponsor|0|||
23343000|NCT02520427|64999782|FG002|Overall Study|Decision by sponsor|0|||
23343001|NCT02520427|64999783|FG003|Overall Study|Decision by sponsor|0|||
23343002|NCT02520427|64999784|FG004|Overall Study|Decision by sponsor|0|||
23343003|NCT02520427|64999785|FG005|Overall Study|Decision by sponsor|0|||
23343004|NCT02520427|64999786|FG006|Overall Study|Decision by sponsor|0|||
23343005|NCT02520427|64999787|FG007|Overall Study|Decision by sponsor|0|||
23343006|NCT02520427|64999788|FG008|Overall Study|Decision by sponsor|1|||
23343007|NCT02520427|64999789|FG009|Overall Study|Decision by sponsor|1|||
23343008|NCT02520427|64999790|FG010|Overall Study|Decision by sponsor|0|||
23343009|NCT02520427|64999791|FG011|Overall Study|Decision by sponsor|0|||
23343010|NCT02520427|64999792|FG012|Overall Study|Decision by sponsor|0|||
23343011|NCT02520427|64999793|FG013|Overall Study|Decision by sponsor|0|||
23343012|NCT02520427|64999794|FG014|Overall Study|Decision by sponsor|0|||
23343013|NCT02520427|64999795|FG015|Overall Study|Decision by sponsor|0|||
23343014|NCT02520427|64999796|FG016|Overall Study|Decision by sponsor|0|||
23343015|NCT02520427|64999797|FG017|Overall Study|Decision by sponsor|0|||
23343016|NCT02520427|64999798|FG018|Overall Study|Decision by sponsor|0|||
23343017|NCT02520427|64999799|FG019|Overall Study|Decision by sponsor|0|||
23343018|NCT02520427|64999800|FG020|Overall Study|Decision by sponsor|0|||
23343019|NCT02520427|64999801|FG021|Overall Study|Decision by sponsor|0|||
23343020|NCT02520427|64999802|FG022|Overall Study|Decision by sponsor|0|||
23343021|NCT02520427|64999803|FG023|Overall Study|Decision by sponsor|0|||
23343022|NCT02520427|64999804|FG024|Overall Study|Decision by sponsor|0|||
23343023|NCT02520427|64999805|FG025|Overall Study|Decision by sponsor|0|||
23343024|NCT02520427|64999780|FG000|Overall Study|Withdrawal by Subject|0|||
23343025|NCT02520427|64999781|FG001|Overall Study|Withdrawal by Subject|0|||
23343026|NCT02520427|64999782|FG002|Overall Study|Withdrawal by Subject|1|||
23343027|NCT02520427|64999783|FG003|Overall Study|Withdrawal by Subject|0|||
23343028|NCT02520427|64999784|FG004|Overall Study|Withdrawal by Subject|0|||
23343029|NCT02520427|64999785|FG005|Overall Study|Withdrawal by Subject|0|||
23343030|NCT02520427|64999786|FG006|Overall Study|Withdrawal by Subject|0|||
23343031|NCT02520427|64999787|FG007|Overall Study|Withdrawal by Subject|0|||
23343032|NCT02520427|64999788|FG008|Overall Study|Withdrawal by Subject|0|||
23343033|NCT02520427|64999789|FG009|Overall Study|Withdrawal by Subject|0|||
23343034|NCT02520427|64999790|FG010|Overall Study|Withdrawal by Subject|0|||
23343035|NCT02520427|64999791|FG011|Overall Study|Withdrawal by Subject|0|||
23343036|NCT02520427|64999792|FG012|Overall Study|Withdrawal by Subject|1|||
23343037|NCT02520427|64999793|FG013|Overall Study|Withdrawal by Subject|1|||
23343038|NCT02520427|64999794|FG014|Overall Study|Withdrawal by Subject|1|||
23343039|NCT02520427|64999795|FG015|Overall Study|Withdrawal by Subject|0|||
23343040|NCT02520427|64999796|FG016|Overall Study|Withdrawal by Subject|1|||
23343041|NCT02520427|64999797|FG017|Overall Study|Withdrawal by Subject|0|||
23343042|NCT02520427|64999798|FG018|Overall Study|Withdrawal by Subject|0|||
23343043|NCT02520427|64999799|FG019|Overall Study|Withdrawal by Subject|3|||
23343044|NCT02520427|64999800|FG020|Overall Study|Withdrawal by Subject|2|||
23343045|NCT02520427|64999801|FG021|Overall Study|Withdrawal by Subject|0|||
23343046|NCT02520427|64999802|FG022|Overall Study|Withdrawal by Subject|0|||
23454776|NCT03001557|65407240|FG004|Extension Phase|Withdrawal by Subject|0|||
23343047|NCT02520427|64999803|FG023|Overall Study|Withdrawal by Subject|0|||
23343048|NCT02520427|64999804|FG024|Overall Study|Withdrawal by Subject|0|||
23343049|NCT02520427|64999805|FG025|Overall Study|Withdrawal by Subject|0|||
23343050|NCT02520427|64999780|FG000|Overall Study|Death|1|||
23343051|NCT02520427|64999781|FG001|Overall Study|Death|0|||
23343052|NCT02520427|64999782|FG002|Overall Study|Death|0|||
23343053|NCT02520427|64999783|FG003|Overall Study|Death|0|||
23343054|NCT02520427|64999784|FG004|Overall Study|Death|0|||
23343055|NCT02520427|64999785|FG005|Overall Study|Death|0|||
23343056|NCT02520427|64999786|FG006|Overall Study|Death|0|||
23343057|NCT02520427|64999787|FG007|Overall Study|Death|0|||
23343058|NCT02520427|64999788|FG008|Overall Study|Death|0|||
23343059|NCT02520427|64999789|FG009|Overall Study|Death|0|||
23343060|NCT02520427|64999790|FG010|Overall Study|Death|0|||
23343061|NCT02520427|64999791|FG011|Overall Study|Death|0|||
23343062|NCT02520427|64999792|FG012|Overall Study|Death|0|||
23343063|NCT02520427|64999793|FG013|Overall Study|Death|0|||
23343064|NCT02520427|64999794|FG014|Overall Study|Death|0|||
23343065|NCT02520427|64999795|FG015|Overall Study|Death|0|||
23343066|NCT02520427|64999796|FG016|Overall Study|Death|2|||
23343067|NCT02520427|64999797|FG017|Overall Study|Death|1|||
23343068|NCT02520427|64999798|FG018|Overall Study|Death|3|||
23343069|NCT02520427|64999799|FG019|Overall Study|Death|2|||
23343070|NCT02520427|64999800|FG020|Overall Study|Death|0|||
23343071|NCT02520427|64999801|FG021|Overall Study|Death|0|||
23343072|NCT02520427|64999802|FG022|Overall Study|Death|1|||
23343073|NCT02520427|64999803|FG023|Overall Study|Death|0|||
23343074|NCT02520427|64999804|FG024|Overall Study|Death|1|||
23343075|NCT02520427|64999805|FG025|Overall Study|Death|0|||
23343076|NCT01471340|64999806|FG000|Overall Study|Death|5|||
23343077|NCT01471340|64999807|FG001|Overall Study|Death|4|||
23343078|NCT01471340|64999806|FG000|Overall Study|Lost to Follow-up|0|||
23343079|NCT01471340|64999807|FG001|Overall Study|Lost to Follow-up|1|||
23343080|NCT01471340|64999806|FG000|Overall Study|Investigational site closure|0|||
23343081|NCT01471340|64999807|FG001|Overall Study|Investigational site closure|1|||
23343082|NCT01471340|64999806|FG000|Overall Study|Invalid informed consent|1|||
23343083|NCT01471340|64999807|FG001|Overall Study|Invalid informed consent|0|||
23343084|NCT01582178|64999809|FG000|Overall Study|Physician Decision|6|||
23343085|NCT01582178|64999810|FG001|Overall Study|Physician Decision|5|||
23343086|NCT02100670|64999814|FG000|Overall Study|Adverse Event|10|||
23343087|NCT02100670|64999815|FG001|Overall Study|Adverse Event|3|||
23343088|NCT02100670|64999816|FG002|Overall Study|Adverse Event|3|||
23343089|NCT02100670|64999817|FG003|Overall Study|Adverse Event|0|||
23343090|NCT02100670|64999814|FG000|Overall Study|Lost to Follow-up|1|||
23343091|NCT02100670|64999815|FG001|Overall Study|Lost to Follow-up|0|||
23343092|NCT02100670|64999816|FG002|Overall Study|Lost to Follow-up|0|||
23343093|NCT02100670|64999817|FG003|Overall Study|Lost to Follow-up|0|||
23343094|NCT02100670|64999814|FG000|Overall Study|Protocol Violation|0|||
23343095|NCT02100670|64999815|FG001|Overall Study|Protocol Violation|1|||
23343096|NCT02100670|64999816|FG002|Overall Study|Protocol Violation|0|||
23343097|NCT02100670|64999817|FG003|Overall Study|Protocol Violation|1|||
23343098|NCT02100670|64999814|FG000|Overall Study|Withdrawal of Consent|0|||
23343099|NCT02100670|64999815|FG001|Overall Study|Withdrawal of Consent|1|||
23343100|NCT02100670|64999816|FG002|Overall Study|Withdrawal of Consent|1|||
23343101|NCT02100670|64999817|FG003|Overall Study|Withdrawal of Consent|0|||
23343102|NCT02100670|64999814|FG000|Overall Study|No swelling no pain|1|||
23343103|NCT02100670|64999815|FG001|Overall Study|No swelling no pain|0|||
23343104|NCT02100670|64999816|FG002|Overall Study|No swelling no pain|0|||
23343105|NCT02100670|64999817|FG003|Overall Study|No swelling no pain|0|||
23343106|NCT02100670|64999814|FG000|Overall Study|Poor Efficacy|0|||
23343107|NCT02100670|64999815|FG001|Overall Study|Poor Efficacy|1|||
23343108|NCT02100670|64999816|FG002|Overall Study|Poor Efficacy|0|||
23343109|NCT02100670|64999817|FG003|Overall Study|Poor Efficacy|0|||
23343110|NCT02100670|64999814|FG000|Overall Study|Physician Decision|0|||
23343111|NCT02100670|64999815|FG001|Overall Study|Physician Decision|1|||
23343112|NCT02100670|64999816|FG002|Overall Study|Physician Decision|0|||
23343113|NCT02100670|64999817|FG003|Overall Study|Physician Decision|0|||
23343114|NCT02100670|64999814|FG000|Overall Study|Withdrawal by Subject|1|||
23343115|NCT02100670|64999815|FG001|Overall Study|Withdrawal by Subject|0|||
23343116|NCT02100670|64999816|FG002|Overall Study|Withdrawal by Subject|0|||
23343117|NCT02100670|64999817|FG003|Overall Study|Withdrawal by Subject|0|||
23343118|NCT00425061|64999825|FG000|Overall Study|Adverse Event|1|||
23343119|NCT00425061|64999826|FG001|Overall Study|Adverse Event|0|||
23343120|NCT00425061|64999827|FG002|Overall Study|Adverse Event|0|||
23343121|NCT00425061|64999828|FG003|Overall Study|Adverse Event|2|||
23343122|NCT00425061|64999829|FG004|Overall Study|Adverse Event|2|||
23343123|NCT00425061|64999830|FG005|Overall Study|Adverse Event|0|||
23343124|NCT00425061|64999831|FG006|Overall Study|Adverse Event|0|||
23343125|NCT00425061|64999825|FG000|Overall Study|Lost to Follow-up|0|||
23343126|NCT00425061|64999826|FG001|Overall Study|Lost to Follow-up|1|||
23343127|NCT00425061|64999827|FG002|Overall Study|Lost to Follow-up|0|||
23343128|NCT00425061|64999828|FG003|Overall Study|Lost to Follow-up|0|||
23343129|NCT00425061|64999829|FG004|Overall Study|Lost to Follow-up|0|||
23343130|NCT00425061|64999830|FG005|Overall Study|Lost to Follow-up|0|||
23343131|NCT00425061|64999831|FG006|Overall Study|Lost to Follow-up|0|||
23343132|NCT00425061|64999825|FG000|Overall Study|Protocol Violation|1|||
23343133|NCT00425061|64999826|FG001|Overall Study|Protocol Violation|0|||
23343134|NCT00425061|64999827|FG002|Overall Study|Protocol Violation|0|||
23343135|NCT00425061|64999828|FG003|Overall Study|Protocol Violation|0|||
23343136|NCT00425061|64999829|FG004|Overall Study|Protocol Violation|0|||
23343137|NCT00425061|64999830|FG005|Overall Study|Protocol Violation|0|||
23343138|NCT00425061|64999831|FG006|Overall Study|Protocol Violation|0|||
23343139|NCT00425061|64999825|FG000|Overall Study|Withdrawal by Subject|0|||
23343140|NCT00425061|64999826|FG001|Overall Study|Withdrawal by Subject|1|||
23343141|NCT00425061|64999827|FG002|Overall Study|Withdrawal by Subject|0|||
23343142|NCT00425061|64999828|FG003|Overall Study|Withdrawal by Subject|0|||
23343143|NCT00425061|64999829|FG004|Overall Study|Withdrawal by Subject|1|||
23343144|NCT00425061|64999830|FG005|Overall Study|Withdrawal by Subject|0|||
23343145|NCT00425061|64999831|FG006|Overall Study|Withdrawal by Subject|3|||
23343146|NCT00425061|64999825|FG000|Overall Study|Sponsor's request|0|||
23343147|NCT00425061|64999826|FG001|Overall Study|Sponsor's request|0|||
23343148|NCT00425061|64999827|FG002|Overall Study|Sponsor's request|0|||
23343149|NCT00425061|64999828|FG003|Overall Study|Sponsor's request|0|||
23343150|NCT00425061|64999829|FG004|Overall Study|Sponsor's request|19|||
23343151|NCT00425061|64999830|FG005|Overall Study|Sponsor's request|4|||
23343152|NCT00425061|64999831|FG006|Overall Study|Sponsor's request|15|||
23343153|NCT00425061|64999825|FG000|Overall Study|Physician Decision|0|||
23343154|NCT00425061|64999826|FG001|Overall Study|Physician Decision|0|||
23343155|NCT00425061|64999827|FG002|Overall Study|Physician Decision|0|||
23343156|NCT00425061|64999828|FG003|Overall Study|Physician Decision|0|||
23343157|NCT00425061|64999829|FG004|Overall Study|Physician Decision|1|||
23343158|NCT00425061|64999830|FG005|Overall Study|Physician Decision|0|||
23343159|NCT00425061|64999831|FG006|Overall Study|Physician Decision|0|||
23343160|NCT00425061|64999825|FG000|Overall Study|Other|0|||
23343161|NCT00425061|64999826|FG001|Overall Study|Other|0|||
23343162|NCT00425061|64999827|FG002|Overall Study|Other|0|||
23343163|NCT00425061|64999828|FG003|Overall Study|Other|0|||
23343164|NCT00425061|64999829|FG004|Overall Study|Other|3|||
23343165|NCT00425061|64999830|FG005|Overall Study|Other|0|||
23343166|NCT00425061|64999831|FG006|Overall Study|Other|1|||
23343167|NCT03634033|64999834|FG000|Overall Study|Did not have a post-assessment|384|||
23343168|NCT03634033|64999835|FG001|Overall Study|Did not have a post-assessment|291|||
23343169|NCT03634033|64999836|FG002|Overall Study|Did not have a post-assessment|114|||
23343170|NCT03634033|64999837|FG003|Overall Study|Did not have a post-assessment|161|||
23343171|NCT03634033|64999838|FG004|Overall Study|Did not have a post-assessment|5|||
23343172|NCT03634033|64999839|FG005|Overall Study|Did not have a post-assessment|0|||
23343173|NCT03634033|64999840|FG006|Overall Study|Did not have a post-assessment|0|||
23343174|NCT03634033|64999834|FG000|Overall Study|Death|0|||
23343175|NCT03634033|64999835|FG001|Overall Study|Death|0|||
23343176|NCT03634033|64999836|FG002|Overall Study|Death|0|||
23343177|NCT03634033|64999837|FG003|Overall Study|Death|0|||
23343178|NCT03634033|64999838|FG004|Overall Study|Death|0|||
23343179|NCT03634033|64999839|FG005|Overall Study|Death|7|||
23343180|NCT03634033|64999840|FG006|Overall Study|Death|7|||
23343181|NCT03634033|64999834|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23343182|NCT03634033|64999835|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23582571|NCT02974010|65862498|FG003|Overall Study|Lack of Efficacy|0|||
23582572|NCT00015457|65862499|FG000|First Intervention|Adverse Event|0|||
23582573|NCT00015457|65862500|FG001|First Intervention|Adverse Event|2|||
23582574|NCT00015457|65862499|FG000|First Intervention|Lack of Efficacy|0|||
23582575|NCT00015457|65862500|FG001|First Intervention|Lack of Efficacy|1|||
23582576|NCT00015457|65862499|FG000|Second Intervention|Withdrawal by Subject|1|||
23582577|NCT00015457|65862500|FG001|Second Intervention|Withdrawal by Subject|0|||
23582578|NCT03239210|65862503|FG000|Overall Study|Lost to Follow-up|2|||
23582579|NCT03239210|65862504|FG001|Overall Study|Lost to Follow-up|2|||
23582580|NCT03239210|65862503|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
23582581|NCT03239210|65862504|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
23582582|NCT03239210|65862503|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
23343183|NCT03634033|64999836|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23343184|NCT03634033|64999837|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23582583|NCT03239210|65862504|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
23582584|NCT03732820|65862505|FG000|Overall Study|Death|168|||
23343185|NCT03634033|64999838|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
23343186|NCT03634033|64999839|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
23343187|NCT03634033|64999840|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
23343188|NCT03634033|64999834|FG000|Overall Study|Lost to Follow-up|0|||
23343189|NCT03634033|64999835|FG001|Overall Study|Lost to Follow-up|0|||
23343190|NCT03634033|64999836|FG002|Overall Study|Lost to Follow-up|0|||
23343191|NCT03634033|64999837|FG003|Overall Study|Lost to Follow-up|0|||
23343192|NCT03634033|64999838|FG004|Overall Study|Lost to Follow-up|0|||
23582585|NCT03732820|65862506|FG001|Overall Study|Death|203|||
23582586|NCT03732820|65862505|FG000|Overall Study|Other|2|||
23582587|NCT03732820|65862506|FG001|Overall Study|Other|2|||
23582588|NCT03732820|65862505|FG000|Overall Study|Failure to meet randomisation criteria|1|||
23582589|NCT03732820|65862506|FG001|Overall Study|Failure to meet randomisation criteria|1|||
23582590|NCT03732820|65862505|FG000|Overall Study|Patient decision|14|||
23582591|NCT03732820|65862506|FG001|Overall Study|Patient decision|10|||
23582592|NCT03732820|65862505|FG000|Overall Study|Screen failure|0|||
23582593|NCT03732820|65862506|FG001|Overall Study|Screen failure|1|||
23582594|NCT03732820|65862505|FG000|Overall Study|Patients ongoing study at data cut off|210|||
23582595|NCT03732820|65862506|FG001|Overall Study|Patients ongoing study at data cut off|178|||
23582596|NCT03732820|65862505|FG000|Overall Study|Lost to Follow-up|4|||
23582597|NCT03732820|65862506|FG001|Overall Study|Lost to Follow-up|2|||
23582598|NCT03111095|65862507|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
23582599|NCT03111095|65862508|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
23582600|NCT03111095|65862507|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
23582601|NCT03111095|65862508|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
23582602|NCT04995419|65862512|FG000|Overall Study|Withdrawal by Subject|3|||
23582603|NCT04995419|65862512|FG000|Overall Study|Progressive Disease|19|||
23582604|NCT04995419|65862512|FG000|Overall Study|Adverse Event|2|||
23582605|NCT04995419|65862512|FG000|Overall Study|Ongoing|16|||
23582606|NCT02040844|65862517|FG000|Overall Study|Adverse Event|0|||
23582607|NCT02040844|65862518|FG001|Overall Study|Adverse Event|0|||
23582608|NCT02040844|65862519|FG002|Overall Study|Adverse Event|1|||
23582609|NCT02040844|65862517|FG000|Overall Study|Withdrawal by Subject|16|||
23582610|NCT02040844|65862518|FG001|Overall Study|Withdrawal by Subject|22|||
23582611|NCT02040844|65862519|FG002|Overall Study|Withdrawal by Subject|25|||
23582612|NCT02040844|65862517|FG000|Overall Study|Lost to Follow-up|12|||
23582613|NCT02040844|65862518|FG001|Overall Study|Lost to Follow-up|9|||
23582614|NCT02040844|65862519|FG002|Overall Study|Lost to Follow-up|13|||
23582615|NCT02040844|65862517|FG000|Overall Study|Missing|13|||
23582616|NCT02040844|65862518|FG001|Overall Study|Missing|3|||
23582617|NCT02040844|65862519|FG002|Overall Study|Missing|2|||
23582618|NCT02040844|65862517|FG000|Overall Study|Non-specified|8|||
23582619|NCT02040844|65862518|FG001|Overall Study|Non-specified|2|||
23582620|NCT02040844|65862519|FG002|Overall Study|Non-specified|5|||
23582621|NCT02040844|65862517|FG000|Overall Study|Concomitant medication|1|||
23582622|NCT02040844|65862518|FG001|Overall Study|Concomitant medication|3|||
23582623|NCT02040844|65862519|FG002|Overall Study|Concomitant medication|1|||
23582624|NCT00723294|65862521|FG000|Overall Study|Lobular histology|2|||
23582625|NCT00723294|65862521|FG000|Overall Study|>25% intraductal component|1|||
23582626|NCT00723294|65862521|FG000|Overall Study|No MRI tumor enhancement|1|||
23343193|NCT03634033|64999839|FG005|Overall Study|Lost to Follow-up|1|||
23343194|NCT03634033|64999840|FG006|Overall Study|Lost to Follow-up|2|||
23343195|NCT03634033|64999834|FG000|Overall Study|Withdrawal by Subject|0|||
23343196|NCT03634033|64999835|FG001|Overall Study|Withdrawal by Subject|0|||
23343197|NCT03634033|64999836|FG002|Overall Study|Withdrawal by Subject|0|||
23343198|NCT03634033|64999837|FG003|Overall Study|Withdrawal by Subject|0|||
23343199|NCT03634033|64999838|FG004|Overall Study|Withdrawal by Subject|0|||
23343200|NCT03634033|64999839|FG005|Overall Study|Withdrawal by Subject|0|||
23343201|NCT03634033|64999840|FG006|Overall Study|Withdrawal by Subject|1|||
23343202|NCT00978250|64999841|FG000|Overall Study|Late determination of ineligibility|0|||
23343203|NCT00978250|64999842|FG001|Overall Study|Late determination of ineligibility|1|||
23343204|NCT00978250|64999843|FG002|Overall Study|Late determination of ineligibility|0|||
23343205|NCT00978250|64999844|FG003|Overall Study|Late determination of ineligibility|1|||
23343206|NCT05249127|64999846|FG000|Overall Study|Protocol Violation|13|||
23343207|NCT05249127|64999846|FG000|Overall Study|Physician Decision|4|||
23343208|NCT05249127|64999846|FG000|Overall Study|Withdrawal by Subject|2|||
23343209|NCT05249127|64999846|FG000|Overall Study|Participant Non-compliance|1|||
23343210|NCT02589522|64999856|FG000|Overall Study|Physician Decision|1|||
23343211|NCT02589522|64999857|FG001|Overall Study|Physician Decision|2|||
23343212|NCT02589522|64999858|FG002|Overall Study|Physician Decision|0|||
23343213|NCT02589522|64999856|FG000|Overall Study|Did not start treatment|1|||
23343214|NCT02589522|64999857|FG001|Overall Study|Did not start treatment|0|||
23343215|NCT02589522|64999858|FG002|Overall Study|Did not start treatment|0|||
23343216|NCT00514904|64999859|FG000|Overall Study|Withdrawal by Subject|3|||
23343217|NCT00514904|64999860|FG001|Overall Study|Withdrawal by Subject|2|||
23343218|NCT00514904|64999859|FG000|Overall Study|Lost to Follow-up|21|||
23343219|NCT00514904|64999860|FG001|Overall Study|Lost to Follow-up|3|||
23343220|NCT00654875|64999866|FG000|Overall Study|Adverse Event|5|||
23343221|NCT00654875|64999867|FG001|Overall Study|Adverse Event|5|||
23343222|NCT00654875|64999866|FG000|Overall Study|Withdrawal by Subject|4|||
23343223|NCT00654875|64999867|FG001|Overall Study|Withdrawal by Subject|4|||
23343224|NCT00654875|64999866|FG000|Overall Study|Protocol Violation|3|||
23343225|NCT00654875|64999867|FG001|Overall Study|Protocol Violation|3|||
23343226|NCT00654875|64999866|FG000|Overall Study|Lack of Efficacy|2|||
23343227|NCT00654875|64999867|FG001|Overall Study|Lack of Efficacy|2|||
23343228|NCT00654875|64999866|FG000|Overall Study|Lost to Follow-up|1|||
23343229|NCT00654875|64999867|FG001|Overall Study|Lost to Follow-up|3|||
23343230|NCT00654875|64999866|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
23343231|NCT00654875|64999867|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23343232|NCT00654875|64999866|FG000|Overall Study|Administrative Problems|1|||
23343233|NCT00654875|64999867|FG001|Overall Study|Administrative Problems|0|||
23343234|NCT04743804|64999868|FG000|Overall Study|Other|1|||
23343235|NCT04743804|64999869|FG001|Overall Study|Other|0|||
23343236|NCT04743804|64999868|FG000|Overall Study|Withdrawal by Subject|0|||
23343237|NCT04743804|64999869|FG001|Overall Study|Withdrawal by Subject|1|||
23343238|NCT04743804|64999868|FG000|Overall Study|Study Terminated by Sponsor|1|||
23343239|NCT04743804|64999869|FG001|Overall Study|Study Terminated by Sponsor|4|||
23343240|NCT04743804|64999868|FG000|Overall Study|Physician Decision|0|||
23343241|NCT04743804|64999869|FG001|Overall Study|Physician Decision|1|||
23343242|NCT04743804|64999868|FG000|Overall Study|Death|3|||
23343243|NCT04743804|64999869|FG001|Overall Study|Death|0|||
23343244|NCT02703272|64999870|FG000|Overall Study|Death|4|||
23343245|NCT02703272|64999871|FG001|Overall Study|Death|9|||
23343246|NCT02703272|64999872|FG002|Overall Study|Death|19|||
23343247|NCT02703272|64999873|FG003|Overall Study|Death|10|||
23343248|NCT02703272|64999870|FG000|Overall Study|Withdrawal by Subject|0|||
23343249|NCT02703272|64999871|FG001|Overall Study|Withdrawal by Subject|0|||
23582627|NCT00723294|65862521|FG000|Overall Study|1.0-Tesla MRI|1|||
23582628|NCT00723294|65862521|FG000|Overall Study|No cryoabalation|2|||
23343250|NCT02703272|64999872|FG002|Overall Study|Withdrawal by Subject|4|||
23343251|NCT02703272|64999873|FG003|Overall Study|Withdrawal by Subject|2|||
23343252|NCT02703272|64999870|FG000|Overall Study|Study Terminated by Sponsor|6|||
23343253|NCT02703272|64999871|FG001|Overall Study|Study Terminated by Sponsor|1|||
23343254|NCT02703272|64999872|FG002|Overall Study|Study Terminated by Sponsor|12|||
23343255|NCT02703272|64999873|FG003|Overall Study|Study Terminated by Sponsor|4|||
23343256|NCT02703272|64999870|FG000|Overall Study|Other|1|||
23343257|NCT02703272|64999871|FG001|Overall Study|Other|0|||
23343258|NCT02703272|64999872|FG002|Overall Study|Other|0|||
23343259|NCT02703272|64999873|FG003|Overall Study|Other|0|||
23343260|NCT04852276|64999876|FG000|Overall Study|Death|2|||
23343261|NCT04852276|64999877|FG001|Overall Study|Death|0|||
23343262|NCT04852276|64999876|FG000|Overall Study|Lost to Follow-up|15|||
23343263|NCT04852276|64999877|FG001|Overall Study|Lost to Follow-up|9|||
23343264|NCT04852276|64999876|FG000|Overall Study|Withdrawal by Subject|26|||
23343265|NCT04852276|64999877|FG001|Overall Study|Withdrawal by Subject|6|||
23343266|NCT04216589|64999878|FG000|Overall Study|Withdrawal by Subject|2|||
23343267|NCT04216589|64999878|FG000|Overall Study|Protocol Violation|1|||
23343268|NCT04216589|64999878|FG000|Overall Study|Incarceration|1|||
23343269|NCT01966068|64999879|FG000|Overall Study|Withdrawal by Subject|57|||
23343270|NCT01966068|64999879|FG000|Overall Study|Lost to Follow-up|81|||
23343271|NCT02883049|64999881|FG000|Induction|Adverse Event|52|||
23343272|NCT02883049|64999882|FG001|Induction|Adverse Event|2|||
23343273|NCT02883049|64999883|FG002|Induction|Adverse Event|0|||
23343274|NCT02883049|64999884|FG003|Induction|Adverse Event|0|||
23343275|NCT02883049|64999885|FG004|Induction|Adverse Event|0|||
23343276|NCT02883049|64999886|FG005|Induction|Adverse Event|0|||
23343277|NCT02883049|64999887|FG006|Induction|Adverse Event|0|||
23343278|NCT02883049|64999888|FG007|Induction|Adverse Event|0|||
23343279|NCT02883049|64999889|FG008|Induction|Adverse Event|0|||
23343280|NCT02883049|64999890|FG009|Induction|Adverse Event|0|||
23343281|NCT02883049|64999891|FG010|Induction|Adverse Event|0|||
23343282|NCT02883049|64999892|FG011|Induction|Adverse Event|0|||
23343283|NCT02883049|64999893|FG012|Induction|Adverse Event|0|||
23343284|NCT02883049|64999894|FG013|Induction|Adverse Event|0|||
23343285|NCT02883049|64999895|FG014|Induction|Adverse Event|0|||
23343286|NCT02883049|64999896|FG015|Induction|Adverse Event|0|||
23343287|NCT02883049|64999881|FG000|Induction|Death|76|||
23343288|NCT02883049|64999882|FG001|Induction|Death|8|||
23343289|NCT02883049|64999883|FG002|Induction|Death|0|||
23343290|NCT02883049|64999884|FG003|Induction|Death|0|||
23343291|NCT02883049|64999885|FG004|Induction|Death|0|||
23343292|NCT02883049|64999886|FG005|Induction|Death|0|||
23343293|NCT02883049|64999887|FG006|Induction|Death|0|||
23343294|NCT02883049|64999888|FG007|Induction|Death|0|||
23343295|NCT02883049|64999889|FG008|Induction|Death|0|||
23343296|NCT02883049|64999890|FG009|Induction|Death|0|||
23343297|NCT02883049|64999891|FG010|Induction|Death|0|||
23343298|NCT02883049|64999892|FG011|Induction|Death|0|||
23343299|NCT02883049|64999893|FG012|Induction|Death|0|||
23343300|NCT02883049|64999894|FG013|Induction|Death|0|||
23343301|NCT02883049|64999895|FG014|Induction|Death|0|||
23343302|NCT02883049|64999896|FG015|Induction|Death|0|||
23343303|NCT02883049|64999881|FG000|Induction|Lost to Follow-up|2|||
23343304|NCT02883049|64999882|FG001|Induction|Lost to Follow-up|0|||
23343305|NCT02883049|64999883|FG002|Induction|Lost to Follow-up|0|||
23343306|NCT02883049|64999884|FG003|Induction|Lost to Follow-up|0|||
23343307|NCT02883049|64999885|FG004|Induction|Lost to Follow-up|0|||
23343308|NCT02883049|64999886|FG005|Induction|Lost to Follow-up|0|||
23343309|NCT02883049|64999887|FG006|Induction|Lost to Follow-up|0|||
23343310|NCT02883049|64999888|FG007|Induction|Lost to Follow-up|0|||
23343311|NCT02883049|64999889|FG008|Induction|Lost to Follow-up|0|||
23343312|NCT02883049|64999890|FG009|Induction|Lost to Follow-up|0|||
23343313|NCT02883049|64999891|FG010|Induction|Lost to Follow-up|0|||
23343314|NCT02883049|64999892|FG011|Induction|Lost to Follow-up|0|||
23343315|NCT02883049|64999893|FG012|Induction|Lost to Follow-up|0|||
23343316|NCT02883049|64999894|FG013|Induction|Lost to Follow-up|0|||
23343317|NCT02883049|64999895|FG014|Induction|Lost to Follow-up|0|||
23343318|NCT02883049|64999896|FG015|Induction|Lost to Follow-up|0|||
23343319|NCT02883049|64999881|FG000|Induction|Physician Decision|1407|||
23343320|NCT02883049|64999882|FG001|Induction|Physician Decision|8|||
23343321|NCT02883049|64999883|FG002|Induction|Physician Decision|0|||
23343322|NCT02883049|64999884|FG003|Induction|Physician Decision|0|||
23343323|NCT02883049|64999885|FG004|Induction|Physician Decision|0|||
23343324|NCT02883049|64999886|FG005|Induction|Physician Decision|0|||
23343325|NCT02883049|64999887|FG006|Induction|Physician Decision|0|||
23343326|NCT02883049|64999888|FG007|Induction|Physician Decision|0|||
23343327|NCT02883049|64999889|FG008|Induction|Physician Decision|0|||
23343328|NCT02883049|64999890|FG009|Induction|Physician Decision|0|||
23343329|NCT02883049|64999891|FG010|Induction|Physician Decision|0|||
23582629|NCT00723294|65862521|FG000|Overall Study|Did not undergo surgery|1|||
23582630|NCT00723294|65862521|FG000|Overall Study|Treated prior to registration|1|||
23343330|NCT02883049|64999892|FG011|Induction|Physician Decision|0|||
23343331|NCT02883049|64999893|FG012|Induction|Physician Decision|0|||
23582631|NCT00723294|65862521|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
23582632|NCT00723294|65862521|FG000|Overall Study|Benign lesion|1|||
23343332|NCT02883049|64999894|FG013|Induction|Physician Decision|0|||
23343333|NCT02883049|64999895|FG014|Induction|Physician Decision|0|||
23343334|NCT02883049|64999896|FG015|Induction|Physician Decision|0|||
23343335|NCT02883049|64999881|FG000|Induction|Protocol Violation|6|||
23343336|NCT02883049|64999882|FG001|Induction|Protocol Violation|0|||
23343337|NCT02883049|64999883|FG002|Induction|Protocol Violation|0|||
23343338|NCT02883049|64999884|FG003|Induction|Protocol Violation|0|||
23343339|NCT02883049|64999885|FG004|Induction|Protocol Violation|0|||
23343340|NCT02883049|64999886|FG005|Induction|Protocol Violation|0|||
23343341|NCT02883049|64999887|FG006|Induction|Protocol Violation|0|||
23343342|NCT02883049|64999888|FG007|Induction|Protocol Violation|0|||
23343343|NCT02883049|64999889|FG008|Induction|Protocol Violation|0|||
23343344|NCT02883049|64999890|FG009|Induction|Protocol Violation|0|||
23343345|NCT02883049|64999891|FG010|Induction|Protocol Violation|0|||
23343346|NCT02883049|64999892|FG011|Induction|Protocol Violation|0|||
23343347|NCT02883049|64999893|FG012|Induction|Protocol Violation|0|||
23343348|NCT02883049|64999894|FG013|Induction|Protocol Violation|0|||
23343349|NCT02883049|64999895|FG014|Induction|Protocol Violation|0|||
23343350|NCT02883049|64999896|FG015|Induction|Protocol Violation|0|||
23343351|NCT02883049|64999881|FG000|Induction|Withdrawal by Subject|6|||
23343352|NCT02883049|64999882|FG001|Induction|Withdrawal by Subject|0|||
23343353|NCT02883049|64999883|FG002|Induction|Withdrawal by Subject|0|||
23343354|NCT02883049|64999884|FG003|Induction|Withdrawal by Subject|0|||
23343355|NCT02883049|64999885|FG004|Induction|Withdrawal by Subject|0|||
23343356|NCT02883049|64999886|FG005|Induction|Withdrawal by Subject|0|||
23343357|NCT02883049|64999887|FG006|Induction|Withdrawal by Subject|0|||
23343358|NCT02883049|64999888|FG007|Induction|Withdrawal by Subject|0|||
23343359|NCT02883049|64999889|FG008|Induction|Withdrawal by Subject|0|||
23343360|NCT02883049|64999890|FG009|Induction|Withdrawal by Subject|0|||
23343361|NCT02883049|64999891|FG010|Induction|Withdrawal by Subject|0|||
23343362|NCT02883049|64999892|FG011|Induction|Withdrawal by Subject|0|||
23343363|NCT02883049|64999893|FG012|Induction|Withdrawal by Subject|0|||
23343364|NCT02883049|64999894|FG013|Induction|Withdrawal by Subject|0|||
23343365|NCT02883049|64999895|FG014|Induction|Withdrawal by Subject|0|||
23343366|NCT02883049|64999896|FG015|Induction|Withdrawal by Subject|0|||
23343367|NCT02883049|64999881|FG000|Induction|Ineligible|35|||
23343368|NCT02883049|64999882|FG001|Induction|Ineligible|1|||
23343369|NCT02883049|64999883|FG002|Induction|Ineligible|0|||
23343370|NCT02883049|64999884|FG003|Induction|Ineligible|0|||
23343371|NCT02883049|64999885|FG004|Induction|Ineligible|0|||
23343372|NCT02883049|64999886|FG005|Induction|Ineligible|0|||
23343373|NCT02883049|64999887|FG006|Induction|Ineligible|0|||
23343374|NCT02883049|64999888|FG007|Induction|Ineligible|0|||
23343375|NCT02883049|64999889|FG008|Induction|Ineligible|0|||
23343376|NCT02883049|64999890|FG009|Induction|Ineligible|0|||
23343377|NCT02883049|64999891|FG010|Induction|Ineligible|0|||
23343378|NCT02883049|64999892|FG011|Induction|Ineligible|0|||
23343379|NCT02883049|64999893|FG012|Induction|Ineligible|0|||
23343380|NCT02883049|64999894|FG013|Induction|Ineligible|0|||
23343381|NCT02883049|64999895|FG014|Induction|Ineligible|0|||
23343382|NCT02883049|64999896|FG015|Induction|Ineligible|0|||
23343383|NCT02883049|64999881|FG000|Induction|Refusal of further protocol therapy|466|||
23343384|NCT02883049|64999882|FG001|Induction|Refusal of further protocol therapy|2|||
23343385|NCT02883049|64999883|FG002|Induction|Refusal of further protocol therapy|0|||
23343386|NCT02883049|64999884|FG003|Induction|Refusal of further protocol therapy|0|||
23343387|NCT02883049|64999885|FG004|Induction|Refusal of further protocol therapy|0|||
23343388|NCT02883049|64999886|FG005|Induction|Refusal of further protocol therapy|0|||
23343389|NCT02883049|64999887|FG006|Induction|Refusal of further protocol therapy|0|||
23343390|NCT02883049|64999888|FG007|Induction|Refusal of further protocol therapy|0|||
23343391|NCT02883049|64999889|FG008|Induction|Refusal of further protocol therapy|0|||
23343392|NCT02883049|64999890|FG009|Induction|Refusal of further protocol therapy|0|||
23343393|NCT02883049|64999891|FG010|Induction|Refusal of further protocol therapy|0|||
23454777|NCT03001557|65407241|FG005|Extension Phase|Withdrawal by Subject|1|||
23454778|NCT03001557|65407242|FG006|Extension Phase|Withdrawal by Subject|5|||
23454779|NCT03001557|65407243|FG007|Extension Phase|Withdrawal by Subject|2|||
23454780|NCT03001557|65407236|FG000|Extension Phase|Lost to Follow-up|0|||
23454781|NCT03001557|65407237|FG001|Extension Phase|Lost to Follow-up|0|||
23454782|NCT03001557|65407238|FG002|Extension Phase|Lost to Follow-up|0|||
23454783|NCT03001557|65407239|FG003|Extension Phase|Lost to Follow-up|0|||
23454784|NCT03001557|65407240|FG004|Extension Phase|Lost to Follow-up|0|||
23454785|NCT03001557|65407241|FG005|Extension Phase|Lost to Follow-up|0|||
23454786|NCT03001557|65407242|FG006|Extension Phase|Lost to Follow-up|2|||
23454787|NCT03001557|65407243|FG007|Extension Phase|Lost to Follow-up|1|||
23454788|NCT03001557|65407236|FG000|Extension Phase|Administrative Reason|0|||
23454789|NCT03001557|65407237|FG001|Extension Phase|Administrative Reason|0|||
23454790|NCT03001557|65407238|FG002|Extension Phase|Administrative Reason|0|||
23454791|NCT03001557|65407239|FG003|Extension Phase|Administrative Reason|0|||
23454792|NCT03001557|65407240|FG004|Extension Phase|Administrative Reason|0|||
23343394|NCT02883049|64999892|FG011|Induction|Refusal of further protocol therapy|0|||
23343395|NCT02883049|64999893|FG012|Induction|Refusal of further protocol therapy|0|||
23343396|NCT02883049|64999894|FG013|Induction|Refusal of further protocol therapy|0|||
23343397|NCT02883049|64999895|FG014|Induction|Refusal of further protocol therapy|0|||
23343398|NCT02883049|64999896|FG015|Induction|Refusal of further protocol therapy|0|||
23343399|NCT02883049|64999881|FG000|Induction|Identified as Ph+ patients|279|||
23343400|NCT02883049|64999882|FG001|Induction|Identified as Ph+ patients|1|||
23343401|NCT02883049|64999883|FG002|Induction|Identified as Ph+ patients|0|||
23343402|NCT02883049|64999884|FG003|Induction|Identified as Ph+ patients|0|||
23343403|NCT02883049|64999885|FG004|Induction|Identified as Ph+ patients|0|||
23343404|NCT02883049|64999886|FG005|Induction|Identified as Ph+ patients|0|||
23343405|NCT02883049|64999887|FG006|Induction|Identified as Ph+ patients|0|||
23454793|NCT03001557|65407241|FG005|Extension Phase|Administrative Reason|1|||
23454794|NCT03001557|65407242|FG006|Extension Phase|Administrative Reason|3|||
23454795|NCT03001557|65407243|FG007|Extension Phase|Administrative Reason|3|||
23343406|NCT02883049|64999888|FG007|Induction|Identified as Ph+ patients|0|||
23343407|NCT02883049|64999889|FG008|Induction|Identified as Ph+ patients|0|||
23343408|NCT02883049|64999890|FG009|Induction|Identified as Ph+ patients|0|||
23343409|NCT02883049|64999891|FG010|Induction|Identified as Ph+ patients|0|||
23343410|NCT02883049|64999892|FG011|Induction|Identified as Ph+ patients|0|||
23343411|NCT02883049|64999893|FG012|Induction|Identified as Ph+ patients|0|||
23343412|NCT02883049|64999894|FG013|Induction|Identified as Ph+ patients|0|||
23343413|NCT02883049|64999895|FG014|Induction|Identified as Ph+ patients|0|||
23343414|NCT02883049|64999896|FG015|Induction|Identified as Ph+ patients|0|||
23343415|NCT02883049|64999881|FG000|Induction|M3 Marrow at Day29|8|||
23343416|NCT02883049|64999882|FG001|Induction|M3 Marrow at Day29|1|||
23343417|NCT02883049|64999883|FG002|Induction|M3 Marrow at Day29|0|||
23343418|NCT02883049|64999884|FG003|Induction|M3 Marrow at Day29|0|||
23343419|NCT02883049|64999885|FG004|Induction|M3 Marrow at Day29|0|||
23343420|NCT02883049|64999886|FG005|Induction|M3 Marrow at Day29|0|||
23343421|NCT02883049|64999887|FG006|Induction|M3 Marrow at Day29|0|||
23343422|NCT02883049|64999888|FG007|Induction|M3 Marrow at Day29|0|||
23343423|NCT02883049|64999889|FG008|Induction|M3 Marrow at Day29|0|||
23343424|NCT02883049|64999890|FG009|Induction|M3 Marrow at Day29|0|||
23343425|NCT02883049|64999891|FG010|Induction|M3 Marrow at Day29|0|||
23343426|NCT02883049|64999892|FG011|Induction|M3 Marrow at Day29|0|||
23343427|NCT02883049|64999893|FG012|Induction|M3 Marrow at Day29|0|||
23343428|NCT02883049|64999894|FG013|Induction|M3 Marrow at Day29|0|||
23343429|NCT02883049|64999895|FG014|Induction|M3 Marrow at Day29|0|||
23343430|NCT02883049|64999896|FG015|Induction|M3 Marrow at Day29|0|||
23343431|NCT02883049|64999881|FG000|Induction|Inevaluable|33|||
23343432|NCT02883049|64999882|FG001|Induction|Inevaluable|1|||
23343433|NCT02883049|64999883|FG002|Induction|Inevaluable|0|||
23454796|NCT03001557|65407236|FG000|Extension Phase|Loss of caregiver|0|||
23237521|NCT01265719|64611549|FG000|Overall Study|Withdrawal by Subject|8|||
23237522|NCT01265719|64611550|FG001|Overall Study|Withdrawal by Subject|3|||
23237523|NCT01265719|64611549|FG000|Overall Study|Lost to Follow-up|2|||
23237524|NCT01265719|64611550|FG001|Overall Study|Lost to Follow-up|7|||
23237525|NCT01265719|64611549|FG000|Overall Study|Adverse Event|2|||
23237526|NCT01265719|64611550|FG001|Overall Study|Adverse Event|0|||
23343434|NCT02883049|64999884|FG003|Induction|Inevaluable|0|||
23343435|NCT02883049|64999885|FG004|Induction|Inevaluable|0|||
23343436|NCT02883049|64999886|FG005|Induction|Inevaluable|0|||
23343437|NCT02883049|64999887|FG006|Induction|Inevaluable|0|||
23343438|NCT02883049|64999888|FG007|Induction|Inevaluable|0|||
23343439|NCT02883049|64999889|FG008|Induction|Inevaluable|0|||
23177211|NCT01109940|64390416|FG000|Overall Study|Serious Adverse Event|2|||
23177212|NCT01109940|64390417|FG001|Overall Study|Serious Adverse Event|1|||
23177213|NCT01109940|64390418|FG002|Overall Study|Serious Adverse Event|0|||
23177214|NCT01109940|64390419|FG003|Overall Study|Serious Adverse Event|0|||
23177215|NCT01109940|64390416|FG000|Overall Study|Lost to Follow-up|1|||
23177216|NCT01109940|64390417|FG001|Overall Study|Lost to Follow-up|0|||
23177217|NCT01109940|64390418|FG002|Overall Study|Lost to Follow-up|0|||
23177218|NCT01109940|64390419|FG003|Overall Study|Lost to Follow-up|0|||
23177219|NCT01109940|64390416|FG000|Overall Study|Patient withdrew consent|1|||
23177220|NCT01109940|64390417|FG001|Overall Study|Patient withdrew consent|1|||
23177221|NCT01109940|64390418|FG002|Overall Study|Patient withdrew consent|0|||
23177222|NCT01109940|64390419|FG003|Overall Study|Patient withdrew consent|0|||
23177223|NCT01109940|64390416|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23177224|NCT01109940|64390417|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23177225|NCT01109940|64390418|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
23177226|NCT01109940|64390419|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23177227|NCT00542997|64390420|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
23177228|NCT00542997|64390420|FG000|Wash in / Wash Out Period|Adverse Event|3|||
23177229|NCT00542997|64390420|FG000|Efficacy Period|Adverse Event|3|||
23177230|NCT03118947|64390421|FG000|Overall Study|Adverse Event|7|||
23177231|NCT03118947|64390421|FG000|Overall Study|Death|3|||
23177232|NCT03118947|64390421|FG000|Overall Study|Lack of Efficacy|4|||
23177233|NCT03118947|64390421|FG000|Overall Study|Non-compliance with study drug|1|||
23177234|NCT03118947|64390421|FG000|Overall Study|Protocol Violation|2|||
23177235|NCT03118947|64390421|FG000|Overall Study|Withdrawal by Subject|3|||
23177236|NCT03118947|64390421|FG000|Overall Study|Withdrawal by caregiver|3|||
23177237|NCT03118947|64390421|FG000|Overall Study|Change in patient's living situation|4|||
23177238|NCT03118947|64390421|FG000|Overall Study|Lost to Follow-up|2|||
23177239|NCT02149810|64390427|FG000|Overall Study|Physician Decision|1|||
23177240|NCT02149810|64390428|FG001|Overall Study|Physician Decision|2|||
23177241|NCT02149810|64390427|FG000|Overall Study|Lost to Follow-up|2|||
23177242|NCT02149810|64390428|FG001|Overall Study|Lost to Follow-up|1|||
23177243|NCT02149810|64390427|FG000|Overall Study|Withdrawal by Subject|5|||
23177244|NCT02149810|64390428|FG001|Overall Study|Withdrawal by Subject|1|||
23177245|NCT01284114|64390429|FG000|Overall Study|viral infection|1|||
23177246|NCT01284114|64390429|FG000|Overall Study|From the results of ALLTITUDE study|1|||
23177247|NCT01284114|64390429|FG000|Overall Study|Symptomatic hypotension|1|||
23343440|NCT02883049|64999890|FG009|Induction|Inevaluable|0|||
23343441|NCT02883049|64999891|FG010|Induction|Inevaluable|0|||
23343442|NCT02883049|64999892|FG011|Induction|Inevaluable|0|||
23343443|NCT02883049|64999893|FG012|Induction|Inevaluable|0|||
23343444|NCT02883049|64999894|FG013|Induction|Inevaluable|0|||
23343445|NCT02883049|64999895|FG014|Induction|Inevaluable|0|||
23343446|NCT02883049|64999896|FG015|Induction|Inevaluable|0|||
23343447|NCT02883049|64999881|FG000|Induction|Identified as VHR at end of Induction|244|||
23343448|NCT02883049|64999882|FG001|Induction|Identified as VHR at end of Induction|0|||
23343449|NCT02883049|64999883|FG002|Induction|Identified as VHR at end of Induction|0|||
23343450|NCT02883049|64999884|FG003|Induction|Identified as VHR at end of Induction|0|||
23343451|NCT02883049|64999885|FG004|Induction|Identified as VHR at end of Induction|0|||
23343452|NCT02883049|64999886|FG005|Induction|Identified as VHR at end of Induction|0|||
23343453|NCT02883049|64999887|FG006|Induction|Identified as VHR at end of Induction|0|||
23343454|NCT02883049|64999888|FG007|Induction|Identified as VHR at end of Induction|0|||
23343455|NCT02883049|64999889|FG008|Induction|Identified as VHR at end of Induction|0|||
23343456|NCT02883049|64999890|FG009|Induction|Identified as VHR at end of Induction|0|||
23343457|NCT02883049|64999891|FG010|Induction|Identified as VHR at end of Induction|0|||
23343458|NCT02883049|64999892|FG011|Induction|Identified as VHR at end of Induction|0|||
23343459|NCT02883049|64999893|FG012|Induction|Identified as VHR at end of Induction|0|||
23343460|NCT02883049|64999894|FG013|Induction|Identified as VHR at end of Induction|0|||
23343461|NCT02883049|64999895|FG014|Induction|Identified as VHR at end of Induction|0|||
23343462|NCT02883049|64999896|FG015|Induction|Identified as VHR at end of Induction|0|||
23343463|NCT02883049|64999881|FG000|Induction|Moved to another non-COG institution|3|||
23343464|NCT02883049|64999882|FG001|Induction|Moved to another non-COG institution|0|||
23343465|NCT02883049|64999883|FG002|Induction|Moved to another non-COG institution|0|||
23343466|NCT02883049|64999884|FG003|Induction|Moved to another non-COG institution|0|||
23343467|NCT02883049|64999885|FG004|Induction|Moved to another non-COG institution|0|||
23343468|NCT02883049|64999886|FG005|Induction|Moved to another non-COG institution|0|||
23343469|NCT02883049|64999887|FG006|Induction|Moved to another non-COG institution|0|||
23343470|NCT02883049|64999888|FG007|Induction|Moved to another non-COG institution|0|||
23343471|NCT02883049|64999889|FG008|Induction|Moved to another non-COG institution|0|||
23343472|NCT02883049|64999890|FG009|Induction|Moved to another non-COG institution|0|||
23343473|NCT02883049|64999891|FG010|Induction|Moved to another non-COG institution|0|||
23343474|NCT02883049|64999892|FG011|Induction|Moved to another non-COG institution|0|||
23343475|NCT02883049|64999893|FG012|Induction|Moved to another non-COG institution|0|||
23343476|NCT02883049|64999894|FG013|Induction|Moved to another non-COG institution|0|||
23343477|NCT02883049|64999895|FG014|Induction|Moved to another non-COG institution|0|||
23343478|NCT02883049|64999896|FG015|Induction|Moved to another non-COG institution|0|||
23343479|NCT02883049|64999881|FG000|Induction|Randomization closed|41|||
23343480|NCT02883049|64999882|FG001|Induction|Randomization closed|0|||
23343481|NCT02883049|64999883|FG002|Induction|Randomization closed|0|||
23343482|NCT02883049|64999884|FG003|Induction|Randomization closed|0|||
23343483|NCT02883049|64999885|FG004|Induction|Randomization closed|0|||
23343484|NCT02883049|64999886|FG005|Induction|Randomization closed|0|||
23343485|NCT02883049|64999887|FG006|Induction|Randomization closed|0|||
23343486|NCT02883049|64999888|FG007|Induction|Randomization closed|0|||
23343487|NCT02883049|64999889|FG008|Induction|Randomization closed|0|||
23343488|NCT02883049|64999890|FG009|Induction|Randomization closed|0|||
23343489|NCT02883049|64999891|FG010|Induction|Randomization closed|0|||
23177248|NCT01284114|64390429|FG000|Overall Study|dizziness|1|||
23177249|NCT04178772|64390432|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
23177250|NCT04178772|64390432|FG000|Overall Study|study terminated early due to COVID-19|7|||
23177251|NCT00984204|64390433|FG000|Overall Study|Death|1|||
23177252|NCT00984204|64390433|FG000|Overall Study|Lost to Follow-up|4|||
23177253|NCT00984204|64390433|FG000|Overall Study|Lack of Efficacy|10|||
23177254|NCT00996203|64390436|FG000|Overall Study|Adverse Event|3|||
23177255|NCT00996203|64390436|FG000|Overall Study|Lost to Follow-up|1|||
23177256|NCT00996203|64390436|FG000|Overall Study|Lack of Efficacy|1|||
23177257|NCT00996203|64390436|FG000|Overall Study|Protocol Violation|2|||
23177258|NCT01925209|64390439|FG000|Treatment Epoch|Physician Decision|1|||
23177259|NCT01925209|64390440|FG001|Treatment Epoch|Physician Decision|0|||
23177260|NCT01925209|64390441|FG002|Treatment Epoch|Physician Decision|0|||
23177261|NCT01925209|64390442|FG003|Treatment Epoch|Physician Decision|0|||
23343490|NCT02883049|64999892|FG011|Induction|Randomization closed|0|||
23343491|NCT02883049|64999893|FG012|Induction|Randomization closed|0|||
23343492|NCT02883049|64999894|FG013|Induction|Randomization closed|0|||
23177262|NCT01925209|64390439|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
23177263|NCT01925209|64390440|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
23177264|NCT01925209|64390441|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
23177265|NCT01925209|64390442|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
23343493|NCT02883049|64999895|FG014|Induction|Randomization closed|0|||
23343494|NCT02883049|64999896|FG015|Induction|Randomization closed|0|||
23343495|NCT02883049|64999881|FG000|Induction|MRD negative|36|||
23343496|NCT02883049|64999882|FG001|Induction|MRD negative|0|||
23237527|NCT00310440|64611551|FG000|Overall Study|Lost to Follow-up|17|||
23237528|NCT00310440|64611552|FG001|Overall Study|Lost to Follow-up|8|||
23237529|NCT00310440|64611551|FG000|Overall Study|Withdrawal by Subject|2|||
23454797|NCT03001557|65407237|FG001|Extension Phase|Loss of caregiver|0|||
23454798|NCT03001557|65407238|FG002|Extension Phase|Loss of caregiver|0|||
23454799|NCT03001557|65407239|FG003|Extension Phase|Loss of caregiver|0|||
23454800|NCT03001557|65407240|FG004|Extension Phase|Loss of caregiver|0|||
23237530|NCT00310440|64611552|FG001|Overall Study|Withdrawal by Subject|1|||
23237531|NCT00310440|64611551|FG000|Overall Study|Missed 12 Month Visit|7|||
23237532|NCT00310440|64611552|FG001|Overall Study|Missed 12 Month Visit|4|||
23237533|NCT00960869|64611561|FG000|Overall Study|Adverse Event|17|||
23237534|NCT00960869|64611562|FG001|Overall Study|Adverse Event|26|||
23237535|NCT00960869|64611561|FG000|Overall Study|Withdrawal by Subject|16|||
23237536|NCT00960869|64611562|FG001|Overall Study|Withdrawal by Subject|14|||
23237537|NCT00960869|64611561|FG000|Overall Study|Lost to Follow-up|1|||
23237538|NCT00960869|64611562|FG001|Overall Study|Lost to Follow-up|4|||
23343497|NCT02883049|64999883|FG002|Induction|MRD negative|0|||
23343498|NCT02883049|64999884|FG003|Induction|MRD negative|0|||
23343499|NCT02883049|64999885|FG004|Induction|MRD negative|0|||
23343500|NCT02883049|64999886|FG005|Induction|MRD negative|0|||
23343501|NCT02883049|64999887|FG006|Induction|MRD negative|0|||
23454801|NCT03001557|65407241|FG005|Extension Phase|Loss of caregiver|0|||
23343502|NCT02883049|64999888|FG007|Induction|MRD negative|0|||
23343503|NCT02883049|64999889|FG008|Induction|MRD negative|0|||
23343504|NCT02883049|64999890|FG009|Induction|MRD negative|0|||
23343505|NCT02883049|64999891|FG010|Induction|MRD negative|0|||
23343506|NCT02883049|64999892|FG011|Induction|MRD negative|0|||
23343507|NCT02883049|64999893|FG012|Induction|MRD negative|0|||
23343508|NCT02883049|64999894|FG013|Induction|MRD negative|0|||
23343509|NCT02883049|64999895|FG014|Induction|MRD negative|0|||
23343510|NCT02883049|64999896|FG015|Induction|MRD negative|0|||
23343511|NCT02883049|64999881|FG000|Induction|Identified as HR patients|165|||
23343512|NCT02883049|64999882|FG001|Induction|Identified as HR patients|0|||
23454802|NCT03001557|65407242|FG006|Extension Phase|Loss of caregiver|1|||
23454803|NCT03001557|65407243|FG007|Extension Phase|Loss of caregiver|0|||
23454804|NCT03001557|65407236|FG000|Extension Phase|Others|0|||
23454805|NCT03001557|65407237|FG001|Extension Phase|Others|0|||
23454806|NCT03001557|65407238|FG002|Extension Phase|Others|0|||
23454807|NCT03001557|65407239|FG003|Extension Phase|Others|0|||
23454808|NCT03001557|65407240|FG004|Extension Phase|Others|0|||
23454809|NCT03001557|65407241|FG005|Extension Phase|Others|1|||
23454810|NCT03001557|65407242|FG006|Extension Phase|Others|3|||
23454811|NCT03001557|65407243|FG007|Extension Phase|Others|0|||
23454812|NCT03905096|65407244|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
23454813|NCT03905096|65407245|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
23454814|NCT03452540|65407248|FG000|Overall Study|Adverse Event|1|||
23454815|NCT03452540|65407248|FG000|Overall Study|Withdrawal by Subject|1|||
23454816|NCT03452540|65407248|FG000|Overall Study|Other SAE and AE|2|||
23454817|NCT02782676|65407249|FG000|Overall Study|Lost to Follow-up|0|||
23454818|NCT02782676|65407250|FG001|Overall Study|Lost to Follow-up|1|||
23454819|NCT03305666|65407251|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
23454820|NCT03305666|65407252|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
23454821|NCT01808196|65407255|FG000|Overall Study|Lost to Follow-up|1|||
23454822|NCT01350999|65407257|FG000|Overall Study|Adverse Event|4|||
23454823|NCT01350999|65407258|FG001|Overall Study|Adverse Event|9|||
23454824|NCT01350999|65407259|FG002|Overall Study|Adverse Event|10|||
23454825|NCT01350999|65407257|FG000|Overall Study|Voluntary withdrawal|3|||
23454826|NCT01350999|65407258|FG001|Overall Study|Voluntary withdrawal|4|||
23237539|NCT00960869|64611561|FG000|Overall Study|Misc|19|||
23343513|NCT02883049|64999883|FG002|Induction|Identified as HR patients|0|||
23343514|NCT02883049|64999884|FG003|Induction|Identified as HR patients|0|||
23343515|NCT02883049|64999885|FG004|Induction|Identified as HR patients|0|||
23343516|NCT02883049|64999886|FG005|Induction|Identified as HR patients|0|||
23454827|NCT01350999|65407259|FG002|Overall Study|Voluntary withdrawal|6|||
23343517|NCT02883049|64999887|FG006|Induction|Identified as HR patients|0|||
23454828|NCT01350999|65407257|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
23454829|NCT01350999|65407258|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
23454830|NCT01350999|65407259|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
23454831|NCT04924062|65407266|FG000|Overall Study|Death|49|||
23454832|NCT04924062|65407267|FG001|Overall Study|Death|63|||
23454833|NCT04924062|65407266|FG000|Overall Study|Participant On-going|26|||
23454834|NCT04924062|65407267|FG001|Overall Study|Participant On-going|20|||
23454835|NCT00481832|65407268|FG000|Enrollment|Physician Decision|8|||
23454836|NCT00481832|65407268|FG000|Enrollment|Unable to collect enough stem cells|2|||
23237540|NCT00960869|64611562|FG001|Overall Study|Misc|18|||
23454837|NCT00481832|65407268|FG000|Inter-transplant Period|Adverse Event|4|||
23454838|NCT00481832|65407268|FG000|Inter-transplant Period|Death|3|||
23454839|NCT00481832|65407268|FG000|Inter-transplant Period|Physician Decision|4|||
23454840|NCT00481832|65407268|FG000|Inter-transplant Period|Disease relapse|11|||
23454841|NCT00481832|65407268|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
23454842|NCT03041038|65407277|FG000|Overall Study|Withdrawal by Subject|4|||
23454843|NCT03041038|65407278|FG001|Overall Study|Withdrawal by Subject|0|||
23454844|NCT03041038|65407277|FG000|Overall Study|Lost to Follow-up|1|||
23454845|NCT03041038|65407278|FG001|Overall Study|Lost to Follow-up|1|||
23454846|NCT03041038|65407277|FG000|Overall Study|Protocol Violation|1|||
23454847|NCT03041038|65407278|FG001|Overall Study|Protocol Violation|1|||
23454848|NCT02285855|65407279|FG000|Overall Study|Withdrawal by Subject|2|||
23454849|NCT02285855|65407280|FG001|Overall Study|Withdrawal by Subject|1|||
23454850|NCT00447226|65407281|FG000|12-Week Open-label Phase|Adverse Event|0|||
23454851|NCT00447226|65407282|FG001|12-Week Open-label Phase|Adverse Event|3|||
23454852|NCT00447226|65407281|FG000|12-Week Open-label Phase|Protocol Violation|0|||
23454853|NCT00447226|65407282|FG001|12-Week Open-label Phase|Protocol Violation|1|||
23454854|NCT00447226|65407281|FG000|12-Week Open-label Phase|Disease Progression|0|||
23454855|NCT00447226|65407282|FG001|12-Week Open-label Phase|Disease Progression|20|||
23454856|NCT00447226|65407281|FG000|12-Week Open-label Phase|Physician Decision|0|||
23454857|NCT00447226|65407282|FG001|12-Week Open-label Phase|Physician Decision|1|||
23454858|NCT00447226|65407281|FG000|Double-blind Phase|Disease Progression|4|||
23454859|NCT00447226|65407282|FG001|Double-blind Phase|Disease Progression|3|||
23454860|NCT00981149|65407284|FG000|Overall Study|Lost to Follow-up|1|||
23454861|NCT00981149|65407285|FG001|Overall Study|Lost to Follow-up|2|||
23454862|NCT00981149|65407284|FG000|Overall Study|Withdrawal by Subject|1|||
23454863|NCT00981149|65407285|FG001|Overall Study|Withdrawal by Subject|1|||
23454864|NCT04725188|65407286|FG000|Overall Study|Death|44|||
23454865|NCT04725188|65407287|FG001|Overall Study|Death|46|||
23454866|NCT04725188|65407288|FG002|Overall Study|Death|48|||
23454867|NCT04725188|65407286|FG000|Overall Study|Lost to Follow-up|0|||
23454868|NCT04725188|65407287|FG001|Overall Study|Lost to Follow-up|0|||
23454869|NCT04725188|65407288|FG002|Overall Study|Lost to Follow-up|1|||
23454870|NCT04725188|65407286|FG000|Overall Study|Withdrawal by Subject|2|||
23454871|NCT04725188|65407287|FG001|Overall Study|Withdrawal by Subject|2|||
23454872|NCT04725188|65407288|FG002|Overall Study|Withdrawal by Subject|1|||
23454873|NCT04725188|65407286|FG000|Overall Study|Participants ongoing in the study|41|||
23454874|NCT04725188|65407287|FG001|Overall Study|Participants ongoing in the study|35|||
23454875|NCT04725188|65407288|FG002|Overall Study|Participants ongoing in the study|35|||
23454876|NCT01381016|65407289|FG000|Overall Study|Lost to Follow-up|1|||
23454877|NCT01381016|65407290|FG001|Overall Study|Lost to Follow-up|1|||
23454878|NCT01381016|65407289|FG000|Overall Study|Screen Failure|2|||
23454879|NCT01381016|65407290|FG001|Overall Study|Screen Failure|2|||
23454880|NCT01381016|65407289|FG000|Overall Study|Withdrawal by Subject|0|||
23177266|NCT01925209|64390439|FG000|Treatment Epoch|Death|1|||
23177267|NCT01925209|64390440|FG001|Treatment Epoch|Death|0|||
23177268|NCT01925209|64390441|FG002|Treatment Epoch|Death|0|||
23177269|NCT01925209|64390442|FG003|Treatment Epoch|Death|0|||
23177270|NCT01925209|64390439|FG000|Treatment Epoch|Protocol deviation|0|||
23177271|NCT01925209|64390440|FG001|Treatment Epoch|Protocol deviation|0|||
23177272|NCT01925209|64390441|FG002|Treatment Epoch|Protocol deviation|1|||
23177273|NCT01925209|64390442|FG003|Treatment Epoch|Protocol deviation|1|||
23177274|NCT01925209|64390439|FG000|Treatment Epoch|Withdrawal by Subject|4|||
23177275|NCT01925209|64390440|FG001|Treatment Epoch|Withdrawal by Subject|3|||
23177276|NCT01925209|64390441|FG002|Treatment Epoch|Withdrawal by Subject|3|||
23177277|NCT01925209|64390442|FG003|Treatment Epoch|Withdrawal by Subject|2|||
23454881|NCT01381016|65407290|FG001|Overall Study|Withdrawal by Subject|1|||
23454882|NCT01381016|65407289|FG000|Overall Study|Physician Decision|0|||
23454883|NCT01381016|65407290|FG001|Overall Study|Physician Decision|2|||
23454884|NCT04426318|65407293|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
23454885|NCT04426318|65407294|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
23454886|NCT01844765|65407299|FG000|Overall Study|Adverse Event|6|||
23177278|NCT01925209|64390439|FG000|Treatment Epoch|Adverse Event|3|||
23237541|NCT02643420|64611563|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
23177279|NCT01925209|64390440|FG001|Treatment Epoch|Adverse Event|5|||
23454887|NCT01844765|65407300|FG001|Overall Study|Adverse Event|8|||
23454888|NCT01844765|65407299|FG000|Overall Study|Withdrawal by Subject|2|||
23454889|NCT01844765|65407300|FG001|Overall Study|Withdrawal by Subject|3|||
23454890|NCT01844765|65407299|FG000|Overall Study|Disease progression|1|||
23454891|NCT01844765|65407300|FG001|Overall Study|Disease progression|0|||
23454892|NCT01844765|65407299|FG000|Overall Study|Administrative problems|3|||
23582633|NCT00723294|65862521|FG000|Overall Study|Withdrawal by Subject|1|||
23582634|NCT00723294|65862521|FG000|Overall Study|No treatment due to probe failure|1|||
23582635|NCT01097655|65862522|FG000|Overall Study|Withdrawal by Subject|1|||
23582636|NCT01097655|65862522|FG000|Overall Study|Subject Documented Twice|1|||
23237542|NCT02643420|64611564|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
23237543|NCT02643420|64611563|FG000|Overall Study|Withdrawal by Subject|25|||
23237544|NCT02643420|64611564|FG001|Overall Study|Withdrawal by Subject|19|||
23237545|NCT02643420|64611563|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
23582637|NCT01097655|65862522|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
23582638|NCT00868231|65862523|FG000|Treatment Period 1|Adverse Event|0|||
23582639|NCT00868231|65862524|FG001|Treatment Period 1|Adverse Event|0|||
23582640|NCT00868231|65862525|FG002|Treatment Period 1|Adverse Event|0|||
23582641|NCT00868231|65862526|FG003|Treatment Period 1|Adverse Event|0|||
23582642|NCT00868231|65862527|FG004|Treatment Period 1|Adverse Event|1|||
23582643|NCT00868231|65862528|FG005|Treatment Period 1|Adverse Event|0|||
23582644|NCT00868231|65862523|FG000|Treatment Period 2|Adverse Event|1|||
23582645|NCT00868231|65862524|FG001|Treatment Period 2|Adverse Event|0|||
23582646|NCT00868231|65862525|FG002|Treatment Period 2|Adverse Event|0|||
23582647|NCT00868231|65862526|FG003|Treatment Period 2|Adverse Event|0|||
23582648|NCT00868231|65862527|FG004|Treatment Period 2|Adverse Event|0|||
23582649|NCT00868231|65862528|FG005|Treatment Period 2|Adverse Event|0|||
23582650|NCT00868231|65862523|FG000|Treatment Period 3|Adverse Event|0|||
23582651|NCT00868231|65862524|FG001|Treatment Period 3|Adverse Event|0|||
23582652|NCT00868231|65862525|FG002|Treatment Period 3|Adverse Event|1|||
23582653|NCT00868231|65862526|FG003|Treatment Period 3|Adverse Event|0|||
23582654|NCT00868231|65862527|FG004|Treatment Period 3|Adverse Event|0|||
23582655|NCT00868231|65862528|FG005|Treatment Period 3|Adverse Event|0|||
23582656|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
23582657|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
23582658|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
23582659|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
23582660|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
23582661|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
23582662|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
23582663|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
23582664|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
23582665|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
23582666|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
23582667|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
23582668|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
23582669|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23582670|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23582671|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23582672|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23582673|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
23582674|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582675|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582676|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582677|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582678|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
23582679|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
23582680|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582681|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582682|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582683|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582684|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23582685|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23582686|NCT01323660|65862530|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
23582687|NCT01323660|65862531|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23582688|NCT01323660|65862532|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23582689|NCT01323660|65862533|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23343518|NCT02883049|64999888|FG007|Induction|Identified as HR patients|0|||
23343519|NCT02883049|64999889|FG008|Induction|Identified as HR patients|0|||
23454893|NCT01844765|65407300|FG001|Overall Study|Administrative problems|4|||
23454894|NCT01844765|65407299|FG000|Overall Study|Protocol deviation|2|||
23454895|NCT01844765|65407300|FG001|Overall Study|Protocol deviation|0|||
23582690|NCT01323660|65862534|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
23582691|NCT01323660|65862535|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23454896|NCT01844765|65407299|FG000|Overall Study|Untreated|1|||
23454897|NCT01844765|65407300|FG001|Overall Study|Untreated|0|||
23454898|NCT01755234|65407303|FG000|Overall Study|Lost to Follow-up|11|||
23454899|NCT01755234|65407304|FG001|Overall Study|Lost to Follow-up|6|||
23454900|NCT01755234|65407303|FG000|Overall Study|Change in surgical case|2|||
23454901|NCT01755234|65407304|FG001|Overall Study|Change in surgical case|1|||
23454902|NCT01755234|65407303|FG000|Overall Study|case cancelled|1|||
23454903|NCT01755234|65407304|FG001|Overall Study|case cancelled|0|||
23454904|NCT01755234|65407303|FG000|Overall Study|Withdrawal by Subject|0|||
23177280|NCT01925209|64390441|FG002|Treatment Epoch|Adverse Event|3|||
23177281|NCT01925209|64390442|FG003|Treatment Epoch|Adverse Event|1|||
23177282|NCT01925209|64390439|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
23177283|NCT01925209|64390440|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
23177284|NCT01925209|64390441|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
23177285|NCT01925209|64390442|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
23177286|NCT01925209|64390439|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
23177287|NCT01925209|64390440|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
23177288|NCT01925209|64390441|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
23177289|NCT01925209|64390442|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
23454905|NCT01755234|65407304|FG001|Overall Study|Withdrawal by Subject|1|||
23237546|NCT02643420|64611564|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
23237547|NCT02643420|64611563|FG000|Overall Study|Lost to Follow-up|6|||
23237548|NCT02643420|64611564|FG001|Overall Study|Lost to Follow-up|10|||
23237549|NCT02643420|64611563|FG000|Overall Study|Investigator Decision|2|||
23454906|NCT01755234|65407303|FG000|Overall Study|unblinded|1|||
23237550|NCT02643420|64611564|FG001|Overall Study|Investigator Decision|4|||
23343520|NCT02883049|64999890|FG009|Induction|Identified as HR patients|0|||
23454907|NCT01755234|65407304|FG001|Overall Study|unblinded|0|||
23454908|NCT01611792|65407305|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
23454909|NCT01611792|65407306|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
23582692|NCT01323660|65862530|FG000|Washout Period (14 Days)|Adverse Event|0|||
23582693|NCT01323660|65862531|FG001|Washout Period (14 Days)|Adverse Event|0|||
23582694|NCT01323660|65862532|FG002|Washout Period (14 Days)|Adverse Event|0|||
23582695|NCT01323660|65862533|FG003|Washout Period (14 Days)|Adverse Event|0|||
23582696|NCT01323660|65862534|FG004|Washout Period (14 Days)|Adverse Event|1|||
23582697|NCT01323660|65862535|FG005|Washout Period (14 Days)|Adverse Event|0|||
23582698|NCT01323660|65862530|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
23582699|NCT01323660|65862531|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
23582700|NCT01323660|65862532|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
23582701|NCT01323660|65862533|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
23582702|NCT01323660|65862534|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
23582703|NCT01323660|65862535|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
23582704|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23582705|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23582706|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23582707|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23582708|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23582709|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
23582710|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
23582711|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
23582712|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
23177290|NCT01925209|64390439|FG000|Follow-up|Adverse Event|1|||
23177291|NCT01925209|64390440|FG001|Follow-up|Adverse Event|4|||
23177292|NCT01925209|64390441|FG002|Follow-up|Adverse Event|0|||
23177293|NCT01925209|64390442|FG003|Follow-up|Adverse Event|1|||
23177294|NCT01925209|64390439|FG000|Follow-up|Physician Decision|0|||
23177295|NCT01925209|64390440|FG001|Follow-up|Physician Decision|0|||
23177296|NCT01925209|64390441|FG002|Follow-up|Physician Decision|1|||
23177297|NCT01925209|64390442|FG003|Follow-up|Physician Decision|0|||
23177298|NCT01925209|64390439|FG000|Follow-up|Non-compliance with study treatment|0|||
23177299|NCT01925209|64390440|FG001|Follow-up|Non-compliance with study treatment|0|||
23237551|NCT02643420|64611563|FG000|Overall Study|Sponsor decision|1|||
23237552|NCT02643420|64611564|FG001|Overall Study|Sponsor decision|1|||
23454910|NCT01611792|65407305|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
23454911|NCT01611792|65407306|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
23582713|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
23582714|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
23582715|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
23582716|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23177300|NCT01925209|64390441|FG002|Follow-up|Non-compliance with study treatment|0|||
23177301|NCT01925209|64390442|FG003|Follow-up|Non-compliance with study treatment|1|||
23177302|NCT01925209|64390439|FG000|Follow-up|Withdrawal by Subject|0|||
23177303|NCT01925209|64390440|FG001|Follow-up|Withdrawal by Subject|2|||
23237553|NCT02643420|64611563|FG000|Overall Study|Death|0|||
23454912|NCT00474812|65407307|FG000|Overall Study|Withdrawal by Subject|5|||
23237554|NCT02643420|64611564|FG001|Overall Study|Death|2|||
23237555|NCT02643420|64611563|FG000|Overall Study|Reason not Specified|8|||
23237556|NCT02643420|64611564|FG001|Overall Study|Reason not Specified|7|||
23237557|NCT02431559|64611565|FG000|Overall Study|Adverse Event|0|||
23237558|NCT02431559|64611566|FG001|Overall Study|Adverse Event|1|||
23237559|NCT02431559|64611567|FG002|Overall Study|Adverse Event|0|||
23237560|NCT02431559|64611568|FG003|Overall Study|Adverse Event|4|||
23237561|NCT02431559|64611565|FG000|Overall Study|Progressive disease|2|||
23237562|NCT02431559|64611566|FG001|Overall Study|Progressive disease|1|||
23237563|NCT02431559|64611567|FG002|Overall Study|Progressive disease|4|||
23237564|NCT02431559|64611568|FG003|Overall Study|Progressive disease|22|||
23237565|NCT02431559|64611565|FG000|Overall Study|Withdrawal by Subject|0|||
23237566|NCT02431559|64611566|FG001|Overall Study|Withdrawal by Subject|1|||
23237567|NCT02431559|64611567|FG002|Overall Study|Withdrawal by Subject|0|||
23237568|NCT02431559|64611568|FG003|Overall Study|Withdrawal by Subject|4|||
23237569|NCT02431559|64611565|FG000|Overall Study|Physician Decision|0|||
23237570|NCT02431559|64611566|FG001|Overall Study|Physician Decision|0|||
23237571|NCT02431559|64611567|FG002|Overall Study|Physician Decision|0|||
23237572|NCT02431559|64611568|FG003|Overall Study|Physician Decision|1|||
23237573|NCT02756182|64611569|FG000|Overall Study|StudyTechnical Difficulties|4|||
23177304|NCT01925209|64390441|FG002|Follow-up|Withdrawal by Subject|0|||
23177305|NCT01925209|64390442|FG003|Follow-up|Withdrawal by Subject|2|||
23177306|NCT01449708|64390443|FG000|Overall Study|Protocol Violation|0|||
23177307|NCT01449708|64390444|FG001|Overall Study|Protocol Violation|1|||
23177308|NCT01449708|64390443|FG000|Overall Study|surgical complication|1|||
23177309|NCT01449708|64390444|FG001|Overall Study|surgical complication|2|||
23177310|NCT01449708|64390443|FG000|Overall Study|respiratory failure|1|||
23237574|NCT01756846|64611570|FG000|Overall Study|Lost to Follow-up|5|||
23237575|NCT01756846|64611571|FG001|Overall Study|Lost to Follow-up|10|||
23237576|NCT01756846|64611570|FG000|Overall Study|Withdrawal by Subject|1|||
23237577|NCT01756846|64611571|FG001|Overall Study|Withdrawal by Subject|2|||
23237578|NCT03287960|64611576|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
23237579|NCT03287960|64611576|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
23237580|NCT02600559|64611581|FG000|Overall Study|Withdrawal by Subject|3|||
23237581|NCT02600559|64611581|FG000|Overall Study|Lost to Follow-up|20|||
23343521|NCT02883049|64999891|FG010|Induction|Identified as HR patients|0|||
23177311|NCT01449708|64390444|FG001|Overall Study|respiratory failure|0|||
23177312|NCT02440581|64390445|FG000|Overall Study|Death|0|||
23177313|NCT02440581|64390446|FG001|Overall Study|Death|0|||
23177314|NCT02440581|64390447|FG002|Overall Study|Death|7|||
23177315|NCT02440581|64390448|FG003|Overall Study|Death|5|||
23177316|NCT02440581|64390445|FG000|Overall Study|Transplanted|1|||
23177317|NCT02440581|64390446|FG001|Overall Study|Transplanted|0|||
23177318|NCT02440581|64390447|FG002|Overall Study|Transplanted|3|||
23177319|NCT02440581|64390448|FG003|Overall Study|Transplanted|2|||
23177320|NCT02440581|64390445|FG000|Overall Study|Withdrawal by Subject|4|||
23177321|NCT02440581|64390446|FG001|Overall Study|Withdrawal by Subject|11|||
23177322|NCT02440581|64390447|FG002|Overall Study|Withdrawal by Subject|3|||
23177323|NCT02440581|64390448|FG003|Overall Study|Withdrawal by Subject|7|||
23177324|NCT01929135|64390449|FG000|Overall Study|Lost to Follow-up|1|||
23177325|NCT01929135|64390450|FG001|Overall Study|Lost to Follow-up|1|||
23177326|NCT00553462|64390451|FG000|Overall Study|Adverse Event|4|||
23177327|NCT00553462|64390451|FG000|Overall Study|Progression|4|||
23177328|NCT00553462|64390451|FG000|Overall Study|Withdrawal by Subject|5|||
23177329|NCT00553462|64390451|FG000|Overall Study|Physician Decision|1|||
23177330|NCT01214044|64390454|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
23177331|NCT01214044|64390454|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
23177332|NCT01214044|64390454|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
23177333|NCT01214044|64390454|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
23177334|NCT01214044|64390454|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
23177335|NCT01214044|64390454|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
23177336|NCT03064490|64390455|FG000|Overall Study|Physician Decision|5|||
23177337|NCT00264004|64390456|FG000|Overall Study|Adverse Event|2|||
23177338|NCT00264004|64390457|FG001|Overall Study|Adverse Event|3|||
23177339|NCT00264004|64390458|FG002|Overall Study|Adverse Event|6|||
23177340|NCT00264004|64390459|FG003|Overall Study|Adverse Event|4|||
23237582|NCT02442284|64611582|FG000|Overall Study|Adverse Event|1|||
23237583|NCT02442284|64611582|FG000|Overall Study|Withdrew Consent|2|||
23177341|NCT00264004|64390456|FG000|Overall Study|Withdrawal by Subject|0|||
23177342|NCT00264004|64390457|FG001|Overall Study|Withdrawal by Subject|1|||
23177343|NCT00264004|64390458|FG002|Overall Study|Withdrawal by Subject|2|||
23177344|NCT00264004|64390459|FG003|Overall Study|Withdrawal by Subject|2|||
23177345|NCT00264004|64390456|FG000|Overall Study|Other|2|||
23177346|NCT00264004|64390457|FG001|Overall Study|Other|2|||
23177347|NCT00264004|64390458|FG002|Overall Study|Other|0|||
23177348|NCT00264004|64390459|FG003|Overall Study|Other|3|||
23177349|NCT00264004|64390456|FG000|Overall Study|Development study specific disc. crit.|1|||
23177350|NCT00264004|64390457|FG001|Overall Study|Development study specific disc. crit.|0|||
23343522|NCT02883049|64999892|FG011|Induction|Identified as HR patients|0|||
23343523|NCT02883049|64999893|FG012|Induction|Identified as HR patients|0|||
23343524|NCT02883049|64999894|FG013|Induction|Identified as HR patients|0|||
23343525|NCT02883049|64999895|FG014|Induction|Identified as HR patients|0|||
23343526|NCT02883049|64999896|FG015|Induction|Identified as HR patients|0|||
23343527|NCT02883049|64999881|FG000|Induction|Developed SMN|0|||
23343528|NCT02883049|64999882|FG001|Induction|Developed SMN|1|||
23343529|NCT02883049|64999883|FG002|Induction|Developed SMN|0|||
23343530|NCT02883049|64999884|FG003|Induction|Developed SMN|0|||
23343531|NCT02883049|64999885|FG004|Induction|Developed SMN|0|||
23343532|NCT02883049|64999886|FG005|Induction|Developed SMN|0|||
23343533|NCT02883049|64999887|FG006|Induction|Developed SMN|0|||
23343534|NCT02883049|64999888|FG007|Induction|Developed SMN|0|||
23343535|NCT02883049|64999889|FG008|Induction|Developed SMN|0|||
23343536|NCT02883049|64999890|FG009|Induction|Developed SMN|0|||
23343537|NCT02883049|64999891|FG010|Induction|Developed SMN|0|||
23343538|NCT02883049|64999892|FG011|Induction|Developed SMN|0|||
23343539|NCT02883049|64999893|FG012|Induction|Developed SMN|0|||
23343540|NCT02883049|64999894|FG013|Induction|Developed SMN|0|||
23343541|NCT02883049|64999895|FG014|Induction|Developed SMN|0|||
23343542|NCT02883049|64999896|FG015|Induction|Developed SMN|0|||
23343543|NCT02883049|64999881|FG000|Induction|Enrolled onto another COG study|72|||
23343544|NCT02883049|64999882|FG001|Induction|Enrolled onto another COG study|0|||
23343545|NCT02883049|64999883|FG002|Induction|Enrolled onto another COG study|0|||
23343546|NCT02883049|64999884|FG003|Induction|Enrolled onto another COG study|0|||
23343547|NCT02883049|64999885|FG004|Induction|Enrolled onto another COG study|0|||
23343548|NCT02883049|64999886|FG005|Induction|Enrolled onto another COG study|0|||
23343549|NCT02883049|64999887|FG006|Induction|Enrolled onto another COG study|0|||
23343550|NCT02883049|64999888|FG007|Induction|Enrolled onto another COG study|0|||
23343551|NCT02883049|64999889|FG008|Induction|Enrolled onto another COG study|0|||
23343552|NCT02883049|64999890|FG009|Induction|Enrolled onto another COG study|0|||
23343553|NCT02883049|64999891|FG010|Induction|Enrolled onto another COG study|0|||
23343554|NCT02883049|64999892|FG011|Induction|Enrolled onto another COG study|0|||
23343555|NCT02883049|64999893|FG012|Induction|Enrolled onto another COG study|0|||
23343556|NCT02883049|64999894|FG013|Induction|Enrolled onto another COG study|0|||
23343557|NCT02883049|64999895|FG014|Induction|Enrolled onto another COG study|0|||
23343558|NCT02883049|64999896|FG015|Induction|Enrolled onto another COG study|0|||
23343559|NCT02883049|64999881|FG000|Induction|Incomplete induction data|17|||
23343560|NCT02883049|64999882|FG001|Induction|Incomplete induction data|0|||
23343561|NCT02883049|64999883|FG002|Induction|Incomplete induction data|0|||
23237584|NCT02442284|64611582|FG000|Overall Study|Lost to Follow-up|3|||
23343562|NCT02883049|64999884|FG003|Induction|Incomplete induction data|0|||
23343563|NCT02883049|64999885|FG004|Induction|Incomplete induction data|0|||
23343564|NCT02883049|64999886|FG005|Induction|Incomplete induction data|0|||
23454913|NCT00474812|65407307|FG000|Overall Study|No Initiation of treatment|2|||
23454914|NCT00771914|65407308|FG000|Overall Study|Physician Decision|0|||
23582717|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23582718|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23582719|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23582720|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
23582721|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
23582722|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23582723|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23582724|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23582725|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23582726|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23582727|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23582728|NCT01323660|65862530|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23177351|NCT00264004|64390458|FG002|Overall Study|Development study specific disc. crit.|1|||
23343565|NCT02883049|64999887|FG006|Induction|Incomplete induction data|0|||
23343566|NCT02883049|64999888|FG007|Induction|Incomplete induction data|0|||
23343567|NCT02883049|64999889|FG008|Induction|Incomplete induction data|0|||
23343568|NCT02883049|64999890|FG009|Induction|Incomplete induction data|0|||
23343569|NCT02883049|64999891|FG010|Induction|Incomplete induction data|0|||
23343570|NCT02883049|64999892|FG011|Induction|Incomplete induction data|0|||
23343571|NCT02883049|64999893|FG012|Induction|Incomplete induction data|0|||
23454915|NCT00771914|65407309|FG001|Overall Study|Physician Decision|0|||
23454916|NCT00771914|65407310|FG002|Overall Study|Physician Decision|0|||
23454917|NCT00771914|65407311|FG003|Overall Study|Physician Decision|1|||
23454918|NCT00771914|65407308|FG000|Overall Study|Lost to Follow-up|0|||
23454919|NCT00771914|65407309|FG001|Overall Study|Lost to Follow-up|0|||
23454920|NCT00771914|65407310|FG002|Overall Study|Lost to Follow-up|0|||
23454921|NCT00771914|65407311|FG003|Overall Study|Lost to Follow-up|1|||
23454922|NCT01045460|65407312|FG000|Overall Study|Physician Decision|3|||
23454923|NCT01045460|65407313|FG001|Overall Study|Physician Decision|2|||
23454924|NCT01045460|65407312|FG000|Overall Study|Lost to Follow-up|0|||
23454925|NCT01045460|65407313|FG001|Overall Study|Lost to Follow-up|1|||
23454926|NCT01045460|65407312|FG000|Overall Study|Lack of Efficacy|3|||
23454927|NCT01045460|65407313|FG001|Overall Study|Lack of Efficacy|0|||
23454928|NCT03253679|65407316|FG000|Overall Study|Screen Failure|1|||
23454929|NCT04233801|65407317|FG000|Overall Study|Other than listed|0|||
23454930|NCT04233801|65407318|FG001|Overall Study|Other than listed|0|||
23454931|NCT04233801|65407319|FG002|Overall Study|Other than listed|1|||
23454932|NCT04233801|65407317|FG000|Overall Study|Withdrawal by Subject|0|||
23454933|NCT04233801|65407318|FG001|Overall Study|Withdrawal by Subject|2|||
23454934|NCT04233801|65407319|FG002|Overall Study|Withdrawal by Subject|3|||
23454935|NCT00928486|65407321|FG000|Overall Study|Adverse Event|2|||
23454936|NCT00928486|65407321|FG000|Overall Study|Disease Progression|7|||
23454937|NCT00928486|65407321|FG000|Overall Study|Withdrawal by Subject|1|||
23454938|NCT00387881|65407322|FG000|Overall Study|Lost to Follow-up|23|||
23454939|NCT00387881|65407323|FG001|Overall Study|Lost to Follow-up|23|||
23454940|NCT00387881|65407322|FG000|Overall Study|Protocol Violation|2|||
23454941|NCT00387881|65407323|FG001|Overall Study|Protocol Violation|12|||
23454942|NCT00387881|65407322|FG000|Overall Study|Withdrawal by Subject|15|||
23454943|NCT00387881|65407323|FG001|Overall Study|Withdrawal by Subject|18|||
23454944|NCT00387881|65407322|FG000|Overall Study|Sponsor terminated Study|0|||
23454945|NCT00387881|65407323|FG001|Overall Study|Sponsor terminated Study|1|||
23454946|NCT00387881|65407322|FG000|Overall Study|Not eligible|6|||
23454947|NCT00387881|65407323|FG001|Overall Study|Not eligible|7|||
23454948|NCT00387881|65407322|FG000|Overall Study|No opportunity to treat headache|32|||
23454949|NCT00387881|65407323|FG001|Overall Study|No opportunity to treat headache|34|||
23454950|NCT00387881|65407322|FG000|Overall Study|Not otherwise specified|11|||
23454951|NCT00387881|65407323|FG001|Overall Study|Not otherwise specified|7|||
23454952|NCT00617734|65407324|FG000|Overall Study|Withdrew Consent|2|||
23454953|NCT00617734|65407325|FG001|Overall Study|Withdrew Consent|0|||
23454954|NCT00617734|65407324|FG000|Overall Study|Adverse Event|4|||
23454955|NCT00617734|65407325|FG001|Overall Study|Adverse Event|1|||
23237585|NCT02442284|64611582|FG000|Overall Study|Other|1|||
23237586|NCT04308668|64611589|FG000|Overall Study|Lost to Follow-up|32|||
23237587|NCT04308668|64611590|FG001|Overall Study|Lost to Follow-up|38|||
23237588|NCT04308668|64611589|FG000|Overall Study|Withdrawal by Subject|4|||
23237589|NCT04308668|64611590|FG001|Overall Study|Withdrawal by Subject|4|||
23237590|NCT00561795|64611591|FG000|Overall Study|Adverse Event|3|||
23237591|NCT00561795|64611592|FG001|Overall Study|Adverse Event|3|||
23237592|NCT00561795|64611593|FG002|Overall Study|Adverse Event|0|||
23237593|NCT00561795|64611594|FG003|Overall Study|Adverse Event|0|||
23237594|NCT00561795|64611591|FG000|Overall Study|Study Closed/Terminated|0|||
23237595|NCT00561795|64611592|FG001|Overall Study|Study Closed/Terminated|3|||
23237596|NCT00561795|64611593|FG002|Overall Study|Study Closed/Terminated|0|||
23237597|NCT00561795|64611594|FG003|Overall Study|Study Closed/Terminated|0|||
23237598|NCT00561795|64611591|FG000|Overall Study|Physician Decision|1|||
23237599|NCT00561795|64611592|FG001|Overall Study|Physician Decision|0|||
23237600|NCT00561795|64611593|FG002|Overall Study|Physician Decision|0|||
23237601|NCT00561795|64611594|FG003|Overall Study|Physician Decision|0|||
23237602|NCT00374452|64611595|FG000|Overall Study|Left clinic before intervention started|4|||
23237603|NCT00374452|64611596|FG001|Overall Study|Left clinic before intervention started|1|||
23237604|NCT00374452|64611595|FG000|Overall Study|Change in job role before intervention|0|||
23237605|NCT00374452|64611596|FG001|Overall Study|Change in job role before intervention|1|||
23237606|NCT00374452|64611595|FG000|Overall Study|Left clinic after intervention started|1|||
23237607|NCT00374452|64611596|FG001|Overall Study|Left clinic after intervention started|1|||
23237608|NCT00374452|64611595|FG000|Overall Study|Withdrawal by Subject|0|||
23237609|NCT00374452|64611596|FG001|Overall Study|Withdrawal by Subject|2|||
23237610|NCT01189201|64611597|FG000|Overall Study|Adverse Event|1|||
23237611|NCT03831282|64611599|FG000|Overall Study|Could not place sensor|1|||
23237612|NCT00408408|64611605|FG000|Overall Study|No follow up data|2|||
23237613|NCT00408408|64611606|FG001|Overall Study|No follow up data|3|||
23237614|NCT00408408|64611607|FG002|Overall Study|No follow up data|0|||
23237615|NCT00408408|64611608|FG003|Overall Study|No follow up data|7|||
23237616|NCT00408408|64611609|FG004|Overall Study|No follow up data|5|||
23237617|NCT00408408|64611610|FG005|Overall Study|No follow up data|3|||
23237618|NCT03007472|64611611|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
23237619|NCT03007472|64611611|FG000|Overall Study|Death|2|||
23237620|NCT03007472|64611611|FG000|Overall Study|Loss to Follow Up|1|||
23237621|NCT00787527|64611612|FG000|Overall Study|Toxicity|3|||
23237622|NCT00033514|64611613|FG000|Overall Study|Lost to Follow-up|1|||
23237623|NCT00033514|64611614|FG001|Overall Study|Lost to Follow-up|1|||
23237624|NCT00033514|64611613|FG000|Overall Study|Withdrawal by Subject|0|||
23237625|NCT00033514|64611614|FG001|Overall Study|Withdrawal by Subject|3|||
23237626|NCT01233076|64615352|FG000|Period 2, One Week|Lost to Follow-up|1|||
23237627|NCT01233076|64615353|FG001|Period 2, One Week|Lost to Follow-up|0|||
23237628|NCT03219372|64615354|FG000|Overall Study|Withdrawal by Subject|1|||
23237629|NCT03219372|64615355|FG001|Overall Study|Withdrawal by Subject|0|||
23237630|NCT00505765|64615356|FG000|Overall Study|Withdrawal by Subject|1|||
23237631|NCT00505765|64615357|FG001|Overall Study|Withdrawal by Subject|0|||
23237632|NCT00505765|64615358|FG002|Overall Study|Withdrawal by Subject|0|||
23237633|NCT00505765|64615356|FG000|Overall Study|Adverse Event|1|||
23237634|NCT00505765|64615357|FG001|Overall Study|Adverse Event|2|||
23237635|NCT00505765|64615358|FG002|Overall Study|Adverse Event|0|||
23237636|NCT00505765|64615356|FG000|Overall Study|Noncompliance|0|||
23237637|NCT00505765|64615357|FG001|Overall Study|Noncompliance|1|||
23237638|NCT00505765|64615358|FG002|Overall Study|Noncompliance|3|||
23237639|NCT01348828|64615359|FG000|Overall Study|Death|20|||
23237640|NCT01348828|64615359|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
23237641|NCT01348828|64615359|FG000|Overall Study|Conversion|2|||
23237642|NCT01348828|64615359|FG000|Overall Study|missed visit|1|||
23237643|NCT01308476|64615360|FG000|Overall Study|Lost to Follow-up|2|||
23237644|NCT01308476|64615361|FG001|Overall Study|Lost to Follow-up|2|||
23237645|NCT01308476|64615360|FG000|Overall Study|Other|1|||
23237646|NCT01308476|64615361|FG001|Overall Study|Other|0|||
23237647|NCT02534324|64615362|FG000|Overall Study|Protocol Violation|4|||
23237648|NCT02534324|64615363|FG001|Overall Study|Protocol Violation|1|||
23237649|NCT02534324|64615362|FG000|Overall Study|Lost to Follow-up|20|||
23237650|NCT02534324|64615363|FG001|Overall Study|Lost to Follow-up|7|||
23237651|NCT02534324|64615362|FG000|Overall Study|Adverse Event|1|||
23237652|NCT02534324|64615363|FG001|Overall Study|Adverse Event|0|||
23237653|NCT02545504|64615364|FG000|Overall Study|Death|174|||
23237654|NCT02545504|64615365|FG001|Overall Study|Death|168|||
23237655|NCT02545504|64615364|FG000|Overall Study|Unknown reason|30|||
23237656|NCT02545504|64615365|FG001|Overall Study|Unknown reason|32|||
23237657|NCT02545504|64615364|FG000|Overall Study|Withdrew consent|9|||
23237658|NCT02545504|64615365|FG001|Overall Study|Withdrew consent|11|||
23237659|NCT02545504|64615364|FG000|Overall Study|Investigator's discretion|3|||
23237660|NCT02545504|64615365|FG001|Overall Study|Investigator's discretion|1|||
23237661|NCT02545504|64615364|FG000|Overall Study|Lost to Follow-up|2|||
23237662|NCT02545504|64615365|FG001|Overall Study|Lost to Follow-up|2|||
23343572|NCT02883049|64999894|FG013|Induction|Incomplete induction data|0|||
23343573|NCT02883049|64999895|FG014|Induction|Incomplete induction data|0|||
23343574|NCT02883049|64999896|FG015|Induction|Incomplete induction data|0|||
23343575|NCT02883049|64999881|FG000|Post Induction|Adverse Event|0|||
23343576|NCT02883049|64999882|FG001|Post Induction|Adverse Event|0|||
23343577|NCT02883049|64999883|FG002|Post Induction|Adverse Event|0|||
23343578|NCT02883049|64999884|FG003|Post Induction|Adverse Event|7|||
23343579|NCT02883049|64999885|FG004|Post Induction|Adverse Event|8|||
23343580|NCT02883049|64999886|FG005|Post Induction|Adverse Event|3|||
23343581|NCT02883049|64999887|FG006|Post Induction|Adverse Event|4|||
23343582|NCT02883049|64999888|FG007|Post Induction|Adverse Event|5|||
23343583|NCT02883049|64999889|FG008|Post Induction|Adverse Event|6|||
23343584|NCT02883049|64999890|FG009|Post Induction|Adverse Event|7|||
23343585|NCT02883049|64999891|FG010|Post Induction|Adverse Event|2|||
23343586|NCT02883049|64999892|FG011|Post Induction|Adverse Event|2|||
23343587|NCT02883049|64999893|FG012|Post Induction|Adverse Event|0|||
23343588|NCT02883049|64999894|FG013|Post Induction|Adverse Event|0|||
23343589|NCT02883049|64999895|FG014|Post Induction|Adverse Event|5|||
23343590|NCT02883049|64999896|FG015|Post Induction|Adverse Event|2|||
23343591|NCT02883049|64999881|FG000|Post Induction|Death|0|||
23343592|NCT02883049|64999882|FG001|Post Induction|Death|0|||
23343593|NCT02883049|64999883|FG002|Post Induction|Death|0|||
23343594|NCT02883049|64999884|FG003|Post Induction|Death|9|||
23343595|NCT02883049|64999885|FG004|Post Induction|Death|9|||
23343596|NCT02883049|64999886|FG005|Post Induction|Death|0|||
23343597|NCT02883049|64999887|FG006|Post Induction|Death|1|||
23343598|NCT02883049|64999888|FG007|Post Induction|Death|6|||
23343599|NCT02883049|64999889|FG008|Post Induction|Death|5|||
23343600|NCT02883049|64999890|FG009|Post Induction|Death|3|||
23343601|NCT02883049|64999891|FG010|Post Induction|Death|1|||
23343602|NCT02883049|64999892|FG011|Post Induction|Death|0|||
23343603|NCT02883049|64999893|FG012|Post Induction|Death|1|||
23343604|NCT02883049|64999894|FG013|Post Induction|Death|1|||
23343605|NCT02883049|64999895|FG014|Post Induction|Death|10|||
23343606|NCT02883049|64999896|FG015|Post Induction|Death|2|||
23343607|NCT02883049|64999881|FG000|Post Induction|Lost to Follow-up|0|||
23343608|NCT02883049|64999882|FG001|Post Induction|Lost to Follow-up|0|||
23343609|NCT02883049|64999883|FG002|Post Induction|Lost to Follow-up|0|||
23343610|NCT02883049|64999884|FG003|Post Induction|Lost to Follow-up|0|||
23343611|NCT02883049|64999885|FG004|Post Induction|Lost to Follow-up|1|||
23343612|NCT02883049|64999886|FG005|Post Induction|Lost to Follow-up|1|||
23343613|NCT02883049|64999887|FG006|Post Induction|Lost to Follow-up|0|||
23343614|NCT02883049|64999888|FG007|Post Induction|Lost to Follow-up|0|||
23343615|NCT02883049|64999889|FG008|Post Induction|Lost to Follow-up|3|||
23343616|NCT02883049|64999890|FG009|Post Induction|Lost to Follow-up|0|||
23343617|NCT02883049|64999891|FG010|Post Induction|Lost to Follow-up|1|||
23343618|NCT02883049|64999892|FG011|Post Induction|Lost to Follow-up|0|||
23343619|NCT02883049|64999893|FG012|Post Induction|Lost to Follow-up|0|||
23343620|NCT02883049|64999894|FG013|Post Induction|Lost to Follow-up|0|||
23343621|NCT02883049|64999895|FG014|Post Induction|Lost to Follow-up|0|||
23343622|NCT02883049|64999896|FG015|Post Induction|Lost to Follow-up|0|||
23343623|NCT02883049|64999881|FG000|Post Induction|Physician Decision|0|||
23343624|NCT02883049|64999882|FG001|Post Induction|Physician Decision|0|||
23343625|NCT02883049|64999883|FG002|Post Induction|Physician Decision|0|||
23343626|NCT02883049|64999884|FG003|Post Induction|Physician Decision|27|||
23343627|NCT02883049|64999885|FG004|Post Induction|Physician Decision|27|||
23343628|NCT02883049|64999886|FG005|Post Induction|Physician Decision|23|||
23343629|NCT02883049|64999887|FG006|Post Induction|Physician Decision|30|||
23343630|NCT02883049|64999888|FG007|Post Induction|Physician Decision|56|||
23343631|NCT02883049|64999889|FG008|Post Induction|Physician Decision|85|||
23343632|NCT02883049|64999890|FG009|Post Induction|Physician Decision|12|||
23454956|NCT00617734|65407324|FG000|Overall Study|Protocol Violation|1|||
23454957|NCT00617734|65407325|FG001|Overall Study|Protocol Violation|0|||
23454958|NCT00617734|65407324|FG000|Overall Study|Found Ineligible After Randomization|1|||
23454959|NCT00617734|65407325|FG001|Overall Study|Found Ineligible After Randomization|4|||
23454960|NCT00617734|65407324|FG000|Overall Study|Lost to Follow-up|0|||
23454961|NCT00617734|65407325|FG001|Overall Study|Lost to Follow-up|1|||
23454962|NCT04439136|65407329|FG000|Overall Study|Ineligible|1|||
23177352|NCT00264004|64390459|FG003|Overall Study|Development study specific disc. crit.|0|||
23343633|NCT02883049|64999891|FG010|Post Induction|Physician Decision|5|||
23343634|NCT02883049|64999892|FG011|Post Induction|Physician Decision|14|||
23343635|NCT02883049|64999893|FG012|Post Induction|Physician Decision|1|||
23343636|NCT02883049|64999894|FG013|Post Induction|Physician Decision|11|||
23343637|NCT02883049|64999895|FG014|Post Induction|Physician Decision|19|||
23343638|NCT02883049|64999896|FG015|Post Induction|Physician Decision|5|||
23343639|NCT02883049|64999881|FG000|Post Induction|Protocol Violation|0|||
23343640|NCT02883049|64999882|FG001|Post Induction|Protocol Violation|0|||
23343641|NCT02883049|64999883|FG002|Post Induction|Protocol Violation|0|||
23343642|NCT02883049|64999884|FG003|Post Induction|Protocol Violation|0|||
23343643|NCT02883049|64999885|FG004|Post Induction|Protocol Violation|0|||
23343644|NCT02883049|64999886|FG005|Post Induction|Protocol Violation|0|||
23343645|NCT02883049|64999887|FG006|Post Induction|Protocol Violation|0|||
23343646|NCT02883049|64999888|FG007|Post Induction|Protocol Violation|1|||
23343647|NCT02883049|64999889|FG008|Post Induction|Protocol Violation|0|||
23343648|NCT02883049|64999890|FG009|Post Induction|Protocol Violation|0|||
23343649|NCT02883049|64999891|FG010|Post Induction|Protocol Violation|0|||
23343650|NCT02883049|64999892|FG011|Post Induction|Protocol Violation|0|||
23343651|NCT02883049|64999893|FG012|Post Induction|Protocol Violation|0|||
23343652|NCT02883049|64999894|FG013|Post Induction|Protocol Violation|0|||
23343653|NCT02883049|64999895|FG014|Post Induction|Protocol Violation|0|||
23343654|NCT02883049|64999896|FG015|Post Induction|Protocol Violation|0|||
23343655|NCT02883049|64999881|FG000|Post Induction|Withdrawal by Subject|0|||
23343656|NCT02883049|64999882|FG001|Post Induction|Withdrawal by Subject|0|||
23343657|NCT02883049|64999883|FG002|Post Induction|Withdrawal by Subject|0|||
23343658|NCT02883049|64999884|FG003|Post Induction|Withdrawal by Subject|5|||
23343659|NCT02883049|64999885|FG004|Post Induction|Withdrawal by Subject|2|||
23343660|NCT02883049|64999886|FG005|Post Induction|Withdrawal by Subject|1|||
23343661|NCT02883049|64999887|FG006|Post Induction|Withdrawal by Subject|0|||
23454963|NCT04439136|65407329|FG000|Overall Study|Never Started Treatment|2|||
23454964|NCT04439136|65407329|FG000|Overall Study|Adverse Event|4|||
23454965|NCT04439136|65407329|FG000|Overall Study|Death|3|||
23454966|NCT04439136|65407329|FG000|Overall Study|Disease Progression|27|||
23454967|NCT04439136|65407329|FG000|Overall Study|Alternative Therapy|1|||
23454968|NCT04439136|65407329|FG000|Overall Study|Increased Tumor Burden|1|||
23454969|NCT04439136|65407329|FG000|Overall Study|Symptomatic Detrioration|1|||
23454970|NCT00383552|65407330|FG000|Overall Study|Adverse Event|7|||
23454971|NCT00383552|65407331|FG001|Overall Study|Adverse Event|6|||
23454972|NCT00383552|65407332|FG002|Overall Study|Adverse Event|9|||
23454973|NCT00383552|65407333|FG003|Overall Study|Adverse Event|6|||
23454974|NCT00383552|65407330|FG000|Overall Study|Lack of Efficacy|4|||
23454975|NCT00383552|65407331|FG001|Overall Study|Lack of Efficacy|13|||
23454976|NCT00383552|65407332|FG002|Overall Study|Lack of Efficacy|29|||
23454977|NCT00383552|65407333|FG003|Overall Study|Lack of Efficacy|42|||
23454978|NCT00383552|65407330|FG000|Overall Study|Lost to Follow-up|0|||
23177353|NCT00264004|64390456|FG000|Overall Study|Cond. under inv. worsened|9|||
23177354|NCT00264004|64390457|FG001|Overall Study|Cond. under inv. worsened|5|||
23177355|NCT00264004|64390458|FG002|Overall Study|Cond. under inv. worsened|3|||
23177356|NCT00264004|64390459|FG003|Overall Study|Cond. under inv. worsened|4|||
23177357|NCT00264004|64390456|FG000|Overall Study|Not treated|3|||
23177358|NCT00264004|64390457|FG001|Overall Study|Not treated|0|||
23177359|NCT00264004|64390458|FG002|Overall Study|Not treated|2|||
23177360|NCT00264004|64390459|FG003|Overall Study|Not treated|2|||
23177361|NCT03663166|64390460|FG000|Overall Study|Withdrawal by Subject|1|||
23177362|NCT03446456|64390461|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
23237663|NCT04366258|64615366|FG000|Baseline Assessments|Screen Failure|21|||
23237664|NCT04366258|64615366|FG000|Baseline Assessments|Early Termination|3|||
23237665|NCT01159665|64615367|FG000|Overall Study|Withdrawal by Subject|0|||
23237666|NCT01159665|64615368|FG001|Overall Study|Withdrawal by Subject|1|||
23237667|NCT01159665|64615369|FG002|Overall Study|Withdrawal by Subject|0|||
23237668|NCT01159665|64615370|FG003|Overall Study|Withdrawal by Subject|0|||
23237669|NCT01159665|64615371|FG004|Overall Study|Withdrawal by Subject|0|||
23237670|NCT01159665|64615372|FG005|Overall Study|Withdrawal by Subject|0|||
23237671|NCT01801475|64615378|FG000|Overall Study|Withdrawal by Subject|0|||
23237672|NCT01801475|64615379|FG001|Overall Study|Withdrawal by Subject|0|||
23237673|NCT01801475|64615380|FG002|Overall Study|Withdrawal by Subject|0|||
23237674|NCT01801475|64615381|FG003|Overall Study|Withdrawal by Subject|0|||
23237675|NCT01801475|64615382|FG004|Overall Study|Withdrawal by Subject|1|||
23237676|NCT01054443|64615385|FG000|Overall Study|Withdrawal by Subject|0|||
23237677|NCT01054443|64615386|FG001|Overall Study|Withdrawal by Subject|0|||
23237678|NCT01054443|64615387|FG002|Overall Study|Withdrawal by Subject|0|||
23237679|NCT01054443|64615388|FG003|Overall Study|Withdrawal by Subject|1|||
23237680|NCT03841331|64615391|FG000|Overall Study|Withdrawal by Subject|4|||
23237681|NCT03841331|64615392|FG001|Overall Study|Withdrawal by Subject|9|||
23237682|NCT03841331|64615391|FG000|Overall Study|Lost to Follow-up|5|||
23237683|NCT03841331|64615392|FG001|Overall Study|Lost to Follow-up|1|||
23343662|NCT02883049|64999888|FG007|Post Induction|Withdrawal by Subject|0|||
23343663|NCT02883049|64999889|FG008|Post Induction|Withdrawal by Subject|2|||
23343664|NCT02883049|64999890|FG009|Post Induction|Withdrawal by Subject|0|||
23177363|NCT03446456|64390462|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
23237684|NCT00148109|64615393|FG000|Overall Study|Lack of Efficacy|10|||
23343665|NCT02883049|64999891|FG010|Post Induction|Withdrawal by Subject|1|||
23343666|NCT02883049|64999892|FG011|Post Induction|Withdrawal by Subject|1|||
23237685|NCT00148109|64615394|FG001|Overall Study|Lack of Efficacy|18|||
23237686|NCT00148109|64615393|FG000|Overall Study|Adverse Event|0|||
23237687|NCT00148109|64615394|FG001|Overall Study|Adverse Event|2|||
23343667|NCT02883049|64999893|FG012|Post Induction|Withdrawal by Subject|0|||
23343668|NCT02883049|64999894|FG013|Post Induction|Withdrawal by Subject|0|||
23177364|NCT03446456|64390461|FG000|Overall Study|Lost to Follow-up|1|||
23177365|NCT03446456|64390462|FG001|Overall Study|Lost to Follow-up|3|||
23177366|NCT03446456|64390461|FG000|Overall Study|Participant failed the toxicology test|1|||
23177367|NCT03446456|64390462|FG001|Overall Study|Participant failed the toxicology test|0|||
23343669|NCT02883049|64999895|FG014|Post Induction|Withdrawal by Subject|1|||
23343670|NCT02883049|64999896|FG015|Post Induction|Withdrawal by Subject|0|||
23454979|NCT00383552|65407331|FG001|Overall Study|Lost to Follow-up|1|||
23454980|NCT00383552|65407332|FG002|Overall Study|Lost to Follow-up|5|||
23454981|NCT00383552|65407333|FG003|Overall Study|Lost to Follow-up|1|||
23454982|NCT00383552|65407330|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
23454983|NCT00383552|65407331|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
23454984|NCT00383552|65407332|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
23454985|NCT00383552|65407333|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
23454986|NCT00383552|65407330|FG000|Overall Study|Did not wish to continue (related)|1|||
23454987|NCT00383552|65407331|FG001|Overall Study|Did not wish to continue (related)|0|||
23454988|NCT00383552|65407332|FG002|Overall Study|Did not wish to continue (related)|2|||
23454989|NCT00383552|65407333|FG003|Overall Study|Did not wish to continue (related)|3|||
23454990|NCT00383552|65407330|FG000|Overall Study|Noncompliance with the protocol|11|||
23177368|NCT03446456|64390461|FG000|Overall Study|Break down of the experimental equipment|1|||
23177369|NCT03446456|64390462|FG001|Overall Study|Break down of the experimental equipment|0|||
23177370|NCT04269395|64390463|FG000|Overall Study|Lost to Follow-up|1|||
23177371|NCT04269395|64390464|FG001|Overall Study|Lost to Follow-up|0|||
23177372|NCT04269395|64390463|FG000|Overall Study|Study terminated by Sponsor|13|||
23177373|NCT04269395|64390464|FG001|Overall Study|Study terminated by Sponsor|10|||
23177374|NCT00159432|64390465|FG000|Overall Study|Adverse Event|1|||
23177375|NCT00159432|64390465|FG000|Overall Study|Death|1|||
23177376|NCT00159432|64390465|FG000|Overall Study|Lack of Efficacy|8|||
23177377|NCT01957137|64390466|FG000|Randomized Portion|Adverse Event|1|||
23177378|NCT01957137|64390466|FG000|Randomized Portion|Withdrawal by Subject|1|||
23177379|NCT01940484|64390467|FG000|Overall Study|Withdrawal by Subject|3|||
23177380|NCT01940484|64390467|FG000|Overall Study|Underwent transplantation|4|||
23177381|NCT01940484|64390467|FG000|Overall Study|Death|2|||
23454991|NCT00383552|65407331|FG001|Overall Study|Noncompliance with the protocol|6|||
23454992|NCT00383552|65407332|FG002|Overall Study|Noncompliance with the protocol|8|||
23454993|NCT00383552|65407333|FG003|Overall Study|Noncompliance with the protocol|10|||
23454994|NCT00383552|65407330|FG000|Overall Study|Did not meet protocol eligibility|8|||
23454995|NCT00383552|65407331|FG001|Overall Study|Did not meet protocol eligibility|6|||
23454996|NCT00383552|65407332|FG002|Overall Study|Did not meet protocol eligibility|2|||
23454997|NCT00383552|65407333|FG003|Overall Study|Did not meet protocol eligibility|3|||
23454998|NCT00383552|65407330|FG000|Overall Study|Administrative|1|||
23454999|NCT00383552|65407331|FG001|Overall Study|Administrative|0|||
23455000|NCT00383552|65407332|FG002|Overall Study|Administrative|1|||
23455001|NCT00383552|65407333|FG003|Overall Study|Administrative|1|||
23237688|NCT00148109|64615393|FG000|Overall Study|Withdrawal by Subject|2|||
23237689|NCT00148109|64615394|FG001|Overall Study|Withdrawal by Subject|0|||
23237690|NCT00379639|64615400|FG000|Overall Study|Disease Progression|3|||
23237691|NCT00379639|64615401|FG001|Overall Study|Disease Progression|3|||
23237692|NCT00379639|64615402|FG002|Overall Study|Disease Progression|3|||
23237693|NCT00379639|64615403|FG003|Overall Study|Disease Progression|4|||
23237694|NCT00379639|64615404|FG004|Overall Study|Disease Progression|4|||
23237695|NCT00379639|64615400|FG000|Overall Study|Physician Decision|0|||
23237696|NCT00379639|64615401|FG001|Overall Study|Physician Decision|2|||
23237697|NCT00379639|64615402|FG002|Overall Study|Physician Decision|1|||
23237698|NCT00379639|64615403|FG003|Overall Study|Physician Decision|1|||
23237699|NCT00379639|64615404|FG004|Overall Study|Physician Decision|0|||
23237700|NCT00379639|64615400|FG000|Overall Study|Symptomatic Deterioration|0|||
23237701|NCT00379639|64615401|FG001|Overall Study|Symptomatic Deterioration|0|||
23237702|NCT00379639|64615402|FG002|Overall Study|Symptomatic Deterioration|1|||
23237703|NCT00379639|64615403|FG003|Overall Study|Symptomatic Deterioration|0|||
23237704|NCT00379639|64615404|FG004|Overall Study|Symptomatic Deterioration|1|||
23237705|NCT00379639|64615400|FG000|Overall Study|Adverse Event|0|||
23237706|NCT00379639|64615401|FG001|Overall Study|Adverse Event|0|||
23237707|NCT00379639|64615402|FG002|Overall Study|Adverse Event|1|||
23237708|NCT00379639|64615403|FG003|Overall Study|Adverse Event|0|||
23237709|NCT00379639|64615404|FG004|Overall Study|Adverse Event|1|||
23237710|NCT00379639|64615400|FG000|Overall Study|Lost to Follow-up|0|||
23237711|NCT00379639|64615401|FG001|Overall Study|Lost to Follow-up|0|||
23343671|NCT02883049|64999881|FG000|Post Induction|Ineligible|0|||
23177382|NCT01940484|64390467|FG000|Overall Study|Adverse Event|1|||
23177383|NCT00988247|64390472|FG000|Overall Study|Adverse Event|17|||
23582729|NCT01323660|65862531|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23177384|NCT00988247|64390473|FG001|Overall Study|Adverse Event|3|||
23237712|NCT00379639|64615402|FG002|Overall Study|Lost to Follow-up|0|||
23237713|NCT00379639|64615403|FG003|Overall Study|Lost to Follow-up|1|||
23237714|NCT00379639|64615404|FG004|Overall Study|Lost to Follow-up|0|||
23343672|NCT02883049|64999882|FG001|Post Induction|Ineligible|0|||
23343673|NCT02883049|64999883|FG002|Post Induction|Ineligible|2|||
23343674|NCT02883049|64999884|FG003|Post Induction|Ineligible|0|||
23343675|NCT02883049|64999885|FG004|Post Induction|Ineligible|0|||
23343676|NCT02883049|64999886|FG005|Post Induction|Ineligible|0|||
23343677|NCT02883049|64999887|FG006|Post Induction|Ineligible|1|||
23343678|NCT02883049|64999888|FG007|Post Induction|Ineligible|0|||
23343679|NCT02883049|64999889|FG008|Post Induction|Ineligible|0|||
23343680|NCT02883049|64999890|FG009|Post Induction|Ineligible|0|||
23343681|NCT02883049|64999891|FG010|Post Induction|Ineligible|1|||
23343682|NCT02883049|64999892|FG011|Post Induction|Ineligible|0|||
23343683|NCT02883049|64999893|FG012|Post Induction|Ineligible|0|||
23343684|NCT02883049|64999894|FG013|Post Induction|Ineligible|0|||
23343685|NCT02883049|64999895|FG014|Post Induction|Ineligible|0|||
23343686|NCT02883049|64999896|FG015|Post Induction|Ineligible|1|||
23343687|NCT02883049|64999881|FG000|Post Induction|Refusal of further protocol therapy|0|||
23343688|NCT02883049|64999882|FG001|Post Induction|Refusal of further protocol therapy|0|||
23343689|NCT02883049|64999883|FG002|Post Induction|Refusal of further protocol therapy|0|||
23343690|NCT02883049|64999884|FG003|Post Induction|Refusal of further protocol therapy|11|||
23343691|NCT02883049|64999885|FG004|Post Induction|Refusal of further protocol therapy|15|||
23343692|NCT02883049|64999886|FG005|Post Induction|Refusal of further protocol therapy|9|||
23343693|NCT02883049|64999887|FG006|Post Induction|Refusal of further protocol therapy|13|||
23343694|NCT02883049|64999888|FG007|Post Induction|Refusal of further protocol therapy|5|||
23343695|NCT02883049|64999889|FG008|Post Induction|Refusal of further protocol therapy|21|||
23343696|NCT02883049|64999890|FG009|Post Induction|Refusal of further protocol therapy|7|||
23343697|NCT02883049|64999891|FG010|Post Induction|Refusal of further protocol therapy|0|||
23343698|NCT02883049|64999892|FG011|Post Induction|Refusal of further protocol therapy|7|||
23343699|NCT02883049|64999893|FG012|Post Induction|Refusal of further protocol therapy|3|||
23343700|NCT02883049|64999894|FG013|Post Induction|Refusal of further protocol therapy|0|||
23343701|NCT02883049|64999895|FG014|Post Induction|Refusal of further protocol therapy|4|||
23343702|NCT02883049|64999896|FG015|Post Induction|Refusal of further protocol therapy|1|||
23343703|NCT02883049|64999881|FG000|Post Induction|Inevaluable|0|||
23343704|NCT02883049|64999882|FG001|Post Induction|Inevaluable|0|||
23343705|NCT02883049|64999883|FG002|Post Induction|Inevaluable|0|||
23343706|NCT02883049|64999884|FG003|Post Induction|Inevaluable|1|||
23343707|NCT02883049|64999885|FG004|Post Induction|Inevaluable|1|||
23343708|NCT02883049|64999886|FG005|Post Induction|Inevaluable|2|||
23343709|NCT02883049|64999887|FG006|Post Induction|Inevaluable|7|||
23343710|NCT02883049|64999888|FG007|Post Induction|Inevaluable|6|||
23343711|NCT02883049|64999889|FG008|Post Induction|Inevaluable|4|||
23343712|NCT02883049|64999890|FG009|Post Induction|Inevaluable|4|||
23343713|NCT02883049|64999891|FG010|Post Induction|Inevaluable|1|||
23343714|NCT02883049|64999892|FG011|Post Induction|Inevaluable|1|||
23455002|NCT03291067|65407334|FG000|Overall Study|Adverse Event|0|||
23343715|NCT02883049|64999893|FG012|Post Induction|Inevaluable|2|||
23455003|NCT03291067|65407335|FG001|Overall Study|Adverse Event|2|||
23455004|NCT03291067|65407336|FG002|Overall Study|Adverse Event|17|||
23455005|NCT03291067|65407337|FG003|Overall Study|Adverse Event|3|||
23455006|NCT03291067|65407334|FG000|Overall Study|Lost to Follow-up|2|||
23455007|NCT03291067|65407335|FG001|Overall Study|Lost to Follow-up|1|||
23455008|NCT03291067|65407336|FG002|Overall Study|Lost to Follow-up|0|||
23455009|NCT03291067|65407337|FG003|Overall Study|Lost to Follow-up|1|||
23455010|NCT03291067|65407334|FG000|Overall Study|Physician Decision|0|||
23455011|NCT03291067|65407335|FG001|Overall Study|Physician Decision|0|||
23455012|NCT03291067|65407336|FG002|Overall Study|Physician Decision|1|||
23455013|NCT03291067|65407337|FG003|Overall Study|Physician Decision|0|||
23455014|NCT03291067|65407334|FG000|Overall Study|Protocol Violation|5|||
23455015|NCT03291067|65407335|FG001|Overall Study|Protocol Violation|3|||
23455016|NCT03291067|65407336|FG002|Overall Study|Protocol Violation|4|||
23455017|NCT03291067|65407337|FG003|Overall Study|Protocol Violation|2|||
23455018|NCT03291067|65407334|FG000|Overall Study|Withdrawal by Subject|3|||
23455019|NCT03291067|65407335|FG001|Overall Study|Withdrawal by Subject|4|||
23455020|NCT03291067|65407336|FG002|Overall Study|Withdrawal by Subject|7|||
23455021|NCT03291067|65407337|FG003|Overall Study|Withdrawal by Subject|5|||
23455022|NCT03291067|65407334|FG000|Overall Study|Other|0|||
23455023|NCT03291067|65407335|FG001|Overall Study|Other|4|||
23343716|NCT02883049|64999894|FG013|Post Induction|Inevaluable|0|||
23343717|NCT02883049|64999895|FG014|Post Induction|Inevaluable|0|||
23343718|NCT02883049|64999896|FG015|Post Induction|Inevaluable|1|||
23343719|NCT02883049|64999881|FG000|Post Induction|Moved to another non-COG institution|0|||
23343720|NCT02883049|64999882|FG001|Post Induction|Moved to another non-COG institution|0|||
23343721|NCT02883049|64999883|FG002|Post Induction|Moved to another non-COG institution|0|||
23343722|NCT02883049|64999884|FG003|Post Induction|Moved to another non-COG institution|0|||
23343723|NCT02883049|64999885|FG004|Post Induction|Moved to another non-COG institution|0|||
23343724|NCT02883049|64999886|FG005|Post Induction|Moved to another non-COG institution|0|||
23343725|NCT02883049|64999887|FG006|Post Induction|Moved to another non-COG institution|0|||
23455024|NCT03291067|65407336|FG002|Overall Study|Other|4|||
23455025|NCT03291067|65407337|FG003|Overall Study|Other|6|||
23455026|NCT03617172|65407338|FG000|Overall Study|Lost to Follow-up|1|||
23455027|NCT03617172|65407339|FG001|Overall Study|Lost to Follow-up|0|||
23455028|NCT00524485|65409563|FG000|Overall Study|Withdrawal by Subject|5|||
23455029|NCT00231777|65409567|FG000|Overall Study|Lost to Follow-up|3|||
23455030|NCT00231777|65409568|FG001|Overall Study|Lost to Follow-up|0|||
23455031|NCT00231777|65409567|FG000|Overall Study|Other|3|||
23455032|NCT00231777|65409568|FG001|Overall Study|Other|2|||
23455033|NCT02174731|65409571|FG000|Overall Study|Participant decision|67|||
23455034|NCT02174731|65409572|FG001|Overall Study|Participant decision|64|||
23455035|NCT02174731|65409571|FG000|Overall Study|Incorrect enrolment before randomization|0|||
23455036|NCT02174731|65409572|FG001|Overall Study|Incorrect enrolment before randomization|1|||
23455037|NCT02174731|65409571|FG000|Overall Study|Missing|2|||
23455038|NCT02174731|65409572|FG001|Overall Study|Missing|0|||
23455039|NCT00231816|65409585|FG000|Overall Study|Adverse Event|1|||
23455040|NCT00231816|65409586|FG001|Overall Study|Adverse Event|0|||
23177385|NCT00988247|64390472|FG000|Overall Study|Withdrawal by Subject|44|||
23177386|NCT00988247|64390473|FG001|Overall Study|Withdrawal by Subject|13|||
23177387|NCT00988247|64390472|FG000|Overall Study|Pregnancy|1|||
23177388|NCT00988247|64390473|FG001|Overall Study|Pregnancy|2|||
23177389|NCT00988247|64390472|FG000|Overall Study|Lost to Follow-up|11|||
23177390|NCT00988247|64390473|FG001|Overall Study|Lost to Follow-up|2|||
23177391|NCT00988247|64390472|FG000|Overall Study|Protocol Violation|4|||
23177392|NCT00988247|64390473|FG001|Overall Study|Protocol Violation|5|||
23177393|NCT00988247|64390472|FG000|Overall Study|Sponsor requested withdrawal|3|||
23177394|NCT00988247|64390473|FG001|Overall Study|Sponsor requested withdrawal|1|||
23177395|NCT00988247|64390472|FG000|Overall Study|Other|3|||
23177396|NCT00988247|64390473|FG001|Overall Study|Other|0|||
23177397|NCT01461044|64393777|FG000|Overall Study|Death|58|||
23177398|NCT01461044|64393778|FG001|Overall Study|Death|35|||
23177399|NCT01461044|64393777|FG000|Overall Study|Lost to Follow-up|12|||
23177400|NCT01461044|64393778|FG001|Overall Study|Lost to Follow-up|5|||
23177401|NCT02471716|64393779|FG000|Overall Study|Withdrawal by Subject|0|||
23177402|NCT02471716|64393780|FG001|Overall Study|Withdrawal by Subject|1|||
23177403|NCT02471716|64393781|FG002|Overall Study|Withdrawal by Subject|0|||
23177404|NCT02471716|64393782|FG003|Overall Study|Withdrawal by Subject|2|||
23177405|NCT02471716|64393783|FG004|Overall Study|Withdrawal by Subject|5|||
23177406|NCT02471716|64393779|FG000|Overall Study|Study Terminiated by sponsor|0|||
23177407|NCT02471716|64393780|FG001|Overall Study|Study Terminiated by sponsor|0|||
23177408|NCT02471716|64393781|FG002|Overall Study|Study Terminiated by sponsor|0|||
23177409|NCT02471716|64393782|FG003|Overall Study|Study Terminiated by sponsor|1|||
23177410|NCT02471716|64393783|FG004|Overall Study|Study Terminiated by sponsor|0|||
23177411|NCT02471716|64393779|FG000|Overall Study|Lost to Follow-up|0|||
23177412|NCT02471716|64393780|FG001|Overall Study|Lost to Follow-up|0|||
23177413|NCT02471716|64393781|FG002|Overall Study|Lost to Follow-up|0|||
23177414|NCT02471716|64393782|FG003|Overall Study|Lost to Follow-up|3|||
23177415|NCT02471716|64393783|FG004|Overall Study|Lost to Follow-up|2|||
23177416|NCT02471716|64393779|FG000|Overall Study|Death|0|||
23177417|NCT02471716|64393780|FG001|Overall Study|Death|0|||
23177418|NCT02471716|64393781|FG002|Overall Study|Death|0|||
23177419|NCT02471716|64393782|FG003|Overall Study|Death|1|||
23177420|NCT02471716|64393783|FG004|Overall Study|Death|0|||
23177421|NCT02471716|64393779|FG000|Overall Study|Other|0|||
23177422|NCT02471716|64393780|FG001|Overall Study|Other|0|||
23177423|NCT02471716|64393781|FG002|Overall Study|Other|0|||
23177424|NCT02471716|64393782|FG003|Overall Study|Other|8|||
23177425|NCT02471716|64393783|FG004|Overall Study|Other|9|||
23177426|NCT03308188|64393784|FG000|Overall Study|Withdrawal by Subject|0|||
23177427|NCT03308188|64393785|FG001|Overall Study|Withdrawal by Subject|3|||
23177428|NCT03308188|64393784|FG000|Overall Study|Death|0|||
23237715|NCT00379639|64615400|FG000|Overall Study|Other|0|||
23237716|NCT00379639|64615401|FG001|Overall Study|Other|0|||
23343726|NCT02883049|64999888|FG007|Post Induction|Moved to another non-COG institution|2|||
23343727|NCT02883049|64999889|FG008|Post Induction|Moved to another non-COG institution|2|||
23343728|NCT02883049|64999890|FG009|Post Induction|Moved to another non-COG institution|0|||
23343729|NCT02883049|64999891|FG010|Post Induction|Moved to another non-COG institution|0|||
23177429|NCT03308188|64393785|FG001|Overall Study|Death|1|||
23177430|NCT00395967|64393786|FG000|Treatment Period|Failed Mobilization|1|||
23177431|NCT00395967|64393786|FG000|Follow-up Period|Death|1|||
23177432|NCT00395967|64393786|FG000|Follow-up Period|Lost to Follow-up|1|||
23177433|NCT02949128|64393787|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
23177434|NCT02949128|64393787|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
23177435|NCT02949128|64393787|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
23177436|NCT02949128|64393787|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
23177437|NCT02949128|64393787|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
23177438|NCT02949128|64393787|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
23237717|NCT00379639|64615402|FG002|Overall Study|Other|3|||
23455041|NCT00231816|65409585|FG000|Overall Study|Lost to Follow-up|8|||
23455042|NCT00231816|65409586|FG001|Overall Study|Lost to Follow-up|5|||
23455043|NCT00231816|65409585|FG000|Overall Study|Protocol Violation|2|||
23455044|NCT00231816|65409586|FG001|Overall Study|Protocol Violation|3|||
23455045|NCT00231816|65409585|FG000|Overall Study|Withdrawal by Subject|3|||
23455046|NCT00231816|65409586|FG001|Overall Study|Withdrawal by Subject|3|||
23455047|NCT00231816|65409585|FG000|Overall Study|Other|2|||
23455048|NCT00231816|65409586|FG001|Overall Study|Other|1|||
23455049|NCT04124939|65409588|FG000|Overall Study|Lost to Follow-up|1|||
23455050|NCT04124939|65409589|FG001|Overall Study|Lost to Follow-up|3|||
23455051|NCT01358877|65409596|FG000|Overall Study|Death|80|||
23455052|NCT01358877|65409597|FG001|Overall Study|Death|89|||
23455053|NCT01358877|65409596|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
23455054|NCT01358877|65409597|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
23455055|NCT01358877|65409596|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
23455056|NCT01358877|65409597|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
23455057|NCT01358877|65409596|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
23455058|NCT01358877|65409597|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
23455059|NCT01358877|65409596|FG000|Overall Study|Other|142|||
23455060|NCT01358877|65409597|FG001|Overall Study|Other|129|||
23455061|NCT00129402|65409600|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
23455062|NCT00129402|65409601|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
23455063|NCT00129402|65409602|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
23455064|NCT00129402|65409603|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
23455065|NCT00129402|65409604|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
23455066|NCT00129402|65409605|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
23455067|NCT00129402|65409606|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
23455068|NCT00129402|65409600|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455069|NCT00129402|65409601|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455070|NCT00129402|65409602|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455071|NCT00129402|65409603|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455072|NCT00129402|65409604|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455073|NCT00129402|65409605|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
23455074|NCT00129402|65409606|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
23455075|NCT00129402|65409600|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455076|NCT00129402|65409601|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455077|NCT00129402|65409602|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455078|NCT00129402|65409603|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
23455079|NCT00129402|65409604|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455080|NCT00129402|65409605|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455081|NCT00129402|65409606|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
23455082|NCT00129402|65409600|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455083|NCT00129402|65409601|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455084|NCT00129402|65409602|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
23455085|NCT00129402|65409603|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455086|NCT00129402|65409604|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
23455087|NCT00129402|65409605|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455088|NCT00129402|65409606|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
23455089|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455090|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455091|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
23455092|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455093|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455094|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455095|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
23455096|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455097|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455098|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
23455099|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455100|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455101|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
23455102|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
23455103|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455104|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455105|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
23455106|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455107|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455108|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23177439|NCT02949128|64393787|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
23455109|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
23455110|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455111|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455112|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
23455113|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455114|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455115|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
23455116|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
23455117|NCT00129402|65409600|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455118|NCT00129402|65409601|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455119|NCT00129402|65409602|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
23455120|NCT00129402|65409603|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455121|NCT00129402|65409604|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455122|NCT00129402|65409605|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
23455123|NCT00129402|65409606|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
23455124|NCT00129402|65409600|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455125|NCT00129402|65409601|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455126|NCT00129402|65409602|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455127|NCT00129402|65409603|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455128|NCT00129402|65409604|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23455129|NCT00129402|65409605|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
23177440|NCT02949128|64393787|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
23177441|NCT02949128|64393787|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
23177442|NCT02949128|64393787|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
23177443|NCT00531960|64393792|FG000|Overall Study|Adverse Event|5|||
23177444|NCT00531960|64393793|FG001|Overall Study|Adverse Event|4|||
23177445|NCT00531960|64393792|FG000|Overall Study|Death|3|||
23177446|NCT00531960|64393793|FG001|Overall Study|Death|2|||
23177447|NCT00531960|64393792|FG000|Overall Study|Lack of Efficacy|42|||
23177448|NCT00531960|64393793|FG001|Overall Study|Lack of Efficacy|41|||
23177449|NCT00531960|64393792|FG000|Overall Study|Violation of Selection Criteria|2|||
23177450|NCT00531960|64393793|FG001|Overall Study|Violation of Selection Criteria|0|||
23177451|NCT00531960|64393792|FG000|Overall Study|Refused Treatment|5|||
23177452|NCT00531960|64393793|FG001|Overall Study|Refused Treatment|6|||
23177453|NCT00531960|64393792|FG000|Overall Study|Other|4|||
23237718|NCT00379639|64615403|FG003|Overall Study|Other|0|||
23237719|NCT00379639|64615404|FG004|Overall Study|Other|0|||
23237720|NCT02452320|64615407|FG000|Overall Study|Adverse Event|0|||
23237721|NCT02452320|64615408|FG001|Overall Study|Adverse Event|1|||
23455130|NCT00129402|65409606|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
23455131|NCT00129402|65409600|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455132|NCT00129402|65409601|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455133|NCT00129402|65409602|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455134|NCT00129402|65409603|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455135|NCT00129402|65409604|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455136|NCT00129402|65409605|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
23455137|NCT00129402|65409606|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
23455138|NCT00129402|65409600|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23237722|NCT02195531|64615409|FG000|Overall Study|Withdrawal by Subject|1|||
23237723|NCT02195531|64615410|FG001|Overall Study|Withdrawal by Subject|1|||
23237724|NCT02195531|64615411|FG002|Overall Study|Withdrawal by Subject|1|||
23237725|NCT01098266|64615417|FG000|Overall Study|Physician Decision|1|||
23237726|NCT01098266|64615418|FG001|Overall Study|Physician Decision|0|||
23237727|NCT01098266|64615417|FG000|Overall Study|Death|3|||
23237728|NCT01098266|64615418|FG001|Overall Study|Death|2|||
23455139|NCT00129402|65409601|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455140|NCT00129402|65409602|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455141|NCT00129402|65409603|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455142|NCT00129402|65409604|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455143|NCT00129402|65409605|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
23455144|NCT00129402|65409606|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
23177454|NCT00531960|64393793|FG001|Overall Study|Other|10|||
23177455|NCT01709331|64393794|FG000|Overall Study|Adverse Event|1|||
23237729|NCT01098266|64615417|FG000|Overall Study|Withdrawal by Subject|3|||
23177456|NCT04698525|64393797|FG000|Overall Study|Lost to Follow-up|1|||
23237730|NCT01098266|64615418|FG001|Overall Study|Withdrawal by Subject|5|||
23237731|NCT04398030|64615419|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
23455145|NCT00129402|65409600|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455146|NCT00129402|65409601|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455147|NCT00129402|65409602|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455148|NCT00129402|65409603|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455149|NCT00129402|65409604|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455150|NCT00129402|65409605|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
23455151|NCT00129402|65409606|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
23455152|NCT04685798|65409607|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
23455153|NCT00997035|65409608|FG000|3-week Followup Visit|Lost to Follow-up|9|||
23455154|NCT00997035|65409609|FG001|3-week Followup Visit|Lost to Follow-up|6|||
23455155|NCT00997035|65409608|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
23455156|NCT00997035|65409609|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
23455157|NCT03309020|65409610|FG000|Overall Study|Death|1|||
23455158|NCT03309020|65409611|FG001|Overall Study|Death|0|||
23455159|NCT03309020|65409610|FG000|Overall Study|Did not undergo surgery|2|||
23455160|NCT03309020|65409611|FG001|Overall Study|Did not undergo surgery|1|||
23455161|NCT03858049|65409612|FG000|Overall Study|Adverse Event|16|||
23455162|NCT03858049|65409613|FG001|Overall Study|Adverse Event|9|||
23455163|NCT03858049|65409612|FG000|Overall Study|Other|1|||
23455164|NCT03858049|65409613|FG001|Overall Study|Other|1|||
23455165|NCT01045967|65409616|FG000|Second Intervention|Protocol Violation|0|||
23455166|NCT01045967|65409617|FG001|Second Intervention|Protocol Violation|1|||
23455167|NCT05482308|65409618|FG000|Overall Study|Withdrawal by Subject|1|||
23455168|NCT05482308|65409619|FG001|Overall Study|Withdrawal by Subject|0|||
23455169|NCT05482308|65409618|FG000|Overall Study|No longer meets eligibility criteria|0|||
23455170|NCT05482308|65409619|FG001|Overall Study|No longer meets eligibility criteria|1|||
23455171|NCT00904969|65409630|FG000|Overall Study|Lost to Follow-up|4|||
23455172|NCT00904969|65409630|FG000|Overall Study|Withdrawal by Subject|3|||
23455173|NCT00904969|65409630|FG000|Overall Study|Additional Treatments|11|||
23455174|NCT00904969|65409630|FG000|Overall Study|Case Aborted; Subject Exited|1|||
23455175|NCT00107653|65409635|FG000|Overall Study|Adverse Event|24|||
23455176|NCT00107653|65409636|FG001|Overall Study|Adverse Event|43|||
23455177|NCT00107653|65409635|FG000|Overall Study|Insufficient Therapeutic Response|25|||
23455178|NCT00107653|65409636|FG001|Overall Study|Insufficient Therapeutic Response|11|||
23455179|NCT00107653|65409635|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23455180|NCT00107653|65409636|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23455181|NCT00107653|65409635|FG000|Overall Study|Protocol Violation|1|||
23455182|NCT00107653|65409636|FG001|Overall Study|Protocol Violation|0|||
23455183|NCT00107653|65409635|FG000|Overall Study|Withdrawal by Subject|12|||
23455184|NCT00107653|65409636|FG001|Overall Study|Withdrawal by Subject|13|||
23455185|NCT00107653|65409635|FG000|Overall Study|Lost to Follow-up|13|||
23455186|NCT00107653|65409636|FG001|Overall Study|Lost to Follow-up|5|||
23455187|NCT00107653|65409635|FG000|Overall Study|Administrative Reasons|3|||
23455188|NCT00107653|65409636|FG001|Overall Study|Administrative Reasons|3|||
23455189|NCT04366349|65409637|FG000|Overall Study|Withdrawal by Subject|1|||
23455190|NCT04366349|65409638|FG001|Overall Study|Withdrawal by Subject|0|||
23455191|NCT04366349|65409639|FG002|Overall Study|Withdrawal by Subject|0|||
23455192|NCT04366349|65409640|FG003|Overall Study|Withdrawal by Subject|0|||
23455193|NCT04366349|65409641|FG004|Overall Study|Withdrawal by Subject|0|||
23455194|NCT04366349|65409642|FG005|Overall Study|Withdrawal by Subject|0|||
23455195|NCT02219464|65409645|FG000|Overall Study|Withdrawal by Subject|1|||
23455196|NCT02219464|65409646|FG001|Overall Study|Withdrawal by Subject|0|||
23455197|NCT02219464|65409645|FG000|Overall Study|case cancelled|1|||
23455198|NCT02219464|65409646|FG001|Overall Study|case cancelled|0|||
23455199|NCT02219464|65409645|FG000|Overall Study|catheter malfunction|1|||
23455200|NCT02219464|65409646|FG001|Overall Study|catheter malfunction|0|||
23455201|NCT03212326|65409647|FG000|Overall Study|Physician Decision|4|||
23455202|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
23455203|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
23455204|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
23455205|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
23455206|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
23455207|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
23455208|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
23455209|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23455210|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23455211|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
23455212|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23455213|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23455214|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
23455215|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
23455216|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
23455217|NCT01436149|65409652|FG000|Antidepressant Lead-in Phase|Other|119|||
23455218|NCT01436149|65409653|FG001|Antidepressant Lead-in Phase|Other|0|||
23455219|NCT01436149|65409654|FG002|Antidepressant Lead-in Phase|Other|0|||
23455220|NCT01436149|65409652|FG000|Randomized Phase|Adverse Event|9|||
23455221|NCT01436149|65409653|FG001|Randomized Phase|Adverse Event|10|||
23455222|NCT01436149|65409654|FG002|Randomized Phase|Adverse Event|11|||
23455223|NCT01436149|65409652|FG000|Randomized Phase|Protocol Violation|4|||
23455224|NCT01436149|65409653|FG001|Randomized Phase|Protocol Violation|5|||
23455225|NCT01436149|65409654|FG002|Randomized Phase|Protocol Violation|0|||
23455226|NCT01436149|65409652|FG000|Randomized Phase|Withdrawal by Subject|16|||
23455227|NCT01436149|65409653|FG001|Randomized Phase|Withdrawal by Subject|10|||
23455228|NCT01436149|65409654|FG002|Randomized Phase|Withdrawal by Subject|10|||
23455229|NCT01436149|65409652|FG000|Randomized Phase|Lost to Follow-up|34|||
23455230|NCT01436149|65409653|FG001|Randomized Phase|Lost to Follow-up|5|||
23455231|NCT01436149|65409654|FG002|Randomized Phase|Lost to Follow-up|6|||
23455232|NCT01436149|65409652|FG000|Randomized Phase|Lack of Efficacy|0|||
23455233|NCT01436149|65409653|FG001|Randomized Phase|Lack of Efficacy|0|||
23455234|NCT01436149|65409654|FG002|Randomized Phase|Lack of Efficacy|1|||
23455235|NCT01436149|65409652|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
23455236|NCT01436149|65409653|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
23455237|NCT01436149|65409654|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
23455238|NCT01436149|65409652|FG000|Randomized Phase|Other|12|||
23455239|NCT01436149|65409653|FG001|Randomized Phase|Other|5|||
23455240|NCT01436149|65409654|FG002|Randomized Phase|Other|11|||
23455241|NCT00642356|65409655|FG000|Overall Study|Adverse Event|1|||
23455242|NCT00642356|65409656|FG001|Overall Study|Adverse Event|0|||
23455243|NCT00642356|65409655|FG000|Overall Study|Protocol Violation|0|||
23455244|NCT00642356|65409656|FG001|Overall Study|Protocol Violation|3|||
23455245|NCT00642356|65409655|FG000|Overall Study|Lack of Efficacy|1|||
23455246|NCT00642356|65409656|FG001|Overall Study|Lack of Efficacy|0|||
23455247|NCT03040999|65409657|FG000|Overall Study|Lost to Follow-up|1|||
23455248|NCT03040999|65409658|FG001|Overall Study|Lost to Follow-up|0|||
23455249|NCT03040999|65409657|FG000|Overall Study|Withdrawal by Subject|7|||
23455250|NCT03040999|65409658|FG001|Overall Study|Withdrawal by Subject|12|||
23455251|NCT03040999|65409657|FG000|Overall Study|Death|128|||
23455252|NCT03040999|65409658|FG001|Overall Study|Death|138|||
23455253|NCT03040999|65409657|FG000|Overall Study|Participants Ongoing in Trial|266|||
23455254|NCT03040999|65409658|FG001|Overall Study|Participants Ongoing in Trial|252|||
23455255|NCT03416868|65409662|FG000|Overall Study|Withdrawal by Subject|2|||
23455256|NCT03416868|65409662|FG000|Overall Study|Lost to Follow-up|1|||
23455257|NCT03115359|65409666|FG000|Overall Study|Withdrawal by Subject|29|||
23455258|NCT03115359|65409667|FG001|Overall Study|Withdrawal by Subject|39|||
23455259|NCT03115359|65409666|FG000|Overall Study|Scheduling conflict|25|||
23455260|NCT03115359|65409667|FG001|Overall Study|Scheduling conflict|23|||
23455261|NCT03115359|65409666|FG000|Overall Study|Personal reasons including health|12|||
23455262|NCT03115359|65409667|FG001|Overall Study|Personal reasons including health|9|||
23455263|NCT03115359|65409666|FG000|Overall Study|Transportation barriers|3|||
23455264|NCT03115359|65409667|FG001|Overall Study|Transportation barriers|0|||
23455265|NCT03115359|65409666|FG000|Overall Study|No longer interested|5|||
23455266|NCT03115359|65409667|FG001|Overall Study|No longer interested|4|||
23455267|NCT03115359|65409666|FG000|Overall Study|No reason provided|45|||
23455268|NCT03115359|65409667|FG001|Overall Study|No reason provided|47|||
23455269|NCT01231984|65409668|FG000|Study Period 1|Withdrawal by Subject|0|||
23455270|NCT01231984|65409669|FG001|Study Period 1|Withdrawal by Subject|0|||
23455271|NCT01231984|65409670|FG002|Study Period 1|Withdrawal by Subject|0|||
23455272|NCT01231984|65409671|FG003|Study Period 1|Withdrawal by Subject|1|||
23455273|NCT01231984|65409668|FG000|Study Period 1|Lost to Follow-up|1|||
23455274|NCT01231984|65409669|FG001|Study Period 1|Lost to Follow-up|1|||
23455275|NCT01231984|65409670|FG002|Study Period 1|Lost to Follow-up|1|||
23455276|NCT01231984|65409671|FG003|Study Period 1|Lost to Follow-up|0|||
23455277|NCT01231984|65409668|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
23455278|NCT01231984|65409669|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
23455279|NCT01231984|65409670|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
23455280|NCT01231984|65409671|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
23455281|NCT01231984|65409668|FG000|Study Period 1|Screen Failure|0|||
23455282|NCT01231984|65409669|FG001|Study Period 1|Screen Failure|0|||
23455283|NCT01231984|65409670|FG002|Study Period 1|Screen Failure|0|||
23455284|NCT01231984|65409671|FG003|Study Period 1|Screen Failure|1|||
23455285|NCT01231984|65409668|FG000|Study Period 1|Non-compliance with study requirements|5|||
23455286|NCT01231984|65409669|FG001|Study Period 1|Non-compliance with study requirements|0|||
23455287|NCT01231984|65409670|FG002|Study Period 1|Non-compliance with study requirements|2|||
23455288|NCT01231984|65409671|FG003|Study Period 1|Non-compliance with study requirements|1|||
23455289|NCT01231984|65409668|FG000|Study Period 1|Protocol Violation|3|||
23455290|NCT01231984|65409669|FG001|Study Period 1|Protocol Violation|4|||
23455291|NCT01231984|65409670|FG002|Study Period 1|Protocol Violation|2|||
23455292|NCT01231984|65409671|FG003|Study Period 1|Protocol Violation|3|||
23455293|NCT01231984|65409668|FG000|Study Period 1|Adverse Event|1|||
23455294|NCT01231984|65409669|FG001|Study Period 1|Adverse Event|0|||
23455295|NCT01231984|65409670|FG002|Study Period 1|Adverse Event|0|||
23455296|NCT01231984|65409671|FG003|Study Period 1|Adverse Event|0|||
23455297|NCT01231984|65409668|FG000|Study Period 1|Other|0|||
23455298|NCT01231984|65409669|FG001|Study Period 1|Other|0|||
23455299|NCT01231984|65409670|FG002|Study Period 1|Other|0|||
23455300|NCT01231984|65409671|FG003|Study Period 1|Other|1|||
23455301|NCT01231984|65409668|FG000|Study Period 2|Withdrawal by Subject|1|||
23455302|NCT01231984|65409669|FG001|Study Period 2|Withdrawal by Subject|1|||
23455303|NCT01231984|65409670|FG002|Study Period 2|Withdrawal by Subject|0|||
23455304|NCT01231984|65409671|FG003|Study Period 2|Withdrawal by Subject|0|||
23455305|NCT01231984|65409668|FG000|Study Period 2|Lost to Follow-up|1|||
23455306|NCT01231984|65409669|FG001|Study Period 2|Lost to Follow-up|0|||
23455307|NCT01231984|65409670|FG002|Study Period 2|Lost to Follow-up|0|||
23455308|NCT01231984|65409671|FG003|Study Period 2|Lost to Follow-up|3|||
23455309|NCT01231984|65409668|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
23455310|NCT01231984|65409669|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
23455311|NCT01231984|65409670|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
23455312|NCT01231984|65409671|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
23455313|NCT02343263|65409672|FG000|Overall Study|Physician Decision|5|||
23455314|NCT02343263|65409673|FG001|Overall Study|Physician Decision|3|||
23455315|NCT02343263|65409674|FG002|Overall Study|Physician Decision|1|||
23455316|NCT02177123|65409675|FG000|Overall Study|Lost to Follow-up|6|||
23455317|NCT02177123|65409675|FG000|Overall Study|Withdrawal by Subject|4|||
23455318|NCT02177123|65409675|FG000|Overall Study|Adverse Event|4|||
23455319|NCT02177123|65409675|FG000|Overall Study|Physician Decision|3|||
23455320|NCT02177123|65409675|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
23455321|NCT02177123|65409675|FG000|Overall Study|Excluded for medical reasons|2|||
23455322|NCT02177123|65409675|FG000|Overall Study|Death|1|||
23455323|NCT02177123|65409675|FG000|Overall Study|Other|1|||
23455324|NCT02177123|65409675|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
23455325|NCT00445549|65409676|FG000|Overall Study|progressive disease|12|||
23455326|NCT01393158|65409677|FG000|Overall Study|Adverse Event|1|||
23455327|NCT01393158|65409678|FG001|Overall Study|Adverse Event|0|||
23455328|NCT04606134|65409679|FG000|Overall Study|Adverse Event|0|||
23455329|NCT04606134|65409680|FG001|Overall Study|Adverse Event|1|||
23455330|NCT00981656|65409681|FG000|Overall Study|Protocol Violation|1|||
23455331|NCT00981656|65409681|FG000|Overall Study|Did not start protocol treatment|2|||
23455332|NCT03924622|65409683|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
23455333|NCT03924622|65409684|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
23455334|NCT03924622|65409685|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
23455335|NCT03924622|65409686|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
23455336|NCT03924622|65409687|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
23455337|NCT03924622|65409688|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
23455338|NCT00894803|65409689|FG000|Overall Study|Death|20|||
23455339|NCT00894803|65409690|FG001|Overall Study|Death|4|||
23455340|NCT00894803|65409689|FG000|Overall Study|Lost to Follow-up|0|||
23455341|NCT00894803|65409690|FG001|Overall Study|Lost to Follow-up|1|||
23455342|NCT04416204|65409694|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
23455343|NCT04416204|65409695|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
23455344|NCT04416204|65409696|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
23455345|NCT04416204|65409697|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
23455346|NCT01690052|65409698|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
23455347|NCT01690052|65409699|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
23455348|NCT03253796|65409700|FG000|Period 1: Run-In|Adverse Event|4|||
23455349|NCT03253796|65409701|FG001|Period 1: Run-In|Adverse Event|0|||
23455350|NCT03253796|65409702|FG002|Period 1: Run-In|Adverse Event|0|||
23455351|NCT03253796|65409703|FG003|Period 1: Run-In|Adverse Event|0|||
23455352|NCT03253796|65409704|FG004|Period 1: Run-In|Adverse Event|0|||
23455353|NCT03253796|65409700|FG000|Period 1: Run-In|Lack of Efficacy|1|||
23455354|NCT03253796|65409701|FG001|Period 1: Run-In|Lack of Efficacy|0|||
23455355|NCT03253796|65409702|FG002|Period 1: Run-In|Lack of Efficacy|0|||
23582730|NCT01323660|65862532|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23582731|NCT01323660|65862533|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23582732|NCT01323660|65862534|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
23455356|NCT03253796|65409703|FG003|Period 1: Run-In|Lack of Efficacy|0|||
23455357|NCT03253796|65409704|FG004|Period 1: Run-In|Lack of Efficacy|0|||
23455358|NCT03253796|65409700|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
23455359|NCT03253796|65409701|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
23455360|NCT03253796|65409702|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
23455361|NCT03253796|65409703|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
23455362|NCT03253796|65409704|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
23455363|NCT03253796|65409700|FG000|Period 1: Run-In|Protocol Violation|5|||
23455364|NCT03253796|65409701|FG001|Period 1: Run-In|Protocol Violation|0|||
23455365|NCT03253796|65409702|FG002|Period 1: Run-In|Protocol Violation|0|||
23177457|NCT04698525|64393798|FG001|Overall Study|Lost to Follow-up|2|||
23177458|NCT04698525|64393797|FG000|Overall Study|Three suffered of Covid-19|2|||
23177459|NCT04698525|64393798|FG001|Overall Study|Three suffered of Covid-19|1|||
23177460|NCT01451645|64393799|FG000|Overall Study|Protocol Violation|1|||
23177461|NCT01451645|64393800|FG001|Overall Study|Protocol Violation|0|||
23177462|NCT01451645|64393799|FG000|Overall Study|Adverse Event|0|||
23455366|NCT03253796|65409703|FG003|Period 1: Run-In|Protocol Violation|0|||
23455367|NCT03253796|65409704|FG004|Period 1: Run-In|Protocol Violation|0|||
23455368|NCT03253796|65409700|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
23455369|NCT03253796|65409701|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
23455370|NCT03253796|65409702|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
23455371|NCT03253796|65409703|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
23455372|NCT03253796|65409704|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
23455373|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
23455374|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
23455375|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
23455376|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
23455377|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
23455378|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
23455379|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
23455380|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
23455381|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
23455382|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
23455383|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
23455384|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
23455385|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
23455386|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
23455387|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
23455388|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
23455389|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
23177463|NCT01451645|64393800|FG001|Overall Study|Adverse Event|3|||
23177464|NCT01451645|64393799|FG000|Overall Study|Withdrawal by Subject|4|||
23177465|NCT01451645|64393800|FG001|Overall Study|Withdrawal by Subject|2|||
23177466|NCT01451645|64393799|FG000|Overall Study|Lost to Follow-up|4|||
23177467|NCT01451645|64393800|FG001|Overall Study|Lost to Follow-up|3|||
23177468|NCT00654498|64393801|FG000|Overall Study|Not Treated|1|||
23177469|NCT00654498|64393802|FG001|Overall Study|Not Treated|0|||
23177470|NCT00654498|64393801|FG000|Overall Study|Adverse Event|6|||
23177471|NCT00654498|64393802|FG001|Overall Study|Adverse Event|1|||
23177472|NCT00654498|64393801|FG000|Overall Study|Protocol Violation|1|||
23177473|NCT00654498|64393802|FG001|Overall Study|Protocol Violation|1|||
23177474|NCT00654498|64393801|FG000|Overall Study|Lost to Follow-up|1|||
23177475|NCT00654498|64393802|FG001|Overall Study|Lost to Follow-up|5|||
23177476|NCT00654498|64393801|FG000|Overall Study|Withdrawal by Subject|1|||
23177477|NCT00654498|64393802|FG001|Overall Study|Withdrawal by Subject|0|||
23177478|NCT00654498|64393801|FG000|Overall Study|Other reason not defined above|4|||
23177479|NCT00654498|64393802|FG001|Overall Study|Other reason not defined above|5|||
23177480|NCT00621504|64393805|FG000|Overall Study|Adverse Event|1|||
23177481|NCT00621504|64393806|FG001|Overall Study|Adverse Event|3|||
23177482|NCT00621504|64393805|FG000|Overall Study|At the request of sponsor/investigator|1|||
23177483|NCT00621504|64393806|FG001|Overall Study|At the request of sponsor/investigator|0|||
23177484|NCT00621504|64393805|FG000|Overall Study|Withdrew consent|9|||
23177485|NCT00621504|64393806|FG001|Overall Study|Withdrew consent|6|||
23177486|NCT00621504|64393805|FG000|Overall Study|Lost to Follow-up|8|||
23177487|NCT00621504|64393806|FG001|Overall Study|Lost to Follow-up|10|||
23177488|NCT00621504|64393805|FG000|Overall Study|Other|1|||
23177489|NCT00621504|64393806|FG001|Overall Study|Other|0|||
23177490|NCT00621504|64393805|FG000|Overall Study|Death|6|||
23177491|NCT00621504|64393806|FG001|Overall Study|Death|6|||
23177492|NCT03029832|64393808|FG000|Overall Study|Safety Follow-Up Completed|2|||
23343730|NCT02883049|64999892|FG011|Post Induction|Moved to another non-COG institution|1|||
23343731|NCT02883049|64999893|FG012|Post Induction|Moved to another non-COG institution|0|||
23177493|NCT03029832|64393809|FG001|Overall Study|Safety Follow-Up Completed|0|||
23177494|NCT03029832|64393808|FG000|Overall Study|Death due to Disease Progression|1|||
23177495|NCT03029832|64393809|FG001|Overall Study|Death due to Disease Progression|0|||
23343732|NCT02883049|64999894|FG013|Post Induction|Moved to another non-COG institution|0|||
23455390|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
23582733|NCT01323660|65862535|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23177496|NCT03029832|64393808|FG000|Overall Study|Study Terminated By Sponsor|1|||
23177497|NCT03029832|64393809|FG001|Overall Study|Study Terminated By Sponsor|1|||
23343733|NCT02883049|64999895|FG014|Post Induction|Moved to another non-COG institution|0|||
23455391|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
23455392|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
23455393|NCT03253796|65409700|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
23455394|NCT03253796|65409701|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
23455395|NCT03253796|65409702|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
23455396|NCT03253796|65409703|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
23455397|NCT03253796|65409704|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
23455398|NCT03253796|65409700|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
23455399|NCT03253796|65409701|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
23455400|NCT03253796|65409702|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
23455401|NCT03253796|65409703|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
23455402|NCT03253796|65409704|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
23455403|NCT00436332|65409707|FG000|Overall Study|Adverse Event|9|||
23455404|NCT00436332|65409707|FG000|Overall Study|Withdrawal by Subject|2|||
23455405|NCT00436332|65409707|FG000|Overall Study|Progression|59|||
23455406|NCT00436332|65409707|FG000|Overall Study|Death|2|||
23455407|NCT00436332|65409707|FG000|Overall Study|Not Protocol Specified|6|||
23455408|NCT00436332|65409707|FG000|Overall Study|Ineligible|2|||
23455409|NCT00436332|65409707|FG000|Overall Study|Never Received Treatment|3|||
23455410|NCT00062439|65409708|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
23455411|NCT00062439|65409708|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
23455412|NCT00062439|65409708|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
23455413|NCT00062439|65409708|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
23455414|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Death|1|||
23455415|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Disease progression|2|||
23455416|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
23455417|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
23455418|NCT00062439|65409708|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
23455419|NCT00062439|65409708|FG000|Surgery|Physician Decision|4|||
23455420|NCT00062439|65409708|FG000|Surgery|Death|1|||
23455421|NCT00062439|65409708|FG000|Surgery|Adverse Event|2|||
23455422|NCT00062439|65409708|FG000|Consolidation Chemotherapy|Adverse Event|2|||
23455423|NCT04050553|65409709|FG000|Period 1|Physician Decision|2|||
23455424|NCT04050553|65409710|FG001|Period 1|Physician Decision|2|||
23455425|NCT04050553|65409709|FG000|Period 1|Adverse Event|1|||
23455426|NCT04050553|65409710|FG001|Period 1|Adverse Event|1|||
23455427|NCT04050553|65409709|FG000|Period 1|Withdrawal by Subject|0|||
23455428|NCT04050553|65409710|FG001|Period 1|Withdrawal by Subject|1|||
23455429|NCT04050553|65409709|FG000|Wash-out|Adverse Event|0|||
23455430|NCT04050553|65409710|FG001|Wash-out|Adverse Event|1|||
23455431|NCT04050553|65409709|FG000|Wash-out|Withdrawal by Subject|0|||
23455432|NCT04050553|65409710|FG001|Wash-out|Withdrawal by Subject|1|||
23455433|NCT00301808|65409711|FG000|Overall Study|Adverse Event|5|||
23455434|NCT00301808|65409711|FG000|Overall Study|Death|3|||
23455435|NCT00301808|65409711|FG000|Overall Study|Lack of Efficacy|4|||
23455436|NCT05473026|65409714|FG000|Overall Study|Lost to Follow-up|5|||
23455437|NCT05473026|65409715|FG001|Overall Study|Lost to Follow-up|2|||
23455438|NCT01009060|65409719|FG000|Overall Study|Adverse Event|1|||
23455439|NCT01009060|65409720|FG001|Overall Study|Adverse Event|2|||
23455440|NCT01009060|65409719|FG000|Overall Study|Protocol Violation|0|||
23455441|NCT01009060|65409720|FG001|Overall Study|Protocol Violation|1|||
23455442|NCT01009060|65409719|FG000|Overall Study|Lost to Follow-up|1|||
23455443|NCT01009060|65409720|FG001|Overall Study|Lost to Follow-up|0|||
23455444|NCT01009060|65409719|FG000|Overall Study|Physician Decision|1|||
23455445|NCT01009060|65409720|FG001|Overall Study|Physician Decision|1|||
23455446|NCT01009060|65409719|FG000|Overall Study|Withdrawal by Subject|1|||
23455447|NCT01009060|65409720|FG001|Overall Study|Withdrawal by Subject|1|||
23455448|NCT02927301|65409725|FG000|Overall Study|Death|39|||
23455449|NCT02927301|65409725|FG000|Overall Study|Lost to Follow-up|8|||
23455450|NCT02927301|65409725|FG000|Overall Study|Physician Decision|2|||
23455451|NCT02927301|65409725|FG000|Overall Study|Withdrawal by Subject|12|||
23455452|NCT02927301|65409725|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
23455453|NCT03337308|65409727|FG000|Overall Study|Adverse Event|2|||
23455454|NCT03337308|65409728|FG001|Overall Study|Adverse Event|3|||
23455455|NCT03337308|65409729|FG002|Overall Study|Adverse Event|3|||
23455456|NCT03337308|65409730|FG003|Overall Study|Adverse Event|1|||
23455457|NCT03337308|65409727|FG000|Overall Study|Lost to Follow-up|1|||
23455458|NCT03337308|65409728|FG001|Overall Study|Lost to Follow-up|2|||
23455459|NCT03337308|65409729|FG002|Overall Study|Lost to Follow-up|0|||
23455460|NCT03337308|65409730|FG003|Overall Study|Lost to Follow-up|0|||
23455461|NCT03337308|65409727|FG000|Overall Study|Withdrawal by Subject|2|||
23455462|NCT03337308|65409728|FG001|Overall Study|Withdrawal by Subject|1|||
23455463|NCT03337308|65409729|FG002|Overall Study|Withdrawal by Subject|2|||
23455464|NCT03337308|65409730|FG003|Overall Study|Withdrawal by Subject|1|||
23455465|NCT03337308|65409727|FG000|Overall Study|Protocol Violation|0|||
23455466|NCT03337308|65409728|FG001|Overall Study|Protocol Violation|1|||
23455467|NCT03337308|65409729|FG002|Overall Study|Protocol Violation|0|||
23455468|NCT03337308|65409730|FG003|Overall Study|Protocol Violation|0|||
23455469|NCT02163902|65409731|FG000|Overall Study|Subject's Request|3|||
23455470|NCT02163902|65409732|FG001|Overall Study|Subject's Request|4|||
23455471|NCT02163902|65409731|FG000|Overall Study|Lost to Follow-up|6|||
23455472|NCT02163902|65409732|FG001|Overall Study|Lost to Follow-up|7|||
23455473|NCT02163902|65409731|FG000|Overall Study|Administrative Decision|2|||
23455474|NCT02163902|65409732|FG001|Overall Study|Administrative Decision|2|||
23455475|NCT00453154|65409733|FG000|Double BIind Maintenance|Adverse Event|0|||
23455476|NCT00453154|65409734|FG001|Double BIind Maintenance|Adverse Event|0|||
23455477|NCT00453154|65409735|FG002|Double BIind Maintenance|Adverse Event|3|||
23455478|NCT00453154|65409736|FG003|Double BIind Maintenance|Adverse Event|12|||
23455479|NCT00453154|65409733|FG000|Double BIind Maintenance|Death|0|||
23455480|NCT00453154|65409734|FG001|Double BIind Maintenance|Death|0|||
23455481|NCT00453154|65409735|FG002|Double BIind Maintenance|Death|2|||
23455482|NCT00453154|65409736|FG003|Double BIind Maintenance|Death|1|||
23455483|NCT00453154|65409733|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
23455484|NCT00453154|65409734|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
23455485|NCT00453154|65409735|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
23455486|NCT00453154|65409736|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
23455487|NCT00453154|65409733|FG000|Double BIind Maintenance|Progression|0|||
23455488|NCT00453154|65409734|FG001|Double BIind Maintenance|Progression|0|||
23455489|NCT00453154|65409735|FG002|Double BIind Maintenance|Progression|29|||
23455490|NCT00453154|65409736|FG003|Double BIind Maintenance|Progression|26|||
23455491|NCT00453154|65409733|FG000|Double BIind Maintenance|Medical Issues|0|||
23455492|NCT00453154|65409734|FG001|Double BIind Maintenance|Medical Issues|0|||
23455493|NCT00453154|65409735|FG002|Double BIind Maintenance|Medical Issues|3|||
23237732|NCT04398030|64615420|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
23237733|NCT04398030|64615419|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
23455494|NCT00453154|65409736|FG003|Double BIind Maintenance|Medical Issues|1|||
23455495|NCT00453154|65409733|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
23455496|NCT00453154|65409734|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
23455497|NCT00453154|65409735|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
23455498|NCT00453154|65409736|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
23455499|NCT04869982|65409740|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
23455500|NCT04869982|65409741|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
23455501|NCT04869982|65409740|FG000|Overall Study|Migrated / moved from the study area|1|||
23455502|NCT04869982|65409741|FG001|Overall Study|Migrated / moved from the study area|1|||
23455503|NCT04869982|65409740|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
23455504|NCT04869982|65409741|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
23455505|NCT04869982|65409740|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
23582734|NCT01688973|65862536|FG000|Overall Study|Ineligible|2|||
23582735|NCT01688973|65862537|FG001|Overall Study|Ineligible|3|||
23582736|NCT00567164|65862538|FG000|Overall Study|Withdrawal by Subject|171|||
23237734|NCT04398030|64615420|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
23237735|NCT01013207|64615424|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
23237736|NCT01821391|64615430|FG000|Overall Study|Adverse Event|1|||
23237737|NCT01821391|64615431|FG001|Overall Study|Adverse Event|0|||
23237738|NCT03781167|64615432|FG000|Overall Study|Adverse Event|23|||
23237739|NCT03781167|64615433|FG001|Overall Study|Adverse Event|25|||
23237740|NCT03781167|64615432|FG000|Overall Study|Withdrew consent|16|||
23237741|NCT03781167|64615433|FG001|Overall Study|Withdrew consent|12|||
23237742|NCT03781167|64615432|FG000|Overall Study|Lost to Follow-up|0|||
23237743|NCT03781167|64615433|FG001|Overall Study|Lost to Follow-up|1|||
23237744|NCT03781167|64615432|FG000|Overall Study|Lack of Efficacy|4|||
23237745|NCT03781167|64615433|FG001|Overall Study|Lack of Efficacy|5|||
23237746|NCT03781167|64615432|FG000|Overall Study|Difficulty with drug delivery system|2|||
23237747|NCT03781167|64615433|FG001|Overall Study|Difficulty with drug delivery system|3|||
23237748|NCT03781167|64615432|FG000|Overall Study|Other, not specified|2|||
23237749|NCT03781167|64615433|FG001|Overall Study|Other, not specified|2|||
23237750|NCT04678557|64615435|FG000|Overall Study|Withdrawal by Subject|1|||
23343734|NCT02883049|64999896|FG015|Post Induction|Moved to another non-COG institution|0|||
23455506|NCT04869982|65409741|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
23582737|NCT00567164|65862539|FG001|Overall Study|Withdrawal by Subject|21|||
23582738|NCT00567164|65862540|FG002|Overall Study|Withdrawal by Subject|17|||
23582739|NCT00567164|65862538|FG000|Overall Study|Protocol Violation|23|||
23177498|NCT01752023|64393810|FG000|Overall Study|Physician Decision|2|||
23177499|NCT01752023|64393811|FG001|Overall Study|Physician Decision|1|||
23177500|NCT01756274|64393812|FG000|Overall Study|Protocol Violation|2|||
23177501|NCT01756274|64393812|FG000|Overall Study|Laboratory error|1|||
23177502|NCT00552110|64393813|FG000|Overall Study|Serious or Life-Threatening AE|0|||
23177503|NCT00552110|64393814|FG001|Overall Study|Serious or Life-Threatening AE|0|||
23177504|NCT00552110|64393815|FG002|Overall Study|Serious or Life-Threatening AE|1|||
23177505|NCT00552110|64393816|FG003|Overall Study|Serious or Life-Threatening AE|0|||
23177506|NCT00552110|64393817|FG004|Overall Study|Serious or Life-Threatening AE|0|||
23177507|NCT00552110|64393813|FG000|Overall Study|Lack of Efficacy|1|||
23177508|NCT00552110|64393814|FG001|Overall Study|Lack of Efficacy|0|||
23177509|NCT00552110|64393815|FG002|Overall Study|Lack of Efficacy|0|||
23177510|NCT00552110|64393816|FG003|Overall Study|Lack of Efficacy|1|||
23177511|NCT00552110|64393817|FG004|Overall Study|Lack of Efficacy|4|||
23177512|NCT00552110|64393813|FG000|Overall Study|Withdrawal by Subject|0|||
23177513|NCT00552110|64393814|FG001|Overall Study|Withdrawal by Subject|2|||
23177514|NCT00552110|64393815|FG002|Overall Study|Withdrawal by Subject|0|||
23177515|NCT00552110|64393816|FG003|Overall Study|Withdrawal by Subject|3|||
23177516|NCT00552110|64393817|FG004|Overall Study|Withdrawal by Subject|2|||
23177517|NCT00552110|64393813|FG000|Overall Study|Lost to Follow-up|0|||
23177518|NCT00552110|64393814|FG001|Overall Study|Lost to Follow-up|0|||
23177519|NCT00552110|64393815|FG002|Overall Study|Lost to Follow-up|0|||
23177520|NCT00552110|64393816|FG003|Overall Study|Lost to Follow-up|1|||
23177521|NCT00552110|64393817|FG004|Overall Study|Lost to Follow-up|1|||
23177522|NCT00552110|64393813|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
23177523|NCT00552110|64393814|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
23237751|NCT04678557|64615436|FG001|Overall Study|Withdrawal by Subject|0|||
23237752|NCT04678557|64615435|FG000|Overall Study|Lack of Efficacy|0|||
23582740|NCT00567164|65862539|FG001|Overall Study|Protocol Violation|4|||
23177524|NCT00552110|64393815|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
23177525|NCT00552110|64393816|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
23237753|NCT04678557|64615436|FG001|Overall Study|Lack of Efficacy|13|||
23343735|NCT02883049|64999881|FG000|Post Induction|Randomization closed|0|||
23177526|NCT00552110|64393817|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
23237754|NCT04678557|64615435|FG000|Overall Study|Safety Evaluation|0|||
23343736|NCT02883049|64999882|FG001|Post Induction|Randomization closed|0|||
23343737|NCT02883049|64999883|FG002|Post Induction|Randomization closed|0|||
23343738|NCT02883049|64999884|FG003|Post Induction|Randomization closed|0|||
23343739|NCT02883049|64999885|FG004|Post Induction|Randomization closed|0|||
23343740|NCT02883049|64999886|FG005|Post Induction|Randomization closed|0|||
23343741|NCT02883049|64999887|FG006|Post Induction|Randomization closed|0|||
23343742|NCT02883049|64999888|FG007|Post Induction|Randomization closed|20|||
23343743|NCT02883049|64999889|FG008|Post Induction|Randomization closed|0|||
23343744|NCT02883049|64999890|FG009|Post Induction|Randomization closed|0|||
23343745|NCT02883049|64999891|FG010|Post Induction|Randomization closed|0|||
23343746|NCT02883049|64999892|FG011|Post Induction|Randomization closed|0|||
23343747|NCT02883049|64999893|FG012|Post Induction|Randomization closed|0|||
23343748|NCT02883049|64999894|FG013|Post Induction|Randomization closed|0|||
23343749|NCT02883049|64999895|FG014|Post Induction|Randomization closed|0|||
23343750|NCT02883049|64999896|FG015|Post Induction|Randomization closed|0|||
23343751|NCT02883049|64999881|FG000|Post Induction|MRD negative|0|||
23455507|NCT04869982|65409740|FG000|Overall Study|Solicited adverse event|2|||
23455508|NCT04869982|65409741|FG001|Overall Study|Solicited adverse event|1|||
23582741|NCT00567164|65862540|FG002|Overall Study|Protocol Violation|2|||
23582742|NCT00567164|65862538|FG000|Overall Study|Adverse Event|92|||
23582743|NCT00567164|65862539|FG001|Overall Study|Adverse Event|13|||
23582744|NCT00567164|65862540|FG002|Overall Study|Adverse Event|9|||
23582745|NCT00567164|65862538|FG000|Overall Study|Death|0|||
23582746|NCT00567164|65862539|FG001|Overall Study|Death|0|||
23582747|NCT00567164|65862540|FG002|Overall Study|Death|1|||
23582748|NCT00567164|65862538|FG000|Overall Study|Lost to Follow-up|202|||
23582749|NCT00567164|65862539|FG001|Overall Study|Lost to Follow-up|23|||
23582750|NCT00567164|65862540|FG002|Overall Study|Lost to Follow-up|21|||
23582751|NCT00567164|65862538|FG000|Overall Study|Pregnancy|20|||
23582752|NCT00567164|65862539|FG001|Overall Study|Pregnancy|4|||
23582753|NCT00567164|65862540|FG002|Overall Study|Pregnancy|6|||
23582754|NCT00567164|65862538|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
23582755|NCT00567164|65862539|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
23582756|NCT00567164|65862540|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
23582757|NCT00567164|65862538|FG000|Overall Study|Missing|1|||
23582758|NCT00567164|65862539|FG001|Overall Study|Missing|0|||
23582759|NCT00567164|65862540|FG002|Overall Study|Missing|0|||
23582760|NCT04984876|65862543|FG000|Overall Study|Subject decision|2|||
23582761|NCT04984876|65862544|FG001|Overall Study|Subject decision|10|||
23582762|NCT04984876|65862545|FG002|Overall Study|Subject decision|3|||
23582763|NCT04984876|65862546|FG003|Overall Study|Subject decision|3|||
23582764|NCT04984876|65862547|FG004|Overall Study|Subject decision|3|||
23582765|NCT04984876|65862548|FG005|Overall Study|Subject decision|0|||
23582766|NCT04984876|65862543|FG000|Overall Study|Guardian decision|0|||
23582767|NCT04984876|65862544|FG001|Overall Study|Guardian decision|1|||
23582768|NCT04984876|65862545|FG002|Overall Study|Guardian decision|0|||
23582769|NCT04984876|65862546|FG003|Overall Study|Guardian decision|2|||
23582770|NCT04984876|65862547|FG004|Overall Study|Guardian decision|0|||
23582771|NCT04984876|65862548|FG005|Overall Study|Guardian decision|1|||
23177527|NCT00552110|64393813|FG000|Overall Study|Withdrawn per Sponsor|0|||
23177528|NCT00552110|64393814|FG001|Overall Study|Withdrawn per Sponsor|1|||
23177529|NCT00552110|64393815|FG002|Overall Study|Withdrawn per Sponsor|0|||
23177530|NCT00552110|64393816|FG003|Overall Study|Withdrawn per Sponsor|0|||
23177531|NCT00552110|64393817|FG004|Overall Study|Withdrawn per Sponsor|1|||
23177532|NCT00552110|64393813|FG000|Overall Study|Use of Prohibited Medication|1|||
23177533|NCT00552110|64393814|FG001|Overall Study|Use of Prohibited Medication|1|||
23177534|NCT00552110|64393815|FG002|Overall Study|Use of Prohibited Medication|0|||
23177535|NCT00552110|64393816|FG003|Overall Study|Use of Prohibited Medication|0|||
23177536|NCT00552110|64393817|FG004|Overall Study|Use of Prohibited Medication|0|||
23177537|NCT00552110|64393813|FG000|Overall Study|Delay of Study due to Relabeling|0|||
23177538|NCT00552110|64393814|FG001|Overall Study|Delay of Study due to Relabeling|0|||
23177539|NCT00552110|64393815|FG002|Overall Study|Delay of Study due to Relabeling|0|||
23177540|NCT00552110|64393816|FG003|Overall Study|Delay of Study due to Relabeling|1|||
23177541|NCT00552110|64393817|FG004|Overall Study|Delay of Study due to Relabeling|0|||
23177542|NCT00552110|64393813|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
23177543|NCT00552110|64393814|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
23177544|NCT00552110|64393815|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
23177545|NCT00552110|64393816|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
23177546|NCT00552110|64393817|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
23177547|NCT00552110|64393813|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
23177548|NCT00552110|64393814|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
23343752|NCT02883049|64999882|FG001|Post Induction|MRD negative|0|||
23343753|NCT02883049|64999883|FG002|Post Induction|MRD negative|0|||
23343754|NCT02883049|64999884|FG003|Post Induction|MRD negative|0|||
23582772|NCT04984876|65862543|FG000|Overall Study|Lost to Follow-up|0|||
23582773|NCT04984876|65862544|FG001|Overall Study|Lost to Follow-up|0|||
23582774|NCT04984876|65862545|FG002|Overall Study|Lost to Follow-up|1|||
23343755|NCT02883049|64999885|FG004|Post Induction|MRD negative|0|||
23343756|NCT02883049|64999886|FG005|Post Induction|MRD negative|0|||
23343757|NCT02883049|64999887|FG006|Post Induction|MRD negative|0|||
23177549|NCT00552110|64393815|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
23177550|NCT00552110|64393816|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
23343758|NCT02883049|64999888|FG007|Post Induction|MRD negative|11|||
23343759|NCT02883049|64999889|FG008|Post Induction|MRD negative|0|||
23343760|NCT02883049|64999890|FG009|Post Induction|MRD negative|0|||
23343761|NCT02883049|64999891|FG010|Post Induction|MRD negative|0|||
23177551|NCT00552110|64393817|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
23177552|NCT01934140|64393820|FG000|Persistence Phase (Year 6-10)|Other|24|||
23177553|NCT01934140|64393821|FG001|Persistence Phase (Year 6-10)|Other|6|||
23177554|NCT01934140|64393820|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
23177555|NCT01934140|64393821|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
23177556|NCT01934140|64393820|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
23177557|NCT01934140|64393821|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
23343762|NCT02883049|64999892|FG011|Post Induction|MRD negative|0|||
23343763|NCT02883049|64999893|FG012|Post Induction|MRD negative|0|||
23343764|NCT02883049|64999894|FG013|Post Induction|MRD negative|0|||
23582775|NCT04984876|65862546|FG003|Overall Study|Lost to Follow-up|1|||
23582776|NCT04984876|65862547|FG004|Overall Study|Lost to Follow-up|0|||
23343765|NCT02883049|64999895|FG014|Post Induction|MRD negative|0|||
23582777|NCT04984876|65862548|FG005|Overall Study|Lost to Follow-up|0|||
23343766|NCT02883049|64999896|FG015|Post Induction|MRD negative|0|||
23177558|NCT01934140|64393820|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
23177559|NCT01934140|64393821|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
23343767|NCT02883049|64999881|FG000|Post Induction|Developed SMN|0|||
23343768|NCT02883049|64999882|FG001|Post Induction|Developed SMN|0|||
23343769|NCT02883049|64999883|FG002|Post Induction|Developed SMN|0|||
23343770|NCT02883049|64999884|FG003|Post Induction|Developed SMN|0|||
23343771|NCT02883049|64999885|FG004|Post Induction|Developed SMN|1|||
23343772|NCT02883049|64999886|FG005|Post Induction|Developed SMN|0|||
23343773|NCT02883049|64999887|FG006|Post Induction|Developed SMN|1|||
23343774|NCT02883049|64999888|FG007|Post Induction|Developed SMN|0|||
23177560|NCT01934140|64393820|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
23177561|NCT01934140|64393821|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
23177562|NCT01934140|64393820|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
23177563|NCT01934140|64393821|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
23237755|NCT04678557|64615436|FG001|Overall Study|Safety Evaluation|1|||
23237756|NCT00368069|64615437|FG000|Overall Study|Adverse Event|5|||
23237757|NCT00368069|64615438|FG001|Overall Study|Adverse Event|2|||
23237758|NCT00368069|64615437|FG000|Overall Study|Lack of Efficacy|0|||
23343775|NCT02883049|64999889|FG008|Post Induction|Developed SMN|0|||
23343776|NCT02883049|64999890|FG009|Post Induction|Developed SMN|0|||
23343777|NCT02883049|64999891|FG010|Post Induction|Developed SMN|1|||
23343778|NCT02883049|64999892|FG011|Post Induction|Developed SMN|1|||
23343779|NCT02883049|64999893|FG012|Post Induction|Developed SMN|0|||
23343780|NCT02883049|64999894|FG013|Post Induction|Developed SMN|0|||
23343781|NCT02883049|64999895|FG014|Post Induction|Developed SMN|1|||
23343782|NCT02883049|64999896|FG015|Post Induction|Developed SMN|0|||
23343783|NCT02883049|64999881|FG000|Post Induction|Enrolled onto another COG study|0|||
23343784|NCT02883049|64999882|FG001|Post Induction|Enrolled onto another COG study|0|||
23343785|NCT02883049|64999883|FG002|Post Induction|Enrolled onto another COG study|0|||
23343786|NCT02883049|64999884|FG003|Post Induction|Enrolled onto another COG study|1|||
23343787|NCT02883049|64999885|FG004|Post Induction|Enrolled onto another COG study|1|||
23177564|NCT01934140|64393820|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
23237759|NCT00368069|64615438|FG001|Overall Study|Lack of Efficacy|1|||
23237760|NCT00368069|64615437|FG000|Overall Study|Lost to Follow-up|1|||
23237761|NCT00368069|64615438|FG001|Overall Study|Lost to Follow-up|0|||
23237762|NCT00368069|64615437|FG000|Overall Study|Protocol Violation|0|||
23343788|NCT02883049|64999886|FG005|Post Induction|Enrolled onto another COG study|0|||
23343789|NCT02883049|64999887|FG006|Post Induction|Enrolled onto another COG study|0|||
23343790|NCT02883049|64999888|FG007|Post Induction|Enrolled onto another COG study|4|||
23177565|NCT01934140|64393821|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
23237763|NCT00368069|64615438|FG001|Overall Study|Protocol Violation|2|||
23237764|NCT00368069|64615437|FG000|Overall Study|Withdrawal of Consent|2|||
23343791|NCT02883049|64999889|FG008|Post Induction|Enrolled onto another COG study|0|||
23343792|NCT02883049|64999890|FG009|Post Induction|Enrolled onto another COG study|0|||
23343793|NCT02883049|64999891|FG010|Post Induction|Enrolled onto another COG study|0|||
23343794|NCT02883049|64999892|FG011|Post Induction|Enrolled onto another COG study|2|||
23343795|NCT02883049|64999893|FG012|Post Induction|Enrolled onto another COG study|0|||
23343796|NCT02883049|64999894|FG013|Post Induction|Enrolled onto another COG study|1|||
23343797|NCT02883049|64999895|FG014|Post Induction|Enrolled onto another COG study|0|||
23343798|NCT02883049|64999896|FG015|Post Induction|Enrolled onto another COG study|0|||
23582778|NCT04984876|65862543|FG000|Overall Study|Physician Decision|1|||
23177566|NCT01934140|64393820|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
23177567|NCT01934140|64393821|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
23177568|NCT01220414|64393822|FG000|Overall Study|Withdrawal by Subject|1|||
23177569|NCT01220414|64393823|FG001|Overall Study|Withdrawal by Subject|0|||
23177570|NCT01220414|64393824|FG002|Overall Study|Withdrawal by Subject|0|||
23177571|NCT01220414|64393825|FG003|Overall Study|Withdrawal by Subject|1|||
23177572|NCT02908516|64393826|FG000|Overall Study|Study Terminated|3|||
23177573|NCT02908516|64393827|FG001|Overall Study|Study Terminated|3|||
23343799|NCT02883049|64999881|FG000|Post Induction|Recurrent leukemia|0|||
23343800|NCT02883049|64999882|FG001|Post Induction|Recurrent leukemia|0|||
23343801|NCT02883049|64999883|FG002|Post Induction|Recurrent leukemia|0|||
23343802|NCT02883049|64999884|FG003|Post Induction|Recurrent leukemia|17|||
23343803|NCT02883049|64999885|FG004|Post Induction|Recurrent leukemia|12|||
23237765|NCT00368069|64615438|FG001|Overall Study|Withdrawal of Consent|1|||
23237766|NCT00368069|64615437|FG000|Overall Study|no blood sampling possible|0|||
23237767|NCT00368069|64615438|FG001|Overall Study|no blood sampling possible|1|||
23237768|NCT00948896|64615441|FG000|Randomization to 24 Months of Age|Death|1|||
23237769|NCT00948896|64615442|FG001|Randomization to 24 Months of Age|Death|0|||
23343804|NCT02883049|64999886|FG005|Post Induction|Recurrent leukemia|4|||
23343805|NCT02883049|64999887|FG006|Post Induction|Recurrent leukemia|1|||
23343806|NCT02883049|64999888|FG007|Post Induction|Recurrent leukemia|13|||
23343807|NCT02883049|64999889|FG008|Post Induction|Recurrent leukemia|27|||
23343808|NCT02883049|64999890|FG009|Post Induction|Recurrent leukemia|5|||
23343809|NCT02883049|64999891|FG010|Post Induction|Recurrent leukemia|3|||
23343810|NCT02883049|64999892|FG011|Post Induction|Recurrent leukemia|12|||
23343811|NCT02883049|64999893|FG012|Post Induction|Recurrent leukemia|1|||
23343812|NCT02883049|64999894|FG013|Post Induction|Recurrent leukemia|1|||
23343813|NCT02883049|64999895|FG014|Post Induction|Recurrent leukemia|9|||
23343814|NCT02883049|64999896|FG015|Post Induction|Recurrent leukemia|3|||
23343815|NCT02883049|64999881|FG000|Post Induction|Induction Failure|0|||
23343816|NCT02883049|64999882|FG001|Post Induction|Induction Failure|0|||
23343817|NCT02883049|64999883|FG002|Post Induction|Induction Failure|0|||
23343818|NCT02883049|64999884|FG003|Post Induction|Induction Failure|0|||
23343819|NCT02883049|64999885|FG004|Post Induction|Induction Failure|0|||
23343820|NCT02883049|64999886|FG005|Post Induction|Induction Failure|0|||
23343821|NCT02883049|64999887|FG006|Post Induction|Induction Failure|0|||
23455509|NCT02636699|65409742|FG000|Overall Study|Adverse Event|4|||
23177574|NCT00944034|64393828|FG000|Overall Study|Inappropriate enrollment|0|||
23177575|NCT00944034|64393829|FG001|Overall Study|Inappropriate enrollment|1|||
23177576|NCT00944034|64393830|FG002|Overall Study|Inappropriate enrollment|0|||
23177577|NCT00944034|64393831|FG003|Overall Study|Inappropriate enrollment|1|||
23177578|NCT00944034|64393832|FG004|Overall Study|Inappropriate enrollment|2|||
23177579|NCT00944034|64393833|FG005|Overall Study|Inappropriate enrollment|1|||
23177580|NCT00944034|64393834|FG006|Overall Study|Inappropriate enrollment|0|||
23177581|NCT00944034|64393835|FG007|Overall Study|Inappropriate enrollment|0|||
23177582|NCT00944034|64393836|FG008|Overall Study|Inappropriate enrollment|1|||
23177583|NCT00944034|64393837|FG009|Overall Study|Inappropriate enrollment|1|||
23177584|NCT00944034|64393838|FG010|Overall Study|Inappropriate enrollment|0|||
23177585|NCT00944034|64393839|FG011|Overall Study|Inappropriate enrollment|0|||
23237770|NCT00948896|64615443|FG002|Randomization to 24 Months of Age|Death|0|||
23237771|NCT00948896|64615444|FG003|Randomization to 24 Months of Age|Death|0|||
23237772|NCT00948896|64615445|FG004|Randomization to 24 Months of Age|Death|2|||
23237773|NCT00948896|64615446|FG005|Randomization to 24 Months of Age|Death|1|||
23237774|NCT00948896|64615447|FG006|Randomization to 24 Months of Age|Death|2|||
23237775|NCT00948896|64615448|FG007|Randomization to 24 Months of Age|Death|1|||
23237776|NCT00948896|64615441|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
23237777|NCT00948896|64615442|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
23237778|NCT00948896|64615443|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
23237779|NCT00948896|64615444|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
23237780|NCT00948896|64615445|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
23237781|NCT00948896|64615446|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
23237782|NCT00948896|64615447|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
23237783|NCT00948896|64615448|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
23237784|NCT00948896|64615441|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
23237785|NCT00948896|64615442|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
23343822|NCT02883049|64999888|FG007|Post Induction|Induction Failure|2|||
23343823|NCT02883049|64999889|FG008|Post Induction|Induction Failure|2|||
23343824|NCT02883049|64999890|FG009|Post Induction|Induction Failure|0|||
23343825|NCT02883049|64999891|FG010|Post Induction|Induction Failure|0|||
23343826|NCT02883049|64999892|FG011|Post Induction|Induction Failure|0|||
23343827|NCT02883049|64999893|FG012|Post Induction|Induction Failure|0|||
23343828|NCT02883049|64999894|FG013|Post Induction|Induction Failure|2|||
23177586|NCT00944034|64393828|FG000|Overall Study|Withdrawal by Subject|3|||
23177587|NCT00944034|64393829|FG001|Overall Study|Withdrawal by Subject|2|||
23177588|NCT00944034|64393830|FG002|Overall Study|Withdrawal by Subject|6|||
23343829|NCT02883049|64999895|FG014|Post Induction|Induction Failure|0|||
23343830|NCT02883049|64999896|FG015|Post Induction|Induction Failure|0|||
23343831|NCT04506905|64999910|FG000|Overall Study|Lost to Follow-up|1|||
23343832|NCT04506905|64999911|FG001|Overall Study|Lost to Follow-up|0|||
23343833|NCT04506905|64999912|FG002|Overall Study|Lost to Follow-up|0|||
23343834|NCT04506905|64999913|FG003|Overall Study|Lost to Follow-up|1|||
23343835|NCT04506905|64999914|FG004|Overall Study|Lost to Follow-up|0|||
23343836|NCT04506905|64999915|FG005|Overall Study|Lost to Follow-up|0|||
23343837|NCT04506905|64999916|FG006|Overall Study|Lost to Follow-up|0|||
23343838|NCT04506905|64999917|FG007|Overall Study|Lost to Follow-up|0|||
23343839|NCT04506905|64999918|FG008|Overall Study|Lost to Follow-up|0|||
23343840|NCT04506905|64999910|FG000|Overall Study|Withdrawal by Subject|0|||
23343841|NCT04506905|64999911|FG001|Overall Study|Withdrawal by Subject|0|||
23343842|NCT04506905|64999912|FG002|Overall Study|Withdrawal by Subject|0|||
23343843|NCT04506905|64999913|FG003|Overall Study|Withdrawal by Subject|2|||
23343844|NCT04506905|64999914|FG004|Overall Study|Withdrawal by Subject|0|||
23343845|NCT04506905|64999915|FG005|Overall Study|Withdrawal by Subject|0|||
23343846|NCT04506905|64999916|FG006|Overall Study|Withdrawal by Subject|0|||
23343847|NCT04506905|64999917|FG007|Overall Study|Withdrawal by Subject|0|||
23343848|NCT04506905|64999918|FG008|Overall Study|Withdrawal by Subject|0|||
23343849|NCT04776018|64999919|FG000|Overall Study|Death|0|||
23343850|NCT04776018|64999920|FG001|Overall Study|Death|1|||
23343851|NCT04776018|64999921|FG002|Overall Study|Death|4|||
23343852|NCT04776018|64999922|FG003|Overall Study|Death|1|||
23343853|NCT04776018|64999923|FG004|Overall Study|Death|4|||
23343854|NCT04776018|64999924|FG005|Overall Study|Death|0|||
23343855|NCT04776018|64999925|FG006|Overall Study|Death|0|||
23343856|NCT04776018|64999919|FG000|Overall Study|Study terminated by sponsor|2|||
23343857|NCT04776018|64999920|FG001|Overall Study|Study terminated by sponsor|1|||
23343858|NCT04776018|64999921|FG002|Overall Study|Study terminated by sponsor|4|||
23343859|NCT04776018|64999922|FG003|Overall Study|Study terminated by sponsor|0|||
23343860|NCT04776018|64999923|FG004|Overall Study|Study terminated by sponsor|3|||
23343861|NCT04776018|64999924|FG005|Overall Study|Study terminated by sponsor|0|||
23343862|NCT04776018|64999925|FG006|Overall Study|Study terminated by sponsor|0|||
23343863|NCT04776018|64999919|FG000|Overall Study|Withdrawal by Subject|1|||
23343864|NCT04776018|64999920|FG001|Overall Study|Withdrawal by Subject|0|||
23343865|NCT04776018|64999921|FG002|Overall Study|Withdrawal by Subject|0|||
23343866|NCT04776018|64999922|FG003|Overall Study|Withdrawal by Subject|2|||
23343867|NCT04776018|64999923|FG004|Overall Study|Withdrawal by Subject|1|||
23343868|NCT04776018|64999924|FG005|Overall Study|Withdrawal by Subject|0|||
23343869|NCT04776018|64999925|FG006|Overall Study|Withdrawal by Subject|0|||
23343870|NCT04776018|64999919|FG000|Overall Study|Other|0|||
23343871|NCT04776018|64999920|FG001|Overall Study|Other|1|||
23343872|NCT04776018|64999921|FG002|Overall Study|Other|1|||
23343873|NCT04776018|64999922|FG003|Overall Study|Other|0|||
23343874|NCT04776018|64999923|FG004|Overall Study|Other|0|||
23343875|NCT04776018|64999924|FG005|Overall Study|Other|0|||
23343876|NCT04776018|64999925|FG006|Overall Study|Other|0|||
23343877|NCT04776018|64999919|FG000|Overall Study|Lost to Follow-up|0|||
23343878|NCT04776018|64999920|FG001|Overall Study|Lost to Follow-up|0|||
23343879|NCT04776018|64999921|FG002|Overall Study|Lost to Follow-up|1|||
23343880|NCT04776018|64999922|FG003|Overall Study|Lost to Follow-up|0|||
23343881|NCT04776018|64999923|FG004|Overall Study|Lost to Follow-up|0|||
23343882|NCT04776018|64999924|FG005|Overall Study|Lost to Follow-up|0|||
23343883|NCT04776018|64999925|FG006|Overall Study|Lost to Follow-up|0|||
23343884|NCT04696861|65001488|FG000|Overall Study|Death|1|||
23343885|NCT04696861|65001489|FG001|Overall Study|Death|0|||
23343886|NCT04696861|65001488|FG000|Overall Study|Lost to Follow-up|3|||
23343887|NCT04696861|65001489|FG001|Overall Study|Lost to Follow-up|0|||
23343888|NCT01984892|65001490|FG000|Overall Study|Progressive disease|7|||
23343889|NCT01093326|65001494|FG000|Overall Study|Death|0|||
23343890|NCT01093326|65001495|FG001|Overall Study|Death|1|||
23343891|NCT01093326|65001496|FG002|Overall Study|Death|0|||
23343892|NCT01093326|65001494|FG000|Overall Study|Lack of Efficacy|7|||
23343893|NCT01093326|65001495|FG001|Overall Study|Lack of Efficacy|6|||
23343894|NCT01093326|65001496|FG002|Overall Study|Lack of Efficacy|3|||
23343895|NCT01093326|65001494|FG000|Overall Study|Lost to Follow-up|2|||
23343896|NCT01093326|65001495|FG001|Overall Study|Lost to Follow-up|5|||
23343897|NCT01093326|65001496|FG002|Overall Study|Lost to Follow-up|4|||
23343898|NCT01093326|65001494|FG000|Overall Study|Physician Decision|3|||
23343899|NCT01093326|65001495|FG001|Overall Study|Physician Decision|1|||
23343900|NCT01093326|65001496|FG002|Overall Study|Physician Decision|3|||
23343901|NCT01093326|65001494|FG000|Overall Study|Withdrawal by Subject|30|||
23343902|NCT01093326|65001495|FG001|Overall Study|Withdrawal by Subject|27|||
23343903|NCT01093326|65001496|FG002|Overall Study|Withdrawal by Subject|26|||
23343904|NCT01093326|65001494|FG000|Overall Study|Adverse Event|2|||
23343905|NCT01093326|65001495|FG001|Overall Study|Adverse Event|1|||
23343906|NCT01093326|65001496|FG002|Overall Study|Adverse Event|4|||
23343907|NCT01093326|65001494|FG000|Overall Study|Other|0|||
23343908|NCT01093326|65001495|FG001|Overall Study|Other|0|||
23343909|NCT01093326|65001496|FG002|Overall Study|Other|1|||
23343910|NCT05072964|65001500|FG000|Overall Study|Withdrawal by Subject|4|||
23177589|NCT00944034|64393831|FG003|Overall Study|Withdrawal by Subject|2|||
23177590|NCT00944034|64393832|FG004|Overall Study|Withdrawal by Subject|5|||
23177591|NCT00944034|64393833|FG005|Overall Study|Withdrawal by Subject|8|||
23177592|NCT00944034|64393834|FG006|Overall Study|Withdrawal by Subject|2|||
23455510|NCT02636699|65409743|FG001|Overall Study|Adverse Event|0|||
23177593|NCT00944034|64393835|FG007|Overall Study|Withdrawal by Subject|2|||
23177594|NCT00944034|64393836|FG008|Overall Study|Withdrawal by Subject|3|||
23177595|NCT00944034|64393837|FG009|Overall Study|Withdrawal by Subject|4|||
23177596|NCT00944034|64393838|FG010|Overall Study|Withdrawal by Subject|0|||
23177597|NCT00944034|64393839|FG011|Overall Study|Withdrawal by Subject|4|||
23455511|NCT02636699|65409742|FG000|Overall Study|Lost to Follow-up|3|||
23455512|NCT02636699|65409743|FG001|Overall Study|Lost to Follow-up|3|||
23455513|NCT02636699|65409742|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
23455514|NCT02636699|65409743|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
23455515|NCT02636699|65409742|FG000|Overall Study|Physician Decision|0|||
23455516|NCT02636699|65409743|FG001|Overall Study|Physician Decision|1|||
23455517|NCT02636699|65409742|FG000|Overall Study|Withdrawal by Subject|13|||
23455518|NCT02636699|65409743|FG001|Overall Study|Withdrawal by Subject|6|||
23455519|NCT02636699|65409742|FG000|Overall Study|Other|3|||
23455520|NCT02636699|65409743|FG001|Overall Study|Other|1|||
23455521|NCT00388349|65409747|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
23455522|NCT00388349|65409748|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
23455523|NCT02063724|65409749|FG000|Overall Study|Disease progression|1|||
23455524|NCT03259230|65409752|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
23455525|NCT03259230|65409753|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
23455526|NCT00644423|65409754|FG000|Overall Study|Lost to Follow-up|1|||
23455527|NCT00644423|65409755|FG001|Overall Study|Lost to Follow-up|1|||
23455528|NCT03655132|65409756|FG000|Overall Study|Lost to Follow-up|2|||
23455529|NCT03655132|65409757|FG001|Overall Study|Lost to Follow-up|1|||
23455530|NCT03655132|65409756|FG000|Overall Study|Withdrawal by Subject|0|||
23455531|NCT03655132|65409757|FG001|Overall Study|Withdrawal by Subject|1|||
23455532|NCT03655132|65409756|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
23455533|NCT03655132|65409757|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
23455534|NCT00739401|65409761|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
23455535|NCT00739401|65409761|FG000|Overall Study|Death|3|||
23455536|NCT00739401|65409761|FG000|Overall Study|Withdrawal by Subject|4|||
23455537|NCT01680341|65409764|FG000|Overall Study|Adverse Event|3|||
23455538|NCT01680341|65409765|FG001|Overall Study|Adverse Event|2|||
23455539|NCT01680341|65409764|FG000|Overall Study|Unclassified|18|||
23455540|NCT01680341|65409765|FG001|Overall Study|Unclassified|15|||
23455541|NCT06308822|65409766|FG000|Overall Study|Mutation Status Not Confirmed|17|||
23455542|NCT06308822|65409766|FG000|Overall Study|Adverse Event|1|||
23455543|NCT06308822|65409766|FG000|Overall Study|Death|5|||
23455544|NCT06308822|65409766|FG000|Overall Study|Disease progression|8|||
23455545|NCT06308822|65409766|FG000|Overall Study|Withdrawal by Subject|1|||
23455546|NCT06308822|65409766|FG000|Overall Study|Physician Decision|3|||
23455547|NCT02558894|65409767|FG000|Overall Study|Death; any cause, entire study duration|28|||
23455548|NCT02558894|65409768|FG001|Overall Study|Death; any cause, entire study duration|31|||
23455549|NCT02558894|65409767|FG000|Overall Study|Withdrawal by Subject|2|||
23455550|NCT02558894|65409768|FG001|Overall Study|Withdrawal by Subject|1|||
23455551|NCT02558894|65409767|FG000|Overall Study|Closure of Part A|2|||
23455552|NCT02558894|65409768|FG001|Overall Study|Closure of Part A|1|||
23455553|NCT03466658|65409779|FG000|Overall Study|Withdrawal by Subject|3|||
23455554|NCT03341299|65409780|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
23455555|NCT03341299|65409781|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
23455556|NCT03341299|65409782|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
23455557|NCT03341299|65409783|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
23455558|NCT04196686|65409784|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
23455559|NCT04196686|65409785|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
23455560|NCT00435409|65409787|FG000|Overall Study|Protocol Violation|1|||
23455561|NCT00435409|65409788|FG001|Overall Study|Protocol Violation|2|||
23455562|NCT00435409|65409789|FG002|Overall Study|Protocol Violation|0|||
23455563|NCT00435409|65409787|FG000|Overall Study|Lost to Follow-up|1|||
23455564|NCT00435409|65409788|FG001|Overall Study|Lost to Follow-up|2|||
23455565|NCT00435409|65409789|FG002|Overall Study|Lost to Follow-up|0|||
23455566|NCT00435409|65409787|FG000|Overall Study|Death|8|||
23177598|NCT00944034|64393828|FG000|Overall Study|Lost to Follow-up|0|||
23177599|NCT00944034|64393829|FG001|Overall Study|Lost to Follow-up|4|||
23455567|NCT00435409|65409788|FG001|Overall Study|Death|6|||
23455568|NCT00435409|65409789|FG002|Overall Study|Death|6|||
23455569|NCT00435409|65409787|FG000|Overall Study|Objective progression or relapse|158|||
23455570|NCT00435409|65409788|FG001|Overall Study|Objective progression or relapse|93|||
23237786|NCT00948896|64615443|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
23177600|NCT00944034|64393830|FG002|Overall Study|Lost to Follow-up|2|||
23455571|NCT00435409|65409789|FG002|Overall Study|Objective progression or relapse|58|||
23455572|NCT00435409|65409787|FG000|Overall Study|Global deterioration of health status|0|||
23455573|NCT00435409|65409788|FG001|Overall Study|Global deterioration of health status|0|||
23455574|NCT00435409|65409789|FG002|Overall Study|Global deterioration of health status|4|||
23455575|NCT00435409|65409787|FG000|Overall Study|Withdrawal by Subject|8|||
23455576|NCT00435409|65409788|FG001|Overall Study|Withdrawal by Subject|7|||
23455577|NCT00435409|65409789|FG002|Overall Study|Withdrawal by Subject|1|||
23455578|NCT00435409|65409787|FG000|Overall Study|Other|45|||
23455579|NCT00435409|65409788|FG001|Overall Study|Other|30|||
23455580|NCT00435409|65409789|FG002|Overall Study|Other|1|||
23455581|NCT00435409|65409787|FG000|Overall Study|Adverse Event|0|||
23455582|NCT00435409|65409788|FG001|Overall Study|Adverse Event|0|||
23455583|NCT00435409|65409789|FG002|Overall Study|Adverse Event|8|||
23455584|NCT00435409|65409787|FG000|Overall Study|Sponsor decision|0|||
23455585|NCT00435409|65409788|FG001|Overall Study|Sponsor decision|3|||
23455586|NCT00435409|65409789|FG002|Overall Study|Sponsor decision|0|||
23455587|NCT00918281|65409795|FG000|Overall Study|Physician Decision|29|||
23455588|NCT02426580|65409798|FG000|Overall Study|Death|2|||
23455589|NCT02426580|65409799|FG001|Overall Study|Death|2|||
23177601|NCT00944034|64393831|FG003|Overall Study|Lost to Follow-up|0|||
23177602|NCT00944034|64393832|FG004|Overall Study|Lost to Follow-up|5|||
23177603|NCT00944034|64393833|FG005|Overall Study|Lost to Follow-up|7|||
23177604|NCT00944034|64393834|FG006|Overall Study|Lost to Follow-up|0|||
23177605|NCT00944034|64393835|FG007|Overall Study|Lost to Follow-up|1|||
23177606|NCT00944034|64393836|FG008|Overall Study|Lost to Follow-up|5|||
23177607|NCT00944034|64393837|FG009|Overall Study|Lost to Follow-up|1|||
23177608|NCT00944034|64393838|FG010|Overall Study|Lost to Follow-up|1|||
23177609|NCT00944034|64393839|FG011|Overall Study|Lost to Follow-up|0|||
23177610|NCT00944034|64393828|FG000|Overall Study|Death|0|||
23177611|NCT00944034|64393829|FG001|Overall Study|Death|0|||
23237787|NCT00948896|64615444|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
23237788|NCT00948896|64615445|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
23237789|NCT00948896|64615446|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
23237790|NCT00948896|64615447|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
23237791|NCT00948896|64615448|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
23237792|NCT00948896|64615441|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
23237793|NCT00948896|64615442|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
23237794|NCT00948896|64615443|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
23237795|NCT00948896|64615444|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
23237796|NCT00948896|64615445|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
23237797|NCT00948896|64615446|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
23237798|NCT00948896|64615447|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
23237799|NCT00948896|64615448|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
23177612|NCT00944034|64393830|FG002|Overall Study|Death|1|||
23177613|NCT00944034|64393831|FG003|Overall Study|Death|0|||
23237800|NCT00948896|64615441|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
23237801|NCT00948896|64615442|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
23237802|NCT00948896|64615443|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
23237803|NCT00948896|64615444|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
23237804|NCT00948896|64615445|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
23237805|NCT00948896|64615446|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
23237806|NCT00948896|64615447|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
23237807|NCT00948896|64615448|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
23237808|NCT00948896|64615441|FG000|24 Months of Age to 36 Months of Age|Death|0|||
23237809|NCT00948896|64615442|FG001|24 Months of Age to 36 Months of Age|Death|2|||
23237810|NCT00948896|64615443|FG002|24 Months of Age to 36 Months of Age|Death|2|||
23237811|NCT00948896|64615444|FG003|24 Months of Age to 36 Months of Age|Death|0|||
23237812|NCT00948896|64615445|FG004|24 Months of Age to 36 Months of Age|Death|0|||
23237813|NCT00948896|64615446|FG005|24 Months of Age to 36 Months of Age|Death|1|||
23237814|NCT00948896|64615447|FG006|24 Months of Age to 36 Months of Age|Death|0|||
23343911|NCT05072964|65001500|FG000|Overall Study|Death|1|||
23177614|NCT00944034|64393832|FG004|Overall Study|Death|0|||
23455590|NCT02426580|65409798|FG000|Overall Study|Lost to Follow-up|0|||
23455591|NCT02426580|65409799|FG001|Overall Study|Lost to Follow-up|9|||
23455592|NCT02426580|65409798|FG000|Overall Study|transfer to hemodialysis|5|||
23455593|NCT02426580|65409799|FG001|Overall Study|transfer to hemodialysis|5|||
23177615|NCT00944034|64393833|FG005|Overall Study|Death|0|||
23177616|NCT00944034|64393834|FG006|Overall Study|Death|0|||
23177617|NCT00944034|64393835|FG007|Overall Study|Death|0|||
23177618|NCT00944034|64393836|FG008|Overall Study|Death|0|||
23177619|NCT00944034|64393837|FG009|Overall Study|Death|0|||
23177620|NCT00944034|64393838|FG010|Overall Study|Death|0|||
23177621|NCT00944034|64393839|FG011|Overall Study|Death|0|||
23177622|NCT00944034|64393828|FG000|Overall Study|Protocol Violation|2|||
23177623|NCT00944034|64393829|FG001|Overall Study|Protocol Violation|0|||
23177624|NCT00944034|64393830|FG002|Overall Study|Protocol Violation|0|||
23177625|NCT00944034|64393831|FG003|Overall Study|Protocol Violation|1|||
23177626|NCT00944034|64393832|FG004|Overall Study|Protocol Violation|2|||
23177627|NCT00944034|64393833|FG005|Overall Study|Protocol Violation|3|||
23237815|NCT00948896|64615448|FG007|24 Months of Age to 36 Months of Age|Death|0|||
23237816|NCT00948896|64615441|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
23237817|NCT00948896|64615442|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23237818|NCT00948896|64615443|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
23177628|NCT00944034|64393834|FG006|Overall Study|Protocol Violation|0|||
23177629|NCT00944034|64393835|FG007|Overall Study|Protocol Violation|1|||
23177630|NCT00944034|64393836|FG008|Overall Study|Protocol Violation|1|||
23177631|NCT00944034|64393837|FG009|Overall Study|Protocol Violation|4|||
23177632|NCT00944034|64393838|FG010|Overall Study|Protocol Violation|0|||
23343912|NCT05619536|65001501|FG000|Overall Study|Withdrawal by Subject|0|||
23343913|NCT05619536|65001502|FG001|Overall Study|Withdrawal by Subject|1|||
23343914|NCT05619536|65001503|FG002|Overall Study|Withdrawal by Subject|0|||
23343915|NCT05619536|65001504|FG003|Overall Study|Withdrawal by Subject|1|||
23343916|NCT05619536|65001501|FG000|Overall Study|Lost to Follow-up|0|||
23455594|NCT02426580|65409798|FG000|Overall Study|Kidney transplant|3|||
23455595|NCT02426580|65409799|FG001|Overall Study|Kidney transplant|0|||
23455596|NCT02426580|65409798|FG000|Overall Study|Allergic to egg white|1|||
23455597|NCT02426580|65409799|FG001|Overall Study|Allergic to egg white|0|||
23455598|NCT04663321|65409800|FG000|Overall Study|Study terminated by Sponsor|2|||
23455599|NCT04663321|65409801|FG001|Overall Study|Study terminated by Sponsor|1|||
23455600|NCT04663321|65409802|FG002|Overall Study|Study terminated by Sponsor|2|||
23455601|NCT04663321|65409800|FG000|Overall Study|Withdrawal by Subject|10|||
23455602|NCT04663321|65409801|FG001|Overall Study|Withdrawal by Subject|3|||
23455603|NCT04663321|65409802|FG002|Overall Study|Withdrawal by Subject|2|||
23455604|NCT04663321|65409800|FG000|Overall Study|Not provided|0|||
23455605|NCT04663321|65409801|FG001|Overall Study|Not provided|0|||
23455606|NCT04663321|65409802|FG002|Overall Study|Not provided|1|||
23455607|NCT03271151|65409805|FG000|Overall Study|Lost to Follow-up|1|||
23455608|NCT03271151|65409806|FG001|Overall Study|Lost to Follow-up|3|||
23177633|NCT00944034|64393839|FG011|Overall Study|Protocol Violation|0|||
23177634|NCT00944034|64393828|FG000|Overall Study|Unable to classify|0|||
23177635|NCT00944034|64393829|FG001|Overall Study|Unable to classify|0|||
23177636|NCT00944034|64393830|FG002|Overall Study|Unable to classify|0|||
23177637|NCT00944034|64393831|FG003|Overall Study|Unable to classify|0|||
23177638|NCT00944034|64393832|FG004|Overall Study|Unable to classify|0|||
23177639|NCT00944034|64393833|FG005|Overall Study|Unable to classify|1|||
23177640|NCT00944034|64393834|FG006|Overall Study|Unable to classify|1|||
23177641|NCT00944034|64393835|FG007|Overall Study|Unable to classify|1|||
23177642|NCT00944034|64393836|FG008|Overall Study|Unable to classify|0|||
23177643|NCT00944034|64393837|FG009|Overall Study|Unable to classify|0|||
23177644|NCT00944034|64393838|FG010|Overall Study|Unable to classify|0|||
23177645|NCT00944034|64393839|FG011|Overall Study|Unable to classify|0|||
23177646|NCT00944034|64393828|FG000|Overall Study|Administrative reason|0|||
23177647|NCT00944034|64393829|FG001|Overall Study|Administrative reason|0|||
23177648|NCT00944034|64393830|FG002|Overall Study|Administrative reason|0|||
23177649|NCT00944034|64393831|FG003|Overall Study|Administrative reason|0|||
23177650|NCT00944034|64393832|FG004|Overall Study|Administrative reason|0|||
23177651|NCT00944034|64393833|FG005|Overall Study|Administrative reason|0|||
23177652|NCT00944034|64393834|FG006|Overall Study|Administrative reason|1|||
23237819|NCT00948896|64615444|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
23343917|NCT05619536|65001502|FG001|Overall Study|Lost to Follow-up|1|||
23343918|NCT05619536|65001503|FG002|Overall Study|Lost to Follow-up|1|||
23343919|NCT05619536|65001504|FG003|Overall Study|Lost to Follow-up|0|||
23343920|NCT03205761|65001507|FG000|Overall Study|Withdrawal by Subject|1|||
23237820|NCT00948896|64615445|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23455609|NCT03271151|65409805|FG000|Overall Study|Withdrawal by Subject|1|||
23455610|NCT03271151|65409806|FG001|Overall Study|Withdrawal by Subject|0|||
23455611|NCT00713609|65409812|FG000|Overall Study|Adverse Event|2|||
23177653|NCT00944034|64393835|FG007|Overall Study|Administrative reason|0|||
23177654|NCT00944034|64393836|FG008|Overall Study|Administrative reason|0|||
23177655|NCT00944034|64393837|FG009|Overall Study|Administrative reason|0|||
23343921|NCT03205761|65001507|FG000|Overall Study|Progressive Disease|10|||
23177656|NCT00944034|64393838|FG010|Overall Study|Administrative reason|0|||
23177657|NCT00944034|64393839|FG011|Overall Study|Administrative reason|0|||
23177658|NCT01869348|64393844|FG000|Overall Study|Withdrawal by Subject|1|||
23177659|NCT01869348|64393845|FG001|Overall Study|Withdrawal by Subject|1|||
23177660|NCT01176916|64393846|FG000|Overall Study|Adverse Event|61|||
23177661|NCT01176916|64393846|FG000|Overall Study|Death|1|||
23177662|NCT01176916|64393846|FG000|Overall Study|Lost to Follow-up|15|||
23177663|NCT01176916|64393846|FG000|Overall Study|Objective progression or relapse|17|||
23177664|NCT01176916|64393846|FG000|Overall Study|Protocol Violation|24|||
23177665|NCT01176916|64393846|FG000|Overall Study|Withdrawal by Subject|37|||
23177666|NCT01176916|64393846|FG000|Overall Study|Other|6|||
23177667|NCT01176916|64393846|FG000|Overall Study|Withdrawal prior to Treatment|6|||
23455612|NCT00713609|65409813|FG001|Overall Study|Adverse Event|0|||
23582779|NCT04984876|65862544|FG001|Overall Study|Physician Decision|0|||
23582780|NCT04984876|65862545|FG002|Overall Study|Physician Decision|0|||
23582781|NCT04984876|65862546|FG003|Overall Study|Physician Decision|1|||
23582782|NCT04984876|65862547|FG004|Overall Study|Physician Decision|0|||
23582783|NCT04984876|65862548|FG005|Overall Study|Physician Decision|0|||
23582784|NCT04984876|65862543|FG000|Overall Study|Adverse Event|0|||
23582785|NCT04984876|65862544|FG001|Overall Study|Adverse Event|0|||
23582786|NCT04984876|65862545|FG002|Overall Study|Adverse Event|1|||
23582787|NCT04984876|65862546|FG003|Overall Study|Adverse Event|0|||
23582788|NCT04984876|65862547|FG004|Overall Study|Adverse Event|0|||
23582789|NCT04984876|65862548|FG005|Overall Study|Adverse Event|0|||
23582790|NCT01195675|65862551|FG000|Overall Study|Adverse Event|1|||
23582791|NCT01195675|65862551|FG000|Overall Study|Withdrawal by Subject|2|||
23582792|NCT00248287|65862554|FG000|Overall Study|Adverse Event|11|||
23582793|NCT00248287|65862555|FG001|Overall Study|Adverse Event|10|||
23582794|NCT00248287|65862554|FG000|Overall Study|Death|1|||
23582795|NCT00248287|65862555|FG001|Overall Study|Death|0|||
23582796|NCT00248287|65862554|FG000|Overall Study|Lost to Follow-up|0|||
23582797|NCT00248287|65862555|FG001|Overall Study|Lost to Follow-up|1|||
23582798|NCT00248287|65862554|FG000|Overall Study|Investigator Request|4|||
23582799|NCT00248287|65862555|FG001|Overall Study|Investigator Request|3|||
23582800|NCT00248287|65862554|FG000|Overall Study|Patient Request|5|||
23582801|NCT00248287|65862555|FG001|Overall Study|Patient Request|3|||
23582802|NCT00248287|65862554|FG000|Overall Study|Other|3|||
23582803|NCT00248287|65862555|FG001|Overall Study|Other|2|||
23582804|NCT02469064|65862556|FG000|Overall Study|Request not to receive intervention.|1|||
23582805|NCT02469064|65862557|FG001|Overall Study|Request not to receive intervention.|3|||
23582806|NCT02062827|65862559|FG000|Overall Study|Death|1|||
23582807|NCT02062827|65862560|FG001|Overall Study|Death|0|||
23582808|NCT02062827|65862561|FG002|Overall Study|Death|0|||
23582809|NCT02062827|65862562|FG003|Overall Study|Death|0|||
23582810|NCT02062827|65862563|FG004|Overall Study|Death|0|||
23582811|NCT02062827|65862564|FG005|Overall Study|Death|0|||
23582812|NCT02062827|65862565|FG006|Overall Study|Death|0|||
23582813|NCT02062827|65862566|FG007|Overall Study|Death|0|||
23582814|NCT02062827|65862559|FG000|Overall Study|Withdrawal by Subject|3|||
23582815|NCT02062827|65862560|FG001|Overall Study|Withdrawal by Subject|1|||
23582816|NCT02062827|65862561|FG002|Overall Study|Withdrawal by Subject|1|||
23582817|NCT02062827|65862562|FG003|Overall Study|Withdrawal by Subject|2|||
23582818|NCT02062827|65862563|FG004|Overall Study|Withdrawal by Subject|6|||
23582819|NCT02062827|65862564|FG005|Overall Study|Withdrawal by Subject|0|||
23582820|NCT02062827|65862565|FG006|Overall Study|Withdrawal by Subject|5|||
23582821|NCT02062827|65862566|FG007|Overall Study|Withdrawal by Subject|0|||
23582822|NCT02062827|65862559|FG000|Overall Study|Screen Fail|0|||
23582823|NCT02062827|65862560|FG001|Overall Study|Screen Fail|0|||
23582824|NCT02062827|65862561|FG002|Overall Study|Screen Fail|0|||
23582825|NCT02062827|65862562|FG003|Overall Study|Screen Fail|0|||
23582826|NCT02062827|65862563|FG004|Overall Study|Screen Fail|0|||
23582827|NCT02062827|65862564|FG005|Overall Study|Screen Fail|0|||
23582828|NCT02062827|65862565|FG006|Overall Study|Screen Fail|0|||
23582829|NCT02062827|65862566|FG007|Overall Study|Screen Fail|8|||
23582830|NCT03563053|65865861|FG000|Overall Study|Withdrawal by Subject|17|||
23582831|NCT03563053|65865861|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
23582832|NCT03563053|65865861|FG000|Overall Study|Adverse Event|3|||
23582833|NCT03563053|65865861|FG000|Overall Study|Physician Decision|1|||
23582834|NCT03563053|65865861|FG000|Overall Study|study terminated by sponsor|71|||
23582835|NCT00049517|65865865|FG000|Induction|Disease progression|0|||
23582836|NCT00049517|65865866|FG001|Induction|Disease progression|0|||
23582837|NCT00049517|65865867|FG002|Induction|Disease progression|0|||
23582838|NCT00049517|65865868|FG003|Induction|Disease progression|0|||
23582839|NCT00049517|65865869|FG004|Induction|Disease progression|18|||
23582840|NCT00049517|65865870|FG005|Induction|Disease progression|11|||
23582841|NCT00049517|65865865|FG000|Induction|Adverse Event|0|||
23582842|NCT00049517|65865866|FG001|Induction|Adverse Event|0|||
23582843|NCT00049517|65865867|FG002|Induction|Adverse Event|0|||
23582844|NCT00049517|65865868|FG003|Induction|Adverse Event|0|||
23177668|NCT00179959|64393850|FG000|Overall Study|Lost to Follow-up|3|||
23582845|NCT00049517|65865869|FG004|Induction|Adverse Event|5|||
23582846|NCT00049517|65865870|FG005|Induction|Adverse Event|7|||
23177669|NCT00179959|64393851|FG001|Overall Study|Lost to Follow-up|1|||
23177670|NCT00179959|64393850|FG000|Overall Study|Withdrawal by Subject|3|||
23177671|NCT00179959|64393851|FG001|Overall Study|Withdrawal by Subject|2|||
23177672|NCT03072160|64393852|FG000|Overall Study|Adverse Event|3|||
23177673|NCT03072160|64393853|FG001|Overall Study|Adverse Event|1|||
23177674|NCT03072160|64393852|FG000|Overall Study|Refused further treatment|6|||
23177675|NCT03072160|64393853|FG001|Overall Study|Refused further treatment|1|||
23177676|NCT03072160|64393852|FG000|Overall Study|Physician Decision|1|||
23177677|NCT03072160|64393853|FG001|Overall Study|Physician Decision|0|||
23177678|NCT03072160|64393852|FG000|Overall Study|Disease progression on study|1|||
23177679|NCT03072160|64393853|FG001|Overall Study|Disease progression on study|1|||
23177680|NCT03072160|64393852|FG000|Overall Study|No contact|0|||
23177681|NCT03072160|64393853|FG001|Overall Study|No contact|1|||
23177682|NCT01444300|64393854|FG000|Overall Study|Adverse Event|4|||
23177683|NCT01444300|64393855|FG001|Overall Study|Adverse Event|0|||
23177684|NCT03269344|64393856|FG000|Overall Study|Protocol Violation|4|||
23177685|NCT03269344|64393857|FG001|Overall Study|Protocol Violation|3|||
23177686|NCT04436276|64393858|FG000|Overall Study|Adverse Event|0|||
23177687|NCT04436276|64393859|FG001|Overall Study|Adverse Event|0|||
23177688|NCT04436276|64393860|FG002|Overall Study|Adverse Event|0|||
23177689|NCT04436276|64393861|FG003|Overall Study|Adverse Event|0|||
23177690|NCT04436276|64393862|FG004|Overall Study|Adverse Event|0|||
23177691|NCT04436276|64393863|FG005|Overall Study|Adverse Event|0|||
23177692|NCT04436276|64393864|FG006|Overall Study|Adverse Event|0|||
23177693|NCT04436276|64393865|FG007|Overall Study|Adverse Event|0|||
23177694|NCT04436276|64393866|FG008|Overall Study|Adverse Event|0|||
23177695|NCT04436276|64393867|FG009|Overall Study|Adverse Event|0|||
23177696|NCT04436276|64393868|FG010|Overall Study|Adverse Event|0|||
23177697|NCT04436276|64393869|FG011|Overall Study|Adverse Event|0|||
23177698|NCT04436276|64393870|FG012|Overall Study|Adverse Event|0|||
23177699|NCT04436276|64393871|FG013|Overall Study|Adverse Event|0|||
23177700|NCT04436276|64393872|FG014|Overall Study|Adverse Event|0|||
23177701|NCT04436276|64393873|FG015|Overall Study|Adverse Event|0|||
23177702|NCT04436276|64393874|FG016|Overall Study|Adverse Event|1|||
23177703|NCT04436276|64393875|FG017|Overall Study|Adverse Event|0|||
23177704|NCT04436276|64393876|FG018|Overall Study|Adverse Event|0|||
23177705|NCT04436276|64393877|FG019|Overall Study|Adverse Event|0|||
23177706|NCT04436276|64393878|FG020|Overall Study|Adverse Event|0|||
23343922|NCT03698994|65001509|FG000|Overall Study|Adverse Event|2|||
23455613|NCT00713609|65409814|FG002|Overall Study|Adverse Event|2|||
23455614|NCT00713609|65409815|FG003|Overall Study|Adverse Event|2|||
23177707|NCT04436276|64393879|FG021|Overall Study|Adverse Event|0|||
23177708|NCT04436276|64393880|FG022|Overall Study|Adverse Event|0|||
23177709|NCT04436276|64393858|FG000|Overall Study|Death|0|||
23177710|NCT04436276|64393859|FG001|Overall Study|Death|0|||
23177711|NCT04436276|64393860|FG002|Overall Study|Death|0|||
23177712|NCT04436276|64393861|FG003|Overall Study|Death|0|||
23177713|NCT04436276|64393862|FG004|Overall Study|Death|0|||
23177714|NCT04436276|64393863|FG005|Overall Study|Death|0|||
23177715|NCT04436276|64393864|FG006|Overall Study|Death|0|||
23177716|NCT04436276|64393865|FG007|Overall Study|Death|0|||
23177717|NCT04436276|64393866|FG008|Overall Study|Death|0|||
23177718|NCT04436276|64393867|FG009|Overall Study|Death|0|||
23177719|NCT04436276|64393868|FG010|Overall Study|Death|0|||
23177720|NCT04436276|64393869|FG011|Overall Study|Death|0|||
23177721|NCT04436276|64393870|FG012|Overall Study|Death|1|||
23177722|NCT04436276|64393871|FG013|Overall Study|Death|0|||
23177723|NCT04436276|64393872|FG014|Overall Study|Death|1|||
23455615|NCT00713609|65409816|FG004|Overall Study|Adverse Event|3|||
23582847|NCT00049517|65865865|FG000|Induction|Death|0|||
23582848|NCT00049517|65865866|FG001|Induction|Death|0|||
23582849|NCT00049517|65865867|FG002|Induction|Death|0|||
23582850|NCT00049517|65865868|FG003|Induction|Death|0|||
23582851|NCT00049517|65865869|FG004|Induction|Death|9|||
23582852|NCT00049517|65865870|FG005|Induction|Death|6|||
23582853|NCT00049517|65865865|FG000|Induction|Withdrawal by Subject|0|||
23177724|NCT04436276|64393873|FG015|Overall Study|Death|0|||
23177725|NCT04436276|64393874|FG016|Overall Study|Death|0|||
23177726|NCT04436276|64393875|FG017|Overall Study|Death|0|||
23177727|NCT04436276|64393876|FG018|Overall Study|Death|0|||
23177728|NCT04436276|64393877|FG019|Overall Study|Death|2|||
23177729|NCT04436276|64393878|FG020|Overall Study|Death|0|||
23177730|NCT04436276|64393879|FG021|Overall Study|Death|1|||
23177731|NCT04436276|64393880|FG022|Overall Study|Death|0|||
23455616|NCT00713609|65409817|FG005|Overall Study|Adverse Event|1|||
23455617|NCT00713609|65409812|FG000|Overall Study|Lost to Follow-up|5|||
23177732|NCT04436276|64393858|FG000|Overall Study|Lost to Follow-up|0|||
23177733|NCT04436276|64393859|FG001|Overall Study|Lost to Follow-up|2|||
23177734|NCT04436276|64393860|FG002|Overall Study|Lost to Follow-up|2|||
23177735|NCT04436276|64393861|FG003|Overall Study|Lost to Follow-up|1|||
23177736|NCT04436276|64393862|FG004|Overall Study|Lost to Follow-up|4|||
23177737|NCT04436276|64393863|FG005|Overall Study|Lost to Follow-up|1|||
23582854|NCT00049517|65865866|FG001|Induction|Withdrawal by Subject|0|||
23582855|NCT00049517|65865867|FG002|Induction|Withdrawal by Subject|0|||
23177738|NCT04436276|64393864|FG006|Overall Study|Lost to Follow-up|0|||
23177739|NCT04436276|64393865|FG007|Overall Study|Lost to Follow-up|0|||
23177740|NCT04436276|64393866|FG008|Overall Study|Lost to Follow-up|1|||
23177741|NCT04436276|64393867|FG009|Overall Study|Lost to Follow-up|0|||
23177742|NCT04436276|64393868|FG010|Overall Study|Lost to Follow-up|5|||
23177743|NCT04436276|64393869|FG011|Overall Study|Lost to Follow-up|5|||
23177744|NCT04436276|64393870|FG012|Overall Study|Lost to Follow-up|4|||
23177745|NCT04436276|64393871|FG013|Overall Study|Lost to Follow-up|1|||
23177746|NCT04436276|64393872|FG014|Overall Study|Lost to Follow-up|7|||
23177747|NCT04436276|64393873|FG015|Overall Study|Lost to Follow-up|7|||
23177748|NCT04436276|64393874|FG016|Overall Study|Lost to Follow-up|1|||
23177749|NCT04436276|64393875|FG017|Overall Study|Lost to Follow-up|0|||
23177750|NCT04436276|64393876|FG018|Overall Study|Lost to Follow-up|1|||
23177751|NCT04436276|64393877|FG019|Overall Study|Lost to Follow-up|1|||
23343923|NCT03698994|65001509|FG000|Overall Study|Death|1|||
23343924|NCT03698994|65001509|FG000|Overall Study|Physician Decision|1|||
23343925|NCT03698994|65001509|FG000|Overall Study|Withdrawal by Subject|3|||
23343926|NCT03698994|65001509|FG000|Overall Study|Progressive Disease|12|||
23343927|NCT00308087|65001510|FG000|Overall Study|Progressive Disease|19|||
23343928|NCT00308087|65001511|FG001|Overall Study|Progressive Disease|21|||
23343929|NCT00308087|65001510|FG000|Overall Study|Study Closure|11|||
23343930|NCT00308087|65001511|FG001|Overall Study|Study Closure|12|||
23343931|NCT00308087|65001510|FG000|Overall Study|Withdrawal by Subject|2|||
23343932|NCT00308087|65001511|FG001|Overall Study|Withdrawal by Subject|1|||
23343933|NCT00308087|65001510|FG000|Overall Study|Other|4|||
23343934|NCT00308087|65001511|FG001|Overall Study|Other|3|||
23343935|NCT01970475|65001512|FG000|Overall Study|Withdrawal by Subject|11|||
23343936|NCT01970475|65001513|FG001|Overall Study|Withdrawal by Subject|6|||
23343937|NCT01970475|65001512|FG000|Overall Study|Adverse Event|7|||
23343938|NCT01970475|65001513|FG001|Overall Study|Adverse Event|3|||
23177752|NCT04436276|64393878|FG020|Overall Study|Lost to Follow-up|2|||
23177753|NCT04436276|64393879|FG021|Overall Study|Lost to Follow-up|1|||
23177754|NCT04436276|64393880|FG022|Overall Study|Lost to Follow-up|1|||
23177755|NCT04436276|64393858|FG000|Overall Study|Physician Decision|1|||
23343939|NCT01970475|65001512|FG000|Overall Study|Lost to Follow-up|2|||
23343940|NCT01970475|65001513|FG001|Overall Study|Lost to Follow-up|2|||
23343941|NCT01970475|65001512|FG000|Overall Study|Protocol Violation|1|||
23343942|NCT01970475|65001513|FG001|Overall Study|Protocol Violation|0|||
23343943|NCT00520481|65001514|FG000|Overall Study|Adverse Event|4|||
23343944|NCT00520481|65001515|FG001|Overall Study|Adverse Event|1|||
23343945|NCT00520481|65001514|FG000|Overall Study|Withdrawal by Subject|3|||
23343946|NCT00520481|65001515|FG001|Overall Study|Withdrawal by Subject|0|||
23343947|NCT01895608|65001521|FG000|Overall Study|change in health status|0|||
23343948|NCT01895608|65001522|FG001|Overall Study|change in health status|1|||
23343949|NCT01895608|65001523|FG002|Overall Study|change in health status|1|||
23343950|NCT01895608|65001524|FG003|Overall Study|change in health status|0|||
23343951|NCT01895608|65001521|FG000|Overall Study|Withdrawal by Subject|0|||
23343952|NCT01895608|65001522|FG001|Overall Study|Withdrawal by Subject|0|||
23343953|NCT01895608|65001523|FG002|Overall Study|Withdrawal by Subject|2|||
23343954|NCT01895608|65001524|FG003|Overall Study|Withdrawal by Subject|0|||
23343955|NCT04325698|65001525|FG000|Overall Study|Study Terminated By Sponsor|1|||
23343956|NCT04325698|65001526|FG001|Overall Study|Study Terminated By Sponsor|1|||
23343957|NCT04325698|65001525|FG000|Overall Study|Withdrawal by Subject|0|||
23343958|NCT04325698|65001526|FG001|Overall Study|Withdrawal by Subject|2|||
23343959|NCT02487771|65001533|FG000|Overall Study|Lost to Follow-up|2|||
23343960|NCT02487771|65001534|FG001|Overall Study|Lost to Follow-up|3|||
23343961|NCT02487771|65001533|FG000|Overall Study|Moved out of area|5|||
23343962|NCT02487771|65001534|FG001|Overall Study|Moved out of area|6|||
23343963|NCT02487771|65001533|FG000|Overall Study|Withdrawal by Subject|3|||
23343964|NCT02487771|65001534|FG001|Overall Study|Withdrawal by Subject|5|||
23343965|NCT02447497|65001535|FG000|Overall Study|Did not meet treatment day baseline.|6|||
23343966|NCT02447497|65001536|FG001|Overall Study|Did not meet treatment day baseline.|5|||
23343967|NCT02447497|65001537|FG002|Overall Study|Did not meet treatment day baseline.|2|||
23343968|NCT02447497|65001538|FG003|Overall Study|Did not meet treatment day baseline.|2|||
23343969|NCT02447497|65001535|FG000|Overall Study|Dressing was compromised|0|||
23343970|NCT02447497|65001536|FG001|Overall Study|Dressing was compromised|1|||
23343971|NCT02447497|65001537|FG002|Overall Study|Dressing was compromised|0|||
23343972|NCT02447497|65001538|FG003|Overall Study|Dressing was compromised|0|||
23343973|NCT06137703|65001539|FG000|Overall Study|Other|0|||
23343974|NCT06137703|65001540|FG001|Overall Study|Other|1|||
23455618|NCT00713609|65409813|FG001|Overall Study|Lost to Follow-up|7|||
23177756|NCT04436276|64393859|FG001|Overall Study|Physician Decision|0|||
23177757|NCT04436276|64393860|FG002|Overall Study|Physician Decision|2|||
23343975|NCT06137703|65001541|FG002|Overall Study|Other|0|||
23455619|NCT00713609|65409814|FG002|Overall Study|Lost to Follow-up|5|||
23177758|NCT04436276|64393861|FG003|Overall Study|Physician Decision|1|||
23343976|NCT06137703|65001542|FG003|Overall Study|Other|0|||
23343977|NCT06137703|65001539|FG000|Overall Study|Adverse Event|0|||
23343978|NCT06137703|65001540|FG001|Overall Study|Adverse Event|0|||
23343979|NCT06137703|65001541|FG002|Overall Study|Adverse Event|1|||
23343980|NCT06137703|65001542|FG003|Overall Study|Adverse Event|0|||
23343981|NCT04464720|65001543|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
23343982|NCT02276053|65001547|FG000|Overall Study|Death|2|||
23343983|NCT02276053|65001547|FG000|Overall Study|Adverse Event|5|||
23343984|NCT02276053|65001547|FG000|Overall Study|Lack of Efficacy|2|||
23343985|NCT02276053|65001547|FG000|Overall Study|Withdrawal by Subject|1|||
23343986|NCT02276053|65001547|FG000|Overall Study|Patient does not meet selection criteria|3|||
23343987|NCT02276053|65001547|FG000|Overall Study|Patient needs to increase baseline AED|1|||
23343988|NCT04323306|65001548|FG000|Overall Study|Physician Decision|1|||
23343989|NCT04323306|65001549|FG001|Overall Study|Physician Decision|0|||
23343990|NCT04323306|65001550|FG002|Overall Study|Physician Decision|0|||
23343991|NCT04323306|65001551|FG003|Overall Study|Physician Decision|0|||
23343992|NCT04323306|65001552|FG004|Overall Study|Physician Decision|0|||
23343993|NCT04323306|65001553|FG005|Overall Study|Physician Decision|0|||
23343994|NCT04323306|65001554|FG006|Overall Study|Physician Decision|0|||
23343995|NCT04323306|65001555|FG007|Overall Study|Physician Decision|0|||
23343996|NCT04323306|65001556|FG008|Overall Study|Physician Decision|0|||
23343997|NCT04323306|65001548|FG000|Overall Study|Withdrawal by Subject|0|||
23343998|NCT04323306|65001549|FG001|Overall Study|Withdrawal by Subject|0|||
23343999|NCT04323306|65001550|FG002|Overall Study|Withdrawal by Subject|0|||
23344000|NCT04323306|65001551|FG003|Overall Study|Withdrawal by Subject|0|||
23344001|NCT04323306|65001552|FG004|Overall Study|Withdrawal by Subject|0|||
23344002|NCT04323306|65001553|FG005|Overall Study|Withdrawal by Subject|1|||
23344003|NCT04323306|65001554|FG006|Overall Study|Withdrawal by Subject|3|||
23344004|NCT04323306|65001555|FG007|Overall Study|Withdrawal by Subject|0|||
23344005|NCT04323306|65001556|FG008|Overall Study|Withdrawal by Subject|1|||
23344006|NCT01806961|65001557|FG000|Overall Study|sponsor decision|16|||
23344007|NCT03861273|65001558|FG000|Screening Phase (3 Weeks)|Other|1|||
23344008|NCT03861273|65001558|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
23344009|NCT03861273|65001558|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
23344010|NCT03861273|65001558|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
23344011|NCT03861273|65001558|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
23344012|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Adverse Event|6|||
23344013|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Adverse Event|14|||
23344014|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Death|3|||
23344015|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Death|1|||
23344016|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
23344017|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
23344018|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
23344019|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
23344020|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
23344021|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
23344022|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
23455620|NCT00713609|65409815|FG003|Overall Study|Lost to Follow-up|5|||
23455621|NCT00713609|65409816|FG004|Overall Study|Lost to Follow-up|7|||
23455622|NCT00713609|65409817|FG005|Overall Study|Lost to Follow-up|0|||
23455623|NCT00713609|65409812|FG000|Overall Study|Lack of Efficacy|1|||
23177759|NCT04436276|64393862|FG004|Overall Study|Physician Decision|0|||
23177760|NCT04436276|64393863|FG005|Overall Study|Physician Decision|0|||
23177761|NCT04436276|64393864|FG006|Overall Study|Physician Decision|0|||
23177762|NCT04436276|64393865|FG007|Overall Study|Physician Decision|0|||
23177763|NCT04436276|64393866|FG008|Overall Study|Physician Decision|0|||
23177764|NCT04436276|64393867|FG009|Overall Study|Physician Decision|0|||
23177765|NCT04436276|64393868|FG010|Overall Study|Physician Decision|0|||
23177766|NCT04436276|64393869|FG011|Overall Study|Physician Decision|1|||
23177767|NCT04436276|64393870|FG012|Overall Study|Physician Decision|2|||
23177768|NCT04436276|64393871|FG013|Overall Study|Physician Decision|0|||
23177769|NCT04436276|64393872|FG014|Overall Study|Physician Decision|0|||
23177770|NCT04436276|64393873|FG015|Overall Study|Physician Decision|0|||
23177771|NCT04436276|64393874|FG016|Overall Study|Physician Decision|0|||
23177772|NCT04436276|64393875|FG017|Overall Study|Physician Decision|0|||
23177773|NCT04436276|64393876|FG018|Overall Study|Physician Decision|0|||
23177774|NCT04436276|64393877|FG019|Overall Study|Physician Decision|0|||
23177775|NCT04436276|64393878|FG020|Overall Study|Physician Decision|1|||
23177776|NCT04436276|64393879|FG021|Overall Study|Physician Decision|2|||
23177777|NCT04436276|64393880|FG022|Overall Study|Physician Decision|0|||
23177778|NCT04436276|64393858|FG000|Overall Study|Protocol Violation|0|||
23177779|NCT04436276|64393859|FG001|Overall Study|Protocol Violation|0|||
23177780|NCT04436276|64393860|FG002|Overall Study|Protocol Violation|0|||
23177781|NCT04436276|64393861|FG003|Overall Study|Protocol Violation|0|||
23177782|NCT04436276|64393862|FG004|Overall Study|Protocol Violation|0|||
23177783|NCT04436276|64393863|FG005|Overall Study|Protocol Violation|0|||
23177784|NCT04436276|64393864|FG006|Overall Study|Protocol Violation|0|||
23177785|NCT04436276|64393865|FG007|Overall Study|Protocol Violation|0|||
23177786|NCT04436276|64393866|FG008|Overall Study|Protocol Violation|0|||
23177787|NCT04436276|64393867|FG009|Overall Study|Protocol Violation|0|||
23177788|NCT04436276|64393868|FG010|Overall Study|Protocol Violation|0|||
23177789|NCT04436276|64393869|FG011|Overall Study|Protocol Violation|0|||
23177790|NCT04436276|64393870|FG012|Overall Study|Protocol Violation|0|||
23177791|NCT04436276|64393871|FG013|Overall Study|Protocol Violation|1|||
23177792|NCT04436276|64393872|FG014|Overall Study|Protocol Violation|0|||
23177793|NCT04436276|64393873|FG015|Overall Study|Protocol Violation|1|||
23177794|NCT04436276|64393874|FG016|Overall Study|Protocol Violation|0|||
23177795|NCT04436276|64393875|FG017|Overall Study|Protocol Violation|0|||
23177796|NCT04436276|64393876|FG018|Overall Study|Protocol Violation|0|||
23177797|NCT04436276|64393877|FG019|Overall Study|Protocol Violation|0|||
23177798|NCT04436276|64393878|FG020|Overall Study|Protocol Violation|0|||
23177799|NCT04436276|64393879|FG021|Overall Study|Protocol Violation|0|||
23177800|NCT04436276|64393880|FG022|Overall Study|Protocol Violation|0|||
23177801|NCT04436276|64393858|FG000|Overall Study|Withdrawal by Subject|25|||
23177802|NCT04436276|64393859|FG001|Overall Study|Withdrawal by Subject|22|||
23177803|NCT04436276|64393860|FG002|Overall Study|Withdrawal by Subject|24|||
23177804|NCT04436276|64393861|FG003|Overall Study|Withdrawal by Subject|23|||
23177805|NCT04436276|64393862|FG004|Overall Study|Withdrawal by Subject|14|||
23455624|NCT00713609|65409813|FG001|Overall Study|Lack of Efficacy|3|||
23455625|NCT00713609|65409814|FG002|Overall Study|Lack of Efficacy|0|||
23455626|NCT00713609|65409815|FG003|Overall Study|Lack of Efficacy|0|||
23455627|NCT00713609|65409816|FG004|Overall Study|Lack of Efficacy|1|||
23455628|NCT00713609|65409817|FG005|Overall Study|Lack of Efficacy|0|||
23455629|NCT00713609|65409812|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
23455630|NCT00713609|65409813|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
23455631|NCT00713609|65409814|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
23455632|NCT00713609|65409815|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
23455633|NCT00713609|65409816|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
23177806|NCT04436276|64393863|FG005|Overall Study|Withdrawal by Subject|0|||
23177807|NCT04436276|64393864|FG006|Overall Study|Withdrawal by Subject|0|||
23177808|NCT04436276|64393865|FG007|Overall Study|Withdrawal by Subject|1|||
23177809|NCT04436276|64393866|FG008|Overall Study|Withdrawal by Subject|0|||
23177810|NCT04436276|64393867|FG009|Overall Study|Withdrawal by Subject|1|||
23177811|NCT04436276|64393868|FG010|Overall Study|Withdrawal by Subject|17|||
23177812|NCT04436276|64393869|FG011|Overall Study|Withdrawal by Subject|7|||
23177813|NCT04436276|64393870|FG012|Overall Study|Withdrawal by Subject|10|||
23177814|NCT04436276|64393871|FG013|Overall Study|Withdrawal by Subject|6|||
23177815|NCT04436276|64393872|FG014|Overall Study|Withdrawal by Subject|20|||
23177816|NCT04436276|64393873|FG015|Overall Study|Withdrawal by Subject|6|||
23177817|NCT04436276|64393874|FG016|Overall Study|Withdrawal by Subject|11|||
23177818|NCT04436276|64393875|FG017|Overall Study|Withdrawal by Subject|4|||
23177819|NCT04436276|64393876|FG018|Overall Study|Withdrawal by Subject|14|||
23177820|NCT04436276|64393877|FG019|Overall Study|Withdrawal by Subject|24|||
23177821|NCT04436276|64393878|FG020|Overall Study|Withdrawal by Subject|24|||
23177822|NCT04436276|64393879|FG021|Overall Study|Withdrawal by Subject|16|||
23177823|NCT04436276|64393880|FG022|Overall Study|Withdrawal by Subject|14|||
23177824|NCT04436276|64393858|FG000|Overall Study|Other|3|||
23177825|NCT04436276|64393859|FG001|Overall Study|Other|2|||
23177826|NCT04436276|64393860|FG002|Overall Study|Other|5|||
23177827|NCT04436276|64393861|FG003|Overall Study|Other|9|||
23177828|NCT04436276|64393862|FG004|Overall Study|Other|23|||
23455634|NCT00713609|65409817|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
23455635|NCT00713609|65409812|FG000|Overall Study|Withdrawal by Subject|6|||
23455636|NCT00713609|65409813|FG001|Overall Study|Withdrawal by Subject|1|||
23455637|NCT00713609|65409814|FG002|Overall Study|Withdrawal by Subject|5|||
23455638|NCT00713609|65409815|FG003|Overall Study|Withdrawal by Subject|1|||
23455639|NCT00713609|65409816|FG004|Overall Study|Withdrawal by Subject|5|||
23455640|NCT00713609|65409817|FG005|Overall Study|Withdrawal by Subject|7|||
23455641|NCT00713609|65409812|FG000|Overall Study|Protocol Violation|6|||
23455642|NCT00713609|65409813|FG001|Overall Study|Protocol Violation|3|||
23177829|NCT04436276|64393863|FG005|Overall Study|Other|1|||
23177830|NCT04436276|64393864|FG006|Overall Study|Other|0|||
23177831|NCT04436276|64393865|FG007|Overall Study|Other|0|||
23177832|NCT04436276|64393866|FG008|Overall Study|Other|0|||
23177833|NCT04436276|64393867|FG009|Overall Study|Other|0|||
23177834|NCT04436276|64393868|FG010|Overall Study|Other|3|||
23177835|NCT04436276|64393869|FG011|Overall Study|Other|1|||
23177836|NCT04436276|64393870|FG012|Overall Study|Other|1|||
23177837|NCT04436276|64393871|FG013|Overall Study|Other|2|||
23177838|NCT04436276|64393872|FG014|Overall Study|Other|3|||
23177839|NCT04436276|64393873|FG015|Overall Study|Other|0|||
23177840|NCT04436276|64393874|FG016|Overall Study|Other|0|||
23455643|NCT00713609|65409814|FG002|Overall Study|Protocol Violation|1|||
23177841|NCT04436276|64393875|FG017|Overall Study|Other|6|||
23177842|NCT04436276|64393876|FG018|Overall Study|Other|1|||
23177843|NCT04436276|64393877|FG019|Overall Study|Other|0|||
23177844|NCT04436276|64393878|FG020|Overall Study|Other|2|||
23177845|NCT04436276|64393879|FG021|Overall Study|Other|2|||
23177846|NCT04436276|64393880|FG022|Overall Study|Other|60|||
23455644|NCT00713609|65409815|FG003|Overall Study|Protocol Violation|1|||
23455645|NCT00713609|65409816|FG004|Overall Study|Protocol Violation|2|||
23455646|NCT00713609|65409817|FG005|Overall Study|Protocol Violation|0|||
23455647|NCT03597347|65409818|FG000|Overall Study|Withdrawal by Subject|1|||
23455648|NCT03597347|65409819|FG001|Overall Study|Withdrawal by Subject|1|||
23455649|NCT03597347|65409820|FG002|Overall Study|Withdrawal by Subject|0|||
23455650|NCT03597347|65409818|FG000|Overall Study|Withdrawal due to Covid-19|3|||
23455651|NCT03597347|65409819|FG001|Overall Study|Withdrawal due to Covid-19|0|||
23455652|NCT03597347|65409820|FG002|Overall Study|Withdrawal due to Covid-19|0|||
23455653|NCT03597347|65409818|FG000|Overall Study|Sponsor decision to terminate study|3|||
23455654|NCT03597347|65409819|FG001|Overall Study|Sponsor decision to terminate study|2|||
23455655|NCT03597347|65409820|FG002|Overall Study|Sponsor decision to terminate study|4|||
23455656|NCT02513563|65409821|FG000|Overall Study|Death|4|||
23455657|NCT02513563|65409821|FG000|Overall Study|Withdrawal by Subject|4|||
23455658|NCT02513563|65409821|FG000|Overall Study|Physician Decision|1|||
23455659|NCT04551989|65409824|FG000|Overall Study|Adverse Event|4|||
23455660|NCT04551989|65409824|FG000|Overall Study|Protocol Violation|3|||
23455661|NCT04551989|65409824|FG000|Overall Study|Lost to Follow-up|1|||
23455662|NCT04551989|65409824|FG000|Overall Study|Physician Decision|3|||
23455663|NCT01777308|65409827|FG000|Overall Study|Withdrawal by Subject|5|||
23455664|NCT01777308|65409828|FG001|Overall Study|Withdrawal by Subject|1|||
23455665|NCT01777308|65409827|FG000|Overall Study|Migrated/moved from study area|1|||
23455666|NCT01777308|65409828|FG001|Overall Study|Migrated/moved from study area|0|||
23455667|NCT01777308|65409827|FG000|Overall Study|Lost to Follow-up|7|||
23455668|NCT01777308|65409828|FG001|Overall Study|Lost to Follow-up|2|||
23455669|NCT01777308|65409827|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
23455670|NCT01777308|65409828|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
23455671|NCT03287791|65409829|FG000|Overall Study|Insufficient Therapeutic Response|0|||
23455672|NCT03287791|65409830|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23455673|NCT03287791|65409831|FG002|Overall Study|Insufficient Therapeutic Response|1|||
23455674|NCT03287791|65409829|FG000|Overall Study|Adverse Event|0|||
23455675|NCT03287791|65409830|FG001|Overall Study|Adverse Event|4|||
23455676|NCT03287791|65409831|FG002|Overall Study|Adverse Event|3|||
23177847|NCT00122135|64393884|FG000|Overall Study|Withdrawal by Subject|3|||
23455677|NCT03287791|65409829|FG000|Overall Study|Withdrawal by Subject|12|||
23455678|NCT03287791|65409830|FG001|Overall Study|Withdrawal by Subject|12|||
23455679|NCT03287791|65409831|FG002|Overall Study|Withdrawal by Subject|17|||
23455680|NCT03287791|65409829|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
23455681|NCT03287791|65409830|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
23582856|NCT00049517|65865868|FG003|Induction|Withdrawal by Subject|0|||
23582857|NCT00049517|65865869|FG004|Induction|Withdrawal by Subject|1|||
23582858|NCT00049517|65865870|FG005|Induction|Withdrawal by Subject|3|||
23582859|NCT00049517|65865865|FG000|Induction|Alternative therapy|0|||
23582860|NCT00049517|65865866|FG001|Induction|Alternative therapy|0|||
23582861|NCT00049517|65865867|FG002|Induction|Alternative therapy|0|||
23582862|NCT00049517|65865868|FG003|Induction|Alternative therapy|0|||
23582863|NCT00049517|65865869|FG004|Induction|Alternative therapy|2|||
23582864|NCT00049517|65865870|FG005|Induction|Alternative therapy|2|||
23582865|NCT00049517|65865865|FG000|Induction|Other complicating disease|0|||
23582866|NCT00049517|65865866|FG001|Induction|Other complicating disease|0|||
23582867|NCT00049517|65865867|FG002|Induction|Other complicating disease|0|||
23582868|NCT00049517|65865868|FG003|Induction|Other complicating disease|0|||
23582869|NCT00049517|65865869|FG004|Induction|Other complicating disease|3|||
23582870|NCT00049517|65865870|FG005|Induction|Other complicating disease|0|||
23582871|NCT00049517|65865865|FG000|Induction|Reasons not reported|0|||
23582872|NCT00049517|65865866|FG001|Induction|Reasons not reported|0|||
23582873|NCT00049517|65865867|FG002|Induction|Reasons not reported|0|||
23582874|NCT00049517|65865868|FG003|Induction|Reasons not reported|0|||
23582875|NCT00049517|65865869|FG004|Induction|Reasons not reported|22|||
23582876|NCT00049517|65865870|FG005|Induction|Reasons not reported|25|||
23582877|NCT00049517|65865865|FG000|Conditioning/Transplant|Disease progression|14|||
23582878|NCT00049517|65865866|FG001|Conditioning/Transplant|Disease progression|6|||
23582879|NCT00049517|65865867|FG002|Conditioning/Transplant|Disease progression|10|||
23455682|NCT03287791|65409831|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
23455683|NCT03287791|65409829|FG000|Overall Study|Lost to Follow-up|8|||
23582880|NCT00049517|65865868|FG003|Conditioning/Transplant|Disease progression|6|||
23455684|NCT03287791|65409830|FG001|Overall Study|Lost to Follow-up|14|||
23455685|NCT03287791|65409831|FG002|Overall Study|Lost to Follow-up|11|||
23455686|NCT03287791|65409829|FG000|Overall Study|Protocol Violation|7|||
23455687|NCT03287791|65409830|FG001|Overall Study|Protocol Violation|2|||
23455688|NCT03287791|65409831|FG002|Overall Study|Protocol Violation|1|||
23455689|NCT03287791|65409829|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
23582881|NCT00049517|65865869|FG004|Conditioning/Transplant|Disease progression|0|||
23455690|NCT03287791|65409830|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
23455691|NCT03287791|65409831|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
23455692|NCT03287791|65409829|FG000|Overall Study|Too much time between 2 visits|0|||
23455693|NCT03287791|65409830|FG001|Overall Study|Too much time between 2 visits|1|||
23455694|NCT03287791|65409831|FG002|Overall Study|Too much time between 2 visits|0|||
23455695|NCT03287791|65409829|FG000|Overall Study|Non-compliance|0|||
23455696|NCT03287791|65409830|FG001|Overall Study|Non-compliance|1|||
23455697|NCT03287791|65409831|FG002|Overall Study|Non-compliance|0|||
23455698|NCT03287791|65409829|FG000|Overall Study|Did not meet inclusion criteria|1|||
23455699|NCT03287791|65409830|FG001|Overall Study|Did not meet inclusion criteria|0|||
23455700|NCT03287791|65409831|FG002|Overall Study|Did not meet inclusion criteria|0|||
23455701|NCT04890652|65409835|FG000|Overall Study|Withdrawal by Subject|2|||
23455702|NCT02648204|65412724|FG000|Overall Study|Withdrawal by Subject|12|||
23455703|NCT02648204|65412725|FG001|Overall Study|Withdrawal by Subject|8|||
23455704|NCT02648204|65412726|FG002|Overall Study|Withdrawal by Subject|2|||
23455705|NCT02648204|65412727|FG003|Overall Study|Withdrawal by Subject|6|||
23455706|NCT02648204|65412724|FG000|Overall Study|Lost to Follow-up|5|||
23455707|NCT02648204|65412725|FG001|Overall Study|Lost to Follow-up|8|||
23455708|NCT02648204|65412726|FG002|Overall Study|Lost to Follow-up|4|||
23455709|NCT02648204|65412727|FG003|Overall Study|Lost to Follow-up|6|||
23455710|NCT02648204|65412724|FG000|Overall Study|Missing follow-up information|4|||
23455711|NCT02648204|65412725|FG001|Overall Study|Missing follow-up information|4|||
23455712|NCT02648204|65412726|FG002|Overall Study|Missing follow-up information|4|||
23455713|NCT02648204|65412727|FG003|Overall Study|Missing follow-up information|2|||
23455714|NCT02648204|65412724|FG000|Overall Study|Death|1|||
23455715|NCT02648204|65412725|FG001|Overall Study|Death|1|||
23455716|NCT02648204|65412726|FG002|Overall Study|Death|2|||
23455717|NCT02648204|65412727|FG003|Overall Study|Death|2|||
23455718|NCT02648204|65412724|FG000|Overall Study|Adverse Event|0|||
23455719|NCT02648204|65412725|FG001|Overall Study|Adverse Event|0|||
23455720|NCT02648204|65412726|FG002|Overall Study|Adverse Event|1|||
23455721|NCT02648204|65412727|FG003|Overall Study|Adverse Event|0|||
23455722|NCT02246530|65412728|FG000|Overall Study|Lost to Follow-up|4|||
23455723|NCT02246530|65412729|FG001|Overall Study|Lost to Follow-up|0|||
23455724|NCT01743469|65412731|FG000|Active Treatment Phase|Adverse Event|10|||
23455725|NCT01743469|65412732|FG001|Active Treatment Phase|Adverse Event|5|||
23455726|NCT01743469|65412733|FG002|Active Treatment Phase|Adverse Event|8|||
23455727|NCT01743469|65412734|FG003|Active Treatment Phase|Adverse Event|1|||
23455728|NCT01743469|65412731|FG000|Active Treatment Phase|Disease Progression|40|||
23455729|NCT01743469|65412732|FG001|Active Treatment Phase|Disease Progression|47|||
23455730|NCT01743469|65412733|FG002|Active Treatment Phase|Disease Progression|30|||
23455731|NCT01743469|65412734|FG003|Active Treatment Phase|Disease Progression|20|||
23455732|NCT01743469|65412731|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
23455733|NCT01743469|65412732|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
23455734|NCT01743469|65412733|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
23455735|NCT01743469|65412734|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
23455736|NCT01743469|65412731|FG000|Active Treatment Phase|Missing|1|||
23455737|NCT01743469|65412732|FG001|Active Treatment Phase|Missing|0|||
23455738|NCT01743469|65412733|FG002|Active Treatment Phase|Missing|0|||
23455739|NCT01743469|65412734|FG003|Active Treatment Phase|Missing|0|||
23455740|NCT01743469|65412731|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
23455741|NCT01743469|65412732|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
23455742|NCT01743469|65412733|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
23455743|NCT01743469|65412734|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
23455744|NCT01743469|65412731|FG000|Follow-up Period - Post-Treatment|Death|43|||
23455745|NCT01743469|65412732|FG001|Follow-up Period - Post-Treatment|Death|47|||
23455746|NCT01743469|65412733|FG002|Follow-up Period - Post-Treatment|Death|22|||
23455747|NCT01743469|65412734|FG003|Follow-up Period - Post-Treatment|Death|16|||
23455748|NCT01743469|65412731|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
23455749|NCT01743469|65412732|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
23455750|NCT01743469|65412733|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
23455751|NCT01743469|65412734|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
23455752|NCT00984256|65412735|FG000|Overall Study|Withdrawal by Subject|0|||
23455753|NCT00984256|65412736|FG001|Overall Study|Withdrawal by Subject|1|||
23455754|NCT00667628|65412739|FG000|Overall Study|Lost to Follow-up|1|||
23455755|NCT00667628|65412740|FG001|Overall Study|Lost to Follow-up|0|||
23455756|NCT00667628|65412739|FG000|Overall Study|Death|6|||
23455757|NCT00667628|65412740|FG001|Overall Study|Death|6|||
23455758|NCT00667628|65412739|FG000|Overall Study|Investigator Considers in Best Interest|1|||
23455759|NCT00667628|65412740|FG001|Overall Study|Investigator Considers in Best Interest|0|||
23455760|NCT00667628|65412739|FG000|Overall Study|Sponsor Terminated Study|17|||
23455761|NCT00667628|65412740|FG001|Overall Study|Sponsor Terminated Study|21|||
23455762|NCT01451606|65412741|FG000|Overall Study|Withdrawal by Subject|4|||
23455763|NCT01451606|65412742|FG001|Overall Study|Withdrawal by Subject|3|||
23455764|NCT03092726|65412747|FG000|Overall Study|Adverse Event|3|||
23237821|NCT00948896|64615446|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23237822|NCT00948896|64615447|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23237823|NCT00948896|64615448|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
23237824|NCT00948896|64615441|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
23455765|NCT03092726|65412748|FG001|Overall Study|Adverse Event|10|||
23455766|NCT03092726|65412747|FG000|Overall Study|Lack of Efficacy|0|||
23455767|NCT03092726|65412748|FG001|Overall Study|Lack of Efficacy|1|||
23455768|NCT03092726|65412747|FG000|Overall Study|Lost to Follow-up|1|||
23177848|NCT00122135|64393885|FG001|Overall Study|Withdrawal by Subject|0|||
23455769|NCT03092726|65412748|FG001|Overall Study|Lost to Follow-up|0|||
23582882|NCT00049517|65865870|FG005|Conditioning/Transplant|Disease progression|0|||
23582883|NCT00049517|65865865|FG000|Conditioning/Transplant|Adverse Event|2|||
23582884|NCT00049517|65865866|FG001|Conditioning/Transplant|Adverse Event|1|||
23582885|NCT00049517|65865867|FG002|Conditioning/Transplant|Adverse Event|4|||
23582886|NCT00049517|65865868|FG003|Conditioning/Transplant|Adverse Event|8|||
23455770|NCT03092726|65412747|FG000|Overall Study|Withdrawal by Subject|5|||
23455771|NCT03092726|65412748|FG001|Overall Study|Withdrawal by Subject|3|||
23455772|NCT03759379|65412752|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
23582887|NCT00049517|65865869|FG004|Conditioning/Transplant|Adverse Event|0|||
23582888|NCT00049517|65865870|FG005|Conditioning/Transplant|Adverse Event|0|||
23177849|NCT04187092|64393886|FG000|Overall Study|Lost to Follow-up|1|||
23455773|NCT03759379|65412753|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
23455774|NCT03759379|65412752|FG000|Treatment Period|Death|2|||
23455775|NCT03759379|65412753|FG001|Treatment Period|Death|3|||
23455776|NCT03759379|65412752|FG000|Treatment Period|Lost to Follow-up|1|||
23455777|NCT03759379|65412753|FG001|Treatment Period|Lost to Follow-up|0|||
23455778|NCT03759379|65412752|FG000|Treatment Period|Physician Decision|0|||
23455779|NCT03759379|65412753|FG001|Treatment Period|Physician Decision|1|||
23455780|NCT04529083|65412754|FG000|Overall Study|Withdrawal by Subject|3|||
23455781|NCT03633396|65412755|FG000|Overall Study|Withdrawal by Subject|4|||
23455782|NCT03633396|65412756|FG001|Overall Study|Withdrawal by Subject|4|||
23455783|NCT03633396|65412755|FG000|Overall Study|Adverse Event|1|||
23455784|NCT03633396|65412756|FG001|Overall Study|Adverse Event|1|||
23455785|NCT03633396|65412755|FG000|Overall Study|Lack of Efficacy|1|||
23455786|NCT03633396|65412756|FG001|Overall Study|Lack of Efficacy|0|||
23455787|NCT03633396|65412755|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
23455788|NCT03633396|65412756|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
23455789|NCT00764699|65412759|FG000|Overall Study|PI left and study terminated|3|||
23455790|NCT03095651|65412764|FG000|Overall Study|Lost to Follow-up|1|||
23455791|NCT03095651|65412765|FG001|Overall Study|Lost to Follow-up|1|||
23455792|NCT03095651|65412766|FG002|Overall Study|Lost to Follow-up|0|||
23455793|NCT03095651|65412767|FG003|Overall Study|Lost to Follow-up|1|||
23455794|NCT03095651|65412768|FG004|Overall Study|Lost to Follow-up|0|||
23455795|NCT03095651|65412769|FG005|Overall Study|Lost to Follow-up|0|||
23455796|NCT03095651|65412770|FG006|Overall Study|Lost to Follow-up|0|||
23455797|NCT03095651|65412771|FG007|Overall Study|Lost to Follow-up|0|||
23455798|NCT03095651|65412764|FG000|Overall Study|Withdrawal by Subject|0|||
23455799|NCT03095651|65412765|FG001|Overall Study|Withdrawal by Subject|0|||
23455800|NCT03095651|65412766|FG002|Overall Study|Withdrawal by Subject|0|||
23455801|NCT03095651|65412767|FG003|Overall Study|Withdrawal by Subject|0|||
23455802|NCT03095651|65412768|FG004|Overall Study|Withdrawal by Subject|0|||
23455803|NCT03095651|65412769|FG005|Overall Study|Withdrawal by Subject|1|||
23455804|NCT03095651|65412770|FG006|Overall Study|Withdrawal by Subject|0|||
23455805|NCT03095651|65412771|FG007|Overall Study|Withdrawal by Subject|0|||
23177850|NCT04187092|64393887|FG001|Overall Study|Lost to Follow-up|1|||
23177851|NCT04187092|64393886|FG000|Overall Study|Withdrawal by Subject|1|||
23177852|NCT04187092|64393887|FG001|Overall Study|Withdrawal by Subject|1|||
23177853|NCT04187092|64393886|FG000|Overall Study|Adverse Event|0|||
23177854|NCT04187092|64393887|FG001|Overall Study|Adverse Event|1|||
23177855|NCT01900002|64393888|FG000|Overall Study|Withdrawal by Subject|2|||
23344023|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
23344024|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
23455806|NCT01097668|65412781|FG000|Overall Study|Withdrawal by Subject|1|||
23455807|NCT01097668|65412782|FG001|Overall Study|Withdrawal by Subject|2|||
23455808|NCT01097668|65412781|FG000|Overall Study|Lost to Follow-up|1|||
23582889|NCT00049517|65865865|FG000|Conditioning/Transplant|Death|1|||
23455809|NCT01097668|65412782|FG001|Overall Study|Lost to Follow-up|0|||
23455810|NCT00625131|65412784|FG000|Overall Study|Lost to Follow-up|3|||
23237825|NCT00948896|64615442|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23237826|NCT00948896|64615443|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
23237827|NCT00948896|64615444|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23237828|NCT00948896|64615445|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
23237829|NCT00948896|64615446|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23237830|NCT00948896|64615447|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23237831|NCT00948896|64615448|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
23237832|NCT00948896|64615441|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23237833|NCT00948896|64615442|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23237834|NCT00948896|64615443|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
23237835|NCT00948896|64615444|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23237836|NCT00948896|64615445|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23237837|NCT00948896|64615446|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
23237838|NCT00948896|64615447|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23237839|NCT00948896|64615448|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
23237840|NCT00948896|64615441|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23237841|NCT00948896|64615442|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23237842|NCT00948896|64615443|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23237843|NCT00948896|64615444|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
23237844|NCT00948896|64615445|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23237845|NCT00948896|64615446|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23237846|NCT00948896|64615447|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23455811|NCT00625131|65412785|FG001|Overall Study|Lost to Follow-up|2|||
23455812|NCT00625131|65412786|FG002|Overall Study|Lost to Follow-up|0|||
23582890|NCT00049517|65865866|FG001|Conditioning/Transplant|Death|0|||
23582891|NCT00049517|65865867|FG002|Conditioning/Transplant|Death|0|||
23582892|NCT00049517|65865868|FG003|Conditioning/Transplant|Death|2|||
23582893|NCT00049517|65865869|FG004|Conditioning/Transplant|Death|0|||
23582894|NCT00049517|65865870|FG005|Conditioning/Transplant|Death|0|||
23582895|NCT00049517|65865865|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
23582896|NCT00049517|65865866|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
23582897|NCT00049517|65865867|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
23582898|NCT00049517|65865868|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
23582899|NCT00049517|65865869|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
23582900|NCT00049517|65865870|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
23582901|NCT00049517|65865865|FG000|Conditioning/Transplant|Alternative therapy|4|||
23582902|NCT00049517|65865866|FG001|Conditioning/Transplant|Alternative therapy|4|||
23582903|NCT00049517|65865867|FG002|Conditioning/Transplant|Alternative therapy|2|||
23177856|NCT01900002|64393888|FG000|Overall Study|ineligible for Y-90|4|||
23177857|NCT03569202|64393890|FG000|Part 3|Physician Decision|1|||
23177858|NCT03569202|64393891|FG001|Part 3|Physician Decision|0|||
23177859|NCT03569202|64393890|FG000|Part 3|Other|1|||
23177860|NCT03569202|64393891|FG001|Part 3|Other|1|||
23177861|NCT03049449|64393892|FG000|Overall Study|Did not receive treatment.|0|||
23177862|NCT03049449|64393893|FG001|Overall Study|Did not receive treatment.|0|||
23177863|NCT03049449|64393894|FG002|Overall Study|Did not receive treatment.|0|||
23177864|NCT03049449|64393895|FG003|Overall Study|Did not receive treatment.|0|||
23177865|NCT03049449|64393896|FG004|Overall Study|Did not receive treatment.|0|||
23177866|NCT03049449|64393897|FG005|Overall Study|Did not receive treatment.|0|||
23177867|NCT03049449|64393898|FG006|Overall Study|Did not receive treatment.|0|||
23177868|NCT03049449|64393899|FG007|Overall Study|Did not receive treatment.|0|||
23177869|NCT03049449|64393900|FG008|Overall Study|Did not receive treatment.|1|||
23177870|NCT03049449|64393901|FG009|Overall Study|Did not receive treatment.|0|||
23177871|NCT03049449|64393892|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
23177872|NCT03049449|64393893|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
23177873|NCT03049449|64393894|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
23177874|NCT03049449|64393895|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
23177875|NCT03049449|64393896|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
23177876|NCT03049449|64393897|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
23177877|NCT03049449|64393898|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
23177878|NCT03049449|64393899|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
23177879|NCT03049449|64393900|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
23177880|NCT03049449|64393901|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
23177881|NCT03049449|64393892|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23177882|NCT03049449|64393893|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23177883|NCT03049449|64393894|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23582904|NCT00049517|65865868|FG003|Conditioning/Transplant|Alternative therapy|1|||
23582905|NCT00049517|65865869|FG004|Conditioning/Transplant|Alternative therapy|1|||
23582906|NCT00049517|65865870|FG005|Conditioning/Transplant|Alternative therapy|0|||
23582907|NCT00049517|65865865|FG000|Conditioning/Transplant|Other complicating disease|2|||
23582908|NCT00049517|65865866|FG001|Conditioning/Transplant|Other complicating disease|0|||
23582909|NCT00049517|65865867|FG002|Conditioning/Transplant|Other complicating disease|0|||
23582910|NCT00049517|65865868|FG003|Conditioning/Transplant|Other complicating disease|4|||
23582911|NCT00049517|65865869|FG004|Conditioning/Transplant|Other complicating disease|0|||
23582912|NCT00049517|65865870|FG005|Conditioning/Transplant|Other complicating disease|1|||
23582913|NCT00049517|65865865|FG000|Conditioning/Transplant|Reasons not reported|25|||
23582914|NCT00049517|65865866|FG001|Conditioning/Transplant|Reasons not reported|31|||
23237847|NCT00948896|64615448|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
23237848|NCT00761462|64615453|FG000|Treatment|Subjects never received study medication|23|||
23455813|NCT00625131|65412784|FG000|Overall Study|Withdrawal by Subject|1|||
23455814|NCT00625131|65412785|FG001|Overall Study|Withdrawal by Subject|0|||
23455815|NCT00625131|65412786|FG002|Overall Study|Withdrawal by Subject|5|||
23455816|NCT00758771|65412787|FG000|Overall Study|Withdrawal by Subject|1|||
23455817|NCT00758771|65412788|FG001|Overall Study|Withdrawal by Subject|1|||
23455818|NCT00758771|65412787|FG000|Overall Study|Did not meet eligibility criteria|2|||
23455819|NCT00758771|65412788|FG001|Overall Study|Did not meet eligibility criteria|4|||
23455820|NCT00521079|65412790|FG000|Overall Study|Adverse Event|7|||
23455821|NCT00521079|65412791|FG001|Overall Study|Adverse Event|1|||
23455822|NCT00521079|65412790|FG000|Overall Study|Lost to Follow-up|2|||
23455823|NCT00521079|65412791|FG001|Overall Study|Lost to Follow-up|1|||
23455824|NCT00521079|65412790|FG000|Overall Study|Withdrawal by Subject|5|||
23455825|NCT00521079|65412791|FG001|Overall Study|Withdrawal by Subject|3|||
23455826|NCT02973100|65412795|FG000|Overall Study|Adverse Event|1|||
23455827|NCT02973100|65412796|FG001|Overall Study|Adverse Event|2|||
23455828|NCT02973100|65412797|FG002|Overall Study|Adverse Event|1|||
23455829|NCT02973100|65412798|FG003|Overall Study|Adverse Event|2|||
23455830|NCT02973100|65412795|FG000|Overall Study|Lost to Follow-up|3|||
23455831|NCT02973100|65412796|FG001|Overall Study|Lost to Follow-up|1|||
23455832|NCT02973100|65412797|FG002|Overall Study|Lost to Follow-up|1|||
23455833|NCT02973100|65412798|FG003|Overall Study|Lost to Follow-up|0|||
23455834|NCT02973100|65412795|FG000|Overall Study|Withdrawal by Subject|3|||
23455835|NCT02973100|65412796|FG001|Overall Study|Withdrawal by Subject|5|||
23455836|NCT02973100|65412797|FG002|Overall Study|Withdrawal by Subject|1|||
23455837|NCT02973100|65412798|FG003|Overall Study|Withdrawal by Subject|4|||
23455838|NCT02973100|65412795|FG000|Overall Study|Notification of change in address|0|||
23455839|NCT02973100|65412796|FG001|Overall Study|Notification of change in address|0|||
23455840|NCT02973100|65412797|FG002|Overall Study|Notification of change in address|0|||
23455841|NCT02973100|65412798|FG003|Overall Study|Notification of change in address|1|||
23455842|NCT02973100|65412795|FG000|Overall Study|Failed to attend Safety followup period|0|||
23455843|NCT02973100|65412796|FG001|Overall Study|Failed to attend Safety followup period|0|||
23455844|NCT02973100|65412797|FG002|Overall Study|Failed to attend Safety followup period|1|||
23455845|NCT02973100|65412798|FG003|Overall Study|Failed to attend Safety followup period|0|||
23455846|NCT00262860|65412800|FG000|Overall Study|Adverse Event|2|||
23455847|NCT00865345|65412801|FG000|Overall Study|Withdrawal by Subject|2|||
23237849|NCT00761462|64615454|FG001|Treatment|Subjects never received study medication|12|||
23237850|NCT00761462|64615453|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
23237851|NCT00761462|64615454|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
23237852|NCT00761462|64615453|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
23237853|NCT00761462|64615454|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
23237854|NCT00761462|64615453|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
23237855|NCT00761462|64615454|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
23237856|NCT02983305|64615455|FG000|Overall Study|incomplete data|2|||
23455848|NCT01478971|65412802|FG000|Standard of Care Period|Adverse Event|1|||
23455849|NCT01478971|65412802|FG000|Standard of Care Period|Withdrawal by Subject|3|||
23582915|NCT00049517|65865867|FG002|Conditioning/Transplant|Reasons not reported|18|||
23177884|NCT03049449|64393895|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23237857|NCT02983305|64615456|FG001|Overall Study|incomplete data|0|||
23455850|NCT01478971|65412802|FG000|Standard of Care Period|Death|8|||
23455851|NCT01478971|65412802|FG000|Standard of Care Period|Lost to Follow-up|9|||
23455852|NCT01478971|65412802|FG000|Standard of Care Period|Other|4|||
23455853|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Adverse Event|1|||
23455854|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
23455855|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Death|4|||
23455856|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
23455857|NCT01478971|65412802|FG000|Peginesatide Treatment Period|Other|4|||
23582916|NCT00049517|65865868|FG003|Conditioning/Transplant|Reasons not reported|15|||
23582917|NCT00049517|65865869|FG004|Conditioning/Transplant|Reasons not reported|5|||
23582918|NCT00049517|65865870|FG005|Conditioning/Transplant|Reasons not reported|5|||
23582919|NCT05419557|65865877|FG000|Overall Study|Lost to Follow-up|11|||
23582920|NCT05419557|65865878|FG001|Overall Study|Lost to Follow-up|4|||
23582921|NCT03722446|65865879|FG000|Overall Study|Protocol Violation|15|||
23582922|NCT03722446|65865880|FG001|Overall Study|Protocol Violation|2|||
23455858|NCT03656562|65412805|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
23455859|NCT03656562|65412806|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
23177885|NCT03049449|64393896|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23237858|NCT01786707|64615465|FG000|Overall Study|Lost to Follow-up|1|||
23455860|NCT03656562|65412807|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
23582923|NCT01474538|65865881|FG000|Treatment Period 1|Death|1|||
23582924|NCT01474538|65865882|FG001|Treatment Period 1|Death|0|||
23237859|NCT01786707|64615466|FG001|Overall Study|Lost to Follow-up|1|||
23237860|NCT01021423|64615473|FG000|Overall Study|Study terminated|4|||
23237861|NCT01021423|64615474|FG001|Overall Study|Study terminated|5|||
23237862|NCT00508872|64615475|FG000|Overall Study|Lost to Follow-up|1|||
23237863|NCT00508872|64615475|FG000|Overall Study|Physician Decision|1|||
23237864|NCT03799198|64615476|FG000|Overall Study|Lost to Follow-up|4|||
23237865|NCT03799198|64615477|FG001|Overall Study|Lost to Follow-up|8|||
23237866|NCT03799198|64615476|FG000|Overall Study|Death|0|||
23237867|NCT03799198|64615477|FG001|Overall Study|Death|1|||
23237868|NCT00598585|64615478|FG000|Overall Study|Lost to Follow-up|1|||
23237869|NCT00598585|64615479|FG001|Overall Study|Lost to Follow-up|0|||
23237870|NCT03053180|64615480|FG000|Overall Study|Failure to Return|1|||
23237871|NCT00711009|64615486|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
23237872|NCT00711009|64615487|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
23237873|NCT00711009|64615486|FG000|Overall Study|Withdrawal by Subject|4|||
23237874|NCT00711009|64615487|FG001|Overall Study|Withdrawal by Subject|2|||
23177886|NCT03049449|64393897|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23177887|NCT03049449|64393898|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23177888|NCT03049449|64393899|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
23177889|NCT03049449|64393900|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
23177890|NCT03049449|64393901|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
23177891|NCT03969875|64393902|FG000|Overall Study|did not receive allocated intervention|3|||
23177892|NCT03969875|64393903|FG001|Overall Study|did not receive allocated intervention|3|||
23177893|NCT03969875|64393904|FG002|Overall Study|did not receive allocated intervention|4|||
23177894|NCT03969875|64393902|FG000|Overall Study|Protocol Violation|4|||
23177895|NCT03969875|64393903|FG001|Overall Study|Protocol Violation|2|||
23177896|NCT03969875|64393904|FG002|Overall Study|Protocol Violation|2|||
23177897|NCT00927563|64393905|FG000|Overall Study|Lost to Follow-up|1|||
23177898|NCT00927563|64393905|FG000|Overall Study|Withdrawal by Subject|1|||
23177899|NCT02771522|64393906|FG000|Overall Study|Lost to Follow-up|3|||
23177900|NCT02771522|64393906|FG000|Overall Study|Withdrawal by Subject|2|||
23177901|NCT02771522|64393906|FG000|Overall Study|No white spot lesions|3|||
23177902|NCT01570244|64393907|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
23582925|NCT01474538|65865881|FG000|Treatment Period 1|Physician Decision|1|||
23582926|NCT01474538|65865882|FG001|Treatment Period 1|Physician Decision|0|||
23582927|NCT01474538|65865881|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23582928|NCT01474538|65865882|FG001|Treatment Period 1|Withdrawal by Subject|3|||
23582929|NCT01474538|65865881|FG000|Treatment Period 1|Protocol Violation|0|||
23582930|NCT01474538|65865882|FG001|Treatment Period 1|Protocol Violation|1|||
23582931|NCT01474538|65865881|FG000|Treatment Period 2|Death|1|||
23582932|NCT01474538|65865882|FG001|Treatment Period 2|Death|0|||
23582933|NCT01474538|65865881|FG000|Treatment Period 2|Adverse Event|1|||
23582934|NCT01474538|65865882|FG001|Treatment Period 2|Adverse Event|1|||
23582935|NCT01474538|65865881|FG000|Treatment Period 2|Withdrawal by Subject|2|||
23582936|NCT01474538|65865882|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23582937|NCT01474538|65865881|FG000|Treatment Period 2|Sponsor decision|1|||
23582938|NCT01474538|65865882|FG001|Treatment Period 2|Sponsor decision|0|||
23582939|NCT01474538|65865881|FG000|Treatment Period 2|Physician Decision|0|||
23582940|NCT01474538|65865882|FG001|Treatment Period 2|Physician Decision|1|||
23582941|NCT01474538|65865881|FG000|Treatment Period 2|Protocol Violation|1|||
23582942|NCT01474538|65865882|FG001|Treatment Period 2|Protocol Violation|0|||
23582943|NCT00320489|65865883|FG000|Overall Study|Adverse Event|26|||
23582944|NCT00320489|65865884|FG001|Overall Study|Adverse Event|25|||
23582945|NCT00320489|65865883|FG000|Overall Study|Clinical Relapse|26|||
23582946|NCT00320489|65865884|FG001|Overall Study|Clinical Relapse|20|||
23582947|NCT00320489|65865883|FG000|Overall Study|Death|0|||
23582948|NCT00320489|65865884|FG001|Overall Study|Death|2|||
23582949|NCT00320489|65865883|FG000|Overall Study|Entry Criteria Exclusion|2|||
23177903|NCT03370770|64393915|FG000|Overall Study|Patient was followed in another hospital center|1|||
23177904|NCT03370770|64393915|FG000|Overall Study|Progressive Disease|98|||
23177905|NCT03370770|64393915|FG000|Overall Study|Adverse Event|2|||
23177906|NCT03370770|64393915|FG000|Overall Study|Death|5|||
23237875|NCT00711009|64615486|FG000|Overall Study|Lost to Follow-up|3|||
23237876|NCT00711009|64615487|FG001|Overall Study|Lost to Follow-up|9|||
23177907|NCT01622569|64393917|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
23237877|NCT00711009|64615486|FG000|Overall Study|Participant Noncompliant|0|||
23237878|NCT00711009|64615487|FG001|Overall Study|Participant Noncompliant|1|||
23237879|NCT00711009|64615486|FG000|Overall Study|Virologic Failure|2|||
23582950|NCT00320489|65865884|FG001|Overall Study|Entry Criteria Exclusion|4|||
23582951|NCT00320489|65865883|FG000|Overall Study|Lack of Efficacy|16|||
23582952|NCT00320489|65865884|FG001|Overall Study|Lack of Efficacy|7|||
23582953|NCT00320489|65865883|FG000|Overall Study|Lost to Follow-up|21|||
23582954|NCT00320489|65865884|FG001|Overall Study|Lost to Follow-up|22|||
23582955|NCT00320489|65865883|FG000|Overall Study|Physician Decision|8|||
23177908|NCT01622569|64393918|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
23177909|NCT01622569|64393919|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
23177910|NCT01622569|64393920|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
23582956|NCT00320489|65865884|FG001|Overall Study|Physician Decision|8|||
23582957|NCT00320489|65865883|FG000|Overall Study|Protocol Violation|4|||
23582958|NCT00320489|65865884|FG001|Overall Study|Protocol Violation|4|||
23582959|NCT00320489|65865883|FG000|Overall Study|Sponsor Decision|3|||
23582960|NCT00320489|65865884|FG001|Overall Study|Sponsor Decision|3|||
23582961|NCT00320489|65865883|FG000|Overall Study|Withdrawal by Subject|39|||
23582962|NCT00320489|65865884|FG001|Overall Study|Withdrawal by Subject|41|||
23582963|NCT02195479|65865885|FG000|Overall Study|Lost to Follow-up|3|||
23582964|NCT02195479|65865886|FG001|Overall Study|Lost to Follow-up|0|||
23582965|NCT02195479|65865885|FG000|Overall Study|Death|48|||
23582966|NCT02195479|65865886|FG001|Overall Study|Death|45|||
23582967|NCT02195479|65865885|FG000|Overall Study|Physician Decision|1|||
23582968|NCT02195479|65865886|FG001|Overall Study|Physician Decision|0|||
23177911|NCT01622569|64393917|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
23237880|NCT00711009|64615487|FG001|Overall Study|Virologic Failure|1|||
23237881|NCT00711009|64615486|FG000|Overall Study|Pregnancy|1|||
23237882|NCT00711009|64615487|FG001|Overall Study|Pregnancy|0|||
23237883|NCT00711009|64615486|FG000|Overall Study|Site closing|0|||
23237884|NCT00711009|64615487|FG001|Overall Study|Site closing|1|||
23237885|NCT00711009|64615486|FG000|Overall Study|Dose adjustment|1|||
23237886|NCT00711009|64615487|FG001|Overall Study|Dose adjustment|0|||
23237887|NCT02058940|64615488|FG000|Overall Study|Discharged from Critical Care Unit|1|||
23237888|NCT02500732|64615493|FG000|Overall Study|Physician Decision|0|||
23237889|NCT02500732|64615494|FG001|Overall Study|Physician Decision|1|||
23237890|NCT01072175|64615496|FG000|Part A (Drug-Drug Interaction)|Death|1|||
23237891|NCT01072175|64615497|FG001|Part A (Drug-Drug Interaction)|Death|0|||
23237892|NCT01072175|64615498|FG002|Part A (Drug-Drug Interaction)|Death|0|||
23237893|NCT01072175|64615499|FG003|Part A (Drug-Drug Interaction)|Death|0|||
23237894|NCT01072175|64615500|FG004|Part A (Drug-Drug Interaction)|Death|0|||
23237895|NCT01072175|64615501|FG005|Part A (Drug-Drug Interaction)|Death|0|||
23237896|NCT01072175|64615502|FG006|Part A (Drug-Drug Interaction)|Death|0|||
23237897|NCT01072175|64615503|FG007|Part A (Drug-Drug Interaction)|Death|0|||
23237898|NCT01072175|64615504|FG008|Part A (Drug-Drug Interaction)|Death|0|||
23237899|NCT01072175|64615505|FG009|Part A (Drug-Drug Interaction)|Death|0|||
23237900|NCT01072175|64615506|FG010|Part A (Drug-Drug Interaction)|Death|0|||
23237901|NCT01072175|64615507|FG011|Part A (Drug-Drug Interaction)|Death|0|||
23237902|NCT01072175|64615508|FG012|Part A (Drug-Drug Interaction)|Death|0|||
23237903|NCT01072175|64615496|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
23237904|NCT01072175|64615497|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23237905|NCT01072175|64615498|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23237906|NCT01072175|64615499|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23237907|NCT01072175|64615500|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23237908|NCT01072175|64615501|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23177912|NCT01622569|64393918|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
23177913|NCT01622569|64393919|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
23177914|NCT01622569|64393920|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
23177915|NCT01622569|64393917|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
23177916|NCT01622569|64393918|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
23177917|NCT01622569|64393919|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
23177918|NCT01622569|64393920|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
23177919|NCT01622569|64393917|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23177920|NCT01622569|64393918|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
23177921|NCT01622569|64393919|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
23177922|NCT01622569|64393920|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
23177923|NCT01622569|64393917|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
23177924|NCT01622569|64393918|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
23177925|NCT01622569|64393919|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
23177926|NCT01622569|64393920|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
23177927|NCT01622569|64393917|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
23177928|NCT01622569|64393918|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
23177929|NCT01622569|64393919|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
23177930|NCT01622569|64393920|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
23177931|NCT01622569|64393917|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
23177932|NCT01622569|64393918|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
23237909|NCT01072175|64615502|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23237910|NCT01072175|64615503|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23582969|NCT02195479|65865885|FG000|Overall Study|Withdrawal by Subject|11|||
23582970|NCT02195479|65865886|FG001|Overall Study|Withdrawal by Subject|6|||
23177933|NCT01622569|64393919|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
23177934|NCT01622569|64393920|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
23177935|NCT01622569|64393917|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23177936|NCT01622569|64393918|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23177937|NCT01622569|64393919|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
23177938|NCT01622569|64393920|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
23177939|NCT00110019|64393922|FG000|Overall Study|Lack of Efficacy|253|||
23177940|NCT00110019|64393923|FG001|Overall Study|Lack of Efficacy|285|||
23177941|NCT00110019|64393922|FG000|Overall Study|Adverse Event|61|||
23177942|NCT00110019|64393923|FG001|Overall Study|Adverse Event|40|||
23177943|NCT00110019|64393922|FG000|Overall Study|Death|13|||
23177944|NCT00110019|64393923|FG001|Overall Study|Death|15|||
23177945|NCT00110019|64393922|FG000|Overall Study|Withdrawal by Subject|21|||
23177946|NCT00110019|64393923|FG001|Overall Study|Withdrawal by Subject|9|||
23177947|NCT00110019|64393922|FG000|Overall Study|alternative therapy|5|||
23177948|NCT00110019|64393923|FG001|Overall Study|alternative therapy|1|||
23177949|NCT00110019|64393922|FG000|Overall Study|complicating disease|1|||
23177950|NCT00110019|64393923|FG001|Overall Study|complicating disease|1|||
23177951|NCT00110019|64393922|FG000|Overall Study|symptom deterioration|13|||
23177952|NCT00110019|64393923|FG001|Overall Study|symptom deterioration|16|||
23177953|NCT00110019|64393922|FG000|Overall Study|Not start protocol therapy|17|||
23177954|NCT00110019|64393923|FG001|Overall Study|Not start protocol therapy|16|||
23177955|NCT00110019|64393922|FG000|Overall Study|other reasons|22|||
23177956|NCT00110019|64393923|FG001|Overall Study|other reasons|30|||
23177957|NCT00059202|64393926|FG000|Overall Study|Withdrawal by Subject|5|||
23177958|NCT00059202|64393927|FG001|Overall Study|Withdrawal by Subject|9|||
23177959|NCT00059202|64393926|FG000|Overall Study|Protocol Violation|1|||
23177960|NCT00059202|64393927|FG001|Overall Study|Protocol Violation|3|||
23177961|NCT00059202|64393926|FG000|Overall Study|drug toxicity|0|||
23177962|NCT00059202|64393927|FG001|Overall Study|drug toxicity|3|||
23177963|NCT02152345|64393928|FG000|Overall Study|Case Cancellations|2|||
23177964|NCT02152345|64393929|FG001|Overall Study|Case Cancellations|4|||
23177965|NCT02152345|64393928|FG000|Overall Study|Withdrawal by Subject|2|||
23177966|NCT02152345|64393929|FG001|Overall Study|Withdrawal by Subject|1|||
23177967|NCT02605642|64393934|FG000|Overall Study|Other|11|||
23177968|NCT02605642|64393935|FG001|Overall Study|Other|1|||
23177969|NCT02605642|64393934|FG000|Overall Study|Participant non-compliance|2|||
23177970|NCT02605642|64393935|FG001|Overall Study|Participant non-compliance|4|||
23177971|NCT02605642|64393934|FG000|Overall Study|Physician Decision|10|||
23177972|NCT02605642|64393935|FG001|Overall Study|Physician Decision|0|||
23177973|NCT02605642|64393934|FG000|Overall Study|Lost to Follow-up|12|||
23177974|NCT02605642|64393935|FG001|Overall Study|Lost to Follow-up|1|||
23177975|NCT02605642|64393934|FG000|Overall Study|Adverse Event|14|||
23177976|NCT02605642|64393935|FG001|Overall Study|Adverse Event|2|||
23177977|NCT02605642|64393934|FG000|Overall Study|Withdrawal by Subject|23|||
23177978|NCT02605642|64393935|FG001|Overall Study|Withdrawal by Subject|2|||
23177979|NCT02605642|64393934|FG000|Overall Study|Lack of response|24|||
23177980|NCT02605642|64393935|FG001|Overall Study|Lack of response|11|||
23177981|NCT02159807|64393936|FG000|Overall Study|Adverse Event|0|||
23177982|NCT02159807|64393937|FG001|Overall Study|Adverse Event|0|||
23177983|NCT02159807|64393938|FG002|Overall Study|Adverse Event|1|||
23177984|NCT02159807|64393936|FG000|Overall Study|No CSF|1|||
23177985|NCT02159807|64393937|FG001|Overall Study|No CSF|1|||
23177986|NCT02159807|64393938|FG002|Overall Study|No CSF|1|||
23177987|NCT02159807|64393936|FG000|Overall Study|elevated blood pressure|0|||
23177988|NCT02159807|64393937|FG001|Overall Study|elevated blood pressure|0|||
23177989|NCT02159807|64393938|FG002|Overall Study|elevated blood pressure|1|||
23177990|NCT03468309|64393941|FG000|Overall Study|Lost to Follow-up|4|||
23177991|NCT03468309|64393941|FG000|Overall Study|Withdrawal by Subject|2|||
23177992|NCT04270760|64393943|FG000|Overall Study|Withdrawal by Subject|0|||
23177993|NCT04270760|64393944|FG001|Overall Study|Withdrawal by Subject|1|||
23177994|NCT04270760|64393945|FG002|Overall Study|Withdrawal by Subject|3|||
23177995|NCT04270760|64393946|FG003|Overall Study|Withdrawal by Subject|0|||
23177996|NCT04270760|64393947|FG004|Overall Study|Withdrawal by Subject|0|||
23177997|NCT04270760|64393943|FG000|Overall Study|Lost to Follow-up|1|||
23177998|NCT04270760|64393944|FG001|Overall Study|Lost to Follow-up|2|||
23177999|NCT04270760|64393945|FG002|Overall Study|Lost to Follow-up|1|||
23178000|NCT04270760|64393946|FG003|Overall Study|Lost to Follow-up|0|||
23178001|NCT04270760|64393947|FG004|Overall Study|Lost to Follow-up|0|||
23178002|NCT04270760|64393943|FG000|Overall Study|Death|0|||
23178003|NCT04270760|64393944|FG001|Overall Study|Death|0|||
23178004|NCT04270760|64393945|FG002|Overall Study|Death|0|||
23178005|NCT04270760|64393946|FG003|Overall Study|Death|0|||
23582971|NCT02195479|65865885|FG000|Overall Study|Other|2|||
23582972|NCT02195479|65865886|FG001|Overall Study|Other|2|||
23582973|NCT02195479|65865885|FG000|Overall Study|Ongoing|291|||
23582974|NCT02195479|65865886|FG001|Overall Study|Ongoing|297|||
23582975|NCT00906282|65865893|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
23582976|NCT00906282|65865893|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
23582977|NCT00906282|65865893|FG000|Preoperative Chemotherapy|Progressive disease|6|||
23582978|NCT00906282|65865893|FG000|Preoperative Chemotherapy|Toxicity|1|||
23178006|NCT04270760|64393947|FG004|Overall Study|Death|1|||
23178007|NCT00947531|64393957|FG000|Overall Study|Withdrawal by Subject|10|||
23178008|NCT00947531|64393958|FG001|Overall Study|Withdrawal by Subject|7|||
23178009|NCT00947531|64393957|FG000|Overall Study|Administrative Reason|0|||
23178010|NCT00947531|64393958|FG001|Overall Study|Administrative Reason|1|||
23178011|NCT00947531|64393957|FG000|Overall Study|Adverse Event|2|||
23178012|NCT00947531|64393958|FG001|Overall Study|Adverse Event|2|||
23178013|NCT00947531|64393957|FG000|Overall Study|Lack of Efficacy|1|||
23178014|NCT00947531|64393958|FG001|Overall Study|Lack of Efficacy|0|||
23178015|NCT00947531|64393957|FG000|Overall Study|Other|1|||
23178016|NCT00947531|64393958|FG001|Overall Study|Other|1|||
23178017|NCT01773421|64393961|FG000|Treatment Phase|Other|0|||
23455861|NCT03656562|65412808|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
23455862|NCT03656562|65412805|FG000|Overall Study|Physician Decision|1|||
23455863|NCT03656562|65412806|FG001|Overall Study|Physician Decision|2|||
23455864|NCT03656562|65412807|FG002|Overall Study|Physician Decision|0|||
23455865|NCT03656562|65412808|FG003|Overall Study|Physician Decision|0|||
23455866|NCT03656562|65412805|FG000|Overall Study|Subject Decision|3|||
23455867|NCT03656562|65412806|FG001|Overall Study|Subject Decision|5|||
23455868|NCT03656562|65412807|FG002|Overall Study|Subject Decision|0|||
23455869|NCT03656562|65412808|FG003|Overall Study|Subject Decision|2|||
23455870|NCT02435212|65412813|FG000|Core Phase|Adverse Event|8|||
23178018|NCT01773421|64393962|FG001|Treatment Phase|Other|0|||
23178019|NCT01773421|64393963|FG002|Treatment Phase|Other|2|||
23178020|NCT01773421|64393964|FG003|Treatment Phase|Other|0|||
23178021|NCT01773421|64393965|FG004|Treatment Phase|Other|0|||
23178022|NCT01773421|64393966|FG005|Treatment Phase|Other|0|||
23178023|NCT01773421|64393967|FG006|Treatment Phase|Other|0|||
23178024|NCT01773421|64393961|FG000|Treatment Phase|Adverse Event|0|||
23178025|NCT01773421|64393962|FG001|Treatment Phase|Adverse Event|0|||
23178026|NCT01773421|64393963|FG002|Treatment Phase|Adverse Event|3|||
23178027|NCT01773421|64393964|FG003|Treatment Phase|Adverse Event|1|||
23344025|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
23344026|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Physician Decision|2|||
23344027|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Physician Decision|4|||
23344028|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Pregnancy|2|||
23344029|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Pregnancy|1|||
23344030|NCT02275780|65001559|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
23344031|NCT02275780|65001560|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
23344032|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
23344033|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
23344034|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
23344035|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
23344036|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
23344037|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
23344038|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
23344039|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
23344040|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
23344041|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
23344042|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
23344043|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
23344044|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
23344045|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
23455871|NCT02435212|65412814|FG001|Core Phase|Adverse Event|5|||
23582979|NCT03113487|65865894|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
23178028|NCT01773421|64393965|FG004|Treatment Phase|Adverse Event|0|||
23178029|NCT01773421|64393966|FG005|Treatment Phase|Adverse Event|0|||
23178030|NCT01773421|64393967|FG006|Treatment Phase|Adverse Event|0|||
23344046|NCT02275780|65001559|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
23344047|NCT02275780|65001560|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
23455872|NCT02435212|65412813|FG000|Core Phase|Withdrawal by Subject|3|||
23455873|NCT02435212|65412814|FG001|Core Phase|Withdrawal by Subject|0|||
23455874|NCT02435212|65412813|FG000|Core Phase|Withdrawal by parent/guardian|9|||
23178031|NCT01773421|64393961|FG000|Treatment Phase|Withdrawal by Subject|0|||
23178032|NCT01773421|64393962|FG001|Treatment Phase|Withdrawal by Subject|0|||
23344048|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
23344049|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
23344050|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
23344051|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
23344052|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
23344053|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
23344054|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
23344055|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
23344056|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
23344057|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
23344058|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
23344059|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
23344060|NCT02275780|65001559|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
23344061|NCT02275780|65001560|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
23344062|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
23344063|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
23344064|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
23344065|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
23237911|NCT01072175|64615504|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23237912|NCT01072175|64615505|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23237913|NCT01072175|64615506|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23344066|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
23344067|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
23344068|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
23344069|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
23344070|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
23344071|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
23344072|NCT02275780|65001559|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
23344073|NCT02275780|65001560|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
23344074|NCT03990571|65001569|FG000|Overall Study|Withdrawal by Subject|1|||
23344075|NCT03990571|65001569|FG000|Overall Study|Insurance Issues|3|||
23344076|NCT03990571|65001569|FG000|Overall Study|Covid Restrictions|2|||
23344077|NCT01171898|65001570|FG000|Overall Study|Death|0|||
23344078|NCT01171898|65001571|FG001|Overall Study|Death|0|||
23344079|NCT01171898|65001572|FG002|Overall Study|Death|2|||
23344080|NCT01171898|65001573|FG003|Overall Study|Death|0|||
23344081|NCT01171898|65001570|FG000|Overall Study|Lost to Follow-up|0|||
23344082|NCT01171898|65001571|FG001|Overall Study|Lost to Follow-up|1|||
23344083|NCT01171898|65001572|FG002|Overall Study|Lost to Follow-up|1|||
23344084|NCT01171898|65001573|FG003|Overall Study|Lost to Follow-up|1|||
23344085|NCT01171898|65001570|FG000|Overall Study|Withdrawal by Subject|1|||
23344086|NCT01171898|65001571|FG001|Overall Study|Withdrawal by Subject|4|||
23344087|NCT01171898|65001572|FG002|Overall Study|Withdrawal by Subject|6|||
23344088|NCT01171898|65001573|FG003|Overall Study|Withdrawal by Subject|3|||
23344089|NCT01171898|65001570|FG000|Overall Study|Terminated by Sponsor|1|||
23455875|NCT02435212|65412814|FG001|Core Phase|Withdrawal by parent/guardian|4|||
23455876|NCT02435212|65412813|FG000|Core Phase|Protocol Violation|1|||
23237914|NCT01072175|64615507|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23237915|NCT01072175|64615508|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
23237916|NCT01072175|64615496|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
23237917|NCT01072175|64615497|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237918|NCT01072175|64615498|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237919|NCT01072175|64615499|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237920|NCT01072175|64615500|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237921|NCT01072175|64615501|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237922|NCT01072175|64615502|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237923|NCT01072175|64615503|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237924|NCT01072175|64615504|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237925|NCT01072175|64615505|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237926|NCT01072175|64615506|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237927|NCT01072175|64615507|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23455877|NCT02435212|65412814|FG001|Core Phase|Protocol Violation|2|||
23455878|NCT02435212|65412813|FG000|Core Phase|Physician Decision|3|||
23455879|NCT02435212|65412814|FG001|Core Phase|Physician Decision|0|||
23455880|NCT02435212|65412813|FG000|Core Phase|Lost to Follow-up|0|||
23455881|NCT02435212|65412814|FG001|Core Phase|Lost to Follow-up|1|||
23455882|NCT02435212|65412813|FG000|Core Phase|Lack of Efficacy|0|||
23455883|NCT02435212|65412814|FG001|Core Phase|Lack of Efficacy|1|||
23455884|NCT02435212|65412813|FG000|Core Phase|Recovery|1|||
23344090|NCT01171898|65001571|FG001|Overall Study|Terminated by Sponsor|0|||
23344091|NCT01171898|65001572|FG002|Overall Study|Terminated by Sponsor|0|||
23344092|NCT01171898|65001573|FG003|Overall Study|Terminated by Sponsor|0|||
23344093|NCT01171898|65001570|FG000|Overall Study|Ongoing|1|||
23344094|NCT01171898|65001571|FG001|Overall Study|Ongoing|9|||
23344095|NCT01171898|65001572|FG002|Overall Study|Ongoing|3|||
23344096|NCT01171898|65001573|FG003|Overall Study|Ongoing|0|||
23344097|NCT01171898|65001570|FG000|Overall Study|Other|1|||
23344098|NCT01171898|65001571|FG001|Overall Study|Other|5|||
23344099|NCT01171898|65001572|FG002|Overall Study|Other|0|||
23344100|NCT01171898|65001573|FG003|Overall Study|Other|2|||
23344101|NCT04034251|65001575|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
23344102|NCT04034251|65001576|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
23344103|NCT04034251|65001577|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
23344104|NCT04598451|65001579|FG000|Overall Study|Adverse Event|3|||
23344105|NCT04598451|65001580|FG001|Overall Study|Adverse Event|2|||
23344106|NCT04598451|65001579|FG000|Overall Study|Withdrawal by Subject|3|||
23344107|NCT04598451|65001580|FG001|Overall Study|Withdrawal by Subject|7|||
23344108|NCT04598451|65001579|FG000|Overall Study|Lost to Follow-up|2|||
23344109|NCT04598451|65001580|FG001|Overall Study|Lost to Follow-up|0|||
23344110|NCT04598451|65001579|FG000|Overall Study|Physician Decision|4|||
23344111|NCT04598451|65001580|FG001|Overall Study|Physician Decision|1|||
23344112|NCT04598451|65001579|FG000|Overall Study|Requires Prohibited Medication|1|||
23344113|NCT04598451|65001580|FG001|Overall Study|Requires Prohibited Medication|0|||
23344114|NCT04598451|65001579|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
23344115|NCT04598451|65001580|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
23344116|NCT00504725|65001581|FG000|Overall Study|Protocol Violation|1|||
23344117|NCT00504725|65001582|FG001|Overall Study|Protocol Violation|0|||
23344118|NCT04186806|65001583|FG000|Period 1: 7 Days|Adverse Event|1|||
23344119|NCT04186806|65001584|FG001|Period 1: 7 Days|Adverse Event|0|||
23344120|NCT02963558|65001585|FG000|Overall Study|Withdrawn by investigator|1|||
23178033|NCT01773421|64393963|FG002|Treatment Phase|Withdrawal by Subject|1|||
23178034|NCT01773421|64393964|FG003|Treatment Phase|Withdrawal by Subject|1|||
23178035|NCT01773421|64393965|FG004|Treatment Phase|Withdrawal by Subject|0|||
23178036|NCT01773421|64393966|FG005|Treatment Phase|Withdrawal by Subject|0|||
23178037|NCT01773421|64393967|FG006|Treatment Phase|Withdrawal by Subject|0|||
23178038|NCT01773421|64393961|FG000|Extension Phase|Other|0|||
23178039|NCT01773421|64393962|FG001|Extension Phase|Other|0|||
23178040|NCT01773421|64393963|FG002|Extension Phase|Other|0|||
23178041|NCT01773421|64393964|FG003|Extension Phase|Other|0|||
23178042|NCT01773421|64393965|FG004|Extension Phase|Other|1|||
23178043|NCT01773421|64393966|FG005|Extension Phase|Other|2|||
23178044|NCT01773421|64393967|FG006|Extension Phase|Other|0|||
23178045|NCT01773421|64393961|FG000|Extension Phase|Adverse Event|0|||
23178046|NCT01773421|64393962|FG001|Extension Phase|Adverse Event|0|||
23178047|NCT01773421|64393963|FG002|Extension Phase|Adverse Event|0|||
23178048|NCT01773421|64393964|FG003|Extension Phase|Adverse Event|0|||
23178049|NCT01773421|64393965|FG004|Extension Phase|Adverse Event|2|||
23178050|NCT01773421|64393966|FG005|Extension Phase|Adverse Event|0|||
23178051|NCT01773421|64393967|FG006|Extension Phase|Adverse Event|0|||
23178052|NCT02911688|64393970|FG000|Washout|Lost to Follow-up|1|||
23178053|NCT02911688|64393971|FG001|Washout|Lost to Follow-up|1|||
23178054|NCT02911688|64393970|FG000|Washout|Withdrawal by Subject|0|||
23178055|NCT02911688|64393971|FG001|Washout|Withdrawal by Subject|1|||
23178056|NCT01524991|64393972|FG000|Overall Study|Adverse Event|12|||
23178057|NCT01524991|64393972|FG000|Overall Study|Death|1|||
23178058|NCT01524991|64393972|FG000|Overall Study|Disease ProgressionDu|17|||
23178059|NCT01524991|64393972|FG000|Overall Study|Other complicating disease|1|||
23178060|NCT01524991|64393972|FG000|Overall Study|Withdrawal by Subject|2|||
23178061|NCT01524991|64393972|FG000|Overall Study|Symptomatic Deterioration|1|||
23344121|NCT02963558|65001586|FG001|Overall Study|Withdrawn by investigator|0|||
23344122|NCT02963558|65001585|FG000|Overall Study|Withdrawal by Subject|0|||
23178062|NCT00709956|64393973|FG000|Overall Study|Withdrawal by Subject|1|||
23178063|NCT00709956|64393974|FG001|Overall Study|Withdrawal by Subject|1|||
23178064|NCT00709956|64393973|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
23344123|NCT02963558|65001586|FG001|Overall Study|Withdrawal by Subject|1|||
23344124|NCT03091192|65001587|FG000|Overall Study|Study terminated by sponsor|21|||
23344125|NCT03091192|65001588|FG001|Overall Study|Study terminated by sponsor|14|||
23344126|NCT03091192|65001587|FG000|Overall Study|Death|9|||
23344127|NCT03091192|65001588|FG001|Overall Study|Death|13|||
23344128|NCT03091192|65001587|FG000|Overall Study|Withdrawal by Subject|2|||
23344129|NCT03091192|65001588|FG001|Overall Study|Withdrawal by Subject|0|||
23344130|NCT03091192|65001587|FG000|Overall Study|Lost to Follow-up|1|||
23344131|NCT03091192|65001588|FG001|Overall Study|Lost to Follow-up|0|||
23344132|NCT00614523|65001589|FG000|Overall Study|Adverse Event|4|||
23344133|NCT00614523|65001590|FG001|Overall Study|Adverse Event|20|||
23344134|NCT00614523|65001589|FG000|Overall Study|Death|5|||
23344135|NCT00614523|65001590|FG001|Overall Study|Death|8|||
23344136|NCT00614523|65001589|FG000|Overall Study|Lack of Efficacy|9|||
23344137|NCT00614523|65001590|FG001|Overall Study|Lack of Efficacy|11|||
23344138|NCT00614523|65001589|FG000|Overall Study|Lost to Follow-up|0|||
23344139|NCT00614523|65001590|FG001|Overall Study|Lost to Follow-up|1|||
23344140|NCT00614523|65001589|FG000|Overall Study|Protocol Violation|3|||
23344141|NCT00614523|65001590|FG001|Overall Study|Protocol Violation|2|||
23344142|NCT00614523|65001589|FG000|Overall Study|Withdrawal by Subject|12|||
23344143|NCT00614523|65001590|FG001|Overall Study|Withdrawal by Subject|22|||
23344144|NCT00614523|65001589|FG000|Overall Study|Other|6|||
23344145|NCT00614523|65001590|FG001|Overall Study|Other|11|||
23344146|NCT00614523|65001589|FG000|Overall Study|Ineligibility Determined|1|||
23344147|NCT00614523|65001590|FG001|Overall Study|Ineligibility Determined|2|||
23344148|NCT00614523|65001589|FG000|Overall Study|Disease Progression|0|||
23344149|NCT00614523|65001590|FG001|Overall Study|Disease Progression|8|||
23344150|NCT00614523|65001589|FG000|Overall Study|Administrative Decision|23|||
23344151|NCT00614523|65001590|FG001|Overall Study|Administrative Decision|46|||
23344152|NCT05177354|65001593|FG000|Implant to 30-day Visit|Physician Decision|1|||
23344153|NCT05177354|65001593|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
23344154|NCT05177354|65001593|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
23344155|NCT05177354|65001593|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
23344156|NCT03581292|65001594|FG000|Overall Study|Physician Decision|9|||
23344157|NCT03581292|65001595|FG001|Overall Study|Physician Decision|5|||
23344158|NCT03581292|65001594|FG000|Overall Study|Withdrawal by Subject|3|||
23344159|NCT03581292|65001595|FG001|Overall Study|Withdrawal by Subject|0|||
23344160|NCT03581292|65001594|FG000|Overall Study|Withdrawal before Therapy Start|1|||
23344161|NCT03581292|65001595|FG001|Overall Study|Withdrawal before Therapy Start|0|||
23344162|NCT01143064|65001596|FG000|Overall Study|Death|109|||
23344163|NCT01143064|65001597|FG001|Overall Study|Death|91|||
23344164|NCT01143064|65001596|FG000|Overall Study|Adverse Event|0|||
23344165|NCT01143064|65001597|FG001|Overall Study|Adverse Event|1|||
23344166|NCT01143064|65001596|FG000|Overall Study|Withdrawal by Subject|7|||
23344167|NCT01143064|65001597|FG001|Overall Study|Withdrawal by Subject|5|||
23344168|NCT01143064|65001596|FG000|Overall Study|Lost to Follow-up|17|||
23344169|NCT01143064|65001597|FG001|Overall Study|Lost to Follow-up|14|||
23455885|NCT02435212|65412814|FG001|Core Phase|Recovery|0|||
23455886|NCT02435212|65412813|FG000|Optional Extension Phase|Adverse Event|3|||
23455887|NCT02435212|65412814|FG001|Optional Extension Phase|Adverse Event|9|||
23455888|NCT02435212|65412813|FG000|Optional Extension Phase|Physician Decision|6|||
23455889|NCT02435212|65412814|FG001|Optional Extension Phase|Physician Decision|8|||
23455890|NCT02435212|65412813|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
23455891|NCT02435212|65412814|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
23455892|NCT02435212|65412813|FG000|Optional Extension Phase|Lack of Efficacy|2|||
23455893|NCT02435212|65412814|FG001|Optional Extension Phase|Lack of Efficacy|3|||
23455894|NCT02435212|65412813|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
23455895|NCT02435212|65412814|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
23455896|NCT02435212|65412813|FG000|Optional Extension Phase|Protocol Violation|0|||
23455897|NCT02435212|65412814|FG001|Optional Extension Phase|Protocol Violation|1|||
23455898|NCT02435212|65412813|FG000|Optional Extension Phase|Recovery|1|||
23455899|NCT02435212|65412814|FG001|Optional Extension Phase|Recovery|1|||
23344170|NCT01143064|65001596|FG000|Overall Study|Physician Decision|0|||
23344171|NCT01143064|65001597|FG001|Overall Study|Physician Decision|4|||
23344172|NCT03692325|65001601|FG000|Overall Study|Adverse Event|2|||
23344173|NCT03692325|65001601|FG000|Overall Study|Progression/Recurrence|2|||
23344174|NCT00412217|65001604|FG000|Overall Study|Insufficient Data Available|8|||
23344175|NCT00412217|65001605|FG001|Overall Study|Insufficient Data Available|3|||
23344176|NCT00412217|65001604|FG000|Overall Study|Death|5|||
23344177|NCT00412217|65001605|FG001|Overall Study|Death|4|||
23455900|NCT02435212|65412813|FG000|Optional Extension Phase|Death|1|||
23455901|NCT02435212|65412814|FG001|Optional Extension Phase|Death|0|||
23455902|NCT02435212|65412813|FG000|Optional Extension Phase|Technical problems|2|||
23344178|NCT00412217|65001604|FG000|Overall Study|Disease Progression|2|||
23344179|NCT00412217|65001605|FG001|Overall Study|Disease Progression|3|||
23344180|NCT00412217|65001604|FG000|Overall Study|Investigator Decision|1|||
23344181|NCT00412217|65001605|FG001|Overall Study|Investigator Decision|0|||
23344182|NCT00412217|65001604|FG000|Overall Study|Withdrawal by Subject|2|||
23344183|NCT00412217|65001605|FG001|Overall Study|Withdrawal by Subject|0|||
23344184|NCT00412217|65001604|FG000|Overall Study|Lost to Follow-up|1|||
23344185|NCT00412217|65001605|FG001|Overall Study|Lost to Follow-up|4|||
23344186|NCT00412217|65001604|FG000|Overall Study|Study Terminated by Sponsor|26|||
23237928|NCT01072175|64615508|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
23237929|NCT01072175|64615496|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
23237930|NCT01072175|64615497|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
23237931|NCT01072175|64615498|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
23237932|NCT01072175|64615499|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
23237933|NCT01072175|64615500|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
23237934|NCT01072175|64615501|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
23237935|NCT01072175|64615502|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
23237936|NCT01072175|64615503|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
23237937|NCT01072175|64615504|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
23237938|NCT01072175|64615505|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
23237939|NCT01072175|64615506|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
23237940|NCT01072175|64615507|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
23237941|NCT01072175|64615508|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
23237942|NCT01072175|64615496|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237943|NCT01072175|64615497|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237944|NCT01072175|64615498|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
23237945|NCT01072175|64615499|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237946|NCT01072175|64615500|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
23237947|NCT01072175|64615501|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237948|NCT01072175|64615502|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237949|NCT01072175|64615503|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237950|NCT01072175|64615504|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237951|NCT01072175|64615505|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237952|NCT01072175|64615506|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237953|NCT01072175|64615507|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237954|NCT01072175|64615508|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
23237955|NCT01072175|64615496|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23237956|NCT01072175|64615497|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
23237957|NCT01072175|64615498|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23237958|NCT01072175|64615499|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
23237959|NCT01072175|64615500|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
23237960|NCT01072175|64615501|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23344187|NCT00412217|65001605|FG001|Overall Study|Study Terminated by Sponsor|33|||
23344188|NCT00412217|65001604|FG000|Overall Study|Other|1|||
23344189|NCT00412217|65001605|FG001|Overall Study|Other|1|||
23344190|NCT03729570|65001608|FG000|Overall Study|Lost to Follow-up|16|||
23344191|NCT03729570|65001609|FG001|Overall Study|Lost to Follow-up|20|||
23344192|NCT03729570|65001608|FG000|Overall Study|Seroconversion|5|||
23344193|NCT03729570|65001609|FG001|Overall Study|Seroconversion|0|||
23344194|NCT03729570|65001608|FG000|Overall Study|Moved out of the city|1|||
23344195|NCT03729570|65001609|FG001|Overall Study|Moved out of the city|0|||
23344196|NCT03729570|65001608|FG000|Overall Study|Time Conflict|1|||
23344197|NCT03729570|65001609|FG001|Overall Study|Time Conflict|0|||
23344198|NCT03729570|65001608|FG000|Overall Study|Time Commitment|2|||
23344199|NCT03729570|65001609|FG001|Overall Study|Time Commitment|0|||
23344200|NCT03729570|65001608|FG000|Overall Study|Bad Experience|0|||
23344201|NCT03729570|65001609|FG001|Overall Study|Bad Experience|1|||
23344202|NCT03729570|65001608|FG000|Overall Study|No reason provided|2|||
23344203|NCT03729570|65001609|FG001|Overall Study|No reason provided|1|||
23344204|NCT03729570|65001608|FG000|Overall Study|Family Conflict|0|||
23344205|NCT03729570|65001609|FG001|Overall Study|Family Conflict|1|||
23344206|NCT03729570|65001608|FG000|Overall Study|Did not want to continue taking medications|0|||
23344207|NCT03729570|65001609|FG001|Overall Study|Did not want to continue taking medications|1|||
23344208|NCT03729570|65001608|FG000|Overall Study|Found another PrEP provider|1|||
23344209|NCT03729570|65001609|FG001|Overall Study|Found another PrEP provider|0|||
23344210|NCT03729570|65001608|FG000|Overall Study|Did not enjoy being in the control group|0|||
23344211|NCT03729570|65001609|FG001|Overall Study|Did not enjoy being in the control group|1|||
23344212|NCT04420585|65001616|FG000|Overall Study|Adverse Event|1|||
23344213|NCT04420585|65001616|FG000|Overall Study|Never initiated medication|2|||
23344214|NCT00558896|65003781|FG000|Overall Study|Adverse Event|1|||
23344215|NCT00558896|65003782|FG001|Overall Study|Adverse Event|1|||
23344216|NCT00558896|65003783|FG002|Overall Study|Adverse Event|1|||
23344217|NCT00558896|65003784|FG003|Overall Study|Adverse Event|3|||
23344218|NCT00558896|65003785|FG004|Overall Study|Adverse Event|4|||
23582980|NCT01068249|65865895|FG000|Overall Study|Death|1|||
23237961|NCT01072175|64615502|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23237962|NCT01072175|64615503|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23237963|NCT01072175|64615504|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23237964|NCT01072175|64615505|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23237965|NCT01072175|64615506|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23237966|NCT01072175|64615507|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23237967|NCT01072175|64615508|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
23237968|NCT01072175|64615496|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23237969|NCT01072175|64615497|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23237970|NCT01072175|64615498|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
23237971|NCT01072175|64615499|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
23237972|NCT01072175|64615500|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
23237973|NCT01072175|64615501|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23237974|NCT01072175|64615502|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23237975|NCT01072175|64615503|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23237976|NCT01072175|64615504|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23237977|NCT01072175|64615505|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23237978|NCT01072175|64615506|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23237979|NCT01072175|64615507|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23178065|NCT00709956|64393974|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
23178066|NCT02597855|64393983|FG000|Overall Study|Lost to Follow-up|2|||
23237980|NCT01072175|64615508|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
23237981|NCT01072175|64615496|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23237982|NCT01072175|64615497|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
23237983|NCT01072175|64615498|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23178067|NCT02597855|64393984|FG001|Overall Study|Lost to Follow-up|1|||
23178068|NCT02090855|64393985|FG000|Overall Study|no evaluable Standard of Truth results|2|||
23178069|NCT01468311|64393988|FG000|Overall Study|mobilization failure|1|||
23178070|NCT01468311|64393988|FG000|Overall Study|Withdrawal by Subject|1|||
23178071|NCT03474679|64393993|FG000|Overall Study|Death|7|||
23178072|NCT03474679|64393993|FG000|Overall Study|Withdrawal by Subject|1|||
23237984|NCT01072175|64615499|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
23237985|NCT01072175|64615500|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
23237986|NCT01072175|64615501|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23237987|NCT01072175|64615502|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23237988|NCT01072175|64615503|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23237989|NCT01072175|64615504|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23344219|NCT00558896|65003786|FG005|Overall Study|Adverse Event|10|||
23344220|NCT00558896|65003787|FG006|Overall Study|Adverse Event|3|||
23344221|NCT00558896|65003781|FG000|Overall Study|Death|3|||
23344222|NCT00558896|65003782|FG001|Overall Study|Death|0|||
23344223|NCT00558896|65003783|FG002|Overall Study|Death|2|||
23344224|NCT00558896|65003784|FG003|Overall Study|Death|3|||
23344225|NCT00558896|65003785|FG004|Overall Study|Death|2|||
23344226|NCT00558896|65003786|FG005|Overall Study|Death|2|||
23344227|NCT00558896|65003787|FG006|Overall Study|Death|6|||
23344228|NCT00558896|65003781|FG000|Overall Study|Withdrawal by Subject|2|||
23344229|NCT00558896|65003782|FG001|Overall Study|Withdrawal by Subject|1|||
23344230|NCT00558896|65003783|FG002|Overall Study|Withdrawal by Subject|1|||
23178073|NCT00667576|64393995|FG000|Overall Study|Withdrawal by Subject|1|||
23178074|NCT00667576|64393996|FG001|Overall Study|Withdrawal by Subject|0|||
23344231|NCT00558896|65003784|FG003|Overall Study|Withdrawal by Subject|1|||
23344232|NCT00558896|65003785|FG004|Overall Study|Withdrawal by Subject|1|||
23344233|NCT00558896|65003786|FG005|Overall Study|Withdrawal by Subject|5|||
23344234|NCT00558896|65003787|FG006|Overall Study|Withdrawal by Subject|5|||
23344235|NCT00558896|65003781|FG000|Overall Study|Alternative Treatment|2|||
23344236|NCT00558896|65003782|FG001|Overall Study|Alternative Treatment|2|||
23344237|NCT00558896|65003783|FG002|Overall Study|Alternative Treatment|0|||
23344238|NCT00558896|65003784|FG003|Overall Study|Alternative Treatment|2|||
23344239|NCT00558896|65003785|FG004|Overall Study|Alternative Treatment|6|||
23344240|NCT00558896|65003786|FG005|Overall Study|Alternative Treatment|7|||
23344241|NCT00558896|65003787|FG006|Overall Study|Alternative Treatment|1|||
23582981|NCT01068249|65865895|FG000|Overall Study|Withdrawal by Subject|3|||
23582982|NCT00712166|65865900|FG000|Overall Study|Noncompliance|0|||
23582983|NCT00712166|65865901|FG001|Overall Study|Noncompliance|1|||
23582984|NCT00906698|65865902|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
23178075|NCT00667576|64393997|FG002|Overall Study|Withdrawal by Subject|1|||
23344242|NCT00558896|65003781|FG000|Overall Study|Physician discretion|3|||
23344243|NCT00558896|65003782|FG001|Overall Study|Physician discretion|2|||
23344244|NCT00558896|65003783|FG002|Overall Study|Physician discretion|1|||
23237990|NCT01072175|64615505|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23237991|NCT01072175|64615506|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23237992|NCT01072175|64615507|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23237993|NCT01072175|64615508|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
23237994|NCT01072175|64615496|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
23237995|NCT01072175|64615497|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
23237996|NCT01072175|64615498|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
23237997|NCT01072175|64615499|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
23237998|NCT01072175|64615500|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
23237999|NCT01072175|64615501|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
23238000|NCT01072175|64615502|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
23238001|NCT01072175|64615503|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
23238002|NCT01072175|64615504|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
23238003|NCT01072175|64615505|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
23238004|NCT01072175|64615506|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
23238005|NCT01072175|64615507|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
23238006|NCT01072175|64615508|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
23344245|NCT00558896|65003784|FG003|Overall Study|Physician discretion|2|||
23344246|NCT00558896|65003785|FG004|Overall Study|Physician discretion|1|||
23344247|NCT00558896|65003786|FG005|Overall Study|Physician discretion|3|||
23344248|NCT00558896|65003787|FG006|Overall Study|Physician discretion|3|||
23344249|NCT00558896|65003781|FG000|Overall Study|Continues on treatment|10|||
23344250|NCT00558896|65003782|FG001|Overall Study|Continues on treatment|1|||
23344251|NCT00558896|65003783|FG002|Overall Study|Continues on treatment|0|||
23344252|NCT00558896|65003784|FG003|Overall Study|Continues on treatment|1|||
23344253|NCT00558896|65003785|FG004|Overall Study|Continues on treatment|9|||
23344254|NCT00558896|65003786|FG005|Overall Study|Continues on treatment|25|||
23344255|NCT00558896|65003787|FG006|Overall Study|Continues on treatment|6|||
23344256|NCT01647516|65003788|FG000|Induction Period (IP)|Physician Decision|2|||
23344257|NCT01647516|65003789|FG001|Induction Period (IP)|Physician Decision|0|||
23344258|NCT01647516|65003790|FG002|Induction Period (IP)|Physician Decision|0|||
23344259|NCT01647516|65003791|FG003|Induction Period (IP)|Physician Decision|0|||
23344260|NCT01647516|65003792|FG004|Induction Period (IP)|Physician Decision|0|||
23344261|NCT01647516|65003793|FG005|Induction Period (IP)|Physician Decision|0|||
23344262|NCT01647516|65003788|FG000|Induction Period (IP)|Adverse Event|1|||
23344263|NCT01647516|65003789|FG001|Induction Period (IP)|Adverse Event|2|||
23344264|NCT01647516|65003790|FG002|Induction Period (IP)|Adverse Event|0|||
23344265|NCT01647516|65003791|FG003|Induction Period (IP)|Adverse Event|0|||
23344266|NCT01647516|65003792|FG004|Induction Period (IP)|Adverse Event|0|||
23344267|NCT01647516|65003793|FG005|Induction Period (IP)|Adverse Event|0|||
23344268|NCT01647516|65003788|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
23344269|NCT01647516|65003789|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
23344270|NCT01647516|65003790|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
23344271|NCT01647516|65003791|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
23344272|NCT01647516|65003792|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
23344273|NCT01647516|65003793|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
23344274|NCT01647516|65003788|FG000|Induction Period (IP)|Participant Choice|0|||
23344275|NCT01647516|65003789|FG001|Induction Period (IP)|Participant Choice|0|||
23344276|NCT01647516|65003790|FG002|Induction Period (IP)|Participant Choice|1|||
23344277|NCT01647516|65003791|FG003|Induction Period (IP)|Participant Choice|0|||
23344278|NCT01647516|65003792|FG004|Induction Period (IP)|Participant Choice|0|||
23344279|NCT01647516|65003793|FG005|Induction Period (IP)|Participant Choice|0|||
23344280|NCT01647516|65003788|FG000|Induction Period (IP)|Lack of Efficacy|1|||
23344281|NCT01647516|65003789|FG001|Induction Period (IP)|Lack of Efficacy|0|||
23344282|NCT01647516|65003790|FG002|Induction Period (IP)|Lack of Efficacy|0|||
23344283|NCT01647516|65003791|FG003|Induction Period (IP)|Lack of Efficacy|0|||
23344284|NCT01647516|65003792|FG004|Induction Period (IP)|Lack of Efficacy|0|||
23344285|NCT01647516|65003793|FG005|Induction Period (IP)|Lack of Efficacy|0|||
23344286|NCT01647516|65003788|FG000|Induction Period (IP)|No study drug received|1|||
23238007|NCT01072175|64615496|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23344287|NCT01647516|65003789|FG001|Induction Period (IP)|No study drug received|1|||
23344288|NCT01647516|65003790|FG002|Induction Period (IP)|No study drug received|0|||
23344289|NCT01647516|65003791|FG003|Induction Period (IP)|No study drug received|0|||
23344290|NCT01647516|65003792|FG004|Induction Period (IP)|No study drug received|0|||
23344291|NCT01647516|65003793|FG005|Induction Period (IP)|No study drug received|0|||
23344292|NCT01647516|65003788|FG000|Maintenance Period (MP)|Adverse Event|2|||
23455903|NCT02435212|65412814|FG001|Optional Extension Phase|Technical problems|0|||
23455904|NCT05106959|65412815|FG000|Overall Study|Lost to Follow-up|1|||
23238008|NCT01072175|64615497|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23344293|NCT01647516|65003789|FG001|Maintenance Period (MP)|Adverse Event|1|||
23178076|NCT00667576|64393998|FG003|Overall Study|Withdrawal by Subject|1|||
23178077|NCT00667576|64393999|FG004|Overall Study|Withdrawal by Subject|1|||
23178078|NCT00667576|64393995|FG000|Overall Study|Adverse Event|1|||
23178079|NCT00667576|64393996|FG001|Overall Study|Adverse Event|1|||
23178080|NCT00667576|64393997|FG002|Overall Study|Adverse Event|0|||
23178081|NCT00667576|64393998|FG003|Overall Study|Adverse Event|0|||
23178082|NCT00667576|64393999|FG004|Overall Study|Adverse Event|0|||
23178083|NCT00667576|64393995|FG000|Overall Study|Lost to Follow-up|0|||
23178084|NCT00667576|64393996|FG001|Overall Study|Lost to Follow-up|0|||
23178085|NCT00667576|64393997|FG002|Overall Study|Lost to Follow-up|1|||
23178086|NCT00667576|64393998|FG003|Overall Study|Lost to Follow-up|0|||
23178087|NCT00667576|64393999|FG004|Overall Study|Lost to Follow-up|0|||
23178088|NCT00667576|64393995|FG000|Overall Study|Protocol Violation|0|||
23178089|NCT00667576|64393996|FG001|Overall Study|Protocol Violation|0|||
23178090|NCT00667576|64393997|FG002|Overall Study|Protocol Violation|0|||
23178091|NCT00667576|64393998|FG003|Overall Study|Protocol Violation|1|||
23178092|NCT00667576|64393999|FG004|Overall Study|Protocol Violation|0|||
23178093|NCT00667576|64393995|FG000|Overall Study|Physician Decision|0|||
23178094|NCT00667576|64393996|FG001|Overall Study|Physician Decision|0|||
23178095|NCT00667576|64393997|FG002|Overall Study|Physician Decision|0|||
23178096|NCT00667576|64393998|FG003|Overall Study|Physician Decision|1|||
23178097|NCT00667576|64393999|FG004|Overall Study|Physician Decision|0|||
23178098|NCT00667576|64393995|FG000|Overall Study|Missed Visit|0|||
23178099|NCT00667576|64393996|FG001|Overall Study|Missed Visit|0|||
23178100|NCT00667576|64393997|FG002|Overall Study|Missed Visit|0|||
23178101|NCT00667576|64393998|FG003|Overall Study|Missed Visit|1|||
23178102|NCT00667576|64393999|FG004|Overall Study|Missed Visit|0|||
23178103|NCT01225562|64394000|FG000|Overall Study|Withdrawal by Subject|52|||
23178104|NCT01225562|64394001|FG001|Overall Study|Withdrawal by Subject|50|||
23178105|NCT01225562|64394002|FG002|Overall Study|Withdrawal by Subject|52|||
23178106|NCT01225562|64394000|FG000|Overall Study|Lost to Follow-up|3|||
23178107|NCT01225562|64394001|FG001|Overall Study|Lost to Follow-up|6|||
23178108|NCT01225562|64394002|FG002|Overall Study|Lost to Follow-up|1|||
23178109|NCT02546986|64394009|FG000|Treatment Period|Progressive Disease|20|||
23178110|NCT02546986|64394010|FG001|Treatment Period|Progressive Disease|22|||
23178111|NCT02546986|64394009|FG000|Treatment Period|Adverse Event|14|||
23178112|NCT02546986|64394010|FG001|Treatment Period|Adverse Event|6|||
23178113|NCT02546986|64394009|FG000|Treatment Period|Symptomatic Deterioration|4|||
23178114|NCT02546986|64394010|FG001|Treatment Period|Symptomatic Deterioration|3|||
23178115|NCT02546986|64394009|FG000|Treatment Period|Death|3|||
23178116|NCT02546986|64394010|FG001|Treatment Period|Death|4|||
23178117|NCT02546986|64394009|FG000|Treatment Period|Physician Decision|1|||
23178118|NCT02546986|64394010|FG001|Treatment Period|Physician Decision|2|||
23178119|NCT02546986|64394009|FG000|Treatment Period|Protocol Violation|1|||
23178120|NCT02546986|64394010|FG001|Treatment Period|Protocol Violation|0|||
23178121|NCT02546986|64394009|FG000|Treatment Period|Withdrawal by Subject|1|||
23178122|NCT02546986|64394010|FG001|Treatment Period|Withdrawal by Subject|1|||
23178123|NCT02546986|64394009|FG000|Treatment Period|Non-compliance with Study Drug|0|||
23238009|NCT01072175|64615498|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23238010|NCT01072175|64615499|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23238011|NCT01072175|64615500|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23238012|NCT01072175|64615501|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
23238013|NCT01072175|64615502|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
23238014|NCT01072175|64615503|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
23238015|NCT01072175|64615504|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23455905|NCT05323084|65412818|FG000|Period 2 - Washout|Lost to Follow-up|0|||
23455906|NCT05323084|65412819|FG001|Period 2 - Washout|Lost to Follow-up|1|||
23455907|NCT04199351|65412820|FG000|Overall Study|Decision by sponsor|0|||
23178124|NCT02546986|64394010|FG001|Treatment Period|Non-compliance with Study Drug|1|||
23178125|NCT02546986|64394009|FG000|Treatment Period|Study Terminated by Sponsor|0|||
23178126|NCT02546986|64394010|FG001|Treatment Period|Study Terminated by Sponsor|1|||
23178127|NCT02546986|64394009|FG000|Treatment Period|Miscellaneous|7|||
23178128|NCT02546986|64394010|FG001|Treatment Period|Miscellaneous|9|||
23178129|NCT02546986|64394009|FG000|Survival Follow-Up Phase|Missing Status|3|||
23178130|NCT02546986|64394010|FG001|Survival Follow-Up Phase|Missing Status|5|||
23178131|NCT02546986|64394009|FG000|Survival Follow-Up Phase|Death|18|||
23178132|NCT02546986|64394010|FG001|Survival Follow-Up Phase|Death|12|||
23178133|NCT02546986|64394009|FG000|Survival Follow-Up Phase|Alive|13|||
23238016|NCT01072175|64615505|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23178134|NCT02546986|64394010|FG001|Survival Follow-Up Phase|Alive|16|||
23455908|NCT04199351|65412821|FG001|Overall Study|Decision by sponsor|0|||
23178135|NCT02546986|64394009|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
23178136|NCT02546986|64394010|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
23178137|NCT00559273|64394011|FG000|Correction Period (20 Weeks)|Death|3|||
23178138|NCT00559273|64394012|FG001|Correction Period (20 Weeks)|Death|4|||
23238017|NCT01072175|64615506|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23238018|NCT01072175|64615507|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23455909|NCT04199351|65412822|FG002|Overall Study|Decision by sponsor|0|||
23455910|NCT04199351|65412823|FG003|Overall Study|Decision by sponsor|2|||
23455911|NCT04199351|65412824|FG004|Overall Study|Decision by sponsor|0|||
23455912|NCT04199351|65412825|FG005|Overall Study|Decision by sponsor|0|||
23455913|NCT04199351|65412826|FG006|Overall Study|Decision by sponsor|0|||
23455914|NCT04199351|65412827|FG007|Overall Study|Decision by sponsor|0|||
23455915|NCT04199351|65412828|FG008|Overall Study|Decision by sponsor|0|||
23455916|NCT04199351|65412829|FG009|Overall Study|Decision by sponsor|6|||
23455917|NCT04199351|65412820|FG000|Overall Study|Lost to Follow-up|0|||
23455918|NCT04199351|65412821|FG001|Overall Study|Lost to Follow-up|0|||
23455919|NCT04199351|65412822|FG002|Overall Study|Lost to Follow-up|1|||
23455920|NCT04199351|65412823|FG003|Overall Study|Lost to Follow-up|0|||
23178139|NCT00559273|64394011|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
23178140|NCT00559273|64394012|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
23178141|NCT00559273|64394011|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
23178142|NCT00559273|64394012|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
23178143|NCT00559273|64394011|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
23178144|NCT00559273|64394012|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
23178145|NCT00559273|64394011|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
23238019|NCT01072175|64615508|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
23238020|NCT01072175|64615496|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238021|NCT01072175|64615497|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238022|NCT01072175|64615498|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238023|NCT01072175|64615499|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238024|NCT01072175|64615500|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238025|NCT01072175|64615501|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238026|NCT01072175|64615502|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
23238027|NCT01072175|64615503|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
23238028|NCT01072175|64615504|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238029|NCT01072175|64615505|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238030|NCT01072175|64615506|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238031|NCT01072175|64615507|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238032|NCT01072175|64615508|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
23238033|NCT01072175|64615496|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238034|NCT01072175|64615497|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238035|NCT01072175|64615498|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238036|NCT01072175|64615499|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238037|NCT01072175|64615500|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238038|NCT01072175|64615501|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
23238039|NCT01072175|64615502|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
23238040|NCT01072175|64615503|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
23238041|NCT01072175|64615504|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238042|NCT01072175|64615505|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238043|NCT01072175|64615506|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238044|NCT01072175|64615507|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238045|NCT01072175|64615508|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
23238046|NCT01072175|64615496|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238047|NCT01072175|64615497|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238048|NCT01072175|64615498|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238049|NCT01072175|64615499|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238050|NCT01072175|64615500|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238051|NCT01072175|64615501|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
23455921|NCT04199351|65412824|FG004|Overall Study|Lost to Follow-up|0|||
23455922|NCT04199351|65412825|FG005|Overall Study|Lost to Follow-up|1|||
23455923|NCT04199351|65412826|FG006|Overall Study|Lost to Follow-up|0|||
23178146|NCT00559273|64394012|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
23178147|NCT00559273|64394011|FG000|Evaluation Period (8 Weeks)|Death|1|||
23178148|NCT00559273|64394012|FG001|Evaluation Period (8 Weeks)|Death|3|||
23178149|NCT00559273|64394011|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
23178150|NCT00559273|64394012|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
23238052|NCT01072175|64615502|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
23238053|NCT01072175|64615503|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23455924|NCT04199351|65412827|FG007|Overall Study|Lost to Follow-up|0|||
23455925|NCT04199351|65412828|FG008|Overall Study|Lost to Follow-up|0|||
23455926|NCT04199351|65412829|FG009|Overall Study|Lost to Follow-up|0|||
23455927|NCT04199351|65412820|FG000|Overall Study|Withdrawal by Subject|0|||
23455928|NCT04199351|65412821|FG001|Overall Study|Withdrawal by Subject|1|||
23455929|NCT04199351|65412822|FG002|Overall Study|Withdrawal by Subject|0|||
23455930|NCT04199351|65412823|FG003|Overall Study|Withdrawal by Subject|0|||
23455931|NCT04199351|65412824|FG004|Overall Study|Withdrawal by Subject|1|||
23455932|NCT04199351|65412825|FG005|Overall Study|Withdrawal by Subject|4|||
23455933|NCT04199351|65412826|FG006|Overall Study|Withdrawal by Subject|2|||
23455934|NCT04199351|65412827|FG007|Overall Study|Withdrawal by Subject|0|||
23455935|NCT04199351|65412828|FG008|Overall Study|Withdrawal by Subject|3|||
23455936|NCT04199351|65412829|FG009|Overall Study|Withdrawal by Subject|0|||
23455937|NCT03363841|65412832|FG000|Overall Study|Adverse Event|1|||
23455938|NCT03363841|65412832|FG000|Overall Study|Withdrawal by Subject|1|||
23455939|NCT03363841|65412832|FG000|Overall Study|Death|7|||
23455940|NCT03363841|65412832|FG000|Overall Study|Physician Decision|1|||
23455941|NCT03040141|65412833|FG000|Overall Study|Death|1|||
23455942|NCT03040141|65412834|FG001|Overall Study|Death|2|||
23455943|NCT03040141|65412835|FG002|Overall Study|Death|3|||
23455944|NCT03040141|65412833|FG000|Overall Study|Withdrawal by Subject|3|||
23455945|NCT03040141|65412834|FG001|Overall Study|Withdrawal by Subject|1|||
23455946|NCT03040141|65412835|FG002|Overall Study|Withdrawal by Subject|1|||
23455947|NCT03040141|65412833|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
23455948|NCT03040141|65412834|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
23455949|NCT03040141|65412835|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
23455950|NCT03040141|65412833|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
23455951|NCT03040141|65412834|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
23455952|NCT03040141|65412835|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
23455953|NCT00360230|65412838|FG000|Overall Study|Withdrawal by Subject|1|||
23455954|NCT00360230|65412839|FG001|Overall Study|Withdrawal by Subject|1|||
23455955|NCT00360230|65412840|FG002|Overall Study|Withdrawal by Subject|0|||
23455956|NCT00360230|65412841|FG003|Overall Study|Withdrawal by Subject|1|||
23455957|NCT00360230|65412842|FG004|Overall Study|Withdrawal by Subject|1|||
23455958|NCT00360230|65412843|FG005|Overall Study|Withdrawal by Subject|1|||
23455959|NCT00360230|65412844|FG006|Overall Study|Withdrawal by Subject|0|||
23455960|NCT00360230|65412838|FG000|Overall Study|Migrated|4|||
23455961|NCT00360230|65412839|FG001|Overall Study|Migrated|1|||
23455962|NCT00360230|65412840|FG002|Overall Study|Migrated|3|||
23455963|NCT00360230|65412841|FG003|Overall Study|Migrated|1|||
23455964|NCT00360230|65412842|FG004|Overall Study|Migrated|4|||
23455965|NCT00360230|65412843|FG005|Overall Study|Migrated|1|||
23455966|NCT00360230|65412844|FG006|Overall Study|Migrated|1|||
23455967|NCT00360230|65412838|FG000|Overall Study|Other|1|||
23455968|NCT00360230|65412839|FG001|Overall Study|Other|0|||
23455969|NCT00360230|65412840|FG002|Overall Study|Other|0|||
23455970|NCT00360230|65412841|FG003|Overall Study|Other|0|||
23455971|NCT00360230|65412842|FG004|Overall Study|Other|0|||
23455972|NCT00360230|65412843|FG005|Overall Study|Other|0|||
23455973|NCT00360230|65412844|FG006|Overall Study|Other|0|||
23455974|NCT00360230|65412838|FG000|Overall Study|Protocol Violation|0|||
23455975|NCT00360230|65412839|FG001|Overall Study|Protocol Violation|0|||
23455976|NCT00360230|65412840|FG002|Overall Study|Protocol Violation|0|||
23455977|NCT00360230|65412841|FG003|Overall Study|Protocol Violation|0|||
23455978|NCT00360230|65412842|FG004|Overall Study|Protocol Violation|0|||
23455979|NCT00360230|65412843|FG005|Overall Study|Protocol Violation|1|||
23455980|NCT00360230|65412844|FG006|Overall Study|Protocol Violation|0|||
23455981|NCT00360230|65412838|FG000|Overall Study|Death|0|||
23455982|NCT00360230|65412839|FG001|Overall Study|Death|1|||
23455983|NCT00360230|65412840|FG002|Overall Study|Death|0|||
23455984|NCT00360230|65412841|FG003|Overall Study|Death|0|||
23455985|NCT00360230|65412842|FG004|Overall Study|Death|0|||
23455986|NCT00360230|65412843|FG005|Overall Study|Death|1|||
23455987|NCT00360230|65412844|FG006|Overall Study|Death|1|||
23455988|NCT02647281|65412853|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455989|NCT02647281|65412854|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455990|NCT02647281|65412855|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455991|NCT02647281|65412856|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455992|NCT02647281|65412857|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455993|NCT02647281|65412858|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455994|NCT02647281|65412859|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455995|NCT02647281|65412860|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
23455996|NCT02647281|65412861|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
23455997|NCT01285401|65412862|FG000|Overall Study|Prematurely withdrawn from the study|17|||
23455998|NCT01285401|65412863|FG001|Overall Study|Prematurely withdrawn from the study|29|||
23455999|NCT01064440|65412864|FG000|Overall Study|Lost to Follow-up|1|||
23456000|NCT01064440|65412865|FG001|Overall Study|Lost to Follow-up|1|||
23456001|NCT01064440|65412866|FG002|Overall Study|Lost to Follow-up|1|||
23456002|NCT01064440|65412864|FG000|Overall Study|Non-compliance|0|||
23456003|NCT01064440|65412865|FG001|Overall Study|Non-compliance|1|||
23456004|NCT01064440|65412866|FG002|Overall Study|Non-compliance|0|||
23456005|NCT01064440|65412864|FG000|Overall Study|Death|1|||
23456006|NCT01064440|65412865|FG001|Overall Study|Death|0|||
23456007|NCT01064440|65412866|FG002|Overall Study|Death|1|||
23456008|NCT01064440|65412864|FG000|Overall Study|Withdrawal by Subject|0|||
23456009|NCT01064440|65412865|FG001|Overall Study|Withdrawal by Subject|1|||
23456010|NCT01064440|65412866|FG002|Overall Study|Withdrawal by Subject|1|||
23456011|NCT01064440|65412864|FG000|Overall Study|Other: amputation|1|||
23456012|NCT01064440|65412865|FG001|Overall Study|Other: amputation|0|||
23456013|NCT01064440|65412866|FG002|Overall Study|Other: amputation|0|||
23344294|NCT01647516|65003790|FG002|Maintenance Period (MP)|Adverse Event|0|||
23344295|NCT01647516|65003791|FG003|Maintenance Period (MP)|Adverse Event|0|||
23344296|NCT01647516|65003792|FG004|Maintenance Period (MP)|Adverse Event|0|||
23344297|NCT01647516|65003793|FG005|Maintenance Period (MP)|Adverse Event|0|||
23344298|NCT01647516|65003788|FG000|Maintenance Period (MP)|Non-compliance|1|||
23344299|NCT01647516|65003789|FG001|Maintenance Period (MP)|Non-compliance|0|||
23456014|NCT00771758|65412867|FG000|Overall Study|Adverse Event|2|||
23238054|NCT01072175|64615504|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238055|NCT01072175|64615505|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238056|NCT01072175|64615506|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238057|NCT01072175|64615507|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238058|NCT01072175|64615508|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
23238059|NCT01072175|64615496|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238060|NCT01072175|64615497|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238061|NCT01072175|64615498|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238062|NCT01072175|64615499|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238063|NCT01072175|64615500|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238064|NCT01072175|64615501|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23344300|NCT01647516|65003790|FG002|Maintenance Period (MP)|Non-compliance|0|||
23344301|NCT01647516|65003791|FG003|Maintenance Period (MP)|Non-compliance|0|||
23456015|NCT00771758|65412868|FG001|Overall Study|Adverse Event|8|||
23456016|NCT00771758|65412869|FG002|Overall Study|Adverse Event|1|||
23456017|NCT00771758|65412867|FG000|Overall Study|Lack of Efficacy|0|||
23456018|NCT00771758|65412868|FG001|Overall Study|Lack of Efficacy|2|||
23582985|NCT00906698|65865903|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
23582986|NCT00906698|65865904|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
23582987|NCT00906698|65865905|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
23582988|NCT00906698|65865906|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
23582989|NCT00906698|65865907|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
23582990|NCT00906698|65865902|FG000|Overall Study|Adverse Event|0|||
23582991|NCT00906698|65865903|FG001|Overall Study|Adverse Event|0|||
23582992|NCT00906698|65865904|FG002|Overall Study|Adverse Event|2|||
23456019|NCT00771758|65412869|FG002|Overall Study|Lack of Efficacy|1|||
23456020|NCT00771758|65412867|FG000|Overall Study|Lost to Follow-up|1|||
23456021|NCT00771758|65412868|FG001|Overall Study|Lost to Follow-up|0|||
23456022|NCT00771758|65412869|FG002|Overall Study|Lost to Follow-up|0|||
23238065|NCT01072175|64615502|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23456023|NCT00771758|65412867|FG000|Overall Study|Protocol Violation|1|||
23456024|NCT00771758|65412868|FG001|Overall Study|Protocol Violation|0|||
23456025|NCT00771758|65412869|FG002|Overall Study|Protocol Violation|0|||
23456026|NCT00771758|65412867|FG000|Overall Study|Withdrawal by Subject|1|||
23456027|NCT00771758|65412868|FG001|Overall Study|Withdrawal by Subject|0|||
23456028|NCT00771758|65412869|FG002|Overall Study|Withdrawal by Subject|0|||
23456029|NCT00771758|65412867|FG000|Overall Study|Other|3|||
23456030|NCT00771758|65412868|FG001|Overall Study|Other|2|||
23456031|NCT00771758|65412869|FG002|Overall Study|Other|0|||
23456032|NCT04349891|65412870|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
23582993|NCT00906698|65865905|FG003|Overall Study|Adverse Event|0|||
23456033|NCT04349891|65412871|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
23582994|NCT00906698|65865906|FG004|Overall Study|Adverse Event|4|||
23238066|NCT01072175|64615503|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238067|NCT01072175|64615504|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
23238068|NCT01072175|64615505|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238069|NCT01072175|64615506|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238070|NCT01072175|64615507|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238071|NCT01072175|64615508|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
23238072|NCT01072175|64615496|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238073|NCT01072175|64615497|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238074|NCT01072175|64615498|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238075|NCT01072175|64615499|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238076|NCT01072175|64615500|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238077|NCT01072175|64615501|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238078|NCT01072175|64615502|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238079|NCT01072175|64615503|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238080|NCT01072175|64615504|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
23178151|NCT00559273|64394011|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
23178152|NCT00559273|64394012|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
23178153|NCT00559273|64394011|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
23178154|NCT00559273|64394012|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
23178155|NCT02901431|64394024|FG000|PK Part|Adverse Event|0|||
23178156|NCT02901431|64394025|FG001|PK Part|Adverse Event|1|||
23178157|NCT02901431|64394026|FG002|PK Part|Adverse Event|0|||
23178158|NCT02901431|64394027|FG003|PK Part|Adverse Event|0|||
23178159|NCT02901431|64394028|FG004|PK Part|Adverse Event|0|||
23178160|NCT02901431|64394029|FG005|PK Part|Adverse Event|0|||
23178161|NCT02901431|64394030|FG006|PK Part|Adverse Event|0|||
23178162|NCT02901431|64394031|FG007|PK Part|Adverse Event|0|||
23178163|NCT02901431|64394032|FG008|PK Part|Adverse Event|0|||
23178164|NCT02901431|64394033|FG009|PK Part|Adverse Event|0|||
23238081|NCT01072175|64615505|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238082|NCT01072175|64615506|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238083|NCT01072175|64615507|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238084|NCT01072175|64615508|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
23238085|NCT01072175|64615496|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23238086|NCT01072175|64615497|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23238087|NCT01072175|64615498|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23238088|NCT01072175|64615499|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23238089|NCT01072175|64615500|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23238090|NCT01072175|64615501|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23582995|NCT00906698|65865907|FG005|Overall Study|Adverse Event|1|||
23582996|NCT00906698|65865902|FG000|Overall Study|Disease progression|3|||
23582997|NCT00906698|65865903|FG001|Overall Study|Disease progression|12|||
23582998|NCT00906698|65865904|FG002|Overall Study|Disease progression|4|||
23582999|NCT00906698|65865905|FG003|Overall Study|Disease progression|4|||
23583000|NCT00906698|65865906|FG004|Overall Study|Disease progression|12|||
23583001|NCT00906698|65865907|FG005|Overall Study|Disease progression|4|||
23583002|NCT00906698|65865902|FG000|Overall Study|Withdrawal by Subject|0|||
23583003|NCT00906698|65865903|FG001|Overall Study|Withdrawal by Subject|0|||
23583004|NCT00906698|65865904|FG002|Overall Study|Withdrawal by Subject|0|||
23583005|NCT00906698|65865905|FG003|Overall Study|Withdrawal by Subject|0|||
23583006|NCT00906698|65865906|FG004|Overall Study|Withdrawal by Subject|1|||
23583007|NCT00906698|65865907|FG005|Overall Study|Withdrawal by Subject|0|||
23583008|NCT00906698|65865902|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
23583009|NCT00906698|65865903|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
23583010|NCT00906698|65865904|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
23583011|NCT00906698|65865905|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
23583012|NCT00906698|65865906|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
23583013|NCT00906698|65865907|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
23583014|NCT01789203|65865914|FG000|Overall Study|Adverse Event|2|||
23583015|NCT01789203|65865915|FG001|Overall Study|Adverse Event|2|||
23178165|NCT02901431|64394034|FG010|PK Part|Adverse Event|0|||
23178166|NCT02901431|64394035|FG011|PK Part|Adverse Event|0|||
23178167|NCT02901431|64394036|FG012|PK Part|Adverse Event|0|||
23178168|NCT02901431|64394024|FG000|PK Part|Lost to Follow-up|0|||
23178169|NCT02901431|64394025|FG001|PK Part|Lost to Follow-up|0|||
23583016|NCT01789203|65865914|FG000|Overall Study|Withdrawal by Subject|1|||
23583017|NCT01789203|65865915|FG001|Overall Study|Withdrawal by Subject|0|||
23583018|NCT01789203|65865914|FG000|Overall Study|Death|1|||
23583019|NCT01789203|65865915|FG001|Overall Study|Death|0|||
23583020|NCT01789203|65865914|FG000|Overall Study|Protocol Violation|2|||
23583021|NCT01789203|65865915|FG001|Overall Study|Protocol Violation|1|||
23583022|NCT01789203|65865914|FG000|Overall Study|Other|1|||
23583023|NCT01789203|65865915|FG001|Overall Study|Other|1|||
23583024|NCT01789203|65865914|FG000|Overall Study|patient non-adherent|2|||
23583025|NCT01789203|65865915|FG001|Overall Study|patient non-adherent|0|||
23583026|NCT02333630|65865917|FG000|Overall Study|Lost to Follow-up|5|||
23583027|NCT02333630|65865918|FG001|Overall Study|Lost to Follow-up|2|||
23583028|NCT00631475|65865919|FG000|Overall Study|Death|18|||
23583029|NCT00631475|65865919|FG000|Overall Study|Adverse Event|14|||
23583030|NCT00631475|65865919|FG000|Overall Study|Withdrew consent|5|||
23583031|NCT00631475|65865919|FG000|Overall Study|Preparation for lung transplant|8|||
23583032|NCT03310983|65865920|FG000|Overall Study|Lost to Follow-up|15|||
23583033|NCT03310983|65865921|FG001|Overall Study|Lost to Follow-up|17|||
23583034|NCT03852433|65865922|FG000|Overall Study|Withdrawal of consent|5|||
23583035|NCT03852433|65865923|FG001|Overall Study|Withdrawal of consent|8|||
23583036|NCT03852433|65865924|FG002|Overall Study|Withdrawal of consent|1|||
23583037|NCT03852433|65865925|FG003|Overall Study|Withdrawal of consent|1|||
23583038|NCT03852433|65865922|FG000|Overall Study|Adverse Event|1|||
23583039|NCT03852433|65865923|FG001|Overall Study|Adverse Event|1|||
23583040|NCT03852433|65865924|FG002|Overall Study|Adverse Event|1|||
23583041|NCT03852433|65865925|FG003|Overall Study|Adverse Event|1|||
23583042|NCT03852433|65865922|FG000|Overall Study|Lost to Follow-up|0|||
23583043|NCT03852433|65865923|FG001|Overall Study|Lost to Follow-up|1|||
23583044|NCT03852433|65865924|FG002|Overall Study|Lost to Follow-up|0|||
23583045|NCT03852433|65865925|FG003|Overall Study|Lost to Follow-up|1|||
23583046|NCT03852433|65865922|FG000|Overall Study|Pregnancy|0|||
23583047|NCT03852433|65865923|FG001|Overall Study|Pregnancy|1|||
23583048|NCT03852433|65865924|FG002|Overall Study|Pregnancy|1|||
23583049|NCT03852433|65865925|FG003|Overall Study|Pregnancy|0|||
23583050|NCT03852433|65865922|FG000|Overall Study|Protocol Violation|0|||
23583051|NCT03852433|65865923|FG001|Overall Study|Protocol Violation|0|||
23583052|NCT03852433|65865924|FG002|Overall Study|Protocol Violation|1|||
23583053|NCT03852433|65865925|FG003|Overall Study|Protocol Violation|1|||
23583054|NCT03852433|65865922|FG000|Overall Study|Death|0|||
23583055|NCT03852433|65865923|FG001|Overall Study|Death|0|||
23583056|NCT03852433|65865924|FG002|Overall Study|Death|1|||
23583057|NCT03852433|65865925|FG003|Overall Study|Death|0|||
23583058|NCT03852433|65865922|FG000|Overall Study|Lack of Efficacy|0|||
23583059|NCT03852433|65865923|FG001|Overall Study|Lack of Efficacy|1|||
23583060|NCT03852433|65865924|FG002|Overall Study|Lack of Efficacy|0|||
23583061|NCT03852433|65865925|FG003|Overall Study|Lack of Efficacy|0|||
23583062|NCT03852433|65865922|FG000|Overall Study|Non-compliance with study drug|0|||
23583063|NCT03852433|65865923|FG001|Overall Study|Non-compliance with study drug|0|||
23583064|NCT03852433|65865924|FG002|Overall Study|Non-compliance with study drug|0|||
23583065|NCT03852433|65865925|FG003|Overall Study|Non-compliance with study drug|1|||
23583066|NCT03852433|65865922|FG000|Overall Study|Physician Decision|1|||
23583067|NCT03852433|65865923|FG001|Overall Study|Physician Decision|0|||
23583068|NCT03852433|65865924|FG002|Overall Study|Physician Decision|0|||
23583069|NCT03852433|65865925|FG003|Overall Study|Physician Decision|0|||
23583070|NCT03852433|65865922|FG000|Overall Study|Randomized but never treated|1|||
23583071|NCT03852433|65865923|FG001|Overall Study|Randomized but never treated|0|||
23583072|NCT03852433|65865924|FG002|Overall Study|Randomized but never treated|0|||
23583073|NCT03852433|65865925|FG003|Overall Study|Randomized but never treated|0|||
23583074|NCT00303303|65865926|FG000|Overall Study|Withdrawal by Subject|0|||
23583075|NCT00303303|65865927|FG001|Overall Study|Withdrawal by Subject|0|||
23583076|NCT00303303|65865928|FG002|Overall Study|Withdrawal by Subject|1|||
23583077|NCT03064074|65865929|FG000|Overall Study|Physician Decision|0|||
23583078|NCT03064074|65865930|FG001|Overall Study|Physician Decision|0|||
23583079|NCT03064074|65865931|FG002|Overall Study|Physician Decision|0|||
23583080|NCT03064074|65865932|FG003|Overall Study|Physician Decision|1|||
23583081|NCT01763047|65865933|FG000|Period 1|Test Article Not Available|4|||
23583082|NCT01763047|65865934|FG001|Period 1|Test Article Not Available|1|||
23583083|NCT01763047|65865933|FG000|Period 1|Protocol Violation|4|||
23583084|NCT01763047|65865934|FG001|Period 1|Protocol Violation|4|||
23583085|NCT01763047|65865933|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
23238091|NCT01072175|64615502|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23583086|NCT01763047|65865934|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
23583087|NCT01763047|65865933|FG000|Period 1|Adverse Event|0|||
23583088|NCT01763047|65865934|FG001|Period 1|Adverse Event|1|||
23583089|NCT01763047|65865933|FG000|Period 1|Unsatisfactory Visual Response|0|||
23583090|NCT01763047|65865934|FG001|Period 1|Unsatisfactory Visual Response|3|||
23583091|NCT01763047|65865933|FG000|Period 1|Lens Power Not Available|0|||
23583092|NCT01763047|65865934|FG001|Period 1|Lens Power Not Available|1|||
23583093|NCT01763047|65865933|FG000|Period 1|Study Site office Closed|0|||
23583094|NCT01763047|65865934|FG001|Period 1|Study Site office Closed|1|||
23583095|NCT01763047|65865933|FG000|Period 2|Lens Discomfort|1|||
23583096|NCT01763047|65865934|FG001|Period 2|Lens Discomfort|0|||
23583097|NCT01763047|65865933|FG000|Period 2|No longer meets Eligibility Criteria|1|||
23583098|NCT01763047|65865934|FG001|Period 2|No longer meets Eligibility Criteria|0|||
23583099|NCT01763047|65865933|FG000|Period 2|Study Site office Closed|1|||
23583100|NCT01763047|65865934|FG001|Period 2|Study Site office Closed|1|||
23583101|NCT01763047|65865933|FG000|Period 2|Unsatisfactory Visual Response|1|||
23583102|NCT01763047|65865934|FG001|Period 2|Unsatisfactory Visual Response|1|||
23583103|NCT01763047|65865933|FG000|Period 2|Protocol Violation|0|||
23583104|NCT01763047|65865934|FG001|Period 2|Protocol Violation|2|||
23583105|NCT01763047|65865933|FG000|Period 2|Unsatisfactory lens Fitting|0|||
23583106|NCT01763047|65865934|FG001|Period 2|Unsatisfactory lens Fitting|1|||
23583107|NCT02377362|65865936|FG000|Part A Second Treatment|Protocol Violation|0|||
23583108|NCT02377362|65865937|FG001|Part A Second Treatment|Protocol Violation|0|||
23583109|NCT02377362|65865938|FG002|Part A Second Treatment|Protocol Violation|0|||
23583110|NCT02377362|65865939|FG003|Part A Second Treatment|Protocol Violation|0|||
23583111|NCT02377362|65865940|FG004|Part A Second Treatment|Protocol Violation|1|||
23583112|NCT02377362|65865941|FG005|Part A Second Treatment|Protocol Violation|0|||
23583113|NCT02377362|65865942|FG006|Part A Second Treatment|Protocol Violation|0|||
23583114|NCT02377362|65865943|FG007|Part A Second Treatment|Protocol Violation|0|||
23583115|NCT02377362|65865944|FG008|Part A Second Treatment|Protocol Violation|0|||
23583116|NCT02377362|65865945|FG009|Part A Second Treatment|Protocol Violation|0|||
23583117|NCT02377362|65865946|FG010|Part A Second Treatment|Protocol Violation|0|||
23583118|NCT02377362|65865947|FG011|Part A Second Treatment|Protocol Violation|0|||
23583119|NCT02377362|65865948|FG012|Part A Second Treatment|Protocol Violation|0|||
23583120|NCT02377362|65865936|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583121|NCT02377362|65865937|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583122|NCT02377362|65865938|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583123|NCT02377362|65865939|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
23583124|NCT02377362|65865940|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
23583125|NCT02377362|65865941|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
23583126|NCT02377362|65865942|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583127|NCT02377362|65865943|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583128|NCT02377362|65865944|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583129|NCT02377362|65865945|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583130|NCT02377362|65865946|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583131|NCT02377362|65865947|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583132|NCT02377362|65865948|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
23583133|NCT02377362|65865936|FG000|Part B Overall|Protocol Violation|0|||
23583134|NCT02377362|65865937|FG001|Part B Overall|Protocol Violation|0|||
23583135|NCT02377362|65865938|FG002|Part B Overall|Protocol Violation|0|||
23583136|NCT02377362|65865939|FG003|Part B Overall|Protocol Violation|0|||
23583137|NCT02377362|65865940|FG004|Part B Overall|Protocol Violation|0|||
23583138|NCT02377362|65865941|FG005|Part B Overall|Protocol Violation|0|||
23583139|NCT02377362|65865942|FG006|Part B Overall|Protocol Violation|0|||
23583140|NCT02377362|65865943|FG007|Part B Overall|Protocol Violation|0|||
23583141|NCT02377362|65865944|FG008|Part B Overall|Protocol Violation|0|||
23583142|NCT02377362|65865945|FG009|Part B Overall|Protocol Violation|1|||
23583143|NCT02377362|65865946|FG010|Part B Overall|Protocol Violation|0|||
23583144|NCT02377362|65865947|FG011|Part B Overall|Protocol Violation|0|||
23583145|NCT02377362|65865948|FG012|Part B Overall|Protocol Violation|0|||
23583146|NCT02377362|65865936|FG000|Part B Overall|Adverse Event|0|||
23583147|NCT02377362|65865937|FG001|Part B Overall|Adverse Event|0|||
23583148|NCT02377362|65865938|FG002|Part B Overall|Adverse Event|0|||
23583149|NCT02377362|65865939|FG003|Part B Overall|Adverse Event|0|||
23583150|NCT02377362|65865940|FG004|Part B Overall|Adverse Event|0|||
23583151|NCT02377362|65865941|FG005|Part B Overall|Adverse Event|0|||
23583152|NCT02377362|65865942|FG006|Part B Overall|Adverse Event|1|||
23583153|NCT02377362|65865943|FG007|Part B Overall|Adverse Event|1|||
23583154|NCT02377362|65865944|FG008|Part B Overall|Adverse Event|0|||
23583155|NCT02377362|65865945|FG009|Part B Overall|Adverse Event|0|||
23583156|NCT02377362|65865946|FG010|Part B Overall|Adverse Event|0|||
23583157|NCT02377362|65865947|FG011|Part B Overall|Adverse Event|0|||
23583158|NCT02377362|65865948|FG012|Part B Overall|Adverse Event|0|||
23583159|NCT02377362|65865936|FG000|Part B Overall|Withdrawal by Subject|0|||
23583160|NCT02377362|65865937|FG001|Part B Overall|Withdrawal by Subject|0|||
23583161|NCT02377362|65865938|FG002|Part B Overall|Withdrawal by Subject|0|||
23583162|NCT02377362|65865939|FG003|Part B Overall|Withdrawal by Subject|0|||
23583163|NCT02377362|65865940|FG004|Part B Overall|Withdrawal by Subject|0|||
23178170|NCT02901431|64394026|FG002|PK Part|Lost to Follow-up|1|||
23178171|NCT02901431|64394027|FG003|PK Part|Lost to Follow-up|0|||
23583164|NCT02377362|65865941|FG005|Part B Overall|Withdrawal by Subject|0|||
23583165|NCT02377362|65865942|FG006|Part B Overall|Withdrawal by Subject|1|||
23178172|NCT02901431|64394028|FG004|PK Part|Lost to Follow-up|0|||
23344302|NCT01647516|65003792|FG004|Maintenance Period (MP)|Non-compliance|0|||
23344303|NCT01647516|65003793|FG005|Maintenance Period (MP)|Non-compliance|0|||
23583166|NCT02377362|65865943|FG007|Part B Overall|Withdrawal by Subject|0|||
23583167|NCT02377362|65865944|FG008|Part B Overall|Withdrawal by Subject|0|||
23583168|NCT02377362|65865945|FG009|Part B Overall|Withdrawal by Subject|0|||
23583169|NCT02377362|65865946|FG010|Part B Overall|Withdrawal by Subject|0|||
23583170|NCT02377362|65865947|FG011|Part B Overall|Withdrawal by Subject|1|||
23583171|NCT02377362|65865948|FG012|Part B Overall|Withdrawal by Subject|0|||
23583172|NCT03503773|65865949|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
23583173|NCT03503773|65865950|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
23583174|NCT03503773|65865949|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
23583175|NCT03503773|65865950|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
23583176|NCT03503773|65865949|FG000|Overall Study|Not completing the primary ABPM|3|||
23583177|NCT03503773|65865950|FG001|Overall Study|Not completing the primary ABPM|1|||
23583178|NCT03503773|65865949|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23583179|NCT03503773|65865950|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23583180|NCT02857283|65865953|FG000|First Exposure|Withdrawal by Subject|1|||
23583181|NCT02857283|65865954|FG001|First Exposure|Withdrawal by Subject|0|||
23583182|NCT02624778|65865955|FG000|Overall Study|Lost to Follow-up|0|||
23583183|NCT02624778|65865956|FG001|Overall Study|Lost to Follow-up|0|||
23583184|NCT02624778|65865957|FG002|Overall Study|Lost to Follow-up|1|||
23583185|NCT02624778|65865958|FG003|Overall Study|Lost to Follow-up|0|||
23583186|NCT02624778|65865959|FG004|Overall Study|Lost to Follow-up|0|||
23583187|NCT02624778|65865960|FG005|Overall Study|Lost to Follow-up|0|||
23583188|NCT02624778|65865961|FG006|Overall Study|Lost to Follow-up|0|||
23583189|NCT02624778|65865962|FG007|Overall Study|Lost to Follow-up|0|||
23583190|NCT02624778|65865963|FG008|Overall Study|Lost to Follow-up|0|||
23583191|NCT02624778|65865955|FG000|Overall Study|Withdrawal by Subject|0|||
23583192|NCT02624778|65865956|FG001|Overall Study|Withdrawal by Subject|1|||
23583193|NCT02624778|65865957|FG002|Overall Study|Withdrawal by Subject|0|||
23583194|NCT02624778|65865958|FG003|Overall Study|Withdrawal by Subject|0|||
23583195|NCT02624778|65865959|FG004|Overall Study|Withdrawal by Subject|0|||
23583196|NCT02624778|65865960|FG005|Overall Study|Withdrawal by Subject|1|||
23583197|NCT02624778|65865961|FG006|Overall Study|Withdrawal by Subject|1|||
23583198|NCT02624778|65865962|FG007|Overall Study|Withdrawal by Subject|1|||
23583199|NCT02624778|65865963|FG008|Overall Study|Withdrawal by Subject|1|||
23583200|NCT02624778|65865955|FG000|Overall Study|Adverse Event|0|||
23583201|NCT02624778|65865956|FG001|Overall Study|Adverse Event|0|||
23583202|NCT02624778|65865957|FG002|Overall Study|Adverse Event|0|||
23583203|NCT02624778|65865958|FG003|Overall Study|Adverse Event|0|||
23583204|NCT02624778|65865959|FG004|Overall Study|Adverse Event|0|||
23583205|NCT02624778|65865960|FG005|Overall Study|Adverse Event|0|||
23178173|NCT02901431|64394029|FG005|PK Part|Lost to Follow-up|0|||
23178174|NCT02901431|64394030|FG006|PK Part|Lost to Follow-up|0|||
23178175|NCT02901431|64394031|FG007|PK Part|Lost to Follow-up|0|||
23238092|NCT01072175|64615503|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23178176|NCT02901431|64394032|FG008|PK Part|Lost to Follow-up|0|||
23583206|NCT02624778|65865961|FG006|Overall Study|Adverse Event|0|||
23583207|NCT02624778|65865962|FG007|Overall Study|Adverse Event|0|||
23583208|NCT02624778|65865963|FG008|Overall Study|Adverse Event|2|||
23583209|NCT02624778|65865955|FG000|Overall Study|Death|0|||
23583210|NCT02624778|65865956|FG001|Overall Study|Death|0|||
23583211|NCT02624778|65865957|FG002|Overall Study|Death|0|||
23583212|NCT02624778|65865958|FG003|Overall Study|Death|0|||
23583213|NCT02624778|65865959|FG004|Overall Study|Death|0|||
23583214|NCT02624778|65865960|FG005|Overall Study|Death|0|||
23583215|NCT02624778|65865961|FG006|Overall Study|Death|1|||
23583216|NCT02624778|65865962|FG007|Overall Study|Death|0|||
23583217|NCT02624778|65865963|FG008|Overall Study|Death|0|||
23583218|NCT02624778|65865955|FG000|Overall Study|Physician Decision|0|||
23583219|NCT02624778|65865956|FG001|Overall Study|Physician Decision|0|||
23583220|NCT02624778|65865957|FG002|Overall Study|Physician Decision|0|||
23583221|NCT02624778|65865958|FG003|Overall Study|Physician Decision|0|||
23583222|NCT02624778|65865959|FG004|Overall Study|Physician Decision|0|||
23583223|NCT02624778|65865960|FG005|Overall Study|Physician Decision|0|||
23583224|NCT02624778|65865961|FG006|Overall Study|Physician Decision|0|||
23583225|NCT02624778|65865962|FG007|Overall Study|Physician Decision|3|||
23583226|NCT02624778|65865963|FG008|Overall Study|Physician Decision|3|||
23583227|NCT04423393|65865964|FG000|Overall Study|Withdrawal by Subject|0|||
23583228|NCT04423393|65865965|FG001|Overall Study|Withdrawal by Subject|0|||
23583229|NCT04423393|65865966|FG002|Overall Study|Withdrawal by Subject|0|||
23583230|NCT04423393|65865967|FG003|Overall Study|Withdrawal by Subject|0|||
23583231|NCT04423393|65865968|FG004|Overall Study|Withdrawal by Subject|0|||
23583232|NCT04423393|65865969|FG005|Overall Study|Withdrawal by Subject|1|||
23583233|NCT04423393|65865970|FG006|Overall Study|Withdrawal by Subject|0|||
23583234|NCT04423393|65865971|FG007|Overall Study|Withdrawal by Subject|0|||
23344304|NCT01647516|65003788|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
23583235|NCT04423393|65865972|FG008|Overall Study|Withdrawal by Subject|0|||
23583236|NCT04423393|65865973|FG009|Overall Study|Withdrawal by Subject|0|||
23583237|NCT04423393|65865974|FG010|Overall Study|Withdrawal by Subject|0|||
23583238|NCT04423393|65865975|FG011|Overall Study|Withdrawal by Subject|0|||
23583239|NCT04423393|65865976|FG012|Overall Study|Withdrawal by Subject|0|||
23583240|NCT04423393|65865977|FG013|Overall Study|Withdrawal by Subject|1|||
23583241|NCT04423393|65865978|FG014|Overall Study|Withdrawal by Subject|0|||
23583242|NCT04423393|65865979|FG015|Overall Study|Withdrawal by Subject|0|||
23583243|NCT04423393|65865980|FG016|Overall Study|Withdrawal by Subject|0|||
23583244|NCT04423393|65865981|FG017|Overall Study|Withdrawal by Subject|0|||
23583245|NCT04423393|65865964|FG000|Overall Study|Sponsor Decision|0|||
23583246|NCT04423393|65865965|FG001|Overall Study|Sponsor Decision|0|||
23583247|NCT04423393|65865966|FG002|Overall Study|Sponsor Decision|0|||
23583248|NCT04423393|65865967|FG003|Overall Study|Sponsor Decision|0|||
23583249|NCT04423393|65865968|FG004|Overall Study|Sponsor Decision|0|||
23583250|NCT04423393|65865969|FG005|Overall Study|Sponsor Decision|0|||
23583251|NCT04423393|65865970|FG006|Overall Study|Sponsor Decision|0|||
23583252|NCT04423393|65865971|FG007|Overall Study|Sponsor Decision|0|||
23583253|NCT04423393|65865972|FG008|Overall Study|Sponsor Decision|0|||
23583254|NCT04423393|65865973|FG009|Overall Study|Sponsor Decision|0|||
23583255|NCT04423393|65865974|FG010|Overall Study|Sponsor Decision|0|||
23583256|NCT04423393|65865975|FG011|Overall Study|Sponsor Decision|0|||
23583257|NCT04423393|65865976|FG012|Overall Study|Sponsor Decision|0|||
23583258|NCT04423393|65865977|FG013|Overall Study|Sponsor Decision|1|||
23583259|NCT04423393|65865978|FG014|Overall Study|Sponsor Decision|0|||
23583260|NCT04423393|65865979|FG015|Overall Study|Sponsor Decision|0|||
23583261|NCT04423393|65865980|FG016|Overall Study|Sponsor Decision|0|||
23583262|NCT04423393|65865981|FG017|Overall Study|Sponsor Decision|0|||
23583263|NCT03829332|65865982|FG000|Overall Study|Death|145|||
23583264|NCT03829332|65865983|FG001|Overall Study|Death|135|||
23583265|NCT03829332|65865982|FG000|Overall Study|Withdrawal by Subject|10|||
23583266|NCT03829332|65865983|FG001|Overall Study|Withdrawal by Subject|4|||
23583267|NCT03829332|65865982|FG000|Overall Study|Ongoing in Study|154|||
23583268|NCT03829332|65865983|FG001|Overall Study|Ongoing in Study|175|||
23583269|NCT00849147|65865986|FG000|Overall Study|Withdrawal by Subject|1|||
23583270|NCT00849147|65865986|FG000|Overall Study|Protocol Violation|2|||
23583271|NCT00849147|65865986|FG000|Overall Study|Disease Relapse/Progression|2|||
23583272|NCT05650333|65865987|FG000|Treatment Period (7 Days)|Adverse Event|1|||
23583273|NCT04927975|65865990|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
23583274|NCT04927975|65865991|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
23583275|NCT04927975|65865992|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
23583276|NCT04927975|65865993|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
23583277|NCT04927975|65865994|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
23583278|NCT04927975|65865995|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
23583279|NCT04927975|65865990|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
23583280|NCT04927975|65865991|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
23583281|NCT04927975|65865992|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
23583282|NCT04927975|65865993|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
23583283|NCT04927975|65865994|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
23583284|NCT04927975|65865995|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
23583285|NCT04927975|65865990|FG000|Period 1 (Baseline-Week 24)|Death|0|||
23583286|NCT04927975|65865991|FG001|Period 1 (Baseline-Week 24)|Death|0|||
23583287|NCT04927975|65865992|FG002|Period 1 (Baseline-Week 24)|Death|0|||
23583288|NCT04927975|65865993|FG003|Period 1 (Baseline-Week 24)|Death|0|||
23583289|NCT04927975|65865994|FG004|Period 1 (Baseline-Week 24)|Death|0|||
23583290|NCT04927975|65865995|FG005|Period 1 (Baseline-Week 24)|Death|1|||
23583291|NCT04927975|65865990|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
23583292|NCT04927975|65865991|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
23583293|NCT04927975|65865992|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
23583294|NCT04927975|65865993|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
23583295|NCT04927975|65865994|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
23583296|NCT04927975|65865995|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
23583297|NCT04927975|65865990|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
23583298|NCT04927975|65865991|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
23583299|NCT04927975|65865992|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
23583300|NCT04927975|65865993|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
23583301|NCT04927975|65865994|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
23583302|NCT04927975|65865995|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
23583303|NCT01311713|65865996|FG000|Overall Study|Death|0|||
23344305|NCT01647516|65003789|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
23344306|NCT01647516|65003790|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
23344307|NCT01647516|65003791|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
23344308|NCT01647516|65003792|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
23344309|NCT01647516|65003793|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
23344310|NCT01647516|65003788|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
23344311|NCT01647516|65003789|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
23344312|NCT01647516|65003790|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
23344313|NCT01647516|65003791|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
23344314|NCT01647516|65003792|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
23344315|NCT01647516|65003793|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
23344316|NCT01647516|65003788|FG000|Open-Label Period|Adverse Event|0|||
23344317|NCT01647516|65003789|FG001|Open-Label Period|Adverse Event|0|||
23344318|NCT01647516|65003790|FG002|Open-Label Period|Adverse Event|0|||
23344319|NCT01647516|65003791|FG003|Open-Label Period|Adverse Event|5|||
23344320|NCT01647516|65003792|FG004|Open-Label Period|Adverse Event|6|||
23344321|NCT01647516|65003793|FG005|Open-Label Period|Adverse Event|3|||
23456034|NCT04349891|65412870|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
23456035|NCT04349891|65412871|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
23583304|NCT01311713|65865997|FG001|Overall Study|Death|0|||
23583305|NCT01311713|65865998|FG002|Overall Study|Death|1|||
23583306|NCT01311713|65865999|FG003|Overall Study|Death|1|||
23583307|NCT01311713|65866000|FG004|Overall Study|Death|0|||
23583308|NCT01311713|65866001|FG005|Overall Study|Death|1|||
23583309|NCT01311713|65866002|FG006|Overall Study|Death|0|||
23583310|NCT01311713|65865996|FG000|Overall Study|Adverse Event|0|||
23583311|NCT01311713|65865997|FG001|Overall Study|Adverse Event|1|||
23583312|NCT01311713|65865998|FG002|Overall Study|Adverse Event|0|||
23583313|NCT01311713|65865999|FG003|Overall Study|Adverse Event|2|||
23583314|NCT01311713|65866000|FG004|Overall Study|Adverse Event|0|||
23583315|NCT01311713|65866001|FG005|Overall Study|Adverse Event|0|||
23583316|NCT01311713|65866002|FG006|Overall Study|Adverse Event|2|||
23583317|NCT01311713|65865996|FG000|Overall Study|Withdrawal by Subject|0|||
23583318|NCT01311713|65865997|FG001|Overall Study|Withdrawal by Subject|1|||
23583319|NCT01311713|65865998|FG002|Overall Study|Withdrawal by Subject|1|||
23583320|NCT01311713|65865999|FG003|Overall Study|Withdrawal by Subject|0|||
23583321|NCT01311713|65866000|FG004|Overall Study|Withdrawal by Subject|0|||
23583322|NCT01311713|65866001|FG005|Overall Study|Withdrawal by Subject|1|||
23583323|NCT01311713|65866002|FG006|Overall Study|Withdrawal by Subject|2|||
23583324|NCT01311713|65865996|FG000|Overall Study|Disease progression|3|||
23583325|NCT01311713|65865997|FG001|Overall Study|Disease progression|4|||
23583326|NCT01311713|65865998|FG002|Overall Study|Disease progression|3|||
23583327|NCT01311713|65865999|FG003|Overall Study|Disease progression|2|||
23583328|NCT01311713|65866000|FG004|Overall Study|Disease progression|4|||
23583329|NCT01311713|65866001|FG005|Overall Study|Disease progression|4|||
23583330|NCT01311713|65866002|FG006|Overall Study|Disease progression|5|||
23583331|NCT01311713|65865996|FG000|Overall Study|Lost to Follow-up|0|||
23583332|NCT01311713|65865997|FG001|Overall Study|Lost to Follow-up|0|||
23583333|NCT01311713|65865998|FG002|Overall Study|Lost to Follow-up|1|||
23583334|NCT01311713|65865999|FG003|Overall Study|Lost to Follow-up|0|||
23238093|NCT01072175|64615504|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
23583335|NCT01311713|65866000|FG004|Overall Study|Lost to Follow-up|0|||
23583336|NCT01311713|65866001|FG005|Overall Study|Lost to Follow-up|0|||
23344322|NCT01647516|65003788|FG000|Open-Label Period|Pregnancy|0|||
23344323|NCT01647516|65003789|FG001|Open-Label Period|Pregnancy|0|||
23344324|NCT01647516|65003790|FG002|Open-Label Period|Pregnancy|0|||
23178177|NCT02901431|64394033|FG009|PK Part|Lost to Follow-up|0|||
23178178|NCT02901431|64394034|FG010|PK Part|Lost to Follow-up|0|||
23178179|NCT02901431|64394035|FG011|PK Part|Lost to Follow-up|0|||
23178180|NCT02901431|64394036|FG012|PK Part|Lost to Follow-up|0|||
23178181|NCT02901431|64394024|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
23178182|NCT02901431|64394025|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23344325|NCT01647516|65003791|FG003|Open-Label Period|Pregnancy|0|||
23344326|NCT01647516|65003792|FG004|Open-Label Period|Pregnancy|0|||
23344327|NCT01647516|65003793|FG005|Open-Label Period|Pregnancy|1|||
23344328|NCT01647516|65003788|FG000|Open-Label Period|Non-compliance|0|||
23344329|NCT01647516|65003789|FG001|Open-Label Period|Non-compliance|0|||
23344330|NCT01647516|65003790|FG002|Open-Label Period|Non-compliance|0|||
23344331|NCT01647516|65003791|FG003|Open-Label Period|Non-compliance|1|||
23344332|NCT01647516|65003792|FG004|Open-Label Period|Non-compliance|0|||
23344333|NCT01647516|65003793|FG005|Open-Label Period|Non-compliance|1|||
23344334|NCT01647516|65003788|FG000|Open-Label Period|Physician Decision|0|||
23344335|NCT01647516|65003789|FG001|Open-Label Period|Physician Decision|0|||
23344336|NCT01647516|65003790|FG002|Open-Label Period|Physician Decision|0|||
23344337|NCT01647516|65003791|FG003|Open-Label Period|Physician Decision|1|||
23344338|NCT01647516|65003792|FG004|Open-Label Period|Physician Decision|1|||
23344339|NCT01647516|65003793|FG005|Open-Label Period|Physician Decision|0|||
23344340|NCT01647516|65003788|FG000|Open-Label Period|Withdrawal by Subject|0|||
23344341|NCT01647516|65003789|FG001|Open-Label Period|Withdrawal by Subject|0|||
23344342|NCT01647516|65003790|FG002|Open-Label Period|Withdrawal by Subject|0|||
23344343|NCT01647516|65003791|FG003|Open-Label Period|Withdrawal by Subject|9|||
23344344|NCT01647516|65003792|FG004|Open-Label Period|Withdrawal by Subject|11|||
23344345|NCT01647516|65003793|FG005|Open-Label Period|Withdrawal by Subject|6|||
23344346|NCT01647516|65003788|FG000|Open-Label Period|Lost to Follow-up|0|||
23344347|NCT01647516|65003789|FG001|Open-Label Period|Lost to Follow-up|0|||
23344348|NCT01647516|65003790|FG002|Open-Label Period|Lost to Follow-up|0|||
23344349|NCT01647516|65003791|FG003|Open-Label Period|Lost to Follow-up|1|||
23344350|NCT01647516|65003792|FG004|Open-Label Period|Lost to Follow-up|0|||
23344351|NCT01647516|65003793|FG005|Open-Label Period|Lost to Follow-up|1|||
23344352|NCT01647516|65003788|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
23344353|NCT01647516|65003789|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
23344354|NCT01647516|65003790|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
23344355|NCT01647516|65003791|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
23344356|NCT01647516|65003792|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
23344357|NCT01647516|65003793|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
23344358|NCT01647516|65003788|FG000|Open-Label Period|Lack of Efficacy|0|||
23344359|NCT01647516|65003789|FG001|Open-Label Period|Lack of Efficacy|0|||
23344360|NCT01647516|65003790|FG002|Open-Label Period|Lack of Efficacy|0|||
23344361|NCT01647516|65003791|FG003|Open-Label Period|Lack of Efficacy|7|||
23344362|NCT01647516|65003792|FG004|Open-Label Period|Lack of Efficacy|9|||
23344363|NCT01647516|65003793|FG005|Open-Label Period|Lack of Efficacy|10|||
23344364|NCT01647516|65003788|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
23344365|NCT01647516|65003789|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
23344366|NCT01647516|65003790|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
23344367|NCT01647516|65003791|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
23344368|NCT01647516|65003792|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
23344369|NCT01647516|65003793|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
23344370|NCT01647516|65003788|FG000|Open-Label Period|No completion / discontinuation visit|0|||
23344371|NCT01647516|65003789|FG001|Open-Label Period|No completion / discontinuation visit|0|||
23344372|NCT01647516|65003790|FG002|Open-Label Period|No completion / discontinuation visit|0|||
23344373|NCT01647516|65003791|FG003|Open-Label Period|No completion / discontinuation visit|0|||
23344374|NCT01647516|65003792|FG004|Open-Label Period|No completion / discontinuation visit|2|||
23344375|NCT01647516|65003793|FG005|Open-Label Period|No completion / discontinuation visit|1|||
23344376|NCT00189306|65003798|FG000|Treatment Period|Withdrawal by Subject|2|||
23344377|NCT00189306|65003798|FG000|Treatment Period|Adverse Event|2|||
23344378|NCT00189306|65003798|FG000|Treatment Period|Protocol Violation|1|||
23344379|NCT00189306|65003798|FG000|Posttreatment Period|Death|1|||
23344380|NCT00189306|65003798|FG000|Posttreatment Period|Withdrawal by Subject|2|||
23344381|NCT00189306|65003798|FG000|Posttreatment Period|Noncompliance|1|||
23344382|NCT00189306|65003798|FG000|Posttreatment Period|Target lesion excised|1|||
23344383|NCT00189306|65003798|FG000|Posttreatment Period|Protocol Violation|1|||
23344384|NCT00189306|65003798|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
23344385|NCT00189306|65003798|FG000|Posttreatment Period|Local skin reaction/sign|1|||
23344386|NCT00189306|65003798|FG000|Long-Term Follow-up|Adverse Event|2|||
23344387|NCT00189306|65003798|FG000|Long-Term Follow-up|Death|4|||
23344388|NCT00189306|65003798|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
23344389|NCT00189306|65003798|FG000|Long-Term Follow-up|Intercurrent disease|2|||
23344390|NCT00189306|65003798|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
23344391|NCT00189306|65003798|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
23344392|NCT02889835|65003799|FG000|Overall Study|Lost to Follow-up|13|||
23344393|NCT02889835|65003800|FG001|Overall Study|Lost to Follow-up|13|||
23344394|NCT02889835|65003801|FG002|Overall Study|Lost to Follow-up|13|||
23344395|NCT02889835|65003799|FG000|Overall Study|Withdrawal by Subject|2|||
23344396|NCT02889835|65003800|FG001|Overall Study|Withdrawal by Subject|2|||
23344397|NCT02889835|65003801|FG002|Overall Study|Withdrawal by Subject|2|||
23178183|NCT02901431|64394026|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178184|NCT02901431|64394027|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178185|NCT02901431|64394028|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178186|NCT02901431|64394029|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178187|NCT02901431|64394030|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178188|NCT02901431|64394031|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178189|NCT02901431|64394032|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178190|NCT02901431|64394033|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178191|NCT02901431|64394034|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178192|NCT02901431|64394035|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178193|NCT02901431|64394036|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
23178194|NCT02901431|64394024|FG000|PK Part|Pending dose confirmation|0|||
23178195|NCT02901431|64394025|FG001|PK Part|Pending dose confirmation|1|||
23178196|NCT02901431|64394026|FG002|PK Part|Pending dose confirmation|0|||
23178197|NCT02901431|64394027|FG003|PK Part|Pending dose confirmation|0|||
23178198|NCT02901431|64394028|FG004|PK Part|Pending dose confirmation|0|||
23178199|NCT02901431|64394029|FG005|PK Part|Pending dose confirmation|0|||
23178200|NCT02901431|64394030|FG006|PK Part|Pending dose confirmation|0|||
23178201|NCT02901431|64394031|FG007|PK Part|Pending dose confirmation|0|||
23178202|NCT02901431|64394032|FG008|PK Part|Pending dose confirmation|0|||
23178203|NCT02901431|64394033|FG009|PK Part|Pending dose confirmation|0|||
23238094|NCT01072175|64615505|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23238095|NCT01072175|64615506|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23238096|NCT01072175|64615507|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23238097|NCT01072175|64615508|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
23238098|NCT01072175|64615496|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238099|NCT01072175|64615497|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238100|NCT01072175|64615498|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238101|NCT01072175|64615499|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238102|NCT01072175|64615500|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238103|NCT01072175|64615501|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238104|NCT01072175|64615502|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238105|NCT01072175|64615503|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238106|NCT01072175|64615504|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
23238107|NCT01072175|64615505|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238108|NCT01072175|64615506|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238109|NCT01072175|64615507|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238110|NCT01072175|64615508|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
23238111|NCT01072175|64615496|FG000|Part D (HPMC Capsules)|Death|0|||
23238112|NCT01072175|64615497|FG001|Part D (HPMC Capsules)|Death|0|||
23238113|NCT01072175|64615498|FG002|Part D (HPMC Capsules)|Death|0|||
23238114|NCT01072175|64615499|FG003|Part D (HPMC Capsules)|Death|0|||
23238115|NCT01072175|64615500|FG004|Part D (HPMC Capsules)|Death|0|||
23238116|NCT01072175|64615501|FG005|Part D (HPMC Capsules)|Death|0|||
23238117|NCT01072175|64615502|FG006|Part D (HPMC Capsules)|Death|0|||
23456036|NCT04349891|65412870|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
23456037|NCT04349891|65412871|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
23456038|NCT04349891|65412870|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
23178204|NCT02901431|64394034|FG010|PK Part|Pending dose confirmation|0|||
23456039|NCT04349891|65412871|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
23456040|NCT03624881|65412877|FG000|Overall Study|Screen Failure|14|||
23456041|NCT03624881|65412878|FG001|Overall Study|Screen Failure|0|||
23456042|NCT03624881|65412877|FG000|Overall Study|No Catheter Inserted|6|||
23456043|NCT03624881|65412878|FG001|Overall Study|No Catheter Inserted|1|||
23456044|NCT03624881|65412877|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
23456045|NCT03624881|65412878|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
23456046|NCT03624881|65412877|FG000|Overall Study|Death|2|||
23456047|NCT03624881|65412878|FG001|Overall Study|Death|0|||
23456048|NCT03624881|65412877|FG000|Overall Study|Lost to Follow-up|10|||
23456049|NCT03624881|65412878|FG001|Overall Study|Lost to Follow-up|4|||
23456050|NCT03624881|65412877|FG000|Overall Study|Withdrawal by Subject|12|||
23456051|NCT03624881|65412878|FG001|Overall Study|Withdrawal by Subject|1|||
23456052|NCT00152503|65412879|FG000|Overall Study|Adverse Event|4|||
23456053|NCT01126749|65412880|FG000|Phase 1b|Other|0|||
23456054|NCT01126749|65412881|FG001|Phase 1b|Other|1|||
23456055|NCT01126749|65412882|FG002|Phase 1b|Other|0|||
23456056|NCT01126749|65412883|FG003|Phase 1b|Other|0|||
23456057|NCT01126749|65412880|FG000|Phase 1b|Withdrawal by Subject|0|||
23456058|NCT01126749|65412881|FG001|Phase 1b|Withdrawal by Subject|1|||
23178205|NCT02901431|64394035|FG011|PK Part|Pending dose confirmation|0|||
23178206|NCT02901431|64394036|FG012|PK Part|Pending dose confirmation|0|||
23178207|NCT02901431|64394024|FG000|PK Part|8 weeks of treatment ran out|2|||
23178208|NCT02901431|64394025|FG001|PK Part|8 weeks of treatment ran out|0|||
23178209|NCT02901431|64394026|FG002|PK Part|8 weeks of treatment ran out|0|||
23178210|NCT02901431|64394027|FG003|PK Part|8 weeks of treatment ran out|0|||
23178211|NCT02901431|64394028|FG004|PK Part|8 weeks of treatment ran out|0|||
23178212|NCT02901431|64394029|FG005|PK Part|8 weeks of treatment ran out|0|||
23178213|NCT02901431|64394030|FG006|PK Part|8 weeks of treatment ran out|0|||
23178214|NCT02901431|64394031|FG007|PK Part|8 weeks of treatment ran out|0|||
23178215|NCT02901431|64394032|FG008|PK Part|8 weeks of treatment ran out|0|||
23178216|NCT02901431|64394033|FG009|PK Part|8 weeks of treatment ran out|0|||
23178217|NCT02901431|64394034|FG010|PK Part|8 weeks of treatment ran out|0|||
23238118|NCT01072175|64615503|FG007|Part D (HPMC Capsules)|Death|0|||
23238119|NCT01072175|64615504|FG008|Part D (HPMC Capsules)|Death|0|||
23238120|NCT01072175|64615505|FG009|Part D (HPMC Capsules)|Death|10|||
23238121|NCT01072175|64615506|FG010|Part D (HPMC Capsules)|Death|12|||
23238122|NCT01072175|64615507|FG011|Part D (HPMC Capsules)|Death|28|||
23344398|NCT02889835|65003799|FG000|Overall Study|Protocol Violation|1|||
23344399|NCT02889835|65003800|FG001|Overall Study|Protocol Violation|1|||
23344400|NCT02889835|65003801|FG002|Overall Study|Protocol Violation|1|||
23344401|NCT02889835|65003799|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
23344402|NCT02889835|65003800|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
23344403|NCT02889835|65003801|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
23344404|NCT02889835|65003799|FG000|Overall Study|Death|1|||
23344405|NCT02889835|65003800|FG001|Overall Study|Death|1|||
23344406|NCT02889835|65003801|FG002|Overall Study|Death|1|||
23344407|NCT03652636|65003802|FG000|Overall Study|Withdrawal by Subject|7|||
23344408|NCT01546168|65003803|FG000|Overall Study|Lost to Follow-up|1|||
23344409|NCT01546168|65003804|FG001|Overall Study|Lost to Follow-up|0|||
23344410|NCT01546168|65003803|FG000|Overall Study|Withdrawal by Subject|1|||
23344411|NCT01546168|65003804|FG001|Overall Study|Withdrawal by Subject|0|||
23344412|NCT01546168|65003803|FG000|Overall Study|ineligible after signing consent|2|||
23344413|NCT01546168|65003804|FG001|Overall Study|ineligible after signing consent|0|||
23344414|NCT00336024|65003808|FG000|Overall Study|Death|2|||
23344415|NCT00336024|65003809|FG001|Overall Study|Death|1|||
23344416|NCT00336024|65003808|FG000|Overall Study|Physician Decision|4|||
23344417|NCT00336024|65003809|FG001|Overall Study|Physician Decision|1|||
23344418|NCT00336024|65003808|FG000|Overall Study|Protocol Violation|1|||
23344419|NCT00336024|65003809|FG001|Overall Study|Protocol Violation|0|||
23344420|NCT00336024|65003808|FG000|Overall Study|Withdrawal by Subject|1|||
23344421|NCT00336024|65003809|FG001|Overall Study|Withdrawal by Subject|2|||
23344422|NCT00336024|65003808|FG000|Overall Study|Failure to fulfill consolidation|1|||
23344423|NCT00336024|65003809|FG001|Overall Study|Failure to fulfill consolidation|1|||
23238123|NCT01072175|64615508|FG012|Part D (HPMC Capsules)|Death|26|||
23238124|NCT01072175|64615496|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
23238125|NCT01072175|64615497|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
23238126|NCT01072175|64615498|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
23238127|NCT01072175|64615499|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
23344424|NCT00336024|65003808|FG000|Overall Study|Progressive Disease|4|||
23344425|NCT00336024|65003809|FG001|Overall Study|Progressive Disease|7|||
23344426|NCT00336024|65003808|FG000|Overall Study|Ineligible|7|||
23344427|NCT00336024|65003809|FG001|Overall Study|Ineligible|7|||
23344428|NCT01831596|65003810|FG000|Overall Study|Other|8|||
23344429|NCT01328548|65003815|FG000|Overall Study|Death|3|||
23344430|NCT01328548|65003816|FG001|Overall Study|Death|0|||
23344431|NCT01328548|65003815|FG000|Overall Study|Protocol Violation|1|||
23344432|NCT01328548|65003816|FG001|Overall Study|Protocol Violation|0|||
23344433|NCT02089334|65003821|FG000|Overall Study|Withdrawal by Subject|0|||
23344434|NCT02089334|65003822|FG001|Overall Study|Withdrawal by Subject|0|||
23344435|NCT02089334|65003823|FG002|Overall Study|Withdrawal by Subject|0|||
23344436|NCT02089334|65003824|FG003|Overall Study|Withdrawal by Subject|2|||
23344437|NCT02089334|65003821|FG000|Overall Study|Adverse Event|0|||
23344438|NCT02089334|65003822|FG001|Overall Study|Adverse Event|0|||
23344439|NCT02089334|65003823|FG002|Overall Study|Adverse Event|0|||
23344440|NCT02089334|65003824|FG003|Overall Study|Adverse Event|2|||
23344441|NCT02089334|65003821|FG000|Overall Study|Progressive disease|0|||
23344442|NCT02089334|65003822|FG001|Overall Study|Progressive disease|0|||
23344443|NCT02089334|65003823|FG002|Overall Study|Progressive disease|0|||
23344444|NCT02089334|65003824|FG003|Overall Study|Progressive disease|2|||
23344445|NCT02089334|65003821|FG000|Overall Study|Physician Decision|0|||
23344446|NCT02089334|65003822|FG001|Overall Study|Physician Decision|0|||
23344447|NCT02089334|65003823|FG002|Overall Study|Physician Decision|1|||
23344448|NCT02089334|65003824|FG003|Overall Study|Physician Decision|1|||
23344449|NCT04253782|65003825|FG000|Overall Study|Death|2|||
23344450|NCT04253782|65003826|FG001|Overall Study|Death|0|||
23344451|NCT02344290|65003827|FG000|Overall Study|Withdrawal by Subject|315|||
23344452|NCT02344290|65003828|FG001|Overall Study|Withdrawal by Subject|324|||
23344453|NCT02344290|65003827|FG000|Overall Study|Lost to Follow-up|258|||
23178218|NCT02901431|64394035|FG011|PK Part|8 weeks of treatment ran out|0|||
23178219|NCT02901431|64394036|FG012|PK Part|8 weeks of treatment ran out|0|||
23238128|NCT01072175|64615500|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
23344454|NCT02344290|65003828|FG001|Overall Study|Lost to Follow-up|249|||
23178220|NCT02901431|64394024|FG000|PK Part|Stopped treatment after 8 weeks|1|||
23178221|NCT02901431|64394025|FG001|PK Part|Stopped treatment after 8 weeks|0|||
23178222|NCT02901431|64394026|FG002|PK Part|Stopped treatment after 8 weeks|1|||
23178223|NCT02901431|64394027|FG003|PK Part|Stopped treatment after 8 weeks|0|||
23178224|NCT02901431|64394028|FG004|PK Part|Stopped treatment after 8 weeks|0|||
23178225|NCT02901431|64394029|FG005|PK Part|Stopped treatment after 8 weeks|0|||
23178226|NCT02901431|64394030|FG006|PK Part|Stopped treatment after 8 weeks|0|||
23178227|NCT02901431|64394031|FG007|PK Part|Stopped treatment after 8 weeks|0|||
23178228|NCT02901431|64394032|FG008|PK Part|Stopped treatment after 8 weeks|0|||
23178229|NCT02901431|64394033|FG009|PK Part|Stopped treatment after 8 weeks|0|||
23178230|NCT02901431|64394034|FG010|PK Part|Stopped treatment after 8 weeks|0|||
23178231|NCT02901431|64394035|FG011|PK Part|Stopped treatment after 8 weeks|0|||
23238129|NCT01072175|64615501|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
23238130|NCT01072175|64615502|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
23238131|NCT01072175|64615503|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
23238132|NCT01072175|64615504|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
23238133|NCT01072175|64615505|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
23238134|NCT01072175|64615506|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
23238135|NCT01072175|64615507|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
23238136|NCT01072175|64615508|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
23238137|NCT01072175|64615496|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238138|NCT01072175|64615497|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238139|NCT01072175|64615498|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238140|NCT01072175|64615499|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238141|NCT01072175|64615500|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238142|NCT01072175|64615501|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238143|NCT01072175|64615502|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238144|NCT01072175|64615503|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238145|NCT01072175|64615504|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238146|NCT01072175|64615505|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
23238147|NCT01072175|64615506|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
23238148|NCT01072175|64615507|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
23238149|NCT01072175|64615508|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
23238150|NCT01072175|64615496|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
23238151|NCT01072175|64615497|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
23238152|NCT01072175|64615498|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
23238153|NCT01072175|64615499|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
23238154|NCT01072175|64615500|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
23238155|NCT01072175|64615501|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
23238156|NCT01072175|64615502|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
23238157|NCT01072175|64615503|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
23238158|NCT01072175|64615504|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
23238159|NCT01072175|64615505|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
23238160|NCT01072175|64615506|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
23238161|NCT01072175|64615507|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
23238162|NCT01072175|64615508|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
23238163|NCT01072175|64615496|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238164|NCT01072175|64615497|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23344455|NCT02344290|65003827|FG000|Overall Study|Unable to get to clinic|69|||
23344456|NCT02344290|65003828|FG001|Overall Study|Unable to get to clinic|60|||
23344457|NCT02344290|65003827|FG000|Overall Study|Physician Decision|25|||
23344458|NCT02344290|65003828|FG001|Overall Study|Physician Decision|25|||
23344459|NCT02344290|65003827|FG000|Overall Study|Site Closure|15|||
23178232|NCT02901431|64394036|FG012|PK Part|Stopped treatment after 8 weeks|0|||
23178233|NCT02901431|64394024|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
23178234|NCT02901431|64394025|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23344460|NCT02344290|65003828|FG001|Overall Study|Site Closure|19|||
23344461|NCT02344290|65003827|FG000|Overall Study|Other|5|||
23344462|NCT02344290|65003828|FG001|Overall Study|Other|3|||
23344463|NCT01258075|65003832|FG000|Overall Study|Adverse Event|8|||
23456059|NCT01126749|65412882|FG002|Phase 1b|Withdrawal by Subject|0|||
23456060|NCT01126749|65412883|FG003|Phase 1b|Withdrawal by Subject|0|||
23456061|NCT01126749|65412880|FG000|Phase 1b|Death|3|||
23178235|NCT02901431|64394026|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
23238165|NCT01072175|64615498|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238166|NCT01072175|64615499|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238167|NCT01072175|64615500|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238168|NCT01072175|64615501|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238169|NCT01072175|64615502|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238170|NCT01072175|64615503|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238171|NCT01072175|64615504|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238172|NCT01072175|64615505|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238173|NCT01072175|64615506|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
23238174|NCT01072175|64615507|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
23344464|NCT01258075|65003833|FG001|Overall Study|Adverse Event|3|||
23344465|NCT01258075|65003832|FG000|Overall Study|Lost to Follow-up|11|||
23344466|NCT01258075|65003833|FG001|Overall Study|Lost to Follow-up|6|||
23344467|NCT01258075|65003832|FG000|Overall Study|Withdrawal by Subject|10|||
23344468|NCT01258075|65003833|FG001|Overall Study|Withdrawal by Subject|7|||
23344469|NCT01258075|65003832|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
23344470|NCT01258075|65003833|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
23344471|NCT01258075|65003832|FG000|Overall Study|Other|12|||
23344472|NCT01258075|65003833|FG001|Overall Study|Other|5|||
23344473|NCT04489381|65003834|FG000|Overall Study|Lost to Follow-up|2|||
23344474|NCT04489381|65003835|FG001|Overall Study|Lost to Follow-up|3|||
23344475|NCT04489381|65003834|FG000|Overall Study|Withdrawal by Subject|1|||
23344476|NCT04489381|65003835|FG001|Overall Study|Withdrawal by Subject|0|||
23344477|NCT05323994|65003836|FG000|Overall Study|Protocol Violation|1|||
23344478|NCT04683939|65003838|FG000|Overall Study|Study termination by the sponsor|0|||
23456062|NCT01126749|65412881|FG001|Phase 1b|Death|4|||
23456063|NCT01126749|65412882|FG002|Phase 1b|Death|0|||
23456064|NCT01126749|65412883|FG003|Phase 1b|Death|0|||
23456065|NCT01126749|65412880|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
23456066|NCT01126749|65412881|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
23456067|NCT01126749|65412882|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
23344479|NCT04683939|65003839|FG001|Overall Study|Study termination by the sponsor|1|||
23456068|NCT01126749|65412883|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
23456069|NCT01126749|65412880|FG000|Phase 2|Study Termination by Sponsor|0|||
23456070|NCT01126749|65412881|FG001|Phase 2|Study Termination by Sponsor|0|||
23456071|NCT01126749|65412882|FG002|Phase 2|Study Termination by Sponsor|12|||
23456072|NCT01126749|65412883|FG003|Phase 2|Study Termination by Sponsor|6|||
23456073|NCT01126749|65412880|FG000|Phase 2|Other|0|||
23456074|NCT01126749|65412881|FG001|Phase 2|Other|0|||
23456075|NCT01126749|65412882|FG002|Phase 2|Other|4|||
23456076|NCT01126749|65412883|FG003|Phase 2|Other|2|||
23456077|NCT01126749|65412880|FG000|Phase 2|Withdrawal by Subject|0|||
23456078|NCT01126749|65412881|FG001|Phase 2|Withdrawal by Subject|0|||
23456079|NCT01126749|65412882|FG002|Phase 2|Withdrawal by Subject|0|||
23456080|NCT01126749|65412883|FG003|Phase 2|Withdrawal by Subject|2|||
23456081|NCT01126749|65412880|FG000|Phase 2|Lost to Follow-up|0|||
23456082|NCT01126749|65412881|FG001|Phase 2|Lost to Follow-up|0|||
23456083|NCT01126749|65412882|FG002|Phase 2|Lost to Follow-up|0|||
23456084|NCT01126749|65412883|FG003|Phase 2|Lost to Follow-up|1|||
23456085|NCT01126749|65412880|FG000|Phase 2|Death|0|||
23456086|NCT01126749|65412881|FG001|Phase 2|Death|0|||
23456087|NCT01126749|65412882|FG002|Phase 2|Death|22|||
23456088|NCT01126749|65412883|FG003|Phase 2|Death|22|||
23456089|NCT01126749|65412880|FG000|Phase 2|Adverse Event|0|||
23456090|NCT01126749|65412881|FG001|Phase 2|Adverse Event|0|||
23456091|NCT01126749|65412882|FG002|Phase 2|Adverse Event|0|||
23456092|NCT01126749|65412883|FG003|Phase 2|Adverse Event|1|||
23456093|NCT03737123|65412884|FG000|Study Treatment|Adverse Event|2|||
23456094|NCT03737123|65412885|FG001|Study Treatment|Adverse Event|0|||
23456095|NCT03737123|65412884|FG000|Study Treatment|Disease Progression|2|||
23456096|NCT03737123|65412885|FG001|Study Treatment|Disease Progression|0|||
23456097|NCT03737123|65412884|FG000|Study Treatment|Withdrawal by Subject|2|||
23456098|NCT03737123|65412885|FG001|Study Treatment|Withdrawal by Subject|0|||
23456099|NCT03737123|65412884|FG000|Follow up|Death|1|||
23344480|NCT04683939|65003840|FG002|Overall Study|Study termination by the sponsor|2|||
23456100|NCT03737123|65412885|FG001|Follow up|Death|0|||
23344481|NCT04683939|65003841|FG003|Overall Study|Study termination by the sponsor|2|||
23456101|NCT03737123|65412884|FG000|Follow up|Withdrawal by Subject|1|||
23456102|NCT03737123|65412885|FG001|Follow up|Withdrawal by Subject|0|||
23456103|NCT03737123|65412884|FG000|Follow up|Termination of study|4|||
23456104|NCT03737123|65412885|FG001|Follow up|Termination of study|0|||
23178236|NCT02901431|64394027|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178237|NCT02901431|64394028|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178238|NCT02901431|64394029|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178239|NCT02901431|64394030|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178240|NCT02901431|64394031|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178241|NCT02901431|64394032|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178242|NCT02901431|64394033|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178243|NCT02901431|64394034|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178244|NCT02901431|64394035|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178245|NCT02901431|64394036|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
23178246|NCT02901431|64394024|FG000|PK Part|Discontinued per Sponsor|0|||
23178247|NCT02901431|64394025|FG001|PK Part|Discontinued per Sponsor|3|||
23178248|NCT02901431|64394026|FG002|PK Part|Discontinued per Sponsor|0|||
23178249|NCT02901431|64394027|FG003|PK Part|Discontinued per Sponsor|0|||
23178250|NCT02901431|64394028|FG004|PK Part|Discontinued per Sponsor|0|||
23238175|NCT01072175|64615508|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
23238176|NCT02706327|64615509|FG000|Overall Study|Lost to Follow-up|1|||
23238177|NCT02706327|64615510|FG001|Overall Study|Lost to Follow-up|1|||
23178251|NCT02901431|64394029|FG005|PK Part|Discontinued per Sponsor|0|||
23178252|NCT02901431|64394030|FG006|PK Part|Discontinued per Sponsor|0|||
23178253|NCT02901431|64394031|FG007|PK Part|Discontinued per Sponsor|0|||
23178254|NCT02901431|64394032|FG008|PK Part|Discontinued per Sponsor|0|||
23238178|NCT02706327|64615511|FG002|Overall Study|Lost to Follow-up|2|||
23238179|NCT00229931|64615512|FG000|Overall Study|Death|1|||
23238180|NCT00229931|64615513|FG001|Overall Study|Death|0|||
23238181|NCT00229931|64615512|FG000|Overall Study|Lost to Follow-up|3|||
23344482|NCT04683939|65003838|FG000|Overall Study|Death|1|||
23344483|NCT04683939|65003839|FG001|Overall Study|Death|1|||
23344484|NCT04683939|65003840|FG002|Overall Study|Death|2|||
23344485|NCT04683939|65003841|FG003|Overall Study|Death|1|||
23344486|NCT04683939|65003838|FG000|Overall Study|Withdrawal by Subject|1|||
23344487|NCT04683939|65003839|FG001|Overall Study|Withdrawal by Subject|0|||
23344488|NCT04683939|65003840|FG002|Overall Study|Withdrawal by Subject|0|||
23178255|NCT02901431|64394033|FG009|PK Part|Discontinued per Sponsor|0|||
23344489|NCT04683939|65003841|FG003|Overall Study|Withdrawal by Subject|0|||
23583337|NCT01311713|65866002|FG006|Overall Study|Lost to Follow-up|0|||
23178256|NCT02901431|64394034|FG010|PK Part|Discontinued per Sponsor|0|||
23178257|NCT02901431|64394035|FG011|PK Part|Discontinued per Sponsor|0|||
23178258|NCT02901431|64394036|FG012|PK Part|Discontinued per Sponsor|0|||
23178259|NCT02901431|64394024|FG000|PK Part|Withdrawal by Subject|1|||
23238182|NCT00229931|64615513|FG001|Overall Study|Lost to Follow-up|2|||
23238183|NCT03205605|64615514|FG000|Overall Study|Withdrawal by Subject|1|||
23344490|NCT04683939|65003838|FG000|Overall Study|Physician Decision|1|||
23344491|NCT04683939|65003839|FG001|Overall Study|Physician Decision|0|||
23344492|NCT04683939|65003840|FG002|Overall Study|Physician Decision|0|||
23583338|NCT01311713|65865996|FG000|Overall Study|Stopped taking study medication|0|||
23583339|NCT01311713|65865997|FG001|Overall Study|Stopped taking study medication|0|||
23583340|NCT01311713|65865998|FG002|Overall Study|Stopped taking study medication|0|||
23583341|NCT01311713|65865999|FG003|Overall Study|Stopped taking study medication|1|||
23583342|NCT01311713|65866000|FG004|Overall Study|Stopped taking study medication|1|||
23583343|NCT01311713|65866001|FG005|Overall Study|Stopped taking study medication|0|||
23583344|NCT01311713|65866002|FG006|Overall Study|Stopped taking study medication|0|||
23583345|NCT01311713|65865996|FG000|Overall Study|Enrolled but not treated|0|||
23583346|NCT01311713|65865997|FG001|Overall Study|Enrolled but not treated|0|||
23583347|NCT01311713|65865998|FG002|Overall Study|Enrolled but not treated|1|||
23583348|NCT01311713|65865999|FG003|Overall Study|Enrolled but not treated|0|||
23583349|NCT01311713|65866000|FG004|Overall Study|Enrolled but not treated|0|||
23583350|NCT01311713|65866001|FG005|Overall Study|Enrolled but not treated|0|||
23583351|NCT01311713|65866002|FG006|Overall Study|Enrolled but not treated|0|||
23583352|NCT01311713|65865996|FG000|Overall Study|Other than specified|0|||
23583353|NCT01311713|65865997|FG001|Overall Study|Other than specified|1|||
23583354|NCT01311713|65865998|FG002|Overall Study|Other than specified|2|||
23238184|NCT03890731|64615515|FG000|Overall Study|Progressive disease|1|||
23238185|NCT03890731|64615515|FG000|Overall Study|Patient's decision|1|||
23238186|NCT03890731|64615515|FG000|Overall Study|Adverse Event|4|||
23238187|NCT01884675|64615518|FG000|Overall Study|Study closed/terminated|3|||
23238188|NCT01884675|64615519|FG001|Overall Study|Study closed/terminated|2|||
23238189|NCT01636076|64615521|FG000|Overall Study|Terminated by sponsor|1|||
23238190|NCT01636076|64615522|FG001|Overall Study|Terminated by sponsor|1|||
23238191|NCT01636076|64615521|FG000|Overall Study|Lack of Efficacy|0|||
23238192|NCT01636076|64615522|FG001|Overall Study|Lack of Efficacy|1|||
23238193|NCT01636076|64615521|FG000|Overall Study|Lost to Follow-up|1|||
23238194|NCT01636076|64615522|FG001|Overall Study|Lost to Follow-up|0|||
23238195|NCT01636076|64615521|FG000|Overall Study|Physician Decision|1|||
23238196|NCT01636076|64615522|FG001|Overall Study|Physician Decision|1|||
23238197|NCT01636076|64615521|FG000|Overall Study|Non-compliance with study treatment|1|||
23238198|NCT01636076|64615522|FG001|Overall Study|Non-compliance with study treatment|1|||
23238199|NCT01636076|64615521|FG000|Overall Study|Adverse Event|6|||
23238200|NCT01636076|64615522|FG001|Overall Study|Adverse Event|11|||
23238201|NCT01636076|64615521|FG000|Overall Study|Withdrawal by Subject|7|||
23238202|NCT01636076|64615522|FG001|Overall Study|Withdrawal by Subject|10|||
23238203|NCT01654666|64615531|FG000|Overall Study|Protocol Violation|7|||
23583355|NCT01311713|65865999|FG003|Overall Study|Other than specified|0|||
23583356|NCT01311713|65866000|FG004|Overall Study|Other than specified|0|||
23583357|NCT01311713|65866001|FG005|Overall Study|Other than specified|0|||
23583358|NCT01311713|65866002|FG006|Overall Study|Other than specified|0|||
23583359|NCT02027935|65866005|FG000|Overall Study|Death|1|||
23583360|NCT02027935|65866005|FG000|Overall Study|Lack of Efficacy|5|||
23583361|NCT02027935|65866005|FG000|Overall Study|Study Closure|1|||
23583362|NCT02711826|65866008|FG000|Overall Study|Physician Decision|0|||
23583363|NCT02711826|65866009|FG001|Overall Study|Physician Decision|0|||
23583364|NCT02711826|65866010|FG002|Overall Study|Physician Decision|0|||
23583365|NCT02711826|65866011|FG003|Overall Study|Physician Decision|1|||
23583366|NCT02711826|65866012|FG004|Overall Study|Physician Decision|0|||
23583367|NCT02711826|65866008|FG000|Overall Study|Withdrawal by Subject|0|||
23583368|NCT02711826|65866009|FG001|Overall Study|Withdrawal by Subject|1|||
23583369|NCT02711826|65866010|FG002|Overall Study|Withdrawal by Subject|0|||
23583370|NCT02711826|65866011|FG003|Overall Study|Withdrawal by Subject|4|||
23583371|NCT02711826|65866012|FG004|Overall Study|Withdrawal by Subject|0|||
23583372|NCT02711826|65866008|FG000|Overall Study|Failure to manufacture cellular product|0|||
23583373|NCT02711826|65866009|FG001|Overall Study|Failure to manufacture cellular product|0|||
23583374|NCT02711826|65866010|FG002|Overall Study|Failure to manufacture cellular product|5|||
23583375|NCT02711826|65866011|FG003|Overall Study|Failure to manufacture cellular product|0|||
23583376|NCT02711826|65866012|FG004|Overall Study|Failure to manufacture cellular product|0|||
23583377|NCT02711826|65866008|FG000|Overall Study|Infusion canceled for active infection|0|||
23583378|NCT02711826|65866009|FG001|Overall Study|Infusion canceled for active infection|1|||
23583379|NCT02711826|65866010|FG002|Overall Study|Infusion canceled for active infection|0|||
23583380|NCT02711826|65866011|FG003|Overall Study|Infusion canceled for active infection|0|||
23583381|NCT02711826|65866012|FG004|Overall Study|Infusion canceled for active infection|0|||
23583382|NCT02711826|65866008|FG000|Overall Study|Screen failures|0|||
23583383|NCT02711826|65866009|FG001|Overall Study|Screen failures|0|||
23583384|NCT02711826|65866010|FG002|Overall Study|Screen failures|0|||
23583385|NCT02711826|65866011|FG003|Overall Study|Screen failures|4|||
23583386|NCT02711826|65866012|FG004|Overall Study|Screen failures|0|||
23583387|NCT03681691|65866013|FG000|Overall Study|COVID|1|||
23583388|NCT03681691|65866014|FG001|Overall Study|COVID|0|||
23583389|NCT03681691|65866013|FG000|Overall Study|prolonged bleeding|1|||
23583390|NCT03681691|65866014|FG001|Overall Study|prolonged bleeding|0|||
23238204|NCT01654666|64615532|FG001|Overall Study|Protocol Violation|4|||
23238205|NCT01654666|64615533|FG002|Overall Study|Protocol Violation|8|||
23238206|NCT01654666|64615531|FG000|Overall Study|Lost to Follow-up|4|||
23238207|NCT01654666|64615532|FG001|Overall Study|Lost to Follow-up|5|||
23178260|NCT02901431|64394025|FG001|PK Part|Withdrawal by Subject|1|||
23178261|NCT02901431|64394026|FG002|PK Part|Withdrawal by Subject|3|||
23178262|NCT02901431|64394027|FG003|PK Part|Withdrawal by Subject|0|||
23178263|NCT02901431|64394028|FG004|PK Part|Withdrawal by Subject|0|||
23178264|NCT02901431|64394029|FG005|PK Part|Withdrawal by Subject|0|||
23178265|NCT02901431|64394030|FG006|PK Part|Withdrawal by Subject|0|||
23178266|NCT02901431|64394031|FG007|PK Part|Withdrawal by Subject|0|||
23178267|NCT02901431|64394032|FG008|PK Part|Withdrawal by Subject|0|||
23178268|NCT02901431|64394033|FG009|PK Part|Withdrawal by Subject|0|||
23178269|NCT02901431|64394034|FG010|PK Part|Withdrawal by Subject|0|||
23178270|NCT02901431|64394035|FG011|PK Part|Withdrawal by Subject|0|||
23238208|NCT01654666|64615533|FG002|Overall Study|Lost to Follow-up|5|||
23238209|NCT01654666|64615531|FG000|Overall Study|Withdrawal by Subject|4|||
23238210|NCT01654666|64615532|FG001|Overall Study|Withdrawal by Subject|4|||
23238211|NCT01654666|64615533|FG002|Overall Study|Withdrawal by Subject|1|||
23238212|NCT02613910|64615534|FG000|Overall Study|Termination of study|1|||
23178271|NCT02901431|64394036|FG012|PK Part|Withdrawal by Subject|0|||
23178272|NCT02901431|64394024|FG000|Main Treatment Part|Adverse Event|0|||
23178273|NCT02901431|64394025|FG001|Main Treatment Part|Adverse Event|0|||
23178274|NCT02901431|64394026|FG002|Main Treatment Part|Adverse Event|0|||
23178275|NCT02901431|64394027|FG003|Main Treatment Part|Adverse Event|3|||
23178276|NCT02901431|64394028|FG004|Main Treatment Part|Adverse Event|3|||
23238213|NCT00649220|64615535|FG000|Overall Study|Adverse Event|2|||
23238214|NCT00649220|64615535|FG000|Overall Study|Withdrawal by Subject|1|||
23238215|NCT04145531|64615538|FG000|Part A|Adverse Event|2|||
23238216|NCT04145531|64615539|FG001|Part A|Adverse Event|12|||
23238217|NCT04145531|64615540|FG002|Part A|Adverse Event|6|||
23238218|NCT04145531|64615541|FG003|Part A|Adverse Event|0|||
23238219|NCT04145531|64615538|FG000|Part A|Death|1|||
23238220|NCT04145531|64615539|FG001|Part A|Death|2|||
23238221|NCT04145531|64615540|FG002|Part A|Death|0|||
23238222|NCT04145531|64615541|FG003|Part A|Death|0|||
23238223|NCT04145531|64615538|FG000|Part A|Physician Decision|2|||
23238224|NCT04145531|64615539|FG001|Part A|Physician Decision|5|||
23238225|NCT04145531|64615540|FG002|Part A|Physician Decision|2|||
23238226|NCT04145531|64615541|FG003|Part A|Physician Decision|0|||
23456105|NCT01690143|65412886|FG000|Overall Study|Withdrawal by Subject|1|||
23456106|NCT04065048|65412887|FG000|Overall Study|Withdrawal by Subject|1|||
23456107|NCT04065048|65412888|FG001|Overall Study|Withdrawal by Subject|2|||
23456108|NCT04065048|65412889|FG002|Overall Study|Withdrawal by Subject|1|||
23456109|NCT04065048|65412890|FG003|Overall Study|Withdrawal by Subject|1|||
23456110|NCT04065048|65412887|FG000|Overall Study|Adverse Event|1|||
23456111|NCT04065048|65412888|FG001|Overall Study|Adverse Event|0|||
23456112|NCT04065048|65412889|FG002|Overall Study|Adverse Event|1|||
23456113|NCT04065048|65412890|FG003|Overall Study|Adverse Event|0|||
23456114|NCT00374140|65412891|FG000|Overall Study|Lost to Follow-up|1|||
23456115|NCT00374140|65412891|FG000|Overall Study|Protocol Violation|1|||
23456116|NCT03796728|65412892|FG000|Overall Study|Lost to Follow-up|8|||
23456117|NCT03796728|65412892|FG000|Overall Study|Reason not Specified|16|||
23456118|NCT04515771|65412893|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
23456119|NCT04515771|65412894|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
23456120|NCT04515771|65412893|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
23456121|NCT04515771|65412894|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
23456122|NCT04515771|65412893|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
23456123|NCT04515771|65412894|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
23456124|NCT04097678|65412897|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
23456125|NCT04097678|65412898|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
23456126|NCT00878501|65412899|FG000|Overall Study|Adverse Event|11|||
23456127|NCT00878501|65412900|FG001|Overall Study|Adverse Event|3|||
23456128|NCT00878501|65412901|FG002|Overall Study|Adverse Event|3|||
23583391|NCT03681691|65866013|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
23583392|NCT03681691|65866014|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
23583393|NCT04886596|65866015|FG000|Overall Study|Adverse Event|73|||
23178277|NCT02901431|64394029|FG005|Main Treatment Part|Adverse Event|4|||
23178278|NCT02901431|64394030|FG006|Main Treatment Part|Adverse Event|1|||
23178279|NCT02901431|64394031|FG007|Main Treatment Part|Adverse Event|0|||
23178280|NCT02901431|64394032|FG008|Main Treatment Part|Adverse Event|0|||
23178281|NCT02901431|64394033|FG009|Main Treatment Part|Adverse Event|0|||
23178282|NCT02901431|64394034|FG010|Main Treatment Part|Adverse Event|0|||
23178283|NCT02901431|64394035|FG011|Main Treatment Part|Adverse Event|0|||
23178284|NCT02901431|64394036|FG012|Main Treatment Part|Adverse Event|0|||
23178285|NCT02901431|64394024|FG000|Main Treatment Part|Lack of Efficacy|0|||
23178286|NCT02901431|64394025|FG001|Main Treatment Part|Lack of Efficacy|0|||
23178287|NCT02901431|64394026|FG002|Main Treatment Part|Lack of Efficacy|0|||
23178288|NCT02901431|64394027|FG003|Main Treatment Part|Lack of Efficacy|1|||
23178289|NCT02901431|64394028|FG004|Main Treatment Part|Lack of Efficacy|0|||
23178290|NCT02901431|64394029|FG005|Main Treatment Part|Lack of Efficacy|0|||
23178291|NCT02901431|64394030|FG006|Main Treatment Part|Lack of Efficacy|0|||
23178292|NCT02901431|64394031|FG007|Main Treatment Part|Lack of Efficacy|0|||
23178293|NCT02901431|64394032|FG008|Main Treatment Part|Lack of Efficacy|0|||
23178294|NCT02901431|64394033|FG009|Main Treatment Part|Lack of Efficacy|0|||
23238227|NCT04145531|64615538|FG000|Part A|Progressive disease|0|||
23238228|NCT04145531|64615539|FG001|Part A|Progressive disease|2|||
23238229|NCT04145531|64615540|FG002|Part A|Progressive disease|1|||
23238230|NCT04145531|64615541|FG003|Part A|Progressive disease|0|||
23238231|NCT04145531|64615538|FG000|Part A|Protocol deviation|0|||
23238232|NCT04145531|64615539|FG001|Part A|Protocol deviation|0|||
23238233|NCT04145531|64615540|FG002|Part A|Protocol deviation|1|||
23238234|NCT04145531|64615541|FG003|Part A|Protocol deviation|0|||
23583394|NCT04886596|65866016|FG001|Overall Study|Adverse Event|78|||
23583395|NCT04886596|65866015|FG000|Overall Study|Lost to Follow-up|104|||
23583396|NCT04886596|65866016|FG001|Overall Study|Lost to Follow-up|104|||
23583397|NCT04886596|65866015|FG000|Overall Study|Ongoing|12095|||
23238235|NCT04145531|64615538|FG000|Part A|Withdrawal by parent or guardian|1|||
23238236|NCT04145531|64615539|FG001|Part A|Withdrawal by parent or guardian|0|||
23583398|NCT04886596|65866016|FG001|Overall Study|Ongoing|12107|||
23238237|NCT04145531|64615540|FG002|Part A|Withdrawal by parent or guardian|0|||
23238238|NCT04145531|64615541|FG003|Part A|Withdrawal by parent or guardian|0|||
23238239|NCT04145531|64615538|FG000|Part A|Withdrawal by participant|0|||
23238240|NCT04145531|64615539|FG001|Part A|Withdrawal by participant|0|||
23238241|NCT04145531|64615540|FG002|Part A|Withdrawal by participant|1|||
23238242|NCT04145531|64615541|FG003|Part A|Withdrawal by participant|0|||
23238243|NCT04145531|64615538|FG000|Part A|Other|0|||
23238244|NCT04145531|64615539|FG001|Part A|Other|0|||
23238245|NCT04145531|64615540|FG002|Part A|Other|1|||
23178295|NCT02901431|64394034|FG010|Main Treatment Part|Lack of Efficacy|0|||
23178296|NCT02901431|64394035|FG011|Main Treatment Part|Lack of Efficacy|0|||
23178297|NCT02901431|64394036|FG012|Main Treatment Part|Lack of Efficacy|0|||
23178298|NCT02901431|64394024|FG000|Main Treatment Part|Lost to Follow-up|0|||
23178299|NCT02901431|64394025|FG001|Main Treatment Part|Lost to Follow-up|0|||
23178300|NCT02901431|64394026|FG002|Main Treatment Part|Lost to Follow-up|0|||
23178301|NCT02901431|64394027|FG003|Main Treatment Part|Lost to Follow-up|3|||
23178302|NCT02901431|64394028|FG004|Main Treatment Part|Lost to Follow-up|1|||
23178303|NCT02901431|64394029|FG005|Main Treatment Part|Lost to Follow-up|2|||
23178304|NCT02901431|64394030|FG006|Main Treatment Part|Lost to Follow-up|3|||
23178305|NCT02901431|64394031|FG007|Main Treatment Part|Lost to Follow-up|0|||
23178306|NCT02901431|64394032|FG008|Main Treatment Part|Lost to Follow-up|0|||
23178307|NCT02901431|64394033|FG009|Main Treatment Part|Lost to Follow-up|0|||
23238246|NCT04145531|64615541|FG003|Part A|Other|0|||
23238247|NCT04145531|64615538|FG000|Part B|Adverse Event|0|||
23238248|NCT04145531|64615539|FG001|Part B|Adverse Event|0|||
23238249|NCT04145531|64615540|FG002|Part B|Adverse Event|0|||
23238250|NCT04145531|64615541|FG003|Part B|Adverse Event|21|||
23238251|NCT04145531|64615538|FG000|Part B|Physician Decision|0|||
23238252|NCT04145531|64615539|FG001|Part B|Physician Decision|0|||
23344493|NCT04683939|65003841|FG003|Overall Study|Physician Decision|0|||
23344494|NCT04683939|65003838|FG000|Overall Study|Lost to Follow-up|0|||
23344495|NCT04683939|65003839|FG001|Overall Study|Lost to Follow-up|1|||
23344496|NCT04683939|65003840|FG002|Overall Study|Lost to Follow-up|0|||
23344497|NCT04683939|65003841|FG003|Overall Study|Lost to Follow-up|0|||
23344498|NCT00843037|65003844|FG000|Overall Study|Lost to Follow-up|1|||
23344499|NCT01446237|65003845|FG000|Overall Study|Adverse Event|1|||
23344500|NCT01446237|65003845|FG000|Overall Study|Lost to Follow-up|2|||
23344501|NCT01446237|65003845|FG000|Overall Study|Withdrawal by Subject|7|||
23344502|NCT00970632|65003855|FG000|Overall Study|Adverse Event|2|||
23344503|NCT00970632|65003856|FG001|Overall Study|Adverse Event|2|||
23344504|NCT00970632|65003857|FG002|Overall Study|Adverse Event|1|||
23344505|NCT00970632|65003855|FG000|Overall Study|Lack of Efficacy|3|||
23344506|NCT00970632|65003856|FG001|Overall Study|Lack of Efficacy|0|||
23344507|NCT00970632|65003857|FG002|Overall Study|Lack of Efficacy|0|||
23344508|NCT00970632|65003855|FG000|Overall Study|Lost to Follow-up|3|||
23344509|NCT00970632|65003856|FG001|Overall Study|Lost to Follow-up|0|||
23344510|NCT00970632|65003857|FG002|Overall Study|Lost to Follow-up|2|||
23344511|NCT00970632|65003855|FG000|Overall Study|Protocol Violation|8|||
23344512|NCT00970632|65003856|FG001|Overall Study|Protocol Violation|5|||
23344513|NCT00970632|65003857|FG002|Overall Study|Protocol Violation|8|||
23344514|NCT00970632|65003855|FG000|Overall Study|Withdrawal by Subject|7|||
23344515|NCT00970632|65003856|FG001|Overall Study|Withdrawal by Subject|6|||
23344516|NCT00970632|65003857|FG002|Overall Study|Withdrawal by Subject|4|||
23344517|NCT00970632|65003855|FG000|Overall Study|Entry criteria not met|0|||
23344518|NCT00970632|65003856|FG001|Overall Study|Entry criteria not met|2|||
23344519|NCT00970632|65003857|FG002|Overall Study|Entry criteria not met|2|||
23344520|NCT00970632|65003855|FG000|Overall Study|Sponsor decision|1|||
23344521|NCT00970632|65003856|FG001|Overall Study|Sponsor decision|0|||
23344522|NCT00970632|65003857|FG002|Overall Study|Sponsor decision|1|||
23344523|NCT02908672|65003858|FG000|Overall Study|Death|112|||
23344524|NCT02908672|65003859|FG001|Overall Study|Death|93|||
23344525|NCT02908672|65003858|FG000|Overall Study|Lost to Follow-up|3|||
23344526|NCT02908672|65003859|FG001|Overall Study|Lost to Follow-up|3|||
23344527|NCT02908672|65003858|FG000|Overall Study|Other|2|||
23344528|NCT02908672|65003859|FG001|Overall Study|Other|0|||
23344529|NCT02908672|65003858|FG000|Overall Study|Protocol Violation|1|||
23344530|NCT02908672|65003859|FG001|Overall Study|Protocol Violation|1|||
23344531|NCT02908672|65003858|FG000|Overall Study|Withdrawal by Subject|13|||
23344532|NCT02908672|65003859|FG001|Overall Study|Withdrawal by Subject|18|||
23344533|NCT02908672|65003858|FG000|Overall Study|Study is ongoing|124|||
23344534|NCT02908672|65003859|FG001|Overall Study|Study is ongoing|141|||
23344535|NCT02908672|65003858|FG000|Overall Study|Discontinued the study during run-in|3|||
23344536|NCT02908672|65003859|FG001|Overall Study|Discontinued the study during run-in|0|||
23238253|NCT04145531|64615540|FG002|Part B|Physician Decision|0|||
23238254|NCT04145531|64615541|FG003|Part B|Physician Decision|7|||
23238255|NCT04145531|64615538|FG000|Part B|Progressive disease|0|||
23344537|NCT02278367|65003862|FG000|Overall Study|Physician Decision|5|||
23238256|NCT04145531|64615539|FG001|Part B|Progressive disease|0|||
23238257|NCT04145531|64615540|FG002|Part B|Progressive disease|0|||
23238258|NCT04145531|64615541|FG003|Part B|Progressive disease|1|||
23238259|NCT04145531|64615538|FG000|Part B|Recurrent disease|0|||
23238260|NCT04145531|64615539|FG001|Part B|Recurrent disease|0|||
23238261|NCT04145531|64615540|FG002|Part B|Recurrent disease|0|||
23238262|NCT04145531|64615541|FG003|Part B|Recurrent disease|1|||
23238263|NCT04145531|64615538|FG000|Part B|Withdrawal by parent or guardian|0|||
23238264|NCT04145531|64615539|FG001|Part B|Withdrawal by parent or guardian|0|||
23238265|NCT04145531|64615540|FG002|Part B|Withdrawal by parent or guardian|0|||
23238266|NCT04145531|64615541|FG003|Part B|Withdrawal by parent or guardian|3|||
23238267|NCT04145531|64615538|FG000|Part B|Withdrawal by participant|0|||
23238268|NCT04145531|64615539|FG001|Part B|Withdrawal by participant|0|||
23238269|NCT04145531|64615540|FG002|Part B|Withdrawal by participant|0|||
23238270|NCT04145531|64615541|FG003|Part B|Withdrawal by participant|1|||
23238271|NCT04145531|64615538|FG000|Part B|Other|0|||
23344538|NCT02278367|65003863|FG001|Overall Study|Physician Decision|0|||
23344539|NCT02278367|65003862|FG000|Overall Study|Withdrawal by Subject|5|||
23344540|NCT02278367|65003863|FG001|Overall Study|Withdrawal by Subject|0|||
23344541|NCT05500274|65003867|FG000|Overall Study|Not able to complete the session and follow-up visits.|2|||
23344542|NCT05500274|65003868|FG001|Overall Study|Not able to complete the session and follow-up visits.|0|||
23344543|NCT05500274|65003867|FG000|Overall Study|Lost to Follow-up|86|||
23238272|NCT04145531|64615539|FG001|Part B|Other|0|||
23238273|NCT04145531|64615540|FG002|Part B|Other|0|||
23238274|NCT04145531|64615541|FG003|Part B|Other|1|||
23238275|NCT04576702|64615542|FG000|Overall Study|Death|1|||
23238276|NCT04576702|64615543|FG001|Overall Study|Death|0|||
23238277|NCT04576702|64615544|FG002|Overall Study|Death|0|||
23238278|NCT04576702|64615545|FG003|Overall Study|Death|0|||
23344544|NCT05500274|65003868|FG001|Overall Study|Lost to Follow-up|93|||
23344545|NCT00637000|65003869|FG000|Overall Study|Withdrawal by Subject|4|||
23344546|NCT00637000|65003870|FG001|Overall Study|Withdrawal by Subject|3|||
23344547|NCT04507256|65003873|FG000|Overall Study|Withdrawal by Subject|1|||
23344548|NCT04507256|65003874|FG001|Overall Study|Withdrawal by Subject|0|||
23344549|NCT04507256|65003875|FG002|Overall Study|Withdrawal by Subject|0|||
23344550|NCT04507256|65003876|FG003|Overall Study|Withdrawal by Subject|1|||
23344551|NCT04507256|65003877|FG004|Overall Study|Withdrawal by Subject|0|||
23344552|NCT04507256|65003878|FG005|Overall Study|Withdrawal by Subject|0|||
23344553|NCT03142334|65003879|FG000|Overall Study|Death|18|||
23344554|NCT03142334|65003880|FG001|Overall Study|Death|33|||
23344555|NCT03142334|65003879|FG000|Overall Study|Withdrawal by Subject|15|||
23344556|NCT03142334|65003880|FG001|Overall Study|Withdrawal by Subject|11|||
23344557|NCT03142334|65003879|FG000|Overall Study|Ongoing on trial follow up|463|||
23344558|NCT03142334|65003880|FG001|Overall Study|Ongoing on trial follow up|454|||
23344559|NCT01149421|65003887|FG000|Overall Study|Adverse Event|22|||
23344560|NCT01149421|65003888|FG001|Overall Study|Adverse Event|6|||
23344561|NCT01149421|65003889|FG002|Overall Study|Adverse Event|11|||
23344562|NCT01149421|65003887|FG000|Overall Study|Withdrawal by Subject|20|||
23344563|NCT01149421|65003888|FG001|Overall Study|Withdrawal by Subject|12|||
23344564|NCT01149421|65003889|FG002|Overall Study|Withdrawal by Subject|13|||
23344565|NCT01149421|65003887|FG000|Overall Study|Sponsor Decision|0|||
23344566|NCT01149421|65003888|FG001|Overall Study|Sponsor Decision|1|||
23344567|NCT01149421|65003889|FG002|Overall Study|Sponsor Decision|1|||
23344568|NCT01149421|65003887|FG000|Overall Study|Lost to Follow-up|2|||
23178308|NCT02901431|64394034|FG010|Main Treatment Part|Lost to Follow-up|0|||
23178309|NCT02901431|64394035|FG011|Main Treatment Part|Lost to Follow-up|0|||
23178310|NCT02901431|64394036|FG012|Main Treatment Part|Lost to Follow-up|0|||
23178311|NCT02901431|64394024|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
23344569|NCT01149421|65003888|FG001|Overall Study|Lost to Follow-up|4|||
23344570|NCT01149421|65003889|FG002|Overall Study|Lost to Follow-up|5|||
23344571|NCT01149421|65003887|FG000|Overall Study|Physician Decision|5|||
23344572|NCT01149421|65003888|FG001|Overall Study|Physician Decision|3|||
23344573|NCT01149421|65003889|FG002|Overall Study|Physician Decision|6|||
23344574|NCT01149421|65003887|FG000|Overall Study|Entry Criteria Not Met|1|||
23344575|NCT01149421|65003888|FG001|Overall Study|Entry Criteria Not Met|1|||
23344576|NCT01149421|65003889|FG002|Overall Study|Entry Criteria Not Met|2|||
23344577|NCT01149421|65003887|FG000|Overall Study|Protocol Violation|2|||
23344578|NCT01149421|65003888|FG001|Overall Study|Protocol Violation|2|||
23344579|NCT01149421|65003889|FG002|Overall Study|Protocol Violation|6|||
23344580|NCT05523323|65003895|FG000|Overall Study|Death|26|||
23178312|NCT02901431|64394025|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
23344581|NCT05523323|65003896|FG001|Overall Study|Death|21|||
23344582|NCT05523323|65003895|FG000|Overall Study|Ongoing participants|35|||
23344583|NCT05523323|65003896|FG001|Overall Study|Ongoing participants|30|||
23344584|NCT00972816|65003901|FG000|Overall Study|Adverse Event|0|||
23344585|NCT00972816|65003902|FG001|Overall Study|Adverse Event|0|||
23344586|NCT00972816|65003903|FG002|Overall Study|Adverse Event|1|||
23344587|NCT00972816|65003904|FG003|Overall Study|Adverse Event|0|||
23344588|NCT00972816|65003905|FG004|Overall Study|Adverse Event|0|||
23344589|NCT00972816|65003906|FG005|Overall Study|Adverse Event|0|||
23344590|NCT00972816|65003907|FG006|Overall Study|Adverse Event|0|||
23344591|NCT00972816|65003908|FG007|Overall Study|Adverse Event|0|||
23344592|NCT00972816|65003901|FG000|Overall Study|Withdrawal by Subject|4|||
23344593|NCT00972816|65003902|FG001|Overall Study|Withdrawal by Subject|2|||
23344594|NCT00972816|65003903|FG002|Overall Study|Withdrawal by Subject|1|||
23344595|NCT00972816|65003904|FG003|Overall Study|Withdrawal by Subject|3|||
23344596|NCT00972816|65003905|FG004|Overall Study|Withdrawal by Subject|0|||
23344597|NCT00972816|65003906|FG005|Overall Study|Withdrawal by Subject|1|||
23344598|NCT00972816|65003907|FG006|Overall Study|Withdrawal by Subject|1|||
23344599|NCT00972816|65003908|FG007|Overall Study|Withdrawal by Subject|2|||
23344600|NCT00972816|65003901|FG000|Overall Study|Lost to Follow-up|11|||
23344601|NCT00972816|65003902|FG001|Overall Study|Lost to Follow-up|9|||
23344602|NCT00972816|65003903|FG002|Overall Study|Lost to Follow-up|7|||
23178313|NCT02901431|64394026|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
23344603|NCT00972816|65003904|FG003|Overall Study|Lost to Follow-up|5|||
23344604|NCT00972816|65003905|FG004|Overall Study|Lost to Follow-up|11|||
23344605|NCT00972816|65003906|FG005|Overall Study|Lost to Follow-up|10|||
23344606|NCT00972816|65003907|FG006|Overall Study|Lost to Follow-up|7|||
23344607|NCT00972816|65003908|FG007|Overall Study|Lost to Follow-up|7|||
23344608|NCT00972816|65003901|FG000|Overall Study|Inappropriate enrolment|0|||
23344609|NCT00972816|65003902|FG001|Overall Study|Inappropriate enrolment|0|||
23344610|NCT00972816|65003903|FG002|Overall Study|Inappropriate enrolment|0|||
23344611|NCT00972816|65003904|FG003|Overall Study|Inappropriate enrolment|0|||
23344612|NCT00972816|65003905|FG004|Overall Study|Inappropriate enrolment|0|||
23456129|NCT00878501|65412899|FG000|Overall Study|Lack of Efficacy|2|||
23456130|NCT00878501|65412900|FG001|Overall Study|Lack of Efficacy|1|||
23344613|NCT00972816|65003906|FG005|Overall Study|Inappropriate enrolment|0|||
23344614|NCT00972816|65003907|FG006|Overall Study|Inappropriate enrolment|2|||
23344615|NCT00972816|65003908|FG007|Overall Study|Inappropriate enrolment|0|||
23344616|NCT00972816|65003901|FG000|Overall Study|Unable to classify|2|||
23344617|NCT00972816|65003902|FG001|Overall Study|Unable to classify|0|||
23344618|NCT00972816|65003903|FG002|Overall Study|Unable to classify|0|||
23344619|NCT00972816|65003904|FG003|Overall Study|Unable to classify|0|||
23344620|NCT00972816|65003905|FG004|Overall Study|Unable to classify|1|||
23344621|NCT00972816|65003906|FG005|Overall Study|Unable to classify|0|||
23344622|NCT00972816|65003907|FG006|Overall Study|Unable to classify|0|||
23344623|NCT00972816|65003908|FG007|Overall Study|Unable to classify|0|||
23344624|NCT02203851|65003909|FG000|Overall Study|Lost to Follow-up|4|||
23344625|NCT02203851|65003909|FG000|Overall Study|Withdrawal by Subject|6|||
23344626|NCT02203851|65003909|FG000|Overall Study|Other|1|||
23344627|NCT04325828|65003910|FG000|Overall Study|Ongoing|26|||
23344628|NCT01482962|65003911|FG000|Overall Study|Progressive Disease|65|||
23344629|NCT01482962|65003912|FG001|Overall Study|Progressive Disease|53|||
23344630|NCT01482962|65003911|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
23344631|NCT01482962|65003912|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
23344632|NCT01482962|65003911|FG000|Overall Study|Adverse Event|18|||
23344633|NCT01482962|65003912|FG001|Overall Study|Adverse Event|22|||
23344634|NCT01482962|65003911|FG000|Overall Study|Withdrawal by Participant|8|||
23344635|NCT01482962|65003912|FG001|Overall Study|Withdrawal by Participant|13|||
23344636|NCT01482962|65003911|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
23456131|NCT00878501|65412901|FG002|Overall Study|Lack of Efficacy|0|||
23178314|NCT02901431|64394027|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
23178315|NCT02901431|64394028|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
23178316|NCT02901431|64394029|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
23178317|NCT02901431|64394030|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
23178318|NCT02901431|64394031|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
23178319|NCT02901431|64394032|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
23178320|NCT02901431|64394033|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
23178321|NCT02901431|64394034|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
23178322|NCT02901431|64394035|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
23178323|NCT02901431|64394036|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
23178324|NCT02901431|64394024|FG000|Main Treatment Part|Physician Decision|0|||
23178325|NCT02901431|64394025|FG001|Main Treatment Part|Physician Decision|0|||
23178326|NCT02901431|64394026|FG002|Main Treatment Part|Physician Decision|0|||
23178327|NCT02901431|64394027|FG003|Main Treatment Part|Physician Decision|1|||
23178328|NCT02901431|64394028|FG004|Main Treatment Part|Physician Decision|0|||
23178329|NCT02901431|64394029|FG005|Main Treatment Part|Physician Decision|0|||
23178330|NCT02901431|64394030|FG006|Main Treatment Part|Physician Decision|1|||
23178331|NCT02901431|64394031|FG007|Main Treatment Part|Physician Decision|0|||
23178332|NCT02901431|64394032|FG008|Main Treatment Part|Physician Decision|0|||
23178333|NCT02901431|64394033|FG009|Main Treatment Part|Physician Decision|0|||
23178334|NCT02901431|64394034|FG010|Main Treatment Part|Physician Decision|0|||
23178335|NCT02901431|64394035|FG011|Main Treatment Part|Physician Decision|0|||
23178336|NCT02901431|64394036|FG012|Main Treatment Part|Physician Decision|0|||
23178337|NCT02901431|64394024|FG000|Main Treatment Part|Withdrawal by Subject|0|||
23178338|NCT02901431|64394025|FG001|Main Treatment Part|Withdrawal by Subject|0|||
23178339|NCT02901431|64394026|FG002|Main Treatment Part|Withdrawal by Subject|0|||
23178340|NCT02901431|64394027|FG003|Main Treatment Part|Withdrawal by Subject|18|||
23178341|NCT02901431|64394028|FG004|Main Treatment Part|Withdrawal by Subject|3|||
23178342|NCT02901431|64394029|FG005|Main Treatment Part|Withdrawal by Subject|5|||
23178343|NCT02901431|64394030|FG006|Main Treatment Part|Withdrawal by Subject|6|||
23178344|NCT02901431|64394031|FG007|Main Treatment Part|Withdrawal by Subject|0|||
23178345|NCT02901431|64394032|FG008|Main Treatment Part|Withdrawal by Subject|0|||
23178346|NCT02901431|64394033|FG009|Main Treatment Part|Withdrawal by Subject|0|||
23178347|NCT02901431|64394034|FG010|Main Treatment Part|Withdrawal by Subject|0|||
23178348|NCT02901431|64394035|FG011|Main Treatment Part|Withdrawal by Subject|0|||
23456132|NCT00878501|65412899|FG000|Overall Study|Withdrawal by Subject|2|||
23456133|NCT00878501|65412900|FG001|Overall Study|Withdrawal by Subject|1|||
23456134|NCT00878501|65412901|FG002|Overall Study|Withdrawal by Subject|2|||
23456135|NCT00878501|65412899|FG000|Overall Study|Protocol Violation|0|||
23456136|NCT00878501|65412900|FG001|Overall Study|Protocol Violation|0|||
23178349|NCT02901431|64394036|FG012|Main Treatment Part|Withdrawal by Subject|0|||
23178350|NCT02901431|64394024|FG000|Open Label Part|Adverse Event|0|||
23178351|NCT02901431|64394025|FG001|Open Label Part|Adverse Event|0|||
23178352|NCT02901431|64394026|FG002|Open Label Part|Adverse Event|0|||
23178353|NCT02901431|64394027|FG003|Open Label Part|Adverse Event|0|||
23178354|NCT02901431|64394028|FG004|Open Label Part|Adverse Event|0|||
23178355|NCT02901431|64394029|FG005|Open Label Part|Adverse Event|0|||
23178356|NCT02901431|64394030|FG006|Open Label Part|Adverse Event|0|||
23178357|NCT02901431|64394031|FG007|Open Label Part|Adverse Event|0|||
23344637|NCT01482962|65003912|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
23344638|NCT01482962|65003911|FG000|Overall Study|Other Reason|1|||
23344639|NCT01482962|65003912|FG001|Overall Study|Other Reason|5|||
23344640|NCT01482962|65003911|FG000|Overall Study|Study Terminated by Sponsor|5|||
23344641|NCT01482962|65003912|FG001|Overall Study|Study Terminated by Sponsor|2|||
23344642|NCT01482962|65003911|FG000|Overall Study|Did not Receive Study Drug|1|||
23178358|NCT02901431|64394032|FG008|Open Label Part|Adverse Event|4|||
23178359|NCT02901431|64394033|FG009|Open Label Part|Adverse Event|4|||
23178360|NCT02901431|64394034|FG010|Open Label Part|Adverse Event|0|||
23178361|NCT02901431|64394035|FG011|Open Label Part|Adverse Event|4|||
23178362|NCT02901431|64394036|FG012|Open Label Part|Adverse Event|1|||
23178363|NCT02901431|64394024|FG000|Open Label Part|Lost to Follow-up|0|||
23344643|NCT01482962|65003912|FG001|Overall Study|Did not Receive Study Drug|6|||
23344644|NCT00131365|65003917|FG000|Overall Study|Withdrawal by Subject|1|||
23344645|NCT00131365|65003917|FG000|Overall Study|Alternative treatment|3|||
23583399|NCT04886596|65866015|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
23583400|NCT04886596|65866016|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
23583401|NCT04886596|65866015|FG000|Overall Study|Migrated / Moved from the study area|17|||
23344662|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
23344663|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
23344664|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
23344665|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
23344666|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
23456137|NCT00878501|65412901|FG002|Overall Study|Protocol Violation|1|||
23178364|NCT02901431|64394025|FG001|Open Label Part|Lost to Follow-up|0|||
23178365|NCT02901431|64394026|FG002|Open Label Part|Lost to Follow-up|0|||
23178366|NCT02901431|64394027|FG003|Open Label Part|Lost to Follow-up|0|||
23178367|NCT02901431|64394028|FG004|Open Label Part|Lost to Follow-up|0|||
23178368|NCT02901431|64394029|FG005|Open Label Part|Lost to Follow-up|0|||
23178369|NCT02901431|64394030|FG006|Open Label Part|Lost to Follow-up|0|||
23178370|NCT02901431|64394031|FG007|Open Label Part|Lost to Follow-up|0|||
23178371|NCT02901431|64394032|FG008|Open Label Part|Lost to Follow-up|2|||
23178372|NCT02901431|64394033|FG009|Open Label Part|Lost to Follow-up|2|||
23178373|NCT02901431|64394034|FG010|Open Label Part|Lost to Follow-up|1|||
23178374|NCT02901431|64394035|FG011|Open Label Part|Lost to Follow-up|1|||
23178375|NCT02901431|64394036|FG012|Open Label Part|Lost to Follow-up|1|||
23178376|NCT02901431|64394024|FG000|Open Label Part|Physician Decision|0|||
23178377|NCT02901431|64394025|FG001|Open Label Part|Physician Decision|0|||
23178378|NCT02901431|64394026|FG002|Open Label Part|Physician Decision|0|||
23178379|NCT02901431|64394027|FG003|Open Label Part|Physician Decision|0|||
23178380|NCT02901431|64394028|FG004|Open Label Part|Physician Decision|0|||
23178381|NCT02901431|64394029|FG005|Open Label Part|Physician Decision|0|||
23178382|NCT02901431|64394030|FG006|Open Label Part|Physician Decision|0|||
23178383|NCT02901431|64394031|FG007|Open Label Part|Physician Decision|0|||
23178384|NCT02901431|64394032|FG008|Open Label Part|Physician Decision|1|||
23178385|NCT02901431|64394033|FG009|Open Label Part|Physician Decision|1|||
23178386|NCT02901431|64394034|FG010|Open Label Part|Physician Decision|0|||
23178387|NCT02901431|64394035|FG011|Open Label Part|Physician Decision|0|||
23178388|NCT02901431|64394036|FG012|Open Label Part|Physician Decision|0|||
23178389|NCT02901431|64394024|FG000|Open Label Part|Study Terminated By Sponsor|0|||
23238279|NCT04576702|64615542|FG000|Overall Study|Withdrawal by Subject|0|||
23344667|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
23344668|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
23344669|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
23456138|NCT00878501|65412899|FG000|Overall Study|Incorrect enrolment|1|||
23456139|NCT00878501|65412900|FG001|Overall Study|Incorrect enrolment|2|||
23456140|NCT00878501|65412901|FG002|Overall Study|Incorrect enrolment|0|||
23238280|NCT04576702|64615543|FG001|Overall Study|Withdrawal by Subject|2|||
23344670|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Death|0|||
23344671|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Death|1|||
23344672|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
23344673|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
23344674|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
23344675|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
23344676|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
23344677|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
23456141|NCT00878501|65412899|FG000|Overall Study|Intake of prohibited concom. medication|0|||
23456142|NCT00878501|65412900|FG001|Overall Study|Intake of prohibited concom. medication|0|||
23456143|NCT00878501|65412901|FG002|Overall Study|Intake of prohibited concom. medication|1|||
23456144|NCT00878501|65412899|FG000|Overall Study|Mis-randomisation of patient|1|||
23456145|NCT00878501|65412900|FG001|Overall Study|Mis-randomisation of patient|0|||
23456146|NCT00878501|65412901|FG002|Overall Study|Mis-randomisation of patient|0|||
23456147|NCT00878501|65412899|FG000|Overall Study|Administrative|0|||
23456148|NCT00878501|65412900|FG001|Overall Study|Administrative|0|||
23456149|NCT00878501|65412901|FG002|Overall Study|Administrative|1|||
23456150|NCT00107198|65412904|FG000|Overall Study|Lack of Efficacy|28|||
23456151|NCT00107198|65412904|FG000|Overall Study|Lost to Follow-up|12|||
23456152|NCT00107198|65412904|FG000|Overall Study|Protocol Violation|1|||
23456153|NCT00107198|65412904|FG000|Overall Study|Withdrawal by Subject|6|||
23456154|NCT00107198|65412904|FG000|Overall Study|Ineligible|5|||
23178390|NCT02901431|64394025|FG001|Open Label Part|Study Terminated By Sponsor|0|||
23178391|NCT02901431|64394026|FG002|Open Label Part|Study Terminated By Sponsor|0|||
23178392|NCT02901431|64394027|FG003|Open Label Part|Study Terminated By Sponsor|0|||
23178393|NCT02901431|64394028|FG004|Open Label Part|Study Terminated By Sponsor|0|||
23178394|NCT02901431|64394029|FG005|Open Label Part|Study Terminated By Sponsor|0|||
23178395|NCT02901431|64394030|FG006|Open Label Part|Study Terminated By Sponsor|0|||
23178396|NCT02901431|64394031|FG007|Open Label Part|Study Terminated By Sponsor|0|||
23178397|NCT02901431|64394032|FG008|Open Label Part|Study Terminated By Sponsor|35|||
23178398|NCT02901431|64394033|FG009|Open Label Part|Study Terminated By Sponsor|12|||
23178399|NCT02901431|64394034|FG010|Open Label Part|Study Terminated By Sponsor|21|||
23178400|NCT02901431|64394035|FG011|Open Label Part|Study Terminated By Sponsor|31|||
23178401|NCT02901431|64394036|FG012|Open Label Part|Study Terminated By Sponsor|0|||
23178402|NCT02901431|64394024|FG000|Open Label Part|Withdrawal by Subject|0|||
23238281|NCT04576702|64615544|FG002|Overall Study|Withdrawal by Subject|1|||
23238282|NCT04576702|64615545|FG003|Overall Study|Withdrawal by Subject|0|||
23238283|NCT04576702|64615542|FG000|Overall Study|Lost to Follow-up|3|||
23238284|NCT04576702|64615543|FG001|Overall Study|Lost to Follow-up|3|||
23238285|NCT04576702|64615544|FG002|Overall Study|Lost to Follow-up|3|||
23238286|NCT04576702|64615545|FG003|Overall Study|Lost to Follow-up|4|||
23238287|NCT00486720|64615546|FG000|Overall Study|Adverse Event|1|||
23238288|NCT00486720|64615547|FG001|Overall Study|Adverse Event|2|||
23238289|NCT00486720|64615546|FG000|Overall Study|Lack of Efficacy|4|||
23238290|NCT00486720|64615547|FG001|Overall Study|Lack of Efficacy|6|||
23238291|NCT00486720|64615546|FG000|Overall Study|Physician Decision|1|||
23238292|NCT00486720|64615547|FG001|Overall Study|Physician Decision|2|||
23238293|NCT00486720|64615546|FG000|Overall Study|Protocol Violation|1|||
23238294|NCT00486720|64615547|FG001|Overall Study|Protocol Violation|0|||
23238295|NCT00486720|64615546|FG000|Overall Study|Withdrawal by Subject|3|||
23238296|NCT00486720|64615547|FG001|Overall Study|Withdrawal by Subject|1|||
23238297|NCT00486720|64615546|FG000|Overall Study|Progressive Disease|0|||
23238298|NCT00486720|64615547|FG001|Overall Study|Progressive Disease|1|||
23238299|NCT00594958|64615548|FG000|Overall Study|Withdrawal by Subject|1|||
23238300|NCT00594958|64615549|FG001|Overall Study|Withdrawal by Subject|0|||
23238301|NCT00594958|64615550|FG002|Overall Study|Withdrawal by Subject|1|||
23456155|NCT05498649|65412908|FG000|Overall Study|Lost to Follow-up|1|||
23456156|NCT00948246|65412909|FG000|Overall Study|Lost to Follow-up|11|||
23456157|NCT00948246|65412909|FG000|Overall Study|Adverse Event|11|||
23456158|NCT00948246|65412909|FG000|Overall Study|Death|1|||
23456159|NCT00948246|65412909|FG000|Overall Study|Withdrawal by Subject|1|||
23456160|NCT04742556|65412919|FG000|Overall Study|Withdrawal by Subject|0|||
23456161|NCT04742556|65412920|FG001|Overall Study|Withdrawal by Subject|1|||
23456162|NCT04742556|65412921|FG002|Overall Study|Withdrawal by Subject|0|||
23456163|NCT04742556|65412919|FG000|Overall Study|Adverse Event|0|||
23456164|NCT04742556|65412920|FG001|Overall Study|Adverse Event|0|||
23456165|NCT04742556|65412921|FG002|Overall Study|Adverse Event|2|||
23456166|NCT04742556|65412919|FG000|Overall Study|Clinical disease progression|0|||
23456167|NCT04742556|65412920|FG001|Overall Study|Clinical disease progression|1|||
23456168|NCT04742556|65412921|FG002|Overall Study|Clinical disease progression|2|||
23456169|NCT04742556|65412919|FG000|Overall Study|Objective disease progression|3|||
23456170|NCT04742556|65412920|FG001|Overall Study|Objective disease progression|2|||
23456171|NCT04742556|65412921|FG002|Overall Study|Objective disease progression|4|||
23456172|NCT03922581|65412929|FG000|Overall Study|Lost to Follow-up|20|||
23456173|NCT03922581|65412930|FG001|Overall Study|Lost to Follow-up|9|||
23456174|NCT03922581|65412929|FG000|Overall Study|Physician Decision|1|||
23456175|NCT03922581|65412930|FG001|Overall Study|Physician Decision|1|||
23456176|NCT03922581|65412929|FG000|Overall Study|Withdrawal by Subject|1|||
23456177|NCT03922581|65412930|FG001|Overall Study|Withdrawal by Subject|0|||
23456178|NCT02177695|65412931|FG000|ITT Analysis|Ineligible|5|||
23456179|NCT02177695|65412932|FG001|ITT Analysis|Ineligible|5|||
23178403|NCT02901431|64394025|FG001|Open Label Part|Withdrawal by Subject|0|||
23178404|NCT02901431|64394026|FG002|Open Label Part|Withdrawal by Subject|0|||
23238302|NCT00594958|64615548|FG000|Overall Study|Adverse Event|4|||
23238303|NCT00594958|64615549|FG001|Overall Study|Adverse Event|1|||
23456180|NCT02177695|65412931|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
23456181|NCT02177695|65412932|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
23456182|NCT02177695|65412931|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
23456183|NCT02177695|65412932|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
23178405|NCT02901431|64394027|FG003|Open Label Part|Withdrawal by Subject|0|||
23238304|NCT00594958|64615550|FG002|Overall Study|Adverse Event|2|||
23456184|NCT02177695|65412931|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
23456185|NCT02177695|65412932|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
23238305|NCT00594958|64615548|FG000|Overall Study|Pregnancy|0|||
23238306|NCT00594958|64615549|FG001|Overall Study|Pregnancy|2|||
23238307|NCT00594958|64615550|FG002|Overall Study|Pregnancy|0|||
23238308|NCT00594958|64615548|FG000|Overall Study|Protocol Violation|1|||
23238309|NCT00594958|64615549|FG001|Overall Study|Protocol Violation|0|||
23178406|NCT02901431|64394028|FG004|Open Label Part|Withdrawal by Subject|0|||
23178407|NCT02901431|64394029|FG005|Open Label Part|Withdrawal by Subject|0|||
23178408|NCT02901431|64394030|FG006|Open Label Part|Withdrawal by Subject|0|||
23178409|NCT02901431|64394031|FG007|Open Label Part|Withdrawal by Subject|0|||
23178410|NCT02901431|64394032|FG008|Open Label Part|Withdrawal by Subject|6|||
23178411|NCT02901431|64394033|FG009|Open Label Part|Withdrawal by Subject|5|||
23178412|NCT02901431|64394034|FG010|Open Label Part|Withdrawal by Subject|7|||
23178413|NCT02901431|64394035|FG011|Open Label Part|Withdrawal by Subject|3|||
23178414|NCT02901431|64394036|FG012|Open Label Part|Withdrawal by Subject|1|||
23178415|NCT02554929|64394043|FG000|Overall Study|Lost to Follow-up|4|||
23178416|NCT02554929|64394044|FG001|Overall Study|Lost to Follow-up|4|||
23178417|NCT02554929|64394043|FG000|Overall Study|Withdrawal by Subject|2|||
23178418|NCT02554929|64394044|FG001|Overall Study|Withdrawal by Subject|8|||
23178419|NCT00675025|64394047|FG000|Overall Study|Study Terminated by Sponsor|38|||
23178420|NCT00675025|64394048|FG001|Overall Study|Study Terminated by Sponsor|42|||
23178421|NCT00675025|64394047|FG000|Overall Study|Adverse Event|6|||
23178422|NCT00675025|64394048|FG001|Overall Study|Adverse Event|11|||
23178423|NCT00675025|64394047|FG000|Overall Study|Lost to Follow-up|6|||
23178424|NCT00675025|64394048|FG001|Overall Study|Lost to Follow-up|4|||
23178425|NCT00675025|64394047|FG000|Overall Study|Withdrawal by Subject|4|||
23178426|NCT00675025|64394048|FG001|Overall Study|Withdrawal by Subject|6|||
23178427|NCT02266433|64394049|FG000|Overall Study|Lost to Follow-up|54|||
23178428|NCT02266433|64394050|FG001|Overall Study|Lost to Follow-up|46|||
23178429|NCT02266433|64394049|FG000|Overall Study|Withdrawal by Subject|5|||
23178430|NCT02266433|64394050|FG001|Overall Study|Withdrawal by Subject|7|||
23178431|NCT01097629|64394051|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
23178432|NCT01097629|64394052|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
23178433|NCT01097629|64394053|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
23178434|NCT01097629|64394054|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23178435|NCT01097629|64394055|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23178436|NCT01097629|64394056|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23178437|NCT01097629|64394057|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23178438|NCT01097629|64394058|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23178439|NCT01097629|64394051|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
23178440|NCT01097629|64394052|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
23178441|NCT01097629|64394053|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
23178442|NCT01097629|64394054|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23456186|NCT04247347|65412934|FG000|Overall Study|Withdrawal by Subject|2|||
23178443|NCT01097629|64394055|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23456187|NCT04247347|65412935|FG001|Overall Study|Withdrawal by Subject|3|||
23178444|NCT01097629|64394056|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23178445|NCT01097629|64394057|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23178446|NCT01097629|64394058|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23178447|NCT01097629|64394051|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
23178448|NCT01097629|64394052|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
23178449|NCT01097629|64394053|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
23178450|NCT01097629|64394054|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23178451|NCT01097629|64394055|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23178452|NCT01097629|64394056|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23178453|NCT01097629|64394057|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23178454|NCT01097629|64394058|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23178455|NCT01097629|64394051|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
23178456|NCT01097629|64394052|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
23178457|NCT01097629|64394053|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
23178458|NCT01097629|64394054|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23178459|NCT01097629|64394055|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23178460|NCT01097629|64394056|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23178461|NCT01097629|64394057|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23178462|NCT01097629|64394058|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23178463|NCT01097629|64394051|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
23178464|NCT01097629|64394052|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
23178465|NCT01097629|64394053|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
23178466|NCT01097629|64394054|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23178467|NCT01097629|64394055|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23178468|NCT01097629|64394056|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23178469|NCT01097629|64394057|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23178470|NCT01097629|64394058|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23178471|NCT01097629|64394051|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
23178472|NCT01097629|64394052|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
23178473|NCT01097629|64394053|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23178474|NCT01097629|64394054|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23178475|NCT01097629|64394055|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23178476|NCT01097629|64394056|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23178477|NCT01097629|64394057|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23178478|NCT01097629|64394058|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23178479|NCT01097629|64394051|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
23238310|NCT00594958|64615550|FG002|Overall Study|Protocol Violation|2|||
23344678|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
23344679|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
23344680|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
23344681|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
23344682|NCT00394836|65003922|FG000|Teatment or Follow-up Phase|Non compliance|0|||
23344683|NCT00394836|65003923|FG001|Teatment or Follow-up Phase|Non compliance|1|||
23344684|NCT00394836|65003922|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
23344685|NCT00394836|65003923|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
23344686|NCT00394836|65003922|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
23344687|NCT00394836|65003923|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
23344688|NCT00394836|65003922|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
23344689|NCT00394836|65003923|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
23344690|NCT00394836|65003922|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
23344691|NCT00394836|65003923|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
23344692|NCT00176644|65003926|FG000|Overall Study|Withdrawal by Subject|1|||
23344693|NCT02600845|65003933|FG000|Overall Study|Reason Not Specified|3|||
23344694|NCT02600845|65003933|FG000|Overall Study|Non-compliance with Study Procedures|10|||
23344695|NCT02600845|65003933|FG000|Overall Study|Consent Withdrawal|5|||
23344696|NCT00432276|65003934|FG000|Overall Study|Hyperglycemic Rescue|44|||
23344697|NCT00432276|65003935|FG001|Overall Study|Hyperglycemic Rescue|87|||
23344698|NCT00432276|65003934|FG000|Overall Study|Adverse Event|13|||
23344699|NCT00432276|65003935|FG001|Overall Study|Adverse Event|16|||
23344700|NCT00432276|65003934|FG000|Overall Study|Protocol Violation|25|||
23456188|NCT04247347|65412936|FG002|Overall Study|Withdrawal by Subject|3|||
23238311|NCT00594958|64615548|FG000|Overall Study|Lost to Follow-up|5|||
23344701|NCT00432276|65003935|FG001|Overall Study|Protocol Violation|20|||
23344702|NCT00432276|65003934|FG000|Overall Study|Lost to Follow-up|6|||
23344703|NCT00432276|65003935|FG001|Overall Study|Lost to Follow-up|2|||
23344704|NCT00432276|65003934|FG000|Overall Study|Withdrawal by Subject|25|||
23344705|NCT00432276|65003935|FG001|Overall Study|Withdrawal by Subject|20|||
23344706|NCT00432276|65003934|FG000|Overall Study|Physician Decision|6|||
23344707|NCT00432276|65003935|FG001|Overall Study|Physician Decision|8|||
23344708|NCT00432276|65003934|FG000|Overall Study|Other|2|||
23344709|NCT00432276|65003935|FG001|Overall Study|Other|3|||
23344710|NCT03244618|65003942|FG000|Overall Study|Lost to Follow-up|3|||
23344711|NCT03244618|65003943|FG001|Overall Study|Lost to Follow-up|4|||
23344712|NCT03244618|65003942|FG000|Overall Study|Protocol Violation|4|||
23344713|NCT03244618|65003943|FG001|Overall Study|Protocol Violation|3|||
23344714|NCT03244618|65003942|FG000|Overall Study|Withdrawal by Subject|0|||
23344715|NCT03244618|65003943|FG001|Overall Study|Withdrawal by Subject|2|||
23344716|NCT03104400|65003950|FG000|Overall Study|Adverse Event|5|||
23344717|NCT03104400|65003951|FG001|Overall Study|Adverse Event|7|||
23456189|NCT04247347|65412934|FG000|Overall Study|Lost to Follow-up|1|||
23238312|NCT00594958|64615549|FG001|Overall Study|Lost to Follow-up|0|||
23238313|NCT00594958|64615550|FG002|Overall Study|Lost to Follow-up|3|||
23238314|NCT00594958|64615548|FG000|Overall Study|administrative|3|||
23238315|NCT00594958|64615549|FG001|Overall Study|administrative|0|||
23238316|NCT00594958|64615550|FG002|Overall Study|administrative|2|||
23238317|NCT02985996|64615551|FG000|Overall Study|Withdrawal by Subject|0|||
23238318|NCT02985996|64615552|FG001|Overall Study|Withdrawal by Subject|0|||
23238319|NCT02985996|64615553|FG002|Overall Study|Withdrawal by Subject|1|||
23238320|NCT02985996|64615554|FG003|Overall Study|Withdrawal by Subject|0|||
23238321|NCT02985996|64615555|FG004|Overall Study|Withdrawal by Subject|0|||
23238322|NCT02985996|64615551|FG000|Overall Study|Protocol Violation|0|||
23238323|NCT02985996|64615552|FG001|Overall Study|Protocol Violation|1|||
23238324|NCT02985996|64615553|FG002|Overall Study|Protocol Violation|0|||
23238325|NCT02985996|64615554|FG003|Overall Study|Protocol Violation|0|||
23238326|NCT02985996|64615555|FG004|Overall Study|Protocol Violation|0|||
23238327|NCT03319368|64615556|FG000|Overall Study|Discharge swabs not collected from resident|57|||
23238328|NCT03319368|64615557|FG001|Overall Study|Discharge swabs not collected from resident|46|||
23238329|NCT00772031|64615558|FG000|Overall Study|Early termination of trial|12|||
23238330|NCT00772031|64615559|FG001|Overall Study|Early termination of trial|10|||
23238331|NCT00772031|64615558|FG000|Overall Study|Lost to Follow-up|20|||
23238332|NCT00772031|64615559|FG001|Overall Study|Lost to Follow-up|33|||
23238333|NCT03772574|64615560|FG000|Overall Study|Protocol Violation|2|||
23238334|NCT03772574|64615561|FG001|Overall Study|Protocol Violation|0|||
23238335|NCT03772574|64615562|FG002|Overall Study|Protocol Violation|0|||
23238336|NCT03772574|64615560|FG000|Overall Study|Discomfort|0|||
23238337|NCT03772574|64615561|FG001|Overall Study|Discomfort|5|||
23238338|NCT03772574|64615562|FG002|Overall Study|Discomfort|4|||
23238339|NCT02030067|64615565|FG000|Overall Study|Disease Progression|1|||
23238340|NCT02030067|64615566|FG001|Overall Study|Disease Progression|1|||
23238341|NCT02030067|64615567|FG002|Overall Study|Disease Progression|2|||
23238342|NCT02030067|64615568|FG003|Overall Study|Disease Progression|2|||
23238343|NCT02030067|64615569|FG004|Overall Study|Disease Progression|3|||
23238344|NCT02030067|64615570|FG005|Overall Study|Disease Progression|2|||
23238345|NCT02030067|64615571|FG006|Overall Study|Disease Progression|3|||
23238346|NCT02030067|64615572|FG007|Overall Study|Disease Progression|3|||
23238347|NCT02030067|64615573|FG008|Overall Study|Disease Progression|4|||
23238348|NCT02030067|64615574|FG009|Overall Study|Disease Progression|3|||
23238349|NCT02030067|64615575|FG010|Overall Study|Disease Progression|7|||
23238350|NCT02030067|64615576|FG011|Overall Study|Disease Progression|2|||
23238351|NCT02030067|64615577|FG012|Overall Study|Disease Progression|59|||
23238352|NCT02030067|64615565|FG000|Overall Study|Withdrawal by Subject|0|||
23238353|NCT02030067|64615566|FG001|Overall Study|Withdrawal by Subject|0|||
23238354|NCT02030067|64615567|FG002|Overall Study|Withdrawal by Subject|0|||
23238355|NCT02030067|64615568|FG003|Overall Study|Withdrawal by Subject|1|||
23344718|NCT03104400|65003952|FG002|Overall Study|Adverse Event|11|||
23344719|NCT03104400|65003953|FG003|Overall Study|Adverse Event|9|||
23344720|NCT03104400|65003954|FG004|Overall Study|Adverse Event|21|||
23344721|NCT03104400|65003950|FG000|Overall Study|Withdrawal by Subject|17|||
23344722|NCT03104400|65003951|FG001|Overall Study|Withdrawal by Subject|19|||
23456190|NCT04247347|65412935|FG001|Overall Study|Lost to Follow-up|1|||
23238356|NCT02030067|64615569|FG004|Overall Study|Withdrawal by Subject|0|||
23238357|NCT02030067|64615570|FG005|Overall Study|Withdrawal by Subject|0|||
23238358|NCT02030067|64615571|FG006|Overall Study|Withdrawal by Subject|0|||
23238359|NCT02030067|64615572|FG007|Overall Study|Withdrawal by Subject|1|||
23238360|NCT02030067|64615573|FG008|Overall Study|Withdrawal by Subject|0|||
23238361|NCT02030067|64615574|FG009|Overall Study|Withdrawal by Subject|0|||
23238362|NCT02030067|64615575|FG010|Overall Study|Withdrawal by Subject|3|||
23238363|NCT02030067|64615576|FG011|Overall Study|Withdrawal by Subject|0|||
23238364|NCT02030067|64615577|FG012|Overall Study|Withdrawal by Subject|6|||
23344723|NCT03104400|65003952|FG002|Overall Study|Withdrawal by Subject|29|||
23344724|NCT03104400|65003953|FG003|Overall Study|Withdrawal by Subject|25|||
23344725|NCT03104400|65003954|FG004|Overall Study|Withdrawal by Subject|24|||
23344726|NCT03104400|65003950|FG000|Overall Study|Lost to Follow-up|4|||
23344727|NCT03104400|65003951|FG001|Overall Study|Lost to Follow-up|1|||
23344728|NCT03104400|65003952|FG002|Overall Study|Lost to Follow-up|4|||
23238365|NCT02030067|64615565|FG000|Overall Study|Physician Decision|0|||
23238366|NCT02030067|64615566|FG001|Overall Study|Physician Decision|0|||
23238367|NCT02030067|64615567|FG002|Overall Study|Physician Decision|0|||
23238368|NCT02030067|64615568|FG003|Overall Study|Physician Decision|0|||
23238369|NCT02030067|64615569|FG004|Overall Study|Physician Decision|0|||
23238370|NCT02030067|64615570|FG005|Overall Study|Physician Decision|0|||
23238371|NCT02030067|64615571|FG006|Overall Study|Physician Decision|0|||
23238372|NCT02030067|64615572|FG007|Overall Study|Physician Decision|0|||
23238373|NCT02030067|64615573|FG008|Overall Study|Physician Decision|0|||
23238374|NCT02030067|64615574|FG009|Overall Study|Physician Decision|0|||
23238375|NCT02030067|64615575|FG010|Overall Study|Physician Decision|1|||
23238376|NCT02030067|64615576|FG011|Overall Study|Physician Decision|0|||
23238377|NCT02030067|64615577|FG012|Overall Study|Physician Decision|3|||
23238378|NCT02030067|64615565|FG000|Overall Study|other reasons|0|||
23238379|NCT02030067|64615566|FG001|Overall Study|other reasons|0|||
23238380|NCT02030067|64615567|FG002|Overall Study|other reasons|0|||
23238381|NCT02030067|64615568|FG003|Overall Study|other reasons|0|||
23238382|NCT02030067|64615569|FG004|Overall Study|other reasons|0|||
23238383|NCT02030067|64615570|FG005|Overall Study|other reasons|1|||
23238384|NCT02030067|64615571|FG006|Overall Study|other reasons|0|||
23238385|NCT02030067|64615572|FG007|Overall Study|other reasons|0|||
23238386|NCT02030067|64615573|FG008|Overall Study|other reasons|2|||
23238387|NCT02030067|64615574|FG009|Overall Study|other reasons|0|||
23238388|NCT02030067|64615575|FG010|Overall Study|other reasons|0|||
23238389|NCT02030067|64615576|FG011|Overall Study|other reasons|0|||
23238390|NCT02030067|64615577|FG012|Overall Study|other reasons|4|||
23238391|NCT02030067|64615565|FG000|Overall Study|Adverse Event|0|||
23238392|NCT02030067|64615566|FG001|Overall Study|Adverse Event|0|||
23238393|NCT02030067|64615567|FG002|Overall Study|Adverse Event|0|||
23238394|NCT02030067|64615568|FG003|Overall Study|Adverse Event|0|||
23238395|NCT02030067|64615569|FG004|Overall Study|Adverse Event|0|||
23238396|NCT02030067|64615570|FG005|Overall Study|Adverse Event|0|||
23344729|NCT03104400|65003953|FG003|Overall Study|Lost to Follow-up|8|||
23344730|NCT03104400|65003954|FG004|Overall Study|Lost to Follow-up|7|||
23344731|NCT03104400|65003950|FG000|Overall Study|Lack of Efficacy|6|||
23344732|NCT03104400|65003951|FG001|Overall Study|Lack of Efficacy|3|||
23344733|NCT03104400|65003952|FG002|Overall Study|Lack of Efficacy|8|||
23344734|NCT03104400|65003953|FG003|Overall Study|Lack of Efficacy|2|||
23178480|NCT01097629|64394052|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
23178481|NCT01097629|64394053|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
23178482|NCT01097629|64394054|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23178483|NCT01097629|64394055|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23178484|NCT01097629|64394056|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23178485|NCT01097629|64394057|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23344735|NCT03104400|65003954|FG004|Overall Study|Lack of Efficacy|1|||
23344736|NCT03104400|65003950|FG000|Overall Study|COVID Logistical Restrictions|0|||
23344737|NCT03104400|65003951|FG001|Overall Study|COVID Logistical Restrictions|0|||
23344738|NCT03104400|65003952|FG002|Overall Study|COVID Logistical Restrictions|0|||
23344739|NCT03104400|65003953|FG003|Overall Study|COVID Logistical Restrictions|1|||
23344740|NCT03104400|65003954|FG004|Overall Study|COVID Logistical Restrictions|0|||
23178486|NCT01097629|64394058|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23178487|NCT01097629|64394051|FG000|DB RO Phase|Withdrawal by Subject|0|||
23178488|NCT01097629|64394052|FG001|DB RO Phase|Withdrawal by Subject|0|||
23178489|NCT01097629|64394053|FG002|DB RO Phase|Withdrawal by Subject|0|||
23178490|NCT01097629|64394054|FG003|DB RO Phase|Withdrawal by Subject|0|||
23178491|NCT01097629|64394055|FG004|DB RO Phase|Withdrawal by Subject|0|||
23178492|NCT01097629|64394056|FG005|DB RO Phase|Withdrawal by Subject|0|||
23178493|NCT01097629|64394057|FG006|DB RO Phase|Withdrawal by Subject|0|||
23178494|NCT01097629|64394058|FG007|DB RO Phase|Withdrawal by Subject|1|||
23178495|NCT01097629|64394051|FG000|DB RO Phase|Protocol Violation|0|||
23344741|NCT03104400|65003950|FG000|Overall Study|Other|2|||
23344742|NCT03104400|65003951|FG001|Overall Study|Other|3|||
23344743|NCT03104400|65003952|FG002|Overall Study|Other|7|||
23344744|NCT03104400|65003953|FG003|Overall Study|Other|6|||
23344745|NCT03104400|65003954|FG004|Overall Study|Other|4|||
23344746|NCT03104400|65003950|FG000|Overall Study|Other|0|||
23344747|NCT03104400|65003951|FG001|Overall Study|Other|1|||
23344748|NCT03104400|65003952|FG002|Overall Study|Other|0|||
23178496|NCT01097629|64394052|FG001|DB RO Phase|Protocol Violation|0|||
23238397|NCT02030067|64615571|FG006|Overall Study|Adverse Event|0|||
23238398|NCT02030067|64615572|FG007|Overall Study|Adverse Event|0|||
23238399|NCT02030067|64615573|FG008|Overall Study|Adverse Event|0|||
23238400|NCT02030067|64615574|FG009|Overall Study|Adverse Event|0|||
23238401|NCT02030067|64615575|FG010|Overall Study|Adverse Event|0|||
23238402|NCT02030067|64615576|FG011|Overall Study|Adverse Event|1|||
23238403|NCT02030067|64615577|FG012|Overall Study|Adverse Event|8|||
23238404|NCT01874288|64615581|FG000|Overall Study|Withdrawal by Subject|1|||
23238405|NCT01874288|64615582|FG001|Overall Study|Withdrawal by Subject|0|||
23344749|NCT03104400|65003953|FG003|Overall Study|Other|0|||
23178497|NCT01097629|64394053|FG002|DB RO Phase|Protocol Violation|0|||
23178498|NCT01097629|64394054|FG003|DB RO Phase|Protocol Violation|1|||
23178499|NCT01097629|64394055|FG004|DB RO Phase|Protocol Violation|0|||
23178500|NCT01097629|64394056|FG005|DB RO Phase|Protocol Violation|1|||
23178501|NCT01097629|64394057|FG006|DB RO Phase|Protocol Violation|1|||
23178502|NCT01097629|64394058|FG007|DB RO Phase|Protocol Violation|0|||
23178503|NCT01097629|64394051|FG000|DB RO Phase|Lost to Follow-up|0|||
23178504|NCT01097629|64394052|FG001|DB RO Phase|Lost to Follow-up|0|||
23178505|NCT01097629|64394053|FG002|DB RO Phase|Lost to Follow-up|0|||
23178506|NCT01097629|64394054|FG003|DB RO Phase|Lost to Follow-up|0|||
23178507|NCT01097629|64394055|FG004|DB RO Phase|Lost to Follow-up|0|||
23178508|NCT01097629|64394056|FG005|DB RO Phase|Lost to Follow-up|0|||
23344750|NCT03104400|65003954|FG004|Overall Study|Other|0|||
23344751|NCT03535740|65003955|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
23344752|NCT03535740|65003955|FG000|Overall Study|Death|34|||
23344753|NCT03535740|65003955|FG000|Overall Study|Lost to Follow-up|1|||
23344754|NCT03535740|65003955|FG000|Overall Study|Withdrawal by Subject|13|||
23344755|NCT02954653|65003956|FG000|Overall Study|Death|3|||
23344756|NCT02954653|65003957|FG001|Overall Study|Death|1|||
23344757|NCT02954653|65003958|FG002|Overall Study|Death|0|||
23344758|NCT02954653|65003959|FG003|Overall Study|Death|0|||
23344759|NCT02954653|65003960|FG004|Overall Study|Death|0|||
23344760|NCT02954653|65003961|FG005|Overall Study|Death|0|||
23344761|NCT02954653|65003962|FG006|Overall Study|Death|0|||
23344762|NCT02954653|65003963|FG007|Overall Study|Death|0|||
23344763|NCT02954653|65003964|FG008|Overall Study|Death|0|||
23344764|NCT02954653|65003956|FG000|Overall Study|Randomized but did not receive treatment|1|||
23344765|NCT02954653|65003957|FG001|Overall Study|Randomized but did not receive treatment|0|||
23344766|NCT02954653|65003958|FG002|Overall Study|Randomized but did not receive treatment|0|||
23344767|NCT02954653|65003959|FG003|Overall Study|Randomized but did not receive treatment|0|||
23344768|NCT02954653|65003960|FG004|Overall Study|Randomized but did not receive treatment|0|||
23178509|NCT01097629|64394057|FG006|DB RO Phase|Lost to Follow-up|2|||
23178510|NCT01097629|64394058|FG007|DB RO Phase|Lost to Follow-up|0|||
23238406|NCT01874288|64615583|FG002|Overall Study|Withdrawal by Subject|2|||
23238407|NCT01874288|64615584|FG003|Overall Study|Withdrawal by Subject|1|||
23238408|NCT01874288|64615585|FG004|Overall Study|Withdrawal by Subject|1|||
23238409|NCT01874288|64615581|FG000|Overall Study|Physician Decision|0|||
23238410|NCT01874288|64615582|FG001|Overall Study|Physician Decision|0|||
23238411|NCT01874288|64615583|FG002|Overall Study|Physician Decision|0|||
23238412|NCT01874288|64615584|FG003|Overall Study|Physician Decision|1|||
23238413|NCT01874288|64615585|FG004|Overall Study|Physician Decision|0|||
23238414|NCT01874288|64615581|FG000|Overall Study|Progressive disease|2|||
23238415|NCT01874288|64615582|FG001|Overall Study|Progressive disease|0|||
23238416|NCT01874288|64615583|FG002|Overall Study|Progressive disease|3|||
23238417|NCT01874288|64615584|FG003|Overall Study|Progressive disease|5|||
23238418|NCT01874288|64615585|FG004|Overall Study|Progressive disease|1|||
23238419|NCT01425268|64615588|FG000|Overall Study|Withdrawal by Subject|2|||
23238420|NCT01425268|64615589|FG001|Overall Study|Withdrawal by Subject|0|||
23238421|NCT01425268|64615588|FG000|Overall Study|Sponsor Decision|5|||
23238422|NCT01425268|64615589|FG001|Overall Study|Sponsor Decision|0|||
23238423|NCT01425268|64615588|FG000|Overall Study|Physician Decision|1|||
23238424|NCT01425268|64615589|FG001|Overall Study|Physician Decision|0|||
23238425|NCT03769753|64615590|FG000|Overall Study|Not Treated|6|||
23344769|NCT02954653|65003961|FG005|Overall Study|Randomized but did not receive treatment|0|||
23344770|NCT02954653|65003962|FG006|Overall Study|Randomized but did not receive treatment|0|||
23344771|NCT02954653|65003963|FG007|Overall Study|Randomized but did not receive treatment|0|||
23344772|NCT02954653|65003964|FG008|Overall Study|Randomized but did not receive treatment|0|||
23344773|NCT02954653|65003956|FG000|Overall Study|Started another anti-cancer therapy|0|||
23344774|NCT02954653|65003957|FG001|Overall Study|Started another anti-cancer therapy|1|||
23344775|NCT02954653|65003958|FG002|Overall Study|Started another anti-cancer therapy|0|||
23344776|NCT02954653|65003959|FG003|Overall Study|Started another anti-cancer therapy|0|||
23344777|NCT02954653|65003960|FG004|Overall Study|Started another anti-cancer therapy|0|||
23344778|NCT02954653|65003961|FG005|Overall Study|Started another anti-cancer therapy|0|||
23344779|NCT02954653|65003962|FG006|Overall Study|Started another anti-cancer therapy|0|||
23178511|NCT00655928|64394059|FG000|Overall Study|Withdrawal by Subject|2|||
23238426|NCT03769753|64615590|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
23238427|NCT02383966|64615591|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
23238428|NCT02383966|64615592|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
23238429|NCT02383966|64615591|FG000|Overall Study|Randomized, but not treated|1|||
23344780|NCT02954653|65003963|FG007|Overall Study|Started another anti-cancer therapy|0|||
23344781|NCT02954653|65003964|FG008|Overall Study|Started another anti-cancer therapy|0|||
23344782|NCT02954653|65003956|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
23344783|NCT02954653|65003957|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
23238430|NCT02383966|64615592|FG001|Overall Study|Randomized, but not treated|3|||
23238431|NCT00423137|64615595|FG000|Overall Study|Lost to Follow-up|0|||
23238432|NCT00423137|64615596|FG001|Overall Study|Lost to Follow-up|0|||
23238433|NCT00423137|64615597|FG002|Overall Study|Lost to Follow-up|1|||
23238434|NCT00423137|64615598|FG003|Overall Study|Lost to Follow-up|0|||
23344784|NCT02954653|65003958|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
23344785|NCT02954653|65003959|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
23344786|NCT02954653|65003960|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
23344787|NCT02954653|65003961|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
23238435|NCT00423137|64615595|FG000|Overall Study|Protocol Violation|0|||
23238436|NCT00423137|64615596|FG001|Overall Study|Protocol Violation|0|||
23238437|NCT00423137|64615597|FG002|Overall Study|Protocol Violation|0|||
23238438|NCT00423137|64615598|FG003|Overall Study|Protocol Violation|1|||
23238439|NCT00423137|64615595|FG000|Overall Study|Adverse Event Study disease worse|1|||
23238440|NCT00423137|64615596|FG001|Overall Study|Adverse Event Study disease worse|0|||
23238441|NCT00423137|64615597|FG002|Overall Study|Adverse Event Study disease worse|3|||
23238442|NCT00423137|64615598|FG003|Overall Study|Adverse Event Study disease worse|1|||
23238443|NCT00423137|64615595|FG000|Overall Study|Adverse Event Other|0|||
23344788|NCT02954653|65003962|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
23344789|NCT02954653|65003963|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
23344790|NCT02954653|65003964|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
23344791|NCT00976209|65003965|FG000|Treatment Period 1|Protocol Violation|1|||
23344792|NCT00976209|65003966|FG001|Treatment Period 1|Protocol Violation|0|||
23344793|NCT00976209|65003965|FG000|Treatment Period 1|Lost to Follow-up|2|||
23344794|NCT00976209|65003966|FG001|Treatment Period 1|Lost to Follow-up|0|||
23344795|NCT00976209|65003965|FG000|Treatment Period 1|Other|0|||
23344796|NCT00976209|65003966|FG001|Treatment Period 1|Other|1|||
23344797|NCT00976209|65003965|FG000|Wash-out Period|Adverse Event|1|||
23344798|NCT00976209|65003966|FG001|Wash-out Period|Adverse Event|2|||
23178512|NCT00655928|64394060|FG001|Overall Study|Withdrawal by Subject|1|||
23178513|NCT00655928|64394059|FG000|Overall Study|Physician Decision|1|||
23178514|NCT00655928|64394060|FG001|Overall Study|Physician Decision|1|||
23178515|NCT03038308|64394061|FG000|Overall Study|Surgical resection|1|||
23178516|NCT03038308|64394061|FG000|Overall Study|Withdrawal by Subject|2|||
23178517|NCT03038308|64394061|FG000|Overall Study|Lost to Follow-up|1|||
23178518|NCT00045032|64394062|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
23178519|NCT00045032|64394063|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
23238444|NCT00423137|64615596|FG001|Overall Study|Adverse Event Other|0|||
23238445|NCT00423137|64615597|FG002|Overall Study|Adverse Event Other|2|||
23238446|NCT00423137|64615598|FG003|Overall Study|Adverse Event Other|0|||
23238447|NCT02569996|64615599|FG000|Overall Study|Adverse Event|6|||
23238448|NCT02569996|64615599|FG000|Overall Study|Physician Decision|3|||
23238449|NCT02569996|64615599|FG000|Overall Study|Progression of the disease|18|||
23238450|NCT02569996|64615599|FG000|Overall Study|New anti-lymphoma treatment|1|||
23238451|NCT02569996|64615599|FG000|Overall Study|Non-compliance|9|||
23238452|NCT02569996|64615599|FG000|Overall Study|Withdrawal by Subject|5|||
23238453|NCT02569996|64615599|FG000|Overall Study|Lost to Follow-up|5|||
23238454|NCT02569996|64615599|FG000|Overall Study|Complete remission|7|||
23238455|NCT02569996|64615599|FG000|Overall Study|Unknown reason|1|||
23238456|NCT00135694|64615600|FG000|Overall Study|Adverse Event|17|||
23238457|NCT00135694|64615601|FG001|Overall Study|Adverse Event|4|||
23238458|NCT00135694|64615602|FG002|Overall Study|Adverse Event|0|||
23238459|NCT00135694|64615600|FG000|Overall Study|Death|14|||
23238460|NCT00135694|64615601|FG001|Overall Study|Death|1|||
23238461|NCT00135694|64615602|FG002|Overall Study|Death|2|||
23238462|NCT00135694|64615600|FG000|Overall Study|Lost to Follow-up|8|||
23238463|NCT00135694|64615601|FG001|Overall Study|Lost to Follow-up|7|||
23238464|NCT00135694|64615602|FG002|Overall Study|Lost to Follow-up|1|||
23238465|NCT00135694|64615600|FG000|Overall Study|Withdrawal by Subject|41|||
23178520|NCT00045032|64394064|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
23238466|NCT00135694|64615601|FG001|Overall Study|Withdrawal by Subject|7|||
23238467|NCT00135694|64615602|FG002|Overall Study|Withdrawal by Subject|4|||
23344799|NCT00976209|65003965|FG000|Wash-out Period|Lost to Follow-up|1|||
23344800|NCT00976209|65003966|FG001|Wash-out Period|Lost to Follow-up|0|||
23238468|NCT00135694|64615600|FG000|Overall Study|Protocol Violation|19|||
23238469|NCT00135694|64615601|FG001|Overall Study|Protocol Violation|1|||
23238470|NCT00135694|64615602|FG002|Overall Study|Protocol Violation|0|||
23238471|NCT00135694|64615600|FG000|Overall Study|Hepatitis C related reasons|39|||
23238472|NCT00135694|64615601|FG001|Overall Study|Hepatitis C related reasons|1|||
23238473|NCT00135694|64615602|FG002|Overall Study|Hepatitis C related reasons|0|||
23238474|NCT00135694|64615600|FG000|Overall Study|Ineligible for Random assignment|42|||
23238475|NCT00135694|64615601|FG001|Overall Study|Ineligible for Random assignment|0|||
23456191|NCT04247347|65412936|FG002|Overall Study|Lost to Follow-up|1|||
23456192|NCT00079417|65412938|FG000|Overall Study|Physician Decision|2|||
23456193|NCT00079417|65412938|FG000|Overall Study|Ineligible|7|||
23456194|NCT02723773|65412939|FG000|Overall Study|Adverse Event|934|||
23456195|NCT02723773|65412940|FG001|Overall Study|Adverse Event|3|||
23456196|NCT02723773|65412941|FG002|Overall Study|Adverse Event|1|||
23456197|NCT02723773|65412942|FG003|Overall Study|Adverse Event|9|||
23456198|NCT02723773|65412939|FG000|Overall Study|Protocol Violation|1|||
23456199|NCT02723773|65412940|FG001|Overall Study|Protocol Violation|0|||
23456200|NCT02723773|65412941|FG002|Overall Study|Protocol Violation|0|||
23456201|NCT02723773|65412942|FG003|Overall Study|Protocol Violation|0|||
23456202|NCT02723773|65412939|FG000|Overall Study|Withdrawal by Subject|360|||
23456203|NCT02723773|65412940|FG001|Overall Study|Withdrawal by Subject|5|||
23456204|NCT02723773|65412941|FG002|Overall Study|Withdrawal by Subject|6|||
23456205|NCT02723773|65412942|FG003|Overall Study|Withdrawal by Subject|10|||
23456206|NCT02723773|65412939|FG000|Overall Study|Migrated/moved from study area|37|||
23456207|NCT02723773|65412940|FG001|Overall Study|Migrated/moved from study area|0|||
23456208|NCT02723773|65412941|FG002|Overall Study|Migrated/moved from study area|0|||
23456209|NCT02723773|65412942|FG003|Overall Study|Migrated/moved from study area|1|||
23456210|NCT02723773|65412939|FG000|Overall Study|Lost to Follow-up|198|||
23456211|NCT02723773|65412940|FG001|Overall Study|Lost to Follow-up|0|||
23456212|NCT02723773|65412941|FG002|Overall Study|Lost to Follow-up|0|||
23456213|NCT02723773|65412942|FG003|Overall Study|Lost to Follow-up|0|||
23456214|NCT02723773|65412939|FG000|Overall Study|Other|189|||
23456215|NCT02723773|65412940|FG001|Overall Study|Other|1|||
23456216|NCT02723773|65412941|FG002|Overall Study|Other|2|||
23456217|NCT02723773|65412942|FG003|Overall Study|Other|2|||
23456218|NCT01746368|65412943|FG000|Overall Study|Lost to Follow-up|2|||
23456219|NCT01746368|65412944|FG001|Overall Study|Lost to Follow-up|0|||
23456220|NCT01746368|65412943|FG000|Overall Study|Withdrawal by Subject|0|||
23456221|NCT01746368|65412944|FG001|Overall Study|Withdrawal by Subject|1|||
23456222|NCT03182374|65412945|FG000|Overall Study|Lost to Follow-up|3|||
23456223|NCT03182374|65412946|FG001|Overall Study|Lost to Follow-up|2|||
23456224|NCT03182374|65412945|FG000|Overall Study|Lack of Efficacy|8|||
23456225|NCT03182374|65412946|FG001|Overall Study|Lack of Efficacy|14|||
23456226|NCT03182374|65412945|FG000|Overall Study|Withdrawal by Subject|1|||
23456227|NCT03182374|65412946|FG001|Overall Study|Withdrawal by Subject|1|||
23456228|NCT03182374|65412945|FG000|Overall Study|exit for non-compliance|1|||
23456229|NCT03182374|65412946|FG001|Overall Study|exit for non-compliance|1|||
23456230|NCT03182374|65412945|FG000|Overall Study|one subject was randomized but not treated|1|||
23456231|NCT03182374|65412946|FG001|Overall Study|one subject was randomized but not treated|0|||
23456232|NCT03182374|65412945|FG000|Overall Study|Other reasons|0|||
23456233|NCT03182374|65412946|FG001|Overall Study|Other reasons|3|||
23456234|NCT04388111|65412947|FG000|Overall Study|Lost to Follow-up|5|||
23456235|NCT04388111|65412948|FG001|Overall Study|Lost to Follow-up|3|||
23456236|NCT04388111|65412947|FG000|Overall Study|Adverse Event|1|||
23456237|NCT04388111|65412948|FG001|Overall Study|Adverse Event|1|||
23456238|NCT04388111|65412947|FG000|Overall Study|Protocol Violation|2|||
23456239|NCT04388111|65412948|FG001|Overall Study|Protocol Violation|4|||
23178521|NCT00045032|64394062|FG000|Overall Study|Death|22|||
23178522|NCT00045032|64394063|FG001|Overall Study|Death|24|||
23178523|NCT00045032|64394064|FG002|Overall Study|Death|17|||
23178524|NCT00045032|64394062|FG000|Overall Study|Insufficient Therapeutic Response|542|||
23178525|NCT00045032|64394063|FG001|Overall Study|Insufficient Therapeutic Response|437|||
23178526|NCT00045032|64394064|FG002|Overall Study|Insufficient Therapeutic Response|445|||
23178527|NCT00045032|64394062|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
23456240|NCT04388111|65412947|FG000|Overall Study|Withdrawal by Subject|1|||
23456241|NCT04388111|65412948|FG001|Overall Study|Withdrawal by Subject|0|||
23456242|NCT03661723|65412949|FG000|Overall Study|Disease Progression|4|||
23456243|NCT03661723|65412950|FG001|Overall Study|Disease Progression|24|||
23456244|NCT03661723|65412951|FG002|Overall Study|Disease Progression|4|||
23456245|NCT03661723|65412952|FG003|Overall Study|Disease Progression|19|||
23456246|NCT03661723|65412949|FG000|Overall Study|Withdrawal by Subject|1|||
23456247|NCT03661723|65412950|FG001|Overall Study|Withdrawal by Subject|0|||
23456248|NCT03661723|65412951|FG002|Overall Study|Withdrawal by Subject|2|||
23456249|NCT03661723|65412952|FG003|Overall Study|Withdrawal by Subject|4|||
23238476|NCT00135694|64615602|FG002|Overall Study|Ineligible for Random assignment|0|||
23238477|NCT01266967|64615603|FG000|Overall Study|Death|69|||
23238478|NCT01266967|64615604|FG001|Overall Study|Death|61|||
23238479|NCT01266967|64615603|FG000|Overall Study|Study Closed/Terminated|15|||
23238480|NCT01266967|64615604|FG001|Overall Study|Study Closed/Terminated|17|||
23238481|NCT01266967|64615603|FG000|Overall Study|Lost to Follow-up|2|||
23238482|NCT01266967|64615604|FG001|Overall Study|Lost to Follow-up|1|||
23344801|NCT00976209|65003965|FG000|Wash-out Period|Protocol Violation|1|||
23344802|NCT00976209|65003966|FG001|Wash-out Period|Protocol Violation|0|||
23344803|NCT00976209|65003965|FG000|Wash-out Period|Other|1|||
23344804|NCT00976209|65003966|FG001|Wash-out Period|Other|0|||
23344805|NCT00976209|65003965|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23344806|NCT00976209|65003966|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23344807|NCT00976209|65003965|FG000|Treatment Period 2|Lost to Follow-up|0|||
23344808|NCT00976209|65003966|FG001|Treatment Period 2|Lost to Follow-up|1|||
23344809|NCT03875092|65003968|FG000|Overall Study|Adverse Event|2|||
23344810|NCT03875092|65003969|FG001|Overall Study|Adverse Event|5|||
23344811|NCT03875092|65003968|FG000|Overall Study|Death|44|||
23344812|NCT03875092|65003969|FG001|Overall Study|Death|51|||
23344813|NCT03875092|65003968|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
23238483|NCT01266967|64615603|FG000|Overall Study|Physician Decision|0|||
23238484|NCT01266967|64615604|FG001|Overall Study|Physician Decision|1|||
23238485|NCT01266967|64615603|FG000|Overall Study|Withdrawal by Subject|3|||
23238486|NCT01266967|64615604|FG001|Overall Study|Withdrawal by Subject|3|||
23238487|NCT00934661|64615605|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
23238488|NCT00934661|64615606|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
23238489|NCT00727246|64615607|FG000|Overall Study|could not complete MRI|0|||
23238490|NCT00727246|64615608|FG001|Overall Study|could not complete MRI|1|||
23238491|NCT00727246|64615609|FG002|Overall Study|could not complete MRI|0|||
23238492|NCT00727246|64615610|FG003|Overall Study|could not complete MRI|1|||
23238493|NCT00727246|64615607|FG000|Overall Study|incidental finding|0|||
23238494|NCT00727246|64615608|FG001|Overall Study|incidental finding|0|||
23238495|NCT00727246|64615609|FG002|Overall Study|incidental finding|0|||
23238496|NCT00727246|64615610|FG003|Overall Study|incidental finding|1|||
23238497|NCT00727246|64615607|FG000|Overall Study|withdrawn|0|||
23238498|NCT00727246|64615608|FG001|Overall Study|withdrawn|0|||
23238499|NCT00727246|64615609|FG002|Overall Study|withdrawn|1|||
23238500|NCT00727246|64615610|FG003|Overall Study|withdrawn|0|||
23238501|NCT02441517|64615611|FG000|Overall Study|Lost to Follow-up|1|||
23238502|NCT02441517|64615611|FG000|Overall Study|Withdrawal by Subject|2|||
23238503|NCT02441517|64615611|FG000|Overall Study|Study Terminated by Sponsor|1|||
23238504|NCT03783026|64615612|FG000|Treatment Phase|Adverse Event|15|||
23238505|NCT03783026|64615612|FG000|Treatment Phase|Lack of Efficacy|11|||
23238506|NCT03783026|64615612|FG000|Treatment Phase|Withdrawal by Subject|6|||
23238507|NCT03783026|64615612|FG000|Treatment Phase|Lost to Follow-up|2|||
23238508|NCT03783026|64615612|FG000|Treatment Phase|Protocol Deviation|8|||
23238509|NCT03783026|64615612|FG000|Treatment Phase|Did Not Receive Treatment|1|||
23238510|NCT03783026|64615612|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
23238511|NCT00596466|64615613|FG000|Overall Study|Lack of Efficacy|5|||
23238512|NCT00596466|64615613|FG000|Overall Study|Adverse Event|4|||
23238513|NCT00596466|64615613|FG000|Overall Study|Withdrawal by Subject|2|||
23238514|NCT00596466|64615613|FG000|Overall Study|Protocol Violation|2|||
23238515|NCT00596466|64615613|FG000|Overall Study|Unpecified|2|||
23238516|NCT00596466|64615613|FG000|Overall Study|Enrolled, not treated|2|||
23238517|NCT00689611|64615614|FG000|Overall Study|Death|6|||
23238518|NCT00689611|64615615|FG001|Overall Study|Death|9|||
23238519|NCT00689611|64615614|FG000|Overall Study|Withdrawal by Subject|8|||
23238520|NCT00689611|64615615|FG001|Overall Study|Withdrawal by Subject|9|||
23238521|NCT00689611|64615614|FG000|Overall Study|Lost to Follow-up|27|||
23344814|NCT03875092|65003969|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
23344815|NCT01077739|65003973|FG000|Overall Study|Premature withdrawal|1|||
23344816|NCT01077739|65003974|FG001|Overall Study|Premature withdrawal|3|||
23456250|NCT03661723|65412949|FG000|Overall Study|Physician Decision|1|||
23456251|NCT03661723|65412950|FG001|Overall Study|Physician Decision|0|||
23238522|NCT00689611|64615615|FG001|Overall Study|Lost to Follow-up|28|||
23238523|NCT01258738|64615616|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
23238524|NCT01258738|64615617|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
23238525|NCT01258738|64615616|FG000|Double-blind Period|Withdrawal by Subject|2|||
23238526|NCT01258738|64615617|FG001|Double-blind Period|Withdrawal by Subject|2|||
23344817|NCT01077739|65003973|FG000|Overall Study|Withdrawal by Subject|1|||
23344818|NCT01077739|65003974|FG001|Overall Study|Withdrawal by Subject|0|||
23238527|NCT01258738|64615616|FG000|Double-blind Period|Protocol Violation|1|||
23238528|NCT01258738|64615617|FG001|Double-blind Period|Protocol Violation|1|||
23238529|NCT01258738|64615616|FG000|Double-blind Period|Adverse Event|3|||
23238530|NCT01258738|64615617|FG001|Double-blind Period|Adverse Event|1|||
23238531|NCT01258738|64615616|FG000|Open-label Period|Did not meet inclusion criteria|0|||
23238532|NCT01258738|64615617|FG001|Open-label Period|Did not meet inclusion criteria|1|||
23344819|NCT01077739|65003973|FG000|Overall Study|Death|0|||
23456252|NCT03661723|65412951|FG002|Overall Study|Physician Decision|0|||
23456253|NCT03661723|65412952|FG003|Overall Study|Physician Decision|0|||
23456254|NCT03661723|65412949|FG000|Overall Study|Clinical Deterioration|0|||
23456255|NCT03661723|65412950|FG001|Overall Study|Clinical Deterioration|0|||
23456256|NCT03661723|65412951|FG002|Overall Study|Clinical Deterioration|0|||
23456257|NCT03661723|65412952|FG003|Overall Study|Clinical Deterioration|1|||
23456258|NCT03744312|65412955|FG000|Overall Study|Withdrawal by Subject|0|||
23456259|NCT03744312|65412956|FG001|Overall Study|Withdrawal by Subject|1|||
23456260|NCT03744312|65412955|FG000|Overall Study|Screen fail|0|||
23456261|NCT03744312|65412956|FG001|Overall Study|Screen fail|1|||
23456262|NCT02087423|65412962|FG000|Overall Study|Withdrawal by Subject|20|||
23456263|NCT02087423|65412963|FG001|Overall Study|Withdrawal by Subject|20|||
23456264|NCT02087423|65412964|FG002|Overall Study|Withdrawal by Subject|3|||
23456265|NCT02087423|65412962|FG000|Overall Study|Death|68|||
23456266|NCT02087423|65412963|FG001|Overall Study|Death|207|||
23456267|NCT02087423|65412964|FG002|Overall Study|Death|40|||
23456268|NCT02087423|65412962|FG000|Overall Study|Lost to Follow-up|0|||
23456269|NCT02087423|65412963|FG001|Overall Study|Lost to Follow-up|2|||
23456270|NCT02087423|65412964|FG002|Overall Study|Lost to Follow-up|0|||
23456271|NCT02087423|65412962|FG000|Overall Study|Terminated from study at final DCO|23|||
23456272|NCT02087423|65412963|FG001|Overall Study|Terminated from study at final DCO|36|||
23456273|NCT02087423|65412964|FG002|Overall Study|Terminated from study at final DCO|25|||
23456274|NCT02891174|65412969|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
23456275|NCT02891174|65412970|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
23456276|NCT02891174|65412969|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
23456277|NCT02891174|65412970|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
23456278|NCT02891174|65412969|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
23456279|NCT02891174|65412970|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
23456280|NCT02891174|65412969|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
23456281|NCT02891174|65412970|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
23456282|NCT02891174|65412969|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
23178528|NCT00045032|64394063|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
23456283|NCT02891174|65412970|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
23456284|NCT02891174|65412969|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
23456285|NCT02891174|65412970|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
23456286|NCT02891174|65412969|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
23456287|NCT02891174|65412970|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
23456288|NCT00141453|65412971|FG000|Overall Study|Protocol Violation|6|||
23456289|NCT00141453|65412972|FG001|Overall Study|Protocol Violation|5|||
23456290|NCT02336282|65412973|FG000|Overall Study|Unrelated illness|1|||
23456291|NCT02336282|65412973|FG000|Overall Study|Uncomfortable with technology|1|||
23456292|NCT02336282|65412973|FG000|Overall Study|Lost to Follow-up|1|||
23456293|NCT02336282|65412973|FG000|Overall Study|Not enough time to complete sessions|2|||
23456294|NCT01251965|65412977|FG000|Overall Study|Participant/physician decision|1|||
23456295|NCT01251965|65412978|FG001|Overall Study|Participant/physician decision|2|||
23456296|NCT01251965|65412979|FG002|Overall Study|Participant/physician decision|0|||
23456297|NCT01251965|65412977|FG000|Overall Study|Death|0|||
23456298|NCT01251965|65412978|FG001|Overall Study|Death|0|||
23456299|NCT01251965|65412979|FG002|Overall Study|Death|11|||
23456300|NCT01169103|65412980|FG000|Overall Study|Lost to Follow-up|3|||
23456301|NCT01169103|65412981|FG001|Overall Study|Lost to Follow-up|3|||
23456302|NCT01169103|65412980|FG000|Overall Study|Withdrawal by Subject|3|||
23456303|NCT01169103|65412981|FG001|Overall Study|Withdrawal by Subject|1|||
23456304|NCT02016781|65412982|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
23456305|NCT02016781|65412983|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
23456306|NCT02016781|65412982|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
23456307|NCT02016781|65412983|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
23456308|NCT02016781|65412982|FG000|Final Database Lock|Withdrawal by Subject|2|||
23456309|NCT02016781|65412983|FG001|Final Database Lock|Withdrawal by Subject|1|||
23456310|NCT02016781|65412982|FG000|Final Database Lock|Lost to Follow-up|11|||
23456311|NCT02016781|65412983|FG001|Final Database Lock|Lost to Follow-up|4|||
23456312|NCT02016781|65412982|FG000|Final Database Lock|Missing data|0|||
23456313|NCT02016781|65412983|FG001|Final Database Lock|Missing data|3|||
23456314|NCT02183675|65416371|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
23456315|NCT02183675|65416372|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
23456316|NCT02183675|65416373|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
23456317|NCT02183675|65416374|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
23456318|NCT02183675|65416375|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
23178529|NCT00045032|64394064|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
23178530|NCT00045032|64394062|FG000|Overall Study|Other Protocol Violation|2|||
23456319|NCT02183675|65416376|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
23456320|NCT03486912|65416377|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
23456321|NCT03486912|65416378|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
23456322|NCT03486912|65416379|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
23456323|NCT03486912|65416380|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
23456324|NCT03486912|65416377|FG000|Treatment Period|Withdrawal by Subject|3|||
23456325|NCT03486912|65416378|FG001|Treatment Period|Withdrawal by Subject|3|||
23456326|NCT03486912|65416379|FG002|Treatment Period|Withdrawal by Subject|3|||
23456327|NCT03486912|65416380|FG003|Treatment Period|Withdrawal by Subject|2|||
23456328|NCT03486912|65416377|FG000|Treatment Period|Other Reasons|0|||
23456329|NCT03486912|65416378|FG001|Treatment Period|Other Reasons|2|||
23456330|NCT03486912|65416379|FG002|Treatment Period|Other Reasons|1|||
23456331|NCT03486912|65416380|FG003|Treatment Period|Other Reasons|1|||
23456332|NCT03486912|65416377|FG000|Treatment Period|Adverse Event|0|||
23456333|NCT03486912|65416378|FG001|Treatment Period|Adverse Event|1|||
23456334|NCT03486912|65416379|FG002|Treatment Period|Adverse Event|1|||
23456335|NCT03486912|65416380|FG003|Treatment Period|Adverse Event|0|||
23456336|NCT03486912|65416377|FG000|Treatment Period|Lost to Follow-up|1|||
23456337|NCT03486912|65416378|FG001|Treatment Period|Lost to Follow-up|0|||
23456338|NCT03486912|65416379|FG002|Treatment Period|Lost to Follow-up|0|||
23456339|NCT03486912|65416380|FG003|Treatment Period|Lost to Follow-up|2|||
23456340|NCT03227757|65416381|FG000|Overall Study|Death|7|||
23456341|NCT03227757|65416381|FG000|Overall Study|Withdrawal|5|||
23456342|NCT03227757|65416381|FG000|Overall Study|Missed visits|4|||
23456343|NCT00784563|65416382|FG000|Years 1 & 2|Withdrawal by Subject|3|||
23456344|NCT00784563|65416383|FG001|Years 1 & 2|Withdrawal by Subject|2|||
23456345|NCT00784563|65416384|FG002|Years 1 & 2|Withdrawal by Subject|0|||
23178531|NCT00045032|64394063|FG001|Overall Study|Other Protocol Violation|0|||
23178532|NCT00045032|64394064|FG002|Overall Study|Other Protocol Violation|1|||
23178533|NCT00045032|64394062|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
23178534|NCT00045032|64394063|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
23178535|NCT00045032|64394064|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
23178536|NCT00045032|64394062|FG000|Overall Study|Failure to Return|57|||
23178537|NCT00045032|64394063|FG001|Overall Study|Failure to Return|62|||
23178538|NCT00045032|64394064|FG002|Overall Study|Failure to Return|61|||
23178539|NCT00045032|64394062|FG000|Overall Study|Other|93|||
23178540|NCT00045032|64394063|FG001|Overall Study|Other|84|||
23178541|NCT00045032|64394064|FG002|Overall Study|Other|105|||
23178542|NCT04373460|64394066|FG000|Overall Study|Did not receive tranfusion|18|||
23178543|NCT04373460|64394067|FG001|Overall Study|Did not receive tranfusion|26|||
23178544|NCT01468987|64394068|FG000|Overall Study|Adverse Event|12|||
23178545|NCT01468987|64394069|FG001|Overall Study|Adverse Event|9|||
23178546|NCT01468987|64394068|FG000|Overall Study|Death|4|||
23178547|NCT01468987|64394069|FG001|Overall Study|Death|1|||
23178548|NCT01468987|64394068|FG000|Overall Study|Lost to Follow-up|10|||
23178549|NCT01468987|64394069|FG001|Overall Study|Lost to Follow-up|5|||
23178550|NCT01468987|64394068|FG000|Overall Study|Protocol Violation|8|||
23178551|NCT01468987|64394069|FG001|Overall Study|Protocol Violation|2|||
23178552|NCT01468987|64394068|FG000|Overall Study|Withdrawal by Subject|28|||
23178553|NCT01468987|64394069|FG001|Overall Study|Withdrawal by Subject|28|||
23178554|NCT01468987|64394068|FG000|Overall Study|Physician Decision|8|||
23178555|NCT01468987|64394069|FG001|Overall Study|Physician Decision|15|||
23178556|NCT01468987|64394068|FG000|Overall Study|Sponsor Decision|1|||
23178557|NCT01468987|64394069|FG001|Overall Study|Sponsor Decision|0|||
23178558|NCT01703000|64394082|FG000|Overall Study|Death|1|||
23178559|NCT02629159|64394083|FG000|Overall Study|Adverse Event|17|||
23178560|NCT02629159|64394084|FG001|Overall Study|Adverse Event|20|||
23178561|NCT02629159|64394085|FG002|Overall Study|Adverse Event|22|||
23178562|NCT02629159|64394083|FG000|Overall Study|Withdrawal by Subject|22|||
23178563|NCT02629159|64394084|FG001|Overall Study|Withdrawal by Subject|11|||
23178564|NCT02629159|64394085|FG002|Overall Study|Withdrawal by Subject|15|||
23178565|NCT02629159|64394083|FG000|Overall Study|Lost to Follow-up|7|||
23178566|NCT02629159|64394084|FG001|Overall Study|Lost to Follow-up|4|||
23178567|NCT02629159|64394085|FG002|Overall Study|Lost to Follow-up|5|||
23178568|NCT02629159|64394083|FG000|Overall Study|Lack of Efficacy|4|||
23178569|NCT02629159|64394084|FG001|Overall Study|Lack of Efficacy|0|||
23178570|NCT02629159|64394085|FG002|Overall Study|Lack of Efficacy|1|||
23178571|NCT02629159|64394083|FG000|Overall Study|Other|6|||
23456346|NCT00784563|65416382|FG000|Years 1 & 2|Adverse Event|0|||
23456347|NCT00784563|65416383|FG001|Years 1 & 2|Adverse Event|3|||
23456348|NCT00784563|65416384|FG002|Years 1 & 2|Adverse Event|0|||
23456349|NCT00784563|65416382|FG000|Year 3|Withdrawal by Subject|0|||
23178572|NCT02629159|64394084|FG001|Overall Study|Other|4|||
23178573|NCT02629159|64394085|FG002|Overall Study|Other|8|||
23178574|NCT01126580|64394086|FG000|Overall Study|Adverse Event|14|||
23456350|NCT00784563|65416383|FG001|Year 3|Withdrawal by Subject|0|||
23456351|NCT00784563|65416384|FG002|Year 3|Withdrawal by Subject|2|||
23456352|NCT00784563|65416382|FG000|Year 3|Adverse Event|0|||
23456353|NCT00784563|65416383|FG001|Year 3|Adverse Event|0|||
23178575|NCT01126580|64394087|FG001|Overall Study|Adverse Event|8|||
23178576|NCT01126580|64394088|FG002|Overall Study|Adverse Event|12|||
23178577|NCT01126580|64394086|FG000|Overall Study|Withdrawal by Subject|11|||
23178578|NCT01126580|64394087|FG001|Overall Study|Withdrawal by Subject|19|||
23178579|NCT01126580|64394088|FG002|Overall Study|Withdrawal by Subject|14|||
23178580|NCT01126580|64394086|FG000|Overall Study|Sponsor Decision|5|||
23178581|NCT01126580|64394087|FG001|Overall Study|Sponsor Decision|4|||
23178582|NCT01126580|64394088|FG002|Overall Study|Sponsor Decision|7|||
23178583|NCT01126580|64394086|FG000|Overall Study|Physician Decision|1|||
23178584|NCT01126580|64394087|FG001|Overall Study|Physician Decision|1|||
23178585|NCT01126580|64394088|FG002|Overall Study|Physician Decision|2|||
23178586|NCT01126580|64394086|FG000|Overall Study|Entry Criteria Not Met|1|||
23178587|NCT01126580|64394087|FG001|Overall Study|Entry Criteria Not Met|1|||
23178588|NCT01126580|64394088|FG002|Overall Study|Entry Criteria Not Met|2|||
23178589|NCT01126580|64394086|FG000|Overall Study|Lack of Efficacy|2|||
23178590|NCT01126580|64394087|FG001|Overall Study|Lack of Efficacy|3|||
23178591|NCT01126580|64394088|FG002|Overall Study|Lack of Efficacy|4|||
23178592|NCT01126580|64394086|FG000|Overall Study|Protocol Violation|0|||
23178593|NCT01126580|64394087|FG001|Overall Study|Protocol Violation|1|||
23178594|NCT01126580|64394088|FG002|Overall Study|Protocol Violation|2|||
23178595|NCT01126580|64394086|FG000|Overall Study|Lost to Follow-up|15|||
23178596|NCT01126580|64394087|FG001|Overall Study|Lost to Follow-up|13|||
23178597|NCT01126580|64394088|FG002|Overall Study|Lost to Follow-up|9|||
23178598|NCT01126580|64394086|FG000|Overall Study|Treatment Non-compliance|0|||
23178599|NCT01126580|64394087|FG001|Overall Study|Treatment Non-compliance|2|||
23178600|NCT01126580|64394088|FG002|Overall Study|Treatment Non-compliance|3|||
23178601|NCT01307033|64394093|FG000|8-week Double-blind Period|Adverse Event|2|||
23178602|NCT01307033|64394094|FG001|8-week Double-blind Period|Adverse Event|0|||
23178603|NCT01307033|64394095|FG002|8-week Double-blind Period|Adverse Event|0|||
23178604|NCT01307033|64394096|FG003|8-week Double-blind Period|Adverse Event|0|||
23456354|NCT00784563|65416384|FG002|Year 3|Adverse Event|1|||
23456355|NCT03585660|65416385|FG000|Overall Study|operator error|1|||
23456356|NCT03585660|65416385|FG000|Overall Study|technical error|2|||
23456357|NCT03585660|65416385|FG000|Overall Study|hip prosthesis|2|||
23456358|NCT03585660|65416385|FG000|Overall Study|did not undergo biopsy|8|||
23456359|NCT03585660|65416385|FG000|Overall Study|scanner problem|2|||
23456360|NCT03391466|65416386|FG000|Overall Study|Death|82|||
23456361|NCT03391466|65416387|FG001|Overall Study|Death|85|||
23456362|NCT03391466|65416386|FG000|Overall Study|Still on study|93|||
23456363|NCT03391466|65416387|FG001|Overall Study|Still on study|74|||
23456364|NCT03391466|65416386|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
23456365|NCT03391466|65416387|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
23456366|NCT03391466|65416386|FG000|Overall Study|Lost to Follow-up|5|||
23456367|NCT03391466|65416387|FG001|Overall Study|Lost to Follow-up|5|||
23456368|NCT03391466|65416386|FG000|Overall Study|Investigator decision|0|||
23456369|NCT03391466|65416387|FG001|Overall Study|Investigator decision|1|||
23456370|NCT03391466|65416386|FG000|Overall Study|Other|0|||
23456371|NCT03391466|65416387|FG001|Overall Study|Other|1|||
23456372|NCT04179500|65416390|FG000|Treatment|Withdrawal by Subject|1|||
23456373|NCT04179500|65416390|FG000|Treatment|Adverse Event|2|||
23456374|NCT04179500|65416390|FG000|Treatment|pyrazinamide resistance|1|||
23456375|NCT00886379|65416391|FG000|Overall Study|Transferred Schools|0|||
23456376|NCT00886379|65416392|FG001|Overall Study|Transferred Schools|0|||
23456377|NCT00886379|65416393|FG002|Overall Study|Transferred Schools|2|||
23456378|NCT00886379|65416394|FG003|Overall Study|Transferred Schools|1|||
23456379|NCT00886379|65416395|FG004|Overall Study|Transferred Schools|1|||
23456380|NCT00886379|65416391|FG000|Overall Study|Final blood draw not obtained|3|||
23456381|NCT00886379|65416392|FG001|Overall Study|Final blood draw not obtained|3|||
23456382|NCT00886379|65416393|FG002|Overall Study|Final blood draw not obtained|4|||
23456383|NCT00886379|65416394|FG003|Overall Study|Final blood draw not obtained|2|||
23456384|NCT00886379|65416395|FG004|Overall Study|Final blood draw not obtained|2|||
23456385|NCT00870740|65416396|FG000|Overall Study|Adverse Event|2|||
23456386|NCT00870740|65416397|FG001|Overall Study|Adverse Event|1|||
23456387|NCT00870740|65416398|FG002|Overall Study|Adverse Event|3|||
23456388|NCT00870740|65416399|FG003|Overall Study|Adverse Event|2|||
23456389|NCT00870740|65416400|FG004|Overall Study|Adverse Event|1|||
23583402|NCT04886596|65866016|FG001|Overall Study|Migrated / Moved from the study area|14|||
23583403|NCT04886596|65866015|FG000|Overall Study|Unknown reason|16|||
23178605|NCT01307033|64394093|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
23456390|NCT00870740|65416401|FG005|Overall Study|Adverse Event|6|||
23456391|NCT00870740|65416396|FG000|Overall Study|Consent Withdrawn|6|||
23456392|NCT00870740|65416397|FG001|Overall Study|Consent Withdrawn|3|||
23456393|NCT00870740|65416398|FG002|Overall Study|Consent Withdrawn|4|||
23456394|NCT00870740|65416399|FG003|Overall Study|Consent Withdrawn|6|||
23178606|NCT01307033|64394094|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
23238533|NCT01258738|64615616|FG000|Open-label Period|Insufficient clinical response|5|||
23456395|NCT00870740|65416400|FG004|Overall Study|Consent Withdrawn|6|||
23456396|NCT00870740|65416401|FG005|Overall Study|Consent Withdrawn|5|||
23456397|NCT00870740|65416396|FG000|Overall Study|Investigator Decision|2|||
23456398|NCT00870740|65416397|FG001|Overall Study|Investigator Decision|0|||
23456399|NCT00870740|65416398|FG002|Overall Study|Investigator Decision|1|||
23456400|NCT00870740|65416399|FG003|Overall Study|Investigator Decision|0|||
23456401|NCT00870740|65416400|FG004|Overall Study|Investigator Decision|0|||
23456402|NCT00870740|65416401|FG005|Overall Study|Investigator Decision|0|||
23456403|NCT00870740|65416396|FG000|Overall Study|Subject Non-compliance|0|||
23456404|NCT00870740|65416397|FG001|Overall Study|Subject Non-compliance|0|||
23456405|NCT00870740|65416398|FG002|Overall Study|Subject Non-compliance|0|||
23178607|NCT01307033|64394095|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
23178608|NCT01307033|64394096|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
23178609|NCT01307033|64394093|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
23178610|NCT01307033|64394094|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
23178611|NCT01307033|64394095|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
23178612|NCT01307033|64394096|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
23178613|NCT01307033|64394093|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
23178614|NCT01307033|64394094|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
23178615|NCT01307033|64394095|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
23178616|NCT01307033|64394096|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
23178617|NCT01307033|64394093|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
23178618|NCT01307033|64394094|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
23178619|NCT01307033|64394095|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
23178620|NCT01307033|64394096|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
23178621|NCT01307033|64394093|FG000|44-week Open-label Extension|Adverse Event|0|||
23178622|NCT01307033|64394094|FG001|44-week Open-label Extension|Adverse Event|0|||
23238534|NCT01258738|64615617|FG001|Open-label Period|Insufficient clinical response|3|||
23238535|NCT01258738|64615616|FG000|Open-label Period|Lost to Follow-up|0|||
23344820|NCT01077739|65003974|FG001|Overall Study|Death|3|||
23344821|NCT01077739|65003973|FG000|Overall Study|Unacceptable toxicity|1|||
23344822|NCT01077739|65003974|FG001|Overall Study|Unacceptable toxicity|2|||
23344823|NCT01077739|65003973|FG000|Overall Study|Other|2|||
23344824|NCT01077739|65003974|FG001|Overall Study|Other|2|||
23344825|NCT02777970|65003977|FG000|Overall Study|Lost to Follow-up|0|||
23344826|NCT02777970|65003978|FG001|Overall Study|Lost to Follow-up|1|||
23344827|NCT02777970|65003979|FG002|Overall Study|Lost to Follow-up|0|||
23344828|NCT02777970|65003977|FG000|Overall Study|Protocol Violation|1|||
23344829|NCT02777970|65003978|FG001|Overall Study|Protocol Violation|0|||
23344830|NCT02777970|65003979|FG002|Overall Study|Protocol Violation|0|||
23344831|NCT03045276|65006636|FG000|Intervention Phase|Withdrawal by Subject|7|||
23344832|NCT03045276|65006637|FG001|Intervention Phase|Withdrawal by Subject|2|||
23344833|NCT03045276|65006638|FG002|Intervention Phase|Withdrawal by Subject|3|||
23344834|NCT03045276|65006639|FG003|Intervention Phase|Withdrawal by Subject|7|||
23344835|NCT03045276|65006636|FG000|Intervention Phase|Developed exclusionary criteria|3|||
23344836|NCT03045276|65006637|FG001|Intervention Phase|Developed exclusionary criteria|3|||
23344837|NCT03045276|65006638|FG002|Intervention Phase|Developed exclusionary criteria|0|||
23344838|NCT03045276|65006639|FG003|Intervention Phase|Developed exclusionary criteria|0|||
23344839|NCT03045276|65006636|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
23344840|NCT03045276|65006637|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
23344841|NCT03045276|65006638|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
23344842|NCT03045276|65006639|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
23344843|NCT03045276|65006636|FG000|Follow-Up Phase|Lost to Follow-up|0|||
23344844|NCT03045276|65006637|FG001|Follow-Up Phase|Lost to Follow-up|1|||
23344845|NCT03045276|65006638|FG002|Follow-Up Phase|Lost to Follow-up|0|||
23344846|NCT03045276|65006639|FG003|Follow-Up Phase|Lost to Follow-up|1|||
23344847|NCT03045276|65006636|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
23344848|NCT03045276|65006637|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
23344849|NCT03045276|65006638|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
23344850|NCT03045276|65006639|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
23344851|NCT00712881|65006643|FG000|Overall Study|Adverse Event|3|||
23344852|NCT00712881|65006644|FG001|Overall Study|Adverse Event|3|||
23456406|NCT00870740|65416399|FG003|Overall Study|Subject Non-compliance|0|||
23456407|NCT00870740|65416400|FG004|Overall Study|Subject Non-compliance|0|||
23456408|NCT00870740|65416401|FG005|Overall Study|Subject Non-compliance|1|||
23344853|NCT00712881|65006643|FG000|Overall Study|Withdrawal by Subject|1|||
23344854|NCT00712881|65006644|FG001|Overall Study|Withdrawal by Subject|1|||
23344855|NCT00712881|65006643|FG000|Overall Study|Disease Progression|2|||
23344856|NCT00712881|65006644|FG001|Overall Study|Disease Progression|1|||
23344857|NCT00712881|65006643|FG000|Overall Study|Lost to Follow-up|1|||
23344858|NCT00712881|65006644|FG001|Overall Study|Lost to Follow-up|1|||
23456409|NCT00870740|65416396|FG000|Overall Study|Death|0|||
23456410|NCT00870740|65416397|FG001|Overall Study|Death|0|||
23456411|NCT00870740|65416398|FG002|Overall Study|Death|0|||
23456412|NCT00870740|65416399|FG003|Overall Study|Death|0|||
23344859|NCT00712881|65006643|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
23456413|NCT00870740|65416400|FG004|Overall Study|Death|1|||
23456414|NCT00870740|65416401|FG005|Overall Study|Death|0|||
23456415|NCT00870740|65416396|FG000|Overall Study|Other|2|||
23456416|NCT00870740|65416397|FG001|Overall Study|Other|5|||
23456417|NCT00870740|65416398|FG002|Overall Study|Other|2|||
23456418|NCT00870740|65416399|FG003|Overall Study|Other|4|||
23456419|NCT00870740|65416400|FG004|Overall Study|Other|3|||
23456420|NCT00870740|65416401|FG005|Overall Study|Other|5|||
23456421|NCT02953652|65416404|FG000|Overall Study|Adverse Event|18|||
23456422|NCT02953652|65416404|FG000|Overall Study|Withdrawal by Subject|6|||
23456423|NCT02953652|65416404|FG000|Overall Study|Protocol Violation|1|||
23456424|NCT02953652|65416404|FG000|Overall Study|Disease Progression|27|||
23456425|NCT00280917|65416406|FG000|Overall Study|Adverse Event|1|||
23456426|NCT00280917|65416407|FG001|Overall Study|Adverse Event|1|||
23456427|NCT00280917|65416408|FG002|Overall Study|Adverse Event|4|||
23456428|NCT00280917|65416409|FG003|Overall Study|Adverse Event|1|||
23456429|NCT00280917|65416406|FG000|Overall Study|Change Therapy|1|||
23456430|NCT00280917|65416407|FG001|Overall Study|Change Therapy|2|||
23456431|NCT00280917|65416408|FG002|Overall Study|Change Therapy|0|||
23456432|NCT00280917|65416409|FG003|Overall Study|Change Therapy|0|||
23456433|NCT00280917|65416406|FG000|Overall Study|Withdrawal by Subject|0|||
23456434|NCT00280917|65416407|FG001|Overall Study|Withdrawal by Subject|2|||
23456435|NCT00280917|65416408|FG002|Overall Study|Withdrawal by Subject|0|||
23456436|NCT00280917|65416409|FG003|Overall Study|Withdrawal by Subject|1|||
23456437|NCT00280917|65416406|FG000|Overall Study|Noncompliance|0|||
23456438|NCT00280917|65416407|FG001|Overall Study|Noncompliance|1|||
23456439|NCT00280917|65416408|FG002|Overall Study|Noncompliance|2|||
23456440|NCT00280917|65416409|FG003|Overall Study|Noncompliance|0|||
23456441|NCT03409796|65416410|FG000|Overall Study|Adverse Event|2|||
23456442|NCT03409796|65416411|FG001|Overall Study|Adverse Event|0|||
23456443|NCT03409796|65416410|FG000|Overall Study|Other|0|||
23456444|NCT03409796|65416411|FG001|Overall Study|Other|1|||
23456445|NCT00005780|65416412|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
23456446|NCT02731638|65416413|FG000|Overall Study|Lost to Follow-up|6|||
23456447|NCT02731638|65416414|FG001|Overall Study|Lost to Follow-up|9|||
23456448|NCT03379675|65416421|FG000|Overall Study|Lost to Follow-up|0|||
23456449|NCT03379675|65416422|FG001|Overall Study|Lost to Follow-up|1|||
23456450|NCT03379675|65416423|FG002|Overall Study|Lost to Follow-up|0|||
23456451|NCT03379675|65416421|FG000|Overall Study|Adverse Event|2|||
23456452|NCT03379675|65416422|FG001|Overall Study|Adverse Event|0|||
23456453|NCT03379675|65416423|FG002|Overall Study|Adverse Event|0|||
23456454|NCT03379675|65416421|FG000|Overall Study|Withdrawal by Subject|2|||
23456455|NCT03379675|65416422|FG001|Overall Study|Withdrawal by Subject|1|||
23456456|NCT03379675|65416423|FG002|Overall Study|Withdrawal by Subject|2|||
23456457|NCT00468169|65416424|FG000|Overall Study|Withdrawal by Subject|1|||
23583404|NCT04886596|65866016|FG001|Overall Study|Unknown reason|23|||
23583405|NCT03631199|65866019|FG000|Overall Study|Progressive disease|9|||
23178623|NCT01307033|64394095|FG002|44-week Open-label Extension|Adverse Event|2|||
23178624|NCT01307033|64394096|FG003|44-week Open-label Extension|Adverse Event|1|||
23178625|NCT01307033|64394093|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
23178626|NCT01307033|64394094|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
23178627|NCT01307033|64394095|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
23178628|NCT01307033|64394096|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
23178629|NCT01307033|64394093|FG000|44-week Open-label Extension|Physician Decision|0|||
23178630|NCT01307033|64394094|FG001|44-week Open-label Extension|Physician Decision|0|||
23238536|NCT01258738|64615617|FG001|Open-label Period|Lost to Follow-up|2|||
23344860|NCT00712881|65006644|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
23344861|NCT00712881|65006643|FG000|Overall Study|Protocol Violation|1|||
23344862|NCT00712881|65006644|FG001|Overall Study|Protocol Violation|1|||
23344863|NCT00712881|65006643|FG000|Overall Study|Randomized but not treated|1|||
23344864|NCT00712881|65006644|FG001|Overall Study|Randomized but not treated|0|||
23344865|NCT03605849|65006647|FG000|Overall Study|Adverse Event|20|||
23344866|NCT03605849|65006648|FG001|Overall Study|Adverse Event|21|||
23344867|NCT03605849|65006649|FG002|Overall Study|Adverse Event|29|||
23344868|NCT03605849|65006650|FG003|Overall Study|Adverse Event|11|||
23456458|NCT00468169|65416425|FG001|Overall Study|Withdrawal by Subject|0|||
23456459|NCT01345240|65416428|FG000|Overall Study|Adverse Event|3|||
23456460|NCT01345240|65416429|FG001|Overall Study|Adverse Event|5|||
23456461|NCT01345240|65416430|FG002|Overall Study|Adverse Event|4|||
23456462|NCT01345240|65416431|FG003|Overall Study|Adverse Event|2|||
23456463|NCT01345240|65416432|FG004|Overall Study|Adverse Event|1|||
23456464|NCT01345240|65416428|FG000|Overall Study|Lost to Follow-up|8|||
23456465|NCT01345240|65416429|FG001|Overall Study|Lost to Follow-up|9|||
23583406|NCT03631199|65866020|FG001|Overall Study|Progressive disease|5|||
23456466|NCT01345240|65416430|FG002|Overall Study|Lost to Follow-up|14|||
23456467|NCT01345240|65416431|FG003|Overall Study|Lost to Follow-up|7|||
23456468|NCT01345240|65416432|FG004|Overall Study|Lost to Follow-up|9|||
23456469|NCT02903914|65416433|FG000|Overall Study|Adverse Event|0|||
23456470|NCT02903914|65416434|FG001|Overall Study|Adverse Event|0|||
23456471|NCT02903914|65416435|FG002|Overall Study|Adverse Event|1|||
23456472|NCT02903914|65416436|FG003|Overall Study|Adverse Event|0|||
23456473|NCT02903914|65416437|FG004|Overall Study|Adverse Event|0|||
23456474|NCT02903914|65416438|FG005|Overall Study|Adverse Event|0|||
23456475|NCT02903914|65416439|FG006|Overall Study|Adverse Event|2|||
23456476|NCT02903914|65416440|FG007|Overall Study|Adverse Event|0|||
23456477|NCT02903914|65416433|FG000|Overall Study|Withdrawal by Subject|3|||
23456478|NCT02903914|65416434|FG001|Overall Study|Withdrawal by Subject|1|||
23456479|NCT02903914|65416435|FG002|Overall Study|Withdrawal by Subject|28|||
23456480|NCT02903914|65416436|FG003|Overall Study|Withdrawal by Subject|0|||
23456481|NCT02903914|65416437|FG004|Overall Study|Withdrawal by Subject|1|||
23456482|NCT02903914|65416438|FG005|Overall Study|Withdrawal by Subject|2|||
23456483|NCT02903914|65416439|FG006|Overall Study|Withdrawal by Subject|12|||
23456484|NCT02903914|65416440|FG007|Overall Study|Withdrawal by Subject|0|||
23178631|NCT01307033|64394095|FG002|44-week Open-label Extension|Physician Decision|1|||
23178632|NCT01307033|64394096|FG003|44-week Open-label Extension|Physician Decision|0|||
23178633|NCT01307033|64394093|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
23178634|NCT01307033|64394094|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
23178635|NCT01307033|64394095|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
23178636|NCT01307033|64394096|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
23178637|NCT01307033|64394093|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
23178638|NCT01307033|64394094|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
23178639|NCT01307033|64394095|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
23178640|NCT01307033|64394096|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
23178641|NCT01307033|64394093|FG000|44-week Open-label Extension|Death|0|||
23178642|NCT01307033|64394094|FG001|44-week Open-label Extension|Death|0|||
23238537|NCT01258738|64615616|FG000|Open-label Period|Withdrawal by Subject|5|||
23238538|NCT01258738|64615617|FG001|Open-label Period|Withdrawal by Subject|6|||
23456485|NCT02903914|65416433|FG000|Overall Study|Progressive Disease|1|||
23178643|NCT01307033|64394095|FG002|44-week Open-label Extension|Death|0|||
23178644|NCT01307033|64394096|FG003|44-week Open-label Extension|Death|1|||
23178645|NCT02690194|64394097|FG000|Overall Study|Withdrawal by Subject|1|||
23178646|NCT02690194|64394098|FG001|Overall Study|Withdrawal by Subject|4|||
23178647|NCT02690194|64394099|FG002|Overall Study|Withdrawal by Subject|0|||
23178648|NCT03208231|64394107|FG000|Overall Study|Death|1|||
23178649|NCT03208231|64394108|FG001|Overall Study|Death|2|||
23178650|NCT03208231|64394107|FG000|Overall Study|Moved and unable to get to clinic|1|||
23178651|NCT03208231|64394108|FG001|Overall Study|Moved and unable to get to clinic|0|||
23238539|NCT01258738|64615616|FG000|Open-label Period|Protocol Violation|2|||
23238540|NCT01258738|64615617|FG001|Open-label Period|Protocol Violation|2|||
23456486|NCT02903914|65416434|FG001|Overall Study|Progressive Disease|0|||
23456487|NCT02903914|65416435|FG002|Overall Study|Progressive Disease|4|||
23456488|NCT02903914|65416436|FG003|Overall Study|Progressive Disease|0|||
23456489|NCT02903914|65416437|FG004|Overall Study|Progressive Disease|0|||
23456490|NCT02903914|65416438|FG005|Overall Study|Progressive Disease|0|||
23456491|NCT02903914|65416439|FG006|Overall Study|Progressive Disease|2|||
23456492|NCT02903914|65416440|FG007|Overall Study|Progressive Disease|0|||
23456493|NCT02903914|65416433|FG000|Overall Study|Death|0|||
23456494|NCT02903914|65416434|FG001|Overall Study|Death|0|||
23456495|NCT02903914|65416435|FG002|Overall Study|Death|9|||
23456496|NCT02903914|65416436|FG003|Overall Study|Death|0|||
23456497|NCT02903914|65416437|FG004|Overall Study|Death|1|||
23456498|NCT02903914|65416438|FG005|Overall Study|Death|3|||
23456499|NCT02903914|65416439|FG006|Overall Study|Death|24|||
23456500|NCT02903914|65416440|FG007|Overall Study|Death|2|||
23456501|NCT02903914|65416433|FG000|Overall Study|Lost to Follow-up|0|||
23456502|NCT02903914|65416434|FG001|Overall Study|Lost to Follow-up|1|||
23456503|NCT02903914|65416435|FG002|Overall Study|Lost to Follow-up|0|||
23178652|NCT03208231|64394107|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
23238541|NCT01258738|64615616|FG000|Open-label Period|Adverse Event|4|||
23178653|NCT03208231|64394108|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
23456504|NCT02903914|65416436|FG003|Overall Study|Lost to Follow-up|0|||
23456505|NCT02903914|65416437|FG004|Overall Study|Lost to Follow-up|2|||
23456506|NCT02903914|65416438|FG005|Overall Study|Lost to Follow-up|0|||
23456507|NCT02903914|65416439|FG006|Overall Study|Lost to Follow-up|1|||
23456508|NCT02903914|65416440|FG007|Overall Study|Lost to Follow-up|0|||
23456509|NCT02903914|65416433|FG000|Overall Study|Physician Decision|0|||
23456510|NCT02903914|65416434|FG001|Overall Study|Physician Decision|0|||
23456511|NCT02903914|65416435|FG002|Overall Study|Physician Decision|1|||
23456512|NCT02903914|65416436|FG003|Overall Study|Physician Decision|0|||
23456513|NCT02903914|65416437|FG004|Overall Study|Physician Decision|0|||
23456514|NCT02903914|65416438|FG005|Overall Study|Physician Decision|0|||
23456515|NCT02903914|65416439|FG006|Overall Study|Physician Decision|1|||
23456516|NCT02903914|65416440|FG007|Overall Study|Physician Decision|0|||
23456517|NCT02903914|65416433|FG000|Overall Study|Symptomatic Deterioration|0|||
23456518|NCT02903914|65416434|FG001|Overall Study|Symptomatic Deterioration|0|||
23456519|NCT02903914|65416435|FG002|Overall Study|Symptomatic Deterioration|1|||
23456520|NCT02903914|65416436|FG003|Overall Study|Symptomatic Deterioration|0|||
23456521|NCT02903914|65416437|FG004|Overall Study|Symptomatic Deterioration|0|||
23456522|NCT02903914|65416438|FG005|Overall Study|Symptomatic Deterioration|0|||
23456523|NCT02903914|65416439|FG006|Overall Study|Symptomatic Deterioration|0|||
23456524|NCT02903914|65416440|FG007|Overall Study|Symptomatic Deterioration|0|||
23456525|NCT02903914|65416433|FG000|Overall Study|New Cancer Therapy|2|||
23178654|NCT01354028|64394109|FG000|Overall Study|Physician Decision|0|||
23178655|NCT01354028|64394110|FG001|Overall Study|Physician Decision|2|||
23178656|NCT01354028|64394109|FG000|Overall Study|Discharged before study start|2|||
23178657|NCT01354028|64394110|FG001|Overall Study|Discharged before study start|2|||
23178658|NCT01354028|64394109|FG000|Overall Study|No quiet alert state|0|||
23178659|NCT01354028|64394110|FG001|Overall Study|No quiet alert state|1|||
23178660|NCT03665038|64394111|FG000|Overall Study|Lost to Follow-up|0|||
23178661|NCT03665038|64394112|FG001|Overall Study|Lost to Follow-up|0|||
23178662|NCT03665038|64394113|FG002|Overall Study|Lost to Follow-up|1|||
23178663|NCT00584233|64394114|FG000|Overall Study|Withdrawal by Subject|5|||
23178664|NCT00584233|64394114|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
23178665|NCT01573910|64394115|FG000|Overall Study|Adverse Event|4|||
23178666|NCT01573910|64394116|FG001|Overall Study|Adverse Event|4|||
23456526|NCT02903914|65416434|FG001|Overall Study|New Cancer Therapy|2|||
23456527|NCT02903914|65416435|FG002|Overall Study|New Cancer Therapy|21|||
23456528|NCT02903914|65416436|FG003|Overall Study|New Cancer Therapy|4|||
23456529|NCT02903914|65416437|FG004|Overall Study|New Cancer Therapy|3|||
23456530|NCT02903914|65416438|FG005|Overall Study|New Cancer Therapy|6|||
23456531|NCT02903914|65416439|FG006|Overall Study|New Cancer Therapy|56|||
23456532|NCT02903914|65416440|FG007|Overall Study|New Cancer Therapy|3|||
23456533|NCT02903914|65416433|FG000|Overall Study|Didn't Return to Site|1|||
23456534|NCT02903914|65416434|FG001|Overall Study|Didn't Return to Site|0|||
23456535|NCT02903914|65416435|FG002|Overall Study|Didn't Return to Site|1|||
23456536|NCT02903914|65416436|FG003|Overall Study|Didn't Return to Site|1|||
23456537|NCT02903914|65416437|FG004|Overall Study|Didn't Return to Site|0|||
23456538|NCT02903914|65416438|FG005|Overall Study|Didn't Return to Site|0|||
23456539|NCT02903914|65416439|FG006|Overall Study|Didn't Return to Site|2|||
23456540|NCT02903914|65416440|FG007|Overall Study|Didn't Return to Site|0|||
23456541|NCT02903914|65416433|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
23456542|NCT02903914|65416434|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
23456543|NCT02903914|65416435|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
23456544|NCT02903914|65416436|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
23456545|NCT02903914|65416437|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
23456546|NCT02903914|65416438|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
23456547|NCT02903914|65416439|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
23456548|NCT02903914|65416440|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
23456549|NCT02903914|65416433|FG000|Overall Study|Follow-up Did Not Occur|0|||
23456550|NCT02903914|65416434|FG001|Overall Study|Follow-up Did Not Occur|1|||
23456551|NCT02903914|65416435|FG002|Overall Study|Follow-up Did Not Occur|1|||
23456552|NCT02903914|65416436|FG003|Overall Study|Follow-up Did Not Occur|0|||
23456553|NCT02903914|65416437|FG004|Overall Study|Follow-up Did Not Occur|2|||
23456554|NCT02903914|65416438|FG005|Overall Study|Follow-up Did Not Occur|0|||
23456555|NCT02903914|65416439|FG006|Overall Study|Follow-up Did Not Occur|8|||
23456556|NCT02903914|65416440|FG007|Overall Study|Follow-up Did Not Occur|0|||
23456557|NCT02903914|65416433|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
23456558|NCT02903914|65416434|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
23456559|NCT02903914|65416435|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
23456560|NCT02903914|65416436|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
23178667|NCT01573910|64394115|FG000|Overall Study|Lost to Follow-up|2|||
23456561|NCT02903914|65416437|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
23456562|NCT02903914|65416438|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
23583407|NCT03631199|65866021|FG002|Overall Study|Progressive disease|5|||
23178668|NCT01573910|64394116|FG001|Overall Study|Lost to Follow-up|1|||
23178669|NCT01573910|64394115|FG000|Overall Study|Withdrawal by Subject|0|||
23178670|NCT01573910|64394116|FG001|Overall Study|Withdrawal by Subject|1|||
23178671|NCT01573910|64394115|FG000|Overall Study|Protocol Violation|3|||
23456563|NCT02903914|65416439|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
23456564|NCT02903914|65416440|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
23456565|NCT02903914|65416433|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456566|NCT02903914|65416434|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
23178672|NCT01573910|64394116|FG001|Overall Study|Protocol Violation|0|||
23344869|NCT03605849|65006647|FG000|Overall Study|Lack of Efficacy|4|||
23456567|NCT02903914|65416435|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
23456568|NCT02903914|65416436|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456569|NCT02903914|65416437|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456570|NCT02903914|65416438|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
23456571|NCT02903914|65416439|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456572|NCT02903914|65416440|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
23456573|NCT02903914|65416433|FG000|Overall Study|Clinical Disease Progression|0|||
23456574|NCT02903914|65416434|FG001|Overall Study|Clinical Disease Progression|0|||
23456575|NCT02903914|65416435|FG002|Overall Study|Clinical Disease Progression|2|||
23456576|NCT02903914|65416436|FG003|Overall Study|Clinical Disease Progression|0|||
23456577|NCT02903914|65416437|FG004|Overall Study|Clinical Disease Progression|0|||
23456578|NCT02903914|65416438|FG005|Overall Study|Clinical Disease Progression|0|||
23456579|NCT02903914|65416439|FG006|Overall Study|Clinical Disease Progression|0|||
23456580|NCT02903914|65416440|FG007|Overall Study|Clinical Disease Progression|0|||
23456581|NCT02903914|65416433|FG000|Overall Study|Completed Follow-up Period|0|||
23456582|NCT02903914|65416434|FG001|Overall Study|Completed Follow-up Period|0|||
23456583|NCT02903914|65416435|FG002|Overall Study|Completed Follow-up Period|6|||
23456584|NCT02903914|65416436|FG003|Overall Study|Completed Follow-up Period|2|||
23456585|NCT02903914|65416437|FG004|Overall Study|Completed Follow-up Period|1|||
23456586|NCT02903914|65416438|FG005|Overall Study|Completed Follow-up Period|0|||
23456587|NCT02903914|65416439|FG006|Overall Study|Completed Follow-up Period|9|||
23456588|NCT02903914|65416440|FG007|Overall Study|Completed Follow-up Period|1|||
23456589|NCT02903914|65416433|FG000|Overall Study|Taken off Treatment per Protocol|0|||
23456590|NCT02903914|65416434|FG001|Overall Study|Taken off Treatment per Protocol|0|||
23456591|NCT02903914|65416435|FG002|Overall Study|Taken off Treatment per Protocol|0|||
23456592|NCT02903914|65416436|FG003|Overall Study|Taken off Treatment per Protocol|0|||
23456593|NCT02903914|65416437|FG004|Overall Study|Taken off Treatment per Protocol|0|||
23456594|NCT02903914|65416438|FG005|Overall Study|Taken off Treatment per Protocol|1|||
23456595|NCT02903914|65416439|FG006|Overall Study|Taken off Treatment per Protocol|0|||
23456596|NCT02903914|65416440|FG007|Overall Study|Taken off Treatment per Protocol|0|||
23456597|NCT02903914|65416433|FG000|Overall Study|Refused Further Treatment/Contact|0|||
23456598|NCT02903914|65416434|FG001|Overall Study|Refused Further Treatment/Contact|0|||
23456599|NCT02903914|65416435|FG002|Overall Study|Refused Further Treatment/Contact|0|||
23456600|NCT02903914|65416436|FG003|Overall Study|Refused Further Treatment/Contact|0|||
23456601|NCT02903914|65416437|FG004|Overall Study|Refused Further Treatment/Contact|0|||
23456602|NCT02903914|65416438|FG005|Overall Study|Refused Further Treatment/Contact|0|||
23456603|NCT02903914|65416439|FG006|Overall Study|Refused Further Treatment/Contact|1|||
23456604|NCT02903914|65416440|FG007|Overall Study|Refused Further Treatment/Contact|0|||
23456605|NCT02903914|65416433|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456606|NCT02903914|65416434|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456607|NCT02903914|65416435|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456608|NCT02903914|65416436|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456609|NCT02903914|65416437|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456610|NCT02903914|65416438|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456611|NCT02903914|65416439|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
23456612|NCT02903914|65416440|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
23456613|NCT00703014|65416447|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
23456614|NCT00703014|65416448|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
23456615|NCT00703014|65416449|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
23456616|NCT00703014|65416450|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
23456617|NCT00703014|65416447|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
23456618|NCT00703014|65416448|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
23456619|NCT00703014|65416449|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
23456620|NCT00703014|65416450|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
23456621|NCT04698343|65416451|FG000|Overall Study|Withdrawal by Subject|6|||
23456622|NCT04698343|65416451|FG000|Overall Study|Physician Decision|2|||
23456623|NCT04698343|65416451|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
23456624|NCT04698343|65416451|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
23456625|NCT04698343|65416451|FG000|Overall Study|Personal reasons|3|||
23456626|NCT04698343|65416451|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
23456627|NCT03629886|65416455|FG000|Overall Study|Migrated / moved from the study area|0|||
23238542|NCT01258738|64615617|FG001|Open-label Period|Adverse Event|5|||
23456628|NCT03629886|65416456|FG001|Overall Study|Migrated / moved from the study area|55|||
23238543|NCT01258738|64615616|FG000|Open-label Period|Other Reasons|0|||
23238544|NCT01258738|64615617|FG001|Open-label Period|Other Reasons|1|||
23456629|NCT03629886|65416455|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
23456630|NCT03629886|65416456|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
23456631|NCT03629886|65416455|FG000|Overall Study|Study vaccine not administrated|0|||
23456632|NCT03629886|65416456|FG001|Overall Study|Study vaccine not administrated|3|||
23456633|NCT03629886|65416455|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
23456634|NCT03629886|65416456|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
23456635|NCT03629886|65416455|FG000|Overall Study|Refused vaccination step of the study|0|||
23456636|NCT03629886|65416456|FG001|Overall Study|Refused vaccination step of the study|44|||
23456637|NCT02163538|65416457|FG000|Overall Study|Protocol Violation|1|||
23456638|NCT02163538|65416458|FG001|Overall Study|Protocol Violation|0|||
23456639|NCT02163538|65416457|FG000|Overall Study|Physician Decision|0|||
23456640|NCT02163538|65416458|FG001|Overall Study|Physician Decision|1|||
23456641|NCT01502293|65416462|FG000|Overall Study|Progressive Disease|20|||
23456642|NCT01502293|65416463|FG001|Overall Study|Progressive Disease|12|||
23456643|NCT01502293|65416464|FG002|Overall Study|Progressive Disease|2|||
23456644|NCT01502293|65416462|FG000|Overall Study|Withdrawal by Subject|3|||
23456645|NCT01502293|65416463|FG001|Overall Study|Withdrawal by Subject|3|||
23456646|NCT01502293|65416464|FG002|Overall Study|Withdrawal by Subject|1|||
23456647|NCT01502293|65416462|FG000|Overall Study|Adverse Event|0|||
23456648|NCT01502293|65416463|FG001|Overall Study|Adverse Event|2|||
23456649|NCT01502293|65416464|FG002|Overall Study|Adverse Event|0|||
23456650|NCT01502293|65416462|FG000|Overall Study|Reason Not Specified|2|||
23456651|NCT01502293|65416463|FG001|Overall Study|Reason Not Specified|0|||
23456652|NCT01502293|65416464|FG002|Overall Study|Reason Not Specified|0|||
23456653|NCT01502293|65416462|FG000|Overall Study|Physician Decision|0|||
23456654|NCT01502293|65416463|FG001|Overall Study|Physician Decision|0|||
23456655|NCT01502293|65416464|FG002|Overall Study|Physician Decision|1|||
23456656|NCT00633477|65416469|FG000|Overall Study|Death|1|||
23456657|NCT00633477|65416470|FG001|Overall Study|Death|0|||
23456658|NCT00633477|65416469|FG000|Overall Study|Randomized but not treated|1|||
23456659|NCT00633477|65416470|FG001|Overall Study|Randomized but not treated|0|||
23456660|NCT03547518|65416471|FG000|Overall Study|Lost to Follow-up|2|||
23238545|NCT01258738|64615616|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
23238546|NCT01258738|64615617|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
23238547|NCT00965562|64615620|FG000|Overall Study|Lost to Follow-up|1|||
23238548|NCT00965562|64615621|FG001|Overall Study|Lost to Follow-up|2|||
23238549|NCT00965562|64615622|FG002|Overall Study|Lost to Follow-up|3|||
23344870|NCT03605849|65006648|FG001|Overall Study|Lack of Efficacy|7|||
23456661|NCT03547518|65416472|FG001|Overall Study|Lost to Follow-up|0|||
23456662|NCT02741128|65416473|FG000|Overall Study|Protocol Violation|4|||
23456663|NCT02741128|65416474|FG001|Overall Study|Protocol Violation|1|||
23456664|NCT02741128|65416473|FG000|Overall Study|Withdrawal by Subject|2|||
23456665|NCT02741128|65416474|FG001|Overall Study|Withdrawal by Subject|0|||
23456666|NCT02741128|65416473|FG000|Overall Study|Lost to Follow-up|1|||
23456667|NCT02741128|65416474|FG001|Overall Study|Lost to Follow-up|0|||
23456668|NCT04235140|65416475|FG000|Overall Study|Adverse Event|2|||
23456669|NCT04235140|65416475|FG000|Overall Study|Lost to Follow-up|1|||
23456670|NCT04235140|65416475|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
23456671|NCT04235140|65416475|FG000|Overall Study|Commercial drug is available for participants|7|||
23456672|NCT03724942|65416476|FG000|Overall Study|Adverse Event|20|||
23456673|NCT03724942|65416477|FG001|Overall Study|Adverse Event|14|||
23456674|NCT03724942|65416476|FG000|Overall Study|Lack of Efficacy|0|||
23456675|NCT03724942|65416477|FG001|Overall Study|Lack of Efficacy|1|||
23456676|NCT03724942|65416476|FG000|Overall Study|Physician Decision|5|||
23456677|NCT03724942|65416477|FG001|Overall Study|Physician Decision|2|||
23456678|NCT03724942|65416476|FG000|Overall Study|Protocol Violation|1|||
23456679|NCT03724942|65416477|FG001|Overall Study|Protocol Violation|0|||
23456680|NCT03724942|65416476|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
23456681|NCT03724942|65416477|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
23456682|NCT03724942|65416476|FG000|Overall Study|Withdrawal by Legal Representative|3|||
23456683|NCT03724942|65416477|FG001|Overall Study|Withdrawal by Legal Representative|0|||
23456684|NCT01903356|65416478|FG000|Overall Study|Lost to Follow-up|7|||
23456685|NCT01903356|65416478|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
23456686|NCT01903356|65416478|FG000|Overall Study|Violated the dosage and administration|3|||
23456687|NCT01383928|65416479|FG000|Overall Study|Initiation of ASCT|2|||
23456688|NCT01383928|65416480|FG001|Overall Study|Initiation of ASCT|1|||
23456689|NCT01383928|65416481|FG002|Overall Study|Initiation of ASCT|18|||
23456690|NCT01383928|65416479|FG000|Overall Study|Adverse Event|1|||
23456691|NCT01383928|65416480|FG001|Overall Study|Adverse Event|2|||
23456692|NCT01383928|65416481|FG002|Overall Study|Adverse Event|8|||
23456693|NCT01383928|65416479|FG000|Overall Study|Other|1|||
23456694|NCT01383928|65416480|FG001|Overall Study|Other|3|||
23456695|NCT01383928|65416481|FG002|Overall Study|Other|4|||
23456696|NCT01383928|65416479|FG000|Overall Study|Progressive Disease|1|||
23456697|NCT01383928|65416480|FG001|Overall Study|Progressive Disease|1|||
23238550|NCT00965562|64615620|FG000|Overall Study|Withdrawal by Subject|2|||
23456698|NCT01383928|65416481|FG002|Overall Study|Progressive Disease|5|||
23456699|NCT01383928|65416479|FG000|Overall Study|Withdrawal by Subject|0|||
23456700|NCT01383928|65416480|FG001|Overall Study|Withdrawal by Subject|0|||
23456701|NCT01383928|65416481|FG002|Overall Study|Withdrawal by Subject|4|||
23456702|NCT01383928|65416479|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
23456703|NCT01383928|65416480|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
23456704|NCT01383928|65416481|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
23456705|NCT01339832|65416482|FG000|Overall Study|Lost to Follow-up|3|||
23456706|NCT01339832|65416482|FG000|Overall Study|Death|11|||
23456707|NCT05543265|65416483|FG000|Overall Study|Lost to Follow-up|3|||
23456708|NCT05543265|65416484|FG001|Overall Study|Lost to Follow-up|3|||
23456709|NCT05543265|65416483|FG000|Overall Study|Withdrawal by Subject|0|||
23456710|NCT05543265|65416484|FG001|Overall Study|Withdrawal by Subject|1|||
23456711|NCT02101775|65416497|FG000|Overall Study|Adverse Event|4|||
23456712|NCT02101775|65416498|FG001|Overall Study|Adverse Event|0|||
23456713|NCT02101775|65416499|FG002|Overall Study|Adverse Event|0|||
23456714|NCT02101775|65416497|FG000|Overall Study|Admission to Hospital|0|||
23456715|NCT02101775|65416498|FG001|Overall Study|Admission to Hospital|1|||
23456716|NCT02101775|65416499|FG002|Overall Study|Admission to Hospital|0|||
23456717|NCT00005906|65416502|FG000|Overall Study|Lack of Efficacy|3|||
23456718|NCT05468814|65416504|FG000|Overall Study|Lost to Follow-up|5|||
23456719|NCT05468814|65416505|FG001|Overall Study|Lost to Follow-up|6|||
23456720|NCT01775501|65416506|FG000|Overall Study|Discontinued prior to treatment|1|||
23456721|NCT04949191|65416512|FG000|Overall Study|Non-compliance with Study Drug|1|||
23456722|NCT04949191|65416513|FG001|Overall Study|Non-compliance with Study Drug|0|||
23456723|NCT04949191|65416514|FG002|Overall Study|Non-compliance with Study Drug|0|||
23456724|NCT04949191|65416515|FG003|Overall Study|Non-compliance with Study Drug|0|||
23456725|NCT04949191|65416512|FG000|Overall Study|Progressive Disease|0|||
23456726|NCT04949191|65416513|FG001|Overall Study|Progressive Disease|1|||
23456727|NCT04949191|65416514|FG002|Overall Study|Progressive Disease|0|||
23456728|NCT04949191|65416515|FG003|Overall Study|Progressive Disease|0|||
23456729|NCT04949191|65416512|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
23456730|NCT04949191|65416513|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
23456731|NCT04949191|65416514|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
23456732|NCT04949191|65416515|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
23456733|NCT04949191|65416512|FG000|Overall Study|Sponsor Terminated Study|0|||
23456734|NCT04949191|65416513|FG001|Overall Study|Sponsor Terminated Study|0|||
23456735|NCT04949191|65416514|FG002|Overall Study|Sponsor Terminated Study|1|||
23456736|NCT04949191|65416515|FG003|Overall Study|Sponsor Terminated Study|1|||
23456737|NCT03770260|65416518|FG000|Overall Study|Disease progression|0|||
23456738|NCT03770260|65416519|FG001|Overall Study|Disease progression|1|||
23456739|NCT03770260|65416520|FG002|Overall Study|Disease progression|0|||
23456740|NCT03770260|65416521|FG003|Overall Study|Disease progression|0|||
23456741|NCT04913610|65416522|FG000|Randomized Participants|Did Not Receive Treatment|0|||
23456742|NCT04913610|65416523|FG001|Randomized Participants|Did Not Receive Treatment|0|||
23456743|NCT04913610|65416524|FG002|Randomized Participants|Did Not Receive Treatment|1|||
23456744|NCT04913610|65416525|FG003|Randomized Participants|Did Not Receive Treatment|1|||
23456745|NCT04913610|65416526|FG004|Randomized Participants|Did Not Receive Treatment|0|||
23456746|NCT04913610|65416522|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
23456747|NCT04913610|65416523|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
23456748|NCT04913610|65416524|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
23456749|NCT04913610|65416525|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
23456750|NCT04913610|65416526|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
23456751|NCT00537394|65416536|FG000|First Year of Follow-up|Death|7|||
23456752|NCT00537394|65416537|FG001|First Year of Follow-up|Death|0|||
23456753|NCT00537394|65416538|FG002|First Year of Follow-up|Death|0|||
23456754|NCT00537394|65416536|FG000|First Year of Follow-up|Severe debilitation|1|||
23456755|NCT00537394|65416537|FG001|First Year of Follow-up|Severe debilitation|0|||
23456756|NCT00537394|65416538|FG002|First Year of Follow-up|Severe debilitation|1|||
23456757|NCT00537394|65416536|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
23456758|NCT00537394|65416537|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
23456759|NCT00537394|65416538|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
23456760|NCT00537394|65416536|FG000|First Year of Follow-up|Lost to Follow-up|1|||
23344871|NCT03605849|65006649|FG002|Overall Study|Lack of Efficacy|9|||
23456761|NCT00537394|65416537|FG001|First Year of Follow-up|Lost to Follow-up|5|||
23456762|NCT00537394|65416538|FG002|First Year of Follow-up|Lost to Follow-up|1|||
23456763|NCT00537394|65416536|FG000|2nd Year of Follow-up|Death|4|||
23456764|NCT00537394|65416537|FG001|2nd Year of Follow-up|Death|1|||
23456765|NCT00537394|65416538|FG002|2nd Year of Follow-up|Death|2|||
23456766|NCT00537394|65416536|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
23456767|NCT00537394|65416537|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
23456768|NCT00537394|65416538|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
23456769|NCT00537394|65416536|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
23456770|NCT00537394|65416537|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
23456771|NCT00537394|65416538|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
23456772|NCT00537394|65416536|FG000|2nd Year of Follow-up|Clinic site closure|1|||
23456773|NCT00537394|65416537|FG001|2nd Year of Follow-up|Clinic site closure|0|||
23456774|NCT00537394|65416538|FG002|2nd Year of Follow-up|Clinic site closure|0|||
23456775|NCT03985761|65416539|FG000|Overall Study|Withdrawal by Subject|2|||
23456776|NCT03985761|65416540|FG001|Overall Study|Withdrawal by Subject|3|||
23456777|NCT03096834|65416545|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
23456778|NCT03096834|65416546|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
23456779|NCT03096834|65416547|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
23456780|NCT03096834|65416548|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
23456781|NCT03096834|65416545|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
23456782|NCT03096834|65416546|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
23456783|NCT03096834|65416547|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
23456784|NCT03096834|65416548|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
23456785|NCT03096834|65416545|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
23456786|NCT03096834|65416546|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
23456787|NCT03096834|65416547|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
23456788|NCT03096834|65416548|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
23456789|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
23456790|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
23456791|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
23456792|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
23456793|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
23456794|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
23456795|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
23456796|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
23456797|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
23456798|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
23456799|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
23456800|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
23456801|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
23456802|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
23456803|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
23456804|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
23456805|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
23456806|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
23456807|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
23456808|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
23456809|NCT03096834|65416545|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
23456810|NCT03096834|65416546|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
23456811|NCT03096834|65416547|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
23456812|NCT03096834|65416548|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
23456813|NCT03096834|65416545|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
23456814|NCT03096834|65416546|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
23456815|NCT03096834|65416547|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
23456816|NCT03096834|65416548|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
23456817|NCT03096834|65416545|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
23456818|NCT03096834|65416546|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
23456819|NCT03096834|65416547|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
23456820|NCT03096834|65416548|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
23456821|NCT03096834|65416545|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
23456822|NCT03096834|65416546|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
23456823|NCT03096834|65416547|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
23456824|NCT03096834|65416548|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
23456825|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
23456826|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
23456827|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
23456828|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
23456829|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
23456830|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
23456831|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
23456832|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
23456833|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
23456834|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
23456835|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
23456836|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
23583408|NCT03631199|65866022|FG003|Overall Study|Progressive disease|149|||
23583409|NCT03631199|65866023|FG004|Overall Study|Progressive disease|148|||
23456837|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
23456838|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
23456839|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
23456840|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
23456841|NCT03773978|65416552|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
23456842|NCT03773978|65416553|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
23456843|NCT03773978|65416552|FG000|DBW Period|Adverse Event|2|||
23456844|NCT03773978|65416553|FG001|DBW Period|Adverse Event|2|||
23456845|NCT03773978|65416552|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
23456846|NCT03773978|65416553|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
23456847|NCT03773978|65416552|FG000|DBW Period|Withdrawal by Subject|2|||
23456848|NCT03773978|65416553|FG001|DBW Period|Withdrawal by Subject|1|||
23456849|NCT03773978|65416552|FG000|DBW Period|Due to epidemic or pandemic|5|||
23456850|NCT03773978|65416553|FG001|DBW Period|Due to epidemic or pandemic|6|||
23456851|NCT03773978|65416552|FG000|DBW Period|Study team decision|1|||
23456852|NCT03773978|65416553|FG001|DBW Period|Study team decision|0|||
23456853|NCT02476617|65416556|FG000|Overall Study|Adverse Event|1|||
23456854|NCT02476617|65416556|FG000|Overall Study|Lost to Follow-up|1|||
23456855|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
23456856|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
23456857|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
23456858|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
23456859|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
23456860|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
23456861|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456862|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
23456863|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
23456864|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
23456865|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
23456866|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
23456867|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
23456868|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
23456869|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456870|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456871|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456872|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456873|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456874|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456875|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456876|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456877|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
23456878|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456879|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456880|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456881|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456882|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456883|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456884|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
23456885|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456886|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
23456887|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456888|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456889|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456890|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
23456891|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
23456892|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456893|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456894|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456895|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456896|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23583410|NCT03631199|65866019|FG000|Overall Study|Physician Decision|0|||
23238551|NCT00965562|64615621|FG001|Overall Study|Withdrawal by Subject|2|||
23344872|NCT03605849|65006650|FG003|Overall Study|Lack of Efficacy|2|||
23344873|NCT03605849|65006647|FG000|Overall Study|Lost to Follow-up|8|||
23238552|NCT00965562|64615622|FG002|Overall Study|Withdrawal by Subject|0|||
23344874|NCT03605849|65006648|FG001|Overall Study|Lost to Follow-up|8|||
23456897|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456898|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456899|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456900|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
23456901|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456902|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456903|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456904|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456905|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456906|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456907|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456908|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456909|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456910|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456911|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456912|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456913|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456914|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
23456915|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456916|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456917|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456918|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456919|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456920|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456921|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456922|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456923|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
23456924|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
23456925|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
23456926|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
23178673|NCT01573910|64394115|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
23178674|NCT01573910|64394116|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
23178675|NCT01790048|64394121|FG000|Overall Study|Incorrect Age|9|||
23178676|NCT01790048|64394122|FG001|Overall Study|Incorrect Age|14|||
23178677|NCT01790048|64394121|FG000|Overall Study|data entry error|0|||
23178678|NCT01790048|64394122|FG001|Overall Study|data entry error|1|||
23178679|NCT01790048|64394121|FG000|Overall Study|Other|0|||
23178680|NCT01790048|64394122|FG001|Overall Study|Other|2|||
23178681|NCT01790048|64394121|FG000|Overall Study|SAM at Enrollment|2|||
23178682|NCT01790048|64394122|FG001|Overall Study|SAM at Enrollment|0|||
23178683|NCT01790048|64394121|FG000|Overall Study|Measurement error|1|||
23178684|NCT01790048|64394122|FG001|Overall Study|Measurement error|0|||
23178685|NCT00700804|64397453|FG000|Overall Study|Withdrawal by Subject|1|||
23178686|NCT00700804|64397454|FG001|Overall Study|Withdrawal by Subject|2|||
23178687|NCT00700804|64397453|FG000|Overall Study|Protocol Violation|1|||
23178688|NCT00700804|64397454|FG001|Overall Study|Protocol Violation|1|||
23178689|NCT00700804|64397453|FG000|Overall Study|Loose Stools|1|||
23178690|NCT00700804|64397454|FG001|Overall Study|Loose Stools|1|||
23178691|NCT02327260|64397465|FG000|Overall Study|Lost to Follow-up|2|||
23178692|NCT02327260|64397466|FG001|Overall Study|Lost to Follow-up|3|||
23178693|NCT02327260|64397467|FG002|Overall Study|Lost to Follow-up|2|||
23456927|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
23583411|NCT03631199|65866020|FG001|Overall Study|Physician Decision|2|||
23178694|NCT02327260|64397465|FG000|Overall Study|invalid phone number|1|||
23178695|NCT02327260|64397466|FG001|Overall Study|invalid phone number|1|||
23178696|NCT02327260|64397467|FG002|Overall Study|invalid phone number|0|||
23178697|NCT02327260|64397465|FG000|Overall Study|non-adherence to protocol|2|||
23178698|NCT02327260|64397466|FG001|Overall Study|non-adherence to protocol|0|||
23178699|NCT02327260|64397467|FG002|Overall Study|non-adherence to protocol|0|||
23178700|NCT02327260|64397465|FG000|Overall Study|cognitive concerns|1|||
23178701|NCT02327260|64397466|FG001|Overall Study|cognitive concerns|0|||
23178702|NCT02327260|64397467|FG002|Overall Study|cognitive concerns|0|||
23178703|NCT01552057|64397470|FG000|Overall Study|Adverse Event|14|||
23178704|NCT01552057|64397471|FG001|Overall Study|Adverse Event|15|||
23178705|NCT01552057|64397470|FG000|Overall Study|Lack of Efficacy|8|||
23178706|NCT01552057|64397471|FG001|Overall Study|Lack of Efficacy|23|||
23238553|NCT04668066|64615623|FG000|Part 1: Treatment Phase|Adverse Event|0|||
23238554|NCT04668066|64615624|FG001|Part 1: Treatment Phase|Adverse Event|0|||
23238555|NCT04668066|64615625|FG002|Part 1: Treatment Phase|Adverse Event|0|||
23238556|NCT04668066|64615626|FG003|Part 1: Treatment Phase|Adverse Event|0|||
23238557|NCT04668066|64615627|FG004|Part 1: Treatment Phase|Adverse Event|0|||
23456928|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
23178707|NCT01552057|64397470|FG000|Overall Study|Withdrawal by Subject|5|||
23178708|NCT01552057|64397471|FG001|Overall Study|Withdrawal by Subject|8|||
23178709|NCT01552057|64397470|FG000|Overall Study|Entry Criteria Not Met|2|||
23344875|NCT03605849|65006649|FG002|Overall Study|Lost to Follow-up|14|||
23456929|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
23456930|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
23456931|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
23456932|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
23456933|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
23456934|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
23456935|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
23456936|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
23456937|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
23456938|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
23456939|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
23456940|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
23456941|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
23456942|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
23456943|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
23456944|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
23456945|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
23456946|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
23456947|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456948|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456949|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456950|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456951|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456952|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456953|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456954|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456955|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
23456956|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456957|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456958|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456959|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456960|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
23456961|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456962|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23583412|NCT03631199|65866021|FG002|Overall Study|Physician Decision|3|||
23344876|NCT03605849|65006650|FG003|Overall Study|Lost to Follow-up|11|||
23178710|NCT01552057|64397471|FG001|Overall Study|Entry Criteria Not Met|2|||
23178711|NCT01552057|64397470|FG000|Overall Study|Physician Decision|1|||
23238558|NCT04668066|64615628|FG005|Part 1: Treatment Phase|Adverse Event|0|||
23238559|NCT04668066|64615629|FG006|Part 1: Treatment Phase|Adverse Event|0|||
23238560|NCT04668066|64615630|FG007|Part 1: Treatment Phase|Adverse Event|0|||
23344877|NCT03605849|65006647|FG000|Overall Study|Non-compliance With IMP|6|||
23456963|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456964|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456965|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456966|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456967|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456968|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456969|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
23456970|NCT02052778|65416560|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456971|NCT02052778|65416561|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456972|NCT02052778|65416562|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23178712|NCT01552057|64397471|FG001|Overall Study|Physician Decision|0|||
23178713|NCT02700984|64397475|FG000|Overall Study|Death|2|||
23178714|NCT02700984|64397476|FG001|Overall Study|Death|1|||
23178715|NCT02700984|64397475|FG000|Overall Study|Lost to Follow-up|2|||
23178716|NCT02700984|64397476|FG001|Overall Study|Lost to Follow-up|1|||
23178717|NCT02700984|64397475|FG000|Overall Study|Physician Decision|0|||
23178718|NCT02700984|64397476|FG001|Overall Study|Physician Decision|1|||
23456973|NCT02052778|65416563|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456974|NCT02052778|65416564|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456975|NCT02052778|65416565|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
23456976|NCT02052778|65416566|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456977|NCT02052778|65416567|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23178719|NCT02700984|64397475|FG000|Overall Study|Withdrawal by Subject|8|||
23178720|NCT02700984|64397476|FG001|Overall Study|Withdrawal by Subject|9|||
23178721|NCT02700984|64397475|FG000|Overall Study|Reason not specified|3|||
23178722|NCT02700984|64397476|FG001|Overall Study|Reason not specified|2|||
23178723|NCT02804763|64397479|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
23178724|NCT02804763|64397480|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
23178725|NCT02804763|64397481|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
23178726|NCT02804763|64397482|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
23178727|NCT02804763|64397479|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
23178728|NCT02804763|64397480|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
23178729|NCT02804763|64397481|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
23178730|NCT02804763|64397482|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
23178731|NCT02804763|64397479|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
23178732|NCT02804763|64397480|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
23178733|NCT02804763|64397481|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
23178734|NCT02804763|64397482|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
23178735|NCT02804763|64397479|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
23178736|NCT02804763|64397480|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
23178737|NCT02804763|64397481|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
23178738|NCT02804763|64397482|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
23178739|NCT02804763|64397479|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
23178740|NCT02804763|64397480|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
23178741|NCT02804763|64397481|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
23178742|NCT02804763|64397482|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
23178743|NCT02804763|64397479|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
23178744|NCT02804763|64397480|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
23178745|NCT02804763|64397481|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
23178746|NCT02804763|64397482|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
23178747|NCT01658514|64397483|FG000|Overall Study|Protocol Violation|1|||
23178748|NCT01658514|64397484|FG001|Overall Study|Protocol Violation|0|||
23178749|NCT01658514|64397485|FG002|Overall Study|Protocol Violation|2|||
23178750|NCT01268293|64397486|FG000|Overall Study|Disease progression|7|||
23178751|NCT01268293|64397486|FG000|Overall Study|Adverse Event|1|||
23178752|NCT01268293|64397486|FG000|Overall Study|Subject choice|1|||
23178753|NCT02495948|64397495|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
23178754|NCT02495948|64397496|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
23178755|NCT02495948|64397495|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
23178756|NCT02495948|64397496|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
23178757|NCT02397473|64397499|FG000|Treatment Phase|Adverse Event|1|||
23178758|NCT02397473|64397500|FG001|Treatment Phase|Adverse Event|2|||
23178759|NCT02397473|64397499|FG000|Treatment Phase|Lack of Efficacy|8|||
23178760|NCT02397473|64397500|FG001|Treatment Phase|Lack of Efficacy|1|||
23178761|NCT02397473|64397499|FG000|Treatment Phase|Lost to Follow-up|1|||
23238561|NCT04668066|64615631|FG008|Part 1: Treatment Phase|Adverse Event|0|||
23238562|NCT04668066|64615632|FG009|Part 1: Treatment Phase|Adverse Event|0|||
23238563|NCT04668066|64615633|FG010|Part 1: Treatment Phase|Adverse Event|0|||
23238564|NCT04668066|64615634|FG011|Part 1: Treatment Phase|Adverse Event|1|||
23238565|NCT04668066|64615635|FG012|Part 1: Treatment Phase|Adverse Event|1|||
23238566|NCT04668066|64615636|FG013|Part 1: Treatment Phase|Adverse Event|0|||
23178762|NCT02397473|64397500|FG001|Treatment Phase|Lost to Follow-up|0|||
23178763|NCT02397473|64397499|FG000|Treatment Phase|Withdrawal by Subject|2|||
23178764|NCT02397473|64397500|FG001|Treatment Phase|Withdrawal by Subject|1|||
23178765|NCT02397473|64397499|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
23178766|NCT02397473|64397500|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
23178767|NCT02397473|64397499|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
23178768|NCT02397473|64397500|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
23178769|NCT02397473|64397499|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
23178770|NCT02397473|64397500|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
23178771|NCT02397473|64397499|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
23178772|NCT02397473|64397500|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
23238567|NCT04668066|64615637|FG014|Part 1: Treatment Phase|Adverse Event|0|||
23238568|NCT04668066|64615638|FG015|Part 1: Treatment Phase|Adverse Event|0|||
23238569|NCT04668066|64615639|FG016|Part 1: Treatment Phase|Adverse Event|0|||
23238570|NCT04668066|64615640|FG017|Part 1: Treatment Phase|Adverse Event|0|||
23238571|NCT04668066|64615641|FG018|Part 1: Treatment Phase|Adverse Event|0|||
23238572|NCT04668066|64615623|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238573|NCT04668066|64615624|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238574|NCT04668066|64615625|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
23238575|NCT04668066|64615626|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
23456978|NCT02052778|65416568|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23178773|NCT02397473|64397499|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
23238576|NCT04668066|64615627|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238577|NCT04668066|64615628|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238578|NCT04668066|64615629|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
23344878|NCT03605849|65006648|FG001|Overall Study|Non-compliance With IMP|5|||
23344879|NCT03605849|65006649|FG002|Overall Study|Non-compliance With IMP|2|||
23344880|NCT03605849|65006650|FG003|Overall Study|Non-compliance With IMP|1|||
23344881|NCT03605849|65006647|FG000|Overall Study|Protocol Deviation|1|||
23344882|NCT03605849|65006648|FG001|Overall Study|Protocol Deviation|2|||
23344883|NCT03605849|65006649|FG002|Overall Study|Protocol Deviation|1|||
23344884|NCT03605849|65006650|FG003|Overall Study|Protocol Deviation|3|||
23344885|NCT03605849|65006647|FG000|Overall Study|Withdrawal by Subject|33|||
23238579|NCT04668066|64615630|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238580|NCT04668066|64615631|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238581|NCT04668066|64615632|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238582|NCT04668066|64615633|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238583|NCT04668066|64615634|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238584|NCT04668066|64615635|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
23344886|NCT03605849|65006648|FG001|Overall Study|Withdrawal by Subject|28|||
23344887|NCT03605849|65006649|FG002|Overall Study|Withdrawal by Subject|30|||
23344888|NCT03605849|65006650|FG003|Overall Study|Withdrawal by Subject|28|||
23344889|NCT03605849|65006647|FG000|Overall Study|Site Terminated by Sponsor|0|||
23344890|NCT03605849|65006648|FG001|Overall Study|Site Terminated by Sponsor|0|||
23344891|NCT03605849|65006649|FG002|Overall Study|Site Terminated by Sponsor|0|||
23344892|NCT03605849|65006650|FG003|Overall Study|Site Terminated by Sponsor|1|||
23344893|NCT03605849|65006647|FG000|Overall Study|Physician Decision|2|||
23344894|NCT03605849|65006648|FG001|Overall Study|Physician Decision|1|||
23344895|NCT03605849|65006649|FG002|Overall Study|Physician Decision|2|||
23344896|NCT03605849|65006650|FG003|Overall Study|Physician Decision|1|||
23178774|NCT02397473|64397500|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
23238585|NCT04668066|64615636|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238586|NCT04668066|64615637|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238587|NCT04668066|64615638|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238588|NCT04668066|64615639|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238589|NCT04668066|64615640|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
23344897|NCT03605849|65006647|FG000|Overall Study|Enrolled, but not Treated|2|||
23344898|NCT03605849|65006648|FG001|Overall Study|Enrolled, but not Treated|2|||
23344899|NCT03605849|65006649|FG002|Overall Study|Enrolled, but not Treated|3|||
23344900|NCT03605849|65006650|FG003|Overall Study|Enrolled, but not Treated|2|||
23344901|NCT03605849|65006647|FG000|Overall Study|Other (COVID-19 Related)|0|||
23344902|NCT03605849|65006648|FG001|Overall Study|Other (COVID-19 Related)|1|||
23344903|NCT03605849|65006649|FG002|Overall Study|Other (COVID-19 Related)|1|||
23344904|NCT03605849|65006650|FG003|Overall Study|Other (COVID-19 Related)|0|||
23238590|NCT04668066|64615641|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
23238591|NCT04668066|64615623|FG000|Part 1: Treatment Phase|Other|0|||
23238592|NCT04668066|64615624|FG001|Part 1: Treatment Phase|Other|0|||
23238593|NCT04668066|64615625|FG002|Part 1: Treatment Phase|Other|0|||
23238594|NCT04668066|64615626|FG003|Part 1: Treatment Phase|Other|0|||
23238595|NCT04668066|64615627|FG004|Part 1: Treatment Phase|Other|0|||
23238596|NCT04668066|64615628|FG005|Part 1: Treatment Phase|Other|0|||
23238597|NCT04668066|64615629|FG006|Part 1: Treatment Phase|Other|0|||
23238598|NCT04668066|64615630|FG007|Part 1: Treatment Phase|Other|0|||
23238599|NCT04668066|64615631|FG008|Part 1: Treatment Phase|Other|0|||
23238600|NCT04668066|64615632|FG009|Part 1: Treatment Phase|Other|0|||
23238601|NCT04668066|64615633|FG010|Part 1: Treatment Phase|Other|0|||
23238602|NCT04668066|64615634|FG011|Part 1: Treatment Phase|Other|1|||
23238603|NCT04668066|64615635|FG012|Part 1: Treatment Phase|Other|0|||
23238604|NCT04668066|64615636|FG013|Part 1: Treatment Phase|Other|0|||
23238605|NCT04668066|64615637|FG014|Part 1: Treatment Phase|Other|0|||
23238606|NCT04668066|64615638|FG015|Part 1: Treatment Phase|Other|0|||
23238607|NCT04668066|64615639|FG016|Part 1: Treatment Phase|Other|0|||
23238608|NCT04668066|64615640|FG017|Part 1: Treatment Phase|Other|0|||
23238609|NCT04668066|64615641|FG018|Part 1: Treatment Phase|Other|0|||
23238610|NCT04668066|64615623|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238611|NCT04668066|64615624|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238612|NCT04668066|64615625|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238613|NCT04668066|64615626|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238614|NCT04668066|64615627|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238615|NCT04668066|64615628|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238616|NCT04668066|64615629|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238617|NCT04668066|64615630|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238618|NCT04668066|64615631|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238619|NCT04668066|64615632|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238620|NCT04668066|64615633|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238621|NCT04668066|64615634|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238622|NCT04668066|64615635|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
23238623|NCT04668066|64615636|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238624|NCT04668066|64615637|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238625|NCT04668066|64615638|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
23238626|NCT04668066|64615639|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238627|NCT04668066|64615640|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238628|NCT04668066|64615641|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
23238629|NCT04668066|64615623|FG000|Part 1: Follow-Up|Adverse Event|0|||
23238630|NCT04668066|64615624|FG001|Part 1: Follow-Up|Adverse Event|0|||
23238631|NCT04668066|64615625|FG002|Part 1: Follow-Up|Adverse Event|0|||
23238632|NCT04668066|64615626|FG003|Part 1: Follow-Up|Adverse Event|0|||
23238633|NCT04668066|64615627|FG004|Part 1: Follow-Up|Adverse Event|0|||
23238634|NCT04668066|64615628|FG005|Part 1: Follow-Up|Adverse Event|0|||
23238635|NCT04668066|64615629|FG006|Part 1: Follow-Up|Adverse Event|0|||
23238636|NCT04668066|64615630|FG007|Part 1: Follow-Up|Adverse Event|0|||
23238637|NCT04668066|64615631|FG008|Part 1: Follow-Up|Adverse Event|0|||
23238638|NCT04668066|64615632|FG009|Part 1: Follow-Up|Adverse Event|0|||
23238639|NCT04668066|64615633|FG010|Part 1: Follow-Up|Adverse Event|0|||
23238640|NCT04668066|64615634|FG011|Part 1: Follow-Up|Adverse Event|1|||
23238641|NCT04668066|64615635|FG012|Part 1: Follow-Up|Adverse Event|0|||
23238642|NCT04668066|64615636|FG013|Part 1: Follow-Up|Adverse Event|0|||
23238643|NCT04668066|64615637|FG014|Part 1: Follow-Up|Adverse Event|0|||
23238644|NCT04668066|64615638|FG015|Part 1: Follow-Up|Adverse Event|0|||
23238645|NCT04668066|64615639|FG016|Part 1: Follow-Up|Adverse Event|0|||
23238646|NCT04668066|64615640|FG017|Part 1: Follow-Up|Adverse Event|0|||
23238647|NCT04668066|64615641|FG018|Part 1: Follow-Up|Adverse Event|0|||
23238648|NCT04668066|64615623|FG000|Part 1: Follow-Up|Other|0|||
23238649|NCT04668066|64615624|FG001|Part 1: Follow-Up|Other|0|||
23238650|NCT04668066|64615625|FG002|Part 1: Follow-Up|Other|0|||
23238651|NCT04668066|64615626|FG003|Part 1: Follow-Up|Other|0|||
23238652|NCT04668066|64615627|FG004|Part 1: Follow-Up|Other|0|||
23238653|NCT04668066|64615628|FG005|Part 1: Follow-Up|Other|0|||
23238654|NCT04668066|64615629|FG006|Part 1: Follow-Up|Other|0|||
23238655|NCT04668066|64615630|FG007|Part 1: Follow-Up|Other|0|||
23238656|NCT04668066|64615631|FG008|Part 1: Follow-Up|Other|0|||
23238657|NCT04668066|64615632|FG009|Part 1: Follow-Up|Other|0|||
23238658|NCT04668066|64615633|FG010|Part 1: Follow-Up|Other|0|||
23238659|NCT04668066|64615634|FG011|Part 1: Follow-Up|Other|1|||
23238660|NCT04668066|64615635|FG012|Part 1: Follow-Up|Other|1|||
23238661|NCT04668066|64615636|FG013|Part 1: Follow-Up|Other|0|||
23238662|NCT04668066|64615637|FG014|Part 1: Follow-Up|Other|0|||
23238663|NCT04668066|64615638|FG015|Part 1: Follow-Up|Other|0|||
23238664|NCT04668066|64615639|FG016|Part 1: Follow-Up|Other|0|||
23238665|NCT04668066|64615640|FG017|Part 1: Follow-Up|Other|0|||
23238666|NCT04668066|64615641|FG018|Part 1: Follow-Up|Other|0|||
23238667|NCT04668066|64615623|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238668|NCT04668066|64615624|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238669|NCT04668066|64615625|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238670|NCT04668066|64615626|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238671|NCT04668066|64615627|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238672|NCT04668066|64615628|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238673|NCT04668066|64615629|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238674|NCT04668066|64615630|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238675|NCT04668066|64615631|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
23344905|NCT03605849|65006647|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
23344906|NCT03605849|65006648|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
23344907|NCT03605849|65006649|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
23344908|NCT03605849|65006650|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
23344909|NCT01195844|65006651|FG000|Overall Study|Fecal sample not collected|40|||
23344910|NCT01854879|65006652|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
23344911|NCT01854879|65006652|FG000|Overall Study|screen fail|3|||
23344912|NCT01854879|65006652|FG000|Overall Study|incomplete data set|1|||
23344913|NCT00199797|65006653|FG000|Overall Study|Progressive Disease|1|||
23344914|NCT00199797|65006653|FG000|Overall Study|Adverse Event|1|||
23344915|NCT00199797|65006653|FG000|Overall Study|Physician Decision|1|||
23344916|NCT00595517|65006656|FG000|Overall Study|Adverse Event|6|||
23344917|NCT00595517|65006656|FG000|Overall Study|Withdrawal by Subject|4|||
23344918|NCT00595517|65006656|FG000|Overall Study|Protocol Violation|2|||
23344919|NCT00595517|65006656|FG000|Overall Study|Recurrence of ulcer|5|||
23344920|NCT00595517|65006656|FG000|Overall Study|usage of prohibited treatment|1|||
23344921|NCT00595517|65006656|FG000|Overall Study|No intention to attend regularly|1|||
23344922|NCT06011161|65006657|FG000|Overall Study|Withdrawal by Subject|2|||
23344923|NCT06011161|65006657|FG000|Overall Study|Lost to Follow-up|5|||
23344924|NCT02143791|65006658|FG000|Enrolled|Withdrawal by Subject|4|||
23344925|NCT02143791|65006658|FG000|Trial Stimulation|Lack of Efficacy|21|||
23344926|NCT02143791|65006658|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
23344927|NCT02143791|65006658|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
23344928|NCT02143791|65006658|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
23344929|NCT02143791|65006658|FG000|Any Programming (3-6 Months)|Missing Data|1|||
23344930|NCT02143791|65006658|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
23344931|NCT02691936|65006659|FG000|Overall Study|Withdrawal by Subject|2|||
23344932|NCT02691936|65006660|FG001|Overall Study|Withdrawal by Subject|5|||
23344933|NCT00452673|65006668|FG000|Dose Escalation Period|Disease Progression|6|||
23344934|NCT00452673|65006669|FG001|Dose Escalation Period|Disease Progression|6|||
23344935|NCT00452673|65006670|FG002|Dose Escalation Period|Disease Progression|2|||
23344936|NCT00452673|65006671|FG003|Dose Escalation Period|Disease Progression|6|||
23344937|NCT00452673|65006672|FG004|Dose Escalation Period|Disease Progression|0|||
23344938|NCT00452673|65006668|FG000|Dose Escalation Period|study drug toxicity|1|||
23178775|NCT04426695|64397501|FG000|Overall Study|Death|2|||
23178776|NCT04426695|64397502|FG001|Overall Study|Death|0|||
23178777|NCT04426695|64397503|FG002|Overall Study|Death|1|||
23178778|NCT04426695|64397504|FG003|Overall Study|Death|27|||
23178779|NCT04426695|64397505|FG004|Overall Study|Death|25|||
23178780|NCT04426695|64397506|FG005|Overall Study|Death|21|||
23178781|NCT04426695|64397507|FG006|Overall Study|Death|42|||
23178782|NCT04426695|64397508|FG007|Overall Study|Death|23|||
23178783|NCT04426695|64397509|FG008|Overall Study|Death|37|||
23178784|NCT04426695|64397510|FG009|Overall Study|Death|14|||
23178785|NCT04426695|64397511|FG010|Overall Study|Death|8|||
23178786|NCT04426695|64397512|FG011|Overall Study|Death|7|||
23178787|NCT04426695|64397513|FG012|Overall Study|Death|13|||
23178788|NCT04426695|64397514|FG013|Overall Study|Death|25|||
23178789|NCT04426695|64397515|FG014|Overall Study|Death|19|||
23178790|NCT04426695|64397516|FG015|Overall Study|Death|7|||
23178791|NCT04426695|64397517|FG016|Overall Study|Death|8|||
23178792|NCT04426695|64397518|FG017|Overall Study|Death|4|||
23344939|NCT00452673|65006669|FG001|Dose Escalation Period|study drug toxicity|3|||
23344940|NCT00452673|65006670|FG002|Dose Escalation Period|study drug toxicity|3|||
23344941|NCT00452673|65006671|FG003|Dose Escalation Period|study drug toxicity|1|||
23344942|NCT00452673|65006672|FG004|Dose Escalation Period|study drug toxicity|0|||
23344943|NCT00452673|65006668|FG000|Dose Escalation Period|Other|0|||
23178793|NCT04426695|64397501|FG000|Overall Study|Lost to Follow-up|2|||
23178794|NCT04426695|64397502|FG001|Overall Study|Lost to Follow-up|4|||
23178795|NCT04426695|64397503|FG002|Overall Study|Lost to Follow-up|1|||
23178796|NCT04426695|64397504|FG003|Overall Study|Lost to Follow-up|19|||
23178797|NCT04426695|64397505|FG004|Overall Study|Lost to Follow-up|10|||
23178798|NCT04426695|64397506|FG005|Overall Study|Lost to Follow-up|14|||
23178799|NCT04426695|64397507|FG006|Overall Study|Lost to Follow-up|5|||
23178800|NCT04426695|64397508|FG007|Overall Study|Lost to Follow-up|14|||
23178801|NCT04426695|64397509|FG008|Overall Study|Lost to Follow-up|10|||
23344944|NCT00452673|65006669|FG001|Dose Escalation Period|Other|0|||
23178802|NCT04426695|64397510|FG009|Overall Study|Lost to Follow-up|11|||
23178803|NCT04426695|64397511|FG010|Overall Study|Lost to Follow-up|12|||
23178804|NCT04426695|64397512|FG011|Overall Study|Lost to Follow-up|6|||
23238676|NCT04668066|64615632|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
23178805|NCT04426695|64397513|FG012|Overall Study|Lost to Follow-up|2|||
23178806|NCT04426695|64397514|FG013|Overall Study|Lost to Follow-up|2|||
23344945|NCT00452673|65006670|FG002|Dose Escalation Period|Other|1|||
23344946|NCT00452673|65006671|FG003|Dose Escalation Period|Other|0|||
23344947|NCT00452673|65006672|FG004|Dose Escalation Period|Other|0|||
23344948|NCT00452673|65006668|FG000|Dose Escalation Period|Adverse Event|0|||
23344949|NCT00452673|65006669|FG001|Dose Escalation Period|Adverse Event|0|||
23344950|NCT00452673|65006670|FG002|Dose Escalation Period|Adverse Event|0|||
23344951|NCT00452673|65006671|FG003|Dose Escalation Period|Adverse Event|1|||
23344952|NCT00452673|65006672|FG004|Dose Escalation Period|Adverse Event|0|||
23344953|NCT00452673|65006668|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
23344954|NCT00452673|65006669|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
23344955|NCT00452673|65006670|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
23344956|NCT00452673|65006671|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
23344957|NCT00452673|65006672|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
23344958|NCT00452673|65006668|FG000|Dose Expansion Period|Disease Progression|0|||
23344959|NCT00452673|65006669|FG001|Dose Expansion Period|Disease Progression|0|||
23344960|NCT00452673|65006670|FG002|Dose Expansion Period|Disease Progression|0|||
23344961|NCT00452673|65006671|FG003|Dose Expansion Period|Disease Progression|0|||
23344962|NCT00452673|65006672|FG004|Dose Expansion Period|Disease Progression|19|||
23344963|NCT00452673|65006668|FG000|Dose Expansion Period|Other|0|||
23344964|NCT00452673|65006669|FG001|Dose Expansion Period|Other|0|||
23344965|NCT00452673|65006670|FG002|Dose Expansion Period|Other|0|||
23344966|NCT00452673|65006671|FG003|Dose Expansion Period|Other|0|||
23344967|NCT00452673|65006672|FG004|Dose Expansion Period|Other|2|||
23344968|NCT01764997|65006673|FG000|Run-in Period|Adverse Event|15|||
23344969|NCT01764997|65006674|FG001|Run-in Period|Adverse Event|0|||
23344970|NCT01764997|65006675|FG002|Run-in Period|Adverse Event|0|||
23344971|NCT01764997|65006676|FG003|Run-in Period|Adverse Event|0|||
23344972|NCT01764997|65006677|FG004|Run-in Period|Adverse Event|0|||
23344973|NCT01764997|65006673|FG000|Run-in Period|Lack of Efficacy|5|||
23344974|NCT01764997|65006674|FG001|Run-in Period|Lack of Efficacy|0|||
23238677|NCT04668066|64615633|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238678|NCT04668066|64615634|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238679|NCT04668066|64615635|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
23238680|NCT04668066|64615636|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238681|NCT04668066|64615637|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238682|NCT04668066|64615638|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
23238683|NCT04668066|64615639|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238684|NCT04668066|64615640|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238685|NCT04668066|64615641|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
23238686|NCT04668066|64615623|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238687|NCT04668066|64615624|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238688|NCT04668066|64615625|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23456979|NCT02052778|65416569|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456980|NCT02052778|65416570|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23178807|NCT04426695|64397515|FG014|Overall Study|Lost to Follow-up|2|||
23178808|NCT04426695|64397516|FG015|Overall Study|Lost to Follow-up|0|||
23178809|NCT04426695|64397517|FG016|Overall Study|Lost to Follow-up|0|||
23178810|NCT04426695|64397518|FG017|Overall Study|Lost to Follow-up|0|||
23178811|NCT04426695|64397501|FG000|Overall Study|Participant Decision|1|||
23178812|NCT04426695|64397502|FG001|Overall Study|Participant Decision|2|||
23178813|NCT04426695|64397503|FG002|Overall Study|Participant Decision|2|||
23178814|NCT04426695|64397504|FG003|Overall Study|Participant Decision|12|||
23178815|NCT04426695|64397505|FG004|Overall Study|Participant Decision|18|||
23178816|NCT04426695|64397506|FG005|Overall Study|Participant Decision|22|||
23178817|NCT04426695|64397507|FG006|Overall Study|Participant Decision|13|||
23178818|NCT04426695|64397508|FG007|Overall Study|Participant Decision|13|||
23238689|NCT04668066|64615626|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238690|NCT04668066|64615627|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23344975|NCT01764997|65006675|FG002|Run-in Period|Lack of Efficacy|0|||
23178819|NCT04426695|64397509|FG008|Overall Study|Participant Decision|10|||
23178820|NCT04426695|64397510|FG009|Overall Study|Participant Decision|15|||
23178821|NCT04426695|64397511|FG010|Overall Study|Participant Decision|16|||
23178822|NCT04426695|64397512|FG011|Overall Study|Participant Decision|17|||
23178823|NCT04426695|64397513|FG012|Overall Study|Participant Decision|2|||
23178824|NCT04426695|64397514|FG013|Overall Study|Participant Decision|1|||
23178825|NCT04426695|64397515|FG014|Overall Study|Participant Decision|2|||
23178826|NCT04426695|64397516|FG015|Overall Study|Participant Decision|0|||
23238691|NCT04668066|64615628|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23344976|NCT01764997|65006676|FG003|Run-in Period|Lack of Efficacy|0|||
23344977|NCT01764997|65006677|FG004|Run-in Period|Lack of Efficacy|0|||
23344978|NCT01764997|65006673|FG000|Run-in Period|Poor compliance to protocol|1|||
23344979|NCT01764997|65006674|FG001|Run-in Period|Poor compliance to protocol|0|||
23344980|NCT01764997|65006675|FG002|Run-in Period|Poor compliance to protocol|0|||
23344981|NCT01764997|65006676|FG003|Run-in Period|Poor compliance to protocol|0|||
23238692|NCT04668066|64615629|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238693|NCT04668066|64615630|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238694|NCT04668066|64615631|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238695|NCT04668066|64615632|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23344982|NCT01764997|65006677|FG004|Run-in Period|Poor compliance to protocol|0|||
23238696|NCT04668066|64615633|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238697|NCT04668066|64615634|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238698|NCT04668066|64615635|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238699|NCT04668066|64615636|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238700|NCT04668066|64615637|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238701|NCT04668066|64615638|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238702|NCT04668066|64615639|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238703|NCT04668066|64615640|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
23238704|NCT04668066|64615641|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
23238705|NCT04668066|64615623|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238706|NCT04668066|64615624|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238707|NCT04668066|64615625|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238708|NCT04668066|64615626|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238709|NCT04668066|64615627|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238710|NCT04668066|64615628|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238711|NCT04668066|64615629|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238712|NCT04668066|64615630|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238713|NCT04668066|64615631|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238714|NCT04668066|64615632|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238715|NCT04668066|64615633|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238716|NCT04668066|64615634|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238717|NCT04668066|64615635|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238718|NCT04668066|64615636|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238719|NCT04668066|64615637|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238720|NCT04668066|64615638|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238721|NCT04668066|64615639|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238722|NCT04668066|64615640|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
23238723|NCT04668066|64615641|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
23238724|NCT04668066|64615623|FG000|Part 2: Treatment Phase|Other|0|||
23238725|NCT04668066|64615624|FG001|Part 2: Treatment Phase|Other|0|||
23238726|NCT04668066|64615625|FG002|Part 2: Treatment Phase|Other|0|||
23238727|NCT04668066|64615626|FG003|Part 2: Treatment Phase|Other|0|||
23238728|NCT04668066|64615627|FG004|Part 2: Treatment Phase|Other|0|||
23238729|NCT04668066|64615628|FG005|Part 2: Treatment Phase|Other|0|||
23238730|NCT04668066|64615629|FG006|Part 2: Treatment Phase|Other|0|||
23238731|NCT04668066|64615630|FG007|Part 2: Treatment Phase|Other|0|||
23238732|NCT04668066|64615631|FG008|Part 2: Treatment Phase|Other|0|||
23178827|NCT04426695|64397517|FG016|Overall Study|Participant Decision|0|||
23178828|NCT04426695|64397518|FG017|Overall Study|Participant Decision|0|||
23178829|NCT04426695|64397501|FG000|Overall Study|Adverse Event|0|||
23178830|NCT04426695|64397502|FG001|Overall Study|Adverse Event|0|||
23238733|NCT04668066|64615632|FG009|Part 2: Treatment Phase|Other|0|||
23238734|NCT04668066|64615633|FG010|Part 2: Treatment Phase|Other|0|||
23178831|NCT04426695|64397503|FG002|Overall Study|Adverse Event|0|||
23178832|NCT04426695|64397504|FG003|Overall Study|Adverse Event|0|||
23178833|NCT04426695|64397505|FG004|Overall Study|Adverse Event|0|||
23178834|NCT04426695|64397506|FG005|Overall Study|Adverse Event|0|||
23178835|NCT04426695|64397507|FG006|Overall Study|Adverse Event|0|||
23178836|NCT04426695|64397508|FG007|Overall Study|Adverse Event|1|||
23178837|NCT04426695|64397509|FG008|Overall Study|Adverse Event|0|||
23178838|NCT04426695|64397510|FG009|Overall Study|Adverse Event|0|||
23178839|NCT04426695|64397511|FG010|Overall Study|Adverse Event|1|||
23178840|NCT04426695|64397512|FG011|Overall Study|Adverse Event|1|||
23178841|NCT04426695|64397513|FG012|Overall Study|Adverse Event|0|||
23238735|NCT04668066|64615634|FG011|Part 2: Treatment Phase|Other|0|||
23238736|NCT04668066|64615635|FG012|Part 2: Treatment Phase|Other|0|||
23344983|NCT01764997|65006673|FG000|Run-in Period|Other than specified above|17|||
23456981|NCT02052778|65416571|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23178842|NCT04426695|64397514|FG013|Overall Study|Adverse Event|0|||
23178843|NCT04426695|64397515|FG014|Overall Study|Adverse Event|0|||
23178844|NCT04426695|64397516|FG015|Overall Study|Adverse Event|0|||
23178845|NCT04426695|64397517|FG016|Overall Study|Adverse Event|0|||
23178846|NCT04426695|64397518|FG017|Overall Study|Adverse Event|0|||
23178847|NCT04426695|64397501|FG000|Overall Study|Sponsor Request|0|||
23178848|NCT04426695|64397502|FG001|Overall Study|Sponsor Request|0|||
23178849|NCT04426695|64397503|FG002|Overall Study|Sponsor Request|0|||
23178850|NCT04426695|64397504|FG003|Overall Study|Sponsor Request|0|||
23238737|NCT04668066|64615636|FG013|Part 2: Treatment Phase|Other|0|||
23238738|NCT04668066|64615637|FG014|Part 2: Treatment Phase|Other|0|||
23238739|NCT04668066|64615638|FG015|Part 2: Treatment Phase|Other|0|||
23238740|NCT04668066|64615639|FG016|Part 2: Treatment Phase|Other|0|||
23238741|NCT04668066|64615640|FG017|Part 2: Treatment Phase|Other|0|||
23238742|NCT04668066|64615641|FG018|Part 2: Treatment Phase|Other|1|||
23238743|NCT04668066|64615623|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238744|NCT04668066|64615624|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238745|NCT04668066|64615625|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238746|NCT04668066|64615626|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238747|NCT04668066|64615627|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238748|NCT04668066|64615628|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238749|NCT04668066|64615629|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238750|NCT04668066|64615630|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238751|NCT04668066|64615631|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238752|NCT04668066|64615632|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238753|NCT04668066|64615633|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238754|NCT04668066|64615634|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
23344984|NCT01764997|65006674|FG001|Run-in Period|Other than specified above|0|||
23344985|NCT01764997|65006675|FG002|Run-in Period|Other than specified above|0|||
23344986|NCT01764997|65006676|FG003|Run-in Period|Other than specified above|0|||
23344987|NCT01764997|65006677|FG004|Run-in Period|Other than specified above|0|||
23344988|NCT01764997|65006673|FG000|Study Drug Treatment Period|Adverse Event|0|||
23178851|NCT04426695|64397505|FG004|Overall Study|Sponsor Request|0|||
23178852|NCT04426695|64397506|FG005|Overall Study|Sponsor Request|0|||
23178853|NCT04426695|64397507|FG006|Overall Study|Sponsor Request|1|||
23178854|NCT04426695|64397508|FG007|Overall Study|Sponsor Request|0|||
23178855|NCT04426695|64397509|FG008|Overall Study|Sponsor Request|0|||
23178856|NCT04426695|64397510|FG009|Overall Study|Sponsor Request|0|||
23344989|NCT01764997|65006674|FG001|Study Drug Treatment Period|Adverse Event|1|||
23344990|NCT01764997|65006675|FG002|Study Drug Treatment Period|Adverse Event|0|||
23344991|NCT01764997|65006676|FG003|Study Drug Treatment Period|Adverse Event|0|||
23344992|NCT01764997|65006677|FG004|Study Drug Treatment Period|Adverse Event|24|||
23344993|NCT01764997|65006673|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
23344994|NCT01764997|65006674|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
23344995|NCT01764997|65006675|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
23344996|NCT01764997|65006676|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
23238755|NCT04668066|64615635|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238756|NCT04668066|64615636|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238757|NCT04668066|64615637|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238758|NCT04668066|64615638|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238759|NCT04668066|64615639|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238760|NCT04668066|64615640|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
23238761|NCT04668066|64615641|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
23238762|NCT01241591|64615646|FG000|Overall Study|Lack of Efficacy|5|||
23238763|NCT01241591|64615647|FG001|Overall Study|Lack of Efficacy|2|||
23238764|NCT01241591|64615648|FG002|Overall Study|Lack of Efficacy|2|||
23238765|NCT01241591|64615649|FG003|Overall Study|Lack of Efficacy|3|||
23178857|NCT04426695|64397511|FG010|Overall Study|Sponsor Request|0|||
23178858|NCT04426695|64397512|FG011|Overall Study|Sponsor Request|0|||
23178859|NCT04426695|64397513|FG012|Overall Study|Sponsor Request|0|||
23178860|NCT04426695|64397514|FG013|Overall Study|Sponsor Request|0|||
23178861|NCT04426695|64397515|FG014|Overall Study|Sponsor Request|0|||
23178862|NCT04426695|64397516|FG015|Overall Study|Sponsor Request|0|||
23178863|NCT04426695|64397517|FG016|Overall Study|Sponsor Request|0|||
23178864|NCT04426695|64397518|FG017|Overall Study|Sponsor Request|0|||
23178865|NCT04426695|64397501|FG000|Overall Study|Physician Decision|0|||
23178866|NCT04426695|64397502|FG001|Overall Study|Physician Decision|0|||
23178867|NCT04426695|64397503|FG002|Overall Study|Physician Decision|0|||
23178868|NCT04426695|64397504|FG003|Overall Study|Physician Decision|0|||
23178869|NCT04426695|64397505|FG004|Overall Study|Physician Decision|0|||
23178870|NCT04426695|64397506|FG005|Overall Study|Physician Decision|0|||
23178871|NCT04426695|64397507|FG006|Overall Study|Physician Decision|0|||
23178872|NCT04426695|64397508|FG007|Overall Study|Physician Decision|0|||
23178873|NCT04426695|64397509|FG008|Overall Study|Physician Decision|0|||
23178874|NCT04426695|64397510|FG009|Overall Study|Physician Decision|1|||
23178875|NCT04426695|64397511|FG010|Overall Study|Physician Decision|0|||
23178876|NCT04426695|64397512|FG011|Overall Study|Physician Decision|0|||
23178877|NCT04426695|64397513|FG012|Overall Study|Physician Decision|1|||
23178878|NCT04426695|64397514|FG013|Overall Study|Physician Decision|0|||
23178879|NCT04426695|64397515|FG014|Overall Study|Physician Decision|0|||
23238766|NCT01241591|64615646|FG000|Overall Study|Protocol Violation|5|||
23238767|NCT01241591|64615647|FG001|Overall Study|Protocol Violation|2|||
23344997|NCT01764997|65006677|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
23344998|NCT01764997|65006673|FG000|Study Drug Treatment Period|Other than specified above|0|||
23178880|NCT04426695|64397516|FG015|Overall Study|Physician Decision|0|||
23178881|NCT04426695|64397517|FG016|Overall Study|Physician Decision|0|||
23583413|NCT03631199|65866022|FG003|Overall Study|Physician Decision|19|||
23178882|NCT04426695|64397518|FG017|Overall Study|Physician Decision|0|||
23178883|NCT04426695|64397501|FG000|Overall Study|Randomized but Never Treated|3|||
23238768|NCT01241591|64615648|FG002|Overall Study|Protocol Violation|3|||
23238769|NCT01241591|64615649|FG003|Overall Study|Protocol Violation|0|||
23238770|NCT01241591|64615646|FG000|Overall Study|Lost to Follow-up|1|||
23178884|NCT04426695|64397502|FG001|Overall Study|Randomized but Never Treated|1|||
23178885|NCT04426695|64397503|FG002|Overall Study|Randomized but Never Treated|0|||
23178886|NCT04426695|64397504|FG003|Overall Study|Randomized but Never Treated|4|||
23178887|NCT04426695|64397505|FG004|Overall Study|Randomized but Never Treated|5|||
23178888|NCT04426695|64397506|FG005|Overall Study|Randomized but Never Treated|5|||
23178889|NCT04426695|64397507|FG006|Overall Study|Randomized but Never Treated|4|||
23178890|NCT04426695|64397508|FG007|Overall Study|Randomized but Never Treated|6|||
23178891|NCT04426695|64397509|FG008|Overall Study|Randomized but Never Treated|6|||
23178892|NCT04426695|64397510|FG009|Overall Study|Randomized but Never Treated|3|||
23344999|NCT01764997|65006674|FG001|Study Drug Treatment Period|Other than specified above|0|||
23345000|NCT01764997|65006675|FG002|Study Drug Treatment Period|Other than specified above|0|||
23345001|NCT01764997|65006676|FG003|Study Drug Treatment Period|Other than specified above|0|||
23345002|NCT01764997|65006677|FG004|Study Drug Treatment Period|Other than specified above|10|||
23345003|NCT01777295|65006679|FG000|Overall Study|Withdrawal by Subject|2|||
23345004|NCT01777295|65006680|FG001|Overall Study|Withdrawal by Subject|2|||
23345005|NCT01777295|65006679|FG000|Overall Study|Pregnancy|0|||
23345006|NCT01777295|65006680|FG001|Overall Study|Pregnancy|1|||
23345007|NCT01777295|65006679|FG000|Overall Study|Personal problem|1|||
23345008|NCT01777295|65006680|FG001|Overall Study|Personal problem|0|||
23345009|NCT01777295|65006679|FG000|Overall Study|Investigator call for AEs check|1|||
23345010|NCT01777295|65006680|FG001|Overall Study|Investigator call for AEs check|0|||
23345011|NCT01892085|65006681|FG000|Overall Study|Death|4|||
23345012|NCT01892085|65006682|FG001|Overall Study|Death|1|||
23345013|NCT01892085|65006683|FG002|Overall Study|Death|3|||
23345014|NCT01892085|65006681|FG000|Overall Study|Withdrawal by Subject|2|||
23345015|NCT01892085|65006682|FG001|Overall Study|Withdrawal by Subject|0|||
23345016|NCT01892085|65006683|FG002|Overall Study|Withdrawal by Subject|2|||
23178893|NCT04426695|64397511|FG010|Overall Study|Randomized but Never Treated|3|||
23178894|NCT04426695|64397512|FG011|Overall Study|Randomized but Never Treated|6|||
23178895|NCT04426695|64397513|FG012|Overall Study|Randomized but Never Treated|1|||
23178896|NCT04426695|64397514|FG013|Overall Study|Randomized but Never Treated|2|||
23178897|NCT04426695|64397515|FG014|Overall Study|Randomized but Never Treated|0|||
23178898|NCT04426695|64397516|FG015|Overall Study|Randomized but Never Treated|0|||
23178899|NCT04426695|64397517|FG016|Overall Study|Randomized but Never Treated|0|||
23178900|NCT04426695|64397518|FG017|Overall Study|Randomized but Never Treated|0|||
23238771|NCT01241591|64615647|FG001|Overall Study|Lost to Follow-up|2|||
23238772|NCT01241591|64615648|FG002|Overall Study|Lost to Follow-up|2|||
23238773|NCT01241591|64615649|FG003|Overall Study|Lost to Follow-up|2|||
23238774|NCT01241591|64615646|FG000|Overall Study|Screen Failure|3|||
23238775|NCT01241591|64615647|FG001|Overall Study|Screen Failure|2|||
23238776|NCT01241591|64615648|FG002|Overall Study|Screen Failure|1|||
23238777|NCT01241591|64615649|FG003|Overall Study|Screen Failure|0|||
23238778|NCT01241591|64615646|FG000|Overall Study|Withdrawal by Subject|6|||
23345017|NCT00477750|65006684|FG000|Overall Study|Currently Receiving Treatment|11|||
23345018|NCT02396420|65006693|FG000|Overall Study|Death|1|||
23345019|NCT02333383|65006694|FG000|Overall Study|Adalimumab discontinuation|21|||
23345020|NCT02333383|65006694|FG000|Overall Study|Lost to Follow-up|15|||
23345021|NCT02333383|65006694|FG000|Overall Study|Withdrawal by Subject|3|||
23345022|NCT02333383|65006694|FG000|Overall Study|Transfer to another hospital|2|||
23345023|NCT02474589|65006695|FG000|Overall Study|Adverse Event|6|||
23345024|NCT02474589|65006696|FG001|Overall Study|Adverse Event|2|||
23345025|NCT02474589|65006695|FG000|Overall Study|Lost to Follow-up|6|||
23345026|NCT02474589|65006696|FG001|Overall Study|Lost to Follow-up|1|||
23345027|NCT02474589|65006695|FG000|Overall Study|Protocol Violation|4|||
23345028|NCT02474589|65006696|FG001|Overall Study|Protocol Violation|1|||
23345029|NCT02474589|65006695|FG000|Overall Study|Withdrawal by Subject|4|||
23345030|NCT02474589|65006696|FG001|Overall Study|Withdrawal by Subject|0|||
23456982|NCT02052778|65416572|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
23238779|NCT01241591|64615647|FG001|Overall Study|Withdrawal by Subject|4|||
23238780|NCT01241591|64615648|FG002|Overall Study|Withdrawal by Subject|2|||
23238781|NCT01241591|64615649|FG003|Overall Study|Withdrawal by Subject|2|||
23238782|NCT01241591|64615646|FG000|Overall Study|Other|0|||
23238783|NCT01241591|64615647|FG001|Overall Study|Other|1|||
23238784|NCT01241591|64615648|FG002|Overall Study|Other|0|||
23178901|NCT01728779|64397523|FG000|Overall Study|Withdrawal by Subject|1|||
23178902|NCT01505894|64397529|FG000|Overall Study|Adverse Event|1|||
23238785|NCT01241591|64615649|FG003|Overall Study|Other|1|||
23345031|NCT02474589|65006695|FG000|Overall Study|Inability to complete study procedures|5|||
23345032|NCT02474589|65006696|FG001|Overall Study|Inability to complete study procedures|1|||
23345033|NCT02052596|65006697|FG000|Active Phase|Adverse Event|3|||
23345034|NCT02052596|65006698|FG001|Active Phase|Adverse Event|2|||
23345035|NCT02052596|65006697|FG000|Active Phase|Lost to Follow-up|8|||
23345036|NCT02052596|65006698|FG001|Active Phase|Lost to Follow-up|11|||
23345037|NCT02052596|65006697|FG000|Active Phase|Protocol Violation|1|||
23345038|NCT02052596|65006698|FG001|Active Phase|Protocol Violation|2|||
23238786|NCT01241591|64615646|FG000|Overall Study|Adverse Event|3|||
23238787|NCT01241591|64615647|FG001|Overall Study|Adverse Event|11|||
23238788|NCT01241591|64615648|FG002|Overall Study|Adverse Event|12|||
23238789|NCT01241591|64615649|FG003|Overall Study|Adverse Event|4|||
23238790|NCT02331680|64615654|FG000|Overall Study|Adverse Event|3|||
23238791|NCT02331680|64615655|FG001|Overall Study|Adverse Event|0|||
23238792|NCT02331680|64615656|FG002|Overall Study|Adverse Event|2|||
23238793|NCT02331680|64615654|FG000|Overall Study|Physician Decision|1|||
23238794|NCT02331680|64615655|FG001|Overall Study|Physician Decision|1|||
23238795|NCT02331680|64615656|FG002|Overall Study|Physician Decision|2|||
23238796|NCT02331680|64615654|FG000|Overall Study|Withdrawal by Subject|0|||
23238797|NCT02331680|64615655|FG001|Overall Study|Withdrawal by Subject|1|||
23345039|NCT02052596|65006697|FG000|Active Phase|Withdrawal by Subject|3|||
23345040|NCT02052596|65006698|FG001|Active Phase|Withdrawal by Subject|4|||
23345041|NCT02052596|65006697|FG000|Active Phase|Enrolled in error|1|||
23345042|NCT02052596|65006698|FG001|Active Phase|Enrolled in error|0|||
23345043|NCT02052596|65006697|FG000|Active Phase|Lost due to Crohn's disease|0|||
23345044|NCT02052596|65006698|FG001|Active Phase|Lost due to Crohn's disease|1|||
23345045|NCT02052596|65006697|FG000|Safety Phase|Adverse Event|6|||
23345046|NCT02052596|65006698|FG001|Safety Phase|Adverse Event|3|||
23345047|NCT02052596|65006697|FG000|Safety Phase|Lost to Follow-up|11|||
23345048|NCT02052596|65006698|FG001|Safety Phase|Lost to Follow-up|18|||
23345049|NCT02052596|65006697|FG000|Safety Phase|Protocol Violation|1|||
23345050|NCT02052596|65006698|FG001|Safety Phase|Protocol Violation|2|||
23345051|NCT02052596|65006697|FG000|Safety Phase|Withdrawal by Subject|8|||
23345052|NCT02052596|65006698|FG001|Safety Phase|Withdrawal by Subject|11|||
23345053|NCT02052596|65006697|FG000|Safety Phase|Enrolled in error|1|||
23345054|NCT02052596|65006698|FG001|Safety Phase|Enrolled in error|0|||
23345055|NCT02052596|65006697|FG000|Safety Phase|Lost due to Crohn's disease|0|||
23345056|NCT02052596|65006698|FG001|Safety Phase|Lost due to Crohn's disease|1|||
23345057|NCT00705718|65006699|FG000|Overall Study|Death|6|||
23178903|NCT01505894|64397530|FG001|Overall Study|Adverse Event|0|||
23178904|NCT01505894|64397531|FG002|Overall Study|Adverse Event|0|||
23178905|NCT01505894|64397532|FG003|Overall Study|Adverse Event|0|||
23178906|NCT01505894|64397533|FG004|Overall Study|Adverse Event|0|||
23178907|NCT01505894|64397534|FG005|Overall Study|Adverse Event|0|||
23178908|NCT01505894|64397535|FG006|Overall Study|Adverse Event|0|||
23178909|NCT01505894|64397536|FG007|Overall Study|Adverse Event|0|||
23178910|NCT01505894|64397537|FG008|Overall Study|Adverse Event|0|||
23178911|NCT01505894|64397529|FG000|Overall Study|Other than specified|0|||
23178912|NCT01505894|64397530|FG001|Overall Study|Other than specified|0|||
23178913|NCT01505894|64397531|FG002|Overall Study|Other than specified|0|||
23345058|NCT00705718|65006700|FG001|Overall Study|Death|6|||
23345059|NCT00705718|65006699|FG000|Overall Study|Not due for Visit|0|||
23345060|NCT00705718|65006700|FG001|Overall Study|Not due for Visit|12|||
23345061|NCT00705718|65006699|FG000|Overall Study|Follow up not done|1|||
23238798|NCT02331680|64615656|FG002|Overall Study|Withdrawal by Subject|2|||
23238799|NCT02331680|64615654|FG000|Overall Study|Met withdrawal criteria|2|||
23238800|NCT02331680|64615655|FG001|Overall Study|Met withdrawal criteria|2|||
23238801|NCT02331680|64615656|FG002|Overall Study|Met withdrawal criteria|5|||
23178914|NCT01505894|64397532|FG003|Overall Study|Other than specified|0|||
23178915|NCT01505894|64397533|FG004|Overall Study|Other than specified|1|||
23238802|NCT02331680|64615654|FG000|Overall Study|Non-compliance with study drug|0|||
23345062|NCT00705718|65006700|FG001|Overall Study|Follow up not done|4|||
23583414|NCT03631199|65866023|FG004|Overall Study|Physician Decision|13|||
23178916|NCT01505894|64397534|FG005|Overall Study|Other than specified|0|||
23178917|NCT01505894|64397535|FG006|Overall Study|Other than specified|0|||
23178918|NCT01505894|64397536|FG007|Overall Study|Other than specified|0|||
23238803|NCT02331680|64615655|FG001|Overall Study|Non-compliance with study drug|0|||
23238804|NCT02331680|64615656|FG002|Overall Study|Non-compliance with study drug|1|||
23238805|NCT02331680|64615654|FG000|Overall Study|Protocol Violation|0|||
23238806|NCT02331680|64615655|FG001|Overall Study|Protocol Violation|0|||
23178919|NCT01505894|64397537|FG008|Overall Study|Other than specified|0|||
23178920|NCT00792298|64397538|FG000|Treatment Period 1|Adverse Event|0|||
23178921|NCT00792298|64397539|FG001|Treatment Period 1|Adverse Event|1|||
23178922|NCT00792298|64397540|FG002|Treatment Period 1|Adverse Event|0|||
23238807|NCT02331680|64615656|FG002|Overall Study|Protocol Violation|3|||
23178923|NCT00792298|64397541|FG003|Treatment Period 1|Adverse Event|1|||
23238808|NCT01215968|64615658|FG000|Overall Study|Adverse Event|0|||
23238809|NCT01215968|64615659|FG001|Overall Study|Adverse Event|2|||
23238810|NCT01215968|64615658|FG000|Overall Study|Protocol Violation|2|||
23238811|NCT01215968|64615659|FG001|Overall Study|Protocol Violation|4|||
23345063|NCT00875433|65006701|FG000|Overall Study|Progressive disease|41|||
23345064|NCT00875433|65006701|FG000|Overall Study|Other Adverse Event|14|||
23345065|NCT00875433|65006701|FG000|Overall Study|Withdrawal by Subject|2|||
23583415|NCT03631199|65866019|FG000|Overall Study|Adverse Event|1|||
23238812|NCT01215968|64615658|FG000|Overall Study|Not received study drug|0|||
23345066|NCT00875433|65006701|FG000|Overall Study|Other|3|||
23456983|NCT02052778|65416573|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456984|NCT02052778|65416574|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456985|NCT02052778|65416575|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456986|NCT02052778|65416576|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456987|NCT02052778|65416577|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456988|NCT02052778|65416578|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456989|NCT02052778|65416579|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456990|NCT02052778|65416580|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456991|NCT02052778|65416581|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456992|NCT02052778|65416582|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
23456993|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456994|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456995|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456996|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456997|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456998|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23456999|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457000|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457001|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457002|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457003|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457004|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457005|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457006|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457007|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
23457008|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
23457009|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
23457010|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
23457011|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
23457012|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
23457013|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
23457014|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
23457015|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
23457016|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457017|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457018|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457019|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457020|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457021|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457022|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457023|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457024|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457025|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457026|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457027|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23345067|NCT02956057|65006702|FG000|Overall Study|Discontinued intervention|14|||
23345068|NCT02956057|65006703|FG001|Overall Study|Discontinued intervention|10|||
23345069|NCT02956057|65006704|FG002|Overall Study|Discontinued intervention|7|||
23345070|NCT02956057|65006705|FG003|Overall Study|Discontinued intervention|14|||
23345071|NCT02956057|65006706|FG004|Overall Study|Discontinued intervention|4|||
23345072|NCT02956057|65006707|FG005|Overall Study|Discontinued intervention|17|||
23345073|NCT02956057|65006702|FG000|Overall Study|Lost to Follow-up|0|||
23345074|NCT02956057|65006703|FG001|Overall Study|Lost to Follow-up|2|||
23345075|NCT02956057|65006704|FG002|Overall Study|Lost to Follow-up|1|||
23345076|NCT02956057|65006705|FG003|Overall Study|Lost to Follow-up|1|||
23345077|NCT02956057|65006706|FG004|Overall Study|Lost to Follow-up|1|||
23345078|NCT02956057|65006707|FG005|Overall Study|Lost to Follow-up|0|||
23345079|NCT00373958|65006709|FG000|Infant Series|Withdrawal by Subject|13|||
23457028|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23345080|NCT00373958|65006710|FG001|Infant Series|Withdrawal by Subject|15|||
23345081|NCT00373958|65006709|FG000|Infant Series|Failed to return|8|||
23345082|NCT00373958|65006710|FG001|Infant Series|Failed to return|13|||
23345083|NCT00373958|65006709|FG000|Infant Series|Lost to Follow-up|6|||
23457029|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457030|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
23457031|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
23457032|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457033|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
23457034|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
23457035|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
23457036|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
23457037|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
23457038|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
23457039|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457040|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457041|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457042|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457043|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457044|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457045|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457046|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457047|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457048|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457049|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457050|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457051|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457052|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457053|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
23457054|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
23457055|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
23457056|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457057|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
23457058|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
23457059|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457060|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23457061|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
23583416|NCT03631199|65866020|FG001|Overall Study|Adverse Event|1|||
23583417|NCT03631199|65866021|FG002|Overall Study|Adverse Event|0|||
23583418|NCT03631199|65866022|FG003|Overall Study|Adverse Event|28|||
23583419|NCT03631199|65866023|FG004|Overall Study|Adverse Event|29|||
23583420|NCT03631199|65866019|FG000|Overall Study|Death|0|||
23583421|NCT03631199|65866020|FG001|Overall Study|Death|1|||
23583422|NCT03631199|65866021|FG002|Overall Study|Death|0|||
23583423|NCT03631199|65866022|FG003|Overall Study|Death|35|||
23583424|NCT03631199|65866023|FG004|Overall Study|Death|48|||
23583425|NCT03631199|65866019|FG000|Overall Study|Subject decision|0|||
23583426|NCT03631199|65866020|FG001|Overall Study|Subject decision|1|||
23583427|NCT03631199|65866021|FG002|Overall Study|Subject decision|0|||
23583428|NCT03631199|65866022|FG003|Overall Study|Subject decision|12|||
23583429|NCT03631199|65866023|FG004|Overall Study|Subject decision|12|||
23583430|NCT03631199|65866019|FG000|Overall Study|No treated|0|||
23583431|NCT03631199|65866020|FG001|Overall Study|No treated|0|||
23583432|NCT03631199|65866021|FG002|Overall Study|No treated|0|||
23583433|NCT03631199|65866022|FG003|Overall Study|No treated|0|||
23583434|NCT03631199|65866023|FG004|Overall Study|No treated|1|||
23583435|NCT03631199|65866019|FG000|Overall Study|Treatment ongoing|0|||
23583436|NCT03631199|65866020|FG001|Overall Study|Treatment ongoing|1|||
23583437|NCT03631199|65866021|FG002|Overall Study|Treatment ongoing|1|||
23583438|NCT03631199|65866022|FG003|Overall Study|Treatment ongoing|76|||
23583439|NCT03631199|65866023|FG004|Overall Study|Treatment ongoing|71|||
23583440|NCT03631199|65866019|FG000|Overall Study|Guardian decision|0|||
23583441|NCT03631199|65866020|FG001|Overall Study|Guardian decision|0|||
23583442|NCT03631199|65866021|FG002|Overall Study|Guardian decision|0|||
23583443|NCT03631199|65866022|FG003|Overall Study|Guardian decision|1|||
23583444|NCT03631199|65866023|FG004|Overall Study|Guardian decision|1|||
23583445|NCT04011033|65866024|FG000|Overall Study|Physician Decision|2|||
23583446|NCT04011033|65866025|FG001|Overall Study|Physician Decision|3|||
23583447|NCT04011033|65866024|FG000|Overall Study|Withdrawal by Subject|1|||
23457062|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457063|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457064|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457065|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457066|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457067|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457068|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457069|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457070|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457071|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457072|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457073|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457074|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457075|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457076|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
23345084|NCT00373958|65006710|FG001|Infant Series|Lost to Follow-up|5|||
23345085|NCT00373958|65006709|FG000|Infant Series|Protocol Violation|3|||
23345086|NCT00373958|65006710|FG001|Infant Series|Protocol Violation|7|||
23345087|NCT00373958|65006709|FG000|Infant Series|Lost Kaiser coverage|4|||
23345088|NCT00373958|65006710|FG001|Infant Series|Lost Kaiser coverage|0|||
23345089|NCT00373958|65006709|FG000|Infant Series|Child relocated|1|||
23345090|NCT00373958|65006710|FG001|Infant Series|Child relocated|0|||
23345091|NCT00373958|65006709|FG000|Infant Series|Consent was not received|1|||
23345092|NCT00373958|65006710|FG001|Infant Series|Consent was not received|0|||
23345093|NCT00373958|65006709|FG000|Infant Series|Adverse Event|3|||
23345094|NCT00373958|65006710|FG001|Infant Series|Adverse Event|1|||
23345095|NCT00373958|65006709|FG000|Infant Series|Physician Decision|1|||
23345096|NCT00373958|65006710|FG001|Infant Series|Physician Decision|1|||
23345097|NCT00373958|65006709|FG000|Toddler Dose|Lost to Follow-up|5|||
23345098|NCT00373958|65006710|FG001|Toddler Dose|Lost to Follow-up|8|||
23345099|NCT00373958|65006709|FG000|Toddler Dose|Withdrawal by Subject|2|||
23345100|NCT00373958|65006710|FG001|Toddler Dose|Withdrawal by Subject|2|||
23345101|NCT00373958|65006709|FG000|Toddler Dose|Failed to return|1|||
23345102|NCT00373958|65006710|FG001|Toddler Dose|Failed to return|2|||
23345103|NCT00373958|65006709|FG000|Toddler Dose|Protocol Violation|0|||
23345104|NCT00373958|65006710|FG001|Toddler Dose|Protocol Violation|1|||
23345105|NCT00373958|65006709|FG000|Toddler Dose|Withdrawn after infant series|22|||
23345106|NCT00373958|65006710|FG001|Toddler Dose|Withdrawn after infant series|25|||
23345107|NCT00732758|65006713|FG000|Overall Study|Lost to Follow-up|8|||
23345108|NCT00732758|65006714|FG001|Overall Study|Lost to Follow-up|16|||
23345109|NCT00501059|65006715|FG000|Overall Study|Protocol Violation|80|||
23345110|NCT00501059|65006716|FG001|Overall Study|Protocol Violation|69|||
23345111|NCT00501059|65006715|FG000|Overall Study|Death|140|||
23345112|NCT00501059|65006716|FG001|Overall Study|Death|137|||
23345113|NCT00501059|65006715|FG000|Overall Study|Other|236|||
23345114|NCT00501059|65006716|FG001|Overall Study|Other|239|||
23345115|NCT00501059|65006715|FG000|Overall Study|Missing end-of-study page|91|||
23345116|NCT00501059|65006716|FG001|Overall Study|Missing end-of-study page|92|||
23345117|NCT00501059|65006715|FG000|Overall Study|Clinical endpoint reached|110|||
23345118|NCT00501059|65006716|FG001|Overall Study|Clinical endpoint reached|123|||
23345119|NCT00501059|65006715|FG000|Overall Study|Insufficient therapeutic effect|4|||
23345120|NCT00501059|65006716|FG001|Overall Study|Insufficient therapeutic effect|5|||
23345121|NCT00501059|65006715|FG000|Overall Study|Consent withdrawn by subject|817|||
23345122|NCT00501059|65006716|FG001|Overall Study|Consent withdrawn by subject|873|||
23345123|NCT00501059|65006715|FG000|Overall Study|Non-compliant with study treatment|23|||
23345124|NCT00501059|65006716|FG001|Overall Study|Non-compliant with study treatment|16|||
23345125|NCT00501059|65006715|FG000|Overall Study|Reason not given|3|||
23345126|NCT00501059|65006716|FG001|Overall Study|Reason not given|1|||
23345127|NCT00501059|65006715|FG000|Overall Study|Adverse Event|129|||
23345128|NCT00501059|65006716|FG001|Overall Study|Adverse Event|122|||
23178924|NCT00792298|64397542|FG004|Treatment Period 1|Adverse Event|0|||
23345129|NCT00501059|65006715|FG000|Overall Study|Lost to Follow-up|210|||
23345130|NCT00501059|65006716|FG001|Overall Study|Lost to Follow-up|198|||
23345131|NCT00501059|65006715|FG000|Overall Study|Not treated|25|||
23345132|NCT00501059|65006716|FG001|Overall Study|Not treated|17|||
23345133|NCT01664949|65006717|FG000|Overall Study|Adverse Event|11|||
23345134|NCT01664949|65006718|FG001|Overall Study|Adverse Event|12|||
23345135|NCT01664949|65006717|FG000|Overall Study|Lack of Efficacy|1|||
23345136|NCT01664949|65006718|FG001|Overall Study|Lack of Efficacy|1|||
23345137|NCT01664949|65006717|FG000|Overall Study|Lost to Follow-up|1|||
23345138|NCT01664949|65006718|FG001|Overall Study|Lost to Follow-up|2|||
23345139|NCT01664949|65006717|FG000|Overall Study|Personal Reasons|3|||
23345140|NCT01664949|65006718|FG001|Overall Study|Personal Reasons|4|||
23345141|NCT01664949|65006717|FG000|Overall Study|Protocol Violation|5|||
23457077|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
23457078|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457079|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457080|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23345142|NCT01664949|65006718|FG001|Overall Study|Protocol Violation|5|||
23345143|NCT01664949|65006717|FG000|Overall Study|Other Miscellaneous Reasons|3|||
23457081|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457082|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457083|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457084|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
23457085|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457086|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457087|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457088|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457089|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457090|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457091|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457092|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457093|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457094|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457095|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457096|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457097|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457098|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457099|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
23457100|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
23457101|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457102|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457103|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457104|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
23457105|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457106|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457107|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
23457108|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
23457109|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
23457110|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
23457111|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
23457112|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
23457113|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
23457114|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
23457115|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
23457116|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
23457117|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
23457118|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
23457119|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
23457120|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
23457121|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
23457122|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
23457123|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
23457124|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
23457125|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
23457126|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
23457127|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
23457128|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
23457129|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
23457130|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
23457131|NCT02052778|65416560|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457132|NCT02052778|65416561|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457133|NCT02052778|65416562|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457134|NCT02052778|65416563|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457135|NCT02052778|65416564|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457136|NCT02052778|65416565|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457137|NCT02052778|65416566|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457138|NCT02052778|65416567|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457139|NCT02052778|65416568|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457140|NCT02052778|65416569|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457141|NCT02052778|65416570|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457142|NCT02052778|65416571|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457143|NCT02052778|65416572|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457144|NCT02052778|65416573|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457145|NCT02052778|65416574|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
23457146|NCT02052778|65416575|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
23457147|NCT02052778|65416576|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
23457148|NCT02052778|65416577|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457149|NCT02052778|65416578|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
23457150|NCT02052778|65416579|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457151|NCT02052778|65416580|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457152|NCT02052778|65416581|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457153|NCT02052778|65416582|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
23457154|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457155|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457156|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23345144|NCT01664949|65006718|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23345145|NCT00784238|65006722|FG000|Overall Study|Adverse Event|14|||
23345146|NCT00784238|65006722|FG000|Overall Study|Death|2|||
23345147|NCT00784238|65006722|FG000|Overall Study|Lack of Efficacy|33|||
23345148|NCT00784238|65006722|FG000|Overall Study|Lost to Follow-up|29|||
23457157|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457158|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23178925|NCT00792298|64397543|FG005|Treatment Period 1|Adverse Event|1|||
23457159|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23178926|NCT00792298|64397544|FG006|Treatment Period 1|Adverse Event|1|||
23178927|NCT00792298|64397545|FG007|Treatment Period 1|Adverse Event|0|||
23178928|NCT00792298|64397538|FG000|Treatment Period 1|Lack of Efficacy|0|||
23457160|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457161|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457162|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457163|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457164|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457165|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23583448|NCT04011033|65866025|FG001|Overall Study|Withdrawal by Subject|0|||
23583449|NCT00580801|65866026|FG000|Overall Study|Physician Decision|1|||
23178929|NCT00792298|64397539|FG001|Treatment Period 1|Lack of Efficacy|0|||
23178930|NCT00792298|64397540|FG002|Treatment Period 1|Lack of Efficacy|1|||
23583450|NCT00580801|65866027|FG001|Overall Study|Physician Decision|0|||
23583451|NCT00580801|65866028|FG002|Overall Study|Physician Decision|0|||
23583452|NCT00580801|65866026|FG000|Overall Study|Adverse Event|2|||
23583453|NCT00580801|65866027|FG001|Overall Study|Adverse Event|0|||
23583454|NCT00580801|65866028|FG002|Overall Study|Adverse Event|0|||
23583455|NCT00580801|65866026|FG000|Overall Study|Lost to Follow-up|2|||
23583456|NCT00580801|65866027|FG001|Overall Study|Lost to Follow-up|0|||
23583457|NCT00580801|65866028|FG002|Overall Study|Lost to Follow-up|0|||
23583458|NCT00580801|65866026|FG000|Overall Study|Reached a virologic endpoint|0|||
23583459|NCT00580801|65866027|FG001|Overall Study|Reached a virologic endpoint|1|||
23583460|NCT00580801|65866028|FG002|Overall Study|Reached a virologic endpoint|2|||
23583461|NCT00580801|65866026|FG000|Overall Study|Participant non-compliant|0|||
23583462|NCT00580801|65866027|FG001|Overall Study|Participant non-compliant|0|||
23583463|NCT00580801|65866028|FG002|Overall Study|Participant non-compliant|1|||
23583464|NCT00580801|65866026|FG000|Overall Study|Travel|1|||
23178931|NCT00792298|64397541|FG003|Treatment Period 1|Lack of Efficacy|0|||
23583465|NCT00580801|65866027|FG001|Overall Study|Travel|0|||
23583466|NCT00580801|65866028|FG002|Overall Study|Travel|0|||
23583467|NCT04109118|65866029|FG000|Overall Study|Lost to Follow-up|3|||
23583468|NCT02155829|65866030|FG000|Overall Study|Adverse Event|1|||
23178932|NCT00792298|64397542|FG004|Treatment Period 1|Lack of Efficacy|0|||
23457166|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457167|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457168|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457169|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457170|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457171|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457172|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457173|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457174|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457175|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
23457176|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
23457177|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457178|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457179|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457180|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457181|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23178933|NCT00792298|64397543|FG005|Treatment Period 1|Lack of Efficacy|0|||
23178934|NCT00792298|64397544|FG006|Treatment Period 1|Lack of Efficacy|0|||
23178935|NCT00792298|64397545|FG007|Treatment Period 1|Lack of Efficacy|0|||
23178936|NCT00792298|64397538|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23178937|NCT00792298|64397539|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23178938|NCT00792298|64397540|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23178939|NCT00792298|64397541|FG003|Treatment Period 1|Withdrawal by Subject|2|||
23178940|NCT00792298|64397542|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23178941|NCT00792298|64397543|FG005|Treatment Period 1|Withdrawal by Subject|2|||
23178942|NCT00792298|64397544|FG006|Treatment Period 1|Withdrawal by Subject|1|||
23178943|NCT00792298|64397545|FG007|Treatment Period 1|Withdrawal by Subject|0|||
23178944|NCT00792298|64397538|FG000|Treatment Period 1|Lost to Follow-up|0|||
23178945|NCT00792298|64397539|FG001|Treatment Period 1|Lost to Follow-up|0|||
23178946|NCT00792298|64397540|FG002|Treatment Period 1|Lost to Follow-up|0|||
23178947|NCT00792298|64397541|FG003|Treatment Period 1|Lost to Follow-up|0|||
23178948|NCT00792298|64397542|FG004|Treatment Period 1|Lost to Follow-up|0|||
23178949|NCT00792298|64397543|FG005|Treatment Period 1|Lost to Follow-up|0|||
23178950|NCT00792298|64397544|FG006|Treatment Period 1|Lost to Follow-up|1|||
23178951|NCT00792298|64397545|FG007|Treatment Period 1|Lost to Follow-up|0|||
23178952|NCT00792298|64397538|FG000|Treatment Period 1|Physician Decision|0|||
23178953|NCT00792298|64397539|FG001|Treatment Period 1|Physician Decision|0|||
23178954|NCT00792298|64397540|FG002|Treatment Period 1|Physician Decision|0|||
23457182|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23583469|NCT02155829|65866031|FG001|Overall Study|Adverse Event|0|||
23583470|NCT02155829|65866030|FG000|Overall Study|Withdrawal by Subject|3|||
23583471|NCT02155829|65866031|FG001|Overall Study|Withdrawal by Subject|3|||
23583472|NCT02155829|65866030|FG000|Overall Study|Protocol Violation|2|||
23583473|NCT02155829|65866031|FG001|Overall Study|Protocol Violation|0|||
23583474|NCT01582945|65866032|FG000|Overall Study|Intolerable side-effects|1|||
23583475|NCT01582945|65866032|FG000|Overall Study|Scheduling conflicts|1|||
23583476|NCT02451943|65866036|FG000|Overall Study|On Treatment|4|||
23583477|NCT02451943|65866037|FG001|Overall Study|On Treatment|4|||
23583478|NCT02451943|65866036|FG000|Overall Study|Withdrawal by Subject|13|||
23583479|NCT02451943|65866037|FG001|Overall Study|Withdrawal by Subject|16|||
23583480|NCT02451943|65866036|FG000|Overall Study|Lost to Follow-up|3|||
23583481|NCT02451943|65866037|FG001|Overall Study|Lost to Follow-up|4|||
23583482|NCT02812966|65866040|FG000|Overall Study|Death|1|||
23583483|NCT02812966|65866041|FG001|Overall Study|Death|0|||
23583484|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
23583485|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
23583486|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583487|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583488|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583489|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583490|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583491|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583492|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583493|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583494|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583495|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583496|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583497|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
23583498|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
23178955|NCT00792298|64397541|FG003|Treatment Period 1|Physician Decision|1|||
23457183|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457184|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457185|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23238813|NCT01215968|64615659|FG001|Overall Study|Not received study drug|1|||
23238814|NCT00903357|64615660|FG000|First Intervention|Withdrawal by Subject|5|||
23238815|NCT00903357|64615661|FG001|First Intervention|Withdrawal by Subject|3|||
23238816|NCT00903357|64615660|FG000|First Intervention|Flu|0|||
23238817|NCT00903357|64615661|FG001|First Intervention|Flu|1|||
23457186|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457187|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457188|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23178956|NCT00792298|64397542|FG004|Treatment Period 1|Physician Decision|0|||
23178957|NCT00792298|64397543|FG005|Treatment Period 1|Physician Decision|0|||
23178958|NCT00792298|64397544|FG006|Treatment Period 1|Physician Decision|1|||
23178959|NCT00792298|64397545|FG007|Treatment Period 1|Physician Decision|0|||
23178960|NCT00792298|64397538|FG000|Treatment Period 1|Protocol Violation|0|||
23178961|NCT00792298|64397539|FG001|Treatment Period 1|Protocol Violation|0|||
23238818|NCT00903357|64615660|FG000|Wash Out Period of 2 Weeks|Flu|0|||
23238819|NCT00903357|64615661|FG001|Wash Out Period of 2 Weeks|Flu|1|||
23238820|NCT00903357|64615660|FG000|Second Intervention|Lost to Follow-up|1|||
23238821|NCT00903357|64615661|FG001|Second Intervention|Lost to Follow-up|0|||
23238822|NCT02815670|64615663|FG000|Overall Study|Prematurely discontinued of the trial|1|||
23238823|NCT01151085|64615665|FG000|Overall Study|Lost to Follow-up|31|||
23238824|NCT01151085|64615665|FG000|Overall Study|Protocol Violation|25|||
23238825|NCT01317199|64615667|FG000|Dose-escalation Phase 1|Physician Decision|5|||
23238826|NCT01317199|64615668|FG001|Dose-escalation Phase 1|Physician Decision|0|||
23238827|NCT01317199|64615669|FG002|Dose-escalation Phase 1|Physician Decision|0|||
23238828|NCT01317199|64615670|FG003|Dose-escalation Phase 1|Physician Decision|0|||
23238829|NCT01317199|64615667|FG000|Dose-escalation Phase 1|Disease progression|1|||
23238830|NCT01317199|64615668|FG001|Dose-escalation Phase 1|Disease progression|0|||
23238831|NCT01317199|64615669|FG002|Dose-escalation Phase 1|Disease progression|0|||
23238832|NCT01317199|64615670|FG003|Dose-escalation Phase 1|Disease progression|0|||
23238833|NCT01317199|64615667|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
23238834|NCT01317199|64615668|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
23238835|NCT01317199|64615669|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
23238836|NCT01317199|64615670|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
23238837|NCT01317199|64615667|FG000|Randomized Phase 2|Disease progression|0|||
23238838|NCT01317199|64615668|FG001|Randomized Phase 2|Disease progression|3|||
23238839|NCT01317199|64615669|FG002|Randomized Phase 2|Disease progression|7|||
23238840|NCT01317199|64615670|FG003|Randomized Phase 2|Disease progression|5|||
23238841|NCT01317199|64615667|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
23238842|NCT01317199|64615668|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
23238843|NCT01317199|64615669|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
23238844|NCT01317199|64615670|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
23238845|NCT01317199|64615667|FG000|Randomized Phase 2|Adverse Event|0|||
23238846|NCT01317199|64615668|FG001|Randomized Phase 2|Adverse Event|0|||
23178962|NCT00792298|64397540|FG002|Treatment Period 1|Protocol Violation|0|||
23178963|NCT00792298|64397541|FG003|Treatment Period 1|Protocol Violation|0|||
23238847|NCT01317199|64615669|FG002|Randomized Phase 2|Adverse Event|0|||
23238848|NCT01317199|64615670|FG003|Randomized Phase 2|Adverse Event|1|||
23238849|NCT01317199|64615667|FG000|Randomized Phase 2|Comorbidities|0|||
23345149|NCT00784238|65006722|FG000|Overall Study|Pregnancy|1|||
23178964|NCT00792298|64397542|FG004|Treatment Period 1|Protocol Violation|0|||
23238850|NCT01317199|64615668|FG001|Randomized Phase 2|Comorbidities|2|||
23238851|NCT01317199|64615669|FG002|Randomized Phase 2|Comorbidities|2|||
23345150|NCT00784238|65006722|FG000|Overall Study|Withdrawal by Subject|26|||
23345151|NCT00784238|65006722|FG000|Overall Study|Other|14|||
23345152|NCT01044290|65006723|FG000|Follow-up 1|Death|3|||
23345153|NCT01044290|65006724|FG001|Follow-up 1|Death|3|||
23345154|NCT01044290|65006725|FG002|Follow-up 1|Death|1|||
23345155|NCT01044290|65006723|FG000|Follow-up 1|Withdrawal by Subject|2|||
23345156|NCT01044290|65006724|FG001|Follow-up 1|Withdrawal by Subject|2|||
23345157|NCT01044290|65006725|FG002|Follow-up 1|Withdrawal by Subject|0|||
23345158|NCT01044290|65006723|FG000|Follow-Up 2|Death|0|||
23345159|NCT01044290|65006724|FG001|Follow-Up 2|Death|1|||
23345160|NCT01044290|65006725|FG002|Follow-Up 2|Death|1|||
23345161|NCT01044290|65006723|FG000|Follow-Up 2|Withdrawal by Subject|0|||
23345162|NCT01044290|65006724|FG001|Follow-Up 2|Withdrawal by Subject|1|||
23345163|NCT01044290|65006725|FG002|Follow-Up 2|Withdrawal by Subject|1|||
23457189|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457190|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457191|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23178965|NCT00792298|64397543|FG005|Treatment Period 1|Protocol Violation|0|||
23178966|NCT00792298|64397544|FG006|Treatment Period 1|Protocol Violation|0|||
23178967|NCT00792298|64397545|FG007|Treatment Period 1|Protocol Violation|1|||
23457192|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23583499|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
23178968|NCT00792298|64397538|FG000|Washout|Adverse Event|0|||
23178969|NCT00792298|64397539|FG001|Washout|Adverse Event|0|||
23178970|NCT00792298|64397540|FG002|Washout|Adverse Event|0|||
23178971|NCT00792298|64397541|FG003|Washout|Adverse Event|0|||
23178972|NCT00792298|64397542|FG004|Washout|Adverse Event|0|||
23178973|NCT00792298|64397543|FG005|Washout|Adverse Event|1|||
23178974|NCT00792298|64397544|FG006|Washout|Adverse Event|0|||
23178975|NCT00792298|64397545|FG007|Washout|Adverse Event|0|||
23238852|NCT01317199|64615670|FG003|Randomized Phase 2|Comorbidities|2|||
23238853|NCT01317199|64615667|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
23238854|NCT01317199|64615668|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
23238855|NCT01317199|64615669|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
23238856|NCT01317199|64615670|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
23238857|NCT01317199|64615667|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
23238858|NCT01317199|64615668|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
23238859|NCT01317199|64615669|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
23238860|NCT01317199|64615670|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
23238861|NCT01317199|64615667|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
23238862|NCT01317199|64615668|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
23238863|NCT01317199|64615669|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
23238864|NCT01317199|64615670|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
23238865|NCT01317199|64615667|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
23238866|NCT01317199|64615668|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
23238867|NCT01317199|64615669|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
23238868|NCT01317199|64615670|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
23238869|NCT02061293|64615671|FG000|Overall Study|Elevated Blood Pressure|1|||
23238870|NCT02061293|64615672|FG001|Overall Study|Elevated Blood Pressure|1|||
23238871|NCT04988035|64615673|FG000|Overall Study|Death|19|||
23238872|NCT04988035|64615674|FG001|Overall Study|Death|13|||
23238873|NCT04988035|64615673|FG000|Overall Study|Lost to Follow-up|12|||
23238874|NCT04988035|64615674|FG001|Overall Study|Lost to Follow-up|6|||
23238875|NCT04988035|64615673|FG000|Overall Study|Protocol Violation|0|||
23238876|NCT04988035|64615674|FG001|Overall Study|Protocol Violation|1|||
23238877|NCT04988035|64615673|FG000|Overall Study|Withdrawal by Subject|2|||
23238878|NCT04988035|64615674|FG001|Overall Study|Withdrawal by Subject|4|||
23238879|NCT04988035|64615673|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
23238880|NCT04988035|64615674|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
23238881|NCT01495793|64615675|FG000|Overall Study|Lost to Follow-up|1|||
23238882|NCT01495793|64615675|FG000|Overall Study|Violation of inclusion criteria|1|||
23345164|NCT00664859|65006726|FG000|Overall Study|Adverse Event|2|||
23345165|NCT00664859|65006727|FG001|Overall Study|Adverse Event|1|||
23345166|NCT00664859|65006728|FG002|Overall Study|Adverse Event|3|||
23345167|NCT00664859|65006726|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
23583500|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583501|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583502|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583503|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583504|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583505|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583506|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583507|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23178976|NCT00792298|64397538|FG000|Washout|Withdrawal by Subject|0|||
23345168|NCT00664859|65006727|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
23345169|NCT00664859|65006728|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
23345170|NCT00664859|65006726|FG000|Overall Study|Noncompliance with protocol|1|||
23345171|NCT00664859|65006727|FG001|Overall Study|Noncompliance with protocol|0|||
23345172|NCT00664859|65006728|FG002|Overall Study|Noncompliance with protocol|4|||
23345173|NCT00664859|65006726|FG000|Overall Study|Laboratory abnormality|2|||
23345174|NCT00664859|65006727|FG001|Overall Study|Laboratory abnormality|1|||
23345175|NCT00664859|65006728|FG002|Overall Study|Laboratory abnormality|4|||
23178977|NCT00792298|64397539|FG001|Washout|Withdrawal by Subject|0|||
23178978|NCT00792298|64397540|FG002|Washout|Withdrawal by Subject|1|||
23345176|NCT00664859|65006726|FG000|Overall Study|Withdrawal by Subject|4|||
23345177|NCT00664859|65006727|FG001|Overall Study|Withdrawal by Subject|1|||
23345178|NCT00664859|65006728|FG002|Overall Study|Withdrawal by Subject|3|||
23345179|NCT00664859|65006726|FG000|Overall Study|Lost to Follow-up|2|||
23345180|NCT00664859|65006727|FG001|Overall Study|Lost to Follow-up|2|||
23345181|NCT00664859|65006728|FG002|Overall Study|Lost to Follow-up|1|||
23345182|NCT00664859|65006726|FG000|Overall Study|Other|0|||
23345183|NCT00664859|65006727|FG001|Overall Study|Other|1|||
23345184|NCT00664859|65006728|FG002|Overall Study|Other|2|||
23345185|NCT03379792|65006729|FG000|Overall Study|Physician Decision|0|||
23345186|NCT03379792|65006730|FG001|Overall Study|Physician Decision|0|||
23345187|NCT03379792|65006731|FG002|Overall Study|Physician Decision|0|||
23345188|NCT03379792|65006732|FG003|Overall Study|Physician Decision|1|||
23345189|NCT03379792|65006733|FG004|Overall Study|Physician Decision|0|||
23345190|NCT03379792|65006734|FG005|Overall Study|Physician Decision|0|||
23345191|NCT03379792|65006729|FG000|Overall Study|Withdrawal by Subject|0|||
23345192|NCT03379792|65006730|FG001|Overall Study|Withdrawal by Subject|0|||
23345193|NCT03379792|65006731|FG002|Overall Study|Withdrawal by Subject|0|||
23345194|NCT03379792|65006732|FG003|Overall Study|Withdrawal by Subject|0|||
23345195|NCT03379792|65006733|FG004|Overall Study|Withdrawal by Subject|1|||
23345196|NCT03379792|65006734|FG005|Overall Study|Withdrawal by Subject|1|||
23345197|NCT01282164|65006735|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
23345198|NCT01282164|65006736|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
23345199|NCT00784550|65006738|FG000|Overall Study|Adverse Event|12|||
23345200|NCT00784550|65006739|FG001|Overall Study|Adverse Event|10|||
23345201|NCT00784550|65006738|FG000|Overall Study|Lack of Efficacy|0|||
23345202|NCT00784550|65006739|FG001|Overall Study|Lack of Efficacy|1|||
23345203|NCT00784550|65006738|FG000|Overall Study|Protocol Violation|10|||
23345204|NCT00784550|65006739|FG001|Overall Study|Protocol Violation|10|||
23345205|NCT00784550|65006738|FG000|Overall Study|Lost to Follow-up|8|||
23345206|NCT00784550|65006739|FG001|Overall Study|Lost to Follow-up|5|||
23345207|NCT00784550|65006738|FG000|Overall Study|Physician Decision|2|||
23345208|NCT00784550|65006739|FG001|Overall Study|Physician Decision|3|||
23178979|NCT00792298|64397541|FG003|Washout|Withdrawal by Subject|0|||
23345209|NCT00784550|65006738|FG000|Overall Study|Withdrawal by Subject|4|||
23345210|NCT00784550|65006739|FG001|Overall Study|Withdrawal by Subject|13|||
23345211|NCT00270231|65006740|FG000|First Intervention|Lost to Follow-up|1|||
23345212|NCT00270231|65006741|FG001|First Intervention|Lost to Follow-up|1|||
23345213|NCT00270231|65006740|FG000|Washout Period|Lost to Follow-up|1|||
23345214|NCT00270231|65006741|FG001|Washout Period|Lost to Follow-up|0|||
23345215|NCT00270231|65006740|FG000|Second Intervention|Lost to Follow-up|0|||
23178980|NCT00792298|64397542|FG004|Washout|Withdrawal by Subject|0|||
23178981|NCT00792298|64397543|FG005|Washout|Withdrawal by Subject|1|||
23178982|NCT00792298|64397544|FG006|Washout|Withdrawal by Subject|0|||
23178983|NCT00792298|64397545|FG007|Washout|Withdrawal by Subject|0|||
23178984|NCT00792298|64397538|FG000|Treatment Period 2|Lack of Efficacy|0|||
23178985|NCT00792298|64397539|FG001|Treatment Period 2|Lack of Efficacy|0|||
23178986|NCT00792298|64397540|FG002|Treatment Period 2|Lack of Efficacy|0|||
23345216|NCT00270231|65006741|FG001|Second Intervention|Lost to Follow-up|1|||
23345217|NCT02928770|65006742|FG000|Overall Study|Withdrawal by Subject|2|||
23345218|NCT00819780|65006744|FG000|Overall Study|Did not receive study drug|3|||
23345219|NCT00819780|65006745|FG001|Overall Study|Did not receive study drug|4|||
23345220|NCT00819780|65006744|FG000|Overall Study|Still in treatment|25|||
23345221|NCT00819780|65006745|FG001|Overall Study|Still in treatment|17|||
23345222|NCT02706886|65006746|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
23345223|NCT02706886|65006747|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
23345224|NCT02706886|65006748|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
23345225|NCT02706886|65006749|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
23345226|NCT02706886|65006750|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
23345227|NCT02706886|65006751|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
23345228|NCT02706886|65006752|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
23178987|NCT00792298|64397541|FG003|Treatment Period 2|Lack of Efficacy|0|||
23178988|NCT00792298|64397542|FG004|Treatment Period 2|Lack of Efficacy|1|||
23178989|NCT00792298|64397543|FG005|Treatment Period 2|Lack of Efficacy|0|||
23345229|NCT02706886|65006753|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
23345230|NCT02706886|65006754|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
23345231|NCT02062944|65006755|FG000|Overall Study|Lost to Follow-up|1|||
23345232|NCT02062944|65006755|FG000|Overall Study|New hemotological disorder identified|1|||
23345233|NCT02062944|65006755|FG000|Overall Study|Uncontrolled Hypertension|1|||
23345234|NCT02062944|65006755|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
23345235|NCT03417024|65006756|FG000|Overall Study|Study Termination prior to follow-up|11|||
23345236|NCT03417024|65006756|FG000|Overall Study|Physician Decision|2|||
23345237|NCT03673345|65006760|FG000|Overall Study|Lost to Follow-up|1|||
23345238|NCT03673345|65006761|FG001|Overall Study|Lost to Follow-up|0|||
23345239|NCT03673345|65006762|FG002|Overall Study|Lost to Follow-up|3|||
23345240|NCT03673345|65006763|FG003|Overall Study|Lost to Follow-up|3|||
23345241|NCT03673345|65006764|FG004|Overall Study|Lost to Follow-up|2|||
23345242|NCT03673345|65006765|FG005|Overall Study|Lost to Follow-up|1|||
23345243|NCT03673345|65006766|FG006|Overall Study|Lost to Follow-up|0|||
23345244|NCT03673345|65006767|FG007|Overall Study|Lost to Follow-up|0|||
23345245|NCT03673345|65006760|FG000|Overall Study|Withdrawal by Subject|1|||
23345246|NCT03673345|65006761|FG001|Overall Study|Withdrawal by Subject|0|||
23345247|NCT03673345|65006762|FG002|Overall Study|Withdrawal by Subject|4|||
23345248|NCT03673345|65006763|FG003|Overall Study|Withdrawal by Subject|2|||
23345249|NCT03673345|65006764|FG004|Overall Study|Withdrawal by Subject|0|||
23345250|NCT03673345|65006765|FG005|Overall Study|Withdrawal by Subject|0|||
23345251|NCT03673345|65006766|FG006|Overall Study|Withdrawal by Subject|0|||
23345252|NCT03673345|65006767|FG007|Overall Study|Withdrawal by Subject|0|||
23345253|NCT03673345|65006760|FG000|Overall Study|Physician Decision|0|||
23345254|NCT03673345|65006761|FG001|Overall Study|Physician Decision|0|||
23345255|NCT03673345|65006762|FG002|Overall Study|Physician Decision|2|||
23345256|NCT03673345|65006763|FG003|Overall Study|Physician Decision|0|||
23345257|NCT03673345|65006764|FG004|Overall Study|Physician Decision|0|||
23345258|NCT03673345|65006765|FG005|Overall Study|Physician Decision|0|||
23345259|NCT03673345|65006766|FG006|Overall Study|Physician Decision|0|||
23345260|NCT03673345|65006767|FG007|Overall Study|Physician Decision|0|||
23345261|NCT04601103|65006768|FG000|Overall Study|Needed crown & cleaning|0|||
23345262|NCT04601103|65006769|FG001|Overall Study|Needed crown & cleaning|0|||
23345263|NCT04601103|65006770|FG002|Overall Study|Needed crown & cleaning|1|||
23345264|NCT04601103|65006768|FG000|Overall Study|study was terminated|18|||
23345265|NCT04601103|65006769|FG001|Overall Study|study was terminated|18|||
23345266|NCT04601103|65006770|FG002|Overall Study|study was terminated|16|||
23345267|NCT04299048|65006771|FG000|Overall Study|Death|1|||
23345268|NCT04299048|65006771|FG000|Overall Study|Global deterioration of health status|2|||
23345269|NCT04299048|65006771|FG000|Overall Study|Enrolled and not treated|1|||
23345270|NCT04676022|65006782|FG000|Overall Study|Screen Failure/|1|||
23345271|NCT04676022|65006783|FG001|Overall Study|Screen Failure/|1|||
23345272|NCT04676022|65006784|FG002|Overall Study|Screen Failure/|85|||
23345273|NCT04676022|65006782|FG000|Overall Study|Lost to Follow-up|1|||
23345274|NCT04676022|65006783|FG001|Overall Study|Lost to Follow-up|1|||
23345275|NCT04676022|65006784|FG002|Overall Study|Lost to Follow-up|0|||
23345276|NCT04676022|65006782|FG000|Overall Study|Adverse Event|2|||
23345277|NCT04676022|65006783|FG001|Overall Study|Adverse Event|0|||
23345278|NCT04676022|65006784|FG002|Overall Study|Adverse Event|1|||
23345279|NCT04676022|65006782|FG000|Overall Study|Physician Decision|2|||
23345280|NCT04676022|65006783|FG001|Overall Study|Physician Decision|0|||
23345281|NCT04676022|65006784|FG002|Overall Study|Physician Decision|1|||
23345282|NCT04676022|65006782|FG000|Overall Study|Withdrawal by Subject|3|||
23345283|NCT04676022|65006783|FG001|Overall Study|Withdrawal by Subject|1|||
23345284|NCT04676022|65006784|FG002|Overall Study|Withdrawal by Subject|6|||
23345285|NCT04676022|65006782|FG000|Overall Study|Will not move forward with permanent implant|6|||
23345286|NCT04676022|65006783|FG001|Overall Study|Will not move forward with permanent implant|0|||
23345287|NCT04676022|65006784|FG002|Overall Study|Will not move forward with permanent implant|0|||
23345288|NCT04676022|65006782|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
23345289|NCT04676022|65006783|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
23345290|NCT04676022|65006784|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
23345291|NCT03409107|65006785|FG000|Overall Study|Withdrawal by Subject|4|||
23238883|NCT01000311|64615676|FG000|Overall Study|Adverse Event|2|||
23345292|NCT03409107|65006786|FG001|Overall Study|Withdrawal by Subject|2|||
23345293|NCT03409107|65006785|FG000|Overall Study|Physician Decision|1|||
23345294|NCT03409107|65006786|FG001|Overall Study|Physician Decision|0|||
23345295|NCT03409107|65006785|FG000|Overall Study|Lost to Follow-up|7|||
23345296|NCT03409107|65006786|FG001|Overall Study|Lost to Follow-up|2|||
23345297|NCT03409107|65006785|FG000|Overall Study|Adverse Event|5|||
23345298|NCT03409107|65006786|FG001|Overall Study|Adverse Event|3|||
23345299|NCT03671564|65006787|FG000|Overall Study|Progressive Disease|3|||
23345300|NCT03671564|65006788|FG001|Overall Study|Progressive Disease|5|||
23345301|NCT03671564|65006789|FG002|Overall Study|Progressive Disease|3|||
23345302|NCT03671564|65006787|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
23345303|NCT03671564|65006788|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
23345304|NCT03671564|65006789|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
23345305|NCT03671564|65006787|FG000|Overall Study|Withdrawal by Subject|1|||
23345306|NCT03671564|65006788|FG001|Overall Study|Withdrawal by Subject|1|||
23345307|NCT03671564|65006789|FG002|Overall Study|Withdrawal by Subject|0|||
23345308|NCT04392167|65006790|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
23345309|NCT01867294|65006791|FG000|Overall Study|Withdrawal by Subject|1|||
23345310|NCT01867294|65006792|FG001|Overall Study|Withdrawal by Subject|1|||
23345311|NCT01867294|65006793|FG002|Overall Study|Withdrawal by Subject|0|||
23238884|NCT01000311|64615677|FG001|Overall Study|Adverse Event|5|||
23238885|NCT01000311|64615676|FG000|Overall Study|Withdrawal by Subject|16|||
23238886|NCT01000311|64615677|FG001|Overall Study|Withdrawal by Subject|24|||
23238887|NCT01000311|64615676|FG000|Overall Study|Lost to Follow-up|15|||
23238888|NCT01000311|64615677|FG001|Overall Study|Lost to Follow-up|24|||
23238889|NCT01000311|64615676|FG000|Overall Study|Protocol Violation|1|||
23238890|NCT01000311|64615677|FG001|Overall Study|Protocol Violation|2|||
23238891|NCT01000311|64615676|FG000|Overall Study|Inappropriate enrollment|2|||
23238892|NCT01000311|64615677|FG001|Overall Study|Inappropriate enrollment|0|||
23238893|NCT01000311|64615676|FG000|Overall Study|Administrative reason|9|||
23238894|NCT01000311|64615677|FG001|Overall Study|Administrative reason|15|||
23238895|NCT03532048|64615682|FG000|Overall Study|Lost to Follow-up|12|||
23238896|NCT03532048|64615683|FG001|Overall Study|Lost to Follow-up|17|||
23238897|NCT03532048|64615682|FG000|Overall Study|Withdrawal by Subject|7|||
23238898|NCT03532048|64615683|FG001|Overall Study|Withdrawal by Subject|0|||
23238899|NCT00334893|64615684|FG000|Overall Study|Not Treated|1|||
23238900|NCT00334893|64615685|FG001|Overall Study|Not Treated|0|||
23238901|NCT03710824|64618707|FG000|Overall Study|Withdrawal by Subject|1|||
23238902|NCT03710824|64618707|FG000|Overall Study|Lost to Follow-up|3|||
23238903|NCT03710824|64618707|FG000|Overall Study|Adverse Event|25|||
23238904|NCT03710824|64618707|FG000|Overall Study|Treatment discontinuation|2|||
23238905|NCT04621227|64618710|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
23238906|NCT04621227|64618710|FG000|Period 3 (29 Days)|Adverse Event|1|||
23238907|NCT04621227|64618710|FG000|Period 8 (2 Days)|Adverse Event|1|||
23238908|NCT03099096|64618711|FG000|Overall Study|Adverse Event|1|||
23238909|NCT03099096|64618711|FG000|Overall Study|Physician Decision|1|||
23238910|NCT01474291|64618712|FG000|Overall Study|Not Evaluable for Efficacy|26|||
23238911|NCT01474291|64618712|FG000|Overall Study|Lack of Treatment Efficacy|88|||
23238912|NCT01474291|64618712|FG000|Overall Study|Adverse Event|53|||
23238913|NCT01474291|64618712|FG000|Overall Study|Lost to Follow-up|29|||
23238914|NCT01474291|64618712|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
23238915|NCT01474291|64618712|FG000|Overall Study|No Reason Reported|10|||
23238916|NCT01474291|64618712|FG000|Overall Study|Death|2|||
23238917|NCT00938366|64618715|FG000|Overall Study|Withdrawal by Subject|1|||
23238918|NCT00938366|64618716|FG001|Overall Study|Withdrawal by Subject|0|||
23238919|NCT01411917|64618717|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
23238920|NCT01411917|64618718|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
23238921|NCT02992743|64618722|FG000|Overall Study|Withdrawal by Subject|1|||
23238922|NCT02992743|64618723|FG001|Overall Study|Withdrawal by Subject|1|||
23238923|NCT02992743|64618722|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
23238924|NCT02992743|64618723|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
23238925|NCT02992743|64618722|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
23238926|NCT02992743|64618723|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
23238927|NCT02992743|64618722|FG000|Overall Study|No measurable disease|1|||
23238928|NCT02992743|64618723|FG001|Overall Study|No measurable disease|0|||
23238929|NCT02992743|64618722|FG000|Overall Study|Lost to Follow-up|0|||
23238930|NCT02992743|64618723|FG001|Overall Study|Lost to Follow-up|1|||
23238931|NCT00690573|64618724|FG000|Overall Study|Lack of Efficacy|8|||
23238932|NCT00690573|64618724|FG000|Overall Study|Withdrawal by Subject|1|||
23238933|NCT01283282|64618730|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
23238934|NCT01283282|64618731|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
23238935|NCT01283282|64618730|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
23238936|NCT01283282|64618731|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
23238937|NCT01283282|64618730|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
23238938|NCT01283282|64618731|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
23238939|NCT01945034|64618734|FG000|Overall Study|Medication Error|0|||
23238940|NCT01945034|64618735|FG001|Overall Study|Medication Error|1|||
23238941|NCT01945034|64618736|FG002|Overall Study|Medication Error|0|||
23238942|NCT01945034|64618734|FG000|Overall Study|Withdrawal by Subject|0|||
23238943|NCT01945034|64618735|FG001|Overall Study|Withdrawal by Subject|3|||
23238944|NCT01945034|64618736|FG002|Overall Study|Withdrawal by Subject|1|||
23345312|NCT01867294|65006794|FG003|Overall Study|Withdrawal by Subject|0|||
23345313|NCT04521621|65006797|FG000|Overall Study|Death|17|||
23345314|NCT04521621|65006798|FG001|Overall Study|Death|8|||
23345315|NCT04521621|65006799|FG002|Overall Study|Death|8|||
23345316|NCT04521621|65006800|FG003|Overall Study|Death|5|||
23345317|NCT04521621|65006801|FG004|Overall Study|Death|2|||
23345318|NCT04521621|65006802|FG005|Overall Study|Death|7|||
23345319|NCT04521621|65006803|FG006|Overall Study|Death|0|||
23345320|NCT04521621|65006804|FG007|Overall Study|Death|0|||
23345321|NCT04521621|65006797|FG000|Overall Study|Study Terminated by Sponsor|4|||
23345322|NCT04521621|65006798|FG001|Overall Study|Study Terminated by Sponsor|6|||
23345323|NCT04521621|65006799|FG002|Overall Study|Study Terminated by Sponsor|8|||
23345324|NCT04521621|65006800|FG003|Overall Study|Study Terminated by Sponsor|0|||
23345325|NCT04521621|65006801|FG004|Overall Study|Study Terminated by Sponsor|1|||
23345326|NCT04521621|65006802|FG005|Overall Study|Study Terminated by Sponsor|7|||
23345327|NCT04521621|65006803|FG006|Overall Study|Study Terminated by Sponsor|0|||
23345328|NCT04521621|65006804|FG007|Overall Study|Study Terminated by Sponsor|0|||
23345329|NCT04521621|65006797|FG000|Overall Study|Withdrawal by Subject|0|||
23345330|NCT04521621|65006798|FG001|Overall Study|Withdrawal by Subject|0|||
23345331|NCT04521621|65006799|FG002|Overall Study|Withdrawal by Subject|1|||
23345332|NCT04521621|65006800|FG003|Overall Study|Withdrawal by Subject|1|||
23345333|NCT04521621|65006801|FG004|Overall Study|Withdrawal by Subject|0|||
23345334|NCT04521621|65006802|FG005|Overall Study|Withdrawal by Subject|0|||
23345335|NCT04521621|65006803|FG006|Overall Study|Withdrawal by Subject|0|||
23345336|NCT04521621|65006804|FG007|Overall Study|Withdrawal by Subject|0|||
23345337|NCT04521621|65006797|FG000|Overall Study|Allocated in error without study intervention|1|||
23345338|NCT04521621|65006798|FG001|Overall Study|Allocated in error without study intervention|0|||
23345339|NCT04521621|65006799|FG002|Overall Study|Allocated in error without study intervention|0|||
23457193|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23583508|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23178990|NCT00792298|64397544|FG006|Treatment Period 2|Lack of Efficacy|0|||
23178991|NCT00792298|64397545|FG007|Treatment Period 2|Lack of Efficacy|0|||
23178992|NCT00792298|64397538|FG000|Treatment Period 2|Physician Decision|0|||
23178993|NCT00792298|64397539|FG001|Treatment Period 2|Physician Decision|0|||
23178994|NCT00792298|64397540|FG002|Treatment Period 2|Physician Decision|0|||
23178995|NCT00792298|64397541|FG003|Treatment Period 2|Physician Decision|0|||
23178996|NCT00792298|64397542|FG004|Treatment Period 2|Physician Decision|0|||
23178997|NCT00792298|64397543|FG005|Treatment Period 2|Physician Decision|0|||
23178998|NCT00792298|64397544|FG006|Treatment Period 2|Physician Decision|1|||
23178999|NCT00792298|64397545|FG007|Treatment Period 2|Physician Decision|0|||
23179000|NCT00792298|64397538|FG000|Treatment Period 2|Pregnancy|0|||
23179001|NCT00792298|64397539|FG001|Treatment Period 2|Pregnancy|0|||
23179002|NCT00792298|64397540|FG002|Treatment Period 2|Pregnancy|1|||
23179003|NCT00792298|64397541|FG003|Treatment Period 2|Pregnancy|0|||
23179004|NCT00792298|64397542|FG004|Treatment Period 2|Pregnancy|0|||
23179005|NCT00792298|64397543|FG005|Treatment Period 2|Pregnancy|0|||
23179006|NCT00792298|64397544|FG006|Treatment Period 2|Pregnancy|0|||
23179007|NCT00792298|64397545|FG007|Treatment Period 2|Pregnancy|0|||
23179008|NCT00792298|64397538|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23179009|NCT00792298|64397539|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23179010|NCT00792298|64397540|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23179011|NCT00792298|64397541|FG003|Treatment Period 2|Withdrawal by Subject|2|||
23179012|NCT00792298|64397542|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23179013|NCT00792298|64397543|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23179014|NCT00792298|64397544|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23179015|NCT00792298|64397545|FG007|Treatment Period 2|Withdrawal by Subject|2|||
23179016|NCT04258579|64397547|FG000|Overall Study|Withdrawal by Subject|7|||
23179017|NCT04258579|64397547|FG000|Overall Study|Lost to Follow-up|3|||
23179018|NCT04258579|64397547|FG000|Overall Study|Protocol Violation|2|||
23179019|NCT04258579|64397547|FG000|Overall Study|Adverse Event|1|||
23179020|NCT00546364|64397548|FG000|Overall Study|Disease progression|5|||
23179021|NCT00546364|64397549|FG001|Overall Study|Disease progression|11|||
23179022|NCT00546364|64397550|FG002|Overall Study|Disease progression|8|||
23179023|NCT00546364|64397548|FG000|Overall Study|Completed and off treatment|1|||
23179024|NCT00546364|64397549|FG001|Overall Study|Completed and off treatment|0|||
23179025|NCT00546364|64397550|FG002|Overall Study|Completed and off treatment|2|||
23179026|NCT00546364|64397548|FG000|Overall Study|Administrative reason by sponsor|1|||
23179027|NCT00546364|64397549|FG001|Overall Study|Administrative reason by sponsor|0|||
23179028|NCT00546364|64397550|FG002|Overall Study|Administrative reason by sponsor|0|||
23179029|NCT00546364|64397548|FG000|Overall Study|Poor compliance/noncompliance|0|||
23179030|NCT00546364|64397549|FG001|Overall Study|Poor compliance/noncompliance|0|||
23179031|NCT00546364|64397550|FG002|Overall Study|Poor compliance/noncompliance|1|||
23179032|NCT00546364|64397548|FG000|Overall Study|No longer meets study criteria|1|||
23179033|NCT00546364|64397549|FG001|Overall Study|No longer meets study criteria|1|||
23179034|NCT00546364|64397550|FG002|Overall Study|No longer meets study criteria|0|||
23179035|NCT00546364|64397548|FG000|Overall Study|Withdrawal by Subject|5|||
23179036|NCT00546364|64397549|FG001|Overall Study|Withdrawal by Subject|6|||
23179037|NCT00546364|64397550|FG002|Overall Study|Withdrawal by Subject|3|||
23345340|NCT04521621|65006800|FG003|Overall Study|Allocated in error without study intervention|0|||
23345341|NCT04521621|65006801|FG004|Overall Study|Allocated in error without study intervention|0|||
23238945|NCT01945034|64618734|FG000|Overall Study|Other|0|||
23238946|NCT01945034|64618735|FG001|Overall Study|Other|1|||
23238947|NCT01945034|64618736|FG002|Overall Study|Other|3|||
23238948|NCT01945034|64618734|FG000|Overall Study|Lost to Follow-up|0|||
23238949|NCT01945034|64618735|FG001|Overall Study|Lost to Follow-up|0|||
23238950|NCT01945034|64618736|FG002|Overall Study|Lost to Follow-up|2|||
23238951|NCT01945034|64618734|FG000|Overall Study|Protocol Violation|1|||
23238952|NCT01945034|64618735|FG001|Overall Study|Protocol Violation|0|||
23238953|NCT01945034|64618736|FG002|Overall Study|Protocol Violation|1|||
23238954|NCT04822701|64618737|FG000|Overall Study|Not treated|2|||
23238955|NCT04822701|64618738|FG001|Overall Study|Not treated|0|||
23238956|NCT04822701|64618737|FG000|Overall Study|Lost to Follow-up|1|||
23238957|NCT04822701|64618738|FG001|Overall Study|Lost to Follow-up|0|||
23345342|NCT04521621|65006802|FG005|Overall Study|Allocated in error without study intervention|0|||
23345343|NCT04521621|65006803|FG006|Overall Study|Allocated in error without study intervention|0|||
23179038|NCT00546364|64397548|FG000|Overall Study|Prior taxotere|1|||
23179039|NCT00546364|64397549|FG001|Overall Study|Prior taxotere|0|||
23345344|NCT04521621|65006804|FG007|Overall Study|Allocated in error without study intervention|0|||
23345345|NCT04258254|65006807|FG000|Overall Study|Withdrawal by Subject|0|||
23345346|NCT04258254|65006808|FG001|Overall Study|Withdrawal by Subject|1|||
23345347|NCT04258254|65006809|FG002|Overall Study|Withdrawal by Subject|0|||
23345348|NCT04416737|65006810|FG000|Week 1 (First Injection)|Physician Decision|0|||
23345349|NCT04416737|65006811|FG001|Week 1 (First Injection)|Physician Decision|1|||
23345350|NCT00386425|65006813|FG000|Overall Study|Physician Decision|3|||
23345351|NCT00386425|65006814|FG001|Overall Study|Physician Decision|0|||
23345352|NCT00386425|65006815|FG002|Overall Study|Physician Decision|0|||
23345353|NCT00386425|65006813|FG000|Overall Study|Withdrawal by Subject|0|||
23345354|NCT00386425|65006814|FG001|Overall Study|Withdrawal by Subject|1|||
23345355|NCT00386425|65006815|FG002|Overall Study|Withdrawal by Subject|0|||
23345356|NCT02091986|65006816|FG000|Overall Study|7 rand in error 1 patient decision|2|||
23345357|NCT02091986|65006817|FG001|Overall Study|7 rand in error 1 patient decision|3|||
23345358|NCT02091986|65006818|FG002|Overall Study|7 rand in error 1 patient decision|3|||
23345359|NCT02091986|65006816|FG000|Overall Study|Lost to Follow-up|1|||
23179040|NCT00546364|64397550|FG002|Overall Study|Prior taxotere|0|||
23179041|NCT00546364|64397548|FG000|Overall Study|Mixed response|1|||
23179042|NCT00546364|64397549|FG001|Overall Study|Mixed response|0|||
23179043|NCT00546364|64397550|FG002|Overall Study|Mixed response|0|||
23179044|NCT00546364|64397548|FG000|Overall Study|Palliative treatment|1|||
23179045|NCT00546364|64397549|FG001|Overall Study|Palliative treatment|0|||
23179046|NCT00546364|64397550|FG002|Overall Study|Palliative treatment|1|||
23345360|NCT02091986|65006817|FG001|Overall Study|Lost to Follow-up|0|||
23345361|NCT02091986|65006818|FG002|Overall Study|Lost to Follow-up|0|||
23345362|NCT02091986|65006816|FG000|Overall Study|Withdrawal by Subject|4|||
23345363|NCT02091986|65006817|FG001|Overall Study|Withdrawal by Subject|8|||
23345364|NCT02091986|65006818|FG002|Overall Study|Withdrawal by Subject|3|||
23345365|NCT02091986|65006816|FG000|Overall Study|Adverse Event|0|||
23345366|NCT02091986|65006817|FG001|Overall Study|Adverse Event|0|||
23345367|NCT02091986|65006818|FG002|Overall Study|Adverse Event|2|||
23345368|NCT01871402|65006819|FG000|Overall Study|Lost to Follow-up|1|||
23345369|NCT01871402|65006820|FG001|Overall Study|Lost to Follow-up|0|||
23345370|NCT01871402|65006819|FG000|Overall Study|Withdrawal by Subject|0|||
23457194|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457195|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457196|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23238958|NCT04822701|64618737|FG000|Overall Study|Withdrawal by Subject|1|||
23457197|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457198|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
23457199|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
23179047|NCT00546364|64397548|FG000|Overall Study|Target lesions resected|1|||
23179048|NCT00546364|64397549|FG001|Overall Study|Target lesions resected|0|||
23238959|NCT04822701|64618738|FG001|Overall Study|Withdrawal by Subject|0|||
23238960|NCT00313716|64618740|FG000|Overall Study|Death|3|||
23238961|NCT00313716|64618741|FG001|Overall Study|Death|2|||
23345371|NCT01871402|65006820|FG001|Overall Study|Withdrawal by Subject|2|||
23345372|NCT01871402|65006819|FG000|Overall Study|Non-compliance|0|||
23345373|NCT01871402|65006820|FG001|Overall Study|Non-compliance|1|||
23345374|NCT01306045|65006821|FG000|Met General Eligibility Criteria|Screen failures|193|||
23345375|NCT01306045|65006822|FG001|Met General Eligibility Criteria|Screen failures|11|||
23179049|NCT00546364|64397550|FG002|Overall Study|Target lesions resected|0|||
23238962|NCT00313716|64618742|FG002|Overall Study|Death|9|||
23238963|NCT00313716|64618743|FG003|Overall Study|Death|3|||
23238964|NCT00313716|64618744|FG004|Overall Study|Death|5|||
23238965|NCT00313716|64618745|FG005|Overall Study|Death|9|||
23238966|NCT00313716|64618740|FG000|Overall Study|Lost to Follow-up|2|||
23238967|NCT00313716|64618741|FG001|Overall Study|Lost to Follow-up|5|||
23238968|NCT00313716|64618742|FG002|Overall Study|Lost to Follow-up|2|||
23238969|NCT00313716|64618743|FG003|Overall Study|Lost to Follow-up|1|||
23238970|NCT00313716|64618744|FG004|Overall Study|Lost to Follow-up|0|||
23238971|NCT00313716|64618745|FG005|Overall Study|Lost to Follow-up|4|||
23238972|NCT00313716|64618740|FG000|Overall Study|Withdrawal by Subject|0|||
23238973|NCT00313716|64618741|FG001|Overall Study|Withdrawal by Subject|1|||
23238974|NCT00313716|64618742|FG002|Overall Study|Withdrawal by Subject|1|||
23238975|NCT00313716|64618743|FG003|Overall Study|Withdrawal by Subject|0|||
23238976|NCT00313716|64618744|FG004|Overall Study|Withdrawal by Subject|1|||
23457200|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23179050|NCT00546364|64397548|FG000|Overall Study|Physician Decision|0|||
23179051|NCT00546364|64397549|FG001|Overall Study|Physician Decision|0|||
23179052|NCT00546364|64397550|FG002|Overall Study|Physician Decision|1|||
23179053|NCT00546364|64397548|FG000|Overall Study|Sponsor decision|0|||
23179054|NCT00546364|64397549|FG001|Overall Study|Sponsor decision|0|||
23179055|NCT00546364|64397550|FG002|Overall Study|Sponsor decision|1|||
23179056|NCT01262625|64397551|FG000|Overall Study|Administrative Error|1|||
23179057|NCT01262625|64397552|FG001|Overall Study|Administrative Error|1|||
23179058|NCT01262625|64397551|FG000|Overall Study|Site Closed|1|||
23179059|NCT01262625|64397552|FG001|Overall Study|Site Closed|0|||
23179060|NCT02522767|64397553|FG000|Double-blind|Withdrawal by Subject|8|||
23179061|NCT02522767|64397554|FG001|Double-blind|Withdrawal by Subject|11|||
23179062|NCT02522767|64397553|FG000|Double-blind|Lost to Follow-up|1|||
23179063|NCT02522767|64397554|FG001|Double-blind|Lost to Follow-up|0|||
23179064|NCT02522767|64397553|FG000|Double-blind|Adverse Event|1|||
23179065|NCT02522767|64397554|FG001|Double-blind|Adverse Event|10|||
23179066|NCT02522767|64397553|FG000|Double-blind|Protocol Violation|0|||
23179067|NCT02522767|64397554|FG001|Double-blind|Protocol Violation|1|||
23238977|NCT00313716|64618745|FG005|Overall Study|Withdrawal by Subject|0|||
23238978|NCT02438787|64618746|FG000|Overall Study|Adverse Event|1|||
23238979|NCT02438787|64618747|FG001|Overall Study|Adverse Event|0|||
23238980|NCT02438787|64618748|FG002|Overall Study|Adverse Event|2|||
23238981|NCT02438787|64618746|FG000|Overall Study|Lack of Efficacy|1|||
23238982|NCT02438787|64618747|FG001|Overall Study|Lack of Efficacy|2|||
23238983|NCT02438787|64618748|FG002|Overall Study|Lack of Efficacy|0|||
23238984|NCT02438787|64618746|FG000|Overall Study|Lost to Follow-up|0|||
23179068|NCT02522767|64397553|FG000|Double-blind|Lack of Efficacy|0|||
23179069|NCT02522767|64397554|FG001|Double-blind|Lack of Efficacy|2|||
23179070|NCT02522767|64397553|FG000|Double-blind|Protocol Deviation|1|||
23238985|NCT02438787|64618747|FG001|Overall Study|Lost to Follow-up|1|||
23179071|NCT02522767|64397554|FG001|Double-blind|Protocol Deviation|0|||
23179072|NCT02522767|64397553|FG000|Open-label|Withdrawal by Subject|2|||
23179073|NCT02522767|64397554|FG001|Open-label|Withdrawal by Subject|3|||
23179074|NCT02522767|64397553|FG000|Open-label|Lost to Follow-up|0|||
23179075|NCT02522767|64397554|FG001|Open-label|Lost to Follow-up|1|||
23179076|NCT02522767|64397553|FG000|Open-label|Adverse Event|2|||
23179077|NCT02522767|64397554|FG001|Open-label|Adverse Event|1|||
23179078|NCT02522767|64397553|FG000|Open-label|Lack of Efficacy|1|||
23179079|NCT02522767|64397554|FG001|Open-label|Lack of Efficacy|1|||
23238986|NCT02438787|64618748|FG002|Overall Study|Lost to Follow-up|0|||
23238987|NCT02438787|64618746|FG000|Overall Study|Protocol Violation|0|||
23238988|NCT02438787|64618747|FG001|Overall Study|Protocol Violation|0|||
23238989|NCT02438787|64618748|FG002|Overall Study|Protocol Violation|1|||
23238990|NCT02438787|64618746|FG000|Overall Study|Withdrawal by Subject|15|||
23238991|NCT02438787|64618747|FG001|Overall Study|Withdrawal by Subject|7|||
23238992|NCT02438787|64618748|FG002|Overall Study|Withdrawal by Subject|10|||
23238993|NCT02438787|64618746|FG000|Overall Study|Study discontinued by sponsor|64|||
23345376|NCT01306045|65006823|FG002|Met General Eligibility Criteria|Screen failures|8|||
23345377|NCT02677038|65006824|FG000|Overall Study|Physician Decision|1|||
23345378|NCT02677038|65006824|FG000|Overall Study|Withdrawal by Subject|1|||
23345379|NCT03320850|65006829|FG000|Overall Study|Lost to Follow-up|0|||
23345380|NCT03320850|65006830|FG001|Overall Study|Lost to Follow-up|0|||
23345381|NCT03320850|65006831|FG002|Overall Study|Lost to Follow-up|0|||
23345382|NCT03320850|65006832|FG003|Overall Study|Lost to Follow-up|0|||
23345383|NCT03320850|65006833|FG004|Overall Study|Lost to Follow-up|1|||
23345384|NCT03320850|65006834|FG005|Overall Study|Lost to Follow-up|2|||
23345385|NCT03320850|65006835|FG006|Overall Study|Lost to Follow-up|2|||
23345386|NCT03320850|65006836|FG007|Overall Study|Lost to Follow-up|0|||
23345387|NCT03320850|65006837|FG008|Overall Study|Lost to Follow-up|6|||
23345388|NCT03320850|65006838|FG009|Overall Study|Lost to Follow-up|4|||
23345389|NCT03320850|65006829|FG000|Overall Study|Withdrawal by Subject|0|||
23345390|NCT03320850|65006830|FG001|Overall Study|Withdrawal by Subject|0|||
23345391|NCT03320850|65006831|FG002|Overall Study|Withdrawal by Subject|0|||
23345392|NCT03320850|65006832|FG003|Overall Study|Withdrawal by Subject|0|||
23345393|NCT03320850|65006833|FG004|Overall Study|Withdrawal by Subject|1|||
23238994|NCT02438787|64618747|FG001|Overall Study|Study discontinued by sponsor|72|||
23238995|NCT02438787|64618748|FG002|Overall Study|Study discontinued by sponsor|69|||
23238996|NCT02438787|64618746|FG000|Overall Study|Other|0|||
23238997|NCT02438787|64618747|FG001|Overall Study|Other|1|||
23238998|NCT02438787|64618748|FG002|Overall Study|Other|0|||
23238999|NCT02438787|64618746|FG000|Overall Study|Site terminated by sponsor|0|||
23239000|NCT02438787|64618747|FG001|Overall Study|Site terminated by sponsor|0|||
23239001|NCT02438787|64618748|FG002|Overall Study|Site terminated by sponsor|1|||
23239002|NCT02341482|64618749|FG000|Overall Study|Adverse Event|1|||
23239003|NCT01381068|64618750|FG000|Overall Study|Death|1|||
23239004|NCT01381068|64618751|FG001|Overall Study|Death|0|||
23239005|NCT00689728|64618752|FG000|Double-Blind Treatment|Adverse Event|1|||
23239006|NCT00689728|64618753|FG001|Double-Blind Treatment|Adverse Event|0|||
23239007|NCT00689728|64618754|FG002|Double-Blind Treatment|Adverse Event|0|||
23239008|NCT00689728|64618752|FG000|Double-Blind Treatment|Protocol Violation|0|||
23239009|NCT00689728|64618753|FG001|Double-Blind Treatment|Protocol Violation|0|||
23345394|NCT03320850|65006834|FG005|Overall Study|Withdrawal by Subject|2|||
23345395|NCT03320850|65006835|FG006|Overall Study|Withdrawal by Subject|4|||
23345396|NCT03320850|65006836|FG007|Overall Study|Withdrawal by Subject|5|||
23345397|NCT03320850|65006837|FG008|Overall Study|Withdrawal by Subject|2|||
23345398|NCT03320850|65006838|FG009|Overall Study|Withdrawal by Subject|1|||
23345399|NCT03320850|65006829|FG000|Overall Study|Lack of Efficacy|0|||
23345400|NCT03320850|65006830|FG001|Overall Study|Lack of Efficacy|0|||
23345401|NCT03320850|65006831|FG002|Overall Study|Lack of Efficacy|0|||
23345402|NCT03320850|65006832|FG003|Overall Study|Lack of Efficacy|1|||
23345403|NCT03320850|65006833|FG004|Overall Study|Lack of Efficacy|0|||
23345404|NCT03320850|65006834|FG005|Overall Study|Lack of Efficacy|1|||
23457201|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23239010|NCT00689728|64618754|FG002|Double-Blind Treatment|Protocol Violation|1|||
23179080|NCT02522767|64397553|FG000|Open-label|Protocol Violation|0|||
23179081|NCT02522767|64397554|FG001|Open-label|Protocol Violation|1|||
23239011|NCT00689728|64618752|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
23345405|NCT03320850|65006835|FG006|Overall Study|Lack of Efficacy|0|||
23345406|NCT03320850|65006836|FG007|Overall Study|Lack of Efficacy|2|||
23345407|NCT03320850|65006837|FG008|Overall Study|Lack of Efficacy|0|||
23345408|NCT03320850|65006838|FG009|Overall Study|Lack of Efficacy|3|||
23345409|NCT03320850|65006829|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
23345410|NCT03320850|65006830|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
23345411|NCT03320850|65006831|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
23345412|NCT03320850|65006832|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
23345413|NCT03320850|65006833|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
23345414|NCT03320850|65006834|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
23345415|NCT03320850|65006835|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
23345416|NCT03320850|65006836|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
23345417|NCT03320850|65006837|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
23345418|NCT03320850|65006838|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
23345419|NCT03320850|65006829|FG000|Overall Study|Adverse Event|0|||
23345420|NCT03320850|65006830|FG001|Overall Study|Adverse Event|0|||
23345421|NCT03320850|65006831|FG002|Overall Study|Adverse Event|0|||
23345422|NCT03320850|65006832|FG003|Overall Study|Adverse Event|0|||
23345423|NCT03320850|65006833|FG004|Overall Study|Adverse Event|0|||
23345424|NCT03320850|65006834|FG005|Overall Study|Adverse Event|2|||
23345425|NCT03320850|65006835|FG006|Overall Study|Adverse Event|1|||
23345426|NCT03320850|65006836|FG007|Overall Study|Adverse Event|0|||
23345427|NCT03320850|65006837|FG008|Overall Study|Adverse Event|2|||
23345428|NCT03320850|65006838|FG009|Overall Study|Adverse Event|0|||
23345429|NCT03320850|65006829|FG000|Overall Study|Reason Not Specified|0|||
23345430|NCT03320850|65006830|FG001|Overall Study|Reason Not Specified|0|||
23345431|NCT03320850|65006831|FG002|Overall Study|Reason Not Specified|0|||
23345432|NCT03320850|65006832|FG003|Overall Study|Reason Not Specified|0|||
23345433|NCT03320850|65006833|FG004|Overall Study|Reason Not Specified|0|||
23345434|NCT03320850|65006834|FG005|Overall Study|Reason Not Specified|1|||
23345435|NCT03320850|65006835|FG006|Overall Study|Reason Not Specified|0|||
23345436|NCT03320850|65006836|FG007|Overall Study|Reason Not Specified|0|||
23345437|NCT03320850|65006837|FG008|Overall Study|Reason Not Specified|0|||
23345438|NCT03320850|65006838|FG009|Overall Study|Reason Not Specified|1|||
23345439|NCT00348595|65006844|FG000|Overall Study|Adverse Event|5|||
23345440|NCT00348595|65006845|FG001|Overall Study|Adverse Event|8|||
23345441|NCT01732471|65006846|FG000|Overall Study|Withdrawal by Subject|1|||
23345442|NCT00916344|65006847|FG000|Overall Study|Death|2|||
23345443|NCT00916344|65006847|FG000|Overall Study|ICD upgrade|1|||
23345444|NCT00916344|65006847|FG000|Overall Study|Drop-out|5|||
23345445|NCT01801358|65006848|FG000|Overall Study|Adverse Event|0|||
23345446|NCT01801358|65006849|FG001|Overall Study|Adverse Event|2|||
23345447|NCT01801358|65006850|FG002|Overall Study|Adverse Event|1|||
23345448|NCT01801358|65006851|FG003|Overall Study|Adverse Event|0|||
23457202|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457203|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457204|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457205|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457206|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457207|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457208|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457209|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457210|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457211|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457212|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457213|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457214|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457215|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457216|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457217|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457218|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457219|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23583509|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583510|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23583511|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
23345449|NCT01801358|65006852|FG004|Overall Study|Adverse Event|0|||
23345450|NCT01801358|65006853|FG005|Overall Study|Adverse Event|1|||
23345451|NCT01801358|65006848|FG000|Overall Study|Physician Decision|0|||
23345452|NCT01801358|65006849|FG001|Overall Study|Physician Decision|0|||
23345453|NCT01801358|65006850|FG002|Overall Study|Physician Decision|1|||
23345454|NCT01801358|65006851|FG003|Overall Study|Physician Decision|0|||
23345455|NCT01801358|65006852|FG004|Overall Study|Physician Decision|0|||
23345456|NCT01801358|65006853|FG005|Overall Study|Physician Decision|0|||
23345457|NCT01801358|65006848|FG000|Overall Study|Progressive Disease|6|||
23345458|NCT01801358|65006849|FG001|Overall Study|Progressive Disease|4|||
23345459|NCT01801358|65006850|FG002|Overall Study|Progressive Disease|4|||
23345460|NCT01801358|65006851|FG003|Overall Study|Progressive Disease|5|||
23345461|NCT01801358|65006852|FG004|Overall Study|Progressive Disease|6|||
23345462|NCT01801358|65006853|FG005|Overall Study|Progressive Disease|5|||
23345463|NCT01801358|65006848|FG000|Overall Study|Withdrawal by Subject|0|||
23345464|NCT01801358|65006849|FG001|Overall Study|Withdrawal by Subject|0|||
23345465|NCT01801358|65006850|FG002|Overall Study|Withdrawal by Subject|0|||
23345466|NCT01801358|65006851|FG003|Overall Study|Withdrawal by Subject|1|||
23345467|NCT01801358|65006852|FG004|Overall Study|Withdrawal by Subject|0|||
23457220|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457221|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
23457222|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
23457223|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457224|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457225|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457226|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457227|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457228|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457229|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457230|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457231|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457232|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457233|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457234|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457235|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457236|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457237|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457238|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457239|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457240|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457241|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457242|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457243|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457244|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
23457245|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
23457246|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457247|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457248|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457249|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457250|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457251|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457252|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457253|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457254|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457255|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457256|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457257|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457258|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457259|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457260|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457261|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457262|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457263|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457264|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457265|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457266|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457267|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
23457268|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
23457269|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
23457270|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
23457271|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
23457272|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
23457273|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
23457274|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
23457275|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
23457276|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
23345468|NCT01801358|65006853|FG005|Overall Study|Withdrawal by Subject|2|||
23179082|NCT00450580|64397559|FG000|Overall Study|Adverse Event|5|||
23345469|NCT05108922|65006856|FG000|Overall Study|Adverse Event|0|||
23345470|NCT05108922|65006857|FG001|Overall Study|Adverse Event|1|||
23345471|NCT05108922|65006856|FG000|Overall Study|Physician Decision|1|||
23345472|NCT05108922|65006857|FG001|Overall Study|Physician Decision|1|||
23345473|NCT05108922|65006856|FG000|Overall Study|Screen Failure|1|||
23345474|NCT05108922|65006857|FG001|Overall Study|Screen Failure|1|||
23345475|NCT05108922|65006856|FG000|Overall Study|Withdrawal by Subject|7|||
23345476|NCT05108922|65006857|FG001|Overall Study|Withdrawal by Subject|4|||
23345477|NCT01104246|65006858|FG000|Overall Study|Withdrawal by Subject|1|||
23345478|NCT01104246|65006858|FG000|Overall Study|did not meet inclusion criteria|4|||
23345479|NCT02429310|65006859|FG000|Overall Study|Lost to Follow-up|1|||
23345480|NCT02429310|65006860|FG001|Overall Study|Lost to Follow-up|2|||
23345481|NCT02429310|65006859|FG000|Overall Study|Protocol Violation|1|||
23345482|NCT02429310|65006860|FG001|Overall Study|Protocol Violation|1|||
23345483|NCT01300338|65006861|FG000|Overall Study|Lost to Follow-up|5|||
23345484|NCT01300338|65006862|FG001|Overall Study|Lost to Follow-up|0|||
23345485|NCT05153148|65006863|FG000|Overall Study|Adverse Event|1|||
23345486|NCT05153148|65006864|FG001|Overall Study|Adverse Event|0|||
23345487|NCT05153148|65006865|FG002|Overall Study|Adverse Event|3|||
23345488|NCT05153148|65006866|FG003|Overall Study|Adverse Event|5|||
23345489|NCT05153148|65006863|FG000|Overall Study|Lost to Follow-up|1|||
23345490|NCT05153148|65006864|FG001|Overall Study|Lost to Follow-up|1|||
23239012|NCT00689728|64618753|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
23239013|NCT00689728|64618754|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
23239014|NCT00689728|64618752|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
23239015|NCT00689728|64618753|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
23239016|NCT00689728|64618754|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
23239017|NCT00689728|64618752|FG000|Rescue|Adverse Event|0|||
23239018|NCT00689728|64618753|FG001|Rescue|Adverse Event|1|||
23239019|NCT00689728|64618754|FG002|Rescue|Adverse Event|0|||
23239020|NCT00689728|64618752|FG000|Rescue|Withdrawal by Subject|1|||
23239021|NCT00689728|64618753|FG001|Rescue|Withdrawal by Subject|1|||
23239022|NCT00689728|64618754|FG002|Rescue|Withdrawal by Subject|1|||
23239023|NCT00689728|64618752|FG000|Optional Follow-Up|Adverse Event|1|||
23239024|NCT00689728|64618753|FG001|Optional Follow-Up|Adverse Event|0|||
23239025|NCT00689728|64618754|FG002|Optional Follow-Up|Adverse Event|0|||
23239026|NCT00689728|64618752|FG000|Optional Follow-Up|Lack of Efficacy|0|||
23239027|NCT00689728|64618753|FG001|Optional Follow-Up|Lack of Efficacy|1|||
23345491|NCT05153148|65006865|FG002|Overall Study|Lost to Follow-up|2|||
23345492|NCT05153148|65006866|FG003|Overall Study|Lost to Follow-up|0|||
23239028|NCT00689728|64618754|FG002|Optional Follow-Up|Lack of Efficacy|1|||
23239029|NCT00689728|64618752|FG000|Optional Follow-Up|Lost to Follow-up|0|||
23345493|NCT05153148|65006863|FG000|Overall Study|Withdrawal by Subject|6|||
23345494|NCT05153148|65006864|FG001|Overall Study|Withdrawal by Subject|8|||
23345495|NCT05153148|65006865|FG002|Overall Study|Withdrawal by Subject|6|||
23345496|NCT05153148|65006866|FG003|Overall Study|Withdrawal by Subject|8|||
23239030|NCT00689728|64618753|FG001|Optional Follow-Up|Lost to Follow-up|1|||
23345497|NCT05153148|65006863|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
23345498|NCT05153148|65006864|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
23345499|NCT05153148|65006865|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
23457277|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
23457278|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
23457279|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
23179083|NCT00450580|64397560|FG001|Overall Study|Adverse Event|7|||
23345500|NCT05153148|65006866|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
23345501|NCT05153148|65006863|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
23345502|NCT05153148|65006864|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
23345503|NCT05153148|65006865|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
23345504|NCT05153148|65006866|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
23345505|NCT05153148|65006863|FG000|Overall Study|Reason not Specified|1|||
23345506|NCT05153148|65006864|FG001|Overall Study|Reason not Specified|1|||
23345507|NCT05153148|65006865|FG002|Overall Study|Reason not Specified|1|||
23345508|NCT05153148|65006866|FG003|Overall Study|Reason not Specified|1|||
23345509|NCT01362244|65006867|FG000|Overall Study|Adverse Event|3|||
23345510|NCT01362244|65006868|FG001|Overall Study|Adverse Event|5|||
23345511|NCT01362244|65006867|FG000|Overall Study|Lack of Efficacy|5|||
23345512|NCT01362244|65006868|FG001|Overall Study|Lack of Efficacy|11|||
23345513|NCT01362244|65006867|FG000|Overall Study|Lost to Follow-up|0|||
23345514|NCT01362244|65006868|FG001|Overall Study|Lost to Follow-up|2|||
23345515|NCT01362244|65006867|FG000|Overall Study|Protocol Violation|5|||
23345516|NCT01362244|65006868|FG001|Overall Study|Protocol Violation|1|||
23345517|NCT01362244|65006867|FG000|Overall Study|Withdrawal by Subject|2|||
23345518|NCT01362244|65006868|FG001|Overall Study|Withdrawal by Subject|1|||
23345519|NCT01362244|65006867|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
23345520|NCT01362244|65006868|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
23345521|NCT01362244|65006867|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
23345522|NCT01362244|65006868|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
23345523|NCT02658734|65006873|FG000|Overall Study|Adverse Event|2|||
23345524|NCT02658734|65006873|FG000|Overall Study|Death|4|||
23345525|NCT02658734|65006873|FG000|Overall Study|Lost to Follow-up|7|||
23345526|NCT02658734|65006873|FG000|Overall Study|Withdrawal of Consent|16|||
23345527|NCT02658734|65006873|FG000|Overall Study|Disease Progression|28|||
23345530|NCT03696108|65006875|FG000|Overall Study|Physician Decision|1|||
23345531|NCT03696108|65006876|FG001|Overall Study|Physician Decision|0|||
23345532|NCT03696108|65006875|FG000|Overall Study|Withdrawal by Subject|3|||
23345533|NCT03696108|65006876|FG001|Overall Study|Withdrawal by Subject|6|||
23345534|NCT01286168|65006877|FG000|Overall Study|Withdrawal by Subject|1|||
23345535|NCT01286168|65006877|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
23345536|NCT04569968|65006883|FG000|Overall Study|Lost to Follow-up|2|||
23345537|NCT04569968|65006884|FG001|Overall Study|Lost to Follow-up|5|||
23345538|NCT04569968|65006883|FG000|Overall Study|Story of head and/or neck surgery|2|||
23345539|NCT04569968|65006884|FG001|Overall Study|Story of head and/or neck surgery|2|||
23345540|NCT04569968|65006883|FG000|Overall Study|Time of stroke onset|8|||
23345541|NCT04569968|65006884|FG001|Overall Study|Time of stroke onset|7|||
23345542|NCT04569968|65006883|FG000|Overall Study|Type of strokr|12|||
23345543|NCT04569968|65006884|FG001|Overall Study|Type of strokr|8|||
23345544|NCT04569968|65006883|FG000|Overall Study|Cooperation|8|||
23345545|NCT04569968|65006884|FG001|Overall Study|Cooperation|8|||
23345546|NCT04569968|65006883|FG000|Overall Study|Age interval|17|||
23345547|NCT04569968|65006884|FG001|Overall Study|Age interval|6|||
23345548|NCT04569968|65006883|FG000|Overall Study|Denial of participation to the study|0|||
23345549|NCT04569968|65006884|FG001|Overall Study|Denial of participation to the study|3|||
23345550|NCT04569968|65006883|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
23345551|NCT04569968|65006884|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
23345552|NCT04569968|65006883|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
23345553|NCT04569968|65006884|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
23345554|NCT04569968|65006883|FG000|Overall Study|Quarantine|1|||
23345555|NCT04569968|65006884|FG001|Overall Study|Quarantine|0|||
23345556|NCT04569968|65006883|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
23345557|NCT04569968|65006884|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
23345558|NCT04569968|65006883|FG000|Overall Study|Repetitive stroke|8|||
23345559|NCT04569968|65006884|FG001|Overall Study|Repetitive stroke|0|||
23345560|NCT04569968|65006883|FG000|Overall Study|Insufficient mastication|1|||
23345561|NCT04569968|65006884|FG001|Overall Study|Insufficient mastication|0|||
23345562|NCT04569968|65006883|FG000|Overall Study|Infection|1|||
23345563|NCT04569968|65006884|FG001|Overall Study|Infection|0|||
23345564|NCT04972968|65006885|FG000|Overall Study|Adverse Event|3|||
23345565|NCT04972968|65006886|FG001|Overall Study|Adverse Event|1|||
23345566|NCT04972968|65006887|FG002|Overall Study|Adverse Event|1|||
23345567|NCT04972968|65006888|FG003|Overall Study|Adverse Event|7|||
23345568|NCT04972968|65006885|FG000|Overall Study|Lack of Efficacy|2|||
23345569|NCT04972968|65006886|FG001|Overall Study|Lack of Efficacy|1|||
23345570|NCT04972968|65006887|FG002|Overall Study|Lack of Efficacy|0|||
23345571|NCT04972968|65006888|FG003|Overall Study|Lack of Efficacy|0|||
23179084|NCT00450580|64397559|FG000|Overall Study|Lost to Follow-up|4|||
23179085|NCT00450580|64397560|FG001|Overall Study|Lost to Follow-up|5|||
23179086|NCT00450580|64397559|FG000|Overall Study|Withdrawal by Subject|2|||
23179087|NCT00450580|64397560|FG001|Overall Study|Withdrawal by Subject|2|||
23179088|NCT00450580|64397559|FG000|Overall Study|Protocol Violation|1|||
23345572|NCT04972968|65006885|FG000|Overall Study|Withdrawal by Subject|7|||
23179089|NCT00450580|64397560|FG001|Overall Study|Protocol Violation|1|||
23179090|NCT00450580|64397559|FG000|Overall Study|Protocol-defined virologic failure|1|||
23179091|NCT00450580|64397560|FG001|Overall Study|Protocol-defined virologic failure|0|||
23179092|NCT00450580|64397559|FG000|Overall Study|Could not comply with scheduled visits|1|||
23179093|NCT00450580|64397560|FG001|Overall Study|Could not comply with scheduled visits|0|||
23179094|NCT00450580|64397559|FG000|Overall Study|Patient went to Brazil|1|||
23179095|NCT00450580|64397560|FG001|Overall Study|Patient went to Brazil|0|||
23179096|NCT00450580|64397559|FG000|Overall Study|Patient could not swallow Norvir|1|||
23179097|NCT00450580|64397560|FG001|Overall Study|Patient could not swallow Norvir|0|||
23179098|NCT00450580|64397559|FG000|Overall Study|Withdrawal due to pregnancy|0|||
23179099|NCT00450580|64397560|FG001|Overall Study|Withdrawal due to pregnancy|1|||
23179100|NCT01795547|64397561|FG000|Overall Study|Adverse Event|16|||
23179101|NCT01795547|64397562|FG001|Overall Study|Adverse Event|27|||
23179102|NCT01795547|64397561|FG000|Overall Study|Lack of Efficacy|8|||
23179103|NCT01795547|64397562|FG001|Overall Study|Lack of Efficacy|3|||
23239031|NCT00689728|64618754|FG002|Optional Follow-Up|Lost to Follow-up|1|||
23239032|NCT00689728|64618752|FG000|Optional Follow-Up|Protocol Violation|0|||
23239033|NCT00689728|64618753|FG001|Optional Follow-Up|Protocol Violation|0|||
23239034|NCT00689728|64618754|FG002|Optional Follow-Up|Protocol Violation|1|||
23239035|NCT00689728|64618752|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
23239036|NCT00689728|64618753|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
23239037|NCT00689728|64618754|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
23239038|NCT03938857|64618756|FG000|Overall Study|Physician Decision|1|||
23239039|NCT03938857|64618757|FG001|Overall Study|Physician Decision|0|||
23239040|NCT03938857|64618758|FG002|Overall Study|Physician Decision|0|||
23345573|NCT04972968|65006886|FG001|Overall Study|Withdrawal by Subject|4|||
23345574|NCT04972968|65006887|FG002|Overall Study|Withdrawal by Subject|3|||
23345575|NCT04972968|65006888|FG003|Overall Study|Withdrawal by Subject|2|||
23345576|NCT04972968|65006885|FG000|Overall Study|Study Terminated by Sponsor|25|||
23345577|NCT04972968|65006886|FG001|Overall Study|Study Terminated by Sponsor|28|||
23345578|NCT04972968|65006887|FG002|Overall Study|Study Terminated by Sponsor|32|||
23345579|NCT04972968|65006888|FG003|Overall Study|Study Terminated by Sponsor|27|||
23345580|NCT04972968|65006885|FG000|Overall Study|Other|1|||
23345581|NCT04972968|65006886|FG001|Overall Study|Other|0|||
23345582|NCT04972968|65006887|FG002|Overall Study|Other|1|||
23345583|NCT04972968|65006888|FG003|Overall Study|Other|1|||
23345584|NCT03605862|65006889|FG000|Overall Study|Withdrawal by Subject|12|||
23345585|NCT03605862|65006890|FG001|Overall Study|Withdrawal by Subject|9|||
23345586|NCT03605862|65006889|FG000|Overall Study|Adverse Event|2|||
23345587|NCT03605862|65006890|FG001|Overall Study|Adverse Event|1|||
23345588|NCT03605862|65006889|FG000|Overall Study|Physician Decision|3|||
23345589|NCT03605862|65006890|FG001|Overall Study|Physician Decision|1|||
23345590|NCT03605862|65006889|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
23345591|NCT03605862|65006890|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
23345592|NCT00900731|65006891|FG000|Overall Study|Adverse Event|31|||
23345593|NCT00900731|65006892|FG001|Overall Study|Adverse Event|27|||
23345594|NCT00900731|65006891|FG000|Overall Study|Withdrawal by Subject|8|||
23345595|NCT00900731|65006892|FG001|Overall Study|Withdrawal by Subject|7|||
23345596|NCT00900731|65006891|FG000|Overall Study|Protocol Deviation|8|||
23345597|NCT00900731|65006892|FG001|Overall Study|Protocol Deviation|11|||
23345598|NCT00900731|65006891|FG000|Overall Study|Administrative Problems|5|||
23345599|NCT00900731|65006892|FG001|Overall Study|Administrative Problems|4|||
23345600|NCT00900731|65006891|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
23345601|NCT00900731|65006892|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23345602|NCT00900731|65006891|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
23345603|NCT00900731|65006892|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
23345604|NCT00900731|65006891|FG000|Overall Study|Lost to Follow-up|2|||
23345605|NCT00900731|65006892|FG001|Overall Study|Lost to Follow-up|3|||
23345606|NCT00900731|65006891|FG000|Overall Study|Lack of Efficacy|1|||
23179104|NCT01795547|64397561|FG000|Overall Study|Protocol Violation|6|||
23179105|NCT01795547|64397562|FG001|Overall Study|Protocol Violation|4|||
23179106|NCT01795547|64397561|FG000|Overall Study|Lost to Follow-up|2|||
23239041|NCT03938857|64618759|FG003|Overall Study|Physician Decision|0|||
23239042|NCT00579059|64618760|FG000|Overall Study|Study Canceled at 1 Year|21|||
23345607|NCT00900731|65006892|FG001|Overall Study|Lack of Efficacy|3|||
23179107|NCT01795547|64397562|FG001|Overall Study|Lost to Follow-up|5|||
23345608|NCT00900731|65006891|FG000|Overall Study|Death|0|||
23345609|NCT00900731|65006892|FG001|Overall Study|Death|2|||
23345610|NCT02951533|65006893|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
23345611|NCT02951533|65006894|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
23457280|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
23457281|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
23457282|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
23457283|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
23457284|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
23457285|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
23457286|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
23457287|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
23457288|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
23457289|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
23457290|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
23457291|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
23457292|NCT02052778|65416560|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457293|NCT02052778|65416561|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457294|NCT02052778|65416562|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457295|NCT02052778|65416563|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457296|NCT02052778|65416564|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457297|NCT02052778|65416565|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457298|NCT02052778|65416566|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457299|NCT02052778|65416567|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457300|NCT02052778|65416568|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457301|NCT02052778|65416569|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457302|NCT02052778|65416570|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457303|NCT02052778|65416571|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457304|NCT02052778|65416572|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457305|NCT02052778|65416573|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457306|NCT02052778|65416574|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457307|NCT02052778|65416575|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457308|NCT02052778|65416576|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457309|NCT02052778|65416577|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457310|NCT02052778|65416578|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457311|NCT02052778|65416579|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457312|NCT02052778|65416580|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457313|NCT02052778|65416581|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
23457314|NCT02052778|65416582|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
23457315|NCT03532542|65416586|FG000|Overall Study|Death|1|||
23457316|NCT03532542|65416587|FG001|Overall Study|Death|0|||
23457317|NCT03532542|65416586|FG000|Overall Study|Study Terminated by Sponsor|41|||
23457318|NCT03532542|65416587|FG001|Overall Study|Study Terminated by Sponsor|65|||
23457319|NCT03532542|65416586|FG000|Overall Study|Withdrawal by Subject|6|||
23457320|NCT03532542|65416587|FG001|Overall Study|Withdrawal by Subject|5|||
23457321|NCT05137041|65416588|FG000|Overall Study|Lost to Follow-up|1|||
23457322|NCT05137041|65416589|FG001|Overall Study|Lost to Follow-up|1|||
23457323|NCT05137041|65416588|FG000|Overall Study|Withdrawal by Subject|0|||
23457324|NCT05137041|65416589|FG001|Overall Study|Withdrawal by Subject|2|||
23457325|NCT05137041|65416588|FG000|Overall Study|Reason not Specified|0|||
23457326|NCT05137041|65416589|FG001|Overall Study|Reason not Specified|1|||
23457327|NCT06271993|65416590|FG000|Overall Study|Not reactive to histamine|5|||
23457328|NCT06271993|65416591|FG001|Overall Study|Not reactive to histamine|5|||
23457329|NCT06271993|65416592|FG002|Overall Study|Not reactive to histamine|5|||
23457330|NCT03346434|65416593|FG000|Overall Study|Randomized in Error|0|||
23457331|NCT03346434|65416594|FG001|Overall Study|Randomized in Error|0|||
23239043|NCT00579059|64618761|FG001|Overall Study|Study Canceled at 1 Year|10|||
23239044|NCT02312934|64618762|FG000|Overall Study|Lost to Follow-up|1|||
23239045|NCT02312934|64618763|FG001|Overall Study|Lost to Follow-up|0|||
23239046|NCT02312934|64618762|FG000|Overall Study|Physician Decision|1|||
23239047|NCT02312934|64618763|FG001|Overall Study|Physician Decision|0|||
23239048|NCT00834366|64618764|FG000|Treatment Period 1|Adverse Event|1|||
23239049|NCT00834366|64618765|FG001|Treatment Period 1|Adverse Event|1|||
23239050|NCT02545270|64618766|FG000|Overall Study|technical difficulties|0|||
23239051|NCT02545270|64618767|FG001|Overall Study|technical difficulties|1|||
23239052|NCT02545270|64618768|FG002|Overall Study|technical difficulties|0|||
23345612|NCT02951533|65006895|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
23345613|NCT02951533|65006893|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
23457332|NCT03346434|65416595|FG002|Overall Study|Randomized in Error|0|||
23457333|NCT03346434|65416596|FG003|Overall Study|Randomized in Error|0|||
23457334|NCT03346434|65416597|FG004|Overall Study|Randomized in Error|1|||
23457335|NCT03346434|65416598|FG005|Overall Study|Randomized in Error|0|||
23457336|NCT03346434|65416593|FG000|Overall Study|Withdrawal by Subject|0|||
23457337|NCT03346434|65416594|FG001|Overall Study|Withdrawal by Subject|0|||
23457338|NCT03346434|65416595|FG002|Overall Study|Withdrawal by Subject|1|||
23457339|NCT03346434|65416596|FG003|Overall Study|Withdrawal by Subject|0|||
23457340|NCT03346434|65416597|FG004|Overall Study|Withdrawal by Subject|1|||
23345614|NCT02951533|65006894|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
23239053|NCT02545270|64618766|FG000|Overall Study|Videos being too similar to other|0|||
23239054|NCT02545270|64618767|FG001|Overall Study|Videos being too similar to other|0|||
23239055|NCT02545270|64618768|FG002|Overall Study|Videos being too similar to other|2|||
23239056|NCT01858701|64618769|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
23239057|NCT01858701|64618770|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
23239058|NCT01858701|64618769|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
23239059|NCT01858701|64618770|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
23239060|NCT01858701|64618769|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
23239061|NCT01858701|64618770|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
23239062|NCT01858701|64618769|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
23239063|NCT01858701|64618770|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
23179108|NCT01795547|64397561|FG000|Overall Study|Withdrawal of consent|7|||
23179109|NCT01795547|64397562|FG001|Overall Study|Withdrawal of consent|12|||
23239064|NCT04524663|64618771|FG000|Overall Study|Withdrawal by Subject|0|||
23239065|NCT04524663|64618772|FG001|Overall Study|Withdrawal by Subject|2|||
23239066|NCT02543918|64618783|FG000|Overall Study|Never treated|0|||
23239067|NCT02543918|64618784|FG001|Overall Study|Never treated|1|||
23239068|NCT02543918|64618783|FG000|Overall Study|Lost to Follow-up|1|||
23239069|NCT02543918|64618784|FG001|Overall Study|Lost to Follow-up|1|||
23239070|NCT02543918|64618783|FG000|Overall Study|Withdrawal by Subject|1|||
23239071|NCT02543918|64618784|FG001|Overall Study|Withdrawal by Subject|1|||
23179110|NCT01795547|64397561|FG000|Overall Study|Not Treated|4|||
23179111|NCT01795547|64397562|FG001|Overall Study|Not Treated|10|||
23179112|NCT01795547|64397561|FG000|Overall Study|Non-compliance with IMP|1|||
23179113|NCT01795547|64397562|FG001|Overall Study|Non-compliance with IMP|1|||
23179114|NCT01795547|64397561|FG000|Overall Study|Others|4|||
23179115|NCT01795547|64397562|FG001|Overall Study|Others|1|||
23179116|NCT01795547|64397561|FG000|Overall Study|Not stated|0|||
23179117|NCT01795547|64397562|FG001|Overall Study|Not stated|1|||
23179118|NCT00755079|64397563|FG000|Overall Study|Lost to Follow-up|1|||
23179119|NCT00755079|64397564|FG001|Overall Study|Lost to Follow-up|3|||
23179120|NCT00755079|64397563|FG000|Overall Study|Adverse Event|0|||
23179121|NCT00755079|64397564|FG001|Overall Study|Adverse Event|1|||
23179122|NCT00755079|64397563|FG000|Overall Study|Withdrawal by Subject|0|||
23179123|NCT00755079|64397564|FG001|Overall Study|Withdrawal by Subject|2|||
23179124|NCT00556426|64397567|FG000|Overall Study|Withdrawal by Subject|3|||
23179125|NCT00556426|64397567|FG000|Overall Study|Death|6|||
23179126|NCT02613208|64397568|FG000|Overall Study|Withdrawal by Subject|1|||
23179127|NCT02613208|64397568|FG000|Overall Study|Change of address|2|||
23179128|NCT02613208|64397568|FG000|Overall Study|Physician Decision|2|||
23179129|NCT02613208|64397568|FG000|Overall Study|Lost to Follow-up|5|||
23179130|NCT02613208|64397568|FG000|Overall Study|Death|37|||
23179131|NCT01256177|64397569|FG000|Overall Study|Withdrawal by Subject|23|||
23179132|NCT01256177|64397570|FG001|Overall Study|Withdrawal by Subject|22|||
23239072|NCT02543918|64618783|FG000|Overall Study|Adverse Event|1|||
23239073|NCT02543918|64618784|FG001|Overall Study|Adverse Event|1|||
23239074|NCT02163759|64618787|FG000|Overall Study|Withdrawal by Subject|1|||
23179133|NCT01256177|64397569|FG000|Overall Study|Lost to Follow-up|2|||
23179134|NCT01256177|64397570|FG001|Overall Study|Lost to Follow-up|2|||
23179135|NCT01256177|64397569|FG000|Overall Study|Adverse Event|8|||
23179136|NCT01256177|64397570|FG001|Overall Study|Adverse Event|9|||
23179137|NCT01256177|64397569|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
23179138|NCT01256177|64397570|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
23179139|NCT01256177|64397569|FG000|Overall Study|Condition under Investigation Worsened|1|||
23179140|NCT01256177|64397570|FG001|Overall Study|Condition under Investigation Worsened|0|||
23179141|NCT01256177|64397569|FG000|Overall Study|Lack of Efficacy|11|||
23179142|NCT01256177|64397570|FG001|Overall Study|Lack of Efficacy|2|||
23179143|NCT01256177|64397569|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
23179144|NCT01256177|64397570|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
23179145|NCT00804687|64397580|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
23179146|NCT00804687|64397581|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
23179147|NCT00804687|64397582|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
23179148|NCT00804687|64397583|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
23179149|NCT00804687|64397584|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
23583512|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
23583513|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
23583514|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583515|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583516|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583517|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583518|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583519|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583520|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583521|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583522|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583523|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583524|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583525|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
23583526|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
23583527|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
23583528|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583529|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583530|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583531|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583532|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583533|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583534|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583535|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583536|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583537|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583538|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583539|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
23583540|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
23583541|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
23583542|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583543|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583544|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583545|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583546|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583547|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583548|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583549|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583550|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583551|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583552|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583553|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
23583554|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
23583555|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
23583556|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583557|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583558|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583559|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583560|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583561|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583562|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583563|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583564|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583565|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583566|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23583567|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
23179150|NCT00804687|64397585|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
23239075|NCT02163759|64618788|FG001|Overall Study|Withdrawal by Subject|5|||
23239076|NCT02163759|64618789|FG002|Overall Study|Withdrawal by Subject|1|||
23239077|NCT02163759|64618787|FG000|Overall Study|Adverse Event|0|||
23239078|NCT02163759|64618788|FG001|Overall Study|Adverse Event|0|||
23239079|NCT02163759|64618789|FG002|Overall Study|Adverse Event|1|||
23239080|NCT02163759|64618787|FG000|Overall Study|Death|0|||
23239081|NCT02163759|64618788|FG001|Overall Study|Death|0|||
23239082|NCT02163759|64618789|FG002|Overall Study|Death|1|||
23239083|NCT00663208|64618790|FG000|Treatment Period|Lost to Follow-up|0|||
23239084|NCT00663208|64618791|FG001|Treatment Period|Lost to Follow-up|1|||
23239085|NCT00663208|64618792|FG002|Treatment Period|Lost to Follow-up|0|||
23239086|NCT00663208|64618793|FG003|Treatment Period|Lost to Follow-up|0|||
23239087|NCT00663208|64618794|FG004|Treatment Period|Lost to Follow-up|0|||
23239088|NCT00663208|64618795|FG005|Treatment Period|Lost to Follow-up|0|||
23239089|NCT00663208|64618796|FG006|Treatment Period|Lost to Follow-up|0|||
23239090|NCT00663208|64618790|FG000|Follow-up Period|Lost to Follow-up|2|||
23239091|NCT00663208|64618791|FG001|Follow-up Period|Lost to Follow-up|0|||
23345615|NCT02951533|65006895|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
23345616|NCT02951533|65006893|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
23345617|NCT02951533|65006894|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
23345618|NCT02951533|65006895|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
23345619|NCT02951533|65006893|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
23345620|NCT02951533|65006894|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
23345621|NCT02951533|65006895|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
23345622|NCT02951533|65006893|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
23345623|NCT02951533|65006894|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
23345624|NCT02951533|65006895|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
23345625|NCT02951533|65006893|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
23345626|NCT02951533|65006894|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
23345627|NCT02951533|65006895|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
23345628|NCT02951533|65006893|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
23345629|NCT02951533|65006894|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
23345630|NCT02951533|65006895|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
23345631|NCT02951533|65006893|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
23345632|NCT02951533|65006894|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
23345633|NCT02951533|65006895|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
23345634|NCT02951533|65006893|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
23345635|NCT02951533|65006894|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
23345636|NCT02951533|65006895|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
23345637|NCT02951533|65006893|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
23345638|NCT02951533|65006894|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
23345639|NCT02951533|65006895|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
23345640|NCT02951533|65006893|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
23345641|NCT02951533|65006894|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
23345642|NCT02951533|65006895|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
23345643|NCT02553499|65010829|FG000|Overall Study|Adverse Event|0|||
23345644|NCT02553499|65010830|FG001|Overall Study|Adverse Event|0|||
23345645|NCT02553499|65010831|FG002|Overall Study|Adverse Event|0|||
23345646|NCT02553499|65010832|FG003|Overall Study|Adverse Event|0|||
23583568|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
23239092|NCT00663208|64618792|FG002|Follow-up Period|Lost to Follow-up|3|||
23239093|NCT00663208|64618793|FG003|Follow-up Period|Lost to Follow-up|2|||
23239094|NCT00663208|64618794|FG004|Follow-up Period|Lost to Follow-up|0|||
23239095|NCT00663208|64618795|FG005|Follow-up Period|Lost to Follow-up|0|||
23239096|NCT00663208|64618796|FG006|Follow-up Period|Lost to Follow-up|0|||
23345647|NCT02553499|65010833|FG004|Overall Study|Adverse Event|0|||
23345648|NCT02553499|65010834|FG005|Overall Study|Adverse Event|0|||
23345649|NCT02553499|65010835|FG006|Overall Study|Adverse Event|1|||
23345650|NCT02553499|65010836|FG007|Overall Study|Adverse Event|1|||
23345651|NCT02553499|65010837|FG008|Overall Study|Adverse Event|0|||
23345652|NCT02553499|65010838|FG009|Overall Study|Adverse Event|0|||
23345653|NCT02553499|65010839|FG010|Overall Study|Adverse Event|0|||
23345654|NCT02553499|65010840|FG011|Overall Study|Adverse Event|0|||
23345655|NCT02553499|65010841|FG012|Overall Study|Adverse Event|0|||
23345656|NCT02553499|65010842|FG013|Overall Study|Adverse Event|1|||
23345657|NCT02553499|65010829|FG000|Overall Study|Death|0|||
23345658|NCT02553499|65010830|FG001|Overall Study|Death|1|||
23345659|NCT02553499|65010831|FG002|Overall Study|Death|1|||
23345660|NCT02553499|65010832|FG003|Overall Study|Death|0|||
23345661|NCT02553499|65010833|FG004|Overall Study|Death|1|||
23345662|NCT02553499|65010834|FG005|Overall Study|Death|2|||
23345663|NCT02553499|65010835|FG006|Overall Study|Death|0|||
23345664|NCT02553499|65010836|FG007|Overall Study|Death|0|||
23345665|NCT02553499|65010837|FG008|Overall Study|Death|0|||
23345666|NCT02553499|65010838|FG009|Overall Study|Death|0|||
23345667|NCT02553499|65010839|FG010|Overall Study|Death|1|||
23345668|NCT02553499|65010840|FG011|Overall Study|Death|0|||
23345669|NCT02553499|65010841|FG012|Overall Study|Death|0|||
23345670|NCT02553499|65010842|FG013|Overall Study|Death|0|||
23345671|NCT02553499|65010829|FG000|Overall Study|Lost to Follow-up|0|||
23345672|NCT02553499|65010830|FG001|Overall Study|Lost to Follow-up|0|||
23345673|NCT02553499|65010831|FG002|Overall Study|Lost to Follow-up|0|||
23345674|NCT02553499|65010832|FG003|Overall Study|Lost to Follow-up|0|||
23345675|NCT02553499|65010833|FG004|Overall Study|Lost to Follow-up|0|||
23345676|NCT02553499|65010834|FG005|Overall Study|Lost to Follow-up|0|||
23345677|NCT02553499|65010835|FG006|Overall Study|Lost to Follow-up|1|||
23345678|NCT02553499|65010836|FG007|Overall Study|Lost to Follow-up|0|||
23345679|NCT02553499|65010837|FG008|Overall Study|Lost to Follow-up|0|||
23345680|NCT02553499|65010838|FG009|Overall Study|Lost to Follow-up|0|||
23345681|NCT02553499|65010839|FG010|Overall Study|Lost to Follow-up|0|||
23345682|NCT02553499|65010840|FG011|Overall Study|Lost to Follow-up|0|||
23345683|NCT02553499|65010841|FG012|Overall Study|Lost to Follow-up|0|||
23345684|NCT02553499|65010842|FG013|Overall Study|Lost to Follow-up|0|||
23345685|NCT02553499|65010829|FG000|Overall Study|Physician Decision|0|||
23345686|NCT02553499|65010830|FG001|Overall Study|Physician Decision|1|||
23345687|NCT02553499|65010831|FG002|Overall Study|Physician Decision|1|||
23345688|NCT02553499|65010832|FG003|Overall Study|Physician Decision|0|||
23345689|NCT02553499|65010833|FG004|Overall Study|Physician Decision|1|||
23345690|NCT02553499|65010834|FG005|Overall Study|Physician Decision|0|||
23345691|NCT02553499|65010835|FG006|Overall Study|Physician Decision|0|||
23345692|NCT02553499|65010836|FG007|Overall Study|Physician Decision|1|||
23345693|NCT02553499|65010837|FG008|Overall Study|Physician Decision|1|||
23345694|NCT02553499|65010838|FG009|Overall Study|Physician Decision|2|||
23345695|NCT02553499|65010839|FG010|Overall Study|Physician Decision|1|||
23345696|NCT02553499|65010840|FG011|Overall Study|Physician Decision|3|||
23345697|NCT02553499|65010841|FG012|Overall Study|Physician Decision|1|||
23345698|NCT02553499|65010842|FG013|Overall Study|Physician Decision|0|||
23345699|NCT02553499|65010829|FG000|Overall Study|Progressive Disease|0|||
23345700|NCT02553499|65010830|FG001|Overall Study|Progressive Disease|0|||
23345701|NCT02553499|65010831|FG002|Overall Study|Progressive Disease|0|||
23345702|NCT02553499|65010832|FG003|Overall Study|Progressive Disease|2|||
23345703|NCT02553499|65010833|FG004|Overall Study|Progressive Disease|1|||
23345704|NCT02553499|65010834|FG005|Overall Study|Progressive Disease|1|||
23345705|NCT02553499|65010835|FG006|Overall Study|Progressive Disease|1|||
23345706|NCT02553499|65010836|FG007|Overall Study|Progressive Disease|0|||
23345707|NCT02553499|65010837|FG008|Overall Study|Progressive Disease|0|||
23345708|NCT02553499|65010838|FG009|Overall Study|Progressive Disease|1|||
23345709|NCT02553499|65010839|FG010|Overall Study|Progressive Disease|0|||
23345710|NCT02553499|65010840|FG011|Overall Study|Progressive Disease|0|||
23345711|NCT02553499|65010841|FG012|Overall Study|Progressive Disease|2|||
23345712|NCT02553499|65010842|FG013|Overall Study|Progressive Disease|1|||
23345713|NCT02553499|65010829|FG000|Overall Study|Study Terminated by Sponsor|0|||
23345714|NCT02553499|65010830|FG001|Overall Study|Study Terminated by Sponsor|0|||
23345715|NCT02553499|65010831|FG002|Overall Study|Study Terminated by Sponsor|0|||
23345716|NCT02553499|65010832|FG003|Overall Study|Study Terminated by Sponsor|0|||
23345717|NCT02553499|65010833|FG004|Overall Study|Study Terminated by Sponsor|0|||
23345718|NCT02553499|65010834|FG005|Overall Study|Study Terminated by Sponsor|0|||
23345719|NCT02553499|65010835|FG006|Overall Study|Study Terminated by Sponsor|0|||
23345720|NCT02553499|65010836|FG007|Overall Study|Study Terminated by Sponsor|0|||
23345721|NCT02553499|65010837|FG008|Overall Study|Study Terminated by Sponsor|1|||
23345722|NCT02553499|65010838|FG009|Overall Study|Study Terminated by Sponsor|0|||
23345723|NCT02553499|65010839|FG010|Overall Study|Study Terminated by Sponsor|0|||
23345724|NCT02553499|65010840|FG011|Overall Study|Study Terminated by Sponsor|0|||
23345725|NCT02553499|65010841|FG012|Overall Study|Study Terminated by Sponsor|0|||
23345726|NCT02553499|65010842|FG013|Overall Study|Study Terminated by Sponsor|0|||
23345727|NCT02553499|65010829|FG000|Overall Study|Withdrawal by Subject|2|||
23345728|NCT02553499|65010830|FG001|Overall Study|Withdrawal by Subject|0|||
23345729|NCT02553499|65010831|FG002|Overall Study|Withdrawal by Subject|0|||
23345730|NCT02553499|65010832|FG003|Overall Study|Withdrawal by Subject|0|||
23345731|NCT02553499|65010833|FG004|Overall Study|Withdrawal by Subject|0|||
23345732|NCT02553499|65010834|FG005|Overall Study|Withdrawal by Subject|0|||
23345733|NCT02553499|65010835|FG006|Overall Study|Withdrawal by Subject|0|||
23345734|NCT02553499|65010836|FG007|Overall Study|Withdrawal by Subject|1|||
23345735|NCT02553499|65010837|FG008|Overall Study|Withdrawal by Subject|1|||
23345736|NCT02553499|65010838|FG009|Overall Study|Withdrawal by Subject|0|||
23345737|NCT02553499|65010839|FG010|Overall Study|Withdrawal by Subject|1|||
23345738|NCT02553499|65010840|FG011|Overall Study|Withdrawal by Subject|0|||
23345739|NCT02553499|65010841|FG012|Overall Study|Withdrawal by Subject|0|||
23345740|NCT02553499|65010842|FG013|Overall Study|Withdrawal by Subject|0|||
23345741|NCT02071706|65010845|FG000|Overall Study|Adverse Event|1|||
23345742|NCT02071706|65010845|FG000|Overall Study|Withdrawal by Subject|2|||
23345743|NCT02059434|65010846|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
23345744|NCT02059434|65010847|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
23345745|NCT02059434|65010848|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
23345746|NCT02059434|65010849|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
23345747|NCT02059434|65010850|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
23345748|NCT02059434|65010851|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
23345749|NCT02059434|65010852|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
23345750|NCT02059434|65010853|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
23179151|NCT00804687|64397580|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
23345751|NCT02059434|65010854|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
23345752|NCT02059434|65010846|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
23345753|NCT02059434|65010847|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
23345754|NCT02059434|65010848|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
23345755|NCT02059434|65010849|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
23345756|NCT02059434|65010850|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
23345757|NCT02059434|65010851|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
23345758|NCT02059434|65010852|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
23345759|NCT02059434|65010853|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
23345760|NCT02059434|65010854|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
23345761|NCT02059434|65010846|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
23345762|NCT02059434|65010847|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
23457341|NCT03346434|65416598|FG005|Overall Study|Withdrawal by Subject|0|||
23179152|NCT00804687|64397581|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
23345763|NCT02059434|65010848|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
23345764|NCT02059434|65010849|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
23345765|NCT02059434|65010850|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
23345766|NCT02059434|65010851|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
23345767|NCT02059434|65010852|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
23345768|NCT02059434|65010853|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
23345769|NCT02059434|65010854|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
23345770|NCT02059434|65010846|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
23345771|NCT02059434|65010847|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
23345772|NCT02059434|65010848|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
23345773|NCT02059434|65010849|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
23345774|NCT02059434|65010850|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
23345775|NCT02059434|65010851|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
23345776|NCT02059434|65010852|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
23345777|NCT02059434|65010853|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
23345778|NCT02059434|65010854|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
23345779|NCT02059434|65010846|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23179153|NCT00804687|64397582|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
23345780|NCT02059434|65010847|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345781|NCT02059434|65010848|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345782|NCT02059434|65010849|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345783|NCT02059434|65010850|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345784|NCT02059434|65010851|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345785|NCT02059434|65010852|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345786|NCT02059434|65010853|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
23345787|NCT02059434|65010854|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
23345788|NCT00460265|65010855|FG000|Overall Study|Lost to Follow-up|14|||
23345789|NCT00460265|65010856|FG001|Overall Study|Lost to Follow-up|15|||
23345790|NCT00460265|65010855|FG000|Overall Study|Physician Decision|1|||
23179154|NCT00804687|64397583|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
23179155|NCT00804687|64397584|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
23179156|NCT00804687|64397585|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
23179157|NCT00804687|64397580|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
23179158|NCT00804687|64397581|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
23179159|NCT00804687|64397582|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
23179160|NCT00804687|64397583|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
23179161|NCT00804687|64397584|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
23239097|NCT00663208|64618790|FG000|Follow-up Period|Other reason|1|||
23345791|NCT00460265|65010856|FG001|Overall Study|Physician Decision|2|||
23345792|NCT00460265|65010855|FG000|Overall Study|Withdrawal by Subject|10|||
23345793|NCT00460265|65010856|FG001|Overall Study|Withdrawal by Subject|25|||
23345794|NCT00460265|65010855|FG000|Overall Study|Ongoing|60|||
23345795|NCT00460265|65010856|FG001|Overall Study|Ongoing|47|||
23345796|NCT02847182|65010857|FG000|Overall Study|Withdrawal by Subject|0|||
23345797|NCT02847182|65010858|FG001|Overall Study|Withdrawal by Subject|1|||
23345798|NCT03646305|65010859|FG000|Overall Study|Lost to Follow-up|4|||
23345799|NCT03646305|65010860|FG001|Overall Study|Lost to Follow-up|2|||
23345800|NCT03646305|65010861|FG002|Overall Study|Lost to Follow-up|2|||
23345801|NCT03646305|65010862|FG003|Overall Study|Lost to Follow-up|1|||
23345802|NCT03646305|65010859|FG000|Overall Study|Withdrawal by Subject|1|||
23345803|NCT03646305|65010860|FG001|Overall Study|Withdrawal by Subject|0|||
23345804|NCT03646305|65010861|FG002|Overall Study|Withdrawal by Subject|0|||
23345805|NCT03646305|65010862|FG003|Overall Study|Withdrawal by Subject|1|||
23345806|NCT03521817|65010863|FG000|Overall Study|Protocol Violation|0|||
23345807|NCT03521817|65010864|FG001|Overall Study|Protocol Violation|1|||
23345808|NCT00655681|65010865|FG000|Overall Study|Lost to Follow-up|1|||
23345809|NCT00655681|65010866|FG001|Overall Study|Lost to Follow-up|1|||
23345810|NCT02987972|65010867|FG000|Overall Study|Adverse Event|1|||
23345811|NCT02987972|65010868|FG001|Overall Study|Adverse Event|1|||
23345812|NCT02987972|65010869|FG002|Overall Study|Adverse Event|0|||
23345813|NCT02987972|65010867|FG000|Overall Study|Death|1|||
23345814|NCT02987972|65010868|FG001|Overall Study|Death|0|||
23345815|NCT02987972|65010869|FG002|Overall Study|Death|0|||
23345816|NCT02987972|65010867|FG000|Overall Study|Lack of Efficacy|9|||
23345817|NCT02987972|65010868|FG001|Overall Study|Lack of Efficacy|12|||
23345818|NCT02987972|65010869|FG002|Overall Study|Lack of Efficacy|12|||
23345819|NCT02987972|65010867|FG000|Overall Study|Lost to Follow-up|7|||
23345820|NCT02987972|65010868|FG001|Overall Study|Lost to Follow-up|8|||
23345821|NCT02987972|65010869|FG002|Overall Study|Lost to Follow-up|4|||
23345822|NCT02987972|65010867|FG000|Overall Study|Physician Decision|1|||
23345823|NCT02987972|65010868|FG001|Overall Study|Physician Decision|6|||
23345824|NCT02987972|65010869|FG002|Overall Study|Physician Decision|0|||
23345825|NCT02987972|65010867|FG000|Overall Study|Protocol Violation|2|||
23345826|NCT02987972|65010868|FG001|Overall Study|Protocol Violation|1|||
23345827|NCT02987972|65010869|FG002|Overall Study|Protocol Violation|5|||
23345828|NCT02987972|65010867|FG000|Overall Study|Withdrawal by Subject|22|||
23345829|NCT02987972|65010868|FG001|Overall Study|Withdrawal by Subject|17|||
23345830|NCT02987972|65010869|FG002|Overall Study|Withdrawal by Subject|21|||
23345831|NCT02255552|65010870|FG000|Overall Study|Participants enrolled into another study|0|||
23345832|NCT02255552|65010871|FG001|Overall Study|Participants enrolled into another study|11|||
23345833|NCT02255552|65010870|FG000|Overall Study|Withdrawal by Subject|1|||
23345834|NCT02255552|65010871|FG001|Overall Study|Withdrawal by Subject|4|||
23345835|NCT04829331|65010872|FG000|Overall Study|Lost to Follow-up|1|||
23345836|NCT04829331|65010873|FG001|Overall Study|Lost to Follow-up|0|||
23345837|NCT02091375|65010874|FG000|Overall Study|Adverse Event|8|||
23345838|NCT02091375|65010875|FG001|Overall Study|Adverse Event|1|||
23345839|NCT02091375|65010874|FG000|Overall Study|Lost to Follow-up|0|||
23345840|NCT02091375|65010875|FG001|Overall Study|Lost to Follow-up|1|||
23345841|NCT02091375|65010874|FG000|Overall Study|Withdrawal by Subject|0|||
23345842|NCT02091375|65010875|FG001|Overall Study|Withdrawal by Subject|1|||
23345843|NCT02091375|65010874|FG000|Overall Study|Withdrawn by the investigator|1|||
23345844|NCT02091375|65010875|FG001|Overall Study|Withdrawn by the investigator|0|||
23345845|NCT02284568|65010879|FG000|Overall Study|Adverse Event|2|||
23345846|NCT02284568|65010880|FG001|Overall Study|Adverse Event|9|||
23345847|NCT02284568|65010881|FG002|Overall Study|Adverse Event|4|||
23345848|NCT02284568|65010879|FG000|Overall Study|Withdrawal by Subject|22|||
23345849|NCT02284568|65010880|FG001|Overall Study|Withdrawal by Subject|21|||
23345850|NCT02284568|65010881|FG002|Overall Study|Withdrawal by Subject|1|||
23345851|NCT02284568|65010879|FG000|Overall Study|Noncompliance with study drug admin|1|||
23345852|NCT02284568|65010880|FG001|Overall Study|Noncompliance with study drug admin|2|||
23345853|NCT02284568|65010881|FG002|Overall Study|Noncompliance with study drug admin|0|||
23345854|NCT02284568|65010879|FG000|Overall Study|Noncompliance|1|||
23345855|NCT02284568|65010880|FG001|Overall Study|Noncompliance|0|||
23345856|NCT02284568|65010881|FG002|Overall Study|Noncompliance|0|||
23345857|NCT02284568|65010879|FG000|Overall Study|Protocol Violation|0|||
23345858|NCT02284568|65010880|FG001|Overall Study|Protocol Violation|1|||
23345859|NCT02284568|65010881|FG002|Overall Study|Protocol Violation|0|||
23345860|NCT02284568|65010879|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
23345861|NCT02284568|65010880|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
23345862|NCT02284568|65010881|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
23345863|NCT02284568|65010879|FG000|Overall Study|Lost to Follow-up|0|||
23345864|NCT02284568|65010880|FG001|Overall Study|Lost to Follow-up|3|||
23345865|NCT02284568|65010881|FG002|Overall Study|Lost to Follow-up|0|||
23345866|NCT02284568|65010879|FG000|Overall Study|Lack of Efficacy|4|||
23345867|NCT02284568|65010880|FG001|Overall Study|Lack of Efficacy|7|||
23345868|NCT02284568|65010881|FG002|Overall Study|Lack of Efficacy|0|||
23345869|NCT02284568|65010879|FG000|Overall Study|Other|1|||
23345870|NCT02284568|65010880|FG001|Overall Study|Other|2|||
23345871|NCT02284568|65010881|FG002|Overall Study|Other|0|||
23345872|NCT02284568|65010879|FG000|Overall Study|Withdrew before taking study drug|0|||
23345873|NCT02284568|65010880|FG001|Overall Study|Withdrew before taking study drug|1|||
23345874|NCT02284568|65010881|FG002|Overall Study|Withdrew before taking study drug|0|||
23345875|NCT01846221|65010882|FG000|Overall Study|Catheter Failure|2|||
23345876|NCT01846221|65010883|FG001|Overall Study|Catheter Failure|0|||
23345877|NCT01846221|65010882|FG000|Overall Study|Age Exclusion|1|||
23345878|NCT01846221|65010883|FG001|Overall Study|Age Exclusion|0|||
23345879|NCT01527487|65010884|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
23345880|NCT01527487|65010885|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
23345881|NCT01527487|65010884|FG000|Overall Study|Disease Progression|4|||
23345882|NCT01527487|65010885|FG001|Overall Study|Disease Progression|1|||
23345883|NCT01527487|65010884|FG000|Overall Study|Adverse Event|1|||
23345884|NCT01527487|65010885|FG001|Overall Study|Adverse Event|1|||
23345885|NCT01527487|65010884|FG000|Overall Study|Death|0|||
23345886|NCT01527487|65010885|FG001|Overall Study|Death|1|||
23345887|NCT00829829|65010886|FG000|Overall Study|Protocol Violation|0|||
23345888|NCT00829829|65010887|FG001|Overall Study|Protocol Violation|3|||
23345889|NCT00829829|65010888|FG002|Overall Study|Protocol Violation|0|||
23345890|NCT00829829|65010886|FG000|Overall Study|Adverse Event|4|||
23345891|NCT00829829|65010887|FG001|Overall Study|Adverse Event|4|||
23345892|NCT00829829|65010888|FG002|Overall Study|Adverse Event|3|||
23345893|NCT00829829|65010886|FG000|Overall Study|Withdrawal by Subject|8|||
23345894|NCT00829829|65010887|FG001|Overall Study|Withdrawal by Subject|4|||
23345895|NCT00829829|65010888|FG002|Overall Study|Withdrawal by Subject|2|||
23345896|NCT00829829|65010886|FG000|Overall Study|Decision by the Sponsor|1|||
23345897|NCT00829829|65010887|FG001|Overall Study|Decision by the Sponsor|0|||
23345898|NCT00829829|65010888|FG002|Overall Study|Decision by the Sponsor|2|||
23345899|NCT00829829|65010886|FG000|Overall Study|Lost to Follow-up|7|||
23345900|NCT00829829|65010887|FG001|Overall Study|Lost to Follow-up|3|||
23345901|NCT00829829|65010888|FG002|Overall Study|Lost to Follow-up|3|||
23345902|NCT00829829|65010886|FG000|Overall Study|Other than specified above|2|||
23345903|NCT00829829|65010887|FG001|Overall Study|Other than specified above|2|||
23345904|NCT00829829|65010888|FG002|Overall Study|Other than specified above|1|||
23345905|NCT03168919|65010891|FG000|Overall Study|Withdrawal by Subject|2|||
23345906|NCT00932698|65010892|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
23345907|NCT00932698|65010893|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
23345908|NCT00932698|65010894|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
23345909|NCT00932698|65010895|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
23345910|NCT00932698|65010896|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
23345911|NCT00932698|65010897|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
23239098|NCT00663208|64618791|FG001|Follow-up Period|Other reason|0|||
23239099|NCT00663208|64618792|FG002|Follow-up Period|Other reason|0|||
23345912|NCT00932698|65010898|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
23345913|NCT00932698|65010899|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
23345914|NCT00932698|65010900|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
23345915|NCT00932698|65010901|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
23345916|NCT00932698|65010902|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
23345917|NCT00932698|65010892|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345918|NCT00932698|65010893|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
23345919|NCT00932698|65010894|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345920|NCT00932698|65010895|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
23345921|NCT00932698|65010896|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345922|NCT00932698|65010897|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
23345923|NCT00932698|65010898|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
23239100|NCT00663208|64618793|FG003|Follow-up Period|Other reason|0|||
23345924|NCT00932698|65010899|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345925|NCT00932698|65010900|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23239101|NCT00663208|64618794|FG004|Follow-up Period|Other reason|0|||
23239102|NCT00663208|64618795|FG005|Follow-up Period|Other reason|0|||
23345926|NCT00932698|65010901|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345927|NCT00932698|65010902|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
23345928|NCT00932698|65010892|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
23345929|NCT00932698|65010893|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
23345930|NCT00932698|65010894|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
23239103|NCT00663208|64618796|FG006|Follow-up Period|Other reason|1|||
23239104|NCT01161173|64618797|FG000|Overall Study|Protocol Violation|13|||
23239105|NCT01161173|64618797|FG000|Overall Study|Lost to Follow-up|7|||
23345931|NCT00932698|65010895|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
23345932|NCT00932698|65010896|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
23345933|NCT00932698|65010897|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
23345934|NCT00932698|65010898|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
23239106|NCT01161173|64618797|FG000|Overall Study|Progressive Disease|82|||
23457342|NCT03346434|65416593|FG000|Overall Study|Lost to Follow-up|0|||
23457343|NCT03346434|65416594|FG001|Overall Study|Lost to Follow-up|0|||
23457344|NCT03346434|65416595|FG002|Overall Study|Lost to Follow-up|0|||
23179162|NCT00804687|64397585|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
23179163|NCT00804687|64397580|FG000|Period 5: Treatment Period|Positive drug test|1|||
23179164|NCT00804687|64397581|FG001|Period 5: Treatment Period|Positive drug test|0|||
23179165|NCT00804687|64397582|FG002|Period 5: Treatment Period|Positive drug test|0|||
23179166|NCT00804687|64397583|FG003|Period 5: Treatment Period|Positive drug test|0|||
23179167|NCT00804687|64397584|FG004|Period 5: Treatment Period|Positive drug test|0|||
23179168|NCT00804687|64397585|FG005|Period 5: Treatment Period|Positive drug test|0|||
23179169|NCT00709202|64397586|FG000|Overall Study|Withdrawal by Subject|6|||
23179170|NCT00709202|64397587|FG001|Overall Study|Withdrawal by Subject|6|||
23179171|NCT01412957|64397593|FG000|Overall Study|Withdrawal by Subject|6|||
23179172|NCT01412957|64397594|FG001|Overall Study|Withdrawal by Subject|22|||
23179173|NCT01412957|64397593|FG000|Overall Study|Lost to Follow-up|7|||
23179174|NCT01412957|64397594|FG001|Overall Study|Lost to Follow-up|2|||
23179175|NCT01412957|64397593|FG000|Overall Study|Death|136|||
23179176|NCT01412957|64397594|FG001|Overall Study|Death|133|||
23179177|NCT02582658|64397595|FG000|Overall Study|Failure to Return|10|||
23179178|NCT02582658|64397595|FG000|Overall Study|Insufficient Virological Response|2|||
23179179|NCT02582658|64397595|FG000|Overall Study|Withdrawn Consent|1|||
23179180|NCT02582658|64397595|FG000|Overall Study|Death|1|||
23179181|NCT02582658|64397595|FG000|Overall Study|Not further specified|11|||
23179182|NCT03619213|64397598|FG000|Overall Study|Lost to Follow-up|2|||
23179183|NCT03619213|64397599|FG001|Overall Study|Lost to Follow-up|1|||
23179184|NCT03619213|64397598|FG000|Overall Study|Withdrawal by Subject|8|||
23179185|NCT03619213|64397599|FG001|Overall Study|Withdrawal by Subject|10|||
23179186|NCT03828487|64397600|FG000|Overall Study|Physician Decision|1|||
23179187|NCT02700451|64397601|FG000|Overall Study|Protocol Violation|2|||
23179188|NCT02700451|64397602|FG001|Overall Study|Protocol Violation|2|||
23179189|NCT02700451|64397603|FG002|Overall Study|Protocol Violation|3|||
23239107|NCT01161173|64618797|FG000|Overall Study|Withdrawal of Consent|5|||
23239108|NCT01161173|64618797|FG000|Overall Study|Unacceptable Toxicity|21|||
23239109|NCT01161173|64618797|FG000|Overall Study|Death|194|||
23239110|NCT01161173|64618797|FG000|Overall Study|End of Study|2|||
23239111|NCT01161173|64618797|FG000|Overall Study|Reasons Not Specified|23|||
23239112|NCT00777920|64618798|FG000|Overall Study|Adverse Event|39|||
23239113|NCT00777920|64618798|FG000|Overall Study|Withdrawal of Consent|4|||
23239114|NCT00777920|64618798|FG000|Overall Study|Lost to Follow-up|1|||
23239115|NCT00777920|64618798|FG000|Overall Study|Investigator's discretion|1|||
23239116|NCT00777920|64618798|FG000|Overall Study|Clinical status did not improve|1|||
23239117|NCT00777920|64618798|FG000|Overall Study|Other, not specified|4|||
23239118|NCT00690612|64618799|FG000|Overall Study|Adverse Event|1|||
23239119|NCT00690612|64618799|FG000|Overall Study|Withdrawal by Subject|2|||
23239120|NCT00483119|64618800|FG000|Overall Study|Adverse Event|0|||
23239121|NCT00483119|64618801|FG001|Overall Study|Adverse Event|1|||
23239122|NCT00483119|64618800|FG000|Overall Study|Physician Decision|1|||
23239123|NCT00483119|64618801|FG001|Overall Study|Physician Decision|0|||
23239124|NCT03802331|64618802|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
23239125|NCT03802331|64618803|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
23239126|NCT00761891|64618808|FG000|Overall Study|Withdrawal by Subject|10|||
23239127|NCT03426995|64618809|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239128|NCT03426995|64618810|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239129|NCT03426995|64618811|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
23239130|NCT03426995|64618812|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239131|NCT03426995|64618813|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239132|NCT03426995|64618814|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239133|NCT03426995|64618815|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239134|NCT03426995|64618816|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239135|NCT03426995|64618817|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239136|NCT03426995|64618818|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239137|NCT03426995|64618819|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239138|NCT03426995|64618820|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239139|NCT03426995|64618821|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239140|NCT03426995|64618822|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239141|NCT03426995|64618823|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23457345|NCT03346434|65416596|FG003|Overall Study|Lost to Follow-up|0|||
23457346|NCT03346434|65416597|FG004|Overall Study|Lost to Follow-up|1|||
23179190|NCT02700451|64397601|FG000|Overall Study|Discontinued intervention|14|||
23179191|NCT02700451|64397602|FG001|Overall Study|Discontinued intervention|15|||
23179192|NCT02700451|64397603|FG002|Overall Study|Discontinued intervention|14|||
23179193|NCT01275222|64397604|FG000|Phase l by Treatment|Adverse Event|1|||
23457347|NCT03346434|65416598|FG005|Overall Study|Lost to Follow-up|1|||
23457348|NCT03346434|65416593|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
23457349|NCT03346434|65416594|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
23457350|NCT03346434|65416595|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
23457351|NCT03346434|65416596|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
23457352|NCT03346434|65416597|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
23457353|NCT03346434|65416598|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
23457354|NCT04244253|65416599|FG000|Overall Study|Adverse Event|2|||
23457355|NCT04244253|65416600|FG001|Overall Study|Adverse Event|2|||
23457356|NCT04244253|65416601|FG002|Overall Study|Adverse Event|4|||
23457357|NCT04244253|65416599|FG000|Overall Study|Protocol Violation|1|||
23457358|NCT04244253|65416600|FG001|Overall Study|Protocol Violation|2|||
23457359|NCT04244253|65416601|FG002|Overall Study|Protocol Violation|1|||
23179194|NCT01275222|64397605|FG001|Phase l by Treatment|Adverse Event|4|||
23239142|NCT03426995|64618824|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239143|NCT03426995|64618825|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239144|NCT03426995|64618826|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239145|NCT03426995|64618827|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
23239146|NCT03426995|64618809|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239147|NCT03426995|64618810|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239148|NCT03426995|64618811|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239149|NCT03426995|64618812|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239150|NCT03426995|64618813|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239151|NCT03426995|64618814|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
23239152|NCT03426995|64618815|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239153|NCT03426995|64618816|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239154|NCT03426995|64618817|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239155|NCT03426995|64618818|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239156|NCT03426995|64618819|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239157|NCT03426995|64618820|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239158|NCT03426995|64618821|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239159|NCT03426995|64618822|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239160|NCT03426995|64618823|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239161|NCT03426995|64618824|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239162|NCT03426995|64618825|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239163|NCT03426995|64618826|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239164|NCT03426995|64618827|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
23239165|NCT03426995|64618809|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239166|NCT03426995|64618810|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239167|NCT03426995|64618811|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239168|NCT03426995|64618812|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239169|NCT03426995|64618813|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
23239170|NCT03426995|64618814|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
23239171|NCT03426995|64618815|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239172|NCT03426995|64618816|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239173|NCT03426995|64618817|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239174|NCT03426995|64618818|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239175|NCT03426995|64618819|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239176|NCT03426995|64618820|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239177|NCT03426995|64618821|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239178|NCT03426995|64618822|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239179|NCT03426995|64618823|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239180|NCT03426995|64618824|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239181|NCT03426995|64618825|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23457360|NCT04244253|65416599|FG000|Overall Study|Withdrawal by Subject|0|||
23457361|NCT04244253|65416600|FG001|Overall Study|Withdrawal by Subject|1|||
23457362|NCT04244253|65416601|FG002|Overall Study|Withdrawal by Subject|6|||
23457363|NCT04244253|65416599|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23457364|NCT04244253|65416600|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23457365|NCT04244253|65416601|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23457366|NCT05131204|65416603|FG000|Overall Study|Sponsor request|2|||
23457367|NCT05131204|65416604|FG001|Overall Study|Sponsor request|1|||
23457368|NCT05526716|65416609|FG000|Overall Study|Death|1|||
23457369|NCT05526716|65416610|FG001|Overall Study|Death|2|||
23457370|NCT05526716|65416609|FG000|Overall Study|Lost to Follow-up|17|||
23457371|NCT05526716|65416610|FG001|Overall Study|Lost to Follow-up|15|||
23457372|NCT05526716|65416609|FG000|Overall Study|Physician Decision|0|||
23457373|NCT05526716|65416610|FG001|Overall Study|Physician Decision|1|||
23457374|NCT05526716|65416609|FG000|Overall Study|Randomized by mistake without study treatment|0|||
23457375|NCT05526716|65416610|FG001|Overall Study|Randomized by mistake without study treatment|1|||
23457376|NCT05526716|65416609|FG000|Overall Study|Withdrawal by Subject|12|||
23457377|NCT05526716|65416610|FG001|Overall Study|Withdrawal by Subject|12|||
23457378|NCT05526716|65416609|FG000|Overall Study|Not reported|0|||
23457379|NCT05526716|65416610|FG001|Overall Study|Not reported|2|||
23457380|NCT05083351|65416616|FG000|Overall Study|Adverse Event|3|||
23457381|NCT05083351|65416616|FG000|Overall Study|Did not meet data inclusion criteria|8|||
23457382|NCT05083351|65416616|FG000|Overall Study|Did not meet eligibility criteria|19|||
23457383|NCT05083351|65416616|FG000|Overall Study|Study Staff Decision|19|||
23457384|NCT02182895|65416617|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
23457385|NCT02182895|65416618|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
23457386|NCT04423718|65416619|FG000|Overall Study|Adverse Event|6|||
23457387|NCT04423718|65416620|FG001|Overall Study|Adverse Event|2|||
23457388|NCT04423718|65416621|FG002|Overall Study|Adverse Event|5|||
23457389|NCT04423718|65416619|FG000|Overall Study|Physician Decision|1|||
23457390|NCT04423718|65416620|FG001|Overall Study|Physician Decision|4|||
23457391|NCT04423718|65416621|FG002|Overall Study|Physician Decision|1|||
23457392|NCT04423718|65416619|FG000|Overall Study|Protocol Violation|0|||
23457393|NCT04423718|65416620|FG001|Overall Study|Protocol Violation|1|||
23457394|NCT04423718|65416621|FG002|Overall Study|Protocol Violation|1|||
23457395|NCT04423718|65416619|FG000|Overall Study|Lost to Follow-up|1|||
23457396|NCT04423718|65416620|FG001|Overall Study|Lost to Follow-up|1|||
23457397|NCT04423718|65416621|FG002|Overall Study|Lost to Follow-up|2|||
23457398|NCT04423718|65416619|FG000|Overall Study|Lack of Efficacy|2|||
23457399|NCT04423718|65416620|FG001|Overall Study|Lack of Efficacy|0|||
23457400|NCT04423718|65416621|FG002|Overall Study|Lack of Efficacy|0|||
23457401|NCT04423718|65416619|FG000|Overall Study|Withdrawal by Subject|6|||
23457402|NCT04423718|65416620|FG001|Overall Study|Withdrawal by Subject|8|||
23457403|NCT04423718|65416621|FG002|Overall Study|Withdrawal by Subject|14|||
23457404|NCT04423718|65416619|FG000|Overall Study|Death|5|||
23457405|NCT04423718|65416620|FG001|Overall Study|Death|3|||
23457406|NCT04423718|65416621|FG002|Overall Study|Death|2|||
23457407|NCT04423718|65416619|FG000|Overall Study|COVID-19 pandemic|2|||
23457408|NCT04423718|65416620|FG001|Overall Study|COVID-19 pandemic|2|||
23457409|NCT04423718|65416621|FG002|Overall Study|COVID-19 pandemic|2|||
23457410|NCT04423718|65416619|FG000|Overall Study|Other|6|||
23179195|NCT01275222|64397606|FG002|Phase l by Treatment|Adverse Event|2|||
23179196|NCT01275222|64397607|FG003|Phase l by Treatment|Adverse Event|3|||
23179197|NCT01275222|64397608|FG004|Phase l by Treatment|Adverse Event|0|||
23179198|NCT01275222|64397609|FG005|Phase l by Treatment|Adverse Event|0|||
23179199|NCT01275222|64397604|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23179200|NCT01275222|64397605|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23179201|NCT01275222|64397606|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
23179202|NCT01275222|64397607|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23179203|NCT01275222|64397608|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23179204|NCT01275222|64397609|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
23179205|NCT01275222|64397604|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23179206|NCT01275222|64397605|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23179207|NCT01275222|64397606|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23179208|NCT01275222|64397607|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
23179209|NCT01275222|64397608|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23179210|NCT01275222|64397609|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
23179211|NCT01275222|64397604|FG000|Phase l by Treatment|Disease progression|12|||
23179212|NCT01275222|64397605|FG001|Phase l by Treatment|Disease progression|8|||
23179213|NCT01275222|64397606|FG002|Phase l by Treatment|Disease progression|2|||
23179214|NCT01275222|64397607|FG003|Phase l by Treatment|Disease progression|5|||
23179215|NCT01275222|64397608|FG004|Phase l by Treatment|Disease progression|0|||
23179216|NCT01275222|64397609|FG005|Phase l by Treatment|Disease progression|0|||
23179217|NCT01275222|64397604|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
23179218|NCT01275222|64397605|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
23457411|NCT04423718|65416620|FG001|Overall Study|Other|2|||
23345935|NCT00932698|65010899|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
23345936|NCT00932698|65010900|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
23345937|NCT00932698|65010901|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
23345938|NCT00932698|65010902|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
23345939|NCT00932698|65010892|FG000|Part 1 (Dose Escalation)|Other|0|||
23457412|NCT04423718|65416621|FG002|Overall Study|Other|2|||
23457413|NCT04423718|65416619|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
23457414|NCT04423718|65416620|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
23457415|NCT04423718|65416621|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
23457416|NCT02140047|65416622|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23457417|NCT02140047|65416623|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23457418|NCT02140047|65416624|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23457419|NCT05789745|65416625|FG000|Overall Study|Withdrawal by Subject|0|||
23457420|NCT05789745|65416626|FG001|Overall Study|Withdrawal by Subject|0|||
23457421|NCT05789745|65416627|FG002|Overall Study|Withdrawal by Subject|0|||
23457422|NCT05789745|65416628|FG003|Overall Study|Withdrawal by Subject|0|||
23457423|NCT05789745|65416629|FG004|Overall Study|Withdrawal by Subject|1|||
23457424|NCT04613362|65416630|FG000|3 Month Follow-up|Lost to Follow-up|1|||
23457425|NCT04613362|65416631|FG001|3 Month Follow-up|Lost to Follow-up|2|||
23457426|NCT04613362|65416630|FG000|6 Month Follow-up|Lost to Follow-up|0|||
23457427|NCT04613362|65416631|FG001|6 Month Follow-up|Lost to Follow-up|1|||
23457428|NCT04218240|65416632|FG000|Overall Study|Withdrawal by Subject|6|||
23457429|NCT04218240|65416633|FG001|Overall Study|Withdrawal by Subject|0|||
23457430|NCT04218240|65416632|FG000|Overall Study|Lack of Efficacy|24|||
23457431|NCT04218240|65416633|FG001|Overall Study|Lack of Efficacy|19|||
23457432|NCT04218240|65416632|FG000|Overall Study|Physician Decision|0|||
23457433|NCT04218240|65416633|FG001|Overall Study|Physician Decision|1|||
23457434|NCT04218240|65416632|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
23457435|NCT04218240|65416633|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
23457436|NCT03524612|65416636|FG000|Overall Study|Lack of Efficacy|10|||
23457437|NCT03524612|65416636|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
23457438|NCT03524612|65416636|FG000|Overall Study|Adverse Event|10|||
23457439|NCT03524612|65416636|FG000|Overall Study|Withdrawal by Subject|7|||
23457440|NCT03524612|65416636|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
23457441|NCT03524612|65416636|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
23457442|NCT03524612|65416636|FG000|Overall Study|New therapy for study indication|6|||
23457443|NCT03524612|65416636|FG000|Overall Study|Death|3|||
23457444|NCT03524612|65416636|FG000|Overall Study|Lost to Follow-up|2|||
23457445|NCT03524612|65416636|FG000|Overall Study|Protocol Violation|1|||
23457446|NCT03755934|65416637|FG000|Overall Study|Adverse Event|4|||
23457447|NCT03755934|65416638|FG001|Overall Study|Adverse Event|1|||
23457448|NCT03755934|65416639|FG002|Overall Study|Adverse Event|1|||
23457449|NCT03755934|65416640|FG003|Overall Study|Adverse Event|3|||
23457450|NCT03755934|65416637|FG000|Overall Study|Physician Decision|2|||
23457451|NCT03755934|65416638|FG001|Overall Study|Physician Decision|0|||
23457452|NCT03755934|65416639|FG002|Overall Study|Physician Decision|0|||
23457453|NCT03755934|65416640|FG003|Overall Study|Physician Decision|1|||
23457454|NCT03755934|65416637|FG000|Overall Study|Withdrawal by Subject|5|||
23239182|NCT03426995|64618826|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239183|NCT03426995|64618827|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
23239184|NCT03426995|64618809|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23457455|NCT03755934|65416638|FG001|Overall Study|Withdrawal by Subject|0|||
23239185|NCT03426995|64618810|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239186|NCT03426995|64618811|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239187|NCT03426995|64618812|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239188|NCT03426995|64618813|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239189|NCT03426995|64618814|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239190|NCT03426995|64618815|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23345940|NCT00932698|65010893|FG001|Part 1 (Dose Escalation)|Other|0|||
23345941|NCT00932698|65010894|FG002|Part 1 (Dose Escalation)|Other|1|||
23345942|NCT00932698|65010895|FG003|Part 1 (Dose Escalation)|Other|0|||
23345943|NCT00932698|65010896|FG004|Part 1 (Dose Escalation)|Other|0|||
23179219|NCT01275222|64397606|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
23239191|NCT03426995|64618816|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239192|NCT03426995|64618817|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239193|NCT03426995|64618818|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23345944|NCT00932698|65010897|FG005|Part 1 (Dose Escalation)|Other|0|||
23457456|NCT03755934|65416639|FG002|Overall Study|Withdrawal by Subject|0|||
23457457|NCT03755934|65416640|FG003|Overall Study|Withdrawal by Subject|1|||
23457458|NCT03755934|65416637|FG000|Overall Study|Other|3|||
23457459|NCT03755934|65416638|FG001|Overall Study|Other|1|||
23457460|NCT03755934|65416639|FG002|Overall Study|Other|3|||
23457461|NCT03755934|65416640|FG003|Overall Study|Other|1|||
23457462|NCT03459079|65416644|FG000|Overall Study|Adverse Event|4|||
23457463|NCT03459079|65416645|FG001|Overall Study|Adverse Event|2|||
23457464|NCT03459079|65416646|FG002|Overall Study|Adverse Event|0|||
23457465|NCT03459079|65416644|FG000|Overall Study|Withdrawal by Subject|2|||
23457466|NCT03459079|65416645|FG001|Overall Study|Withdrawal by Subject|2|||
23457467|NCT03459079|65416646|FG002|Overall Study|Withdrawal by Subject|0|||
23457468|NCT00627393|65416649|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
23457469|NCT00627393|65416650|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
23457470|NCT00627393|65416649|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
23457471|NCT00627393|65416650|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
23457472|NCT00627393|65416649|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
23457473|NCT00627393|65416650|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
23457474|NCT00627393|65416649|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
23457475|NCT00627393|65416650|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
23457476|NCT00392327|65416651|FG000|Overall Study|Death|1|||
23457477|NCT00392327|65416652|FG001|Overall Study|Death|0|||
23457478|NCT00392327|65416653|FG002|Overall Study|Death|1|||
23457479|NCT00392327|65416654|FG003|Overall Study|Death|0|||
23457480|NCT00392327|65416655|FG004|Overall Study|Death|0|||
23457481|NCT00392327|65416656|FG005|Overall Study|Death|0|||
23457482|NCT00392327|65416657|FG006|Overall Study|Death|0|||
23457483|NCT00392327|65416658|FG007|Overall Study|Death|0|||
23457484|NCT00392327|65416651|FG000|Overall Study|Lack of Efficacy|8|||
23457485|NCT00392327|65416652|FG001|Overall Study|Lack of Efficacy|8|||
23457486|NCT00392327|65416653|FG002|Overall Study|Lack of Efficacy|9|||
23457487|NCT00392327|65416654|FG003|Overall Study|Lack of Efficacy|6|||
23457488|NCT00392327|65416655|FG004|Overall Study|Lack of Efficacy|3|||
23457489|NCT00392327|65416656|FG005|Overall Study|Lack of Efficacy|3|||
23457490|NCT00392327|65416657|FG006|Overall Study|Lack of Efficacy|3|||
23457491|NCT00392327|65416658|FG007|Overall Study|Lack of Efficacy|3|||
23457492|NCT00392327|65416651|FG000|Overall Study|Physician Decision|3|||
23457493|NCT00392327|65416652|FG001|Overall Study|Physician Decision|5|||
23457494|NCT00392327|65416653|FG002|Overall Study|Physician Decision|2|||
23457495|NCT00392327|65416654|FG003|Overall Study|Physician Decision|2|||
23457496|NCT00392327|65416655|FG004|Overall Study|Physician Decision|0|||
23457497|NCT00392327|65416656|FG005|Overall Study|Physician Decision|1|||
23457498|NCT00392327|65416657|FG006|Overall Study|Physician Decision|5|||
23457499|NCT00392327|65416658|FG007|Overall Study|Physician Decision|3|||
23457500|NCT00392327|65416651|FG000|Overall Study|Protocol Violation|0|||
23457501|NCT00392327|65416652|FG001|Overall Study|Protocol Violation|0|||
23457502|NCT00392327|65416653|FG002|Overall Study|Protocol Violation|1|||
23457503|NCT00392327|65416654|FG003|Overall Study|Protocol Violation|0|||
23457504|NCT00392327|65416655|FG004|Overall Study|Protocol Violation|0|||
23457505|NCT00392327|65416656|FG005|Overall Study|Protocol Violation|0|||
23457506|NCT00392327|65416657|FG006|Overall Study|Protocol Violation|0|||
23457507|NCT00392327|65416658|FG007|Overall Study|Protocol Violation|0|||
23457508|NCT00392327|65416651|FG000|Overall Study|Withdrawal by Subject|3|||
23457509|NCT00392327|65416652|FG001|Overall Study|Withdrawal by Subject|2|||
23457510|NCT00392327|65416653|FG002|Overall Study|Withdrawal by Subject|4|||
23457511|NCT00392327|65416654|FG003|Overall Study|Withdrawal by Subject|6|||
23457512|NCT00392327|65416655|FG004|Overall Study|Withdrawal by Subject|0|||
23457513|NCT00392327|65416656|FG005|Overall Study|Withdrawal by Subject|1|||
23457514|NCT00392327|65416657|FG006|Overall Study|Withdrawal by Subject|1|||
23457515|NCT00392327|65416658|FG007|Overall Study|Withdrawal by Subject|5|||
23457516|NCT00392327|65416651|FG000|Overall Study|Ineligible|0|||
23457517|NCT00392327|65416652|FG001|Overall Study|Ineligible|4|||
23457518|NCT00392327|65416653|FG002|Overall Study|Ineligible|3|||
23457519|NCT00392327|65416654|FG003|Overall Study|Ineligible|2|||
23457520|NCT00392327|65416655|FG004|Overall Study|Ineligible|0|||
23457521|NCT00392327|65416656|FG005|Overall Study|Ineligible|0|||
23457522|NCT00392327|65416657|FG006|Overall Study|Ineligible|0|||
23457523|NCT00392327|65416658|FG007|Overall Study|Ineligible|0|||
23457524|NCT06303167|65416659|FG000|Overall Study|Ineligible|1|||
23457525|NCT06303167|65416659|FG000|Overall Study|Never start protocol therapy|2|||
23457526|NCT06303167|65416659|FG000|Overall Study|Disease progression|16|||
23345945|NCT00932698|65010898|FG006|Part 1 (Dose Escalation)|Other|1|||
23457527|NCT01766050|65416660|FG000|Overall Study|Adverse Event|1|||
23457528|NCT01766050|65416660|FG000|Overall Study|Lost to Follow-up|1|||
23457529|NCT01766050|65416660|FG000|Overall Study|Withdrawal by Subject|2|||
23457530|NCT04819945|65416663|FG000|Overall Study|Lost to Follow-up|1|||
23457531|NCT03379818|65416664|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
23457532|NCT03379818|65416665|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
23457533|NCT03379818|65416664|FG000|Overall Study|Withdrawal by Subject|2|||
23457534|NCT03379818|65416665|FG001|Overall Study|Withdrawal by Subject|3|||
23457535|NCT03379818|65416664|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
23457536|NCT03379818|65416665|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
23457537|NCT04408989|65416668|FG000|Overall Study|Lost to Follow-up|0|||
23457538|NCT04408989|65416669|FG001|Overall Study|Lost to Follow-up|0|||
23457539|NCT04408989|65416670|FG002|Overall Study|Lost to Follow-up|1|||
23457540|NCT04408989|65416668|FG000|Overall Study|Withdrawal by Subject|0|||
23457541|NCT04408989|65416669|FG001|Overall Study|Withdrawal by Subject|0|||
23457542|NCT04408989|65416670|FG002|Overall Study|Withdrawal by Subject|2|||
23457543|NCT02814916|65416671|FG000|Overall Study|Withdrawal of consent|0|||
23457544|NCT02814916|65416672|FG001|Overall Study|Withdrawal of consent|2|||
23457545|NCT02814916|65416673|FG002|Overall Study|Withdrawal of consent|0|||
23457546|NCT02814916|65416671|FG000|Overall Study|Lost to Follow-up|0|||
23457547|NCT02814916|65416672|FG001|Overall Study|Lost to Follow-up|1|||
23457548|NCT02814916|65416673|FG002|Overall Study|Lost to Follow-up|0|||
23457549|NCT02814916|65416671|FG000|Overall Study|Other, not specified|0|||
23457550|NCT02814916|65416672|FG001|Overall Study|Other, not specified|1|||
23457551|NCT02814916|65416673|FG002|Overall Study|Other, not specified|0|||
23457552|NCT01280903|65416674|FG000|Overall Study|Lost to Follow-up|23|||
23457553|NCT01280903|65416675|FG001|Overall Study|Lost to Follow-up|16|||
23457554|NCT02384551|65416676|FG000|Overall Study|Lost to Follow-up|13|||
23457555|NCT02384551|65416677|FG001|Overall Study|Lost to Follow-up|14|||
23583569|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
23583570|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583571|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583572|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583573|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583574|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583575|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583576|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583577|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583578|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583579|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583580|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583581|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
23583582|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
23583583|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
23239194|NCT03426995|64618819|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
23239195|NCT03426995|64618820|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239196|NCT03426995|64618821|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239197|NCT03426995|64618822|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239198|NCT03426995|64618823|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239199|NCT03426995|64618824|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239200|NCT03426995|64618825|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239201|NCT03426995|64618826|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239202|NCT03426995|64618827|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
23239203|NCT03426995|64618809|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239204|NCT03426995|64618810|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239205|NCT03426995|64618811|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239206|NCT03426995|64618812|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23583584|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583585|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583586|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583587|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583588|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583589|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583590|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583591|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23239207|NCT03426995|64618813|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239208|NCT03426995|64618814|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239209|NCT03426995|64618815|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239210|NCT03426995|64618816|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
23239211|NCT03426995|64618817|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23345946|NCT00932698|65010899|FG007|Part 1 (Dose Escalation)|Other|0|||
23239212|NCT03426995|64618818|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239213|NCT03426995|64618819|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239214|NCT03426995|64618820|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23457556|NCT02384551|65416678|FG002|Overall Study|Lost to Follow-up|14|||
23239215|NCT03426995|64618821|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23345947|NCT00932698|65010900|FG008|Part 1 (Dose Escalation)|Other|0|||
23457557|NCT02384551|65416679|FG003|Overall Study|Lost to Follow-up|14|||
23457558|NCT05121766|65416682|FG000|Overall Study|Covid reinfection|3|||
23457559|NCT05121766|65416683|FG001|Overall Study|Covid reinfection|0|||
23457560|NCT05121766|65416682|FG000|Overall Study|Withdrawal by Subject|3|||
23179220|NCT01275222|64397607|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
23179221|NCT01275222|64397608|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
23179222|NCT01275222|64397609|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
23179223|NCT01275222|64397604|FG000|Phase l by Treatment|Death|0|||
23179224|NCT01275222|64397605|FG001|Phase l by Treatment|Death|1|||
23179225|NCT01275222|64397606|FG002|Phase l by Treatment|Death|0|||
23179226|NCT01275222|64397607|FG003|Phase l by Treatment|Death|1|||
23239216|NCT03426995|64618822|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23179227|NCT01275222|64397608|FG004|Phase l by Treatment|Death|0|||
23239217|NCT03426995|64618823|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23179228|NCT01275222|64397609|FG005|Phase l by Treatment|Death|0|||
23179229|NCT01275222|64397604|FG000|Phase ll by Stratum|Adverse Event|0|||
23179230|NCT01275222|64397605|FG001|Phase ll by Stratum|Adverse Event|0|||
23179231|NCT01275222|64397606|FG002|Phase ll by Stratum|Adverse Event|0|||
23179232|NCT01275222|64397607|FG003|Phase ll by Stratum|Adverse Event|0|||
23179233|NCT01275222|64397608|FG004|Phase ll by Stratum|Adverse Event|2|||
23179234|NCT01275222|64397609|FG005|Phase ll by Stratum|Adverse Event|10|||
23179235|NCT01275222|64397604|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
23179236|NCT01275222|64397605|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
23179237|NCT01275222|64397606|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
23179238|NCT01275222|64397607|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
23179239|NCT01275222|64397608|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
23179240|NCT01275222|64397609|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
23179241|NCT01275222|64397604|FG000|Phase ll by Stratum|Disease progression|0|||
23179242|NCT01275222|64397605|FG001|Phase ll by Stratum|Disease progression|0|||
23179243|NCT01275222|64397606|FG002|Phase ll by Stratum|Disease progression|0|||
23179244|NCT01275222|64397607|FG003|Phase ll by Stratum|Disease progression|0|||
23179245|NCT01275222|64397608|FG004|Phase ll by Stratum|Disease progression|23|||
23179246|NCT01275222|64397609|FG005|Phase ll by Stratum|Disease progression|31|||
23179247|NCT01275222|64397604|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
23179248|NCT01275222|64397605|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
23179249|NCT01275222|64397606|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
23179250|NCT01275222|64397607|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
23179251|NCT01275222|64397608|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
23179252|NCT01275222|64397609|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
23179253|NCT01275222|64397604|FG000|Phase ll by Stratum|Death|0|||
23179254|NCT01275222|64397605|FG001|Phase ll by Stratum|Death|0|||
23179255|NCT01275222|64397606|FG002|Phase ll by Stratum|Death|0|||
23179256|NCT01275222|64397607|FG003|Phase ll by Stratum|Death|0|||
23179257|NCT01275222|64397608|FG004|Phase ll by Stratum|Death|1|||
23179258|NCT01275222|64397609|FG005|Phase ll by Stratum|Death|1|||
23179259|NCT00619957|64397613|FG000|Month 24 Double-Blind|Adverse Event|9|||
23179260|NCT00619957|64397614|FG001|Month 24 Double-Blind|Adverse Event|7|||
23179261|NCT00619957|64397613|FG000|Month 24 Double-Blind|Protocol Violation|1|||
23179262|NCT00619957|64397614|FG001|Month 24 Double-Blind|Protocol Violation|0|||
23179263|NCT00619957|64397613|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
23239218|NCT03426995|64618824|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239219|NCT03426995|64618825|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239220|NCT03426995|64618826|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239221|NCT03426995|64618827|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
23239222|NCT03426995|64618809|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239223|NCT03426995|64618810|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239224|NCT03426995|64618811|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239225|NCT03426995|64618812|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239226|NCT03426995|64618813|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239227|NCT03426995|64618814|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239228|NCT03426995|64618815|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239229|NCT03426995|64618816|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239230|NCT03426995|64618817|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239231|NCT03426995|64618818|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239232|NCT03426995|64618819|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239233|NCT03426995|64618820|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239234|NCT03426995|64618821|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239235|NCT03426995|64618822|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239236|NCT03426995|64618823|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
23239237|NCT03426995|64618824|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
23239238|NCT03426995|64618825|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23345948|NCT00932698|65010901|FG009|Part 1 (Dose Escalation)|Other|0|||
23457561|NCT05121766|65416683|FG001|Overall Study|Withdrawal by Subject|1|||
23457562|NCT05121766|65416682|FG000|Overall Study|Adverse Event|2|||
23457563|NCT05121766|65416683|FG001|Overall Study|Adverse Event|4|||
23239239|NCT03426995|64618826|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23457564|NCT05121766|65416682|FG000|Overall Study|Lost to Follow-up|0|||
23457565|NCT05121766|65416683|FG001|Overall Study|Lost to Follow-up|1|||
23179264|NCT00619957|64397614|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
23179265|NCT00619957|64397613|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
23179266|NCT00619957|64397614|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
23179267|NCT00619957|64397613|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
23179268|NCT00619957|64397614|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
23179269|NCT00619957|64397613|FG000|Month 48 Open-Label|Adverse Event|4|||
23179270|NCT00619957|64397614|FG001|Month 48 Open-Label|Adverse Event|4|||
23179271|NCT00619957|64397613|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
23239240|NCT03426995|64618827|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
23239241|NCT03426995|64618809|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239242|NCT03426995|64618810|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239243|NCT03426995|64618811|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239244|NCT03426995|64618812|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239245|NCT03426995|64618813|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239246|NCT03426995|64618814|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239247|NCT03426995|64618815|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239248|NCT03426995|64618816|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239249|NCT03426995|64618817|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239250|NCT03426995|64618818|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239251|NCT03426995|64618819|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239252|NCT03426995|64618820|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239253|NCT03426995|64618821|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239254|NCT03426995|64618822|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239255|NCT03426995|64618823|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
23239256|NCT03426995|64618824|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
23239257|NCT03426995|64618825|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239258|NCT03426995|64618826|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239259|NCT03426995|64618827|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
23239260|NCT01302366|64618830|FG000|Overall Study|patient choice or noncompliance|5|||
23239261|NCT01911546|64618831|FG000|Overall Study|Lost to Follow-up|1|||
23345949|NCT00932698|65010902|FG010|Part 1 (Dose Escalation)|Other|0|||
23239262|NCT01911546|64618831|FG000|Overall Study|Everolimus was discontinued|5|||
23179272|NCT00619957|64397614|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
23179273|NCT00619957|64397613|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
23239263|NCT02283411|64618832|FG000|Overall Study|Withdrawal by Subject|3|||
23239264|NCT02283411|64618832|FG000|Overall Study|Screen Failed|28|||
23239265|NCT01303159|64618833|FG000|Overall Study|Death|16|||
23239266|NCT01303159|64618833|FG000|Overall Study|Study Termination|7|||
23239267|NCT00726882|64618838|FG000|Overall Study|Withdrawal by Subject|5|||
23239268|NCT00726882|64618838|FG000|Overall Study|Lost to Follow-up|7|||
23239269|NCT00726882|64618838|FG000|Overall Study|Other|10|||
23239270|NCT04052425|64618839|FG000|24-Week Double-blind Period|Adverse Event|0|||
23239271|NCT04052425|64618840|FG001|24-Week Double-blind Period|Adverse Event|1|||
23239272|NCT04052425|64618841|FG002|24-Week Double-blind Period|Adverse Event|0|||
23239273|NCT04052425|64618842|FG003|24-Week Double-blind Period|Adverse Event|0|||
23239274|NCT04052425|64618839|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
23239275|NCT04052425|64618840|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
23239276|NCT04052425|64618841|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
23239277|NCT04052425|64618842|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
23239278|NCT04052425|64618839|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
23239279|NCT04052425|64618840|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
23239280|NCT04052425|64618841|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
23239281|NCT04052425|64618842|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
23239282|NCT04052425|64618839|FG000|24-Week Double-blind Period|Physician Decision|1|||
23239283|NCT04052425|64618840|FG001|24-Week Double-blind Period|Physician Decision|0|||
23239284|NCT04052425|64618841|FG002|24-Week Double-blind Period|Physician Decision|0|||
23239285|NCT04052425|64618842|FG003|24-Week Double-blind Period|Physician Decision|0|||
23239286|NCT04052425|64618839|FG000|24-Week Double-blind Period|Protocol Violation|1|||
23239287|NCT04052425|64618840|FG001|24-Week Double-blind Period|Protocol Violation|0|||
23239288|NCT04052425|64618841|FG002|24-Week Double-blind Period|Protocol Violation|0|||
23239289|NCT04052425|64618842|FG003|24-Week Double-blind Period|Protocol Violation|0|||
23239290|NCT04052425|64618839|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
23239291|NCT04052425|64618840|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
23239292|NCT04052425|64618841|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
23345950|NCT00932698|65010892|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
23239293|NCT04052425|64618842|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
23239294|NCT04052425|64618839|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
23239295|NCT04052425|64618840|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
23239296|NCT04052425|64618841|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
23239297|NCT04052425|64618842|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
23239298|NCT04052425|64618839|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
23239299|NCT04052425|64618840|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
23239300|NCT04052425|64618841|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
23239301|NCT04052425|64618842|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
23239302|NCT04052425|64618839|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
23239303|NCT04052425|64618840|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
23179274|NCT00619957|64397614|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
23345951|NCT00932698|65010893|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345952|NCT00932698|65010894|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345953|NCT00932698|65010895|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345954|NCT00932698|65010896|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345955|NCT00932698|65010897|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345956|NCT00932698|65010898|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
23345957|NCT00932698|65010899|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
23345958|NCT00932698|65010900|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
23345959|NCT00932698|65010901|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
23345960|NCT00932698|65010902|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
23239304|NCT04052425|64618841|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
23179275|NCT04698629|64397617|FG000|Overall Study|Adverse Event|1|||
23179276|NCT00891202|64397618|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
23179277|NCT00891202|64397619|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
23179278|NCT00891202|64397620|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
23179279|NCT00891202|64397621|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
23179280|NCT00891202|64397618|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
23179281|NCT00891202|64397619|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
23179282|NCT00891202|64397620|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
23179283|NCT00891202|64397621|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
23179284|NCT00891202|64397618|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
23239305|NCT04052425|64618842|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
23239306|NCT04052425|64618839|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
23239307|NCT04052425|64618840|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
23239308|NCT04052425|64618841|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
23239309|NCT04052425|64618842|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
23239310|NCT04052425|64618839|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
23239311|NCT04052425|64618840|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
23239312|NCT04052425|64618841|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
23239313|NCT04052425|64618842|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
23239314|NCT04052425|64618839|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
23239315|NCT04052425|64618840|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
23345961|NCT00932698|65010892|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345962|NCT00932698|65010893|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345963|NCT00932698|65010894|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23179285|NCT00891202|64397619|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
23179286|NCT00891202|64397620|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
23179287|NCT00891202|64397621|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
23179288|NCT00891202|64397618|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
23239316|NCT04052425|64618841|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
23457566|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
23457567|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
23457568|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
23457569|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
23179289|NCT00891202|64397619|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
23179290|NCT00891202|64397620|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
23179291|NCT00891202|64397621|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
23179292|NCT02908100|64397626|FG000|Overall Study|Adverse Event|7|||
23179293|NCT02908100|64397627|FG001|Overall Study|Adverse Event|6|||
23179294|NCT02908100|64397628|FG002|Overall Study|Adverse Event|9|||
23179295|NCT02908100|64397626|FG000|Overall Study|Death|2|||
23179296|NCT02908100|64397627|FG001|Overall Study|Death|0|||
23179297|NCT02908100|64397628|FG002|Overall Study|Death|0|||
23179298|NCT02908100|64397626|FG000|Overall Study|Lack of Efficacy|2|||
23179299|NCT02908100|64397627|FG001|Overall Study|Lack of Efficacy|3|||
23179300|NCT02908100|64397628|FG002|Overall Study|Lack of Efficacy|3|||
23179301|NCT02908100|64397626|FG000|Overall Study|Lost to Follow-up|0|||
23179302|NCT02908100|64397627|FG001|Overall Study|Lost to Follow-up|1|||
23457570|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
23457571|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
23457572|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
23457573|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
23179303|NCT02908100|64397628|FG002|Overall Study|Lost to Follow-up|2|||
23179304|NCT02908100|64397626|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23179305|NCT02908100|64397627|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23179306|NCT02908100|64397628|FG002|Overall Study|Non-Compliance With Study Drug|2|||
23239317|NCT04052425|64618842|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
23457574|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
23179307|NCT02908100|64397626|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
23345964|NCT00932698|65010895|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23179308|NCT02908100|64397627|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
23179309|NCT02908100|64397628|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
23179310|NCT02908100|64397626|FG000|Overall Study|Physician Decision|0|||
23179311|NCT02908100|64397627|FG001|Overall Study|Physician Decision|1|||
23179312|NCT02908100|64397628|FG002|Overall Study|Physician Decision|0|||
23179313|NCT02908100|64397626|FG000|Overall Study|Pregnancy|1|||
23179314|NCT02908100|64397627|FG001|Overall Study|Pregnancy|2|||
23239318|NCT04052425|64618839|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
23239319|NCT04052425|64618840|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
23239320|NCT04052425|64618841|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
23239321|NCT04052425|64618842|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
23239322|NCT04052425|64618839|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
23239323|NCT04052425|64618840|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
23239324|NCT04052425|64618841|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
23239325|NCT04052425|64618842|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
23239326|NCT01641952|64618844|FG000|Overall Study|Lost to Follow-up|28|||
23239327|NCT01641952|64618844|FG000|Overall Study|Adverse Event|6|||
23239328|NCT00489411|64618845|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
23239329|NCT00489411|64618846|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
23239330|NCT00489411|64618845|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
23239331|NCT00489411|64618846|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
23239332|NCT00489411|64618845|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
23239333|NCT00489411|64618846|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
23239334|NCT00489411|64618845|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
23239335|NCT00489411|64618846|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
23239336|NCT00489411|64618845|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
23239337|NCT00489411|64618846|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
23239338|NCT00471237|64618850|FG000|Overall Study|Adverse Event|6|||
23239339|NCT00471237|64618851|FG001|Overall Study|Adverse Event|5|||
23239340|NCT00471237|64618852|FG002|Overall Study|Adverse Event|4|||
23239341|NCT00471237|64618853|FG003|Overall Study|Adverse Event|8|||
23239342|NCT00471237|64618854|FG004|Overall Study|Adverse Event|7|||
23239343|NCT00471237|64618855|FG005|Overall Study|Adverse Event|5|||
23239344|NCT00471237|64618856|FG006|Overall Study|Adverse Event|0|||
23239345|NCT00471237|64618850|FG000|Overall Study|Lost to Follow-up|1|||
23239346|NCT00471237|64618851|FG001|Overall Study|Lost to Follow-up|1|||
23239347|NCT00471237|64618852|FG002|Overall Study|Lost to Follow-up|0|||
23239348|NCT00471237|64618853|FG003|Overall Study|Lost to Follow-up|2|||
23239349|NCT00471237|64618854|FG004|Overall Study|Lost to Follow-up|3|||
23239350|NCT00471237|64618855|FG005|Overall Study|Lost to Follow-up|0|||
23239351|NCT00471237|64618856|FG006|Overall Study|Lost to Follow-up|0|||
23239352|NCT00471237|64618850|FG000|Overall Study|Protocol Violation|3|||
23239353|NCT00471237|64618851|FG001|Overall Study|Protocol Violation|6|||
23239354|NCT00471237|64618852|FG002|Overall Study|Protocol Violation|3|||
23239355|NCT00471237|64618853|FG003|Overall Study|Protocol Violation|2|||
23239356|NCT00471237|64618854|FG004|Overall Study|Protocol Violation|2|||
23239357|NCT00471237|64618855|FG005|Overall Study|Protocol Violation|4|||
23239358|NCT00471237|64618856|FG006|Overall Study|Protocol Violation|1|||
23239359|NCT00471237|64618850|FG000|Overall Study|Withdrawal by Subject|8|||
23239360|NCT00471237|64618851|FG001|Overall Study|Withdrawal by Subject|6|||
23239361|NCT00471237|64618852|FG002|Overall Study|Withdrawal by Subject|5|||
23239362|NCT00471237|64618853|FG003|Overall Study|Withdrawal by Subject|8|||
23239363|NCT00471237|64618854|FG004|Overall Study|Withdrawal by Subject|7|||
23239364|NCT00471237|64618855|FG005|Overall Study|Withdrawal by Subject|4|||
23239365|NCT00471237|64618856|FG006|Overall Study|Withdrawal by Subject|2|||
23239366|NCT00471237|64618850|FG000|Overall Study|Sponsor terminated study|20|||
23239367|NCT00471237|64618851|FG001|Overall Study|Sponsor terminated study|23|||
23179315|NCT02908100|64397628|FG002|Overall Study|Pregnancy|0|||
23239368|NCT00471237|64618852|FG002|Overall Study|Sponsor terminated study|19|||
23239369|NCT00471237|64618853|FG003|Overall Study|Sponsor terminated study|22|||
23239370|NCT00471237|64618854|FG004|Overall Study|Sponsor terminated study|18|||
23239371|NCT00471237|64618855|FG005|Overall Study|Sponsor terminated study|24|||
23239372|NCT00471237|64618856|FG006|Overall Study|Sponsor terminated study|0|||
23179316|NCT02908100|64397626|FG000|Overall Study|Withdrawal by Subject|8|||
23239373|NCT00471237|64618850|FG000|Overall Study|Non-compliance|0|||
23239374|NCT00471237|64618851|FG001|Overall Study|Non-compliance|1|||
23239375|NCT00471237|64618852|FG002|Overall Study|Non-compliance|0|||
23239376|NCT00471237|64618853|FG003|Overall Study|Non-compliance|1|||
23239377|NCT00471237|64618854|FG004|Overall Study|Non-compliance|0|||
23239378|NCT00471237|64618855|FG005|Overall Study|Non-compliance|0|||
23239379|NCT00471237|64618856|FG006|Overall Study|Non-compliance|0|||
23179317|NCT02908100|64397627|FG001|Overall Study|Withdrawal by Subject|7|||
23179318|NCT02908100|64397628|FG002|Overall Study|Withdrawal by Subject|5|||
23239380|NCT00471237|64618850|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
23239381|NCT00471237|64618851|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
23239382|NCT00471237|64618852|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
23239383|NCT00471237|64618853|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
23239384|NCT00471237|64618854|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
23239385|NCT00471237|64618855|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
23239386|NCT00471237|64618856|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
23239387|NCT00471237|64618850|FG000|Overall Study|Early stopping due to non-efficacy|1|||
23457575|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
23239388|NCT00471237|64618851|FG001|Overall Study|Early stopping due to non-efficacy|0|||
23239389|NCT00471237|64618852|FG002|Overall Study|Early stopping due to non-efficacy|0|||
23239390|NCT00471237|64618853|FG003|Overall Study|Early stopping due to non-efficacy|0|||
23179319|NCT02908100|64397626|FG000|Overall Study|Randomised in Error|1|||
23179320|NCT02908100|64397627|FG001|Overall Study|Randomised in Error|0|||
23179321|NCT02908100|64397628|FG002|Overall Study|Randomised in Error|0|||
23179322|NCT03588741|64397629|FG000|Overall Study|Withdrawal by Subject|1|||
23179323|NCT05032950|64397632|FG000|Overall Study|Adverse Event|0|||
23179324|NCT05032950|64397633|FG001|Overall Study|Adverse Event|0|||
23179325|NCT05032950|64397634|FG002|Overall Study|Adverse Event|1|||
23179326|NCT05032950|64397635|FG003|Overall Study|Adverse Event|1|||
23345965|NCT00932698|65010896|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345966|NCT00932698|65010897|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345967|NCT00932698|65010898|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345968|NCT00932698|65010899|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
23179327|NCT05032950|64397636|FG004|Overall Study|Adverse Event|0|||
23179328|NCT05032950|64397637|FG005|Overall Study|Adverse Event|0|||
23179329|NCT00805740|64397638|FG000|Overall Study|Death|7|||
23179330|NCT00805740|64397639|FG001|Overall Study|Death|4|||
23179331|NCT00805740|64397638|FG000|Overall Study|Withdrawal by Subject|1|||
23179332|NCT00805740|64397639|FG001|Overall Study|Withdrawal by Subject|0|||
23179333|NCT00805740|64397638|FG000|Overall Study|Lost to Follow-up|1|||
23179334|NCT00805740|64397639|FG001|Overall Study|Lost to Follow-up|0|||
23179335|NCT00805740|64397638|FG000|Overall Study|Randomized, but not treated|2|||
23239391|NCT00471237|64618854|FG004|Overall Study|Early stopping due to non-efficacy|1|||
23239392|NCT00471237|64618855|FG005|Overall Study|Early stopping due to non-efficacy|0|||
23239393|NCT00471237|64618856|FG006|Overall Study|Early stopping due to non-efficacy|0|||
23239394|NCT00471237|64618850|FG000|Overall Study|Participant planned to travel to abraod|1|||
23239395|NCT00471237|64618851|FG001|Overall Study|Participant planned to travel to abraod|0|||
23239396|NCT00471237|64618852|FG002|Overall Study|Participant planned to travel to abraod|0|||
23239397|NCT00471237|64618853|FG003|Overall Study|Participant planned to travel to abraod|0|||
23239398|NCT00471237|64618854|FG004|Overall Study|Participant planned to travel to abraod|0|||
23239399|NCT00471237|64618855|FG005|Overall Study|Participant planned to travel to abraod|1|||
23239400|NCT00471237|64618856|FG006|Overall Study|Participant planned to travel to abraod|0|||
23239401|NCT00471237|64618850|FG000|Overall Study|High parathyroid hormone|0|||
23345969|NCT00932698|65010900|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
23345970|NCT00932698|65010901|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
23345971|NCT00932698|65010902|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
23345972|NCT00932698|65010892|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
23345973|NCT00932698|65010893|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
23345974|NCT00932698|65010894|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
23345975|NCT00932698|65010895|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
23345976|NCT00932698|65010896|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
23345977|NCT00932698|65010897|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
23345978|NCT00932698|65010898|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
23345979|NCT00932698|65010899|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
23345980|NCT00932698|65010900|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
23345981|NCT00932698|65010901|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
23345982|NCT00932698|65010902|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
23345983|NCT04608344|65010903|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
23345984|NCT04608344|65010904|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
23345985|NCT04608344|65010903|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
23345986|NCT04608344|65010904|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
23345987|NCT02829723|65010905|FG000|Overall Study|Adverse Event|0|||
23345988|NCT02829723|65010906|FG001|Overall Study|Adverse Event|0|||
23345989|NCT02829723|65010907|FG002|Overall Study|Adverse Event|1|||
23345990|NCT02829723|65010908|FG003|Overall Study|Adverse Event|1|||
23345991|NCT02829723|65010909|FG004|Overall Study|Adverse Event|0|||
23345992|NCT02829723|65010910|FG005|Overall Study|Adverse Event|0|||
23345993|NCT02829723|65010911|FG006|Overall Study|Adverse Event|0|||
23345994|NCT02829723|65010912|FG007|Overall Study|Adverse Event|1|||
23179336|NCT00805740|64397639|FG001|Overall Study|Randomized, but not treated|0|||
23179337|NCT01818726|64397640|FG000|Overall Study|Administrative reasons|5|||
23239402|NCT00471237|64618851|FG001|Overall Study|High parathyroid hormone|0|||
23239403|NCT00471237|64618852|FG002|Overall Study|High parathyroid hormone|1|||
23345995|NCT02829723|65010913|FG008|Overall Study|Adverse Event|0|||
23345996|NCT02829723|65010914|FG009|Overall Study|Adverse Event|0|||
23345997|NCT02829723|65010915|FG010|Overall Study|Adverse Event|0|||
23179338|NCT01818726|64397641|FG001|Overall Study|Administrative reasons|1|||
23179339|NCT01818726|64397640|FG000|Overall Study|Withdrawal by Subject|0|||
23457576|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
23345998|NCT02829723|65010916|FG011|Overall Study|Adverse Event|0|||
23345999|NCT02829723|65010917|FG012|Overall Study|Adverse Event|0|||
23346000|NCT02829723|65010918|FG013|Overall Study|Adverse Event|0|||
23346001|NCT02829723|65010919|FG014|Overall Study|Adverse Event|1|||
23346002|NCT02829723|65010920|FG015|Overall Study|Adverse Event|1|||
23346003|NCT02829723|65010921|FG016|Overall Study|Adverse Event|1|||
23346004|NCT02829723|65010922|FG017|Overall Study|Adverse Event|2|||
23346005|NCT02829723|65010923|FG018|Overall Study|Adverse Event|1|||
23346006|NCT02829723|65010924|FG019|Overall Study|Adverse Event|1|||
23346007|NCT02829723|65010925|FG020|Overall Study|Adverse Event|3|||
23346008|NCT02829723|65010926|FG021|Overall Study|Adverse Event|0|||
23346009|NCT02829723|65010927|FG022|Overall Study|Adverse Event|0|||
23346010|NCT02829723|65010928|FG023|Overall Study|Adverse Event|1|||
23346011|NCT02829723|65010929|FG024|Overall Study|Adverse Event|1|||
23346012|NCT02829723|65010930|FG025|Overall Study|Adverse Event|3|||
23346013|NCT02829723|65010931|FG026|Overall Study|Adverse Event|5|||
23346014|NCT02829723|65010905|FG000|Overall Study|Death|1|||
23346015|NCT02829723|65010906|FG001|Overall Study|Death|0|||
23346016|NCT02829723|65010907|FG002|Overall Study|Death|1|||
23346017|NCT02829723|65010908|FG003|Overall Study|Death|1|||
23346018|NCT02829723|65010909|FG004|Overall Study|Death|0|||
23346019|NCT02829723|65010910|FG005|Overall Study|Death|0|||
23346020|NCT02829723|65010911|FG006|Overall Study|Death|2|||
23346021|NCT02829723|65010912|FG007|Overall Study|Death|0|||
23346022|NCT02829723|65010913|FG008|Overall Study|Death|1|||
23346023|NCT02829723|65010914|FG009|Overall Study|Death|0|||
23346024|NCT02829723|65010915|FG010|Overall Study|Death|0|||
23346025|NCT02829723|65010916|FG011|Overall Study|Death|0|||
23346026|NCT02829723|65010917|FG012|Overall Study|Death|2|||
23346027|NCT02829723|65010918|FG013|Overall Study|Death|1|||
23346028|NCT02829723|65010919|FG014|Overall Study|Death|0|||
23346029|NCT02829723|65010920|FG015|Overall Study|Death|0|||
23346030|NCT02829723|65010921|FG016|Overall Study|Death|0|||
23346031|NCT02829723|65010922|FG017|Overall Study|Death|0|||
23346032|NCT02829723|65010923|FG018|Overall Study|Death|0|||
23346033|NCT02829723|65010924|FG019|Overall Study|Death|0|||
23346034|NCT02829723|65010925|FG020|Overall Study|Death|0|||
23346035|NCT02829723|65010926|FG021|Overall Study|Death|2|||
23346036|NCT02829723|65010927|FG022|Overall Study|Death|0|||
23346037|NCT02829723|65010928|FG023|Overall Study|Death|0|||
23346038|NCT02829723|65010929|FG024|Overall Study|Death|0|||
23346039|NCT02829723|65010930|FG025|Overall Study|Death|1|||
23346040|NCT02829723|65010931|FG026|Overall Study|Death|2|||
23346041|NCT02829723|65010905|FG000|Overall Study|Physician Decision|0|||
23346042|NCT02829723|65010906|FG001|Overall Study|Physician Decision|0|||
23346043|NCT02829723|65010907|FG002|Overall Study|Physician Decision|0|||
23346044|NCT02829723|65010908|FG003|Overall Study|Physician Decision|0|||
23346045|NCT02829723|65010909|FG004|Overall Study|Physician Decision|0|||
23346046|NCT02829723|65010910|FG005|Overall Study|Physician Decision|0|||
23346047|NCT02829723|65010911|FG006|Overall Study|Physician Decision|0|||
23346048|NCT02829723|65010912|FG007|Overall Study|Physician Decision|0|||
23346049|NCT02829723|65010913|FG008|Overall Study|Physician Decision|0|||
23346050|NCT02829723|65010914|FG009|Overall Study|Physician Decision|1|||
23346051|NCT02829723|65010915|FG010|Overall Study|Physician Decision|1|||
23346052|NCT02829723|65010916|FG011|Overall Study|Physician Decision|0|||
23346053|NCT02829723|65010917|FG012|Overall Study|Physician Decision|0|||
23457577|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
23457578|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
23457579|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
23457580|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23457581|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23346054|NCT02829723|65010918|FG013|Overall Study|Physician Decision|1|||
23346055|NCT02829723|65010919|FG014|Overall Study|Physician Decision|0|||
23346056|NCT02829723|65010920|FG015|Overall Study|Physician Decision|0|||
23346057|NCT02829723|65010921|FG016|Overall Study|Physician Decision|2|||
23346058|NCT02829723|65010922|FG017|Overall Study|Physician Decision|0|||
23346059|NCT02829723|65010923|FG018|Overall Study|Physician Decision|0|||
23346060|NCT02829723|65010924|FG019|Overall Study|Physician Decision|0|||
23346061|NCT02829723|65010925|FG020|Overall Study|Physician Decision|0|||
23346062|NCT02829723|65010926|FG021|Overall Study|Physician Decision|0|||
23346063|NCT02829723|65010927|FG022|Overall Study|Physician Decision|1|||
23346064|NCT02829723|65010928|FG023|Overall Study|Physician Decision|1|||
23346065|NCT02829723|65010929|FG024|Overall Study|Physician Decision|1|||
23346066|NCT02829723|65010930|FG025|Overall Study|Physician Decision|1|||
23346067|NCT02829723|65010931|FG026|Overall Study|Physician Decision|3|||
23457582|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
23346068|NCT02829723|65010905|FG000|Overall Study|Progressive disease|4|||
23346069|NCT02829723|65010906|FG001|Overall Study|Progressive disease|6|||
23346070|NCT02829723|65010907|FG002|Overall Study|Progressive disease|3|||
23346071|NCT02829723|65010908|FG003|Overall Study|Progressive disease|3|||
23346072|NCT02829723|65010909|FG004|Overall Study|Progressive disease|3|||
23346073|NCT02829723|65010910|FG005|Overall Study|Progressive disease|5|||
23179340|NCT01818726|64397641|FG001|Overall Study|Withdrawal by Subject|1|||
23179341|NCT01818726|64397640|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
23179342|NCT01818726|64397641|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
23346074|NCT02829723|65010911|FG006|Overall Study|Progressive disease|4|||
23346075|NCT02829723|65010912|FG007|Overall Study|Progressive disease|6|||
23346076|NCT02829723|65010913|FG008|Overall Study|Progressive disease|8|||
23346077|NCT02829723|65010914|FG009|Overall Study|Progressive disease|4|||
23346078|NCT02829723|65010915|FG010|Overall Study|Progressive disease|9|||
23346079|NCT02829723|65010916|FG011|Overall Study|Progressive disease|0|||
23346080|NCT02829723|65010917|FG012|Overall Study|Progressive disease|3|||
23346081|NCT02829723|65010918|FG013|Overall Study|Progressive disease|4|||
23346082|NCT02829723|65010919|FG014|Overall Study|Progressive disease|2|||
23346083|NCT02829723|65010920|FG015|Overall Study|Progressive disease|4|||
23346084|NCT02829723|65010921|FG016|Overall Study|Progressive disease|5|||
23346085|NCT02829723|65010922|FG017|Overall Study|Progressive disease|3|||
23346086|NCT02829723|65010923|FG018|Overall Study|Progressive disease|4|||
23346087|NCT02829723|65010924|FG019|Overall Study|Progressive disease|4|||
23346088|NCT02829723|65010925|FG020|Overall Study|Progressive disease|7|||
23346089|NCT02829723|65010926|FG021|Overall Study|Progressive disease|6|||
23346090|NCT02829723|65010927|FG022|Overall Study|Progressive disease|3|||
23346091|NCT02829723|65010928|FG023|Overall Study|Progressive disease|3|||
23346092|NCT02829723|65010929|FG024|Overall Study|Progressive disease|3|||
23346093|NCT02829723|65010930|FG025|Overall Study|Progressive disease|16|||
23346094|NCT02829723|65010931|FG026|Overall Study|Progressive disease|10|||
23346095|NCT02829723|65010905|FG000|Overall Study|Subject/guardian decision|0|||
23346096|NCT02829723|65010906|FG001|Overall Study|Subject/guardian decision|1|||
23346097|NCT02829723|65010907|FG002|Overall Study|Subject/guardian decision|0|||
23346098|NCT02829723|65010908|FG003|Overall Study|Subject/guardian decision|1|||
23346099|NCT02829723|65010909|FG004|Overall Study|Subject/guardian decision|0|||
23346100|NCT02829723|65010910|FG005|Overall Study|Subject/guardian decision|0|||
23346101|NCT02829723|65010911|FG006|Overall Study|Subject/guardian decision|0|||
23346102|NCT02829723|65010912|FG007|Overall Study|Subject/guardian decision|1|||
23346103|NCT02829723|65010913|FG008|Overall Study|Subject/guardian decision|0|||
23179343|NCT02604264|64397644|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
23179344|NCT02604264|64397645|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
23179345|NCT01961544|64397646|FG000|Overall Study|Protocol Violation|1|||
23179346|NCT01961544|64397646|FG000|Overall Study|Withdrawal by Subject|7|||
23179347|NCT01961544|64397646|FG000|Overall Study|Adverse Event|1|||
23179348|NCT01961544|64397646|FG000|Overall Study|Physician Decision|2|||
23179349|NCT01961544|64397646|FG000|Overall Study|Poor Tolerance|1|||
23239404|NCT00471237|64618853|FG003|Overall Study|High parathyroid hormone|0|||
23239405|NCT00471237|64618854|FG004|Overall Study|High parathyroid hormone|0|||
23239406|NCT00471237|64618855|FG005|Overall Study|High parathyroid hormone|0|||
23239407|NCT00471237|64618856|FG006|Overall Study|High parathyroid hormone|0|||
23239408|NCT00471237|64618850|FG000|Overall Study|Participant lost medication|0|||
23239409|NCT00471237|64618851|FG001|Overall Study|Participant lost medication|0|||
23239410|NCT00471237|64618852|FG002|Overall Study|Participant lost medication|0|||
23239411|NCT00471237|64618853|FG003|Overall Study|Participant lost medication|0|||
23239412|NCT00471237|64618854|FG004|Overall Study|Participant lost medication|1|||
23239413|NCT00471237|64618855|FG005|Overall Study|Participant lost medication|0|||
23239414|NCT00471237|64618856|FG006|Overall Study|Participant lost medication|0|||
23239415|NCT00471237|64618850|FG000|Overall Study|Administration of prohibited medicine|0|||
23239416|NCT00471237|64618851|FG001|Overall Study|Administration of prohibited medicine|0|||
23239417|NCT00471237|64618852|FG002|Overall Study|Administration of prohibited medicine|0|||
23239418|NCT00471237|64618853|FG003|Overall Study|Administration of prohibited medicine|0|||
23346104|NCT02829723|65010914|FG009|Overall Study|Subject/guardian decision|0|||
23346105|NCT02829723|65010915|FG010|Overall Study|Subject/guardian decision|0|||
23346106|NCT02829723|65010916|FG011|Overall Study|Subject/guardian decision|0|||
23346107|NCT02829723|65010917|FG012|Overall Study|Subject/guardian decision|0|||
23179350|NCT01961544|64397646|FG000|Overall Study|Aggravation of Steral Pain|1|||
23179351|NCT01279057|64397650|FG000|Overall Study|Adverse Event|1|||
23179352|NCT01279057|64397651|FG001|Overall Study|Adverse Event|0|||
23179353|NCT01279057|64397652|FG002|Overall Study|Adverse Event|1|||
23179354|NCT01279057|64397650|FG000|Overall Study|Insufficient therapeutic response|0|||
23179355|NCT01279057|64397651|FG001|Overall Study|Insufficient therapeutic response|0|||
23179356|NCT01279057|64397652|FG002|Overall Study|Insufficient therapeutic response|1|||
23179357|NCT01279057|64397650|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
23179358|NCT01279057|64397651|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
23239419|NCT00471237|64618854|FG004|Overall Study|Administration of prohibited medicine|1|||
23239420|NCT00471237|64618855|FG005|Overall Study|Administration of prohibited medicine|0|||
23346108|NCT02829723|65010918|FG013|Overall Study|Subject/guardian decision|0|||
23346109|NCT02829723|65010919|FG014|Overall Study|Subject/guardian decision|1|||
23346110|NCT02829723|65010920|FG015|Overall Study|Subject/guardian decision|0|||
23346111|NCT02829723|65010921|FG016|Overall Study|Subject/guardian decision|1|||
23457583|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23457584|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23457585|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
23457586|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
23457587|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457588|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457589|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457590|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457591|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
23457592|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457593|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
23457594|NCT02903771|65419003|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457595|NCT02903771|65419004|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457596|NCT02903771|65419005|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457597|NCT02903771|65419006|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457598|NCT02903771|65419007|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457599|NCT02903771|65419008|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
23457600|NCT02903771|65419009|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
23457601|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457602|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457603|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457604|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457605|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
23457606|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457607|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
23457608|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457609|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457610|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457611|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457612|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
23457613|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457614|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
23457615|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457616|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457617|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457618|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457619|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
23457620|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457621|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
23457622|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457623|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457624|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457625|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457626|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
23457627|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457628|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
23457629|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457630|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457631|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457632|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457633|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
23457634|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457635|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
23457636|NCT02903771|65419003|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457637|NCT02903771|65419004|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23583592|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583593|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583594|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583595|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
23583596|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
23583597|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
23583598|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583599|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583600|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583601|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583602|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23179359|NCT01279057|64397652|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
23457638|NCT02903771|65419005|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457639|NCT02903771|65419006|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457640|NCT02903771|65419007|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
23457641|NCT02903771|65419008|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457642|NCT02903771|65419009|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
23457643|NCT00687596|65419010|FG000|Overall Study|Adverse Event (AE)|10|||
23457644|NCT00687596|65419011|FG001|Overall Study|Adverse Event (AE)|3|||
23457645|NCT00687596|65419010|FG000|Overall Study|Radiological Disease Progression|6|||
23457646|NCT00687596|65419011|FG001|Overall Study|Radiological Disease Progression|2|||
23457647|NCT00687596|65419010|FG000|Overall Study|Clinical Disease Progression|1|||
23457648|NCT00687596|65419011|FG001|Overall Study|Clinical Disease Progression|3|||
23457649|NCT00687596|65419010|FG000|Overall Study|Investigator Discretion|3|||
23457650|NCT00687596|65419011|FG001|Overall Study|Investigator Discretion|1|||
23457651|NCT00687596|65419010|FG000|Overall Study|Sponsor Terminated Study|6|||
23457652|NCT00687596|65419011|FG001|Overall Study|Sponsor Terminated Study|17|||
23457653|NCT03284710|65419013|FG000|Overall Study|Withdrawal by Subject|1|||
23457654|NCT03284710|65419014|FG001|Overall Study|Withdrawal by Subject|0|||
23457655|NCT03284710|65419015|FG002|Overall Study|Withdrawal by Subject|1|||
23457656|NCT03284710|65419016|FG003|Overall Study|Withdrawal by Subject|6|||
23457657|NCT03284710|65419013|FG000|Overall Study|Lost to Follow-up|3|||
23457658|NCT03284710|65419014|FG001|Overall Study|Lost to Follow-up|3|||
23457659|NCT03284710|65419015|FG002|Overall Study|Lost to Follow-up|1|||
23457660|NCT03284710|65419016|FG003|Overall Study|Lost to Follow-up|0|||
23457661|NCT03284710|65419013|FG000|Overall Study|Physician Decision|1|||
23457662|NCT03284710|65419014|FG001|Overall Study|Physician Decision|0|||
23457663|NCT03284710|65419015|FG002|Overall Study|Physician Decision|0|||
23457664|NCT03284710|65419016|FG003|Overall Study|Physician Decision|0|||
23457665|NCT03284710|65419013|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
23457666|NCT03284710|65419014|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23457667|NCT03284710|65419015|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
23457668|NCT03284710|65419016|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
23457669|NCT03284710|65419013|FG000|Overall Study|HIV Infection|0|||
23457670|NCT03284710|65419014|FG001|Overall Study|HIV Infection|2|||
23457671|NCT03284710|65419015|FG002|Overall Study|HIV Infection|2|||
23457672|NCT03284710|65419016|FG003|Overall Study|HIV Infection|1|||
23457673|NCT04739982|65419017|FG000|Overall Study|Lost to Follow-up|176|||
23457674|NCT04739982|65419018|FG001|Overall Study|Lost to Follow-up|65|||
23457675|NCT04739982|65419017|FG000|Overall Study|Withdrawal by Subject|19|||
23457676|NCT04739982|65419018|FG001|Overall Study|Withdrawal by Subject|0|||
23457677|NCT04739982|65419017|FG000|Overall Study|Protocol Violation|0|||
23457678|NCT04739982|65419018|FG001|Overall Study|Protocol Violation|5|||
23457679|NCT02529852|65419019|FG000|Overall Study|Withdrawal by Subject|2|||
23457680|NCT04617782|65419026|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
23457681|NCT04617782|65419026|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
23457682|NCT04617782|65419026|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
23457683|NCT04617782|65419026|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
23457684|NCT04617782|65419026|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
23457685|NCT04617782|65419026|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
23457686|NCT05280717|65419027|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
23457687|NCT05280717|65419028|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
23457688|NCT05280717|65419029|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
23457689|NCT05280717|65419030|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
23457690|NCT05280717|65419031|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
23457691|NCT05280717|65419032|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
23457692|NCT05280717|65419033|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
23457693|NCT05280717|65419027|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
23457694|NCT05280717|65419028|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457695|NCT05280717|65419029|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457696|NCT05280717|65419030|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457697|NCT05280717|65419031|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457698|NCT05280717|65419032|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23457699|NCT05280717|65419033|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
23179360|NCT01279057|64397650|FG000|Overall Study|Withdrew consent|2|||
23346112|NCT02829723|65010922|FG017|Overall Study|Subject/guardian decision|0|||
23457700|NCT05280717|65419027|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457701|NCT05280717|65419028|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
23457702|NCT05280717|65419029|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23179361|NCT01279057|64397651|FG001|Overall Study|Withdrew consent|0|||
23346113|NCT02829723|65010923|FG018|Overall Study|Subject/guardian decision|1|||
23179362|NCT01279057|64397652|FG002|Overall Study|Withdrew consent|1|||
23179363|NCT01279057|64397650|FG000|Overall Study|Pregnancy|0|||
23179364|NCT01279057|64397651|FG001|Overall Study|Pregnancy|1|||
23179365|NCT01279057|64397652|FG002|Overall Study|Pregnancy|0|||
23179366|NCT01279057|64397650|FG000|Overall Study|Other|3|||
23179367|NCT01279057|64397651|FG001|Overall Study|Other|3|||
23346114|NCT02829723|65010924|FG019|Overall Study|Subject/guardian decision|0|||
23346115|NCT02829723|65010925|FG020|Overall Study|Subject/guardian decision|1|||
23346116|NCT02829723|65010926|FG021|Overall Study|Subject/guardian decision|0|||
23346117|NCT02829723|65010927|FG022|Overall Study|Subject/guardian decision|0|||
23346118|NCT02829723|65010928|FG023|Overall Study|Subject/guardian decision|1|||
23346119|NCT02829723|65010929|FG024|Overall Study|Subject/guardian decision|0|||
23346120|NCT02829723|65010930|FG025|Overall Study|Subject/guardian decision|1|||
23346121|NCT02829723|65010931|FG026|Overall Study|Subject/guardian decision|1|||
23346122|NCT02829723|65010905|FG000|Overall Study|Study terminated by sponsor|0|||
23346123|NCT02829723|65010906|FG001|Overall Study|Study terminated by sponsor|0|||
23346124|NCT02829723|65010907|FG002|Overall Study|Study terminated by sponsor|0|||
23346125|NCT02829723|65010908|FG003|Overall Study|Study terminated by sponsor|0|||
23346126|NCT02829723|65010909|FG004|Overall Study|Study terminated by sponsor|0|||
23346127|NCT02829723|65010910|FG005|Overall Study|Study terminated by sponsor|0|||
23346128|NCT02829723|65010911|FG006|Overall Study|Study terminated by sponsor|0|||
23346129|NCT02829723|65010912|FG007|Overall Study|Study terminated by sponsor|0|||
23346130|NCT02829723|65010913|FG008|Overall Study|Study terminated by sponsor|0|||
23346131|NCT02829723|65010914|FG009|Overall Study|Study terminated by sponsor|0|||
23346132|NCT02829723|65010915|FG010|Overall Study|Study terminated by sponsor|0|||
23346133|NCT02829723|65010916|FG011|Overall Study|Study terminated by sponsor|0|||
23346134|NCT02829723|65010917|FG012|Overall Study|Study terminated by sponsor|0|||
23346135|NCT02829723|65010918|FG013|Overall Study|Study terminated by sponsor|0|||
23346136|NCT02829723|65010919|FG014|Overall Study|Study terminated by sponsor|0|||
23346137|NCT02829723|65010920|FG015|Overall Study|Study terminated by sponsor|0|||
23346138|NCT02829723|65010921|FG016|Overall Study|Study terminated by sponsor|0|||
23346139|NCT02829723|65010922|FG017|Overall Study|Study terminated by sponsor|0|||
23346140|NCT02829723|65010923|FG018|Overall Study|Study terminated by sponsor|0|||
23346141|NCT02829723|65010924|FG019|Overall Study|Study terminated by sponsor|0|||
23346142|NCT02829723|65010925|FG020|Overall Study|Study terminated by sponsor|0|||
23346143|NCT02829723|65010926|FG021|Overall Study|Study terminated by sponsor|1|||
23346144|NCT02829723|65010927|FG022|Overall Study|Study terminated by sponsor|0|||
23346145|NCT02829723|65010928|FG023|Overall Study|Study terminated by sponsor|0|||
23346146|NCT02829723|65010929|FG024|Overall Study|Study terminated by sponsor|0|||
23346147|NCT02829723|65010930|FG025|Overall Study|Study terminated by sponsor|0|||
23346148|NCT02829723|65010931|FG026|Overall Study|Study terminated by sponsor|0|||
23346149|NCT02294175|65010932|FG000|Overall Study|Withdrawal by Subject|1|||
23346150|NCT02294175|65010933|FG001|Overall Study|Withdrawal by Subject|2|||
23346151|NCT02294175|65010932|FG000|Overall Study|pt taking excluded medication|3|||
23346152|NCT02294175|65010933|FG001|Overall Study|pt taking excluded medication|1|||
23346153|NCT02294175|65010932|FG000|Overall Study|Protocol Violation|1|||
23346154|NCT02294175|65010933|FG001|Overall Study|Protocol Violation|0|||
23346155|NCT02294175|65010932|FG000|Overall Study|Lost to Follow-up|0|||
23179368|NCT01279057|64397652|FG002|Overall Study|Other|0|||
23179369|NCT02435914|64397657|FG000|Overall Study|Ocular Adverse Event|1|||
23179370|NCT02435914|64397658|FG001|Overall Study|Ocular Adverse Event|0|||
23179371|NCT02435914|64397659|FG002|Overall Study|Ocular Adverse Event|0|||
23179372|NCT02435914|64397660|FG003|Overall Study|Ocular Adverse Event|0|||
23179373|NCT02435914|64397657|FG000|Overall Study|Withdrawal by Subject|0|||
23179374|NCT02435914|64397658|FG001|Overall Study|Withdrawal by Subject|1|||
23179375|NCT02435914|64397659|FG002|Overall Study|Withdrawal by Subject|0|||
23179376|NCT02435914|64397660|FG003|Overall Study|Withdrawal by Subject|0|||
23179377|NCT02435914|64397657|FG000|Overall Study|Other Miscellaneous Reason|0|||
23179378|NCT02435914|64397658|FG001|Overall Study|Other Miscellaneous Reason|0|||
23179379|NCT02435914|64397659|FG002|Overall Study|Other Miscellaneous Reason|1|||
23179380|NCT02435914|64397660|FG003|Overall Study|Other Miscellaneous Reason|0|||
23179381|NCT02886702|64397668|FG000|Overall Study|Other|4|||
23179382|NCT02886702|64397669|FG001|Overall Study|Other|3|||
23179383|NCT02886702|64397670|FG002|Overall Study|Other|9|||
23179384|NCT02886702|64397668|FG000|Overall Study|Withdrawal by Subject|24|||
23179385|NCT02886702|64397669|FG001|Overall Study|Withdrawal by Subject|18|||
23239421|NCT00471237|64618856|FG006|Overall Study|Administration of prohibited medicine|0|||
23179386|NCT02886702|64397670|FG002|Overall Study|Withdrawal by Subject|22|||
23179387|NCT02886702|64397668|FG000|Overall Study|Significant Worsening of Condition|0|||
23179388|NCT02886702|64397669|FG001|Overall Study|Significant Worsening of Condition|1|||
23179389|NCT02886702|64397670|FG002|Overall Study|Significant Worsening of Condition|0|||
23179390|NCT02886702|64397668|FG000|Overall Study|Protocol Violation|2|||
23179391|NCT02886702|64397669|FG001|Overall Study|Protocol Violation|2|||
23179392|NCT02886702|64397670|FG002|Overall Study|Protocol Violation|1|||
23179393|NCT02886702|64397668|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23179394|NCT02886702|64397669|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23239422|NCT00471237|64618850|FG000|Overall Study|Participant shifted residence|0|||
23239423|NCT00471237|64618851|FG001|Overall Study|Participant shifted residence|0|||
23239424|NCT00471237|64618852|FG002|Overall Study|Participant shifted residence|0|||
23239425|NCT00471237|64618853|FG003|Overall Study|Participant shifted residence|0|||
23239426|NCT00471237|64618854|FG004|Overall Study|Participant shifted residence|1|||
23239427|NCT00471237|64618855|FG005|Overall Study|Participant shifted residence|0|||
23239428|NCT00471237|64618856|FG006|Overall Study|Participant shifted residence|0|||
23239429|NCT00471237|64618850|FG000|Overall Study|Participant's decision|0|||
23239430|NCT00471237|64618851|FG001|Overall Study|Participant's decision|0|||
23239431|NCT00471237|64618852|FG002|Overall Study|Participant's decision|0|||
23239432|NCT00471237|64618853|FG003|Overall Study|Participant's decision|0|||
23239433|NCT00471237|64618854|FG004|Overall Study|Participant's decision|0|||
23239434|NCT00471237|64618855|FG005|Overall Study|Participant's decision|1|||
23239435|NCT00471237|64618856|FG006|Overall Study|Participant's decision|0|||
23239436|NCT00429026|64618857|FG000|Overall Study|Inevaluable for response.|40|||
23239437|NCT01539512|64618858|FG000|Overall Study|Adverse Event|9|||
23239438|NCT01539512|64618859|FG001|Overall Study|Adverse Event|7|||
23239439|NCT01539512|64618858|FG000|Overall Study|Physician Decision|1|||
23239440|NCT01539512|64618859|FG001|Overall Study|Physician Decision|1|||
23239441|NCT01539512|64618858|FG000|Overall Study|Withdrawal by Subject|12|||
23239442|NCT01539512|64618859|FG001|Overall Study|Withdrawal by Subject|5|||
23239443|NCT01539512|64618858|FG000|Overall Study|Richter's Transformation|1|||
23239444|NCT01539512|64618859|FG001|Overall Study|Richter's Transformation|0|||
23457703|NCT05280717|65419030|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457704|NCT05280717|65419031|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457705|NCT05280717|65419032|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457706|NCT05280717|65419033|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
23457707|NCT05280717|65419027|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23179395|NCT02886702|64397670|FG002|Overall Study|Non-Compliance With Study Drug|4|||
23179396|NCT02886702|64397668|FG000|Overall Study|Lost to Follow-up|11|||
23179397|NCT02886702|64397669|FG001|Overall Study|Lost to Follow-up|13|||
23583603|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583604|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23179398|NCT02886702|64397670|FG002|Overall Study|Lost to Follow-up|8|||
23179399|NCT02886702|64397668|FG000|Overall Study|Lack of Efficacy|3|||
23179400|NCT02886702|64397669|FG001|Overall Study|Lack of Efficacy|4|||
23179401|NCT02886702|64397670|FG002|Overall Study|Lack of Efficacy|5|||
23179402|NCT02886702|64397668|FG000|Overall Study|Adverse Event|4|||
23179403|NCT02886702|64397669|FG001|Overall Study|Adverse Event|9|||
23179404|NCT02886702|64397670|FG002|Overall Study|Adverse Event|3|||
23179405|NCT02886702|64397668|FG000|Overall Study|Administrative Reasons|0|||
23179406|NCT02886702|64397669|FG001|Overall Study|Administrative Reasons|0|||
23179407|NCT02886702|64397670|FG002|Overall Study|Administrative Reasons|1|||
23179408|NCT04897867|64397673|FG000|Overall Study|Withdrawal of Consent|1|||
23179409|NCT04897867|64397673|FG000|Overall Study|Pregnancy|1|||
23179410|NCT04897867|64397673|FG000|Overall Study|Lost to Follow-up|7|||
23179411|NCT04897867|64397673|FG000|Overall Study|Reason not Specified|2|||
23179412|NCT01254669|64397674|FG000|Overall Study|Withdrawal by Subject|0|||
23179413|NCT01254669|64397675|FG001|Overall Study|Withdrawal by Subject|1|||
23179414|NCT01254669|64397674|FG000|Overall Study|time constraint|2|||
23179415|NCT01254669|64397675|FG001|Overall Study|time constraint|2|||
23179416|NCT01254669|64397674|FG000|Overall Study|called to clinic during intervention|1|||
23179417|NCT01254669|64397675|FG001|Overall Study|called to clinic during intervention|1|||
23179418|NCT01707992|64397676|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
23179419|NCT01707992|64397677|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
23179420|NCT01707992|64397678|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
23179421|NCT01707992|64397679|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
23179422|NCT01707992|64397680|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
23179423|NCT01707992|64397681|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
23179424|NCT01707992|64397676|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
23239445|NCT01473602|64618860|FG000|Overall Study|Adverse Event|1|||
23239446|NCT01473602|64618861|FG001|Overall Study|Adverse Event|2|||
23583605|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583606|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583607|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583608|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23583609|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
23239447|NCT01473602|64618860|FG000|Overall Study|Death|0|||
23239448|NCT01473602|64618861|FG001|Overall Study|Death|1|||
23239449|NCT01473602|64618860|FG000|Overall Study|Lost to Follow-up|1|||
23179425|NCT01707992|64397677|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
23179426|NCT01707992|64397678|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
23179427|NCT01707992|64397679|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
23179428|NCT01707992|64397680|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
23179429|NCT01707992|64397681|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
23179430|NCT01707992|64397676|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
23179431|NCT01707992|64397677|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
23179432|NCT01707992|64397678|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
23179433|NCT01707992|64397679|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
23179434|NCT01707992|64397680|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
23179435|NCT01707992|64397681|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
23179436|NCT01707992|64397676|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
23179437|NCT01707992|64397677|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23179438|NCT01707992|64397678|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23583610|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
23583611|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
23583612|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583613|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23239450|NCT01473602|64618861|FG001|Overall Study|Lost to Follow-up|1|||
23239451|NCT01473602|64618860|FG000|Overall Study|Withdrawal by Subject|5|||
23239452|NCT01473602|64618861|FG001|Overall Study|Withdrawal by Subject|4|||
23239453|NCT01473602|64618860|FG000|Overall Study|Physician Decision|1|||
23239454|NCT01473602|64618861|FG001|Overall Study|Physician Decision|0|||
23239455|NCT04563845|64618862|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239456|NCT04563845|64618863|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239457|NCT04563845|64618864|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239458|NCT04563845|64618865|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239459|NCT04563845|64618866|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239460|NCT04563845|64618867|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239461|NCT04563845|64618868|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239462|NCT04563845|64618869|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
23239463|NCT04563845|64618870|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239464|NCT04563845|64618871|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239465|NCT04563845|64618872|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239466|NCT04563845|64618873|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239467|NCT04563845|64618874|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239468|NCT04563845|64618875|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
23239469|NCT04563845|64618862|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239470|NCT04563845|64618863|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239471|NCT04563845|64618864|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239472|NCT04563845|64618865|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239473|NCT04563845|64618866|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
23239474|NCT04563845|64618867|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239475|NCT04563845|64618868|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239476|NCT04563845|64618869|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239477|NCT04563845|64618870|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239478|NCT04563845|64618871|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239479|NCT04563845|64618872|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239480|NCT04563845|64618873|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239481|NCT04563845|64618874|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239482|NCT04563845|64618875|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
23239483|NCT04533204|64618876|FG000|Overall Study|Unable to understand training instructions|1|||
23239484|NCT04533204|64618877|FG001|Overall Study|Unable to understand training instructions|1|||
23239485|NCT00542321|64618882|FG000|Overall Study|Death|0|||
23239486|NCT00542321|64618883|FG001|Overall Study|Death|1|||
23239487|NCT00265382|64618886|FG000|Overall Study|Adverse Event|21|||
23239488|NCT00265382|64618886|FG000|Overall Study|Laboratory Abnormality|1|||
23239489|NCT00265382|64618886|FG000|Overall Study|Lost to Follow-up|3|||
23239490|NCT00265382|64618886|FG000|Overall Study|Lack of Efficacy|6|||
23239491|NCT00265382|64618886|FG000|Overall Study|Miscellaneous|6|||
23239492|NCT00265382|64618886|FG000|Overall Study|Withdrawal by Subject|13|||
23239493|NCT00265382|64618886|FG000|Overall Study|Study terminated by sponsor|94|||
23239494|NCT00265382|64618886|FG000|Overall Study|Death|1|||
23583614|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583615|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23179439|NCT01707992|64397679|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23239495|NCT02539160|64618887|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
23179440|NCT01707992|64397680|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23239496|NCT02539160|64618888|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
23239497|NCT02539160|64618889|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
23239498|NCT02539160|64618890|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
23239499|NCT02539160|64618887|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
23239500|NCT02539160|64618888|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
23239501|NCT02539160|64618889|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
23239502|NCT02539160|64618890|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
23239503|NCT02539160|64618887|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
23239504|NCT02539160|64618888|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
23239505|NCT02539160|64618889|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
23239506|NCT02539160|64618890|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
23239507|NCT00438815|64618891|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
23239508|NCT00438815|64618891|FG000|Overall Study|3-month follow-up no longer required|12|||
23239509|NCT00438815|64618891|FG000|Overall Study|Noncompliance with protocol requirements|9|||
23239510|NCT00438815|64618891|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
23239511|NCT00438815|64618891|FG000|Overall Study|Lost to Follow-up|6|||
23239512|NCT00438815|64618891|FG000|Overall Study|Withdrawal by Subject|6|||
23239513|NCT00438815|64618891|FG000|Overall Study|Death|1|||
23239514|NCT04983589|64618892|FG000|Overall Study|Withdrawal by Subject|0|||
23239515|NCT04983589|64618893|FG001|Overall Study|Withdrawal by Subject|3|||
23239516|NCT04983589|64618892|FG000|Overall Study|COVID-19 Infection|1|||
23239517|NCT04983589|64618893|FG001|Overall Study|COVID-19 Infection|0|||
23239518|NCT04983589|64618892|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
23239519|NCT04983589|64618893|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
23239520|NCT02898662|64618894|FG000|Overall Study|Adverse Event|1|||
23239521|NCT02898662|64618895|FG001|Overall Study|Adverse Event|0|||
23239522|NCT02898662|64618894|FG000|Overall Study|Loss of asthma control|23|||
23239523|NCT02898662|64618895|FG001|Overall Study|Loss of asthma control|24|||
23239524|NCT02898662|64618894|FG000|Overall Study|Withdrawal by Subject|4|||
23239525|NCT02898662|64618895|FG001|Overall Study|Withdrawal by Subject|1|||
23239526|NCT02898662|64618894|FG000|Overall Study|Technical issue|0|||
23239527|NCT02898662|64618895|FG001|Overall Study|Technical issue|1|||
23239528|NCT02898662|64618894|FG000|Overall Study|Randomized in error|0|||
23239529|NCT02898662|64618895|FG001|Overall Study|Randomized in error|1|||
23239530|NCT02898662|64618894|FG000|Overall Study|Subject decision|1|||
23239531|NCT02898662|64618895|FG001|Overall Study|Subject decision|0|||
23239532|NCT02898662|64618894|FG000|Overall Study|Other|0|||
23239533|NCT02898662|64618895|FG001|Overall Study|Other|1|||
23239534|NCT01491802|64618897|FG000|Overall Study|Adverse Event|1|||
23239535|NCT01491802|64618898|FG001|Overall Study|Adverse Event|1|||
23239536|NCT01491802|64618897|FG000|Overall Study|Withdrawal by Subject|0|||
23179441|NCT01707992|64397681|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
23179442|NCT01707992|64397676|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
23179443|NCT01707992|64397677|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
23179444|NCT01707992|64397678|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
23179445|NCT01707992|64397679|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
23179446|NCT01707992|64397680|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
23179447|NCT01707992|64397681|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
23179448|NCT01707992|64397676|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
23179449|NCT01707992|64397677|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
23179450|NCT01707992|64397678|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
23179451|NCT01707992|64397679|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
23179452|NCT01707992|64397680|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
23179453|NCT01707992|64397681|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
23179454|NCT01707992|64397676|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
23179455|NCT01707992|64397677|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
23179456|NCT01707992|64397678|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
23179457|NCT01707992|64397679|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
23179458|NCT01707992|64397680|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
23179459|NCT01707992|64397681|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
23179460|NCT01707992|64397676|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
23179461|NCT01707992|64397677|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
23179462|NCT01707992|64397678|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
23239537|NCT01491802|64618898|FG001|Overall Study|Withdrawal by Subject|1|||
23239538|NCT02491463|64618899|FG000|Overall Study|Withdrawal by Subject|1|||
23239539|NCT02491463|64618900|FG001|Overall Study|Withdrawal by Subject|2|||
23239540|NCT02491463|64618901|FG002|Overall Study|Withdrawal by Subject|0|||
23239541|NCT02491463|64618902|FG003|Overall Study|Withdrawal by Subject|0|||
23239542|NCT02491463|64618899|FG000|Overall Study|Migrated/moved from study area|1|||
23239543|NCT02491463|64618900|FG001|Overall Study|Migrated/moved from study area|5|||
23239544|NCT02491463|64618901|FG002|Overall Study|Migrated/moved from study area|1|||
23179463|NCT01707992|64397679|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
23457708|NCT05280717|65419028|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457709|NCT05280717|65419029|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
23457710|NCT05280717|65419030|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457711|NCT05280717|65419031|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457712|NCT05280717|65419032|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457713|NCT05280717|65419033|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
23457714|NCT05280717|65419027|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457715|NCT05280717|65419028|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457716|NCT05280717|65419029|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457717|NCT05280717|65419030|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457718|NCT05280717|65419031|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457719|NCT05280717|65419032|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
23457720|NCT05280717|65419033|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
23457721|NCT05280717|65419027|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457722|NCT05280717|65419028|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457723|NCT05280717|65419029|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457724|NCT05280717|65419030|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457725|NCT05280717|65419031|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457726|NCT05280717|65419032|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
23457727|NCT05280717|65419033|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
23457728|NCT02250326|65419034|FG000|Treatment|Death|1|||
23457729|NCT02250326|65419035|FG001|Treatment|Death|13|||
23457730|NCT02250326|65419036|FG002|Treatment|Death|2|||
23457731|NCT02250326|65419034|FG000|Treatment|Adverse Event|8|||
23457732|NCT02250326|65419035|FG001|Treatment|Adverse Event|8|||
23457733|NCT02250326|65419036|FG002|Treatment|Adverse Event|9|||
23457734|NCT02250326|65419034|FG000|Treatment|Progressive Disease|42|||
23457735|NCT02250326|65419035|FG001|Treatment|Progressive Disease|40|||
23457736|NCT02250326|65419036|FG002|Treatment|Progressive Disease|47|||
23457737|NCT02250326|65419034|FG000|Treatment|Symptomatic Deterioration|9|||
23457738|NCT02250326|65419035|FG001|Treatment|Symptomatic Deterioration|4|||
23457739|NCT02250326|65419036|FG002|Treatment|Symptomatic Deterioration|10|||
23457740|NCT02250326|65419034|FG000|Treatment|Withdrawal by Subject|11|||
23457741|NCT02250326|65419035|FG001|Treatment|Withdrawal by Subject|6|||
23457742|NCT02250326|65419036|FG002|Treatment|Withdrawal by Subject|4|||
23457743|NCT02250326|65419034|FG000|Treatment|Other reasons|8|||
23457744|NCT02250326|65419035|FG001|Treatment|Other reasons|7|||
23457745|NCT02250326|65419036|FG002|Treatment|Other reasons|7|||
23457746|NCT02250326|65419034|FG000|Extension Period|Progressive Disease|0|||
23457747|NCT02250326|65419035|FG001|Extension Period|Progressive Disease|2|||
23457748|NCT02250326|65419036|FG002|Extension Period|Progressive Disease|0|||
23457749|NCT02250326|65419034|FG000|Extension Period|Withdrawal by Subject|0|||
23457750|NCT02250326|65419035|FG001|Extension Period|Withdrawal by Subject|1|||
23457751|NCT02250326|65419036|FG002|Extension Period|Withdrawal by Subject|0|||
23457752|NCT02250326|65419034|FG000|Extension Period|Withdrawal by investigator|0|||
23179464|NCT01707992|64397680|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
23179465|NCT01707992|64397681|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
23179466|NCT01707992|64397676|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
23179467|NCT01707992|64397677|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
23179468|NCT01707992|64397678|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
23179469|NCT01707992|64397679|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
23179470|NCT01707992|64397680|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
23179471|NCT01707992|64397681|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
23179472|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
23179473|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
23179474|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
23179475|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
23179476|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
23346156|NCT02294175|65010933|FG001|Overall Study|Lost to Follow-up|1|||
23346157|NCT02294175|65010932|FG000|Overall Study|wound healed|0|||
23346158|NCT02294175|65010933|FG001|Overall Study|wound healed|2|||
23346159|NCT02892513|65010934|FG000|Overall Study|Withdrawal by Subject|0|||
23346160|NCT02892513|65010935|FG001|Overall Study|Withdrawal by Subject|1|||
23346161|NCT01298141|65010936|FG000|Overall Study|Adverse Event|3|||
23346162|NCT01298141|65010936|FG000|Overall Study|Refusal of Required Study Procedures|1|||
23346163|NCT01298141|65010936|FG000|Overall Study|Withdrawal by Subject|6|||
23457753|NCT02250326|65419035|FG001|Extension Period|Withdrawal by investigator|1|||
23457754|NCT02250326|65419036|FG002|Extension Period|Withdrawal by investigator|0|||
23179477|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
23346164|NCT01298141|65010936|FG000|Overall Study|Termination of Study by the Investigator|5|||
23346165|NCT01298141|65010936|FG000|Overall Study|Other|5|||
23346166|NCT01298141|65010936|FG000|Overall Study|Lost to Follow-up|1|||
23346167|NCT01298141|65010936|FG000|Overall Study|Death|6|||
23346168|NCT01298141|65010936|FG000|Overall Study|Not treated|4|||
23346169|NCT00115037|65010943|FG000|Phase1|Lost to Follow-up|16|||
23346170|NCT00115037|65010944|FG001|Phase1|Lost to Follow-up|23|||
23346171|NCT00115037|65010945|FG002|Phase1|Lost to Follow-up|0|||
23346172|NCT00115037|65010946|FG003|Phase1|Lost to Follow-up|0|||
23179478|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
23346173|NCT00115037|65010947|FG004|Phase1|Lost to Follow-up|0|||
23346174|NCT00115037|65010948|FG005|Phase1|Lost to Follow-up|0|||
23346175|NCT00115037|65010943|FG000|Phase1|Withdrawal by Subject|9|||
23346176|NCT00115037|65010944|FG001|Phase1|Withdrawal by Subject|4|||
23346177|NCT00115037|65010945|FG002|Phase1|Withdrawal by Subject|0|||
23346178|NCT00115037|65010946|FG003|Phase1|Withdrawal by Subject|0|||
23346179|NCT00115037|65010947|FG004|Phase1|Withdrawal by Subject|0|||
23346180|NCT00115037|65010948|FG005|Phase1|Withdrawal by Subject|0|||
23179479|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
23179480|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
23179481|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
23179482|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
23179483|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
23179484|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
23179485|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
23179486|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
23179487|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
23179488|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
23179489|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
23179490|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
23179491|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
23179492|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
23179493|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
23179494|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
23179495|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
23179496|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
23179497|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
23179498|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
23179499|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
23179500|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
23179501|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
23179502|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Death|0|||
23179503|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Death|0|||
23179504|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Death|0|||
23179505|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Death|2|||
23179506|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Death|0|||
23179507|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Death|0|||
23179508|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
23179509|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
23179510|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
23179511|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
23179512|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
23179513|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
23179514|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
23179515|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
23179516|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
23179517|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
23346181|NCT00115037|65010943|FG000|Phase2|Death|0|||
23346182|NCT00115037|65010944|FG001|Phase2|Death|0|||
23346183|NCT00115037|65010945|FG002|Phase2|Death|1|||
23346184|NCT00115037|65010946|FG003|Phase2|Death|0|||
23346185|NCT00115037|65010947|FG004|Phase2|Death|0|||
23346186|NCT00115037|65010948|FG005|Phase2|Death|1|||
23346187|NCT00115037|65010943|FG000|Phase2|Withdrawal by Subject|0|||
23457755|NCT02340026|65419040|FG000|Treatment Phase|Withdrawal by Subject|2|||
23457756|NCT02340026|65419041|FG001|Treatment Phase|Withdrawal by Subject|2|||
23346188|NCT00115037|65010944|FG001|Phase2|Withdrawal by Subject|0|||
23346189|NCT00115037|65010945|FG002|Phase2|Withdrawal by Subject|2|||
23179518|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
23179519|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
23179520|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
23179521|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
23346190|NCT00115037|65010946|FG003|Phase2|Withdrawal by Subject|1|||
23346191|NCT00115037|65010947|FG004|Phase2|Withdrawal by Subject|2|||
23346192|NCT00115037|65010948|FG005|Phase2|Withdrawal by Subject|1|||
23346193|NCT00115037|65010943|FG000|Phase2|Lost to Follow-up|0|||
23346194|NCT00115037|65010944|FG001|Phase2|Lost to Follow-up|0|||
23346195|NCT00115037|65010945|FG002|Phase2|Lost to Follow-up|12|||
23346196|NCT00115037|65010946|FG003|Phase2|Lost to Follow-up|14|||
23346197|NCT00115037|65010947|FG004|Phase2|Lost to Follow-up|4|||
23346198|NCT00115037|65010948|FG005|Phase2|Lost to Follow-up|10|||
23346199|NCT01500213|65010949|FG000|Overall Study|Adverse Event|35|||
23346200|NCT01500213|65010950|FG001|Overall Study|Adverse Event|35|||
23346201|NCT01500213|65010949|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
23346202|NCT01500213|65010950|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
23346203|NCT01500213|65010949|FG000|Overall Study|Withdrawal by Subject|28|||
23346204|NCT01500213|65010950|FG001|Overall Study|Withdrawal by Subject|37|||
23346205|NCT01500213|65010949|FG000|Overall Study|Death|7|||
23346206|NCT01500213|65010950|FG001|Overall Study|Death|3|||
23346207|NCT01500213|65010949|FG000|Overall Study|Disease Progression|13|||
23346208|NCT01500213|65010950|FG001|Overall Study|Disease Progression|21|||
23346209|NCT01500213|65010949|FG000|Overall Study|Protocol Violation|19|||
23346210|NCT01500213|65010950|FG001|Overall Study|Protocol Violation|19|||
23346211|NCT01500213|65010949|FG000|Overall Study|Physician Decision|12|||
23346212|NCT01500213|65010950|FG001|Overall Study|Physician Decision|10|||
23346213|NCT01500213|65010949|FG000|Overall Study|Lack of Efficacy|9|||
23346214|NCT01500213|65010950|FG001|Overall Study|Lack of Efficacy|7|||
23346215|NCT01500213|65010949|FG000|Overall Study|Lost to Follow-up|3|||
23346216|NCT01500213|65010950|FG001|Overall Study|Lost to Follow-up|6|||
23346217|NCT01500213|65010949|FG000|Overall Study|Other Reasons|7|||
23346218|NCT01500213|65010950|FG001|Overall Study|Other Reasons|5|||
23346219|NCT01001598|65010951|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
23346220|NCT01001598|65010951|FG000|Overall Study|Adverse Event|1|||
23457757|NCT02340026|65419040|FG000|Follow-up Phase|Lost to Follow-up|1|||
23457758|NCT02340026|65419041|FG001|Follow-up Phase|Lost to Follow-up|0|||
23239545|NCT02491463|64618902|FG003|Overall Study|Migrated/moved from study area|1|||
23239546|NCT02491463|64618899|FG000|Overall Study|Lost to Follow-up|0|||
23239547|NCT02491463|64618900|FG001|Overall Study|Lost to Follow-up|3|||
23239548|NCT02491463|64618901|FG002|Overall Study|Lost to Follow-up|3|||
23239549|NCT02491463|64618902|FG003|Overall Study|Lost to Follow-up|0|||
23239550|NCT01519700|64618903|FG000|Overall Study|Death|1|||
23239551|NCT01519700|64618904|FG001|Overall Study|Death|0|||
23239552|NCT01519700|64618905|FG002|Overall Study|Death|0|||
23239553|NCT01519700|64618906|FG003|Overall Study|Death|0|||
23239554|NCT01519700|64618903|FG000|Overall Study|Lost to Follow-up|0|||
23239555|NCT01519700|64618904|FG001|Overall Study|Lost to Follow-up|0|||
23239556|NCT01519700|64618905|FG002|Overall Study|Lost to Follow-up|1|||
23239557|NCT01519700|64618906|FG003|Overall Study|Lost to Follow-up|1|||
23239558|NCT01519700|64618903|FG000|Overall Study|Physician Decision|1|||
23239559|NCT01519700|64618904|FG001|Overall Study|Physician Decision|1|||
23239560|NCT01519700|64618905|FG002|Overall Study|Physician Decision|3|||
23239561|NCT01519700|64618906|FG003|Overall Study|Physician Decision|0|||
23239562|NCT01519700|64618903|FG000|Overall Study|Withdrawal by Subject|5|||
23239563|NCT01519700|64618904|FG001|Overall Study|Withdrawal by Subject|3|||
23239564|NCT01519700|64618905|FG002|Overall Study|Withdrawal by Subject|3|||
23239565|NCT01519700|64618906|FG003|Overall Study|Withdrawal by Subject|2|||
23239566|NCT01519700|64618903|FG000|Overall Study|Other Reason|2|||
23239567|NCT01519700|64618904|FG001|Overall Study|Other Reason|2|||
23239568|NCT01519700|64618905|FG002|Overall Study|Other Reason|0|||
23239569|NCT01519700|64618906|FG003|Overall Study|Other Reason|4|||
23239570|NCT01002573|64618908|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
23239571|NCT01002573|64618909|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
23239572|NCT00561912|64618910|FG000|Overall Study|ineligible|1|||
23239573|NCT03193996|64618916|FG000|Overall Study|Withdrawal by Subject|4|||
23239574|NCT03193996|64618916|FG000|Overall Study|Lost to Follow-up|4|||
23239575|NCT03193996|64618916|FG000|Overall Study|Physician Decision|2|||
23346221|NCT00090987|65010952|FG000|Overall Study|Adverse Event|5|||
23346222|NCT00090987|65010952|FG000|Overall Study|Lack of Efficacy|7|||
23346223|NCT00090987|65010952|FG000|Overall Study|Withdrawal by Subject|3|||
23346224|NCT00090987|65010952|FG000|Overall Study|alternative therapy|1|||
23346225|NCT00090987|65010952|FG000|Overall Study|Non-compliance|4|||
23346226|NCT00090987|65010952|FG000|Overall Study|Incarcerated|1|||
23346227|NCT04331067|65010953|FG000|Overall Study|Adverse Event|1|||
23346228|NCT04331067|65010954|FG001|Overall Study|Adverse Event|3|||
23346229|NCT04331067|65010955|FG002|Overall Study|Adverse Event|1|||
23179522|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
23346230|NCT04331067|65010953|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
23346231|NCT04331067|65010954|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
23239576|NCT03193996|64618916|FG000|Overall Study|Pregnancy|1|||
23239577|NCT03193996|64618916|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
23239578|NCT03193996|64618916|FG000|Overall Study|Complicating disease|1|||
23457759|NCT04038359|65419042|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
23239579|NCT01590628|64618917|FG000|Overall Study|Death|2|||
23239580|NCT01590628|64618918|FG001|Overall Study|Death|0|||
23239581|NCT01589185|64618919|FG000|Overall Study|Death|1|||
23239582|NCT01589185|64618920|FG001|Overall Study|Death|2|||
23239583|NCT01589185|64618921|FG002|Overall Study|Death|2|||
23239584|NCT01589185|64618922|FG003|Overall Study|Death|0|||
23239585|NCT01589185|64618923|FG004|Overall Study|Death|1|||
23239586|NCT01589185|64618919|FG000|Overall Study|Lost to Follow-up|1|||
23239587|NCT01589185|64618920|FG001|Overall Study|Lost to Follow-up|0|||
23346232|NCT04331067|65010955|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
23346233|NCT00937040|65010956|FG000|Overall Study|Adverse Event|5|||
23346234|NCT00937040|65010957|FG001|Overall Study|Adverse Event|8|||
23346235|NCT00937040|65010956|FG000|Overall Study|Lost to Follow-up|12|||
23346236|NCT00937040|65010957|FG001|Overall Study|Lost to Follow-up|12|||
23346237|NCT00937040|65010956|FG000|Overall Study|Protocol Violation|3|||
23346238|NCT00937040|65010957|FG001|Overall Study|Protocol Violation|0|||
23346239|NCT00937040|65010956|FG000|Overall Study|Withdrawal by Subject|13|||
23346240|NCT00937040|65010957|FG001|Overall Study|Withdrawal by Subject|7|||
23346241|NCT00937040|65010956|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
23346242|NCT00937040|65010957|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
23346243|NCT00937040|65010956|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
23346244|NCT00937040|65010957|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
23346245|NCT02386345|65010958|FG000|Overall Study|Not treated|14|||
23346246|NCT02386345|65010958|FG000|Overall Study|Lost to Follow-up|1|||
23346247|NCT02386345|65010958|FG000|Overall Study|Adverse Event|5|||
23346248|NCT02386345|65010958|FG000|Overall Study|Repeat Procedure|10|||
23346249|NCT02386345|65010958|FG000|Overall Study|Did not complete 12-month follow-up|72|||
23346250|NCT02638259|65010959|FG000|Treatment Period 1|Adverse Event|1|||
23346251|NCT02638259|65010960|FG001|Treatment Period 1|Adverse Event|5|||
23346252|NCT02638259|65010959|FG000|Treatment Period 1|Death|0|||
23346253|NCT02638259|65010960|FG001|Treatment Period 1|Death|1|||
23346254|NCT02638259|65010959|FG000|Treatment Period 1|Lack of Efficacy|0|||
23346255|NCT02638259|65010960|FG001|Treatment Period 1|Lack of Efficacy|1|||
23346256|NCT02638259|65010959|FG000|Treatment Period 1|Protocol Violation|0|||
23346257|NCT02638259|65010960|FG001|Treatment Period 1|Protocol Violation|3|||
23346258|NCT02638259|65010959|FG000|Treatment Period 1|Withdrawal by Subject|4|||
23346259|NCT02638259|65010960|FG001|Treatment Period 1|Withdrawal by Subject|6|||
23346260|NCT02638259|65010959|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
23346261|NCT02638259|65010960|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
23346262|NCT02638259|65010959|FG000|Treatment Period 2|Adverse Event|5|||
23346263|NCT02638259|65010960|FG001|Treatment Period 2|Adverse Event|4|||
23346264|NCT02638259|65010959|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23346265|NCT02638259|65010960|FG001|Treatment Period 2|Withdrawal by Subject|7|||
23346266|NCT03408444|65010961|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
23346267|NCT03408444|65010962|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
23346268|NCT03408444|65010963|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
23346269|NCT03408444|65010964|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
23346270|NCT03408444|65010961|FG000|Overall Study|Lens Discomfort|0|||
23346271|NCT03408444|65010962|FG001|Overall Study|Lens Discomfort|1|||
23346272|NCT03408444|65010963|FG002|Overall Study|Lens Discomfort|0|||
23346273|NCT03408444|65010964|FG003|Overall Study|Lens Discomfort|0|||
23346274|NCT03408444|65010961|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
23346275|NCT03408444|65010962|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
23346276|NCT03408444|65010963|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
23346277|NCT03408444|65010964|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
23346278|NCT03408444|65010961|FG000|Overall Study|Withdrawal by Subject|0|||
23346279|NCT03408444|65010962|FG001|Overall Study|Withdrawal by Subject|2|||
23346280|NCT03408444|65010963|FG002|Overall Study|Withdrawal by Subject|3|||
23346281|NCT03408444|65010964|FG003|Overall Study|Withdrawal by Subject|0|||
23346282|NCT03408444|65010961|FG000|Overall Study|Lost to Follow-up|0|||
23346283|NCT03408444|65010962|FG001|Overall Study|Lost to Follow-up|0|||
23346284|NCT03408444|65010963|FG002|Overall Study|Lost to Follow-up|1|||
23346285|NCT03408444|65010964|FG003|Overall Study|Lost to Follow-up|0|||
23346286|NCT03408444|65010961|FG000|Overall Study|Adverse Event|0|||
23346287|NCT03408444|65010962|FG001|Overall Study|Adverse Event|0|||
23239588|NCT01589185|64618921|FG002|Overall Study|Lost to Follow-up|2|||
23346288|NCT03408444|65010963|FG002|Overall Study|Adverse Event|0|||
23346289|NCT03408444|65010964|FG003|Overall Study|Adverse Event|1|||
23346290|NCT03408444|65010961|FG000|Overall Study|Lens Handling Difficulties|0|||
23346291|NCT03408444|65010962|FG001|Overall Study|Lens Handling Difficulties|0|||
23346292|NCT03408444|65010963|FG002|Overall Study|Lens Handling Difficulties|1|||
23346293|NCT03408444|65010964|FG003|Overall Study|Lens Handling Difficulties|0|||
23239589|NCT01589185|64618922|FG003|Overall Study|Lost to Follow-up|3|||
23346294|NCT03408444|65010961|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
23346295|NCT03408444|65010962|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
23346296|NCT03408444|65010963|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
23346297|NCT03408444|65010964|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
23346298|NCT00769067|65010967|FG000|Overall Study|Death|89|||
23346299|NCT00769067|65010968|FG001|Overall Study|Death|86|||
23346300|NCT00769067|65010967|FG000|Overall Study|Lost to Follow-up|3|||
23346301|NCT00769067|65010968|FG001|Overall Study|Lost to Follow-up|1|||
23346302|NCT00769067|65010967|FG000|Overall Study|Study terminated by sponsor|1|||
23346303|NCT00769067|65010968|FG001|Overall Study|Study terminated by sponsor|3|||
23346304|NCT00769067|65010967|FG000|Overall Study|Other|1|||
23346305|NCT00769067|65010968|FG001|Overall Study|Other|3|||
23346306|NCT00769067|65010967|FG000|Overall Study|Withdrawal by Subject|0|||
23346307|NCT00769067|65010968|FG001|Overall Study|Withdrawal by Subject|1|||
23346308|NCT01573767|65010969|FG000|Overall Study|Adverse Event|0|||
23346309|NCT01573767|65010970|FG001|Overall Study|Adverse Event|1|||
23346310|NCT01573767|65010971|FG002|Overall Study|Adverse Event|0|||
23346311|NCT01573767|65010972|FG003|Overall Study|Adverse Event|1|||
23346312|NCT01573767|65010969|FG000|Overall Study|Lack of Efficacy|18|||
23346313|NCT01573767|65010970|FG001|Overall Study|Lack of Efficacy|15|||
23346314|NCT01573767|65010971|FG002|Overall Study|Lack of Efficacy|12|||
23346315|NCT01573767|65010972|FG003|Overall Study|Lack of Efficacy|17|||
23346316|NCT01573767|65010969|FG000|Overall Study|Protocol Violation|3|||
23346317|NCT01573767|65010970|FG001|Overall Study|Protocol Violation|1|||
23346318|NCT01573767|65010971|FG002|Overall Study|Protocol Violation|1|||
23346319|NCT01573767|65010972|FG003|Overall Study|Protocol Violation|3|||
23346320|NCT01573767|65010969|FG000|Overall Study|Lost to Follow-up|0|||
23346321|NCT01573767|65010970|FG001|Overall Study|Lost to Follow-up|1|||
23346322|NCT01573767|65010971|FG002|Overall Study|Lost to Follow-up|1|||
23346323|NCT01573767|65010972|FG003|Overall Study|Lost to Follow-up|1|||
23346324|NCT01573767|65010969|FG000|Overall Study|Physician Decision|1|||
23346325|NCT01573767|65010970|FG001|Overall Study|Physician Decision|2|||
23346326|NCT01573767|65010971|FG002|Overall Study|Physician Decision|0|||
23346327|NCT01573767|65010972|FG003|Overall Study|Physician Decision|2|||
23346328|NCT01573767|65010969|FG000|Overall Study|Withdrawal by Subject|0|||
23346329|NCT01573767|65010970|FG001|Overall Study|Withdrawal by Subject|1|||
23346330|NCT01573767|65010971|FG002|Overall Study|Withdrawal by Subject|0|||
23346331|NCT01573767|65010972|FG003|Overall Study|Withdrawal by Subject|0|||
23346332|NCT00835679|65010973|FG000|Overall Study|Withdrawal by Subject|1|||
23346333|NCT00835679|65010974|FG001|Overall Study|Withdrawal by Subject|0|||
23346334|NCT00835679|65010975|FG002|Overall Study|Withdrawal by Subject|0|||
23346335|NCT00835679|65010976|FG003|Overall Study|Withdrawal by Subject|0|||
23346336|NCT00477607|65010977|FG000|Overall Study|Lost to Follow-up|7|||
23346337|NCT00477607|65010978|FG001|Overall Study|Lost to Follow-up|7|||
23346338|NCT00358956|65010979|FG000|Overall Study|Adverse Event|3|||
23346339|NCT00358956|65010979|FG000|Overall Study|condition under investigation worsened|4|||
23346340|NCT00358956|65010979|FG000|Overall Study|Withdrawal by Subject|1|||
23179523|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
23346341|NCT02543892|65010988|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
23346342|NCT02543892|65010989|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
23346343|NCT02543892|65010990|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
23346344|NCT02543892|65010991|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
23179524|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
23179525|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
23179526|NCT01707992|64397676|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23346345|NCT02543892|65010992|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
23346346|NCT02543892|65010993|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
23346347|NCT02543892|65010994|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
23346348|NCT02543892|65010995|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
23346349|NCT02543892|65010988|FG000|Received Vaccination 2|Physician Decision|0|||
23346350|NCT02543892|65010989|FG001|Received Vaccination 2|Physician Decision|0|||
23346351|NCT02543892|65010990|FG002|Received Vaccination 2|Physician Decision|0|||
23346352|NCT02543892|65010991|FG003|Received Vaccination 2|Physician Decision|0|||
23346353|NCT02543892|65010992|FG004|Received Vaccination 2|Physician Decision|0|||
23346354|NCT02543892|65010993|FG005|Received Vaccination 2|Physician Decision|1|||
23179527|NCT01707992|64397677|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23346355|NCT02543892|65010994|FG006|Received Vaccination 2|Physician Decision|0|||
23346356|NCT02543892|65010995|FG007|Received Vaccination 2|Physician Decision|0|||
23346357|NCT02543892|65010988|FG000|Received Vaccination 2|Adverse Event|0|||
23346358|NCT02543892|65010989|FG001|Received Vaccination 2|Adverse Event|1|||
23346359|NCT02543892|65010990|FG002|Received Vaccination 2|Adverse Event|0|||
23346360|NCT02543892|65010991|FG003|Received Vaccination 2|Adverse Event|0|||
23346361|NCT02543892|65010992|FG004|Received Vaccination 2|Adverse Event|0|||
23346362|NCT02543892|65010993|FG005|Received Vaccination 2|Adverse Event|0|||
23346363|NCT02543892|65010994|FG006|Received Vaccination 2|Adverse Event|0|||
23346364|NCT02543892|65010995|FG007|Received Vaccination 2|Adverse Event|0|||
23346365|NCT02543892|65010988|FG000|Had Immunology Data|Withdrawal by Subject|0|||
23346366|NCT02543892|65010989|FG001|Had Immunology Data|Withdrawal by Subject|0|||
23346367|NCT02543892|65010990|FG002|Had Immunology Data|Withdrawal by Subject|0|||
23346368|NCT02543892|65010991|FG003|Had Immunology Data|Withdrawal by Subject|0|||
23346369|NCT02543892|65010992|FG004|Had Immunology Data|Withdrawal by Subject|0|||
23239590|NCT01589185|64618923|FG004|Overall Study|Lost to Follow-up|0|||
23239591|NCT02369874|64618926|FG000|Overall Study|Lost to Follow-up|2|||
23346370|NCT02543892|65010993|FG005|Had Immunology Data|Withdrawal by Subject|0|||
23346371|NCT02543892|65010994|FG006|Had Immunology Data|Withdrawal by Subject|1|||
23346372|NCT02543892|65010995|FG007|Had Immunology Data|Withdrawal by Subject|0|||
23346373|NCT01430624|65010996|FG000|Overall Study|Lost to Follow-up|23|||
23346374|NCT01430624|65010997|FG001|Overall Study|Lost to Follow-up|29|||
23346375|NCT01430624|65010998|FG002|Overall Study|Lost to Follow-up|27|||
23346376|NCT01430624|65010996|FG000|Overall Study|technical or eligibility|5|||
23346377|NCT01430624|65010997|FG001|Overall Study|technical or eligibility|5|||
23239592|NCT02369874|64618927|FG001|Overall Study|Lost to Follow-up|2|||
23239593|NCT02369874|64618928|FG002|Overall Study|Lost to Follow-up|2|||
23239594|NCT02369874|64618926|FG000|Overall Study|Withdrawal by Subject|7|||
23239595|NCT02369874|64618927|FG001|Overall Study|Withdrawal by Subject|9|||
23239596|NCT02369874|64618928|FG002|Overall Study|Withdrawal by Subject|27|||
23239597|NCT02369874|64618926|FG000|Overall Study|Miscellaneous|1|||
23239598|NCT02369874|64618927|FG001|Overall Study|Miscellaneous|1|||
23346378|NCT01430624|65010998|FG002|Overall Study|technical or eligibility|2|||
23346379|NCT00108485|65010999|FG000|Overall Study|Withdrawal by Subject|3|||
23346380|NCT00108485|65011000|FG001|Overall Study|Withdrawal by Subject|0|||
23346381|NCT00108485|65010999|FG000|Overall Study|Lost to Follow-up|0|||
23346382|NCT00108485|65011000|FG001|Overall Study|Lost to Follow-up|2|||
23346383|NCT01097421|65011001|FG000|Overall Study|Adverse Event|8|||
23346384|NCT01097421|65011001|FG000|Overall Study|Protocol Violation|2|||
23346385|NCT01097421|65011001|FG000|Overall Study|Lost to Follow-up|1|||
23346386|NCT01097421|65011001|FG000|Overall Study|Withdrawal by Subject|3|||
23346387|NCT00467961|65011008|FG000|Overall Study|Technical Failures|5|||
23346388|NCT00467961|65011008|FG000|Overall Study|Disease Progression|2|||
23346389|NCT02122770|65011009|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
23346390|NCT02122770|65011010|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
23346391|NCT02122770|65011011|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
23346392|NCT02122770|65011012|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
23346393|NCT02122770|65011013|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
23346394|NCT02122770|65011014|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
23346395|NCT02122770|65011009|FG000|Part A: Drug-drug Interaction 2|Other|0|||
23346396|NCT02122770|65011010|FG001|Part A: Drug-drug Interaction 2|Other|0|||
23346397|NCT02122770|65011011|FG002|Part A: Drug-drug Interaction 2|Other|1|||
23346398|NCT02122770|65011012|FG003|Part A: Drug-drug Interaction 2|Other|0|||
23346399|NCT02122770|65011013|FG004|Part A: Drug-drug Interaction 2|Other|0|||
23346400|NCT02122770|65011014|FG005|Part A: Drug-drug Interaction 2|Other|0|||
23346401|NCT02122770|65011009|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346402|NCT02122770|65011010|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
23346403|NCT02122770|65011011|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346404|NCT02122770|65011012|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346405|NCT02122770|65011013|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346406|NCT02122770|65011014|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
23346407|NCT02122770|65011009|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
23346408|NCT02122770|65011010|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
23346409|NCT02122770|65011011|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
23346410|NCT02122770|65011012|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
23346411|NCT02122770|65011013|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
23346412|NCT02122770|65011014|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
23583616|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23239599|NCT02369874|64618928|FG002|Overall Study|Miscellaneous|0|||
23239600|NCT02369874|64618926|FG000|Overall Study|On Treatment/Off Study|34|||
23239601|NCT02369874|64618927|FG001|Overall Study|On Treatment/Off Study|45|||
23346413|NCT02122770|65011009|FG000|Part B: Standard of Care|Adverse Event|0|||
23346414|NCT02122770|65011010|FG001|Part B: Standard of Care|Adverse Event|0|||
23346415|NCT02122770|65011011|FG002|Part B: Standard of Care|Adverse Event|0|||
23346416|NCT02122770|65011012|FG003|Part B: Standard of Care|Adverse Event|0|||
23346417|NCT02122770|65011013|FG004|Part B: Standard of Care|Adverse Event|4|||
23346418|NCT02122770|65011014|FG005|Part B: Standard of Care|Adverse Event|1|||
23346419|NCT02122770|65011009|FG000|Part B: Standard of Care|Other|0|||
23346420|NCT02122770|65011010|FG001|Part B: Standard of Care|Other|0|||
23346421|NCT02122770|65011011|FG002|Part B: Standard of Care|Other|0|||
23346422|NCT02122770|65011012|FG003|Part B: Standard of Care|Other|0|||
23346423|NCT02122770|65011013|FG004|Part B: Standard of Care|Other|0|||
23346424|NCT02122770|65011014|FG005|Part B: Standard of Care|Other|2|||
23346425|NCT02122770|65011009|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
23346426|NCT02122770|65011010|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
23346427|NCT02122770|65011011|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
23346428|NCT02122770|65011012|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
23346429|NCT02122770|65011013|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
23346430|NCT02122770|65011014|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
23346431|NCT02122770|65011009|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
23346432|NCT02122770|65011010|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
23346433|NCT02122770|65011011|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
23346434|NCT02122770|65011012|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
23346435|NCT02122770|65011013|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
23346436|NCT02122770|65011014|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
23179528|NCT01707992|64397678|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23179529|NCT01707992|64397679|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23179530|NCT01707992|64397680|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
23179531|NCT01707992|64397681|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
23179532|NCT00404092|64397682|FG000|Overall Study|Death|1|||
23346437|NCT02122770|65011009|FG000|Part B: Standard of Care|Progressive Disease|0|||
23346438|NCT02122770|65011010|FG001|Part B: Standard of Care|Progressive Disease|0|||
23346439|NCT02122770|65011011|FG002|Part B: Standard of Care|Progressive Disease|0|||
23346440|NCT02122770|65011012|FG003|Part B: Standard of Care|Progressive Disease|0|||
23346441|NCT02122770|65011013|FG004|Part B: Standard of Care|Progressive Disease|10|||
23346442|NCT02122770|65011014|FG005|Part B: Standard of Care|Progressive Disease|8|||
23346443|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
23346444|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
23346445|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
23346446|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
23179533|NCT00404092|64397683|FG001|Overall Study|Death|0|||
23179534|NCT00404092|64397684|FG002|Overall Study|Death|0|||
23346447|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
23346448|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
23346449|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
23346450|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
23346451|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
23346452|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
23179535|NCT00404092|64397685|FG003|Overall Study|Death|0|||
23179536|NCT00404092|64397682|FG000|Overall Study|Adverse Event|0|||
23179537|NCT00404092|64397683|FG001|Overall Study|Adverse Event|0|||
23179538|NCT00404092|64397684|FG002|Overall Study|Adverse Event|1|||
23346453|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
23346454|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
23346455|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Death|0|||
23346456|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Death|0|||
23346457|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Death|1|||
23346458|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Death|0|||
23346459|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
23346460|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
23346461|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
23346462|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
23346463|NCT01179737|65011019|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
23346464|NCT01179737|65011020|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
23179539|NCT00404092|64397685|FG003|Overall Study|Adverse Event|0|||
23179540|NCT01707030|64397686|FG000|Overall Study|Death|1|||
23179541|NCT01707030|64397687|FG001|Overall Study|Death|1|||
23179542|NCT01707030|64397686|FG000|Overall Study|Withdrawal by Subject|2|||
23346465|NCT01179737|65011021|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
23346466|NCT01179737|65011022|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
23457760|NCT04038359|65419043|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
23179543|NCT01707030|64397687|FG001|Overall Study|Withdrawal by Subject|3|||
23179544|NCT01707030|64397686|FG000|Overall Study|Lost to Follow-up|8|||
23179545|NCT01707030|64397687|FG001|Overall Study|Lost to Follow-up|13|||
23179546|NCT00977470|64397690|FG000|Overall Study|Lack of Efficacy|32|||
23179547|NCT00977470|64397691|FG001|Overall Study|Lack of Efficacy|30|||
23179548|NCT00977470|64397690|FG000|Overall Study|Physician Decision|2|||
23179549|NCT00977470|64397691|FG001|Overall Study|Physician Decision|0|||
23179550|NCT00977470|64397690|FG000|Overall Study|Adverse Event|1|||
23179551|NCT00977470|64397691|FG001|Overall Study|Adverse Event|2|||
23346467|NCT01179737|65011019|FG000|Extension|The study was terminated|3|||
23346468|NCT01179737|65011020|FG001|Extension|The study was terminated|0|||
23346469|NCT01179737|65011021|FG002|Extension|The study was terminated|0|||
23346470|NCT01179737|65011022|FG003|Extension|The study was terminated|0|||
23346471|NCT01459718|65011023|FG000|Overall Study|Physician Decision|1|||
23346472|NCT01459718|65011023|FG000|Overall Study|Lost to Follow-up|1|||
23179552|NCT00977470|64397690|FG000|Overall Study|Protocol Violation|1|||
23179553|NCT00977470|64397691|FG001|Overall Study|Protocol Violation|0|||
23179554|NCT00977470|64397690|FG000|Overall Study|Withdrawal by Subject|0|||
23179555|NCT00977470|64397691|FG001|Overall Study|Withdrawal by Subject|2|||
23179556|NCT00977470|64397690|FG000|Overall Study|Death|0|||
23179557|NCT00977470|64397691|FG001|Overall Study|Death|2|||
23179558|NCT00977470|64397690|FG000|Overall Study|clinical decline|0|||
23179559|NCT00977470|64397691|FG001|Overall Study|clinical decline|1|||
23179560|NCT00977470|64397690|FG000|Overall Study|prolonged recovery post-surgery|0|||
23179561|NCT00977470|64397691|FG001|Overall Study|prolonged recovery post-surgery|1|||
23179562|NCT00977470|64397690|FG000|Overall Study|Still on-study|2|||
23179563|NCT00977470|64397691|FG001|Overall Study|Still on-study|0|||
23179564|NCT01523873|64397692|FG000|Overall Study|Protocol Violation|422|||
23179565|NCT02487108|64397693|FG000|Overall Study|Adverse Event|1|||
23346473|NCT01459718|65011023|FG000|Overall Study|Adverse Event|1|||
23346474|NCT02620384|65011024|FG000|Overall Study|Adverse Event|2|||
23346475|NCT02620384|65011025|FG001|Overall Study|Adverse Event|1|||
23346476|NCT02620384|65011024|FG000|Overall Study|Discharged prior to 2nd dose|2|||
23346477|NCT02620384|65011025|FG001|Overall Study|Discharged prior to 2nd dose|5|||
23346478|NCT02620384|65011024|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
23346479|NCT02620384|65011025|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
23346480|NCT03802565|65011028|FG000|Overall Study|Adverse Event|0|||
23346481|NCT03802565|65011029|FG001|Overall Study|Adverse Event|1|||
23179566|NCT02487108|64397694|FG001|Overall Study|Adverse Event|6|||
23179567|NCT02487108|64397695|FG002|Overall Study|Adverse Event|12|||
23179568|NCT02487108|64397696|FG003|Overall Study|Adverse Event|6|||
23179569|NCT02487108|64397693|FG000|Overall Study|Withdrawal by Subject|8|||
23179570|NCT02487108|64397694|FG001|Overall Study|Withdrawal by Subject|5|||
23179571|NCT02487108|64397695|FG002|Overall Study|Withdrawal by Subject|5|||
23179572|NCT02487108|64397696|FG003|Overall Study|Withdrawal by Subject|0|||
23179573|NCT02487108|64397693|FG000|Overall Study|Non-compliance to study medication|3|||
23179574|NCT02487108|64397694|FG001|Overall Study|Non-compliance to study medication|2|||
23179575|NCT02487108|64397695|FG002|Overall Study|Non-compliance to study medication|5|||
23179576|NCT02487108|64397696|FG003|Overall Study|Non-compliance to study medication|4|||
23179577|NCT02487108|64397693|FG000|Overall Study|Protocol Violation|1|||
23179578|NCT02487108|64397694|FG001|Overall Study|Protocol Violation|1|||
23179579|NCT02487108|64397695|FG002|Overall Study|Protocol Violation|2|||
23179580|NCT02487108|64397696|FG003|Overall Study|Protocol Violation|0|||
23179581|NCT02487108|64397693|FG000|Overall Study|Non-compliance to study procedures|0|||
23179582|NCT02487108|64397694|FG001|Overall Study|Non-compliance to study procedures|0|||
23179583|NCT02487108|64397695|FG002|Overall Study|Non-compliance to study procedures|0|||
23179584|NCT02487108|64397696|FG003|Overall Study|Non-compliance to study procedures|1|||
23179585|NCT02487108|64397693|FG000|Overall Study|Other than specified|3|||
23179586|NCT02487108|64397694|FG001|Overall Study|Other than specified|2|||
23179587|NCT02487108|64397695|FG002|Overall Study|Other than specified|2|||
23179588|NCT02487108|64397696|FG003|Overall Study|Other than specified|0|||
23179589|NCT02494596|64397697|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23179590|NCT02494596|64397698|FG001|Overall Study|Insufficient Therapeutic Response|3|||
23179591|NCT02494596|64397699|FG002|Overall Study|Insufficient Therapeutic Response|1|||
23179592|NCT02494596|64397697|FG000|Overall Study|Adverse Event|0|||
23179593|NCT02494596|64397698|FG001|Overall Study|Adverse Event|1|||
23179594|NCT02494596|64397699|FG002|Overall Study|Adverse Event|0|||
23179595|NCT02494596|64397697|FG000|Overall Study|Refused Treatment|0|||
23179596|NCT02494596|64397698|FG001|Overall Study|Refused Treatment|1|||
23179597|NCT02494596|64397699|FG002|Overall Study|Refused Treatment|0|||
23179598|NCT04173741|64397704|FG000|Overall Study|IVC measurement cannot be done|1|||
23346482|NCT03802565|65011030|FG002|Overall Study|Adverse Event|2|||
23346483|NCT03802565|65011031|FG003|Overall Study|Adverse Event|1|||
23179599|NCT04173741|64397705|FG001|Overall Study|IVC measurement cannot be done|1|||
23179600|NCT02663895|64397709|FG000|Overall Study|Adverse Event|3|||
23179601|NCT02663895|64397709|FG000|Overall Study|Physician Decision|2|||
23179602|NCT02663895|64397709|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
23179603|NCT02663895|64397709|FG000|Overall Study|Withdrawal by Subject|1|||
23179604|NCT00699348|64397718|FG000|Overall Study|Death|6|||
23179605|NCT00699348|64397718|FG000|Overall Study|Adverse Event|15|||
23179606|NCT00699348|64397718|FG000|Overall Study|Withdrawal by Subject|11|||
23179607|NCT00699348|64397718|FG000|Overall Study|Protocol Violation|10|||
23179608|NCT00699348|64397718|FG000|Overall Study|Lack of Efficacy|8|||
23346484|NCT03802565|65011032|FG004|Overall Study|Adverse Event|1|||
23179609|NCT00699348|64397718|FG000|Overall Study|Failure to return|1|||
23179610|NCT00699348|64397718|FG000|Overall Study|Blood transfusion|24|||
23179611|NCT00699348|64397718|FG000|Overall Study|Renal transplantation|10|||
23179612|NCT00699348|64397718|FG000|Overall Study|Other|5|||
23179613|NCT01553149|64397719|FG000|Overall Study|Adverse Event|0|||
23179614|NCT01553149|64397720|FG001|Overall Study|Adverse Event|9|||
23179615|NCT01553149|64397719|FG000|Overall Study|Physician Decision|5|||
23346485|NCT03802565|65011028|FG000|Overall Study|Withdrawal by Subject|2|||
23179616|NCT01553149|64397720|FG001|Overall Study|Physician Decision|10|||
23179617|NCT01553149|64397719|FG000|Overall Study|Ineligible|0|||
23179618|NCT01553149|64397720|FG001|Overall Study|Ineligible|1|||
23179619|NCT01961115|64397721|FG000|Overall Study|Disease Progression|1|||
23179620|NCT01961115|64397722|FG001|Overall Study|Disease Progression|0|||
23179621|NCT01961115|64397723|FG002|Overall Study|Disease Progression|3|||
23179622|NCT01961115|64397721|FG000|Overall Study|Adverse Event|1|||
23179623|NCT01961115|64397722|FG001|Overall Study|Adverse Event|0|||
23179624|NCT01961115|64397723|FG002|Overall Study|Adverse Event|1|||
23179625|NCT03064763|64397724|FG000|Overall Study|Lost to Follow-up|1|||
23346486|NCT03802565|65011029|FG001|Overall Study|Withdrawal by Subject|2|||
23346487|NCT03802565|65011030|FG002|Overall Study|Withdrawal by Subject|2|||
23179626|NCT03064763|64397724|FG000|Overall Study|Death|8|||
23179627|NCT03882424|64397725|FG000|Overall Study|Lost to Follow-up|3|||
23179628|NCT03882424|64397726|FG001|Overall Study|Lost to Follow-up|0|||
23179629|NCT03882424|64397727|FG002|Overall Study|Lost to Follow-up|0|||
23179630|NCT03882424|64397725|FG000|Overall Study|schedule conflict|1|||
23179631|NCT03882424|64397726|FG001|Overall Study|schedule conflict|0|||
23179632|NCT03882424|64397727|FG002|Overall Study|schedule conflict|0|||
23179633|NCT01446809|64397728|FG000|Overall Study|Adverse Event|0|||
23179634|NCT01446809|64397729|FG001|Overall Study|Adverse Event|0|||
23239602|NCT02369874|64618928|FG002|Overall Study|On Treatment/Off Study|32|||
23239603|NCT00764465|64618931|FG000|Overall Study|Adverse Event|2|||
23239604|NCT00764465|64618932|FG001|Overall Study|Adverse Event|0|||
23457761|NCT04038359|65419042|FG000|Overall Study|Death|8|||
23457762|NCT04038359|65419043|FG001|Overall Study|Death|7|||
23457763|NCT04038359|65419042|FG000|Overall Study|Lost to Follow-up|3|||
23457764|NCT04038359|65419043|FG001|Overall Study|Lost to Follow-up|0|||
23457765|NCT04038359|65419042|FG000|Overall Study|Participant Moved|1|||
23457766|NCT04038359|65419043|FG001|Overall Study|Participant Moved|0|||
23239605|NCT00764465|64618933|FG002|Overall Study|Adverse Event|0|||
23239606|NCT00764465|64618934|FG003|Overall Study|Adverse Event|1|||
23239607|NCT00764465|64618935|FG004|Overall Study|Adverse Event|1|||
23239608|NCT00764465|64618936|FG005|Overall Study|Adverse Event|1|||
23239609|NCT00764465|64618931|FG000|Overall Study|Withdrawal by Subject|0|||
23239610|NCT00764465|64618932|FG001|Overall Study|Withdrawal by Subject|1|||
23239611|NCT00764465|64618933|FG002|Overall Study|Withdrawal by Subject|1|||
23239612|NCT00764465|64618934|FG003|Overall Study|Withdrawal by Subject|0|||
23239613|NCT00764465|64618935|FG004|Overall Study|Withdrawal by Subject|0|||
23239614|NCT00764465|64618936|FG005|Overall Study|Withdrawal by Subject|0|||
23239615|NCT02059265|64618942|FG000|Overall Study|Ineligible|4|||
23239616|NCT00096031|64618943|FG000|Overall Study|Adverse Event|3|||
23239617|NCT00096031|64618943|FG000|Overall Study|Lack of Efficacy|42|||
23239618|NCT00096031|64618943|FG000|Overall Study|Death|4|||
23239619|NCT00096031|64618943|FG000|Overall Study|Withdrawal by Subject|1|||
23239620|NCT00096031|64618943|FG000|Overall Study|Ineligible|8|||
23346488|NCT03802565|65011031|FG003|Overall Study|Withdrawal by Subject|0|||
23346489|NCT03802565|65011032|FG004|Overall Study|Withdrawal by Subject|1|||
23346490|NCT03802565|65011028|FG000|Overall Study|Protocol Violation|2|||
23346491|NCT03802565|65011029|FG001|Overall Study|Protocol Violation|1|||
23346492|NCT03802565|65011030|FG002|Overall Study|Protocol Violation|4|||
23346493|NCT03802565|65011031|FG003|Overall Study|Protocol Violation|5|||
23346494|NCT03802565|65011032|FG004|Overall Study|Protocol Violation|1|||
23346495|NCT03802565|65011028|FG000|Overall Study|Lost to Follow-up|0|||
23346496|NCT03802565|65011029|FG001|Overall Study|Lost to Follow-up|0|||
23346497|NCT03802565|65011030|FG002|Overall Study|Lost to Follow-up|1|||
23457767|NCT04038359|65419042|FG000|Overall Study|Withdrawal by Subject|4|||
23239621|NCT00096031|64618943|FG000|Overall Study|Not protocol specified|5|||
23346498|NCT03802565|65011031|FG003|Overall Study|Lost to Follow-up|0|||
23346499|NCT03802565|65011032|FG004|Overall Study|Lost to Follow-up|0|||
23346500|NCT03802565|65011028|FG000|Overall Study|Subjects Related to Each Other|1|||
23346501|NCT03802565|65011029|FG001|Overall Study|Subjects Related to Each Other|0|||
23346502|NCT03802565|65011030|FG002|Overall Study|Subjects Related to Each Other|0|||
23457768|NCT04038359|65419043|FG001|Overall Study|Withdrawal by Subject|3|||
23239622|NCT03359811|64618944|FG000|Overall Study|Protocol Violation|2|||
23239623|NCT03359811|64618945|FG001|Overall Study|Protocol Violation|0|||
23179635|NCT01446809|64397730|FG002|Overall Study|Adverse Event|1|||
23179636|NCT01446809|64397728|FG000|Overall Study|Failure to complete study procedures|0|||
23179637|NCT01446809|64397729|FG001|Overall Study|Failure to complete study procedures|0|||
23239624|NCT00920582|64618956|FG000|Overall Study|Lost to Follow-up|5|||
23346503|NCT03802565|65011031|FG003|Overall Study|Subjects Related to Each Other|2|||
23346504|NCT03802565|65011032|FG004|Overall Study|Subjects Related to Each Other|1|||
23457769|NCT04038359|65419042|FG000|Overall Study|Physician Decision|3|||
23179638|NCT01446809|64397730|FG002|Overall Study|Failure to complete study procedures|1|||
23179639|NCT00483327|64397737|FG000|Overall Study|Adverse Event|1|||
23179640|NCT00483327|64397737|FG000|Overall Study|Withdrawal by Subject|3|||
23346505|NCT03802565|65011028|FG000|Overall Study|Elevated Enzymes|0|||
23346506|NCT03802565|65011029|FG001|Overall Study|Elevated Enzymes|0|||
23457770|NCT04038359|65419043|FG001|Overall Study|Physician Decision|2|||
23346507|NCT03802565|65011030|FG002|Overall Study|Elevated Enzymes|0|||
23346508|NCT03802565|65011031|FG003|Overall Study|Elevated Enzymes|0|||
23346509|NCT03802565|65011032|FG004|Overall Study|Elevated Enzymes|2|||
23346510|NCT00070018|65011033|FG000|Overall Study|Adverse Event|2|||
23346511|NCT00070018|65011033|FG000|Overall Study|Lack of Efficacy|1|||
23346512|NCT00070018|65011033|FG000|Overall Study|Withdrawal by Subject|1|||
23457771|NCT04038359|65419042|FG000|Overall Study|Adverse Event|0|||
23457772|NCT04038359|65419043|FG001|Overall Study|Adverse Event|2|||
23457773|NCT04038359|65419042|FG000|Overall Study|Progressive Disease|0|||
23457774|NCT04038359|65419043|FG001|Overall Study|Progressive Disease|1|||
23457775|NCT01084252|65419046|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457776|NCT01084252|65419047|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457777|NCT01084252|65419048|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457778|NCT01084252|65419049|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457779|NCT01084252|65419050|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457780|NCT01084252|65419051|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457781|NCT01084252|65419052|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457782|NCT01084252|65419053|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457783|NCT01084252|65419054|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457784|NCT01084252|65419055|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457785|NCT01084252|65419056|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457786|NCT01084252|65419057|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457787|NCT01084252|65419058|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
23457788|NCT01084252|65419059|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
23457789|NCT02197234|65419061|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
23457790|NCT02197234|65419061|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
23457791|NCT02197234|65419061|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
23457792|NCT02197234|65419061|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
23457793|NCT02197234|65419061|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
23457794|NCT02197234|65419061|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
23457795|NCT00626106|65419062|FG000|Overall Study|Withdrawal by Subject|2|||
23457796|NCT00626106|65419063|FG001|Overall Study|Withdrawal by Subject|1|||
23457797|NCT00626106|65419062|FG000|Overall Study|Lost to Follow-up|1|||
23457798|NCT00626106|65419063|FG001|Overall Study|Lost to Follow-up|4|||
23457799|NCT00626106|65419062|FG000|Overall Study|Death|64|||
23457800|NCT00626106|65419063|FG001|Overall Study|Death|19|||
23457801|NCT05176314|65419064|FG000|Overall Study|Lost to Follow-up|2|||
23457802|NCT05176314|65419064|FG000|Overall Study|Physician Decision|1|||
23457803|NCT05176314|65419064|FG000|Overall Study|Adverse Event|1|||
23457804|NCT05291520|65419065|FG000|Overall Study|Lost to Follow-up|0|||
23457805|NCT05291520|65419066|FG001|Overall Study|Lost to Follow-up|0|||
23179641|NCT00483327|64397737|FG000|Overall Study|Lost to Follow-up|4|||
23179642|NCT00483327|64397737|FG000|Overall Study|Patient Non Compliance|2|||
23179643|NCT02320487|64397738|FG000|Overall Study|Reason not Specified|1|||
23179644|NCT02320487|64397738|FG000|Overall Study|Physician Decision|5|||
23179645|NCT02320487|64397738|FG000|Overall Study|Withdrawal by Subject|1|||
23179646|NCT02320487|64397738|FG000|Overall Study|Death|3|||
23179647|NCT02320487|64397738|FG000|Overall Study|Adverse Event|11|||
23179648|NCT00434967|64397739|FG000|Overall Study|Adverse Event|2|||
23179649|NCT00434967|64397740|FG001|Overall Study|Adverse Event|4|||
23179650|NCT00434967|64397741|FG002|Overall Study|Adverse Event|3|||
23346513|NCT02339155|65011034|FG000|Overall Study|Adverse Event|0|||
23346514|NCT02339155|65011035|FG001|Overall Study|Adverse Event|6|||
23457806|NCT05291520|65419067|FG002|Overall Study|Lost to Follow-up|1|||
23457807|NCT03103542|65419068|FG000|Overall Study|Physician Decision|2|||
23457808|NCT03103542|65419068|FG000|Overall Study|Adverse Event|2|||
23457809|NCT03103542|65419068|FG000|Overall Study|Other|2|||
23457810|NCT03103542|65419068|FG000|Overall Study|Withdrawal by Subject|1|||
23457811|NCT02018562|65419069|FG000|Overall Study|Withdrawal by Subject|2|||
23346515|NCT02339155|65011034|FG000|Overall Study|Death|1|||
23346516|NCT02339155|65011035|FG001|Overall Study|Death|1|||
23346517|NCT02339155|65011034|FG000|Overall Study|Lost to Follow-up|8|||
23346518|NCT02339155|65011035|FG001|Overall Study|Lost to Follow-up|9|||
23346519|NCT02339155|65011034|FG000|Overall Study|Physician Decision|2|||
23346520|NCT02339155|65011035|FG001|Overall Study|Physician Decision|1|||
23457812|NCT02018562|65419070|FG001|Overall Study|Withdrawal by Subject|0|||
23179651|NCT00434967|64397742|FG003|Overall Study|Adverse Event|3|||
23179652|NCT00434967|64397739|FG000|Overall Study|Lost to Follow-up|0|||
23179653|NCT00434967|64397740|FG001|Overall Study|Lost to Follow-up|0|||
23179654|NCT00434967|64397741|FG002|Overall Study|Lost to Follow-up|1|||
23179655|NCT00434967|64397742|FG003|Overall Study|Lost to Follow-up|0|||
23346521|NCT02339155|65011034|FG000|Overall Study|Withdrawal by Subject|4|||
23346522|NCT02339155|65011035|FG001|Overall Study|Withdrawal by Subject|4|||
23346523|NCT03627416|65011036|FG000|Overall Study|Adverse Event|0|||
23346524|NCT03627416|65011037|FG001|Overall Study|Adverse Event|1|||
23457813|NCT02018562|65419069|FG000|Overall Study|Discharged prior to study completion|1|||
23457814|NCT02018562|65419070|FG001|Overall Study|Discharged prior to study completion|0|||
23457815|NCT04750824|65419073|FG000|Overall Study|Toxicity/intolerability|3|||
23457816|NCT04750824|65419074|FG001|Overall Study|Toxicity/intolerability|1|||
23457817|NCT04750824|65419073|FG000|Overall Study|Death|1|||
23457818|NCT04750824|65419074|FG001|Overall Study|Death|3|||
23583617|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23179656|NCT00434967|64397739|FG000|Overall Study|Withdrawal by Subject|2|||
23179657|NCT00434967|64397740|FG001|Overall Study|Withdrawal by Subject|2|||
23179658|NCT00434967|64397741|FG002|Overall Study|Withdrawal by Subject|4|||
23179659|NCT00434967|64397742|FG003|Overall Study|Withdrawal by Subject|6|||
23346525|NCT03769675|65011041|FG000|Overall Study|Lost to Follow-up|1|||
23346526|NCT02638129|65011047|FG000|Overall Study|Study terminated|28|||
23346527|NCT02638129|65011048|FG001|Overall Study|Study terminated|30|||
23346528|NCT00984061|65011049|FG000|Clarithromycin Alone|Protocol Violation|1|||
23346529|NCT01935700|65011051|FG000|Overall Study|Withdrawal by Subject|1|||
23346530|NCT01935700|65011052|FG001|Overall Study|Withdrawal by Subject|0|||
23346531|NCT01935700|65011051|FG000|Overall Study|Physician Decision|4|||
23457819|NCT04750824|65419073|FG000|Overall Study|Scheduled duration of therapy complete|1|||
23179660|NCT00434967|64397739|FG000|Overall Study|Randomized in error|0|||
23179661|NCT00434967|64397740|FG001|Overall Study|Randomized in error|0|||
23179662|NCT00434967|64397741|FG002|Overall Study|Randomized in error|0|||
23179663|NCT00434967|64397742|FG003|Overall Study|Randomized in error|1|||
23179664|NCT00434967|64397739|FG000|Overall Study|Protocol Violation|0|||
23179665|NCT00434967|64397740|FG001|Overall Study|Protocol Violation|1|||
23179666|NCT00434967|64397741|FG002|Overall Study|Protocol Violation|0|||
23179667|NCT00434967|64397742|FG003|Overall Study|Protocol Violation|1|||
23179668|NCT00434967|64397739|FG000|Overall Study|Physician Decision|1|||
23239625|NCT00920582|64618957|FG001|Overall Study|Lost to Follow-up|1|||
23239626|NCT00920582|64618958|FG002|Overall Study|Lost to Follow-up|2|||
23239627|NCT00920582|64618959|FG003|Overall Study|Lost to Follow-up|0|||
23239628|NCT00920582|64618956|FG000|Overall Study|Withdrawal by Subject|5|||
23239629|NCT00920582|64618957|FG001|Overall Study|Withdrawal by Subject|4|||
23239630|NCT00920582|64618958|FG002|Overall Study|Withdrawal by Subject|6|||
23239631|NCT00920582|64618959|FG003|Overall Study|Withdrawal by Subject|3|||
23239632|NCT00920582|64618956|FG000|Overall Study|Protocol Violation|1|||
23179669|NCT00434967|64397740|FG001|Overall Study|Physician Decision|1|||
23179670|NCT00434967|64397741|FG002|Overall Study|Physician Decision|1|||
23239633|NCT00920582|64618957|FG001|Overall Study|Protocol Violation|0|||
23239634|NCT00920582|64618958|FG002|Overall Study|Protocol Violation|0|||
23239635|NCT00920582|64618959|FG003|Overall Study|Protocol Violation|0|||
23239636|NCT00920582|64618956|FG000|Overall Study|Other|2|||
23239637|NCT00920582|64618957|FG001|Overall Study|Other|1|||
23457820|NCT04750824|65419074|FG001|Overall Study|Scheduled duration of therapy complete|9|||
23583618|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583619|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583620|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583621|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583622|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583623|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
23583624|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
23179671|NCT00434967|64397742|FG003|Overall Study|Physician Decision|0|||
23239638|NCT00920582|64618958|FG002|Overall Study|Other|3|||
23346532|NCT01935700|65011052|FG001|Overall Study|Physician Decision|0|||
23239639|NCT00920582|64618959|FG003|Overall Study|Other|2|||
23239640|NCT02260804|64618960|FG000|Induction Study Period|Protocol Violation|2|||
23239641|NCT02260804|64618961|FG001|Induction Study Period|Protocol Violation|0|||
23239642|NCT02260804|64618960|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
23239643|NCT02260804|64618961|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
23239644|NCT02260804|64618960|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
23239645|NCT02260804|64618961|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
23239646|NCT02260804|64618960|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
23239647|NCT02260804|64618961|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
23239648|NCT02260804|64618960|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
23239649|NCT02260804|64618961|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
23239650|NCT02260804|64618960|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
23239651|NCT02260804|64618961|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
23239652|NCT02260804|64618960|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
23239653|NCT02260804|64618961|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
23239654|NCT02260804|64618960|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
23239655|NCT02260804|64618961|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
23239656|NCT02260804|64618960|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
23239657|NCT02260804|64618961|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
23239658|NCT02260804|64618960|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
23239659|NCT02260804|64618961|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
23239660|NCT02260804|64618960|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
23239661|NCT02260804|64618961|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
23239662|NCT00660816|64618968|FG000|Overall Study|Adverse Event|1|||
23239663|NCT00660816|64618969|FG001|Overall Study|Adverse Event|2|||
23239664|NCT00660816|64618968|FG000|Overall Study|Withdrawal by Subject|1|||
23239665|NCT00660816|64618969|FG001|Overall Study|Withdrawal by Subject|0|||
23239666|NCT00660816|64618968|FG000|Overall Study|Death|0|||
23239667|NCT00660816|64618969|FG001|Overall Study|Death|2|||
23239668|NCT00660816|64618968|FG000|Overall Study|Lack of Efficacy|1|||
23239669|NCT00660816|64618969|FG001|Overall Study|Lack of Efficacy|0|||
23239670|NCT00660816|64618968|FG000|Overall Study|Physician Decision|0|||
23239671|NCT00660816|64618969|FG001|Overall Study|Physician Decision|2|||
23239672|NCT00660816|64618968|FG000|Overall Study|Protocol Violation|1|||
23239673|NCT00660816|64618969|FG001|Overall Study|Protocol Violation|0|||
23239674|NCT00660816|64618968|FG000|Overall Study|Disease Progression|16|||
23239675|NCT00660816|64618969|FG001|Overall Study|Disease Progression|12|||
23239676|NCT00660816|64618968|FG000|Overall Study|Complicating Disease|0|||
23239677|NCT00660816|64618969|FG001|Overall Study|Complicating Disease|1|||
23239678|NCT01471197|64618970|FG000|Overall Study|Disease Progression|4|||
23239679|NCT01471197|64618971|FG001|Overall Study|Disease Progression|2|||
23239680|NCT01471197|64618970|FG000|Overall Study|Death|1|||
23239681|NCT01471197|64618971|FG001|Overall Study|Death|0|||
23239682|NCT01471197|64618970|FG000|Overall Study|Study Drug Toxicity|1|||
23239683|NCT01471197|64618971|FG001|Overall Study|Study Drug Toxicity|0|||
23239684|NCT02734290|64622030|FG000|Overall Study|Adverse Event|1|||
23239685|NCT02734290|64622031|FG001|Overall Study|Adverse Event|0|||
23239686|NCT02734290|64622030|FG000|Overall Study|Death|1|||
23239687|NCT02734290|64622031|FG001|Overall Study|Death|0|||
23239688|NCT01459016|64622034|FG000|Overall Study|Withdrawal by Subject|11|||
23239689|NCT01459016|64622034|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
23239690|NCT01748162|64622035|FG000|Overall Study|no additional croup episodes to evaluate|2|||
23239691|NCT01748162|64622036|FG001|Overall Study|no additional croup episodes to evaluate|2|||
23239692|NCT01748162|64622035|FG000|Overall Study|participant consented but did not begin|0|||
23239693|NCT01748162|64622036|FG001|Overall Study|participant consented but did not begin|1|||
23239694|NCT01748162|64622035|FG000|Overall Study|reasons not available|3|||
23239695|NCT01748162|64622036|FG001|Overall Study|reasons not available|2|||
23239696|NCT02503215|64622040|FG000|Overall Study|Unable to wear compression stockings|1|||
23239697|NCT02503215|64622040|FG000|Overall Study|Unable to use positive airway pressure|2|||
23239698|NCT02684370|64622041|FG000|Part A|Adverse Event|2|||
23239699|NCT02684370|64622042|FG001|Part A|Adverse Event|0|||
23239700|NCT02684370|64622043|FG002|Part A|Adverse Event|1|||
23239701|NCT02684370|64622044|FG003|Part A|Adverse Event|0|||
23583625|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
23583626|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23239702|NCT02684370|64622045|FG004|Part A|Adverse Event|0|||
23239703|NCT02684370|64622046|FG005|Part A|Adverse Event|0|||
23239704|NCT02684370|64622041|FG000|Part A|Lost to Follow-up|1|||
23239705|NCT02684370|64622042|FG001|Part A|Lost to Follow-up|1|||
23239706|NCT02684370|64622043|FG002|Part A|Lost to Follow-up|0|||
23239707|NCT02684370|64622044|FG003|Part A|Lost to Follow-up|0|||
23239708|NCT02684370|64622045|FG004|Part A|Lost to Follow-up|0|||
23239709|NCT02684370|64622046|FG005|Part A|Lost to Follow-up|0|||
23239710|NCT02684370|64622041|FG000|Part A|Subject Withdrawal|1|||
23239711|NCT02684370|64622042|FG001|Part A|Subject Withdrawal|0|||
23239712|NCT02684370|64622043|FG002|Part A|Subject Withdrawal|3|||
23239713|NCT02684370|64622044|FG003|Part A|Subject Withdrawal|0|||
23239714|NCT02684370|64622045|FG004|Part A|Subject Withdrawal|0|||
23239715|NCT02684370|64622046|FG005|Part A|Subject Withdrawal|0|||
23239716|NCT02684370|64622041|FG000|Part A|Other|0|||
23239717|NCT02684370|64622042|FG001|Part A|Other|0|||
23239718|NCT02684370|64622043|FG002|Part A|Other|1|||
23239719|NCT02684370|64622044|FG003|Part A|Other|0|||
23239720|NCT02684370|64622045|FG004|Part A|Other|0|||
23239721|NCT02684370|64622046|FG005|Part A|Other|0|||
23239722|NCT02684370|64622041|FG000|Part B|Adverse Event|0|||
23239723|NCT02684370|64622042|FG001|Part B|Adverse Event|0|||
23239724|NCT02684370|64622043|FG002|Part B|Adverse Event|0|||
23239725|NCT02684370|64622044|FG003|Part B|Adverse Event|0|||
23239726|NCT02684370|64622045|FG004|Part B|Adverse Event|2|||
23346533|NCT02407457|65011055|FG000|1 Month|Death|3|||
23346534|NCT02407457|65011056|FG001|1 Month|Death|0|||
23346535|NCT02407457|65011055|FG000|1 Month|Lost to Follow-up|1|||
23346536|NCT02407457|65011056|FG001|1 Month|Lost to Follow-up|1|||
23346537|NCT02407457|65011055|FG000|1 Month|missed visit|2|||
23346538|NCT02407457|65011056|FG001|1 Month|missed visit|5|||
23346539|NCT02407457|65011055|FG000|6-Month|Death|2|||
23346540|NCT02407457|65011056|FG001|6-Month|Death|8|||
23346541|NCT02407457|65011055|FG000|6-Month|Lost to Follow-up|2|||
23346542|NCT02407457|65011056|FG001|6-Month|Lost to Follow-up|2|||
23346543|NCT02407457|65011055|FG000|6-Month|missed visit|16|||
23346544|NCT02407457|65011056|FG001|6-Month|missed visit|14|||
23346545|NCT02407457|65011055|FG000|6-Month|Open Repair|0|||
23346546|NCT02407457|65011056|FG001|6-Month|Open Repair|1|||
23346547|NCT02407457|65011055|FG000|1 Year|Death|6|||
23346548|NCT02407457|65011056|FG001|1 Year|Death|11|||
23346549|NCT02407457|65011055|FG000|1 Year|Lost to Follow-up|3|||
23346550|NCT02407457|65011056|FG001|1 Year|Lost to Follow-up|2|||
23346551|NCT02407457|65011055|FG000|1 Year|Missed Visit|24|||
23346552|NCT02407457|65011056|FG001|1 Year|Missed Visit|14|||
23346553|NCT02407457|65011055|FG000|1 Year|Open Repair|0|||
23346554|NCT02407457|65011056|FG001|1 Year|Open Repair|1|||
23346555|NCT02407457|65011055|FG000|2-year|Death|14|||
23346556|NCT02407457|65011056|FG001|2-year|Death|8|||
23346557|NCT02407457|65011055|FG000|2-year|Lost to Follow-up|7|||
23346558|NCT02407457|65011056|FG001|2-year|Lost to Follow-up|10|||
23346559|NCT02407457|65011055|FG000|2-year|Missed Visit|13|||
23346560|NCT02407457|65011056|FG001|2-year|Missed Visit|15|||
23346561|NCT02407457|65011055|FG000|2-year|Open Repair|0|||
23346562|NCT02407457|65011056|FG001|2-year|Open Repair|2|||
23346563|NCT02407457|65011055|FG000|3-year|Death|11|||
23346564|NCT02407457|65011056|FG001|3-year|Death|10|||
23346565|NCT02407457|65011055|FG000|3-year|Lost to Follow-up|9|||
23346566|NCT02407457|65011056|FG001|3-year|Lost to Follow-up|10|||
23346567|NCT02407457|65011055|FG000|3-year|Missed Visit|19|||
23346568|NCT02407457|65011056|FG001|3-year|Missed Visit|16|||
23346569|NCT02407457|65011055|FG000|4-year|Death|18|||
23346570|NCT02407457|65011056|FG001|4-year|Death|10|||
23346571|NCT02407457|65011055|FG000|4-year|Lost to Follow-up|10|||
23346572|NCT02407457|65011056|FG001|4-year|Lost to Follow-up|12|||
23346573|NCT02407457|65011055|FG000|4-year|Missed Visit|18|||
23346574|NCT02407457|65011056|FG001|4-year|Missed Visit|16|||
23346575|NCT02407457|65011055|FG000|5-year|Death|10|||
23346576|NCT02407457|65011056|FG001|5-year|Death|3|||
23346577|NCT02407457|65011055|FG000|5-year|Lost to Follow-up|22|||
23346578|NCT02407457|65011056|FG001|5-year|Lost to Follow-up|13|||
23346579|NCT02407457|65011055|FG000|5-year|Missed Visit|9|||
23239727|NCT02684370|64622046|FG005|Part B|Adverse Event|1|||
23239728|NCT02684370|64622041|FG000|Part B|Lost to Follow-up|0|||
23239729|NCT02684370|64622042|FG001|Part B|Lost to Follow-up|0|||
23239730|NCT02684370|64622043|FG002|Part B|Lost to Follow-up|0|||
23239731|NCT02684370|64622044|FG003|Part B|Lost to Follow-up|1|||
23239732|NCT02684370|64622045|FG004|Part B|Lost to Follow-up|2|||
23239733|NCT02684370|64622046|FG005|Part B|Lost to Follow-up|5|||
23239734|NCT02684370|64622041|FG000|Part B|Subject Withdrawal|0|||
23239735|NCT02684370|64622042|FG001|Part B|Subject Withdrawal|0|||
23346580|NCT02407457|65011056|FG001|5-year|Missed Visit|1|||
23346581|NCT03435224|65011057|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
23346582|NCT00866333|65011058|FG000|Overall Study|Withdrawal of consent|0|||
23346583|NCT00866333|65011059|FG001|Overall Study|Withdrawal of consent|1|||
23346584|NCT00866333|65011060|FG002|Overall Study|Withdrawal of consent|2|||
23346585|NCT00866333|65011058|FG000|Overall Study|Reason not Specified|3|||
23346586|NCT00866333|65011059|FG001|Overall Study|Reason not Specified|1|||
23346587|NCT00866333|65011060|FG002|Overall Study|Reason not Specified|1|||
23346588|NCT00866333|65011058|FG000|Overall Study|Study Terminated by Sponsor|2|||
23346589|NCT00866333|65011059|FG001|Overall Study|Study Terminated by Sponsor|5|||
23346590|NCT00866333|65011060|FG002|Overall Study|Study Terminated by Sponsor|9|||
23346591|NCT04063657|65011061|FG000|Overall Study|Lost to Follow-up|1|||
23346592|NCT04063657|65011062|FG001|Overall Study|Lost to Follow-up|0|||
23346593|NCT01796197|65011063|FG000|Overall Study|Lost to Follow-up|1|||
23346594|NCT01796197|65011063|FG000|Overall Study|Lack of Efficacy|1|||
23346595|NCT00878969|65011066|FG000|Overall Study|Physician Decision|5|||
23346596|NCT00878969|65011067|FG001|Overall Study|Physician Decision|3|||
23239736|NCT02684370|64622043|FG002|Part B|Subject Withdrawal|0|||
23239737|NCT02684370|64622044|FG003|Part B|Subject Withdrawal|1|||
23239738|NCT02684370|64622045|FG004|Part B|Subject Withdrawal|1|||
23239739|NCT02684370|64622046|FG005|Part B|Subject Withdrawal|2|||
23239740|NCT01711736|64622049|FG000|Overall Study|Lost to Follow-up|4|||
23239741|NCT01711736|64622050|FG001|Overall Study|Lost to Follow-up|1|||
23239742|NCT01711736|64622049|FG000|Overall Study|Withdrawal by Subject|6|||
23239743|NCT01711736|64622050|FG001|Overall Study|Withdrawal by Subject|6|||
23239744|NCT01711736|64622049|FG000|Overall Study|Migrated/moved from study area|2|||
23239745|NCT01711736|64622050|FG001|Overall Study|Migrated/moved from study area|1|||
23239746|NCT02304484|64622051|FG000|Overall Study|Death|9|||
23239747|NCT02304484|64622051|FG000|Overall Study|Withdrawal by Subject|14|||
23239748|NCT02304484|64622051|FG000|Overall Study|Lost to Follow-up|2|||
23239749|NCT03288987|64622052|FG000|Overall Study|Protocol Violation|10|||
23239750|NCT03288987|64622053|FG001|Overall Study|Protocol Violation|4|||
23239751|NCT01694849|64622054|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
23239752|NCT01694849|64622055|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
23239753|NCT01694849|64622056|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
23239754|NCT01694849|64622054|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
23239755|NCT01694849|64622055|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
23239756|NCT01694849|64622056|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
23239757|NCT01694849|64622054|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
23239758|NCT01694849|64622055|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
23239759|NCT01694849|64622056|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
23239760|NCT01694849|64622054|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
23239761|NCT01694849|64622055|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
23239762|NCT01694849|64622056|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
23239763|NCT01694849|64622054|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
23239764|NCT01694849|64622055|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
23239765|NCT01694849|64622056|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
23239766|NCT01694849|64622054|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
23239767|NCT01694849|64622055|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
23239768|NCT01694849|64622056|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
23239769|NCT01694849|64622054|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
23239770|NCT01694849|64622055|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
23239771|NCT01694849|64622056|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
23239772|NCT01694849|64622054|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
23239773|NCT01694849|64622055|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
23239774|NCT01694849|64622056|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
23239775|NCT01396434|64622057|FG000|Overall Study|Lost to Follow-up|1|||
23239776|NCT01396434|64622058|FG001|Overall Study|Lost to Follow-up|0|||
23239777|NCT01396434|64622059|FG002|Overall Study|Lost to Follow-up|0|||
23239778|NCT01396434|64622057|FG000|Overall Study|Other|10|||
23239779|NCT01396434|64622058|FG001|Overall Study|Other|0|||
23239780|NCT01396434|64622059|FG002|Overall Study|Other|0|||
23239781|NCT00083226|64622061|FG000|Overall Study|Lack of Efficacy|19|||
23239782|NCT00083226|64622061|FG000|Overall Study|Adverse Event|9|||
23239783|NCT00083226|64622061|FG000|Overall Study|Death|4|||
23239784|NCT00083226|64622061|FG000|Overall Study|Withdrawal by Subject|4|||
23239785|NCT00083226|64622061|FG000|Overall Study|Other|2|||
23239786|NCT00083226|64622061|FG000|Overall Study|ineligible or not receiving treatment|4|||
23239787|NCT03557775|64622062|FG000|Overall Study|Withdrawal by Subject|1|||
23239788|NCT03557775|64622063|FG001|Overall Study|Withdrawal by Subject|2|||
23239789|NCT03557775|64622064|FG002|Overall Study|Withdrawal by Subject|4|||
23239790|NCT03557775|64622062|FG000|Overall Study|Physician Decision|0|||
23239791|NCT03557775|64622063|FG001|Overall Study|Physician Decision|1|||
23239792|NCT03557775|64622064|FG002|Overall Study|Physician Decision|0|||
23239793|NCT03237325|64622066|FG000|Overall Study|Lost to Follow-up|3|||
23239794|NCT03237325|64622067|FG001|Overall Study|Lost to Follow-up|5|||
23239795|NCT03237325|64622066|FG000|Overall Study|Physician Decision|2|||
23239796|NCT03237325|64622067|FG001|Overall Study|Physician Decision|4|||
23239797|NCT03237325|64622066|FG000|Overall Study|Withdrawal by Subject|9|||
23239798|NCT03237325|64622067|FG001|Overall Study|Withdrawal by Subject|12|||
23239799|NCT03237325|64622066|FG000|Overall Study|Noncompliance with Study Procedures|1|||
23239800|NCT03237325|64622067|FG001|Overall Study|Noncompliance with Study Procedures|1|||
23239801|NCT03237325|64622066|FG000|Overall Study|Termination by Sponsor|0|||
23239802|NCT03237325|64622067|FG001|Overall Study|Termination by Sponsor|1|||
23457821|NCT04750824|65419073|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
23239803|NCT03237325|64622066|FG000|Overall Study|Reason other than described|0|||
23239804|NCT03237325|64622067|FG001|Overall Study|Reason other than described|2|||
23239805|NCT00796367|64622068|FG000|Overall Study|Adverse Event|6|||
23239806|NCT00796367|64622069|FG001|Overall Study|Adverse Event|4|||
23239807|NCT00796367|64622070|FG002|Overall Study|Adverse Event|7|||
23457822|NCT04750824|65419074|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
23239808|NCT00796367|64622068|FG000|Overall Study|Lost to Follow-up|5|||
23239809|NCT00796367|64622069|FG001|Overall Study|Lost to Follow-up|4|||
23179672|NCT00434967|64397739|FG000|Overall Study|Patient Disposition Challenges|2|||
23179673|NCT00434967|64397740|FG001|Overall Study|Patient Disposition Challenges|0|||
23179674|NCT00434967|64397741|FG002|Overall Study|Patient Disposition Challenges|0|||
23179675|NCT00434967|64397742|FG003|Overall Study|Patient Disposition Challenges|3|||
23179676|NCT03075163|64397743|FG000|Overall Study|not eligible for treatment limb|138|||
23179677|NCT03075163|64397744|FG001|Overall Study|not eligible for treatment limb|138|||
23179678|NCT00490542|64397745|FG000|Overall Study|Lost to Follow-up|3|||
23179679|NCT00490542|64397746|FG001|Overall Study|Lost to Follow-up|0|||
23179680|NCT00490542|64397745|FG000|Overall Study|Adverse Event|3|||
23179681|NCT00490542|64397746|FG001|Overall Study|Adverse Event|3|||
23179682|NCT00490542|64397745|FG000|Overall Study|Lack of Efficacy|1|||
23179683|NCT00490542|64397746|FG001|Overall Study|Lack of Efficacy|1|||
23179684|NCT00364182|64397747|FG000|First Intervention|Secondary prophylaxis|1|||
23179685|NCT00364182|64397748|FG001|First Intervention|Secondary prophylaxis|0|||
23179686|NCT00364182|64397749|FG002|First Intervention|Secondary prophylaxis|0|||
23179687|NCT00364182|64397747|FG000|First Intervention|Withdrawal by Subject|2|||
23179688|NCT00364182|64397748|FG001|First Intervention|Withdrawal by Subject|0|||
23179689|NCT00364182|64397749|FG002|First Intervention|Withdrawal by Subject|0|||
23179690|NCT00364182|64397747|FG000|Second Intervention|non-compliance|0|||
23179691|NCT00364182|64397748|FG001|Second Intervention|non-compliance|1|||
23179692|NCT00364182|64397749|FG002|Second Intervention|non-compliance|1|||
23179693|NCT00364182|64397747|FG000|Second Intervention|Protocol Violation|0|||
23179694|NCT00364182|64397748|FG001|Second Intervention|Protocol Violation|1|||
23179695|NCT00364182|64397749|FG002|Second Intervention|Protocol Violation|0|||
23179696|NCT00364182|64397747|FG000|Second Intervention|Adverse Event|0|||
23179697|NCT00364182|64397748|FG001|Second Intervention|Adverse Event|0|||
23179698|NCT00364182|64397749|FG002|Second Intervention|Adverse Event|1|||
23179699|NCT00364182|64397747|FG000|Third Intervention|non-compliance|0|||
23179700|NCT00364182|64397748|FG001|Third Intervention|non-compliance|1|||
23179701|NCT00364182|64397749|FG002|Third Intervention|non-compliance|0|||
23179702|NCT00364182|64397747|FG000|Third Intervention|Lost to Follow-up|0|||
23179703|NCT00364182|64397748|FG001|Third Intervention|Lost to Follow-up|0|||
23179704|NCT00364182|64397749|FG002|Third Intervention|Lost to Follow-up|1|||
23179705|NCT02304926|64397750|FG000|Overall Study|Lost to Follow-up|2|||
23179706|NCT02304926|64397751|FG001|Overall Study|Lost to Follow-up|1|||
23179707|NCT00200850|64397752|FG000|Overall Study|relocation|1|||
23179708|NCT00200850|64397753|FG001|Overall Study|relocation|0|||
23179709|NCT00200850|64397754|FG002|Overall Study|relocation|1|||
23179710|NCT00200850|64397752|FG000|Overall Study|too busy|1|||
23179711|NCT00200850|64397753|FG001|Overall Study|too busy|0|||
23179712|NCT00200850|64397754|FG002|Overall Study|too busy|0|||
23179713|NCT00200850|64397752|FG000|Overall Study|Pregnancy|0|||
23179714|NCT00200850|64397753|FG001|Overall Study|Pregnancy|0|||
23179715|NCT00200850|64397754|FG002|Overall Study|Pregnancy|1|||
23179716|NCT00200850|64397752|FG000|Overall Study|Poor adherence|0|||
23179717|NCT00200850|64397753|FG001|Overall Study|Poor adherence|0|||
23179718|NCT00200850|64397754|FG002|Overall Study|Poor adherence|1|||
23179719|NCT00200850|64397752|FG000|Overall Study|optic neuritis|0|||
23179720|NCT00200850|64397753|FG001|Overall Study|optic neuritis|0|||
23179721|NCT00200850|64397754|FG002|Overall Study|optic neuritis|1|||
23179722|NCT00200850|64397752|FG000|Overall Study|Adverse Event|1|||
23179723|NCT00200850|64397753|FG001|Overall Study|Adverse Event|1|||
23179724|NCT00200850|64397754|FG002|Overall Study|Adverse Event|2|||
23179725|NCT01384292|64397755|FG000|Part B|Severe non-compliance to protocol|1|||
23179726|NCT01384292|64397756|FG001|Part B|Severe non-compliance to protocol|0|||
23179727|NCT01384292|64397757|FG002|Part B|Severe non-compliance to protocol|0|||
23239810|NCT00796367|64622070|FG002|Overall Study|Lost to Follow-up|21|||
23346597|NCT00878969|65011068|FG002|Overall Study|Physician Decision|2|||
23346598|NCT00878969|65011066|FG000|Overall Study|Withdrawal by Subject|1|||
23583627|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23179728|NCT01662648|64397760|FG000|Overall Study|Death|1|||
23179729|NCT01662648|64397761|FG001|Overall Study|Death|3|||
23179730|NCT01662648|64397760|FG000|Overall Study|Adverse Event|40|||
23179731|NCT01662648|64397761|FG001|Overall Study|Adverse Event|37|||
23179732|NCT01662648|64397760|FG000|Overall Study|Lack of Efficacy|17|||
23179733|NCT01662648|64397761|FG001|Overall Study|Lack of Efficacy|16|||
23179734|NCT01662648|64397760|FG000|Overall Study|Participant ineligible to continue trial|1|||
23179735|NCT01662648|64397761|FG001|Overall Study|Participant ineligible to continue trial|1|||
23179736|NCT01662648|64397760|FG000|Overall Study|Lost to Follow-up|24|||
23179737|NCT01662648|64397761|FG001|Overall Study|Lost to Follow-up|36|||
23179738|NCT01662648|64397760|FG000|Overall Study|Withdrawal by Subject|36|||
23239811|NCT00796367|64622068|FG000|Overall Study|Withdrawal by Subject|9|||
23179739|NCT01662648|64397761|FG001|Overall Study|Withdrawal by Subject|53|||
23179740|NCT01662648|64397760|FG000|Overall Study|Participant non-compliant|16|||
23179741|NCT01662648|64397761|FG001|Overall Study|Participant non-compliant|20|||
23179742|NCT01662648|64397760|FG000|Overall Study|Other|8|||
23179743|NCT01662648|64397761|FG001|Overall Study|Other|11|||
23179744|NCT01662648|64397760|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
23179745|NCT01662648|64397761|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
23179746|NCT01662648|64397760|FG000|Overall Study|LOE and other reason unspecified|1|||
23179747|NCT01662648|64397761|FG001|Overall Study|LOE and other reason unspecified|0|||
23179748|NCT01662648|64397760|FG000|Overall Study|LOE and Participant non-compliant|0|||
23179749|NCT01662648|64397761|FG001|Overall Study|LOE and Participant non-compliant|1|||
23179750|NCT01227967|64397762|FG000|Overall Study|Protocol Violation|3|||
23179751|NCT01227967|64397763|FG001|Overall Study|Protocol Violation|1|||
23179752|NCT01227967|64397762|FG000|Overall Study|Death|0|||
23179753|NCT01227967|64397763|FG001|Overall Study|Death|1|||
23179754|NCT01227967|64397762|FG000|Overall Study|Lost to Follow-up|8|||
23179755|NCT01227967|64397763|FG001|Overall Study|Lost to Follow-up|3|||
23179756|NCT01227967|64397762|FG000|Overall Study|Withdrawal by Subject|4|||
23239812|NCT00796367|64622069|FG001|Overall Study|Withdrawal by Subject|11|||
23346599|NCT00878969|65011067|FG001|Overall Study|Withdrawal by Subject|6|||
23346600|NCT00878969|65011068|FG002|Overall Study|Withdrawal by Subject|3|||
23346601|NCT00878969|65011066|FG000|Overall Study|kidney transplant|2|||
23346602|NCT00878969|65011067|FG001|Overall Study|kidney transplant|3|||
23346603|NCT00878969|65011068|FG002|Overall Study|kidney transplant|2|||
23346604|NCT00878969|65011066|FG000|Overall Study|Adverse Event|3|||
23346605|NCT00878969|65011067|FG001|Overall Study|Adverse Event|1|||
23346606|NCT00878969|65011068|FG002|Overall Study|Adverse Event|2|||
23346607|NCT00878969|65011066|FG000|Overall Study|Lost to Follow-up|2|||
23346608|NCT00878969|65011067|FG001|Overall Study|Lost to Follow-up|1|||
23346609|NCT00878969|65011068|FG002|Overall Study|Lost to Follow-up|0|||
23239813|NCT00796367|64622070|FG002|Overall Study|Withdrawal by Subject|12|||
23239814|NCT00796367|64622068|FG000|Overall Study|Lack of Efficacy|2|||
23239815|NCT00796367|64622069|FG001|Overall Study|Lack of Efficacy|1|||
23239816|NCT00796367|64622070|FG002|Overall Study|Lack of Efficacy|0|||
23239817|NCT00796367|64622068|FG000|Overall Study|non compliance|3|||
23239818|NCT00796367|64622069|FG001|Overall Study|non compliance|1|||
23239819|NCT00796367|64622070|FG002|Overall Study|non compliance|1|||
23239820|NCT00796367|64622068|FG000|Overall Study|Pregnancy|1|||
23239821|NCT00796367|64622069|FG001|Overall Study|Pregnancy|0|||
23239822|NCT00796367|64622070|FG002|Overall Study|Pregnancy|1|||
23239823|NCT00796367|64622068|FG000|Overall Study|Requirement for restricted medication|2|||
23239824|NCT00796367|64622069|FG001|Overall Study|Requirement for restricted medication|0|||
23239825|NCT00796367|64622070|FG002|Overall Study|Requirement for restricted medication|2|||
23239826|NCT00796367|64622068|FG000|Overall Study|other|2|||
23239827|NCT00796367|64622069|FG001|Overall Study|other|4|||
23346610|NCT00878969|65011066|FG000|Overall Study|Protocol Violation|2|||
23346611|NCT00878969|65011067|FG001|Overall Study|Protocol Violation|0|||
23346612|NCT00878969|65011068|FG002|Overall Study|Protocol Violation|0|||
23346613|NCT00878969|65011066|FG000|Overall Study|Death|0|||
23346614|NCT00878969|65011067|FG001|Overall Study|Death|0|||
23346615|NCT00878969|65011068|FG002|Overall Study|Death|2|||
23346616|NCT00878969|65011066|FG000|Overall Study|Pregnancy|0|||
23346617|NCT00878969|65011067|FG001|Overall Study|Pregnancy|1|||
23346618|NCT00878969|65011068|FG002|Overall Study|Pregnancy|0|||
23346619|NCT02653170|65011077|FG000|Overall Study|Withdrawal by Subject|3|||
23346620|NCT02653170|65011078|FG001|Overall Study|Withdrawal by Subject|8|||
23346621|NCT02653170|65011079|FG002|Overall Study|Withdrawal by Subject|3|||
23346622|NCT02653170|65011077|FG000|Overall Study|withdrawn by study team|2|||
23346623|NCT02653170|65011078|FG001|Overall Study|withdrawn by study team|4|||
23583628|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583629|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583630|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583631|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583632|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583633|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583634|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583635|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23179757|NCT01227967|64397763|FG001|Overall Study|Withdrawal by Subject|3|||
23179758|NCT01227967|64397762|FG000|Overall Study|Physician Decision|0|||
23179759|NCT01227967|64397763|FG001|Overall Study|Physician Decision|1|||
23179760|NCT01227967|64397762|FG000|Overall Study|Never Started Treatment|0|||
23179761|NCT01227967|64397763|FG001|Overall Study|Never Started Treatment|4|||
23239828|NCT00796367|64622070|FG002|Overall Study|other|3|||
23239829|NCT01610752|64622071|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
23239830|NCT01610752|64622072|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
23239831|NCT01610752|64622073|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
23346624|NCT02653170|65011079|FG002|Overall Study|withdrawn by study team|5|||
23346625|NCT02653170|65011077|FG000|Overall Study|Lost to Follow-up|12|||
23346626|NCT02653170|65011078|FG001|Overall Study|Lost to Follow-up|4|||
23346627|NCT02653170|65011079|FG002|Overall Study|Lost to Follow-up|10|||
23346628|NCT01173055|65011080|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
23346629|NCT01173055|65011081|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
23179762|NCT01227967|64397762|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
23179763|NCT01227967|64397763|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
23179764|NCT01290887|64397764|FG000|Overall Study|Adverse Event|6|||
23179765|NCT01290887|64397765|FG001|Overall Study|Adverse Event|11|||
23179766|NCT01290887|64397764|FG000|Overall Study|Lack of Efficacy|4|||
23179767|NCT01290887|64397765|FG001|Overall Study|Lack of Efficacy|5|||
23179768|NCT01290887|64397764|FG000|Overall Study|Withdrawal by Subject|26|||
23179769|NCT01290887|64397765|FG001|Overall Study|Withdrawal by Subject|32|||
23179770|NCT01290887|64397764|FG000|Overall Study|Protocol Violation|2|||
23179771|NCT01290887|64397765|FG001|Overall Study|Protocol Violation|1|||
23179772|NCT01290887|64397764|FG000|Overall Study|Lost to Follow-up|4|||
23179773|NCT01290887|64397765|FG001|Overall Study|Lost to Follow-up|4|||
23179774|NCT01290887|64397764|FG000|Overall Study|Non-compliance to study procedures|0|||
23179775|NCT01290887|64397765|FG001|Overall Study|Non-compliance to study procedures|1|||
23179776|NCT01290887|64397764|FG000|Overall Study|Non-compliance to study medications|1|||
23179777|NCT01290887|64397765|FG001|Overall Study|Non-compliance to study medications|0|||
23179778|NCT01290887|64397764|FG000|Overall Study|Sponsor closure of study|420|||
23179779|NCT01290887|64397765|FG001|Overall Study|Sponsor closure of study|476|||
23179780|NCT01290887|64397764|FG000|Overall Study|Other|3|||
23179781|NCT01290887|64397765|FG001|Overall Study|Other|6|||
23179782|NCT03283085|64397770|FG000|Overall Study|Adverse Event|18|||
23179783|NCT03283085|64397771|FG001|Overall Study|Adverse Event|3|||
23179784|NCT03283085|64397772|FG002|Overall Study|Adverse Event|13|||
23179785|NCT03283085|64397773|FG003|Overall Study|Adverse Event|0|||
23179786|NCT03283085|64397774|FG004|Overall Study|Adverse Event|0|||
23179787|NCT03283085|64397775|FG005|Overall Study|Adverse Event|5|||
23179788|NCT03283085|64397770|FG000|Overall Study|Death|0|||
23179789|NCT03283085|64397771|FG001|Overall Study|Death|0|||
23179790|NCT03283085|64397772|FG002|Overall Study|Death|3|||
23179791|NCT03283085|64397773|FG003|Overall Study|Death|1|||
23179792|NCT03283085|64397774|FG004|Overall Study|Death|0|||
23179793|NCT03283085|64397775|FG005|Overall Study|Death|0|||
23179794|NCT03283085|64397770|FG000|Overall Study|Withdrawal by Subject|42|||
23179795|NCT03283085|64397771|FG001|Overall Study|Withdrawal by Subject|21|||
23179796|NCT03283085|64397772|FG002|Overall Study|Withdrawal by Subject|66|||
23179797|NCT03283085|64397773|FG003|Overall Study|Withdrawal by Subject|3|||
23179798|NCT03283085|64397774|FG004|Overall Study|Withdrawal by Subject|3|||
23179799|NCT03283085|64397775|FG005|Overall Study|Withdrawal by Subject|5|||
23179800|NCT03283085|64397770|FG000|Overall Study|Physician Decision|14|||
23179801|NCT03283085|64397771|FG001|Overall Study|Physician Decision|8|||
23179802|NCT03283085|64397772|FG002|Overall Study|Physician Decision|19|||
23179803|NCT03283085|64397773|FG003|Overall Study|Physician Decision|0|||
23179804|NCT03283085|64397774|FG004|Overall Study|Physician Decision|0|||
23179805|NCT03283085|64397775|FG005|Overall Study|Physician Decision|2|||
23179806|NCT03283085|64397770|FG000|Overall Study|Site Terminated by Sponsor|1|||
23179807|NCT03283085|64397771|FG001|Overall Study|Site Terminated by Sponsor|0|||
23179808|NCT03283085|64397772|FG002|Overall Study|Site Terminated by Sponsor|3|||
23179809|NCT03283085|64397773|FG003|Overall Study|Site Terminated by Sponsor|0|||
23179810|NCT03283085|64397774|FG004|Overall Study|Site Terminated by Sponsor|0|||
23179811|NCT03283085|64397775|FG005|Overall Study|Site Terminated by Sponsor|0|||
23179812|NCT03283085|64397770|FG000|Overall Study|Lost to Follow-up|2|||
23179813|NCT03283085|64397771|FG001|Overall Study|Lost to Follow-up|0|||
23179814|NCT03283085|64397772|FG002|Overall Study|Lost to Follow-up|2|||
23179815|NCT03283085|64397773|FG003|Overall Study|Lost to Follow-up|0|||
23179816|NCT03283085|64397774|FG004|Overall Study|Lost to Follow-up|0|||
23179817|NCT03283085|64397775|FG005|Overall Study|Lost to Follow-up|1|||
23179818|NCT03283085|64397770|FG000|Overall Study|Pregnancy|0|||
23239832|NCT01729559|64622074|FG000|Overall Study|Protocol Violation|31|||
23239833|NCT01729559|64622075|FG001|Overall Study|Protocol Violation|28|||
23239834|NCT02058849|64622076|FG000|Overall Study|Hospitalization|1|||
23239835|NCT02058849|64622077|FG001|Overall Study|Hospitalization|1|||
23239836|NCT02058849|64622076|FG000|Overall Study|Death|1|||
23239837|NCT02058849|64622077|FG001|Overall Study|Death|0|||
23239838|NCT02058849|64622076|FG000|Overall Study|Lost to Follow-up|1|||
23239839|NCT02058849|64622077|FG001|Overall Study|Lost to Follow-up|0|||
23239840|NCT02058849|64622076|FG000|Overall Study|Withdrawal by Subject|4|||
23346630|NCT01173055|65011080|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
23346631|NCT01173055|65011081|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
23457823|NCT01415882|65419081|FG000|Overall Study|Ineligible|1|||
23179819|NCT03283085|64397771|FG001|Overall Study|Pregnancy|0|||
23179820|NCT03283085|64397772|FG002|Overall Study|Pregnancy|1|||
23179821|NCT03283085|64397773|FG003|Overall Study|Pregnancy|0|||
23179822|NCT03283085|64397774|FG004|Overall Study|Pregnancy|0|||
23179823|NCT03283085|64397775|FG005|Overall Study|Pregnancy|0|||
23179824|NCT03283085|64397770|FG000|Overall Study|Lack of Efficacy|12|||
23179825|NCT03283085|64397771|FG001|Overall Study|Lack of Efficacy|6|||
23179826|NCT03283085|64397772|FG002|Overall Study|Lack of Efficacy|24|||
23239841|NCT02058849|64622077|FG001|Overall Study|Withdrawal by Subject|0|||
23239842|NCT01465958|64622079|FG000|Run-in Phase|Protocol Violation|1|||
23239843|NCT01465958|64622080|FG001|Run-in Phase|Protocol Violation|0|||
23346632|NCT00710684|65011087|FG000|Overall Study|Adverse Event|11|||
23346633|NCT00710684|65011088|FG001|Overall Study|Adverse Event|19|||
23346634|NCT00710684|65011089|FG002|Overall Study|Adverse Event|16|||
23346635|NCT00710684|65011087|FG000|Overall Study|Lack of Efficacy|4|||
23346636|NCT00710684|65011088|FG001|Overall Study|Lack of Efficacy|3|||
23346637|NCT00710684|65011089|FG002|Overall Study|Lack of Efficacy|5|||
23179827|NCT03283085|64397773|FG003|Overall Study|Lack of Efficacy|1|||
23179828|NCT03283085|64397774|FG004|Overall Study|Lack of Efficacy|1|||
23179829|NCT03283085|64397775|FG005|Overall Study|Lack of Efficacy|0|||
23179830|NCT03283085|64397770|FG000|Overall Study|Reason not Specified|0|||
23179831|NCT03283085|64397771|FG001|Overall Study|Reason not Specified|4|||
23179832|NCT03283085|64397772|FG002|Overall Study|Reason not Specified|8|||
23179833|NCT03283085|64397773|FG003|Overall Study|Reason not Specified|0|||
23179834|NCT03283085|64397774|FG004|Overall Study|Reason not Specified|0|||
23179835|NCT03283085|64397775|FG005|Overall Study|Reason not Specified|1|||
23179836|NCT01032629|64397781|FG000|Overall Study|Closed Site|21|||
23179837|NCT01032629|64397782|FG001|Overall Study|Closed Site|18|||
23346638|NCT00710684|65011087|FG000|Overall Study|Protocol Violation|5|||
23179838|NCT01032629|64397783|FG002|Overall Study|Closed Site|16|||
23239844|NCT01465958|64622079|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
23179839|NCT01032629|64397781|FG000|Overall Study|Withdrawal by Subject|50|||
23179840|NCT01032629|64397782|FG001|Overall Study|Withdrawal by Subject|36|||
23346639|NCT00710684|65011088|FG001|Overall Study|Protocol Violation|5|||
23346640|NCT00710684|65011089|FG002|Overall Study|Protocol Violation|5|||
23457824|NCT01415882|65419082|FG001|Overall Study|Ineligible|0|||
23457825|NCT01415882|65419083|FG002|Overall Study|Ineligible|0|||
23457826|NCT01415882|65419084|FG003|Overall Study|Ineligible|3|||
23457827|NCT01415882|65419085|FG004|Overall Study|Ineligible|0|||
23457828|NCT01415882|65419081|FG000|Overall Study|Withdrawal by Subject|0|||
23457829|NCT01415882|65419082|FG001|Overall Study|Withdrawal by Subject|1|||
23457830|NCT01415882|65419083|FG002|Overall Study|Withdrawal by Subject|0|||
23457831|NCT01415882|65419084|FG003|Overall Study|Withdrawal by Subject|1|||
23457832|NCT01415882|65419085|FG004|Overall Study|Withdrawal by Subject|0|||
23457833|NCT03019406|65419088|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
23457834|NCT03019406|65419089|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
23583636|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23179841|NCT01032629|64397783|FG002|Overall Study|Withdrawal by Subject|35|||
23179842|NCT01032629|64397781|FG000|Overall Study|Lost to Follow-up|74|||
23179843|NCT01032629|64397782|FG001|Overall Study|Lost to Follow-up|47|||
23179844|NCT01032629|64397783|FG002|Overall Study|Lost to Follow-up|37|||
23179845|NCT02720757|64397784|FG000|Overall Study|Other reason|5|||
23179846|NCT02720757|64397784|FG000|Overall Study|Loss of contact|4|||
23179847|NCT02720757|64397784|FG000|Overall Study|Informed consent withdrawal|1|||
23179848|NCT02720757|64397784|FG000|Overall Study|Patients wish to withdraw|2|||
23179849|NCT02720757|64397784|FG000|Overall Study|Missing|3|||
23179850|NCT02720757|64397784|FG000|Overall Study|General exclusion|3|||
23239845|NCT01465958|64622080|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
23239846|NCT04652245|64622081|FG000|Wash-Out Period|Adverse Event|0|||
23239847|NCT04652245|64622082|FG001|Wash-Out Period|Adverse Event|2|||
23239848|NCT04652245|64622081|FG000|Wash-Out Period|Withdrawal by Subject|0|||
23239849|NCT04652245|64622082|FG001|Wash-Out Period|Withdrawal by Subject|2|||
23239850|NCT01326312|64622092|FG000|Overall Study|Adverse Event|11|||
23239851|NCT01326312|64622093|FG001|Overall Study|Adverse Event|11|||
23239852|NCT01326312|64622094|FG002|Overall Study|Adverse Event|1|||
23239853|NCT01326312|64622092|FG000|Overall Study|Withdrawal by Subject|1|||
23239854|NCT01326312|64622093|FG001|Overall Study|Withdrawal by Subject|2|||
23239855|NCT01326312|64622094|FG002|Overall Study|Withdrawal by Subject|1|||
23239856|NCT01326312|64622092|FG000|Overall Study|Protocol Violation|0|||
23239857|NCT01326312|64622093|FG001|Overall Study|Protocol Violation|1|||
23239858|NCT01326312|64622094|FG002|Overall Study|Protocol Violation|0|||
23239859|NCT01326312|64622092|FG000|Overall Study|Lack of Efficacy|13|||
23239860|NCT01326312|64622093|FG001|Overall Study|Lack of Efficacy|7|||
23583637|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
23583638|NCT03982199|65866043|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
23457835|NCT03019406|65419090|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
23583639|NCT03982199|65866044|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
23583640|NCT03982199|65866045|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583641|NCT03982199|65866046|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583642|NCT03982199|65866047|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583643|NCT03982199|65866048|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583644|NCT03982199|65866049|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583645|NCT03982199|65866050|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23179851|NCT01731002|64397785|FG000|Overall Study|Adverse Event|0|||
23179852|NCT01731002|64397786|FG001|Overall Study|Adverse Event|2|||
23179853|NCT01731002|64397787|FG002|Overall Study|Adverse Event|2|||
23239861|NCT01326312|64622094|FG002|Overall Study|Lack of Efficacy|1|||
23239862|NCT01326312|64622092|FG000|Overall Study|Death|1|||
23239863|NCT01326312|64622093|FG001|Overall Study|Death|0|||
23179854|NCT01731002|64397785|FG000|Overall Study|Non-Compliant|0|||
23179855|NCT01731002|64397786|FG001|Overall Study|Non-Compliant|1|||
23179856|NCT01731002|64397787|FG002|Overall Study|Non-Compliant|0|||
23179857|NCT01731002|64397785|FG000|Overall Study|Lost to Follow-up|1|||
23179858|NCT01731002|64397786|FG001|Overall Study|Lost to Follow-up|0|||
23179859|NCT01731002|64397787|FG002|Overall Study|Lost to Follow-up|0|||
23179860|NCT01731002|64397785|FG000|Overall Study|Test Agent Discontinuation|0|||
23179861|NCT01731002|64397786|FG001|Overall Study|Test Agent Discontinuation|1|||
23179862|NCT01731002|64397787|FG002|Overall Study|Test Agent Discontinuation|0|||
23179863|NCT01731002|64397785|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
23179864|NCT01731002|64397786|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
23179865|NCT01731002|64397787|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
23179866|NCT01731002|64397785|FG000|Overall Study|Elevated IOP|1|||
23179867|NCT01731002|64397786|FG001|Overall Study|Elevated IOP|0|||
23179868|NCT01731002|64397787|FG002|Overall Study|Elevated IOP|0|||
23179869|NCT01731002|64397785|FG000|Overall Study|Inappropriate use of study medications|0|||
23179870|NCT01731002|64397786|FG001|Overall Study|Inappropriate use of study medications|0|||
23179871|NCT01731002|64397787|FG002|Overall Study|Inappropriate use of study medications|1|||
23179872|NCT00684177|64401670|FG000|Overall Study|Adverse Event|4|||
23179873|NCT00684177|64401671|FG001|Overall Study|Adverse Event|3|||
23179874|NCT00684177|64401670|FG000|Overall Study|Lack of Efficacy|10|||
23179875|NCT00684177|64401671|FG001|Overall Study|Lack of Efficacy|15|||
23179876|NCT00684177|64401670|FG000|Overall Study|Protocol Violation|1|||
23179877|NCT00684177|64401671|FG001|Overall Study|Protocol Violation|0|||
23179878|NCT00684177|64401670|FG000|Overall Study|Lost to Follow-up|2|||
23179879|NCT00684177|64401671|FG001|Overall Study|Lost to Follow-up|1|||
23179880|NCT00684177|64401670|FG000|Overall Study|Physician Decision|2|||
23179881|NCT00684177|64401671|FG001|Overall Study|Physician Decision|0|||
23179882|NCT00684177|64401670|FG000|Overall Study|Withdrawal by Subject|1|||
23179883|NCT00684177|64401671|FG001|Overall Study|Withdrawal by Subject|2|||
23179884|NCT00684177|64401670|FG000|Overall Study|Other|1|||
23179885|NCT00684177|64401671|FG001|Overall Study|Other|2|||
23179886|NCT02731742|64401679|FG000|Overall Study|Death|1|||
23179887|NCT02731742|64401680|FG001|Overall Study|Death|2|||
23179888|NCT02731742|64401681|FG002|Overall Study|Death|5|||
23457836|NCT03019406|65419091|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
23457837|NCT00976274|65419097|FG000|Overall Study|Lost to Follow-up|5|||
23457838|NCT00976274|65419098|FG001|Overall Study|Lost to Follow-up|5|||
23457839|NCT00976274|65419097|FG000|Overall Study|Withdrawal by Subject|1|||
23457840|NCT00976274|65419098|FG001|Overall Study|Withdrawal by Subject|1|||
23457841|NCT00976274|65419097|FG000|Overall Study|Physician Decision|1|||
23346641|NCT00710684|65011087|FG000|Overall Study|Lost to Follow-up|4|||
23346642|NCT00710684|65011088|FG001|Overall Study|Lost to Follow-up|6|||
23346643|NCT00710684|65011089|FG002|Overall Study|Lost to Follow-up|7|||
23346644|NCT00710684|65011087|FG000|Overall Study|Physician Decision|0|||
23346645|NCT00710684|65011088|FG001|Overall Study|Physician Decision|2|||
23346646|NCT00710684|65011089|FG002|Overall Study|Physician Decision|4|||
23346647|NCT00710684|65011087|FG000|Overall Study|Withdrawal by Subject|24|||
23457842|NCT00976274|65419098|FG001|Overall Study|Physician Decision|2|||
23457843|NCT03919773|65419099|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
23457844|NCT03919773|65419100|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
23346648|NCT00710684|65011088|FG001|Overall Study|Withdrawal by Subject|18|||
23457845|NCT03919773|65419099|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
23457846|NCT03919773|65419100|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
23457847|NCT01527149|65419101|FG000|Overall Study|Death|2|||
23457848|NCT02242942|65419102|FG000|Overall Study|Death|17|||
23457849|NCT02242942|65419103|FG001|Overall Study|Death|20|||
23457850|NCT02242942|65419104|FG002|Overall Study|Death|2|||
23457851|NCT02242942|65419102|FG000|Overall Study|Physician Decision|1|||
23457852|NCT02242942|65419103|FG001|Overall Study|Physician Decision|0|||
23457853|NCT02242942|65419104|FG002|Overall Study|Physician Decision|0|||
23179889|NCT02731742|64401682|FG003|Overall Study|Death|0|||
23457854|NCT02242942|65419102|FG000|Overall Study|Withdrawal by Subject|8|||
23457855|NCT02242942|65419103|FG001|Overall Study|Withdrawal by Subject|10|||
23457856|NCT02242942|65419104|FG002|Overall Study|Withdrawal by Subject|0|||
23457857|NCT02242942|65419102|FG000|Overall Study|On-going in Study|190|||
23457858|NCT02242942|65419103|FG001|Overall Study|On-going in Study|186|||
23457859|NCT02242942|65419104|FG002|Overall Study|On-going in Study|11|||
23179890|NCT02731742|64401679|FG000|Overall Study|Physician Decision|0|||
23179891|NCT02731742|64401680|FG001|Overall Study|Physician Decision|0|||
23179892|NCT02731742|64401681|FG002|Overall Study|Physician Decision|0|||
23179893|NCT02731742|64401682|FG003|Overall Study|Physician Decision|1|||
23179894|NCT02731742|64401679|FG000|Overall Study|Study Terminated by Sponsor|2|||
23346649|NCT00710684|65011089|FG002|Overall Study|Withdrawal by Subject|11|||
23346650|NCT00710684|65011087|FG000|Overall Study|Missing|1|||
23346651|NCT00710684|65011088|FG001|Overall Study|Missing|0|||
23457860|NCT01506596|65419105|FG000|Overall Study|ineligible pathology|1|||
23457861|NCT00882440|65419106|FG000|Overall Study|Adverse Event|2|||
23457862|NCT00882440|65419107|FG001|Overall Study|Adverse Event|2|||
23457863|NCT00882440|65419108|FG002|Overall Study|Adverse Event|2|||
23457864|NCT00882440|65419109|FG003|Overall Study|Adverse Event|1|||
23457865|NCT00882440|65419110|FG004|Overall Study|Adverse Event|1|||
23457866|NCT00882440|65419111|FG005|Overall Study|Adverse Event|4|||
23457867|NCT00882440|65419112|FG006|Overall Study|Adverse Event|2|||
23457868|NCT00882440|65419106|FG000|Overall Study|Lack of Efficacy|3|||
23457869|NCT00882440|65419107|FG001|Overall Study|Lack of Efficacy|5|||
23457870|NCT00882440|65419108|FG002|Overall Study|Lack of Efficacy|2|||
23457871|NCT00882440|65419109|FG003|Overall Study|Lack of Efficacy|0|||
23179895|NCT02731742|64401680|FG001|Overall Study|Study Terminated by Sponsor|1|||
23179896|NCT02731742|64401681|FG002|Overall Study|Study Terminated by Sponsor|1|||
23179897|NCT02731742|64401682|FG003|Overall Study|Study Terminated by Sponsor|1|||
23179898|NCT00388947|64401683|FG000|Overall Study|Protocol Violation|47|||
23179899|NCT00862251|64401684|FG000|Overall Study|Adverse Event|8|||
23179900|NCT00862251|64401685|FG001|Overall Study|Adverse Event|3|||
23179901|NCT00862251|64401686|FG002|Overall Study|Adverse Event|1|||
23179902|NCT00862251|64401684|FG000|Overall Study|Lost to Follow-up|0|||
23179903|NCT00862251|64401685|FG001|Overall Study|Lost to Follow-up|0|||
23179904|NCT00862251|64401686|FG002|Overall Study|Lost to Follow-up|1|||
23179905|NCT00862251|64401684|FG000|Overall Study|Protocol Violation|2|||
23179906|NCT00862251|64401685|FG001|Overall Study|Protocol Violation|0|||
23457872|NCT00882440|65419110|FG004|Overall Study|Lack of Efficacy|0|||
23457873|NCT00882440|65419111|FG005|Overall Study|Lack of Efficacy|3|||
23457874|NCT00882440|65419112|FG006|Overall Study|Lack of Efficacy|0|||
23457875|NCT00882440|65419106|FG000|Overall Study|Lost to Follow-up|2|||
23457876|NCT00882440|65419107|FG001|Overall Study|Lost to Follow-up|0|||
23457877|NCT00882440|65419108|FG002|Overall Study|Lost to Follow-up|1|||
23457878|NCT00882440|65419109|FG003|Overall Study|Lost to Follow-up|1|||
23457879|NCT00882440|65419110|FG004|Overall Study|Lost to Follow-up|1|||
23457880|NCT00882440|65419111|FG005|Overall Study|Lost to Follow-up|0|||
23457881|NCT00882440|65419112|FG006|Overall Study|Lost to Follow-up|1|||
23457882|NCT00882440|65419106|FG000|Overall Study|Protocol Violation|0|||
23457883|NCT00882440|65419107|FG001|Overall Study|Protocol Violation|0|||
23457884|NCT00882440|65419108|FG002|Overall Study|Protocol Violation|1|||
23457885|NCT00882440|65419109|FG003|Overall Study|Protocol Violation|1|||
23457886|NCT00882440|65419110|FG004|Overall Study|Protocol Violation|1|||
23457887|NCT00882440|65419111|FG005|Overall Study|Protocol Violation|0|||
23457888|NCT00882440|65419112|FG006|Overall Study|Protocol Violation|0|||
23457889|NCT00882440|65419106|FG000|Overall Study|Withdrawal by Subject|2|||
23457890|NCT00882440|65419107|FG001|Overall Study|Withdrawal by Subject|1|||
23457891|NCT00882440|65419108|FG002|Overall Study|Withdrawal by Subject|1|||
23457892|NCT00882440|65419109|FG003|Overall Study|Withdrawal by Subject|0|||
23457893|NCT00882440|65419110|FG004|Overall Study|Withdrawal by Subject|6|||
23457894|NCT00882440|65419111|FG005|Overall Study|Withdrawal by Subject|0|||
23457895|NCT00882440|65419112|FG006|Overall Study|Withdrawal by Subject|1|||
23457896|NCT00882440|65419106|FG000|Overall Study|Patient Uncooperative|2|||
23457897|NCT00882440|65419107|FG001|Overall Study|Patient Uncooperative|0|||
23457898|NCT00882440|65419108|FG002|Overall Study|Patient Uncooperative|0|||
23457899|NCT00882440|65419109|FG003|Overall Study|Patient Uncooperative|0|||
23457900|NCT00882440|65419110|FG004|Overall Study|Patient Uncooperative|1|||
23457901|NCT00882440|65419111|FG005|Overall Study|Patient Uncooperative|0|||
23179907|NCT00862251|64401686|FG002|Overall Study|Protocol Violation|1|||
23179908|NCT00862251|64401684|FG000|Overall Study|Withdrawal by Subject|9|||
23179909|NCT00862251|64401685|FG001|Overall Study|Withdrawal by Subject|2|||
23457902|NCT00882440|65419112|FG006|Overall Study|Patient Uncooperative|0|||
23457903|NCT02230410|65419113|FG000|Overall Study|Screen Failure|3|||
23457904|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
23457905|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
23457906|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
23457907|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
23457908|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Adverse Event|2|||
23583646|NCT03982199|65866051|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583647|NCT03982199|65866052|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583648|NCT03982199|65866053|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583649|NCT03982199|65866054|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583650|NCT03982199|65866055|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23583651|NCT03982199|65866056|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
23457909|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Adverse Event|5|||
23179910|NCT00862251|64401686|FG002|Overall Study|Withdrawal by Subject|6|||
23179911|NCT02939131|64401687|FG000|Overall Study|Unable to get to clinic|6|||
23179912|NCT02939131|64401688|FG001|Overall Study|Unable to get to clinic|4|||
23179913|NCT02939131|64401687|FG000|Overall Study|Lost to Follow-up|2|||
23179914|NCT02939131|64401688|FG001|Overall Study|Lost to Follow-up|4|||
23179915|NCT02939131|64401687|FG000|Overall Study|severe debilitation|1|||
23346652|NCT00710684|65011089|FG002|Overall Study|Missing|0|||
23346653|NCT00710684|65011087|FG000|Overall Study|Did not continue after week 24|25|||
23346654|NCT00710684|65011088|FG001|Overall Study|Did not continue after week 24|21|||
23346655|NCT00710684|65011089|FG002|Overall Study|Did not continue after week 24|16|||
23346656|NCT01668966|65011090|FG000|Overall Study|Withdrawal by Subject|1|||
23346657|NCT01668966|65011090|FG000|Overall Study|Death|1|||
23346658|NCT01668966|65011090|FG000|Overall Study|Not treated|2|||
23346659|NCT03126019|65011092|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
23346660|NCT03126019|65011093|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
23346661|NCT03126019|65011092|FG000|Overall Study|Death|2|||
23346662|NCT03126019|65011093|FG001|Overall Study|Death|7|||
23346663|NCT03126019|65011092|FG000|Overall Study|Lost to Follow-up|2|||
23346664|NCT03126019|65011093|FG001|Overall Study|Lost to Follow-up|3|||
23346665|NCT03126019|65011092|FG000|Overall Study|Withdrawal by Participant|1|||
23346666|NCT03126019|65011093|FG001|Overall Study|Withdrawal by Participant|3|||
23346667|NCT03126019|65011092|FG000|Overall Study|Reason not Specified|1|||
23346668|NCT03126019|65011093|FG001|Overall Study|Reason not Specified|3|||
23346669|NCT01037127|65011096|FG000|Overall Study|Lost to Follow-up|2|||
23346670|NCT01037127|65011097|FG001|Overall Study|Lost to Follow-up|4|||
23346671|NCT01037127|65011096|FG000|Overall Study|Physician Decision|1|||
23346672|NCT01037127|65011097|FG001|Overall Study|Physician Decision|0|||
23346673|NCT01037127|65011096|FG000|Overall Study|Study Closed Terminated|2|||
23346674|NCT01037127|65011097|FG001|Overall Study|Study Closed Terminated|17|||
23346675|NCT02609724|65011098|FG000|Overall Study|Death|2|||
23346676|NCT02609724|65011099|FG001|Overall Study|Death|0|||
23346677|NCT02609724|65011100|FG002|Overall Study|Death|1|||
23346678|NCT02609724|65011098|FG000|Overall Study|Withdrawal by Subject|1|||
23346679|NCT02609724|65011099|FG001|Overall Study|Withdrawal by Subject|2|||
23346680|NCT02609724|65011100|FG002|Overall Study|Withdrawal by Subject|3|||
23346681|NCT02609724|65011098|FG000|Overall Study|Illness|2|||
23346682|NCT02609724|65011099|FG001|Overall Study|Illness|1|||
23346683|NCT02609724|65011100|FG002|Overall Study|Illness|0|||
23346684|NCT02002533|65011101|FG000|Overall Study|Withdrawal by Subject|6|||
23346685|NCT02002533|65011102|FG001|Overall Study|Withdrawal by Subject|13|||
23346686|NCT02002533|65011101|FG000|Overall Study|Protocol Violation|0|||
23346687|NCT02002533|65011102|FG001|Overall Study|Protocol Violation|1|||
23346688|NCT02002533|65011101|FG000|Overall Study|Adverse Event|0|||
23346689|NCT02002533|65011102|FG001|Overall Study|Adverse Event|3|||
23346690|NCT02002533|65011101|FG000|Overall Study|Lost to Follow-up|0|||
23346691|NCT02002533|65011102|FG001|Overall Study|Lost to Follow-up|1|||
23346692|NCT01088243|65011103|FG000|Overall Study|Adverse Event|1|||
23346693|NCT01088243|65011104|FG001|Overall Study|Adverse Event|0|||
23346694|NCT02817516|65011105|FG000|Overall Study|Other|0|||
23346695|NCT02817516|65011106|FG001|Overall Study|Other|0|||
23346696|NCT02817516|65011107|FG002|Overall Study|Other|1|||
23346697|NCT02817516|65011108|FG003|Overall Study|Other|0|||
23346698|NCT01793688|65011109|FG000|Overall Study|Protocol Violation|2|||
23346699|NCT02607306|65011110|FG000|Overall Study|Adverse Event|8|||
23346700|NCT02607306|65011111|FG001|Overall Study|Adverse Event|6|||
23346701|NCT02607306|65011112|FG002|Overall Study|Adverse Event|6|||
23346702|NCT02607306|65011110|FG000|Overall Study|Unclassified|1|||
23346703|NCT02607306|65011111|FG001|Overall Study|Unclassified|4|||
23346704|NCT02607306|65011112|FG002|Overall Study|Unclassified|0|||
23346705|NCT02607306|65011110|FG000|Overall Study|Withdrawal by Subject|8|||
23346706|NCT02607306|65011111|FG001|Overall Study|Withdrawal by Subject|10|||
23346707|NCT02607306|65011112|FG002|Overall Study|Withdrawal by Subject|2|||
23346708|NCT02607306|65011110|FG000|Overall Study|Lack of Efficacy|0|||
23346709|NCT02607306|65011111|FG001|Overall Study|Lack of Efficacy|1|||
23346710|NCT02607306|65011112|FG002|Overall Study|Lack of Efficacy|1|||
23346711|NCT02607306|65011110|FG000|Overall Study|Protocol Violation|4|||
23346712|NCT02607306|65011111|FG001|Overall Study|Protocol Violation|2|||
23346713|NCT02607306|65011112|FG002|Overall Study|Protocol Violation|1|||
23179916|NCT02939131|64401688|FG001|Overall Study|severe debilitation|0|||
23346714|NCT02791438|65011113|FG000|Treatment Period|Adverse Event|1|||
23346715|NCT02791438|65011114|FG001|Treatment Period|Adverse Event|0|||
23346716|NCT02791438|65011113|FG000|Treatment Period|Withdrawal by Subject|0|||
23346717|NCT02791438|65011114|FG001|Treatment Period|Withdrawal by Subject|1|||
23346718|NCT02791438|65011113|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
23346719|NCT02791438|65011114|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
23346720|NCT03954041|65011115|FG000|Overall Study|Lost to Follow-up|3|||
23346721|NCT03954041|65011116|FG001|Overall Study|Lost to Follow-up|3|||
23346722|NCT03954041|65011117|FG002|Overall Study|Lost to Follow-up|6|||
23346723|NCT03954041|65011115|FG000|Overall Study|Death|4|||
23346724|NCT03954041|65011116|FG001|Overall Study|Death|0|||
23457910|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Adverse Event|1|||
23457911|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Adverse Event|2|||
23457912|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Death|13|||
23457913|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Death|17|||
23457914|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Death|1|||
23457915|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Death|0|||
23457916|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
23457917|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
23457918|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
23457919|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
23457920|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Disease Progression|2|||
23457921|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Disease Progression|0|||
23457922|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Disease Progression|0|||
23457923|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Disease Progression|0|||
23457924|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
23457925|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
23457926|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
23457927|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
23457928|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
23457929|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
23457930|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
23457931|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
23457932|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
23457933|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
23457934|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
23457935|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
23457936|NCT03955146|65419116|FG000|DB Period (48 Weeks)|Participant Decision|9|||
23457937|NCT03955146|65419117|FG001|DB Period (48 Weeks)|Participant Decision|12|||
23457938|NCT03955146|65419118|FG002|DB Period (48 Weeks)|Participant Decision|1|||
23457939|NCT03955146|65419119|FG003|DB Period (48 Weeks)|Participant Decision|1|||
23457940|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
23457941|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
23457942|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
23457943|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
23457944|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
23457945|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
23457946|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
23457947|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
23457948|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
23457949|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
23457950|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
23457951|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
23457952|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
23457953|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
23457954|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
23457955|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
23457956|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
23457957|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
23457958|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
23457959|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
23457960|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
23457961|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
23457962|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
23457963|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
23457964|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
23457965|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
23457966|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
23457967|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
23457968|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
23457969|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
23457970|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
23457971|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
23457972|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
23457973|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
23583652|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23457974|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
23457975|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
23457976|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
23457977|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
23457978|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
23457979|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
23457980|NCT03955146|65419116|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
23457981|NCT03955146|65419117|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
23457982|NCT03955146|65419118|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
23457983|NCT03955146|65419119|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
23457984|NCT04780061|65419122|FG000|Overall Study|Withdrawal by Subject|5|||
23457985|NCT04780061|65419123|FG001|Overall Study|Withdrawal by Subject|8|||
23457986|NCT04780061|65419122|FG000|Overall Study|Adverse Event|2|||
23457987|NCT04780061|65419123|FG001|Overall Study|Adverse Event|2|||
23457988|NCT04780061|65419122|FG000|Overall Study|Lost to Follow-up|1|||
23457989|NCT04780061|65419123|FG001|Overall Study|Lost to Follow-up|5|||
23457990|NCT03532451|65419124|FG000|Overall Study|Withdrawal by Subject|0|||
23457991|NCT03532451|65419125|FG001|Overall Study|Withdrawal by Subject|1|||
23457992|NCT03532451|65419124|FG000|Overall Study|Did not undergo surgery|1|||
23457993|NCT03532451|65419125|FG001|Overall Study|Did not undergo surgery|1|||
23457994|NCT05316597|65419126|FG000|First Session|Withdrawal by Subject|0|||
23457995|NCT05316597|65419127|FG001|First Session|Withdrawal by Subject|1|||
23457996|NCT05316597|65419126|FG000|Washout Period|Lost to Follow-up|1|||
23457997|NCT05316597|65419127|FG001|Washout Period|Lost to Follow-up|2|||
23457998|NCT05316597|65419126|FG000|Washout Period|Physician Decision|1|||
23457999|NCT05316597|65419127|FG001|Washout Period|Physician Decision|1|||
23458000|NCT05316597|65419126|FG000|Washout Period|Excluded before second session|1|||
23458001|NCT05316597|65419127|FG001|Washout Period|Excluded before second session|1|||
23458002|NCT05316597|65419126|FG000|Washout Period|Withdrawal by Subject|0|||
23458003|NCT05316597|65419127|FG001|Washout Period|Withdrawal by Subject|4|||
23458004|NCT05720897|65419128|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
23458005|NCT05720897|65419129|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
23458006|NCT01772472|65419130|FG000|Overall Study|Death|56|||
23458007|NCT01772472|65419131|FG001|Overall Study|Death|42|||
23458008|NCT01772472|65419130|FG000|Overall Study|Physician Decision|1|||
23458009|NCT01772472|65419131|FG001|Overall Study|Physician Decision|3|||
23458010|NCT01772472|65419130|FG000|Overall Study|Other|5|||
23458011|NCT01772472|65419131|FG001|Overall Study|Other|5|||
23458012|NCT01772472|65419130|FG000|Overall Study|Lost to Follow-up|12|||
23458013|NCT01772472|65419131|FG001|Overall Study|Lost to Follow-up|8|||
23458014|NCT01772472|65419130|FG000|Overall Study|Withdrawal by Subject|72|||
23458015|NCT01772472|65419131|FG001|Overall Study|Withdrawal by Subject|50|||
23458016|NCT01772472|65419130|FG000|Overall Study|Ongoing|597|||
23458017|NCT01772472|65419131|FG001|Overall Study|Ongoing|635|||
23458018|NCT04825678|65419132|FG000|Overall Study|Decision by Sponsor|2|||
23458019|NCT04825678|65419133|FG001|Overall Study|Decision by Sponsor|3|||
23458020|NCT04825678|65419132|FG000|Overall Study|Withdrawal of Consent From Study|7|||
23458021|NCT04825678|65419133|FG001|Overall Study|Withdrawal of Consent From Study|9|||
23458022|NCT04825678|65419132|FG000|Overall Study|Lost to Follow-up|3|||
23458023|NCT04825678|65419133|FG001|Overall Study|Lost to Follow-up|4|||
23458024|NCT04825678|65419132|FG000|Overall Study|Never Received Investigational Product|1|||
23458025|NCT04825678|65419133|FG001|Overall Study|Never Received Investigational Product|1|||
23458026|NCT05635461|65419136|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458027|NCT05635461|65419137|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458028|NCT05635461|65419138|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458029|NCT05635461|65419139|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458030|NCT05635461|65419140|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
23458031|NCT05635461|65419141|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
23458032|NCT05635461|65419136|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23458033|NCT05635461|65419137|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
23458034|NCT05635461|65419138|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23458035|NCT05635461|65419139|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23458036|NCT05635461|65419140|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23179917|NCT02939131|64401687|FG000|Overall Study|Other|0|||
23179918|NCT02939131|64401688|FG001|Overall Study|Other|1|||
23179919|NCT02939131|64401687|FG000|Overall Study|not willing to adhere to protocol|2|||
23179920|NCT02939131|64401688|FG001|Overall Study|not willing to adhere to protocol|0|||
23458037|NCT05635461|65419141|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
23458038|NCT05635461|65419136|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23458039|NCT05635461|65419137|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23458040|NCT05635461|65419138|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23458041|NCT05635461|65419139|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
23458042|NCT05635461|65419140|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23179921|NCT00611247|64401689|FG000|Overall Study|Death|1|||
23179922|NCT00611247|64401690|FG001|Overall Study|Death|5|||
23179923|NCT00611247|64401689|FG000|Overall Study|Lack of Efficacy|1|||
23179924|NCT00611247|64401690|FG001|Overall Study|Lack of Efficacy|16|||
23458043|NCT05635461|65419141|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
23458044|NCT03279081|65419144|FG000|Overall Study|Withdrawal by Subject|12|||
23458045|NCT03279081|65419145|FG001|Overall Study|Withdrawal by Subject|20|||
23458046|NCT03279081|65419144|FG000|Overall Study|Physician Decision|4|||
23458047|NCT03279081|65419145|FG001|Overall Study|Physician Decision|1|||
23458048|NCT03279081|65419144|FG000|Overall Study|Lost to Follow-up|8|||
23458049|NCT03279081|65419145|FG001|Overall Study|Lost to Follow-up|8|||
23458050|NCT03279081|65419144|FG000|Overall Study|Death|0|||
23458051|NCT03279081|65419145|FG001|Overall Study|Death|1|||
23458052|NCT03279081|65419144|FG000|Overall Study|Adverse Event|1|||
23458053|NCT03279081|65419145|FG001|Overall Study|Adverse Event|0|||
23458054|NCT03279081|65419144|FG000|Overall Study|Reason not Specified|14|||
23458055|NCT03279081|65419145|FG001|Overall Study|Reason not Specified|4|||
23458056|NCT02060721|65419148|FG000|Overall Study|Lost to Follow-up|1|||
23458057|NCT02060721|65419148|FG000|Overall Study|Physician Decision|2|||
23458058|NCT02060721|65419148|FG000|Overall Study|Death|14|||
23458059|NCT02060721|65419148|FG000|Overall Study|Withdrawal by Subject|2|||
23458060|NCT02060721|65419148|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
23458061|NCT05082857|65419149|FG000|Overall Study|participants relocated and could not continue|2|||
23458062|NCT05082857|65419150|FG001|Overall Study|participants relocated and could not continue|1|||
23458063|NCT05082857|65419149|FG000|Overall Study|Lost to Follow-up|1|||
23458064|NCT05082857|65419150|FG001|Overall Study|Lost to Follow-up|3|||
23458065|NCT00581308|65419151|FG000|Pre Discharge|Lost to Follow-up|1|||
23458066|NCT00581308|65419151|FG000|Pre Discharge|Device Removed|1|||
23458067|NCT00581308|65419151|FG000|Month 1|Lost to Follow-up|3|||
23458068|NCT00581308|65419151|FG000|Month 1|Withdrawal by Subject|2|||
23458069|NCT00581308|65419151|FG000|Month 1|Device Removed|2|||
23458070|NCT00581308|65419151|FG000|Month 1|Uknown|1|||
23458071|NCT00581308|65419151|FG000|Month 6|Lost to Follow-up|1|||
23458072|NCT00581308|65419151|FG000|Month 6|Withdrawal by Subject|2|||
23458073|NCT00581308|65419151|FG000|Month 12|Death|1|||
23458074|NCT00581308|65419151|FG000|Month 12|Lost to Follow-up|14|||
23458075|NCT00581308|65419151|FG000|Month 12|Withdrawal by Subject|3|||
23458076|NCT00581308|65419151|FG000|Month 12|Device Removed|1|||
23458077|NCT00581308|65419151|FG000|Month 12|Other|1|||
23458078|NCT04532528|65419155|FG000|Overall Study|Adverse Event|12|||
23458079|NCT04532528|65419156|FG001|Overall Study|Adverse Event|17|||
23458080|NCT04532528|65419155|FG000|Overall Study|Withdrawal of consent|16|||
23458081|NCT04532528|65419156|FG001|Overall Study|Withdrawal of consent|17|||
23458082|NCT04532528|65419155|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
23458083|NCT04532528|65419156|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
23458084|NCT04532528|65419155|FG000|Overall Study|Lost to Follow-up|69|||
23458085|NCT04532528|65419156|FG001|Overall Study|Lost to Follow-up|68|||
23458086|NCT04532528|65419155|FG000|Overall Study|Administrative problems|12|||
23458087|NCT04532528|65419156|FG001|Overall Study|Administrative problems|14|||
23458088|NCT04532528|65419155|FG000|Overall Study|Death|3|||
23458089|NCT04532528|65419156|FG001|Overall Study|Death|3|||
23458090|NCT04532528|65419155|FG000|Overall Study|Other|38|||
23458091|NCT04532528|65419156|FG001|Overall Study|Other|46|||
23458092|NCT05615922|65419162|FG000|Overall Study|Lost to Follow-up|1|||
23458093|NCT03104868|65419163|FG000|6 Week Follow up|Lost to Follow-up|5|||
23458094|NCT03104868|65419164|FG001|6 Week Follow up|Lost to Follow-up|8|||
23458095|NCT03104868|65419163|FG000|6 Week Follow up|Death|1|||
23458096|NCT03104868|65419164|FG001|6 Week Follow up|Death|1|||
23458097|NCT03104868|65419163|FG000|6 Week Follow up|Withdrawal by Subject|7|||
23458098|NCT03104868|65419164|FG001|6 Week Follow up|Withdrawal by Subject|6|||
23458099|NCT03104868|65419163|FG000|6 Week Follow up|Completed Later Timepoint|24|||
23458100|NCT03104868|65419164|FG001|6 Week Follow up|Completed Later Timepoint|22|||
23458101|NCT03104868|65419163|FG000|6 Month Follow up|Lost to Follow-up|2|||
23458102|NCT03104868|65419164|FG001|6 Month Follow up|Lost to Follow-up|2|||
23239864|NCT01326312|64622094|FG002|Overall Study|Death|1|||
23239865|NCT01326312|64622092|FG000|Overall Study|progressive disease|0|||
23458103|NCT03104868|65419163|FG000|6 Month Follow up|Death|0|||
23458104|NCT03104868|65419164|FG001|6 Month Follow up|Death|1|||
23458105|NCT03104868|65419163|FG000|6 Month Follow up|Completed Later Timepoint|22|||
23458106|NCT03104868|65419164|FG001|6 Month Follow up|Completed Later Timepoint|32|||
23458107|NCT03104868|65419163|FG000|12 Month Follow up|Lost to Follow-up|1|||
23458108|NCT03104868|65419164|FG001|12 Month Follow up|Lost to Follow-up|2|||
23458109|NCT03104868|65419163|FG000|12 Month Follow up|Death|0|||
23458110|NCT03104868|65419164|FG001|12 Month Follow up|Death|1|||
23458111|NCT03104868|65419163|FG000|12 Month Follow up|Withdrawal by Subject|0|||
23458112|NCT03104868|65419164|FG001|12 Month Follow up|Withdrawal by Subject|3|||
23458113|NCT03104868|65419163|FG000|12 Month Follow up|Completed Later Timepoint|32|||
23458114|NCT03104868|65419164|FG001|12 Month Follow up|Completed Later Timepoint|29|||
23239866|NCT01326312|64622093|FG001|Overall Study|progressive disease|1|||
23458115|NCT03104868|65419163|FG000|18 Month Follow up|Lost to Follow-up|7|||
23458116|NCT03104868|65419164|FG001|18 Month Follow up|Lost to Follow-up|11|||
23458117|NCT03104868|65419163|FG000|18 Month Follow up|Death|2|||
23458118|NCT03104868|65419164|FG001|18 Month Follow up|Death|1|||
23458119|NCT03104868|65419163|FG000|18 Month Follow up|Withdrawal by Subject|1|||
23458120|NCT03104868|65419164|FG001|18 Month Follow up|Withdrawal by Subject|2|||
23458121|NCT03104868|65419163|FG000|18 Month Follow up|Graft Loss|1|||
23458122|NCT03104868|65419164|FG001|18 Month Follow up|Graft Loss|1|||
23458123|NCT03104868|65419163|FG000|18 Month Follow up|Completed Later Timepoint|19|||
23458124|NCT03104868|65419164|FG001|18 Month Follow up|Completed Later Timepoint|20|||
23458125|NCT03104868|65419163|FG000|24 Month Follow up|Lost to Follow-up|15|||
23458126|NCT03104868|65419164|FG001|24 Month Follow up|Lost to Follow-up|16|||
23458127|NCT03104868|65419163|FG000|24 Month Follow up|Death|3|||
23458128|NCT03104868|65419164|FG001|24 Month Follow up|Death|2|||
23458129|NCT03104868|65419163|FG000|24 Month Follow up|Withdrawal by Subject|1|||
23458130|NCT03104868|65419164|FG001|24 Month Follow up|Withdrawal by Subject|0|||
23458131|NCT03104868|65419163|FG000|24 Month Follow up|Graft Loss|2|||
23458132|NCT03104868|65419164|FG001|24 Month Follow up|Graft Loss|0|||
23458133|NCT04338321|65419165|FG000|Overall Study|Adverse Event|4|||
23179925|NCT00510276|64401692|FG000|Acute Double-Blind Phase|Adverse Event|21|||
23179926|NCT00510276|64401693|FG001|Acute Double-Blind Phase|Adverse Event|6|||
23179927|NCT00510276|64401692|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
23179928|NCT00510276|64401693|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
23179929|NCT00510276|64401692|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
23179930|NCT00510276|64401693|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
23179931|NCT00510276|64401692|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
23179932|NCT00510276|64401693|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
23179933|NCT00510276|64401692|FG000|Acute Double-Blind Phase|Physician Decision|0|||
23179934|NCT00510276|64401693|FG001|Acute Double-Blind Phase|Physician Decision|3|||
23179935|NCT00510276|64401692|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
23179936|NCT00510276|64401693|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
23179937|NCT00510276|64401692|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
23179938|NCT00510276|64401693|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
23179939|NCT00510276|64401692|FG000|Acute Double-Blind Phase|Subject Decision|26|||
23179940|NCT00510276|64401693|FG001|Acute Double-Blind Phase|Subject Decision|28|||
23179941|NCT00510276|64401692|FG000|Extension Open-Label Phase|Adverse Event|9|||
23179942|NCT00510276|64401693|FG001|Extension Open-Label Phase|Adverse Event|18|||
23458134|NCT04338321|65419166|FG001|Overall Study|Adverse Event|10|||
23458135|NCT04338321|65419165|FG000|Overall Study|Death|1|||
23458136|NCT04338321|65419166|FG001|Overall Study|Death|1|||
23458137|NCT04338321|65419165|FG000|Overall Study|Lost to Follow-up|4|||
23458138|NCT04338321|65419166|FG001|Overall Study|Lost to Follow-up|9|||
23179943|NCT00510276|64401692|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
23179944|NCT00510276|64401693|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
23458139|NCT04338321|65419165|FG000|Overall Study|Withdrawal by Subject|45|||
23458140|NCT04338321|65419166|FG001|Overall Study|Withdrawal by Subject|69|||
23458141|NCT04338321|65419165|FG000|Overall Study|Physician Decision|5|||
23458142|NCT04338321|65419166|FG001|Overall Study|Physician Decision|9|||
23458143|NCT04338321|65419165|FG000|Overall Study|Other|3|||
23458144|NCT04338321|65419166|FG001|Overall Study|Other|10|||
23458145|NCT03562195|65419169|FG000|Overall Study|Adverse Event|0|||
23458146|NCT03562195|65419170|FG001|Overall Study|Adverse Event|6|||
23458147|NCT03562195|65419169|FG000|Overall Study|Lack of Efficacy|0|||
23458148|NCT03562195|65419170|FG001|Overall Study|Lack of Efficacy|5|||
23458149|NCT03562195|65419169|FG000|Overall Study|Protocol Violation|0|||
23458150|NCT03562195|65419170|FG001|Overall Study|Protocol Violation|1|||
23458151|NCT03562195|65419169|FG000|Overall Study|Lost to Follow-up|0|||
23458152|NCT03562195|65419170|FG001|Overall Study|Lost to Follow-up|1|||
23458153|NCT03562195|65419169|FG000|Overall Study|Physician Decision|1|||
23458154|NCT03562195|65419170|FG001|Overall Study|Physician Decision|0|||
23458155|NCT03562195|65419169|FG000|Overall Study|Withdrawal by Subject|3|||
23458156|NCT03562195|65419170|FG001|Overall Study|Withdrawal by Subject|0|||
23458157|NCT05119569|65419174|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
23458158|NCT05119569|65419175|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
23458159|NCT05119569|65419176|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
23179945|NCT00510276|64401692|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
23458160|NCT05119569|65419177|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
23458161|NCT05119569|65419174|FG000|Double Blind Treatment Phase|Adverse Event|6|||
23458162|NCT05119569|65419175|FG001|Double Blind Treatment Phase|Adverse Event|0|||
23458163|NCT05119569|65419176|FG002|Double Blind Treatment Phase|Adverse Event|0|||
23458164|NCT05119569|65419177|FG003|Double Blind Treatment Phase|Adverse Event|0|||
23458165|NCT05119569|65419174|FG000|Open Label Extension Phase|Ongoing in the study|0|||
23458166|NCT05119569|65419175|FG001|Open Label Extension Phase|Ongoing in the study|0|||
23179946|NCT00510276|64401693|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
23179947|NCT00510276|64401692|FG000|Extension Open-Label Phase|Physician Decision|2|||
23179948|NCT00510276|64401693|FG001|Extension Open-Label Phase|Physician Decision|3|||
23458167|NCT05119569|65419176|FG002|Open Label Extension Phase|Ongoing in the study|65|||
23458168|NCT05119569|65419177|FG003|Open Label Extension Phase|Ongoing in the study|34|||
23458169|NCT03199976|65419178|FG000|Overall Study|Lack of Efficacy|3|||
23458170|NCT03199976|65419179|FG001|Overall Study|Lack of Efficacy|6|||
23458171|NCT03199976|65419180|FG002|Overall Study|Lack of Efficacy|13|||
23458172|NCT03199976|65419178|FG000|Overall Study|Withdrawal by Subject|1|||
23458173|NCT03199976|65419179|FG001|Overall Study|Withdrawal by Subject|0|||
23458174|NCT03199976|65419180|FG002|Overall Study|Withdrawal by Subject|0|||
23458175|NCT03199976|65419178|FG000|Overall Study|Lost to Follow-up|0|||
23458176|NCT03199976|65419179|FG001|Overall Study|Lost to Follow-up|1|||
23458177|NCT03199976|65419180|FG002|Overall Study|Lost to Follow-up|1|||
23239867|NCT01326312|64622094|FG002|Overall Study|progressive disease|1|||
23239868|NCT01326312|64622092|FG000|Overall Study|Study terminated by Sponsor|8|||
23239869|NCT01326312|64622093|FG001|Overall Study|Study terminated by Sponsor|32|||
23239870|NCT01326312|64622094|FG002|Overall Study|Study terminated by Sponsor|46|||
23239871|NCT01326312|64622092|FG000|Overall Study|Treatment arm terminated|19|||
23239872|NCT01326312|64622093|FG001|Overall Study|Treatment arm terminated|0|||
23239873|NCT01326312|64622094|FG002|Overall Study|Treatment arm terminated|0|||
23239874|NCT01326312|64622092|FG000|Overall Study|QTc > 500|0|||
23239875|NCT01326312|64622093|FG001|Overall Study|QTc > 500|1|||
23239876|NCT01326312|64622094|FG002|Overall Study|QTc > 500|0|||
23239877|NCT03358407|64622096|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23239878|NCT03358407|64622097|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23239879|NCT03358407|64622098|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
23239880|NCT03358407|64622099|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23239881|NCT03358407|64622100|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23239882|NCT03358407|64622101|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23239883|NCT03358407|64622102|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23239884|NCT03358407|64622103|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23239885|NCT03358407|64622104|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23239886|NCT03358407|64622105|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
23239887|NCT03358407|64622096|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239888|NCT03358407|64622097|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239889|NCT03358407|64622098|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239890|NCT03358407|64622099|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239891|NCT03358407|64622100|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
23239892|NCT03358407|64622101|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239893|NCT03358407|64622102|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239894|NCT03358407|64622103|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239895|NCT03358407|64622104|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239896|NCT03358407|64622105|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239897|NCT03358407|64622096|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23239898|NCT03358407|64622097|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23239899|NCT03358407|64622098|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23239900|NCT03358407|64622099|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23239901|NCT03358407|64622100|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23239902|NCT03358407|64622101|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
23239903|NCT03358407|64622102|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23239904|NCT03358407|64622103|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
23239905|NCT03358407|64622104|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23239906|NCT03358407|64622105|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
23239907|NCT03358407|64622096|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23239908|NCT03358407|64622097|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23239909|NCT03358407|64622098|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23239910|NCT03358407|64622099|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23239911|NCT03358407|64622100|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23239912|NCT03358407|64622101|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
23239913|NCT03358407|64622102|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23239914|NCT03358407|64622103|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
23346725|NCT03954041|65011117|FG002|Overall Study|Death|1|||
23346726|NCT03954041|65011115|FG000|Overall Study|Death by neurologic criteria|0|||
23346727|NCT03954041|65011116|FG001|Overall Study|Death by neurologic criteria|0|||
23346728|NCT03954041|65011117|FG002|Overall Study|Death by neurologic criteria|1|||
23346729|NCT03954041|65011115|FG000|Overall Study|Reason not specified|7|||
23346730|NCT03954041|65011116|FG001|Overall Study|Reason not specified|4|||
23346731|NCT03954041|65011117|FG002|Overall Study|Reason not specified|2|||
23346732|NCT03954041|65011115|FG000|Overall Study|Withdrew prior to dosing|4|||
23346733|NCT03954041|65011116|FG001|Overall Study|Withdrew prior to dosing|2|||
23346734|NCT03954041|65011117|FG002|Overall Study|Withdrew prior to dosing|0|||
23458178|NCT05712460|65419181|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458179|NCT05712460|65419182|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23179949|NCT00510276|64401692|FG000|Extension Open-Label Phase|Protocol Violation|0|||
23179950|NCT00510276|64401693|FG001|Extension Open-Label Phase|Protocol Violation|1|||
23179951|NCT00510276|64401692|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
23179952|NCT00510276|64401693|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
23179953|NCT00510276|64401692|FG000|Extension Open-Label Phase|Subject Decision|7|||
23179954|NCT00510276|64401693|FG001|Extension Open-Label Phase|Subject Decision|9|||
23179955|NCT00618748|64401696|FG000|Overall Study|Adverse Event|4|||
23179956|NCT00618748|64401697|FG001|Overall Study|Adverse Event|3|||
23179957|NCT00618748|64401698|FG002|Overall Study|Adverse Event|8|||
23179958|NCT00618748|64401696|FG000|Overall Study|Physician Decision|3|||
23179959|NCT00618748|64401697|FG001|Overall Study|Physician Decision|1|||
23179960|NCT00618748|64401698|FG002|Overall Study|Physician Decision|1|||
23179961|NCT00618748|64401696|FG000|Overall Study|Withdrawal by Subject|4|||
23179962|NCT00618748|64401697|FG001|Overall Study|Withdrawal by Subject|1|||
23179963|NCT00618748|64401698|FG002|Overall Study|Withdrawal by Subject|5|||
23179964|NCT00934102|64401702|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
23179965|NCT00934102|64401703|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
23179966|NCT00934102|64401704|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
23179967|NCT01431287|64401709|FG000|Overall Study|not treated|0|||
23179968|NCT01431287|64401710|FG001|Overall Study|not treated|0|||
23179969|NCT01431287|64401711|FG002|Overall Study|not treated|1|||
23179970|NCT01431287|64401712|FG003|Overall Study|not treated|0|||
23179971|NCT01431287|64401713|FG004|Overall Study|not treated|0|||
23179972|NCT01431287|64401709|FG000|Overall Study|Adverse Event|59|||
23179973|NCT01431287|64401710|FG001|Overall Study|Adverse Event|57|||
23179974|NCT01431287|64401711|FG002|Overall Study|Adverse Event|53|||
23179975|NCT01431287|64401712|FG003|Overall Study|Adverse Event|33|||
23179976|NCT01431287|64401713|FG004|Overall Study|Adverse Event|41|||
23239915|NCT03358407|64622104|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23346735|NCT00435019|65011128|FG000|Overall Study|Adverse Event|1|||
23179977|NCT01431287|64401709|FG000|Overall Study|Non compliant with protocol|6|||
23179978|NCT01431287|64401710|FG001|Overall Study|Non compliant with protocol|6|||
23179979|NCT01431287|64401711|FG002|Overall Study|Non compliant with protocol|5|||
23179980|NCT01431287|64401712|FG003|Overall Study|Non compliant with protocol|6|||
23179981|NCT01431287|64401713|FG004|Overall Study|Non compliant with protocol|5|||
23179982|NCT01431287|64401709|FG000|Overall Study|Lost to Follow-up|0|||
23346736|NCT00435019|65011129|FG001|Overall Study|Adverse Event|0|||
23346737|NCT00435019|65011128|FG000|Overall Study|Lack of Efficacy|1|||
23346738|NCT00435019|65011129|FG001|Overall Study|Lack of Efficacy|2|||
23346739|NCT00435019|65011128|FG000|Overall Study|Protocol Violation|3|||
23346740|NCT00435019|65011129|FG001|Overall Study|Protocol Violation|1|||
23346741|NCT00435019|65011128|FG000|Overall Study|Personal reasons for withdrawal|8|||
23346742|NCT00435019|65011129|FG001|Overall Study|Personal reasons for withdrawal|7|||
23458180|NCT05712460|65419183|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458181|NCT05712460|65419184|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458182|NCT05712460|65419185|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458183|NCT05712460|65419186|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458184|NCT05712460|65419187|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458185|NCT05712460|65419188|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
23458186|NCT05712460|65419189|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458187|NCT05712460|65419190|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23179983|NCT01431287|64401710|FG001|Overall Study|Lost to Follow-up|3|||
23179984|NCT01431287|64401711|FG002|Overall Study|Lost to Follow-up|2|||
23179985|NCT01431287|64401712|FG003|Overall Study|Lost to Follow-up|3|||
23179986|NCT01431287|64401713|FG004|Overall Study|Lost to Follow-up|1|||
23179987|NCT01431287|64401709|FG000|Overall Study|Consent withdrawn not due to AE|29|||
23179988|NCT01431287|64401710|FG001|Overall Study|Consent withdrawn not due to AE|30|||
23179989|NCT01431287|64401711|FG002|Overall Study|Consent withdrawn not due to AE|34|||
23179990|NCT01431287|64401712|FG003|Overall Study|Consent withdrawn not due to AE|19|||
23179991|NCT01431287|64401713|FG004|Overall Study|Consent withdrawn not due to AE|29|||
23179992|NCT01431287|64401709|FG000|Overall Study|not stated above|4|||
23179993|NCT01431287|64401710|FG001|Overall Study|not stated above|2|||
23179994|NCT01431287|64401711|FG002|Overall Study|not stated above|2|||
23179995|NCT01431287|64401712|FG003|Overall Study|not stated above|2|||
23179996|NCT01431287|64401713|FG004|Overall Study|not stated above|1|||
23179997|NCT01552902|64401714|FG000|Overall Study|Adverse Event|1|||
23179998|NCT01552902|64401715|FG001|Overall Study|Adverse Event|15|||
23179999|NCT01552902|64401716|FG002|Overall Study|Adverse Event|14|||
23180000|NCT01552902|64401714|FG000|Overall Study|Protocol Violation|3|||
23180001|NCT01552902|64401715|FG001|Overall Study|Protocol Violation|3|||
23180002|NCT01552902|64401716|FG002|Overall Study|Protocol Violation|3|||
23180003|NCT01552902|64401714|FG000|Overall Study|Lack of Efficacy|4|||
23180004|NCT01552902|64401715|FG001|Overall Study|Lack of Efficacy|3|||
23180005|NCT01552902|64401716|FG002|Overall Study|Lack of Efficacy|1|||
23180006|NCT01552902|64401714|FG000|Overall Study|Withdrawal by Subject|1|||
23346743|NCT04984681|65011130|FG000|Overall Study|Lost to Follow-up|3|||
23346744|NCT04984681|65011131|FG001|Overall Study|Lost to Follow-up|1|||
23458188|NCT05712460|65419191|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23180007|NCT01552902|64401715|FG001|Overall Study|Withdrawal by Subject|9|||
23180008|NCT01552902|64401716|FG002|Overall Study|Withdrawal by Subject|6|||
23180009|NCT01552902|64401714|FG000|Overall Study|Lost to Follow-up|1|||
23180010|NCT01552902|64401715|FG001|Overall Study|Lost to Follow-up|3|||
23180011|NCT01552902|64401716|FG002|Overall Study|Lost to Follow-up|6|||
23180012|NCT01552902|64401714|FG000|Overall Study|Other|3|||
23346745|NCT03488225|65011132|FG000|Overall Study|Off Protocol Therapy|2|||
23458189|NCT05712460|65419192|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
23458190|NCT03818256|65419193|FG000|Overall Study|Withdrawal by Subject|2|||
23458191|NCT03818256|65419194|FG001|Overall Study|Withdrawal by Subject|2|||
23458192|NCT03818256|65419193|FG000|Overall Study|Adverse Event|3|||
23458193|NCT03818256|65419194|FG001|Overall Study|Adverse Event|1|||
23458194|NCT03818256|65419193|FG000|Overall Study|Lost to Follow-up|0|||
23458195|NCT03818256|65419194|FG001|Overall Study|Lost to Follow-up|5|||
23458196|NCT03818256|65419193|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
23458197|NCT03818256|65419194|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
23458198|NCT03818256|65419193|FG000|Overall Study|Not reporting for scheduled visits|1|||
23458199|NCT03818256|65419194|FG001|Overall Study|Not reporting for scheduled visits|0|||
23458200|NCT03818256|65419193|FG000|Overall Study|Non-compliant with investigational product|1|||
23458201|NCT03818256|65419194|FG001|Overall Study|Non-compliant with investigational product|0|||
23458202|NCT03804528|65419199|FG000|Overall Study|Time Commitment|18|||
23458203|NCT03804528|65419199|FG000|Overall Study|Health Reasons|5|||
23458204|NCT03988400|65419202|FG000|Overall Study|Adverse Event|1|||
23458205|NCT03988400|65419203|FG001|Overall Study|Adverse Event|0|||
23458206|NCT03988400|65419202|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
23346746|NCT03488225|65011132|FG000|Overall Study|Stem Cell Transplant|2|||
23346747|NCT00328094|65011133|FG000|Overall Study|Physician Decision|3|||
23346748|NCT00328094|65011134|FG001|Overall Study|Physician Decision|3|||
23346749|NCT01214252|65011135|FG000|Overall Study|Not eligible per protocol|82|||
23346750|NCT01783821|65011138|FG000|Overall Study|Screen Failure|1|||
23346751|NCT01783821|65011139|FG001|Overall Study|Screen Failure|1|||
23346752|NCT01524783|65011140|FG000|Blinded Period|Adverse Event|64|||
23346753|NCT01524783|65011141|FG001|Blinded Period|Adverse Event|7|||
23346754|NCT01524783|65011142|FG002|Blinded Period|Adverse Event|0|||
23346755|NCT01524783|65011140|FG000|Blinded Period|Disease Progression|89|||
23346756|NCT01524783|65011141|FG001|Blinded Period|Disease Progression|75|||
23346757|NCT01524783|65011142|FG002|Blinded Period|Disease Progression|0|||
23346758|NCT01524783|65011140|FG000|Blinded Period|Withdrawal by Subject|19|||
23346759|NCT01524783|65011141|FG001|Blinded Period|Withdrawal by Subject|6|||
23346760|NCT01524783|65011142|FG002|Blinded Period|Withdrawal by Subject|0|||
23346761|NCT01524783|65011140|FG000|Blinded Period|Protocol deviation|2|||
23346762|NCT01524783|65011141|FG001|Blinded Period|Protocol deviation|1|||
23346763|NCT01524783|65011142|FG002|Blinded Period|Protocol deviation|0|||
23346764|NCT01524783|65011140|FG000|Blinded Period|Death|5|||
23346765|NCT01524783|65011141|FG001|Blinded Period|Death|2|||
23346766|NCT01524783|65011142|FG002|Blinded Period|Death|0|||
23346767|NCT01524783|65011140|FG000|Open-label Period|Disease progression|13|||
23346768|NCT01524783|65011141|FG001|Open-label Period|Disease progression|0|||
23346769|NCT01524783|65011142|FG002|Open-label Period|Disease progression|2|||
23346770|NCT01524783|65011140|FG000|Open-label Period|Administrative problems|5|||
23346771|NCT01524783|65011141|FG001|Open-label Period|Administrative problems|0|||
23458207|NCT03988400|65419203|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
23458208|NCT03988400|65419202|FG000|Overall Study|Lost to Follow-up|0|||
23180013|NCT01552902|64401715|FG001|Overall Study|Other|4|||
23180014|NCT01552902|64401716|FG002|Overall Study|Other|3|||
23346772|NCT01524783|65011142|FG002|Open-label Period|Administrative problems|2|||
23346773|NCT01524783|65011140|FG000|Open-label Period|Adverse Event|5|||
23346774|NCT01524783|65011141|FG001|Open-label Period|Adverse Event|0|||
23346775|NCT01524783|65011142|FG002|Open-label Period|Adverse Event|1|||
23346776|NCT01524783|65011140|FG000|Open-label Period|Withdrawal by Subject|2|||
23346777|NCT01524783|65011141|FG001|Open-label Period|Withdrawal by Subject|0|||
23346778|NCT01524783|65011142|FG002|Open-label Period|Withdrawal by Subject|1|||
23346779|NCT01524783|65011140|FG000|Open-label Period|Protocol deviation|1|||
23180015|NCT04336163|64401718|FG000|Overall Study|Lost to Follow-up|55|||
23346780|NCT01524783|65011141|FG001|Open-label Period|Protocol deviation|0|||
23346781|NCT01524783|65011142|FG002|Open-label Period|Protocol deviation|0|||
23346782|NCT01632904|65011147|FG000|Overall Study|Adverse Event|4|||
23346783|NCT01632904|65011148|FG001|Overall Study|Adverse Event|1|||
23346784|NCT01632904|65011147|FG000|Overall Study|Physician Decision|0|||
23346785|NCT01632904|65011148|FG001|Overall Study|Physician Decision|1|||
23346786|NCT01632904|65011147|FG000|Overall Study|Subject decision|3|||
23346787|NCT01632904|65011148|FG001|Overall Study|Subject decision|2|||
23346788|NCT01632904|65011147|FG000|Overall Study|Disease Progression|0|||
23346789|NCT01632904|65011148|FG001|Overall Study|Disease Progression|1|||
23346790|NCT01632904|65011147|FG000|Overall Study|Reason for discontinuation not available|0|||
23346791|NCT01632904|65011148|FG001|Overall Study|Reason for discontinuation not available|1|||
23346792|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
23346793|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
23346794|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
23346795|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
23346796|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
23346797|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
23346798|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
23346799|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
23346800|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
23346801|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
23346802|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
23346803|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
23346804|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
23346805|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
23346806|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
23346807|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
23346808|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
23346809|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
23346810|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
23346811|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
23346812|NCT00550862|65011149|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
23346813|NCT00550862|65011150|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
23458209|NCT03988400|65419203|FG001|Overall Study|Lost to Follow-up|1|||
23458210|NCT03995368|65419204|FG000|Overall Study|Lost to Follow-up|1|||
23458211|NCT03995368|65419205|FG001|Overall Study|Lost to Follow-up|4|||
23458212|NCT03995368|65419206|FG002|Overall Study|Lost to Follow-up|1|||
23458213|NCT03995368|65419204|FG000|Overall Study|Did not meet inclusion criteria|1|||
23458214|NCT03995368|65419205|FG001|Overall Study|Did not meet inclusion criteria|6|||
23458215|NCT03995368|65419206|FG002|Overall Study|Did not meet inclusion criteria|3|||
23458216|NCT03995368|65419204|FG000|Overall Study|Withdrawal by Subject|0|||
23458217|NCT03995368|65419205|FG001|Overall Study|Withdrawal by Subject|1|||
23458218|NCT03995368|65419206|FG002|Overall Study|Withdrawal by Subject|1|||
23239916|NCT03358407|64622105|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
23458219|NCT02783690|65421233|FG000|Overall Study|Withdrawal by Subject|3|||
23458220|NCT02783690|65421234|FG001|Overall Study|Withdrawal by Subject|3|||
23458221|NCT05430854|65421235|FG000|Overall Study|Trial terminated by Sponsor|39|||
23458222|NCT05430854|65421236|FG001|Overall Study|Trial terminated by Sponsor|50|||
23458223|NCT05430854|65421237|FG002|Overall Study|Trial terminated by Sponsor|46|||
23239917|NCT03358407|64622096|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239918|NCT03358407|64622097|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239919|NCT03358407|64622098|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239920|NCT03358407|64622099|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239921|NCT03358407|64622100|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239922|NCT03358407|64622101|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
23239923|NCT03358407|64622102|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
23239924|NCT03358407|64622103|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239925|NCT03358407|64622104|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239926|NCT03358407|64622105|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
23239927|NCT03358407|64622096|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23239928|NCT03358407|64622097|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23239929|NCT03358407|64622098|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23346814|NCT00550862|65011151|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
23346815|NCT00550862|65011152|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
23346816|NCT00550862|65011153|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
23458224|NCT05430854|65421235|FG000|Overall Study|Withdrawal by Subject|0|||
23346817|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
23346818|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
23346819|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
23346820|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
23346821|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
23346822|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
23346823|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
23346824|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
23346825|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
23346826|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
23346827|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
23346828|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
23346829|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
23346830|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
23346831|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
23346832|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
23346833|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
23346834|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
23346835|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
23346836|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
23346837|NCT00550862|65011149|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
23346838|NCT00550862|65011150|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
23346839|NCT00550862|65011151|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
23346840|NCT00550862|65011152|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
23346841|NCT00550862|65011153|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
23346842|NCT02407054|65011156|FG000|Overall Study|Adverse Event|1|||
23346843|NCT02407054|65011157|FG001|Overall Study|Adverse Event|4|||
23346844|NCT02407054|65011158|FG002|Overall Study|Adverse Event|1|||
23346845|NCT02407054|65011156|FG000|Overall Study|Non-compliance with Study|0|||
23346846|NCT02407054|65011157|FG001|Overall Study|Non-compliance with Study|2|||
23346847|NCT02407054|65011158|FG002|Overall Study|Non-compliance with Study|1|||
23346848|NCT02407054|65011156|FG000|Overall Study|Physician Decision|1|||
23346849|NCT02407054|65011157|FG001|Overall Study|Physician Decision|3|||
23346850|NCT02407054|65011158|FG002|Overall Study|Physician Decision|3|||
23346851|NCT02407054|65011156|FG000|Overall Study|Withdrawal by Subject|5|||
23346852|NCT02407054|65011157|FG001|Overall Study|Withdrawal by Subject|9|||
23346853|NCT02407054|65011158|FG002|Overall Study|Withdrawal by Subject|2|||
23583653|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583654|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23346854|NCT01472965|65011159|FG000|Overall Study|Withdrawal by Subject|1|||
23583655|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
23583656|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583657|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583658|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583659|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583660|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583661|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583662|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583663|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583664|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583665|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
23583666|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583667|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583668|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
23346855|NCT01472965|65011160|FG001|Overall Study|Withdrawal by Subject|0|||
23346856|NCT02912455|65011161|FG000|Overall Study|Withdrawal by Subject|0|||
23346857|NCT02912455|65011162|FG001|Overall Study|Withdrawal by Subject|1|||
23180016|NCT04336163|64401719|FG001|Overall Study|Lost to Follow-up|0|||
23239930|NCT03358407|64622099|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23239931|NCT03358407|64622100|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23346858|NCT02912455|65011161|FG000|Overall Study|Lack of Efficacy|0|||
23346859|NCT02912455|65011162|FG001|Overall Study|Lack of Efficacy|1|||
23346860|NCT02912455|65011161|FG000|Overall Study|Lost to Follow-up|2|||
23346861|NCT02912455|65011162|FG001|Overall Study|Lost to Follow-up|1|||
23346862|NCT01447927|65011163|FG000|Overall Study|Adverse Event|4|||
23346863|NCT01447927|65011164|FG001|Overall Study|Adverse Event|3|||
23346864|NCT01447927|65011163|FG000|Overall Study|Withdrawal by Subject|1|||
23346865|NCT01447927|65011164|FG001|Overall Study|Withdrawal by Subject|0|||
23346866|NCT00334802|65011165|FG000|Overall Study|Progressive Disease|2|||
23346867|NCT00334802|65011166|FG001|Overall Study|Progressive Disease|24|||
23346868|NCT00334802|65011165|FG000|Overall Study|Toxicity|1|||
23346869|NCT00334802|65011166|FG001|Overall Study|Toxicity|5|||
23346870|NCT00334802|65011165|FG000|Overall Study|Lack of Efficacy|1|||
23346871|NCT00334802|65011166|FG001|Overall Study|Lack of Efficacy|3|||
23346872|NCT00334802|65011165|FG000|Overall Study|Patient Condition Aggrevated|1|||
23346873|NCT00334802|65011166|FG001|Overall Study|Patient Condition Aggrevated|0|||
23346874|NCT00334802|65011165|FG000|Overall Study|Physician Decision|1|||
23346875|NCT00334802|65011166|FG001|Overall Study|Physician Decision|0|||
23346876|NCT00334802|65011165|FG000|Overall Study|Withdrawal by Subject|0|||
23346877|NCT00334802|65011166|FG001|Overall Study|Withdrawal by Subject|4|||
23346878|NCT00334802|65011165|FG000|Overall Study|Adverse Event|0|||
23346879|NCT00334802|65011166|FG001|Overall Study|Adverse Event|3|||
23583669|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583670|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583671|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583672|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583673|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583674|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583675|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583676|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23239932|NCT03358407|64622101|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
23239933|NCT03358407|64622102|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
23239934|NCT03358407|64622103|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
23239935|NCT03358407|64622104|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23239936|NCT03358407|64622105|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
23239937|NCT02967055|64622108|FG000|Overall Study|Excluded|40|||
23239938|NCT02967055|64622108|FG000|Overall Study|Screen fail|3|||
23239939|NCT02967055|64622108|FG000|Overall Study|Lost to Follow-up|2|||
23239940|NCT02967055|64622108|FG000|Overall Study|Stopped due to side effects|3|||
23583677|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583678|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583679|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
23583680|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23239941|NCT02967055|64622108|FG000|Overall Study|Stopped due to drug cost|1|||
23239942|NCT02120456|64622111|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23239943|NCT02120456|64622112|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23239944|NCT02120456|64622113|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23239945|NCT02120456|64622114|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23239946|NCT02120456|64622115|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23239947|NCT02120456|64622116|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23346880|NCT00334802|65011165|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
23346881|NCT00334802|65011166|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
23346882|NCT00616603|65011176|FG000|Overall Study|Physician Decision|2|||
23346883|NCT00616603|65011177|FG001|Overall Study|Physician Decision|0|||
23346884|NCT00616603|65011178|FG002|Overall Study|Physician Decision|2|||
23239948|NCT02120456|64622117|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
23239949|NCT02120456|64622118|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23239950|NCT02120456|64622119|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
23239951|NCT02120456|64622111|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23239952|NCT02120456|64622112|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23239953|NCT02120456|64622113|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23346885|NCT01552915|65011179|FG000|Overall Study|Adverse Event|3|||
23346886|NCT01552915|65011180|FG001|Overall Study|Adverse Event|14|||
23346887|NCT01552915|65011181|FG002|Overall Study|Adverse Event|3|||
23346888|NCT01552915|65011179|FG000|Overall Study|Lost to Follow-up|4|||
23346889|NCT01552915|65011180|FG001|Overall Study|Lost to Follow-up|6|||
23583681|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583682|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
23583683|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583684|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583685|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583686|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583687|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583688|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583689|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583690|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583691|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583692|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583693|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
23583694|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583695|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583696|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
23583697|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
23583698|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583699|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583700|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583701|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23180017|NCT01324830|64401720|FG000|Overall Study|Progressive Disease|3|||
23180018|NCT01324830|64401721|FG001|Overall Study|Progressive Disease|2|||
23180019|NCT01324830|64401722|FG002|Overall Study|Progressive Disease|3|||
23180020|NCT01324830|64401723|FG003|Overall Study|Progressive Disease|3|||
23180021|NCT01324830|64401724|FG004|Overall Study|Progressive Disease|6|||
23180022|NCT01324830|64401725|FG005|Overall Study|Progressive Disease|6|||
23180023|NCT01324830|64401726|FG006|Overall Study|Progressive Disease|3|||
23180024|NCT01324830|64401727|FG007|Overall Study|Progressive Disease|3|||
23180025|NCT01324830|64401728|FG008|Overall Study|Progressive Disease|3|||
23180026|NCT01324830|64401729|FG009|Overall Study|Progressive Disease|6|||
23180027|NCT01324830|64401730|FG010|Overall Study|Progressive Disease|2|||
23180028|NCT01324830|64401731|FG011|Overall Study|Progressive Disease|1|||
23180029|NCT01324830|64401732|FG012|Overall Study|Progressive Disease|1|||
23180030|NCT01324830|64401733|FG013|Overall Study|Progressive Disease|1|||
23180031|NCT01324830|64401734|FG014|Overall Study|Progressive Disease|1|||
23180032|NCT01324830|64401735|FG015|Overall Study|Progressive Disease|3|||
23180033|NCT01324830|64401736|FG016|Overall Study|Progressive Disease|2|||
23180034|NCT01324830|64401737|FG017|Overall Study|Progressive Disease|3|||
23180035|NCT01324830|64401738|FG018|Overall Study|Progressive Disease|4|||
23180036|NCT01324830|64401720|FG000|Overall Study|Dose limiting toxicity|0|||
23180037|NCT01324830|64401721|FG001|Overall Study|Dose limiting toxicity|0|||
23180038|NCT01324830|64401722|FG002|Overall Study|Dose limiting toxicity|0|||
23180039|NCT01324830|64401723|FG003|Overall Study|Dose limiting toxicity|0|||
23180040|NCT01324830|64401724|FG004|Overall Study|Dose limiting toxicity|1|||
23180041|NCT01324830|64401725|FG005|Overall Study|Dose limiting toxicity|0|||
23180042|NCT01324830|64401726|FG006|Overall Study|Dose limiting toxicity|0|||
23180043|NCT01324830|64401727|FG007|Overall Study|Dose limiting toxicity|0|||
23583702|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23180044|NCT01324830|64401728|FG008|Overall Study|Dose limiting toxicity|0|||
23180045|NCT01324830|64401729|FG009|Overall Study|Dose limiting toxicity|0|||
23180046|NCT01324830|64401730|FG010|Overall Study|Dose limiting toxicity|0|||
23180047|NCT01324830|64401731|FG011|Overall Study|Dose limiting toxicity|0|||
23346890|NCT01552915|65011181|FG002|Overall Study|Lost to Follow-up|5|||
23180048|NCT01324830|64401732|FG012|Overall Study|Dose limiting toxicity|0|||
23180049|NCT01324830|64401733|FG013|Overall Study|Dose limiting toxicity|0|||
23180050|NCT01324830|64401734|FG014|Overall Study|Dose limiting toxicity|0|||
23180051|NCT01324830|64401735|FG015|Overall Study|Dose limiting toxicity|0|||
23180052|NCT01324830|64401736|FG016|Overall Study|Dose limiting toxicity|1|||
23180053|NCT01324830|64401737|FG017|Overall Study|Dose limiting toxicity|1|||
23180054|NCT01324830|64401738|FG018|Overall Study|Dose limiting toxicity|1|||
23180055|NCT01324830|64401720|FG000|Overall Study|Reason not mentioned above|0|||
23180056|NCT01324830|64401721|FG001|Overall Study|Reason not mentioned above|0|||
23180057|NCT01324830|64401722|FG002|Overall Study|Reason not mentioned above|0|||
23180058|NCT01324830|64401723|FG003|Overall Study|Reason not mentioned above|0|||
23180059|NCT01324830|64401724|FG004|Overall Study|Reason not mentioned above|0|||
23180060|NCT01324830|64401725|FG005|Overall Study|Reason not mentioned above|0|||
23180061|NCT01324830|64401726|FG006|Overall Study|Reason not mentioned above|0|||
23180062|NCT01324830|64401727|FG007|Overall Study|Reason not mentioned above|0|||
23180063|NCT01324830|64401728|FG008|Overall Study|Reason not mentioned above|0|||
23180064|NCT01324830|64401729|FG009|Overall Study|Reason not mentioned above|0|||
23180065|NCT01324830|64401730|FG010|Overall Study|Reason not mentioned above|0|||
23180066|NCT01324830|64401731|FG011|Overall Study|Reason not mentioned above|0|||
23180067|NCT01324830|64401732|FG012|Overall Study|Reason not mentioned above|0|||
23180068|NCT01324830|64401733|FG013|Overall Study|Reason not mentioned above|0|||
23180069|NCT01324830|64401734|FG014|Overall Study|Reason not mentioned above|0|||
23180070|NCT01324830|64401735|FG015|Overall Study|Reason not mentioned above|0|||
23180071|NCT01324830|64401736|FG016|Overall Study|Reason not mentioned above|0|||
23180072|NCT01324830|64401737|FG017|Overall Study|Reason not mentioned above|1|||
23180073|NCT01324830|64401738|FG018|Overall Study|Reason not mentioned above|0|||
23180074|NCT01324830|64401720|FG000|Overall Study|Adverse Event, serious fatal|0|||
23180075|NCT01324830|64401721|FG001|Overall Study|Adverse Event, serious fatal|1|||
23180076|NCT01324830|64401722|FG002|Overall Study|Adverse Event, serious fatal|0|||
23180077|NCT01324830|64401723|FG003|Overall Study|Adverse Event, serious fatal|0|||
23180078|NCT01324830|64401724|FG004|Overall Study|Adverse Event, serious fatal|0|||
23180079|NCT01324830|64401725|FG005|Overall Study|Adverse Event, serious fatal|0|||
23180080|NCT01324830|64401726|FG006|Overall Study|Adverse Event, serious fatal|0|||
23180081|NCT01324830|64401727|FG007|Overall Study|Adverse Event, serious fatal|0|||
23180082|NCT01324830|64401728|FG008|Overall Study|Adverse Event, serious fatal|0|||
23180083|NCT01324830|64401729|FG009|Overall Study|Adverse Event, serious fatal|0|||
23180084|NCT01324830|64401730|FG010|Overall Study|Adverse Event, serious fatal|0|||
23180085|NCT01324830|64401731|FG011|Overall Study|Adverse Event, serious fatal|0|||
23180086|NCT01324830|64401732|FG012|Overall Study|Adverse Event, serious fatal|0|||
23180087|NCT01324830|64401733|FG013|Overall Study|Adverse Event, serious fatal|0|||
23239954|NCT02120456|64622114|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23239955|NCT02120456|64622115|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23239956|NCT02120456|64622116|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23239957|NCT02120456|64622117|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
23239958|NCT02120456|64622118|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23239959|NCT02120456|64622119|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
23239960|NCT02120456|64622111|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23239961|NCT02120456|64622112|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23239962|NCT02120456|64622113|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23239963|NCT02120456|64622114|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23239964|NCT02120456|64622115|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23239965|NCT02120456|64622116|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23239966|NCT02120456|64622117|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23239967|NCT02120456|64622118|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
23239968|NCT02120456|64622119|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
23239969|NCT04640168|64622120|FG000|Overall Study|Withdrawal by Subject|8|||
23239970|NCT04640168|64622121|FG001|Overall Study|Withdrawal by Subject|7|||
23239971|NCT04640168|64622120|FG000|Overall Study|Lost to Follow-up|1|||
23239972|NCT04640168|64622121|FG001|Overall Study|Lost to Follow-up|0|||
23239973|NCT04640168|64622120|FG000|Overall Study|Enrolled but not treated|12|||
23239974|NCT04640168|64622121|FG001|Overall Study|Enrolled but not treated|12|||
23239975|NCT01339273|64622127|FG000|Overall Study|Lost to Follow-up|8|||
23239976|NCT01339273|64622128|FG001|Overall Study|Lost to Follow-up|8|||
23239977|NCT00792467|64622133|FG000|Overall Study|progression of disease|17|||
23239978|NCT00792467|64622133|FG000|Overall Study|Adverse Event|1|||
23180088|NCT01324830|64401734|FG014|Overall Study|Adverse Event, serious fatal|0|||
23180089|NCT01324830|64401735|FG015|Overall Study|Adverse Event, serious fatal|0|||
23180090|NCT01324830|64401736|FG016|Overall Study|Adverse Event, serious fatal|0|||
23180091|NCT01324830|64401737|FG017|Overall Study|Adverse Event, serious fatal|0|||
23180092|NCT01324830|64401738|FG018|Overall Study|Adverse Event, serious fatal|0|||
23180093|NCT01324830|64401720|FG000|Overall Study|Adverse Event, non-fatal|0|||
23180094|NCT01324830|64401721|FG001|Overall Study|Adverse Event, non-fatal|0|||
23180095|NCT01324830|64401722|FG002|Overall Study|Adverse Event, non-fatal|0|||
23180096|NCT01324830|64401723|FG003|Overall Study|Adverse Event, non-fatal|0|||
23180097|NCT01324830|64401724|FG004|Overall Study|Adverse Event, non-fatal|0|||
23180098|NCT01324830|64401725|FG005|Overall Study|Adverse Event, non-fatal|0|||
23180099|NCT01324830|64401726|FG006|Overall Study|Adverse Event, non-fatal|0|||
23180100|NCT01324830|64401727|FG007|Overall Study|Adverse Event, non-fatal|0|||
23180101|NCT01324830|64401728|FG008|Overall Study|Adverse Event, non-fatal|2|||
23180102|NCT01324830|64401729|FG009|Overall Study|Adverse Event, non-fatal|0|||
23180103|NCT01324830|64401730|FG010|Overall Study|Adverse Event, non-fatal|1|||
23180104|NCT01324830|64401731|FG011|Overall Study|Adverse Event, non-fatal|0|||
23239979|NCT00792467|64622133|FG000|Overall Study|patient request|1|||
23346891|NCT01552915|65011179|FG000|Overall Study|Withdrawal by Subject|6|||
23346892|NCT01552915|65011180|FG001|Overall Study|Withdrawal by Subject|4|||
23346893|NCT01552915|65011181|FG002|Overall Study|Withdrawal by Subject|5|||
23346894|NCT01552915|65011179|FG000|Overall Study|Protocol Violation|0|||
23346895|NCT01552915|65011180|FG001|Overall Study|Protocol Violation|4|||
23346896|NCT01552915|65011181|FG002|Overall Study|Protocol Violation|4|||
23239980|NCT00792467|64622133|FG000|Overall Study|Lost to Follow-up|1|||
23346897|NCT01552915|65011179|FG000|Overall Study|Lack of Efficacy|8|||
23346898|NCT01552915|65011180|FG001|Overall Study|Lack of Efficacy|1|||
23346899|NCT01552915|65011181|FG002|Overall Study|Lack of Efficacy|4|||
23346900|NCT01552915|65011179|FG000|Overall Study|Other|2|||
23346901|NCT01552915|65011180|FG001|Overall Study|Other|0|||
23458225|NCT05430854|65421236|FG001|Overall Study|Withdrawal by Subject|3|||
23458226|NCT05430854|65421237|FG002|Overall Study|Withdrawal by Subject|0|||
23458227|NCT03675126|65421238|FG000|Overall Study|Study Terminated by Sponsor|9|||
23458228|NCT03675126|65421238|FG000|Overall Study|Death|2|||
23458229|NCT03675126|65421238|FG000|Overall Study|Withdrawal by Subject|4|||
23458230|NCT02432703|65421244|FG000|Overall Study|Adverse Event|1|||
23583703|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583704|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583705|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583706|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583707|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
23583708|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583709|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583710|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583711|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
23583712|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23239981|NCT00792467|64622133|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
23239982|NCT00792467|64622133|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
23346902|NCT01552915|65011181|FG002|Overall Study|Other|6|||
23346903|NCT00535847|65011182|FG000|Overall Study|Adverse Event|5|||
23346904|NCT00535847|65011183|FG001|Overall Study|Adverse Event|3|||
23180105|NCT01324830|64401732|FG012|Overall Study|Adverse Event, non-fatal|0|||
23180106|NCT01324830|64401733|FG013|Overall Study|Adverse Event, non-fatal|0|||
23346905|NCT00535847|65011184|FG002|Overall Study|Adverse Event|2|||
23180107|NCT01324830|64401734|FG014|Overall Study|Adverse Event, non-fatal|0|||
23458231|NCT02432703|65421245|FG001|Overall Study|Adverse Event|4|||
23458232|NCT02432703|65421244|FG000|Overall Study|Lack of Efficacy|1|||
23458233|NCT02432703|65421245|FG001|Overall Study|Lack of Efficacy|0|||
23180108|NCT01324830|64401735|FG015|Overall Study|Adverse Event, non-fatal|0|||
23180109|NCT01324830|64401736|FG016|Overall Study|Adverse Event, non-fatal|0|||
23180110|NCT01324830|64401737|FG017|Overall Study|Adverse Event, non-fatal|1|||
23180111|NCT01324830|64401738|FG018|Overall Study|Adverse Event, non-fatal|0|||
23180112|NCT01324830|64401720|FG000|Overall Study|Withdrawal by Subject|0|||
23180113|NCT01324830|64401721|FG001|Overall Study|Withdrawal by Subject|0|||
23180114|NCT01324830|64401722|FG002|Overall Study|Withdrawal by Subject|0|||
23180115|NCT01324830|64401723|FG003|Overall Study|Withdrawal by Subject|0|||
23180116|NCT01324830|64401724|FG004|Overall Study|Withdrawal by Subject|0|||
23180117|NCT01324830|64401725|FG005|Overall Study|Withdrawal by Subject|1|||
23180118|NCT01324830|64401726|FG006|Overall Study|Withdrawal by Subject|0|||
23180119|NCT01324830|64401727|FG007|Overall Study|Withdrawal by Subject|0|||
23180120|NCT01324830|64401728|FG008|Overall Study|Withdrawal by Subject|0|||
23180121|NCT01324830|64401729|FG009|Overall Study|Withdrawal by Subject|0|||
23180122|NCT01324830|64401730|FG010|Overall Study|Withdrawal by Subject|1|||
23180123|NCT01324830|64401731|FG011|Overall Study|Withdrawal by Subject|0|||
23180124|NCT01324830|64401732|FG012|Overall Study|Withdrawal by Subject|0|||
23180125|NCT01324830|64401733|FG013|Overall Study|Withdrawal by Subject|0|||
23180126|NCT01324830|64401734|FG014|Overall Study|Withdrawal by Subject|0|||
23239983|NCT02190604|64622134|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23346906|NCT00535847|65011182|FG000|Overall Study|Non compliance|1|||
23346907|NCT00535847|65011183|FG001|Overall Study|Non compliance|1|||
23346908|NCT00535847|65011184|FG002|Overall Study|Non compliance|0|||
23346909|NCT00535847|65011182|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
23346910|NCT00535847|65011183|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
23346911|NCT00535847|65011184|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
23346912|NCT00778102|65011186|FG000|Overall Study|Adverse Event|8|||
23346913|NCT00778102|65011187|FG001|Overall Study|Adverse Event|5|||
23346914|NCT00778102|65011186|FG000|Overall Study|Death|1|||
23346915|NCT00778102|65011187|FG001|Overall Study|Death|1|||
23346916|NCT00778102|65011186|FG000|Overall Study|Lost to Follow-up|1|||
23346917|NCT00778102|65011187|FG001|Overall Study|Lost to Follow-up|0|||
23346918|NCT00778102|65011186|FG000|Overall Study|Violation of Selection Criteria|1|||
23346919|NCT00778102|65011187|FG001|Overall Study|Violation of Selection Criteria|1|||
23346920|NCT00778102|65011186|FG000|Overall Study|Protocol Violation|0|||
23346921|NCT00778102|65011187|FG001|Overall Study|Protocol Violation|1|||
23346922|NCT00778102|65011186|FG000|Overall Study|Refused Treatment|2|||
23346923|NCT00778102|65011187|FG001|Overall Study|Refused Treatment|3|||
23346924|NCT00778102|65011186|FG000|Overall Study|Withdrawal by Subject|1|||
23346925|NCT00778102|65011187|FG001|Overall Study|Withdrawal by Subject|1|||
23346926|NCT00778102|65011186|FG000|Overall Study|Administrative Reason|7|||
23346927|NCT00778102|65011187|FG001|Overall Study|Administrative Reason|10|||
23346928|NCT01706575|65011189|FG000|Overall Study|Participant Withdrew Consent|4|||
23346929|NCT01706575|65011189|FG000|Overall Study|Lost to Follow-up|2|||
23346930|NCT01706575|65011189|FG000|Overall Study|Started but not Treated|6|||
23346931|NCT02267135|65011190|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
23346932|NCT02267135|65011191|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
23346933|NCT02267135|65011190|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
23346934|NCT02267135|65011191|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
23346935|NCT02267135|65011190|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
23346936|NCT02267135|65011191|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
23346937|NCT02267135|65011190|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
23346938|NCT02267135|65011191|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
23346939|NCT02267135|65011190|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
23346940|NCT02267135|65011191|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
23346941|NCT04250350|65011194|FG000|Overall Study|Withdrawal by Subject|13|||
23346942|NCT04250350|65011194|FG000|Overall Study|Lost to Follow-up|8|||
23346943|NCT04250350|65011194|FG000|Overall Study|Adverse Event|5|||
23346944|NCT04250350|65011194|FG000|Overall Study|Lack of Efficacy|4|||
23346945|NCT04250350|65011194|FG000|Overall Study|Physician Decision|1|||
23346946|NCT04250350|65011194|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
23346947|NCT01534208|65014167|FG000|Overall Study|Lost to Follow-up|19|||
23180127|NCT01324830|64401735|FG015|Overall Study|Withdrawal by Subject|0|||
23180128|NCT01324830|64401736|FG016|Overall Study|Withdrawal by Subject|0|||
23180129|NCT01324830|64401737|FG017|Overall Study|Withdrawal by Subject|0|||
23239984|NCT02190604|64622135|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23346948|NCT01534208|65014168|FG001|Overall Study|Lost to Follow-up|14|||
23346949|NCT01534208|65014167|FG000|Overall Study|Withdrawal by Subject|6|||
23346950|NCT01534208|65014168|FG001|Overall Study|Withdrawal by Subject|20|||
23346951|NCT01534208|65014167|FG000|Overall Study|Adverse Event|15|||
23346952|NCT01534208|65014168|FG001|Overall Study|Adverse Event|8|||
23458234|NCT02432703|65421244|FG000|Overall Study|Lost to Follow-up|5|||
23458235|NCT02432703|65421245|FG001|Overall Study|Lost to Follow-up|3|||
23458236|NCT02432703|65421244|FG000|Overall Study|Withdrawal by Subject|9|||
23458237|NCT02432703|65421245|FG001|Overall Study|Withdrawal by Subject|6|||
23458238|NCT02432703|65421244|FG000|Overall Study|Other|6|||
23458239|NCT02432703|65421245|FG001|Overall Study|Other|5|||
23458240|NCT01602666|65421246|FG000|Induction Chemotherapy|Death|2|||
23458241|NCT01602666|65421247|FG001|Induction Chemotherapy|Death|1|||
23458242|NCT01602666|65421246|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
23458243|NCT01602666|65421247|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
23458244|NCT01602666|65421246|FG000|Induction Chemotherapy|Physician Decision|12|||
23458245|NCT01602666|65421247|FG001|Induction Chemotherapy|Physician Decision|5|||
23458246|NCT01602666|65421246|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
23458247|NCT01602666|65421247|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
23458248|NCT01602666|65421246|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
23458249|NCT01602666|65421247|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
23458250|NCT01602666|65421246|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
23458251|NCT01602666|65421247|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
23458252|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
23458253|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
23458254|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
23458255|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
23346953|NCT01534208|65014167|FG000|Overall Study|Physician Decision|2|||
23346954|NCT01534208|65014168|FG001|Overall Study|Physician Decision|0|||
23346955|NCT01534208|65014167|FG000|Overall Study|Lack of Efficacy|0|||
23346956|NCT01534208|65014168|FG001|Overall Study|Lack of Efficacy|3|||
23346957|NCT01534208|65014167|FG000|Overall Study|Protocol Violation|2|||
23346958|NCT01534208|65014168|FG001|Overall Study|Protocol Violation|2|||
23346959|NCT01534208|65014167|FG000|Overall Study|Sponsor decision|4|||
23346960|NCT01534208|65014168|FG001|Overall Study|Sponsor decision|1|||
23346961|NCT01534208|65014167|FG000|Overall Study|Subject relocation|2|||
23346962|NCT01534208|65014168|FG001|Overall Study|Subject relocation|0|||
23346963|NCT01534208|65014167|FG000|Overall Study|Lab assessment|2|||
23346964|NCT01534208|65014168|FG001|Overall Study|Lab assessment|1|||
23458256|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
23458257|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
23458258|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
23458259|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
23458260|NCT01602666|65421246|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
23458261|NCT01602666|65421247|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
23458262|NCT01263769|65421248|FG000|Overall Study|Non-Compliant with treatment|1|||
23458263|NCT04531176|65421249|FG000|Overall Study|Study was stopped early|24|||
23458264|NCT04531176|65421250|FG001|Overall Study|Study was stopped early|26|||
23458265|NCT04531176|65421251|FG002|Overall Study|Study was stopped early|24|||
23458266|NCT04672239|65421252|FG000|Week 2 Survey|Failed survey check items|1|||
23458267|NCT04672239|65421253|FG001|Week 2 Survey|Failed survey check items|2|||
23458268|NCT04672239|65421254|FG002|Week 2 Survey|Failed survey check items|3|||
23458269|NCT04672239|65421252|FG000|Week 2 Survey|Partially completed survey|7|||
23458270|NCT04672239|65421253|FG001|Week 2 Survey|Partially completed survey|1|||
23458271|NCT04672239|65421254|FG002|Week 2 Survey|Partially completed survey|4|||
23458272|NCT04672239|65421252|FG000|Week 2 Survey|Withdrawal by Subject|0|||
23458273|NCT04672239|65421253|FG001|Week 2 Survey|Withdrawal by Subject|1|||
23458274|NCT04672239|65421254|FG002|Week 2 Survey|Withdrawal by Subject|0|||
23458275|NCT04672239|65421252|FG000|Week 2 Survey|Lost to Follow-up|3|||
23458276|NCT04672239|65421253|FG001|Week 2 Survey|Lost to Follow-up|2|||
23458277|NCT04672239|65421254|FG002|Week 2 Survey|Lost to Follow-up|5|||
23458278|NCT04672239|65421252|FG000|Week 6 Survey|Failed survey check items|2|||
23458279|NCT04672239|65421253|FG001|Week 6 Survey|Failed survey check items|2|||
23458280|NCT04672239|65421254|FG002|Week 6 Survey|Failed survey check items|2|||
23458281|NCT04672239|65421252|FG000|Week 6 Survey|Partially completed survey|3|||
23458282|NCT04672239|65421253|FG001|Week 6 Survey|Partially completed survey|3|||
23458283|NCT04672239|65421254|FG002|Week 6 Survey|Partially completed survey|2|||
23458284|NCT04672239|65421252|FG000|Week 6 Survey|Withdrawal by Subject|1|||
23458285|NCT04672239|65421253|FG001|Week 6 Survey|Withdrawal by Subject|1|||
23458286|NCT04672239|65421254|FG002|Week 6 Survey|Withdrawal by Subject|1|||
23458287|NCT04672239|65421252|FG000|Week 6 Survey|Withdrawn by PI|0|||
23458288|NCT04672239|65421253|FG001|Week 6 Survey|Withdrawn by PI|1|||
23346965|NCT01534208|65014167|FG000|Overall Study|Eligibility error|3|||
23346966|NCT01534208|65014168|FG001|Overall Study|Eligibility error|0|||
23458289|NCT04672239|65421254|FG002|Week 6 Survey|Withdrawn by PI|0|||
23458290|NCT04672239|65421252|FG000|Week 6 Survey|Lost to Follow-up|12|||
23458291|NCT04672239|65421253|FG001|Week 6 Survey|Lost to Follow-up|2|||
23458292|NCT04672239|65421254|FG002|Week 6 Survey|Lost to Follow-up|5|||
23458293|NCT04672239|65421252|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
23458294|NCT04672239|65421253|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
23458295|NCT04672239|65421254|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
23458296|NCT04672239|65421252|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
23458297|NCT04672239|65421253|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
23458298|NCT04672239|65421254|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
23458299|NCT04672239|65421252|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
23458300|NCT04672239|65421253|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
23458301|NCT04672239|65421254|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
23458302|NCT04672239|65421252|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
23458303|NCT04672239|65421253|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
23458304|NCT04672239|65421254|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
23458305|NCT04672239|65421252|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
23458306|NCT04672239|65421253|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
23458307|NCT04672239|65421254|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
23458308|NCT04672239|65421252|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
23458309|NCT04672239|65421253|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
23458310|NCT04672239|65421254|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
23458311|NCT04672239|65421252|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
23458312|NCT04672239|65421253|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
23458313|NCT04672239|65421254|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
23458314|NCT03221556|65421256|FG000|Allocation|post-randomization exclusion|0|||
23458315|NCT03221556|65421257|FG001|Allocation|post-randomization exclusion|1|||
23458316|NCT03221556|65421256|FG000|Follow-Up|Withdrawal by Subject|0|||
23458317|NCT03221556|65421257|FG001|Follow-Up|Withdrawal by Subject|1|||
23458318|NCT03748823|65421269|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
23458319|NCT03748823|65421270|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
23458320|NCT03748823|65421269|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
23458321|NCT03748823|65421270|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
23458322|NCT03748823|65421269|FG000|Extension Period|Withdrawal by Subject|9|||
23458323|NCT03748823|65421270|FG001|Extension Period|Withdrawal by Subject|12|||
23239985|NCT02190604|64622136|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239986|NCT02190604|64622137|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239987|NCT02190604|64622138|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239988|NCT02190604|64622139|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239989|NCT02190604|64622140|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239990|NCT02190604|64622141|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23458324|NCT03748823|65421269|FG000|Extension Period|Death|2|||
23458325|NCT03748823|65421270|FG001|Extension Period|Death|2|||
23458326|NCT03748823|65421269|FG000|Extension Period|Other than Specified|0|||
23458327|NCT03748823|65421270|FG001|Extension Period|Other than Specified|1|||
23458328|NCT03748823|65421269|FG000|Extension Period|Protocol Violation|1|||
23458329|NCT03748823|65421270|FG001|Extension Period|Protocol Violation|0|||
23458330|NCT03748823|65421269|FG000|Extension Period|Lost to Follow-up|0|||
23458331|NCT03748823|65421270|FG001|Extension Period|Lost to Follow-up|1|||
23458332|NCT03748823|65421269|FG000|Extension Period|Lack of Efficacy|0|||
23458333|NCT03748823|65421270|FG001|Extension Period|Lack of Efficacy|1|||
23458334|NCT03748823|65421269|FG000|Extension Period|Physician Decision|1|||
23458335|NCT03748823|65421270|FG001|Extension Period|Physician Decision|2|||
23458336|NCT00829426|65421271|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23180130|NCT01324830|64401738|FG018|Overall Study|Withdrawal by Subject|1|||
23180131|NCT03529409|64401739|FG000|Randomized|Lost to Follow-up|0|||
23180132|NCT03529409|64401740|FG001|Randomized|Lost to Follow-up|0|||
23180133|NCT03529409|64401741|FG002|Randomized|Lost to Follow-up|4|||
23180134|NCT03529409|64401739|FG000|Randomized|Excluded|0|||
23180135|NCT03529409|64401740|FG001|Randomized|Excluded|0|||
23180136|NCT03529409|64401741|FG002|Randomized|Excluded|1|||
23180137|NCT03529409|64401739|FG000|Post-treatment Assessment|Death|1|||
23180138|NCT03529409|64401740|FG001|Post-treatment Assessment|Death|0|||
23180139|NCT03529409|64401741|FG002|Post-treatment Assessment|Death|0|||
23180140|NCT03529409|64401739|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
23458337|NCT00829426|65421272|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23458338|NCT02004236|65421277|FG000|Overall Study|Lack of Efficacy|0|||
23458339|NCT02004236|65421278|FG001|Overall Study|Lack of Efficacy|0|||
23458340|NCT02004236|65421279|FG002|Overall Study|Lack of Efficacy|16|||
23458341|NCT02129699|65421284|FG000|Overall Study|Did not start treatment|3|||
23458342|NCT02129699|65421285|FG001|Overall Study|Did not start treatment|2|||
23458343|NCT00179621|65421290|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
23180141|NCT03529409|64401740|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
23180142|NCT03529409|64401741|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
23180143|NCT03529409|64401739|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
23239991|NCT02190604|64622142|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23458344|NCT00179621|65421291|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
23458345|NCT00179621|65421292|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
23458346|NCT00179621|65421293|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
23458347|NCT00179621|65421290|FG000|Double-Blind Period|Adverse Event|2|||
23458348|NCT00179621|65421291|FG001|Double-Blind Period|Adverse Event|7|||
23458349|NCT00179621|65421292|FG002|Double-Blind Period|Adverse Event|4|||
23458350|NCT00179621|65421293|FG003|Double-Blind Period|Adverse Event|0|||
23458351|NCT00179621|65421290|FG000|Double-Blind Period|Withdrawal by Subject|2|||
23458352|NCT00179621|65421291|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23458353|NCT00179621|65421292|FG002|Double-Blind Period|Withdrawal by Subject|3|||
23458354|NCT00179621|65421293|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23458355|NCT00179621|65421290|FG000|Double-Blind Period|Death|0|||
23458356|NCT00179621|65421291|FG001|Double-Blind Period|Death|1|||
23458357|NCT00179621|65421292|FG002|Double-Blind Period|Death|2|||
23583713|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583714|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23239992|NCT02190604|64622143|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239993|NCT02190604|64622144|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239994|NCT02190604|64622145|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239995|NCT02190604|64622146|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239996|NCT02190604|64622147|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239997|NCT02190604|64622148|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
23239998|NCT02190604|64622149|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23239999|NCT02190604|64622150|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23583715|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583716|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583717|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583718|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583719|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23180144|NCT03529409|64401740|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
23180145|NCT03529409|64401741|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
23180146|NCT03529409|64401739|FG000|Follow-up Assessment|Death|1|||
23180147|NCT03529409|64401740|FG001|Follow-up Assessment|Death|0|||
23180148|NCT03529409|64401741|FG002|Follow-up Assessment|Death|0|||
23180149|NCT03529409|64401739|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
23180150|NCT03529409|64401740|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
23180151|NCT03529409|64401741|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
23240000|NCT02190604|64622151|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23240001|NCT02190604|64622152|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
23240002|NCT02190604|64622134|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23583720|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23583721|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
23180152|NCT02472847|64401750|FG000|Overall Study|Withdrawal by Subject|1|||
23240003|NCT02190604|64622135|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240004|NCT02190604|64622136|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240005|NCT02190604|64622137|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240006|NCT02190604|64622138|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240007|NCT02190604|64622139|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240008|NCT02190604|64622140|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240009|NCT02190604|64622141|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240010|NCT02190604|64622142|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240011|NCT02190604|64622143|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240012|NCT02190604|64622144|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240013|NCT02190604|64622145|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240014|NCT02190604|64622146|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240015|NCT02190604|64622147|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
23240016|NCT02190604|64622148|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240017|NCT02190604|64622149|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240018|NCT02190604|64622150|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240019|NCT02190604|64622151|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240020|NCT02190604|64622152|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
23240021|NCT04177862|64622155|FG000|Overall Study|Protocol Violation|2|||
23240022|NCT04177862|64622156|FG001|Overall Study|Protocol Violation|7|||
23240023|NCT04235959|64622157|FG000|Overall Study|Protocol Violation|0|||
23458358|NCT00179621|65421293|FG003|Double-Blind Period|Death|0|||
23458359|NCT00179621|65421290|FG000|Double-Blind Period|Protocol Violation|1|||
23458360|NCT00179621|65421291|FG001|Double-Blind Period|Protocol Violation|0|||
23458361|NCT00179621|65421292|FG002|Double-Blind Period|Protocol Violation|0|||
23458362|NCT00179621|65421293|FG003|Double-Blind Period|Protocol Violation|0|||
23240024|NCT04235959|64622158|FG001|Overall Study|Protocol Violation|1|||
23240025|NCT04235959|64622159|FG002|Overall Study|Protocol Violation|0|||
23240026|NCT04235959|64622157|FG000|Overall Study|Adverse Event|1|||
23240027|NCT04235959|64622158|FG001|Overall Study|Adverse Event|0|||
23240028|NCT04235959|64622159|FG002|Overall Study|Adverse Event|0|||
23240029|NCT00077766|64622174|FG000|Overall Study|Adverse Event|1|||
23240030|NCT00077766|64622175|FG001|Overall Study|Adverse Event|1|||
23240031|NCT00077766|64622174|FG000|Overall Study|Withdrawal by Subject|4|||
23240032|NCT00077766|64622175|FG001|Overall Study|Withdrawal by Subject|3|||
23240033|NCT00077766|64622174|FG000|Overall Study|Death|12|||
23240034|NCT00077766|64622175|FG001|Overall Study|Death|10|||
23240035|NCT00077766|64622174|FG000|Overall Study|Lost to Follow-up|2|||
23240036|NCT00077766|64622175|FG001|Overall Study|Lost to Follow-up|0|||
23240037|NCT00077766|64622174|FG000|Overall Study|Protocol Violation|1|||
23240038|NCT00077766|64622175|FG001|Overall Study|Protocol Violation|0|||
23240039|NCT00077766|64622174|FG000|Overall Study|Kidney Transplantation|9|||
23240040|NCT00077766|64622175|FG001|Overall Study|Kidney Transplantation|5|||
23240041|NCT00077766|64622174|FG000|Overall Study|Transplantation|5|||
23240042|NCT00077766|64622175|FG001|Overall Study|Transplantation|1|||
23240043|NCT00077766|64622174|FG000|Overall Study|Investigators Discretion|1|||
23240044|NCT00077766|64622175|FG001|Overall Study|Investigators Discretion|0|||
23240045|NCT00077766|64622174|FG000|Overall Study|Participant's decision|1|||
23240046|NCT00077766|64622175|FG001|Overall Study|Participant's decision|0|||
23240047|NCT00077766|64622174|FG000|Overall Study|Dialysis Discontinued|1|||
23240048|NCT00077766|64622175|FG001|Overall Study|Dialysis Discontinued|0|||
23240049|NCT00077766|64622174|FG000|Overall Study|Dialysis|0|||
23240050|NCT00077766|64622175|FG001|Overall Study|Dialysis|1|||
23240051|NCT00077766|64622174|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
23240052|NCT00077766|64622175|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
23240053|NCT00077766|64622174|FG000|Overall Study|Started Nocturnal Dialysis|0|||
23240054|NCT00077766|64622175|FG001|Overall Study|Started Nocturnal Dialysis|1|||
23240055|NCT00077766|64622174|FG000|Overall Study|Stop Dialysis|0|||
23240056|NCT00077766|64622175|FG001|Overall Study|Stop Dialysis|1|||
23240057|NCT00077766|64622174|FG000|Overall Study|Participants Vacation|2|||
23240058|NCT00077766|64622175|FG001|Overall Study|Participants Vacation|1|||
23240059|NCT01041027|64622176|FG000|Overall Study|Withdrawal by Subject|2|||
23240060|NCT01041027|64622176|FG000|Overall Study|Protocol Violation|1|||
23240061|NCT01041027|64622176|FG000|Overall Study|Delayed Radiation Therapy|1|||
23180153|NCT02472847|64401751|FG001|Overall Study|Withdrawal by Subject|5|||
23180154|NCT01661790|64401754|FG000|Overall Study|Lost to Follow-up|0|||
23240062|NCT01041027|64622176|FG000|Overall Study|Adverse Event|4|||
23240063|NCT02696382|64622177|FG000|Overall Study|Death|7|||
23240064|NCT02696382|64622178|FG001|Overall Study|Death|2|||
23240065|NCT02696382|64622177|FG000|Overall Study|Withdrawal by Subject|5|||
23240066|NCT02696382|64622178|FG001|Overall Study|Withdrawal by Subject|12|||
23240067|NCT02696382|64622177|FG000|Overall Study|Lost to Follow-up|4|||
23240068|NCT02696382|64622178|FG001|Overall Study|Lost to Follow-up|7|||
23240069|NCT02950831|64622179|FG000|Overall Study|Lost to Follow-up|1|||
23180155|NCT01661790|64401755|FG001|Overall Study|Lost to Follow-up|2|||
23180156|NCT00454207|64401756|FG000|Overall Study|Adverse Event|3|||
23180157|NCT00454207|64401757|FG001|Overall Study|Adverse Event|1|||
23180158|NCT00454207|64401756|FG000|Overall Study|Lack of Efficacy|1|||
23180159|NCT00454207|64401757|FG001|Overall Study|Lack of Efficacy|0|||
23180160|NCT00454207|64401756|FG000|Overall Study|Protocol Violation|0|||
23180161|NCT00454207|64401757|FG001|Overall Study|Protocol Violation|1|||
23180162|NCT00331006|64401758|FG000|Screening Phase|Withdrawal by Subject|1|||
23180163|NCT00331006|64401758|FG000|Screening Phase|enrollment halted|1|||
23180164|NCT00331006|64401758|FG000|Screening Phase|Lost to Follow-up|1|||
23180165|NCT00331006|64401758|FG000|Screening Phase|Ineligible for treatment phase|4|||
23180166|NCT00331006|64401758|FG000|Treatment Phase|Withdrawal by Subject|1|||
23180167|NCT00331006|64401758|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
23180168|NCT00331006|64401758|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
23180169|NCT00289913|64401761|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23180170|NCT00289913|64401762|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
23180171|NCT00289913|64401763|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23180172|NCT00289913|64401764|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23240070|NCT02950831|64622179|FG000|Overall Study|Withdrawal by Subject|3|||
23240071|NCT02950831|64622179|FG000|Overall Study|stimulation trail failure|5|||
23240072|NCT01682876|64622180|FG000|Overall Study|Administrative reason|4|||
23240073|NCT01682876|64622181|FG001|Overall Study|Administrative reason|4|||
23240074|NCT01682876|64622182|FG002|Overall Study|Administrative reason|0|||
23346967|NCT01534208|65014167|FG000|Overall Study|PCP decision|1|||
23180173|NCT00289913|64401765|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23180174|NCT00289913|64401761|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
23180175|NCT00289913|64401762|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
23240075|NCT01682876|64622183|FG003|Overall Study|Administrative reason|3|||
23346968|NCT01534208|65014168|FG001|Overall Study|PCP decision|0|||
23346969|NCT01534208|65014167|FG000|Overall Study|Needed prohibited meds|1|||
23346970|NCT01534208|65014168|FG001|Overall Study|Needed prohibited meds|0|||
23346971|NCT04329091|65014171|FG000|Overall Study|Physician Decision|5|||
23346972|NCT01404208|65014174|FG000|Overall Study|Discontinued|3|||
23346973|NCT01404208|65014175|FG001|Overall Study|Discontinued|0|||
23346974|NCT02919267|65014176|FG000|Overall Study|Protocol Violation|0|||
23346975|NCT02919267|65014177|FG001|Overall Study|Protocol Violation|3|||
23346976|NCT02919267|65014178|FG002|Overall Study|Protocol Violation|3|||
23346977|NCT02919267|65014179|FG003|Overall Study|Protocol Violation|4|||
23346978|NCT04481191|65014186|FG000|Overall Study|Withdrawn by parent/guardian|15|||
23346979|NCT04481191|65014187|FG001|Overall Study|Withdrawn by parent/guardian|10|||
23346980|NCT00597012|65014189|FG000|Overall Study|Death|1|||
23346981|NCT00597012|65014190|FG001|Overall Study|Death|1|||
23346982|NCT00597012|65014189|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
23346983|NCT00597012|65014190|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
23346984|NCT00597012|65014189|FG000|Overall Study|Withdrawal by Subject|7|||
23346985|NCT00597012|65014190|FG001|Overall Study|Withdrawal by Subject|4|||
23346986|NCT00597012|65014189|FG000|Overall Study|Ineligible|2|||
23346987|NCT00597012|65014190|FG001|Overall Study|Ineligible|0|||
23346988|NCT00597012|65014189|FG000|Overall Study|Lost to Follow-up|0|||
23346989|NCT00597012|65014190|FG001|Overall Study|Lost to Follow-up|2|||
23346990|NCT02858180|65014191|FG000|Overall Study|Lost to Follow-up|0|||
23346991|NCT02858180|65014192|FG001|Overall Study|Lost to Follow-up|2|||
23346992|NCT01085136|65014196|FG000|Part A|Other Adverse event|223|||
23346993|NCT01085136|65014197|FG001|Part A|Other Adverse event|0|||
23346994|NCT01085136|65014198|FG002|Part A|Other Adverse event|0|||
23346995|NCT01085136|65014196|FG000|Part A|Protocol Violation|3|||
23346996|NCT01085136|65014197|FG001|Part A|Protocol Violation|0|||
23346997|NCT01085136|65014198|FG002|Part A|Protocol Violation|0|||
23346998|NCT01085136|65014196|FG000|Part A|Lost to Follow-up|3|||
23346999|NCT01085136|65014197|FG001|Part A|Lost to Follow-up|0|||
23347000|NCT01085136|65014198|FG002|Part A|Lost to Follow-up|0|||
23347001|NCT01085136|65014196|FG000|Part A|Refusal to continue trial medication|64|||
23347002|NCT01085136|65014197|FG001|Part A|Refusal to continue trial medication|0|||
23347003|NCT01085136|65014198|FG002|Part A|Refusal to continue trial medication|0|||
23347004|NCT01085136|65014196|FG000|Part A|Other reason not defined above|30|||
23347005|NCT01085136|65014197|FG001|Part A|Other reason not defined above|0|||
23347006|NCT01085136|65014198|FG002|Part A|Other reason not defined above|0|||
23347007|NCT01085136|65014196|FG000|Part B|Other AE|0|||
23347008|NCT01085136|65014197|FG001|Part B|Other AE|29|||
23347009|NCT01085136|65014198|FG002|Part B|Other AE|8|||
23347010|NCT01085136|65014196|FG000|Part B|Refusal to continue trial medication|0|||
23347011|NCT01085136|65014197|FG001|Part B|Refusal to continue trial medication|12|||
23347012|NCT01085136|65014198|FG002|Part B|Refusal to continue trial medication|7|||
23347013|NCT01085136|65014196|FG000|Part B|Not treated|0|||
23347014|NCT01085136|65014197|FG001|Part B|Not treated|4|||
23347015|NCT01085136|65014198|FG002|Part B|Not treated|8|||
23347016|NCT01085136|65014196|FG000|Part B|Other reason not defined above|0|||
23180176|NCT00289913|64401763|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
23180177|NCT00289913|64401764|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
23240076|NCT01682876|64622180|FG000|Overall Study|Adverse Event|0|||
23347017|NCT01085136|65014197|FG001|Part B|Other reason not defined above|6|||
23347018|NCT01085136|65014198|FG002|Part B|Other reason not defined above|3|||
23347019|NCT00623597|65014199|FG000|Overall Study|Failed to return|1|||
23347020|NCT00623597|65014200|FG001|Overall Study|Failed to return|0|||
23347021|NCT01322035|65014205|FG000|Overall Study|Lost to Follow-up|8|||
23347022|NCT01322035|65014206|FG001|Overall Study|Lost to Follow-up|3|||
23347023|NCT00081731|65014209|FG000|Overall Study|scientific integrity issue|8|||
23347024|NCT00081731|65014210|FG001|Overall Study|scientific integrity issue|8|||
23347025|NCT00767039|65014211|FG000|Overall Study|Death|5|||
23347026|NCT00767039|65014212|FG001|Overall Study|Death|2|||
23347027|NCT03332628|65014213|FG000|Overall Study|Physician Decision|2|||
23458363|NCT00179621|65421290|FG000|Double-Blind Period|Other|0|||
23458364|NCT00179621|65421291|FG001|Double-Blind Period|Other|2|||
23458365|NCT00179621|65421292|FG002|Double-Blind Period|Other|2|||
23347028|NCT01629823|65014221|FG000|Trial Period|Missed visit|11|||
23347029|NCT01629823|65014222|FG001|Trial Period|Missed visit|9|||
23347030|NCT01629823|65014223|FG002|Trial Period|Missed visit|8|||
23347031|NCT01629823|65014221|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
23347032|NCT01629823|65014222|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
23347033|NCT01629823|65014223|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
23347034|NCT01629823|65014221|FG000|Trial Period|Pregnancy|1|||
23347035|NCT01629823|65014222|FG001|Trial Period|Pregnancy|0|||
23347036|NCT01629823|65014223|FG002|Trial Period|Pregnancy|0|||
23347037|NCT01629823|65014221|FG000|Trial Period|Adverse Event|0|||
23347038|NCT01629823|65014222|FG001|Trial Period|Adverse Event|1|||
23458366|NCT00179621|65421293|FG003|Double-Blind Period|Other|0|||
23347039|NCT01629823|65014223|FG002|Trial Period|Adverse Event|0|||
23347040|NCT01629823|65014221|FG000|Trial Period|Out-of-window visit|0|||
23347041|NCT01629823|65014222|FG001|Trial Period|Out-of-window visit|2|||
23347042|NCT01629823|65014223|FG002|Trial Period|Out-of-window visit|0|||
23347043|NCT01629823|65014221|FG000|Trial Period|Failed to hold medication|0|||
23347044|NCT01629823|65014222|FG001|Trial Period|Failed to hold medication|0|||
23347045|NCT01629823|65014223|FG002|Trial Period|Failed to hold medication|1|||
23347046|NCT01629823|65014221|FG000|Washout Period|Safety|2|||
23347047|NCT01629823|65014222|FG001|Washout Period|Safety|5|||
23347048|NCT01629823|65014223|FG002|Washout Period|Safety|0|||
23347049|NCT01629823|65014221|FG000|Washout Period|Pregnancy|1|||
23347050|NCT01629823|65014222|FG001|Washout Period|Pregnancy|0|||
23347051|NCT01629823|65014223|FG002|Washout Period|Pregnancy|0|||
23347052|NCT01629823|65014221|FG000|Washout Period|Protocol Violation|0|||
23347053|NCT01629823|65014222|FG001|Washout Period|Protocol Violation|1|||
23347054|NCT01629823|65014223|FG002|Washout Period|Protocol Violation|0|||
23347055|NCT00793546|65014224|FG000|Overall Study|Death|3|||
23347056|NCT00793546|65014225|FG001|Overall Study|Death|0|||
23347057|NCT00793546|65014224|FG000|Overall Study|Lost to Follow-up|1|||
23347058|NCT00793546|65014225|FG001|Overall Study|Lost to Follow-up|0|||
23347059|NCT00793546|65014224|FG000|Overall Study|Withdrawal by Subject|1|||
23347060|NCT00793546|65014225|FG001|Overall Study|Withdrawal by Subject|1|||
23347061|NCT00793546|65014224|FG000|Overall Study|Study Terminated by Sponsor|8|||
23180178|NCT00289913|64401765|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
23180179|NCT00289913|64401761|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23347062|NCT00793546|65014225|FG001|Overall Study|Study Terminated by Sponsor|27|||
23180180|NCT00289913|64401762|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23180181|NCT00289913|64401763|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23180182|NCT00289913|64401764|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23180183|NCT00289913|64401765|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23180184|NCT00289913|64401761|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
23180185|NCT00289913|64401762|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
23180186|NCT00289913|64401763|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
23347063|NCT00793546|65014224|FG000|Overall Study|Other|1|||
23347064|NCT00793546|65014225|FG001|Overall Study|Other|0|||
23347065|NCT00622336|65014226|FG000|Treatment Phase|Progression of Disease|181|||
23347066|NCT00622336|65014226|FG000|Treatment Phase|Adverse Event|46|||
23347067|NCT00622336|65014226|FG000|Treatment Phase|Other|40|||
23347068|NCT00622336|65014226|FG000|Treatment Phase|Death|14|||
23347069|NCT00622336|65014226|FG000|Treatment Phase|Lack of therapeutic effect|13|||
23347070|NCT00622336|65014226|FG000|Treatment Phase|Withdrawal by Subject|13|||
23347071|NCT00622336|65014226|FG000|Treatment Phase|Lost to Follow-up|2|||
23347072|NCT00622336|65014226|FG000|Extension Phase|Adverse Event|2|||
23347073|NCT00622336|65014226|FG000|Extension Phase|Progressive Disease|6|||
23347074|NCT00622336|65014226|FG000|Extension Phase|Lack of therapeutic effect|2|||
23347075|NCT00622336|65014226|FG000|Extension Phase|Withdrawal by Subject|1|||
23347076|NCT00622336|65014226|FG000|Extension Phase|Lost to Follow-up|1|||
23347077|NCT00622336|65014226|FG000|Extension Phase|Other|9|||
23347078|NCT01730534|65014227|FG000|Overall Study|Withdrawal by Subject|97|||
23347079|NCT01730534|65014228|FG001|Overall Study|Withdrawal by Subject|127|||
23347080|NCT01730534|65014227|FG000|Overall Study|Lost to Follow-up|12|||
23347081|NCT01730534|65014228|FG001|Overall Study|Lost to Follow-up|18|||
23347082|NCT00177307|65014229|FG000|Overall Study|Withdrawal by Subject|1|||
23347083|NCT04007107|65014233|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
23347084|NCT04007107|65014234|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
23347085|NCT04007107|65014235|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
23347086|NCT04007107|65014236|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
23347087|NCT02306694|65014238|FG000|Overall Study|Withdrawal by Subject|3|||
23347088|NCT02306694|65014238|FG000|Overall Study|Lost to Follow-up|1|||
23347089|NCT00157820|65014239|FG000|Randomized|Physician Decision|4|||
23347090|NCT00157820|65014240|FG001|Randomized|Physician Decision|2|||
23347091|NCT00157820|65014241|FG002|Randomized|Physician Decision|3|||
23347092|NCT00157820|65014239|FG000|Randomized|Withdrawal by Subject|1|||
23347093|NCT00157820|65014240|FG001|Randomized|Withdrawal by Subject|2|||
23347094|NCT00157820|65014241|FG002|Randomized|Withdrawal by Subject|3|||
23347095|NCT00157820|65014239|FG000|Randomized|Protocol Violation|2|||
23347096|NCT00157820|65014240|FG001|Randomized|Protocol Violation|1|||
23347097|NCT00157820|65014241|FG002|Randomized|Protocol Violation|2|||
23347098|NCT00157820|65014239|FG000|1st 8 Month|Death|7|||
23347099|NCT00157820|65014240|FG001|1st 8 Month|Death|8|||
23347100|NCT00157820|65014241|FG002|1st 8 Month|Death|3|||
23347101|NCT00157820|65014239|FG000|1st 8 Month|Lost to Follow-up|1|||
23347102|NCT00157820|65014240|FG001|1st 8 Month|Lost to Follow-up|2|||
23347103|NCT00157820|65014241|FG002|1st 8 Month|Lost to Follow-up|1|||
23347104|NCT00157820|65014239|FG000|1st 8 Month|Premature cross-over|0|||
23347105|NCT00157820|65014240|FG001|1st 8 Month|Premature cross-over|2|||
23347106|NCT00157820|65014241|FG002|1st 8 Month|Premature cross-over|2|||
23347107|NCT00157820|65014239|FG000|2nd 8 Months|Death|3|||
23347108|NCT00157820|65014240|FG001|2nd 8 Months|Death|1|||
23347109|NCT00157820|65014241|FG002|2nd 8 Months|Death|3|||
23347110|NCT00157820|65014239|FG000|2nd 8 Months|Lost to Follow-up|1|||
23347111|NCT00157820|65014240|FG001|2nd 8 Months|Lost to Follow-up|5|||
23347112|NCT00157820|65014241|FG002|2nd 8 Months|Lost to Follow-up|2|||
23347113|NCT00157820|65014239|FG000|2nd 8 Months|Premature cross-over|1|||
23347114|NCT00157820|65014240|FG001|2nd 8 Months|Premature cross-over|7|||
23347115|NCT00157820|65014241|FG002|2nd 8 Months|Premature cross-over|9|||
23347116|NCT03199612|65014245|FG000|Overall Study|Adverse Event|1|||
23347117|NCT03199612|65014246|FG001|Overall Study|Adverse Event|0|||
23347118|NCT02071082|65014248|FG000|Overall Study|Enrolled and Never Treated|1|||
23347119|NCT02071082|65014249|FG001|Overall Study|Enrolled and Never Treated|1|||
23347120|NCT02071082|65014248|FG000|Overall Study|Adverse Event|0|||
23347121|NCT02071082|65014249|FG001|Overall Study|Adverse Event|1|||
23347122|NCT02071082|65014248|FG000|Overall Study|Withdrew Consent|0|||
23347123|NCT02071082|65014249|FG001|Overall Study|Withdrew Consent|4|||
23347124|NCT02071082|65014248|FG000|Overall Study|Lost to Follow-up|1|||
23347125|NCT02071082|65014249|FG001|Overall Study|Lost to Follow-up|1|||
23347126|NCT02450552|65014252|FG000|Overall Study|Withdrawal by Subject|4|||
23347127|NCT02450552|65014253|FG001|Overall Study|Withdrawal by Subject|0|||
23347128|NCT02450552|65014254|FG002|Overall Study|Withdrawal by Subject|4|||
23347129|NCT02450552|65014252|FG000|Overall Study|Physician Decision|1|||
23347130|NCT02450552|65014253|FG001|Overall Study|Physician Decision|0|||
23347131|NCT02450552|65014254|FG002|Overall Study|Physician Decision|1|||
23347132|NCT01995175|65014255|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
23347133|NCT01995175|65014255|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
23347134|NCT01995175|65014255|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
23347135|NCT01995175|65014255|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
23347136|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
23347137|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
23347138|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
23347139|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
23347140|NCT01995175|65014255|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
23347141|NCT02604550|65014256|FG000|Overall Study|Lost to Follow-up|7|||
23347142|NCT02604550|65014257|FG001|Overall Study|Lost to Follow-up|6|||
23347143|NCT02604550|65014256|FG000|Overall Study|Withdrawal by Subject|0|||
23347144|NCT02604550|65014257|FG001|Overall Study|Withdrawal by Subject|1|||
23347145|NCT02604550|65014256|FG000|Overall Study|Incomplete data using paper journal|18|||
23347146|NCT02604550|65014257|FG001|Overall Study|Incomplete data using paper journal|19|||
23347147|NCT02370667|65014260|FG000|Overall Study|Lost to Follow-up|0|||
23347148|NCT02370667|65014261|FG001|Overall Study|Lost to Follow-up|1|||
23347149|NCT02370667|65014262|FG002|Overall Study|Lost to Follow-up|0|||
23347150|NCT01625689|65014264|FG000|Overall Study|Migration|2|||
23347151|NCT01625689|65014265|FG001|Overall Study|Migration|1|||
23347152|NCT00636194|65014266|FG000|Overall Study|Study related symptoms and complaints|1|||
23347153|NCT00636194|65014267|FG001|Overall Study|Study related symptoms and complaints|0|||
23347154|NCT00636194|65014266|FG000|Overall Study|Protocol Violation|2|||
23347155|NCT00636194|65014267|FG001|Overall Study|Protocol Violation|0|||
23347156|NCT03197870|65014268|FG000|Overall Study|Adverse Event|9|||
23347157|NCT03197870|65014269|FG001|Overall Study|Adverse Event|4|||
23347158|NCT03197870|65014270|FG002|Overall Study|Adverse Event|6|||
23347159|NCT03197870|65014268|FG000|Overall Study|Withdrawal by Subject|2|||
23347160|NCT03197870|65014269|FG001|Overall Study|Withdrawal by Subject|3|||
23347161|NCT03197870|65014270|FG002|Overall Study|Withdrawal by Subject|0|||
23347162|NCT03197870|65014268|FG000|Overall Study|Lost to Follow-up|2|||
23347163|NCT03197870|65014269|FG001|Overall Study|Lost to Follow-up|2|||
23347164|NCT03197870|65014270|FG002|Overall Study|Lost to Follow-up|0|||
23347165|NCT03197870|65014268|FG000|Overall Study|data not available|1|||
23347166|NCT03197870|65014269|FG001|Overall Study|data not available|1|||
23347167|NCT03197870|65014270|FG002|Overall Study|data not available|0|||
23347168|NCT02195427|65014273|FG000|Overall Study|Did not consent to study extension|13|||
23347169|NCT02195427|65014274|FG001|Overall Study|Did not consent to study extension|9|||
23347170|NCT02195427|65014273|FG000|Overall Study|Withdrawal by Subject|4|||
23347171|NCT02195427|65014274|FG001|Overall Study|Withdrawal by Subject|2|||
23347172|NCT02195427|65014273|FG000|Overall Study|Lost to Follow-up|0|||
23347173|NCT02195427|65014274|FG001|Overall Study|Lost to Follow-up|1|||
23347174|NCT02195427|65014273|FG000|Overall Study|Protocol Violation|7|||
23347175|NCT02195427|65014274|FG001|Overall Study|Protocol Violation|14|||
23347176|NCT02195427|65014273|FG000|Overall Study|Conditional re-treatment at W52|2|||
23347177|NCT02195427|65014274|FG001|Overall Study|Conditional re-treatment at W52|1|||
23347178|NCT03782974|65014277|FG000|Overall Study|Withdrawal by Subject|7|||
23347179|NCT03782974|65014278|FG001|Overall Study|Withdrawal by Subject|7|||
23240077|NCT01682876|64622181|FG001|Overall Study|Adverse Event|0|||
23347180|NCT03782974|65014277|FG000|Overall Study|Pregnancy|1|||
23347181|NCT03782974|65014278|FG001|Overall Study|Pregnancy|0|||
23347182|NCT03787303|65014279|FG000|Overall Study|Death|1|||
23347183|NCT03787303|65014279|FG000|Overall Study|Premature Termination of Study|1|||
23347184|NCT01955109|65014283|FG000|Overall Study|Adverse Event|2|||
23347185|NCT01955109|65014284|FG001|Overall Study|Adverse Event|0|||
23347186|NCT01955109|65014283|FG000|Overall Study|Participant unwilling to continue|35|||
23347187|NCT01955109|65014284|FG001|Overall Study|Participant unwilling to continue|7|||
23347188|NCT01955109|65014283|FG000|Overall Study|Physician Decision|2|||
23347189|NCT01955109|65014284|FG001|Overall Study|Physician Decision|0|||
23347190|NCT01955109|65014283|FG000|Overall Study|Lost to Follow-up|3|||
23347191|NCT01955109|65014284|FG001|Overall Study|Lost to Follow-up|1|||
23347192|NCT01955109|65014283|FG000|Overall Study|Non-compliance|3|||
23347193|NCT01955109|65014284|FG001|Overall Study|Non-compliance|1|||
23347194|NCT01844505|65014285|FG000|Overall Study|Disease progression|170|||
23347195|NCT01844505|65014286|FG001|Overall Study|Disease progression|88|||
23347196|NCT01844505|65014287|FG002|Overall Study|Disease progression|224|||
23347197|NCT01844505|65014285|FG000|Overall Study|Study drug toxicity|40|||
23347198|NCT01844505|65014286|FG001|Overall Study|Study drug toxicity|131|||
23347199|NCT01844505|65014287|FG002|Overall Study|Study drug toxicity|50|||
23347200|NCT01844505|65014285|FG000|Overall Study|Death|1|||
23347201|NCT01844505|65014286|FG001|Overall Study|Death|3|||
23347202|NCT01844505|65014287|FG002|Overall Study|Death|1|||
23347203|NCT01844505|65014285|FG000|Overall Study|Adverse event unrelated to study drug|7|||
23347204|NCT01844505|65014286|FG001|Overall Study|Adverse event unrelated to study drug|15|||
23347205|NCT01844505|65014287|FG002|Overall Study|Adverse event unrelated to study drug|6|||
23347206|NCT01844505|65014285|FG000|Overall Study|Subject request discontinue treatment|17|||
23347207|NCT01844505|65014286|FG001|Overall Study|Subject request discontinue treatment|14|||
23347208|NCT01844505|65014287|FG002|Overall Study|Subject request discontinue treatment|8|||
23458367|NCT00179621|65421290|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
23458368|NCT00179621|65421291|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
23458369|NCT00179621|65421292|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
23458370|NCT00179621|65421293|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
23458371|NCT00179621|65421290|FG000|Open-Label Period|Adverse Event|0|||
23458372|NCT00179621|65421291|FG001|Open-Label Period|Adverse Event|6|||
23458373|NCT00179621|65421292|FG002|Open-Label Period|Adverse Event|5|||
23458374|NCT00179621|65421293|FG003|Open-Label Period|Adverse Event|6|||
23458375|NCT00179621|65421290|FG000|Open-Label Period|Withdrawal by Subject|0|||
23458376|NCT00179621|65421291|FG001|Open-Label Period|Withdrawal by Subject|2|||
23180187|NCT00289913|64401764|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
23180188|NCT00289913|64401765|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
23180189|NCT00289913|64401761|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180190|NCT00289913|64401762|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180191|NCT00289913|64401763|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180192|NCT00289913|64401764|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
23180193|NCT00289913|64401765|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180194|NCT00289913|64401761|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
23180195|NCT00289913|64401762|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
23180196|NCT00289913|64401763|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23180197|NCT00289913|64401764|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23180198|NCT00289913|64401765|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23180199|NCT00289913|64401761|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
23180200|NCT00289913|64401762|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
23180201|NCT00289913|64401763|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
23180202|NCT00289913|64401764|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
23180203|NCT00289913|64401765|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
23180204|NCT00289913|64401761|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23180205|NCT00289913|64401762|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
23180206|NCT00289913|64401763|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
23180207|NCT00289913|64401764|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
23180208|NCT00289913|64401765|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23180209|NCT00289913|64401761|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
23180210|NCT00289913|64401762|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23180211|NCT00289913|64401763|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
23180212|NCT00289913|64401764|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23180213|NCT00289913|64401765|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23180214|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23240078|NCT01682876|64622182|FG002|Overall Study|Adverse Event|0|||
23347209|NCT01844505|65014285|FG000|Overall Study|Withdrawal by Subject|0|||
23347210|NCT01844505|65014286|FG001|Overall Study|Withdrawal by Subject|3|||
23458377|NCT00179621|65421292|FG002|Open-Label Period|Withdrawal by Subject|2|||
23347211|NCT01844505|65014287|FG002|Overall Study|Withdrawal by Subject|0|||
23347212|NCT01844505|65014285|FG000|Overall Study|Lost to Follow-up|1|||
23347213|NCT01844505|65014286|FG001|Overall Study|Lost to Follow-up|0|||
23347214|NCT01844505|65014287|FG002|Overall Study|Lost to Follow-up|0|||
23347215|NCT01844505|65014285|FG000|Overall Study|Maximum clinical benefit|8|||
23458378|NCT00179621|65421293|FG003|Open-Label Period|Withdrawal by Subject|2|||
23583722|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583723|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583724|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
23583725|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
23583726|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583727|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583728|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583729|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583730|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583731|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583732|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583733|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583734|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583735|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
23583736|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583737|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583738|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583739|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583740|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583741|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583742|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583743|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583744|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
23583745|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583746|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583747|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583748|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583749|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
23583750|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583751|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23240079|NCT01682876|64622183|FG003|Overall Study|Adverse Event|1|||
23240080|NCT01682876|64622180|FG000|Overall Study|Lost to Follow-up|11|||
23240081|NCT01682876|64622181|FG001|Overall Study|Lost to Follow-up|15|||
23240082|NCT01682876|64622182|FG002|Overall Study|Lost to Follow-up|9|||
23240083|NCT01682876|64622183|FG003|Overall Study|Lost to Follow-up|11|||
23240084|NCT01682876|64622180|FG000|Overall Study|Protocol Violation|1|||
23240085|NCT01682876|64622181|FG001|Overall Study|Protocol Violation|1|||
23240086|NCT01682876|64622182|FG002|Overall Study|Protocol Violation|1|||
23240087|NCT01682876|64622183|FG003|Overall Study|Protocol Violation|1|||
23240088|NCT01682876|64622180|FG000|Overall Study|Withdrawal by Subject|4|||
23240089|NCT01682876|64622181|FG001|Overall Study|Withdrawal by Subject|0|||
23240090|NCT01682876|64622182|FG002|Overall Study|Withdrawal by Subject|0|||
23240091|NCT01682876|64622183|FG003|Overall Study|Withdrawal by Subject|2|||
23240092|NCT01682876|64622180|FG000|Overall Study|Other|1|||
23240093|NCT01682876|64622181|FG001|Overall Study|Other|0|||
23240094|NCT01682876|64622182|FG002|Overall Study|Other|1|||
23240095|NCT01682876|64622183|FG003|Overall Study|Other|1|||
23240096|NCT02044094|64622184|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
23240097|NCT02044094|64622184|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
23240098|NCT02044094|64622184|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
23240099|NCT02044094|64622184|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
23240100|NCT02044094|64622184|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
23240101|NCT02044094|64622184|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
23583752|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583753|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23240102|NCT02044094|64622184|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
23240103|NCT02044094|64622184|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
23347216|NCT01844505|65014286|FG001|Overall Study|Maximum clinical benefit|11|||
23347217|NCT01844505|65014287|FG002|Overall Study|Maximum clinical benefit|2|||
23347218|NCT01844505|65014285|FG000|Overall Study|Poor/non-compliance|1|||
23347219|NCT01844505|65014286|FG001|Overall Study|Poor/non-compliance|1|||
23458379|NCT00179621|65421290|FG000|Open-Label Period|Death|0|||
23240104|NCT00465101|64622186|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
23240105|NCT00465101|64622186|FG000|Overall Study|Change in health precluded follow up|4|||
23240106|NCT00465101|64622186|FG000|Overall Study|Did not meet study criteria|4|||
23180215|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23180216|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
23180217|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23458380|NCT00179621|65421291|FG001|Open-Label Period|Death|0|||
23458381|NCT00179621|65421292|FG002|Open-Label Period|Death|1|||
23240107|NCT00465101|64622186|FG000|Overall Study|Lost to Follow-up|5|||
23240108|NCT00465101|64622186|FG000|Overall Study|Other|6|||
23240109|NCT00465101|64622186|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
23240110|NCT00465101|64622186|FG000|Overall Study|Patient postponed procedure|1|||
23240111|NCT00465101|64622186|FG000|Overall Study|Site closed due to IRB expiration|1|||
23240112|NCT00465101|64622186|FG000|Overall Study|Unable to obtain IRB approval|1|||
23240113|NCT00465101|64622186|FG000|Overall Study|Death|3|||
23240114|NCT00465101|64622186|FG000|Overall Study|Withdrawal by Subject|25|||
23240115|NCT00465101|64622186|FG000|Overall Study|Physician Decision|1|||
23240116|NCT00465101|64622186|FG000|Overall Study|Withdrew consent prior to procedure|3|||
23240117|NCT03433482|64622187|FG000|Overall Study|Lost to Follow-up|1|||
23240118|NCT03433482|64622188|FG001|Overall Study|Lost to Follow-up|0|||
23240119|NCT03433482|64622189|FG002|Overall Study|Lost to Follow-up|1|||
23240120|NCT03433482|64622190|FG003|Overall Study|Lost to Follow-up|1|||
23240121|NCT03433482|64622187|FG000|Overall Study|Withdrawal by Subject|0|||
23240122|NCT03433482|64622188|FG001|Overall Study|Withdrawal by Subject|0|||
23240123|NCT03433482|64622189|FG002|Overall Study|Withdrawal by Subject|1|||
23347220|NCT01844505|65014287|FG002|Overall Study|Poor/non-compliance|1|||
23347221|NCT01844505|65014285|FG000|Overall Study|Subject no longer meets criteria|0|||
23347222|NCT01844505|65014286|FG001|Overall Study|Subject no longer meets criteria|1|||
23347223|NCT01844505|65014287|FG002|Overall Study|Subject no longer meets criteria|0|||
23347224|NCT01844505|65014285|FG000|Overall Study|Other Reasons|4|||
23458382|NCT00179621|65421293|FG003|Open-Label Period|Death|2|||
23180218|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23458383|NCT00179621|65421290|FG000|Open-Label Period|Other|0|||
23180219|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
23180220|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
23180221|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
23180222|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
23180223|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
23180224|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
23180225|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
23180226|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
23180227|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
23180228|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
23180229|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
23180230|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
23180231|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
23180232|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23180233|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23180234|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
23180235|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180236|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
23180237|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180238|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180239|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23180240|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
23458384|NCT00179621|65421291|FG001|Open-Label Period|Other|1|||
23458385|NCT00179621|65421292|FG002|Open-Label Period|Other|1|||
23458386|NCT00179621|65421293|FG003|Open-Label Period|Other|2|||
23458387|NCT02475681|65421297|FG000|Overall Study|Death|16|||
23458388|NCT02475681|65421298|FG001|Overall Study|Death|6|||
23458389|NCT02475681|65421299|FG002|Overall Study|Death|9|||
23458390|NCT02475681|65421297|FG000|Overall Study|Physician Decision|0|||
23458391|NCT02475681|65421298|FG001|Overall Study|Physician Decision|3|||
23240124|NCT03433482|64622190|FG003|Overall Study|Withdrawal by Subject|0|||
23240125|NCT03433482|64622187|FG000|Overall Study|Unknown reason|0|||
23240126|NCT03433482|64622188|FG001|Overall Study|Unknown reason|0|||
23240127|NCT03433482|64622189|FG002|Overall Study|Unknown reason|2|||
23347225|NCT01844505|65014286|FG001|Overall Study|Other Reasons|2|||
23458392|NCT02475681|65421299|FG002|Overall Study|Physician Decision|1|||
23458393|NCT02475681|65421297|FG000|Overall Study|Withdrawal by Subject|12|||
23458394|NCT02475681|65421298|FG001|Overall Study|Withdrawal by Subject|6|||
23458395|NCT02475681|65421299|FG002|Overall Study|Withdrawal by Subject|9|||
23458396|NCT02475681|65421297|FG000|Overall Study|Lost to Follow-up|2|||
23458397|NCT02475681|65421298|FG001|Overall Study|Lost to Follow-up|1|||
23458398|NCT02475681|65421299|FG002|Overall Study|Lost to Follow-up|3|||
23458399|NCT02475681|65421297|FG000|Overall Study|Ongoing in Study|0|||
23458400|NCT02475681|65421298|FG001|Overall Study|Ongoing in Study|163|||
23458401|NCT02475681|65421299|FG002|Overall Study|Ongoing in Study|157|||
23458402|NCT02475681|65421297|FG000|Overall Study|Reasons other than above listed|2|||
23458403|NCT02475681|65421298|FG001|Overall Study|Reasons other than above listed|0|||
23458404|NCT02475681|65421299|FG002|Overall Study|Reasons other than above listed|0|||
23458405|NCT01607957|65421300|FG000|Overall Study|Not treated|1|||
23458406|NCT01607957|65421301|FG001|Overall Study|Not treated|1|||
23458407|NCT01607957|65421300|FG000|Overall Study|Death|367|||
23458408|NCT01607957|65421301|FG001|Overall Study|Death|211|||
23458409|NCT01607957|65421300|FG000|Overall Study|Lost to Follow-up|3|||
23458410|NCT01607957|65421301|FG001|Overall Study|Lost to Follow-up|3|||
23458411|NCT01607957|65421300|FG000|Overall Study|Participant refusal|1|||
23458412|NCT01607957|65421301|FG001|Overall Study|Participant refusal|0|||
23458413|NCT03779334|65421302|FG000|Overall Study|Withdrawal by Subject|3|||
23458414|NCT03779334|65421303|FG001|Overall Study|Withdrawal by Subject|0|||
23458415|NCT03779334|65421304|FG002|Overall Study|Withdrawal by Subject|0|||
23458416|NCT03779334|65421302|FG000|Overall Study|Ongoing in Study|5|||
23458417|NCT03779334|65421303|FG001|Overall Study|Ongoing in Study|13|||
23458418|NCT03779334|65421304|FG002|Overall Study|Ongoing in Study|5|||
23458419|NCT05131165|65421307|FG000|Overall Study|Death|1|||
23458420|NCT05131165|65421308|FG001|Overall Study|Death|1|||
23458421|NCT05131165|65421309|FG002|Overall Study|Death|0|||
23458422|NCT05131165|65421307|FG000|Overall Study|Lost to Follow-up|2|||
23458423|NCT05131165|65421308|FG001|Overall Study|Lost to Follow-up|2|||
23458424|NCT05131165|65421309|FG002|Overall Study|Lost to Follow-up|5|||
23458425|NCT05131165|65421307|FG000|Overall Study|Transferred out of clinic|1|||
23458426|NCT05131165|65421308|FG001|Overall Study|Transferred out of clinic|0|||
23458427|NCT05131165|65421309|FG002|Overall Study|Transferred out of clinic|3|||
23458428|NCT05131165|65421307|FG000|Overall Study|Dropped out|1|||
23458429|NCT05131165|65421308|FG001|Overall Study|Dropped out|2|||
23458430|NCT05131165|65421309|FG002|Overall Study|Dropped out|0|||
23458431|NCT02420717|65421310|FG000|Overall Study|Did not receive all study medication|2|||
23458432|NCT02420717|65421311|FG001|Overall Study|Did not receive all study medication|0|||
23458433|NCT02420717|65421312|FG002|Overall Study|Did not receive all study medication|0|||
23458434|NCT04003636|65421315|FG000|Overall Study|Death|409|||
23458435|NCT04003636|65421316|FG001|Overall Study|Death|443|||
23458436|NCT04003636|65421315|FG000|Overall Study|Lost to Follow-up|0|||
23458437|NCT04003636|65421316|FG001|Overall Study|Lost to Follow-up|1|||
23458438|NCT04003636|65421315|FG000|Overall Study|Withdrawal by Subject|5|||
23458439|NCT04003636|65421316|FG001|Overall Study|Withdrawal by Subject|2|||
23458440|NCT04003636|65421315|FG000|Overall Study|Participant On-going|119|||
23458441|NCT04003636|65421316|FG001|Overall Study|Participant On-going|90|||
23458442|NCT01652235|65421317|FG000|Overall Study|Death|9|||
23458443|NCT01652235|65421317|FG000|Overall Study|Lost to Follow-up|5|||
23458444|NCT01652235|65421317|FG000|Overall Study|Withdrawal by Subject|2|||
23458445|NCT05135767|65421318|FG000|Baseline|Lost to Follow-up|1|||
23458446|NCT05135767|65421319|FG001|Baseline|Lost to Follow-up|1|||
23458447|NCT05135767|65421318|FG000|Baseline|Withdrawal by Subject|0|||
23458448|NCT05135767|65421319|FG001|Baseline|Withdrawal by Subject|2|||
23458449|NCT05135767|65421318|FG000|Active Study Phase|Lost to Follow-up|2|||
23458450|NCT05135767|65421319|FG001|Active Study Phase|Lost to Follow-up|0|||
23458451|NCT03453164|65421320|FG000|Overall Study|Lack of Efficacy|16|||
23458452|NCT03453164|65421320|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
23458453|NCT03043794|65421325|FG000|Overall Study|Lost to Follow-up|1|||
23458454|NCT02002598|65421326|FG000|Dose Level 1|Withdrawal by Subject|1|||
23458455|NCT02002598|65421327|FG001|Dose Level 1|Withdrawal by Subject|0|||
23458456|NCT02002598|65421328|FG002|Dose Level 1|Withdrawal by Subject|0|||
23458457|NCT02002598|65421329|FG003|Dose Level 1|Withdrawal by Subject|0|||
23458458|NCT02002598|65421330|FG004|Dose Level 1|Withdrawal by Subject|0|||
23458459|NCT05228470|65421336|FG000|Overall Study|Death|6|||
23458460|NCT05228470|65421337|FG001|Overall Study|Death|11|||
23458461|NCT05228470|65421336|FG000|Overall Study|Withdrawal by Subject|1|||
23458462|NCT05228470|65421337|FG001|Overall Study|Withdrawal by Subject|8|||
23458463|NCT05228470|65421336|FG000|Overall Study|Ongoing|1|||
23458464|NCT05228470|65421337|FG001|Overall Study|Ongoing|11|||
23458465|NCT04583618|65421340|FG000|Overall Study|Adverse Event|0|||
23458466|NCT04583618|65421341|FG001|Overall Study|Adverse Event|0|||
23458467|NCT04583618|65421342|FG002|Overall Study|Adverse Event|1|||
23458468|NCT04583618|65421343|FG003|Overall Study|Adverse Event|0|||
23583754|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583755|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583756|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583757|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583758|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
23458469|NCT04583618|65421344|FG004|Overall Study|Adverse Event|0|||
23458470|NCT04583618|65421340|FG000|Overall Study|Protocol deviation|1|||
23458471|NCT04583618|65421341|FG001|Overall Study|Protocol deviation|1|||
23458472|NCT04583618|65421342|FG002|Overall Study|Protocol deviation|1|||
23458473|NCT04583618|65421343|FG003|Overall Study|Protocol deviation|0|||
23458474|NCT04583618|65421344|FG004|Overall Study|Protocol deviation|0|||
23458475|NCT04583618|65421340|FG000|Overall Study|Withdrawal by Subject|2|||
23458476|NCT04583618|65421341|FG001|Overall Study|Withdrawal by Subject|1|||
23458477|NCT04583618|65421342|FG002|Overall Study|Withdrawal by Subject|3|||
23458478|NCT04583618|65421343|FG003|Overall Study|Withdrawal by Subject|1|||
23458479|NCT04583618|65421344|FG004|Overall Study|Withdrawal by Subject|1|||
23458480|NCT04583618|65421340|FG000|Overall Study|Lost to Follow-up|0|||
23458481|NCT04583618|65421341|FG001|Overall Study|Lost to Follow-up|1|||
23458482|NCT04583618|65421342|FG002|Overall Study|Lost to Follow-up|3|||
23458483|NCT04583618|65421343|FG003|Overall Study|Lost to Follow-up|1|||
23458484|NCT04583618|65421344|FG004|Overall Study|Lost to Follow-up|1|||
23458485|NCT02358473|65421345|FG000|Overall Study|Disease Progession|6|||
23458486|NCT02358473|65421345|FG000|Overall Study|Adverse Event|3|||
23458487|NCT02358473|65421345|FG000|Overall Study|Withdrawal by Subject|2|||
23458488|NCT02358473|65421345|FG000|Overall Study|Physician Decision|2|||
23458489|NCT01394016|65421346|FG000|Overall Study|Progressive Disease|2|||
23458490|NCT01394016|65421347|FG001|Overall Study|Progressive Disease|0|||
23458491|NCT01394016|65421348|FG002|Overall Study|Progressive Disease|0|||
23458492|NCT01394016|65421349|FG003|Overall Study|Progressive Disease|0|||
23458493|NCT01394016|65421350|FG004|Overall Study|Progressive Disease|0|||
23458494|NCT01394016|65421351|FG005|Overall Study|Progressive Disease|0|||
23458495|NCT01394016|65421352|FG006|Overall Study|Progressive Disease|0|||
23458496|NCT01394016|65421353|FG007|Overall Study|Progressive Disease|0|||
23458497|NCT01394016|65421354|FG008|Overall Study|Progressive Disease|0|||
23458498|NCT01394016|65421355|FG009|Overall Study|Progressive Disease|0|||
23458499|NCT01394016|65421356|FG010|Overall Study|Progressive Disease|0|||
23458500|NCT01394016|65421357|FG011|Overall Study|Progressive Disease|0|||
23458501|NCT01394016|65421358|FG012|Overall Study|Progressive Disease|0|||
23458502|NCT01394016|65421359|FG013|Overall Study|Progressive Disease|0|||
23458503|NCT01394016|65421360|FG014|Overall Study|Progressive Disease|0|||
23458504|NCT01394016|65421361|FG015|Overall Study|Progressive Disease|0|||
23458505|NCT01394016|65421362|FG016|Overall Study|Progressive Disease|0|||
23458506|NCT01394016|65421363|FG017|Overall Study|Progressive Disease|0|||
23458507|NCT01394016|65421364|FG018|Overall Study|Progressive Disease|0|||
23458508|NCT01394016|65421346|FG000|Overall Study|Withdrawal by Subject|0|||
23458509|NCT01394016|65421347|FG001|Overall Study|Withdrawal by Subject|0|||
23458510|NCT01394016|65421348|FG002|Overall Study|Withdrawal by Subject|0|||
23458511|NCT01394016|65421349|FG003|Overall Study|Withdrawal by Subject|0|||
23458512|NCT01394016|65421350|FG004|Overall Study|Withdrawal by Subject|0|||
23458513|NCT01394016|65421351|FG005|Overall Study|Withdrawal by Subject|0|||
23458514|NCT01394016|65421352|FG006|Overall Study|Withdrawal by Subject|0|||
23458515|NCT01394016|65421353|FG007|Overall Study|Withdrawal by Subject|1|||
23458516|NCT01394016|65421354|FG008|Overall Study|Withdrawal by Subject|1|||
23458517|NCT01394016|65421355|FG009|Overall Study|Withdrawal by Subject|1|||
23458518|NCT01394016|65421356|FG010|Overall Study|Withdrawal by Subject|4|||
23458519|NCT01394016|65421357|FG011|Overall Study|Withdrawal by Subject|0|||
23458520|NCT01394016|65421358|FG012|Overall Study|Withdrawal by Subject|0|||
23458521|NCT01394016|65421359|FG013|Overall Study|Withdrawal by Subject|3|||
23458522|NCT01394016|65421360|FG014|Overall Study|Withdrawal by Subject|1|||
23458523|NCT01394016|65421361|FG015|Overall Study|Withdrawal by Subject|3|||
23458524|NCT01394016|65421362|FG016|Overall Study|Withdrawal by Subject|1|||
23458525|NCT01394016|65421363|FG017|Overall Study|Withdrawal by Subject|1|||
23583759|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583760|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583761|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23240128|NCT03433482|64622190|FG003|Overall Study|Unknown reason|0|||
23458526|NCT01394016|65421364|FG018|Overall Study|Withdrawal by Subject|2|||
23458527|NCT01394016|65421346|FG000|Overall Study|Adverse Event|0|||
23458528|NCT01394016|65421347|FG001|Overall Study|Adverse Event|0|||
23458529|NCT01394016|65421348|FG002|Overall Study|Adverse Event|0|||
23458530|NCT01394016|65421349|FG003|Overall Study|Adverse Event|0|||
23458531|NCT01394016|65421350|FG004|Overall Study|Adverse Event|0|||
23458532|NCT01394016|65421351|FG005|Overall Study|Adverse Event|0|||
23458533|NCT01394016|65421352|FG006|Overall Study|Adverse Event|0|||
23458534|NCT01394016|65421353|FG007|Overall Study|Adverse Event|0|||
23458535|NCT01394016|65421354|FG008|Overall Study|Adverse Event|0|||
23458536|NCT01394016|65421355|FG009|Overall Study|Adverse Event|1|||
23458537|NCT01394016|65421356|FG010|Overall Study|Adverse Event|0|||
23458538|NCT01394016|65421357|FG011|Overall Study|Adverse Event|0|||
23458539|NCT01394016|65421358|FG012|Overall Study|Adverse Event|0|||
23458540|NCT01394016|65421359|FG013|Overall Study|Adverse Event|0|||
23458541|NCT01394016|65421360|FG014|Overall Study|Adverse Event|0|||
23458542|NCT01394016|65421361|FG015|Overall Study|Adverse Event|0|||
23458543|NCT01394016|65421362|FG016|Overall Study|Adverse Event|1|||
23458544|NCT01394016|65421363|FG017|Overall Study|Adverse Event|1|||
23458545|NCT01394016|65421364|FG018|Overall Study|Adverse Event|0|||
23458546|NCT01394016|65421346|FG000|Overall Study|Sponsor Decision|0|||
23458547|NCT01394016|65421347|FG001|Overall Study|Sponsor Decision|0|||
23458548|NCT01394016|65421348|FG002|Overall Study|Sponsor Decision|0|||
23458549|NCT01394016|65421349|FG003|Overall Study|Sponsor Decision|0|||
23458550|NCT01394016|65421350|FG004|Overall Study|Sponsor Decision|0|||
23458551|NCT01394016|65421351|FG005|Overall Study|Sponsor Decision|0|||
23458552|NCT01394016|65421352|FG006|Overall Study|Sponsor Decision|0|||
23458553|NCT01394016|65421353|FG007|Overall Study|Sponsor Decision|0|||
23458554|NCT01394016|65421354|FG008|Overall Study|Sponsor Decision|0|||
23458555|NCT01394016|65421355|FG009|Overall Study|Sponsor Decision|0|||
23458556|NCT01394016|65421356|FG010|Overall Study|Sponsor Decision|0|||
23458557|NCT01394016|65421357|FG011|Overall Study|Sponsor Decision|0|||
23458558|NCT01394016|65421358|FG012|Overall Study|Sponsor Decision|1|||
23458559|NCT01394016|65421359|FG013|Overall Study|Sponsor Decision|0|||
23458560|NCT01394016|65421360|FG014|Overall Study|Sponsor Decision|0|||
23458561|NCT01394016|65421361|FG015|Overall Study|Sponsor Decision|0|||
23458562|NCT01394016|65421362|FG016|Overall Study|Sponsor Decision|0|||
23458563|NCT01394016|65421363|FG017|Overall Study|Sponsor Decision|0|||
23458564|NCT01394016|65421364|FG018|Overall Study|Sponsor Decision|0|||
23458565|NCT01394016|65421346|FG000|Overall Study|Lost to Follow-up|0|||
23458566|NCT01394016|65421347|FG001|Overall Study|Lost to Follow-up|0|||
23458567|NCT01394016|65421348|FG002|Overall Study|Lost to Follow-up|0|||
23458568|NCT01394016|65421349|FG003|Overall Study|Lost to Follow-up|0|||
23458569|NCT01394016|65421350|FG004|Overall Study|Lost to Follow-up|0|||
23458570|NCT01394016|65421351|FG005|Overall Study|Lost to Follow-up|0|||
23458571|NCT01394016|65421352|FG006|Overall Study|Lost to Follow-up|0|||
23458572|NCT01394016|65421353|FG007|Overall Study|Lost to Follow-up|0|||
23458573|NCT01394016|65421354|FG008|Overall Study|Lost to Follow-up|0|||
23458574|NCT01394016|65421355|FG009|Overall Study|Lost to Follow-up|0|||
23458575|NCT01394016|65421356|FG010|Overall Study|Lost to Follow-up|0|||
23458576|NCT01394016|65421357|FG011|Overall Study|Lost to Follow-up|0|||
23458577|NCT01394016|65421358|FG012|Overall Study|Lost to Follow-up|0|||
23458578|NCT01394016|65421359|FG013|Overall Study|Lost to Follow-up|0|||
23458579|NCT01394016|65421360|FG014|Overall Study|Lost to Follow-up|0|||
23458580|NCT01394016|65421361|FG015|Overall Study|Lost to Follow-up|0|||
23458581|NCT01394016|65421362|FG016|Overall Study|Lost to Follow-up|0|||
23458582|NCT01394016|65421363|FG017|Overall Study|Lost to Follow-up|0|||
23458583|NCT01394016|65421364|FG018|Overall Study|Lost to Follow-up|1|||
23458584|NCT02521285|65421367|FG000|Overall Study|Lost to Follow-up|1|||
23458585|NCT02521285|65421368|FG001|Overall Study|Lost to Follow-up|1|||
23458586|NCT02521285|65421367|FG000|Overall Study|Withdrawal by Subject|1|||
23458587|NCT02521285|65421368|FG001|Overall Study|Withdrawal by Subject|1|||
23458588|NCT02521285|65421367|FG000|Overall Study|Adverse Event|0|||
23458589|NCT02521285|65421368|FG001|Overall Study|Adverse Event|1|||
23458590|NCT02546609|65421369|FG000|Overall Study|Withdrawal by Subject|0|||
23458591|NCT02546609|65421370|FG001|Overall Study|Withdrawal by Subject|1|||
23458592|NCT02546609|65421371|FG002|Overall Study|Withdrawal by Subject|2|||
23458593|NCT02546609|65421369|FG000|Overall Study|Adverse Event|0|||
23458594|NCT02546609|65421370|FG001|Overall Study|Adverse Event|6|||
23458595|NCT02546609|65421371|FG002|Overall Study|Adverse Event|1|||
23458596|NCT02546609|65421369|FG000|Overall Study|Protocol Violation|0|||
23458597|NCT02546609|65421370|FG001|Overall Study|Protocol Violation|1|||
23458598|NCT02546609|65421371|FG002|Overall Study|Protocol Violation|1|||
23458599|NCT02546609|65421369|FG000|Overall Study|Lost to Follow-up|2|||
23458600|NCT02546609|65421370|FG001|Overall Study|Lost to Follow-up|3|||
23458601|NCT02546609|65421371|FG002|Overall Study|Lost to Follow-up|1|||
23458602|NCT02546609|65421369|FG000|Overall Study|travel or work schedule restriction|0|||
23458603|NCT02546609|65421370|FG001|Overall Study|travel or work schedule restriction|0|||
23458604|NCT02546609|65421371|FG002|Overall Study|travel or work schedule restriction|2|||
23458605|NCT04629508|65421375|FG000|Overall Study|Adverse Event|1|||
23458606|NCT04629508|65421375|FG000|Overall Study|Death|2|||
23458607|NCT04629508|65421375|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
23458608|NCT04973449|65421380|FG000|Overall Study|Withdrawal by Subject|3|||
23458609|NCT04973449|65421381|FG001|Overall Study|Withdrawal by Subject|3|||
23458610|NCT04973449|65421382|FG002|Overall Study|Withdrawal by Subject|2|||
23458611|NCT04973449|65421383|FG003|Overall Study|Withdrawal by Subject|5|||
23458612|NCT04973449|65421384|FG004|Overall Study|Withdrawal by Subject|5|||
23458613|NCT04973449|65421385|FG005|Overall Study|Withdrawal by Subject|4|||
23458614|NCT04973449|65421386|FG006|Overall Study|Withdrawal by Subject|7|||
23458615|NCT04973449|65421387|FG007|Overall Study|Withdrawal by Subject|5|||
23458616|NCT04973449|65421380|FG000|Overall Study|Lost to Follow-up|15|||
23458617|NCT04973449|65421381|FG001|Overall Study|Lost to Follow-up|16|||
23458618|NCT04973449|65421382|FG002|Overall Study|Lost to Follow-up|16|||
23458619|NCT04973449|65421383|FG003|Overall Study|Lost to Follow-up|13|||
23458620|NCT04973449|65421384|FG004|Overall Study|Lost to Follow-up|5|||
23458621|NCT04973449|65421385|FG005|Overall Study|Lost to Follow-up|6|||
23458622|NCT04973449|65421386|FG006|Overall Study|Lost to Follow-up|10|||
23458623|NCT04973449|65421387|FG007|Overall Study|Lost to Follow-up|6|||
23458624|NCT04973449|65421380|FG000|Overall Study|Death|1|||
23458625|NCT04973449|65421381|FG001|Overall Study|Death|0|||
23458626|NCT04973449|65421382|FG002|Overall Study|Death|0|||
23458627|NCT04973449|65421383|FG003|Overall Study|Death|0|||
23458628|NCT04973449|65421384|FG004|Overall Study|Death|0|||
23458629|NCT04973449|65421385|FG005|Overall Study|Death|1|||
23458630|NCT04973449|65421386|FG006|Overall Study|Death|0|||
23583762|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583763|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
23583764|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583765|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583766|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583767|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583768|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583769|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583770|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583771|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583772|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
23583773|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583774|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583775|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583776|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583777|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
23583778|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583779|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583780|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583781|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583782|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583783|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583784|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583785|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583786|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
23583787|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583788|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583789|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583790|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583791|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
23583792|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583793|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583794|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583795|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23240129|NCT03000075|64622191|FG000|Part A|Adverse Event|4|||
23458631|NCT04973449|65421387|FG007|Overall Study|Death|0|||
23240130|NCT03000075|64622192|FG001|Part A|Adverse Event|0|||
23240131|NCT03000075|64622193|FG002|Part A|Adverse Event|0|||
23240132|NCT03000075|64622194|FG003|Part A|Adverse Event|0|||
23240133|NCT03000075|64622195|FG004|Part A|Adverse Event|0|||
23240134|NCT03000075|64622196|FG005|Part A|Adverse Event|0|||
23240135|NCT03000075|64622197|FG006|Part A|Adverse Event|0|||
23240136|NCT03000075|64622191|FG000|Part B|Not dosed due to AE|0|||
23240137|NCT03000075|64622192|FG001|Part B|Not dosed due to AE|0|||
23240138|NCT03000075|64622193|FG002|Part B|Not dosed due to AE|0|||
23240139|NCT03000075|64622194|FG003|Part B|Not dosed due to AE|0|||
23240140|NCT03000075|64622195|FG004|Part B|Not dosed due to AE|0|||
23240141|NCT03000075|64622196|FG005|Part B|Not dosed due to AE|2|||
23240142|NCT03000075|64622197|FG006|Part B|Not dosed due to AE|1|||
23240143|NCT03000075|64622191|FG000|Part B|Adverse Event|0|||
23240144|NCT03000075|64622192|FG001|Part B|Adverse Event|0|||
23240145|NCT03000075|64622193|FG002|Part B|Adverse Event|0|||
23240146|NCT03000075|64622194|FG003|Part B|Adverse Event|0|||
23240147|NCT03000075|64622195|FG004|Part B|Adverse Event|1|||
23240148|NCT03000075|64622196|FG005|Part B|Adverse Event|0|||
23240149|NCT03000075|64622197|FG006|Part B|Adverse Event|0|||
23240150|NCT00887822|64622198|FG000|Overall Study|Insufficient therapeutic response|53|||
23240151|NCT00887822|64622199|FG001|Overall Study|Insufficient therapeutic response|55|||
23240152|NCT00887822|64622198|FG000|Overall Study|Adverse Event|14|||
23240153|NCT00887822|64622199|FG001|Overall Study|Adverse Event|17|||
23240154|NCT00887822|64622198|FG000|Overall Study|Failure to return|11|||
23458632|NCT04973449|65421380|FG000|Overall Study|Other|1|||
23458633|NCT04973449|65421381|FG001|Overall Study|Other|1|||
23240155|NCT00887822|64622199|FG001|Overall Study|Failure to return|11|||
23240156|NCT00887822|64622198|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
23458634|NCT04973449|65421382|FG002|Overall Study|Other|2|||
23458635|NCT04973449|65421383|FG003|Overall Study|Other|1|||
23458636|NCT04973449|65421384|FG004|Overall Study|Other|4|||
23458637|NCT04973449|65421385|FG005|Overall Study|Other|0|||
23458638|NCT04973449|65421386|FG006|Overall Study|Other|2|||
23458639|NCT04973449|65421387|FG007|Overall Study|Other|2|||
23458640|NCT04905134|65421393|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
23583796|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583797|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583798|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583799|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583800|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
23583801|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583802|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583803|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583804|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583805|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
23583806|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583807|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583808|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583809|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583810|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583811|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
23583812|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583813|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
23583814|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
23583815|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583816|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583817|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583818|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583819|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
23583820|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583821|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23240157|NCT00887822|64622199|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
23458641|NCT04905134|65421393|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
23240158|NCT00887822|64622198|FG000|Overall Study|Administrative/Other than specified|5|||
23240159|NCT00887822|64622199|FG001|Overall Study|Administrative/Other than specified|4|||
23240160|NCT00887822|64622198|FG000|Overall Study|Death|2|||
23240161|NCT00887822|64622199|FG001|Overall Study|Death|3|||
23240162|NCT00887822|64622198|FG000|Overall Study|Protocol Violation|0|||
23240163|NCT00887822|64622199|FG001|Overall Study|Protocol Violation|1|||
23240164|NCT00887822|64622198|FG000|Overall Study|Randomized but not treated|0|||
23240165|NCT00887822|64622199|FG001|Overall Study|Randomized but not treated|1|||
23240166|NCT00535262|64622200|FG000|Overall Study|No funding|3|||
23240167|NCT02268214|64622203|FG000|Overall Study|Subject no longer meets study criteria|0|||
23240168|NCT02268214|64622204|FG001|Overall Study|Subject no longer meets study criteria|2|||
23240169|NCT02268214|64622205|FG002|Overall Study|Subject no longer meets study criteria|0|||
23240170|NCT02268214|64622203|FG000|Overall Study|Pregnancy|2|||
23240171|NCT02268214|64622204|FG001|Overall Study|Pregnancy|2|||
23240172|NCT02268214|64622205|FG002|Overall Study|Pregnancy|1|||
23240173|NCT02268214|64622203|FG000|Overall Study|Lost to Follow-up|3|||
23240174|NCT02268214|64622204|FG001|Overall Study|Lost to Follow-up|3|||
23240175|NCT02268214|64622205|FG002|Overall Study|Lost to Follow-up|4|||
23240176|NCT02268214|64622203|FG000|Overall Study|Lack of Efficacy|1|||
23240177|NCT02268214|64622204|FG001|Overall Study|Lack of Efficacy|0|||
23240178|NCT02268214|64622205|FG002|Overall Study|Lack of Efficacy|2|||
23240179|NCT02268214|64622203|FG000|Overall Study|Adverse Event|11|||
23240180|NCT02268214|64622204|FG001|Overall Study|Adverse Event|14|||
23240181|NCT02268214|64622205|FG002|Overall Study|Adverse Event|9|||
23240182|NCT02268214|64622203|FG000|Overall Study|Withdrawal by Subject|4|||
23240183|NCT02268214|64622204|FG001|Overall Study|Withdrawal by Subject|5|||
23240184|NCT02268214|64622205|FG002|Overall Study|Withdrawal by Subject|10|||
23240185|NCT02268214|64622203|FG000|Overall Study|Subject request to discontinue treatment|10|||
23240186|NCT02268214|64622204|FG001|Overall Study|Subject request to discontinue treatment|8|||
23240187|NCT02268214|64622205|FG002|Overall Study|Subject request to discontinue treatment|6|||
23240188|NCT02268214|64622203|FG000|Overall Study|Poor/non-compliance|2|||
23240189|NCT02268214|64622204|FG001|Overall Study|Poor/non-compliance|1|||
23240190|NCT02268214|64622205|FG002|Overall Study|Poor/non-compliance|2|||
23240191|NCT02268214|64622203|FG000|Overall Study|Other reasons|7|||
23240192|NCT02268214|64622204|FG001|Overall Study|Other reasons|3|||
23240193|NCT02268214|64622205|FG002|Overall Study|Other reasons|3|||
23240194|NCT02268214|64622203|FG000|Overall Study|Not entering long-term period|2|||
23240195|NCT02268214|64622204|FG001|Overall Study|Not entering long-term period|3|||
23240196|NCT02268214|64622205|FG002|Overall Study|Not entering long-term period|5|||
23240197|NCT03410693|64622206|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
23240198|NCT03410693|64622207|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
23240199|NCT03410693|64622206|FG000|Overall Study|Disc trt: Lost to follow up|0|||
23240200|NCT03410693|64622207|FG001|Overall Study|Disc trt: Lost to follow up|1|||
23240201|NCT03410693|64622206|FG000|Overall Study|Disc trt: radiological progression|58|||
23240202|NCT03410693|64622207|FG001|Overall Study|Disc trt: radiological progression|50|||
23240203|NCT03410693|64622206|FG000|Overall Study|Disc trt: Other|1|||
23240204|NCT03410693|64622207|FG001|Overall Study|Disc trt: Other|0|||
23240205|NCT03410693|64622206|FG000|Overall Study|Study drug never administered|1|||
23240206|NCT03410693|64622207|FG001|Overall Study|Study drug never administered|6|||
23240207|NCT03410693|64622206|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
23240208|NCT03410693|64622207|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
23240209|NCT03410693|64622206|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
23240210|NCT03410693|64622207|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
23240211|NCT03410693|64622206|FG000|Overall Study|Disc trt: Physician decision|0|||
23240212|NCT03410693|64622207|FG001|Overall Study|Disc trt: Physician decision|5|||
23240213|NCT03410693|64622206|FG000|Overall Study|Disc trt: clinical progression|1|||
23240214|NCT03410693|64622207|FG001|Overall Study|Disc trt: clinical progression|5|||
23240215|NCT03410693|64622206|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
23240216|NCT03410693|64622207|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
23240217|NCT03457701|64622210|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
23240218|NCT03457701|64622211|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
23240219|NCT03457701|64622210|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
23458642|NCT04467905|65421394|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
23458643|NCT04467905|65421395|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
23583822|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583823|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583824|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583825|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583826|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583827|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583828|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
23583829|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23180241|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
23347226|NCT01844505|65014287|FG002|Overall Study|Other Reasons|2|||
23458644|NCT04467905|65421396|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
23240220|NCT03457701|64622211|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
23240221|NCT00399542|64622212|FG000|Overall Study|Adverse Event|18|||
23240222|NCT00399542|64622213|FG001|Overall Study|Adverse Event|15|||
23240223|NCT00399542|64622212|FG000|Overall Study|Protocol Violation|13|||
23240224|NCT00399542|64622213|FG001|Overall Study|Protocol Violation|3|||
23240225|NCT00399542|64622212|FG000|Overall Study|Withdrawal by Subject|28|||
23240226|NCT00399542|64622213|FG001|Overall Study|Withdrawal by Subject|10|||
23240227|NCT00399542|64622212|FG000|Overall Study|Lack of Efficacy|18|||
23240228|NCT00399542|64622213|FG001|Overall Study|Lack of Efficacy|8|||
23458645|NCT04467905|65421394|FG000|Overall Study|Conversion to SR|0|||
23458646|NCT04467905|65421395|FG001|Overall Study|Conversion to SR|0|||
23458647|NCT04467905|65421396|FG002|Overall Study|Conversion to SR|3|||
23458648|NCT04467905|65421394|FG000|Overall Study|Technical issue with Holter ECG|0|||
23458649|NCT04467905|65421395|FG001|Overall Study|Technical issue with Holter ECG|0|||
23458650|NCT04467905|65421396|FG002|Overall Study|Technical issue with Holter ECG|3|||
23458651|NCT04467905|65421394|FG000|Overall Study|Hemodynamic instability|0|||
23458652|NCT04467905|65421395|FG001|Overall Study|Hemodynamic instability|0|||
23458653|NCT04467905|65421396|FG002|Overall Study|Hemodynamic instability|1|||
23458654|NCT04467905|65421394|FG000|Overall Study|Site misinterpretation of protocol|0|||
23458655|NCT04467905|65421395|FG001|Overall Study|Site misinterpretation of protocol|0|||
23458656|NCT04467905|65421396|FG002|Overall Study|Site misinterpretation of protocol|1|||
23458657|NCT02023086|65421397|FG000|Overall Study|Withdrawal by Subject|2|||
23458658|NCT02023086|65421398|FG001|Overall Study|Withdrawal by Subject|0|||
23458659|NCT03205423|65421399|FG000|Overall Study|Personal|1|||
23458660|NCT03205423|65421400|FG001|Overall Study|Personal|1|||
23458661|NCT03205423|65421399|FG000|Overall Study|Physician Decision|0|||
23458662|NCT03205423|65421400|FG001|Overall Study|Physician Decision|2|||
23458663|NCT01473134|65421405|FG000|Overall Study|Lost to Follow-up|21|||
23458664|NCT01473134|65421406|FG001|Overall Study|Lost to Follow-up|13|||
23458665|NCT01473134|65421405|FG000|Overall Study|Protocol Violation|32|||
23458666|NCT01473134|65421406|FG001|Overall Study|Protocol Violation|19|||
23458667|NCT01473134|65421405|FG000|Overall Study|Withdrawal by Subject|1|||
23458668|NCT01473134|65421406|FG001|Overall Study|Withdrawal by Subject|2|||
23458669|NCT01473134|65421405|FG000|Overall Study|Death|0|||
23240229|NCT00399542|64622212|FG000|Overall Study|Lost to Follow-up|6|||
23240230|NCT00399542|64622213|FG001|Overall Study|Lost to Follow-up|6|||
23240231|NCT00399542|64622212|FG000|Overall Study|Other|1|||
23240232|NCT00399542|64622213|FG001|Overall Study|Other|0|||
23240233|NCT00399542|64622212|FG000|Overall Study|Physician Decision|0|||
23240234|NCT00399542|64622213|FG001|Overall Study|Physician Decision|1|||
23240235|NCT00812968|64622215|FG000|Overall Study|Relapse after erythroid response|6|||
23240236|NCT00812968|64622215|FG000|Overall Study|Disease progression|1|||
23240237|NCT00812968|64622215|FG000|Overall Study|No further treatment required|1|||
23240238|NCT00812968|64622215|FG000|Overall Study|Study closed due to marketing approval|3|||
23240239|NCT01733758|64622217|FG000|Overall Study|Adverse Event|5|||
23240240|NCT01733758|64622218|FG001|Overall Study|Adverse Event|7|||
23240241|NCT01733758|64622219|FG002|Overall Study|Adverse Event|8|||
23240242|NCT01733758|64622220|FG003|Overall Study|Adverse Event|1|||
23240243|NCT01733758|64622217|FG000|Overall Study|Withdrawal by Subject|1|||
23240244|NCT01733758|64622218|FG001|Overall Study|Withdrawal by Subject|1|||
23240245|NCT01733758|64622219|FG002|Overall Study|Withdrawal by Subject|5|||
23240246|NCT01733758|64622220|FG003|Overall Study|Withdrawal by Subject|3|||
23240247|NCT01733758|64622217|FG000|Overall Study|Persistent Hyperglycemia|3|||
23240248|NCT01733758|64622218|FG001|Overall Study|Persistent Hyperglycemia|2|||
23240249|NCT01733758|64622219|FG002|Overall Study|Persistent Hyperglycemia|0|||
23240250|NCT01733758|64622220|FG003|Overall Study|Persistent Hyperglycemia|0|||
23240251|NCT01733758|64622217|FG000|Overall Study|Protocol Violation|0|||
23240252|NCT01733758|64622218|FG001|Overall Study|Protocol Violation|1|||
23240253|NCT01733758|64622219|FG002|Overall Study|Protocol Violation|2|||
23240254|NCT01733758|64622220|FG003|Overall Study|Protocol Violation|2|||
23240255|NCT01733758|64622217|FG000|Overall Study|Non-compliance|1|||
23458670|NCT01473134|65421406|FG001|Overall Study|Death|1|||
23458671|NCT01473134|65421405|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
23583830|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583831|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23583832|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23240256|NCT01733758|64622218|FG001|Overall Study|Non-compliance|0|||
23240257|NCT01733758|64622219|FG002|Overall Study|Non-compliance|0|||
23240258|NCT01733758|64622220|FG003|Overall Study|Non-compliance|0|||
23240259|NCT01733758|64622217|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
23240260|NCT01733758|64622218|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
23240261|NCT01733758|64622219|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
23458672|NCT01473134|65421406|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
23583833|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
23458673|NCT04500158|65421410|FG000|Overall Study|Physician Decision|17|||
23458674|NCT04500158|65421411|FG001|Overall Study|Physician Decision|11|||
23458675|NCT02694185|65421413|FG000|Overall Study|Withdrawal by Subject|45|||
23458676|NCT02694185|65421414|FG001|Overall Study|Withdrawal by Subject|0|||
23458677|NCT00400179|65421415|FG000|Overall Study|Adverse Event|2|||
23458678|NCT00400179|65421416|FG001|Overall Study|Adverse Event|2|||
23458679|NCT00400179|65421415|FG000|Overall Study|Death|1|||
23458680|NCT00400179|65421416|FG001|Overall Study|Death|2|||
23458681|NCT00400179|65421415|FG000|Overall Study|Withdrew Consent|1|||
23458682|NCT00400179|65421416|FG001|Overall Study|Withdrew Consent|5|||
23458683|NCT00400179|65421415|FG000|Overall Study|Disease progression|1|||
23458684|NCT00400179|65421416|FG001|Overall Study|Disease progression|1|||
23458685|NCT00400179|65421415|FG000|Overall Study|Intercurrent illness|0|||
23458686|NCT00400179|65421416|FG001|Overall Study|Intercurrent illness|1|||
23458687|NCT00400179|65421415|FG000|Overall Study|Investigator judgment|0|||
23347227|NCT01844505|65014285|FG000|Overall Study|Not Reported|0|||
23347228|NCT01844505|65014286|FG001|Overall Study|Not Reported|0|||
23347229|NCT01844505|65014287|FG002|Overall Study|Not Reported|1|||
23347230|NCT04068688|65014292|FG000|Overall Study|Lost to Follow-up|1|||
23240262|NCT01733758|64622220|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
23240263|NCT01733758|64622217|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
23240264|NCT01733758|64622218|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
23240265|NCT01733758|64622219|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
23240266|NCT01733758|64622220|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
23240267|NCT02184988|64622223|FG000|Overall Study|Pregnancy|2|||
23240268|NCT02184988|64622223|FG000|Overall Study|Adverse Event|2|||
23240269|NCT02184988|64622223|FG000|Overall Study|moving away/travelling/unable to complet|6|||
23240270|NCT02184988|64622223|FG000|Overall Study|work scheduling issues|4|||
23347231|NCT04068688|65014293|FG001|Overall Study|Lost to Follow-up|1|||
23347232|NCT04068688|65014294|FG002|Overall Study|Lost to Follow-up|0|||
23347233|NCT04068688|65014295|FG003|Overall Study|Lost to Follow-up|0|||
23347234|NCT04068688|65014296|FG004|Overall Study|Lost to Follow-up|5|||
23583834|NCT03982199|65866043|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583835|NCT03982199|65866044|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583836|NCT03982199|65866045|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583837|NCT03982199|65866046|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583838|NCT03982199|65866047|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23458688|NCT00400179|65421416|FG001|Overall Study|Investigator judgment|1|||
23458689|NCT00400179|65421415|FG000|Overall Study|Randomization error/patient ineligible|1|||
23458690|NCT00400179|65421416|FG001|Overall Study|Randomization error/patient ineligible|6|||
23458691|NCT01210313|65421423|FG000|Overall Study|Withdrawal by Subject|3|||
23458692|NCT01210313|65421423|FG000|Overall Study|Adverse Event|2|||
23458693|NCT01210313|65421423|FG000|Overall Study|Distant recurrence|4|||
23458694|NCT01210313|65421423|FG000|Overall Study|Non-compliance|7|||
23458695|NCT04179175|65421424|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
23458696|NCT04179175|65421425|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
23458697|NCT04179175|65421426|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
23458698|NCT04179175|65421427|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
23458699|NCT04179175|65421428|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
23458700|NCT04179175|65421429|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
23458701|NCT04179175|65421424|FG000|Overall Study|Adverse Event|5|||
23458702|NCT04179175|65421425|FG001|Overall Study|Adverse Event|3|||
23458703|NCT04179175|65421426|FG002|Overall Study|Adverse Event|3|||
23347235|NCT04068688|65014297|FG005|Overall Study|Lost to Follow-up|5|||
23347236|NCT04068688|65014298|FG006|Overall Study|Lost to Follow-up|0|||
23347237|NCT04068688|65014299|FG007|Overall Study|Lost to Follow-up|0|||
23347238|NCT04068688|65014300|FG008|Overall Study|Lost to Follow-up|1|||
23347239|NCT04068688|65014301|FG009|Overall Study|Lost to Follow-up|0|||
23458704|NCT04179175|65421427|FG003|Overall Study|Adverse Event|4|||
23458705|NCT04179175|65421428|FG004|Overall Study|Adverse Event|6|||
23458706|NCT04179175|65421429|FG005|Overall Study|Adverse Event|6|||
23583839|NCT03982199|65866048|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
23180242|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
23240271|NCT02184988|64622223|FG000|Overall Study|various other reasons|9|||
23240272|NCT02184988|64622223|FG000|Overall Study|Lost to Follow-up|32|||
23240273|NCT01871870|64622225|FG000|Overall Study|Hardware issues|7|||
23458707|NCT04179175|65421424|FG000|Overall Study|Lack of Efficacy|5|||
23458708|NCT04179175|65421425|FG001|Overall Study|Lack of Efficacy|1|||
23240274|NCT01871870|64622225|FG000|Overall Study|hyperglycemia|2|||
23347240|NCT04068688|65014292|FG000|Overall Study|Withdrawal by Subject|1|||
23347241|NCT04068688|65014293|FG001|Overall Study|Withdrawal by Subject|1|||
23458709|NCT04179175|65421426|FG002|Overall Study|Lack of Efficacy|3|||
23458710|NCT04179175|65421427|FG003|Overall Study|Lack of Efficacy|2|||
23458711|NCT04179175|65421428|FG004|Overall Study|Lack of Efficacy|18|||
23458712|NCT04179175|65421429|FG005|Overall Study|Lack of Efficacy|7|||
23458713|NCT04179175|65421424|FG000|Overall Study|Lost to Follow-up|5|||
23240275|NCT00914940|64622230|FG000|D0 to D100 Post-transplant|Death|2|||
23240276|NCT00914940|64622230|FG000|D101 to 2 Years Post-transplant|Death|8|||
23240277|NCT00914940|64622230|FG000|2 Years to 5 Years Post-transplant|Death|3|||
23240278|NCT02046993|64622237|FG000|Overall Study|Withdrawal by Subject|2|||
23240279|NCT02046993|64622238|FG001|Overall Study|Withdrawal by Subject|10|||
23240280|NCT02046993|64622237|FG000|Overall Study|Lost to Follow-up|1|||
23240281|NCT02046993|64622238|FG001|Overall Study|Lost to Follow-up|1|||
23240282|NCT01340794|64622256|FG000|Overall Study|Withdrawal by Subject|0|||
23240283|NCT01340794|64622257|FG001|Overall Study|Withdrawal by Subject|1|||
23240284|NCT01869959|64622258|FG000|Randomization Period|Physician Decision|0|||
23240285|NCT01869959|64622259|FG001|Randomization Period|Physician Decision|0|||
23240286|NCT01869959|64622260|FG002|Randomization Period|Physician Decision|0|||
23240287|NCT01869959|64622261|FG003|Randomization Period|Physician Decision|0|||
23240288|NCT01869959|64622262|FG004|Randomization Period|Physician Decision|1|||
23240289|NCT01869959|64622258|FG000|Treatment Period|Adverse Event|1|||
23240290|NCT01869959|64622259|FG001|Treatment Period|Adverse Event|0|||
23240291|NCT01869959|64622260|FG002|Treatment Period|Adverse Event|3|||
23240292|NCT01869959|64622261|FG003|Treatment Period|Adverse Event|1|||
23240293|NCT01869959|64622262|FG004|Treatment Period|Adverse Event|0|||
23240294|NCT01869959|64622258|FG000|Treatment Period|Sponsor decision|0|||
23240295|NCT01869959|64622259|FG001|Treatment Period|Sponsor decision|1|||
23240296|NCT01869959|64622260|FG002|Treatment Period|Sponsor decision|0|||
23240297|NCT01869959|64622261|FG003|Treatment Period|Sponsor decision|1|||
23240298|NCT01869959|64622262|FG004|Treatment Period|Sponsor decision|0|||
23240299|NCT01869959|64622258|FG000|Treatment Period|Withdrawal by Subject|0|||
23240300|NCT01869959|64622259|FG001|Treatment Period|Withdrawal by Subject|1|||
23240301|NCT01869959|64622260|FG002|Treatment Period|Withdrawal by Subject|0|||
23240302|NCT01869959|64622261|FG003|Treatment Period|Withdrawal by Subject|0|||
23240303|NCT01869959|64622262|FG004|Treatment Period|Withdrawal by Subject|0|||
23240304|NCT02158949|64622263|FG000|Overall Study|Withdrawal by Subject|1|||
23240305|NCT02158949|64622264|FG001|Overall Study|Withdrawal by Subject|0|||
23240306|NCT02158949|64622263|FG000|Overall Study|Lost to Follow-up|5|||
23240307|NCT02158949|64622264|FG001|Overall Study|Lost to Follow-up|11|||
23240308|NCT03186794|64622268|FG000|Overall Study|Physician Decision|2|||
23240309|NCT03186794|64622268|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
23240310|NCT00003526|64622269|FG000|Overall Study|Not evaluable|6|||
23240311|NCT00499694|64622270|FG000|Overall Study|Patient never received treatment.|1|||
23240312|NCT01160770|64622271|FG000|Overall Study|Adverse Event|10|||
23240313|NCT01160770|64622271|FG000|Overall Study|Protocol Violation|2|||
23240314|NCT01160770|64622271|FG000|Overall Study|Subject/parent/caregiver request|33|||
23240315|NCT01160770|64622271|FG000|Overall Study|Physician Decision|1|||
23240316|NCT01160770|64622271|FG000|Overall Study|Lost to Follow-up|7|||
23240317|NCT01160770|64622271|FG000|Overall Study|Study termination or sponsor request|1|||
23240318|NCT01160770|64622271|FG000|Overall Study|Death|9|||
23240319|NCT01160770|64622271|FG000|Overall Study|Lack of Efficacy|15|||
23240320|NCT01160770|64622271|FG000|Overall Study|Other Reasons|1|||
23240321|NCT01250418|64622272|FG000|Overall Study|monitor data failure|1|||
23240322|NCT01250418|64622273|FG001|Overall Study|monitor data failure|1|||
23240323|NCT01428882|64622274|FG000|Overall Study|Lack of Efficacy|2|||
23240324|NCT01428882|64622275|FG001|Overall Study|Lack of Efficacy|7|||
23240325|NCT01428882|64622274|FG000|Overall Study|Protocol Violation|4|||
23240326|NCT01428882|64622275|FG001|Overall Study|Protocol Violation|3|||
23240327|NCT01608321|64622277|FG000|Overall Study|Withdrawal by Subject|1|||
23240328|NCT01608321|64622278|FG001|Overall Study|Withdrawal by Subject|0|||
23240329|NCT04196023|64622279|FG000|Overall Study|Withdrawal by Subject|0|||
23240330|NCT04196023|64622280|FG001|Overall Study|Withdrawal by Subject|1|||
23240331|NCT04196023|64622279|FG000|Overall Study|Adverse Event|3|||
23240332|NCT04196023|64622280|FG001|Overall Study|Adverse Event|1|||
23240333|NCT04196023|64622279|FG000|Overall Study|Lost to Follow-up|0|||
23240334|NCT04196023|64622280|FG001|Overall Study|Lost to Follow-up|1|||
23240335|NCT01243762|64622281|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
23240336|NCT01243762|64622282|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
23240337|NCT01243762|64622283|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
23240338|NCT01243762|64622284|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
23240339|NCT01243762|64622285|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
23240340|NCT01243762|64622286|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
23240341|NCT01243762|64622287|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
23240342|NCT01243762|64622281|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23240343|NCT01243762|64622282|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
23240344|NCT01243762|64622283|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23240345|NCT01243762|64622284|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
23240346|NCT01243762|64622285|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23240347|NCT01243762|64622286|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23240348|NCT01243762|64622287|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
23240349|NCT01243762|64622281|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
23347242|NCT04068688|65014294|FG002|Overall Study|Withdrawal by Subject|0|||
23240350|NCT01243762|64622282|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
23240351|NCT01243762|64622283|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
23240352|NCT01243762|64622284|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
23240353|NCT01243762|64622285|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
23240354|NCT01243762|64622286|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
23240355|NCT01243762|64622287|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
23240356|NCT01243762|64622281|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23240357|NCT01243762|64622282|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
23240358|NCT01243762|64622283|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23347243|NCT04068688|65014295|FG003|Overall Study|Withdrawal by Subject|0|||
23583840|NCT03982199|65866049|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583841|NCT03982199|65866050|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
23583842|NCT03982199|65866051|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
23583843|NCT03982199|65866052|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23240359|NCT01243762|64622284|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23347244|NCT04068688|65014296|FG004|Overall Study|Withdrawal by Subject|0|||
23347245|NCT04068688|65014297|FG005|Overall Study|Withdrawal by Subject|0|||
23347246|NCT04068688|65014298|FG006|Overall Study|Withdrawal by Subject|0|||
23347247|NCT04068688|65014299|FG007|Overall Study|Withdrawal by Subject|0|||
23347248|NCT04068688|65014300|FG008|Overall Study|Withdrawal by Subject|0|||
23347249|NCT04068688|65014301|FG009|Overall Study|Withdrawal by Subject|0|||
23347250|NCT04068688|65014292|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
23347251|NCT04068688|65014293|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
23583844|NCT03982199|65866053|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583845|NCT03982199|65866054|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583846|NCT03982199|65866055|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583847|NCT03982199|65866056|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
23583848|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583849|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583850|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583851|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583852|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583853|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583854|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583855|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583856|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
23583857|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
23583858|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
23583859|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
23583860|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
23583861|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
23583862|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583863|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583864|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583865|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583866|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583867|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583868|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583869|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23240360|NCT01243762|64622285|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23240361|NCT01243762|64622286|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23240362|NCT01243762|64622287|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
23240363|NCT01243762|64622281|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23240364|NCT01243762|64622282|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
23240365|NCT01243762|64622283|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23347252|NCT04068688|65014294|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347253|NCT04068688|65014295|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347254|NCT04068688|65014296|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23583870|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583871|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
23583872|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583873|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23347255|NCT04068688|65014297|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347256|NCT04068688|65014298|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347257|NCT04068688|65014299|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347258|NCT04068688|65014300|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23458714|NCT04179175|65421425|FG001|Overall Study|Lost to Follow-up|3|||
23458715|NCT04179175|65421426|FG002|Overall Study|Lost to Follow-up|2|||
23458716|NCT04179175|65421427|FG003|Overall Study|Lost to Follow-up|2|||
23458717|NCT04179175|65421428|FG004|Overall Study|Lost to Follow-up|4|||
23458718|NCT04179175|65421429|FG005|Overall Study|Lost to Follow-up|5|||
23583874|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583875|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
23583876|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583877|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583878|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583879|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583880|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583881|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583882|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583883|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583884|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583885|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583886|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583887|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583888|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
23583889|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
23583890|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583891|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583892|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583893|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583894|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583895|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583896|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583897|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583898|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583899|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583900|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
23583901|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
23583902|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
23583903|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
23583904|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583905|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583906|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583907|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583908|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583909|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583910|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583911|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583912|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583913|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583914|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23180243|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
23180244|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
23583915|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583916|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
23583917|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
23583918|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583919|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583920|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583921|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583922|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583923|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583924|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583925|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583926|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583927|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583928|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583929|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
23583930|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
23583931|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
23583932|NCT03982199|65866043|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23180245|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
23347259|NCT04068688|65014301|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
23347260|NCT01944670|65014302|FG000|Overall Study|Lost to Follow-up|2|||
23347261|NCT00454818|65014304|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
23347262|NCT00454818|65014305|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
23347263|NCT00454818|65014306|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
23347264|NCT00454818|65014307|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
23347265|NCT00454818|65014308|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
23347266|NCT00454818|65014304|FG000|Phase I: Open-label Dose-escalation|Death|0|||
23347267|NCT00454818|65014305|FG001|Phase I: Open-label Dose-escalation|Death|1|||
23347268|NCT00454818|65014306|FG002|Phase I: Open-label Dose-escalation|Death|0|||
23347269|NCT00454818|65014307|FG003|Phase I: Open-label Dose-escalation|Death|0|||
23347270|NCT00454818|65014308|FG004|Phase I: Open-label Dose-escalation|Death|0|||
23347271|NCT00454818|65014304|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
23347272|NCT00454818|65014305|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
23180246|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
23180247|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
23180248|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
23180249|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
23180250|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
23180251|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
23180252|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
23180253|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
23180254|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
23180255|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
23180256|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
23180257|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
23180258|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
23180259|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
23180260|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
23180261|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
23180262|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
23180263|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
23180264|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
23180265|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
23180266|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
23180267|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
23180268|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
23180269|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
23180270|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
23180271|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
23180272|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
23180273|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
23180274|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
23180275|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
23240366|NCT01243762|64622284|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23458719|NCT04179175|65421424|FG000|Overall Study|Physician Decision|2|||
23180276|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
23347273|NCT00454818|65014306|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
23347274|NCT00454818|65014307|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
23347275|NCT00454818|65014308|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
23180277|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
23180278|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
23180279|NCT00289913|64401761|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
23180280|NCT00289913|64401762|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
23180281|NCT00289913|64401763|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
23180282|NCT00289913|64401764|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
23180283|NCT00289913|64401765|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
23180284|NCT00289913|64401761|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23180285|NCT00289913|64401762|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
23180286|NCT00289913|64401763|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23180287|NCT00289913|64401764|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23180288|NCT00289913|64401765|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
23180289|NCT00289913|64401761|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
23180290|NCT00289913|64401762|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
23180291|NCT00289913|64401763|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
23180292|NCT00289913|64401764|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
23180293|NCT00289913|64401765|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
23180294|NCT00289913|64401761|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23180295|NCT00289913|64401762|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23180296|NCT00289913|64401763|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23180297|NCT00289913|64401764|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
23180298|NCT00289913|64401765|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
23180299|NCT00289913|64401761|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180300|NCT00289913|64401762|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180301|NCT00289913|64401763|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180302|NCT00289913|64401764|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
23180303|NCT00289913|64401765|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
23180304|NCT00289913|64401761|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
23180305|NCT00289913|64401762|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
23180306|NCT00289913|64401763|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
23180307|NCT00289913|64401764|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
23180308|NCT00289913|64401765|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
23180309|NCT00289913|64401761|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23180310|NCT00289913|64401762|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
23240367|NCT01243762|64622285|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23240368|NCT01243762|64622286|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
23240369|NCT01243762|64622287|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
23240370|NCT01243762|64622281|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
23240371|NCT01243762|64622282|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
23583933|NCT03982199|65866044|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583934|NCT03982199|65866045|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23240372|NCT01243762|64622283|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
23240373|NCT01243762|64622284|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
23240374|NCT01243762|64622285|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
23240375|NCT01243762|64622286|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
23240376|NCT01243762|64622287|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
23240377|NCT01243762|64622281|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23240378|NCT01243762|64622282|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
23347276|NCT00454818|65014304|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
23347277|NCT00454818|65014305|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
23347278|NCT00454818|65014306|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
23347279|NCT00454818|65014307|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
23347280|NCT00454818|65014308|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
23347281|NCT00454818|65014304|FG000|Phase 2: Randomized Double-blind|Death|0|||
23347282|NCT00454818|65014305|FG001|Phase 2: Randomized Double-blind|Death|1|||
23347283|NCT00454818|65014306|FG002|Phase 2: Randomized Double-blind|Death|0|||
23347284|NCT00454818|65014307|FG003|Phase 2: Randomized Double-blind|Death|0|||
23458720|NCT04179175|65421425|FG001|Overall Study|Physician Decision|0|||
23458721|NCT04179175|65421426|FG002|Overall Study|Physician Decision|2|||
23583935|NCT03982199|65866046|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583936|NCT03982199|65866047|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23347285|NCT00454818|65014308|FG004|Phase 2: Randomized Double-blind|Death|1|||
23180311|NCT00289913|64401763|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
23180312|NCT00289913|64401764|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23180313|NCT00289913|64401765|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
23180314|NCT00289913|64401761|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
23180315|NCT00289913|64401762|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
23180316|NCT00289913|64401763|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
23180317|NCT00289913|64401764|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
23180318|NCT00289913|64401765|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
23180319|NCT00289913|64401761|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23180320|NCT00289913|64401762|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
23180321|NCT00289913|64401763|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23180322|NCT00289913|64401764|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23180323|NCT00289913|64401765|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
23180324|NCT02690701|64401767|FG000|Treatment Period 1|Adverse Event|2|||
23180325|NCT02690701|64401768|FG001|Treatment Period 1|Adverse Event|2|||
23180326|NCT02690701|64401767|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23180327|NCT02690701|64401768|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23180328|NCT02690701|64401767|FG000|Treatment Period 2|Adverse Event|2|||
23180329|NCT02690701|64401768|FG001|Treatment Period 2|Adverse Event|0|||
23180330|NCT02690701|64401767|FG000|Treatment Period 2|Lack of Efficacy|1|||
23180331|NCT02690701|64401768|FG001|Treatment Period 2|Lack of Efficacy|0|||
23180332|NCT02690701|64401767|FG000|Treatment Period 2|Lost to Follow-up|0|||
23180333|NCT02690701|64401768|FG001|Treatment Period 2|Lost to Follow-up|2|||
23240379|NCT01243762|64622283|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23240380|NCT01243762|64622284|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23240381|NCT01243762|64622285|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
23240382|NCT01243762|64622286|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23240383|NCT01243762|64622287|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
23240384|NCT01243762|64622281|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23240385|NCT01243762|64622282|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23240386|NCT01243762|64622283|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23240387|NCT01243762|64622284|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
23240388|NCT01243762|64622285|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
23240389|NCT01243762|64622286|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23240390|NCT01243762|64622287|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
23240391|NCT00348348|64622291|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
23240392|NCT00348348|64622292|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
23240393|NCT00348348|64622291|FG000|Overall Study|Lack of Efficacy|1|||
23240394|NCT00348348|64622292|FG001|Overall Study|Lack of Efficacy|1|||
23240395|NCT00348348|64622291|FG000|Overall Study|Lost to Follow-up|8|||
23240396|NCT00348348|64622292|FG001|Overall Study|Lost to Follow-up|10|||
23240397|NCT00348348|64622291|FG000|Overall Study|Withdrawal by Subject|4|||
23240398|NCT00348348|64622292|FG001|Overall Study|Withdrawal by Subject|1|||
23240399|NCT00348348|64622291|FG000|Overall Study|Other|7|||
23240400|NCT00348348|64622292|FG001|Overall Study|Other|4|||
23240401|NCT00348348|64622291|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
23240402|NCT00348348|64622292|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
23240403|NCT00348348|64622291|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
23240404|NCT00348348|64622292|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
23240405|NCT00348348|64622291|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
23240406|NCT00348348|64622292|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
23240407|NCT00348348|64622291|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
23240408|NCT00348348|64622292|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
23240409|NCT00348348|64622291|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
23240410|NCT00348348|64622292|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
23240411|NCT00348348|64622291|FG000|Overall Study|Adverse event probably related to study|1|||
23240412|NCT00348348|64622292|FG001|Overall Study|Adverse event probably related to study|0|||
23240413|NCT02451137|64622293|FG000|Overall Study|Randomized but not treated|19|||
23240414|NCT02451137|64622294|FG001|Overall Study|Randomized but not treated|27|||
23240415|NCT02451137|64622293|FG000|Overall Study|Adverse Event|43|||
23240416|NCT02451137|64622294|FG001|Overall Study|Adverse Event|42|||
23180334|NCT02690701|64401767|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23180335|NCT02690701|64401768|FG001|Treatment Period 2|Withdrawal by Subject|2|||
23180336|NCT02690701|64401767|FG000|Treatment Period 2|Protocol Violation|0|||
23180337|NCT02690701|64401768|FG001|Treatment Period 2|Protocol Violation|1|||
23240417|NCT02451137|64622293|FG000|Overall Study|Lack of Efficacy|4|||
23240418|NCT02451137|64622294|FG001|Overall Study|Lack of Efficacy|9|||
23458722|NCT04179175|65421427|FG003|Overall Study|Physician Decision|3|||
23180338|NCT00054132|64401769|FG000|Overall Study|Not Treated|1|||
23180339|NCT01023789|64401770|FG000|3 - Year Visit|Death|29|||
23180340|NCT01023789|64401770|FG000|3 - Year Visit|Withdrawal of consent|1|||
23180341|NCT01023789|64401770|FG000|3 - Year Visit|Lost to Follow-up|13|||
23180342|NCT01628926|64401771|FG000|Overall Study|Adverse Event|13|||
23180343|NCT01628926|64401772|FG001|Overall Study|Adverse Event|11|||
23180344|NCT01628926|64401773|FG002|Overall Study|Adverse Event|9|||
23180345|NCT01628926|64401771|FG000|Overall Study|Lack of Efficacy|2|||
23180346|NCT01628926|64401772|FG001|Overall Study|Lack of Efficacy|1|||
23180347|NCT01628926|64401773|FG002|Overall Study|Lack of Efficacy|5|||
23180348|NCT01628926|64401771|FG000|Overall Study|Withdrawal by Subject|6|||
23180349|NCT01628926|64401772|FG001|Overall Study|Withdrawal by Subject|4|||
23180350|NCT01628926|64401773|FG002|Overall Study|Withdrawal by Subject|2|||
23180351|NCT01628926|64401771|FG000|Overall Study|Protocol Violation|0|||
23180352|NCT01628926|64401772|FG001|Overall Study|Protocol Violation|1|||
23180353|NCT01628926|64401773|FG002|Overall Study|Protocol Violation|0|||
23180354|NCT01628926|64401771|FG000|Overall Study|Discontinuation criteria|3|||
23180355|NCT01628926|64401772|FG001|Overall Study|Discontinuation criteria|4|||
23180356|NCT01628926|64401773|FG002|Overall Study|Discontinuation criteria|0|||
23180357|NCT01628926|64401771|FG000|Overall Study|Physician Decision|2|||
23180358|NCT01628926|64401772|FG001|Overall Study|Physician Decision|2|||
23180359|NCT01628926|64401773|FG002|Overall Study|Physician Decision|1|||
23180360|NCT00486902|64401774|FG000|Overall Study|Withdrawal by Subject|1|||
23180361|NCT00486902|64401775|FG001|Overall Study|Withdrawal by Subject|2|||
23180362|NCT00486902|64401774|FG000|Overall Study|decision for postpartum tubal ligation|3|||
23180363|NCT00486902|64401775|FG001|Overall Study|decision for postpartum tubal ligation|1|||
23180364|NCT00486902|64401774|FG000|Overall Study|spinal anesthetic protocal violation|1|||
23180365|NCT00486902|64401775|FG001|Overall Study|spinal anesthetic protocal violation|1|||
23180366|NCT00486902|64401774|FG000|Overall Study|Did not meet inclusion criteria|1|||
23180367|NCT00486902|64401775|FG001|Overall Study|Did not meet inclusion criteria|0|||
23180368|NCT00486902|64401774|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
23180369|NCT00486902|64401775|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
23180370|NCT00151892|64401776|FG000|Overall Study|Lack of Efficacy|50|||
23180371|NCT00151892|64401777|FG001|Overall Study|Lack of Efficacy|57|||
23180372|NCT00151892|64401776|FG000|Overall Study|Patient request|10|||
23180373|NCT00151892|64401777|FG001|Overall Study|Patient request|7|||
23180374|NCT00151892|64401776|FG000|Overall Study|Lost to Follow-up|5|||
23180375|NCT00151892|64401777|FG001|Overall Study|Lost to Follow-up|10|||
23180376|NCT00151892|64401776|FG000|Overall Study|Adverse Event|6|||
23180377|NCT00151892|64401777|FG001|Overall Study|Adverse Event|3|||
23180378|NCT00151892|64401776|FG000|Overall Study|Protocol Violation|3|||
23180379|NCT00151892|64401777|FG001|Overall Study|Protocol Violation|3|||
23180380|NCT00151892|64401776|FG000|Overall Study|Non-compliance|0|||
23180381|NCT00151892|64401777|FG001|Overall Study|Non-compliance|1|||
23180382|NCT00151892|64401776|FG000|Overall Study|Pregnancy|0|||
23180383|NCT00151892|64401777|FG001|Overall Study|Pregnancy|1|||
23180384|NCT00151892|64401776|FG000|Overall Study|Did not return for a visit|1|||
23180385|NCT00151892|64401777|FG001|Overall Study|Did not return for a visit|0|||
23180386|NCT00151892|64401776|FG000|Overall Study|Used prohibited corticosteroids|1|||
23180387|NCT00151892|64401777|FG001|Overall Study|Used prohibited corticosteroids|0|||
23180388|NCT00151892|64401776|FG000|Overall Study|Lack of study medication at center|0|||
23180389|NCT00151892|64401777|FG001|Overall Study|Lack of study medication at center|1|||
23180390|NCT00880750|64401778|FG000|First Intervention|Adverse Event|1|||
23180391|NCT00880750|64401779|FG001|First Intervention|Adverse Event|0|||
23180392|NCT00880750|64401778|FG000|First Intervention|Unable to collect urine|4|||
23458723|NCT04179175|65421428|FG004|Overall Study|Physician Decision|1|||
23180393|NCT00880750|64401779|FG001|First Intervention|Unable to collect urine|0|||
23180394|NCT00880750|64401778|FG000|First Intervention|Non-compliance with meals|0|||
23180395|NCT00880750|64401779|FG001|First Intervention|Non-compliance with meals|1|||
23180396|NCT00880750|64401778|FG000|First Intervention|Withdrawal by Subject|2|||
23180397|NCT00880750|64401779|FG001|First Intervention|Withdrawal by Subject|0|||
23180398|NCT00880750|64401778|FG000|First Intervention|Lost to Follow-up|2|||
23180399|NCT00880750|64401779|FG001|First Intervention|Lost to Follow-up|0|||
23180400|NCT00880750|64401778|FG000|Second Intervention|Withdrawal by Subject|2|||
23180401|NCT00880750|64401779|FG001|Second Intervention|Withdrawal by Subject|2|||
23180402|NCT00880750|64401778|FG000|Second Intervention|Protocol Violation|1|||
23180403|NCT00880750|64401779|FG001|Second Intervention|Protocol Violation|0|||
23180404|NCT00880750|64401778|FG000|Second Intervention|Unable to collect urine|1|||
23180405|NCT00880750|64401779|FG001|Second Intervention|Unable to collect urine|0|||
23180406|NCT04041375|64401780|FG000|Intervention Phase|Withdrawal by Subject|2|||
23180407|NCT04041375|64401781|FG001|Intervention Phase|Withdrawal by Subject|2|||
23180408|NCT04041375|64401780|FG000|Follow-up Phase|Death|2|||
23180409|NCT04041375|64401781|FG001|Follow-up Phase|Death|0|||
23180410|NCT04041375|64401780|FG000|Follow-up Phase|Lost to Follow-up|2|||
23180411|NCT04041375|64401781|FG001|Follow-up Phase|Lost to Follow-up|1|||
23180412|NCT04041375|64401780|FG000|Follow-up Phase|Too ill|3|||
23458724|NCT04179175|65421429|FG005|Overall Study|Physician Decision|1|||
23180413|NCT04041375|64401781|FG001|Follow-up Phase|Too ill|0|||
23180414|NCT01354132|64401786|FG000|Randomization|Physician Decision|1|||
23180415|NCT01354132|64401787|FG001|Randomization|Physician Decision|0|||
23180416|NCT01354132|64401786|FG000|Randomization|Withdrawal by Subject|0|||
23180417|NCT01354132|64401787|FG001|Randomization|Withdrawal by Subject|1|||
23180418|NCT01354132|64401786|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
23180419|NCT01354132|64401787|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
23180420|NCT01354132|64401786|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
23180421|NCT01354132|64401787|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
23180422|NCT01354132|64401786|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
23180423|NCT01354132|64401787|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
23180424|NCT04025632|64401788|FG000|Overall Study|Adverse Event|1|||
23180425|NCT04025632|64401789|FG001|Overall Study|Adverse Event|1|||
23180426|NCT04025632|64401788|FG000|Overall Study|Withdrawal by Subject|1|||
23180427|NCT04025632|64401789|FG001|Overall Study|Withdrawal by Subject|1|||
23180428|NCT04025632|64401788|FG000|Overall Study|Study Terminated by Sponsor|10|||
23180429|NCT04025632|64401789|FG001|Overall Study|Study Terminated by Sponsor|9|||
23180430|NCT04025632|64401788|FG000|Overall Study|Physician Decision|3|||
23180431|NCT04025632|64401789|FG001|Overall Study|Physician Decision|1|||
23180432|NCT02497001|64401790|FG000|Overall Study|Lost to Follow-up|10|||
23180433|NCT02497001|64401791|FG001|Overall Study|Lost to Follow-up|2|||
23180434|NCT02497001|64401792|FG002|Overall Study|Lost to Follow-up|0|||
23180435|NCT02497001|64401793|FG003|Overall Study|Lost to Follow-up|2|||
23180436|NCT02497001|64401790|FG000|Overall Study|Adverse Event|28|||
23180437|NCT02497001|64401791|FG001|Overall Study|Adverse Event|30|||
23180438|NCT02497001|64401792|FG002|Overall Study|Adverse Event|11|||
23180439|NCT02497001|64401793|FG003|Overall Study|Adverse Event|11|||
23180440|NCT02497001|64401790|FG000|Overall Study|Withdrawal by Subject|14|||
23180441|NCT02497001|64401791|FG001|Overall Study|Withdrawal by Subject|37|||
23180442|NCT02497001|64401792|FG002|Overall Study|Withdrawal by Subject|19|||
23180443|NCT02497001|64401793|FG003|Overall Study|Withdrawal by Subject|15|||
23180444|NCT02497001|64401790|FG000|Overall Study|Physician Decision|5|||
23180445|NCT02497001|64401791|FG001|Overall Study|Physician Decision|11|||
23180446|NCT02497001|64401792|FG002|Overall Study|Physician Decision|5|||
23180447|NCT02497001|64401793|FG003|Overall Study|Physician Decision|1|||
23180448|NCT02497001|64401790|FG000|Overall Study|subjects that were not treated|1|||
23180449|NCT02497001|64401791|FG001|Overall Study|subjects that were not treated|2|||
23180450|NCT02497001|64401792|FG002|Overall Study|subjects that were not treated|2|||
23180451|NCT02497001|64401793|FG003|Overall Study|subjects that were not treated|1|||
23180452|NCT02497001|64401790|FG000|Overall Study|Major Protocol Deviation|3|||
23180453|NCT02497001|64401791|FG001|Overall Study|Major Protocol Deviation|4|||
23180454|NCT02497001|64401792|FG002|Overall Study|Major Protocol Deviation|4|||
23180455|NCT02497001|64401793|FG003|Overall Study|Major Protocol Deviation|4|||
23180456|NCT02497001|64401790|FG000|Overall Study|Lack of Efficacy|10|||
23180457|NCT02497001|64401791|FG001|Overall Study|Lack of Efficacy|16|||
23180458|NCT02497001|64401792|FG002|Overall Study|Lack of Efficacy|6|||
23180459|NCT02497001|64401793|FG003|Overall Study|Lack of Efficacy|6|||
23180460|NCT02497001|64401790|FG000|Overall Study|Protocol Violation|3|||
23180461|NCT02497001|64401791|FG001|Overall Study|Protocol Violation|1|||
23180462|NCT02497001|64401792|FG002|Overall Study|Protocol Violation|3|||
23180463|NCT02497001|64401793|FG003|Overall Study|Protocol Violation|1|||
23180464|NCT01727258|64401794|FG000|Overall Study|Adverse Event|0|||
23180465|NCT01727258|64401795|FG001|Overall Study|Adverse Event|2|||
23180466|NCT01727258|64401796|FG002|Overall Study|Adverse Event|0|||
23180467|NCT01727258|64401794|FG000|Overall Study|Noncompliance with Study Drug|0|||
23180468|NCT01727258|64401795|FG001|Overall Study|Noncompliance with Study Drug|0|||
23180469|NCT01727258|64401796|FG002|Overall Study|Noncompliance with Study Drug|1|||
23180470|NCT01727258|64401794|FG000|Overall Study|Withdrawal by Subject|1|||
23180471|NCT01727258|64401795|FG001|Overall Study|Withdrawal by Subject|1|||
23458725|NCT04179175|65421424|FG000|Overall Study|Pregnancy|3|||
23458726|NCT04179175|65421425|FG001|Overall Study|Pregnancy|0|||
23458727|NCT04179175|65421426|FG002|Overall Study|Pregnancy|3|||
23458728|NCT04179175|65421427|FG003|Overall Study|Pregnancy|0|||
23458729|NCT04179175|65421428|FG004|Overall Study|Pregnancy|1|||
23180472|NCT01727258|64401796|FG002|Overall Study|Withdrawal by Subject|0|||
23180473|NCT01727258|64401794|FG000|Overall Study|Lost to Follow-up|1|||
23180474|NCT01727258|64401795|FG001|Overall Study|Lost to Follow-up|0|||
23180475|NCT01727258|64401796|FG002|Overall Study|Lost to Follow-up|0|||
23180476|NCT01756456|64401797|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
23180477|NCT01756456|64401798|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
23180478|NCT01756456|64401799|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
23180479|NCT01756456|64401800|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
23180480|NCT01756456|64401801|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
23180481|NCT01756456|64401802|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
23180482|NCT01756456|64401797|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
23458730|NCT04179175|65421429|FG005|Overall Study|Pregnancy|2|||
23180483|NCT01756456|64401798|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
23180484|NCT01756456|64401799|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
23180485|NCT01756456|64401800|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
23180486|NCT01756456|64401801|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
23180487|NCT01756456|64401802|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
23180488|NCT01756456|64401797|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23180489|NCT01756456|64401798|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
23458731|NCT04179175|65421424|FG000|Overall Study|Withdrawal by Subject|22|||
23458732|NCT04179175|65421425|FG001|Overall Study|Withdrawal by Subject|10|||
23458733|NCT04179175|65421426|FG002|Overall Study|Withdrawal by Subject|12|||
23458734|NCT04179175|65421427|FG003|Overall Study|Withdrawal by Subject|8|||
23458735|NCT04179175|65421428|FG004|Overall Study|Withdrawal by Subject|23|||
23458736|NCT04179175|65421429|FG005|Overall Study|Withdrawal by Subject|31|||
23458737|NCT04179175|65421424|FG000|Overall Study|Technical problems|0|||
23458738|NCT04179175|65421425|FG001|Overall Study|Technical problems|0|||
23458739|NCT04179175|65421426|FG002|Overall Study|Technical problems|1|||
23458740|NCT04179175|65421427|FG003|Overall Study|Technical problems|1|||
23458741|NCT04179175|65421428|FG004|Overall Study|Technical problems|0|||
23458742|NCT04179175|65421429|FG005|Overall Study|Technical problems|0|||
23458743|NCT01346358|65421430|FG000|Overall Study|Withdrawal by Subject|1|||
23458744|NCT01346358|65421431|FG001|Overall Study|Withdrawal by Subject|0|||
23458745|NCT01346358|65421432|FG002|Overall Study|Withdrawal by Subject|1|||
23458746|NCT01346358|65421433|FG003|Overall Study|Withdrawal by Subject|1|||
23458747|NCT01346358|65421434|FG004|Overall Study|Withdrawal by Subject|0|||
23458748|NCT01346358|65421435|FG005|Overall Study|Withdrawal by Subject|2|||
23240419|NCT02451137|64622293|FG000|Overall Study|Participant decision:discontinue insulin|41|||
23240420|NCT02451137|64622294|FG001|Overall Study|Participant decision:discontinue insulin|43|||
23240421|NCT02451137|64622293|FG000|Overall Study|Hypoglycemia|2|||
23240422|NCT02451137|64622294|FG001|Overall Study|Hypoglycemia|1|||
23347286|NCT00454818|65014304|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
23458749|NCT01346358|65421436|FG006|Overall Study|Withdrawal by Subject|1|||
23458750|NCT01346358|65421437|FG007|Overall Study|Withdrawal by Subject|1|||
23458751|NCT01346358|65421438|FG008|Overall Study|Withdrawal by Subject|1|||
23458752|NCT01346358|65421430|FG000|Overall Study|Adverse Event|1|||
23458753|NCT01346358|65421431|FG001|Overall Study|Adverse Event|0|||
23458754|NCT01346358|65421432|FG002|Overall Study|Adverse Event|0|||
23458755|NCT01346358|65421433|FG003|Overall Study|Adverse Event|0|||
23458756|NCT01346358|65421434|FG004|Overall Study|Adverse Event|1|||
23458757|NCT01346358|65421435|FG005|Overall Study|Adverse Event|0|||
23458758|NCT01346358|65421436|FG006|Overall Study|Adverse Event|0|||
23458759|NCT01346358|65421437|FG007|Overall Study|Adverse Event|0|||
23458760|NCT01346358|65421438|FG008|Overall Study|Adverse Event|1|||
23458761|NCT01346358|65421430|FG000|Overall Study|Non-Compliance|0|||
23458762|NCT01346358|65421431|FG001|Overall Study|Non-Compliance|0|||
23458763|NCT01346358|65421432|FG002|Overall Study|Non-Compliance|0|||
23458764|NCT01346358|65421433|FG003|Overall Study|Non-Compliance|0|||
23458765|NCT01346358|65421434|FG004|Overall Study|Non-Compliance|0|||
23458766|NCT01346358|65421435|FG005|Overall Study|Non-Compliance|0|||
23458767|NCT01346358|65421436|FG006|Overall Study|Non-Compliance|0|||
23458768|NCT01346358|65421437|FG007|Overall Study|Non-Compliance|2|||
23458769|NCT01346358|65421438|FG008|Overall Study|Non-Compliance|0|||
23458770|NCT01346358|65421430|FG000|Overall Study|Physician Decision|0|||
23458771|NCT01346358|65421431|FG001|Overall Study|Physician Decision|1|||
23458772|NCT01346358|65421432|FG002|Overall Study|Physician Decision|0|||
23458773|NCT01346358|65421433|FG003|Overall Study|Physician Decision|0|||
23458774|NCT01346358|65421434|FG004|Overall Study|Physician Decision|0|||
23458775|NCT01346358|65421435|FG005|Overall Study|Physician Decision|0|||
23458776|NCT01346358|65421436|FG006|Overall Study|Physician Decision|0|||
23458777|NCT01346358|65421437|FG007|Overall Study|Physician Decision|1|||
23458778|NCT01346358|65421438|FG008|Overall Study|Physician Decision|1|||
23458779|NCT05249582|65421439|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
23458780|NCT05249582|65421440|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
23458781|NCT05249582|65421439|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
23458782|NCT05249582|65421440|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
23458783|NCT05249582|65421439|FG000|Overall Study|Declined to use virtual reality headset|1|||
23458784|NCT05249582|65421440|FG001|Overall Study|Declined to use virtual reality headset|0|||
23458785|NCT03668873|65421443|FG000|Overall Study|Lost to Follow-up|6|||
23458786|NCT03668873|65421444|FG001|Overall Study|Lost to Follow-up|3|||
23458787|NCT03164616|65421445|FG000|Overall Study|Death|250|||
23458788|NCT03164616|65421446|FG001|Overall Study|Death|264|||
23458789|NCT03164616|65421447|FG002|Overall Study|Death|279|||
23458790|NCT03164616|65421445|FG000|Overall Study|Lost to Follow-up|2|||
23458791|NCT03164616|65421446|FG001|Overall Study|Lost to Follow-up|2|||
23458792|NCT03164616|65421447|FG002|Overall Study|Lost to Follow-up|2|||
23240423|NCT02451137|64622293|FG000|Overall Study|Investigator's decision|23|||
23458793|NCT03164616|65421445|FG000|Overall Study|Withdrawal by Subject|6|||
23458794|NCT03164616|65421446|FG001|Overall Study|Withdrawal by Subject|7|||
23458795|NCT03164616|65421447|FG002|Overall Study|Withdrawal by Subject|16|||
23240424|NCT02451137|64622294|FG001|Overall Study|Investigator's decision|19|||
23240425|NCT02451137|64622293|FG000|Overall Study|Lost to Follow-up|53|||
23240426|NCT02451137|64622294|FG001|Overall Study|Lost to Follow-up|61|||
23180490|NCT01756456|64401799|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23180491|NCT01756456|64401800|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23458796|NCT04123470|65421448|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
23458797|NCT04123470|65421449|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
23458798|NCT04123470|65421448|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
23240427|NCT02451137|64622293|FG000|Overall Study|Physician Decision|6|||
23240428|NCT02451137|64622294|FG001|Overall Study|Physician Decision|5|||
23458799|NCT04123470|65421449|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
23458800|NCT04123470|65421448|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
23458801|NCT04123470|65421449|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
23458802|NCT04123470|65421448|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
23180492|NCT01756456|64401801|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23180493|NCT01756456|64401802|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
23180494|NCT01756456|64401797|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
23180495|NCT01756456|64401798|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
23180496|NCT01756456|64401799|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
23180497|NCT01756456|64401800|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
23180498|NCT01756456|64401801|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
23180499|NCT01756456|64401802|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
23180500|NCT01756456|64401797|FG000|Treatment Period: Phase I/II|Other causes|0|||
23180501|NCT01756456|64401798|FG001|Treatment Period: Phase I/II|Other causes|0|||
23180502|NCT01756456|64401799|FG002|Treatment Period: Phase I/II|Other causes|0|||
23180503|NCT01756456|64401800|FG003|Treatment Period: Phase I/II|Other causes|1|||
23180504|NCT01756456|64401801|FG004|Treatment Period: Phase I/II|Other causes|2|||
23458803|NCT04123470|65421449|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
23458804|NCT01231906|65421450|FG000|Overall Study|Lack of Efficacy|75|||
23458805|NCT01231906|65421451|FG001|Overall Study|Lack of Efficacy|68|||
23458806|NCT01231906|65421450|FG000|Overall Study|Lost to Follow-up|1|||
23458807|NCT01231906|65421451|FG001|Overall Study|Lost to Follow-up|0|||
23458808|NCT01231906|65421450|FG000|Overall Study|Physician Decision|34|||
23458809|NCT01231906|65421451|FG001|Overall Study|Physician Decision|24|||
23458810|NCT01231906|65421450|FG000|Overall Study|Withdrawal by Subject|0|||
23458811|NCT01231906|65421451|FG001|Overall Study|Withdrawal by Subject|4|||
23458812|NCT01231906|65421450|FG000|Overall Study|Ineligible|10|||
23458813|NCT01231906|65421451|FG001|Overall Study|Ineligible|3|||
23458814|NCT01231906|65421450|FG000|Overall Study|No treatment|1|||
23458815|NCT01231906|65421451|FG001|Overall Study|No treatment|2|||
23458816|NCT04245111|65421458|FG000|Overall Study|Lost to Follow-up|5|||
23458817|NCT04245111|65421459|FG001|Overall Study|Lost to Follow-up|1|||
23458818|NCT04245111|65421460|FG002|Overall Study|Lost to Follow-up|1|||
23458819|NCT03157830|65421461|FG000|Overall Study|Lost to Follow-up|1|||
23458820|NCT03157830|65421461|FG000|Overall Study|Withdrawal by Subject|1|||
23458821|NCT01864018|65421463|FG000|Overall Study|Ineligible|3|||
23458822|NCT01864018|65421464|FG001|Overall Study|Ineligible|1|||
23458823|NCT03119259|65423519|FG000|Overall Study|Withdrawn as no longer eligible|1|||
23458824|NCT03119259|65423520|FG001|Overall Study|Withdrawn as no longer eligible|0|||
23458825|NCT03119259|65423519|FG000|Overall Study|Withdrawal by Subject|4|||
23458826|NCT03119259|65423520|FG001|Overall Study|Withdrawal by Subject|2|||
23458827|NCT03119259|65423519|FG000|Overall Study|Lost to Follow-up|0|||
23458828|NCT03119259|65423520|FG001|Overall Study|Lost to Follow-up|1|||
23458829|NCT03904693|65423524|FG000|Overall Study|Death|0|||
23458830|NCT03904693|65423525|FG001|Overall Study|Death|0|||
23458831|NCT03904693|65423526|FG002|Overall Study|Death|3|||
23458832|NCT03904693|65423524|FG000|Overall Study|Physician Decision|0|||
23458833|NCT03904693|65423525|FG001|Overall Study|Physician Decision|0|||
23180505|NCT01756456|64401802|FG005|Treatment Period: Phase I/II|Other causes|2|||
23240429|NCT02451137|64622293|FG000|Overall Study|Sponsor decision|13|||
23458834|NCT03904693|65423526|FG002|Overall Study|Physician Decision|2|||
23458835|NCT03904693|65423524|FG000|Overall Study|Withdrawal by Subject|0|||
23458836|NCT03904693|65423525|FG001|Overall Study|Withdrawal by Subject|1|||
23458837|NCT03904693|65423526|FG002|Overall Study|Withdrawal by Subject|4|||
23458838|NCT04439539|65423527|FG000|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|1|||
23180506|NCT01756456|64401797|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
23180507|NCT01756456|64401798|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
23458839|NCT04439539|65423528|FG001|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|0|||
23458840|NCT04439539|65423529|FG002|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|2|||
23458841|NCT04439539|65423527|FG000|Follow-up (FU): FU Week 0 to 48|Ongoing|0|||
23240430|NCT02451137|64622294|FG001|Overall Study|Sponsor decision|25|||
23458842|NCT04439539|65423528|FG001|Follow-up (FU): FU Week 0 to 48|Ongoing|5|||
23458843|NCT04439539|65423529|FG002|Follow-up (FU): FU Week 0 to 48|Ongoing|17|||
23458844|NCT04439539|65423527|FG000|Follow-up (FU): FU Week 0 to 48|Other|0|||
23458845|NCT04439539|65423528|FG001|Follow-up (FU): FU Week 0 to 48|Other|1|||
23458846|NCT04439539|65423529|FG002|Follow-up (FU): FU Week 0 to 48|Other|0|||
23458847|NCT01648751|65423534|FG000|Overall Study|Withdrawal by Subject|2|||
23458848|NCT01648751|65423535|FG001|Overall Study|Withdrawal by Subject|3|||
23458849|NCT04227899|65423536|FG000|Overall Study|Withdrawal by Subject|6|||
23458850|NCT04227899|65423537|FG001|Overall Study|Withdrawal by Subject|3|||
23458851|NCT04227899|65423536|FG000|Overall Study|Death|12|||
23458852|NCT04227899|65423537|FG001|Overall Study|Death|6|||
23458853|NCT04227899|65423536|FG000|Overall Study|Lost to Follow-up|2|||
23458854|NCT04227899|65423537|FG001|Overall Study|Lost to Follow-up|1|||
23458855|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
23458856|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
23458857|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
23458858|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
23458859|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
23458860|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
23458861|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
23458862|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
23458863|NCT04576988|65423538|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
23458864|NCT04576988|65423539|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
23458865|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
23458866|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
23458867|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
23458868|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
23458869|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
23458870|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
23458871|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Death|2|||
23458872|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Death|1|||
23458873|NCT04576988|65423538|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
23458874|NCT04576988|65423539|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
23458875|NCT03264404|65423540|FG000|Overall Study|Death|2|||
23458876|NCT03264404|65423540|FG000|Overall Study|Physician Decision|1|||
23458877|NCT03264404|65423540|FG000|Overall Study|Disease Progression|28|||
23458878|NCT03264404|65423540|FG000|Overall Study|Adverse Event|1|||
23458879|NCT03264404|65423540|FG000|Overall Study|Off study prior to treatment|2|||
23458880|NCT03497676|65423541|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
23458881|NCT03497676|65423542|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
23458882|NCT03497676|65423543|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
23458883|NCT03497676|65423544|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
23458884|NCT03497676|65423541|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
23458885|NCT03497676|65423542|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
23458886|NCT03497676|65423543|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
23458887|NCT03497676|65423544|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
23180508|NCT01756456|64401799|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
23458888|NCT03497676|65423541|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
23180509|NCT01756456|64401800|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
23180510|NCT01756456|64401801|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
23180511|NCT01756456|64401802|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
23458889|NCT03497676|65423542|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
23458890|NCT03497676|65423543|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
23458891|NCT03497676|65423544|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
23458892|NCT03497676|65423541|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
23458893|NCT03497676|65423542|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
23458894|NCT03497676|65423543|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
23458895|NCT03497676|65423544|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
23458896|NCT03497676|65423541|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
23458897|NCT03497676|65423542|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
23458898|NCT03497676|65423543|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
23458899|NCT03497676|65423544|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
23458900|NCT03497676|65423541|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
23458901|NCT03497676|65423542|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
23458902|NCT03497676|65423543|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
23458903|NCT03497676|65423544|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
23180512|NCT01756456|64401797|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23240431|NCT02451137|64622293|FG000|Overall Study|Withdrawal by Subject|40|||
23180513|NCT01756456|64401798|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
23180514|NCT01756456|64401799|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23180515|NCT01756456|64401800|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23180516|NCT01756456|64401801|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23180517|NCT01756456|64401802|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
23180518|NCT01756456|64401797|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23180519|NCT01756456|64401798|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23180520|NCT01756456|64401799|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23180521|NCT01756456|64401800|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23180522|NCT01756456|64401801|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
23180523|NCT01756456|64401802|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
23180524|NCT01756456|64401797|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
23180525|NCT01756456|64401798|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
23180526|NCT01756456|64401799|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
23180527|NCT01756456|64401800|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
23180528|NCT01756456|64401801|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
23180529|NCT01756456|64401802|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
23180530|NCT01756456|64401797|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
23180531|NCT01756456|64401798|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
23180532|NCT01756456|64401799|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
23180533|NCT01756456|64401800|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
23180534|NCT01756456|64401801|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
23180535|NCT01756456|64401802|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
23180536|NCT01756456|64401797|FG000|Follow Up Period Phase I/II|Other causes|0|||
23180537|NCT01756456|64401798|FG001|Follow Up Period Phase I/II|Other causes|0|||
23180538|NCT01756456|64401799|FG002|Follow Up Period Phase I/II|Other causes|0|||
23180539|NCT01756456|64401800|FG003|Follow Up Period Phase I/II|Other causes|1|||
23180540|NCT01756456|64401801|FG004|Follow Up Period Phase I/II|Other causes|3|||
23180541|NCT01756456|64401802|FG005|Follow Up Period Phase I/II|Other causes|5|||
23180542|NCT03480802|64401803|FG000|Overall Study|Lost to Follow-up|5|||
23180543|NCT03480802|64401804|FG001|Overall Study|Lost to Follow-up|1|||
23180544|NCT03480802|64401803|FG000|Overall Study|Withdrawal by Subject|2|||
23180545|NCT03480802|64401804|FG001|Overall Study|Withdrawal by Subject|1|||
23180546|NCT03480802|64401803|FG000|Overall Study|Relocated|0|||
23180547|NCT03480802|64401804|FG001|Overall Study|Relocated|1|||
23180548|NCT00840827|64401805|FG000|Overall Study|Adverse Event|1|||
23180549|NCT00840827|64401805|FG000|Overall Study|Lack of Efficacy|4|||
23180550|NCT00840827|64401805|FG000|Overall Study|Physician Decision|1|||
23180551|NCT03770403|64401807|FG000|Overall Study|Adverse Event|8|||
23180552|NCT03770403|64401807|FG000|Overall Study|Death|5|||
23180553|NCT03770403|64401807|FG000|Overall Study|Physician Decision|1|||
23180554|NCT03770403|64401807|FG000|Overall Study|Sponsor decision|1|||
23180555|NCT03770403|64401807|FG000|Overall Study|Study terminated by Sponsor|1|||
23180556|NCT03770403|64401807|FG000|Overall Study|Withdrawal by Subject|13|||
23180557|NCT03770403|64401807|FG000|Overall Study|Other|88|||
23180558|NCT01409928|64401810|FG000|Overall Study|Physician Decision|12|||
23180559|NCT02305563|64401811|FG000|Treatment Period|Disease progression|0|||
23347287|NCT00454818|65014305|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
23347288|NCT00454818|65014306|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
23347289|NCT00454818|65014307|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
23347290|NCT00454818|65014308|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
23347291|NCT00454818|65014304|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
23347292|NCT00454818|65014305|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
23347293|NCT00454818|65014306|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
23347294|NCT00454818|65014307|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
23347295|NCT00454818|65014308|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
23347296|NCT02461524|65014311|FG000|Overall Study|Death|16|||
23347297|NCT02461524|65014311|FG000|Overall Study|Withdrawal by Subject|4|||
23347298|NCT02461524|65014311|FG000|Overall Study|Device Explanted|5|||
23347299|NCT02461524|65014311|FG000|Overall Study|Missed Visit|6|||
23347300|NCT00197002|65014312|FG000|Overall Study|Adverse Event|0|||
23347301|NCT00197002|65014313|FG001|Overall Study|Adverse Event|1|||
23347302|NCT00197002|65014314|FG002|Overall Study|Adverse Event|0|||
23180560|NCT02305563|64401812|FG001|Treatment Period|Disease progression|0|||
23180561|NCT02305563|64401813|FG002|Treatment Period|Disease progression|15|||
23180562|NCT02305563|64401814|FG003|Treatment Period|Disease progression|6|||
23180563|NCT02305563|64401815|FG004|Treatment Period|Disease progression|6|||
23180564|NCT02305563|64401811|FG000|Treatment Period|Study drug toxicity|0|||
23180565|NCT02305563|64401812|FG001|Treatment Period|Study drug toxicity|0|||
23180566|NCT02305563|64401813|FG002|Treatment Period|Study drug toxicity|0|||
23180567|NCT02305563|64401814|FG003|Treatment Period|Study drug toxicity|1|||
23458904|NCT03497676|65423541|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
23458905|NCT03497676|65423542|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
23458906|NCT03497676|65423543|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
23458907|NCT03497676|65423544|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
23583937|NCT03982199|65866048|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23180568|NCT02305563|64401815|FG004|Treatment Period|Study drug toxicity|2|||
23180569|NCT02305563|64401811|FG000|Treatment Period|Death|0|||
23180570|NCT02305563|64401812|FG001|Treatment Period|Death|0|||
23180571|NCT02305563|64401813|FG002|Treatment Period|Death|1|||
23180572|NCT02305563|64401814|FG003|Treatment Period|Death|2|||
23180573|NCT02305563|64401815|FG004|Treatment Period|Death|1|||
23180574|NCT02305563|64401811|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
23180575|NCT02305563|64401812|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
23180576|NCT02305563|64401813|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
23240432|NCT02451137|64622294|FG001|Overall Study|Withdrawal by Subject|63|||
23240433|NCT02451137|64622293|FG000|Overall Study|Other than specified above|2|||
23240434|NCT02451137|64622294|FG001|Overall Study|Other than specified above|3|||
23180577|NCT02305563|64401814|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
23180578|NCT02305563|64401815|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
23180579|NCT02305563|64401811|FG000|Treatment Period|Participant request to stop therapy|0|||
23180580|NCT02305563|64401812|FG001|Treatment Period|Participant request to stop therapy|2|||
23180581|NCT02305563|64401813|FG002|Treatment Period|Participant request to stop therapy|0|||
23180582|NCT02305563|64401814|FG003|Treatment Period|Participant request to stop therapy|1|||
23180583|NCT02305563|64401815|FG004|Treatment Period|Participant request to stop therapy|0|||
23180584|NCT02305563|64401811|FG000|Treatment Period|Participant withdrew consent|0|||
23180585|NCT02305563|64401812|FG001|Treatment Period|Participant withdrew consent|0|||
23180586|NCT02305563|64401813|FG002|Treatment Period|Participant withdrew consent|1|||
23240435|NCT05056311|64622295|FG000|Overall Study|Lost to Follow-up|14|||
23240436|NCT05056311|64622295|FG000|Overall Study|Withdrawal by Subject|1|||
23240437|NCT05056311|64622295|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
23240438|NCT00945815|64622296|FG000|Overall Study|Death|3|||
23240439|NCT00945815|64622296|FG000|Overall Study|Not protocol specified|1|||
23240440|NCT00945815|64622296|FG000|Overall Study|Ineligible|3|||
23240441|NCT00945815|64622296|FG000|Overall Study|Did not begin protocol therapy|1|||
23240442|NCT00532441|64622297|FG000|Overall Study|Death|1|||
23240443|NCT00532441|64622298|FG001|Overall Study|Death|0|||
23240444|NCT03522506|64622299|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23240445|NCT03522506|64622300|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23240446|NCT03522506|64622301|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23240447|NCT03522506|64622302|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23240448|NCT03522506|64622299|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23240449|NCT03522506|64622300|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23240450|NCT03522506|64622301|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23240451|NCT03522506|64622302|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
23240452|NCT01876901|64622303|FG000|Overall Study|Protocol Violation|10|||
23240453|NCT01876901|64622304|FG001|Overall Study|Protocol Violation|2|||
23240454|NCT01876901|64622303|FG000|Overall Study|No or other surgical intervention|7|||
23240455|NCT01876901|64622304|FG001|Overall Study|No or other surgical intervention|5|||
23240456|NCT01361308|64622305|FG000|Overall Study|Withdrawal by Subject|9|||
23240457|NCT01361308|64622306|FG001|Overall Study|Withdrawal by Subject|13|||
23240458|NCT01361308|64622305|FG000|Overall Study|Physician Decision|3|||
23240459|NCT01361308|64622306|FG001|Overall Study|Physician Decision|3|||
23240460|NCT01361308|64622305|FG000|Overall Study|Lack of Efficacy|2|||
23240461|NCT01361308|64622306|FG001|Overall Study|Lack of Efficacy|0|||
23240462|NCT01361308|64622305|FG000|Overall Study|Protocol Violation|1|||
23240463|NCT01361308|64622306|FG001|Overall Study|Protocol Violation|0|||
23583938|NCT03982199|65866049|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583939|NCT03982199|65866050|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583940|NCT03982199|65866051|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583941|NCT03982199|65866052|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583942|NCT03982199|65866053|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583943|NCT03982199|65866054|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23240464|NCT01361308|64622305|FG000|Overall Study|Lost to Follow-up|5|||
23240465|NCT01361308|64622306|FG001|Overall Study|Lost to Follow-up|4|||
23240466|NCT01361308|64622305|FG000|Overall Study|Adverse Event|8|||
23240467|NCT01361308|64622306|FG001|Overall Study|Adverse Event|4|||
23240468|NCT01361308|64622305|FG000|Overall Study|Eligibility Criteria Not Met|2|||
23240469|NCT01361308|64622306|FG001|Overall Study|Eligibility Criteria Not Met|3|||
23583944|NCT03982199|65866055|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
23180587|NCT02305563|64401814|FG003|Treatment Period|Participant withdrew consent|1|||
23180588|NCT02305563|64401815|FG004|Treatment Period|Participant withdrew consent|1|||
23240470|NCT01361308|64622305|FG000|Overall Study|Failed C-SSRS|5|||
23458908|NCT03497676|65423541|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
23458909|NCT03497676|65423542|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
23458910|NCT03497676|65423543|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
23458911|NCT03497676|65423544|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
23458912|NCT05408429|65423545|FG000|Overall Study|Lost to Follow-up|1|||
23458913|NCT05408429|65423546|FG001|Overall Study|Lost to Follow-up|1|||
23458914|NCT05408429|65423547|FG002|Overall Study|Lost to Follow-up|0|||
23458915|NCT05408429|65423545|FG000|Overall Study|Withdrawal by Subject|5|||
23458916|NCT05408429|65423546|FG001|Overall Study|Withdrawal by Subject|0|||
23458917|NCT05408429|65423547|FG002|Overall Study|Withdrawal by Subject|1|||
23458918|NCT03317405|65423549|FG000|Overall Study|Withdrawal by Subject|1|||
23458919|NCT03317405|65423550|FG001|Overall Study|Withdrawal by Subject|0|||
23180589|NCT02305563|64401811|FG000|Treatment Period|Maximum clinical benefit|0|||
23180590|NCT02305563|64401812|FG001|Treatment Period|Maximum clinical benefit|0|||
23458920|NCT03317405|65423551|FG002|Overall Study|Withdrawal by Subject|0|||
23458921|NCT03317405|65423549|FG000|Overall Study|Physician Decision|0|||
23458922|NCT03317405|65423550|FG001|Overall Study|Physician Decision|0|||
23458923|NCT03317405|65423551|FG002|Overall Study|Physician Decision|1|||
23458924|NCT03317405|65423549|FG000|Overall Study|Surgery Rescheduled|0|||
23458925|NCT03317405|65423550|FG001|Overall Study|Surgery Rescheduled|1|||
23458926|NCT03317405|65423551|FG002|Overall Study|Surgery Rescheduled|0|||
23458927|NCT05523089|65423554|FG000|Overall Study|Withdrawal by Subject|1|||
23458928|NCT05523089|65423555|FG001|Overall Study|Withdrawal by Subject|0|||
23458929|NCT05523089|65423556|FG002|Overall Study|Withdrawal by Subject|0|||
23458930|NCT05523089|65423554|FG000|Overall Study|Lost to Follow-up|1|||
23458931|NCT05523089|65423555|FG001|Overall Study|Lost to Follow-up|0|||
23458932|NCT05523089|65423556|FG002|Overall Study|Lost to Follow-up|0|||
23458933|NCT04298697|65423557|FG000|Overall Study|Lost to Follow-up|5|||
23458934|NCT04298697|65423558|FG001|Overall Study|Lost to Follow-up|5|||
23458935|NCT04298697|65423559|FG002|Overall Study|Lost to Follow-up|1|||
23458936|NCT04298697|65423560|FG003|Overall Study|Lost to Follow-up|0|||
23458937|NCT04298697|65423557|FG000|Overall Study|Withdrawal by Subject|0|||
23180591|NCT02305563|64401813|FG002|Treatment Period|Maximum clinical benefit|0|||
23180592|NCT02305563|64401814|FG003|Treatment Period|Maximum clinical benefit|0|||
23180593|NCT02305563|64401815|FG004|Treatment Period|Maximum clinical benefit|1|||
23180594|NCT02305563|64401811|FG000|Treatment Period|Poor/non-compliance|0|||
23180595|NCT02305563|64401812|FG001|Treatment Period|Poor/non-compliance|0|||
23180596|NCT02305563|64401813|FG002|Treatment Period|Poor/non-compliance|0|||
23180597|NCT02305563|64401814|FG003|Treatment Period|Poor/non-compliance|0|||
23180598|NCT02305563|64401815|FG004|Treatment Period|Poor/non-compliance|1|||
23458938|NCT04298697|65423558|FG001|Overall Study|Withdrawal by Subject|3|||
23458939|NCT04298697|65423559|FG002|Overall Study|Withdrawal by Subject|2|||
23458940|NCT04298697|65423560|FG003|Overall Study|Withdrawal by Subject|3|||
23458941|NCT02003924|65423565|FG000|Double-blind Phase|Lost to Follow-up|2|||
23458942|NCT02003924|65423566|FG001|Double-blind Phase|Lost to Follow-up|1|||
23458943|NCT02003924|65423567|FG002|Double-blind Phase|Lost to Follow-up|0|||
23458944|NCT02003924|65423565|FG000|Double-blind Phase|Protocol Violation|1|||
23458945|NCT02003924|65423566|FG001|Double-blind Phase|Protocol Violation|2|||
23458946|NCT02003924|65423567|FG002|Double-blind Phase|Protocol Violation|0|||
23458947|NCT02003924|65423565|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
23458948|NCT02003924|65423566|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
23458949|NCT02003924|65423567|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
23458950|NCT02003924|65423565|FG000|Double-blind Phase|Disease Progression|229|||
23458951|NCT02003924|65423566|FG001|Double-blind Phase|Disease Progression|247|||
23458952|NCT02003924|65423567|FG002|Double-blind Phase|Disease Progression|0|||
23458953|NCT02003924|65423565|FG000|Double-blind Phase|Adverse Event|120|||
23458954|NCT02003924|65423566|FG001|Double-blind Phase|Adverse Event|31|||
23458955|NCT02003924|65423567|FG002|Double-blind Phase|Adverse Event|0|||
23458956|NCT02003924|65423565|FG000|Double-blind Phase|Randomized But not Treated|3|||
23458957|NCT02003924|65423566|FG001|Double-blind Phase|Randomized But not Treated|3|||
23458958|NCT02003924|65423567|FG002|Double-blind Phase|Randomized But not Treated|0|||
23458959|NCT02003924|65423565|FG000|Double-blind Phase|Other|29|||
23458960|NCT02003924|65423566|FG001|Double-blind Phase|Other|50|||
23458961|NCT02003924|65423567|FG002|Double-blind Phase|Other|0|||
23458962|NCT02003924|65423565|FG000|Open-label Phase|Lost to Follow-up|0|||
23458963|NCT02003924|65423566|FG001|Open-label Phase|Lost to Follow-up|0|||
23240471|NCT01361308|64622306|FG001|Overall Study|Failed C-SSRS|2|||
23458964|NCT02003924|65423567|FG002|Open-label Phase|Lost to Follow-up|1|||
23458965|NCT02003924|65423565|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
23458966|NCT02003924|65423566|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
23180599|NCT02305563|64401811|FG000|Treatment Period|Administrative reason by Sponsor|0|||
23180600|NCT02305563|64401812|FG001|Treatment Period|Administrative reason by Sponsor|0|||
23180601|NCT02305563|64401813|FG002|Treatment Period|Administrative reason by Sponsor|0|||
23458967|NCT02003924|65423567|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
23458968|NCT02003924|65423565|FG000|Open-label Phase|Disease Progression|59|||
23458969|NCT02003924|65423566|FG001|Open-label Phase|Disease Progression|0|||
23458970|NCT02003924|65423567|FG002|Open-label Phase|Disease Progression|5|||
23458971|NCT02003924|65423565|FG000|Open-label Phase|Adverse Event|25|||
23458972|NCT02003924|65423566|FG001|Open-label Phase|Adverse Event|0|||
23458973|NCT02003924|65423567|FG002|Open-label Phase|Adverse Event|10|||
23458974|NCT02003924|65423565|FG000|Open-label Phase|Other|7|||
23458975|NCT02003924|65423566|FG001|Open-label Phase|Other|0|||
23458976|NCT02003924|65423567|FG002|Open-label Phase|Other|0|||
23458977|NCT02003924|65423565|FG000|Long-term Follow-up Phase|Death|288|||
23458978|NCT02003924|65423566|FG001|Long-term Follow-up Phase|Death|174|||
23458979|NCT02003924|65423567|FG002|Long-term Follow-up Phase|Death|4|||
23458980|NCT02003924|65423565|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
23458981|NCT02003924|65423566|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
23458982|NCT02003924|65423567|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
23458983|NCT02003924|65423565|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
23458984|NCT02003924|65423566|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
23458985|NCT02003924|65423567|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
23458986|NCT02003924|65423565|FG000|Long-term Follow-up Phase|Other|5|||
23458987|NCT02003924|65423566|FG001|Long-term Follow-up Phase|Other|2|||
23458988|NCT02003924|65423567|FG002|Long-term Follow-up Phase|Other|1|||
23458989|NCT03521570|65423568|FG000|Overall Study|Not eligible|11|||
23458990|NCT04914364|65423579|FG000|Overall Study|No longer eligible for study|1|||
23240472|NCT01361308|64622305|FG000|Overall Study|Other|0|||
23240473|NCT01361308|64622306|FG001|Overall Study|Other|1|||
23240474|NCT03233009|64622309|FG000|Overall Study|Lost to Follow-up|1|||
23240475|NCT04221373|64622311|FG000|Overall Study|Physician Decision|4|||
23240476|NCT04221373|64622312|FG001|Overall Study|Physician Decision|0|||
23240477|NCT00219349|64622313|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
23240478|NCT00219349|64622313|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
23240479|NCT00219349|64622313|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
23458991|NCT04914364|65423579|FG000|Overall Study|Lost to Follow-up|2|||
23458992|NCT04109547|65423580|FG000|Overall Study|Withdrawal by Subject|3|||
23458993|NCT04109547|65423581|FG001|Overall Study|Withdrawal by Subject|2|||
23458994|NCT04109547|65423582|FG002|Overall Study|Withdrawal by Subject|6|||
23240480|NCT00219349|64622313|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
23240481|NCT01886105|64622314|FG000|Overall Study|Lack of Efficacy|3|||
23240482|NCT00525499|64622316|FG000|Overall Study|Lost to Follow-up|2|||
23240483|NCT00525499|64622317|FG001|Overall Study|Lost to Follow-up|4|||
23240484|NCT00525499|64622318|FG002|Overall Study|Lost to Follow-up|1|||
23240485|NCT00525499|64622319|FG003|Overall Study|Lost to Follow-up|4|||
23240486|NCT00525499|64622316|FG000|Overall Study|Adverse Event|0|||
23240487|NCT00525499|64622317|FG001|Overall Study|Adverse Event|1|||
23240488|NCT00525499|64622318|FG002|Overall Study|Adverse Event|0|||
23240489|NCT00525499|64622319|FG003|Overall Study|Adverse Event|1|||
23240490|NCT00525499|64622316|FG000|Overall Study|Withdrawal by Subject|5|||
23240491|NCT00525499|64622317|FG001|Overall Study|Withdrawal by Subject|1|||
23240492|NCT00525499|64622318|FG002|Overall Study|Withdrawal by Subject|5|||
23240493|NCT00525499|64622319|FG003|Overall Study|Withdrawal by Subject|2|||
23180602|NCT02305563|64401814|FG003|Treatment Period|Administrative reason by Sponsor|0|||
23180603|NCT02305563|64401815|FG004|Treatment Period|Administrative reason by Sponsor|1|||
23180604|NCT02305563|64401811|FG000|Treatment Period|other reason|2|||
23180605|NCT02305563|64401812|FG001|Treatment Period|other reason|0|||
23180606|NCT02305563|64401813|FG002|Treatment Period|other reason|2|||
23180607|NCT02305563|64401814|FG003|Treatment Period|other reason|2|||
23180608|NCT02305563|64401815|FG004|Treatment Period|other reason|1|||
23240494|NCT00525499|64622316|FG000|Overall Study|Protocol Violation|0|||
23240495|NCT00525499|64622317|FG001|Overall Study|Protocol Violation|1|||
23240496|NCT00525499|64622318|FG002|Overall Study|Protocol Violation|1|||
23347303|NCT00197002|65014312|FG000|Overall Study|Protocol Violation|1|||
23458995|NCT04109547|65423583|FG003|Overall Study|Withdrawal by Subject|6|||
23458996|NCT04109547|65423580|FG000|Overall Study|Lost to Follow-up|0|||
23458997|NCT04109547|65423581|FG001|Overall Study|Lost to Follow-up|0|||
23458998|NCT04109547|65423582|FG002|Overall Study|Lost to Follow-up|0|||
23458999|NCT04109547|65423583|FG003|Overall Study|Lost to Follow-up|1|||
23459000|NCT04109547|65423580|FG000|Overall Study|Physician Decision|1|||
23583945|NCT03982199|65866056|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
23583946|NCT03643211|65866057|FG000|Overall Study|Contract violation/deficiency|12|||
23459001|NCT04109547|65423581|FG001|Overall Study|Physician Decision|2|||
23583947|NCT03643211|65866057|FG000|Overall Study|Invalid registration|3|||
23180609|NCT02305563|64401811|FG000|Treatment Period|Randomized but not treated|0|||
23240497|NCT00525499|64622319|FG003|Overall Study|Protocol Violation|0|||
23240498|NCT04823494|64622320|FG000|Overall Study|Programming software malfunction.|1|||
23240499|NCT04823494|64622321|FG001|Overall Study|Programming software malfunction.|0|||
23240500|NCT04823494|64622320|FG000|Overall Study|Withdrawal by Subject|1|||
23459002|NCT04109547|65423582|FG002|Overall Study|Physician Decision|0|||
23459003|NCT04109547|65423583|FG003|Overall Study|Physician Decision|0|||
23459004|NCT05058365|65423585|FG000|Overall Study|Migration|1|||
23459005|NCT05058365|65423586|FG001|Overall Study|Migration|1|||
23459006|NCT02603887|65423590|FG000|Stage 1|Adverse Event|4|||
23459007|NCT02603887|65423590|FG000|Stage 1|Disease progression|1|||
23459008|NCT02603887|65423590|FG000|Stage 2|FDA guidance|1|||
23459009|NCT01074970|65423591|FG000|Overall Study|Never Treated|0|||
23459010|NCT01074970|65423592|FG001|Overall Study|Never Treated|0|||
23459011|NCT01074970|65423593|FG002|Overall Study|Never Treated|8|||
23459012|NCT01074970|65423594|FG003|Overall Study|Never Treated|1|||
23459013|NCT01074970|65423591|FG000|Overall Study|Adverse Event|1|||
23459014|NCT01074970|65423592|FG001|Overall Study|Adverse Event|0|||
23459015|NCT01074970|65423593|FG002|Overall Study|Adverse Event|4|||
23459016|NCT01074970|65423594|FG003|Overall Study|Adverse Event|3|||
23459017|NCT01074970|65423591|FG000|Overall Study|Disease progression during treatment|3|||
23459018|NCT01074970|65423592|FG001|Overall Study|Disease progression during treatment|1|||
23459019|NCT01074970|65423593|FG002|Overall Study|Disease progression during treatment|2|||
23459020|NCT01074970|65423594|FG003|Overall Study|Disease progression during treatment|9|||
23459021|NCT01074970|65423591|FG000|Overall Study|Lost to Follow-up|0|||
23459022|NCT01074970|65423592|FG001|Overall Study|Lost to Follow-up|0|||
23459023|NCT01074970|65423593|FG002|Overall Study|Lost to Follow-up|1|||
23459024|NCT01074970|65423594|FG003|Overall Study|Lost to Follow-up|0|||
23459025|NCT01074970|65423591|FG000|Overall Study|Withdrawal by Subject|0|||
23459026|NCT01074970|65423592|FG001|Overall Study|Withdrawal by Subject|0|||
23459027|NCT01074970|65423593|FG002|Overall Study|Withdrawal by Subject|6|||
23459028|NCT01074970|65423594|FG003|Overall Study|Withdrawal by Subject|4|||
23459029|NCT01474317|65423599|FG000|Overall Study|Adverse Event|1|||
23459030|NCT01474317|65423599|FG000|Overall Study|Subject ineligible for study|1|||
23459031|NCT04102098|65423600|FG000|Main Study Period|Ongoing in study|302|||
23459032|NCT04102098|65423601|FG001|Main Study Period|Ongoing in study|291|||
23459033|NCT04102098|65423600|FG000|Main Study Period|Death|20|||
23459034|NCT04102098|65423601|FG001|Main Study Period|Death|27|||
23459035|NCT04102098|65423600|FG000|Main Study Period|Lost to Follow-up|1|||
23459036|NCT04102098|65423601|FG001|Main Study Period|Lost to Follow-up|1|||
23459037|NCT04102098|65423600|FG000|Main Study Period|Physician Decision|0|||
23459038|NCT04102098|65423601|FG001|Main Study Period|Physician Decision|1|||
23459039|NCT04102098|65423600|FG000|Main Study Period|Withdrawal by Subject|11|||
23459040|NCT04102098|65423601|FG001|Main Study Period|Withdrawal by Subject|14|||
23459041|NCT04102098|65423600|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
23459042|NCT04102098|65423601|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
23459043|NCT04102098|65423600|FG000|Crossover: AS Who Crossed Over|Death|11|||
23459044|NCT04102098|65423601|FG001|Crossover: AS Who Crossed Over|Death|0|||
23459045|NCT04102098|65423600|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
23459046|NCT04102098|65423601|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
23459047|NCT03674411|65423608|FG000|Overall Study|Non-treatment|4|||
23459048|NCT00651742|65423609|FG000|Overall Study|Objective Disease Progression|22|||
23459049|NCT00651742|65423609|FG000|Overall Study|Toxicity|3|||
23459050|NCT00651742|65423609|FG000|Overall Study|Investigator Judgment|1|||
23459051|NCT00651742|65423609|FG000|Overall Study|Withdrawal of Consent|1|||
23459052|NCT00651742|65423609|FG000|Overall Study|Enrolled but not treated|1|||
23459053|NCT00394095|65423610|FG000|Overall Study|Adverse Event|1|||
23459054|NCT00394095|65423611|FG001|Overall Study|Adverse Event|0|||
23459055|NCT03312231|65423614|FG000|Overall Study|Lost to Follow-up|2|||
23459056|NCT03312231|65423615|FG001|Overall Study|Lost to Follow-up|6|||
23459057|NCT03312231|65423616|FG002|Overall Study|Lost to Follow-up|1|||
23459058|NCT03312231|65423617|FG003|Overall Study|Lost to Follow-up|3|||
23459059|NCT03312231|65423618|FG004|Overall Study|Lost to Follow-up|1|||
23459060|NCT03312231|65423614|FG000|Overall Study|Withdrawal by Subject|0|||
23459061|NCT03312231|65423615|FG001|Overall Study|Withdrawal by Subject|3|||
23459062|NCT03312231|65423616|FG002|Overall Study|Withdrawal by Subject|1|||
23459063|NCT03312231|65423617|FG003|Overall Study|Withdrawal by Subject|0|||
23459064|NCT03312231|65423618|FG004|Overall Study|Withdrawal by Subject|0|||
23459065|NCT03312231|65423614|FG000|Overall Study|Death|0|||
23459066|NCT03312231|65423615|FG001|Overall Study|Death|1|||
23459067|NCT03312231|65423616|FG002|Overall Study|Death|1|||
23459068|NCT03312231|65423617|FG003|Overall Study|Death|0|||
23459069|NCT03312231|65423618|FG004|Overall Study|Death|0|||
23459070|NCT03312231|65423614|FG000|Overall Study|Study Vaccination not Received|1|||
23459071|NCT03312231|65423615|FG001|Overall Study|Study Vaccination not Received|1|||
23459072|NCT03312231|65423616|FG002|Overall Study|Study Vaccination not Received|1|||
23459073|NCT03312231|65423617|FG003|Overall Study|Study Vaccination not Received|0|||
23459074|NCT03312231|65423618|FG004|Overall Study|Study Vaccination not Received|0|||
23459075|NCT02589938|65423619|FG000|Overall Study|Withdrawal by Subject|11|||
23459076|NCT02589938|65423620|FG001|Overall Study|Withdrawal by Subject|5|||
23459077|NCT02589938|65423621|FG002|Overall Study|Withdrawal by Subject|6|||
23459078|NCT02589938|65423619|FG000|Overall Study|Lost to Follow-up|3|||
23459079|NCT02589938|65423620|FG001|Overall Study|Lost to Follow-up|3|||
23459080|NCT02589938|65423621|FG002|Overall Study|Lost to Follow-up|3|||
23459081|NCT02589938|65423619|FG000|Overall Study|Death|1|||
23459082|NCT02589938|65423620|FG001|Overall Study|Death|0|||
23459083|NCT02589938|65423621|FG002|Overall Study|Death|1|||
23459084|NCT02589938|65423619|FG000|Overall Study|Protocol Violation|6|||
23459085|NCT02589938|65423620|FG001|Overall Study|Protocol Violation|2|||
23459086|NCT02589938|65423621|FG002|Overall Study|Protocol Violation|3|||
23459087|NCT02589938|65423619|FG000|Overall Study|Physician Decision|1|||
23459088|NCT02589938|65423620|FG001|Overall Study|Physician Decision|0|||
23459089|NCT02589938|65423621|FG002|Overall Study|Physician Decision|0|||
23459090|NCT02589938|65423619|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
23459091|NCT02589938|65423620|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
23459092|NCT02589938|65423621|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
23459093|NCT01838395|65423622|FG000|Overall Study|Withdrawal by Subject|0|||
23459094|NCT01838395|65423623|FG001|Overall Study|Withdrawal by Subject|0|||
23459095|NCT01838395|65423624|FG002|Overall Study|Withdrawal by Subject|0|||
23459096|NCT01838395|65423625|FG003|Overall Study|Withdrawal by Subject|0|||
23459097|NCT01838395|65423626|FG004|Overall Study|Withdrawal by Subject|1|||
23459098|NCT01838395|65423627|FG005|Overall Study|Withdrawal by Subject|0|||
23459099|NCT01838395|65423622|FG000|Overall Study|Death|0|||
23459100|NCT01838395|65423623|FG001|Overall Study|Death|0|||
23459101|NCT01838395|65423624|FG002|Overall Study|Death|1|||
23459102|NCT01838395|65423625|FG003|Overall Study|Death|0|||
23459103|NCT01838395|65423626|FG004|Overall Study|Death|0|||
23459104|NCT01838395|65423627|FG005|Overall Study|Death|0|||
23459105|NCT01838395|65423622|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459106|NCT01838395|65423623|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
23459107|NCT01838395|65423624|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459108|NCT01838395|65423625|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459109|NCT01838395|65423626|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459110|NCT01838395|65423627|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
23459111|NCT04966013|65423628|FG000|Overall Study|Withdrawal by Subject|0|||
23459112|NCT04966013|65423629|FG001|Overall Study|Withdrawal by Subject|2|||
23459113|NCT04966013|65423630|FG002|Overall Study|Withdrawal by Subject|1|||
23459114|NCT04966013|65423628|FG000|Overall Study|Adverse Event|2|||
23459115|NCT04966013|65423629|FG001|Overall Study|Adverse Event|1|||
23459116|NCT04966013|65423630|FG002|Overall Study|Adverse Event|1|||
23459117|NCT01063751|65423631|FG000|Overall Study|Site terminated|45|||
23459118|NCT01063751|65423631|FG000|Overall Study|Lost to Follow-up|28|||
23583948|NCT03643211|65866057|FG000|Overall Study|No treatment information|2|||
23583949|NCT03643211|65866057|FG000|Overall Study|No adverse event information - No revisit|4|||
23583950|NCT01599325|65866058|FG000|Primary Parent Phase|Adverse Event|5|||
23583951|NCT01599325|65866058|FG000|Primary Parent Phase|Disease Progression|7|||
23583952|NCT01599325|65866058|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
23583953|NCT01599325|65866058|FG000|Primary Parent Phase|Death|13|||
23583954|NCT01599325|65866058|FG000|Primary Parent Phase|Protocol Violation|1|||
23583955|NCT01599325|65866058|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
23583956|NCT01599325|65866058|FG000|Primary Parent Phase|Other|2|||
23583957|NCT01599325|65866058|FG000|Extension Phase|Study Closure|1|||
23583958|NCT01599325|65866058|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
23583959|NCT01599325|65866058|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
23583960|NCT01599325|65866058|FG000|Extension Phase|Disease Progression|1|||
23583961|NCT01599325|65866058|FG000|Extension Phase|Withdrawal by Subject|8|||
23583962|NCT01007149|65866059|FG000|Overall Study|Administrative problems|0|||
23583963|NCT01007149|65866060|FG001|Overall Study|Administrative problems|1|||
23583964|NCT02132702|65866061|FG000|Overall Study|Protocol Violation|2|||
23583965|NCT02132702|65866061|FG000|Overall Study|Adverse Event|3|||
23583966|NCT02132702|65866061|FG000|Overall Study|Withdrawal by Subject|3|||
23583967|NCT02781584|65866064|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
23583968|NCT02781584|65866065|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
23583969|NCT02781584|65866066|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
23583970|NCT02781584|65866067|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
23583971|NCT02781584|65866068|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
23583972|NCT02781584|65866069|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
23583973|NCT02781584|65866070|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
23583974|NCT02781584|65866071|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
23583975|NCT02781584|65866072|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
23583976|NCT02781584|65866073|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
23583977|NCT02781584|65866074|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
23583978|NCT02781584|65866075|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
23583979|NCT02781584|65866076|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
23583980|NCT02781584|65866064|FG000|Pre-treatment Phase|Adverse Event|0|||
23459119|NCT01063751|65423631|FG000|Overall Study|Withdrawal by Subject|25|||
23459120|NCT01063751|65423631|FG000|Overall Study|Revision|6|||
23459121|NCT01063751|65423631|FG000|Overall Study|Death|12|||
23459122|NCT01063751|65423631|FG000|Overall Study|Physician Decision|4|||
23459123|NCT01063751|65423631|FG000|Overall Study|Active|91|||
23459124|NCT04163341|65423632|FG000|Overall Study|Withdrawal by Subject|2|||
23459125|NCT04163341|65423633|FG001|Overall Study|Withdrawal by Subject|0|||
23459126|NCT04163341|65423632|FG000|Overall Study|Lost to Follow-up|3|||
23459127|NCT04163341|65423633|FG001|Overall Study|Lost to Follow-up|4|||
23459128|NCT03882021|65423634|FG000|Enrollment|Procedure aborted/cancelled|2|||
23459129|NCT03882021|65423634|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
23459130|NCT03882021|65423634|FG000|Enrollment to 3-Month|Death|1|||
23459131|NCT03882021|65423634|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
23180610|NCT02305563|64401812|FG001|Treatment Period|Randomized but not treated|0|||
23180611|NCT02305563|64401813|FG002|Treatment Period|Randomized but not treated|0|||
23180612|NCT02305563|64401814|FG003|Treatment Period|Randomized but not treated|0|||
23180613|NCT02305563|64401815|FG004|Treatment Period|Randomized but not treated|2|||
23180614|NCT02305563|64401811|FG000|Treatment Period|added ULO, then disease progression|0|||
23180615|NCT02305563|64401812|FG001|Treatment Period|added ULO, then disease progression|0|||
23180616|NCT02305563|64401813|FG002|Treatment Period|added ULO, then disease progression|0|||
23180617|NCT02305563|64401814|FG003|Treatment Period|added ULO, then disease progression|0|||
23180618|NCT02305563|64401815|FG004|Treatment Period|added ULO, then disease progression|4|||
23180619|NCT02305563|64401811|FG000|Treatment Period|added ULO; then other reason|0|||
23180620|NCT02305563|64401812|FG001|Treatment Period|added ULO; then other reason|0|||
23180621|NCT02305563|64401813|FG002|Treatment Period|added ULO; then other reason|0|||
23180622|NCT02305563|64401814|FG003|Treatment Period|added ULO; then other reason|0|||
23180623|NCT02305563|64401815|FG004|Treatment Period|added ULO; then other reason|1|||
23459132|NCT03882021|65423634|FG000|Enrollment to 3-Month|Missed Visit|4|||
23459133|NCT03882021|65423634|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
23583981|NCT02781584|65866065|FG001|Pre-treatment Phase|Adverse Event|0|||
23583982|NCT02781584|65866066|FG002|Pre-treatment Phase|Adverse Event|0|||
23583983|NCT02781584|65866067|FG003|Pre-treatment Phase|Adverse Event|0|||
23583984|NCT02781584|65866068|FG004|Pre-treatment Phase|Adverse Event|0|||
23583985|NCT02781584|65866069|FG005|Pre-treatment Phase|Adverse Event|0|||
23583986|NCT02781584|65866070|FG006|Pre-treatment Phase|Adverse Event|0|||
23583987|NCT02781584|65866071|FG007|Pre-treatment Phase|Adverse Event|0|||
23583988|NCT02781584|65866072|FG008|Pre-treatment Phase|Adverse Event|0|||
23583989|NCT02781584|65866073|FG009|Pre-treatment Phase|Adverse Event|0|||
23583990|NCT02781584|65866074|FG010|Pre-treatment Phase|Adverse Event|0|||
23583991|NCT02781584|65866075|FG011|Pre-treatment Phase|Adverse Event|1|||
23583992|NCT02781584|65866076|FG012|Pre-treatment Phase|Adverse Event|0|||
23583993|NCT02781584|65866064|FG000|Treatment Phase|Withdrew Consent|0|||
23583994|NCT02781584|65866065|FG001|Treatment Phase|Withdrew Consent|0|||
23347304|NCT00197002|65014313|FG001|Overall Study|Protocol Violation|0|||
23459134|NCT03882021|65423634|FG000|6-Month to 12-Month Visit|Death|1|||
23583995|NCT02781584|65866066|FG002|Treatment Phase|Withdrew Consent|0|||
23583996|NCT02781584|65866067|FG003|Treatment Phase|Withdrew Consent|0|||
23583997|NCT02781584|65866068|FG004|Treatment Phase|Withdrew Consent|0|||
23583998|NCT02781584|65866069|FG005|Treatment Phase|Withdrew Consent|1|||
23583999|NCT02781584|65866070|FG006|Treatment Phase|Withdrew Consent|0|||
23584000|NCT02781584|65866071|FG007|Treatment Phase|Withdrew Consent|0|||
23584001|NCT02781584|65866072|FG008|Treatment Phase|Withdrew Consent|0|||
23584002|NCT02781584|65866073|FG009|Treatment Phase|Withdrew Consent|0|||
23347305|NCT00197002|65014314|FG002|Overall Study|Protocol Violation|2|||
23347306|NCT00197002|65014312|FG000|Overall Study|Withdrawal by Subject|9|||
23347307|NCT00197002|65014313|FG001|Overall Study|Withdrawal by Subject|5|||
23347308|NCT00197002|65014314|FG002|Overall Study|Withdrawal by Subject|7|||
23180624|NCT02305563|64401811|FG000|Treatment Period|added ULO, then request to stop|0|||
23180625|NCT02305563|64401812|FG001|Treatment Period|added ULO, then request to stop|0|||
23180626|NCT02305563|64401813|FG002|Treatment Period|added ULO, then request to stop|0|||
23180627|NCT02305563|64401814|FG003|Treatment Period|added ULO, then request to stop|0|||
23347309|NCT00197002|65014312|FG000|Overall Study|Migrated/moved from study area|3|||
23347310|NCT00197002|65014313|FG001|Overall Study|Migrated/moved from study area|5|||
23347311|NCT00197002|65014314|FG002|Overall Study|Migrated/moved from study area|1|||
23347312|NCT00197002|65014312|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
23347313|NCT00197002|65014313|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
23347314|NCT00197002|65014314|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
23347315|NCT00197002|65014312|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
23347316|NCT00197002|65014313|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
23347317|NCT00197002|65014314|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
23347318|NCT00197002|65014312|FG000|Overall Study|Others|3|||
23347319|NCT00197002|65014313|FG001|Overall Study|Others|1|||
23347320|NCT00197002|65014314|FG002|Overall Study|Others|1|||
23347321|NCT02083185|65014315|FG000|Overall Study|Lost to Follow-up|0|||
23347322|NCT02083185|65014316|FG001|Overall Study|Lost to Follow-up|3|||
23347323|NCT02083185|65014317|FG002|Overall Study|Lost to Follow-up|0|||
23347324|NCT02083185|65014315|FG000|Overall Study|Withdrawal by Subject|9|||
23180628|NCT02305563|64401815|FG004|Treatment Period|added ULO, then request to stop|1|||
23180629|NCT02305563|64401811|FG000|Follow-up Period|Death|0|||
23180630|NCT02305563|64401812|FG001|Follow-up Period|Death|0|||
23180631|NCT02305563|64401813|FG002|Follow-up Period|Death|5|||
23180632|NCT02305563|64401814|FG003|Follow-up Period|Death|4|||
23180633|NCT02305563|64401815|FG004|Follow-up Period|Death|7|||
23180634|NCT02305563|64401811|FG000|Follow-up Period|Participant withdrew consent|0|||
23180635|NCT02305563|64401812|FG001|Follow-up Period|Participant withdrew consent|0|||
23180636|NCT02305563|64401813|FG002|Follow-up Period|Participant withdrew consent|2|||
23180637|NCT02305563|64401814|FG003|Follow-up Period|Participant withdrew consent|1|||
23180638|NCT02305563|64401815|FG004|Follow-up Period|Participant withdrew consent|0|||
23180639|NCT02305563|64401811|FG000|Follow-up Period|other reason|0|||
23180640|NCT02305563|64401812|FG001|Follow-up Period|other reason|0|||
23180641|NCT02305563|64401813|FG002|Follow-up Period|other reason|0|||
23180642|NCT02305563|64401814|FG003|Follow-up Period|other reason|0|||
23180643|NCT02305563|64401815|FG004|Follow-up Period|other reason|1|||
23180644|NCT02305563|64401811|FG000|Follow-up Period|Followup no longer required per protocol|3|||
23180645|NCT02305563|64401812|FG001|Follow-up Period|Followup no longer required per protocol|3|||
23180646|NCT02305563|64401813|FG002|Follow-up Period|Followup no longer required per protocol|4|||
23180647|NCT02305563|64401814|FG003|Follow-up Period|Followup no longer required per protocol|1|||
23180648|NCT02305563|64401815|FG004|Follow-up Period|Followup no longer required per protocol|4|||
23180649|NCT03041311|64401818|FG000|Overall Study|Death|39|||
23180650|NCT03041311|64401819|FG001|Overall Study|Death|42|||
23180651|NCT03041311|64401818|FG000|Overall Study|Lost to Follow-up|0|||
23180652|NCT03041311|64401819|FG001|Overall Study|Lost to Follow-up|1|||
23180653|NCT03041311|64401818|FG000|Overall Study|Withdrawal by Subject|8|||
23180654|NCT03041311|64401819|FG001|Overall Study|Withdrawal by Subject|5|||
23180655|NCT03041311|64401818|FG000|Overall Study|Sponsor Terminated Study|2|||
23180656|NCT03041311|64401819|FG001|Overall Study|Sponsor Terminated Study|4|||
23180657|NCT03041311|64401818|FG000|Overall Study|Disease Progression|3|||
23180658|NCT03041311|64401819|FG001|Overall Study|Disease Progression|1|||
23180659|NCT03041311|64401818|FG000|Overall Study|Randomized in error, did not receive drug|2|||
23180660|NCT03041311|64401819|FG001|Overall Study|Randomized in error, did not receive drug|0|||
23180661|NCT03838484|64401820|FG000|Overall Study|Lost to Follow-up|0|||
23240501|NCT04823494|64622321|FG001|Overall Study|Withdrawal by Subject|0|||
23240502|NCT04823494|64622320|FG000|Overall Study|Devices lost|0|||
23240503|NCT04823494|64622321|FG001|Overall Study|Devices lost|1|||
23240504|NCT00227591|64622322|FG000|Overall Study|Withdrawal by Subject|1|||
23240505|NCT01119118|64622323|FG000|Overall Study|Adverse Event|1|||
23240506|NCT03919669|64622326|FG000|Overall Study|Withdrawal by Subject|1|||
23347325|NCT02083185|65014316|FG001|Overall Study|Withdrawal by Subject|15|||
23180662|NCT03838484|64401821|FG001|Overall Study|Lost to Follow-up|1|||
23180663|NCT03838484|64401822|FG002|Overall Study|Lost to Follow-up|0|||
23180664|NCT03838484|64401823|FG003|Overall Study|Lost to Follow-up|0|||
23240507|NCT03919669|64622327|FG001|Overall Study|Withdrawal by Subject|0|||
23240508|NCT03919669|64622328|FG002|Overall Study|Withdrawal by Subject|0|||
23240509|NCT00968539|64622329|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
23240510|NCT00968539|64622330|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23584003|NCT02781584|65866074|FG010|Treatment Phase|Withdrew Consent|1|||
23584004|NCT02781584|65866075|FG011|Treatment Phase|Withdrew Consent|2|||
23584005|NCT02781584|65866076|FG012|Treatment Phase|Withdrew Consent|0|||
23584006|NCT02781584|65866064|FG000|Treatment Phase|Adverse Event|0|||
23584007|NCT02781584|65866065|FG001|Treatment Phase|Adverse Event|0|||
23584008|NCT02781584|65866066|FG002|Treatment Phase|Adverse Event|0|||
23584009|NCT02781584|65866067|FG003|Treatment Phase|Adverse Event|0|||
23584010|NCT02781584|65866068|FG004|Treatment Phase|Adverse Event|0|||
23584011|NCT02781584|65866069|FG005|Treatment Phase|Adverse Event|0|||
23584012|NCT02781584|65866070|FG006|Treatment Phase|Adverse Event|0|||
23584013|NCT02781584|65866071|FG007|Treatment Phase|Adverse Event|1|||
23584014|NCT02781584|65866072|FG008|Treatment Phase|Adverse Event|0|||
23584015|NCT02781584|65866073|FG009|Treatment Phase|Adverse Event|0|||
23584016|NCT02781584|65866074|FG010|Treatment Phase|Adverse Event|0|||
23584017|NCT02781584|65866075|FG011|Treatment Phase|Adverse Event|0|||
23180665|NCT00828464|64401824|FG000|Overall Study|Withdrawal by Subject|1|||
23180666|NCT01107444|64401827|FG000|Overall Study|Withdrawal by Subject|8|||
23180667|NCT01107444|64401828|FG001|Overall Study|Withdrawal by Subject|12|||
23180668|NCT01107444|64401827|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
23180669|NCT01107444|64401828|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
23180670|NCT02507349|64401829|FG000|Overall Study|Death|12|||
23180671|NCT02507349|64401830|FG001|Overall Study|Death|16|||
23180672|NCT02507349|64401829|FG000|Overall Study|Withdrawal by Subject|1|||
23180673|NCT02507349|64401830|FG001|Overall Study|Withdrawal by Subject|1|||
23180674|NCT02507349|64401829|FG000|Overall Study|Lost to Follow-up|174|||
23180675|NCT02507349|64401830|FG001|Overall Study|Lost to Follow-up|144|||
23180676|NCT01299727|64401831|FG000|Overall Study|Withdrawal by Subject|1|||
23180677|NCT01299727|64401832|FG001|Overall Study|Withdrawal by Subject|0|||
23180678|NCT01299727|64401833|FG002|Overall Study|Withdrawal by Subject|0|||
23180679|NCT01299727|64401831|FG000|Overall Study|Adverse Event|0|||
23180680|NCT01299727|64401832|FG001|Overall Study|Adverse Event|0|||
23180681|NCT01299727|64401833|FG002|Overall Study|Adverse Event|1|||
23180682|NCT01299727|64401831|FG000|Overall Study|Completed the Treatment Period|3|||
23180683|NCT01299727|64401832|FG001|Overall Study|Completed the Treatment Period|4|||
23180684|NCT01299727|64401833|FG002|Overall Study|Completed the Treatment Period|3|||
23180685|NCT00206726|64401835|FG000|Overall Study|Delayed recovery of blood counts|1|||
23180686|NCT00206726|64401835|FG000|Overall Study|Progressive disease or relapsed disease|18|||
23180687|NCT00206726|64401835|FG000|Overall Study|Placed on new protocol|1|||
23180688|NCT00206726|64401835|FG000|Overall Study|Bone marrow transplant|1|||
23180689|NCT00206726|64401835|FG000|Overall Study|Adverse Event|17|||
23180690|NCT00206726|64401835|FG000|Overall Study|Death|4|||
23180691|NCT00206726|64401835|FG000|Overall Study|Protocol Violation|1|||
23180692|NCT00206726|64401835|FG000|Overall Study|Withdrawal by Subject|8|||
23180693|NCT01769105|64401836|FG000|First Intervention|Protocol Violation|2|||
23180694|NCT01769105|64401837|FG001|First Intervention|Protocol Violation|2|||
23180695|NCT01769105|64401836|FG000|Cross-over|Lost to Follow-up|5|||
23240511|NCT03326323|64622331|FG000|Overall Study|Unable to receive ANH protocol|3|||
23240512|NCT01646268|64626586|FG000|Overall Study|Adverse Event|6|||
23240513|NCT01646268|64626587|FG001|Overall Study|Adverse Event|7|||
23240514|NCT01646268|64626586|FG000|Overall Study|Lack of Efficacy|1|||
23240515|NCT01646268|64626587|FG001|Overall Study|Lack of Efficacy|3|||
23240516|NCT01646268|64626586|FG000|Overall Study|Protocol Violation|0|||
23240517|NCT01646268|64626587|FG001|Overall Study|Protocol Violation|1|||
23240518|NCT01646268|64626586|FG000|Overall Study|Withdrawal by Subject|2|||
23240519|NCT01646268|64626587|FG001|Overall Study|Withdrawal by Subject|5|||
23240520|NCT01646268|64626586|FG000|Overall Study|Other|2|||
23240521|NCT01646268|64626587|FG001|Overall Study|Other|0|||
23240522|NCT03155269|64626588|FG000|Overall Study|Withdrawal by Subject|4|||
23240523|NCT03155269|64626589|FG001|Overall Study|Withdrawal by Subject|5|||
23240524|NCT03155269|64626588|FG000|Overall Study|Lost to Follow-up|1|||
23240525|NCT03155269|64626589|FG001|Overall Study|Lost to Follow-up|2|||
23240526|NCT00779857|64626590|FG000|Overall Study|Death|1|||
23584018|NCT02781584|65866076|FG012|Treatment Phase|Adverse Event|0|||
23584019|NCT04858425|65866077|FG000|Overall Study|Adverse Event|2|||
23180696|NCT01769105|64401837|FG001|Cross-over|Lost to Follow-up|0|||
23180697|NCT00542191|64401838|FG000|Overall Study|Death|3|||
23180698|NCT00473876|64401839|FG000|Overall Study|Lost to Follow-up|3|||
23240527|NCT00779857|64626590|FG000|Overall Study|Withdrawal by Subject|3|||
23240528|NCT00779857|64626590|FG000|Overall Study|Missed Visit|2|||
23240529|NCT00442572|64626591|FG000|Overall Study|Relapse|8|||
23240530|NCT00442572|64626592|FG001|Overall Study|Relapse|1|||
23584020|NCT04858425|65866078|FG001|Overall Study|Adverse Event|2|||
23180699|NCT00473876|64401840|FG001|Overall Study|Lost to Follow-up|1|||
23180700|NCT00189462|64401841|FG000|Overall Study|Lack of Efficacy|5|||
23180701|NCT00189462|64401842|FG001|Overall Study|Lack of Efficacy|1|||
23240531|NCT00442572|64626591|FG000|Overall Study|Lost to Follow-up|0|||
23584021|NCT04858425|65866077|FG000|Overall Study|Withdrawal by Subject|3|||
23180702|NCT00189462|64401841|FG000|Overall Study|Lost to Follow-up|18|||
23180703|NCT00189462|64401842|FG001|Overall Study|Lost to Follow-up|20|||
23584022|NCT04858425|65866078|FG001|Overall Study|Withdrawal by Subject|1|||
23347326|NCT02083185|65014317|FG002|Overall Study|Withdrawal by Subject|1|||
23347327|NCT02083185|65014315|FG000|Overall Study|Death|2|||
23347328|NCT02083185|65014316|FG001|Overall Study|Death|2|||
23347329|NCT02083185|65014317|FG002|Overall Study|Death|1|||
23347330|NCT02083185|65014315|FG000|Overall Study|Reason not Specified|9|||
23347331|NCT02083185|65014316|FG001|Overall Study|Reason not Specified|6|||
23347332|NCT02083185|65014317|FG002|Overall Study|Reason not Specified|5|||
23347333|NCT02083185|65014315|FG000|Overall Study|Study Terminated by Sponsor|0|||
23584023|NCT04858425|65866077|FG000|Overall Study|Lost to Follow-up|4|||
23584024|NCT04858425|65866078|FG001|Overall Study|Lost to Follow-up|2|||
23584025|NCT04858425|65866077|FG000|Overall Study|Lost to Follow-up|1|||
23584026|NCT04858425|65866078|FG001|Overall Study|Lost to Follow-up|0|||
23584027|NCT03404843|65866079|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
23584028|NCT03404843|65866080|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
23347334|NCT02083185|65014316|FG001|Overall Study|Study Terminated by Sponsor|1|||
23347335|NCT02083185|65014317|FG002|Overall Study|Study Terminated by Sponsor|0|||
23347336|NCT02083185|65014315|FG000|Overall Study|Did not Receive Study Drug|0|||
23347337|NCT02083185|65014316|FG001|Overall Study|Did not Receive Study Drug|2|||
23347338|NCT02083185|65014317|FG002|Overall Study|Did not Receive Study Drug|0|||
23347339|NCT00860249|65014318|FG000|Overall Study|trial was terminated prior to completion|21|||
23347340|NCT00860249|65014319|FG001|Overall Study|trial was terminated prior to completion|18|||
23347341|NCT00860249|65014320|FG002|Overall Study|trial was terminated prior to completion|21|||
23347342|NCT00990665|65014321|FG000|Overall Study|Unsuccessful Implant|8|||
23347343|NCT00990665|65014321|FG000|Overall Study|Death|29|||
23180704|NCT02983604|64401854|FG000|Overall Study|Enrolled but not Treated|0|||
23180705|NCT02983604|64401855|FG001|Overall Study|Enrolled but not Treated|0|||
23180706|NCT02983604|64401856|FG002|Overall Study|Enrolled but not Treated|1|||
23180707|NCT02983604|64401857|FG003|Overall Study|Enrolled but not Treated|0|||
23180708|NCT01777763|64401859|FG000|Overall Study|Adverse Event|2|||
23180709|NCT01777763|64401860|FG001|Overall Study|Adverse Event|32|||
23180710|NCT01777763|64401859|FG000|Overall Study|Protocol Violation|1|||
23180711|NCT01777763|64401860|FG001|Overall Study|Protocol Violation|7|||
23180712|NCT01777763|64401859|FG000|Overall Study|Withdrawal by Subject|0|||
23180713|NCT01777763|64401860|FG001|Overall Study|Withdrawal by Subject|2|||
23347344|NCT00990665|65014321|FG000|Overall Study|Heart Transplant|1|||
23347345|NCT00990665|65014321|FG000|Overall Study|Withdrawal by Subject|6|||
23347346|NCT00990665|65014321|FG000|Overall Study|Lost to Follow-up|1|||
23347347|NCT00990665|65014321|FG000|Overall Study|System Explant|3|||
23347348|NCT02186847|65014322|FG000|Overall Study|Protocol Violation|3|||
23347349|NCT02186847|65014323|FG001|Overall Study|Protocol Violation|0|||
23347350|NCT04326439|65014324|FG000|Overall Study|Withdrawal by Subject|1|||
23347351|NCT04326439|65014325|FG001|Overall Study|Withdrawal by Subject|0|||
23347352|NCT04326439|65014324|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
23347353|NCT04326439|65014325|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
23347354|NCT04326439|65014324|FG000|Overall Study|Relapse after Induction 2|0|||
23347355|NCT04326439|65014325|FG001|Overall Study|Relapse after Induction 2|1|||
23347356|NCT04326439|65014324|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
23347357|NCT04326439|65014325|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
23347358|NCT02678000|65014330|FG000|PART 2|Adverse Event|0|||
23347359|NCT02678000|65014331|FG001|PART 2|Adverse Event|0|||
23584029|NCT03124108|65866081|FG000|Overall Study|Adverse Event|0|||
23584030|NCT03124108|65866082|FG001|Overall Study|Adverse Event|1|||
23584031|NCT03124108|65866083|FG002|Overall Study|Adverse Event|0|||
23584032|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
23584033|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
23584034|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
23180714|NCT01777763|64401859|FG000|Overall Study|Treatment Failure|1|||
23180715|NCT01777763|64401860|FG001|Overall Study|Treatment Failure|6|||
23180716|NCT04167345|64401862|FG000|Overall Study|Other|1|||
23180717|NCT04167345|64401863|FG001|Overall Study|Other|1|||
23180718|NCT04167345|64401864|FG002|Overall Study|Other|0|||
23180719|NCT04167345|64401865|FG003|Overall Study|Other|0|||
23584035|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
23180720|NCT04167345|64401866|FG004|Overall Study|Other|0|||
23180721|NCT01817790|64401871|FG000|Overall Study|Adverse Event|0|||
23180722|NCT01817790|64401872|FG001|Overall Study|Adverse Event|2|||
23180723|NCT01817790|64401871|FG000|Overall Study|Lost to Follow-up|0|||
23180724|NCT01817790|64401872|FG001|Overall Study|Lost to Follow-up|1|||
23180725|NCT01817790|64401871|FG000|Overall Study|Protocol Violation|2|||
23347360|NCT02678000|65014332|FG002|PART 2|Adverse Event|2|||
23347361|NCT02678000|65014333|FG003|PART 2|Adverse Event|1|||
23347362|NCT02678000|65014334|FG004|PART 2|Adverse Event|0|||
23347363|NCT02678000|65014330|FG000|PART 2|Withdrawal by Subject|0|||
23347364|NCT02678000|65014331|FG001|PART 2|Withdrawal by Subject|0|||
23347365|NCT02678000|65014332|FG002|PART 2|Withdrawal by Subject|1|||
23180726|NCT01817790|64401872|FG001|Overall Study|Protocol Violation|1|||
23180727|NCT01817790|64401871|FG000|Overall Study|Withdrawal by Subject|1|||
23180728|NCT01817790|64401872|FG001|Overall Study|Withdrawal by Subject|3|||
23180729|NCT01817790|64401871|FG000|Overall Study|Other: Could not attend appointment|1|||
23180730|NCT01817790|64401872|FG001|Overall Study|Other: Could not attend appointment|1|||
23180731|NCT01614964|64401874|FG000|Overall Study|Withdrawal by Subject|2|||
23180732|NCT01614964|64401875|FG001|Overall Study|Withdrawal by Subject|0|||
23180733|NCT01614964|64401874|FG000|Overall Study|Lost to Follow-up|3|||
23180734|NCT01614964|64401875|FG001|Overall Study|Lost to Follow-up|0|||
23180735|NCT00214461|64401876|FG000|Overall Study|Adverse Event|0|||
23180736|NCT00214461|64401877|FG001|Overall Study|Adverse Event|0|||
23180737|NCT00214461|64401878|FG002|Overall Study|Adverse Event|1|||
23180738|NCT00214461|64401879|FG003|Overall Study|Adverse Event|1|||
23180739|NCT00214461|64401876|FG000|Overall Study|Withdrawal by Subject|0|||
23180740|NCT00214461|64401877|FG001|Overall Study|Withdrawal by Subject|0|||
23180741|NCT00214461|64401878|FG002|Overall Study|Withdrawal by Subject|1|||
23180742|NCT00214461|64401879|FG003|Overall Study|Withdrawal by Subject|0|||
23180743|NCT01445535|64401880|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
23180744|NCT01445535|64401881|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
23180745|NCT01445535|64401882|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
23180746|NCT01445535|64401883|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
23180747|NCT01445535|64401880|FG000|Overall Study|Disease progression|1|||
23180748|NCT01445535|64401881|FG001|Overall Study|Disease progression|0|||
23180749|NCT01445535|64401882|FG002|Overall Study|Disease progression|1|||
23180750|NCT01445535|64401883|FG003|Overall Study|Disease progression|0|||
23180751|NCT01445535|64401880|FG000|Overall Study|PI discretion|0|||
23180752|NCT01445535|64401881|FG001|Overall Study|PI discretion|0|||
23180753|NCT01445535|64401882|FG002|Overall Study|PI discretion|0|||
23180754|NCT01445535|64401883|FG003|Overall Study|PI discretion|1|||
23180755|NCT00855439|64401884|FG000|Overall Study|Withdrawal by Subject|2|||
23180756|NCT00855439|64401885|FG001|Overall Study|Withdrawal by Subject|0|||
23180757|NCT00855439|64401884|FG000|Overall Study|Pregnancy|1|||
23180758|NCT00855439|64401885|FG001|Overall Study|Pregnancy|0|||
23180759|NCT03093402|64401892|FG000|Overall Study|Lost to Follow-up|1|||
23180760|NCT03093402|64401893|FG001|Overall Study|Lost to Follow-up|0|||
23180761|NCT03093402|64401894|FG002|Overall Study|Lost to Follow-up|0|||
23240532|NCT00442572|64626592|FG001|Overall Study|Lost to Follow-up|1|||
23240533|NCT00442572|64626591|FG000|Overall Study|Withdrawal by Subject|0|||
23240534|NCT00442572|64626592|FG001|Overall Study|Withdrawal by Subject|1|||
23240535|NCT01012609|64626593|FG000|Overall Study|Withdrawal by Subject|1|||
23240536|NCT01012609|64626594|FG001|Overall Study|Withdrawal by Subject|1|||
23240537|NCT00563706|64626595|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
23240538|NCT00563706|64626596|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
23240539|NCT00563706|64626597|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
23240540|NCT00563706|64626598|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
23240541|NCT00563706|64626599|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
23240542|NCT00563706|64626600|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
23240543|NCT00563706|64626601|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
23240544|NCT00563706|64626602|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
23240545|NCT00563706|64626603|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
23240546|NCT00563706|64626595|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
23240547|NCT00563706|64626596|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
23240548|NCT00563706|64626597|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
23240549|NCT00563706|64626598|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
23240550|NCT00563706|64626599|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
23240551|NCT00563706|64626600|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
23240552|NCT00563706|64626601|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
23240553|NCT00563706|64626602|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
23240554|NCT00563706|64626603|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
23240555|NCT00563706|64626595|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
23240556|NCT00563706|64626596|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
23240557|NCT00563706|64626597|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
23240558|NCT00563706|64626598|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
23240559|NCT00563706|64626599|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
23240560|NCT00563706|64626600|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
23240561|NCT00563706|64626601|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
23240562|NCT00563706|64626602|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
23180762|NCT03093402|64401895|FG003|Overall Study|Lost to Follow-up|0|||
23180763|NCT03093402|64401892|FG000|Overall Study|Withdrawal by Subject|3|||
23180764|NCT03093402|64401893|FG001|Overall Study|Withdrawal by Subject|3|||
23180765|NCT03093402|64401894|FG002|Overall Study|Withdrawal by Subject|0|||
23180766|NCT03093402|64401895|FG003|Overall Study|Withdrawal by Subject|1|||
23347366|NCT02678000|65014333|FG003|PART 2|Withdrawal by Subject|0|||
23347367|NCT02678000|65014334|FG004|PART 2|Withdrawal by Subject|0|||
23347368|NCT00672841|65014336|FG000|Overall Study|Comfort care|1|||
23347369|NCT00672841|65014337|FG001|Overall Study|Comfort care|4|||
23347370|NCT00672841|65014336|FG000|Overall Study|icteric specimens|0|||
23347371|NCT00672841|65014337|FG001|Overall Study|icteric specimens|3|||
23347372|NCT00672841|65014336|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
23347373|NCT00672841|65014337|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
23347374|NCT00672841|65014336|FG000|Overall Study|Adverse Event|0|||
23347375|NCT00672841|65014337|FG001|Overall Study|Adverse Event|3|||
23347376|NCT00672841|65014336|FG000|Overall Study|Pregnancy|0|||
23347377|NCT00672841|65014337|FG001|Overall Study|Pregnancy|1|||
23347378|NCT03495154|65014338|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
23347379|NCT03495154|65014338|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
23347380|NCT03495154|65014338|FG000|Overall Study|Screen Failures During Surgery|6|||
23347381|NCT03495154|65014338|FG000|Overall Study|Death|2|||
23347382|NCT03495154|65014338|FG000|Overall Study|Lost to Follow-up|16|||
23347383|NCT03495154|65014338|FG000|Overall Study|Withdrawal by Subject|2|||
23347384|NCT03495154|65014338|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
23347385|NCT02054910|65014339|FG000|Overall Study|Lost to Follow-up|4|||
23347386|NCT02054910|65014340|FG001|Overall Study|Lost to Follow-up|1|||
23347387|NCT01382225|65014341|FG000|Overall Study|Adverse Event|3|||
23347388|NCT01382225|65014342|FG001|Overall Study|Adverse Event|2|||
23459135|NCT03882021|65423634|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
23459136|NCT02397096|65423635|FG000|Day 1 to Week 24|Adverse Event|7|||
23180767|NCT03093402|64401892|FG000|Overall Study|Withdrew prior to dosing|2|||
23180768|NCT03093402|64401893|FG001|Overall Study|Withdrew prior to dosing|1|||
23584036|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Adverse Event|198|||
23584037|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Adverse Event|0|||
23584038|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Adverse Event|0|||
23459137|NCT02397096|65423636|FG001|Day 1 to Week 24|Adverse Event|1|||
23459138|NCT02397096|65423635|FG000|Day 1 to Week 24|Death|1|||
23459139|NCT02397096|65423636|FG001|Day 1 to Week 24|Death|0|||
23459140|NCT02397096|65423635|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
23459141|NCT02397096|65423636|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
23459142|NCT02397096|65423635|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
23459143|NCT02397096|65423636|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
23459144|NCT02397096|65423635|FG000|Day 1 to Week 24|Physician Decision|2|||
23459145|NCT02397096|65423636|FG001|Day 1 to Week 24|Physician Decision|3|||
23459146|NCT02397096|65423635|FG000|Day 1 to Week 24|Protocol Violation|1|||
23459147|NCT02397096|65423636|FG001|Day 1 to Week 24|Protocol Violation|4|||
23459148|NCT02397096|65423635|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
23459149|NCT02397096|65423636|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
23459150|NCT02397096|65423635|FG000|Day 1 to Week 24|Randomized, not treated|3|||
23459151|NCT02397096|65423636|FG001|Day 1 to Week 24|Randomized, not treated|0|||
23459152|NCT02397096|65423635|FG000|Week 24 to Week 48|Adverse Event|6|||
23180769|NCT03093402|64401894|FG002|Overall Study|Withdrew prior to dosing|2|||
23180770|NCT03093402|64401895|FG003|Overall Study|Withdrew prior to dosing|3|||
23584039|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Adverse Event|0|||
23584040|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Death|62|||
23584041|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Death|0|||
23584042|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Death|0|||
23584043|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Death|0|||
23584044|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
23584045|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
23584046|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
23180771|NCT03093402|64401892|FG000|Overall Study|Ineligible for study|1|||
23180772|NCT03093402|64401893|FG001|Overall Study|Ineligible for study|0|||
23180773|NCT03093402|64401894|FG002|Overall Study|Ineligible for study|0|||
23180774|NCT03093402|64401895|FG003|Overall Study|Ineligible for study|0|||
23180775|NCT03093402|64401892|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
23180776|NCT03093402|64401893|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
23180777|NCT03093402|64401894|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
23180778|NCT03093402|64401895|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
23240563|NCT00563706|64626603|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
23347389|NCT01382225|65014341|FG000|Overall Study|Protocol Violation|2|||
23459153|NCT02397096|65423636|FG001|Week 24 to Week 48|Adverse Event|2|||
23459154|NCT02397096|65423635|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
23584047|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
23347390|NCT01382225|65014342|FG001|Overall Study|Protocol Violation|1|||
23347391|NCT01382225|65014341|FG000|Overall Study|Subject Withdrew Consent|5|||
23459155|NCT02397096|65423636|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
23459156|NCT02397096|65423635|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
23459157|NCT02397096|65423636|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
23459158|NCT02397096|65423635|FG000|Week 24 to Week 48|Physician Decision|2|||
23459159|NCT02397096|65423636|FG001|Week 24 to Week 48|Physician Decision|1|||
23459160|NCT02397096|65423635|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
23459161|NCT02397096|65423636|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
23459162|NCT02397096|65423635|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
23459163|NCT02397096|65423636|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
23459164|NCT02397096|65423635|FG000|Study Extension 1|Adverse Event|7|||
23459165|NCT02397096|65423636|FG001|Study Extension 1|Adverse Event|5|||
23459166|NCT02397096|65423635|FG000|Study Extension 1|Death|1|||
23459167|NCT02397096|65423636|FG001|Study Extension 1|Death|0|||
23459168|NCT02397096|65423635|FG000|Study Extension 1|Lack of Efficacy|2|||
23459169|NCT02397096|65423636|FG001|Study Extension 1|Lack of Efficacy|5|||
23459170|NCT02397096|65423635|FG000|Study Extension 1|Lost to Follow-up|2|||
23459171|NCT02397096|65423636|FG001|Study Extension 1|Lost to Follow-up|3|||
23459172|NCT02397096|65423635|FG000|Study Extension 1|Non-compliance with study drug|3|||
23459173|NCT02397096|65423636|FG001|Study Extension 1|Non-compliance with study drug|0|||
23459174|NCT02397096|65423635|FG000|Study Extension 1|Physician Decision|4|||
23459175|NCT02397096|65423636|FG001|Study Extension 1|Physician Decision|2|||
23459176|NCT02397096|65423635|FG000|Study Extension 1|Pregnancy|1|||
23459177|NCT02397096|65423636|FG001|Study Extension 1|Pregnancy|0|||
23459178|NCT02397096|65423635|FG000|Study Extension 1|Protocol Violation|0|||
23459179|NCT02397096|65423636|FG001|Study Extension 1|Protocol Violation|1|||
23459180|NCT02397096|65423635|FG000|Study Extension 1|Withdrawal by Subject|21|||
23459181|NCT02397096|65423636|FG001|Study Extension 1|Withdrawal by Subject|7|||
23459182|NCT02397096|65423635|FG000|Study Extension 2|Adverse Event|3|||
23459183|NCT02397096|65423636|FG001|Study Extension 2|Adverse Event|3|||
23459184|NCT02397096|65423635|FG000|Study Extension 2|Availability of study medication locally|152|||
23459185|NCT02397096|65423636|FG001|Study Extension 2|Availability of study medication locally|64|||
23459186|NCT02397096|65423635|FG000|Study Extension 2|Death|2|||
23459187|NCT02397096|65423636|FG001|Study Extension 2|Death|0|||
23459188|NCT02397096|65423635|FG000|Study Extension 2|Lack of Efficacy|1|||
23459189|NCT02397096|65423636|FG001|Study Extension 2|Lack of Efficacy|0|||
23459190|NCT02397096|65423635|FG000|Study Extension 2|Lost to Follow-up|2|||
23180779|NCT02162862|64401897|FG000|Overall Study|Lost to Follow-up|0|||
23180780|NCT02162862|64401898|FG001|Overall Study|Lost to Follow-up|11|||
23180781|NCT02162862|64401899|FG002|Overall Study|Lost to Follow-up|0|||
23180782|NCT02162862|64401897|FG000|Overall Study|Subject did not feel the med was needed|0|||
23347392|NCT01382225|65014342|FG001|Overall Study|Subject Withdrew Consent|2|||
23347393|NCT01382225|65014341|FG000|Overall Study|Other|4|||
23347394|NCT01382225|65014342|FG001|Overall Study|Other|2|||
23347395|NCT00955968|65014349|FG000|Overall Study|Death|2|||
23347396|NCT00955968|65014350|FG001|Overall Study|Death|4|||
23347397|NCT00955968|65014349|FG000|Overall Study|Withdrawal by Subject|35|||
23347398|NCT00955968|65014350|FG001|Overall Study|Withdrawal by Subject|31|||
23347399|NCT00955968|65014349|FG000|Overall Study|Lost to Follow-up|45|||
23347400|NCT00955968|65014350|FG001|Overall Study|Lost to Follow-up|39|||
23347401|NCT00955968|65014349|FG000|Overall Study|Site closed|55|||
23180783|NCT02162862|64401898|FG001|Overall Study|Subject did not feel the med was needed|0|||
23180784|NCT02162862|64401899|FG002|Overall Study|Subject did not feel the med was needed|4|||
23180785|NCT01672957|64401900|FG000|Overall Study|Protocol Violation|48|||
23180786|NCT01672957|64401900|FG000|Overall Study|Death|2|||
23347402|NCT00955968|65014350|FG001|Overall Study|Site closed|52|||
23347403|NCT04459598|65014360|FG000|Overall Study|Adverse Event|1|||
23347404|NCT04459598|65014361|FG001|Overall Study|Adverse Event|1|||
23347405|NCT00766467|65014362|FG000|Overall Study|Withdrawal by Subject|7|||
23347406|NCT00766467|65014363|FG001|Overall Study|Withdrawal by Subject|2|||
23347407|NCT00766467|65014362|FG000|Overall Study|Adverse Event|1|||
23347408|NCT00766467|65014363|FG001|Overall Study|Adverse Event|1|||
23459191|NCT02397096|65423636|FG001|Study Extension 2|Lost to Follow-up|1|||
23180787|NCT01672957|64401900|FG000|Overall Study|ICF Signed After Transplantation|5|||
23180788|NCT00331760|64401901|FG000|Overall Study|Ineligible / no protocol treatment|15|||
23180789|NCT00331760|64401902|FG001|Overall Study|Ineligible / no protocol treatment|8|||
23180790|NCT02203149|64401903|FG000|Part 1|Adverse Event|0|||
23180791|NCT02203149|64401904|FG001|Part 1|Adverse Event|1|||
23180792|NCT02203149|64401905|FG002|Part 1|Adverse Event|0|||
23180793|NCT02203149|64401906|FG003|Part 1|Adverse Event|0|||
23240564|NCT00563706|64626595|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
23347409|NCT00766467|65014362|FG000|Overall Study|Protocol Violation|2|||
23347410|NCT00766467|65014363|FG001|Overall Study|Protocol Violation|4|||
23347411|NCT00766467|65014362|FG000|Overall Study|Tumor Progression on Study|0|||
23347412|NCT00766467|65014363|FG001|Overall Study|Tumor Progression on Study|1|||
23459192|NCT02397096|65423635|FG000|Study Extension 2|Non-compliance with study drug|1|||
23459193|NCT02397096|65423636|FG001|Study Extension 2|Non-compliance with study drug|0|||
23459194|NCT02397096|65423635|FG000|Study Extension 2|Physician Decision|2|||
23459195|NCT02397096|65423636|FG001|Study Extension 2|Physician Decision|5|||
23459196|NCT02397096|65423635|FG000|Study Extension 2|Pregnancy|1|||
23459197|NCT02397096|65423636|FG001|Study Extension 2|Pregnancy|0|||
23459198|NCT02397096|65423635|FG000|Study Extension 2|Withdrawal by Subject|10|||
23459199|NCT02397096|65423636|FG001|Study Extension 2|Withdrawal by Subject|3|||
23459200|NCT02397096|65423635|FG000|Study Extension 3|Adverse Event|1|||
23459201|NCT02397096|65423636|FG001|Study Extension 3|Adverse Event|0|||
23459202|NCT02397096|65423635|FG000|Study Extension 3|Availability of study medication locally|11|||
23459203|NCT02397096|65423636|FG001|Study Extension 3|Availability of study medication locally|3|||
23459204|NCT02397096|65423635|FG000|Study Extension 3|Lost to Follow-up|1|||
23459205|NCT02397096|65423636|FG001|Study Extension 3|Lost to Follow-up|0|||
23459206|NCT02397096|65423635|FG000|Study Extension 3|Withdrawal by Subject|2|||
23459207|NCT02397096|65423636|FG001|Study Extension 3|Withdrawal by Subject|1|||
23459208|NCT04288089|65423637|FG000|Overall Study|Ongoing Treatment|2|||
23459209|NCT04288089|65423638|FG001|Overall Study|Ongoing Treatment|1|||
23459210|NCT04288089|65423639|FG002|Overall Study|Ongoing Treatment|1|||
23459211|NCT04288089|65423640|FG003|Overall Study|Ongoing Treatment|4|||
23459212|NCT03598036|65423641|FG000|Overall Study|Withdrawal by Subject|1|||
23459213|NCT03598036|65423642|FG001|Overall Study|Withdrawal by Subject|0|||
23459214|NCT02081677|65423645|FG000|Overall Study|Adverse Event|0|||
23459215|NCT02081677|65423646|FG001|Overall Study|Adverse Event|0|||
23459216|NCT02081677|65423647|FG002|Overall Study|Adverse Event|1|||
23459217|NCT02081677|65423648|FG003|Overall Study|Adverse Event|0|||
23459218|NCT02081677|65423645|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23459219|NCT02081677|65423646|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23180794|NCT02203149|64401907|FG004|Part 1|Adverse Event|0|||
23180795|NCT02203149|64401903|FG000|Part 2|Death|0|||
23180796|NCT02203149|64401904|FG001|Part 2|Death|0|||
23180797|NCT02203149|64401905|FG002|Part 2|Death|1|||
23180798|NCT02203149|64401906|FG003|Part 2|Death|1|||
23180799|NCT02203149|64401907|FG004|Part 2|Death|0|||
23180800|NCT02203149|64401903|FG000|Part 2|Withdrawal by Subject|0|||
23180801|NCT02203149|64401904|FG001|Part 2|Withdrawal by Subject|0|||
23180802|NCT02203149|64401905|FG002|Part 2|Withdrawal by Subject|0|||
23180803|NCT02203149|64401906|FG003|Part 2|Withdrawal by Subject|1|||
23180804|NCT02203149|64401907|FG004|Part 2|Withdrawal by Subject|0|||
23180805|NCT02203149|64401903|FG000|Part 2|Adverse Event|0|||
23180806|NCT02203149|64401904|FG001|Part 2|Adverse Event|0|||
23180807|NCT02203149|64401905|FG002|Part 2|Adverse Event|0|||
23180808|NCT02203149|64401906|FG003|Part 2|Adverse Event|1|||
23180809|NCT02203149|64401907|FG004|Part 2|Adverse Event|1|||
23180810|NCT00403260|64401908|FG000|Overall Study|Adverse Event|5|||
23180811|NCT00403260|64401909|FG001|Overall Study|Adverse Event|4|||
23180812|NCT00403260|64401908|FG000|Overall Study|Withdrawal by Subject|5|||
23180813|NCT00403260|64401909|FG001|Overall Study|Withdrawal by Subject|6|||
23180814|NCT00403260|64401908|FG000|Overall Study|Lost to Follow-up|49|||
23180815|NCT00403260|64401909|FG001|Overall Study|Lost to Follow-up|25|||
23180816|NCT00403260|64401908|FG000|Overall Study|Re-appearance of P. falciparum|34|||
23180817|NCT00403260|64401909|FG001|Overall Study|Re-appearance of P. falciparum|25|||
23180818|NCT00403260|64401908|FG000|Overall Study|P. vivax infection|26|||
23180819|NCT00403260|64401909|FG001|Overall Study|P. vivax infection|4|||
23180820|NCT00403260|64401908|FG000|Overall Study|Mixed infection with P. vivax|2|||
23180821|NCT00403260|64401909|FG001|Overall Study|Mixed infection with P. vivax|0|||
23180822|NCT00403260|64401908|FG000|Overall Study|Mixed infection with P. falciparum|1|||
23180823|NCT00403260|64401909|FG001|Overall Study|Mixed infection with P. falciparum|0|||
23180824|NCT00403260|64401908|FG000|Overall Study|P. vivax infection at screening|1|||
23180825|NCT00403260|64401909|FG001|Overall Study|P. vivax infection at screening|0|||
23459220|NCT02081677|65423647|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
23459221|NCT02081677|65423648|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23459222|NCT02081677|65423645|FG000|Overall Study|Not comfortable with lens care system|1|||
23459223|NCT02081677|65423646|FG001|Overall Study|Not comfortable with lens care system|0|||
23459224|NCT02081677|65423647|FG002|Overall Study|Not comfortable with lens care system|0|||
23459225|NCT02081677|65423648|FG003|Overall Study|Not comfortable with lens care system|0|||
23459226|NCT02081677|65423645|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
23459227|NCT02081677|65423646|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
23459228|NCT02081677|65423647|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
23459229|NCT02081677|65423648|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
23459230|NCT02782949|65423649|FG000|Overall Study|Protocol Violation|1|||
23459231|NCT02782949|65423650|FG001|Overall Study|Protocol Violation|0|||
23459232|NCT02782949|65423649|FG000|Overall Study|Withdrawal by Subject|0|||
23459233|NCT02782949|65423650|FG001|Overall Study|Withdrawal by Subject|1|||
23459234|NCT03204188|65423654|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
23459235|NCT03204188|65423654|FG000|Immunotherapy Phase (1 Year)|Death|1|||
23459236|NCT03204188|65423654|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
23180826|NCT00403260|64401908|FG000|Overall Study|P. ovale infection|1|||
23180827|NCT00403260|64401909|FG001|Overall Study|P. ovale infection|0|||
23180828|NCT00403260|64401908|FG000|Overall Study|Gametocyte re-appearance|1|||
23180829|NCT00403260|64401909|FG001|Overall Study|Gametocyte re-appearance|1|||
23459237|NCT03204188|65423654|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
23180830|NCT00403260|64401908|FG000|Overall Study|Withdrawn from study accidentally|0|||
23180831|NCT00403260|64401909|FG001|Overall Study|Withdrawn from study accidentally|1|||
23180832|NCT02772757|64401910|FG000|Overall Study|Withdrawal by Subject|1|||
23180833|NCT02772757|64401911|FG001|Overall Study|Withdrawal by Subject|0|||
23180834|NCT02772757|64401912|FG002|Overall Study|Withdrawal by Subject|1|||
23459238|NCT03173560|65423655|FG000|Overall Study|Ongoing on Treatment|38|||
23459239|NCT03173560|65423656|FG001|Overall Study|Ongoing on Treatment|50|||
23459240|NCT03173560|65423655|FG000|Overall Study|Ongoing Survival Follow-up|56|||
23180835|NCT02772757|64401910|FG000|Overall Study|Protocol Violation|0|||
23180836|NCT02772757|64401911|FG001|Overall Study|Protocol Violation|0|||
23180837|NCT02772757|64401912|FG002|Overall Study|Protocol Violation|1|||
23240565|NCT00563706|64626596|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23240566|NCT00563706|64626597|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23240567|NCT00563706|64626598|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23240568|NCT00563706|64626599|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23180838|NCT02772757|64401910|FG000|Overall Study|Physician Decision|0|||
23180839|NCT02772757|64401911|FG001|Overall Study|Physician Decision|3|||
23180840|NCT02772757|64401912|FG002|Overall Study|Physician Decision|3|||
23180841|NCT01246206|64401916|FG000|Overall Study|Patient did not receive study regiments.|1|||
23180842|NCT00441792|64401917|FG000|Overall Study|Lost to Follow-up|0|||
23180843|NCT00441792|64401918|FG001|Overall Study|Lost to Follow-up|2|||
23180844|NCT04223609|64401919|FG000|Overall Study|Adverse Event|0|||
23180845|NCT04223609|64401920|FG001|Overall Study|Adverse Event|1|||
23180846|NCT04223609|64401919|FG000|Overall Study|Missed last visit|0|||
23180847|NCT04223609|64401920|FG001|Overall Study|Missed last visit|1|||
23180848|NCT03157531|64401921|FG000|Overall Study|Death|2|||
23180849|NCT03157531|64401921|FG000|Overall Study|Lost to Follow-up|4|||
23180850|NCT03502330|64401922|FG000|Overall Study|Adverse Event|2|||
23180851|NCT03502330|64401923|FG001|Overall Study|Adverse Event|1|||
23180852|NCT03502330|64401924|FG002|Overall Study|Adverse Event|0|||
23180853|NCT03502330|64401925|FG003|Overall Study|Adverse Event|0|||
23180854|NCT03502330|64401926|FG004|Overall Study|Adverse Event|1|||
23180855|NCT03502330|64401927|FG005|Overall Study|Adverse Event|0|||
23180856|NCT03502330|64401928|FG006|Overall Study|Adverse Event|1|||
23180857|NCT03502330|64401929|FG007|Overall Study|Adverse Event|1|||
23180858|NCT03502330|64401930|FG008|Overall Study|Adverse Event|0|||
23180859|NCT03502330|64401922|FG000|Overall Study|Lack of Efficacy|1|||
23180860|NCT03502330|64401923|FG001|Overall Study|Lack of Efficacy|5|||
23180861|NCT03502330|64401924|FG002|Overall Study|Lack of Efficacy|3|||
23180862|NCT03502330|64401925|FG003|Overall Study|Lack of Efficacy|5|||
23180863|NCT03502330|64401926|FG004|Overall Study|Lack of Efficacy|1|||
23180864|NCT03502330|64401927|FG005|Overall Study|Lack of Efficacy|5|||
23180865|NCT03502330|64401928|FG006|Overall Study|Lack of Efficacy|5|||
23180866|NCT03502330|64401929|FG007|Overall Study|Lack of Efficacy|6|||
23180867|NCT03502330|64401930|FG008|Overall Study|Lack of Efficacy|0|||
23180868|NCT03502330|64401922|FG000|Overall Study|Physician Decision|0|||
23180869|NCT03502330|64401923|FG001|Overall Study|Physician Decision|0|||
23180870|NCT03502330|64401924|FG002|Overall Study|Physician Decision|0|||
23180871|NCT03502330|64401925|FG003|Overall Study|Physician Decision|0|||
23180872|NCT03502330|64401926|FG004|Overall Study|Physician Decision|1|||
23180873|NCT03502330|64401927|FG005|Overall Study|Physician Decision|0|||
23180874|NCT03502330|64401928|FG006|Overall Study|Physician Decision|0|||
23240569|NCT00563706|64626600|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23240570|NCT00563706|64626601|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23347413|NCT00766467|65014362|FG000|Overall Study|Physician Decision|1|||
23459241|NCT03173560|65423656|FG001|Overall Study|Ongoing Survival Follow-up|57|||
23584048|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Complicating disease|13|||
23584049|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Complicating disease|0|||
23584050|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Complicating disease|0|||
23584051|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Complicating disease|0|||
23584052|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
23584053|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
23584054|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
23584055|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
23584056|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
23180875|NCT03502330|64401929|FG007|Overall Study|Physician Decision|0|||
23180876|NCT03502330|64401930|FG008|Overall Study|Physician Decision|0|||
23180877|NCT03502330|64401922|FG000|Overall Study|Withdrawal by Subject|0|||
23180878|NCT03502330|64401923|FG001|Overall Study|Withdrawal by Subject|0|||
23180879|NCT03502330|64401924|FG002|Overall Study|Withdrawal by Subject|0|||
23180880|NCT03502330|64401925|FG003|Overall Study|Withdrawal by Subject|0|||
23180881|NCT03502330|64401926|FG004|Overall Study|Withdrawal by Subject|0|||
23584057|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
23584058|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
23584059|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
23180882|NCT03502330|64401927|FG005|Overall Study|Withdrawal by Subject|1|||
23180883|NCT03502330|64401928|FG006|Overall Study|Withdrawal by Subject|0|||
23180884|NCT03502330|64401929|FG007|Overall Study|Withdrawal by Subject|1|||
23180885|NCT03502330|64401930|FG008|Overall Study|Withdrawal by Subject|0|||
23240571|NCT00563706|64626602|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
23240572|NCT00563706|64626603|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
23240573|NCT00563706|64626595|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23240574|NCT00563706|64626596|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23180886|NCT03502330|64401922|FG000|Overall Study|Death|0|||
23180887|NCT03502330|64401923|FG001|Overall Study|Death|0|||
23180888|NCT03502330|64401924|FG002|Overall Study|Death|0|||
23180889|NCT03502330|64401925|FG003|Overall Study|Death|0|||
23180890|NCT03502330|64401926|FG004|Overall Study|Death|0|||
23180891|NCT03502330|64401927|FG005|Overall Study|Death|0|||
23180892|NCT03502330|64401928|FG006|Overall Study|Death|2|||
23180893|NCT03502330|64401929|FG007|Overall Study|Death|0|||
23180894|NCT03502330|64401930|FG008|Overall Study|Death|0|||
23180895|NCT02468648|64401932|FG000|Overall Study|Death|1|||
23180896|NCT01147497|64401934|FG000|Overall Study|failed insertion|2|||
23180897|NCT01147497|64401935|FG001|Overall Study|failed insertion|0|||
23180898|NCT00793793|64401936|FG000|Overall Study|Adverse Event|0|||
23180899|NCT00793793|64401937|FG001|Overall Study|Adverse Event|0|||
23180900|NCT00793793|64401938|FG002|Overall Study|Adverse Event|1|||
23180901|NCT00793793|64401939|FG003|Overall Study|Adverse Event|1|||
23180902|NCT00793793|64401940|FG004|Overall Study|Adverse Event|0|||
23180903|NCT00793793|64401941|FG005|Overall Study|Adverse Event|1|||
23180904|NCT00793793|64401942|FG006|Overall Study|Adverse Event|2|||
23180905|NCT00793793|64401943|FG007|Overall Study|Adverse Event|0|||
23240575|NCT00563706|64626597|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23240576|NCT00563706|64626598|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23240577|NCT00563706|64626599|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23347414|NCT00766467|65014363|FG001|Overall Study|Physician Decision|0|||
23459242|NCT03173560|65423655|FG000|Overall Study|Lost to Follow-up|1|||
23180906|NCT00793793|64401944|FG008|Overall Study|Adverse Event|0|||
23180907|NCT00793793|64401945|FG009|Overall Study|Adverse Event|0|||
23180908|NCT00793793|64401946|FG010|Overall Study|Adverse Event|0|||
23180909|NCT00793793|64401947|FG011|Overall Study|Adverse Event|2|||
23180910|NCT00793793|64401936|FG000|Overall Study|Protocol Violation|0|||
23180911|NCT00793793|64401937|FG001|Overall Study|Protocol Violation|0|||
23240578|NCT00563706|64626600|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23180912|NCT00793793|64401938|FG002|Overall Study|Protocol Violation|0|||
23180913|NCT00793793|64401939|FG003|Overall Study|Protocol Violation|1|||
23180914|NCT00793793|64401940|FG004|Overall Study|Protocol Violation|0|||
23240579|NCT00563706|64626601|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
23240580|NCT00563706|64626602|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
23180915|NCT00793793|64401941|FG005|Overall Study|Protocol Violation|0|||
23180916|NCT00793793|64401942|FG006|Overall Study|Protocol Violation|0|||
23180917|NCT00793793|64401943|FG007|Overall Study|Protocol Violation|0|||
23180918|NCT00793793|64401944|FG008|Overall Study|Protocol Violation|0|||
23180919|NCT00793793|64401945|FG009|Overall Study|Protocol Violation|0|||
23180920|NCT00793793|64401946|FG010|Overall Study|Protocol Violation|0|||
23180921|NCT00793793|64401947|FG011|Overall Study|Protocol Violation|0|||
23180922|NCT00793793|64401936|FG000|Overall Study|Lost to Follow-up|0|||
23180923|NCT00793793|64401937|FG001|Overall Study|Lost to Follow-up|0|||
23180924|NCT00793793|64401938|FG002|Overall Study|Lost to Follow-up|1|||
23180925|NCT00793793|64401939|FG003|Overall Study|Lost to Follow-up|0|||
23180926|NCT00793793|64401940|FG004|Overall Study|Lost to Follow-up|0|||
23240581|NCT00563706|64626603|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
23240582|NCT00998166|64626604|FG000|Overall Study|Early Study Termination|8|||
23240583|NCT00869362|64626605|FG000|Overall Study|Death|0|||
23240584|NCT00869362|64626606|FG001|Overall Study|Death|2|||
23240585|NCT00869362|64626605|FG000|Overall Study|Lost to Follow-up|1|||
23240586|NCT00869362|64626606|FG001|Overall Study|Lost to Follow-up|3|||
23240587|NCT01714726|64626609|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
23240588|NCT01714726|64626610|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
23240589|NCT01714726|64626611|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
23240590|NCT01714726|64626612|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
23240591|NCT01714726|64626609|FG000|Double-Blinded Induction Period|Adverse Event|0|||
23240592|NCT01714726|64626610|FG001|Double-Blinded Induction Period|Adverse Event|1|||
23240593|NCT01714726|64626611|FG002|Double-Blinded Induction Period|Adverse Event|0|||
23240594|NCT01714726|64626612|FG003|Double-Blinded Induction Period|Adverse Event|0|||
23240595|NCT01714726|64626609|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
23347415|NCT01317797|65014366|FG000|Overall Study|Other|0|||
23347416|NCT01317797|65014367|FG001|Overall Study|Other|1|||
23180927|NCT00793793|64401941|FG005|Overall Study|Lost to Follow-up|0|||
23180928|NCT00793793|64401942|FG006|Overall Study|Lost to Follow-up|0|||
23180929|NCT00793793|64401943|FG007|Overall Study|Lost to Follow-up|0|||
23180930|NCT00793793|64401944|FG008|Overall Study|Lost to Follow-up|1|||
23347417|NCT01317797|65014368|FG002|Overall Study|Other|0|||
23347418|NCT01317797|65014366|FG000|Overall Study|Withdrawal of Patient|0|||
23180931|NCT00793793|64401945|FG009|Overall Study|Lost to Follow-up|3|||
23180932|NCT00793793|64401946|FG010|Overall Study|Lost to Follow-up|1|||
23180933|NCT00793793|64401947|FG011|Overall Study|Lost to Follow-up|0|||
23180934|NCT00793793|64401936|FG000|Overall Study|Withdrawal by Subject|0|||
23180935|NCT00793793|64401937|FG001|Overall Study|Withdrawal by Subject|0|||
23180936|NCT00793793|64401938|FG002|Overall Study|Withdrawal by Subject|0|||
23180937|NCT00793793|64401939|FG003|Overall Study|Withdrawal by Subject|0|||
23180938|NCT00793793|64401940|FG004|Overall Study|Withdrawal by Subject|1|||
23180939|NCT00793793|64401941|FG005|Overall Study|Withdrawal by Subject|0|||
23347419|NCT01317797|65014367|FG001|Overall Study|Withdrawal of Patient|0|||
23347420|NCT01317797|65014368|FG002|Overall Study|Withdrawal of Patient|1|||
23347421|NCT03419598|65014372|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
23347422|NCT00278148|65014373|FG000|Phase II - Expansion Phase|Disease progression|0|||
23347423|NCT00278148|65014374|FG001|Phase II - Expansion Phase|Disease progression|0|||
23347424|NCT00278148|65014375|FG002|Phase II - Expansion Phase|Disease progression|4|||
23347425|NCT00278148|65014373|FG000|Phase II - Expansion Phase|Adverse Event|0|||
23347426|NCT00278148|65014374|FG001|Phase II - Expansion Phase|Adverse Event|0|||
23347427|NCT00278148|65014375|FG002|Phase II - Expansion Phase|Adverse Event|2|||
23347428|NCT00980174|65014376|FG000|Overall Study|Withdrawal by Subject|1|||
23347429|NCT00980174|65014377|FG001|Overall Study|Withdrawal by Subject|4|||
23347430|NCT00980174|65014376|FG000|Overall Study|Adverse Event|0|||
23347431|NCT00980174|65014377|FG001|Overall Study|Adverse Event|3|||
23347432|NCT00980174|65014376|FG000|Overall Study|Ineligibility determined|2|||
23347433|NCT00980174|65014377|FG001|Overall Study|Ineligibility determined|1|||
23347434|NCT00980174|65014376|FG000|Overall Study|Death|1|||
23347435|NCT00980174|65014377|FG001|Overall Study|Death|1|||
23347436|NCT00980174|65014376|FG000|Overall Study|Other|0|||
23347437|NCT00980174|65014377|FG001|Overall Study|Other|1|||
23347438|NCT02998476|65014380|FG000|Overall Study|Lost to Follow-up|1|||
23347439|NCT02998476|65014381|FG001|Overall Study|Lost to Follow-up|0|||
23347440|NCT02998476|65014380|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
23347441|NCT02998476|65014381|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
23347442|NCT02998476|65014380|FG000|Overall Study|Withdrawal by Subject|1|||
23347443|NCT02998476|65014381|FG001|Overall Study|Withdrawal by Subject|2|||
23347444|NCT02998476|65014380|FG000|Overall Study|Death|45|||
23347445|NCT02998476|65014381|FG001|Overall Study|Death|2|||
23347446|NCT02998476|65014380|FG000|Overall Study|Other|6|||
23459243|NCT03173560|65423656|FG001|Overall Study|Lost to Follow-up|4|||
23180940|NCT00793793|64401942|FG006|Overall Study|Withdrawal by Subject|0|||
23180941|NCT00793793|64401943|FG007|Overall Study|Withdrawal by Subject|0|||
23180942|NCT00793793|64401944|FG008|Overall Study|Withdrawal by Subject|1|||
23180943|NCT00793793|64401945|FG009|Overall Study|Withdrawal by Subject|0|||
23180944|NCT00793793|64401946|FG010|Overall Study|Withdrawal by Subject|0|||
23180945|NCT00793793|64401947|FG011|Overall Study|Withdrawal by Subject|0|||
23180946|NCT00793793|64401936|FG000|Overall Study|reason not specified|0|||
23180947|NCT00793793|64401937|FG001|Overall Study|reason not specified|1|||
23180948|NCT00793793|64401938|FG002|Overall Study|reason not specified|0|||
23180949|NCT00793793|64401939|FG003|Overall Study|reason not specified|1|||
23180950|NCT00793793|64401940|FG004|Overall Study|reason not specified|1|||
23180951|NCT00793793|64401941|FG005|Overall Study|reason not specified|1|||
23180952|NCT00793793|64401942|FG006|Overall Study|reason not specified|2|||
23180953|NCT00793793|64401943|FG007|Overall Study|reason not specified|0|||
23180954|NCT00793793|64401944|FG008|Overall Study|reason not specified|7|||
23180955|NCT00793793|64401945|FG009|Overall Study|reason not specified|6|||
23180956|NCT00793793|64401946|FG010|Overall Study|reason not specified|2|||
23180957|NCT00793793|64401947|FG011|Overall Study|reason not specified|4|||
23180958|NCT05195528|64401948|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
23180959|NCT05195528|64401949|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
23180960|NCT05195528|64401950|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
23180961|NCT05195528|64401951|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
23347447|NCT02998476|65014381|FG001|Overall Study|Other|1|||
23347448|NCT03806231|65014383|FG000|Overall Study|Physician Decision|1|||
23459244|NCT03173560|65423655|FG000|Overall Study|Withdrawal by Subject|10|||
23180962|NCT05195528|64401952|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
23180963|NCT05195528|64401948|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
23180964|NCT05195528|64401949|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
23347449|NCT03806231|65014384|FG001|Overall Study|Physician Decision|0|||
23347450|NCT03806231|65014383|FG000|Overall Study|Withdrawal by Subject|1|||
23347451|NCT03806231|65014384|FG001|Overall Study|Withdrawal by Subject|0|||
23347452|NCT02342548|65014389|FG000|Overall Study|Adverse Event|12|||
23347453|NCT02342548|65014390|FG001|Overall Study|Adverse Event|17|||
23347454|NCT02342548|65014391|FG002|Overall Study|Adverse Event|13|||
23347455|NCT02342548|65014389|FG000|Overall Study|Lost to Follow-up|0|||
23347456|NCT02342548|65014390|FG001|Overall Study|Lost to Follow-up|1|||
23347457|NCT02342548|65014391|FG002|Overall Study|Lost to Follow-up|0|||
23347458|NCT02342548|65014389|FG000|Overall Study|Study terminated by sponsor|20|||
23347459|NCT02342548|65014390|FG001|Overall Study|Study terminated by sponsor|39|||
23347460|NCT02342548|65014391|FG002|Overall Study|Study terminated by sponsor|25|||
23347461|NCT02342548|65014389|FG000|Overall Study|Protocol Violation|0|||
23347462|NCT02342548|65014390|FG001|Overall Study|Protocol Violation|1|||
23347463|NCT02342548|65014391|FG002|Overall Study|Protocol Violation|0|||
23347464|NCT02342548|65014389|FG000|Overall Study|Withdrawal by Subject|1|||
23347465|NCT02342548|65014390|FG001|Overall Study|Withdrawal by Subject|3|||
23347466|NCT02342548|65014391|FG002|Overall Study|Withdrawal by Subject|4|||
23347467|NCT02342548|65014389|FG000|Overall Study|Other|1|||
23347468|NCT02342548|65014390|FG001|Overall Study|Other|1|||
23347469|NCT02342548|65014391|FG002|Overall Study|Other|1|||
23347470|NCT01041976|65014392|FG000|Overall Study|Withdrawal by Subject|3|||
23347471|NCT01041976|65014393|FG001|Overall Study|Withdrawal by Subject|0|||
23347472|NCT01041976|65014392|FG000|Overall Study|Incarceration|2|||
23347473|NCT01041976|65014393|FG001|Overall Study|Incarceration|0|||
23347474|NCT01041976|65014392|FG000|Overall Study|Death|0|||
23347475|NCT01041976|65014393|FG001|Overall Study|Death|4|||
23347476|NCT00401544|65014395|FG000|Overall Study|Adverse Event|5|||
23347477|NCT00401544|65014396|FG001|Overall Study|Adverse Event|1|||
23347478|NCT00401544|65014397|FG002|Overall Study|Adverse Event|1|||
23347479|NCT00401544|65014398|FG003|Overall Study|Adverse Event|1|||
23347480|NCT00401544|65014395|FG000|Overall Study|Death|3|||
23347481|NCT00401544|65014396|FG001|Overall Study|Death|6|||
23347482|NCT00401544|65014397|FG002|Overall Study|Death|2|||
23347483|NCT00401544|65014398|FG003|Overall Study|Death|5|||
23347484|NCT00401544|65014395|FG000|Overall Study|Lost to Follow-up|2|||
23347485|NCT00401544|65014396|FG001|Overall Study|Lost to Follow-up|0|||
23347486|NCT00401544|65014397|FG002|Overall Study|Lost to Follow-up|1|||
23347487|NCT00401544|65014398|FG003|Overall Study|Lost to Follow-up|1|||
23347488|NCT00401544|65014395|FG000|Overall Study|Withdrawal by Subject|7|||
23347489|NCT00401544|65014396|FG001|Overall Study|Withdrawal by Subject|6|||
23347490|NCT00401544|65014397|FG002|Overall Study|Withdrawal by Subject|6|||
23347491|NCT00401544|65014398|FG003|Overall Study|Withdrawal by Subject|5|||
23347492|NCT00401544|65014395|FG000|Overall Study|Physician Decision|1|||
23347493|NCT00401544|65014396|FG001|Overall Study|Physician Decision|3|||
23347494|NCT00401544|65014397|FG002|Overall Study|Physician Decision|0|||
23347495|NCT00401544|65014398|FG003|Overall Study|Physician Decision|0|||
23347496|NCT00401544|65014395|FG000|Overall Study|Ineligibility determined|0|||
23347497|NCT00401544|65014396|FG001|Overall Study|Ineligibility determined|1|||
23347498|NCT00401544|65014397|FG002|Overall Study|Ineligibility determined|0|||
23347499|NCT00401544|65014398|FG003|Overall Study|Ineligibility determined|2|||
23347500|NCT00401544|65014395|FG000|Overall Study|Disease progression|0|||
23347501|NCT00401544|65014396|FG001|Overall Study|Disease progression|1|||
23347502|NCT00401544|65014397|FG002|Overall Study|Disease progression|0|||
23347503|NCT00401544|65014398|FG003|Overall Study|Disease progression|0|||
23347504|NCT00401544|65014395|FG000|Overall Study|Other|0|||
23347505|NCT00401544|65014396|FG001|Overall Study|Other|0|||
23347506|NCT00401544|65014397|FG002|Overall Study|Other|2|||
23347507|NCT00401544|65014398|FG003|Overall Study|Other|2|||
23347508|NCT01217385|65014399|FG000|Overall Study|Withdrawal by Subject|3|||
23347509|NCT01217385|65014399|FG000|Overall Study|DOSI not performed/not eval|12|||
23347510|NCT01217385|65014399|FG000|Overall Study|Central Path not Available|1|||
23347511|NCT01217385|65014399|FG000|Overall Study|Normal Breast TOI not available|10|||
23347512|NCT01384019|65014400|FG000|Overall Study|Withdrawal by Subject|3|||
23347513|NCT01384019|65014401|FG001|Overall Study|Withdrawal by Subject|0|||
23347514|NCT01384019|65014400|FG000|Overall Study|Death|1|||
23347515|NCT01384019|65014401|FG001|Overall Study|Death|0|||
23347516|NCT01384019|65014400|FG000|Overall Study|MRI refusal|6|||
23347517|NCT01384019|65014401|FG001|Overall Study|MRI refusal|6|||
23347518|NCT03956615|65014403|FG000|Overall Study|No multiple myeloma confirmed|2|||
23347519|NCT03956615|65014403|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
23347520|NCT03956615|65014403|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
23347521|NCT03956615|65014403|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
23347522|NCT01371877|65014406|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
23347523|NCT01371877|65014407|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
23347524|NCT00985959|65014414|FG000|Overall Study|Adverse Event|0|||
23347525|NCT00985959|65014415|FG001|Overall Study|Adverse Event|0|||
23347526|NCT00985959|65014416|FG002|Overall Study|Adverse Event|19|||
23347527|NCT00985959|65014414|FG000|Overall Study|Withdrawal by Subject|0|||
23347528|NCT00985959|65014415|FG001|Overall Study|Withdrawal by Subject|0|||
23347529|NCT00985959|65014416|FG002|Overall Study|Withdrawal by Subject|8|||
23347530|NCT00985959|65014414|FG000|Overall Study|Progressive disease|1|||
23347531|NCT00985959|65014415|FG001|Overall Study|Progressive disease|2|||
23347532|NCT00985959|65014416|FG002|Overall Study|Progressive disease|8|||
23347533|NCT00985959|65014414|FG000|Overall Study|Unrecovered toxicity|0|||
23347534|NCT00985959|65014415|FG001|Overall Study|Unrecovered toxicity|0|||
23347535|NCT00985959|65014416|FG002|Overall Study|Unrecovered toxicity|7|||
23347536|NCT00985959|65014414|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
23347537|NCT00985959|65014415|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
23347538|NCT00985959|65014416|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
23347539|NCT00985959|65014414|FG000|Overall Study|Complete response observed over 2 cycles|0|||
23347540|NCT00985959|65014415|FG001|Overall Study|Complete response observed over 2 cycles|1|||
23347541|NCT00985959|65014416|FG002|Overall Study|Complete response observed over 2 cycles|4|||
23347542|NCT00985959|65014414|FG000|Overall Study|Other|0|||
23347543|NCT00985959|65014415|FG001|Overall Study|Other|0|||
23347544|NCT00985959|65014416|FG002|Overall Study|Other|11|||
23347545|NCT00347919|65014419|FG000|Overall Study|Lost to Follow-up|11|||
23347546|NCT00347919|65014420|FG001|Overall Study|Lost to Follow-up|13|||
23347547|NCT00347919|65014421|FG002|Overall Study|Lost to Follow-up|0|||
23347548|NCT00347919|65014419|FG000|Overall Study|Withdrawal by Subject|6|||
23347549|NCT00347919|65014420|FG001|Overall Study|Withdrawal by Subject|8|||
23347550|NCT00347919|65014421|FG002|Overall Study|Withdrawal by Subject|0|||
23459245|NCT03173560|65423656|FG001|Overall Study|Withdrawal by Subject|5|||
23459246|NCT03173560|65423655|FG000|Overall Study|Other|0|||
23459247|NCT03173560|65423656|FG001|Overall Study|Other|1|||
23180965|NCT05195528|64401950|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
23180966|NCT05195528|64401951|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23180967|NCT05195528|64401952|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
23180968|NCT05195528|64401948|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23180969|NCT05195528|64401949|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
23180970|NCT05195528|64401950|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
23459248|NCT02991768|65423657|FG000|Overall Study|Physician Decision|4|||
23180971|NCT05195528|64401951|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23180972|NCT05195528|64401952|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
23180973|NCT05195528|64401948|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
23180974|NCT05195528|64401949|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
23180975|NCT05195528|64401950|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
23180976|NCT05195528|64401951|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
23180977|NCT05195528|64401952|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
23180978|NCT05195528|64401948|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
23180979|NCT05195528|64401949|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
23180980|NCT05195528|64401950|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
23180981|NCT05195528|64401951|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
23180982|NCT05195528|64401952|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
23180983|NCT05195528|64401948|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
23180984|NCT05195528|64401949|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
23180985|NCT05195528|64401950|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
23240596|NCT01714726|64626610|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
23240597|NCT01714726|64626611|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
23240598|NCT01714726|64626612|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
23347551|NCT00347919|65014419|FG000|Overall Study|Physician Decision|1|||
23347552|NCT00347919|65014420|FG001|Overall Study|Physician Decision|1|||
23347553|NCT00347919|65014421|FG002|Overall Study|Physician Decision|0|||
23459249|NCT02205736|65423660|FG000|Overall Study|Lost to Follow-up|106|||
23347554|NCT00347919|65014419|FG000|Overall Study|Sponsor terminated study|15|||
23347555|NCT00347919|65014420|FG001|Overall Study|Sponsor terminated study|10|||
23347556|NCT00347919|65014421|FG002|Overall Study|Sponsor terminated study|16|||
23347557|NCT00347919|65014419|FG000|Overall Study|Death|35|||
23459250|NCT03777982|65423661|FG000|Overall Study|Physician Decision|0|||
23459251|NCT03777982|65423662|FG001|Overall Study|Physician Decision|1|||
23459252|NCT01084655|65423664|FG000|Overall Study|Radiographic disease progression|3|||
23459253|NCT01084655|65423665|FG001|Overall Study|Radiographic disease progression|2|||
23459254|NCT01084655|65423666|FG002|Overall Study|Radiographic disease progression|8|||
23459255|NCT01084655|65423664|FG000|Overall Study|Withdrawal by Subject|1|||
23459256|NCT01084655|65423665|FG001|Overall Study|Withdrawal by Subject|0|||
23459257|NCT01084655|65423666|FG002|Overall Study|Withdrawal by Subject|4|||
23459258|NCT01084655|65423664|FG000|Overall Study|Adverse Event|2|||
23459259|NCT01084655|65423665|FG001|Overall Study|Adverse Event|1|||
23459260|NCT01084655|65423666|FG002|Overall Study|Adverse Event|2|||
23459261|NCT01084655|65423664|FG000|Overall Study|Other|0|||
23459262|NCT01084655|65423665|FG001|Overall Study|Other|3|||
23459263|NCT01084655|65423666|FG002|Overall Study|Other|2|||
23459264|NCT01084655|65423664|FG000|Overall Study|Symptomatic deterioration|0|||
23459265|NCT01084655|65423665|FG001|Overall Study|Symptomatic deterioration|0|||
23459266|NCT01084655|65423666|FG002|Overall Study|Symptomatic deterioration|2|||
23459267|NCT01084655|65423664|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
23459268|NCT01084655|65423665|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
23459269|NCT01084655|65423666|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
23459270|NCT01116648|65423671|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
23459271|NCT01116648|65423672|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
23459272|NCT01116648|65423673|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
23459273|NCT01116648|65423674|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
23459274|NCT01116648|65423675|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
23459275|NCT01116648|65423676|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
23459276|NCT01116648|65423677|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
23459277|NCT01116648|65423678|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
23347558|NCT00347919|65014420|FG001|Overall Study|Death|42|||
23240599|NCT01714726|64626609|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
23347559|NCT00347919|65014421|FG002|Overall Study|Death|19|||
23347560|NCT00347919|65014419|FG000|Overall Study|Par. Started Other Treatment|1|||
23347561|NCT00347919|65014420|FG001|Overall Study|Par. Started Other Treatment|1|||
23347562|NCT00347919|65014421|FG002|Overall Study|Par. Started Other Treatment|1|||
23347563|NCT00347919|65014419|FG000|Overall Study|Missing|2|||
23459278|NCT01116648|65423679|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
23180986|NCT05195528|64401951|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
23180987|NCT05195528|64401952|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
23180988|NCT05195528|64401948|FG000|Placebo-controlled Treatment Period|Other|0|||
23459279|NCT01116648|65423680|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
23459280|NCT01116648|65423681|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
23459281|NCT01116648|65423682|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
23459282|NCT01116648|65423683|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
23459283|NCT01116648|65423684|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
23180989|NCT05195528|64401949|FG001|Placebo-controlled Treatment Period|Other|0|||
23180990|NCT05195528|64401950|FG002|Placebo-controlled Treatment Period|Other|1|||
23180991|NCT05195528|64401951|FG003|Placebo-controlled Treatment Period|Other|0|||
23180992|NCT05195528|64401952|FG004|Placebo-controlled Treatment Period|Other|0|||
23180993|NCT05195528|64401948|FG000|Extension Period|PTE or AE or SAE|0|||
23180994|NCT05195528|64401949|FG001|Extension Period|PTE or AE or SAE|4|||
23180995|NCT05195528|64401950|FG002|Extension Period|PTE or AE or SAE|5|||
23180996|NCT05195528|64401951|FG003|Extension Period|PTE or AE or SAE|4|||
23180997|NCT05195528|64401952|FG004|Extension Period|PTE or AE or SAE|4|||
23347564|NCT00347919|65014420|FG001|Overall Study|Missing|1|||
23347565|NCT00347919|65014421|FG002|Overall Study|Missing|2|||
23347566|NCT02360475|65014422|FG000|Overall Study|Lost to Follow-up|4|||
23347567|NCT02360475|65014423|FG001|Overall Study|Lost to Follow-up|12|||
23180998|NCT05195528|64401948|FG000|Extension Period|Protocol Violation|0|||
23180999|NCT05195528|64401949|FG001|Extension Period|Protocol Violation|2|||
23181000|NCT05195528|64401950|FG002|Extension Period|Protocol Violation|1|||
23347568|NCT02360475|65014424|FG002|Overall Study|Lost to Follow-up|6|||
23459284|NCT01116648|65423685|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
23347569|NCT02360475|65014425|FG003|Overall Study|Lost to Follow-up|4|||
23347570|NCT02360475|65014422|FG000|Overall Study|Withdrawal by Subject|0|||
23347571|NCT02360475|65014423|FG001|Overall Study|Withdrawal by Subject|1|||
23347572|NCT02360475|65014424|FG002|Overall Study|Withdrawal by Subject|2|||
23347573|NCT02360475|65014425|FG003|Overall Study|Withdrawal by Subject|0|||
23347574|NCT02360475|65014422|FG000|Overall Study|Migrated/moved from study area|0|||
23347575|NCT02360475|65014423|FG001|Overall Study|Migrated/moved from study area|0|||
23459285|NCT04659044|65423689|FG000|Induction|Physician Decision|1|||
23459286|NCT04659044|65423689|FG000|Induction|Adverse Event|2|||
23459287|NCT02085460|65423690|FG000|Overall Study|Adverse Event|2|||
23459288|NCT02085460|65423691|FG001|Overall Study|Adverse Event|2|||
23459289|NCT02085460|65423692|FG002|Overall Study|Adverse Event|1|||
23459290|NCT02085460|65423690|FG000|Overall Study|Physician Decision|1|||
23347576|NCT02360475|65014424|FG002|Overall Study|Migrated/moved from study area|0|||
23347577|NCT02360475|65014425|FG003|Overall Study|Migrated/moved from study area|1|||
23347578|NCT02035748|65014426|FG000|Overall Study|Adverse Event|5|||
23347579|NCT02035748|65014426|FG000|Overall Study|Death|3|||
23347580|NCT02035748|65014426|FG000|Overall Study|Lost to Follow-up|2|||
23347581|NCT02035748|65014426|FG000|Overall Study|Physician Decision|3|||
23347582|NCT02035748|65014426|FG000|Overall Study|Withdrawal by Subject|6|||
23347583|NCT02035748|65014426|FG000|Overall Study|Progressive Disease|1|||
23347584|NCT02505334|65014427|FG000|Main Treatment Period|Adverse Event|3|||
23347585|NCT02505334|65014428|FG001|Main Treatment Period|Adverse Event|3|||
23347586|NCT02505334|65014427|FG000|Main Treatment Period|Lack of Efficacy|7|||
23347587|NCT02505334|65014428|FG001|Main Treatment Period|Lack of Efficacy|17|||
23347588|NCT02505334|65014427|FG000|Main Treatment Period|Protocol Violation|0|||
23347589|NCT02505334|65014428|FG001|Main Treatment Period|Protocol Violation|1|||
23347590|NCT02505334|65014427|FG000|Main Treatment Period|Withdrawal by Subject|1|||
23347591|NCT02505334|65014428|FG001|Main Treatment Period|Withdrawal by Subject|8|||
23347592|NCT02505334|65014427|FG000|Main Treatment Period|Unclassified|4|||
23347593|NCT02505334|65014428|FG001|Main Treatment Period|Unclassified|10|||
23347594|NCT02505334|65014427|FG000|Extension Treatment Period|Adverse Event|5|||
23347595|NCT02505334|65014428|FG001|Extension Treatment Period|Adverse Event|0|||
23347596|NCT02505334|65014427|FG000|Extension Treatment Period|Lack of Efficacy|4|||
23347597|NCT02505334|65014428|FG001|Extension Treatment Period|Lack of Efficacy|0|||
23347598|NCT02505334|65014427|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
23347599|NCT02505334|65014428|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23347600|NCT02505334|65014427|FG000|Extension Treatment Period|Unclassified|3|||
23347601|NCT02505334|65014428|FG001|Extension Treatment Period|Unclassified|0|||
23347602|NCT00387010|65014429|FG000|Dose Titration Period|Adverse Event|12|||
23347603|NCT00387010|65014429|FG000|Dose Titration Period|Lack of Efficacy|5|||
23347604|NCT00387010|65014429|FG000|Dose Titration Period|Withdrawal by Subject|3|||
23347605|NCT00387010|65014429|FG000|Dose Titration Period|Protocol Violation|1|||
23347606|NCT00387010|65014429|FG000|Dose Titration Period|Lost to Follow-up|2|||
23347607|NCT00387010|65014429|FG000|Dose Titration Period|Noncompliance with study medication|8|||
23347608|NCT00387010|65014429|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
23347609|NCT00387010|65014429|FG000|Treatment Period|Adverse Event|4|||
23347610|NCT00387010|65014429|FG000|Treatment Period|Withdrawal by Subject|1|||
23347611|NCT00387010|65014429|FG000|Treatment Period|Noncompliance with study medication|2|||
23459291|NCT02085460|65423691|FG001|Overall Study|Physician Decision|1|||
23459292|NCT02085460|65423692|FG002|Overall Study|Physician Decision|2|||
23459293|NCT02085460|65423690|FG000|Overall Study|Withdrawal by Subject|11|||
23181001|NCT05195528|64401951|FG003|Extension Period|Protocol Violation|0|||
23347612|NCT00387010|65014429|FG000|Treatment Period|Noncompliance with study procedures|3|||
23347613|NCT00387010|65014429|FG000|Treatment Period|Participant reported study drug stolen|1|||
23347614|NCT00367484|65014437|FG000|Overall Study|Adverse Event|7|||
23347615|NCT00367484|65014437|FG000|Overall Study|Withdrew informed consent|5|||
23347616|NCT00367484|65014437|FG000|Overall Study|Travel to USA|1|||
23347617|NCT00367484|65014437|FG000|Overall Study|Lost to Follow-up|1|||
23347618|NCT00367484|65014437|FG000|Overall Study|Protocol Violation|1|||
23347619|NCT00367484|65014437|FG000|Overall Study|The choice of the patient|1|||
23347620|NCT00367484|65014437|FG000|Overall Study|Lack of Efficacy|1|||
23347621|NCT00723190|65014438|FG000|Overall Study|Withdrawal by Subject|45|||
23347622|NCT00723190|65014438|FG000|Overall Study|Lost to Follow-up|37|||
23347623|NCT00723190|65014438|FG000|Overall Study|Adverse Event|18|||
23459294|NCT02085460|65423691|FG001|Overall Study|Withdrawal by Subject|5|||
23459295|NCT02085460|65423692|FG002|Overall Study|Withdrawal by Subject|7|||
23459296|NCT02946580|65423698|FG000|Overall Study|Withdrawal by Subject|1|||
23459297|NCT02946580|65423699|FG001|Overall Study|Withdrawal by Subject|2|||
23459298|NCT02946580|65423698|FG000|Overall Study|Adverse Event|0|||
23347624|NCT00723190|65014438|FG000|Overall Study|Lack of Efficacy|16|||
23347625|NCT00723190|65014438|FG000|Overall Study|Protocol Violation|15|||
23347626|NCT00723190|65014438|FG000|Overall Study|Other-Premature Discontinuation|9|||
23347627|NCT00723190|65014438|FG000|Overall Study|Other-Not included in safety population|2|||
23347628|NCT02908074|65014439|FG000|Overall Study|sponsor/ICON decision|0|||
23347629|NCT02908074|65014440|FG001|Overall Study|sponsor/ICON decision|0|||
23347630|NCT02908074|65014441|FG002|Overall Study|sponsor/ICON decision|1|||
23347631|NCT02908074|65014442|FG003|Overall Study|sponsor/ICON decision|0|||
23347632|NCT02908074|65014443|FG004|Overall Study|sponsor/ICON decision|0|||
23347633|NCT02908074|65014444|FG005|Overall Study|sponsor/ICON decision|0|||
23347634|NCT02908074|65014439|FG000|Overall Study|Protocol Violation|0|||
23347635|NCT02908074|65014440|FG001|Overall Study|Protocol Violation|1|||
23347636|NCT02908074|65014441|FG002|Overall Study|Protocol Violation|0|||
23347637|NCT02908074|65014442|FG003|Overall Study|Protocol Violation|0|||
23347638|NCT02908074|65014443|FG004|Overall Study|Protocol Violation|0|||
23347639|NCT02908074|65014444|FG005|Overall Study|Protocol Violation|0|||
23347640|NCT02908074|65014439|FG000|Overall Study|Adverse Event|5|||
23347641|NCT02908074|65014440|FG001|Overall Study|Adverse Event|2|||
23347642|NCT02908074|65014441|FG002|Overall Study|Adverse Event|0|||
23347643|NCT02908074|65014442|FG003|Overall Study|Adverse Event|0|||
23347644|NCT02908074|65014443|FG004|Overall Study|Adverse Event|1|||
23347645|NCT02908074|65014444|FG005|Overall Study|Adverse Event|0|||
23347646|NCT02908074|65014439|FG000|Overall Study|AESI|1|||
23347647|NCT02908074|65014440|FG001|Overall Study|AESI|0|||
23347648|NCT02908074|65014441|FG002|Overall Study|AESI|1|||
23347649|NCT02908074|65014442|FG003|Overall Study|AESI|0|||
23347650|NCT02908074|65014443|FG004|Overall Study|AESI|1|||
23347651|NCT02908074|65014444|FG005|Overall Study|AESI|0|||
23347652|NCT02908074|65014439|FG000|Overall Study|Discontinuation criteria per protocol|0|||
23347653|NCT02908074|65014440|FG001|Overall Study|Discontinuation criteria per protocol|0|||
23347654|NCT02908074|65014441|FG002|Overall Study|Discontinuation criteria per protocol|1|||
23347655|NCT02908074|65014442|FG003|Overall Study|Discontinuation criteria per protocol|0|||
23347656|NCT02908074|65014443|FG004|Overall Study|Discontinuation criteria per protocol|0|||
23347657|NCT02908074|65014444|FG005|Overall Study|Discontinuation criteria per protocol|1|||
23347658|NCT02908074|65014439|FG000|Overall Study|Withdrawal by Subject|3|||
23347659|NCT02908074|65014440|FG001|Overall Study|Withdrawal by Subject|2|||
23347660|NCT02908074|65014441|FG002|Overall Study|Withdrawal by Subject|2|||
23347661|NCT02908074|65014442|FG003|Overall Study|Withdrawal by Subject|2|||
23347662|NCT02908074|65014443|FG004|Overall Study|Withdrawal by Subject|2|||
23347663|NCT02908074|65014444|FG005|Overall Study|Withdrawal by Subject|2|||
23347664|NCT02908074|65014439|FG000|Overall Study|Lost to Follow-up|0|||
23347665|NCT02908074|65014440|FG001|Overall Study|Lost to Follow-up|1|||
23347666|NCT02908074|65014441|FG002|Overall Study|Lost to Follow-up|1|||
23347667|NCT02908074|65014442|FG003|Overall Study|Lost to Follow-up|1|||
23347668|NCT02908074|65014443|FG004|Overall Study|Lost to Follow-up|0|||
23347669|NCT02908074|65014444|FG005|Overall Study|Lost to Follow-up|1|||
23459299|NCT02946580|65423699|FG001|Overall Study|Adverse Event|2|||
23459300|NCT02946580|65423698|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
23459301|NCT02946580|65423699|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
23459302|NCT05232682|65423702|FG000|Overall Study|Lost to Follow-up|2|||
23459303|NCT02855125|65425154|FG000|Overall Study|Withdrawal by Subject|2|||
23459304|NCT02855125|65425155|FG001|Overall Study|Withdrawal by Subject|2|||
23459305|NCT02855125|65425154|FG000|Overall Study|Clinical Disease Progression|5|||
23459306|NCT02855125|65425155|FG001|Overall Study|Clinical Disease Progression|4|||
23459307|NCT02855125|65425154|FG000|Overall Study|Radiologic Disease Progression|36|||
23459308|NCT02855125|65425155|FG001|Overall Study|Radiologic Disease Progression|39|||
23347674|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
23347675|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
23347676|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
23347677|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
23347678|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Death|1|||
23347679|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Death|1|||
23347680|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
23347681|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
23347682|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
23347683|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
23347684|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
23347685|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
23347686|NCT00033657|65014449|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
23459309|NCT02855125|65425154|FG000|Overall Study|Adverse Event|11|||
23459310|NCT02855125|65425155|FG001|Overall Study|Adverse Event|7|||
23459311|NCT02855125|65425154|FG000|Overall Study|Physician Decision|1|||
23459312|NCT02855125|65425155|FG001|Overall Study|Physician Decision|0|||
23459313|NCT02855125|65425154|FG000|Overall Study|On Treatment|9|||
23459314|NCT02855125|65425155|FG001|Overall Study|On Treatment|11|||
23459315|NCT02855125|65425154|FG000|Overall Study|Randomized but not treated|0|||
23459316|NCT02855125|65425155|FG001|Overall Study|Randomized but not treated|1|||
23459317|NCT03173248|65425156|FG000|Overall Study|Death|28|||
23459318|NCT03173248|65425157|FG001|Overall Study|Death|46|||
23459319|NCT03173248|65425156|FG000|Overall Study|Lost to Follow-up|0|||
23459320|NCT03173248|65425157|FG001|Overall Study|Lost to Follow-up|1|||
23459321|NCT03173248|65425156|FG000|Overall Study|Withdrawal by Subject|6|||
23459322|NCT03173248|65425157|FG001|Overall Study|Withdrawal by Subject|4|||
23459323|NCT03173248|65425156|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
23459324|NCT03173248|65425157|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
23459325|NCT02796170|65425160|FG000|Overall Study|Lost to Follow-up|3|||
23459326|NCT02796170|65425161|FG001|Overall Study|Lost to Follow-up|0|||
23459327|NCT05567783|65425171|FG000|Overall Study|Death|2|||
23459328|NCT05567783|65425172|FG001|Overall Study|Death|3|||
23459329|NCT05567783|65425173|FG002|Overall Study|Death|0|||
23459330|NCT05567783|65425171|FG000|Overall Study|Lost to Follow-up|25|||
23459331|NCT05567783|65425172|FG001|Overall Study|Lost to Follow-up|19|||
23459332|NCT05567783|65425173|FG002|Overall Study|Lost to Follow-up|17|||
23459333|NCT05567783|65425171|FG000|Overall Study|Physician Decision|10|||
23459334|NCT05567783|65425172|FG001|Overall Study|Physician Decision|7|||
23459335|NCT05567783|65425173|FG002|Overall Study|Physician Decision|9|||
23459336|NCT05567783|65425171|FG000|Overall Study|Study Terminated by Sponsor|924|||
23459337|NCT05567783|65425172|FG001|Overall Study|Study Terminated by Sponsor|937|||
23459338|NCT05567783|65425173|FG002|Overall Study|Study Terminated by Sponsor|941|||
23459339|NCT05567783|65425171|FG000|Overall Study|Withdrawal by Subject|23|||
23459340|NCT05567783|65425172|FG001|Overall Study|Withdrawal by Subject|27|||
23459341|NCT05567783|65425173|FG002|Overall Study|Withdrawal by Subject|24|||
23459342|NCT05567783|65425171|FG000|Overall Study|Incarcerated|1|||
23459343|NCT05567783|65425172|FG001|Overall Study|Incarcerated|0|||
23459344|NCT05567783|65425173|FG002|Overall Study|Incarcerated|0|||
23459345|NCT05567783|65425171|FG000|Overall Study|Participant randomized in error|4|||
23459346|NCT05567783|65425172|FG001|Overall Study|Participant randomized in error|2|||
23459347|NCT05567783|65425173|FG002|Overall Study|Participant randomized in error|2|||
23459348|NCT03425643|65425182|FG000|Overall Study|Withdrawal by Subject|10|||
23459349|NCT03425643|65425183|FG001|Overall Study|Withdrawal by Subject|12|||
23459350|NCT03425643|65425182|FG000|Overall Study|Lost to Follow-up|2|||
23459351|NCT03425643|65425183|FG001|Overall Study|Lost to Follow-up|0|||
23459352|NCT03425643|65425182|FG000|Overall Study|Death|109|||
23459353|NCT03425643|65425183|FG001|Overall Study|Death|141|||
23459354|NCT03425643|65425182|FG000|Overall Study|Ongoing in study|276|||
23459355|NCT03425643|65425183|FG001|Overall Study|Ongoing in study|247|||
23459356|NCT03067077|65425184|FG000|Overall Study|Did not receive surgery|4|||
23459357|NCT03067077|65425185|FG001|Overall Study|Did not receive surgery|5|||
23459358|NCT03067077|65425184|FG000|Overall Study|Lost to Follow-up|3|||
23459359|NCT03067077|65425185|FG001|Overall Study|Lost to Follow-up|2|||
23459360|NCT00762164|65425186|FG000|Overall Study|Lost to Follow-up|1|||
23459361|NCT00762164|65425187|FG001|Overall Study|Lost to Follow-up|1|||
23459362|NCT00762164|65425186|FG000|Overall Study|Discontinued medication|2|||
23459363|NCT00762164|65425187|FG001|Overall Study|Discontinued medication|0|||
23459364|NCT00762164|65425186|FG000|Overall Study|Withdrawal by Subject|0|||
23459365|NCT00762164|65425187|FG001|Overall Study|Withdrawal by Subject|1|||
23459366|NCT01724346|65425190|FG000|Overall Study|Death|42|||
23459367|NCT01724346|65425191|FG001|Overall Study|Death|42|||
23459368|NCT01724346|65425190|FG000|Overall Study|Lost to Follow-up|5|||
23459369|NCT01724346|65425191|FG001|Overall Study|Lost to Follow-up|1|||
23459370|NCT01724346|65425190|FG000|Overall Study|Withdrawal by Subject|27|||
23459371|NCT01724346|65425191|FG001|Overall Study|Withdrawal by Subject|19|||
23459372|NCT01724346|65425190|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
23459373|NCT01724346|65425191|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
23459374|NCT04929249|65425192|FG000|Overall Study|Adverse Event|2|||
23240600|NCT01714726|64626610|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
23459375|NCT04929249|65425193|FG001|Overall Study|Adverse Event|1|||
23459376|NCT04929249|65425192|FG000|Overall Study|Death|2|||
23459377|NCT04929249|65425193|FG001|Overall Study|Death|1|||
23459378|NCT04929249|65425192|FG000|Overall Study|Lost to Follow-up|3|||
23459379|NCT04929249|65425193|FG001|Overall Study|Lost to Follow-up|11|||
23459380|NCT04929249|65425192|FG000|Overall Study|Technical problems|0|||
23459381|NCT04929249|65425193|FG001|Overall Study|Technical problems|1|||
23459382|NCT04929249|65425192|FG000|Overall Study|Subject decision|6|||
23459383|NCT04929249|65425193|FG001|Overall Study|Subject decision|8|||
23459384|NCT04929249|65425192|FG000|Overall Study|Withdrew consent|0|||
23459385|NCT04929249|65425193|FG001|Overall Study|Withdrew consent|8|||
23459386|NCT01033019|65425196|FG000|Overall Study|Withdrawal by Subject|1|||
23459387|NCT01033019|65425197|FG001|Overall Study|Withdrawal by Subject|0|||
23459388|NCT01967238|65425199|FG000|Overall Study|Adverse Event|1|||
23459389|NCT01967238|65425200|FG001|Overall Study|Adverse Event|1|||
23459390|NCT01967238|65425201|FG002|Overall Study|Adverse Event|0|||
23459391|NCT01967238|65425199|FG000|Overall Study|Lost to Follow-up|1|||
23459392|NCT01967238|65425200|FG001|Overall Study|Lost to Follow-up|0|||
23459393|NCT01967238|65425201|FG002|Overall Study|Lost to Follow-up|1|||
23459394|NCT01967238|65425199|FG000|Overall Study|Withdrawal by Subject|0|||
23459395|NCT01967238|65425200|FG001|Overall Study|Withdrawal by Subject|0|||
23459396|NCT01967238|65425201|FG002|Overall Study|Withdrawal by Subject|1|||
23459397|NCT04025710|65425202|FG000|Overall Study|Death|3|||
23459398|NCT04025710|65425202|FG000|Overall Study|Lost to Follow-up|5|||
23459399|NCT04025710|65425202|FG000|Overall Study|Withdrawal by Subject|1|||
23459400|NCT04025710|65425202|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
23459401|NCT04025710|65425202|FG000|Overall Study|Drop-out according to protocol|34|||
23459402|NCT01285557|65425223|FG000|Overall Study|Death|173|||
23459403|NCT01285557|65425224|FG001|Overall Study|Death|90|||
23459404|NCT01285557|65425223|FG000|Overall Study|Lost to Follow-up|6|||
23459405|NCT01285557|65425224|FG001|Overall Study|Lost to Follow-up|2|||
23459406|NCT01285557|65425223|FG000|Overall Study|Withdrew Consent|6|||
23459407|NCT01285557|65425224|FG001|Overall Study|Withdrew Consent|1|||
23459408|NCT01285557|65425223|FG000|Overall Study|Sponsor Study Termination|23|||
23459409|NCT01285557|65425224|FG001|Overall Study|Sponsor Study Termination|13|||
23459410|NCT01285557|65425223|FG000|Overall Study|Randomized but not treated|1|||
23459411|NCT01285557|65425224|FG001|Overall Study|Randomized but not treated|1|||
23459412|NCT01285557|65425223|FG000|Overall Study|Study follow-up ongoing|28|||
23459413|NCT01285557|65425224|FG001|Overall Study|Study follow-up ongoing|14|||
23459414|NCT01285557|65425223|FG000|Overall Study|Sponsor Decision|2|||
23459415|NCT01285557|65425224|FG001|Overall Study|Sponsor Decision|1|||
23459416|NCT02388269|65425225|FG000|Overall Study|Adverse Event|2|||
23459417|NCT02388269|65425226|FG001|Overall Study|Adverse Event|0|||
23459418|NCT02388269|65425227|FG002|Overall Study|Adverse Event|0|||
23459419|NCT02388269|65425225|FG000|Overall Study|Withdrawal by Subject|1|||
23459420|NCT02388269|65425226|FG001|Overall Study|Withdrawal by Subject|2|||
23459421|NCT02388269|65425227|FG002|Overall Study|Withdrawal by Subject|0|||
23459422|NCT02388269|65425225|FG000|Overall Study|less than 50% stimulations|1|||
23459423|NCT02388269|65425226|FG001|Overall Study|less than 50% stimulations|0|||
23459424|NCT02388269|65425227|FG002|Overall Study|less than 50% stimulations|0|||
23181002|NCT05195528|64401952|FG004|Extension Period|Protocol Violation|1|||
23181003|NCT05195528|64401948|FG000|Extension Period|Lost to Follow-up|0|||
23181004|NCT05195528|64401949|FG001|Extension Period|Lost to Follow-up|6|||
23181005|NCT05195528|64401950|FG002|Extension Period|Lost to Follow-up|13|||
23181006|NCT05195528|64401951|FG003|Extension Period|Lost to Follow-up|3|||
23181007|NCT05195528|64401952|FG004|Extension Period|Lost to Follow-up|7|||
23181008|NCT05195528|64401948|FG000|Extension Period|Withdrawal by Subject|0|||
23181009|NCT05195528|64401949|FG001|Extension Period|Withdrawal by Subject|12|||
23181010|NCT05195528|64401950|FG002|Extension Period|Withdrawal by Subject|9|||
23181011|NCT05195528|64401951|FG003|Extension Period|Withdrawal by Subject|6|||
23181012|NCT05195528|64401952|FG004|Extension Period|Withdrawal by Subject|5|||
23181013|NCT05195528|64401948|FG000|Extension Period|Lack of Efficacy|0|||
23181014|NCT05195528|64401949|FG001|Extension Period|Lack of Efficacy|3|||
23181015|NCT05195528|64401950|FG002|Extension Period|Lack of Efficacy|0|||
23181016|NCT05195528|64401951|FG003|Extension Period|Lack of Efficacy|0|||
23181017|NCT05195528|64401952|FG004|Extension Period|Lack of Efficacy|2|||
23181018|NCT05195528|64401948|FG000|Extension Period|Not Treated|0|||
23181019|NCT05195528|64401949|FG001|Extension Period|Not Treated|0|||
23181020|NCT05195528|64401950|FG002|Extension Period|Not Treated|2|||
23181021|NCT05195528|64401951|FG003|Extension Period|Not Treated|3|||
23181022|NCT05195528|64401952|FG004|Extension Period|Not Treated|0|||
23181023|NCT05195528|64401948|FG000|Extension Period|Other|0|||
23181024|NCT05195528|64401949|FG001|Extension Period|Other|1|||
23181025|NCT05195528|64401950|FG002|Extension Period|Other|1|||
23181026|NCT05195528|64401951|FG003|Extension Period|Other|0|||
23181027|NCT05195528|64401952|FG004|Extension Period|Other|0|||
23181028|NCT00348140|64401953|FG000|Overall Study|Adverse Event|46|||
23181029|NCT00348140|64401954|FG001|Overall Study|Adverse Event|49|||
23181030|NCT00348140|64401955|FG002|Overall Study|Adverse Event|78|||
23459425|NCT02388269|65425225|FG000|Overall Study|no diary data|3|||
23459426|NCT02388269|65425226|FG001|Overall Study|no diary data|0|||
23459427|NCT02388269|65425227|FG002|Overall Study|no diary data|0|||
23459428|NCT02388269|65425225|FG000|Overall Study|Protocol Violation|2|||
23459429|NCT02388269|65425226|FG001|Overall Study|Protocol Violation|0|||
23181031|NCT00348140|64401953|FG000|Overall Study|Lost to Follow-up|4|||
23181032|NCT00348140|64401954|FG001|Overall Study|Lost to Follow-up|4|||
23181033|NCT00348140|64401955|FG002|Overall Study|Lost to Follow-up|4|||
23181034|NCT00348140|64401953|FG000|Overall Study|Protocol Violation|12|||
23181035|NCT00348140|64401954|FG001|Overall Study|Protocol Violation|13|||
23459430|NCT02388269|65425227|FG002|Overall Study|Protocol Violation|0|||
23459431|NCT02388269|65425225|FG000|Overall Study|Screen Failure|0|||
23459432|NCT02388269|65425226|FG001|Overall Study|Screen Failure|0|||
23181036|NCT00348140|64401955|FG002|Overall Study|Protocol Violation|14|||
23459433|NCT02388269|65425227|FG002|Overall Study|Screen Failure|10|||
23459434|NCT02992288|65425228|FG000|Overall Study|Adverse Event|8|||
23459435|NCT02992288|65425229|FG001|Overall Study|Adverse Event|2|||
23459436|NCT02992288|65425230|FG002|Overall Study|Adverse Event|2|||
23459437|NCT02992288|65425231|FG003|Overall Study|Adverse Event|2|||
23459438|NCT02992288|65425232|FG004|Overall Study|Adverse Event|2|||
23459439|NCT02992288|65425233|FG005|Overall Study|Adverse Event|7|||
23459440|NCT02992288|65425228|FG000|Overall Study|Non-compliance with study drug|0|||
23459441|NCT02992288|65425229|FG001|Overall Study|Non-compliance with study drug|1|||
23459442|NCT02992288|65425230|FG002|Overall Study|Non-compliance with study drug|1|||
23459443|NCT02992288|65425231|FG003|Overall Study|Non-compliance with study drug|0|||
23459444|NCT02992288|65425232|FG004|Overall Study|Non-compliance with study drug|1|||
23459445|NCT02992288|65425233|FG005|Overall Study|Non-compliance with study drug|0|||
23459446|NCT02992288|65425228|FG000|Overall Study|Physician Decision|3|||
23459447|NCT02992288|65425229|FG001|Overall Study|Physician Decision|0|||
23459448|NCT02992288|65425230|FG002|Overall Study|Physician Decision|1|||
23459449|NCT02992288|65425231|FG003|Overall Study|Physician Decision|0|||
23459450|NCT02992288|65425232|FG004|Overall Study|Physician Decision|0|||
23459451|NCT02992288|65425233|FG005|Overall Study|Physician Decision|1|||
23459452|NCT02992288|65425228|FG000|Overall Study|Death|2|||
23459453|NCT02992288|65425229|FG001|Overall Study|Death|0|||
23459454|NCT02992288|65425230|FG002|Overall Study|Death|2|||
23459455|NCT02992288|65425231|FG003|Overall Study|Death|1|||
23459456|NCT02992288|65425232|FG004|Overall Study|Death|2|||
23459457|NCT02992288|65425233|FG005|Overall Study|Death|0|||
23459458|NCT02992288|65425228|FG000|Overall Study|Lost to Follow-up|0|||
23459459|NCT02992288|65425229|FG001|Overall Study|Lost to Follow-up|0|||
23459460|NCT02992288|65425230|FG002|Overall Study|Lost to Follow-up|0|||
23459461|NCT02992288|65425231|FG003|Overall Study|Lost to Follow-up|1|||
23459462|NCT02992288|65425232|FG004|Overall Study|Lost to Follow-up|0|||
23459463|NCT02992288|65425233|FG005|Overall Study|Lost to Follow-up|0|||
23459464|NCT02992288|65425228|FG000|Overall Study|Protocol Violation|0|||
23459465|NCT02992288|65425229|FG001|Overall Study|Protocol Violation|0|||
23459466|NCT02992288|65425230|FG002|Overall Study|Protocol Violation|0|||
23181037|NCT00348140|64401953|FG000|Overall Study|Withdrawal by Subject|32|||
23459467|NCT02992288|65425231|FG003|Overall Study|Protocol Violation|0|||
23459468|NCT02992288|65425232|FG004|Overall Study|Protocol Violation|0|||
23459469|NCT02992288|65425233|FG005|Overall Study|Protocol Violation|1|||
23459470|NCT02992288|65425228|FG000|Overall Study|Withdrawal by Subject|4|||
23459471|NCT02992288|65425229|FG001|Overall Study|Withdrawal by Subject|2|||
23459472|NCT02992288|65425230|FG002|Overall Study|Withdrawal by Subject|1|||
23459473|NCT02992288|65425231|FG003|Overall Study|Withdrawal by Subject|5|||
23459474|NCT02992288|65425232|FG004|Overall Study|Withdrawal by Subject|3|||
23459475|NCT02992288|65425233|FG005|Overall Study|Withdrawal by Subject|4|||
23459476|NCT00371150|65425234|FG000|Overall Study|Lost to Follow-up|3|||
23459477|NCT00371150|65425235|FG001|Overall Study|Lost to Follow-up|2|||
23459478|NCT03435211|65425236|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
23459479|NCT05417438|65425239|FG000|Overall Study|Withdrawal by Subject|3|||
23459480|NCT04323124|65425247|FG000|Overall Study|Adverse Event|0|||
23459481|NCT04323124|65425248|FG001|Overall Study|Adverse Event|0|||
23459482|NCT04323124|65425249|FG002|Overall Study|Adverse Event|0|||
23459483|NCT04323124|65425250|FG003|Overall Study|Adverse Event|0|||
23459484|NCT04323124|65425251|FG004|Overall Study|Adverse Event|0|||
23459485|NCT04323124|65425252|FG005|Overall Study|Adverse Event|1|||
23459486|NCT04323124|65425253|FG006|Overall Study|Adverse Event|0|||
23459487|NCT04323124|65425254|FG007|Overall Study|Adverse Event|1|||
23459488|NCT04323124|65425255|FG008|Overall Study|Adverse Event|1|||
23459489|NCT04323124|65425256|FG009|Overall Study|Adverse Event|0|||
23459490|NCT04323124|65425257|FG010|Overall Study|Adverse Event|0|||
23459491|NCT04323124|65425258|FG011|Overall Study|Adverse Event|0|||
23181038|NCT00348140|64401954|FG001|Overall Study|Withdrawal by Subject|40|||
23181039|NCT00348140|64401955|FG002|Overall Study|Withdrawal by Subject|40|||
23459492|NCT04323124|65425259|FG012|Overall Study|Adverse Event|0|||
23459493|NCT04323124|65425260|FG013|Overall Study|Adverse Event|0|||
23459494|NCT04323124|65425261|FG014|Overall Study|Adverse Event|0|||
23459495|NCT04323124|65425247|FG000|Overall Study|Other|0|||
23459496|NCT04323124|65425248|FG001|Overall Study|Other|0|||
23459497|NCT04323124|65425249|FG002|Overall Study|Other|0|||
23181040|NCT00348140|64401953|FG000|Overall Study|Non-compliance|8|||
23459498|NCT04323124|65425250|FG003|Overall Study|Other|0|||
23459499|NCT04323124|65425251|FG004|Overall Study|Other|1|||
23459500|NCT04323124|65425252|FG005|Overall Study|Other|0|||
23459501|NCT04323124|65425253|FG006|Overall Study|Other|0|||
23459502|NCT04323124|65425254|FG007|Overall Study|Other|0|||
23459503|NCT04323124|65425255|FG008|Overall Study|Other|1|||
23459504|NCT04323124|65425256|FG009|Overall Study|Other|0|||
23459505|NCT04323124|65425257|FG010|Overall Study|Other|0|||
23459506|NCT04323124|65425258|FG011|Overall Study|Other|0|||
23459507|NCT04323124|65425259|FG012|Overall Study|Other|0|||
23459508|NCT04323124|65425260|FG013|Overall Study|Other|0|||
23181041|NCT00348140|64401954|FG001|Overall Study|Non-compliance|13|||
23181042|NCT00348140|64401955|FG002|Overall Study|Non-compliance|5|||
23181043|NCT00348140|64401953|FG000|Overall Study|Participant at risk due to study drug|2|||
23181044|NCT00348140|64401954|FG001|Overall Study|Participant at risk due to study drug|0|||
23347687|NCT00033657|65014450|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
23347688|NCT00033657|65014449|FG000|Surgical Resection|not complete resection|0|||
23347689|NCT00033657|65014450|FG001|Surgical Resection|not complete resection|3|||
23347690|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
23347691|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
23347692|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
23347693|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
23181045|NCT00348140|64401955|FG002|Overall Study|Participant at risk due to study drug|0|||
23181046|NCT00348140|64401953|FG000|Overall Study|Conditional medication increased dose|1|||
23181047|NCT00348140|64401954|FG001|Overall Study|Conditional medication increased dose|0|||
23181048|NCT00348140|64401955|FG002|Overall Study|Conditional medication increased dose|0|||
23181049|NCT00348140|64401953|FG000|Overall Study|Caregiver related|4|||
23347694|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Death|2|||
23347695|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Death|1|||
23347696|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
23347697|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
23347698|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
23347699|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
23347700|NCT00033657|65014449|FG000|Adjuvant Chemotherapy|Other|0|||
23347701|NCT00033657|65014450|FG001|Adjuvant Chemotherapy|Other|2|||
23347702|NCT03325894|65014451|FG000|Overall Study|Adverse Event|2|||
23347703|NCT03325894|65014452|FG001|Overall Study|Adverse Event|3|||
23347704|NCT03325894|65014451|FG000|Overall Study|Protocol Violation|1|||
23459509|NCT04323124|65425261|FG014|Overall Study|Other|0|||
23459510|NCT04323124|65425247|FG000|Overall Study|Coming from a red zone (COVID)|0|||
23459511|NCT04323124|65425248|FG001|Overall Study|Coming from a red zone (COVID)|0|||
23459512|NCT04323124|65425249|FG002|Overall Study|Coming from a red zone (COVID)|0|||
23181050|NCT00348140|64401954|FG001|Overall Study|Caregiver related|7|||
23181051|NCT00348140|64401955|FG002|Overall Study|Caregiver related|3|||
23459513|NCT04323124|65425250|FG003|Overall Study|Coming from a red zone (COVID)|0|||
23459514|NCT04323124|65425251|FG004|Overall Study|Coming from a red zone (COVID)|1|||
23459515|NCT04323124|65425252|FG005|Overall Study|Coming from a red zone (COVID)|1|||
23459516|NCT04323124|65425253|FG006|Overall Study|Coming from a red zone (COVID)|0|||
23584060|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Non-compliance|4|||
23584061|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Non-compliance|0|||
23584062|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Non-compliance|0|||
23584063|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Non-compliance|0|||
23584064|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Pain|4|||
23584065|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Pain|0|||
23584066|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Pain|0|||
23584067|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Pain|0|||
23584068|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
23584069|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
23584070|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
23584071|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
23584072|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Hospice care|1|||
23584073|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Hospice care|0|||
23584074|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Hospice care|0|||
23584075|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Hospice care|0|||
23584076|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Physician Decision|1|||
23584077|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Physician Decision|0|||
23584078|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Physician Decision|0|||
23584079|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Physician Decision|0|||
23584080|NCT01107626|65866084|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
23584081|NCT01107626|65866085|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
23584082|NCT01107626|65866086|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
23584083|NCT01107626|65866087|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
23584084|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
23584085|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
23584086|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
23181052|NCT00348140|64401953|FG000|Overall Study|Participant hospitalised|3|||
23181053|NCT00348140|64401954|FG001|Overall Study|Participant hospitalised|0|||
23347705|NCT03325894|65014452|FG001|Overall Study|Protocol Violation|2|||
23347706|NCT03325894|65014451|FG000|Overall Study|Withdrawal by Subject|10|||
23347707|NCT03325894|65014452|FG001|Overall Study|Withdrawal by Subject|6|||
23347708|NCT03325894|65014451|FG000|Overall Study|Lost to Follow-up|4|||
23584087|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
23584088|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
23584089|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
23347709|NCT03325894|65014452|FG001|Overall Study|Lost to Follow-up|9|||
23347710|NCT03325894|65014451|FG000|Overall Study|Lack of Efficacy|8|||
23347711|NCT03325894|65014452|FG001|Overall Study|Lack of Efficacy|14|||
23347712|NCT03325894|65014451|FG000|Overall Study|Study Terminated by Sponsor|38|||
23347713|NCT03325894|65014452|FG001|Overall Study|Study Terminated by Sponsor|43|||
23347714|NCT03325894|65014451|FG000|Overall Study|Other (Not received Treatment)|1|||
23347715|NCT03325894|65014452|FG001|Overall Study|Other (Not received Treatment)|0|||
23347716|NCT00742508|65014453|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
23584090|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
23584091|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
23584092|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Death|0|||
23584093|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Death|8|||
23584094|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Death|2|||
23584095|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Death|13|||
23584096|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
23584097|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
23584098|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
23584099|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
23584100|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
23584101|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
23181054|NCT00348140|64401955|FG002|Overall Study|Participant hospitalised|0|||
23584102|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
23584103|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
23584104|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
23584105|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
23181055|NCT00348140|64401953|FG000|Overall Study|Efficacy related|1|||
23181056|NCT00348140|64401954|FG001|Overall Study|Efficacy related|1|||
23181057|NCT00348140|64401955|FG002|Overall Study|Efficacy related|0|||
23181058|NCT00348140|64401953|FG000|Overall Study|Administration related|3|||
23181059|NCT00348140|64401954|FG001|Overall Study|Administration related|1|||
23181060|NCT00348140|64401955|FG002|Overall Study|Administration related|1|||
23181061|NCT00348140|64401953|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
23181062|NCT00348140|64401954|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
23181063|NCT00348140|64401955|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
23181064|NCT00348140|64401953|FG000|Overall Study|Participant unwell|1|||
23181065|NCT00348140|64401954|FG001|Overall Study|Participant unwell|0|||
23181066|NCT00348140|64401955|FG002|Overall Study|Participant unwell|0|||
23181067|NCT00348140|64401953|FG000|Overall Study|Screen failure|1|||
23181068|NCT00348140|64401954|FG001|Overall Study|Screen failure|0|||
23181069|NCT00348140|64401955|FG002|Overall Study|Screen failure|0|||
23181070|NCT00348140|64401953|FG000|Overall Study|Investigator decided to discontinue|4|||
23181071|NCT00348140|64401954|FG001|Overall Study|Investigator decided to discontinue|1|||
23181072|NCT00348140|64401955|FG002|Overall Study|Investigator decided to discontinue|4|||
23181073|NCT00348140|64401953|FG000|Overall Study|Decided to discontinue on their own|1|||
23181074|NCT00348140|64401954|FG001|Overall Study|Decided to discontinue on their own|4|||
23181075|NCT00348140|64401955|FG002|Overall Study|Decided to discontinue on their own|1|||
23181076|NCT00348140|64401953|FG000|Overall Study|Use of prohibited drug|1|||
23584106|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
23347717|NCT00742508|65014454|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
23584107|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
23181077|NCT00348140|64401954|FG001|Overall Study|Use of prohibited drug|0|||
23181078|NCT00348140|64401955|FG002|Overall Study|Use of prohibited drug|2|||
23181079|NCT00348140|64401953|FG000|Overall Study|Disease progression|1|||
23181080|NCT00348140|64401954|FG001|Overall Study|Disease progression|2|||
23181081|NCT00348140|64401955|FG002|Overall Study|Disease progression|5|||
23181082|NCT00348140|64401953|FG000|Overall Study|Increased risk of cardiac infarction|0|||
23181083|NCT00348140|64401954|FG001|Overall Study|Increased risk of cardiac infarction|1|||
23181084|NCT00348140|64401955|FG002|Overall Study|Increased risk of cardiac infarction|0|||
23181085|NCT00348140|64401953|FG000|Overall Study|Serious adverse event|0|||
23181086|NCT00348140|64401954|FG001|Overall Study|Serious adverse event|1|||
23181087|NCT00348140|64401955|FG002|Overall Study|Serious adverse event|0|||
23459517|NCT04323124|65425254|FG007|Overall Study|Coming from a red zone (COVID)|0|||
23459518|NCT04323124|65425255|FG008|Overall Study|Coming from a red zone (COVID)|0|||
23459519|NCT04323124|65425256|FG009|Overall Study|Coming from a red zone (COVID)|0|||
23459520|NCT04323124|65425257|FG010|Overall Study|Coming from a red zone (COVID)|0|||
23459521|NCT04323124|65425258|FG011|Overall Study|Coming from a red zone (COVID)|0|||
23459522|NCT04323124|65425259|FG012|Overall Study|Coming from a red zone (COVID)|0|||
23459523|NCT04323124|65425260|FG013|Overall Study|Coming from a red zone (COVID)|0|||
23181088|NCT00348140|64401953|FG000|Overall Study|Abnormal ECG|0|||
23181089|NCT00348140|64401954|FG001|Overall Study|Abnormal ECG|1|||
23181090|NCT00348140|64401955|FG002|Overall Study|Abnormal ECG|3|||
23240601|NCT01714726|64626611|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
23240602|NCT01714726|64626612|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
23240603|NCT01714726|64626609|FG000|Open-Label Period|Other|0|||
23240604|NCT01714726|64626610|FG001|Open-Label Period|Other|0|||
23240605|NCT01714726|64626611|FG002|Open-Label Period|Other|1|||
23240606|NCT01714726|64626612|FG003|Open-Label Period|Other|3|||
23240607|NCT01714726|64626609|FG000|Open-Label Period|Adverse Event|0|||
23240608|NCT01714726|64626610|FG001|Open-Label Period|Adverse Event|0|||
23240609|NCT01714726|64626611|FG002|Open-Label Period|Adverse Event|1|||
23240610|NCT01714726|64626612|FG003|Open-Label Period|Adverse Event|0|||
23240611|NCT01714726|64626609|FG000|Open-Label Period|Withdrawal by Subject|0|||
23240612|NCT01714726|64626610|FG001|Open-Label Period|Withdrawal by Subject|0|||
23240613|NCT01714726|64626611|FG002|Open-Label Period|Withdrawal by Subject|9|||
23240614|NCT01714726|64626612|FG003|Open-Label Period|Withdrawal by Subject|19|||
23240615|NCT01714726|64626609|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
23240616|NCT01714726|64626610|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
23240617|NCT01714726|64626611|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
23240618|NCT01714726|64626612|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
23240619|NCT01714726|64626609|FG000|Open-Label Period|Lost to Follow-up|0|||
23240620|NCT01714726|64626610|FG001|Open-Label Period|Lost to Follow-up|0|||
23240621|NCT01714726|64626611|FG002|Open-Label Period|Lost to Follow-up|3|||
23240622|NCT01714726|64626612|FG003|Open-Label Period|Lost to Follow-up|4|||
23347718|NCT00742508|65014453|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
23347719|NCT00742508|65014454|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
23347720|NCT00742508|65014453|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
23459524|NCT04323124|65425261|FG014|Overall Study|Coming from a red zone (COVID)|0|||
23459525|NCT04323124|65425247|FG000|Overall Study|No longer meets eligibility criteria|0|||
23459526|NCT04323124|65425248|FG001|Overall Study|No longer meets eligibility criteria|0|||
23181091|NCT00348140|64401953|FG000|Overall Study|Participant died|0|||
23240623|NCT00462501|64626613|FG000|Overall Study|Not treated|3|||
23240624|NCT00462501|64626613|FG000|Overall Study|Adverse Event|2|||
23240625|NCT01976104|64626617|FG000|Overall Study|Adverse Event|0|||
23240626|NCT01976104|64626618|FG001|Overall Study|Adverse Event|0|||
23459527|NCT04323124|65425249|FG002|Overall Study|No longer meets eligibility criteria|0|||
23584108|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
23584109|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
23584110|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
23584111|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
23584112|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
23584113|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
23584114|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
23584115|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
23584116|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
23584117|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
23240627|NCT01976104|64626619|FG002|Overall Study|Adverse Event|1|||
23240628|NCT01976104|64626620|FG003|Overall Study|Adverse Event|0|||
23347721|NCT00742508|65014454|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
23347722|NCT00742508|65014453|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
23347723|NCT00742508|65014454|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
23347724|NCT00742508|65014453|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
23347725|NCT00742508|65014454|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
23347726|NCT01537068|65017827|FG000|Overall Study|Lost to Follow-up|2|||
23347727|NCT01537068|65017828|FG001|Overall Study|Lost to Follow-up|1|||
23347728|NCT01537068|65017827|FG000|Overall Study|Adverse Event|0|||
23347729|NCT01537068|65017828|FG001|Overall Study|Adverse Event|1|||
23347730|NCT01537068|65017827|FG000|Overall Study|Withdrawal by Subject|1|||
23347731|NCT01537068|65017828|FG001|Overall Study|Withdrawal by Subject|1|||
23347732|NCT01537068|65017827|FG000|Overall Study|Lack of Efficacy|1|||
23347733|NCT01537068|65017828|FG001|Overall Study|Lack of Efficacy|0|||
23347734|NCT00717275|65017829|FG000|Overall Study|Premature study termination.|3|||
23347735|NCT02474355|65017833|FG000|Overall Study|Other|43|||
23347736|NCT02474355|65017833|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
23347737|NCT02474355|65017833|FG000|Overall Study|Lost to Follow-up|98|||
23347738|NCT02474355|65017833|FG000|Overall Study|Withdrawal by Subject|124|||
23347739|NCT02474355|65017833|FG000|Overall Study|Death|1361|||
23347740|NCT00232596|65017834|FG000|6-Week Titration Phase|Adverse Event|6|||
23347741|NCT00232596|65017835|FG001|6-Week Titration Phase|Adverse Event|19|||
23347742|NCT00232596|65017834|FG000|6-Week Titration Phase|Failed to Return|2|||
23347743|NCT00232596|65017835|FG001|6-Week Titration Phase|Failed to Return|1|||
23347744|NCT00232596|65017834|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
23347745|NCT00232596|65017835|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
23347746|NCT00232596|65017834|FG000|6-Week Titration Phase|Protocol Violation|1|||
23347747|NCT00232596|65017835|FG001|6-Week Titration Phase|Protocol Violation|3|||
23181092|NCT00348140|64401954|FG001|Overall Study|Participant died|1|||
23181093|NCT00348140|64401955|FG002|Overall Study|Participant died|0|||
23181094|NCT00348140|64401953|FG000|Overall Study|Exclusion criteria met|0|||
23181095|NCT00348140|64401954|FG001|Overall Study|Exclusion criteria met|0|||
23181096|NCT00348140|64401955|FG002|Overall Study|Exclusion criteria met|1|||
23181097|NCT00348140|64401953|FG000|Overall Study|Memory declined|0|||
23181098|NCT00348140|64401954|FG001|Overall Study|Memory declined|0|||
23181099|NCT00348140|64401955|FG002|Overall Study|Memory declined|1|||
23181100|NCT02620020|64401958|FG000|Overall Study|Adverse Event|8|||
23347748|NCT00232596|65017834|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
23347749|NCT00232596|65017835|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
23347750|NCT00232596|65017834|FG000|6-Week Titration Phase|Other|3|||
23347751|NCT00232596|65017835|FG001|6-Week Titration Phase|Other|3|||
23347752|NCT00232596|65017834|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
23584118|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
23584119|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
23584120|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
23181101|NCT02620020|64401959|FG001|Overall Study|Adverse Event|4|||
23181102|NCT02620020|64401960|FG002|Overall Study|Adverse Event|3|||
23181103|NCT02620020|64401961|FG003|Overall Study|Adverse Event|5|||
23181104|NCT02620020|64401958|FG000|Overall Study|Lost to Follow-up|4|||
23181105|NCT02620020|64401959|FG001|Overall Study|Lost to Follow-up|8|||
23181106|NCT02620020|64401960|FG002|Overall Study|Lost to Follow-up|1|||
23584121|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
23584122|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
23584123|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
23181107|NCT02620020|64401961|FG003|Overall Study|Lost to Follow-up|4|||
23181108|NCT02620020|64401958|FG000|Overall Study|Physician Decision|7|||
23181109|NCT02620020|64401959|FG001|Overall Study|Physician Decision|4|||
23181110|NCT02620020|64401960|FG002|Overall Study|Physician Decision|3|||
23347753|NCT00232596|65017835|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
23347754|NCT00232596|65017834|FG000|12-Week Maintenance Phase|Adverse Event|7|||
23347755|NCT00232596|65017835|FG001|12-Week Maintenance Phase|Adverse Event|22|||
23347756|NCT00232596|65017834|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
23347757|NCT00232596|65017835|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
23584124|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
23347758|NCT00232596|65017834|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
23347759|NCT00232596|65017835|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
23181111|NCT02620020|64401961|FG003|Overall Study|Physician Decision|4|||
23181112|NCT02620020|64401958|FG000|Overall Study|Protocol Violation|5|||
23181113|NCT02620020|64401959|FG001|Overall Study|Protocol Violation|2|||
23347760|NCT00232596|65017834|FG000|12-Week Maintenance Phase|Other|1|||
23347761|NCT00232596|65017835|FG001|12-Week Maintenance Phase|Other|3|||
23347762|NCT02470403|65017836|FG000|Overall Study|Adverse Event|1|||
23347763|NCT02470403|65017837|FG001|Overall Study|Adverse Event|0|||
23347764|NCT02470403|65017838|FG002|Overall Study|Adverse Event|0|||
23347765|NCT02470403|65017839|FG003|Overall Study|Adverse Event|0|||
23347766|NCT02470403|65017840|FG004|Overall Study|Adverse Event|0|||
23347767|NCT02470403|65017836|FG000|Overall Study|Lost to Follow-up|0|||
23347768|NCT02470403|65017837|FG001|Overall Study|Lost to Follow-up|1|||
23347769|NCT02470403|65017838|FG002|Overall Study|Lost to Follow-up|0|||
23347770|NCT02470403|65017839|FG003|Overall Study|Lost to Follow-up|0|||
23347771|NCT02470403|65017840|FG004|Overall Study|Lost to Follow-up|0|||
23347772|NCT02470403|65017836|FG000|Overall Study|Subject/guardian decision|1|||
23347773|NCT02470403|65017837|FG001|Overall Study|Subject/guardian decision|0|||
23347774|NCT02470403|65017838|FG002|Overall Study|Subject/guardian decision|0|||
23347775|NCT02470403|65017839|FG003|Overall Study|Subject/guardian decision|4|||
23347776|NCT02470403|65017840|FG004|Overall Study|Subject/guardian decision|0|||
23347777|NCT00106639|65017841|FG000|Overall Study|Adverse Event|3|||
23347778|NCT00106639|65017842|FG001|Overall Study|Adverse Event|4|||
23347779|NCT00106639|65017843|FG002|Overall Study|Adverse Event|1|||
23347780|NCT00106639|65017841|FG000|Overall Study|Protocol Violation|0|||
23347781|NCT00106639|65017842|FG001|Overall Study|Protocol Violation|1|||
23347782|NCT00106639|65017843|FG002|Overall Study|Protocol Violation|0|||
23347783|NCT00106639|65017841|FG000|Overall Study|Withdrawal by Subject|0|||
23347784|NCT00106639|65017842|FG001|Overall Study|Withdrawal by Subject|1|||
23347785|NCT00106639|65017843|FG002|Overall Study|Withdrawal by Subject|0|||
23347786|NCT00106639|65017841|FG000|Overall Study|Participant defaulted|0|||
23347787|NCT00106639|65017842|FG001|Overall Study|Participant defaulted|1|||
23347788|NCT00106639|65017843|FG002|Overall Study|Participant defaulted|1|||
23347789|NCT01917344|65017844|FG000|Overall Study|Withdrawal by Subject|1|||
23347790|NCT01490697|65017849|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
23347791|NCT01490697|65017850|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
23347792|NCT00314132|65017851|FG000|Overall Study|Lost to Follow-up|3|||
23347793|NCT00314132|65017852|FG001|Overall Study|Lost to Follow-up|13|||
23347794|NCT00314132|65017851|FG000|Overall Study|Withdrawal by Subject|3|||
23347795|NCT00314132|65017852|FG001|Overall Study|Withdrawal by Subject|5|||
23347796|NCT00314132|65017851|FG000|Overall Study|Adverse Event|1|||
23347797|NCT00314132|65017852|FG001|Overall Study|Adverse Event|0|||
23347798|NCT00314132|65017851|FG000|Overall Study|Physician Decision|1|||
23347799|NCT00314132|65017852|FG001|Overall Study|Physician Decision|0|||
23347800|NCT01841567|65017853|FG000|Overall Study|Adverse Event|3|||
23347801|NCT01279070|65017857|FG000|Overall Study|Withdrawal by Subject|2|||
23347802|NCT01279070|65017858|FG001|Overall Study|Withdrawal by Subject|3|||
23347803|NCT01279070|65017857|FG000|Overall Study|Acute exacerbation|3|||
23347804|NCT01279070|65017858|FG001|Overall Study|Acute exacerbation|1|||
23347805|NCT00094536|65017859|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
23459528|NCT04323124|65425250|FG003|Overall Study|No longer meets eligibility criteria|0|||
23459529|NCT04323124|65425251|FG004|Overall Study|No longer meets eligibility criteria|0|||
23459530|NCT04323124|65425252|FG005|Overall Study|No longer meets eligibility criteria|0|||
23459531|NCT04323124|65425253|FG006|Overall Study|No longer meets eligibility criteria|0|||
23459532|NCT04323124|65425254|FG007|Overall Study|No longer meets eligibility criteria|1|||
23459533|NCT04323124|65425255|FG008|Overall Study|No longer meets eligibility criteria|0|||
23459534|NCT04323124|65425256|FG009|Overall Study|No longer meets eligibility criteria|0|||
23459535|NCT04323124|65425257|FG010|Overall Study|No longer meets eligibility criteria|0|||
23459536|NCT04323124|65425258|FG011|Overall Study|No longer meets eligibility criteria|0|||
23459537|NCT04323124|65425259|FG012|Overall Study|No longer meets eligibility criteria|0|||
23459538|NCT04323124|65425260|FG013|Overall Study|No longer meets eligibility criteria|1|||
23459539|NCT04323124|65425261|FG014|Overall Study|No longer meets eligibility criteria|1|||
23459540|NCT04323124|65425247|FG000|Overall Study|Study terminated by sponsor|0|||
23347806|NCT00094536|65017859|FG000|Treatment and Follow-up|Adverse Event|4|||
23347807|NCT00094536|65017859|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
23347808|NCT00094536|65017859|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
23347809|NCT00094536|65017859|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
23459541|NCT04323124|65425248|FG001|Overall Study|Study terminated by sponsor|0|||
23347810|NCT00094536|65017859|FG000|Treatment and Follow-up|Subject non-compliance|9|||
23347811|NCT00094536|65017859|FG000|Treatment and Follow-up|Unable to attend visits|1|||
23347812|NCT00430352|65017860|FG000|Overall Study|Disease progression|58|||
23347813|NCT00430352|65017860|FG000|Overall Study|Withdrawal by Subject|11|||
23347814|NCT00430352|65017860|FG000|Overall Study|Adverse Event|16|||
23347815|NCT00430352|65017860|FG000|Overall Study|Death|5|||
23347816|NCT00430352|65017860|FG000|Overall Study|Other|48|||
23347817|NCT03578146|65017861|FG000|Overall Study|Did Not Receive Treatment|1|||
23347818|NCT03578146|65017862|FG001|Overall Study|Did Not Receive Treatment|0|||
23347819|NCT03578146|65017863|FG002|Overall Study|Did Not Receive Treatment|0|||
23347820|NCT03578146|65017864|FG003|Overall Study|Did Not Receive Treatment|0|||
23347821|NCT03578146|65017865|FG004|Overall Study|Did Not Receive Treatment|0|||
23347822|NCT03578146|65017866|FG005|Overall Study|Did Not Receive Treatment|2|||
23347823|NCT03578146|65017861|FG000|Overall Study|Lost to Follow-up|0|||
23347824|NCT03578146|65017862|FG001|Overall Study|Lost to Follow-up|1|||
23347825|NCT03578146|65017863|FG002|Overall Study|Lost to Follow-up|1|||
23347826|NCT03578146|65017864|FG003|Overall Study|Lost to Follow-up|0|||
23347827|NCT03578146|65017865|FG004|Overall Study|Lost to Follow-up|0|||
23347828|NCT03578146|65017866|FG005|Overall Study|Lost to Follow-up|1|||
23347829|NCT01472757|65017875|FG000|Overall Study|Withdrawal by Subject|1|||
23347830|NCT01472757|65017876|FG001|Overall Study|Withdrawal by Subject|2|||
23347831|NCT01472757|65017877|FG002|Overall Study|Withdrawal by Subject|2|||
23347832|NCT01472757|65017878|FG003|Overall Study|Withdrawal by Subject|0|||
23347833|NCT01472757|65017875|FG000|Overall Study|Asthma exacerbation|4|||
23347834|NCT01472757|65017876|FG001|Overall Study|Asthma exacerbation|1|||
23347835|NCT01472757|65017877|FG002|Overall Study|Asthma exacerbation|2|||
23347836|NCT01472757|65017878|FG003|Overall Study|Asthma exacerbation|1|||
23347837|NCT01472757|65017875|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
23347838|NCT01472757|65017876|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
23347839|NCT01472757|65017877|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
23347840|NCT01472757|65017878|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
23347841|NCT01472757|65017875|FG000|Overall Study|Protocol Violation|3|||
23347842|NCT01472757|65017876|FG001|Overall Study|Protocol Violation|2|||
23347843|NCT01472757|65017877|FG002|Overall Study|Protocol Violation|4|||
23347844|NCT01472757|65017878|FG003|Overall Study|Protocol Violation|4|||
23347845|NCT01472757|65017875|FG000|Overall Study|Other reasons|1|||
23347846|NCT01472757|65017876|FG001|Overall Study|Other reasons|0|||
23347847|NCT01472757|65017877|FG002|Overall Study|Other reasons|2|||
23347848|NCT01472757|65017878|FG003|Overall Study|Other reasons|2|||
23347849|NCT03047720|65017880|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
23347850|NCT03047720|65017881|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
23347851|NCT01797081|65017886|FG000|Overall Study|Adverse Event|1|||
23347852|NCT01797081|65017887|FG001|Overall Study|Adverse Event|0|||
23347853|NCT01797081|65017888|FG002|Overall Study|Adverse Event|1|||
23347854|NCT01797081|65017889|FG003|Overall Study|Adverse Event|0|||
23347855|NCT01797081|65017886|FG000|Overall Study|Pregnancy|1|||
23347856|NCT01797081|65017887|FG001|Overall Study|Pregnancy|0|||
23347857|NCT01797081|65017888|FG002|Overall Study|Pregnancy|0|||
23347858|NCT01797081|65017889|FG003|Overall Study|Pregnancy|0|||
23347859|NCT01797081|65017886|FG000|Overall Study|Personal Reasons|12|||
23347860|NCT01797081|65017887|FG001|Overall Study|Personal Reasons|4|||
23347861|NCT01797081|65017888|FG002|Overall Study|Personal Reasons|4|||
23347862|NCT01797081|65017889|FG003|Overall Study|Personal Reasons|8|||
23347863|NCT01797081|65017886|FG000|Overall Study|Protocol Violation|0|||
23347864|NCT01797081|65017887|FG001|Overall Study|Protocol Violation|0|||
23347865|NCT01797081|65017888|FG002|Overall Study|Protocol Violation|0|||
23347866|NCT01797081|65017889|FG003|Overall Study|Protocol Violation|1|||
23347867|NCT01952080|65017890|FG000|Overall Study|Withdrawal by Subject|0|||
23347868|NCT01952080|65017891|FG001|Overall Study|Withdrawal by Subject|0|||
23347869|NCT01952080|65017892|FG002|Overall Study|Withdrawal by Subject|0|||
23347870|NCT01952080|65017893|FG003|Overall Study|Withdrawal by Subject|1|||
23347871|NCT01952080|65017890|FG000|Overall Study|Protocol Non-compliance|0|||
23347872|NCT01952080|65017891|FG001|Overall Study|Protocol Non-compliance|1|||
23347873|NCT01952080|65017892|FG002|Overall Study|Protocol Non-compliance|0|||
23347874|NCT01952080|65017893|FG003|Overall Study|Protocol Non-compliance|0|||
23347875|NCT00574795|65017894|FG000|Infant Series|Withdrawal by Subject|2|||
23347876|NCT00574795|65017894|FG000|Infant Series|Protocol Violation|2|||
23459542|NCT04323124|65425249|FG002|Overall Study|Study terminated by sponsor|0|||
23459543|NCT04323124|65425250|FG003|Overall Study|Study terminated by sponsor|0|||
23459544|NCT04323124|65425251|FG004|Overall Study|Study terminated by sponsor|0|||
23181114|NCT02620020|64401960|FG002|Overall Study|Protocol Violation|1|||
23181115|NCT02620020|64401961|FG003|Overall Study|Protocol Violation|1|||
23181116|NCT02620020|64401958|FG000|Overall Study|Withdrawal by Subject|20|||
23181117|NCT02620020|64401959|FG001|Overall Study|Withdrawal by Subject|16|||
23347877|NCT00574795|65017894|FG000|Infant Series|Adverse Event|1|||
23347878|NCT00574795|65017894|FG000|After Infant Series|Withdrawal by Subject|1|||
23347879|NCT00574795|65017894|FG000|After Infant Series|Adverse Event|2|||
23347880|NCT00574795|65017894|FG000|Toddler Dose|Withdrawal by Subject|1|||
23347881|NCT00551161|65017895|FG000|Overall Study|Withdrawal by Subject|1|||
23347882|NCT00248833|65017896|FG000|Overall Study|Adverse Event|2|||
23459545|NCT04323124|65425252|FG005|Overall Study|Study terminated by sponsor|0|||
23347883|NCT00248833|65017897|FG001|Overall Study|Adverse Event|0|||
23347884|NCT00248833|65017898|FG002|Overall Study|Adverse Event|0|||
23347885|NCT00248833|65017896|FG000|Overall Study|Withdrawal by Subject|0|||
23347886|NCT00248833|65017897|FG001|Overall Study|Withdrawal by Subject|1|||
23347887|NCT00248833|65017898|FG002|Overall Study|Withdrawal by Subject|1|||
23347888|NCT00248833|65017896|FG000|Overall Study|Lost to Follow-up|1|||
23347889|NCT00248833|65017897|FG001|Overall Study|Lost to Follow-up|1|||
23459546|NCT04323124|65425253|FG006|Overall Study|Study terminated by sponsor|0|||
23181118|NCT02620020|64401960|FG002|Overall Study|Withdrawal by Subject|17|||
23347890|NCT00248833|65017898|FG002|Overall Study|Lost to Follow-up|1|||
23347891|NCT00248833|65017896|FG000|Overall Study|Other|0|||
23347892|NCT00248833|65017897|FG001|Overall Study|Other|1|||
23347893|NCT00248833|65017898|FG002|Overall Study|Other|0|||
23347894|NCT02484651|65017902|FG000|Overall Study|Patients' data files were corrupted.|1|||
23347895|NCT02484651|65017903|FG001|Overall Study|Patients' data files were corrupted.|1|||
23347896|NCT02484651|65017902|FG000|Overall Study|BIS monitoring failed.|1|||
23347897|NCT02484651|65017903|FG001|Overall Study|BIS monitoring failed.|1|||
23347898|NCT02484651|65017902|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
23347899|NCT02484651|65017903|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
23347900|NCT00962091|65017906|FG000|Overall Study|Withdrawal by Subject|1|||
23347901|NCT00962091|65017907|FG001|Overall Study|Withdrawal by Subject|2|||
23347902|NCT00962091|65017908|FG002|Overall Study|Withdrawal by Subject|1|||
23347903|NCT00962091|65017909|FG003|Overall Study|Withdrawal by Subject|1|||
23347904|NCT00962091|65017910|FG004|Overall Study|Withdrawal by Subject|0|||
23347905|NCT00962091|65017911|FG005|Overall Study|Withdrawal by Subject|1|||
23347906|NCT00962091|65017912|FG006|Overall Study|Withdrawal by Subject|0|||
23181119|NCT02620020|64401961|FG003|Overall Study|Withdrawal by Subject|12|||
23347907|NCT00962091|65017906|FG000|Overall Study|Adverse Event|0|||
23347908|NCT00962091|65017907|FG001|Overall Study|Adverse Event|0|||
23347909|NCT00962091|65017908|FG002|Overall Study|Adverse Event|0|||
23347910|NCT00962091|65017909|FG003|Overall Study|Adverse Event|0|||
23347911|NCT00962091|65017910|FG004|Overall Study|Adverse Event|0|||
23347912|NCT00962091|65017911|FG005|Overall Study|Adverse Event|0|||
23181120|NCT02620020|64401958|FG000|Overall Study|Death|0|||
23181121|NCT02620020|64401959|FG001|Overall Study|Death|1|||
23181122|NCT02620020|64401960|FG002|Overall Study|Death|0|||
23181123|NCT02620020|64401961|FG003|Overall Study|Death|0|||
23347913|NCT00962091|65017912|FG006|Overall Study|Adverse Event|1|||
23347914|NCT02939716|65017915|FG000|Overall Study|scanner failure|0|||
23347915|NCT02939716|65017916|FG001|Overall Study|scanner failure|0|||
23347916|NCT02939716|65017917|FG002|Overall Study|scanner failure|0|||
23347917|NCT02939716|65017918|FG003|Overall Study|scanner failure|1|||
23347918|NCT02939716|65017919|FG004|Overall Study|scanner failure|1|||
23347919|NCT02939716|65017920|FG005|Overall Study|scanner failure|1|||
23347920|NCT02879994|65017921|FG000|Overall Study|off treatment early|7|||
23347921|NCT02879994|65017921|FG000|Overall Study|Adverse Event|2|||
23347922|NCT02879994|65017921|FG000|Overall Study|Death|2|||
23347923|NCT01378975|65017923|FG000|Overall Study|Death|77|||
23181124|NCT00808444|64401962|FG000|Overall Study|Withdrawal by Subject|1|||
23181125|NCT00808444|64401963|FG001|Overall Study|Withdrawal by Subject|0|||
23181126|NCT00808444|64401962|FG000|Overall Study|Lost to Follow-up|0|||
23181127|NCT00808444|64401963|FG001|Overall Study|Lost to Follow-up|1|||
23181128|NCT01289015|64401964|FG000|Overall Study|Protocol Violation|12|||
23181129|NCT01289015|64401965|FG001|Overall Study|Protocol Violation|9|||
23347924|NCT01378975|65017924|FG001|Overall Study|Death|46|||
23347925|NCT01378975|65017923|FG000|Overall Study|Investigator Request|1|||
23347926|NCT01378975|65017924|FG001|Overall Study|Investigator Request|0|||
23347927|NCT01378975|65017923|FG000|Overall Study|Lost to Follow-up|4|||
23347928|NCT01378975|65017924|FG001|Overall Study|Lost to Follow-up|1|||
23347929|NCT01378975|65017923|FG000|Overall Study|Withdrew Consent|4|||
23181130|NCT01289015|64401964|FG000|Overall Study|Adverse Event|3|||
23347930|NCT01378975|65017924|FG001|Overall Study|Withdrew Consent|3|||
23181131|NCT01289015|64401965|FG001|Overall Study|Adverse Event|0|||
23181132|NCT01289015|64401964|FG000|Overall Study|Lost to Follow-up|33|||
23181133|NCT01289015|64401965|FG001|Overall Study|Lost to Follow-up|17|||
23181134|NCT01289015|64401964|FG000|Overall Study|Withdrawal by Subject|17|||
23181135|NCT01289015|64401965|FG001|Overall Study|Withdrawal by Subject|8|||
23347931|NCT04045132|65017925|FG000|Overall Study|Lost to Follow-up|3|||
23347932|NCT04045132|65017926|FG001|Overall Study|Lost to Follow-up|6|||
23347933|NCT01737268|65017927|FG000|Overall Study|Adverse Event|6|||
23347934|NCT01737268|65017927|FG000|Overall Study|Worsening of Target Disease|2|||
23181136|NCT01289015|64401964|FG000|Overall Study|Disease progression|1|||
23181137|NCT01289015|64401965|FG001|Overall Study|Disease progression|0|||
23347935|NCT01737268|65017927|FG000|Overall Study|In consideration of the patient's safety|1|||
23181138|NCT01289015|64401964|FG000|Overall Study|Negative baseline culture and others|33|||
23347936|NCT00908076|65017932|FG000|Overall Study|Lack of Efficacy|1|||
23347937|NCT00908076|65017933|FG001|Overall Study|Lack of Efficacy|1|||
23347938|NCT00207727|65017936|FG000|Overall Study|Withdrawal by Subject|0|||
23181139|NCT01289015|64401965|FG001|Overall Study|Negative baseline culture and others|20|||
23181140|NCT01412229|64401966|FG000|Overall Study|Physician Decision|1|||
23347939|NCT00207727|65017937|FG001|Overall Study|Withdrawal by Subject|0|||
23347940|NCT00207727|65017938|FG002|Overall Study|Withdrawal by Subject|0|||
23347941|NCT00207727|65017939|FG003|Overall Study|Withdrawal by Subject|0|||
23347942|NCT00207727|65017940|FG004|Overall Study|Withdrawal by Subject|1|||
23347943|NCT00207727|65017936|FG000|Overall Study|Lost to Follow-up|0|||
23181141|NCT05340504|64401967|FG000|Overall Study|Withdrawal by Subject|1|||
23181142|NCT05340504|64401968|FG001|Overall Study|Withdrawal by Subject|0|||
23181143|NCT01955707|64401969|FG000|Overall Study|Adverse Event|1|||
23181144|NCT01955707|64401970|FG001|Overall Study|Adverse Event|2|||
23181145|NCT01955707|64401969|FG000|Overall Study|Lost to Follow-up|2|||
23181146|NCT01955707|64401970|FG001|Overall Study|Lost to Follow-up|1|||
23181147|NCT01955707|64401969|FG000|Overall Study|Withdrawal by Subject|0|||
23181148|NCT01955707|64401970|FG001|Overall Study|Withdrawal by Subject|3|||
23181149|NCT01955707|64401969|FG000|Overall Study|Death|13|||
23181150|NCT01955707|64401970|FG001|Overall Study|Death|14|||
23181151|NCT01955707|64401969|FG000|Overall Study|Other|4|||
23181152|NCT01955707|64401970|FG001|Overall Study|Other|2|||
23181153|NCT03219164|64401971|FG000|Overall Study|Study Terminated by Sponsor|16|||
23181154|NCT03219164|64401972|FG001|Overall Study|Study Terminated by Sponsor|12|||
23181155|NCT03219164|64401971|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
23181156|NCT03219164|64401972|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
23181157|NCT03219164|64401971|FG000|Overall Study|Lost to Follow-up|1|||
23181158|NCT03219164|64401972|FG001|Overall Study|Lost to Follow-up|1|||
23181159|NCT03219164|64401971|FG000|Overall Study|Adverse Event|1|||
23181160|NCT03219164|64401972|FG001|Overall Study|Adverse Event|0|||
23181161|NCT03219164|64401971|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23181162|NCT03219164|64401972|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23181163|NCT03219164|64401971|FG000|Overall Study|Protocol Violation|0|||
23181164|NCT03219164|64401972|FG001|Overall Study|Protocol Violation|1|||
23181165|NCT03219164|64401971|FG000|Overall Study|Withdrew Assent|1|||
23181166|NCT03219164|64401972|FG001|Overall Study|Withdrew Assent|0|||
23181167|NCT00582556|64401973|FG000|Overall Study|Withdrawal by Subject|0|||
23181168|NCT00582556|64401974|FG001|Overall Study|Withdrawal by Subject|1|||
23181169|NCT00582556|64401975|FG002|Overall Study|Withdrawal by Subject|1|||
23181170|NCT00582556|64401973|FG000|Overall Study|Physician Decision|0|||
23181171|NCT00582556|64401974|FG001|Overall Study|Physician Decision|0|||
23181172|NCT00582556|64401975|FG002|Overall Study|Physician Decision|1|||
23181173|NCT03437447|64401985|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23181174|NCT03437447|64401986|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23181175|NCT03437447|64401987|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23181176|NCT01267955|64401988|FG000|Stage 1 (6 Months)|Death|3|||
23181177|NCT01267955|64401988|FG000|Stage 2 (6 Months)|Death|5|||
23181178|NCT01267955|64401988|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
23181179|NCT00961961|64401991|FG000|Phase I|Withdrawal by Subject|7|||
23181180|NCT00961961|64401992|FG001|Phase I|Withdrawal by Subject|0|||
23181181|NCT00961961|64401993|FG002|Phase I|Withdrawal by Subject|0|||
23181182|NCT00961961|64401994|FG003|Phase I|Withdrawal by Subject|0|||
23181183|NCT00961961|64401991|FG000|Phase I|Lost to Follow-up|10|||
23181184|NCT00961961|64401992|FG001|Phase I|Lost to Follow-up|0|||
23181185|NCT00961961|64401993|FG002|Phase I|Lost to Follow-up|0|||
23181186|NCT00961961|64401994|FG003|Phase I|Lost to Follow-up|0|||
23240629|NCT01976104|64626617|FG000|Overall Study|Lost to Follow-up|3|||
23240630|NCT01976104|64626618|FG001|Overall Study|Lost to Follow-up|0|||
23240631|NCT01976104|64626619|FG002|Overall Study|Lost to Follow-up|1|||
23240632|NCT01976104|64626620|FG003|Overall Study|Lost to Follow-up|1|||
23240633|NCT01976104|64626617|FG000|Overall Study|Subject Choice|0|||
23240634|NCT01976104|64626618|FG001|Overall Study|Subject Choice|1|||
23240635|NCT01976104|64626619|FG002|Overall Study|Subject Choice|0|||
23240636|NCT01976104|64626620|FG003|Overall Study|Subject Choice|1|||
23240637|NCT01976104|64626617|FG000|Overall Study|Withdrawal by Subject|3|||
23240638|NCT01976104|64626618|FG001|Overall Study|Withdrawal by Subject|0|||
23240639|NCT01976104|64626619|FG002|Overall Study|Withdrawal by Subject|0|||
23240640|NCT01976104|64626620|FG003|Overall Study|Withdrawal by Subject|1|||
23240641|NCT01976104|64626617|FG000|Overall Study|Other|0|||
23240642|NCT01976104|64626618|FG001|Overall Study|Other|1|||
23240643|NCT01976104|64626619|FG002|Overall Study|Other|0|||
23240644|NCT01976104|64626620|FG003|Overall Study|Other|0|||
23240645|NCT03704194|64626624|FG000|Overall Study|Withdrawal by Subject|0|||
23240646|NCT03704194|64626625|FG001|Overall Study|Withdrawal by Subject|1|||
23240647|NCT02230332|64626627|FG000|Overall Study|Adverse Event|2|||
23240648|NCT02230332|64626628|FG001|Overall Study|Adverse Event|1|||
23240649|NCT02230332|64626627|FG000|Overall Study|Lost to Follow-up|1|||
23240650|NCT02230332|64626628|FG001|Overall Study|Lost to Follow-up|0|||
23181187|NCT00961961|64401991|FG000|Phase I|Lack of Efficacy|94|||
23181188|NCT00961961|64401992|FG001|Phase I|Lack of Efficacy|0|||
23181189|NCT00961961|64401993|FG002|Phase I|Lack of Efficacy|0|||
23181190|NCT00961961|64401994|FG003|Phase I|Lack of Efficacy|0|||
23240651|NCT02230332|64626627|FG000|Overall Study|Protocol Violation|1|||
23181191|NCT00961961|64401991|FG000|Phase I|Adverse Event|7|||
23181192|NCT00961961|64401992|FG001|Phase I|Adverse Event|0|||
23181193|NCT00961961|64401993|FG002|Phase I|Adverse Event|0|||
23181194|NCT00961961|64401994|FG003|Phase I|Adverse Event|0|||
23181195|NCT00961961|64401991|FG000|Phase I|Physician Decision|8|||
23181196|NCT00961961|64401992|FG001|Phase I|Physician Decision|0|||
23240652|NCT02230332|64626628|FG001|Overall Study|Protocol Violation|0|||
23240653|NCT04144140|64626629|FG000|Overall Study|Other|0|||
23240654|NCT04144140|64626630|FG001|Overall Study|Other|0|||
23181197|NCT00961961|64401993|FG002|Phase I|Physician Decision|0|||
23181198|NCT00961961|64401994|FG003|Phase I|Physician Decision|0|||
23181199|NCT00961961|64401991|FG000|Phase II|Lost to Follow-up|0|||
23181200|NCT00961961|64401992|FG001|Phase II|Lost to Follow-up|0|||
23181201|NCT00961961|64401993|FG002|Phase II|Lost to Follow-up|10|||
23181202|NCT00961961|64401994|FG003|Phase II|Lost to Follow-up|7|||
23181203|NCT00961961|64401991|FG000|Phase II|Adverse Event|0|||
23181204|NCT00961961|64401992|FG001|Phase II|Adverse Event|0|||
23181205|NCT00961961|64401993|FG002|Phase II|Adverse Event|0|||
23181206|NCT00961961|64401994|FG003|Phase II|Adverse Event|1|||
23181207|NCT00961961|64401991|FG000|Phase II|Physician Decision|0|||
23181208|NCT00961961|64401992|FG001|Phase II|Physician Decision|0|||
23181209|NCT00961961|64401993|FG002|Phase II|Physician Decision|1|||
23181210|NCT00961961|64401994|FG003|Phase II|Physician Decision|0|||
23181211|NCT00961961|64401991|FG000|Phase II|Withdrawal by Subject|0|||
23181212|NCT00961961|64401992|FG001|Phase II|Withdrawal by Subject|0|||
23181213|NCT00961961|64401993|FG002|Phase II|Withdrawal by Subject|1|||
23181214|NCT00961961|64401994|FG003|Phase II|Withdrawal by Subject|0|||
23181215|NCT01708057|64401995|FG000|Overall Study|Withdrawal due to study termination.|1|||
23181216|NCT01708057|64401996|FG001|Overall Study|Withdrawal due to study termination.|1|||
23181217|NCT01708057|64401997|FG002|Overall Study|Withdrawal due to study termination.|1|||
23181218|NCT00771472|64401998|FG000|Overall Study|Physician Decision|2|||
23181219|NCT00771472|64401999|FG001|Overall Study|Physician Decision|3|||
23181220|NCT00771472|64401998|FG000|Overall Study|Progressive Disease|3|||
23181221|NCT00771472|64401999|FG001|Overall Study|Progressive Disease|1|||
23181222|NCT00771472|64401998|FG000|Overall Study|Protocol Violation|1|||
23181223|NCT00771472|64401999|FG001|Overall Study|Protocol Violation|0|||
23181224|NCT00727402|64402001|FG000|Overall Study|Physician Decision|116|||
23181225|NCT01934504|64404684|FG000|Overall Study|Protocol Deviation|0|||
23181226|NCT01934504|64404685|FG001|Overall Study|Protocol Deviation|0|||
23181227|NCT01934504|64404686|FG002|Overall Study|Protocol Deviation|0|||
23181228|NCT01934504|64404687|FG003|Overall Study|Protocol Deviation|2|||
23181229|NCT01934504|64404684|FG000|Overall Study|Study Terminated by Sponsor|1|||
23181230|NCT01934504|64404685|FG001|Overall Study|Study Terminated by Sponsor|0|||
23181231|NCT01934504|64404686|FG002|Overall Study|Study Terminated by Sponsor|5|||
23181232|NCT01934504|64404687|FG003|Overall Study|Study Terminated by Sponsor|5|||
23181233|NCT01596257|64404688|FG000|Overall Study|Inadequate Collection|23|||
23181234|NCT01596257|64404689|FG001|Overall Study|Inadequate Collection|19|||
23181235|NCT01400932|64404692|FG000|Overall Study|Adverse Event|10|||
23181236|NCT01400932|64404693|FG001|Overall Study|Adverse Event|5|||
23181237|NCT01400932|64404692|FG000|Overall Study|Lack of Efficacy|0|||
23181238|NCT01400932|64404693|FG001|Overall Study|Lack of Efficacy|3|||
23181239|NCT01400932|64404692|FG000|Overall Study|Withdrawal by Subject|2|||
23181240|NCT01400932|64404693|FG001|Overall Study|Withdrawal by Subject|6|||
23181241|NCT01400932|64404692|FG000|Overall Study|Lost to Follow-up|1|||
23181242|NCT01400932|64404693|FG001|Overall Study|Lost to Follow-up|0|||
23181243|NCT01400932|64404692|FG000|Overall Study|Protocol Deviation|0|||
23181244|NCT01400932|64404693|FG001|Overall Study|Protocol Deviation|1|||
23181245|NCT01400932|64404692|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23181246|NCT01400932|64404693|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
23181247|NCT01838044|64404694|FG000|Overall Study|Adverse Event|4|||
23181248|NCT01838044|64404695|FG001|Overall Study|Adverse Event|6|||
23181249|NCT01838044|64404694|FG000|Overall Study|Protocol Violation|3|||
23181250|NCT01838044|64404695|FG001|Overall Study|Protocol Violation|3|||
23181251|NCT01838044|64404694|FG000|Overall Study|Withdrawal by Subject|0|||
23347944|NCT00207727|65017937|FG001|Overall Study|Lost to Follow-up|1|||
23347945|NCT00207727|65017938|FG002|Overall Study|Lost to Follow-up|0|||
23347946|NCT00207727|65017939|FG003|Overall Study|Lost to Follow-up|0|||
23347947|NCT00207727|65017940|FG004|Overall Study|Lost to Follow-up|0|||
23347948|NCT00207727|65017936|FG000|Overall Study|Other|38|||
23347949|NCT00207727|65017937|FG001|Overall Study|Other|41|||
23347950|NCT00207727|65017938|FG002|Overall Study|Other|41|||
23347951|NCT00207727|65017939|FG003|Overall Study|Other|37|||
23459547|NCT04323124|65425254|FG007|Overall Study|Study terminated by sponsor|0|||
23181252|NCT01838044|64404695|FG001|Overall Study|Withdrawal by Subject|2|||
23181253|NCT01838044|64404694|FG000|Overall Study|Insufficient clinical response|1|||
23181254|NCT01838044|64404695|FG001|Overall Study|Insufficient clinical response|2|||
23181255|NCT01838044|64404694|FG000|Overall Study|Medication error without associated AE|0|||
23347952|NCT00207727|65017940|FG004|Overall Study|Other|33|||
23181256|NCT01838044|64404695|FG001|Overall Study|Medication error without associated AE|1|||
23181257|NCT01838044|64404694|FG000|Overall Study|Lost to Follow-up|0|||
23181258|NCT01838044|64404695|FG001|Overall Study|Lost to Follow-up|2|||
23181259|NCT03823391|64404697|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
23181260|NCT03823391|64404698|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
23181261|NCT03823391|64404697|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
23181262|NCT03823391|64404698|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
23181263|NCT01763164|64404703|FG000|Treatment Phase|Participant/Guardian decision|26|||
23181264|NCT01763164|64404704|FG001|Treatment Phase|Participant/Guardian decision|14|||
23459548|NCT04323124|65425255|FG008|Overall Study|Study terminated by sponsor|0|||
23459549|NCT04323124|65425256|FG009|Overall Study|Study terminated by sponsor|0|||
23459550|NCT04323124|65425257|FG010|Overall Study|Study terminated by sponsor|0|||
23459551|NCT04323124|65425258|FG011|Overall Study|Study terminated by sponsor|2|||
23459552|NCT04323124|65425259|FG012|Overall Study|Study terminated by sponsor|1|||
23459553|NCT04323124|65425260|FG013|Overall Study|Study terminated by sponsor|0|||
23459554|NCT04323124|65425261|FG014|Overall Study|Study terminated by sponsor|0|||
23459555|NCT00551642|65425262|FG000|Treatment Period|Protocol Deviation|6|||
23459556|NCT00551642|65425263|FG001|Treatment Period|Protocol Deviation|11|||
23459557|NCT00551642|65425262|FG000|Treatment Period|Delivery device failure|1|||
23459558|NCT00551642|65425263|FG001|Treatment Period|Delivery device failure|3|||
23459559|NCT00551642|65425262|FG000|Treatment Period|Physician Decision|0|||
23459560|NCT00551642|65425263|FG001|Treatment Period|Physician Decision|1|||
23459561|NCT00551642|65425262|FG000|Treatment Period|Death|33|||
23459562|NCT00551642|65425263|FG001|Treatment Period|Death|31|||
23459563|NCT00551642|65425262|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
23459564|NCT00551642|65425263|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
23459565|NCT00551642|65425262|FG000|Treatment Period|Adverse Event|15|||
23459566|NCT00551642|65425263|FG001|Treatment Period|Adverse Event|12|||
23459567|NCT00551642|65425262|FG000|Treatment Period|Withdrawal by Subject|2|||
23459568|NCT00551642|65425263|FG001|Treatment Period|Withdrawal by Subject|1|||
23459569|NCT03938259|65425264|FG000|Overall Study|unable to establish baseline for ventilation|1|||
23459570|NCT03938259|65425265|FG001|Overall Study|unable to establish baseline for ventilation|1|||
23459571|NCT04272242|65425266|FG000|Overall Study|Withdrawal by Subject|3|||
23459572|NCT04272242|65425266|FG000|Overall Study|Lost to Follow-up|1|||
23459573|NCT04272242|65425266|FG000|Overall Study|Adverse Event|1|||
23459574|NCT01521117|65425267|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
23459575|NCT01521117|65425268|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
23459576|NCT01521117|65425267|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
23459577|NCT01521117|65425268|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
23459578|NCT01521117|65425267|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
23459579|NCT01521117|65425268|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
23459580|NCT00412984|65425269|FG000|Overall Study|Death|331|||
23459581|NCT00412984|65425270|FG001|Overall Study|Death|349|||
23459582|NCT00412984|65425269|FG000|Overall Study|Adverse Event|679|||
23459583|NCT00412984|65425270|FG001|Overall Study|Adverse Event|738|||
23459584|NCT00412984|65425269|FG000|Overall Study|Withdrawal by Subject|921|||
23459585|NCT00412984|65425270|FG001|Overall Study|Withdrawal by Subject|989|||
23459586|NCT00412984|65425269|FG000|Overall Study|Lost to Follow-up|51|||
23459587|NCT00412984|65425270|FG001|Overall Study|Lost to Follow-up|39|||
23459588|NCT00412984|65425269|FG000|Overall Study|Poor/Noncompliance|57|||
23459589|NCT00412984|65425270|FG001|Overall Study|Poor/Noncompliance|77|||
23459590|NCT00412984|65425269|FG000|Overall Study|Pregnancy|1|||
23459591|NCT00412984|65425270|FG001|Overall Study|Pregnancy|0|||
23459592|NCT00412984|65425269|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
23459593|NCT00412984|65425270|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
23459594|NCT00412984|65425269|FG000|Overall Study|Administrative Reason by Sponsor|11|||
23459595|NCT00412984|65425270|FG001|Overall Study|Administrative Reason by Sponsor|8|||
23459596|NCT00412984|65425269|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
23459597|NCT00412984|65425270|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
23459598|NCT00412984|65425269|FG000|Overall Study|Other Reason|80|||
23459599|NCT00412984|65425270|FG001|Overall Study|Other Reason|92|||
23459600|NCT00412984|65425269|FG000|Overall Study|Not Reported|11|||
23459601|NCT00412984|65425270|FG001|Overall Study|Not Reported|12|||
23459602|NCT00906204|65425271|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
23459603|NCT00906204|65425272|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
23459604|NCT00906204|65425271|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
23459605|NCT00906204|65425272|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
23459606|NCT00906204|65425271|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
23459607|NCT00906204|65425272|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
23459608|NCT00906204|65425271|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
23459609|NCT00906204|65425272|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
23459610|NCT00906204|65425271|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
23459611|NCT00906204|65425272|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
23459612|NCT04558125|65425281|FG000|Overall Study|Death|1|||
23459613|NCT05767749|65425282|FG000|Overall Study|Withdrawal by Subject|0|||
23459614|NCT05767749|65425283|FG001|Overall Study|Withdrawal by Subject|0|||
23459615|NCT05767749|65425284|FG002|Overall Study|Withdrawal by Subject|2|||
23459616|NCT05767749|65425285|FG003|Overall Study|Withdrawal by Subject|2|||
23459617|NCT05767749|65425286|FG004|Overall Study|Withdrawal by Subject|2|||
23459618|NCT05767749|65425287|FG005|Overall Study|Withdrawal by Subject|2|||
23459619|NCT03610269|65425289|FG000|Overall Study|Physician Decision|10|||
23584125|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
23459620|NCT03610269|65425289|FG000|Overall Study|Protocol Violation|1|||
23459621|NCT03610269|65425289|FG000|Overall Study|Unable to draw blood|1|||
23459622|NCT03610269|65425289|FG000|Overall Study|Screen fail|4|||
23459623|NCT04498832|65427779|FG000|Overall Study|Adverse Event|1|||
23459624|NCT04498832|65427780|FG001|Overall Study|Adverse Event|3|||
23459625|NCT04498832|65427779|FG000|Overall Study|Withdrawal by Subject|0|||
23459626|NCT04498832|65427780|FG001|Overall Study|Withdrawal by Subject|1|||
23459627|NCT00696072|65427781|FG000|Overall Study|continuing active treatment|10|||
23459628|NCT00696072|65427782|FG001|Overall Study|continuing active treatment|13|||
23459629|NCT00696072|65427781|FG000|Overall Study|Adverse Event|10|||
23459630|NCT00696072|65427782|FG001|Overall Study|Adverse Event|6|||
23459631|NCT00696072|65427781|FG000|Overall Study|Patient Request|3|||
23459632|NCT00696072|65427782|FG001|Overall Study|Patient Request|7|||
23459633|NCT00696072|65427781|FG000|Overall Study|Investigator Request|1|||
23459634|NCT00696072|65427782|FG001|Overall Study|Investigator Request|4|||
23459635|NCT00696072|65427781|FG000|Overall Study|Sponsor Request|0|||
23459636|NCT00696072|65427782|FG001|Overall Study|Sponsor Request|1|||
23459637|NCT00696072|65427781|FG000|Overall Study|Disease Progression|32|||
23459638|NCT00696072|65427782|FG001|Overall Study|Disease Progression|30|||
23459639|NCT00696072|65427781|FG000|Overall Study|Non-specified|1|||
23459640|NCT00696072|65427782|FG001|Overall Study|Non-specified|2|||
23459641|NCT02638220|65427783|FG000|Overall Study|Lost to Follow-up|6|||
23459642|NCT02638220|65427783|FG000|Overall Study|Withdrawal by Subject|3|||
23459643|NCT02638220|65427783|FG000|Overall Study|Physician Decision|1|||
23459644|NCT02638220|65427783|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
23459645|NCT04639245|65427784|FG000|Overall Study|Death|1|||
23459646|NCT04163016|65427785|FG000|Enrollment|Adverse Event|1|||
23459647|NCT04163016|65427786|FG001|Enrollment|Adverse Event|0|||
23459648|NCT04163016|65427787|FG002|Enrollment|Adverse Event|0|||
23459649|NCT04163016|65427788|FG003|Enrollment|Adverse Event|0|||
23459650|NCT04163016|65427785|FG000|Treatment|Adverse Event|0|||
23459651|NCT04163016|65427786|FG001|Treatment|Adverse Event|1|||
23459652|NCT04163016|65427787|FG002|Treatment|Adverse Event|0|||
23459653|NCT04163016|65427788|FG003|Treatment|Adverse Event|0|||
23459654|NCT04163016|65427785|FG000|Treatment|Withdrawal by Subject|0|||
23459655|NCT04163016|65427786|FG001|Treatment|Withdrawal by Subject|2|||
23459656|NCT04163016|65427787|FG002|Treatment|Withdrawal by Subject|0|||
23459657|NCT04163016|65427788|FG003|Treatment|Withdrawal by Subject|0|||
23459658|NCT04163016|65427785|FG000|Treatment|Indeterminate TB-test|0|||
23459659|NCT04163016|65427786|FG001|Treatment|Indeterminate TB-test|0|||
23459660|NCT04163016|65427787|FG002|Treatment|Indeterminate TB-test|0|||
23459661|NCT04163016|65427788|FG003|Treatment|Indeterminate TB-test|1|||
23459662|NCT04163016|65427785|FG000|Treatment|Participant did not want to continue in study|0|||
23181265|NCT01763164|64404703|FG000|Treatment Phase|Protocol Violation|1|||
23459663|NCT04163016|65427786|FG001|Treatment|Participant did not want to continue in study|0|||
23459664|NCT04163016|65427787|FG002|Treatment|Participant did not want to continue in study|0|||
23459665|NCT04163016|65427788|FG003|Treatment|Participant did not want to continue in study|1|||
23459666|NCT04945733|65427797|FG000|Overall Study|Physician Decision|1|||
23459667|NCT04945733|65427798|FG001|Overall Study|Physician Decision|3|||
23459668|NCT04945733|65427799|FG002|Overall Study|Physician Decision|0|||
23459669|NCT04945733|65427797|FG000|Overall Study|Withdrawal by Subject|3|||
23459670|NCT04945733|65427798|FG001|Overall Study|Withdrawal by Subject|3|||
23459671|NCT04945733|65427799|FG002|Overall Study|Withdrawal by Subject|0|||
23459672|NCT03493464|65427801|FG000|Overall Study|Surgery not performed|1|||
23459673|NCT01600326|65427802|FG000|Overall Study|Lost to Follow-up|1|||
23459674|NCT01600326|65427803|FG001|Overall Study|Lost to Follow-up|1|||
23459675|NCT01001221|65427804|FG000|Overall Study|Adverse Event|1|||
23459676|NCT01001221|65427805|FG001|Overall Study|Adverse Event|2|||
23459677|NCT01001221|65427806|FG002|Overall Study|Adverse Event|0|||
23459678|NCT01001221|65427807|FG003|Overall Study|Adverse Event|2|||
23459679|NCT01001221|65427808|FG004|Overall Study|Adverse Event|0|||
23459680|NCT01001221|65427804|FG000|Overall Study|Disease progression|3|||
23459681|NCT01001221|65427805|FG001|Overall Study|Disease progression|2|||
23459682|NCT01001221|65427806|FG002|Overall Study|Disease progression|2|||
23459683|NCT01001221|65427807|FG003|Overall Study|Disease progression|4|||
23459684|NCT01001221|65427808|FG004|Overall Study|Disease progression|0|||
23459685|NCT01001221|65427804|FG000|Overall Study|Other|1|||
23459686|NCT01001221|65427805|FG001|Overall Study|Other|1|||
23459687|NCT01001221|65427806|FG002|Overall Study|Other|0|||
23459688|NCT01001221|65427807|FG003|Overall Study|Other|0|||
23459689|NCT01001221|65427808|FG004|Overall Study|Other|0|||
23459690|NCT01001221|65427804|FG000|Overall Study|Not treated; protocol exclusion|0|||
23459691|NCT01001221|65427805|FG001|Overall Study|Not treated; protocol exclusion|0|||
23459692|NCT01001221|65427806|FG002|Overall Study|Not treated; protocol exclusion|1|||
23459693|NCT01001221|65427807|FG003|Overall Study|Not treated; protocol exclusion|0|||
23459694|NCT01001221|65427808|FG004|Overall Study|Not treated; protocol exclusion|0|||
23181266|NCT01763164|64404704|FG001|Treatment Phase|Protocol Violation|1|||
23459695|NCT02484391|65427809|FG000|Overall Study|Lack of Efficacy|15|||
23459696|NCT02484391|65427810|FG001|Overall Study|Lack of Efficacy|14|||
23459697|NCT02484391|65427811|FG002|Overall Study|Lack of Efficacy|3|||
23459698|NCT02484391|65427809|FG000|Overall Study|Lost to Follow-up|0|||
23459699|NCT02484391|65427810|FG001|Overall Study|Lost to Follow-up|0|||
23459700|NCT02484391|65427811|FG002|Overall Study|Lost to Follow-up|2|||
23459701|NCT02484391|65427809|FG000|Overall Study|Physician Decision|1|||
23459702|NCT02484391|65427810|FG001|Overall Study|Physician Decision|3|||
23459703|NCT02484391|65427811|FG002|Overall Study|Physician Decision|0|||
23459704|NCT02484391|65427809|FG000|Overall Study|Went to Transplant|5|||
23459705|NCT02484391|65427810|FG001|Overall Study|Went to Transplant|3|||
23459706|NCT02484391|65427811|FG002|Overall Study|Went to Transplant|2|||
23459707|NCT02072668|65427812|FG000|Second Intervention|Lost to Follow-up|1|||
23459708|NCT02072668|65427813|FG001|Second Intervention|Lost to Follow-up|0|||
23459709|NCT00726063|65427814|FG000|Overall Study|Adverse Event|9|||
23459710|NCT00726063|65427815|FG001|Overall Study|Adverse Event|7|||
23459711|NCT00456846|65427820|FG000|Overall Study|Adverse Event|2|||
23459712|NCT00456846|65427821|FG001|Overall Study|Adverse Event|15|||
23459713|NCT00456846|65427820|FG000|Overall Study|Physician Decision|11|||
23459714|NCT00456846|65427821|FG001|Overall Study|Physician Decision|6|||
23459715|NCT00456846|65427820|FG000|Overall Study|Protocol Deviation|2|||
23459716|NCT00456846|65427821|FG001|Overall Study|Protocol Deviation|0|||
23459717|NCT00456846|65427820|FG000|Overall Study|Participant Discretion|1|||
23459718|NCT00456846|65427821|FG001|Overall Study|Participant Discretion|5|||
23459719|NCT00456846|65427820|FG000|Overall Study|Other|0|||
23459720|NCT00456846|65427821|FG001|Overall Study|Other|2|||
23459721|NCT01283139|65427822|FG000|Overall Study|Lost to Follow-up|5|||
23459722|NCT01283139|65427823|FG001|Overall Study|Lost to Follow-up|2|||
23459723|NCT01283139|65427824|FG002|Overall Study|Lost to Follow-up|3|||
23459724|NCT01283139|65427825|FG003|Overall Study|Lost to Follow-up|1|||
23459725|NCT01283139|65427822|FG000|Overall Study|Withdrawal by Subject|8|||
23459726|NCT01283139|65427823|FG001|Overall Study|Withdrawal by Subject|8|||
23459727|NCT01283139|65427824|FG002|Overall Study|Withdrawal by Subject|6|||
23459728|NCT01283139|65427825|FG003|Overall Study|Withdrawal by Subject|8|||
23459729|NCT01283139|65427822|FG000|Overall Study|Death|2|||
23459730|NCT01283139|65427823|FG001|Overall Study|Death|0|||
23459731|NCT01283139|65427824|FG002|Overall Study|Death|2|||
23459732|NCT01283139|65427825|FG003|Overall Study|Death|2|||
23459733|NCT01283139|65427822|FG000|Overall Study|Lack of Efficacy|1|||
23459734|NCT01283139|65427823|FG001|Overall Study|Lack of Efficacy|2|||
23459735|NCT01283139|65427824|FG002|Overall Study|Lack of Efficacy|2|||
23459736|NCT01283139|65427825|FG003|Overall Study|Lack of Efficacy|1|||
23459737|NCT01283139|65427822|FG000|Overall Study|Early termination due to AE/SAE|1|||
23459738|NCT01283139|65427823|FG001|Overall Study|Early termination due to AE/SAE|1|||
23459739|NCT01283139|65427824|FG002|Overall Study|Early termination due to AE/SAE|0|||
23459740|NCT01283139|65427825|FG003|Overall Study|Early termination due to AE/SAE|0|||
23459741|NCT01283139|65427822|FG000|Overall Study|Participant's refusal to continue|0|||
23459742|NCT01283139|65427823|FG001|Overall Study|Participant's refusal to continue|3|||
23459743|NCT01283139|65427824|FG002|Overall Study|Participant's refusal to continue|1|||
23459744|NCT01283139|65427825|FG003|Overall Study|Participant's refusal to continue|1|||
23459745|NCT01283139|65427822|FG000|Overall Study|Pregnancy|0|||
23459746|NCT01283139|65427823|FG001|Overall Study|Pregnancy|1|||
23181267|NCT01763164|64404703|FG000|Treatment Phase|Progressive Disease|142|||
23181268|NCT01763164|64404704|FG001|Treatment Phase|Progressive Disease|76|||
23181269|NCT01763164|64404703|FG000|Treatment Phase|Physician Decision|24|||
23181270|NCT01763164|64404704|FG001|Treatment Phase|Physician Decision|13|||
23181271|NCT01763164|64404703|FG000|Treatment Phase|Death|10|||
23181272|NCT01763164|64404704|FG001|Treatment Phase|Death|1|||
23181273|NCT01763164|64404703|FG000|Treatment Phase|Adverse Event|66|||
23181274|NCT01763164|64404704|FG001|Treatment Phase|Adverse Event|8|||
23459747|NCT01283139|65427824|FG002|Overall Study|Pregnancy|1|||
23459748|NCT01283139|65427825|FG003|Overall Study|Pregnancy|0|||
23459749|NCT01283139|65427822|FG000|Overall Study|Missed follow-up visit|0|||
23459750|NCT01283139|65427823|FG001|Overall Study|Missed follow-up visit|1|||
23459751|NCT01283139|65427824|FG002|Overall Study|Missed follow-up visit|2|||
23459752|NCT01283139|65427825|FG003|Overall Study|Missed follow-up visit|2|||
23459753|NCT01283139|65427822|FG000|Overall Study|Participant randomized in error|0|||
23459754|NCT01283139|65427823|FG001|Overall Study|Participant randomized in error|0|||
23459755|NCT01283139|65427824|FG002|Overall Study|Participant randomized in error|1|||
23459756|NCT01283139|65427825|FG003|Overall Study|Participant randomized in error|0|||
23181275|NCT01763164|64404703|FG000|Treatment Phase|Randomized but not Treated|0|||
23181276|NCT01763164|64404704|FG001|Treatment Phase|Randomized but not Treated|19|||
23181277|NCT01763164|64404703|FG000|Treatment Phase|Other|0|||
23181278|NCT01763164|64404704|FG001|Treatment Phase|Other|1|||
23181279|NCT01763164|64404703|FG000|Follow up Phase|New therapy for study indication|12|||
23181280|NCT01763164|64404704|FG001|Follow up Phase|New therapy for study indication|3|||
23459757|NCT02603146|65427829|FG000|Overall Study|Lost to Follow-up|5|||
23459758|NCT02603146|65427830|FG001|Overall Study|Lost to Follow-up|6|||
23459759|NCT02603146|65427829|FG000|Overall Study|Withdrawal by Subject|8|||
23459760|NCT02603146|65427830|FG001|Overall Study|Withdrawal by Subject|10|||
23459761|NCT02603146|65427829|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
23459762|NCT02603146|65427830|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
23459763|NCT02603146|65427829|FG000|Overall Study|Participant moved|2|||
23459764|NCT02603146|65427830|FG001|Overall Study|Participant moved|0|||
23459765|NCT02603146|65427829|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
23459766|NCT02603146|65427830|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
23459767|NCT02374450|65427839|FG000|Overall Study|Protocol Violation|0|||
23459768|NCT02374450|65427840|FG001|Overall Study|Protocol Violation|1|||
23459769|NCT02374450|65427841|FG002|Overall Study|Protocol Violation|0|||
23459770|NCT02374450|65427839|FG000|Overall Study|Withdrawal by Subject|91|||
23459771|NCT02374450|65427840|FG001|Overall Study|Withdrawal by Subject|110|||
23459772|NCT02374450|65427841|FG002|Overall Study|Withdrawal by Subject|4|||
23459773|NCT02374450|65427839|FG000|Overall Study|Lost to Follow-up|168|||
23459774|NCT02374450|65427840|FG001|Overall Study|Lost to Follow-up|194|||
23459775|NCT02374450|65427841|FG002|Overall Study|Lost to Follow-up|138|||
23459776|NCT02374450|65427839|FG000|Overall Study|Death|173|||
23459777|NCT02374450|65427840|FG001|Overall Study|Death|185|||
23459778|NCT02374450|65427841|FG002|Overall Study|Death|81|||
23459779|NCT02374450|65427839|FG000|Overall Study|Migrated from the study area|538|||
23459780|NCT02374450|65427840|FG001|Overall Study|Migrated from the study area|648|||
23459781|NCT02374450|65427841|FG002|Overall Study|Migrated from the study area|181|||
23459782|NCT02374450|65427839|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
23459783|NCT02374450|65427840|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
23459784|NCT02374450|65427841|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
23459785|NCT02374450|65427839|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
23459786|NCT02374450|65427840|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
23459787|NCT02374450|65427841|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
23459788|NCT02374450|65427839|FG000|Overall Study|Other|0|||
23459789|NCT02374450|65427840|FG001|Overall Study|Other|21|||
23459790|NCT02374450|65427841|FG002|Overall Study|Other|79|||
23459791|NCT00536744|65427842|FG000|Overall Study|Adverse Event|13|||
23459792|NCT00536744|65427843|FG001|Overall Study|Adverse Event|10|||
23459793|NCT00536744|65427842|FG000|Overall Study|Death|2|||
23459794|NCT00536744|65427843|FG001|Overall Study|Death|1|||
23459795|NCT00536744|65427842|FG000|Overall Study|Physician Decision|3|||
23459796|NCT00536744|65427843|FG001|Overall Study|Physician Decision|1|||
23459797|NCT00536744|65427842|FG000|Overall Study|Lost to Follow-up|3|||
23459798|NCT00536744|65427843|FG001|Overall Study|Lost to Follow-up|5|||
23459799|NCT00536744|65427842|FG000|Overall Study|Withdrawal by Subject|7|||
23459800|NCT00536744|65427843|FG001|Overall Study|Withdrawal by Subject|8|||
23459801|NCT00536744|65427842|FG000|Overall Study|PI tried alternative treatment|1|||
23459802|NCT00536744|65427843|FG001|Overall Study|PI tried alternative treatment|3|||
23459803|NCT03414983|65427844|FG000|Pre-Treatment|Other reasons|1|||
23459804|NCT03414983|65427845|FG001|Pre-Treatment|Other reasons|0|||
23459805|NCT03414983|65427844|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
23459806|NCT03414983|65427845|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
23459807|NCT03414983|65427844|FG000|Pre-Treatment|Participant withdrew consent|1|||
23459808|NCT03414983|65427845|FG001|Pre-Treatment|Participant withdrew consent|3|||
23459809|NCT03414983|65427844|FG000|Treatment|Participant withdrew consent|4|||
23459810|NCT03414983|65427845|FG001|Treatment|Participant withdrew consent|3|||
23459811|NCT03414983|65427844|FG000|Treatment|Participant request to discontinue study treatment|8|||
23459812|NCT03414983|65427845|FG001|Treatment|Participant request to discontinue study treatment|10|||
23459813|NCT03414983|65427844|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
23459814|NCT03414983|65427845|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
23459815|NCT03414983|65427844|FG000|Treatment|Death|0|||
23459816|NCT03414983|65427845|FG001|Treatment|Death|1|||
23459817|NCT03414983|65427844|FG000|Treatment|Study Drug Toxicity|10|||
23459818|NCT03414983|65427845|FG001|Treatment|Study Drug Toxicity|5|||
23459819|NCT03414983|65427844|FG000|Treatment|Disease Progression|75|||
23459820|NCT03414983|65427845|FG001|Treatment|Disease Progression|29|||
23459821|NCT03414983|65427844|FG000|Treatment|Not reported|1|||
23459822|NCT03414983|65427845|FG001|Treatment|Not reported|0|||
23459823|NCT03414983|65427844|FG000|Treatment|Other reasons|3|||
23459824|NCT03414983|65427845|FG001|Treatment|Other reasons|2|||
23459825|NCT03414983|65427844|FG000|Treatment|Poor/non-compliance|2|||
23459826|NCT03414983|65427845|FG001|Treatment|Poor/non-compliance|0|||
23459827|NCT03414983|65427844|FG000|Treatment|Maximum clinical benefit|5|||
23459828|NCT03414983|65427845|FG001|Treatment|Maximum clinical benefit|9|||
23459829|NCT03414983|65427844|FG000|Treatment|Lost to Follow-up|0|||
23459830|NCT03414983|65427845|FG001|Treatment|Lost to Follow-up|1|||
23459831|NCT03414983|65427844|FG000|Treatment|Administrative reasons by sponsor|1|||
23459832|NCT03414983|65427845|FG001|Treatment|Administrative reasons by sponsor|0|||
23459833|NCT00089297|65427849|FG000|Overall Study|Adverse Event|9|||
23459834|NCT00089297|65427849|FG000|Overall Study|Death|1|||
23459835|NCT00089297|65427849|FG000|Overall Study|Withdrawal by Subject|12|||
23459836|NCT00089297|65427849|FG000|Overall Study|Disease progression|2|||
23459837|NCT00089297|65427849|FG000|Overall Study|Ineligible|11|||
23459838|NCT00089297|65427849|FG000|Overall Study|Secondary malignancy|1|||
23459839|NCT00089297|65427849|FG000|Overall Study|IRB approval not ready|1|||
23459840|NCT00089297|65427849|FG000|Overall Study|Non-compliance|1|||
23459841|NCT02681523|65427853|FG000|Overall Study|Adverse Event|1|||
23459842|NCT02681523|65427853|FG000|Overall Study|Patient Non-compliance|1|||
23459843|NCT02864394|65427854|FG000|Overall Study|Death|184|||
23459844|NCT02864394|65427855|FG001|Overall Study|Death|189|||
23459845|NCT02864394|65427854|FG000|Overall Study|Lost to Follow-up|0|||
23459846|NCT02864394|65427855|FG001|Overall Study|Lost to Follow-up|2|||
23459847|NCT02864394|65427854|FG000|Overall Study|Sponsor Decision|26|||
23459848|NCT02864394|65427855|FG001|Overall Study|Sponsor Decision|11|||
23459849|NCT02864394|65427854|FG000|Overall Study|Withdrawal by Subject|3|||
23459850|NCT02864394|65427855|FG001|Overall Study|Withdrawal by Subject|10|||
23459851|NCT00926237|65427856|FG000|Overall Study|Withdrawal by Subject|2|||
23181281|NCT01763164|64404703|FG000|Follow up Phase|Death|21|||
23181282|NCT01763164|64404704|FG001|Follow up Phase|Death|4|||
23459852|NCT00926237|65427857|FG001|Overall Study|Withdrawal by Subject|1|||
23459853|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
23459854|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
23459855|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
23459856|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
23459857|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
23459858|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
23459859|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
23459860|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23459861|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23459862|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
23459863|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
23459864|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
23459865|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23459866|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23459867|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23584126|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
23181283|NCT01763164|64404703|FG000|Follow up Phase|Subject/guardian decision|9|||
23181284|NCT01763164|64404704|FG001|Follow up Phase|Subject/guardian decision|2|||
23181285|NCT01763164|64404703|FG000|Follow up Phase|Progressive disease|127|||
23181286|NCT01763164|64404704|FG001|Follow up Phase|Progressive disease|62|||
23181287|NCT01763164|64404703|FG000|Follow up Phase|Physician Decision|10|||
23181288|NCT01763164|64404704|FG001|Follow up Phase|Physician Decision|3|||
23181289|NCT01763164|64404703|FG000|Follow up Phase|Lost to Follow-up|1|||
23181290|NCT01763164|64404704|FG001|Follow up Phase|Lost to Follow-up|0|||
23181291|NCT01763164|64404703|FG000|Follow up Phase|Adverse Event|17|||
23181292|NCT01763164|64404704|FG001|Follow up Phase|Adverse Event|1|||
23181293|NCT00461175|64404705|FG000|Overall Study|Protocol Violation|522|||
23181294|NCT00461175|64404706|FG001|Overall Study|Protocol Violation|365|||
23181295|NCT00548548|64404708|FG000|Overall Study|Death|345|||
23181296|NCT00548548|64404709|FG001|Overall Study|Death|348|||
23181297|NCT00548548|64404708|FG000|Overall Study|Lost to Follow-up|17|||
23181298|NCT00548548|64404709|FG001|Overall Study|Lost to Follow-up|18|||
23181299|NCT00833092|64404710|FG000|Overall Study|Withdrawal by Subject|2|||
23181300|NCT00833092|64404711|FG001|Overall Study|Withdrawal by Subject|3|||
23181301|NCT00833092|64404710|FG000|Overall Study|Protocol Violation|2|||
23181302|NCT00833092|64404711|FG001|Overall Study|Protocol Violation|1|||
23181303|NCT00833092|64404710|FG000|Overall Study|Diarrhea|0|||
23181304|NCT00833092|64404711|FG001|Overall Study|Diarrhea|2|||
23181305|NCT00833092|64404710|FG000|Overall Study|constipation|0|||
23181306|NCT00833092|64404711|FG001|Overall Study|constipation|1|||
23181307|NCT03168867|64404712|FG000|Overall Study|Withdrawal by Subject|1|||
23181308|NCT03168867|64404713|FG001|Overall Study|Withdrawal by Subject|5|||
23240655|NCT04144140|64626631|FG002|Overall Study|Other|0|||
23240656|NCT04144140|64626632|FG003|Overall Study|Other|0|||
23240657|NCT04144140|64626633|FG004|Overall Study|Other|0|||
23240658|NCT04144140|64626634|FG005|Overall Study|Other|1|||
23240659|NCT04144140|64626635|FG006|Overall Study|Other|0|||
23240660|NCT04409509|64626636|FG000|Overall Study|Failure to meet randomization requirement|1|||
23240661|NCT04409509|64626637|FG001|Overall Study|Failure to meet randomization requirement|0|||
23240662|NCT04409509|64626636|FG000|Overall Study|Adverse Event|0|||
23459868|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23459869|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
23584127|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
23181309|NCT03160560|64404715|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
23181310|NCT03160560|64404716|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23181311|NCT03160560|64404717|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
23181312|NCT03160560|64404718|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
23181313|NCT03160560|64404715|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
23240663|NCT04409509|64626637|FG001|Overall Study|Adverse Event|1|||
23459870|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
23459871|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23459872|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23459873|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23459874|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
23459875|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
23459876|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
23459877|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
23459878|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
23459879|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
23459880|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
23459881|NCT03175367|65427859|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459882|NCT03175367|65427860|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459883|NCT03175367|65427861|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
23459884|NCT03175367|65427862|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459885|NCT03175367|65427863|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
23459886|NCT03175367|65427864|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459887|NCT03175367|65427865|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23459888|NCT03175367|65427859|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459889|NCT03175367|65427860|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459890|NCT03175367|65427861|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459891|NCT03175367|65427862|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459892|NCT03175367|65427863|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459893|NCT03175367|65427864|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
23459894|NCT03175367|65427865|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
23459895|NCT03175367|65427859|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459896|NCT03175367|65427860|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459897|NCT03175367|65427861|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459898|NCT03175367|65427862|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459899|NCT03175367|65427863|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23459900|NCT03175367|65427864|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
23459901|NCT03175367|65427865|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
23459902|NCT02488915|65427866|FG000|Overall Study|Death|21|||
23181314|NCT03160560|64404716|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23181315|NCT03160560|64404717|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23181316|NCT03160560|64404718|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
23181317|NCT02853760|64404720|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
23181318|NCT02853760|64404721|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
23181319|NCT02853760|64404722|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
23181320|NCT02853760|64404723|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
23181321|NCT02853760|64404724|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
23181322|NCT02853760|64404725|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
23181323|NCT04343651|64404727|FG000|Overall Study|Physician Decision|2|||
23181324|NCT04343651|64404728|FG001|Overall Study|Physician Decision|1|||
23181325|NCT04343651|64404727|FG000|Overall Study|Lost to Follow-up|2|||
23181326|NCT04343651|64404728|FG001|Overall Study|Lost to Follow-up|1|||
23459903|NCT02488915|65427866|FG000|Overall Study|Lost to Follow-up|4|||
23459904|NCT02488915|65427866|FG000|Overall Study|Withdrawal by Subject|1|||
23459905|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
23181327|NCT04343651|64404727|FG000|Overall Study|Protocol Violation|4|||
23181328|NCT04343651|64404728|FG001|Overall Study|Protocol Violation|6|||
23181329|NCT04343651|64404727|FG000|Overall Study|Missing|3|||
23181330|NCT04343651|64404728|FG001|Overall Study|Missing|9|||
23181331|NCT04343651|64404727|FG000|Overall Study|Withdrawal by Subject|0|||
23181332|NCT04343651|64404728|FG001|Overall Study|Withdrawal by Subject|4|||
23181333|NCT04343651|64404727|FG000|Overall Study|Death|0|||
23181334|NCT04343651|64404728|FG001|Overall Study|Death|1|||
23181335|NCT04343651|64404727|FG000|Overall Study|Did not start treatment|1|||
23181336|NCT04343651|64404728|FG001|Overall Study|Did not start treatment|1|||
23181337|NCT04343651|64404727|FG000|Overall Study|Patient did not complete visits 3-6|0|||
23181338|NCT04343651|64404728|FG001|Overall Study|Patient did not complete visits 3-6|1|||
23181339|NCT04325503|64404729|FG000|Overall Study|Withdrawal by Subject|1|||
23181340|NCT04325503|64404729|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
23181341|NCT02118792|64404731|FG000|Overall Study|Withdrawal by Subject|6|||
23181342|NCT02118792|64404732|FG001|Overall Study|Withdrawal by Subject|3|||
23181343|NCT02118792|64404731|FG000|Overall Study|Lost to Follow-up|4|||
23181344|NCT02118792|64404732|FG001|Overall Study|Lost to Follow-up|4|||
23181345|NCT02118792|64404731|FG000|Overall Study|Adverse Event|5|||
23181346|NCT02118792|64404732|FG001|Overall Study|Adverse Event|4|||
23181347|NCT02118792|64404731|FG000|Overall Study|Withdrawal by parent/guardian|14|||
23181348|NCT02118792|64404732|FG001|Overall Study|Withdrawal by parent/guardian|20|||
23459906|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
23459907|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
23459908|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
23181349|NCT02118792|64404731|FG000|Overall Study|Other|1|||
23181350|NCT02118792|64404732|FG001|Overall Study|Other|6|||
23181351|NCT02118792|64404731|FG000|Overall Study|Randomised but not treated|1|||
23181352|NCT02118792|64404732|FG001|Overall Study|Randomised but not treated|0|||
23181353|NCT00103012|64404733|FG000|Overall Study|Withdrawal by Subject|2|||
23181354|NCT00103012|64404734|FG001|Overall Study|Withdrawal by Subject|1|||
23181355|NCT00103012|64404735|FG002|Overall Study|Withdrawal by Subject|2|||
23181356|NCT00103012|64404733|FG000|Overall Study|Pregnancy|1|||
23181357|NCT00103012|64404734|FG001|Overall Study|Pregnancy|0|||
23181358|NCT00103012|64404735|FG002|Overall Study|Pregnancy|0|||
23181359|NCT00103012|64404733|FG000|Overall Study|Adverse Event|0|||
23181360|NCT00103012|64404734|FG001|Overall Study|Adverse Event|0|||
23181361|NCT00103012|64404735|FG002|Overall Study|Adverse Event|1|||
23181362|NCT00103012|64404733|FG000|Overall Study|Subject non-compliant with medications|0|||
23181363|NCT00103012|64404734|FG001|Overall Study|Subject non-compliant with medications|0|||
23181364|NCT00103012|64404735|FG002|Overall Study|Subject non-compliant with medications|1|||
23181365|NCT03192904|64404736|FG000|Overall Study|Physician Decision|3|||
23181366|NCT03192904|64404737|FG001|Overall Study|Physician Decision|1|||
23181367|NCT03192904|64404736|FG000|Overall Study|Lost to Follow-up|0|||
23181368|NCT03192904|64404737|FG001|Overall Study|Lost to Follow-up|1|||
23181369|NCT00365989|64404738|FG000|Overall Study|Withdrawal by Subject|1|||
23181370|NCT00365989|64404738|FG000|Overall Study|Non-compliance|1|||
23181371|NCT02357420|64404739|FG000|Overall Study|Adverse Event|3|||
23181372|NCT02357420|64404740|FG001|Overall Study|Adverse Event|3|||
23181373|NCT02357420|64404741|FG002|Overall Study|Adverse Event|8|||
23181374|NCT02357420|64404742|FG003|Overall Study|Adverse Event|9|||
23181375|NCT02357420|64404739|FG000|Overall Study|Investigator Decision|1|||
23181376|NCT02357420|64404740|FG001|Overall Study|Investigator Decision|0|||
23181377|NCT02357420|64404741|FG002|Overall Study|Investigator Decision|0|||
23181378|NCT02357420|64404742|FG003|Overall Study|Investigator Decision|0|||
23181379|NCT02357420|64404739|FG000|Overall Study|Prohibited Medication|1|||
23181380|NCT02357420|64404740|FG001|Overall Study|Prohibited Medication|1|||
23181381|NCT02357420|64404741|FG002|Overall Study|Prohibited Medication|0|||
23181382|NCT02357420|64404742|FG003|Overall Study|Prohibited Medication|0|||
23181383|NCT02357420|64404739|FG000|Overall Study|Protocol Non-compliance|0|||
23181384|NCT02357420|64404740|FG001|Overall Study|Protocol Non-compliance|0|||
23181385|NCT02357420|64404741|FG002|Overall Study|Protocol Non-compliance|0|||
23459909|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
23181386|NCT02357420|64404742|FG003|Overall Study|Protocol Non-compliance|1|||
23181387|NCT02357420|64404739|FG000|Overall Study|Withdrawn Consent|4|||
23181388|NCT02357420|64404740|FG001|Overall Study|Withdrawn Consent|8|||
23240664|NCT04409509|64626636|FG000|Overall Study|Death|11|||
23347953|NCT03026530|65017942|FG000|Overall Study|Lost to Follow-up|19|||
23181389|NCT02357420|64404741|FG002|Overall Study|Withdrawn Consent|6|||
23181390|NCT02357420|64404742|FG003|Overall Study|Withdrawn Consent|6|||
23584128|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
23181391|NCT02357420|64404739|FG000|Overall Study|Lost to Follow-up|3|||
23181392|NCT02357420|64404740|FG001|Overall Study|Lost to Follow-up|0|||
23181393|NCT02357420|64404741|FG002|Overall Study|Lost to Follow-up|2|||
23181394|NCT02357420|64404742|FG003|Overall Study|Lost to Follow-up|3|||
23181395|NCT02502864|64404743|FG000|Overall Study|Withdrawal by Subject|1|||
23181396|NCT02689492|64404746|FG000|Overall Study|Lost to Follow-up|61|||
23181397|NCT02689492|64404746|FG000|Overall Study|Withdrawal by Subject|11|||
23181398|NCT02689492|64404746|FG000|Overall Study|Death|9|||
23181399|NCT02689492|64404746|FG000|Overall Study|Physician Decision|2|||
23181400|NCT02689492|64404746|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
23181401|NCT02689492|64404746|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
23181402|NCT02689492|64404746|FG000|Overall Study|Other than listed|1|||
23181403|NCT03486392|64404747|FG000|Overall Study|Lost to Follow-up|0|||
23181404|NCT03486392|64404748|FG001|Overall Study|Lost to Follow-up|0|||
23181405|NCT03486392|64404749|FG002|Overall Study|Lost to Follow-up|8|||
23181406|NCT03486392|64404750|FG003|Overall Study|Lost to Follow-up|5|||
23181407|NCT03486392|64404751|FG004|Overall Study|Lost to Follow-up|2|||
23181408|NCT03486392|64404747|FG000|Overall Study|Withdrawal by Subject|3|||
23347954|NCT03026530|65017943|FG001|Overall Study|Lost to Follow-up|24|||
23347955|NCT03026530|65017942|FG000|Overall Study|Protocol Violation|2|||
23347956|NCT03026530|65017943|FG001|Overall Study|Protocol Violation|5|||
23347957|NCT02670382|65017944|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
23584129|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
23584130|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
23584131|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
23584132|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
23584133|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
23584134|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
23584135|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
23584136|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Pain|0|||
23584137|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Pain|0|||
23181409|NCT03486392|64404748|FG001|Overall Study|Withdrawal by Subject|0|||
23181410|NCT03486392|64404749|FG002|Overall Study|Withdrawal by Subject|6|||
23181411|NCT03486392|64404750|FG003|Overall Study|Withdrawal by Subject|4|||
23181412|NCT03486392|64404751|FG004|Overall Study|Withdrawal by Subject|1|||
23181413|NCT03486392|64404747|FG000|Overall Study|Death|0|||
23181414|NCT03486392|64404748|FG001|Overall Study|Death|0|||
23181415|NCT03486392|64404749|FG002|Overall Study|Death|0|||
23347958|NCT02670382|65017945|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
23347959|NCT01876979|65017946|FG000|Overall Study|Physician Decision|2|||
23347960|NCT01876979|65017947|FG001|Overall Study|Physician Decision|3|||
23347961|NCT00894790|65017949|FG000|Overall Study|Protocol Violation|0|||
23347962|NCT00894790|65017950|FG001|Overall Study|Protocol Violation|1|||
23347963|NCT00894790|65017949|FG000|Overall Study|Lost to Follow-up|0|||
23347964|NCT00894790|65017950|FG001|Overall Study|Lost to Follow-up|1|||
23347965|NCT00894790|65017949|FG000|Overall Study|Did not meet entrance criteria|1|||
23347966|NCT00894790|65017950|FG001|Overall Study|Did not meet entrance criteria|0|||
23347967|NCT01741792|65017951|FG000|Overall Study|Death|6|||
23347968|NCT01741792|65017952|FG001|Overall Study|Death|1|||
23347969|NCT01741792|65017953|FG002|Overall Study|Death|12|||
23347970|NCT01959698|65017954|FG000|Overall Study|Adverse Event|0|||
23347971|NCT01959698|65017955|FG001|Overall Study|Adverse Event|0|||
23584138|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Pain|0|||
23584139|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Pain|1|||
23181416|NCT03486392|64404750|FG003|Overall Study|Death|0|||
23181417|NCT03486392|64404751|FG004|Overall Study|Death|1|||
23181418|NCT00929240|64404752|FG000|Initial Treatment Phase|Adverse Event|31|||
23181419|NCT00929240|64404753|FG001|Initial Treatment Phase|Adverse Event|0|||
23181420|NCT00929240|64404754|FG002|Initial Treatment Phase|Adverse Event|0|||
23181421|NCT00929240|64404752|FG000|Initial Treatment Phase|Disease progression|41|||
23181422|NCT00929240|64404753|FG001|Initial Treatment Phase|Disease progression|0|||
23181423|NCT00929240|64404754|FG002|Initial Treatment Phase|Disease progression|0|||
23347972|NCT01959698|65017956|FG002|Overall Study|Adverse Event|0|||
23347973|NCT01959698|65017957|FG003|Overall Study|Adverse Event|0|||
23584140|NCT01107626|65866084|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
23584141|NCT01107626|65866085|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
23181424|NCT00929240|64404752|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
23240665|NCT04409509|64626637|FG001|Overall Study|Death|10|||
23347974|NCT01959698|65017958|FG004|Overall Study|Adverse Event|0|||
23347975|NCT01959698|65017959|FG005|Overall Study|Adverse Event|0|||
23347976|NCT01959698|65017960|FG006|Overall Study|Adverse Event|1|||
23347977|NCT01959698|65017954|FG000|Overall Study|Physician Decision|1|||
23347978|NCT01959698|65017955|FG001|Overall Study|Physician Decision|0|||
23347979|NCT01959698|65017956|FG002|Overall Study|Physician Decision|1|||
23347980|NCT01959698|65017957|FG003|Overall Study|Physician Decision|2|||
23347981|NCT01959698|65017958|FG004|Overall Study|Physician Decision|0|||
23347982|NCT01959698|65017959|FG005|Overall Study|Physician Decision|3|||
23347983|NCT01959698|65017960|FG006|Overall Study|Physician Decision|3|||
23347984|NCT02240069|65017967|FG000|Overall Study|Withdrawal by Subject|5|||
23347985|NCT02240069|65017968|FG001|Overall Study|Withdrawal by Subject|5|||
23347986|NCT02240069|65017969|FG002|Overall Study|Withdrawal by Subject|2|||
23347987|NCT02179749|65017970|FG000|Overall Study|Adverse Event|0|||
23347988|NCT02179749|65017971|FG001|Overall Study|Adverse Event|0|||
23347989|NCT02179749|65017972|FG002|Overall Study|Adverse Event|1|||
23347990|NCT02179749|65017970|FG000|Overall Study|Withdrawal by Subject|0|||
23347991|NCT02179749|65017971|FG001|Overall Study|Withdrawal by Subject|0|||
23347992|NCT02179749|65017972|FG002|Overall Study|Withdrawal by Subject|1|||
23347993|NCT00628095|65017975|FG000|Overall Study|Adverse Event|5|||
23347994|NCT00628095|65017976|FG001|Overall Study|Adverse Event|3|||
23347995|NCT00628095|65017975|FG000|Overall Study|Lack of Efficacy|0|||
23347996|NCT00628095|65017976|FG001|Overall Study|Lack of Efficacy|3|||
23347997|NCT00628095|65017975|FG000|Overall Study|Withdrawal by Subject|2|||
23181425|NCT00929240|64404753|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
23347998|NCT00628095|65017976|FG001|Overall Study|Withdrawal by Subject|0|||
23181426|NCT00929240|64404754|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
23181427|NCT00929240|64404752|FG000|Initial Treatment Phase|Protocol Violation|5|||
23347999|NCT00628095|65017975|FG000|Overall Study|Other|0|||
23348000|NCT00628095|65017976|FG001|Overall Study|Other|1|||
23348001|NCT00329641|65017977|FG000|Overall Study|Did not start treatment|1|||
23348002|NCT00329641|65017977|FG000|Overall Study|Not eligible|1|||
23348003|NCT00329641|65017977|FG000|Overall Study|Adverse Event|3|||
23348004|NCT00329641|65017977|FG000|Overall Study|Other reason, not protocol specified|1|||
23181428|NCT00929240|64404753|FG001|Initial Treatment Phase|Protocol Violation|0|||
23348005|NCT02258542|65017980|FG000|Overall Study|eg. not made to the visit|7|||
23348006|NCT02258542|65017981|FG001|Overall Study|eg. not made to the visit|4|||
23348007|NCT02258542|65017982|FG002|Overall Study|eg. not made to the visit|0|||
23348008|NCT02258542|65017983|FG003|Overall Study|eg. not made to the visit|1|||
23348009|NCT02258542|65017980|FG000|Overall Study|study specific discount. criteria|1|||
23348010|NCT02258542|65017981|FG001|Overall Study|study specific discount. criteria|1|||
23348011|NCT02258542|65017982|FG002|Overall Study|study specific discount. criteria|0|||
23348012|NCT02258542|65017983|FG003|Overall Study|study specific discount. criteria|0|||
23348013|NCT02258542|65017980|FG000|Overall Study|Withdrawal by Subject|20|||
23348014|NCT02258542|65017981|FG001|Overall Study|Withdrawal by Subject|20|||
23348015|NCT02258542|65017982|FG002|Overall Study|Withdrawal by Subject|7|||
23348016|NCT02258542|65017983|FG003|Overall Study|Withdrawal by Subject|1|||
23348017|NCT02258542|65017980|FG000|Overall Study|Lost to Follow-up|5|||
23348018|NCT02258542|65017981|FG001|Overall Study|Lost to Follow-up|12|||
23348019|NCT02258542|65017982|FG002|Overall Study|Lost to Follow-up|1|||
23348020|NCT02258542|65017983|FG003|Overall Study|Lost to Follow-up|2|||
23348021|NCT02258542|65017980|FG000|Overall Study|Death|5|||
23348022|NCT02258542|65017981|FG001|Overall Study|Death|4|||
23348023|NCT02258542|65017982|FG002|Overall Study|Death|0|||
23348024|NCT02258542|65017983|FG003|Overall Study|Death|1|||
23348025|NCT02258542|65017980|FG000|Overall Study|Adverse Event|3|||
23348026|NCT02258542|65017981|FG001|Overall Study|Adverse Event|4|||
23348027|NCT02258542|65017982|FG002|Overall Study|Adverse Event|0|||
23348028|NCT02258542|65017983|FG003|Overall Study|Adverse Event|0|||
23348029|NCT02258542|65017980|FG000|Overall Study|Protocol Violation|1|||
23348030|NCT02258542|65017981|FG001|Overall Study|Protocol Violation|2|||
23348031|NCT02258542|65017982|FG002|Overall Study|Protocol Violation|0|||
23348032|NCT02258542|65017983|FG003|Overall Study|Protocol Violation|0|||
23348033|NCT02258542|65017980|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23348034|NCT02258542|65017981|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
23348035|NCT02258542|65017982|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23348036|NCT02258542|65017983|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
23348037|NCT02258334|65017986|FG000|Overall Study|Adverse Event|1|||
23348038|NCT02258334|65017987|FG001|Overall Study|Adverse Event|0|||
23348039|NCT02258334|65017988|FG002|Overall Study|Adverse Event|0|||
23181429|NCT00929240|64404754|FG002|Initial Treatment Phase|Protocol Violation|0|||
23181430|NCT00929240|64404752|FG000|Initial Treatment Phase|Death|2|||
23181431|NCT00929240|64404753|FG001|Initial Treatment Phase|Death|0|||
23181432|NCT00929240|64404754|FG002|Initial Treatment Phase|Death|0|||
23181433|NCT00929240|64404752|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
23181434|NCT00929240|64404753|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
23181435|NCT00929240|64404754|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
23181436|NCT00929240|64404752|FG000|Initial Treatment Phase|Physician Decision|4|||
23181437|NCT00929240|64404753|FG001|Initial Treatment Phase|Physician Decision|0|||
23181438|NCT00929240|64404754|FG002|Initial Treatment Phase|Physician Decision|0|||
23181439|NCT00929240|64404752|FG000|Maintenance Phase|Disease progression|0|||
23181440|NCT00929240|64404753|FG001|Maintenance Phase|Disease progression|73|||
23240666|NCT04409509|64626636|FG000|Overall Study|Non-compliance with study drug|0|||
23240667|NCT04409509|64626637|FG001|Overall Study|Non-compliance with study drug|1|||
23240668|NCT04409509|64626636|FG000|Overall Study|Lost to Follow-up|0|||
23240669|NCT04409509|64626637|FG001|Overall Study|Lost to Follow-up|3|||
23240670|NCT04409509|64626636|FG000|Overall Study|Withdrawal by Subject|0|||
23240671|NCT04409509|64626637|FG001|Overall Study|Withdrawal by Subject|3|||
23240672|NCT04409509|64626636|FG000|Overall Study|Randomized by mistake|0|||
23348040|NCT02258334|65017989|FG003|Overall Study|Adverse Event|0|||
23348041|NCT00785213|65017993|FG000|Quinine Sulfate Alone|Adverse Event|4|||
23348042|NCT00785213|65017993|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
23348043|NCT02918552|65017994|FG000|Overall Study|Failed Pharmacokinetics|1|||
23348044|NCT02918552|65017995|FG001|Overall Study|Failed Pharmacokinetics|0|||
23348045|NCT02918552|65017994|FG000|Overall Study|Withdrawal by Subject|0|||
23348046|NCT02918552|65017995|FG001|Overall Study|Withdrawal by Subject|1|||
23348047|NCT02918552|65017994|FG000|Overall Study|Lost to Follow-up|0|||
23181441|NCT00929240|64404754|FG002|Maintenance Phase|Disease progression|60|||
23240673|NCT04409509|64626637|FG001|Overall Study|Randomized by mistake|1|||
23348048|NCT02918552|65017995|FG001|Overall Study|Lost to Follow-up|1|||
23348049|NCT02223819|65017996|FG000|Overall Study|Lost to Follow-up|2|||
23348050|NCT02515994|65017997|FG000|Overall Study|Protocol Violation|3|||
23348051|NCT02515994|65017998|FG001|Overall Study|Protocol Violation|5|||
23348052|NCT02515994|65017997|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
23348053|NCT02515994|65017998|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
23348054|NCT02515994|65017997|FG000|Overall Study|Adverse Event|3|||
23348055|NCT02515994|65017998|FG001|Overall Study|Adverse Event|1|||
23181442|NCT00929240|64404752|FG000|Maintenance Phase|Adverse Event|0|||
23348056|NCT02515994|65017997|FG000|Overall Study|Withdrawal by Subject|2|||
23240674|NCT04409509|64626636|FG000|Overall Study|Other|1|||
23348057|NCT02515994|65017998|FG001|Overall Study|Withdrawal by Subject|0|||
23348058|NCT01004406|65017999|FG000|Overall Study|Withdrawal by Subject|2|||
23348059|NCT01004406|65018000|FG001|Overall Study|Withdrawal by Subject|0|||
23348060|NCT01004406|65017999|FG000|Overall Study|Lost to Follow-up|1|||
23348061|NCT01004406|65018000|FG001|Overall Study|Lost to Follow-up|0|||
23348062|NCT03672461|65018001|FG000|Overall Study|COVID Related|4|||
23348063|NCT03672461|65018002|FG001|Overall Study|COVID Related|2|||
23181443|NCT00929240|64404753|FG001|Maintenance Phase|Adverse Event|9|||
23181444|NCT00929240|64404754|FG002|Maintenance Phase|Adverse Event|12|||
23181445|NCT00929240|64404752|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23181446|NCT00929240|64404753|FG001|Maintenance Phase|Withdrawal by Subject|2|||
23181447|NCT00929240|64404754|FG002|Maintenance Phase|Withdrawal by Subject|6|||
23181448|NCT00929240|64404752|FG000|Maintenance Phase|Protocol Violation|0|||
23181449|NCT00929240|64404753|FG001|Maintenance Phase|Protocol Violation|1|||
23181450|NCT00929240|64404754|FG002|Maintenance Phase|Protocol Violation|0|||
23181451|NCT00929240|64404752|FG000|Maintenance Phase|Health authority/Study termination|0|||
23181452|NCT00929240|64404753|FG001|Maintenance Phase|Health authority/Study termination|1|||
23181453|NCT00929240|64404754|FG002|Maintenance Phase|Health authority/Study termination|2|||
23181454|NCT00929240|64404752|FG000|Maintenance Phase|Physician Decision|0|||
23240675|NCT04409509|64626637|FG001|Overall Study|Other|1|||
23240676|NCT02777554|64626646|FG000|Overall Study|Adverse Event|4|||
23240677|NCT02777554|64626647|FG001|Overall Study|Adverse Event|4|||
23240678|NCT02777554|64626648|FG002|Overall Study|Adverse Event|0|||
23240679|NCT02777554|64626649|FG003|Overall Study|Adverse Event|1|||
23240680|NCT02777554|64626650|FG004|Overall Study|Adverse Event|0|||
23240681|NCT02777554|64626651|FG005|Overall Study|Adverse Event|0|||
23240682|NCT02777554|64626646|FG000|Overall Study|Withdrawal by Subject|3|||
23240683|NCT02777554|64626647|FG001|Overall Study|Withdrawal by Subject|1|||
23240684|NCT02777554|64626648|FG002|Overall Study|Withdrawal by Subject|1|||
23240685|NCT02777554|64626649|FG003|Overall Study|Withdrawal by Subject|0|||
23240686|NCT02777554|64626650|FG004|Overall Study|Withdrawal by Subject|0|||
23240687|NCT02777554|64626651|FG005|Overall Study|Withdrawal by Subject|0|||
23240688|NCT02777554|64626646|FG000|Overall Study|Discharged early due to hurricane|22|||
23240689|NCT02777554|64626647|FG001|Overall Study|Discharged early due to hurricane|20|||
23240690|NCT02777554|64626648|FG002|Overall Study|Discharged early due to hurricane|0|||
23240691|NCT02777554|64626649|FG003|Overall Study|Discharged early due to hurricane|0|||
23240692|NCT02777554|64626650|FG004|Overall Study|Discharged early due to hurricane|0|||
23240693|NCT02777554|64626651|FG005|Overall Study|Discharged early due to hurricane|0|||
23240694|NCT02777554|64626646|FG000|Overall Study|Other - Miscellaneous|1|||
23240695|NCT02777554|64626647|FG001|Overall Study|Other - Miscellaneous|0|||
23240696|NCT02777554|64626648|FG002|Overall Study|Other - Miscellaneous|0|||
23240697|NCT02777554|64626649|FG003|Overall Study|Other - Miscellaneous|0|||
23240698|NCT02777554|64626650|FG004|Overall Study|Other - Miscellaneous|0|||
23240699|NCT02777554|64626651|FG005|Overall Study|Other - Miscellaneous|0|||
23240700|NCT01422876|64626653|FG000|Week 24|Lost to Follow-up|1|||
23240701|NCT01422876|64626654|FG001|Week 24|Lost to Follow-up|1|||
23240702|NCT01422876|64626655|FG002|Week 24|Lost to Follow-up|2|||
23240703|NCT01422876|64626656|FG003|Week 24|Lost to Follow-up|4|||
23240704|NCT01422876|64626657|FG004|Week 24|Lost to Follow-up|2|||
23240705|NCT01422876|64626658|FG005|Week 24|Lost to Follow-up|0|||
23240706|NCT01422876|64626659|FG006|Week 24|Lost to Follow-up|1|||
23240707|NCT01422876|64626660|FG007|Week 24|Lost to Follow-up|3|||
23240708|NCT01422876|64626661|FG008|Week 24|Lost to Follow-up|3|||
23240709|NCT01422876|64626662|FG009|Week 24|Lost to Follow-up|4|||
23240710|NCT01422876|64626653|FG000|Week 24|Consent withdrawn|5|||
23240711|NCT01422876|64626654|FG001|Week 24|Consent withdrawn|1|||
23240712|NCT01422876|64626655|FG002|Week 24|Consent withdrawn|3|||
23240713|NCT01422876|64626656|FG003|Week 24|Consent withdrawn|4|||
23240714|NCT01422876|64626657|FG004|Week 24|Consent withdrawn|5|||
23240715|NCT01422876|64626658|FG005|Week 24|Consent withdrawn|6|||
23240716|NCT01422876|64626659|FG006|Week 24|Consent withdrawn|5|||
23240717|NCT01422876|64626660|FG007|Week 24|Consent withdrawn|4|||
23240718|NCT01422876|64626661|FG008|Week 24|Consent withdrawn|3|||
23240719|NCT01422876|64626662|FG009|Week 24|Consent withdrawn|6|||
23240720|NCT01422876|64626653|FG000|Week 24|Death|0|||
23240721|NCT01422876|64626654|FG001|Week 24|Death|1|||
23240722|NCT01422876|64626655|FG002|Week 24|Death|0|||
23240723|NCT01422876|64626656|FG003|Week 24|Death|0|||
23240724|NCT01422876|64626657|FG004|Week 24|Death|0|||
23348064|NCT03672461|65018001|FG000|Overall Study|Adverse Event|2|||
23181455|NCT00929240|64404753|FG001|Maintenance Phase|Physician Decision|2|||
23240725|NCT01422876|64626658|FG005|Week 24|Death|0|||
23240726|NCT01422876|64626659|FG006|Week 24|Death|0|||
23240727|NCT01422876|64626660|FG007|Week 24|Death|0|||
23240728|NCT01422876|64626661|FG008|Week 24|Death|0|||
23240729|NCT01422876|64626662|FG009|Week 24|Death|0|||
23240730|NCT01422876|64626653|FG000|Week 52|Lost to Follow-up|3|||
23240731|NCT01422876|64626654|FG001|Week 52|Lost to Follow-up|5|||
23240732|NCT01422876|64626655|FG002|Week 52|Lost to Follow-up|7|||
23240733|NCT01422876|64626656|FG003|Week 52|Lost to Follow-up|5|||
23240734|NCT01422876|64626657|FG004|Week 52|Lost to Follow-up|8|||
23348065|NCT03672461|65018002|FG001|Overall Study|Adverse Event|0|||
23348066|NCT03672461|65018001|FG000|Overall Study|Serious Adverse Event|0|||
23348067|NCT03672461|65018002|FG001|Overall Study|Serious Adverse Event|1|||
23348068|NCT03672461|65018001|FG000|Overall Study|Too Busy|3|||
23348069|NCT03672461|65018002|FG001|Overall Study|Too Busy|1|||
23348070|NCT03672461|65018001|FG000|Overall Study|Lost to Follow-up|1|||
23348071|NCT03672461|65018002|FG001|Overall Study|Lost to Follow-up|2|||
23348072|NCT03672461|65018001|FG000|Overall Study|Family|2|||
23348073|NCT03672461|65018002|FG001|Overall Study|Family|2|||
23348074|NCT03672461|65018001|FG000|Overall Study|No remote technology access|0|||
23348075|NCT03672461|65018002|FG001|Overall Study|No remote technology access|1|||
23348076|NCT03672461|65018001|FG000|Overall Study|Withdrawal by Subject|1|||
23348077|NCT03672461|65018002|FG001|Overall Study|Withdrawal by Subject|0|||
23348078|NCT03672461|65018001|FG000|Overall Study|Cannot tolerate intervention|1|||
23348079|NCT03672461|65018002|FG001|Overall Study|Cannot tolerate intervention|0|||
23348080|NCT03672461|65018001|FG000|Overall Study|Incomplete outcome data|6|||
23348081|NCT03672461|65018002|FG001|Overall Study|Incomplete outcome data|1|||
23348082|NCT01416155|65018005|FG000|Overall Study|Adverse Event|8|||
23348083|NCT01416155|65018005|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
23348084|NCT01416155|65018005|FG000|Overall Study|Withdrawal by Subject|33|||
23348085|NCT01416155|65018005|FG000|Overall Study|Investigator decision|8|||
23348086|NCT01416155|65018005|FG000|Overall Study|Other|7|||
23348087|NCT03535194|65018006|FG000|Induction Period|Adverse Event|2|||
23348088|NCT03535194|65018007|FG001|Induction Period|Adverse Event|2|||
23348089|NCT03535194|65018008|FG002|Induction Period|Adverse Event|1|||
23348090|NCT03535194|65018009|FG003|Induction Period|Adverse Event|3|||
23348091|NCT03535194|65018010|FG004|Induction Period|Adverse Event|0|||
23348092|NCT03535194|65018006|FG000|Induction Period|Death|0|||
23348093|NCT03535194|65018007|FG001|Induction Period|Death|1|||
23348094|NCT03535194|65018008|FG002|Induction Period|Death|0|||
23348095|NCT03535194|65018009|FG003|Induction Period|Death|0|||
23348096|NCT03535194|65018010|FG004|Induction Period|Death|0|||
23348097|NCT03535194|65018006|FG000|Induction Period|Lack of Efficacy|1|||
23348098|NCT03535194|65018007|FG001|Induction Period|Lack of Efficacy|3|||
23348099|NCT03535194|65018008|FG002|Induction Period|Lack of Efficacy|2|||
23348100|NCT03535194|65018009|FG003|Induction Period|Lack of Efficacy|2|||
23348101|NCT03535194|65018010|FG004|Induction Period|Lack of Efficacy|0|||
23348102|NCT03535194|65018006|FG000|Induction Period|Lost to Follow-up|3|||
23348103|NCT03535194|65018007|FG001|Induction Period|Lost to Follow-up|5|||
23348104|NCT03535194|65018008|FG002|Induction Period|Lost to Follow-up|2|||
23348105|NCT03535194|65018009|FG003|Induction Period|Lost to Follow-up|3|||
23348106|NCT03535194|65018010|FG004|Induction Period|Lost to Follow-up|0|||
23348107|NCT03535194|65018006|FG000|Induction Period|Physician Decision|1|||
23348108|NCT03535194|65018007|FG001|Induction Period|Physician Decision|1|||
23348109|NCT03535194|65018008|FG002|Induction Period|Physician Decision|0|||
23348110|NCT03535194|65018009|FG003|Induction Period|Physician Decision|0|||
23348111|NCT03535194|65018010|FG004|Induction Period|Physician Decision|0|||
23348112|NCT03535194|65018006|FG000|Induction Period|Protocol Violation|1|||
23348113|NCT03535194|65018007|FG001|Induction Period|Protocol Violation|0|||
23348114|NCT03535194|65018008|FG002|Induction Period|Protocol Violation|0|||
23348115|NCT03535194|65018009|FG003|Induction Period|Protocol Violation|1|||
23348116|NCT03535194|65018010|FG004|Induction Period|Protocol Violation|0|||
23348117|NCT03535194|65018006|FG000|Induction Period|Screen Failure|0|||
23348118|NCT03535194|65018007|FG001|Induction Period|Screen Failure|1|||
23348119|NCT03535194|65018008|FG002|Induction Period|Screen Failure|0|||
23584142|NCT01107626|65866086|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
23348120|NCT03535194|65018009|FG003|Induction Period|Screen Failure|0|||
23348121|NCT03535194|65018010|FG004|Induction Period|Screen Failure|0|||
23348122|NCT03535194|65018006|FG000|Induction Period|Withdrawal by Subject|3|||
23348123|NCT03535194|65018007|FG001|Induction Period|Withdrawal by Subject|4|||
23348124|NCT03535194|65018008|FG002|Induction Period|Withdrawal by Subject|3|||
23348125|NCT03535194|65018009|FG003|Induction Period|Withdrawal by Subject|2|||
23348126|NCT03535194|65018010|FG004|Induction Period|Withdrawal by Subject|0|||
23348127|NCT03535194|65018006|FG000|Maintenance Period|Adverse Event|6|||
23584143|NCT01107626|65866087|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
23584144|NCT05567159|65866088|FG000|Overall Study|Adverse Event|4|||
23348128|NCT03535194|65018007|FG001|Maintenance Period|Adverse Event|5|||
23348129|NCT03535194|65018008|FG002|Maintenance Period|Adverse Event|1|||
23348130|NCT03535194|65018009|FG003|Maintenance Period|Adverse Event|11|||
23348131|NCT03535194|65018010|FG004|Maintenance Period|Adverse Event|4|||
23348132|NCT03535194|65018006|FG000|Maintenance Period|Lack of Efficacy|3|||
23348133|NCT03535194|65018007|FG001|Maintenance Period|Lack of Efficacy|2|||
23348134|NCT03535194|65018008|FG002|Maintenance Period|Lack of Efficacy|5|||
23348135|NCT03535194|65018009|FG003|Maintenance Period|Lack of Efficacy|9|||
23348136|NCT03535194|65018010|FG004|Maintenance Period|Lack of Efficacy|0|||
23181456|NCT00929240|64404754|FG002|Maintenance Phase|Physician Decision|1|||
23181457|NCT00929240|64404752|FG000|Maintenance Phase|Change of treatment|0|||
23181458|NCT00929240|64404753|FG001|Maintenance Phase|Change of treatment|4|||
23181459|NCT00929240|64404754|FG002|Maintenance Phase|Change of treatment|0|||
23181460|NCT00929240|64404752|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
23181461|NCT00929240|64404753|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
23181462|NCT00929240|64404754|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
23181463|NCT00929240|64404752|FG000|Maintenance Phase|Participant not treated|0|||
23181464|NCT00929240|64404753|FG001|Maintenance Phase|Participant not treated|2|||
23181465|NCT00929240|64404754|FG002|Maintenance Phase|Participant not treated|0|||
23181466|NCT01285349|64404755|FG000|Overall Study|Lost to Follow-up|27|||
23181467|NCT01285349|64404756|FG001|Overall Study|Lost to Follow-up|20|||
23240735|NCT01422876|64626658|FG005|Week 52|Lost to Follow-up|5|||
23240736|NCT01422876|64626659|FG006|Week 52|Lost to Follow-up|5|||
23240737|NCT01422876|64626660|FG007|Week 52|Lost to Follow-up|8|||
23240738|NCT01422876|64626661|FG008|Week 52|Lost to Follow-up|7|||
23240739|NCT01422876|64626662|FG009|Week 52|Lost to Follow-up|8|||
23240740|NCT01422876|64626653|FG000|Week 52|Consent withdrawn|9|||
23240741|NCT01422876|64626654|FG001|Week 52|Consent withdrawn|4|||
23240742|NCT01422876|64626655|FG002|Week 52|Consent withdrawn|6|||
23348137|NCT03535194|65018006|FG000|Maintenance Period|Lost to Follow-up|4|||
23348138|NCT03535194|65018007|FG001|Maintenance Period|Lost to Follow-up|2|||
23348139|NCT03535194|65018008|FG002|Maintenance Period|Lost to Follow-up|1|||
23348140|NCT03535194|65018009|FG003|Maintenance Period|Lost to Follow-up|5|||
23348141|NCT03535194|65018010|FG004|Maintenance Period|Lost to Follow-up|2|||
23348142|NCT03535194|65018006|FG000|Maintenance Period|Other|1|||
23348143|NCT03535194|65018007|FG001|Maintenance Period|Other|2|||
23348144|NCT03535194|65018008|FG002|Maintenance Period|Other|0|||
23348145|NCT03535194|65018009|FG003|Maintenance Period|Other|0|||
23348146|NCT03535194|65018010|FG004|Maintenance Period|Other|0|||
23348147|NCT03535194|65018006|FG000|Maintenance Period|Physician Decision|1|||
23348148|NCT03535194|65018007|FG001|Maintenance Period|Physician Decision|2|||
23348149|NCT03535194|65018008|FG002|Maintenance Period|Physician Decision|0|||
23348150|NCT03535194|65018009|FG003|Maintenance Period|Physician Decision|2|||
23348151|NCT03535194|65018010|FG004|Maintenance Period|Physician Decision|0|||
23348152|NCT03535194|65018006|FG000|Maintenance Period|Pregnancy|0|||
23348153|NCT03535194|65018007|FG001|Maintenance Period|Pregnancy|0|||
23348154|NCT03535194|65018008|FG002|Maintenance Period|Pregnancy|0|||
23348155|NCT03535194|65018009|FG003|Maintenance Period|Pregnancy|2|||
23348156|NCT03535194|65018010|FG004|Maintenance Period|Pregnancy|0|||
23348157|NCT03535194|65018006|FG000|Maintenance Period|Protocol Violation|0|||
23348158|NCT03535194|65018007|FG001|Maintenance Period|Protocol Violation|1|||
23181468|NCT01285349|64404757|FG002|Overall Study|Lost to Follow-up|27|||
23181469|NCT00680836|64404762|FG000|Overall Study|Withdrawal by Subject|3|||
23181470|NCT00680836|64404763|FG001|Overall Study|Withdrawal by Subject|0|||
23181471|NCT00680836|64404762|FG000|Overall Study|Lost to Follow-up|3|||
23181472|NCT00680836|64404763|FG001|Overall Study|Lost to Follow-up|1|||
23181473|NCT00680836|64404762|FG000|Overall Study|Physician Decision|2|||
23181474|NCT00680836|64404763|FG001|Overall Study|Physician Decision|1|||
23181475|NCT02116621|64404764|FG000|Baseline|Withdrawal by Subject|0|||
23181476|NCT02116621|64404765|FG001|Baseline|Withdrawal by Subject|4|||
23181477|NCT02116621|64404764|FG000|Three Month Follow-up|Death|1|||
23181478|NCT02116621|64404765|FG001|Three Month Follow-up|Death|1|||
23181479|NCT02116621|64404764|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
23181480|NCT02116621|64404765|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
23181481|NCT02116621|64404764|FG000|Three Month Follow-up|Lost to Follow-up|0|||
23240743|NCT01422876|64626656|FG003|Week 52|Consent withdrawn|12|||
23240744|NCT01422876|64626657|FG004|Week 52|Consent withdrawn|7|||
23348159|NCT03535194|65018008|FG002|Maintenance Period|Protocol Violation|0|||
23348160|NCT03535194|65018009|FG003|Maintenance Period|Protocol Violation|0|||
23181482|NCT02116621|64404765|FG001|Three Month Follow-up|Lost to Follow-up|1|||
23181483|NCT02116621|64404764|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
23181484|NCT02116621|64404765|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
23181485|NCT02116621|64404764|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
23181486|NCT02116621|64404765|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
23240745|NCT01422876|64626658|FG005|Week 52|Consent withdrawn|12|||
23240746|NCT01422876|64626659|FG006|Week 52|Consent withdrawn|10|||
23348161|NCT03535194|65018010|FG004|Maintenance Period|Protocol Violation|0|||
23348162|NCT03535194|65018006|FG000|Maintenance Period|Withdrawal by Subject|7|||
23348163|NCT03535194|65018007|FG001|Maintenance Period|Withdrawal by Subject|2|||
23240747|NCT01422876|64626660|FG007|Week 52|Consent withdrawn|12|||
23181487|NCT02116621|64404764|FG000|Six Month Follow-up|Lost to Follow-up|2|||
23181488|NCT02116621|64404765|FG001|Six Month Follow-up|Lost to Follow-up|1|||
23181489|NCT02116621|64404764|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
23181490|NCT02116621|64404765|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
23181491|NCT02116621|64404764|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
23181492|NCT02116621|64404765|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
23181493|NCT02116621|64404764|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
23181494|NCT02116621|64404765|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
23181495|NCT02116621|64404764|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
23181496|NCT02116621|64404765|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
23181497|NCT02116621|64404764|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
23181498|NCT02116621|64404765|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
23181499|NCT00600171|64404766|FG000|Overall Study|Adverse Event|0|||
23181500|NCT00600171|64404767|FG001|Overall Study|Adverse Event|1|||
23181501|NCT00600171|64404768|FG002|Overall Study|Adverse Event|0|||
23181502|NCT00600171|64404769|FG003|Overall Study|Adverse Event|0|||
23181503|NCT00600171|64404770|FG004|Overall Study|Adverse Event|1|||
23181504|NCT00600171|64404771|FG005|Overall Study|Adverse Event|0|||
23181505|NCT00600171|64404766|FG000|Overall Study|Lack of Efficacy|9|||
23459910|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
23459911|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
23459912|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
23459913|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
23459914|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
23459915|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
23459916|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
23459917|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
23459918|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
23459919|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
23459920|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Other|1|||
23459921|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Other|5|||
23459922|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Other|0|||
23459923|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Other|2|||
23459924|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Other|3|||
23459925|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
23459926|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
23459927|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
23459928|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
23459929|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
23459930|NCT02006472|65427868|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
23459931|NCT02006472|65427869|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
23459932|NCT02006472|65427870|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
23459933|NCT02006472|65427871|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
23459934|NCT02006472|65427872|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
23459935|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
23459936|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
23459937|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
23459938|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
23584145|NCT05567159|65866088|FG000|Overall Study|Physician Decision|3|||
23584146|NCT05567159|65866088|FG000|Overall Study|Protocol deviation|1|||
23584147|NCT03425539|65866089|FG000|Overall Study|Randomized but not treated|0|||
23584148|NCT03425539|65866090|FG001|Overall Study|Randomized but not treated|1|||
23584149|NCT03425539|65866089|FG000|Overall Study|Adverse Event|2|||
23584150|NCT03425539|65866090|FG001|Overall Study|Adverse Event|2|||
23584151|NCT03425539|65866089|FG000|Overall Study|Withdrawal by Subject|3|||
23584152|NCT03425539|65866090|FG001|Overall Study|Withdrawal by Subject|0|||
23584153|NCT03425539|65866089|FG000|Overall Study|Lost to Follow-up|0|||
23584154|NCT03425539|65866090|FG001|Overall Study|Lost to Follow-up|1|||
23584155|NCT05526911|65866091|FG000|Overall Study|Adverse Event|2|||
23584156|NCT03368001|65866092|FG000|Allocation|Lost to Pretest|16|||
23181506|NCT00600171|64404767|FG001|Overall Study|Lack of Efficacy|12|||
23181507|NCT00600171|64404768|FG002|Overall Study|Lack of Efficacy|3|||
23181508|NCT00600171|64404769|FG003|Overall Study|Lack of Efficacy|5|||
23181509|NCT00600171|64404770|FG004|Overall Study|Lack of Efficacy|4|||
23459939|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
23459940|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
23459941|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
23459942|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
23459943|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
23459944|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
23584157|NCT03368001|65866093|FG001|Allocation|Lost to Pretest|25|||
23584158|NCT03368001|65866092|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
23584159|NCT03368001|65866093|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
23181510|NCT00600171|64404771|FG005|Overall Study|Lack of Efficacy|0|||
23459945|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
23459946|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
23459947|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
23459948|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
23459949|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
23459950|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Other|0|||
23459951|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Other|1|||
23459952|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Other|0|||
23459953|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Other|1|||
23459954|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Other|0|||
23459955|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Not treated|0|||
23459956|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Not treated|0|||
23459957|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Not treated|2|||
23459958|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Not treated|0|||
23459959|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Not treated|0|||
23459960|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
23459961|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
23459962|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
23459963|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
23459964|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
23459965|NCT02006472|65427868|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
23459966|NCT02006472|65427869|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
23459967|NCT02006472|65427870|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
23459968|NCT02006472|65427871|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
23459969|NCT02006472|65427872|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
23459970|NCT03467750|65427877|FG000|Overall Study|Surgery canceled|1|||
23459971|NCT03467750|65427878|FG001|Overall Study|Surgery canceled|0|||
23459972|NCT03467750|65427877|FG000|Overall Study|Protocol Violation|1|||
23459973|NCT03467750|65427878|FG001|Overall Study|Protocol Violation|1|||
23459974|NCT03467750|65427877|FG000|Overall Study|Withdrawal by Subject|0|||
23459975|NCT03467750|65427878|FG001|Overall Study|Withdrawal by Subject|1|||
23459976|NCT03094416|65427879|FG000|Run-in|Screening failure|8|||
23459977|NCT03094416|65427879|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
23459978|NCT03094416|65427879|FG000|Run-in|Withdrawal by Subject|3|||
23459979|NCT03094416|65427879|FG000|Treatment Period|Withdrawal by Subject|2|||
23459980|NCT02514083|65427881|FG000|Overall Study|Adverse Event|1|||
23459981|NCT03011099|65427884|FG000|Overall Study|Withdrawal by Subject|0|||
23459982|NCT03011099|65427885|FG001|Overall Study|Withdrawal by Subject|2|||
23459983|NCT01709721|65427901|FG000|Open Label Phase|Withdrawal by Subject|0|||
23459984|NCT01709721|65427902|FG001|Open Label Phase|Withdrawal by Subject|0|||
23459985|NCT01709721|65427903|FG002|Open Label Phase|Withdrawal by Subject|5|||
23459986|NCT01709721|65427901|FG000|Open Label Phase|Adverse Event|0|||
23459987|NCT01709721|65427902|FG001|Open Label Phase|Adverse Event|0|||
23459988|NCT01709721|65427903|FG002|Open Label Phase|Adverse Event|8|||
23459989|NCT01709721|65427901|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
23459990|NCT01709721|65427902|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
23459991|NCT01709721|65427903|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
23459992|NCT01709721|65427901|FG000|Open Label Phase|Investigator Decision|0|||
23459993|NCT01709721|65427902|FG001|Open Label Phase|Investigator Decision|0|||
23459994|NCT01709721|65427903|FG002|Open Label Phase|Investigator Decision|1|||
23459995|NCT01709721|65427901|FG000|Open Label Phase|Sponsor Decision|0|||
23459996|NCT01709721|65427902|FG001|Open Label Phase|Sponsor Decision|0|||
23459997|NCT01709721|65427903|FG002|Open Label Phase|Sponsor Decision|2|||
23459998|NCT01709721|65427901|FG000|Open Label Phase|Protocol Violation|0|||
23459999|NCT01709721|65427902|FG001|Open Label Phase|Protocol Violation|0|||
23460000|NCT01709721|65427903|FG002|Open Label Phase|Protocol Violation|1|||
23460001|NCT01709721|65427901|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
23460002|NCT01709721|65427902|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
23460003|NCT01709721|65427903|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
23460004|NCT01709721|65427901|FG000|Open Label Phase|Inadequate Pain Control|0|||
23460005|NCT01709721|65427902|FG001|Open Label Phase|Inadequate Pain Control|0|||
23460006|NCT01709721|65427903|FG002|Open Label Phase|Inadequate Pain Control|37|||
23460007|NCT01709721|65427901|FG000|Open Label Phase|Other, Specify in text field in database|0|||
23460008|NCT01709721|65427902|FG001|Open Label Phase|Other, Specify in text field in database|0|||
23460009|NCT01709721|65427903|FG002|Open Label Phase|Other, Specify in text field in database|14|||
23460010|NCT01709721|65427901|FG000|Randomized Phase|Adverse Event|0|||
23460011|NCT01709721|65427902|FG001|Randomized Phase|Adverse Event|1|||
23181511|NCT00600171|64404766|FG000|Overall Study|Protocol Violation|1|||
23460012|NCT01709721|65427903|FG002|Randomized Phase|Adverse Event|0|||
23460013|NCT01709721|65427901|FG000|Randomized Phase|Lost to Follow-up|1|||
23460014|NCT01709721|65427902|FG001|Randomized Phase|Lost to Follow-up|0|||
23460015|NCT01709721|65427903|FG002|Randomized Phase|Lost to Follow-up|0|||
23460016|NCT01709721|65427901|FG000|Randomized Phase|Inadequate Pain Control|1|||
23460017|NCT01709721|65427902|FG001|Randomized Phase|Inadequate Pain Control|2|||
23348164|NCT03535194|65018008|FG002|Maintenance Period|Withdrawal by Subject|1|||
23348165|NCT03535194|65018009|FG003|Maintenance Period|Withdrawal by Subject|8|||
23348166|NCT03535194|65018010|FG004|Maintenance Period|Withdrawal by Subject|0|||
23348167|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Adverse Event|4|||
23348168|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Adverse Event|5|||
23348169|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Adverse Event|1|||
23348170|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Adverse Event|8|||
23348171|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Adverse Event|0|||
23348172|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
23460018|NCT01709721|65427903|FG002|Randomized Phase|Inadequate Pain Control|0|||
23460019|NCT01709721|65427901|FG000|Randomized Phase|Other, Specify text field in database|1|||
23460020|NCT01709721|65427902|FG001|Randomized Phase|Other, Specify text field in database|3|||
23460021|NCT01709721|65427903|FG002|Randomized Phase|Other, Specify text field in database|0|||
23460022|NCT01099267|65427905|FG000|MDS-003 Study|Adverse Event|37|||
23460023|NCT01099267|65427905|FG000|MDS-003 Study|Lack of Efficacy|52|||
23460024|NCT01099267|65427905|FG000|MDS-003 Study|Withdrawal by Subject|8|||
23460025|NCT01099267|65427905|FG000|MDS-003 Study|Lost to Follow-up|1|||
23460026|NCT01099267|65427905|FG000|MDS-003 Study|Death|11|||
23460027|NCT01099267|65427905|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
23460028|NCT01099267|65427905|FG000|MDS-003 Study|Disease Progression|7|||
23460029|NCT01099267|65427905|FG000|MDS-003 Study|Investigator Decision|2|||
23460030|NCT01099267|65427905|FG000|MDS-003 Study|Non-Compliance|2|||
23460031|NCT01099267|65427905|FG000|MDS-003 Study|Loss of Response|1|||
23460032|NCT01099267|65427905|FG000|MDS-003 Study|Secondary Malign Disease|1|||
23460033|NCT04730804|65427911|FG000|Overall Study|Physician Decision|0|||
23460034|NCT04730804|65427912|FG001|Overall Study|Physician Decision|0|||
23460035|NCT04730804|65427913|FG002|Overall Study|Physician Decision|0|||
23460036|NCT04730804|65427914|FG003|Overall Study|Physician Decision|0|||
23460037|NCT04730804|65427915|FG004|Overall Study|Physician Decision|0|||
23460038|NCT04730804|65427916|FG005|Overall Study|Physician Decision|1|||
23460039|NCT04730804|65427911|FG000|Overall Study|Withdrawal by Subject|0|||
23460040|NCT04730804|65427912|FG001|Overall Study|Withdrawal by Subject|0|||
23460041|NCT04730804|65427913|FG002|Overall Study|Withdrawal by Subject|0|||
23460042|NCT04730804|65427914|FG003|Overall Study|Withdrawal by Subject|0|||
23460043|NCT04730804|65427915|FG004|Overall Study|Withdrawal by Subject|1|||
23460044|NCT04730804|65427916|FG005|Overall Study|Withdrawal by Subject|2|||
23460045|NCT00905164|65427917|FG000|Period 1|Protocol Violation|0|||
23460046|NCT00905164|65427918|FG001|Period 1|Protocol Violation|1|||
23460047|NCT03198715|65427919|FG000|Overall Study|Death|0|||
23460048|NCT03198715|65427920|FG001|Overall Study|Death|0|||
23460049|NCT03198715|65427921|FG002|Overall Study|Death|1|||
23460050|NCT03198715|65427922|FG003|Overall Study|Death|0|||
23460051|NCT03198715|65427923|FG004|Overall Study|Death|2|||
23460052|NCT03198715|65427919|FG000|Overall Study|Other|0|||
23460053|NCT03198715|65427920|FG001|Overall Study|Other|1|||
23460054|NCT03198715|65427921|FG002|Overall Study|Other|1|||
23460055|NCT03198715|65427922|FG003|Overall Study|Other|0|||
23460056|NCT03198715|65427923|FG004|Overall Study|Other|0|||
23460057|NCT01615939|65427924|FG000|Overall Study|Lost to Follow-up|5|||
23460058|NCT01615939|65427925|FG001|Overall Study|Lost to Follow-up|0|||
23460059|NCT01614249|65427926|FG000|Overall Study|Lost to Follow-up|11|||
23460060|NCT01614249|65427927|FG001|Overall Study|Lost to Follow-up|23|||
23460061|NCT03361137|65427932|FG000|Overall Study|Reason not specified|1|||
23460062|NCT03361137|65427933|FG001|Overall Study|Reason not specified|0|||
23460063|NCT03361137|65427934|FG002|Overall Study|Reason not specified|0|||
23460064|NCT03361137|65427935|FG003|Overall Study|Reason not specified|0|||
23460065|NCT03361137|65427936|FG004|Overall Study|Reason not specified|0|||
23460066|NCT00307801|65427937|FG000|Overall Study|Adverse Event|12|||
23460067|NCT00307801|65427938|FG001|Overall Study|Adverse Event|4|||
23460068|NCT00307801|65427937|FG000|Overall Study|Withdrawal by Subject|9|||
23460069|NCT00307801|65427938|FG001|Overall Study|Withdrawal by Subject|4|||
23460070|NCT00307801|65427937|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
23460071|NCT00307801|65427938|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
23460072|NCT00307801|65427937|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
23348173|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
23460073|NCT00307801|65427938|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
23460074|NCT00307801|65427937|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
23460075|NCT00307801|65427938|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
23460076|NCT00307801|65427937|FG000|Overall Study|Wrong Randomization|1|||
23460077|NCT00307801|65427938|FG001|Overall Study|Wrong Randomization|0|||
23460078|NCT00307801|65427937|FG000|Overall Study|Lack of Efficacy|0|||
23460079|NCT00307801|65427938|FG001|Overall Study|Lack of Efficacy|2|||
23460080|NCT00307801|65427937|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
23460081|NCT00307801|65427938|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
23460082|NCT00307801|65427937|FG000|Overall Study|Frustration with e-diary|1|||
23460083|NCT00307801|65427938|FG001|Overall Study|Frustration with e-diary|0|||
23240748|NCT01422876|64626661|FG008|Week 52|Consent withdrawn|13|||
23348174|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
23348175|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
23348176|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
23348177|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
23348178|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
23348179|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
23348180|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
23240749|NCT01422876|64626662|FG009|Week 52|Consent withdrawn|9|||
23240750|NCT01422876|64626653|FG000|Week 52|Death|0|||
23240751|NCT01422876|64626654|FG001|Week 52|Death|1|||
23240752|NCT01422876|64626655|FG002|Week 52|Death|0|||
23240753|NCT01422876|64626656|FG003|Week 52|Death|1|||
23240754|NCT01422876|64626657|FG004|Week 52|Death|0|||
23240755|NCT01422876|64626658|FG005|Week 52|Death|0|||
23240756|NCT01422876|64626659|FG006|Week 52|Death|1|||
23240757|NCT01422876|64626660|FG007|Week 52|Death|3|||
23240758|NCT01422876|64626661|FG008|Week 52|Death|1|||
23240759|NCT01422876|64626662|FG009|Week 52|Death|0|||
23240760|NCT05102162|64626663|FG000|Overall Study|Withdrawal by Subject|3|||
23240761|NCT05102162|64626664|FG001|Overall Study|Withdrawal by Subject|0|||
23240762|NCT05102162|64626663|FG000|Overall Study|Baseline cultures negative|4|||
23240763|NCT05102162|64626664|FG001|Overall Study|Baseline cultures negative|2|||
23240764|NCT05102162|64626663|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
23240765|NCT05102162|64626664|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
23240766|NCT05102162|64626663|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
23240767|NCT05102162|64626664|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
23240768|NCT00501969|64626666|FG000|Overall Study|Major Protocol Violation|4|||
23240769|NCT00501969|64626666|FG000|Overall Study|Lack of Efficacy|29|||
23240770|NCT00501969|64626666|FG000|Overall Study|Adverse Event|76|||
23240771|NCT00501969|64626666|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
23240772|NCT00501969|64626666|FG000|Overall Study|Subject withdrew consent|51|||
23240773|NCT00501969|64626666|FG000|Overall Study|Lost to Follow-up|4|||
23240774|NCT00501969|64626666|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
23240775|NCT00501969|64626666|FG000|Overall Study|Other: Sponsors Request|10|||
23240776|NCT00501969|64626666|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
23240777|NCT00501969|64626666|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
23240778|NCT00501969|64626666|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
23240779|NCT00501969|64626666|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
23240780|NCT00501969|64626666|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
23240781|NCT00501969|64626666|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
23240782|NCT00501969|64626666|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
23240783|NCT00501969|64626666|FG000|Overall Study|Other: As Required by Local EC|2|||
23240784|NCT00501969|64626666|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
23240785|NCT00501969|64626666|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
23240786|NCT03480243|64626667|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
23240787|NCT03480243|64626667|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
23240788|NCT00627094|64626668|FG000|Overall Study|Adverse Event|8|||
23240789|NCT00627094|64626669|FG001|Overall Study|Adverse Event|7|||
23240790|NCT00627094|64626668|FG000|Overall Study|Lost to Follow-up|1|||
23240791|NCT00627094|64626669|FG001|Overall Study|Lost to Follow-up|0|||
23240792|NCT00627094|64626668|FG000|Overall Study|Withdrawal by Subject|1|||
23240793|NCT00627094|64626669|FG001|Overall Study|Withdrawal by Subject|1|||
23240794|NCT00627094|64626668|FG000|Overall Study|ulcer healed|1|||
23240795|NCT00627094|64626669|FG001|Overall Study|ulcer healed|7|||
23240796|NCT00627094|64626668|FG000|Overall Study|Other reason|1|||
23240797|NCT00627094|64626669|FG001|Overall Study|Other reason|0|||
23240798|NCT01519635|64626670|FG000|Overall Study|Withdrawal by Subject|0|||
23240799|NCT01519635|64626671|FG001|Overall Study|Withdrawal by Subject|1|||
23240800|NCT01519635|64626670|FG000|Overall Study|No possibility to put a catheter|1|||
23240801|NCT01519635|64626671|FG001|Overall Study|No possibility to put a catheter|2|||
23240802|NCT02764229|64626672|FG000|Overall Study|Withdrawal by Subject|15|||
23240803|NCT02764229|64626672|FG000|Overall Study|Adverse Event|9|||
23240804|NCT02764229|64626672|FG000|Overall Study|Physician Decision|5|||
23240805|NCT02764229|64626672|FG000|Overall Study|Lost to Follow-up|3|||
23240806|NCT02764229|64626672|FG000|Overall Study|Lack of Efficacy|1|||
23240807|NCT02764229|64626672|FG000|Overall Study|Study Stopped by Sponsor|69|||
23240808|NCT00381680|64626673|FG000|Overall Study|Adverse Event|9|||
23240809|NCT00381680|64626674|FG001|Overall Study|Adverse Event|3|||
23240810|NCT00381680|64626673|FG000|Overall Study|Death|10|||
23240811|NCT00381680|64626674|FG001|Overall Study|Death|7|||
23240812|NCT00381680|64626673|FG000|Overall Study|Lost to Follow-up|3|||
23240813|NCT00381680|64626674|FG001|Overall Study|Lost to Follow-up|2|||
23240814|NCT00381680|64626673|FG000|Overall Study|Physician Decision|25|||
23240815|NCT00381680|64626674|FG001|Overall Study|Physician Decision|6|||
23348181|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
23460084|NCT00307801|65427937|FG000|Overall Study|Protocol Violation|3|||
23460085|NCT00307801|65427938|FG001|Overall Study|Protocol Violation|2|||
23460086|NCT00307801|65427937|FG000|Overall Study|No reason specified|2|||
23460087|NCT00307801|65427938|FG001|Overall Study|No reason specified|0|||
23460088|NCT00307801|65427937|FG000|Overall Study|Pregnancy|0|||
23460089|NCT00307801|65427938|FG001|Overall Study|Pregnancy|1|||
23460090|NCT02017405|65427940|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460091|NCT02017405|65427941|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460092|NCT02017405|65427942|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460093|NCT02017405|65427943|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460094|NCT02017405|65427944|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
23460095|NCT02017405|65427945|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
23460096|NCT02017405|65427940|FG000|Open-label Phase|Adverse Event|1|||
23460097|NCT02017405|65427941|FG001|Open-label Phase|Adverse Event|1|||
23460098|NCT02017405|65427942|FG002|Open-label Phase|Adverse Event|0|||
23460099|NCT02017405|65427943|FG003|Open-label Phase|Adverse Event|0|||
23460100|NCT02017405|65427944|FG004|Open-label Phase|Adverse Event|0|||
23460101|NCT02017405|65427945|FG005|Open-label Phase|Adverse Event|0|||
23460102|NCT04106557|65427946|FG000|Overall Study|Physician Decision|0|||
23460103|NCT04106557|65427947|FG001|Overall Study|Physician Decision|1|||
23460104|NCT04106557|65427948|FG002|Overall Study|Physician Decision|0|||
23460105|NCT04106557|65427946|FG000|Overall Study|Protocol Violation|0|||
23460106|NCT04106557|65427947|FG001|Overall Study|Protocol Violation|1|||
23460107|NCT04106557|65427948|FG002|Overall Study|Protocol Violation|0|||
23460108|NCT03448406|65427949|FG000|Overall Study|Noncompliance of scheduled visits|1|||
23460109|NCT03448406|65427950|FG001|Overall Study|Noncompliance of scheduled visits|2|||
23460110|NCT03448406|65427949|FG000|Overall Study|Withdrawal by Subject|1|||
23460111|NCT03448406|65427950|FG001|Overall Study|Withdrawal by Subject|2|||
23460112|NCT03448406|65427949|FG000|Overall Study|Protocol Violation|1|||
23460113|NCT03448406|65427950|FG001|Overall Study|Protocol Violation|0|||
23460114|NCT03448406|65427949|FG000|Overall Study|Adverse Event|8|||
23460115|NCT03448406|65427950|FG001|Overall Study|Adverse Event|9|||
23460116|NCT02151058|65427955|FG000|Overall Study|Withdrawal by Subject|1|||
23460117|NCT02151058|65427956|FG001|Overall Study|Withdrawal by Subject|1|||
23460118|NCT02151058|65427957|FG002|Overall Study|Withdrawal by Subject|3|||
23460119|NCT02151058|65427955|FG000|Overall Study|Lost to Follow-up|1|||
23460120|NCT02151058|65427956|FG001|Overall Study|Lost to Follow-up|0|||
23460121|NCT02151058|65427957|FG002|Overall Study|Lost to Follow-up|2|||
23460122|NCT01419236|65427959|FG000|Overall Study|Adverse Event|1|||
23460123|NCT01419236|65427960|FG001|Overall Study|Adverse Event|0|||
23460124|NCT01419236|65427959|FG000|Overall Study|Lack of Efficacy|0|||
23460125|NCT01419236|65427960|FG001|Overall Study|Lack of Efficacy|1|||
23460126|NCT01419236|65427959|FG000|Overall Study|Lost to Follow-up|1|||
23460127|NCT01419236|65427960|FG001|Overall Study|Lost to Follow-up|0|||
23460128|NCT01419236|65427959|FG000|Overall Study|Physician Decision|1|||
23460129|NCT01419236|65427960|FG001|Overall Study|Physician Decision|0|||
23460130|NCT01419236|65427959|FG000|Overall Study|Withdrawal by Subject|1|||
23460131|NCT01419236|65427960|FG001|Overall Study|Withdrawal by Subject|4|||
23460132|NCT01419236|65427959|FG000|Overall Study|Entry Criteria Not Met|1|||
23460133|NCT01419236|65427960|FG001|Overall Study|Entry Criteria Not Met|0|||
23460134|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
23460135|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
23460136|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
23460137|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
23460138|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
23460139|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
23460140|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
23460141|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
23460142|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
23460143|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
23584160|NCT03368001|65866092|FG000|Posttest|Lost to Posttest|7|||
23584161|NCT03368001|65866093|FG001|Posttest|Lost to Posttest|11|||
23584162|NCT03368001|65866092|FG000|Posttest|Discontinued Intervention|6|||
23181512|NCT00600171|64404767|FG001|Overall Study|Protocol Violation|2|||
23584163|NCT03368001|65866093|FG001|Posttest|Discontinued Intervention|19|||
23584164|NCT03368001|65866092|FG000|Follow-up|Lost to Follow-up|6|||
23584165|NCT03368001|65866093|FG001|Follow-up|Lost to Follow-up|3|||
23584166|NCT04888585|65866094|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
23584167|NCT04888585|65866095|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
23584168|NCT04888585|65866096|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
23181513|NCT00600171|64404768|FG002|Overall Study|Protocol Violation|0|||
23181514|NCT00600171|64404769|FG003|Overall Study|Protocol Violation|1|||
23181515|NCT00600171|64404770|FG004|Overall Study|Protocol Violation|0|||
23181516|NCT00600171|64404771|FG005|Overall Study|Protocol Violation|0|||
23181517|NCT00600171|64404766|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
23181518|NCT00600171|64404767|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23181519|NCT00600171|64404768|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
23181520|NCT00600171|64404769|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
23181521|NCT00600171|64404770|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
23181522|NCT00600171|64404771|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
23181523|NCT00600171|64404766|FG000|Overall Study|Withdrawal by Subject|3|||
23181524|NCT00600171|64404767|FG001|Overall Study|Withdrawal by Subject|0|||
23181525|NCT00600171|64404768|FG002|Overall Study|Withdrawal by Subject|0|||
23181526|NCT00600171|64404769|FG003|Overall Study|Withdrawal by Subject|1|||
23181527|NCT00600171|64404770|FG004|Overall Study|Withdrawal by Subject|1|||
23181528|NCT00600171|64404771|FG005|Overall Study|Withdrawal by Subject|1|||
23181529|NCT00600171|64404766|FG000|Overall Study|Physician Decision|0|||
23181530|NCT00600171|64404767|FG001|Overall Study|Physician Decision|1|||
23181531|NCT00600171|64404768|FG002|Overall Study|Physician Decision|0|||
23181532|NCT00600171|64404769|FG003|Overall Study|Physician Decision|1|||
23181533|NCT00600171|64404770|FG004|Overall Study|Physician Decision|0|||
23181534|NCT00600171|64404771|FG005|Overall Study|Physician Decision|2|||
23181535|NCT00600171|64404766|FG000|Overall Study|Lost to Follow-up|0|||
23181536|NCT00600171|64404767|FG001|Overall Study|Lost to Follow-up|0|||
23181537|NCT00600171|64404768|FG002|Overall Study|Lost to Follow-up|0|||
23181538|NCT00600171|64404769|FG003|Overall Study|Lost to Follow-up|1|||
23181539|NCT00600171|64404770|FG004|Overall Study|Lost to Follow-up|0|||
23181540|NCT00600171|64404771|FG005|Overall Study|Lost to Follow-up|0|||
23181541|NCT00669617|64404773|FG000|Period 1|Withdrawal by Subject|0|||
23181542|NCT00669617|64404774|FG001|Period 1|Withdrawal by Subject|0|||
23181543|NCT00669617|64404775|FG002|Period 1|Withdrawal by Subject|1|||
23181544|NCT00669617|64404776|FG003|Period 1|Withdrawal by Subject|0|||
23181545|NCT00669617|64404777|FG004|Period 1|Withdrawal by Subject|0|||
23181546|NCT00669617|64404773|FG000|Period 1|Protocol Deviation|0|||
23181547|NCT00669617|64404774|FG001|Period 1|Protocol Deviation|0|||
23181548|NCT00669617|64404775|FG002|Period 1|Protocol Deviation|0|||
23181549|NCT00669617|64404776|FG003|Period 1|Protocol Deviation|0|||
23181550|NCT00669617|64404777|FG004|Period 1|Protocol Deviation|1|||
23181551|NCT00669617|64404773|FG000|Period 3|Lost to Follow-up|1|||
23181552|NCT00669617|64404774|FG001|Period 3|Lost to Follow-up|0|||
23181553|NCT00669617|64404775|FG002|Period 3|Lost to Follow-up|0|||
23181554|NCT00669617|64404776|FG003|Period 3|Lost to Follow-up|0|||
23181555|NCT00669617|64404777|FG004|Period 3|Lost to Follow-up|0|||
23181556|NCT00424398|64404778|FG000|Overall Study|Withdrawal by Subject|2|||
23181557|NCT00424398|64404779|FG001|Overall Study|Withdrawal by Subject|1|||
23181558|NCT00424398|64404780|FG002|Overall Study|Withdrawal by Subject|0|||
23181559|NCT00424398|64404778|FG000|Overall Study|Subject met exclusion criteria|1|||
23181560|NCT00424398|64404779|FG001|Overall Study|Subject met exclusion criteria|0|||
23181561|NCT00424398|64404780|FG002|Overall Study|Subject met exclusion criteria|0|||
23181562|NCT00158184|64404781|FG000|Overall Study|personal issues|3|||
23181563|NCT00158184|64404782|FG001|Overall Study|personal issues|1|||
23584169|NCT04888585|65866097|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
23584170|NCT04888585|65866098|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
23181564|NCT00158184|64404781|FG000|Overall Study|failed for follow unit/study rules|2|||
23181565|NCT00158184|64404782|FG001|Overall Study|failed for follow unit/study rules|0|||
23181566|NCT00158184|64404781|FG000|Overall Study|Adverse Event|1|||
23181567|NCT00158184|64404782|FG001|Overall Study|Adverse Event|1|||
23181568|NCT03182738|64404783|FG000|Overall Study|Lost to Follow-up|9|||
23181569|NCT03182738|64404784|FG001|Overall Study|Lost to Follow-up|3|||
23181570|NCT03182738|64404783|FG000|Overall Study|Pregnancy|0|||
23181571|NCT03182738|64404784|FG001|Overall Study|Pregnancy|1|||
23181572|NCT03182738|64404783|FG000|Overall Study|Withdrawal by Subject|0|||
23181573|NCT03182738|64404784|FG001|Overall Study|Withdrawal by Subject|1|||
23181574|NCT02661594|64404785|FG000|Overall Study|Protocol Violation|1|||
23181575|NCT02661594|64404786|FG001|Overall Study|Protocol Violation|0|||
23181576|NCT02661594|64404787|FG002|Overall Study|Protocol Violation|1|||
23181577|NCT02661594|64404788|FG003|Overall Study|Protocol Violation|0|||
23181578|NCT02197377|64404789|FG000|Overall Study|Insertion Failure|0|||
23181579|NCT02197377|64404790|FG001|Overall Study|Insertion Failure|3|||
23181580|NCT00723957|64404793|FG000|Overall Study|Adverse event unrelated to study drug|1|||
23181581|NCT00723957|64404794|FG001|Overall Study|Adverse event unrelated to study drug|4|||
23181582|NCT00723957|64404793|FG000|Overall Study|Death|3|||
23181583|NCT00723957|64404794|FG001|Overall Study|Death|4|||
23181584|NCT00723957|64404793|FG000|Overall Study|Disease progression|27|||
23181585|NCT00723957|64404794|FG001|Overall Study|Disease progression|25|||
23240816|NCT00381680|64626673|FG000|Overall Study|Withdrawal by Subject|3|||
23240817|NCT00381680|64626674|FG001|Overall Study|Withdrawal by Subject|1|||
23240818|NCT00381680|64626673|FG000|Overall Study|Entry onto another COG Trial|1|||
23240819|NCT00381680|64626674|FG001|Overall Study|Entry onto another COG Trial|2|||
23240820|NCT00381680|64626673|FG000|Overall Study|Alternative Therapy|11|||
23240821|NCT00381680|64626674|FG001|Overall Study|Alternative Therapy|5|||
23240822|NCT00381680|64626673|FG000|Overall Study|Secondary Malignancy|3|||
23240823|NCT00381680|64626674|FG001|Overall Study|Secondary Malignancy|0|||
23240824|NCT00381680|64626673|FG000|Overall Study|Delay initiation|1|||
23240825|NCT00381680|64626674|FG001|Overall Study|Delay initiation|0|||
23240826|NCT00381680|64626673|FG000|Overall Study|Stem Cell Transplant|26|||
23240827|NCT00381680|64626674|FG001|Overall Study|Stem Cell Transplant|10|||
23240828|NCT00381680|64626673|FG000|Overall Study|Relapse|18|||
23240829|NCT00381680|64626674|FG001|Overall Study|Relapse|9|||
23240830|NCT00381680|64626673|FG000|Overall Study|Induction Failure|4|||
23348182|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Other|1|||
23348183|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Other|0|||
23348184|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Other|0|||
23348185|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Other|5|||
23348186|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Other|0|||
23348187|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Physician Decision|0|||
23348188|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Physician Decision|2|||
23181586|NCT00723957|64404793|FG000|Overall Study|Maximum clinical benefit|4|||
23181587|NCT00723957|64404794|FG001|Overall Study|Maximum clinical benefit|5|||
23181588|NCT00723957|64404793|FG000|Overall Study|Investigator decision|1|||
23181589|NCT00723957|64404794|FG001|Overall Study|Investigator decision|1|||
23240831|NCT00381680|64626674|FG001|Overall Study|Induction Failure|1|||
23240832|NCT00381680|64626673|FG000|Overall Study|Progression|1|||
23240833|NCT00381680|64626674|FG001|Overall Study|Progression|1|||
23240834|NCT00381680|64626673|FG000|Overall Study|Other not otherwise specified|7|||
23240835|NCT00381680|64626674|FG001|Overall Study|Other not otherwise specified|2|||
23240836|NCT00381680|64626673|FG000|Overall Study|Ineligible|3|||
23240837|NCT00381680|64626674|FG001|Overall Study|Ineligible|1|||
23240838|NCT03778021|64626675|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
23240839|NCT03778021|64626676|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
23240840|NCT04120116|64626677|FG000|Overall Study|Lost to Follow-up|0|||
23240841|NCT04120116|64626678|FG001|Overall Study|Lost to Follow-up|1|||
23240842|NCT04120116|64626679|FG002|Overall Study|Lost to Follow-up|0|||
23240843|NCT04120116|64626680|FG003|Overall Study|Lost to Follow-up|2|||
23240844|NCT04120116|64626677|FG000|Overall Study|Withdrawal by Subject|1|||
23240845|NCT04120116|64626678|FG001|Overall Study|Withdrawal by Subject|0|||
23240846|NCT04120116|64626679|FG002|Overall Study|Withdrawal by Subject|1|||
23240847|NCT04120116|64626680|FG003|Overall Study|Withdrawal by Subject|1|||
23181590|NCT00723957|64404793|FG000|Overall Study|Study drug toxicity|4|||
23181591|NCT00723957|64404794|FG001|Overall Study|Study drug toxicity|6|||
23181592|NCT00723957|64404793|FG000|Overall Study|Withdrawal by Subject|7|||
23181593|NCT00723957|64404794|FG001|Overall Study|Withdrawal by Subject|5|||
23181594|NCT00723957|64404793|FG000|Overall Study|Reason not analyzed|1|||
23181595|NCT00723957|64404794|FG001|Overall Study|Reason not analyzed|0|||
23240848|NCT04120116|64626677|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
23240849|NCT04120116|64626678|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
23240850|NCT04120116|64626679|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
23240851|NCT04120116|64626680|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
23240852|NCT03732534|64626681|FG000|Overall Study|Study terminated by Sponsor|6|||
23240853|NCT00234533|64626688|FG000|Overall Study|Withdrawal by Subject|6|||
23240854|NCT00234533|64626688|FG000|Overall Study|Adverse Event|2|||
23240855|NCT00234533|64626688|FG000|Overall Study|Enrolled but not treated|3|||
23240856|NCT00824993|64626689|FG000|Overall Study|Withdrawal by Subject|1|||
23240857|NCT00824993|64626690|FG001|Overall Study|Withdrawal by Subject|1|||
23240858|NCT00824993|64626689|FG000|Overall Study|Malignancy Relapse|9|||
23240859|NCT00824993|64626690|FG001|Overall Study|Malignancy Relapse|10|||
23240860|NCT00824993|64626689|FG000|Overall Study|Rapid Bone Loss|0|||
23240861|NCT00824993|64626690|FG001|Overall Study|Rapid Bone Loss|1|||
23240862|NCT00824993|64626689|FG000|Overall Study|Non-Compliant|2|||
23240863|NCT00824993|64626690|FG001|Overall Study|Non-Compliant|1|||
23240864|NCT00824993|64626689|FG000|Overall Study|Insurance Issue|2|||
23240865|NCT00824993|64626690|FG001|Overall Study|Insurance Issue|1|||
23240866|NCT00824993|64626689|FG000|Overall Study|Death|0|||
23240867|NCT00824993|64626690|FG001|Overall Study|Death|3|||
23240868|NCT00700115|64626693|FG000|Overall Study|Withdrawal by Subject|1|||
23240869|NCT00700115|64626694|FG001|Overall Study|Withdrawal by Subject|0|||
23348189|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Physician Decision|1|||
23348190|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Physician Decision|1|||
23181596|NCT00723957|64404793|FG000|Overall Study|Never received treatment|3|||
23181597|NCT00723957|64404794|FG001|Overall Study|Never received treatment|3|||
23181598|NCT03772327|64404797|FG000|Overall Study|Lost to Follow-up|3|||
23181599|NCT03772327|64404798|FG001|Overall Study|Lost to Follow-up|4|||
23181600|NCT03772327|64404797|FG000|Overall Study|Withdrawal by Subject|2|||
23181601|NCT03772327|64404798|FG001|Overall Study|Withdrawal by Subject|3|||
23348191|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Physician Decision|0|||
23348192|NCT03535194|65018006|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
23348193|NCT03535194|65018007|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
23348194|NCT03535194|65018008|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
23348195|NCT03535194|65018009|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
23348196|NCT03535194|65018010|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
23348197|NCT02603562|65018013|FG000|Overall Study|Lost to Follow-up|1|||
23348198|NCT00803205|65018018|FG000|Overall Study|Adverse Event|7|||
23348199|NCT00803205|65018019|FG001|Overall Study|Adverse Event|2|||
23460144|NCT01668784|65427963|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
23460145|NCT01668784|65427964|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
23584171|NCT04888585|65866099|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584172|NCT04888585|65866100|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584173|NCT04888585|65866101|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584174|NCT04888585|65866102|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584175|NCT04888585|65866103|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23584176|NCT04888585|65866104|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
23240870|NCT00700115|64626693|FG000|Overall Study|Lost to Follow-up|0|||
23460146|NCT01668784|65427963|FG000|Treatment Period|Disease Progression|316|||
23181602|NCT00868790|64404799|FG000|Period 1|Adverse Event|1|||
23181603|NCT00868790|64404800|FG001|Period 1|Adverse Event|0|||
23240871|NCT00700115|64626694|FG001|Overall Study|Lost to Follow-up|1|||
23181604|NCT00868790|64404801|FG002|Period 1|Adverse Event|0|||
23240872|NCT02180659|64626697|FG000|Overall Study|Adverse Event|1|||
23240873|NCT02180659|64626698|FG001|Overall Study|Adverse Event|0|||
23240874|NCT02180659|64626697|FG000|Overall Study|Lost to Follow-up|4|||
23240875|NCT02180659|64626698|FG001|Overall Study|Lost to Follow-up|2|||
23348200|NCT00803205|65018018|FG000|Overall Study|Lost to Follow-up|1|||
23348201|NCT00803205|65018019|FG001|Overall Study|Lost to Follow-up|0|||
23348202|NCT00803205|65018018|FG000|Overall Study|Withdrawal by Subject|9|||
23348203|NCT00803205|65018019|FG001|Overall Study|Withdrawal by Subject|9|||
23348204|NCT00803205|65018018|FG000|Overall Study|Physician Decision|1|||
23348205|NCT00803205|65018019|FG001|Overall Study|Physician Decision|0|||
23348206|NCT00803205|65018018|FG000|Overall Study|Protocol Violation|1|||
23348207|NCT00803205|65018019|FG001|Overall Study|Protocol Violation|1|||
23348208|NCT00803205|65018018|FG000|Overall Study|Medical Monitor Decision|1|||
23348209|NCT00803205|65018019|FG001|Overall Study|Medical Monitor Decision|0|||
23348210|NCT00803205|65018018|FG000|Overall Study|Acquired a Lung Infection|0|||
23348211|NCT00803205|65018019|FG001|Overall Study|Acquired a Lung Infection|1|||
23348212|NCT00803205|65018018|FG000|Overall Study|Sponsor Decision|0|||
23348213|NCT00803205|65018019|FG001|Overall Study|Sponsor Decision|1|||
23348214|NCT02073565|65018022|FG000|Cohort A|Withdrawal by Subject|1|||
23348215|NCT02073565|65018023|FG001|Cohort A|Withdrawal by Subject|0|||
23348216|NCT02073565|65018022|FG000|Cohort B|Withdrawal by Subject|1|||
23240876|NCT02180659|64626697|FG000|Overall Study|Subject incarcerated during conduct|1|||
23348217|NCT02073565|65018023|FG001|Cohort B|Withdrawal by Subject|2|||
23348218|NCT02073565|65018022|FG000|Cohort C|Withdrawal by Subject|0|||
23348219|NCT02073565|65018023|FG001|Cohort C|Withdrawal by Subject|2|||
23348220|NCT02073565|65018022|FG000|Cohort C|Lost to Follow-up|0|||
23348221|NCT02073565|65018023|FG001|Cohort C|Lost to Follow-up|2|||
23348222|NCT00394433|65018024|FG000|Overall Study|Adverse Event|2|||
23348223|NCT00394433|65018024|FG000|Overall Study|Alternative Therapy|1|||
23348224|NCT02134353|65018025|FG000|Overall Study|Adverse Event|10|||
23181605|NCT00868790|64404802|FG003|Period 1|Adverse Event|0|||
23181606|NCT00868790|64404803|FG004|Period 1|Adverse Event|0|||
23181607|NCT00868790|64404804|FG005|Period 1|Adverse Event|0|||
23181608|NCT00868790|64404805|FG006|Period 1|Adverse Event|0|||
23584177|NCT04888585|65866094|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584178|NCT04888585|65866095|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
23584179|NCT04888585|65866096|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
23584180|NCT04888585|65866097|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
23584181|NCT04888585|65866098|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
23584182|NCT04888585|65866099|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584183|NCT04888585|65866100|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584184|NCT04888585|65866101|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584185|NCT04888585|65866102|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584186|NCT04888585|65866103|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23181609|NCT00868790|64404806|FG007|Period 1|Adverse Event|3|||
23584187|NCT04888585|65866104|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
23584188|NCT04888585|65866094|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584189|NCT04888585|65866095|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584190|NCT04888585|65866096|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
23584191|NCT04888585|65866097|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584192|NCT04888585|65866098|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
23584193|NCT04888585|65866099|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584194|NCT04888585|65866100|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584195|NCT04888585|65866101|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23348225|NCT02134353|65018026|FG001|Overall Study|Adverse Event|6|||
23181610|NCT00868790|64404807|FG008|Period 1|Adverse Event|1|||
23181611|NCT00868790|64404808|FG009|Period 1|Adverse Event|0|||
23181612|NCT00868790|64404809|FG010|Period 1|Adverse Event|0|||
23181613|NCT00868790|64404810|FG011|Period 1|Adverse Event|0|||
23348226|NCT02134353|65018025|FG000|Overall Study|Lost to Follow-up|1|||
23584196|NCT04888585|65866102|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23348227|NCT02134353|65018026|FG001|Overall Study|Lost to Follow-up|1|||
23181614|NCT00868790|64404811|FG012|Period 1|Adverse Event|0|||
23181615|NCT00868790|64404812|FG013|Period 1|Adverse Event|1|||
23181616|NCT00868790|64404799|FG000|Period 1|Protocol Violation|1|||
23181617|NCT00868790|64404800|FG001|Period 1|Protocol Violation|0|||
23181618|NCT00868790|64404801|FG002|Period 1|Protocol Violation|0|||
23181619|NCT00868790|64404802|FG003|Period 1|Protocol Violation|0|||
23181620|NCT00868790|64404803|FG004|Period 1|Protocol Violation|0|||
23181621|NCT00868790|64404804|FG005|Period 1|Protocol Violation|0|||
23181622|NCT00868790|64404805|FG006|Period 1|Protocol Violation|0|||
23181623|NCT00868790|64404806|FG007|Period 1|Protocol Violation|0|||
23181624|NCT00868790|64404807|FG008|Period 1|Protocol Violation|0|||
23181625|NCT00868790|64404808|FG009|Period 1|Protocol Violation|0|||
23181626|NCT00868790|64404809|FG010|Period 1|Protocol Violation|0|||
23181627|NCT00868790|64404810|FG011|Period 1|Protocol Violation|0|||
23181628|NCT00868790|64404811|FG012|Period 1|Protocol Violation|0|||
23181629|NCT00868790|64404812|FG013|Period 1|Protocol Violation|0|||
23181630|NCT00868790|64404799|FG000|Period 1|Withdrawal by Subject|0|||
23181631|NCT00868790|64404800|FG001|Period 1|Withdrawal by Subject|1|||
23181632|NCT00868790|64404801|FG002|Period 1|Withdrawal by Subject|0|||
23240877|NCT02180659|64626698|FG001|Overall Study|Subject incarcerated during conduct|0|||
23240878|NCT02180659|64626697|FG000|Overall Study|Withdrawal by Subject|0|||
23348228|NCT02134353|65018025|FG000|Overall Study|Lack of Efficacy|2|||
23348229|NCT02134353|65018026|FG001|Overall Study|Lack of Efficacy|1|||
23348230|NCT02134353|65018025|FG000|Overall Study|Withdrawal by Subject|12|||
23348231|NCT02134353|65018026|FG001|Overall Study|Withdrawal by Subject|13|||
23348232|NCT02134353|65018025|FG000|Overall Study|Death|0|||
23348233|NCT02134353|65018026|FG001|Overall Study|Death|1|||
23348234|NCT02134353|65018025|FG000|Overall Study|Pregnancy|0|||
23348235|NCT02134353|65018026|FG001|Overall Study|Pregnancy|1|||
23348236|NCT02134353|65018025|FG000|Overall Study|Relocation|1|||
23240879|NCT02180659|64626698|FG001|Overall Study|Withdrawal by Subject|2|||
23240880|NCT02180659|64626697|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
23240881|NCT02180659|64626698|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
23240882|NCT01479777|64626706|FG000|Overall Study|Physician Decision|2|||
23240883|NCT02842736|64626711|FG000|Overall Study|Lost to Follow-up|13|||
23240884|NCT02842736|64626711|FG000|Overall Study|Intervention for menstrual bleeding|17|||
23240885|NCT02842736|64626711|FG000|Overall Study|Withdrawal by Subject|4|||
23240886|NCT02842736|64626711|FG000|Overall Study|Pregnancy|3|||
23240887|NCT02842736|64626711|FG000|Overall Study|Hysterectomy for fibroids|2|||
23240888|NCT02842736|64626711|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
23240889|NCT02842736|64626711|FG000|Overall Study|IUD: Mirena|1|||
23240890|NCT01593761|64626712|FG000|Overall Study|Lost to Follow-up|1|||
23240891|NCT01593761|64626712|FG000|Overall Study|culture negative for MRSA at baseline|5|||
23240892|NCT01593761|64626712|FG000|Overall Study|positive for hepatitis C virus|1|||
23240893|NCT01593761|64626712|FG000|Overall Study|secondary cellulitis|1|||
23240894|NCT00314262|64626713|FG000|Overall Study|Adverse Event|2|||
23240895|NCT00314262|64626713|FG000|Overall Study|Withdrawal by Subject|2|||
23240896|NCT00314262|64626713|FG000|Overall Study|Physician Decision|1|||
23240897|NCT00924820|64626715|FG000|Overall Study|Death|2|||
23240898|NCT00924820|64626715|FG000|Overall Study|Ineligible, Screen Failure|5|||
23240899|NCT04753606|64626716|FG000|Overall Study|Adverse Event|1|||
23240900|NCT04753606|64626717|FG001|Overall Study|Adverse Event|0|||
23240901|NCT04753606|64626718|FG002|Overall Study|Adverse Event|0|||
23240902|NCT01484691|64626721|FG000|Overall Study|Withdrawal by Subject|1|||
23240903|NCT01484691|64626722|FG001|Overall Study|Withdrawal by Subject|1|||
23240904|NCT01484691|64626723|FG002|Overall Study|Withdrawal by Subject|1|||
23240905|NCT01484691|64626721|FG000|Overall Study|Physician Decision|0|||
23240906|NCT01484691|64626722|FG001|Overall Study|Physician Decision|2|||
23240907|NCT01484691|64626723|FG002|Overall Study|Physician Decision|1|||
23240908|NCT02146365|64626729|FG000|Overall Study|Lost to Follow-up|2|||
23240909|NCT02146365|64626730|FG001|Overall Study|Lost to Follow-up|1|||
23240910|NCT02146365|64626731|FG002|Overall Study|Lost to Follow-up|3|||
23240911|NCT02146365|64626732|FG003|Overall Study|Lost to Follow-up|3|||
23240912|NCT02146365|64626733|FG004|Overall Study|Lost to Follow-up|1|||
23348237|NCT02134353|65018026|FG001|Overall Study|Relocation|0|||
23181633|NCT00868790|64404802|FG003|Period 1|Withdrawal by Subject|0|||
23240913|NCT02146365|64626734|FG005|Overall Study|Lost to Follow-up|1|||
23240914|NCT02146365|64626735|FG006|Overall Study|Lost to Follow-up|0|||
23348238|NCT02134353|65018025|FG000|Overall Study|Other - Patient's Choice|0|||
23348239|NCT02134353|65018026|FG001|Overall Study|Other - Patient's Choice|1|||
23181634|NCT00868790|64404803|FG004|Period 1|Withdrawal by Subject|0|||
23181635|NCT00868790|64404804|FG005|Period 1|Withdrawal by Subject|0|||
23181636|NCT00868790|64404805|FG006|Period 1|Withdrawal by Subject|0|||
23181637|NCT00868790|64404806|FG007|Period 1|Withdrawal by Subject|0|||
23181638|NCT00868790|64404807|FG008|Period 1|Withdrawal by Subject|0|||
23181639|NCT00868790|64404808|FG009|Period 1|Withdrawal by Subject|0|||
23240915|NCT02146365|64626736|FG007|Overall Study|Lost to Follow-up|1|||
23348240|NCT02124759|65018027|FG000|Overall Study|Withdrawal by Subject|3|||
23348241|NCT02124759|65018028|FG001|Overall Study|Withdrawal by Subject|1|||
23348242|NCT02124759|65018029|FG002|Overall Study|Withdrawal by Subject|1|||
23348243|NCT02124759|65018027|FG000|Overall Study|Screen Fail|2|||
23348244|NCT02124759|65018028|FG001|Overall Study|Screen Fail|2|||
23348245|NCT02124759|65018029|FG002|Overall Study|Screen Fail|3|||
23348246|NCT01440569|65018030|FG000|Main Study|Enrolled but not treated|1|||
23348247|NCT01440569|65018031|FG001|Main Study|Enrolled but not treated|0|||
23348248|NCT01440569|65018030|FG000|Main Study|Adverse Event|9|||
23348249|NCT01440569|65018031|FG001|Main Study|Adverse Event|0|||
23348250|NCT01440569|65018030|FG000|Main Study|Pregnancy|1|||
23348251|NCT01440569|65018031|FG001|Main Study|Pregnancy|0|||
23348252|NCT01440569|65018030|FG000|Main Study|Investigator's Discretion|1|||
23348253|NCT01440569|65018031|FG001|Main Study|Investigator's Discretion|1|||
23348254|NCT01440569|65018030|FG000|Main Study|Withdrew Consent|7|||
23348255|NCT01440569|65018031|FG001|Main Study|Withdrew Consent|1|||
23348256|NCT01440569|65018030|FG000|Main Study|Lost to Follow-up|13|||
23348257|NCT01440569|65018031|FG001|Main Study|Lost to Follow-up|2|||
23348258|NCT01440569|65018030|FG000|Main Study|Subject Non-Compliance|3|||
23348259|NCT01440569|65018031|FG001|Main Study|Subject Non-Compliance|0|||
23348260|NCT01440569|65018030|FG000|Main Study|Protocol Violation|1|||
23348261|NCT01440569|65018031|FG001|Main Study|Protocol Violation|0|||
23348262|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Adverse Event|3|||
23348263|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Adverse Event|0|||
23348264|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Pregnancy|1|||
23348265|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Pregnancy|0|||
23348266|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
23348267|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
23348268|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
23348269|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
23348270|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
23348271|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
23348272|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
23348273|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
23348274|NCT01440569|65018030|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
23348275|NCT01440569|65018031|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
23348276|NCT01717391|65018032|FG000|Overall Study|Withdrawal by Subject|5|||
23348277|NCT01717391|65018032|FG000|Overall Study|Physician Decision|1|||
23348278|NCT01717391|65018032|FG000|Overall Study|FLT technical failure|3|||
23348279|NCT01606748|65018037|FG000|Overall Study|Adverse Event|1|||
23348280|NCT01606748|65018038|FG001|Overall Study|Adverse Event|0|||
23348281|NCT01606748|65018037|FG000|Overall Study|Progressive Disease|1|||
23348282|NCT01606748|65018038|FG001|Overall Study|Progressive Disease|0|||
23460147|NCT01668784|65427964|FG001|Treatment Period|Disease Progression|293|||
23181640|NCT00868790|64404809|FG010|Period 1|Withdrawal by Subject|0|||
23181641|NCT00868790|64404810|FG011|Period 1|Withdrawal by Subject|0|||
23181642|NCT00868790|64404811|FG012|Period 1|Withdrawal by Subject|0|||
23181643|NCT00868790|64404812|FG013|Period 1|Withdrawal by Subject|1|||
23181644|NCT00868790|64404799|FG000|Period 1|Abnormal Triglycerides|0|||
23181645|NCT00868790|64404800|FG001|Period 1|Abnormal Triglycerides|0|||
23181646|NCT00868790|64404801|FG002|Period 1|Abnormal Triglycerides|0|||
23181647|NCT00868790|64404802|FG003|Period 1|Abnormal Triglycerides|0|||
23240916|NCT02146365|64626729|FG000|Overall Study|Withdrawal by Subject|1|||
23240917|NCT02146365|64626730|FG001|Overall Study|Withdrawal by Subject|2|||
23240918|NCT02146365|64626731|FG002|Overall Study|Withdrawal by Subject|1|||
23240919|NCT02146365|64626732|FG003|Overall Study|Withdrawal by Subject|5|||
23240920|NCT02146365|64626733|FG004|Overall Study|Withdrawal by Subject|1|||
23240921|NCT02146365|64626734|FG005|Overall Study|Withdrawal by Subject|0|||
23240922|NCT02146365|64626735|FG006|Overall Study|Withdrawal by Subject|0|||
23240923|NCT02146365|64626736|FG007|Overall Study|Withdrawal by Subject|0|||
23240924|NCT02146365|64626729|FG000|Overall Study|Unable to Comply with Protocol|0|||
23240925|NCT02146365|64626730|FG001|Overall Study|Unable to Comply with Protocol|1|||
23584197|NCT04888585|65866103|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23181648|NCT00868790|64404803|FG004|Period 1|Abnormal Triglycerides|1|||
23181649|NCT00868790|64404804|FG005|Period 1|Abnormal Triglycerides|0|||
23181650|NCT00868790|64404805|FG006|Period 1|Abnormal Triglycerides|0|||
23240926|NCT02146365|64626731|FG002|Overall Study|Unable to Comply with Protocol|1|||
23240927|NCT02146365|64626732|FG003|Overall Study|Unable to Comply with Protocol|0|||
23240928|NCT02146365|64626733|FG004|Overall Study|Unable to Comply with Protocol|0|||
23181651|NCT00868790|64404806|FG007|Period 1|Abnormal Triglycerides|0|||
23181652|NCT00868790|64404807|FG008|Period 1|Abnormal Triglycerides|0|||
23240929|NCT02146365|64626734|FG005|Overall Study|Unable to Comply with Protocol|0|||
23348283|NCT01606748|65018037|FG000|Overall Study|Withdrawal by Subject|1|||
23348284|NCT01606748|65018038|FG001|Overall Study|Withdrawal by Subject|0|||
23348285|NCT03181503|65018039|FG000|Overall Study|Adverse Event|2|||
23348286|NCT03181503|65018040|FG001|Overall Study|Adverse Event|2|||
23348287|NCT03181503|65018039|FG000|Overall Study|Protocol Violation|1|||
23181653|NCT00868790|64404808|FG009|Period 1|Abnormal Triglycerides|0|||
23584198|NCT04888585|65866104|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
23584199|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584200|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584201|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584202|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
23240930|NCT02146365|64626735|FG006|Overall Study|Unable to Comply with Protocol|0|||
23240931|NCT02146365|64626736|FG007|Overall Study|Unable to Comply with Protocol|0|||
23240932|NCT02146365|64626729|FG000|Overall Study|Other|1|||
23240933|NCT02146365|64626730|FG001|Overall Study|Other|0|||
23240934|NCT02146365|64626731|FG002|Overall Study|Other|2|||
23240935|NCT02146365|64626732|FG003|Overall Study|Other|1|||
23240936|NCT02146365|64626733|FG004|Overall Study|Other|0|||
23240937|NCT02146365|64626734|FG005|Overall Study|Other|0|||
23240938|NCT02146365|64626735|FG006|Overall Study|Other|0|||
23240939|NCT02146365|64626736|FG007|Overall Study|Other|0|||
23240940|NCT01846442|64626737|FG000|Overall Study|Adverse Event|2|||
23240941|NCT01846442|64626738|FG001|Overall Study|Adverse Event|4|||
23240942|NCT01846442|64626739|FG002|Overall Study|Adverse Event|2|||
23240943|NCT01846442|64626740|FG003|Overall Study|Adverse Event|1|||
23584203|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584204|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584205|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584206|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
23584207|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584208|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
23584209|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
23584210|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584211|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584212|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584213|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584214|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
23584215|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
23584216|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
23584217|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
23584218|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
23584219|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
23584220|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
23584221|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584222|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584223|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584224|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584225|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
23584226|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
23584227|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
23584228|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
23584229|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
23584230|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
23584231|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
23584232|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584233|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584234|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584235|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584236|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
23584237|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
23584238|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
23584239|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
23584240|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
23584241|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
23584242|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
23584243|NCT04888585|65866094|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584244|NCT04888585|65866095|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584245|NCT04888585|65866096|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584246|NCT04888585|65866097|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23240944|NCT01846442|64626737|FG000|Overall Study|Lost to Follow-up|0|||
23240945|NCT01846442|64626738|FG001|Overall Study|Lost to Follow-up|0|||
23240946|NCT01846442|64626739|FG002|Overall Study|Lost to Follow-up|1|||
23240947|NCT01846442|64626740|FG003|Overall Study|Lost to Follow-up|0|||
23240948|NCT01846442|64626737|FG000|Overall Study|Withdrawal by Subject|3|||
23181654|NCT00868790|64404809|FG010|Period 1|Abnormal Triglycerides|0|||
23181655|NCT00868790|64404810|FG011|Period 1|Abnormal Triglycerides|0|||
23181656|NCT00868790|64404811|FG012|Period 1|Abnormal Triglycerides|0|||
23181657|NCT00868790|64404812|FG013|Period 1|Abnormal Triglycerides|0|||
23181658|NCT00868790|64404799|FG000|Period 1|Lost to Follow-up|0|||
23181659|NCT00868790|64404800|FG001|Period 1|Lost to Follow-up|0|||
23181660|NCT00868790|64404801|FG002|Period 1|Lost to Follow-up|0|||
23181661|NCT00868790|64404802|FG003|Period 1|Lost to Follow-up|0|||
23181662|NCT00868790|64404803|FG004|Period 1|Lost to Follow-up|0|||
23181663|NCT00868790|64404804|FG005|Period 1|Lost to Follow-up|1|||
23181664|NCT00868790|64404805|FG006|Period 1|Lost to Follow-up|0|||
23181665|NCT00868790|64404806|FG007|Period 1|Lost to Follow-up|0|||
23181666|NCT00868790|64404807|FG008|Period 1|Lost to Follow-up|0|||
23181667|NCT00868790|64404808|FG009|Period 1|Lost to Follow-up|0|||
23181668|NCT00868790|64404809|FG010|Period 1|Lost to Follow-up|0|||
23181669|NCT00868790|64404810|FG011|Period 1|Lost to Follow-up|0|||
23181670|NCT00868790|64404811|FG012|Period 1|Lost to Follow-up|0|||
23181671|NCT00868790|64404812|FG013|Period 1|Lost to Follow-up|0|||
23181672|NCT00868790|64404799|FG000|Period 2|Adverse Event|0|||
23181673|NCT00868790|64404800|FG001|Period 2|Adverse Event|0|||
23181674|NCT00868790|64404801|FG002|Period 2|Adverse Event|0|||
23181675|NCT00868790|64404802|FG003|Period 2|Adverse Event|0|||
23181676|NCT00868790|64404803|FG004|Period 2|Adverse Event|0|||
23181677|NCT00868790|64404804|FG005|Period 2|Adverse Event|0|||
23181678|NCT00868790|64404805|FG006|Period 2|Adverse Event|0|||
23181679|NCT00868790|64404806|FG007|Period 2|Adverse Event|0|||
23181680|NCT00868790|64404807|FG008|Period 2|Adverse Event|1|||
23181681|NCT00868790|64404808|FG009|Period 2|Adverse Event|0|||
23181682|NCT00868790|64404809|FG010|Period 2|Adverse Event|0|||
23181683|NCT00868790|64404810|FG011|Period 2|Adverse Event|0|||
23181684|NCT00868790|64404811|FG012|Period 2|Adverse Event|0|||
23181685|NCT00868790|64404812|FG013|Period 2|Adverse Event|0|||
23181686|NCT00868790|64404799|FG000|Period 2|Lost to Follow-up|0|||
23181687|NCT00868790|64404800|FG001|Period 2|Lost to Follow-up|1|||
23181688|NCT00868790|64404801|FG002|Period 2|Lost to Follow-up|0|||
23181689|NCT00868790|64404802|FG003|Period 2|Lost to Follow-up|0|||
23181690|NCT00868790|64404803|FG004|Period 2|Lost to Follow-up|0|||
23348288|NCT03181503|65018040|FG001|Overall Study|Protocol Violation|0|||
23348289|NCT03181503|65018039|FG000|Overall Study|Withdrawal by Subject|3|||
23348290|NCT03181503|65018040|FG001|Overall Study|Withdrawal by Subject|0|||
23348291|NCT03181503|65018039|FG000|Overall Study|Lost to Follow-up|1|||
23240949|NCT01846442|64626738|FG001|Overall Study|Withdrawal by Subject|2|||
23240950|NCT01846442|64626739|FG002|Overall Study|Withdrawal by Subject|0|||
23240951|NCT01846442|64626740|FG003|Overall Study|Withdrawal by Subject|1|||
23240952|NCT01846442|64626737|FG000|Overall Study|Left the city/Lost medication|1|||
23240953|NCT01846442|64626738|FG001|Overall Study|Left the city/Lost medication|0|||
23240954|NCT01846442|64626739|FG002|Overall Study|Left the city/Lost medication|1|||
23240955|NCT01846442|64626740|FG003|Overall Study|Left the city/Lost medication|1|||
23240956|NCT00422058|64626741|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
23240957|NCT00422058|64626742|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
23348292|NCT03181503|65018040|FG001|Overall Study|Lost to Follow-up|1|||
23348293|NCT03422159|65018044|FG000|Overall Study|Exclusion due to terminal disease|2|||
23348294|NCT03422159|65018045|FG001|Overall Study|Exclusion due to terminal disease|1|||
23348295|NCT04599933|65018047|FG000|Overall Study|Adverse Event|4|||
23584247|NCT04888585|65866098|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584248|NCT04888585|65866099|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23240958|NCT00422058|64626743|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
23240959|NCT00422058|64626744|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
23240960|NCT00422058|64626745|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
23240961|NCT00422058|64626746|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
23240962|NCT00422058|64626741|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
23240963|NCT00422058|64626742|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
23240964|NCT00422058|64626743|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
23584249|NCT04888585|65866100|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
23181691|NCT00868790|64404804|FG005|Period 2|Lost to Follow-up|1|||
23181692|NCT00868790|64404805|FG006|Period 2|Lost to Follow-up|0|||
23181693|NCT00868790|64404806|FG007|Period 2|Lost to Follow-up|0|||
23181694|NCT00868790|64404807|FG008|Period 2|Lost to Follow-up|0|||
23181695|NCT00868790|64404808|FG009|Period 2|Lost to Follow-up|0|||
23181696|NCT00868790|64404809|FG010|Period 2|Lost to Follow-up|0|||
23181697|NCT00868790|64404810|FG011|Period 2|Lost to Follow-up|0|||
23181698|NCT00868790|64404811|FG012|Period 2|Lost to Follow-up|0|||
23240965|NCT00422058|64626744|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
23240966|NCT00422058|64626745|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
23348296|NCT04599933|65018048|FG001|Overall Study|Adverse Event|1|||
23460148|NCT01668784|65427963|FG000|Treatment Period|Study Drug Toxicity|46|||
23181699|NCT00868790|64404812|FG013|Period 2|Lost to Follow-up|0|||
23181700|NCT00868790|64404799|FG000|Period 2|Withdrawal by Subject|0|||
23348297|NCT04599933|65018047|FG000|Overall Study|Withdrawal by Subject|4|||
23348298|NCT04599933|65018048|FG001|Overall Study|Withdrawal by Subject|2|||
23348299|NCT04599933|65018047|FG000|Overall Study|Lost to Follow-up|0|||
23348300|NCT04599933|65018048|FG001|Overall Study|Lost to Follow-up|1|||
23348301|NCT04599933|65018047|FG000|Overall Study|Physician Decision|0|||
23348302|NCT04599933|65018048|FG001|Overall Study|Physician Decision|1|||
23348303|NCT04599933|65018047|FG000|Overall Study|Screen Failure|1|||
23348304|NCT04599933|65018048|FG001|Overall Study|Screen Failure|2|||
23348305|NCT02101359|65018049|FG000|Overall Study|Not included|23|||
23348306|NCT02101359|65018050|FG001|Overall Study|Not included|13|||
23348307|NCT02101359|65018049|FG000|Overall Study|Withdrawal by Subject|5|||
23348308|NCT02101359|65018050|FG001|Overall Study|Withdrawal by Subject|4|||
23348309|NCT02101359|65018049|FG000|Overall Study|Lost to Follow-up|1|||
23348310|NCT02101359|65018050|FG001|Overall Study|Lost to Follow-up|0|||
23348311|NCT02101359|65018049|FG000|Overall Study|Protocol Violation|0|||
23348312|NCT02101359|65018050|FG001|Overall Study|Protocol Violation|2|||
23181701|NCT00868790|64404800|FG001|Period 2|Withdrawal by Subject|0|||
23181702|NCT00868790|64404801|FG002|Period 2|Withdrawal by Subject|0|||
23181703|NCT00868790|64404802|FG003|Period 2|Withdrawal by Subject|0|||
23181704|NCT00868790|64404803|FG004|Period 2|Withdrawal by Subject|0|||
23181705|NCT00868790|64404804|FG005|Period 2|Withdrawal by Subject|0|||
23181706|NCT00868790|64404805|FG006|Period 2|Withdrawal by Subject|0|||
23181707|NCT00868790|64404806|FG007|Period 2|Withdrawal by Subject|0|||
23181708|NCT00868790|64404807|FG008|Period 2|Withdrawal by Subject|1|||
23181709|NCT00868790|64404808|FG009|Period 2|Withdrawal by Subject|0|||
23181710|NCT00868790|64404809|FG010|Period 2|Withdrawal by Subject|0|||
23181711|NCT00868790|64404810|FG011|Period 2|Withdrawal by Subject|0|||
23181712|NCT00868790|64404811|FG012|Period 2|Withdrawal by Subject|0|||
23181713|NCT00868790|64404812|FG013|Period 2|Withdrawal by Subject|1|||
23181714|NCT00868790|64404799|FG000|Period 3|Adverse Event|0|||
23181715|NCT00868790|64404800|FG001|Period 3|Adverse Event|0|||
23181716|NCT00868790|64404801|FG002|Period 3|Adverse Event|0|||
23181717|NCT00868790|64404802|FG003|Period 3|Adverse Event|0|||
23181718|NCT00868790|64404803|FG004|Period 3|Adverse Event|0|||
23181719|NCT00868790|64404804|FG005|Period 3|Adverse Event|0|||
23181720|NCT00868790|64404805|FG006|Period 3|Adverse Event|0|||
23240967|NCT00422058|64626746|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
23240968|NCT00422058|64626741|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
23240969|NCT00422058|64626742|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
23240970|NCT00422058|64626743|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
23240971|NCT00422058|64626744|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
23348313|NCT01472939|65018052|FG000|Overall Study|Adverse Event|3|||
23348314|NCT01472939|65018053|FG001|Overall Study|Adverse Event|7|||
23240972|NCT00422058|64626745|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
23240973|NCT00422058|64626746|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
23240974|NCT00422058|64626741|FG000|Double-Blind, Week 0-20|Other|11|||
23240975|NCT00422058|64626742|FG001|Double-Blind, Week 0-20|Other|3|||
23240976|NCT00422058|64626743|FG002|Double-Blind, Week 0-20|Other|8|||
23240977|NCT00422058|64626744|FG003|Double-Blind, Week 0-20|Other|8|||
23240978|NCT00422058|64626745|FG004|Double-Blind, Week 0-20|Other|4|||
23240979|NCT00422058|64626746|FG005|Double-Blind, Week 0-20|Other|10|||
23240980|NCT00422058|64626741|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
23240981|NCT00422058|64626742|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
23240982|NCT00422058|64626743|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
23240983|NCT00422058|64626744|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
23240984|NCT00422058|64626745|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
23240985|NCT00422058|64626746|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
23240986|NCT00422058|64626741|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
23348315|NCT01472939|65018054|FG002|Overall Study|Adverse Event|7|||
23348316|NCT01472939|65018055|FG003|Overall Study|Adverse Event|14|||
23348317|NCT01472939|65018052|FG000|Overall Study|Lack of Efficacy|1|||
23348318|NCT01472939|65018053|FG001|Overall Study|Lack of Efficacy|0|||
23348319|NCT01472939|65018054|FG002|Overall Study|Lack of Efficacy|0|||
23584250|NCT04888585|65866101|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
23181721|NCT00868790|64404806|FG007|Period 3|Adverse Event|0|||
23181722|NCT00868790|64404807|FG008|Period 3|Adverse Event|0|||
23181723|NCT00868790|64404808|FG009|Period 3|Adverse Event|1|||
23181724|NCT00868790|64404809|FG010|Period 3|Adverse Event|0|||
23181725|NCT00868790|64404810|FG011|Period 3|Adverse Event|0|||
23181726|NCT00868790|64404811|FG012|Period 3|Adverse Event|0|||
23181727|NCT00868790|64404812|FG013|Period 3|Adverse Event|0|||
23348320|NCT01472939|65018055|FG003|Overall Study|Lack of Efficacy|1|||
23348321|NCT01472939|65018052|FG000|Overall Study|Lost to Follow-up|3|||
23348322|NCT01472939|65018053|FG001|Overall Study|Lost to Follow-up|0|||
23348323|NCT01472939|65018054|FG002|Overall Study|Lost to Follow-up|2|||
23348324|NCT01472939|65018055|FG003|Overall Study|Lost to Follow-up|0|||
23348325|NCT01472939|65018052|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
23181728|NCT00868790|64404799|FG000|Period 3|Protocol Violation|0|||
23460149|NCT01668784|65427964|FG001|Treatment Period|Study Drug Toxicity|53|||
23460150|NCT01668784|65427963|FG000|Treatment Period|Death|1|||
23460151|NCT01668784|65427964|FG001|Treatment Period|Death|1|||
23460152|NCT01668784|65427963|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
23460153|NCT01668784|65427964|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
23460154|NCT01668784|65427963|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
23460155|NCT01668784|65427964|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
23460156|NCT01668784|65427963|FG000|Treatment Period|Withdrawal by Subject|5|||
23460157|NCT01668784|65427964|FG001|Treatment Period|Withdrawal by Subject|3|||
23460158|NCT01668784|65427963|FG000|Treatment Period|Maximal Clinical Benefit|3|||
23460159|NCT01668784|65427964|FG001|Treatment Period|Maximal Clinical Benefit|3|||
23460160|NCT01668784|65427963|FG000|Treatment Period|Other|2|||
23460161|NCT01668784|65427964|FG001|Treatment Period|Other|8|||
23460162|NCT01668784|65427963|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
23460163|NCT01668784|65427964|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
23460164|NCT01838694|65427965|FG000|Overall Study|Adverse Event|0|||
23460165|NCT01838694|65427966|FG001|Overall Study|Adverse Event|1|||
23460166|NCT04949490|65427967|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23584251|NCT04888585|65866102|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
23584252|NCT04888585|65866103|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
23584253|NCT04888585|65866104|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
23584254|NCT02577523|65866114|FG000|Overall Study|Adverse Event|1|||
23584255|NCT02577523|65866115|FG001|Overall Study|Adverse Event|1|||
23181729|NCT00868790|64404800|FG001|Period 3|Protocol Violation|0|||
23181730|NCT00868790|64404801|FG002|Period 3|Protocol Violation|0|||
23181731|NCT00868790|64404802|FG003|Period 3|Protocol Violation|0|||
23181732|NCT00868790|64404803|FG004|Period 3|Protocol Violation|0|||
23181733|NCT00868790|64404804|FG005|Period 3|Protocol Violation|0|||
23181734|NCT00868790|64404805|FG006|Period 3|Protocol Violation|0|||
23181735|NCT00868790|64404806|FG007|Period 3|Protocol Violation|0|||
23181736|NCT00868790|64404807|FG008|Period 3|Protocol Violation|0|||
23181737|NCT00868790|64404808|FG009|Period 3|Protocol Violation|0|||
23181738|NCT00868790|64404809|FG010|Period 3|Protocol Violation|1|||
23181739|NCT00868790|64404810|FG011|Period 3|Protocol Violation|0|||
23181740|NCT00868790|64404811|FG012|Period 3|Protocol Violation|0|||
23181741|NCT00868790|64404812|FG013|Period 3|Protocol Violation|0|||
23181742|NCT00868790|64404799|FG000|Period 3|Study Terminated by Sponsor|0|||
23181743|NCT00868790|64404800|FG001|Period 3|Study Terminated by Sponsor|0|||
23181744|NCT00868790|64404801|FG002|Period 3|Study Terminated by Sponsor|0|||
23181745|NCT00868790|64404802|FG003|Period 3|Study Terminated by Sponsor|1|||
23181746|NCT00868790|64404803|FG004|Period 3|Study Terminated by Sponsor|0|||
23181747|NCT00868790|64404804|FG005|Period 3|Study Terminated by Sponsor|0|||
23181748|NCT00868790|64404805|FG006|Period 3|Study Terminated by Sponsor|0|||
23181749|NCT00868790|64404806|FG007|Period 3|Study Terminated by Sponsor|0|||
23181750|NCT00868790|64404807|FG008|Period 3|Study Terminated by Sponsor|0|||
23181751|NCT00868790|64404808|FG009|Period 3|Study Terminated by Sponsor|0|||
23584256|NCT02577523|65866114|FG000|Overall Study|Lack of Efficacy|1|||
23584257|NCT02577523|65866115|FG001|Overall Study|Lack of Efficacy|1|||
23584258|NCT02577523|65866114|FG000|Overall Study|Withdrawal by Subject|1|||
23584259|NCT02577523|65866115|FG001|Overall Study|Withdrawal by Subject|0|||
23584260|NCT01565928|65866116|FG000|Overall Study|Adverse Event|3|||
23584261|NCT01565928|65866116|FG000|Overall Study|Other|3|||
23584262|NCT01565928|65866116|FG000|Overall Study|Progressive Disease|13|||
23584263|NCT01565928|65866116|FG000|Overall Study|Withdrawal by Subject|1|||
23584264|NCT01565928|65866116|FG000|Overall Study|Death|2|||
23584265|NCT03834493|65866117|FG000|Overall Study|Participants Ongoing|311|||
23584266|NCT03834493|65866118|FG001|Overall Study|Participants Ongoing|324|||
23584267|NCT03834493|65866117|FG000|Overall Study|Withdrawal by Subject|20|||
23584268|NCT03834493|65866118|FG001|Overall Study|Withdrawal by Subject|17|||
23584269|NCT03834493|65866117|FG000|Overall Study|Physician Decision|1|||
23181752|NCT00868790|64404809|FG010|Period 3|Study Terminated by Sponsor|0|||
23181753|NCT00868790|64404810|FG011|Period 3|Study Terminated by Sponsor|0|||
23181754|NCT00868790|64404811|FG012|Period 3|Study Terminated by Sponsor|0|||
23460167|NCT04949490|65427968|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23460168|NCT04949490|65427969|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23460169|NCT04949490|65427970|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
23460170|NCT04949490|65427971|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23181755|NCT00868790|64404812|FG013|Period 3|Study Terminated by Sponsor|0|||
23181756|NCT00868790|64404799|FG000|Period 4|Adverse Event|0|||
23584270|NCT03834493|65866118|FG001|Overall Study|Physician Decision|0|||
23181757|NCT00868790|64404800|FG001|Period 4|Adverse Event|0|||
23181758|NCT00868790|64404801|FG002|Period 4|Adverse Event|0|||
23181759|NCT00868790|64404802|FG003|Period 4|Adverse Event|0|||
23181760|NCT00868790|64404803|FG004|Period 4|Adverse Event|0|||
23584271|NCT03834493|65866117|FG000|Overall Study|Death|289|||
23584272|NCT03834493|65866118|FG001|Overall Study|Death|282|||
23584273|NCT02949271|65866119|FG000|Overall Study|Lack of Efficacy|5|||
23181761|NCT00868790|64404804|FG005|Period 4|Adverse Event|0|||
23181762|NCT00868790|64404805|FG006|Period 4|Adverse Event|0|||
23181763|NCT00868790|64404806|FG007|Period 4|Adverse Event|1|||
23181764|NCT00868790|64404807|FG008|Period 4|Adverse Event|0|||
23181765|NCT00868790|64404808|FG009|Period 4|Adverse Event|0|||
23181766|NCT00868790|64404809|FG010|Period 4|Adverse Event|1|||
23460171|NCT04949490|65427972|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
23460172|NCT04949490|65427967|FG000|Group A and Group B|Withdrawal by Subject|0|||
23460173|NCT04949490|65427968|FG001|Group A and Group B|Withdrawal by Subject|0|||
23460174|NCT04949490|65427969|FG002|Group A and Group B|Withdrawal by Subject|1|||
23460175|NCT04949490|65427970|FG003|Group A and Group B|Withdrawal by Subject|0|||
23460176|NCT04949490|65427971|FG004|Group A and Group B|Withdrawal by Subject|0|||
23460177|NCT04949490|65427972|FG005|Group A and Group B|Withdrawal by Subject|0|||
23460178|NCT04949490|65427967|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460179|NCT04949490|65427968|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460180|NCT04949490|65427969|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460181|NCT04949490|65427970|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460182|NCT04949490|65427971|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
23460183|NCT04949490|65427972|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
23460184|NCT04949490|65427967|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460185|NCT04949490|65427968|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460186|NCT04949490|65427969|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460187|NCT04949490|65427970|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460188|NCT04949490|65427971|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
23348326|NCT01472939|65018053|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
23348327|NCT01472939|65018054|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
23348328|NCT01472939|65018055|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
23348329|NCT01472939|65018052|FG000|Overall Study|Prohibited Medication|0|||
23348330|NCT01472939|65018053|FG001|Overall Study|Prohibited Medication|1|||
23348331|NCT01472939|65018054|FG002|Overall Study|Prohibited Medication|0|||
23348332|NCT01472939|65018055|FG003|Overall Study|Prohibited Medication|0|||
23348333|NCT01472939|65018052|FG000|Overall Study|Withdrawal By PI|1|||
23348334|NCT01472939|65018053|FG001|Overall Study|Withdrawal By PI|0|||
23348335|NCT01472939|65018054|FG002|Overall Study|Withdrawal By PI|0|||
23348336|NCT01472939|65018055|FG003|Overall Study|Withdrawal By PI|0|||
23348337|NCT01472939|65018052|FG000|Overall Study|Protocol Violation|3|||
23348338|NCT01472939|65018053|FG001|Overall Study|Protocol Violation|3|||
23348339|NCT01472939|65018054|FG002|Overall Study|Protocol Violation|0|||
23348340|NCT01472939|65018055|FG003|Overall Study|Protocol Violation|1|||
23348341|NCT01472939|65018052|FG000|Overall Study|Withdrawal by Subject|9|||
23348342|NCT01472939|65018053|FG001|Overall Study|Withdrawal by Subject|3|||
23348343|NCT01472939|65018054|FG002|Overall Study|Withdrawal by Subject|1|||
23348344|NCT01472939|65018055|FG003|Overall Study|Withdrawal by Subject|4|||
23348345|NCT00401960|65018056|FG000|Overall Study|Lost to Follow-up|3|||
23348346|NCT00401960|65018057|FG001|Overall Study|Lost to Follow-up|0|||
23348347|NCT00401960|65018056|FG000|Overall Study|Death|2|||
23348348|NCT00401960|65018057|FG001|Overall Study|Death|0|||
23348349|NCT03558152|65018058|FG000|Overall Study|Adverse Event|0|||
23348350|NCT03558152|65018059|FG001|Overall Study|Adverse Event|0|||
23348351|NCT03558152|65018060|FG002|Overall Study|Adverse Event|1|||
23348352|NCT03558152|65018061|FG003|Overall Study|Adverse Event|1|||
23348353|NCT03558152|65018062|FG004|Overall Study|Adverse Event|2|||
23348354|NCT03558152|65018063|FG005|Overall Study|Adverse Event|1|||
23348355|NCT03558152|65018064|FG006|Overall Study|Adverse Event|1|||
23348356|NCT03558152|65018065|FG007|Overall Study|Adverse Event|0|||
23348357|NCT03558152|65018058|FG000|Overall Study|Death|0|||
23348358|NCT03558152|65018059|FG001|Overall Study|Death|0|||
23348359|NCT03558152|65018060|FG002|Overall Study|Death|0|||
23348360|NCT03558152|65018061|FG003|Overall Study|Death|0|||
23348361|NCT03558152|65018062|FG004|Overall Study|Death|1|||
23460189|NCT04949490|65427972|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
23460190|NCT01285323|65427973|FG000|Overall Study|Adverse Event|9|||
23348362|NCT03558152|65018063|FG005|Overall Study|Death|0|||
23181767|NCT00868790|64404810|FG011|Period 4|Adverse Event|0|||
23181768|NCT00868790|64404811|FG012|Period 4|Adverse Event|1|||
23181769|NCT00868790|64404812|FG013|Period 4|Adverse Event|0|||
23181770|NCT00868790|64404799|FG000|Period 4|Lost to Follow-up|0|||
23181771|NCT00868790|64404800|FG001|Period 4|Lost to Follow-up|0|||
23181772|NCT00868790|64404801|FG002|Period 4|Lost to Follow-up|0|||
23181773|NCT00868790|64404802|FG003|Period 4|Lost to Follow-up|0|||
23240987|NCT00422058|64626742|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
23181774|NCT00868790|64404803|FG004|Period 4|Lost to Follow-up|0|||
23181775|NCT00868790|64404804|FG005|Period 4|Lost to Follow-up|0|||
23240988|NCT00422058|64626743|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
23348363|NCT03558152|65018064|FG006|Overall Study|Death|0|||
23348364|NCT03558152|65018065|FG007|Overall Study|Death|0|||
23460191|NCT01285323|65427974|FG001|Overall Study|Adverse Event|8|||
23460192|NCT01285323|65427973|FG000|Overall Study|Lack of Efficacy|4|||
23460193|NCT01285323|65427974|FG001|Overall Study|Lack of Efficacy|2|||
23460194|NCT01285323|65427973|FG000|Overall Study|Withdrawal by Subject|15|||
23460195|NCT01285323|65427974|FG001|Overall Study|Withdrawal by Subject|11|||
23460196|NCT01285323|65427973|FG000|Overall Study|Protocol Violation|1|||
23460197|NCT01285323|65427974|FG001|Overall Study|Protocol Violation|2|||
23460198|NCT01285323|65427973|FG000|Overall Study|Non-compliance with study procedures|2|||
23460199|NCT01285323|65427974|FG001|Overall Study|Non-compliance with study procedures|3|||
23460200|NCT01285323|65427973|FG000|Overall Study|Lost to Follow-up|1|||
23460201|NCT01285323|65427974|FG001|Overall Study|Lost to Follow-up|1|||
23460202|NCT01285323|65427973|FG000|Overall Study|Other|1|||
23460203|NCT01285323|65427974|FG001|Overall Study|Other|3|||
23460204|NCT05530252|65427985|FG000|Overall Study|Lost to Follow-up|1|||
23460205|NCT05530252|65427986|FG001|Overall Study|Lost to Follow-up|1|||
23460206|NCT05530252|65427987|FG002|Overall Study|Lost to Follow-up|1|||
23460207|NCT04456504|65427988|FG000|Overall Study|Lost to Follow-up|2|||
23460208|NCT00541658|65427989|FG000|Overall Study|Adverse Event|28|||
23460209|NCT00541658|65427990|FG001|Overall Study|Adverse Event|37|||
23460210|NCT00541658|65427991|FG002|Overall Study|Adverse Event|25|||
23460211|NCT00541658|65427989|FG000|Overall Study|Physician Decision|0|||
23460212|NCT00541658|65427990|FG001|Overall Study|Physician Decision|0|||
23460213|NCT00541658|65427991|FG002|Overall Study|Physician Decision|4|||
23460214|NCT00541658|65427989|FG000|Overall Study|Lost to Follow-up|3|||
23460215|NCT00541658|65427990|FG001|Overall Study|Lost to Follow-up|3|||
23460216|NCT00541658|65427991|FG002|Overall Study|Lost to Follow-up|6|||
23460217|NCT00541658|65427989|FG000|Overall Study|Protocol Violation|0|||
23460218|NCT00541658|65427990|FG001|Overall Study|Protocol Violation|1|||
23460219|NCT00541658|65427991|FG002|Overall Study|Protocol Violation|1|||
23460220|NCT00541658|65427989|FG000|Overall Study|Withdrawal by Subject|28|||
23460221|NCT00541658|65427990|FG001|Overall Study|Withdrawal by Subject|32|||
23460222|NCT00541658|65427991|FG002|Overall Study|Withdrawal by Subject|32|||
23460223|NCT00541658|65427989|FG000|Overall Study|Took No Study Drug|1|||
23460224|NCT00541658|65427990|FG001|Overall Study|Took No Study Drug|0|||
23460225|NCT00541658|65427991|FG002|Overall Study|Took No Study Drug|0|||
23460226|NCT01409707|65427992|FG000|Overall Study|Withdrawal by Subject|5|||
23460227|NCT01409707|65427993|FG001|Overall Study|Withdrawal by Subject|17|||
23460228|NCT01409707|65427994|FG002|Overall Study|Withdrawal by Subject|16|||
23460229|NCT00911170|65427995|FG000|Treatment Period|Randomized in error|1|||
23460230|NCT00911170|65427996|FG001|Treatment Period|Randomized in error|1|||
23460231|NCT00911170|65427995|FG000|Treatment Period|Ineligibility determined|1|||
23460232|NCT00911170|65427996|FG001|Treatment Period|Ineligibility determined|3|||
23460233|NCT00911170|65427995|FG000|Treatment Period|Protocol deviation|1|||
23348365|NCT03558152|65018058|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
23460234|NCT00911170|65427996|FG001|Treatment Period|Protocol deviation|2|||
23460235|NCT00911170|65427995|FG000|Treatment Period|Adverse Event|9|||
23181776|NCT00868790|64404805|FG006|Period 4|Lost to Follow-up|0|||
23181777|NCT00868790|64404806|FG007|Period 4|Lost to Follow-up|1|||
23181778|NCT00868790|64404807|FG008|Period 4|Lost to Follow-up|0|||
23181779|NCT00868790|64404808|FG009|Period 4|Lost to Follow-up|0|||
23181780|NCT00868790|64404809|FG010|Period 4|Lost to Follow-up|0|||
23460236|NCT00911170|65427996|FG001|Treatment Period|Adverse Event|10|||
23460237|NCT00911170|65427995|FG000|Treatment Period|Withdrawal by Subject|4|||
23460238|NCT00911170|65427996|FG001|Treatment Period|Withdrawal by Subject|4|||
23584274|NCT02949271|65866120|FG001|Overall Study|Lack of Efficacy|4|||
23584275|NCT02949271|65866119|FG000|Overall Study|Lost to Follow-up|3|||
23181781|NCT00868790|64404810|FG011|Period 4|Lost to Follow-up|0|||
23181782|NCT00868790|64404811|FG012|Period 4|Lost to Follow-up|0|||
23181783|NCT00868790|64404812|FG013|Period 4|Lost to Follow-up|0|||
23460239|NCT00911170|65427995|FG000|Treatment Period|Disease progression|0|||
23460240|NCT00911170|65427996|FG001|Treatment Period|Disease progression|2|||
23460241|NCT00911170|65427995|FG000|Treatment Period|Physician Decision|5|||
23460242|NCT00911170|65427996|FG001|Treatment Period|Physician Decision|5|||
23460243|NCT00911170|65427995|FG000|Treatment Period|Lost to Follow-up|0|||
23584276|NCT02949271|65866120|FG001|Overall Study|Lost to Follow-up|6|||
23584277|NCT02949271|65866119|FG000|Overall Study|Physician Decision|5|||
23584278|NCT02949271|65866120|FG001|Overall Study|Physician Decision|5|||
23584279|NCT02949271|65866119|FG000|Overall Study|Protocol Violation|6|||
23584280|NCT02949271|65866120|FG001|Overall Study|Protocol Violation|3|||
23584281|NCT02949271|65866119|FG000|Overall Study|Withdrawal by Subject|1|||
23584282|NCT02949271|65866120|FG001|Overall Study|Withdrawal by Subject|0|||
23181784|NCT00868790|64404799|FG000|Period 4|Study Terminated by Sponsor|2|||
23181785|NCT00868790|64404800|FG001|Period 4|Study Terminated by Sponsor|0|||
23584283|NCT02949271|65866119|FG000|Overall Study|Delivered prior to intervention|7|||
23181786|NCT00868790|64404801|FG002|Period 4|Study Terminated by Sponsor|0|||
23460244|NCT00911170|65427996|FG001|Treatment Period|Lost to Follow-up|1|||
23460245|NCT00911170|65427995|FG000|Treatment Period|Death|6|||
23460246|NCT00911170|65427996|FG001|Treatment Period|Death|9|||
23460247|NCT00911170|65427995|FG000|Long Term Follow-Up|Continuing in study|274|||
23460248|NCT00911170|65427996|FG001|Long Term Follow-Up|Continuing in study|269|||
23460249|NCT00911170|65427995|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
23460250|NCT00911170|65427996|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
23181787|NCT00868790|64404802|FG003|Period 4|Study Terminated by Sponsor|0|||
23181788|NCT00868790|64404803|FG004|Period 4|Study Terminated by Sponsor|0|||
23181789|NCT00868790|64404804|FG005|Period 4|Study Terminated by Sponsor|0|||
23181790|NCT00868790|64404805|FG006|Period 4|Study Terminated by Sponsor|0|||
23181791|NCT00868790|64404806|FG007|Period 4|Study Terminated by Sponsor|1|||
23181792|NCT00868790|64404807|FG008|Period 4|Study Terminated by Sponsor|2|||
23181793|NCT00868790|64404808|FG009|Period 4|Study Terminated by Sponsor|0|||
23181794|NCT00868790|64404809|FG010|Period 4|Study Terminated by Sponsor|2|||
23240989|NCT00422058|64626744|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
23240990|NCT00422058|64626745|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
23240991|NCT00422058|64626746|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
23240992|NCT00422058|64626741|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
23460251|NCT00911170|65427995|FG000|Long Term Follow-Up|Physician Decision|5|||
23460252|NCT00911170|65427996|FG001|Long Term Follow-Up|Physician Decision|4|||
23460253|NCT00911170|65427995|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
23460254|NCT00911170|65427996|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
23460255|NCT00911170|65427995|FG000|Long Term Follow-Up|Death|116|||
23460256|NCT00911170|65427996|FG001|Long Term Follow-Up|Death|121|||
23460257|NCT00385671|65427997|FG000|Overall Study|Adverse Event|14|||
23460258|NCT00385671|65427998|FG001|Overall Study|Adverse Event|27|||
23460259|NCT00385671|65427999|FG002|Overall Study|Adverse Event|18|||
23460260|NCT00385671|65427997|FG000|Overall Study|Lack of Efficacy|5|||
23460261|NCT00385671|65427998|FG001|Overall Study|Lack of Efficacy|9|||
23460262|NCT00385671|65427999|FG002|Overall Study|Lack of Efficacy|5|||
23460263|NCT00385671|65427997|FG000|Overall Study|Lost to Follow-up|6|||
23460264|NCT00385671|65427998|FG001|Overall Study|Lost to Follow-up|6|||
23460265|NCT00385671|65427999|FG002|Overall Study|Lost to Follow-up|5|||
23240993|NCT00422058|64626742|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
23240994|NCT00422058|64626743|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
23240995|NCT00422058|64626744|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
23240996|NCT00422058|64626745|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
23240997|NCT00422058|64626746|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
23240998|NCT00422058|64626741|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
23460266|NCT00385671|65427997|FG000|Overall Study|Physician Decision|2|||
23460267|NCT00385671|65427998|FG001|Overall Study|Physician Decision|1|||
23460268|NCT00385671|65427999|FG002|Overall Study|Physician Decision|2|||
23584284|NCT02949271|65866120|FG001|Overall Study|Delivered prior to intervention|9|||
23584285|NCT02949271|65866119|FG000|Overall Study|Outside the window for cervical dilation|2|||
23584286|NCT02949271|65866120|FG001|Overall Study|Outside the window for cervical dilation|3|||
23584287|NCT01119950|65866128|FG000|Overall Study|Adverse Event|25|||
23584288|NCT01119950|65866128|FG000|Overall Study|Withdrawal by Subject|9|||
23584289|NCT01119950|65866128|FG000|Overall Study|Protocol Violation|5|||
23584290|NCT01119950|65866128|FG000|Overall Study|Lost to Follow-up|4|||
23584291|NCT01119950|65866128|FG000|Overall Study|Administrative|2|||
23584292|NCT01119950|65866128|FG000|Overall Study|Abnormal lab value|1|||
23584293|NCT01119950|65866128|FG000|Overall Study|Death|1|||
23584294|NCT01516892|65866129|FG000|Overall Study|Adverse Event|25|||
23584295|NCT01516892|65866129|FG000|Overall Study|Lack of Efficacy|35|||
23240999|NCT00422058|64626742|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
23241000|NCT00422058|64626743|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
23241001|NCT00422058|64626744|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
23241002|NCT00422058|64626745|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
23241003|NCT00422058|64626746|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
23241004|NCT00422058|64626741|FG000|Open-Label Extension, Week 20-104|Other|13|||
23241005|NCT00422058|64626742|FG001|Open-Label Extension, Week 20-104|Other|14|||
23241006|NCT00422058|64626743|FG002|Open-Label Extension, Week 20-104|Other|6|||
23241007|NCT00422058|64626744|FG003|Open-Label Extension, Week 20-104|Other|13|||
23241008|NCT00422058|64626745|FG004|Open-Label Extension, Week 20-104|Other|16|||
23241009|NCT00422058|64626746|FG005|Open-Label Extension, Week 20-104|Other|18|||
23241010|NCT00965458|64626747|FG000|Overall Study|Adverse Event|1|||
23241011|NCT00965458|64626748|FG001|Overall Study|Adverse Event|0|||
23460269|NCT00385671|65427997|FG000|Overall Study|Protocol Violation|5|||
23460270|NCT00385671|65427998|FG001|Overall Study|Protocol Violation|2|||
23460271|NCT00385671|65427999|FG002|Overall Study|Protocol Violation|1|||
23460272|NCT00385671|65427997|FG000|Overall Study|Sponsor Decision|2|||
23460273|NCT00385671|65427998|FG001|Overall Study|Sponsor Decision|2|||
23584296|NCT01516892|65866129|FG000|Overall Study|Pregnancy|5|||
23181795|NCT00868790|64404810|FG011|Period 4|Study Terminated by Sponsor|1|||
23460274|NCT00385671|65427999|FG002|Overall Study|Sponsor Decision|1|||
23460275|NCT00385671|65427997|FG000|Overall Study|Withdrawal by Subject|4|||
23241012|NCT00965458|64626747|FG000|Overall Study|Lost to Follow-up|1|||
23241013|NCT00965458|64626748|FG001|Overall Study|Lost to Follow-up|3|||
23241014|NCT00965458|64626747|FG000|Overall Study|Withdrawal by Subject|0|||
23241015|NCT00965458|64626748|FG001|Overall Study|Withdrawal by Subject|1|||
23241016|NCT01958619|64626750|FG000|Overall Study|Protocol Violation|2|||
23241017|NCT01958619|64626751|FG001|Overall Study|Protocol Violation|0|||
23241018|NCT01958619|64626752|FG002|Overall Study|Protocol Violation|1|||
23241019|NCT01958619|64626753|FG003|Overall Study|Protocol Violation|0|||
23241020|NCT01418365|64626754|FG000|First Intervention|Withdrawal by Subject|0|||
23241021|NCT01418365|64626755|FG001|First Intervention|Withdrawal by Subject|1|||
23241022|NCT01418365|64626754|FG000|First Intervention|Non-compliance|1|||
23241023|NCT01418365|64626755|FG001|First Intervention|Non-compliance|0|||
23241024|NCT01418365|64626754|FG000|Second Intervention|Withdrawal by Subject|0|||
23241025|NCT01418365|64626755|FG001|Second Intervention|Withdrawal by Subject|1|||
23241026|NCT01333501|64626756|FG000|Overall Study|Adverse Event|3|||
23241027|NCT01333501|64626757|FG001|Overall Study|Adverse Event|1|||
23241028|NCT01333501|64626756|FG000|Overall Study|Abnormal laboratory value|2|||
23241029|NCT01333501|64626757|FG001|Overall Study|Abnormal laboratory value|1|||
23241030|NCT01333501|64626756|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23241031|NCT01333501|64626757|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
23241032|NCT01333501|64626756|FG000|Overall Study|Withdrawn consent|3|||
23241033|NCT01333501|64626757|FG001|Overall Study|Withdrawn consent|12|||
23241034|NCT00344968|64626758|FG000|Overall Study|Adverse Event|5|||
23241035|NCT00344968|64626759|FG001|Overall Study|Adverse Event|4|||
23241036|NCT00344968|64626760|FG002|Overall Study|Adverse Event|15|||
23241037|NCT00344968|64626758|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23241038|NCT00344968|64626759|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23241039|NCT00344968|64626760|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
23241040|NCT00344968|64626758|FG000|Overall Study|Protocol Violation|2|||
23241041|NCT00344968|64626759|FG001|Overall Study|Protocol Violation|2|||
23241042|NCT00344968|64626760|FG002|Overall Study|Protocol Violation|5|||
23241043|NCT00344968|64626758|FG000|Overall Study|Withdrawal by Subject|14|||
23241044|NCT00344968|64626759|FG001|Overall Study|Withdrawal by Subject|31|||
23348366|NCT03558152|65018059|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348367|NCT03558152|65018060|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348368|NCT03558152|65018061|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348369|NCT03558152|65018062|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348370|NCT03558152|65018063|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348371|NCT03558152|65018064|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348372|NCT03558152|65018065|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
23348373|NCT03558152|65018058|FG000|Overall Study|Miscalculation in mmcs|0|||
23348374|NCT03558152|65018059|FG001|Overall Study|Miscalculation in mmcs|0|||
23348375|NCT03558152|65018060|FG002|Overall Study|Miscalculation in mmcs|0|||
23348376|NCT03558152|65018061|FG003|Overall Study|Miscalculation in mmcs|0|||
23348377|NCT03558152|65018062|FG004|Overall Study|Miscalculation in mmcs|0|||
23348378|NCT03558152|65018063|FG005|Overall Study|Miscalculation in mmcs|0|||
23348379|NCT03558152|65018064|FG006|Overall Study|Miscalculation in mmcs|1|||
23241045|NCT00344968|64626760|FG002|Overall Study|Withdrawal by Subject|27|||
23241046|NCT00344968|64626758|FG000|Overall Study|Lost to Follow-up|24|||
23241047|NCT00344968|64626759|FG001|Overall Study|Lost to Follow-up|37|||
23348380|NCT03558152|65018065|FG007|Overall Study|Miscalculation in mmcs|0|||
23348381|NCT03558152|65018058|FG000|Overall Study|Mistake in calculation|0|||
23348382|NCT03558152|65018059|FG001|Overall Study|Mistake in calculation|0|||
23241048|NCT00344968|64626760|FG002|Overall Study|Lost to Follow-up|37|||
23241049|NCT00344968|64626758|FG000|Overall Study|Death|11|||
23241050|NCT00344968|64626759|FG001|Overall Study|Death|27|||
23241051|NCT00344968|64626760|FG002|Overall Study|Death|31|||
23241052|NCT00344968|64626758|FG000|Overall Study|Other|0|||
23241053|NCT00344968|64626759|FG001|Overall Study|Other|1|||
23241054|NCT00344968|64626760|FG002|Overall Study|Other|0|||
23348383|NCT03558152|65018060|FG002|Overall Study|Mistake in calculation|0|||
23241055|NCT00621309|64626761|FG000|Overall Study|Withdrawal by Subject|2|||
23241056|NCT00621309|64626762|FG001|Overall Study|Withdrawal by Subject|0|||
23241057|NCT00621309|64626763|FG002|Overall Study|Withdrawal by Subject|1|||
23241058|NCT00621309|64626764|FG003|Overall Study|Withdrawal by Subject|1|||
23241059|NCT00621309|64626765|FG004|Overall Study|Withdrawal by Subject|1|||
23241060|NCT00621309|64626766|FG005|Overall Study|Withdrawal by Subject|1|||
23241061|NCT00909857|64626767|FG000|Overall Study|Withdrawal by Subject|6|||
23241062|NCT00909857|64626768|FG001|Overall Study|Withdrawal by Subject|10|||
23241063|NCT00909857|64626767|FG000|Overall Study|Adverse Event|5|||
23241064|NCT00909857|64626768|FG001|Overall Study|Adverse Event|5|||
23241065|NCT00909857|64626767|FG000|Overall Study|Lost to Follow-up|2|||
23241066|NCT00909857|64626768|FG001|Overall Study|Lost to Follow-up|5|||
23241067|NCT00909857|64626767|FG000|Overall Study|Protocol Violation|2|||
23241068|NCT00909857|64626768|FG001|Overall Study|Protocol Violation|1|||
23241069|NCT00909857|64626767|FG000|Overall Study|Pregnancy|1|||
23241070|NCT00909857|64626768|FG001|Overall Study|Pregnancy|0|||
23241071|NCT00909857|64626767|FG000|Overall Study|Other|1|||
23241072|NCT00909857|64626768|FG001|Overall Study|Other|0|||
23241073|NCT00909857|64626767|FG000|Overall Study|Did not receive study medication|19|||
23241074|NCT00909857|64626768|FG001|Overall Study|Did not receive study medication|24|||
23241075|NCT01761565|64626777|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
23241076|NCT01503229|64626778|FG000|Overall Study|Withdrew consent|1|||
23241077|NCT00346775|64626779|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
23241078|NCT00346775|64626780|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
23241079|NCT00346775|64626779|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
23241080|NCT00346775|64626780|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
23241081|NCT00346775|64626779|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
23241082|NCT00346775|64626780|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
23241083|NCT01399619|64626781|FG000|Overall Study|Adverse Event|10|||
23241084|NCT01399619|64626782|FG001|Overall Study|Adverse Event|0|||
23241085|NCT01399619|64626783|FG002|Overall Study|Adverse Event|4|||
23241086|NCT01399619|64626784|FG003|Overall Study|Adverse Event|10|||
23241087|NCT01399619|64626781|FG000|Overall Study|Lack of Efficacy|9|||
23241088|NCT01399619|64626782|FG001|Overall Study|Lack of Efficacy|0|||
23241089|NCT01399619|64626783|FG002|Overall Study|Lack of Efficacy|5|||
23241090|NCT01399619|64626784|FG003|Overall Study|Lack of Efficacy|0|||
23241091|NCT01399619|64626781|FG000|Overall Study|Withdrawal by Subject|6|||
23241092|NCT01399619|64626782|FG001|Overall Study|Withdrawal by Subject|0|||
23241093|NCT01399619|64626783|FG002|Overall Study|Withdrawal by Subject|3|||
23241094|NCT01399619|64626784|FG003|Overall Study|Withdrawal by Subject|4|||
23241095|NCT01399619|64626781|FG000|Overall Study|Protocol Violation|0|||
23241096|NCT01399619|64626782|FG001|Overall Study|Protocol Violation|0|||
23241097|NCT01399619|64626783|FG002|Overall Study|Protocol Violation|0|||
23241098|NCT01399619|64626784|FG003|Overall Study|Protocol Violation|1|||
23241099|NCT01399619|64626781|FG000|Overall Study|Not treated|0|||
23241100|NCT01399619|64626782|FG001|Overall Study|Not treated|0|||
23241101|NCT01399619|64626783|FG002|Overall Study|Not treated|0|||
23241102|NCT01399619|64626784|FG003|Overall Study|Not treated|2|||
23241103|NCT03246152|64626789|FG000|Overall Study|Lost to Follow-up|2|||
23460276|NCT00385671|65427998|FG001|Overall Study|Withdrawal by Subject|4|||
23460277|NCT00385671|65427999|FG002|Overall Study|Withdrawal by Subject|4|||
23241104|NCT03246152|64626789|FG000|Overall Study|Protocol Violation|1|||
23241105|NCT03075826|64626795|FG000|Overall Study|Withdrawal by Subject|1|||
23241106|NCT03075826|64626795|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
23241107|NCT00464308|64626796|FG000|Overall Study|Adverse Event|22|||
23241108|NCT00464308|64626797|FG001|Overall Study|Adverse Event|27|||
23241109|NCT00464308|64626798|FG002|Overall Study|Adverse Event|16|||
23241110|NCT00464308|64626796|FG000|Overall Study|Lost to Follow-up|29|||
23241111|NCT00464308|64626797|FG001|Overall Study|Lost to Follow-up|19|||
23241112|NCT00464308|64626798|FG002|Overall Study|Lost to Follow-up|20|||
23241113|NCT00464308|64626796|FG000|Overall Study|Patient discontinued and other reasons|17|||
23241114|NCT00464308|64626797|FG001|Overall Study|Patient discontinued and other reasons|17|||
23241115|NCT00464308|64626798|FG002|Overall Study|Patient discontinued and other reasons|23|||
23241116|NCT00464308|64626796|FG000|Overall Study|Physician Decision|1|||
23241117|NCT00464308|64626797|FG001|Overall Study|Physician Decision|0|||
23460278|NCT02277444|65430681|FG000|Overall Study|Adverse Event|10|||
23460279|NCT02277444|65430681|FG000|Overall Study|Withdrawal by Subject|3|||
23241118|NCT00464308|64626798|FG002|Overall Study|Physician Decision|0|||
23241119|NCT00198107|64626803|FG000|Double-Blind Period|Adverse Event|1|||
23241120|NCT00198107|64626804|FG001|Double-Blind Period|Adverse Event|1|||
23241121|NCT00198107|64626805|FG002|Double-Blind Period|Adverse Event|0|||
23241122|NCT00198107|64626803|FG000|Double-Blind Period|Lack of Efficacy|2|||
23241123|NCT00198107|64626804|FG001|Double-Blind Period|Lack of Efficacy|0|||
23241124|NCT00198107|64626805|FG002|Double-Blind Period|Lack of Efficacy|0|||
23241125|NCT00198107|64626803|FG000|Double-Blind Period|Lost to Follow-up|2|||
23241126|NCT00198107|64626804|FG001|Double-Blind Period|Lost to Follow-up|1|||
23241127|NCT00198107|64626805|FG002|Double-Blind Period|Lost to Follow-up|0|||
23241128|NCT00198107|64626803|FG000|Double-Blind Period|Physician Decision|1|||
23241129|NCT00198107|64626804|FG001|Double-Blind Period|Physician Decision|0|||
23241130|NCT00198107|64626805|FG002|Double-Blind Period|Physician Decision|0|||
23241131|NCT00198107|64626803|FG000|Double-Blind Period|Withdrawal by Subject|0|||
23241132|NCT00198107|64626804|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23241133|NCT00198107|64626805|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23241134|NCT00198107|64626803|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
23241135|NCT00198107|64626804|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
23241136|NCT00198107|64626805|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
23241137|NCT01409382|64626806|FG000|Overall Study|Lost to Follow-up|1|||
23241138|NCT01409382|64626807|FG001|Overall Study|Lost to Follow-up|1|||
23241139|NCT01409382|64626806|FG000|Overall Study|Protocol Violation|0|||
23241140|NCT01409382|64626807|FG001|Overall Study|Protocol Violation|3|||
23241141|NCT01409382|64626806|FG000|Overall Study|Multiple pregnancy|2|||
23241142|NCT01409382|64626807|FG001|Overall Study|Multiple pregnancy|4|||
23241143|NCT01409382|64626806|FG000|Overall Study|Still pregnant when study ended|13|||
23241144|NCT01409382|64626807|FG001|Overall Study|Still pregnant when study ended|2|||
23241145|NCT01409382|64626806|FG000|Overall Study|Did not manage to get pregnant|64|||
23241146|NCT01409382|64626807|FG001|Overall Study|Did not manage to get pregnant|70|||
23241147|NCT01409382|64626806|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
23241148|NCT01409382|64626807|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
23241149|NCT01336647|64626808|FG000|Overall Study|Lost to Follow-up|4|||
23241150|NCT01336647|64626809|FG001|Overall Study|Lost to Follow-up|1|||
23241151|NCT01336647|64626810|FG002|Overall Study|Lost to Follow-up|3|||
23241152|NCT00483717|64626811|FG000|Overall Study|Protocol Violation|5|||
23241153|NCT00483717|64626812|FG001|Overall Study|Protocol Violation|7|||
23241154|NCT00483717|64626811|FG000|Overall Study|Time of dosing missing|1|||
23241155|NCT00483717|64626812|FG001|Overall Study|Time of dosing missing|1|||
23348384|NCT03558152|65018061|FG003|Overall Study|Mistake in calculation|1|||
23348385|NCT03558152|65018062|FG004|Overall Study|Mistake in calculation|0|||
23348386|NCT03558152|65018063|FG005|Overall Study|Mistake in calculation|0|||
23348387|NCT03558152|65018064|FG006|Overall Study|Mistake in calculation|0|||
23348388|NCT03558152|65018065|FG007|Overall Study|Mistake in calculation|0|||
23348389|NCT03558152|65018058|FG000|Overall Study|Mistake in evaluation of disease status|0|||
23348390|NCT03558152|65018059|FG001|Overall Study|Mistake in evaluation of disease status|0|||
23348391|NCT03558152|65018060|FG002|Overall Study|Mistake in evaluation of disease status|0|||
23348392|NCT03558152|65018061|FG003|Overall Study|Mistake in evaluation of disease status|0|||
23348393|NCT03558152|65018062|FG004|Overall Study|Mistake in evaluation of disease status|0|||
23348394|NCT03558152|65018063|FG005|Overall Study|Mistake in evaluation of disease status|0|||
23348395|NCT03558152|65018064|FG006|Overall Study|Mistake in evaluation of disease status|0|||
23348396|NCT03558152|65018065|FG007|Overall Study|Mistake in evaluation of disease status|1|||
23181796|NCT00868790|64404811|FG012|Period 4|Study Terminated by Sponsor|0|||
23181797|NCT00868790|64404812|FG013|Period 4|Study Terminated by Sponsor|1|||
23181798|NCT00868790|64404799|FG000|Period 4|Abnormal ALT/AST|0|||
23181799|NCT00868790|64404800|FG001|Period 4|Abnormal ALT/AST|0|||
23181800|NCT00868790|64404801|FG002|Period 4|Abnormal ALT/AST|1|||
23181801|NCT00868790|64404802|FG003|Period 4|Abnormal ALT/AST|0|||
23181802|NCT00868790|64404803|FG004|Period 4|Abnormal ALT/AST|0|||
23181803|NCT00868790|64404804|FG005|Period 4|Abnormal ALT/AST|0|||
23181804|NCT00868790|64404805|FG006|Period 4|Abnormal ALT/AST|0|||
23181805|NCT00868790|64404806|FG007|Period 4|Abnormal ALT/AST|0|||
23181806|NCT00868790|64404807|FG008|Period 4|Abnormal ALT/AST|0|||
23181807|NCT00868790|64404808|FG009|Period 4|Abnormal ALT/AST|0|||
23181808|NCT00868790|64404809|FG010|Period 4|Abnormal ALT/AST|0|||
23241156|NCT00483717|64626811|FG000|Overall Study|No treatment for migraine|16|||
23241157|NCT00483717|64626812|FG001|Overall Study|No treatment for migraine|13|||
23241158|NCT00483717|64626811|FG000|Overall Study|Lost to Follow-up|1|||
23348397|NCT03558152|65018058|FG000|Overall Study|Physician Decision|0|||
23348398|NCT03558152|65018059|FG001|Overall Study|Physician Decision|0|||
23181809|NCT00868790|64404810|FG011|Period 4|Abnormal ALT/AST|0|||
23181810|NCT00868790|64404811|FG012|Period 4|Abnormal ALT/AST|0|||
23181811|NCT00868790|64404812|FG013|Period 4|Abnormal ALT/AST|0|||
23181812|NCT00868790|64404799|FG000|Post-study|Withdrawal by Subject|0|||
23241159|NCT00483717|64626812|FG001|Overall Study|Lost to Follow-up|0|||
23241160|NCT00483717|64626811|FG000|Overall Study|Withdrawal by Subject|1|||
23241161|NCT00483717|64626812|FG001|Overall Study|Withdrawal by Subject|0|||
23241162|NCT03446157|64626814|FG000|Overall Study|Death|11|||
23241163|NCT03446157|64626815|FG001|Overall Study|Death|9|||
23241164|NCT03446157|64626814|FG000|Overall Study|Lost to Follow-up|0|||
23181813|NCT00868790|64404800|FG001|Post-study|Withdrawal by Subject|0|||
23181814|NCT00868790|64404801|FG002|Post-study|Withdrawal by Subject|0|||
23241165|NCT03446157|64626815|FG001|Overall Study|Lost to Follow-up|1|||
23241166|NCT03446157|64626814|FG000|Overall Study|Withdrawal by Subject|2|||
23241167|NCT03446157|64626815|FG001|Overall Study|Withdrawal by Subject|1|||
23241168|NCT00719706|64626820|FG000|Overall Study|Adverse Event|5|||
23241169|NCT00719706|64626821|FG001|Overall Study|Adverse Event|4|||
23348399|NCT03558152|65018060|FG002|Overall Study|Physician Decision|0|||
23348400|NCT03558152|65018061|FG003|Overall Study|Physician Decision|0|||
23348401|NCT03558152|65018062|FG004|Overall Study|Physician Decision|0|||
23348402|NCT03558152|65018063|FG005|Overall Study|Physician Decision|0|||
23348403|NCT03558152|65018064|FG006|Overall Study|Physician Decision|1|||
23348404|NCT03558152|65018065|FG007|Overall Study|Physician Decision|0|||
23348405|NCT03558152|65018058|FG000|Overall Study|Withdrawal by Subject|2|||
23348406|NCT03558152|65018059|FG001|Overall Study|Withdrawal by Subject|3|||
23348407|NCT03558152|65018060|FG002|Overall Study|Withdrawal by Subject|2|||
23348408|NCT03558152|65018061|FG003|Overall Study|Withdrawal by Subject|1|||
23241170|NCT00719706|64626820|FG000|Overall Study|Withdrawal by Subject|1|||
23348409|NCT03558152|65018062|FG004|Overall Study|Withdrawal by Subject|1|||
23348410|NCT03558152|65018063|FG005|Overall Study|Withdrawal by Subject|1|||
23348411|NCT03558152|65018064|FG006|Overall Study|Withdrawal by Subject|3|||
23348412|NCT03558152|65018065|FG007|Overall Study|Withdrawal by Subject|2|||
23348413|NCT03558152|65018058|FG000|Overall Study|Lack of Efficacy|11|||
23348414|NCT03558152|65018059|FG001|Overall Study|Lack of Efficacy|11|||
23348415|NCT03558152|65018060|FG002|Overall Study|Lack of Efficacy|10|||
23348416|NCT03558152|65018061|FG003|Overall Study|Lack of Efficacy|11|||
23348417|NCT03558152|65018062|FG004|Overall Study|Lack of Efficacy|14|||
23348418|NCT03558152|65018063|FG005|Overall Study|Lack of Efficacy|12|||
23348419|NCT03558152|65018064|FG006|Overall Study|Lack of Efficacy|14|||
23348420|NCT03558152|65018065|FG007|Overall Study|Lack of Efficacy|13|||
23348421|NCT03558152|65018058|FG000|Overall Study|Protocol Violation|1|||
23348422|NCT03558152|65018059|FG001|Overall Study|Protocol Violation|1|||
23348423|NCT03558152|65018060|FG002|Overall Study|Protocol Violation|0|||
23348424|NCT03558152|65018061|FG003|Overall Study|Protocol Violation|1|||
23348425|NCT03558152|65018062|FG004|Overall Study|Protocol Violation|1|||
23348426|NCT03558152|65018063|FG005|Overall Study|Protocol Violation|0|||
23348427|NCT03558152|65018064|FG006|Overall Study|Protocol Violation|2|||
23348428|NCT03558152|65018065|FG007|Overall Study|Protocol Violation|0|||
23348429|NCT00415597|65018066|FG000|Enrollment|Withdrawal by Subject|1|||
23348430|NCT00415597|65018066|FG000|Enrollment|Protocol Violation|1|||
23348431|NCT00415597|65018066|FG000|Treatment|Adverse Event|110|||
23348432|NCT00415597|65018066|FG000|Treatment|Lack of Efficacy|39|||
23348433|NCT00415597|65018066|FG000|Treatment|Protocol Violation|67|||
23348434|NCT00415597|65018066|FG000|Treatment|Physician Decision|3|||
23348435|NCT00415597|65018066|FG000|Treatment|Withdrawal by Subject|51|||
23348436|NCT00415597|65018066|FG000|Treatment|Lost to Follow-up|28|||
23348437|NCT00415597|65018066|FG000|Treatment|Drug Screen|2|||
23348438|NCT00415597|65018066|FG000|Treatment|Administrative|3|||
23348439|NCT00415597|65018066|FG000|Treatment|Sponsor Decision|1|||
23348440|NCT00415597|65018066|FG000|Treatment|Multiple Reasons|1|||
23348441|NCT00844480|65018074|FG000|Overall Study|Withdrawal by Subject|2|||
23348442|NCT00844480|65018075|FG001|Overall Study|Withdrawal by Subject|3|||
23348443|NCT01333956|65018076|FG000|Overall Study|Lost to Follow-up|1|||
23348444|NCT01333956|65018077|FG001|Overall Study|Lost to Follow-up|2|||
23584297|NCT01516892|65866129|FG000|Overall Study|Lost to Follow-up|82|||
23584298|NCT01516892|65866129|FG000|Overall Study|Subject Withdrew Consent|92|||
23584299|NCT01516892|65866129|FG000|Overall Study|Protocol Violation|60|||
23584300|NCT01516892|65866129|FG000|Overall Study|Other Miscellaneous Reasons|43|||
23584301|NCT01516892|65866129|FG000|Overall Study|Missing|1|||
23584302|NCT01769391|65866130|FG000|Overall Study|Death|10|||
23584303|NCT01769391|65866131|FG001|Overall Study|Death|1|||
23348445|NCT01333956|65018078|FG002|Overall Study|Lost to Follow-up|0|||
23348446|NCT01333956|65018079|FG003|Overall Study|Lost to Follow-up|1|||
23348447|NCT01333956|65018076|FG000|Overall Study|Unable to complete study procedure|1|||
23348448|NCT01333956|65018077|FG001|Overall Study|Unable to complete study procedure|0|||
23348449|NCT01333956|65018078|FG002|Overall Study|Unable to complete study procedure|0|||
23348450|NCT01333956|65018079|FG003|Overall Study|Unable to complete study procedure|1|||
23348451|NCT01333956|65018076|FG000|Overall Study|Withdrawal by Subject|0|||
23348452|NCT01333956|65018077|FG001|Overall Study|Withdrawal by Subject|2|||
23348453|NCT01333956|65018078|FG002|Overall Study|Withdrawal by Subject|1|||
23460280|NCT02277444|65430681|FG000|Overall Study|Other|1|||
23584304|NCT01769391|65866130|FG000|Overall Study|Adverse Event|0|||
23348454|NCT01333956|65018079|FG003|Overall Study|Withdrawal by Subject|0|||
23348455|NCT00603382|65018082|FG000|Overall Study|Adverse Event|0|||
23348456|NCT00603382|65018083|FG001|Overall Study|Adverse Event|1|||
23348457|NCT00603382|65018084|FG002|Overall Study|Adverse Event|1|||
23348458|NCT00603382|65018085|FG003|Overall Study|Adverse Event|2|||
23584305|NCT01769391|65866131|FG001|Overall Study|Adverse Event|3|||
23348459|NCT00603382|65018086|FG004|Overall Study|Adverse Event|1|||
23584306|NCT01769391|65866130|FG000|Overall Study|Progressive Disease|1|||
23241171|NCT00719706|64626821|FG001|Overall Study|Withdrawal by Subject|2|||
23584307|NCT01769391|65866131|FG001|Overall Study|Progressive Disease|2|||
23348460|NCT00603382|65018087|FG005|Overall Study|Adverse Event|2|||
23348461|NCT00603382|65018082|FG000|Overall Study|Lack of Efficacy|14|||
23348462|NCT00603382|65018083|FG001|Overall Study|Lack of Efficacy|9|||
23348463|NCT00603382|65018084|FG002|Overall Study|Lack of Efficacy|3|||
23348464|NCT00603382|65018085|FG003|Overall Study|Lack of Efficacy|6|||
23348465|NCT00603382|65018086|FG004|Overall Study|Lack of Efficacy|6|||
23348466|NCT00603382|65018087|FG005|Overall Study|Lack of Efficacy|11|||
23348467|NCT00603382|65018082|FG000|Overall Study|Protocol Violation|1|||
23348468|NCT00603382|65018083|FG001|Overall Study|Protocol Violation|0|||
23348469|NCT00603382|65018084|FG002|Overall Study|Protocol Violation|1|||
23348470|NCT00603382|65018085|FG003|Overall Study|Protocol Violation|2|||
23348471|NCT00603382|65018086|FG004|Overall Study|Protocol Violation|1|||
23348472|NCT00603382|65018087|FG005|Overall Study|Protocol Violation|0|||
23348473|NCT00603382|65018082|FG000|Overall Study|Lost to Follow-up|0|||
23348474|NCT00603382|65018083|FG001|Overall Study|Lost to Follow-up|1|||
23348475|NCT00603382|65018084|FG002|Overall Study|Lost to Follow-up|1|||
23348476|NCT00603382|65018085|FG003|Overall Study|Lost to Follow-up|1|||
23348477|NCT00603382|65018086|FG004|Overall Study|Lost to Follow-up|0|||
23348478|NCT00603382|65018087|FG005|Overall Study|Lost to Follow-up|1|||
23348479|NCT00603382|65018082|FG000|Overall Study|Physician Decision|0|||
23348480|NCT00603382|65018083|FG001|Overall Study|Physician Decision|0|||
23348481|NCT00603382|65018084|FG002|Overall Study|Physician Decision|2|||
23348482|NCT00603382|65018085|FG003|Overall Study|Physician Decision|0|||
23348483|NCT00603382|65018086|FG004|Overall Study|Physician Decision|1|||
23348484|NCT00603382|65018087|FG005|Overall Study|Physician Decision|3|||
23348485|NCT00603382|65018082|FG000|Overall Study|Withdrawal by Subject|3|||
23348486|NCT00603382|65018083|FG001|Overall Study|Withdrawal by Subject|3|||
23348487|NCT00603382|65018084|FG002|Overall Study|Withdrawal by Subject|1|||
23348488|NCT00603382|65018085|FG003|Overall Study|Withdrawal by Subject|1|||
23348489|NCT00603382|65018086|FG004|Overall Study|Withdrawal by Subject|0|||
23348490|NCT00603382|65018087|FG005|Overall Study|Withdrawal by Subject|1|||
23348491|NCT01069419|65018091|FG000|Overall Study|Adverse Event|233|||
23348492|NCT01069419|65018091|FG000|Overall Study|Lack of Efficacy|332|||
23348493|NCT01069419|65018091|FG000|Overall Study|Lost to Follow-up|49|||
23348494|NCT01069419|65018091|FG000|Overall Study|Remission of disease|11|||
23348495|NCT01069419|65018091|FG000|Overall Study|Withdrawal by Subject|34|||
23348496|NCT01069419|65018091|FG000|Overall Study|Other Reason|43|||
23348497|NCT01069419|65018091|FG000|Overall Study|Missing termination information|13|||
23348498|NCT00987402|65018092|FG000|Overall Study|Insufficient data entry|86|||
23348499|NCT00987402|65018093|FG001|Overall Study|Insufficient data entry|98|||
23348500|NCT00904839|65018094|FG000|Overall Study|Adverse Event|0|||
23348501|NCT00904839|65018095|FG001|Overall Study|Adverse Event|5|||
23348502|NCT00904839|65018096|FG002|Overall Study|Adverse Event|4|||
23348503|NCT00904839|65018094|FG000|Overall Study|Protocol Violation|0|||
23348504|NCT00904839|65018095|FG001|Overall Study|Protocol Violation|1|||
23348505|NCT00904839|65018096|FG002|Overall Study|Protocol Violation|1|||
23348506|NCT00904839|65018094|FG000|Overall Study|Lost to Follow-up|0|||
23460281|NCT02277444|65430681|FG000|Overall Study|Enrolled and not Treated|3|||
23460282|NCT02277444|65430681|FG000|Overall Study|Ongoing|113|||
23460283|NCT03350672|65430684|FG000|Overall Study|Withdrawal by Subject|7|||
23460284|NCT03350672|65430685|FG001|Overall Study|Withdrawal by Subject|0|||
23460285|NCT03350672|65430686|FG002|Overall Study|Withdrawal by Subject|0|||
23181815|NCT00868790|64404802|FG003|Post-study|Withdrawal by Subject|0|||
23181816|NCT00868790|64404803|FG004|Post-study|Withdrawal by Subject|1|||
23181817|NCT00868790|64404804|FG005|Post-study|Withdrawal by Subject|0|||
23181818|NCT00868790|64404805|FG006|Post-study|Withdrawal by Subject|0|||
23181819|NCT00868790|64404806|FG007|Post-study|Withdrawal by Subject|0|||
23181820|NCT00868790|64404807|FG008|Post-study|Withdrawal by Subject|0|||
23181821|NCT00868790|64404808|FG009|Post-study|Withdrawal by Subject|0|||
23181822|NCT00868790|64404809|FG010|Post-study|Withdrawal by Subject|0|||
23181823|NCT00868790|64404810|FG011|Post-study|Withdrawal by Subject|0|||
23181824|NCT00868790|64404811|FG012|Post-study|Withdrawal by Subject|0|||
23181825|NCT00868790|64404812|FG013|Post-study|Withdrawal by Subject|0|||
23181826|NCT00868790|64404799|FG000|Post-study|Excluded Medication|0|||
23181827|NCT00868790|64404800|FG001|Post-study|Excluded Medication|0|||
23181828|NCT00868790|64404801|FG002|Post-study|Excluded Medication|0|||
23348507|NCT00904839|65018095|FG001|Overall Study|Lost to Follow-up|1|||
23348508|NCT00904839|65018096|FG002|Overall Study|Lost to Follow-up|2|||
23348509|NCT00904839|65018094|FG000|Overall Study|Withdrawal by Subject|0|||
23348510|NCT00904839|65018095|FG001|Overall Study|Withdrawal by Subject|2|||
23181829|NCT00868790|64404802|FG003|Post-study|Excluded Medication|0|||
23348511|NCT00904839|65018096|FG002|Overall Study|Withdrawal by Subject|0|||
23348512|NCT00904839|65018094|FG000|Overall Study|Not treated|1|||
23181830|NCT00868790|64404803|FG004|Post-study|Excluded Medication|0|||
23460286|NCT03219723|65430687|FG000|Overall Study|Case Report Forms Uncollected|6|||
23460287|NCT03219723|65430687|FG000|Overall Study|Protocol Deviation|4|||
23241172|NCT00719706|64626820|FG000|Overall Study|Protocol Violation|3|||
23348513|NCT00904839|65018095|FG001|Overall Study|Not treated|0|||
23348514|NCT00904839|65018096|FG002|Overall Study|Not treated|1|||
23348515|NCT00904839|65018094|FG000|Overall Study|Other than above|0|||
23241173|NCT00719706|64626821|FG001|Overall Study|Protocol Violation|0|||
23241174|NCT02210559|64626824|FG000|Overall Study|Progressive Disease|3|||
23241175|NCT02210559|64626825|FG001|Overall Study|Progressive Disease|2|||
23241176|NCT02210559|64626824|FG000|Overall Study|Adverse Event|2|||
23241177|NCT02210559|64626825|FG001|Overall Study|Adverse Event|2|||
23241178|NCT02210559|64626824|FG000|Overall Study|Physician Decision|1|||
23241179|NCT02210559|64626825|FG001|Overall Study|Physician Decision|0|||
23241180|NCT02210559|64626824|FG000|Overall Study|Withdrawal by Subject|0|||
23241181|NCT02210559|64626825|FG001|Overall Study|Withdrawal by Subject|1|||
23241182|NCT02210559|64626824|FG000|Overall Study|Other than specified|0|||
23241183|NCT02210559|64626825|FG001|Overall Study|Other than specified|1|||
23241184|NCT04837807|64626826|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
23241185|NCT04837807|64626827|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
23241186|NCT00718809|64626828|FG000|Overall Study|Disease progression|9|||
23241187|NCT00718809|64626829|FG001|Overall Study|Disease progression|7|||
23241188|NCT00718809|64626828|FG000|Overall Study|Adverse Event|1|||
23241189|NCT00718809|64626829|FG001|Overall Study|Adverse Event|1|||
23241190|NCT00718809|64626828|FG000|Overall Study|Withdrawal by Subject|0|||
23241191|NCT00718809|64626829|FG001|Overall Study|Withdrawal by Subject|1|||
23241192|NCT00718809|64626828|FG000|Overall Study|Lost to Follow-up|1|||
23348516|NCT00904839|65018095|FG001|Overall Study|Other than above|9|||
23348517|NCT00904839|65018096|FG002|Overall Study|Other than above|7|||
23348518|NCT03760458|65018098|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
23348519|NCT03760458|65018099|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
23348520|NCT03760458|65018100|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
23348521|NCT03760458|65018101|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
23348522|NCT03760458|65018102|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
23241193|NCT00718809|64626829|FG001|Overall Study|Lost to Follow-up|0|||
23348523|NCT02044874|65018103|FG000|Overall Study|Adverse Event|5|||
23348524|NCT02044874|65018104|FG001|Overall Study|Adverse Event|6|||
23348525|NCT02044874|65018105|FG002|Overall Study|Adverse Event|6|||
23348526|NCT02044874|65018103|FG000|Overall Study|Withdrawal by Subject|8|||
23348527|NCT02044874|65018104|FG001|Overall Study|Withdrawal by Subject|16|||
23348528|NCT02044874|65018105|FG002|Overall Study|Withdrawal by Subject|23|||
23348529|NCT02044874|65018103|FG000|Overall Study|Physician Decision|0|||
23348530|NCT02044874|65018104|FG001|Overall Study|Physician Decision|2|||
23348531|NCT02044874|65018105|FG002|Overall Study|Physician Decision|1|||
23348532|NCT02044874|65018103|FG000|Overall Study|Lost to Follow-up|10|||
23348533|NCT02044874|65018104|FG001|Overall Study|Lost to Follow-up|27|||
23348534|NCT02044874|65018105|FG002|Overall Study|Lost to Follow-up|21|||
23348535|NCT02044874|65018103|FG000|Overall Study|Sponsor Decision|0|||
23241194|NCT00718809|64626828|FG000|Overall Study|Noncompliance|1|||
23241195|NCT00718809|64626829|FG001|Overall Study|Noncompliance|0|||
23241196|NCT00650806|64626830|FG000|Overall Study|Adverse Event|0|||
23241197|NCT00650806|64626831|FG001|Overall Study|Adverse Event|5|||
23241198|NCT00650806|64626832|FG002|Overall Study|Adverse Event|3|||
23241199|NCT00650806|64626833|FG003|Overall Study|Adverse Event|4|||
23348536|NCT02044874|65018104|FG001|Overall Study|Sponsor Decision|1|||
23348537|NCT02044874|65018105|FG002|Overall Study|Sponsor Decision|1|||
23348538|NCT02044874|65018103|FG000|Overall Study|Other|7|||
23348539|NCT02044874|65018104|FG001|Overall Study|Other|3|||
23348540|NCT02044874|65018105|FG002|Overall Study|Other|8|||
23348541|NCT00932451|65018107|FG000|Overall Study|Withdrawal by Subject|69|||
23348542|NCT00932451|65018107|FG000|Overall Study|Lost to Follow-up|22|||
23348543|NCT00932451|65018107|FG000|Overall Study|Death|726|||
23348544|NCT00932451|65018107|FG000|Overall Study|Other reasons|5|||
23348545|NCT00787917|65018110|FG000|Blinded Treatment|Adverse Event|1|||
23348546|NCT00787917|65018111|FG001|Blinded Treatment|Adverse Event|0|||
23348547|NCT00787917|65018110|FG000|Blinded Treatment|Lack of Efficacy|1|||
23460288|NCT00538902|65430688|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
23460289|NCT00538902|65430689|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
23460290|NCT00538902|65430690|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
23460291|NCT00538902|65430688|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
23241200|NCT00650806|64626830|FG000|Overall Study|Lost to Follow-up|7|||
23241201|NCT00650806|64626831|FG001|Overall Study|Lost to Follow-up|6|||
23241202|NCT00650806|64626832|FG002|Overall Study|Lost to Follow-up|11|||
23348548|NCT00787917|65018111|FG001|Blinded Treatment|Lack of Efficacy|0|||
23348549|NCT00787917|65018110|FG000|Blinded Treatment|Administrative problems|3|||
23348550|NCT00787917|65018111|FG001|Blinded Treatment|Administrative problems|2|||
23348551|NCT00787917|65018110|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
23348552|NCT00787917|65018111|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
23348553|NCT00787917|65018110|FG000|Open Label|Administrative problems|3|||
23241203|NCT00650806|64626833|FG003|Overall Study|Lost to Follow-up|10|||
23241204|NCT00650806|64626830|FG000|Overall Study|Protocol Violation|0|||
23241205|NCT00650806|64626831|FG001|Overall Study|Protocol Violation|0|||
23348554|NCT00787917|65018111|FG001|Open Label|Administrative problems|0|||
23348555|NCT02945254|65018112|FG000|Overall Study|Lost to Follow-up|1|||
23348556|NCT02945254|65018113|FG001|Overall Study|Lost to Follow-up|0|||
23348557|NCT02945254|65018112|FG000|Overall Study|Withdrawal by Subject|1|||
23348558|NCT02945254|65018113|FG001|Overall Study|Withdrawal by Subject|0|||
23348559|NCT01210144|65018119|FG000|Overall Study|Lack of ovarian response|1|||
23348560|NCT01210144|65018120|FG001|Overall Study|Lack of ovarian response|0|||
23348561|NCT01210144|65018119|FG000|Overall Study|No fertilization|1|||
23348562|NCT01210144|65018120|FG001|Overall Study|No fertilization|0|||
23348563|NCT01210144|65018119|FG000|Overall Study|No transfer|1|||
23348564|NCT01210144|65018120|FG001|Overall Study|No transfer|0|||
23348565|NCT02614131|65018121|FG000|Overall Study|Withdrawal by Subject|1|||
23348566|NCT02614131|65018122|FG001|Overall Study|Withdrawal by Subject|0|||
23181831|NCT00868790|64404804|FG005|Post-study|Excluded Medication|0|||
23181832|NCT00868790|64404805|FG006|Post-study|Excluded Medication|0|||
23181833|NCT00868790|64404806|FG007|Post-study|Excluded Medication|2|||
23181834|NCT00868790|64404807|FG008|Post-study|Excluded Medication|0|||
23181835|NCT00868790|64404808|FG009|Post-study|Excluded Medication|1|||
23181836|NCT00868790|64404809|FG010|Post-study|Excluded Medication|0|||
23181837|NCT00868790|64404810|FG011|Post-study|Excluded Medication|0|||
23181838|NCT00868790|64404811|FG012|Post-study|Excluded Medication|0|||
23241206|NCT00650806|64626832|FG002|Overall Study|Protocol Violation|0|||
23348567|NCT02614131|65018123|FG002|Overall Study|Withdrawal by Subject|0|||
23348568|NCT02614131|65018124|FG003|Overall Study|Withdrawal by Subject|0|||
23348569|NCT02614131|65018125|FG004|Overall Study|Withdrawal by Subject|0|||
23348570|NCT02614131|65018126|FG005|Overall Study|Withdrawal by Subject|0|||
23348571|NCT02614131|65018127|FG006|Overall Study|Withdrawal by Subject|0|||
23348572|NCT02614131|65018121|FG000|Overall Study|Adverse Event|0|||
23348573|NCT02614131|65018122|FG001|Overall Study|Adverse Event|0|||
23348574|NCT02614131|65018123|FG002|Overall Study|Adverse Event|0|||
23348575|NCT02614131|65018124|FG003|Overall Study|Adverse Event|0|||
23348576|NCT02614131|65018125|FG004|Overall Study|Adverse Event|0|||
23348577|NCT02614131|65018126|FG005|Overall Study|Adverse Event|0|||
23348578|NCT02614131|65018127|FG006|Overall Study|Adverse Event|1|||
23348579|NCT00526331|65018129|FG000|Overall Study|Sponsor Termination|55|||
23348580|NCT02631746|65018132|FG000|Overall Study|Lack of Efficacy|3|||
23348581|NCT02552888|65018133|FG000|Overall Study|Lost to Follow-up|1|||
23348582|NCT02552888|65018134|FG001|Overall Study|Lost to Follow-up|1|||
23348583|NCT03172364|65018135|FG000|Overall Study|Adverse Event|1|||
23348584|NCT03172364|65018136|FG001|Overall Study|Adverse Event|1|||
23348585|NCT03172364|65018135|FG000|Overall Study|Protocol Violation|1|||
23348586|NCT03172364|65018136|FG001|Overall Study|Protocol Violation|0|||
23348587|NCT01603407|65018137|FG000|Overall Study|Adverse Event|1|||
23348588|NCT01603407|65018138|FG001|Overall Study|Adverse Event|1|||
23348589|NCT01603407|65018139|FG002|Overall Study|Adverse Event|1|||
23348590|NCT01603407|65018137|FG000|Overall Study|Protocol Violation|2|||
23348591|NCT01603407|65018138|FG001|Overall Study|Protocol Violation|2|||
23348592|NCT01603407|65018139|FG002|Overall Study|Protocol Violation|0|||
23348593|NCT01603407|65018137|FG000|Overall Study|Withdrawal by Subject|8|||
23348594|NCT01603407|65018138|FG001|Overall Study|Withdrawal by Subject|5|||
23348595|NCT01603407|65018139|FG002|Overall Study|Withdrawal by Subject|7|||
23348596|NCT01603407|65018137|FG000|Overall Study|Lost to Follow-up|0|||
23348597|NCT01603407|65018138|FG001|Overall Study|Lost to Follow-up|3|||
23348598|NCT01603407|65018139|FG002|Overall Study|Lost to Follow-up|2|||
23348599|NCT00856843|65021567|FG000|Overall Study|Withdrawal by Subject|1|||
23348600|NCT00856843|65021568|FG001|Overall Study|Withdrawal by Subject|5|||
23348601|NCT00856843|65021567|FG000|Overall Study|Lack of Efficacy|1|||
23348602|NCT00856843|65021568|FG001|Overall Study|Lack of Efficacy|0|||
23348603|NCT02012959|65021569|FG000|Treatment Phase A|Adverse Event|2|||
23348604|NCT02012959|65021570|FG001|Treatment Phase A|Adverse Event|0|||
23348605|NCT02012959|65021571|FG002|Treatment Phase A|Adverse Event|0|||
23348606|NCT02012959|65021572|FG003|Treatment Phase A|Adverse Event|0|||
23348607|NCT02012959|65021573|FG004|Treatment Phase A|Adverse Event|0|||
23348608|NCT01280682|65021574|FG000|Overall Study|Lost to Follow-up|0|||
23348609|NCT01280682|65021575|FG001|Overall Study|Lost to Follow-up|6|||
23348610|NCT01280682|65021574|FG000|Overall Study|Withdrawal by Subject|0|||
23348611|NCT01280682|65021575|FG001|Overall Study|Withdrawal by Subject|7|||
23348612|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
23348613|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
23348614|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
23348615|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
23348616|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
23348617|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
23348618|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
23348619|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
23348620|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
23348621|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
23348622|NCT02418585|65021576|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
23181839|NCT00868790|64404812|FG013|Post-study|Excluded Medication|0|||
23348623|NCT02418585|65021577|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
23348624|NCT02418585|65021576|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
23348625|NCT02418585|65021577|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
23348626|NCT02418585|65021576|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
23348627|NCT02418585|65021577|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
23348628|NCT02418585|65021576|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
23460292|NCT00538902|65430689|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
23460293|NCT00538902|65430690|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
23460294|NCT00538902|65430688|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
23460295|NCT00538902|65430689|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
23460296|NCT00538902|65430690|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
23460297|NCT00538902|65430688|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
23460298|NCT00538902|65430689|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
23460299|NCT00538902|65430690|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
23460300|NCT00538902|65430688|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
23460301|NCT00538902|65430689|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
23460302|NCT00538902|65430690|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
23460303|NCT00538902|65430688|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
23460304|NCT00538902|65430689|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
23460305|NCT00538902|65430690|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
23460306|NCT00538902|65430688|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
23460307|NCT00538902|65430689|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
23460308|NCT00538902|65430690|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
23460309|NCT00538902|65430688|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
23460310|NCT00538902|65430689|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
23460311|NCT00538902|65430690|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
23460312|NCT03962491|65430696|FG000|Overall Study|Lost to Follow-up|4|||
23460313|NCT03962491|65430697|FG001|Overall Study|Lost to Follow-up|5|||
23460314|NCT00425269|65430699|FG000|Overall Study|Pregnancy|5|||
23460315|NCT00425269|65430700|FG001|Overall Study|Pregnancy|7|||
23460316|NCT00425269|65430699|FG000|Overall Study|Lost to Follow-up|9|||
23460317|NCT00425269|65430700|FG001|Overall Study|Lost to Follow-up|9|||
23460318|NCT00425269|65430699|FG000|Overall Study|moved or medical reason|5|||
23460319|NCT00425269|65430700|FG001|Overall Study|moved or medical reason|4|||
23181840|NCT03822884|64404815|FG000|Overall Study|Withdrawal by Subject|0|||
23181841|NCT03822884|64404816|FG001|Overall Study|Withdrawal by Subject|0|||
23181842|NCT03822884|64404817|FG002|Overall Study|Withdrawal by Subject|0|||
23181843|NCT03822884|64404818|FG003|Overall Study|Withdrawal by Subject|0|||
23181844|NCT03822884|64404819|FG004|Overall Study|Withdrawal by Subject|1|||
23181845|NCT03822884|64404820|FG005|Overall Study|Withdrawal by Subject|0|||
23460320|NCT02059278|65430701|FG000|Overall Study|Adverse Event|1|||
23460321|NCT02059278|65430702|FG001|Overall Study|Adverse Event|1|||
23460322|NCT02059278|65430701|FG000|Overall Study|Lost to Follow-up|1|||
23460323|NCT02059278|65430702|FG001|Overall Study|Lost to Follow-up|0|||
23460324|NCT02059278|65430701|FG000|Overall Study|Withdrawal by Subject|0|||
23460325|NCT02059278|65430702|FG001|Overall Study|Withdrawal by Subject|3|||
23460326|NCT02059278|65430701|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
23181846|NCT01889602|64404823|FG000|First Intervention|Adverse Event|1|||
23181847|NCT01889602|64404824|FG001|First Intervention|Adverse Event|1|||
23181848|NCT01889602|64404825|FG002|First Intervention|Adverse Event|1|||
23181849|NCT01889602|64404823|FG000|First Intervention|Protocol Violation|0|||
23181850|NCT01889602|64404824|FG001|First Intervention|Protocol Violation|1|||
23181851|NCT01889602|64404825|FG002|First Intervention|Protocol Violation|1|||
23181852|NCT01889602|64404823|FG000|First Intervention|Study ending|0|||
23181853|NCT01889602|64404824|FG001|First Intervention|Study ending|1|||
23181854|NCT01889602|64404825|FG002|First Intervention|Study ending|0|||
23181855|NCT01889602|64404823|FG000|Second Intervention|Adverse Event|0|||
23181856|NCT01889602|64404824|FG001|Second Intervention|Adverse Event|0|||
23181857|NCT01889602|64404825|FG002|Second Intervention|Adverse Event|1|||
23181858|NCT01889602|64404823|FG000|Second Intervention|Study ending|1|||
23181859|NCT01889602|64404824|FG001|Second Intervention|Study ending|0|||
23181860|NCT01889602|64404825|FG002|Second Intervention|Study ending|0|||
23181861|NCT01889602|64404823|FG000|Second Intervention|Withdrawal by Subject|0|||
23181862|NCT01889602|64404824|FG001|Second Intervention|Withdrawal by Subject|0|||
23181863|NCT01889602|64404825|FG002|Second Intervention|Withdrawal by Subject|1|||
23460327|NCT02059278|65430702|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
23181864|NCT01889602|64404823|FG000|Third Intervention|Protocol Violation|1|||
23181865|NCT01889602|64404824|FG001|Third Intervention|Protocol Violation|0|||
23181866|NCT01889602|64404825|FG002|Third Intervention|Protocol Violation|0|||
23181867|NCT01889602|64404823|FG000|Third Intervention|Withdrawal by Subject|2|||
23181868|NCT01889602|64404824|FG001|Third Intervention|Withdrawal by Subject|2|||
23181869|NCT01889602|64404825|FG002|Third Intervention|Withdrawal by Subject|0|||
23181870|NCT00670007|64404826|FG000|Overall Study|Drug abuse|1|||
23460328|NCT01499355|65430714|FG000|Run-In Period|Study Termination|15|||
23460329|NCT01499355|65430715|FG001|Run-In Period|Study Termination|0|||
23460330|NCT01499355|65430716|FG002|Run-In Period|Study Termination|0|||
23460331|NCT01499355|65430717|FG003|Run-In Period|Study Termination|0|||
23460332|NCT01499355|65430714|FG000|Run-In Period|Other|3|||
23460333|NCT01499355|65430715|FG001|Run-In Period|Other|0|||
23460334|NCT01499355|65430716|FG002|Run-In Period|Other|0|||
23460335|NCT01499355|65430717|FG003|Run-In Period|Other|0|||
23460336|NCT01499355|65430714|FG000|Run-In Period|Death|2|||
23460337|NCT01499355|65430715|FG001|Run-In Period|Death|0|||
23460338|NCT01499355|65430716|FG002|Run-In Period|Death|0|||
23460339|NCT01499355|65430717|FG003|Run-In Period|Death|0|||
23460340|NCT01499355|65430714|FG000|Run-In Period|Investigator Decision|2|||
23460341|NCT01499355|65430715|FG001|Run-In Period|Investigator Decision|0|||
23460342|NCT01499355|65430716|FG002|Run-In Period|Investigator Decision|0|||
23460343|NCT01499355|65430717|FG003|Run-In Period|Investigator Decision|0|||
23460344|NCT01499355|65430714|FG000|Run-In Period|Consent Withdrawn|1|||
23460345|NCT01499355|65430715|FG001|Run-In Period|Consent Withdrawn|0|||
23460346|NCT01499355|65430716|FG002|Run-In Period|Consent Withdrawn|0|||
23460347|NCT01499355|65430717|FG003|Run-In Period|Consent Withdrawn|0|||
23460348|NCT01499355|65430714|FG000|Run-In Period|Adverse Event|8|||
23460349|NCT01499355|65430715|FG001|Run-In Period|Adverse Event|0|||
23460350|NCT01499355|65430716|FG002|Run-In Period|Adverse Event|0|||
23460351|NCT01499355|65430717|FG003|Run-In Period|Adverse Event|0|||
23460352|NCT01499355|65430714|FG000|Double-Blind Period|Adverse Event|0|||
23460353|NCT01499355|65430715|FG001|Double-Blind Period|Adverse Event|2|||
23460354|NCT01499355|65430716|FG002|Double-Blind Period|Adverse Event|3|||
23460355|NCT01499355|65430717|FG003|Double-Blind Period|Adverse Event|2|||
23460356|NCT01499355|65430714|FG000|Double-Blind Period|Study Termination|0|||
23460357|NCT01499355|65430715|FG001|Double-Blind Period|Study Termination|18|||
23460358|NCT01499355|65430716|FG002|Double-Blind Period|Study Termination|16|||
23460359|NCT01499355|65430717|FG003|Double-Blind Period|Study Termination|14|||
23460360|NCT01499355|65430714|FG000|Double-Blind Period|Other|0|||
23460361|NCT01499355|65430715|FG001|Double-Blind Period|Other|1|||
23460362|NCT01499355|65430716|FG002|Double-Blind Period|Other|2|||
23460363|NCT01499355|65430717|FG003|Double-Blind Period|Other|2|||
23181871|NCT00670007|64404826|FG000|Overall Study|Lung transplant|1|||
23181872|NCT00670007|64404826|FG000|Overall Study|Travel/Vacation|1|||
23181873|NCT00670007|64404826|FG000|Overall Study|Adverse event, serious fatal|1|||
23181874|NCT00670007|64404826|FG000|Overall Study|Adverse Event|1|||
23181875|NCT00670007|64404826|FG000|Overall Study|Withdrawal by Subject|4|||
23181876|NCT02076165|64404827|FG000|Overall Study|Lost to Follow-up|7|||
23460364|NCT01499355|65430714|FG000|Double-Blind Period|Death|0|||
23460365|NCT01499355|65430715|FG001|Double-Blind Period|Death|1|||
23460366|NCT01499355|65430716|FG002|Double-Blind Period|Death|0|||
23460367|NCT01499355|65430717|FG003|Double-Blind Period|Death|0|||
23460368|NCT01499355|65430714|FG000|Double-Blind Period|Investigator Decision|0|||
23460369|NCT01499355|65430715|FG001|Double-Blind Period|Investigator Decision|0|||
23460370|NCT01499355|65430716|FG002|Double-Blind Period|Investigator Decision|3|||
23460371|NCT01499355|65430717|FG003|Double-Blind Period|Investigator Decision|3|||
23460372|NCT01499355|65430714|FG000|Double-Blind Period|Consent Withdrawn|0|||
23460373|NCT01499355|65430715|FG001|Double-Blind Period|Consent Withdrawn|0|||
23460374|NCT01499355|65430716|FG002|Double-Blind Period|Consent Withdrawn|1|||
23460375|NCT01499355|65430717|FG003|Double-Blind Period|Consent Withdrawn|2|||
23460376|NCT01499355|65430714|FG000|Double-Blind Period|Lost to Follow-up|0|||
23460377|NCT01499355|65430715|FG001|Double-Blind Period|Lost to Follow-up|1|||
23460378|NCT01499355|65430716|FG002|Double-Blind Period|Lost to Follow-up|0|||
23460379|NCT01499355|65430717|FG003|Double-Blind Period|Lost to Follow-up|0|||
23460380|NCT00092417|65430718|FG000|Overall Study|Lost to Follow-up|2|||
23460381|NCT00092417|65430719|FG001|Overall Study|Lost to Follow-up|0|||
23460382|NCT00092417|65430718|FG000|Overall Study|Withdrawal by Subject|2|||
23460383|NCT00092417|65430719|FG001|Overall Study|Withdrawal by Subject|1|||
23460384|NCT00092417|65430718|FG000|Overall Study|Other|1|||
23460385|NCT00092417|65430719|FG001|Overall Study|Other|0|||
23460386|NCT02120898|65430721|FG000|Overall Study|Withdrawal by Subject|4|||
23460387|NCT02120898|65430722|FG001|Overall Study|Withdrawal by Subject|2|||
23181877|NCT02076165|64404828|FG001|Overall Study|Lost to Follow-up|5|||
23181878|NCT02076165|64404827|FG000|Overall Study|Refused follow-up assessment|1|||
23348629|NCT02418585|65021577|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
23348630|NCT02418585|65021576|FG000|Follow-up Phase (24 Weeks)|Other|3|||
23460388|NCT02120898|65430723|FG002|Overall Study|Withdrawal by Subject|2|||
23460389|NCT02120898|65430721|FG000|Overall Study|Non-compliance with study drug|3|||
23460390|NCT02120898|65430722|FG001|Overall Study|Non-compliance with study drug|0|||
23460391|NCT02120898|65430723|FG002|Overall Study|Non-compliance with study drug|0|||
23460392|NCT02120898|65430721|FG000|Overall Study|Adverse Event|1|||
23460393|NCT02120898|65430722|FG001|Overall Study|Adverse Event|2|||
23460394|NCT02120898|65430723|FG002|Overall Study|Adverse Event|1|||
23460395|NCT02120898|65430721|FG000|Overall Study|Protocol Violation|1|||
23460396|NCT02120898|65430722|FG001|Overall Study|Protocol Violation|2|||
23460397|NCT02120898|65430723|FG002|Overall Study|Protocol Violation|0|||
23460398|NCT02120898|65430721|FG000|Overall Study|Lost to Follow-up|0|||
23460399|NCT02120898|65430722|FG001|Overall Study|Lost to Follow-up|0|||
23460400|NCT02120898|65430723|FG002|Overall Study|Lost to Follow-up|1|||
23460401|NCT00888173|65430724|FG000|Overall Study|Wrong Primary|1|||
23460402|NCT00888173|65430724|FG000|Overall Study|Ineligible: required test not done|1|||
23460403|NCT00734149|65430743|FG000|Overall Study|Withdrawal by Subject|1|||
23460404|NCT01131507|65430744|FG000|Overall Study|Adverse Event|1|||
23460405|NCT01131507|65430744|FG000|Overall Study|Lost to Follow-up|1|||
23460406|NCT01131507|65430744|FG000|Overall Study|Withdrawal by Subject|1|||
23460407|NCT01815918|65430745|FG000|Overall Study|Patient samples not analyzable|3|||
23460408|NCT01815918|65430746|FG001|Overall Study|Patient samples not analyzable|4|||
23460409|NCT01815918|65430745|FG000|Overall Study|Lack of Efficacy|15|||
23460410|NCT01815918|65430746|FG001|Overall Study|Lack of Efficacy|15|||
23460411|NCT01292486|65430749|FG000|Overall Study|Protocol Violation|2|||
23460412|NCT01292486|65430749|FG000|Overall Study|Did not meet screening criteria|2|||
23460413|NCT01292486|65430749|FG000|Overall Study|Adverse Event|1|||
23460414|NCT01292486|65430749|FG000|Overall Study|Physician Decision|1|||
23460415|NCT01056822|65430750|FG000|Overall Study|Adverse Event|0|||
23460416|NCT01056822|65430751|FG001|Overall Study|Adverse Event|1|||
23460417|NCT01056822|65430750|FG000|Overall Study|Protocol Violation|6|||
23460418|NCT01056822|65430751|FG001|Overall Study|Protocol Violation|5|||
23460419|NCT01056822|65430750|FG000|Overall Study|Withdrawal by Subject|1|||
23460420|NCT01056822|65430751|FG001|Overall Study|Withdrawal by Subject|1|||
23460421|NCT01056822|65430750|FG000|Overall Study|Lost to Follow-up|1|||
23460422|NCT01056822|65430751|FG001|Overall Study|Lost to Follow-up|0|||
23460423|NCT03155841|65430755|FG000|Overall Study|Protocol Violation|3|||
23460424|NCT03155841|65430756|FG001|Overall Study|Protocol Violation|4|||
23460425|NCT00787644|65430761|FG000|Overall Study|Lost to Follow-up|1|||
23460426|NCT00787644|65430762|FG001|Overall Study|Lost to Follow-up|1|||
23460427|NCT00787644|65430761|FG000|Overall Study|Withdrawal by Subject|1|||
23460428|NCT00787644|65430762|FG001|Overall Study|Withdrawal by Subject|1|||
23460429|NCT00935584|65430764|FG000|Overall Study|Withdrawal by Subject|9|||
23460430|NCT00935584|65430765|FG001|Overall Study|Withdrawal by Subject|0|||
23460431|NCT00935584|65430764|FG000|Overall Study|Death|3|||
23460432|NCT00935584|65430765|FG001|Overall Study|Death|0|||
23460433|NCT00935584|65430764|FG000|Overall Study|Lost to Follow-up|8|||
23460434|NCT00935584|65430765|FG001|Overall Study|Lost to Follow-up|0|||
23460435|NCT00935584|65430764|FG000|Overall Study|No show|9|||
23460436|NCT00935584|65430765|FG001|Overall Study|No show|0|||
23460437|NCT00935584|65430764|FG000|Overall Study|Relocated|3|||
23460438|NCT00935584|65430765|FG001|Overall Study|Relocated|0|||
23460439|NCT00935584|65430764|FG000|Overall Study|Patient changed provider|3|||
23460440|NCT00935584|65430765|FG001|Overall Study|Patient changed provider|0|||
23460441|NCT00935584|65430764|FG000|Overall Study|Provider dropped out of study|14|||
23460442|NCT00935584|65430765|FG001|Overall Study|Provider dropped out of study|4|||
23460443|NCT00459316|65430768|FG000|Steps 1 & 2|Other eligibility failure|1|||
23460444|NCT00459316|65430769|FG001|Steps 1 & 2|Other eligibility failure|1|||
23460445|NCT00459316|65430770|FG002|Steps 1 & 2|Other eligibility failure|0|||
23460446|NCT00459316|65430768|FG000|Steps 1 & 2|Death|1|||
23460447|NCT00459316|65430769|FG001|Steps 1 & 2|Death|1|||
23460448|NCT00459316|65430770|FG002|Steps 1 & 2|Death|0|||
23460449|NCT00459316|65430768|FG000|Steps 1 & 2|Not able to get to clinic|7|||
23460450|NCT00459316|65430769|FG001|Steps 1 & 2|Not able to get to clinic|4|||
23460451|NCT00459316|65430770|FG002|Steps 1 & 2|Not able to get to clinic|0|||
23460452|NCT00459316|65430768|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
23460453|NCT00459316|65430769|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
23460454|NCT00459316|65430770|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
23460455|NCT00459316|65430768|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
23460456|NCT00459316|65430769|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
23460457|NCT00459316|65430770|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
23460458|NCT00459316|65430768|FG000|Steps 1 & 2|Lost to Follow-up|5|||
23460459|NCT00459316|65430769|FG001|Steps 1 & 2|Lost to Follow-up|0|||
23460460|NCT00459316|65430770|FG002|Steps 1 & 2|Lost to Follow-up|2|||
23460461|NCT00459316|65430768|FG000|Step 3|Withdrawal by Subject|3|||
23460462|NCT00459316|65430769|FG001|Step 3|Withdrawal by Subject|0|||
23460463|NCT00459316|65430770|FG002|Step 3|Withdrawal by Subject|1|||
23460464|NCT00992108|65430771|FG000|Overall Study|Lost to Follow-up|0|||
23460465|NCT00992108|65430772|FG001|Overall Study|Lost to Follow-up|1|||
23460466|NCT02613507|65430773|FG000|Overall Study|Disease Progression|237|||
23460467|NCT02613507|65430774|FG001|Overall Study|Disease Progression|109|||
23460468|NCT02613507|65430773|FG000|Overall Study|Study Drug Toxicity|15|||
23460469|NCT02613507|65430774|FG001|Overall Study|Study Drug Toxicity|14|||
23460470|NCT02613507|65430773|FG000|Overall Study|Death|3|||
23460471|NCT02613507|65430774|FG001|Overall Study|Death|0|||
23460472|NCT02613507|65430773|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
23460473|NCT02613507|65430774|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23460474|NCT02613507|65430773|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
23460475|NCT02613507|65430774|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
23460476|NCT02613507|65430773|FG000|Overall Study|Participant Withdrew Consent|0|||
23460477|NCT02613507|65430774|FG001|Overall Study|Participant Withdrew Consent|2|||
23460478|NCT02613507|65430773|FG000|Overall Study|Lost to Follow-up|1|||
23460479|NCT02613507|65430774|FG001|Overall Study|Lost to Follow-up|0|||
23460480|NCT02613507|65430773|FG000|Overall Study|Maximum Clinical Benefit|4|||
23460481|NCT02613507|65430774|FG001|Overall Study|Maximum Clinical Benefit|10|||
23460482|NCT02613507|65430773|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
23460483|NCT02613507|65430774|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
23460484|NCT02613507|65430773|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
23460485|NCT02613507|65430774|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
23460486|NCT02613507|65430773|FG000|Overall Study|Randomized but not Treated|1|||
23460487|NCT02613507|65430774|FG001|Overall Study|Randomized but not Treated|10|||
23460488|NCT00684021|65430775|FG000|Overall Study|MRI Contraindicated|1|||
23460489|NCT00684021|65430776|FG001|Overall Study|MRI Contraindicated|1|||
23460490|NCT00684021|65430777|FG002|Overall Study|MRI Contraindicated|1|||
23460491|NCT00684021|65430778|FG003|Overall Study|MRI Contraindicated|0|||
23460492|NCT00684021|65430775|FG000|Overall Study|MRI not performed|0|||
23460493|NCT00684021|65430776|FG001|Overall Study|MRI not performed|1|||
23460494|NCT00684021|65430777|FG002|Overall Study|MRI not performed|1|||
23460495|NCT00684021|65430778|FG003|Overall Study|MRI not performed|2|||
23181879|NCT02076165|64404828|FG001|Overall Study|Refused follow-up assessment|1|||
23181880|NCT00950170|64404829|FG000|Overall Study|Parent/Legal Guardian Request|1|||
23181881|NCT00950170|64404829|FG000|Overall Study|Adverse Event|2|||
23181882|NCT00950170|64404829|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
23181883|NCT03377634|64404830|FG000|Study Period|Adverse Event|1|||
23181884|NCT03377634|64404831|FG001|Study Period|Adverse Event|0|||
23181885|NCT03377634|64404830|FG000|Study Period|Withdrawal by Subject|1|||
23181886|NCT03377634|64404831|FG001|Study Period|Withdrawal by Subject|0|||
23181887|NCT01993888|64404832|FG000|Overall Study|Death|1|||
23181888|NCT01993888|64404833|FG001|Overall Study|Death|1|||
23181889|NCT01993888|64404832|FG000|Overall Study|Lost to Follow-up|1|||
23181890|NCT01993888|64404833|FG001|Overall Study|Lost to Follow-up|1|||
23460496|NCT00684021|65430775|FG000|Overall Study|Death|1|||
23460497|NCT00684021|65430776|FG001|Overall Study|Death|0|||
23460498|NCT00684021|65430777|FG002|Overall Study|Death|0|||
23460499|NCT00684021|65430778|FG003|Overall Study|Death|0|||
23460500|NCT02220920|65430779|FG000|Overall Study|Adverse Event|1|||
23460501|NCT02220920|65430780|FG001|Overall Study|Adverse Event|0|||
23460502|NCT02220920|65430779|FG000|Overall Study|Lack of Efficacy|0|||
23460503|NCT02220920|65430780|FG001|Overall Study|Lack of Efficacy|1|||
23460504|NCT02220920|65430779|FG000|Overall Study|Withdrawal by Subject|1|||
23241207|NCT00650806|64626833|FG003|Overall Study|Protocol Violation|1|||
23241208|NCT00650806|64626830|FG000|Overall Study|Pregnancy|0|||
23241209|NCT00650806|64626831|FG001|Overall Study|Pregnancy|0|||
23460505|NCT02220920|65430780|FG001|Overall Study|Withdrawal by Subject|0|||
23460506|NCT02220920|65430779|FG000|Overall Study|Conflict with the stopping criteria|1|||
23460507|NCT02220920|65430780|FG001|Overall Study|Conflict with the stopping criteria|2|||
23460508|NCT02691507|65430783|FG000|Overall Study|Missed Visit 3|0|||
23460509|NCT02691507|65430784|FG001|Overall Study|Missed Visit 3|1|||
23460510|NCT04177823|65430785|FG000|Overall Study|Physician Decision|1|||
23460511|NCT04177823|65430785|FG000|Overall Study|Withdrawal by Subject|1|||
23460512|NCT00474487|65430786|FG000|Overall Study|Withdrawal by Subject|6|||
23460513|NCT00474487|65430787|FG001|Overall Study|Withdrawal by Subject|0|||
23460514|NCT00474487|65430788|FG002|Overall Study|Withdrawal by Subject|0|||
23460515|NCT00474487|65430789|FG003|Overall Study|Withdrawal by Subject|0|||
23460516|NCT00474487|65430786|FG000|Overall Study|Lost to Follow-up|20|||
23460517|NCT00474487|65430787|FG001|Overall Study|Lost to Follow-up|1|||
23460518|NCT00474487|65430788|FG002|Overall Study|Lost to Follow-up|7|||
23460519|NCT00474487|65430789|FG003|Overall Study|Lost to Follow-up|0|||
23460520|NCT00474487|65430786|FG000|Overall Study|Inappropriate enrollment|4|||
23460521|NCT00474487|65430787|FG001|Overall Study|Inappropriate enrollment|0|||
23460522|NCT00474487|65430788|FG002|Overall Study|Inappropriate enrollment|7|||
23181891|NCT01993888|64404832|FG000|Overall Study|Withdrawal by Subject|0|||
23181892|NCT01993888|64404833|FG001|Overall Study|Withdrawal by Subject|1|||
23181893|NCT03367871|64404836|FG000|Overall Study|Lost to Follow-up|1|||
23460523|NCT00474487|65430789|FG003|Overall Study|Inappropriate enrollment|0|||
23460524|NCT00474487|65430786|FG000|Overall Study|Death|0|||
23460525|NCT00474487|65430787|FG001|Overall Study|Death|1|||
23460526|NCT00474487|65430788|FG002|Overall Study|Death|0|||
23460527|NCT00474487|65430789|FG003|Overall Study|Death|0|||
23460528|NCT00910650|65430794|FG000|Overall Study|Death|2|||
23460529|NCT00283296|65430795|FG000|Overall Study|in-home trial not completed|5|||
23181894|NCT04003610|64404837|FG000|Overall Study|Lost to Follow-up|0|||
23460530|NCT04774094|65430796|FG000|Overall Study|Other|2|||
23460531|NCT04774094|65430796|FG000|Overall Study|Withdrawal by Subject|9|||
23460532|NCT04774094|65430796|FG000|Overall Study|Lost to Follow-up|7|||
23181895|NCT04003610|64404838|FG001|Overall Study|Lost to Follow-up|1|||
23181896|NCT04003610|64404839|FG002|Overall Study|Lost to Follow-up|0|||
23460533|NCT04774094|65430796|FG000|Overall Study|Lack of Efficacy|5|||
23460534|NCT04774094|65430796|FG000|Overall Study|Death|17|||
23460535|NCT04774094|65430796|FG000|Overall Study|Adverse Event|4|||
23460536|NCT03278249|65430797|FG000|Overall Study|Withdrawal by Subject|2|||
23460537|NCT03278249|65430797|FG000|Overall Study|Lost to Follow-up|1|||
23460538|NCT02158546|65430798|FG000|Overall Study|Physician Decision|0|||
23460539|NCT02158546|65430799|FG001|Overall Study|Physician Decision|1|||
23460540|NCT02158546|65430800|FG002|Overall Study|Physician Decision|0|||
23460541|NCT02158546|65430801|FG003|Overall Study|Physician Decision|0|||
23181897|NCT04003610|64404837|FG000|Overall Study|Death|0|||
23181898|NCT04003610|64404838|FG001|Overall Study|Death|0|||
23181899|NCT04003610|64404839|FG002|Overall Study|Death|3|||
23181900|NCT04003610|64404837|FG000|Overall Study|Study Terminated by Sponsor|0|||
23181901|NCT04003610|64404838|FG001|Overall Study|Study Terminated by Sponsor|0|||
23181902|NCT04003610|64404839|FG002|Overall Study|Study Terminated by Sponsor|3|||
23181903|NCT00480857|64404847|FG000|Overall Study|Lack of Efficacy|2|||
23181904|NCT02382133|64404852|FG000|Overall Study|Death|22|||
23181905|NCT02382133|64404852|FG000|Overall Study|transfer out of ICU|4|||
23181906|NCT02382133|64404852|FG000|Overall Study|Physician Decision|2|||
23181907|NCT02382133|64404852|FG000|Overall Study|arterial catheter loss|4|||
23181908|NCT02382133|64404852|FG000|Overall Study|pressure injury both sites|1|||
23181909|NCT01805180|64404853|FG000|Lead-in Donor Phase|screen failure|1|||
23181910|NCT01805180|64404854|FG001|Lead-in Donor Phase|screen failure|0|||
23181911|NCT01805180|64404855|FG002|Lead-in Donor Phase|screen failure|0|||
23181912|NCT02251912|64404859|FG000|Overall Study|Withdrawal by Subject|2|||
23181913|NCT02251912|64404860|FG001|Overall Study|Withdrawal by Subject|3|||
23181914|NCT02251912|64404859|FG000|Overall Study|Adverse Event|0|||
23181915|NCT02251912|64404860|FG001|Overall Study|Adverse Event|2|||
23181916|NCT00100048|64404861|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
23181917|NCT00100048|64404862|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
23181918|NCT00100048|64404863|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
23181919|NCT00100048|64404864|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
23181920|NCT00100048|64404865|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
23181921|NCT00100048|64404866|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
23181922|NCT00100048|64404861|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
23181923|NCT00100048|64404862|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
23181924|NCT00100048|64404863|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
23181925|NCT00100048|64404864|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
23181926|NCT00100048|64404865|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
23181927|NCT00100048|64404866|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
23181928|NCT00100048|64404861|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
23181929|NCT00100048|64404862|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
23181930|NCT00100048|64404863|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
23181931|NCT00100048|64404864|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
23460542|NCT02158546|65430798|FG000|Overall Study|Non-compliance|0|||
23460543|NCT02158546|65430799|FG001|Overall Study|Non-compliance|1|||
23460544|NCT02158546|65430800|FG002|Overall Study|Non-compliance|0|||
23460545|NCT02158546|65430801|FG003|Overall Study|Non-compliance|1|||
23460546|NCT02158546|65430798|FG000|Overall Study|Failure to meet eligibility criteria|0|||
23460547|NCT02158546|65430799|FG001|Overall Study|Failure to meet eligibility criteria|1|||
23460548|NCT02158546|65430800|FG002|Overall Study|Failure to meet eligibility criteria|0|||
23584308|NCT01769391|65866130|FG000|Overall Study|Withdrawal by Subject|4|||
23181932|NCT00100048|64404865|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
23181933|NCT00100048|64404866|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
23181934|NCT00100048|64404861|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
23241210|NCT00650806|64626832|FG002|Overall Study|Pregnancy|0|||
23181935|NCT00100048|64404862|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
23181936|NCT00100048|64404863|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
23181937|NCT00100048|64404864|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
23181938|NCT00100048|64404865|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
23181939|NCT00100048|64404866|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
23181940|NCT00100048|64404861|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
23181941|NCT00100048|64404862|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
23241211|NCT00650806|64626833|FG003|Overall Study|Pregnancy|1|||
23460549|NCT02158546|65430801|FG003|Overall Study|Failure to meet eligibility criteria|0|||
23460550|NCT02158546|65430798|FG000|Overall Study|Lack of Efficacy|1|||
23584309|NCT01769391|65866131|FG001|Overall Study|Withdrawal by Subject|3|||
23181942|NCT00100048|64404863|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
23181943|NCT00100048|64404864|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
23181944|NCT00100048|64404865|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
23181945|NCT00100048|64404866|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
23460551|NCT02158546|65430799|FG001|Overall Study|Lack of Efficacy|1|||
23584310|NCT01769391|65866130|FG000|Overall Study|Investigator Decision|2|||
23181946|NCT00100048|64404861|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
23181947|NCT00100048|64404862|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
23181948|NCT00100048|64404863|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
23241212|NCT00650806|64626830|FG000|Overall Study|Withdrawal by Subject|7|||
23241213|NCT00650806|64626831|FG001|Overall Study|Withdrawal by Subject|5|||
23241214|NCT00650806|64626832|FG002|Overall Study|Withdrawal by Subject|8|||
23241215|NCT00650806|64626833|FG003|Overall Study|Withdrawal by Subject|6|||
23241216|NCT00650806|64626830|FG000|Overall Study|Noncompliance with study drug regimen|1|||
23241217|NCT00650806|64626831|FG001|Overall Study|Noncompliance with study drug regimen|1|||
23241218|NCT00650806|64626832|FG002|Overall Study|Noncompliance with study drug regimen|0|||
23241219|NCT00650806|64626833|FG003|Overall Study|Noncompliance with study drug regimen|0|||
23241220|NCT00650806|64626830|FG000|Overall Study|Study terminated by sponsor|2|||
23241221|NCT00650806|64626831|FG001|Overall Study|Study terminated by sponsor|3|||
23241222|NCT00650806|64626832|FG002|Overall Study|Study terminated by sponsor|5|||
23241223|NCT00650806|64626833|FG003|Overall Study|Study terminated by sponsor|4|||
23460552|NCT02158546|65430800|FG002|Overall Study|Lack of Efficacy|0|||
23460553|NCT02158546|65430801|FG003|Overall Study|Lack of Efficacy|0|||
23181949|NCT00100048|64404864|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
23181950|NCT00100048|64404865|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
23181951|NCT00100048|64404866|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
23181952|NCT00100048|64404861|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
23181953|NCT00100048|64404862|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
23181954|NCT00100048|64404863|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
23181955|NCT00100048|64404864|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
23241224|NCT00650806|64626830|FG000|Overall Study|Other|1|||
23241225|NCT00650806|64626831|FG001|Overall Study|Other|1|||
23241226|NCT00650806|64626832|FG002|Overall Study|Other|2|||
23241227|NCT00650806|64626833|FG003|Overall Study|Other|0|||
23241228|NCT01096017|64626840|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
23241229|NCT01096017|64626841|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
23241230|NCT00066573|64626844|FG000|Overall Study|Did not received protocol treatment|28|||
23241231|NCT00066573|64626845|FG001|Overall Study|Did not received protocol treatment|28|||
23241232|NCT01707667|64626846|FG000|Period 1|expulsion of colonic sensor catheter|1|||
23241233|NCT01707667|64626847|FG001|Period 1|expulsion of colonic sensor catheter|0|||
23241234|NCT00752206|64626851|FG000|Overall Study|Disease progression|8|||
23241235|NCT00752206|64626852|FG001|Overall Study|Disease progression|11|||
23460554|NCT02158546|65430798|FG000|Overall Study|Adverse Event|2|||
23460555|NCT02158546|65430799|FG001|Overall Study|Adverse Event|2|||
23460556|NCT02158546|65430800|FG002|Overall Study|Adverse Event|0|||
23460557|NCT02158546|65430801|FG003|Overall Study|Adverse Event|0|||
23460558|NCT02158546|65430798|FG000|Overall Study|Withdrawal by Subject|6|||
23460559|NCT02158546|65430799|FG001|Overall Study|Withdrawal by Subject|2|||
23460560|NCT02158546|65430800|FG002|Overall Study|Withdrawal by Subject|1|||
23460561|NCT02158546|65430801|FG003|Overall Study|Withdrawal by Subject|0|||
23460562|NCT02158546|65430798|FG000|Overall Study|Lost to Follow-up|5|||
23460563|NCT02158546|65430799|FG001|Overall Study|Lost to Follow-up|4|||
23460564|NCT02158546|65430800|FG002|Overall Study|Lost to Follow-up|0|||
23460565|NCT02158546|65430801|FG003|Overall Study|Lost to Follow-up|1|||
23460566|NCT02158546|65430798|FG000|Overall Study|Site Excluded|5|||
23460567|NCT02158546|65430799|FG001|Overall Study|Site Excluded|5|||
23460568|NCT02158546|65430800|FG002|Overall Study|Site Excluded|3|||
23460569|NCT02158546|65430801|FG003|Overall Study|Site Excluded|4|||
23460570|NCT00423579|65430802|FG000|Overall Study|Lost to Follow-up|3|||
23460571|NCT00423579|65430803|FG001|Overall Study|Lost to Follow-up|0|||
23460572|NCT00423579|65430802|FG000|Overall Study|Protocol Violation|1|||
23584311|NCT01769391|65866131|FG001|Overall Study|Investigator Decision|0|||
23584312|NCT02465359|65866132|FG000|Overall Study|Lack of Efficacy|1|||
23584313|NCT02465359|65866132|FG000|Overall Study|Withdrawal by Subject|1|||
23241236|NCT00752206|64626851|FG000|Overall Study|Pregnancy|1|||
23241237|NCT00752206|64626852|FG001|Overall Study|Pregnancy|0|||
23241238|NCT00633217|64626853|FG000|Overall Study|Adverse Event|5|||
23241239|NCT00633217|64626854|FG001|Overall Study|Adverse Event|9|||
23241240|NCT00633217|64626853|FG000|Overall Study|Lack of Efficacy|0|||
23241241|NCT00633217|64626854|FG001|Overall Study|Lack of Efficacy|2|||
23460573|NCT00423579|65430803|FG001|Overall Study|Protocol Violation|3|||
23460574|NCT00423579|65430802|FG000|Overall Study|Diagnosis of diabetes|0|||
23460575|NCT00423579|65430803|FG001|Overall Study|Diagnosis of diabetes|1|||
23460576|NCT01194830|65430805|FG000|Overall Study|Adverse Event|3|||
23241242|NCT00633217|64626853|FG000|Overall Study|Protocol Violation|3|||
23241243|NCT00633217|64626854|FG001|Overall Study|Protocol Violation|7|||
23241244|NCT00633217|64626853|FG000|Overall Study|Lost to Follow-up|2|||
23241245|NCT00633217|64626854|FG001|Overall Study|Lost to Follow-up|2|||
23241246|NCT00633217|64626853|FG000|Overall Study|Investigator Discretion|2|||
23460577|NCT01194830|65430806|FG001|Overall Study|Adverse Event|2|||
23460578|NCT01194830|65430805|FG000|Overall Study|Protocol Violation|5|||
23460579|NCT01194830|65430806|FG001|Overall Study|Protocol Violation|4|||
23460580|NCT01194830|65430805|FG000|Overall Study|Lost to Follow-up|9|||
23460581|NCT01194830|65430806|FG001|Overall Study|Lost to Follow-up|7|||
23460582|NCT01194830|65430805|FG000|Overall Study|Withdrawal by Subject|2|||
23460583|NCT01194830|65430806|FG001|Overall Study|Withdrawal by Subject|1|||
23460584|NCT01194830|65430805|FG000|Overall Study|Lack of Efficacy|1|||
23460585|NCT01194830|65430806|FG001|Overall Study|Lack of Efficacy|1|||
23460586|NCT01194830|65430805|FG000|Overall Study|Non-compliance issues|4|||
23460587|NCT01194830|65430806|FG001|Overall Study|Non-compliance issues|4|||
23460588|NCT01194830|65430805|FG000|Overall Study|Other Reason|12|||
23460589|NCT01194830|65430806|FG001|Overall Study|Other Reason|8|||
23460590|NCT02749422|65430812|FG000|Overall Study|Lost to Follow-up|0|||
23460591|NCT02749422|65430813|FG001|Overall Study|Lost to Follow-up|2|||
23460592|NCT02749422|65430812|FG000|Overall Study|Ineligible|0|||
23460593|NCT02749422|65430813|FG001|Overall Study|Ineligible|1|||
23460594|NCT00389610|65430814|FG000|Overall Study|Disease Progression|0|||
23460595|NCT00389610|65430815|FG001|Overall Study|Disease Progression|19|||
23460596|NCT00389610|65430814|FG000|Overall Study|Death|0|||
23460597|NCT00389610|65430815|FG001|Overall Study|Death|1|||
23460598|NCT00389610|65430814|FG000|Overall Study|Physician Decision|0|||
23460599|NCT00389610|65430815|FG001|Overall Study|Physician Decision|1|||
23460600|NCT00389610|65430814|FG000|Overall Study|Withdrawal by Subject|0|||
23460601|NCT00389610|65430815|FG001|Overall Study|Withdrawal by Subject|1|||
23460602|NCT00174187|65430818|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
23460603|NCT00174187|65430819|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
23460604|NCT00174187|65430820|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
23460605|NCT00174187|65430818|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
23460606|NCT00174187|65430819|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
23460607|NCT00174187|65430820|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
23460608|NCT00174187|65430818|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
23460609|NCT00174187|65430819|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
23460610|NCT00174187|65430820|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
23460611|NCT00174187|65430818|FG000|Period 1 (up to 3 Years)|Other|0|||
23460612|NCT00174187|65430819|FG001|Period 1 (up to 3 Years)|Other|1|||
23460613|NCT00174187|65430820|FG002|Period 1 (up to 3 Years)|Other|0|||
23460614|NCT00174187|65430818|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
23460615|NCT00174187|65430819|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
23460616|NCT00174187|65430820|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
23460617|NCT00174187|65430818|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
23460618|NCT00174187|65430819|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
23460619|NCT00174187|65430820|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
23460620|NCT00174187|65430818|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
23460621|NCT00174187|65430819|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
23460622|NCT00174187|65430820|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
23460623|NCT00174187|65430818|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
23460624|NCT00174187|65430819|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
23460625|NCT00174187|65430820|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
23460626|NCT00174187|65430818|FG000|Period 2 (After 3 Years)|Other|0|||
23460627|NCT00174187|65430819|FG001|Period 2 (After 3 Years)|Other|0|||
23460628|NCT00174187|65430820|FG002|Period 2 (After 3 Years)|Other|5|||
23460629|NCT03299166|65430821|FG000|Overall Study|Adverse Event|9|||
23460630|NCT03299166|65430822|FG001|Overall Study|Adverse Event|4|||
23460631|NCT03299166|65430821|FG000|Overall Study|Withdrawal by Subject|6|||
23460632|NCT03299166|65430822|FG001|Overall Study|Withdrawal by Subject|5|||
23460633|NCT03299166|65430821|FG000|Overall Study|Physician Decision|1|||
23460634|NCT03299166|65430822|FG001|Overall Study|Physician Decision|1|||
23584314|NCT02465359|65866132|FG000|Overall Study|Adverse Event|1|||
23181956|NCT00100048|64404865|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
23181957|NCT00100048|64404866|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
23181958|NCT00100048|64404861|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23181959|NCT00100048|64404862|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23181960|NCT00100048|64404863|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23181961|NCT00100048|64404864|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
23348631|NCT02418585|65021577|FG001|Follow-up Phase (24 Weeks)|Other|2|||
23460635|NCT03299166|65430821|FG000|Overall Study|Sponsor Decision|3|||
23460636|NCT03299166|65430822|FG001|Overall Study|Sponsor Decision|0|||
23460637|NCT03299166|65430821|FG000|Overall Study|Lost to Follow-up|2|||
23460638|NCT03299166|65430822|FG001|Overall Study|Lost to Follow-up|4|||
23460639|NCT03299166|65430821|FG000|Overall Study|Randomization Error|0|||
23460640|NCT03299166|65430822|FG001|Overall Study|Randomization Error|1|||
23460641|NCT03299166|65430821|FG000|Overall Study|Subject unable to return due to COVID|1|||
23460642|NCT03299166|65430822|FG001|Overall Study|Subject unable to return due to COVID|0|||
23460643|NCT03299166|65430821|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
23181962|NCT00100048|64404865|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23181963|NCT00100048|64404866|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
23181964|NCT02347631|64404870|FG000|First Intervention (2 Months)|Adverse Event|1|||
23181965|NCT02347631|64404871|FG001|First Intervention (2 Months)|Adverse Event|1|||
23181966|NCT02347631|64404870|FG000|First Intervention (2 Months)|Pregnancy|1|||
23460644|NCT03299166|65430822|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
23460645|NCT04634253|65430823|FG000|Overall Study|Adverse Event|1|||
23460646|NCT04634253|65430824|FG001|Overall Study|Adverse Event|1|||
23460647|NCT04634253|65430825|FG002|Overall Study|Adverse Event|0|||
23584315|NCT02775435|65866136|FG000|Overall Study|Adverse Event|32|||
23241247|NCT00633217|64626854|FG001|Overall Study|Investigator Discretion|0|||
23241248|NCT00633217|64626853|FG000|Overall Study|Withdrew Consent|3|||
23241249|NCT00633217|64626854|FG001|Overall Study|Withdrew Consent|3|||
23241250|NCT04139642|64626859|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
23241251|NCT04139642|64626860|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
23241252|NCT00577382|64626861|FG000|Overall Study|Adverse Event|0|||
23241253|NCT00577382|64626862|FG001|Overall Study|Adverse Event|6|||
23241254|NCT00577382|64626861|FG000|Overall Study|Withdrawal by Subject|0|||
23241255|NCT00577382|64626862|FG001|Overall Study|Withdrawal by Subject|1|||
23241256|NCT00577382|64626861|FG000|Overall Study|Progressive Disease|17|||
23241257|NCT00577382|64626862|FG001|Overall Study|Progressive Disease|19|||
23241258|NCT00577382|64626861|FG000|Overall Study|Intercurrent Illness|1|||
23241259|NCT00577382|64626862|FG001|Overall Study|Intercurrent Illness|2|||
23241260|NCT00577382|64626861|FG000|Overall Study|Death|1|||
23241261|NCT00577382|64626862|FG001|Overall Study|Death|1|||
23241262|NCT00577382|64626861|FG000|Overall Study|Lost to Follow-up|2|||
23241263|NCT00577382|64626862|FG001|Overall Study|Lost to Follow-up|2|||
23348632|NCT02949908|65021592|FG000|Overall Study|Study termination|2|||
23348633|NCT03003000|65021595|FG000|Overall Study|Adverse Event|1|||
23348634|NCT03003000|65021596|FG001|Overall Study|Adverse Event|2|||
23584316|NCT02775435|65866137|FG001|Overall Study|Adverse Event|27|||
23584317|NCT02775435|65866136|FG000|Overall Study|Lost to Follow-up|2|||
23181967|NCT02347631|64404871|FG001|First Intervention (2 Months)|Pregnancy|0|||
23181968|NCT02347631|64404870|FG000|First Intervention (2 Months)|Moved out of area|0|||
23181969|NCT02347631|64404871|FG001|First Intervention (2 Months)|Moved out of area|2|||
23181970|NCT02347631|64404870|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
23181971|NCT02347631|64404871|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
23181972|NCT02347631|64404870|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
23181973|NCT02347631|64404871|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
23181974|NCT02347631|64404870|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
23181975|NCT02347631|64404871|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
23241264|NCT02087865|64626871|FG000|Overall Study|Withdrawal by Subject|6|||
23241265|NCT02087865|64626872|FG001|Overall Study|Withdrawal by Subject|0|||
23241266|NCT02087865|64626873|FG002|Overall Study|Withdrawal by Subject|1|||
23241267|NCT02087865|64626871|FG000|Overall Study|Lost to Follow-up|0|||
23241268|NCT02087865|64626872|FG001|Overall Study|Lost to Follow-up|0|||
23584318|NCT02775435|65866137|FG001|Overall Study|Lost to Follow-up|2|||
23584319|NCT02775435|65866136|FG000|Overall Study|Sponsor decision|44|||
23584320|NCT02775435|65866137|FG001|Overall Study|Sponsor decision|19|||
23584321|NCT02775435|65866136|FG000|Overall Study|Withdrawal by Subject|4|||
23584322|NCT02775435|65866137|FG001|Overall Study|Withdrawal by Subject|9|||
23584323|NCT02775435|65866136|FG000|Overall Study|Death|196|||
23584324|NCT02775435|65866137|FG001|Overall Study|Death|224|||
23584325|NCT01174550|65866138|FG000|Overall Study|Death|75|||
23584326|NCT01174550|65866139|FG001|Overall Study|Death|74|||
23584327|NCT01174550|65866138|FG000|Overall Study|Lost to Follow-up|652|||
23584328|NCT01174550|65866139|FG001|Overall Study|Lost to Follow-up|510|||
23584329|NCT01174550|65866138|FG000|Overall Study|Withdrawal by Subject|543|||
23584330|NCT01174550|65866139|FG001|Overall Study|Withdrawal by Subject|289|||
23584331|NCT03396913|65866146|FG000|Overall Study|Lost to Follow-up|0|||
23584332|NCT03396913|65866147|FG001|Overall Study|Lost to Follow-up|6|||
23584333|NCT03523962|65866150|FG000|Closed Fractures|Death|86|||
23181976|NCT02347631|64404870|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
23241269|NCT02087865|64626873|FG002|Overall Study|Lost to Follow-up|1|||
23241270|NCT02087865|64626871|FG000|Overall Study|Drug Non-compliance|0|||
23348635|NCT03003000|65021597|FG002|Overall Study|Adverse Event|3|||
23584334|NCT03523962|65866151|FG001|Closed Fractures|Death|71|||
23584335|NCT03523962|65866152|FG002|Closed Fractures|Death|0|||
23584336|NCT03523962|65866153|FG003|Closed Fractures|Death|0|||
23584337|NCT03523962|65866150|FG000|Closed Fractures|Lost to Follow-up|62|||
23181977|NCT02347631|64404871|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
23241271|NCT02087865|64626872|FG001|Overall Study|Drug Non-compliance|2|||
23241272|NCT02087865|64626873|FG002|Overall Study|Drug Non-compliance|0|||
23241273|NCT02087865|64626871|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
23348636|NCT03003000|65021595|FG000|Overall Study|Lack of Efficacy|1|||
23460648|NCT04634253|65430823|FG000|Overall Study|Physician Decision|0|||
23584338|NCT03523962|65866151|FG001|Closed Fractures|Lost to Follow-up|36|||
23241274|NCT02087865|64626872|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
23348637|NCT03003000|65021596|FG001|Overall Study|Lack of Efficacy|0|||
23348638|NCT03003000|65021597|FG002|Overall Study|Lack of Efficacy|0|||
23348639|NCT03003000|65021595|FG000|Overall Study|Non-compliant with protocol|0|||
23241275|NCT02087865|64626873|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
23241276|NCT02674568|64626876|FG000|Overall Study|Withdrawal by Subject|5|||
23241277|NCT02674568|64626876|FG000|Overall Study|Death|303|||
23241278|NCT02674568|64626876|FG000|Overall Study|Physician Decision|2|||
23241279|NCT02674568|64626876|FG000|Overall Study|Lost to Follow-up|9|||
23241280|NCT02674568|64626876|FG000|Overall Study|Other, Not Specified|20|||
23241281|NCT03878108|64626879|FG000|Overall Study|Adverse Event|1|||
23241282|NCT03878108|64626880|FG001|Overall Study|Adverse Event|0|||
23241283|NCT00594568|64626883|FG000|Initial Treatment|Adverse Event|51|||
23241284|NCT00594568|64626884|FG001|Initial Treatment|Adverse Event|121|||
23241285|NCT00594568|64626885|FG002|Initial Treatment|Adverse Event|144|||
23241286|NCT00594568|64626883|FG000|Initial Treatment|Death|6|||
23241287|NCT00594568|64626884|FG001|Initial Treatment|Death|11|||
23241288|NCT00594568|64626885|FG002|Initial Treatment|Death|15|||
23241289|NCT00594568|64626883|FG000|Initial Treatment|Lost to Follow-up|4|||
23241290|NCT00594568|64626884|FG001|Initial Treatment|Lost to Follow-up|1|||
23241291|NCT00594568|64626885|FG002|Initial Treatment|Lost to Follow-up|4|||
23241292|NCT00594568|64626883|FG000|Initial Treatment|Physician Decision|3|||
23241293|NCT00594568|64626884|FG001|Initial Treatment|Physician Decision|2|||
23241294|NCT00594568|64626885|FG002|Initial Treatment|Physician Decision|4|||
23241295|NCT00594568|64626883|FG000|Initial Treatment|Protocol Violation|2|||
23241296|NCT00594568|64626884|FG001|Initial Treatment|Protocol Violation|2|||
23348640|NCT03003000|65021596|FG001|Overall Study|Non-compliant with protocol|1|||
23348641|NCT03003000|65021597|FG002|Overall Study|Non-compliant with protocol|1|||
23348642|NCT03003000|65021595|FG000|Overall Study|Refused to continue medication|2|||
23348643|NCT03003000|65021596|FG001|Overall Study|Refused to continue medication|0|||
23348644|NCT03003000|65021597|FG002|Overall Study|Refused to continue medication|0|||
23348645|NCT03003000|65021595|FG000|Overall Study|Other than listed|1|||
23348646|NCT03003000|65021596|FG001|Overall Study|Other than listed|1|||
23348647|NCT03003000|65021597|FG002|Overall Study|Other than listed|1|||
23348648|NCT00505661|65021598|FG000|Overall Study|Not Eligible|4|||
23348649|NCT02079636|65021599|FG000|Overall Study|Death|2|||
23584339|NCT03523962|65866152|FG002|Closed Fractures|Lost to Follow-up|0|||
23584340|NCT03523962|65866153|FG003|Closed Fractures|Lost to Follow-up|0|||
23241297|NCT00594568|64626885|FG002|Initial Treatment|Protocol Violation|5|||
23241298|NCT00594568|64626883|FG000|Initial Treatment|Withdrawal by Subject|25|||
23241299|NCT00594568|64626884|FG001|Initial Treatment|Withdrawal by Subject|31|||
23241300|NCT00594568|64626885|FG002|Initial Treatment|Withdrawal by Subject|46|||
23584341|NCT03523962|65866150|FG000|Closed Fractures|Withdrawal by Subject|19|||
23584342|NCT03523962|65866151|FG001|Closed Fractures|Withdrawal by Subject|29|||
23241301|NCT00594568|64626883|FG000|Initial Treatment|Sponsor decision|193|||
23241302|NCT00594568|64626884|FG001|Initial Treatment|Sponsor decision|142|||
23241303|NCT00594568|64626885|FG002|Initial Treatment|Sponsor decision|147|||
23584343|NCT03523962|65866152|FG002|Closed Fractures|Withdrawal by Subject|0|||
23584344|NCT03523962|65866153|FG003|Closed Fractures|Withdrawal by Subject|0|||
23584345|NCT03523962|65866150|FG000|Closed Fractures|Incarceration|1|||
23584346|NCT03523962|65866151|FG001|Closed Fractures|Incarceration|4|||
23584347|NCT03523962|65866152|FG002|Closed Fractures|Incarceration|0|||
23584348|NCT03523962|65866153|FG003|Closed Fractures|Incarceration|0|||
23584349|NCT03523962|65866150|FG000|Open Fractures|Death|0|||
23584350|NCT03523962|65866151|FG001|Open Fractures|Death|0|||
23584351|NCT03523962|65866152|FG002|Open Fractures|Death|11|||
23584352|NCT03523962|65866153|FG003|Open Fractures|Death|6|||
23584353|NCT03523962|65866150|FG000|Open Fractures|Lost to Follow-up|0|||
23241304|NCT00594568|64626883|FG000|Initial Treatment|Caregiver decision|21|||
23348650|NCT02079636|65021600|FG001|Overall Study|Death|1|||
23584354|NCT03523962|65866151|FG001|Open Fractures|Lost to Follow-up|0|||
23584355|NCT03523962|65866152|FG002|Open Fractures|Lost to Follow-up|15|||
23241305|NCT00594568|64626884|FG001|Initial Treatment|Caregiver decision|36|||
23241306|NCT00594568|64626885|FG002|Initial Treatment|Caregiver decision|36|||
23241307|NCT00594568|64626883|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
23241308|NCT00594568|64626884|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
23241309|NCT00594568|64626885|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
23241310|NCT00594568|64626883|FG000|Initial Treatment|Entry criteria exclusion|0|||
23241311|NCT00594568|64626884|FG001|Initial Treatment|Entry criteria exclusion|1|||
23241312|NCT00594568|64626885|FG002|Initial Treatment|Entry criteria exclusion|1|||
23348651|NCT02079636|65021601|FG002|Overall Study|Death|0|||
23241313|NCT00594568|64626883|FG000|Delayed Start|Death|0|||
23584356|NCT03523962|65866153|FG003|Open Fractures|Lost to Follow-up|8|||
23241314|NCT00594568|64626884|FG001|Delayed Start|Death|0|||
23241315|NCT00594568|64626885|FG002|Delayed Start|Death|1|||
23584357|NCT03523962|65866150|FG000|Open Fractures|Withdrawal by Subject|0|||
23584358|NCT03523962|65866151|FG001|Open Fractures|Withdrawal by Subject|0|||
23181978|NCT02347631|64404870|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
23181979|NCT02347631|64404871|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
23181980|NCT02115308|64404872|FG000|Overall Study|Safety Screening|2|||
23181981|NCT02115308|64404873|FG001|Overall Study|Safety Screening|2|||
23181982|NCT01243268|64404874|FG000|Overall Study|Lost to Follow-up|4|||
23181983|NCT01243268|64404874|FG000|Overall Study|Protocol Violation|51|||
23181984|NCT01243268|64404874|FG000|Overall Study|Deviation with contract date|7|||
23181985|NCT01243268|64404874|FG000|Overall Study|Duplicate subject|2|||
23181986|NCT05172544|64404875|FG000|Overall Study|Withdrawal by Subject|1|||
23241316|NCT00594568|64626883|FG000|Delayed Start|Adverse Event|12|||
23348652|NCT02079636|65021602|FG003|Overall Study|Death|5|||
23348653|NCT02079636|65021603|FG004|Overall Study|Death|1|||
23348654|NCT02079636|65021604|FG005|Overall Study|Death|2|||
23348655|NCT02079636|65021605|FG006|Overall Study|Death|1|||
23348656|NCT02079636|65021606|FG007|Overall Study|Death|0|||
23348657|NCT02079636|65021607|FG008|Overall Study|Death|0|||
23348658|NCT02079636|65021608|FG009|Overall Study|Death|0|||
23348659|NCT02079636|65021609|FG010|Overall Study|Death|0|||
23348660|NCT02079636|65021610|FG011|Overall Study|Death|1|||
23348661|NCT02079636|65021611|FG012|Overall Study|Death|1|||
23348662|NCT02079636|65021612|FG013|Overall Study|Death|0|||
23348663|NCT02079636|65021613|FG014|Overall Study|Death|2|||
23584359|NCT03523962|65866152|FG002|Open Fractures|Withdrawal by Subject|6|||
23584360|NCT03523962|65866153|FG003|Open Fractures|Withdrawal by Subject|2|||
23584361|NCT03523962|65866150|FG000|Open Fractures|Incarceration|0|||
23584362|NCT03523962|65866151|FG001|Open Fractures|Incarceration|0|||
23584363|NCT03523962|65866152|FG002|Open Fractures|Incarceration|1|||
23584364|NCT03523962|65866153|FG003|Open Fractures|Incarceration|0|||
23584365|NCT03568162|65866154|FG000|Overall Study|Adverse Event|0|||
23584366|NCT03568162|65866155|FG001|Overall Study|Adverse Event|1|||
23584367|NCT03568162|65866156|FG002|Overall Study|Adverse Event|2|||
23584368|NCT03568162|65866157|FG003|Overall Study|Adverse Event|0|||
23584369|NCT03568162|65866158|FG004|Overall Study|Adverse Event|0|||
23584370|NCT03568162|65866159|FG005|Overall Study|Adverse Event|1|||
23584371|NCT03568162|65866154|FG000|Overall Study|Death|0|||
23584372|NCT03568162|65866155|FG001|Overall Study|Death|0|||
23584373|NCT03568162|65866156|FG002|Overall Study|Death|0|||
23584374|NCT03568162|65866157|FG003|Overall Study|Death|0|||
23584375|NCT03568162|65866158|FG004|Overall Study|Death|1|||
23584376|NCT03568162|65866159|FG005|Overall Study|Death|0|||
23584377|NCT03568162|65866154|FG000|Overall Study|Lost to Follow-up|3|||
23584378|NCT03568162|65866155|FG001|Overall Study|Lost to Follow-up|2|||
23584379|NCT03568162|65866156|FG002|Overall Study|Lost to Follow-up|4|||
23584380|NCT03568162|65866157|FG003|Overall Study|Lost to Follow-up|2|||
23584381|NCT03568162|65866158|FG004|Overall Study|Lost to Follow-up|3|||
23584382|NCT03568162|65866159|FG005|Overall Study|Lost to Follow-up|2|||
23584383|NCT03568162|65866154|FG000|Overall Study|Physician Decision|0|||
23584384|NCT03568162|65866155|FG001|Overall Study|Physician Decision|1|||
23584385|NCT03568162|65866156|FG002|Overall Study|Physician Decision|1|||
23584386|NCT03568162|65866157|FG003|Overall Study|Physician Decision|0|||
23584387|NCT03568162|65866158|FG004|Overall Study|Physician Decision|1|||
23584388|NCT03568162|65866159|FG005|Overall Study|Physician Decision|0|||
23584389|NCT03568162|65866154|FG000|Overall Study|Pregnancy|0|||
23584390|NCT03568162|65866155|FG001|Overall Study|Pregnancy|0|||
23584391|NCT03568162|65866156|FG002|Overall Study|Pregnancy|0|||
23584392|NCT03568162|65866157|FG003|Overall Study|Pregnancy|1|||
23584393|NCT03568162|65866158|FG004|Overall Study|Pregnancy|0|||
23584394|NCT03568162|65866159|FG005|Overall Study|Pregnancy|0|||
23584395|NCT03568162|65866154|FG000|Overall Study|Protocol Violation|1|||
23584396|NCT03568162|65866155|FG001|Overall Study|Protocol Violation|0|||
23584397|NCT03568162|65866156|FG002|Overall Study|Protocol Violation|1|||
23584398|NCT03568162|65866157|FG003|Overall Study|Protocol Violation|1|||
23584399|NCT03568162|65866158|FG004|Overall Study|Protocol Violation|1|||
23584400|NCT03568162|65866159|FG005|Overall Study|Protocol Violation|1|||
23584401|NCT03568162|65866154|FG000|Overall Study|Withdrawal by Subject|15|||
23584402|NCT03568162|65866155|FG001|Overall Study|Withdrawal by Subject|15|||
23584403|NCT03568162|65866156|FG002|Overall Study|Withdrawal by Subject|26|||
23584404|NCT03568162|65866157|FG003|Overall Study|Withdrawal by Subject|22|||
23584405|NCT03568162|65866158|FG004|Overall Study|Withdrawal by Subject|6|||
23584406|NCT03568162|65866159|FG005|Overall Study|Withdrawal by Subject|9|||
23584407|NCT03568162|65866154|FG000|Overall Study|Others|3|||
23584408|NCT03568162|65866155|FG001|Overall Study|Others|4|||
23181987|NCT05172544|64404876|FG001|Overall Study|Withdrawal by Subject|0|||
23348664|NCT02079636|65021599|FG000|Overall Study|Adverse Event|1|||
23348665|NCT02079636|65021600|FG001|Overall Study|Adverse Event|1|||
23584409|NCT03568162|65866156|FG002|Overall Study|Others|1|||
23584410|NCT03568162|65866157|FG003|Overall Study|Others|4|||
23584411|NCT03568162|65866158|FG004|Overall Study|Others|2|||
23584412|NCT03568162|65866159|FG005|Overall Study|Others|1|||
23584413|NCT03538054|65866160|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
23584414|NCT03538054|65866160|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
23584415|NCT03538054|65866160|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
23181988|NCT05172544|64404877|FG002|Overall Study|Withdrawal by Subject|0|||
23181989|NCT05172544|64404875|FG000|Overall Study|Physician Decision|0|||
23181990|NCT05172544|64404876|FG001|Overall Study|Physician Decision|0|||
23181991|NCT05172544|64404877|FG002|Overall Study|Physician Decision|1|||
23241317|NCT00594568|64626884|FG001|Delayed Start|Adverse Event|2|||
23241318|NCT00594568|64626885|FG002|Delayed Start|Adverse Event|2|||
23241319|NCT00594568|64626883|FG000|Delayed Start|Withdrawal by Subject|4|||
23241320|NCT00594568|64626884|FG001|Delayed Start|Withdrawal by Subject|3|||
23181992|NCT00430755|64404878|FG000|Overall Study|Withdrawal by Subject|53|||
23181993|NCT01976806|64404879|FG000|Overall Study|Lost to Follow-up|1|||
23181994|NCT01976806|64404880|FG001|Overall Study|Lost to Follow-up|4|||
23181995|NCT01976806|64404879|FG000|Overall Study|Adverse Event|1|||
23181996|NCT01976806|64404880|FG001|Overall Study|Adverse Event|1|||
23181997|NCT01976806|64404879|FG000|Overall Study|Withdrawal by Subject|1|||
23181998|NCT01976806|64404880|FG001|Overall Study|Withdrawal by Subject|1|||
23181999|NCT01587989|64404881|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
23182000|NCT01587989|64404882|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
23182001|NCT01587989|64404883|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
23182002|NCT01587989|64404881|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
23182003|NCT01587989|64404882|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
23182004|NCT01587989|64404883|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
23182005|NCT01587989|64404881|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
23182006|NCT01587989|64404882|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
23182007|NCT01587989|64404883|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
23182008|NCT01587989|64404881|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
23182009|NCT01587989|64404882|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
23182010|NCT01587989|64404883|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
23182011|NCT01587989|64404881|FG000|Randomized Study Treatment|Screening failure|0|||
23182012|NCT01587989|64404882|FG001|Randomized Study Treatment|Screening failure|1|||
23182013|NCT01587989|64404883|FG002|Randomized Study Treatment|Screening failure|0|||
23182014|NCT01587989|64404881|FG000|Randomized Study Treatment|Physician Decision|0|||
23182015|NCT01587989|64404882|FG001|Randomized Study Treatment|Physician Decision|0|||
23182016|NCT01587989|64404883|FG002|Randomized Study Treatment|Physician Decision|1|||
23182017|NCT04134494|64404884|FG000|Overall Study|Lost to Follow-up|2|||
23182018|NCT02029976|64404885|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
23182019|NCT02029976|64404886|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
23241321|NCT00594568|64626885|FG002|Delayed Start|Withdrawal by Subject|0|||
23241322|NCT00594568|64626883|FG000|Delayed Start|Physician Decision|0|||
23241323|NCT00594568|64626884|FG001|Delayed Start|Physician Decision|0|||
23241324|NCT00594568|64626885|FG002|Delayed Start|Physician Decision|1|||
23241325|NCT00594568|64626883|FG000|Delayed Start|Lost to Follow-up|0|||
23241326|NCT00594568|64626884|FG001|Delayed Start|Lost to Follow-up|0|||
23241327|NCT00594568|64626885|FG002|Delayed Start|Lost to Follow-up|1|||
23241328|NCT00594568|64626883|FG000|Delayed Start|Caregiver Decision|5|||
23241329|NCT00594568|64626884|FG001|Delayed Start|Caregiver Decision|6|||
23241330|NCT00594568|64626885|FG002|Delayed Start|Caregiver Decision|2|||
23241331|NCT00594568|64626883|FG000|Delayed Start|Sponsor Decision|77|||
23241332|NCT00594568|64626884|FG001|Delayed Start|Sponsor Decision|66|||
23241333|NCT00594568|64626885|FG002|Delayed Start|Sponsor Decision|59|||
23241334|NCT00594568|64626883|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
23241335|NCT00594568|64626884|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
23241336|NCT00594568|64626885|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
23241337|NCT00594568|64626883|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
23241338|NCT00594568|64626884|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
23241339|NCT00594568|64626885|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
23241340|NCT00594568|64626883|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
23241341|NCT00594568|64626884|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
23241342|NCT00594568|64626885|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
23241343|NCT00594568|64626883|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
23241344|NCT00594568|64626884|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
23182020|NCT02029976|64404885|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
23182021|NCT02029976|64404886|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
23182022|NCT02029976|64404885|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
23182023|NCT02029976|64404886|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
23182024|NCT02029976|64404885|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
23182025|NCT02029976|64404886|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
23182026|NCT01053429|64404887|FG000|Overall Study|Adverse Event|64|||
23182027|NCT01053429|64404887|FG000|Overall Study|Other|309|||
23182028|NCT00924703|64404890|FG000|Overall Study|Withdrawal by Subject|11|||
23182029|NCT00924703|64404890|FG000|Overall Study|Physician Decision|5|||
23182030|NCT00924703|64404890|FG000|Overall Study|Lost to Follow-up|3|||
23182031|NCT00924703|64404890|FG000|Overall Study|Adverse Event|2|||
23182032|NCT00924703|64404890|FG000|Overall Study|Withdrawal by Sponsor|1|||
23182033|NCT00773279|64404901|FG000|Period 1|Adverse Event|2|||
23182034|NCT00773279|64404902|FG001|Period 1|Adverse Event|1|||
23182035|NCT00773279|64404901|FG000|Period 1|Lack of Efficacy|0|||
23182036|NCT00773279|64404902|FG001|Period 1|Lack of Efficacy|2|||
23182037|NCT00773279|64404901|FG000|Period 1|Unclassified|5|||
23241345|NCT00594568|64626885|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
23241346|NCT00594568|64626883|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
23241347|NCT00594568|64626884|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
23241348|NCT00594568|64626885|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
23241349|NCT00594568|64626883|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
23241350|NCT00594568|64626884|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
23241351|NCT00594568|64626885|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
23241352|NCT01050998|64626886|FG000|Overall Study|Adverse Event|1|||
23241353|NCT01050998|64626887|FG001|Overall Study|Adverse Event|0|||
23241354|NCT01050998|64626888|FG002|Overall Study|Adverse Event|1|||
23241355|NCT01050998|64626889|FG003|Overall Study|Adverse Event|0|||
23241356|NCT01050998|64626890|FG004|Overall Study|Adverse Event|2|||
23241357|NCT01050998|64626886|FG000|Overall Study|Withdrawal by Subject|0|||
23241358|NCT01050998|64626887|FG001|Overall Study|Withdrawal by Subject|0|||
23241359|NCT01050998|64626888|FG002|Overall Study|Withdrawal by Subject|0|||
23241360|NCT01050998|64626889|FG003|Overall Study|Withdrawal by Subject|1|||
23241361|NCT01050998|64626890|FG004|Overall Study|Withdrawal by Subject|3|||
23241362|NCT01050998|64626886|FG000|Overall Study|Other|3|||
23241363|NCT01050998|64626887|FG001|Overall Study|Other|2|||
23241364|NCT01050998|64626888|FG002|Overall Study|Other|1|||
23241365|NCT01050998|64626889|FG003|Overall Study|Other|1|||
23241366|NCT01050998|64626890|FG004|Overall Study|Other|5|||
23241367|NCT01050998|64626886|FG000|Overall Study|Data integrity issues|0|||
23241368|NCT01050998|64626887|FG001|Overall Study|Data integrity issues|0|||
23182038|NCT00773279|64404902|FG001|Period 1|Unclassified|1|||
23241369|NCT01050998|64626888|FG002|Overall Study|Data integrity issues|1|||
23241370|NCT01050998|64626889|FG003|Overall Study|Data integrity issues|1|||
23241371|NCT01050998|64626890|FG004|Overall Study|Data integrity issues|4|||
23241372|NCT00604175|64626891|FG000|Entry Through Week 28|Death|2|||
23241373|NCT00604175|64626892|FG001|Entry Through Week 28|Death|0|||
23241374|NCT00604175|64626893|FG002|Entry Through Week 28|Death|0|||
23241375|NCT00604175|64626891|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
23241376|NCT00604175|64626892|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
23241377|NCT00604175|64626893|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
23241378|NCT00604175|64626891|FG000|Entry Through Week 28|Lost to Follow-up|4|||
23241379|NCT00604175|64626892|FG001|Entry Through Week 28|Lost to Follow-up|3|||
23241380|NCT00604175|64626893|FG002|Entry Through Week 28|Lost to Follow-up|0|||
23241381|NCT00604175|64626891|FG000|Entry Through Week 28|Ineligible|1|||
23241382|NCT00604175|64626892|FG001|Entry Through Week 28|Ineligible|0|||
23241383|NCT00604175|64626893|FG002|Entry Through Week 28|Ineligible|0|||
23241384|NCT00604175|64626891|FG000|Entry Through Week 28|Did not start intervention|2|||
23241385|NCT00604175|64626892|FG001|Entry Through Week 28|Did not start intervention|0|||
23241386|NCT00604175|64626893|FG002|Entry Through Week 28|Did not start intervention|1|||
23241387|NCT00604175|64626891|FG000|Week 29 Through Week 72|Death|0|||
23241388|NCT00604175|64626892|FG001|Week 29 Through Week 72|Death|0|||
23241389|NCT00604175|64626893|FG002|Week 29 Through Week 72|Death|1|||
23241390|NCT00604175|64626891|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
23241391|NCT00604175|64626892|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
23241392|NCT00604175|64626893|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
23241393|NCT00604175|64626891|FG000|Week 29 Through Week 72|Site closure|0|||
23241394|NCT00604175|64626892|FG001|Week 29 Through Week 72|Site closure|1|||
23241395|NCT00604175|64626893|FG002|Week 29 Through Week 72|Site closure|0|||
23241396|NCT00604175|64626891|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
23241397|NCT00604175|64626892|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
23241398|NCT00604175|64626893|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
23241399|NCT01347931|64626895|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
23241400|NCT00548340|64629450|FG000|Overall Study|Protocol Violation|2|||
23241401|NCT00548340|64629451|FG001|Overall Study|Protocol Violation|3|||
23241402|NCT00548340|64629452|FG002|Overall Study|Protocol Violation|3|||
23241403|NCT00548340|64629450|FG000|Overall Study|Adverse Event|2|||
23241404|NCT00548340|64629451|FG001|Overall Study|Adverse Event|2|||
23241405|NCT00548340|64629452|FG002|Overall Study|Adverse Event|2|||
23241406|NCT00548340|64629450|FG000|Overall Study|Lost to Follow-up|1|||
23241407|NCT00548340|64629451|FG001|Overall Study|Lost to Follow-up|1|||
23241408|NCT00548340|64629452|FG002|Overall Study|Lost to Follow-up|0|||
23241409|NCT00548340|64629450|FG000|Overall Study|Withdrawal by Subject|2|||
23241410|NCT00548340|64629451|FG001|Overall Study|Withdrawal by Subject|4|||
23241411|NCT00548340|64629452|FG002|Overall Study|Withdrawal by Subject|3|||
23241412|NCT00548340|64629450|FG000|Overall Study|Other|1|||
23241413|NCT00548340|64629451|FG001|Overall Study|Other|1|||
23241414|NCT00548340|64629452|FG002|Overall Study|Other|1|||
23241415|NCT02851069|64629455|FG000|Overall Study|Failure to Return|3|||
23241416|NCT02851069|64629455|FG000|Overall Study|Other|3|||
23241417|NCT03014570|64629456|FG000|Overall Study|COVID-19 Restrictions|38|||
23241418|NCT03014570|64629457|FG001|Overall Study|COVID-19 Restrictions|24|||
23241419|NCT03014570|64629456|FG000|Overall Study|Death|70|||
23241420|NCT03014570|64629457|FG001|Overall Study|Death|79|||
23241421|NCT03014570|64629456|FG000|Overall Study|Transfer from facility|11|||
23241422|NCT03014570|64629457|FG001|Overall Study|Transfer from facility|14|||
23241423|NCT03014570|64629456|FG000|Overall Study|Hospitalized|5|||
23241424|NCT03014570|64629457|FG001|Overall Study|Hospitalized|3|||
23241425|NCT03014570|64629456|FG000|Overall Study|Transfer within facility|1|||
23241426|NCT03014570|64629457|FG001|Overall Study|Transfer within facility|0|||
23241427|NCT03014570|64629456|FG000|Overall Study|Site refusal|0|||
23241428|NCT03014570|64629457|FG001|Overall Study|Site refusal|11|||
23241429|NCT02551874|64629461|FG000|Overall Study|Lost to Follow-up|0|||
23241430|NCT02551874|64629462|FG001|Overall Study|Lost to Follow-up|2|||
23241431|NCT02551874|64629461|FG000|Overall Study|Pregnancy|0|||
23241432|NCT02551874|64629462|FG001|Overall Study|Pregnancy|1|||
23241433|NCT02551874|64629461|FG000|Overall Study|Reason not reported|10|||
23241434|NCT02551874|64629462|FG001|Overall Study|Reason not reported|4|||
23241435|NCT02551874|64629461|FG000|Overall Study|Did not receive randomized treatment|0|||
23241436|NCT02551874|64629462|FG001|Overall Study|Did not receive randomized treatment|7|||
23241437|NCT02551874|64629461|FG000|Overall Study|Did not enter long-term study|18|||
23241438|NCT02551874|64629462|FG001|Overall Study|Did not enter long-term study|25|||
23241439|NCT03735680|64629463|FG000|Overall Study|Withdrawal by Subject|0|||
23241440|NCT03735680|64629464|FG001|Overall Study|Withdrawal by Subject|1|||
23241441|NCT03735680|64629465|FG002|Overall Study|Withdrawal by Subject|0|||
23241442|NCT03735680|64629466|FG003|Overall Study|Withdrawal by Subject|0|||
23241443|NCT03735680|64629467|FG004|Overall Study|Withdrawal by Subject|0|||
23241444|NCT03735680|64629468|FG005|Overall Study|Withdrawal by Subject|1|||
23241445|NCT03735680|64629463|FG000|Overall Study|Patient unable or unwilling to continue|0|||
23241446|NCT03735680|64629464|FG001|Overall Study|Patient unable or unwilling to continue|0|||
23460649|NCT04634253|65430824|FG001|Overall Study|Physician Decision|1|||
23460650|NCT04634253|65430825|FG002|Overall Study|Physician Decision|0|||
23460651|NCT04634253|65430823|FG000|Overall Study|Withdrawal by Subject|1|||
23460652|NCT04634253|65430824|FG001|Overall Study|Withdrawal by Subject|0|||
23584416|NCT04889664|65866161|FG000|Screen|Lost to Follow-up|1|||
23584417|NCT04889664|65866161|FG000|Screen|Failed to meet screening criteria|1|||
23241447|NCT03735680|64629465|FG002|Overall Study|Patient unable or unwilling to continue|1|||
23241448|NCT03735680|64629466|FG003|Overall Study|Patient unable or unwilling to continue|0|||
23241449|NCT03735680|64629467|FG004|Overall Study|Patient unable or unwilling to continue|0|||
23241450|NCT03735680|64629468|FG005|Overall Study|Patient unable or unwilling to continue|0|||
23241451|NCT02687815|64629470|FG000|Overall Study|Lost to Follow-up|2|||
23241452|NCT02687815|64629471|FG001|Overall Study|Lost to Follow-up|4|||
23241453|NCT02687815|64629470|FG000|Overall Study|Withdrawal by Subject|2|||
23241454|NCT02687815|64629471|FG001|Overall Study|Withdrawal by Subject|4|||
23241455|NCT02067728|64629473|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
23241456|NCT02067728|64629474|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
23241457|NCT02067728|64629473|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
23241458|NCT02067728|64629474|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
23241459|NCT02067728|64629473|FG000|6 Month Measurements|Unable to attend|114|||
23241460|NCT02067728|64629474|FG001|6 Month Measurements|Unable to attend|97|||
23241461|NCT00762073|64629482|FG000|Overall Study|Lack of Efficacy|1|||
23241462|NCT00762073|64629483|FG001|Overall Study|Lack of Efficacy|1|||
23241463|NCT00762073|64629484|FG002|Overall Study|Lack of Efficacy|0|||
23241464|NCT00762073|64629485|FG003|Overall Study|Lack of Efficacy|0|||
23241465|NCT00762073|64629482|FG000|Overall Study|Adverse Event|1|||
23241466|NCT00762073|64629483|FG001|Overall Study|Adverse Event|0|||
23241467|NCT00762073|64629484|FG002|Overall Study|Adverse Event|1|||
23460653|NCT04634253|65430825|FG002|Overall Study|Withdrawal by Subject|3|||
23241468|NCT00762073|64629485|FG003|Overall Study|Adverse Event|1|||
23241469|NCT00762073|64629482|FG000|Overall Study|Significant Subject Noncompliance|0|||
23348666|NCT02079636|65021601|FG002|Overall Study|Adverse Event|0|||
23460654|NCT02863419|65430829|FG000|Overall Study|Lost to Follow-up|0|||
23460655|NCT02863419|65430830|FG001|Overall Study|Lost to Follow-up|1|||
23460656|NCT02863419|65430831|FG002|Overall Study|Lost to Follow-up|4|||
23460657|NCT02863419|65430829|FG000|Overall Study|Withdrawal by Subject|5|||
23460658|NCT02863419|65430830|FG001|Overall Study|Withdrawal by Subject|5|||
23460659|NCT02863419|65430831|FG002|Overall Study|Withdrawal by Subject|3|||
23348667|NCT02079636|65021602|FG003|Overall Study|Adverse Event|1|||
23348668|NCT02079636|65021603|FG004|Overall Study|Adverse Event|1|||
23348669|NCT02079636|65021604|FG005|Overall Study|Adverse Event|2|||
23348670|NCT02079636|65021605|FG006|Overall Study|Adverse Event|0|||
23348671|NCT02079636|65021606|FG007|Overall Study|Adverse Event|0|||
23348672|NCT02079636|65021607|FG008|Overall Study|Adverse Event|0|||
23348673|NCT02079636|65021608|FG009|Overall Study|Adverse Event|0|||
23348674|NCT02079636|65021609|FG010|Overall Study|Adverse Event|0|||
23348675|NCT02079636|65021610|FG011|Overall Study|Adverse Event|0|||
23348676|NCT02079636|65021611|FG012|Overall Study|Adverse Event|0|||
23348677|NCT02079636|65021612|FG013|Overall Study|Adverse Event|0|||
23348678|NCT02079636|65021613|FG014|Overall Study|Adverse Event|0|||
23348679|NCT02079636|65021599|FG000|Overall Study|Progressive disease|0|||
23348680|NCT02079636|65021600|FG001|Overall Study|Progressive disease|0|||
23348681|NCT02079636|65021601|FG002|Overall Study|Progressive disease|0|||
23348682|NCT02079636|65021602|FG003|Overall Study|Progressive disease|2|||
23348683|NCT02079636|65021603|FG004|Overall Study|Progressive disease|0|||
23348684|NCT02079636|65021604|FG005|Overall Study|Progressive disease|0|||
23348685|NCT02079636|65021605|FG006|Overall Study|Progressive disease|0|||
23348686|NCT02079636|65021606|FG007|Overall Study|Progressive disease|0|||
23348687|NCT02079636|65021607|FG008|Overall Study|Progressive disease|0|||
23348688|NCT02079636|65021608|FG009|Overall Study|Progressive disease|0|||
23348689|NCT02079636|65021609|FG010|Overall Study|Progressive disease|0|||
23348690|NCT02079636|65021610|FG011|Overall Study|Progressive disease|0|||
23348691|NCT02079636|65021611|FG012|Overall Study|Progressive disease|1|||
23348692|NCT02079636|65021612|FG013|Overall Study|Progressive disease|0|||
23348693|NCT02079636|65021613|FG014|Overall Study|Progressive disease|0|||
23348694|NCT02079636|65021599|FG000|Overall Study|Withdrawal by Subject|0|||
23348695|NCT02079636|65021600|FG001|Overall Study|Withdrawal by Subject|0|||
23348696|NCT02079636|65021601|FG002|Overall Study|Withdrawal by Subject|0|||
23348697|NCT02079636|65021602|FG003|Overall Study|Withdrawal by Subject|4|||
23348698|NCT02079636|65021603|FG004|Overall Study|Withdrawal by Subject|0|||
23348699|NCT02079636|65021604|FG005|Overall Study|Withdrawal by Subject|1|||
23348700|NCT02079636|65021605|FG006|Overall Study|Withdrawal by Subject|0|||
23348701|NCT02079636|65021606|FG007|Overall Study|Withdrawal by Subject|0|||
23348702|NCT02079636|65021607|FG008|Overall Study|Withdrawal by Subject|0|||
23348703|NCT02079636|65021608|FG009|Overall Study|Withdrawal by Subject|2|||
23348704|NCT02079636|65021609|FG010|Overall Study|Withdrawal by Subject|1|||
23348705|NCT02079636|65021610|FG011|Overall Study|Withdrawal by Subject|1|||
23348706|NCT02079636|65021611|FG012|Overall Study|Withdrawal by Subject|1|||
23348707|NCT02079636|65021612|FG013|Overall Study|Withdrawal by Subject|0|||
23348708|NCT02079636|65021613|FG014|Overall Study|Withdrawal by Subject|2|||
23348709|NCT02079636|65021599|FG000|Overall Study|Physician Decision|0|||
23348710|NCT02079636|65021600|FG001|Overall Study|Physician Decision|0|||
23348711|NCT02079636|65021601|FG002|Overall Study|Physician Decision|0|||
23348712|NCT02079636|65021602|FG003|Overall Study|Physician Decision|0|||
23348713|NCT02079636|65021603|FG004|Overall Study|Physician Decision|0|||
23348714|NCT02079636|65021604|FG005|Overall Study|Physician Decision|1|||
23348715|NCT02079636|65021605|FG006|Overall Study|Physician Decision|0|||
23348716|NCT02079636|65021606|FG007|Overall Study|Physician Decision|0|||
23348717|NCT02079636|65021607|FG008|Overall Study|Physician Decision|0|||
23348718|NCT02079636|65021608|FG009|Overall Study|Physician Decision|1|||
23348719|NCT02079636|65021609|FG010|Overall Study|Physician Decision|1|||
23348720|NCT02079636|65021610|FG011|Overall Study|Physician Decision|0|||
23348721|NCT02079636|65021611|FG012|Overall Study|Physician Decision|0|||
23460660|NCT02863419|65430829|FG000|Overall Study|Died|3|||
23348722|NCT02079636|65021612|FG013|Overall Study|Physician Decision|0|||
23348723|NCT02079636|65021613|FG014|Overall Study|Physician Decision|1|||
23460661|NCT02863419|65430830|FG001|Overall Study|Died|4|||
23182039|NCT00773279|64404901|FG000|Period 2|Adverse Event|0|||
23348724|NCT02079636|65021599|FG000|Overall Study|Lost to Follow-up|0|||
23348725|NCT02079636|65021600|FG001|Overall Study|Lost to Follow-up|0|||
23348726|NCT02079636|65021601|FG002|Overall Study|Lost to Follow-up|0|||
23348727|NCT02079636|65021602|FG003|Overall Study|Lost to Follow-up|0|||
23348728|NCT02079636|65021603|FG004|Overall Study|Lost to Follow-up|0|||
23348729|NCT02079636|65021604|FG005|Overall Study|Lost to Follow-up|0|||
23348730|NCT02079636|65021605|FG006|Overall Study|Lost to Follow-up|0|||
23460662|NCT02863419|65430831|FG002|Overall Study|Died|1|||
23460663|NCT02443688|65430832|FG000|Overall Study|Adverse Event|2|||
23460664|NCT02443688|65430833|FG001|Overall Study|Adverse Event|3|||
23348731|NCT02079636|65021606|FG007|Overall Study|Lost to Follow-up|1|||
23348732|NCT02079636|65021607|FG008|Overall Study|Lost to Follow-up|0|||
23348733|NCT02079636|65021608|FG009|Overall Study|Lost to Follow-up|0|||
23348734|NCT02079636|65021609|FG010|Overall Study|Lost to Follow-up|0|||
23348735|NCT02079636|65021610|FG011|Overall Study|Lost to Follow-up|0|||
23348736|NCT02079636|65021611|FG012|Overall Study|Lost to Follow-up|0|||
23348737|NCT02079636|65021612|FG013|Overall Study|Lost to Follow-up|0|||
23348738|NCT02079636|65021613|FG014|Overall Study|Lost to Follow-up|0|||
23348739|NCT00250458|65021614|FG000|Overall Study|Lost to Follow-up|4|||
23348740|NCT00250458|65021615|FG001|Overall Study|Lost to Follow-up|2|||
23348741|NCT00250458|65021614|FG000|Overall Study|Protocol Violation|0|||
23348742|NCT00250458|65021615|FG001|Overall Study|Protocol Violation|1|||
23348743|NCT00250458|65021614|FG000|Overall Study|Withdrawal by Subject|4|||
23348744|NCT00250458|65021615|FG001|Overall Study|Withdrawal by Subject|2|||
23348745|NCT00250458|65021614|FG000|Overall Study|Lack of Migraine Attack|20|||
23348746|NCT00250458|65021615|FG001|Overall Study|Lack of Migraine Attack|9|||
23348747|NCT00250458|65021614|FG000|Overall Study|Qualifying migraine but did not treat|3|||
23348748|NCT00250458|65021615|FG001|Overall Study|Qualifying migraine but did not treat|3|||
23348749|NCT00250458|65021614|FG000|Overall Study|Other|1|||
23348750|NCT00250458|65021615|FG001|Overall Study|Other|0|||
23348751|NCT01731470|65021622|FG000|Overall Study|Withdrawal by Subject|1|||
23348752|NCT01731470|65021622|FG000|Overall Study|Did not meet study criteria|1|||
23348753|NCT01606202|65021636|FG000|Overall Study|Adverse Event|5|||
23348754|NCT01606202|65021637|FG001|Overall Study|Adverse Event|0|||
23348755|NCT01606202|65021636|FG000|Overall Study|Withdrawal by Subject|2|||
23348756|NCT01606202|65021637|FG001|Overall Study|Withdrawal by Subject|1|||
23348757|NCT01606202|65021636|FG000|Overall Study|Personal problems|0|||
23348758|NCT01606202|65021637|FG001|Overall Study|Personal problems|1|||
23348759|NCT01606202|65021636|FG000|Overall Study|Problems with administration|0|||
23348760|NCT01606202|65021637|FG001|Overall Study|Problems with administration|1|||
23348761|NCT02839876|65021640|FG000|Overall Study|Protocol Violation|10|||
23348762|NCT02839876|65021641|FG001|Overall Study|Protocol Violation|11|||
23348763|NCT00503997|65021642|FG000|Overall Study|disease progression|1|||
23348764|NCT00503997|65021642|FG000|Overall Study|Adverse Event|5|||
23348765|NCT00503997|65021642|FG000|Overall Study|Death|1|||
23460665|NCT02443688|65430834|FG002|Overall Study|Adverse Event|2|||
23460666|NCT02443688|65430832|FG000|Overall Study|Lost to Follow-up|1|||
23241470|NCT00762073|64629483|FG001|Overall Study|Significant Subject Noncompliance|1|||
23241471|NCT00762073|64629484|FG002|Overall Study|Significant Subject Noncompliance|0|||
23241472|NCT00762073|64629485|FG003|Overall Study|Significant Subject Noncompliance|1|||
23241473|NCT00762073|64629482|FG000|Overall Study|Withdrawal by Subject|1|||
23241474|NCT00762073|64629483|FG001|Overall Study|Withdrawal by Subject|2|||
23241475|NCT00762073|64629484|FG002|Overall Study|Withdrawal by Subject|1|||
23241476|NCT00762073|64629485|FG003|Overall Study|Withdrawal by Subject|1|||
23241477|NCT00762073|64629482|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
23241478|NCT00762073|64629483|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
23241479|NCT00762073|64629484|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
23241480|NCT00762073|64629485|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
23241481|NCT00978120|64629486|FG000|Overall Study|Death|0|||
23241482|NCT00978120|64629487|FG001|Overall Study|Death|0|||
23241483|NCT00978120|64629488|FG002|Overall Study|Death|0|||
23241484|NCT00978120|64629489|FG003|Overall Study|Death|1|||
23241485|NCT00978120|64629486|FG000|Overall Study|Lost to Follow-up|0|||
23241486|NCT00978120|64629487|FG001|Overall Study|Lost to Follow-up|0|||
23241487|NCT00978120|64629488|FG002|Overall Study|Lost to Follow-up|3|||
23241488|NCT00978120|64629489|FG003|Overall Study|Lost to Follow-up|0|||
23241489|NCT00978120|64629486|FG000|Overall Study|Withdrawal by Subject|2|||
23241490|NCT00978120|64629487|FG001|Overall Study|Withdrawal by Subject|0|||
23241491|NCT00978120|64629488|FG002|Overall Study|Withdrawal by Subject|0|||
23241492|NCT00978120|64629489|FG003|Overall Study|Withdrawal by Subject|0|||
23241493|NCT00978120|64629486|FG000|Overall Study|Moved out of state|0|||
23241494|NCT00978120|64629487|FG001|Overall Study|Moved out of state|0|||
23241495|NCT00978120|64629488|FG002|Overall Study|Moved out of state|0|||
23241496|NCT00978120|64629489|FG003|Overall Study|Moved out of state|1|||
23241497|NCT00483574|64629492|FG000|Overall Study|Adverse Event|6|||
23241498|NCT00483574|64629493|FG001|Overall Study|Adverse Event|0|||
23241499|NCT00483574|64629492|FG000|Overall Study|Protocol Violation|28|||
23241500|NCT00483574|64629493|FG001|Overall Study|Protocol Violation|9|||
23241501|NCT00483574|64629492|FG000|Overall Study|Lost to Follow-up|16|||
23241502|NCT00483574|64629493|FG001|Overall Study|Lost to Follow-up|4|||
23241503|NCT00483574|64629492|FG000|Overall Study|Withdrawal by Subject|52|||
23241504|NCT00483574|64629493|FG001|Overall Study|Withdrawal by Subject|0|||
23348766|NCT00503997|65021642|FG000|Overall Study|Withdrawal by Subject|1|||
23348767|NCT01156051|65021647|FG000|Overall Study|Lost to Follow-up|1|||
23348768|NCT01156051|65021648|FG001|Overall Study|Lost to Follow-up|0|||
23348769|NCT01156051|65021647|FG000|Overall Study|patient not compliant with protocol|0|||
23460667|NCT02443688|65430833|FG001|Overall Study|Lost to Follow-up|0|||
23241505|NCT01855607|64629494|FG000|Overall Study|Withdrawal by Subject|1|||
23348770|NCT01156051|65021648|FG001|Overall Study|patient not compliant with protocol|1|||
23348771|NCT01211483|65021657|FG000|Phase 1b|Death|6|||
23348772|NCT01211483|65021658|FG001|Phase 1b|Death|0|||
23348773|NCT01211483|65021659|FG002|Phase 1b|Death|0|||
23348774|NCT01211483|65021660|FG003|Phase 1b|Death|0|||
23348775|NCT01211483|65021657|FG000|Phase 1b|Withdrawal by Subject|1|||
23348776|NCT01211483|65021658|FG001|Phase 1b|Withdrawal by Subject|0|||
23348777|NCT01211483|65021659|FG002|Phase 1b|Withdrawal by Subject|0|||
23348778|NCT01211483|65021660|FG003|Phase 1b|Withdrawal by Subject|0|||
23348779|NCT01211483|65021657|FG000|Phase 2|Lost to Follow-up|0|||
23348780|NCT01211483|65021658|FG001|Phase 2|Lost to Follow-up|1|||
23348781|NCT01211483|65021659|FG002|Phase 2|Lost to Follow-up|1|||
23348782|NCT01211483|65021660|FG003|Phase 2|Lost to Follow-up|2|||
23348783|NCT01211483|65021657|FG000|Phase 2|Death|0|||
23348784|NCT01211483|65021658|FG001|Phase 2|Death|64|||
23348785|NCT01211483|65021659|FG002|Phase 2|Death|53|||
23348786|NCT01211483|65021660|FG003|Phase 2|Death|53|||
23348787|NCT01211483|65021657|FG000|Phase 2|Withdrawal by Subject|0|||
23348788|NCT01211483|65021658|FG001|Phase 2|Withdrawal by Subject|1|||
23348789|NCT01211483|65021659|FG002|Phase 2|Withdrawal by Subject|10|||
23348790|NCT01211483|65021660|FG003|Phase 2|Withdrawal by Subject|5|||
23348791|NCT01211483|65021657|FG000|Phase 2|Study terminated by Sponsor|0|||
23348792|NCT01211483|65021658|FG001|Phase 2|Study terminated by Sponsor|6|||
23348793|NCT01211483|65021659|FG002|Phase 2|Study terminated by Sponsor|8|||
23348794|NCT01211483|65021660|FG003|Phase 2|Study terminated by Sponsor|11|||
23348795|NCT01904903|65021667|FG000|Overall Study|Withdrawal by Subject|1|||
23182040|NCT00773279|64404902|FG001|Period 2|Adverse Event|1|||
23182041|NCT00773279|64404901|FG000|Period 2|Lack of Efficacy|1|||
23182042|NCT00773279|64404902|FG001|Period 2|Lack of Efficacy|0|||
23182043|NCT00773279|64404901|FG000|Period 2|Protocol Violation|0|||
23182044|NCT00773279|64404902|FG001|Period 2|Protocol Violation|3|||
23182045|NCT00773279|64404901|FG000|Period 2|Unclassified|2|||
23182046|NCT00773279|64404902|FG001|Period 2|Unclassified|2|||
23182047|NCT01193686|64404903|FG000|Overall Study|Withdrawal by Subject|4|||
23182048|NCT01193686|64404904|FG001|Overall Study|Withdrawal by Subject|1|||
23182049|NCT01193686|64404903|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
23182050|NCT01193686|64404904|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
23348796|NCT01634659|65021668|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
23584418|NCT04889664|65866161|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
23584419|NCT00831792|65869170|FG000|Overall Study|Not Eligible|3|||
23584420|NCT00831792|65869170|FG000|Overall Study|Adverse Event|1|||
23584421|NCT00831792|65869170|FG000|Overall Study|Death|1|||
23584422|NCT00831792|65869170|FG000|Overall Study|Lack of Efficacy|1|||
23584423|NCT00613301|65869171|FG000|Overall Study|Adverse Event|49|||
23584424|NCT00613301|65869171|FG000|Overall Study|Lost to Follow-up|88|||
23584425|NCT00613301|65869171|FG000|Overall Study|Withdrawal by Subject|5|||
23584426|NCT00613301|65869171|FG000|Overall Study|Death|6|||
23584427|NCT00613301|65869171|FG000|Overall Study|Lack of Efficacy|13|||
23584428|NCT00613301|65869171|FG000|Overall Study|Physician Decision|2|||
23584429|NCT00613301|65869171|FG000|Overall Study|No data was collected|53|||
23584430|NCT00613301|65869171|FG000|Overall Study|Irregularly enrolled patients|12|||
23584431|NCT01839877|65869186|FG000|Overall Study|Protocol Violation|1|||
23584432|NCT05567952|65869187|FG000|Overall Study|Lost to Follow-up|3|||
23584433|NCT05567952|65869188|FG001|Overall Study|Lost to Follow-up|2|||
23584434|NCT05567952|65869187|FG000|Overall Study|Withdrawal by Subject|6|||
23584435|NCT05567952|65869188|FG001|Overall Study|Withdrawal by Subject|3|||
23584436|NCT05567952|65869187|FG000|Overall Study|Other|3|||
23584437|NCT05567952|65869188|FG001|Overall Study|Other|1|||
23584438|NCT01450943|65869189|FG000|Overall Study|Screen failure, loss to follow-up|2|||
23584439|NCT01450943|65869190|FG001|Overall Study|Screen failure, loss to follow-up|7|||
23584440|NCT01450943|65869191|FG002|Overall Study|Screen failure, loss to follow-up|6|||
23584441|NCT01249092|65869195|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
23584442|NCT01249092|65869195|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
23584443|NCT03781804|65869196|FG000|Overall Study|Adverse Event|2|||
23584444|NCT03781804|65869197|FG001|Overall Study|Adverse Event|2|||
23584445|NCT03781804|65869198|FG002|Overall Study|Adverse Event|3|||
23182051|NCT00974220|64404905|FG000|Treatment Period 1|Adverse Event|2|||
23182052|NCT00974220|64404906|FG001|Treatment Period 1|Adverse Event|1|||
23584446|NCT03781804|65869196|FG000|Overall Study|Lost to Follow-up|1|||
23584447|NCT03781804|65869197|FG001|Overall Study|Lost to Follow-up|1|||
23584448|NCT03781804|65869198|FG002|Overall Study|Lost to Follow-up|2|||
23584449|NCT03781804|65869196|FG000|Overall Study|Lack of Efficacy|4|||
23584450|NCT03781804|65869197|FG001|Overall Study|Lack of Efficacy|2|||
23348797|NCT01634659|65021669|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
23348798|NCT01634659|65021668|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
23348799|NCT01634659|65021669|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
23182053|NCT00974220|64404905|FG000|Treatment Period 1|noncompliant subjects|0|||
23348800|NCT00335959|65021674|FG000|Overall Study|Adverse Event|2|||
23348801|NCT00335959|65021674|FG000|Overall Study|Ineligible|1|||
23182054|NCT00974220|64404906|FG001|Treatment Period 1|noncompliant subjects|1|||
23348802|NCT03304184|65021675|FG000|Overall Study|Withdrawal by Subject|1|||
23348803|NCT03304184|65021676|FG001|Overall Study|Withdrawal by Subject|2|||
23348804|NCT00904917|65021679|FG000|Overall Study|Lost to Follow-up|2|||
23348805|NCT00904917|65021680|FG001|Overall Study|Lost to Follow-up|2|||
23348806|NCT00904917|65021681|FG002|Overall Study|Lost to Follow-up|2|||
23348807|NCT00904917|65021682|FG003|Overall Study|Lost to Follow-up|2|||
23348808|NCT04495816|65021687|FG000|Overall Study|Lost to Follow-up|10|||
23348809|NCT04495816|65021688|FG001|Overall Study|Lost to Follow-up|4|||
23348810|NCT04495816|65021687|FG000|Overall Study|Withdrawal by Subject|3|||
23348811|NCT04495816|65021688|FG001|Overall Study|Withdrawal by Subject|5|||
23348812|NCT00334295|65021689|FG000|Overall Study|Patients received fewer than 3 injection|5|||
23348813|NCT00426660|65021693|FG000|Overall Study|Death|14|||
23348814|NCT00426660|65021693|FG000|Overall Study|Adverse Event|23|||
23348815|NCT00426660|65021693|FG000|Overall Study|Insufficient Clinical Response|22|||
23348816|NCT00426660|65021693|FG000|Overall Study|Lost to Follow-up|15|||
23348817|NCT00426660|65021693|FG000|Overall Study|Other|23|||
23348818|NCT00426660|65021693|FG000|Overall Study|Withdrawal by Subject|18|||
23348819|NCT00426660|65021693|FG000|Overall Study|Protocol Violation|1|||
23348820|NCT00426660|65021693|FG000|Overall Study|Enrolled Not Treated|15|||
23348821|NCT01249833|65021694|FG000|Overall Study|Lost to Follow-up|0|||
23348822|NCT01249833|65021695|FG001|Overall Study|Lost to Follow-up|1|||
23460668|NCT02443688|65430834|FG002|Overall Study|Lost to Follow-up|0|||
23460669|NCT02443688|65430832|FG000|Overall Study|Physician Decision|3|||
23182055|NCT03403400|64404908|FG000|Overall Study|Lost to Follow-up|1|||
23182056|NCT03403400|64404909|FG001|Overall Study|Lost to Follow-up|0|||
23182057|NCT03403400|64404910|FG002|Overall Study|Lost to Follow-up|1|||
23241506|NCT01855607|64629494|FG000|Overall Study|Study was terminated|11|||
23241507|NCT02064231|64629495|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
23241508|NCT02064231|64629496|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
23241509|NCT02064231|64629497|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
23241510|NCT02064231|64629498|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
23241511|NCT02064231|64629495|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
23182058|NCT03403400|64404908|FG000|Overall Study|Hospitalization|1|||
23182059|NCT03403400|64404909|FG001|Overall Study|Hospitalization|0|||
23182060|NCT03403400|64404910|FG002|Overall Study|Hospitalization|0|||
23182061|NCT03403400|64404908|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
23182062|NCT03403400|64404909|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
23182063|NCT03403400|64404910|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
23241512|NCT02064231|64629496|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
23241513|NCT02064231|64629497|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
23241514|NCT02064231|64629498|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
23241515|NCT02064231|64629495|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
23241516|NCT02064231|64629496|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
23241517|NCT02064231|64629497|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
23241518|NCT02064231|64629498|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
23241519|NCT02064231|64629495|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
23241520|NCT02064231|64629496|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
23241521|NCT02064231|64629497|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
23241522|NCT02064231|64629498|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
23241523|NCT03927846|64629501|FG000|Overall Study|Lost to Follow-up|10|||
23241524|NCT03927846|64629502|FG001|Overall Study|Lost to Follow-up|11|||
23241525|NCT01864746|64629503|FG000|Overall Study|Disease recurrence|25|||
23241526|NCT01864746|64629504|FG001|Overall Study|Disease recurrence|40|||
23241527|NCT01864746|64629503|FG000|Overall Study|Second primary invasive nonbreast|2|||
23241528|NCT01864746|64629504|FG001|Overall Study|Second primary invasive nonbreast|3|||
23241529|NCT01864746|64629503|FG000|Overall Study|Death|2|||
23241530|NCT01864746|64629504|FG001|Overall Study|Death|1|||
23241531|NCT01864746|64629503|FG000|Overall Study|Adverse Event|33|||
23241532|NCT01864746|64629504|FG001|Overall Study|Adverse Event|5|||
23241533|NCT01864746|64629503|FG000|Overall Study|Withdrawal by Subject|56|||
23241534|NCT01864746|64629504|FG001|Overall Study|Withdrawal by Subject|41|||
23348823|NCT03611582|65021696|FG000|Overall Study|Adverse Event|26|||
23348824|NCT03611582|65021697|FG001|Overall Study|Adverse Event|6|||
23348825|NCT03611582|65021696|FG000|Overall Study|Protocol Violation|0|||
23460670|NCT02443688|65430833|FG001|Overall Study|Physician Decision|0|||
23460671|NCT02443688|65430834|FG002|Overall Study|Physician Decision|1|||
23182064|NCT00474240|64404911|FG000|Overall Study|Withdrawal by Subject|1|||
23182065|NCT00474240|64404912|FG001|Overall Study|Withdrawal by Subject|1|||
23348826|NCT03611582|65021697|FG001|Overall Study|Protocol Violation|1|||
23348827|NCT03611582|65021696|FG000|Overall Study|Pregnancy|1|||
23460672|NCT02443688|65430832|FG000|Overall Study|Pregnancy|0|||
23182066|NCT00474240|64404913|FG002|Overall Study|Withdrawal by Subject|0|||
23182067|NCT00474240|64404914|FG003|Overall Study|Withdrawal by Subject|2|||
23182068|NCT00474240|64404915|FG004|Overall Study|Withdrawal by Subject|3|||
23348828|NCT03611582|65021697|FG001|Overall Study|Pregnancy|2|||
23348829|NCT03611582|65021696|FG000|Overall Study|Lack of Efficacy|0|||
23348830|NCT03611582|65021697|FG001|Overall Study|Lack of Efficacy|1|||
23348831|NCT03611582|65021696|FG000|Overall Study|At the discretion of the investigator|1|||
23348832|NCT03611582|65021697|FG001|Overall Study|At the discretion of the investigator|0|||
23348833|NCT03611582|65021696|FG000|Overall Study|Safety concern as judged by the investigator|1|||
23460673|NCT02443688|65430833|FG001|Overall Study|Pregnancy|0|||
23460674|NCT02443688|65430834|FG002|Overall Study|Pregnancy|1|||
23584451|NCT03781804|65869198|FG002|Overall Study|Lack of Efficacy|9|||
23182069|NCT00474240|64404916|FG005|Overall Study|Withdrawal by Subject|1|||
23241535|NCT01864746|64629503|FG000|Overall Study|Physician Decision|5|||
23241536|NCT01864746|64629504|FG001|Overall Study|Physician Decision|6|||
23241537|NCT00347776|64629508|FG000|1.5 Month Follow-up|Death|2|||
23241538|NCT00347776|64629509|FG001|1.5 Month Follow-up|Death|0|||
23241539|NCT00347776|64629510|FG002|1.5 Month Follow-up|Death|0|||
23241540|NCT00347776|64629508|FG000|1.5 Month Follow-up|reached the endpoint|12|||
23241541|NCT00347776|64629509|FG001|1.5 Month Follow-up|reached the endpoint|8|||
23241542|NCT00347776|64629510|FG002|1.5 Month Follow-up|reached the endpoint|12|||
23241543|NCT00347776|64629508|FG000|6 Month Follow-up|Death|2|||
23241544|NCT00347776|64629509|FG001|6 Month Follow-up|Death|1|||
23241545|NCT00347776|64629510|FG002|6 Month Follow-up|Death|3|||
23241546|NCT00347776|64629508|FG000|6 Month Follow-up|reached endpont|20|||
23241547|NCT00347776|64629509|FG001|6 Month Follow-up|reached endpont|12|||
23241548|NCT00347776|64629510|FG002|6 Month Follow-up|reached endpont|15|||
23241549|NCT00347776|64629508|FG000|12 Month Follow-up|Lost to Follow-up|7|||
23182070|NCT00474240|64404911|FG000|Overall Study|Adverse Event|0|||
23182071|NCT00474240|64404912|FG001|Overall Study|Adverse Event|0|||
23182072|NCT00474240|64404913|FG002|Overall Study|Adverse Event|9|||
23182073|NCT00474240|64404914|FG003|Overall Study|Adverse Event|14|||
23182074|NCT00474240|64404915|FG004|Overall Study|Adverse Event|5|||
23182075|NCT00474240|64404916|FG005|Overall Study|Adverse Event|16|||
23182076|NCT00474240|64404911|FG000|Overall Study|Removed due to lab value|0|||
23182077|NCT00474240|64404912|FG001|Overall Study|Removed due to lab value|0|||
23182078|NCT00474240|64404913|FG002|Overall Study|Removed due to lab value|0|||
23182079|NCT00474240|64404914|FG003|Overall Study|Removed due to lab value|0|||
23182080|NCT00474240|64404915|FG004|Overall Study|Removed due to lab value|0|||
23182081|NCT00474240|64404916|FG005|Overall Study|Removed due to lab value|1|||
23182082|NCT02393209|64404917|FG000|Overall Study|Study Terminated by Sponsor|1|||
23182083|NCT02393209|64404918|FG001|Overall Study|Study Terminated by Sponsor|1|||
23182084|NCT02393209|64404919|FG002|Overall Study|Study Terminated by Sponsor|0|||
23182085|NCT02393209|64404920|FG003|Overall Study|Study Terminated by Sponsor|0|||
23182086|NCT02393209|64404917|FG000|Overall Study|Withdrawal by Patient|1|||
23182087|NCT02393209|64404918|FG001|Overall Study|Withdrawal by Patient|0|||
23182088|NCT02393209|64404919|FG002|Overall Study|Withdrawal by Patient|0|||
23182089|NCT02393209|64404920|FG003|Overall Study|Withdrawal by Patient|0|||
23182090|NCT02393209|64404917|FG000|Overall Study|Death|2|||
23182091|NCT02393209|64404918|FG001|Overall Study|Death|2|||
23182092|NCT02393209|64404919|FG002|Overall Study|Death|0|||
23182093|NCT02393209|64404920|FG003|Overall Study|Death|0|||
23182094|NCT02393209|64404917|FG000|Overall Study|Death due to Disease Progression|2|||
23182095|NCT02393209|64404918|FG001|Overall Study|Death due to Disease Progression|2|||
23182096|NCT02393209|64404919|FG002|Overall Study|Death due to Disease Progression|0|||
23182097|NCT02393209|64404920|FG003|Overall Study|Death due to Disease Progression|0|||
23182098|NCT02393209|64404917|FG000|Overall Study|Death from Legionella Infection|0|||
23182099|NCT02393209|64404918|FG001|Overall Study|Death from Legionella Infection|1|||
23182100|NCT02393209|64404919|FG002|Overall Study|Death from Legionella Infection|0|||
23182101|NCT02393209|64404920|FG003|Overall Study|Death from Legionella Infection|0|||
23182102|NCT02393209|64404917|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
23241550|NCT00347776|64629509|FG001|12 Month Follow-up|Lost to Follow-up|6|||
23584452|NCT03781804|65869196|FG000|Overall Study|Protocol Violation|0|||
23182103|NCT02393209|64404918|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
23182104|NCT02393209|64404919|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
23182105|NCT02393209|64404920|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
23182106|NCT02393209|64404917|FG000|Overall Study|Lost to Follow-up|0|||
23182107|NCT02393209|64404918|FG001|Overall Study|Lost to Follow-up|1|||
23241551|NCT00347776|64629510|FG002|12 Month Follow-up|Lost to Follow-up|6|||
23241552|NCT00347776|64629508|FG000|12 Month Follow-up|Death|3|||
23241553|NCT00347776|64629509|FG001|12 Month Follow-up|Death|4|||
23182108|NCT02393209|64404919|FG002|Overall Study|Lost to Follow-up|0|||
23182109|NCT02393209|64404920|FG003|Overall Study|Lost to Follow-up|0|||
23241554|NCT00347776|64629510|FG002|12 Month Follow-up|Death|4|||
23348834|NCT03611582|65021697|FG001|Overall Study|Safety concern as judged by the investigator|2|||
23460675|NCT02443688|65430832|FG000|Overall Study|Withdrawal by Subject|3|||
23241555|NCT00347776|64629508|FG000|12 Month Follow-up|Reached endpoint|13|||
23348835|NCT03611582|65021696|FG000|Overall Study|Withdrawal by Subject|4|||
23348836|NCT03611582|65021697|FG001|Overall Study|Withdrawal by Subject|3|||
23348837|NCT03611582|65021696|FG000|Overall Study|Lost to Follow-up|18|||
23348838|NCT03611582|65021697|FG001|Overall Study|Lost to Follow-up|7|||
23348839|NCT03611582|65021696|FG000|Overall Study|other|17|||
23348840|NCT03611582|65021697|FG001|Overall Study|other|16|||
23348841|NCT01790516|65021698|FG000|Overall Study|Physician Decision|1|||
23348842|NCT01790516|65021699|FG001|Overall Study|Physician Decision|0|||
23348843|NCT02772276|65021700|FG000|Overall Study|Lost to Follow-up|0|||
23348844|NCT02772276|65021701|FG001|Overall Study|Lost to Follow-up|0|||
23348845|NCT02772276|65021702|FG002|Overall Study|Lost to Follow-up|0|||
23348846|NCT02772276|65021703|FG003|Overall Study|Lost to Follow-up|0|||
23348847|NCT02772276|65021704|FG004|Overall Study|Lost to Follow-up|0|||
23348848|NCT02772276|65021705|FG005|Overall Study|Lost to Follow-up|0|||
23348849|NCT02772276|65021706|FG006|Overall Study|Lost to Follow-up|1|||
23348850|NCT02772276|65021707|FG007|Overall Study|Lost to Follow-up|0|||
23348851|NCT02772276|65021708|FG008|Overall Study|Lost to Follow-up|0|||
23348852|NCT02772276|65021709|FG009|Overall Study|Lost to Follow-up|0|||
23348853|NCT02772276|65021710|FG010|Overall Study|Lost to Follow-up|0|||
23348854|NCT02772276|65021711|FG011|Overall Study|Lost to Follow-up|0|||
23348855|NCT02772276|65021712|FG012|Overall Study|Lost to Follow-up|0|||
23348856|NCT02772276|65021700|FG000|Overall Study|Withdrew consent|0|||
23348857|NCT02772276|65021701|FG001|Overall Study|Withdrew consent|0|||
23348858|NCT02772276|65021702|FG002|Overall Study|Withdrew consent|0|||
23348859|NCT02772276|65021703|FG003|Overall Study|Withdrew consent|0|||
23348860|NCT02772276|65021704|FG004|Overall Study|Withdrew consent|0|||
23348861|NCT02772276|65021705|FG005|Overall Study|Withdrew consent|0|||
23460676|NCT02443688|65430833|FG001|Overall Study|Withdrawal by Subject|3|||
23182110|NCT00688909|64404924|FG000|Overall Study|Adverse Event|28|||
23182111|NCT00688909|64404924|FG000|Overall Study|Patient withdrew consent|2|||
23182112|NCT00688909|64404924|FG000|Overall Study|Administrative problems|1|||
23182113|NCT00688909|64404924|FG000|Overall Study|Protocol Violation|2|||
23182114|NCT02932267|64404925|FG000|Overall Study|Withdrawal by Subject|3|||
23182115|NCT02932267|64404925|FG000|Overall Study|Lost to Follow-up|4|||
23182116|NCT02932267|64404925|FG000|Overall Study|Pregnancy|1|||
23182117|NCT00355264|64404926|FG000|Extension (Variable Duration)|Adverse Event|1|||
23182118|NCT00355264|64404926|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
23182119|NCT00619502|64404929|FG000|Overall Study|Lost to Follow-up|8|||
23182120|NCT00619502|64404930|FG001|Overall Study|Lost to Follow-up|10|||
23182121|NCT02965378|64404932|FG000|Overall Study|Progression|16|||
23182122|NCT02965378|64404933|FG001|Overall Study|Progression|4|||
23182123|NCT02965378|64404932|FG000|Overall Study|Adverse Event|5|||
23182124|NCT02965378|64404933|FG001|Overall Study|Adverse Event|2|||
23182125|NCT02965378|64404932|FG000|Overall Study|Death|2|||
23182126|NCT02965378|64404933|FG001|Overall Study|Death|0|||
23182127|NCT02965378|64404932|FG000|Overall Study|Refusal|2|||
23182128|NCT02965378|64404933|FG001|Overall Study|Refusal|1|||
23182129|NCT02965378|64404932|FG000|Overall Study|Not protocol specified|0|||
23182130|NCT02965378|64404933|FG001|Overall Study|Not protocol specified|2|||
23182131|NCT02959814|64404935|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
23182132|NCT02959814|64404935|FG000|Overall Study|Excluded based on anatomical criteria|2|||
23182133|NCT02959814|64404935|FG000|Overall Study|Protocol Violation|7|||
23182134|NCT02959814|64404935|FG000|Overall Study|FFR not measured|2|||
23182135|NCT02959814|64404935|FG000|Overall Study|In-procedure QFR not computed|6|||
23182136|NCT02959814|64404935|FG000|Overall Study|Excluded by FFR core-lab|24|||
23182137|NCT01413958|64404938|FG000|Overall Study|Lost to Follow-up|0|||
23182138|NCT01413958|64404939|FG001|Overall Study|Lost to Follow-up|1|||
23182139|NCT03539432|64404940|FG000|Overall Study|Lost to Follow-up|0|||
23182140|NCT03539432|64404941|FG001|Overall Study|Lost to Follow-up|1|||
23182141|NCT00981526|64404942|FG000|Overall Study|Withdrawal by Subject|0|||
23182142|NCT00981526|64404943|FG001|Overall Study|Withdrawal by Subject|2|||
23182143|NCT00981526|64404942|FG000|Overall Study|Physician Decision|4|||
23182144|NCT00981526|64404943|FG001|Overall Study|Physician Decision|4|||
23182145|NCT00345605|64404947|FG000|Arm 1|Adverse Event|0|||
23182146|NCT00345605|64404948|FG001|Arm 1|Adverse Event|1|||
23182147|NCT00345605|64404947|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
23182148|NCT00345605|64404948|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
23182149|NCT04574999|64404949|FG000|Overall Study|Adverse Event|1|||
23182150|NCT04574999|64404950|FG001|Overall Study|Adverse Event|0|||
23182151|NCT04574999|64404949|FG000|Overall Study|Lack of Efficacy|2|||
23348862|NCT02772276|65021706|FG006|Overall Study|Withdrew consent|0|||
23348863|NCT02772276|65021707|FG007|Overall Study|Withdrew consent|1|||
23348864|NCT02772276|65021708|FG008|Overall Study|Withdrew consent|0|||
23348865|NCT02772276|65021709|FG009|Overall Study|Withdrew consent|0|||
23348866|NCT02772276|65021710|FG010|Overall Study|Withdrew consent|0|||
23348867|NCT02772276|65021711|FG011|Overall Study|Withdrew consent|0|||
23348868|NCT02772276|65021712|FG012|Overall Study|Withdrew consent|0|||
23348869|NCT01362517|65021713|FG000|Overall Study|Protocol Violation|1|||
23182152|NCT04574999|64404950|FG001|Overall Study|Lack of Efficacy|3|||
23182153|NCT04574999|64404949|FG000|Overall Study|Protocol Violation|1|||
23348870|NCT01362517|65021713|FG000|Overall Study|Lost to Follow-up|1|||
23348871|NCT02774005|65021714|FG000|Overall Study|Adverse Event|8|||
23348872|NCT02774005|65021714|FG000|Overall Study|Withdrawal by Subject|23|||
23348873|NCT02774005|65021714|FG000|Overall Study|Lost to Follow-up|7|||
23348874|NCT02774005|65021714|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
23348875|NCT02774005|65021714|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
23348876|NCT02774005|65021714|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
23348877|NCT02774005|65021714|FG000|Overall Study|Death|1|||
23348878|NCT02774005|65021714|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
23348879|NCT02774005|65021714|FG000|Overall Study|Lack of compliance with study medication|4|||
23348880|NCT02774005|65021714|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
23348881|NCT02774005|65021714|FG000|Overall Study|another study|1|||
23348882|NCT02774005|65021714|FG000|Overall Study|cardiologist imposed travel restriction|1|||
23348883|NCT03054064|65021715|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
23348884|NCT03054064|65021715|FG000|Overall Study|Investigator Decision|2|||
23348885|NCT03054064|65021715|FG000|Overall Study|Bladder Issue|1|||
23348886|NCT03054064|65021715|FG000|Overall Study|High Blood Pressure|1|||
23348887|NCT03054064|65021715|FG000|Overall Study|Change in Status|1|||
23348888|NCT01283334|65021716|FG000|Overall Study|Withdrawal by Subject|1|||
23348889|NCT01283334|65021716|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
23348890|NCT01283334|65021716|FG000|Overall Study|Adverse Event|4|||
23348891|NCT01283334|65021716|FG000|Overall Study|Physician Decision|1|||
23348892|NCT01346540|65021718|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
23348893|NCT01346540|65021719|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
23348894|NCT01346540|65021718|FG000|Overall Study|Adverse Event|0|||
23348895|NCT01346540|65021719|FG001|Overall Study|Adverse Event|4|||
23348896|NCT02686658|65021721|FG000|Overall Study|Adverse Event|0|||
23348897|NCT02686658|65021722|FG001|Overall Study|Adverse Event|0|||
23348898|NCT02686658|65021723|FG002|Overall Study|Adverse Event|1|||
23348899|NCT02686658|65021724|FG003|Overall Study|Adverse Event|1|||
23348900|NCT02686658|65021725|FG004|Overall Study|Adverse Event|2|||
23348901|NCT02686658|65021726|FG005|Overall Study|Adverse Event|1|||
23348902|NCT02686658|65021721|FG000|Overall Study|Investigator decision|0|||
23348903|NCT02686658|65021722|FG001|Overall Study|Investigator decision|0|||
23348904|NCT02686658|65021723|FG002|Overall Study|Investigator decision|0|||
23348905|NCT02686658|65021724|FG003|Overall Study|Investigator decision|1|||
23348906|NCT02686658|65021725|FG004|Overall Study|Investigator decision|2|||
23348907|NCT02686658|65021726|FG005|Overall Study|Investigator decision|1|||
23348908|NCT02686658|65021721|FG000|Overall Study|Sponsor decision|1|||
23348909|NCT02686658|65021722|FG001|Overall Study|Sponsor decision|2|||
23348910|NCT02686658|65021723|FG002|Overall Study|Sponsor decision|1|||
23348911|NCT02686658|65021724|FG003|Overall Study|Sponsor decision|5|||
23348912|NCT02686658|65021725|FG004|Overall Study|Sponsor decision|13|||
23348913|NCT02686658|65021726|FG005|Overall Study|Sponsor decision|2|||
23348914|NCT02686658|65021721|FG000|Overall Study|Lost to Follow-up|0|||
23348915|NCT02686658|65021722|FG001|Overall Study|Lost to Follow-up|0|||
23348916|NCT02686658|65021723|FG002|Overall Study|Lost to Follow-up|2|||
23348917|NCT02686658|65021724|FG003|Overall Study|Lost to Follow-up|0|||
23348918|NCT02686658|65021725|FG004|Overall Study|Lost to Follow-up|0|||
23348919|NCT02686658|65021726|FG005|Overall Study|Lost to Follow-up|1|||
23348920|NCT02686658|65021721|FG000|Overall Study|Death|1|||
23348921|NCT02686658|65021722|FG001|Overall Study|Death|0|||
23348922|NCT02686658|65021723|FG002|Overall Study|Death|0|||
23348923|NCT02686658|65021724|FG003|Overall Study|Death|1|||
23348924|NCT02686658|65021725|FG004|Overall Study|Death|1|||
23348925|NCT02686658|65021726|FG005|Overall Study|Death|1|||
23348926|NCT02686658|65021721|FG000|Overall Study|Withdrawal by Subject|2|||
23348927|NCT02686658|65021722|FG001|Overall Study|Withdrawal by Subject|5|||
23348928|NCT02686658|65021723|FG002|Overall Study|Withdrawal by Subject|4|||
23348929|NCT02686658|65021724|FG003|Overall Study|Withdrawal by Subject|4|||
23348930|NCT02686658|65021725|FG004|Overall Study|Withdrawal by Subject|17|||
23348931|NCT02686658|65021726|FG005|Overall Study|Withdrawal by Subject|8|||
23348932|NCT02686658|65021721|FG000|Overall Study|Placed in hospice care|0|||
23348933|NCT02686658|65021722|FG001|Overall Study|Placed in hospice care|0|||
23348934|NCT02686658|65021723|FG002|Overall Study|Placed in hospice care|1|||
23348935|NCT02686658|65021724|FG003|Overall Study|Placed in hospice care|0|||
23584453|NCT03781804|65869197|FG001|Overall Study|Protocol Violation|0|||
23348936|NCT02686658|65021725|FG004|Overall Study|Placed in hospice care|0|||
23348937|NCT02686658|65021726|FG005|Overall Study|Placed in hospice care|0|||
23348938|NCT02686658|65021721|FG000|Overall Study|Participant non-compliance|0|||
23348939|NCT02686658|65021722|FG001|Overall Study|Participant non-compliance|0|||
23348940|NCT02686658|65021723|FG002|Overall Study|Participant non-compliance|0|||
23584454|NCT03781804|65869198|FG002|Overall Study|Protocol Violation|1|||
23348941|NCT02686658|65021724|FG003|Overall Study|Participant non-compliance|0|||
23348942|NCT02686658|65021725|FG004|Overall Study|Participant non-compliance|0|||
23348943|NCT02686658|65021726|FG005|Overall Study|Participant non-compliance|1|||
23348944|NCT02686658|65021721|FG000|Overall Study|Concern over coronavirus disease care|0|||
23348945|NCT02686658|65021722|FG001|Overall Study|Concern over coronavirus disease care|0|||
23348946|NCT02686658|65021723|FG002|Overall Study|Concern over coronavirus disease care|0|||
23348947|NCT02686658|65021724|FG003|Overall Study|Concern over coronavirus disease care|0|||
23348948|NCT02686658|65021725|FG004|Overall Study|Concern over coronavirus disease care|2|||
23348949|NCT02686658|65021726|FG005|Overall Study|Concern over coronavirus disease care|1|||
23348950|NCT01432275|65021727|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
23241556|NCT00347776|64629509|FG001|12 Month Follow-up|Reached endpoint|6|||
23241557|NCT00347776|64629510|FG002|12 Month Follow-up|Reached endpoint|9|||
23348951|NCT01432275|65021728|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
23348952|NCT01432275|65021727|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
23241558|NCT04189224|64629511|FG000|Period 2|Adverse Event|0|||
23241559|NCT04189224|64629512|FG001|Period 2|Adverse Event|1|||
23241560|NCT01569074|64629513|FG000|Overall Study|Study stopped|6|||
23241561|NCT01569074|64629514|FG001|Overall Study|Study stopped|6|||
23241562|NCT01569074|64629515|FG002|Overall Study|Study stopped|8|||
23241563|NCT01569074|64629516|FG003|Overall Study|Study stopped|7|||
23241564|NCT01569074|64629517|FG004|Overall Study|Study stopped|7|||
23348953|NCT01432275|65021728|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
23348954|NCT01432275|65021727|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
23348955|NCT01432275|65021728|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
23348956|NCT01432275|65021727|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
23348957|NCT01432275|65021728|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
23348958|NCT01432275|65021727|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
23348959|NCT01432275|65021728|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
23348960|NCT01432275|65021727|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
23348961|NCT01432275|65021728|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
23348962|NCT01432275|65021727|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
23348963|NCT01432275|65021728|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
23348964|NCT01432275|65021727|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
23348965|NCT01432275|65021728|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
23348966|NCT01432275|65021727|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
23348967|NCT01432275|65021728|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
23348968|NCT01185509|65021732|FG000|Overall Study|Progression/Relapse|9|||
23348969|NCT01185509|65021733|FG001|Overall Study|Progression/Relapse|15|||
23348970|NCT01185509|65021732|FG000|Overall Study|Physician Decision|2|||
23348971|NCT01185509|65021733|FG001|Overall Study|Physician Decision|2|||
23348972|NCT01185509|65021732|FG000|Overall Study|Withdrawal by Subject|0|||
23348973|NCT01185509|65021733|FG001|Overall Study|Withdrawal by Subject|1|||
23348974|NCT01185509|65021732|FG000|Overall Study|Death|0|||
23348975|NCT01185509|65021733|FG001|Overall Study|Death|1|||
23348976|NCT01185509|65021732|FG000|Overall Study|Intercurrent Illness|0|||
23348977|NCT01185509|65021733|FG001|Overall Study|Intercurrent Illness|1|||
23348978|NCT01542034|65021740|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
23348979|NCT01542034|65021741|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
23348980|NCT01542034|65021740|FG000|Overall Study|Administrative decision|0|||
23348981|NCT01542034|65021741|FG001|Overall Study|Administrative decision|3|||
23348982|NCT01542034|65021740|FG000|Overall Study|Subject Noncompliance|1|||
23348983|NCT01542034|65021741|FG001|Overall Study|Subject Noncompliance|0|||
23348984|NCT01542034|65021740|FG000|Overall Study|Adverse Event|2|||
23348985|NCT01542034|65021741|FG001|Overall Study|Adverse Event|2|||
23348986|NCT01542034|65021740|FG000|Overall Study|Lost to Follow-up|7|||
23348987|NCT01542034|65021741|FG001|Overall Study|Lost to Follow-up|6|||
23348988|NCT00581542|65021742|FG000|Overall Study|they met an exclusion criteria|2|||
23348989|NCT00581542|65021743|FG001|Overall Study|they met an exclusion criteria|2|||
23348990|NCT00581542|65021742|FG000|Overall Study|Lost to Follow-up|9|||
23348991|NCT00581542|65021743|FG001|Overall Study|Lost to Follow-up|21|||
23348992|NCT03515629|65021744|FG000|Overall Study|Death|0|||
23460677|NCT02443688|65430834|FG002|Overall Study|Withdrawal by Subject|4|||
23460678|NCT02443688|65430832|FG000|Overall Study|Non-compliance with study drug|1|||
23460679|NCT02443688|65430833|FG001|Overall Study|Non-compliance with study drug|2|||
23584455|NCT03781804|65869196|FG000|Overall Study|Withdrawal by Subject|0|||
23584456|NCT03781804|65869197|FG001|Overall Study|Withdrawal by Subject|1|||
23241565|NCT01569074|64629513|FG000|Overall Study|Study-specific discontinuation criteria|0|||
23241566|NCT01569074|64629514|FG001|Overall Study|Study-specific discontinuation criteria|1|||
23348993|NCT03515629|65021745|FG001|Overall Study|Death|1|||
23348994|NCT03515629|65021746|FG002|Overall Study|Death|1|||
23348995|NCT03515629|65021744|FG000|Overall Study|Progressive disease|0|||
23348996|NCT03515629|65021745|FG001|Overall Study|Progressive disease|1|||
23348997|NCT03515629|65021746|FG002|Overall Study|Progressive disease|0|||
23348998|NCT03426436|65021747|FG000|Overall Study|Incorrect lead placement|12|||
23348999|NCT03426436|65021747|FG000|Overall Study|Withdrawal by Subject|2|||
23349000|NCT03426436|65021747|FG000|Overall Study|Consent issue|1|||
23241567|NCT01569074|64629515|FG002|Overall Study|Study-specific discontinuation criteria|0|||
23241568|NCT01569074|64629516|FG003|Overall Study|Study-specific discontinuation criteria|0|||
23241569|NCT01569074|64629517|FG004|Overall Study|Study-specific discontinuation criteria|0|||
23241570|NCT01569074|64629513|FG000|Overall Study|Severe non-compliance to protocol|0|||
23241571|NCT01569074|64629514|FG001|Overall Study|Severe non-compliance to protocol|0|||
23241572|NCT01569074|64629515|FG002|Overall Study|Severe non-compliance to protocol|1|||
23241573|NCT01569074|64629516|FG003|Overall Study|Severe non-compliance to protocol|0|||
23241574|NCT01569074|64629517|FG004|Overall Study|Severe non-compliance to protocol|0|||
23241575|NCT01569074|64629513|FG000|Overall Study|eg change in circumstances|0|||
23241576|NCT01569074|64629514|FG001|Overall Study|eg change in circumstances|2|||
23241577|NCT01569074|64629515|FG002|Overall Study|eg change in circumstances|0|||
23241578|NCT01569074|64629516|FG003|Overall Study|eg change in circumstances|1|||
23241579|NCT01569074|64629517|FG004|Overall Study|eg change in circumstances|1|||
23241580|NCT01569074|64629513|FG000|Overall Study|Adverse Event|1|||
23241581|NCT01569074|64629514|FG001|Overall Study|Adverse Event|0|||
23241582|NCT01569074|64629515|FG002|Overall Study|Adverse Event|3|||
23241583|NCT01569074|64629516|FG003|Overall Study|Adverse Event|0|||
23241584|NCT01569074|64629517|FG004|Overall Study|Adverse Event|0|||
23241585|NCT00145795|64629518|FG000|Overall Study|Adverse Event|1|||
23241586|NCT00145795|64629519|FG001|Overall Study|Adverse Event|0|||
23241587|NCT00131937|64629520|FG000|Overall Study|Adverse Event|3|||
23241588|NCT00131937|64629520|FG000|Overall Study|Withdrawal by Subject|2|||
23241589|NCT00131937|64629520|FG000|Overall Study|Physician Decision|1|||
23241590|NCT00131937|64629520|FG000|Overall Study|Disease Progression|7|||
23241591|NCT00131937|64629520|FG000|Overall Study|Alternative therapy|1|||
23241592|NCT00253747|64629521|FG000|Overall Study|Lost to Follow-up|13|||
23241593|NCT00253747|64629522|FG001|Overall Study|Lost to Follow-up|14|||
23241594|NCT00253747|64629521|FG000|Overall Study|Withdrawal by Subject|10|||
23241595|NCT00253747|64629522|FG001|Overall Study|Withdrawal by Subject|11|||
23241596|NCT00253747|64629521|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
23241597|NCT00253747|64629522|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
23241598|NCT00122954|64629523|FG000|Overall Study|Withdrawal by Subject|2|||
23241599|NCT00122954|64629524|FG001|Overall Study|Withdrawal by Subject|2|||
23241600|NCT00122954|64629523|FG000|Overall Study|Protocol Violation|0|||
23241601|NCT00122954|64629524|FG001|Overall Study|Protocol Violation|1|||
23241602|NCT00656669|64629535|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
23241603|NCT00656669|64629535|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
23241604|NCT00656669|64629535|FG000|AC (Cycles 6-9)|Adverse Event|1|||
23349001|NCT03426436|65021747|FG000|Overall Study|ECGs not saved|4|||
23349002|NCT03427268|65021748|FG000|Overall Study|Progressive disease|25|||
23349003|NCT03427268|65021748|FG000|Overall Study|Never treated|2|||
23349004|NCT03427268|65021748|FG000|Overall Study|Compassionate use|1|||
23349005|NCT03427268|65021748|FG000|Overall Study|Withdrawal by Subject|1|||
23182154|NCT04574999|64404950|FG001|Overall Study|Protocol Violation|0|||
23182155|NCT04574999|64404949|FG000|Overall Study|Withdrawal by Subject|2|||
23182156|NCT04574999|64404950|FG001|Overall Study|Withdrawal by Subject|2|||
23182157|NCT04574999|64404949|FG000|Overall Study|Lost to Follow-up|1|||
23182158|NCT04574999|64404950|FG001|Overall Study|Lost to Follow-up|0|||
23182159|NCT04574999|64404949|FG000|Overall Study|Personal problems|1|||
23182160|NCT04574999|64404950|FG001|Overall Study|Personal problems|0|||
23182161|NCT04574999|64404949|FG000|Overall Study|Previous planned surgery|1|||
23182162|NCT04574999|64404950|FG001|Overall Study|Previous planned surgery|0|||
23349006|NCT03427268|65021748|FG000|Overall Study|Adverse Event|3|||
23349007|NCT00980655|65021749|FG000|Overall Study|Adverse Event|13|||
23349008|NCT00980655|65021750|FG001|Overall Study|Adverse Event|31|||
23349009|NCT00980655|65021749|FG000|Overall Study|Death|0|||
23349010|NCT00980655|65021750|FG001|Overall Study|Death|7|||
23349011|NCT00980655|65021749|FG000|Overall Study|Protocol Violation|2|||
23349012|NCT00980655|65021750|FG001|Overall Study|Protocol Violation|7|||
23349013|NCT00980655|65021749|FG000|Overall Study|Withdrawal by Subject|0|||
23349014|NCT00980655|65021750|FG001|Overall Study|Withdrawal by Subject|4|||
23349015|NCT00980655|65021749|FG000|Overall Study|Lost to Follow-up|0|||
23349016|NCT00980655|65021750|FG001|Overall Study|Lost to Follow-up|1|||
23349017|NCT00980655|65021749|FG000|Overall Study|Parent/legal guardian request|1|||
23349018|NCT00980655|65021750|FG001|Overall Study|Parent/legal guardian request|0|||
23349019|NCT00980655|65021749|FG000|Overall Study|Other|0|||
23182163|NCT00127127|64404958|FG000|Overall Study|Adverse Event|0|||
23584457|NCT03781804|65869198|FG002|Overall Study|Withdrawal by Subject|1|||
23182164|NCT00127127|64404959|FG001|Overall Study|Adverse Event|2|||
23241605|NCT00656669|64629535|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
23241606|NCT01826201|64629536|FG000|Overall Study|Non compliance with protocol|4|||
23241607|NCT03668613|64629549|FG000|Overall Study|Adverse Event|1|||
23241608|NCT03668613|64629550|FG001|Overall Study|Adverse Event|2|||
23241609|NCT03668613|64629549|FG000|Overall Study|Lack of Efficacy|5|||
23241610|NCT03668613|64629550|FG001|Overall Study|Lack of Efficacy|1|||
23349020|NCT00980655|65021750|FG001|Overall Study|Other|1|||
23584458|NCT03781804|65869196|FG000|Overall Study|Reason not provided|2|||
23349021|NCT01886781|65021751|FG000|Overall Study|Protocol Violation|5|||
23349022|NCT01886781|65021752|FG001|Overall Study|Protocol Violation|0|||
23349023|NCT01886781|65021751|FG000|Overall Study|Adverse Event|1|||
23349024|NCT01886781|65021752|FG001|Overall Study|Adverse Event|0|||
23349025|NCT01886781|65021751|FG000|Overall Study|Lost to Follow-up|5|||
23349026|NCT01886781|65021752|FG001|Overall Study|Lost to Follow-up|0|||
23349027|NCT01886781|65021751|FG000|Overall Study|Withdrawal by Subject|2|||
23349028|NCT01886781|65021752|FG001|Overall Study|Withdrawal by Subject|1|||
23349029|NCT01886781|65021751|FG000|Overall Study|Worsening of symptoms|1|||
23349030|NCT01886781|65021752|FG001|Overall Study|Worsening of symptoms|1|||
23349031|NCT04245202|65021753|FG000|Overall Study|Lack of Efficacy|10|||
23349032|NCT04245202|65021754|FG001|Overall Study|Lack of Efficacy|1|||
23349033|NCT00980018|65021755|FG000|Overall Study|Adverse Event|8|||
23349034|NCT00980018|65021755|FG000|Overall Study|Patient withdrew consent|3|||
23349035|NCT00980018|65021755|FG000|Overall Study|Lost to Follow-up|1|||
23349036|NCT01210495|65021758|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
23349037|NCT01210495|65021759|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
23349038|NCT01210495|65021760|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
23349039|NCT01210495|65021761|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
23349040|NCT01210495|65021758|FG000|Overall Study|Death|14|||
23349041|NCT01210495|65021759|FG001|Overall Study|Death|7|||
23349042|NCT01210495|65021760|FG002|Overall Study|Death|112|||
23349043|NCT01210495|65021761|FG003|Overall Study|Death|54|||
23349044|NCT01210495|65021758|FG000|Overall Study|Study Terminated by Sponsor|0|||
23349045|NCT01210495|65021759|FG001|Overall Study|Study Terminated by Sponsor|0|||
23349046|NCT01210495|65021760|FG002|Overall Study|Study Terminated by Sponsor|4|||
23349047|NCT01210495|65021761|FG003|Overall Study|Study Terminated by Sponsor|11|||
23349048|NCT01210495|65021758|FG000|Overall Study|Lost to Follow-up|0|||
23349049|NCT01210495|65021759|FG001|Overall Study|Lost to Follow-up|0|||
23349050|NCT01210495|65021760|FG002|Overall Study|Lost to Follow-up|1|||
23349051|NCT01210495|65021761|FG003|Overall Study|Lost to Follow-up|1|||
23349052|NCT01210495|65021758|FG000|Overall Study|Other unspecified|0|||
23349053|NCT01210495|65021759|FG001|Overall Study|Other unspecified|0|||
23460680|NCT02443688|65430834|FG002|Overall Study|Non-compliance with study drug|4|||
23460681|NCT02443688|65430832|FG000|Overall Study|Sponsor Request|2|||
23460682|NCT02443688|65430833|FG001|Overall Study|Sponsor Request|1|||
23182165|NCT00127127|64404960|FG002|Overall Study|Adverse Event|0|||
23182166|NCT00127127|64404961|FG003|Overall Study|Adverse Event|1|||
23182167|NCT00127127|64404958|FG000|Overall Study|Lack of Efficacy|1|||
23182168|NCT00127127|64404959|FG001|Overall Study|Lack of Efficacy|3|||
23182169|NCT00127127|64404960|FG002|Overall Study|Lack of Efficacy|0|||
23182170|NCT00127127|64404961|FG003|Overall Study|Lack of Efficacy|2|||
23349054|NCT01210495|65021760|FG002|Overall Study|Other unspecified|6|||
23349055|NCT01210495|65021761|FG003|Overall Study|Other unspecified|0|||
23349056|NCT03434249|65021767|FG000|Overall Study|Adverse Event|1|||
23349057|NCT03434249|65021768|FG001|Overall Study|Adverse Event|0|||
23349058|NCT03434249|65021767|FG000|Overall Study|Lost to Follow-up|0|||
23349059|NCT03434249|65021768|FG001|Overall Study|Lost to Follow-up|1|||
23349060|NCT03434249|65021767|FG000|Overall Study|Non-compliance of family|2|||
23182171|NCT01070329|64404964|FG000|Overall Study|Adverse Event|13|||
23182172|NCT01070329|64404965|FG001|Overall Study|Adverse Event|10|||
23182173|NCT01070329|64404964|FG000|Overall Study|Lost to Follow-up|22|||
23182174|NCT01070329|64404965|FG001|Overall Study|Lost to Follow-up|12|||
23182175|NCT01070329|64404964|FG000|Overall Study|Withdrawal by Subject|9|||
23182176|NCT01070329|64404965|FG001|Overall Study|Withdrawal by Subject|11|||
23182177|NCT01070329|64404964|FG000|Overall Study|Protocol Violation|3|||
23182178|NCT01070329|64404965|FG001|Overall Study|Protocol Violation|8|||
23182179|NCT01070329|64404964|FG000|Overall Study|Lack of Efficacy|2|||
23182180|NCT01070329|64404965|FG001|Overall Study|Lack of Efficacy|6|||
23182181|NCT01070329|64404964|FG000|Overall Study|Physician Decision|2|||
23182182|NCT01070329|64404965|FG001|Overall Study|Physician Decision|1|||
23182183|NCT01070329|64404964|FG000|Overall Study|Entry Criteria Not Met|1|||
23182184|NCT01070329|64404965|FG001|Overall Study|Entry Criteria Not Met|0|||
23182185|NCT01070329|64404964|FG000|Overall Study|Sponsor Decision|0|||
23182186|NCT01070329|64404965|FG001|Overall Study|Sponsor Decision|1|||
23182187|NCT01392183|64404966|FG000|First Drug Administration|Adverse Event|3|||
23182188|NCT01392183|64404967|FG001|First Drug Administration|Adverse Event|2|||
23182189|NCT01392183|64404966|FG000|First Drug Administration|Death|1|||
23182190|NCT01392183|64404967|FG001|First Drug Administration|Death|0|||
23182191|NCT01392183|64404966|FG000|First Drug Administration|Withdrawal by Subject|10|||
23182192|NCT01392183|64404967|FG001|First Drug Administration|Withdrawal by Subject|17|||
23182193|NCT00699192|64404968|FG000|Overall Study|Missing|1|||
23182194|NCT00699192|64404969|FG001|Overall Study|Missing|1|||
23349061|NCT03434249|65021768|FG001|Overall Study|Non-compliance of family|1|||
23349062|NCT03434249|65021767|FG000|Overall Study|Difficulties in completing daily diary|2|||
23349063|NCT03434249|65021768|FG001|Overall Study|Difficulties in completing daily diary|1|||
23349064|NCT04394624|65021769|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|6|||
23460683|NCT02443688|65430834|FG002|Overall Study|Sponsor Request|0|||
23241611|NCT03668613|64629549|FG000|Overall Study|Pregnancy|0|||
23241612|NCT03668613|64629550|FG001|Overall Study|Pregnancy|2|||
23241613|NCT03668613|64629549|FG000|Overall Study|Protocol Violation|1|||
23241614|NCT03668613|64629550|FG001|Overall Study|Protocol Violation|0|||
23241615|NCT03668613|64629549|FG000|Overall Study|Physician Decision|1|||
23241616|NCT03668613|64629550|FG001|Overall Study|Physician Decision|0|||
23241617|NCT03668613|64629549|FG000|Overall Study|Withdrawal by Subject|2|||
23241618|NCT03668613|64629550|FG001|Overall Study|Withdrawal by Subject|1|||
23349065|NCT04394624|65021769|FG000|Overall Study|Adverse Event|5|||
23349066|NCT04394624|65021769|FG000|Overall Study|Progressive disease|20|||
23349067|NCT01047332|65021770|FG000|Overall Study|SEMS Obstruction|11|||
23349068|NCT01047332|65021771|FG001|Overall Study|SEMS Obstruction|20|||
23349069|NCT01047332|65021770|FG000|Overall Study|Died Unobstructed|38|||
23349070|NCT01047332|65021771|FG001|Overall Study|Died Unobstructed|41|||
23349071|NCT01047332|65021770|FG000|Overall Study|Lost to Follow-up|8|||
23349072|NCT01047332|65021771|FG001|Overall Study|Lost to Follow-up|3|||
23349073|NCT02248974|65021772|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
23349074|NCT02248974|65021773|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
23182195|NCT00699192|64404970|FG002|Overall Study|Missing|1|||
23182196|NCT00699192|64404968|FG000|Overall Study|Adverse Event|9|||
23182197|NCT00699192|64404969|FG001|Overall Study|Adverse Event|4|||
23349075|NCT02248974|65021772|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
23349076|NCT02248974|65021773|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
23349077|NCT02248974|65021772|FG000|1-Day Follow-Up|Enrolled in another study|1|||
23349078|NCT02248974|65021773|FG001|1-Day Follow-Up|Enrolled in another study|0|||
23182198|NCT00699192|64404970|FG002|Overall Study|Adverse Event|3|||
23182199|NCT00699192|64404968|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23182200|NCT00699192|64404969|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23349079|NCT02248974|65021772|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
23349080|NCT02248974|65021773|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
23349081|NCT02248974|65021772|FG000|1-Week Follow-Up|Enrolled in another study|1|||
23349082|NCT02248974|65021773|FG001|1-Week Follow-Up|Enrolled in another study|1|||
23349083|NCT02248974|65021772|FG000|1-Week Follow-Up|Transferred to another facility|1|||
23349084|NCT02248974|65021773|FG001|1-Week Follow-Up|Transferred to another facility|0|||
23349085|NCT02248974|65021772|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
23349086|NCT02248974|65021773|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
23349087|NCT02248974|65021772|FG000|1-Week Follow-Up|Death|1|||
23349088|NCT02248974|65021773|FG001|1-Week Follow-Up|Death|1|||
23349089|NCT02248974|65021772|FG000|1-Week Follow-Up|Excluded because of age|0|||
23349090|NCT02248974|65021773|FG001|1-Week Follow-Up|Excluded because of age|1|||
23349091|NCT02248974|65021772|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
23182201|NCT00699192|64404970|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23182202|NCT00699192|64404968|FG000|Overall Study|Lack of Efficacy|0|||
23241619|NCT03668613|64629549|FG000|Overall Study|Guardian decision|1|||
23241620|NCT03668613|64629550|FG001|Overall Study|Guardian decision|0|||
23241621|NCT00859313|64629554|FG000|Overall Study|Lack of Efficacy|2|||
23241622|NCT00859313|64629554|FG000|Overall Study|Adverse Event|1|||
23241623|NCT00859313|64629554|FG000|Overall Study|staff error|1|||
23241624|NCT03329404|64629556|FG000|Overall Study|The study was suspended.|1|||
23241625|NCT03329404|64629557|FG001|Overall Study|The study was suspended.|4|||
23241626|NCT01374516|64629558|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
23241627|NCT01374516|64629559|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
23241628|NCT01374516|64629558|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
23241629|NCT01374516|64629559|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
23241630|NCT01374516|64629558|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
23241631|NCT01374516|64629559|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
23241632|NCT01374516|64629558|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
23241633|NCT01374516|64629559|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
23241634|NCT01374516|64629558|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
23241635|NCT01374516|64629559|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
23241636|NCT01374516|64629558|FG000|Surveillance Expansion Period|Protocol Violation|386|||
23349092|NCT02248974|65021773|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
23349093|NCT02248974|65021772|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
23349094|NCT02248974|65021773|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
23584459|NCT03781804|65869197|FG001|Overall Study|Reason not provided|2|||
23182203|NCT00699192|64404969|FG001|Overall Study|Lack of Efficacy|0|||
23241637|NCT01374516|64629559|FG001|Surveillance Expansion Period|Protocol Violation|217|||
23241638|NCT01374516|64629558|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
23241639|NCT01374516|64629559|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
23241640|NCT01374516|64629558|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
23241641|NCT01374516|64629559|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
23241642|NCT01374516|64629558|FG000|Surveillance Expansion Period|Serious adverse event|20|||
23349095|NCT02248974|65021772|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
23349096|NCT02248974|65021773|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
23349097|NCT02248974|65021772|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
23182204|NCT00699192|64404970|FG002|Overall Study|Lack of Efficacy|1|||
23182205|NCT00699192|64404968|FG000|Overall Study|Withdrawal by Subject|3|||
23349098|NCT02248974|65021773|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
23349099|NCT02248974|65021772|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
23349100|NCT02248974|65021773|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
23349101|NCT00306787|65021774|FG000|Overall Study|Discontinued without taking study drug|208|||
23349102|NCT00306787|65021775|FG001|Overall Study|Discontinued without taking study drug|215|||
23349103|NCT00306787|65021774|FG000|Overall Study|Adverse Event|1|||
23349104|NCT00306787|65021775|FG001|Overall Study|Adverse Event|1|||
23349105|NCT00306787|65021774|FG000|Overall Study|Lack of Efficacy|1|||
23349106|NCT00306787|65021775|FG001|Overall Study|Lack of Efficacy|0|||
23349107|NCT00306787|65021774|FG000|Overall Study|Protocol Violation|8|||
23349108|NCT00306787|65021775|FG001|Overall Study|Protocol Violation|10|||
23349109|NCT00306787|65021774|FG000|Overall Study|Withdrawal by Subject|2|||
23349110|NCT00306787|65021775|FG001|Overall Study|Withdrawal by Subject|9|||
23349111|NCT00306787|65021774|FG000|Overall Study|Lost to Follow-up|9|||
23349112|NCT00306787|65021775|FG001|Overall Study|Lost to Follow-up|6|||
23349113|NCT00306787|65021774|FG000|Overall Study|Administrative problems|4|||
23349114|NCT00306787|65021775|FG001|Overall Study|Administrative problems|0|||
23349115|NCT00306787|65021774|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23349116|NCT00306787|65021775|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23349117|NCT01458951|65021776|FG000|Overall Study|Other|1|||
23349118|NCT01458951|65021777|FG001|Overall Study|Other|0|||
23460684|NCT01499940|65430835|FG000|Overall Study|Study was withdrawn before completion.|9|||
23182206|NCT00699192|64404969|FG001|Overall Study|Withdrawal by Subject|2|||
23182207|NCT00699192|64404970|FG002|Overall Study|Withdrawal by Subject|4|||
23182208|NCT00699192|64404968|FG000|Overall Study|Administrative problems|1|||
23182209|NCT00699192|64404969|FG001|Overall Study|Administrative problems|3|||
23182210|NCT00699192|64404970|FG002|Overall Study|Administrative problems|1|||
23182211|NCT00699192|64404968|FG000|Overall Study|Protocol Violation|2|||
23182212|NCT00699192|64404969|FG001|Overall Study|Protocol Violation|2|||
23182213|NCT00699192|64404970|FG002|Overall Study|Protocol Violation|0|||
23182214|NCT00420511|64404971|FG000|Overall Study|Adverse Event|1|||
23182215|NCT00420511|64404972|FG001|Overall Study|Adverse Event|1|||
23182216|NCT00420511|64404971|FG000|Overall Study|Lost to Follow-up|1|||
23182217|NCT00420511|64404972|FG001|Overall Study|Lost to Follow-up|0|||
23182218|NCT00442598|64404975|FG000|Overall Study|Adverse Event|1|||
23182219|NCT00442598|64404976|FG001|Overall Study|Adverse Event|0|||
23182220|NCT00442598|64404977|FG002|Overall Study|Adverse Event|0|||
23182221|NCT00442598|64404975|FG000|Overall Study|Tumor progression|3|||
23182222|NCT00442598|64404976|FG001|Overall Study|Tumor progression|4|||
23182223|NCT00442598|64404977|FG002|Overall Study|Tumor progression|0|||
23182224|NCT00442598|64404975|FG000|Overall Study|Clinical deterioration|1|||
23182225|NCT00442598|64404976|FG001|Overall Study|Clinical deterioration|2|||
23182226|NCT00442598|64404977|FG002|Overall Study|Clinical deterioration|0|||
23182227|NCT00442598|64404975|FG000|Overall Study|CA125 progression|0|||
23182228|NCT00442598|64404976|FG001|Overall Study|CA125 progression|1|||
23182229|NCT00442598|64404977|FG002|Overall Study|CA125 progression|0|||
23182230|NCT00442598|64404975|FG000|Overall Study|Reduced creatinine clearance|1|||
23182231|NCT00442598|64404976|FG001|Overall Study|Reduced creatinine clearance|0|||
23182232|NCT00442598|64404977|FG002|Overall Study|Reduced creatinine clearance|0|||
23182233|NCT00442598|64404975|FG000|Overall Study|Death|0|||
23182234|NCT00442598|64404976|FG001|Overall Study|Death|1|||
23182235|NCT00442598|64404977|FG002|Overall Study|Death|0|||
23182236|NCT00501228|64404978|FG000|Overall Study|Withdrawal by Subject|1|||
23182237|NCT04007159|64404979|FG000|Induction Phase|(missed study visits)|16|||
23182238|NCT04007159|64404979|FG000|Induction Phase|Withdrawal by Subject|4|||
23182239|NCT04007159|64404979|FG000|Induction Phase|Adverse Event|2|||
23182240|NCT04007159|64404979|FG000|Challenge Phase|missed study visits|3|||
23182241|NCT03968419|64404980|FG000|Treatment Period|Adverse Event|0|||
23182242|NCT03968419|64404981|FG001|Treatment Period|Adverse Event|0|||
23182243|NCT03968419|64404982|FG002|Treatment Period|Adverse Event|1|||
23349119|NCT01458951|65021778|FG002|Overall Study|Other|0|||
23349120|NCT01458951|65021776|FG000|Overall Study|Protocol Violation|5|||
23349121|NCT01458951|65021777|FG001|Overall Study|Protocol Violation|1|||
23349122|NCT01458951|65021778|FG002|Overall Study|Protocol Violation|0|||
23349123|NCT01458951|65021776|FG000|Overall Study|Withdrawal by Subject|2|||
23460685|NCT00751296|65430836|FG000|Overall Study|Adverse Event|2|||
23349124|NCT01458951|65021777|FG001|Overall Study|Withdrawal by Subject|0|||
23349125|NCT01458951|65021778|FG002|Overall Study|Withdrawal by Subject|2|||
23182244|NCT03968419|64404980|FG000|Safety Follow-up Period|Death|3|||
23182245|NCT03968419|64404981|FG001|Safety Follow-up Period|Death|2|||
23182246|NCT03968419|64404982|FG002|Safety Follow-up Period|Death|1|||
23182247|NCT03968419|64404980|FG000|Safety Follow-up Period|Subject Decision|2|||
23182248|NCT03968419|64404981|FG001|Safety Follow-up Period|Subject Decision|1|||
23349126|NCT01458951|65021776|FG000|Overall Study|Adverse Event|7|||
23349127|NCT01458951|65021777|FG001|Overall Study|Adverse Event|0|||
23460686|NCT02606643|65430840|FG000|Overall Study|did not meet inclusion criteria|1|||
23460687|NCT02606643|65430841|FG001|Overall Study|did not meet inclusion criteria|3|||
23460688|NCT00836693|65430842|FG000|Overall Study|Adverse Event|4|||
23460689|NCT00836693|65430843|FG001|Overall Study|Adverse Event|1|||
23460690|NCT00836693|65430842|FG000|Overall Study|Sponsor Decision|0|||
23460691|NCT00836693|65430843|FG001|Overall Study|Sponsor Decision|1|||
23460692|NCT00836693|65430842|FG000|Overall Study|Physician Decision|2|||
23460693|NCT00836693|65430843|FG001|Overall Study|Physician Decision|0|||
23460694|NCT00836693|65430842|FG000|Overall Study|Withdrawal by Subject|9|||
23460695|NCT00836693|65430843|FG001|Overall Study|Withdrawal by Subject|4|||
23460696|NCT00836693|65430842|FG000|Overall Study|Protocol Violation|1|||
23460697|NCT00836693|65430843|FG001|Overall Study|Protocol Violation|0|||
23460698|NCT00836693|65430842|FG000|Overall Study|Lost to Follow-up|1|||
23460699|NCT00836693|65430843|FG001|Overall Study|Lost to Follow-up|0|||
23460700|NCT03722238|65430844|FG000|Overall Study|Protocol Violation|1|||
23460701|NCT03722238|65430845|FG001|Overall Study|Protocol Violation|0|||
23349128|NCT01458951|65021778|FG002|Overall Study|Adverse Event|2|||
23349129|NCT01458951|65021776|FG000|Overall Study|Insufficient Clinical Response|17|||
23349130|NCT01458951|65021777|FG001|Overall Study|Insufficient Clinical Response|0|||
23349131|NCT01458951|65021778|FG002|Overall Study|Insufficient Clinical Response|11|||
23349132|NCT02637713|65021779|FG000|Overall Study|Screen Failure|2|||
23349133|NCT03738800|65021780|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
23349134|NCT03738800|65021781|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23349135|NCT03738800|65021782|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23349136|NCT03738800|65021780|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
23349137|NCT03738800|65021781|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
23349138|NCT03738800|65021782|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
23349139|NCT03738800|65021780|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
23349140|NCT03738800|65021781|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
23349141|NCT03738800|65021782|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
23349142|NCT01592292|65021783|FG000|Overall Study|Follow-up loss|3|||
23349143|NCT01592292|65021784|FG001|Overall Study|Follow-up loss|3|||
23349144|NCT01592292|65021785|FG002|Overall Study|Follow-up loss|1|||
23349145|NCT01592292|65021786|FG003|Overall Study|Follow-up loss|0|||
23349146|NCT01592292|65021783|FG000|Overall Study|Withdrew consent|2|||
23460702|NCT03722238|65430844|FG000|Overall Study|Physician Decision|1|||
23460703|NCT03722238|65430845|FG001|Overall Study|Physician Decision|0|||
23460704|NCT03722238|65430844|FG000|Overall Study|Death|1|||
23460705|NCT03722238|65430845|FG001|Overall Study|Death|0|||
23460706|NCT03722238|65430844|FG000|Overall Study|Lost to Follow-up|6|||
23460707|NCT03722238|65430845|FG001|Overall Study|Lost to Follow-up|0|||
23460708|NCT03722238|65430844|FG000|Overall Study|Partial missing data|44|||
23460709|NCT03722238|65430845|FG001|Overall Study|Partial missing data|1|||
23460710|NCT03722238|65430844|FG000|Overall Study|Withdrawal by Subject|2|||
23460711|NCT03722238|65430845|FG001|Overall Study|Withdrawal by Subject|0|||
23460712|NCT03722238|65430844|FG000|Overall Study|Other|4|||
23460713|NCT03722238|65430845|FG001|Overall Study|Other|0|||
23460714|NCT03722238|65430844|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
23460715|NCT03722238|65430845|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
23460716|NCT03722238|65430844|FG000|Overall Study|Did not meet risk classification group criteria|90|||
23460717|NCT03722238|65430845|FG001|Overall Study|Did not meet risk classification group criteria|0|||
23460718|NCT03722238|65430844|FG000|Overall Study|Did not sign consent|17|||
23460719|NCT03722238|65430845|FG001|Overall Study|Did not sign consent|0|||
23460720|NCT03722238|65430844|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
23460721|NCT03722238|65430845|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
23460722|NCT03722238|65430844|FG000|Overall Study|Not willing to purchase study medication|142|||
23460723|NCT03722238|65430845|FG001|Overall Study|Not willing to purchase study medication|0|||
23460724|NCT03722238|65430844|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
23460725|NCT03722238|65430845|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
23349147|NCT01592292|65021784|FG001|Overall Study|Withdrew consent|1|||
23349148|NCT01592292|65021785|FG002|Overall Study|Withdrew consent|0|||
23349149|NCT01592292|65021786|FG003|Overall Study|Withdrew consent|0|||
23349150|NCT01592292|65021783|FG000|Overall Study|Other|1|||
23349151|NCT01592292|65021784|FG001|Overall Study|Other|1|||
23349152|NCT01592292|65021785|FG002|Overall Study|Other|2|||
23460726|NCT04682366|65430846|FG000|Overall Study|Lost to Follow-up|1|||
23460727|NCT04682366|65430847|FG001|Overall Study|Lost to Follow-up|1|||
23460728|NCT02954536|65430851|FG000|Overall Study|Adverse Event|2|||
23460729|NCT02954536|65430851|FG000|Overall Study|Death|12|||
23349153|NCT01592292|65021786|FG003|Overall Study|Other|1|||
23460730|NCT03387085|65430852|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
23460731|NCT01256788|65430855|FG000|Overall Study|Lost to Follow-up|5|||
23460732|NCT01256788|65430856|FG001|Overall Study|Lost to Follow-up|8|||
23460733|NCT01256788|65430857|FG002|Overall Study|Lost to Follow-up|3|||
23460734|NCT01744977|65430858|FG000|Overall Study|Withdrawal by Subject|1|||
23460735|NCT01744977|65430859|FG001|Overall Study|Withdrawal by Subject|2|||
23460736|NCT01744977|65430858|FG000|Overall Study|Death|2|||
23460737|NCT01744977|65430859|FG001|Overall Study|Death|3|||
23460738|NCT01744977|65430858|FG000|Overall Study|Lost to Follow-up|2|||
23460739|NCT01744977|65430859|FG001|Overall Study|Lost to Follow-up|0|||
23460740|NCT01744977|65430858|FG000|Overall Study|No longer meets inclusion|6|||
23460741|NCT01744977|65430859|FG001|Overall Study|No longer meets inclusion|0|||
23460742|NCT04030143|65430860|FG000|Overall Study|Adverse Event|5|||
23460743|NCT04030143|65430861|FG001|Overall Study|Adverse Event|10|||
23460744|NCT04030143|65430860|FG000|Overall Study|Lost to Follow-up|3|||
23460745|NCT04030143|65430861|FG001|Overall Study|Lost to Follow-up|7|||
23460746|NCT04030143|65430860|FG000|Overall Study|Protocol Deviation|2|||
23460747|NCT04030143|65430861|FG001|Overall Study|Protocol Deviation|2|||
23460748|NCT04030143|65430860|FG000|Overall Study|Withdrawal by Subject|16|||
23460749|NCT04030143|65430861|FG001|Overall Study|Withdrawal by Subject|18|||
23460750|NCT04030143|65430860|FG000|Overall Study|Physician Decision|1|||
23460751|NCT04030143|65430861|FG001|Overall Study|Physician Decision|1|||
23460752|NCT04030143|65430860|FG000|Overall Study|Due to Covid-19|2|||
23460753|NCT04030143|65430861|FG001|Overall Study|Due to Covid-19|3|||
23460754|NCT04030143|65430860|FG000|Overall Study|Not Due to Covid-19|1|||
23460755|NCT04030143|65430861|FG001|Overall Study|Not Due to Covid-19|1|||
23460756|NCT00791934|65430862|FG000|Overall Study|Withdrawal by Subject|2|||
23460757|NCT00791934|65430862|FG000|Overall Study|Did not consent for extended follow-up|13|||
23460758|NCT00453206|65430863|FG000|Overall Study|Death|1|||
23460759|NCT02326155|65430867|FG000|Overall Study|Adverse Event|21|||
23460760|NCT02326155|65430868|FG001|Overall Study|Adverse Event|5|||
23460761|NCT02326155|65430867|FG000|Overall Study|Death|3|||
23460762|NCT02326155|65430868|FG001|Overall Study|Death|0|||
23460763|NCT02326155|65430867|FG000|Overall Study|Lack of Efficacy|49|||
23460764|NCT02326155|65430868|FG001|Overall Study|Lack of Efficacy|5|||
23460765|NCT02326155|65430867|FG000|Overall Study|Lost to Follow-up|14|||
23460766|NCT02326155|65430868|FG001|Overall Study|Lost to Follow-up|3|||
23460767|NCT02326155|65430867|FG000|Overall Study|Protocol Violation|2|||
23460768|NCT02326155|65430868|FG001|Overall Study|Protocol Violation|0|||
23460769|NCT02326155|65430867|FG000|Overall Study|Withdrawal by Subject|34|||
23460770|NCT02326155|65430868|FG001|Overall Study|Withdrawal by Subject|11|||
23460771|NCT02326155|65430867|FG000|Overall Study|Disease progression|37|||
23460772|NCT02326155|65430868|FG001|Overall Study|Disease progression|4|||
23460773|NCT02326155|65430867|FG000|Overall Study|Study close|188|||
23460774|NCT02326155|65430868|FG001|Overall Study|Study close|21|||
23182249|NCT03968419|64404982|FG002|Safety Follow-up Period|Subject Decision|0|||
23182250|NCT02586805|64404983|FG000|Overall Study|Withdrawal by Subject|3|||
23182251|NCT02586805|64404984|FG001|Overall Study|Withdrawal by Subject|1|||
23182252|NCT02586805|64404985|FG002|Overall Study|Withdrawal by Subject|1|||
23182253|NCT02586805|64404986|FG003|Overall Study|Withdrawal by Subject|2|||
23182254|NCT02586805|64404983|FG000|Overall Study|Adverse Event|2|||
23182255|NCT02586805|64404984|FG001|Overall Study|Adverse Event|0|||
23182256|NCT02586805|64404985|FG002|Overall Study|Adverse Event|1|||
23182257|NCT02586805|64404986|FG003|Overall Study|Adverse Event|0|||
23460775|NCT02326155|65430867|FG000|Overall Study|except for study close|46|||
23460776|NCT02326155|65430868|FG001|Overall Study|except for study close|13|||
23460777|NCT01553084|65430869|FG000|Overall Study|Withdrawal by Subject|15|||
23460778|NCT01553084|65430870|FG001|Overall Study|Withdrawal by Subject|13|||
23460779|NCT01553084|65430871|FG002|Overall Study|Withdrawal by Subject|35|||
23460780|NCT02536976|65430872|FG000|Overall Study|Physician Decision|0|||
23460781|NCT02536976|65430873|FG001|Overall Study|Physician Decision|1|||
23460782|NCT01458392|65430876|FG000|Overall Study|Death|2|||
23460783|NCT01458392|65430877|FG001|Overall Study|Death|11|||
23460784|NCT01458392|65430878|FG002|Overall Study|Death|22|||
23460785|NCT01458392|65430876|FG000|Overall Study|At the discretion of the sponsor|0|||
23460786|NCT01458392|65430877|FG001|Overall Study|At the discretion of the sponsor|2|||
23182258|NCT02586805|64404983|FG000|Overall Study|Lost to Follow-up|0|||
23460787|NCT01458392|65430878|FG002|Overall Study|At the discretion of the sponsor|7|||
23460788|NCT01458392|65430876|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
23460789|NCT01458392|65430877|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
23460790|NCT01458392|65430878|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
23182259|NCT02586805|64404984|FG001|Overall Study|Lost to Follow-up|0|||
23182260|NCT02586805|64404985|FG002|Overall Study|Lost to Follow-up|1|||
23349154|NCT00741091|65021789|FG000|Overall Study|Death|13|||
23460791|NCT00928408|65430879|FG000|Overall Study|Other|2|||
23460792|NCT00928408|65430879|FG000|Overall Study|Withdrawal by Subject|4|||
23460793|NCT00928408|65430879|FG000|Overall Study|Death|5|||
23460794|NCT00928408|65430879|FG000|Overall Study|Lost to Follow-up|12|||
23460795|NCT03051178|65430880|FG000|Overall Study|Withdrawal by Subject|5|||
23460796|NCT00260533|65430882|FG000|Overall Study|Other|3|||
23460797|NCT00260533|65430883|FG001|Overall Study|Other|3|||
23460798|NCT01352715|65430884|FG000|Overall Study|Death|3|||
23460799|NCT01352715|65430885|FG001|Overall Study|Death|3|||
23460800|NCT01352715|65430884|FG000|Overall Study|Lost to Follow-up|5|||
23460801|NCT01352715|65430885|FG001|Overall Study|Lost to Follow-up|7|||
23460802|NCT01352715|65430884|FG000|Overall Study|Withdrawal by Subject|4|||
23460803|NCT01352715|65430885|FG001|Overall Study|Withdrawal by Subject|8|||
23460804|NCT01352715|65430884|FG000|Overall Study|site closure|16|||
23460805|NCT01352715|65430885|FG001|Overall Study|site closure|15|||
23460806|NCT01352715|65430884|FG000|Overall Study|no final visit in closeout period|15|||
23460807|NCT01352715|65430885|FG001|Overall Study|no final visit in closeout period|12|||
23460808|NCT01352715|65430884|FG000|Overall Study|major ineligibility|2|||
23460809|NCT01352715|65430885|FG001|Overall Study|major ineligibility|1|||
23460810|NCT00904982|65430889|FG000|Overall Study|Withdrawal by Subject|2|||
23182261|NCT02586805|64404986|FG003|Overall Study|Lost to Follow-up|0|||
23182262|NCT02586805|64404983|FG000|Overall Study|Physician Decision|1|||
23460811|NCT00904982|65430890|FG001|Overall Study|Withdrawal by Subject|0|||
23460812|NCT00904982|65430891|FG002|Overall Study|Withdrawal by Subject|0|||
23460813|NCT00904982|65430892|FG003|Overall Study|Withdrawal by Subject|0|||
23460814|NCT01710501|65430893|FG000|Overall Study|Lost to Follow-up|2|||
23460815|NCT01710501|65430894|FG001|Overall Study|Lost to Follow-up|0|||
23460816|NCT01710501|65430895|FG002|Overall Study|Lost to Follow-up|0|||
23460817|NCT00830440|65430896|FG000|Overall Study|Protocol Violation|1|||
23460818|NCT00830440|65430897|FG001|Overall Study|Protocol Violation|0|||
23460819|NCT00830440|65430896|FG000|Overall Study|Withdrawal by Subject|1|||
23460820|NCT00830440|65430897|FG001|Overall Study|Withdrawal by Subject|0|||
23460821|NCT00830440|65430896|FG000|Overall Study|unsuccessful procedure|4|||
23460822|NCT00830440|65430897|FG001|Overall Study|unsuccessful procedure|0|||
23460823|NCT00830440|65430896|FG000|Overall Study|Adverse Event|2|||
23460824|NCT00830440|65430897|FG001|Overall Study|Adverse Event|0|||
23460825|NCT03873116|65430898|FG000|Part 1|Study drug discontinuation due to rash|0|||
23460826|NCT03873116|65430899|FG001|Part 1|Study drug discontinuation due to rash|0|||
23460827|NCT03873116|65430900|FG002|Part 1|Study drug discontinuation due to rash|0|||
23460828|NCT03873116|65430901|FG003|Part 1|Study drug discontinuation due to rash|0|||
23460829|NCT03873116|65430902|FG004|Part 1|Study drug discontinuation due to rash|0|||
23460830|NCT03873116|65430903|FG005|Part 1|Study drug discontinuation due to rash|1|||
23460831|NCT03873116|65430898|FG000|Part 2|Withdrawal by Subject|0|||
23460832|NCT03873116|65430899|FG001|Part 2|Withdrawal by Subject|0|||
23460833|NCT03873116|65430900|FG002|Part 2|Withdrawal by Subject|1|||
23460834|NCT03873116|65430901|FG003|Part 2|Withdrawal by Subject|0|||
23460835|NCT03873116|65430902|FG004|Part 2|Withdrawal by Subject|0|||
23460836|NCT03873116|65430903|FG005|Part 2|Withdrawal by Subject|0|||
23460837|NCT03873116|65430898|FG000|Part 2|Lab abnormality or AE|0|||
23460838|NCT03873116|65430899|FG001|Part 2|Lab abnormality or AE|0|||
23460839|NCT03873116|65430900|FG002|Part 2|Lab abnormality or AE|0|||
23460840|NCT03873116|65430901|FG003|Part 2|Lab abnormality or AE|0|||
23460841|NCT03873116|65430902|FG004|Part 2|Lab abnormality or AE|1|||
23460842|NCT03873116|65430903|FG005|Part 2|Lab abnormality or AE|0|||
23460843|NCT03873116|65430898|FG000|Part 3|Withdrawal by Subject|0|||
23460844|NCT03873116|65430899|FG001|Part 3|Withdrawal by Subject|0|||
23460845|NCT03873116|65430900|FG002|Part 3|Withdrawal by Subject|0|||
23460846|NCT03873116|65430901|FG003|Part 3|Withdrawal by Subject|0|||
23460847|NCT03873116|65430902|FG004|Part 3|Withdrawal by Subject|1|||
23460848|NCT03873116|65430903|FG005|Part 3|Withdrawal by Subject|0|||
23460849|NCT01149096|65430905|FG000|Overall Study|Lost to Follow-up|0|||
23460850|NCT01149096|65430906|FG001|Overall Study|Lost to Follow-up|1|||
23460851|NCT00248625|65430907|FG000|Overall Study|Withdrawal by Subject|0|||
23460852|NCT00248625|65430908|FG001|Overall Study|Withdrawal by Subject|2|||
23182263|NCT02586805|64404984|FG001|Overall Study|Physician Decision|0|||
23182264|NCT02586805|64404985|FG002|Overall Study|Physician Decision|0|||
23182265|NCT02586805|64404986|FG003|Overall Study|Physician Decision|0|||
23182266|NCT02581995|64409138|FG000|Overall Study|Unspecified other|3|||
23182267|NCT02581995|64409138|FG000|Overall Study|Adverse Event|6|||
23182268|NCT02581995|64409138|FG000|Overall Study|Lost to Follow-up|5|||
23182269|NCT02581995|64409138|FG000|Overall Study|Withdrawal by participant|12|||
23182270|NCT02581995|64409138|FG000|Overall Study|Physician Decision|1|||
23182271|NCT02581995|64409138|FG000|Overall Study|Death|4|||
23241643|NCT01374516|64629559|FG001|Surveillance Expansion Period|Serious adverse event|5|||
23241644|NCT02243709|64629561|FG000|Phase 1|Lost to Follow-up|0|||
23182272|NCT01562028|64409139|FG000|Overall Study|Withdrawal by Subject|1|||
23460853|NCT02379728|65430909|FG000|Overall Study|Lost to Follow-up|1|||
23460854|NCT02379728|65430910|FG001|Overall Study|Lost to Follow-up|0|||
23460855|NCT02379728|65430911|FG002|Overall Study|Lost to Follow-up|3|||
23460856|NCT02379728|65430912|FG003|Overall Study|Lost to Follow-up|0|||
23460857|NCT02379728|65430909|FG000|Overall Study|Withdrawal by Subject|5|||
23460858|NCT02379728|65430910|FG001|Overall Study|Withdrawal by Subject|0|||
23460859|NCT02379728|65430911|FG002|Overall Study|Withdrawal by Subject|5|||
23460860|NCT02379728|65430912|FG003|Overall Study|Withdrawal by Subject|3|||
23460861|NCT02379728|65430909|FG000|Overall Study|Protocol Violation|0|||
23460862|NCT02379728|65430910|FG001|Overall Study|Protocol Violation|0|||
23182273|NCT01562028|64409140|FG001|Overall Study|Withdrawal by Subject|1|||
23182274|NCT01562028|64409139|FG000|Overall Study|Lost to Follow-up|2|||
23182275|NCT01562028|64409140|FG001|Overall Study|Lost to Follow-up|1|||
23182276|NCT01228747|64409141|FG000|Overall Study|Adverse Event|8|||
23182277|NCT01228747|64409142|FG001|Overall Study|Adverse Event|4|||
23182278|NCT01228747|64409141|FG000|Overall Study|Lack of Efficacy|40|||
23182279|NCT01228747|64409142|FG001|Overall Study|Lack of Efficacy|27|||
23182280|NCT01228747|64409141|FG000|Overall Study|Protocol Violation|6|||
23182281|NCT01228747|64409142|FG001|Overall Study|Protocol Violation|5|||
23182282|NCT01228747|64409141|FG000|Overall Study|Lost to Follow-up|4|||
23182283|NCT01228747|64409142|FG001|Overall Study|Lost to Follow-up|3|||
23241645|NCT02243709|64629562|FG001|Phase 1|Lost to Follow-up|1|||
23182284|NCT01228747|64409141|FG000|Overall Study|Withdrawal by Subject|5|||
23182285|NCT01228747|64409142|FG001|Overall Study|Withdrawal by Subject|1|||
23182286|NCT01228747|64409141|FG000|Overall Study|Other Reason|2|||
23182287|NCT01228747|64409142|FG001|Overall Study|Other Reason|5|||
23182288|NCT00716976|64409143|FG000|Overall Study|Adverse Event|2|||
23182289|NCT00716976|64409144|FG001|Overall Study|Adverse Event|0|||
23182290|NCT00716976|64409143|FG000|Overall Study|Death|1|||
23182291|NCT00716976|64409144|FG001|Overall Study|Death|0|||
23182292|NCT00716976|64409143|FG000|Overall Study|Physician Decision|2|||
23182293|NCT00716976|64409144|FG001|Overall Study|Physician Decision|2|||
23182294|NCT00716976|64409143|FG000|Overall Study|Withdrawal by Subject|5|||
23182295|NCT00716976|64409144|FG001|Overall Study|Withdrawal by Subject|1|||
23182296|NCT00716976|64409143|FG000|Overall Study|Premature discontinuation cisplatin|5|||
23182297|NCT00716976|64409144|FG001|Overall Study|Premature discontinuation cisplatin|4|||
23182298|NCT00716976|64409143|FG000|Overall Study|Radiation during protocol|1|||
23182299|NCT00716976|64409144|FG001|Overall Study|Radiation during protocol|0|||
23182300|NCT00716976|64409143|FG000|Overall Study|Ineligibles|4|||
23182301|NCT00716976|64409144|FG001|Overall Study|Ineligibles|2|||
23182302|NCT01361711|64409145|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
23182303|NCT01361711|64409145|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
23182304|NCT01361711|64409145|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
23182305|NCT01361711|64409145|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
23182306|NCT01361711|64409145|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
23182307|NCT01361711|64409145|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
23182308|NCT01361711|64409145|FG000|Completed Week 18 of Treatment|Other|9|||
23182309|NCT01361711|64409145|FG000|10 Year Follow-up|Still in follow-up|22|||
23241646|NCT02243709|64629561|FG000|Phase 1|Withdrawal by Subject|1|||
23241647|NCT02243709|64629562|FG001|Phase 1|Withdrawal by Subject|0|||
23241648|NCT02243709|64629561|FG000|Phase 1|Protocol Violation|0|||
23241649|NCT02243709|64629562|FG001|Phase 1|Protocol Violation|1|||
23241650|NCT02243709|64629561|FG000|Phase 1|Adverse Event|0|||
23241651|NCT02243709|64629562|FG001|Phase 1|Adverse Event|1|||
23241652|NCT03471507|64629567|FG000|Overall Study|Lost to Follow-up|1|||
23241653|NCT03471507|64629568|FG001|Overall Study|Lost to Follow-up|3|||
23241654|NCT03471507|64629567|FG000|Overall Study|Physician Decision|0|||
23241655|NCT03471507|64629568|FG001|Overall Study|Physician Decision|1|||
23241656|NCT03471507|64629567|FG000|Overall Study|Withdrawal by Subject|2|||
23241657|NCT03471507|64629568|FG001|Overall Study|Withdrawal by Subject|1|||
23182310|NCT01361711|64409145|FG000|10 Year Follow-up|Death|7|||
23182311|NCT01361711|64409145|FG000|10 Year Follow-up|Developed new cancer|1|||
23182312|NCT01361711|64409145|FG000|10 Year Follow-up|Lost to Follow-up|2|||
23182313|NCT01361711|64409145|FG000|10 Year Follow-up|New treatment started|6|||
23182314|NCT01361711|64409145|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
23182315|NCT01361711|64409145|FG000|10 Year Follow-up|Progressive Disease|1|||
23241658|NCT00536991|64629569|FG000|Overall Study|Withdrawal by Subject|10|||
23241659|NCT00536991|64629569|FG000|Overall Study|Physician Decision|1|||
23241660|NCT00536991|64629569|FG000|Overall Study|patient ineligible|2|||
23349155|NCT00741091|65021789|FG000|Overall Study|Lost to Follow-up|16|||
23460863|NCT02379728|65430911|FG002|Overall Study|Protocol Violation|2|||
23182316|NCT00888355|64409146|FG000|Overall Study|Adverse Event|10|||
23182317|NCT00888355|64409147|FG001|Overall Study|Adverse Event|0|||
23182318|NCT00888355|64409148|FG002|Overall Study|Adverse Event|3|||
23182319|NCT00888355|64409149|FG003|Overall Study|Adverse Event|3|||
23182320|NCT00888355|64409146|FG000|Overall Study|Lack of Efficacy|9|||
23182321|NCT00888355|64409147|FG001|Overall Study|Lack of Efficacy|2|||
23182322|NCT00888355|64409148|FG002|Overall Study|Lack of Efficacy|5|||
23182323|NCT00888355|64409149|FG003|Overall Study|Lack of Efficacy|2|||
23182324|NCT00888355|64409146|FG000|Overall Study|Lost to Follow-up|0|||
23182325|NCT00888355|64409147|FG001|Overall Study|Lost to Follow-up|2|||
23182326|NCT00888355|64409148|FG002|Overall Study|Lost to Follow-up|2|||
23182327|NCT00888355|64409149|FG003|Overall Study|Lost to Follow-up|0|||
23182328|NCT00888355|64409146|FG000|Overall Study|Protocol Violation|3|||
23182329|NCT00888355|64409147|FG001|Overall Study|Protocol Violation|2|||
23349156|NCT00741091|65021789|FG000|Overall Study|Withdrawal by Subject|6|||
23584460|NCT03781804|65869198|FG002|Overall Study|Reason not provided|0|||
23584461|NCT04555044|65869199|FG000|Overall Study|Adverse Event|0|||
23584462|NCT04555044|65869200|FG001|Overall Study|Adverse Event|1|||
23584463|NCT05487703|65869205|FG000|Overall Study|Other|19|||
23584464|NCT05487703|65869205|FG000|Overall Study|Participant not well|5|||
23584465|NCT05487703|65869205|FG000|Overall Study|Insurance Reasons|6|||
23584466|NCT05487703|65869205|FG000|Overall Study|Physician Decision|19|||
23584467|NCT05487703|65869205|FG000|Overall Study|Lack of Efficacy|60|||
23584468|NCT03302156|65869206|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
23584469|NCT03302156|65869207|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
23584470|NCT03302156|65869208|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
23584471|NCT01306331|65869209|FG000|Overall Study|Adverse Event|28|||
23584472|NCT01306331|65869210|FG001|Overall Study|Adverse Event|25|||
23584473|NCT01306331|65869209|FG000|Overall Study|Lost to Follow-up|321|||
23584474|NCT01306331|65869210|FG001|Overall Study|Lost to Follow-up|323|||
23584475|NCT01306331|65869209|FG000|Overall Study|Physician Decision|26|||
23584476|NCT01306331|65869210|FG001|Overall Study|Physician Decision|22|||
23584477|NCT01306331|65869209|FG000|Overall Study|Pregnancy|136|||
23584478|NCT01306331|65869210|FG001|Overall Study|Pregnancy|151|||
23584479|NCT01306331|65869209|FG000|Overall Study|Protocol Violation|154|||
23584480|NCT01306331|65869210|FG001|Overall Study|Protocol Violation|124|||
23584481|NCT01306331|65869209|FG000|Overall Study|Withdrawal by Subject|163|||
23584482|NCT01306331|65869210|FG001|Overall Study|Withdrawal by Subject|152|||
23182330|NCT00888355|64409148|FG002|Overall Study|Protocol Violation|1|||
23182331|NCT00888355|64409149|FG003|Overall Study|Protocol Violation|2|||
23182332|NCT00888355|64409146|FG000|Overall Study|Withdrawal by Subject|0|||
23584483|NCT01306331|65869209|FG000|Overall Study|Not sexually active|29|||
23460864|NCT02379728|65430912|FG003|Overall Study|Protocol Violation|0|||
23460865|NCT01527370|65430920|FG000|Overall Study|Withdrawal by Subject|4|||
23460866|NCT01527370|65430920|FG000|Overall Study|Physician Decision|1|||
23460867|NCT01527370|65430920|FG000|Overall Study|Death|1|||
23460868|NCT01972217|65430923|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
23584484|NCT01306331|65869210|FG001|Overall Study|Not sexually active|28|||
23182333|NCT00888355|64409147|FG001|Overall Study|Withdrawal by Subject|3|||
23584485|NCT01306331|65869209|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
23584486|NCT01306331|65869210|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
23584487|NCT01306331|65869209|FG000|Overall Study|Other|34|||
23584488|NCT01306331|65869210|FG001|Overall Study|Other|32|||
23584489|NCT01837641|65869213|FG000|Overall Study|Sponsor decision|1|||
23584490|NCT01837641|65869214|FG001|Overall Study|Sponsor decision|0|||
23584491|NCT01837641|65869215|FG002|Overall Study|Sponsor decision|0|||
23584492|NCT01837641|65869216|FG003|Overall Study|Sponsor decision|0|||
23584493|NCT01837641|65869217|FG004|Overall Study|Sponsor decision|0|||
23584494|NCT01837641|65869218|FG005|Overall Study|Sponsor decision|1|||
23584495|NCT01837641|65869219|FG006|Overall Study|Sponsor decision|0|||
23584496|NCT01837641|65869220|FG007|Overall Study|Sponsor decision|0|||
23584497|NCT01837641|65869213|FG000|Overall Study|Adverse Event|0|||
23584498|NCT01837641|65869214|FG001|Overall Study|Adverse Event|0|||
23584499|NCT01837641|65869215|FG002|Overall Study|Adverse Event|0|||
23584500|NCT01837641|65869216|FG003|Overall Study|Adverse Event|0|||
23584501|NCT01837641|65869217|FG004|Overall Study|Adverse Event|0|||
23584502|NCT01837641|65869218|FG005|Overall Study|Adverse Event|1|||
23584503|NCT01837641|65869219|FG006|Overall Study|Adverse Event|0|||
23584504|NCT01837641|65869220|FG007|Overall Study|Adverse Event|0|||
23584505|NCT01837641|65869213|FG000|Overall Study|Withdrawal by Subject|0|||
23584506|NCT01837641|65869214|FG001|Overall Study|Withdrawal by Subject|0|||
23584507|NCT01837641|65869215|FG002|Overall Study|Withdrawal by Subject|0|||
23584508|NCT01837641|65869216|FG003|Overall Study|Withdrawal by Subject|0|||
23584509|NCT01837641|65869217|FG004|Overall Study|Withdrawal by Subject|1|||
23584510|NCT01837641|65869218|FG005|Overall Study|Withdrawal by Subject|0|||
23584511|NCT01837641|65869219|FG006|Overall Study|Withdrawal by Subject|1|||
23182334|NCT00888355|64409148|FG002|Overall Study|Withdrawal by Subject|1|||
23584512|NCT01837641|65869220|FG007|Overall Study|Withdrawal by Subject|0|||
23182335|NCT00888355|64409149|FG003|Overall Study|Withdrawal by Subject|3|||
23584513|NCT05052983|65869221|FG000|Overall Study|Lack of Efficacy|3|||
23584514|NCT05052983|65869222|FG001|Overall Study|Lack of Efficacy|12|||
23349157|NCT00741091|65021789|FG000|Overall Study|Missed Visit|22|||
23349158|NCT04500769|65021790|FG000|Overall Study|Withdrawal by Subject|5|||
23349159|NCT03217968|65021793|FG000|Overall Study|Withdrawal by Subject|4|||
23349160|NCT03217968|65021793|FG000|Overall Study|Lost to Follow-up|1|||
23349161|NCT03217968|65021793|FG000|Overall Study|Protocol Violation|6|||
23182336|NCT01151137|64409150|FG000|Overall Study|Death|15|||
23182337|NCT01151137|64409151|FG001|Overall Study|Death|27|||
23349162|NCT00725101|65021797|FG000|Overall Study|Death|3|||
23349163|NCT00725101|65021797|FG000|Overall Study|Lost to Follow-up|353|||
23349164|NCT00725101|65021797|FG000|Overall Study|Protocol Violation|1|||
23349165|NCT00725101|65021797|FG000|Overall Study|Withdrawal by Subject|127|||
23349166|NCT00725101|65021797|FG000|Overall Study|not specified/no reason given|11|||
23349167|NCT00090584|65021798|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
23349168|NCT00090584|65021799|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
23349169|NCT00090584|65021798|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
23349170|NCT00090584|65021799|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
23349171|NCT01549041|65021800|FG000|Overall Study|Lack of Efficacy|2|||
23349172|NCT01549041|65021801|FG001|Overall Study|Lack of Efficacy|4|||
23349173|NCT01549041|65021800|FG000|Overall Study|Adverse Event|0|||
23349174|NCT01549041|65021801|FG001|Overall Study|Adverse Event|4|||
23349175|NCT02719353|65021806|FG000|First Intervention|Physician Decision|0|||
23349176|NCT02719353|65021807|FG001|First Intervention|Physician Decision|1|||
23349177|NCT00900757|65021815|FG000|Overall Study|screen failure|19|||
23349178|NCT03085238|65021816|FG000|Overall Study|Adverse Event|2|||
23349179|NCT03085238|65021816|FG000|Overall Study|Death|2|||
23349180|NCT01314105|65021824|FG000|Overall Study|Progressive Disease|6|||
23349181|NCT01314105|65021825|FG001|Overall Study|Progressive Disease|10|||
23349182|NCT01314105|65021824|FG000|Overall Study|Refused to continue taking medication|0|||
23349183|NCT01314105|65021825|FG001|Overall Study|Refused to continue taking medication|1|||
23349184|NCT01314105|65021824|FG000|Overall Study|Other Adverse Event|1|||
23182338|NCT01151137|64409150|FG000|Overall Study|Lost to Follow-up|1|||
23182339|NCT01151137|64409151|FG001|Overall Study|Lost to Follow-up|1|||
23182340|NCT01929083|64409152|FG000|Intervention 1|Lost to Follow-up|2|||
23182341|NCT01929083|64409153|FG001|Intervention 1|Lost to Follow-up|0|||
23182342|NCT01929083|64409152|FG000|Intervention 1|Nonadherent to study medications|1|||
23182343|NCT01929083|64409153|FG001|Intervention 1|Nonadherent to study medications|0|||
23241661|NCT00556166|64629572|FG000|Overall Study|Withdrawal by Subject|1|||
23182344|NCT01929083|64409152|FG000|Intervention 2|Adverse Event|0|||
23182345|NCT01929083|64409153|FG001|Intervention 2|Adverse Event|1|||
23241662|NCT00090259|64629574|FG000|Overall Study|Lost to Follow-up|30|||
23349185|NCT01314105|65021825|FG001|Overall Study|Other Adverse Event|1|||
23349186|NCT02570750|65021826|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
23349187|NCT02570750|65021827|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
23349188|NCT02570750|65021826|FG000|Overall Study|Protocol deviation|4|||
23349189|NCT02570750|65021827|FG001|Overall Study|Protocol deviation|2|||
23349190|NCT02570750|65021826|FG000|Overall Study|Withdrawal by Subject|5|||
23349191|NCT02570750|65021827|FG001|Overall Study|Withdrawal by Subject|0|||
23349192|NCT02570750|65021826|FG000|Overall Study|Lost to Follow-up|2|||
23349193|NCT02570750|65021827|FG001|Overall Study|Lost to Follow-up|2|||
23349194|NCT02570750|65021826|FG000|Overall Study|Adverse Event|2|||
23349195|NCT02570750|65021827|FG001|Overall Study|Adverse Event|1|||
23349196|NCT00597506|65021828|FG000|Overall Study|Subject is being followed for survival|1|||
23349197|NCT00380718|65021831|FG000|Overall Study|Adverse Event|1|||
23349198|NCT00380718|65021831|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
23349199|NCT01294371|65021832|FG000|Overall Study|Adverse Event|1|||
23349200|NCT01294371|65021832|FG000|Overall Study|Withdrawal by Subject|12|||
23349201|NCT01294371|65021832|FG000|Overall Study|Lost to Follow-up|6|||
23349202|NCT01294371|65021832|FG000|Overall Study|Administrative Reason|1|||
23349203|NCT01294371|65021832|FG000|Overall Study|Other|14|||
23349204|NCT03840148|65021835|FG000|Study Drug Disposition|Adverse Event|13|||
23349205|NCT03840148|65021836|FG001|Study Drug Disposition|Adverse Event|2|||
23182346|NCT03636906|64409172|FG000|Overall Study|Adverse Event|0|||
23349206|NCT03840148|65021835|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
23349207|NCT03840148|65021836|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
23349208|NCT03840148|65021835|FG000|Study Drug Disposition|Lack of Efficacy|3|||
23349209|NCT03840148|65021836|FG001|Study Drug Disposition|Lack of Efficacy|0|||
23349210|NCT03840148|65021835|FG000|Study Drug Disposition|Physician Decision|2|||
23349211|NCT03840148|65021836|FG001|Study Drug Disposition|Physician Decision|0|||
23349212|NCT03840148|65021835|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
23349213|NCT03840148|65021836|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
23182347|NCT03636906|64409173|FG001|Overall Study|Adverse Event|0|||
23182348|NCT03636906|64409174|FG002|Overall Study|Adverse Event|1|||
23182349|NCT03636906|64409172|FG000|Overall Study|Lost to Follow-up|1|||
23182350|NCT03636906|64409173|FG001|Overall Study|Lost to Follow-up|0|||
23182351|NCT03636906|64409174|FG002|Overall Study|Lost to Follow-up|0|||
23182352|NCT03636906|64409172|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
23182353|NCT03636906|64409173|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
23182354|NCT03636906|64409174|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
23182355|NCT03636906|64409172|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
23182356|NCT03636906|64409173|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23182357|NCT03636906|64409174|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
23182358|NCT03636906|64409172|FG000|Overall Study|Other|0|||
23349214|NCT03840148|65021835|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
23349215|NCT03840148|65021836|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
23349216|NCT03840148|65021835|FG000|Study Completion Disposition|Physician Decision|2|||
23182359|NCT03636906|64409173|FG001|Overall Study|Other|0|||
23182360|NCT03636906|64409174|FG002|Overall Study|Other|1|||
23182361|NCT00316264|64409175|FG000|Overall Study|Lost to Follow-up|0|||
23182362|NCT00316264|64409176|FG001|Overall Study|Lost to Follow-up|1|||
23182363|NCT00316264|64409177|FG002|Overall Study|Lost to Follow-up|0|||
23182364|NCT00316264|64409175|FG000|Overall Study|Withdrawal of Consent|3|||
23182365|NCT00316264|64409176|FG001|Overall Study|Withdrawal of Consent|5|||
23182366|NCT00316264|64409177|FG002|Overall Study|Withdrawal of Consent|6|||
23182367|NCT00316264|64409175|FG000|Overall Study|Death|2|||
23349217|NCT03840148|65021836|FG001|Study Completion Disposition|Physician Decision|0|||
23349218|NCT03840148|65021835|FG000|Study Completion Disposition|Covid-19 related|2|||
23349219|NCT03840148|65021836|FG001|Study Completion Disposition|Covid-19 related|0|||
23349220|NCT03840148|65021835|FG000|Study Completion Disposition|Lost to Follow-up|1|||
23349221|NCT03840148|65021836|FG001|Study Completion Disposition|Lost to Follow-up|1|||
23349222|NCT03840148|65021835|FG000|Study Completion Disposition|Death|1|||
23584515|NCT05052983|65869221|FG000|Overall Study|Adverse Event|1|||
23584516|NCT05052983|65869222|FG001|Overall Study|Adverse Event|0|||
23584517|NCT05460663|65869223|FG000|Overall Study|Withdrawal by Subject|2|||
23584518|NCT05460663|65869224|FG001|Overall Study|Withdrawal by Subject|5|||
23584519|NCT05305040|65869225|FG000|Overall Study|Not Dosed|37|||
23584520|NCT05305040|65869226|FG001|Overall Study|Not Dosed|37|||
23584521|NCT05305040|65869225|FG000|Overall Study|Study Closure|34|||
23584522|NCT05305040|65869226|FG001|Overall Study|Study Closure|46|||
23182368|NCT00316264|64409176|FG001|Overall Study|Death|0|||
23241663|NCT00090259|64629575|FG001|Overall Study|Lost to Follow-up|26|||
23349223|NCT03840148|65021836|FG001|Study Completion Disposition|Death|0|||
23402705|NCT03289143|65219983|FG000|Overall Study|Study Terminated By Sponsor|101|||
23584523|NCT05305040|65869225|FG000|Overall Study|Death|14|||
23584524|NCT05305040|65869226|FG001|Overall Study|Death|13|||
23182369|NCT00316264|64409177|FG002|Overall Study|Death|0|||
23182370|NCT00316264|64409175|FG000|Overall Study|Other|1|||
23182371|NCT00316264|64409176|FG001|Overall Study|Other|1|||
23182372|NCT00316264|64409177|FG002|Overall Study|Other|0|||
23182373|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
23349224|NCT03840148|65021835|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
23349225|NCT03840148|65021836|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
23349226|NCT02483572|65021837|FG000|Overall Study|Withdrawal by Subject|1|||
23182374|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
23182375|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
23182376|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
23182377|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
23182378|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
23182379|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
23182380|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
23182381|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
23182382|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
23182383|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
23182384|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
23182385|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
23182386|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
23182387|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
23182388|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
23182389|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
23182390|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
23182391|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
23182392|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
23182393|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
23182394|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
23182395|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
23182396|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
23182397|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
23182398|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
23182399|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
23182400|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
23182401|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
23182402|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
23182403|NCT00849017|64409178|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
23182404|NCT00849017|64409179|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
23182405|NCT00849017|64409180|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
23182406|NCT00849017|64409178|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
23182407|NCT00849017|64409179|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
23182408|NCT00849017|64409180|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
23182409|NCT00849017|64409178|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
23182410|NCT00849017|64409179|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
23182411|NCT00849017|64409180|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
23182412|NCT00849017|64409178|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
23182413|NCT00849017|64409179|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
23182414|NCT00849017|64409180|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
23182415|NCT00849017|64409178|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
23182416|NCT00849017|64409179|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
23182417|NCT00849017|64409180|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
23182418|NCT00849017|64409178|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
23182419|NCT00849017|64409179|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
23182420|NCT00849017|64409180|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
23182421|NCT00849017|64409178|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
23182422|NCT00849017|64409179|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
23182423|NCT00849017|64409180|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
23182424|NCT00849017|64409178|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
23182425|NCT00849017|64409179|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
23182426|NCT00849017|64409180|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
23182427|NCT00849017|64409178|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
23349227|NCT02483572|65021838|FG001|Overall Study|Withdrawal by Subject|0|||
23349228|NCT02483572|65021837|FG000|Overall Study|Lost to Follow-up|1|||
23182428|NCT00849017|64409179|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
23182429|NCT00849017|64409180|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
23182430|NCT02949830|64409184|FG000|Overall Study|Adverse Event|1|||
23349229|NCT02483572|65021838|FG001|Overall Study|Lost to Follow-up|0|||
23349230|NCT02483572|65021837|FG000|Overall Study|Physician Decision|0|||
23349231|NCT02483572|65021838|FG001|Overall Study|Physician Decision|1|||
23349232|NCT00394771|65021839|FG000|Overall Study|Did not meet protocol requirements|1|||
23349233|NCT00394771|65021840|FG001|Overall Study|Did not meet protocol requirements|0|||
23349234|NCT00394771|65021841|FG002|Overall Study|Did not meet protocol requirements|2|||
23349235|NCT00394771|65021842|FG003|Overall Study|Did not meet protocol requirements|0|||
23349236|NCT00394771|65021839|FG000|Overall Study|Protocol Violation|2|||
23349237|NCT00394771|65021840|FG001|Overall Study|Protocol Violation|4|||
23349238|NCT00394771|65021841|FG002|Overall Study|Protocol Violation|9|||
23349239|NCT00394771|65021842|FG003|Overall Study|Protocol Violation|7|||
23349240|NCT00394771|65021839|FG000|Overall Study|Withdrawal by Subject|10|||
23349241|NCT00394771|65021840|FG001|Overall Study|Withdrawal by Subject|6|||
23349242|NCT00394771|65021841|FG002|Overall Study|Withdrawal by Subject|8|||
23349243|NCT00394771|65021842|FG003|Overall Study|Withdrawal by Subject|12|||
23349244|NCT00394771|65021839|FG000|Overall Study|Adverse Event|10|||
23349245|NCT00394771|65021840|FG001|Overall Study|Adverse Event|5|||
23349246|NCT00394771|65021841|FG002|Overall Study|Adverse Event|12|||
23349247|NCT00394771|65021842|FG003|Overall Study|Adverse Event|8|||
23349248|NCT00394771|65021839|FG000|Overall Study|Participant pregnant|0|||
23349249|NCT00394771|65021840|FG001|Overall Study|Participant pregnant|1|||
23349250|NCT00394771|65021841|FG002|Overall Study|Participant pregnant|2|||
23349251|NCT00394771|65021842|FG003|Overall Study|Participant pregnant|2|||
23349252|NCT00394771|65021839|FG000|Overall Study|Lost to Follow-up|15|||
23349253|NCT00394771|65021840|FG001|Overall Study|Lost to Follow-up|15|||
23349254|NCT00394771|65021841|FG002|Overall Study|Lost to Follow-up|13|||
23349255|NCT00394771|65021842|FG003|Overall Study|Lost to Follow-up|10|||
23349256|NCT00394771|65021839|FG000|Overall Study|Other|3|||
23349257|NCT00394771|65021840|FG001|Overall Study|Other|3|||
23349258|NCT00394771|65021841|FG002|Overall Study|Other|1|||
23349259|NCT00394771|65021842|FG003|Overall Study|Other|0|||
23349260|NCT00659776|65021848|FG000|Overall Study|Withdrawal by Subject|12|||
23349261|NCT00659776|65021849|FG001|Overall Study|Withdrawal by Subject|2|||
23349262|NCT00659776|65021850|FG002|Overall Study|Withdrawal by Subject|0|||
23349263|NCT02685072|65021852|FG000|Treatment Period|Lost to Follow-up|12|||
23349264|NCT02685072|65021853|FG001|Treatment Period|Lost to Follow-up|6|||
23349265|NCT02685072|65021852|FG000|Treatment Period|Withdrawal by Subject|1|||
23349266|NCT02685072|65021853|FG001|Treatment Period|Withdrawal by Subject|3|||
23349267|NCT02685072|65021852|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
23349268|NCT02685072|65021853|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
23349269|NCT02382796|65021861|FG000|Overall Study|Global deterioration of health status|1|||
23349270|NCT02382796|65021861|FG000|Overall Study|Objective progression or relapse|3|||
23349271|NCT02382796|65021861|FG000|Overall Study|Commercial dacomitinib became available|3|||
23349272|NCT00423189|65021862|FG000|Overall Study|Death|0|||
23349273|NCT00423189|65021863|FG001|Overall Study|Death|1|||
23349274|NCT00423189|65021864|FG002|Overall Study|Death|0|||
23349275|NCT03301740|65021865|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
23349276|NCT03301740|65021866|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
23349277|NCT03301740|65021865|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
23349278|NCT03301740|65021866|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
23349279|NCT04150068|65021867|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
23349280|NCT04150068|65021868|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
23349281|NCT04150068|65021869|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
23349282|NCT04150068|65021867|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
23349283|NCT04150068|65021868|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
23349284|NCT04150068|65021869|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
23349285|NCT00084318|65021871|FG000|Overall Study|Withdrawal by Subject|5|||
23349286|NCT00084318|65021872|FG001|Overall Study|Withdrawal by Subject|2|||
23349287|NCT00084318|65021871|FG000|Overall Study|Protocol Violation|15|||
23349288|NCT00084318|65021872|FG001|Overall Study|Protocol Violation|11|||
23349289|NCT00084318|65021871|FG000|Overall Study|No protocol treatment|2|||
23349290|NCT00084318|65021872|FG001|Overall Study|No protocol treatment|0|||
23349291|NCT02667626|65021877|FG000|Overall Study|Withdrawal by Subject|0|||
23349292|NCT02667626|65021878|FG001|Overall Study|Withdrawal by Subject|1|||
23349293|NCT03536949|65021879|FG000|Overall Study|Adverse Event|4|||
23349294|NCT03536949|65021880|FG001|Overall Study|Adverse Event|0|||
23349295|NCT03536949|65021879|FG000|Overall Study|Lost to Follow-up|2|||
23349296|NCT03536949|65021880|FG001|Overall Study|Lost to Follow-up|1|||
23349297|NCT03536949|65021879|FG000|Overall Study|Withdrawal by Subject|6|||
23349298|NCT03536949|65021880|FG001|Overall Study|Withdrawal by Subject|0|||
23349299|NCT03536949|65021879|FG000|Overall Study|Non-compliance|2|||
23460869|NCT01972217|65430924|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
23349300|NCT03536949|65021880|FG001|Overall Study|Non-compliance|1|||
23349301|NCT03673501|65021881|FG000|Overall Study|Participants ongoing.|36|||
23349302|NCT03673501|65021882|FG001|Overall Study|Participants ongoing.|24|||
23349303|NCT02669082|65021883|FG000|Overall Study|Adverse Event|1|||
23460870|NCT01972217|65430925|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
23460871|NCT01972217|65430926|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
23460872|NCT01972217|65430923|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
23460873|NCT01972217|65430924|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
23460874|NCT01972217|65430925|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
23460875|NCT01972217|65430926|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
23460876|NCT01972217|65430923|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
23460877|NCT01972217|65430924|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
23460878|NCT01972217|65430925|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
23460879|NCT01972217|65430926|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
23460880|NCT01972217|65430923|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
23460881|NCT01972217|65430924|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
23460882|NCT01972217|65430925|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
23460883|NCT01972217|65430926|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
23460884|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Death|0|||
23460885|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Death|0|||
23460886|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Death|43|||
23460887|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Death|44|||
23460888|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
23460889|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
23460890|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
23460891|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
23460892|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
23460893|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
23460894|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
23460895|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
23460896|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
23460897|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
23460898|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
23460899|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
23460900|NCT01972217|65430923|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
23460901|NCT01972217|65430924|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
23460902|NCT01972217|65430925|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
23460903|NCT01972217|65430926|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
23460904|NCT00561925|65430927|FG000|14 Day Lead-In Period|Adverse Event|38|||
23460905|NCT00561925|65430928|FG001|14 Day Lead-In Period|Adverse Event|0|||
23460906|NCT00561925|65430929|FG002|14 Day Lead-In Period|Adverse Event|0|||
23460907|NCT00561925|65430930|FG003|14 Day Lead-In Period|Adverse Event|0|||
23460908|NCT00561925|65430931|FG004|14 Day Lead-In Period|Adverse Event|0|||
23460909|NCT00561925|65430927|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
23460910|NCT00561925|65430928|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
23460911|NCT00561925|65430929|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
23460912|NCT00561925|65430930|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
23460913|NCT00561925|65430931|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
23460914|NCT00561925|65430927|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
23460915|NCT00561925|65430928|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
23460916|NCT00561925|65430929|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
23460917|NCT00561925|65430930|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
23460918|NCT00561925|65430931|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
23460919|NCT00561925|65430927|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
23460920|NCT00561925|65430928|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
23460921|NCT00561925|65430929|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
23584525|NCT05305040|65869225|FG000|Overall Study|Withdrawal by Subject|15|||
23584526|NCT05305040|65869226|FG001|Overall Study|Withdrawal by Subject|10|||
23241664|NCT00090259|64629574|FG000|Overall Study|Withdrawal by Subject|21|||
23241665|NCT00090259|64629575|FG001|Overall Study|Withdrawal by Subject|15|||
23241666|NCT00090259|64629574|FG000|Overall Study|Investigator site closed|11|||
23241667|NCT00090259|64629575|FG001|Overall Study|Investigator site closed|7|||
23241668|NCT01789476|64629576|FG000|Overall Study|Lack of Efficacy|6|||
23241669|NCT01789476|64629577|FG001|Overall Study|Lack of Efficacy|2|||
23241670|NCT01789476|64629576|FG000|Overall Study|Adverse Event|1|||
23241671|NCT01789476|64629577|FG001|Overall Study|Adverse Event|0|||
23241672|NCT01789476|64629576|FG000|Overall Study|Unable to get IV access|1|||
23241673|NCT01789476|64629577|FG001|Overall Study|Unable to get IV access|0|||
23241674|NCT00071006|64629578|FG000|Overall Study|Lack of Efficacy|7|||
23241675|NCT00071006|64629578|FG000|Overall Study|Adverse Event|1|||
23241676|NCT00071006|64629578|FG000|Overall Study|Withdrawal by Subject|1|||
23241677|NCT00071006|64629578|FG000|Overall Study|Other|3|||
23241678|NCT02409680|64629592|FG000|Overall Study|Lost to Follow-up|15|||
23460922|NCT00561925|65430930|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
23460923|NCT00561925|65430931|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
23241679|NCT02409680|64629593|FG001|Overall Study|Lost to Follow-up|30|||
23241680|NCT01298362|64629594|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
23241681|NCT01298362|64629595|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
23241682|NCT04516291|64629600|FG000|Treatment Period (24 Weeks)|Other|1|||
23241683|NCT04516291|64629601|FG001|Treatment Period (24 Weeks)|Other|0|||
23241684|NCT04516291|64629602|FG002|Treatment Period (24 Weeks)|Other|0|||
23241685|NCT04516291|64629603|FG003|Treatment Period (24 Weeks)|Other|2|||
23241686|NCT04516291|64629604|FG004|Treatment Period (24 Weeks)|Other|2|||
23241687|NCT04516291|64629605|FG005|Treatment Period (24 Weeks)|Other|4|||
23241688|NCT04516291|64629606|FG006|Treatment Period (24 Weeks)|Other|2|||
23241689|NCT04516291|64629607|FG007|Treatment Period (24 Weeks)|Other|0|||
23241690|NCT04516291|64629600|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23241691|NCT04516291|64629601|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
23241692|NCT04516291|64629602|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23241693|NCT04516291|64629603|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23241694|NCT04516291|64629604|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23241695|NCT04516291|64629605|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23241696|NCT04516291|64629606|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23241697|NCT04516291|64629607|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23241698|NCT04516291|64629600|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
23241699|NCT04516291|64629601|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
23241700|NCT04516291|64629602|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
23241701|NCT04516291|64629603|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
23241702|NCT04516291|64629604|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
23241703|NCT04516291|64629605|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
23241704|NCT04516291|64629606|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
23241705|NCT04516291|64629607|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
23349304|NCT05385224|65021884|FG000|Overall Study|Unable to swallow capsule|2|||
23349305|NCT05385224|65021884|FG000|Overall Study|Withdrawal by Subject|2|||
23349306|NCT05385224|65021884|FG000|Overall Study|Did not meet study criteria|1|||
23241706|NCT04516291|64629600|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23460924|NCT00561925|65430927|FG000|14 Day Lead-In Period|Other|5|||
23460925|NCT00561925|65430928|FG001|14 Day Lead-In Period|Other|0|||
23460926|NCT00561925|65430929|FG002|14 Day Lead-In Period|Other|0|||
23460927|NCT00561925|65430930|FG003|14 Day Lead-In Period|Other|0|||
23460928|NCT00561925|65430931|FG004|14 Day Lead-In Period|Other|0|||
23460929|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
23460930|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
23460931|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
23460932|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
23460933|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
23241707|NCT04516291|64629601|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23241708|NCT04516291|64629602|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23241709|NCT04516291|64629603|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23241710|NCT04516291|64629604|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23241711|NCT04516291|64629605|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23241712|NCT04516291|64629606|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23241713|NCT04516291|64629607|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23241714|NCT04516291|64629600|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
23349307|NCT00561470|65021885|FG000|Overall Study|Adverse Event|74|||
23241715|NCT04516291|64629601|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
23241716|NCT04516291|64629602|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
23241717|NCT04516291|64629603|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
23241718|NCT04516291|64629604|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
23349308|NCT00561470|65021886|FG001|Overall Study|Adverse Event|163|||
23349309|NCT00561470|65021885|FG000|Overall Study|Disease progression|437|||
23460934|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
23460935|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
23460936|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
23460937|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
23460938|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
23460939|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
23460940|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
23241719|NCT04516291|64629605|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
23241720|NCT04516291|64629606|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
23241721|NCT04516291|64629607|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
23241722|NCT04516291|64629600|FG000|Follow-up Period (12 Weeks)|Other|0|||
23241723|NCT04516291|64629601|FG001|Follow-up Period (12 Weeks)|Other|1|||
23241724|NCT04516291|64629602|FG002|Follow-up Period (12 Weeks)|Other|0|||
23349310|NCT00561470|65021886|FG001|Overall Study|Disease progression|305|||
23349311|NCT00561470|65021885|FG000|Overall Study|poor compliance to protocol|4|||
23241725|NCT04516291|64629603|FG003|Follow-up Period (12 Weeks)|Other|2|||
23241726|NCT04516291|64629604|FG004|Follow-up Period (12 Weeks)|Other|0|||
23241727|NCT04516291|64629605|FG005|Follow-up Period (12 Weeks)|Other|0|||
23241728|NCT04516291|64629606|FG006|Follow-up Period (12 Weeks)|Other|0|||
23241729|NCT04516291|64629607|FG007|Follow-up Period (12 Weeks)|Other|0|||
23241730|NCT04516291|64629600|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23241731|NCT04516291|64629601|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23349312|NCT00561470|65021886|FG001|Overall Study|poor compliance to protocol|4|||
23349313|NCT00561470|65021885|FG000|Overall Study|Lost to Follow-up|2|||
23182431|NCT02949830|64409184|FG000|Overall Study|Withdrawal by Subject|1|||
23182432|NCT01535235|64409185|FG000|Overall Study|Adverse Event|1|||
23182433|NCT01535235|64409186|FG001|Overall Study|Adverse Event|0|||
23182434|NCT00008385|64409191|FG000|Overall Study|Off treatment reasons not reported|79|||
23182435|NCT00008385|64409192|FG001|Overall Study|Off treatment reasons not reported|70|||
23182436|NCT00008385|64409191|FG000|Overall Study|Progressive disease|52|||
23182437|NCT00008385|64409192|FG001|Overall Study|Progressive disease|117|||
23182438|NCT00008385|64409191|FG000|Overall Study|Adverse Event|8|||
23182439|NCT00008385|64409192|FG001|Overall Study|Adverse Event|20|||
23182440|NCT00008385|64409191|FG000|Overall Study|Death|12|||
23182441|NCT00008385|64409192|FG001|Overall Study|Death|18|||
23182442|NCT00008385|64409191|FG000|Overall Study|Withdrawal by Subject|67|||
23182443|NCT00008385|64409192|FG001|Overall Study|Withdrawal by Subject|157|||
23182444|NCT00008385|64409191|FG000|Overall Study|Start non-protocol therapy|3|||
23182445|NCT00008385|64409192|FG001|Overall Study|Start non-protocol therapy|1|||
23182446|NCT00008385|64409191|FG000|Overall Study|Other complicating disease|17|||
23182447|NCT00008385|64409192|FG001|Overall Study|Other complicating disease|30|||
23182448|NCT00008385|64409191|FG000|Overall Study|Maximum dose reached|0|||
23182449|NCT00008385|64409192|FG001|Overall Study|Maximum dose reached|2|||
23182450|NCT00008385|64409191|FG000|Overall Study|Other|105|||
23182451|NCT00008385|64409192|FG001|Overall Study|Other|212|||
23182452|NCT00008385|64409191|FG000|Overall Study|Not start protocol therapy|44|||
23182453|NCT00008385|64409192|FG001|Overall Study|Not start protocol therapy|175|||
23182454|NCT00389207|64409193|FG000|Overall Study|Adverse Event|26|||
23182455|NCT00389207|64409194|FG001|Overall Study|Adverse Event|32|||
23182456|NCT00389207|64409195|FG002|Overall Study|Adverse Event|10|||
23182457|NCT00389207|64409193|FG000|Overall Study|Protocol Violation|3|||
23182458|NCT00389207|64409194|FG001|Overall Study|Protocol Violation|1|||
23182459|NCT00389207|64409195|FG002|Overall Study|Protocol Violation|4|||
23182460|NCT00389207|64409193|FG000|Overall Study|Lost to Follow-up|12|||
23182461|NCT00389207|64409194|FG001|Overall Study|Lost to Follow-up|9|||
23182462|NCT00389207|64409195|FG002|Overall Study|Lost to Follow-up|7|||
23182463|NCT00389207|64409193|FG000|Overall Study|Withdrawal by Subject|5|||
23182464|NCT00389207|64409194|FG001|Overall Study|Withdrawal by Subject|7|||
23182465|NCT00389207|64409195|FG002|Overall Study|Withdrawal by Subject|11|||
23182466|NCT00389207|64409193|FG000|Overall Study|Other|17|||
23182467|NCT00389207|64409194|FG001|Overall Study|Other|23|||
23241732|NCT04516291|64629602|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23460941|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
23460942|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
23182468|NCT00389207|64409195|FG002|Overall Study|Other|9|||
23182469|NCT01705691|64409196|FG000|Overall Study|Death|1|||
23182470|NCT01705691|64409197|FG001|Overall Study|Death|2|||
23182471|NCT01705691|64409196|FG000|Overall Study|Withdrawal by Subject|1|||
23349314|NCT00561470|65021886|FG001|Overall Study|Lost to Follow-up|0|||
23349315|NCT00561470|65021885|FG000|Overall Study|Physician Decision|21|||
23349316|NCT00561470|65021886|FG001|Overall Study|Physician Decision|20|||
23349317|NCT00561470|65021885|FG000|Overall Study|Consent Withdrawn|2|||
23349318|NCT00561470|65021886|FG001|Overall Study|Consent Withdrawn|6|||
23349319|NCT00561470|65021885|FG000|Overall Study|Subject request|43|||
23349320|NCT00561470|65021886|FG001|Overall Study|Subject request|77|||
23349321|NCT00561470|65021885|FG000|Overall Study|Metastatic surgery|10|||
23349322|NCT00561470|65021886|FG001|Overall Study|Metastatic surgery|12|||
23349323|NCT00561470|65021885|FG000|Overall Study|Unauthorized procedure|3|||
23349324|NCT00561470|65021886|FG001|Overall Study|Unauthorized procedure|1|||
23349325|NCT00561470|65021885|FG000|Overall Study|Randomized but not treated|5|||
23349326|NCT00561470|65021886|FG001|Overall Study|Randomized but not treated|5|||
23349327|NCT00561470|65021885|FG000|Overall Study|Missed visit window|1|||
23349328|NCT00561470|65021886|FG001|Overall Study|Missed visit window|4|||
23349329|NCT00561470|65021885|FG000|Overall Study|Planning surgery|1|||
23349330|NCT00561470|65021886|FG001|Overall Study|Planning surgery|1|||
23349331|NCT00561470|65021885|FG000|Overall Study|Ongoing Treatment|11|||
23349332|NCT00561470|65021886|FG001|Overall Study|Ongoing Treatment|14|||
23349333|NCT02147067|65021887|FG000|Overall Study|Withdrawal by Subject|2|||
23349334|NCT02147067|65021888|FG001|Overall Study|Withdrawal by Subject|2|||
23349335|NCT01420679|65021889|FG000|Overall Study|Disease Progression|3|||
23349336|NCT01420679|65021890|FG001|Overall Study|Disease Progression|2|||
23349337|NCT01420679|65021889|FG000|Overall Study|Adverse Event|4|||
23349338|NCT01420679|65021890|FG001|Overall Study|Adverse Event|0|||
23349339|NCT01420679|65021889|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
23349340|NCT01420679|65021890|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
23349341|NCT01420679|65021889|FG000|Overall Study|Patient Decision|1|||
23349342|NCT01420679|65021890|FG001|Overall Study|Patient Decision|0|||
23349343|NCT01420679|65021889|FG000|Overall Study|Investigator Decision|1|||
23349344|NCT01420679|65021890|FG001|Overall Study|Investigator Decision|2|||
23349345|NCT01420679|65021889|FG000|Overall Study|Sponsor Decision|3|||
23182472|NCT01705691|64409197|FG001|Overall Study|Withdrawal by Subject|2|||
23182473|NCT01705691|64409196|FG000|Overall Study|Lost to Follow-up|1|||
23182474|NCT01705691|64409197|FG001|Overall Study|Lost to Follow-up|1|||
23182475|NCT01705691|64409196|FG000|Overall Study|Other|0|||
23182476|NCT01705691|64409197|FG001|Overall Study|Other|1|||
23182477|NCT01276288|64409198|FG000|Overall Study|Adverse Event|1|||
23182478|NCT01276288|64409199|FG001|Overall Study|Adverse Event|1|||
23182479|NCT01276288|64409200|FG002|Overall Study|Adverse Event|0|||
23182480|NCT01276288|64409201|FG003|Overall Study|Adverse Event|0|||
23182481|NCT01276288|64409198|FG000|Overall Study|not treated|1|||
23182482|NCT01276288|64409199|FG001|Overall Study|not treated|0|||
23349346|NCT01420679|65021890|FG001|Overall Study|Sponsor Decision|3|||
23349347|NCT01420679|65021889|FG000|Overall Study|Other|1|||
23349348|NCT01420679|65021890|FG001|Overall Study|Other|0|||
23349349|NCT02923245|65021891|FG000|Overall Study|ultrasound order was cancelled|2|||
23349350|NCT02923245|65021892|FG001|Overall Study|ultrasound order was cancelled|1|||
23349351|NCT02607280|65021893|FG000|Overall Study|Adverse Event|4|||
23349352|NCT02607280|65021894|FG001|Overall Study|Adverse Event|0|||
23349353|NCT02607280|65021893|FG000|Overall Study|Decrease in CrCl <15|0|||
23182483|NCT01276288|64409200|FG002|Overall Study|not treated|0|||
23349354|NCT02607280|65021894|FG001|Overall Study|Decrease in CrCl <15|1|||
23349355|NCT01877382|65021899|FG000|Dose Escalation|Progressive disease|2|||
23460943|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
23460944|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
23460945|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
23460946|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
23460947|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
23460948|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
23584527|NCT05305040|65869225|FG000|Overall Study|Other|13|||
23584528|NCT05305040|65869226|FG001|Overall Study|Other|10|||
23584529|NCT05305040|65869225|FG000|Overall Study|Primary Malignancy Relapse|3|||
23584530|NCT05305040|65869226|FG001|Overall Study|Primary Malignancy Relapse|4|||
23584531|NCT05305040|65869225|FG000|Overall Study|Adverse Event|3|||
23584532|NCT05305040|65869226|FG001|Overall Study|Adverse Event|3|||
23584533|NCT05305040|65869225|FG000|Overall Study|Lost to Follow-up|2|||
23584534|NCT05305040|65869226|FG001|Overall Study|Lost to Follow-up|1|||
23584535|NCT05305040|65869225|FG000|Overall Study|Graft versus host disease|2|||
23584536|NCT05305040|65869226|FG001|Overall Study|Graft versus host disease|0|||
23584537|NCT05305040|65869225|FG000|Overall Study|Investigator's Decision|1|||
23584538|NCT05305040|65869226|FG001|Overall Study|Investigator's Decision|1|||
23584539|NCT05305040|65869225|FG000|Overall Study|COVID-19 Reasons|1|||
23584540|NCT05305040|65869226|FG001|Overall Study|COVID-19 Reasons|0|||
23584541|NCT01972152|65869227|FG000|First Treatment Visit|Lost to Follow-up|0|||
23584542|NCT01972152|65869228|FG001|First Treatment Visit|Lost to Follow-up|1|||
23584543|NCT01972152|65869229|FG002|First Treatment Visit|Lost to Follow-up|0|||
23584544|NCT01972152|65869230|FG003|First Treatment Visit|Lost to Follow-up|0|||
23584545|NCT01972152|65869231|FG004|First Treatment Visit|Lost to Follow-up|0|||
23584546|NCT01972152|65869232|FG005|First Treatment Visit|Lost to Follow-up|0|||
23584547|NCT01972152|65869227|FG000|Second Treatment Visit|Protocol Violation|0|||
23584548|NCT01972152|65869228|FG001|Second Treatment Visit|Protocol Violation|1|||
23584549|NCT01972152|65869229|FG002|Second Treatment Visit|Protocol Violation|0|||
23584550|NCT01972152|65869230|FG003|Second Treatment Visit|Protocol Violation|0|||
23584551|NCT01972152|65869231|FG004|Second Treatment Visit|Protocol Violation|0|||
23584552|NCT01972152|65869232|FG005|Second Treatment Visit|Protocol Violation|0|||
23584553|NCT02499328|65869236|FG000|Overall Study|Withdrawal by Subject|1|||
23584554|NCT02499328|65869237|FG001|Overall Study|Withdrawal by Subject|1|||
23584555|NCT02499328|65869238|FG002|Overall Study|Withdrawal by Subject|5|||
23584556|NCT02499328|65869239|FG003|Overall Study|Withdrawal by Subject|3|||
23584557|NCT02499328|65869240|FG004|Overall Study|Withdrawal by Subject|5|||
23584558|NCT02499328|65869241|FG005|Overall Study|Withdrawal by Subject|0|||
23584559|NCT02499328|65869242|FG006|Overall Study|Withdrawal by Subject|0|||
23584560|NCT02499328|65869243|FG007|Overall Study|Withdrawal by Subject|0|||
23584561|NCT02499328|65869244|FG008|Overall Study|Withdrawal by Subject|2|||
23584562|NCT02499328|65869245|FG009|Overall Study|Withdrawal by Subject|2|||
23584563|NCT02499328|65869246|FG010|Overall Study|Withdrawal by Subject|0|||
23584564|NCT02499328|65869247|FG011|Overall Study|Withdrawal by Subject|3|||
23584565|NCT02499328|65869248|FG012|Overall Study|Withdrawal by Subject|7|||
23584566|NCT02499328|65869249|FG013|Overall Study|Withdrawal by Subject|3|||
23584567|NCT02499328|65869250|FG014|Overall Study|Withdrawal by Subject|1|||
23584568|NCT02499328|65869251|FG015|Overall Study|Withdrawal by Subject|0|||
23584569|NCT02499328|65869252|FG016|Overall Study|Withdrawal by Subject|0|||
23584570|NCT02499328|65869253|FG017|Overall Study|Withdrawal by Subject|3|||
23584571|NCT02499328|65869254|FG018|Overall Study|Withdrawal by Subject|0|||
23584572|NCT02499328|65869236|FG000|Overall Study|Lost to Follow-up|0|||
23584573|NCT02499328|65869237|FG001|Overall Study|Lost to Follow-up|1|||
23584574|NCT02499328|65869238|FG002|Overall Study|Lost to Follow-up|1|||
23584575|NCT02499328|65869239|FG003|Overall Study|Lost to Follow-up|2|||
23584576|NCT02499328|65869240|FG004|Overall Study|Lost to Follow-up|0|||
23584577|NCT02499328|65869241|FG005|Overall Study|Lost to Follow-up|0|||
23584578|NCT02499328|65869242|FG006|Overall Study|Lost to Follow-up|0|||
23584579|NCT02499328|65869243|FG007|Overall Study|Lost to Follow-up|2|||
23584580|NCT02499328|65869244|FG008|Overall Study|Lost to Follow-up|3|||
23182484|NCT01276288|64409201|FG003|Overall Study|not treated|0|||
23182485|NCT00706628|64409202|FG000|Overall Study|Other Adverse Event|16|||
23182486|NCT00706628|64409203|FG001|Overall Study|Other Adverse Event|5|||
23182487|NCT00706628|64409204|FG002|Overall Study|Other Adverse Event|5|||
23182488|NCT00706628|64409205|FG003|Overall Study|Other Adverse Event|2|||
23182489|NCT00706628|64409202|FG000|Overall Study|Non compliant with protocol|0|||
23182490|NCT00706628|64409203|FG001|Overall Study|Non compliant with protocol|1|||
23182491|NCT00706628|64409204|FG002|Overall Study|Non compliant with protocol|0|||
23182492|NCT00706628|64409205|FG003|Overall Study|Non compliant with protocol|0|||
23182493|NCT00706628|64409202|FG000|Overall Study|Consent withdrawn|6|||
23182494|NCT00706628|64409203|FG001|Overall Study|Consent withdrawn|1|||
23584581|NCT02499328|65869245|FG009|Overall Study|Lost to Follow-up|0|||
23584582|NCT02499328|65869246|FG010|Overall Study|Lost to Follow-up|0|||
23584583|NCT02499328|65869247|FG011|Overall Study|Lost to Follow-up|0|||
23584584|NCT02499328|65869248|FG012|Overall Study|Lost to Follow-up|0|||
23241733|NCT04516291|64629603|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23241734|NCT04516291|64629604|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
23241735|NCT04516291|64629605|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23241736|NCT04516291|64629606|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23349356|NCT01877382|65021900|FG001|Dose Escalation|Progressive disease|0|||
23349357|NCT01877382|65021901|FG002|Dose Escalation|Progressive disease|1|||
23349358|NCT01877382|65021902|FG003|Dose Escalation|Progressive disease|6|||
23241737|NCT04516291|64629607|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23241738|NCT04516291|64629600|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
23349359|NCT01877382|65021903|FG004|Dose Escalation|Progressive disease|1|||
23349360|NCT01877382|65021904|FG005|Dose Escalation|Progressive disease|0|||
23349361|NCT01877382|65021905|FG006|Dose Escalation|Progressive disease|3|||
23349362|NCT01877382|65021906|FG007|Dose Escalation|Progressive disease|10|||
23349363|NCT01877382|65021907|FG008|Dose Escalation|Progressive disease|4|||
23349364|NCT01877382|65021908|FG009|Dose Escalation|Progressive disease|2|||
23349365|NCT01877382|65021909|FG010|Dose Escalation|Progressive disease|3|||
23349366|NCT01877382|65021910|FG011|Dose Escalation|Progressive disease|3|||
23349367|NCT01877382|65021911|FG012|Dose Escalation|Progressive disease|13|||
23349368|NCT01877382|65021912|FG013|Dose Escalation|Progressive disease|1|||
23349369|NCT01877382|65021913|FG014|Dose Escalation|Progressive disease|0|||
23349370|NCT01877382|65021899|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
23349371|NCT01877382|65021900|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349372|NCT01877382|65021901|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349373|NCT01877382|65021902|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
23349374|NCT01877382|65021903|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349375|NCT01877382|65021904|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349376|NCT01877382|65021905|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
23349377|NCT01877382|65021906|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349378|NCT01877382|65021907|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349379|NCT01877382|65021908|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349380|NCT01877382|65021909|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349381|NCT01877382|65021910|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349382|NCT01877382|65021911|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349383|NCT01877382|65021912|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349384|NCT01877382|65021913|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349385|NCT01877382|65021899|FG000|Dose Escalation|Clinical progression|0|||
23349386|NCT01877382|65021900|FG001|Dose Escalation|Clinical progression|1|||
23349387|NCT01877382|65021901|FG002|Dose Escalation|Clinical progression|0|||
23241739|NCT04516291|64629601|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
23349388|NCT01877382|65021902|FG003|Dose Escalation|Clinical progression|2|||
23349389|NCT01877382|65021903|FG004|Dose Escalation|Clinical progression|0|||
23349390|NCT01877382|65021904|FG005|Dose Escalation|Clinical progression|0|||
23349391|NCT01877382|65021905|FG006|Dose Escalation|Clinical progression|1|||
23182495|NCT00706628|64409204|FG002|Overall Study|Consent withdrawn|3|||
23182496|NCT00706628|64409205|FG003|Overall Study|Consent withdrawn|0|||
23182497|NCT00706628|64409202|FG000|Overall Study|Progressive disease|20|||
23182498|NCT00706628|64409203|FG001|Overall Study|Progressive disease|13|||
23182499|NCT00706628|64409204|FG002|Overall Study|Progressive disease|8|||
23182500|NCT00706628|64409205|FG003|Overall Study|Progressive disease|1|||
23182501|NCT00706628|64409202|FG000|Overall Study|Other than those stated above|4|||
23182502|NCT00706628|64409203|FG001|Overall Study|Other than those stated above|0|||
23182503|NCT00706628|64409204|FG002|Overall Study|Other than those stated above|0|||
23182504|NCT00706628|64409205|FG003|Overall Study|Other than those stated above|0|||
23182505|NCT00706628|64409202|FG000|Overall Study|Not treated|1|||
23182506|NCT00706628|64409203|FG001|Overall Study|Not treated|1|||
23182507|NCT00706628|64409204|FG002|Overall Study|Not treated|0|||
23182508|NCT00706628|64409205|FG003|Overall Study|Not treated|0|||
23241740|NCT04516291|64629602|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
23349392|NCT01877382|65021906|FG007|Dose Escalation|Clinical progression|0|||
23349393|NCT01877382|65021907|FG008|Dose Escalation|Clinical progression|0|||
23349394|NCT01877382|65021908|FG009|Dose Escalation|Clinical progression|1|||
23349395|NCT01877382|65021909|FG010|Dose Escalation|Clinical progression|0|||
23349396|NCT01877382|65021910|FG011|Dose Escalation|Clinical progression|0|||
23349397|NCT01877382|65021911|FG012|Dose Escalation|Clinical progression|2|||
23349398|NCT01877382|65021912|FG013|Dose Escalation|Clinical progression|1|||
23349399|NCT01877382|65021913|FG014|Dose Escalation|Clinical progression|0|||
23349400|NCT01877382|65021899|FG000|Dose Escalation|Adverse Event|0|||
23182509|NCT01381094|64409207|FG000|Overall Study|Adverse Event|1|||
23182510|NCT01381094|64409208|FG001|Overall Study|Adverse Event|2|||
23182511|NCT01381094|64409209|FG002|Overall Study|Adverse Event|0|||
23241741|NCT04516291|64629603|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
23241742|NCT04516291|64629604|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
23241743|NCT04516291|64629605|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
23241744|NCT04516291|64629606|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
23241745|NCT04516291|64629607|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
23584585|NCT02499328|65869249|FG013|Overall Study|Lost to Follow-up|0|||
23584586|NCT02499328|65869250|FG014|Overall Study|Lost to Follow-up|0|||
23241746|NCT03179462|64629612|FG000|Overall Study|screening failure|1|||
23241747|NCT03179462|64629613|FG001|Overall Study|screening failure|2|||
23241748|NCT03179462|64629614|FG002|Overall Study|screening failure|0|||
23241749|NCT04984889|64629616|FG000|Extension Part|Ongoing|5|||
23241750|NCT02219477|64629617|FG000|Overall Study|Adverse Event|0|||
23241751|NCT02219477|64629618|FG001|Overall Study|Adverse Event|1|||
23584587|NCT02499328|65869251|FG015|Overall Study|Lost to Follow-up|0|||
23584588|NCT02499328|65869252|FG016|Overall Study|Lost to Follow-up|0|||
23584589|NCT02499328|65869253|FG017|Overall Study|Lost to Follow-up|0|||
23584590|NCT02499328|65869254|FG018|Overall Study|Lost to Follow-up|1|||
23584591|NCT02499328|65869236|FG000|Overall Study|Death|0|||
23584592|NCT02499328|65869237|FG001|Overall Study|Death|3|||
23584593|NCT02499328|65869238|FG002|Overall Study|Death|3|||
23584594|NCT02499328|65869239|FG003|Overall Study|Death|2|||
23584595|NCT02499328|65869240|FG004|Overall Study|Death|4|||
23584596|NCT02499328|65869241|FG005|Overall Study|Death|7|||
23584597|NCT02499328|65869242|FG006|Overall Study|Death|3|||
23584598|NCT02499328|65869243|FG007|Overall Study|Death|0|||
23584599|NCT02499328|65869244|FG008|Overall Study|Death|2|||
23584600|NCT02499328|65869245|FG009|Overall Study|Death|6|||
23584601|NCT02499328|65869246|FG010|Overall Study|Death|6|||
23584602|NCT02499328|65869247|FG011|Overall Study|Death|20|||
23584603|NCT02499328|65869248|FG012|Overall Study|Death|9|||
23584604|NCT02499328|65869249|FG013|Overall Study|Death|7|||
23584605|NCT02499328|65869250|FG014|Overall Study|Death|3|||
23584606|NCT02499328|65869251|FG015|Overall Study|Death|1|||
23584607|NCT02499328|65869252|FG016|Overall Study|Death|1|||
23584608|NCT02499328|65869253|FG017|Overall Study|Death|16|||
23584609|NCT02499328|65869254|FG018|Overall Study|Death|5|||
23584610|NCT02499328|65869236|FG000|Overall Study|"Other"|2|||
23584611|NCT02499328|65869237|FG001|Overall Study|"Other"|2|||
23584612|NCT02499328|65869238|FG002|Overall Study|"Other"|1|||
23584613|NCT02499328|65869239|FG003|Overall Study|"Other"|3|||
23584614|NCT02499328|65869240|FG004|Overall Study|"Other"|6|||
23182512|NCT01381094|64409210|FG003|Overall Study|Adverse Event|1|||
23182513|NCT01381094|64409211|FG004|Overall Study|Adverse Event|0|||
23182514|NCT01381094|64409207|FG000|Overall Study|Lost to Follow-up|0|||
23182515|NCT01381094|64409208|FG001|Overall Study|Lost to Follow-up|0|||
23182516|NCT01381094|64409209|FG002|Overall Study|Lost to Follow-up|0|||
23182517|NCT01381094|64409210|FG003|Overall Study|Lost to Follow-up|0|||
23182518|NCT01381094|64409211|FG004|Overall Study|Lost to Follow-up|1|||
23182519|NCT01381094|64409207|FG000|Overall Study|Withdrawal of informed consent|0|||
23182520|NCT01381094|64409208|FG001|Overall Study|Withdrawal of informed consent|1|||
23182521|NCT01381094|64409209|FG002|Overall Study|Withdrawal of informed consent|0|||
23182522|NCT01381094|64409210|FG003|Overall Study|Withdrawal of informed consent|0|||
23182523|NCT01381094|64409211|FG004|Overall Study|Withdrawal of informed consent|0|||
23182524|NCT01381094|64409207|FG000|Overall Study|Participant given Aranesp injection|1|||
23182525|NCT01381094|64409208|FG001|Overall Study|Participant given Aranesp injection|0|||
23182526|NCT01381094|64409209|FG002|Overall Study|Participant given Aranesp injection|0|||
23241752|NCT02219477|64629619|FG002|Overall Study|Adverse Event|1|||
23241753|NCT02219477|64629617|FG000|Overall Study|Withdrawal by Subject|0|||
23241754|NCT02219477|64629618|FG001|Overall Study|Withdrawal by Subject|1|||
23241755|NCT02219477|64629619|FG002|Overall Study|Withdrawal by Subject|0|||
23241756|NCT01740297|64629620|FG000|Overall Study|Withdrawal by Subject|4|||
23241757|NCT01740297|64629621|FG001|Overall Study|Withdrawal by Subject|16|||
23241758|NCT01740297|64629622|FG002|Overall Study|Withdrawal by Subject|17|||
23241759|NCT01740297|64629620|FG000|Overall Study|Death|8|||
23584615|NCT02499328|65869241|FG005|Overall Study|"Other"|2|||
23584616|NCT02499328|65869242|FG006|Overall Study|"Other"|3|||
23584617|NCT02499328|65869243|FG007|Overall Study|"Other"|4|||
23584618|NCT02499328|65869244|FG008|Overall Study|"Other"|6|||
23584619|NCT02499328|65869245|FG009|Overall Study|"Other"|16|||
23182527|NCT01381094|64409210|FG003|Overall Study|Participant given Aranesp injection|0|||
23182528|NCT01381094|64409211|FG004|Overall Study|Participant given Aranesp injection|0|||
23182529|NCT01948830|64409214|FG000|Overall Study|Physician Decision|1|||
23182530|NCT01948830|64409215|FG001|Overall Study|Physician Decision|3|||
23182531|NCT01948830|64409214|FG000|Overall Study|Protocol deviation|1|||
23182532|NCT01948830|64409215|FG001|Overall Study|Protocol deviation|2|||
23182533|NCT01948830|64409214|FG000|Overall Study|Lost to Follow-up|5|||
23182534|NCT01948830|64409215|FG001|Overall Study|Lost to Follow-up|4|||
23182535|NCT01948830|64409214|FG000|Overall Study|Withdrawal by Subject|14|||
23182536|NCT01948830|64409215|FG001|Overall Study|Withdrawal by Subject|17|||
23182537|NCT01948830|64409214|FG000|Overall Study|Adverse Event|9|||
23349401|NCT01877382|65021900|FG001|Dose Escalation|Adverse Event|0|||
23349402|NCT01877382|65021901|FG002|Dose Escalation|Adverse Event|0|||
23349403|NCT01877382|65021902|FG003|Dose Escalation|Adverse Event|4|||
23349404|NCT01877382|65021903|FG004|Dose Escalation|Adverse Event|1|||
23349405|NCT01877382|65021904|FG005|Dose Escalation|Adverse Event|2|||
23182538|NCT01948830|64409215|FG001|Overall Study|Adverse Event|2|||
23182539|NCT01948830|64409214|FG000|Overall Study|Death|3|||
23182540|NCT01948830|64409215|FG001|Overall Study|Death|4|||
23182541|NCT00522392|64409221|FG000|Overall Study|Disease progression|0|||
23182542|NCT00522392|64409222|FG001|Overall Study|Disease progression|3|||
23182543|NCT00522392|64409221|FG000|Overall Study|Adverse Event|7|||
23182544|NCT00522392|64409222|FG001|Overall Study|Adverse Event|7|||
23182545|NCT00522392|64409221|FG000|Overall Study|Withdrawal by Subject|1|||
23182546|NCT00522392|64409222|FG001|Overall Study|Withdrawal by Subject|1|||
23182547|NCT00522392|64409221|FG000|Overall Study|Physician Decision|0|||
23182548|NCT00522392|64409222|FG001|Overall Study|Physician Decision|1|||
23182549|NCT00522392|64409221|FG000|Overall Study|Non-compliance|0|||
23182550|NCT00522392|64409222|FG001|Overall Study|Non-compliance|1|||
23182551|NCT04401267|64409223|FG000|Overall Study|Death|0|||
23182552|NCT04401267|64409224|FG001|Overall Study|Death|1|||
23182553|NCT04401267|64409223|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
23182554|NCT04401267|64409224|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
23182555|NCT04401267|64409223|FG000|Overall Study|Found to be Ineligible|1|||
23182556|NCT04401267|64409224|FG001|Overall Study|Found to be Ineligible|0|||
23182557|NCT00355121|64409225|FG000|Overall Study|Did not receive study vaccine|1|||
23182558|NCT00355121|64409226|FG001|Overall Study|Did not receive study vaccine|0|||
23182559|NCT00355121|64409227|FG002|Overall Study|Did not receive study vaccine|1|||
23182560|NCT00355121|64409225|FG000|Overall Study|Adverse Event|0|||
23182561|NCT00355121|64409226|FG001|Overall Study|Adverse Event|1|||
23182562|NCT00355121|64409227|FG002|Overall Study|Adverse Event|0|||
23182563|NCT00355121|64409225|FG000|Overall Study|Protocol Violation|7|||
23182564|NCT00355121|64409226|FG001|Overall Study|Protocol Violation|9|||
23182565|NCT00355121|64409227|FG002|Overall Study|Protocol Violation|1|||
23182566|NCT00355121|64409225|FG000|Overall Study|Lost to Follow-up|4|||
23182567|NCT00355121|64409226|FG001|Overall Study|Lost to Follow-up|7|||
23241760|NCT01740297|64629621|FG001|Overall Study|Death|46|||
23241761|NCT01740297|64629622|FG002|Overall Study|Death|40|||
23241762|NCT01740297|64629620|FG000|Overall Study|Lost to Follow-up|1|||
23241763|NCT01740297|64629621|FG001|Overall Study|Lost to Follow-up|2|||
23241764|NCT01740297|64629622|FG002|Overall Study|Lost to Follow-up|4|||
23241765|NCT05147311|64629623|FG000|Overall Study|Did not complete survey|2|||
23241766|NCT05147311|64629624|FG001|Overall Study|Did not complete survey|1|||
23241767|NCT05147311|64629623|FG000|Overall Study|Patient too sick|1|||
23241768|NCT05147311|64629624|FG001|Overall Study|Patient too sick|2|||
23241769|NCT05147311|64629623|FG000|Overall Study|Death|0|||
23241770|NCT05147311|64629624|FG001|Overall Study|Death|1|||
23241771|NCT05147311|64629623|FG000|Overall Study|Declined survey|1|||
23241772|NCT05147311|64629624|FG001|Overall Study|Declined survey|0|||
23241773|NCT01980056|64629625|FG000|Overall Study|Death|1|||
23241774|NCT01980056|64629626|FG001|Overall Study|Death|1|||
23241775|NCT01980056|64629627|FG002|Overall Study|Death|0|||
23349406|NCT01877382|65021905|FG006|Dose Escalation|Adverse Event|1|||
23349407|NCT01877382|65021906|FG007|Dose Escalation|Adverse Event|2|||
23241776|NCT01060007|64629631|FG000|Overall Study|Withdrawal by Subject|1|||
23349408|NCT01877382|65021907|FG008|Dose Escalation|Adverse Event|0|||
23349409|NCT01877382|65021908|FG009|Dose Escalation|Adverse Event|0|||
23349410|NCT01877382|65021909|FG010|Dose Escalation|Adverse Event|0|||
23349411|NCT01877382|65021910|FG011|Dose Escalation|Adverse Event|0|||
23182568|NCT00355121|64409227|FG002|Overall Study|Lost to Follow-up|1|||
23182569|NCT00355121|64409225|FG000|Overall Study|Withdrawal by Subject|9|||
23182570|NCT00355121|64409226|FG001|Overall Study|Withdrawal by Subject|10|||
23182571|NCT00355121|64409227|FG002|Overall Study|Withdrawal by Subject|2|||
23182572|NCT00355121|64409225|FG000|Overall Study|Serious adverse events|0|||
23349412|NCT01877382|65021911|FG012|Dose Escalation|Adverse Event|1|||
23182573|NCT00355121|64409226|FG001|Overall Study|Serious adverse events|2|||
23241777|NCT01060007|64629631|FG000|Overall Study|Inevaluable for response at surgery|3|||
23182574|NCT00355121|64409227|FG002|Overall Study|Serious adverse events|0|||
23349413|NCT01877382|65021912|FG013|Dose Escalation|Adverse Event|0|||
23349414|NCT01877382|65021913|FG014|Dose Escalation|Adverse Event|0|||
23182575|NCT00846742|64409233|FG000|Overall Study|Withdrawal by Subject|1|||
23349415|NCT01877382|65021899|FG000|Dose Escalation|Withdrawal by Subject|0|||
23349416|NCT01877382|65021900|FG001|Dose Escalation|Withdrawal by Subject|0|||
23349417|NCT01877382|65021901|FG002|Dose Escalation|Withdrawal by Subject|0|||
23349418|NCT01877382|65021902|FG003|Dose Escalation|Withdrawal by Subject|0|||
23349419|NCT01877382|65021903|FG004|Dose Escalation|Withdrawal by Subject|0|||
23349420|NCT01877382|65021904|FG005|Dose Escalation|Withdrawal by Subject|3|||
23349421|NCT01877382|65021905|FG006|Dose Escalation|Withdrawal by Subject|2|||
23349422|NCT01877382|65021906|FG007|Dose Escalation|Withdrawal by Subject|1|||
23349423|NCT01877382|65021907|FG008|Dose Escalation|Withdrawal by Subject|1|||
23349424|NCT01877382|65021908|FG009|Dose Escalation|Withdrawal by Subject|0|||
23349425|NCT01877382|65021909|FG010|Dose Escalation|Withdrawal by Subject|0|||
23349426|NCT01877382|65021910|FG011|Dose Escalation|Withdrawal by Subject|0|||
23349427|NCT01877382|65021911|FG012|Dose Escalation|Withdrawal by Subject|0|||
23349428|NCT01877382|65021912|FG013|Dose Escalation|Withdrawal by Subject|0|||
23349429|NCT01877382|65021913|FG014|Dose Escalation|Withdrawal by Subject|0|||
23349430|NCT01877382|65021899|FG000|Dose Escalation|Protocol Violation|0|||
23349431|NCT01877382|65021900|FG001|Dose Escalation|Protocol Violation|0|||
23349432|NCT01877382|65021901|FG002|Dose Escalation|Protocol Violation|0|||
23349433|NCT01877382|65021902|FG003|Dose Escalation|Protocol Violation|0|||
23349434|NCT01877382|65021903|FG004|Dose Escalation|Protocol Violation|0|||
23349435|NCT01877382|65021904|FG005|Dose Escalation|Protocol Violation|0|||
23349436|NCT01877382|65021905|FG006|Dose Escalation|Protocol Violation|1|||
23349437|NCT01877382|65021906|FG007|Dose Escalation|Protocol Violation|0|||
23349438|NCT01877382|65021907|FG008|Dose Escalation|Protocol Violation|0|||
23349439|NCT01877382|65021908|FG009|Dose Escalation|Protocol Violation|0|||
23349440|NCT01877382|65021909|FG010|Dose Escalation|Protocol Violation|0|||
23349441|NCT01877382|65021910|FG011|Dose Escalation|Protocol Violation|0|||
23349442|NCT01877382|65021911|FG012|Dose Escalation|Protocol Violation|0|||
23349443|NCT01877382|65021912|FG013|Dose Escalation|Protocol Violation|0|||
23349444|NCT01877382|65021913|FG014|Dose Escalation|Protocol Violation|0|||
23349445|NCT01877382|65021899|FG000|Dose Escalation|Study terminated by sponsor|0|||
23349446|NCT01877382|65021900|FG001|Dose Escalation|Study terminated by sponsor|0|||
23349447|NCT01877382|65021901|FG002|Dose Escalation|Study terminated by sponsor|0|||
23349448|NCT01877382|65021902|FG003|Dose Escalation|Study terminated by sponsor|0|||
23349449|NCT01877382|65021903|FG004|Dose Escalation|Study terminated by sponsor|0|||
23182576|NCT02582671|64409234|FG000|Overall Study|Failure to return|1|||
23182577|NCT02582671|64409234|FG000|Overall Study|Other, not specified|1|||
23182578|NCT01850615|64409235|FG000|Overall Study|Protocol Violation|4|||
23182579|NCT01850615|64409236|FG001|Overall Study|Protocol Violation|1|||
23182580|NCT01850615|64409235|FG000|Overall Study|Adverse Event|2|||
23182581|NCT01850615|64409236|FG001|Overall Study|Adverse Event|1|||
23182582|NCT01850615|64409235|FG000|Overall Study|Withdrawal by Subject|3|||
23182583|NCT01850615|64409236|FG001|Overall Study|Withdrawal by Subject|1|||
23182584|NCT01850615|64409235|FG000|Overall Study|Lost to Follow-up|0|||
23182585|NCT01850615|64409236|FG001|Overall Study|Lost to Follow-up|1|||
23182586|NCT01850615|64409235|FG000|Overall Study|Unclassified|0|||
23182587|NCT01850615|64409236|FG001|Overall Study|Unclassified|1|||
23349450|NCT01877382|65021904|FG005|Dose Escalation|Study terminated by sponsor|0|||
23349451|NCT01877382|65021905|FG006|Dose Escalation|Study terminated by sponsor|0|||
23349452|NCT01877382|65021906|FG007|Dose Escalation|Study terminated by sponsor|1|||
23349453|NCT01877382|65021907|FG008|Dose Escalation|Study terminated by sponsor|1|||
23460949|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
23182588|NCT03403192|64409238|FG000|Overall Study|Lost to Follow-up|1|||
23349454|NCT01877382|65021908|FG009|Dose Escalation|Study terminated by sponsor|0|||
23349455|NCT01877382|65021909|FG010|Dose Escalation|Study terminated by sponsor|0|||
23349456|NCT01877382|65021910|FG011|Dose Escalation|Study terminated by sponsor|0|||
23349457|NCT01877382|65021911|FG012|Dose Escalation|Study terminated by sponsor|3|||
23349458|NCT01877382|65021912|FG013|Dose Escalation|Study terminated by sponsor|0|||
23349459|NCT01877382|65021913|FG014|Dose Escalation|Study terminated by sponsor|0|||
23349460|NCT01877382|65021899|FG000|Dose Escalation|Death|0|||
23349461|NCT01877382|65021900|FG001|Dose Escalation|Death|0|||
23349462|NCT01877382|65021901|FG002|Dose Escalation|Death|0|||
23349463|NCT01877382|65021902|FG003|Dose Escalation|Death|0|||
23349464|NCT01877382|65021903|FG004|Dose Escalation|Death|0|||
23349465|NCT01877382|65021904|FG005|Dose Escalation|Death|0|||
23349466|NCT01877382|65021905|FG006|Dose Escalation|Death|0|||
23349467|NCT01877382|65021906|FG007|Dose Escalation|Death|1|||
23349468|NCT01877382|65021907|FG008|Dose Escalation|Death|0|||
23349469|NCT01877382|65021908|FG009|Dose Escalation|Death|0|||
23349470|NCT01877382|65021909|FG010|Dose Escalation|Death|0|||
23349471|NCT01877382|65021910|FG011|Dose Escalation|Death|0|||
23182589|NCT03403192|64409239|FG001|Overall Study|Lost to Follow-up|2|||
23182590|NCT03403192|64409240|FG002|Overall Study|Lost to Follow-up|0|||
23182591|NCT03403192|64409241|FG003|Overall Study|Lost to Follow-up|0|||
23349472|NCT01877382|65021911|FG012|Dose Escalation|Death|1|||
23182592|NCT03403192|64409238|FG000|Overall Study|Unable to respond|0|||
23182593|NCT03403192|64409239|FG001|Overall Study|Unable to respond|1|||
23182594|NCT03403192|64409240|FG002|Overall Study|Unable to respond|0|||
23182595|NCT03403192|64409241|FG003|Overall Study|Unable to respond|0|||
23182596|NCT03403192|64409238|FG000|Overall Study|Incomplete|3|||
23182597|NCT03403192|64409239|FG001|Overall Study|Incomplete|1|||
23182598|NCT03403192|64409240|FG002|Overall Study|Incomplete|3|||
23182599|NCT03403192|64409241|FG003|Overall Study|Incomplete|6|||
23182600|NCT02344576|64409242|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
23182601|NCT02344576|64409243|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
23182602|NCT02344576|64409244|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
23182603|NCT02344576|64409245|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
23182604|NCT02344576|64409242|FG000|1-Month Follow-Up|Death|13|||
23182605|NCT02344576|64409243|FG001|1-Month Follow-Up|Death|8|||
23182606|NCT02344576|64409244|FG002|1-Month Follow-Up|Death|0|||
23182607|NCT02344576|64409245|FG003|1-Month Follow-Up|Death|0|||
23182608|NCT02344576|64409242|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
23182609|NCT02344576|64409243|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
23241778|NCT01945866|64629639|FG000|Overall Study|Eyes did not complete or were dropped|2|||
23241779|NCT01945866|64629640|FG001|Overall Study|Eyes did not complete or were dropped|0|||
23241780|NCT01014442|64629644|FG000|Overall Study|Adverse Event|0|||
23241781|NCT01014442|64629645|FG001|Overall Study|Adverse Event|8|||
23241782|NCT01014442|64629644|FG000|Overall Study|Withdrawal by Subject|4|||
23241783|NCT01014442|64629645|FG001|Overall Study|Withdrawal by Subject|4|||
23241784|NCT01014442|64629644|FG000|Overall Study|Protocol Violation|2|||
23241785|NCT01014442|64629645|FG001|Overall Study|Protocol Violation|5|||
23241786|NCT01014442|64629644|FG000|Overall Study|Lack of Compliance|0|||
23241787|NCT01014442|64629645|FG001|Overall Study|Lack of Compliance|1|||
23241788|NCT01014442|64629644|FG000|Overall Study|Unspecified Reason|1|||
23241789|NCT01014442|64629645|FG001|Overall Study|Unspecified Reason|1|||
23241790|NCT04150107|64629646|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
23241791|NCT04150107|64629647|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
23241792|NCT04150107|64629646|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
23241793|NCT04150107|64629647|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
23241794|NCT02389621|64629648|FG000|Treatment Period|Withdrawal by Subject|1|||
23241795|NCT02389621|64629649|FG001|Treatment Period|Withdrawal by Subject|1|||
23241796|NCT02389621|64629648|FG000|Posttreatment Period|Adverse Event|3|||
23241797|NCT02389621|64629649|FG001|Posttreatment Period|Adverse Event|1|||
23241798|NCT02389621|64629648|FG000|Posttreatment Period|Withdrawal by Subject|3|||
23241799|NCT02389621|64629649|FG001|Posttreatment Period|Withdrawal by Subject|2|||
23241800|NCT02389621|64629648|FG000|Posttreatment Period|Lost to Follow-up|1|||
23241801|NCT02389621|64629649|FG001|Posttreatment Period|Lost to Follow-up|1|||
23241802|NCT02389621|64629648|FG000|Posttreatment Period|Other - Miscellaneous|2|||
23241803|NCT02389621|64629649|FG001|Posttreatment Period|Other - Miscellaneous|0|||
23241804|NCT00779142|64629650|FG000|Overall Study|Screen Failures|3|||
23241805|NCT00625846|64629654|FG000|Overall Study|Withdrawal by Subject|2|||
23241806|NCT00625846|64629655|FG001|Overall Study|Withdrawal by Subject|0|||
23241807|NCT00625846|64629656|FG002|Overall Study|Withdrawal by Subject|1|||
23241808|NCT00625846|64629657|FG003|Overall Study|Withdrawal by Subject|2|||
23241809|NCT00795886|64629662|FG000|Overall Study|Death|10|||
23241810|NCT01366846|64629664|FG000|Overall Study|Withdrawal by Subject|2|||
23241811|NCT01366846|64629665|FG001|Overall Study|Withdrawal by Subject|0|||
23241812|NCT01366846|64629666|FG002|Overall Study|Withdrawal by Subject|0|||
23241813|NCT01366846|64629667|FG003|Overall Study|Withdrawal by Subject|0|||
23241814|NCT01366846|64629664|FG000|Overall Study|Communication Difficulties|1|||
23241815|NCT01366846|64629665|FG001|Overall Study|Communication Difficulties|4|||
23241816|NCT01366846|64629666|FG002|Overall Study|Communication Difficulties|0|||
23241817|NCT01366846|64629667|FG003|Overall Study|Communication Difficulties|1|||
23241818|NCT01366846|64629664|FG000|Overall Study|Scheduling Conflicts|0|||
23241819|NCT01366846|64629665|FG001|Overall Study|Scheduling Conflicts|0|||
23241820|NCT01366846|64629666|FG002|Overall Study|Scheduling Conflicts|1|||
23241821|NCT01366846|64629667|FG003|Overall Study|Scheduling Conflicts|0|||
23241822|NCT02422186|64629668|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
23241823|NCT02422186|64629669|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
23241824|NCT02422186|64629668|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
23349473|NCT01877382|65021912|FG013|Dose Escalation|Death|1|||
23182610|NCT02344576|64409244|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
23182611|NCT02344576|64409245|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
23241825|NCT02422186|64629669|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
23241826|NCT02422186|64629668|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
23241827|NCT02422186|64629669|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
23241828|NCT02422186|64629668|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
23182612|NCT02344576|64409242|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
23182613|NCT02344576|64409243|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
23182614|NCT02344576|64409244|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
23182615|NCT02344576|64409245|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
23241829|NCT02422186|64629669|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
23349474|NCT01877382|65021913|FG014|Dose Escalation|Death|0|||
23349475|NCT01877382|65021899|FG000|Dose Expansion|Progressive disease|0|||
23349476|NCT01877382|65021900|FG001|Dose Expansion|Progressive disease|0|||
23349477|NCT01877382|65021901|FG002|Dose Expansion|Progressive disease|0|||
23349478|NCT01877382|65021902|FG003|Dose Expansion|Progressive disease|0|||
23349479|NCT01877382|65021903|FG004|Dose Expansion|Progressive disease|0|||
23349480|NCT01877382|65021904|FG005|Dose Expansion|Progressive disease|0|||
23349481|NCT01877382|65021905|FG006|Dose Expansion|Progressive disease|0|||
23349482|NCT01877382|65021906|FG007|Dose Expansion|Progressive disease|0|||
23349483|NCT01877382|65021907|FG008|Dose Expansion|Progressive disease|0|||
23349484|NCT01877382|65021908|FG009|Dose Expansion|Progressive disease|0|||
23349485|NCT01877382|65021909|FG010|Dose Expansion|Progressive disease|0|||
23349486|NCT01877382|65021910|FG011|Dose Expansion|Progressive disease|0|||
23349487|NCT01877382|65021911|FG012|Dose Expansion|Progressive disease|0|||
23349488|NCT01877382|65021912|FG013|Dose Expansion|Progressive disease|0|||
23460950|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
23460951|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
23460952|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
23460953|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
23460954|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
23460955|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
23460956|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
23460957|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
23460958|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
23460959|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Death|0|||
23460960|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Death|6|||
23460961|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Death|3|||
23460962|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Death|0|||
23460963|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Death|0|||
23460964|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
23460965|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
23584620|NCT02499328|65869246|FG010|Overall Study|"Other"|13|||
23584621|NCT02499328|65869247|FG011|Overall Study|"Other"|31|||
23584622|NCT02499328|65869248|FG012|Overall Study|"Other"|8|||
23584623|NCT02499328|65869249|FG013|Overall Study|"Other"|7|||
23584624|NCT02499328|65869250|FG014|Overall Study|"Other"|6|||
23584625|NCT02499328|65869251|FG015|Overall Study|"Other"|0|||
23584626|NCT02499328|65869252|FG016|Overall Study|"Other"|0|||
23584627|NCT02499328|65869253|FG017|Overall Study|"Other"|34|||
23584628|NCT02499328|65869254|FG018|Overall Study|"Other"|43|||
23584629|NCT02499328|65869236|FG000|Overall Study|Disease Progression|0|||
23584630|NCT02499328|65869237|FG001|Overall Study|Disease Progression|0|||
23584631|NCT02499328|65869238|FG002|Overall Study|Disease Progression|0|||
23584632|NCT02499328|65869239|FG003|Overall Study|Disease Progression|0|||
23584633|NCT02499328|65869240|FG004|Overall Study|Disease Progression|0|||
23584634|NCT02499328|65869241|FG005|Overall Study|Disease Progression|0|||
23584635|NCT02499328|65869242|FG006|Overall Study|Disease Progression|1|||
23584636|NCT02499328|65869243|FG007|Overall Study|Disease Progression|0|||
23584637|NCT02499328|65869244|FG008|Overall Study|Disease Progression|1|||
23584638|NCT02499328|65869245|FG009|Overall Study|Disease Progression|0|||
23584639|NCT02499328|65869246|FG010|Overall Study|Disease Progression|1|||
23584640|NCT02499328|65869247|FG011|Overall Study|Disease Progression|0|||
23584641|NCT02499328|65869248|FG012|Overall Study|Disease Progression|0|||
23584642|NCT02499328|65869249|FG013|Overall Study|Disease Progression|0|||
23182616|NCT02344576|64409242|FG000|6-Month Follow-Up|Death|14|||
23182617|NCT02344576|64409243|FG001|6-Month Follow-Up|Death|14|||
23182618|NCT02344576|64409244|FG002|6-Month Follow-Up|Death|0|||
23182619|NCT02344576|64409245|FG003|6-Month Follow-Up|Death|0|||
23182620|NCT02344576|64409242|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
23182621|NCT02344576|64409243|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
23182622|NCT02344576|64409244|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
23182623|NCT02344576|64409245|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
23182624|NCT02344576|64409242|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
23182625|NCT02344576|64409243|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
23182626|NCT02344576|64409244|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
23182627|NCT02344576|64409245|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
23182628|NCT03371355|64409246|FG000|Overall Study|Investigator judgment|0|||
23182629|NCT03371355|64409247|FG001|Overall Study|Investigator judgment|0|||
23182630|NCT03371355|64409248|FG002|Overall Study|Investigator judgment|1|||
23182631|NCT03371355|64409249|FG003|Overall Study|Investigator judgment|1|||
23460966|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
23584643|NCT02499328|65869250|FG014|Overall Study|Disease Progression|0|||
23584644|NCT02499328|65869251|FG015|Overall Study|Disease Progression|0|||
23584645|NCT02499328|65869252|FG016|Overall Study|Disease Progression|0|||
23182632|NCT03371355|64409246|FG000|Overall Study|Voluntary withdrawal|1|||
23182633|NCT03371355|64409247|FG001|Overall Study|Voluntary withdrawal|0|||
23460967|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
23460968|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
23460969|NCT00561925|65430927|FG000|144-week Double-blind, Double-dummy|Other|0|||
23460970|NCT00561925|65430928|FG001|144-week Double-blind, Double-dummy|Other|8|||
23460971|NCT00561925|65430929|FG002|144-week Double-blind, Double-dummy|Other|11|||
23460972|NCT00561925|65430930|FG003|144-week Double-blind, Double-dummy|Other|0|||
23460973|NCT00561925|65430931|FG004|144-week Double-blind, Double-dummy|Other|0|||
23460974|NCT00561925|65430927|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
23460975|NCT00561925|65430928|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
23460976|NCT00561925|65430929|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
23460977|NCT00561925|65430930|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
23460978|NCT00561925|65430931|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
23460979|NCT04314284|65430934|FG000|Overall Study|Withdrawal by Subject|4|||
23460980|NCT04314284|65430935|FG001|Overall Study|Withdrawal by Subject|7|||
23460981|NCT04314284|65430934|FG000|Overall Study|Consented but did not complete survey|0|||
23460982|NCT04314284|65430935|FG001|Overall Study|Consented but did not complete survey|6|||
23460983|NCT00087152|65430936|FG000|Overall Study|Ineligible|6|||
23460984|NCT01761877|65430937|FG000|Overall Study|Adverse Event|7|||
23460985|NCT01761877|65430938|FG001|Overall Study|Adverse Event|0|||
23460986|NCT01761877|65430937|FG000|Overall Study|Withdrawal by Subject|6|||
23460987|NCT01761877|65430938|FG001|Overall Study|Withdrawal by Subject|4|||
23460988|NCT01761877|65430937|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
23460989|NCT01761877|65430938|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
23460990|NCT01761877|65430937|FG000|Overall Study|Death|0|||
23460991|NCT01761877|65430938|FG001|Overall Study|Death|1|||
23460992|NCT01761877|65430937|FG000|Overall Study|MRI intolerant|1|||
23460993|NCT01761877|65430938|FG001|Overall Study|MRI intolerant|6|||
23460994|NCT02351817|65430939|FG000|Period 1|Adverse Event|1|||
23460995|NCT02351817|65430940|FG001|Period 1|Adverse Event|2|||
23460996|NCT02351817|65430939|FG000|Period 1|Lack of Efficacy|0|||
23460997|NCT02351817|65430940|FG001|Period 1|Lack of Efficacy|1|||
23460998|NCT02351817|65430939|FG000|Period 2|Adverse Event|0|||
23460999|NCT02351817|65430940|FG001|Period 2|Adverse Event|2|||
23461000|NCT02351817|65430939|FG000|Period 2|Protocol Violation|1|||
23461001|NCT02351817|65430940|FG001|Period 2|Protocol Violation|0|||
23461002|NCT02345070|65430943|FG000|Overall Study|Adverse Event|12|||
23461003|NCT02345070|65430944|FG001|Overall Study|Adverse Event|8|||
23461004|NCT02345070|65430945|FG002|Overall Study|Adverse Event|16|||
23461005|NCT02345070|65430943|FG000|Overall Study|Poor compliance to protocol|2|||
23461006|NCT02345070|65430944|FG001|Overall Study|Poor compliance to protocol|0|||
23461007|NCT02345070|65430945|FG002|Overall Study|Poor compliance to protocol|0|||
23461008|NCT02345070|65430943|FG000|Overall Study|Other than specified above|6|||
23461009|NCT02345070|65430944|FG001|Overall Study|Other than specified above|3|||
23461010|NCT02345070|65430945|FG002|Overall Study|Other than specified above|7|||
23461011|NCT01389596|65434737|FG000|Overall Study|Protocol Violation|3|||
23461012|NCT01389596|65434738|FG001|Overall Study|Protocol Violation|4|||
23461013|NCT01389596|65434739|FG002|Overall Study|Protocol Violation|3|||
23461014|NCT01389596|65434737|FG000|Overall Study|Withdrawal by Subject|1|||
23461015|NCT01389596|65434738|FG001|Overall Study|Withdrawal by Subject|2|||
23461016|NCT01389596|65434739|FG002|Overall Study|Withdrawal by Subject|2|||
23461017|NCT01389596|65434737|FG000|Overall Study|Insufficient Clinical Response|3|||
23461018|NCT01389596|65434738|FG001|Overall Study|Insufficient Clinical Response|4|||
23461019|NCT01389596|65434739|FG002|Overall Study|Insufficient Clinical Response|5|||
23461020|NCT01389596|65434737|FG000|Overall Study|Adverse Event|1|||
23461021|NCT01389596|65434738|FG001|Overall Study|Adverse Event|4|||
23461022|NCT01389596|65434739|FG002|Overall Study|Adverse Event|0|||
23461023|NCT01389596|65434737|FG000|Overall Study|Death|0|||
23461024|NCT01389596|65434738|FG001|Overall Study|Death|1|||
23349489|NCT01877382|65021913|FG014|Dose Expansion|Progressive disease|11|||
23349490|NCT01877382|65021899|FG000|Dose Expansion|Clinical progression|0|||
23349491|NCT01877382|65021900|FG001|Dose Expansion|Clinical progression|0|||
23349492|NCT01877382|65021901|FG002|Dose Expansion|Clinical progression|0|||
23349493|NCT01877382|65021902|FG003|Dose Expansion|Clinical progression|0|||
23349494|NCT01877382|65021903|FG004|Dose Expansion|Clinical progression|0|||
23349495|NCT01877382|65021904|FG005|Dose Expansion|Clinical progression|0|||
23349496|NCT01877382|65021905|FG006|Dose Expansion|Clinical progression|0|||
23349497|NCT01877382|65021906|FG007|Dose Expansion|Clinical progression|0|||
23349498|NCT01877382|65021907|FG008|Dose Expansion|Clinical progression|0|||
23461025|NCT01389596|65434739|FG002|Overall Study|Death|0|||
23461026|NCT01389596|65434737|FG000|Overall Study|Other Unspecified|2|||
23461027|NCT01389596|65434738|FG001|Overall Study|Other Unspecified|1|||
23461028|NCT01389596|65434739|FG002|Overall Study|Other Unspecified|0|||
23461029|NCT03413891|65434742|FG000|Overall Study|Lost to Follow-up|2|||
23461030|NCT03413891|65434743|FG001|Overall Study|Lost to Follow-up|1|||
23349499|NCT01877382|65021908|FG009|Dose Expansion|Clinical progression|0|||
23349500|NCT01877382|65021909|FG010|Dose Expansion|Clinical progression|0|||
23349501|NCT01877382|65021910|FG011|Dose Expansion|Clinical progression|0|||
23349502|NCT01877382|65021911|FG012|Dose Expansion|Clinical progression|0|||
23461031|NCT03413891|65434742|FG000|Overall Study|Protocol Violation|0|||
23461032|NCT03413891|65434743|FG001|Overall Study|Protocol Violation|1|||
23461033|NCT01586364|65434744|FG000|Overall Study|Withdrawal by Subject|40|||
23461034|NCT01586364|65434744|FG000|Overall Study|Adverse Event|37|||
23461035|NCT01586364|65434744|FG000|Overall Study|Lost to Follow-up|17|||
23461036|NCT01586364|65434744|FG000|Overall Study|Protocol Violation|16|||
23461037|NCT01586364|65434744|FG000|Overall Study|Lack of Efficacy|1|||
23461038|NCT01586364|65434744|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
23461039|NCT01586364|65434744|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
23461040|NCT01586364|65434744|FG000|Overall Study|Other-Site closure due to PI illness|1|||
23461041|NCT01586364|65434744|FG000|Overall Study|Other-PI discretion, site closing|2|||
23461042|NCT01586364|65434744|FG000|Overall Study|Other-Not specified|1|||
23461043|NCT03137381|65434749|FG000|Overall Study|Adverse Event|3|||
23461044|NCT03137381|65434750|FG001|Overall Study|Adverse Event|0|||
23461045|NCT03137381|65434751|FG002|Overall Study|Adverse Event|2|||
23461046|NCT03137381|65434752|FG003|Overall Study|Adverse Event|0|||
23461047|NCT03137381|65434749|FG000|Overall Study|Lost to Follow-up|2|||
23461048|NCT03137381|65434750|FG001|Overall Study|Lost to Follow-up|1|||
23461049|NCT03137381|65434751|FG002|Overall Study|Lost to Follow-up|1|||
23461050|NCT03137381|65434752|FG003|Overall Study|Lost to Follow-up|0|||
23461051|NCT03137381|65434749|FG000|Overall Study|Protocol deviation|1|||
23461052|NCT03137381|65434750|FG001|Overall Study|Protocol deviation|1|||
23461053|NCT03137381|65434751|FG002|Overall Study|Protocol deviation|0|||
23461054|NCT03137381|65434752|FG003|Overall Study|Protocol deviation|1|||
23461055|NCT03137381|65434749|FG000|Overall Study|Withdrawal by Investigator|0|||
23461056|NCT03137381|65434750|FG001|Overall Study|Withdrawal by Investigator|1|||
23461057|NCT03137381|65434751|FG002|Overall Study|Withdrawal by Investigator|1|||
23461058|NCT03137381|65434752|FG003|Overall Study|Withdrawal by Investigator|0|||
23461059|NCT03137381|65434749|FG000|Overall Study|Withdrawal by Subject|3|||
23461060|NCT03137381|65434750|FG001|Overall Study|Withdrawal by Subject|4|||
23461061|NCT03137381|65434751|FG002|Overall Study|Withdrawal by Subject|3|||
23461062|NCT03137381|65434752|FG003|Overall Study|Withdrawal by Subject|0|||
23461063|NCT03137381|65434749|FG000|Overall Study|Pregnancy|0|||
23461064|NCT03137381|65434750|FG001|Overall Study|Pregnancy|0|||
23461065|NCT03137381|65434751|FG002|Overall Study|Pregnancy|1|||
23461066|NCT03137381|65434752|FG003|Overall Study|Pregnancy|0|||
23461067|NCT00966654|65434753|FG000|Overall Study|Study was terminated,PI left institution|12|||
23461068|NCT02557139|65434754|FG000|Overall Study|Significant liver elevation|1|||
23461069|NCT02557139|65434755|FG001|Overall Study|Significant liver elevation|0|||
23461070|NCT02557139|65434756|FG002|Overall Study|Significant liver elevation|1|||
23461071|NCT02557139|65434754|FG000|Overall Study|Withdrawal by Subject|1|||
23461072|NCT02557139|65434755|FG001|Overall Study|Withdrawal by Subject|0|||
23461073|NCT02557139|65434756|FG002|Overall Study|Withdrawal by Subject|0|||
23461074|NCT02557139|65434754|FG000|Overall Study|Illness of prohibited medication|0|||
23461075|NCT02557139|65434755|FG001|Overall Study|Illness of prohibited medication|0|||
23461076|NCT02557139|65434756|FG002|Overall Study|Illness of prohibited medication|1|||
23461077|NCT00812708|65434760|FG000|Overall Study|Device could not be implanted|2|||
23461078|NCT00812708|65434760|FG000|Overall Study|Lack of medical insurance|1|||
23461079|NCT00812708|65434760|FG000|Overall Study|Switched to another study|1|||
23461080|NCT00812708|65434760|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
23461081|NCT00812708|65434760|FG000|Overall Study|Signed consent but later withdrew|3|||
23461082|NCT05038982|65434764|FG000|Overall Study|Withdrawal by Subject|0|||
23461083|NCT05038982|65434765|FG001|Overall Study|Withdrawal by Subject|2|||
23461084|NCT05050318|65434770|FG000|Overall Study|Protocol Deviation|1|||
23461085|NCT05050318|65434771|FG001|Overall Study|Protocol Deviation|0|||
23461086|NCT05050318|65434772|FG002|Overall Study|Protocol Deviation|0|||
23461087|NCT03592186|65434773|FG000|Overall Study|Withdrawal by Subject|1|||
23461088|NCT03592186|65434774|FG001|Overall Study|Withdrawal by Subject|0|||
23461089|NCT03592186|65434773|FG000|Overall Study|Lost to Follow-up|16|||
23461090|NCT03592186|65434774|FG001|Overall Study|Lost to Follow-up|11|||
23182634|NCT03371355|64409248|FG002|Overall Study|Voluntary withdrawal|1|||
23182635|NCT03371355|64409249|FG003|Overall Study|Voluntary withdrawal|2|||
23182636|NCT03371355|64409246|FG000|Overall Study|Adverse Event|0|||
23182637|NCT03371355|64409247|FG001|Overall Study|Adverse Event|1|||
23182638|NCT03371355|64409248|FG002|Overall Study|Adverse Event|2|||
23182639|NCT03371355|64409249|FG003|Overall Study|Adverse Event|3|||
23182640|NCT03371355|64409246|FG000|Overall Study|Reason not Specified|0|||
23182641|NCT03371355|64409247|FG001|Overall Study|Reason not Specified|1|||
23461091|NCT00630838|65434777|FG000|Overall Study|Death|0|||
23461092|NCT00630838|65434778|FG001|Overall Study|Death|1|||
23461093|NCT00630838|65434777|FG000|Overall Study|Lost to Follow-up|0|||
23461094|NCT00630838|65434778|FG001|Overall Study|Lost to Follow-up|1|||
23461095|NCT01198795|65434779|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
23461096|NCT01198795|65434779|FG000|Overall Study|Withdrawal by Subject|17|||
23461097|NCT01198795|65434779|FG000|Overall Study|Lost to Follow-up|15|||
23182642|NCT03371355|64409248|FG002|Overall Study|Reason not Specified|0|||
23182643|NCT03371355|64409249|FG003|Overall Study|Reason not Specified|1|||
23241830|NCT02422186|64629668|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
23241831|NCT02422186|64629669|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
23241832|NCT02422186|64629668|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
23241833|NCT02422186|64629669|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
23241834|NCT02422186|64629668|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
23241835|NCT02422186|64629669|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
23241836|NCT02422186|64629668|FG000|Follow-up Phase (2 Weeks)|Other|3|||
23241837|NCT02422186|64629669|FG001|Follow-up Phase (2 Weeks)|Other|0|||
23241838|NCT00054639|64629674|FG000|Overall Study|Lack of Efficacy|1|||
23241839|NCT00054639|64629674|FG000|Overall Study|Physician Decision|1|||
23241840|NCT00467051|64629675|FG000|Overall Study|Adverse Event|2|||
23241841|NCT00326625|64629676|FG000|Overall Study|Adverse Event|20|||
23241842|NCT00326625|64629677|FG001|Overall Study|Adverse Event|9|||
23241843|NCT00326625|64629676|FG000|Overall Study|Withdrawal by Subject|15|||
23241844|NCT00326625|64629677|FG001|Overall Study|Withdrawal by Subject|12|||
23241845|NCT00326625|64629676|FG000|Overall Study|Death|18|||
23241846|NCT00326625|64629677|FG001|Overall Study|Death|16|||
23241847|NCT00326625|64629676|FG000|Overall Study|Lost to Follow-up|1|||
23241848|NCT00326625|64629677|FG001|Overall Study|Lost to Follow-up|0|||
23241849|NCT00326625|64629676|FG000|Overall Study|prescheduled medical intervention|0|||
23241850|NCT00326625|64629677|FG001|Overall Study|prescheduled medical intervention|1|||
23349503|NCT01877382|65021912|FG013|Dose Expansion|Clinical progression|0|||
23349504|NCT01877382|65021913|FG014|Dose Expansion|Clinical progression|6|||
23349505|NCT01877382|65021899|FG000|Dose Expansion|Adverse Event|0|||
23349506|NCT01877382|65021900|FG001|Dose Expansion|Adverse Event|0|||
23349507|NCT01877382|65021901|FG002|Dose Expansion|Adverse Event|0|||
23349508|NCT01877382|65021902|FG003|Dose Expansion|Adverse Event|0|||
23349509|NCT01877382|65021903|FG004|Dose Expansion|Adverse Event|0|||
23349510|NCT01877382|65021904|FG005|Dose Expansion|Adverse Event|0|||
23349511|NCT01877382|65021905|FG006|Dose Expansion|Adverse Event|0|||
23349512|NCT01877382|65021906|FG007|Dose Expansion|Adverse Event|0|||
23349513|NCT01877382|65021907|FG008|Dose Expansion|Adverse Event|0|||
23349514|NCT01877382|65021908|FG009|Dose Expansion|Adverse Event|0|||
23349515|NCT01877382|65021909|FG010|Dose Expansion|Adverse Event|0|||
23349516|NCT01877382|65021910|FG011|Dose Expansion|Adverse Event|0|||
23349517|NCT01877382|65021911|FG012|Dose Expansion|Adverse Event|0|||
23349518|NCT01877382|65021912|FG013|Dose Expansion|Adverse Event|0|||
23349519|NCT01877382|65021913|FG014|Dose Expansion|Adverse Event|1|||
23349520|NCT01877382|65021899|FG000|Dose Expansion|Death|0|||
23349521|NCT01877382|65021900|FG001|Dose Expansion|Death|0|||
23349522|NCT01877382|65021901|FG002|Dose Expansion|Death|0|||
23349523|NCT01877382|65021902|FG003|Dose Expansion|Death|0|||
23349524|NCT01877382|65021903|FG004|Dose Expansion|Death|0|||
23349525|NCT01877382|65021904|FG005|Dose Expansion|Death|0|||
23182644|NCT00374556|64409256|FG000|Overall Study|Lost to Follow-up|1|||
23182645|NCT00374556|64409257|FG001|Overall Study|Lost to Follow-up|0|||
23182646|NCT00374556|64409256|FG000|Overall Study|Removed at baseline due to medical cond|0|||
23182647|NCT00374556|64409257|FG001|Overall Study|Removed at baseline due to medical cond|1|||
23182648|NCT03812510|64409258|FG000|Overall Study|Lost to Follow-up|39|||
23182649|NCT03812510|64409258|FG000|Overall Study|Withdrawal by Subject|42|||
23182650|NCT03812510|64409258|FG000|Overall Study|Physician Decision|2|||
23182651|NCT03812510|64409258|FG000|Overall Study|Study Terminated by Sponsor|9|||
23182652|NCT03812510|64409258|FG000|Overall Study|Did Not Start Study Medication|55|||
23182653|NCT03812510|64409258|FG000|Overall Study|Adverse Event|5|||
23182654|NCT01309737|64409259|FG000|Week 0 to 16|Death|1|||
23182655|NCT01309737|64409260|FG001|Week 0 to 16|Death|0|||
23182656|NCT01309737|64409261|FG002|Week 0 to 16|Death|1|||
23182657|NCT01309737|64409262|FG003|Week 0 to 16|Death|0|||
23182658|NCT01309737|64409263|FG004|Week 0 to 16|Death|0|||
23182659|NCT01309737|64409259|FG000|Week 0 to 16|Adverse Event|11|||
23182660|NCT01309737|64409260|FG001|Week 0 to 16|Adverse Event|10|||
23182661|NCT01309737|64409261|FG002|Week 0 to 16|Adverse Event|5|||
23182662|NCT01309737|64409262|FG003|Week 0 to 16|Adverse Event|0|||
23182663|NCT01309737|64409263|FG004|Week 0 to 16|Adverse Event|0|||
23182664|NCT01309737|64409259|FG000|Week 0 to 16|Lack of Efficacy|15|||
23182665|NCT01309737|64409260|FG001|Week 0 to 16|Lack of Efficacy|2|||
23182666|NCT01309737|64409261|FG002|Week 0 to 16|Lack of Efficacy|24|||
23241851|NCT02501642|64629681|FG000|Overall Study|Lost to Follow-up|7|||
23349526|NCT01877382|65021905|FG006|Dose Expansion|Death|0|||
23349527|NCT01877382|65021906|FG007|Dose Expansion|Death|0|||
23349528|NCT01877382|65021907|FG008|Dose Expansion|Death|0|||
23349529|NCT01877382|65021908|FG009|Dose Expansion|Death|0|||
23349530|NCT01877382|65021909|FG010|Dose Expansion|Death|0|||
23349531|NCT01877382|65021910|FG011|Dose Expansion|Death|0|||
23182667|NCT01309737|64409262|FG003|Week 0 to 16|Lack of Efficacy|0|||
23349532|NCT01877382|65021911|FG012|Dose Expansion|Death|0|||
23349533|NCT01877382|65021912|FG013|Dose Expansion|Death|0|||
23349534|NCT01877382|65021913|FG014|Dose Expansion|Death|1|||
23241852|NCT02501642|64629682|FG001|Overall Study|Lost to Follow-up|11|||
23241853|NCT01353209|64629684|FG000|Overall Study|Adverse Event|1|||
23241854|NCT01353209|64629685|FG001|Overall Study|Adverse Event|1|||
23241855|NCT01846039|64629690|FG000|Overall Study|Protocol Violation|1|||
23241856|NCT01846039|64629690|FG000|Overall Study|Subject Withdrew Consent|1|||
23241857|NCT01195662|64629693|FG000|Double Blind Treatment Period|Adverse Event|4|||
23241858|NCT01195662|64629694|FG001|Double Blind Treatment Period|Adverse Event|1|||
23241859|NCT01195662|64629695|FG002|Double Blind Treatment Period|Adverse Event|2|||
23241860|NCT01195662|64629693|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
23241861|NCT01195662|64629694|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
23241862|NCT01195662|64629695|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
23241863|NCT01195662|64629693|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
23584646|NCT02499328|65869253|FG017|Overall Study|Disease Progression|2|||
23182668|NCT01309737|64409263|FG004|Week 0 to 16|Lack of Efficacy|0|||
23182669|NCT01309737|64409259|FG000|Week 0 to 16|Lost to Follow-up|7|||
23182670|NCT01309737|64409260|FG001|Week 0 to 16|Lost to Follow-up|8|||
23182671|NCT01309737|64409261|FG002|Week 0 to 16|Lost to Follow-up|3|||
23182672|NCT01309737|64409262|FG003|Week 0 to 16|Lost to Follow-up|0|||
23182673|NCT01309737|64409263|FG004|Week 0 to 16|Lost to Follow-up|0|||
23182674|NCT01309737|64409259|FG000|Week 0 to 16|Withdrawal by Subject|7|||
23182675|NCT01309737|64409260|FG001|Week 0 to 16|Withdrawal by Subject|6|||
23182676|NCT01309737|64409261|FG002|Week 0 to 16|Withdrawal by Subject|7|||
23182677|NCT01309737|64409262|FG003|Week 0 to 16|Withdrawal by Subject|0|||
23182678|NCT01309737|64409263|FG004|Week 0 to 16|Withdrawal by Subject|0|||
23182679|NCT01309737|64409259|FG000|Week 0 to 16|Other|10|||
23182680|NCT01309737|64409260|FG001|Week 0 to 16|Other|14|||
23182681|NCT01309737|64409261|FG002|Week 0 to 16|Other|4|||
23182682|NCT01309737|64409262|FG003|Week 0 to 16|Other|0|||
23182683|NCT01309737|64409263|FG004|Week 0 to 16|Other|0|||
23182684|NCT01309737|64409259|FG000|Week 0 to 16|Randomized, but not treated|1|||
23182685|NCT01309737|64409260|FG001|Week 0 to 16|Randomized, but not treated|0|||
23182686|NCT01309737|64409261|FG002|Week 0 to 16|Randomized, but not treated|0|||
23182687|NCT01309737|64409262|FG003|Week 0 to 16|Randomized, but not treated|0|||
23182688|NCT01309737|64409263|FG004|Week 0 to 16|Randomized, but not treated|0|||
23182689|NCT01309737|64409259|FG000|Week 16 to 52|Death|0|||
23182690|NCT01309737|64409260|FG001|Week 16 to 52|Death|0|||
23182691|NCT01309737|64409261|FG002|Week 16 to 52|Death|0|||
23182692|NCT01309737|64409262|FG003|Week 16 to 52|Death|0|||
23182693|NCT01309737|64409263|FG004|Week 16 to 52|Death|1|||
23182694|NCT01309737|64409259|FG000|Week 16 to 52|Adverse Event|7|||
23182695|NCT01309737|64409260|FG001|Week 16 to 52|Adverse Event|7|||
23182696|NCT01309737|64409261|FG002|Week 16 to 52|Adverse Event|0|||
23182697|NCT01309737|64409262|FG003|Week 16 to 52|Adverse Event|6|||
23182698|NCT01309737|64409263|FG004|Week 16 to 52|Adverse Event|5|||
23182699|NCT01309737|64409259|FG000|Week 16 to 52|Lack of Efficacy|107|||
23182700|NCT01309737|64409260|FG001|Week 16 to 52|Lack of Efficacy|76|||
23182701|NCT01309737|64409261|FG002|Week 16 to 52|Lack of Efficacy|0|||
23182702|NCT01309737|64409262|FG003|Week 16 to 52|Lack of Efficacy|25|||
23182703|NCT01309737|64409263|FG004|Week 16 to 52|Lack of Efficacy|21|||
23182704|NCT01309737|64409259|FG000|Week 16 to 52|Lost to Follow-up|4|||
23182705|NCT01309737|64409260|FG001|Week 16 to 52|Lost to Follow-up|2|||
23182706|NCT01309737|64409261|FG002|Week 16 to 52|Lost to Follow-up|0|||
23182707|NCT01309737|64409262|FG003|Week 16 to 52|Lost to Follow-up|1|||
23182708|NCT01309737|64409263|FG004|Week 16 to 52|Lost to Follow-up|4|||
23182709|NCT01309737|64409259|FG000|Week 16 to 52|Withdrawal by Subject|5|||
23182710|NCT01309737|64409260|FG001|Week 16 to 52|Withdrawal by Subject|6|||
23584647|NCT02499328|65869254|FG018|Overall Study|Disease Progression|0|||
23584648|NCT02499328|65869236|FG000|Overall Study|Adverse Event|1|||
23584649|NCT02499328|65869237|FG001|Overall Study|Adverse Event|0|||
23584650|NCT02499328|65869238|FG002|Overall Study|Adverse Event|0|||
23584651|NCT02499328|65869239|FG003|Overall Study|Adverse Event|1|||
23584652|NCT02499328|65869240|FG004|Overall Study|Adverse Event|0|||
23584653|NCT02499328|65869241|FG005|Overall Study|Adverse Event|0|||
23584654|NCT02499328|65869242|FG006|Overall Study|Adverse Event|0|||
23584655|NCT02499328|65869243|FG007|Overall Study|Adverse Event|0|||
23182711|NCT01309737|64409261|FG002|Week 16 to 52|Withdrawal by Subject|0|||
23182712|NCT01309737|64409262|FG003|Week 16 to 52|Withdrawal by Subject|0|||
23182713|NCT01309737|64409263|FG004|Week 16 to 52|Withdrawal by Subject|2|||
23182714|NCT01309737|64409259|FG000|Week 16 to 52|Other|10|||
23182715|NCT01309737|64409260|FG001|Week 16 to 52|Other|12|||
23241864|NCT01195662|64629694|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
23182716|NCT01309737|64409261|FG002|Week 16 to 52|Other|0|||
23182717|NCT01309737|64409262|FG003|Week 16 to 52|Other|2|||
23182718|NCT01309737|64409263|FG004|Week 16 to 52|Other|0|||
23182719|NCT02970929|64409265|FG000|Overall Study|Adverse Event|18|||
23584656|NCT02499328|65869244|FG008|Overall Study|Adverse Event|0|||
23182720|NCT02970929|64409265|FG000|Overall Study|Lack of Efficacy|8|||
23182721|NCT02970929|64409265|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
23182722|NCT02970929|64409265|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
23584657|NCT02499328|65869245|FG009|Overall Study|Adverse Event|0|||
23584658|NCT02499328|65869246|FG010|Overall Study|Adverse Event|0|||
23584659|NCT02499328|65869247|FG011|Overall Study|Adverse Event|0|||
23584660|NCT02499328|65869248|FG012|Overall Study|Adverse Event|1|||
23584661|NCT02499328|65869249|FG013|Overall Study|Adverse Event|0|||
23584662|NCT02499328|65869250|FG014|Overall Study|Adverse Event|0|||
23584663|NCT02499328|65869251|FG015|Overall Study|Adverse Event|0|||
23182723|NCT02970929|64409265|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
23182724|NCT02970929|64409265|FG000|Overall Study|LOST TO FOLLOWUP|6|||
23182725|NCT02970929|64409265|FG000|Overall Study|MOVED OUT OF STATE|1|||
23182726|NCT02970929|64409265|FG000|Overall Study|Withdrawal by Subject|16|||
23182727|NCT01859403|64409266|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
23182728|NCT01859403|64409267|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
23182729|NCT01859403|64409266|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
23182730|NCT01859403|64409267|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
23182731|NCT01859403|64409266|FG000|Primary Endpoint Measure|Physician Decision|0|||
23182732|NCT01859403|64409267|FG001|Primary Endpoint Measure|Physician Decision|1|||
23182733|NCT01859403|64409266|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
23182734|NCT01859403|64409267|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
23182735|NCT01128387|64409270|FG000|Overall Study|Physician Decision|0|||
23182736|NCT01128387|64409271|FG001|Overall Study|Physician Decision|1|||
23182737|NCT02945657|64409275|FG000|Overall Study|Adverse Event|1|||
23461098|NCT01198795|65434779|FG000|Overall Study|Adverse Event|9|||
23461099|NCT01198795|65434779|FG000|Overall Study|Lack of Efficacy|5|||
23461100|NCT01198795|65434779|FG000|Overall Study|Protocol Violation|2|||
23461101|NCT01198795|65434779|FG000|Overall Study|Other Reason|4|||
23461102|NCT03558737|65434780|FG000|Overall Study|Death|1|||
23461103|NCT03558737|65434781|FG001|Overall Study|Death|1|||
23461104|NCT00744497|65434782|FG000|Overall Study|Withdrawal by Subject|21|||
23461105|NCT00744497|65434783|FG001|Overall Study|Withdrawal by Subject|18|||
23461106|NCT00744497|65434782|FG000|Overall Study|Death|11|||
23461107|NCT00744497|65434783|FG001|Overall Study|Death|9|||
23461108|NCT00744497|65434782|FG000|Overall Study|Lost to Follow-up|4|||
23461109|NCT00744497|65434783|FG001|Overall Study|Lost to Follow-up|2|||
23461110|NCT00744497|65434782|FG000|Overall Study|Poor compliance/noncompliance|9|||
23461111|NCT00744497|65434783|FG001|Overall Study|Poor compliance/noncompliance|5|||
23461112|NCT00744497|65434782|FG000|Overall Study|No longer meets study criteria|7|||
23461113|NCT00744497|65434783|FG001|Overall Study|No longer meets study criteria|3|||
23461114|NCT00744497|65434782|FG000|Overall Study|Administrative Reason By Sponsor|25|||
23461115|NCT00744497|65434783|FG001|Overall Study|Administrative Reason By Sponsor|8|||
23461116|NCT00744497|65434782|FG000|Overall Study|Disease progression|312|||
23461117|NCT00744497|65434783|FG001|Overall Study|Disease progression|219|||
23461118|NCT00744497|65434782|FG000|Overall Study|Study drug toxicity|68|||
23461119|NCT00744497|65434783|FG001|Overall Study|Study drug toxicity|141|||
23461120|NCT00744497|65434782|FG000|Overall Study|Adverse event unrelated to study drug|78|||
23461121|NCT00744497|65434783|FG001|Overall Study|Adverse event unrelated to study drug|122|||
23584664|NCT02499328|65869252|FG016|Overall Study|Adverse Event|0|||
23182738|NCT02945657|64409275|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
23182739|NCT00768222|64409276|FG000|Overall Study|Lost to Follow-up|1|||
23182740|NCT00768222|64409277|FG001|Overall Study|Lost to Follow-up|1|||
23182741|NCT00768222|64409276|FG000|Overall Study|Withdrawal by Subject|3|||
23182742|NCT00768222|64409277|FG001|Overall Study|Withdrawal by Subject|1|||
23182743|NCT00768222|64409276|FG000|Overall Study|Protocol Violation|0|||
23182744|NCT00768222|64409277|FG001|Overall Study|Protocol Violation|2|||
23182745|NCT01111604|64409278|FG000|Overall Study|Lost to Follow-up|0|||
23182746|NCT01111604|64409279|FG001|Overall Study|Lost to Follow-up|0|||
23182747|NCT01111604|64409280|FG002|Overall Study|Lost to Follow-up|1|||
23182748|NCT01111604|64409278|FG000|Overall Study|Withdrew Consent|3|||
23182749|NCT01111604|64409279|FG001|Overall Study|Withdrew Consent|0|||
23182750|NCT01111604|64409280|FG002|Overall Study|Withdrew Consent|2|||
23182751|NCT01111604|64409278|FG000|Overall Study|Withdrawal by Subject|2|||
23182752|NCT01111604|64409279|FG001|Overall Study|Withdrawal by Subject|0|||
23182753|NCT01111604|64409280|FG002|Overall Study|Withdrawal by Subject|0|||
23182754|NCT01111604|64409278|FG000|Overall Study|Death|1|||
23241865|NCT01195662|64629695|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
23241866|NCT01195662|64629693|FG000|Double Blind Treatment Period|Administrative reason|2|||
23241867|NCT01195662|64629694|FG001|Double Blind Treatment Period|Administrative reason|1|||
23241868|NCT01195662|64629695|FG002|Double Blind Treatment Period|Administrative reason|1|||
23584665|NCT02499328|65869253|FG017|Overall Study|Adverse Event|0|||
23584666|NCT02499328|65869254|FG018|Overall Study|Adverse Event|0|||
23182755|NCT01111604|64409279|FG001|Overall Study|Death|0|||
23182756|NCT01111604|64409280|FG002|Overall Study|Death|0|||
23182757|NCT01111604|64409278|FG000|Overall Study|Met Exclusion Criteria|2|||
23241869|NCT01195662|64629693|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
23461122|NCT00744497|65434782|FG000|Overall Study|Patient requested to stop study drug|65|||
23584667|NCT00975806|65869255|FG000|Overall Study|Adverse Event|2|||
23241870|NCT01195662|64629694|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
23241871|NCT01195662|64629695|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
23241872|NCT01195662|64629693|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
23241873|NCT01195662|64629694|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
23241874|NCT01195662|64629695|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
23241875|NCT01195662|64629693|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
23241876|NCT01195662|64629694|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
23241877|NCT01195662|64629695|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
23241878|NCT01195662|64629693|FG000|Double Blind Treatment Period|Non-specified|3|||
23241879|NCT01195662|64629694|FG001|Double Blind Treatment Period|Non-specified|0|||
23182758|NCT01111604|64409279|FG001|Overall Study|Met Exclusion Criteria|0|||
23241880|NCT01195662|64629695|FG002|Double Blind Treatment Period|Non-specified|0|||
23241881|NCT01195662|64629693|FG000|Double Blind Treatment Period|Missing disposition information|0|||
23241882|NCT01195662|64629694|FG001|Double Blind Treatment Period|Missing disposition information|1|||
23241883|NCT01195662|64629695|FG002|Double Blind Treatment Period|Missing disposition information|1|||
23241884|NCT01195662|64629693|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
23241885|NCT01195662|64629694|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
23241886|NCT01195662|64629695|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
23241887|NCT01195662|64629693|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
23241888|NCT01195662|64629694|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
23241889|NCT01195662|64629695|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
23241890|NCT01891669|64629696|FG000|Overall Study|Death|0|||
23241891|NCT01891669|64629697|FG001|Overall Study|Death|0|||
23241892|NCT01891669|64629698|FG002|Overall Study|Death|0|||
23241893|NCT01891669|64629699|FG003|Overall Study|Death|0|||
23241894|NCT01891669|64629700|FG004|Overall Study|Death|0|||
23241895|NCT01891669|64629701|FG005|Overall Study|Death|0|||
23241896|NCT01891669|64629702|FG006|Overall Study|Death|0|||
23241897|NCT01891669|64629703|FG007|Overall Study|Death|1|||
23241898|NCT01891669|64629704|FG008|Overall Study|Death|0|||
23241899|NCT01891669|64629705|FG009|Overall Study|Death|1|||
23241900|NCT01891669|64629696|FG000|Overall Study|Withdrawal by Subject|1|||
23241901|NCT01891669|64629697|FG001|Overall Study|Withdrawal by Subject|1|||
23349535|NCT01877382|65021899|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349536|NCT01877382|65021900|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349537|NCT01877382|65021901|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349538|NCT01877382|65021902|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349539|NCT01877382|65021903|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349540|NCT01877382|65021904|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349541|NCT01877382|65021905|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349542|NCT01877382|65021906|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349543|NCT01877382|65021907|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349544|NCT01877382|65021908|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349545|NCT01877382|65021909|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349546|NCT01877382|65021910|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349547|NCT01877382|65021911|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349548|NCT01877382|65021912|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
23349549|NCT01877382|65021913|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
23349550|NCT01712334|65021914|FG000|Treatment Period 1|Randomized in Error|0|||
23349551|NCT01712334|65021915|FG001|Treatment Period 1|Randomized in Error|2|||
23182759|NCT01111604|64409280|FG002|Overall Study|Met Exclusion Criteria|0|||
23182760|NCT00275561|64409281|FG000|Overall Study|Withdrawal by Subject|0|||
23182761|NCT00275561|64409282|FG001|Overall Study|Withdrawal by Subject|1|||
23182762|NCT00275561|64409281|FG000|Overall Study|Travel|1|||
23182763|NCT00275561|64409282|FG001|Overall Study|Travel|1|||
23182764|NCT00275561|64409281|FG000|Overall Study|Scheduling|1|||
23182765|NCT00275561|64409282|FG001|Overall Study|Scheduling|2|||
23182766|NCT00275561|64409281|FG000|Overall Study|Family Issues|0|||
23182767|NCT00275561|64409282|FG001|Overall Study|Family Issues|2|||
23182768|NCT01499290|64409285|FG000|Overall Study|Withdrawal by Subject|22|||
23241902|NCT01891669|64629698|FG002|Overall Study|Withdrawal by Subject|0|||
23241903|NCT01891669|64629699|FG003|Overall Study|Withdrawal by Subject|0|||
23349552|NCT02655419|65021916|FG000|Overall Study|Enrolled but not treated|1|||
23349553|NCT02655419|65021917|FG001|Overall Study|Enrolled but not treated|5|||
23182769|NCT01499290|64409286|FG001|Overall Study|Withdrawal by Subject|15|||
23182770|NCT01499290|64409285|FG000|Overall Study|Not specified in study report|11|||
23182771|NCT01499290|64409286|FG001|Overall Study|Not specified in study report|5|||
23241904|NCT01891669|64629700|FG004|Overall Study|Withdrawal by Subject|0|||
23461123|NCT00744497|65434783|FG001|Overall Study|Patient requested to stop study drug|80|||
23461124|NCT00744497|65434782|FG000|Overall Study|Maximum clinical benefit|141|||
23461125|NCT00744497|65434783|FG001|Overall Study|Maximum clinical benefit|142|||
23461126|NCT00744497|65434782|FG000|Overall Study|Not defined|19|||
23461127|NCT00744497|65434783|FG001|Overall Study|Not defined|13|||
23461128|NCT01457703|65434796|FG000|Overall Study|Screen Failure|5|||
23461129|NCT01457703|65434797|FG001|Overall Study|Screen Failure|7|||
23461130|NCT01457703|65434796|FG000|Overall Study|Withdrawal by Subject|1|||
23461131|NCT01457703|65434797|FG001|Overall Study|Withdrawal by Subject|4|||
23461132|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
23461133|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
23461134|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
23461135|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
23461136|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
23461137|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
23461138|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
23461139|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
23461140|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
23461141|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
23461142|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
23461143|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
23461144|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
23461145|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
23461146|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
23461147|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
23461148|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
23461149|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
23461150|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
23461151|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
23461152|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
23461153|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
23461154|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
23461155|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
23461156|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
23461157|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
23461158|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
23461159|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
23461160|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461161|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461162|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461163|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461164|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461165|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461166|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
23461167|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461168|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461169|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461170|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461171|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461172|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461173|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
23461174|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Transplant|0|||
23461175|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Transplant|1|||
23461176|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Transplant|0|||
23461177|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Transplant|0|||
23461178|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Transplant|0|||
23461179|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Transplant|1|||
23461180|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Transplant|0|||
23461181|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Transplant|0|||
23461182|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Transplant|0|||
23461183|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Transplant|0|||
23461184|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Transplant|0|||
23461185|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Transplant|0|||
23461186|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Transplant|0|||
23461187|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Transplant|0|||
23461188|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
23461189|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
23241905|NCT01891669|64629701|FG005|Overall Study|Withdrawal by Subject|0|||
23461190|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
23461191|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
23461192|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
23461193|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
23461194|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
23461195|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
23461196|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
23461197|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
23461198|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
23461199|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
23461200|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
23461201|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
23461202|NCT02113982|65434801|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
23461203|NCT02113982|65434802|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
23461204|NCT02113982|65434803|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
23461205|NCT02113982|65434804|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
23461206|NCT02113982|65434805|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
23461207|NCT02113982|65434806|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
23461208|NCT02113982|65434807|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
23461209|NCT02113982|65434808|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
23461210|NCT02113982|65434809|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
23461211|NCT02113982|65434810|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
23461212|NCT02113982|65434811|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
23461213|NCT02113982|65434812|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
23461214|NCT02113982|65434813|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
23461215|NCT02113982|65434814|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
23461216|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
23461217|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
23461218|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
23461219|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
23461220|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
23461221|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
23461222|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
23461223|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
23461224|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
23461225|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
23461226|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
23461227|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
23461228|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
23461229|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
23461230|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
23461231|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
23461232|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
23461233|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
23461234|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
23461235|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
23241906|NCT01891669|64629702|FG006|Overall Study|Withdrawal by Subject|1|||
23241907|NCT01891669|64629703|FG007|Overall Study|Withdrawal by Subject|2|||
23241908|NCT01891669|64629704|FG008|Overall Study|Withdrawal by Subject|1|||
23241909|NCT01891669|64629705|FG009|Overall Study|Withdrawal by Subject|1|||
23241910|NCT01891669|64629696|FG000|Overall Study|Other|1|||
23241911|NCT01891669|64629697|FG001|Overall Study|Other|0|||
23461236|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
23461237|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
23461238|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
23461239|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
23461240|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
23461241|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
23461242|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
23461243|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
23461244|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
23584668|NCT00975806|65869256|FG001|Overall Study|Adverse Event|1|||
23241912|NCT01891669|64629698|FG002|Overall Study|Other|0|||
23241913|NCT01891669|64629699|FG003|Overall Study|Other|0|||
23584669|NCT00975806|65869257|FG002|Overall Study|Adverse Event|2|||
23584670|NCT00975806|65869255|FG000|Overall Study|Disease Progression|1|||
23241914|NCT01891669|64629700|FG004|Overall Study|Other|0|||
23241915|NCT01891669|64629701|FG005|Overall Study|Other|0|||
23461245|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461246|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461247|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461248|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461249|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461250|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461251|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
23241916|NCT01891669|64629702|FG006|Overall Study|Other|0|||
23241917|NCT01891669|64629703|FG007|Overall Study|Other|1|||
23241918|NCT01891669|64629704|FG008|Overall Study|Other|0|||
23241919|NCT01891669|64629705|FG009|Overall Study|Other|0|||
23461252|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461253|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
23461254|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
23461255|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461256|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461257|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
23461258|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461259|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461260|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461261|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23584671|NCT00975806|65869256|FG001|Overall Study|Disease Progression|5|||
23584672|NCT00975806|65869257|FG002|Overall Study|Disease Progression|1|||
23241920|NCT00494234|64629707|FG000|Overall Study|Withdrawal by Subject|1|||
23241921|NCT00494234|64629708|FG001|Overall Study|Withdrawal by Subject|0|||
23241922|NCT00494234|64629707|FG000|Overall Study|Disease progression|11|||
23241923|NCT00494234|64629708|FG001|Overall Study|Disease progression|8|||
23241924|NCT00494234|64629707|FG000|Overall Study|Death|2|||
23241925|NCT00494234|64629708|FG001|Overall Study|Death|1|||
23241926|NCT02513732|64629709|FG000|Overall Study|Lost to Follow-up|11|||
23241927|NCT02513732|64629709|FG000|Overall Study|Death|9|||
23241928|NCT02513732|64629709|FG000|Overall Study|Changing hospital|2|||
23241929|NCT00814502|64629710|FG000|Overall Study|Adverse Event|1|||
23349554|NCT02655419|65021916|FG000|Overall Study|Withdrawal by Subject|4|||
23349555|NCT02655419|65021917|FG001|Overall Study|Withdrawal by Subject|1|||
23349556|NCT02655419|65021916|FG000|Overall Study|Other|0|||
23241930|NCT00814502|64629711|FG001|Overall Study|Adverse Event|0|||
23241931|NCT00814502|64629710|FG000|Overall Study|Withdrawal by Subject|0|||
23241932|NCT00814502|64629711|FG001|Overall Study|Withdrawal by Subject|2|||
23241933|NCT04478994|64632813|FG000|Overall Study|Withdrawal by Subject|1|||
23349557|NCT02655419|65021917|FG001|Overall Study|Other|1|||
23241934|NCT04478994|64632814|FG001|Overall Study|Withdrawal by Subject|1|||
23241935|NCT00924313|64632815|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
23402706|NCT03289143|65219984|FG001|Overall Study|Study Terminated By Sponsor|75|||
23402707|NCT03289143|65219985|FG002|Overall Study|Study Terminated By Sponsor|100|||
23402708|NCT03289143|65219986|FG003|Overall Study|Study Terminated By Sponsor|69|||
23402709|NCT03289143|65219983|FG000|Overall Study|Withdrawal by Subject|14|||
23402710|NCT03289143|65219984|FG001|Overall Study|Withdrawal by Subject|6|||
23402711|NCT03289143|65219985|FG002|Overall Study|Withdrawal by Subject|14|||
23402712|NCT03289143|65219986|FG003|Overall Study|Withdrawal by Subject|12|||
23402713|NCT03289143|65219983|FG000|Overall Study|Adverse Event|10|||
23402714|NCT03289143|65219984|FG001|Overall Study|Adverse Event|7|||
23402715|NCT03289143|65219985|FG002|Overall Study|Adverse Event|6|||
23402716|NCT03289143|65219986|FG003|Overall Study|Adverse Event|5|||
23402717|NCT03289143|65219983|FG000|Overall Study|Death|2|||
23402718|NCT03289143|65219984|FG001|Overall Study|Death|0|||
23402719|NCT03289143|65219985|FG002|Overall Study|Death|2|||
23402720|NCT03289143|65219986|FG003|Overall Study|Death|1|||
23402721|NCT03289143|65219983|FG000|Overall Study|Lost to Follow-up|2|||
23402722|NCT03289143|65219984|FG001|Overall Study|Lost to Follow-up|1|||
23402723|NCT03289143|65219985|FG002|Overall Study|Lost to Follow-up|1|||
23402724|NCT03289143|65219986|FG003|Overall Study|Lost to Follow-up|0|||
23402725|NCT03289143|65219983|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
23402726|NCT03289143|65219984|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
23402727|NCT03289143|65219985|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
23402728|NCT03289143|65219986|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
23402729|NCT03289143|65219983|FG000|Overall Study|Withdrawal by Caregiver|0|||
23402730|NCT03289143|65219984|FG001|Overall Study|Withdrawal by Caregiver|1|||
23402731|NCT03289143|65219985|FG002|Overall Study|Withdrawal by Caregiver|0|||
23402732|NCT03289143|65219986|FG003|Overall Study|Withdrawal by Caregiver|0|||
23402733|NCT03289143|65219983|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
23402734|NCT03289143|65219984|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
23402735|NCT03289143|65219985|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
23402736|NCT03289143|65219986|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
23402737|NCT03289143|65219983|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
23402738|NCT03289143|65219984|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
23402739|NCT03289143|65219985|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
23402740|NCT03289143|65219986|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
23402741|NCT01724216|65219987|FG000|Overall Study|Scan was not completed|1|||
23402742|NCT01459666|65219989|FG000|Overall Study|PI left institution|5|||
23402743|NCT01459666|65219990|FG001|Overall Study|PI left institution|4|||
23402744|NCT03745768|65219991|FG000|Overall Study|discontinued study|2|||
23402745|NCT03745768|65219992|FG001|Overall Study|discontinued study|0|||
23402746|NCT01669902|65219993|FG000|Overall Study|Adverse Event|11|||
23349558|NCT02612610|65025241|FG000|Overall Study|Withdrawal by Subject|1|||
23349559|NCT02612610|65025242|FG001|Overall Study|Withdrawal by Subject|1|||
23349560|NCT02612610|65025243|FG002|Overall Study|Withdrawal by Subject|0|||
23349561|NCT02612610|65025244|FG003|Overall Study|Withdrawal by Subject|2|||
23349562|NCT02612610|65025241|FG000|Overall Study|Adverse Event|2|||
23349563|NCT02612610|65025242|FG001|Overall Study|Adverse Event|2|||
23461262|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461263|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461264|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461265|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
23461266|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461267|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
23461268|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461269|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461270|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461271|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
23461272|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461273|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461274|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461275|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461276|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461277|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461278|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461279|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
23461280|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461281|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461282|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461283|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461284|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461285|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
23461286|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Transplant|0|||
23461287|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Transplant|0|||
23461288|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Transplant|0|||
23461289|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Transplant|0|||
23461290|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Transplant|0|||
23461291|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Transplant|0|||
23461292|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Transplant|0|||
23584673|NCT00975806|65869255|FG000|Overall Study|Withdrawal by Subject|1|||
23584674|NCT00975806|65869256|FG001|Overall Study|Withdrawal by Subject|0|||
23182772|NCT01499290|64409285|FG000|Overall Study|Condition improved/subject recovered|1|||
23182773|NCT01499290|64409286|FG001|Overall Study|Condition improved/subject recovered|0|||
23182774|NCT01499290|64409285|FG000|Overall Study|Lack of Efficacy|7|||
23182775|NCT01499290|64409286|FG001|Overall Study|Lack of Efficacy|8|||
23182776|NCT01499290|64409285|FG000|Overall Study|Adverse Event|14|||
23182777|NCT01499290|64409286|FG001|Overall Study|Adverse Event|7|||
23182778|NCT02370121|64409296|FG000|Overall Study|Lost to Follow-up|1|||
23182779|NCT02370121|64409297|FG001|Overall Study|Lost to Follow-up|1|||
23182780|NCT03244059|64409298|FG000|Specific Aim 1|Physician Decision|1|||
23182781|NCT03244059|64409299|FG001|Specific Aim 1|Physician Decision|0|||
23182782|NCT03244059|64409298|FG000|Specific Aim 2|Physician Decision|1|||
23182783|NCT03244059|64409299|FG001|Specific Aim 2|Physician Decision|0|||
23182784|NCT01427309|64409300|FG000|Overall Study|Lost to Follow-up|130|||
23182785|NCT01427309|64409301|FG001|Overall Study|Lost to Follow-up|145|||
23182786|NCT01427309|64409302|FG002|Overall Study|Lost to Follow-up|122|||
23182787|NCT01427309|64409303|FG003|Overall Study|Lost to Follow-up|135|||
23182788|NCT01427309|64409300|FG000|Overall Study|Protocol Violation|42|||
23182789|NCT01427309|64409301|FG001|Overall Study|Protocol Violation|69|||
23182790|NCT01427309|64409302|FG002|Overall Study|Protocol Violation|125|||
23182791|NCT01427309|64409303|FG003|Overall Study|Protocol Violation|124|||
23182792|NCT01427309|64409300|FG000|Overall Study|Adverse Event|0|||
23182793|NCT01427309|64409301|FG001|Overall Study|Adverse Event|0|||
23182794|NCT01427309|64409302|FG002|Overall Study|Adverse Event|3|||
23182795|NCT01427309|64409303|FG003|Overall Study|Adverse Event|1|||
23182796|NCT01427309|64409300|FG000|Overall Study|Serious adverse event|52|||
23182797|NCT01427309|64409301|FG001|Overall Study|Serious adverse event|45|||
23349564|NCT02612610|65025243|FG002|Overall Study|Adverse Event|3|||
23584675|NCT00975806|65869257|FG002|Overall Study|Withdrawal by Subject|0|||
23461293|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Transplant|0|||
23461294|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Transplant|0|||
23182798|NCT01427309|64409302|FG002|Overall Study|Serious adverse event|50|||
23182799|NCT01427309|64409303|FG003|Overall Study|Serious adverse event|61|||
23182800|NCT01427309|64409300|FG000|Overall Study|Withdrawal by Subject|148|||
23182801|NCT01427309|64409301|FG001|Overall Study|Withdrawal by Subject|148|||
23182802|NCT01427309|64409302|FG002|Overall Study|Withdrawal by Subject|61|||
23182803|NCT01427309|64409303|FG003|Overall Study|Withdrawal by Subject|55|||
23241936|NCT00877799|64632816|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
23241937|NCT00877799|64632817|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
23241938|NCT00877799|64632818|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
23241939|NCT00877799|64632819|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
23349565|NCT02612610|65025244|FG003|Overall Study|Adverse Event|10|||
23349566|NCT02612610|65025241|FG000|Overall Study|Lost to Follow-up|0|||
23349567|NCT02612610|65025242|FG001|Overall Study|Lost to Follow-up|1|||
23349568|NCT02612610|65025243|FG002|Overall Study|Lost to Follow-up|0|||
23182804|NCT02928952|64409308|FG000|Overall Study|Lost to Follow-up|5|||
23182805|NCT02928952|64409309|FG001|Overall Study|Lost to Follow-up|5|||
23182806|NCT02928952|64409308|FG000|Overall Study|Withdrawal by Subject|5|||
23182807|NCT02928952|64409309|FG001|Overall Study|Withdrawal by Subject|1|||
23182808|NCT02928952|64409308|FG000|Overall Study|Physician Decision|0|||
23182809|NCT02928952|64409309|FG001|Overall Study|Physician Decision|1|||
23182810|NCT01264939|64409310|FG000|Overall Study|Adverse Event|1|||
23182811|NCT01264939|64409311|FG001|Overall Study|Adverse Event|3|||
23182812|NCT01264939|64409310|FG000|Overall Study|Lost to Follow-up|0|||
23182813|NCT01264939|64409311|FG001|Overall Study|Lost to Follow-up|3|||
23182814|NCT01264939|64409310|FG000|Overall Study|Physician Decision|1|||
23182815|NCT01264939|64409311|FG001|Overall Study|Physician Decision|1|||
23182816|NCT01264939|64409310|FG000|Overall Study|Patient/Guardian Decision|8|||
23182817|NCT01264939|64409311|FG001|Overall Study|Patient/Guardian Decision|10|||
23182818|NCT01264939|64409310|FG000|Overall Study|Disease Progression|8|||
23182819|NCT01264939|64409311|FG001|Overall Study|Disease Progression|11|||
23182820|NCT00712348|64409312|FG000|Overall Study|Withdrawal by Subject|1|||
23182821|NCT01157117|64409315|FG000|Overall Study|Dosing Symptoms|0|||
23182822|NCT01157117|64409316|FG001|Overall Study|Dosing Symptoms|4|||
23182823|NCT01157117|64409317|FG002|Overall Study|Dosing Symptoms|0|||
23182824|NCT01157117|64409315|FG000|Overall Study|Withdrawal by Subject|4|||
23182825|NCT01157117|64409316|FG001|Overall Study|Withdrawal by Subject|1|||
23182826|NCT01157117|64409317|FG002|Overall Study|Withdrawal by Subject|1|||
23182827|NCT01157117|64409315|FG000|Overall Study|Lack of Efficacy|1|||
23182828|NCT01157117|64409316|FG001|Overall Study|Lack of Efficacy|1|||
23182829|NCT01157117|64409317|FG002|Overall Study|Lack of Efficacy|0|||
23182830|NCT01157117|64409315|FG000|Overall Study|Lost to Follow-up|0|||
23182831|NCT01157117|64409316|FG001|Overall Study|Lost to Follow-up|0|||
23182832|NCT01157117|64409317|FG002|Overall Study|Lost to Follow-up|1|||
23182833|NCT01157117|64409315|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
23182834|NCT01157117|64409316|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
23182835|NCT01157117|64409317|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
23182836|NCT01802281|64409324|FG000|Overall Study|Death|1|||
23182837|NCT01802281|64409325|FG001|Overall Study|Death|2|||
23182838|NCT01802281|64409324|FG000|Overall Study|Withdrawal by Subject|2|||
23182839|NCT01802281|64409325|FG001|Overall Study|Withdrawal by Subject|1|||
23182840|NCT01802281|64409324|FG000|Overall Study|Ineligible|5|||
23182841|NCT01802281|64409325|FG001|Overall Study|Ineligible|3|||
23182842|NCT00828451|64409331|FG000|Overall Study|Death|2|||
23182843|NCT00828451|64409331|FG000|Overall Study|Lack of intravenous line|7|||
23182844|NCT00828451|64409331|FG000|Overall Study|Withdrawal by Subject|1|||
23182845|NCT00828451|64409331|FG000|Overall Study|Deterioration in clinical status|1|||
23182846|NCT00960076|64409332|FG000|Overall Study|Adverse Event|1|||
23182847|NCT00960076|64409333|FG001|Overall Study|Adverse Event|7|||
23182848|NCT00960076|64409332|FG000|Overall Study|No longer met study criteria|1|||
23182849|NCT00960076|64409333|FG001|Overall Study|No longer met study criteria|5|||
23349569|NCT02612610|65025244|FG003|Overall Study|Lost to Follow-up|0|||
23349570|NCT02612610|65025241|FG000|Overall Study|Protocol Violation|0|||
23182850|NCT00960076|64409332|FG000|Overall Study|Withdrawal by Subject|1|||
23182851|NCT00960076|64409333|FG001|Overall Study|Withdrawal by Subject|2|||
23182852|NCT00960076|64409332|FG000|Overall Study|Lost to Follow-up|3|||
23349571|NCT02612610|65025242|FG001|Overall Study|Protocol Violation|1|||
23349572|NCT02612610|65025243|FG002|Overall Study|Protocol Violation|1|||
23349573|NCT02612610|65025244|FG003|Overall Study|Protocol Violation|0|||
23349574|NCT02612610|65025241|FG000|Overall Study|Lack of Efficacy|1|||
23349575|NCT02612610|65025242|FG001|Overall Study|Lack of Efficacy|2|||
23349576|NCT02612610|65025243|FG002|Overall Study|Lack of Efficacy|0|||
23349577|NCT02612610|65025244|FG003|Overall Study|Lack of Efficacy|1|||
23349578|NCT02612610|65025241|FG000|Overall Study|Physician Decision|0|||
23349579|NCT02612610|65025242|FG001|Overall Study|Physician Decision|1|||
23349580|NCT02612610|65025243|FG002|Overall Study|Physician Decision|0|||
23182853|NCT00960076|64409333|FG001|Overall Study|Lost to Follow-up|3|||
23241940|NCT00877799|64632820|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
23241941|NCT00877799|64632816|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
23241942|NCT00877799|64632817|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
23349581|NCT02612610|65025244|FG003|Overall Study|Physician Decision|0|||
23182854|NCT00960076|64409332|FG000|Overall Study|Severe non-compliance to protocol|1|||
23182855|NCT00960076|64409333|FG001|Overall Study|Severe non-compliance to protocol|2|||
23182856|NCT00960076|64409332|FG000|Overall Study|Hyperglycemia|1|||
23182857|NCT00960076|64409333|FG001|Overall Study|Hyperglycemia|5|||
23182858|NCT00960076|64409332|FG000|Overall Study|Did not attend the termination visit|0|||
23182859|NCT00960076|64409333|FG001|Overall Study|Did not attend the termination visit|1|||
23182860|NCT00609622|64409334|FG000|Overall Study|Adverse Event|14|||
23182861|NCT00609622|64409335|FG001|Overall Study|Adverse Event|10|||
23182862|NCT00609622|64409334|FG000|Overall Study|Withdrawal by Subject|4|||
23182863|NCT00609622|64409335|FG001|Overall Study|Withdrawal by Subject|20|||
23182864|NCT00609622|64409334|FG000|Overall Study|Death|1|||
23182865|NCT00609622|64409335|FG001|Overall Study|Death|4|||
23182866|NCT00609622|64409334|FG000|Overall Study|Protocol Violation|1|||
23182867|NCT00609622|64409335|FG001|Overall Study|Protocol Violation|1|||
23182868|NCT00609622|64409334|FG000|Overall Study|Objective progression or relapse|47|||
23182869|NCT00609622|64409335|FG001|Overall Study|Objective progression or relapse|41|||
23182870|NCT00609622|64409334|FG000|Overall Study|Study terminated by sponsor|16|||
23182871|NCT00609622|64409335|FG001|Overall Study|Study terminated by sponsor|3|||
23182872|NCT00609622|64409334|FG000|Overall Study|Other|7|||
23182873|NCT00609622|64409335|FG001|Overall Study|Other|14|||
23182874|NCT00609622|64409334|FG000|Overall Study|Global deterioration of health status|6|||
23241943|NCT00877799|64632818|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
23241944|NCT00877799|64632819|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
23241945|NCT00877799|64632820|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
23241946|NCT00877799|64632816|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
23241947|NCT00877799|64632817|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
23241948|NCT00877799|64632818|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
23241949|NCT00877799|64632819|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
23349582|NCT02612610|65025241|FG000|Overall Study|Noncompliance|1|||
23349583|NCT02612610|65025242|FG001|Overall Study|Noncompliance|0|||
23349584|NCT02612610|65025243|FG002|Overall Study|Noncompliance|0|||
23349585|NCT02612610|65025244|FG003|Overall Study|Noncompliance|0|||
23349586|NCT02612610|65025241|FG000|Overall Study|Cough Improvement|0|||
23349587|NCT02612610|65025242|FG001|Overall Study|Cough Improvement|0|||
23349588|NCT02612610|65025243|FG002|Overall Study|Cough Improvement|1|||
23349589|NCT02612610|65025244|FG003|Overall Study|Cough Improvement|0|||
23349590|NCT00738062|65025245|FG000|Open Label Treatment|Lack of Efficacy|5|||
23349591|NCT00738062|65025246|FG001|Open Label Treatment|Lack of Efficacy|0|||
23349592|NCT00738062|65025247|FG002|Open Label Treatment|Lack of Efficacy|0|||
23349593|NCT00738062|65025245|FG000|Open Label Treatment|Adverse Event|11|||
23349594|NCT00738062|65025246|FG001|Open Label Treatment|Adverse Event|0|||
23349595|NCT00738062|65025247|FG002|Open Label Treatment|Adverse Event|0|||
23349596|NCT00738062|65025245|FG000|Open Label Treatment|Protocol Violation|2|||
23349597|NCT00738062|65025246|FG001|Open Label Treatment|Protocol Violation|0|||
23349598|NCT00738062|65025247|FG002|Open Label Treatment|Protocol Violation|0|||
23349599|NCT00738062|65025245|FG000|Open Label Treatment|Withdrawal by Subject|9|||
23349600|NCT00738062|65025246|FG001|Open Label Treatment|Withdrawal by Subject|0|||
23349601|NCT00738062|65025247|FG002|Open Label Treatment|Withdrawal by Subject|0|||
23349602|NCT00738062|65025245|FG000|Open Label Treatment|Investigator Decision|1|||
23349603|NCT00738062|65025246|FG001|Open Label Treatment|Investigator Decision|0|||
23349604|NCT00738062|65025247|FG002|Open Label Treatment|Investigator Decision|0|||
23349605|NCT00738062|65025245|FG000|Open-Label Extension|Adverse Event|5|||
23349606|NCT00738062|65025246|FG001|Open-Label Extension|Adverse Event|0|||
23349607|NCT00738062|65025247|FG002|Open-Label Extension|Adverse Event|0|||
23349608|NCT00738062|65025245|FG000|Open-Label Extension|Physician Decision|1|||
23349609|NCT00738062|65025246|FG001|Open-Label Extension|Physician Decision|0|||
23349610|NCT00738062|65025247|FG002|Open-Label Extension|Physician Decision|0|||
23349611|NCT00738062|65025245|FG000|Open-Label Extension|Lack of Efficacy|2|||
23349612|NCT00738062|65025246|FG001|Open-Label Extension|Lack of Efficacy|0|||
23349613|NCT00738062|65025247|FG002|Open-Label Extension|Lack of Efficacy|0|||
23349614|NCT00738062|65025245|FG000|Open-Label Extension|Withdrawal by Subject|6|||
23349615|NCT00738062|65025246|FG001|Open-Label Extension|Withdrawal by Subject|0|||
23349616|NCT00738062|65025247|FG002|Open-Label Extension|Withdrawal by Subject|0|||
23349617|NCT00738062|65025245|FG000|Open-Label Extension|Protocol Violation|1|||
23349618|NCT00738062|65025246|FG001|Open-Label Extension|Protocol Violation|0|||
23349619|NCT00738062|65025247|FG002|Open-Label Extension|Protocol Violation|0|||
23182875|NCT00609622|64409335|FG001|Overall Study|Global deterioration of health status|2|||
23241950|NCT00877799|64632820|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
23349620|NCT00738062|65025245|FG000|Open-Label Extension|Study Terminated|2|||
23349621|NCT00738062|65025246|FG001|Open-Label Extension|Study Terminated|0|||
23349622|NCT00738062|65025247|FG002|Open-Label Extension|Study Terminated|0|||
23349623|NCT01752634|65025250|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
23349624|NCT01752634|65025251|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
23241951|NCT00877799|64632816|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
23182876|NCT00749190|64409336|FG000|Overall Study|Adverse Event|0|||
23182877|NCT00749190|64409337|FG001|Overall Study|Adverse Event|2|||
23241952|NCT00877799|64632817|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
23241953|NCT00877799|64632818|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
23241954|NCT00877799|64632819|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
23241955|NCT00877799|64632820|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
23241956|NCT00877799|64632816|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
23241957|NCT00877799|64632817|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
23241958|NCT00877799|64632818|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
23241959|NCT00877799|64632819|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
23241960|NCT00877799|64632820|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
23241961|NCT03107715|64632822|FG000|Overall Study|did not deliver at the home hospital|4|||
23241962|NCT03107715|64632823|FG001|Overall Study|did not deliver at the home hospital|6|||
23241963|NCT03107715|64632822|FG000|Overall Study|infant stillborn|0|||
23241964|NCT03107715|64632823|FG001|Overall Study|infant stillborn|1|||
23241965|NCT02322866|64632824|FG000|Overall Study|Adverse Event|6|||
23241966|NCT02322866|64632825|FG001|Overall Study|Adverse Event|11|||
23241967|NCT02322866|64632824|FG000|Overall Study|Withdrawal of Consent|16|||
23241968|NCT02322866|64632825|FG001|Overall Study|Withdrawal of Consent|25|||
23241969|NCT02322866|64632824|FG000|Overall Study|Lost to Follow-up|36|||
23241970|NCT02322866|64632825|FG001|Overall Study|Lost to Follow-up|39|||
23241971|NCT02322866|64632824|FG000|Overall Study|Protocol Violation|1|||
23241972|NCT02322866|64632825|FG001|Overall Study|Protocol Violation|0|||
23241973|NCT02322866|64632824|FG000|Overall Study|Noncompliance with Treatment|3|||
23241974|NCT02322866|64632825|FG001|Overall Study|Noncompliance with Treatment|4|||
23241975|NCT02322866|64632824|FG000|Overall Study|Lack of Efficacy|3|||
23241976|NCT02322866|64632825|FG001|Overall Study|Lack of Efficacy|1|||
23241977|NCT02322866|64632824|FG000|Overall Study|Other Miscellaneous Reasons|6|||
23241978|NCT02322866|64632825|FG001|Overall Study|Other Miscellaneous Reasons|6|||
23349625|NCT01752634|65025252|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
23584676|NCT00975806|65869255|FG000|Overall Study|Death|0|||
23584677|NCT00975806|65869256|FG001|Overall Study|Death|1|||
23584678|NCT00975806|65869257|FG002|Overall Study|Death|0|||
23584679|NCT00975806|65869255|FG000|Overall Study|Physician decision and disease related|1|||
23584680|NCT00975806|65869256|FG001|Overall Study|Physician decision and disease related|0|||
23584681|NCT00975806|65869257|FG002|Overall Study|Physician decision and disease related|1|||
23584682|NCT00777556|65869258|FG000|Overall Study|Inappropriate self-selection|34|||
23584683|NCT00777556|65869258|FG000|Overall Study|Dispensed but did not use product|12|||
23182878|NCT00749190|64409338|FG002|Overall Study|Adverse Event|0|||
23182879|NCT00749190|64409339|FG003|Overall Study|Adverse Event|4|||
23182880|NCT00749190|64409340|FG004|Overall Study|Adverse Event|0|||
23182881|NCT00749190|64409341|FG005|Overall Study|Adverse Event|3|||
23182882|NCT00749190|64409342|FG006|Overall Study|Adverse Event|0|||
23182883|NCT00749190|64409336|FG000|Overall Study|Lack of Efficacy|3|||
23182884|NCT00749190|64409337|FG001|Overall Study|Lack of Efficacy|1|||
23182885|NCT00749190|64409338|FG002|Overall Study|Lack of Efficacy|1|||
23182886|NCT00749190|64409339|FG003|Overall Study|Lack of Efficacy|0|||
23182887|NCT00749190|64409340|FG004|Overall Study|Lack of Efficacy|0|||
23182888|NCT00749190|64409341|FG005|Overall Study|Lack of Efficacy|1|||
23241979|NCT00446134|64632826|FG000|Overall Study|Adverse Event|7|||
23241980|NCT00446134|64632827|FG001|Overall Study|Adverse Event|17|||
23241981|NCT00446134|64632828|FG002|Overall Study|Adverse Event|13|||
23241982|NCT00446134|64632829|FG003|Overall Study|Adverse Event|18|||
23241983|NCT00446134|64632826|FG000|Overall Study|Lack of Efficacy|19|||
23241984|NCT00446134|64632827|FG001|Overall Study|Lack of Efficacy|19|||
23241985|NCT00446134|64632828|FG002|Overall Study|Lack of Efficacy|24|||
23241986|NCT00446134|64632829|FG003|Overall Study|Lack of Efficacy|19|||
23241987|NCT00446134|64632826|FG000|Overall Study|Protocol Violation|0|||
23241988|NCT00446134|64632827|FG001|Overall Study|Protocol Violation|2|||
23241989|NCT00446134|64632828|FG002|Overall Study|Protocol Violation|1|||
23241990|NCT00446134|64632829|FG003|Overall Study|Protocol Violation|0|||
23241991|NCT00446134|64632826|FG000|Overall Study|Lost to Follow-up|1|||
23241992|NCT00446134|64632827|FG001|Overall Study|Lost to Follow-up|3|||
23241993|NCT00446134|64632828|FG002|Overall Study|Lost to Follow-up|1|||
23584684|NCT00777556|65869258|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
23182889|NCT00749190|64409342|FG006|Overall Study|Lack of Efficacy|0|||
23241994|NCT00446134|64632829|FG003|Overall Study|Lost to Follow-up|1|||
23241995|NCT00446134|64632826|FG000|Overall Study|Withdrawal by Subject|3|||
23241996|NCT00446134|64632827|FG001|Overall Study|Withdrawal by Subject|3|||
23241997|NCT00446134|64632828|FG002|Overall Study|Withdrawal by Subject|1|||
23241998|NCT00446134|64632829|FG003|Overall Study|Withdrawal by Subject|3|||
23241999|NCT00446134|64632826|FG000|Overall Study|Physician Decision|0|||
23242000|NCT00446134|64632827|FG001|Overall Study|Physician Decision|0|||
23242001|NCT00446134|64632828|FG002|Overall Study|Physician Decision|0|||
23242002|NCT00446134|64632829|FG003|Overall Study|Physician Decision|2|||
23242003|NCT00446134|64632826|FG000|Overall Study|Adverse Event-Diarrhea|1|||
23242004|NCT00446134|64632827|FG001|Overall Study|Adverse Event-Diarrhea|1|||
23242005|NCT00446134|64632828|FG002|Overall Study|Adverse Event-Diarrhea|2|||
23242006|NCT00446134|64632829|FG003|Overall Study|Adverse Event-Diarrhea|0|||
23242007|NCT00446134|64632826|FG000|Overall Study|Reason Not Completed|3|||
23242008|NCT00446134|64632827|FG001|Overall Study|Reason Not Completed|0|||
23242009|NCT00446134|64632828|FG002|Overall Study|Reason Not Completed|1|||
23242010|NCT00446134|64632829|FG003|Overall Study|Reason Not Completed|2|||
23242011|NCT02222246|64632832|FG000|Overall Study|No Emergency Department Visits|27|||
23349626|NCT01752634|65025253|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
23349627|NCT01752634|65025254|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
23349628|NCT01752634|65025255|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
23349629|NCT01752634|65025250|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349630|NCT01752634|65025251|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
23349631|NCT01752634|65025252|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349632|NCT01752634|65025253|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349633|NCT01752634|65025254|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349634|NCT01752634|65025255|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
23349635|NCT01752634|65025250|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
23349636|NCT01752634|65025251|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
23349637|NCT01752634|65025252|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
23349638|NCT01752634|65025253|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
23349639|NCT01752634|65025254|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
23182890|NCT00749190|64409336|FG000|Overall Study|Withdrawal by Subject|2|||
23182891|NCT00749190|64409337|FG001|Overall Study|Withdrawal by Subject|1|||
23182892|NCT00749190|64409338|FG002|Overall Study|Withdrawal by Subject|0|||
23182893|NCT00749190|64409339|FG003|Overall Study|Withdrawal by Subject|0|||
23182894|NCT00749190|64409340|FG004|Overall Study|Withdrawal by Subject|0|||
23182895|NCT00749190|64409341|FG005|Overall Study|Withdrawal by Subject|1|||
23182896|NCT00749190|64409342|FG006|Overall Study|Withdrawal by Subject|0|||
23182897|NCT00749190|64409336|FG000|Overall Study|Protocol Violation|0|||
23182898|NCT00749190|64409337|FG001|Overall Study|Protocol Violation|1|||
23182899|NCT00749190|64409338|FG002|Overall Study|Protocol Violation|0|||
23182900|NCT00749190|64409339|FG003|Overall Study|Protocol Violation|0|||
23182901|NCT00749190|64409340|FG004|Overall Study|Protocol Violation|0|||
23182902|NCT00749190|64409341|FG005|Overall Study|Protocol Violation|0|||
23182903|NCT00749190|64409342|FG006|Overall Study|Protocol Violation|1|||
23182904|NCT00749190|64409336|FG000|Overall Study|Other reason not defined above|0|||
23182905|NCT00749190|64409337|FG001|Overall Study|Other reason not defined above|0|||
23349640|NCT01752634|65025255|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
23349641|NCT01752634|65025250|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
23349642|NCT01752634|65025251|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
23349643|NCT01752634|65025252|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
23349644|NCT01752634|65025253|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
23349645|NCT01752634|65025254|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
23349646|NCT01752634|65025255|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
23461295|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Transplant|4|||
23461296|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Transplant|2|||
23461297|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Transplant|0|||
23584685|NCT01784068|65869262|FG000|NTCS Phase|Adverse Event|5|||
23182906|NCT00749190|64409338|FG002|Overall Study|Other reason not defined above|0|||
23182907|NCT00749190|64409339|FG003|Overall Study|Other reason not defined above|1|||
23182908|NCT00749190|64409340|FG004|Overall Study|Other reason not defined above|0|||
23242012|NCT02222246|64632833|FG001|Overall Study|No Emergency Department Visits|26|||
23242013|NCT02222246|64632832|FG000|Overall Study|Physician Decision|0|||
23242014|NCT02222246|64632833|FG001|Overall Study|Physician Decision|1|||
23242015|NCT00539006|64632836|FG000|Pre-treatment|Other|0|||
23242016|NCT00539006|64632837|FG001|Pre-treatment|Other|1|||
23242017|NCT00539006|64632838|FG002|Pre-treatment|Other|0|||
23242018|NCT00539006|64632839|FG003|Pre-treatment|Other|0|||
23242019|NCT00539006|64632836|FG000|Treatment Period 1|Lost to Follow-up|0|||
23242020|NCT00539006|64632837|FG001|Treatment Period 1|Lost to Follow-up|0|||
23242021|NCT00539006|64632838|FG002|Treatment Period 1|Lost to Follow-up|1|||
23242022|NCT00539006|64632839|FG003|Treatment Period 1|Lost to Follow-up|0|||
23242023|NCT00539006|64632836|FG000|Treatment Period 1|Protocol Violation|0|||
23242024|NCT00539006|64632837|FG001|Treatment Period 1|Protocol Violation|0|||
23242025|NCT00539006|64632838|FG002|Treatment Period 1|Protocol Violation|1|||
23242026|NCT00539006|64632839|FG003|Treatment Period 1|Protocol Violation|0|||
23242027|NCT00539006|64632836|FG000|Treatment Period 1|Lack of Efficacy|0|||
23242028|NCT00539006|64632837|FG001|Treatment Period 1|Lack of Efficacy|0|||
23242029|NCT00539006|64632838|FG002|Treatment Period 1|Lack of Efficacy|0|||
23242030|NCT00539006|64632839|FG003|Treatment Period 1|Lack of Efficacy|1|||
23242031|NCT00539006|64632836|FG000|Washout|Adverse Event|2|||
23349647|NCT01752634|65025250|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
23584686|NCT01784068|65869263|FG001|NTCS Phase|Adverse Event|0|||
23584687|NCT01784068|65869262|FG000|NTCS Phase|Physician Decision|2|||
23584688|NCT01784068|65869263|FG001|NTCS Phase|Physician Decision|0|||
23584689|NCT01784068|65869262|FG000|NTCS Phase|Patient/guardian decision|3|||
23584690|NCT01784068|65869263|FG001|NTCS Phase|Patient/guardian decision|0|||
23584691|NCT01784068|65869262|FG000|NTCS Phase|Death|2|||
23584692|NCT01784068|65869263|FG001|NTCS Phase|Death|0|||
23584693|NCT01784068|65869262|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
23584694|NCT01784068|65869263|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
23584695|NCT01784068|65869262|FG000|TFR Phase|Physician Decision|0|||
23584696|NCT01784068|65869263|FG001|TFR Phase|Physician Decision|1|||
23584697|NCT01784068|65869262|FG000|TFR Phase|Patient/guardian decision|0|||
23584698|NCT01784068|65869263|FG001|TFR Phase|Patient/guardian decision|3|||
23584699|NCT01784068|65869262|FG000|TFR Phase|Death|0|||
23584700|NCT01784068|65869263|FG001|TFR Phase|Death|1|||
23584701|NCT01784068|65869262|FG000|TFR Phase|Lack of Efficacy|0|||
23584702|NCT01784068|65869263|FG001|TFR Phase|Lack of Efficacy|88|||
23182909|NCT00749190|64409341|FG005|Overall Study|Other reason not defined above|0|||
23182910|NCT00749190|64409342|FG006|Overall Study|Other reason not defined above|0|||
23182911|NCT01946178|64409344|FG000|Overall Study|Pregnancy|1|||
23182912|NCT01946178|64409344|FG000|Overall Study|Lost to Follow-up|1|||
23182913|NCT00781365|64409349|FG000|Overall Study|Withdrawal by Subject|13|||
23182914|NCT00781365|64409350|FG001|Overall Study|Withdrawal by Subject|8|||
23182915|NCT00781365|64409349|FG000|Overall Study|Did Not Attend Visit|20|||
23182916|NCT00781365|64409350|FG001|Overall Study|Did Not Attend Visit|28|||
23182917|NCT00781365|64409349|FG000|Overall Study|Language barrier|1|||
23182918|NCT00781365|64409350|FG001|Overall Study|Language barrier|0|||
23182919|NCT00496366|64409351|FG000|Overall Study|Death|1|||
23182920|NCT00642642|64409354|FG000|Treatment & Follow Up|Adverse Event|2|||
23182921|NCT00642642|64409354|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
23182922|NCT00642642|64409354|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
23182923|NCT01990261|64409355|FG000|Overall Study|Death Before Treatment Start|2|||
23182924|NCT01990261|64409355|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
23182925|NCT01990261|64409355|FG000|Overall Study|Death From other Causes|1|||
23182926|NCT01990261|64409355|FG000|Overall Study|Disease Progression (PD)|8|||
23182927|NCT01990261|64409355|FG000|Overall Study|PD Before Treatment Start|1|||
23182928|NCT01990261|64409355|FG000|Overall Study|Dossier not Approved|1|||
23182929|NCT01990261|64409355|FG000|Overall Study|Lost to Follow-up|2|||
23182930|NCT01237951|64409356|FG000|Overall Study|Death|1|||
23584703|NCT01333514|65869264|FG000|Overall Study|Withdrawal by Subject|1|||
23242032|NCT00539006|64632837|FG001|Washout|Adverse Event|1|||
23242033|NCT00539006|64632838|FG002|Washout|Adverse Event|0|||
23242034|NCT00539006|64632839|FG003|Washout|Adverse Event|0|||
23242035|NCT00539006|64632836|FG000|Washout|Protocol Violation|1|||
23242036|NCT00539006|64632837|FG001|Washout|Protocol Violation|1|||
23242037|NCT00539006|64632838|FG002|Washout|Protocol Violation|0|||
23242038|NCT00539006|64632839|FG003|Washout|Protocol Violation|0|||
23242039|NCT00539006|64632836|FG000|Washout|Withdrawal by Subject|0|||
23242040|NCT00539006|64632837|FG001|Washout|Withdrawal by Subject|2|||
23242041|NCT00539006|64632838|FG002|Washout|Withdrawal by Subject|0|||
23242042|NCT00539006|64632839|FG003|Washout|Withdrawal by Subject|0|||
23242043|NCT00539006|64632836|FG000|Washout|Failed to meet continuation criteria|16|||
23242044|NCT00539006|64632837|FG001|Washout|Failed to meet continuation criteria|5|||
23242045|NCT00539006|64632838|FG002|Washout|Failed to meet continuation criteria|14|||
23242046|NCT00539006|64632839|FG003|Washout|Failed to meet continuation criteria|6|||
23242047|NCT00539006|64632836|FG000|Washout|Other|1|||
23242048|NCT00539006|64632837|FG001|Washout|Other|1|||
23242049|NCT00539006|64632838|FG002|Washout|Other|2|||
23242050|NCT00539006|64632839|FG003|Washout|Other|3|||
23242051|NCT00539006|64632836|FG000|Treatment Period 2|Protocol Violation|1|||
23242052|NCT00539006|64632837|FG001|Treatment Period 2|Protocol Violation|0|||
23182931|NCT00195650|64409357|FG000|Overall Study|Adverse Event|194|||
23182932|NCT00195650|64409357|FG000|Overall Study|Lack of Efficacy|99|||
23182933|NCT00195650|64409357|FG000|Overall Study|Withdrawal by Subject|67|||
23182934|NCT00195650|64409357|FG000|Overall Study|Lost to Follow-up|44|||
23182935|NCT00195650|64409357|FG000|Overall Study|Death|23|||
23182936|NCT00195650|64409357|FG000|Overall Study|Protocol Violation|15|||
23182937|NCT00195650|64409357|FG000|Overall Study|Administrative reasons|83|||
23182938|NCT01169779|64409358|FG000|Overall Study|Adverse Event|3|||
23182939|NCT01169779|64409359|FG001|Overall Study|Adverse Event|11|||
23182940|NCT01169779|64409358|FG000|Overall Study|Lack of Efficacy|1|||
23242053|NCT00539006|64632838|FG002|Treatment Period 2|Protocol Violation|0|||
23242054|NCT00539006|64632839|FG003|Treatment Period 2|Protocol Violation|0|||
23182941|NCT01169779|64409359|FG001|Overall Study|Lack of Efficacy|0|||
23182942|NCT01169779|64409358|FG000|Overall Study|Protocol Violation|1|||
23182943|NCT01169779|64409359|FG001|Overall Study|Protocol Violation|1|||
23182944|NCT01169779|64409358|FG000|Overall Study|Withdrawal by Subject|3|||
23182945|NCT01169779|64409359|FG001|Overall Study|Withdrawal by Subject|2|||
23182946|NCT01169779|64409358|FG000|Overall Study|Familial and personal reasons|3|||
23182947|NCT01169779|64409359|FG001|Overall Study|Familial and personal reasons|3|||
23182948|NCT01147926|64409360|FG000|Overall Study|Subject Withdrew Consent|9|||
23182949|NCT01147926|64409361|FG001|Overall Study|Subject Withdrew Consent|10|||
23182950|NCT01147926|64409360|FG000|Overall Study|Adverse Event|7|||
23182951|NCT01147926|64409361|FG001|Overall Study|Adverse Event|6|||
23182952|NCT01147926|64409360|FG000|Overall Study|Subject Non-Compliant|5|||
23182953|NCT01147926|64409361|FG001|Overall Study|Subject Non-Compliant|4|||
23182954|NCT01147926|64409360|FG000|Overall Study|Principal investigator left hospital|1|||
23182955|NCT01147926|64409361|FG001|Overall Study|Principal investigator left hospital|3|||
23182956|NCT01147926|64409360|FG000|Overall Study|Selection criteria not met|3|||
23182957|NCT01147926|64409361|FG001|Overall Study|Selection criteria not met|1|||
23242055|NCT00539006|64632836|FG000|Treatment Period 2|Other|0|||
23402747|NCT01669902|65219993|FG000|Overall Study|Lack of Efficacy|10|||
23182958|NCT01147926|64409360|FG000|Overall Study|Lost to Follow-up|0|||
23182959|NCT01147926|64409361|FG001|Overall Study|Lost to Follow-up|2|||
23242056|NCT00539006|64632837|FG001|Treatment Period 2|Other|1|||
23242057|NCT00539006|64632838|FG002|Treatment Period 2|Other|0|||
23242058|NCT00539006|64632839|FG003|Treatment Period 2|Other|0|||
23242059|NCT00285012|64632840|FG000|Assigned to Study Treatment (Tx)|Other|2|||
23242060|NCT00285012|64632841|FG001|Assigned to Study Treatment (Tx)|Other|3|||
23242061|NCT00285012|64632840|FG000|Received Study Tx|Death|2|||
23242062|NCT00285012|64632841|FG001|Received Study Tx|Death|1|||
23242063|NCT00285012|64632840|FG000|Received Study Tx|Adverse Event|5|||
23242064|NCT00285012|64632841|FG001|Received Study Tx|Adverse Event|11|||
23349648|NCT01752634|65025251|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
23349649|NCT01752634|65025252|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
23349650|NCT01752634|65025253|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
23349651|NCT01752634|65025254|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
23349652|NCT01752634|65025255|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
23461298|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Transplant|0|||
23461299|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Transplant|0|||
23461300|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
23461301|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
23461302|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
23461303|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
23461304|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
23461305|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
23461306|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
23461307|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
23461308|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
23461309|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
23461310|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
23461311|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
23461312|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
23461313|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
23461314|NCT02113982|65434801|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
23461315|NCT02113982|65434802|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
23461316|NCT02113982|65434803|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
23461317|NCT02113982|65434804|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
23461318|NCT02113982|65434805|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
23461319|NCT02113982|65434806|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
23461320|NCT02113982|65434807|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
23461321|NCT02113982|65434808|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
23461322|NCT02113982|65434809|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
23461323|NCT02113982|65434810|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
23461324|NCT02113982|65434811|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
23461325|NCT02113982|65434812|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
23461326|NCT02113982|65434813|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
23461327|NCT02113982|65434814|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
23461328|NCT02113982|65434801|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461329|NCT02113982|65434802|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461330|NCT02113982|65434803|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461331|NCT02113982|65434804|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461332|NCT02113982|65434805|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461333|NCT02113982|65434806|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461334|NCT02113982|65434807|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461335|NCT02113982|65434808|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461336|NCT02113982|65434809|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461337|NCT02113982|65434810|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461338|NCT02113982|65434811|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461339|NCT02113982|65434812|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
23461340|NCT02113982|65434813|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461341|NCT02113982|65434814|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
23461342|NCT02113982|65434801|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461343|NCT02113982|65434802|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461344|NCT02113982|65434803|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461345|NCT02113982|65434804|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461346|NCT02113982|65434805|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461347|NCT02113982|65434806|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461348|NCT02113982|65434807|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461349|NCT02113982|65434808|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461350|NCT02113982|65434809|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461351|NCT02113982|65434810|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461352|NCT02113982|65434811|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461353|NCT02113982|65434812|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
23461354|NCT02113982|65434813|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461355|NCT02113982|65434814|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
23461356|NCT02113982|65434801|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23584704|NCT01333514|65869265|FG001|Overall Study|Withdrawal by Subject|0|||
23584705|NCT02534896|65869266|FG000|Overall Study|Adverse Event|2|||
23182960|NCT01147926|64409360|FG000|Overall Study|Sponsor's Decision|0|||
23182961|NCT01147926|64409361|FG001|Overall Study|Sponsor's Decision|1|||
23182962|NCT01147926|64409360|FG000|Overall Study|Lack of Efficacy|1|||
23182963|NCT01147926|64409361|FG001|Overall Study|Lack of Efficacy|0|||
23182964|NCT01147926|64409360|FG000|Overall Study|Too busy, no time for study|1|||
23182965|NCT01147926|64409361|FG001|Overall Study|Too busy, no time for study|0|||
23349653|NCT01752634|65025250|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
23461357|NCT02113982|65434802|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461358|NCT02113982|65434803|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461359|NCT02113982|65434804|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461360|NCT02113982|65434805|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461361|NCT02113982|65434806|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461362|NCT02113982|65434807|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461363|NCT02113982|65434808|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461364|NCT02113982|65434809|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461365|NCT02113982|65434810|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461366|NCT02113982|65434811|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461367|NCT02113982|65434812|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
23461368|NCT02113982|65434813|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23182966|NCT01147926|64409360|FG000|Overall Study|Went on holiday|0|||
23182967|NCT01147926|64409361|FG001|Overall Study|Went on holiday|1|||
23182968|NCT01147926|64409360|FG000|Overall Study|Colonoscopy result|0|||
23182969|NCT01147926|64409361|FG001|Overall Study|Colonoscopy result|1|||
23182970|NCT01335971|64409364|FG000|Overall Study|Withdrawal by Subject|1|||
23461369|NCT02113982|65434814|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
23461370|NCT02113982|65434801|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
23461371|NCT02113982|65434802|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
23461372|NCT02113982|65434803|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
23461373|NCT02113982|65434804|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
23461374|NCT02113982|65434805|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
23461375|NCT02113982|65434806|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
23461376|NCT02113982|65434807|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
23461377|NCT02113982|65434808|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
23461378|NCT02113982|65434809|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
23461379|NCT02113982|65434810|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
23461380|NCT02113982|65434811|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
23461381|NCT02113982|65434812|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
23461382|NCT02113982|65434813|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
23461383|NCT02113982|65434814|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
23461384|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461385|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461386|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461387|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461388|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461389|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461390|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461391|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461392|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461393|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461394|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461395|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461396|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
23461397|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
23461398|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461399|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461400|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461401|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461402|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461403|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461404|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461405|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461406|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461407|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461408|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461409|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
23461410|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
23461411|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
23461412|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461413|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461414|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461415|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461416|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461417|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461418|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461419|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461420|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461421|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461422|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461423|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
23461424|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
23461425|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
23461426|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461427|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461428|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23584706|NCT02534896|65869267|FG001|Overall Study|Adverse Event|1|||
23461429|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461430|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461431|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461432|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461433|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461434|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23584707|NCT02534896|65869268|FG002|Overall Study|Adverse Event|1|||
23461435|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461436|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23461437|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
23584708|NCT02534896|65869266|FG000|Overall Study|Insufficient therapeutic response|2|||
23461438|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
23461439|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
23461440|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461441|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461442|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461443|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461444|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461445|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461446|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461447|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461448|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461449|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461450|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461451|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461452|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
23461453|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
23461454|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461455|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461456|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461457|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461458|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461459|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461460|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461461|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461462|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461463|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461464|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461465|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461466|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
23461467|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
23461468|NCT02113982|65434801|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461469|NCT02113982|65434802|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461470|NCT02113982|65434803|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461471|NCT02113982|65434804|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461472|NCT02113982|65434805|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461473|NCT02113982|65434806|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461474|NCT02113982|65434807|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461475|NCT02113982|65434808|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461476|NCT02113982|65434809|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461477|NCT02113982|65434810|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461478|NCT02113982|65434811|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461479|NCT02113982|65434812|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461480|NCT02113982|65434813|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
23461481|NCT02113982|65434814|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
23461482|NCT02612779|65434815|FG000|Overall Study|Administrative reason by sponsor|4|||
23461483|NCT02612779|65434816|FG001|Overall Study|Administrative reason by sponsor|1|||
23461484|NCT02612779|65434815|FG000|Overall Study|No longer meet study criteria|0|||
23461485|NCT02612779|65434816|FG001|Overall Study|No longer meet study criteria|1|||
23461486|NCT02612779|65434815|FG000|Overall Study|Disease progression|29|||
23461487|NCT02612779|65434816|FG001|Overall Study|Disease progression|2|||
23461488|NCT02612779|65434815|FG000|Overall Study|Study drug toxicity|10|||
23461489|NCT02612779|65434816|FG001|Overall Study|Study drug toxicity|1|||
23461490|NCT02612779|65434815|FG000|Overall Study|Death|1|||
23461491|NCT02612779|65434816|FG001|Overall Study|Death|0|||
23461492|NCT02612779|65434815|FG000|Overall Study|Adverse event unrelated to study drug|5|||
23461493|NCT02612779|65434816|FG001|Overall Study|Adverse event unrelated to study drug|0|||
23461494|NCT02612779|65434815|FG000|Overall Study|Participant withdrew consent|4|||
23461495|NCT02612779|65434816|FG001|Overall Study|Participant withdrew consent|0|||
23461496|NCT02612779|65434815|FG000|Overall Study|Lost to Follow-up|1|||
23461497|NCT02612779|65434816|FG001|Overall Study|Lost to Follow-up|0|||
23461498|NCT02612779|65434815|FG000|Overall Study|Maximum clinical benefit|10|||
23461499|NCT02612779|65434816|FG001|Overall Study|Maximum clinical benefit|1|||
23461500|NCT02612779|65434815|FG000|Overall Study|Other reasons|4|||
23461501|NCT02612779|65434816|FG001|Overall Study|Other reasons|0|||
23461502|NCT00335777|65434820|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
23461503|NCT00335777|65434820|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
23461504|NCT00335777|65434820|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
23461505|NCT00335777|65434820|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
23461506|NCT00335777|65434820|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
23461507|NCT04944992|65434823|FG000|Overall Study|Lost to Follow-up|1|||
23461508|NCT04944992|65434824|FG001|Overall Study|Lost to Follow-up|1|||
23461509|NCT04944992|65434823|FG000|Overall Study|Physician Decision|1|||
23461510|NCT04944992|65434824|FG001|Overall Study|Physician Decision|0|||
23461511|NCT04944992|65434823|FG000|Overall Study|Withdrawal by Subject|6|||
23461512|NCT04944992|65434824|FG001|Overall Study|Withdrawal by Subject|1|||
23461513|NCT02491684|65434825|FG000|Treatment Phase|Adverse Event|2|||
23461514|NCT02491684|65434826|FG001|Treatment Phase|Adverse Event|2|||
23461515|NCT02491684|65434825|FG000|Treatment Phase|Incorrect randomisation|1|||
23461516|NCT02491684|65434826|FG001|Treatment Phase|Incorrect randomisation|0|||
23461517|NCT02491684|65434825|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
23461518|NCT02491684|65434826|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
23461519|NCT01748292|65434827|FG000|Overall Study|Adverse Event|2|||
23461520|NCT01748292|65434828|FG001|Overall Study|Adverse Event|4|||
23461521|NCT01748292|65434827|FG000|Overall Study|Lost to Follow-up|0|||
23461522|NCT01748292|65434828|FG001|Overall Study|Lost to Follow-up|3|||
23461523|NCT01748292|65434827|FG000|Overall Study|Death|0|||
23461524|NCT01748292|65434828|FG001|Overall Study|Death|3|||
23461525|NCT01748292|65434827|FG000|Overall Study|Withdrawal by Subject|0|||
23461526|NCT01748292|65434828|FG001|Overall Study|Withdrawal by Subject|2|||
23461527|NCT04154904|65434829|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
23461528|NCT04154904|65434830|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
23182971|NCT01335971|64409365|FG001|Overall Study|Withdrawal by Subject|0|||
23461529|NCT04154904|65434831|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
23461530|NCT03058146|65434832|FG000|Overall Study|Withdrawal by Subject|4|||
23461531|NCT03058146|65434833|FG001|Overall Study|Withdrawal by Subject|1|||
23461532|NCT03058146|65434832|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
23461533|NCT03058146|65434833|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
23461534|NCT00303069|65434834|FG000|Overall Study|Lost to Follow-up|1|||
23461535|NCT00303069|65434835|FG001|Overall Study|Lost to Follow-up|0|||
23461536|NCT00303069|65434836|FG002|Overall Study|Lost to Follow-up|0|||
23461537|NCT00303069|65434837|FG003|Overall Study|Lost to Follow-up|2|||
23461538|NCT00303069|65434834|FG000|Overall Study|subject moved|1|||
23461539|NCT00303069|65434835|FG001|Overall Study|subject moved|0|||
23461540|NCT00303069|65434836|FG002|Overall Study|subject moved|0|||
23461541|NCT00303069|65434837|FG003|Overall Study|subject moved|0|||
23461542|NCT00303069|65434834|FG000|Overall Study|Recruitment into Army Reserves|0|||
23461543|NCT00303069|65434835|FG001|Overall Study|Recruitment into Army Reserves|0|||
23461544|NCT00303069|65434836|FG002|Overall Study|Recruitment into Army Reserves|1|||
23461545|NCT00303069|65434837|FG003|Overall Study|Recruitment into Army Reserves|0|||
23461546|NCT00091949|65434838|FG000|Overall Study|Withdrawal by Subject|117|||
23461547|NCT00091949|65434839|FG001|Overall Study|Withdrawal by Subject|110|||
23461548|NCT00091949|65434838|FG000|Overall Study|Lost to Follow-up|58|||
23461549|NCT00091949|65434839|FG001|Overall Study|Lost to Follow-up|41|||
23461550|NCT02144610|65434840|FG000|Overall Study|Physician Decision|1|||
23461551|NCT02144610|65434841|FG001|Overall Study|Physician Decision|0|||
23461552|NCT02144610|65434840|FG000|Overall Study|Withdrawal by Subject|1|||
23461553|NCT02144610|65434841|FG001|Overall Study|Withdrawal by Subject|5|||
23461554|NCT02144610|65434840|FG000|Overall Study|Death|2|||
23461555|NCT02144610|65434841|FG001|Overall Study|Death|2|||
23461556|NCT02144610|65434840|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
23461557|NCT02144610|65434841|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
23461558|NCT02144610|65434840|FG000|Overall Study|Other|0|||
23461559|NCT02144610|65434841|FG001|Overall Study|Other|1|||
23182972|NCT01335971|64409366|FG002|Overall Study|Withdrawal by Subject|0|||
23461560|NCT00004563|65434845|FG000|Overall Study|Withdrawal by Subject|20|||
23461561|NCT00004563|65434846|FG001|Overall Study|Withdrawal by Subject|16|||
23461562|NCT00004563|65434845|FG000|Overall Study|Lack of Efficacy|3|||
23461563|NCT00004563|65434846|FG001|Overall Study|Lack of Efficacy|5|||
23461564|NCT00004563|65434845|FG000|Overall Study|Death|2|||
23461565|NCT00004563|65434846|FG001|Overall Study|Death|3|||
23461566|NCT04313244|65434847|FG000|Overall Study|Withdrawal of Consent|3|||
23461567|NCT04313244|65434848|FG001|Overall Study|Withdrawal of Consent|3|||
23461568|NCT04313244|65434847|FG000|Overall Study|Met Exclusion Criteria|1|||
23461569|NCT04313244|65434848|FG001|Overall Study|Met Exclusion Criteria|0|||
23461570|NCT04313244|65434847|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
23461571|NCT04313244|65434848|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
23461572|NCT01217229|65434850|FG000|Overall Study|Adverse Event|1|||
23461573|NCT01217229|65434850|FG000|Overall Study|Disease progression, deterioration|2|||
23461574|NCT01217229|65434850|FG000|Overall Study|Disease progression, Cheson criteria|14|||
23461575|NCT01217229|65434850|FG000|Overall Study|Protocol Violation|1|||
23461576|NCT01217229|65434850|FG000|Overall Study|Disease progression not confirmed|2|||
23461577|NCT00318643|65434853|FG000|Overall Study|Adverse Event|0|||
23461578|NCT00318643|65434854|FG001|Overall Study|Adverse Event|0|||
23461579|NCT00318643|65434855|FG002|Overall Study|Adverse Event|0|||
23461580|NCT00318643|65434856|FG003|Overall Study|Adverse Event|0|||
23461581|NCT00318643|65434857|FG004|Overall Study|Adverse Event|1|||
23461582|NCT00318643|65434853|FG000|Overall Study|Participant's Decision|0|||
23461583|NCT00318643|65434854|FG001|Overall Study|Participant's Decision|0|||
23461584|NCT00318643|65434855|FG002|Overall Study|Participant's Decision|0|||
23461585|NCT00318643|65434856|FG003|Overall Study|Participant's Decision|0|||
23461586|NCT00318643|65434857|FG004|Overall Study|Participant's Decision|1|||
23461587|NCT00318643|65434853|FG000|Overall Study|Investigator's Decision|0|||
23461588|NCT00318643|65434854|FG001|Overall Study|Investigator's Decision|0|||
23461589|NCT00318643|65434855|FG002|Overall Study|Investigator's Decision|0|||
23461590|NCT00318643|65434856|FG003|Overall Study|Investigator's Decision|0|||
23461591|NCT00318643|65434857|FG004|Overall Study|Investigator's Decision|1|||
23461592|NCT00949702|65434858|FG000|Overall Study|Death|40|||
23461593|NCT00949702|65434858|FG000|Overall Study|Disease progression|7|||
23461594|NCT00949702|65434858|FG000|Overall Study|Withdrawal of consent|1|||
23461595|NCT03112603|65434859|FG000|End of Randomization Period|Lost to Follow-up|3|||
23461596|NCT03112603|65434860|FG001|End of Randomization Period|Lost to Follow-up|0|||
23461597|NCT03112603|65434861|FG002|End of Randomization Period|Lost to Follow-up|0|||
23461598|NCT03112603|65434859|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
23461599|NCT03112603|65434860|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
23461600|NCT03112603|65434861|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
23461601|NCT03112603|65434859|FG000|End of Randomization Period|Physician Decision|43|||
23461602|NCT03112603|65434860|FG001|End of Randomization Period|Physician Decision|18|||
23461603|NCT03112603|65434861|FG002|End of Randomization Period|Physician Decision|0|||
23461604|NCT03112603|65434859|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
23461605|NCT03112603|65434860|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
23461606|NCT03112603|65434861|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
23461607|NCT03112603|65434859|FG000|End of Randomization Period|Death|10|||
23461608|NCT03112603|65434860|FG001|End of Randomization Period|Death|7|||
23461609|NCT03112603|65434861|FG002|End of Randomization Period|Death|0|||
23461610|NCT03112603|65434859|FG000|End of Randomization Period|Disease Relapse|12|||
23461611|NCT03112603|65434860|FG001|End of Randomization Period|Disease Relapse|7|||
23461612|NCT03112603|65434861|FG002|End of Randomization Period|Disease Relapse|0|||
23461613|NCT03112603|65434859|FG000|End of Randomization Period|Lack of Efficacy|25|||
23461614|NCT03112603|65434860|FG001|End of Randomization Period|Lack of Efficacy|77|||
23461615|NCT03112603|65434861|FG002|End of Randomization Period|Lack of Efficacy|0|||
23461616|NCT03112603|65434859|FG000|End of Randomization Period|Adverse Event|32|||
23461617|NCT03112603|65434860|FG001|End of Randomization Period|Adverse Event|12|||
23461618|NCT03112603|65434861|FG002|End of Randomization Period|Adverse Event|0|||
23461619|NCT03112603|65434859|FG000|End of Cross Over Period|Death|0|||
23461620|NCT03112603|65434860|FG001|End of Cross Over Period|Death|0|||
23461621|NCT03112603|65434861|FG002|End of Cross Over Period|Death|2|||
23461622|NCT03112603|65434859|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
23461623|NCT03112603|65434860|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
23461624|NCT03112603|65434861|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
23461625|NCT03112603|65434859|FG000|End of Cross Over Period|Physician Decision|0|||
23461626|NCT03112603|65434860|FG001|End of Cross Over Period|Physician Decision|0|||
23182973|NCT01335971|64409364|FG000|Overall Study|Did not complete bronchoscopy|1|||
23182974|NCT01335971|64409365|FG001|Overall Study|Did not complete bronchoscopy|1|||
23182975|NCT01335971|64409366|FG002|Overall Study|Did not complete bronchoscopy|1|||
23182976|NCT02337387|64409367|FG000|Overall Study|Adverse Event|0|||
23182977|NCT02337387|64409368|FG001|Overall Study|Adverse Event|1|||
23182978|NCT02337387|64409369|FG002|Overall Study|Adverse Event|0|||
23182979|NCT02337387|64409370|FG003|Overall Study|Adverse Event|0|||
23461627|NCT03112603|65434861|FG002|End of Cross Over Period|Physician Decision|29|||
23584709|NCT02534896|65869267|FG001|Overall Study|Insufficient therapeutic response|0|||
23584710|NCT02534896|65869268|FG002|Overall Study|Insufficient therapeutic response|0|||
23584711|NCT03768206|65869269|FG000|Overall Study|Lost to Follow-up|2|||
23584712|NCT03768206|65869270|FG001|Overall Study|Lost to Follow-up|1|||
23182980|NCT02337387|64409367|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
23182981|NCT02337387|64409368|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
23182982|NCT02337387|64409369|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
23182983|NCT02337387|64409370|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
23182984|NCT05499520|64409371|FG000|Overall Study|Lost to Follow-up|0|||
23461628|NCT03112603|65434859|FG000|End of Cross Over Period|Lack of Efficacy|0|||
23461629|NCT03112603|65434860|FG001|End of Cross Over Period|Lack of Efficacy|0|||
23461630|NCT03112603|65434861|FG002|End of Cross Over Period|Lack of Efficacy|8|||
23182985|NCT05499520|64409372|FG001|Overall Study|Lost to Follow-up|0|||
23182986|NCT05499520|64409373|FG002|Overall Study|Lost to Follow-up|38|||
23182987|NCT05499520|64409374|FG003|Overall Study|Lost to Follow-up|41|||
23182988|NCT05499520|64409375|FG004|Overall Study|Lost to Follow-up|46|||
23182989|NCT05499520|64409376|FG005|Overall Study|Lost to Follow-up|0|||
23182990|NCT05499520|64409377|FG006|Overall Study|Lost to Follow-up|31|||
23182991|NCT05499520|64409378|FG007|Overall Study|Lost to Follow-up|45|||
23461631|NCT03112603|65434859|FG000|End of Cross Over Period|Adverse Event|0|||
23461632|NCT03112603|65434860|FG001|End of Cross Over Period|Adverse Event|0|||
23461633|NCT03112603|65434861|FG002|End of Cross Over Period|Adverse Event|6|||
23461634|NCT03112603|65434859|FG000|End of Cross Over Period|Disease Relapse|0|||
23461635|NCT03112603|65434860|FG001|End of Cross Over Period|Disease Relapse|0|||
23461636|NCT03112603|65434861|FG002|End of Cross Over Period|Disease Relapse|2|||
23461637|NCT02121535|65434862|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
23461638|NCT02121535|65434863|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
23461639|NCT02121535|65434862|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
23461640|NCT02121535|65434863|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
23461641|NCT01393821|65434866|FG000|Overall Study|Cancel|1|||
23461642|NCT01393821|65434867|FG001|Overall Study|Cancel|1|||
23461643|NCT01393821|65434866|FG000|Overall Study|not evaluable for primary endpoint|4|||
23461644|NCT01393821|65434867|FG001|Overall Study|not evaluable for primary endpoint|2|||
23461645|NCT01907854|65434868|FG000|Overall Study|Protocol Violation|1|||
23461646|NCT01907854|65434869|FG001|Overall Study|Protocol Violation|1|||
23461647|NCT01907854|65434868|FG000|Overall Study|Withdrawal by Subject|9|||
23461648|NCT01907854|65434869|FG001|Overall Study|Withdrawal by Subject|7|||
23461649|NCT01907854|65434868|FG000|Overall Study|Lost to Follow-up|2|||
23461650|NCT01907854|65434869|FG001|Overall Study|Lost to Follow-up|2|||
23461651|NCT01907854|65434868|FG000|Overall Study|Unclassified|4|||
23461652|NCT01907854|65434869|FG001|Overall Study|Unclassified|3|||
23461653|NCT01310777|65434872|FG000|Overall Study|Adverse Event|23|||
23461654|NCT01310777|65434873|FG001|Overall Study|Adverse Event|1|||
23461655|NCT01310777|65434874|FG002|Overall Study|Adverse Event|15|||
23461656|NCT01310777|65434872|FG000|Overall Study|Lost to Follow-up|0|||
23461657|NCT01310777|65434873|FG001|Overall Study|Lost to Follow-up|4|||
23461658|NCT01310777|65434874|FG002|Overall Study|Lost to Follow-up|1|||
23461659|NCT01310777|65434872|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
23461660|NCT01310777|65434873|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
23461661|NCT01310777|65434874|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
23461662|NCT01310777|65434872|FG000|Overall Study|Inadequate Control of IOP|5|||
23461663|NCT01310777|65434873|FG001|Overall Study|Inadequate Control of IOP|7|||
23461664|NCT01310777|65434874|FG002|Overall Study|Inadequate Control of IOP|10|||
23461665|NCT01310777|65434872|FG000|Overall Study|Other|4|||
23461666|NCT01310777|65434873|FG001|Overall Study|Other|1|||
23461667|NCT01310777|65434874|FG002|Overall Study|Other|2|||
23461668|NCT03591406|65434875|FG000|Overall Study|Adverse Event|5|||
23461669|NCT03591406|65434876|FG001|Overall Study|Adverse Event|3|||
23182992|NCT05499520|64409379|FG008|Overall Study|Lost to Follow-up|42|||
23182993|NCT05499520|64409380|FG009|Overall Study|Lost to Follow-up|0|||
23182994|NCT05499520|64409381|FG010|Overall Study|Lost to Follow-up|0|||
23182995|NCT05499520|64409382|FG011|Overall Study|Lost to Follow-up|37|||
23182996|NCT05499520|64409383|FG012|Overall Study|Lost to Follow-up|53|||
23182997|NCT05499520|64409384|FG013|Overall Study|Lost to Follow-up|49|||
23182998|NCT05499520|64409385|FG014|Overall Study|Lost to Follow-up|0|||
23182999|NCT05499520|64409386|FG015|Overall Study|Lost to Follow-up|36|||
23183000|NCT05499520|64409387|FG016|Overall Study|Lost to Follow-up|58|||
23183001|NCT05499520|64409388|FG017|Overall Study|Lost to Follow-up|53|||
23183002|NCT02786901|64409391|FG000|Overall Study|Adverse Event|1|||
23183003|NCT02786901|64409392|FG001|Overall Study|Adverse Event|1|||
23183004|NCT02786901|64409393|FG002|Overall Study|Adverse Event|2|||
23183005|NCT02786901|64409391|FG000|Overall Study|Physician Decision|1|||
23183006|NCT02786901|64409392|FG001|Overall Study|Physician Decision|0|||
23183007|NCT02786901|64409393|FG002|Overall Study|Physician Decision|0|||
23242065|NCT00285012|64632840|FG000|Received Study Tx|Lack of Efficacy|0|||
23461670|NCT03591406|65434875|FG000|Overall Study|Protocol Violation|2|||
23461671|NCT03591406|65434876|FG001|Overall Study|Protocol Violation|1|||
23461672|NCT03591406|65434875|FG000|Overall Study|Withdrawal by Subject|0|||
23461673|NCT03591406|65434876|FG001|Overall Study|Withdrawal by Subject|5|||
23461674|NCT00687193|65434877|FG000|Overall Study|Adverse Event|0|||
23461675|NCT00687193|65434878|FG001|Overall Study|Adverse Event|1|||
23461676|NCT00687193|65434879|FG002|Overall Study|Adverse Event|2|||
23242066|NCT00285012|64632841|FG001|Received Study Tx|Lack of Efficacy|3|||
23461677|NCT00687193|65434880|FG003|Overall Study|Adverse Event|3|||
23461678|NCT00687193|65434881|FG004|Overall Study|Adverse Event|0|||
23461679|NCT00687193|65434882|FG005|Overall Study|Adverse Event|2|||
23461680|NCT00687193|65434877|FG000|Overall Study|Lack of Efficacy|1|||
23461681|NCT00687193|65434878|FG001|Overall Study|Lack of Efficacy|1|||
23183008|NCT02786901|64409391|FG000|Overall Study|Rescue Therapy Use|71|||
23183009|NCT02786901|64409392|FG001|Overall Study|Rescue Therapy Use|49|||
23183010|NCT02786901|64409393|FG002|Overall Study|Rescue Therapy Use|33|||
23183011|NCT02786901|64409391|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
23461682|NCT00687193|65434879|FG002|Overall Study|Lack of Efficacy|0|||
23461683|NCT00687193|65434880|FG003|Overall Study|Lack of Efficacy|0|||
23461684|NCT00687193|65434881|FG004|Overall Study|Lack of Efficacy|0|||
23461685|NCT00687193|65434882|FG005|Overall Study|Lack of Efficacy|2|||
23461686|NCT00687193|65434877|FG000|Overall Study|Protocol Violation|1|||
23461687|NCT00687193|65434878|FG001|Overall Study|Protocol Violation|2|||
23461688|NCT00687193|65434879|FG002|Overall Study|Protocol Violation|0|||
23461689|NCT00687193|65434880|FG003|Overall Study|Protocol Violation|1|||
23461690|NCT00687193|65434881|FG004|Overall Study|Protocol Violation|2|||
23461691|NCT00687193|65434882|FG005|Overall Study|Protocol Violation|0|||
23461692|NCT01959503|65434883|FG000|Overall Study|Death|2|||
23461693|NCT01959503|65434884|FG001|Overall Study|Death|1|||
23461694|NCT01959503|65434883|FG000|Overall Study|Randomized but not treated|1|||
23461695|NCT01959503|65434884|FG001|Overall Study|Randomized but not treated|1|||
23461696|NCT00914849|65434885|FG000|Overall Study|Withdrawal by Subject|1|||
23461697|NCT00914849|65434886|FG001|Overall Study|Withdrawal by Subject|0|||
23461698|NCT00914849|65434885|FG000|Overall Study|Not eligible|0|||
23461699|NCT00914849|65434886|FG001|Overall Study|Not eligible|1|||
23461700|NCT01046396|65434888|FG000|Overall Study|Withdrawal by Subject|5|||
23461701|NCT01294553|65434889|FG000|Overall Study|Duplicated Participants|1|||
23461702|NCT01294553|65434889|FG000|Overall Study|Protocol Violation|268|||
23461703|NCT02420821|65434890|FG000|Overall Study|Lost to Follow-up|6|||
23461704|NCT02420821|65434891|FG001|Overall Study|Lost to Follow-up|6|||
23461705|NCT02420821|65434890|FG000|Overall Study|Non-compliance|0|||
23461706|NCT02420821|65434891|FG001|Overall Study|Non-compliance|2|||
23461707|NCT02420821|65434890|FG000|Overall Study|Physician Decision|6|||
23461708|NCT02420821|65434891|FG001|Overall Study|Physician Decision|2|||
23461709|NCT02420821|65434890|FG000|Overall Study|Withdrawal by Subject|32|||
23461710|NCT02420821|65434891|FG001|Overall Study|Withdrawal by Subject|25|||
23461711|NCT02420821|65434890|FG000|Overall Study|Death|270|||
23461712|NCT02420821|65434891|FG001|Overall Study|Death|263|||
23461713|NCT02420821|65434890|FG000|Overall Study|Study Terminated By Sponsor|145|||
23183012|NCT02786901|64409392|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
23183013|NCT02786901|64409393|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
23461714|NCT02420821|65434891|FG001|Overall Study|Study Terminated By Sponsor|149|||
23461715|NCT02420821|65434890|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
23461716|NCT02420821|65434891|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
23461717|NCT02420821|65434890|FG000|Overall Study|Adverse Event|0|||
23461718|NCT02420821|65434891|FG001|Overall Study|Adverse Event|1|||
23461719|NCT02420821|65434890|FG000|Overall Study|Protinuria|0|||
23461720|NCT02420821|65434891|FG001|Overall Study|Protinuria|1|||
23461721|NCT02420821|65434890|FG000|Overall Study|Progressive Disease|1|||
23461722|NCT02420821|65434891|FG001|Overall Study|Progressive Disease|1|||
23461723|NCT02420821|65434890|FG000|Overall Study|Disease Progression|0|||
23461724|NCT02420821|65434891|FG001|Overall Study|Disease Progression|1|||
23461725|NCT02420821|65434890|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
23461726|NCT02420821|65434891|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
23461727|NCT00763035|65434895|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
23461728|NCT00763035|65434896|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
23461729|NCT00763035|65434895|FG000|First Intervention|Adverse Event|0|||
23461730|NCT00763035|65434896|FG001|First Intervention|Adverse Event|1|||
23461731|NCT00763035|65434895|FG000|Second Intervention|Adverse Event|1|||
23461732|NCT00763035|65434896|FG001|Second Intervention|Adverse Event|0|||
23461733|NCT00763035|65434895|FG000|Second Intervention|Physician Decision|2|||
23461734|NCT00763035|65434896|FG001|Second Intervention|Physician Decision|0|||
23461735|NCT02158442|65434897|FG000|Overall Study|Withdrawal by Subject|1|||
23461736|NCT02158442|65434898|FG001|Overall Study|Withdrawal by Subject|0|||
23461737|NCT02158442|65434897|FG000|Overall Study|Perfusion staff not available|1|||
23461738|NCT02158442|65434898|FG001|Overall Study|Perfusion staff not available|0|||
23461739|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
23461740|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
23461741|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
23461742|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
23461743|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
23461744|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
23461745|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
23584713|NCT03768206|65869269|FG000|Overall Study|Withdrawal by Subject|0|||
23183014|NCT02786901|64409391|FG000|Overall Study|Disallowed medication|1|||
23461746|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23461747|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23183015|NCT02786901|64409392|FG001|Overall Study|Disallowed medication|1|||
23461748|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23461749|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23461750|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
23584714|NCT03768206|65869270|FG001|Overall Study|Withdrawal by Subject|1|||
23461751|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
23461752|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461753|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461754|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461755|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461756|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
23461757|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
23183016|NCT02786901|64409393|FG002|Overall Study|Disallowed medication|0|||
23183017|NCT02786901|64409391|FG000|Overall Study|Randomized in error|2|||
23183018|NCT02786901|64409392|FG001|Overall Study|Randomized in error|0|||
23461758|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
23461759|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
23461760|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
23461761|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
23461762|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
23461763|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461764|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
23461765|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461766|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461767|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461768|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
23461769|NCT03895203|65434902|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461770|NCT03895203|65434903|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
23461771|NCT03895203|65434904|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461772|NCT03895203|65434905|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461773|NCT03895203|65434906|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461774|NCT03895203|65434907|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
23461775|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461776|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461777|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461778|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
23461779|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461780|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
23461781|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
23461782|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
23461783|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
23461784|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
23461785|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
23461786|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
23461787|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
23461788|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
23461789|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
23461790|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
23461791|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
23461792|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
23461793|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
23461794|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
23461795|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
23461796|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
23461797|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
23461798|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
23461799|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
23461800|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
23183019|NCT02786901|64409393|FG002|Overall Study|Randomized in error|1|||
23183020|NCT00484315|64409394|FG000|12-Month Clinical Follow-up|Death|6|||
23183021|NCT00484315|64409395|FG001|12-Month Clinical Follow-up|Death|2|||
23183022|NCT00484315|64409394|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
23349654|NCT01752634|65025251|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
23183023|NCT00484315|64409395|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
23183024|NCT00484315|64409394|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
23349655|NCT01752634|65025252|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
23461801|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
23461802|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
23461803|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
23461804|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
23461805|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461806|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461807|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461808|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
23461809|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461810|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
23461811|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461812|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461813|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461814|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
23461815|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461816|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
23461817|NCT03895203|65434902|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461818|NCT03895203|65434903|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461819|NCT03895203|65434904|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461820|NCT03895203|65434905|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461821|NCT03895203|65434906|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
23461822|NCT03895203|65434907|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
23461823|NCT05375760|65434908|FG000|Overall Study|Adverse Event|1|||
23461824|NCT05375760|65434909|FG001|Overall Study|Adverse Event|0|||
23461825|NCT05375760|65434908|FG000|Overall Study|Death|0|||
23461826|NCT05375760|65434909|FG001|Overall Study|Death|1|||
23461827|NCT05375760|65434908|FG000|Overall Study|Lost to Follow-up|6|||
23461828|NCT05375760|65434909|FG001|Overall Study|Lost to Follow-up|6|||
23461829|NCT05375760|65434908|FG000|Overall Study|Withdrawal by Subject|17|||
23461830|NCT05375760|65434909|FG001|Overall Study|Withdrawal by Subject|19|||
23461831|NCT05375760|65434908|FG000|Overall Study|Dosing halted by FDA|96|||
23461832|NCT05375760|65434909|FG001|Overall Study|Dosing halted by FDA|100|||
23461833|NCT05375760|65434908|FG000|Overall Study|Not compliant with study visit|2|||
23461834|NCT05375760|65434909|FG001|Overall Study|Not compliant with study visit|0|||
23461835|NCT05375760|65434908|FG000|Overall Study|Physician Decision|1|||
23461836|NCT05375760|65434909|FG001|Overall Study|Physician Decision|0|||
23461837|NCT05375760|65434908|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
23461838|NCT05375760|65434909|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
23461839|NCT05375760|65434908|FG000|Overall Study|Participant moved|1|||
23461840|NCT05375760|65434909|FG001|Overall Study|Participant moved|0|||
23461841|NCT04971109|65434913|FG000|Overall Study|Adverse Event|4|||
23461842|NCT04971109|65434914|FG001|Overall Study|Adverse Event|3|||
23461843|NCT04971109|65434913|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
23461844|NCT04971109|65434914|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
23461845|NCT04971109|65434913|FG000|Overall Study|Lost to Follow-up|8|||
23461846|NCT04971109|65434914|FG001|Overall Study|Lost to Follow-up|2|||
23461847|NCT04971109|65434913|FG000|Overall Study|Physician Decision|5|||
23461848|NCT04971109|65434914|FG001|Overall Study|Physician Decision|0|||
23461849|NCT04971109|65434913|FG000|Overall Study|Protocol Violation|0|||
23461850|NCT04971109|65434914|FG001|Overall Study|Protocol Violation|1|||
23461851|NCT04971109|65434913|FG000|Overall Study|Withdrawal by Subject|18|||
23461852|NCT04971109|65434914|FG001|Overall Study|Withdrawal by Subject|3|||
23461853|NCT04971109|65434913|FG000|Overall Study|Subject was randomized in error|1|||
23461854|NCT04971109|65434914|FG001|Overall Study|Subject was randomized in error|0|||
23461855|NCT02115282|65434915|FG000|Overall Study|Disease progression during treatment|216|||
23461856|NCT02115282|65434916|FG001|Overall Study|Disease progression during treatment|229|||
23461857|NCT02115282|65434915|FG000|Overall Study|Adverse Event|49|||
23461858|NCT02115282|65434916|FG001|Overall Study|Adverse Event|23|||
23584715|NCT00404079|65869271|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
23183025|NCT00484315|64409395|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
23183026|NCT00484315|64409394|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
23183027|NCT00484315|64409395|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
23183028|NCT00484315|64409394|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
23183029|NCT00484315|64409395|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
23183030|NCT00484315|64409394|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
23183031|NCT00484315|64409395|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
23183032|NCT00484315|64409394|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
23183033|NCT00484315|64409395|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
23183034|NCT01700829|64409396|FG000|Overall Study|Withdrawal by Subject|1|||
23183035|NCT01700829|64409397|FG001|Overall Study|Withdrawal by Subject|1|||
23183036|NCT04026568|64409399|FG000|Overall Study|study terminated|0|||
23183037|NCT04026568|64409400|FG001|Overall Study|study terminated|1|||
23183038|NCT03124459|64409401|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23183039|NCT03124459|64409402|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23183040|NCT03124459|64409403|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23183041|NCT03124459|64409404|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23461859|NCT02115282|65434915|FG000|Overall Study|Death|1|||
23461860|NCT02115282|65434916|FG001|Overall Study|Death|3|||
23183042|NCT03124459|64409405|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
23183043|NCT03124459|64409406|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
23183044|NCT03124459|64409401|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23183045|NCT03124459|64409402|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23183046|NCT03124459|64409403|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23183047|NCT03124459|64409404|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23183048|NCT03124459|64409405|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
23183049|NCT03124459|64409406|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
23183050|NCT03124459|64409401|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
23183051|NCT03124459|64409402|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
23183052|NCT03124459|64409403|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
23183053|NCT03124459|64409404|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
23461861|NCT02115282|65434915|FG000|Overall Study|Alternative therapy|1|||
23461862|NCT02115282|65434916|FG001|Overall Study|Alternative therapy|1|||
23183054|NCT03124459|64409405|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
23183055|NCT03124459|64409406|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
23461863|NCT02115282|65434915|FG000|Overall Study|Complicating disease|0|||
23461864|NCT02115282|65434916|FG001|Overall Study|Complicating disease|3|||
23461865|NCT02115282|65434915|FG000|Overall Study|Withdrawal by Subject|12|||
23461866|NCT02115282|65434916|FG001|Overall Study|Withdrawal by Subject|10|||
23461867|NCT02115282|65434915|FG000|Overall Study|Symptomatic progression/deterioration|7|||
23461868|NCT02115282|65434916|FG001|Overall Study|Symptomatic progression/deterioration|18|||
23461869|NCT02115282|65434915|FG000|Overall Study|Non-compliance|5|||
23461870|NCT02115282|65434916|FG001|Overall Study|Non-compliance|1|||
23461871|NCT02115282|65434915|FG000|Overall Study|Protocol Violation|2|||
23461872|NCT02115282|65434916|FG001|Overall Study|Protocol Violation|2|||
23461873|NCT02115282|65434915|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
23461874|NCT02115282|65434916|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
23461875|NCT02115282|65434915|FG000|Overall Study|Not start protocol therapy|9|||
23461876|NCT02115282|65434916|FG001|Overall Study|Not start protocol therapy|10|||
23461877|NCT00539591|65434917|FG000|Overall Study|Toxicity|3|||
23461878|NCT00539591|65434918|FG001|Overall Study|Toxicity|0|||
23461879|NCT00539591|65434919|FG002|Overall Study|Toxicity|0|||
23461880|NCT00539591|65434917|FG000|Overall Study|Disease progression|2|||
23461881|NCT00539591|65434918|FG001|Overall Study|Disease progression|2|||
23461882|NCT00539591|65434919|FG002|Overall Study|Disease progression|3|||
23461883|NCT00098475|65434920|FG000|Step 1|Progressive disease|33|||
23461884|NCT00098475|65434921|FG001|Step 1|Progressive disease|35|||
23461885|NCT00098475|65434922|FG002|Step 1|Progressive disease|2|||
23461886|NCT00098475|65434923|FG003|Step 1|Progressive disease|1|||
23461887|NCT00098475|65434920|FG000|Step 1|Adverse Event|56|||
23461888|NCT00098475|65434921|FG001|Step 1|Adverse Event|37|||
23461889|NCT00098475|65434922|FG002|Step 1|Adverse Event|0|||
23461890|NCT00098475|65434923|FG003|Step 1|Adverse Event|1|||
23461891|NCT00098475|65434920|FG000|Step 1|Death|8|||
23461892|NCT00098475|65434921|FG001|Step 1|Death|5|||
23461893|NCT00098475|65434922|FG002|Step 1|Death|0|||
23461894|NCT00098475|65434923|FG003|Step 1|Death|1|||
23461895|NCT00098475|65434920|FG000|Step 1|Withdrawal by Subject|14|||
23461896|NCT00098475|65434921|FG001|Step 1|Withdrawal by Subject|11|||
23183056|NCT03124459|64409401|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
23183057|NCT03124459|64409402|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
23461897|NCT00098475|65434922|FG002|Step 1|Withdrawal by Subject|0|||
23461898|NCT00098475|65434923|FG003|Step 1|Withdrawal by Subject|0|||
23461899|NCT00098475|65434920|FG000|Step 1|Physician Decision|5|||
23461900|NCT00098475|65434921|FG001|Step 1|Physician Decision|2|||
23461901|NCT00098475|65434922|FG002|Step 1|Physician Decision|0|||
23461902|NCT00098475|65434923|FG003|Step 1|Physician Decision|0|||
23183058|NCT03124459|64409403|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
23183059|NCT03124459|64409404|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
23183060|NCT03124459|64409405|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
23183061|NCT03124459|64409406|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
23183062|NCT03124459|64409401|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23183063|NCT03124459|64409402|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23183064|NCT03124459|64409403|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23183065|NCT03124459|64409404|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23183066|NCT03124459|64409405|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
23183067|NCT03124459|64409406|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
23183068|NCT03124459|64409401|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23183069|NCT03124459|64409402|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23183070|NCT03124459|64409403|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23183071|NCT03124459|64409404|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23183072|NCT03124459|64409405|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
23183073|NCT03124459|64409406|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
23183074|NCT00733902|64409407|FG000|Overall Study|Death|0|||
23584716|NCT00404079|65869272|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
23584717|NCT04084769|65869273|FG000|Overall Study|Protocol Violation|1|||
23584718|NCT04084769|65869274|FG001|Overall Study|Protocol Violation|3|||
23584719|NCT04084769|65869275|FG002|Overall Study|Protocol Violation|0|||
23584720|NCT04084769|65869276|FG003|Overall Study|Protocol Violation|1|||
23584721|NCT04084769|65869273|FG000|Overall Study|Withdrawal by Subject|0|||
23584722|NCT04084769|65869274|FG001|Overall Study|Withdrawal by Subject|1|||
23584723|NCT04084769|65869275|FG002|Overall Study|Withdrawal by Subject|0|||
23584724|NCT04084769|65869276|FG003|Overall Study|Withdrawal by Subject|0|||
23584725|NCT04084769|65869273|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23584726|NCT04084769|65869274|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23584727|NCT04084769|65869275|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23584728|NCT04084769|65869276|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23584729|NCT04084769|65869273|FG000|Overall Study|Lost to Follow-up|2|||
23584730|NCT04084769|65869274|FG001|Overall Study|Lost to Follow-up|0|||
23584731|NCT04084769|65869275|FG002|Overall Study|Lost to Follow-up|0|||
23584732|NCT04084769|65869276|FG003|Overall Study|Lost to Follow-up|0|||
23584733|NCT01191086|65869277|FG000|Overall Study|Adverse Event|20|||
23584734|NCT01191086|65869277|FG000|Overall Study|Lack of Efficacy|10|||
23584735|NCT01191086|65869277|FG000|Overall Study|Lost to Follow-up|4|||
23584736|NCT01191086|65869277|FG000|Overall Study|Physician Decision|2|||
23584737|NCT01191086|65869277|FG000|Overall Study|Withdrawal by Subject|24|||
23584738|NCT01191086|65869277|FG000|Overall Study|Discontinuation criterion met|1|||
23584739|NCT01191086|65869277|FG000|Overall Study|Other|1|||
23584740|NCT02140554|65869279|FG000|Overall Study|Withdrawal of consent|1|||
23584741|NCT02140554|65869280|FG001|Overall Study|Withdrawal of consent|0|||
23584742|NCT02140554|65869281|FG002|Overall Study|Withdrawal of consent|4|||
23584743|NCT02140554|65869279|FG000|Overall Study|Physician Decision|1|||
23584744|NCT02140554|65869280|FG001|Overall Study|Physician Decision|0|||
23584745|NCT02140554|65869281|FG002|Overall Study|Physician Decision|2|||
23584746|NCT02140554|65869279|FG000|Overall Study|Death|0|||
23584747|NCT02140554|65869280|FG001|Overall Study|Death|0|||
23584748|NCT02140554|65869281|FG002|Overall Study|Death|1|||
23584749|NCT02140554|65869279|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
23584750|NCT02140554|65869280|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
23584751|NCT02140554|65869281|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
23584752|NCT01605136|65869282|FG000|Study Period|Withdrawal by Subject|2|||
23584753|NCT01605136|65869283|FG001|Study Period|Withdrawal by Subject|0|||
23584754|NCT01605136|65869282|FG000|Study Period|Physician Decision|1|||
23584755|NCT01605136|65869283|FG001|Study Period|Physician Decision|1|||
23584756|NCT01605136|65869282|FG000|Study Period|Lost to Follow-up|0|||
23584757|NCT01605136|65869283|FG001|Study Period|Lost to Follow-up|2|||
23584758|NCT01605136|65869282|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
23584759|NCT01605136|65869283|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
23183075|NCT00733902|64409408|FG001|Overall Study|Death|0|||
23242067|NCT00285012|64632840|FG000|Received Study Tx|Lost to Follow-up|29|||
23242068|NCT00285012|64632841|FG001|Received Study Tx|Lost to Follow-up|31|||
23242069|NCT00285012|64632840|FG000|Received Study Tx|Withdrawal by Subject|31|||
23242070|NCT00285012|64632841|FG001|Received Study Tx|Withdrawal by Subject|43|||
23242071|NCT00285012|64632840|FG000|Received Study Tx|Other|5|||
23242072|NCT00285012|64632841|FG001|Received Study Tx|Other|5|||
23242073|NCT03586427|64632844|FG000|Overall Study|Lost to Follow-up|0|||
23242074|NCT03586427|64632845|FG001|Overall Study|Lost to Follow-up|3|||
23242075|NCT03586427|64632846|FG002|Overall Study|Lost to Follow-up|1|||
23242076|NCT03586427|64632847|FG003|Overall Study|Lost to Follow-up|3|||
23242077|NCT03586427|64632848|FG004|Overall Study|Lost to Follow-up|3|||
23242078|NCT03586427|64632844|FG000|Overall Study|Withdrawal by Subject|0|||
23242079|NCT03586427|64632845|FG001|Overall Study|Withdrawal by Subject|1|||
23242080|NCT03586427|64632846|FG002|Overall Study|Withdrawal by Subject|2|||
23242081|NCT03586427|64632847|FG003|Overall Study|Withdrawal by Subject|1|||
23242082|NCT03586427|64632848|FG004|Overall Study|Withdrawal by Subject|1|||
23242083|NCT03586427|64632844|FG000|Overall Study|Adverse Event|0|||
23242084|NCT03586427|64632845|FG001|Overall Study|Adverse Event|0|||
23242085|NCT03586427|64632846|FG002|Overall Study|Adverse Event|1|||
23242086|NCT03586427|64632847|FG003|Overall Study|Adverse Event|0|||
23242087|NCT03586427|64632848|FG004|Overall Study|Adverse Event|0|||
23242088|NCT03586427|64632844|FG000|Overall Study|Protocol Violation|0|||
23349656|NCT01752634|65025253|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
23349657|NCT01752634|65025254|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
23349658|NCT01752634|65025255|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
23349659|NCT01752634|65025250|FG000|Week 24 to Week 260|Physician Decision|1|||
23349660|NCT01752634|65025251|FG001|Week 24 to Week 260|Physician Decision|2|||
23349661|NCT01752634|65025252|FG002|Week 24 to Week 260|Physician Decision|4|||
23349662|NCT01752634|65025253|FG003|Week 24 to Week 260|Physician Decision|2|||
23349663|NCT01752634|65025254|FG004|Week 24 to Week 260|Physician Decision|1|||
23349664|NCT01752634|65025255|FG005|Week 24 to Week 260|Physician Decision|0|||
23584760|NCT03593070|65869284|FG000|Overall Study|administrative withdrawal|1|||
23584761|NCT03593070|65869285|FG001|Overall Study|administrative withdrawal|1|||
23584762|NCT01178762|65869286|FG000|Overall Study|Lost to Follow-up|15|||
23584763|NCT04044664|65869287|FG000|Stage 1|Adverse Event|3|||
23584764|NCT04044664|65869288|FG001|Stage 1|Adverse Event|3|||
23584765|NCT04044664|65869289|FG002|Stage 1|Adverse Event|1|||
23584766|NCT04044664|65869287|FG000|Stage 1|Lost to Follow-up|3|||
23584767|NCT04044664|65869288|FG001|Stage 1|Lost to Follow-up|2|||
23584768|NCT04044664|65869289|FG002|Stage 1|Lost to Follow-up|2|||
23584769|NCT04044664|65869287|FG000|Stage 1|Withdrawal by Subject|9|||
23584770|NCT04044664|65869288|FG001|Stage 1|Withdrawal by Subject|1|||
23584771|NCT04044664|65869289|FG002|Stage 1|Withdrawal by Subject|0|||
23584772|NCT04044664|65869287|FG000|Stage 1|noncompliance, personal reason|2|||
23584773|NCT04044664|65869288|FG001|Stage 1|noncompliance, personal reason|0|||
23584774|NCT04044664|65869289|FG002|Stage 1|noncompliance, personal reason|0|||
23584775|NCT04044664|65869287|FG000|Stage 1|randomization error|0|||
23242089|NCT03586427|64632845|FG001|Overall Study|Protocol Violation|0|||
23242090|NCT03586427|64632846|FG002|Overall Study|Protocol Violation|1|||
23584776|NCT04044664|65869288|FG001|Stage 1|randomization error|1|||
23584777|NCT04044664|65869289|FG002|Stage 1|randomization error|0|||
23242091|NCT03586427|64632847|FG003|Overall Study|Protocol Violation|0|||
23349665|NCT01752634|65025250|FG000|Week 24 to Week 260|Death|0|||
23584778|NCT04044664|65869287|FG000|Stage 2|Adverse Event|2|||
23242092|NCT03586427|64632848|FG004|Overall Study|Protocol Violation|1|||
23242093|NCT03586427|64632844|FG000|Overall Study|Noncompliance with study drug|0|||
23242094|NCT03586427|64632845|FG001|Overall Study|Noncompliance with study drug|0|||
23242095|NCT03586427|64632846|FG002|Overall Study|Noncompliance with study drug|1|||
23242096|NCT03586427|64632847|FG003|Overall Study|Noncompliance with study drug|0|||
23242097|NCT03586427|64632848|FG004|Overall Study|Noncompliance with study drug|0|||
23242098|NCT03466060|64632849|FG000|Period 1|Test Lens Damage|0|||
23242099|NCT03466060|64632850|FG001|Period 1|Test Lens Damage|2|||
23242100|NCT03466060|64632851|FG002|Period 1|Test Lens Damage|0|||
23242101|NCT03466060|64632852|FG003|Period 1|Test Lens Damage|0|||
23349666|NCT01752634|65025251|FG001|Week 24 to Week 260|Death|1|||
23349667|NCT01752634|65025252|FG002|Week 24 to Week 260|Death|0|||
23349668|NCT01752634|65025253|FG003|Week 24 to Week 260|Death|0|||
23349669|NCT01752634|65025254|FG004|Week 24 to Week 260|Death|0|||
23349670|NCT01752634|65025255|FG005|Week 24 to Week 260|Death|0|||
23349671|NCT01752634|65025250|FG000|Week 24 to Week 260|Pregnancy|0|||
23349672|NCT01752634|65025251|FG001|Week 24 to Week 260|Pregnancy|0|||
23349673|NCT01752634|65025252|FG002|Week 24 to Week 260|Pregnancy|1|||
23349674|NCT01752634|65025253|FG003|Week 24 to Week 260|Pregnancy|0|||
23349675|NCT01752634|65025254|FG004|Week 24 to Week 260|Pregnancy|0|||
23349676|NCT01752634|65025255|FG005|Week 24 to Week 260|Pregnancy|0|||
23349677|NCT01752634|65025250|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349678|NCT01752634|65025251|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349679|NCT01752634|65025252|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
23242102|NCT03466060|64632853|FG004|Period 1|Test Lens Damage|0|||
23242103|NCT03466060|64632854|FG005|Period 1|Test Lens Damage|0|||
23242104|NCT03466060|64632849|FG000|Period 1|Withdrawal by Subject|0|||
23242105|NCT03466060|64632850|FG001|Period 1|Withdrawal by Subject|0|||
23242106|NCT03466060|64632851|FG002|Period 1|Withdrawal by Subject|2|||
23242107|NCT03466060|64632852|FG003|Period 1|Withdrawal by Subject|0|||
23242108|NCT03466060|64632853|FG004|Period 1|Withdrawal by Subject|0|||
23242109|NCT03466060|64632854|FG005|Period 1|Withdrawal by Subject|0|||
23242110|NCT03466060|64632849|FG000|Period 1|Lost to Follow-up|0|||
23349680|NCT01752634|65025253|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349681|NCT01752634|65025254|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349682|NCT01752634|65025255|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
23349683|NCT01752634|65025250|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
23349684|NCT01752634|65025251|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
23349685|NCT01752634|65025252|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
23349686|NCT01752634|65025253|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
23349687|NCT01752634|65025254|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
23349688|NCT01752634|65025255|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
23349689|NCT01752634|65025250|FG000|Week 24 to Week 260|Adverse Event|4|||
23349690|NCT01752634|65025251|FG001|Week 24 to Week 260|Adverse Event|8|||
23349691|NCT01752634|65025252|FG002|Week 24 to Week 260|Adverse Event|8|||
23349692|NCT01752634|65025253|FG003|Week 24 to Week 260|Adverse Event|4|||
23349693|NCT01752634|65025254|FG004|Week 24 to Week 260|Adverse Event|2|||
23349694|NCT01752634|65025255|FG005|Week 24 to Week 260|Adverse Event|0|||
23349695|NCT01078298|65025259|FG000|Overall Study|Lost to Follow-up|12|||
23349696|NCT01078298|65025260|FG001|Overall Study|Lost to Follow-up|13|||
23349697|NCT01078298|65025259|FG000|Overall Study|Withdrawal by Subject|31|||
23349698|NCT01078298|65025260|FG001|Overall Study|Withdrawal by Subject|33|||
23349699|NCT01078298|65025259|FG000|Overall Study|Protocol Violation|6|||
23349700|NCT01078298|65025260|FG001|Overall Study|Protocol Violation|6|||
23349701|NCT01078298|65025259|FG000|Overall Study|Adverse Event|6|||
23349702|NCT01078298|65025260|FG001|Overall Study|Adverse Event|5|||
23349703|NCT01078298|65025259|FG000|Overall Study|Death|2|||
23349704|NCT01078298|65025260|FG001|Overall Study|Death|0|||
23349705|NCT01078298|65025259|FG000|Overall Study|Did not meet entrance criteria|0|||
23349706|NCT01078298|65025260|FG001|Overall Study|Did not meet entrance criteria|1|||
23349707|NCT01078298|65025259|FG000|Overall Study|Other|24|||
23349708|NCT01078298|65025260|FG001|Overall Study|Other|32|||
23242111|NCT03466060|64632850|FG001|Period 1|Lost to Follow-up|0|||
23242112|NCT03466060|64632851|FG002|Period 1|Lost to Follow-up|0|||
23242113|NCT03466060|64632852|FG003|Period 1|Lost to Follow-up|1|||
23349709|NCT01651000|65025263|FG000|Overall Study|Adverse Event|2|||
23349710|NCT01651000|65025264|FG001|Overall Study|Adverse Event|8|||
23349711|NCT01651000|65025263|FG000|Overall Study|Lost to Follow-up|3|||
23349712|NCT01651000|65025264|FG001|Overall Study|Lost to Follow-up|2|||
23242114|NCT03466060|64632853|FG004|Period 1|Lost to Follow-up|0|||
23242115|NCT03466060|64632854|FG005|Period 1|Lost to Follow-up|0|||
23242116|NCT03466060|64632849|FG000|Period 1|Grade 2 Conjunctivitis|0|||
23242117|NCT03466060|64632850|FG001|Period 1|Grade 2 Conjunctivitis|0|||
23349713|NCT01651000|65025263|FG000|Overall Study|Protocol Violation|0|||
23349714|NCT01651000|65025264|FG001|Overall Study|Protocol Violation|3|||
23349715|NCT01651000|65025263|FG000|Overall Study|Withdrawal by Subject|2|||
23349716|NCT01651000|65025264|FG001|Overall Study|Withdrawal by Subject|10|||
23349717|NCT01651000|65025263|FG000|Overall Study|Subject noncompliance|0|||
23349718|NCT01651000|65025264|FG001|Overall Study|Subject noncompliance|3|||
23461903|NCT00098475|65434920|FG000|Step 1|Alternative therapy|31|||
23461904|NCT00098475|65434921|FG001|Step 1|Alternative therapy|43|||
23461905|NCT00098475|65434922|FG002|Step 1|Alternative therapy|1|||
23461906|NCT00098475|65434923|FG003|Step 1|Alternative therapy|0|||
23461907|NCT00098475|65434920|FG000|Step 1|Other disease|2|||
23461908|NCT00098475|65434921|FG001|Step 1|Other disease|1|||
23461909|NCT00098475|65434922|FG002|Step 1|Other disease|1|||
23461910|NCT00098475|65434923|FG003|Step 1|Other disease|0|||
23461911|NCT00098475|65434920|FG000|Step 1|Never started treatment|0|||
23461912|NCT00098475|65434921|FG001|Step 1|Never started treatment|2|||
23461913|NCT00098475|65434922|FG002|Step 1|Never started treatment|0|||
23461914|NCT00098475|65434923|FG003|Step 1|Never started treatment|0|||
23461915|NCT00098475|65434920|FG000|Step 1|Still on treatment as of this analysis|14|||
23461916|NCT00098475|65434921|FG001|Step 1|Still on treatment as of this analysis|27|||
23461917|NCT00098475|65434922|FG002|Step 1|Still on treatment as of this analysis|0|||
23461918|NCT00098475|65434923|FG003|Step 1|Still on treatment as of this analysis|0|||
23461919|NCT00098475|65434920|FG000|Step 1|Knee surgery|1|||
23461920|NCT00098475|65434921|FG001|Step 1|Knee surgery|0|||
23461921|NCT00098475|65434922|FG002|Step 1|Knee surgery|0|||
23461922|NCT00098475|65434923|FG003|Step 1|Knee surgery|0|||
23461923|NCT00098475|65434920|FG000|Step 1|Complications|1|||
23461924|NCT00098475|65434921|FG001|Step 1|Complications|0|||
23461925|NCT00098475|65434922|FG002|Step 1|Complications|0|||
23461926|NCT00098475|65434923|FG003|Step 1|Complications|0|||
23461927|NCT00098475|65434920|FG000|Step 1|Cannot comply due to other tx|0|||
23461928|NCT00098475|65434921|FG001|Step 1|Cannot comply due to other tx|1|||
23461929|NCT00098475|65434922|FG002|Step 1|Cannot comply due to other tx|0|||
23461930|NCT00098475|65434923|FG003|Step 1|Cannot comply due to other tx|0|||
23461931|NCT00098475|65434920|FG000|Step 1|Both patient and physician's decision|2|||
23461932|NCT00098475|65434921|FG001|Step 1|Both patient and physician's decision|1|||
23461933|NCT00098475|65434922|FG002|Step 1|Both patient and physician's decision|0|||
23461934|NCT00098475|65434923|FG003|Step 1|Both patient and physician's decision|0|||
23461935|NCT00098475|65434920|FG000|Step 1|Incorrect disease assessment|2|||
23461936|NCT00098475|65434921|FG001|Step 1|Incorrect disease assessment|0|||
23461937|NCT00098475|65434922|FG002|Step 1|Incorrect disease assessment|0|||
23461938|NCT00098475|65434923|FG003|Step 1|Incorrect disease assessment|0|||
23461939|NCT00098475|65434920|FG000|Step 1|Off treatment for > specified timeframe|1|||
23461940|NCT00098475|65434921|FG001|Step 1|Off treatment for > specified timeframe|1|||
23461941|NCT00098475|65434922|FG002|Step 1|Off treatment for > specified timeframe|0|||
23461942|NCT00098475|65434923|FG003|Step 1|Off treatment for > specified timeframe|0|||
23461943|NCT00098475|65434920|FG000|Step 1|Declining performance status|0|||
23461944|NCT00098475|65434921|FG001|Step 1|Declining performance status|1|||
23461945|NCT00098475|65434922|FG002|Step 1|Declining performance status|0|||
23461946|NCT00098475|65434923|FG003|Step 1|Declining performance status|0|||
23461947|NCT00098475|65434920|FG000|Step 1|Insurance issue|0|||
23584779|NCT04044664|65869288|FG001|Stage 2|Adverse Event|0|||
23584780|NCT04044664|65869289|FG002|Stage 2|Adverse Event|0|||
23584781|NCT04044664|65869287|FG000|Stage 2|Lost to Follow-up|3|||
23584782|NCT04044664|65869288|FG001|Stage 2|Lost to Follow-up|2|||
23584783|NCT04044664|65869289|FG002|Stage 2|Lost to Follow-up|1|||
23183076|NCT00733902|64409409|FG002|Overall Study|Death|0|||
23183077|NCT00733902|64409410|FG003|Overall Study|Death|1|||
23183078|NCT00733902|64409407|FG000|Overall Study|Adverse Event|3|||
23183079|NCT00733902|64409408|FG001|Overall Study|Adverse Event|4|||
23183080|NCT00733902|64409409|FG002|Overall Study|Adverse Event|7|||
23183081|NCT00733902|64409410|FG003|Overall Study|Adverse Event|11|||
23183082|NCT00733902|64409407|FG000|Overall Study|Lack of Efficacy|56|||
23183083|NCT00733902|64409408|FG001|Overall Study|Lack of Efficacy|21|||
23183084|NCT00733902|64409409|FG002|Overall Study|Lack of Efficacy|34|||
23183085|NCT00733902|64409410|FG003|Overall Study|Lack of Efficacy|23|||
23183086|NCT00733902|64409407|FG000|Overall Study|Protocol Violation|4|||
23183087|NCT00733902|64409408|FG001|Overall Study|Protocol Violation|6|||
23183088|NCT00733902|64409409|FG002|Overall Study|Protocol Violation|3|||
23183089|NCT00733902|64409410|FG003|Overall Study|Protocol Violation|3|||
23183090|NCT00733902|64409407|FG000|Overall Study|Withdrawal by Subject|10|||
23183091|NCT00733902|64409408|FG001|Overall Study|Withdrawal by Subject|5|||
23461948|NCT00098475|65434921|FG001|Step 1|Insurance issue|1|||
23461949|NCT00098475|65434922|FG002|Step 1|Insurance issue|0|||
23461950|NCT00098475|65434923|FG003|Step 1|Insurance issue|0|||
23461951|NCT00098475|65434920|FG000|Step 1|Rising paraprotein|0|||
23461952|NCT00098475|65434921|FG001|Step 1|Rising paraprotein|1|||
23461953|NCT00098475|65434922|FG002|Step 1|Rising paraprotein|0|||
23461954|NCT00098475|65434923|FG003|Step 1|Rising paraprotein|0|||
23461955|NCT00098475|65434920|FG000|Step 1|Referred to other physicians|0|||
23183092|NCT00733902|64409409|FG002|Overall Study|Withdrawal by Subject|4|||
23183093|NCT00733902|64409410|FG003|Overall Study|Withdrawal by Subject|16|||
23183094|NCT00733902|64409407|FG000|Overall Study|Entered extension study|89|||
23183095|NCT00733902|64409408|FG001|Overall Study|Entered extension study|124|||
23461956|NCT00098475|65434921|FG001|Step 1|Referred to other physicians|1|||
23584784|NCT04044664|65869287|FG000|Stage 2|Withdrawal by Subject|3|||
23242118|NCT03466060|64632851|FG002|Period 1|Grade 2 Conjunctivitis|1|||
23242119|NCT03466060|64632852|FG003|Period 1|Grade 2 Conjunctivitis|0|||
23242120|NCT03466060|64632853|FG004|Period 1|Grade 2 Conjunctivitis|0|||
23242121|NCT03466060|64632854|FG005|Period 1|Grade 2 Conjunctivitis|0|||
23242122|NCT03466060|64632849|FG000|Period 2|Lens Handling Difficulties|0|||
23242123|NCT03466060|64632850|FG001|Period 2|Lens Handling Difficulties|0|||
23461957|NCT00098475|65434922|FG002|Step 1|Referred to other physicians|0|||
23461958|NCT00098475|65434923|FG003|Step 1|Referred to other physicians|0|||
23461959|NCT00098475|65434920|FG000|Step 1|Criteria to continue treatment not met|0|||
23461960|NCT00098475|65434921|FG001|Step 1|Criteria to continue treatment not met|1|||
23461961|NCT00098475|65434922|FG002|Step 1|Criteria to continue treatment not met|0|||
23461962|NCT00098475|65434923|FG003|Step 1|Criteria to continue treatment not met|0|||
23461963|NCT00098475|65434920|FG000|Step 1|Misinterpretation of lab data|0|||
23242124|NCT03466060|64632851|FG002|Period 2|Lens Handling Difficulties|1|||
23242125|NCT03466060|64632852|FG003|Period 2|Lens Handling Difficulties|0|||
23242126|NCT03466060|64632853|FG004|Period 2|Lens Handling Difficulties|0|||
23461964|NCT00098475|65434921|FG001|Step 1|Misinterpretation of lab data|1|||
23461965|NCT00098475|65434922|FG002|Step 1|Misinterpretation of lab data|0|||
23461966|NCT00098475|65434923|FG003|Step 1|Misinterpretation of lab data|0|||
23461967|NCT00098475|65434920|FG000|Step 1|Patient fell with fracture|1|||
23461968|NCT00098475|65434921|FG001|Step 1|Patient fell with fracture|0|||
23461969|NCT00098475|65434922|FG002|Step 1|Patient fell with fracture|0|||
23461970|NCT00098475|65434923|FG003|Step 1|Patient fell with fracture|0|||
23461971|NCT00098475|65434920|FG000|Step 1|Not documented|0|||
23461972|NCT00098475|65434921|FG001|Step 1|Not documented|1|||
23461973|NCT00098475|65434922|FG002|Step 1|Not documented|0|||
23461974|NCT00098475|65434923|FG003|Step 1|Not documented|0|||
23461975|NCT00098475|65434920|FG000|Step 2|Disease progression|1|||
23461976|NCT00098475|65434921|FG001|Step 2|Disease progression|4|||
23461977|NCT00098475|65434922|FG002|Step 2|Disease progression|0|||
23461978|NCT00098475|65434923|FG003|Step 2|Disease progression|0|||
23461979|NCT00098475|65434920|FG000|Step 2|Adverse Event|2|||
23461980|NCT00098475|65434921|FG001|Step 2|Adverse Event|0|||
23461981|NCT00098475|65434922|FG002|Step 2|Adverse Event|0|||
23461982|NCT00098475|65434923|FG003|Step 2|Adverse Event|0|||
23461983|NCT00098475|65434920|FG000|Step 2|Withdrawal by Subject|0|||
23461984|NCT00098475|65434921|FG001|Step 2|Withdrawal by Subject|2|||
23461985|NCT00098475|65434922|FG002|Step 2|Withdrawal by Subject|0|||
23461986|NCT00098475|65434923|FG003|Step 2|Withdrawal by Subject|0|||
23461987|NCT00098475|65434920|FG000|Step 2|Physician Decision|0|||
23461988|NCT00098475|65434921|FG001|Step 2|Physician Decision|1|||
23461989|NCT00098475|65434922|FG002|Step 2|Physician Decision|0|||
23461990|NCT00098475|65434923|FG003|Step 2|Physician Decision|0|||
23461991|NCT00098475|65434920|FG000|Step 2|Alternative therapy|1|||
23461992|NCT00098475|65434921|FG001|Step 2|Alternative therapy|2|||
23461993|NCT00098475|65434922|FG002|Step 2|Alternative therapy|0|||
23461994|NCT00098475|65434923|FG003|Step 2|Alternative therapy|0|||
23461995|NCT00098475|65434920|FG000|Step 2|Never started treatment|1|||
23461996|NCT00098475|65434921|FG001|Step 2|Never started treatment|1|||
23461997|NCT00098475|65434922|FG002|Step 2|Never started treatment|0|||
23461998|NCT00098475|65434923|FG003|Step 2|Never started treatment|0|||
23461999|NCT05786651|65434929|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
23462000|NCT02516241|65434931|FG000|Overall Study|Death|255|||
23462001|NCT02516241|65434932|FG001|Overall Study|Death|262|||
23462002|NCT02516241|65434933|FG002|Overall Study|Death|270|||
23462003|NCT02516241|65434931|FG000|Overall Study|Lost to Follow-up|1|||
23584785|NCT04044664|65869288|FG001|Stage 2|Withdrawal by Subject|0|||
23584786|NCT04044664|65869289|FG002|Stage 2|Withdrawal by Subject|0|||
23584787|NCT04044664|65869287|FG000|Stage 2|protocol deviation|1|||
23584788|NCT04044664|65869288|FG001|Stage 2|protocol deviation|0|||
23584789|NCT04044664|65869289|FG002|Stage 2|protocol deviation|0|||
23584790|NCT00542386|65869290|FG000|Overall Study|Adverse Event|1|||
23584791|NCT00542386|65869291|FG001|Overall Study|Adverse Event|7|||
23584792|NCT00542386|65869292|FG002|Overall Study|Adverse Event|7|||
23462004|NCT02516241|65434932|FG001|Overall Study|Lost to Follow-up|1|||
23462005|NCT02516241|65434933|FG002|Overall Study|Lost to Follow-up|3|||
23462006|NCT02516241|65434931|FG000|Overall Study|Withdrawal by Subject|2|||
23462007|NCT02516241|65434932|FG001|Overall Study|Withdrawal by Subject|7|||
23584793|NCT00542386|65869293|FG003|Overall Study|Adverse Event|8|||
23584794|NCT00542386|65869294|FG004|Overall Study|Adverse Event|13|||
23584795|NCT00542386|65869295|FG005|Overall Study|Adverse Event|4|||
23584796|NCT00542386|65869290|FG000|Overall Study|Death|0|||
23242127|NCT03466060|64632854|FG005|Period 2|Lens Handling Difficulties|0|||
23462008|NCT02516241|65434933|FG002|Overall Study|Withdrawal by Subject|12|||
23584797|NCT00542386|65869291|FG001|Overall Study|Death|0|||
23462009|NCT02516241|65434931|FG000|Overall Study|participants ongoing at data cut-off|84|||
23462010|NCT02516241|65434932|FG001|Overall Study|participants ongoing at data cut-off|76|||
23462011|NCT02516241|65434933|FG002|Overall Study|participants ongoing at data cut-off|59|||
23462012|NCT04201262|65434934|FG000|Overall Study|Adverse Event|1|||
23462013|NCT04201262|65434935|FG001|Overall Study|Adverse Event|2|||
23462014|NCT04201262|65434934|FG000|Overall Study|Continuing in the study|57|||
23462015|NCT04201262|65434935|FG001|Overall Study|Continuing in the study|0|||
23462016|NCT04201262|65434934|FG000|Overall Study|Withdrawal by Subject|0|||
23462017|NCT04201262|65434935|FG001|Overall Study|Withdrawal by Subject|1|||
23462018|NCT03213691|65434936|FG000|Overall Study|Adverse Event|2|||
23462019|NCT03213691|65434936|FG000|Overall Study|Death|3|||
23462020|NCT03213691|65434936|FG000|Overall Study|Physician Decision|1|||
23462021|NCT03213691|65434936|FG000|Overall Study|Progressive Disease|14|||
23462022|NCT03213691|65434936|FG000|Overall Study|Ineligible|1|||
23462023|NCT03043872|65434937|FG000|Overall Study|Withdrawal by Subject|6|||
23462024|NCT03043872|65434938|FG001|Overall Study|Withdrawal by Subject|6|||
23462025|NCT03043872|65434939|FG002|Overall Study|Withdrawal by Subject|15|||
23462026|NCT03043872|65434937|FG000|Overall Study|Lost to Follow-up|2|||
23462027|NCT03043872|65434938|FG001|Overall Study|Lost to Follow-up|1|||
23462028|NCT03043872|65434939|FG002|Overall Study|Lost to Follow-up|1|||
23462029|NCT03043872|65434937|FG000|Overall Study|Death|270|||
23462030|NCT03043872|65434938|FG001|Overall Study|Death|269|||
23462031|NCT03043872|65434939|FG002|Overall Study|Death|296|||
23462032|NCT02939287|65434940|FG000|Overall Study|met exclusion criteria|1|||
23462033|NCT02939287|65434941|FG001|Overall Study|met exclusion criteria|1|||
23462034|NCT02939287|65434942|FG002|Overall Study|met exclusion criteria|1|||
23462035|NCT02939287|65434940|FG000|Overall Study|Did not complete survey|2|||
23462036|NCT02939287|65434941|FG001|Overall Study|Did not complete survey|2|||
23462037|NCT02939287|65434942|FG002|Overall Study|Did not complete survey|0|||
23462038|NCT02939287|65434940|FG000|Overall Study|Withdrawal by Subject|1|||
23462039|NCT02939287|65434941|FG001|Overall Study|Withdrawal by Subject|1|||
23462040|NCT02939287|65434942|FG002|Overall Study|Withdrawal by Subject|0|||
23462041|NCT04139798|65434943|FG000|Overall Study|Withdrawal by Subject|6|||
23462042|NCT04139798|65434944|FG001|Overall Study|Withdrawal by Subject|5|||
23462043|NCT04139798|65434943|FG000|Overall Study|Lost to Follow-up|2|||
23462044|NCT04139798|65434944|FG001|Overall Study|Lost to Follow-up|5|||
23462045|NCT04139798|65434943|FG000|Overall Study|Discontinued|4|||
23462046|NCT04139798|65434944|FG001|Overall Study|Discontinued|2|||
23462047|NCT04139798|65434943|FG000|Overall Study|Adverse Event|1|||
23462048|NCT04139798|65434944|FG001|Overall Study|Adverse Event|3|||
23462049|NCT04139798|65434943|FG000|Overall Study|Protocol Violation|1|||
23462050|NCT04139798|65434944|FG001|Overall Study|Protocol Violation|0|||
23462051|NCT01721044|65434945|FG000|Treatment Period|Adverse Event|7|||
23462052|NCT01721044|65434946|FG001|Treatment Period|Adverse Event|7|||
23462053|NCT01721044|65434947|FG002|Treatment Period|Adverse Event|10|||
23462054|NCT01721044|65434945|FG000|Treatment Period|Death|0|||
23462055|NCT01721044|65434946|FG001|Treatment Period|Death|0|||
23462056|NCT01721044|65434947|FG002|Treatment Period|Death|1|||
23462057|NCT01721044|65434945|FG000|Treatment Period|Lack of Efficacy|16|||
23462058|NCT01721044|65434946|FG001|Treatment Period|Lack of Efficacy|4|||
23462059|NCT01721044|65434947|FG002|Treatment Period|Lack of Efficacy|4|||
23462060|NCT01721044|65434945|FG000|Treatment Period|Lost to Follow-up|0|||
23462061|NCT01721044|65434946|FG001|Treatment Period|Lost to Follow-up|0|||
23462062|NCT01721044|65434947|FG002|Treatment Period|Lost to Follow-up|1|||
23462063|NCT01721044|65434945|FG000|Treatment Period|Physician Decision|1|||
23462064|NCT01721044|65434946|FG001|Treatment Period|Physician Decision|0|||
23462065|NCT01721044|65434947|FG002|Treatment Period|Physician Decision|2|||
23462066|NCT01721044|65434945|FG000|Treatment Period|Protocol Violation|1|||
23462067|NCT01721044|65434946|FG001|Treatment Period|Protocol Violation|0|||
23462068|NCT01721044|65434947|FG002|Treatment Period|Protocol Violation|0|||
23462069|NCT01721044|65434945|FG000|Treatment Period|Withdrawal by Subject|7|||
23462070|NCT01721044|65434946|FG001|Treatment Period|Withdrawal by Subject|6|||
23462071|NCT01721044|65434947|FG002|Treatment Period|Withdrawal by Subject|1|||
23462072|NCT04385277|65434948|FG000|Overall Study|Physician Decision|2|||
23462073|NCT04385277|65434948|FG000|Overall Study|Ineligible|1|||
23183096|NCT00733902|64409409|FG002|Overall Study|Entered extension study|111|||
23462074|NCT04385277|65434948|FG000|Overall Study|Patient/Parent Refusal|2|||
23462075|NCT01002339|65434949|FG000|Overall Study|Withdrawal by Subject|0|||
23183097|NCT00733902|64409410|FG003|Overall Study|Entered extension study|109|||
23183098|NCT00733902|64409407|FG000|Overall Study|Randomized but not treated|2|||
23183099|NCT00733902|64409408|FG001|Overall Study|Randomized but not treated|2|||
23183100|NCT00733902|64409409|FG002|Overall Study|Randomized but not treated|2|||
23462076|NCT01002339|65434950|FG001|Overall Study|Withdrawal by Subject|1|||
23462077|NCT01002339|65434951|FG002|Overall Study|Withdrawal by Subject|0|||
23462078|NCT01002339|65434949|FG000|Overall Study|Incorrect treatment assignment|0|||
23462079|NCT01002339|65434950|FG001|Overall Study|Incorrect treatment assignment|0|||
23462080|NCT01002339|65434951|FG002|Overall Study|Incorrect treatment assignment|1|||
23462081|NCT01002339|65434949|FG000|Overall Study|Protocol Violation|0|||
23462082|NCT01002339|65434950|FG001|Overall Study|Protocol Violation|0|||
23462083|NCT01002339|65434951|FG002|Overall Study|Protocol Violation|2|||
23462084|NCT01002339|65434949|FG000|Overall Study|Lung cancer detected before transplant|0|||
23183101|NCT00733902|64409410|FG003|Overall Study|Randomized but not treated|1|||
23462085|NCT01002339|65434950|FG001|Overall Study|Lung cancer detected before transplant|0|||
23462086|NCT01002339|65434951|FG002|Overall Study|Lung cancer detected before transplant|1|||
23462087|NCT01002339|65434949|FG000|Overall Study|Randomized. Not transplanted|0|||
23462088|NCT01002339|65434950|FG001|Overall Study|Randomized. Not transplanted|0|||
23183102|NCT00666562|64409412|FG000|Overall Study|Withdrawal by Subject|0|||
23183103|NCT00666562|64409413|FG001|Overall Study|Withdrawal by Subject|1|||
23183104|NCT00666562|64409414|FG002|Overall Study|Withdrawal by Subject|0|||
23183105|NCT00666562|64409412|FG000|Overall Study|Concomitant Medication|0|||
23183106|NCT00666562|64409413|FG001|Overall Study|Concomitant Medication|1|||
23183107|NCT00666562|64409414|FG002|Overall Study|Concomitant Medication|0|||
23183108|NCT01624194|64409415|FG000|Overall Study|Lost to Follow-up|1|||
23183109|NCT01624194|64409416|FG001|Overall Study|Lost to Follow-up|0|||
23183110|NCT01624194|64409415|FG000|Overall Study|Withdrawal by Subject|1|||
23183111|NCT01624194|64409416|FG001|Overall Study|Withdrawal by Subject|0|||
23183112|NCT00623831|64409417|FG000|Overall Study|Withdrawal by Subject|1|||
23183113|NCT00623831|64409418|FG001|Overall Study|Withdrawal by Subject|0|||
23183114|NCT00623831|64409417|FG000|Overall Study|Progressive Disease|0|||
23183115|NCT00623831|64409418|FG001|Overall Study|Progressive Disease|1|||
23183116|NCT01147809|64409419|FG000|Phase I (168 Days)|Adverse Event|0|||
23183117|NCT01147809|64409420|FG001|Phase I (168 Days)|Adverse Event|0|||
23462089|NCT01002339|65434951|FG002|Overall Study|Randomized. Not transplanted|1|||
23462090|NCT00535496|65434956|FG000|Overall Study|Lost to Follow-up|0|||
23462091|NCT00535496|65434957|FG001|Overall Study|Lost to Follow-up|1|||
23462092|NCT00535496|65434958|FG002|Overall Study|Lost to Follow-up|0|||
23462093|NCT00535496|65434959|FG003|Overall Study|Lost to Follow-up|0|||
23462094|NCT00535496|65434956|FG000|Overall Study|Not treated with sugammadex|0|||
23462095|NCT00535496|65434957|FG001|Overall Study|Not treated with sugammadex|1|||
23462096|NCT00535496|65434958|FG002|Overall Study|Not treated with sugammadex|0|||
23462097|NCT00535496|65434959|FG003|Overall Study|Not treated with sugammadex|0|||
23462098|NCT03877510|65434960|FG000|Overall Study|Death|6|||
23462099|NCT03877510|65434960|FG000|Overall Study|Lost to Follow-up|2|||
23462100|NCT03877510|65434960|FG000|Overall Study|Non-compliance with study drug|2|||
23462101|NCT03877510|65434960|FG000|Overall Study|Lack of Efficacy|14|||
23462102|NCT03877510|65434960|FG000|Overall Study|Adverse Event|20|||
23462103|NCT03877510|65434960|FG000|Overall Study|Withdrawal by Subject|22|||
23462104|NCT03877510|65434960|FG000|Overall Study|Miscellaneous|1|||
23462105|NCT02628873|65434961|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
23462106|NCT02628873|65434962|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
23462107|NCT02628873|65434961|FG000|Second Test (1 Hour)|Physician Decision|1|||
23462108|NCT02628873|65434962|FG001|Second Test (1 Hour)|Physician Decision|0|||
23462109|NCT01550003|65434965|FG000|Overall Study|Adverse Event|0|||
23462110|NCT01550003|65434966|FG001|Overall Study|Adverse Event|9|||
23462111|NCT01550003|65434967|FG002|Overall Study|Adverse Event|15|||
23462112|NCT01550003|65434965|FG000|Overall Study|Lack of Efficacy|4|||
23462113|NCT01550003|65434966|FG001|Overall Study|Lack of Efficacy|11|||
23462114|NCT01550003|65434967|FG002|Overall Study|Lack of Efficacy|15|||
23462115|NCT01550003|65434965|FG000|Overall Study|Protocol Violation|0|||
23462116|NCT01550003|65434966|FG001|Overall Study|Protocol Violation|3|||
23462117|NCT01550003|65434967|FG002|Overall Study|Protocol Violation|2|||
23462118|NCT01550003|65434965|FG000|Overall Study|Lost to Follow-up|1|||
23462119|NCT01550003|65434966|FG001|Overall Study|Lost to Follow-up|4|||
23462120|NCT01550003|65434967|FG002|Overall Study|Lost to Follow-up|8|||
23462121|NCT01550003|65434965|FG000|Overall Study|Consent withdrawn|2|||
23462122|NCT01550003|65434966|FG001|Overall Study|Consent withdrawn|11|||
23462123|NCT01550003|65434967|FG002|Overall Study|Consent withdrawn|23|||
23462124|NCT01550003|65434965|FG000|Overall Study|Missing|1|||
23462125|NCT01550003|65434966|FG001|Overall Study|Missing|0|||
23462126|NCT01550003|65434967|FG002|Overall Study|Missing|2|||
23462127|NCT01550003|65434965|FG000|Overall Study|Study closure as announced by sponsor|7|||
23462128|NCT01550003|65434966|FG001|Overall Study|Study closure as announced by sponsor|6|||
23462129|NCT01550003|65434967|FG002|Overall Study|Study closure as announced by sponsor|24|||
23462130|NCT01550003|65434965|FG000|Overall Study|Protocol Noncompliance|1|||
23462131|NCT01550003|65434966|FG001|Overall Study|Protocol Noncompliance|0|||
23183118|NCT01147809|64409421|FG002|Phase I (168 Days)|Adverse Event|0|||
23462132|NCT01550003|65434967|FG002|Overall Study|Protocol Noncompliance|0|||
23462133|NCT01550003|65434965|FG000|Overall Study|Study closure|0|||
23462134|NCT01550003|65434966|FG001|Overall Study|Study closure|1|||
23462135|NCT01550003|65434967|FG002|Overall Study|Study closure|1|||
23462136|NCT01550003|65434965|FG000|Overall Study|Patient reached adulthood|0|||
23462137|NCT01550003|65434966|FG001|Overall Study|Patient reached adulthood|1|||
23462138|NCT01550003|65434967|FG002|Overall Study|Patient reached adulthood|0|||
23462139|NCT01550003|65434965|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
23462140|NCT01550003|65434966|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
23462141|NCT01550003|65434967|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
23183119|NCT01147809|64409422|FG003|Phase I (168 Days)|Adverse Event|1|||
23183120|NCT01147809|64409423|FG004|Phase I (168 Days)|Adverse Event|0|||
23183121|NCT01147809|64409424|FG005|Phase I (168 Days)|Adverse Event|0|||
23183122|NCT01147809|64409419|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
23462142|NCT01550003|65434965|FG000|Overall Study|Sponsor's order|0|||
23462143|NCT01550003|65434966|FG001|Overall Study|Sponsor's order|3|||
23462144|NCT01550003|65434967|FG002|Overall Study|Sponsor's order|3|||
23462145|NCT01550003|65434965|FG000|Overall Study|Sponsor's decision|1|||
23462146|NCT01550003|65434966|FG001|Overall Study|Sponsor's decision|5|||
23462147|NCT01550003|65434967|FG002|Overall Study|Sponsor's decision|4|||
23462148|NCT01550003|65434965|FG000|Overall Study|Subject mother passed away|0|||
23462149|NCT01550003|65434966|FG001|Overall Study|Subject mother passed away|1|||
23462150|NCT01550003|65434967|FG002|Overall Study|Subject mother passed away|0|||
23462151|NCT01550003|65434965|FG000|Overall Study|Discontinuation|0|||
23462152|NCT01550003|65434966|FG001|Overall Study|Discontinuation|1|||
23462153|NCT01550003|65434967|FG002|Overall Study|Discontinuation|0|||
23462154|NCT01550003|65434965|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
23462155|NCT01550003|65434966|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
23462156|NCT01550003|65434967|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
23462157|NCT01550003|65434965|FG000|Overall Study|Site closure|0|||
23462158|NCT01550003|65434966|FG001|Overall Study|Site closure|2|||
23462159|NCT01550003|65434967|FG002|Overall Study|Site closure|0|||
23462160|NCT01550003|65434965|FG000|Overall Study|Pregnancy|0|||
23462161|NCT01550003|65434966|FG001|Overall Study|Pregnancy|1|||
23462162|NCT01550003|65434967|FG002|Overall Study|Pregnancy|0|||
23462163|NCT01550003|65434965|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
23462164|NCT01550003|65434966|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
23462165|NCT01550003|65434967|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
23462166|NCT01550003|65434965|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
23462167|NCT01550003|65434966|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
23462168|NCT01550003|65434967|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
23462169|NCT01550003|65434965|FG000|Overall Study|Switching to adult rheumatologist|0|||
23462170|NCT01550003|65434966|FG001|Overall Study|Switching to adult rheumatologist|0|||
23462171|NCT01550003|65434967|FG002|Overall Study|Switching to adult rheumatologist|1|||
23462172|NCT01550003|65434965|FG000|Overall Study|Patient transition to adult care|0|||
23462173|NCT01550003|65434966|FG001|Overall Study|Patient transition to adult care|0|||
23462174|NCT01550003|65434967|FG002|Overall Study|Patient transition to adult care|1|||
23462175|NCT01550003|65434965|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
23462176|NCT01550003|65434966|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
23462177|NCT01550003|65434967|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
23462178|NCT01550003|65434965|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
23462179|NCT01550003|65434966|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
23462180|NCT01550003|65434967|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
23462181|NCT01550003|65434965|FG000|Overall Study|Per Sponsor request|1|||
23462182|NCT01550003|65434966|FG001|Overall Study|Per Sponsor request|0|||
23462183|NCT01550003|65434967|FG002|Overall Study|Per Sponsor request|1|||
23462184|NCT01550003|65434965|FG000|Overall Study|Patient not compliance|0|||
23462185|NCT01550003|65434966|FG001|Overall Study|Patient not compliance|0|||
23462186|NCT01550003|65434967|FG002|Overall Study|Patient not compliance|1|||
23462187|NCT01550003|65434965|FG000|Overall Study|Non-compliance|0|||
23462188|NCT01550003|65434966|FG001|Overall Study|Non-compliance|0|||
23462189|NCT01550003|65434967|FG002|Overall Study|Non-compliance|1|||
23462190|NCT01550003|65434965|FG000|Overall Study|Study closed|0|||
23462191|NCT01550003|65434966|FG001|Overall Study|Study closed|1|||
23462192|NCT01550003|65434967|FG002|Overall Study|Study closed|0|||
23462193|NCT01550003|65434965|FG000|Overall Study|Transitioned to adult rheumatology|0|||
23462194|NCT01550003|65434966|FG001|Overall Study|Transitioned to adult rheumatology|0|||
23462195|NCT01550003|65434967|FG002|Overall Study|Transitioned to adult rheumatology|1|||
23462196|NCT01909453|65434968|FG000|Overall Study|Ongoing|118|||
23462197|NCT01909453|65434969|FG001|Overall Study|Ongoing|103|||
23462198|NCT01909453|65434970|FG002|Overall Study|Ongoing|83|||
23462199|NCT01909453|65434971|FG003|Overall Study|Ongoing|164|||
23462200|NCT01909453|65434972|FG004|Overall Study|Ongoing|50|||
23462201|NCT01909453|65434968|FG000|Overall Study|Death|69|||
23462202|NCT01909453|65434969|FG001|Overall Study|Death|74|||
23462203|NCT01909453|65434970|FG002|Overall Study|Death|88|||
23462204|NCT01909453|65434971|FG003|Overall Study|Death|86|||
23462205|NCT01909453|65434972|FG004|Overall Study|Death|29|||
23462206|NCT01909453|65434968|FG000|Overall Study|Lost to Follow-up|3|||
23462207|NCT01909453|65434969|FG001|Overall Study|Lost to Follow-up|4|||
23462208|NCT01909453|65434970|FG002|Overall Study|Lost to Follow-up|4|||
23462209|NCT01909453|65434971|FG003|Overall Study|Lost to Follow-up|3|||
23462210|NCT01909453|65434972|FG004|Overall Study|Lost to Follow-up|3|||
23242128|NCT00910000|64632855|FG000|Overall Study|Adverse Event|0|||
23462211|NCT01909453|65434968|FG000|Overall Study|Withdrawal by Subject|2|||
23462212|NCT01909453|65434969|FG001|Overall Study|Withdrawal by Subject|13|||
23462213|NCT01909453|65434970|FG002|Overall Study|Withdrawal by Subject|16|||
23462214|NCT01909453|65434971|FG003|Overall Study|Withdrawal by Subject|5|||
23584798|NCT00542386|65869292|FG002|Overall Study|Death|1|||
23462215|NCT01909453|65434972|FG004|Overall Study|Withdrawal by Subject|4|||
23462216|NCT04885998|65434973|FG000|Overall Study|Ongoing in study|3|||
23462217|NCT04885998|65434974|FG001|Overall Study|Ongoing in study|2|||
23462218|NCT04885998|65434975|FG002|Overall Study|Ongoing in study|2|||
23462219|NCT04885998|65434976|FG003|Overall Study|Ongoing in study|6|||
23462220|NCT04885998|65434973|FG000|Overall Study|Withdrawal by Subject|0|||
23462221|NCT04885998|65434974|FG001|Overall Study|Withdrawal by Subject|2|||
23462222|NCT04885998|65434975|FG002|Overall Study|Withdrawal by Subject|1|||
23462223|NCT04885998|65434976|FG003|Overall Study|Withdrawal by Subject|1|||
23462224|NCT04885998|65434973|FG000|Overall Study|Lost to Follow-up|1|||
23462225|NCT04885998|65434974|FG001|Overall Study|Lost to Follow-up|0|||
23462226|NCT04885998|65434975|FG002|Overall Study|Lost to Follow-up|0|||
23462227|NCT04885998|65434976|FG003|Overall Study|Lost to Follow-up|0|||
23462228|NCT04885998|65434973|FG000|Overall Study|Death|2|||
23462229|NCT04885998|65434974|FG001|Overall Study|Death|1|||
23462230|NCT04885998|65434975|FG002|Overall Study|Death|1|||
23462231|NCT04885998|65434976|FG003|Overall Study|Death|0|||
23462232|NCT01317472|65434978|FG000|Overall Study|Withdrawal by Subject|1|||
23462233|NCT01317472|65434979|FG001|Overall Study|Withdrawal by Subject|0|||
23462234|NCT01317472|65434978|FG000|Overall Study|Unrelated hospitalization|1|||
23462235|NCT01317472|65434979|FG001|Overall Study|Unrelated hospitalization|0|||
23462236|NCT03815929|65434980|FG000|Overall Study|Lost to Follow-up|2|||
23462237|NCT03815929|65434981|FG001|Overall Study|Lost to Follow-up|1|||
23462238|NCT03815929|65434982|FG002|Overall Study|Lost to Follow-up|0|||
23462239|NCT03815929|65434980|FG000|Overall Study|Physician Decision|2|||
23462240|NCT03815929|65434981|FG001|Overall Study|Physician Decision|2|||
23462241|NCT03815929|65434982|FG002|Overall Study|Physician Decision|0|||
23462242|NCT03815929|65434980|FG000|Overall Study|Withdrawal by Subject|0|||
23462243|NCT03815929|65434981|FG001|Overall Study|Withdrawal by Subject|0|||
23462244|NCT03815929|65434982|FG002|Overall Study|Withdrawal by Subject|1|||
23462245|NCT04225897|65434987|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462246|NCT04225897|65434988|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
23462247|NCT04225897|65434989|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462248|NCT04225897|65434990|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462249|NCT04225897|65434991|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462250|NCT04225897|65434992|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462251|NCT04225897|65434993|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462252|NCT04225897|65434994|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462253|NCT04225897|65434995|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462254|NCT04225897|65434996|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462255|NCT04225897|65434997|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462256|NCT04225897|65434998|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
23462257|NCT04225897|65434987|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462258|NCT04225897|65434988|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462259|NCT04225897|65434989|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
23462260|NCT04225897|65434990|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462261|NCT04225897|65434991|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462262|NCT04225897|65434992|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462263|NCT04225897|65434993|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462264|NCT04225897|65434994|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462265|NCT04225897|65434995|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462266|NCT04225897|65434996|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462267|NCT04225897|65434997|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462268|NCT04225897|65434998|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
23462269|NCT04225897|65434987|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462270|NCT04225897|65434988|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462271|NCT04225897|65434989|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
23462272|NCT04225897|65434990|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462273|NCT04225897|65434991|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462274|NCT04225897|65434992|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462275|NCT04225897|65434993|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462276|NCT04225897|65434994|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462277|NCT04225897|65434995|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462278|NCT04225897|65434996|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462279|NCT04225897|65434997|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23462280|NCT04225897|65434998|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
23242129|NCT00910000|64632856|FG001|Overall Study|Adverse Event|3|||
23242130|NCT00910000|64632857|FG002|Overall Study|Adverse Event|2|||
23462281|NCT04225897|65434987|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462282|NCT04225897|65434988|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462283|NCT04225897|65434989|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462284|NCT04225897|65434990|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462285|NCT04225897|65434991|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462286|NCT04225897|65434992|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462287|NCT04225897|65434993|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462288|NCT04225897|65434994|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
23462289|NCT04225897|65434995|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462290|NCT04225897|65434996|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462291|NCT04225897|65434997|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462292|NCT04225897|65434998|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
23462293|NCT04798196|65434999|FG000|Overall Study|Lost to Follow-up|3|||
23462294|NCT04798196|65435000|FG001|Overall Study|Lost to Follow-up|1|||
23462295|NCT04798196|65435001|FG002|Overall Study|Lost to Follow-up|3|||
23462296|NCT00724698|65435003|FG000|Overall Study|Adverse Event|9|||
23462297|NCT00724698|65435003|FG000|Overall Study|Failure of Therapy|4|||
23462298|NCT00724698|65435003|FG000|Overall Study|Poor Compliance|16|||
23462299|NCT00724698|65435003|FG000|Overall Study|Lost to Follow-up|36|||
23462300|NCT00724698|65435003|FG000|Overall Study|No Info|25|||
23462301|NCT03780244|65435009|FG000|Overall Study|Lost to Follow-up|1|||
23462302|NCT03780244|65435010|FG001|Overall Study|Lost to Follow-up|0|||
23462303|NCT02458313|65435011|FG000|Overall Study|Withdrawal by Subject|6|||
23462304|NCT02458313|65435012|FG001|Overall Study|Withdrawal by Subject|8|||
23462305|NCT02458313|65435011|FG000|Overall Study|Excluded for motion during MRI|1|||
23462306|NCT02458313|65435012|FG001|Overall Study|Excluded for motion during MRI|2|||
23462307|NCT02892344|65435013|FG000|Overall Study|Protocol deviation|3|||
23462308|NCT02892344|65435014|FG001|Overall Study|Protocol deviation|4|||
23462309|NCT02892344|65435013|FG000|Overall Study|Adverse Event|1|||
23462310|NCT02892344|65435014|FG001|Overall Study|Adverse Event|8|||
23462311|NCT02892344|65435013|FG000|Overall Study|Lost to Follow-up|0|||
23462312|NCT02892344|65435014|FG001|Overall Study|Lost to Follow-up|1|||
23462313|NCT02892344|65435013|FG000|Overall Study|Non-compliance with study treatment|0|||
23462314|NCT02892344|65435014|FG001|Overall Study|Non-compliance with study treatment|1|||
23462315|NCT02892344|65435013|FG000|Overall Study|Physician Decision|0|||
23462316|NCT02892344|65435014|FG001|Overall Study|Physician Decision|2|||
23462317|NCT02892344|65435013|FG000|Overall Study|Subject/guardian decision|0|||
23462318|NCT02892344|65435014|FG001|Overall Study|Subject/guardian decision|4|||
23462319|NCT02892344|65435013|FG000|Overall Study|Technical problems|0|||
23462320|NCT02892344|65435014|FG001|Overall Study|Technical problems|1|||
23462321|NCT01598532|65435015|FG000|Overall Study|Lost to Follow-up|3|||
23462322|NCT01598532|65435015|FG000|Overall Study|Did not meet inclusion criteria|8|||
23462323|NCT01353898|65435016|FG000|Overall Study|Study site terminated|0|||
23462324|NCT01353898|65435017|FG001|Overall Study|Study site terminated|0|||
23462325|NCT01353898|65435018|FG002|Overall Study|Study site terminated|0|||
23462326|NCT01353898|65435019|FG003|Overall Study|Study site terminated|0|||
23462327|NCT01353898|65435020|FG004|Overall Study|Study site terminated|0|||
23462328|NCT01353898|65435021|FG005|Overall Study|Study site terminated|1|||
23462329|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
23462330|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
23462331|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
23462332|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
23462333|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
23462334|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
23462335|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
23462336|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
23462337|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
23462338|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
23462339|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
23462340|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
23462341|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
23462342|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
23462343|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
23462344|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
23462345|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
23462346|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
23462347|NCT02952820|65435025|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
23462348|NCT02952820|65435026|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
23584799|NCT00542386|65869293|FG003|Overall Study|Death|2|||
23462349|NCT02952820|65435027|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
23462350|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
23462351|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
23242131|NCT00910000|64632858|FG003|Overall Study|Adverse Event|2|||
23462352|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
23462353|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
23462354|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
23462355|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
23462356|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
23462357|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
23462358|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
23242132|NCT00910000|64632859|FG004|Overall Study|Adverse Event|0|||
23462359|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
23462360|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
23462361|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
23462362|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
23462363|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
23462364|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
23462365|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
23462366|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
23462367|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
23462368|NCT02952820|65435025|FG000|Active Treatment Period (6 Months)|Not treated|0|||
23462369|NCT02952820|65435026|FG001|Active Treatment Period (6 Months)|Not treated|0|||
23462370|NCT02952820|65435027|FG002|Active Treatment Period (6 Months)|Not treated|1|||
23462371|NCT01910298|65435028|FG000|Overall Study|Adverse Event|1|||
23462372|NCT01910298|65435029|FG001|Overall Study|Adverse Event|0|||
23462373|NCT01910298|65435028|FG000|Overall Study|Withdrawal by Subject|2|||
23462374|NCT01910298|65435029|FG001|Overall Study|Withdrawal by Subject|7|||
23462375|NCT01910298|65435028|FG000|Overall Study|Protocol Deviation|0|||
23462376|NCT01910298|65435029|FG001|Overall Study|Protocol Deviation|5|||
23462377|NCT01910298|65435028|FG000|Overall Study|Lost to Follow-up|1|||
23462378|NCT01910298|65435029|FG001|Overall Study|Lost to Follow-up|1|||
23462379|NCT01910298|65435028|FG000|Overall Study|Study Terminated by Sponsor|1|||
23462380|NCT01910298|65435029|FG001|Overall Study|Study Terminated by Sponsor|17|||
23462381|NCT01910298|65435028|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23462382|NCT01910298|65435029|FG001|Overall Study|Other Miscellaneous Reasons|2|||
23462383|NCT01213472|65435030|FG000|Overall Study|Recurrence/Progressive disease|25|||
23462384|NCT01213472|65435030|FG000|Overall Study|Withdrawal by Subject|1|||
23462385|NCT01213472|65435030|FG000|Overall Study|Physician Decision|1|||
23462386|NCT00632229|65435031|FG000|Overall Study|Adverse Event|6|||
23462387|NCT00632229|65435032|FG001|Overall Study|Adverse Event|0|||
23462388|NCT00632229|65435031|FG000|Overall Study|Lost to Follow-up|0|||
23462389|NCT00632229|65435032|FG001|Overall Study|Lost to Follow-up|3|||
23462390|NCT00632229|65435031|FG000|Overall Study|Lack of Efficacy|0|||
23462391|NCT00632229|65435032|FG001|Overall Study|Lack of Efficacy|2|||
23462392|NCT00632229|65435031|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
23462393|NCT00632229|65435032|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
23462394|NCT02807402|65435033|FG000|Overall Study|Failure to Return|1|||
23462395|NCT02807402|65435033|FG000|Overall Study|Death|3|||
23462396|NCT02807402|65435033|FG000|Overall Study|Other|2|||
23462397|NCT02202759|65435034|FG000|Overall Study|Study Terminated by Sponsor|3|||
23462398|NCT02202759|65435035|FG001|Overall Study|Study Terminated by Sponsor|3|||
23462399|NCT02202759|65435036|FG002|Overall Study|Study Terminated by Sponsor|3|||
23462400|NCT02202759|65435034|FG000|Overall Study|Withdrawal by Subject|2|||
23462401|NCT02202759|65435035|FG001|Overall Study|Withdrawal by Subject|1|||
23462402|NCT02202759|65435036|FG002|Overall Study|Withdrawal by Subject|1|||
23462403|NCT02202759|65435034|FG000|Overall Study|Reason not Specified|4|||
23462404|NCT02202759|65435035|FG001|Overall Study|Reason not Specified|11|||
23462405|NCT02202759|65435036|FG002|Overall Study|Reason not Specified|10|||
23462406|NCT04322526|65435037|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
23462407|NCT04322526|65435038|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
23462408|NCT04322526|65435037|FG000|Washout (1 Week)|Lost to Follow-up|1|||
23462409|NCT04322526|65435038|FG001|Washout (1 Week)|Lost to Follow-up|2|||
23462410|NCT01352793|65435039|FG000|Overall Study|Lost to Follow-up|289|||
23462411|NCT01352793|65435040|FG001|Overall Study|Lost to Follow-up|125|||
23242133|NCT00910000|64632860|FG005|Overall Study|Adverse Event|1|||
23242134|NCT00910000|64632855|FG000|Overall Study|Withdrawal by Subject|0|||
23242135|NCT00910000|64632856|FG001|Overall Study|Withdrawal by Subject|0|||
23242136|NCT00910000|64632857|FG002|Overall Study|Withdrawal by Subject|1|||
23242137|NCT00910000|64632858|FG003|Overall Study|Withdrawal by Subject|0|||
23242138|NCT00910000|64632859|FG004|Overall Study|Withdrawal by Subject|1|||
23242139|NCT00910000|64632860|FG005|Overall Study|Withdrawal by Subject|0|||
23462412|NCT01352793|65435039|FG000|Overall Study|Withdrawal by Subject|120|||
23462413|NCT01352793|65435040|FG001|Overall Study|Withdrawal by Subject|55|||
23462414|NCT01352793|65435039|FG000|Overall Study|Protocol Violation|44|||
23462415|NCT01352793|65435040|FG001|Overall Study|Protocol Violation|23|||
23462416|NCT01352793|65435039|FG000|Overall Study|Adverse Event|44|||
23242140|NCT01165424|64632862|FG000|Overall Study|Clinical adverse experiences|1|||
23462417|NCT01352793|65435040|FG001|Overall Study|Adverse Event|10|||
23462418|NCT01352793|65435039|FG000|Overall Study|Physician Decision|1|||
23462419|NCT01352793|65435040|FG001|Overall Study|Physician Decision|0|||
23462420|NCT01352793|65435039|FG000|Overall Study|Pregnancy|26|||
23462421|NCT01352793|65435040|FG001|Overall Study|Pregnancy|8|||
23462422|NCT01352793|65435039|FG000|Overall Study|Other|25|||
23462423|NCT01352793|65435040|FG001|Overall Study|Other|7|||
23462424|NCT01352793|65435039|FG000|Overall Study|Medication error|2|||
23462425|NCT01352793|65435040|FG001|Overall Study|Medication error|2|||
23462426|NCT01352793|65435039|FG000|Overall Study|Death|1|||
23462427|NCT01352793|65435040|FG001|Overall Study|Death|0|||
23462428|NCT01352793|65435039|FG000|Overall Study|Randomized but not vaccinated|8|||
23462429|NCT01352793|65435040|FG001|Overall Study|Randomized but not vaccinated|0|||
23462430|NCT01352793|65435039|FG000|Overall Study|No longer meets eligibility criteria|25|||
23462431|NCT01352793|65435040|FG001|Overall Study|No longer meets eligibility criteria|15|||
23462432|NCT00656513|65435045|FG000|Overall Study|Protocol Violation|1|||
23462433|NCT00656513|65435046|FG001|Overall Study|Protocol Violation|0|||
23462434|NCT00656513|65435047|FG002|Overall Study|Protocol Violation|2|||
23462435|NCT00656513|65435045|FG000|Overall Study|Withdrawal by Subject|0|||
23462436|NCT00656513|65435046|FG001|Overall Study|Withdrawal by Subject|11|||
23462437|NCT00656513|65435047|FG002|Overall Study|Withdrawal by Subject|4|||
23462438|NCT00656513|65435045|FG000|Overall Study|Death|0|||
23462439|NCT00656513|65435046|FG001|Overall Study|Death|0|||
23462440|NCT00656513|65435047|FG002|Overall Study|Death|1|||
23462441|NCT00656513|65435045|FG000|Overall Study|Missing data|0|||
23462442|NCT00656513|65435046|FG001|Overall Study|Missing data|11|||
23462443|NCT00656513|65435047|FG002|Overall Study|Missing data|9|||
23462444|NCT00656513|65435045|FG000|Overall Study|Incomplete treatment|3|||
23462445|NCT00656513|65435046|FG001|Overall Study|Incomplete treatment|0|||
23462446|NCT00656513|65435047|FG002|Overall Study|Incomplete treatment|0|||
23462447|NCT00656513|65435045|FG000|Overall Study|Treatment completed outside of timeframe|0|||
23462448|NCT00656513|65435046|FG001|Overall Study|Treatment completed outside of timeframe|3|||
23462449|NCT00656513|65435047|FG002|Overall Study|Treatment completed outside of timeframe|1|||
23462450|NCT00656513|65435045|FG000|Overall Study|Missing baseline form|0|||
23462451|NCT00656513|65435046|FG001|Overall Study|Missing baseline form|5|||
23462452|NCT00656513|65435047|FG002|Overall Study|Missing baseline form|5|||
23462453|NCT00885170|65435051|FG000|Overall Study|Adverse Event|12|||
23462454|NCT00885170|65435052|FG001|Overall Study|Adverse Event|4|||
23462455|NCT00885170|65435051|FG000|Overall Study|Excessive bone loss|6|||
23462456|NCT00885170|65435052|FG001|Overall Study|Excessive bone loss|3|||
23462457|NCT00885170|65435051|FG000|Overall Study|Lost to Follow-up|2|||
23462458|NCT00885170|65435052|FG001|Overall Study|Lost to Follow-up|1|||
23462459|NCT00885170|65435051|FG000|Overall Study|Physician Decision|2|||
23462460|NCT00885170|65435052|FG001|Overall Study|Physician Decision|1|||
23462461|NCT00885170|65435051|FG000|Overall Study|Protocol Violation|3|||
23462462|NCT00885170|65435052|FG001|Overall Study|Protocol Violation|1|||
23462463|NCT00885170|65435051|FG000|Overall Study|Withdrawal by Subject|13|||
23462464|NCT00885170|65435052|FG001|Overall Study|Withdrawal by Subject|13|||
23462465|NCT01980017|65435053|FG000|Overall Study|Lost to Follow-up|30|||
23462466|NCT01980017|65435054|FG001|Overall Study|Lost to Follow-up|21|||
23462467|NCT01980017|65435053|FG000|Overall Study|Death|0|||
23462468|NCT01980017|65435054|FG001|Overall Study|Death|1|||
23462469|NCT00887809|65435055|FG000|Overall Study|Patient Not Treated|3|||
23462470|NCT00887809|65435056|FG001|Overall Study|Patient Not Treated|0|||
23462471|NCT00887809|65435055|FG000|Overall Study|Death|1|||
23462472|NCT00887809|65435056|FG001|Overall Study|Death|0|||
23462473|NCT02038933|65435057|FG000|Overall Study|Disease progression|104|||
23462474|NCT02038933|65435057|FG000|Overall Study|Study drug toxicity|6|||
23462475|NCT02038933|65435057|FG000|Overall Study|Adverse event unrelated to study drug|6|||
23183123|NCT01147809|64409420|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
23183124|NCT01147809|64409421|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
23183125|NCT01147809|64409422|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
23183126|NCT01147809|64409423|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
23183127|NCT01147809|64409424|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
23183128|NCT01147809|64409419|FG000|Phase I (168 Days)|Physician Decision|0|||
23462476|NCT02038933|65435057|FG000|Overall Study|Participant request to discontinue treatment|2|||
23462477|NCT02038933|65435057|FG000|Overall Study|Lost to Follow-up|1|||
23462478|NCT02038933|65435057|FG000|Overall Study|Other reasons|2|||
23462479|NCT03472885|65435058|FG000|24-Week Treatment Period|Adverse Event|1|||
23462480|NCT01491607|65435059|FG000|Overall Study|Lost to Follow-up|7|||
23462481|NCT01491607|65435059|FG000|Overall Study|Withdrawal by Subject|3|||
23462482|NCT00446849|65437889|FG000|Acute Phase|Lack of Efficacy|64|||
23462483|NCT00446849|65437889|FG000|Acute Phase|Protocol Violation|10|||
23584800|NCT00542386|65869294|FG004|Overall Study|Death|1|||
23462484|NCT00446849|65437889|FG000|Acute Phase|Consent withdrawn|4|||
23462485|NCT00446849|65437889|FG000|Acute Phase|Lost to Follow-up|2|||
23462486|NCT00446849|65437889|FG000|Acute Phase|Physician Decision|1|||
23462487|NCT00446849|65437889|FG000|Acute Phase|noncompliance|1|||
23462488|NCT00446849|65437889|FG000|Maintenance Phase|Lack of Efficacy|40|||
23183129|NCT01147809|64409420|FG001|Phase I (168 Days)|Physician Decision|1|||
23183130|NCT01147809|64409421|FG002|Phase I (168 Days)|Physician Decision|2|||
23183131|NCT01147809|64409422|FG003|Phase I (168 Days)|Physician Decision|0|||
23462489|NCT00446849|65437889|FG000|Maintenance Phase|Protocol Violation|7|||
23462490|NCT00446849|65437889|FG000|Maintenance Phase|Adverse Event|6|||
23462491|NCT00446849|65437889|FG000|Maintenance Phase|Consent withdrawn|5|||
23462492|NCT00446849|65437889|FG000|Maintenance Phase|Lost to Follow-up|3|||
23462493|NCT00446849|65437889|FG000|Maintenance Phase|Pregnancy|1|||
23462494|NCT00446849|65437889|FG000|Maintenance Phase|noncompliance|2|||
23462495|NCT00446849|65437889|FG000|Maintenance Phase|prohibited medication use|2|||
23462496|NCT00446849|65437889|FG000|Maintenance Phase|antibiotic use|1|||
23462497|NCT00446849|65437889|FG000|Maintenance Phase|study closure|1|||
23183132|NCT01147809|64409423|FG004|Phase I (168 Days)|Physician Decision|0|||
23183133|NCT01147809|64409424|FG005|Phase I (168 Days)|Physician Decision|0|||
23183134|NCT01147809|64409419|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
23183135|NCT01147809|64409420|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
23183136|NCT01147809|64409421|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
23183137|NCT01147809|64409422|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
23183138|NCT01147809|64409423|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
23183139|NCT01147809|64409424|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
23183140|NCT01147809|64409419|FG000|Phase II (168 Days)|Adverse Event|0|||
23183141|NCT01147809|64409420|FG001|Phase II (168 Days)|Adverse Event|0|||
23183142|NCT01147809|64409421|FG002|Phase II (168 Days)|Adverse Event|0|||
23183143|NCT01147809|64409422|FG003|Phase II (168 Days)|Adverse Event|0|||
23183144|NCT01147809|64409423|FG004|Phase II (168 Days)|Adverse Event|3|||
23183145|NCT01147809|64409424|FG005|Phase II (168 Days)|Adverse Event|6|||
23183146|NCT01147809|64409419|FG000|Phase II (168 Days)|Protocol Violation|0|||
23183147|NCT01147809|64409420|FG001|Phase II (168 Days)|Protocol Violation|0|||
23183148|NCT01147809|64409421|FG002|Phase II (168 Days)|Protocol Violation|0|||
23183149|NCT01147809|64409422|FG003|Phase II (168 Days)|Protocol Violation|0|||
23183150|NCT01147809|64409423|FG004|Phase II (168 Days)|Protocol Violation|0|||
23183151|NCT01147809|64409424|FG005|Phase II (168 Days)|Protocol Violation|1|||
23183152|NCT01147809|64409419|FG000|Phase II (168 Days)|Physician Decision|0|||
23183153|NCT01147809|64409420|FG001|Phase II (168 Days)|Physician Decision|0|||
23183154|NCT01147809|64409421|FG002|Phase II (168 Days)|Physician Decision|0|||
23462498|NCT00446849|65437889|FG000|Maintenance Phase|hydrocodone use|1|||
23183155|NCT01147809|64409422|FG003|Phase II (168 Days)|Physician Decision|0|||
23183156|NCT01147809|64409423|FG004|Phase II (168 Days)|Physician Decision|5|||
23183157|NCT01147809|64409424|FG005|Phase II (168 Days)|Physician Decision|11|||
23183158|NCT01147809|64409419|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
23462499|NCT00446849|65437889|FG000|Maintenance Phase|concomitant medication use|1|||
23462500|NCT01498068|65437890|FG000|Overall Study|Withdrawal by Subject|1|||
23349719|NCT01651000|65025263|FG000|Overall Study|Lack of Efficacy|1|||
23349720|NCT01651000|65025264|FG001|Overall Study|Lack of Efficacy|1|||
23242141|NCT01165424|64632862|FG000|Overall Study|Laboratory adverse experiences|1|||
23242142|NCT01165424|64632862|FG000|Overall Study|Did not meet entry criteria|1|||
23242143|NCT01165424|64632862|FG000|Overall Study|Participant moved (relocated)|1|||
23242144|NCT04113746|64632865|FG000|Overall Study|Lost to Follow-up|4|||
23242145|NCT04113746|64632866|FG001|Overall Study|Lost to Follow-up|4|||
23242146|NCT01463631|64632867|FG000|Overall Study|Withdrawal by Subject|0|||
23242147|NCT01463631|64632868|FG001|Overall Study|Withdrawal by Subject|0|||
23242148|NCT01463631|64632869|FG002|Overall Study|Withdrawal by Subject|0|||
23349721|NCT01651000|65025263|FG000|Overall Study|Physician Decision|1|||
23349722|NCT01651000|65025264|FG001|Overall Study|Physician Decision|0|||
23183159|NCT01147809|64409420|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
23183160|NCT01147809|64409421|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
23183161|NCT01147809|64409422|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
23183162|NCT01147809|64409423|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
23183163|NCT01147809|64409424|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
23183164|NCT01147809|64409419|FG000|Phase II (168 Days)|Ongoing|0|||
23183165|NCT01147809|64409420|FG001|Phase II (168 Days)|Ongoing|0|||
23183166|NCT01147809|64409421|FG002|Phase II (168 Days)|Ongoing|0|||
23183167|NCT01147809|64409422|FG003|Phase II (168 Days)|Ongoing|0|||
23183168|NCT01147809|64409423|FG004|Phase II (168 Days)|Ongoing|1|||
23183169|NCT01147809|64409424|FG005|Phase II (168 Days)|Ongoing|0|||
23183170|NCT00191854|64409425|FG000|Overall Study|Death|26|||
23183171|NCT00191854|64409426|FG001|Overall Study|Death|23|||
23183172|NCT00191854|64409427|FG002|Overall Study|Death|29|||
23183173|NCT00191854|64409425|FG000|Overall Study|Lost to Follow-up|7|||
23183174|NCT00191854|64409426|FG001|Overall Study|Lost to Follow-up|5|||
23183175|NCT00191854|64409427|FG002|Overall Study|Lost to Follow-up|5|||
23349723|NCT01651000|65025263|FG000|Overall Study|Administrative reason|1|||
23349724|NCT01651000|65025264|FG001|Overall Study|Administrative reason|0|||
23349725|NCT01651000|65025263|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
23349726|NCT01651000|65025264|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
23183176|NCT00191854|64409425|FG000|Overall Study|Withdrawal by Subject|4|||
23183177|NCT00191854|64409426|FG001|Overall Study|Withdrawal by Subject|2|||
23183178|NCT00191854|64409427|FG002|Overall Study|Withdrawal by Subject|3|||
23183179|NCT00191854|64409425|FG000|Overall Study|Sponsor Decision|0|||
23183180|NCT00191854|64409426|FG001|Overall Study|Sponsor Decision|0|||
23183181|NCT00191854|64409427|FG002|Overall Study|Sponsor Decision|1|||
23183182|NCT00191854|64409425|FG000|Overall Study|Screen Failure|0|||
23183183|NCT00191854|64409426|FG001|Overall Study|Screen Failure|0|||
23183184|NCT00191854|64409427|FG002|Overall Study|Screen Failure|1|||
23242149|NCT01463631|64632870|FG003|Overall Study|Withdrawal by Subject|1|||
23183185|NCT01445171|64409428|FG000|Overall Study|Lost to Follow-up|11|||
23183186|NCT01445171|64409428|FG000|Overall Study|Withdrawal by Subject|16|||
23183187|NCT01445171|64409428|FG000|Overall Study|Death|51|||
23183188|NCT01445171|64409428|FG000|Overall Study|Subjects declined to return for followup|9|||
23183189|NCT01445171|64409428|FG000|Overall Study|Consented but did not receive device|8|||
23242150|NCT01463631|64632867|FG000|Overall Study|Death|0|||
23242151|NCT01463631|64632868|FG001|Overall Study|Death|0|||
23349727|NCT01199822|65025267|FG000|Overall Study|Investigator discontinued therapy|0|||
23349728|NCT01199822|65025268|FG001|Overall Study|Investigator discontinued therapy|1|||
23462501|NCT01498068|65437891|FG001|Overall Study|Withdrawal by Subject|1|||
23584801|NCT00542386|65869295|FG005|Overall Study|Death|2|||
23584802|NCT00542386|65869290|FG000|Overall Study|Lack of Efficacy|32|||
23584803|NCT00542386|65869291|FG001|Overall Study|Lack of Efficacy|12|||
23584804|NCT00542386|65869292|FG002|Overall Study|Lack of Efficacy|10|||
23584805|NCT00542386|65869293|FG003|Overall Study|Lack of Efficacy|13|||
23584806|NCT00542386|65869294|FG004|Overall Study|Lack of Efficacy|7|||
23584807|NCT00542386|65869295|FG005|Overall Study|Lack of Efficacy|31|||
23584808|NCT00542386|65869290|FG000|Overall Study|Physician Decision|1|||
23584809|NCT00542386|65869291|FG001|Overall Study|Physician Decision|0|||
23584810|NCT00542386|65869292|FG002|Overall Study|Physician Decision|0|||
23584811|NCT00542386|65869293|FG003|Overall Study|Physician Decision|1|||
23584812|NCT00542386|65869294|FG004|Overall Study|Physician Decision|0|||
23584813|NCT00542386|65869295|FG005|Overall Study|Physician Decision|0|||
23584814|NCT00542386|65869290|FG000|Overall Study|Protocol Violation|0|||
23183190|NCT00603239|64409437|FG000|Overall Study|Adverse Event|4|||
23183191|NCT00603239|64409438|FG001|Overall Study|Adverse Event|1|||
23183192|NCT00603239|64409437|FG000|Overall Study|Entry criteria not met|0|||
23183193|NCT00603239|64409438|FG001|Overall Study|Entry criteria not met|1|||
23183194|NCT00603239|64409437|FG000|Overall Study|Loss of glucose control|3|||
23183195|NCT00603239|64409438|FG001|Overall Study|Loss of glucose control|0|||
23183196|NCT00603239|64409437|FG000|Overall Study|Lost to Follow-up|2|||
23183197|NCT00603239|64409438|FG001|Overall Study|Lost to Follow-up|1|||
23183198|NCT00603239|64409437|FG000|Overall Study|Physician Decision|2|||
23349729|NCT01199822|65025269|FG002|Overall Study|Investigator discontinued therapy|0|||
23183199|NCT00603239|64409438|FG001|Overall Study|Physician Decision|0|||
23183200|NCT00603239|64409437|FG000|Overall Study|Protocol Violation|2|||
23183201|NCT00603239|64409438|FG001|Overall Study|Protocol Violation|0|||
23183202|NCT00603239|64409437|FG000|Overall Study|Subject decision|2|||
23183203|NCT00603239|64409438|FG001|Overall Study|Subject decision|1|||
23183204|NCT02210780|64409440|FG000|Overall Study|Adverse Event|0|||
23183205|NCT02210780|64409441|FG001|Overall Study|Adverse Event|5|||
23183206|NCT02210780|64409440|FG000|Overall Study|Lost to Follow-up|2|||
23183207|NCT02210780|64409441|FG001|Overall Study|Lost to Follow-up|1|||
23183208|NCT02210780|64409440|FG000|Overall Study|Withdrawal by Subject|1|||
23183209|NCT02210780|64409441|FG001|Overall Study|Withdrawal by Subject|1|||
23183210|NCT02210780|64409440|FG000|Overall Study|Physician Decision|1|||
23183211|NCT02210780|64409441|FG001|Overall Study|Physician Decision|0|||
23183212|NCT02210780|64409440|FG000|Overall Study|Protocol Violation|1|||
23183213|NCT02210780|64409441|FG001|Overall Study|Protocol Violation|0|||
23183214|NCT02210780|64409440|FG000|Overall Study|Other than specified above|0|||
23183215|NCT02210780|64409441|FG001|Overall Study|Other than specified above|1|||
23349730|NCT03871829|65025270|FG000|Overall Study|Lost to Follow-up|0|||
23349731|NCT03871829|65025271|FG001|Overall Study|Lost to Follow-up|1|||
23349732|NCT03871829|65025270|FG000|Overall Study|Withdrawal by Subject|1|||
23349733|NCT03871829|65025271|FG001|Overall Study|Withdrawal by Subject|1|||
23349734|NCT03871829|65025270|FG000|Overall Study|Death|12|||
23349735|NCT03871829|65025271|FG001|Overall Study|Death|8|||
23349736|NCT03871829|65025270|FG000|Overall Study|Study terminated by sponsor|31|||
23349737|NCT03871829|65025271|FG001|Overall Study|Study terminated by sponsor|34|||
23349738|NCT04594941|65025273|FG000|Overall Study|Other|0|||
23183216|NCT02485717|64409442|FG000|Overall Study|Lost to Follow-up|6|||
23183217|NCT02485717|64409443|FG001|Overall Study|Lost to Follow-up|0|||
23349739|NCT04594941|65025274|FG001|Overall Study|Other|3|||
23183218|NCT02485717|64409444|FG002|Overall Study|Lost to Follow-up|0|||
23183219|NCT02485717|64409442|FG000|Overall Study|Withdrawal by Subject|0|||
23349740|NCT04594941|65025275|FG002|Overall Study|Other|1|||
23584815|NCT00542386|65869291|FG001|Overall Study|Protocol Violation|0|||
23584816|NCT00542386|65869292|FG002|Overall Study|Protocol Violation|1|||
23584817|NCT00542386|65869293|FG003|Overall Study|Protocol Violation|0|||
23584818|NCT00542386|65869294|FG004|Overall Study|Protocol Violation|0|||
23584819|NCT00542386|65869295|FG005|Overall Study|Protocol Violation|4|||
23584820|NCT00542386|65869290|FG000|Overall Study|Withdrawal by Subject|5|||
23584821|NCT00542386|65869291|FG001|Overall Study|Withdrawal by Subject|8|||
23584822|NCT00542386|65869292|FG002|Overall Study|Withdrawal by Subject|10|||
23584823|NCT00542386|65869293|FG003|Overall Study|Withdrawal by Subject|11|||
23584824|NCT00542386|65869294|FG004|Overall Study|Withdrawal by Subject|15|||
23183220|NCT02485717|64409443|FG001|Overall Study|Withdrawal by Subject|0|||
23183221|NCT02485717|64409444|FG002|Overall Study|Withdrawal by Subject|1|||
23183222|NCT02485717|64409442|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
23183223|NCT02485717|64409443|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
23183224|NCT02485717|64409444|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
23183225|NCT02485717|64409442|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
23183226|NCT02485717|64409443|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
23242152|NCT01463631|64632869|FG002|Overall Study|Death|1|||
23242153|NCT01463631|64632870|FG003|Overall Study|Death|0|||
23242154|NCT01463631|64632867|FG000|Overall Study|Progressive Disease|0|||
23242155|NCT01463631|64632868|FG001|Overall Study|Progressive Disease|0|||
23242156|NCT01463631|64632869|FG002|Overall Study|Progressive Disease|0|||
23242157|NCT01463631|64632870|FG003|Overall Study|Progressive Disease|5|||
23242158|NCT01803464|64632871|FG000|Overall Study|Incomplete data|0|||
23242159|NCT01803464|64632872|FG001|Overall Study|Incomplete data|0|||
23242160|NCT01803464|64632873|FG002|Overall Study|Incomplete data|4|||
23242161|NCT01803464|64632874|FG003|Overall Study|Incomplete data|0|||
23242162|NCT01803464|64632871|FG000|Overall Study|Withdrawal by Subject|1|||
23242163|NCT01803464|64632872|FG001|Overall Study|Withdrawal by Subject|0|||
23242164|NCT01803464|64632873|FG002|Overall Study|Withdrawal by Subject|0|||
23242165|NCT01803464|64632874|FG003|Overall Study|Withdrawal by Subject|0|||
23242166|NCT02769832|64632875|FG000|Overall Study|Death|30|||
23242167|NCT03526549|64632876|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
23242168|NCT03526549|64632877|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
23242169|NCT03526549|64632876|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
23242170|NCT03526549|64632877|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
23242171|NCT03526549|64632876|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
23242172|NCT03526549|64632877|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
23462502|NCT04434937|65437892|FG000|Overall Study|Death|4|||
23462503|NCT04434937|65437892|FG000|Overall Study|Withdrawal by Subject|1|||
23462504|NCT04434937|65437892|FG000|Overall Study|Transitioned to Rollover Study|19|||
23462505|NCT04434937|65437892|FG000|Overall Study|Progressive Disease|18|||
23462506|NCT03220035|65437893|FG000|Overall Study|Adverse Event|1|||
23462507|NCT03220035|65437893|FG000|Overall Study|Protocol Violation|1|||
23584825|NCT00542386|65869295|FG005|Overall Study|Withdrawal by Subject|7|||
23584826|NCT00542386|65869290|FG000|Overall Study|Other Reasons|4|||
23584827|NCT00542386|65869291|FG001|Overall Study|Other Reasons|1|||
23584828|NCT00542386|65869292|FG002|Overall Study|Other Reasons|4|||
23584829|NCT00542386|65869293|FG003|Overall Study|Other Reasons|3|||
23584830|NCT00542386|65869294|FG004|Overall Study|Other Reasons|4|||
23242173|NCT03526549|64632876|FG000|Open-label Phase|Adverse Event|4|||
23242174|NCT03526549|64632877|FG001|Open-label Phase|Adverse Event|0|||
23242175|NCT03526549|64632876|FG000|Open-label Phase|Withdrawal by Subject|54|||
23242176|NCT03526549|64632877|FG001|Open-label Phase|Withdrawal by Subject|0|||
23242177|NCT03526549|64632876|FG000|Open-label Phase|Lost to Follow-up|35|||
23242178|NCT03526549|64632877|FG001|Open-label Phase|Lost to Follow-up|0|||
23584831|NCT00542386|65869295|FG005|Overall Study|Other Reasons|2|||
23584832|NCT00545844|65869296|FG000|Overall Study|Lost to Follow-up|9|||
23584833|NCT00545844|65869296|FG000|Overall Study|Protocol Violation|1|||
23584834|NCT00545844|65869296|FG000|Overall Study|Withdrawal by Subject|2|||
23584835|NCT03210402|65869297|FG000|Overall Study|Withdrawal by Subject|0|||
23584836|NCT03210402|65869298|FG001|Overall Study|Withdrawal by Subject|1|||
23584837|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
23584838|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
23584839|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
23584840|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
23584841|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
23584842|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
23584843|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
23584844|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
23584845|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Death|1|||
23584846|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Death|0|||
23242179|NCT03526549|64632876|FG000|Open-label Phase|Other than Specified|5|||
23242180|NCT03526549|64632877|FG001|Open-label Phase|Other than Specified|0|||
23349741|NCT04594941|65025276|FG003|Overall Study|Other|0|||
23349742|NCT01167634|65025277|FG000|Overall Study|Lost to Follow-up|1|||
23462508|NCT03220035|65437893|FG000|Overall Study|Progressive Disease|2|||
23584847|NCT01080131|65869299|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
23584848|NCT01080131|65869300|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
23584849|NCT01080131|65869299|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
23584850|NCT01080131|65869300|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
23242181|NCT00151775|64632878|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
23242182|NCT00151775|64632879|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
23242183|NCT00151775|64632880|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23349743|NCT01167634|65025278|FG001|Overall Study|Lost to Follow-up|3|||
23462509|NCT04986904|65437894|FG000|Overall Study|Lost to Follow-up|11|||
23242184|NCT00151775|64632881|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23242185|NCT00151775|64632882|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23242186|NCT00151775|64632883|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23242187|NCT00151775|64632884|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23242188|NCT00151775|64632885|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23242189|NCT00151775|64632886|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23242190|NCT00151775|64632887|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23242191|NCT00151775|64632888|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23242192|NCT00151775|64632889|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
23242193|NCT00151775|64632878|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
23242194|NCT00151775|64632879|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23242195|NCT00151775|64632880|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23242196|NCT00151775|64632881|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23242197|NCT00151775|64632882|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23242198|NCT00151775|64632883|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23242199|NCT00151775|64632884|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
23242200|NCT00151775|64632885|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23183227|NCT02485717|64409444|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
23183228|NCT00928070|64409445|FG000|Overall Study|Lost to Follow-up|1|||
23183229|NCT00928070|64409446|FG001|Overall Study|Lost to Follow-up|2|||
23183230|NCT00928070|64409445|FG000|Overall Study|Withdrawal by Subject|10|||
23183231|NCT00928070|64409446|FG001|Overall Study|Withdrawal by Subject|3|||
23183232|NCT00928070|64409445|FG000|Overall Study|Adverse Event|14|||
23183233|NCT00928070|64409446|FG001|Overall Study|Adverse Event|26|||
23183234|NCT00928070|64409445|FG000|Overall Study|Lack of Efficacy|9|||
23183235|NCT00928070|64409446|FG001|Overall Study|Lack of Efficacy|5|||
23183236|NCT00928070|64409445|FG000|Overall Study|Did not meet entrance criteria|16|||
23183237|NCT00928070|64409446|FG001|Overall Study|Did not meet entrance criteria|9|||
23183238|NCT00928070|64409445|FG000|Overall Study|Protocol Violation|6|||
23183239|NCT00928070|64409446|FG001|Overall Study|Protocol Violation|5|||
23183240|NCT00928070|64409445|FG000|Overall Study|Randomized but not treated|2|||
23183241|NCT00928070|64409446|FG001|Overall Study|Randomized but not treated|2|||
23183242|NCT00928070|64409445|FG000|Overall Study|Other|5|||
23183243|NCT00928070|64409446|FG001|Overall Study|Other|5|||
23183244|NCT01822561|64409447|FG000|Overall Study|Withdrawal by Subject|2|||
23183245|NCT04525703|64409448|FG000|Overall Study|Lost to Follow-up|6|||
23183246|NCT04525703|64409449|FG001|Overall Study|Lost to Follow-up|15|||
23183247|NCT04525703|64409450|FG002|Overall Study|Lost to Follow-up|8|||
23183248|NCT01412879|64409454|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
23183249|NCT01412879|64409455|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
23183250|NCT01412879|64409456|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
23183251|NCT01412879|64409454|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
23183252|NCT01412879|64409455|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
23183253|NCT01412879|64409456|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
23183254|NCT01412879|64409454|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
23183255|NCT01412879|64409455|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
23183256|NCT01412879|64409456|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
23183257|NCT01412879|64409454|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
23183258|NCT01412879|64409455|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
23183259|NCT01412879|64409456|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
23183260|NCT01412879|64409454|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
23183261|NCT01412879|64409455|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
23183262|NCT01412879|64409456|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
23183263|NCT01642212|64409458|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
23183264|NCT01642212|64409459|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
23183265|NCT01642212|64409460|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
23183266|NCT01642212|64409461|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
23242201|NCT00151775|64632886|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23242202|NCT00151775|64632887|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23349744|NCT01167634|65025279|FG002|Overall Study|Lost to Follow-up|3|||
23349745|NCT01167634|65025280|FG003|Overall Study|Lost to Follow-up|4|||
23349746|NCT01167634|65025277|FG000|Overall Study|Withdrawal by Subject|1|||
23349747|NCT01167634|65025278|FG001|Overall Study|Withdrawal by Subject|1|||
23349748|NCT01167634|65025279|FG002|Overall Study|Withdrawal by Subject|0|||
23349749|NCT01167634|65025280|FG003|Overall Study|Withdrawal by Subject|0|||
23242203|NCT00151775|64632888|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
23242204|NCT00151775|64632889|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
23242205|NCT00151775|64632878|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242206|NCT00151775|64632879|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
23242207|NCT00151775|64632880|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242208|NCT00151775|64632881|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242209|NCT00151775|64632882|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242210|NCT00151775|64632883|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242211|NCT00151775|64632884|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242212|NCT00151775|64632885|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242213|NCT00151775|64632886|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242214|NCT00151775|64632887|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242215|NCT00151775|64632888|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242216|NCT00151775|64632889|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
23242217|NCT00151775|64632878|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
23349750|NCT03338569|65025281|FG000|Overall Study|Physician Decision|8|||
23349751|NCT03338569|65025282|FG001|Overall Study|Physician Decision|3|||
23349752|NCT03338569|65025281|FG000|Overall Study|Withdrawal by Subject|0|||
23349753|NCT03338569|65025282|FG001|Overall Study|Withdrawal by Subject|1|||
23349754|NCT03338569|65025281|FG000|Overall Study|Lost to Follow-up|0|||
23349755|NCT03338569|65025282|FG001|Overall Study|Lost to Follow-up|1|||
23349756|NCT02854605|65025285|FG000|Overall Study|Adverse Event|1|||
23349757|NCT02854605|65025286|FG001|Overall Study|Adverse Event|5|||
23349758|NCT02854605|65025287|FG002|Overall Study|Adverse Event|2|||
23349759|NCT02854605|65025285|FG000|Overall Study|Lost to Follow-up|0|||
23349760|NCT02854605|65025286|FG001|Overall Study|Lost to Follow-up|2|||
23349761|NCT02854605|65025287|FG002|Overall Study|Lost to Follow-up|0|||
23349762|NCT02854605|65025285|FG000|Overall Study|Withdrew Consent|1|||
23349763|NCT02854605|65025286|FG001|Overall Study|Withdrew Consent|0|||
23349764|NCT02854605|65025287|FG002|Overall Study|Withdrew Consent|1|||
23349765|NCT02854605|65025285|FG000|Overall Study|Investigator's Discretion|1|||
23349766|NCT02854605|65025286|FG001|Overall Study|Investigator's Discretion|0|||
23349767|NCT02854605|65025287|FG002|Overall Study|Investigator's Discretion|0|||
23349768|NCT02854605|65025285|FG000|Overall Study|Protocol Violation|0|||
23349769|NCT02854605|65025286|FG001|Overall Study|Protocol Violation|0|||
23349770|NCT02854605|65025287|FG002|Overall Study|Protocol Violation|1|||
23349771|NCT04529850|65025288|FG000|Overall Study|Death|2|||
23349772|NCT04529850|65025288|FG000|Overall Study|Physician Decision|1|||
23349773|NCT04529850|65025288|FG000|Overall Study|Withdrawal by Subject|2|||
23349774|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349775|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349776|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
23462510|NCT04986904|65437894|FG000|Overall Study|Withdrawal by Subject|1|||
23462511|NCT00807911|65437895|FG000|Overall Study|Withdrawal by Subject|12|||
23462512|NCT00807911|65437896|FG001|Overall Study|Withdrawal by Subject|10|||
23462513|NCT00807911|65437895|FG000|Overall Study|Ineligible|0|||
23462514|NCT00807911|65437896|FG001|Overall Study|Ineligible|4|||
23462515|NCT01704599|65437897|FG000|Overall Study|Adverse Event|1|||
23462516|NCT02636595|65437902|FG000|Overall Study|Lost to Follow-up|1|||
23462517|NCT02636595|65437902|FG000|Overall Study|Other|1|||
23462518|NCT02007096|65437903|FG000|Overall Study|medication not available|2|||
23462519|NCT02007096|65437904|FG001|Overall Study|medication not available|0|||
23462520|NCT02007096|65437903|FG000|Overall Study|did not inject saline|0|||
23462521|NCT02007096|65437904|FG001|Overall Study|did not inject saline|3|||
23462522|NCT02007096|65437903|FG000|Overall Study|did not follow postoperative protocol|8|||
23462523|NCT02007096|65437904|FG001|Overall Study|did not follow postoperative protocol|11|||
23349777|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349778|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349779|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349780|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349781|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349782|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349783|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349784|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349785|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23462524|NCT02007096|65437903|FG000|Overall Study|converted to open surgery|1|||
23462525|NCT02007096|65437904|FG001|Overall Study|converted to open surgery|1|||
23349786|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349787|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23349788|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
23462526|NCT02007096|65437903|FG000|Overall Study|no mesh placed|0|||
23462527|NCT02007096|65437904|FG001|Overall Study|no mesh placed|1|||
23462528|NCT02703597|65437905|FG000|Assignment to Baseline|Lost to Follow-up|17|||
23462529|NCT02703597|65437906|FG001|Assignment to Baseline|Lost to Follow-up|16|||
23462530|NCT02703597|65437905|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
23462531|NCT02703597|65437906|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
23462532|NCT02703597|65437905|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
23462533|NCT02703597|65437906|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
23462534|NCT02703597|65437905|FG000|First Post-test to First Follow-up|Site drop out|0|||
23462535|NCT02703597|65437906|FG001|First Post-test to First Follow-up|Site drop out|58|||
23462536|NCT02703597|65437905|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
23462537|NCT02703597|65437906|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
23462538|NCT02703597|65437905|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
23462539|NCT02703597|65437906|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
23349789|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349790|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349791|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349792|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349793|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349794|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349795|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349796|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23462540|NCT02703597|65437905|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
23462541|NCT02703597|65437906|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
23584851|NCT01080131|65869299|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
23584852|NCT01080131|65869300|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
23584853|NCT01080131|65869299|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
23584854|NCT01080131|65869300|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
23584855|NCT01080131|65869299|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
23584856|NCT01080131|65869300|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
23462542|NCT03100149|65437907|FG000|Overall Study|Adverse Event|0|||
23462543|NCT03100149|65437908|FG001|Overall Study|Adverse Event|1|||
23462544|NCT03100149|65437909|FG002|Overall Study|Adverse Event|0|||
23584857|NCT01080131|65869299|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
23584858|NCT01080131|65869300|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
23584859|NCT01080131|65869299|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
23584860|NCT01080131|65869300|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
23462545|NCT03100149|65437907|FG000|Overall Study|Participant Moved out of Country|0|||
23462546|NCT03100149|65437908|FG001|Overall Study|Participant Moved out of Country|0|||
23462547|NCT03100149|65437909|FG002|Overall Study|Participant Moved out of Country|1|||
23462548|NCT03100149|65437907|FG000|Overall Study|Withdrawal by Subject|0|||
23462549|NCT03100149|65437908|FG001|Overall Study|Withdrawal by Subject|3|||
23462550|NCT03100149|65437909|FG002|Overall Study|Withdrawal by Subject|1|||
23462551|NCT03848728|65437910|FG000|Overall Study|Death|16|||
23462552|NCT03848728|65437911|FG001|Overall Study|Death|13|||
23462553|NCT03848728|65437910|FG000|Overall Study|Outmigrated to non-study community|98|||
23462554|NCT03848728|65437911|FG001|Overall Study|Outmigrated to non-study community|106|||
23462555|NCT03848728|65437910|FG000|Overall Study|Transfered to non-study clinic|32|||
23462556|NCT03848728|65437911|FG001|Overall Study|Transfered to non-study clinic|48|||
23462557|NCT03848728|65437910|FG000|Overall Study|Withdrawal by Subject|1|||
23462558|NCT03848728|65437911|FG001|Overall Study|Withdrawal by Subject|0|||
23462559|NCT03405792|65437916|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
23462560|NCT03405792|65437917|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
23462561|NCT03405792|65437916|FG000|Overall Study|o Did not receive pembrolizumab|1|||
23462562|NCT03405792|65437917|FG001|Overall Study|o Did not receive pembrolizumab|0|||
23462563|NCT03331315|65437918|FG000|Overall Study|Physician Decision|18|||
23584861|NCT01080131|65869299|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
23584862|NCT01080131|65869300|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
23462564|NCT03331315|65437919|FG001|Overall Study|Physician Decision|14|||
23462565|NCT03525678|65437923|FG000|Overall Study|Withdrawal by Subject|8|||
23462566|NCT03525678|65437924|FG001|Overall Study|Withdrawal by Subject|2|||
23462567|NCT03525678|65437925|FG002|Overall Study|Withdrawal by Subject|2|||
23462568|NCT03525678|65437923|FG000|Overall Study|Physician Decision|2|||
23462569|NCT03525678|65437924|FG001|Overall Study|Physician Decision|4|||
23462570|NCT03525678|65437925|FG002|Overall Study|Physician Decision|0|||
23462571|NCT03525678|65437923|FG000|Overall Study|Lost to Follow-up|2|||
23462572|NCT03525678|65437924|FG001|Overall Study|Lost to Follow-up|1|||
23462573|NCT03525678|65437925|FG002|Overall Study|Lost to Follow-up|2|||
23242218|NCT00151775|64632879|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
23242219|NCT00151775|64632880|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
23242220|NCT00151775|64632881|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
23242221|NCT00151775|64632882|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
23242222|NCT00151775|64632883|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
23242223|NCT00151775|64632884|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
23349797|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23462574|NCT03525678|65437923|FG000|Overall Study|Death|70|||
23462575|NCT03525678|65437924|FG001|Overall Study|Death|80|||
23462576|NCT03525678|65437925|FG002|Overall Study|Death|16|||
23462577|NCT03525678|65437923|FG000|Overall Study|other reasons|14|||
23462578|NCT03525678|65437924|FG001|Overall Study|other reasons|10|||
23462579|NCT03525678|65437925|FG002|Overall Study|other reasons|5|||
23462580|NCT03525678|65437923|FG000|Overall Study|ongoing at the time of analysis|1|||
23462581|NCT03525678|65437924|FG001|Overall Study|ongoing at the time of analysis|2|||
23462582|NCT03525678|65437925|FG002|Overall Study|ongoing at the time of analysis|0|||
23462583|NCT01435382|65437928|FG000|Overall Study|Lost to Follow-up|1|||
23462584|NCT01435382|65437929|FG001|Overall Study|Lost to Follow-up|0|||
23462585|NCT01435382|65437930|FG002|Overall Study|Lost to Follow-up|1|||
23462586|NCT01435382|65437931|FG003|Overall Study|Lost to Follow-up|0|||
23462587|NCT01435382|65437928|FG000|Overall Study|Withdrawal by Subject|0|||
23462588|NCT01435382|65437929|FG001|Overall Study|Withdrawal by Subject|2|||
23462589|NCT01435382|65437930|FG002|Overall Study|Withdrawal by Subject|0|||
23462590|NCT01435382|65437931|FG003|Overall Study|Withdrawal by Subject|1|||
23462591|NCT03910244|65437932|FG000|Overall Study|Adverse Event|14|||
23462592|NCT03910244|65437933|FG001|Overall Study|Adverse Event|0|||
23462593|NCT03910244|65437932|FG000|Overall Study|Death|1|||
23462594|NCT03910244|65437933|FG001|Overall Study|Death|0|||
23462595|NCT03910244|65437932|FG000|Overall Study|Lost to Follow-up|0|||
23462596|NCT03910244|65437933|FG001|Overall Study|Lost to Follow-up|2|||
23462597|NCT03910244|65437932|FG000|Overall Study|Joint withdrawal decision|1|||
23462598|NCT03910244|65437933|FG001|Overall Study|Joint withdrawal decision|0|||
23462599|NCT03910244|65437932|FG000|Overall Study|Study Terminated by Sponsor|7|||
23462600|NCT03910244|65437933|FG001|Overall Study|Study Terminated by Sponsor|4|||
23462601|NCT03910244|65437932|FG000|Overall Study|Physician Decision|1|||
23462602|NCT03910244|65437933|FG001|Overall Study|Physician Decision|0|||
23462603|NCT03910244|65437932|FG000|Overall Study|Protocol Violation|1|||
23462604|NCT03910244|65437933|FG001|Overall Study|Protocol Violation|0|||
23462605|NCT03910244|65437932|FG000|Overall Study|Withdrawal by Subject|7|||
23462606|NCT03910244|65437933|FG001|Overall Study|Withdrawal by Subject|2|||
23462607|NCT03126591|65437936|FG000|Overall Study|Death|6|||
23462608|NCT03126591|65437937|FG001|Overall Study|Death|3|||
23462609|NCT03126591|65437938|FG002|Overall Study|Death|17|||
23462610|NCT03126591|65437936|FG000|Overall Study|Progressive Disease|0|||
23462611|NCT03126591|65437937|FG001|Overall Study|Progressive Disease|1|||
23584863|NCT02759731|65869301|FG000|Overall Study|Did not complete treatment.|8|||
23242224|NCT00151775|64632885|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
23242225|NCT00151775|64632886|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
23242226|NCT00151775|64632887|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
23242227|NCT00151775|64632888|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
23242228|NCT00151775|64632889|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
23242229|NCT00151775|64632878|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242230|NCT00151775|64632879|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242231|NCT00151775|64632880|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242232|NCT00151775|64632881|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242233|NCT00151775|64632882|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242234|NCT00151775|64632883|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
23242235|NCT00151775|64632884|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242236|NCT00151775|64632885|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242237|NCT00151775|64632886|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242238|NCT00151775|64632887|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242239|NCT00151775|64632888|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23462612|NCT03126591|65437938|FG002|Overall Study|Progressive Disease|2|||
23462613|NCT03126591|65437936|FG000|Overall Study|Terminated by Sponsor|0|||
23462614|NCT03126591|65437937|FG001|Overall Study|Terminated by Sponsor|1|||
23462615|NCT03126591|65437938|FG002|Overall Study|Terminated by Sponsor|4|||
23462616|NCT03126591|65437936|FG000|Overall Study|Withdrawal by Subject|1|||
23462617|NCT03126591|65437937|FG001|Overall Study|Withdrawal by Subject|1|||
23462618|NCT03126591|65437938|FG002|Overall Study|Withdrawal by Subject|4|||
23462619|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
23462620|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
23462621|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
23462622|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Death|9|||
23462623|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Death|0|||
23462624|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Death|0|||
23462625|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
23462626|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
23462627|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
23462628|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
23462629|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
23462630|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
23462631|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Other|135|||
23462632|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Other|0|||
23462633|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Other|0|||
23462634|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
23462635|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
23462636|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
23462637|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
23462638|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
23462639|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
23462640|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
23462641|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
23462642|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
23462643|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Other|3|||
23462644|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Other|0|||
23462645|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Other|0|||
23462646|NCT02118584|65437939|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
23462647|NCT02118584|65437940|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
23462648|NCT02118584|65437941|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
23462649|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
23462650|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
23462651|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
23462652|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
23462653|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
23462654|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
23462655|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
23462656|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
23462657|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
23462658|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
23462659|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
23462660|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
23462661|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
23462662|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
23462663|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
23462664|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
23183267|NCT01642212|64409462|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
23183268|NCT01642212|64409458|FG000|Double-blind Treatment|Other|0|||
23183269|NCT01642212|64409459|FG001|Double-blind Treatment|Other|2|||
23183270|NCT01642212|64409460|FG002|Double-blind Treatment|Other|1|||
23183271|NCT01642212|64409461|FG003|Double-blind Treatment|Other|0|||
23183272|NCT01642212|64409462|FG004|Double-blind Treatment|Other|0|||
23183273|NCT01642212|64409458|FG000|Double-blind Treatment|Non-compliance|0|||
23183274|NCT01642212|64409459|FG001|Double-blind Treatment|Non-compliance|1|||
23183275|NCT01642212|64409460|FG002|Double-blind Treatment|Non-compliance|0|||
23183276|NCT01642212|64409461|FG003|Double-blind Treatment|Non-compliance|0|||
23183277|NCT01642212|64409462|FG004|Double-blind Treatment|Non-compliance|0|||
23183278|NCT01642212|64409458|FG000|Double-blind Treatment|Adverse Event|0|||
23183279|NCT01642212|64409459|FG001|Double-blind Treatment|Adverse Event|0|||
23183280|NCT01642212|64409460|FG002|Double-blind Treatment|Adverse Event|1|||
23183281|NCT01642212|64409461|FG003|Double-blind Treatment|Adverse Event|0|||
23183282|NCT01642212|64409462|FG004|Double-blind Treatment|Adverse Event|0|||
23183283|NCT01642212|64409458|FG000|Open-label Extension|Adverse Event|0|||
23462665|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
23462666|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
23462667|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
23462668|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
23183284|NCT01642212|64409459|FG001|Open-label Extension|Adverse Event|0|||
23183285|NCT01642212|64409460|FG002|Open-label Extension|Adverse Event|0|||
23183286|NCT01642212|64409461|FG003|Open-label Extension|Adverse Event|3|||
23183287|NCT01642212|64409462|FG004|Open-label Extension|Adverse Event|0|||
23183288|NCT01642212|64409458|FG000|Open-label Extension|Sponsor Decision|0|||
23183289|NCT01642212|64409459|FG001|Open-label Extension|Sponsor Decision|0|||
23183290|NCT01642212|64409460|FG002|Open-label Extension|Sponsor Decision|0|||
23183291|NCT01642212|64409461|FG003|Open-label Extension|Sponsor Decision|7|||
23183292|NCT01642212|64409462|FG004|Open-label Extension|Sponsor Decision|4|||
23183293|NCT01642212|64409458|FG000|Open-label Extension|Consent Withdrawn|0|||
23183294|NCT01642212|64409459|FG001|Open-label Extension|Consent Withdrawn|0|||
23183295|NCT01642212|64409460|FG002|Open-label Extension|Consent Withdrawn|0|||
23183296|NCT01642212|64409461|FG003|Open-label Extension|Consent Withdrawn|0|||
23183297|NCT01642212|64409462|FG004|Open-label Extension|Consent Withdrawn|2|||
23183298|NCT01642212|64409458|FG000|Open-label Extension|Lost to Follow-up|0|||
23183299|NCT01642212|64409459|FG001|Open-label Extension|Lost to Follow-up|0|||
23183300|NCT01642212|64409460|FG002|Open-label Extension|Lost to Follow-up|0|||
23183301|NCT01642212|64409461|FG003|Open-label Extension|Lost to Follow-up|0|||
23183302|NCT01642212|64409462|FG004|Open-label Extension|Lost to Follow-up|1|||
23183303|NCT01642212|64409458|FG000|Open-label Extension|Other|0|||
23183304|NCT01642212|64409459|FG001|Open-label Extension|Other|0|||
23183305|NCT01642212|64409460|FG002|Open-label Extension|Other|0|||
23183306|NCT01642212|64409461|FG003|Open-label Extension|Other|0|||
23183307|NCT01642212|64409462|FG004|Open-label Extension|Other|1|||
23183308|NCT01145560|64409463|FG000|Overall Study|Withdrawal by Subject|2|||
23183309|NCT01145560|64409464|FG001|Overall Study|Withdrawal by Subject|1|||
23183310|NCT01145560|64409465|FG002|Overall Study|Withdrawal by Subject|0|||
23183311|NCT01145560|64409463|FG000|Overall Study|Lost to Follow-up|1|||
23349798|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349799|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349800|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23183312|NCT01145560|64409464|FG001|Overall Study|Lost to Follow-up|1|||
23183313|NCT01145560|64409465|FG002|Overall Study|Lost to Follow-up|1|||
23183314|NCT01145560|64409463|FG000|Overall Study|No study drug by 24h after organ failure|1|||
23242240|NCT00151775|64632889|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
23242241|NCT00151775|64632878|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23242242|NCT00151775|64632879|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23242243|NCT00151775|64632880|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23349801|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
23349802|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
23242244|NCT00151775|64632881|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23349803|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
23349804|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349805|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349806|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349807|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349808|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349809|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349810|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349811|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23462669|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
23183315|NCT01145560|64409464|FG001|Overall Study|No study drug by 24h after organ failure|0|||
23349812|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23183316|NCT01145560|64409465|FG002|Overall Study|No study drug by 24h after organ failure|0|||
23183317|NCT01145560|64409463|FG000|Overall Study|Accidental unblinding of study treatment|0|||
23183318|NCT01145560|64409464|FG001|Overall Study|Accidental unblinding of study treatment|1|||
23462670|NCT02118584|65437939|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
23462671|NCT02118584|65437940|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
23183319|NCT01145560|64409465|FG002|Overall Study|Accidental unblinding of study treatment|0|||
23183320|NCT01145560|64409463|FG000|Overall Study|False insurance information|0|||
23183321|NCT01145560|64409464|FG001|Overall Study|False insurance information|1|||
23183322|NCT01145560|64409465|FG002|Overall Study|False insurance information|0|||
23183323|NCT01145560|64409463|FG000|Overall Study|Withdrawal of therapy|0|||
23183324|NCT01145560|64409464|FG001|Overall Study|Withdrawal of therapy|0|||
23183325|NCT01145560|64409465|FG002|Overall Study|Withdrawal of therapy|1|||
23462672|NCT02118584|65437941|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
23462673|NCT01169337|65437942|FG000|Overall Study|Lack of Efficacy|5|||
23462674|NCT01169337|65437943|FG001|Overall Study|Lack of Efficacy|7|||
23462675|NCT01169337|65437944|FG002|Overall Study|Lack of Efficacy|0|||
23183326|NCT03502187|64409468|FG000|Overall Study|Withdrawal by Subject|4|||
23462676|NCT01169337|65437942|FG000|Overall Study|Adverse Event|12|||
23462677|NCT01169337|65437943|FG001|Overall Study|Adverse Event|18|||
23462678|NCT01169337|65437944|FG002|Overall Study|Adverse Event|0|||
23462679|NCT01169337|65437942|FG000|Overall Study|Death|2|||
23462680|NCT01169337|65437943|FG001|Overall Study|Death|0|||
23462681|NCT01169337|65437944|FG002|Overall Study|Death|0|||
23462682|NCT01169337|65437942|FG000|Overall Study|Withdrawal by Subject|11|||
23462683|NCT01169337|65437943|FG001|Overall Study|Withdrawal by Subject|11|||
23462684|NCT01169337|65437944|FG002|Overall Study|Withdrawal by Subject|6|||
23462685|NCT01169337|65437942|FG000|Overall Study|Noncompliance|2|||
23462686|NCT01169337|65437943|FG001|Overall Study|Noncompliance|0|||
23462687|NCT01169337|65437944|FG002|Overall Study|Noncompliance|0|||
23462688|NCT01169337|65437942|FG000|Overall Study|Other complicating disease|1|||
23462689|NCT01169337|65437943|FG001|Overall Study|Other complicating disease|1|||
23462690|NCT01169337|65437944|FG002|Overall Study|Other complicating disease|0|||
23462691|NCT01169337|65437942|FG000|Overall Study|Physician Decision|1|||
23462692|NCT01169337|65437943|FG001|Overall Study|Physician Decision|5|||
23584864|NCT03389477|65869303|FG000|Step 1|Withdrawal by Subject|1|||
23584865|NCT03389477|65869304|FG001|Step 1|Withdrawal by Subject|0|||
23584866|NCT03389477|65869303|FG000|Step 2|Withdrawal by Subject|1|||
23584867|NCT03389477|65869304|FG001|Step 2|Withdrawal by Subject|2|||
23584868|NCT03389477|65869303|FG000|Step 2|Disease progression|1|||
23584869|NCT03389477|65869304|FG001|Step 2|Disease progression|0|||
23584870|NCT03389477|65869303|FG000|Step 2|Death|0|||
23584871|NCT03389477|65869304|FG001|Step 2|Death|1|||
23584872|NCT03389477|65869303|FG000|Step 2|Poor performance status and nutrition|0|||
23584873|NCT03389477|65869304|FG001|Step 2|Poor performance status and nutrition|1|||
23584874|NCT03389477|65869303|FG000|Step 3|Withdrawal after 3 cycles|0|||
23584875|NCT03389477|65869304|FG001|Step 3|Withdrawal after 3 cycles|1|||
23584876|NCT03389477|65869303|FG000|Step 3|Still receiving active treatment|4|||
23584877|NCT03389477|65869304|FG001|Step 3|Still receiving active treatment|0|||
23584878|NCT03389477|65869303|FG000|Step 3|Progressive disease after 2 cycles|1|||
23584879|NCT03389477|65869304|FG001|Step 3|Progressive disease after 2 cycles|0|||
23584880|NCT01329328|65869305|FG000|Overall Study|Withdrawal by Subject|2|||
23584881|NCT01329328|65869306|FG001|Overall Study|Withdrawal by Subject|4|||
23584882|NCT01329328|65869307|FG002|Overall Study|Withdrawal by Subject|3|||
23584883|NCT04565249|65869310|FG000|Overall Study|Death|0|||
23584884|NCT04565249|65869311|FG001|Overall Study|Death|0|||
23584885|NCT04565249|65869312|FG002|Overall Study|Death|0|||
23584886|NCT04565249|65869313|FG003|Overall Study|Death|1|||
23584887|NCT02520154|65869314|FG000|Overall Study|Death|1|||
23584888|NCT02520154|65869314|FG000|Overall Study|Withdrawal by Subject|2|||
23584889|NCT02520154|65869314|FG000|Overall Study|Physician Decision|2|||
23584890|NCT04335591|65869315|FG000|Overall Study|Adverse Event|5|||
23584891|NCT04335591|65869316|FG001|Overall Study|Adverse Event|2|||
23584892|NCT04335591|65869317|FG002|Overall Study|Adverse Event|3|||
23584893|NCT04335591|65869318|FG003|Overall Study|Adverse Event|2|||
23584894|NCT04335591|65869315|FG000|Overall Study|Protocol Violation|1|||
23584895|NCT04335591|65869316|FG001|Overall Study|Protocol Violation|0|||
23584896|NCT04335591|65869317|FG002|Overall Study|Protocol Violation|0|||
23584897|NCT04335591|65869318|FG003|Overall Study|Protocol Violation|0|||
23584898|NCT04335591|65869315|FG000|Overall Study|Withdrawal by Subject|8|||
23183327|NCT03502187|64409469|FG001|Overall Study|Withdrawal by Subject|3|||
23462693|NCT01169337|65437944|FG002|Overall Study|Physician Decision|0|||
23462694|NCT01169337|65437942|FG000|Overall Study|Alternative therapy|0|||
23462695|NCT01169337|65437943|FG001|Overall Study|Alternative therapy|2|||
23462696|NCT01169337|65437944|FG002|Overall Study|Alternative therapy|0|||
23584899|NCT04335591|65869316|FG001|Overall Study|Withdrawal by Subject|4|||
23584900|NCT04335591|65869317|FG002|Overall Study|Withdrawal by Subject|4|||
23584901|NCT04335591|65869318|FG003|Overall Study|Withdrawal by Subject|5|||
23584902|NCT04335591|65869315|FG000|Overall Study|Subject planning pregnancy|0|||
23183328|NCT03502187|64409470|FG002|Overall Study|Withdrawal by Subject|3|||
23462697|NCT01169337|65437942|FG000|Overall Study|Changed hospital|0|||
23462698|NCT01169337|65437943|FG001|Overall Study|Changed hospital|1|||
23462699|NCT01169337|65437944|FG002|Overall Study|Changed hospital|0|||
23462700|NCT01169337|65437942|FG000|Overall Study|Never started treatment|0|||
23462701|NCT01169337|65437943|FG001|Overall Study|Never started treatment|2|||
23462702|NCT01169337|65437944|FG002|Overall Study|Never started treatment|0|||
23462703|NCT01169337|65437942|FG000|Overall Study|Reason not reported|1|||
23462704|NCT01169337|65437943|FG001|Overall Study|Reason not reported|0|||
23462705|NCT01169337|65437944|FG002|Overall Study|Reason not reported|0|||
23462706|NCT01169337|65437942|FG000|Overall Study|Continuing lenalidomide|9|||
23462707|NCT01169337|65437943|FG001|Overall Study|Continuing lenalidomide|43|||
23462708|NCT01169337|65437944|FG002|Overall Study|Continuing lenalidomide|0|||
23462709|NCT01207414|65437946|FG000|Overall Study|Adverse Event|25|||
23183329|NCT03502187|64409468|FG000|Overall Study|Lost to Follow-up|5|||
23183330|NCT03502187|64409469|FG001|Overall Study|Lost to Follow-up|4|||
23183331|NCT03502187|64409470|FG002|Overall Study|Lost to Follow-up|5|||
23183332|NCT02318784|64409476|FG000|Overall Study|Adverse Event|13|||
23349813|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349814|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349815|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23349816|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
23349817|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
23349818|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23462710|NCT01207414|65437947|FG001|Overall Study|Adverse Event|39|||
23462711|NCT01207414|65437946|FG000|Overall Study|Abnormal test procedure results|0|||
23462712|NCT01207414|65437947|FG001|Overall Study|Abnormal test procedure results|1|||
23462713|NCT01207414|65437946|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23462714|NCT01207414|65437947|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23462715|NCT01207414|65437946|FG000|Overall Study|Patient withdrew consent|14|||
23462716|NCT01207414|65437947|FG001|Overall Study|Patient withdrew consent|11|||
23462717|NCT01207414|65437946|FG000|Overall Study|Lost to Follow-up|15|||
23462718|NCT01207414|65437947|FG001|Overall Study|Lost to Follow-up|17|||
23462719|NCT01207414|65437946|FG000|Overall Study|Administrative problems|1|||
23462720|NCT01207414|65437947|FG001|Overall Study|Administrative problems|1|||
23462721|NCT01207414|65437946|FG000|Overall Study|Protocol deviation|12|||
23462722|NCT01207414|65437947|FG001|Overall Study|Protocol deviation|9|||
23462723|NCT01207414|65437946|FG000|Overall Study|Randomized in error|1|||
23462724|NCT01207414|65437947|FG001|Overall Study|Randomized in error|0|||
23462725|NCT02594124|65437948|FG000|Overall Study|Adverse Event|0|||
23462726|NCT02594124|65437949|FG001|Overall Study|Adverse Event|5|||
23462727|NCT02594124|65437950|FG002|Overall Study|Adverse Event|8|||
23462728|NCT02594124|65437951|FG003|Overall Study|Adverse Event|1|||
23462729|NCT02594124|65437952|FG004|Overall Study|Adverse Event|0|||
23462730|NCT02594124|65437953|FG005|Overall Study|Adverse Event|0|||
23462731|NCT02594124|65437954|FG006|Overall Study|Adverse Event|2|||
23462732|NCT02594124|65437955|FG007|Overall Study|Adverse Event|2|||
23462733|NCT02594124|65437956|FG008|Overall Study|Adverse Event|0|||
23462734|NCT02594124|65437948|FG000|Overall Study|Withdrawal by Subject|2|||
23462735|NCT02594124|65437949|FG001|Overall Study|Withdrawal by Subject|3|||
23462736|NCT02594124|65437950|FG002|Overall Study|Withdrawal by Subject|5|||
23462737|NCT02594124|65437951|FG003|Overall Study|Withdrawal by Subject|1|||
23462738|NCT02594124|65437952|FG004|Overall Study|Withdrawal by Subject|8|||
23462739|NCT02594124|65437953|FG005|Overall Study|Withdrawal by Subject|4|||
23462740|NCT02594124|65437954|FG006|Overall Study|Withdrawal by Subject|13|||
23462741|NCT02594124|65437955|FG007|Overall Study|Withdrawal by Subject|19|||
23462742|NCT02594124|65437956|FG008|Overall Study|Withdrawal by Subject|0|||
23584903|NCT04335591|65869316|FG001|Overall Study|Subject planning pregnancy|1|||
23584904|NCT04335591|65869317|FG002|Overall Study|Subject planning pregnancy|0|||
23584905|NCT04335591|65869318|FG003|Overall Study|Subject planning pregnancy|0|||
23584906|NCT04335591|65869315|FG000|Overall Study|Ukrainian Russian war conflict|4|||
23584907|NCT04335591|65869316|FG001|Overall Study|Ukrainian Russian war conflict|5|||
23183333|NCT02318784|64409476|FG000|Overall Study|Death|2|||
23349819|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349820|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349821|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349822|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23462743|NCT02594124|65437948|FG000|Overall Study|Physician Decision|0|||
23462744|NCT02594124|65437949|FG001|Overall Study|Physician Decision|2|||
23462745|NCT02594124|65437950|FG002|Overall Study|Physician Decision|0|||
23462746|NCT02594124|65437951|FG003|Overall Study|Physician Decision|0|||
23462747|NCT02594124|65437952|FG004|Overall Study|Physician Decision|0|||
23462748|NCT02594124|65437953|FG005|Overall Study|Physician Decision|0|||
23584908|NCT04335591|65869317|FG002|Overall Study|Ukrainian Russian war conflict|2|||
23183334|NCT02318784|64409476|FG000|Overall Study|Progressive Disease|37|||
23462749|NCT02594124|65437954|FG006|Overall Study|Physician Decision|0|||
23462750|NCT02594124|65437955|FG007|Overall Study|Physician Decision|1|||
23462751|NCT02594124|65437956|FG008|Overall Study|Physician Decision|0|||
23462752|NCT02594124|65437948|FG000|Overall Study|Commercial drug|0|||
23242245|NCT00151775|64632882|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23242246|NCT00151775|64632883|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
23242247|NCT00151775|64632884|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23242248|NCT00151775|64632885|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23242249|NCT00151775|64632886|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23242250|NCT00151775|64632887|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23242251|NCT00151775|64632888|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23242252|NCT00151775|64632889|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
23242253|NCT00151775|64632878|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23242254|NCT00151775|64632879|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23349823|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23462753|NCT02594124|65437949|FG001|Overall Study|Commercial drug|1|||
23462754|NCT02594124|65437950|FG002|Overall Study|Commercial drug|6|||
23462755|NCT02594124|65437951|FG003|Overall Study|Commercial drug|3|||
23462756|NCT02594124|65437952|FG004|Overall Study|Commercial drug|0|||
23462757|NCT02594124|65437953|FG005|Overall Study|Commercial drug|0|||
23462758|NCT02594124|65437954|FG006|Overall Study|Commercial drug|7|||
23462759|NCT02594124|65437955|FG007|Overall Study|Commercial drug|11|||
23462760|NCT02594124|65437956|FG008|Overall Study|Commercial drug|2|||
23462761|NCT02594124|65437948|FG000|Overall Study|Reason Not Specified|1|||
23462762|NCT02594124|65437949|FG001|Overall Study|Reason Not Specified|3|||
23462763|NCT02594124|65437950|FG002|Overall Study|Reason Not Specified|4|||
23462764|NCT02594124|65437951|FG003|Overall Study|Reason Not Specified|0|||
23462765|NCT02594124|65437952|FG004|Overall Study|Reason Not Specified|0|||
23462766|NCT02594124|65437953|FG005|Overall Study|Reason Not Specified|1|||
23462767|NCT02594124|65437954|FG006|Overall Study|Reason Not Specified|1|||
23462768|NCT02594124|65437955|FG007|Overall Study|Reason Not Specified|6|||
23462769|NCT02594124|65437956|FG008|Overall Study|Reason Not Specified|1|||
23462770|NCT02923726|65437962|FG000|Overall Study|Death|196|||
23462771|NCT02923726|65437963|FG001|Overall Study|Death|175|||
23462772|NCT02923726|65437962|FG000|Overall Study|Withdrawal by Subject|337|||
23462773|NCT02923726|65437963|FG001|Overall Study|Withdrawal by Subject|307|||
23462774|NCT04081103|65437964|FG000|Overall Study|Adverse Event|1|||
23183335|NCT02318784|64409476|FG000|Overall Study|Withdrawal by Subject|10|||
23183336|NCT00943683|64409477|FG000|Overall Study|Adverse Event|3|||
23183337|NCT00943683|64409478|FG001|Overall Study|Adverse Event|3|||
23183338|NCT00943683|64409477|FG000|Overall Study|Lost to Follow-up|1|||
23349824|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23183339|NCT00943683|64409478|FG001|Overall Study|Lost to Follow-up|1|||
23183340|NCT00943683|64409477|FG000|Overall Study|Protocol Violation|1|||
23183341|NCT00943683|64409478|FG001|Overall Study|Protocol Violation|2|||
23183342|NCT00943683|64409477|FG000|Overall Study|Withdrawal by Subject|1|||
23183343|NCT00943683|64409478|FG001|Overall Study|Withdrawal by Subject|0|||
23183344|NCT00943683|64409477|FG000|Overall Study|Patient Moved|1|||
23183345|NCT00943683|64409478|FG001|Overall Study|Patient Moved|0|||
23349825|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349826|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349827|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349828|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349829|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23349830|NCT02326298|65025289|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349831|NCT02326298|65025290|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349832|NCT02326298|65025291|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
23462775|NCT04081103|65437965|FG001|Overall Study|Adverse Event|1|||
23462776|NCT04081103|65437966|FG002|Overall Study|Adverse Event|1|||
23462777|NCT04081103|65437964|FG000|Overall Study|Physician Decision|0|||
23462778|NCT04081103|65437965|FG001|Overall Study|Physician Decision|0|||
23462779|NCT04081103|65437966|FG002|Overall Study|Physician Decision|1|||
23183346|NCT01287104|64409481|FG000|Overall Study|Patient developed progressive disease|1|||
23462780|NCT02419001|65437968|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
23462781|NCT02419001|65437969|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
23462782|NCT03944577|65437970|FG000|Overall Study|Adverse Event|3|||
23462783|NCT04139018|65437975|FG000|Overall Study|Screen fail|1|||
23183347|NCT01287104|64409482|FG001|Overall Study|Patient developed progressive disease|1|||
23183348|NCT01287104|64409483|FG002|Overall Study|Patient developed progressive disease|3|||
23183349|NCT01287104|64409484|FG003|Overall Study|Patient developed progressive disease|2|||
23183350|NCT01287104|64409481|FG000|Overall Study|Donor anaphylaxis|0|||
23183351|NCT01287104|64409482|FG001|Overall Study|Donor anaphylaxis|1|||
23183352|NCT01287104|64409483|FG002|Overall Study|Donor anaphylaxis|0|||
23183353|NCT01287104|64409484|FG003|Overall Study|Donor anaphylaxis|1|||
23183354|NCT01287104|64409481|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
23183355|NCT01287104|64409482|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
23462784|NCT04139018|65437976|FG001|Overall Study|Screen fail|0|||
23183356|NCT01287104|64409483|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
23183357|NCT01287104|64409484|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
23183358|NCT01287104|64409481|FG000|Overall Study|Low donor chimerism|0|||
23183359|NCT01287104|64409482|FG001|Overall Study|Low donor chimerism|1|||
23183360|NCT01287104|64409483|FG002|Overall Study|Low donor chimerism|0|||
23183361|NCT01287104|64409484|FG003|Overall Study|Low donor chimerism|0|||
23183362|NCT01287104|64409481|FG000|Overall Study|NK cells did not meet release criteria|0|||
23183363|NCT01287104|64409482|FG001|Overall Study|NK cells did not meet release criteria|1|||
23183364|NCT01287104|64409483|FG002|Overall Study|NK cells did not meet release criteria|0|||
23183365|NCT01287104|64409484|FG003|Overall Study|NK cells did not meet release criteria|0|||
23183366|NCT00891735|64409485|FG000|Overall Study|Adverse Event|2|||
23183367|NCT00891735|64409486|FG001|Overall Study|Adverse Event|0|||
23183368|NCT00891735|64409487|FG002|Overall Study|Adverse Event|2|||
23183369|NCT00891735|64409488|FG003|Overall Study|Adverse Event|0|||
23183370|NCT00891735|64409485|FG000|Overall Study|Death|8|||
23183371|NCT00891735|64409486|FG001|Overall Study|Death|5|||
23183372|NCT00891735|64409487|FG002|Overall Study|Death|4|||
23183373|NCT00891735|64409488|FG003|Overall Study|Death|5|||
23183374|NCT00891735|64409485|FG000|Overall Study|Lost to Follow-up|2|||
23183375|NCT00891735|64409486|FG001|Overall Study|Lost to Follow-up|2|||
23183376|NCT00891735|64409487|FG002|Overall Study|Lost to Follow-up|2|||
23183377|NCT00891735|64409488|FG003|Overall Study|Lost to Follow-up|2|||
23183378|NCT00891735|64409485|FG000|Overall Study|Physician's decision to withdraw patient|1|||
23183379|NCT00891735|64409486|FG001|Overall Study|Physician's decision to withdraw patient|0|||
23183380|NCT00891735|64409487|FG002|Overall Study|Physician's decision to withdraw patient|0|||
23183381|NCT00891735|64409488|FG003|Overall Study|Physician's decision to withdraw patient|0|||
23183382|NCT00891735|64409485|FG000|Overall Study|Patient's decision to withdraw|4|||
23183383|NCT00891735|64409486|FG001|Overall Study|Patient's decision to withdraw|9|||
23183384|NCT00891735|64409487|FG002|Overall Study|Patient's decision to withdraw|4|||
23183385|NCT00891735|64409488|FG003|Overall Study|Patient's decision to withdraw|8|||
23183386|NCT03068715|64409489|FG000|Overall Study|No longer met inclusion criteria|1|||
23183387|NCT03068715|64409490|FG001|Overall Study|No longer met inclusion criteria|0|||
23183388|NCT01355289|64409495|FG000|Core Study|Adverse Event, Non-Fatal|1|||
23183389|NCT01355289|64409496|FG001|Core Study|Adverse Event, Non-Fatal|0|||
23183390|NCT01355289|64409497|FG002|Core Study|Adverse Event, Non-Fatal|0|||
23183391|NCT01355289|64409498|FG003|Core Study|Adverse Event, Non-Fatal|0|||
23183392|NCT01355289|64409499|FG004|Core Study|Adverse Event, Non-Fatal|0|||
23183393|NCT01355289|64409495|FG000|Core Study|Inadequate Therapeutic Effect|0|||
23183394|NCT01355289|64409496|FG001|Core Study|Inadequate Therapeutic Effect|0|||
23183395|NCT01355289|64409497|FG002|Core Study|Inadequate Therapeutic Effect|0|||
23183396|NCT01355289|64409498|FG003|Core Study|Inadequate Therapeutic Effect|1|||
23183397|NCT01355289|64409499|FG004|Core Study|Inadequate Therapeutic Effect|0|||
23183398|NCT01355289|64409495|FG000|Core Study|Other|0|||
23183399|NCT01355289|64409496|FG001|Core Study|Other|0|||
23183400|NCT01355289|64409497|FG002|Core Study|Other|0|||
23183401|NCT01355289|64409498|FG003|Core Study|Other|1|||
23183402|NCT01355289|64409499|FG004|Core Study|Other|0|||
23183403|NCT01355289|64409495|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
23183404|NCT01355289|64409496|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
23183405|NCT01355289|64409497|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
23183406|NCT01355289|64409498|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
23183407|NCT01355289|64409499|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
23183408|NCT01355289|64409495|FG000|Open Label Extension|Lost to Follow-up|0|||
23183409|NCT01355289|64409496|FG001|Open Label Extension|Lost to Follow-up|0|||
23183410|NCT01355289|64409497|FG002|Open Label Extension|Lost to Follow-up|0|||
23183411|NCT01355289|64409498|FG003|Open Label Extension|Lost to Follow-up|0|||
23183412|NCT01355289|64409499|FG004|Open Label Extension|Lost to Follow-up|1|||
23183413|NCT01355289|64409495|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
23584909|NCT04335591|65869318|FG003|Overall Study|Ukrainian Russian war conflict|0|||
23584910|NCT03256344|65869319|FG000|Overall Study|Death|6|||
23183414|NCT01355289|64409496|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
23183415|NCT01355289|64409497|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
23183416|NCT01355289|64409498|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
23183417|NCT01355289|64409499|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
23183418|NCT01355289|64409495|FG000|Open Label Extension|Other|0|||
23183419|NCT01355289|64409496|FG001|Open Label Extension|Other|0|||
23183420|NCT01355289|64409497|FG002|Open Label Extension|Other|0|||
23183421|NCT01355289|64409498|FG003|Open Label Extension|Other|0|||
23183422|NCT01355289|64409499|FG004|Open Label Extension|Other|3|||
23183423|NCT03195894|64413480|FG000|Overall Study|"An example is Started other treatment."|4|||
23183424|NCT03195894|64413481|FG001|Overall Study|"An example is Started other treatment."|5|||
23349833|NCT02326298|65025292|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349834|NCT02326298|65025293|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349835|NCT02326298|65025294|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349836|NCT02326298|65025295|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349837|NCT02326298|65025296|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349838|NCT02326298|65025297|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23183425|NCT03195894|64413480|FG000|Overall Study|Withdrawal by Subject|15|||
23183426|NCT03195894|64413481|FG001|Overall Study|Withdrawal by Subject|4|||
23183427|NCT03195894|64413480|FG000|Overall Study|Lost to Follow-up|14|||
23183428|NCT03195894|64413481|FG001|Overall Study|Lost to Follow-up|19|||
23349839|NCT02326298|65025298|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349840|NCT02326298|65025299|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349841|NCT02326298|65025300|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349842|NCT02326298|65025301|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23183429|NCT05148884|64413487|FG000|Overall Study|Withdrawal by Subject|3|||
23183430|NCT05148884|64413488|FG001|Overall Study|Withdrawal by Subject|0|||
23183431|NCT05148884|64413487|FG000|Overall Study|Deep brain stimulation operation|0|||
23183432|NCT05148884|64413488|FG001|Overall Study|Deep brain stimulation operation|1|||
23349843|NCT02326298|65025302|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
23349844|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349845|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23183438|NCT01097044|64413492|FG000|Overall Study|Withdrawal by Subject|4|||
23183439|NCT01097044|64413493|FG001|Overall Study|Withdrawal by Subject|4|||
23183440|NCT01097044|64413492|FG000|Overall Study|Lost to Follow-up|1|||
23183441|NCT01097044|64413493|FG001|Overall Study|Lost to Follow-up|0|||
23183442|NCT01097044|64413492|FG000|Overall Study|Withdrawal by Sponsor|0|||
23183443|NCT01097044|64413493|FG001|Overall Study|Withdrawal by Sponsor|1|||
23183444|NCT01238120|64413494|FG000|Overall Study|Withdrawal by Subject|4|||
23183445|NCT01238120|64413495|FG001|Overall Study|Withdrawal by Subject|1|||
23183446|NCT01238120|64413496|FG002|Overall Study|Withdrawal by Subject|2|||
23183447|NCT01238120|64413497|FG003|Overall Study|Withdrawal by Subject|5|||
23183448|NCT01238120|64413494|FG000|Overall Study|Lost to Follow-up|2|||
23183449|NCT01238120|64413495|FG001|Overall Study|Lost to Follow-up|0|||
23183450|NCT01238120|64413496|FG002|Overall Study|Lost to Follow-up|1|||
23183451|NCT01238120|64413497|FG003|Overall Study|Lost to Follow-up|1|||
23183452|NCT01238120|64413494|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
23183453|NCT01238120|64413495|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
23183454|NCT01238120|64413496|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
23183455|NCT01238120|64413497|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
23183456|NCT00693706|64413498|FG000|Overall Study|Protocol Violation|0|||
23183457|NCT00693706|64413499|FG001|Overall Study|Protocol Violation|1|||
23183458|NCT03715465|64413507|FG000|Overall Study|Withdrawal by Subject|1|||
23183459|NCT03715465|64413508|FG001|Overall Study|Withdrawal by Subject|2|||
23183460|NCT00254566|64413515|FG000|Overall Study|Death|1|||
23183461|NCT00254566|64413516|FG001|Overall Study|Death|0|||
23183462|NCT00254566|64413515|FG000|Overall Study|Adverse Event|5|||
23183463|NCT00254566|64413516|FG001|Overall Study|Adverse Event|4|||
23349846|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349847|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349848|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349849|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23402748|NCT01669902|65219993|FG000|Overall Study|Other|8|||
23183464|NCT00254566|64413515|FG000|Overall Study|Lack of Efficacy|12|||
23183465|NCT00254566|64413516|FG001|Overall Study|Lack of Efficacy|9|||
23183466|NCT00254566|64413515|FG000|Overall Study|Other|1|||
23183467|NCT00254566|64413516|FG001|Overall Study|Other|5|||
23183468|NCT00254566|64413515|FG000|Overall Study|Withdrawal by Subject|5|||
23183469|NCT00254566|64413516|FG001|Overall Study|Withdrawal by Subject|6|||
23183470|NCT00254566|64413515|FG000|Overall Study|Lost to Follow-up|7|||
23462785|NCT04139018|65437975|FG000|Overall Study|Withdrawal by Subject|2|||
23462786|NCT04139018|65437976|FG001|Overall Study|Withdrawal by Subject|0|||
23462787|NCT04139018|65437975|FG000|Overall Study|Lost to Follow-up|0|||
23462788|NCT04139018|65437976|FG001|Overall Study|Lost to Follow-up|1|||
23183471|NCT00254566|64413516|FG001|Overall Study|Lost to Follow-up|2|||
23462789|NCT01597596|65437978|FG000|Overall Study|Study terminated by sponsor|1|||
23462790|NCT01597596|65437979|FG001|Overall Study|Study terminated by sponsor|0|||
23462791|NCT01597596|65437978|FG000|Overall Study|Physician Decision|0|||
23183472|NCT02054702|64413517|FG000|Overall Study|Lost to Follow-up|3|||
23183473|NCT02054702|64413518|FG001|Overall Study|Lost to Follow-up|5|||
23183474|NCT02054702|64413517|FG000|Overall Study|Adverse Event|3|||
23183475|NCT02054702|64413518|FG001|Overall Study|Adverse Event|1|||
23183476|NCT02054702|64413517|FG000|Overall Study|Met Withdrawal Criteria|4|||
23183477|NCT02054702|64413518|FG001|Overall Study|Met Withdrawal Criteria|1|||
23183478|NCT02054702|64413517|FG000|Overall Study|Physician Decision|0|||
23183479|NCT02054702|64413518|FG001|Overall Study|Physician Decision|1|||
23183480|NCT02054702|64413517|FG000|Overall Study|Withdrawal by Subject|14|||
23183481|NCT02054702|64413518|FG001|Overall Study|Withdrawal by Subject|4|||
23183482|NCT00500266|64413523|FG000|Overall Study|Death|3|||
23183483|NCT00500266|64413523|FG000|Overall Study|Lost to Follow-up|3|||
23183484|NCT00500266|64413523|FG000|Overall Study|Withdrawal by Subject|3|||
23183485|NCT00500266|64413523|FG000|Overall Study|Assigned, not treated|4|||
23183486|NCT00778830|64413524|FG000|Overall Study|Ongoing at data cut-off|0|||
23183487|NCT00778830|64413525|FG001|Overall Study|Ongoing at data cut-off|1|||
23183488|NCT01245673|64413526|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
23183489|NCT01511445|64413535|FG000|Overall Study|Lost to Follow-up|3|||
23183490|NCT01511445|64413536|FG001|Overall Study|Lost to Follow-up|1|||
23183491|NCT01511445|64413535|FG000|Overall Study|Protocol Violation|1|||
23183492|NCT01511445|64413536|FG001|Overall Study|Protocol Violation|3|||
23183493|NCT01511445|64413535|FG000|Overall Study|Protocol Violation|1|||
23183494|NCT01511445|64413536|FG001|Overall Study|Protocol Violation|0|||
23183495|NCT01491178|64413538|FG000|Overall Study|Adverse Event|1016|||
23183496|NCT01491178|64413538|FG000|Overall Study|Improvement of NVAF|210|||
23183497|NCT01491178|64413538|FG000|Overall Study|To conduct invasive treatment|59|||
23183498|NCT01491178|64413538|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
23183499|NCT01491178|64413538|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
23183500|NCT01491178|64413538|FG000|Overall Study|To take a contraindication|20|||
23183501|NCT01491178|64413538|FG000|Overall Study|Other than specified above|657|||
23183502|NCT03133767|64413539|FG000|Overall Study|Lost to Follow-up|38|||
23462792|NCT01597596|65437979|FG001|Overall Study|Physician Decision|1|||
23462793|NCT00003475|65437980|FG000|Overall Study|Not evaluable|13|||
23462794|NCT00674817|65437983|FG000|Period 1|Withdrawal by Subject|2|||
23462795|NCT00674817|65437983|FG000|Period 1|Protocol Violation|1|||
23462796|NCT00674817|65437983|FG000|Period 3|Adverse Event|1|||
23462797|NCT00674817|65437983|FG000|Period 3|Protocol Violation|1|||
23462798|NCT00674817|65437983|FG000|Period 4|Adverse Event|1|||
23462799|NCT03879772|65437984|FG000|Overall Study|Adverse Event|2|||
23462800|NCT03879772|65437985|FG001|Overall Study|Adverse Event|2|||
23462801|NCT03879772|65437986|FG002|Overall Study|Adverse Event|3|||
23462802|NCT03879772|65437987|FG003|Overall Study|Adverse Event|4|||
23462803|NCT03879772|65437988|FG004|Overall Study|Adverse Event|3|||
23462804|NCT03879772|65437984|FG000|Overall Study|Treatment Failure|1|||
23462805|NCT03879772|65437985|FG001|Overall Study|Treatment Failure|0|||
23462806|NCT03879772|65437986|FG002|Overall Study|Treatment Failure|0|||
23462807|NCT03879772|65437987|FG003|Overall Study|Treatment Failure|2|||
23462808|NCT03879772|65437988|FG004|Overall Study|Treatment Failure|1|||
23462809|NCT03879772|65437984|FG000|Overall Study|Lost to Follow-up|0|||
23462810|NCT03879772|65437985|FG001|Overall Study|Lost to Follow-up|0|||
23462811|NCT03879772|65437986|FG002|Overall Study|Lost to Follow-up|0|||
23462812|NCT03879772|65437987|FG003|Overall Study|Lost to Follow-up|0|||
23462813|NCT03879772|65437988|FG004|Overall Study|Lost to Follow-up|1|||
23462814|NCT03879772|65437984|FG000|Overall Study|Withdrawal by Subject|0|||
23462815|NCT03879772|65437985|FG001|Overall Study|Withdrawal by Subject|1|||
23462816|NCT03879772|65437986|FG002|Overall Study|Withdrawal by Subject|3|||
23462817|NCT03879772|65437987|FG003|Overall Study|Withdrawal by Subject|1|||
23462818|NCT03879772|65437988|FG004|Overall Study|Withdrawal by Subject|1|||
23462819|NCT03879772|65437984|FG000|Overall Study|Protocol Violation|0|||
23462820|NCT03879772|65437985|FG001|Overall Study|Protocol Violation|0|||
23462821|NCT03879772|65437986|FG002|Overall Study|Protocol Violation|3|||
23183503|NCT03133767|64413540|FG001|Overall Study|Lost to Follow-up|24|||
23183504|NCT03133767|64413539|FG000|Overall Study|Protocol Violation|0|||
23183505|NCT03133767|64413540|FG001|Overall Study|Protocol Violation|1|||
23183506|NCT00591734|64413541|FG000|Overall Study|Lack of Efficacy|35|||
23183507|NCT00591734|64413541|FG000|Overall Study|Adverse Event|5|||
23242255|NCT00151775|64632880|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23462822|NCT03879772|65437987|FG003|Overall Study|Protocol Violation|1|||
23462823|NCT03879772|65437988|FG004|Overall Study|Protocol Violation|2|||
23462824|NCT03879772|65437984|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
23462825|NCT03879772|65437985|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
23462826|NCT03879772|65437986|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
23183508|NCT00591734|64413541|FG000|Overall Study|Physician Decision|5|||
23183509|NCT00591734|64413541|FG000|Overall Study|Intercurrent Illness|8|||
23183510|NCT00376961|64413542|FG000|Initial Registration|Adverse Event|1|||
23462827|NCT03879772|65437987|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
23462828|NCT03879772|65437988|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
23462829|NCT00665652|65437989|FG000|Overall Study|Adverse Event|4|||
23183511|NCT00376961|64413543|FG001|Initial Registration|Adverse Event|0|||
23183512|NCT00376961|64413542|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
23183513|NCT00376961|64413543|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23183514|NCT00376961|64413542|FG000|Initial Registration|Progression/relapse|1|||
23183515|NCT00376961|64413543|FG001|Initial Registration|Progression/relapse|0|||
23183516|NCT00376961|64413542|FG000|Initial Registration|Ineligible|3|||
23183517|NCT00376961|64413543|FG001|Initial Registration|Ineligible|0|||
23183518|NCT00376961|64413542|FG000|Maintenance|Adverse Event|0|||
23183519|NCT00376961|64413543|FG001|Maintenance|Adverse Event|1|||
23183520|NCT00376961|64413542|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
23183521|NCT00376961|64413543|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
23183522|NCT00376961|64413542|FG000|Maintenance|Progression/relapse|0|||
23183523|NCT00376961|64413543|FG001|Maintenance|Progression/relapse|18|||
23183524|NCT00376961|64413542|FG000|Maintenance|Ineligible|0|||
23183525|NCT00376961|64413543|FG001|Maintenance|Ineligible|3|||
23183526|NCT00502840|64413544|FG000|Overall Study|Adverse Event|5|||
23242256|NCT00151775|64632881|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23242257|NCT00151775|64632882|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23242258|NCT00151775|64632883|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23242259|NCT00151775|64632884|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
23242260|NCT00151775|64632885|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23242261|NCT00151775|64632886|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23242262|NCT00151775|64632887|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23242263|NCT00151775|64632888|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23242264|NCT00151775|64632889|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
23242265|NCT00151775|64632878|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242266|NCT00151775|64632879|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242267|NCT00151775|64632880|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242268|NCT00151775|64632881|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242269|NCT00151775|64632882|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242270|NCT00151775|64632883|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
23242271|NCT00151775|64632884|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242272|NCT00151775|64632885|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242273|NCT00151775|64632886|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242274|NCT00151775|64632887|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242275|NCT00151775|64632888|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242276|NCT00151775|64632889|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
23242277|NCT00151775|64632878|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
23242278|NCT00151775|64632879|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
23242279|NCT00151775|64632880|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
23242280|NCT00151775|64632881|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
23242281|NCT00151775|64632882|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
23242282|NCT00151775|64632883|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
23242283|NCT00151775|64632884|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
23242284|NCT00151775|64632885|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
23242285|NCT00151775|64632886|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
23242286|NCT00151775|64632887|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
23242287|NCT00151775|64632888|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
23242288|NCT00151775|64632889|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
23242289|NCT00151775|64632878|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23242290|NCT00151775|64632879|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23242291|NCT00151775|64632880|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23183527|NCT00502840|64413544|FG000|Overall Study|Additional or changed therapy|48|||
23183528|NCT00502840|64413544|FG000|Overall Study|Lack of Efficacy|11|||
23183529|NCT00502840|64413544|FG000|Overall Study|Protocol Violation|4|||
23183530|NCT00502840|64413544|FG000|Overall Study|Withdrawal by Subject|5|||
23349850|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
23349851|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23349852|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23349853|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23349854|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349855|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349856|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23242292|NCT00151775|64632881|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23349857|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23349858|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349859|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349860|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349861|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349862|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349863|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
23349864|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
23349865|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349866|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
23349867|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349868|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349869|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349870|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349871|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
23349872|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349873|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349874|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349875|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349876|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349877|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
23349878|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349879|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349880|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349881|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349882|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349883|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349884|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23349885|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
23584911|NCT03256344|65869320|FG001|Overall Study|Death|22|||
23584912|NCT03256344|65869319|FG000|Overall Study|Withdrawal by Subject|3|||
23242293|NCT00151775|64632882|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23242294|NCT00151775|64632883|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23242295|NCT00151775|64632884|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
23242296|NCT00151775|64632885|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23242297|NCT00151775|64632886|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23242298|NCT00151775|64632887|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23242299|NCT00151775|64632888|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23242300|NCT00151775|64632889|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
23242301|NCT00151775|64632878|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242302|NCT00151775|64632879|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242303|NCT00151775|64632880|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
23242304|NCT00151775|64632881|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242305|NCT00151775|64632882|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242306|NCT00151775|64632883|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242307|NCT00151775|64632884|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242308|NCT00151775|64632885|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242309|NCT00151775|64632886|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242310|NCT00151775|64632887|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242311|NCT00151775|64632888|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242312|NCT00151775|64632889|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
23242313|NCT00151775|64632878|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23242314|NCT00151775|64632879|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23349886|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349887|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349888|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349889|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349890|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23462830|NCT00665652|65437989|FG000|Overall Study|Death|1|||
23462831|NCT00665652|65437989|FG000|Overall Study|No longer met inclusion criteria.|1|||
23462832|NCT01074502|65437996|FG000|Overall Study|Withdrawal by Subject|1|||
23462833|NCT01347112|65438013|FG000|Overall Study|Withdrawal by Subject|1|||
23462834|NCT01347112|65438014|FG001|Overall Study|Withdrawal by Subject|7|||
23462835|NCT01347112|65438013|FG000|Overall Study|Lost to Follow-up|3|||
23462836|NCT01347112|65438014|FG001|Overall Study|Lost to Follow-up|5|||
23462837|NCT02201953|65438017|FG000|Overall Study|Randomized but Never Treated|1|||
23462838|NCT02201953|65438018|FG001|Overall Study|Randomized but Never Treated|5|||
23462839|NCT02201953|65438017|FG000|Overall Study|Lack of Efficacy|9|||
23462840|NCT02201953|65438018|FG001|Overall Study|Lack of Efficacy|30|||
23462841|NCT02201953|65438017|FG000|Overall Study|Lost to Follow-up|8|||
23462842|NCT02201953|65438018|FG001|Overall Study|Lost to Follow-up|8|||
23462843|NCT02201953|65438017|FG000|Overall Study|Withdrew Consent|2|||
23462844|NCT02201953|65438018|FG001|Overall Study|Withdrew Consent|5|||
23462845|NCT02201953|65438017|FG000|Overall Study|Adverse Event|0|||
23462846|NCT02201953|65438018|FG001|Overall Study|Adverse Event|5|||
23462847|NCT02201953|65438017|FG000|Overall Study|Death|0|||
23462848|NCT02201953|65438018|FG001|Overall Study|Death|3|||
23462849|NCT01614886|65438022|FG000|Overall Study|Adverse Event|15|||
23462850|NCT01614886|65438023|FG001|Overall Study|Adverse Event|20|||
23462851|NCT01614886|65438022|FG000|Overall Study|Withdrawal by Subject|4|||
23462852|NCT01614886|65438023|FG001|Overall Study|Withdrawal by Subject|4|||
23462853|NCT01614886|65438022|FG000|Overall Study|Death|1|||
23462854|NCT01614886|65438023|FG001|Overall Study|Death|0|||
23462855|NCT01614886|65438022|FG000|Overall Study|Protocol deviation|0|||
23462856|NCT01614886|65438023|FG001|Overall Study|Protocol deviation|2|||
23462857|NCT01772316|65438024|FG000|Overall Study|Serious adverse event|1|||
23462858|NCT01772316|65438024|FG000|Overall Study|Inform consent withdrawn|1|||
23462859|NCT01772316|65438024|FG000|Overall Study|Withdrawn by sponsor decision|5|||
23462860|NCT02392624|65438025|FG000|Overall Study|Withdrawal by Subject|15|||
23462861|NCT02392624|65438026|FG001|Overall Study|Withdrawal by Subject|12|||
23462862|NCT02392624|65438027|FG002|Overall Study|Withdrawal by Subject|9|||
23462863|NCT02392624|65438025|FG000|Overall Study|Adverse Event|4|||
23462864|NCT02392624|65438026|FG001|Overall Study|Adverse Event|1|||
23462865|NCT02392624|65438027|FG002|Overall Study|Adverse Event|2|||
23462866|NCT02392624|65438025|FG000|Overall Study|Pregnancy|1|||
23462867|NCT02392624|65438026|FG001|Overall Study|Pregnancy|0|||
23462868|NCT02392624|65438027|FG002|Overall Study|Pregnancy|0|||
23462869|NCT02392624|65438025|FG000|Overall Study|Protocol Violation|0|||
23462870|NCT02392624|65438026|FG001|Overall Study|Protocol Violation|0|||
23462871|NCT02392624|65438027|FG002|Overall Study|Protocol Violation|1|||
23462872|NCT02392624|65438025|FG000|Overall Study|Sponsor/Investigator Decision|2|||
23462873|NCT02392624|65438026|FG001|Overall Study|Sponsor/Investigator Decision|1|||
23462874|NCT02392624|65438027|FG002|Overall Study|Sponsor/Investigator Decision|0|||
23462875|NCT02392624|65438025|FG000|Overall Study|Other|49|||
23462876|NCT02392624|65438026|FG001|Overall Study|Other|1|||
23462877|NCT02392624|65438027|FG002|Overall Study|Other|1|||
23462878|NCT02435992|65438028|FG000|Overall Study|non compliance with protocol|2|||
23462879|NCT02435992|65438029|FG001|Overall Study|non compliance with protocol|0|||
23462880|NCT02435992|65438030|FG002|Overall Study|non compliance with protocol|1|||
23462881|NCT02435992|65438031|FG003|Overall Study|non compliance with protocol|0|||
23462882|NCT02435992|65438032|FG004|Overall Study|non compliance with protocol|0|||
23462883|NCT02435992|65438028|FG000|Overall Study|Adverse Event|11|||
23462884|NCT02435992|65438029|FG001|Overall Study|Adverse Event|6|||
23349891|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23462885|NCT02435992|65438030|FG002|Overall Study|Adverse Event|12|||
23462886|NCT02435992|65438031|FG003|Overall Study|Adverse Event|0|||
23462887|NCT02435992|65438032|FG004|Overall Study|Adverse Event|0|||
23349892|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
23402749|NCT01621178|65219994|FG000|Overall Study|Adverse Event|5|||
23462888|NCT02435992|65438028|FG000|Overall Study|Lack of Efficacy|4|||
23462889|NCT02435992|65438029|FG001|Overall Study|Lack of Efficacy|10|||
23462890|NCT02435992|65438030|FG002|Overall Study|Lack of Efficacy|9|||
23462891|NCT02435992|65438031|FG003|Overall Study|Lack of Efficacy|0|||
23462892|NCT02435992|65438032|FG004|Overall Study|Lack of Efficacy|0|||
23462893|NCT02435992|65438028|FG000|Overall Study|Withdrawal by Subject|10|||
23462894|NCT02435992|65438029|FG001|Overall Study|Withdrawal by Subject|8|||
23462895|NCT02435992|65438030|FG002|Overall Study|Withdrawal by Subject|20|||
23462896|NCT02435992|65438031|FG003|Overall Study|Withdrawal by Subject|0|||
23462897|NCT02435992|65438032|FG004|Overall Study|Withdrawal by Subject|0|||
23462898|NCT02435992|65438028|FG000|Overall Study|Other Reason|1|||
23462899|NCT02435992|65438029|FG001|Overall Study|Other Reason|0|||
23462900|NCT02435992|65438030|FG002|Overall Study|Other Reason|0|||
23462901|NCT02435992|65438031|FG003|Overall Study|Other Reason|0|||
23462902|NCT02435992|65438032|FG004|Overall Study|Other Reason|0|||
23462903|NCT02435992|65438028|FG000|Overall Study|Physician Decision|0|||
23462904|NCT02435992|65438029|FG001|Overall Study|Physician Decision|0|||
23462905|NCT02435992|65438030|FG002|Overall Study|Physician Decision|1|||
23462906|NCT02435992|65438031|FG003|Overall Study|Physician Decision|0|||
23462907|NCT02435992|65438032|FG004|Overall Study|Physician Decision|0|||
23462908|NCT02900378|65438033|FG000|Randomization (Visit 2)|Adverse Event|14|||
23462909|NCT02900378|65438034|FG001|Randomization (Visit 2)|Adverse Event|11|||
23462910|NCT02900378|65438033|FG000|Randomization (Visit 2)|Death|1|||
23462911|NCT02900378|65438034|FG001|Randomization (Visit 2)|Death|4|||
23462912|NCT02900378|65438033|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
23462913|NCT02900378|65438034|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
23462914|NCT02900378|65438033|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
23462915|NCT02900378|65438034|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
23462916|NCT02900378|65438033|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
23462917|NCT02900378|65438034|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
23462918|NCT02900378|65438033|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
23462919|NCT02900378|65438034|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
23462920|NCT02900378|65438033|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
23462921|NCT02900378|65438034|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
23462922|NCT01193244|65438040|FG000|Overall Study|Withdrawal by Subject|79|||
23462923|NCT01193244|65438041|FG001|Overall Study|Withdrawal by Subject|97|||
23462924|NCT01193244|65438040|FG000|Overall Study|Other|303|||
23462925|NCT01193244|65438041|FG001|Overall Study|Other|278|||
23462926|NCT01193244|65438040|FG000|Overall Study|Lost to Follow-up|6|||
23462927|NCT01193244|65438041|FG001|Overall Study|Lost to Follow-up|15|||
23462928|NCT00912197|65438045|FG000|Overall Study|Withdrawal by Subject|3|||
23462929|NCT00912197|65438046|FG001|Overall Study|Withdrawal by Subject|3|||
23462930|NCT00313014|65438047|FG000|Overall Study|Withdrawal by Subject|11|||
23462931|NCT00313014|65438048|FG001|Overall Study|Withdrawal by Subject|7|||
23462932|NCT00313014|65438049|FG002|Overall Study|Withdrawal by Subject|5|||
23462933|NCT00313014|65438047|FG000|Overall Study|Adverse Event|14|||
23462934|NCT00313014|65438048|FG001|Overall Study|Adverse Event|29|||
23462935|NCT00313014|65438049|FG002|Overall Study|Adverse Event|16|||
23462936|NCT00313014|65438047|FG000|Overall Study|Lost to Follow-up|7|||
23462937|NCT00313014|65438048|FG001|Overall Study|Lost to Follow-up|6|||
23462938|NCT00313014|65438049|FG002|Overall Study|Lost to Follow-up|10|||
23462939|NCT00313014|65438047|FG000|Overall Study|Administrative|9|||
23462940|NCT00313014|65438048|FG001|Overall Study|Administrative|6|||
23462941|NCT00313014|65438049|FG002|Overall Study|Administrative|14|||
23462942|NCT00313014|65438047|FG000|Overall Study|Lack of Efficacy|52|||
23462943|NCT00313014|65438048|FG001|Overall Study|Lack of Efficacy|25|||
23462944|NCT00313014|65438049|FG002|Overall Study|Lack of Efficacy|16|||
23462945|NCT02177032|65438053|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
23462946|NCT02177032|65438054|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
23462947|NCT02177032|65438055|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
23462948|NCT02177032|65438056|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
23462949|NCT02177032|65438053|FG000|Overall Study|Lost to Follow-up|0|||
23462950|NCT02177032|65438054|FG001|Overall Study|Lost to Follow-up|2|||
23462951|NCT02177032|65438055|FG002|Overall Study|Lost to Follow-up|0|||
23462952|NCT02177032|65438056|FG003|Overall Study|Lost to Follow-up|0|||
23462953|NCT02177032|65438053|FG000|Overall Study|OTHER|2|||
23462954|NCT02177032|65438054|FG001|Overall Study|OTHER|0|||
23462955|NCT02177032|65438055|FG002|Overall Study|OTHER|1|||
23462956|NCT02177032|65438056|FG003|Overall Study|OTHER|0|||
23462957|NCT02177032|65438053|FG000|Overall Study|Withdrawal by Subject|1|||
23462958|NCT02177032|65438054|FG001|Overall Study|Withdrawal by Subject|0|||
23462959|NCT02177032|65438055|FG002|Overall Study|Withdrawal by Subject|1|||
23462960|NCT02177032|65438056|FG003|Overall Study|Withdrawal by Subject|0|||
23462961|NCT02195518|65438057|FG000|Overall Study|Adverse Event|1|||
23584913|NCT03256344|65869320|FG001|Overall Study|Withdrawal by Subject|3|||
23584914|NCT03256344|65869319|FG000|Overall Study|Sponsor Decision|1|||
23462962|NCT02195518|65438057|FG000|Overall Study|Protocol Violation|4|||
23462963|NCT02195518|65438057|FG000|Overall Study|Pregnancy|2|||
23462964|NCT02195518|65438057|FG000|Overall Study|Withdrawal by Subject|1|||
23462965|NCT02195518|65438057|FG000|Overall Study|Lost to Follow-up|1|||
23462966|NCT01967940|65438060|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
23462967|NCT01967940|65438061|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
23462968|NCT01967940|65438062|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
23462969|NCT01967940|65438063|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
23462970|NCT01967940|65438060|FG000|Part 2|Adverse Event|0|||
23584915|NCT03256344|65869320|FG001|Overall Study|Sponsor Decision|0|||
23462971|NCT01967940|65438061|FG001|Part 2|Adverse Event|0|||
23462972|NCT01967940|65438062|FG002|Part 2|Adverse Event|0|||
23462973|NCT01967940|65438063|FG003|Part 2|Adverse Event|1|||
23349893|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349894|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349895|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349896|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349897|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349898|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349899|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23349900|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349901|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349902|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349903|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349904|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349905|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349906|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349907|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
23349908|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349909|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349910|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349911|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349912|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349913|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
23349914|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349915|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349916|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349917|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349918|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349919|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349920|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
23349921|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
23349922|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349923|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349924|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349925|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349926|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349927|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23349928|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349929|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349930|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349931|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349932|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349933|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349934|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349935|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23349936|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349937|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349938|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349939|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349940|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349941|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23349942|NCT02326298|65025289|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349943|NCT02326298|65025290|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349944|NCT02326298|65025291|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349945|NCT02326298|65025292|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349946|NCT02326298|65025293|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349947|NCT02326298|65025294|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
23349948|NCT02326298|65025295|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349949|NCT02326298|65025296|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349950|NCT02326298|65025297|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349951|NCT02326298|65025298|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23462974|NCT01967940|65438060|FG000|Part 2|Unknown Reason|0|||
23462975|NCT01967940|65438061|FG001|Part 2|Unknown Reason|0|||
23462976|NCT01967940|65438062|FG002|Part 2|Unknown Reason|0|||
23462977|NCT01967940|65438063|FG003|Part 2|Unknown Reason|1|||
23462978|NCT04119414|65438064|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
23462979|NCT02141295|65438065|FG000|Overall Study|Adverse Event|1|||
23462980|NCT02141295|65438066|FG001|Overall Study|Adverse Event|18|||
23462981|NCT02141295|65438067|FG002|Overall Study|Adverse Event|11|||
23462982|NCT02141295|65438065|FG000|Overall Study|Physician Decision|2|||
23462983|NCT02141295|65438066|FG001|Overall Study|Physician Decision|19|||
23462984|NCT02141295|65438067|FG002|Overall Study|Physician Decision|14|||
23462985|NCT02141295|65438065|FG000|Overall Study|Study terminated by sponsor|0|||
23462986|NCT02141295|65438066|FG001|Overall Study|Study terminated by sponsor|6|||
23462987|NCT02141295|65438067|FG002|Overall Study|Study terminated by sponsor|6|||
23462988|NCT02141295|65438065|FG000|Overall Study|Non-compliance|0|||
23462989|NCT02141295|65438066|FG001|Overall Study|Non-compliance|1|||
23462990|NCT02141295|65438067|FG002|Overall Study|Non-compliance|0|||
23462991|NCT02141295|65438065|FG000|Overall Study|Progressive disease|3|||
23462992|NCT02141295|65438066|FG001|Overall Study|Progressive disease|32|||
23462993|NCT02141295|65438067|FG002|Overall Study|Progressive disease|50|||
23462994|NCT02141295|65438065|FG000|Overall Study|Reason not specified|0|||
23462995|NCT02141295|65438066|FG001|Overall Study|Reason not specified|9|||
23462996|NCT02141295|65438067|FG002|Overall Study|Reason not specified|10|||
23462997|NCT02141295|65438065|FG000|Overall Study|Withdrawal by Subject|0|||
23462998|NCT02141295|65438066|FG001|Overall Study|Withdrawal by Subject|9|||
23462999|NCT02141295|65438067|FG002|Overall Study|Withdrawal by Subject|4|||
23463000|NCT02383576|65438068|FG000|Overall Study|Death|53|||
23463001|NCT02383576|65438069|FG001|Overall Study|Death|33|||
23463002|NCT02383576|65438068|FG000|Overall Study|Lost to Follow-up|7|||
23463003|NCT02383576|65438069|FG001|Overall Study|Lost to Follow-up|1|||
23463004|NCT02383576|65438068|FG000|Overall Study|Withdrew Consent|1|||
23463005|NCT02383576|65438069|FG001|Overall Study|Withdrew Consent|6|||
23463006|NCT02383576|65438068|FG000|Overall Study|Investigator's Decision|0|||
23463007|NCT02383576|65438069|FG001|Overall Study|Investigator's Decision|1|||
23463008|NCT02383576|65438068|FG000|Overall Study|Administrative/Other|2|||
23463009|NCT02383576|65438069|FG001|Overall Study|Administrative/Other|4|||
23463010|NCT04393454|65438070|FG000|Overall Study|Death|1|||
23463011|NCT04393454|65438070|FG000|Overall Study|Lost to Follow-up|1|||
23463012|NCT02079246|65438071|FG000|OLEX|Withdrawal before treatment|1|||
23463013|NCT02079246|65438072|FG001|OLEX|Withdrawal before treatment|0|||
23463014|NCT02079246|65438071|FG000|OLEX|Death|11|||
23463015|NCT02079246|65438072|FG001|OLEX|Death|0|||
23463016|NCT02079246|65438071|FG000|OLEX|Adverse Event|66|||
23463017|NCT02079246|65438072|FG001|OLEX|Adverse Event|0|||
23463018|NCT02079246|65438071|FG000|OLEX|Withdrawal by Subject|60|||
23463019|NCT02079246|65438072|FG001|OLEX|Withdrawal by Subject|0|||
23463020|NCT02079246|65438071|FG000|OLEX|Lost to Follow-up|6|||
23463021|NCT02079246|65438072|FG001|OLEX|Lost to Follow-up|0|||
23463022|NCT02079246|65438071|FG000|OLEX|Protocol Violation|6|||
23463023|NCT02079246|65438072|FG001|OLEX|Protocol Violation|0|||
23463024|NCT02079246|65438071|FG000|OLEX|Lack of Efficacy|3|||
23463025|NCT02079246|65438072|FG001|OLEX|Lack of Efficacy|0|||
23463026|NCT02079246|65438071|FG000|OLEX|Results of the lead-in studies|58|||
23463027|NCT02079246|65438072|FG001|OLEX|Results of the lead-in studies|0|||
23463028|NCT02079246|65438071|FG000|OLEX|Other: Disallowed medication|8|||
23463029|NCT02079246|65438072|FG001|OLEX|Other: Disallowed medication|0|||
23584916|NCT03586544|65869323|FG000|First Intervention|Adverse Event|0|||
23584917|NCT03586544|65869324|FG001|First Intervention|Adverse Event|1|||
23584918|NCT03586544|65869323|FG000|Second Intervention|Withdrawal by Subject|0|||
23584919|NCT03586544|65869324|FG001|Second Intervention|Withdrawal by Subject|1|||
23584920|NCT00099437|65869325|FG000|Overall Study|Lost to Follow-up|30|||
23584921|NCT00099437|65869326|FG001|Overall Study|Lost to Follow-up|33|||
23584922|NCT00099437|65869325|FG000|Overall Study|Death|293|||
23584923|NCT00099437|65869326|FG001|Overall Study|Death|261|||
23584924|NCT00099437|65869325|FG000|Overall Study|Withdrawal by Subject|6|||
23584925|NCT00099437|65869326|FG001|Overall Study|Withdrawal by Subject|10|||
23463030|NCT02079246|65438071|FG000|OLEX|Other: Insufficient compliance|2|||
23463031|NCT02079246|65438072|FG001|OLEX|Other: Insufficient compliance|0|||
23463032|NCT02079246|65438071|FG000|OLEX|Other: Caregiver unavailable|3|||
23584926|NCT00099437|65869325|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
23463033|NCT02079246|65438072|FG001|OLEX|Other: Caregiver unavailable|0|||
23463034|NCT02079246|65438071|FG000|OLEX|Other: Coordinator decision|1|||
23463035|NCT02079246|65438072|FG001|OLEX|Other: Coordinator decision|0|||
23463036|NCT02079246|65438071|FG000|OLEX|Other: Worsening of condition|1|||
23463037|NCT02079246|65438072|FG001|OLEX|Other: Worsening of condition|0|||
23463038|NCT02079246|65438071|FG000|OLEX|Other: Moved to nursing home|1|||
23584927|NCT00099437|65869326|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
23584928|NCT02954055|65869327|FG000|Overall Study|Did not initiate therapy|6|||
23463039|NCT02079246|65438072|FG001|OLEX|Other: Moved to nursing home|0|||
23463040|NCT02079246|65438071|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
23463041|NCT02079246|65438072|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
23463042|NCT02079246|65438071|FG000|OLEX-MEM|Adverse Event|0|||
23463043|NCT02079246|65438072|FG001|OLEX-MEM|Adverse Event|6|||
23463044|NCT02079246|65438071|FG000|OLEX-MEM|Withdrawal by Subject|0|||
23463045|NCT02079246|65438072|FG001|OLEX-MEM|Withdrawal by Subject|7|||
23463046|NCT02079246|65438071|FG000|OLEX-MEM|Protocol Violation|0|||
23463047|NCT02079246|65438072|FG001|OLEX-MEM|Protocol Violation|2|||
23463048|NCT02079246|65438071|FG000|OLEX-MEM|Lost to Follow-up|0|||
23463049|NCT02079246|65438072|FG001|OLEX-MEM|Lost to Follow-up|1|||
23463050|NCT02079246|65438071|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
23463051|NCT02079246|65438072|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
23463052|NCT00124943|65438073|FG000|Phase II|Adverse Event|0|||
23463053|NCT00124943|65438074|FG001|Phase II|Adverse Event|2|||
23463054|NCT00124943|65438075|FG002|Phase II|Adverse Event|0|||
23463055|NCT00124943|65438076|FG003|Phase II|Adverse Event|1|||
23463056|NCT00124943|65438073|FG000|Phase II|Protocol Violation|0|||
23463057|NCT00124943|65438074|FG001|Phase II|Protocol Violation|0|||
23463058|NCT00124943|65438075|FG002|Phase II|Protocol Violation|0|||
23463059|NCT00124943|65438076|FG003|Phase II|Protocol Violation|1|||
23463060|NCT00124943|65438073|FG000|Phase II|Lost to Follow-up|0|||
23463061|NCT00124943|65438074|FG001|Phase II|Lost to Follow-up|0|||
23463062|NCT00124943|65438075|FG002|Phase II|Lost to Follow-up|0|||
23463063|NCT00124943|65438076|FG003|Phase II|Lost to Follow-up|1|||
23463064|NCT00124943|65438073|FG000|Phase II|Withdrawal by Subject|0|||
23463065|NCT00124943|65438074|FG001|Phase II|Withdrawal by Subject|0|||
23183531|NCT00502840|64413544|FG000|Overall Study|Lost to Follow-up|6|||
23183532|NCT00502840|64413544|FG000|Overall Study|Administrative problems|1|||
23183533|NCT00502840|64413544|FG000|Overall Study|Other|20|||
23183534|NCT02388295|64413545|FG000|Dose Escalation Week 1|Adverse Event|1|||
23183535|NCT02388295|64413546|FG001|Dose Escalation Week 1|Adverse Event|2|||
23183536|NCT02388295|64413547|FG002|Dose Escalation Week 1|Adverse Event|1|||
23183537|NCT02388295|64413545|FG000|Dose Escalation Week 1|Determined not eligible|1|||
23183538|NCT02388295|64413546|FG001|Dose Escalation Week 1|Determined not eligible|1|||
23183539|NCT02388295|64413547|FG002|Dose Escalation Week 1|Determined not eligible|1|||
23183540|NCT02388295|64413545|FG000|Dose Escalation Week 2|Protocol Violation|0|||
23183541|NCT02388295|64413546|FG001|Dose Escalation Week 2|Protocol Violation|1|||
23183542|NCT02388295|64413547|FG002|Dose Escalation Week 2|Protocol Violation|0|||
23183543|NCT02388295|64413545|FG000|Dose Escalation Week 2|Determined not eligible|1|||
23183544|NCT02388295|64413546|FG001|Dose Escalation Week 2|Determined not eligible|1|||
23183545|NCT02388295|64413547|FG002|Dose Escalation Week 2|Determined not eligible|1|||
23183546|NCT02388295|64413545|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
23183547|NCT02388295|64413546|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
23183548|NCT02388295|64413547|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
23183549|NCT02207907|64413567|FG000|Overall Study|Lost to Follow-up|3|||
23183550|NCT02207907|64413568|FG001|Overall Study|Lost to Follow-up|1|||
23183551|NCT02207907|64413567|FG000|Overall Study|Withdrawal by Subject|5|||
23183552|NCT02207907|64413568|FG001|Overall Study|Withdrawal by Subject|6|||
23183553|NCT02207907|64413567|FG000|Overall Study|Did not meet study criteria|3|||
23183554|NCT02207907|64413568|FG001|Overall Study|Did not meet study criteria|0|||
23183555|NCT02207907|64413567|FG000|Overall Study|Pregnancy|0|||
23183556|NCT02207907|64413568|FG001|Overall Study|Pregnancy|1|||
23183557|NCT03440944|64413572|FG000|Overall Study|Physician Decision|1|||
23183558|NCT03440944|64413573|FG001|Overall Study|Physician Decision|0|||
23183559|NCT03440944|64413572|FG000|Overall Study|No Acceptable Vasculature|0|||
23183560|NCT03440944|64413573|FG001|Overall Study|No Acceptable Vasculature|1|||
23183561|NCT02185521|64413574|FG000|Overall Study|Withdrawal by Subject|1|||
23183562|NCT02185521|64413574|FG000|Overall Study|Protocol Violation|1|||
23183563|NCT03521791|64413578|FG000|Overall Study|Protocol Violation|7|||
23183564|NCT03521791|64413579|FG001|Overall Study|Protocol Violation|17|||
23584929|NCT02954055|65869328|FG001|Overall Study|Did not initiate therapy|1|||
23584930|NCT00256243|65869329|FG000|Overall Study|Lost to Follow-up|2|||
23584931|NCT00256243|65869329|FG000|Overall Study|Death|7|||
23584932|NCT00256243|65869329|FG000|Overall Study|Not treated|1|||
23584933|NCT05025449|65869331|FG000|Overall Study|Withdrawal by Subject|1|||
23584934|NCT05025449|65869331|FG000|Overall Study|Patient emergently taken to operating room|1|||
23584935|NCT01175707|65869332|FG000|Overall Study|Adverse Event|4|||
23463066|NCT00124943|65438075|FG002|Phase II|Withdrawal by Subject|0|||
23463067|NCT00124943|65438076|FG003|Phase II|Withdrawal by Subject|2|||
23584936|NCT01175707|65869333|FG001|Overall Study|Adverse Event|6|||
23584937|NCT01124162|65869334|FG000|First Intervention|Adverse Event|2|||
23463068|NCT01295814|65438077|FG000|Overall Study|Lack of Efficacy|0|||
23463069|NCT01295814|65438078|FG001|Overall Study|Lack of Efficacy|2|||
23463070|NCT01295814|65438077|FG000|Overall Study|Withdrawal by Subject|2|||
23463071|NCT01295814|65438078|FG001|Overall Study|Withdrawal by Subject|0|||
23463072|NCT03096288|65438079|FG000|Overall Study|Withdrawal by Subject|0|||
23463073|NCT03096288|65438080|FG001|Overall Study|Withdrawal by Subject|1|||
23584938|NCT01124162|65869335|FG001|First Intervention|Adverse Event|0|||
23584939|NCT01124162|65869334|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23584940|NCT01124162|65869335|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23463074|NCT03096288|65438081|FG002|Overall Study|Withdrawal by Subject|0|||
23584941|NCT00886613|65869336|FG000|Overall Study|Protocol deviation (Part B)|1|||
23584942|NCT00886613|65869337|FG001|Overall Study|Protocol deviation (Part B)|0|||
23584943|NCT00886613|65869338|FG002|Overall Study|Protocol deviation (Part B)|0|||
23584944|NCT00886613|65869336|FG000|Overall Study|Lost to follow-up (Part B)|1|||
23584945|NCT00886613|65869337|FG001|Overall Study|Lost to follow-up (Part B)|0|||
23584946|NCT00886613|65869338|FG002|Overall Study|Lost to follow-up (Part B)|1|||
23584947|NCT00886613|65869336|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
23584948|NCT00886613|65869337|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
23584949|NCT00886613|65869338|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
23584950|NCT01268891|65869339|FG000|Overall Study|Adverse Event|3|||
23584951|NCT01268891|65869340|FG001|Overall Study|Adverse Event|7|||
23584952|NCT01268891|65869339|FG000|Overall Study|Lack of Efficacy|1|||
23584953|NCT01268891|65869340|FG001|Overall Study|Lack of Efficacy|0|||
23584954|NCT01268891|65869339|FG000|Overall Study|Withdrawal of Consent|3|||
23584955|NCT01268891|65869340|FG001|Overall Study|Withdrawal of Consent|1|||
23584956|NCT01268891|65869339|FG000|Overall Study|Administrative or other reason(s)|1|||
23584957|NCT01268891|65869340|FG001|Overall Study|Administrative or other reason(s)|0|||
23584958|NCT03213678|65869352|FG000|Overall Study|Death|1|||
23242315|NCT00151775|64632880|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
23242316|NCT00151775|64632881|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23242317|NCT00151775|64632882|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23242318|NCT00151775|64632883|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23242319|NCT00151775|64632884|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23242320|NCT00151775|64632885|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23242321|NCT00151775|64632886|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23242322|NCT00151775|64632887|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23242323|NCT00151775|64632888|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23349952|NCT02326298|65025299|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23584959|NCT03213678|65869352|FG000|Overall Study|Physician Decision|1|||
23349953|NCT02326298|65025300|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349954|NCT02326298|65025301|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349955|NCT02326298|65025302|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
23349956|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
23349957|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
23349958|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
23349959|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
23349960|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
23349961|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
23349962|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
23349963|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
23349964|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
23349965|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
23349966|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
23349967|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
23349968|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
23349969|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
23349970|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349971|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349972|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349973|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349974|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349975|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349976|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349977|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349978|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349979|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349980|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349981|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
23349982|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
23349983|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23349984|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349985|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349986|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23584960|NCT03213678|65869352|FG000|Overall Study|Progressive disease|16|||
23584961|NCT02968004|65869356|FG000|Overall Study|Adverse Event|1|||
23242324|NCT00151775|64632889|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
23242325|NCT00151775|64632878|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23584962|NCT02968004|65869357|FG001|Overall Study|Adverse Event|0|||
23584963|NCT02968004|65869356|FG000|Overall Study|Withdrawal by Subject|0|||
23463075|NCT03096288|65438082|FG003|Overall Study|Withdrawal by Subject|1|||
23463076|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
23463077|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
23463078|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
23463079|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
23463080|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
23463081|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
23584964|NCT02968004|65869357|FG001|Overall Study|Withdrawal by Subject|1|||
23183601|NCT01287754|64413587|FG000|Overall Study|Death|2|||
23183602|NCT01287754|64413588|FG001|Overall Study|Death|12|||
23183603|NCT01287754|64413587|FG000|Overall Study|Lost to Follow-up|1|||
23183604|NCT01287754|64413588|FG001|Overall Study|Lost to Follow-up|6|||
23183605|NCT01287754|64413587|FG000|Overall Study|Protocol Violation|0|||
23183606|NCT01287754|64413588|FG001|Overall Study|Protocol Violation|3|||
23183607|NCT02006576|64413590|FG000|Overall Study|Withdrawal by Subject|4|||
23183608|NCT02006576|64413591|FG001|Overall Study|Withdrawal by Subject|6|||
23183609|NCT02006576|64413592|FG002|Overall Study|Withdrawal by Subject|2|||
23183610|NCT02006576|64413590|FG000|Overall Study|Death|0|||
23183611|NCT02006576|64413591|FG001|Overall Study|Death|0|||
23183612|NCT02006576|64413592|FG002|Overall Study|Death|1|||
23183613|NCT02006576|64413590|FG000|Overall Study|Lost to Follow-up|1|||
23183614|NCT02006576|64413591|FG001|Overall Study|Lost to Follow-up|0|||
23463082|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
23463083|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
23463084|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
23463085|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
23463086|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
23463087|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
23463088|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
23463089|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
23463090|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
23463091|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23463092|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23463093|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23463094|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
23463095|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23463096|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
23463097|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
23463098|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23463099|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
23463100|NCT01106690|65438083|FG000|Core Period: Baseline to Week 26|Other|10|||
23463101|NCT01106690|65438084|FG001|Core Period: Baseline to Week 26|Other|2|||
23463102|NCT01106690|65438085|FG002|Core Period: Baseline to Week 26|Other|6|||
23463103|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23463104|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23463105|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
23463106|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23463107|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23463108|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23463109|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23183615|NCT02006576|64413592|FG002|Overall Study|Lost to Follow-up|1|||
23183616|NCT02006576|64413590|FG000|Overall Study|Screen Failure, too sick, other|13|||
23183617|NCT02006576|64413591|FG001|Overall Study|Screen Failure, too sick, other|1|||
23183618|NCT02006576|64413592|FG002|Overall Study|Screen Failure, too sick, other|13|||
23183619|NCT00607048|64413593|FG000|Overall Study|Adverse Event|0|||
23183620|NCT00607048|64413594|FG001|Overall Study|Adverse Event|1|||
23183621|NCT00607048|64413595|FG002|Overall Study|Adverse Event|0|||
23183622|NCT00607048|64413596|FG003|Overall Study|Adverse Event|0|||
23183623|NCT00607048|64413597|FG004|Overall Study|Adverse Event|4|||
23183624|NCT00607048|64413598|FG005|Overall Study|Adverse Event|0|||
23463110|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23463111|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
23463112|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
23183625|NCT00607048|64413593|FG000|Overall Study|Global deterioration of health|1|||
23183626|NCT00607048|64413594|FG001|Overall Study|Global deterioration of health|0|||
23183627|NCT00607048|64413595|FG002|Overall Study|Global deterioration of health|0|||
23183628|NCT00607048|64413596|FG003|Overall Study|Global deterioration of health|0|||
23183629|NCT00607048|64413597|FG004|Overall Study|Global deterioration of health|0|||
23584965|NCT02403674|65869358|FG000|Base Study|Death|1|||
23402750|NCT01621178|65219995|FG001|Overall Study|Adverse Event|2|||
23183630|NCT00607048|64413598|FG005|Overall Study|Global deterioration of health|0|||
23183631|NCT00607048|64413593|FG000|Overall Study|Objective disease progression - relapse|1|||
23183632|NCT00607048|64413594|FG001|Overall Study|Objective disease progression - relapse|2|||
23183633|NCT00607048|64413595|FG002|Overall Study|Objective disease progression - relapse|4|||
23463113|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
23463114|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
23463115|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23463116|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
23463117|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
23463118|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Other|8|||
23463119|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Other|3|||
23463120|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Other|4|||
23463121|NCT01106690|65438083|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
23463122|NCT01106690|65438084|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23463123|NCT01106690|65438085|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23463124|NCT04476797|65438088|FG000|Overall Study|Withdrawal by Subject|1|||
23463125|NCT04476797|65438089|FG001|Overall Study|Withdrawal by Subject|0|||
23463126|NCT04476797|65438090|FG002|Overall Study|Withdrawal by Subject|0|||
23463127|NCT04476797|65438088|FG000|Overall Study|Death|0|||
23463128|NCT04476797|65438089|FG001|Overall Study|Death|1|||
23183634|NCT00607048|64413596|FG003|Overall Study|Objective disease progression - relapse|2|||
23183635|NCT00607048|64413597|FG004|Overall Study|Objective disease progression - relapse|2|||
23183636|NCT00607048|64413598|FG005|Overall Study|Objective disease progression - relapse|2|||
23183637|NCT00607048|64413593|FG000|Overall Study|Withdrawal by Subject|0|||
23183638|NCT00607048|64413594|FG001|Overall Study|Withdrawal by Subject|0|||
23183639|NCT00607048|64413595|FG002|Overall Study|Withdrawal by Subject|0|||
23183640|NCT00607048|64413596|FG003|Overall Study|Withdrawal by Subject|1|||
23183641|NCT00607048|64413597|FG004|Overall Study|Withdrawal by Subject|0|||
23183642|NCT00607048|64413598|FG005|Overall Study|Withdrawal by Subject|2|||
23183643|NCT00607048|64413593|FG000|Overall Study|Other|1|||
23183644|NCT00607048|64413594|FG001|Overall Study|Other|1|||
23183645|NCT00607048|64413595|FG002|Overall Study|Other|0|||
23183646|NCT00607048|64413596|FG003|Overall Study|Other|0|||
23183647|NCT00607048|64413597|FG004|Overall Study|Other|0|||
23183648|NCT00607048|64413598|FG005|Overall Study|Other|1|||
23463129|NCT04476797|65438090|FG002|Overall Study|Death|2|||
23463130|NCT04476797|65438088|FG000|Overall Study|Sponsor Terminated Study|0|||
23463131|NCT04476797|65438089|FG001|Overall Study|Sponsor Terminated Study|18|||
23463132|NCT04476797|65438090|FG002|Overall Study|Sponsor Terminated Study|17|||
23463133|NCT03038100|65438091|FG000|Overall Study|Death|289|||
23183649|NCT01914679|64413600|FG000|Overall Study|Lack of Efficacy|1|||
23183650|NCT01914679|64413600|FG000|Overall Study|Sponsor terminated study|4|||
23183651|NCT00883493|64413601|FG000|Overall Study|Adverse Event|11|||
23183652|NCT00883493|64413602|FG001|Overall Study|Adverse Event|12|||
23183653|NCT00883493|64413601|FG000|Overall Study|Lack of Efficacy|4|||
23183654|NCT00883493|64413602|FG001|Overall Study|Lack of Efficacy|3|||
23183655|NCT00883493|64413601|FG000|Overall Study|Lost to Follow-up|7|||
23183656|NCT00883493|64413602|FG001|Overall Study|Lost to Follow-up|6|||
23183657|NCT00883493|64413601|FG000|Overall Study|Withdrawal by Subject|11|||
23183658|NCT00883493|64413602|FG001|Overall Study|Withdrawal by Subject|20|||
23183659|NCT00883493|64413601|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
23183660|NCT00883493|64413602|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
23463134|NCT03038100|65438092|FG001|Overall Study|Death|272|||
23463135|NCT03038100|65438091|FG000|Overall Study|Lost to Follow-up|9|||
23463136|NCT03038100|65438092|FG001|Overall Study|Lost to Follow-up|10|||
23463137|NCT03038100|65438091|FG000|Overall Study|Protocol Deviation|1|||
23463138|NCT03038100|65438092|FG001|Overall Study|Protocol Deviation|4|||
23463139|NCT03038100|65438091|FG000|Overall Study|Withdrawal by Subject|45|||
23463140|NCT03038100|65438092|FG001|Overall Study|Withdrawal by Subject|51|||
23463141|NCT03038100|65438091|FG000|Overall Study|Study Terminated By Sponsor|305|||
23463142|NCT03038100|65438092|FG001|Overall Study|Study Terminated By Sponsor|311|||
23183661|NCT00883493|64413601|FG000|Overall Study|Study specific disc. criteria|2|||
23463143|NCT03038100|65438091|FG000|Overall Study|Physician Decision|1|||
23463144|NCT03038100|65438092|FG001|Overall Study|Physician Decision|3|||
23463145|NCT02085161|65438094|FG000|Overall Study|Not Treated|1|||
23463146|NCT02085161|65438095|FG001|Overall Study|Not Treated|0|||
23183662|NCT00883493|64413602|FG001|Overall Study|Study specific disc. criteria|0|||
23183663|NCT00883493|64413601|FG000|Overall Study|Other|5|||
23183664|NCT00883493|64413602|FG001|Overall Study|Other|3|||
23183665|NCT01892722|64413605|FG000|Overall Study|Protocol deviation|0|||
23463147|NCT02085161|65438096|FG002|Overall Study|Not Treated|0|||
23463148|NCT02085161|65438097|FG003|Overall Study|Not Treated|0|||
23463149|NCT02085161|65438094|FG000|Overall Study|Adverse Event|8|||
23463150|NCT02085161|65438095|FG001|Overall Study|Adverse Event|5|||
23463151|NCT02085161|65438096|FG002|Overall Study|Adverse Event|4|||
23463152|NCT02085161|65438097|FG003|Overall Study|Adverse Event|5|||
23463153|NCT02085161|65438094|FG000|Overall Study|Protocol Violation|0|||
23463154|NCT02085161|65438095|FG001|Overall Study|Protocol Violation|1|||
23463155|NCT02085161|65438096|FG002|Overall Study|Protocol Violation|0|||
23463156|NCT02085161|65438097|FG003|Overall Study|Protocol Violation|1|||
23463157|NCT02085161|65438094|FG000|Overall Study|Withdrawal by Subject|2|||
23463158|NCT02085161|65438095|FG001|Overall Study|Withdrawal by Subject|4|||
23463159|NCT02085161|65438096|FG002|Overall Study|Withdrawal by Subject|0|||
23463160|NCT02085161|65438097|FG003|Overall Study|Withdrawal by Subject|3|||
23463161|NCT02085161|65438094|FG000|Overall Study|Other Reason|1|||
23463162|NCT02085161|65438095|FG001|Overall Study|Other Reason|0|||
23463163|NCT02085161|65438096|FG002|Overall Study|Other Reason|1|||
23463164|NCT02085161|65438097|FG003|Overall Study|Other Reason|1|||
23463165|NCT03085095|65438098|FG000|Overall Study|Adverse Event|23|||
23463166|NCT03085095|65438099|FG001|Overall Study|Adverse Event|8|||
23463167|NCT03085095|65438098|FG000|Overall Study|Protocol Violation|0|||
23463168|NCT03085095|65438099|FG001|Overall Study|Protocol Violation|1|||
23463169|NCT03085095|65438098|FG000|Overall Study|Lost to Follow-up|2|||
23463170|NCT03085095|65438099|FG001|Overall Study|Lost to Follow-up|1|||
23463171|NCT03085095|65438098|FG000|Overall Study|Withdrawal by Subject|17|||
23463172|NCT03085095|65438099|FG001|Overall Study|Withdrawal by Subject|6|||
23463173|NCT03085095|65438098|FG000|Overall Study|Physician Decision|9|||
23463174|NCT03085095|65438099|FG001|Overall Study|Physician Decision|3|||
23463175|NCT03085095|65438098|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
23463176|NCT03085095|65438099|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
23463177|NCT03085095|65438098|FG000|Overall Study|Did not Receive Study Drug|2|||
23463178|NCT03085095|65438099|FG001|Overall Study|Did not Receive Study Drug|2|||
23463179|NCT03085095|65438098|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
23463180|NCT03085095|65438099|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
23463181|NCT01942837|65438102|FG000|Overall Study|Death|1|||
23463182|NCT01942837|65438102|FG000|Overall Study|Symptomatic or radiographic progression|49|||
23463183|NCT01942837|65438102|FG000|Overall Study|Adverse Event|6|||
23463184|NCT01942837|65438102|FG000|Overall Study|Physician Decision|3|||
23463185|NCT01942837|65438102|FG000|Overall Study|Withdrawal by Subject|2|||
23463186|NCT01942837|65438102|FG000|Overall Study|Intercurrent Illness|1|||
23463187|NCT01942837|65438102|FG000|Overall Study|On treatment|3|||
23463188|NCT01942837|65438102|FG000|Overall Study|Never initiate the treatment|2|||
23463189|NCT02153086|65438105|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
23463190|NCT02153086|65438105|FG000|Overall Study|Other|2|||
23463191|NCT04596267|65438106|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
23463192|NCT04596267|65438107|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
23183666|NCT01892722|64413606|FG001|Overall Study|Protocol deviation|1|||
23183667|NCT01892722|64413605|FG000|Overall Study|Administrative problems|0|||
23183668|NCT01892722|64413606|FG001|Overall Study|Administrative problems|1|||
23183669|NCT01892722|64413605|FG000|Overall Study|Patient/guardian decision|0|||
23463193|NCT04596267|65438106|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
23463194|NCT04596267|65438107|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
23463195|NCT01108185|65438109|FG000|Overall Study|Non-compliance|15|||
23463196|NCT01108185|65438109|FG000|Overall Study|Lost to Follow-up|12|||
23463197|NCT01462370|65438110|FG000|Overall Study|Lack of Qualifying Event|1|||
23463198|NCT01462370|65438111|FG001|Overall Study|Lack of Qualifying Event|1|||
23463199|NCT01462370|65438110|FG000|Overall Study|Physician Decision|0|||
23463200|NCT01462370|65438111|FG001|Overall Study|Physician Decision|1|||
23463201|NCT01462370|65438110|FG000|Overall Study|Withdrawal by Subject|0|||
23463202|NCT01462370|65438111|FG001|Overall Study|Withdrawal by Subject|3|||
23463203|NCT00199381|65438112|FG000|Overall Study|Withdrawal by Subject|38|||
23463204|NCT00199381|65438112|FG000|Overall Study|Adverse Event|73|||
23463205|NCT00199381|65438112|FG000|Overall Study|Protocol Violation|6|||
23463206|NCT00199381|65438112|FG000|Overall Study|Lack of Efficacy|27|||
23463207|NCT00199381|65438112|FG000|Overall Study|Not including due to early termination|37|||
23463208|NCT00199381|65438112|FG000|Overall Study|Study termination by Sponsor|323|||
23463209|NCT01716234|65438113|FG000|Overall Study|Protocol Violation|0|||
23463210|NCT01716234|65438114|FG001|Overall Study|Protocol Violation|0|||
23463211|NCT01716234|65438115|FG002|Overall Study|Protocol Violation|0|||
23463212|NCT01716234|65438116|FG003|Overall Study|Protocol Violation|1|||
23463213|NCT01716234|65438117|FG004|Overall Study|Protocol Violation|1|||
23584966|NCT02403674|65869359|FG001|Base Study|Death|4|||
23183670|NCT01892722|64413606|FG001|Overall Study|Patient/guardian decision|2|||
23183671|NCT01892722|64413605|FG000|Overall Study|Physician Decision|1|||
23463214|NCT01716234|65438118|FG005|Overall Study|Protocol Violation|1|||
23463215|NCT01716234|65438119|FG006|Overall Study|Protocol Violation|0|||
23463216|NCT01716234|65438113|FG000|Overall Study|Lack of Efficacy|0|||
23463217|NCT01716234|65438114|FG001|Overall Study|Lack of Efficacy|0|||
23463218|NCT01716234|65438115|FG002|Overall Study|Lack of Efficacy|0|||
23463219|NCT01716234|65438116|FG003|Overall Study|Lack of Efficacy|1|||
23463220|NCT01716234|65438117|FG004|Overall Study|Lack of Efficacy|0|||
23463221|NCT01716234|65438118|FG005|Overall Study|Lack of Efficacy|0|||
23463222|NCT01716234|65438119|FG006|Overall Study|Lack of Efficacy|0|||
23463223|NCT01716234|65438113|FG000|Overall Study|Did not meet protocol eligibility|0|||
23463224|NCT01716234|65438114|FG001|Overall Study|Did not meet protocol eligibility|0|||
23463225|NCT01716234|65438115|FG002|Overall Study|Did not meet protocol eligibility|1|||
23242326|NCT00151775|64632879|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23242327|NCT00151775|64632880|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23463226|NCT01716234|65438116|FG003|Overall Study|Did not meet protocol eligibility|0|||
23463227|NCT01716234|65438117|FG004|Overall Study|Did not meet protocol eligibility|0|||
23463228|NCT01716234|65438118|FG005|Overall Study|Did not meet protocol eligibility|4|||
23463229|NCT01716234|65438119|FG006|Overall Study|Did not meet protocol eligibility|0|||
23183672|NCT01892722|64413606|FG001|Overall Study|Physician Decision|2|||
23183673|NCT01892722|64413605|FG000|Overall Study|Adverse Event|3|||
23183674|NCT01892722|64413606|FG001|Overall Study|Adverse Event|2|||
23183675|NCT01892722|64413605|FG000|Overall Study|Lack of Efficacy|0|||
23183676|NCT01892722|64413606|FG001|Overall Study|Lack of Efficacy|7|||
23183677|NCT01892722|64413605|FG000|Overall Study|Withdrawal by Subject|3|||
23183678|NCT01892722|64413606|FG001|Overall Study|Withdrawal by Subject|5|||
23183679|NCT01341457|64413607|FG000|Overall Study|Adverse Event|2|||
23183680|NCT01341457|64413608|FG001|Overall Study|Adverse Event|0|||
23183681|NCT00393718|64413609|FG000|Overall Study|Adverse Event|20|||
23183682|NCT00393718|64413610|FG001|Overall Study|Adverse Event|8|||
23183683|NCT00393718|64413609|FG000|Overall Study|Protocol Violation|1|||
23463230|NCT01716234|65438113|FG000|Overall Study|Adverse Event|7|||
23463231|NCT01716234|65438114|FG001|Overall Study|Adverse Event|10|||
23463232|NCT01716234|65438115|FG002|Overall Study|Adverse Event|2|||
23463233|NCT01716234|65438116|FG003|Overall Study|Adverse Event|8|||
23463234|NCT01716234|65438117|FG004|Overall Study|Adverse Event|3|||
23463235|NCT01716234|65438118|FG005|Overall Study|Adverse Event|6|||
23463236|NCT01716234|65438119|FG006|Overall Study|Adverse Event|0|||
23463237|NCT01716234|65438113|FG000|Overall Study|Withdrawal by Subject|3|||
23463238|NCT01716234|65438114|FG001|Overall Study|Withdrawal by Subject|0|||
23463239|NCT01716234|65438115|FG002|Overall Study|Withdrawal by Subject|2|||
23463240|NCT01716234|65438116|FG003|Overall Study|Withdrawal by Subject|2|||
23463241|NCT01716234|65438117|FG004|Overall Study|Withdrawal by Subject|1|||
23463242|NCT01716234|65438118|FG005|Overall Study|Withdrawal by Subject|3|||
23463243|NCT01716234|65438119|FG006|Overall Study|Withdrawal by Subject|0|||
23463244|NCT03841604|65438127|FG000|Overall Study|Withdrawal by Subject|3|||
23463245|NCT03841604|65438128|FG001|Overall Study|Withdrawal by Subject|1|||
23463246|NCT03841604|65438127|FG000|Overall Study|Adverse Event|4|||
23463247|NCT03841604|65438128|FG001|Overall Study|Adverse Event|2|||
23463248|NCT03841604|65438127|FG000|Overall Study|Physician Decision|1|||
23463249|NCT03841604|65438128|FG001|Overall Study|Physician Decision|0|||
23463250|NCT00760617|65438131|FG000|Overall Study|Adverse Event|5|||
23463251|NCT00760617|65438132|FG001|Overall Study|Adverse Event|2|||
23463252|NCT00760617|65438133|FG002|Overall Study|Adverse Event|0|||
23463253|NCT00760617|65438131|FG000|Overall Study|Lost to Follow-up|0|||
23463254|NCT00760617|65438132|FG001|Overall Study|Lost to Follow-up|0|||
23463255|NCT00760617|65438133|FG002|Overall Study|Lost to Follow-up|5|||
23463256|NCT00361296|65440790|FG000|Overall Study|Physician Decision|1|||
23463257|NCT00361296|65440790|FG000|Overall Study|Lack of Efficacy|2|||
23463258|NCT02851615|65440791|FG000|Overall Study|Cognitive Issue|1|||
23463259|NCT02851615|65440792|FG001|Overall Study|Cognitive Issue|0|||
23463260|NCT02851615|65440791|FG000|Overall Study|Lost to Follow-up|0|||
23463261|NCT02851615|65440792|FG001|Overall Study|Lost to Follow-up|4|||
23463262|NCT02004093|65440793|FG000|Overall Study|Death|2|||
23183684|NCT00393718|64413610|FG001|Overall Study|Protocol Violation|2|||
23242328|NCT00151775|64632881|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23242329|NCT00151775|64632882|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23242330|NCT00151775|64632883|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23242331|NCT00151775|64632884|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23242332|NCT00151775|64632885|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23242333|NCT00151775|64632886|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23242334|NCT00151775|64632887|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23242335|NCT00151775|64632888|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
23463263|NCT02004093|65440794|FG001|Overall Study|Death|1|||
23463264|NCT02004093|65440793|FG000|Overall Study|Lack of Efficacy|66|||
23463265|NCT02004093|65440794|FG001|Overall Study|Lack of Efficacy|62|||
23463266|NCT02004093|65440793|FG000|Overall Study|Protocol Violation|0|||
23463267|NCT02004093|65440794|FG001|Overall Study|Protocol Violation|1|||
23463268|NCT02004093|65440793|FG000|Overall Study|Lost to Follow-up|0|||
23463269|NCT02004093|65440794|FG001|Overall Study|Lost to Follow-up|1|||
23183685|NCT00393718|64413609|FG000|Overall Study|Lack of Efficacy|10|||
23183686|NCT00393718|64413610|FG001|Overall Study|Lack of Efficacy|9|||
23183687|NCT00393718|64413609|FG000|Overall Study|Hypoglycaemia|3|||
23463270|NCT02004093|65440793|FG000|Overall Study|Withdrawal by Subject|3|||
23463271|NCT02004093|65440794|FG001|Overall Study|Withdrawal by Subject|7|||
23463272|NCT02004093|65440793|FG000|Overall Study|Other|3|||
23183688|NCT00393718|64413610|FG001|Overall Study|Hypoglycaemia|2|||
23242336|NCT00151775|64632889|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
23463273|NCT02004093|65440794|FG001|Overall Study|Other|1|||
23463274|NCT01662102|65440796|FG000|Overall Study|Sponsor's decision|1|||
23463275|NCT01662102|65440797|FG001|Overall Study|Sponsor's decision|0|||
23183689|NCT00393718|64413609|FG000|Overall Study|Subject decision|5|||
23183690|NCT00393718|64413610|FG001|Overall Study|Subject decision|0|||
23183691|NCT00393718|64413609|FG000|Overall Study|Withdrawal of consent|2|||
23183692|NCT00393718|64413610|FG001|Overall Study|Withdrawal of consent|1|||
23183693|NCT00393718|64413609|FG000|Overall Study|Missed measurement|1|||
23183694|NCT00393718|64413610|FG001|Overall Study|Missed measurement|0|||
23183695|NCT00393718|64413609|FG000|Overall Study|Move|1|||
23183696|NCT00393718|64413610|FG001|Overall Study|Move|0|||
23242337|NCT00151775|64632878|FG000|Period 4: Open Label|Increased blood pressure|0|||
23242338|NCT00151775|64632879|FG001|Period 4: Open Label|Increased blood pressure|0|||
23242339|NCT00151775|64632880|FG002|Period 4: Open Label|Increased blood pressure|0|||
23242340|NCT00151775|64632881|FG003|Period 4: Open Label|Increased blood pressure|0|||
23242341|NCT00151775|64632882|FG004|Period 4: Open Label|Increased blood pressure|1|||
23242342|NCT00151775|64632883|FG005|Period 4: Open Label|Increased blood pressure|0|||
23242343|NCT00151775|64632884|FG006|Period 4: Open Label|Increased blood pressure|0|||
23242344|NCT00151775|64632885|FG007|Period 4: Open Label|Increased blood pressure|0|||
23242345|NCT00151775|64632886|FG008|Period 4: Open Label|Increased blood pressure|0|||
23242346|NCT00151775|64632887|FG009|Period 4: Open Label|Increased blood pressure|1|||
23242347|NCT00151775|64632888|FG010|Period 4: Open Label|Increased blood pressure|0|||
23242348|NCT00151775|64632889|FG011|Period 4: Open Label|Increased blood pressure|0|||
23242349|NCT00151775|64632878|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
23242350|NCT00151775|64632879|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
23242351|NCT00151775|64632880|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
23242352|NCT00151775|64632881|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
23242353|NCT00151775|64632882|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
23242354|NCT00151775|64632883|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
23242355|NCT00151775|64632884|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
23242356|NCT00151775|64632885|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
23242357|NCT00151775|64632886|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
23242358|NCT00151775|64632887|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
23242359|NCT00151775|64632888|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
23242360|NCT00151775|64632889|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
23242361|NCT00151775|64632878|FG000|Period 4: Open Label|Adverse Event|0|||
23242362|NCT00151775|64632879|FG001|Period 4: Open Label|Adverse Event|0|||
23242363|NCT00151775|64632880|FG002|Period 4: Open Label|Adverse Event|0|||
23242364|NCT00151775|64632881|FG003|Period 4: Open Label|Adverse Event|0|||
23242365|NCT00151775|64632882|FG004|Period 4: Open Label|Adverse Event|1|||
23242366|NCT00151775|64632883|FG005|Period 4: Open Label|Adverse Event|0|||
23463276|NCT03829228|65440798|FG000|Overall Study|Protocol Violation|1|||
23463277|NCT05101122|65440799|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
23463278|NCT05101122|65440799|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
23463279|NCT05101122|65440799|FG000|AD313 80/5|Withdrawal by Subject|1|||
23463280|NCT05101122|65440799|FG000|AD313 80/10|Physician Decision|1|||
23463281|NCT01188343|65440800|FG000|Overall Study|Not vaccinated|0|||
23463282|NCT01188343|65440801|FG001|Overall Study|Not vaccinated|2|||
23463283|NCT01188343|65440802|FG002|Overall Study|Not vaccinated|1|||
23463284|NCT01188343|65440800|FG000|Overall Study|Withdrawal by Subject|1|||
23463285|NCT01188343|65440801|FG001|Overall Study|Withdrawal by Subject|24|||
23463286|NCT01188343|65440802|FG002|Overall Study|Withdrawal by Subject|0|||
23463287|NCT03771664|65440803|FG000|Overall Study|Adverse Event|1|||
23463288|NCT03771664|65440804|FG001|Overall Study|Adverse Event|0|||
23463289|NCT03771664|65440803|FG000|Overall Study|Lost to Follow-up|1|||
23463290|NCT03771664|65440804|FG001|Overall Study|Lost to Follow-up|0|||
23463291|NCT03771664|65440803|FG000|Overall Study|Withdrawal by Participant|1|||
23463292|NCT03771664|65440804|FG001|Overall Study|Withdrawal by Participant|4|||
23463293|NCT03771664|65440803|FG000|Overall Study|Randomized but not Treated|0|||
23242367|NCT00151775|64632884|FG006|Period 4: Open Label|Adverse Event|0|||
23242368|NCT00151775|64632885|FG007|Period 4: Open Label|Adverse Event|0|||
23242369|NCT00151775|64632886|FG008|Period 4: Open Label|Adverse Event|0|||
23242370|NCT00151775|64632887|FG009|Period 4: Open Label|Adverse Event|2|||
23242371|NCT00151775|64632888|FG010|Period 4: Open Label|Adverse Event|0|||
23463294|NCT03771664|65440804|FG001|Overall Study|Randomized but not Treated|1|||
23349987|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349988|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23183697|NCT00809133|64413611|FG000|Overall Study|Progressive disease|2|||
23463295|NCT03044106|65440805|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
23242372|NCT00151775|64632889|FG011|Period 4: Open Label|Adverse Event|0|||
23242373|NCT00151775|64632878|FG000|Period 4: Open Label|Lost to Follow-up|0|||
23349989|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23242374|NCT00151775|64632879|FG001|Period 4: Open Label|Lost to Follow-up|0|||
23242375|NCT00151775|64632880|FG002|Period 4: Open Label|Lost to Follow-up|0|||
23242376|NCT00151775|64632881|FG003|Period 4: Open Label|Lost to Follow-up|0|||
23183698|NCT00809133|64413612|FG001|Overall Study|Progressive disease|5|||
23183699|NCT00809133|64413613|FG002|Overall Study|Progressive disease|5|||
23349990|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23183700|NCT00809133|64413614|FG003|Overall Study|Progressive disease|3|||
23183701|NCT00809133|64413615|FG004|Overall Study|Progressive disease|4|||
23183702|NCT00809133|64413616|FG005|Overall Study|Progressive disease|1|||
23183703|NCT00809133|64413617|FG006|Overall Study|Progressive disease|3|||
23183704|NCT00809133|64413618|FG007|Overall Study|Progressive disease|3|||
23183705|NCT00809133|64413619|FG008|Overall Study|Progressive disease|3|||
23183706|NCT00809133|64413620|FG009|Overall Study|Progressive disease|9|||
23183707|NCT00809133|64413621|FG010|Overall Study|Progressive disease|5|||
23183708|NCT00809133|64413622|FG011|Overall Study|Progressive disease|7|||
23183709|NCT00809133|64413623|FG012|Overall Study|Progressive disease|5|||
23183710|NCT00809133|64413624|FG013|Overall Study|Progressive disease|4|||
23183711|NCT00809133|64413611|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183712|NCT00809133|64413612|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183713|NCT00809133|64413613|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183714|NCT00809133|64413614|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183715|NCT00809133|64413615|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183716|NCT00809133|64413616|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23183717|NCT00809133|64413617|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23183718|NCT00809133|64413618|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23183719|NCT00809133|64413619|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183720|NCT00809133|64413620|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183721|NCT00809133|64413621|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183722|NCT00809133|64413622|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183723|NCT00809133|64413623|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23183724|NCT00809133|64413624|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
23183725|NCT00809133|64413611|FG000|Overall Study|Other adverse event|1|||
23183726|NCT00809133|64413612|FG001|Overall Study|Other adverse event|1|||
23183727|NCT00809133|64413613|FG002|Overall Study|Other adverse event|1|||
23242377|NCT00151775|64632882|FG004|Period 4: Open Label|Lost to Follow-up|17|||
23242378|NCT00151775|64632883|FG005|Period 4: Open Label|Lost to Follow-up|0|||
23242379|NCT00151775|64632884|FG006|Period 4: Open Label|Lost to Follow-up|0|||
23242380|NCT00151775|64632885|FG007|Period 4: Open Label|Lost to Follow-up|0|||
23349991|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349992|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349993|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349994|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349995|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23349996|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23349997|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23349998|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23349999|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350000|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350001|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350002|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350003|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350004|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350005|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350006|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23463296|NCT03044106|65440806|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
23183728|NCT00809133|64413614|FG003|Overall Study|Other adverse event|0|||
23183729|NCT00809133|64413615|FG004|Overall Study|Other adverse event|0|||
23183730|NCT00809133|64413616|FG005|Overall Study|Other adverse event|3|||
23183731|NCT00809133|64413617|FG006|Overall Study|Other adverse event|2|||
23183732|NCT00809133|64413618|FG007|Overall Study|Other adverse event|4|||
23183733|NCT00809133|64413619|FG008|Overall Study|Other adverse event|0|||
23242381|NCT00151775|64632886|FG008|Period 4: Open Label|Lost to Follow-up|0|||
23242382|NCT00151775|64632887|FG009|Period 4: Open Label|Lost to Follow-up|7|||
23183734|NCT00809133|64413620|FG009|Overall Study|Other adverse event|0|||
23183735|NCT00809133|64413621|FG010|Overall Study|Other adverse event|1|||
23183736|NCT00809133|64413622|FG011|Overall Study|Other adverse event|1|||
23183737|NCT00809133|64413623|FG012|Overall Study|Other adverse event|0|||
23183738|NCT00809133|64413624|FG013|Overall Study|Other adverse event|1|||
23183739|NCT00809133|64413611|FG000|Overall Study|Lost to Follow-up|0|||
23242383|NCT00151775|64632888|FG010|Period 4: Open Label|Lost to Follow-up|0|||
23242384|NCT00151775|64632889|FG011|Period 4: Open Label|Lost to Follow-up|0|||
23242385|NCT00151775|64632878|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
23183740|NCT00809133|64413612|FG001|Overall Study|Lost to Follow-up|0|||
23350007|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23183741|NCT00809133|64413613|FG002|Overall Study|Lost to Follow-up|0|||
23183742|NCT00809133|64413614|FG003|Overall Study|Lost to Follow-up|0|||
23183743|NCT00809133|64413615|FG004|Overall Study|Lost to Follow-up|0|||
23183744|NCT00809133|64413616|FG005|Overall Study|Lost to Follow-up|1|||
23183745|NCT00809133|64413617|FG006|Overall Study|Lost to Follow-up|0|||
23183746|NCT00809133|64413618|FG007|Overall Study|Lost to Follow-up|0|||
23183747|NCT00809133|64413619|FG008|Overall Study|Lost to Follow-up|0|||
23183748|NCT00809133|64413620|FG009|Overall Study|Lost to Follow-up|0|||
23183749|NCT00809133|64413621|FG010|Overall Study|Lost to Follow-up|0|||
23183750|NCT00809133|64413622|FG011|Overall Study|Lost to Follow-up|0|||
23183751|NCT00809133|64413623|FG012|Overall Study|Lost to Follow-up|0|||
23183752|NCT00809133|64413624|FG013|Overall Study|Lost to Follow-up|0|||
23183753|NCT00809133|64413611|FG000|Overall Study|Consent withdrawn|0|||
23183754|NCT00809133|64413612|FG001|Overall Study|Consent withdrawn|0|||
23183755|NCT00809133|64413613|FG002|Overall Study|Consent withdrawn|0|||
23183756|NCT00809133|64413614|FG003|Overall Study|Consent withdrawn|0|||
23183757|NCT00809133|64413615|FG004|Overall Study|Consent withdrawn|1|||
23183758|NCT00809133|64413616|FG005|Overall Study|Consent withdrawn|0|||
23183759|NCT00809133|64413617|FG006|Overall Study|Consent withdrawn|0|||
23183760|NCT00809133|64413618|FG007|Overall Study|Consent withdrawn|0|||
23183761|NCT00809133|64413619|FG008|Overall Study|Consent withdrawn|0|||
23183762|NCT00809133|64413620|FG009|Overall Study|Consent withdrawn|0|||
23183763|NCT00809133|64413621|FG010|Overall Study|Consent withdrawn|0|||
23183764|NCT00809133|64413622|FG011|Overall Study|Consent withdrawn|0|||
23183765|NCT00809133|64413623|FG012|Overall Study|Consent withdrawn|0|||
23183766|NCT00809133|64413624|FG013|Overall Study|Consent withdrawn|0|||
23183767|NCT00809133|64413611|FG000|Overall Study|Other not mentioned above|0|||
23242386|NCT00151775|64632879|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
23242387|NCT00151775|64632880|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
23242388|NCT00151775|64632881|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
23242389|NCT00151775|64632882|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
23183768|NCT00809133|64413612|FG001|Overall Study|Other not mentioned above|1|||
23183769|NCT00809133|64413613|FG002|Overall Study|Other not mentioned above|0|||
23183770|NCT00809133|64413614|FG003|Overall Study|Other not mentioned above|0|||
23183771|NCT00809133|64413615|FG004|Overall Study|Other not mentioned above|0|||
23183772|NCT00809133|64413616|FG005|Overall Study|Other not mentioned above|1|||
23183773|NCT00809133|64413617|FG006|Overall Study|Other not mentioned above|0|||
23242390|NCT00151775|64632883|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
23242391|NCT00151775|64632884|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
23242392|NCT00151775|64632885|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
23242393|NCT00151775|64632886|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
23242394|NCT00151775|64632887|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
23242395|NCT00151775|64632888|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
23242396|NCT00151775|64632889|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
23242397|NCT00151775|64632878|FG000|Period 4: Open Label|Other|0|||
23242398|NCT00151775|64632879|FG001|Period 4: Open Label|Other|0|||
23242399|NCT00151775|64632880|FG002|Period 4: Open Label|Other|0|||
23242400|NCT00151775|64632881|FG003|Period 4: Open Label|Other|0|||
23242401|NCT00151775|64632882|FG004|Period 4: Open Label|Other|1|||
23242402|NCT00151775|64632883|FG005|Period 4: Open Label|Other|0|||
23242403|NCT00151775|64632884|FG006|Period 4: Open Label|Other|0|||
23242404|NCT00151775|64632885|FG007|Period 4: Open Label|Other|0|||
23242405|NCT00151775|64632886|FG008|Period 4: Open Label|Other|0|||
23242406|NCT00151775|64632887|FG009|Period 4: Open Label|Other|3|||
23242407|NCT00151775|64632888|FG010|Period 4: Open Label|Other|0|||
23242408|NCT00151775|64632889|FG011|Period 4: Open Label|Other|0|||
23242409|NCT00151775|64632878|FG000|Period 4: Open Label|Physician Decision|0|||
23242410|NCT00151775|64632879|FG001|Period 4: Open Label|Physician Decision|0|||
23242411|NCT00151775|64632880|FG002|Period 4: Open Label|Physician Decision|0|||
23242412|NCT00151775|64632881|FG003|Period 4: Open Label|Physician Decision|0|||
23242413|NCT00151775|64632882|FG004|Period 4: Open Label|Physician Decision|0|||
23242414|NCT00151775|64632883|FG005|Period 4: Open Label|Physician Decision|0|||
23242415|NCT00151775|64632884|FG006|Period 4: Open Label|Physician Decision|0|||
23242416|NCT00151775|64632885|FG007|Period 4: Open Label|Physician Decision|0|||
23242417|NCT00151775|64632886|FG008|Period 4: Open Label|Physician Decision|0|||
23183774|NCT00809133|64413618|FG007|Overall Study|Other not mentioned above|0|||
23242418|NCT00151775|64632887|FG009|Period 4: Open Label|Physician Decision|2|||
23183775|NCT00809133|64413619|FG008|Overall Study|Other not mentioned above|0|||
23183776|NCT00809133|64413620|FG009|Overall Study|Other not mentioned above|0|||
23183777|NCT00809133|64413621|FG010|Overall Study|Other not mentioned above|0|||
23183778|NCT00809133|64413622|FG011|Overall Study|Other not mentioned above|0|||
23183779|NCT00809133|64413623|FG012|Overall Study|Other not mentioned above|0|||
23183780|NCT00809133|64413624|FG013|Overall Study|Other not mentioned above|0|||
23242419|NCT00151775|64632888|FG010|Period 4: Open Label|Physician Decision|0|||
23242420|NCT00151775|64632889|FG011|Period 4: Open Label|Physician Decision|0|||
23242421|NCT00151775|64632878|FG000|Period 4: Open Label|Protocol Violation|0|||
23183781|NCT02013544|64413625|FG000|Overall Study|Adverse Event|5|||
23183782|NCT02013544|64413626|FG001|Overall Study|Adverse Event|5|||
23183783|NCT02013544|64413625|FG000|Overall Study|Lost to Follow-up|2|||
23183784|NCT02013544|64413626|FG001|Overall Study|Lost to Follow-up|3|||
23183785|NCT02013544|64413625|FG000|Overall Study|Withdrawal by Subject|2|||
23183786|NCT02013544|64413626|FG001|Overall Study|Withdrawal by Subject|8|||
23183787|NCT02013544|64413625|FG000|Overall Study|Physician Decision|0|||
23183788|NCT02013544|64413626|FG001|Overall Study|Physician Decision|1|||
23183789|NCT02013544|64413625|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
23183790|NCT02013544|64413626|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
23183791|NCT00260208|64413627|FG000|Overall Study|Subject withdrew consent|11|||
23242422|NCT00151775|64632879|FG001|Period 4: Open Label|Protocol Violation|0|||
23242423|NCT00151775|64632880|FG002|Period 4: Open Label|Protocol Violation|0|||
23242424|NCT00151775|64632881|FG003|Period 4: Open Label|Protocol Violation|0|||
23242425|NCT00151775|64632882|FG004|Period 4: Open Label|Protocol Violation|1|||
23242426|NCT00151775|64632883|FG005|Period 4: Open Label|Protocol Violation|0|||
23242427|NCT00151775|64632884|FG006|Period 4: Open Label|Protocol Violation|0|||
23242428|NCT00151775|64632885|FG007|Period 4: Open Label|Protocol Violation|0|||
23242429|NCT00151775|64632886|FG008|Period 4: Open Label|Protocol Violation|0|||
23242430|NCT00151775|64632887|FG009|Period 4: Open Label|Protocol Violation|0|||
23242431|NCT00151775|64632888|FG010|Period 4: Open Label|Protocol Violation|0|||
23242432|NCT00151775|64632889|FG011|Period 4: Open Label|Protocol Violation|0|||
23242433|NCT01153971|64632890|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
23242434|NCT01153971|64632890|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
23242435|NCT01153971|64632890|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
23242436|NCT01153971|64632890|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
23242437|NCT01153971|64632890|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
23242438|NCT01153971|64632890|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
23242439|NCT01153971|64632890|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
23242440|NCT00678652|64632894|FG000|Overall Study|Protocol Violation|2|||
23242441|NCT00678652|64632895|FG001|Overall Study|Protocol Violation|0|||
23242442|NCT00678652|64632896|FG002|Overall Study|Protocol Violation|0|||
23242443|NCT00678652|64632897|FG003|Overall Study|Protocol Violation|0|||
23242444|NCT00678652|64632894|FG000|Overall Study|Pregnancy|0|||
23242445|NCT00678652|64632895|FG001|Overall Study|Pregnancy|0|||
23242446|NCT00678652|64632896|FG002|Overall Study|Pregnancy|1|||
23242447|NCT00678652|64632897|FG003|Overall Study|Pregnancy|0|||
23242448|NCT00678652|64632894|FG000|Overall Study|Relocation|1|||
23242449|NCT00678652|64632895|FG001|Overall Study|Relocation|0|||
23242450|NCT00678652|64632896|FG002|Overall Study|Relocation|0|||
23242451|NCT00678652|64632897|FG003|Overall Study|Relocation|0|||
23242452|NCT01157065|64632898|FG000|Overall Study|Death|0|||
23242453|NCT01157065|64632899|FG001|Overall Study|Death|1|||
23242454|NCT00822237|64632900|FG000|Dose 1 Vaccination|Not vaccinated|3|||
23242455|NCT00822237|64632901|FG001|Dose 1 Vaccination|Not vaccinated|0|||
23242456|NCT00822237|64632900|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
23242457|NCT00822237|64632901|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
23242458|NCT00822237|64632900|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
23242459|NCT00822237|64632901|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
23242460|NCT00822237|64632900|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
23242461|NCT00822237|64632901|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
23242462|NCT00822237|64632900|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
23242463|NCT00822237|64632901|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
23242464|NCT03575806|64632902|FG000|Overall Study|Withdrawal by Subject|0|||
23242465|NCT03575806|64632903|FG001|Overall Study|Withdrawal by Subject|2|||
23242466|NCT03575806|64632902|FG000|Overall Study|Protocol Violation|0|||
23242467|NCT03575806|64632903|FG001|Overall Study|Protocol Violation|2|||
23242468|NCT00905437|64632904|FG000|Overall Study|Adverse Event|3|||
23242469|NCT00905437|64632905|FG001|Overall Study|Adverse Event|2|||
23242470|NCT00905437|64632904|FG000|Overall Study|Lost to Follow-up|0|||
23242471|NCT00905437|64632905|FG001|Overall Study|Lost to Follow-up|1|||
23242472|NCT00905437|64632904|FG000|Overall Study|Withdrawal by Subject|0|||
23242473|NCT00905437|64632905|FG001|Overall Study|Withdrawal by Subject|1|||
23242474|NCT00905437|64632904|FG000|Overall Study|Other|5|||
23242475|NCT00905437|64632905|FG001|Overall Study|Other|6|||
23242476|NCT02325414|64632908|FG000|Overall Study|Withdrawal by Subject|3|||
23242477|NCT02325414|64632909|FG001|Overall Study|Withdrawal by Subject|1|||
23242478|NCT02325414|64632908|FG000|Overall Study|Lost to Follow-up|5|||
23183792|NCT00260208|64413628|FG001|Overall Study|Subject withdrew consent|7|||
23183793|NCT00260208|64413627|FG000|Overall Study|Lost to Follow-up|6|||
23242479|NCT02325414|64632909|FG001|Overall Study|Lost to Follow-up|5|||
23242480|NCT00509223|64632910|FG000|Overall Study|Lost to Follow-up|1|||
23242481|NCT00509223|64632911|FG001|Overall Study|Lost to Follow-up|1|||
23242482|NCT00509223|64632910|FG000|Overall Study|Adverse Event|1|||
23242483|NCT00509223|64632911|FG001|Overall Study|Adverse Event|1|||
23242484|NCT00509223|64632910|FG000|Overall Study|Withdrawal by Subject|25|||
23242485|NCT00509223|64632911|FG001|Overall Study|Withdrawal by Subject|6|||
23242486|NCT00509223|64632910|FG000|Overall Study|Including: subject change of address|5|||
23242487|NCT00509223|64632911|FG001|Overall Study|Including: subject change of address|2|||
23242488|NCT00509223|64632910|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
23242489|NCT00509223|64632911|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
23242490|NCT01545375|64632912|FG000|Overall Study|Adverse Event|2|||
23242491|NCT01545375|64632913|FG001|Overall Study|Adverse Event|1|||
23242492|NCT01545375|64632912|FG000|Overall Study|Lost to Follow-up|34|||
23242493|NCT01545375|64632913|FG001|Overall Study|Lost to Follow-up|31|||
23242494|NCT01545375|64632912|FG000|Overall Study|Protocol Violation|3|||
23242495|NCT01545375|64632913|FG001|Overall Study|Protocol Violation|3|||
23242496|NCT01545375|64632912|FG000|Overall Study|Withdrawal by Subject|58|||
23242497|NCT01545375|64632913|FG001|Overall Study|Withdrawal by Subject|55|||
23242498|NCT03253809|64632914|FG000|Overall Study|Unable to obtain study related data|14|||
23242499|NCT01283009|64632915|FG000|Overall Study|Death|83|||
23242500|NCT01283009|64632916|FG001|Overall Study|Death|78|||
23242501|NCT01283009|64632915|FG000|Overall Study|Study ended early|23|||
23242502|NCT01283009|64632916|FG001|Overall Study|Study ended early|26|||
23242503|NCT01283009|64632915|FG000|Overall Study|Withdrawal by Subject|10|||
23242504|NCT01283009|64632916|FG001|Overall Study|Withdrawal by Subject|8|||
23242505|NCT01283009|64632915|FG000|Overall Study|Physician Decision|1|||
23242506|NCT01283009|64632916|FG001|Overall Study|Physician Decision|1|||
23242507|NCT01283009|64632915|FG000|Overall Study|Lost to Follow-up|1|||
23242508|NCT01283009|64632916|FG001|Overall Study|Lost to Follow-up|0|||
23242509|NCT01283009|64632915|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
23242510|NCT01283009|64632916|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
23242511|NCT01808508|64632917|FG000|Overall Study|Lost to Follow-up|1|||
23242512|NCT01808508|64632918|FG001|Overall Study|Lost to Follow-up|0|||
23242513|NCT01808508|64632919|FG002|Overall Study|Lost to Follow-up|0|||
23242514|NCT03602976|64632920|FG000|Overall Study|Withdrawal by Subject|1|||
23242515|NCT00620776|64632921|FG000|Overall Study|Did not receive treatment|3|||
23242516|NCT00620776|64632922|FG001|Overall Study|Did not receive treatment|5|||
23242517|NCT00620776|64632921|FG000|Overall Study|Adverse Event|2|||
23242518|NCT00620776|64632922|FG001|Overall Study|Adverse Event|3|||
23183794|NCT00260208|64413628|FG001|Overall Study|Lost to Follow-up|1|||
23183795|NCT00260208|64413627|FG000|Overall Study|Death|12|||
23183796|NCT00260208|64413628|FG001|Overall Study|Death|10|||
23183797|NCT00260208|64413627|FG000|Overall Study|Missing|18|||
23183798|NCT00260208|64413628|FG001|Overall Study|Missing|16|||
23183799|NCT00246259|64413630|FG000|Overall Study|Other|3|||
23183800|NCT00246259|64413631|FG001|Overall Study|Other|3|||
23183801|NCT00246259|64413630|FG000|Overall Study|Not stable by Week 18|2|||
23183802|NCT00246259|64413631|FG001|Overall Study|Not stable by Week 18|1|||
23183803|NCT00246259|64413630|FG000|Overall Study|Participant non-compliant|4|||
23183804|NCT00246259|64413631|FG001|Overall Study|Participant non-compliant|9|||
23183805|NCT00246259|64413630|FG000|Overall Study|Lack of Efficacy|2|||
23183806|NCT00246259|64413631|FG001|Overall Study|Lack of Efficacy|2|||
23183807|NCT00246259|64413630|FG000|Overall Study|Investigator withdrew participant|2|||
23183808|NCT00246259|64413631|FG001|Overall Study|Investigator withdrew participant|0|||
23183809|NCT00246259|64413630|FG000|Overall Study|Adverse Event|5|||
23183810|NCT00246259|64413631|FG001|Overall Study|Adverse Event|0|||
23183811|NCT00246259|64413630|FG000|Overall Study|Lost to Follow-up|3|||
23183812|NCT00246259|64413631|FG001|Overall Study|Lost to Follow-up|4|||
23183813|NCT00246259|64413630|FG000|Overall Study|Withdrawal by Subject|5|||
23183814|NCT00246259|64413631|FG001|Overall Study|Withdrawal by Subject|1|||
23183815|NCT00246259|64413630|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
23183816|NCT00246259|64413631|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
23183817|NCT00282243|64413632|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
23183818|NCT00282243|64413632|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
23183819|NCT00282243|64413632|FG000|Extension Treatment Period|Adverse Event|15|||
23183820|NCT00282243|64413632|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
23183821|NCT00282243|64413632|FG000|Extension Treatment Period|Non-compliance|2|||
23183822|NCT00282243|64413632|FG000|Extension Treatment Period|Physician Decision|1|||
23183823|NCT00619229|64413637|FG000|Overall Study|Withdrawal by Subject|1|||
23183824|NCT00619229|64413638|FG001|Overall Study|Withdrawal by Subject|1|||
23242519|NCT00620776|64632921|FG000|Overall Study|Lack of Efficacy|2|||
23242520|NCT00620776|64632922|FG001|Overall Study|Lack of Efficacy|1|||
23242521|NCT00620776|64632921|FG000|Overall Study|Lost to Follow-up|2|||
23242522|NCT00620776|64632922|FG001|Overall Study|Lost to Follow-up|5|||
23242523|NCT00620776|64632921|FG000|Overall Study|Withdrawal by Subject|3|||
23183825|NCT00619229|64413637|FG000|Overall Study|Lost to Follow-up|1|||
23183826|NCT00619229|64413638|FG001|Overall Study|Lost to Follow-up|0|||
23242524|NCT00620776|64632922|FG001|Overall Study|Withdrawal by Subject|2|||
23242525|NCT00592007|64632931|FG000|Overall Study|Withdrawal by Subject|1|||
23183827|NCT00619229|64413637|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
23183828|NCT00619229|64413638|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
23242526|NCT00592007|64632931|FG000|Overall Study|patient ineligible (out of lab range)|1|||
23402751|NCT01621178|65219996|FG002|Overall Study|Adverse Event|8|||
23183829|NCT00619229|64413637|FG000|Overall Study|Investigator planned Cataract Operation|1|||
23183830|NCT00619229|64413638|FG001|Overall Study|Investigator planned Cataract Operation|0|||
23183831|NCT03542682|64413642|FG000|Overall Study|COVID-19 Protocol|0|||
23183832|NCT03542682|64413643|FG001|Overall Study|COVID-19 Protocol|1|||
23183833|NCT01475734|64413644|FG000|Overall Study|Withdrawal by Subject|1|||
23183834|NCT01475734|64413645|FG001|Overall Study|Withdrawal by Subject|0|||
23183835|NCT01475734|64413644|FG000|Overall Study|Protocol Violation|1|||
23183836|NCT01475734|64413645|FG001|Overall Study|Protocol Violation|0|||
23183837|NCT01475734|64413644|FG000|Overall Study|Physician Decision|0|||
23183838|NCT01475734|64413645|FG001|Overall Study|Physician Decision|1|||
23183839|NCT01950819|64413647|FG000|Overall Study|Graft Loss|35|||
23183840|NCT01950819|64413648|FG001|Overall Study|Graft Loss|30|||
23183841|NCT01950819|64413647|FG000|Overall Study|Death|29|||
23183842|NCT01950819|64413648|FG001|Overall Study|Death|34|||
23183843|NCT01950819|64413647|FG000|Overall Study|Subject / Gardian decision|54|||
23183844|NCT01950819|64413648|FG001|Overall Study|Subject / Gardian decision|51|||
23242527|NCT01656850|64632932|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
23242528|NCT01656850|64632933|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
23242529|NCT00943826|64632934|FG000|Concurrent Phase|Adverse Event|50|||
23242530|NCT00943826|64632935|FG001|Concurrent Phase|Adverse Event|27|||
23242531|NCT00943826|64632934|FG000|Concurrent Phase|Withdrew consent|3|||
23350008|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350009|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350010|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23350011|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
23350012|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350013|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23242532|NCT00943826|64632935|FG001|Concurrent Phase|Withdrew consent|7|||
23242533|NCT00943826|64632934|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
23242534|NCT00943826|64632935|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
23242535|NCT00943826|64632934|FG000|Concurrent Phase|Administrative reasons|2|||
23242536|NCT00943826|64632935|FG001|Concurrent Phase|Administrative reasons|1|||
23242537|NCT00943826|64632934|FG000|Concurrent Phase|Protocol Violation|1|||
23242538|NCT00943826|64632935|FG001|Concurrent Phase|Protocol Violation|0|||
23242539|NCT00943826|64632934|FG000|Maintenance Phase|Adverse Event|31|||
23242540|NCT00943826|64632935|FG001|Maintenance Phase|Adverse Event|30|||
23242541|NCT00943826|64632934|FG000|Maintenance Phase|Withdrew consent|2|||
23242542|NCT00943826|64632935|FG001|Maintenance Phase|Withdrew consent|4|||
23242543|NCT00943826|64632934|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
23242544|NCT00943826|64632935|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
23242545|NCT00943826|64632934|FG000|Maintenance Phase|Administrative reasons|4|||
23242546|NCT00943826|64632935|FG001|Maintenance Phase|Administrative reasons|1|||
23350014|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350015|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350016|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350017|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350018|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350019|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350020|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350021|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23242547|NCT00943826|64632934|FG000|Maintenance Phase|Failure to return|0|||
23242548|NCT00943826|64632935|FG001|Maintenance Phase|Failure to return|1|||
23242549|NCT00943826|64632934|FG000|Monotherapy Phase|Adverse Event|42|||
23242550|NCT00943826|64632935|FG001|Monotherapy Phase|Adverse Event|5|||
23242551|NCT00943826|64632934|FG000|Monotherapy Phase|Administrative reasons|11|||
23242552|NCT00943826|64632935|FG001|Monotherapy Phase|Administrative reasons|5|||
23242553|NCT00943826|64632934|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
23242554|NCT00943826|64632935|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
23242555|NCT00943826|64632934|FG000|Monotherapy Phase|Withdrew Consent|2|||
23242556|NCT00943826|64632935|FG001|Monotherapy Phase|Withdrew Consent|3|||
23242557|NCT00943826|64632934|FG000|Monotherapy Phase|Failure to return|2|||
23242558|NCT00943826|64632935|FG001|Monotherapy Phase|Failure to return|1|||
23183845|NCT01950819|64413647|FG000|Overall Study|technical problems|2|||
23183846|NCT01950819|64413648|FG001|Overall Study|technical problems|0|||
23183847|NCT01950819|64413647|FG000|Overall Study|Pregnancy|0|||
23183848|NCT01950819|64413648|FG001|Overall Study|Pregnancy|2|||
23183849|NCT01950819|64413647|FG000|Overall Study|Lost to Follow-up|9|||
23183850|NCT01950819|64413648|FG001|Overall Study|Lost to Follow-up|17|||
23242559|NCT00943826|64632934|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
23242560|NCT00943826|64632935|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
23242561|NCT00943826|64632934|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
23242562|NCT00943826|64632935|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
23350022|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23350023|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
23350024|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
23350025|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
23350026|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350027|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350028|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350029|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350030|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350031|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350032|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350033|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350034|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350035|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350036|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23350037|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
23350038|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
23350039|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
23350040|NCT02326298|65025289|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350041|NCT02326298|65025290|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350042|NCT02326298|65025291|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350043|NCT02326298|65025292|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350044|NCT02326298|65025293|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350045|NCT02326298|65025294|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350046|NCT02326298|65025295|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350047|NCT02326298|65025296|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350048|NCT02326298|65025297|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350049|NCT02326298|65025298|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350050|NCT02326298|65025299|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23350051|NCT02326298|65025300|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
23350052|NCT02326298|65025301|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
23183851|NCT01485614|64413654|FG000|Randomization|Not Treated|1|||
23183852|NCT01485614|64413655|FG001|Randomization|Not Treated|0|||
23183853|NCT01485614|64413656|FG002|Randomization|Not Treated|0|||
23183854|NCT01485614|64413657|FG003|Randomization|Not Treated|0|||
23350053|NCT02326298|65025302|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
23350054|NCT03015194|65025304|FG000|Overall Study|Death|10|||
23350055|NCT03015194|65025304|FG000|Overall Study|Withdrawal by Subject|2|||
23183855|NCT01485614|64413654|FG000|Weeks 0-20|Lost to Follow-up|2|||
23183856|NCT01485614|64413655|FG001|Weeks 0-20|Lost to Follow-up|0|||
23183857|NCT01485614|64413656|FG002|Weeks 0-20|Lost to Follow-up|0|||
23183858|NCT01485614|64413657|FG003|Weeks 0-20|Lost to Follow-up|0|||
23183859|NCT01485614|64413654|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
23183860|NCT01485614|64413655|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
23183861|NCT01485614|64413656|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
23183862|NCT01485614|64413657|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
23183863|NCT01485614|64413654|FG000|Weeks 0-20|Withdrawal by Subject|3|||
23183864|NCT01485614|64413655|FG001|Weeks 0-20|Withdrawal by Subject|2|||
23183865|NCT01485614|64413656|FG002|Weeks 0-20|Withdrawal by Subject|1|||
23183866|NCT01485614|64413657|FG003|Weeks 0-20|Withdrawal by Subject|0|||
23183867|NCT01485614|64413654|FG000|Weeks 20-54|Lost to Follow-up|4|||
23183868|NCT01485614|64413655|FG001|Weeks 20-54|Lost to Follow-up|3|||
23183869|NCT01485614|64413656|FG002|Weeks 20-54|Lost to Follow-up|1|||
23183870|NCT01485614|64413657|FG003|Weeks 20-54|Lost to Follow-up|0|||
23183871|NCT01485614|64413654|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
23183872|NCT01485614|64413655|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
23183873|NCT01485614|64413656|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
23183874|NCT01485614|64413657|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
23183875|NCT01485614|64413654|FG000|Weeks 20-54|Withdrawal by Subject|5|||
23183876|NCT01485614|64413655|FG001|Weeks 20-54|Withdrawal by Subject|3|||
23183877|NCT01485614|64413656|FG002|Weeks 20-54|Withdrawal by Subject|0|||
23183878|NCT01485614|64413657|FG003|Weeks 20-54|Withdrawal by Subject|0|||
23183879|NCT04125680|64413660|FG000|Overall Study|Lost to Follow-up|15|||
23183880|NCT02921425|64413661|FG000|Overall Study|Protocol Violation|9|||
23183881|NCT00832819|64413662|FG000|Overall Study|Adverse Event|0|||
23183882|NCT00832819|64413663|FG001|Overall Study|Adverse Event|1|||
23183883|NCT00832819|64413664|FG002|Overall Study|Adverse Event|0|||
23183884|NCT00832819|64413662|FG000|Overall Study|Protocol Violation|0|||
23183885|NCT00832819|64413663|FG001|Overall Study|Protocol Violation|0|||
23183886|NCT00832819|64413664|FG002|Overall Study|Protocol Violation|1|||
23183887|NCT00432237|64413665|FG000|Overall Study|Adverse Event|0|||
23183888|NCT00432237|64413666|FG001|Overall Study|Adverse Event|0|||
23183889|NCT00432237|64413667|FG002|Overall Study|Adverse Event|0|||
23183890|NCT00432237|64413668|FG003|Overall Study|Adverse Event|1|||
23350056|NCT00431067|65025305|FG000|Overall Study|Other Adverse Event|9|||
23350057|NCT00431067|65025305|FG000|Overall Study|Progressive disease|30|||
23350058|NCT00431067|65025305|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
23350059|NCT01068626|65025306|FG000|Overall Study|Adverse Event|3|||
23350060|NCT01068626|65025307|FG001|Overall Study|Adverse Event|0|||
23350061|NCT01068626|65025306|FG000|Overall Study|Withdrawal by Subject|0|||
23350062|NCT01068626|65025307|FG001|Overall Study|Withdrawal by Subject|2|||
23350063|NCT02717442|65025320|FG000|Overall Study|Study Terminated by Sponsor|31|||
23350064|NCT02717442|65025321|FG001|Overall Study|Study Terminated by Sponsor|29|||
23183891|NCT00432237|64413665|FG000|Overall Study|Lack of Efficacy|0|||
23183892|NCT00432237|64413666|FG001|Overall Study|Lack of Efficacy|0|||
23183893|NCT00432237|64413667|FG002|Overall Study|Lack of Efficacy|0|||
23183894|NCT00432237|64413668|FG003|Overall Study|Lack of Efficacy|1|||
23183895|NCT00432237|64413665|FG000|Overall Study|Lost to Follow-up|10|||
23350065|NCT02717442|65025320|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
23350066|NCT02717442|65025321|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
23350067|NCT02717442|65025320|FG000|Overall Study|Other - Not Specified|2|||
23350068|NCT02717442|65025321|FG001|Overall Study|Other - Not Specified|0|||
23350069|NCT01907217|65025322|FG000|Overall Study|Withdrawal by Subject|0|||
23350070|NCT01907217|65025323|FG001|Overall Study|Withdrawal by Subject|2|||
23350071|NCT02117713|65025324|FG000|Week 48|Adverse Event|4|||
23350072|NCT02117713|65025324|FG000|Week 48|Withdrawal by caregiver|2|||
23350073|NCT02117713|65025324|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
23350074|NCT02117713|65025324|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
23350075|NCT02117713|65025324|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
23350076|NCT02117713|65025324|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
23350077|NCT01398410|65025325|FG000|Overall Study|Adverse Event|12|||
23350078|NCT01398410|65025326|FG001|Overall Study|Adverse Event|16|||
23350079|NCT01398410|65025325|FG000|Overall Study|Participants Choice|8|||
23350080|NCT01398410|65025326|FG001|Overall Study|Participants Choice|11|||
23350081|NCT01398410|65025325|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
23350082|NCT01398410|65025326|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
23350083|NCT01398410|65025325|FG000|Overall Study|Other|36|||
23350084|NCT01398410|65025326|FG001|Overall Study|Other|29|||
23350085|NCT01714609|65025327|FG000|Overall Study|Protocol Violation|1|||
23350086|NCT01714609|65025328|FG001|Overall Study|Protocol Violation|0|||
23350087|NCT03570554|65025329|FG000|Overall Study|Non-compliance with study drug|0|||
23350088|NCT03570554|65025330|FG001|Overall Study|Non-compliance with study drug|0|||
23350089|NCT03570554|65025331|FG002|Overall Study|Non-compliance with study drug|1|||
23350090|NCT03570554|65025332|FG003|Overall Study|Non-compliance with study drug|0|||
23350091|NCT03570554|65025329|FG000|Overall Study|Adverse Event|0|||
23350092|NCT03570554|65025330|FG001|Overall Study|Adverse Event|0|||
23350093|NCT03570554|65025331|FG002|Overall Study|Adverse Event|0|||
23350094|NCT03570554|65025332|FG003|Overall Study|Adverse Event|1|||
23350095|NCT00524173|65025336|FG000|Overall Study|Lost to Follow-up|0|||
23350096|NCT00524173|65025337|FG001|Overall Study|Lost to Follow-up|1|||
23350097|NCT00524173|65025336|FG000|Overall Study|Death|1|||
23350098|NCT00524173|65025337|FG001|Overall Study|Death|0|||
23350099|NCT00524173|65025336|FG000|Overall Study|Had not reached endpoint at study close|4|||
23350100|NCT00524173|65025337|FG001|Overall Study|Had not reached endpoint at study close|1|||
23350101|NCT02083653|65025340|FG000|Overall Study|Randomized but not Treated|0|||
23350102|NCT02083653|65025341|FG001|Overall Study|Randomized but not Treated|2|||
23350103|NCT02083653|65025342|FG002|Overall Study|Randomized but not Treated|7|||
23350104|NCT02083653|65025340|FG000|Overall Study|Adverse Event|12|||
23350105|NCT02083653|65025341|FG001|Overall Study|Adverse Event|5|||
23350106|NCT02083653|65025342|FG002|Overall Study|Adverse Event|4|||
23350107|NCT02083653|65025340|FG000|Overall Study|Lost to Follow-up|1|||
23350108|NCT02083653|65025341|FG001|Overall Study|Lost to Follow-up|0|||
23350109|NCT02083653|65025342|FG002|Overall Study|Lost to Follow-up|0|||
23183896|NCT00432237|64413666|FG001|Overall Study|Lost to Follow-up|10|||
23183897|NCT00432237|64413667|FG002|Overall Study|Lost to Follow-up|18|||
23183898|NCT00432237|64413668|FG003|Overall Study|Lost to Follow-up|18|||
23183899|NCT00432237|64413665|FG000|Overall Study|Physician Decision|1|||
23183900|NCT00432237|64413666|FG001|Overall Study|Physician Decision|3|||
23183901|NCT00432237|64413667|FG002|Overall Study|Physician Decision|2|||
23350110|NCT02083653|65025340|FG000|Overall Study|Death|2|||
23350111|NCT02083653|65025341|FG001|Overall Study|Death|2|||
23350112|NCT02083653|65025342|FG002|Overall Study|Death|2|||
23350113|NCT02083653|65025340|FG000|Overall Study|Progressive Disease|65|||
23350114|NCT02083653|65025341|FG001|Overall Study|Progressive Disease|73|||
23350115|NCT02083653|65025342|FG002|Overall Study|Progressive Disease|63|||
23350116|NCT02083653|65025340|FG000|Overall Study|Withdrawal by Subject|2|||
23350117|NCT02083653|65025341|FG001|Overall Study|Withdrawal by Subject|1|||
23350118|NCT02083653|65025342|FG002|Overall Study|Withdrawal by Subject|2|||
23350119|NCT02083653|65025340|FG000|Overall Study|Other Events|0|||
23350120|NCT02083653|65025341|FG001|Overall Study|Other Events|2|||
23350121|NCT02083653|65025342|FG002|Overall Study|Other Events|2|||
23183902|NCT00432237|64413668|FG003|Overall Study|Physician Decision|1|||
23183903|NCT00432237|64413665|FG000|Overall Study|Pregnancy|0|||
23183904|NCT00432237|64413666|FG001|Overall Study|Pregnancy|1|||
23183905|NCT00432237|64413667|FG002|Overall Study|Pregnancy|0|||
23183906|NCT00432237|64413668|FG003|Overall Study|Pregnancy|0|||
23183907|NCT00432237|64413665|FG000|Overall Study|Protocol Violation|13|||
23183908|NCT00432237|64413666|FG001|Overall Study|Protocol Violation|10|||
23183909|NCT00432237|64413667|FG002|Overall Study|Protocol Violation|11|||
23183910|NCT00432237|64413668|FG003|Overall Study|Protocol Violation|8|||
23183911|NCT00432237|64413665|FG000|Overall Study|Withdrawal by Subject|5|||
23183912|NCT00432237|64413666|FG001|Overall Study|Withdrawal by Subject|6|||
23350122|NCT02083653|65025340|FG000|Overall Study|Reason Missing|0|||
23350123|NCT02083653|65025341|FG001|Overall Study|Reason Missing|0|||
23350124|NCT02083653|65025342|FG002|Overall Study|Reason Missing|4|||
23350125|NCT02332239|65025343|FG000|Overall Study|Lost to Follow-up|4|||
23350126|NCT02332239|65025344|FG001|Overall Study|Lost to Follow-up|6|||
23350127|NCT01397786|65025347|FG000|Phase A|Lost to Follow-up|0|||
23350128|NCT01397786|65025348|FG001|Phase A|Lost to Follow-up|0|||
23350129|NCT01397786|65025349|FG002|Phase A|Lost to Follow-up|6|||
23463297|NCT00999804|65440807|FG000|Overall Study|Lack of Efficacy|9|||
23463298|NCT00999804|65440808|FG001|Overall Study|Lack of Efficacy|2|||
23463299|NCT00999804|65440807|FG000|Overall Study|Adverse Event|4|||
23463300|NCT00999804|65440808|FG001|Overall Study|Adverse Event|3|||
23463301|NCT00999804|65440807|FG000|Overall Study|Withdrawal by Subject|4|||
23463302|NCT00999804|65440808|FG001|Overall Study|Withdrawal by Subject|0|||
23463303|NCT00999804|65440807|FG000|Overall Study|Death|1|||
23463304|NCT00999804|65440808|FG001|Overall Study|Death|0|||
23463305|NCT00999804|65440807|FG000|Overall Study|Ineligible|3|||
23463306|NCT00999804|65440808|FG001|Overall Study|Ineligible|0|||
23463307|NCT01318915|65440815|FG000|Overall Study|Lost to Follow-up|1|||
23463308|NCT01520506|65440817|FG000|Overall Study|Missed Visit|4|||
23463309|NCT01520506|65440817|FG000|Overall Study|Lost to Follow-up|1|||
23242563|NCT00943826|64632934|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
23463310|NCT01520506|65440817|FG000|Overall Study|Withdrawal by Subject|1|||
23463311|NCT02156076|65440818|FG000|Treatment Period|no longer meets study criteria|0|||
23463312|NCT02156076|65440819|FG001|Treatment Period|no longer meets study criteria|0|||
23463313|NCT02156076|65440820|FG002|Treatment Period|no longer meets study criteria|1|||
23463314|NCT02156076|65440821|FG003|Treatment Period|no longer meets study criteria|0|||
23463315|NCT02156076|65440818|FG000|Treatment Period|Poor/non-compliance|0|||
23463316|NCT02156076|65440819|FG001|Treatment Period|Poor/non-compliance|1|||
23463317|NCT02156076|65440820|FG002|Treatment Period|Poor/non-compliance|0|||
23463318|NCT02156076|65440821|FG003|Treatment Period|Poor/non-compliance|0|||
23463319|NCT02156076|65440818|FG000|Treatment Period|Lost to Follow-up|0|||
23463320|NCT02156076|65440819|FG001|Treatment Period|Lost to Follow-up|0|||
23463321|NCT02156076|65440820|FG002|Treatment Period|Lost to Follow-up|0|||
23463322|NCT02156076|65440821|FG003|Treatment Period|Lost to Follow-up|1|||
23463323|NCT02156076|65440818|FG000|Treatment Period|Withdrawal by Subject|0|||
23463324|NCT02156076|65440819|FG001|Treatment Period|Withdrawal by Subject|0|||
23242564|NCT00943826|64632935|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
23242565|NCT00943826|64632934|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
23242566|NCT00943826|64632935|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
23242567|NCT01360021|64632936|FG000|Overall Study|Eligibility criteria + other|2|||
23242568|NCT01360021|64632937|FG001|Overall Study|Eligibility criteria + other|1|||
23242569|NCT01360021|64632938|FG002|Overall Study|Eligibility criteria + other|1|||
23242570|NCT01360021|64632936|FG000|Overall Study|Protocol Violation|0|||
23242571|NCT01360021|64632937|FG001|Overall Study|Protocol Violation|0|||
23242572|NCT01360021|64632938|FG002|Overall Study|Protocol Violation|1|||
23242573|NCT01360021|64632936|FG000|Overall Study|Withdrawal by Subject|4|||
23242574|NCT01360021|64632937|FG001|Overall Study|Withdrawal by Subject|0|||
23242575|NCT01360021|64632938|FG002|Overall Study|Withdrawal by Subject|2|||
23242576|NCT01360021|64632936|FG000|Overall Study|Adverse Event|2|||
23242577|NCT01360021|64632937|FG001|Overall Study|Adverse Event|3|||
23463325|NCT02156076|65440820|FG002|Treatment Period|Withdrawal by Subject|1|||
23463326|NCT02156076|65440821|FG003|Treatment Period|Withdrawal by Subject|0|||
23242578|NCT01360021|64632938|FG002|Overall Study|Adverse Event|3|||
23463327|NCT02156076|65440818|FG000|Treatment Period|Subject request to discontinue treatment|0|||
23463328|NCT02156076|65440819|FG001|Treatment Period|Subject request to discontinue treatment|1|||
23463329|NCT02156076|65440820|FG002|Treatment Period|Subject request to discontinue treatment|0|||
23463330|NCT02156076|65440821|FG003|Treatment Period|Subject request to discontinue treatment|0|||
23584967|NCT02403674|65869358|FG000|Base Study|Adverse Event|11|||
23584968|NCT02403674|65869359|FG001|Base Study|Adverse Event|26|||
23242579|NCT02319642|64632939|FG000|Overall Study|Adverse Event|2|||
23242580|NCT02319642|64632940|FG001|Overall Study|Adverse Event|4|||
23350130|NCT01397786|65025347|FG000|Phase A|Adverse Event|0|||
23183913|NCT00432237|64413667|FG002|Overall Study|Withdrawal by Subject|9|||
23350131|NCT01397786|65025348|FG001|Phase A|Adverse Event|0|||
23350132|NCT01397786|65025349|FG002|Phase A|Adverse Event|8|||
23350133|NCT01397786|65025347|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
23350134|NCT01397786|65025348|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
23350135|NCT01397786|65025349|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
23350136|NCT01397786|65025347|FG000|Phase A|Physician Decision|0|||
23350137|NCT01397786|65025348|FG001|Phase A|Physician Decision|0|||
23350138|NCT01397786|65025349|FG002|Phase A|Physician Decision|1|||
23350139|NCT01397786|65025347|FG000|Phase A|Withdrawal by Subject|0|||
23350140|NCT01397786|65025348|FG001|Phase A|Withdrawal by Subject|0|||
23350141|NCT01397786|65025349|FG002|Phase A|Withdrawal by Subject|5|||
23350142|NCT01397786|65025347|FG000|Phase A|Lack of Efficacy|0|||
23350143|NCT01397786|65025348|FG001|Phase A|Lack of Efficacy|0|||
23350144|NCT01397786|65025349|FG002|Phase A|Lack of Efficacy|1|||
23350145|NCT01397786|65025347|FG000|Phase B|Lost to Follow-up|22|||
23350146|NCT01397786|65025348|FG001|Phase B|Lost to Follow-up|12|||
23350147|NCT01397786|65025349|FG002|Phase B|Lost to Follow-up|22|||
23350148|NCT01397786|65025347|FG000|Phase B|Adverse Event|109|||
23350149|NCT01397786|65025348|FG001|Phase B|Adverse Event|23|||
23350150|NCT01397786|65025349|FG002|Phase B|Adverse Event|27|||
23350151|NCT01397786|65025347|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
23350152|NCT01397786|65025348|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
23350153|NCT01397786|65025349|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
23350154|NCT01397786|65025347|FG000|Phase B|Physician Decision|9|||
23350155|NCT01397786|65025348|FG001|Phase B|Physician Decision|1|||
23350156|NCT01397786|65025349|FG002|Phase B|Physician Decision|3|||
23350157|NCT01397786|65025347|FG000|Phase B|Withdrawal by Subject|102|||
23350158|NCT01397786|65025348|FG001|Phase B|Withdrawal by Subject|45|||
23350159|NCT01397786|65025349|FG002|Phase B|Withdrawal by Subject|30|||
23350160|NCT01397786|65025347|FG000|Phase B|Protocol Deviation|1|||
23350161|NCT01397786|65025348|FG001|Phase B|Protocol Deviation|2|||
23350162|NCT01397786|65025349|FG002|Phase B|Protocol Deviation|4|||
23350163|NCT01397786|65025347|FG000|Phase B|Lack of Efficacy|22|||
23350164|NCT01397786|65025348|FG001|Phase B|Lack of Efficacy|7|||
23350165|NCT01397786|65025349|FG002|Phase B|Lack of Efficacy|14|||
23350166|NCT03235115|65025351|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350167|NCT03235115|65025352|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350168|NCT03235115|65025353|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350169|NCT03235115|65025354|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350170|NCT03235115|65025355|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
23350171|NCT03235115|65025356|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
23350172|NCT04907227|65025360|FG000|Overall Study|Death|12|||
23350173|NCT04907227|65025361|FG001|Overall Study|Death|8|||
23350174|NCT04907227|65025360|FG000|Overall Study|Withdrawal by Subject|2|||
23350175|NCT04907227|65025361|FG001|Overall Study|Withdrawal by Subject|2|||
23350176|NCT04907227|65025360|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
23350177|NCT04907227|65025361|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
23350178|NCT04907227|65025360|FG000|Overall Study|Sponsor Decision|25|||
23350179|NCT04907227|65025361|FG001|Overall Study|Sponsor Decision|30|||
23350180|NCT04907227|65025360|FG000|Overall Study|Physician Decision|1|||
23350181|NCT04907227|65025361|FG001|Overall Study|Physician Decision|0|||
23350182|NCT02921750|65025363|FG000|Overall Study|Adverse Event|1|||
23350183|NCT02921750|65025364|FG001|Overall Study|Adverse Event|2|||
23350184|NCT02921750|65025363|FG000|Overall Study|Withdrawal by Subject|1|||
23350185|NCT02921750|65025364|FG001|Overall Study|Withdrawal by Subject|1|||
23350186|NCT02921750|65025363|FG000|Overall Study|Lost to Follow-up|3|||
23350187|NCT02921750|65025364|FG001|Overall Study|Lost to Follow-up|3|||
23350188|NCT02921750|65025363|FG000|Overall Study|Wound healed|3|||
23242581|NCT02319642|64632939|FG000|Overall Study|Lack of Efficacy|1|||
23242582|NCT02319642|64632940|FG001|Overall Study|Lack of Efficacy|1|||
23242583|NCT02319642|64632939|FG000|Overall Study|Withdrawal by Subject|1|||
23242584|NCT02319642|64632940|FG001|Overall Study|Withdrawal by Subject|1|||
23242585|NCT00061568|64632948|FG000|Overall Study|Lost to Follow-up|12|||
23242586|NCT00061568|64632949|FG001|Overall Study|Lost to Follow-up|0|||
23242587|NCT00061568|64632948|FG000|Overall Study|Death|6|||
23242588|NCT00061568|64632949|FG001|Overall Study|Death|0|||
23242589|NCT00061568|64632948|FG000|Overall Study|Withdrawal by Subject|1|||
23242590|NCT00061568|64632949|FG001|Overall Study|Withdrawal by Subject|0|||
23350189|NCT02921750|65025364|FG001|Overall Study|Wound healed|3|||
23350190|NCT02921750|65025363|FG000|Overall Study|Serious Adverse Event|1|||
23350191|NCT02921750|65025364|FG001|Overall Study|Serious Adverse Event|2|||
23350192|NCT01675154|65025365|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
23350193|NCT01675154|65025366|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
23350194|NCT01675154|65025367|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
23350195|NCT01675154|65025368|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
23350196|NCT04472026|65025373|FG000|Overall Study|Lost to Follow-up|5|||
23350197|NCT01627782|65025374|FG000|Overall Study|Adverse Event|1|||
23242591|NCT00124709|64632950|FG000|Overall Study|Randomized but did not take medication|3|||
23463331|NCT02156076|65440818|FG000|Treatment Period|Adverse Event|0|||
23463332|NCT02156076|65440819|FG001|Treatment Period|Adverse Event|0|||
23463333|NCT02156076|65440820|FG002|Treatment Period|Adverse Event|0|||
23463334|NCT02156076|65440821|FG003|Treatment Period|Adverse Event|1|||
23463335|NCT02156076|65440818|FG000|Follow-up Period|Withdrawal by Subject|1|||
23463336|NCT02156076|65440819|FG001|Follow-up Period|Withdrawal by Subject|0|||
23463337|NCT02156076|65440820|FG002|Follow-up Period|Withdrawal by Subject|0|||
23463338|NCT02156076|65440821|FG003|Follow-up Period|Withdrawal by Subject|0|||
23463339|NCT00853307|65440822|FG000|Overall Study|Adverse Event|1|||
23463340|NCT00853307|65440823|FG001|Overall Study|Adverse Event|2|||
23463341|NCT00853307|65440822|FG000|Overall Study|Withdrawal by Subject|1|||
23463342|NCT00853307|65440823|FG001|Overall Study|Withdrawal by Subject|2|||
23463343|NCT00853307|65440822|FG000|Overall Study|Reason Not Specified|0|||
23463344|NCT00853307|65440823|FG001|Overall Study|Reason Not Specified|1|||
23463345|NCT02057250|65440824|FG000|AID Assessment Phase|Adverse Event|3|||
23463346|NCT02057250|65440825|FG001|AID Assessment Phase|Adverse Event|2|||
23463347|NCT02057250|65440826|FG002|AID Assessment Phase|Adverse Event|6|||
23463348|NCT02057250|65440827|FG003|AID Assessment Phase|Adverse Event|1|||
23463349|NCT02057250|65440828|FG004|AID Assessment Phase|Adverse Event|0|||
23463350|NCT02057250|65440824|FG000|AID Assessment Phase|Other than specified above|1|||
23463351|NCT02057250|65440825|FG001|AID Assessment Phase|Other than specified above|1|||
23463352|NCT02057250|65440826|FG002|AID Assessment Phase|Other than specified above|1|||
23463353|NCT02057250|65440827|FG003|AID Assessment Phase|Other than specified above|1|||
23463354|NCT02057250|65440828|FG004|AID Assessment Phase|Other than specified above|0|||
23463355|NCT02057250|65440824|FG000|Extension Phase|Adverse Event|0|||
23463356|NCT02057250|65440825|FG001|Extension Phase|Adverse Event|0|||
23463357|NCT02057250|65440826|FG002|Extension Phase|Adverse Event|0|||
23463358|NCT02057250|65440827|FG003|Extension Phase|Adverse Event|0|||
23463359|NCT02057250|65440828|FG004|Extension Phase|Adverse Event|15|||
23463360|NCT02057250|65440824|FG000|Extension Phase|Lack of Efficacy|0|||
23463361|NCT02057250|65440825|FG001|Extension Phase|Lack of Efficacy|0|||
23463362|NCT02057250|65440826|FG002|Extension Phase|Lack of Efficacy|0|||
23463363|NCT02057250|65440827|FG003|Extension Phase|Lack of Efficacy|0|||
23463364|NCT02057250|65440828|FG004|Extension Phase|Lack of Efficacy|10|||
23463365|NCT02057250|65440824|FG000|Extension Phase|Entered in this period but not treated|0|||
23463366|NCT02057250|65440825|FG001|Extension Phase|Entered in this period but not treated|0|||
23463367|NCT02057250|65440826|FG002|Extension Phase|Entered in this period but not treated|0|||
23463368|NCT02057250|65440827|FG003|Extension Phase|Entered in this period but not treated|0|||
23463369|NCT02057250|65440828|FG004|Extension Phase|Entered in this period but not treated|4|||
23463370|NCT02057250|65440824|FG000|Extension Phase|Other than specified above|0|||
23463371|NCT02057250|65440825|FG001|Extension Phase|Other than specified above|0|||
23463372|NCT02057250|65440826|FG002|Extension Phase|Other than specified above|0|||
23463373|NCT02057250|65440827|FG003|Extension Phase|Other than specified above|0|||
23463374|NCT02057250|65440828|FG004|Extension Phase|Other than specified above|7|||
23463375|NCT02131259|65440829|FG000|Overall Study|Progressive disease|751|||
23463376|NCT02131259|65440829|FG000|Overall Study|Adverse Event|341|||
23463377|NCT02131259|65440829|FG000|Overall Study|Lost to Follow-up|7|||
23463378|NCT02131259|65440829|FG000|Overall Study|Relocation|32|||
23463379|NCT02131259|65440829|FG000|Overall Study|Other|63|||
23463380|NCT02131259|65440829|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
23463381|NCT02131259|65440829|FG000|Overall Study|Progressive disease/relocation|1|||
23463382|NCT02131259|65440829|FG000|Overall Study|Progressive disease/other|2|||
23463383|NCT02131259|65440829|FG000|Overall Study|AE/lost to follow-up|1|||
23463384|NCT02131259|65440829|FG000|Overall Study|AE/other|1|||
23463385|NCT02131259|65440829|FG000|Overall Study|Progressive disease/AE/other|1|||
23463386|NCT02131259|65440829|FG000|Overall Study|Missing|3|||
23463387|NCT01488890|65440836|FG000|Overall Study|Serious adverse event|2|||
23463388|NCT01488890|65440837|FG001|Overall Study|Serious adverse event|0|||
23463389|NCT01488890|65440838|FG002|Overall Study|Serious adverse event|0|||
23463390|NCT01488890|65440839|FG003|Overall Study|Serious adverse event|0|||
23463391|NCT01488890|65440836|FG000|Overall Study|Protocol Violation|3|||
23463392|NCT01488890|65440837|FG001|Overall Study|Protocol Violation|0|||
23463393|NCT01488890|65440838|FG002|Overall Study|Protocol Violation|4|||
23463394|NCT01488890|65440839|FG003|Overall Study|Protocol Violation|0|||
23463395|NCT01488890|65440836|FG000|Overall Study|Lost to Follow-up|13|||
23463396|NCT01488890|65440837|FG001|Overall Study|Lost to Follow-up|10|||
23463397|NCT01488890|65440838|FG002|Overall Study|Lost to Follow-up|20|||
23463398|NCT01488890|65440839|FG003|Overall Study|Lost to Follow-up|3|||
23463399|NCT01488890|65440836|FG000|Overall Study|Withdrawal by Subject|14|||
23463400|NCT01488890|65440837|FG001|Overall Study|Withdrawal by Subject|10|||
23463401|NCT01488890|65440838|FG002|Overall Study|Withdrawal by Subject|11|||
23463402|NCT01488890|65440839|FG003|Overall Study|Withdrawal by Subject|2|||
23463403|NCT01600716|65440840|FG000|Overall Study|Other Reasons|3|||
23463404|NCT01600716|65440841|FG001|Overall Study|Other Reasons|1|||
23463405|NCT01600716|65440840|FG000|Overall Study|Personal Reasons|0|||
23463406|NCT01600716|65440841|FG001|Overall Study|Personal Reasons|2|||
23463407|NCT01600716|65440840|FG000|Overall Study|Lost to Follow-up|0|||
23463408|NCT01600716|65440841|FG001|Overall Study|Lost to Follow-up|2|||
23463409|NCT01600716|65440840|FG000|Overall Study|Pregnancy|1|||
23463410|NCT01600716|65440841|FG001|Overall Study|Pregnancy|0|||
23463411|NCT01600716|65440840|FG000|Overall Study|Lack of Efficacy|2|||
23463412|NCT01600716|65440841|FG001|Overall Study|Lack of Efficacy|1|||
23463413|NCT01600716|65440840|FG000|Overall Study|Adverse Event|1|||
23463414|NCT01600716|65440841|FG001|Overall Study|Adverse Event|1|||
23463415|NCT01532986|65440847|FG000|Overall Study|Death|9|||
23463416|NCT01532986|65440848|FG001|Overall Study|Death|9|||
23463417|NCT01532986|65440847|FG000|Overall Study|Withdrawal by Subject|7|||
23463418|NCT01532986|65440848|FG001|Overall Study|Withdrawal by Subject|10|||
23463419|NCT01532986|65440847|FG000|Overall Study|Physician Decision|7|||
23463420|NCT01532986|65440848|FG001|Overall Study|Physician Decision|5|||
23463421|NCT02066181|65440849|FG000|Overall Study|Withdrawal by Subject|1|||
23463422|NCT02066181|65440850|FG001|Overall Study|Withdrawal by Subject|1|||
23463423|NCT03399552|65440853|FG000|Overall Study|No evidence of disease|1|||
23463424|NCT03399552|65440853|FG000|Overall Study|Unevaluable|1|||
23463425|NCT03367793|65440857|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463426|NCT03367793|65440858|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463427|NCT03367793|65440859|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
23463428|NCT03367793|65440860|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463429|NCT03367793|65440861|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463430|NCT03367793|65440862|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
23463431|NCT00918255|65440864|FG000|Overall Study|Adverse Event|1|||
23463432|NCT00918255|65440865|FG001|Overall Study|Adverse Event|0|||
23463433|NCT00918255|65440866|FG002|Overall Study|Adverse Event|0|||
23463434|NCT00918255|65440864|FG000|Overall Study|Withdrawal by Subject|1|||
23463435|NCT00918255|65440865|FG001|Overall Study|Withdrawal by Subject|0|||
23463436|NCT00918255|65440866|FG002|Overall Study|Withdrawal by Subject|2|||
23463437|NCT00918255|65440864|FG000|Overall Study|Lack of Efficacy|1|||
23463438|NCT00918255|65440865|FG001|Overall Study|Lack of Efficacy|0|||
23463439|NCT00918255|65440866|FG002|Overall Study|Lack of Efficacy|0|||
23463440|NCT00918255|65440864|FG000|Overall Study|Lost to Follow-up|1|||
23463441|NCT00918255|65440865|FG001|Overall Study|Lost to Follow-up|0|||
23463442|NCT00918255|65440866|FG002|Overall Study|Lost to Follow-up|2|||
23463443|NCT00918255|65440864|FG000|Overall Study|Exceeded allowed number of interventions|0|||
23463444|NCT00918255|65440865|FG001|Overall Study|Exceeded allowed number of interventions|0|||
23463445|NCT00918255|65440866|FG002|Overall Study|Exceeded allowed number of interventions|1|||
23463446|NCT00918255|65440864|FG000|Overall Study|Non-compliance|1|||
23463447|NCT00918255|65440865|FG001|Overall Study|Non-compliance|0|||
23463448|NCT00918255|65440866|FG002|Overall Study|Non-compliance|0|||
23463449|NCT00918255|65440864|FG000|Overall Study|Investigator discretion|1|||
23463450|NCT00918255|65440865|FG001|Overall Study|Investigator discretion|0|||
23463451|NCT00918255|65440866|FG002|Overall Study|Investigator discretion|0|||
23463452|NCT01454102|65440867|FG000|Overall Study|Continuing in the treatment period|0|||
23463453|NCT01454102|65440868|FG001|Overall Study|Continuing in the treatment period|0|||
23463454|NCT01454102|65440869|FG002|Overall Study|Continuing in the treatment period|0|||
23463455|NCT01454102|65440870|FG003|Overall Study|Continuing in the treatment period|0|||
23463456|NCT01454102|65440871|FG004|Overall Study|Continuing in the treatment period|3|||
23463457|NCT01454102|65440872|FG005|Overall Study|Continuing in the treatment period|3|||
23183914|NCT00432237|64413668|FG003|Overall Study|Withdrawal by Subject|11|||
23183915|NCT00432237|64413665|FG000|Overall Study|Lack of Qualifying Event|38|||
23183916|NCT00432237|64413666|FG001|Overall Study|Lack of Qualifying Event|71|||
23183917|NCT00432237|64413667|FG002|Overall Study|Lack of Qualifying Event|69|||
23183918|NCT00432237|64413668|FG003|Overall Study|Lack of Qualifying Event|84|||
23183919|NCT02034123|64413669|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23463458|NCT01454102|65440873|FG006|Overall Study|Continuing in the treatment period|2|||
23183920|NCT02034123|64413670|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183921|NCT02034123|64413671|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183922|NCT02034123|64413672|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183923|NCT02034123|64413673|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
23183924|NCT02034123|64413674|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23463459|NCT01454102|65440874|FG007|Overall Study|Continuing in the treatment period|0|||
23463460|NCT01454102|65440875|FG008|Overall Study|Continuing in the treatment period|1|||
23463461|NCT01454102|65440876|FG009|Overall Study|Continuing in the treatment period|0|||
23183925|NCT02034123|64413675|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23463462|NCT01454102|65440877|FG010|Overall Study|Continuing in the treatment period|0|||
23463463|NCT01454102|65440878|FG011|Overall Study|Continuing in the treatment period|4|||
23463464|NCT01454102|65440879|FG012|Overall Study|Continuing in the treatment period|7|||
23463465|NCT01454102|65440880|FG013|Overall Study|Continuing in the treatment period|4|||
23463466|NCT01454102|65440881|FG014|Overall Study|Continuing in the treatment period|3|||
23463467|NCT01454102|65440882|FG015|Overall Study|Continuing in the treatment period|1|||
23463468|NCT03895840|65440884|FG000|Overall Study|Withdrawal by Subject|21|||
23183926|NCT02034123|64413676|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
23183927|NCT02034123|64413677|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
23183928|NCT02034123|64413678|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183929|NCT02034123|64413679|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183930|NCT02034123|64413680|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183931|NCT02034123|64413681|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183932|NCT02034123|64413682|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183933|NCT02034123|64413683|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183934|NCT02034123|64413684|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183935|NCT02034123|64413685|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23242592|NCT00124709|64632951|FG001|Overall Study|Randomized but did not take medication|1|||
23242593|NCT00124709|64632950|FG000|Overall Study|Adverse Event|3|||
23242594|NCT00124709|64632951|FG001|Overall Study|Adverse Event|0|||
23242595|NCT00124709|64632950|FG000|Overall Study|Lack of Efficacy|5|||
23242596|NCT00124709|64632951|FG001|Overall Study|Lack of Efficacy|10|||
23242597|NCT00124709|64632950|FG000|Overall Study|Protocol Violation|3|||
23242598|NCT00124709|64632951|FG001|Overall Study|Protocol Violation|5|||
23242599|NCT00124709|64632950|FG000|Overall Study|Withdrawal by Subject|127|||
23242600|NCT00124709|64632951|FG001|Overall Study|Withdrawal by Subject|136|||
23242601|NCT00124709|64632950|FG000|Overall Study|Lost to Follow-up|114|||
23242602|NCT00124709|64632951|FG001|Overall Study|Lost to Follow-up|120|||
23242603|NCT00167414|64632952|FG000|Overall Study|Death|10|||
23242604|NCT04066894|64632960|FG000|Overall Study|Lack of Efficacy|1|||
23242605|NCT04066894|64632960|FG000|Overall Study|Screen Failure|1|||
23242606|NCT00956813|64632961|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
23183936|NCT02034123|64413686|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
23183937|NCT02034123|64413669|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183938|NCT02034123|64413670|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183939|NCT02034123|64413671|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183940|NCT02034123|64413672|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
23183941|NCT02034123|64413673|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23242607|NCT00956813|64632962|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
23242608|NCT00956813|64632961|FG000|Flaxseed and Placebo|Ineligible|3|||
23242609|NCT00956813|64632962|FG001|Flaxseed and Placebo|Ineligible|1|||
23242610|NCT03808298|64632965|FG000|Overall Study|Adverse Event|3|||
23242611|NCT03808298|64632965|FG000|Overall Study|Physician Decision|1|||
23350198|NCT01627782|65025375|FG001|Overall Study|Adverse Event|2|||
23350199|NCT01627782|65025376|FG002|Overall Study|Adverse Event|0|||
23350200|NCT01627782|65025377|FG003|Overall Study|Adverse Event|1|||
23350201|NCT01627782|65025374|FG000|Overall Study|Lack of Efficacy|11|||
23350202|NCT01627782|65025375|FG001|Overall Study|Lack of Efficacy|1|||
23350203|NCT01627782|65025376|FG002|Overall Study|Lack of Efficacy|15|||
23350204|NCT01627782|65025377|FG003|Overall Study|Lack of Efficacy|2|||
23350205|NCT01627782|65025374|FG000|Overall Study|Protocol Violation|1|||
23350206|NCT01627782|65025375|FG001|Overall Study|Protocol Violation|0|||
23350207|NCT01627782|65025376|FG002|Overall Study|Protocol Violation|0|||
23350208|NCT01627782|65025377|FG003|Overall Study|Protocol Violation|0|||
23350209|NCT01627782|65025374|FG000|Overall Study|Withdrawal by Subject|2|||
23350210|NCT01627782|65025375|FG001|Overall Study|Withdrawal by Subject|1|||
23350211|NCT01627782|65025376|FG002|Overall Study|Withdrawal by Subject|0|||
23350212|NCT01627782|65025377|FG003|Overall Study|Withdrawal by Subject|0|||
23350213|NCT01627782|65025374|FG000|Overall Study|Other|0|||
23350214|NCT01627782|65025375|FG001|Overall Study|Other|2|||
23350215|NCT01627782|65025376|FG002|Overall Study|Other|0|||
23350216|NCT01627782|65025377|FG003|Overall Study|Other|3|||
23350217|NCT01627782|65025374|FG000|Overall Study|Randomized But Not Treated|1|||
23350218|NCT01627782|65025375|FG001|Overall Study|Randomized But Not Treated|0|||
23350219|NCT01627782|65025376|FG002|Overall Study|Randomized But Not Treated|0|||
23350220|NCT01627782|65025377|FG003|Overall Study|Randomized But Not Treated|0|||
23350221|NCT00480493|65025387|FG000|Overall Study|moved|2|||
23463469|NCT02651675|65440885|FG000|Overall Study|Death|0|||
23350222|NCT00480493|65025388|FG001|Overall Study|moved|7|||
23350223|NCT03004924|65025391|FG000|Overall Study|Adverse Event|6|||
23350224|NCT03004924|65025392|FG001|Overall Study|Adverse Event|5|||
23350225|NCT03004924|65025393|FG002|Overall Study|Adverse Event|10|||
23350226|NCT03004924|65025391|FG000|Overall Study|Protocol Violation|4|||
23350227|NCT03004924|65025392|FG001|Overall Study|Protocol Violation|0|||
23350228|NCT03004924|65025393|FG002|Overall Study|Protocol Violation|1|||
23463470|NCT02651675|65440886|FG001|Overall Study|Death|0|||
23242612|NCT03808298|64632965|FG000|Overall Study|Withdrawal by Subject|1|||
23242613|NCT03808298|64632965|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
23242614|NCT01329562|64632966|FG000|Overall Study|Protocol Violation|5|||
23350229|NCT03004924|65025391|FG000|Overall Study|Withdrawal by Subject|5|||
23350230|NCT03004924|65025392|FG001|Overall Study|Withdrawal by Subject|3|||
23350231|NCT03004924|65025393|FG002|Overall Study|Withdrawal by Subject|5|||
23350232|NCT03004924|65025391|FG000|Overall Study|Lost to Follow-up|6|||
23242615|NCT01329562|64632967|FG001|Overall Study|Protocol Violation|3|||
23242616|NCT01329562|64632966|FG000|Overall Study|Lost to Follow-up|1|||
23242617|NCT01329562|64632967|FG001|Overall Study|Lost to Follow-up|1|||
23242618|NCT01329562|64632966|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
23242619|NCT01329562|64632967|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
23242620|NCT01329562|64632966|FG000|Overall Study|Physician Decision|0|||
23242621|NCT01329562|64632967|FG001|Overall Study|Physician Decision|1|||
23242622|NCT02396849|64632968|FG000|Overall Study|Lost to Follow-up|1|||
23242623|NCT02396849|64632969|FG001|Overall Study|Lost to Follow-up|1|||
23242624|NCT02396849|64632968|FG000|Overall Study|Did not tolerate intervention|1|||
23242625|NCT02396849|64632969|FG001|Overall Study|Did not tolerate intervention|1|||
23242626|NCT01725217|64632978|FG000|Overall Study|Withdrawal by Subject|1|||
23242627|NCT01725217|64632979|FG001|Overall Study|Withdrawal by Subject|0|||
23242628|NCT01725217|64632980|FG002|Overall Study|Withdrawal by Subject|0|||
23242629|NCT01004822|64632984|FG000|Overall Study|Objective progression or relapse|3|||
23242630|NCT01004822|64632985|FG001|Overall Study|Objective progression or relapse|3|||
23242631|NCT01004822|64632986|FG002|Overall Study|Objective progression or relapse|0|||
23242632|NCT01004822|64632987|FG003|Overall Study|Objective progression or relapse|1|||
23463471|NCT02651675|65440887|FG002|Overall Study|Death|1|||
23463472|NCT01599637|65440888|FG000|Overall Study|administrative problems|0|||
23463473|NCT01599637|65440889|FG001|Overall Study|administrative problems|2|||
23463474|NCT01599637|65440890|FG002|Overall Study|administrative problems|0|||
23463475|NCT01599637|65440888|FG000|Overall Study|Adverse Event|1|||
23463476|NCT01599637|65440889|FG001|Overall Study|Adverse Event|0|||
23463477|NCT01599637|65440890|FG002|Overall Study|Adverse Event|0|||
23463478|NCT01001325|65440893|FG000|Overall Study|Lost to Follow-up|16|||
23463479|NCT01001325|65440894|FG001|Overall Study|Lost to Follow-up|10|||
23463480|NCT01001325|65440893|FG000|Overall Study|Protocol Violation|2|||
23463481|NCT01001325|65440894|FG001|Overall Study|Protocol Violation|0|||
23463482|NCT02667119|65440896|FG000|Overall Study|Lost to Follow-up|3|||
23463483|NCT02667119|65440897|FG001|Overall Study|Lost to Follow-up|0|||
23463484|NCT00325897|65440903|FG000|Overall Study|Lost to Follow-up|12|||
23463485|NCT00325897|65440904|FG001|Overall Study|Lost to Follow-up|13|||
23183942|NCT02034123|64413674|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23242633|NCT01004822|64632988|FG004|Overall Study|Objective progression or relapse|2|||
23242634|NCT01004822|64632989|FG005|Overall Study|Objective progression or relapse|2|||
23242635|NCT01004822|64632990|FG006|Overall Study|Objective progression or relapse|1|||
23242636|NCT01004822|64632991|FG007|Overall Study|Objective progression or relapse|4|||
23242637|NCT01004822|64632984|FG000|Overall Study|Global deterioration of health status|0|||
23242638|NCT01004822|64632985|FG001|Overall Study|Global deterioration of health status|0|||
23463486|NCT02675634|65440905|FG000|Test Period 1|Adverse Event|0|||
23463487|NCT02675634|65440906|FG001|Test Period 1|Adverse Event|1|||
23463488|NCT02675634|65440907|FG002|Test Period 1|Adverse Event|0|||
23463489|NCT02675634|65440908|FG003|Test Period 1|Adverse Event|1|||
23584969|NCT02403674|65869358|FG000|Base Study|Lack of Efficacy|31|||
23584970|NCT02403674|65869359|FG001|Base Study|Lack of Efficacy|23|||
23183943|NCT02034123|64413675|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183944|NCT02034123|64413676|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23463490|NCT02675634|65440909|FG004|Test Period 1|Adverse Event|0|||
23463491|NCT02675634|65440910|FG005|Test Period 1|Adverse Event|0|||
23463492|NCT02675634|65440905|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
23463493|NCT02675634|65440906|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
23463494|NCT02675634|65440907|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
23463495|NCT02675634|65440908|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
23463496|NCT02675634|65440909|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
23463497|NCT02675634|65440910|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
23463498|NCT02675634|65440905|FG000|Test Period 2|Lack of Efficacy|1|||
23463499|NCT02675634|65440906|FG001|Test Period 2|Lack of Efficacy|0|||
23463500|NCT02675634|65440907|FG002|Test Period 2|Lack of Efficacy|0|||
23463501|NCT02675634|65440908|FG003|Test Period 2|Lack of Efficacy|0|||
23463502|NCT02675634|65440909|FG004|Test Period 2|Lack of Efficacy|0|||
23183945|NCT02034123|64413677|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183946|NCT02034123|64413678|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183947|NCT02034123|64413679|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183948|NCT02034123|64413680|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23463503|NCT02675634|65440910|FG005|Test Period 2|Lack of Efficacy|0|||
23463504|NCT02675634|65440905|FG000|Test Period 2|Adverse Event|0|||
23463505|NCT02675634|65440906|FG001|Test Period 2|Adverse Event|0|||
23463506|NCT02675634|65440907|FG002|Test Period 2|Adverse Event|0|||
23463507|NCT02675634|65440908|FG003|Test Period 2|Adverse Event|0|||
23183949|NCT02034123|64413681|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23242639|NCT01004822|64632986|FG002|Overall Study|Global deterioration of health status|0|||
23242640|NCT01004822|64632987|FG003|Overall Study|Global deterioration of health status|1|||
23463508|NCT02675634|65440909|FG004|Test Period 2|Adverse Event|0|||
23463509|NCT02675634|65440910|FG005|Test Period 2|Adverse Event|1|||
23463510|NCT03697252|65440911|FG000|Overall Study|Adverse Event|3|||
23463511|NCT03697252|65440912|FG001|Overall Study|Adverse Event|2|||
23463512|NCT03697252|65440911|FG000|Overall Study|Withdrawal by Subject|14|||
23463513|NCT03697252|65440912|FG001|Overall Study|Withdrawal by Subject|14|||
23463514|NCT03697252|65440911|FG000|Overall Study|Lost to Follow-up|0|||
23463515|NCT03697252|65440912|FG001|Overall Study|Lost to Follow-up|1|||
23463516|NCT03697252|65440911|FG000|Overall Study|Physician Decision|1|||
23463517|NCT03697252|65440912|FG001|Overall Study|Physician Decision|1|||
23463518|NCT03697252|65440911|FG000|Overall Study|Other|0|||
23463519|NCT03697252|65440912|FG001|Overall Study|Other|1|||
23584971|NCT02403674|65869358|FG000|Base Study|Lost to Follow-up|6|||
23584972|NCT02403674|65869359|FG001|Base Study|Lost to Follow-up|8|||
23584973|NCT02403674|65869358|FG000|Base Study|Withdrawal by Subject|10|||
23584974|NCT02403674|65869359|FG001|Base Study|Withdrawal by Subject|17|||
23584975|NCT02403674|65869358|FG000|Base Study|Physician Decision|2|||
23584976|NCT02403674|65869359|FG001|Base Study|Physician Decision|2|||
23584977|NCT02403674|65869358|FG000|Base Study|Pregnancy|2|||
23584978|NCT02403674|65869359|FG001|Base Study|Pregnancy|2|||
23584979|NCT02403674|65869358|FG000|Base Study|Protocol Violation|8|||
23584980|NCT02403674|65869359|FG001|Base Study|Protocol Violation|4|||
23584981|NCT02403674|65869358|FG000|Base Study|Non-Compliance with study drug|1|||
23584982|NCT02403674|65869359|FG001|Base Study|Non-Compliance with study drug|4|||
23584983|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
23584984|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
23584985|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
23584986|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
23584987|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
23584988|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
23584989|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
23584990|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
23584991|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
23584992|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
23584993|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
23584994|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
23584995|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Death|1|||
23584996|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Death|0|||
23584997|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
23584998|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
23584999|NCT02403674|65869358|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
23183950|NCT02034123|64413682|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183951|NCT02034123|64413683|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183952|NCT02034123|64413684|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23183953|NCT02034123|64413685|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23242641|NCT01004822|64632988|FG004|Overall Study|Global deterioration of health status|0|||
23242642|NCT01004822|64632989|FG005|Overall Study|Global deterioration of health status|0|||
23242643|NCT01004822|64632990|FG006|Overall Study|Global deterioration of health status|1|||
23242644|NCT01004822|64632991|FG007|Overall Study|Global deterioration of health status|0|||
23242645|NCT01004822|64632984|FG000|Overall Study|No longer willing to continue|0|||
23242646|NCT01004822|64632985|FG001|Overall Study|No longer willing to continue|0|||
23242647|NCT01004822|64632986|FG002|Overall Study|No longer willing to continue|0|||
23242648|NCT01004822|64632987|FG003|Overall Study|No longer willing to continue|1|||
23242649|NCT01004822|64632988|FG004|Overall Study|No longer willing to continue|2|||
23242650|NCT01004822|64632989|FG005|Overall Study|No longer willing to continue|1|||
23242651|NCT01004822|64632990|FG006|Overall Study|No longer willing to continue|1|||
23242652|NCT01004822|64632991|FG007|Overall Study|No longer willing to continue|0|||
23242653|NCT01004822|64632984|FG000|Overall Study|Adverse Event|0|||
23242654|NCT01004822|64632985|FG001|Overall Study|Adverse Event|0|||
23242655|NCT01004822|64632986|FG002|Overall Study|Adverse Event|0|||
23585000|NCT02403674|65869359|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
23585001|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
23585002|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
23183954|NCT02034123|64413686|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
23585003|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
23183955|NCT02034123|64413669|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183956|NCT02034123|64413670|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183957|NCT02034123|64413671|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23242656|NCT01004822|64632987|FG003|Overall Study|Adverse Event|0|||
23242657|NCT01004822|64632988|FG004|Overall Study|Adverse Event|0|||
23463520|NCT02963506|65440913|FG000|Double-Blind Period|Adverse Event|0|||
23463521|NCT02963506|65440914|FG001|Double-Blind Period|Adverse Event|0|||
23463522|NCT02963506|65440915|FG002|Double-Blind Period|Adverse Event|1|||
23463523|NCT02963506|65440916|FG003|Double-Blind Period|Adverse Event|0|||
23463524|NCT02963506|65440917|FG004|Double-Blind Period|Adverse Event|0|||
23463525|NCT02963506|65440918|FG005|Double-Blind Period|Adverse Event|0|||
23463526|NCT02963506|65440919|FG006|Double-Blind Period|Adverse Event|0|||
23463527|NCT02963506|65440920|FG007|Double-Blind Period|Adverse Event|0|||
23463528|NCT02963506|65440921|FG008|Double-Blind Period|Adverse Event|0|||
23463529|NCT02963506|65440922|FG009|Double-Blind Period|Adverse Event|0|||
23463530|NCT02963506|65440923|FG010|Double-Blind Period|Adverse Event|0|||
23463531|NCT02963506|65440924|FG011|Double-Blind Period|Adverse Event|0|||
23463532|NCT02963506|65440925|FG012|Double-Blind Period|Adverse Event|0|||
23463533|NCT02963506|65440913|FG000|Double-Blind Period|Death|0|||
23463534|NCT02963506|65440914|FG001|Double-Blind Period|Death|0|||
23463535|NCT02963506|65440915|FG002|Double-Blind Period|Death|0|||
23463536|NCT02963506|65440916|FG003|Double-Blind Period|Death|1|||
23463537|NCT02963506|65440917|FG004|Double-Blind Period|Death|0|||
23463538|NCT02963506|65440918|FG005|Double-Blind Period|Death|0|||
23463539|NCT02963506|65440919|FG006|Double-Blind Period|Death|0|||
23463540|NCT02963506|65440920|FG007|Double-Blind Period|Death|0|||
23463541|NCT02963506|65440921|FG008|Double-Blind Period|Death|0|||
23463542|NCT02963506|65440922|FG009|Double-Blind Period|Death|0|||
23463543|NCT02963506|65440923|FG010|Double-Blind Period|Death|0|||
23463544|NCT02963506|65440924|FG011|Double-Blind Period|Death|0|||
23463545|NCT02963506|65440925|FG012|Double-Blind Period|Death|0|||
23463546|NCT02963506|65440913|FG000|Double-Blind Period|Lost to Follow-up|0|||
23463547|NCT02963506|65440914|FG001|Double-Blind Period|Lost to Follow-up|1|||
23463548|NCT02963506|65440915|FG002|Double-Blind Period|Lost to Follow-up|0|||
23463549|NCT02963506|65440916|FG003|Double-Blind Period|Lost to Follow-up|0|||
23463550|NCT02963506|65440917|FG004|Double-Blind Period|Lost to Follow-up|0|||
23463551|NCT02963506|65440918|FG005|Double-Blind Period|Lost to Follow-up|0|||
23463552|NCT02963506|65440919|FG006|Double-Blind Period|Lost to Follow-up|0|||
23463553|NCT02963506|65440920|FG007|Double-Blind Period|Lost to Follow-up|0|||
23463554|NCT02963506|65440921|FG008|Double-Blind Period|Lost to Follow-up|0|||
23463555|NCT02963506|65440922|FG009|Double-Blind Period|Lost to Follow-up|0|||
23463556|NCT02963506|65440923|FG010|Double-Blind Period|Lost to Follow-up|0|||
23463557|NCT02963506|65440924|FG011|Double-Blind Period|Lost to Follow-up|0|||
23463558|NCT02963506|65440925|FG012|Double-Blind Period|Lost to Follow-up|0|||
23463559|NCT02963506|65440913|FG000|Double-Blind Period|Withdrawal by Subject|0|||
23463560|NCT02963506|65440914|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23463561|NCT02963506|65440915|FG002|Double-Blind Period|Withdrawal by Subject|1|||
23463562|NCT02963506|65440916|FG003|Double-Blind Period|Withdrawal by Subject|1|||
23463563|NCT02963506|65440917|FG004|Double-Blind Period|Withdrawal by Subject|0|||
23463564|NCT02963506|65440918|FG005|Double-Blind Period|Withdrawal by Subject|0|||
23463565|NCT02963506|65440919|FG006|Double-Blind Period|Withdrawal by Subject|0|||
23463566|NCT02963506|65440920|FG007|Double-Blind Period|Withdrawal by Subject|0|||
23463567|NCT02963506|65440921|FG008|Double-Blind Period|Withdrawal by Subject|0|||
23463568|NCT02963506|65440922|FG009|Double-Blind Period|Withdrawal by Subject|0|||
23463569|NCT02963506|65440923|FG010|Double-Blind Period|Withdrawal by Subject|0|||
23463570|NCT02963506|65440924|FG011|Double-Blind Period|Withdrawal by Subject|0|||
23463571|NCT02963506|65440925|FG012|Double-Blind Period|Withdrawal by Subject|0|||
23463572|NCT02963506|65440913|FG000|Double-Blind Period|No compliance|0|||
23463573|NCT02963506|65440914|FG001|Double-Blind Period|No compliance|1|||
23463574|NCT02963506|65440915|FG002|Double-Blind Period|No compliance|0|||
23463575|NCT02963506|65440916|FG003|Double-Blind Period|No compliance|0|||
23463576|NCT02963506|65440917|FG004|Double-Blind Period|No compliance|0|||
23463577|NCT02963506|65440918|FG005|Double-Blind Period|No compliance|0|||
23463578|NCT02963506|65440919|FG006|Double-Blind Period|No compliance|0|||
23463579|NCT02963506|65440920|FG007|Double-Blind Period|No compliance|0|||
23463580|NCT02963506|65440921|FG008|Double-Blind Period|No compliance|0|||
23463581|NCT02963506|65440922|FG009|Double-Blind Period|No compliance|0|||
23463582|NCT02963506|65440923|FG010|Double-Blind Period|No compliance|0|||
23463583|NCT02963506|65440924|FG011|Double-Blind Period|No compliance|0|||
23463584|NCT02963506|65440925|FG012|Double-Blind Period|No compliance|0|||
23463585|NCT02963506|65440913|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23183958|NCT02034123|64413672|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23242658|NCT01004822|64632989|FG005|Overall Study|Adverse Event|0|||
23350233|NCT03004924|65025392|FG001|Overall Study|Lost to Follow-up|1|||
23350234|NCT03004924|65025393|FG002|Overall Study|Lost to Follow-up|4|||
23463586|NCT02963506|65440914|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
23463587|NCT02963506|65440915|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463588|NCT02963506|65440916|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463589|NCT02963506|65440917|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463590|NCT02963506|65440918|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463591|NCT02963506|65440919|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463592|NCT02963506|65440920|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463593|NCT02963506|65440921|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463594|NCT02963506|65440922|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463595|NCT02963506|65440923|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463596|NCT02963506|65440924|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463597|NCT02963506|65440925|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
23463598|NCT02963506|65440913|FG000|Dose-Blind Period|Adverse Event|0|||
23463599|NCT02963506|65440914|FG001|Dose-Blind Period|Adverse Event|0|||
23183959|NCT02034123|64413673|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23463600|NCT02963506|65440915|FG002|Dose-Blind Period|Adverse Event|0|||
23463601|NCT02963506|65440916|FG003|Dose-Blind Period|Adverse Event|0|||
23183960|NCT02034123|64413674|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183961|NCT02034123|64413675|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183962|NCT02034123|64413676|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23463602|NCT02963506|65440917|FG004|Dose-Blind Period|Adverse Event|0|||
23463603|NCT02963506|65440918|FG005|Dose-Blind Period|Adverse Event|1|||
23463604|NCT02963506|65440919|FG006|Dose-Blind Period|Adverse Event|3|||
23463605|NCT02963506|65440920|FG007|Dose-Blind Period|Adverse Event|2|||
23463606|NCT02963506|65440921|FG008|Dose-Blind Period|Adverse Event|2|||
23463607|NCT02963506|65440922|FG009|Dose-Blind Period|Adverse Event|2|||
23463608|NCT02963506|65440923|FG010|Dose-Blind Period|Adverse Event|1|||
23463609|NCT02963506|65440924|FG011|Dose-Blind Period|Adverse Event|1|||
23463610|NCT02963506|65440925|FG012|Dose-Blind Period|Adverse Event|6|||
23463611|NCT02963506|65440913|FG000|Dose-Blind Period|Lack of Efficacy|0|||
23463612|NCT02963506|65440914|FG001|Dose-Blind Period|Lack of Efficacy|0|||
23463613|NCT02963506|65440915|FG002|Dose-Blind Period|Lack of Efficacy|0|||
23463614|NCT02963506|65440916|FG003|Dose-Blind Period|Lack of Efficacy|0|||
23463615|NCT02963506|65440917|FG004|Dose-Blind Period|Lack of Efficacy|0|||
23463616|NCT02963506|65440918|FG005|Dose-Blind Period|Lack of Efficacy|0|||
23463617|NCT02963506|65440919|FG006|Dose-Blind Period|Lack of Efficacy|0|||
23463618|NCT02963506|65440920|FG007|Dose-Blind Period|Lack of Efficacy|1|||
23463619|NCT02963506|65440921|FG008|Dose-Blind Period|Lack of Efficacy|0|||
23463620|NCT02963506|65440922|FG009|Dose-Blind Period|Lack of Efficacy|1|||
23463621|NCT02963506|65440923|FG010|Dose-Blind Period|Lack of Efficacy|0|||
23463622|NCT02963506|65440924|FG011|Dose-Blind Period|Lack of Efficacy|0|||
23463623|NCT02963506|65440925|FG012|Dose-Blind Period|Lack of Efficacy|0|||
23463624|NCT02963506|65440913|FG000|Dose-Blind Period|Lost to Follow-up|0|||
23463625|NCT02963506|65440914|FG001|Dose-Blind Period|Lost to Follow-up|0|||
23463626|NCT02963506|65440915|FG002|Dose-Blind Period|Lost to Follow-up|0|||
23463627|NCT02963506|65440916|FG003|Dose-Blind Period|Lost to Follow-up|0|||
23463628|NCT02963506|65440917|FG004|Dose-Blind Period|Lost to Follow-up|0|||
23463629|NCT02963506|65440918|FG005|Dose-Blind Period|Lost to Follow-up|1|||
23463630|NCT02963506|65440919|FG006|Dose-Blind Period|Lost to Follow-up|0|||
23463631|NCT02963506|65440920|FG007|Dose-Blind Period|Lost to Follow-up|0|||
23463632|NCT02963506|65440921|FG008|Dose-Blind Period|Lost to Follow-up|1|||
23463633|NCT02963506|65440922|FG009|Dose-Blind Period|Lost to Follow-up|0|||
23463634|NCT02963506|65440923|FG010|Dose-Blind Period|Lost to Follow-up|0|||
23463635|NCT02963506|65440924|FG011|Dose-Blind Period|Lost to Follow-up|1|||
23463636|NCT02963506|65440925|FG012|Dose-Blind Period|Lost to Follow-up|0|||
23463637|NCT02963506|65440913|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
23463638|NCT02963506|65440914|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
23463639|NCT02963506|65440915|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
23463640|NCT02963506|65440916|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
23463641|NCT02963506|65440917|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
23463642|NCT02963506|65440918|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
23463643|NCT02963506|65440919|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
23463644|NCT02963506|65440920|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
23463645|NCT02963506|65440921|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
23463646|NCT02963506|65440922|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
23463647|NCT02963506|65440923|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
23463648|NCT02963506|65440924|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
23463649|NCT02963506|65440925|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
23463650|NCT02963506|65440913|FG000|Dose-Blind Period|Sponsor decision|0|||
23463651|NCT02963506|65440914|FG001|Dose-Blind Period|Sponsor decision|0|||
23463652|NCT02963506|65440915|FG002|Dose-Blind Period|Sponsor decision|0|||
23463653|NCT02963506|65440916|FG003|Dose-Blind Period|Sponsor decision|0|||
23463654|NCT02963506|65440917|FG004|Dose-Blind Period|Sponsor decision|0|||
23463655|NCT02963506|65440918|FG005|Dose-Blind Period|Sponsor decision|1|||
23463656|NCT02963506|65440919|FG006|Dose-Blind Period|Sponsor decision|0|||
23463657|NCT02963506|65440920|FG007|Dose-Blind Period|Sponsor decision|0|||
23463658|NCT02963506|65440921|FG008|Dose-Blind Period|Sponsor decision|0|||
23463659|NCT02963506|65440922|FG009|Dose-Blind Period|Sponsor decision|0|||
23463660|NCT02963506|65440923|FG010|Dose-Blind Period|Sponsor decision|0|||
23463661|NCT02963506|65440924|FG011|Dose-Blind Period|Sponsor decision|0|||
23463662|NCT02963506|65440925|FG012|Dose-Blind Period|Sponsor decision|0|||
23463663|NCT02963506|65440913|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463664|NCT02963506|65440914|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463665|NCT02963506|65440915|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23242659|NCT01004822|64632990|FG006|Overall Study|Adverse Event|1|||
23463666|NCT02963506|65440916|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463667|NCT02963506|65440917|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463668|NCT02963506|65440918|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463669|NCT02963506|65440919|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463670|NCT02963506|65440920|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463671|NCT02963506|65440921|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463672|NCT02963506|65440922|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463673|NCT02963506|65440923|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463674|NCT02963506|65440924|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
23463675|NCT02963506|65440925|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
23463676|NCT00525161|65440928|FG000|Overall Study|Adverse Event|1|||
23463677|NCT04004988|65440933|FG000|Period 1|Physician Decision|2|||
23463678|NCT04004988|65440934|FG001|Period 1|Physician Decision|0|||
23463679|NCT04004988|65440933|FG000|Period 1|Withdrawal by Subject|0|||
23463680|NCT04004988|65440934|FG001|Period 1|Withdrawal by Subject|1|||
23463681|NCT04004988|65440933|FG000|Period 1|Adverse Event|1|||
23242660|NCT01004822|64632991|FG007|Overall Study|Adverse Event|1|||
23242661|NCT01004822|64632984|FG000|Overall Study|Other|0|||
23242662|NCT01004822|64632985|FG001|Overall Study|Other|0|||
23242663|NCT01004822|64632986|FG002|Overall Study|Other|4|||
23242664|NCT01004822|64632987|FG003|Overall Study|Other|1|||
23242665|NCT01004822|64632988|FG004|Overall Study|Other|0|||
23242666|NCT01004822|64632989|FG005|Overall Study|Other|1|||
23242667|NCT01004822|64632990|FG006|Overall Study|Other|0|||
23242668|NCT01004822|64632991|FG007|Overall Study|Other|0|||
23242669|NCT03605758|64632992|FG000|Overall Study|Lost to Follow-up|2|||
23242670|NCT03605758|64632993|FG001|Overall Study|Lost to Follow-up|1|||
23242671|NCT03605758|64632992|FG000|Overall Study|Illness|0|||
23242672|NCT03605758|64632993|FG001|Overall Study|Illness|1|||
23242673|NCT03605758|64632992|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
23242674|NCT03605758|64632993|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
23242675|NCT00828009|64632994|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
23242676|NCT00828009|64632994|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
23242677|NCT00828009|64632994|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
23242678|NCT00828009|64632994|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
23463682|NCT04004988|65440934|FG001|Period 1|Adverse Event|2|||
23463683|NCT00067002|65440937|FG000|Overall Study|Early Death|1|||
23463684|NCT00067002|65440938|FG001|Overall Study|Early Death|2|||
23242679|NCT00828009|64632994|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
23242680|NCT00828009|64632994|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
23463685|NCT00067002|65440937|FG000|Overall Study|Delayed|1|||
23463686|NCT00067002|65440938|FG001|Overall Study|Delayed|1|||
23463687|NCT00067002|65440937|FG000|Overall Study|Graft Failure|5|||
23463688|NCT00067002|65440938|FG001|Overall Study|Graft Failure|6|||
23463689|NCT00478023|65440941|FG000|Overall Study|Adverse Event|11|||
23463690|NCT00478023|65440942|FG001|Overall Study|Adverse Event|7|||
23463691|NCT00478023|65440943|FG002|Overall Study|Adverse Event|8|||
23463692|NCT00478023|65440944|FG003|Overall Study|Adverse Event|14|||
23242681|NCT00828009|64632994|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
23242682|NCT00828009|64632994|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
23463693|NCT00478023|65440945|FG004|Overall Study|Adverse Event|6|||
23463694|NCT00478023|65440941|FG000|Overall Study|Death|1|||
23463695|NCT00478023|65440942|FG001|Overall Study|Death|0|||
23463696|NCT00478023|65440943|FG002|Overall Study|Death|0|||
23463697|NCT00478023|65440944|FG003|Overall Study|Death|0|||
23463698|NCT00478023|65440945|FG004|Overall Study|Death|0|||
23463699|NCT00478023|65440941|FG000|Overall Study|Lack of Efficacy|11|||
23463700|NCT00478023|65440942|FG001|Overall Study|Lack of Efficacy|10|||
23463701|NCT00478023|65440943|FG002|Overall Study|Lack of Efficacy|4|||
23463702|NCT00478023|65440944|FG003|Overall Study|Lack of Efficacy|5|||
23463703|NCT00478023|65440945|FG004|Overall Study|Lack of Efficacy|41|||
23463704|NCT00478023|65440941|FG000|Overall Study|Lost to Follow-up|3|||
23463705|NCT00478023|65440942|FG001|Overall Study|Lost to Follow-up|1|||
23463706|NCT00478023|65440943|FG002|Overall Study|Lost to Follow-up|1|||
23463707|NCT00478023|65440944|FG003|Overall Study|Lost to Follow-up|1|||
23242683|NCT00828009|64632994|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
23463708|NCT00478023|65440945|FG004|Overall Study|Lost to Follow-up|0|||
23463709|NCT00478023|65440941|FG000|Overall Study|Withdrawal by Subject|2|||
23242684|NCT00828009|64632994|FG000|Step 2 - Maintenance Therapy|Death|1|||
23242685|NCT00828009|64632994|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
23463710|NCT00478023|65440942|FG001|Overall Study|Withdrawal by Subject|3|||
23242686|NCT00828009|64632994|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
23463711|NCT00478023|65440943|FG002|Overall Study|Withdrawal by Subject|2|||
23463712|NCT00478023|65440944|FG003|Overall Study|Withdrawal by Subject|4|||
23463713|NCT00478023|65440945|FG004|Overall Study|Withdrawal by Subject|5|||
23463714|NCT00478023|65440941|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
23463715|NCT00478023|65440942|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
23463716|NCT00478023|65440943|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
23463717|NCT00478023|65440944|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
23463718|NCT00478023|65440945|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
23463719|NCT00912808|65440946|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
23463720|NCT00912808|65440947|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
23463721|NCT00912808|65440946|FG000|Washout|Withdrawal by Subject|0|||
23463722|NCT00912808|65440947|FG001|Washout|Withdrawal by Subject|1|||
23463723|NCT00912808|65440946|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
23463724|NCT00912808|65440947|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
23463725|NCT00912808|65440946|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
23463726|NCT00912808|65440947|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
23463727|NCT00728689|65440948|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
23463728|NCT00728689|65440949|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
23463729|NCT00914316|65440951|FG000|Phase 1|Physician Decision|4|||
23463730|NCT00914316|65440952|FG001|Phase 1|Physician Decision|0|||
23463731|NCT00914316|65440953|FG002|Phase 1|Physician Decision|1|||
23463732|NCT00914316|65440954|FG003|Phase 1|Physician Decision|2|||
23463733|NCT00914316|65440951|FG000|Phase 1|Withdrawal by Subject|0|||
23463734|NCT00914316|65440952|FG001|Phase 1|Withdrawal by Subject|2|||
23463735|NCT00914316|65440953|FG002|Phase 1|Withdrawal by Subject|4|||
23463736|NCT00914316|65440954|FG003|Phase 1|Withdrawal by Subject|0|||
23463737|NCT00914316|65440951|FG000|Phase 1|Adverse Event|1|||
23463738|NCT00914316|65440952|FG001|Phase 1|Adverse Event|0|||
23463739|NCT00914316|65440953|FG002|Phase 1|Adverse Event|0|||
23463740|NCT00914316|65440954|FG003|Phase 1|Adverse Event|0|||
23463741|NCT00914316|65440951|FG000|Phase 2|Withdrawal by Subject|1|||
23463742|NCT00914316|65440952|FG001|Phase 2|Withdrawal by Subject|0|||
23463743|NCT00914316|65440953|FG002|Phase 2|Withdrawal by Subject|1|||
23463744|NCT00914316|65440954|FG003|Phase 2|Withdrawal by Subject|0|||
23463745|NCT00577889|65440957|FG000|Overall Study|Withdrawal by Subject|1|||
23463746|NCT00577889|65440958|FG001|Overall Study|Withdrawal by Subject|0|||
23463747|NCT00577889|65440959|FG002|Overall Study|Withdrawal by Subject|0|||
23463748|NCT01652534|65440960|FG000|Overall Study|Lack of Efficacy|1|||
23463749|NCT01652534|65440961|FG001|Overall Study|Lack of Efficacy|0|||
23350235|NCT03004924|65025391|FG000|Overall Study|Lack of Efficacy|2|||
23350236|NCT03004924|65025392|FG001|Overall Study|Lack of Efficacy|4|||
23350237|NCT03004924|65025393|FG002|Overall Study|Lack of Efficacy|2|||
23350238|NCT03004924|65025391|FG000|Overall Study|Physician Decision|1|||
23350239|NCT03004924|65025392|FG001|Overall Study|Physician Decision|0|||
23350240|NCT03004924|65025393|FG002|Overall Study|Physician Decision|1|||
23350241|NCT03004924|65025391|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23350242|NCT03004924|65025392|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23350243|NCT03004924|65025393|FG002|Overall Study|Withdrawal by parent/guardian|2|||
23350244|NCT03004924|65025391|FG000|Overall Study|Screen Failure|1|||
23350245|NCT03004924|65025392|FG001|Overall Study|Screen Failure|0|||
23350246|NCT03004924|65025393|FG002|Overall Study|Screen Failure|0|||
23350247|NCT03004924|65025391|FG000|Overall Study|Pregnancy|0|||
23350248|NCT03004924|65025392|FG001|Overall Study|Pregnancy|1|||
23350249|NCT03004924|65025393|FG002|Overall Study|Pregnancy|0|||
23350250|NCT03004924|65025391|FG000|Overall Study|Terminated by Sponsor|0|||
23350251|NCT03004924|65025392|FG001|Overall Study|Terminated by Sponsor|0|||
23350252|NCT03004924|65025393|FG002|Overall Study|Terminated by Sponsor|1|||
23350253|NCT03004924|65025391|FG000|Overall Study|Missed Study Visit|0|||
23350254|NCT03004924|65025392|FG001|Overall Study|Missed Study Visit|0|||
23350255|NCT03004924|65025393|FG002|Overall Study|Missed Study Visit|2|||
23350256|NCT03004924|65025391|FG000|Overall Study|HSV1 Positive|1|||
23350257|NCT03004924|65025392|FG001|Overall Study|HSV1 Positive|0|||
23350258|NCT03004924|65025393|FG002|Overall Study|HSV1 Positive|0|||
23350259|NCT01273155|65025396|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
23350260|NCT01273155|65025397|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
23463750|NCT02083354|65440962|FG000|Overall Study|Withdrawal by Subject|9|||
23242687|NCT00828009|64632994|FG000|Step 2 - Maintenance Therapy|Other|1|||
23350261|NCT01273155|65025398|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
23350262|NCT01273155|65025399|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
23350263|NCT01273155|65025400|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
23350264|NCT01273155|65025401|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
23350265|NCT01273155|65025402|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
23350266|NCT01273155|65025396|FG000|Overall Study|Change in liver function/no longer eval.|0|||
23242688|NCT00240331|64632995|FG000|Overall Study|Withdrawal by Subject|125|||
23463751|NCT02083354|65440962|FG000|Overall Study|Lost to Follow-up|1|||
23463752|NCT02083354|65440962|FG000|Overall Study|Adverse Event|3|||
23463753|NCT02083354|65440962|FG000|Overall Study|Disease progression|46|||
23463754|NCT02083354|65440962|FG000|Overall Study|Study closed/terminated|5|||
23463755|NCT02015637|65440966|FG000|Overall Study|Lost to Follow-up|3|||
23463756|NCT02015637|65440967|FG001|Overall Study|Lost to Follow-up|5|||
23463757|NCT02015637|65440966|FG000|Overall Study|Adverse Event|3|||
23463758|NCT02015637|65440967|FG001|Overall Study|Adverse Event|0|||
23463759|NCT02015637|65440966|FG000|Overall Study|Did not take study drug|2|||
23463760|NCT02015637|65440967|FG001|Overall Study|Did not take study drug|0|||
23463761|NCT01782378|65440968|FG000|First Series|Lost to Follow-up|7|||
23463762|NCT01782378|65440969|FG001|First Series|Lost to Follow-up|8|||
23463763|NCT01782378|65440968|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
23463764|NCT01782378|65440969|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
23463765|NCT01782378|65440968|FG000|Second Series|Lost to Follow-up|8|||
23463766|NCT01782378|65440969|FG001|Second Series|Lost to Follow-up|7|||
23463767|NCT01782378|65440968|FG000|Second Series|Did not choose to complete S2 Optional|18|||
23463768|NCT01782378|65440969|FG001|Second Series|Did not choose to complete S2 Optional|0|||
23463769|NCT00321620|65440970|FG000|Overall Study|Death|269|||
23183963|NCT02034123|64413677|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
23183964|NCT02034123|64413678|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183965|NCT02034123|64413679|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183966|NCT02034123|64413680|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183967|NCT02034123|64413681|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183968|NCT02034123|64413682|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183969|NCT02034123|64413683|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183970|NCT02034123|64413684|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183971|NCT02034123|64413685|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183972|NCT02034123|64413686|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
23183973|NCT02034123|64413669|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183974|NCT02034123|64413670|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183975|NCT02034123|64413671|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183976|NCT02034123|64413672|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
23183977|NCT02034123|64413673|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
23183978|NCT02034123|64413674|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23350267|NCT01273155|65025397|FG001|Overall Study|Change in liver function/no longer eval.|1|||
23350268|NCT01273155|65025398|FG002|Overall Study|Change in liver function/no longer eval.|0|||
23463770|NCT00321620|65440971|FG001|Overall Study|Death|294|||
23463771|NCT00321620|65440970|FG000|Overall Study|Withdrawal by Subject|164|||
23463772|NCT00321620|65440971|FG001|Overall Study|Withdrawal by Subject|147|||
23463773|NCT00321620|65440970|FG000|Overall Study|Disease progression|113|||
23463774|NCT00321620|65440971|FG001|Overall Study|Disease progression|117|||
23463775|NCT00321620|65440970|FG000|Overall Study|Adverse Event|43|||
23463776|NCT00321620|65440971|FG001|Overall Study|Adverse Event|56|||
23463777|NCT00321620|65440970|FG000|Overall Study|Lost to Follow-up|13|||
23463778|NCT00321620|65440971|FG001|Overall Study|Lost to Follow-up|9|||
23463779|NCT00321620|65440970|FG000|Overall Study|Physician Decision|4|||
23463780|NCT00321620|65440971|FG001|Overall Study|Physician Decision|1|||
23463781|NCT00321620|65440970|FG000|Overall Study|Noncompliance|14|||
23463782|NCT00321620|65440971|FG001|Overall Study|Noncompliance|7|||
23463783|NCT00321620|65440970|FG000|Overall Study|Protocol deviation|4|||
23463784|NCT00321620|65440971|FG001|Overall Study|Protocol deviation|3|||
23463785|NCT00321620|65440970|FG000|Overall Study|Ineligibility determined|2|||
23463786|NCT00321620|65440971|FG001|Overall Study|Ineligibility determined|3|||
23463787|NCT00321620|65440970|FG000|Overall Study|Participant request|75|||
23463788|NCT00321620|65440971|FG001|Overall Study|Participant request|52|||
23463789|NCT00321620|65440970|FG000|Overall Study|Other|42|||
23463790|NCT00321620|65440971|FG001|Overall Study|Other|33|||
23463791|NCT00716417|65440972|FG000|Overall Study|Adverse Event|0|||
23463792|NCT00716417|65440973|FG001|Overall Study|Adverse Event|0|||
23463793|NCT00716417|65440974|FG002|Overall Study|Adverse Event|2|||
23463794|NCT00716417|65440975|FG003|Overall Study|Adverse Event|1|||
23463795|NCT00716417|65440976|FG004|Overall Study|Adverse Event|0|||
23463796|NCT00716417|65440977|FG005|Overall Study|Adverse Event|0|||
23463797|NCT00716417|65440978|FG006|Overall Study|Adverse Event|3|||
23463798|NCT00716417|65440979|FG007|Overall Study|Adverse Event|1|||
23463799|NCT00716417|65440980|FG008|Overall Study|Adverse Event|0|||
23463800|NCT00716417|65440981|FG009|Overall Study|Adverse Event|3|||
23463801|NCT00716417|65440972|FG000|Overall Study|Withdrawal by Subject|0|||
23463802|NCT00716417|65440973|FG001|Overall Study|Withdrawal by Subject|1|||
23463803|NCT00716417|65440974|FG002|Overall Study|Withdrawal by Subject|0|||
23463804|NCT00716417|65440975|FG003|Overall Study|Withdrawal by Subject|2|||
23463805|NCT00716417|65440976|FG004|Overall Study|Withdrawal by Subject|0|||
23463806|NCT00716417|65440977|FG005|Overall Study|Withdrawal by Subject|0|||
23463807|NCT00716417|65440978|FG006|Overall Study|Withdrawal by Subject|1|||
23463808|NCT00716417|65440979|FG007|Overall Study|Withdrawal by Subject|0|||
23463809|NCT00716417|65440980|FG008|Overall Study|Withdrawal by Subject|0|||
23463810|NCT00716417|65440981|FG009|Overall Study|Withdrawal by Subject|0|||
23463811|NCT00716417|65440972|FG000|Overall Study|Progressive disease|3|||
23463812|NCT00716417|65440973|FG001|Overall Study|Progressive disease|5|||
23463813|NCT00716417|65440974|FG002|Overall Study|Progressive disease|3|||
23463814|NCT00716417|65440975|FG003|Overall Study|Progressive disease|8|||
23463815|NCT00716417|65440976|FG004|Overall Study|Progressive disease|0|||
23463816|NCT00716417|65440977|FG005|Overall Study|Progressive disease|3|||
23463817|NCT00716417|65440978|FG006|Overall Study|Progressive disease|3|||
23242689|NCT00240331|64632996|FG001|Overall Study|Withdrawal by Subject|132|||
23242690|NCT00240331|64632995|FG000|Overall Study|Option selected by investigator|1|||
23463818|NCT00716417|65440979|FG007|Overall Study|Progressive disease|1|||
23463819|NCT00716417|65440980|FG008|Overall Study|Progressive disease|5|||
23463820|NCT00716417|65440981|FG009|Overall Study|Progressive disease|0|||
23463821|NCT00716417|65440972|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
23463822|NCT00716417|65440973|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
23463823|NCT00716417|65440974|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
23463824|NCT00716417|65440975|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
23463825|NCT00716417|65440976|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
23463826|NCT00716417|65440977|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
23463827|NCT00716417|65440978|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
23463828|NCT00716417|65440979|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
23463829|NCT00716417|65440980|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
23463830|NCT00716417|65440981|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
23463831|NCT00716417|65440972|FG000|Overall Study|On patient request due to toxicities|0|||
23463832|NCT00716417|65440973|FG001|Overall Study|On patient request due to toxicities|0|||
23463833|NCT00716417|65440974|FG002|Overall Study|On patient request due to toxicities|0|||
23463834|NCT00716417|65440975|FG003|Overall Study|On patient request due to toxicities|0|||
23463835|NCT00716417|65440976|FG004|Overall Study|On patient request due to toxicities|0|||
23463836|NCT00716417|65440977|FG005|Overall Study|On patient request due to toxicities|0|||
23463837|NCT00716417|65440978|FG006|Overall Study|On patient request due to toxicities|0|||
23463838|NCT00716417|65440979|FG007|Overall Study|On patient request due to toxicities|1|||
23463839|NCT00716417|65440980|FG008|Overall Study|On patient request due to toxicities|0|||
23463840|NCT00716417|65440981|FG009|Overall Study|On patient request due to toxicities|0|||
23463841|NCT00369265|65440986|FG000|Overall Study|Study terminated|4|||
23585004|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
23585005|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
23183979|NCT02034123|64413675|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183980|NCT02034123|64413676|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183981|NCT02034123|64413677|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183982|NCT02034123|64413678|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183983|NCT02034123|64413679|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183984|NCT02034123|64413680|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183985|NCT02034123|64413681|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183986|NCT02034123|64413682|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183987|NCT02034123|64413683|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183988|NCT02034123|64413684|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23242691|NCT00240331|64632996|FG001|Overall Study|Option selected by investigator|2|||
23242692|NCT00593385|64632999|FG000|Overall Study|Death|14|||
23242693|NCT00593385|64632999|FG000|Overall Study|Lost to Follow-up|17|||
23242694|NCT00593385|64632999|FG000|Overall Study|Withdrawal by Subject|9|||
23242695|NCT01275170|64633002|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
23242696|NCT01275170|64633003|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
23242697|NCT01275170|64633004|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
23242698|NCT01275170|64633005|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
23242699|NCT01275170|64633006|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
23402752|NCT01621178|65219994|FG000|Overall Study|Death|6|||
23402753|NCT01621178|65219995|FG001|Overall Study|Death|7|||
23402754|NCT01621178|65219996|FG002|Overall Study|Death|2|||
23402755|NCT01621178|65219994|FG000|Overall Study|Lost to Follow-up|1|||
23402756|NCT01621178|65219995|FG001|Overall Study|Lost to Follow-up|2|||
23402757|NCT01621178|65219996|FG002|Overall Study|Lost to Follow-up|1|||
23402758|NCT01621178|65219994|FG000|Overall Study|Withdrawal by Subject|14|||
23402759|NCT01621178|65219995|FG001|Overall Study|Withdrawal by Subject|17|||
23402760|NCT01621178|65219996|FG002|Overall Study|Withdrawal by Subject|18|||
23402761|NCT01621178|65219994|FG000|Overall Study|Physician Decision|5|||
23402762|NCT01621178|65219995|FG001|Overall Study|Physician Decision|2|||
23402763|NCT01621178|65219996|FG002|Overall Study|Physician Decision|7|||
23402764|NCT01535287|65219999|FG000|Overall Study|drug not prepared in time|5|||
23402765|NCT01535287|65220000|FG001|Overall Study|drug not prepared in time|6|||
23402766|NCT03493958|65220002|FG000|Overall Study|Withdrawal by Subject|6|||
23402767|NCT03493958|65220002|FG000|Overall Study|Lost to Follow-up|7|||
23402768|NCT03493958|65220002|FG000|Overall Study|Did not complete all required study procedures|2|||
23402769|NCT01446874|65220003|FG000|Overall Study|Not eligible|1|||
23242700|NCT01275170|64633007|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
23242701|NCT01275170|64633008|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
23242702|NCT01275170|64633009|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
23242703|NCT05022121|64633012|FG000|Overall Study|Lack of Efficacy|1|||
23242704|NCT05022121|64633013|FG001|Overall Study|Lack of Efficacy|0|||
23242705|NCT05022121|64633012|FG000|Overall Study|Lost to Follow-up|0|||
23242706|NCT05022121|64633013|FG001|Overall Study|Lost to Follow-up|2|||
23242707|NCT03290131|64633014|FG000|Overall Study|Adverse Event|22|||
23242708|NCT03290131|64633015|FG001|Overall Study|Adverse Event|57|||
23242709|NCT03290131|64633016|FG002|Overall Study|Adverse Event|11|||
23242710|NCT03290131|64633014|FG000|Overall Study|Withdrawal by Subject|18|||
23242711|NCT03290131|64633015|FG001|Overall Study|Withdrawal by Subject|13|||
23463842|NCT00369265|65440987|FG001|Overall Study|Study terminated|7|||
23463843|NCT01055197|65440990|FG000|Overall Study|Protocol Violation|7|||
23463844|NCT01055197|65440991|FG001|Overall Study|Protocol Violation|2|||
23585006|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
23463845|NCT01055197|65440990|FG000|Overall Study|Withdrawal by Subject|2|||
23463846|NCT01055197|65440991|FG001|Overall Study|Withdrawal by Subject|0|||
23463847|NCT03131219|65441000|FG000|Initial Evaluation Period|Adverse Event|2|||
23463848|NCT03131219|65441001|FG001|Initial Evaluation Period|Adverse Event|0|||
23463849|NCT03131219|65441000|FG000|Initial Evaluation Period|Protocol Violation|1|||
23463850|NCT03131219|65441001|FG001|Initial Evaluation Period|Protocol Violation|0|||
23463851|NCT03131219|65441000|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
23463852|NCT03131219|65441001|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
23463853|NCT03131219|65441000|FG000|Initial Evaluation Period|Physician Decision|1|||
23463854|NCT03131219|65441001|FG001|Initial Evaluation Period|Physician Decision|0|||
23463855|NCT03131219|65441000|FG000|Extension Period|Physician Decision|1|||
23463856|NCT03131219|65441001|FG001|Extension Period|Physician Decision|0|||
23463857|NCT00391586|65441007|FG000|Overall Study|Progressive disease|13|||
23463858|NCT00391586|65441007|FG000|Overall Study|Adverse Event|5|||
23463859|NCT00391586|65441007|FG000|Overall Study|Physician Decision|2|||
23463860|NCT00391586|65441007|FG000|Overall Study|Death|4|||
23463861|NCT02395081|65441008|FG000|Overall Study|Withdrawal by Subject|1|||
23463862|NCT02395081|65441009|FG001|Overall Study|Withdrawal by Subject|1|||
23463863|NCT02395081|65441010|FG002|Overall Study|Withdrawal by Subject|0|||
23463864|NCT02395081|65441008|FG000|Overall Study|Moved where blood couldn't be collected|4|||
23463865|NCT02395081|65441009|FG001|Overall Study|Moved where blood couldn't be collected|1|||
23463866|NCT02395081|65441010|FG002|Overall Study|Moved where blood couldn't be collected|3|||
23463867|NCT02395081|65441008|FG000|Overall Study|Fetal Loss|2|||
23463868|NCT02395081|65441009|FG001|Overall Study|Fetal Loss|3|||
23463869|NCT02395081|65441010|FG002|Overall Study|Fetal Loss|1|||
23463870|NCT03822117|65441011|FG000|Overall Study|Death|18|||
23463871|NCT03822117|65441012|FG001|Overall Study|Death|17|||
23463872|NCT03822117|65441013|FG002|Overall Study|Death|12|||
23463873|NCT03822117|65441014|FG003|Overall Study|Death|4|||
23463874|NCT03822117|65441011|FG000|Overall Study|Lost to Follow-up|1|||
23463875|NCT03822117|65441012|FG001|Overall Study|Lost to Follow-up|2|||
23463876|NCT03822117|65441013|FG002|Overall Study|Lost to Follow-up|3|||
23463877|NCT03822117|65441014|FG003|Overall Study|Lost to Follow-up|0|||
23463878|NCT03822117|65441011|FG000|Overall Study|Study Terminated by Sponsor|25|||
23183989|NCT02034123|64413685|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183990|NCT02034123|64413686|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
23183991|NCT02209506|64413687|FG000|Overall Study|Withdrawal by Subject|0|||
23183992|NCT02209506|64413688|FG001|Overall Study|Withdrawal by Subject|0|||
23183993|NCT02209506|64413689|FG002|Overall Study|Withdrawal by Subject|0|||
23183994|NCT02209506|64413690|FG003|Overall Study|Withdrawal by Subject|0|||
23183995|NCT02209506|64413691|FG004|Overall Study|Withdrawal by Subject|1|||
23183996|NCT00486603|64413692|FG000|Overall Study|Withdrawal by Subject|1|||
23183997|NCT00486603|64413693|FG001|Overall Study|Withdrawal by Subject|0|||
23183998|NCT00486603|64413694|FG002|Overall Study|Withdrawal by Subject|0|||
23183999|NCT00486603|64413695|FG003|Overall Study|Withdrawal by Subject|0|||
23242712|NCT03290131|64633016|FG002|Overall Study|Withdrawal by Subject|8|||
23242713|NCT03290131|64633014|FG000|Overall Study|MS Relapse|2|||
23585007|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
23242714|NCT03290131|64633015|FG001|Overall Study|MS Relapse|1|||
23585008|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
23463879|NCT03822117|65441012|FG001|Overall Study|Study Terminated by Sponsor|11|||
23184000|NCT00486603|64413696|FG004|Overall Study|Withdrawal by Subject|0|||
23184001|NCT00486603|64413692|FG000|Overall Study|Physician Decision|0|||
23184002|NCT00486603|64413693|FG001|Overall Study|Physician Decision|1|||
23184003|NCT00486603|64413694|FG002|Overall Study|Physician Decision|0|||
23184004|NCT00486603|64413695|FG003|Overall Study|Physician Decision|0|||
23463880|NCT03822117|65441013|FG002|Overall Study|Study Terminated by Sponsor|6|||
23463881|NCT03822117|65441014|FG003|Overall Study|Study Terminated by Sponsor|0|||
23463882|NCT03822117|65441011|FG000|Overall Study|Withdrawal by Subject|4|||
23463883|NCT03822117|65441012|FG001|Overall Study|Withdrawal by Subject|0|||
23463884|NCT03822117|65441013|FG002|Overall Study|Withdrawal by Subject|3|||
23463885|NCT03822117|65441014|FG003|Overall Study|Withdrawal by Subject|0|||
23463886|NCT03822117|65441011|FG000|Overall Study|Disease Progression|1|||
23463887|NCT03822117|65441012|FG001|Overall Study|Disease Progression|2|||
23463888|NCT03822117|65441013|FG002|Overall Study|Disease Progression|1|||
23463889|NCT03822117|65441014|FG003|Overall Study|Disease Progression|0|||
23463890|NCT03822117|65441011|FG000|Overall Study|Never Returned to Hospital|0|||
23463891|NCT03822117|65441012|FG001|Overall Study|Never Returned to Hospital|0|||
23463892|NCT03822117|65441013|FG002|Overall Study|Never Returned to Hospital|1|||
23463893|NCT03822117|65441014|FG003|Overall Study|Never Returned to Hospital|0|||
23463894|NCT02668653|65441015|FG000|Overall Study|Refractory disease|41|||
23184005|NCT00486603|64413696|FG004|Overall Study|Physician Decision|0|||
23184006|NCT05300087|64413704|FG000|Overall Study|Withdrawal by Subject|0|||
23184007|NCT05300087|64413705|FG001|Overall Study|Withdrawal by Subject|1|||
23184008|NCT04826900|64413708|FG000|Overall Study|Family factor|1|||
23184009|NCT04826900|64413709|FG001|Overall Study|Family factor|1|||
23184010|NCT04317690|64413710|FG000|Overall Study|did not have complete information for primary outcome|0|||
23184011|NCT04317690|64413711|FG001|Overall Study|did not have complete information for primary outcome|4|||
23184012|NCT04317690|64413712|FG002|Overall Study|did not have complete information for primary outcome|0|||
23463895|NCT02668653|65441016|FG001|Overall Study|Refractory disease|70|||
23463896|NCT02668653|65441015|FG000|Overall Study|Relapse|44|||
23463897|NCT02668653|65441016|FG001|Overall Study|Relapse|65|||
23463898|NCT02668653|65441015|FG000|Overall Study|Adverse Event|58|||
23463899|NCT02668653|65441016|FG001|Overall Study|Adverse Event|23|||
23463900|NCT02668653|65441015|FG000|Overall Study|Subject decision to stop study drug|25|||
23463901|NCT02668653|65441016|FG001|Overall Study|Subject decision to stop study drug|23|||
23463902|NCT02668653|65441015|FG000|Overall Study|Other reasons not specified|16|||
23463903|NCT02668653|65441016|FG001|Overall Study|Other reasons not specified|11|||
23463904|NCT02668653|65441015|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
23463905|NCT02668653|65441016|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
23463906|NCT02668653|65441015|FG000|Overall Study|Investigator decision|10|||
23463907|NCT02668653|65441016|FG001|Overall Study|Investigator decision|7|||
23463908|NCT02668653|65441015|FG000|Overall Study|Failure to meet continuation criteria|5|||
23463909|NCT02668653|65441016|FG001|Overall Study|Failure to meet continuation criteria|12|||
23463910|NCT02668653|65441015|FG000|Overall Study|Lost to Follow-up|1|||
23463911|NCT02668653|65441016|FG001|Overall Study|Lost to Follow-up|0|||
23463912|NCT02668653|65441015|FG000|Overall Study|Pregnancy|0|||
23463913|NCT02668653|65441016|FG001|Overall Study|Pregnancy|1|||
23463914|NCT02668653|65441015|FG000|Overall Study|Death|0|||
23463915|NCT02668653|65441016|FG001|Overall Study|Death|1|||
23463916|NCT03863080|65441017|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
23463917|NCT03863080|65441018|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
23463918|NCT03863080|65441019|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
23463919|NCT03863080|65441020|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
23463920|NCT03863080|65441017|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
23463921|NCT03863080|65441018|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
23463922|NCT03863080|65441019|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
23463923|NCT03863080|65441020|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
23463924|NCT03863080|65441017|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
23463925|NCT03863080|65441018|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
23463926|NCT03863080|65441019|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
23463927|NCT03863080|65441020|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
23463928|NCT01868997|65441027|FG000|Overall Study|Adverse Event|2|||
23463929|NCT01868997|65441028|FG001|Overall Study|Adverse Event|5|||
23463930|NCT01868997|65441027|FG000|Overall Study|Lack of Efficacy|2|||
23184013|NCT04317690|64413713|FG003|Overall Study|did not have complete information for primary outcome|2|||
23184014|NCT04317690|64413714|FG004|Overall Study|did not have complete information for primary outcome|0|||
23184015|NCT00384956|64413715|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
23184016|NCT02764541|64413716|FG000|Overall Study|Withdrawal by Subject|0|||
23463931|NCT01868997|65441028|FG001|Overall Study|Lack of Efficacy|0|||
23463932|NCT01868997|65441027|FG000|Overall Study|Other|3|||
23585009|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
23184017|NCT02764541|64413717|FG001|Overall Study|Withdrawal by Subject|0|||
23463933|NCT01868997|65441028|FG001|Overall Study|Other|1|||
23463934|NCT00106704|65441029|FG000|Overall Study|Adverse Event|10|||
23463935|NCT00106704|65441030|FG001|Overall Study|Adverse Event|7|||
23463936|NCT00106704|65441029|FG000|Overall Study|Death|2|||
23463937|NCT00106704|65441030|FG001|Overall Study|Death|1|||
23463938|NCT00106704|65441029|FG000|Overall Study|Lack of Efficacy|67|||
23463939|NCT00106704|65441030|FG001|Overall Study|Lack of Efficacy|69|||
23585010|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
23585011|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Death|2|||
23463940|NCT00106704|65441029|FG000|Overall Study|Lost to Follow-up|7|||
23463941|NCT00106704|65441030|FG001|Overall Study|Lost to Follow-up|3|||
23463942|NCT00106704|65441029|FG000|Overall Study|Pregnancy|1|||
23463943|NCT00106704|65441030|FG001|Overall Study|Pregnancy|0|||
23463944|NCT00106704|65441029|FG000|Overall Study|Protocol Violation|4|||
23463945|NCT00106704|65441030|FG001|Overall Study|Protocol Violation|7|||
23463946|NCT00106704|65441029|FG000|Overall Study|Withdrawal by Subject|14|||
23463947|NCT00106704|65441030|FG001|Overall Study|Withdrawal by Subject|21|||
23463948|NCT00106704|65441029|FG000|Overall Study|Patient moved|1|||
23463949|NCT00106704|65441030|FG001|Overall Study|Patient moved|0|||
23463950|NCT00106704|65441029|FG000|Overall Study|Site terminated|0|||
23463951|NCT00106704|65441030|FG001|Overall Study|Site terminated|1|||
23463952|NCT00106704|65441029|FG000|Overall Study|Planned major surgery|1|||
23463953|NCT00106704|65441030|FG001|Overall Study|Planned major surgery|0|||
23463954|NCT00106704|65441029|FG000|Overall Study|Patient Received Glycemic Medication|22|||
23463955|NCT00106704|65441030|FG001|Overall Study|Patient Received Glycemic Medication|41|||
23463956|NCT00106704|65441029|FG000|Overall Study|Unable to re-enter US|1|||
23463957|NCT00106704|65441030|FG001|Overall Study|Unable to re-enter US|0|||
23463958|NCT00106704|65441029|FG000|Overall Study|Laboratory test|1|||
23463959|NCT00106704|65441030|FG001|Overall Study|Laboratory test|1|||
23463960|NCT01120964|65441031|FG000|Overall Study|Did not receive full treatment|1|||
23463961|NCT01120964|65441032|FG001|Overall Study|Did not receive full treatment|0|||
23463962|NCT01987453|65441035|FG000|Overall Study|Death|0|||
23463963|NCT01987453|65441036|FG001|Overall Study|Death|0|||
23463964|NCT01987453|65441037|FG002|Overall Study|Death|1|||
23463965|NCT01987453|65441035|FG000|Overall Study|Lack of Efficacy|1|||
23463966|NCT01987453|65441036|FG001|Overall Study|Lack of Efficacy|12|||
23463967|NCT01987453|65441037|FG002|Overall Study|Lack of Efficacy|0|||
23463968|NCT00702221|65441038|FG000|Overall Study|Adverse Event|4|||
23463969|NCT00702221|65441039|FG001|Overall Study|Adverse Event|3|||
23463970|NCT01709084|65441046|FG000|Overall Study|Lost to Follow-up|4|||
23463971|NCT01709084|65441047|FG001|Overall Study|Lost to Follow-up|7|||
23463972|NCT01709084|65441046|FG000|Overall Study|Withdrawal by Subject|2|||
23463973|NCT01709084|65441047|FG001|Overall Study|Withdrawal by Subject|2|||
23463974|NCT01709084|65441046|FG000|Overall Study|Adverse Event|5|||
23463975|NCT01709084|65441047|FG001|Overall Study|Adverse Event|0|||
23463976|NCT01709084|65441046|FG000|Overall Study|Other|5|||
23463977|NCT01709084|65441047|FG001|Overall Study|Other|3|||
23463978|NCT01709084|65441046|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
23463979|NCT01709084|65441047|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
23463980|NCT01709084|65441046|FG000|Overall Study|Not Treated|0|||
23463981|NCT01709084|65441047|FG001|Overall Study|Not Treated|2|||
23463982|NCT02461134|65441048|FG000|Overall Study|Adverse Event|1|||
23463983|NCT02699749|65441050|FG000|Overall Study|Other|0|||
23463984|NCT02699749|65441051|FG001|Overall Study|Other|0|||
23463985|NCT02699749|65441052|FG002|Overall Study|Other|2|||
23463986|NCT02699749|65441053|FG003|Overall Study|Other|0|||
23463987|NCT02699749|65441054|FG004|Overall Study|Other|0|||
23463988|NCT02699749|65441055|FG005|Overall Study|Other|1|||
23463989|NCT02699749|65441056|FG006|Overall Study|Other|1|||
23463990|NCT02699749|65441057|FG007|Overall Study|Other|0|||
23463991|NCT02699749|65441058|FG008|Overall Study|Other|0|||
23463992|NCT02699749|65441059|FG009|Overall Study|Other|0|||
23463993|NCT02699749|65441060|FG010|Overall Study|Other|1|||
23463994|NCT02699749|65441061|FG011|Overall Study|Other|0|||
23463995|NCT02699749|65441062|FG012|Overall Study|Other|0|||
23463996|NCT02699749|65441063|FG013|Overall Study|Other|0|||
23463997|NCT02699749|65441050|FG000|Overall Study|Progressive Disease|3|||
23463998|NCT02699749|65441051|FG001|Overall Study|Progressive Disease|3|||
23463999|NCT02699749|65441052|FG002|Overall Study|Progressive Disease|14|||
23464000|NCT02699749|65441053|FG003|Overall Study|Progressive Disease|3|||
23464001|NCT02699749|65441054|FG004|Overall Study|Progressive Disease|3|||
23464002|NCT02699749|65441055|FG005|Overall Study|Progressive Disease|7|||
23464003|NCT02699749|65441056|FG006|Overall Study|Progressive Disease|5|||
23464004|NCT02699749|65441057|FG007|Overall Study|Progressive Disease|5|||
23464005|NCT02699749|65441058|FG008|Overall Study|Progressive Disease|6|||
23464006|NCT02699749|65441059|FG009|Overall Study|Progressive Disease|6|||
23464007|NCT02699749|65441060|FG010|Overall Study|Progressive Disease|5|||
23464008|NCT02699749|65441061|FG011|Overall Study|Progressive Disease|4|||
23464009|NCT02699749|65441062|FG012|Overall Study|Progressive Disease|3|||
23464010|NCT02699749|65441063|FG013|Overall Study|Progressive Disease|5|||
23464011|NCT02699749|65441050|FG000|Overall Study|Death|0|||
23464012|NCT02699749|65441051|FG001|Overall Study|Death|0|||
23464013|NCT02699749|65441052|FG002|Overall Study|Death|0|||
23464014|NCT02699749|65441053|FG003|Overall Study|Death|0|||
23464015|NCT02699749|65441054|FG004|Overall Study|Death|0|||
23464016|NCT02699749|65441055|FG005|Overall Study|Death|0|||
23464017|NCT02699749|65441056|FG006|Overall Study|Death|0|||
23464018|NCT02699749|65441057|FG007|Overall Study|Death|0|||
23464019|NCT02699749|65441058|FG008|Overall Study|Death|0|||
23464020|NCT02699749|65441059|FG009|Overall Study|Death|0|||
23464021|NCT02699749|65441060|FG010|Overall Study|Death|0|||
23464022|NCT02699749|65441061|FG011|Overall Study|Death|0|||
23464023|NCT02699749|65441062|FG012|Overall Study|Death|0|||
23464024|NCT02699749|65441063|FG013|Overall Study|Death|1|||
23464025|NCT02699749|65441050|FG000|Overall Study|Lost to Follow-up|0|||
23464026|NCT02699749|65441051|FG001|Overall Study|Lost to Follow-up|0|||
23464027|NCT02699749|65441052|FG002|Overall Study|Lost to Follow-up|0|||
23464028|NCT02699749|65441053|FG003|Overall Study|Lost to Follow-up|0|||
23464029|NCT02699749|65441054|FG004|Overall Study|Lost to Follow-up|0|||
23464030|NCT02699749|65441055|FG005|Overall Study|Lost to Follow-up|1|||
23464031|NCT02699749|65441056|FG006|Overall Study|Lost to Follow-up|0|||
23464032|NCT02699749|65441057|FG007|Overall Study|Lost to Follow-up|1|||
23464033|NCT02699749|65441058|FG008|Overall Study|Lost to Follow-up|0|||
23464034|NCT02699749|65441059|FG009|Overall Study|Lost to Follow-up|0|||
23464035|NCT02699749|65441060|FG010|Overall Study|Lost to Follow-up|0|||
23464036|NCT02699749|65441061|FG011|Overall Study|Lost to Follow-up|0|||
23464037|NCT02699749|65441062|FG012|Overall Study|Lost to Follow-up|0|||
23464038|NCT02699749|65441063|FG013|Overall Study|Lost to Follow-up|0|||
23464039|NCT00976560|65441065|FG000|Overall Study|Adverse Event|5|||
23464040|NCT00976560|65441066|FG001|Overall Study|Adverse Event|5|||
23464041|NCT00976560|65441065|FG000|Overall Study|Lack of Efficacy|3|||
23464042|NCT00976560|65441066|FG001|Overall Study|Lack of Efficacy|5|||
23464043|NCT00976560|65441065|FG000|Overall Study|Protocol Violation|1|||
23464044|NCT00976560|65441066|FG001|Overall Study|Protocol Violation|0|||
23464045|NCT00976560|65441065|FG000|Overall Study|Lost to Follow-up|1|||
23464046|NCT00976560|65441066|FG001|Overall Study|Lost to Follow-up|0|||
23184018|NCT02764541|64413718|FG002|Overall Study|Withdrawal by Subject|0|||
23184019|NCT02764541|64413719|FG003|Overall Study|Withdrawal by Subject|0|||
23184020|NCT02764541|64413720|FG004|Overall Study|Withdrawal by Subject|1|||
23184021|NCT02764541|64413721|FG005|Overall Study|Withdrawal by Subject|1|||
23184022|NCT02764541|64413722|FG006|Overall Study|Withdrawal by Subject|0|||
23184023|NCT02764541|64413723|FG007|Overall Study|Withdrawal by Subject|1|||
23184024|NCT02764541|64413716|FG000|Overall Study|Adverse Event|1|||
23184025|NCT02764541|64413717|FG001|Overall Study|Adverse Event|0|||
23184026|NCT02764541|64413718|FG002|Overall Study|Adverse Event|0|||
23184027|NCT02764541|64413719|FG003|Overall Study|Adverse Event|0|||
23184028|NCT02764541|64413720|FG004|Overall Study|Adverse Event|0|||
23184029|NCT02764541|64413721|FG005|Overall Study|Adverse Event|0|||
23184030|NCT02764541|64413722|FG006|Overall Study|Adverse Event|1|||
23184031|NCT02764541|64413723|FG007|Overall Study|Adverse Event|0|||
23184032|NCT02764541|64413716|FG000|Overall Study|Metastasis|1|||
23184033|NCT02764541|64413717|FG001|Overall Study|Metastasis|0|||
23184034|NCT02764541|64413718|FG002|Overall Study|Metastasis|0|||
23184035|NCT02764541|64413719|FG003|Overall Study|Metastasis|0|||
23184036|NCT02764541|64413720|FG004|Overall Study|Metastasis|0|||
23184037|NCT02764541|64413721|FG005|Overall Study|Metastasis|0|||
23184038|NCT02764541|64413722|FG006|Overall Study|Metastasis|0|||
23184039|NCT02764541|64413723|FG007|Overall Study|Metastasis|0|||
23184040|NCT02764541|64413716|FG000|Overall Study|Disease progression|1|||
23184041|NCT02764541|64413717|FG001|Overall Study|Disease progression|1|||
23184042|NCT02764541|64413718|FG002|Overall Study|Disease progression|0|||
23184043|NCT02764541|64413719|FG003|Overall Study|Disease progression|0|||
23184044|NCT02764541|64413720|FG004|Overall Study|Disease progression|0|||
23184045|NCT02764541|64413721|FG005|Overall Study|Disease progression|0|||
23184046|NCT02764541|64413722|FG006|Overall Study|Disease progression|0|||
23184047|NCT02764541|64413723|FG007|Overall Study|Disease progression|1|||
23184048|NCT02764541|64413716|FG000|Overall Study|Protocol Violation|0|||
23184049|NCT02764541|64413717|FG001|Overall Study|Protocol Violation|0|||
23184050|NCT02764541|64413718|FG002|Overall Study|Protocol Violation|0|||
23184051|NCT02764541|64413719|FG003|Overall Study|Protocol Violation|1|||
23184052|NCT02764541|64413720|FG004|Overall Study|Protocol Violation|0|||
23184053|NCT02764541|64413721|FG005|Overall Study|Protocol Violation|1|||
23184054|NCT02764541|64413722|FG006|Overall Study|Protocol Violation|0|||
23184055|NCT02764541|64413723|FG007|Overall Study|Protocol Violation|0|||
23184056|NCT02764541|64413716|FG000|Overall Study|Physician Decision|0|||
23350269|NCT01273155|65025399|FG003|Overall Study|Change in liver function/no longer eval.|0|||
23464047|NCT00976560|65441065|FG000|Overall Study|Physician Decision|2|||
23464048|NCT00976560|65441066|FG001|Overall Study|Physician Decision|0|||
23464049|NCT00976560|65441065|FG000|Overall Study|Withdrawal by Subject|2|||
23464050|NCT00976560|65441066|FG001|Overall Study|Withdrawal by Subject|3|||
23464051|NCT03125395|65441067|FG000|Overall Study|Adverse Event|2|||
23184057|NCT02764541|64413717|FG001|Overall Study|Physician Decision|0|||
23184058|NCT02764541|64413718|FG002|Overall Study|Physician Decision|0|||
23184059|NCT02764541|64413719|FG003|Overall Study|Physician Decision|1|||
23184060|NCT02764541|64413720|FG004|Overall Study|Physician Decision|0|||
23464052|NCT03125395|65441067|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
23464053|NCT03125395|65441067|FG000|Overall Study|Physician Decision|2|||
23184061|NCT02764541|64413721|FG005|Overall Study|Physician Decision|0|||
23184062|NCT02764541|64413722|FG006|Overall Study|Physician Decision|0|||
23184063|NCT02764541|64413723|FG007|Overall Study|Physician Decision|1|||
23464054|NCT03125395|65441067|FG000|Overall Study|Commercial drug is available|5|||
23184064|NCT02764541|64413716|FG000|Overall Study|Three Cycles completed before surgery|0|||
23184065|NCT02764541|64413717|FG001|Overall Study|Three Cycles completed before surgery|0|||
23184066|NCT02764541|64413718|FG002|Overall Study|Three Cycles completed before surgery|0|||
23184067|NCT02764541|64413719|FG003|Overall Study|Three Cycles completed before surgery|1|||
23184068|NCT02764541|64413720|FG004|Overall Study|Three Cycles completed before surgery|0|||
23184069|NCT02764541|64413721|FG005|Overall Study|Three Cycles completed before surgery|0|||
23184070|NCT02764541|64413722|FG006|Overall Study|Three Cycles completed before surgery|0|||
23184071|NCT02764541|64413723|FG007|Overall Study|Three Cycles completed before surgery|0|||
23184072|NCT02764541|64413716|FG000|Overall Study|Patient Compliance|0|||
23184073|NCT02764541|64413717|FG001|Overall Study|Patient Compliance|0|||
23184074|NCT02764541|64413718|FG002|Overall Study|Patient Compliance|1|||
23184075|NCT02764541|64413719|FG003|Overall Study|Patient Compliance|0|||
23184076|NCT02764541|64413720|FG004|Overall Study|Patient Compliance|0|||
23184077|NCT02764541|64413721|FG005|Overall Study|Patient Compliance|0|||
23184078|NCT02764541|64413722|FG006|Overall Study|Patient Compliance|0|||
23184079|NCT02764541|64413723|FG007|Overall Study|Patient Compliance|0|||
23184080|NCT02764541|64413716|FG000|Overall Study|Death|0|||
23184081|NCT02764541|64413717|FG001|Overall Study|Death|0|||
23184082|NCT02764541|64413718|FG002|Overall Study|Death|0|||
23184083|NCT02764541|64413719|FG003|Overall Study|Death|0|||
23184084|NCT02764541|64413720|FG004|Overall Study|Death|0|||
23184085|NCT02764541|64413721|FG005|Overall Study|Death|0|||
23184086|NCT02764541|64413722|FG006|Overall Study|Death|1|||
23184087|NCT02764541|64413723|FG007|Overall Study|Death|0|||
23184088|NCT02764541|64413716|FG000|Overall Study|Insurance reasons|0|||
23184089|NCT02764541|64413717|FG001|Overall Study|Insurance reasons|0|||
23184090|NCT02764541|64413718|FG002|Overall Study|Insurance reasons|0|||
23350270|NCT01273155|65025400|FG004|Overall Study|Change in liver function/no longer eval.|1|||
23350271|NCT01273155|65025401|FG005|Overall Study|Change in liver function/no longer eval.|0|||
23350272|NCT01273155|65025402|FG006|Overall Study|Change in liver function/no longer eval.|0|||
23350273|NCT01273155|65025396|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
23350274|NCT01273155|65025397|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
23350275|NCT01273155|65025398|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
23350276|NCT01273155|65025399|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
23350277|NCT01273155|65025400|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
23350278|NCT01273155|65025401|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
23350279|NCT01273155|65025402|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
23350280|NCT01273155|65025396|FG000|Overall Study|Died during Cycle 1|0|||
23350281|NCT01273155|65025397|FG001|Overall Study|Died during Cycle 1|0|||
23350282|NCT01273155|65025398|FG002|Overall Study|Died during Cycle 1|1|||
23350283|NCT01273155|65025399|FG003|Overall Study|Died during Cycle 1|1|||
23350284|NCT01273155|65025400|FG004|Overall Study|Died during Cycle 1|0|||
23350285|NCT01273155|65025401|FG005|Overall Study|Died during Cycle 1|2|||
23350286|NCT01273155|65025402|FG006|Overall Study|Died during Cycle 1|2|||
23350287|NCT01273155|65025396|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
23350288|NCT01273155|65025397|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
23184091|NCT02764541|64413719|FG003|Overall Study|Insurance reasons|0|||
23184092|NCT02764541|64413720|FG004|Overall Study|Insurance reasons|0|||
23585012|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Death|2|||
23184093|NCT02764541|64413721|FG005|Overall Study|Insurance reasons|0|||
23184094|NCT02764541|64413722|FG006|Overall Study|Insurance reasons|1|||
23184095|NCT02764541|64413723|FG007|Overall Study|Insurance reasons|0|||
23585013|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
23184096|NCT02909153|64413724|FG000|Overall Study|Withdrawal by Subject|0|||
23242715|NCT03290131|64633016|FG002|Overall Study|MS Relapse|0|||
23242716|NCT03290131|64633014|FG000|Overall Study|Unknown reason|0|||
23242717|NCT03290131|64633015|FG001|Overall Study|Unknown reason|1|||
23242718|NCT03290131|64633016|FG002|Overall Study|Unknown reason|0|||
23242719|NCT00437294|64633019|FG000|Overall Study|Adverse Event|5|||
23242720|NCT00437294|64633020|FG001|Overall Study|Adverse Event|4|||
23242721|NCT00437294|64633019|FG000|Overall Study|Death|5|||
23242722|NCT00437294|64633020|FG001|Overall Study|Death|2|||
23350289|NCT01273155|65025398|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
23350290|NCT01273155|65025399|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
23184097|NCT02909153|64413725|FG001|Overall Study|Withdrawal by Subject|1|||
23184098|NCT02909153|64413726|FG002|Overall Study|Withdrawal by Subject|0|||
23184099|NCT02909153|64413727|FG003|Overall Study|Withdrawal by Subject|0|||
23184100|NCT02909153|64413728|FG004|Overall Study|Withdrawal by Subject|0|||
23184101|NCT01085682|64413729|FG000|Overall Study|Withdrawal by Subject|25|||
23184102|NCT01085682|64413730|FG001|Overall Study|Withdrawal by Subject|25|||
23184103|NCT01974817|64413731|FG000|Overall Study|Death|4|||
23184104|NCT01974817|64413731|FG000|Overall Study|Lost to Follow-up|2|||
23242723|NCT00437294|64633019|FG000|Overall Study|Physician Decision|0|||
23242724|NCT00437294|64633020|FG001|Overall Study|Physician Decision|3|||
23242725|NCT00437294|64633019|FG000|Overall Study|Withdrawal by Subject|5|||
23184105|NCT01974817|64413731|FG000|Overall Study|Protocol Violation|2|||
23184106|NCT00238264|64413732|FG000|Overall Study|Death|7|||
23184107|NCT00238264|64413732|FG000|Overall Study|Lost to Follow-up|18|||
23184108|NCT00238264|64413732|FG000|Overall Study|Withdrawal by Subject|4|||
23184109|NCT00238264|64413732|FG000|Overall Study|Ineligible|7|||
23184110|NCT03617705|64413736|FG000|Overall Study|Withdrawal by Subject|2|||
23350291|NCT01273155|65025400|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
23350292|NCT01273155|65025401|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
23350293|NCT01273155|65025402|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
23350294|NCT00424021|65025405|FG000|NCT00046319 Study Period|Adverse Event|1|||
23464055|NCT02976038|65441068|FG000|Overall Study|Physician Decision|22|||
23464056|NCT02976038|65441068|FG000|Overall Study|Withdrawal by Subject|3|||
23464057|NCT02976038|65441068|FG000|Overall Study|Lost to Follow-up|2|||
23464058|NCT02976038|65441068|FG000|Overall Study|Adverse Event|1|||
23464059|NCT04085289|65441069|FG000|Overall Study|Withdrawal by Subject|0|||
23464060|NCT04085289|65441070|FG001|Overall Study|Withdrawal by Subject|0|||
23464061|NCT04085289|65441071|FG002|Overall Study|Withdrawal by Subject|1|||
23464062|NCT04411667|65441074|FG000|Overall Study|Physician Decision|1|||
23464063|NCT04411667|65441075|FG001|Overall Study|Physician Decision|0|||
23464064|NCT03304626|65441076|FG000|Overall Study|Adverse Event|1|||
23585014|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
23585015|NCT02403674|65869358|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
23585016|NCT02403674|65869359|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
23585017|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
23585018|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
23585019|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
23585020|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
23585021|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
23585022|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
23585023|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
23585024|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
23585025|NCT02403674|65869358|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
23585026|NCT02403674|65869359|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
23585027|NCT02750709|65869360|FG000|Treatment Period 1|Adverse Event|0|||
23585028|NCT02750709|65869361|FG001|Treatment Period 1|Adverse Event|0|||
23585029|NCT02750709|65869362|FG002|Treatment Period 1|Adverse Event|0|||
23585030|NCT02750709|65869363|FG003|Treatment Period 1|Adverse Event|0|||
23585031|NCT02750709|65869364|FG004|Treatment Period 1|Adverse Event|0|||
23585032|NCT02750709|65869365|FG005|Treatment Period 1|Adverse Event|1|||
23585033|NCT01710514|65869366|FG000|Overall Study|Adverse Event|6|||
23585034|NCT01710514|65869367|FG001|Overall Study|Adverse Event|7|||
23585035|NCT01710514|65869366|FG000|Overall Study|Withdrawal by Subject|1|||
23585036|NCT01710514|65869367|FG001|Overall Study|Withdrawal by Subject|0|||
23585037|NCT01362491|65869370|FG000|Overall Study|Ineligible|1|||
23585038|NCT01362491|65869371|FG001|Overall Study|Ineligible|0|||
23585039|NCT01362491|65869372|FG002|Overall Study|Ineligible|0|||
23585040|NCT01280591|65869376|FG000|Overall Study|Withdrawal by Subject|0|||
23585041|NCT01280591|65869377|FG001|Overall Study|Withdrawal by Subject|0|||
23585042|NCT01280591|65869378|FG002|Overall Study|Withdrawal by Subject|0|||
23350295|NCT00424021|65025406|FG001|NCT00046319 Study Period|Adverse Event|0|||
23350296|NCT00424021|65025407|FG002|NCT00046319 Study Period|Adverse Event|1|||
23585043|NCT01280591|65869379|FG003|Overall Study|Withdrawal by Subject|2|||
23585044|NCT01280591|65869376|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
23585045|NCT01280591|65869377|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
23184111|NCT03617705|64413736|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
23184112|NCT03617705|64413736|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
23184113|NCT02966314|64413737|FG000|Overall Study|Lost to Follow-up|1|||
23184114|NCT02966314|64413738|FG001|Overall Study|Lost to Follow-up|0|||
23184115|NCT01075178|64413739|FG000|Subject Matching|eligible but not matched|130|||
23184116|NCT01075178|64413740|FG001|Subject Matching|eligible but not matched|403|||
23184117|NCT01075178|64413739|FG000|Subject Chart Review|died before chart review period|0|||
23184118|NCT01075178|64413740|FG001|Subject Chart Review|died before chart review period|2|||
23184119|NCT01075178|64413739|FG000|Subject Chart Review|no data collected due to site closure|3|||
23184120|NCT01075178|64413740|FG001|Subject Chart Review|no data collected due to site closure|4|||
23184121|NCT01075178|64413739|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
23184122|NCT01075178|64413740|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
23464065|NCT03304626|65441077|FG001|Overall Study|Adverse Event|0|||
23464066|NCT03304626|65441076|FG000|Overall Study|Lack of Efficacy|1|||
23184123|NCT04439903|64413743|FG000|Overall Study|Withdrawal by Subject|2|||
23464067|NCT03304626|65441077|FG001|Overall Study|Lack of Efficacy|1|||
23585046|NCT01280591|65869378|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
23585047|NCT01280591|65869379|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
23585048|NCT05512949|65869380|FG000|Overall Study|Lost to Follow-up|4|||
23184124|NCT04439903|64413743|FG000|Overall Study|Screen Failure|1|||
23184125|NCT01591330|64413746|FG000|Period 1|Adverse Event|1|||
23184126|NCT01591330|64413747|FG001|Period 1|Adverse Event|0|||
23184127|NCT01591330|64413748|FG002|Period 1|Adverse Event|0|||
23184128|NCT01591330|64413749|FG003|Period 1|Adverse Event|0|||
23242726|NCT00437294|64633020|FG001|Overall Study|Withdrawal by Subject|0|||
23242727|NCT00437294|64633019|FG000|Overall Study|Progressive Disease|19|||
23350297|NCT00424021|65025408|FG003|NCT00046319 Study Period|Adverse Event|1|||
23350298|NCT00424021|65025405|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
23350299|NCT00424021|65025406|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
23350300|NCT00424021|65025407|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
23350301|NCT00424021|65025408|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
23350302|NCT00424021|65025405|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
23350303|NCT00424021|65025406|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
23350304|NCT00424021|65025407|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
23350305|NCT00424021|65025408|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
23350306|NCT00424021|65025405|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
23350307|NCT00424021|65025406|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
23350308|NCT00424021|65025407|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
23350309|NCT00424021|65025408|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
23350310|NCT00424021|65025405|FG000|AMB-220-E Study Period|Adverse Event|1|||
23464068|NCT03337477|65441078|FG000|Overall Study|not categorized into the listed ones|11|||
23464069|NCT03337477|65441079|FG001|Overall Study|not categorized into the listed ones|9|||
23464070|NCT03337477|65441078|FG000|Overall Study|Withdrawal by Subject|0|||
23464071|NCT03337477|65441079|FG001|Overall Study|Withdrawal by Subject|1|||
23242728|NCT00437294|64633020|FG001|Overall Study|Progressive Disease|23|||
23242729|NCT00437294|64633019|FG000|Overall Study|Sponsor Decision|8|||
23464072|NCT03337477|65441078|FG000|Overall Study|Death|0|||
23464073|NCT03337477|65441079|FG001|Overall Study|Death|1|||
23242730|NCT00437294|64633020|FG001|Overall Study|Sponsor Decision|9|||
23242731|NCT00437294|64633019|FG000|Overall Study|Protocol Violation|0|||
23242732|NCT00437294|64633020|FG001|Overall Study|Protocol Violation|1|||
23242733|NCT00437294|64633019|FG000|Overall Study|Entry criteria not met|1|||
23242734|NCT00437294|64633020|FG001|Overall Study|Entry criteria not met|1|||
23585049|NCT05512949|65869381|FG001|Overall Study|Lost to Follow-up|6|||
23585050|NCT05512949|65869382|FG002|Overall Study|Lost to Follow-up|2|||
23184129|NCT01591330|64413746|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
23184130|NCT01591330|64413747|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
23184131|NCT01591330|64413748|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
23184132|NCT01591330|64413749|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
23184133|NCT01591330|64413746|FG000|Period 2|Adverse Event|1|||
23184134|NCT01591330|64413747|FG001|Period 2|Adverse Event|0|||
23184135|NCT01591330|64413748|FG002|Period 2|Adverse Event|0|||
23184136|NCT01591330|64413749|FG003|Period 2|Adverse Event|0|||
23184137|NCT01454076|64413750|FG000|Overall Study|Other|2|||
23184138|NCT01454076|64413751|FG001|Overall Study|Other|0|||
23184139|NCT01454076|64413752|FG002|Overall Study|Other|0|||
23184140|NCT01454076|64413753|FG003|Overall Study|Other|1|||
23184141|NCT01454076|64413754|FG004|Overall Study|Other|2|||
23184142|NCT01454076|64413750|FG000|Overall Study|Withdrawal by Subject|3|||
23184143|NCT01454076|64413751|FG001|Overall Study|Withdrawal by Subject|4|||
23184144|NCT01454076|64413752|FG002|Overall Study|Withdrawal by Subject|2|||
23184145|NCT01454076|64413753|FG003|Overall Study|Withdrawal by Subject|1|||
23184146|NCT01454076|64413754|FG004|Overall Study|Withdrawal by Subject|2|||
23184147|NCT01454076|64413750|FG000|Overall Study|Adverse Event|8|||
23184148|NCT01454076|64413751|FG001|Overall Study|Adverse Event|2|||
23184149|NCT01454076|64413752|FG002|Overall Study|Adverse Event|7|||
23184150|NCT01454076|64413753|FG003|Overall Study|Adverse Event|0|||
23184151|NCT01454076|64413754|FG004|Overall Study|Adverse Event|2|||
23184152|NCT02292849|64413757|FG000|Overall Study|Lost to Follow-up|0|||
23184153|NCT02292849|64413758|FG001|Overall Study|Lost to Follow-up|2|||
23184154|NCT02292849|64413759|FG002|Overall Study|Lost to Follow-up|2|||
23184155|NCT02292849|64413757|FG000|Overall Study|Physician Decision|4|||
23184156|NCT02292849|64413758|FG001|Overall Study|Physician Decision|0|||
23184157|NCT02292849|64413759|FG002|Overall Study|Physician Decision|0|||
23184158|NCT03304522|64413763|FG000|Overall Study|Adverse Event|0|||
23184159|NCT03304522|64413764|FG001|Overall Study|Adverse Event|4|||
23184160|NCT03304522|64413763|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
23184161|NCT03304522|64413764|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
23184162|NCT03304522|64413763|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
23184163|NCT03304522|64413764|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
23242735|NCT02508649|64633023|FG000|Overall Study|Withdrawal by Subject|4|||
23350311|NCT00424021|65025406|FG001|AMB-220-E Study Period|Adverse Event|1|||
23585051|NCT05512949|65869380|FG000|Overall Study|Protocol Violation|0|||
23184164|NCT03304522|64413763|FG000|Overall Study|Other|0|||
23184165|NCT03304522|64413764|FG001|Overall Study|Other|1|||
23184166|NCT02601573|64413773|FG000|Overall Study|Lost to Follow-up|0|||
23350312|NCT00424021|65025407|FG002|AMB-220-E Study Period|Adverse Event|3|||
23350313|NCT00424021|65025408|FG003|AMB-220-E Study Period|Adverse Event|7|||
23350314|NCT00424021|65025405|FG000|AMB-220-E Study Period|Death|0|||
23350315|NCT00424021|65025406|FG001|AMB-220-E Study Period|Death|0|||
23350316|NCT00424021|65025407|FG002|AMB-220-E Study Period|Death|1|||
23350317|NCT00424021|65025408|FG003|AMB-220-E Study Period|Death|1|||
23350318|NCT00424021|65025405|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
23350319|NCT00424021|65025406|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
23350320|NCT00424021|65025407|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
23350321|NCT00424021|65025408|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
23350322|NCT00424021|65025405|FG000|AMB-220-E Study Period|Physician Decision|0|||
23350323|NCT00424021|65025406|FG001|AMB-220-E Study Period|Physician Decision|0|||
23350324|NCT00424021|65025407|FG002|AMB-220-E Study Period|Physician Decision|0|||
23350325|NCT00424021|65025408|FG003|AMB-220-E Study Period|Physician Decision|1|||
23350326|NCT01237327|65025409|FG000|Overall Study|Protocol Violation: Core Study|1|||
23350327|NCT01237327|65025410|FG001|Overall Study|Protocol Violation: Core Study|0|||
23350328|NCT01237327|65025409|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
23350329|NCT01237327|65025410|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
23350330|NCT01237327|65025409|FG000|Overall Study|Progression of Disease: Core Study|18|||
23350331|NCT01237327|65025410|FG001|Overall Study|Progression of Disease: Core Study|22|||
23350332|NCT01237327|65025409|FG000|Overall Study|Progression of Disease: Extension Study|15|||
23350333|NCT01237327|65025410|FG001|Overall Study|Progression of Disease: Extension Study|13|||
23350334|NCT01237327|65025409|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
23350335|NCT01237327|65025410|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
23350336|NCT01237327|65025409|FG000|Overall Study|Withdrawal by Subject|1|||
23350337|NCT01237327|65025410|FG001|Overall Study|Withdrawal by Subject|3|||
23350338|NCT01237327|65025409|FG000|Overall Study|Lost to Follow-up|3|||
23350339|NCT01237327|65025410|FG001|Overall Study|Lost to Follow-up|0|||
23350340|NCT00630747|65025414|FG000|Overall Study|Death|1|||
23350341|NCT00630747|65025414|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
23350342|NCT00630747|65025414|FG000|Overall Study|Returned to country of origin|1|||
23464074|NCT03337477|65441078|FG000|Overall Study|Lost to Follow-up|0|||
23464075|NCT03337477|65441079|FG001|Overall Study|Lost to Follow-up|2|||
23464076|NCT02266888|65441084|FG000|Overall Study|Death|2|||
23464077|NCT02266888|65441085|FG001|Overall Study|Death|2|||
23464078|NCT02266888|65441086|FG002|Overall Study|Death|4|||
23464079|NCT02266888|65441087|FG003|Overall Study|Death|2|||
23464080|NCT02266888|65441084|FG000|Overall Study|Physician Decision|0|||
23464081|NCT02266888|65441085|FG001|Overall Study|Physician Decision|1|||
23464082|NCT02266888|65441086|FG002|Overall Study|Physician Decision|2|||
23464083|NCT02266888|65441087|FG003|Overall Study|Physician Decision|2|||
23464084|NCT02266888|65441084|FG000|Overall Study|Study Terminated|5|||
23184167|NCT02601573|64413774|FG001|Overall Study|Lost to Follow-up|3|||
23184168|NCT02601573|64413775|FG002|Overall Study|Lost to Follow-up|1|||
23184169|NCT02601573|64413776|FG003|Overall Study|Lost to Follow-up|0|||
23184170|NCT02601573|64413777|FG004|Overall Study|Lost to Follow-up|2|||
23184171|NCT02601573|64413773|FG000|Overall Study|Withdrawal by Subject|0|||
23184172|NCT02601573|64413774|FG001|Overall Study|Withdrawal by Subject|1|||
23184173|NCT02601573|64413775|FG002|Overall Study|Withdrawal by Subject|0|||
23184174|NCT02601573|64413776|FG003|Overall Study|Withdrawal by Subject|1|||
23184175|NCT02601573|64413777|FG004|Overall Study|Withdrawal by Subject|0|||
23184176|NCT00811252|64413778|FG000|Overall Study|Adverse Event|6|||
23184177|NCT00811252|64413779|FG001|Overall Study|Adverse Event|10|||
23184178|NCT00811252|64413780|FG002|Overall Study|Adverse Event|15|||
23464085|NCT02266888|65441085|FG001|Overall Study|Study Terminated|1|||
23464086|NCT02266888|65441086|FG002|Overall Study|Study Terminated|0|||
23464087|NCT02266888|65441087|FG003|Overall Study|Study Terminated|0|||
23464088|NCT02266888|65441084|FG000|Overall Study|No Longer Eligible|0|||
23464089|NCT02266888|65441085|FG001|Overall Study|No Longer Eligible|0|||
23464090|NCT02266888|65441086|FG002|Overall Study|No Longer Eligible|0|||
23464091|NCT02266888|65441087|FG003|Overall Study|No Longer Eligible|2|||
23464092|NCT02266888|65441084|FG000|Overall Study|Randomization Closed|0|||
23464093|NCT02266888|65441085|FG001|Overall Study|Randomization Closed|0|||
23464094|NCT02266888|65441086|FG002|Overall Study|Randomization Closed|4|||
23464095|NCT02266888|65441087|FG003|Overall Study|Randomization Closed|0|||
23184179|NCT00811252|64413778|FG000|Overall Study|Lack of Efficacy|7|||
23184180|NCT00811252|64413779|FG001|Overall Study|Lack of Efficacy|2|||
23350343|NCT00078949|65025415|FG000|Overall Study|No treated|4|||
23350344|NCT00078949|65025416|FG001|Overall Study|No treated|5|||
23350345|NCT00078949|65025417|FG002|Overall Study|No treated|3|||
23350346|NCT00078949|65025418|FG003|Overall Study|No treated|3|||
23350347|NCT04526574|65025421|FG000|Overall Study|Protocol Violation|3|||
23464096|NCT02266888|65441084|FG000|Overall Study|Personnel unavailable at transplant|0|||
23184181|NCT00811252|64413780|FG002|Overall Study|Lack of Efficacy|0|||
23184182|NCT00811252|64413778|FG000|Overall Study|Protocol Violation|3|||
23585052|NCT05512949|65869381|FG001|Overall Study|Protocol Violation|0|||
23350348|NCT04526574|65025422|FG001|Overall Study|Protocol Violation|1|||
23184183|NCT00811252|64413779|FG001|Overall Study|Protocol Violation|3|||
23184184|NCT00811252|64413780|FG002|Overall Study|Protocol Violation|2|||
23350349|NCT04526574|65025421|FG000|Overall Study|Withdrawal by Subject|12|||
23350350|NCT04526574|65025422|FG001|Overall Study|Withdrawal by Subject|9|||
23350351|NCT04526574|65025421|FG000|Overall Study|Other|1|||
23350352|NCT04526574|65025422|FG001|Overall Study|Other|2|||
23350353|NCT04526574|65025421|FG000|Overall Study|Adverse Event|1|||
23350354|NCT04526574|65025422|FG001|Overall Study|Adverse Event|1|||
23350355|NCT04526574|65025421|FG000|Overall Study|Death|2|||
23350356|NCT04526574|65025422|FG001|Overall Study|Death|3|||
23350357|NCT04526574|65025421|FG000|Overall Study|Lost to Follow-up|9|||
23350358|NCT04526574|65025422|FG001|Overall Study|Lost to Follow-up|9|||
23350359|NCT04526574|65025421|FG000|Overall Study|No longer meets eligibility criteria|8|||
23350360|NCT04526574|65025422|FG001|Overall Study|No longer meets eligibility criteria|8|||
23350361|NCT00290693|65025423|FG000|Overall Study|Withdrawal by Subject|2|||
23350362|NCT00986986|65025424|FG000|Overall Study|Lost to Follow-up|0|||
23350363|NCT00986986|65025425|FG001|Overall Study|Lost to Follow-up|1|||
23350364|NCT00821015|65025432|FG000|Overall Study|Lost to Follow-up|12|||
23350365|NCT01043705|65025433|FG000|Overall Study|Death|28|||
23350366|NCT01043705|65025434|FG001|Overall Study|Death|60|||
23350367|NCT01043705|65025435|FG002|Overall Study|Death|26|||
23350368|NCT01043705|65025433|FG000|Overall Study|Lost to Follow-up|27|||
23350369|NCT01043705|65025434|FG001|Overall Study|Lost to Follow-up|12|||
23350370|NCT01043705|65025435|FG002|Overall Study|Lost to Follow-up|0|||
23350371|NCT01043705|65025433|FG000|Overall Study|Multiple Reasons|4|||
23350372|NCT01043705|65025434|FG001|Overall Study|Multiple Reasons|7|||
23350373|NCT01043705|65025435|FG002|Overall Study|Multiple Reasons|0|||
23464097|NCT02266888|65441085|FG001|Overall Study|Personnel unavailable at transplant|0|||
23242736|NCT02508649|64633024|FG001|Overall Study|Withdrawal by Subject|6|||
23242737|NCT02508649|64633025|FG002|Overall Study|Withdrawal by Subject|5|||
23242738|NCT02508649|64633026|FG003|Overall Study|Withdrawal by Subject|6|||
23242739|NCT02508649|64633023|FG000|Overall Study|Investigator withdrew the subject|1|||
23242740|NCT02508649|64633024|FG001|Overall Study|Investigator withdrew the subject|2|||
23242741|NCT02508649|64633025|FG002|Overall Study|Investigator withdrew the subject|1|||
23242742|NCT02508649|64633026|FG003|Overall Study|Investigator withdrew the subject|0|||
23242743|NCT02508649|64633023|FG000|Overall Study|Post randomization screening failure|12|||
23242744|NCT02508649|64633024|FG001|Overall Study|Post randomization screening failure|4|||
23242745|NCT02508649|64633025|FG002|Overall Study|Post randomization screening failure|9|||
23242746|NCT02508649|64633026|FG003|Overall Study|Post randomization screening failure|3|||
23242747|NCT02508649|64633023|FG000|Overall Study|Lost to Follow-up|1|||
23350374|NCT01043705|65025433|FG000|Overall Study|Protocol Violation|2|||
23464098|NCT02266888|65441086|FG002|Overall Study|Personnel unavailable at transplant|0|||
23350375|NCT01043705|65025434|FG001|Overall Study|Protocol Violation|1|||
23350376|NCT01043705|65025435|FG002|Overall Study|Protocol Violation|0|||
23350377|NCT01043705|65025433|FG000|Overall Study|Withdrawal by Subject|8|||
23350378|NCT01043705|65025434|FG001|Overall Study|Withdrawal by Subject|6|||
23464099|NCT02266888|65441087|FG003|Overall Study|Personnel unavailable at transplant|1|||
23184185|NCT00811252|64413778|FG000|Overall Study|Withdrawal of Consent|1|||
23184186|NCT00811252|64413779|FG001|Overall Study|Withdrawal of Consent|2|||
23184187|NCT00811252|64413780|FG002|Overall Study|Withdrawal of Consent|2|||
23184188|NCT00811252|64413778|FG000|Overall Study|Lost to Follow-up|0|||
23184189|NCT00811252|64413779|FG001|Overall Study|Lost to Follow-up|0|||
23184190|NCT00811252|64413780|FG002|Overall Study|Lost to Follow-up|2|||
23184191|NCT00811252|64413778|FG000|Overall Study|Administrative or Other Reasons|0|||
23184192|NCT00811252|64413779|FG001|Overall Study|Administrative or Other Reasons|3|||
23184193|NCT00811252|64413780|FG002|Overall Study|Administrative or Other Reasons|2|||
23350379|NCT01043705|65025435|FG002|Overall Study|Withdrawal by Subject|0|||
23350380|NCT01043705|65025433|FG000|Overall Study|Site Closure|8|||
23464100|NCT02266888|65441084|FG000|Overall Study|Transfer of care|0|||
23184194|NCT00935883|64413781|FG000|Treatment Period|Physician Decision|1|||
23184195|NCT00935883|64413782|FG001|Treatment Period|Physician Decision|0|||
23184196|NCT00935883|64413781|FG000|Treatment Period|Withdrawal by Subject|0|||
23184197|NCT00935883|64413782|FG001|Treatment Period|Withdrawal by Subject|2|||
23242748|NCT02508649|64633024|FG001|Overall Study|Lost to Follow-up|1|||
23242749|NCT02508649|64633025|FG002|Overall Study|Lost to Follow-up|0|||
23242750|NCT02508649|64633026|FG003|Overall Study|Lost to Follow-up|1|||
23242751|NCT01071278|64633027|FG000|Overall Study|Premature Discontinuation|254|||
23242752|NCT01071278|64633027|FG000|Overall Study|Completion Status Unknown|459|||
23242753|NCT00572910|64633030|FG000|Overall Study|Adverse Event|1|||
23350381|NCT01043705|65025434|FG001|Overall Study|Site Closure|0|||
23350382|NCT01043705|65025435|FG002|Overall Study|Site Closure|0|||
23350383|NCT01043705|65025433|FG000|Overall Study|Subsequent Procedure|9|||
23350384|NCT01043705|65025434|FG001|Overall Study|Subsequent Procedure|24|||
23350385|NCT01043705|65025435|FG002|Overall Study|Subsequent Procedure|29|||
23350386|NCT01043705|65025433|FG000|Overall Study|Adverse Event|0|||
23350387|NCT01043705|65025434|FG001|Overall Study|Adverse Event|2|||
23242754|NCT00572910|64633031|FG001|Overall Study|Adverse Event|2|||
23242755|NCT00572910|64633032|FG002|Overall Study|Adverse Event|0|||
23242756|NCT00572910|64633033|FG003|Overall Study|Adverse Event|2|||
23242757|NCT00572910|64633034|FG004|Overall Study|Adverse Event|0|||
23242758|NCT00572910|64633035|FG005|Overall Study|Adverse Event|0|||
23350388|NCT01043705|65025435|FG002|Overall Study|Adverse Event|0|||
23350389|NCT01043705|65025433|FG000|Overall Study|Screen Fail|21|||
23350390|NCT01043705|65025434|FG001|Overall Study|Screen Fail|0|||
23350391|NCT01043705|65025435|FG002|Overall Study|Screen Fail|0|||
23242759|NCT00572910|64633036|FG006|Overall Study|Adverse Event|4|||
23242760|NCT00572910|64633037|FG007|Overall Study|Adverse Event|2|||
23242761|NCT00572910|64633038|FG008|Overall Study|Adverse Event|1|||
23242762|NCT00572910|64633039|FG009|Overall Study|Adverse Event|3|||
23242763|NCT00572910|64633040|FG010|Overall Study|Adverse Event|2|||
23242764|NCT00572910|64633030|FG000|Overall Study|Lost to Follow-up|0|||
23242765|NCT00572910|64633031|FG001|Overall Study|Lost to Follow-up|1|||
23242766|NCT00572910|64633032|FG002|Overall Study|Lost to Follow-up|1|||
23242767|NCT00572910|64633033|FG003|Overall Study|Lost to Follow-up|2|||
23242768|NCT00572910|64633034|FG004|Overall Study|Lost to Follow-up|1|||
23242769|NCT00572910|64633035|FG005|Overall Study|Lost to Follow-up|0|||
23242770|NCT00572910|64633036|FG006|Overall Study|Lost to Follow-up|0|||
23242771|NCT00572910|64633037|FG007|Overall Study|Lost to Follow-up|0|||
23242772|NCT00572910|64633038|FG008|Overall Study|Lost to Follow-up|0|||
23242773|NCT00572910|64633039|FG009|Overall Study|Lost to Follow-up|1|||
23242774|NCT00572910|64633040|FG010|Overall Study|Lost to Follow-up|0|||
23242775|NCT00572910|64633030|FG000|Overall Study|Withdrawal by Subject|3|||
23242776|NCT00572910|64633031|FG001|Overall Study|Withdrawal by Subject|0|||
23242777|NCT00572910|64633032|FG002|Overall Study|Withdrawal by Subject|1|||
23242778|NCT00572910|64633033|FG003|Overall Study|Withdrawal by Subject|0|||
23242779|NCT00572910|64633034|FG004|Overall Study|Withdrawal by Subject|1|||
23242780|NCT00572910|64633035|FG005|Overall Study|Withdrawal by Subject|3|||
23242781|NCT00572910|64633036|FG006|Overall Study|Withdrawal by Subject|0|||
23242782|NCT00572910|64633037|FG007|Overall Study|Withdrawal by Subject|2|||
23242783|NCT00572910|64633038|FG008|Overall Study|Withdrawal by Subject|2|||
23242784|NCT00572910|64633039|FG009|Overall Study|Withdrawal by Subject|2|||
23242785|NCT00572910|64633040|FG010|Overall Study|Withdrawal by Subject|1|||
23242786|NCT00807040|64633041|FG000|Overall Study|Death|24|||
23242787|NCT00807040|64633042|FG001|Overall Study|Death|29|||
23242788|NCT00807040|64633041|FG000|Overall Study|Withdrawal by Subject|8|||
23242789|NCT00807040|64633042|FG001|Overall Study|Withdrawal by Subject|6|||
23242790|NCT00807040|64633041|FG000|Overall Study|Lost to Follow-up|4|||
23242791|NCT00807040|64633042|FG001|Overall Study|Lost to Follow-up|6|||
23242792|NCT02985515|64633044|FG000|Olfaction Testing|Lost to Follow-up|0|||
23242793|NCT02985515|64633045|FG001|Olfaction Testing|Lost to Follow-up|5|||
23242794|NCT02985515|64633044|FG000|Olfaction Testing|Protocol Violation|0|||
23242795|NCT02985515|64633045|FG001|Olfaction Testing|Protocol Violation|3|||
23242796|NCT01018680|64633046|FG000|Overall Study|Adverse Event|23|||
23242797|NCT01018680|64633047|FG001|Overall Study|Adverse Event|40|||
23242798|NCT01018680|64633046|FG000|Overall Study|Withdrawal by Subject|10|||
23242799|NCT01018680|64633047|FG001|Overall Study|Withdrawal by Subject|10|||
23242800|NCT01018680|64633046|FG000|Overall Study|Protocol Violation|5|||
23242801|NCT01018680|64633047|FG001|Overall Study|Protocol Violation|8|||
23242802|NCT01018680|64633046|FG000|Overall Study|Sponsor Decision|6|||
23242803|NCT01018680|64633047|FG001|Overall Study|Sponsor Decision|7|||
23242804|NCT01018680|64633046|FG000|Overall Study|Lack of Efficacy|8|||
23242805|NCT01018680|64633047|FG001|Overall Study|Lack of Efficacy|2|||
23242806|NCT01018680|64633046|FG000|Overall Study|Lost to Follow-up|5|||
23242807|NCT01018680|64633047|FG001|Overall Study|Lost to Follow-up|3|||
23242808|NCT01018680|64633046|FG000|Overall Study|Entry Criteria Not Met|1|||
23242809|NCT01018680|64633047|FG001|Overall Study|Entry Criteria Not Met|4|||
23242810|NCT01018680|64633046|FG000|Overall Study|Physician Decision|3|||
23242811|NCT01018680|64633047|FG001|Overall Study|Physician Decision|1|||
23242812|NCT00953017|64633048|FG000|Overall Study|DId not show up for colonoscopy|4|||
23242813|NCT00953017|64633049|FG001|Overall Study|DId not show up for colonoscopy|4|||
23242814|NCT00953017|64633050|FG002|Overall Study|DId not show up for colonoscopy|5|||
23242815|NCT00953017|64633051|FG003|Overall Study|DId not show up for colonoscopy|4|||
23242816|NCT00953017|64633048|FG000|Overall Study|Incomplete data|1|||
23242817|NCT00953017|64633049|FG001|Overall Study|Incomplete data|1|||
23242818|NCT00953017|64633050|FG002|Overall Study|Incomplete data|0|||
23242819|NCT00953017|64633051|FG003|Overall Study|Incomplete data|0|||
23242820|NCT00953017|64633048|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
23242821|NCT00953017|64633049|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
23242822|NCT00953017|64633050|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
23242823|NCT00953017|64633051|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
23242824|NCT00953017|64633048|FG000|Overall Study|Brown stool prior to procedure|0|||
23242825|NCT00953017|64633049|FG001|Overall Study|Brown stool prior to procedure|0|||
23242826|NCT00953017|64633050|FG002|Overall Study|Brown stool prior to procedure|1|||
23350392|NCT01043705|65025433|FG000|Overall Study|Other|0|||
23184198|NCT01244737|64413785|FG000|Overall Study|Physician Decision|2|||
23184199|NCT01244737|64413786|FG001|Overall Study|Physician Decision|18|||
23184200|NCT01244737|64413787|FG002|Overall Study|Physician Decision|5|||
23184201|NCT01244737|64413785|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
23184202|NCT01244737|64413786|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
23464101|NCT02266888|65441085|FG001|Overall Study|Transfer of care|0|||
23464102|NCT02266888|65441086|FG002|Overall Study|Transfer of care|1|||
23464103|NCT02266888|65441087|FG003|Overall Study|Transfer of care|0|||
23464104|NCT01147874|65441088|FG000|Overall Study|Adverse Event|5|||
23464105|NCT01147874|65441088|FG000|Overall Study|Investigator's Request|1|||
23464106|NCT01147874|65441088|FG000|Overall Study|Lost to Follow-up|25|||
23464107|NCT01147874|65441088|FG000|Overall Study|Other|5|||
23464108|NCT01147874|65441088|FG000|Overall Study|Protocol Violation|5|||
23464109|NCT01147874|65441088|FG000|Overall Study|Sponsor's Decision|2|||
23464110|NCT01147874|65441088|FG000|Overall Study|Withdrawal by Subject|24|||
23464111|NCT01708902|65441089|FG000|Overall Study|Adverse Event|3|||
23464112|NCT01708902|65441090|FG001|Overall Study|Adverse Event|4|||
23464113|NCT01708902|65441091|FG002|Overall Study|Adverse Event|9|||
23464114|NCT01708902|65441092|FG003|Overall Study|Adverse Event|2|||
23464115|NCT01708902|65441093|FG004|Overall Study|Adverse Event|7|||
23464116|NCT01708902|65441094|FG005|Overall Study|Adverse Event|3|||
23464117|NCT01708902|65441095|FG006|Overall Study|Adverse Event|5|||
23464118|NCT01708902|65441089|FG000|Overall Study|Lack of Efficacy|3|||
23464119|NCT01708902|65441090|FG001|Overall Study|Lack of Efficacy|1|||
23464120|NCT01708902|65441091|FG002|Overall Study|Lack of Efficacy|0|||
23464121|NCT01708902|65441092|FG003|Overall Study|Lack of Efficacy|0|||
23464122|NCT01708902|65441093|FG004|Overall Study|Lack of Efficacy|0|||
23464123|NCT01708902|65441094|FG005|Overall Study|Lack of Efficacy|1|||
23464124|NCT01708902|65441095|FG006|Overall Study|Lack of Efficacy|0|||
23242827|NCT00953017|64633051|FG003|Overall Study|Brown stool prior to procedure|0|||
23184203|NCT01244737|64413787|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
23184204|NCT01244737|64413785|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
23184205|NCT01244737|64413786|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
23184206|NCT01244737|64413787|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
23184207|NCT01244737|64413785|FG000|Overall Study|MIB immunopathology results not available|3|||
23184208|NCT01244737|64413786|FG001|Overall Study|MIB immunopathology results not available|2|||
23464125|NCT01708902|65441089|FG000|Overall Study|Non compliance with protocol|0|||
23184209|NCT01244737|64413787|FG002|Overall Study|MIB immunopathology results not available|0|||
23242828|NCT00247416|64633052|FG000|Overall Study|3 patients were found to be ineligible|1|||
23242829|NCT00247416|64633053|FG001|Overall Study|3 patients were found to be ineligible|2|||
23242830|NCT03075215|64633056|FG000|12-Month Primary Endpoint|Death|152|||
23242831|NCT03075215|64633056|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
23242832|NCT03075215|64633056|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
23242833|NCT03075215|64633056|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
23242834|NCT00908375|64633059|FG000|Overall Study|Withdrawal by Subject|2|||
23242835|NCT00908375|64633060|FG001|Overall Study|Withdrawal by Subject|4|||
23242836|NCT00908375|64633059|FG000|Overall Study|Lost to Follow-up|8|||
23464126|NCT01708902|65441090|FG001|Overall Study|Non compliance with protocol|2|||
23464127|NCT01708902|65441091|FG002|Overall Study|Non compliance with protocol|1|||
23464128|NCT01708902|65441092|FG003|Overall Study|Non compliance with protocol|3|||
23184210|NCT01244737|64413785|FG000|Overall Study|PET data failure|0|||
23184211|NCT01244737|64413786|FG001|Overall Study|PET data failure|1|||
23184212|NCT01244737|64413787|FG002|Overall Study|PET data failure|0|||
23184213|NCT01244737|64413785|FG000|Overall Study|Withdrawal by Subject|0|||
23184214|NCT01244737|64413786|FG001|Overall Study|Withdrawal by Subject|0|||
23184215|NCT01244737|64413787|FG002|Overall Study|Withdrawal by Subject|1|||
23184216|NCT04348851|64413792|FG000|Post-Test 1|Withdrawal by Subject|0|||
23184217|NCT04348851|64413793|FG001|Post-Test 1|Withdrawal by Subject|1|||
23184218|NCT04348851|64413794|FG002|Post-Test 1|Withdrawal by Subject|0|||
23184219|NCT04348851|64413795|FG003|Post-Test 1|Withdrawal by Subject|0|||
23184220|NCT04348851|64413792|FG000|Post-Test 1|Lost to Follow-up|0|||
23184221|NCT04348851|64413793|FG001|Post-Test 1|Lost to Follow-up|1|||
23184222|NCT04348851|64413794|FG002|Post-Test 1|Lost to Follow-up|0|||
23242837|NCT00908375|64633060|FG001|Overall Study|Lost to Follow-up|6|||
23464129|NCT01708902|65441093|FG004|Overall Study|Non compliance with protocol|0|||
23464130|NCT01708902|65441094|FG005|Overall Study|Non compliance with protocol|0|||
23464131|NCT01708902|65441095|FG006|Overall Study|Non compliance with protocol|0|||
23464132|NCT01708902|65441089|FG000|Overall Study|Lost to Follow-up|2|||
23184223|NCT04348851|64413795|FG003|Post-Test 1|Lost to Follow-up|0|||
23242838|NCT01556490|64633061|FG000|Randomized Patients Summary|Protocol Violation|22|||
23242839|NCT01556490|64633062|FG001|Randomized Patients Summary|Protocol Violation|23|||
23464133|NCT01708902|65441090|FG001|Overall Study|Lost to Follow-up|1|||
23464134|NCT01708902|65441091|FG002|Overall Study|Lost to Follow-up|2|||
23464135|NCT01708902|65441092|FG003|Overall Study|Lost to Follow-up|2|||
23184224|NCT04348851|64413792|FG000|Post-Test 2|Stroke survivor death|0|||
23184225|NCT04348851|64413793|FG001|Post-Test 2|Stroke survivor death|1|||
23184226|NCT04348851|64413794|FG002|Post-Test 2|Stroke survivor death|0|||
23184227|NCT04348851|64413795|FG003|Post-Test 2|Stroke survivor death|1|||
23350393|NCT01043705|65025434|FG001|Overall Study|Other|19|||
23350394|NCT01043705|65025435|FG002|Overall Study|Other|25|||
23350395|NCT01785849|65025438|FG000|Overall Study|Death|7|||
23350396|NCT01785849|65025439|FG001|Overall Study|Death|9|||
23350397|NCT01785849|65025438|FG000|Overall Study|Protocol Specified Criteria|29|||
23350398|NCT01785849|65025439|FG001|Overall Study|Protocol Specified Criteria|1|||
23350399|NCT01785849|65025438|FG000|Overall Study|Withdrawal by Subject|15|||
23350400|NCT01785849|65025439|FG001|Overall Study|Withdrawal by Subject|12|||
23350401|NCT01785849|65025438|FG000|Overall Study|Sponsor Decision|0|||
23350402|NCT01785849|65025439|FG001|Overall Study|Sponsor Decision|1|||
23350403|NCT01785849|65025438|FG000|Overall Study|Lost to Follow-up|10|||
23350404|NCT01785849|65025439|FG001|Overall Study|Lost to Follow-up|11|||
23350405|NCT01826370|65025442|FG000|Overall Study|Protocol Violation|6|||
23350406|NCT01826370|65025442|FG000|Overall Study|Lost to Follow-up|12|||
23350407|NCT01826370|65025442|FG000|Overall Study|Other reason not defined above|2|||
23350408|NCT00525902|65025443|FG000|Overall Study|Lack of Efficacy|1|||
23350409|NCT00552032|65025447|FG000|Overall Study|Withdrawal by Subject|2|||
23350410|NCT00552032|65025448|FG001|Overall Study|Withdrawal by Subject|2|||
23350411|NCT00552032|65025447|FG000|Overall Study|Protocol Violation|7|||
23350412|NCT00552032|65025448|FG001|Overall Study|Protocol Violation|12|||
23350413|NCT00552032|65025447|FG000|Overall Study|Lost to Follow-up|8|||
23350414|NCT00552032|65025448|FG001|Overall Study|Lost to Follow-up|5|||
23350415|NCT00948506|65025452|FG000|Overall Study|Withdrawal by Subject|3|||
23350416|NCT00948506|65025453|FG001|Overall Study|Withdrawal by Subject|1|||
23350417|NCT00979420|65025454|FG000|Overall Study|Adverse Event|1|||
23350418|NCT00979420|65025455|FG001|Overall Study|Adverse Event|0|||
23350419|NCT00979420|65025456|FG002|Overall Study|Adverse Event|0|||
23350420|NCT00979420|65025457|FG003|Overall Study|Adverse Event|0|||
23350421|NCT00979420|65025454|FG000|Overall Study|Lack of Efficacy|3|||
23350422|NCT00979420|65025455|FG001|Overall Study|Lack of Efficacy|0|||
23350423|NCT00979420|65025456|FG002|Overall Study|Lack of Efficacy|1|||
23350424|NCT00979420|65025457|FG003|Overall Study|Lack of Efficacy|1|||
23350425|NCT00979420|65025454|FG000|Overall Study|Other reasons not related to Viramune|3|||
23350426|NCT00979420|65025455|FG001|Overall Study|Other reasons not related to Viramune|0|||
23350427|NCT00979420|65025456|FG002|Overall Study|Other reasons not related to Viramune|0|||
23350428|NCT00979420|65025457|FG003|Overall Study|Other reasons not related to Viramune|1|||
23350429|NCT00085098|65025464|FG000|Overall Study|Withdrawal by Subject|0|||
23350430|NCT00085098|65025465|FG001|Overall Study|Withdrawal by Subject|1|||
23350431|NCT00085098|65025464|FG000|Overall Study|Ineligible|1|||
23350432|NCT00085098|65025465|FG001|Overall Study|Ineligible|1|||
23350433|NCT01764659|65025466|FG000|Overall Study|Death|1|||
23350434|NCT01764659|65025466|FG000|Overall Study|Physician Decision|1|||
23350435|NCT02273908|65025476|FG000|Overall Study|Adverse Event|16|||
23350436|NCT02273908|65025477|FG001|Overall Study|Adverse Event|0|||
23350437|NCT02273908|65025476|FG000|Overall Study|Lost to Follow-up|10|||
23350438|NCT02273908|65025477|FG001|Overall Study|Lost to Follow-up|1|||
23350439|NCT02273908|65025476|FG000|Overall Study|Did not meet entrance criteria|3|||
23350440|NCT02273908|65025477|FG001|Overall Study|Did not meet entrance criteria|2|||
23350441|NCT02273908|65025476|FG000|Overall Study|Withdrawal by Subject|4|||
23350442|NCT02273908|65025477|FG001|Overall Study|Withdrawal by Subject|2|||
23350443|NCT01643798|65025478|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
23350444|NCT01643798|65025479|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
23350445|NCT04811664|65025481|FG000|Overall Study|Lost to Follow-up|78|||
23350446|NCT04811664|65025482|FG001|Overall Study|Lost to Follow-up|125|||
23350447|NCT04811664|65025483|FG002|Overall Study|Lost to Follow-up|46|||
23350448|NCT04811664|65025481|FG000|Overall Study|Withdrawal by Subject|39|||
23350449|NCT04811664|65025482|FG001|Overall Study|Withdrawal by Subject|76|||
23350450|NCT04811664|65025483|FG002|Overall Study|Withdrawal by Subject|12|||
23350451|NCT04811664|65025481|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
23184228|NCT02722044|64413796|FG000|Overall Study|Adverse Event|2|||
23184229|NCT02722044|64413796|FG000|Overall Study|Physician Decision|1|||
23184230|NCT02722044|64413796|FG000|Overall Study|Withdrawal by Subject|1|||
23350452|NCT04811664|65025482|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
23350453|NCT04811664|65025483|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
23350454|NCT04811664|65025481|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
23350455|NCT04811664|65025482|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
23350456|NCT04811664|65025483|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
23350457|NCT04811664|65025481|FG000|Overall Study|Protocol Violation|0|||
23350458|NCT04811664|65025482|FG001|Overall Study|Protocol Violation|5|||
23350459|NCT04811664|65025483|FG002|Overall Study|Protocol Violation|11|||
23350460|NCT04811664|65025481|FG000|Overall Study|Study Terminated by Sponsor|4|||
23350461|NCT04811664|65025482|FG001|Overall Study|Study Terminated by Sponsor|3|||
23184231|NCT02722044|64413796|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
23184232|NCT04800315|64413797|FG000|Randomization|Did not receive study treatment|1|||
23184233|NCT04800315|64413798|FG001|Randomization|Did not receive study treatment|0|||
23184234|NCT04800315|64413799|FG002|Randomization|Did not receive study treatment|0|||
23184235|NCT04800315|64413800|FG003|Randomization|Did not receive study treatment|0|||
23184236|NCT04800315|64413797|FG000|Treatment Period|Adverse Event|4|||
23184237|NCT04800315|64413798|FG001|Treatment Period|Adverse Event|2|||
23184238|NCT04800315|64413799|FG002|Treatment Period|Adverse Event|1|||
23184239|NCT04800315|64413800|FG003|Treatment Period|Adverse Event|2|||
23184240|NCT04800315|64413797|FG000|Treatment Period|Lack of Efficacy|1|||
23184241|NCT04800315|64413798|FG001|Treatment Period|Lack of Efficacy|0|||
23184242|NCT04800315|64413799|FG002|Treatment Period|Lack of Efficacy|0|||
23184243|NCT04800315|64413800|FG003|Treatment Period|Lack of Efficacy|3|||
23184244|NCT04800315|64413797|FG000|Treatment Period|Lost to Follow-up|0|||
23184245|NCT04800315|64413798|FG001|Treatment Period|Lost to Follow-up|1|||
23184246|NCT04800315|64413799|FG002|Treatment Period|Lost to Follow-up|2|||
23184247|NCT04800315|64413800|FG003|Treatment Period|Lost to Follow-up|2|||
23184248|NCT04800315|64413797|FG000|Treatment Period|Withdrawal by participant|0|||
23184249|NCT04800315|64413798|FG001|Treatment Period|Withdrawal by participant|0|||
23184250|NCT04800315|64413799|FG002|Treatment Period|Withdrawal by participant|0|||
23184251|NCT04800315|64413800|FG003|Treatment Period|Withdrawal by participant|4|||
23350462|NCT04811664|65025483|FG002|Overall Study|Study Terminated by Sponsor|34|||
23350463|NCT04811664|65025481|FG000|Overall Study|Early Study Closure|3|||
23350464|NCT04811664|65025482|FG001|Overall Study|Early Study Closure|7|||
23350465|NCT04811664|65025483|FG002|Overall Study|Early Study Closure|79|||
23350466|NCT04811664|65025481|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
23350467|NCT04811664|65025482|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
23350468|NCT04811664|65025483|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
23350469|NCT05007041|65025486|FG000|Overall Study|Missing Diary Entries|0|||
23350470|NCT05007041|65025487|FG001|Overall Study|Missing Diary Entries|1|||
23350471|NCT03436199|65025488|FG000|Overall Study|Adverse Event|15|||
23350472|NCT03436199|65025489|FG001|Overall Study|Adverse Event|40|||
23350473|NCT03436199|65025490|FG002|Overall Study|Adverse Event|7|||
23350474|NCT03436199|65025488|FG000|Overall Study|Withdrawal by Subject|4|||
23350475|NCT03436199|65025489|FG001|Overall Study|Withdrawal by Subject|10|||
23350476|NCT03436199|65025490|FG002|Overall Study|Withdrawal by Subject|3|||
23350477|NCT03436199|65025488|FG000|Overall Study|Lost to Follow-up|1|||
23350478|NCT03436199|65025489|FG001|Overall Study|Lost to Follow-up|0|||
23350479|NCT03436199|65025490|FG002|Overall Study|Lost to Follow-up|2|||
23350480|NCT03436199|65025488|FG000|Overall Study|Protocol Violation|1|||
23350481|NCT03436199|65025489|FG001|Overall Study|Protocol Violation|1|||
23350482|NCT03436199|65025490|FG002|Overall Study|Protocol Violation|0|||
23350483|NCT03436199|65025488|FG000|Overall Study|Physician Decision|0|||
23350484|NCT03436199|65025489|FG001|Overall Study|Physician Decision|1|||
23350485|NCT03436199|65025490|FG002|Overall Study|Physician Decision|0|||
23350486|NCT03436199|65025488|FG000|Overall Study|Could not return to clinic|1|||
23350487|NCT03436199|65025489|FG001|Overall Study|Could not return to clinic|0|||
23350488|NCT03436199|65025490|FG002|Overall Study|Could not return to clinic|0|||
23350489|NCT03436199|65025488|FG000|Overall Study|Withdrawn per physician|0|||
23350490|NCT03436199|65025489|FG001|Overall Study|Withdrawn per physician|1|||
23350491|NCT03436199|65025490|FG002|Overall Study|Withdrawn per physician|0|||
23350492|NCT01380691|65025491|FG000|Washout (7 Days)|Protocol Violation|0|||
23350493|NCT01380691|65025492|FG001|Washout (7 Days)|Protocol Violation|0|||
23350494|NCT01380691|65025493|FG002|Washout (7 Days)|Protocol Violation|0|||
23350495|NCT01380691|65025494|FG003|Washout (7 Days)|Protocol Violation|1|||
23350496|NCT01380691|65025491|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
23350497|NCT01380691|65025492|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
23350498|NCT01380691|65025493|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
23350499|NCT01380691|65025494|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
23350500|NCT03077659|65025495|FG000|Overall Study|Withdrawal by Subject|0|||
23350501|NCT03077659|65025496|FG001|Overall Study|Withdrawal by Subject|0|||
23350502|NCT03077659|65025497|FG002|Overall Study|Withdrawal by Subject|1|||
23350503|NCT01546038|65025498|FG000|Overall Study|Death|15|||
23350504|NCT01546038|65025499|FG001|Overall Study|Death|6|||
23350505|NCT01546038|65025500|FG002|Overall Study|Death|4|||
23350506|NCT01546038|65025501|FG003|Overall Study|Death|2|||
23464136|NCT01708902|65441093|FG004|Overall Study|Lost to Follow-up|0|||
23585053|NCT05512949|65869382|FG002|Overall Study|Protocol Violation|1|||
23585054|NCT05512949|65869380|FG000|Overall Study|Withdrawal by Subject|1|||
23585055|NCT05512949|65869381|FG001|Overall Study|Withdrawal by Subject|1|||
23184252|NCT04800315|64413797|FG000|Treatment Period|Other Reasons|0|||
23184253|NCT04800315|64413798|FG001|Treatment Period|Other Reasons|2|||
23184254|NCT04800315|64413799|FG002|Treatment Period|Other Reasons|0|||
23184255|NCT04800315|64413800|FG003|Treatment Period|Other Reasons|1|||
23350507|NCT01546038|65025502|FG004|Overall Study|Death|9|||
23350508|NCT01546038|65025503|FG005|Overall Study|Death|3|||
23350509|NCT01546038|65025504|FG006|Overall Study|Death|46|||
23184256|NCT01389245|64413801|FG000|Overall Study|Protocol Violation|10|||
23184257|NCT01389245|64413801|FG000|Overall Study|Lost to Follow-up|3|||
23184258|NCT01389245|64413801|FG000|Overall Study|Withdrawal by Subject|2|||
23184259|NCT04672083|64413804|FG000|Overall Study|Lost to Follow-up|1|||
23184260|NCT04672083|64413805|FG001|Overall Study|Lost to Follow-up|0|||
23184261|NCT04672083|64413806|FG002|Overall Study|Lost to Follow-up|0|||
23184262|NCT04672083|64413807|FG003|Overall Study|Lost to Follow-up|0|||
23184263|NCT04672083|64413808|FG004|Overall Study|Lost to Follow-up|0|||
23184264|NCT01891643|64413811|FG000|Overall Study|Adverse event unrelated to study drug|2|||
23184265|NCT01891643|64413812|FG001|Overall Study|Adverse event unrelated to study drug|5|||
23184266|NCT01891643|64413811|FG000|Overall Study|Disease Progression|4|||
23464137|NCT01708902|65441094|FG005|Overall Study|Lost to Follow-up|0|||
23464138|NCT01708902|65441095|FG006|Overall Study|Lost to Follow-up|1|||
23464139|NCT01708902|65441089|FG000|Overall Study|Refused to continue trial medication|8|||
23464140|NCT01708902|65441090|FG001|Overall Study|Refused to continue trial medication|0|||
23464141|NCT01708902|65441091|FG002|Overall Study|Refused to continue trial medication|4|||
23464142|NCT01708902|65441092|FG003|Overall Study|Refused to continue trial medication|2|||
23464143|NCT01708902|65441093|FG004|Overall Study|Refused to continue trial medication|8|||
23464144|NCT01708902|65441094|FG005|Overall Study|Refused to continue trial medication|1|||
23464145|NCT01708902|65441095|FG006|Overall Study|Refused to continue trial medication|1|||
23464146|NCT01708902|65441089|FG000|Overall Study|Other Reason|1|||
23464147|NCT01708902|65441090|FG001|Overall Study|Other Reason|0|||
23464148|NCT01708902|65441091|FG002|Overall Study|Other Reason|1|||
23464149|NCT01708902|65441092|FG003|Overall Study|Other Reason|1|||
23464150|NCT01708902|65441093|FG004|Overall Study|Other Reason|1|||
23464151|NCT01708902|65441094|FG005|Overall Study|Other Reason|2|||
23464152|NCT01708902|65441095|FG006|Overall Study|Other Reason|0|||
23464153|NCT00907335|65441096|FG000|Overall Study|Withdrawal by Subject|2|||
23464154|NCT00907335|65441097|FG001|Overall Study|Withdrawal by Subject|0|||
23464155|NCT00907335|65441096|FG000|Overall Study|Adverse Event|4|||
23464156|NCT00907335|65441097|FG001|Overall Study|Adverse Event|1|||
23464157|NCT00907335|65441096|FG000|Overall Study|Lost to Follow-up|2|||
23464158|NCT00907335|65441097|FG001|Overall Study|Lost to Follow-up|0|||
23464159|NCT03131570|65441098|FG000|Overall Study|Adverse Event|1|||
23464160|NCT03131570|65441099|FG001|Overall Study|Adverse Event|0|||
23464161|NCT03857867|65441100|FG000|Overall Study|Physician Decision|1|||
23464162|NCT01958164|65441101|FG000|Overall Study|Adverse Event|0|||
23464163|NCT01958164|65441102|FG001|Overall Study|Adverse Event|2|||
23464164|NCT01958164|65441101|FG000|Overall Study|Lost to Follow-up|2|||
23464165|NCT01958164|65441102|FG001|Overall Study|Lost to Follow-up|3|||
23464166|NCT03133793|65441104|FG000|Overall Study|Withdrawal by Subject|0|||
23464167|NCT03133793|65441105|FG001|Overall Study|Withdrawal by Subject|4|||
23464168|NCT03133793|65441106|FG002|Overall Study|Withdrawal by Subject|2|||
23464169|NCT03133793|65441107|FG003|Overall Study|Withdrawal by Subject|4|||
23464170|NCT03133793|65441104|FG000|Overall Study|Lost to Follow-up|1|||
23464171|NCT03133793|65441105|FG001|Overall Study|Lost to Follow-up|0|||
23464172|NCT03133793|65441106|FG002|Overall Study|Lost to Follow-up|2|||
23464173|NCT03133793|65441107|FG003|Overall Study|Lost to Follow-up|0|||
23464174|NCT03133793|65441104|FG000|Overall Study|Death|0|||
23464175|NCT03133793|65441105|FG001|Overall Study|Death|0|||
23464176|NCT03133793|65441106|FG002|Overall Study|Death|0|||
23184267|NCT01891643|64413812|FG001|Overall Study|Disease Progression|3|||
23184268|NCT01891643|64413811|FG000|Overall Study|Study Drug Toxicity|3|||
23184269|NCT01891643|64413812|FG001|Overall Study|Study Drug Toxicity|0|||
23184270|NCT01891643|64413811|FG000|Overall Study|Maximum Clinical Benefit|0|||
23184271|NCT01891643|64413812|FG001|Overall Study|Maximum Clinical Benefit|1|||
23184272|NCT01891643|64413811|FG000|Overall Study|Poor/Non-compliance|0|||
23184273|NCT01891643|64413812|FG001|Overall Study|Poor/Non-compliance|1|||
23184274|NCT01891643|64413811|FG000|Overall Study|Participant request to discontinue|1|||
23184275|NCT01891643|64413812|FG001|Overall Study|Participant request to discontinue|0|||
23184276|NCT00702143|64413815|FG000|Overall Study|Lost to Follow-up|0|||
23184277|NCT00702143|64413816|FG001|Overall Study|Lost to Follow-up|0|||
23184278|NCT00702143|64413817|FG002|Overall Study|Lost to Follow-up|1|||
23184279|NCT01551745|64413818|FG000|Overall Study|Withdrawal by Subject|1|||
23184280|NCT01551745|64413818|FG000|Overall Study|Disease Progression|2|||
23464177|NCT03133793|65441107|FG003|Overall Study|Death|1|||
23184281|NCT00270894|64413821|FG000|Overall Study|Adverse Event|1|||
23464178|NCT01112917|65441108|FG000|Overall Study|Death|2|||
23464179|NCT01112917|65441109|FG001|Overall Study|Death|11|||
23464180|NCT01112917|65441108|FG000|Overall Study|Lost to Follow-up|1|||
23464181|NCT01112917|65441109|FG001|Overall Study|Lost to Follow-up|1|||
23184282|NCT00270894|64413821|FG000|Overall Study|Withdrawal by Subject|1|||
23184283|NCT00686543|64413823|FG000|Overall Study|Adverse Event|9|||
23184284|NCT00686543|64413824|FG001|Overall Study|Adverse Event|1|||
23464182|NCT01112917|65441108|FG000|Overall Study|Withdrawal by Subject|1|||
23464183|NCT01112917|65441109|FG001|Overall Study|Withdrawal by Subject|3|||
23464184|NCT01112917|65441108|FG000|Overall Study|Unable to Convert Filter|3|||
23184285|NCT00686543|64413825|FG002|Overall Study|Adverse Event|3|||
23464185|NCT01112917|65441109|FG001|Overall Study|Unable to Convert Filter|0|||
23464186|NCT01780506|65444535|FG000|Double-Blind Phase|Randomized but not Treated|3|||
23464187|NCT01780506|65444536|FG001|Double-Blind Phase|Randomized but not Treated|2|||
23464188|NCT01780506|65444535|FG000|Double-Blind Phase|Adverse Event|4|||
23464189|NCT01780506|65444536|FG001|Double-Blind Phase|Adverse Event|14|||
23464190|NCT01780506|65444535|FG000|Double-Blind Phase|Death|1|||
23464191|NCT01780506|65444536|FG001|Double-Blind Phase|Death|2|||
23464192|NCT01780506|65444535|FG000|Double-Blind Phase|Pregnancy|2|||
23464193|NCT01780506|65444536|FG001|Double-Blind Phase|Pregnancy|1|||
23464194|NCT01780506|65444535|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23464195|NCT01780506|65444536|FG001|Double-Blind Phase|Lack of Efficacy|1|||
23464196|NCT01780506|65444535|FG000|Double-Blind Phase|Investigator's Discretion|5|||
23464197|NCT01780506|65444536|FG001|Double-Blind Phase|Investigator's Discretion|2|||
23464198|NCT01780506|65444535|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
23464199|NCT01780506|65444536|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
23464200|NCT01780506|65444535|FG000|Double-Blind Phase|Protocol Violation|4|||
23464201|NCT01780506|65444536|FG001|Double-Blind Phase|Protocol Violation|3|||
23464202|NCT01780506|65444535|FG000|Double-Blind Phase|Withdrew Consent|23|||
23464203|NCT01780506|65444536|FG001|Double-Blind Phase|Withdrew Consent|24|||
23464204|NCT01780506|65444535|FG000|Double-Blind Phase|Lost to Follow-up|23|||
23464205|NCT01780506|65444536|FG001|Double-Blind Phase|Lost to Follow-up|26|||
23464206|NCT01780506|65444535|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
23464207|NCT01780506|65444536|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
23464208|NCT04161157|65444538|FG000|Overall Study|Lost to Follow-up|4|||
23464209|NCT04161157|65444538|FG000|Overall Study|Death|3|||
23464210|NCT04161157|65444538|FG000|Overall Study|Ineligible|2|||
23464211|NCT04161157|65444538|FG000|Overall Study|Withdrawal by Subject|4|||
23464212|NCT03682770|65444539|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464213|NCT03682770|65444540|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
23464214|NCT03682770|65444541|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464215|NCT03682770|65444542|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464216|NCT03682770|65444543|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464217|NCT03682770|65444544|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464218|NCT03682770|65444545|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
23464219|NCT03682770|65444539|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
23464220|NCT03682770|65444540|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
23464221|NCT03682770|65444541|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464222|NCT03682770|65444542|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464223|NCT03682770|65444543|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464224|NCT03682770|65444544|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464225|NCT03682770|65444545|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
23464226|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464227|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464228|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
23464229|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
23464230|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464231|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464232|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
23464233|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464234|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464235|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464236|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
23464237|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464238|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464239|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
23464240|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464241|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464242|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
23464243|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
23464244|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464245|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464246|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
23464247|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464248|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464249|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
23464250|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464251|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464252|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464253|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
23464254|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464255|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464256|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
23464257|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464258|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464259|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464260|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
23464261|NCT03682770|65444539|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464262|NCT03682770|65444540|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464263|NCT03682770|65444541|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464264|NCT03682770|65444542|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
23464265|NCT03682770|65444543|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464266|NCT03682770|65444544|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464267|NCT03682770|65444545|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
23464268|NCT03682770|65444539|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
23464269|NCT03682770|65444540|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
23464270|NCT03682770|65444541|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
23464271|NCT03682770|65444542|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
23464272|NCT03682770|65444543|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
23464273|NCT03682770|65444544|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
23464274|NCT03682770|65444545|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
23464275|NCT03682770|65444539|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464276|NCT03682770|65444540|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464277|NCT03682770|65444541|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464278|NCT03682770|65444542|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464279|NCT03682770|65444543|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
23464280|NCT03682770|65444544|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464281|NCT03682770|65444545|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
23464282|NCT03682770|65444539|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464283|NCT03682770|65444540|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464284|NCT03682770|65444541|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464285|NCT03682770|65444542|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464286|NCT03682770|65444543|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464287|NCT03682770|65444544|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
23464288|NCT03682770|65444545|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
23464289|NCT03682770|65444539|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464290|NCT03682770|65444540|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464291|NCT03682770|65444541|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464292|NCT03682770|65444542|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464293|NCT03682770|65444543|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
23464294|NCT03682770|65444544|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
23464295|NCT03682770|65444545|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
23464296|NCT01812252|65444546|FG000|Overall Study|Persistent Disease|1|||
23464297|NCT01812252|65444547|FG001|Overall Study|Persistent Disease|0|||
23464298|NCT01812252|65444546|FG000|Overall Study|Not transplanted|11|||
23464299|NCT01812252|65444547|FG001|Overall Study|Not transplanted|11|||
23464300|NCT01812252|65444546|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
23464301|NCT01812252|65444547|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
23464302|NCT01812252|65444546|FG000|Overall Study|Withdrawal by Subject|1|||
23464303|NCT01812252|65444547|FG001|Overall Study|Withdrawal by Subject|1|||
23464304|NCT01812252|65444546|FG000|Overall Study|Screen Failure|1|||
23464305|NCT01812252|65444547|FG001|Overall Study|Screen Failure|0|||
23464306|NCT02919995|65444549|FG000|Overall Study|Adverse Event|0|||
23464307|NCT02919995|65444550|FG001|Overall Study|Adverse Event|0|||
23464308|NCT02919995|65444551|FG002|Overall Study|Adverse Event|0|||
23464309|NCT02919995|65444552|FG003|Overall Study|Adverse Event|0|||
23464310|NCT02919995|65444553|FG004|Overall Study|Adverse Event|0|||
23464311|NCT02919995|65444554|FG005|Overall Study|Adverse Event|1|||
23464312|NCT01780974|65444557|FG000|Overall Study|Death|1|||
23464313|NCT01780974|65444558|FG001|Overall Study|Death|0|||
23464314|NCT01780974|65444557|FG000|Overall Study|Adverse Event|1|||
23464315|NCT01780974|65444558|FG001|Overall Study|Adverse Event|3|||
23464316|NCT02565108|65444559|FG000|Overall Study|Adverse Event|1|||
23464317|NCT02565108|65444560|FG001|Overall Study|Adverse Event|0|||
23464318|NCT02565108|65444559|FG000|Overall Study|Withdrew Consent|1|||
23464319|NCT02565108|65444560|FG001|Overall Study|Withdrew Consent|0|||
23464320|NCT00753506|65444561|FG000|Overall Study|Withdrawal by Subject|4|||
23464321|NCT00753506|65444562|FG001|Overall Study|Withdrawal by Subject|1|||
23184286|NCT00686543|64413826|FG003|Overall Study|Adverse Event|2|||
23184287|NCT00686543|64413823|FG000|Overall Study|Withdrawal by Subject|2|||
23184288|NCT00686543|64413824|FG001|Overall Study|Withdrawal by Subject|0|||
23184289|NCT00686543|64413825|FG002|Overall Study|Withdrawal by Subject|0|||
23184290|NCT00686543|64413826|FG003|Overall Study|Withdrawal by Subject|0|||
23350510|NCT01546038|65025505|FG007|Overall Study|Death|76|||
23350511|NCT01546038|65025506|FG008|Overall Study|Death|39|||
23350512|NCT01546038|65025498|FG000|Overall Study|Lost to Follow-up|0|||
23350513|NCT01546038|65025499|FG001|Overall Study|Lost to Follow-up|0|||
23350514|NCT01546038|65025500|FG002|Overall Study|Lost to Follow-up|0|||
23350515|NCT01546038|65025501|FG003|Overall Study|Lost to Follow-up|0|||
23350516|NCT01546038|65025502|FG004|Overall Study|Lost to Follow-up|1|||
23350517|NCT01546038|65025503|FG005|Overall Study|Lost to Follow-up|0|||
23350518|NCT01546038|65025504|FG006|Overall Study|Lost to Follow-up|2|||
23350519|NCT01546038|65025505|FG007|Overall Study|Lost to Follow-up|1|||
23350520|NCT01546038|65025506|FG008|Overall Study|Lost to Follow-up|0|||
23350521|NCT01546038|65025498|FG000|Overall Study|Withdrawal by Subject|1|||
23350522|NCT01546038|65025499|FG001|Overall Study|Withdrawal by Subject|0|||
23350523|NCT01546038|65025500|FG002|Overall Study|Withdrawal by Subject|0|||
23350524|NCT01546038|65025501|FG003|Overall Study|Withdrawal by Subject|1|||
23350525|NCT01546038|65025502|FG004|Overall Study|Withdrawal by Subject|0|||
23350526|NCT01546038|65025503|FG005|Overall Study|Withdrawal by Subject|1|||
23350527|NCT01546038|65025504|FG006|Overall Study|Withdrawal by Subject|3|||
23350528|NCT01546038|65025505|FG007|Overall Study|Withdrawal by Subject|3|||
23350529|NCT01546038|65025506|FG008|Overall Study|Withdrawal by Subject|1|||
23350530|NCT01546038|65025498|FG000|Overall Study|: Randomized, not treated|0|||
23350531|NCT01546038|65025499|FG001|Overall Study|: Randomized, not treated|0|||
23350532|NCT01546038|65025500|FG002|Overall Study|: Randomized, not treated|0|||
23350533|NCT01546038|65025501|FG003|Overall Study|: Randomized, not treated|0|||
23350534|NCT01546038|65025502|FG004|Overall Study|: Randomized, not treated|0|||
23350535|NCT01546038|65025503|FG005|Overall Study|: Randomized, not treated|0|||
23350536|NCT01546038|65025504|FG006|Overall Study|: Randomized, not treated|2|||
23350537|NCT01546038|65025505|FG007|Overall Study|: Randomized, not treated|4|||
23350538|NCT01546038|65025506|FG008|Overall Study|: Randomized, not treated|3|||
23350539|NCT00087126|65025509|FG000|Overall Study|Ineligible - second primary|1|||
23350540|NCT00087126|65025509|FG000|Overall Study|Never treated|1|||
23350541|NCT01473394|65025510|FG000|Overall Study|Adverse Event|13|||
23350542|NCT01473394|65025511|FG001|Overall Study|Adverse Event|16|||
23350543|NCT01473394|65025510|FG000|Overall Study|Insufficient Therapeutic Response|4|||
23350544|NCT01473394|65025511|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23350545|NCT01473394|65025510|FG000|Overall Study|Protocol Violation|7|||
23350546|NCT01473394|65025511|FG001|Overall Study|Protocol Violation|5|||
23350547|NCT01473394|65025510|FG000|Overall Study|Withdrew Consent|12|||
23350548|NCT01473394|65025511|FG001|Overall Study|Withdrew Consent|10|||
23350549|NCT01473394|65025510|FG000|Overall Study|Lost to Follow-up|9|||
23350550|NCT01473394|65025511|FG001|Overall Study|Lost to Follow-up|11|||
23350551|NCT00586898|65025512|FG000|Overall Study|Adverse Event|1|||
23350552|NCT00586898|65025512|FG000|Overall Study|Patiemt Non-compliance|1|||
23350553|NCT00586898|65025512|FG000|Overall Study|Evaluable for Toxicity Only|5|||
23350554|NCT00574249|65025513|FG000|Overall Study|Adverse Event|6|||
23350555|NCT00574249|65025514|FG001|Overall Study|Adverse Event|18|||
23350556|NCT00574249|65025513|FG000|Overall Study|Lack of Efficacy|5|||
23350557|NCT00574249|65025514|FG001|Overall Study|Lack of Efficacy|3|||
23350558|NCT00574249|65025513|FG000|Overall Study|Lost to Follow-up|4|||
23350559|NCT00574249|65025514|FG001|Overall Study|Lost to Follow-up|3|||
23350560|NCT00574249|65025513|FG000|Overall Study|Protocol Violation|5|||
23350561|NCT00574249|65025514|FG001|Overall Study|Protocol Violation|2|||
23350562|NCT00574249|65025513|FG000|Overall Study|History of carcinoma|1|||
23350563|NCT00574249|65025514|FG001|Overall Study|History of carcinoma|0|||
23350564|NCT00574249|65025513|FG000|Overall Study|Withdrawal by Subject|3|||
23350565|NCT00574249|65025514|FG001|Overall Study|Withdrawal by Subject|0|||
23350566|NCT00574249|65025513|FG000|Overall Study|Physician Decision|1|||
23350567|NCT00574249|65025514|FG001|Overall Study|Physician Decision|0|||
23350568|NCT00574249|65025513|FG000|Overall Study|Pregnancy|1|||
23350569|NCT00574249|65025514|FG001|Overall Study|Pregnancy|0|||
23350570|NCT00574249|65025513|FG000|Overall Study|Excluded by company|0|||
23184291|NCT00686543|64413823|FG000|Overall Study|Protocol Violation|3|||
23350571|NCT00574249|65025514|FG001|Overall Study|Excluded by company|1|||
23350572|NCT00574249|65025513|FG000|Overall Study|PPD test taken twice|0|||
23184292|NCT00686543|64413824|FG001|Overall Study|Protocol Violation|0|||
23350573|NCT00574249|65025514|FG001|Overall Study|PPD test taken twice|1|||
23350574|NCT01702532|65025515|FG000|Overall Study|Adverse Event|0|||
23184293|NCT00686543|64413825|FG002|Overall Study|Protocol Violation|2|||
23350575|NCT01702532|65025516|FG001|Overall Study|Adverse Event|1|||
23350576|NCT01900431|65025517|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
23350577|NCT01900431|65025518|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
23350578|NCT01900431|65025519|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
23350579|NCT01900431|65025517|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
23464322|NCT00753506|65444561|FG000|Overall Study|Lost to Follow-up|2|||
23464323|NCT00753506|65444562|FG001|Overall Study|Lost to Follow-up|0|||
23464324|NCT00753506|65444561|FG000|Overall Study|Other reason|1|||
23464325|NCT00753506|65444562|FG001|Overall Study|Other reason|1|||
23464326|NCT04032093|65444563|FG000|Overall Study|Lost to Follow-up|7|||
23464327|NCT04032093|65444564|FG001|Overall Study|Lost to Follow-up|7|||
23464328|NCT04032093|65444565|FG002|Overall Study|Lost to Follow-up|6|||
23464329|NCT04032093|65444566|FG003|Overall Study|Lost to Follow-up|10|||
23464330|NCT04032093|65444567|FG004|Overall Study|Lost to Follow-up|13|||
23464331|NCT04032093|65444568|FG005|Overall Study|Lost to Follow-up|7|||
23464332|NCT04032093|65444569|FG006|Overall Study|Lost to Follow-up|7|||
23464333|NCT04032093|65444570|FG007|Overall Study|Lost to Follow-up|5|||
23464334|NCT04032093|65444571|FG008|Overall Study|Lost to Follow-up|9|||
23464335|NCT04032093|65444572|FG009|Overall Study|Lost to Follow-up|12|||
23464336|NCT04032093|65444563|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464337|NCT04032093|65444564|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464338|NCT04032093|65444565|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464339|NCT04032093|65444566|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
23464340|NCT04032093|65444567|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
23464341|NCT04032093|65444568|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464342|NCT04032093|65444569|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464343|NCT04032093|65444570|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
23464344|NCT04032093|65444571|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
23464345|NCT04032093|65444572|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
23464346|NCT04032093|65444563|FG000|Overall Study|Other|1|||
23464347|NCT04032093|65444564|FG001|Overall Study|Other|0|||
23464348|NCT04032093|65444565|FG002|Overall Study|Other|0|||
23464349|NCT04032093|65444566|FG003|Overall Study|Other|1|||
23464350|NCT04032093|65444567|FG004|Overall Study|Other|1|||
23464351|NCT04032093|65444568|FG005|Overall Study|Other|0|||
23464352|NCT04032093|65444569|FG006|Overall Study|Other|0|||
23464353|NCT04032093|65444570|FG007|Overall Study|Other|0|||
23464354|NCT04032093|65444571|FG008|Overall Study|Other|0|||
23464355|NCT04032093|65444572|FG009|Overall Study|Other|1|||
23464356|NCT04032093|65444563|FG000|Overall Study|Withdrawal by Subject|1|||
23464357|NCT04032093|65444564|FG001|Overall Study|Withdrawal by Subject|3|||
23464358|NCT04032093|65444565|FG002|Overall Study|Withdrawal by Subject|2|||
23464359|NCT04032093|65444566|FG003|Overall Study|Withdrawal by Subject|2|||
23464360|NCT04032093|65444567|FG004|Overall Study|Withdrawal by Subject|3|||
23464361|NCT04032093|65444568|FG005|Overall Study|Withdrawal by Subject|0|||
23464362|NCT04032093|65444569|FG006|Overall Study|Withdrawal by Subject|0|||
23464363|NCT04032093|65444570|FG007|Overall Study|Withdrawal by Subject|0|||
23464364|NCT04032093|65444571|FG008|Overall Study|Withdrawal by Subject|0|||
23464365|NCT04032093|65444572|FG009|Overall Study|Withdrawal by Subject|0|||
23464366|NCT04032093|65444563|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23464367|NCT04032093|65444564|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23464368|NCT04032093|65444565|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23464369|NCT04032093|65444566|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23464370|NCT04032093|65444567|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23464371|NCT04032093|65444568|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23464372|NCT04032093|65444569|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
23464373|NCT04032093|65444570|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
23464374|NCT04032093|65444571|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
23464375|NCT04032093|65444572|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
23464376|NCT04032093|65444563|FG000|Overall Study|Adverse Event|0|||
23464377|NCT04032093|65444564|FG001|Overall Study|Adverse Event|0|||
23464378|NCT04032093|65444565|FG002|Overall Study|Adverse Event|0|||
23464379|NCT04032093|65444566|FG003|Overall Study|Adverse Event|0|||
23585056|NCT05512949|65869382|FG002|Overall Study|Withdrawal by Subject|2|||
23464380|NCT04032093|65444567|FG004|Overall Study|Adverse Event|0|||
23464381|NCT04032093|65444568|FG005|Overall Study|Adverse Event|0|||
23464382|NCT04032093|65444569|FG006|Overall Study|Adverse Event|0|||
23464383|NCT04032093|65444570|FG007|Overall Study|Adverse Event|0|||
23464384|NCT04032093|65444571|FG008|Overall Study|Adverse Event|0|||
23464385|NCT04032093|65444572|FG009|Overall Study|Adverse Event|1|||
23464386|NCT04032093|65444563|FG000|Overall Study|Physician Decision|0|||
23464387|NCT04032093|65444564|FG001|Overall Study|Physician Decision|0|||
23464388|NCT04032093|65444565|FG002|Overall Study|Physician Decision|0|||
23464389|NCT04032093|65444566|FG003|Overall Study|Physician Decision|0|||
23464390|NCT04032093|65444567|FG004|Overall Study|Physician Decision|0|||
23464391|NCT04032093|65444568|FG005|Overall Study|Physician Decision|1|||
23184294|NCT00686543|64413826|FG003|Overall Study|Protocol Violation|1|||
23402770|NCT01446874|65220004|FG001|Overall Study|Not eligible|0|||
23464392|NCT04032093|65444569|FG006|Overall Study|Physician Decision|0|||
23464393|NCT04032093|65444570|FG007|Overall Study|Physician Decision|0|||
23464394|NCT04032093|65444571|FG008|Overall Study|Physician Decision|0|||
23464395|NCT04032093|65444572|FG009|Overall Study|Physician Decision|0|||
23464396|NCT00686712|65444573|FG000|Overall Study|Protocol Violation|8|||
23464397|NCT00686712|65444574|FG001|Overall Study|Protocol Violation|8|||
23464398|NCT00686712|65444575|FG002|Overall Study|Protocol Violation|10|||
23464399|NCT00686712|65444573|FG000|Overall Study|Lost to Follow-up|1|||
23464400|NCT00686712|65444574|FG001|Overall Study|Lost to Follow-up|2|||
23464401|NCT00686712|65444575|FG002|Overall Study|Lost to Follow-up|3|||
23464402|NCT00686712|65444573|FG000|Overall Study|Adverse Event|1|||
23464403|NCT00686712|65444574|FG001|Overall Study|Adverse Event|1|||
23464404|NCT00686712|65444575|FG002|Overall Study|Adverse Event|0|||
23464405|NCT00473564|65444578|FG000|Overall Study|robot surgery aborted in OR|23|||
23464406|NCT03557034|65444579|FG000|Overall Study|Withdrawal by Subject|1|||
23464407|NCT03557034|65444580|FG001|Overall Study|Withdrawal by Subject|0|||
23464408|NCT04226742|65444581|FG000|Overall Study|Lost to Follow-up|16|||
23464409|NCT04226742|65444582|FG001|Overall Study|Lost to Follow-up|13|||
23464410|NCT04226742|65444581|FG000|Overall Study|Withdrawal by Subject|5|||
23464411|NCT04226742|65444582|FG001|Overall Study|Withdrawal by Subject|3|||
23464412|NCT00408317|65444583|FG000|First Intervention Period|Adverse Event|0|||
23464413|NCT00408317|65444584|FG001|First Intervention Period|Adverse Event|1|||
23464414|NCT00408317|65444583|FG000|Second Intervention Period|Adverse Event|2|||
23464415|NCT00408317|65444584|FG001|Second Intervention Period|Adverse Event|0|||
23464416|NCT00408317|65444583|FG000|Second Intervention Period|Protocol Violation|0|||
23464417|NCT00408317|65444584|FG001|Second Intervention Period|Protocol Violation|1|||
23464418|NCT00408317|65444583|FG000|Second Intervention Period|Withdrawal of consent|0|||
23464419|NCT00408317|65444584|FG001|Second Intervention Period|Withdrawal of consent|1|||
23464420|NCT01760733|65444585|FG000|Waiting List|Death|18|||
23464421|NCT01760733|65444585|FG000|Waiting List|Removed from waiting list|41|||
23464422|NCT01760733|65444585|FG000|Waiting List|Not received a transplant yet|13|||
23464423|NCT01760733|65444585|FG000|Transplanted|Not reached 10 years post transplant|184|||
23464424|NCT01760733|65444585|FG000|Transplanted|Death|26|||
23464425|NCT01760733|65444585|FG000|Transplanted|Graft loss|7|||
23464426|NCT01654302|65444586|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
23464427|NCT01654302|65444587|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
23464428|NCT02766023|65444588|FG000|Overall Study|Lost to Follow-up|23|||
23464429|NCT02766023|65444589|FG001|Overall Study|Lost to Follow-up|11|||
23464430|NCT02766023|65444588|FG000|Overall Study|Pregnancy|1|||
23464431|NCT02766023|65444589|FG001|Overall Study|Pregnancy|0|||
23464432|NCT02766023|65444588|FG000|Overall Study|Adverse Event|1|||
23464433|NCT02766023|65444589|FG001|Overall Study|Adverse Event|0|||
23464434|NCT02766023|65444588|FG000|Overall Study|Withdrawal by Subject|4|||
23464435|NCT02766023|65444589|FG001|Overall Study|Withdrawal by Subject|5|||
23585057|NCT05512949|65869380|FG000|Overall Study|Completion status unknown|1|||
23585058|NCT05512949|65869381|FG001|Overall Study|Completion status unknown|3|||
23585059|NCT05512949|65869382|FG002|Overall Study|Completion status unknown|0|||
23585060|NCT00631917|65869383|FG000|Overall Study|Adverse Event|34|||
23585061|NCT00631917|65869384|FG001|Overall Study|Adverse Event|45|||
23585062|NCT00631917|65869383|FG000|Overall Study|Abnormal laboratory value(s)|2|||
23585063|NCT00631917|65869384|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23585064|NCT00631917|65869383|FG000|Overall Study|Abnormal test procedure result(s)|3|||
23585065|NCT00631917|65869384|FG001|Overall Study|Abnormal test procedure result(s)|2|||
23585066|NCT00631917|65869383|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
23585067|NCT00631917|65869384|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
23585068|NCT00631917|65869383|FG000|Overall Study|No longer required study drug|0|||
23585069|NCT00631917|65869384|FG001|Overall Study|No longer required study drug|1|||
23585070|NCT00631917|65869383|FG000|Overall Study|Protocol deviation|6|||
23585071|NCT00631917|65869384|FG001|Overall Study|Protocol deviation|5|||
23585072|NCT00631917|65869383|FG000|Overall Study|Subject withdrew consent|25|||
23585073|NCT00631917|65869384|FG001|Overall Study|Subject withdrew consent|33|||
23585074|NCT00631917|65869383|FG000|Overall Study|Lost to Follow-up|7|||
23585075|NCT00631917|65869384|FG001|Overall Study|Lost to Follow-up|7|||
23585076|NCT00631917|65869383|FG000|Overall Study|Administrative problems|2|||
23585077|NCT00631917|65869384|FG001|Overall Study|Administrative problems|0|||
23184295|NCT02698189|64413827|FG000|Overall Study|Physician Decision|3|||
23464436|NCT02766023|65444588|FG000|Overall Study|Physician Decision|1|||
23464437|NCT02766023|65444589|FG001|Overall Study|Physician Decision|0|||
23464438|NCT02766023|65444588|FG000|Overall Study|Not Eligible at Enrollment|0|||
23464439|NCT02766023|65444589|FG001|Overall Study|Not Eligible at Enrollment|1|||
23585078|NCT00631917|65869383|FG000|Overall Study|Death|1|||
23585079|NCT00631917|65869384|FG001|Overall Study|Death|0|||
23585080|NCT03107611|65869385|FG000|Overall Study|Adverse Event|1|||
23585081|NCT03107611|65869386|FG001|Overall Study|Adverse Event|0|||
23464440|NCT01077076|65444591|FG000|First Intervention|Withdrawal by Subject|1|||
23464441|NCT01077076|65444592|FG001|First Intervention|Withdrawal by Subject|0|||
23585082|NCT03107611|65869387|FG002|Overall Study|Adverse Event|2|||
23464442|NCT01077076|65444593|FG002|First Intervention|Withdrawal by Subject|0|||
23464443|NCT01077076|65444594|FG003|First Intervention|Withdrawal by Subject|0|||
23242840|NCT01556490|64633061|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
23242841|NCT01556490|64633062|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
23242842|NCT01319994|64633063|FG000|Overall Study|Protocol Violation|7|||
23242843|NCT01319994|64633064|FG001|Overall Study|Protocol Violation|6|||
23242844|NCT00975000|64633067|FG000|Overall Study|Other|1|||
23242845|NCT00975000|64633068|FG001|Overall Study|Other|0|||
23242846|NCT00975000|64633067|FG000|Overall Study|Adverse Event|1|||
23242847|NCT00975000|64633068|FG001|Overall Study|Adverse Event|1|||
23242848|NCT00975000|64633067|FG000|Overall Study|Withdrawal by Subject|2|||
23242849|NCT00975000|64633068|FG001|Overall Study|Withdrawal by Subject|2|||
23242850|NCT00975000|64633067|FG000|Overall Study|Lost to Follow-up|0|||
23242851|NCT00975000|64633068|FG001|Overall Study|Lost to Follow-up|1|||
23242852|NCT00975000|64633067|FG000|Overall Study|Protocol-specified Criteria|1|||
23242853|NCT00975000|64633068|FG001|Overall Study|Protocol-specified Criteria|0|||
23242854|NCT00975000|64633067|FG000|Overall Study|Non-compliance|0|||
23242855|NCT00975000|64633068|FG001|Overall Study|Non-compliance|1|||
23242856|NCT02057549|64633069|FG000|Overall Study|Lost to Follow-up|1|||
23242857|NCT02057549|64633070|FG001|Overall Study|Lost to Follow-up|0|||
23242858|NCT02057549|64633069|FG000|Overall Study|Physician Decision|1|||
23242859|NCT02057549|64633070|FG001|Overall Study|Physician Decision|0|||
23242860|NCT02057549|64633069|FG000|Overall Study|Withdrawal by Subject|1|||
23242861|NCT02057549|64633070|FG001|Overall Study|Withdrawal by Subject|0|||
23242862|NCT04456998|64633071|FG000|Overall Study|Adverse Event|0|||
23242863|NCT04456998|64633072|FG001|Overall Study|Adverse Event|4|||
23242864|NCT04456998|64633071|FG000|Overall Study|Protocol Deviation|0|||
23242865|NCT04456998|64633072|FG001|Overall Study|Protocol Deviation|1|||
23242866|NCT04456998|64633071|FG000|Overall Study|Withdrawal by Subject|0|||
23242867|NCT04456998|64633072|FG001|Overall Study|Withdrawal by Subject|1|||
23242868|NCT01458535|64633073|FG000|Overall Study|Other|0|||
23242869|NCT01458535|64633074|FG001|Overall Study|Other|0|||
23242870|NCT01458535|64633075|FG002|Overall Study|Other|0|||
23242871|NCT01458535|64633076|FG003|Overall Study|Other|0|||
23242872|NCT01458535|64633077|FG004|Overall Study|Other|1|||
23585083|NCT03107611|65869385|FG000|Overall Study|Lost to Follow-up|3|||
23585084|NCT03107611|65869386|FG001|Overall Study|Lost to Follow-up|3|||
23585085|NCT03107611|65869387|FG002|Overall Study|Lost to Follow-up|3|||
23585086|NCT03107611|65869385|FG000|Overall Study|Protocol Violation|0|||
23585087|NCT03107611|65869386|FG001|Overall Study|Protocol Violation|0|||
23585088|NCT03107611|65869387|FG002|Overall Study|Protocol Violation|1|||
23585089|NCT03107611|65869385|FG000|Overall Study|Withdrawal by Subject|1|||
23585090|NCT03107611|65869386|FG001|Overall Study|Withdrawal by Subject|0|||
23585091|NCT03107611|65869387|FG002|Overall Study|Withdrawal by Subject|1|||
23585092|NCT03107611|65869385|FG000|Overall Study|Worsening signs/symptoms|2|||
23585093|NCT03107611|65869386|FG001|Overall Study|Worsening signs/symptoms|1|||
23585094|NCT03107611|65869387|FG002|Overall Study|Worsening signs/symptoms|2|||
23585095|NCT02689349|65869388|FG000|Overall Study|Not implanted|4|||
23585096|NCT02689349|65869389|FG001|Overall Study|Not implanted|0|||
23585097|NCT02689349|65869388|FG000|Overall Study|Withdrawal by Subject|9|||
23585098|NCT02689349|65869389|FG001|Overall Study|Withdrawal by Subject|0|||
23585099|NCT00995709|65869393|FG000|Overall Study|Adverse Event|4|||
23585100|NCT00995709|65869394|FG001|Overall Study|Adverse Event|2|||
23585101|NCT00995709|65869395|FG002|Overall Study|Adverse Event|0|||
23585102|NCT00995709|65869393|FG000|Overall Study|Lack of Efficacy|0|||
23184296|NCT02698189|64413828|FG001|Overall Study|Physician Decision|0|||
23184297|NCT02698189|64413827|FG000|Overall Study|Progressive disease|0|||
23184298|NCT02698189|64413828|FG001|Overall Study|Progressive disease|5|||
23184299|NCT02698189|64413827|FG000|Overall Study|Study terminated by sponsor|0|||
23184300|NCT02698189|64413828|FG001|Overall Study|Study terminated by sponsor|1|||
23184301|NCT00398112|64413829|FG000|Overall Study|Adverse Event|4|||
23184302|NCT00398112|64413829|FG000|Overall Study|Disease progression|9|||
23184303|NCT00398112|64413829|FG000|Overall Study|Alternative treatment|1|||
23184304|NCT00398112|64413829|FG000|Overall Study|Withdrawal by Subject|3|||
23184305|NCT00398112|64413829|FG000|Overall Study|Death|1|||
23184306|NCT00087438|64413830|FG000|Overall Study|Ineligible / No protocol treatment|4|||
23184307|NCT01748071|64416842|FG000|Overall Study|Adverse Event|2|||
23184308|NCT01748071|64416843|FG001|Overall Study|Adverse Event|2|||
23184309|NCT01748071|64416844|FG002|Overall Study|Adverse Event|0|||
23242873|NCT01458535|64633078|FG005|Overall Study|Other|1|||
23242874|NCT01458535|64633073|FG000|Overall Study|Withdrawal by Subject|0|||
23242875|NCT01458535|64633074|FG001|Overall Study|Withdrawal by Subject|0|||
23242876|NCT01458535|64633075|FG002|Overall Study|Withdrawal by Subject|2|||
23242877|NCT01458535|64633076|FG003|Overall Study|Withdrawal by Subject|0|||
23242878|NCT01458535|64633077|FG004|Overall Study|Withdrawal by Subject|1|||
23242879|NCT01458535|64633078|FG005|Overall Study|Withdrawal by Subject|1|||
23242880|NCT01458535|64633073|FG000|Overall Study|Lost to Follow-up|0|||
23242881|NCT01458535|64633074|FG001|Overall Study|Lost to Follow-up|2|||
23242882|NCT01458535|64633075|FG002|Overall Study|Lost to Follow-up|0|||
23242883|NCT01458535|64633076|FG003|Overall Study|Lost to Follow-up|3|||
23242884|NCT01458535|64633077|FG004|Overall Study|Lost to Follow-up|2|||
23585103|NCT00995709|65869394|FG001|Overall Study|Lack of Efficacy|1|||
23585104|NCT00995709|65869395|FG002|Overall Study|Lack of Efficacy|4|||
23585105|NCT00995709|65869393|FG000|Overall Study|Withdrawal by Subject|0|||
23585106|NCT00995709|65869394|FG001|Overall Study|Withdrawal by Subject|4|||
23585107|NCT00995709|65869395|FG002|Overall Study|Withdrawal by Subject|1|||
23585108|NCT00995709|65869393|FG000|Overall Study|Lost to Follow-up|1|||
23350580|NCT01900431|65025518|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
23350581|NCT01900431|65025519|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
23350582|NCT01900431|65025517|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
23585109|NCT00995709|65869394|FG001|Overall Study|Lost to Follow-up|0|||
23242885|NCT01458535|64633078|FG005|Overall Study|Lost to Follow-up|2|||
23242886|NCT01458535|64633073|FG000|Overall Study|Adverse Event|0|||
23585110|NCT00995709|65869395|FG002|Overall Study|Lost to Follow-up|0|||
23585111|NCT00995709|65869393|FG000|Overall Study|Death|0|||
23585112|NCT00995709|65869394|FG001|Overall Study|Death|1|||
23585113|NCT00995709|65869395|FG002|Overall Study|Death|0|||
23242887|NCT01458535|64633074|FG001|Overall Study|Adverse Event|0|||
23242888|NCT01458535|64633075|FG002|Overall Study|Adverse Event|0|||
23242889|NCT01458535|64633076|FG003|Overall Study|Adverse Event|1|||
23242890|NCT01458535|64633077|FG004|Overall Study|Adverse Event|0|||
23242891|NCT01458535|64633078|FG005|Overall Study|Adverse Event|0|||
23242892|NCT00669110|64633084|FG000|Overall Study|Adverse Event|4|||
23242893|NCT00669110|64633085|FG001|Overall Study|Adverse Event|3|||
23242894|NCT00669110|64633084|FG000|Overall Study|Caregiver request|3|||
23242895|NCT00669110|64633085|FG001|Overall Study|Caregiver request|2|||
23242896|NCT00669110|64633084|FG000|Overall Study|Physician Decision|0|||
23350583|NCT01900431|65025518|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
23585114|NCT00995709|65869393|FG000|Overall Study|Protocol Violation|2|||
23585115|NCT00995709|65869394|FG001|Overall Study|Protocol Violation|1|||
23585116|NCT00995709|65869395|FG002|Overall Study|Protocol Violation|0|||
23585117|NCT01823341|65869398|FG000|Overall Study|Failed run-in|7|||
23585118|NCT01823341|65869398|FG000|Overall Study|Withdrawal by Subject|7|||
23585119|NCT01823341|65869398|FG000|Overall Study|Adverse Event|1|||
23585120|NCT01537133|65869399|FG000|Overall Study|Withdrawal by Subject|2|||
23585121|NCT01537133|65869400|FG001|Overall Study|Withdrawal by Subject|0|||
23585122|NCT01537133|65869401|FG002|Overall Study|Withdrawal by Subject|0|||
23585123|NCT01537133|65869402|FG003|Overall Study|Withdrawal by Subject|0|||
23585124|NCT01537133|65869399|FG000|Overall Study|Lost to Follow-up|1|||
23585125|NCT01537133|65869400|FG001|Overall Study|Lost to Follow-up|0|||
23585126|NCT01537133|65869401|FG002|Overall Study|Lost to Follow-up|0|||
23585127|NCT01537133|65869402|FG003|Overall Study|Lost to Follow-up|0|||
23585128|NCT00536380|65869403|FG000|Overall Study|Adverse Event|0|||
23585129|NCT00536380|65869404|FG001|Overall Study|Adverse Event|2|||
23585130|NCT00536380|65869405|FG002|Overall Study|Adverse Event|2|||
23585131|NCT00536380|65869403|FG000|Overall Study|Lost to Follow-up|0|||
23585132|NCT00536380|65869404|FG001|Overall Study|Lost to Follow-up|0|||
23585133|NCT00536380|65869405|FG002|Overall Study|Lost to Follow-up|1|||
23585134|NCT00536380|65869403|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
23585135|NCT00536380|65869404|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
23585136|NCT00536380|65869405|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
23585137|NCT00536380|65869403|FG000|Overall Study|Withdrawal related to study drug|7|||
23585138|NCT00536380|65869404|FG001|Overall Study|Withdrawal related to study drug|5|||
23585139|NCT00536380|65869405|FG002|Overall Study|Withdrawal related to study drug|2|||
23585140|NCT00536380|65869403|FG000|Overall Study|Noncompliance with protocol|3|||
23585141|NCT00536380|65869404|FG001|Overall Study|Noncompliance with protocol|2|||
23585142|NCT00536380|65869405|FG002|Overall Study|Noncompliance with protocol|2|||
23585143|NCT00536380|65869403|FG000|Overall Study|Did not meet protocol eligibility|0|||
23585144|NCT00536380|65869404|FG001|Overall Study|Did not meet protocol eligibility|0|||
23585145|NCT00536380|65869405|FG002|Overall Study|Did not meet protocol eligibility|1|||
23585146|NCT00536380|65869403|FG000|Overall Study|Administrative|0|||
23585147|NCT00536380|65869404|FG001|Overall Study|Administrative|0|||
23585148|NCT00536380|65869405|FG002|Overall Study|Administrative|1|||
23585149|NCT04163458|65869406|FG000|Overall Study|Protocol Deviation|7|||
23585150|NCT04163458|65869407|FG001|Overall Study|Protocol Deviation|13|||
23350584|NCT01900431|65025519|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
23585151|NCT04163458|65869406|FG000|Overall Study|Adverse Event|5|||
23585152|NCT04163458|65869407|FG001|Overall Study|Adverse Event|8|||
23585153|NCT04163458|65869406|FG000|Overall Study|Due to COVID-19 pandemic|4|||
23585154|NCT04163458|65869407|FG001|Overall Study|Due to COVID-19 pandemic|2|||
23585155|NCT04163458|65869406|FG000|Overall Study|Participant withdrew consent|2|||
23585156|NCT04163458|65869407|FG001|Overall Study|Participant withdrew consent|3|||
23585157|NCT04163458|65869406|FG000|Overall Study|Randomization failure|2|||
23585158|NCT04163458|65869407|FG001|Overall Study|Randomization failure|2|||
23242897|NCT00669110|64633085|FG001|Overall Study|Physician Decision|1|||
23242898|NCT00669110|64633084|FG000|Overall Study|Lost to Follow-up|1|||
23242899|NCT00669110|64633085|FG001|Overall Study|Lost to Follow-up|0|||
23242900|NCT00669110|64633084|FG000|Overall Study|Protocol Violation|0|||
23585159|NCT04163458|65869406|FG000|Overall Study|Other|4|||
23464444|NCT01077076|65444595|FG004|First Intervention|Withdrawal by Subject|0|||
23464445|NCT01077076|65444596|FG005|First Intervention|Withdrawal by Subject|0|||
23464446|NCT01077076|65444591|FG000|Third Intervention|Death in the participant's family|0|||
23464447|NCT01077076|65444592|FG001|Third Intervention|Death in the participant's family|0|||
23585160|NCT04163458|65869407|FG001|Overall Study|Other|2|||
23585161|NCT01090024|65869408|FG000|Period 1|Met exclusion criteria|0|||
23585162|NCT01090024|65869409|FG001|Period 1|Met exclusion criteria|0|||
23585163|NCT01090024|65869410|FG002|Period 1|Met exclusion criteria|0|||
23585164|NCT01090024|65869411|FG003|Period 1|Met exclusion criteria|0|||
23585165|NCT01090024|65869412|FG004|Period 1|Met exclusion criteria|0|||
23585166|NCT01090024|65869413|FG005|Period 1|Met exclusion criteria|0|||
23585167|NCT01090024|65869414|FG006|Period 1|Met exclusion criteria|0|||
23585168|NCT01090024|65869415|FG007|Period 1|Met exclusion criteria|0|||
23585169|NCT01090024|65869416|FG008|Period 1|Met exclusion criteria|0|||
23585170|NCT01090024|65869417|FG009|Period 1|Met exclusion criteria|0|||
23585171|NCT01090024|65869418|FG010|Period 1|Met exclusion criteria|0|||
23585172|NCT01090024|65869419|FG011|Period 1|Met exclusion criteria|0|||
23585173|NCT01090024|65869420|FG012|Period 1|Met exclusion criteria|0|||
23585174|NCT01090024|65869421|FG013|Period 1|Met exclusion criteria|0|||
23585175|NCT01090024|65869422|FG014|Period 1|Met exclusion criteria|1|||
23585176|NCT01090024|65869423|FG015|Period 1|Met exclusion criteria|0|||
23585177|NCT01090024|65869424|FG016|Period 1|Met exclusion criteria|0|||
23585178|NCT01090024|65869425|FG017|Period 1|Met exclusion criteria|0|||
23585179|NCT01090024|65869408|FG000|Period 1|Adverse Event|0|||
23585180|NCT01090024|65869409|FG001|Period 1|Adverse Event|0|||
23585181|NCT01090024|65869410|FG002|Period 1|Adverse Event|0|||
23585182|NCT01090024|65869411|FG003|Period 1|Adverse Event|0|||
23585183|NCT01090024|65869412|FG004|Period 1|Adverse Event|0|||
23585184|NCT01090024|65869413|FG005|Period 1|Adverse Event|0|||
23585185|NCT01090024|65869414|FG006|Period 1|Adverse Event|0|||
23585186|NCT01090024|65869415|FG007|Period 1|Adverse Event|0|||
23585187|NCT01090024|65869416|FG008|Period 1|Adverse Event|0|||
23585188|NCT01090024|65869417|FG009|Period 1|Adverse Event|1|||
23585189|NCT01090024|65869418|FG010|Period 1|Adverse Event|0|||
23585190|NCT01090024|65869419|FG011|Period 1|Adverse Event|1|||
23585191|NCT01090024|65869420|FG012|Period 1|Adverse Event|0|||
23585192|NCT01090024|65869421|FG013|Period 1|Adverse Event|0|||
23585193|NCT01090024|65869422|FG014|Period 1|Adverse Event|0|||
23585194|NCT01090024|65869423|FG015|Period 1|Adverse Event|0|||
23242901|NCT00669110|64633085|FG001|Overall Study|Protocol Violation|5|||
23242902|NCT00669110|64633084|FG000|Overall Study|Withdrawal by Subject|0|||
23242903|NCT00669110|64633085|FG001|Overall Study|Withdrawal by Subject|2|||
23242904|NCT00648739|64633086|FG000|Overall Study|Adverse Event|1|||
23242905|NCT00648739|64633087|FG001|Overall Study|Adverse Event|0|||
23242906|NCT00648739|64633088|FG002|Overall Study|Adverse Event|1|||
23242907|NCT00648739|64633089|FG003|Overall Study|Adverse Event|2|||
23242908|NCT00648739|64633090|FG004|Overall Study|Adverse Event|1|||
23242909|NCT00648739|64633091|FG005|Overall Study|Adverse Event|0|||
23242910|NCT00648739|64633092|FG006|Overall Study|Adverse Event|0|||
23242911|NCT00648739|64633086|FG000|Overall Study|Withdrawal by Subject|1|||
23242912|NCT00648739|64633087|FG001|Overall Study|Withdrawal by Subject|0|||
23242913|NCT00648739|64633088|FG002|Overall Study|Withdrawal by Subject|1|||
23242914|NCT00648739|64633089|FG003|Overall Study|Withdrawal by Subject|0|||
23242915|NCT00648739|64633090|FG004|Overall Study|Withdrawal by Subject|0|||
23242916|NCT00648739|64633091|FG005|Overall Study|Withdrawal by Subject|2|||
23242917|NCT00648739|64633092|FG006|Overall Study|Withdrawal by Subject|0|||
23242918|NCT00648739|64633086|FG000|Overall Study|Lack of Efficacy|0|||
23242919|NCT00648739|64633087|FG001|Overall Study|Lack of Efficacy|0|||
23242920|NCT00648739|64633088|FG002|Overall Study|Lack of Efficacy|0|||
23242921|NCT00648739|64633089|FG003|Overall Study|Lack of Efficacy|0|||
23242922|NCT00648739|64633090|FG004|Overall Study|Lack of Efficacy|1|||
23242923|NCT00648739|64633091|FG005|Overall Study|Lack of Efficacy|2|||
23242924|NCT00648739|64633092|FG006|Overall Study|Lack of Efficacy|0|||
23242925|NCT00648739|64633086|FG000|Overall Study|Investigator Considered it Advisable|0|||
23464448|NCT01077076|65444593|FG002|Third Intervention|Death in the participant's family|0|||
23585195|NCT01090024|65869424|FG016|Period 1|Adverse Event|0|||
23585196|NCT01090024|65869425|FG017|Period 1|Adverse Event|1|||
23585197|NCT01090024|65869408|FG000|Period 1|Withdrawal by Subject|0|||
23585198|NCT01090024|65869409|FG001|Period 1|Withdrawal by Subject|0|||
23585199|NCT01090024|65869410|FG002|Period 1|Withdrawal by Subject|0|||
23585200|NCT01090024|65869411|FG003|Period 1|Withdrawal by Subject|1|||
23585201|NCT01090024|65869412|FG004|Period 1|Withdrawal by Subject|0|||
23585202|NCT01090024|65869413|FG005|Period 1|Withdrawal by Subject|0|||
23585203|NCT01090024|65869414|FG006|Period 1|Withdrawal by Subject|0|||
23585204|NCT01090024|65869415|FG007|Period 1|Withdrawal by Subject|0|||
23242926|NCT00648739|64633087|FG001|Overall Study|Investigator Considered it Advisable|0|||
23242927|NCT00648739|64633088|FG002|Overall Study|Investigator Considered it Advisable|0|||
23242928|NCT00648739|64633089|FG003|Overall Study|Investigator Considered it Advisable|0|||
23242929|NCT00648739|64633090|FG004|Overall Study|Investigator Considered it Advisable|0|||
23184310|NCT04398732|64416845|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
23184311|NCT02041962|64416846|FG000|Overall Study|Lost Aetna Coverage|43|||
23184312|NCT02041962|64416847|FG001|Overall Study|Lost Aetna Coverage|40|||
23184313|NCT02041962|64416846|FG000|Overall Study|Death|1|||
23184314|NCT02041962|64416847|FG001|Overall Study|Death|1|||
23184315|NCT02041962|64416846|FG000|Overall Study|Lost to Follow-up|37|||
23184316|NCT02041962|64416847|FG001|Overall Study|Lost to Follow-up|32|||
23184317|NCT02041962|64416846|FG000|Overall Study|Withdrawal by Subject|0|||
23184318|NCT02041962|64416847|FG001|Overall Study|Withdrawal by Subject|11|||
23184319|NCT01573442|64416852|FG000|Overall Study|Cancels|9|||
23464449|NCT01077076|65444594|FG003|Third Intervention|Death in the participant's family|0|||
23464450|NCT01077076|65444595|FG004|Third Intervention|Death in the participant's family|0|||
23184320|NCT01573442|64416853|FG001|Overall Study|Cancels|10|||
23184321|NCT03514914|64416858|FG000|Overall Study|Death|3|||
23184322|NCT03514914|64416859|FG001|Overall Study|Death|3|||
23184323|NCT03514914|64416858|FG000|Overall Study|Lost to Follow-up|117|||
23184324|NCT03514914|64416859|FG001|Overall Study|Lost to Follow-up|89|||
23184325|NCT00618722|64416862|FG000|Overall Study|Refusal of Treatment|0|||
23184326|NCT00618722|64416863|FG001|Overall Study|Refusal of Treatment|0|||
23184327|NCT00618722|64416864|FG002|Overall Study|Refusal of Treatment|1|||
23184328|NCT00618722|64416865|FG003|Overall Study|Refusal of Treatment|0|||
23184329|NCT00618722|64416862|FG000|Overall Study|Patient Request|1|||
23184330|NCT00618722|64416863|FG001|Overall Study|Patient Request|1|||
23184331|NCT00618722|64416864|FG002|Overall Study|Patient Request|1|||
23184332|NCT00618722|64416865|FG003|Overall Study|Patient Request|1|||
23184333|NCT00618722|64416862|FG000|Overall Study|Inability to Complete Study Procedure|0|||
23242930|NCT00648739|64633091|FG005|Overall Study|Investigator Considered it Advisable|1|||
23242931|NCT00648739|64633092|FG006|Overall Study|Investigator Considered it Advisable|1|||
23242932|NCT00648739|64633086|FG000|Overall Study|Death|0|||
23242933|NCT00648739|64633087|FG001|Overall Study|Death|1|||
23242934|NCT00648739|64633088|FG002|Overall Study|Death|0|||
23242935|NCT00648739|64633089|FG003|Overall Study|Death|0|||
23242936|NCT00648739|64633090|FG004|Overall Study|Death|0|||
23242937|NCT00648739|64633091|FG005|Overall Study|Death|0|||
23242938|NCT00648739|64633092|FG006|Overall Study|Death|0|||
23242939|NCT00648739|64633086|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
23242940|NCT00648739|64633087|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
23242941|NCT00648739|64633088|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
23242942|NCT00648739|64633089|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
23242943|NCT00648739|64633090|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
23242944|NCT00648739|64633091|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
23350585|NCT01900431|65025517|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
23242945|NCT00648739|64633092|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
23242946|NCT00648739|64633086|FG000|Overall Study|Follow-up Visits Not Completed|0|||
23242947|NCT00648739|64633087|FG001|Overall Study|Follow-up Visits Not Completed|1|||
23242948|NCT00648739|64633088|FG002|Overall Study|Follow-up Visits Not Completed|0|||
23242949|NCT00648739|64633089|FG003|Overall Study|Follow-up Visits Not Completed|0|||
23242950|NCT00648739|64633090|FG004|Overall Study|Follow-up Visits Not Completed|0|||
23242951|NCT00648739|64633091|FG005|Overall Study|Follow-up Visits Not Completed|0|||
23242952|NCT00648739|64633092|FG006|Overall Study|Follow-up Visits Not Completed|0|||
23242953|NCT03644927|64633096|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
23242954|NCT03644927|64633097|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
23242955|NCT01301625|64633098|FG000|Overall Study|Death|5|||
23242956|NCT01301625|64633098|FG000|Overall Study|Not Due|21|||
23242957|NCT01301625|64633098|FG000|Overall Study|Expected|8|||
23242958|NCT01301625|64633098|FG000|Overall Study|Lost to Follow-up|1|||
23242959|NCT01683565|64633110|FG000|Overall Study|Lost to Follow-up|2|||
23242960|NCT01683565|64633111|FG001|Overall Study|Lost to Follow-up|0|||
23350586|NCT01900431|65025518|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
23184334|NCT00618722|64416863|FG001|Overall Study|Inability to Complete Study Procedure|1|||
23242961|NCT01683565|64633110|FG000|Overall Study|Discontinued Intervention|1|||
23184335|NCT00618722|64416864|FG002|Overall Study|Inability to Complete Study Procedure|0|||
23184336|NCT00618722|64416865|FG003|Overall Study|Inability to Complete Study Procedure|0|||
23184337|NCT00618722|64416862|FG000|Overall Study|Lost to Follow-up|2|||
23184338|NCT00618722|64416863|FG001|Overall Study|Lost to Follow-up|0|||
23184339|NCT00618722|64416864|FG002|Overall Study|Lost to Follow-up|0|||
23184340|NCT00618722|64416865|FG003|Overall Study|Lost to Follow-up|2|||
23184341|NCT00618722|64416862|FG000|Overall Study|Miscellaneous Reasons|0|||
23184342|NCT00618722|64416863|FG001|Overall Study|Miscellaneous Reasons|0|||
23242962|NCT01683565|64633111|FG001|Overall Study|Discontinued Intervention|1|||
23242963|NCT02074982|64633112|FG000|Overall Study|Adverse Event|15|||
23242964|NCT02074982|64633113|FG001|Overall Study|Adverse Event|7|||
23242965|NCT02074982|64633112|FG000|Overall Study|Lack of Efficacy|6|||
23242966|NCT02074982|64633113|FG001|Overall Study|Lack of Efficacy|1|||
23242967|NCT02074982|64633112|FG000|Overall Study|Lost to Follow-up|9|||
23242968|NCT02074982|64633113|FG001|Overall Study|Lost to Follow-up|10|||
23242969|NCT02074982|64633112|FG000|Overall Study|Non-compliance with study treatment|0|||
23242970|NCT02074982|64633113|FG001|Overall Study|Non-compliance with study treatment|2|||
23242971|NCT02074982|64633112|FG000|Overall Study|Physician Decision|1|||
23242972|NCT02074982|64633113|FG001|Overall Study|Physician Decision|1|||
23242973|NCT02074982|64633112|FG000|Overall Study|Pregnancy|1|||
23242974|NCT02074982|64633113|FG001|Overall Study|Pregnancy|2|||
23242975|NCT02074982|64633112|FG000|Overall Study|Protocol deviation|4|||
23242976|NCT02074982|64633113|FG001|Overall Study|Protocol deviation|3|||
23242977|NCT02074982|64633112|FG000|Overall Study|Technical problems|0|||
23350587|NCT01900431|65025519|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
23350588|NCT01900431|65025517|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
23464451|NCT01077076|65444596|FG005|Third Intervention|Death in the participant's family|1|||
23464452|NCT01526733|65444597|FG000|Phase 1|Protocol Violation|1|||
23464453|NCT01526733|65444598|FG001|Phase 1|Protocol Violation|0|||
23464454|NCT01526733|65444597|FG000|Phase 1|Withdrawal by Subject|1|||
23464455|NCT01526733|65444598|FG001|Phase 1|Withdrawal by Subject|1|||
23585205|NCT01090024|65869416|FG008|Period 1|Withdrawal by Subject|0|||
23585206|NCT01090024|65869417|FG009|Period 1|Withdrawal by Subject|0|||
23585207|NCT01090024|65869418|FG010|Period 1|Withdrawal by Subject|0|||
23585208|NCT01090024|65869419|FG011|Period 1|Withdrawal by Subject|0|||
23585209|NCT01090024|65869420|FG012|Period 1|Withdrawal by Subject|0|||
23585210|NCT01090024|65869421|FG013|Period 1|Withdrawal by Subject|0|||
23585211|NCT01090024|65869422|FG014|Period 1|Withdrawal by Subject|0|||
23585212|NCT01090024|65869423|FG015|Period 1|Withdrawal by Subject|0|||
23585213|NCT01090024|65869424|FG016|Period 1|Withdrawal by Subject|0|||
23585214|NCT01090024|65869425|FG017|Period 1|Withdrawal by Subject|0|||
23585215|NCT01090024|65869408|FG000|Period 1|Lost to Follow-up|0|||
23585216|NCT01090024|65869409|FG001|Period 1|Lost to Follow-up|1|||
23585217|NCT01090024|65869410|FG002|Period 1|Lost to Follow-up|0|||
23585218|NCT01090024|65869411|FG003|Period 1|Lost to Follow-up|0|||
23585219|NCT01090024|65869412|FG004|Period 1|Lost to Follow-up|0|||
23585220|NCT01090024|65869413|FG005|Period 1|Lost to Follow-up|0|||
23585221|NCT01090024|65869414|FG006|Period 1|Lost to Follow-up|0|||
23585222|NCT01090024|65869415|FG007|Period 1|Lost to Follow-up|0|||
23585223|NCT01090024|65869416|FG008|Period 1|Lost to Follow-up|0|||
23585224|NCT01090024|65869417|FG009|Period 1|Lost to Follow-up|0|||
23585225|NCT01090024|65869418|FG010|Period 1|Lost to Follow-up|0|||
23585226|NCT01090024|65869419|FG011|Period 1|Lost to Follow-up|0|||
23585227|NCT01090024|65869420|FG012|Period 1|Lost to Follow-up|0|||
23585228|NCT01090024|65869421|FG013|Period 1|Lost to Follow-up|0|||
23585229|NCT01090024|65869422|FG014|Period 1|Lost to Follow-up|0|||
23585230|NCT01090024|65869423|FG015|Period 1|Lost to Follow-up|0|||
23585231|NCT01090024|65869424|FG016|Period 1|Lost to Follow-up|0|||
23585232|NCT01090024|65869425|FG017|Period 1|Lost to Follow-up|0|||
23242978|NCT02074982|64633113|FG001|Overall Study|Technical problems|2|||
23242979|NCT02074982|64633112|FG000|Overall Study|Subject/guardian decision|15|||
23585233|NCT01090024|65869408|FG000|Period 2|Lost to Follow-up|0|||
23585234|NCT01090024|65869409|FG001|Period 2|Lost to Follow-up|0|||
23242980|NCT02074982|64633113|FG001|Overall Study|Subject/guardian decision|24|||
23242981|NCT02074982|64633112|FG000|Overall Study|Death|0|||
23242982|NCT02074982|64633113|FG001|Overall Study|Death|2|||
23242983|NCT00664066|64633114|FG000|Overall Study|Study terminated|3|||
23242984|NCT05111548|64633115|FG000|Overall Study|Withdrawal by Subject|2|||
23242985|NCT05111548|64633116|FG001|Overall Study|Withdrawal by Subject|1|||
23242986|NCT05111548|64633115|FG000|Overall Study|Adverse Event|1|||
23242987|NCT05111548|64633116|FG001|Overall Study|Adverse Event|0|||
23242988|NCT00698009|64633122|FG000|Overall Study|Withdrawal by Subject|1|||
23242989|NCT03205046|64633123|FG000|Overall Study|Death|10|||
23242990|NCT03205046|64633124|FG001|Overall Study|Death|6|||
23242991|NCT03205046|64633123|FG000|Overall Study|Withdrawal by Subject|1|||
23242992|NCT03205046|64633124|FG001|Overall Study|Withdrawal by Subject|2|||
23242993|NCT03205046|64633123|FG000|Overall Study|Lost to Follow-up|0|||
23242994|NCT03205046|64633124|FG001|Overall Study|Lost to Follow-up|1|||
23242995|NCT03205046|64633123|FG000|Overall Study|Study terminated by sponsor|2|||
23242996|NCT03205046|64633124|FG001|Overall Study|Study terminated by sponsor|1|||
23242997|NCT01682681|64633125|FG000|Overall Study|Lack of Efficacy|62|||
23242998|NCT01682681|64633125|FG000|Overall Study|Withdrawal by Subject|1|||
23242999|NCT01682681|64633125|FG000|Overall Study|Moved to other hospital|10|||
23243000|NCT01682681|64633125|FG000|Overall Study|Lost to Follow-up|174|||
23243001|NCT01682681|64633125|FG000|Overall Study|Adverse Event|46|||
23243002|NCT01682681|64633125|FG000|Overall Study|tapering of topiramate|5|||
23585235|NCT01090024|65869410|FG002|Period 2|Lost to Follow-up|0|||
23585236|NCT01090024|65869411|FG003|Period 2|Lost to Follow-up|1|||
23585237|NCT01090024|65869412|FG004|Period 2|Lost to Follow-up|0|||
23585238|NCT01090024|65869413|FG005|Period 2|Lost to Follow-up|0|||
23585239|NCT01090024|65869414|FG006|Period 2|Lost to Follow-up|0|||
23243003|NCT01682681|64633125|FG000|Overall Study|Other|21|||
23585240|NCT01090024|65869415|FG007|Period 2|Lost to Follow-up|0|||
23585241|NCT01090024|65869416|FG008|Period 2|Lost to Follow-up|0|||
23585242|NCT01090024|65869417|FG009|Period 2|Lost to Follow-up|0|||
23585243|NCT01090024|65869418|FG010|Period 2|Lost to Follow-up|0|||
23585244|NCT01090024|65869419|FG011|Period 2|Lost to Follow-up|0|||
23585245|NCT01090024|65869420|FG012|Period 2|Lost to Follow-up|0|||
23585246|NCT01090024|65869421|FG013|Period 2|Lost to Follow-up|0|||
23585247|NCT01090024|65869422|FG014|Period 2|Lost to Follow-up|0|||
23585248|NCT01090024|65869423|FG015|Period 2|Lost to Follow-up|0|||
23585249|NCT01090024|65869424|FG016|Period 2|Lost to Follow-up|0|||
23585250|NCT01090024|65869425|FG017|Period 2|Lost to Follow-up|0|||
23585251|NCT01090024|65869408|FG000|Period 2|Adverse Event|1|||
23585252|NCT01090024|65869409|FG001|Period 2|Adverse Event|0|||
23585253|NCT01090024|65869410|FG002|Period 2|Adverse Event|0|||
23585254|NCT01090024|65869411|FG003|Period 2|Adverse Event|0|||
23585255|NCT01090024|65869412|FG004|Period 2|Adverse Event|0|||
23585256|NCT01090024|65869413|FG005|Period 2|Adverse Event|0|||
23585257|NCT01090024|65869414|FG006|Period 2|Adverse Event|0|||
23585258|NCT01090024|65869415|FG007|Period 2|Adverse Event|0|||
23585259|NCT01090024|65869416|FG008|Period 2|Adverse Event|0|||
23585260|NCT01090024|65869417|FG009|Period 2|Adverse Event|0|||
23585261|NCT01090024|65869418|FG010|Period 2|Adverse Event|0|||
23585262|NCT01090024|65869419|FG011|Period 2|Adverse Event|0|||
23585263|NCT01090024|65869420|FG012|Period 2|Adverse Event|0|||
23585264|NCT01090024|65869421|FG013|Period 2|Adverse Event|0|||
23585265|NCT01090024|65869422|FG014|Period 2|Adverse Event|0|||
23585266|NCT01090024|65869423|FG015|Period 2|Adverse Event|0|||
23585267|NCT01090024|65869424|FG016|Period 2|Adverse Event|0|||
23585268|NCT01090024|65869425|FG017|Period 2|Adverse Event|0|||
23585269|NCT01090024|65869408|FG000|Period 3|Withdrawal by Subject|0|||
23585270|NCT01090024|65869409|FG001|Period 3|Withdrawal by Subject|0|||
23585271|NCT01090024|65869410|FG002|Period 3|Withdrawal by Subject|0|||
23585272|NCT01090024|65869411|FG003|Period 3|Withdrawal by Subject|0|||
23585273|NCT01090024|65869412|FG004|Period 3|Withdrawal by Subject|0|||
23585274|NCT01090024|65869413|FG005|Period 3|Withdrawal by Subject|0|||
23585275|NCT01090024|65869414|FG006|Period 3|Withdrawal by Subject|0|||
23585276|NCT01090024|65869415|FG007|Period 3|Withdrawal by Subject|0|||
23585277|NCT01090024|65869416|FG008|Period 3|Withdrawal by Subject|0|||
23585278|NCT01090024|65869417|FG009|Period 3|Withdrawal by Subject|0|||
23585279|NCT01090024|65869418|FG010|Period 3|Withdrawal by Subject|0|||
23585280|NCT01090024|65869419|FG011|Period 3|Withdrawal by Subject|0|||
23585281|NCT01090024|65869420|FG012|Period 3|Withdrawal by Subject|0|||
23243004|NCT01682681|64633125|FG000|Overall Study|Low compliance|13|||
23402771|NCT01446874|65220005|FG002|Overall Study|Not eligible|0|||
23585282|NCT01090024|65869421|FG013|Period 3|Withdrawal by Subject|0|||
23585283|NCT01090024|65869422|FG014|Period 3|Withdrawal by Subject|0|||
23243005|NCT04768881|64633126|FG000|Overall Study|Completed Study Follow-up|0|||
23243006|NCT04768881|64633127|FG001|Overall Study|Completed Study Follow-up|2|||
23585284|NCT01090024|65869423|FG015|Period 3|Withdrawal by Subject|1|||
23585285|NCT01090024|65869424|FG016|Period 3|Withdrawal by Subject|0|||
23585286|NCT01090024|65869425|FG017|Period 3|Withdrawal by Subject|0|||
23585287|NCT01090024|65869408|FG000|Period 3|Protocol Violation|0|||
23585288|NCT01090024|65869409|FG001|Period 3|Protocol Violation|0|||
23184343|NCT00618722|64416864|FG002|Overall Study|Miscellaneous Reasons|1|||
23184344|NCT00618722|64416865|FG003|Overall Study|Miscellaneous Reasons|1|||
23184345|NCT00752986|64416866|FG000|Overall Study|Withdrawal by Subject|2|||
23184346|NCT00752986|64416867|FG001|Overall Study|Withdrawal by Subject|1|||
23184347|NCT00752986|64416868|FG002|Overall Study|Withdrawal by Subject|2|||
23184348|NCT00752986|64416866|FG000|Overall Study|Protocol Violation|3|||
23184349|NCT00752986|64416867|FG001|Overall Study|Protocol Violation|0|||
23184350|NCT00752986|64416868|FG002|Overall Study|Protocol Violation|0|||
23184351|NCT01856114|64416869|FG000|Overall Study|Withdrawal by Subject|1|||
23184352|NCT01856114|64416870|FG001|Overall Study|Withdrawal by Subject|0|||
23184353|NCT01856114|64416869|FG000|Overall Study|Adverse Event|1|||
23184354|NCT01856114|64416870|FG001|Overall Study|Adverse Event|0|||
23184355|NCT00332202|64416871|FG000|Overall Study|Adverse Event|72|||
23184356|NCT00332202|64416872|FG001|Overall Study|Adverse Event|28|||
23184357|NCT00332202|64416871|FG000|Overall Study|Lost to Follow-up|2|||
23184358|NCT00332202|64416872|FG001|Overall Study|Lost to Follow-up|1|||
23184359|NCT00332202|64416871|FG000|Overall Study|Physician Decision|6|||
23184360|NCT00332202|64416872|FG001|Overall Study|Physician Decision|8|||
23184361|NCT00332202|64416871|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
23184362|NCT00332202|64416872|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
23184363|NCT00332202|64416871|FG000|Overall Study|Protocol Violation|7|||
23184364|NCT00332202|64416872|FG001|Overall Study|Protocol Violation|2|||
23184365|NCT00332202|64416871|FG000|Overall Study|Sponsor Decision|1|||
23184366|NCT00332202|64416872|FG001|Overall Study|Sponsor Decision|2|||
23184367|NCT00332202|64416871|FG000|Overall Study|Withdrawal by Subject|36|||
23184368|NCT00332202|64416872|FG001|Overall Study|Withdrawal by Subject|17|||
23184369|NCT00332202|64416871|FG000|Overall Study|Progressive Disease|106|||
23184370|NCT00332202|64416872|FG001|Overall Study|Progressive Disease|60|||
23184371|NCT00332202|64416871|FG000|Overall Study|Death|5|||
23184372|NCT00332202|64416872|FG001|Overall Study|Death|2|||
23184373|NCT02665689|64416880|FG000|Overall Study|Adverse Event|1|||
23184374|NCT02665689|64416881|FG001|Overall Study|Adverse Event|0|||
23184375|NCT02665689|64416880|FG000|Overall Study|Trial termination|1|||
23184376|NCT02665689|64416881|FG001|Overall Study|Trial termination|1|||
23184377|NCT02665689|64416880|FG000|Overall Study|Lost to Follow-up|0|||
23184378|NCT02665689|64416881|FG001|Overall Study|Lost to Follow-up|1|||
23184379|NCT02500537|64416886|FG000|Overall Study|Death|2|||
23184380|NCT02500537|64416887|FG001|Overall Study|Death|0|||
23184381|NCT02500537|64416886|FG000|Overall Study|Lost to Follow-up|0|||
23184382|NCT02500537|64416887|FG001|Overall Study|Lost to Follow-up|1|||
23184383|NCT02500537|64416886|FG000|Overall Study|Withdrawal by Subject|1|||
23184384|NCT02500537|64416887|FG001|Overall Study|Withdrawal by Subject|0|||
23184385|NCT02360098|64416888|FG000|Overall Study|Physician Decision|7|||
23184386|NCT02504541|64416889|FG000|Overall Study|Adverse Event|4|||
23184387|NCT02504541|64416889|FG000|Overall Study|Withdrawal by Subject|4|||
23184388|NCT02504541|64416889|FG000|Overall Study|Lost to Follow-up|1|||
23184389|NCT02504541|64416889|FG000|Overall Study|Met Stopping Criteria|1|||
23243007|NCT04768881|64633126|FG000|Overall Study|Death|3|||
23243008|NCT04768881|64633127|FG001|Overall Study|Death|2|||
23243009|NCT04768881|64633126|FG000|Overall Study|Study Terminated by Sponsor|2|||
23243010|NCT04768881|64633127|FG001|Overall Study|Study Terminated by Sponsor|2|||
23243011|NCT04768881|64633126|FG000|Overall Study|Withdrawal by Subject|2|||
23243012|NCT04768881|64633127|FG001|Overall Study|Withdrawal by Subject|0|||
23243013|NCT04768881|64633126|FG000|Overall Study|Other|2|||
23243014|NCT04768881|64633127|FG001|Overall Study|Other|0|||
23243015|NCT03417245|64633128|FG000|Overall Study|Adverse Event|1|||
23243016|NCT03417245|64633129|FG001|Overall Study|Adverse Event|0|||
23243017|NCT03417245|64633128|FG000|Overall Study|Protocol Violation|1|||
23243018|NCT03417245|64633129|FG001|Overall Study|Protocol Violation|0|||
23243019|NCT03417245|64633128|FG000|Overall Study|Withdrawal by Subject|1|||
23184390|NCT02504541|64416889|FG000|Overall Study|Protocol Violation|2|||
23184391|NCT02504541|64416889|FG000|Overall Study|Termination by Sponsor|1|||
23243020|NCT03417245|64633129|FG001|Overall Study|Withdrawal by Subject|1|||
23243021|NCT01269346|64633130|FG000|Treatment Phase|Disease progression|3|||
23243022|NCT01269346|64633130|FG000|Treatment Phase|Adverse Event|3|||
23243023|NCT01269346|64633130|FG000|Treatment Phase|Withdrawal by Subject|1|||
23184392|NCT02504541|64416889|FG000|Overall Study|Other|2|||
23184393|NCT02504541|64416889|FG000|Overall Study|Multiple|5|||
23184394|NCT01021007|64416895|FG000|Overall Study|Lost to Follow-up|1|||
23184395|NCT01021007|64416896|FG001|Overall Study|Lost to Follow-up|1|||
23184396|NCT01021007|64416895|FG000|Overall Study|Adverse Event|1|||
23184397|NCT01021007|64416896|FG001|Overall Study|Adverse Event|3|||
23184398|NCT01925703|64416908|FG000|Overall Study|Physician Decision|1|||
23184399|NCT01925703|64416908|FG000|Overall Study|Lost to Follow-up|2|||
23243024|NCT01269346|64633130|FG000|Treatment Phase|Other|2|||
23243025|NCT01269346|64633130|FG000|Extension Phase|Adverse Event|6|||
23243026|NCT01269346|64633130|FG000|Extension Phase|Withdrawal by Subject|4|||
23350589|NCT01900431|65025518|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
23350590|NCT01900431|65025519|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
23350591|NCT01900431|65025517|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
23184400|NCT01925703|64416908|FG000|Overall Study|Discharge prior to full iron repletion|1|||
23350592|NCT01900431|65025518|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
23350593|NCT01900431|65025519|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
23350594|NCT01900431|65025517|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
23350595|NCT01900431|65025518|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
23350596|NCT01900431|65025519|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
23350597|NCT01900431|65025517|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
23184401|NCT00432809|64416909|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
23184402|NCT00432809|64416910|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
23184403|NCT00432809|64416911|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
23184404|NCT00432809|64416909|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
23184405|NCT00432809|64416910|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
23184406|NCT00432809|64416911|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
23184407|NCT00446030|64416912|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
23184408|NCT00446030|64416913|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
23184409|NCT00446030|64416912|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
23184410|NCT00446030|64416913|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
23184411|NCT00446030|64416912|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
23184412|NCT00446030|64416913|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
23184413|NCT00446030|64416912|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
23184414|NCT00446030|64416913|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
23184415|NCT00446030|64416912|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
23184416|NCT00446030|64416913|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
23184417|NCT00446030|64416912|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
23184418|NCT00446030|64416913|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
23184419|NCT00446030|64416912|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
23184420|NCT00446030|64416913|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
23184421|NCT00446030|64416912|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
23184422|NCT00446030|64416913|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
23184423|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
23184424|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
23184425|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
23184426|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
23184427|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
23184428|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
23350598|NCT01900431|65025518|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
23350599|NCT01900431|65025519|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
23350600|NCT01900431|65025517|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
23350601|NCT01900431|65025518|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
23350602|NCT01900431|65025519|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
23350603|NCT02631070|65025522|FG000|Overall Study|Withdrawal by Subject|35|||
23350604|NCT02631070|65025523|FG001|Overall Study|Withdrawal by Subject|13|||
23350605|NCT02631070|65025522|FG000|Overall Study|Death|45|||
23350606|NCT02631070|65025523|FG001|Overall Study|Death|24|||
23350607|NCT02631070|65025522|FG000|Overall Study|Lost to Follow-up|5|||
23350608|NCT02631070|65025523|FG001|Overall Study|Lost to Follow-up|1|||
23350609|NCT02631070|65025522|FG000|Overall Study|Transition to rollover protocol|52|||
23350610|NCT02631070|65025523|FG001|Overall Study|Transition to rollover protocol|21|||
23350611|NCT02631070|65025522|FG000|Overall Study|Other reasons|12|||
23350612|NCT02631070|65025523|FG001|Overall Study|Other reasons|5|||
23350613|NCT02943785|65025543|FG000|Overall Study|Adverse Event|112|||
23350614|NCT02943785|65025544|FG001|Overall Study|Adverse Event|97|||
23350615|NCT02943785|65025543|FG000|Overall Study|Withdrawal by Subject|63|||
23350616|NCT02943785|65025544|FG001|Overall Study|Withdrawal by Subject|126|||
23350617|NCT02943785|65025543|FG000|Overall Study|Physician Decision|23|||
23350618|NCT02943785|65025544|FG001|Overall Study|Physician Decision|47|||
23350619|NCT02943785|65025543|FG000|Overall Study|Death|46|||
23350620|NCT02943785|65025544|FG001|Overall Study|Death|46|||
23350621|NCT02943785|65025543|FG000|Overall Study|Lost to Follow-up|1|||
23350622|NCT02943785|65025544|FG001|Overall Study|Lost to Follow-up|0|||
23350623|NCT02943785|65025543|FG000|Overall Study|Other|16|||
23350624|NCT02943785|65025544|FG001|Overall Study|Other|19|||
23350625|NCT02943785|65025543|FG000|Overall Study|Did not receive any study medication|21|||
23350626|NCT02943785|65025544|FG001|Overall Study|Did not receive any study medication|28|||
23184429|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
23184430|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
23184431|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
23184432|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
23585289|NCT01090024|65869410|FG002|Period 3|Protocol Violation|0|||
23184433|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
23184434|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
23184435|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
23184436|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
23184437|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
23184438|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
23184439|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
23184440|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
23184441|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
23184442|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
23184443|NCT00446030|64416912|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
23184444|NCT00446030|64416913|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
23184445|NCT02272790|64416914|FG000|Overall Study|Physician Decision|0|||
23184446|NCT02272790|64416915|FG001|Overall Study|Physician Decision|1|||
23184447|NCT02272790|64416916|FG002|Overall Study|Physician Decision|0|||
23184448|NCT02272790|64416917|FG003|Overall Study|Physician Decision|0|||
23184449|NCT02272790|64416918|FG004|Overall Study|Physician Decision|0|||
23184450|NCT02272790|64416919|FG005|Overall Study|Physician Decision|0|||
23184451|NCT01973283|64416925|FG000|Overall Study|Lost to Follow-up|4|||
23184452|NCT04429022|64416926|FG000|Overall Study|Protocol Violation|18|||
23184453|NCT04429022|64416927|FG001|Overall Study|Protocol Violation|1|||
23184454|NCT02318095|64416930|FG000|Overall Study|Adverse Event|1|||
23184455|NCT04964258|64416932|FG000|Overall Study|Lost to Follow-up|1|||
23184456|NCT04964258|64416933|FG001|Overall Study|Lost to Follow-up|0|||
23184457|NCT04964258|64416934|FG002|Overall Study|Lost to Follow-up|0|||
23184458|NCT04964258|64416935|FG003|Overall Study|Lost to Follow-up|0|||
23184459|NCT04964258|64416936|FG004|Overall Study|Lost to Follow-up|0|||
23184460|NCT04964258|64416937|FG005|Overall Study|Lost to Follow-up|1|||
23184461|NCT04964258|64416938|FG006|Overall Study|Lost to Follow-up|0|||
23184462|NCT04964258|64416939|FG007|Overall Study|Lost to Follow-up|0|||
23184463|NCT04964258|64416940|FG008|Overall Study|Lost to Follow-up|0|||
23184464|NCT04964258|64416941|FG009|Overall Study|Lost to Follow-up|0|||
23184465|NCT04964258|64416942|FG010|Overall Study|Lost to Follow-up|0|||
23184466|NCT00900796|64416943|FG000|Phase 1|Lacked sufficient information|4|||
23184467|NCT00900796|64416943|FG000|Phase 1|Missing information at Week 16|7|||
23184468|NCT00900796|64416943|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
23184469|NCT00900796|64416943|FG000|Phase 2|Lost to Follow-up|5|||
23184470|NCT00737529|64416948|FG000|Overall Study|Disease Progression|95|||
23184471|NCT00737529|64416948|FG000|Overall Study|Adverse Event|24|||
23184472|NCT00737529|64416948|FG000|Overall Study|Withdrawal by Subject|5|||
23184473|NCT00737529|64416948|FG000|Overall Study|Death|4|||
23184474|NCT00737529|64416948|FG000|Overall Study|Protocol Violation|1|||
23243027|NCT01269346|64633130|FG000|Extension Phase|Disease progression|22|||
23243028|NCT01269346|64633130|FG000|Extension Phase|Physician decision or participant choice|9|||
23243029|NCT01269346|64633130|FG000|Extension Phase|Clinical progression|1|||
23243030|NCT01269346|64633130|FG000|Extension Phase|Started a prohibited con med|1|||
23243031|NCT00761969|64633131|FG000|Overall Study|Death|112|||
23243032|NCT00761969|64633132|FG001|Overall Study|Death|47|||
23243033|NCT00761969|64633131|FG000|Overall Study|Lost to Follow-up|88|||
23243034|NCT00761969|64633132|FG001|Overall Study|Lost to Follow-up|93|||
23243035|NCT01600755|64633136|FG000|Overall Study|Withdrawal by Subject|6|||
23243036|NCT00684645|64633137|FG000|Overall Study|Death|2|||
23243037|NCT00684645|64633137|FG000|Overall Study|Progressive disease|67|||
23243038|NCT00684645|64633137|FG000|Overall Study|Adverse Event|27|||
23243039|NCT00684645|64633137|FG000|Overall Study|Lost to Follow-up|3|||
23243040|NCT00684645|64633137|FG000|Overall Study|Other|15|||
23243041|NCT00578448|64633138|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
23243042|NCT00578448|64633138|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
23243043|NCT00578448|64633138|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
23243044|NCT00578448|64633138|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
23243045|NCT01207219|64633139|FG000|Overall Study|changed diagnosis during study period|5|||
23243046|NCT01207219|64633140|FG001|Overall Study|changed diagnosis during study period|3|||
23243047|NCT01207219|64633141|FG002|Overall Study|changed diagnosis during study period|1|||
23243048|NCT01207219|64633139|FG000|Overall Study|Lost to Follow-up|6|||
23243049|NCT01207219|64633140|FG001|Overall Study|Lost to Follow-up|8|||
23243050|NCT01207219|64633141|FG002|Overall Study|Lost to Follow-up|6|||
23243051|NCT01640964|64633146|FG000|Overall Study|Lost to Follow-up|0|||
23243052|NCT01640964|64633147|FG001|Overall Study|Lost to Follow-up|0|||
23585290|NCT01090024|65869411|FG003|Period 3|Protocol Violation|0|||
23184475|NCT00737529|64416948|FG000|Overall Study|Other|4|||
23184476|NCT02338843|64416952|FG000|Overall Study|Adverse Event|2|||
23184477|NCT02338843|64416953|FG001|Overall Study|Adverse Event|1|||
23184478|NCT02338843|64416952|FG000|Overall Study|Death|40|||
23184479|NCT02338843|64416953|FG001|Overall Study|Death|53|||
23585291|NCT01090024|65869412|FG004|Period 3|Protocol Violation|0|||
23464456|NCT01759446|65444599|FG000|Overall Study|Protocol Violation|1|||
23464457|NCT01759446|65444600|FG001|Overall Study|Protocol Violation|0|||
23464458|NCT01759446|65444601|FG002|Overall Study|Protocol Violation|1|||
23464459|NCT01759446|65444602|FG003|Overall Study|Protocol Violation|0|||
23464460|NCT01759446|65444603|FG004|Overall Study|Protocol Violation|0|||
23464461|NCT01759446|65444599|FG000|Overall Study|Withdrawal by Subject|0|||
23464462|NCT01759446|65444600|FG001|Overall Study|Withdrawal by Subject|1|||
23464463|NCT01759446|65444601|FG002|Overall Study|Withdrawal by Subject|0|||
23464464|NCT01759446|65444602|FG003|Overall Study|Withdrawal by Subject|1|||
23464465|NCT01759446|65444603|FG004|Overall Study|Withdrawal by Subject|0|||
23464466|NCT01658436|65444639|FG000|Overall Study|Adverse Event|6|||
23464467|NCT01658436|65444640|FG001|Overall Study|Adverse Event|5|||
23184480|NCT02338843|64416952|FG000|Overall Study|Physician Decision|1|||
23184481|NCT02338843|64416953|FG001|Overall Study|Physician Decision|0|||
23184482|NCT02338843|64416952|FG000|Overall Study|Withdrawal by Subject|0|||
23184483|NCT02338843|64416953|FG001|Overall Study|Withdrawal by Subject|2|||
23184484|NCT02338843|64416952|FG000|Overall Study|Subject Recovered|0|||
23184485|NCT02338843|64416953|FG001|Overall Study|Subject Recovered|2|||
23184486|NCT02338843|64416952|FG000|Overall Study|Discontinued prior to randomizat|1|||
23184487|NCT02338843|64416953|FG001|Overall Study|Discontinued prior to randomizat|0|||
23184488|NCT01028352|64416959|FG000|Overall Study|Ineligible due to baseline average pain|5|||
23184489|NCT01028352|64416959|FG000|Overall Study|Withdrawal by Subject|1|||
23184490|NCT00222105|64416960|FG000|Overall Study|Removed due to wrong diagnosis|1|||
23184491|NCT00222105|64416960|FG000|Overall Study|Withdrawal by Subject|1|||
23184492|NCT00222105|64416960|FG000|Overall Study|Adverse Event|8|||
23184493|NCT00222105|64416960|FG000|Overall Study|Treatment delays|2|||
23184494|NCT00222105|64416960|FG000|Overall Study|Death|2|||
23184495|NCT00628355|64416963|FG000|Overall Study|Withdrawal by Subject|1|||
23184496|NCT00628355|64416964|FG001|Overall Study|Withdrawal by Subject|1|||
23184497|NCT01120626|64416965|FG000|Overall Study|Withdrawal by Subject|1|||
23184498|NCT01120626|64416966|FG001|Overall Study|Withdrawal by Subject|0|||
23184499|NCT02599402|64416969|FG000|Overall Study|Disease progression|153|||
23184500|NCT02599402|64416969|FG000|Overall Study|Study drug toxicity|201|||
23184501|NCT02599402|64416969|FG000|Overall Study|Death|26|||
23184502|NCT02599402|64416969|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
23184503|NCT02599402|64416969|FG000|Overall Study|Participant request to discontinue study treatment|13|||
23184504|NCT02599402|64416969|FG000|Overall Study|Participant withdrew consent|5|||
23243053|NCT01640964|64633148|FG002|Overall Study|Lost to Follow-up|1|||
23243054|NCT01640964|64633146|FG000|Overall Study|Protocol Deviation|1|||
23243055|NCT01640964|64633147|FG001|Overall Study|Protocol Deviation|1|||
23243056|NCT01640964|64633148|FG002|Overall Study|Protocol Deviation|2|||
23243057|NCT04281030|64633155|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
23243058|NCT04281030|64633156|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
23243059|NCT04281030|64633155|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
23243060|NCT04281030|64633156|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
23243061|NCT03209973|64635734|FG000|Overall Study|Withdrawal by Subject|7|||
23243062|NCT03209973|64635734|FG000|Overall Study|Lost to Follow-up|2|||
23243063|NCT03209973|64635734|FG000|Overall Study|Death|8|||
23243064|NCT03209973|64635734|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
23243065|NCT03209973|64635734|FG000|Overall Study|Sponsor Decision|18|||
23243066|NCT03209973|64635734|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
23243067|NCT03209973|64635734|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
23243068|NCT04165824|64635736|FG000|Overall Study|Adverse Event|23|||
23243069|NCT04165824|64635736|FG000|Overall Study|Physician Decision|1|||
23243070|NCT04165824|64635736|FG000|Overall Study|Withdrawal by Subject|17|||
23243071|NCT04165824|64635736|FG000|Overall Study|Other|5|||
23243072|NCT03185949|64635737|FG000|ITT Analysis|Withdrawal by Subject|4|||
23243073|NCT03185949|64635738|FG001|ITT Analysis|Withdrawal by Subject|3|||
23243074|NCT03185949|64635737|FG000|PP Analysis|Protocol Violation|2|||
23243075|NCT03185949|64635738|FG001|PP Analysis|Protocol Violation|2|||
23243076|NCT03185949|64635737|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
23243077|NCT03185949|64635738|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
23243078|NCT01965600|64635743|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
23243079|NCT01965600|64635744|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
23243080|NCT01965600|64635745|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
23464468|NCT01658436|65444639|FG000|Overall Study|Physician Decision|1|||
23464469|NCT01658436|65444640|FG001|Overall Study|Physician Decision|0|||
23464470|NCT01658436|65444639|FG000|Overall Study|Progressive disease|12|||
23184505|NCT02599402|64416969|FG000|Overall Study|Lost to Follow-up|1|||
23184506|NCT02599402|64416969|FG000|Overall Study|Maximum Clinical Benefit|7|||
23184507|NCT02599402|64416969|FG000|Overall Study|Poor/non-compliance|1|||
23184508|NCT02599402|64416969|FG000|Overall Study|Pregnancy|1|||
23464471|NCT01658436|65444640|FG001|Overall Study|Progressive disease|4|||
23464472|NCT01658436|65444639|FG000|Overall Study|Study terminated by sponsor|0|||
23464473|NCT01658436|65444640|FG001|Overall Study|Study terminated by sponsor|1|||
23464474|NCT01658436|65444639|FG000|Overall Study|Subject/guardian decision|0|||
23464475|NCT01658436|65444640|FG001|Overall Study|Subject/guardian decision|1|||
23464476|NCT01658436|65444639|FG000|Overall Study|Death|1|||
23464477|NCT01658436|65444640|FG001|Overall Study|Death|0|||
23464478|NCT01092546|65444646|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
23464479|NCT01354314|65444656|FG000|Overall Study|Lost to Follow-up|1|||
23464480|NCT01354314|65444657|FG001|Overall Study|Lost to Follow-up|0|||
23464481|NCT01354314|65444658|FG002|Overall Study|Lost to Follow-up|1|||
23464482|NCT01354314|65444659|FG003|Overall Study|Lost to Follow-up|1|||
23464483|NCT01354314|65444656|FG000|Overall Study|Withdrawal by Subject|0|||
23464484|NCT01354314|65444657|FG001|Overall Study|Withdrawal by Subject|0|||
23464485|NCT01354314|65444658|FG002|Overall Study|Withdrawal by Subject|1|||
23464486|NCT01354314|65444659|FG003|Overall Study|Withdrawal by Subject|0|||
23464487|NCT01354314|65444656|FG000|Overall Study|Adverse Event|0|||
23464488|NCT01354314|65444657|FG001|Overall Study|Adverse Event|0|||
23464489|NCT01354314|65444658|FG002|Overall Study|Adverse Event|0|||
23464490|NCT01354314|65444659|FG003|Overall Study|Adverse Event|1|||
23464491|NCT01354314|65444656|FG000|Overall Study|Protocol Violation|1|||
23464492|NCT01354314|65444657|FG001|Overall Study|Protocol Violation|1|||
23464493|NCT01354314|65444658|FG002|Overall Study|Protocol Violation|0|||
23464494|NCT01354314|65444659|FG003|Overall Study|Protocol Violation|0|||
23350627|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
23464495|NCT01354314|65444656|FG000|Overall Study|Less than 90% Adherence|4|||
23464496|NCT01354314|65444657|FG001|Overall Study|Less than 90% Adherence|2|||
23464497|NCT01354314|65444658|FG002|Overall Study|Less than 90% Adherence|6|||
23464498|NCT01354314|65444659|FG003|Overall Study|Less than 90% Adherence|4|||
23464499|NCT00198822|65444662|FG000|Overall Study|Lost to Follow-up|14|||
23464500|NCT00198822|65444663|FG001|Overall Study|Lost to Follow-up|20|||
23464501|NCT00198822|65444664|FG002|Overall Study|Lost to Follow-up|21|||
23464502|NCT04292899|65444665|FG000|Overall Study|Death|21|||
23464503|NCT04292899|65444666|FG001|Overall Study|Death|28|||
23464504|NCT04292899|65444667|FG002|Overall Study|Death|188|||
23464505|NCT04292899|65444668|FG003|Overall Study|Death|371|||
23464506|NCT04292899|65444665|FG000|Overall Study|Lost to Follow-up|8|||
23464507|NCT04292899|65444666|FG001|Overall Study|Lost to Follow-up|4|||
23464508|NCT04292899|65444667|FG002|Overall Study|Lost to Follow-up|22|||
23464509|NCT04292899|65444668|FG003|Overall Study|Lost to Follow-up|235|||
23464510|NCT04292899|65444665|FG000|Overall Study|Withdrew consent|1|||
23464511|NCT04292899|65444666|FG001|Overall Study|Withdrew consent|0|||
23464512|NCT04292899|65444667|FG002|Overall Study|Withdrew consent|11|||
23464513|NCT04292899|65444668|FG003|Overall Study|Withdrew consent|32|||
23464514|NCT04292899|65444665|FG000|Overall Study|Adverse Event|2|||
23464515|NCT04292899|65444666|FG001|Overall Study|Adverse Event|1|||
23184509|NCT02599402|64416969|FG000|Overall Study|Participant no longer met study criteria|7|||
23184510|NCT02599402|64416969|FG000|Overall Study|Other Reasons|95|||
23184511|NCT00541307|64416970|FG000|Overall Study|Death|5|||
23184512|NCT00541307|64416970|FG000|Overall Study|Physician Decision|3|||
23184513|NCT00541307|64416970|FG000|Overall Study|Withdrawal by Subject|6|||
23184514|NCT00541307|64416970|FG000|Overall Study|Lost to Follow-up|4|||
23184515|NCT00541307|64416970|FG000|Overall Study|Subject returned early (outside window)|1|||
23184516|NCT00541307|64416970|FG000|Overall Study|Surgical Bypass|5|||
23184517|NCT00768560|64416971|FG000|Intervention Set 1|Adverse Event|0|||
23184518|NCT00768560|64416972|FG001|Intervention Set 1|Adverse Event|1|||
23184519|NCT00768560|64416973|FG002|Intervention Set 1|Adverse Event|0|||
23184520|NCT00768560|64416974|FG003|Intervention Set 1|Adverse Event|0|||
23184521|NCT00768560|64416975|FG004|Intervention Set 1|Adverse Event|0|||
23184522|NCT00768560|64416976|FG005|Intervention Set 1|Adverse Event|0|||
23184523|NCT00885365|64416977|FG000|4 Weeks ON Treatment|Adverse Event|2|||
23184524|NCT00885365|64416978|FG001|4 Weeks ON Treatment|Adverse Event|4|||
23184525|NCT00885365|64416977|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
23585292|NCT01090024|65869413|FG005|Period 3|Protocol Violation|0|||
23184526|NCT00885365|64416978|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
23350628|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
23464516|NCT04292899|65444667|FG002|Overall Study|Adverse Event|2|||
23464517|NCT04292899|65444668|FG003|Overall Study|Adverse Event|2|||
23585293|NCT01090024|65869414|FG006|Period 3|Protocol Violation|0|||
23464518|NCT04292899|65444665|FG000|Overall Study|Investigator's Discretion|0|||
23464519|NCT04292899|65444666|FG001|Overall Study|Investigator's Discretion|0|||
23464520|NCT04292899|65444667|FG002|Overall Study|Investigator's Discretion|0|||
23464521|NCT04292899|65444668|FG003|Overall Study|Investigator's Discretion|3|||
23464522|NCT04292899|65444665|FG000|Overall Study|Non-compliance With Study Drug|0|||
23464523|NCT04292899|65444666|FG001|Overall Study|Non-compliance With Study Drug|0|||
23184527|NCT00885365|64416977|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
23184528|NCT00885365|64416978|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
23184529|NCT03596164|64416980|FG000|Overall Study|Adverse Event|0|||
23464524|NCT04292899|65444667|FG002|Overall Study|Non-compliance With Study Drug|0|||
23464525|NCT04292899|65444668|FG003|Overall Study|Non-compliance With Study Drug|1|||
23464526|NCT04292899|65444665|FG000|Overall Study|Protocol Violation|0|||
23464527|NCT04292899|65444666|FG001|Overall Study|Protocol Violation|0|||
23464528|NCT04292899|65444667|FG002|Overall Study|Protocol Violation|0|||
23464529|NCT04292899|65444668|FG003|Overall Study|Protocol Violation|1|||
23464530|NCT01668589|65444669|FG000|Overall Study|Lost to Follow-up|29|||
23464531|NCT01668589|65444670|FG001|Overall Study|Lost to Follow-up|37|||
23464532|NCT01668589|65444671|FG002|Overall Study|Lost to Follow-up|15|||
23464533|NCT01668589|65444672|FG003|Overall Study|Lost to Follow-up|5|||
23464534|NCT01668589|65444669|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
23464535|NCT01668589|65444670|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
23464536|NCT01668589|65444671|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
23464537|NCT01668589|65444672|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
23464538|NCT01668589|65444669|FG000|Overall Study|Death|12|||
23464539|NCT01668589|65444670|FG001|Overall Study|Death|3|||
23464540|NCT01668589|65444671|FG002|Overall Study|Death|2|||
23464541|NCT01668589|65444672|FG003|Overall Study|Death|11|||
23464542|NCT01668589|65444669|FG000|Overall Study|Other|44|||
23464543|NCT01668589|65444670|FG001|Overall Study|Other|10|||
23464544|NCT01668589|65444671|FG002|Overall Study|Other|7|||
23464545|NCT01668589|65444672|FG003|Overall Study|Other|15|||
23464546|NCT01021020|65444673|FG000|Period I|Protocol Violation|1|||
23464547|NCT01021020|65444673|FG000|Period I|Withdrawal by Subject|1|||
23464548|NCT01021020|65444673|FG000|14 Day Washout Period A|Physician Decision|1|||
23464549|NCT00815659|65444674|FG000|Overall Study|Adverse Event|9|||
23464550|NCT00815659|65444674|FG000|Overall Study|Withdrawal by Subject|9|||
23464551|NCT00815659|65444674|FG000|Overall Study|Lost to Follow-up|4|||
23464552|NCT00815659|65444674|FG000|Overall Study|Protocol Violation|1|||
23464553|NCT00891904|65444675|FG000|Overall Study|Death|1|||
23464554|NCT00891904|65444675|FG000|Overall Study|Adverse Event|1|||
23464555|NCT00831181|65444676|FG000|Overall Study|Adverse Event|12|||
23464556|NCT00071058|65444677|FG000|Overall Study|brain tumor-removed from study|1|||
23464557|NCT01472289|65444680|FG000|Overall Study|Death|2|||
23464558|NCT02055118|65444681|FG000|Overall Study|Withdrawal by Subject|0|||
23464559|NCT02055118|65444682|FG001|Overall Study|Withdrawal by Subject|2|||
23464560|NCT02055118|65444683|FG002|Overall Study|Withdrawal by Subject|0|||
23464561|NCT02904954|65444686|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
23464562|NCT02904954|65444687|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
23464563|NCT02904954|65444686|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
23464564|NCT02904954|65444687|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
23464565|NCT02904954|65444686|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
23464566|NCT02904954|65444687|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
23464567|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Recurrence|2|||
23464568|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Recurrence|0|||
23464569|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Adverse Event|2|||
23464570|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Adverse Event|6|||
23464571|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Participant wishes|12|||
23464572|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Participant wishes|7|||
23464573|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Physician Decision|2|||
23464574|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Physician Decision|1|||
23464575|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
23464576|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
23464577|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Death|0|||
23464578|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Death|1|||
23464579|NCT02904954|65444686|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
23464580|NCT02904954|65444687|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
23464581|NCT02035267|65444691|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
23464582|NCT02035267|65444692|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
23464583|NCT02035267|65444693|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
23464584|NCT02035267|65444694|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
23464585|NCT02035267|65444691|FG000|Overall Study|Adverse Event|0|||
23464586|NCT02035267|65444692|FG001|Overall Study|Adverse Event|0|||
23585294|NCT01090024|65869415|FG007|Period 3|Protocol Violation|0|||
23243081|NCT01965600|64635746|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
23243082|NCT01965600|64635743|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
23464587|NCT02035267|65444693|FG002|Overall Study|Adverse Event|1|||
23464588|NCT02035267|65444694|FG003|Overall Study|Adverse Event|0|||
23464589|NCT02035267|65444691|FG000|Overall Study|Lost to Follow-up|0|||
23464590|NCT02035267|65444692|FG001|Overall Study|Lost to Follow-up|0|||
23464591|NCT02035267|65444693|FG002|Overall Study|Lost to Follow-up|0|||
23464592|NCT02035267|65444694|FG003|Overall Study|Lost to Follow-up|1|||
23464593|NCT02035267|65444691|FG000|Overall Study|Other unspecified|0|||
23464594|NCT02035267|65444692|FG001|Overall Study|Other unspecified|1|||
23464595|NCT02035267|65444693|FG002|Overall Study|Other unspecified|0|||
23464596|NCT02035267|65444694|FG003|Overall Study|Other unspecified|0|||
23464597|NCT03774576|65444695|FG000|Period 2|Adverse Event|1|||
23464598|NCT01442103|65444696|FG000|Overall Study|Lost to Follow-up|2|||
23464599|NCT02454517|65444697|FG000|Overall Study|Withdrawal by Subject|3|||
23464600|NCT02454517|65444698|FG001|Overall Study|Withdrawal by Subject|0|||
23464601|NCT02454517|65444697|FG000|Overall Study|Lost to Follow-up|4|||
23464602|NCT02454517|65444698|FG001|Overall Study|Lost to Follow-up|7|||
23464603|NCT02454517|65444697|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
23464604|NCT02454517|65444698|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
23585295|NCT01090024|65869416|FG008|Period 3|Protocol Violation|1|||
23585296|NCT01090024|65869417|FG009|Period 3|Protocol Violation|0|||
23585297|NCT01090024|65869418|FG010|Period 3|Protocol Violation|0|||
23585298|NCT01090024|65869419|FG011|Period 3|Protocol Violation|0|||
23585299|NCT01090024|65869420|FG012|Period 3|Protocol Violation|0|||
23585300|NCT01090024|65869421|FG013|Period 3|Protocol Violation|0|||
23585301|NCT01090024|65869422|FG014|Period 3|Protocol Violation|0|||
23585302|NCT01090024|65869423|FG015|Period 3|Protocol Violation|0|||
23585303|NCT01090024|65869424|FG016|Period 3|Protocol Violation|0|||
23585304|NCT01090024|65869425|FG017|Period 3|Protocol Violation|0|||
23585305|NCT01090024|65869408|FG000|Period 3|Adverse Event|0|||
23585306|NCT01090024|65869409|FG001|Period 3|Adverse Event|0|||
23585307|NCT01090024|65869410|FG002|Period 3|Adverse Event|0|||
23585308|NCT01090024|65869411|FG003|Period 3|Adverse Event|0|||
23585309|NCT01090024|65869412|FG004|Period 3|Adverse Event|0|||
23585310|NCT01090024|65869413|FG005|Period 3|Adverse Event|1|||
23585311|NCT01090024|65869414|FG006|Period 3|Adverse Event|0|||
23585312|NCT01090024|65869415|FG007|Period 3|Adverse Event|0|||
23585313|NCT01090024|65869416|FG008|Period 3|Adverse Event|0|||
23585314|NCT01090024|65869417|FG009|Period 3|Adverse Event|0|||
23585315|NCT01090024|65869418|FG010|Period 3|Adverse Event|0|||
23585316|NCT01090024|65869419|FG011|Period 3|Adverse Event|0|||
23585317|NCT01090024|65869420|FG012|Period 3|Adverse Event|0|||
23585318|NCT01090024|65869421|FG013|Period 3|Adverse Event|0|||
23585319|NCT01090024|65869422|FG014|Period 3|Adverse Event|0|||
23585320|NCT01090024|65869423|FG015|Period 3|Adverse Event|0|||
23585321|NCT01090024|65869424|FG016|Period 3|Adverse Event|0|||
23585322|NCT01090024|65869425|FG017|Period 3|Adverse Event|0|||
23585323|NCT00290706|65869426|FG000|Overall Study|Withdrawal by Subject|2|||
23585324|NCT00290706|65869427|FG001|Overall Study|Withdrawal by Subject|0|||
23585325|NCT00290706|65869428|FG002|Overall Study|Withdrawal by Subject|0|||
23585326|NCT00290706|65869429|FG003|Overall Study|Withdrawal by Subject|0|||
23585327|NCT00290706|65869426|FG000|Overall Study|Progressive Disease|3|||
23585328|NCT00290706|65869427|FG001|Overall Study|Progressive Disease|5|||
23184530|NCT03596164|64416981|FG001|Overall Study|Adverse Event|1|||
23184531|NCT03596164|64416980|FG000|Overall Study|Death|1|||
23184532|NCT03596164|64416981|FG001|Overall Study|Death|0|||
23184533|NCT01276821|64416983|FG000|Overall Study|Protocol Violation|0|||
23184534|NCT01276821|64416984|FG001|Overall Study|Protocol Violation|1|||
23184535|NCT00947349|64416985|FG000|Triple Treatment Combination Period|Adverse Event|0|||
23184536|NCT00947349|64416986|FG001|Triple Treatment Combination Period|Adverse Event|1|||
23585329|NCT00290706|65869428|FG002|Overall Study|Progressive Disease|4|||
23585330|NCT00290706|65869429|FG003|Overall Study|Progressive Disease|10|||
23585331|NCT00290706|65869426|FG000|Overall Study|Adverse Event|0|||
23585332|NCT00290706|65869427|FG001|Overall Study|Adverse Event|1|||
23585333|NCT00290706|65869428|FG002|Overall Study|Adverse Event|2|||
23184537|NCT00947349|64416987|FG002|Triple Treatment Combination Period|Adverse Event|0|||
23184538|NCT00947349|64416988|FG003|Triple Treatment Combination Period|Adverse Event|0|||
23184539|NCT00947349|64416985|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
23184540|NCT00947349|64416986|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
23184541|NCT00947349|64416987|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
23184542|NCT00947349|64416988|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
23184543|NCT00947349|64416985|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
23585334|NCT00290706|65869429|FG003|Overall Study|Adverse Event|0|||
23585335|NCT00290706|65869426|FG000|Overall Study|Receive auto transplant or radiation|0|||
23585336|NCT00290706|65869427|FG001|Overall Study|Receive auto transplant or radiation|0|||
23585337|NCT00290706|65869428|FG002|Overall Study|Receive auto transplant or radiation|0|||
23585338|NCT00290706|65869429|FG003|Overall Study|Receive auto transplant or radiation|1|||
23585339|NCT00290706|65869426|FG000|Overall Study|Physician Decision|0|||
23464605|NCT03818321|65444701|FG000|Overall Study|Withdrawal by Subject|1|||
23464606|NCT03818321|65444702|FG001|Overall Study|Withdrawal by Subject|2|||
23585340|NCT00290706|65869427|FG001|Overall Study|Physician Decision|0|||
23585341|NCT00290706|65869428|FG002|Overall Study|Physician Decision|0|||
23585342|NCT00290706|65869429|FG003|Overall Study|Physician Decision|1|||
23585343|NCT00771667|65869430|FG000|Induction Phase|Adverse Event|5|||
23585344|NCT00771667|65869431|FG001|Induction Phase|Adverse Event|2|||
23585345|NCT00771667|65869432|FG002|Induction Phase|Adverse Event|4|||
23585346|NCT00771667|65869433|FG003|Induction Phase|Adverse Event|1|||
23184544|NCT00947349|64416986|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
23585347|NCT00771667|65869434|FG004|Induction Phase|Adverse Event|0|||
23585348|NCT00771667|65869435|FG005|Induction Phase|Adverse Event|0|||
23184545|NCT00947349|64416987|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
23184546|NCT00947349|64416988|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
23464607|NCT02453321|65444703|FG000|Overall Study|Weakness|1|||
23464608|NCT02453321|65444704|FG001|Overall Study|Weakness|1|||
23464609|NCT02453321|65444705|FG002|Overall Study|Weakness|2|||
23464610|NCT02453321|65444703|FG000|Overall Study|Deep Venous Thrombosis|0|||
23464611|NCT02453321|65444704|FG001|Overall Study|Deep Venous Thrombosis|1|||
23464612|NCT02453321|65444705|FG002|Overall Study|Deep Venous Thrombosis|0|||
23464613|NCT04639258|65444706|FG000|Overall Study|Screen failure|5|||
23464614|NCT04639258|65444706|FG000|Overall Study|Physician Decision|2|||
23464615|NCT04639258|65444706|FG000|Overall Study|Early study termination|3|||
23464616|NCT04639258|65444706|FG000|Overall Study|Withdrawal by Subject|1|||
23464617|NCT02531802|65444707|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
23464618|NCT02531802|65444708|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
23464619|NCT02531802|65444709|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
23464620|NCT02531802|65444710|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
23464621|NCT02531802|65444711|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
23464622|NCT02531802|65444712|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
23464623|NCT02531802|65444713|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
23464624|NCT02531802|65444714|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
23464625|NCT02531802|65444715|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
23464626|NCT02531802|65444716|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
23464627|NCT02531802|65444717|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
23464628|NCT02531802|65444718|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
23464629|NCT02531802|65444719|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
23464630|NCT02531802|65444720|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
23464631|NCT02531802|65444721|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
23464632|NCT02531802|65444722|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
23464633|NCT02531802|65444723|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
23464634|NCT02531802|65444724|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
23464635|NCT02531802|65444725|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
23464636|NCT02531802|65444726|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
23464637|NCT02531802|65444727|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
23464638|NCT02531802|65444707|FG000|Received Vaccination 2|Physician Decision|0|||
23464639|NCT02531802|65444708|FG001|Received Vaccination 2|Physician Decision|0|||
23464640|NCT02531802|65444709|FG002|Received Vaccination 2|Physician Decision|0|||
23464641|NCT02531802|65444710|FG003|Received Vaccination 2|Physician Decision|0|||
23464642|NCT02531802|65444711|FG004|Received Vaccination 2|Physician Decision|0|||
23464643|NCT02531802|65444712|FG005|Received Vaccination 2|Physician Decision|1|||
23464644|NCT02531802|65444713|FG006|Received Vaccination 2|Physician Decision|0|||
23184547|NCT00947349|64416985|FG000|Overall Study Standard of Care|Other|0|||
23184548|NCT00947349|64416986|FG001|Overall Study Standard of Care|Other|0|||
23184549|NCT00947349|64416987|FG002|Overall Study Standard of Care|Other|0|||
23184550|NCT00947349|64416988|FG003|Overall Study Standard of Care|Other|1|||
23184551|NCT01686568|64417002|FG000|Main Study|Withdrawal by Subject|1|||
23184552|NCT01686568|64417003|FG001|Main Study|Withdrawal by Subject|3|||
23184553|NCT01686568|64417002|FG000|Main Study|Noncompliance with protocol|0|||
23184554|NCT01686568|64417003|FG001|Main Study|Noncompliance with protocol|1|||
23184555|NCT01686568|64417002|FG000|Main Study|Liver enzymes above range of exclusion|1|||
23184556|NCT01686568|64417003|FG001|Main Study|Liver enzymes above range of exclusion|0|||
23184557|NCT01686568|64417002|FG000|Sub-Study|Not consented for sub-study|2|||
23184558|NCT01686568|64417003|FG001|Sub-Study|Not consented for sub-study|2|||
23184559|NCT01307423|64417004|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
23184560|NCT01307423|64417005|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
23184561|NCT01307423|64417006|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
23184562|NCT01307423|64417007|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23184563|NCT01307423|64417008|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23184564|NCT01307423|64417009|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23184565|NCT01307423|64417010|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23184566|NCT01307423|64417011|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23243083|NCT01965600|64635744|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
23464645|NCT02531802|65444714|FG007|Received Vaccination 2|Physician Decision|0|||
23464646|NCT02531802|65444715|FG008|Received Vaccination 2|Physician Decision|0|||
23464647|NCT02531802|65444716|FG009|Received Vaccination 2|Physician Decision|2|||
23464648|NCT02531802|65444717|FG010|Received Vaccination 2|Physician Decision|0|||
23184567|NCT01307423|64417012|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23184568|NCT01307423|64417004|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
23243084|NCT01965600|64635745|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
23464649|NCT02531802|65444718|FG011|Received Vaccination 2|Physician Decision|0|||
23464650|NCT02531802|65444719|FG012|Received Vaccination 2|Physician Decision|0|||
23464651|NCT02531802|65444720|FG013|Received Vaccination 2|Physician Decision|1|||
23464652|NCT02531802|65444721|FG014|Received Vaccination 2|Physician Decision|0|||
23464653|NCT02531802|65444722|FG015|Received Vaccination 2|Physician Decision|0|||
23184569|NCT01307423|64417005|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
23184570|NCT01307423|64417006|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
23184571|NCT01307423|64417007|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23184572|NCT01307423|64417008|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23184573|NCT01307423|64417009|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23184574|NCT01307423|64417010|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23184575|NCT01307423|64417011|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23184576|NCT01307423|64417012|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23184577|NCT01307423|64417004|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
23184578|NCT01307423|64417005|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
23184579|NCT01307423|64417006|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
23464654|NCT02531802|65444723|FG016|Received Vaccination 2|Physician Decision|0|||
23464655|NCT02531802|65444724|FG017|Received Vaccination 2|Physician Decision|1|||
23464656|NCT02531802|65444725|FG018|Received Vaccination 2|Physician Decision|0|||
23464657|NCT02531802|65444726|FG019|Received Vaccination 2|Physician Decision|0|||
23464658|NCT02531802|65444727|FG020|Received Vaccination 2|Physician Decision|0|||
23464659|NCT02531802|65444707|FG000|Received Vaccination 2|Adverse Event|0|||
23464660|NCT02531802|65444708|FG001|Received Vaccination 2|Adverse Event|0|||
23464661|NCT02531802|65444709|FG002|Received Vaccination 2|Adverse Event|0|||
23464662|NCT02531802|65444710|FG003|Received Vaccination 2|Adverse Event|0|||
23464663|NCT02531802|65444711|FG004|Received Vaccination 2|Adverse Event|0|||
23464664|NCT02531802|65444712|FG005|Received Vaccination 2|Adverse Event|2|||
23464665|NCT02531802|65444713|FG006|Received Vaccination 2|Adverse Event|0|||
23464666|NCT02531802|65444714|FG007|Received Vaccination 2|Adverse Event|0|||
23464667|NCT02531802|65444715|FG008|Received Vaccination 2|Adverse Event|0|||
23464668|NCT02531802|65444716|FG009|Received Vaccination 2|Adverse Event|0|||
23464669|NCT02531802|65444717|FG010|Received Vaccination 2|Adverse Event|0|||
23184580|NCT01307423|64417007|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23184581|NCT01307423|64417008|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23184582|NCT01307423|64417009|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23184583|NCT01307423|64417010|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23184584|NCT01307423|64417011|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23184585|NCT01307423|64417012|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23184586|NCT01307423|64417004|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23184587|NCT01307423|64417005|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23184588|NCT01307423|64417006|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
23184589|NCT01307423|64417007|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23184590|NCT01307423|64417008|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23184591|NCT01307423|64417009|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23184592|NCT01307423|64417010|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23184593|NCT01307423|64417011|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23184594|NCT01307423|64417012|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23184595|NCT01307423|64417004|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
23184596|NCT01307423|64417005|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23184597|NCT01307423|64417006|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
23184598|NCT01307423|64417007|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23184599|NCT01307423|64417008|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23184600|NCT01307423|64417009|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23184601|NCT01307423|64417010|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23184602|NCT01307423|64417011|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23184603|NCT01307423|64417012|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23184604|NCT01307423|64417004|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23184605|NCT01307423|64417005|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23184606|NCT01307423|64417006|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23184607|NCT01307423|64417007|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23184608|NCT01307423|64417008|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23184609|NCT01307423|64417009|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23184610|NCT01307423|64417010|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23184611|NCT01307423|64417011|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23464670|NCT02531802|65444718|FG011|Received Vaccination 2|Adverse Event|0|||
23464671|NCT02531802|65444719|FG012|Received Vaccination 2|Adverse Event|0|||
23464672|NCT02531802|65444720|FG013|Received Vaccination 2|Adverse Event|0|||
23464673|NCT02531802|65444721|FG014|Received Vaccination 2|Adverse Event|0|||
23585349|NCT00771667|65869436|FG006|Induction Phase|Adverse Event|0|||
23184612|NCT01307423|64417012|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23184613|NCT01307423|64417004|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
23184614|NCT01307423|64417005|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
23184615|NCT01307423|64417006|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23184616|NCT01307423|64417007|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23184617|NCT01307423|64417008|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23184618|NCT01307423|64417009|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23184619|NCT01307423|64417010|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23184620|NCT01307423|64417011|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23184621|NCT01307423|64417012|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23184622|NCT01307423|64417004|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23184623|NCT01307423|64417005|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
23184624|NCT01307423|64417006|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
23184625|NCT01307423|64417007|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23184626|NCT01307423|64417008|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23184627|NCT01307423|64417009|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23184628|NCT01307423|64417010|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23184629|NCT01307423|64417011|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23184630|NCT01307423|64417012|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
23184631|NCT01307423|64417004|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23184632|NCT01307423|64417005|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
23184633|NCT01307423|64417006|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
23184634|NCT01307423|64417007|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
23184635|NCT01307423|64417008|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
23184636|NCT01307423|64417009|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23184637|NCT01307423|64417010|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23184638|NCT01307423|64417011|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23184639|NCT01307423|64417012|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
23184640|NCT01307423|64417004|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23184641|NCT01307423|64417005|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
23184642|NCT01307423|64417006|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
23184643|NCT01307423|64417007|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
23184644|NCT01307423|64417008|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
23184645|NCT01307423|64417009|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23184646|NCT01307423|64417010|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23184647|NCT01307423|64417011|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23184648|NCT01307423|64417012|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
23184649|NCT01307423|64417004|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23184650|NCT01307423|64417005|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23184651|NCT01307423|64417006|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23243085|NCT01965600|64635746|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
23243086|NCT01965600|64635743|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
23243087|NCT01965600|64635744|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
23243088|NCT01965600|64635745|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
23243089|NCT01965600|64635746|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
23243090|NCT01965600|64635743|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
23243091|NCT01965600|64635744|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
23464674|NCT02531802|65444722|FG015|Received Vaccination 2|Adverse Event|0|||
23464675|NCT02531802|65444723|FG016|Received Vaccination 2|Adverse Event|0|||
23464676|NCT02531802|65444724|FG017|Received Vaccination 2|Adverse Event|2|||
23464677|NCT02531802|65444725|FG018|Received Vaccination 2|Adverse Event|1|||
23464678|NCT02531802|65444726|FG019|Received Vaccination 2|Adverse Event|0|||
23243092|NCT01965600|64635745|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
23243093|NCT01965600|64635746|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
23243094|NCT01965600|64635743|FG000|Second Intervention|Study terminated by Sponsor|0|||
23243095|NCT01965600|64635744|FG001|Second Intervention|Study terminated by Sponsor|0|||
23243096|NCT01965600|64635745|FG002|Second Intervention|Study terminated by Sponsor|2|||
23243097|NCT01965600|64635746|FG003|Second Intervention|Study terminated by Sponsor|2|||
23243098|NCT03292731|64635747|FG000|Overall Study|Protocol Violation|4|||
23243099|NCT03292731|64635748|FG001|Overall Study|Protocol Violation|11|||
23243100|NCT03292731|64635749|FG002|Overall Study|Protocol Violation|1|||
23243101|NCT01058707|64635751|FG000|Overall Study|Disease Progression|15|||
23243102|NCT01058707|64635752|FG001|Overall Study|Disease Progression|20|||
23464679|NCT02531802|65444727|FG020|Received Vaccination 2|Adverse Event|1|||
23464680|NCT02531802|65444707|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
23464681|NCT02531802|65444708|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
23243103|NCT01058707|64635753|FG002|Overall Study|Disease Progression|20|||
23585350|NCT00771667|65869437|FG007|Induction Phase|Adverse Event|0|||
23585351|NCT00771667|65869438|FG008|Induction Phase|Adverse Event|0|||
23585352|NCT00771667|65869439|FG009|Induction Phase|Adverse Event|0|||
23585353|NCT00771667|65869430|FG000|Induction Phase|Lack of Efficacy|9|||
23585354|NCT00771667|65869431|FG001|Induction Phase|Lack of Efficacy|2|||
23585355|NCT00771667|65869432|FG002|Induction Phase|Lack of Efficacy|4|||
23585356|NCT00771667|65869433|FG003|Induction Phase|Lack of Efficacy|3|||
23585357|NCT00771667|65869434|FG004|Induction Phase|Lack of Efficacy|0|||
23585358|NCT00771667|65869435|FG005|Induction Phase|Lack of Efficacy|0|||
23585359|NCT00771667|65869436|FG006|Induction Phase|Lack of Efficacy|0|||
23585360|NCT00771667|65869437|FG007|Induction Phase|Lack of Efficacy|0|||
23585361|NCT00771667|65869438|FG008|Induction Phase|Lack of Efficacy|0|||
23585362|NCT00771667|65869439|FG009|Induction Phase|Lack of Efficacy|0|||
23184652|NCT01307423|64417007|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23184653|NCT01307423|64417008|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23184654|NCT01307423|64417009|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
23184655|NCT01307423|64417010|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23184656|NCT01307423|64417011|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23184657|NCT01307423|64417012|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
23184658|NCT01307423|64417004|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23184659|NCT01307423|64417005|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
23184660|NCT01307423|64417006|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
23184661|NCT01307423|64417007|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23184662|NCT01307423|64417008|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23184663|NCT01307423|64417009|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
23184664|NCT01307423|64417010|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
23184665|NCT01307423|64417011|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23184666|NCT01307423|64417012|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
23184667|NCT01307423|64417004|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23184668|NCT01307423|64417005|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23184669|NCT01307423|64417006|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23184670|NCT01307423|64417007|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
23184671|NCT01307423|64417008|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23184672|NCT01307423|64417009|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23184673|NCT01307423|64417010|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23184674|NCT01307423|64417011|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23184675|NCT01307423|64417012|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
23184676|NCT01307423|64417004|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
23184677|NCT01307423|64417005|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
23184678|NCT01307423|64417006|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
23184679|NCT01307423|64417007|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
23184680|NCT01307423|64417008|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
23184681|NCT01307423|64417009|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
23184682|NCT01307423|64417010|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
23184683|NCT01307423|64417011|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
23184684|NCT01307423|64417012|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
23184685|NCT01307423|64417004|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23184686|NCT01307423|64417005|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23184687|NCT01307423|64417006|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23184688|NCT01307423|64417007|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23184689|NCT01307423|64417008|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23184690|NCT01307423|64417009|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
23184691|NCT01307423|64417010|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23184692|NCT01307423|64417011|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23184693|NCT01307423|64417012|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
23184694|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23184695|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
23184696|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
23184697|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23184698|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23184699|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23184700|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
23184701|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
23184702|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
23243104|NCT01058707|64635754|FG003|Overall Study|Disease Progression|15|||
23243105|NCT01058707|64635755|FG004|Overall Study|Disease Progression|23|||
23243106|NCT01058707|64635756|FG005|Overall Study|Disease Progression|10|||
23585363|NCT00771667|65869430|FG000|Induction Phase|Lost to Follow-up|1|||
23585364|NCT00771667|65869431|FG001|Induction Phase|Lost to Follow-up|0|||
23585365|NCT00771667|65869432|FG002|Induction Phase|Lost to Follow-up|1|||
23464682|NCT02531802|65444709|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
23464683|NCT02531802|65444710|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
23464684|NCT02531802|65444711|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
23464685|NCT02531802|65444712|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
23464686|NCT02531802|65444713|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
23464687|NCT02531802|65444714|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
23464688|NCT02531802|65444715|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
23464689|NCT02531802|65444716|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
23464690|NCT02531802|65444717|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
23184703|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23184704|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
23184705|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
23184706|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23184707|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23184708|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23184709|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
23184710|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
23184711|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
23184712|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23184713|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23184714|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
23184715|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23184716|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23184717|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23184718|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23184719|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23184720|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
23184721|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23184722|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
23184723|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
23184724|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23184725|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23184726|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23184727|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23184728|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
23184729|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
23184730|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23184731|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23184732|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23184733|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23184734|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23184735|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23184736|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
23184737|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23184738|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
23184739|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23184740|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
23184741|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
23464691|NCT02531802|65444718|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
23464692|NCT02531802|65444719|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
23464693|NCT02531802|65444720|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
23464694|NCT02531802|65444721|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
23464695|NCT02531802|65444722|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
23464696|NCT02531802|65444723|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
23464697|NCT02531802|65444724|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
23464698|NCT02531802|65444725|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
23464699|NCT02531802|65444726|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
23464700|NCT02531802|65444727|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
23464701|NCT02633020|65444728|FG000|Overall Study|Adverse Event|1|||
23464702|NCT02633020|65444729|FG001|Overall Study|Adverse Event|0|||
23464703|NCT01298648|65444730|FG000|Overall Study|Withdrawal by Subject|2|||
23464704|NCT01298648|65444730|FG000|Overall Study|Lost to Follow-up|21|||
23464705|NCT03077412|65444731|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
23464706|NCT03077412|65444732|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
23184742|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23464707|NCT03077412|65444733|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
23464708|NCT03077412|65444731|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
23184743|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23464709|NCT03077412|65444732|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
23464710|NCT03077412|65444733|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
23464711|NCT03077412|65444731|FG000|Overall Study|Adverse Event|1|||
23184744|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23184745|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
23184746|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
23184747|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
23184748|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23184749|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
23184750|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
23184751|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23184752|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23585366|NCT00771667|65869433|FG003|Induction Phase|Lost to Follow-up|0|||
23184753|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23184754|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
23585367|NCT00771667|65869434|FG004|Induction Phase|Lost to Follow-up|0|||
23585368|NCT00771667|65869435|FG005|Induction Phase|Lost to Follow-up|0|||
23585369|NCT00771667|65869436|FG006|Induction Phase|Lost to Follow-up|0|||
23585370|NCT00771667|65869437|FG007|Induction Phase|Lost to Follow-up|0|||
23585371|NCT00771667|65869438|FG008|Induction Phase|Lost to Follow-up|0|||
23585372|NCT00771667|65869439|FG009|Induction Phase|Lost to Follow-up|0|||
23585373|NCT00771667|65869430|FG000|Induction Phase|Other|4|||
23585374|NCT00771667|65869431|FG001|Induction Phase|Other|6|||
23585375|NCT00771667|65869432|FG002|Induction Phase|Other|3|||
23585376|NCT00771667|65869433|FG003|Induction Phase|Other|4|||
23585377|NCT00771667|65869434|FG004|Induction Phase|Other|0|||
23585378|NCT00771667|65869435|FG005|Induction Phase|Other|0|||
23585379|NCT00771667|65869436|FG006|Induction Phase|Other|0|||
23585380|NCT00771667|65869437|FG007|Induction Phase|Other|0|||
23585381|NCT00771667|65869438|FG008|Induction Phase|Other|0|||
23585382|NCT00771667|65869439|FG009|Induction Phase|Other|0|||
23585383|NCT00771667|65869430|FG000|Maintenance Phase|Adverse Event|0|||
23585384|NCT00771667|65869431|FG001|Maintenance Phase|Adverse Event|0|||
23585385|NCT00771667|65869432|FG002|Maintenance Phase|Adverse Event|0|||
23585386|NCT00771667|65869433|FG003|Maintenance Phase|Adverse Event|0|||
23585387|NCT00771667|65869434|FG004|Maintenance Phase|Adverse Event|1|||
23585388|NCT00771667|65869435|FG005|Maintenance Phase|Adverse Event|3|||
23184755|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
23184756|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
23184757|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23184758|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
23184759|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
23184760|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23184761|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23184762|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23184763|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23184764|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23184765|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
23184766|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23184767|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
23184768|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
23184769|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23184770|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23184771|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23184772|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23184773|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
23184774|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
23184775|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23184776|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
23243107|NCT01058707|64635757|FG006|Overall Study|Disease Progression|12|||
23585389|NCT00771667|65869436|FG006|Maintenance Phase|Adverse Event|5|||
23585390|NCT00771667|65869437|FG007|Maintenance Phase|Adverse Event|1|||
23585391|NCT00771667|65869438|FG008|Maintenance Phase|Adverse Event|8|||
23585392|NCT00771667|65869439|FG009|Maintenance Phase|Adverse Event|7|||
23585393|NCT00771667|65869430|FG000|Maintenance Phase|Lack of Efficacy|0|||
23585394|NCT00771667|65869431|FG001|Maintenance Phase|Lack of Efficacy|0|||
23585395|NCT00771667|65869432|FG002|Maintenance Phase|Lack of Efficacy|0|||
23585396|NCT00771667|65869433|FG003|Maintenance Phase|Lack of Efficacy|0|||
23243108|NCT01058707|64635751|FG000|Overall Study|Adverse Event|11|||
23464712|NCT03077412|65444732|FG001|Overall Study|Adverse Event|2|||
23585397|NCT00771667|65869434|FG004|Maintenance Phase|Lack of Efficacy|1|||
23585398|NCT00771667|65869435|FG005|Maintenance Phase|Lack of Efficacy|3|||
23184777|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
23184778|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23350629|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
23350630|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
23350631|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
23350632|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
23464713|NCT03077412|65444733|FG002|Overall Study|Adverse Event|2|||
23184779|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23243109|NCT01058707|64635752|FG001|Overall Study|Adverse Event|4|||
23464714|NCT03077412|65444731|FG000|Overall Study|Investigator's Discretion|0|||
23464715|NCT03077412|65444732|FG001|Overall Study|Investigator's Discretion|1|||
23464716|NCT03077412|65444733|FG002|Overall Study|Investigator's Discretion|1|||
23243110|NCT01058707|64635753|FG002|Overall Study|Adverse Event|7|||
23243111|NCT01058707|64635754|FG003|Overall Study|Adverse Event|6|||
23243112|NCT01058707|64635755|FG004|Overall Study|Adverse Event|7|||
23243113|NCT01058707|64635756|FG005|Overall Study|Adverse Event|3|||
23243114|NCT01058707|64635757|FG006|Overall Study|Adverse Event|1|||
23243115|NCT01058707|64635751|FG000|Overall Study|Subject Decision|5|||
23243116|NCT01058707|64635752|FG001|Overall Study|Subject Decision|3|||
23243117|NCT01058707|64635753|FG002|Overall Study|Subject Decision|3|||
23243118|NCT01058707|64635754|FG003|Overall Study|Subject Decision|1|||
23184780|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23184781|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
23184782|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
23184783|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
23184784|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23184785|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23184786|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23184787|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23184788|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23184789|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23184790|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23184791|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
23184792|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
23184793|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23184794|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
23184795|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23184796|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23184797|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23184798|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23184799|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23184800|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23184801|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
23184802|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23184803|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
23184804|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23184805|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23243119|NCT01058707|64635755|FG004|Overall Study|Subject Decision|2|||
23184806|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23243120|NCT01058707|64635756|FG005|Overall Study|Subject Decision|3|||
23243121|NCT01058707|64635757|FG006|Overall Study|Subject Decision|6|||
23243122|NCT01058707|64635751|FG000|Overall Study|Lost to Follow-up|0|||
23243123|NCT01058707|64635752|FG001|Overall Study|Lost to Follow-up|0|||
23243124|NCT01058707|64635753|FG002|Overall Study|Lost to Follow-up|1|||
23585399|NCT00771667|65869436|FG006|Maintenance Phase|Lack of Efficacy|3|||
23184807|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23184808|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23243125|NCT01058707|64635754|FG003|Overall Study|Lost to Follow-up|0|||
23243126|NCT01058707|64635755|FG004|Overall Study|Lost to Follow-up|0|||
23243127|NCT01058707|64635756|FG005|Overall Study|Lost to Follow-up|0|||
23243128|NCT01058707|64635757|FG006|Overall Study|Lost to Follow-up|0|||
23184809|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
23184810|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
23184811|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23184812|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
23184813|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
23184814|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23184815|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23243129|NCT01058707|64635751|FG000|Overall Study|Reason Not Specified|0|||
23243130|NCT01058707|64635752|FG001|Overall Study|Reason Not Specified|3|||
23243131|NCT01058707|64635753|FG002|Overall Study|Reason Not Specified|2|||
23243132|NCT01058707|64635754|FG003|Overall Study|Reason Not Specified|0|||
23184816|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23184817|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23350633|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
23350634|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
23350635|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
23350636|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
23350637|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
23350638|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
23350639|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
23350640|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
23350641|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
23350642|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
23350643|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
23350644|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
23350645|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
23350646|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
23350647|NCT00994214|65025545|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
23350648|NCT00994214|65025546|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
23350649|NCT00994214|65025547|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
23350650|NCT00994214|65025548|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
23350651|NCT00934856|65025550|FG000|Feasibility Part|Progressive disease|4|||
23350652|NCT00934856|65025551|FG001|Feasibility Part|Progressive disease|4|||
23350653|NCT00934856|65025552|FG002|Feasibility Part|Progressive disease|2|||
23350654|NCT00934856|65025553|FG003|Feasibility Part|Progressive disease|3|||
23350655|NCT00934856|65025554|FG004|Feasibility Part|Progressive disease|0|||
23350656|NCT00934856|65025555|FG005|Feasibility Part|Progressive disease|0|||
23350657|NCT00934856|65025550|FG000|Feasibility Part|Physician Decision|0|||
23350658|NCT00934856|65025551|FG001|Feasibility Part|Physician Decision|0|||
23350659|NCT00934856|65025552|FG002|Feasibility Part|Physician Decision|1|||
23350660|NCT00934856|65025553|FG003|Feasibility Part|Physician Decision|0|||
23350661|NCT00934856|65025554|FG004|Feasibility Part|Physician Decision|0|||
23350662|NCT00934856|65025555|FG005|Feasibility Part|Physician Decision|0|||
23350663|NCT00934856|65025550|FG000|Feasibility Part|Adverse Event|1|||
23350664|NCT00934856|65025551|FG001|Feasibility Part|Adverse Event|1|||
23350665|NCT00934856|65025552|FG002|Feasibility Part|Adverse Event|0|||
23350666|NCT00934856|65025553|FG003|Feasibility Part|Adverse Event|1|||
23184818|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
23184819|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
23184820|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23184821|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23184822|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
23184823|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23184824|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23184825|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23184826|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23184827|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23184828|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
23184829|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23184830|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23184831|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23184832|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23184833|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23184834|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23184835|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23184836|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
23184837|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
23184838|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23184839|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
23184840|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
23184841|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23184842|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23184843|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23350667|NCT00934856|65025554|FG004|Feasibility Part|Adverse Event|0|||
23350668|NCT00934856|65025555|FG005|Feasibility Part|Adverse Event|2|||
23350669|NCT00934856|65025550|FG000|Feasibility Part|Withdrawal by Subject|0|||
23350670|NCT00934856|65025551|FG001|Feasibility Part|Withdrawal by Subject|0|||
23350671|NCT00934856|65025552|FG002|Feasibility Part|Withdrawal by Subject|0|||
23350672|NCT00934856|65025553|FG003|Feasibility Part|Withdrawal by Subject|1|||
23350673|NCT00934856|65025554|FG004|Feasibility Part|Withdrawal by Subject|0|||
23350674|NCT00934856|65025555|FG005|Feasibility Part|Withdrawal by Subject|1|||
23350675|NCT00934856|65025550|FG000|Extension Part|Adverse Event|0|||
23350676|NCT00934856|65025551|FG001|Extension Part|Adverse Event|0|||
23350677|NCT00934856|65025552|FG002|Extension Part|Adverse Event|0|||
23350678|NCT00934856|65025553|FG003|Extension Part|Adverse Event|1|||
23350679|NCT00934856|65025554|FG004|Extension Part|Adverse Event|4|||
23350680|NCT00934856|65025555|FG005|Extension Part|Adverse Event|4|||
23350681|NCT00934856|65025550|FG000|Extension Part|Progressive disease|0|||
23350682|NCT00934856|65025551|FG001|Extension Part|Progressive disease|0|||
23350683|NCT00934856|65025552|FG002|Extension Part|Progressive disease|0|||
23350684|NCT00934856|65025553|FG003|Extension Part|Progressive disease|1|||
23350685|NCT00934856|65025554|FG004|Extension Part|Progressive disease|0|||
23350686|NCT00934856|65025555|FG005|Extension Part|Progressive disease|0|||
23350687|NCT00934856|65025550|FG000|Extension Part|Non-compliance with drug|0|||
23350688|NCT00934856|65025551|FG001|Extension Part|Non-compliance with drug|0|||
23464717|NCT03077412|65444731|FG000|Overall Study|Withdrew Consent|0|||
23464718|NCT03077412|65444732|FG001|Overall Study|Withdrew Consent|2|||
23184844|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23184845|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
23184846|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
23184847|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23184848|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
23184849|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
23184850|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23184851|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23184852|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23184853|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23184854|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23184855|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
23184856|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23184857|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
23184858|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
23184859|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23184860|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23184861|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23184862|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23184863|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23184864|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23184865|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23184866|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
23184867|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23184868|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23184869|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23184870|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23184871|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23184872|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23184873|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
23184874|NCT01307423|64417004|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23184875|NCT01307423|64417005|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23464719|NCT03077412|65444733|FG002|Overall Study|Withdrew Consent|0|||
23184876|NCT01307423|64417006|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
23184877|NCT01307423|64417007|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23184878|NCT01307423|64417008|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23184879|NCT01307423|64417009|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23184880|NCT01307423|64417010|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
23184881|NCT01307423|64417011|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
23184882|NCT01307423|64417012|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
23184883|NCT00469079|64417013|FG000|Overall Study|Lack of Efficacy|3|||
23184884|NCT00469079|64417014|FG001|Overall Study|Lack of Efficacy|8|||
23184885|NCT00469079|64417015|FG002|Overall Study|Lack of Efficacy|5|||
23243133|NCT01058707|64635755|FG004|Overall Study|Reason Not Specified|7|||
23350689|NCT00934856|65025552|FG002|Extension Part|Non-compliance with drug|0|||
23350690|NCT00934856|65025553|FG003|Extension Part|Non-compliance with drug|0|||
23464720|NCT02578706|65444734|FG000|Overall Study|Withdrawal by Subject|1|||
23464721|NCT02578706|65444735|FG001|Overall Study|Withdrawal by Subject|0|||
23350691|NCT00934856|65025554|FG004|Extension Part|Non-compliance with drug|0|||
23350692|NCT00934856|65025555|FG005|Extension Part|Non-compliance with drug|1|||
23350693|NCT03099694|65025556|FG000|Overall Study|Withdrawal by Subject|11|||
23350694|NCT03099694|65025557|FG001|Overall Study|Withdrawal by Subject|13|||
23184886|NCT00469079|64417013|FG000|Overall Study|Adverse Event|1|||
23184887|NCT00469079|64417014|FG001|Overall Study|Adverse Event|3|||
23184888|NCT00469079|64417015|FG002|Overall Study|Adverse Event|2|||
23184889|NCT00469079|64417013|FG000|Overall Study|Lost to Follow-up|4|||
23184890|NCT00469079|64417014|FG001|Overall Study|Lost to Follow-up|8|||
23184891|NCT00469079|64417015|FG002|Overall Study|Lost to Follow-up|10|||
23184892|NCT00469079|64417013|FG000|Overall Study|Withdrawal by Subject|1|||
23184893|NCT00469079|64417014|FG001|Overall Study|Withdrawal by Subject|2|||
23184894|NCT00469079|64417015|FG002|Overall Study|Withdrawal by Subject|2|||
23184895|NCT00469079|64417013|FG000|Overall Study|Ineligible|0|||
23184896|NCT00469079|64417014|FG001|Overall Study|Ineligible|1|||
23184897|NCT00469079|64417015|FG002|Overall Study|Ineligible|0|||
23184898|NCT01254344|64417021|FG000|Overall Study|Adverse Event|2|||
23184899|NCT01254344|64417022|FG001|Overall Study|Adverse Event|5|||
23184900|NCT01254344|64417021|FG000|Overall Study|Physician Decision|7|||
23184901|NCT01254344|64417022|FG001|Overall Study|Physician Decision|4|||
23184902|NCT01254344|64417021|FG000|Overall Study|Protocol Violation|1|||
23184903|NCT01254344|64417022|FG001|Overall Study|Protocol Violation|4|||
23184904|NCT01254344|64417021|FG000|Overall Study|Withdrawal by Subject|3|||
23184905|NCT01254344|64417022|FG001|Overall Study|Withdrawal by Subject|6|||
23184906|NCT01390389|64417025|FG000|Overall Study|Withdrawal by Subject|2|||
23184907|NCT01390389|64417026|FG001|Overall Study|Withdrawal by Subject|0|||
23184908|NCT01390389|64417025|FG000|Overall Study|Screen Fail|2|||
23184909|NCT01390389|64417026|FG001|Overall Study|Screen Fail|1|||
23184910|NCT02770807|64417031|FG000|Overall Study|Adverse Event|3|||
23184911|NCT02770807|64417032|FG001|Overall Study|Adverse Event|3|||
23184912|NCT02770807|64417033|FG002|Overall Study|Adverse Event|1|||
23184913|NCT02770807|64417031|FG000|Overall Study|Withdrawal by Subject|7|||
23184914|NCT02770807|64417032|FG001|Overall Study|Withdrawal by Subject|3|||
23184915|NCT02770807|64417033|FG002|Overall Study|Withdrawal by Subject|4|||
23184916|NCT02770807|64417031|FG000|Overall Study|Other|0|||
23184917|NCT02770807|64417032|FG001|Overall Study|Other|1|||
23184918|NCT02770807|64417033|FG002|Overall Study|Other|0|||
23184919|NCT02770807|64417031|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
23184920|NCT02770807|64417032|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
23184921|NCT02770807|64417033|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
23184922|NCT02770807|64417031|FG000|Overall Study|Physician Decision|0|||
23184923|NCT02770807|64417032|FG001|Overall Study|Physician Decision|0|||
23184924|NCT02770807|64417033|FG002|Overall Study|Physician Decision|1|||
23184925|NCT02658448|64417037|FG000|Overall Study|Lost to Follow-up|1|||
23350695|NCT03099694|65025556|FG000|Overall Study|Lost to Follow-up|9|||
23350696|NCT03099694|65025557|FG001|Overall Study|Lost to Follow-up|5|||
23350697|NCT01428115|65025558|FG000|Overall Study|Lack of Efficacy|3|||
23464722|NCT02578706|65444736|FG002|Overall Study|Withdrawal by Subject|0|||
23464723|NCT02578706|65444734|FG000|Overall Study|Lost to Follow-up|0|||
23464724|NCT02578706|65444735|FG001|Overall Study|Lost to Follow-up|4|||
23464725|NCT02578706|65444736|FG002|Overall Study|Lost to Follow-up|0|||
23464726|NCT02578706|65444734|FG000|Overall Study|Physician Decision|0|||
23464727|NCT02578706|65444735|FG001|Overall Study|Physician Decision|1|||
23464728|NCT02578706|65444736|FG002|Overall Study|Physician Decision|0|||
23464729|NCT02839200|65444738|FG000|Overall Study|Withdrawal by Subject|2|||
23464730|NCT02839200|65444739|FG001|Overall Study|Withdrawal by Subject|0|||
23464731|NCT02839200|65444740|FG002|Overall Study|Withdrawal by Subject|1|||
23464732|NCT02839200|65444741|FG003|Overall Study|Withdrawal by Subject|0|||
23464733|NCT02839200|65444742|FG004|Overall Study|Withdrawal by Subject|0|||
23464734|NCT02839200|65444743|FG005|Overall Study|Withdrawal by Subject|1|||
23464735|NCT02839200|65444738|FG000|Overall Study|Lost to Follow-up|2|||
23464736|NCT02839200|65444739|FG001|Overall Study|Lost to Follow-up|0|||
23464737|NCT02839200|65444740|FG002|Overall Study|Lost to Follow-up|0|||
23464738|NCT02839200|65444741|FG003|Overall Study|Lost to Follow-up|0|||
23464739|NCT02839200|65444742|FG004|Overall Study|Lost to Follow-up|1|||
23464740|NCT02839200|65444743|FG005|Overall Study|Lost to Follow-up|0|||
23464741|NCT02839200|65444738|FG000|Overall Study|Adverse Event|0|||
23464742|NCT02839200|65444739|FG001|Overall Study|Adverse Event|0|||
23464743|NCT02839200|65444740|FG002|Overall Study|Adverse Event|0|||
23464744|NCT02839200|65444741|FG003|Overall Study|Adverse Event|0|||
23464745|NCT02839200|65444742|FG004|Overall Study|Adverse Event|1|||
23184926|NCT00925600|64417038|FG000|Overall Study|Withdrawal by Subject|16|||
23184927|NCT00925600|64417039|FG001|Overall Study|Withdrawal by Subject|14|||
23184928|NCT00925600|64417038|FG000|Overall Study|Death|4|||
23184929|NCT00925600|64417039|FG001|Overall Study|Death|3|||
23184930|NCT00925600|64417038|FG000|Overall Study|Lost to Follow-up|2|||
23184931|NCT00925600|64417039|FG001|Overall Study|Lost to Follow-up|2|||
23184932|NCT00925600|64417038|FG000|Overall Study|Disease Progression|1|||
23184933|NCT00925600|64417039|FG001|Overall Study|Disease Progression|3|||
23184934|NCT00925600|64417038|FG000|Overall Study|Administrative Decision|1|||
23184935|NCT00925600|64417039|FG001|Overall Study|Administrative Decision|1|||
23464746|NCT02839200|65444743|FG005|Overall Study|Adverse Event|0|||
23350698|NCT01428115|65025558|FG000|Overall Study|Lost to Follow-up|10|||
23464747|NCT02839200|65444738|FG000|Overall Study|Randomized in error|0|||
23350699|NCT01428115|65025558|FG000|Overall Study|Pregnancy|1|||
23350700|NCT01428115|65025558|FG000|Overall Study|Protocol Violation|3|||
23350701|NCT01428115|65025558|FG000|Overall Study|Withdrawal by Subject|4|||
23350702|NCT05940077|65025560|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
23350703|NCT02984267|65025561|FG000|Overall Study|Protocol Violation|1|||
23350704|NCT02984267|65025562|FG001|Overall Study|Protocol Violation|0|||
23350705|NCT02984267|65025561|FG000|Overall Study|Withdrawal by Subject|0|||
23464748|NCT02839200|65444739|FG001|Overall Study|Randomized in error|1|||
23464749|NCT02839200|65444740|FG002|Overall Study|Randomized in error|0|||
23464750|NCT02839200|65444741|FG003|Overall Study|Randomized in error|0|||
23464751|NCT02839200|65444742|FG004|Overall Study|Randomized in error|0|||
23464752|NCT02839200|65444743|FG005|Overall Study|Randomized in error|0|||
23464753|NCT04198714|65444745|FG000|Overall Study|Physician Decision|0|||
23464754|NCT04198714|65444746|FG001|Overall Study|Physician Decision|1|||
23464755|NCT02396199|65444748|FG000|Overall Study|Lost to Follow-up|1|||
23464756|NCT02396199|65444748|FG000|Overall Study|Death|4|||
23464757|NCT02506244|65444749|FG000|Overall Study|Did not undergo active monitoring|458|||
23464758|NCT02506244|65444750|FG001|Overall Study|Did not undergo active monitoring|459|||
23464759|NCT02506244|65444751|FG002|Overall Study|Did not undergo active monitoring|0|||
23464760|NCT03486834|65444753|FG000|Overall Study|Withdrawal by Subject|46|||
23464761|NCT03486834|65444754|FG001|Overall Study|Withdrawal by Subject|46|||
23464762|NCT03486834|65444755|FG002|Overall Study|Withdrawal by Subject|52|||
23464763|NCT03486834|65444753|FG000|Overall Study|Adverse Event|8|||
23464764|NCT03486834|65444754|FG001|Overall Study|Adverse Event|7|||
23464765|NCT03486834|65444755|FG002|Overall Study|Adverse Event|0|||
23464766|NCT03486834|65444753|FG000|Overall Study|Lost to Follow-up|41|||
23184936|NCT00925600|64417038|FG000|Overall Study|Noncompliance|2|||
23184937|NCT00925600|64417039|FG001|Overall Study|Noncompliance|0|||
23184938|NCT00925600|64417038|FG000|Overall Study|Ineligibility Determined|2|||
23184939|NCT00925600|64417039|FG001|Overall Study|Ineligibility Determined|0|||
23184940|NCT00925600|64417038|FG000|Overall Study|Protocol Deviation|0|||
23184941|NCT00925600|64417039|FG001|Overall Study|Protocol Deviation|1|||
23184942|NCT00925600|64417038|FG000|Overall Study|Requirement for Alternative Therapy|0|||
23184943|NCT00925600|64417039|FG001|Overall Study|Requirement for Alternative Therapy|1|||
23184944|NCT00925600|64417038|FG000|Overall Study|Other|3|||
23184945|NCT00925600|64417039|FG001|Overall Study|Other|1|||
23184946|NCT00925600|64417038|FG000|Overall Study|Adverse Event|1|||
23184947|NCT00925600|64417039|FG001|Overall Study|Adverse Event|2|||
23184948|NCT02537678|64417040|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
23184949|NCT02537678|64417041|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
23184950|NCT02537678|64417040|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
23184951|NCT02537678|64417041|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
23184952|NCT02537678|64417040|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
23184953|NCT02537678|64417041|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
23184954|NCT02537678|64417040|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
23184955|NCT02537678|64417041|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
23184956|NCT02537678|64417040|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
23184957|NCT02537678|64417041|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
23184958|NCT02537678|64417040|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
23243134|NCT01058707|64635756|FG005|Overall Study|Reason Not Specified|1|||
23243135|NCT01058707|64635757|FG006|Overall Study|Reason Not Specified|7|||
23243145|NCT00276458|64635782|FG000|Overall Study|Adverse Event|0|||
23243146|NCT00276458|64635783|FG001|Overall Study|Adverse Event|2|||
23464767|NCT03486834|65444754|FG001|Overall Study|Lost to Follow-up|24|||
23464768|NCT03486834|65444755|FG002|Overall Study|Lost to Follow-up|39|||
23464769|NCT03486834|65444753|FG000|Overall Study|Non-compliance with Study Drug|2|||
23464770|NCT03486834|65444754|FG001|Overall Study|Non-compliance with Study Drug|2|||
23464771|NCT03486834|65444755|FG002|Overall Study|Non-compliance with Study Drug|0|||
23243147|NCT00276458|64635782|FG000|Overall Study|Lost to Follow-up|2|||
23243148|NCT00276458|64635783|FG001|Overall Study|Lost to Follow-up|2|||
23243149|NCT00276458|64635782|FG000|Overall Study|Protocol Violation|4|||
23243150|NCT00276458|64635783|FG001|Overall Study|Protocol Violation|3|||
23350706|NCT02984267|65025562|FG001|Overall Study|Withdrawal by Subject|1|||
23464772|NCT03486834|65444753|FG000|Overall Study|Physician Decision|5|||
23350707|NCT00743288|65025563|FG000|Overall Study|Adverse Event|1|||
23464773|NCT03486834|65444754|FG001|Overall Study|Physician Decision|2|||
23464774|NCT03486834|65444755|FG002|Overall Study|Physician Decision|3|||
23464775|NCT03486834|65444753|FG000|Overall Study|Pregnancy|10|||
23464776|NCT03486834|65444754|FG001|Overall Study|Pregnancy|12|||
23464777|NCT03486834|65444755|FG002|Overall Study|Pregnancy|12|||
23464778|NCT03486834|65444753|FG000|Overall Study|Protocol Deviation|2|||
23464779|NCT03486834|65444754|FG001|Overall Study|Protocol Deviation|3|||
23464780|NCT03486834|65444755|FG002|Overall Study|Protocol Deviation|3|||
23464781|NCT03486834|65444753|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23464782|NCT03486834|65444754|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23464783|NCT03486834|65444755|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
23464784|NCT03486834|65444753|FG000|Overall Study|Randomized but not treated|4|||
23464785|NCT03486834|65444754|FG001|Overall Study|Randomized but not treated|4|||
23464786|NCT03486834|65444755|FG002|Overall Study|Randomized but not treated|1|||
23464787|NCT02761330|65444756|FG000|Treatment Week 1|Withdrawal by Subject|0|||
23464788|NCT02761330|65444757|FG001|Treatment Week 1|Withdrawal by Subject|0|||
23464789|NCT02761330|65444758|FG002|Treatment Week 1|Withdrawal by Subject|0|||
23464790|NCT02761330|65444759|FG003|Treatment Week 1|Withdrawal by Subject|1|||
23464791|NCT02761330|65444760|FG004|Treatment Week 1|Withdrawal by Subject|0|||
23464792|NCT02761330|65444761|FG005|Treatment Week 1|Withdrawal by Subject|1|||
23464793|NCT02577718|65444768|FG000|Overall Study|Death|6|||
23464794|NCT02577718|65444768|FG000|Overall Study|Withdrawal by Subject|2|||
23464795|NCT01337960|65444769|FG000|Overall Study|Lost to Follow-up|1|||
23464796|NCT01337960|65444770|FG001|Overall Study|Lost to Follow-up|0|||
23464797|NCT01337960|65444771|FG002|Overall Study|Lost to Follow-up|0|||
23464798|NCT01337960|65444769|FG000|Overall Study|Withdrawal by Subject|1|||
23464799|NCT01337960|65444770|FG001|Overall Study|Withdrawal by Subject|0|||
23464800|NCT01337960|65444771|FG002|Overall Study|Withdrawal by Subject|0|||
23464801|NCT04960202|65444777|FG000|Overall Study|Other|12|||
23464802|NCT04960202|65444778|FG001|Overall Study|Other|10|||
23464803|NCT04960202|65444777|FG000|Overall Study|Withdrawal by Subject|43|||
23464804|NCT04960202|65444778|FG001|Overall Study|Withdrawal by Subject|45|||
23464805|NCT04960202|65444777|FG000|Overall Study|Lost to Follow-up|20|||
23464806|NCT04960202|65444778|FG001|Overall Study|Lost to Follow-up|17|||
23464807|NCT04960202|65444777|FG000|Overall Study|Death|0|||
23464808|NCT04960202|65444778|FG001|Overall Study|Death|15|||
23464809|NCT01177397|65444779|FG000|Overall Study|Protocol Violation|0|||
23464810|NCT01177397|65444780|FG001|Overall Study|Protocol Violation|0|||
23464811|NCT01177397|65444781|FG002|Overall Study|Protocol Violation|0|||
23464812|NCT01177397|65444782|FG003|Overall Study|Protocol Violation|0|||
23464813|NCT01177397|65444783|FG004|Overall Study|Protocol Violation|0|||
23464814|NCT01177397|65444784|FG005|Overall Study|Protocol Violation|1|||
23464815|NCT01177397|65444785|FG006|Overall Study|Protocol Violation|0|||
23464816|NCT01177397|65444786|FG007|Overall Study|Protocol Violation|0|||
23464817|NCT01177397|65444787|FG008|Overall Study|Protocol Violation|0|||
23464818|NCT01177397|65444788|FG009|Overall Study|Protocol Violation|0|||
23464819|NCT01177397|65444789|FG010|Overall Study|Protocol Violation|0|||
23464820|NCT01177397|65444790|FG011|Overall Study|Protocol Violation|0|||
23464821|NCT01177397|65444779|FG000|Overall Study|Lost to Follow-up|0|||
23464822|NCT01177397|65444780|FG001|Overall Study|Lost to Follow-up|0|||
23464823|NCT01177397|65444781|FG002|Overall Study|Lost to Follow-up|0|||
23464824|NCT01177397|65444782|FG003|Overall Study|Lost to Follow-up|0|||
23464825|NCT01177397|65444783|FG004|Overall Study|Lost to Follow-up|1|||
23464826|NCT01177397|65444784|FG005|Overall Study|Lost to Follow-up|0|||
23464827|NCT01177397|65444785|FG006|Overall Study|Lost to Follow-up|0|||
23184959|NCT02537678|64417041|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
23184960|NCT02537678|64417040|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
23184961|NCT02537678|64417041|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
23184962|NCT00785577|64417045|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
23184963|NCT00785577|64417046|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
23184964|NCT00785577|64417047|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
23184965|NCT00785577|64417048|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
23350708|NCT00743288|65025564|FG001|Overall Study|Adverse Event|1|||
23464828|NCT01177397|65444786|FG007|Overall Study|Lost to Follow-up|2|||
23464829|NCT01177397|65444787|FG008|Overall Study|Lost to Follow-up|0|||
23464830|NCT01177397|65444788|FG009|Overall Study|Lost to Follow-up|0|||
23464831|NCT01177397|65444789|FG010|Overall Study|Lost to Follow-up|0|||
23464832|NCT01177397|65444790|FG011|Overall Study|Lost to Follow-up|0|||
23464833|NCT01177397|65444779|FG000|Overall Study|Death|0|||
23464834|NCT01177397|65444780|FG001|Overall Study|Death|0|||
23464835|NCT01177397|65444781|FG002|Overall Study|Death|1|||
23464836|NCT01177397|65444782|FG003|Overall Study|Death|1|||
23350709|NCT00743288|65025565|FG002|Overall Study|Adverse Event|2|||
23464837|NCT01177397|65444783|FG004|Overall Study|Death|0|||
23464838|NCT01177397|65444784|FG005|Overall Study|Death|0|||
23464839|NCT01177397|65444785|FG006|Overall Study|Death|0|||
23464840|NCT01177397|65444786|FG007|Overall Study|Death|5|||
23464841|NCT01177397|65444787|FG008|Overall Study|Death|2|||
23464842|NCT01177397|65444788|FG009|Overall Study|Death|1|||
23464843|NCT01177397|65444789|FG010|Overall Study|Death|0|||
23464844|NCT01177397|65444790|FG011|Overall Study|Death|0|||
23464845|NCT01177397|65444779|FG000|Overall Study|Withdrawal by Subject|0|||
23464846|NCT01177397|65444780|FG001|Overall Study|Withdrawal by Subject|0|||
23464847|NCT01177397|65444781|FG002|Overall Study|Withdrawal by Subject|1|||
23464848|NCT01177397|65444782|FG003|Overall Study|Withdrawal by Subject|1|||
23464849|NCT01177397|65444783|FG004|Overall Study|Withdrawal by Subject|1|||
23464850|NCT01177397|65444784|FG005|Overall Study|Withdrawal by Subject|2|||
23464851|NCT01177397|65444785|FG006|Overall Study|Withdrawal by Subject|0|||
23184966|NCT00785577|64417049|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
23184967|NCT00785577|64417045|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23350710|NCT00743288|65025566|FG003|Overall Study|Adverse Event|2|||
23350711|NCT00743288|65025567|FG004|Overall Study|Adverse Event|1|||
23350712|NCT00743288|65025568|FG005|Overall Study|Adverse Event|1|||
23350713|NCT00743288|65025569|FG006|Overall Study|Adverse Event|2|||
23350714|NCT00743288|65025563|FG000|Overall Study|Withdrawal by Subject|0|||
23350715|NCT00743288|65025564|FG001|Overall Study|Withdrawal by Subject|0|||
23350716|NCT00743288|65025565|FG002|Overall Study|Withdrawal by Subject|1|||
23350717|NCT00743288|65025566|FG003|Overall Study|Withdrawal by Subject|0|||
23350718|NCT00743288|65025567|FG004|Overall Study|Withdrawal by Subject|0|||
23350719|NCT00743288|65025568|FG005|Overall Study|Withdrawal by Subject|1|||
23350720|NCT00743288|65025569|FG006|Overall Study|Withdrawal by Subject|1|||
23350721|NCT00743288|65025563|FG000|Overall Study|Progressive disease (PD)|2|||
23350722|NCT00743288|65025564|FG001|Overall Study|Progressive disease (PD)|0|||
23350723|NCT00743288|65025565|FG002|Overall Study|Progressive disease (PD)|1|||
23350724|NCT00743288|65025566|FG003|Overall Study|Progressive disease (PD)|4|||
23350725|NCT00743288|65025567|FG004|Overall Study|Progressive disease (PD)|5|||
23350726|NCT00743288|65025568|FG005|Overall Study|Progressive disease (PD)|3|||
23350727|NCT00743288|65025569|FG006|Overall Study|Progressive disease (PD)|6|||
23350728|NCT00743288|65025563|FG000|Overall Study|Worsening of condition (Not PD)|0|||
23350729|NCT00743288|65025564|FG001|Overall Study|Worsening of condition (Not PD)|2|||
23350730|NCT00743288|65025565|FG002|Overall Study|Worsening of condition (Not PD)|1|||
23350731|NCT00743288|65025566|FG003|Overall Study|Worsening of condition (Not PD)|1|||
23350732|NCT00743288|65025567|FG004|Overall Study|Worsening of condition (Not PD)|0|||
23350733|NCT00743288|65025568|FG005|Overall Study|Worsening of condition (Not PD)|0|||
23350734|NCT00743288|65025569|FG006|Overall Study|Worsening of condition (Not PD)|0|||
23350735|NCT00337779|65025570|FG000|Overall Study|Withdrawal by Subject|10|||
23350736|NCT00337779|65025571|FG001|Overall Study|Withdrawal by Subject|12|||
23350737|NCT00337779|65025570|FG000|Overall Study|Sponsor decision|1|||
23350738|NCT00337779|65025571|FG001|Overall Study|Sponsor decision|1|||
23350739|NCT00337779|65025570|FG000|Overall Study|Physician Decision|3|||
23350740|NCT00337779|65025571|FG001|Overall Study|Physician Decision|6|||
23350741|NCT00337779|65025570|FG000|Overall Study|Protocol Violation|1|||
23350742|NCT00337779|65025571|FG001|Overall Study|Protocol Violation|1|||
23350743|NCT00337779|65025570|FG000|Overall Study|Lost to Follow-up|6|||
23350744|NCT00337779|65025571|FG001|Overall Study|Lost to Follow-up|5|||
23350745|NCT00337779|65025570|FG000|Overall Study|Adverse Event|28|||
23350746|NCT00337779|65025571|FG001|Overall Study|Adverse Event|51|||
23350747|NCT00337779|65025570|FG000|Overall Study|Pregnancy|3|||
23350748|NCT00337779|65025571|FG001|Overall Study|Pregnancy|2|||
23350749|NCT00337779|65025570|FG000|Overall Study|Death|0|||
23464852|NCT01177397|65444786|FG007|Overall Study|Withdrawal by Subject|5|||
23464853|NCT01177397|65444787|FG008|Overall Study|Withdrawal by Subject|9|||
23464854|NCT01177397|65444788|FG009|Overall Study|Withdrawal by Subject|1|||
23464855|NCT01177397|65444789|FG010|Overall Study|Withdrawal by Subject|1|||
23464856|NCT01177397|65444790|FG011|Overall Study|Withdrawal by Subject|0|||
23184968|NCT00785577|64417046|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23184969|NCT00785577|64417047|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23184970|NCT00785577|64417048|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23184971|NCT00785577|64417049|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
23184972|NCT00785577|64417045|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
23184973|NCT00785577|64417046|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
23184974|NCT00785577|64417047|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
23184975|NCT00785577|64417048|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
23184976|NCT00785577|64417049|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
23184977|NCT00785577|64417045|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
23184978|NCT00785577|64417046|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
23184979|NCT00785577|64417047|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
23184980|NCT00785577|64417048|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
23350750|NCT00337779|65025571|FG001|Overall Study|Death|1|||
23350751|NCT00114738|65025574|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
23350752|NCT00114738|65025575|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
23350753|NCT00114738|65025576|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
23350754|NCT00114738|65025574|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
23350755|NCT00114738|65025575|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
23464857|NCT01177397|65444779|FG000|Overall Study|Adverse Event|0|||
23464858|NCT01177397|65444780|FG001|Overall Study|Adverse Event|0|||
23464859|NCT01177397|65444781|FG002|Overall Study|Adverse Event|1|||
23464860|NCT01177397|65444782|FG003|Overall Study|Adverse Event|2|||
23464861|NCT01177397|65444783|FG004|Overall Study|Adverse Event|0|||
23464862|NCT01177397|65444784|FG005|Overall Study|Adverse Event|12|||
23464863|NCT01177397|65444785|FG006|Overall Study|Adverse Event|1|||
23464864|NCT01177397|65444786|FG007|Overall Study|Adverse Event|14|||
23464865|NCT01177397|65444787|FG008|Overall Study|Adverse Event|8|||
23464866|NCT01177397|65444788|FG009|Overall Study|Adverse Event|6|||
23464867|NCT01177397|65444789|FG010|Overall Study|Adverse Event|3|||
23464868|NCT01177397|65444790|FG011|Overall Study|Adverse Event|7|||
23464869|NCT01177397|65444779|FG000|Overall Study|Disease progression|1|||
23464870|NCT01177397|65444780|FG001|Overall Study|Disease progression|2|||
23464871|NCT01177397|65444781|FG002|Overall Study|Disease progression|5|||
23464872|NCT01177397|65444782|FG003|Overall Study|Disease progression|5|||
23464873|NCT01177397|65444783|FG004|Overall Study|Disease progression|4|||
23464874|NCT01177397|65444784|FG005|Overall Study|Disease progression|10|||
23464875|NCT01177397|65444785|FG006|Overall Study|Disease progression|10|||
23464876|NCT01177397|65444786|FG007|Overall Study|Disease progression|21|||
23464877|NCT01177397|65444787|FG008|Overall Study|Disease progression|18|||
23464878|NCT01177397|65444788|FG009|Overall Study|Disease progression|12|||
23464879|NCT01177397|65444789|FG010|Overall Study|Disease progression|10|||
23464880|NCT01177397|65444790|FG011|Overall Study|Disease progression|8|||
23464881|NCT01177397|65444779|FG000|Overall Study|Other reasons|0|||
23464882|NCT01177397|65444780|FG001|Overall Study|Other reasons|0|||
23464883|NCT01177397|65444781|FG002|Overall Study|Other reasons|1|||
23464884|NCT01177397|65444782|FG003|Overall Study|Other reasons|0|||
23184981|NCT00785577|64417049|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
23464885|NCT01177397|65444783|FG004|Overall Study|Other reasons|1|||
23464886|NCT01177397|65444784|FG005|Overall Study|Other reasons|1|||
23464887|NCT01177397|65444785|FG006|Overall Study|Other reasons|2|||
23464888|NCT01177397|65444786|FG007|Overall Study|Other reasons|6|||
23464889|NCT01177397|65444787|FG008|Overall Study|Other reasons|10|||
23464890|NCT01177397|65444788|FG009|Overall Study|Other reasons|8|||
23464891|NCT01177397|65444789|FG010|Overall Study|Other reasons|0|||
23464892|NCT01177397|65444790|FG011|Overall Study|Other reasons|2|||
23464893|NCT00068692|65444791|FG000|Step 1: Registration|Disese progression/relapse|5|||
23464894|NCT00068692|65444792|FG001|Step 1: Registration|Disese progression/relapse|0|||
23464895|NCT00068692|65444793|FG002|Step 1: Registration|Disese progression/relapse|0|||
23464896|NCT00068692|65444794|FG003|Step 1: Registration|Disese progression/relapse|0|||
23464897|NCT00068692|65444795|FG004|Step 1: Registration|Disese progression/relapse|0|||
23184982|NCT00785577|64417045|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
23184983|NCT00785577|64417046|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
23184984|NCT00785577|64417047|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
23184985|NCT00785577|64417048|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
23184986|NCT00785577|64417049|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
23184987|NCT00785577|64417045|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
23184988|NCT00785577|64417046|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
23184989|NCT00785577|64417047|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
23184990|NCT00785577|64417048|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
23184991|NCT00785577|64417049|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
23184992|NCT00785577|64417045|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
23184993|NCT00785577|64417046|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
23184994|NCT00785577|64417047|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
23184995|NCT00785577|64417048|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
23184996|NCT00785577|64417049|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
23184997|NCT00785577|64417045|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
23184998|NCT00785577|64417046|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
23184999|NCT00785577|64417047|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
23185000|NCT00785577|64417048|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
23464898|NCT00068692|65444796|FG005|Step 1: Registration|Disese progression/relapse|0|||
23464899|NCT00068692|65444797|FG006|Step 1: Registration|Disese progression/relapse|0|||
23464900|NCT00068692|65444798|FG007|Step 1: Registration|Disese progression/relapse|0|||
23464901|NCT00068692|65444791|FG000|Step 1: Registration|Adverse Event|7|||
23585400|NCT00771667|65869437|FG007|Maintenance Phase|Lack of Efficacy|2|||
23585401|NCT00771667|65869438|FG008|Maintenance Phase|Lack of Efficacy|11|||
23464902|NCT00068692|65444792|FG001|Step 1: Registration|Adverse Event|0|||
23464903|NCT00068692|65444793|FG002|Step 1: Registration|Adverse Event|0|||
23464904|NCT00068692|65444794|FG003|Step 1: Registration|Adverse Event|0|||
23464905|NCT00068692|65444795|FG004|Step 1: Registration|Adverse Event|0|||
23464906|NCT00068692|65444796|FG005|Step 1: Registration|Adverse Event|0|||
23464907|NCT00068692|65444797|FG006|Step 1: Registration|Adverse Event|0|||
23185001|NCT00785577|64417049|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
23185002|NCT00785577|64417045|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
23185003|NCT00785577|64417046|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
23185004|NCT00785577|64417047|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
23185005|NCT00785577|64417048|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
23185006|NCT00785577|64417049|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
23185007|NCT00785577|64417045|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
23185008|NCT00785577|64417046|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
23185009|NCT00785577|64417047|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
23243151|NCT01674010|64635784|FG000|Open Treatment Phase 1|Adverse Event|10|||
23464908|NCT00068692|65444798|FG007|Step 1: Registration|Adverse Event|0|||
23464909|NCT00068692|65444791|FG000|Step 1: Registration|Death|1|||
23464910|NCT00068692|65444792|FG001|Step 1: Registration|Death|0|||
23464911|NCT00068692|65444793|FG002|Step 1: Registration|Death|0|||
23464912|NCT00068692|65444794|FG003|Step 1: Registration|Death|0|||
23464913|NCT00068692|65444795|FG004|Step 1: Registration|Death|0|||
23464914|NCT00068692|65444796|FG005|Step 1: Registration|Death|0|||
23464915|NCT00068692|65444797|FG006|Step 1: Registration|Death|0|||
23464916|NCT00068692|65444798|FG007|Step 1: Registration|Death|0|||
23464917|NCT00068692|65444791|FG000|Step 1: Registration|Withdrawal by Subject|11|||
23464918|NCT00068692|65444792|FG001|Step 1: Registration|Withdrawal by Subject|0|||
23464919|NCT00068692|65444793|FG002|Step 1: Registration|Withdrawal by Subject|0|||
23585402|NCT00771667|65869439|FG009|Maintenance Phase|Lack of Efficacy|7|||
23585403|NCT00771667|65869430|FG000|Maintenance Phase|Other|0|||
23243152|NCT01674010|64635785|FG001|Open Treatment Phase 1|Adverse Event|0|||
23243153|NCT01674010|64635786|FG002|Open Treatment Phase 1|Adverse Event|0|||
23243154|NCT01674010|64635784|FG000|Open Treatment Phase 1|Death|1|||
23243155|NCT01674010|64635785|FG001|Open Treatment Phase 1|Death|0|||
23243156|NCT01674010|64635786|FG002|Open Treatment Phase 1|Death|0|||
23243157|NCT01674010|64635784|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
23243158|NCT01674010|64635785|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
23243159|NCT01674010|64635786|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
23243160|NCT01674010|64635784|FG000|Open Treatment Phase 1|Physician Decision|9|||
23243161|NCT01674010|64635785|FG001|Open Treatment Phase 1|Physician Decision|0|||
23243162|NCT01674010|64635786|FG002|Open Treatment Phase 1|Physician Decision|0|||
23243163|NCT01674010|64635784|FG000|Open Treatment Phase 1|Protocol Violation|7|||
23243164|NCT01674010|64635785|FG001|Open Treatment Phase 1|Protocol Violation|0|||
23243165|NCT01674010|64635786|FG002|Open Treatment Phase 1|Protocol Violation|0|||
23243166|NCT01674010|64635784|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
23243167|NCT01674010|64635785|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
23243168|NCT01674010|64635786|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
23243169|NCT01674010|64635784|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
23243170|NCT01674010|64635785|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
23243171|NCT01674010|64635786|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
23243172|NCT01674010|64635784|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
23243173|NCT01674010|64635785|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
23243174|NCT01674010|64635786|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
23243175|NCT01674010|64635784|FG000|Randomization Phase 2|Adverse Event|0|||
23243176|NCT01674010|64635785|FG001|Randomization Phase 2|Adverse Event|1|||
23243177|NCT01674010|64635786|FG002|Randomization Phase 2|Adverse Event|1|||
23243178|NCT01674010|64635784|FG000|Randomization Phase 2|Lost to Follow-up|0|||
23243179|NCT01674010|64635785|FG001|Randomization Phase 2|Lost to Follow-up|1|||
23243180|NCT01674010|64635786|FG002|Randomization Phase 2|Lost to Follow-up|2|||
23243181|NCT01674010|64635784|FG000|Randomization Phase 2|Mood episode recurrence|0|||
23350756|NCT00114738|65025576|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
23350757|NCT00114738|65025574|FG000|Screening for Randomization|Neuropathy|17|||
23585404|NCT00771667|65869431|FG001|Maintenance Phase|Other|0|||
23585405|NCT00771667|65869432|FG002|Maintenance Phase|Other|0|||
23585406|NCT00771667|65869433|FG003|Maintenance Phase|Other|0|||
23585407|NCT00771667|65869434|FG004|Maintenance Phase|Other|0|||
23585408|NCT00771667|65869435|FG005|Maintenance Phase|Other|1|||
23585409|NCT00771667|65869436|FG006|Maintenance Phase|Other|2|||
23585410|NCT00771667|65869437|FG007|Maintenance Phase|Other|2|||
23585411|NCT00771667|65869438|FG008|Maintenance Phase|Other|3|||
23585412|NCT00771667|65869439|FG009|Maintenance Phase|Other|3|||
23243182|NCT01674010|64635785|FG001|Randomization Phase 2|Mood episode recurrence|8|||
23243183|NCT01674010|64635786|FG002|Randomization Phase 2|Mood episode recurrence|2|||
23350758|NCT00114738|65025575|FG001|Screening for Randomization|Neuropathy|0|||
23464920|NCT00068692|65444794|FG003|Step 1: Registration|Withdrawal by Subject|0|||
23464921|NCT00068692|65444795|FG004|Step 1: Registration|Withdrawal by Subject|0|||
23464922|NCT00068692|65444796|FG005|Step 1: Registration|Withdrawal by Subject|0|||
23464923|NCT00068692|65444797|FG006|Step 1: Registration|Withdrawal by Subject|0|||
23585413|NCT00864682|65869441|FG000|Overall Study|Protocol Violation|2|||
23243184|NCT01674010|64635784|FG000|Randomization Phase 2|Physician Decision|0|||
23585414|NCT00864682|65869442|FG001|Overall Study|Protocol Violation|1|||
23464924|NCT00068692|65444798|FG007|Step 1: Registration|Withdrawal by Subject|0|||
23464925|NCT00068692|65444791|FG000|Step 1: Registration|Alternative therapy|2|||
23464926|NCT00068692|65444792|FG001|Step 1: Registration|Alternative therapy|0|||
23464927|NCT00068692|65444793|FG002|Step 1: Registration|Alternative therapy|0|||
23464928|NCT00068692|65444794|FG003|Step 1: Registration|Alternative therapy|0|||
23464929|NCT00068692|65444795|FG004|Step 1: Registration|Alternative therapy|0|||
23464930|NCT00068692|65444796|FG005|Step 1: Registration|Alternative therapy|0|||
23464931|NCT00068692|65444797|FG006|Step 1: Registration|Alternative therapy|0|||
23464932|NCT00068692|65444798|FG007|Step 1: Registration|Alternative therapy|0|||
23464933|NCT00068692|65444791|FG000|Step 1: Registration|Complicating disease|2|||
23464934|NCT00068692|65444792|FG001|Step 1: Registration|Complicating disease|0|||
23464935|NCT00068692|65444793|FG002|Step 1: Registration|Complicating disease|0|||
23464936|NCT00068692|65444794|FG003|Step 1: Registration|Complicating disease|0|||
23464937|NCT00068692|65444795|FG004|Step 1: Registration|Complicating disease|0|||
23464938|NCT00068692|65444796|FG005|Step 1: Registration|Complicating disease|0|||
23464939|NCT00068692|65444797|FG006|Step 1: Registration|Complicating disease|0|||
23464940|NCT00068692|65444798|FG007|Step 1: Registration|Complicating disease|0|||
23464941|NCT00068692|65444791|FG000|Step 1: Registration|Protocol Violation|1|||
23464942|NCT00068692|65444792|FG001|Step 1: Registration|Protocol Violation|0|||
23464943|NCT00068692|65444793|FG002|Step 1: Registration|Protocol Violation|0|||
23464944|NCT00068692|65444794|FG003|Step 1: Registration|Protocol Violation|0|||
23464945|NCT00068692|65444795|FG004|Step 1: Registration|Protocol Violation|0|||
23464946|NCT00068692|65444796|FG005|Step 1: Registration|Protocol Violation|0|||
23464947|NCT00068692|65444797|FG006|Step 1: Registration|Protocol Violation|0|||
23464948|NCT00068692|65444798|FG007|Step 1: Registration|Protocol Violation|0|||
23464949|NCT00068692|65444791|FG000|Step 1: Registration|Not eligible|6|||
23464950|NCT00068692|65444792|FG001|Step 1: Registration|Not eligible|0|||
23464951|NCT00068692|65444793|FG002|Step 1: Registration|Not eligible|0|||
23464952|NCT00068692|65444794|FG003|Step 1: Registration|Not eligible|0|||
23464953|NCT00068692|65444795|FG004|Step 1: Registration|Not eligible|0|||
23464954|NCT00068692|65444796|FG005|Step 1: Registration|Not eligible|0|||
23464955|NCT00068692|65444797|FG006|Step 1: Registration|Not eligible|0|||
23464956|NCT00068692|65444798|FG007|Step 1: Registration|Not eligible|0|||
23464957|NCT00068692|65444791|FG000|Step 1: Registration|Other|2|||
23185010|NCT00785577|64417048|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
23185011|NCT00785577|64417049|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
23185012|NCT01059448|64417050|FG000|Overall Study|Adverse Event|1|||
23185013|NCT01059448|64417051|FG001|Overall Study|Adverse Event|3|||
23185014|NCT01059448|64417052|FG002|Overall Study|Adverse Event|0|||
23185015|NCT01059448|64417053|FG003|Overall Study|Adverse Event|1|||
23185016|NCT01059448|64417050|FG000|Overall Study|Withdrawal by Subject|2|||
23185017|NCT01059448|64417051|FG001|Overall Study|Withdrawal by Subject|0|||
23185018|NCT01059448|64417052|FG002|Overall Study|Withdrawal by Subject|2|||
23350759|NCT00114738|65025576|FG002|Screening for Randomization|Neuropathy|0|||
23350760|NCT00114738|65025574|FG000|Screening for Randomization|Progressive disease|2|||
23350761|NCT00114738|65025575|FG001|Screening for Randomization|Progressive disease|0|||
23350762|NCT00114738|65025576|FG002|Screening for Randomization|Progressive disease|0|||
23350763|NCT00114738|65025574|FG000|Screening for Randomization|CNS Hemorrhage|1|||
23350764|NCT00114738|65025575|FG001|Screening for Randomization|CNS Hemorrhage|0|||
23350765|NCT00114738|65025576|FG002|Screening for Randomization|CNS Hemorrhage|0|||
23350766|NCT00114738|65025574|FG000|Screening for Randomization|Other|1|||
23350767|NCT00114738|65025575|FG001|Screening for Randomization|Other|0|||
23350768|NCT00114738|65025576|FG002|Screening for Randomization|Other|0|||
23350769|NCT00958412|65025577|FG000|Overall Study|Study prematurely terminated|18|||
23350770|NCT01868165|65025578|FG000|Overall Study|Withdrawal by Subject|36|||
23350771|NCT01868165|65025578|FG000|Overall Study|Physician Decision|2|||
23350772|NCT01868165|65025578|FG000|Overall Study|Lost to Follow-up|3|||
23350773|NCT01868165|65025578|FG000|Overall Study|Death|4|||
23350774|NCT00636961|65025579|FG000|Period 1|Administrative problems|1|||
23350775|NCT00636961|65025580|FG001|Period 1|Administrative problems|1|||
23350776|NCT00636961|65025579|FG000|Period 2|Adverse Event|1|||
23350777|NCT00636961|65025580|FG001|Period 2|Adverse Event|0|||
23350778|NCT01877551|65029398|FG000|Overall Study|Physician Decision|0|||
23185019|NCT01059448|64417053|FG003|Overall Study|Withdrawal by Subject|4|||
23350779|NCT01877551|65029399|FG001|Overall Study|Physician Decision|1|||
23350780|NCT03970200|65029402|FG000|Overall Study|Death|2|||
23350781|NCT03970200|65029403|FG001|Overall Study|Death|2|||
23350782|NCT03970200|65029404|FG002|Overall Study|Death|1|||
23350783|NCT03970200|65029402|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
23464958|NCT00068692|65444792|FG001|Step 1: Registration|Other|0|||
23464959|NCT00068692|65444793|FG002|Step 1: Registration|Other|0|||
23464960|NCT00068692|65444794|FG003|Step 1: Registration|Other|0|||
23464961|NCT00068692|65444795|FG004|Step 1: Registration|Other|0|||
23464962|NCT00068692|65444796|FG005|Step 1: Registration|Other|0|||
23464963|NCT00068692|65444797|FG006|Step 1: Registration|Other|0|||
23464964|NCT00068692|65444798|FG007|Step 1: Registration|Other|0|||
23464965|NCT00068692|65444791|FG000|Step 1: Registration|Not start protocol therapy|3|||
23464966|NCT00068692|65444792|FG001|Step 1: Registration|Not start protocol therapy|0|||
23464967|NCT00068692|65444793|FG002|Step 1: Registration|Not start protocol therapy|0|||
23464968|NCT00068692|65444794|FG003|Step 1: Registration|Not start protocol therapy|0|||
23464969|NCT00068692|65444795|FG004|Step 1: Registration|Not start protocol therapy|0|||
23350784|NCT03970200|65029403|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
23350785|NCT03970200|65029404|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
23350786|NCT00524680|65029405|FG000|Overall Study|progression|0|||
23350787|NCT00524680|65029406|FG001|Overall Study|progression|0|||
23464970|NCT00068692|65444796|FG005|Step 1: Registration|Not start protocol therapy|0|||
23464971|NCT00068692|65444797|FG006|Step 1: Registration|Not start protocol therapy|0|||
23464972|NCT00068692|65444798|FG007|Step 1: Registration|Not start protocol therapy|0|||
23585415|NCT00864682|65869443|FG002|Overall Study|Protocol Violation|2|||
23585416|NCT03721016|65869445|FG000|Overall Study|Adverse Event|0|||
23185020|NCT01059448|64417050|FG000|Overall Study|Disease Progression|2|||
23185021|NCT01059448|64417051|FG001|Overall Study|Disease Progression|1|||
23185022|NCT01059448|64417052|FG002|Overall Study|Disease Progression|4|||
23185023|NCT01059448|64417053|FG003|Overall Study|Disease Progression|2|||
23185024|NCT01059448|64417050|FG000|Overall Study|Administrative Decision|43|||
23185025|NCT01059448|64417051|FG001|Overall Study|Administrative Decision|49|||
23185026|NCT01059448|64417052|FG002|Overall Study|Administrative Decision|45|||
23185027|NCT01059448|64417053|FG003|Overall Study|Administrative Decision|46|||
23185028|NCT01059448|64417050|FG000|Overall Study|Lost to Follow-up|0|||
23185029|NCT01059448|64417051|FG001|Overall Study|Lost to Follow-up|0|||
23185030|NCT01059448|64417052|FG002|Overall Study|Lost to Follow-up|2|||
23185031|NCT01059448|64417053|FG003|Overall Study|Lost to Follow-up|0|||
23185032|NCT01059448|64417050|FG000|Overall Study|Death|0|||
23185033|NCT01059448|64417051|FG001|Overall Study|Death|1|||
23185034|NCT01059448|64417052|FG002|Overall Study|Death|0|||
23185035|NCT01059448|64417053|FG003|Overall Study|Death|0|||
23185036|NCT01059448|64417050|FG000|Overall Study|Other|1|||
23185037|NCT01059448|64417051|FG001|Overall Study|Other|1|||
23185038|NCT01059448|64417052|FG002|Overall Study|Other|0|||
23185039|NCT01059448|64417053|FG003|Overall Study|Other|1|||
23185040|NCT00635102|64417055|FG000|Overall Study|Withdrawal by Subject|7|||
23185041|NCT00635102|64417056|FG001|Overall Study|Withdrawal by Subject|8|||
23185042|NCT01650805|64417057|FG000|Overall Study|Withdrawal by Subject|1|||
23185043|NCT01650805|64417058|FG001|Overall Study|Withdrawal by Subject|0|||
23185044|NCT00476086|64417061|FG000|Overall Study|Alternative therapy|1|||
23243185|NCT01674010|64635785|FG001|Randomization Phase 2|Physician Decision|0|||
23243186|NCT01674010|64635786|FG002|Randomization Phase 2|Physician Decision|2|||
23243187|NCT01674010|64635784|FG000|Randomization Phase 2|Pregnancy|0|||
23243188|NCT01674010|64635785|FG001|Randomization Phase 2|Pregnancy|1|||
23243189|NCT01674010|64635786|FG002|Randomization Phase 2|Pregnancy|1|||
23243190|NCT01674010|64635784|FG000|Randomization Phase 2|Protocol Violation|0|||
23243191|NCT01674010|64635785|FG001|Randomization Phase 2|Protocol Violation|1|||
23243192|NCT01674010|64635786|FG002|Randomization Phase 2|Protocol Violation|1|||
23243193|NCT01674010|64635784|FG000|Randomization Phase 2|Sponsor Decision|0|||
23243194|NCT01674010|64635785|FG001|Randomization Phase 2|Sponsor Decision|42|||
23243195|NCT01674010|64635786|FG002|Randomization Phase 2|Sponsor Decision|45|||
23243196|NCT01674010|64635784|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
23243197|NCT01674010|64635785|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
23243198|NCT01674010|64635786|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
23243199|NCT01118949|64635787|FG000|Overall Study|Adverse Event|5|||
23243200|NCT01118949|64635787|FG000|Overall Study|Withdrawal by Subject|4|||
23243201|NCT00290511|64635790|FG000|Overall Study|Adverse Event|1|||
23243202|NCT00290511|64635790|FG000|Overall Study|Death|1|||
23243203|NCT00290511|64635790|FG000|Overall Study|Physician Decision|1|||
23243204|NCT00290511|64635790|FG000|Overall Study|Withdrawal by Subject|1|||
23243205|NCT02918318|64635795|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
23243206|NCT02918318|64635796|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
23243207|NCT02918318|64635797|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
23243208|NCT02918318|64635798|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
23350788|NCT00524680|65029407|FG002|Overall Study|progression|0|||
23350789|NCT00524680|65029408|FG003|Overall Study|progression|1|||
23350790|NCT00524680|65029405|FG000|Overall Study|Adverse Event|2|||
23464973|NCT00068692|65444791|FG000|Step 1: Registration|Registered but not randomized|0|||
23464974|NCT00068692|65444792|FG001|Step 1: Registration|Registered but not randomized|1|||
23464975|NCT00068692|65444793|FG002|Step 1: Registration|Registered but not randomized|0|||
23585417|NCT03721016|65869446|FG001|Overall Study|Adverse Event|1|||
23185045|NCT00476086|64417061|FG000|Overall Study|Progressive Disease|4|||
23185046|NCT01607892|64417062|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
23185047|NCT01607892|64417063|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
23185048|NCT01607892|64417064|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
23243209|NCT02918318|64635799|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
23243210|NCT02918318|64635795|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
23185049|NCT01607892|64417065|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
23464976|NCT00068692|65444794|FG003|Step 1: Registration|Registered but not randomized|0|||
23464977|NCT00068692|65444795|FG004|Step 1: Registration|Registered but not randomized|0|||
23585418|NCT03721016|65869447|FG002|Overall Study|Adverse Event|1|||
23585419|NCT03721016|65869445|FG000|Overall Study|Withdrawal by Subject|8|||
23350791|NCT00524680|65029406|FG001|Overall Study|Adverse Event|0|||
23585420|NCT03721016|65869446|FG001|Overall Study|Withdrawal by Subject|16|||
23585421|NCT03721016|65869447|FG002|Overall Study|Withdrawal by Subject|13|||
23350792|NCT00524680|65029407|FG002|Overall Study|Adverse Event|0|||
23350793|NCT00524680|65029408|FG003|Overall Study|Adverse Event|1|||
23350794|NCT00524680|65029405|FG000|Overall Study|Other|0|||
23350795|NCT00524680|65029406|FG001|Overall Study|Other|1|||
23350796|NCT00524680|65029407|FG002|Overall Study|Other|2|||
23350797|NCT00524680|65029408|FG003|Overall Study|Other|3|||
23350798|NCT00524680|65029405|FG000|Overall Study|Withdrawal by Subject|1|||
23350799|NCT00524680|65029406|FG001|Overall Study|Withdrawal by Subject|0|||
23350800|NCT00524680|65029407|FG002|Overall Study|Withdrawal by Subject|1|||
23585422|NCT03721016|65869445|FG000|Overall Study|Lost to Follow-up|4|||
23585423|NCT03721016|65869446|FG001|Overall Study|Lost to Follow-up|6|||
23243211|NCT02918318|64635796|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
23243212|NCT02918318|64635797|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
23243213|NCT02918318|64635798|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
23243214|NCT02918318|64635799|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
23243215|NCT02918318|64635795|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
23243216|NCT02918318|64635796|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
23243217|NCT02918318|64635797|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
23243218|NCT02918318|64635798|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
23243219|NCT02918318|64635799|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
23243220|NCT02918318|64635795|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
23243221|NCT02918318|64635796|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
23243222|NCT02918318|64635797|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
23585424|NCT03721016|65869447|FG002|Overall Study|Lost to Follow-up|5|||
23185050|NCT01607892|64417066|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
23185051|NCT01607892|64417062|FG000|Overall Study|Death|4|||
23243223|NCT02918318|64635798|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
23243224|NCT02918318|64635799|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
23243225|NCT02918318|64635795|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
23243226|NCT02918318|64635796|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
23243227|NCT02918318|64635797|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
23243228|NCT02918318|64635798|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
23243229|NCT02918318|64635799|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
23243230|NCT02918318|64635795|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
23243231|NCT02918318|64635796|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
23243232|NCT02918318|64635797|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
23243233|NCT02918318|64635798|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
23243234|NCT02918318|64635799|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
23350801|NCT00524680|65029408|FG003|Overall Study|Withdrawal by Subject|1|||
23185052|NCT01607892|64417063|FG001|Overall Study|Death|2|||
23185053|NCT01607892|64417064|FG002|Overall Study|Death|8|||
23185054|NCT01607892|64417065|FG003|Overall Study|Death|10|||
23185055|NCT01607892|64417066|FG004|Overall Study|Death|3|||
23185056|NCT01607892|64417062|FG000|Overall Study|Investigator discretion|2|||
23185057|NCT01607892|64417063|FG001|Overall Study|Investigator discretion|4|||
23185058|NCT01607892|64417064|FG002|Overall Study|Investigator discretion|4|||
23185059|NCT01607892|64417065|FG003|Overall Study|Investigator discretion|8|||
23185060|NCT01607892|64417066|FG004|Overall Study|Investigator discretion|0|||
23185061|NCT01607892|64417062|FG000|Overall Study|Other treatments became available|1|||
23185062|NCT01607892|64417063|FG001|Overall Study|Other treatments became available|1|||
23185063|NCT01607892|64417064|FG002|Overall Study|Other treatments became available|0|||
23185064|NCT01607892|64417065|FG003|Overall Study|Other treatments became available|0|||
23185065|NCT01607892|64417066|FG004|Overall Study|Other treatments became available|2|||
23185066|NCT01607892|64417062|FG000|Overall Study|Intercurrent illness|1|||
23243235|NCT02918318|64635795|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
23350802|NCT00628927|65029409|FG000|Overall Study|Problems performing blood draw|6|||
23350803|NCT00628927|65029410|FG001|Overall Study|Problems performing blood draw|0|||
23350804|NCT00628927|65029409|FG000|Overall Study|Lost to Follow-up|1|||
23350805|NCT00628927|65029410|FG001|Overall Study|Lost to Follow-up|0|||
23585425|NCT03721016|65869445|FG000|Overall Study|Physician Decision|0|||
23185067|NCT01607892|64417063|FG001|Overall Study|Intercurrent illness|0|||
23185068|NCT01607892|64417064|FG002|Overall Study|Intercurrent illness|0|||
23185069|NCT01607892|64417065|FG003|Overall Study|Intercurrent illness|3|||
23185070|NCT01607892|64417066|FG004|Overall Study|Intercurrent illness|0|||
23185071|NCT01607892|64417062|FG000|Overall Study|Non-Compliance with study procedures|0|||
23243236|NCT02918318|64635796|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
23243237|NCT02918318|64635797|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
23585426|NCT03721016|65869446|FG001|Overall Study|Physician Decision|1|||
23585427|NCT03721016|65869447|FG002|Overall Study|Physician Decision|2|||
23585428|NCT03721016|65869445|FG000|Overall Study|Protocol Violation|0|||
23585429|NCT03721016|65869446|FG001|Overall Study|Protocol Violation|1|||
23585430|NCT03721016|65869447|FG002|Overall Study|Protocol Violation|0|||
23585431|NCT03721016|65869445|FG000|Overall Study|Site terminated by sponsor|3|||
23585432|NCT03721016|65869446|FG001|Overall Study|Site terminated by sponsor|7|||
23585433|NCT03721016|65869447|FG002|Overall Study|Site terminated by sponsor|6|||
23585434|NCT03721016|65869445|FG000|Overall Study|Subject exited early due to COVID-19|1|||
23585435|NCT03721016|65869446|FG001|Overall Study|Subject exited early due to COVID-19|0|||
23585436|NCT03721016|65869447|FG002|Overall Study|Subject exited early due to COVID-19|0|||
23585437|NCT00768066|65869449|FG000|Overall Study|Did not receive study product injection.|3|||
23243238|NCT02918318|64635798|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
23243239|NCT02918318|64635799|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
23243240|NCT02918318|64635795|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
23243241|NCT02918318|64635796|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
23243242|NCT02918318|64635797|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
23243243|NCT02918318|64635798|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
23243244|NCT02918318|64635799|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
23243245|NCT02918318|64635795|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
23243246|NCT02918318|64635796|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
23243247|NCT02918318|64635797|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
23243248|NCT02918318|64635798|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
23243249|NCT02918318|64635799|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
23243250|NCT02918318|64635795|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
23243251|NCT02918318|64635796|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
23243252|NCT02918318|64635797|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
23243253|NCT02918318|64635798|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
23243254|NCT02918318|64635799|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
23243255|NCT02918318|64635795|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
23243256|NCT02918318|64635796|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
23243257|NCT02918318|64635797|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
23243258|NCT02918318|64635798|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
23243259|NCT02918318|64635799|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
23243260|NCT02918318|64635795|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
23243261|NCT02918318|64635796|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
23243262|NCT02918318|64635797|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
23243263|NCT02918318|64635798|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
23243264|NCT02918318|64635799|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
23243265|NCT02325401|64635800|FG000|Overall Study|Withdrawal by Subject|0|||
23243266|NCT02325401|64635801|FG001|Overall Study|Withdrawal by Subject|1|||
23243267|NCT02325401|64635802|FG002|Overall Study|Withdrawal by Subject|1|||
23243268|NCT00674440|64635808|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
23585438|NCT00768066|65869450|FG001|Overall Study|Did not receive study product injection.|3|||
23585439|NCT00768066|65869451|FG002|Overall Study|Did not receive study product injection.|0|||
23585440|NCT02359435|65869454|FG000|Overall Study|Lost to Follow-up|4|||
23585441|NCT02359435|65869455|FG001|Overall Study|Lost to Follow-up|4|||
23585442|NCT00151996|65869456|FG000|Overall Study|Adverse Event|3|||
23243269|NCT00674440|64635808|FG000|Overall Study|did not have surgery, so unevaluable|7|||
23464978|NCT00068692|65444796|FG005|Step 1: Registration|Registered but not randomized|0|||
23464979|NCT00068692|65444797|FG006|Step 1: Registration|Registered but not randomized|0|||
23464980|NCT00068692|65444798|FG007|Step 1: Registration|Registered but not randomized|0|||
23464981|NCT00068692|65444791|FG000|Step 2: Randomization|Disesae progression/replase|0|||
23464982|NCT00068692|65444792|FG001|Step 2: Randomization|Disesae progression/replase|0|||
23464983|NCT00068692|65444793|FG002|Step 2: Randomization|Disesae progression/replase|1|||
23464984|NCT00068692|65444794|FG003|Step 2: Randomization|Disesae progression/replase|1|||
23464985|NCT00068692|65444795|FG004|Step 2: Randomization|Disesae progression/replase|0|||
23464986|NCT00068692|65444796|FG005|Step 2: Randomization|Disesae progression/replase|0|||
23464987|NCT00068692|65444797|FG006|Step 2: Randomization|Disesae progression/replase|0|||
23464988|NCT00068692|65444798|FG007|Step 2: Randomization|Disesae progression/replase|0|||
23464989|NCT00068692|65444791|FG000|Step 2: Randomization|Adverse Event|0|||
23464990|NCT00068692|65444792|FG001|Step 2: Randomization|Adverse Event|0|||
23585443|NCT00151996|65869457|FG001|Overall Study|Adverse Event|2|||
23350806|NCT00628927|65029409|FG000|Overall Study|Equipment failure|1|||
23464991|NCT00068692|65444793|FG002|Step 2: Randomization|Adverse Event|4|||
23585444|NCT00151996|65869456|FG000|Overall Study|Withdrawal by Subject|1|||
23585445|NCT00151996|65869457|FG001|Overall Study|Withdrawal by Subject|1|||
23585446|NCT00151996|65869456|FG000|Overall Study|Protocol Violation|1|||
23585447|NCT00151996|65869457|FG001|Overall Study|Protocol Violation|2|||
23585448|NCT00151996|65869456|FG000|Overall Study|Sponsor's decision|0|||
23585449|NCT00151996|65869457|FG001|Overall Study|Sponsor's decision|2|||
23585450|NCT01345292|65869458|FG000|Overall Study|Withdrawal by Subject|2|||
23585451|NCT01345292|65869459|FG001|Overall Study|Withdrawal by Subject|0|||
23585452|NCT01345292|65869460|FG002|Overall Study|Withdrawal by Subject|1|||
23585453|NCT03635567|65869463|FG000|Overall Study|Lost to Follow-up|0|||
23585454|NCT03635567|65869464|FG001|Overall Study|Lost to Follow-up|2|||
23585455|NCT03635567|65869463|FG000|Overall Study|Withdrawal by Subject|9|||
23585456|NCT03635567|65869464|FG001|Overall Study|Withdrawal by Subject|10|||
23585457|NCT03635567|65869463|FG000|Overall Study|Ongoing in Study|125|||
23585458|NCT03635567|65869464|FG001|Overall Study|Ongoing in Study|76|||
23585459|NCT03635567|65869463|FG000|Overall Study|Death|174|||
23585460|NCT03635567|65869464|FG001|Overall Study|Death|221|||
23585461|NCT00817635|65869465|FG000|Overall Study|Adverse Event|1|||
23585462|NCT00817635|65869466|FG001|Overall Study|Adverse Event|0|||
23585463|NCT00817635|65869467|FG002|Overall Study|Adverse Event|0|||
23243270|NCT00674440|64635808|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
23243271|NCT02871921|64635809|FG000|Overall Study|Withdrawal by Subject|34|||
23243272|NCT02871921|64635810|FG001|Overall Study|Withdrawal by Subject|27|||
23243273|NCT02871921|64635811|FG002|Overall Study|Withdrawal by Subject|27|||
23243274|NCT02871921|64635812|FG003|Overall Study|Withdrawal by Subject|30|||
23243275|NCT02797951|64635813|FG000|Overall Study|Adverse Event|4|||
23185072|NCT01607892|64417063|FG001|Overall Study|Non-Compliance with study procedures|0|||
23185073|NCT01607892|64417064|FG002|Overall Study|Non-Compliance with study procedures|1|||
23585464|NCT00817635|65869468|FG003|Overall Study|Adverse Event|1|||
23585465|NCT00817635|65869469|FG004|Overall Study|Adverse Event|1|||
23585466|NCT00817635|65869465|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
23585467|NCT00817635|65869466|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
23585468|NCT00817635|65869467|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
23585469|NCT00817635|65869468|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
23585470|NCT00817635|65869469|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
23585471|NCT00817635|65869465|FG000|Overall Study|Withdrawal by Subject|2|||
23585472|NCT00817635|65869466|FG001|Overall Study|Withdrawal by Subject|1|||
23585473|NCT00817635|65869467|FG002|Overall Study|Withdrawal by Subject|0|||
23185074|NCT01607892|64417065|FG003|Overall Study|Non-Compliance with study procedures|0|||
23185075|NCT01607892|64417066|FG004|Overall Study|Non-Compliance with study procedures|0|||
23185076|NCT01607892|64417062|FG000|Overall Study|Consent withdrawn by participant|9|||
23185077|NCT01607892|64417063|FG001|Overall Study|Consent withdrawn by participant|4|||
23185078|NCT01607892|64417064|FG002|Overall Study|Consent withdrawn by participant|24|||
23185079|NCT01607892|64417065|FG003|Overall Study|Consent withdrawn by participant|14|||
23185080|NCT01607892|64417066|FG004|Overall Study|Consent withdrawn by participant|4|||
23185081|NCT01607892|64417062|FG000|Overall Study|Disease progression|38|||
23350807|NCT00628927|65029410|FG001|Overall Study|Equipment failure|0|||
23350808|NCT00590538|65029411|FG000|Overall Study|Study terminated before completed|2|||
23464992|NCT00068692|65444794|FG003|Step 2: Randomization|Adverse Event|2|||
23464993|NCT00068692|65444795|FG004|Step 2: Randomization|Adverse Event|2|||
23464994|NCT00068692|65444796|FG005|Step 2: Randomization|Adverse Event|3|||
23464995|NCT00068692|65444797|FG006|Step 2: Randomization|Adverse Event|4|||
23464996|NCT00068692|65444798|FG007|Step 2: Randomization|Adverse Event|4|||
23464997|NCT00068692|65444791|FG000|Step 2: Randomization|Death|0|||
23464998|NCT00068692|65444792|FG001|Step 2: Randomization|Death|0|||
23464999|NCT00068692|65444793|FG002|Step 2: Randomization|Death|0|||
23465000|NCT00068692|65444794|FG003|Step 2: Randomization|Death|0|||
23465001|NCT00068692|65444795|FG004|Step 2: Randomization|Death|1|||
23465002|NCT00068692|65444796|FG005|Step 2: Randomization|Death|0|||
23465003|NCT00068692|65444797|FG006|Step 2: Randomization|Death|0|||
23465004|NCT00068692|65444798|FG007|Step 2: Randomization|Death|1|||
23465005|NCT00068692|65444791|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
23465006|NCT00068692|65444792|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
23465007|NCT00068692|65444793|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
23465008|NCT00068692|65444794|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
23243276|NCT02797951|64635813|FG000|Overall Study|Death|1|||
23465009|NCT00068692|65444795|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
23243277|NCT02797951|64635813|FG000|Overall Study|Lack of Efficacy|19|||
23350809|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
23465010|NCT00068692|65444796|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
23585474|NCT00817635|65869468|FG003|Overall Study|Withdrawal by Subject|1|||
23585475|NCT00817635|65869469|FG004|Overall Study|Withdrawal by Subject|2|||
23585476|NCT00817635|65869465|FG000|Overall Study|Lost to Follow-up|0|||
23585477|NCT00817635|65869466|FG001|Overall Study|Lost to Follow-up|1|||
23585478|NCT00817635|65869467|FG002|Overall Study|Lost to Follow-up|0|||
23585479|NCT00817635|65869468|FG003|Overall Study|Lost to Follow-up|1|||
23585480|NCT00817635|65869469|FG004|Overall Study|Lost to Follow-up|0|||
23585481|NCT00817635|65869465|FG000|Overall Study|Administrative Problems|0|||
23585482|NCT00817635|65869466|FG001|Overall Study|Administrative Problems|0|||
23465011|NCT00068692|65444797|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
23465012|NCT00068692|65444798|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
23465013|NCT00068692|65444791|FG000|Step 2: Randomization|alternative therapy|0|||
23465014|NCT00068692|65444792|FG001|Step 2: Randomization|alternative therapy|0|||
23465015|NCT00068692|65444793|FG002|Step 2: Randomization|alternative therapy|0|||
23465016|NCT00068692|65444794|FG003|Step 2: Randomization|alternative therapy|1|||
23465017|NCT00068692|65444795|FG004|Step 2: Randomization|alternative therapy|1|||
23465018|NCT00068692|65444796|FG005|Step 2: Randomization|alternative therapy|0|||
23465019|NCT00068692|65444797|FG006|Step 2: Randomization|alternative therapy|0|||
23465020|NCT00068692|65444798|FG007|Step 2: Randomization|alternative therapy|0|||
23465021|NCT00068692|65444791|FG000|Step 2: Randomization|Physician Decision|0|||
23585483|NCT00817635|65869467|FG002|Overall Study|Administrative Problems|0|||
23243278|NCT02797951|64635813|FG000|Overall Study|Lost to Follow-up|4|||
23243279|NCT02797951|64635813|FG000|Overall Study|Physician Decision|6|||
23243280|NCT02797951|64635813|FG000|Overall Study|Withdrawal by Subject|15|||
23243281|NCT00209560|64635814|FG000|Overall Study|Lack of Efficacy|1|||
23243282|NCT00209560|64635815|FG001|Overall Study|Lack of Efficacy|0|||
23243283|NCT00351611|64635823|FG000|Overall Study|Adverse Event|11|||
23243284|NCT00351611|64635824|FG001|Overall Study|Adverse Event|3|||
23243285|NCT00351611|64635823|FG000|Overall Study|Death|1|||
23243286|NCT00351611|64635824|FG001|Overall Study|Death|0|||
23243287|NCT00351611|64635823|FG000|Overall Study|Lost to Follow-up|1|||
23243288|NCT00351611|64635824|FG001|Overall Study|Lost to Follow-up|0|||
23243289|NCT00351611|64635823|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
23243290|NCT00351611|64635824|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
23243291|NCT00351611|64635823|FG000|Overall Study|Other|1|||
23585484|NCT00817635|65869468|FG003|Overall Study|Administrative Problems|0|||
23585485|NCT00817635|65869469|FG004|Overall Study|Administrative Problems|1|||
23585486|NCT00817635|65869465|FG000|Overall Study|Protocol Violation|5|||
23585487|NCT00817635|65869466|FG001|Overall Study|Protocol Violation|1|||
23585488|NCT00817635|65869467|FG002|Overall Study|Protocol Violation|3|||
23585489|NCT00817635|65869468|FG003|Overall Study|Protocol Violation|2|||
23585490|NCT00817635|65869469|FG004|Overall Study|Protocol Violation|3|||
23585491|NCT00586339|65869472|FG000|Overall Study|Withdrawal by Subject|1|||
23585492|NCT00586339|65869473|FG001|Overall Study|Withdrawal by Subject|3|||
23585493|NCT00586339|65869474|FG002|Overall Study|Withdrawal by Subject|1|||
23585494|NCT00586339|65869472|FG000|Overall Study|Migrated/moved from study area|3|||
23585495|NCT00586339|65869473|FG001|Overall Study|Migrated/moved from study area|2|||
23243292|NCT00351611|64635824|FG001|Overall Study|Other|0|||
23243293|NCT00351611|64635823|FG000|Overall Study|Protocol Violation|0|||
23243294|NCT00351611|64635824|FG001|Overall Study|Protocol Violation|2|||
23243295|NCT00352664|64635826|FG000|Overall Study|Withdrawal by Subject|7|||
23243296|NCT00352664|64635827|FG001|Overall Study|Withdrawal by Subject|0|||
23243297|NCT00054275|64635828|FG000|Overall Study|Withdrawal by Subject|4|||
23243298|NCT00054275|64635828|FG000|Overall Study|Adverse Event|5|||
23243299|NCT00054275|64635828|FG000|Overall Study|Progressive disease in cycle 1|1|||
23243300|NCT00054275|64635828|FG000|Overall Study|Physician Decision|1|||
23243301|NCT01300741|64635829|FG000|Overall Study|Lens deposits|1|||
23243302|NCT01300741|64635829|FG000|Overall Study|Lost to Follow-up|1|||
23243303|NCT01300741|64635829|FG000|Overall Study|Discomfort|1|||
23243304|NCT04054011|64635831|FG000|Overall Study|COVID|3|||
23243305|NCT00111007|64635837|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
23243306|NCT00111007|64635838|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
23243307|NCT00111007|64635837|FG000|Double-blind (DB) Treatment|Death|5|||
23243308|NCT00111007|64635838|FG001|Double-blind (DB) Treatment|Death|2|||
23243309|NCT00111007|64635837|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
23243310|NCT00111007|64635838|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
23243311|NCT00111007|64635837|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
23243312|NCT00111007|64635838|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
23243313|NCT00111007|64635837|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
23243314|NCT00111007|64635838|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
23243315|NCT00111007|64635837|FG000|Double-blind (DB) Treatment|Relapse|1|||
23465022|NCT00068692|65444792|FG001|Step 2: Randomization|Physician Decision|0|||
23243316|NCT00111007|64635838|FG001|Double-blind (DB) Treatment|Relapse|0|||
23465023|NCT00068692|65444793|FG002|Step 2: Randomization|Physician Decision|0|||
23465024|NCT00068692|65444794|FG003|Step 2: Randomization|Physician Decision|1|||
23465025|NCT00068692|65444795|FG004|Step 2: Randomization|Physician Decision|1|||
23585496|NCT00586339|65869474|FG002|Overall Study|Migrated/moved from study area|4|||
23585497|NCT00586339|65869472|FG000|Overall Study|Lost to Follow-up|3|||
23585498|NCT00586339|65869473|FG001|Overall Study|Lost to Follow-up|2|||
23585499|NCT00586339|65869474|FG002|Overall Study|Lost to Follow-up|1|||
23185082|NCT01607892|64417063|FG001|Overall Study|Disease progression|13|||
23243317|NCT00111007|64635837|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
23585500|NCT02701361|65869480|FG000|Overall Study|Lost to Follow-up|5|||
23585501|NCT02701361|65869481|FG001|Overall Study|Lost to Follow-up|2|||
23585502|NCT02701361|65869482|FG002|Overall Study|Lost to Follow-up|1|||
23585503|NCT02701361|65869480|FG000|Overall Study|Withdrawal by Subject|4|||
23585504|NCT02701361|65869481|FG001|Overall Study|Withdrawal by Subject|0|||
23585505|NCT02701361|65869482|FG002|Overall Study|Withdrawal by Subject|0|||
23585506|NCT02701361|65869480|FG000|Overall Study|timed out in rehab center|0|||
23585507|NCT02701361|65869481|FG001|Overall Study|timed out in rehab center|1|||
23585508|NCT02701361|65869482|FG002|Overall Study|timed out in rehab center|0|||
23585509|NCT02701361|65869480|FG000|Overall Study|incarceration|0|||
23585510|NCT02701361|65869481|FG001|Overall Study|incarceration|0|||
23585511|NCT02701361|65869482|FG002|Overall Study|incarceration|1|||
23585512|NCT01981954|65869484|FG000|Titration Period|Protocol Deviation|1|||
23243318|NCT00111007|64635838|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
23350810|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350811|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350812|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350813|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350814|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23243319|NCT00111007|64635837|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
23243320|NCT00111007|64635838|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
23243321|NCT00111007|64635837|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
23243322|NCT00111007|64635838|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
23350815|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350816|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350817|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
23350818|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
23350819|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
23350820|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
23350821|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
23350822|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
23350823|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
23465026|NCT00068692|65444796|FG005|Step 2: Randomization|Physician Decision|0|||
23465027|NCT00068692|65444797|FG006|Step 2: Randomization|Physician Decision|0|||
23465028|NCT00068692|65444798|FG007|Step 2: Randomization|Physician Decision|0|||
23465029|NCT00068692|65444791|FG000|Step 2: Randomization|Other|0|||
23465030|NCT00068692|65444792|FG001|Step 2: Randomization|Other|0|||
23465031|NCT00068692|65444793|FG002|Step 2: Randomization|Other|0|||
23465032|NCT00068692|65444794|FG003|Step 2: Randomization|Other|1|||
23465033|NCT00068692|65444795|FG004|Step 2: Randomization|Other|0|||
23465034|NCT00068692|65444796|FG005|Step 2: Randomization|Other|1|||
23465035|NCT00068692|65444797|FG006|Step 2: Randomization|Other|0|||
23465036|NCT00068692|65444798|FG007|Step 2: Randomization|Other|0|||
23465037|NCT00068692|65444791|FG000|Step 2: Randomization|never start protocol therapy|0|||
23465038|NCT00068692|65444792|FG001|Step 2: Randomization|never start protocol therapy|0|||
23465039|NCT00068692|65444793|FG002|Step 2: Randomization|never start protocol therapy|1|||
23465040|NCT00068692|65444794|FG003|Step 2: Randomization|never start protocol therapy|0|||
23465041|NCT00068692|65444795|FG004|Step 2: Randomization|never start protocol therapy|1|||
23465042|NCT00068692|65444796|FG005|Step 2: Randomization|never start protocol therapy|0|||
23465043|NCT00068692|65444797|FG006|Step 2: Randomization|never start protocol therapy|0|||
23465044|NCT00068692|65444798|FG007|Step 2: Randomization|never start protocol therapy|0|||
23465045|NCT01931566|65444801|FG000|Overall Study|Randomized But Not Treated|6|||
23465046|NCT01931566|65444802|FG001|Overall Study|Randomized But Not Treated|9|||
23243323|NCT00111007|64635837|FG000|Active Follow-up|Adverse Event|1|||
23243324|NCT00111007|64635838|FG001|Active Follow-up|Adverse Event|0|||
23243325|NCT00111007|64635837|FG000|Active Follow-up|Death|2|||
23243326|NCT00111007|64635838|FG001|Active Follow-up|Death|0|||
23243327|NCT00111007|64635837|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
23243328|NCT00111007|64635838|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
23243329|NCT00111007|64635837|FG000|Long Term Follow-up|Death|34|||
23243330|NCT00111007|64635838|FG001|Long Term Follow-up|Death|39|||
23243331|NCT00111007|64635837|FG000|Long Term Follow-up|Lost to Follow-up|1|||
23243332|NCT00111007|64635838|FG001|Long Term Follow-up|Lost to Follow-up|1|||
23585513|NCT01981954|65869484|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
23585514|NCT03586167|65869485|FG000|Overall Study|Other|1|||
23243333|NCT00111007|64635837|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
23585515|NCT03586167|65869486|FG001|Overall Study|Other|0|||
23585516|NCT00554801|65869487|FG000|Overall Study|left area before completion|5|||
23585517|NCT00554801|65869488|FG001|Overall Study|left area before completion|0|||
23585518|NCT00554801|65869487|FG000|Overall Study|Withdrawal by Subject|14|||
23585519|NCT00554801|65869488|FG001|Overall Study|Withdrawal by Subject|0|||
23465047|NCT01931566|65444803|FG002|Overall Study|Randomized But Not Treated|14|||
23465048|NCT01931566|65444801|FG000|Overall Study|Adverse Event|37|||
23585520|NCT03545984|65869489|FG000|Overall Study|CSF cases not present during rotation|11|||
23585521|NCT03545984|65869490|FG001|Overall Study|CSF cases not present during rotation|9|||
23585522|NCT04567615|65869497|FG000|Randomization|Participant withdrew consent|1|||
23585523|NCT04567615|65869498|FG001|Randomization|Participant withdrew consent|0|||
23585524|NCT04567615|65869499|FG002|Randomization|Participant withdrew consent|0|||
23585525|NCT04567615|65869497|FG000|Randomization|Adverse event unrelated to study drug|0|||
23585526|NCT04567615|65869498|FG001|Randomization|Adverse event unrelated to study drug|1|||
23465049|NCT01931566|65444802|FG001|Overall Study|Adverse Event|167|||
23465050|NCT01931566|65444803|FG002|Overall Study|Adverse Event|132|||
23465051|NCT01931566|65444801|FG000|Overall Study|Major Protocol Deviation|5|||
23465052|NCT01931566|65444802|FG001|Overall Study|Major Protocol Deviation|14|||
23465053|NCT01931566|65444803|FG002|Overall Study|Major Protocol Deviation|21|||
23465054|NCT01931566|65444801|FG000|Overall Study|Lost to Follow-up|3|||
23465055|NCT01931566|65444802|FG001|Overall Study|Lost to Follow-up|26|||
23465056|NCT01931566|65444803|FG002|Overall Study|Lost to Follow-up|23|||
23465057|NCT01931566|65444801|FG000|Overall Study|Voluntary Withdrawal|78|||
23585527|NCT04567615|65869499|FG002|Randomization|Adverse event unrelated to study drug|0|||
23585528|NCT04567615|65869497|FG000|Treatment Period|Participant Withdrew Consent|2|||
23185083|NCT01607892|64417064|FG002|Overall Study|Disease progression|37|||
23185084|NCT01607892|64417065|FG003|Overall Study|Disease progression|57|||
23185085|NCT01607892|64417066|FG004|Overall Study|Disease progression|9|||
23185086|NCT01607892|64417062|FG000|Overall Study|Incidence or severity of Adverse events|3|||
23185087|NCT01607892|64417063|FG001|Overall Study|Incidence or severity of Adverse events|3|||
23185088|NCT01607892|64417064|FG002|Overall Study|Incidence or severity of Adverse events|7|||
23185089|NCT01607892|64417065|FG003|Overall Study|Incidence or severity of Adverse events|2|||
23185090|NCT01607892|64417066|FG004|Overall Study|Incidence or severity of Adverse events|6|||
23185091|NCT00684814|64417073|FG000|Washout Period of 7 Days|Adverse Event|1|||
23185092|NCT00684814|64417074|FG001|Washout Period of 7 Days|Adverse Event|2|||
23185093|NCT00684814|64417073|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
23185094|NCT00684814|64417074|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
23185095|NCT00684814|64417073|FG000|Second Intervention|Adverse Event|1|||
23185096|NCT00684814|64417074|FG001|Second Intervention|Adverse Event|0|||
23185097|NCT03358472|64417075|FG000|Overall Study|Death|6|||
23185098|NCT03358472|64417076|FG001|Overall Study|Death|3|||
23185099|NCT03358472|64417077|FG002|Overall Study|Death|10|||
23185100|NCT03358472|64417075|FG000|Overall Study|Physician Decision|0|||
23185101|NCT03358472|64417076|FG001|Overall Study|Physician Decision|1|||
23185102|NCT03358472|64417077|FG002|Overall Study|Physician Decision|0|||
23185103|NCT03358472|64417075|FG000|Overall Study|Withdrawal by Subject|0|||
23465058|NCT01931566|65444802|FG001|Overall Study|Voluntary Withdrawal|245|||
23465059|NCT01931566|65444803|FG002|Overall Study|Voluntary Withdrawal|225|||
23465060|NCT01931566|65444801|FG000|Overall Study|Study Termination|289|||
23465061|NCT01931566|65444802|FG001|Overall Study|Study Termination|968|||
23465062|NCT01931566|65444803|FG002|Overall Study|Study Termination|1037|||
23185104|NCT03358472|64417076|FG001|Overall Study|Withdrawal by Subject|0|||
23185105|NCT03358472|64417077|FG002|Overall Study|Withdrawal by Subject|1|||
23185106|NCT03358472|64417075|FG000|Overall Study|On-going at clinical cut off date|9|||
23185107|NCT03358472|64417076|FG001|Overall Study|On-going at clinical cut off date|6|||
23185108|NCT03358472|64417077|FG002|Overall Study|On-going at clinical cut off date|5|||
23185109|NCT01262898|64417078|FG000|Overall Study|Protocol Violation|1|||
23185110|NCT01262898|64417079|FG001|Overall Study|Protocol Violation|1|||
23185111|NCT01262898|64417080|FG002|Overall Study|Protocol Violation|0|||
23185112|NCT01262898|64417081|FG003|Overall Study|Protocol Violation|0|||
23185113|NCT01262898|64417078|FG000|Overall Study|Lost to Follow-up|1|||
23185114|NCT01262898|64417079|FG001|Overall Study|Lost to Follow-up|0|||
23185115|NCT01262898|64417080|FG002|Overall Study|Lost to Follow-up|0|||
23185116|NCT01262898|64417081|FG003|Overall Study|Lost to Follow-up|0|||
23185117|NCT01262898|64417078|FG000|Overall Study|Withdrawal by Subject|1|||
23185118|NCT01262898|64417079|FG001|Overall Study|Withdrawal by Subject|1|||
23185119|NCT01262898|64417080|FG002|Overall Study|Withdrawal by Subject|0|||
23185120|NCT01262898|64417081|FG003|Overall Study|Withdrawal by Subject|0|||
23465063|NCT01931566|65444801|FG000|Overall Study|Reason Not Specified|11|||
23465064|NCT01931566|65444802|FG001|Overall Study|Reason Not Specified|47|||
23465065|NCT01931566|65444803|FG002|Overall Study|Reason Not Specified|53|||
23465066|NCT01931566|65444801|FG000|Overall Study|Missing|0|||
23185121|NCT04426630|64417086|FG000|Overall Study|Death|4|||
23185122|NCT04426630|64417086|FG000|Overall Study|Lost to Follow-up|2|||
23185123|NCT00104871|64417092|FG000|Overall Study|Not evaluable|1|||
23185124|NCT00749203|64417093|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
23185125|NCT00749203|64417094|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
23585529|NCT04567615|65869498|FG001|Treatment Period|Participant Withdrew Consent|5|||
23585530|NCT04567615|65869499|FG002|Treatment Period|Participant Withdrew Consent|1|||
23585531|NCT04567615|65869497|FG000|Treatment Period|Death|1|||
23585532|NCT04567615|65869498|FG001|Treatment Period|Death|2|||
23185126|NCT00749203|64417093|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
23185127|NCT00749203|64417094|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
23185128|NCT00749203|64417093|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
23185129|NCT00749203|64417094|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
23185130|NCT00749203|64417093|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
23185131|NCT00749203|64417094|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
23185132|NCT00749203|64417093|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
23185133|NCT00749203|64417094|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
23185134|NCT00749203|64417093|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
23185135|NCT00749203|64417094|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
23185136|NCT02706938|64417095|FG000|First Period, 6 Weeks|Adverse Event|8|||
23185137|NCT02706938|64417096|FG001|First Period, 6 Weeks|Adverse Event|0|||
23185138|NCT02706938|64417095|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
23185139|NCT02706938|64417096|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
23185140|NCT02706938|64417095|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
23185141|NCT02706938|64417096|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
23185142|NCT02706938|64417095|FG000|Second Period, 6 Weeks|Adverse Event|0|||
23185143|NCT02706938|64417096|FG001|Second Period, 6 Weeks|Adverse Event|7|||
23185144|NCT02706938|64417095|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
23185145|NCT02706938|64417096|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
23465067|NCT01931566|65444802|FG001|Overall Study|Missing|0|||
23465068|NCT01931566|65444803|FG002|Overall Study|Missing|1|||
23465069|NCT02556177|65444806|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
23465070|NCT02556177|65444807|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
23465071|NCT02840461|65444811|FG000|Overall Study|Adverse Event|1|||
23465072|NCT02840461|65444812|FG001|Overall Study|Adverse Event|5|||
23465073|NCT02840461|65444813|FG002|Overall Study|Adverse Event|3|||
23465074|NCT02840461|65444811|FG000|Overall Study|Lost to Follow-up|10|||
23465075|NCT02840461|65444812|FG001|Overall Study|Lost to Follow-up|7|||
23465076|NCT02840461|65444813|FG002|Overall Study|Lost to Follow-up|6|||
23465077|NCT02840461|65444811|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
23465078|NCT02840461|65444812|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
23465079|NCT02840461|65444813|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
23465080|NCT02840461|65444811|FG000|Overall Study|Protocol Violation|2|||
23465081|NCT02840461|65444812|FG001|Overall Study|Protocol Violation|3|||
23465082|NCT02840461|65444813|FG002|Overall Study|Protocol Violation|1|||
23465083|NCT02840461|65444811|FG000|Overall Study|Withdrawal by Subject|10|||
23465084|NCT02840461|65444812|FG001|Overall Study|Withdrawal by Subject|6|||
23465085|NCT02840461|65444813|FG002|Overall Study|Withdrawal by Subject|2|||
23465086|NCT02840461|65444811|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
23465087|NCT02840461|65444812|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
23465088|NCT02840461|65444813|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
23465089|NCT01774721|65444829|FG000|Overall Study|Death|133|||
23465090|NCT01774721|65444830|FG001|Overall Study|Death|152|||
23465091|NCT01774721|65444829|FG000|Overall Study|Withdrawal by Subject|20|||
23465092|NCT01774721|65444830|FG001|Overall Study|Withdrawal by Subject|14|||
23465093|NCT01774721|65444829|FG000|Overall Study|Lost to Follow-up|6|||
23465094|NCT01774721|65444830|FG001|Overall Study|Lost to Follow-up|7|||
23465095|NCT01774721|65444829|FG000|Overall Study|Did not meet eligibility criteria|0|||
23465096|NCT01774721|65444830|FG001|Overall Study|Did not meet eligibility criteria|3|||
23465097|NCT01774721|65444829|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
23465098|NCT01774721|65444830|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
23465099|NCT01774721|65444829|FG000|Overall Study|Study terminated by sponsor|5|||
23465100|NCT01774721|65444830|FG001|Overall Study|Study terminated by sponsor|0|||
23465101|NCT01774721|65444829|FG000|Overall Study|Disease progression|5|||
23465102|NCT01774721|65444830|FG001|Overall Study|Disease progression|0|||
23465103|NCT01094119|65444831|FG000|Overall Study|Lack of Efficacy|2|||
23465104|NCT01094119|65444832|FG001|Overall Study|Lack of Efficacy|4|||
23465105|NCT00929695|65444834|FG000|Overall Study|Death|2|||
23465106|NCT00929695|65444835|FG001|Overall Study|Death|1|||
23465107|NCT00929695|65444834|FG000|Overall Study|Withdrawal by Subject|0|||
23465108|NCT00929695|65444835|FG001|Overall Study|Withdrawal by Subject|2|||
23465109|NCT00929695|65444834|FG000|Overall Study|discharge home|4|||
23465110|NCT00929695|65444835|FG001|Overall Study|discharge home|3|||
23465111|NCT00929695|65444834|FG000|Overall Study|incorrect stratification|2|||
23465112|NCT00929695|65444835|FG001|Overall Study|incorrect stratification|0|||
23465113|NCT04396639|65444836|FG000|Overall Study|Withdrawal by Subject|1|||
23465114|NCT04396639|65444836|FG000|Overall Study|Other|1|||
23465115|NCT00705016|65444841|FG000|Overall Study|Adverse Event|6|||
23465116|NCT00705016|65444842|FG001|Overall Study|Adverse Event|11|||
23185146|NCT01478958|64417097|FG000|Overall Study|Withdrawal by Subject|1|||
23465117|NCT00705016|65444843|FG002|Overall Study|Adverse Event|10|||
23465118|NCT00705016|65444841|FG000|Overall Study|Death|5|||
23465119|NCT00705016|65444842|FG001|Overall Study|Death|7|||
23465120|NCT00705016|65444843|FG002|Overall Study|Death|5|||
23185147|NCT01478958|64417098|FG001|Overall Study|Withdrawal by Subject|1|||
23185148|NCT01478958|64417099|FG002|Overall Study|Withdrawal by Subject|1|||
23185149|NCT01478958|64417097|FG000|Overall Study|Weight loss|1|||
23185150|NCT01478958|64417098|FG001|Overall Study|Weight loss|0|||
23185151|NCT01478958|64417099|FG002|Overall Study|Weight loss|0|||
23185152|NCT01478958|64417097|FG000|Overall Study|Re-located|0|||
23185153|NCT01478958|64417098|FG001|Overall Study|Re-located|1|||
23350824|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
23350825|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
23350826|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
23185154|NCT01478958|64417099|FG002|Overall Study|Re-located|0|||
23185155|NCT01478958|64417097|FG000|Overall Study|Unable to comply|0|||
23185156|NCT01478958|64417098|FG001|Overall Study|Unable to comply|0|||
23185157|NCT01478958|64417099|FG002|Overall Study|Unable to comply|2|||
23185158|NCT02333227|64420227|FG000|Overall Study|Lost to Follow-up|137|||
23185159|NCT02333227|64420228|FG001|Overall Study|Lost to Follow-up|106|||
23185160|NCT02333227|64420227|FG000|Overall Study|Pregnancy Interrupted|42|||
23185161|NCT02333227|64420228|FG001|Overall Study|Pregnancy Interrupted|89|||
23185162|NCT02333227|64420227|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
23185163|NCT02333227|64420228|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
23185164|NCT00190775|64420230|FG000|Overall Study|Adverse Event|57|||
23185165|NCT00190775|64420231|FG001|Overall Study|Adverse Event|22|||
23185166|NCT00190775|64420230|FG000|Overall Study|Satisfactory Response|1|||
23185167|NCT00190775|64420231|FG001|Overall Study|Satisfactory Response|0|||
23185168|NCT00190775|64420230|FG000|Overall Study|Lack of Efficacy|28|||
23185169|NCT00190775|64420231|FG001|Overall Study|Lack of Efficacy|32|||
23185170|NCT00190775|64420230|FG000|Overall Study|Lost to Follow-up|31|||
23185171|NCT00190775|64420231|FG001|Overall Study|Lost to Follow-up|23|||
23185172|NCT00190775|64420230|FG000|Overall Study|Participant Moved|0|||
23185173|NCT00190775|64420231|FG001|Overall Study|Participant Moved|1|||
23185174|NCT00190775|64420230|FG000|Overall Study|Withdrawal by Subject|24|||
23185175|NCT00190775|64420231|FG001|Overall Study|Withdrawal by Subject|13|||
23185176|NCT00190775|64420230|FG000|Overall Study|Sponsor Decision|1|||
23185177|NCT00190775|64420231|FG001|Overall Study|Sponsor Decision|0|||
23185178|NCT00190775|64420230|FG000|Overall Study|Physician Decision|3|||
23185179|NCT00190775|64420231|FG001|Overall Study|Physician Decision|0|||
23185180|NCT00190775|64420230|FG000|Overall Study|Noncompliance|3|||
23185181|NCT00190775|64420231|FG001|Overall Study|Noncompliance|5|||
23185182|NCT00190775|64420230|FG000|Overall Study|Protocol Violation|0|||
23185183|NCT00190775|64420231|FG001|Overall Study|Protocol Violation|1|||
23185184|NCT00190775|64420230|FG000|Overall Study|Exclusion Criteria Met|1|||
23185185|NCT00190775|64420231|FG001|Overall Study|Exclusion Criteria Met|3|||
23185186|NCT00942162|64420232|FG000|Overall Study|Death|45|||
23185187|NCT00942162|64420233|FG001|Overall Study|Death|35|||
23185188|NCT00942162|64420234|FG002|Overall Study|Death|0|||
23185189|NCT00942162|64420232|FG000|Overall Study|Withdrawal by Subject|7|||
23185190|NCT00942162|64420233|FG001|Overall Study|Withdrawal by Subject|2|||
23185191|NCT00942162|64420234|FG002|Overall Study|Withdrawal by Subject|0|||
23185192|NCT00942162|64420232|FG000|Overall Study|Lost to Follow-up|4|||
23185193|NCT00942162|64420233|FG001|Overall Study|Lost to Follow-up|0|||
23185194|NCT00942162|64420234|FG002|Overall Study|Lost to Follow-up|0|||
23185195|NCT00942162|64420232|FG000|Overall Study|Other|14|||
23185196|NCT00942162|64420233|FG001|Overall Study|Other|13|||
23185197|NCT00942162|64420234|FG002|Overall Study|Other|2|||
23185198|NCT03567187|64420243|FG000|Overall Study|Lost to Follow-up|18|||
23185199|NCT00629083|64420244|FG000|Overall Study|Adverse Event|0|||
23185200|NCT00629083|64420245|FG001|Overall Study|Adverse Event|2|||
23185201|NCT00629083|64420244|FG000|Overall Study|Lack of Efficacy|3|||
23185202|NCT00629083|64420245|FG001|Overall Study|Lack of Efficacy|1|||
23185203|NCT00629083|64420244|FG000|Overall Study|Withdrawal by Subject|10|||
23185204|NCT00629083|64420245|FG001|Overall Study|Withdrawal by Subject|2|||
23185205|NCT00629083|64420244|FG000|Overall Study|Lost to Follow-up|12|||
23185206|NCT00629083|64420245|FG001|Overall Study|Lost to Follow-up|8|||
23185207|NCT00629083|64420244|FG000|Overall Study|Moved out of country/state|2|||
23185208|NCT00629083|64420245|FG001|Overall Study|Moved out of country/state|1|||
23185209|NCT00629083|64420244|FG000|Overall Study|Refused to return for 12 month visit|1|||
23185210|NCT00629083|64420245|FG001|Overall Study|Refused to return for 12 month visit|0|||
23185211|NCT00162773|64420248|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
23185212|NCT01009294|64420249|FG000|Overall Study|Study discontinued by Sponsor|6|||
23185213|NCT03022422|64420250|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
23185214|NCT03022422|64420251|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
23185215|NCT03022422|64420252|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
23185216|NCT03022422|64420253|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
23465121|NCT00705016|65444841|FG000|Overall Study|Protocol Violation|0|||
23465122|NCT00705016|65444842|FG001|Overall Study|Protocol Violation|1|||
23465123|NCT00705016|65444843|FG002|Overall Study|Protocol Violation|1|||
23465124|NCT00705016|65444841|FG000|Overall Study|Withdrawal by Subject|4|||
23465125|NCT00705016|65444842|FG001|Overall Study|Withdrawal by Subject|3|||
23465126|NCT00705016|65444843|FG002|Overall Study|Withdrawal by Subject|2|||
23465127|NCT00705016|65444841|FG000|Overall Study|Progressive Disease|33|||
23465128|NCT00705016|65444842|FG001|Overall Study|Progressive Disease|29|||
23465129|NCT00705016|65444843|FG002|Overall Study|Progressive Disease|33|||
23465130|NCT00705016|65444841|FG000|Overall Study|Symptomatic Deterioration|3|||
23465131|NCT00705016|65444842|FG001|Overall Study|Symptomatic Deterioration|1|||
23465132|NCT00705016|65444843|FG002|Overall Study|Symptomatic Deterioration|1|||
23465133|NCT00705016|65444841|FG000|Overall Study|Other|9|||
23465134|NCT00705016|65444842|FG001|Overall Study|Other|6|||
23465135|NCT00705016|65444843|FG002|Overall Study|Other|6|||
23465136|NCT01189032|65444845|FG000|Overall Study|Adverse Event|1|||
23465137|NCT01189032|65444846|FG001|Overall Study|Adverse Event|3|||
23465138|NCT01189032|65444847|FG002|Overall Study|Adverse Event|4|||
23465139|NCT01189032|65444845|FG000|Overall Study|Lack of Efficacy|2|||
23465140|NCT01189032|65444846|FG001|Overall Study|Lack of Efficacy|3|||
23465141|NCT01189032|65444847|FG002|Overall Study|Lack of Efficacy|0|||
23465142|NCT01189032|65444845|FG000|Overall Study|Withdrawal by Subject|1|||
23465143|NCT01189032|65444846|FG001|Overall Study|Withdrawal by Subject|0|||
23465144|NCT01189032|65444847|FG002|Overall Study|Withdrawal by Subject|1|||
23465145|NCT01189032|65444845|FG000|Overall Study|Protocol Violation|1|||
23465146|NCT01189032|65444846|FG001|Overall Study|Protocol Violation|1|||
23465147|NCT01189032|65444847|FG002|Overall Study|Protocol Violation|1|||
23465148|NCT05660577|65444850|FG000|Overall Study|Discontinued|9|||
23465149|NCT01456039|65444853|FG000|Phase 1 (First Step)|Disease Progression|1|||
23465150|NCT01456039|65444854|FG001|Phase 1 (First Step)|Disease Progression|1|||
23465151|NCT01456039|65444855|FG002|Phase 1 (First Step)|Disease Progression|0|||
23465152|NCT01456039|65444853|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
23465153|NCT01456039|65444854|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
23465154|NCT01456039|65444855|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
23465155|NCT01456039|65444853|FG000|Phase 1 (First Step)|Adverse Event|0|||
23465156|NCT01456039|65444854|FG001|Phase 1 (First Step)|Adverse Event|3|||
23465157|NCT01456039|65444855|FG002|Phase 1 (First Step)|Adverse Event|0|||
23465158|NCT01456039|65444853|FG000|Phase 1 (First Step)|Other|0|||
23465159|NCT01456039|65444854|FG001|Phase 1 (First Step)|Other|1|||
23465160|NCT01456039|65444855|FG002|Phase 1 (First Step)|Other|0|||
23465161|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Disease Progression|0|||
23465162|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Disease Progression|0|||
23465163|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Disease Progression|17|||
23465164|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Adverse Event|0|||
23465165|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Adverse Event|0|||
23465166|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Adverse Event|10|||
23465167|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
23465168|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
23465169|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
23465170|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
23465171|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
23465172|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
23465173|NCT01456039|65444853|FG000|Phase 2 (Second Step)|Other|0|||
23465174|NCT01456039|65444854|FG001|Phase 2 (Second Step)|Other|0|||
23465175|NCT01456039|65444855|FG002|Phase 2 (Second Step)|Other|1|||
23465176|NCT01929317|65444856|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
23465177|NCT01929317|65444857|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
23465178|NCT01929317|65444856|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
23465179|NCT01929317|65444857|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
23465180|NCT01929317|65444856|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
23465181|NCT01929317|65444857|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
23465182|NCT01929317|65444856|FG000|Long-term Phase|Adverse Event|5|||
23465183|NCT01929317|65444857|FG001|Long-term Phase|Adverse Event|1|||
23465184|NCT01929317|65444856|FG000|Long-term Phase|Physician Decision|3|||
23465185|NCT01929317|65444857|FG001|Long-term Phase|Physician Decision|0|||
23465186|NCT01929317|65444856|FG000|Long-term Phase|Withdrawal by Subject|4|||
23465187|NCT01929317|65444857|FG001|Long-term Phase|Withdrawal by Subject|0|||
23465188|NCT01929317|65444856|FG000|Long-term Phase|Protocol Violation|1|||
23465189|NCT01929317|65444857|FG001|Long-term Phase|Protocol Violation|0|||
23465190|NCT01929317|65444856|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
23465191|NCT01929317|65444857|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
23465192|NCT01929317|65444856|FG000|Long-term Phase|Study Closed/Terminated|5|||
23465193|NCT01929317|65444857|FG001|Long-term Phase|Study Closed/Terminated|3|||
23465194|NCT02377817|65444858|FG000|Overall Study|Transportation/childcare barriers.|2|||
23465195|NCT02377817|65444859|FG001|Overall Study|Transportation/childcare barriers.|0|||
23465196|NCT02377817|65444858|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
23465197|NCT02377817|65444859|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
23465198|NCT05021978|65444862|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
23465199|NCT05021978|65444863|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
23465200|NCT05021978|65444864|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
23465201|NCT05021978|65444865|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
23585533|NCT04567615|65869499|FG002|Treatment Period|Death|0|||
23585534|NCT04567615|65869497|FG000|Treatment Period|Lost to Follow-up|0|||
23585535|NCT04567615|65869498|FG001|Treatment Period|Lost to Follow-up|1|||
23585536|NCT04567615|65869499|FG002|Treatment Period|Lost to Follow-up|0|||
23585537|NCT04567615|65869497|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
23585538|NCT04567615|65869498|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
23585539|NCT04567615|65869499|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
23585540|NCT04567615|65869497|FG000|Treatment Period|Disease Progression|85|||
23585541|NCT04567615|65869498|FG001|Treatment Period|Disease Progression|63|||
23585542|NCT04567615|65869499|FG002|Treatment Period|Disease Progression|16|||
23585543|NCT04567615|65869497|FG000|Treatment Period|Study Drug Toxicity|3|||
23585544|NCT04567615|65869498|FG001|Treatment Period|Study Drug Toxicity|10|||
23585545|NCT04567615|65869499|FG002|Treatment Period|Study Drug Toxicity|4|||
23585546|NCT04567615|65869497|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
23243334|NCT00111007|64635838|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
23243335|NCT00111007|64635837|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
23243336|NCT00111007|64635838|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
23243337|NCT00111007|64635837|FG000|Long Term Follow-up|Missing|10|||
23243338|NCT00111007|64635838|FG001|Long Term Follow-up|Missing|3|||
23243339|NCT02946515|64635839|FG000|Overall Study|Lost to Follow-up|2|||
23243340|NCT02946515|64635840|FG001|Overall Study|Lost to Follow-up|1|||
23243341|NCT01238861|64635843|FG000|Overall Study|Lost to Follow-up|4|||
23243342|NCT01238861|64635844|FG001|Overall Study|Lost to Follow-up|2|||
23243343|NCT01238861|64635845|FG002|Overall Study|Lost to Follow-up|3|||
23243344|NCT01238861|64635846|FG003|Overall Study|Lost to Follow-up|1|||
23243345|NCT01238861|64635847|FG004|Overall Study|Lost to Follow-up|1|||
23243346|NCT01238861|64635848|FG005|Overall Study|Lost to Follow-up|2|||
23243347|NCT01238861|64635843|FG000|Overall Study|Unplanned surgery|1|||
23243348|NCT01238861|64635844|FG001|Overall Study|Unplanned surgery|0|||
23243349|NCT01238861|64635845|FG002|Overall Study|Unplanned surgery|0|||
23243350|NCT01238861|64635846|FG003|Overall Study|Unplanned surgery|0|||
23243351|NCT01238861|64635847|FG004|Overall Study|Unplanned surgery|0|||
23243352|NCT01238861|64635848|FG005|Overall Study|Unplanned surgery|0|||
23243353|NCT01238861|64635843|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
23243354|NCT01238861|64635844|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
23243355|NCT01238861|64635845|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
23243356|NCT01238861|64635846|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
23243357|NCT01238861|64635847|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
23465202|NCT05021978|65444862|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
23465203|NCT05021978|65444863|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
23585547|NCT04567615|65869498|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
23243358|NCT01238861|64635848|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
23243359|NCT01238861|64635843|FG000|Overall Study|Incorrect enrollment/randomization|0|||
23243360|NCT01238861|64635844|FG001|Overall Study|Incorrect enrollment/randomization|0|||
23243361|NCT01238861|64635845|FG002|Overall Study|Incorrect enrollment/randomization|1|||
23243362|NCT01238861|64635846|FG003|Overall Study|Incorrect enrollment/randomization|0|||
23585548|NCT04567615|65869499|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
23585549|NCT04567615|65869497|FG000|Treatment Period|Other Reasons|1|||
23585550|NCT04567615|65869498|FG001|Treatment Period|Other Reasons|2|||
23585551|NCT04567615|65869499|FG002|Treatment Period|Other Reasons|0|||
23585552|NCT04567615|65869497|FG000|Treatment Period|Still On-going Treatment|21|||
23585553|NCT04567615|65869498|FG001|Treatment Period|Still On-going Treatment|22|||
23585554|NCT04567615|65869499|FG002|Treatment Period|Still On-going Treatment|2|||
23585555|NCT00465985|65869501|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
23585556|NCT00465985|65869502|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
23585557|NCT00465985|65869501|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
23585558|NCT00465985|65869502|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
23585559|NCT00465985|65869501|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
23585560|NCT00465985|65869502|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
23585561|NCT00465985|65869501|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
23585562|NCT00465985|65869502|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
23585563|NCT03386929|65872785|FG000|Overall Study|Death|0|||
23585564|NCT03386929|65872786|FG001|Overall Study|Death|0|||
23585565|NCT03386929|65872787|FG002|Overall Study|Death|1|||
23585566|NCT03386929|65872785|FG000|Overall Study|Withdrawal by Subject|0|||
23585567|NCT03386929|65872786|FG001|Overall Study|Withdrawal by Subject|1|||
23585568|NCT03386929|65872787|FG002|Overall Study|Withdrawal by Subject|0|||
23585569|NCT03386929|65872785|FG000|Overall Study|Physician Decision|0|||
23585570|NCT03386929|65872786|FG001|Overall Study|Physician Decision|0|||
23585571|NCT03386929|65872787|FG002|Overall Study|Physician Decision|1|||
23585572|NCT03386929|65872785|FG000|Overall Study|Progression|4|||
23585573|NCT03386929|65872786|FG001|Overall Study|Progression|4|||
23585574|NCT03386929|65872787|FG002|Overall Study|Progression|0|||
23585575|NCT03386929|65872785|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
23585576|NCT03386929|65872786|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
23585577|NCT03386929|65872787|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
23585578|NCT03386929|65872785|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
23585579|NCT03386929|65872786|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
23585580|NCT03386929|65872787|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
23585581|NCT00290732|65872788|FG000|Overall Study|Inability to instill drug intraductally.|0|||
23585582|NCT00290732|65872789|FG001|Overall Study|Inability to instill drug intraductally.|1|||
23585583|NCT00290732|65872790|FG002|Overall Study|Inability to instill drug intraductally.|1|||
23585584|NCT00290732|65872791|FG003|Overall Study|Inability to instill drug intraductally.|0|||
23585585|NCT00290732|65872792|FG004|Overall Study|Inability to instill drug intraductally.|0|||
23585586|NCT02390557|65872793|FG000|Wave 2|Survey non-respondent|72|||
23585587|NCT02390557|65872794|FG001|Wave 2|Survey non-respondent|41|||
23585588|NCT02390557|65872795|FG002|Wave 2|Survey non-respondent|23|||
23585589|NCT02930343|65872798|FG000|Overall Study|Lost to Follow-up|9|||
23585590|NCT02930343|65872799|FG001|Overall Study|Lost to Follow-up|7|||
23585591|NCT03264456|65872801|FG000|Overall Study|Withdrawal by Subject|3|||
23243363|NCT01238861|64635847|FG004|Overall Study|Incorrect enrollment/randomization|1|||
23243364|NCT01238861|64635848|FG005|Overall Study|Incorrect enrollment/randomization|0|||
23243365|NCT01238861|64635843|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
23243366|NCT01238861|64635844|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
23243367|NCT01238861|64635845|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
23243368|NCT01238861|64635846|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
23585592|NCT03264456|65872801|FG000|Overall Study|Lost to Follow-up|1|||
23585593|NCT02236559|65872802|FG000|Overall Study|Met Exclusion|3|||
23585594|NCT02236559|65872803|FG001|Overall Study|Met Exclusion|6|||
23585595|NCT02236559|65872802|FG000|Overall Study|Did not Meet Inclusion|3|||
23585596|NCT02236559|65872803|FG001|Overall Study|Did not Meet Inclusion|3|||
23585597|NCT02236559|65872802|FG000|Overall Study|Subject Did Not Consent|4|||
23585598|NCT02236559|65872803|FG001|Overall Study|Subject Did Not Consent|2|||
23243369|NCT01238861|64635847|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
23243370|NCT01238861|64635848|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
23243371|NCT01238861|64635843|FG000|Overall Study|Subject moved out of state/area|0|||
23243372|NCT01238861|64635844|FG001|Overall Study|Subject moved out of state/area|0|||
23243373|NCT01238861|64635845|FG002|Overall Study|Subject moved out of state/area|1|||
23243374|NCT01238861|64635846|FG003|Overall Study|Subject moved out of state/area|1|||
23243375|NCT01238861|64635847|FG004|Overall Study|Subject moved out of state/area|0|||
23243376|NCT01238861|64635848|FG005|Overall Study|Subject moved out of state/area|0|||
23243377|NCT01238861|64635843|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
23243378|NCT01238861|64635844|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
23243379|NCT01238861|64635845|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
23243380|NCT01238861|64635846|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
23243381|NCT01238861|64635847|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
23243382|NCT01238861|64635848|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
23243383|NCT01238861|64635843|FG000|Overall Study|Personal problems|0|||
23243384|NCT01238861|64635844|FG001|Overall Study|Personal problems|0|||
23243385|NCT01238861|64635845|FG002|Overall Study|Personal problems|0|||
23243386|NCT01238861|64635846|FG003|Overall Study|Personal problems|1|||
23243387|NCT01238861|64635847|FG004|Overall Study|Personal problems|0|||
23243388|NCT01238861|64635848|FG005|Overall Study|Personal problems|0|||
23243389|NCT01238861|64635843|FG000|Overall Study|Unable to continue visits|0|||
23243390|NCT01238861|64635844|FG001|Overall Study|Unable to continue visits|0|||
23243391|NCT01238861|64635845|FG002|Overall Study|Unable to continue visits|0|||
23243392|NCT01238861|64635846|FG003|Overall Study|Unable to continue visits|1|||
23243393|NCT01238861|64635847|FG004|Overall Study|Unable to continue visits|0|||
23243394|NCT01238861|64635848|FG005|Overall Study|Unable to continue visits|1|||
23243395|NCT01238861|64635843|FG000|Overall Study|Serious adverse event|0|||
23243396|NCT01238861|64635844|FG001|Overall Study|Serious adverse event|0|||
23243397|NCT01238861|64635845|FG002|Overall Study|Serious adverse event|0|||
23243398|NCT01238861|64635846|FG003|Overall Study|Serious adverse event|0|||
23243399|NCT01238861|64635847|FG004|Overall Study|Serious adverse event|0|||
23243400|NCT01238861|64635848|FG005|Overall Study|Serious adverse event|1|||
23243401|NCT01238861|64635843|FG000|Overall Study|Lack of compliance|0|||
23243402|NCT01238861|64635844|FG001|Overall Study|Lack of compliance|0|||
23243403|NCT01238861|64635845|FG002|Overall Study|Lack of compliance|0|||
23243404|NCT01238861|64635846|FG003|Overall Study|Lack of compliance|0|||
23243405|NCT01238861|64635847|FG004|Overall Study|Lack of compliance|0|||
23243406|NCT01238861|64635848|FG005|Overall Study|Lack of compliance|1|||
23243407|NCT01238861|64635843|FG000|Overall Study|Adverse Event|0|||
23243408|NCT01238861|64635844|FG001|Overall Study|Adverse Event|1|||
23243409|NCT01238861|64635845|FG002|Overall Study|Adverse Event|0|||
23243410|NCT01238861|64635846|FG003|Overall Study|Adverse Event|0|||
23243411|NCT01238861|64635847|FG004|Overall Study|Adverse Event|0|||
23243412|NCT01238861|64635848|FG005|Overall Study|Adverse Event|0|||
23243413|NCT01238861|64635843|FG000|Overall Study|Withdrawal by Subject|6|||
23243414|NCT01238861|64635844|FG001|Overall Study|Withdrawal by Subject|5|||
23243415|NCT01238861|64635845|FG002|Overall Study|Withdrawal by Subject|4|||
23243416|NCT01238861|64635846|FG003|Overall Study|Withdrawal by Subject|8|||
23243417|NCT01238861|64635847|FG004|Overall Study|Withdrawal by Subject|10|||
23243418|NCT01238861|64635848|FG005|Overall Study|Withdrawal by Subject|9|||
23585599|NCT02236559|65872802|FG000|Overall Study|Physician Decision|1|||
23585600|NCT02236559|65872803|FG001|Overall Study|Physician Decision|1|||
23585601|NCT02236559|65872802|FG000|Overall Study|Withdrawal by Subject|1|||
23585602|NCT02236559|65872803|FG001|Overall Study|Withdrawal by Subject|0|||
23585603|NCT01806714|65872805|FG000|Overall Study|No functioning phone number|200|||
23585604|NCT01806714|65872806|FG001|Overall Study|No functioning phone number|170|||
23585605|NCT01076335|65872807|FG000|Overall Study|Withdrawal by Subject|3|||
23585606|NCT01076335|65872807|FG000|Overall Study|Withdrawal without treatment|1|||
23585607|NCT03278028|65872808|FG000|Overall Study|Lost to Follow-up|1|||
23585608|NCT03278028|65872809|FG001|Overall Study|Lost to Follow-up|0|||
23585609|NCT03278028|65872808|FG000|Overall Study|Withdrawal by Subject|3|||
23585610|NCT03278028|65872809|FG001|Overall Study|Withdrawal by Subject|1|||
23585611|NCT03278028|65872808|FG000|Overall Study|Pregnancy|0|||
23585612|NCT03278028|65872809|FG001|Overall Study|Pregnancy|1|||
23585613|NCT03467724|65872811|FG000|Overall Study|Lost to Follow-up|5|||
23585614|NCT03467724|65872811|FG000|Overall Study|Withdrawal by Subject|1|||
23585615|NCT03467724|65872811|FG000|Overall Study|Protocol Violation|1|||
23585616|NCT03467724|65872811|FG000|Overall Study|Adverse Event|1|||
23585617|NCT03537651|65872814|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
23585618|NCT03537651|65872814|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
23243439|NCT03628781|64635857|FG000|Overall Study|Lost to Follow-up|16|||
23243440|NCT03628781|64635858|FG001|Overall Study|Lost to Follow-up|8|||
23243441|NCT03628781|64635857|FG000|Overall Study|Withdrawal by Subject|16|||
23243442|NCT03628781|64635858|FG001|Overall Study|Withdrawal by Subject|1|||
23243443|NCT00665366|64635861|FG000|Overall Study|Lack of Efficacy|11|||
23243444|NCT00665366|64635862|FG001|Overall Study|Lack of Efficacy|10|||
23243445|NCT00665366|64635861|FG000|Overall Study|Adverse Event|25|||
23243446|NCT00665366|64635862|FG001|Overall Study|Adverse Event|23|||
23243447|NCT00665366|64635861|FG000|Overall Study|Withdrawal by Subject|11|||
23243448|NCT00665366|64635862|FG001|Overall Study|Withdrawal by Subject|14|||
23243449|NCT00665366|64635861|FG000|Overall Study|Lost to Follow-up|3|||
23243450|NCT00665366|64635862|FG001|Overall Study|Lost to Follow-up|5|||
23243451|NCT00665366|64635861|FG000|Overall Study|Poor compliance/noncompliance|3|||
23243452|NCT00665366|64635862|FG001|Overall Study|Poor compliance/noncompliance|5|||
23243453|NCT00665366|64635861|FG000|Overall Study|Pregnancy|1|||
23243454|NCT00665366|64635862|FG001|Overall Study|Pregnancy|0|||
23243455|NCT00665366|64635861|FG000|Overall Study|No longer meets study criteria|0|||
23243456|NCT00665366|64635862|FG001|Overall Study|No longer meets study criteria|1|||
23465204|NCT05021978|65444864|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
23465205|NCT05021978|65444865|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
23465206|NCT01642589|65444866|FG000|Overall Study|Withdrawal by Subject|1|||
23465207|NCT01642589|65444867|FG001|Overall Study|Withdrawal by Subject|1|||
23465208|NCT00482053|65444868|FG000|Inter-treatment Period|Disease progression|1|||
23465209|NCT03388164|65444869|FG000|Overall Study|Withdrawal by Subject|3|||
23465210|NCT03388164|65444870|FG001|Overall Study|Withdrawal by Subject|1|||
23465211|NCT00888134|65444871|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
23465212|NCT00888134|65444871|FG000|Follow-up|being followed for long-term survival|1|||
23465213|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Adverse Event|9|||
23465214|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Adverse Event|3|||
23465215|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Death|7|||
23465216|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Death|7|||
23465217|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
23465218|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
23465219|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Physician Decision|1|||
23465220|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Physician Decision|0|||
23465221|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
23465222|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
23465223|NCT02558296|65444872|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
23185217|NCT03022422|64420254|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
23185218|NCT03022422|64420255|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
23185219|NCT02635204|64420256|FG000|Overall Study|Adverse Event|1|||
23185220|NCT02635204|64420257|FG001|Overall Study|Adverse Event|0|||
23185221|NCT02635204|64420256|FG000|Overall Study|Lost to Follow-up|1|||
23185222|NCT02635204|64420257|FG001|Overall Study|Lost to Follow-up|1|||
23185223|NCT00927485|64420258|FG000|Overall Study|Adverse Event|4|||
23185224|NCT00927485|64420259|FG001|Overall Study|Adverse Event|2|||
23185225|NCT00927485|64420258|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
23185226|NCT00927485|64420259|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
23185227|NCT00002850|64420262|FG000|Overall Study|Death|4|||
23185228|NCT00002850|64420263|FG001|Overall Study|Death|1|||
23185229|NCT00002850|64420264|FG002|Overall Study|Death|3|||
23185230|NCT00002850|64420262|FG000|Overall Study|Protocol Violation|1|||
23185231|NCT00002850|64420263|FG001|Overall Study|Protocol Violation|0|||
23185232|NCT00002850|64420264|FG002|Overall Study|Protocol Violation|1|||
23185233|NCT00002850|64420262|FG000|Overall Study|Withdrawal by Subject|0|||
23185234|NCT00002850|64420263|FG001|Overall Study|Withdrawal by Subject|1|||
23185235|NCT00002850|64420264|FG002|Overall Study|Withdrawal by Subject|0|||
23185236|NCT00140855|64420266|FG000|Overall Study|Progressive disease|2|||
23185237|NCT03832387|64420267|FG000|Overall Study|Protocol Violation|2|||
23185238|NCT03832387|64420268|FG001|Overall Study|Protocol Violation|6|||
23185239|NCT03832387|64420267|FG000|Overall Study|EXCLUSION CRITERIA|3|||
23185240|NCT03832387|64420268|FG001|Overall Study|EXCLUSION CRITERIA|1|||
23185241|NCT02443402|64420269|FG000|Overall Study|Withdrawal by Subject|3|||
23185242|NCT02443402|64420270|FG001|Overall Study|Withdrawal by Subject|1|||
23185243|NCT02443402|64420269|FG000|Overall Study|Screen Failure|1|||
23185244|NCT02443402|64420270|FG001|Overall Study|Screen Failure|2|||
23185245|NCT03584009|64420271|FG000|Overall Study|Death|25|||
23185246|NCT03584009|64420272|FG001|Overall Study|Death|18|||
23185247|NCT03584009|64420271|FG000|Overall Study|Lost to Follow-up|0|||
23185248|NCT03584009|64420272|FG001|Overall Study|Lost to Follow-up|1|||
23185249|NCT03584009|64420271|FG000|Overall Study|Physician Decision|1|||
23185250|NCT03584009|64420272|FG001|Overall Study|Physician Decision|1|||
23185251|NCT03584009|64420271|FG000|Overall Study|Study Terminated by Sponsor|22|||
23185252|NCT03584009|64420272|FG001|Overall Study|Study Terminated by Sponsor|30|||
23185253|NCT03584009|64420271|FG000|Overall Study|Withdrawal by Subject|3|||
23185254|NCT03584009|64420272|FG001|Overall Study|Withdrawal by Subject|2|||
23185255|NCT02048904|64420273|FG000|Overall Study|Withdrawal by Subject|7|||
23243457|NCT00665366|64635861|FG000|Overall Study|Other reasons|4|||
23243458|NCT00665366|64635862|FG001|Overall Study|Other reasons|1|||
23185256|NCT02048904|64420273|FG000|Overall Study|Physician Decision|70|||
23243459|NCT04887922|64635863|FG000|1st Randomization|Decided not to have surgery|0|||
23585619|NCT03537651|65872814|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
23585620|NCT03537651|65872814|FG000|Part A (Up to 96 Weeks)|Other|1|||
23585621|NCT03537651|65872814|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
23585622|NCT03537651|65872814|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
23585623|NCT03537651|65872814|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
23585624|NCT03537651|65872814|FG000|Part B (Up to 192 Weeks)|Other|1|||
23585625|NCT03612804|65872818|FG000|Overall Study|Death|0|||
23585626|NCT03612804|65872819|FG001|Overall Study|Death|7|||
23585627|NCT03612804|65872820|FG002|Overall Study|Death|0|||
23585628|NCT03612804|65872821|FG003|Overall Study|Death|8|||
23585629|NCT03612804|65872818|FG000|Overall Study|Medication copay coverage issues|0|||
23585630|NCT03612804|65872819|FG001|Overall Study|Medication copay coverage issues|0|||
23585631|NCT03612804|65872820|FG002|Overall Study|Medication copay coverage issues|0|||
23585632|NCT03612804|65872821|FG003|Overall Study|Medication copay coverage issues|17|||
23585633|NCT03612804|65872818|FG000|Overall Study|Not current smoker at time of screening|0|||
23585634|NCT03612804|65872819|FG001|Overall Study|Not current smoker at time of screening|1|||
23585635|NCT03612804|65872820|FG002|Overall Study|Not current smoker at time of screening|0|||
23585636|NCT03612804|65872821|FG003|Overall Study|Not current smoker at time of screening|3|||
23585637|NCT03612804|65872818|FG000|Overall Study|Non-veteran status|0|||
23585638|NCT03612804|65872819|FG001|Overall Study|Non-veteran status|1|||
23585639|NCT03612804|65872820|FG002|Overall Study|Non-veteran status|0|||
23585640|NCT03612804|65872821|FG003|Overall Study|Non-veteran status|0|||
23585641|NCT03612804|65872818|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
23585642|NCT03612804|65872819|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
23585643|NCT03612804|65872820|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
23585644|NCT03612804|65872821|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
23585645|NCT03612804|65872818|FG000|Overall Study|Provider retired from VA|0|||
23585646|NCT03612804|65872819|FG001|Overall Study|Provider retired from VA|0|||
23585647|NCT03612804|65872820|FG002|Overall Study|Provider retired from VA|2|||
23585648|NCT03612804|65872821|FG003|Overall Study|Provider retired from VA|0|||
23585649|NCT03612804|65872818|FG000|Overall Study|Withdrawal by Subject|0|||
23585650|NCT03612804|65872819|FG001|Overall Study|Withdrawal by Subject|0|||
23585651|NCT03612804|65872820|FG002|Overall Study|Withdrawal by Subject|7|||
23585652|NCT03612804|65872821|FG003|Overall Study|Withdrawal by Subject|0|||
23585653|NCT03612804|65872818|FG000|Overall Study|Provider involved with study activities|1|||
23585654|NCT03612804|65872819|FG001|Overall Study|Provider involved with study activities|0|||
23585655|NCT03612804|65872820|FG002|Overall Study|Provider involved with study activities|0|||
23585656|NCT03612804|65872821|FG003|Overall Study|Provider involved with study activities|0|||
23185257|NCT01486264|64420287|FG000|Overall Study|Death|1|||
23185258|NCT01486264|64420288|FG001|Overall Study|Death|1|||
23185259|NCT01486264|64420287|FG000|Overall Study|Adverse Event|3|||
23185260|NCT01486264|64420288|FG001|Overall Study|Adverse Event|3|||
23185261|NCT01486264|64420287|FG000|Overall Study|Lack of Efficacy|6|||
23185262|NCT01486264|64420288|FG001|Overall Study|Lack of Efficacy|10|||
23185263|NCT01486264|64420287|FG000|Overall Study|Withdrawal by Subject|7|||
23243460|NCT04887922|64635864|FG001|1st Randomization|Decided not to have surgery|1|||
23243461|NCT04887922|64635865|FG002|1st Randomization|Decided not to have surgery|0|||
23585657|NCT00920686|65872822|FG000|Overall Study|Lost to Follow-up|2|||
23185264|NCT01486264|64420288|FG001|Overall Study|Withdrawal by Subject|18|||
23185265|NCT01486264|64420287|FG000|Overall Study|Physician Decision|1|||
23185266|NCT01486264|64420288|FG001|Overall Study|Physician Decision|1|||
23185267|NCT01486264|64420287|FG000|Overall Study|Protocol Violation|3|||
23185268|NCT01486264|64420288|FG001|Overall Study|Protocol Violation|0|||
23185269|NCT01486264|64420287|FG000|Overall Study|Lost to Follow-up|3|||
23185270|NCT01486264|64420288|FG001|Overall Study|Lost to Follow-up|2|||
23185271|NCT01486264|64420287|FG000|Overall Study|Other|5|||
23185272|NCT01486264|64420288|FG001|Overall Study|Other|11|||
23185273|NCT01486264|64420287|FG000|Overall Study|Not treated|0|||
23185274|NCT01486264|64420288|FG001|Overall Study|Not treated|1|||
23185275|NCT00317044|64420295|FG000|Overall Study|Protocol Violation|28|||
23243462|NCT04887922|64635866|FG003|1st Randomization|Decided not to have surgery|0|||
23585658|NCT00920686|65872823|FG001|Overall Study|Lost to Follow-up|3|||
23585659|NCT00920686|65872824|FG002|Overall Study|Lost to Follow-up|1|||
23585660|NCT00920686|65872822|FG000|Overall Study|Study drug dosing criteria not met|17|||
23585661|NCT00920686|65872823|FG001|Overall Study|Study drug dosing criteria not met|19|||
23585662|NCT00920686|65872824|FG002|Overall Study|Study drug dosing criteria not met|12|||
23585663|NCT02380742|65872825|FG000|Overall Study|Withdrawal by Subject|1|||
23585664|NCT02380742|65872826|FG001|Overall Study|Withdrawal by Subject|0|||
23585665|NCT03601507|65872827|FG000|Overall Study|Adverse Event|1|||
23585666|NCT00038103|65872828|FG000|Overall Study|Adverse Event|5|||
23185276|NCT00317044|64420296|FG001|Overall Study|Protocol Violation|22|||
23185277|NCT00317044|64420297|FG002|Overall Study|Protocol Violation|20|||
23185278|NCT00317044|64420295|FG000|Overall Study|Adverse Event|4|||
23185279|NCT00317044|64420296|FG001|Overall Study|Adverse Event|7|||
23243463|NCT04887922|64635867|FG004|1st Randomization|Decided not to have surgery|0|||
23585667|NCT00038103|65872829|FG001|Overall Study|Adverse Event|6|||
23585668|NCT00038103|65872828|FG000|Overall Study|Lack of Efficacy|48|||
23585669|NCT00038103|65872829|FG001|Overall Study|Lack of Efficacy|41|||
23585670|NCT00038103|65872828|FG000|Overall Study|Withdrawal by Subject|0|||
23585671|NCT00038103|65872829|FG001|Overall Study|Withdrawal by Subject|3|||
23585672|NCT00038103|65872828|FG000|Overall Study|Lost to Follow-up|0|||
23585673|NCT00038103|65872829|FG001|Overall Study|Lost to Follow-up|3|||
23585674|NCT00038103|65872828|FG000|Overall Study|Protocol Violation|0|||
23243464|NCT00646282|64635868|FG000|Overall Study|Protocol terminated|4|||
23243465|NCT00646282|64635869|FG001|Overall Study|Protocol terminated|4|||
23243466|NCT00902265|64635871|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
23243467|NCT00902265|64635871|FG000|Overall Study|Adverse Event|2|||
23243468|NCT00902265|64635871|FG000|Overall Study|Lack of Efficacy|2|||
23243469|NCT00902265|64635871|FG000|Overall Study|Protocol Violation|1|||
23243470|NCT00183170|64635875|FG000|First Intervention|Did not complete study|1|||
23243471|NCT00183170|64635876|FG001|First Intervention|Did not complete study|0|||
23243472|NCT00183170|64635875|FG000|First Intervention|Did not meet targeted BrAC|1|||
23243473|NCT00183170|64635876|FG001|First Intervention|Did not meet targeted BrAC|0|||
23243474|NCT00183170|64635875|FG000|Washout 1 Week|Did not complete study|6|||
23243475|NCT00183170|64635876|FG001|Washout 1 Week|Did not complete study|8|||
23243476|NCT00183170|64635875|FG000|Second Intervention|Did not complete study|1|||
23243477|NCT00183170|64635876|FG001|Second Intervention|Did not complete study|0|||
23243478|NCT00183170|64635875|FG000|Second Intervention|Did not meet targeted BrAC|0|||
23243479|NCT00183170|64635876|FG001|Second Intervention|Did not meet targeted BrAC|2|||
23243480|NCT03930615|64635877|FG000|Overall Study|Death|9|||
23243481|NCT03930615|64635878|FG001|Overall Study|Death|3|||
23243482|NCT03930615|64635877|FG000|Overall Study|Lost to Follow-up|1|||
23243483|NCT03930615|64635878|FG001|Overall Study|Lost to Follow-up|2|||
23243484|NCT03930615|64635877|FG000|Overall Study|Physician Decision|3|||
23243485|NCT03930615|64635878|FG001|Overall Study|Physician Decision|4|||
23243486|NCT03930615|64635877|FG000|Overall Study|Withdrawal by Subject|13|||
23243487|NCT03930615|64635878|FG001|Overall Study|Withdrawal by Subject|2|||
23243488|NCT03930615|64635877|FG000|Overall Study|Not treated|1|||
23243489|NCT03930615|64635878|FG001|Overall Study|Not treated|1|||
23243490|NCT03409328|64635879|FG000|Overall Study|Lost to Follow-up|6|||
23243491|NCT03409328|64635880|FG001|Overall Study|Lost to Follow-up|3|||
23243492|NCT00538473|64635881|FG000|Overall Study|Adverse Event|1|||
23243493|NCT00538473|64635882|FG001|Overall Study|Adverse Event|0|||
23243494|NCT04003103|64635887|FG000|Overall Study|Death|1|||
23243495|NCT04003103|64635888|FG001|Overall Study|Death|0|||
23243496|NCT04003103|64635889|FG002|Overall Study|Death|0|||
23243497|NCT04003103|64635887|FG000|Overall Study|Lost to Follow-up|4|||
23243498|NCT04003103|64635888|FG001|Overall Study|Lost to Follow-up|3|||
23243499|NCT04003103|64635889|FG002|Overall Study|Lost to Follow-up|2|||
23243500|NCT04003103|64635887|FG000|Overall Study|Withdrawal by Subject|10|||
23243501|NCT04003103|64635888|FG001|Overall Study|Withdrawal by Subject|1|||
23243502|NCT04003103|64635889|FG002|Overall Study|Withdrawal by Subject|1|||
23243503|NCT04003103|64635887|FG000|Overall Study|Status not recorded|0|||
23243504|NCT04003103|64635888|FG001|Overall Study|Status not recorded|2|||
23243505|NCT04003103|64635889|FG002|Overall Study|Status not recorded|0|||
23243506|NCT00308555|64635890|FG000|Overall Study|Withdrawal by Subject|1|||
23243507|NCT00308555|64635891|FG001|Overall Study|Withdrawal by Subject|0|||
23243508|NCT00308555|64635890|FG000|Overall Study|Physician Decision|2|||
23243509|NCT00308555|64635891|FG001|Overall Study|Physician Decision|0|||
23243510|NCT01607398|64635892|FG000|Overall Study|Adverse Event|0|||
23243511|NCT01607398|64635893|FG001|Overall Study|Adverse Event|2|||
23243512|NCT01607398|64635892|FG000|Overall Study|Severe COPD|2|||
23243513|NCT01607398|64635893|FG001|Overall Study|Severe COPD|0|||
23243514|NCT01392469|64635894|FG000|Overall Study|Adverse Event|2|||
23243515|NCT01392469|64635894|FG000|Overall Study|Withdrawal by Subject|1|||
23243516|NCT01392469|64635894|FG000|Overall Study|Protocol Violation|1|||
23585675|NCT00038103|65872829|FG001|Overall Study|Protocol Violation|2|||
23585676|NCT00038103|65872828|FG000|Overall Study|Sponsor Decision|0|||
23185280|NCT00317044|64420297|FG002|Overall Study|Adverse Event|4|||
23585677|NCT00038103|65872829|FG001|Overall Study|Sponsor Decision|1|||
23185281|NCT00317044|64420295|FG000|Overall Study|Withdrawal by Subject|10|||
23243517|NCT01819467|64635905|FG000|Overall Study|Physician Decision|20|||
23243518|NCT01819467|64635906|FG001|Overall Study|Physician Decision|9|||
23243519|NCT03353415|64635909|FG000|Masked CGM Wear|Lost to Follow-up|2|||
23243520|NCT03353415|64635909|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
23243521|NCT01353586|64635910|FG000|Overall Study|Procedure terminated prior to ablation|3|||
23243522|NCT01353586|64635911|FG001|Overall Study|Procedure terminated prior to ablation|0|||
23243523|NCT01353586|64635910|FG000|Overall Study|Never had insertion of study catheter|4|||
23243524|NCT01353586|64635911|FG001|Overall Study|Never had insertion of study catheter|1|||
23243525|NCT01353586|64635910|FG000|Overall Study|Neurological exam not done|0|||
23585678|NCT00038103|65872828|FG000|Overall Study|Randomized/never treated|2|||
23243526|NCT01353586|64635911|FG001|Overall Study|Neurological exam not done|1|||
23243527|NCT00883129|64635912|FG000|Overall Study|Adverse Event|7|||
23243528|NCT00883129|64635913|FG001|Overall Study|Adverse Event|15|||
23243529|NCT00883129|64635912|FG000|Overall Study|Withdrawal by Subject|8|||
23243530|NCT00883129|64635913|FG001|Overall Study|Withdrawal by Subject|9|||
23243531|NCT00883129|64635912|FG000|Overall Study|Non-compliance|3|||
23243532|NCT00883129|64635913|FG001|Overall Study|Non-compliance|6|||
23243533|NCT00883129|64635912|FG000|Overall Study|Lost to Follow-up|1|||
23243534|NCT00883129|64635913|FG001|Overall Study|Lost to Follow-up|2|||
23243535|NCT00883129|64635912|FG000|Overall Study|Death|1|||
23243536|NCT00883129|64635913|FG001|Overall Study|Death|2|||
23243537|NCT00883129|64635912|FG000|Overall Study|Defined Treatment Failure|0|||
23243538|NCT00883129|64635913|FG001|Overall Study|Defined Treatment Failure|2|||
23243539|NCT03839693|64635917|FG000|Overall Study|Lost to Follow-up|0|||
23243540|NCT03839693|64635918|FG001|Overall Study|Lost to Follow-up|2|||
23243541|NCT03839693|64635919|FG002|Overall Study|Lost to Follow-up|2|||
23243542|NCT03839693|64635917|FG000|Overall Study|Withdrawal by Subject|1|||
23243543|NCT03839693|64635918|FG001|Overall Study|Withdrawal by Subject|0|||
23243544|NCT03839693|64635919|FG002|Overall Study|Withdrawal by Subject|2|||
23243545|NCT03839693|64635917|FG000|Overall Study|subject moved out of the area|1|||
23243546|NCT03839693|64635918|FG001|Overall Study|subject moved out of the area|0|||
23243547|NCT03839693|64635919|FG002|Overall Study|subject moved out of the area|0|||
23243548|NCT00798161|64635924|FG000|Overall Study|Adverse Event|3|||
23243549|NCT00798161|64635925|FG001|Overall Study|Adverse Event|4|||
23243550|NCT00798161|64635926|FG002|Overall Study|Adverse Event|6|||
23243551|NCT00798161|64635927|FG003|Overall Study|Adverse Event|6|||
23243552|NCT00798161|64635928|FG004|Overall Study|Adverse Event|5|||
23243553|NCT00798161|64635929|FG005|Overall Study|Adverse Event|2|||
23243554|NCT00798161|64635930|FG006|Overall Study|Adverse Event|4|||
23243555|NCT00798161|64635924|FG000|Overall Study|Protocol Violation|2|||
23243556|NCT00798161|64635925|FG001|Overall Study|Protocol Violation|1|||
23243557|NCT00798161|64635926|FG002|Overall Study|Protocol Violation|3|||
23243558|NCT00798161|64635927|FG003|Overall Study|Protocol Violation|3|||
23243559|NCT00798161|64635928|FG004|Overall Study|Protocol Violation|3|||
23243560|NCT00798161|64635929|FG005|Overall Study|Protocol Violation|2|||
23243561|NCT00798161|64635930|FG006|Overall Study|Protocol Violation|0|||
23243562|NCT00798161|64635924|FG000|Overall Study|Lost to Follow-up|1|||
23243563|NCT00798161|64635925|FG001|Overall Study|Lost to Follow-up|3|||
23243564|NCT00798161|64635926|FG002|Overall Study|Lost to Follow-up|4|||
23243565|NCT00798161|64635927|FG003|Overall Study|Lost to Follow-up|3|||
23185282|NCT00317044|64420296|FG001|Overall Study|Withdrawal by Subject|7|||
23185283|NCT00317044|64420297|FG002|Overall Study|Withdrawal by Subject|12|||
23185284|NCT00317044|64420295|FG000|Overall Study|Lost to Follow-up|0|||
23185285|NCT00317044|64420296|FG001|Overall Study|Lost to Follow-up|2|||
23185286|NCT00317044|64420297|FG002|Overall Study|Lost to Follow-up|3|||
23185287|NCT00317044|64420295|FG000|Overall Study|Multiple Reasons|6|||
23185288|NCT00317044|64420296|FG001|Overall Study|Multiple Reasons|2|||
23185289|NCT00317044|64420297|FG002|Overall Study|Multiple Reasons|6|||
23185290|NCT04725682|64420299|FG000|Overall Study|Withdrawal by Subject|7|||
23185291|NCT04725682|64420300|FG001|Overall Study|Withdrawal by Subject|5|||
23185292|NCT04725682|64420299|FG000|Overall Study|Failed to comply with the requirements|2|||
23185293|NCT04725682|64420300|FG001|Overall Study|Failed to comply with the requirements|1|||
23243566|NCT00798161|64635928|FG004|Overall Study|Lost to Follow-up|4|||
23243567|NCT00798161|64635929|FG005|Overall Study|Lost to Follow-up|0|||
23243568|NCT00798161|64635930|FG006|Overall Study|Lost to Follow-up|0|||
23243569|NCT00798161|64635924|FG000|Overall Study|Withdrawal by Subject|5|||
23243570|NCT00798161|64635925|FG001|Overall Study|Withdrawal by Subject|4|||
23243571|NCT00798161|64635926|FG002|Overall Study|Withdrawal by Subject|5|||
23185294|NCT04725682|64420299|FG000|Overall Study|Adverse Event|1|||
23185295|NCT04725682|64420300|FG001|Overall Study|Adverse Event|1|||
23185296|NCT04725682|64420299|FG000|Overall Study|Death|0|||
23185297|NCT04725682|64420300|FG001|Overall Study|Death|1|||
23185298|NCT03417440|64420304|FG000|Overall Study|Lost to Follow-up|0|||
23185299|NCT03417440|64420305|FG001|Overall Study|Lost to Follow-up|1|||
23185300|NCT03417440|64420306|FG002|Overall Study|Lost to Follow-up|0|||
23185301|NCT03417440|64420307|FG003|Overall Study|Lost to Follow-up|0|||
23185302|NCT03417440|64420308|FG004|Overall Study|Lost to Follow-up|1|||
23243572|NCT00798161|64635927|FG003|Overall Study|Withdrawal by Subject|4|||
23243573|NCT00798161|64635928|FG004|Overall Study|Withdrawal by Subject|2|||
23243574|NCT00798161|64635929|FG005|Overall Study|Withdrawal by Subject|3|||
23243575|NCT00798161|64635930|FG006|Overall Study|Withdrawal by Subject|1|||
23243576|NCT00798161|64635924|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
23243577|NCT00798161|64635925|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
23185303|NCT03417440|64420309|FG005|Overall Study|Lost to Follow-up|0|||
23185304|NCT03417440|64420310|FG006|Overall Study|Lost to Follow-up|0|||
23185305|NCT03417440|64420311|FG007|Overall Study|Lost to Follow-up|0|||
23243578|NCT00798161|64635926|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
23243579|NCT00798161|64635927|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
23350827|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
23350828|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
23350829|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
23350830|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
23350831|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
23350832|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
23350833|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
23350834|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
23350835|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
23185306|NCT03417440|64420304|FG000|Overall Study|Withdrawal by Subject|2|||
23185307|NCT03417440|64420305|FG001|Overall Study|Withdrawal by Subject|0|||
23185308|NCT03417440|64420306|FG002|Overall Study|Withdrawal by Subject|2|||
23185309|NCT03417440|64420307|FG003|Overall Study|Withdrawal by Subject|1|||
23350836|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
23350837|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
23350838|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
23350839|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
23350840|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
23465224|NCT02558296|65444873|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
23585679|NCT00038103|65872829|FG001|Overall Study|Randomized/never treated|0|||
23585680|NCT01191788|65872840|FG000|Overall Study|Lost to Follow-up|21|||
23185310|NCT03417440|64420308|FG004|Overall Study|Withdrawal by Subject|1|||
23185311|NCT03417440|64420309|FG005|Overall Study|Withdrawal by Subject|0|||
23185312|NCT03417440|64420310|FG006|Overall Study|Withdrawal by Subject|0|||
23185313|NCT03417440|64420311|FG007|Overall Study|Withdrawal by Subject|1|||
23185314|NCT05369806|64420315|FG000|Overall Study|Lost to Follow-up|1|||
23185315|NCT04052139|64420316|FG000|Overall Study|Lost to Follow-up|2|||
23185316|NCT04052139|64420317|FG001|Overall Study|Lost to Follow-up|0|||
23185317|NCT04052139|64420318|FG002|Overall Study|Lost to Follow-up|0|||
23185318|NCT04052139|64420316|FG000|Overall Study|Withdrawal by Subject|1|||
23185319|NCT04052139|64420317|FG001|Overall Study|Withdrawal by Subject|0|||
23185320|NCT04052139|64420318|FG002|Overall Study|Withdrawal by Subject|0|||
23185321|NCT02835495|64420319|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
23185322|NCT02835495|64420320|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
23185323|NCT02835495|64420319|FG000|Overall Study|Declined in-person follow-up visit|4|||
23185324|NCT02835495|64420320|FG001|Overall Study|Declined in-person follow-up visit|2|||
23185325|NCT00870688|64420322|FG000|Overall Study|Lost to Follow-up|2|||
23185326|NCT00870688|64420322|FG000|Overall Study|Death, Unrelated|1|||
23185327|NCT00870688|64420322|FG000|Overall Study|Granules in the Stools|1|||
23185328|NCT03487445|64420328|FG000|Randomization|Not treated for administrative reasons|1|||
23185329|NCT03487445|64420329|FG001|Randomization|Not treated for administrative reasons|0|||
23185330|NCT00049127|64420330|FG000|Overall Study|Withdrawal by Subject|0|||
23185331|NCT00049127|64420331|FG001|Overall Study|Withdrawal by Subject|0|||
23185332|NCT00049127|64420332|FG002|Overall Study|Withdrawal by Subject|1|||
23185333|NCT00049127|64420333|FG003|Overall Study|Withdrawal by Subject|0|||
23185334|NCT00049127|64420334|FG004|Overall Study|Withdrawal by Subject|0|||
23185335|NCT01931865|64420337|FG000|Overall Study|Lost to Follow-up|2|||
23185336|NCT01931865|64420337|FG000|Overall Study|Withdrawal by Subject|2|||
23185337|NCT01624142|64420338|FG000|Overall Study|Withdrawal by Subject|14|||
23185338|NCT01624142|64420339|FG001|Overall Study|Withdrawal by Subject|4|||
23185339|NCT01624142|64420338|FG000|Overall Study|Death|3|||
23185340|NCT01624142|64420339|FG001|Overall Study|Death|6|||
23185341|NCT01624142|64420338|FG000|Overall Study|Study Closure|12|||
23185342|NCT01624142|64420339|FG001|Overall Study|Study Closure|6|||
23185343|NCT01624142|64420338|FG000|Overall Study|Lost to Follow-up|2|||
23185344|NCT01624142|64420339|FG001|Overall Study|Lost to Follow-up|0|||
23185345|NCT01624142|64420338|FG000|Overall Study|Other|1|||
23465225|NCT02558296|65444872|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
23465226|NCT02558296|65444873|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
23465227|NCT02558296|65444872|FG000|Completed the Study|Adverse Event|14|||
23465228|NCT02558296|65444873|FG001|Completed the Study|Adverse Event|5|||
23465229|NCT02558296|65444872|FG000|Completed the Study|Death|39|||
23465230|NCT02558296|65444873|FG001|Completed the Study|Death|25|||
23465231|NCT02558296|65444872|FG000|Completed the Study|Lost to Follow-up|31|||
23465232|NCT02558296|65444873|FG001|Completed the Study|Lost to Follow-up|23|||
23465233|NCT02558296|65444872|FG000|Completed the Study|Physician Decision|6|||
23185346|NCT01624142|64420339|FG001|Overall Study|Other|0|||
23185347|NCT03874234|64420342|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185348|NCT03874234|64420343|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185349|NCT03874234|64420344|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185350|NCT03874234|64420345|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
23185351|NCT03874234|64420346|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185352|NCT03874234|64420347|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23465234|NCT02558296|65444873|FG001|Completed the Study|Physician Decision|0|||
23465235|NCT02558296|65444872|FG000|Completed the Study|Protocol Violation|2|||
23465236|NCT02558296|65444873|FG001|Completed the Study|Protocol Violation|1|||
23465237|NCT02558296|65444872|FG000|Completed the Study|Withdrawal by Subject|53|||
23465238|NCT02558296|65444873|FG001|Completed the Study|Withdrawal by Subject|31|||
23465239|NCT02558296|65444872|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
23465240|NCT02558296|65444873|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
23465241|NCT01747876|65444875|FG000|Overall Study|Adverse Event|1|||
23465242|NCT01747876|65444876|FG001|Overall Study|Adverse Event|0|||
23465243|NCT01747876|65444877|FG002|Overall Study|Adverse Event|2|||
23465244|NCT01747876|65444875|FG000|Overall Study|Withdrawal by Subject|0|||
23465245|NCT01747876|65444876|FG001|Overall Study|Withdrawal by Subject|1|||
23465246|NCT01747876|65444877|FG002|Overall Study|Withdrawal by Subject|1|||
23465247|NCT01747876|65444875|FG000|Overall Study|Disease progression|4|||
23465248|NCT01747876|65444876|FG001|Overall Study|Disease progression|13|||
23465249|NCT01747876|65444877|FG002|Overall Study|Disease progression|8|||
23465250|NCT01747876|65444875|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
23465251|NCT01747876|65444876|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
23465252|NCT01747876|65444877|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
23465253|NCT02948634|65447974|FG000|Overall Study|Lack of efficacy and study suspended|10|||
23465254|NCT02948634|65447975|FG001|Overall Study|Lack of efficacy and study suspended|2|||
23465255|NCT01459497|65447976|FG000|Overall Study|Inability to meet trial constraints.|1|||
23465256|NCT01459497|65447977|FG001|Overall Study|Inability to meet trial constraints.|0|||
23465257|NCT01459497|65447976|FG000|Overall Study|Physician Decision|1|||
23465258|NCT01459497|65447977|FG001|Overall Study|Physician Decision|1|||
23465259|NCT01459497|65447976|FG000|Overall Study|Hospitalization.|0|||
23465260|NCT01459497|65447977|FG001|Overall Study|Hospitalization.|3|||
23465261|NCT01459497|65447976|FG000|Overall Study|Disease progression.|0|||
23465262|NCT01459497|65447977|FG001|Overall Study|Disease progression.|1|||
23465263|NCT00432172|65447979|FG000|Overall Study|Physician Decision|0|||
23465264|NCT00432172|65447980|FG001|Overall Study|Physician Decision|0|||
23465265|NCT00432172|65447981|FG002|Overall Study|Physician Decision|2|||
23465266|NCT00432172|65447982|FG003|Overall Study|Physician Decision|0|||
23465267|NCT00432172|65447979|FG000|Overall Study|Adverse Event|4|||
23465268|NCT00432172|65447980|FG001|Overall Study|Adverse Event|2|||
23465269|NCT00432172|65447981|FG002|Overall Study|Adverse Event|4|||
23585681|NCT01191788|65872841|FG001|Overall Study|Lost to Follow-up|22|||
23585682|NCT00946114|65872845|FG000|Overall Study|Death|5|||
23585683|NCT00946114|65872846|FG001|Overall Study|Death|2|||
23585684|NCT00946114|65872845|FG000|Overall Study|Other|1|||
23585685|NCT00946114|65872846|FG001|Overall Study|Other|0|||
23585686|NCT00946114|65872845|FG000|Overall Study|Withdrawal by Subject|2|||
23585687|NCT00946114|65872846|FG001|Overall Study|Withdrawal by Subject|0|||
23585688|NCT01585038|65872847|FG000|Overall Study|Adverse Event|2|||
23585689|NCT01585038|65872848|FG001|Overall Study|Adverse Event|2|||
23585690|NCT03034915|65872850|FG000|Overall Study|Adverse Event|29|||
23465270|NCT00432172|65447982|FG003|Overall Study|Adverse Event|3|||
23465271|NCT00432172|65447979|FG000|Overall Study|Disease progression|0|||
23465272|NCT00432172|65447980|FG001|Overall Study|Disease progression|2|||
23465273|NCT00432172|65447981|FG002|Overall Study|Disease progression|5|||
23465274|NCT00432172|65447982|FG003|Overall Study|Disease progression|1|||
23465275|NCT00432172|65447979|FG000|Overall Study|Withdrawal by Subject|0|||
23465276|NCT00432172|65447980|FG001|Overall Study|Withdrawal by Subject|1|||
23465277|NCT00432172|65447981|FG002|Overall Study|Withdrawal by Subject|0|||
23465278|NCT00432172|65447982|FG003|Overall Study|Withdrawal by Subject|2|||
23465279|NCT00432172|65447979|FG000|Overall Study|No treatment received|2|||
23585691|NCT03034915|65872851|FG001|Overall Study|Adverse Event|32|||
23585692|NCT03034915|65872852|FG002|Overall Study|Adverse Event|22|||
23185353|NCT03874234|64420348|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185354|NCT03874234|64420349|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185355|NCT03874234|64420350|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185356|NCT03874234|64420351|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185357|NCT03874234|64420352|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185358|NCT03874234|64420353|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185359|NCT03874234|64420354|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
23185360|NCT03874234|64420342|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
23185361|NCT03874234|64420343|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185362|NCT03874234|64420344|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185363|NCT03874234|64420345|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185364|NCT03874234|64420346|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185365|NCT03874234|64420347|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185366|NCT03874234|64420348|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185367|NCT03874234|64420349|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185368|NCT03874234|64420350|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185369|NCT03874234|64420351|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185370|NCT03874234|64420352|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185371|NCT03874234|64420353|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185372|NCT03874234|64420354|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
23185373|NCT03874234|64420342|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185374|NCT03874234|64420343|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185375|NCT03874234|64420344|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185376|NCT03874234|64420345|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
23185377|NCT03874234|64420346|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185378|NCT03874234|64420347|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185379|NCT03874234|64420348|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185380|NCT03874234|64420349|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23243580|NCT00798161|64635928|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
23350841|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
23350842|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
23465280|NCT00432172|65447980|FG001|Overall Study|No treatment received|2|||
23465281|NCT00432172|65447981|FG002|Overall Study|No treatment received|0|||
23465282|NCT00432172|65447982|FG003|Overall Study|No treatment received|1|||
23465283|NCT01598506|65447987|FG000|Overall Study|Withdrawal by Subject|2|||
23465284|NCT01134055|65447989|FG000|Overall Study|Adverse Event|5|||
23465285|NCT01134055|65447990|FG001|Overall Study|Adverse Event|2|||
23465286|NCT01134055|65447991|FG002|Overall Study|Adverse Event|2|||
23465287|NCT01134055|65447992|FG003|Overall Study|Adverse Event|2|||
23465288|NCT01134055|65447993|FG004|Overall Study|Adverse Event|5|||
23465289|NCT01134055|65447994|FG005|Overall Study|Adverse Event|7|||
23465290|NCT01134055|65447995|FG006|Overall Study|Adverse Event|2|||
23465291|NCT01134055|65447989|FG000|Overall Study|Lost to Follow-up|0|||
23465292|NCT01134055|65447990|FG001|Overall Study|Lost to Follow-up|1|||
23465293|NCT01134055|65447991|FG002|Overall Study|Lost to Follow-up|0|||
23465294|NCT01134055|65447992|FG003|Overall Study|Lost to Follow-up|1|||
23465295|NCT01134055|65447993|FG004|Overall Study|Lost to Follow-up|0|||
23465296|NCT01134055|65447994|FG005|Overall Study|Lost to Follow-up|0|||
23465297|NCT01134055|65447995|FG006|Overall Study|Lost to Follow-up|0|||
23465298|NCT01134055|65447989|FG000|Overall Study|Withdrawal by Subject|3|||
23465299|NCT01134055|65447990|FG001|Overall Study|Withdrawal by Subject|3|||
23465300|NCT01134055|65447991|FG002|Overall Study|Withdrawal by Subject|1|||
23465301|NCT01134055|65447992|FG003|Overall Study|Withdrawal by Subject|2|||
23465302|NCT01134055|65447993|FG004|Overall Study|Withdrawal by Subject|0|||
23465303|NCT01134055|65447994|FG005|Overall Study|Withdrawal by Subject|0|||
23465304|NCT01134055|65447995|FG006|Overall Study|Withdrawal by Subject|8|||
23465305|NCT01134055|65447989|FG000|Overall Study|Protocol Violation|0|||
23465306|NCT01134055|65447990|FG001|Overall Study|Protocol Violation|0|||
23465307|NCT01134055|65447991|FG002|Overall Study|Protocol Violation|0|||
23465308|NCT01134055|65447992|FG003|Overall Study|Protocol Violation|1|||
23465309|NCT01134055|65447993|FG004|Overall Study|Protocol Violation|1|||
23465310|NCT01134055|65447994|FG005|Overall Study|Protocol Violation|0|||
23465311|NCT01134055|65447995|FG006|Overall Study|Protocol Violation|0|||
23465312|NCT01134055|65447989|FG000|Overall Study|Physician Decision|0|||
23465313|NCT01134055|65447990|FG001|Overall Study|Physician Decision|0|||
23465314|NCT01134055|65447991|FG002|Overall Study|Physician Decision|0|||
23465315|NCT01134055|65447992|FG003|Overall Study|Physician Decision|0|||
23465316|NCT01134055|65447993|FG004|Overall Study|Physician Decision|0|||
23465317|NCT01134055|65447994|FG005|Overall Study|Physician Decision|0|||
23585693|NCT03034915|65872850|FG000|Overall Study|Lost to Follow-up|5|||
23585694|NCT03034915|65872851|FG001|Overall Study|Lost to Follow-up|13|||
23585695|NCT03034915|65872852|FG002|Overall Study|Lost to Follow-up|3|||
23585696|NCT03034915|65872850|FG000|Overall Study|Withdrawal by Subject|29|||
23585697|NCT03034915|65872851|FG001|Overall Study|Withdrawal by Subject|46|||
23585698|NCT03034915|65872852|FG002|Overall Study|Withdrawal by Subject|41|||
23585699|NCT03034915|65872850|FG000|Overall Study|Protocol Deviation|2|||
23585700|NCT03034915|65872851|FG001|Overall Study|Protocol Deviation|14|||
23585701|NCT03034915|65872852|FG002|Overall Study|Protocol Deviation|7|||
23585702|NCT03034915|65872850|FG000|Overall Study|Lack of Efficacy|8|||
23585703|NCT03034915|65872851|FG001|Overall Study|Lack of Efficacy|16|||
23465318|NCT01134055|65447995|FG006|Overall Study|Physician Decision|1|||
23465319|NCT02581410|65447996|FG000|Vaccination Phase|Adverse Event|2|||
23465320|NCT02581410|65447997|FG001|Vaccination Phase|Adverse Event|1|||
23465321|NCT02581410|65447996|FG000|Vaccination Phase|Withdrawal by Subject|0|||
23465322|NCT02581410|65447997|FG001|Vaccination Phase|Withdrawal by Subject|1|||
23465323|NCT02581410|65447996|FG000|Vaccination Phase|Migrated/moved from study area|0|||
23465324|NCT02581410|65447997|FG001|Vaccination Phase|Migrated/moved from study area|1|||
23465325|NCT02581410|65447996|FG000|End of Study Phase|Adverse Event|4|||
23585704|NCT03034915|65872852|FG002|Overall Study|Lack of Efficacy|18|||
23585705|NCT03034915|65872850|FG000|Overall Study|Site closed|2|||
23585706|NCT03034915|65872851|FG001|Overall Study|Site closed|2|||
23465326|NCT02581410|65447997|FG001|End of Study Phase|Adverse Event|3|||
23465327|NCT02581410|65447996|FG000|End of Study Phase|Withdrawal by Subject|1|||
23465328|NCT02581410|65447997|FG001|End of Study Phase|Withdrawal by Subject|2|||
23465329|NCT02581410|65447996|FG000|End of Study Phase|Migrated/moved from study area|0|||
23185381|NCT03874234|64420350|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185382|NCT03874234|64420351|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185383|NCT03874234|64420352|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185384|NCT03874234|64420353|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185385|NCT03874234|64420354|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
23185386|NCT03874234|64420342|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23465330|NCT02581410|65447997|FG001|End of Study Phase|Migrated/moved from study area|3|||
23465331|NCT02581410|65447996|FG000|End of Study Phase|Lost to Follow-up|0|||
23465332|NCT02581410|65447997|FG001|End of Study Phase|Lost to Follow-up|2|||
23465333|NCT02581410|65447996|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
23465334|NCT02581410|65447997|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
23465335|NCT02492763|65447999|FG000|Overall Study|Withdrawal by Subject|0|||
23465336|NCT02492763|65448000|FG001|Overall Study|Withdrawal by Subject|2|||
23465337|NCT02492763|65448001|FG002|Overall Study|Withdrawal by Subject|1|||
23465338|NCT02492763|65448002|FG003|Overall Study|Withdrawal by Subject|0|||
23465339|NCT02492763|65447999|FG000|Overall Study|Adverse Event|3|||
23465340|NCT02492763|65448000|FG001|Overall Study|Adverse Event|1|||
23465341|NCT02492763|65448001|FG002|Overall Study|Adverse Event|1|||
23465342|NCT02492763|65448002|FG003|Overall Study|Adverse Event|2|||
23465343|NCT02492763|65447999|FG000|Overall Study|Death|0|||
23465344|NCT02492763|65448000|FG001|Overall Study|Death|0|||
23465345|NCT02492763|65448001|FG002|Overall Study|Death|1|||
23465346|NCT02492763|65448002|FG003|Overall Study|Death|0|||
23465347|NCT02492763|65447999|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
23465348|NCT02492763|65448000|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
23465349|NCT02492763|65448001|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
23465350|NCT02492763|65448002|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
23465351|NCT02492763|65447999|FG000|Overall Study|Lost to Follow-up|0|||
23465352|NCT02492763|65448000|FG001|Overall Study|Lost to Follow-up|0|||
23185387|NCT03874234|64420343|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23185388|NCT03874234|64420344|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23185389|NCT03874234|64420345|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23185390|NCT03874234|64420346|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
23185391|NCT03874234|64420347|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23350843|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
23350844|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
23350845|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350846|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350847|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350848|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
23350849|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23185392|NCT03874234|64420348|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23185393|NCT03874234|64420349|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23185394|NCT03874234|64420350|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23185395|NCT03874234|64420351|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23185396|NCT03874234|64420352|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23350850|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
23465353|NCT02492763|65448001|FG002|Overall Study|Lost to Follow-up|1|||
23465354|NCT02492763|65448002|FG003|Overall Study|Lost to Follow-up|0|||
23185397|NCT03874234|64420353|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23350851|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23465355|NCT02492763|65447999|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23465356|NCT02492763|65448000|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23465357|NCT02492763|65448001|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23465358|NCT02492763|65448002|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23465359|NCT02492763|65447999|FG000|Overall Study|Screen Failure|0|||
23465360|NCT02492763|65448000|FG001|Overall Study|Screen Failure|0|||
23465361|NCT02492763|65448001|FG002|Overall Study|Screen Failure|0|||
23465362|NCT02492763|65448002|FG003|Overall Study|Screen Failure|1|||
23465363|NCT02492763|65447999|FG000|Overall Study|Study Terminated by Sponsor|13|||
23465364|NCT02492763|65448000|FG001|Overall Study|Study Terminated by Sponsor|10|||
23465365|NCT02492763|65448001|FG002|Overall Study|Study Terminated by Sponsor|6|||
23465366|NCT02492763|65448002|FG003|Overall Study|Study Terminated by Sponsor|10|||
23465367|NCT00060840|65448003|FG000|Overall Study|Change in surgical plan|2|||
23465368|NCT00060840|65448004|FG001|Overall Study|Change in surgical plan|6|||
23465369|NCT00060840|65448003|FG000|Overall Study|Death|0|||
23465370|NCT00060840|65448004|FG001|Overall Study|Death|1|||
23465371|NCT00060840|65448003|FG000|Overall Study|Withdrawal by Subject|0|||
23465372|NCT00060840|65448004|FG001|Overall Study|Withdrawal by Subject|1|||
23465373|NCT00060840|65448003|FG000|Overall Study|Subinvestigator unavailable|0|||
23465374|NCT00060840|65448004|FG001|Overall Study|Subinvestigator unavailable|1|||
23465375|NCT00060840|65448003|FG000|Overall Study|Physician Decision|1|||
23465376|NCT00060840|65448004|FG001|Overall Study|Physician Decision|0|||
23465377|NCT00060840|65448003|FG000|Overall Study|Other|1|||
23465378|NCT00060840|65448004|FG001|Overall Study|Other|0|||
23465379|NCT01077050|65448005|FG000|Overall Study|Subjects signed ICF could not be located|1|||
23465380|NCT01077050|65448005|FG000|Overall Study|Screen failure|8|||
23465381|NCT04287517|65448006|FG000|Overall Study|Withdrawal by Subject|1|||
23243581|NCT00798161|64635929|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
23243582|NCT00798161|64635930|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
23243583|NCT02392377|64635931|FG000|Overall Study|Withdrawal by Subject|0|||
23243584|NCT02392377|64635932|FG001|Overall Study|Withdrawal by Subject|1|||
23243585|NCT02646566|64635933|FG000|Overall Study|Lost to Follow-up|5|||
23243586|NCT02646566|64635934|FG001|Overall Study|Lost to Follow-up|4|||
23465382|NCT04287517|65448007|FG001|Overall Study|Withdrawal by Subject|1|||
23465383|NCT01287741|65448008|FG000|Overall Study|Withdrawal by Subject|35|||
23465384|NCT01287741|65448009|FG001|Overall Study|Withdrawal by Subject|38|||
23465385|NCT01287741|65448008|FG000|Overall Study|Protocol Violation|2|||
23465386|NCT01287741|65448009|FG001|Overall Study|Protocol Violation|0|||
23465387|NCT01287741|65448008|FG000|Overall Study|Physician Decision|15|||
23465388|NCT01287741|65448009|FG001|Overall Study|Physician Decision|23|||
23465389|NCT01287741|65448008|FG000|Overall Study|Non-compliance|8|||
23465390|NCT01287741|65448009|FG001|Overall Study|Non-compliance|6|||
23465391|NCT01287741|65448008|FG000|Overall Study|Lost to Follow-up|10|||
23465392|NCT01287741|65448009|FG001|Overall Study|Lost to Follow-up|8|||
23185398|NCT03874234|64420354|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
23185399|NCT03874234|64420342|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185400|NCT03874234|64420343|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185401|NCT03874234|64420344|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185402|NCT03874234|64420345|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185403|NCT03874234|64420346|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185404|NCT03874234|64420347|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185405|NCT03874234|64420348|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185406|NCT03874234|64420349|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
23185407|NCT03874234|64420350|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185408|NCT03874234|64420351|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185409|NCT03874234|64420352|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185410|NCT03874234|64420353|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185411|NCT03874234|64420354|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
23185412|NCT03874234|64420342|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185413|NCT03874234|64420343|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185414|NCT03874234|64420344|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185415|NCT03874234|64420345|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185416|NCT03874234|64420346|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
23185417|NCT03874234|64420347|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
23185418|NCT03874234|64420348|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185419|NCT03874234|64420349|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185420|NCT03874234|64420350|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23243587|NCT02646566|64635935|FG002|Overall Study|Lost to Follow-up|5|||
23243588|NCT02646566|64635933|FG000|Overall Study|Treatment failure|1|||
23465393|NCT01287741|65448008|FG000|Overall Study|Death|32|||
23465394|NCT01287741|65448009|FG001|Overall Study|Death|44|||
23465395|NCT01287741|65448008|FG000|Overall Study|Adverse Event|4|||
23243589|NCT02646566|64635934|FG001|Overall Study|Treatment failure|0|||
23465396|NCT01287741|65448009|FG001|Overall Study|Adverse Event|6|||
23465397|NCT01287741|65448008|FG000|Overall Study|Study terminated by Sponsor|307|||
23465398|NCT01287741|65448009|FG001|Overall Study|Study terminated by Sponsor|315|||
23465399|NCT01287741|65448008|FG000|Overall Study|Progressive disease|190|||
23465400|NCT01287741|65448009|FG001|Overall Study|Progressive disease|166|||
23465401|NCT01287741|65448008|FG000|Overall Study|Reason not specified|23|||
23465402|NCT01287741|65448009|FG001|Overall Study|Reason not specified|9|||
23465403|NCT01342211|65448010|FG000|Overall Study|Lost to Follow-up|0|||
23465404|NCT01342211|65448011|FG001|Overall Study|Lost to Follow-up|0|||
23465405|NCT01342211|65448012|FG002|Overall Study|Lost to Follow-up|0|||
23465406|NCT01342211|65448013|FG003|Overall Study|Lost to Follow-up|1|||
23465407|NCT01342211|65448014|FG004|Overall Study|Lost to Follow-up|0|||
23465408|NCT01342211|65448010|FG000|Overall Study|Adverse Event|0|||
23465409|NCT01342211|65448011|FG001|Overall Study|Adverse Event|0|||
23465410|NCT01342211|65448012|FG002|Overall Study|Adverse Event|0|||
23185421|NCT03874234|64420351|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185422|NCT03874234|64420352|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185423|NCT03874234|64420353|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185424|NCT03874234|64420354|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
23185425|NCT03874234|64420342|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23465411|NCT01342211|65448013|FG003|Overall Study|Adverse Event|0|||
23465412|NCT01342211|65448014|FG004|Overall Study|Adverse Event|1|||
23465413|NCT01342211|65448010|FG000|Overall Study|Withdrawal by Subject|0|||
23465414|NCT01342211|65448011|FG001|Overall Study|Withdrawal by Subject|0|||
23465415|NCT01342211|65448012|FG002|Overall Study|Withdrawal by Subject|0|||
23465416|NCT01342211|65448013|FG003|Overall Study|Withdrawal by Subject|1|||
23465417|NCT01342211|65448014|FG004|Overall Study|Withdrawal by Subject|0|||
23465418|NCT01342211|65448010|FG000|Overall Study|Randomized, but not Treated|0|||
23465419|NCT01342211|65448011|FG001|Overall Study|Randomized, but not Treated|2|||
23465420|NCT01342211|65448012|FG002|Overall Study|Randomized, but not Treated|0|||
23465421|NCT01342211|65448013|FG003|Overall Study|Randomized, but not Treated|0|||
23465422|NCT01342211|65448014|FG004|Overall Study|Randomized, but not Treated|1|||
23465423|NCT01936870|65448015|FG000|Overall Study|No Visit After Treatment|176|||
23465424|NCT01936870|65448015|FG000|Overall Study|Protocol Violation|12|||
23465425|NCT01936870|65448015|FG000|Overall Study|No Drug Administration|1|||
23465426|NCT01208207|65448019|FG000|Part I|Adverse Event|19|||
23465427|NCT01208207|65448020|FG001|Part I|Adverse Event|2|||
23465428|NCT01208207|65448021|FG002|Part I|Adverse Event|6|||
23465429|NCT01208207|65448022|FG003|Part I|Adverse Event|0|||
23465430|NCT01208207|65448023|FG004|Part I|Adverse Event|0|||
23465431|NCT01208207|65448024|FG005|Part I|Adverse Event|0|||
23465432|NCT01208207|65448025|FG006|Part I|Adverse Event|0|||
23465433|NCT01208207|65448019|FG000|Part I|Lack of Efficacy|21|||
23465434|NCT01208207|65448020|FG001|Part I|Lack of Efficacy|3|||
23465435|NCT01208207|65448021|FG002|Part I|Lack of Efficacy|2|||
23465436|NCT01208207|65448022|FG003|Part I|Lack of Efficacy|0|||
23465437|NCT01208207|65448023|FG004|Part I|Lack of Efficacy|0|||
23465438|NCT01208207|65448024|FG005|Part I|Lack of Efficacy|0|||
23465439|NCT01208207|65448025|FG006|Part I|Lack of Efficacy|0|||
23465440|NCT01208207|65448019|FG000|Part I|Lost to Follow-up|6|||
23465441|NCT01208207|65448020|FG001|Part I|Lost to Follow-up|1|||
23465442|NCT01208207|65448021|FG002|Part I|Lost to Follow-up|0|||
23465443|NCT01208207|65448022|FG003|Part I|Lost to Follow-up|0|||
23465444|NCT01208207|65448023|FG004|Part I|Lost to Follow-up|0|||
23465445|NCT01208207|65448024|FG005|Part I|Lost to Follow-up|0|||
23465446|NCT01208207|65448025|FG006|Part I|Lost to Follow-up|0|||
23465447|NCT01208207|65448019|FG000|Part I|Non-Compliance With Study Drug|1|||
23185426|NCT03874234|64420343|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185427|NCT03874234|64420344|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185428|NCT03874234|64420345|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185429|NCT03874234|64420346|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185430|NCT03874234|64420347|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23465448|NCT01208207|65448020|FG001|Part I|Non-Compliance With Study Drug|0|||
23465449|NCT01208207|65448021|FG002|Part I|Non-Compliance With Study Drug|1|||
23465450|NCT01208207|65448022|FG003|Part I|Non-Compliance With Study Drug|0|||
23465451|NCT01208207|65448023|FG004|Part I|Non-Compliance With Study Drug|0|||
23465452|NCT01208207|65448024|FG005|Part I|Non-Compliance With Study Drug|0|||
23465453|NCT01208207|65448025|FG006|Part I|Non-Compliance With Study Drug|0|||
23465454|NCT01208207|65448019|FG000|Part I|Physician Decision|0|||
23185431|NCT03874234|64420348|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
23243590|NCT02646566|64635935|FG002|Overall Study|Treatment failure|0|||
23465455|NCT01208207|65448020|FG001|Part I|Physician Decision|1|||
23465456|NCT01208207|65448021|FG002|Part I|Physician Decision|0|||
23465457|NCT01208207|65448022|FG003|Part I|Physician Decision|0|||
23465458|NCT01208207|65448023|FG004|Part I|Physician Decision|0|||
23465459|NCT01208207|65448024|FG005|Part I|Physician Decision|0|||
23465460|NCT01208207|65448025|FG006|Part I|Physician Decision|0|||
23465461|NCT01208207|65448019|FG000|Part I|Progressive Disease|1|||
23465462|NCT01208207|65448020|FG001|Part I|Progressive Disease|0|||
23465463|NCT01208207|65448021|FG002|Part I|Progressive Disease|0|||
23465464|NCT01208207|65448022|FG003|Part I|Progressive Disease|0|||
23185432|NCT03874234|64420349|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185433|NCT03874234|64420350|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185434|NCT03874234|64420351|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185435|NCT03874234|64420352|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185436|NCT03874234|64420353|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185437|NCT03874234|64420354|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
23185438|NCT03874234|64420342|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23185439|NCT03874234|64420343|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23185440|NCT03874234|64420344|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23185441|NCT03874234|64420345|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23185442|NCT03874234|64420346|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
23185443|NCT03874234|64420347|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23465465|NCT01208207|65448023|FG004|Part I|Progressive Disease|0|||
23465466|NCT01208207|65448024|FG005|Part I|Progressive Disease|0|||
23465467|NCT01208207|65448025|FG006|Part I|Progressive Disease|0|||
23465468|NCT01208207|65448019|FG000|Part I|Protocol Violation|8|||
23465469|NCT01208207|65448020|FG001|Part I|Protocol Violation|0|||
23465470|NCT01208207|65448021|FG002|Part I|Protocol Violation|2|||
23465471|NCT01208207|65448022|FG003|Part I|Protocol Violation|0|||
23465472|NCT01208207|65448023|FG004|Part I|Protocol Violation|0|||
23465473|NCT01208207|65448024|FG005|Part I|Protocol Violation|0|||
23465474|NCT01208207|65448025|FG006|Part I|Protocol Violation|0|||
23465475|NCT01208207|65448019|FG000|Part I|Withdrawal by Subject|14|||
23465476|NCT01208207|65448020|FG001|Part I|Withdrawal by Subject|4|||
23465477|NCT01208207|65448021|FG002|Part I|Withdrawal by Subject|4|||
23465478|NCT01208207|65448022|FG003|Part I|Withdrawal by Subject|0|||
23465479|NCT01208207|65448023|FG004|Part I|Withdrawal by Subject|0|||
23465480|NCT01208207|65448024|FG005|Part I|Withdrawal by Subject|0|||
23185444|NCT03874234|64420348|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23185445|NCT03874234|64420349|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23465481|NCT01208207|65448025|FG006|Part I|Withdrawal by Subject|0|||
23465482|NCT01208207|65448019|FG000|Part II|Withdrawal by Subject|0|||
23465483|NCT01208207|65448020|FG001|Part II|Withdrawal by Subject|0|||
23465484|NCT01208207|65448021|FG002|Part II|Withdrawal by Subject|0|||
23465485|NCT01208207|65448022|FG003|Part II|Withdrawal by Subject|10|||
23465486|NCT01208207|65448023|FG004|Part II|Withdrawal by Subject|9|||
23465487|NCT01208207|65448024|FG005|Part II|Withdrawal by Subject|3|||
23465488|NCT01208207|65448025|FG006|Part II|Withdrawal by Subject|5|||
23465489|NCT01208207|65448019|FG000|Part II|Adverse Event|0|||
23465490|NCT01208207|65448020|FG001|Part II|Adverse Event|0|||
23465491|NCT01208207|65448021|FG002|Part II|Adverse Event|0|||
23465492|NCT01208207|65448022|FG003|Part II|Adverse Event|5|||
23465493|NCT01208207|65448023|FG004|Part II|Adverse Event|9|||
23465494|NCT01208207|65448024|FG005|Part II|Adverse Event|4|||
23465495|NCT01208207|65448025|FG006|Part II|Adverse Event|2|||
23465496|NCT01208207|65448019|FG000|Part II|Lack of Efficacy|0|||
23465497|NCT01208207|65448020|FG001|Part II|Lack of Efficacy|0|||
23465498|NCT01208207|65448021|FG002|Part II|Lack of Efficacy|0|||
23465499|NCT01208207|65448022|FG003|Part II|Lack of Efficacy|6|||
23465500|NCT01208207|65448023|FG004|Part II|Lack of Efficacy|4|||
23465501|NCT01208207|65448024|FG005|Part II|Lack of Efficacy|3|||
23465502|NCT01208207|65448025|FG006|Part II|Lack of Efficacy|3|||
23465503|NCT01208207|65448019|FG000|Part II|Lost to Follow-up|0|||
23465504|NCT01208207|65448020|FG001|Part II|Lost to Follow-up|0|||
23465505|NCT01208207|65448021|FG002|Part II|Lost to Follow-up|0|||
23465506|NCT01208207|65448022|FG003|Part II|Lost to Follow-up|4|||
23465507|NCT01208207|65448023|FG004|Part II|Lost to Follow-up|0|||
23465508|NCT01208207|65448024|FG005|Part II|Lost to Follow-up|2|||
23465509|NCT01208207|65448025|FG006|Part II|Lost to Follow-up|1|||
23465510|NCT01208207|65448019|FG000|Part II|Non-Compliance With Study Drug|0|||
23465511|NCT01208207|65448020|FG001|Part II|Non-Compliance With Study Drug|0|||
23465512|NCT01208207|65448021|FG002|Part II|Non-Compliance With Study Drug|0|||
23465513|NCT01208207|65448022|FG003|Part II|Non-Compliance With Study Drug|4|||
23465514|NCT01208207|65448023|FG004|Part II|Non-Compliance With Study Drug|1|||
23465515|NCT01208207|65448024|FG005|Part II|Non-Compliance With Study Drug|1|||
23465516|NCT01208207|65448025|FG006|Part II|Non-Compliance With Study Drug|0|||
23465517|NCT01208207|65448019|FG000|Part II|Physician Decision|0|||
23243591|NCT01798056|64635938|FG000|Overall Study|Serious Adverse Event|13|||
23243592|NCT01798056|64635939|FG001|Overall Study|Serious Adverse Event|12|||
23465518|NCT01208207|65448020|FG001|Part II|Physician Decision|0|||
23465519|NCT01208207|65448021|FG002|Part II|Physician Decision|0|||
23465520|NCT01208207|65448022|FG003|Part II|Physician Decision|1|||
23465521|NCT01208207|65448023|FG004|Part II|Physician Decision|0|||
23465522|NCT01208207|65448024|FG005|Part II|Physician Decision|2|||
23465523|NCT01208207|65448025|FG006|Part II|Physician Decision|0|||
23465524|NCT01208207|65448019|FG000|Part II|Protocol Violation|0|||
23465525|NCT01208207|65448020|FG001|Part II|Protocol Violation|0|||
23465526|NCT01208207|65448021|FG002|Part II|Protocol Violation|0|||
23465527|NCT01208207|65448022|FG003|Part II|Protocol Violation|1|||
23465528|NCT01208207|65448023|FG004|Part II|Protocol Violation|0|||
23350852|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350853|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
23350854|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
23350855|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350856|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
23350857|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350858|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350859|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
23350860|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350861|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350862|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
23350863|NCT00528372|65029412|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
23350864|NCT00528372|65029413|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23350865|NCT00528372|65029414|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23350866|NCT00528372|65029415|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
23350867|NCT00528372|65029416|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23465529|NCT01208207|65448024|FG005|Part II|Protocol Violation|0|||
23465530|NCT01208207|65448025|FG006|Part II|Protocol Violation|0|||
23465531|NCT01208207|65448019|FG000|Part II|Technical Problems|0|||
23465532|NCT01208207|65448020|FG001|Part II|Technical Problems|0|||
23465533|NCT01208207|65448021|FG002|Part II|Technical Problems|0|||
23465534|NCT01208207|65448022|FG003|Part II|Technical Problems|1|||
23465535|NCT01208207|65448023|FG004|Part II|Technical Problems|0|||
23465536|NCT01208207|65448024|FG005|Part II|Technical Problems|1|||
23465537|NCT01208207|65448025|FG006|Part II|Technical Problems|0|||
23465538|NCT01635153|65448027|FG000|Overall Study|Lost to Follow-up|40|||
23465539|NCT01635153|65448028|FG001|Overall Study|Lost to Follow-up|43|||
23465540|NCT01803607|65448031|FG000|Overall Study|Adverse Event|5|||
23465541|NCT01803607|65448032|FG001|Overall Study|Adverse Event|3|||
23465542|NCT01803607|65448031|FG000|Overall Study|Lack of Efficacy|0|||
23465543|NCT01803607|65448032|FG001|Overall Study|Lack of Efficacy|1|||
23465544|NCT01803607|65448031|FG000|Overall Study|Protocol Violation|3|||
23465545|NCT01803607|65448032|FG001|Overall Study|Protocol Violation|2|||
23465546|NCT01803607|65448031|FG000|Overall Study|Study terminated by sponsor|54|||
23185446|NCT03874234|64420350|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23185447|NCT03874234|64420351|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23185448|NCT03874234|64420352|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23185449|NCT03874234|64420353|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23185450|NCT03874234|64420354|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
23243593|NCT01798056|64635938|FG000|Overall Study|Withdrawal by Subject|12|||
23243594|NCT01798056|64635939|FG001|Overall Study|Withdrawal by Subject|9|||
23243595|NCT01798056|64635938|FG000|Overall Study|Migrated/moved from study area|1|||
23243596|NCT01798056|64635939|FG001|Overall Study|Migrated/moved from study area|1|||
23243597|NCT01798056|64635938|FG000|Overall Study|Lost to Follow-up|1|||
23243598|NCT01798056|64635939|FG001|Overall Study|Lost to Follow-up|1|||
23243599|NCT01798056|64635938|FG000|Overall Study|Other|0|||
23243600|NCT01798056|64635939|FG001|Overall Study|Other|2|||
23243601|NCT02596009|64635940|FG000|Overall Study|Administrative problems|0|||
23243602|NCT02596009|64635941|FG001|Overall Study|Administrative problems|1|||
23243603|NCT02596009|64635942|FG002|Overall Study|Administrative problems|0|||
23243604|NCT02596009|64635943|FG003|Overall Study|Administrative problems|0|||
23243605|NCT02596009|64635944|FG004|Overall Study|Administrative problems|0|||
23243606|NCT02596009|64635945|FG005|Overall Study|Administrative problems|0|||
23243607|NCT02875340|64635946|FG000|Overall Study|Death|2|||
23243608|NCT02875340|64635946|FG000|Overall Study|Withdrawal by Subject|2|||
23243609|NCT02875340|64635946|FG000|Overall Study|Physician Decision|3|||
23185451|NCT00098787|64420355|FG000|Overall Study|Never started treatment|3|||
23185452|NCT00098787|64420356|FG001|Overall Study|Never started treatment|2|||
23185453|NCT00098787|64420357|FG002|Overall Study|Never started treatment|1|||
23185454|NCT00098787|64420355|FG000|Overall Study|Ineligible|9|||
23185455|NCT00098787|64420356|FG001|Overall Study|Ineligible|7|||
23185456|NCT00098787|64420357|FG002|Overall Study|Ineligible|3|||
23465547|NCT01803607|65448032|FG001|Overall Study|Study terminated by sponsor|56|||
23465548|NCT01803607|65448031|FG000|Overall Study|Withdrawal by Subject|6|||
23185457|NCT00098787|64420355|FG000|Overall Study|Disease progression|28|||
23243610|NCT02875340|64635946|FG000|Overall Study|Adverse Event|1|||
23243611|NCT02116309|64635947|FG000|Overall Study|Lost to Follow-up|0|||
23243612|NCT02116309|64635948|FG001|Overall Study|Lost to Follow-up|1|||
23243613|NCT01541644|64635951|FG000|Overall Study|Withdrawal by Subject|3|||
23243614|NCT00457249|64635952|FG000|Overall Study|Lost to Follow-up|3|||
23243615|NCT00457249|64635953|FG001|Overall Study|Lost to Follow-up|0|||
23465549|NCT01803607|65448032|FG001|Overall Study|Withdrawal by Subject|5|||
23243616|NCT00457249|64635952|FG000|Overall Study|Protocol Violation|4|||
23243617|NCT00457249|64635953|FG001|Overall Study|Protocol Violation|1|||
23243618|NCT00457249|64635952|FG000|Overall Study|Withdrawal by Subject|3|||
23243619|NCT00457249|64635953|FG001|Overall Study|Withdrawal by Subject|1|||
23243620|NCT00457249|64635952|FG000|Overall Study|Serious Adverse Events|2|||
23243621|NCT00457249|64635953|FG001|Overall Study|Serious Adverse Events|0|||
23243622|NCT03053102|64635954|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
23243623|NCT03053102|64635954|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
23243624|NCT02641730|64635959|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
23243625|NCT02641730|64635960|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23243626|NCT02641730|64635961|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
23243627|NCT02641730|64635962|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
23243628|NCT02641730|64635963|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
23243629|NCT02641730|64635959|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
23243630|NCT02641730|64635960|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
23243631|NCT02641730|64635961|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
23243632|NCT02641730|64635962|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
23243633|NCT02641730|64635963|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
23243634|NCT02641730|64635959|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
23243635|NCT02641730|64635960|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
23243636|NCT02641730|64635961|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
23243637|NCT02641730|64635962|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
23243638|NCT02641730|64635963|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
23243639|NCT02641730|64635959|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23243640|NCT02641730|64635960|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23243641|NCT02641730|64635961|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
23185458|NCT00098787|64420356|FG001|Overall Study|Disease progression|17|||
23185459|NCT00098787|64420357|FG002|Overall Study|Disease progression|23|||
23185460|NCT00098787|64420355|FG000|Overall Study|Adverse Event|8|||
23185461|NCT00098787|64420356|FG001|Overall Study|Adverse Event|17|||
23243642|NCT02641730|64635962|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
23243643|NCT02641730|64635963|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
23243644|NCT02641730|64635959|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
23243645|NCT02641730|64635960|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
23243646|NCT02641730|64635961|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
23243647|NCT02641730|64635962|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
23243648|NCT02641730|64635963|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
23243649|NCT02641730|64635959|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
23185462|NCT00098787|64420357|FG002|Overall Study|Adverse Event|8|||
23185463|NCT00098787|64420355|FG000|Overall Study|Death|6|||
23185464|NCT00098787|64420356|FG001|Overall Study|Death|1|||
23185465|NCT00098787|64420357|FG002|Overall Study|Death|0|||
23185466|NCT00098787|64420355|FG000|Overall Study|Withdrawal by Subject|4|||
23185467|NCT00098787|64420356|FG001|Overall Study|Withdrawal by Subject|12|||
23185468|NCT00098787|64420357|FG002|Overall Study|Withdrawal by Subject|6|||
23185469|NCT00098787|64420355|FG000|Overall Study|Alternative therapy|8|||
23185470|NCT00098787|64420356|FG001|Overall Study|Alternative therapy|13|||
23185471|NCT00098787|64420357|FG002|Overall Study|Alternative therapy|13|||
23185472|NCT00098787|64420355|FG000|Overall Study|Other|7|||
23185473|NCT00098787|64420356|FG001|Overall Study|Other|6|||
23185474|NCT00098787|64420357|FG002|Overall Study|Other|9|||
23185475|NCT01717638|64420360|FG000|Overall Study|Lost to Follow-up|0|||
23185476|NCT01717638|64420361|FG001|Overall Study|Lost to Follow-up|0|||
23185477|NCT01717638|64420362|FG002|Overall Study|Lost to Follow-up|0|||
23185478|NCT01717638|64420363|FG003|Overall Study|Lost to Follow-up|0|||
23185479|NCT01717638|64420364|FG004|Overall Study|Lost to Follow-up|0|||
23243650|NCT02641730|64635960|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
23243651|NCT02641730|64635961|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
23243652|NCT02641730|64635962|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
23243653|NCT02641730|64635963|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
23243654|NCT01907516|64635964|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
23585707|NCT03034915|65872852|FG002|Overall Study|Site closed|4|||
23585708|NCT03034915|65872850|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
23185480|NCT01717638|64420365|FG005|Overall Study|Lost to Follow-up|1|||
23243655|NCT01907516|64635965|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
23465550|NCT01039376|65448033|FG000|Overall Study|Lost to Follow-up|5|||
23585709|NCT03034915|65872851|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
23585710|NCT03034915|65872852|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
23185481|NCT01717638|64420366|FG006|Overall Study|Lost to Follow-up|0|||
23243656|NCT01907516|64635964|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
23243657|NCT01907516|64635965|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
23243658|NCT01907516|64635964|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
23243659|NCT01907516|64635965|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
23243660|NCT01907516|64635964|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
23243661|NCT01907516|64635965|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
23243662|NCT04355767|64635966|FG000|Overall Study|Withdrawal by Subject|2|||
23243663|NCT04355767|64635967|FG001|Overall Study|Withdrawal by Subject|2|||
23243664|NCT04355767|64635966|FG000|Overall Study|Death|5|||
23243665|NCT04355767|64635967|FG001|Overall Study|Death|1|||
23243666|NCT03128931|64635968|FG000|Overall Study|Physician Decision|1|||
23243667|NCT03128931|64635968|FG000|Overall Study|Equipment Issues|3|||
23243668|NCT02325739|64635973|FG000|Phase I Part|Adverse Event|1|||
23243669|NCT02325739|64635974|FG001|Phase I Part|Adverse Event|0|||
23243670|NCT02325739|64635975|FG002|Phase I Part|Adverse Event|1|||
23243671|NCT02325739|64635976|FG003|Phase I Part|Adverse Event|2|||
23243672|NCT02325739|64635977|FG004|Phase I Part|Adverse Event|3|||
23243673|NCT02325739|64635978|FG005|Phase I Part|Adverse Event|1|||
23243674|NCT02325739|64635979|FG006|Phase I Part|Adverse Event|0|||
23243675|NCT02325739|64635980|FG007|Phase I Part|Adverse Event|2|||
23243676|NCT02325739|64635981|FG008|Phase I Part|Adverse Event|0|||
23243677|NCT02325739|64635982|FG009|Phase I Part|Adverse Event|0|||
23243678|NCT02325739|64635983|FG010|Phase I Part|Adverse Event|0|||
23243679|NCT02325739|64635973|FG000|Phase I Part|Progressive disease|9|||
23243680|NCT02325739|64635974|FG001|Phase I Part|Progressive disease|6|||
23243681|NCT02325739|64635975|FG002|Phase I Part|Progressive disease|3|||
23243682|NCT02325739|64635976|FG003|Phase I Part|Progressive disease|23|||
23243683|NCT02325739|64635977|FG004|Phase I Part|Progressive disease|14|||
23243684|NCT02325739|64635978|FG005|Phase I Part|Progressive disease|6|||
23243685|NCT02325739|64635979|FG006|Phase I Part|Progressive disease|6|||
23243686|NCT02325739|64635980|FG007|Phase I Part|Progressive disease|3|||
23243687|NCT02325739|64635981|FG008|Phase I Part|Progressive disease|0|||
23243688|NCT02325739|64635982|FG009|Phase I Part|Progressive disease|0|||
23243689|NCT02325739|64635983|FG010|Phase I Part|Progressive disease|0|||
23243690|NCT02325739|64635973|FG000|Phase I Part|Subject/guardian decision|1|||
23243691|NCT02325739|64635974|FG001|Phase I Part|Subject/guardian decision|0|||
23243692|NCT02325739|64635975|FG002|Phase I Part|Subject/guardian decision|1|||
23243693|NCT02325739|64635976|FG003|Phase I Part|Subject/guardian decision|1|||
23243694|NCT02325739|64635977|FG004|Phase I Part|Subject/guardian decision|0|||
23243695|NCT02325739|64635978|FG005|Phase I Part|Subject/guardian decision|0|||
23243696|NCT02325739|64635979|FG006|Phase I Part|Subject/guardian decision|0|||
23243697|NCT02325739|64635980|FG007|Phase I Part|Subject/guardian decision|1|||
23350868|NCT00528372|65029417|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23350869|NCT00528372|65029418|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23585711|NCT03034915|65872850|FG000|Overall Study|Physician Decision|1|||
23585712|NCT03034915|65872851|FG001|Overall Study|Physician Decision|5|||
23585713|NCT03034915|65872852|FG002|Overall Study|Physician Decision|2|||
23585714|NCT01913340|65872853|FG000|Overall Study|Death|2|||
23585715|NCT01913340|65872854|FG001|Overall Study|Death|5|||
23585716|NCT01913340|65872853|FG000|Overall Study|Lost to Follow-up|1|||
23585717|NCT01913340|65872854|FG001|Overall Study|Lost to Follow-up|1|||
23585718|NCT01729819|65872855|FG000|Overall Study|Adverse Event|2|||
23585719|NCT01729819|65872856|FG001|Overall Study|Adverse Event|4|||
23585720|NCT01729819|65872855|FG000|Overall Study|Lack of Efficacy|1|||
23585721|NCT01729819|65872856|FG001|Overall Study|Lack of Efficacy|0|||
23585722|NCT01729819|65872855|FG000|Overall Study|Lost to Follow-up|2|||
23585723|NCT01729819|65872856|FG001|Overall Study|Lost to Follow-up|0|||
23585724|NCT01729819|65872855|FG000|Overall Study|Other reason|1|||
23585725|NCT01729819|65872856|FG001|Overall Study|Other reason|0|||
23585726|NCT01729819|65872855|FG000|Overall Study|Protocol Violation|0|||
23585727|NCT01729819|65872856|FG001|Overall Study|Protocol Violation|1|||
23585728|NCT01729819|65872855|FG000|Overall Study|Withdrawal by Subject|0|||
23585729|NCT01729819|65872856|FG001|Overall Study|Withdrawal by Subject|2|||
23585730|NCT01751724|65872858|FG000|Overall Study|extubated bef.start assigned treatment|1|||
23585731|NCT01751724|65872859|FG001|Overall Study|extubated bef.start assigned treatment|0|||
23585732|NCT01751724|65872858|FG000|Overall Study|withdrawn by parent|0|||
23585733|NCT01751724|65872859|FG001|Overall Study|withdrawn by parent|2|||
23243698|NCT02325739|64635981|FG008|Phase I Part|Subject/guardian decision|0|||
23243699|NCT02325739|64635982|FG009|Phase I Part|Subject/guardian decision|0|||
23243700|NCT02325739|64635983|FG010|Phase I Part|Subject/guardian decision|0|||
23243701|NCT02325739|64635973|FG000|Phase I Part|Death|0|||
23243702|NCT02325739|64635974|FG001|Phase I Part|Death|0|||
23243703|NCT02325739|64635975|FG002|Phase I Part|Death|0|||
23243704|NCT02325739|64635976|FG003|Phase I Part|Death|0|||
23585734|NCT03518112|65872861|FG000|Overall Study|Withdrawal by Subject|1|||
23585735|NCT00587288|65872864|FG000|Overall Study|Adverse Event|0|||
23350870|NCT00528372|65029419|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
23350871|NCT00528372|65029420|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
23350872|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
23350873|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
23350874|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
23350875|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
23350876|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
23350877|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
23465551|NCT01039376|65448034|FG001|Overall Study|Lost to Follow-up|12|||
23465552|NCT01039376|65448033|FG000|Overall Study|Physician Decision|15|||
23465553|NCT01039376|65448034|FG001|Overall Study|Physician Decision|10|||
23465554|NCT01039376|65448033|FG000|Overall Study|Withdrawal by Subject|20|||
23465555|NCT01039376|65448034|FG001|Overall Study|Withdrawal by Subject|32|||
23465556|NCT01039376|65448033|FG000|Overall Study|Study terminated by Sponsor|90|||
23465557|NCT01039376|65448034|FG001|Overall Study|Study terminated by Sponsor|72|||
23465558|NCT01417377|65448037|FG000|Overall Study|Lost to Follow-up|12|||
23465559|NCT01417377|65448037|FG000|Overall Study|Enrolled, but not treated|1|||
23465560|NCT00975780|65448038|FG000|Follow Up|Death|88|||
23465561|NCT00975780|65448039|FG001|Follow Up|Death|122|||
23465562|NCT00975780|65448038|FG000|Follow Up|Facility Withdrawal|7|||
23465563|NCT00975780|65448039|FG001|Follow Up|Facility Withdrawal|23|||
23465564|NCT00975780|65448038|FG000|Follow Up|Discharged from Facility|7|||
23465565|NCT00975780|65448039|FG001|Follow Up|Discharged from Facility|12|||
23465566|NCT00714870|65448040|FG000|Overall Study|Lost to Follow-up|22|||
23465567|NCT00714870|65448041|FG001|Overall Study|Lost to Follow-up|5|||
23465568|NCT00714870|65448040|FG000|Overall Study|patient unable to come b/c back pain|1|||
23465569|NCT00714870|65448041|FG001|Overall Study|patient unable to come b/c back pain|0|||
23465570|NCT00714870|65448040|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
23185482|NCT01717638|64420367|FG007|Overall Study|Lost to Follow-up|0|||
23185483|NCT01717638|64420368|FG008|Overall Study|Lost to Follow-up|0|||
23185484|NCT01717638|64420369|FG009|Overall Study|Lost to Follow-up|0|||
23185485|NCT01717638|64420370|FG010|Overall Study|Lost to Follow-up|0|||
23185486|NCT01717638|64420371|FG011|Overall Study|Lost to Follow-up|0|||
23185487|NCT01717638|64420372|FG012|Overall Study|Lost to Follow-up|0|||
23185488|NCT01717638|64420360|FG000|Overall Study|Father in hospital|0|||
23185489|NCT01717638|64420361|FG001|Overall Study|Father in hospital|0|||
23185490|NCT01717638|64420362|FG002|Overall Study|Father in hospital|0|||
23185491|NCT01717638|64420363|FG003|Overall Study|Father in hospital|0|||
23185492|NCT01717638|64420364|FG004|Overall Study|Father in hospital|0|||
23185493|NCT01717638|64420365|FG005|Overall Study|Father in hospital|0|||
23185494|NCT01717638|64420366|FG006|Overall Study|Father in hospital|0|||
23465571|NCT00714870|65448041|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
23185495|NCT01717638|64420367|FG007|Overall Study|Father in hospital|0|||
23185496|NCT01717638|64420368|FG008|Overall Study|Father in hospital|0|||
23185497|NCT01717638|64420369|FG009|Overall Study|Father in hospital|0|||
23185498|NCT01717638|64420370|FG010|Overall Study|Father in hospital|0|||
23185499|NCT01717638|64420371|FG011|Overall Study|Father in hospital|0|||
23185500|NCT01717638|64420372|FG012|Overall Study|Father in hospital|1|||
23185501|NCT01717638|64420360|FG000|Overall Study|Withdrawal by Subject|0|||
23185502|NCT01717638|64420361|FG001|Overall Study|Withdrawal by Subject|1|||
23185503|NCT01717638|64420362|FG002|Overall Study|Withdrawal by Subject|1|||
23185504|NCT01717638|64420363|FG003|Overall Study|Withdrawal by Subject|0|||
23185505|NCT01717638|64420364|FG004|Overall Study|Withdrawal by Subject|1|||
23185506|NCT01717638|64420365|FG005|Overall Study|Withdrawal by Subject|0|||
23185507|NCT01717638|64420366|FG006|Overall Study|Withdrawal by Subject|2|||
23185508|NCT01717638|64420367|FG007|Overall Study|Withdrawal by Subject|1|||
23185509|NCT01717638|64420368|FG008|Overall Study|Withdrawal by Subject|2|||
23185510|NCT01717638|64420369|FG009|Overall Study|Withdrawal by Subject|1|||
23185511|NCT01717638|64420370|FG010|Overall Study|Withdrawal by Subject|0|||
23243705|NCT02325739|64635977|FG004|Phase I Part|Death|2|||
23243706|NCT02325739|64635978|FG005|Phase I Part|Death|0|||
23185512|NCT01717638|64420371|FG011|Overall Study|Withdrawal by Subject|0|||
23185513|NCT01717638|64420372|FG012|Overall Study|Withdrawal by Subject|18|||
23185514|NCT00851903|64420373|FG000|Overall Study|Withdrawal by Subject|2|||
23185515|NCT00097539|64420374|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
23185516|NCT00097539|64420375|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
23185517|NCT00097539|64420376|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
23243707|NCT02325739|64635979|FG006|Phase I Part|Death|0|||
23243708|NCT02325739|64635980|FG007|Phase I Part|Death|0|||
23243709|NCT02325739|64635981|FG008|Phase I Part|Death|0|||
23243710|NCT02325739|64635982|FG009|Phase I Part|Death|0|||
23243711|NCT02325739|64635983|FG010|Phase I Part|Death|0|||
23243712|NCT02325739|64635973|FG000|Phase II Part|Adverse Event|0|||
23243713|NCT02325739|64635974|FG001|Phase II Part|Adverse Event|0|||
23243714|NCT02325739|64635975|FG002|Phase II Part|Adverse Event|0|||
23243715|NCT02325739|64635976|FG003|Phase II Part|Adverse Event|0|||
23243716|NCT02325739|64635977|FG004|Phase II Part|Adverse Event|0|||
23243717|NCT02325739|64635978|FG005|Phase II Part|Adverse Event|0|||
23243718|NCT02325739|64635979|FG006|Phase II Part|Adverse Event|0|||
23243719|NCT02325739|64635980|FG007|Phase II Part|Adverse Event|0|||
23243720|NCT02325739|64635981|FG008|Phase II Part|Adverse Event|4|||
23243721|NCT02325739|64635982|FG009|Phase II Part|Adverse Event|5|||
23243722|NCT02325739|64635983|FG010|Phase II Part|Adverse Event|1|||
23243723|NCT02325739|64635973|FG000|Phase II Part|Physician Decision|0|||
23585736|NCT00587288|65872865|FG001|Overall Study|Adverse Event|1|||
23585737|NCT00587288|65872864|FG000|Overall Study|Lack of Efficacy|2|||
23585738|NCT00587288|65872865|FG001|Overall Study|Lack of Efficacy|8|||
23585739|NCT00587288|65872864|FG000|Overall Study|Protocol Violation|1|||
23585740|NCT00587288|65872865|FG001|Overall Study|Protocol Violation|0|||
23585741|NCT03357341|65872866|FG000|Overall Study|Withdrawal by Subject|3|||
23585742|NCT03357341|65872867|FG001|Overall Study|Withdrawal by Subject|6|||
23585743|NCT03357341|65872866|FG000|Overall Study|Lost to Follow-up|4|||
23585744|NCT03357341|65872867|FG001|Overall Study|Lost to Follow-up|5|||
23585745|NCT03357341|65872866|FG000|Overall Study|Death|0|||
23185518|NCT00097539|64420377|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
23185519|NCT00097539|64420378|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
23243724|NCT02325739|64635974|FG001|Phase II Part|Physician Decision|0|||
23243725|NCT02325739|64635975|FG002|Phase II Part|Physician Decision|0|||
23243726|NCT02325739|64635976|FG003|Phase II Part|Physician Decision|0|||
23243727|NCT02325739|64635977|FG004|Phase II Part|Physician Decision|0|||
23243728|NCT02325739|64635978|FG005|Phase II Part|Physician Decision|0|||
23243729|NCT02325739|64635979|FG006|Phase II Part|Physician Decision|0|||
23585746|NCT03357341|65872867|FG001|Overall Study|Death|1|||
23585747|NCT05298111|65872869|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
23243730|NCT02325739|64635980|FG007|Phase II Part|Physician Decision|0|||
23243731|NCT02325739|64635981|FG008|Phase II Part|Physician Decision|0|||
23243732|NCT02325739|64635982|FG009|Phase II Part|Physician Decision|1|||
23243733|NCT02325739|64635983|FG010|Phase II Part|Physician Decision|0|||
23243734|NCT02325739|64635973|FG000|Phase II Part|Progressive disease|0|||
23243735|NCT02325739|64635974|FG001|Phase II Part|Progressive disease|0|||
23243736|NCT02325739|64635975|FG002|Phase II Part|Progressive disease|0|||
23243737|NCT02325739|64635976|FG003|Phase II Part|Progressive disease|0|||
23243738|NCT02325739|64635977|FG004|Phase II Part|Progressive disease|0|||
23243739|NCT02325739|64635978|FG005|Phase II Part|Progressive disease|0|||
23243740|NCT02325739|64635979|FG006|Phase II Part|Progressive disease|0|||
23243741|NCT02325739|64635980|FG007|Phase II Part|Progressive disease|0|||
23243742|NCT02325739|64635981|FG008|Phase II Part|Progressive disease|22|||
23243743|NCT02325739|64635982|FG009|Phase II Part|Progressive disease|29|||
23243744|NCT02325739|64635983|FG010|Phase II Part|Progressive disease|18|||
23243745|NCT02325739|64635973|FG000|Phase II Part|Subject/guardian decision|0|||
23243746|NCT02325739|64635974|FG001|Phase II Part|Subject/guardian decision|0|||
23243747|NCT02325739|64635975|FG002|Phase II Part|Subject/guardian decision|0|||
23243748|NCT02325739|64635976|FG003|Phase II Part|Subject/guardian decision|0|||
23243749|NCT02325739|64635977|FG004|Phase II Part|Subject/guardian decision|0|||
23243750|NCT02325739|64635978|FG005|Phase II Part|Subject/guardian decision|0|||
23243751|NCT02325739|64635979|FG006|Phase II Part|Subject/guardian decision|0|||
23350878|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
23350879|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
23350880|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
23350881|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
23350882|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
23350883|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
23350884|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
23350885|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
23243752|NCT02325739|64635980|FG007|Phase II Part|Subject/guardian decision|0|||
23243753|NCT02325739|64635981|FG008|Phase II Part|Subject/guardian decision|4|||
23350886|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
23585748|NCT05298111|65872870|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
23243754|NCT02325739|64635982|FG009|Phase II Part|Subject/guardian decision|1|||
23243755|NCT02325739|64635983|FG010|Phase II Part|Subject/guardian decision|1|||
23585749|NCT00771849|65872873|FG000|Overall Study|Lost to Follow-up|1|||
23185520|NCT00097539|64420379|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
23185521|NCT00097539|64420380|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
23185522|NCT00097539|64420374|FG000|Overall Study|Withdrawal by Subject|925|||
23185523|NCT00097539|64420375|FG001|Overall Study|Withdrawal by Subject|323|||
23185524|NCT00097539|64420376|FG002|Overall Study|Withdrawal by Subject|346|||
23185525|NCT00097539|64420377|FG003|Overall Study|Withdrawal by Subject|217|||
23185526|NCT00097539|64420378|FG004|Overall Study|Withdrawal by Subject|68|||
23185527|NCT00097539|64420379|FG005|Overall Study|Withdrawal by Subject|229|||
23185528|NCT00097539|64420380|FG006|Overall Study|Withdrawal by Subject|3|||
23185529|NCT00097539|64420374|FG000|Overall Study|Participant Non-compliant|2140|||
23185530|NCT00097539|64420375|FG001|Overall Study|Participant Non-compliant|567|||
23185531|NCT00097539|64420376|FG002|Overall Study|Participant Non-compliant|1067|||
23185532|NCT00097539|64420377|FG003|Overall Study|Participant Non-compliant|353|||
23185533|NCT00097539|64420378|FG004|Overall Study|Participant Non-compliant|136|||
23185534|NCT00097539|64420379|FG005|Overall Study|Participant Non-compliant|543|||
23185535|NCT00097539|64420380|FG006|Overall Study|Participant Non-compliant|18|||
23185536|NCT00097539|64420374|FG000|Overall Study|Lack of Efficacy|249|||
23185537|NCT00097539|64420375|FG001|Overall Study|Lack of Efficacy|122|||
23185538|NCT00097539|64420376|FG002|Overall Study|Lack of Efficacy|202|||
23185539|NCT00097539|64420377|FG003|Overall Study|Lack of Efficacy|105|||
23185540|NCT00097539|64420378|FG004|Overall Study|Lack of Efficacy|45|||
23185541|NCT00097539|64420379|FG005|Overall Study|Lack of Efficacy|228|||
23185542|NCT00097539|64420380|FG006|Overall Study|Lack of Efficacy|5|||
23185543|NCT00097539|64420374|FG000|Overall Study|Adverse Event|78|||
23185544|NCT00097539|64420375|FG001|Overall Study|Adverse Event|133|||
23185545|NCT00097539|64420376|FG002|Overall Study|Adverse Event|37|||
23185546|NCT00097539|64420377|FG003|Overall Study|Adverse Event|27|||
23185547|NCT00097539|64420378|FG004|Overall Study|Adverse Event|30|||
23185548|NCT00097539|64420379|FG005|Overall Study|Adverse Event|59|||
23185549|NCT00097539|64420380|FG006|Overall Study|Adverse Event|1|||
23185550|NCT00097539|64420374|FG000|Overall Study|Death|2|||
23185551|NCT00097539|64420375|FG001|Overall Study|Death|7|||
23185552|NCT00097539|64420376|FG002|Overall Study|Death|0|||
23185553|NCT00097539|64420377|FG003|Overall Study|Death|0|||
23185554|NCT00097539|64420378|FG004|Overall Study|Death|1|||
23185555|NCT00097539|64420379|FG005|Overall Study|Death|3|||
23185556|NCT00097539|64420380|FG006|Overall Study|Death|0|||
23185557|NCT00097539|64420374|FG000|Overall Study|Reasons Other Than Above|3602|||
23185558|NCT00097539|64420375|FG001|Overall Study|Reasons Other Than Above|1382|||
23185559|NCT00097539|64420376|FG002|Overall Study|Reasons Other Than Above|1757|||
23185560|NCT00097539|64420377|FG003|Overall Study|Reasons Other Than Above|692|||
23185561|NCT00097539|64420378|FG004|Overall Study|Reasons Other Than Above|361|||
23185562|NCT00097539|64420379|FG005|Overall Study|Reasons Other Than Above|1244|||
23185563|NCT00097539|64420380|FG006|Overall Study|Reasons Other Than Above|34|||
23185564|NCT00097539|64420374|FG000|Overall Study|Reason not Specified|111|||
23185565|NCT00097539|64420375|FG001|Overall Study|Reason not Specified|49|||
23185566|NCT00097539|64420376|FG002|Overall Study|Reason not Specified|53|||
23185567|NCT00097539|64420377|FG003|Overall Study|Reason not Specified|21|||
23185568|NCT00097539|64420378|FG004|Overall Study|Reason not Specified|11|||
23185569|NCT00097539|64420379|FG005|Overall Study|Reason not Specified|40|||
23185570|NCT00097539|64420380|FG006|Overall Study|Reason not Specified|2|||
23185571|NCT02978222|64420381|FG000|Overall Study|Withdrawal by Subject|2|||
23185572|NCT02978222|64420382|FG001|Overall Study|Withdrawal by Subject|2|||
23185573|NCT02978222|64420381|FG000|Overall Study|Physician Decision|2|||
23185574|NCT02978222|64420382|FG001|Overall Study|Physician Decision|0|||
23185575|NCT02978222|64420381|FG000|Overall Study|Adverse Event|0|||
23185576|NCT02978222|64420382|FG001|Overall Study|Adverse Event|1|||
23185577|NCT02978222|64420381|FG000|Overall Study|Death|1|||
23185578|NCT02978222|64420382|FG001|Overall Study|Death|0|||
23185579|NCT02978222|64420381|FG000|Overall Study|Disease Progression|32|||
23185580|NCT02978222|64420382|FG001|Overall Study|Disease Progression|32|||
23185581|NCT02978222|64420381|FG000|Overall Study|Early Study Termination|24|||
23185582|NCT02978222|64420382|FG001|Overall Study|Early Study Termination|21|||
23185583|NCT02031679|64420383|FG000|Overall Study|Protocol Violation|0|||
23185584|NCT02031679|64420384|FG001|Overall Study|Protocol Violation|1|||
23185585|NCT02031679|64420383|FG000|Overall Study|Lack of Efficacy|0|||
23185586|NCT02031679|64420384|FG001|Overall Study|Lack of Efficacy|1|||
23185587|NCT02498821|64420394|FG000|Overall Study|Screen failure|3|||
23185588|NCT02498821|64420395|FG001|Overall Study|Screen failure|5|||
23185589|NCT00283387|64420398|FG000|First Intervention|Subject non-compliant|1|||
23185590|NCT00283387|64420399|FG001|First Intervention|Subject non-compliant|1|||
23185591|NCT00283387|64420398|FG000|First Intervention|Withdrawal by Subject|0|||
23185592|NCT00283387|64420399|FG001|First Intervention|Withdrawal by Subject|1|||
23185593|NCT03593915|64420400|FG000|Overall Study|Adverse Event|0|||
23185594|NCT03593915|64420401|FG001|Overall Study|Adverse Event|0|||
23585750|NCT00771849|65872874|FG001|Overall Study|Lost to Follow-up|2|||
23185595|NCT03593915|64420402|FG002|Overall Study|Adverse Event|0|||
23185596|NCT03593915|64420403|FG003|Overall Study|Adverse Event|1|||
23585751|NCT00771849|65872873|FG000|Overall Study|Withdrawal by Subject|1|||
23585752|NCT00771849|65872874|FG001|Overall Study|Withdrawal by Subject|1|||
23585753|NCT00771849|65872873|FG000|Overall Study|Not vaccinated|0|||
23585754|NCT00771849|65872874|FG001|Overall Study|Not vaccinated|1|||
23585755|NCT00470626|65872875|FG000|Overall Study|Lost to Follow-up|10|||
23585756|NCT00470626|65872875|FG000|Overall Study|Withdrawal by Subject|7|||
23585757|NCT02351180|65872879|FG000|Overall Study|Withdrawal by Subject|1|||
23585758|NCT02351180|65872880|FG001|Overall Study|Withdrawal by Subject|0|||
23585759|NCT02839330|65872881|FG000|Overall Study|Adverse Event|0|||
23585760|NCT02839330|65872882|FG001|Overall Study|Adverse Event|1|||
23585761|NCT02839330|65872883|FG002|Overall Study|Adverse Event|2|||
23585762|NCT02839330|65872884|FG003|Overall Study|Adverse Event|2|||
23243772|NCT00938015|64635992|FG000|Overall Study|Death|2|||
23243773|NCT00938015|64635992|FG000|Overall Study|Lost to Follow-up|32|||
23350887|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
23350888|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
23350889|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
23350890|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
23350891|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
23350892|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
23350893|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
23350894|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
23350895|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
23350896|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
23350897|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
23350898|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
23350899|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
23350900|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
23350901|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
23350902|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
23350903|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
23350904|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
23350905|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
23350906|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
23350907|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
23350908|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350909|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
23350910|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
23350911|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
23350912|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350913|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350914|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
23350915|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350916|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
23350917|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350918|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350919|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350920|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350921|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
23350922|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
23350923|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350924|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23350925|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
23243774|NCT00938015|64635992|FG000|Overall Study|Adverse Event|32|||
23243775|NCT00938015|64635992|FG000|Overall Study|Non-responder|52|||
23243776|NCT00938015|64635992|FG000|Overall Study|Reason not related to Etanercept|29|||
23585763|NCT02839330|65872881|FG000|Overall Study|Death|4|||
23585764|NCT02839330|65872882|FG001|Overall Study|Death|6|||
23243777|NCT03917654|64635993|FG000|Year 1|Withdrawal by Subject|1|||
23585765|NCT02839330|65872883|FG002|Overall Study|Death|1|||
23585766|NCT02839330|65872884|FG003|Overall Study|Death|1|||
23585767|NCT02839330|65872881|FG000|Overall Study|Withdrawal by Subject|27|||
23585768|NCT02839330|65872882|FG001|Overall Study|Withdrawal by Subject|19|||
23585769|NCT02839330|65872883|FG002|Overall Study|Withdrawal by Subject|11|||
23585770|NCT02839330|65872884|FG003|Overall Study|Withdrawal by Subject|13|||
23585771|NCT02839330|65872881|FG000|Overall Study|Lost to Follow-up|22|||
23585772|NCT02839330|65872882|FG001|Overall Study|Lost to Follow-up|27|||
23585773|NCT02839330|65872883|FG002|Overall Study|Lost to Follow-up|29|||
23585774|NCT02839330|65872884|FG003|Overall Study|Lost to Follow-up|25|||
23585775|NCT02839330|65872881|FG000|Overall Study|Administrative Reason|0|||
23585776|NCT02839330|65872882|FG001|Overall Study|Administrative Reason|0|||
23585777|NCT02839330|65872883|FG002|Overall Study|Administrative Reason|0|||
23585778|NCT02839330|65872884|FG003|Overall Study|Administrative Reason|1|||
23585779|NCT02839330|65872881|FG000|Overall Study|Protocol Violation|1|||
23585780|NCT02839330|65872882|FG001|Overall Study|Protocol Violation|2|||
23585781|NCT02839330|65872883|FG002|Overall Study|Protocol Violation|2|||
23585782|NCT02839330|65872884|FG003|Overall Study|Protocol Violation|3|||
23585783|NCT02839330|65872881|FG000|Overall Study|Other reason, not specified|4|||
23585784|NCT02839330|65872882|FG001|Overall Study|Other reason, not specified|3|||
23585785|NCT02839330|65872883|FG002|Overall Study|Other reason, not specified|3|||
23585786|NCT02839330|65872884|FG003|Overall Study|Other reason, not specified|6|||
23243778|NCT03917654|64635994|FG001|Year 1|Withdrawal by Subject|0|||
23243779|NCT03917654|64635995|FG002|Year 1|Withdrawal by Subject|0|||
23350926|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23350927|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
23350928|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23350929|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23243780|NCT03917654|64635996|FG003|Year 1|Withdrawal by Subject|0|||
23350930|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23350931|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23465572|NCT01411891|65448047|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
23585787|NCT03822351|65872887|FG000|Overall Study|Death|27|||
23585788|NCT03822351|65872888|FG001|Overall Study|Death|23|||
23585789|NCT03822351|65872889|FG002|Overall Study|Death|24|||
23585790|NCT03822351|65872887|FG000|Overall Study|Lost to Follow-up|6|||
23585791|NCT03822351|65872888|FG001|Overall Study|Lost to Follow-up|2|||
23585792|NCT03822351|65872889|FG002|Overall Study|Lost to Follow-up|1|||
23243781|NCT03917654|64635997|FG004|Year 1|Withdrawal by Subject|0|||
23243782|NCT03917654|64635998|FG005|Year 1|Withdrawal by Subject|1|||
23243783|NCT03917654|64635999|FG006|Year 1|Withdrawal by Subject|6|||
23243784|NCT03917654|64636000|FG007|Year 1|Withdrawal by Subject|2|||
23243785|NCT03917654|64636001|FG008|Year 1|Withdrawal by Subject|5|||
23243786|NCT03917654|64636002|FG009|Year 1|Withdrawal by Subject|3|||
23243787|NCT03917654|64636003|FG010|Year 1|Withdrawal by Subject|1|||
23243788|NCT03917654|64636004|FG011|Year 1|Withdrawal by Subject|0|||
23243789|NCT03917654|64635993|FG000|Year 1|Travel|0|||
23243790|NCT03917654|64635994|FG001|Year 1|Travel|1|||
23243791|NCT03917654|64635995|FG002|Year 1|Travel|1|||
23243792|NCT03917654|64635996|FG003|Year 1|Travel|0|||
23243793|NCT03917654|64635997|FG004|Year 1|Travel|4|||
23243794|NCT03917654|64635998|FG005|Year 1|Travel|4|||
23243795|NCT03917654|64635999|FG006|Year 1|Travel|10|||
23243796|NCT03917654|64636000|FG007|Year 1|Travel|8|||
23243797|NCT03917654|64636001|FG008|Year 1|Travel|2|||
23243798|NCT03917654|64636002|FG009|Year 1|Travel|5|||
23243799|NCT03917654|64636003|FG010|Year 1|Travel|3|||
23585793|NCT03822351|65872887|FG000|Overall Study|Withdrawal by Subject|10|||
23585794|NCT03822351|65872888|FG001|Overall Study|Withdrawal by Subject|4|||
23585795|NCT03822351|65872889|FG002|Overall Study|Withdrawal by Subject|6|||
23243800|NCT03917654|64636004|FG011|Year 1|Travel|3|||
23243801|NCT03917654|64635993|FG000|Year 1|Subject moved away from site|0|||
23243802|NCT03917654|64635994|FG001|Year 1|Subject moved away from site|1|||
23243803|NCT03917654|64635995|FG002|Year 1|Subject moved away from site|0|||
23243804|NCT03917654|64635996|FG003|Year 1|Subject moved away from site|0|||
23243805|NCT03917654|64635997|FG004|Year 1|Subject moved away from site|0|||
23243806|NCT03917654|64635998|FG005|Year 1|Subject moved away from site|0|||
23243807|NCT03917654|64635999|FG006|Year 1|Subject moved away from site|1|||
23243808|NCT03917654|64636000|FG007|Year 1|Subject moved away from site|2|||
23585796|NCT03822351|65872887|FG000|Overall Study|Progressive Disease|2|||
23585797|NCT03822351|65872888|FG001|Overall Study|Progressive Disease|1|||
23585798|NCT03822351|65872889|FG002|Overall Study|Progressive Disease|0|||
23585799|NCT03822351|65872887|FG000|Overall Study|Not Treated|1|||
23585800|NCT03822351|65872888|FG001|Overall Study|Not Treated|1|||
23585801|NCT03822351|65872889|FG002|Overall Study|Not Treated|1|||
23585802|NCT03613129|65872890|FG000|Pre-treatment Assessment|Protocol Violation|2|||
23185597|NCT03593915|64420404|FG004|Overall Study|Adverse Event|0|||
23185598|NCT03593915|64420405|FG005|Overall Study|Adverse Event|0|||
23185599|NCT03593915|64420400|FG000|Overall Study|Physician Decision|0|||
23350932|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
23350933|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
23350934|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
23350935|NCT00528372|65029412|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
23350936|NCT00528372|65029413|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
23350937|NCT00528372|65029414|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
23350938|NCT00528372|65029415|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
23350939|NCT00528372|65029416|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
23350940|NCT00528372|65029417|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
23585803|NCT03613129|65872891|FG001|Pre-treatment Assessment|Protocol Violation|0|||
23585804|NCT03613129|65872892|FG002|Pre-treatment Assessment|Protocol Violation|0|||
23585805|NCT03613129|65872893|FG003|Pre-treatment Assessment|Protocol Violation|0|||
23585806|NCT03613129|65872894|FG004|Pre-treatment Assessment|Protocol Violation|0|||
23585807|NCT03613129|65872890|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
23585808|NCT03613129|65872891|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
23585809|NCT03613129|65872892|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
23585810|NCT03613129|65872893|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
23585811|NCT03613129|65872894|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
23585812|NCT04511650|65872895|FG000|Overall Study|Lost to Follow-up|1|||
23585813|NCT04511650|65872896|FG001|Overall Study|Lost to Follow-up|0|||
23585814|NCT04511650|65872897|FG002|Overall Study|Lost to Follow-up|0|||
23585815|NCT04511650|65872895|FG000|Overall Study|Withdrawal by Subject|1|||
23585816|NCT04511650|65872896|FG001|Overall Study|Withdrawal by Subject|0|||
23585817|NCT04511650|65872897|FG002|Overall Study|Withdrawal by Subject|0|||
23585818|NCT04511650|65872895|FG000|Overall Study|reason not provided|0|||
23585819|NCT04511650|65872896|FG001|Overall Study|reason not provided|0|||
23350941|NCT00528372|65029418|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
23585820|NCT04511650|65872897|FG002|Overall Study|reason not provided|1|||
23243809|NCT03917654|64636001|FG008|Year 1|Subject moved away from site|1|||
23243810|NCT03917654|64636002|FG009|Year 1|Subject moved away from site|0|||
23243811|NCT03917654|64636003|FG010|Year 1|Subject moved away from site|0|||
23243812|NCT03917654|64636004|FG011|Year 1|Subject moved away from site|3|||
23243813|NCT03917654|64635993|FG000|Year 1|Spouse/Family member request|0|||
23243814|NCT03917654|64635994|FG001|Year 1|Spouse/Family member request|0|||
23243815|NCT03917654|64635995|FG002|Year 1|Spouse/Family member request|1|||
23243816|NCT03917654|64635996|FG003|Year 1|Spouse/Family member request|0|||
23465573|NCT01411891|65448048|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
23465574|NCT03962504|65448049|FG000|Overall Study|Other|11|||
23465575|NCT03962504|65448050|FG001|Overall Study|Other|32|||
23465576|NCT00414596|65448051|FG000|Overall Study|Protocol Violation|2|||
23465577|NCT00936715|65448054|FG000|Overall Study|Investigators Discretion|1|||
23465578|NCT00936715|65448054|FG000|Overall Study|Protocol Violation|1|||
23465579|NCT00936715|65448054|FG000|Overall Study|Safety or Tolerability Reasons|4|||
23465580|NCT00953056|65448055|FG000|Overall Study|Withdrew Consent|0|||
23465581|NCT00953056|65448056|FG001|Overall Study|Withdrew Consent|0|||
23465582|NCT00953056|65448057|FG002|Overall Study|Withdrew Consent|0|||
23465583|NCT00953056|65448058|FG003|Overall Study|Withdrew Consent|0|||
23465584|NCT00953056|65448059|FG004|Overall Study|Withdrew Consent|2|||
23465585|NCT00953056|65448060|FG005|Overall Study|Withdrew Consent|3|||
23465586|NCT00953056|65448055|FG000|Overall Study|Serious Adverse Event|0|||
23465587|NCT00953056|65448056|FG001|Overall Study|Serious Adverse Event|0|||
23465588|NCT00953056|65448057|FG002|Overall Study|Serious Adverse Event|0|||
23465589|NCT00953056|65448058|FG003|Overall Study|Serious Adverse Event|0|||
23465590|NCT00953056|65448059|FG004|Overall Study|Serious Adverse Event|0|||
23465591|NCT00953056|65448060|FG005|Overall Study|Serious Adverse Event|1|||
23465592|NCT02284243|65448061|FG000|Overall Study|Lack of Efficacy|3|||
23585821|NCT04511650|65872895|FG000|Overall Study|Death|1|||
23585822|NCT04511650|65872896|FG001|Overall Study|Death|1|||
23585823|NCT04511650|65872897|FG002|Overall Study|Death|1|||
23585824|NCT00197015|65872898|FG000|Overall Study|Adverse Event|3|||
23585825|NCT00197015|65872899|FG001|Overall Study|Adverse Event|0|||
23585826|NCT00197015|65872900|FG002|Overall Study|Adverse Event|1|||
23585827|NCT00197015|65872898|FG000|Overall Study|Protocol Violation|0|||
23585828|NCT00197015|65872899|FG001|Overall Study|Protocol Violation|3|||
23585829|NCT00197015|65872900|FG002|Overall Study|Protocol Violation|3|||
23585830|NCT00197015|65872898|FG000|Overall Study|Withdrawal by Subject|17|||
23185600|NCT03593915|64420401|FG001|Overall Study|Physician Decision|0|||
23185601|NCT03593915|64420402|FG002|Overall Study|Physician Decision|0|||
23185602|NCT03593915|64420403|FG003|Overall Study|Physician Decision|0|||
23185603|NCT03593915|64420404|FG004|Overall Study|Physician Decision|0|||
23185604|NCT03593915|64420405|FG005|Overall Study|Physician Decision|1|||
23185605|NCT01171612|64420406|FG000|Overall Study|Lost to Follow-up|51|||
23185606|NCT03258814|64420409|FG000|Overall Study|Early Termination|4|||
23185607|NCT03258814|64420410|FG001|Overall Study|Early Termination|3|||
23185608|NCT03258814|64420411|FG002|Overall Study|Early Termination|10|||
23185609|NCT00110305|64420415|FG000|Overall Study|Adverse Event|46|||
23185610|NCT00110305|64420416|FG001|Overall Study|Adverse Event|13|||
23185611|NCT00110305|64420415|FG000|Overall Study|Sponsors Decision|1|||
23185612|NCT00110305|64420416|FG001|Overall Study|Sponsors Decision|0|||
23185613|NCT00110305|64420415|FG000|Overall Study|Subject Non-Compliant|9|||
23185614|NCT00110305|64420416|FG001|Overall Study|Subject Non-Compliant|2|||
23185615|NCT00110305|64420415|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
23185616|NCT00110305|64420416|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
23185617|NCT00110305|64420415|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
23185618|NCT00110305|64420416|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
23185619|NCT00110305|64420415|FG000|Overall Study|Protocol Violation|0|||
23185620|NCT00110305|64420416|FG001|Overall Study|Protocol Violation|1|||
23185621|NCT00110305|64420415|FG000|Overall Study|Withdrawal by Subject|7|||
23243817|NCT03917654|64635997|FG004|Year 1|Spouse/Family member request|1|||
23243818|NCT03917654|64635998|FG005|Year 1|Spouse/Family member request|0|||
23243819|NCT03917654|64635999|FG006|Year 1|Spouse/Family member request|0|||
23465593|NCT02284243|65448062|FG001|Overall Study|Lack of Efficacy|3|||
23465594|NCT02284243|65448061|FG000|Overall Study|Adverse Event|1|||
23585831|NCT00197015|65872899|FG001|Overall Study|Withdrawal by Subject|37|||
23585832|NCT00197015|65872900|FG002|Overall Study|Withdrawal by Subject|34|||
23585833|NCT00197015|65872898|FG000|Overall Study|Lost to Follow-up|28|||
23465595|NCT02284243|65448062|FG001|Overall Study|Adverse Event|0|||
23465596|NCT01281124|65448063|FG000|Overall Study|Death|1|||
23465597|NCT05024032|65448064|FG000|Overall Study|Withdrawal by Subject|0|||
23465598|NCT05024032|65448065|FG001|Overall Study|Withdrawal by Subject|3|||
23465599|NCT05024032|65448066|FG002|Overall Study|Withdrawal by Subject|4|||
23465600|NCT05024032|65448064|FG000|Overall Study|Adverse Event|0|||
23465601|NCT05024032|65448065|FG001|Overall Study|Adverse Event|1|||
23465602|NCT05024032|65448066|FG002|Overall Study|Adverse Event|0|||
23465603|NCT05024032|65448064|FG000|Overall Study|Protocol Deviation|1|||
23465604|NCT05024032|65448065|FG001|Overall Study|Protocol Deviation|0|||
23465605|NCT05024032|65448066|FG002|Overall Study|Protocol Deviation|0|||
23465606|NCT01198977|65448069|FG000|Overall Study|Lost to Follow-up|1|||
23465607|NCT01198977|65448070|FG001|Overall Study|Lost to Follow-up|0|||
23465608|NCT04237116|65448071|FG000|Overall Study|Adverse Event|0|||
23465609|NCT04237116|65448072|FG001|Overall Study|Adverse Event|1|||
23465610|NCT04237116|65448071|FG000|Overall Study|Study terminated by Sponsor|4|||
23465611|NCT04237116|65448072|FG001|Overall Study|Study terminated by Sponsor|1|||
23465612|NCT01216189|65448077|FG000|Overall Study|Lost to Follow-up|21|||
23465613|NCT01216189|65448078|FG001|Overall Study|Lost to Follow-up|3|||
23465614|NCT01216189|65448077|FG000|Overall Study|Death|4|||
23465615|NCT01216189|65448078|FG001|Overall Study|Death|2|||
23465616|NCT04308291|65448079|FG000|Run-In Phase|Withdrawal by Subject|4|||
23465617|NCT04308291|65448079|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
23465618|NCT04308291|65448079|FG000|Study Phase 6-M|Physician Decision|2|||
23185622|NCT00110305|64420416|FG001|Overall Study|Withdrawal by Subject|7|||
23185623|NCT00110305|64420415|FG000|Overall Study|Lost to Follow-up|20|||
23185624|NCT00110305|64420416|FG001|Overall Study|Lost to Follow-up|3|||
23185625|NCT00110305|64420415|FG000|Overall Study|Other|8|||
23465619|NCT04308291|65448079|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
23465620|NCT04308291|65448079|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
23465621|NCT04308291|65448079|FG000|Study Phase 12-M|Physician Decision|2|||
23465622|NCT04308291|65448079|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
23465623|NCT02873377|65448080|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
23465624|NCT02873377|65448081|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
23465625|NCT02873377|65448080|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
23465626|NCT02873377|65448081|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
23465627|NCT02161016|65448082|FG000|Overall Study|withdrawn by IRB|1|||
23465628|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
23465629|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465630|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465631|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465632|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465633|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465634|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23465635|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
23465636|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465637|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465638|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465639|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465640|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465641|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
23465642|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
23465643|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465644|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465645|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465646|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465647|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465648|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23465649|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
23465650|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23185626|NCT00110305|64420416|FG001|Overall Study|Other|2|||
23465651|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23465652|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23185627|NCT02318602|64420417|FG000|Overall Study|Adverse Event|0|||
23185628|NCT02318602|64420418|FG001|Overall Study|Adverse Event|1|||
23185629|NCT02318602|64420419|FG002|Overall Study|Adverse Event|1|||
23465653|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23465654|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23465655|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23185630|NCT02318602|64420417|FG000|Overall Study|Withdrawal by Subject|0|||
23185631|NCT02318602|64420418|FG001|Overall Study|Withdrawal by Subject|3|||
23465656|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
23465657|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465658|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465659|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465660|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465661|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
23585834|NCT00197015|65872899|FG001|Overall Study|Lost to Follow-up|46|||
23585835|NCT00197015|65872900|FG002|Overall Study|Lost to Follow-up|37|||
23585836|NCT00197015|65872898|FG000|Overall Study|Other|2|||
23465662|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
23465663|NCT01054885|65448084|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
23465664|NCT01054885|65448085|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465665|NCT01054885|65448086|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465666|NCT01054885|65448087|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465667|NCT01054885|65448088|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23185632|NCT02318602|64420419|FG002|Overall Study|Withdrawal by Subject|0|||
23185633|NCT02318602|64420417|FG000|Overall Study|Death|1|||
23185634|NCT02318602|64420418|FG001|Overall Study|Death|0|||
23185635|NCT02318602|64420419|FG002|Overall Study|Death|0|||
23185636|NCT02318602|64420417|FG000|Overall Study|Guardian decision to withdraw|0|||
23185637|NCT02318602|64420418|FG001|Overall Study|Guardian decision to withdraw|0|||
23185638|NCT02318602|64420419|FG002|Overall Study|Guardian decision to withdraw|1|||
23185639|NCT03263091|64420420|FG000|OL Component|Withdrawal by Subject|1|||
23185640|NCT03263091|64420421|FG001|OL Component|Withdrawal by Subject|1|||
23185641|NCT03263091|64420422|FG002|OL Component|Withdrawal by Subject|0|||
23185642|NCT03263091|64420423|FG003|OL Component|Withdrawal by Subject|0|||
23185643|NCT03263091|64420424|FG004|OL Component|Withdrawal by Subject|0|||
23465668|NCT01054885|65448089|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465669|NCT01054885|65448090|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
23465670|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
23465671|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
23465672|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
23465673|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
23465674|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
23465675|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
23465676|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
23465677|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23465678|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23465679|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
23465680|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
23465681|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23465682|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
23465683|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23465684|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
23465685|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
23585837|NCT00197015|65872899|FG001|Overall Study|Other|3|||
23585838|NCT00197015|65872900|FG002|Overall Study|Other|2|||
23585839|NCT01494662|65872902|FG000|Overall Study|Withdrawal by Subject|0|||
23585840|NCT01494662|65872903|FG001|Overall Study|Withdrawal by Subject|0|||
23585841|NCT01494662|65872904|FG002|Overall Study|Withdrawal by Subject|1|||
23185644|NCT03263091|64420425|FG005|OL Component|Withdrawal by Subject|0|||
23185645|NCT03263091|64420420|FG000|OL Component|Physician Decision|0|||
23185646|NCT03263091|64420421|FG001|OL Component|Physician Decision|1|||
23185647|NCT03263091|64420422|FG002|OL Component|Physician Decision|2|||
23185648|NCT03263091|64420423|FG003|OL Component|Physician Decision|0|||
23185649|NCT03263091|64420424|FG004|OL Component|Physician Decision|0|||
23185650|NCT03263091|64420425|FG005|OL Component|Physician Decision|0|||
23185651|NCT03263091|64420420|FG000|OL Component|Death|1|||
23185652|NCT03263091|64420421|FG001|OL Component|Death|0|||
23185653|NCT03263091|64420422|FG002|OL Component|Death|0|||
23185654|NCT03263091|64420423|FG003|OL Component|Death|0|||
23185655|NCT03263091|64420424|FG004|OL Component|Death|0|||
23185656|NCT03263091|64420425|FG005|OL Component|Death|0|||
23185657|NCT03263091|64420420|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
23585842|NCT01494662|65872905|FG003|Overall Study|Withdrawal by Subject|0|||
23185658|NCT03263091|64420421|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
23185659|NCT03263091|64420422|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
23185660|NCT03263091|64420423|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
23185661|NCT03263091|64420424|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
23585843|NCT01494662|65872906|FG004|Overall Study|Withdrawal by Subject|0|||
23585844|NCT01494662|65872907|FG005|Overall Study|Withdrawal by Subject|0|||
23465686|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
23465687|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
23465688|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
23465689|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
23465690|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
23465691|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23465692|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
23465693|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
23465694|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
23465695|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
23465696|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
23465697|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
23465698|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
23465699|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
23465700|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
23465701|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
23465702|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
23465703|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
23465704|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
23465705|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465706|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465707|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
23465708|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465709|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465710|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
23465711|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
23465712|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23465713|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
23465714|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
23465715|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23465716|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23465717|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
23465718|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
23465719|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
23465720|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
23465721|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
23465722|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
23465723|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
23465724|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
23465725|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
23465726|NCT01054885|65448084|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23465727|NCT01054885|65448085|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
23465728|NCT01054885|65448086|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23465729|NCT01054885|65448087|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
23465730|NCT01054885|65448088|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
23465731|NCT01054885|65448089|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
23465732|NCT01054885|65448090|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
23465733|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
23465734|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
23465735|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
23465736|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
23465737|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Other|2|||
23465738|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
23465739|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
23465740|NCT02509026|65448092|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
23465741|NCT02509026|65448092|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
23465742|NCT02509026|65448092|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
23465743|NCT02509026|65448092|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
23465744|NCT02509026|65448092|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
23465745|NCT02509026|65448092|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
23465746|NCT02592798|65448097|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
23465747|NCT02592798|65448098|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
23465748|NCT02592798|65448097|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
23465749|NCT02592798|65448098|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
23465750|NCT02592798|65448097|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
23465751|NCT02592798|65448098|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
23465752|NCT02592798|65448097|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
23465753|NCT02592798|65448098|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
23465754|NCT02592798|65448097|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
23465755|NCT02592798|65448098|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
23465756|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
23465757|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
23465758|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
23465759|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
23465760|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
23465761|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
23465762|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
23465763|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
23465764|NCT02592798|65448097|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
23465765|NCT02592798|65448098|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
23465766|NCT02592798|65448097|FG000|Transition From DB2 to OLE|Other reasons|1|||
23465767|NCT02592798|65448098|FG001|Transition From DB2 to OLE|Other reasons|0|||
23465768|NCT02592798|65448097|FG000|Open Label Period (OLE)|Other reasons|0|||
23465769|NCT02592798|65448098|FG001|Open Label Period (OLE)|Other reasons|2|||
23465770|NCT02592798|65448097|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
23465771|NCT02592798|65448098|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
23465772|NCT02592798|65448097|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
23465773|NCT02592798|65448098|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
23465774|NCT02592798|65448097|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
23465775|NCT02592798|65448098|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
23465776|NCT02592798|65448097|FG000|Open Label Period (OLE)|Adverse Event|0|||
23465777|NCT02592798|65448098|FG001|Open Label Period (OLE)|Adverse Event|1|||
23465778|NCT02608684|65448102|FG000|Overall Study|Physician Decision|2|||
23465779|NCT02608684|65448102|FG000|Overall Study|Withdrawal by Subject|1|||
23465780|NCT01519921|65448121|FG000|Overall Study|Adverse Event|10|||
23465781|NCT01519921|65448122|FG001|Overall Study|Adverse Event|9|||
23465782|NCT01519921|65448121|FG000|Overall Study|Lack of Efficacy|4|||
23465783|NCT01519921|65448122|FG001|Overall Study|Lack of Efficacy|3|||
23465784|NCT01519921|65448121|FG000|Overall Study|Withdrawal by Subject|3|||
23465785|NCT01519921|65448122|FG001|Overall Study|Withdrawal by Subject|0|||
23465786|NCT01519921|65448121|FG000|Overall Study|Lost to Follow-up|2|||
23465787|NCT01519921|65448122|FG001|Overall Study|Lost to Follow-up|1|||
23465788|NCT01519921|65448121|FG000|Overall Study|Treatment refusal|2|||
23465789|NCT01519921|65448122|FG001|Overall Study|Treatment refusal|1|||
23465790|NCT01519921|65448121|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
23465791|NCT01519921|65448122|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
23465792|NCT02892448|65448123|FG000|Overall Study|Screening failure|2|||
23465793|NCT02892448|65448124|FG001|Overall Study|Screening failure|2|||
23465794|NCT02892448|65448125|FG002|Overall Study|Screening failure|1|||
23465795|NCT00148317|65448126|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
23585845|NCT01494662|65872908|FG006|Overall Study|Withdrawal by Subject|0|||
23585846|NCT01494662|65872902|FG000|Overall Study|Physician Decision|0|||
23585847|NCT01494662|65872903|FG001|Overall Study|Physician Decision|0|||
23585848|NCT01494662|65872904|FG002|Overall Study|Physician Decision|1|||
23585849|NCT01494662|65872905|FG003|Overall Study|Physician Decision|0|||
23585850|NCT01494662|65872906|FG004|Overall Study|Physician Decision|0|||
23185662|NCT03263091|64420425|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
23185663|NCT03263091|64420420|FG000|OL High-EPO Component|Physician Decision|0|||
23185664|NCT03263091|64420421|FG001|OL High-EPO Component|Physician Decision|0|||
23185665|NCT03263091|64420422|FG002|OL High-EPO Component|Physician Decision|0|||
23185666|NCT03263091|64420423|FG003|OL High-EPO Component|Physician Decision|1|||
23185667|NCT03263091|64420424|FG004|OL High-EPO Component|Physician Decision|0|||
23185668|NCT03263091|64420425|FG005|OL High-EPO Component|Physician Decision|0|||
23185669|NCT03263091|64420420|FG000|OL High-EPO Component|Death|0|||
23243820|NCT03917654|64636000|FG007|Year 1|Spouse/Family member request|2|||
23465796|NCT00148317|65448126|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
23465797|NCT00148317|65448126|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
23465798|NCT01263197|65448128|FG000|First Intervention (Period 1)|Adverse Event|0|||
23465799|NCT01263197|65448129|FG001|First Intervention (Period 1)|Adverse Event|0|||
23465800|NCT01263197|65448130|FG002|First Intervention (Period 1)|Adverse Event|0|||
23465801|NCT01263197|65448131|FG003|First Intervention (Period 1)|Adverse Event|0|||
23585851|NCT01494662|65872907|FG005|Overall Study|Physician Decision|0|||
23185670|NCT03263091|64420421|FG001|OL High-EPO Component|Death|0|||
23185671|NCT03263091|64420422|FG002|OL High-EPO Component|Death|0|||
23185672|NCT03263091|64420423|FG003|OL High-EPO Component|Death|3|||
23185673|NCT03263091|64420424|FG004|OL High-EPO Component|Death|0|||
23185674|NCT03263091|64420425|FG005|OL High-EPO Component|Death|0|||
23185675|NCT03263091|64420420|FG000|DB Component|Withdrawal by Subject|0|||
23185676|NCT03263091|64420421|FG001|DB Component|Withdrawal by Subject|0|||
23185677|NCT03263091|64420422|FG002|DB Component|Withdrawal by Subject|0|||
23185678|NCT03263091|64420423|FG003|DB Component|Withdrawal by Subject|0|||
23185679|NCT03263091|64420424|FG004|DB Component|Withdrawal by Subject|22|||
23185680|NCT03263091|64420425|FG005|DB Component|Withdrawal by Subject|8|||
23185681|NCT03263091|64420420|FG000|DB Component|Physician Decision|0|||
23185682|NCT03263091|64420421|FG001|DB Component|Physician Decision|0|||
23185683|NCT03263091|64420422|FG002|DB Component|Physician Decision|0|||
23185684|NCT03263091|64420423|FG003|DB Component|Physician Decision|0|||
23185685|NCT03263091|64420424|FG004|DB Component|Physician Decision|3|||
23185686|NCT03263091|64420425|FG005|DB Component|Physician Decision|1|||
23243821|NCT03917654|64636001|FG008|Year 1|Spouse/Family member request|0|||
23243822|NCT03917654|64636002|FG009|Year 1|Spouse/Family member request|0|||
23243823|NCT03917654|64636003|FG010|Year 1|Spouse/Family member request|0|||
23243824|NCT03917654|64636004|FG011|Year 1|Spouse/Family member request|1|||
23243825|NCT03917654|64635993|FG000|Year 1|Death|0|||
23465802|NCT01263197|65448132|FG004|First Intervention (Period 1)|Adverse Event|0|||
23465803|NCT01263197|65448133|FG005|First Intervention (Period 1)|Adverse Event|1|||
23465804|NCT01263197|65448128|FG000|Washout Period 1|Protocol Violation|0|||
23465805|NCT01263197|65448129|FG001|Washout Period 1|Protocol Violation|0|||
23465806|NCT01263197|65448130|FG002|Washout Period 1|Protocol Violation|0|||
23465807|NCT01263197|65448131|FG003|Washout Period 1|Protocol Violation|0|||
23465808|NCT01263197|65448132|FG004|Washout Period 1|Protocol Violation|1|||
23465809|NCT01263197|65448133|FG005|Washout Period 1|Protocol Violation|0|||
23465810|NCT01263197|65448128|FG000|Washout Period 2|Physician Decision|0|||
23465811|NCT01263197|65448129|FG001|Washout Period 2|Physician Decision|0|||
23465812|NCT01263197|65448130|FG002|Washout Period 2|Physician Decision|0|||
23465813|NCT01263197|65448131|FG003|Washout Period 2|Physician Decision|0|||
23465814|NCT01263197|65448132|FG004|Washout Period 2|Physician Decision|0|||
23465815|NCT01263197|65448133|FG005|Washout Period 2|Physician Decision|1|||
23465816|NCT01263197|65448128|FG000|Washout Period 2|Protocol Violation|0|||
23465817|NCT01263197|65448129|FG001|Washout Period 2|Protocol Violation|0|||
23465818|NCT01263197|65448130|FG002|Washout Period 2|Protocol Violation|0|||
23465819|NCT01263197|65448131|FG003|Washout Period 2|Protocol Violation|1|||
23465820|NCT01263197|65448132|FG004|Washout Period 2|Protocol Violation|0|||
23465821|NCT01263197|65448133|FG005|Washout Period 2|Protocol Violation|0|||
23465822|NCT01263197|65448128|FG000|Third Intervention (Period 3)|Adverse Event|0|||
23465823|NCT01263197|65448129|FG001|Third Intervention (Period 3)|Adverse Event|1|||
23465824|NCT01263197|65448130|FG002|Third Intervention (Period 3)|Adverse Event|0|||
23465825|NCT01263197|65448131|FG003|Third Intervention (Period 3)|Adverse Event|0|||
23465826|NCT01263197|65448132|FG004|Third Intervention (Period 3)|Adverse Event|0|||
23465827|NCT01263197|65448133|FG005|Third Intervention (Period 3)|Adverse Event|0|||
23465828|NCT03349034|65448151|FG000|Overall Study|catheters dislodged during transport|2|||
23465829|NCT03349034|65448152|FG001|Overall Study|catheters dislodged during transport|0|||
23465830|NCT03349034|65448151|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
23465831|NCT03349034|65448152|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
23465832|NCT03349034|65448151|FG000|Overall Study|soft tissue flap used|1|||
23243826|NCT03917654|64635994|FG001|Year 1|Death|0|||
23243827|NCT03917654|64635995|FG002|Year 1|Death|0|||
23243828|NCT03917654|64635996|FG003|Year 1|Death|0|||
23243829|NCT03917654|64635997|FG004|Year 1|Death|0|||
23350942|NCT00528372|65029419|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
23350943|NCT00528372|65029420|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
23350944|NCT00583102|65029421|FG000|Overall Study|Adverse Event|3|||
23350945|NCT00467558|65029422|FG000|Overall Study|Lost to Follow-up|2|||
23350946|NCT00467558|65029423|FG001|Overall Study|Lost to Follow-up|0|||
23350947|NCT05020366|65029424|FG000|Overall Study|Lost to Follow-up|2|||
23350948|NCT05020366|65029425|FG001|Overall Study|Lost to Follow-up|0|||
23350949|NCT05020366|65029424|FG000|Overall Study|Withdrawal by Subject|2|||
23243830|NCT03917654|64635998|FG005|Year 1|Death|0|||
23465833|NCT03349034|65448152|FG001|Overall Study|soft tissue flap used|0|||
23465834|NCT03349034|65448151|FG000|Overall Study|Other|0|||
23465835|NCT03349034|65448152|FG001|Overall Study|Other|1|||
23465836|NCT01470326|65448163|FG000|Overall Study|Protocol Violation|32|||
23465837|NCT01470326|65448163|FG000|Overall Study|No Drug Administration Information|2|||
23185687|NCT03263091|64420420|FG000|DB Component|Adverse Event|0|||
23185688|NCT03263091|64420421|FG001|DB Component|Adverse Event|0|||
23243831|NCT03917654|64635999|FG006|Year 1|Death|0|||
23350950|NCT05020366|65029425|FG001|Overall Study|Withdrawal by Subject|0|||
23350951|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
23243832|NCT03917654|64636000|FG007|Year 1|Death|0|||
23465838|NCT01470326|65448163|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
23465839|NCT02304367|65448164|FG000|Overall Study|Lack of Response to Bruosumab|1|||
23465840|NCT02304367|65448164|FG000|Overall Study|Sponsor Decision|3|||
23465841|NCT02304367|65448164|FG000|Overall Study|Death|2|||
23465842|NCT02304367|65448164|FG000|Overall Study|Physician Decision|1|||
23465843|NCT02304367|65448164|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
23465844|NCT00960999|65448165|FG000|Overall Study|Withdrawal by Subject|1|||
23465845|NCT00960999|65448166|FG001|Overall Study|Withdrawal by Subject|0|||
23465846|NCT00960999|65448165|FG000|Overall Study|Protocol Violation|5|||
23465847|NCT00960999|65448166|FG001|Overall Study|Protocol Violation|2|||
23465848|NCT00960999|65448165|FG000|Overall Study|RT dose constraints not met|2|||
23465849|NCT00960999|65448166|FG001|Overall Study|RT dose constraints not met|0|||
23465850|NCT03860259|65448167|FG000|Overall Study|Lost to Follow-up|5|||
23465851|NCT03860259|65448168|FG001|Overall Study|Lost to Follow-up|5|||
23465852|NCT03860259|65448167|FG000|Overall Study|Protocol Violation|1|||
23465853|NCT03860259|65448168|FG001|Overall Study|Protocol Violation|0|||
23465854|NCT00711191|65448169|FG000|Overall Study|Adverse Event|1|||
23465855|NCT00711191|65448170|FG001|Overall Study|Adverse Event|1|||
23465856|NCT00711191|65448171|FG002|Overall Study|Adverse Event|2|||
23465857|NCT00711191|65448169|FG000|Overall Study|Objective progression or relapse|2|||
23243833|NCT03917654|64636001|FG008|Year 1|Death|1|||
23243834|NCT03917654|64636002|FG009|Year 1|Death|1|||
23243835|NCT03917654|64636003|FG010|Year 1|Death|0|||
23243836|NCT03917654|64636004|FG011|Year 1|Death|0|||
23243837|NCT03917654|64635993|FG000|Year 1|Lost to Follow-up|0|||
23243838|NCT03917654|64635994|FG001|Year 1|Lost to Follow-up|0|||
23243839|NCT03917654|64635995|FG002|Year 1|Lost to Follow-up|0|||
23243840|NCT03917654|64635996|FG003|Year 1|Lost to Follow-up|0|||
23243841|NCT03917654|64635997|FG004|Year 1|Lost to Follow-up|0|||
23243842|NCT03917654|64635998|FG005|Year 1|Lost to Follow-up|0|||
23243843|NCT03917654|64635999|FG006|Year 1|Lost to Follow-up|2|||
23243844|NCT03917654|64636000|FG007|Year 1|Lost to Follow-up|0|||
23243845|NCT03917654|64636001|FG008|Year 1|Lost to Follow-up|0|||
23243846|NCT03917654|64636002|FG009|Year 1|Lost to Follow-up|0|||
23243847|NCT03917654|64636003|FG010|Year 1|Lost to Follow-up|0|||
23243848|NCT03917654|64636004|FG011|Year 1|Lost to Follow-up|0|||
23243849|NCT03917654|64635993|FG000|Year 1|Missed visits|0|||
23243850|NCT03917654|64635994|FG001|Year 1|Missed visits|0|||
23243851|NCT03917654|64635995|FG002|Year 1|Missed visits|0|||
23243852|NCT03917654|64635996|FG003|Year 1|Missed visits|0|||
23243853|NCT03917654|64635997|FG004|Year 1|Missed visits|0|||
23243854|NCT03917654|64635998|FG005|Year 1|Missed visits|0|||
23243855|NCT03917654|64635999|FG006|Year 1|Missed visits|0|||
23465858|NCT00711191|65448170|FG001|Overall Study|Objective progression or relapse|3|||
23465859|NCT00711191|65448171|FG002|Overall Study|Objective progression or relapse|7|||
23465860|NCT00711191|65448169|FG000|Overall Study|Withdrawal by Subject|0|||
23465861|NCT00711191|65448170|FG001|Overall Study|Withdrawal by Subject|1|||
23465862|NCT00711191|65448171|FG002|Overall Study|Withdrawal by Subject|3|||
23465863|NCT00494676|65448176|FG000|Allocation|Withdrawal by Subject|2|||
23465864|NCT00494676|65448177|FG001|Allocation|Withdrawal by Subject|4|||
23465865|NCT00494676|65448176|FG000|First Intervention|Withdrawal by Subject|1|||
23465866|NCT00494676|65448177|FG001|First Intervention|Withdrawal by Subject|3|||
23465867|NCT00494676|65448176|FG000|Second Intervention|Withdrawal by Subject|1|||
23465868|NCT00494676|65448177|FG001|Second Intervention|Withdrawal by Subject|1|||
23465869|NCT02367833|65448178|FG000|Overall Study|Withdrawal by Subject|1|||
23465870|NCT02367833|65448179|FG001|Overall Study|Withdrawal by Subject|1|||
23585852|NCT01494662|65872908|FG006|Overall Study|Physician Decision|0|||
23465871|NCT02367833|65448180|FG002|Overall Study|Withdrawal by Subject|0|||
23465872|NCT01578486|65448181|FG000|Overall Study|Physician Decision|3|||
23243856|NCT03917654|64636000|FG007|Year 1|Missed visits|0|||
23243857|NCT03917654|64636001|FG008|Year 1|Missed visits|0|||
23243858|NCT03917654|64636002|FG009|Year 1|Missed visits|0|||
23243859|NCT03917654|64636003|FG010|Year 1|Missed visits|1|||
23243860|NCT03917654|64636004|FG011|Year 1|Missed visits|1|||
23243861|NCT03917654|64635993|FG000|Year 1|Pregnancy|0|||
23243862|NCT03917654|64635994|FG001|Year 1|Pregnancy|0|||
23243863|NCT03917654|64635995|FG002|Year 1|Pregnancy|0|||
23465873|NCT01578486|65448181|FG000|Overall Study|Withdrawal by Subject|2|||
23465874|NCT01339052|65448182|FG000|Overall Study|Disease progression|13|||
23465875|NCT01339052|65448183|FG001|Overall Study|Disease progression|46|||
23585853|NCT00711646|65872909|FG000|Overall Study|Adverse Event|6|||
23585854|NCT00711646|65872910|FG001|Overall Study|Adverse Event|1|||
23585855|NCT00711646|65872909|FG000|Overall Study|Withdrawal by Subject|4|||
23585856|NCT00711646|65872910|FG001|Overall Study|Withdrawal by Subject|0|||
23585857|NCT00711646|65872909|FG000|Overall Study|Protocol Violation|0|||
23585858|NCT00711646|65872910|FG001|Overall Study|Protocol Violation|1|||
23585859|NCT00711646|65872909|FG000|Overall Study|Lost to Follow-up|1|||
23465876|NCT01339052|65448182|FG000|Overall Study|Adverse Event|1|||
23465877|NCT01339052|65448183|FG001|Overall Study|Adverse Event|1|||
23465878|NCT01339052|65448182|FG000|Overall Study|Withdrawal by Subject|0|||
23465879|NCT01339052|65448183|FG001|Overall Study|Withdrawal by Subject|3|||
23465880|NCT01339052|65448182|FG000|Overall Study|Physician Decision|1|||
23465881|NCT01339052|65448183|FG001|Overall Study|Physician Decision|0|||
23465882|NCT00439517|65448185|FG000|Overall Study|Subject on treatment|1|||
23465883|NCT00439517|65448186|FG001|Overall Study|Subject on treatment|0|||
23465884|NCT00439517|65448185|FG000|Overall Study|Subject in survival follow-up|1|||
23465885|NCT00439517|65448186|FG001|Overall Study|Subject in survival follow-up|0|||
23465886|NCT00560352|65448193|FG000|Overall Study|Adverse event unrelated to study drug|2|||
23465887|NCT00560352|65448194|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23465888|NCT00560352|65448195|FG002|Overall Study|Adverse event unrelated to study drug|1|||
23465889|NCT00560352|65448193|FG000|Overall Study|Study drug toxicity|3|||
23465890|NCT00560352|65448194|FG001|Overall Study|Study drug toxicity|0|||
23465891|NCT00560352|65448195|FG002|Overall Study|Study drug toxicity|1|||
23465892|NCT00560352|65448193|FG000|Overall Study|Disease progression|0|||
23465893|NCT00560352|65448194|FG001|Overall Study|Disease progression|1|||
23465894|NCT00560352|65448195|FG002|Overall Study|Disease progression|1|||
23465895|NCT00560352|65448193|FG000|Overall Study|Withdrawal by Subject|1|||
23465896|NCT00560352|65448194|FG001|Overall Study|Withdrawal by Subject|1|||
23465897|NCT00560352|65448195|FG002|Overall Study|Withdrawal by Subject|1|||
23465898|NCT00560352|65448193|FG000|Overall Study|Maximum clinical benefit|1|||
23465899|NCT00560352|65448194|FG001|Overall Study|Maximum clinical benefit|0|||
23465900|NCT00560352|65448195|FG002|Overall Study|Maximum clinical benefit|0|||
23465901|NCT02561832|65448215|FG000|Overall Study|Withdrawal by Subject|1|||
23465902|NCT02561832|65448216|FG001|Overall Study|Withdrawal by Subject|1|||
23465903|NCT02561832|65448215|FG000|Overall Study|Adverse Event|3|||
23465904|NCT02561832|65448216|FG001|Overall Study|Adverse Event|0|||
23465905|NCT02561832|65448215|FG000|Overall Study|Disease progression|3|||
23465906|NCT02561832|65448216|FG001|Overall Study|Disease progression|3|||
23465907|NCT00275509|65448217|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
23465908|NCT00275509|65448218|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
23465909|NCT03694353|65448219|FG000|Overall Study|Withdrawal by Subject|1|||
23465910|NCT03694353|65448219|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
23465911|NCT03041181|65448220|FG000|Overall Study|Disease Progression|1|||
23185689|NCT03263091|64420422|FG002|DB Component|Adverse Event|0|||
23185690|NCT03263091|64420423|FG003|DB Component|Adverse Event|0|||
23185691|NCT03263091|64420424|FG004|DB Component|Adverse Event|2|||
23185692|NCT03263091|64420425|FG005|DB Component|Adverse Event|1|||
23185693|NCT03263091|64420420|FG000|DB Component|Lost to Follow-up|0|||
23465912|NCT03041181|65448221|FG001|Overall Study|Disease Progression|2|||
23465913|NCT00759941|65448226|FG000|Overall Study|Use of medication|1|||
23465914|NCT00759941|65448227|FG001|Overall Study|Use of medication|0|||
23465915|NCT00759941|65448226|FG000|Overall Study|Adverse Event|1|||
23465916|NCT00759941|65448227|FG001|Overall Study|Adverse Event|0|||
23465917|NCT00759941|65448226|FG000|Overall Study|Exited in error by site|1|||
23465918|NCT00759941|65448227|FG001|Overall Study|Exited in error by site|1|||
23465919|NCT02000440|65448230|FG000|Overall Study|Adverse Event|3|||
23465920|NCT02000440|65448230|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
23465921|NCT01143246|65448231|FG000|Overall Study|Adverse Event|24|||
23465922|NCT01143246|65448232|FG001|Overall Study|Adverse Event|28|||
23465923|NCT01143246|65448231|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
23465924|NCT01143246|65448232|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
23465925|NCT01143246|65448231|FG000|Overall Study|Lost to Follow-up|0|||
23465926|NCT01143246|65448232|FG001|Overall Study|Lost to Follow-up|1|||
23465927|NCT01143246|65448231|FG000|Overall Study|Death|16|||
23465928|NCT01143246|65448232|FG001|Overall Study|Death|15|||
23465929|NCT01143246|65448231|FG000|Overall Study|Reason not Specified|3|||
23185694|NCT03263091|64420421|FG001|DB Component|Lost to Follow-up|0|||
23185695|NCT03263091|64420422|FG002|DB Component|Lost to Follow-up|0|||
23185696|NCT03263091|64420423|FG003|DB Component|Lost to Follow-up|0|||
23185697|NCT03263091|64420424|FG004|DB Component|Lost to Follow-up|2|||
23185698|NCT03263091|64420425|FG005|DB Component|Lost to Follow-up|1|||
23465930|NCT01143246|65448232|FG001|Overall Study|Reason not Specified|5|||
23465931|NCT00400946|65448233|FG000|Overall Study|Ineligible|0|||
23465932|NCT00400946|65448234|FG001|Overall Study|Ineligible|0|||
23465933|NCT00400946|65448235|FG002|Overall Study|Ineligible|0|||
23465934|NCT00400946|65448236|FG003|Overall Study|Ineligible|5|||
23465935|NCT00400946|65448237|FG004|Overall Study|Ineligible|1|||
23465936|NCT00400946|65448233|FG000|Overall Study|Induction Failure|0|||
23465937|NCT00400946|65448234|FG001|Overall Study|Induction Failure|0|||
23465938|NCT00400946|65448235|FG002|Overall Study|Induction Failure|0|||
23465939|NCT00400946|65448236|FG003|Overall Study|Induction Failure|11|||
23465940|NCT00400946|65448237|FG004|Overall Study|Induction Failure|8|||
23465941|NCT00400946|65448233|FG000|Overall Study|Induction Death|0|||
23465942|NCT00400946|65448234|FG001|Overall Study|Induction Death|0|||
23465943|NCT00400946|65448235|FG002|Overall Study|Induction Death|0|||
23465944|NCT00400946|65448236|FG003|Overall Study|Induction Death|13|||
23465945|NCT00400946|65448237|FG004|Overall Study|Induction Death|3|||
23465946|NCT00400946|65448233|FG000|Overall Study|Lost to Follow-up|1|||
23185699|NCT03263091|64420420|FG000|DB Component|Death|0|||
23185700|NCT03263091|64420421|FG001|DB Component|Death|0|||
23465947|NCT00400946|65448234|FG001|Overall Study|Lost to Follow-up|1|||
23465948|NCT00400946|65448235|FG002|Overall Study|Lost to Follow-up|0|||
23465949|NCT00400946|65448236|FG003|Overall Study|Lost to Follow-up|0|||
23465950|NCT00400946|65448237|FG004|Overall Study|Lost to Follow-up|1|||
23465951|NCT00400946|65448233|FG000|Overall Study|Remission Death|1|||
23465952|NCT00400946|65448234|FG001|Overall Study|Remission Death|1|||
23465953|NCT00400946|65448235|FG002|Overall Study|Remission Death|0|||
23585860|NCT00711646|65872910|FG001|Overall Study|Lost to Follow-up|0|||
23585861|NCT00711646|65872909|FG000|Overall Study|administrative decision|0|||
23585862|NCT00711646|65872910|FG001|Overall Study|administrative decision|1|||
23585863|NCT00711646|65872909|FG000|Overall Study|patient non-compliance|1|||
23585864|NCT00711646|65872910|FG001|Overall Study|patient non-compliance|0|||
23585865|NCT01981356|65872914|FG000|Overall Study|Lost to Follow-up|4|||
23585866|NCT01981356|65872915|FG001|Overall Study|Lost to Follow-up|1|||
23185701|NCT03263091|64420422|FG002|DB Component|Death|0|||
23185702|NCT03263091|64420423|FG003|DB Component|Death|0|||
23243864|NCT03917654|64635996|FG003|Year 1|Pregnancy|0|||
23465954|NCT00400946|65448236|FG003|Overall Study|Remission Death|0|||
23465955|NCT00400946|65448237|FG004|Overall Study|Remission Death|1|||
23585867|NCT01981356|65872914|FG000|Overall Study|Withdrawal by Subject|1|||
23585868|NCT01981356|65872915|FG001|Overall Study|Withdrawal by Subject|1|||
23185703|NCT03263091|64420424|FG004|DB Component|Death|7|||
23185704|NCT03263091|64420425|FG005|DB Component|Death|4|||
23185705|NCT03263091|64420420|FG000|DB Component|Other than specified|0|||
23185706|NCT03263091|64420421|FG001|DB Component|Other than specified|0|||
23185707|NCT03263091|64420422|FG002|DB Component|Other than specified|0|||
23185708|NCT03263091|64420423|FG003|DB Component|Other than specified|0|||
23185709|NCT03263091|64420424|FG004|DB Component|Other than specified|8|||
23185710|NCT03263091|64420425|FG005|DB Component|Other than specified|6|||
23185711|NCT00817414|64420426|FG000|Overall Study|Adverse Event|1|||
23185712|NCT00817414|64420427|FG001|Overall Study|Adverse Event|1|||
23185713|NCT00817414|64420428|FG002|Overall Study|Adverse Event|1|||
23185714|NCT00817414|64420429|FG003|Overall Study|Adverse Event|0|||
23185715|NCT00817414|64420430|FG004|Overall Study|Adverse Event|0|||
23185716|NCT00817414|64420426|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
23185717|NCT00817414|64420427|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
23185718|NCT00817414|64420428|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
23185719|NCT00817414|64420429|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
23185720|NCT00817414|64420430|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
23185721|NCT00817414|64420426|FG000|Overall Study|Withdrawal by Subject|1|||
23243865|NCT03917654|64635997|FG004|Year 1|Pregnancy|0|||
23465956|NCT00400946|65448233|FG000|Overall Study|Relapse|9|||
23465957|NCT00400946|65448234|FG001|Overall Study|Relapse|2|||
23465958|NCT00400946|65448235|FG002|Overall Study|Relapse|1|||
23465959|NCT00400946|65448236|FG003|Overall Study|Relapse|1|||
23465960|NCT00400946|65448237|FG004|Overall Study|Relapse|5|||
23465961|NCT00400946|65448233|FG000|Overall Study|Transplant in CR1|0|||
23465962|NCT00400946|65448234|FG001|Overall Study|Transplant in CR1|0|||
23243866|NCT03917654|64635998|FG005|Year 1|Pregnancy|0|||
23243867|NCT03917654|64635999|FG006|Year 1|Pregnancy|0|||
23243868|NCT03917654|64636000|FG007|Year 1|Pregnancy|1|||
23243869|NCT03917654|64636001|FG008|Year 1|Pregnancy|0|||
23243870|NCT03917654|64636002|FG009|Year 1|Pregnancy|1|||
23243871|NCT03917654|64636003|FG010|Year 1|Pregnancy|0|||
23243872|NCT03917654|64636004|FG011|Year 1|Pregnancy|0|||
23243873|NCT03917654|64635993|FG000|Year 2|Travel|1|||
23243874|NCT03917654|64635994|FG001|Year 2|Travel|0|||
23243875|NCT03917654|64635995|FG002|Year 2|Travel|0|||
23243876|NCT03917654|64635996|FG003|Year 2|Travel|0|||
23243877|NCT03917654|64635997|FG004|Year 2|Travel|1|||
23243878|NCT03917654|64635998|FG005|Year 2|Travel|1|||
23243879|NCT03917654|64635999|FG006|Year 2|Travel|2|||
23243880|NCT03917654|64636000|FG007|Year 2|Travel|1|||
23243881|NCT03917654|64636001|FG008|Year 2|Travel|0|||
23243882|NCT03917654|64636002|FG009|Year 2|Travel|1|||
23243883|NCT03917654|64636003|FG010|Year 2|Travel|0|||
23243884|NCT03917654|64636004|FG011|Year 2|Travel|1|||
23243885|NCT03917654|64635993|FG000|Year 2|Married|1|||
23243886|NCT03917654|64635994|FG001|Year 2|Married|0|||
23243887|NCT03917654|64635995|FG002|Year 2|Married|0|||
23243888|NCT03917654|64635996|FG003|Year 2|Married|0|||
23465963|NCT00400946|65448235|FG002|Overall Study|Transplant in CR1|0|||
23465964|NCT00400946|65448236|FG003|Overall Study|Transplant in CR1|10|||
23465965|NCT00400946|65448237|FG004|Overall Study|Transplant in CR1|1|||
23465966|NCT00400946|65448233|FG000|Overall Study|Withdrawal by Subject|2|||
23465967|NCT00400946|65448234|FG001|Overall Study|Withdrawal by Subject|5|||
23465968|NCT00400946|65448235|FG002|Overall Study|Withdrawal by Subject|1|||
23465969|NCT00400946|65448236|FG003|Overall Study|Withdrawal by Subject|5|||
23465970|NCT00400946|65448237|FG004|Overall Study|Withdrawal by Subject|8|||
23465971|NCT00400946|65448233|FG000|Overall Study|Clinical|1|||
23465972|NCT00400946|65448234|FG001|Overall Study|Clinical|2|||
23465973|NCT00400946|65448235|FG002|Overall Study|Clinical|0|||
23465974|NCT00400946|65448236|FG003|Overall Study|Clinical|2|||
23243889|NCT03917654|64635997|FG004|Year 2|Married|0|||
23243890|NCT03917654|64635998|FG005|Year 2|Married|0|||
23243891|NCT03917654|64635999|FG006|Year 2|Married|1|||
23243892|NCT03917654|64636000|FG007|Year 2|Married|1|||
23243893|NCT03917654|64636001|FG008|Year 2|Married|0|||
23243894|NCT03917654|64636002|FG009|Year 2|Married|0|||
23243895|NCT03917654|64636003|FG010|Year 2|Married|0|||
23243896|NCT03917654|64636004|FG011|Year 2|Married|0|||
23243897|NCT03917654|64635993|FG000|Year 2|Subject moved away from site|1|||
23243898|NCT03917654|64635994|FG001|Year 2|Subject moved away from site|0|||
23243899|NCT03917654|64635995|FG002|Year 2|Subject moved away from site|0|||
23243900|NCT03917654|64635996|FG003|Year 2|Subject moved away from site|0|||
23243901|NCT03917654|64635997|FG004|Year 2|Subject moved away from site|1|||
23243902|NCT03917654|64635998|FG005|Year 2|Subject moved away from site|0|||
23243903|NCT03917654|64635999|FG006|Year 2|Subject moved away from site|2|||
23243904|NCT03917654|64636000|FG007|Year 2|Subject moved away from site|3|||
23243905|NCT03917654|64636001|FG008|Year 2|Subject moved away from site|0|||
23243906|NCT03917654|64636002|FG009|Year 2|Subject moved away from site|2|||
23243907|NCT03917654|64636003|FG010|Year 2|Subject moved away from site|0|||
23243908|NCT03917654|64636004|FG011|Year 2|Subject moved away from site|1|||
23243909|NCT03917654|64635993|FG000|Year 2|Year 2 Screening failure|0|||
23243910|NCT03917654|64635994|FG001|Year 2|Year 2 Screening failure|1|||
23243911|NCT03917654|64635995|FG002|Year 2|Year 2 Screening failure|0|||
23243912|NCT03917654|64635996|FG003|Year 2|Year 2 Screening failure|0|||
23350952|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
23465975|NCT00400946|65448237|FG004|Overall Study|Clinical|9|||
23243913|NCT03917654|64635997|FG004|Year 2|Year 2 Screening failure|2|||
23243914|NCT03917654|64635998|FG005|Year 2|Year 2 Screening failure|0|||
23243915|NCT03917654|64635999|FG006|Year 2|Year 2 Screening failure|4|||
23243916|NCT03917654|64636000|FG007|Year 2|Year 2 Screening failure|3|||
23243917|NCT03917654|64636001|FG008|Year 2|Year 2 Screening failure|10|||
23243918|NCT03917654|64636002|FG009|Year 2|Year 2 Screening failure|2|||
23243919|NCT03917654|64636003|FG010|Year 2|Year 2 Screening failure|1|||
23243920|NCT03917654|64636004|FG011|Year 2|Year 2 Screening failure|1|||
23243921|NCT03917654|64635993|FG000|Year 2|Death|0|||
23243922|NCT03917654|64635994|FG001|Year 2|Death|0|||
23243923|NCT03917654|64635995|FG002|Year 2|Death|0|||
23243924|NCT03917654|64635996|FG003|Year 2|Death|0|||
23243925|NCT03917654|64635997|FG004|Year 2|Death|0|||
23243926|NCT03917654|64635998|FG005|Year 2|Death|1|||
23243927|NCT03917654|64635999|FG006|Year 2|Death|0|||
23243928|NCT03917654|64636000|FG007|Year 2|Death|0|||
23243929|NCT03917654|64636001|FG008|Year 2|Death|1|||
23465976|NCT00400946|65448233|FG000|Overall Study|Other|0|||
23465977|NCT00400946|65448234|FG001|Overall Study|Other|0|||
23465978|NCT00400946|65448235|FG002|Overall Study|Other|0|||
23465979|NCT00400946|65448236|FG003|Overall Study|Other|0|||
23465980|NCT00400946|65448237|FG004|Overall Study|Other|1|||
23465981|NCT00658359|65448240|FG000|Overall Study|Death|3|||
23243930|NCT03917654|64636002|FG009|Year 2|Death|1|||
23243931|NCT03917654|64636003|FG010|Year 2|Death|0|||
23243932|NCT03917654|64636004|FG011|Year 2|Death|0|||
23243933|NCT03917654|64635993|FG000|Year 2|Withdrawal by Subject|0|||
23243934|NCT03917654|64635994|FG001|Year 2|Withdrawal by Subject|0|||
23243935|NCT03917654|64635995|FG002|Year 2|Withdrawal by Subject|0|||
23243936|NCT03917654|64635996|FG003|Year 2|Withdrawal by Subject|0|||
23243937|NCT03917654|64635997|FG004|Year 2|Withdrawal by Subject|0|||
23243938|NCT03917654|64635998|FG005|Year 2|Withdrawal by Subject|0|||
23243939|NCT03917654|64635999|FG006|Year 2|Withdrawal by Subject|3|||
23243940|NCT03917654|64636000|FG007|Year 2|Withdrawal by Subject|0|||
23243941|NCT03917654|64636001|FG008|Year 2|Withdrawal by Subject|2|||
23243942|NCT03917654|64636002|FG009|Year 2|Withdrawal by Subject|5|||
23243943|NCT03917654|64636003|FG010|Year 2|Withdrawal by Subject|0|||
23243944|NCT03917654|64636004|FG011|Year 2|Withdrawal by Subject|0|||
23243945|NCT03917654|64635993|FG000|Year 2|Spouse/family member request|0|||
23243946|NCT03917654|64635994|FG001|Year 2|Spouse/family member request|0|||
23243947|NCT03917654|64635995|FG002|Year 2|Spouse/family member request|0|||
23243948|NCT03917654|64635996|FG003|Year 2|Spouse/family member request|0|||
23243949|NCT03917654|64635997|FG004|Year 2|Spouse/family member request|0|||
23243950|NCT03917654|64635998|FG005|Year 2|Spouse/family member request|0|||
23243951|NCT03917654|64635999|FG006|Year 2|Spouse/family member request|1|||
23243952|NCT03917654|64636000|FG007|Year 2|Spouse/family member request|0|||
23243953|NCT03917654|64636001|FG008|Year 2|Spouse/family member request|0|||
23243954|NCT03917654|64636002|FG009|Year 2|Spouse/family member request|0|||
23243955|NCT03917654|64636003|FG010|Year 2|Spouse/family member request|0|||
23243956|NCT03917654|64636004|FG011|Year 2|Spouse/family member request|0|||
23243957|NCT03917654|64635993|FG000|Year 2|Lost to Follow-up|0|||
23243958|NCT03917654|64635994|FG001|Year 2|Lost to Follow-up|0|||
23243959|NCT03917654|64635995|FG002|Year 2|Lost to Follow-up|0|||
23243960|NCT03917654|64635996|FG003|Year 2|Lost to Follow-up|0|||
23243961|NCT03917654|64635997|FG004|Year 2|Lost to Follow-up|0|||
23243962|NCT03917654|64635998|FG005|Year 2|Lost to Follow-up|0|||
23243963|NCT03917654|64635999|FG006|Year 2|Lost to Follow-up|1|||
23243964|NCT03917654|64636000|FG007|Year 2|Lost to Follow-up|0|||
23243965|NCT03917654|64636001|FG008|Year 2|Lost to Follow-up|1|||
23243966|NCT03917654|64636002|FG009|Year 2|Lost to Follow-up|0|||
23243967|NCT03917654|64636003|FG010|Year 2|Lost to Follow-up|0|||
23350953|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
23350954|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
23350955|NCT00943670|65029427|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
23350956|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
23350957|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
23350958|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
23350959|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
23465982|NCT00658359|65448241|FG001|Overall Study|Death|1|||
23465983|NCT00658359|65448242|FG002|Overall Study|Death|2|||
23243968|NCT03917654|64636004|FG011|Year 2|Lost to Follow-up|1|||
23243969|NCT03917654|64635993|FG000|Year 2|Adverse Event|0|||
23243970|NCT03917654|64635994|FG001|Year 2|Adverse Event|0|||
23243971|NCT03917654|64635995|FG002|Year 2|Adverse Event|0|||
23243972|NCT03917654|64635996|FG003|Year 2|Adverse Event|0|||
23243973|NCT03917654|64635997|FG004|Year 2|Adverse Event|0|||
23243974|NCT03917654|64635998|FG005|Year 2|Adverse Event|0|||
23243975|NCT03917654|64635999|FG006|Year 2|Adverse Event|0|||
23243976|NCT03917654|64636000|FG007|Year 2|Adverse Event|0|||
23243977|NCT03917654|64636001|FG008|Year 2|Adverse Event|0|||
23243978|NCT03917654|64636002|FG009|Year 2|Adverse Event|1|||
23243979|NCT03917654|64636003|FG010|Year 2|Adverse Event|0|||
23243980|NCT03917654|64636004|FG011|Year 2|Adverse Event|0|||
23465984|NCT00658359|65448240|FG000|Overall Study|Adverse Event|13|||
23243984|NCT03273257|64638702|FG000|Overall Study|Death|0|||
23243985|NCT03273257|64638703|FG001|Overall Study|Death|1|||
23243986|NCT03273257|64638702|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
23243987|NCT03273257|64638703|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
23243988|NCT03273257|64638702|FG000|Overall Study|Study terminated|3|||
23243989|NCT03273257|64638703|FG001|Overall Study|Study terminated|2|||
23243990|NCT04158739|64638704|FG000|Overall Study|Adverse Event|1|||
23243991|NCT04158739|64638705|FG001|Overall Study|Adverse Event|0|||
23243992|NCT04158739|64638704|FG000|Overall Study|Death|0|||
23243993|NCT04158739|64638705|FG001|Overall Study|Death|1|||
23243994|NCT04158739|64638704|FG000|Overall Study|Lack of Efficacy|3|||
23243995|NCT04158739|64638705|FG001|Overall Study|Lack of Efficacy|7|||
23243996|NCT04158739|64638704|FG000|Overall Study|Physician Decision|0|||
23465985|NCT00658359|65448241|FG001|Overall Study|Adverse Event|6|||
23243997|NCT04158739|64638705|FG001|Overall Study|Physician Decision|1|||
23243998|NCT04158739|64638704|FG000|Overall Study|Withdrawal by Subject|3|||
23243999|NCT04158739|64638705|FG001|Overall Study|Withdrawal by Subject|0|||
23465986|NCT00658359|65448242|FG002|Overall Study|Adverse Event|9|||
23465987|NCT00658359|65448240|FG000|Overall Study|Protocol Violation|1|||
23350960|NCT00943670|65029427|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
23185722|NCT00817414|64420427|FG001|Overall Study|Withdrawal by Subject|1|||
23185723|NCT00817414|64420428|FG002|Overall Study|Withdrawal by Subject|0|||
23185724|NCT00817414|64420429|FG003|Overall Study|Withdrawal by Subject|0|||
23185725|NCT00817414|64420430|FG004|Overall Study|Withdrawal by Subject|0|||
23185726|NCT00817414|64420426|FG000|Overall Study|Lost to Follow-up|0|||
23185727|NCT00817414|64420427|FG001|Overall Study|Lost to Follow-up|0|||
23185728|NCT00817414|64420428|FG002|Overall Study|Lost to Follow-up|1|||
23185729|NCT00817414|64420429|FG003|Overall Study|Lost to Follow-up|1|||
23185730|NCT00817414|64420430|FG004|Overall Study|Lost to Follow-up|1|||
23185731|NCT00817414|64420426|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
23185732|NCT00817414|64420427|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
23350961|NCT00862459|65029428|FG000|Overall Study|Lost to Follow-up|1|||
23350962|NCT00862459|65029429|FG001|Overall Study|Lost to Follow-up|2|||
23350963|NCT00862459|65029430|FG002|Overall Study|Lost to Follow-up|2|||
23350964|NCT00862459|65029428|FG000|Overall Study|Protocol Violation|1|||
23350965|NCT00862459|65029429|FG001|Overall Study|Protocol Violation|0|||
23350966|NCT00862459|65029430|FG002|Overall Study|Protocol Violation|0|||
23350967|NCT00862459|65029428|FG000|Overall Study|Withdrawal by Subject|1|||
23465988|NCT00658359|65448241|FG001|Overall Study|Protocol Violation|0|||
23185733|NCT00817414|64420428|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
23185734|NCT00817414|64420429|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
23185735|NCT00817414|64420430|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
23185736|NCT00817414|64420426|FG000|Overall Study|Protocol Violation|0|||
23185737|NCT00817414|64420427|FG001|Overall Study|Protocol Violation|0|||
23185738|NCT00817414|64420428|FG002|Overall Study|Protocol Violation|0|||
23185739|NCT00817414|64420429|FG003|Overall Study|Protocol Violation|0|||
23185740|NCT00817414|64420430|FG004|Overall Study|Protocol Violation|1|||
23244000|NCT00891527|64638706|FG000|Overall Study|Withdrawal by Subject|2|||
23244001|NCT03940742|64638717|FG000|Overall Study|Lost to Follow-up|0|||
23244002|NCT03940742|64638718|FG001|Overall Study|Lost to Follow-up|0|||
23244003|NCT03940742|64638719|FG002|Overall Study|Lost to Follow-up|0|||
23244004|NCT03940742|64638720|FG003|Overall Study|Lost to Follow-up|1|||
23244005|NCT04449354|64638723|FG000|Overall Study|Withdrawal by Subject|1|||
23350968|NCT00862459|65029429|FG001|Overall Study|Withdrawal by Subject|1|||
23465989|NCT00658359|65448242|FG002|Overall Study|Protocol Violation|0|||
23465990|NCT00658359|65448240|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
23465991|NCT00658359|65448241|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
23465992|NCT00658359|65448242|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
23465993|NCT00658359|65448240|FG000|Overall Study|Withdrawal by Subject|7|||
23585869|NCT01981356|65872914|FG000|Overall Study|Protocol Violation|2|||
23585870|NCT01981356|65872915|FG001|Overall Study|Protocol Violation|0|||
23350969|NCT00862459|65029430|FG002|Overall Study|Withdrawal by Subject|3|||
23350970|NCT00862459|65029428|FG000|Overall Study|Adverse Event|0|||
23350971|NCT00862459|65029429|FG001|Overall Study|Adverse Event|1|||
23350972|NCT00862459|65029430|FG002|Overall Study|Adverse Event|0|||
23350973|NCT00862459|65029428|FG000|Overall Study|Personal reasons|1|||
23350974|NCT00862459|65029429|FG001|Overall Study|Personal reasons|0|||
23350975|NCT00862459|65029430|FG002|Overall Study|Personal reasons|0|||
23350976|NCT00862459|65029428|FG000|Overall Study|Operation|1|||
23350977|NCT00862459|65029429|FG001|Overall Study|Operation|1|||
23350978|NCT00862459|65029430|FG002|Overall Study|Operation|0|||
23350979|NCT00862459|65029428|FG000|Overall Study|Intravenous (IV) site problems|1|||
23350980|NCT00862459|65029429|FG001|Overall Study|Intravenous (IV) site problems|0|||
23350981|NCT00862459|65029430|FG002|Overall Study|Intravenous (IV) site problems|1|||
23350982|NCT00862459|65029428|FG000|Overall Study|Unable to hold still for imaging|0|||
23350983|NCT00862459|65029429|FG001|Overall Study|Unable to hold still for imaging|1|||
23350984|NCT00862459|65029430|FG002|Overall Study|Unable to hold still for imaging|0|||
23350985|NCT00862459|65029428|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
23350986|NCT00862459|65029429|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
23350987|NCT00862459|65029430|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
23350988|NCT00862459|65029428|FG000|Overall Study|Administrative problems|0|||
23585871|NCT01405924|65872916|FG000|Overall Study|Protocol Violation|8|||
23585872|NCT01405924|65872916|FG000|Overall Study|Missing/Incomplete Data|2|||
23585873|NCT00891618|65872917|FG000|Overall Study|Withdrawal by Subject|1|||
23585874|NCT04310579|65872918|FG000|Overall Study|Adverse Event|0|||
23585875|NCT04310579|65872919|FG001|Overall Study|Adverse Event|0|||
23585876|NCT04310579|65872920|FG002|Overall Study|Adverse Event|0|||
23585877|NCT04310579|65872921|FG003|Overall Study|Adverse Event|0|||
23585878|NCT04310579|65872922|FG004|Overall Study|Adverse Event|0|||
23585879|NCT04310579|65872923|FG005|Overall Study|Adverse Event|0|||
23585880|NCT04310579|65872924|FG006|Overall Study|Adverse Event|2|||
23585881|NCT04310579|65872925|FG007|Overall Study|Adverse Event|0|||
23585882|NCT04310579|65872926|FG008|Overall Study|Adverse Event|1|||
23585883|NCT04310579|65872927|FG009|Overall Study|Adverse Event|1|||
23585884|NCT04310579|65872928|FG010|Overall Study|Adverse Event|0|||
23585885|NCT04310579|65872918|FG000|Overall Study|Withdrawal by Subject|0|||
23585886|NCT04310579|65872919|FG001|Overall Study|Withdrawal by Subject|0|||
23585887|NCT04310579|65872920|FG002|Overall Study|Withdrawal by Subject|0|||
23585888|NCT04310579|65872921|FG003|Overall Study|Withdrawal by Subject|0|||
23244030|NCT03707145|64638730|FG000|Overall Study|Lost to Follow-up|0|||
23244031|NCT03707145|64638731|FG001|Overall Study|Lost to Follow-up|1|||
23244032|NCT03707145|64638732|FG002|Overall Study|Lost to Follow-up|1|||
23244033|NCT03707145|64638733|FG003|Overall Study|Lost to Follow-up|0|||
23244034|NCT02476916|64638734|FG000|Core Period|Adverse Event|2|||
23244035|NCT02476916|64638735|FG001|Core Period|Adverse Event|2|||
23244036|NCT02476916|64638734|FG000|Core Period|Investigator decision|1|||
23244037|NCT02476916|64638735|FG001|Core Period|Investigator decision|1|||
23244038|NCT02476916|64638734|FG000|Core Period|Withdrawal by Subject|3|||
23244039|NCT02476916|64638735|FG001|Core Period|Withdrawal by Subject|0|||
23244040|NCT02476916|64638734|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
23244041|NCT02476916|64638735|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
23244042|NCT02476916|64638734|FG000|Extension Period|On Treatment|12|||
23244043|NCT02476916|64638735|FG001|Extension Period|On Treatment|17|||
23244044|NCT00564486|64638746|FG000|Overall Study|Adverse Event|0|||
23244045|NCT00564486|64638747|FG001|Overall Study|Adverse Event|1|||
23244046|NCT00564486|64638748|FG002|Overall Study|Adverse Event|0|||
23244047|NCT00564486|64638749|FG003|Overall Study|Adverse Event|0|||
23244048|NCT00564486|64638746|FG000|Overall Study|Withdrawal by Subject|4|||
23244049|NCT00564486|64638747|FG001|Overall Study|Withdrawal by Subject|0|||
23244050|NCT00564486|64638748|FG002|Overall Study|Withdrawal by Subject|0|||
23244051|NCT00564486|64638749|FG003|Overall Study|Withdrawal by Subject|5|||
23244052|NCT00564486|64638746|FG000|Overall Study|Subject refused to have blood drawn|0|||
23244053|NCT00564486|64638747|FG001|Overall Study|Subject refused to have blood drawn|0|||
23244054|NCT00564486|64638748|FG002|Overall Study|Subject refused to have blood drawn|1|||
23244055|NCT00564486|64638749|FG003|Overall Study|Subject refused to have blood drawn|0|||
23350989|NCT00862459|65029429|FG001|Overall Study|Administrative problems|1|||
23350990|NCT00862459|65029430|FG002|Overall Study|Administrative problems|0|||
23350991|NCT02539134|65029441|FG000|Overall Study|Lost to Follow-up|1|||
23244056|NCT00564486|64638746|FG000|Overall Study|Lost to Follow-up|3|||
23244057|NCT00564486|64638747|FG001|Overall Study|Lost to Follow-up|0|||
23244058|NCT00564486|64638748|FG002|Overall Study|Lost to Follow-up|2|||
23244059|NCT00564486|64638749|FG003|Overall Study|Lost to Follow-up|2|||
23244060|NCT03768414|64638758|FG000|Overall Study|Adverse Event or side effects|72|||
23244061|NCT03768414|64638759|FG001|Overall Study|Adverse Event or side effects|28|||
23244062|NCT03768414|64638758|FG000|Overall Study|Refusal unrelated to adverse event|33|||
23244063|NCT03768414|64638759|FG001|Overall Study|Refusal unrelated to adverse event|33|||
23244064|NCT03768414|64638758|FG000|Overall Study|Progression/relapse|132|||
23244065|NCT03768414|64638759|FG001|Overall Study|Progression/relapse|60|||
23244066|NCT03768414|64638758|FG000|Overall Study|Death|9|||
23244067|NCT03768414|64638759|FG001|Overall Study|Death|6|||
23585889|NCT04310579|65872922|FG004|Overall Study|Withdrawal by Subject|0|||
23350992|NCT02539134|65029442|FG001|Overall Study|Lost to Follow-up|0|||
23350993|NCT02539134|65029443|FG002|Overall Study|Lost to Follow-up|0|||
23350994|NCT02539134|65029444|FG003|Overall Study|Lost to Follow-up|0|||
23244068|NCT03768414|64638758|FG000|Overall Study|Other - not protocol specified|45|||
23585890|NCT04310579|65872923|FG005|Overall Study|Withdrawal by Subject|1|||
23585891|NCT04310579|65872924|FG006|Overall Study|Withdrawal by Subject|0|||
23585892|NCT04310579|65872925|FG007|Overall Study|Withdrawal by Subject|0|||
23585893|NCT04310579|65872926|FG008|Overall Study|Withdrawal by Subject|0|||
23585894|NCT04310579|65872927|FG009|Overall Study|Withdrawal by Subject|0|||
23585895|NCT04310579|65872928|FG010|Overall Study|Withdrawal by Subject|0|||
23585896|NCT04310579|65872918|FG000|Overall Study|Positive COVID-19 test|0|||
23585897|NCT04310579|65872919|FG001|Overall Study|Positive COVID-19 test|0|||
23585898|NCT04310579|65872920|FG002|Overall Study|Positive COVID-19 test|0|||
23585899|NCT04310579|65872921|FG003|Overall Study|Positive COVID-19 test|0|||
23585900|NCT04310579|65872922|FG004|Overall Study|Positive COVID-19 test|0|||
23585901|NCT04310579|65872923|FG005|Overall Study|Positive COVID-19 test|0|||
23585902|NCT04310579|65872924|FG006|Overall Study|Positive COVID-19 test|0|||
23585903|NCT04310579|65872925|FG007|Overall Study|Positive COVID-19 test|0|||
23585904|NCT04310579|65872926|FG008|Overall Study|Positive COVID-19 test|0|||
23585905|NCT04310579|65872927|FG009|Overall Study|Positive COVID-19 test|0|||
23585906|NCT04310579|65872928|FG010|Overall Study|Positive COVID-19 test|1|||
23244069|NCT03768414|64638759|FG001|Overall Study|Other - not protocol specified|18|||
23350995|NCT02539134|65029445|FG004|Overall Study|Lost to Follow-up|0|||
23350996|NCT02539134|65029446|FG005|Overall Study|Lost to Follow-up|0|||
23350997|NCT01618916|65029447|FG000|Overall Study|Adverse Event|1|||
23350998|NCT01618916|65029448|FG001|Overall Study|Adverse Event|0|||
23350999|NCT01618916|65029449|FG002|Overall Study|Adverse Event|0|||
23351000|NCT01618916|65029450|FG003|Overall Study|Adverse Event|0|||
23351001|NCT01618916|65029451|FG004|Overall Study|Adverse Event|0|||
23351002|NCT01618916|65029452|FG005|Overall Study|Adverse Event|0|||
23585907|NCT03254394|65872929|FG000|Overall Study|Withdrawal by Subject|0|||
23585908|NCT03254394|65872930|FG001|Overall Study|Withdrawal by Subject|2|||
23585909|NCT00371566|65872933|FG000|Treatment Phase|Withdrawal by Subject|0|||
23585910|NCT00371566|65872934|FG001|Treatment Phase|Withdrawal by Subject|1|||
23585911|NCT00371566|65872933|FG000|Treatment Phase|Adverse Event|0|||
23585912|NCT00371566|65872934|FG001|Treatment Phase|Adverse Event|1|||
23585913|NCT00371566|65872933|FG000|Treatment Phase|Protocol Violation|0|||
23585914|NCT00371566|65872934|FG001|Treatment Phase|Protocol Violation|1|||
23585915|NCT00371566|65872933|FG000|Chemoradiation Phase|Physician Decision|2|||
23585916|NCT00371566|65872934|FG001|Chemoradiation Phase|Physician Decision|0|||
23585917|NCT00371566|65872933|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
23585918|NCT00371566|65872934|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
23585919|NCT00371566|65872933|FG000|Chemoradiation Phase|Non compliant|0|||
23585920|NCT00371566|65872934|FG001|Chemoradiation Phase|Non compliant|1|||
23585921|NCT00371566|65872933|FG000|Chemoradiation Phase|Progressive Disease|1|||
23585922|NCT00371566|65872934|FG001|Chemoradiation Phase|Progressive Disease|1|||
23585923|NCT00371566|65872933|FG000|Chemoradiation Phase|Death|2|||
23585924|NCT00371566|65872934|FG001|Chemoradiation Phase|Death|0|||
23351003|NCT01618916|65029447|FG000|Overall Study|Withdrawal by Subject|0|||
23351004|NCT01618916|65029448|FG001|Overall Study|Withdrawal by Subject|1|||
23585925|NCT00371566|65872933|FG000|Follow Up Phase|Death|0|||
23585926|NCT00371566|65872934|FG001|Follow Up Phase|Death|5|||
23585927|NCT00371566|65872933|FG000|Follow Up Phase|Disease progression|1|||
23585928|NCT00371566|65872934|FG001|Follow Up Phase|Disease progression|0|||
23585929|NCT00371566|65872933|FG000|Follow Up Phase|Withdrawal by Subject|0|||
23585930|NCT00371566|65872934|FG001|Follow Up Phase|Withdrawal by Subject|1|||
23585931|NCT00371566|65872933|FG000|Follow Up Phase|Physician Decision|1|||
23585932|NCT00371566|65872934|FG001|Follow Up Phase|Physician Decision|1|||
23244070|NCT03768414|64638758|FG000|Overall Study|Reason under review|3|||
23585933|NCT00371566|65872933|FG000|Follow Up Phase|Lost to Follow-up|1|||
23244071|NCT03768414|64638759|FG001|Overall Study|Reason under review|2|||
23244072|NCT00816166|64638760|FG000|Overall Study|Lost to Follow-up|6|||
23351005|NCT01618916|65029449|FG002|Overall Study|Withdrawal by Subject|1|||
23351006|NCT01618916|65029450|FG003|Overall Study|Withdrawal by Subject|0|||
23351007|NCT01618916|65029451|FG004|Overall Study|Withdrawal by Subject|1|||
23351008|NCT01618916|65029452|FG005|Overall Study|Withdrawal by Subject|0|||
23585934|NCT00371566|65872934|FG001|Follow Up Phase|Lost to Follow-up|0|||
23585935|NCT00530335|65872936|FG000|Overall Study|Adverse Event|3|||
23585936|NCT00530335|65872936|FG000|Overall Study|Protocol Violation|1|||
23585937|NCT00530335|65872936|FG000|Overall Study|Withdrawal by Subject|1|||
23585938|NCT00530335|65872936|FG000|Overall Study|Physician Decision|1|||
23351009|NCT01618916|65029447|FG000|Overall Study|Lost to Follow-up|1|||
23244073|NCT00816166|64638761|FG001|Overall Study|Lost to Follow-up|10|||
23244074|NCT00816166|64638760|FG000|Overall Study|Death|4|||
23244075|NCT00816166|64638761|FG001|Overall Study|Death|2|||
23244076|NCT04513665|64638767|FG000|Overall Study|Adverse Event|2|||
23351010|NCT01618916|65029448|FG001|Overall Study|Lost to Follow-up|0|||
23351011|NCT01618916|65029449|FG002|Overall Study|Lost to Follow-up|0|||
23585939|NCT01664104|65872945|FG000|Overall Study|Adverse Event|6|||
23585940|NCT01664104|65872945|FG000|Overall Study|Lack of Efficacy|2|||
23585941|NCT01664104|65872945|FG000|Overall Study|Withdrawal by Subject|1|||
23585942|NCT01664104|65872945|FG000|Overall Study|Lost to Follow-up|4|||
23585943|NCT01664104|65872945|FG000|Overall Study|Other|1|||
23585944|NCT01664104|65872945|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
23585945|NCT03140176|65872948|FG000|Overall Study|Reason missing|23|||
23585946|NCT03140176|65872948|FG000|Overall Study|Death|33|||
23585947|NCT03140176|65872948|FG000|Overall Study|Disease progression|1|||
23585948|NCT03140176|65872948|FG000|Overall Study|Physician Decision|1|||
23585949|NCT03140176|65872948|FG000|Overall Study|Withdrawal by Subject|1|||
23585950|NCT03140176|65872948|FG000|Overall Study|Lost to Follow-up|15|||
23585951|NCT03158948|65872949|FG000|Overall Study|Death|1|||
23585952|NCT03158948|65872950|FG001|Overall Study|Death|1|||
23585953|NCT03158948|65872951|FG002|Overall Study|Death|3|||
23585954|NCT03158948|65872952|FG003|Overall Study|Death|2|||
23585955|NCT03158948|65872949|FG000|Overall Study|Physician Decision|0|||
23585956|NCT03158948|65872950|FG001|Overall Study|Physician Decision|0|||
23585957|NCT03158948|65872951|FG002|Overall Study|Physician Decision|0|||
23585958|NCT03158948|65872952|FG003|Overall Study|Physician Decision|1|||
23585959|NCT01167426|65872953|FG000|Overall Study|Lost to Follow-up|6|||
23585960|NCT01167426|65872953|FG000|Overall Study|Protocol Violation|1|||
23585961|NCT01167426|65872953|FG000|Overall Study|Withdrawal by Subject|2|||
23585962|NCT01167426|65872953|FG000|Overall Study|Sponsor Decision|1|||
23585963|NCT02046616|65872954|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
23585964|NCT02046616|65872954|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
23585965|NCT02046616|65872954|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
23585966|NCT02046616|65872954|FG000|24-Week Treatment Period|Physician Decision|3|||
23585967|NCT02046616|65872954|FG000|24-Week Treatment Period|Other|1|||
23585968|NCT02046616|65872954|FG000|8-Week FU Period|Lost to Follow-up|1|||
23585969|NCT03098030|65872955|FG000|Overall Study|Death|10|||
23585970|NCT03098030|65872956|FG001|Overall Study|Death|156|||
23585971|NCT03098030|65872957|FG002|Overall Study|Death|156|||
23585972|NCT03098030|65872958|FG003|Overall Study|Death|82|||
23585973|NCT03098030|65872955|FG000|Overall Study|Withdrawal by Subject|0|||
23585974|NCT03098030|65872956|FG001|Overall Study|Withdrawal by Subject|7|||
23585975|NCT03098030|65872957|FG002|Overall Study|Withdrawal by Subject|8|||
23244077|NCT04513665|64638768|FG001|Overall Study|Adverse Event|0|||
23351012|NCT01618916|65029450|FG003|Overall Study|Lost to Follow-up|2|||
23351013|NCT01618916|65029451|FG004|Overall Study|Lost to Follow-up|0|||
23351014|NCT01618916|65029452|FG005|Overall Study|Lost to Follow-up|0|||
23351015|NCT04093492|65029453|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
23351016|NCT04093492|65029454|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
23351017|NCT04093492|65029455|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
23351018|NCT04093492|65029456|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
23351019|NCT04093492|65029453|FG000|25 Weeks Gestational Age (GA)|No response|5|||
23351020|NCT04093492|65029454|FG001|25 Weeks Gestational Age (GA)|No response|5|||
23351021|NCT04093492|65029455|FG002|25 Weeks Gestational Age (GA)|No response|5|||
23351022|NCT04093492|65029456|FG003|25 Weeks Gestational Age (GA)|No response|2|||
23351023|NCT04093492|65029453|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
23351024|NCT04093492|65029454|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
23351025|NCT04093492|65029455|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
23351026|NCT04093492|65029456|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
23351027|NCT04093492|65029453|FG000|30 Weeks GA|Delivered before assessment|1|||
23351028|NCT04093492|65029454|FG001|30 Weeks GA|Delivered before assessment|2|||
23465994|NCT00658359|65448241|FG001|Overall Study|Withdrawal by Subject|4|||
23585976|NCT03098030|65872958|FG003|Overall Study|Withdrawal by Subject|2|||
23585977|NCT03098030|65872955|FG000|Overall Study|Lost to Follow-up|0|||
23351029|NCT04093492|65029455|FG002|30 Weeks GA|Delivered before assessment|0|||
23244078|NCT04513665|64638767|FG000|Overall Study|Lack of Efficacy|14|||
23585978|NCT03098030|65872956|FG001|Overall Study|Lost to Follow-up|0|||
23585979|NCT03098030|65872957|FG002|Overall Study|Lost to Follow-up|2|||
23585980|NCT03098030|65872958|FG003|Overall Study|Lost to Follow-up|1|||
23585981|NCT02784704|65872959|FG000|Overall Study|Adverse Event|4|||
23244079|NCT04513665|64638768|FG001|Overall Study|Lack of Efficacy|0|||
23244080|NCT02297438|64638769|FG000|Overall Study|Death|79|||
23585982|NCT02784704|65872960|FG001|Overall Study|Adverse Event|2|||
23585983|NCT02784704|65872959|FG000|Overall Study|Lost to Follow-up|6|||
23585984|NCT02784704|65872960|FG001|Overall Study|Lost to Follow-up|4|||
23244081|NCT02297438|64638770|FG001|Overall Study|Death|86|||
23244082|NCT02297438|64638769|FG000|Overall Study|Lost to Follow-up|9|||
23244083|NCT02297438|64638770|FG001|Overall Study|Lost to Follow-up|7|||
23244084|NCT02297438|64638769|FG000|Overall Study|Withdrawal by Subject|7|||
23244085|NCT02297438|64638770|FG001|Overall Study|Withdrawal by Subject|0|||
23244086|NCT02297438|64638769|FG000|Overall Study|Other|9|||
23244087|NCT02297438|64638770|FG001|Overall Study|Other|5|||
23244088|NCT02297438|64638769|FG000|Overall Study|Ongoing|65|||
23244089|NCT02297438|64638770|FG001|Overall Study|Ongoing|73|||
23244090|NCT04505592|64638771|FG000|Overall Study|Death|2|||
23244091|NCT04505592|64638772|FG001|Overall Study|Death|1|||
23244092|NCT00337727|64638773|FG000|Overall Study|Adverse Event|5|||
23244093|NCT00337727|64638774|FG001|Overall Study|Adverse Event|3|||
23244094|NCT00337727|64638773|FG000|Overall Study|Lost to Follow-up|5|||
23244095|NCT00337727|64638774|FG001|Overall Study|Lost to Follow-up|4|||
23244096|NCT00337727|64638773|FG000|Overall Study|Physician Decision|1|||
23244097|NCT00337727|64638774|FG001|Overall Study|Physician Decision|0|||
23244098|NCT00337727|64638773|FG000|Overall Study|Protocol Violation|4|||
23244099|NCT00337727|64638774|FG001|Overall Study|Protocol Violation|0|||
23244100|NCT00337727|64638773|FG000|Overall Study|Withdrawal by Subject|3|||
23244101|NCT00337727|64638774|FG001|Overall Study|Withdrawal by Subject|5|||
23244102|NCT02860039|64638775|FG000|Overall Study|Death|4|||
23244103|NCT02860039|64638776|FG001|Overall Study|Death|0|||
23244104|NCT02860039|64638775|FG000|Overall Study|Lost to Follow-up|2|||
23244105|NCT02860039|64638776|FG001|Overall Study|Lost to Follow-up|2|||
23244106|NCT02860039|64638775|FG000|Overall Study|Protocol Violation|3|||
23244107|NCT02860039|64638776|FG001|Overall Study|Protocol Violation|1|||
23244108|NCT02860039|64638775|FG000|Overall Study|Withdrawal by Subject|1|||
23244109|NCT02860039|64638776|FG001|Overall Study|Withdrawal by Subject|0|||
23244110|NCT02860039|64638775|FG000|Overall Study|Not otherwise eligible|1|||
23244111|NCT02860039|64638776|FG001|Overall Study|Not otherwise eligible|1|||
23244112|NCT05168657|64638777|FG000|Overall Study|Adverse Event|0|||
23244113|NCT05168657|64638778|FG001|Overall Study|Adverse Event|0|||
23244114|NCT05168657|64638779|FG002|Overall Study|Adverse Event|1|||
23244115|NCT05168657|64638780|FG003|Overall Study|Adverse Event|0|||
23244116|NCT05168657|64638781|FG004|Overall Study|Adverse Event|0|||
23244117|NCT05168657|64638782|FG005|Overall Study|Adverse Event|0|||
23244118|NCT05168657|64638783|FG006|Overall Study|Adverse Event|0|||
23244119|NCT05168657|64638784|FG007|Overall Study|Adverse Event|0|||
23244120|NCT03387423|64638785|FG000|Overall Study|Lost to Follow-up|16|||
23244121|NCT03387423|64638786|FG001|Overall Study|Lost to Follow-up|12|||
23244122|NCT03387423|64638787|FG002|Overall Study|Lost to Follow-up|1|||
23244123|NCT03387423|64638788|FG003|Overall Study|Lost to Follow-up|0|||
23244124|NCT03387423|64638785|FG000|Overall Study|Other|0|||
23244125|NCT03387423|64638786|FG001|Overall Study|Other|3|||
23244126|NCT03387423|64638787|FG002|Overall Study|Other|0|||
23244127|NCT03387423|64638788|FG003|Overall Study|Other|0|||
23244128|NCT03387423|64638785|FG000|Overall Study|Administrative Reason|166|||
23244129|NCT03387423|64638786|FG001|Overall Study|Administrative Reason|89|||
23244130|NCT03387423|64638787|FG002|Overall Study|Administrative Reason|17|||
23244131|NCT03387423|64638788|FG003|Overall Study|Administrative Reason|19|||
23244132|NCT03387423|64638785|FG000|Overall Study|Revocation Consent|76|||
23244133|NCT03387423|64638786|FG001|Overall Study|Revocation Consent|32|||
23244134|NCT03387423|64638787|FG002|Overall Study|Revocation Consent|3|||
23244135|NCT03387423|64638788|FG003|Overall Study|Revocation Consent|5|||
23244136|NCT03958045|64638789|FG000|Overall Study|Withdrawal by Subject|1|||
23585985|NCT02784704|65872959|FG000|Overall Study|Withdrawal by Subject|1|||
23585986|NCT02784704|65872960|FG001|Overall Study|Withdrawal by Subject|3|||
23585987|NCT02784704|65872959|FG000|Overall Study|Subject Non Compliance|2|||
23585988|NCT02784704|65872960|FG001|Overall Study|Subject Non Compliance|0|||
23585989|NCT04716933|65872961|FG000|Overall Study|Ongoing|46|||
23351030|NCT04093492|65029456|FG003|30 Weeks GA|Delivered before assessment|0|||
23351031|NCT04093492|65029453|FG000|30 Weeks GA|No response|7|||
23585990|NCT04716933|65872962|FG001|Overall Study|Ongoing|37|||
23585991|NCT04716933|65872961|FG000|Overall Study|Sponsor Decision|55|||
23585992|NCT04716933|65872962|FG001|Overall Study|Sponsor Decision|63|||
23585993|NCT04088188|65872964|FG000|Overall Study|Withdrawal by Subject|2|||
23585994|NCT04088188|65872965|FG001|Overall Study|Withdrawal by Subject|0|||
23585995|NCT04088188|65872964|FG000|Overall Study|Adverse Event|2|||
23585996|NCT04088188|65872965|FG001|Overall Study|Adverse Event|0|||
23585997|NCT00837616|65872968|FG000|Overall Study|Withdrawal by Subject|0|||
23585998|NCT00837616|65872969|FG001|Overall Study|Withdrawal by Subject|1|||
23585999|NCT00938340|65872976|FG000|Overall Study|Withdrawal by Subject|3|||
23586000|NCT00938340|65872976|FG000|Overall Study|Protocol Violation|1|||
23586001|NCT00938340|65872976|FG000|Overall Study|Adverse Event|1|||
23586002|NCT00425503|65872977|FG000|Overall Study|Adverse Event|2|||
23586003|NCT00425503|65872977|FG000|Overall Study|Protocol Violation|1|||
23586004|NCT00506519|65872980|FG000|Overall Study|Death|4|||
23244157|NCT03843775|64638792|FG000|Overall Study|Adverse Event|1|||
23244158|NCT03843775|64638793|FG001|Overall Study|Adverse Event|1|||
23244159|NCT03843775|64638792|FG000|Overall Study|Lack of Efficacy|2|||
23586005|NCT00506519|65872981|FG001|Overall Study|Death|6|||
23586006|NCT00506519|65872982|FG002|Overall Study|Death|0|||
23586007|NCT00506519|65872980|FG000|Overall Study|Adverse Event|1|||
23586008|NCT00506519|65872981|FG001|Overall Study|Adverse Event|0|||
23185759|NCT01903876|64420451|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
23185760|NCT01903876|64420452|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
23185761|NCT01903876|64420451|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
23185762|NCT01903876|64420452|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
23185763|NCT04927312|64420454|FG000|Overall Study|Adverse Event|1|||
23185764|NCT04927312|64420454|FG000|Overall Study|Death|1|||
23185765|NCT04927312|64420454|FG000|Overall Study|Withdrawal by Subject|1|||
23185766|NCT04927312|64420454|FG000|Overall Study|Other|1|||
23244160|NCT03843775|64638793|FG001|Overall Study|Lack of Efficacy|6|||
23244161|NCT03843775|64638792|FG000|Overall Study|Withdrawal by Subject|0|||
23185767|NCT02612909|64420457|FG000|Phase 2|Withdrawal by Subject|2|||
23185768|NCT02612909|64420458|FG001|Phase 2|Withdrawal by Subject|5|||
23244162|NCT03843775|64638793|FG001|Overall Study|Withdrawal by Subject|1|||
23244163|NCT03728257|64638794|FG000|Overall Study|Death|3|||
23244164|NCT03728257|64638795|FG001|Overall Study|Death|0|||
23244165|NCT04964960|64638796|FG000|Overall Study|Withdrawal by Subject|1|||
23244166|NCT03092674|64638797|FG000|Overall Study|Adverse Event or Side Effects|1|||
23244167|NCT03092674|64638798|FG001|Overall Study|Adverse Event or Side Effects|4|||
23244168|NCT03092674|64638799|FG002|Overall Study|Adverse Event or Side Effects|4|||
23244169|NCT03092674|64638797|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
23244170|NCT03092674|64638798|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
23244171|NCT03092674|64638799|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
23244172|NCT03092674|64638797|FG000|Overall Study|Progression/Relapse|5|||
23244173|NCT03092674|64638798|FG001|Overall Study|Progression/Relapse|4|||
23244174|NCT03092674|64638799|FG002|Overall Study|Progression/Relapse|8|||
23244175|NCT03092674|64638797|FG000|Overall Study|Death|4|||
23244176|NCT03092674|64638798|FG001|Overall Study|Death|8|||
23244177|NCT03092674|64638799|FG002|Overall Study|Death|2|||
23244178|NCT03092674|64638797|FG000|Overall Study|Other - Not Protocol Specified|11|||
23244179|NCT03092674|64638798|FG001|Overall Study|Other - Not Protocol Specified|8|||
23244180|NCT03092674|64638799|FG002|Overall Study|Other - Not Protocol Specified|8|||
23244181|NCT01946204|64638800|FG000|Overall Study|Death|38|||
23244182|NCT01946204|64638801|FG001|Overall Study|Death|59|||
23244183|NCT01946204|64638800|FG000|Overall Study|Withdrawal by Subject|37|||
23244184|NCT01946204|64638801|FG001|Overall Study|Withdrawal by Subject|50|||
23244185|NCT01946204|64638800|FG000|Overall Study|Lost to Follow-up|3|||
23244186|NCT01946204|64638801|FG001|Overall Study|Lost to Follow-up|7|||
23244187|NCT01946204|64638800|FG000|Overall Study|Ongoing|316|||
23244188|NCT01946204|64638801|FG001|Overall Study|Ongoing|687|||
23244189|NCT01946204|64638800|FG000|Overall Study|Other|7|||
23244190|NCT01946204|64638801|FG001|Overall Study|Other|3|||
23244191|NCT03375320|64638802|FG000|Overall Study|Adverse Event|34|||
23244192|NCT03375320|64638803|FG001|Overall Study|Adverse Event|9|||
23244193|NCT03375320|64638804|FG002|Overall Study|Adverse Event|10|||
23244194|NCT03375320|64638805|FG003|Overall Study|Adverse Event|0|||
23244195|NCT03375320|64638802|FG000|Overall Study|Death|6|||
23244196|NCT03375320|64638803|FG001|Overall Study|Death|3|||
23244197|NCT03375320|64638804|FG002|Overall Study|Death|0|||
23244198|NCT03375320|64638805|FG003|Overall Study|Death|0|||
23244199|NCT03375320|64638802|FG000|Overall Study|Withdrawal by Subject|7|||
23244200|NCT03375320|64638803|FG001|Overall Study|Withdrawal by Subject|4|||
23244201|NCT03375320|64638804|FG002|Overall Study|Withdrawal by Subject|5|||
23244202|NCT03375320|64638805|FG003|Overall Study|Withdrawal by Subject|4|||
23244203|NCT03375320|64638802|FG000|Overall Study|Progressive disease|55|||
23244204|NCT03375320|64638803|FG001|Overall Study|Progressive disease|41|||
23244205|NCT03375320|64638804|FG002|Overall Study|Progressive disease|29|||
23244206|NCT03375320|64638805|FG003|Overall Study|Progressive disease|24|||
23244207|NCT03375320|64638802|FG000|Overall Study|Alternative treatment|6|||
23244208|NCT03375320|64638803|FG001|Overall Study|Alternative treatment|1|||
23586009|NCT00506519|65872982|FG002|Overall Study|Adverse Event|0|||
23185769|NCT02612909|64420459|FG002|Phase 2|Withdrawal by Subject|0|||
23185770|NCT02612909|64420460|FG003|Phase 2|Withdrawal by Subject|0|||
23244209|NCT03375320|64638804|FG002|Overall Study|Alternative treatment|1|||
23244210|NCT03375320|64638805|FG003|Overall Study|Alternative treatment|0|||
23244211|NCT03375320|64638802|FG000|Overall Study|Other disease|1|||
23244212|NCT03375320|64638803|FG001|Overall Study|Other disease|1|||
23244213|NCT03375320|64638804|FG002|Overall Study|Other disease|3|||
23244214|NCT03375320|64638805|FG003|Overall Study|Other disease|0|||
23244215|NCT03375320|64638802|FG000|Overall Study|Withdrawal prior to initiation|2|||
23244216|NCT03375320|64638803|FG001|Overall Study|Withdrawal prior to initiation|2|||
23244217|NCT03375320|64638804|FG002|Overall Study|Withdrawal prior to initiation|1|||
23244218|NCT03375320|64638805|FG003|Overall Study|Withdrawal prior to initiation|0|||
23244219|NCT03375320|64638802|FG000|Overall Study|Physician Decision|1|||
23244220|NCT03375320|64638803|FG001|Overall Study|Physician Decision|1|||
23586010|NCT02013037|65872983|FG000|Overall Study|Death|6|||
23244221|NCT03375320|64638804|FG002|Overall Study|Physician Decision|1|||
23244222|NCT03375320|64638805|FG003|Overall Study|Physician Decision|1|||
23244223|NCT03375320|64638802|FG000|Overall Study|Non-compliance|1|||
23244224|NCT03375320|64638803|FG001|Overall Study|Non-compliance|0|||
23244225|NCT03375320|64638804|FG002|Overall Study|Non-compliance|0|||
23244226|NCT03375320|64638805|FG003|Overall Study|Non-compliance|0|||
23244227|NCT00433511|64638809|FG000|Step 1|Adverse Event|50|||
23244228|NCT00433511|64638810|FG001|Step 1|Adverse Event|157|||
23244229|NCT00433511|64638811|FG002|Step 1|Adverse Event|153|||
23465995|NCT00658359|65448242|FG002|Overall Study|Withdrawal by Subject|2|||
23465996|NCT00658359|65448240|FG000|Overall Study|Lost to Follow-up|2|||
23465997|NCT00658359|65448241|FG001|Overall Study|Lost to Follow-up|2|||
23465998|NCT00658359|65448242|FG002|Overall Study|Lost to Follow-up|4|||
23465999|NCT00658359|65448240|FG000|Overall Study|Lack of Efficacy|0|||
23466000|NCT00658359|65448241|FG001|Overall Study|Lack of Efficacy|1|||
23466001|NCT00658359|65448242|FG002|Overall Study|Lack of Efficacy|0|||
23466002|NCT02362282|65448243|FG000|Overall Study|Withdrawal by Subject|1|||
23466003|NCT02362282|65448244|FG001|Overall Study|Withdrawal by Subject|0|||
23244230|NCT00433511|64638809|FG000|Step 1|Withdrawal by Subject|45|||
23185771|NCT02612909|64420461|FG004|Phase 2|Withdrawal by Subject|0|||
23185772|NCT02612909|64420457|FG000|Phase 2|Pregnancy|0|||
23185773|NCT02612909|64420458|FG001|Phase 2|Pregnancy|0|||
23185774|NCT02612909|64420459|FG002|Phase 2|Pregnancy|1|||
23185775|NCT02612909|64420460|FG003|Phase 2|Pregnancy|0|||
23185776|NCT02612909|64420461|FG004|Phase 2|Pregnancy|0|||
23185777|NCT02612909|64420457|FG000|Phase 3|Withdrawal by Subject|0|||
23185778|NCT02612909|64420458|FG001|Phase 3|Withdrawal by Subject|0|||
23185779|NCT02612909|64420459|FG002|Phase 3|Withdrawal by Subject|0|||
23185780|NCT02612909|64420460|FG003|Phase 3|Withdrawal by Subject|1|||
23185781|NCT02612909|64420461|FG004|Phase 3|Withdrawal by Subject|0|||
23244231|NCT00433511|64638810|FG001|Step 1|Withdrawal by Subject|143|||
23244232|NCT00433511|64638811|FG002|Step 1|Withdrawal by Subject|154|||
23466004|NCT00297258|65448245|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
23466005|NCT00297258|65448245|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
23466006|NCT00297258|65448245|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
23466007|NCT00297258|65448245|FG000|Overall Study|Intercurrent Illness|3|||
23466008|NCT00297258|65448245|FG000|Overall Study|Intercurrent Death|2|||
23466009|NCT00297258|65448245|FG000|Overall Study|Deteriorization of General Condition|1|||
23466010|NCT00297258|65448245|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
23466011|NCT00297258|65448245|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
23466012|NCT00297258|65448245|FG000|Overall Study|Switch to Commercial Treatment|1|||
23466013|NCT00297258|65448245|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
23466014|NCT01656408|65448249|FG000|Overall Study|Adverse Event|0|||
23466015|NCT01656408|65448250|FG001|Overall Study|Adverse Event|0|||
23466016|NCT01656408|65448251|FG002|Overall Study|Adverse Event|1|||
23466017|NCT01656408|65448252|FG003|Overall Study|Adverse Event|0|||
23466018|NCT01656408|65448253|FG004|Overall Study|Adverse Event|0|||
23466019|NCT01656408|65448254|FG005|Overall Study|Adverse Event|1|||
23466020|NCT01656408|65448255|FG006|Overall Study|Adverse Event|1|||
23466021|NCT01656408|65448256|FG007|Overall Study|Adverse Event|0|||
23466022|NCT01656408|65448257|FG008|Overall Study|Adverse Event|1|||
23244233|NCT00433511|64638809|FG000|Step 1|Death|3|||
23244234|NCT00433511|64638810|FG001|Step 1|Death|1|||
23244235|NCT00433511|64638811|FG002|Step 1|Death|1|||
23244236|NCT00433511|64638809|FG000|Step 1|Physician Decision|1|||
23244237|NCT00433511|64638810|FG001|Step 1|Physician Decision|4|||
23244238|NCT00433511|64638811|FG002|Step 1|Physician Decision|3|||
23244239|NCT00433511|64638809|FG000|Step 1|Never started protocol therapy|28|||
23244240|NCT00433511|64638810|FG001|Step 1|Never started protocol therapy|64|||
23244241|NCT00433511|64638811|FG002|Step 1|Never started protocol therapy|66|||
23244242|NCT00433511|64638809|FG000|Step 1|Alternative therapy|2|||
23244243|NCT00433511|64638810|FG001|Step 1|Alternative therapy|1|||
23244244|NCT00433511|64638811|FG002|Step 1|Alternative therapy|3|||
23185782|NCT00613626|64420462|FG000|Overall Study|Ineligible|0|||
23244245|NCT00433511|64638809|FG000|Step 1|Disease progression, relapse|5|||
23244246|NCT00433511|64638810|FG001|Step 1|Disease progression, relapse|3|||
23244247|NCT00433511|64638811|FG002|Step 1|Disease progression, relapse|3|||
23466023|NCT01656408|65448258|FG009|Overall Study|Adverse Event|0|||
23466024|NCT01656408|65448249|FG000|Overall Study|Physician Decision|1|||
23185783|NCT00613626|64420463|FG001|Overall Study|Ineligible|1|||
23185784|NCT00613626|64420464|FG002|Overall Study|Ineligible|0|||
23244248|NCT00433511|64638809|FG000|Step 1|Other complicating disease|2|||
23244249|NCT00433511|64638810|FG001|Step 1|Other complicating disease|6|||
23244250|NCT00433511|64638811|FG002|Step 1|Other complicating disease|3|||
23244251|NCT00433511|64638809|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
23466025|NCT01656408|65448250|FG001|Overall Study|Physician Decision|0|||
23466026|NCT01656408|65448251|FG002|Overall Study|Physician Decision|1|||
23466027|NCT01656408|65448252|FG003|Overall Study|Physician Decision|0|||
23466028|NCT01656408|65448253|FG004|Overall Study|Physician Decision|1|||
23466029|NCT01656408|65448254|FG005|Overall Study|Physician Decision|1|||
23466030|NCT01656408|65448255|FG006|Overall Study|Physician Decision|0|||
23466031|NCT01656408|65448256|FG007|Overall Study|Physician Decision|1|||
23466032|NCT01656408|65448257|FG008|Overall Study|Physician Decision|1|||
23185785|NCT01217606|64420465|FG000|Initial Treatment Phase|Other Reasons|0|||
23185786|NCT01217606|64420466|FG001|Initial Treatment Phase|Other Reasons|2|||
23185787|NCT01217606|64420465|FG000|Initial Treatment Phase|Protocol Violation|3|||
23185788|NCT01217606|64420466|FG001|Initial Treatment Phase|Protocol Violation|2|||
23185789|NCT01217606|64420465|FG000|Initial Treatment Phase|Personal Reasons|0|||
23185790|NCT01217606|64420466|FG001|Initial Treatment Phase|Personal Reasons|2|||
23185791|NCT01217606|64420465|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
23185792|NCT01217606|64420466|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
23185793|NCT01217606|64420465|FG000|Initial Treatment Phase|Adverse Event|10|||
23185794|NCT01217606|64420466|FG001|Initial Treatment Phase|Adverse Event|6|||
23185795|NCT01217606|64420465|FG000|9-Month Masked Extension|Adverse Event|3|||
23185796|NCT01217606|64420466|FG001|9-Month Masked Extension|Adverse Event|6|||
23185797|NCT01217606|64420465|FG000|9-Month Masked Extension|Other Reasons|4|||
23185798|NCT01217606|64420466|FG001|9-Month Masked Extension|Other Reasons|4|||
23244252|NCT00433511|64638810|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
23244253|NCT00433511|64638811|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
23351032|NCT04093492|65029454|FG001|30 Weeks GA|No response|5|||
23351033|NCT04093492|65029455|FG002|30 Weeks GA|No response|5|||
23351034|NCT04093492|65029456|FG003|30 Weeks GA|No response|2|||
23351035|NCT04093492|65029453|FG000|30 Weeks GA|Lost to Follow-up|0|||
23351036|NCT04093492|65029454|FG001|30 Weeks GA|Lost to Follow-up|1|||
23466033|NCT01656408|65448258|FG009|Overall Study|Physician Decision|3|||
23466034|NCT01083771|65448269|FG000|Overall Study|non-compliant|2|||
23466035|NCT01083771|65448269|FG000|Overall Study|Withdrawal by Subject|3|||
23466036|NCT03809104|65448271|FG000|Overall Study|Withdrawal by Subject|3|||
23466037|NCT00942604|65448272|FG000|Overall Study|Protocol Violation|1|||
23466038|NCT00942604|65448273|FG001|Overall Study|Protocol Violation|1|||
23466039|NCT00942604|65448272|FG000|Overall Study|Adverse Event|0|||
23466040|NCT00942604|65448273|FG001|Overall Study|Adverse Event|1|||
23466041|NCT00942604|65448272|FG000|Overall Study|Withdrawal by Subject|0|||
23466042|NCT00942604|65448273|FG001|Overall Study|Withdrawal by Subject|1|||
23466043|NCT00942604|65448272|FG000|Overall Study|Patient relocation|1|||
23466044|NCT00942604|65448273|FG001|Overall Study|Patient relocation|1|||
23466045|NCT03040336|65448281|FG000|Overall Study|Death|1|||
23351037|NCT04093492|65029455|FG002|30 Weeks GA|Lost to Follow-up|0|||
23351038|NCT04093492|65029456|FG003|30 Weeks GA|Lost to Follow-up|0|||
23351039|NCT04093492|65029453|FG000|34 Weeks GA|Delivered before assessment|6|||
23466046|NCT03040336|65448282|FG001|Overall Study|Death|0|||
23466047|NCT03040336|65448281|FG000|Overall Study|Withdrawal by Subject|2|||
23466048|NCT03040336|65448282|FG001|Overall Study|Withdrawal by Subject|3|||
23466049|NCT00807001|65448283|FG000|Overall Study|Non-compliance|0|||
23466050|NCT00807001|65448284|FG001|Overall Study|Non-compliance|1|||
23466051|NCT00807001|65448285|FG002|Overall Study|Non-compliance|0|||
23466052|NCT00807001|65448286|FG003|Overall Study|Non-compliance|0|||
23466053|NCT00807001|65448287|FG004|Overall Study|Non-compliance|0|||
23466054|NCT01702311|65448288|FG000|Overall Study|Withdrawal by Subject|3|||
23466055|NCT01702311|65448289|FG001|Overall Study|Withdrawal by Subject|2|||
23466056|NCT01702311|65448288|FG000|Overall Study|Discharge less than 24 hours|10|||
23466057|NCT01702311|65448289|FG001|Overall Study|Discharge less than 24 hours|7|||
23466058|NCT01702311|65448288|FG000|Overall Study|Physician Decision|3|||
23466059|NCT01702311|65448289|FG001|Overall Study|Physician Decision|4|||
23466060|NCT00472030|65448290|FG000|Overall Study|Physician Decision|1|||
23466061|NCT00472030|65448291|FG001|Overall Study|Physician Decision|0|||
23185799|NCT01217606|64420465|FG000|9-Month Masked Extension|Personal Reasons|2|||
23244254|NCT00433511|64638809|FG000|Step 1|Suspected recurrence|0|||
23244255|NCT00433511|64638810|FG001|Step 1|Suspected recurrence|1|||
23244256|NCT00433511|64638811|FG002|Step 1|Suspected recurrence|0|||
23244257|NCT00433511|64638809|FG000|Step 1|Insurance/drug distribution issues|0|||
23244258|NCT00433511|64638810|FG001|Step 1|Insurance/drug distribution issues|1|||
23244259|NCT00433511|64638811|FG002|Step 1|Insurance/drug distribution issues|2|||
23244260|NCT00433511|64638809|FG000|Step 1|Patient moved|0|||
23244261|NCT00433511|64638810|FG001|Step 1|Patient moved|0|||
23244262|NCT00433511|64638811|FG002|Step 1|Patient moved|1|||
23351040|NCT04093492|65029454|FG001|34 Weeks GA|Delivered before assessment|3|||
23466062|NCT01995838|65448293|FG000|Overall Study|Lost to Follow-up|0|||
23466063|NCT01995838|65448294|FG001|Overall Study|Lost to Follow-up|1|||
23466064|NCT01995838|65448295|FG002|Overall Study|Lost to Follow-up|0|||
23466065|NCT01995838|65448296|FG003|Overall Study|Lost to Follow-up|0|||
23466066|NCT01995838|65448297|FG004|Overall Study|Lost to Follow-up|0|||
23466067|NCT01995838|65448298|FG005|Overall Study|Lost to Follow-up|0|||
23466068|NCT01995838|65448299|FG006|Overall Study|Lost to Follow-up|1|||
23466069|NCT01995838|65448293|FG000|Overall Study|Participant choice|2|||
23466070|NCT01995838|65448294|FG001|Overall Study|Participant choice|0|||
23466071|NCT01995838|65448295|FG002|Overall Study|Participant choice|0|||
23466072|NCT01995838|65448296|FG003|Overall Study|Participant choice|0|||
23466073|NCT01995838|65448297|FG004|Overall Study|Participant choice|0|||
23466074|NCT01995838|65448298|FG005|Overall Study|Participant choice|1|||
23466075|NCT01995838|65448299|FG006|Overall Study|Participant choice|1|||
23466076|NCT01995838|65448293|FG000|Overall Study|Adverse Event|0|||
23466077|NCT01995838|65448294|FG001|Overall Study|Adverse Event|0|||
23466078|NCT01995838|65448295|FG002|Overall Study|Adverse Event|0|||
23466079|NCT01995838|65448296|FG003|Overall Study|Adverse Event|0|||
23466080|NCT01995838|65448297|FG004|Overall Study|Adverse Event|0|||
23466081|NCT01995838|65448298|FG005|Overall Study|Adverse Event|0|||
23466082|NCT01995838|65448299|FG006|Overall Study|Adverse Event|1|||
23466083|NCT01995838|65448293|FG000|Overall Study|Withdrawal by Subject|0|||
23466084|NCT01995838|65448294|FG001|Overall Study|Withdrawal by Subject|0|||
23466085|NCT01995838|65448295|FG002|Overall Study|Withdrawal by Subject|0|||
23466086|NCT01995838|65448296|FG003|Overall Study|Withdrawal by Subject|0|||
23466087|NCT01995838|65448297|FG004|Overall Study|Withdrawal by Subject|1|||
23466088|NCT01995838|65448298|FG005|Overall Study|Withdrawal by Subject|0|||
23466089|NCT01995838|65448299|FG006|Overall Study|Withdrawal by Subject|0|||
23466090|NCT01995838|65448293|FG000|Overall Study|Other|3|||
23466091|NCT01995838|65448294|FG001|Overall Study|Other|1|||
23466092|NCT01995838|65448295|FG002|Overall Study|Other|0|||
23466093|NCT01995838|65448296|FG003|Overall Study|Other|2|||
23466094|NCT01995838|65448297|FG004|Overall Study|Other|1|||
23466095|NCT01995838|65448298|FG005|Overall Study|Other|1|||
23466096|NCT01995838|65448299|FG006|Overall Study|Other|2|||
23466097|NCT04953728|65448302|FG000|Overall Study|Withdrawal by Subject|3|||
23466098|NCT04953728|65448302|FG000|Overall Study|Physician Decision|1|||
23466099|NCT02754440|65448303|FG000|Overall Study|Protocol Violation|3|||
23466100|NCT02754440|65448304|FG001|Overall Study|Protocol Violation|2|||
23466101|NCT02754440|65448305|FG002|Overall Study|Protocol Violation|2|||
23466102|NCT02754440|65448306|FG003|Overall Study|Protocol Violation|6|||
23466103|NCT02754440|65448303|FG000|Overall Study|Adverse Event|3|||
23466104|NCT02754440|65448304|FG001|Overall Study|Adverse Event|1|||
23466105|NCT02754440|65448305|FG002|Overall Study|Adverse Event|0|||
23466106|NCT02754440|65448306|FG003|Overall Study|Adverse Event|9|||
23466107|NCT02754440|65448303|FG000|Overall Study|Withdrawal by Subject|0|||
23466108|NCT02754440|65448304|FG001|Overall Study|Withdrawal by Subject|0|||
23466109|NCT02754440|65448305|FG002|Overall Study|Withdrawal by Subject|0|||
23466110|NCT02754440|65448306|FG003|Overall Study|Withdrawal by Subject|1|||
23466111|NCT02754440|65448303|FG000|Overall Study|Equipment failure|0|||
23466112|NCT02754440|65448304|FG001|Overall Study|Equipment failure|5|||
23466113|NCT02754440|65448305|FG002|Overall Study|Equipment failure|5|||
23466114|NCT02754440|65448306|FG003|Overall Study|Equipment failure|7|||
23466115|NCT02754440|65448303|FG000|Overall Study|Subject issues not resulting in AE|0|||
23466116|NCT02754440|65448304|FG001|Overall Study|Subject issues not resulting in AE|0|||
23466117|NCT02754440|65448305|FG002|Overall Study|Subject issues not resulting in AE|0|||
23466118|NCT02754440|65448306|FG003|Overall Study|Subject issues not resulting in AE|12|||
23466119|NCT02170077|65448307|FG000|Overall Study|Withdrawal by Subject|3|||
23466120|NCT02170077|65448308|FG001|Overall Study|Withdrawal by Subject|4|||
23586011|NCT02013037|65872983|FG000|Overall Study|Withdrawal by Subject|1|||
23185800|NCT01217606|64420466|FG001|9-Month Masked Extension|Personal Reasons|1|||
23185801|NCT01217606|64420465|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
23185802|NCT01217606|64420466|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
23185803|NCT01217606|64420465|FG000|9-Month Masked Extension|Pregnancy|1|||
23185804|NCT01217606|64420466|FG001|9-Month Masked Extension|Pregnancy|0|||
23185805|NCT01217606|64420465|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
23185806|NCT01217606|64420466|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
23185807|NCT00816036|64420468|FG000|Overall Study|Death|47|||
23185808|NCT00816036|64420469|FG001|Overall Study|Death|28|||
23466121|NCT02170077|65448309|FG002|Overall Study|Withdrawal by Subject|2|||
23466122|NCT02170077|65448307|FG000|Overall Study|Adverse Event|4|||
23586012|NCT02013037|65872983|FG000|Overall Study|Awaiting Transplantation|7|||
23185809|NCT00816036|64420468|FG000|Overall Study|Lost to Follow-up|75|||
23185810|NCT00816036|64420469|FG001|Overall Study|Lost to Follow-up|57|||
23185811|NCT00816036|64420468|FG000|Overall Study|Withdrawal by Subject|54|||
23185812|NCT00816036|64420469|FG001|Overall Study|Withdrawal by Subject|23|||
23466123|NCT02170077|65448308|FG001|Overall Study|Adverse Event|4|||
23466124|NCT02170077|65448309|FG002|Overall Study|Adverse Event|4|||
23466125|NCT02170077|65448307|FG000|Overall Study|Lost to Follow-up|0|||
23466126|NCT02170077|65448308|FG001|Overall Study|Lost to Follow-up|1|||
23466127|NCT02170077|65448309|FG002|Overall Study|Lost to Follow-up|0|||
23466128|NCT02170077|65448307|FG000|Overall Study|Exclusion criteria|2|||
23466129|NCT02170077|65448308|FG001|Overall Study|Exclusion criteria|2|||
23466130|NCT02170077|65448309|FG002|Overall Study|Exclusion criteria|5|||
23466131|NCT02170077|65448307|FG000|Overall Study|Exacerbation of seizures|0|||
23466132|NCT02170077|65448308|FG001|Overall Study|Exacerbation of seizures|2|||
23466133|NCT02170077|65448309|FG002|Overall Study|Exacerbation of seizures|1|||
23466134|NCT01523756|65448310|FG000|Baseline Period|Adverse Event|0|||
23466135|NCT01523756|65448311|FG001|Baseline Period|Adverse Event|1|||
23466136|NCT01523756|65448310|FG000|Test Period 1|Adverse Event|1|||
23466137|NCT01523756|65448311|FG001|Test Period 1|Adverse Event|0|||
23466138|NCT01523756|65448310|FG000|Test Period 2|Withdrawal by Subject|0|||
23466139|NCT01523756|65448311|FG001|Test Period 2|Withdrawal by Subject|1|||
23466140|NCT00774566|65451966|FG000|Overall Study|Protocol Violation|18|||
23466141|NCT00774566|65451967|FG001|Overall Study|Protocol Violation|15|||
23466142|NCT03181932|65451968|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
23466143|NCT03181932|65451969|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
23466144|NCT03181932|65451968|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
23466145|NCT03181932|65451969|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
23466146|NCT03181932|65451968|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
23466147|NCT03181932|65451969|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
23466148|NCT03181932|65451968|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
23466149|NCT03181932|65451969|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
23466150|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
23466151|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
23466152|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
23466153|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
23466154|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
23466155|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
23185813|NCT03459040|64420470|FG000|Overall Study|Death|8|||
23185814|NCT03459040|64420470|FG000|Overall Study|Withdrawal by Subject|1|||
23185815|NCT05292755|64420474|FG000|Overall Study|Lost to Follow-up|5|||
23185816|NCT05292755|64420475|FG001|Overall Study|Lost to Follow-up|9|||
23185817|NCT03293654|64420476|FG000|Overall Study|Lost to Follow-up|0|||
23466156|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
23466157|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
23466158|NCT03181932|65451968|FG000|Period 2 (Open-label Period)|Reason missing|2|||
23466159|NCT03181932|65451969|FG001|Period 2 (Open-label Period)|Reason missing|0|||
23466160|NCT02640508|65451970|FG000|Overall Study|Death|19|||
23466161|NCT02640508|65451970|FG000|Overall Study|Withdrawal by Subject|8|||
23466162|NCT02640508|65451970|FG000|Overall Study|Physician Decision|1|||
23466163|NCT02640508|65451970|FG000|Overall Study|Lost to Follow-up|1|||
23466164|NCT00566696|65451971|FG000|Overall Study|Met Exclusion Criteria|2|||
23466165|NCT00566696|65451971|FG000|Overall Study|Muromonab not available|1|||
23466166|NCT00566696|65451971|FG000|Overall Study|Health Status Change|1|||
23466167|NCT00566696|65451971|FG000|Overall Study|Physician Decision|1|||
23466168|NCT00566696|65451971|FG000|Overall Study|Non-Patient Donors|37|||
23466169|NCT04421027|65451972|FG000|Treatment Period|Adverse Event|5|||
23466170|NCT04421027|65451973|FG001|Treatment Period|Adverse Event|3|||
23466171|NCT04421027|65451974|FG002|Treatment Period|Adverse Event|0|||
23466172|NCT04421027|65451975|FG003|Treatment Period|Adverse Event|0|||
23466173|NCT04421027|65451972|FG000|Treatment Period|Death|98|||
23466174|NCT04421027|65451973|FG001|Treatment Period|Death|61|||
23466175|NCT04421027|65451974|FG002|Treatment Period|Death|0|||
23466176|NCT04421027|65451975|FG003|Treatment Period|Death|0|||
23466177|NCT04421027|65451972|FG000|Treatment Period|Lost to Follow-up|22|||
23466178|NCT04421027|65451973|FG001|Treatment Period|Lost to Follow-up|20|||
23466179|NCT04421027|65451974|FG002|Treatment Period|Lost to Follow-up|0|||
23466180|NCT04421027|65451975|FG003|Treatment Period|Lost to Follow-up|0|||
23466181|NCT04421027|65451972|FG000|Treatment Period|Other-Unknown|15|||
23466182|NCT04421027|65451973|FG001|Treatment Period|Other-Unknown|9|||
23466183|NCT04421027|65451974|FG002|Treatment Period|Other-Unknown|0|||
23466184|NCT04421027|65451975|FG003|Treatment Period|Other-Unknown|0|||
23466185|NCT04421027|65451972|FG000|Treatment Period|Physician Decision|1|||
23466186|NCT04421027|65451973|FG001|Treatment Period|Physician Decision|1|||
23466187|NCT04421027|65451974|FG002|Treatment Period|Physician Decision|0|||
23466188|NCT04421027|65451975|FG003|Treatment Period|Physician Decision|0|||
23185818|NCT03293654|64420477|FG001|Overall Study|Lost to Follow-up|1|||
23185819|NCT03293654|64420478|FG002|Overall Study|Lost to Follow-up|0|||
23185820|NCT03245814|64420484|FG000|Overall Study|Lost to Follow-up|5|||
23185821|NCT03245814|64420485|FG001|Overall Study|Lost to Follow-up|8|||
23466189|NCT04421027|65451972|FG000|Treatment Period|Withdrawal by Subject|7|||
23466190|NCT04421027|65451973|FG001|Treatment Period|Withdrawal by Subject|12|||
23466191|NCT04421027|65451974|FG002|Treatment Period|Withdrawal by Subject|0|||
23466192|NCT04421027|65451975|FG003|Treatment Period|Withdrawal by Subject|0|||
23466193|NCT04421027|65451972|FG000|Treatment Period|Randomized Not Dosed|9|||
23466194|NCT04421027|65451973|FG001|Treatment Period|Randomized Not Dosed|14|||
23466195|NCT04421027|65451974|FG002|Treatment Period|Randomized Not Dosed|0|||
23466196|NCT04421027|65451975|FG003|Treatment Period|Randomized Not Dosed|0|||
23466197|NCT04421027|65451972|FG000|Follow-Up Period|Adverse Event|0|||
23466198|NCT04421027|65451973|FG001|Follow-Up Period|Adverse Event|0|||
23466199|NCT04421027|65451974|FG002|Follow-Up Period|Adverse Event|0|||
23466200|NCT04421027|65451975|FG003|Follow-Up Period|Adverse Event|3|||
23466201|NCT04421027|65451972|FG000|Follow-Up Period|Death|0|||
23466202|NCT04421027|65451973|FG001|Follow-Up Period|Death|0|||
23586013|NCT02013037|65872983|FG000|Overall Study|Transplanted without DSA|2|||
23586014|NCT00984282|65872984|FG000|Double Blind Treatment|Adverse Event|40|||
23586015|NCT00984282|65872985|FG001|Double Blind Treatment|Adverse Event|6|||
23586016|NCT00984282|65872984|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
23586017|NCT00984282|65872985|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
23466203|NCT04421027|65451974|FG002|Follow-Up Period|Death|16|||
23466204|NCT04421027|65451975|FG003|Follow-Up Period|Death|17|||
23466205|NCT04421027|65451972|FG000|Follow-Up Period|Lost to Follow-up|0|||
23466206|NCT04421027|65451973|FG001|Follow-Up Period|Lost to Follow-up|0|||
23466207|NCT04421027|65451974|FG002|Follow-Up Period|Lost to Follow-up|7|||
23466208|NCT04421027|65451975|FG003|Follow-Up Period|Lost to Follow-up|7|||
23466209|NCT04421027|65451972|FG000|Follow-Up Period|Protocol Deviation|0|||
23466210|NCT04421027|65451973|FG001|Follow-Up Period|Protocol Deviation|0|||
23466211|NCT04421027|65451974|FG002|Follow-Up Period|Protocol Deviation|1|||
23466212|NCT04421027|65451975|FG003|Follow-Up Period|Protocol Deviation|0|||
23466213|NCT04421027|65451972|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
23466214|NCT04421027|65451973|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
23466215|NCT04421027|65451974|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
23466216|NCT04421027|65451975|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
23466217|NCT04421027|65451972|FG000|Follow-Up Period|Left message, participant did not call back|0|||
23466218|NCT04421027|65451973|FG001|Follow-Up Period|Left message, participant did not call back|0|||
23466219|NCT04421027|65451974|FG002|Follow-Up Period|Left message, participant did not call back|0|||
23466220|NCT04421027|65451975|FG003|Follow-Up Period|Left message, participant did not call back|1|||
23466221|NCT04421027|65451972|FG000|Follow-Up Period|Participant died|0|||
23466222|NCT04421027|65451973|FG001|Follow-Up Period|Participant died|0|||
23466223|NCT04421027|65451974|FG002|Follow-Up Period|Participant died|0|||
23466224|NCT04421027|65451975|FG003|Follow-Up Period|Participant died|1|||
23466225|NCT04421027|65451972|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
23185822|NCT03245814|64420484|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
23466226|NCT04421027|65451973|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
23466227|NCT04421027|65451974|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
23466228|NCT04421027|65451975|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
23466229|NCT01165216|65451976|FG000|Overall Study|Adverse Event|6|||
23466230|NCT01165216|65451977|FG001|Overall Study|Adverse Event|3|||
23466231|NCT01165216|65451976|FG000|Overall Study|Withdrawal by Subject|1|||
23466232|NCT01165216|65451977|FG001|Overall Study|Withdrawal by Subject|1|||
23466233|NCT01165216|65451976|FG000|Overall Study|Disease progression|1|||
23466234|NCT01165216|65451977|FG001|Overall Study|Disease progression|3|||
23466235|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
23466236|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
23466237|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Adverse Event|31|||
23466238|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Adverse Event|21|||
23466239|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
23466240|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
23466241|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
23466242|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
23466243|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
23466244|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
23466245|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
23466246|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
23466247|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Administrative problems|3|||
23466248|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Administrative problems|3|||
23466249|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Death|5|||
23466250|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Death|8|||
23466251|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Disease progression|139|||
23466252|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Disease progression|119|||
23466253|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
23466254|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
23466255|NCT00785785|65451978|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
23466256|NCT00785785|65451979|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
23466257|NCT00785785|65451978|FG000|Optional Extension Phase|Adverse Event|4|||
23466258|NCT00785785|65451979|FG001|Optional Extension Phase|Adverse Event|5|||
23586018|NCT00984282|65872984|FG000|Double Blind Treatment|Physician Decision|1|||
23586019|NCT00984282|65872985|FG001|Double Blind Treatment|Physician Decision|2|||
23586020|NCT00984282|65872984|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
23466259|NCT00785785|65451978|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
23466260|NCT00785785|65451979|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
23466261|NCT00785785|65451978|FG000|Optional Extension Phase|Lost to Follow-up|1|||
23466262|NCT00785785|65451979|FG001|Optional Extension Phase|Lost to Follow-up|0|||
23586021|NCT00984282|65872985|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
23466263|NCT00785785|65451978|FG000|Optional Extension Phase|Administrative problems|2|||
23466264|NCT00785785|65451979|FG001|Optional Extension Phase|Administrative problems|0|||
23466265|NCT00785785|65451978|FG000|Optional Extension Phase|Death|1|||
23466266|NCT00785785|65451979|FG001|Optional Extension Phase|Death|5|||
23466267|NCT00785785|65451978|FG000|Optional Extension Phase|Disease progression|22|||
23466268|NCT00785785|65451979|FG001|Optional Extension Phase|Disease progression|70|||
23466269|NCT00785785|65451978|FG000|Optional Extension Phase|Protocol deviation|0|||
23466270|NCT00785785|65451979|FG001|Optional Extension Phase|Protocol deviation|2|||
23466271|NCT00785785|65451978|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
23466272|NCT00785785|65451979|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
23466273|NCT02745119|65451980|FG000|Overall Study|Adverse Event|1|||
23466274|NCT02745119|65451981|FG001|Overall Study|Adverse Event|0|||
23466275|NCT02745119|65451982|FG002|Overall Study|Adverse Event|1|||
23466276|NCT02745119|65451983|FG003|Overall Study|Adverse Event|3|||
23466277|NCT02745119|65451980|FG000|Overall Study|Death|3|||
23466278|NCT02745119|65451981|FG001|Overall Study|Death|3|||
23466279|NCT02745119|65451982|FG002|Overall Study|Death|0|||
23586022|NCT00984282|65872984|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
23586023|NCT00984282|65872985|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
23586024|NCT00984282|65872984|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
23586025|NCT00984282|65872985|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
23244263|NCT00433511|64638809|FG000|Step 2 (Arm D)|Adverse Event|0|||
23244264|NCT00433511|64638810|FG001|Step 2 (Arm D)|Adverse Event|0|||
23244265|NCT00433511|64638811|FG002|Step 2 (Arm D)|Adverse Event|135|||
23244266|NCT00433511|64638809|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
23244267|NCT00433511|64638810|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
23244268|NCT00433511|64638811|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
23244269|NCT00433511|64638809|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
23244270|NCT00433511|64638810|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
23244271|NCT00433511|64638811|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
23244272|NCT00433511|64638809|FG000|Step 2 (Arm D)|Physician Decision|0|||
23244273|NCT00433511|64638810|FG001|Step 2 (Arm D)|Physician Decision|0|||
23244274|NCT00433511|64638811|FG002|Step 2 (Arm D)|Physician Decision|9|||
23244275|NCT00433511|64638809|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
23244276|NCT00433511|64638810|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
23244277|NCT00433511|64638811|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
23244278|NCT00433511|64638809|FG000|Step 2 (Arm D)|Other complicating disease|0|||
23244279|NCT00433511|64638810|FG001|Step 2 (Arm D)|Other complicating disease|0|||
23244280|NCT00433511|64638811|FG002|Step 2 (Arm D)|Other complicating disease|3|||
23466280|NCT02745119|65451983|FG003|Overall Study|Death|4|||
23466281|NCT02745119|65451980|FG000|Overall Study|Lost to Follow-up|0|||
23586026|NCT00984282|65872984|FG000|Double Blind Treatment|Lost to Follow-up|3|||
23586027|NCT00984282|65872985|FG001|Double Blind Treatment|Lost to Follow-up|0|||
23586028|NCT00984282|65872984|FG000|Double Blind Treatment|Death|8|||
23586029|NCT00984282|65872985|FG001|Double Blind Treatment|Death|4|||
23586030|NCT00984282|65872984|FG000|Double Blind Treatment|Not treated|0|||
23586031|NCT00984282|65872985|FG001|Double Blind Treatment|Not treated|1|||
23185823|NCT03245814|64420485|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
23185824|NCT03430310|64420488|FG000|Overall Study|Protocol Violation|2|||
23185825|NCT03430310|64420489|FG001|Overall Study|Protocol Violation|0|||
23185826|NCT03430310|64420488|FG000|Overall Study|Withdrawal by Subject|3|||
23185827|NCT03430310|64420489|FG001|Overall Study|Withdrawal by Subject|2|||
23185828|NCT03430310|64420488|FG000|Overall Study|COVID shutdown March 2020|0|||
23185829|NCT03430310|64420489|FG001|Overall Study|COVID shutdown March 2020|1|||
23185830|NCT03851510|64420490|FG000|Overall Study|Screen Fail|1|||
23185831|NCT03851510|64420490|FG000|Overall Study|Adverse Event|1|||
23185832|NCT03851510|64420490|FG000|Overall Study|Withdrawal by Subject|1|||
23185833|NCT03138564|64420491|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
23185834|NCT03138564|64420492|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
23185835|NCT03138564|64420491|FG000|Overall Study|Lost to Follow-up|16|||
23185836|NCT03138564|64420492|FG001|Overall Study|Lost to Follow-up|2|||
23185837|NCT03138564|64420491|FG000|Overall Study|Withdrawal by Subject|48|||
23185838|NCT03138564|64420492|FG001|Overall Study|Withdrawal by Subject|4|||
23185839|NCT03138564|64420491|FG000|Overall Study|No longer met eligibility criteria|2|||
23185840|NCT03138564|64420492|FG001|Overall Study|No longer met eligibility criteria|0|||
23185841|NCT03138564|64420491|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
23185842|NCT03138564|64420492|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
23185843|NCT03138564|64420491|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
23466282|NCT02745119|65451981|FG001|Overall Study|Lost to Follow-up|0|||
23466283|NCT02745119|65451982|FG002|Overall Study|Lost to Follow-up|0|||
23466284|NCT02745119|65451983|FG003|Overall Study|Lost to Follow-up|1|||
23466285|NCT02745119|65451980|FG000|Overall Study|Protocol Deviation|0|||
23466286|NCT02745119|65451981|FG001|Overall Study|Protocol Deviation|0|||
23586032|NCT00984282|65872984|FG000|Double Blind Treatment|Switched to commercial drug|6|||
23586033|NCT00984282|65872985|FG001|Double Blind Treatment|Switched to commercial drug|1|||
23586034|NCT00984282|65872984|FG000|Double Blind Treatment|protocol driven decision point|1|||
23586035|NCT00984282|65872985|FG001|Double Blind Treatment|protocol driven decision point|1|||
23586036|NCT00984282|65872984|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
23586037|NCT00984282|65872985|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
23586038|NCT00984282|65872984|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
23586039|NCT00984282|65872985|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
23586040|NCT00984282|65872984|FG000|Open-label Treatment|Adverse Event|20|||
23586041|NCT00984282|65872985|FG001|Open-label Treatment|Adverse Event|30|||
23586042|NCT00984282|65872984|FG000|Open-label Treatment|Withdrawal by Subject|6|||
23586043|NCT00984282|65872985|FG001|Open-label Treatment|Withdrawal by Subject|21|||
23586044|NCT00984282|65872984|FG000|Open-label Treatment|Death|7|||
23586045|NCT00984282|65872985|FG001|Open-label Treatment|Death|15|||
23586046|NCT00984282|65872984|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
23586047|NCT00984282|65872985|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
23586048|NCT00984282|65872984|FG000|Open-label Treatment|Lost to Follow-up|1|||
23586049|NCT00984282|65872985|FG001|Open-label Treatment|Lost to Follow-up|1|||
23586050|NCT00984282|65872984|FG000|Open-label Treatment|Patient convenience|1|||
23586051|NCT00984282|65872985|FG001|Open-label Treatment|Patient convenience|0|||
23586052|NCT00984282|65872984|FG000|Open-label Treatment|Non-compliant with study medication|1|||
23586053|NCT00984282|65872985|FG001|Open-label Treatment|Non-compliant with study medication|0|||
23586054|NCT00984282|65872984|FG000|Open-label Treatment|Target lesion removed|0|||
23586055|NCT00984282|65872985|FG001|Open-label Treatment|Target lesion removed|1|||
23586056|NCT00984282|65872984|FG000|Open-label Treatment|Protocol driven decision point|1|||
23586057|NCT00984282|65872985|FG001|Open-label Treatment|Protocol driven decision point|1|||
23586058|NCT00984282|65872984|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
23586059|NCT00984282|65872985|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
23586060|NCT00984282|65872984|FG000|Open-label Treatment|Switched to commercial drug|6|||
23586061|NCT00984282|65872985|FG001|Open-label Treatment|Switched to commercial drug|7|||
23586062|NCT00984282|65872984|FG000|Open-label Treatment|Physician Decision|1|||
23586063|NCT00984282|65872985|FG001|Open-label Treatment|Physician Decision|0|||
23586064|NCT00984282|65872984|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
23586065|NCT00984282|65872985|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
23586066|NCT00984282|65872984|FG000|Long Term Follow-up|Death|27|||
23586067|NCT00984282|65872985|FG001|Long Term Follow-up|Death|68|||
23586068|NCT00984282|65872984|FG000|Long Term Follow-up|Lost to Follow-up|3|||
23586069|NCT00984282|65872985|FG001|Long Term Follow-up|Lost to Follow-up|6|||
23586070|NCT00984282|65872984|FG000|Long Term Follow-up|Protocol driven decision point|25|||
23586071|NCT00984282|65872985|FG001|Long Term Follow-up|Protocol driven decision point|26|||
23586072|NCT00984282|65872984|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
23586073|NCT00984282|65872985|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
23586074|NCT00984282|65872984|FG000|Long Term Follow-up|Switched to commercial drug|4|||
23586075|NCT00984282|65872985|FG001|Long Term Follow-up|Switched to commercial drug|2|||
23586076|NCT00984282|65872984|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
23185844|NCT03138564|64420492|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
23185845|NCT03138564|64420491|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
23185846|NCT03138564|64420492|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
23185847|NCT03138564|64420491|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
23185848|NCT03138564|64420492|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
23185849|NCT04538664|64420493|FG000|Overall Study|Withdrawal by Subject|5|||
23185850|NCT04538664|64420494|FG001|Overall Study|Withdrawal by Subject|9|||
23185851|NCT04538664|64420493|FG000|Overall Study|Lost to Follow-up|2|||
23244281|NCT00433511|64638809|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
23244282|NCT00433511|64638810|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
23244283|NCT00433511|64638811|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
23244284|NCT00433511|64638809|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
23244285|NCT00433511|64638810|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
23244286|NCT00433511|64638811|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
23244287|NCT00433511|64638809|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
23244288|NCT00433511|64638810|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
23244289|NCT00433511|64638811|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
23244290|NCT00433511|64638809|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
23586077|NCT00984282|65872985|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
23586078|NCT00941031|65872986|FG000|Induction Period|Lack of Efficacy|2|||
23351041|NCT04093492|65029455|FG002|34 Weeks GA|Delivered before assessment|0|||
23244291|NCT00433511|64638810|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
23244292|NCT00433511|64638811|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
23244293|NCT00070499|64638812|FG000|Overall Study|Adverse Event|6|||
23244294|NCT00070499|64638813|FG001|Overall Study|Adverse Event|6|||
23244295|NCT00070499|64638814|FG002|Overall Study|Adverse Event|19|||
23244296|NCT00070499|64638815|FG003|Overall Study|Adverse Event|15|||
23244297|NCT00070499|64638812|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
23351042|NCT04093492|65029456|FG003|34 Weeks GA|Delivered before assessment|0|||
23351043|NCT04093492|65029453|FG000|34 Weeks GA|No response|0|||
23351044|NCT04093492|65029454|FG001|34 Weeks GA|No response|7|||
23351045|NCT04093492|65029455|FG002|34 Weeks GA|No response|5|||
23351046|NCT04093492|65029456|FG003|34 Weeks GA|No response|3|||
23351047|NCT04093492|65029453|FG000|34 Weeks GA|Lost to Follow-up|0|||
23351048|NCT04093492|65029454|FG001|34 Weeks GA|Lost to Follow-up|1|||
23351049|NCT04093492|65029455|FG002|34 Weeks GA|Lost to Follow-up|0|||
23351050|NCT04093492|65029456|FG003|34 Weeks GA|Lost to Follow-up|0|||
23351051|NCT02906033|65029457|FG000|Baseline|Protocol Violation|37|||
23351052|NCT02906033|65029458|FG001|Baseline|Protocol Violation|33|||
23351053|NCT02906033|65029457|FG000|Follow-up|Lost to Follow-up|46|||
23351054|NCT02906033|65029458|FG001|Follow-up|Lost to Follow-up|62|||
23351055|NCT04643964|65029461|FG000|Overall Study|Lost to Follow-up|55|||
23351056|NCT04643964|65029462|FG001|Overall Study|Lost to Follow-up|59|||
23351057|NCT04643964|65029463|FG002|Overall Study|Lost to Follow-up|54|||
23351058|NCT04643964|65029464|FG003|Overall Study|Lost to Follow-up|129|||
23351059|NCT04643964|65029465|FG004|Overall Study|Lost to Follow-up|48|||
23351060|NCT04643964|65029461|FG000|Overall Study|Failed attention check|1|||
23351061|NCT04643964|65029462|FG001|Overall Study|Failed attention check|8|||
23351062|NCT04643964|65029463|FG002|Overall Study|Failed attention check|2|||
23351063|NCT04643964|65029464|FG003|Overall Study|Failed attention check|14|||
23351064|NCT04643964|65029465|FG004|Overall Study|Failed attention check|11|||
23351065|NCT04401202|65029466|FG000|Overall Study|Lost to Follow-up|2|||
23351066|NCT04401202|65029467|FG001|Overall Study|Lost to Follow-up|2|||
23351067|NCT04401202|65029466|FG000|Overall Study|Adverse Event|0|||
23351068|NCT04401202|65029467|FG001|Overall Study|Adverse Event|1|||
23351069|NCT04401202|65029466|FG000|Overall Study|Hospitalized|4|||
23351070|NCT04401202|65029467|FG001|Overall Study|Hospitalized|1|||
23351071|NCT00308750|65029468|FG000|Overall Study|Adverse Event|9|||
23351072|NCT00308750|65029469|FG001|Overall Study|Adverse Event|9|||
23351073|NCT00308750|65029470|FG002|Overall Study|Adverse Event|13|||
23351074|NCT00308750|65029468|FG000|Overall Study|Withdrawal by Subject|6|||
23351075|NCT00308750|65029469|FG001|Overall Study|Withdrawal by Subject|2|||
23351076|NCT00308750|65029470|FG002|Overall Study|Withdrawal by Subject|3|||
23351077|NCT00308750|65029468|FG000|Overall Study|Physician Decision|3|||
23351078|NCT00308750|65029469|FG001|Overall Study|Physician Decision|4|||
23351079|NCT00308750|65029470|FG002|Overall Study|Physician Decision|3|||
23351080|NCT00308750|65029468|FG000|Overall Study|Sponsor Decision|1|||
23586079|NCT00941031|65872987|FG001|Induction Period|Lack of Efficacy|1|||
23586080|NCT00941031|65872988|FG002|Induction Period|Lack of Efficacy|0|||
23586081|NCT00941031|65872989|FG003|Induction Period|Lack of Efficacy|5|||
23586082|NCT00941031|65872990|FG004|Induction Period|Lack of Efficacy|0|||
23586083|NCT00941031|65872991|FG005|Induction Period|Lack of Efficacy|0|||
23586084|NCT00941031|65872992|FG006|Induction Period|Lack of Efficacy|0|||
23586085|NCT00941031|65872986|FG000|Induction Period|Withdrawal by Subject|1|||
23586086|NCT00941031|65872987|FG001|Induction Period|Withdrawal by Subject|2|||
23586087|NCT00941031|65872988|FG002|Induction Period|Withdrawal by Subject|2|||
23586088|NCT00941031|65872989|FG003|Induction Period|Withdrawal by Subject|2|||
23586089|NCT00941031|65872990|FG004|Induction Period|Withdrawal by Subject|0|||
23244298|NCT00070499|64638813|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
23244299|NCT00070499|64638814|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
23244300|NCT00070499|64638815|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
23244301|NCT00070499|64638812|FG000|Overall Study|Progression/relapse|4|||
23244302|NCT00070499|64638813|FG001|Overall Study|Progression/relapse|2|||
23351081|NCT00308750|65029469|FG001|Overall Study|Sponsor Decision|0|||
23244303|NCT00070499|64638814|FG002|Overall Study|Progression/relapse|1|||
23244304|NCT00070499|64638815|FG003|Overall Study|Progression/relapse|4|||
23351082|NCT00308750|65029470|FG002|Overall Study|Sponsor Decision|0|||
23351083|NCT00308750|65029468|FG000|Overall Study|Disease Progression|47|||
23586090|NCT00941031|65872991|FG005|Induction Period|Withdrawal by Subject|0|||
23244305|NCT00070499|64638812|FG000|Overall Study|Death|1|||
23244306|NCT00070499|64638813|FG001|Overall Study|Death|1|||
23351084|NCT00308750|65029469|FG001|Overall Study|Disease Progression|24|||
23351085|NCT00308750|65029470|FG002|Overall Study|Disease Progression|28|||
23351086|NCT00308750|65029468|FG000|Overall Study|Unrelated Complication|3|||
23351087|NCT00308750|65029469|FG001|Overall Study|Unrelated Complication|0|||
23351088|NCT00308750|65029470|FG002|Overall Study|Unrelated Complication|1|||
23351089|NCT00308750|65029468|FG000|Overall Study|Death|1|||
23586091|NCT00941031|65872992|FG006|Induction Period|Withdrawal by Subject|0|||
23586092|NCT00941031|65872986|FG000|Induction Period|Adminstative Problems|1|||
23586093|NCT00941031|65872987|FG001|Induction Period|Adminstative Problems|1|||
23586094|NCT00941031|65872988|FG002|Induction Period|Adminstative Problems|1|||
23586095|NCT00941031|65872989|FG003|Induction Period|Adminstative Problems|0|||
23586096|NCT00941031|65872990|FG004|Induction Period|Adminstative Problems|0|||
23586097|NCT00941031|65872991|FG005|Induction Period|Adminstative Problems|0|||
23586098|NCT00941031|65872992|FG006|Induction Period|Adminstative Problems|0|||
23586099|NCT00941031|65872986|FG000|Induction Period|Adverse Event|1|||
23586100|NCT00941031|65872987|FG001|Induction Period|Adverse Event|0|||
23586101|NCT00941031|65872988|FG002|Induction Period|Adverse Event|3|||
23586102|NCT00941031|65872989|FG003|Induction Period|Adverse Event|2|||
23586103|NCT00941031|65872990|FG004|Induction Period|Adverse Event|0|||
23586104|NCT00941031|65872991|FG005|Induction Period|Adverse Event|0|||
23586105|NCT00941031|65872992|FG006|Induction Period|Adverse Event|0|||
23586106|NCT00941031|65872986|FG000|Maintenance Period|Withdrawal by Subject|0|||
23586107|NCT00941031|65872987|FG001|Maintenance Period|Withdrawal by Subject|0|||
23586108|NCT00941031|65872988|FG002|Maintenance Period|Withdrawal by Subject|0|||
23586109|NCT00941031|65872989|FG003|Maintenance Period|Withdrawal by Subject|0|||
23244307|NCT00070499|64638814|FG002|Overall Study|Death|1|||
23244308|NCT00070499|64638815|FG003|Overall Study|Death|2|||
23244309|NCT00070499|64638812|FG000|Overall Study|Other - not protocol specified|7|||
23185852|NCT04538664|64420494|FG001|Overall Study|Lost to Follow-up|1|||
23185853|NCT04538664|64420493|FG000|Overall Study|Ongoing|106|||
23185854|NCT04538664|64420494|FG001|Overall Study|Ongoing|115|||
23185855|NCT04488822|64420495|FG000|Overall Study|Adverse Event|8|||
23244310|NCT00070499|64638813|FG001|Overall Study|Other - not protocol specified|3|||
23185856|NCT04488822|64420495|FG000|Overall Study|Withdrawal by Subject|1|||
23185857|NCT03885284|64420496|FG000|Overall Study|Disease Progression|1|||
23185858|NCT03885284|64420497|FG001|Overall Study|Disease Progression|3|||
23185859|NCT03885284|64420496|FG000|Overall Study|Physician Decision|0|||
23185860|NCT03885284|64420497|FG001|Overall Study|Physician Decision|1|||
23185861|NCT04197713|64420501|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
23185862|NCT04197713|64420502|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
23185863|NCT00601900|64420503|FG000|Overall Study|Withdrawal by Subject|0|||
23185864|NCT00601900|64420504|FG001|Overall Study|Withdrawal by Subject|3|||
23185865|NCT03213665|64420505|FG000|Overall Study|Adverse Event|1|||
23185866|NCT03213665|64420505|FG000|Overall Study|Physician Decision|2|||
23244311|NCT00070499|64638814|FG002|Overall Study|Other - not protocol specified|12|||
23244312|NCT00070499|64638815|FG003|Overall Study|Other - not protocol specified|20|||
23244313|NCT00070499|64638812|FG000|Overall Study|Still on protocol treatment|10|||
23244314|NCT00070499|64638813|FG001|Overall Study|Still on protocol treatment|4|||
23244315|NCT00070499|64638814|FG002|Overall Study|Still on protocol treatment|79|||
23244316|NCT00070499|64638815|FG003|Overall Study|Still on protocol treatment|57|||
23244317|NCT00070499|64638812|FG000|Overall Study|Did not start treatment|1|||
23244318|NCT00070499|64638813|FG001|Overall Study|Did not start treatment|0|||
23244319|NCT00070499|64638814|FG002|Overall Study|Did not start treatment|0|||
23244320|NCT00070499|64638815|FG003|Overall Study|Did not start treatment|2|||
23244321|NCT00070499|64638812|FG000|Overall Study|Not eligible|2|||
23244322|NCT00070499|64638813|FG001|Overall Study|Not eligible|5|||
23244323|NCT00070499|64638814|FG002|Overall Study|Not eligible|3|||
23244324|NCT00070499|64638815|FG003|Overall Study|Not eligible|2|||
23244325|NCT05182840|64638818|FG000|Run-in Period|Not treated|0|||
23244326|NCT05182840|64638819|FG001|Run-in Period|Not treated|1|||
23244327|NCT05182840|64638820|FG002|Run-in Period|Not treated|0|||
23244328|NCT05182840|64638821|FG003|Run-in Period|Not treated|0|||
23244329|NCT05182840|64638822|FG004|Run-in Period|Not treated|0|||
23244330|NCT05182840|64638823|FG005|Run-in Period|Not treated|0|||
23244331|NCT05182840|64638824|FG006|Run-in Period|Not treated|0|||
23244332|NCT05182840|64638825|FG007|Run-in Period|Not treated|0|||
23244333|NCT05182840|64638826|FG008|Run-in Period|Not treated|0|||
23244334|NCT05182840|64638827|FG009|Run-in Period|Not treated|0|||
23586110|NCT00941031|65872990|FG004|Maintenance Period|Withdrawal by Subject|6|||
23244335|NCT05182840|64638818|FG000|Run-in Period|Other reason but not sponsor termination|14|||
23244336|NCT05182840|64638819|FG001|Run-in Period|Other reason but not sponsor termination|18|||
23244337|NCT05182840|64638820|FG002|Run-in Period|Other reason but not sponsor termination|0|||
23244338|NCT05182840|64638821|FG003|Run-in Period|Other reason but not sponsor termination|0|||
23244339|NCT05182840|64638822|FG004|Run-in Period|Other reason but not sponsor termination|0|||
23244340|NCT05182840|64638823|FG005|Run-in Period|Other reason but not sponsor termination|0|||
23244341|NCT05182840|64638824|FG006|Run-in Period|Other reason but not sponsor termination|0|||
23586111|NCT00941031|65872991|FG005|Maintenance Period|Withdrawal by Subject|2|||
23586112|NCT00941031|65872992|FG006|Maintenance Period|Withdrawal by Subject|13|||
23586113|NCT00941031|65872986|FG000|Maintenance Period|Administrative Problems|0|||
23351090|NCT00308750|65029469|FG001|Overall Study|Death|0|||
23351091|NCT00308750|65029470|FG002|Overall Study|Death|1|||
23351092|NCT00308750|65029468|FG000|Overall Study|Protocol Violation|1|||
23351093|NCT00308750|65029469|FG001|Overall Study|Protocol Violation|0|||
23351094|NCT00308750|65029470|FG002|Overall Study|Protocol Violation|0|||
23351095|NCT00308750|65029468|FG000|Overall Study|New Primary Disease Identified|1|||
23351096|NCT00308750|65029469|FG001|Overall Study|New Primary Disease Identified|1|||
23351097|NCT00308750|65029470|FG002|Overall Study|New Primary Disease Identified|0|||
23351098|NCT00312572|65029471|FG000|Overall Study|Adverse Event|10|||
23351099|NCT00312572|65029472|FG001|Overall Study|Adverse Event|16|||
23351100|NCT00312572|65029471|FG000|Overall Study|Lost to Follow-up|1|||
23185867|NCT03213665|64420505|FG000|Overall Study|Withdrawal by Subject|3|||
23185868|NCT03213665|64420505|FG000|Overall Study|Progressive Disease|13|||
23185869|NCT05087030|64420506|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
23185870|NCT05087030|64420507|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
23351101|NCT00312572|65029472|FG001|Overall Study|Lost to Follow-up|1|||
23351102|NCT00312572|65029471|FG000|Overall Study|Administrative|4|||
23351103|NCT00312572|65029472|FG001|Overall Study|Administrative|2|||
23351104|NCT00312572|65029471|FG000|Overall Study|Lack of Efficacy|1|||
23351105|NCT00312572|65029472|FG001|Overall Study|Lack of Efficacy|2|||
23351106|NCT00492232|65029475|FG000|Placebo Run-in|Adverse Event|0|||
23351107|NCT00492232|65029476|FG001|Placebo Run-in|Adverse Event|2|||
23351108|NCT00492232|65029475|FG000|Placebo Run-in|Protocol Violation|0|||
23351109|NCT00492232|65029476|FG001|Placebo Run-in|Protocol Violation|3|||
23351110|NCT00492232|65029475|FG000|Placebo Run-in|Lost to Follow-up|0|||
23351111|NCT00492232|65029476|FG001|Placebo Run-in|Lost to Follow-up|3|||
23351112|NCT00492232|65029475|FG000|Placebo Run-in|Withdrawal by Subject|0|||
23351113|NCT00492232|65029476|FG001|Placebo Run-in|Withdrawal by Subject|8|||
23351114|NCT00492232|65029475|FG000|Placebo Run-in|Pregnancy|0|||
23351115|NCT00492232|65029476|FG001|Placebo Run-in|Pregnancy|1|||
23351116|NCT00492232|65029475|FG000|Placebo Run-in|Entrance criteria not met|0|||
23351117|NCT00492232|65029476|FG001|Placebo Run-in|Entrance criteria not met|45|||
23351118|NCT00492232|65029475|FG000|Placebo Run-in|Other|0|||
23351119|NCT00492232|65029476|FG001|Placebo Run-in|Other|6|||
23351120|NCT00492232|65029475|FG000|Placebo Run-in|Missing|0|||
23351121|NCT00492232|65029476|FG001|Placebo Run-in|Missing|2|||
23351122|NCT00492232|65029475|FG000|Double-Blind Treatment|Adverse Event|1|||
23351123|NCT00492232|65029476|FG001|Double-Blind Treatment|Adverse Event|2|||
23351124|NCT00492232|65029475|FG000|Double-Blind Treatment|Protocol Violation|3|||
23351125|NCT00492232|65029476|FG001|Double-Blind Treatment|Protocol Violation|7|||
23351126|NCT00492232|65029475|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
23351127|NCT00492232|65029476|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
23351128|NCT00492232|65029475|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
23351129|NCT00492232|65029476|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
23351130|NCT00492232|65029475|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
23351131|NCT00492232|65029476|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
23351132|NCT00492232|65029475|FG000|Double-Blind Treatment|Other|6|||
23351133|NCT00492232|65029476|FG001|Double-Blind Treatment|Other|5|||
23351134|NCT00492232|65029475|FG000|Double-Blind Treatment|Randomized not treated|1|||
23351135|NCT00492232|65029476|FG001|Double-Blind Treatment|Randomized not treated|0|||
23351136|NCT00492232|65029475|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
23351137|NCT00492232|65029476|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
23351138|NCT01267201|65029477|FG000|First Intervention Period|Withdrawal by Subject|1|||
23351139|NCT01267201|65029478|FG001|First Intervention Period|Withdrawal by Subject|0|||
23185871|NCT05087030|64420508|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
23185872|NCT05087030|64420509|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
23185873|NCT05087030|64420510|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
23185874|NCT05087030|64420506|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
23185875|NCT05087030|64420507|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
23185876|NCT05087030|64420508|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
23185877|NCT05087030|64420509|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
23185878|NCT05087030|64420510|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
23185879|NCT05087030|64420506|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
23185880|NCT05087030|64420507|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23185881|NCT05087030|64420508|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23244342|NCT05182840|64638825|FG007|Run-in Period|Other reason but not sponsor termination|0|||
23244343|NCT05182840|64638826|FG008|Run-in Period|Other reason but not sponsor termination|0|||
23351140|NCT01267201|65029479|FG002|First Intervention Period|Withdrawal by Subject|0|||
23351141|NCT01267201|65029480|FG003|First Intervention Period|Withdrawal by Subject|0|||
23351142|NCT01267201|65029481|FG004|First Intervention Period|Withdrawal by Subject|0|||
23351143|NCT01267201|65029482|FG005|First Intervention Period|Withdrawal by Subject|0|||
23351144|NCT01267201|65029477|FG000|Second Intervention Period|Withdrawal by Subject|0|||
23351145|NCT01267201|65029478|FG001|Second Intervention Period|Withdrawal by Subject|1|||
23351146|NCT01267201|65029479|FG002|Second Intervention Period|Withdrawal by Subject|0|||
23351147|NCT01267201|65029480|FG003|Second Intervention Period|Withdrawal by Subject|0|||
23185882|NCT05087030|64420509|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23185883|NCT05087030|64420510|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
23185884|NCT05087030|64420506|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
23185885|NCT05087030|64420507|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
23244344|NCT05182840|64638827|FG009|Run-in Period|Other reason but not sponsor termination|0|||
23586114|NCT00941031|65872987|FG001|Maintenance Period|Administrative Problems|0|||
23586115|NCT00941031|65872988|FG002|Maintenance Period|Administrative Problems|0|||
23586116|NCT00941031|65872989|FG003|Maintenance Period|Administrative Problems|0|||
23586117|NCT00941031|65872990|FG004|Maintenance Period|Administrative Problems|1|||
23586118|NCT00941031|65872991|FG005|Maintenance Period|Administrative Problems|0|||
23586119|NCT00941031|65872992|FG006|Maintenance Period|Administrative Problems|1|||
23586120|NCT00941031|65872986|FG000|Maintenance Period|Protocol Violation|0|||
23586121|NCT00941031|65872987|FG001|Maintenance Period|Protocol Violation|0|||
23244345|NCT05182840|64638818|FG000|Run-in Period|No reason available|2|||
23244346|NCT05182840|64638819|FG001|Run-in Period|No reason available|2|||
23244347|NCT05182840|64638820|FG002|Run-in Period|No reason available|0|||
23244348|NCT05182840|64638821|FG003|Run-in Period|No reason available|0|||
23244349|NCT05182840|64638822|FG004|Run-in Period|No reason available|0|||
23244350|NCT05182840|64638823|FG005|Run-in Period|No reason available|0|||
23244351|NCT05182840|64638824|FG006|Run-in Period|No reason available|0|||
23244352|NCT05182840|64638825|FG007|Run-in Period|No reason available|0|||
23244353|NCT05182840|64638826|FG008|Run-in Period|No reason available|0|||
23244354|NCT05182840|64638827|FG009|Run-in Period|No reason available|0|||
23244355|NCT05182840|64638818|FG000|Run-in Period|Burden of study procedures|2|||
23244356|NCT05182840|64638819|FG001|Run-in Period|Burden of study procedures|2|||
23185886|NCT05087030|64420508|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
23185887|NCT05087030|64420509|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
23185888|NCT05087030|64420510|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
23185889|NCT05087030|64420506|FG000|Main Period (Week 0 to Week 52)|Death|0|||
23185890|NCT05087030|64420507|FG001|Main Period (Week 0 to Week 52)|Death|1|||
23185891|NCT05087030|64420508|FG002|Main Period (Week 0 to Week 52)|Death|0|||
23185892|NCT05087030|64420509|FG003|Main Period (Week 0 to Week 52)|Death|0|||
23185893|NCT05087030|64420510|FG004|Main Period (Week 0 to Week 52)|Death|0|||
23185894|NCT05087030|64420506|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
23185895|NCT05087030|64420507|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
23185896|NCT05087030|64420508|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
23185897|NCT05087030|64420509|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
23185898|NCT05087030|64420510|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
23185899|NCT05087030|64420506|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
23185900|NCT05087030|64420507|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
23185901|NCT05087030|64420508|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
23185902|NCT05087030|64420509|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
23185903|NCT05087030|64420510|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
23185904|NCT05087030|64420506|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
23185905|NCT05087030|64420507|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
23185906|NCT05087030|64420508|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
23185907|NCT05087030|64420509|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
23185908|NCT05087030|64420510|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
23185909|NCT05087030|64420506|FG000|Main Period (Week 0 to Week 52)|Other|1|||
23185910|NCT05087030|64420507|FG001|Main Period (Week 0 to Week 52)|Other|2|||
23185911|NCT05087030|64420508|FG002|Main Period (Week 0 to Week 52)|Other|0|||
23185912|NCT05087030|64420509|FG003|Main Period (Week 0 to Week 52)|Other|0|||
23185913|NCT05087030|64420510|FG004|Main Period (Week 0 to Week 52)|Other|0|||
23185914|NCT05087030|64420506|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23185915|NCT05087030|64420507|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23185916|NCT05087030|64420508|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23185917|NCT05087030|64420509|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23185918|NCT05087030|64420510|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
23185919|NCT03668223|64420511|FG000|Overall Study|Death|10|||
23185920|NCT03668223|64420512|FG001|Overall Study|Death|5|||
23185921|NCT03668223|64420511|FG000|Overall Study|Lost to Follow-up|12|||
23185922|NCT03668223|64420512|FG001|Overall Study|Lost to Follow-up|12|||
23185923|NCT03668223|64420511|FG000|Overall Study|Withdrawal by Subject|8|||
23244357|NCT05182840|64638820|FG002|Run-in Period|Burden of study procedures|0|||
23244358|NCT05182840|64638821|FG003|Run-in Period|Burden of study procedures|0|||
23586122|NCT00941031|65872988|FG002|Maintenance Period|Protocol Violation|0|||
23185924|NCT03668223|64420512|FG001|Overall Study|Withdrawal by Subject|3|||
23244359|NCT05182840|64638822|FG004|Run-in Period|Burden of study procedures|0|||
23351148|NCT01267201|65029481|FG004|Second Intervention Period|Withdrawal by Subject|0|||
23351149|NCT01267201|65029482|FG005|Second Intervention Period|Withdrawal by Subject|0|||
23351150|NCT02696434|65029483|FG000|Overall Study|Adverse Event|3|||
23351151|NCT02696434|65029484|FG001|Overall Study|Adverse Event|1|||
23351152|NCT02696434|65029483|FG000|Overall Study|Lost to Follow-up|5|||
23351153|NCT02696434|65029484|FG001|Overall Study|Lost to Follow-up|4|||
23351154|NCT02696434|65029483|FG000|Overall Study|Withdrawal by Subject|14|||
23351155|NCT02696434|65029484|FG001|Overall Study|Withdrawal by Subject|12|||
23351156|NCT02696434|65029483|FG000|Overall Study|Physician Decision|0|||
23351157|NCT02696434|65029484|FG001|Overall Study|Physician Decision|1|||
23351158|NCT03597022|65029487|FG000|Overall Study|Premature termination of the study|7|||
23351159|NCT03597022|65029488|FG001|Overall Study|Premature termination of the study|7|||
23351160|NCT03597022|65029489|FG002|Overall Study|Premature termination of the study|8|||
23351161|NCT03597022|65029487|FG000|Overall Study|Serious adverse event|1|||
23351162|NCT03597022|65029488|FG001|Overall Study|Serious adverse event|1|||
23351163|NCT03597022|65029489|FG002|Overall Study|Serious adverse event|0|||
23351164|NCT02494401|65029490|FG000|Overall Study|Lost to Follow-up|22|||
23351165|NCT02494401|65029491|FG001|Overall Study|Lost to Follow-up|25|||
23351166|NCT02494401|65029490|FG000|Overall Study|Withdrawal by Subject|3|||
23351167|NCT02494401|65029491|FG001|Overall Study|Withdrawal by Subject|2|||
23351168|NCT02093390|65029492|FG000|Overall Study|Withdrawal by Subject|0|||
23351169|NCT02093390|65029493|FG001|Overall Study|Withdrawal by Subject|1|||
23351170|NCT02045732|65029494|FG000|Overall Study|At the discretion of the investigator|1|||
23351171|NCT02045732|65029495|FG001|Overall Study|At the discretion of the investigator|1|||
23351172|NCT00636636|65029496|FG000|Overall Study|Other reason|4|||
23351173|NCT00636636|65029497|FG001|Overall Study|Other reason|6|||
23351174|NCT00636636|65029496|FG000|Overall Study|Adverse Event|19|||
23351175|NCT00636636|65029497|FG001|Overall Study|Adverse Event|8|||
23351176|NCT00636636|65029496|FG000|Overall Study|Lack of Efficacy|7|||
23351177|NCT00636636|65029497|FG001|Overall Study|Lack of Efficacy|12|||
23351178|NCT00636636|65029496|FG000|Overall Study|Protocol Violation|2|||
23351179|NCT00636636|65029497|FG001|Overall Study|Protocol Violation|2|||
23351180|NCT00636636|65029496|FG000|Overall Study|Lost to Follow-up|0|||
23351181|NCT00636636|65029497|FG001|Overall Study|Lost to Follow-up|1|||
23351182|NCT00636636|65029496|FG000|Overall Study|Death|0|||
23351183|NCT00636636|65029497|FG001|Overall Study|Death|1|||
23351184|NCT00636636|65029496|FG000|Overall Study|Withdrawal by Subject|4|||
23351185|NCT00636636|65029497|FG001|Overall Study|Withdrawal by Subject|9|||
23351186|NCT01801280|65029500|FG000|Period 1|Withdrawal by Subject|0|||
23351187|NCT01801280|65029501|FG001|Period 1|Withdrawal by Subject|1|||
23351188|NCT01801280|65029502|FG002|Period 1|Withdrawal by Subject|0|||
23351189|NCT01801280|65029503|FG003|Period 1|Withdrawal by Subject|0|||
23351190|NCT01801280|65029500|FG000|Period 2|Withdrawal by Subject|1|||
23351191|NCT01801280|65029501|FG001|Period 2|Withdrawal by Subject|0|||
23351192|NCT01801280|65029502|FG002|Period 2|Withdrawal by Subject|0|||
23351193|NCT01801280|65029503|FG003|Period 2|Withdrawal by Subject|0|||
23351194|NCT01801280|65029500|FG000|Period 4|Protocol Violation|0|||
23351195|NCT01801280|65029501|FG001|Period 4|Protocol Violation|0|||
23351196|NCT01801280|65029502|FG002|Period 4|Protocol Violation|1|||
23351197|NCT01801280|65029503|FG003|Period 4|Protocol Violation|0|||
23351198|NCT01124292|65029505|FG000|Overall Study|Lost to Follow-up|2|||
23351199|NCT01124292|65029506|FG001|Overall Study|Lost to Follow-up|4|||
23351200|NCT01124292|65029507|FG002|Overall Study|Lost to Follow-up|3|||
23351201|NCT01124292|65029505|FG000|Overall Study|Physician Decision|0|||
23351202|NCT01124292|65029506|FG001|Overall Study|Physician Decision|3|||
23351203|NCT01124292|65029507|FG002|Overall Study|Physician Decision|2|||
23351204|NCT01124292|65029505|FG000|Overall Study|Withdrawal by Subject|0|||
23351205|NCT01124292|65029506|FG001|Overall Study|Withdrawal by Subject|6|||
23351206|NCT01124292|65029507|FG002|Overall Study|Withdrawal by Subject|2|||
23351207|NCT01124292|65029505|FG000|Overall Study|medical issue unrelated to the study|0|||
23351208|NCT01124292|65029506|FG001|Overall Study|medical issue unrelated to the study|0|||
23351209|NCT01124292|65029507|FG002|Overall Study|medical issue unrelated to the study|2|||
23351210|NCT01124292|65029505|FG000|Overall Study|piercing track closed|0|||
23351211|NCT01124292|65029506|FG001|Overall Study|piercing track closed|2|||
23351212|NCT01124292|65029507|FG002|Overall Study|piercing track closed|1|||
23351213|NCT00568334|65029510|FG000|Overall Study|Withdrawal by Subject|0|||
23351214|NCT00568334|65029511|FG001|Overall Study|Withdrawal by Subject|1|||
23351215|NCT00568334|65029510|FG000|Overall Study|Lost to Follow-up|1|||
23351216|NCT00568334|65029511|FG001|Overall Study|Lost to Follow-up|0|||
23351217|NCT00422292|65029512|FG000|Overall Study|Serious adverse events|1|||
23351218|NCT00422292|65029513|FG001|Overall Study|Serious adverse events|4|||
23351219|NCT00422292|65029514|FG002|Overall Study|Serious adverse events|0|||
23351220|NCT00422292|65029515|FG003|Overall Study|Serious adverse events|0|||
23351221|NCT00422292|65029512|FG000|Overall Study|Adverse Event|1|||
23351222|NCT00422292|65029513|FG001|Overall Study|Adverse Event|0|||
23351223|NCT00422292|65029514|FG002|Overall Study|Adverse Event|1|||
23351224|NCT00422292|65029515|FG003|Overall Study|Adverse Event|0|||
23351225|NCT00422292|65029512|FG000|Overall Study|Protocol Violation|4|||
23351226|NCT00422292|65029513|FG001|Overall Study|Protocol Violation|25|||
23351227|NCT00422292|65029514|FG002|Overall Study|Protocol Violation|8|||
23351228|NCT00422292|65029515|FG003|Overall Study|Protocol Violation|5|||
23351229|NCT00422292|65029512|FG000|Overall Study|Lost to Follow-up|6|||
23351230|NCT00422292|65029513|FG001|Overall Study|Lost to Follow-up|12|||
23351231|NCT00422292|65029514|FG002|Overall Study|Lost to Follow-up|6|||
23351232|NCT00422292|65029515|FG003|Overall Study|Lost to Follow-up|6|||
23351233|NCT00422292|65029512|FG000|Overall Study|Withdrawal by Subject|6|||
23351234|NCT00422292|65029513|FG001|Overall Study|Withdrawal by Subject|25|||
23351235|NCT00422292|65029514|FG002|Overall Study|Withdrawal by Subject|7|||
23351236|NCT00422292|65029515|FG003|Overall Study|Withdrawal by Subject|13|||
23351237|NCT01969084|65029524|FG000|Overall Study|Adverse Event|0|||
23351238|NCT01969084|65029525|FG001|Overall Study|Adverse Event|1|||
23351239|NCT00783224|65029529|FG000|Overall Study|Adverse Event|0|||
23351240|NCT00783224|65029530|FG001|Overall Study|Adverse Event|0|||
23586123|NCT00941031|65872989|FG003|Maintenance Period|Protocol Violation|0|||
23586124|NCT00941031|65872990|FG004|Maintenance Period|Protocol Violation|0|||
23586125|NCT00941031|65872991|FG005|Maintenance Period|Protocol Violation|0|||
23586126|NCT00941031|65872992|FG006|Maintenance Period|Protocol Violation|1|||
23351241|NCT00783224|65029531|FG002|Overall Study|Adverse Event|1|||
23351242|NCT00783224|65029532|FG003|Overall Study|Adverse Event|0|||
23351243|NCT00783224|65029529|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
23351244|NCT00783224|65029530|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
23351245|NCT00783224|65029531|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
23351246|NCT00783224|65029532|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
23351247|NCT00783224|65029529|FG000|Overall Study|Inappropriate as a study subject|0|||
23351248|NCT00783224|65029530|FG001|Overall Study|Inappropriate as a study subject|0|||
23351249|NCT00783224|65029531|FG002|Overall Study|Inappropriate as a study subject|0|||
23351250|NCT00783224|65029532|FG003|Overall Study|Inappropriate as a study subject|1|||
23351251|NCT00427999|65029538|FG000|Overall Study|Adverse Event|6|||
23351252|NCT00427999|65029538|FG000|Overall Study|Abnormal laboratory values|1|||
23351253|NCT00427999|65029538|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
23351254|NCT00427999|65029538|FG000|Overall Study|Protocol Violation|2|||
23351255|NCT00427999|65029538|FG000|Overall Study|Withdrawal by Subject|9|||
23351256|NCT00427999|65029538|FG000|Overall Study|Death|1|||
23351257|NCT01632150|65029541|FG000|Overall Study|Disease progression|27|||
23351258|NCT01632150|65029541|FG000|Overall Study|Study drug toxicity|1|||
23351259|NCT01632150|65029541|FG000|Overall Study|Unrelated adverse event|7|||
23351260|NCT01632150|65029541|FG000|Overall Study|Withdrawal by Subject|2|||
23351261|NCT01632150|65029541|FG000|Overall Study|Patient underwent autologous transplant|1|||
23351262|NCT01632150|65029541|FG000|Overall Study|Moved to compassionate program|2|||
23586127|NCT00941031|65872986|FG000|Maintenance Period|Adverse Event|0|||
23586128|NCT00941031|65872987|FG001|Maintenance Period|Adverse Event|0|||
23586129|NCT00941031|65872988|FG002|Maintenance Period|Adverse Event|0|||
23586130|NCT00941031|65872989|FG003|Maintenance Period|Adverse Event|0|||
23586131|NCT00941031|65872990|FG004|Maintenance Period|Adverse Event|0|||
23586132|NCT00941031|65872991|FG005|Maintenance Period|Adverse Event|2|||
23586133|NCT00941031|65872992|FG006|Maintenance Period|Adverse Event|8|||
23586134|NCT00941031|65872986|FG000|Maintenance Period|Lost to Follow-up|0|||
23586135|NCT00941031|65872987|FG001|Maintenance Period|Lost to Follow-up|0|||
23586136|NCT00941031|65872988|FG002|Maintenance Period|Lost to Follow-up|0|||
23586137|NCT00941031|65872989|FG003|Maintenance Period|Lost to Follow-up|0|||
23586138|NCT00941031|65872990|FG004|Maintenance Period|Lost to Follow-up|2|||
23244360|NCT05182840|64638823|FG005|Run-in Period|Burden of study procedures|0|||
23244361|NCT05182840|64638824|FG006|Run-in Period|Burden of study procedures|0|||
23244362|NCT05182840|64638825|FG007|Run-in Period|Burden of study procedures|0|||
23244363|NCT05182840|64638826|FG008|Run-in Period|Burden of study procedures|0|||
23244364|NCT05182840|64638827|FG009|Run-in Period|Burden of study procedures|0|||
23244365|NCT05182840|64638818|FG000|Run-in Period|Change of residence|1|||
23244366|NCT05182840|64638819|FG001|Run-in Period|Change of residence|0|||
23244367|NCT05182840|64638820|FG002|Run-in Period|Change of residence|0|||
23244368|NCT05182840|64638821|FG003|Run-in Period|Change of residence|0|||
23244369|NCT05182840|64638822|FG004|Run-in Period|Change of residence|0|||
23351263|NCT01389258|65029542|FG000|Overall Study|Lost to Follow-up|5|||
23351264|NCT00388297|65029543|FG000|Overall Study|Lost to Follow-up|16|||
23244370|NCT05182840|64638823|FG005|Run-in Period|Change of residence|0|||
23244371|NCT05182840|64638824|FG006|Run-in Period|Change of residence|0|||
23244372|NCT05182840|64638825|FG007|Run-in Period|Change of residence|0|||
23244373|NCT05182840|64638826|FG008|Run-in Period|Change of residence|0|||
23351265|NCT00388297|65029544|FG001|Overall Study|Lost to Follow-up|12|||
23244374|NCT05182840|64638827|FG009|Run-in Period|Change of residence|0|||
23351266|NCT00388297|65029545|FG002|Overall Study|Lost to Follow-up|11|||
23351267|NCT00388297|65029546|FG003|Overall Study|Lost to Follow-up|8|||
23466287|NCT02745119|65451982|FG002|Overall Study|Protocol Deviation|0|||
23586139|NCT00941031|65872991|FG005|Maintenance Period|Lost to Follow-up|2|||
23586140|NCT00941031|65872992|FG006|Maintenance Period|Lost to Follow-up|7|||
23244375|NCT05182840|64638818|FG000|Run-in Period|Adverse Event|5|||
23244376|NCT05182840|64638819|FG001|Run-in Period|Adverse Event|5|||
23244377|NCT05182840|64638820|FG002|Run-in Period|Adverse Event|0|||
23244378|NCT05182840|64638821|FG003|Run-in Period|Adverse Event|0|||
23244379|NCT05182840|64638822|FG004|Run-in Period|Adverse Event|0|||
23244380|NCT05182840|64638823|FG005|Run-in Period|Adverse Event|0|||
23244381|NCT05182840|64638824|FG006|Run-in Period|Adverse Event|0|||
23244382|NCT05182840|64638825|FG007|Run-in Period|Adverse Event|0|||
23244383|NCT05182840|64638826|FG008|Run-in Period|Adverse Event|0|||
23244384|NCT05182840|64638827|FG009|Run-in Period|Adverse Event|0|||
23244385|NCT05182840|64638818|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
23244386|NCT05182840|64638819|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
23244387|NCT05182840|64638820|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23244388|NCT05182840|64638821|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23244389|NCT05182840|64638822|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23244390|NCT05182840|64638823|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23586141|NCT00941031|65872986|FG000|Maintenance Period|Lack of Efficacy|0|||
23586142|NCT00941031|65872987|FG001|Maintenance Period|Lack of Efficacy|0|||
23586143|NCT00941031|65872988|FG002|Maintenance Period|Lack of Efficacy|0|||
23586144|NCT00941031|65872989|FG003|Maintenance Period|Lack of Efficacy|0|||
23586145|NCT00941031|65872990|FG004|Maintenance Period|Lack of Efficacy|0|||
23586146|NCT00941031|65872991|FG005|Maintenance Period|Lack of Efficacy|0|||
23586147|NCT00941031|65872992|FG006|Maintenance Period|Lack of Efficacy|13|||
23586148|NCT01670019|65872998|FG000|Overall Study|Adverse Event|3|||
23586149|NCT01670019|65872999|FG001|Overall Study|Adverse Event|0|||
23586150|NCT01670019|65872998|FG000|Overall Study|Withdrawal by Subject|6|||
23586151|NCT01670019|65872999|FG001|Overall Study|Withdrawal by Subject|0|||
23586152|NCT01720446|65873000|FG000|Overall Study|Lost to Follow-up|12|||
23586153|NCT01720446|65873001|FG001|Overall Study|Lost to Follow-up|6|||
23586154|NCT01720446|65873002|FG002|Overall Study|Lost to Follow-up|16|||
23586155|NCT01720446|65873003|FG003|Overall Study|Lost to Follow-up|16|||
23586156|NCT01720446|65873000|FG000|Overall Study|Withdrawal by Subject|2|||
23586157|NCT01720446|65873001|FG001|Overall Study|Withdrawal by Subject|5|||
23586158|NCT01720446|65873002|FG002|Overall Study|Withdrawal by Subject|4|||
23351268|NCT04679051|65029551|FG000|Overall Study|felt tired after restricted time in bed|3|||
23351269|NCT04679051|65029552|FG001|Overall Study|felt tired after restricted time in bed|0|||
23351270|NCT04679051|65029551|FG000|Overall Study|discomfort with blood pressure cuff|2|||
23351271|NCT04679051|65029552|FG001|Overall Study|discomfort with blood pressure cuff|0|||
23351272|NCT04679051|65029551|FG000|Overall Study|scheduling conflict|1|||
23351273|NCT04679051|65029552|FG001|Overall Study|scheduling conflict|1|||
23351274|NCT04679051|65029551|FG000|Overall Study|Protocol Violation|0|||
23351275|NCT04679051|65029552|FG001|Overall Study|Protocol Violation|4|||
23351276|NCT01987232|65029553|FG000|Overall Study|Ongoing in Study|0|||
23351277|NCT01987232|65029554|FG001|Overall Study|Ongoing in Study|0|||
23351278|NCT01987232|65029555|FG002|Overall Study|Ongoing in Study|0|||
23351279|NCT01987232|65029556|FG003|Overall Study|Ongoing in Study|1|||
23351280|NCT01987232|65029557|FG004|Overall Study|Ongoing in Study|0|||
23351281|NCT00553358|65029562|FG000|Overall Study|Randomized but did not receive treatment|3|||
23351282|NCT00553358|65029563|FG001|Overall Study|Randomized but did not receive treatment|3|||
23351283|NCT00553358|65029564|FG002|Overall Study|Randomized but did not receive treatment|1|||
23351284|NCT00553358|65029562|FG000|Overall Study|Lost to Follow-up|22|||
23351285|NCT00553358|65029563|FG001|Overall Study|Lost to Follow-up|26|||
23351286|NCT00553358|65029564|FG002|Overall Study|Lost to Follow-up|18|||
23351287|NCT00553358|65029562|FG000|Overall Study|Withdrew completely|23|||
23351288|NCT00553358|65029563|FG001|Overall Study|Withdrew completely|33|||
23351289|NCT00553358|65029564|FG002|Overall Study|Withdrew completely|34|||
23351290|NCT00553358|65029562|FG000|Overall Study|Died during clinical follow-up|25|||
23466288|NCT02745119|65451983|FG003|Overall Study|Protocol Deviation|1|||
23586159|NCT01720446|65873003|FG003|Overall Study|Withdrawal by Subject|4|||
23586160|NCT00502593|65873004|FG000|Overall Study|Withdrawn unspecified reason|1|||
23586161|NCT00502593|65873005|FG001|Overall Study|Withdrawn unspecified reason|1|||
23586162|NCT00502593|65873006|FG002|Overall Study|Withdrawn unspecified reason|3|||
23586163|NCT00502593|65873007|FG003|Overall Study|Withdrawn unspecified reason|1|||
23244391|NCT05182840|64638824|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23351291|NCT00553358|65029563|FG001|Overall Study|Died during clinical follow-up|29|||
23351292|NCT00553358|65029564|FG002|Overall Study|Died during clinical follow-up|32|||
23402772|NCT01446874|65220003|FG000|Overall Study|No surgery/No qualifying surgery|1|||
23586164|NCT00502593|65873008|FG004|Overall Study|Withdrawn unspecified reason|2|||
23586165|NCT00502593|65873009|FG005|Overall Study|Withdrawn unspecified reason|0|||
23586166|NCT00502593|65873010|FG006|Overall Study|Withdrawn unspecified reason|2|||
23586167|NCT00502593|65873011|FG007|Overall Study|Withdrawn unspecified reason|0|||
23586168|NCT00502593|65873012|FG008|Overall Study|Withdrawn unspecified reason|0|||
23586169|NCT00502593|65873013|FG009|Overall Study|Withdrawn unspecified reason|0|||
23586170|NCT00502593|65873014|FG010|Overall Study|Withdrawn unspecified reason|0|||
23586171|NCT00502593|65873015|FG011|Overall Study|Withdrawn unspecified reason|0|||
23586172|NCT00502593|65873004|FG000|Overall Study|Withdrawal by Subject|0|||
23244392|NCT05182840|64638825|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23244393|NCT05182840|64638826|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23466289|NCT02745119|65451980|FG000|Overall Study|Withdrawal by Subject|7|||
23466290|NCT02745119|65451981|FG001|Overall Study|Withdrawal by Subject|15|||
23466291|NCT02745119|65451982|FG002|Overall Study|Withdrawal by Subject|8|||
23466292|NCT02745119|65451983|FG003|Overall Study|Withdrawal by Subject|14|||
23466293|NCT02745119|65451980|FG000|Overall Study|Study Terminated by Sponsor|134|||
23586173|NCT00502593|65873005|FG001|Overall Study|Withdrawal by Subject|0|||
23586174|NCT00502593|65873006|FG002|Overall Study|Withdrawal by Subject|6|||
23586175|NCT00502593|65873007|FG003|Overall Study|Withdrawal by Subject|2|||
23586176|NCT00502593|65873008|FG004|Overall Study|Withdrawal by Subject|2|||
23586177|NCT00502593|65873009|FG005|Overall Study|Withdrawal by Subject|0|||
23586178|NCT00502593|65873010|FG006|Overall Study|Withdrawal by Subject|3|||
23586179|NCT00502593|65873011|FG007|Overall Study|Withdrawal by Subject|0|||
23586180|NCT00502593|65873012|FG008|Overall Study|Withdrawal by Subject|3|||
23586181|NCT00502593|65873013|FG009|Overall Study|Withdrawal by Subject|0|||
23586182|NCT00502593|65873014|FG010|Overall Study|Withdrawal by Subject|1|||
23586183|NCT00502593|65873015|FG011|Overall Study|Withdrawal by Subject|0|||
23586184|NCT00502593|65873004|FG000|Overall Study|Lost to Follow-up|2|||
23586185|NCT00502593|65873005|FG001|Overall Study|Lost to Follow-up|1|||
23586186|NCT00502593|65873006|FG002|Overall Study|Lost to Follow-up|1|||
23586187|NCT00502593|65873007|FG003|Overall Study|Lost to Follow-up|1|||
23586188|NCT00502593|65873008|FG004|Overall Study|Lost to Follow-up|0|||
23586189|NCT00502593|65873009|FG005|Overall Study|Lost to Follow-up|0|||
23586190|NCT00502593|65873010|FG006|Overall Study|Lost to Follow-up|0|||
23586191|NCT00502593|65873011|FG007|Overall Study|Lost to Follow-up|0|||
23586192|NCT00502593|65873012|FG008|Overall Study|Lost to Follow-up|3|||
23586193|NCT00502593|65873013|FG009|Overall Study|Lost to Follow-up|0|||
23586194|NCT00502593|65873014|FG010|Overall Study|Lost to Follow-up|1|||
23185925|NCT03311126|64422874|FG000|Induction|Death|1|||
23185926|NCT03311126|64422874|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
23185927|NCT03570892|64422877|FG000|Overall Study|Death|51|||
23586195|NCT00502593|65873015|FG011|Overall Study|Lost to Follow-up|0|||
23586196|NCT02993471|65873021|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
23586197|NCT02993471|65873021|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
23586198|NCT01123083|65873022|FG000|Overall Study|Investigator recommendation|1|||
23586199|NCT01123083|65873023|FG001|Overall Study|Investigator recommendation|1|||
23586200|NCT01123083|65873022|FG000|Overall Study|Administrative reasons|0|||
23586201|NCT01123083|65873023|FG001|Overall Study|Administrative reasons|4|||
23586202|NCT01123083|65873022|FG000|Overall Study|Lost to Follow-up|2|||
23586203|NCT01123083|65873023|FG001|Overall Study|Lost to Follow-up|6|||
23586204|NCT01123083|65873022|FG000|Overall Study|Adverse Event|1|||
23185928|NCT03570892|64422878|FG001|Overall Study|Death|45|||
23185929|NCT03570892|64422877|FG000|Overall Study|Subject decision|5|||
23185930|NCT03570892|64422878|FG001|Overall Study|Subject decision|3|||
23185931|NCT03570892|64422877|FG000|Overall Study|Protocol Violation|1|||
23185932|NCT03570892|64422878|FG001|Overall Study|Protocol Violation|4|||
23185933|NCT03570892|64422877|FG000|Overall Study|Physician Decision|0|||
23185934|NCT03570892|64422878|FG001|Overall Study|Physician Decision|2|||
23185935|NCT03814746|64422879|FG000|Overall Study|Participant decision|9|||
23185936|NCT03814746|64422880|FG001|Overall Study|Participant decision|6|||
23185937|NCT03814746|64422881|FG002|Overall Study|Participant decision|15|||
23185938|NCT03814746|64422879|FG000|Overall Study|Physician Decision|2|||
23185939|NCT03814746|64422880|FG001|Overall Study|Physician Decision|2|||
23185940|NCT03814746|64422881|FG002|Overall Study|Physician Decision|4|||
23185941|NCT03814746|64422879|FG000|Overall Study|Death|2|||
23185942|NCT03814746|64422880|FG001|Overall Study|Death|2|||
23185943|NCT03814746|64422881|FG002|Overall Study|Death|2|||
23185944|NCT03814746|64422879|FG000|Overall Study|Adverse Event|2|||
23185945|NCT03814746|64422880|FG001|Overall Study|Adverse Event|2|||
23185946|NCT03814746|64422881|FG002|Overall Study|Adverse Event|1|||
23185947|NCT03814746|64422879|FG000|Overall Study|Lost to Follow-up|2|||
23185948|NCT03814746|64422880|FG001|Overall Study|Lost to Follow-up|1|||
23185949|NCT03814746|64422881|FG002|Overall Study|Lost to Follow-up|2|||
23586205|NCT01123083|65873023|FG001|Overall Study|Adverse Event|0|||
23586206|NCT01123083|65873022|FG000|Overall Study|Withdrew for another reason not covered|0|||
23586207|NCT01123083|65873023|FG001|Overall Study|Withdrew for another reason not covered|1|||
23586208|NCT01123083|65873022|FG000|Overall Study|Participant/legal representative request|7|||
23586209|NCT01123083|65873023|FG001|Overall Study|Participant/legal representative request|3|||
23586210|NCT00424762|65873027|FG000|Overall Study|Withdrawal by Subject|18|||
23185950|NCT03814746|64422879|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23586211|NCT00424762|65873028|FG001|Overall Study|Withdrawal by Subject|19|||
23586212|NCT00424762|65873027|FG000|Overall Study|Lost to Follow-up|2|||
23586213|NCT00424762|65873028|FG001|Overall Study|Lost to Follow-up|3|||
23586214|NCT02430532|65873029|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
23586215|NCT02430532|65873030|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
23586216|NCT02430532|65873029|FG000|Overall Study|Consent Withdrawn|0|||
23586217|NCT02430532|65873030|FG001|Overall Study|Consent Withdrawn|2|||
23586218|NCT02430532|65873029|FG000|Overall Study|Adverse Event|0|||
23586219|NCT02430532|65873030|FG001|Overall Study|Adverse Event|1|||
23586220|NCT02943993|65873031|FG000|Overall Study|Withdrawal by Subject|52|||
23586221|NCT02943993|65873031|FG000|Overall Study|Transfer to another institution|6|||
23586222|NCT02943993|65873031|FG000|Overall Study|Lost to Follow-up|135|||
23586223|NCT02943993|65873031|FG000|Overall Study|Death|98|||
23586224|NCT02943993|65873031|FG000|Overall Study|Other reason for premature termination|32|||
23586225|NCT02943993|65873031|FG000|Overall Study|Missing reason for termination|7|||
23586226|NCT03532178|65873033|FG000|First Period|Withdrawal by Subject|1|||
23586227|NCT03532178|65873034|FG001|First Period|Withdrawal by Subject|3|||
23586228|NCT03532178|65873033|FG000|First Period|technical issues in data collection Technical issues|0|||
23586229|NCT03532178|65873034|FG001|First Period|technical issues in data collection Technical issues|1|||
23586230|NCT03532178|65873033|FG000|Second Period|Withdrawal by Subject|1|||
23586231|NCT03532178|65873034|FG001|Second Period|Withdrawal by Subject|1|||
23586232|NCT03532178|65873033|FG000|Second Period|Technical issues|0|||
23586233|NCT03532178|65873034|FG001|Second Period|Technical issues|1|||
23586234|NCT01235949|65873039|FG000|Primary Phase|Migrated/moved from study area|1|||
23586235|NCT01235949|65873040|FG001|Primary Phase|Migrated/moved from study area|1|||
23586236|NCT01235949|65873041|FG002|Primary Phase|Migrated/moved from study area|0|||
23586237|NCT01235949|65873042|FG003|Primary Phase|Migrated/moved from study area|0|||
23586238|NCT01235949|65873043|FG004|Primary Phase|Migrated/moved from study area|1|||
23586239|NCT01235949|65873044|FG005|Primary Phase|Migrated/moved from study area|2|||
23586240|NCT01235949|65873045|FG006|Primary Phase|Migrated/moved from study area|0|||
23586241|NCT01235949|65873046|FG007|Primary Phase|Migrated/moved from study area|0|||
23586242|NCT01235949|65873047|FG008|Primary Phase|Migrated/moved from study area|0|||
23586243|NCT01235949|65873048|FG009|Primary Phase|Migrated/moved from study area|0|||
23586244|NCT01235949|65873049|FG010|Primary Phase|Migrated/moved from study area|0|||
23586245|NCT01235949|65873050|FG011|Primary Phase|Migrated/moved from study area|0|||
23586246|NCT01235949|65873051|FG012|Primary Phase|Migrated/moved from study area|0|||
23586247|NCT01235949|65873052|FG013|Primary Phase|Migrated/moved from study area|0|||
23586248|NCT01235949|65873053|FG014|Primary Phase|Migrated/moved from study area|0|||
23586249|NCT01235949|65873054|FG015|Primary Phase|Migrated/moved from study area|0|||
23586250|NCT01235949|65873055|FG016|Primary Phase|Migrated/moved from study area|0|||
23586251|NCT01235949|65873056|FG017|Primary Phase|Migrated/moved from study area|0|||
23586252|NCT01235949|65873039|FG000|Primary Phase|Adverse Event|0|||
23586253|NCT01235949|65873040|FG001|Primary Phase|Adverse Event|0|||
23586254|NCT01235949|65873041|FG002|Primary Phase|Adverse Event|0|||
23586255|NCT01235949|65873042|FG003|Primary Phase|Adverse Event|1|||
23586256|NCT01235949|65873043|FG004|Primary Phase|Adverse Event|0|||
23586257|NCT01235949|65873044|FG005|Primary Phase|Adverse Event|0|||
23586258|NCT01235949|65873045|FG006|Primary Phase|Adverse Event|0|||
23586259|NCT01235949|65873046|FG007|Primary Phase|Adverse Event|0|||
23586260|NCT01235949|65873047|FG008|Primary Phase|Adverse Event|0|||
23586261|NCT01235949|65873048|FG009|Primary Phase|Adverse Event|0|||
23586262|NCT01235949|65873049|FG010|Primary Phase|Adverse Event|0|||
23586263|NCT01235949|65873050|FG011|Primary Phase|Adverse Event|0|||
23586264|NCT01235949|65873051|FG012|Primary Phase|Adverse Event|0|||
23586265|NCT01235949|65873052|FG013|Primary Phase|Adverse Event|0|||
23586266|NCT01235949|65873053|FG014|Primary Phase|Adverse Event|0|||
23586267|NCT01235949|65873054|FG015|Primary Phase|Adverse Event|0|||
23586268|NCT01235949|65873055|FG016|Primary Phase|Adverse Event|0|||
23586269|NCT01235949|65873056|FG017|Primary Phase|Adverse Event|0|||
23586270|NCT01235949|65873039|FG000|Primary Phase|Withdrawal by Subject|3|||
23586271|NCT01235949|65873040|FG001|Primary Phase|Withdrawal by Subject|2|||
23586272|NCT01235949|65873041|FG002|Primary Phase|Withdrawal by Subject|2|||
23586273|NCT01235949|65873042|FG003|Primary Phase|Withdrawal by Subject|0|||
23586274|NCT01235949|65873043|FG004|Primary Phase|Withdrawal by Subject|0|||
23586275|NCT01235949|65873044|FG005|Primary Phase|Withdrawal by Subject|3|||
23586276|NCT01235949|65873045|FG006|Primary Phase|Withdrawal by Subject|0|||
23351293|NCT00553358|65029562|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
23586277|NCT01235949|65873046|FG007|Primary Phase|Withdrawal by Subject|0|||
23586278|NCT01235949|65873047|FG008|Primary Phase|Withdrawal by Subject|0|||
23586279|NCT01235949|65873048|FG009|Primary Phase|Withdrawal by Subject|0|||
23586280|NCT01235949|65873049|FG010|Primary Phase|Withdrawal by Subject|0|||
23586281|NCT01235949|65873050|FG011|Primary Phase|Withdrawal by Subject|0|||
23586282|NCT01235949|65873051|FG012|Primary Phase|Withdrawal by Subject|0|||
23185951|NCT03814746|64422880|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23185952|NCT03814746|64422881|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23185953|NCT03814746|64422879|FG000|Overall Study|Pregnancy|0|||
23185954|NCT03814746|64422880|FG001|Overall Study|Pregnancy|1|||
23185955|NCT03814746|64422881|FG002|Overall Study|Pregnancy|1|||
23185956|NCT03814746|64422879|FG000|Overall Study|Protocol Violation|1|||
23185957|NCT03814746|64422880|FG001|Overall Study|Protocol Violation|0|||
23185958|NCT03814746|64422881|FG002|Overall Study|Protocol Violation|0|||
23185959|NCT02432807|64422882|FG000|Overall Study|Adverse Event|0|||
23185960|NCT02432807|64422883|FG001|Overall Study|Adverse Event|2|||
23185961|NCT02432807|64422882|FG000|Overall Study|Lost to Follow-up|1|||
23185962|NCT02432807|64422883|FG001|Overall Study|Lost to Follow-up|0|||
23185963|NCT02432807|64422882|FG000|Overall Study|Withdrawal by Subject|1|||
23185964|NCT02432807|64422883|FG001|Overall Study|Withdrawal by Subject|1|||
23185965|NCT02432807|64422882|FG000|Overall Study|Other|1|||
23185966|NCT02432807|64422883|FG001|Overall Study|Other|1|||
23185967|NCT05593432|64422885|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
23185968|NCT05593432|64422886|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
23185969|NCT05593432|64422887|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
23185970|NCT05593432|64422888|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
23244394|NCT05182840|64638827|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
23244395|NCT05182840|64638818|FG000|Treatment Period|Reason missing|0|||
23185971|NCT05593432|64422885|FG000|16-Week OLE Period|Lack of Efficacy|0|||
23185972|NCT05593432|64422886|FG001|16-Week OLE Period|Lack of Efficacy|0|||
23185973|NCT05593432|64422887|FG002|16-Week OLE Period|Lack of Efficacy|0|||
23185974|NCT05593432|64422888|FG003|16-Week OLE Period|Lack of Efficacy|1|||
23185975|NCT05593432|64422885|FG000|16-Week OLE Period|Lost to Follow-up|0|||
23185976|NCT05593432|64422886|FG001|16-Week OLE Period|Lost to Follow-up|0|||
23185977|NCT05593432|64422887|FG002|16-Week OLE Period|Lost to Follow-up|1|||
23185978|NCT05593432|64422888|FG003|16-Week OLE Period|Lost to Follow-up|2|||
23185979|NCT05593432|64422885|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
23185980|NCT05593432|64422886|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
23185981|NCT05593432|64422887|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
23185982|NCT05593432|64422888|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
23185983|NCT03106779|64422889|FG000|Overall Study|Lack of Efficacy|33|||
23185984|NCT03106779|64422890|FG001|Overall Study|Lack of Efficacy|24|||
23185985|NCT03106779|64422889|FG000|Overall Study|Adverse Event|8|||
23244396|NCT05182840|64638819|FG001|Treatment Period|Reason missing|0|||
23244397|NCT05182840|64638820|FG002|Treatment Period|Reason missing|1|||
23244398|NCT05182840|64638821|FG003|Treatment Period|Reason missing|0|||
23244399|NCT05182840|64638822|FG004|Treatment Period|Reason missing|0|||
23244400|NCT05182840|64638823|FG005|Treatment Period|Reason missing|0|||
23244401|NCT05182840|64638824|FG006|Treatment Period|Reason missing|0|||
23244402|NCT05182840|64638825|FG007|Treatment Period|Reason missing|0|||
23244403|NCT05182840|64638826|FG008|Treatment Period|Reason missing|0|||
23244404|NCT05182840|64638827|FG009|Treatment Period|Reason missing|0|||
23244405|NCT05182840|64638818|FG000|Treatment Period|Other but not sponsor termination|0|||
23244406|NCT05182840|64638819|FG001|Treatment Period|Other but not sponsor termination|0|||
23244407|NCT05182840|64638820|FG002|Treatment Period|Other but not sponsor termination|8|||
23244408|NCT05182840|64638821|FG003|Treatment Period|Other but not sponsor termination|6|||
23244409|NCT05182840|64638822|FG004|Treatment Period|Other but not sponsor termination|6|||
23244410|NCT05182840|64638823|FG005|Treatment Period|Other but not sponsor termination|7|||
23244411|NCT05182840|64638824|FG006|Treatment Period|Other but not sponsor termination|5|||
23244412|NCT05182840|64638825|FG007|Treatment Period|Other but not sponsor termination|8|||
23244413|NCT05182840|64638826|FG008|Treatment Period|Other but not sponsor termination|7|||
23244414|NCT05182840|64638827|FG009|Treatment Period|Other but not sponsor termination|2|||
23244415|NCT05182840|64638818|FG000|Treatment Period|Protocol deviation|0|||
23244416|NCT05182840|64638819|FG001|Treatment Period|Protocol deviation|0|||
23244417|NCT05182840|64638820|FG002|Treatment Period|Protocol deviation|0|||
23244418|NCT05182840|64638821|FG003|Treatment Period|Protocol deviation|0|||
23185986|NCT03106779|64422890|FG001|Overall Study|Adverse Event|16|||
23185987|NCT03106779|64422889|FG000|Overall Study|Physician Decision|10|||
23185988|NCT03106779|64422890|FG001|Overall Study|Physician Decision|6|||
23185989|NCT03106779|64422889|FG000|Overall Study|Patient/guardian decision|4|||
23185990|NCT03106779|64422890|FG001|Overall Study|Patient/guardian decision|3|||
23185991|NCT03106779|64422889|FG000|Overall Study|Progressive disease|1|||
23185992|NCT03106779|64422890|FG001|Overall Study|Progressive disease|3|||
23244419|NCT05182840|64638822|FG004|Treatment Period|Protocol deviation|0|||
23185993|NCT03106779|64422889|FG000|Overall Study|Lost to Follow-up|1|||
23185994|NCT03106779|64422890|FG001|Overall Study|Lost to Follow-up|2|||
23185995|NCT03106779|64422889|FG000|Overall Study|Death|1|||
23185996|NCT03106779|64422890|FG001|Overall Study|Death|0|||
23185997|NCT03106779|64422889|FG000|Overall Study|Protocol Violation|1|||
23185998|NCT03106779|64422890|FG001|Overall Study|Protocol Violation|0|||
23185999|NCT03106779|64422889|FG000|Overall Study|Not treated|1|||
23186000|NCT03106779|64422890|FG001|Overall Study|Not treated|0|||
23186001|NCT04963231|64422897|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
23186002|NCT04963231|64422898|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
23186003|NCT04963231|64422899|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
23186004|NCT04963231|64422897|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
23186005|NCT04963231|64422898|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
23186006|NCT04963231|64422899|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
23186007|NCT04963231|64422897|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
23186008|NCT04963231|64422898|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
23186009|NCT04963231|64422899|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
23186010|NCT04963231|64422897|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
23186011|NCT04963231|64422898|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
23186012|NCT04963231|64422899|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
23186013|NCT04963231|64422897|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
23186014|NCT04963231|64422898|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
23186015|NCT04963231|64422899|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
23186016|NCT04963231|64422897|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
23351294|NCT00553358|65029563|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
23351295|NCT00553358|65029564|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
23351296|NCT00553358|65029562|FG000|Overall Study|Died after clinical follow-up ended|1|||
23351297|NCT00553358|65029563|FG001|Overall Study|Died after clinical follow-up ended|2|||
23351298|NCT00553358|65029564|FG002|Overall Study|Died after clinical follow-up ended|0|||
23351299|NCT00553358|65029562|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
23351300|NCT00553358|65029563|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
23351301|NCT00553358|65029564|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
23351302|NCT04908475|65029565|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
23186017|NCT04963231|64422898|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
23186018|NCT04963231|64422899|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
23351303|NCT04908475|65029566|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351304|NCT04908475|65029567|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351305|NCT04908475|65029568|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351306|NCT04908475|65029569|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351307|NCT04908475|65029570|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
23351308|NCT04908475|65029565|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
23351309|NCT04908475|65029566|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351310|NCT04908475|65029567|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351311|NCT04908475|65029568|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351312|NCT04908475|65029569|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351313|NCT04908475|65029570|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
23351314|NCT04908475|65029565|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
23351315|NCT04908475|65029566|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351316|NCT04908475|65029567|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351317|NCT04908475|65029568|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351318|NCT04908475|65029569|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351319|NCT04908475|65029570|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
23351320|NCT04908475|65029565|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23351321|NCT04908475|65029566|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
23351322|NCT04908475|65029567|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
23351323|NCT04908475|65029568|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
23351324|NCT04908475|65029569|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23351325|NCT04908475|65029570|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
23351326|NCT04908475|65029565|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
23351327|NCT04908475|65029566|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
23351328|NCT04908475|65029567|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
23351329|NCT04908475|65029568|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
23351330|NCT04908475|65029569|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
23351331|NCT04908475|65029570|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
23351332|NCT04908475|65029565|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
23351333|NCT04908475|65029566|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
23351334|NCT04908475|65029567|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
23586283|NCT01235949|65873052|FG013|Primary Phase|Withdrawal by Subject|0|||
23586284|NCT01235949|65873053|FG014|Primary Phase|Withdrawal by Subject|0|||
23586285|NCT01235949|65873054|FG015|Primary Phase|Withdrawal by Subject|0|||
23586286|NCT01235949|65873055|FG016|Primary Phase|Withdrawal by Subject|0|||
23586287|NCT01235949|65873056|FG017|Primary Phase|Withdrawal by Subject|0|||
23244420|NCT05182840|64638823|FG005|Treatment Period|Protocol deviation|0|||
23244421|NCT05182840|64638824|FG006|Treatment Period|Protocol deviation|0|||
23244422|NCT05182840|64638825|FG007|Treatment Period|Protocol deviation|0|||
23244423|NCT05182840|64638826|FG008|Treatment Period|Protocol deviation|1|||
23244424|NCT05182840|64638827|FG009|Treatment Period|Protocol deviation|0|||
23244425|NCT05182840|64638818|FG000|Treatment Period|No reason available|0|||
23244426|NCT05182840|64638819|FG001|Treatment Period|No reason available|0|||
23244427|NCT05182840|64638820|FG002|Treatment Period|No reason available|0|||
23244428|NCT05182840|64638821|FG003|Treatment Period|No reason available|1|||
23244429|NCT05182840|64638822|FG004|Treatment Period|No reason available|0|||
23244430|NCT05182840|64638823|FG005|Treatment Period|No reason available|2|||
23244431|NCT05182840|64638824|FG006|Treatment Period|No reason available|0|||
23244432|NCT05182840|64638825|FG007|Treatment Period|No reason available|1|||
23244433|NCT05182840|64638826|FG008|Treatment Period|No reason available|0|||
23244434|NCT05182840|64638827|FG009|Treatment Period|No reason available|0|||
23186019|NCT04963231|64422897|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
23186020|NCT04963231|64422898|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
23186021|NCT04963231|64422899|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
23186022|NCT03095703|64422902|FG000|Overall Study|Withdrawal by Subject|1|||
23186023|NCT03615222|64422903|FG000|Overall Study|Ineligible|26|||
23186024|NCT03615222|64422903|FG000|Overall Study|Withdrawal by Subject|7|||
23186025|NCT03615222|64422903|FG000|Overall Study|Death|1|||
23186026|NCT05047523|64422904|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23186027|NCT05047523|64422905|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23186028|NCT05047523|64422906|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
23186029|NCT05047523|64422907|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23186030|NCT05047523|64422908|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23186031|NCT05047523|64422909|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
23186032|NCT05047523|64422904|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23186033|NCT05047523|64422905|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
23186034|NCT05047523|64422906|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23186035|NCT05047523|64422907|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23186036|NCT05047523|64422908|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23244435|NCT05182840|64638818|FG000|Treatment Period|Burden of study procedures|0|||
23244436|NCT05182840|64638819|FG001|Treatment Period|Burden of study procedures|0|||
23244437|NCT05182840|64638820|FG002|Treatment Period|Burden of study procedures|0|||
23244438|NCT05182840|64638821|FG003|Treatment Period|Burden of study procedures|0|||
23244439|NCT05182840|64638822|FG004|Treatment Period|Burden of study procedures|1|||
23244440|NCT05182840|64638823|FG005|Treatment Period|Burden of study procedures|0|||
23244441|NCT05182840|64638824|FG006|Treatment Period|Burden of study procedures|0|||
23244442|NCT05182840|64638825|FG007|Treatment Period|Burden of study procedures|0|||
23244443|NCT05182840|64638826|FG008|Treatment Period|Burden of study procedures|0|||
23244444|NCT05182840|64638827|FG009|Treatment Period|Burden of study procedures|0|||
23351335|NCT04908475|65029568|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
23351336|NCT04908475|65029569|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
23351337|NCT04908475|65029570|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
23351338|NCT01573754|65029575|FG000|Overall Study|Noncompliance or remission not achieved|3|||
23351339|NCT01573754|65029576|FG001|Overall Study|Noncompliance or remission not achieved|15|||
23351340|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
23351341|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
23351342|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
23351343|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
23351344|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
23351345|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
23351346|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
23351347|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
23351348|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
23351349|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
23351350|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
23351351|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
23351352|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
23351353|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
23351354|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
23586288|NCT01235949|65873039|FG000|Primary Phase|Lost to Follow-up|0|||
23586289|NCT01235949|65873040|FG001|Primary Phase|Lost to Follow-up|0|||
23244445|NCT05182840|64638818|FG000|Treatment Period|Change of residence|0|||
23244446|NCT05182840|64638819|FG001|Treatment Period|Change of residence|0|||
23244447|NCT05182840|64638820|FG002|Treatment Period|Change of residence|0|||
23466294|NCT02745119|65451981|FG001|Overall Study|Study Terminated by Sponsor|252|||
23466295|NCT02745119|65451982|FG002|Overall Study|Study Terminated by Sponsor|135|||
23466296|NCT02745119|65451983|FG003|Overall Study|Study Terminated by Sponsor|251|||
23466297|NCT02745119|65451980|FG000|Overall Study|Physician Decision|0|||
23466298|NCT02745119|65451981|FG001|Overall Study|Physician Decision|2|||
23466299|NCT02745119|65451982|FG002|Overall Study|Physician Decision|2|||
23466300|NCT02745119|65451983|FG003|Overall Study|Physician Decision|2|||
23466301|NCT02745119|65451980|FG000|Overall Study|Reason Not Specified|0|||
23186037|NCT05047523|64422909|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
23186038|NCT05047523|64422904|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
23186039|NCT05047523|64422905|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
23244448|NCT05182840|64638821|FG003|Treatment Period|Change of residence|0|||
23244449|NCT05182840|64638822|FG004|Treatment Period|Change of residence|0|||
23244450|NCT05182840|64638823|FG005|Treatment Period|Change of residence|1|||
23244451|NCT05182840|64638824|FG006|Treatment Period|Change of residence|0|||
23244452|NCT05182840|64638825|FG007|Treatment Period|Change of residence|0|||
23244453|NCT05182840|64638826|FG008|Treatment Period|Change of residence|0|||
23244454|NCT05182840|64638827|FG009|Treatment Period|Change of residence|0|||
23244455|NCT05182840|64638818|FG000|Treatment Period|Adverse Event|0|||
23244456|NCT05182840|64638819|FG001|Treatment Period|Adverse Event|0|||
23244457|NCT05182840|64638820|FG002|Treatment Period|Adverse Event|4|||
23244458|NCT05182840|64638821|FG003|Treatment Period|Adverse Event|16|||
23244459|NCT05182840|64638822|FG004|Treatment Period|Adverse Event|12|||
23244460|NCT05182840|64638823|FG005|Treatment Period|Adverse Event|6|||
23244461|NCT05182840|64638824|FG006|Treatment Period|Adverse Event|4|||
23244462|NCT05182840|64638825|FG007|Treatment Period|Adverse Event|8|||
23244463|NCT05182840|64638826|FG008|Treatment Period|Adverse Event|16|||
23244464|NCT05182840|64638827|FG009|Treatment Period|Adverse Event|5|||
23466302|NCT02745119|65451981|FG001|Overall Study|Reason Not Specified|2|||
23466303|NCT02745119|65451982|FG002|Overall Study|Reason Not Specified|0|||
23466304|NCT02745119|65451983|FG003|Overall Study|Reason Not Specified|1|||
23466305|NCT03023397|65451986|FG000|Run-In|Failed screening allergen challenge|1|||
23186040|NCT05047523|64422906|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
23186041|NCT05047523|64422907|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
23186042|NCT05047523|64422908|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
23186043|NCT05047523|64422909|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
23186044|NCT05047523|64422904|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
23186045|NCT05047523|64422905|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23186046|NCT05047523|64422906|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23186047|NCT05047523|64422907|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23186048|NCT05047523|64422908|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23244465|NCT05182840|64638818|FG000|Treatment Period|Not treated with study drug|0|||
23466306|NCT03023397|65451987|FG001|Run-In|Failed screening allergen challenge|0|||
23466307|NCT03023397|65451988|FG002|Run-In|Failed screening allergen challenge|0|||
23466308|NCT03023397|65451986|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
23466309|NCT03023397|65451987|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
23466310|NCT03023397|65451988|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
23466311|NCT02224560|65451989|FG000|Overall Study|Protocol Deviation|1|||
23466312|NCT02224560|65451990|FG001|Overall Study|Protocol Deviation|0|||
23466313|NCT02224560|65451991|FG002|Overall Study|Protocol Deviation|0|||
23466314|NCT02224560|65451989|FG000|Overall Study|Withdrawal by Subject|2|||
23466315|NCT02224560|65451990|FG001|Overall Study|Withdrawal by Subject|0|||
23466316|NCT02224560|65451991|FG002|Overall Study|Withdrawal by Subject|1|||
23466317|NCT02224560|65451989|FG000|Overall Study|Met Withdrawal Criteria|1|||
23466318|NCT02224560|65451990|FG001|Overall Study|Met Withdrawal Criteria|0|||
23466319|NCT02224560|65451991|FG002|Overall Study|Met Withdrawal Criteria|0|||
23466320|NCT02224560|65451989|FG000|Overall Study|Adverse Event|4|||
23466321|NCT02224560|65451990|FG001|Overall Study|Adverse Event|1|||
23466322|NCT02224560|65451991|FG002|Overall Study|Adverse Event|1|||
23466323|NCT02224560|65451989|FG000|Overall Study|Withdrawn by Investigator|1|||
23466324|NCT02224560|65451990|FG001|Overall Study|Withdrawn by Investigator|1|||
23466325|NCT02224560|65451991|FG002|Overall Study|Withdrawn by Investigator|0|||
23244466|NCT05182840|64638819|FG001|Treatment Period|Not treated with study drug|0|||
23244467|NCT05182840|64638820|FG002|Treatment Period|Not treated with study drug|0|||
23244468|NCT05182840|64638821|FG003|Treatment Period|Not treated with study drug|1|||
23244469|NCT05182840|64638822|FG004|Treatment Period|Not treated with study drug|0|||
23466326|NCT01941186|65451996|FG000|Follow-up|Lost to Follow-up|1|||
23466327|NCT01941186|65451997|FG001|Follow-up|Lost to Follow-up|0|||
23466328|NCT02624986|65451998|FG000|Overall Study|Death|0|||
23466329|NCT02624986|65451999|FG001|Overall Study|Death|1|||
23466330|NCT02624986|65452000|FG002|Overall Study|Death|2|||
23466331|NCT02624986|65452001|FG003|Overall Study|Death|2|||
23466332|NCT02624986|65452002|FG004|Overall Study|Death|2|||
23466333|NCT02624986|65452003|FG005|Overall Study|Death|0|||
23466334|NCT02624986|65452004|FG006|Overall Study|Death|0|||
23466335|NCT02624986|65452005|FG007|Overall Study|Death|1|||
23466336|NCT02624986|65451998|FG000|Overall Study|Study Terminated by Sponsor|1|||
23466337|NCT02624986|65451999|FG001|Overall Study|Study Terminated by Sponsor|1|||
23466338|NCT02624986|65452000|FG002|Overall Study|Study Terminated by Sponsor|0|||
23244470|NCT05182840|64638823|FG005|Treatment Period|Not treated with study drug|0|||
23244471|NCT05182840|64638824|FG006|Treatment Period|Not treated with study drug|1|||
23351355|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
23351356|NCT02362425|65029578|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
23351357|NCT02362425|65029579|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
23351358|NCT02362425|65029580|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
23466339|NCT02624986|65452001|FG003|Overall Study|Study Terminated by Sponsor|1|||
23466340|NCT02624986|65452002|FG004|Overall Study|Study Terminated by Sponsor|2|||
23466341|NCT02624986|65452003|FG005|Overall Study|Study Terminated by Sponsor|2|||
23466342|NCT02624986|65452004|FG006|Overall Study|Study Terminated by Sponsor|4|||
23466343|NCT02624986|65452005|FG007|Overall Study|Study Terminated by Sponsor|3|||
23466344|NCT02624986|65451998|FG000|Overall Study|Progressive Disease|0|||
23466345|NCT02624986|65451999|FG001|Overall Study|Progressive Disease|1|||
23466346|NCT02624986|65452000|FG002|Overall Study|Progressive Disease|0|||
23466347|NCT02624986|65452001|FG003|Overall Study|Progressive Disease|0|||
23466348|NCT02624986|65452002|FG004|Overall Study|Progressive Disease|0|||
23466349|NCT02624986|65452003|FG005|Overall Study|Progressive Disease|0|||
23466350|NCT02624986|65452004|FG006|Overall Study|Progressive Disease|0|||
23466351|NCT02624986|65452005|FG007|Overall Study|Progressive Disease|0|||
23466352|NCT02624986|65451998|FG000|Overall Study|Protocol Violation|1|||
23466353|NCT02624986|65451999|FG001|Overall Study|Protocol Violation|0|||
23466354|NCT02624986|65452000|FG002|Overall Study|Protocol Violation|0|||
23466355|NCT02624986|65452001|FG003|Overall Study|Protocol Violation|0|||
23466356|NCT02624986|65452002|FG004|Overall Study|Protocol Violation|0|||
23466357|NCT02624986|65452003|FG005|Overall Study|Protocol Violation|0|||
23466358|NCT02624986|65452004|FG006|Overall Study|Protocol Violation|0|||
23586290|NCT01235949|65873041|FG002|Primary Phase|Lost to Follow-up|1|||
23586291|NCT01235949|65873042|FG003|Primary Phase|Lost to Follow-up|1|||
23586292|NCT01235949|65873043|FG004|Primary Phase|Lost to Follow-up|0|||
23351359|NCT02362425|65029581|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
23351360|NCT02362425|65029578|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
23351361|NCT02362425|65029579|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
23351362|NCT02362425|65029580|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
23351363|NCT02362425|65029581|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
23351364|NCT02362425|65029578|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
23351365|NCT02362425|65029579|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
23351366|NCT02362425|65029580|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
23351367|NCT02362425|65029581|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
23351368|NCT02362425|65029578|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
23351369|NCT02362425|65029579|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
23351370|NCT02362425|65029580|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
23351371|NCT02362425|65029581|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
23351372|NCT00637806|65029593|FG000|Double-blind Phase|Study Discontinued|2|||
23351373|NCT00637806|65029594|FG001|Double-blind Phase|Study Discontinued|0|||
23351374|NCT00637806|65029595|FG002|Double-blind Phase|Study Discontinued|1|||
23351375|NCT00637806|65029596|FG003|Double-blind Phase|Study Discontinued|0|||
23351376|NCT00637806|65029593|FG000|Extension Phase|Study Discontinued|0|||
23351377|NCT00637806|65029594|FG001|Extension Phase|Study Discontinued|0|||
23351378|NCT00637806|65029595|FG002|Extension Phase|Study Discontinued|0|||
23351379|NCT00637806|65029596|FG003|Extension Phase|Study Discontinued|1|||
23351380|NCT02243046|65029604|FG000|Overall Study|Lost to Follow-up|1|||
23466359|NCT02624986|65452005|FG007|Overall Study|Protocol Violation|0|||
23466360|NCT02624986|65451998|FG000|Overall Study|Withdrawal by Subject|0|||
23466361|NCT02624986|65451999|FG001|Overall Study|Withdrawal by Subject|0|||
23586293|NCT01235949|65873044|FG005|Primary Phase|Lost to Follow-up|2|||
23586294|NCT01235949|65873045|FG006|Primary Phase|Lost to Follow-up|0|||
23466362|NCT02624986|65452000|FG002|Overall Study|Withdrawal by Subject|0|||
23466363|NCT02624986|65452001|FG003|Overall Study|Withdrawal by Subject|0|||
23466364|NCT02624986|65452002|FG004|Overall Study|Withdrawal by Subject|0|||
23351381|NCT02243046|65029605|FG001|Overall Study|Lost to Follow-up|1|||
23351382|NCT02243046|65029606|FG002|Overall Study|Lost to Follow-up|4|||
23351383|NCT01451554|65029611|FG000|Overall Study|Withdrawal by Subject|14|||
23466365|NCT02624986|65452003|FG005|Overall Study|Withdrawal by Subject|0|||
23586295|NCT01235949|65873046|FG007|Primary Phase|Lost to Follow-up|0|||
23586296|NCT01235949|65873047|FG008|Primary Phase|Lost to Follow-up|0|||
23466366|NCT02624986|65452004|FG006|Overall Study|Withdrawal by Subject|0|||
23466367|NCT02624986|65452005|FG007|Overall Study|Withdrawal by Subject|1|||
23466368|NCT02215252|65452006|FG000|Overall Study|Adverse Event|1|||
23466369|NCT02215252|65452007|FG001|Overall Study|Adverse Event|5|||
23466370|NCT02215252|65452008|FG002|Overall Study|Adverse Event|2|||
23466371|NCT02215252|65452006|FG000|Overall Study|Lost to Follow-up|0|||
23466372|NCT02215252|65452007|FG001|Overall Study|Lost to Follow-up|0|||
23466373|NCT02215252|65452008|FG002|Overall Study|Lost to Follow-up|1|||
23466374|NCT02215252|65452006|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
23466375|NCT02215252|65452007|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
23466376|NCT02215252|65452008|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
23466377|NCT02215252|65452006|FG000|Overall Study|Protocol Violation|0|||
23466378|NCT02215252|65452007|FG001|Overall Study|Protocol Violation|1|||
23466379|NCT02215252|65452008|FG002|Overall Study|Protocol Violation|0|||
23466380|NCT02215252|65452006|FG000|Overall Study|Withdrawal by Subject|1|||
23466381|NCT02215252|65452007|FG001|Overall Study|Withdrawal by Subject|0|||
23466382|NCT02215252|65452008|FG002|Overall Study|Withdrawal by Subject|0|||
23466383|NCT02215252|65452006|FG000|Overall Study|Other|0|||
23466384|NCT02215252|65452007|FG001|Overall Study|Other|1|||
23466385|NCT02215252|65452008|FG002|Overall Study|Other|1|||
23466386|NCT01317277|65452009|FG000|Overall Study|Lost to Follow-up|3|||
23466387|NCT01317277|65452010|FG001|Overall Study|Lost to Follow-up|1|||
23466388|NCT01317277|65452009|FG000|Overall Study|Lost MEMS|1|||
23466389|NCT01317277|65452010|FG001|Overall Study|Lost MEMS|1|||
23466390|NCT01317277|65452009|FG000|Overall Study|Unable to comply with intervention|1|||
23466391|NCT01317277|65452010|FG001|Overall Study|Unable to comply with intervention|0|||
23466392|NCT01317277|65452009|FG000|Overall Study|Withdrawal by Subject|1|||
23186049|NCT05047523|64422909|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
23186050|NCT05047523|64422904|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
23186051|NCT05047523|64422905|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
23186052|NCT05047523|64422906|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
23186053|NCT05047523|64422907|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
23186054|NCT05047523|64422908|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
23186055|NCT05047523|64422909|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
23186056|NCT05047523|64422904|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
23186057|NCT05047523|64422905|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
23186058|NCT05047523|64422906|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
23186059|NCT05047523|64422907|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
23351384|NCT01451554|65029612|FG001|Overall Study|Withdrawal by Subject|9|||
23351385|NCT02536781|65029613|FG000|Overall Study|Lost to Follow-up|2|||
23351386|NCT02536781|65029614|FG001|Overall Study|Lost to Follow-up|0|||
23466393|NCT01317277|65452010|FG001|Overall Study|Withdrawal by Subject|0|||
23466394|NCT01317277|65452009|FG000|Overall Study|Adverse Event|1|||
23466395|NCT01317277|65452010|FG001|Overall Study|Adverse Event|0|||
23586297|NCT01235949|65873048|FG009|Primary Phase|Lost to Follow-up|0|||
23351387|NCT01853696|65029615|FG000|Overall Study|Withdrawal by Subject|1|||
23351388|NCT01853696|65029616|FG001|Overall Study|Withdrawal by Subject|1|||
23351389|NCT01853696|65029615|FG000|Overall Study|Lost to Follow-up|5|||
23351390|NCT01853696|65029616|FG001|Overall Study|Lost to Follow-up|4|||
23351391|NCT02735096|65029617|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
23351392|NCT00396383|65029618|FG000|Overall Study|Death|2|||
23351393|NCT00396383|65029618|FG000|Overall Study|Lost to Follow-up|1|||
23351394|NCT01593254|65029619|FG000|Overall Study|Disease progression|2|||
23351395|NCT01593254|65029620|FG001|Overall Study|Disease progression|7|||
23466396|NCT00889720|65452011|FG000|Overall Study|Withdrawal by Subject|4|||
23586298|NCT01235949|65873049|FG010|Primary Phase|Lost to Follow-up|0|||
23586299|NCT01235949|65873050|FG011|Primary Phase|Lost to Follow-up|0|||
23586300|NCT01235949|65873051|FG012|Primary Phase|Lost to Follow-up|0|||
23586301|NCT01235949|65873052|FG013|Primary Phase|Lost to Follow-up|0|||
23586302|NCT01235949|65873053|FG014|Primary Phase|Lost to Follow-up|0|||
23586303|NCT01235949|65873054|FG015|Primary Phase|Lost to Follow-up|0|||
23586304|NCT01235949|65873055|FG016|Primary Phase|Lost to Follow-up|0|||
23586305|NCT01235949|65873056|FG017|Primary Phase|Lost to Follow-up|0|||
23586306|NCT01235949|65873039|FG000|Booster Phase|Migrated/moved from study area|0|||
23586307|NCT01235949|65873040|FG001|Booster Phase|Migrated/moved from study area|0|||
23586308|NCT01235949|65873041|FG002|Booster Phase|Migrated/moved from study area|0|||
23466397|NCT00889720|65452011|FG000|Overall Study|Other|4|||
23466398|NCT00048074|65452012|FG000|Overall Study|Adverse Event|46|||
23466399|NCT00048074|65452013|FG001|Overall Study|Adverse Event|41|||
23351396|NCT01593254|65029619|FG000|Overall Study|Study drug toxicity|6|||
23351397|NCT01593254|65029620|FG001|Overall Study|Study drug toxicity|20|||
23351398|NCT01593254|65029619|FG000|Overall Study|Death|3|||
23351399|NCT01593254|65029620|FG001|Overall Study|Death|3|||
23466400|NCT00048074|65452014|FG002|Overall Study|Adverse Event|53|||
23466401|NCT00048074|65452012|FG000|Overall Study|Death|3|||
23466402|NCT00048074|65452013|FG001|Overall Study|Death|3|||
23586309|NCT01235949|65873042|FG003|Booster Phase|Migrated/moved from study area|0|||
23466403|NCT00048074|65452014|FG002|Overall Study|Death|2|||
23466404|NCT00048074|65452012|FG000|Overall Study|Lost to Follow-up|2|||
23466405|NCT00048074|65452013|FG001|Overall Study|Lost to Follow-up|6|||
23466406|NCT00048074|65452014|FG002|Overall Study|Lost to Follow-up|6|||
23466407|NCT00048074|65452012|FG000|Overall Study|Withdrawal by Subject|28|||
23466408|NCT00048074|65452013|FG001|Overall Study|Withdrawal by Subject|30|||
23466409|NCT00048074|65452014|FG002|Overall Study|Withdrawal by Subject|35|||
23466410|NCT00048074|65452012|FG000|Overall Study|Protocol Violation|1|||
23466411|NCT00048074|65452013|FG001|Overall Study|Protocol Violation|3|||
23466412|NCT00048074|65452014|FG002|Overall Study|Protocol Violation|0|||
23466413|NCT00048074|65452012|FG000|Overall Study|Study participation was terminated|0|||
23466414|NCT00048074|65452013|FG001|Overall Study|Study participation was terminated|1|||
23466415|NCT00048074|65452014|FG002|Overall Study|Study participation was terminated|0|||
23466416|NCT00048074|65452012|FG000|Overall Study|Husband ill|0|||
23466417|NCT00048074|65452013|FG001|Overall Study|Husband ill|1|||
23466418|NCT00048074|65452014|FG002|Overall Study|Husband ill|0|||
23466419|NCT00048074|65452012|FG000|Overall Study|Poor compliance|0|||
23186060|NCT05047523|64422908|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
23186061|NCT05047523|64422909|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
23186062|NCT05900115|64422910|FG000|Overall Study|Lost to Follow-up|129|||
23186063|NCT05900115|64422911|FG001|Overall Study|Lost to Follow-up|98|||
23186064|NCT03367156|64422912|FG000|Overall Study|Lack of interest|3|||
23186065|NCT03367156|64422913|FG001|Overall Study|Lack of interest|1|||
23466420|NCT00048074|65452013|FG001|Overall Study|Poor compliance|1|||
23466421|NCT00048074|65452014|FG002|Overall Study|Poor compliance|0|||
23466422|NCT00048074|65452012|FG000|Overall Study|Out of station|0|||
23466423|NCT00048074|65452013|FG001|Overall Study|Out of station|1|||
23466424|NCT00048074|65452014|FG002|Overall Study|Out of station|1|||
23466425|NCT00048074|65452012|FG000|Overall Study|Social reasons|1|||
23466426|NCT00048074|65452013|FG001|Overall Study|Social reasons|0|||
23466427|NCT00048074|65452014|FG002|Overall Study|Social reasons|0|||
23466428|NCT02504151|65452015|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
23466429|NCT02504151|65452016|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
23466430|NCT02504151|65452015|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
23466431|NCT02504151|65452016|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
23466432|NCT02504151|65452015|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23466433|NCT02504151|65452016|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23466434|NCT02504151|65452015|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
23466435|NCT02504151|65452016|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
23466436|NCT00927953|65452017|FG000|Overall Study|Death|2|||
23466437|NCT00927953|65452018|FG001|Overall Study|Death|1|||
23466438|NCT00521404|65452019|FG000|Overall Study|Adverse Event|13|||
23466439|NCT00521404|65452019|FG000|Overall Study|Disease Progression|33|||
23466440|NCT00521404|65452019|FG000|Overall Study|Investigator decision|5|||
23466441|NCT00521404|65452019|FG000|Overall Study|Withdrawal of consent|3|||
23466442|NCT00521404|65452019|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
23466443|NCT00521404|65452019|FG000|Overall Study|Other|7|||
23466444|NCT01867671|65452021|FG000|Overall Study|Adverse Event|5|||
23466445|NCT01867671|65452022|FG001|Overall Study|Adverse Event|3|||
23586310|NCT01235949|65873043|FG004|Booster Phase|Migrated/moved from study area|0|||
23586311|NCT01235949|65873044|FG005|Booster Phase|Migrated/moved from study area|0|||
23586312|NCT01235949|65873045|FG006|Booster Phase|Migrated/moved from study area|0|||
23586313|NCT01235949|65873046|FG007|Booster Phase|Migrated/moved from study area|0|||
23586314|NCT01235949|65873047|FG008|Booster Phase|Migrated/moved from study area|0|||
23586315|NCT01235949|65873048|FG009|Booster Phase|Migrated/moved from study area|0|||
23586316|NCT01235949|65873049|FG010|Booster Phase|Migrated/moved from study area|0|||
23586317|NCT01235949|65873050|FG011|Booster Phase|Migrated/moved from study area|1|||
23586318|NCT01235949|65873051|FG012|Booster Phase|Migrated/moved from study area|1|||
23586319|NCT01235949|65873052|FG013|Booster Phase|Migrated/moved from study area|0|||
23586320|NCT01235949|65873053|FG014|Booster Phase|Migrated/moved from study area|0|||
23186066|NCT03367156|64422912|FG000|Overall Study|Death|2|||
23586321|NCT01235949|65873054|FG015|Booster Phase|Migrated/moved from study area|0|||
23586322|NCT01235949|65873055|FG016|Booster Phase|Migrated/moved from study area|0|||
23186067|NCT03367156|64422913|FG001|Overall Study|Death|0|||
23244472|NCT05182840|64638825|FG007|Treatment Period|Not treated with study drug|1|||
23244473|NCT05182840|64638826|FG008|Treatment Period|Not treated with study drug|0|||
23244474|NCT05182840|64638827|FG009|Treatment Period|Not treated with study drug|0|||
23466446|NCT01867671|65452021|FG000|Overall Study|Anaphylaxis|0|||
23466447|NCT01867671|65452022|FG001|Overall Study|Anaphylaxis|1|||
23466448|NCT01867671|65452021|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
23466449|NCT01867671|65452022|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
23466450|NCT01867671|65452021|FG000|Overall Study|Lost to Follow-up|0|||
23466451|NCT01867671|65452022|FG001|Overall Study|Lost to Follow-up|1|||
23466452|NCT01867671|65452021|FG000|Overall Study|Non-compliance with Study Drug|1|||
23466453|NCT01867671|65452022|FG001|Overall Study|Non-compliance with Study Drug|2|||
23586323|NCT01235949|65873056|FG017|Booster Phase|Migrated/moved from study area|1|||
23186068|NCT03367156|64422912|FG000|Overall Study|Lost to Follow-up|2|||
23186069|NCT03367156|64422913|FG001|Overall Study|Lost to Follow-up|1|||
23186070|NCT03367156|64422912|FG000|Overall Study|Became ineligible|1|||
23186071|NCT03367156|64422913|FG001|Overall Study|Became ineligible|2|||
23186072|NCT03367156|64422912|FG000|Overall Study|Hospitalization|1|||
23186073|NCT03367156|64422913|FG001|Overall Study|Hospitalization|0|||
23186074|NCT03367156|64422912|FG000|Overall Study|Concerned about Treatment|11|||
23186075|NCT03367156|64422913|FG001|Overall Study|Concerned about Treatment|3|||
23186076|NCT03367156|64422912|FG000|Overall Study|Started new treatment|4|||
23186077|NCT03367156|64422913|FG001|Overall Study|Started new treatment|1|||
23586324|NCT01235949|65873039|FG000|Booster Phase|Adverse Event|0|||
23586325|NCT01235949|65873040|FG001|Booster Phase|Adverse Event|0|||
23586326|NCT01235949|65873041|FG002|Booster Phase|Adverse Event|0|||
23466454|NCT01867671|65452021|FG000|Overall Study|Withdrawal by Subject|21|||
23466455|NCT01867671|65452022|FG001|Overall Study|Withdrawal by Subject|21|||
23586327|NCT01235949|65873042|FG003|Booster Phase|Adverse Event|0|||
23586328|NCT01235949|65873043|FG004|Booster Phase|Adverse Event|0|||
23586329|NCT01235949|65873044|FG005|Booster Phase|Adverse Event|0|||
23466456|NCT00628108|65452023|FG000|Overall Study|Adverse Event|0|||
23466457|NCT00628108|65452024|FG001|Overall Study|Adverse Event|3|||
23466458|NCT00628108|65452023|FG000|Overall Study|Withdrawal by Subject|1|||
23466459|NCT00628108|65452024|FG001|Overall Study|Withdrawal by Subject|0|||
23466460|NCT01265537|65452025|FG000|Overall Study|Adverse Event|2|||
23466461|NCT01265537|65452026|FG001|Overall Study|Adverse Event|1|||
23466462|NCT01265537|65452025|FG000|Overall Study|Physician Decision|0|||
23466463|NCT01265537|65452026|FG001|Overall Study|Physician Decision|1|||
23466464|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
23466465|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
23466466|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
23351400|NCT01593254|65029619|FG000|Overall Study|AE unrelated to study drug|0|||
23466467|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
23466468|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23466469|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
23466470|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
23466471|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
23466472|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
23466473|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
23466474|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
23466475|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
23466476|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
23466477|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
23466478|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
23466479|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
23466480|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
23466481|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
23466482|NCT03739203|65452028|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
23466483|NCT03739203|65452029|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
23466484|NCT03739203|65452030|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
23466485|NCT03739203|65452028|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
23466486|NCT03739203|65452029|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
23466487|NCT03739203|65452030|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
23466488|NCT03739203|65452028|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
23466489|NCT03739203|65452029|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
23466490|NCT03739203|65452030|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
23466491|NCT03739203|65452028|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
23466492|NCT03739203|65452029|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
23466493|NCT03739203|65452030|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
23466494|NCT03739203|65452028|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
23466495|NCT03739203|65452029|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
23466496|NCT03739203|65452030|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
23466497|NCT02560558|65452031|FG000|Overall Study|Adverse Event|1|||
23466498|NCT02560558|65452032|FG001|Overall Study|Adverse Event|0|||
23466499|NCT02560558|65452031|FG000|Overall Study|Death|0|||
23466500|NCT02560558|65452032|FG001|Overall Study|Death|2|||
23466501|NCT02560558|65452031|FG000|Overall Study|Lost to Follow-up|0|||
23186084|NCT05113940|64422915|FG000|Part A (18 Days)|Adverse Event|0|||
23186085|NCT05113940|64422916|FG001|Part A (18 Days)|Adverse Event|0|||
23466502|NCT02560558|65452032|FG001|Overall Study|Lost to Follow-up|4|||
23186086|NCT05113940|64422917|FG002|Part A (18 Days)|Adverse Event|1|||
23186087|NCT05113940|64422918|FG003|Part A (18 Days)|Adverse Event|1|||
23186088|NCT05113940|64422919|FG004|Part A (18 Days)|Adverse Event|1|||
23186089|NCT05113940|64422920|FG005|Part A (18 Days)|Adverse Event|0|||
23466503|NCT02560558|65452031|FG000|Overall Study|Protocol Violation|3|||
23466504|NCT02560558|65452032|FG001|Overall Study|Protocol Violation|0|||
23466505|NCT02560558|65452031|FG000|Overall Study|Withdrawal by Subject|3|||
23466506|NCT02560558|65452032|FG001|Overall Study|Withdrawal by Subject|0|||
23466507|NCT02351856|65452033|FG000|Overall Study|Adverse Event|2|||
23466508|NCT02351856|65452033|FG000|Overall Study|Physician Decision|5|||
23466509|NCT02351856|65452033|FG000|Overall Study|Study terminated by sponsor|1|||
23466510|NCT03819114|65452039|FG000|Overall Study|Protocol Violation|0|||
23466511|NCT03819114|65452040|FG001|Overall Study|Protocol Violation|1|||
23466512|NCT03819114|65452041|FG002|Overall Study|Protocol Violation|1|||
23466513|NCT03819114|65452042|FG003|Overall Study|Protocol Violation|0|||
23466514|NCT03819114|65452039|FG000|Overall Study|Lost to Follow-up|0|||
23466515|NCT03819114|65452040|FG001|Overall Study|Lost to Follow-up|0|||
23466516|NCT03819114|65452041|FG002|Overall Study|Lost to Follow-up|1|||
23466517|NCT03819114|65452042|FG003|Overall Study|Lost to Follow-up|0|||
23466518|NCT01166282|65452054|FG000|Open-label Period|Adverse Event|0|||
23466519|NCT01166282|65452055|FG001|Open-label Period|Adverse Event|0|||
23466520|NCT01166282|65452056|FG002|Open-label Period|Adverse Event|6|||
23466521|NCT01166282|65452054|FG000|Open-label Period|Withdrawal by Subject|0|||
23466522|NCT01166282|65452055|FG001|Open-label Period|Withdrawal by Subject|0|||
23466523|NCT01166282|65452056|FG002|Open-label Period|Withdrawal by Subject|4|||
23466524|NCT01166282|65452054|FG000|Open-label Period|Lack of Efficacy|0|||
23466525|NCT01166282|65452055|FG001|Open-label Period|Lack of Efficacy|0|||
23466526|NCT01166282|65452056|FG002|Open-label Period|Lack of Efficacy|2|||
23466527|NCT01166282|65452054|FG000|Open-label Period|Remission|0|||
23466528|NCT01166282|65452055|FG001|Open-label Period|Remission|0|||
23466529|NCT01166282|65452056|FG002|Open-label Period|Remission|4|||
23466530|NCT01166282|65452054|FG000|Open-label Period|Irregular Compliance|0|||
23466531|NCT01166282|65452055|FG001|Open-label Period|Irregular Compliance|0|||
23466532|NCT01166282|65452056|FG002|Open-label Period|Irregular Compliance|1|||
23466533|NCT00196313|65452057|FG000|Overall Study|Protocol Violation|2|||
23466534|NCT00196313|65452058|FG001|Overall Study|Protocol Violation|3|||
23466535|NCT00196313|65452057|FG000|Overall Study|Withdrawal by Subject|3|||
23466536|NCT00196313|65452058|FG001|Overall Study|Withdrawal by Subject|1|||
23466537|NCT00196313|65452057|FG000|Overall Study|Adverse Event|3|||
23586330|NCT01235949|65873045|FG006|Booster Phase|Adverse Event|0|||
23586331|NCT01235949|65873046|FG007|Booster Phase|Adverse Event|0|||
23586332|NCT01235949|65873047|FG008|Booster Phase|Adverse Event|0|||
23586333|NCT01235949|65873048|FG009|Booster Phase|Adverse Event|0|||
23586334|NCT01235949|65873049|FG010|Booster Phase|Adverse Event|0|||
23586335|NCT01235949|65873050|FG011|Booster Phase|Adverse Event|0|||
23586336|NCT01235949|65873051|FG012|Booster Phase|Adverse Event|0|||
23586337|NCT01235949|65873052|FG013|Booster Phase|Adverse Event|0|||
23586338|NCT01235949|65873053|FG014|Booster Phase|Adverse Event|0|||
23586339|NCT01235949|65873054|FG015|Booster Phase|Adverse Event|1|||
23586340|NCT01235949|65873055|FG016|Booster Phase|Adverse Event|0|||
23586341|NCT01235949|65873056|FG017|Booster Phase|Adverse Event|0|||
23586342|NCT01235949|65873039|FG000|Booster Phase|Withdrawal by Subject|0|||
23244475|NCT03345485|64638828|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
23244476|NCT03345485|64638829|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
23244477|NCT03345485|64638830|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
23244478|NCT03345485|64638831|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
23244479|NCT03345485|64638832|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
23244480|NCT03345485|64638833|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
23244481|NCT03345485|64638834|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
23244482|NCT03345485|64638835|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
23244483|NCT03345485|64638836|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
23244484|NCT03345485|64638837|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
23244485|NCT03345485|64638838|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
23466538|NCT00196313|65452058|FG001|Overall Study|Adverse Event|1|||
23586343|NCT01235949|65873040|FG001|Booster Phase|Withdrawal by Subject|0|||
23466539|NCT00196313|65452057|FG000|Overall Study|Subject Pregnant|1|||
23466540|NCT00196313|65452058|FG001|Overall Study|Subject Pregnant|1|||
23466541|NCT00196313|65452057|FG000|Overall Study|Lost to Follow-up|2|||
23466542|NCT00196313|65452058|FG001|Overall Study|Lost to Follow-up|2|||
23586344|NCT01235949|65873041|FG002|Booster Phase|Withdrawal by Subject|0|||
23586345|NCT01235949|65873042|FG003|Booster Phase|Withdrawal by Subject|0|||
23586346|NCT01235949|65873043|FG004|Booster Phase|Withdrawal by Subject|0|||
23586347|NCT01235949|65873044|FG005|Booster Phase|Withdrawal by Subject|0|||
23186090|NCT05113940|64422921|FG006|Part A (18 Days)|Adverse Event|0|||
23586348|NCT01235949|65873045|FG006|Booster Phase|Withdrawal by Subject|0|||
23586349|NCT01235949|65873046|FG007|Booster Phase|Withdrawal by Subject|1|||
23586350|NCT01235949|65873047|FG008|Booster Phase|Withdrawal by Subject|1|||
23586351|NCT01235949|65873048|FG009|Booster Phase|Withdrawal by Subject|0|||
23586352|NCT01235949|65873049|FG010|Booster Phase|Withdrawal by Subject|1|||
23586353|NCT01235949|65873050|FG011|Booster Phase|Withdrawal by Subject|1|||
23586354|NCT01235949|65873051|FG012|Booster Phase|Withdrawal by Subject|2|||
23586355|NCT01235949|65873052|FG013|Booster Phase|Withdrawal by Subject|0|||
23586356|NCT01235949|65873053|FG014|Booster Phase|Withdrawal by Subject|2|||
23586357|NCT01235949|65873054|FG015|Booster Phase|Withdrawal by Subject|0|||
23586358|NCT01235949|65873055|FG016|Booster Phase|Withdrawal by Subject|0|||
23586359|NCT01235949|65873056|FG017|Booster Phase|Withdrawal by Subject|0|||
23586360|NCT01235949|65873039|FG000|Booster Phase|Lost to Follow-up|0|||
23586361|NCT01235949|65873040|FG001|Booster Phase|Lost to Follow-up|0|||
23586362|NCT01235949|65873041|FG002|Booster Phase|Lost to Follow-up|0|||
23586363|NCT01235949|65873042|FG003|Booster Phase|Lost to Follow-up|0|||
23586364|NCT01235949|65873043|FG004|Booster Phase|Lost to Follow-up|0|||
23586365|NCT01235949|65873044|FG005|Booster Phase|Lost to Follow-up|0|||
23586366|NCT01235949|65873045|FG006|Booster Phase|Lost to Follow-up|0|||
23586367|NCT01235949|65873046|FG007|Booster Phase|Lost to Follow-up|0|||
23586368|NCT01235949|65873047|FG008|Booster Phase|Lost to Follow-up|1|||
23586369|NCT01235949|65873048|FG009|Booster Phase|Lost to Follow-up|1|||
23586370|NCT01235949|65873049|FG010|Booster Phase|Lost to Follow-up|1|||
23586371|NCT01235949|65873050|FG011|Booster Phase|Lost to Follow-up|1|||
23586372|NCT01235949|65873051|FG012|Booster Phase|Lost to Follow-up|0|||
23244486|NCT03345485|64638839|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
23244487|NCT03345485|64638840|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
23586373|NCT01235949|65873052|FG013|Booster Phase|Lost to Follow-up|0|||
23586374|NCT01235949|65873053|FG014|Booster Phase|Lost to Follow-up|0|||
23586375|NCT01235949|65873054|FG015|Booster Phase|Lost to Follow-up|0|||
23586376|NCT01235949|65873055|FG016|Booster Phase|Lost to Follow-up|0|||
23586377|NCT01235949|65873056|FG017|Booster Phase|Lost to Follow-up|1|||
23586378|NCT02107014|65873057|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
23586379|NCT00387465|65873058|FG000|Overall Study|Withdrawal by Subject|0|||
23586380|NCT00387465|65873059|FG001|Overall Study|Withdrawal by Subject|1|||
23586381|NCT00387465|65873060|FG002|Overall Study|Withdrawal by Subject|0|||
23586382|NCT00763282|65873061|FG000|Overall Study|Withdrawal by Subject|6|||
23586383|NCT00763282|65873062|FG001|Overall Study|Withdrawal by Subject|5|||
23586384|NCT00763282|65873061|FG000|Overall Study|Death|4|||
23586385|NCT00763282|65873062|FG001|Overall Study|Death|3|||
23466543|NCT00981058|65452061|FG000|Overall Study|Adverse Event|1|||
23466544|NCT00981058|65452062|FG001|Overall Study|Adverse Event|1|||
23466545|NCT00981058|65452061|FG000|Overall Study|Progressive Disease|61|||
23466546|NCT00981058|65452062|FG001|Overall Study|Progressive Disease|49|||
23586386|NCT00763282|65873061|FG000|Overall Study|Lost to Follow-up|22|||
23586387|NCT00763282|65873062|FG001|Overall Study|Lost to Follow-up|26|||
23586388|NCT00608907|65873063|FG000|Overall Study|Adverse Event|6|||
23586389|NCT00608907|65873064|FG001|Overall Study|Adverse Event|0|||
23586390|NCT00608907|65873065|FG002|Overall Study|Adverse Event|1|||
23586391|NCT00608907|65873063|FG000|Overall Study|Death|1|||
23586392|NCT00608907|65873064|FG001|Overall Study|Death|0|||
23586393|NCT00608907|65873065|FG002|Overall Study|Death|0|||
23586394|NCT00608907|65873063|FG000|Overall Study|Withdrawal by Subject|4|||
23586395|NCT00608907|65873064|FG001|Overall Study|Withdrawal by Subject|0|||
23586396|NCT00608907|65873065|FG002|Overall Study|Withdrawal by Subject|0|||
23586397|NCT00608907|65873063|FG000|Overall Study|Progressive Disease|1|||
23586398|NCT00608907|65873064|FG001|Overall Study|Progressive Disease|0|||
23586399|NCT00608907|65873065|FG002|Overall Study|Progressive Disease|0|||
23586400|NCT02282527|65873066|FG000|Overall Study|Lost to Follow-up|0|||
23244524|NCT01134614|64638844|FG000|Overall Study|Still on treatment as of March 2013|21|||
23244525|NCT01134614|64638845|FG001|Overall Study|Still on treatment as of March 2013|13|||
23244526|NCT01134614|64638844|FG000|Overall Study|Progressive disease|60|||
23244527|NCT01134614|64638845|FG001|Overall Study|Progressive disease|54|||
23244528|NCT01134614|64638844|FG000|Overall Study|Adverse Event|26|||
23244529|NCT01134614|64638845|FG001|Overall Study|Adverse Event|39|||
23244530|NCT01134614|64638844|FG000|Overall Study|Death|5|||
23244531|NCT01134614|64638845|FG001|Overall Study|Death|8|||
23244532|NCT01134614|64638844|FG000|Overall Study|Withdrawal by Subject|3|||
23244533|NCT01134614|64638845|FG001|Overall Study|Withdrawal by Subject|2|||
23244534|NCT01134614|64638844|FG000|Overall Study|Alternative therapy|2|||
23244535|NCT01134614|64638845|FG001|Overall Study|Alternative therapy|0|||
23244536|NCT01134614|64638844|FG000|Overall Study|Complicating disease|2|||
23244537|NCT01134614|64638845|FG001|Overall Study|Complicating disease|1|||
23244538|NCT01134614|64638844|FG000|Overall Study|Physician's decision|0|||
23244539|NCT01134614|64638845|FG001|Overall Study|Physician's decision|1|||
23244540|NCT01134614|64638844|FG000|Overall Study|Never started treatment|4|||
23244541|NCT01134614|64638845|FG001|Overall Study|Never started treatment|1|||
23244542|NCT01134614|64638844|FG000|Overall Study|Pt received tx not allowed on study|0|||
23244543|NCT01134614|64638845|FG001|Overall Study|Pt received tx not allowed on study|1|||
23244544|NCT01134614|64638844|FG000|Overall Study|Symptomatic deterioration|0|||
23244545|NCT01134614|64638845|FG001|Overall Study|Symptomatic deterioration|1|||
23244546|NCT01134614|64638844|FG000|Overall Study|Patient in hospice care|0|||
23244547|NCT01134614|64638845|FG001|Overall Study|Patient in hospice care|1|||
23244548|NCT02007512|64638846|FG000|Double Blind Treatment Period|Adverse Event|4|||
23186091|NCT05113940|64422922|FG007|Part A (18 Days)|Adverse Event|0|||
23244549|NCT02007512|64638847|FG001|Double Blind Treatment Period|Adverse Event|2|||
23244550|NCT02007512|64638848|FG002|Double Blind Treatment Period|Adverse Event|6|||
23244551|NCT02007512|64638849|FG003|Double Blind Treatment Period|Adverse Event|2|||
23244552|NCT02007512|64638846|FG000|Double Blind Treatment Period|Death|1|||
23244553|NCT02007512|64638847|FG001|Double Blind Treatment Period|Death|0|||
23244554|NCT02007512|64638848|FG002|Double Blind Treatment Period|Death|0|||
23244555|NCT02007512|64638849|FG003|Double Blind Treatment Period|Death|0|||
23244556|NCT02007512|64638846|FG000|Double Blind Treatment Period|Disease progression|44|||
23466547|NCT00981058|65452061|FG000|Overall Study|Lost to Follow-up|16|||
23466548|NCT00981058|65452062|FG001|Overall Study|Lost to Follow-up|15|||
23466549|NCT00981058|65452061|FG000|Overall Study|New Anticancer Therapy|6|||
23466550|NCT00981058|65452062|FG001|Overall Study|New Anticancer Therapy|6|||
23466551|NCT00981058|65452061|FG000|Overall Study|Noncompliance|1|||
23466552|NCT00981058|65452062|FG001|Overall Study|Noncompliance|0|||
23466553|NCT00981058|65452061|FG000|Overall Study|Radiologist Error|0|||
23466554|NCT00981058|65452062|FG001|Overall Study|Radiologist Error|1|||
23466555|NCT00981058|65452061|FG000|Overall Study|Randomization Error|1|||
23466556|NCT00981058|65452062|FG001|Overall Study|Randomization Error|2|||
23466557|NCT00981058|65452061|FG000|Overall Study|Withdrawal by Subject|25|||
23466558|NCT00981058|65452062|FG001|Overall Study|Withdrawal by Subject|23|||
23466559|NCT00981058|65452061|FG000|Overall Study|On study treatment at conclusion|9|||
23466560|NCT00981058|65452062|FG001|Overall Study|On study treatment at conclusion|0|||
23466561|NCT02350478|65452064|FG000|Overall Study|Lost to Follow-up|5|||
23466562|NCT02350478|65452065|FG001|Overall Study|Lost to Follow-up|1|||
23466563|NCT00035932|65452066|FG000|Overall Study|Adverse Event|10|||
23466564|NCT00035932|65452067|FG001|Overall Study|Adverse Event|9|||
23466565|NCT00035932|65452068|FG002|Overall Study|Adverse Event|9|||
23466566|NCT00035932|65452066|FG000|Overall Study|Death|0|||
23466567|NCT00035932|65452067|FG001|Overall Study|Death|0|||
23466568|NCT00035932|65452068|FG002|Overall Study|Death|1|||
23466569|NCT00035932|65452066|FG000|Overall Study|Disease Progression / Relapse|1|||
23466570|NCT00035932|65452067|FG001|Overall Study|Disease Progression / Relapse|1|||
23244557|NCT02007512|64638847|FG001|Double Blind Treatment Period|Disease progression|49|||
23244558|NCT02007512|64638848|FG002|Double Blind Treatment Period|Disease progression|45|||
23244559|NCT02007512|64638849|FG003|Double Blind Treatment Period|Disease progression|51|||
23244560|NCT02007512|64638846|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
23244561|NCT02007512|64638847|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
23244562|NCT02007512|64638848|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
23244563|NCT02007512|64638849|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
23244564|NCT02007512|64638846|FG000|Double Blind Treatment Period|Protocol Violation|0|||
23244565|NCT02007512|64638847|FG001|Double Blind Treatment Period|Protocol Violation|0|||
23244566|NCT02007512|64638848|FG002|Double Blind Treatment Period|Protocol Violation|0|||
23244567|NCT02007512|64638849|FG003|Double Blind Treatment Period|Protocol Violation|1|||
23244568|NCT02007512|64638846|FG000|Double Blind Treatment Period|Other|0|||
23244569|NCT02007512|64638847|FG001|Double Blind Treatment Period|Other|0|||
23244570|NCT02007512|64638848|FG002|Double Blind Treatment Period|Other|1|||
23244571|NCT02007512|64638849|FG003|Double Blind Treatment Period|Other|2|||
23244572|NCT02007512|64638846|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
23244573|NCT02007512|64638847|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
23244574|NCT02007512|64638848|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
23244575|NCT02007512|64638849|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
23244576|NCT02007512|64638846|FG000|Open Label Treatment Period|Adverse Event|0|||
23351401|NCT01593254|65029620|FG001|Overall Study|AE unrelated to study drug|1|||
23351402|NCT01593254|65029619|FG000|Overall Study|participant request to discontinue study treatment|1|||
23351403|NCT01593254|65029620|FG001|Overall Study|participant request to discontinue study treatment|3|||
23351404|NCT01593254|65029619|FG000|Overall Study|participant withdrew consent|0|||
23351405|NCT01593254|65029620|FG001|Overall Study|participant withdrew consent|9|||
23466571|NCT00035932|65452068|FG002|Overall Study|Disease Progression / Relapse|0|||
23466572|NCT00035932|65452066|FG000|Overall Study|Lost to Follow-up|4|||
23586401|NCT02282527|65873067|FG001|Overall Study|Lost to Follow-up|1|||
23244577|NCT02007512|64638847|FG001|Open Label Treatment Period|Adverse Event|1|||
23244578|NCT02007512|64638848|FG002|Open Label Treatment Period|Adverse Event|0|||
23244579|NCT02007512|64638849|FG003|Open Label Treatment Period|Adverse Event|0|||
23586402|NCT02282527|65873066|FG000|Overall Study|Lack of home health aid|1|||
23586403|NCT02282527|65873067|FG001|Overall Study|Lack of home health aid|0|||
23586404|NCT01211665|65873068|FG000|Overall Study|Withdrawal by Subject|1|||
23586405|NCT01211665|65873069|FG001|Overall Study|Withdrawal by Subject|0|||
23586406|NCT01211665|65873068|FG000|Overall Study|Death|1|||
23586407|NCT01211665|65873069|FG001|Overall Study|Death|0|||
23586408|NCT01549652|65873070|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
23586409|NCT01549652|65873071|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
23586410|NCT01549652|65873072|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
23586411|NCT01549652|65873073|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
23586412|NCT01549652|65873070|FG000|Overall Study|Study Drug Titration Failure|5|||
23586413|NCT01549652|65873071|FG001|Overall Study|Study Drug Titration Failure|6|||
23586414|NCT01549652|65873072|FG002|Overall Study|Study Drug Titration Failure|0|||
23586415|NCT01549652|65873073|FG003|Overall Study|Study Drug Titration Failure|0|||
23586416|NCT01549652|65873070|FG000|Overall Study|Withdrawal Effect|0|||
23586417|NCT01549652|65873071|FG001|Overall Study|Withdrawal Effect|2|||
23586418|NCT01549652|65873072|FG002|Overall Study|Withdrawal Effect|0|||
23244580|NCT02007512|64638846|FG000|Open Label Treatment Period|Other|0|||
23244581|NCT02007512|64638847|FG001|Open Label Treatment Period|Other|0|||
23244582|NCT02007512|64638848|FG002|Open Label Treatment Period|Other|0|||
23244583|NCT02007512|64638849|FG003|Open Label Treatment Period|Other|1|||
23351406|NCT01593254|65029619|FG000|Overall Study|lost to follow up|1|||
23466573|NCT00035932|65452067|FG001|Overall Study|Lost to Follow-up|4|||
23586419|NCT01549652|65873073|FG003|Overall Study|Withdrawal Effect|0|||
23244584|NCT02007512|64638846|FG000|Open Label Treatment Period|Disease progression|0|||
23244585|NCT02007512|64638847|FG001|Open Label Treatment Period|Disease progression|17|||
23244586|NCT02007512|64638848|FG002|Open Label Treatment Period|Disease progression|0|||
23244587|NCT02007512|64638849|FG003|Open Label Treatment Period|Disease progression|11|||
23244588|NCT02007512|64638846|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
23244589|NCT02007512|64638847|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
23244590|NCT02007512|64638848|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
23244591|NCT02007512|64638849|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
23244592|NCT03505606|64638850|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
23244593|NCT03505606|64638851|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
23244594|NCT03505606|64638852|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
23244595|NCT03505606|64638850|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
23466574|NCT00035932|65452068|FG002|Overall Study|Lost to Follow-up|3|||
23466575|NCT00035932|65452066|FG000|Overall Study|Noncompliance|6|||
23466576|NCT00035932|65452067|FG001|Overall Study|Noncompliance|7|||
23466577|NCT00035932|65452068|FG002|Overall Study|Noncompliance|6|||
23466578|NCT00035932|65452066|FG000|Overall Study|Protocol Violation While on Study|0|||
23466579|NCT00035932|65452067|FG001|Overall Study|Protocol Violation While on Study|1|||
23466580|NCT00035932|65452068|FG002|Overall Study|Protocol Violation While on Study|2|||
23466581|NCT00035932|65452066|FG000|Overall Study|Withdrawal by Subject|1|||
23466582|NCT00035932|65452067|FG001|Overall Study|Withdrawal by Subject|5|||
23466583|NCT00035932|65452068|FG002|Overall Study|Withdrawal by Subject|0|||
23466584|NCT00035932|65452066|FG000|Overall Study|Study Termination by Sponsor|1|||
23466585|NCT00035932|65452067|FG001|Overall Study|Study Termination by Sponsor|0|||
23466586|NCT00035932|65452068|FG002|Overall Study|Study Termination by Sponsor|0|||
23466587|NCT00035932|65452066|FG000|Overall Study|Lack of Efficacy|33|||
23466588|NCT00035932|65452067|FG001|Overall Study|Lack of Efficacy|33|||
23586420|NCT01549652|65873070|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
23586421|NCT01549652|65873071|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
23586422|NCT01549652|65873072|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
23586423|NCT01549652|65873073|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
23586424|NCT01549652|65873070|FG000|Overall Study|Problem with Infusion|1|||
23586425|NCT01549652|65873071|FG001|Overall Study|Problem with Infusion|0|||
23186092|NCT05113940|64422923|FG008|Part A (18 Days)|Adverse Event|0|||
23186093|NCT05113940|64422924|FG009|Part A (18 Days)|Adverse Event|0|||
23186094|NCT05113940|64422925|FG010|Part A (18 Days)|Adverse Event|0|||
23186095|NCT05113940|64422926|FG011|Part A (18 Days)|Adverse Event|2|||
23186096|NCT05113940|64422927|FG012|Part A (18 Days)|Adverse Event|0|||
23186097|NCT05113940|64422928|FG013|Part A (18 Days)|Adverse Event|0|||
23186098|NCT05113940|64422929|FG014|Part A (18 Days)|Adverse Event|0|||
23186099|NCT05113940|64422915|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186100|NCT05113940|64422916|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186101|NCT05113940|64422917|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186102|NCT05113940|64422918|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186103|NCT05113940|64422919|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186104|NCT05113940|64422920|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186105|NCT05113940|64422921|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186106|NCT05113940|64422922|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186107|NCT05113940|64422923|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186108|NCT05113940|64422924|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186109|NCT05113940|64422925|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186110|NCT05113940|64422926|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186111|NCT05113940|64422927|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186112|NCT05113940|64422928|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
23186113|NCT05113940|64422929|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
23186114|NCT01670500|64422930|FG000|Overall Study|Withdrawal by Subject|1|||
23186115|NCT01670500|64422931|FG001|Overall Study|Withdrawal by Subject|0|||
23186116|NCT03818035|64422932|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
23186117|NCT03818035|64422933|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
23186118|NCT03818035|64422934|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
23186119|NCT03818035|64422935|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
23186120|NCT03818035|64422932|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
23186121|NCT03818035|64422933|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
23186122|NCT03818035|64422934|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
23186123|NCT03818035|64422935|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
23244596|NCT03505606|64638851|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
23466589|NCT00035932|65452068|FG002|Overall Study|Lack of Efficacy|28|||
23186124|NCT03818035|64422932|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
23186125|NCT03818035|64422933|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
23186126|NCT03818035|64422934|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
23186127|NCT03818035|64422935|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
23186128|NCT03818035|64422932|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
23186129|NCT03818035|64422933|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
23466590|NCT01388335|65452071|FG000|Period 1|Progressive Disease|1|||
23186130|NCT03818035|64422934|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
23186131|NCT03818035|64422935|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
23186132|NCT03818035|64422932|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
23186133|NCT03818035|64422933|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
23186134|NCT03818035|64422934|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
23186135|NCT03818035|64422935|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
23186136|NCT03818035|64422932|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
23244597|NCT03505606|64638852|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
23186137|NCT03818035|64422933|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
23186138|NCT03818035|64422934|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
23186139|NCT03818035|64422935|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
23186140|NCT03818035|64422932|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
23186141|NCT03818035|64422933|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
23186142|NCT03818035|64422934|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
23186143|NCT03818035|64422935|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
23186144|NCT03818035|64422932|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
23244598|NCT03505606|64638850|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
23244599|NCT03505606|64638851|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
23244600|NCT03505606|64638852|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
23244601|NCT03505606|64638850|FG000|Overall Study|Poor compliance with refractive correction|0|||
23244602|NCT03505606|64638851|FG001|Overall Study|Poor compliance with refractive correction|0|||
23244603|NCT03505606|64638852|FG002|Overall Study|Poor compliance with refractive correction|1|||
23244604|NCT03505606|64638850|FG000|Overall Study|Insufficient anisometropia|0|||
23244605|NCT03505606|64638851|FG001|Overall Study|Insufficient anisometropia|0|||
23244606|NCT03505606|64638852|FG002|Overall Study|Insufficient anisometropia|2|||
23244607|NCT03505606|64638850|FG000|Overall Study|Ectopia Lentis|0|||
23244608|NCT03505606|64638851|FG001|Overall Study|Ectopia Lentis|0|||
23244609|NCT03505606|64638852|FG002|Overall Study|Ectopia Lentis|1|||
23186145|NCT03818035|64422933|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
23186146|NCT03818035|64422934|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
23186147|NCT03818035|64422935|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
23186148|NCT03818035|64422932|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
23186149|NCT03818035|64422933|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
23186150|NCT03818035|64422934|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
23244610|NCT03505606|64638850|FG000|Overall Study|alternation of amblyopic eye|0|||
23244611|NCT03505606|64638851|FG001|Overall Study|alternation of amblyopic eye|1|||
23244612|NCT03505606|64638852|FG002|Overall Study|alternation of amblyopic eye|0|||
23244613|NCT00602641|64638853|FG000|Overall Study|Never started protocol therapy|6|||
23244614|NCT00602641|64638854|FG001|Overall Study|Never started protocol therapy|2|||
23186151|NCT03818035|64422935|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
23186152|NCT03818035|64422932|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
23186153|NCT03818035|64422933|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
23186154|NCT03818035|64422934|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
23351407|NCT01593254|65029620|FG001|Overall Study|lost to follow up|6|||
23351408|NCT01593254|65029619|FG000|Overall Study|maximum clinical benefit|1|||
23351409|NCT01593254|65029620|FG001|Overall Study|maximum clinical benefit|2|||
23351410|NCT01593254|65029619|FG000|Overall Study|Poor/non compliance|1|||
23351411|NCT01593254|65029620|FG001|Overall Study|Poor/non compliance|1|||
23186155|NCT03818035|64422935|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
23186156|NCT03818035|64422932|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
23186157|NCT03818035|64422933|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
23186158|NCT03818035|64422934|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
23186159|NCT03818035|64422935|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
23186160|NCT03818035|64422932|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
23186161|NCT03818035|64422933|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
23186162|NCT03818035|64422934|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
23351412|NCT01593254|65029619|FG000|Overall Study|Pregnancy|0|||
23351413|NCT01593254|65029620|FG001|Overall Study|Pregnancy|3|||
23466591|NCT01388335|65452071|FG000|Period 2|Progressive Disease|2|||
23586426|NCT01549652|65873072|FG002|Overall Study|Problem with Infusion|0|||
23586427|NCT01549652|65873073|FG003|Overall Study|Problem with Infusion|0|||
23586428|NCT01549652|65873070|FG000|Overall Study|Titration Non-Compliance|1|||
23586429|NCT01549652|65873071|FG001|Overall Study|Titration Non-Compliance|3|||
23586430|NCT01549652|65873072|FG002|Overall Study|Titration Non-Compliance|4|||
23586431|NCT01549652|65873073|FG003|Overall Study|Titration Non-Compliance|5|||
23586432|NCT01549652|65873070|FG000|Overall Study|Titration Side Effects|0|||
23586433|NCT01549652|65873071|FG001|Overall Study|Titration Side Effects|0|||
23586434|NCT01549652|65873072|FG002|Overall Study|Titration Side Effects|6|||
23586435|NCT01549652|65873073|FG003|Overall Study|Titration Side Effects|3|||
23586436|NCT01549652|65873070|FG000|Overall Study|Withdrawal by Subject|0|||
23586437|NCT01549652|65873071|FG001|Overall Study|Withdrawal by Subject|0|||
23586438|NCT01549652|65873072|FG002|Overall Study|Withdrawal by Subject|5|||
23186163|NCT03818035|64422935|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
23186164|NCT03818035|64422932|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
23186165|NCT03818035|64422933|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
23186166|NCT03818035|64422934|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
23186167|NCT03818035|64422935|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
23186168|NCT03818035|64422932|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
23186169|NCT03818035|64422933|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
23186170|NCT03818035|64422934|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
23186171|NCT03818035|64422935|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
23186172|NCT03818035|64422932|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
23186173|NCT03818035|64422933|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
23186174|NCT03818035|64422934|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
23186175|NCT03818035|64422935|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
23186176|NCT02143414|64422936|FG000|Induction|Adverse Event|1|||
23186177|NCT02143414|64422937|FG001|Induction|Adverse Event|2|||
23186178|NCT02143414|64422936|FG000|Induction|Death|1|||
23186179|NCT02143414|64422937|FG001|Induction|Death|2|||
23186180|NCT02143414|64422936|FG000|Induction|Patient refusal|1|||
23186181|NCT02143414|64422937|FG001|Induction|Patient refusal|1|||
23186182|NCT02143414|64422936|FG000|Induction|Refractory|1|||
23186183|NCT02143414|64422937|FG001|Induction|Refractory|0|||
23186184|NCT02143414|64422936|FG000|Induction|Began alternative treatment|1|||
23186185|NCT02143414|64422937|FG001|Induction|Began alternative treatment|0|||
23186186|NCT02143414|64422936|FG000|Induction|Ineligible for postremission|5|||
23186187|NCT02143414|64422937|FG001|Induction|Ineligible for postremission|1|||
23186188|NCT02143414|64422936|FG000|Post-remission|Adverse Event|0|||
23186189|NCT02143414|64422937|FG001|Post-remission|Adverse Event|2|||
23186190|NCT02143414|64422936|FG000|Post-remission|Disease progression/relapse|5|||
23186191|NCT02143414|64422937|FG001|Post-remission|Disease progression/relapse|0|||
23186192|NCT02143414|64422936|FG000|Maintenance|Adverse Event|4|||
23186193|NCT02143414|64422937|FG001|Maintenance|Adverse Event|6|||
23186194|NCT02143414|64422936|FG000|Maintenance|Disease progression/relapse|3|||
23186195|NCT02143414|64422937|FG001|Maintenance|Disease progression/relapse|2|||
23186196|NCT02143414|64422936|FG000|Maintenance|Patient refusal|2|||
23186197|NCT02143414|64422937|FG001|Maintenance|Patient refusal|1|||
23186198|NCT02143414|64422936|FG000|Maintenance|Physician Decision|1|||
23186199|NCT02143414|64422937|FG001|Maintenance|Physician Decision|0|||
23186200|NCT02143414|64422936|FG000|Maintenance|Death|0|||
23186201|NCT02143414|64422937|FG001|Maintenance|Death|1|||
23186202|NCT02143414|64422936|FG000|Maintenance|On protocol treatment|0|||
23186203|NCT02143414|64422937|FG001|Maintenance|On protocol treatment|6|||
23186204|NCT03842709|64422938|FG000|Overall Study|Withdrawal by Subject|3|||
23186205|NCT03842709|64422939|FG001|Overall Study|Withdrawal by Subject|3|||
23186206|NCT03842709|64422938|FG000|Overall Study|Lost to Follow-up|1|||
23186207|NCT03842709|64422939|FG001|Overall Study|Lost to Follow-up|0|||
23186208|NCT03748641|64422940|FG000|Overall Study|Ongoing|155|||
23186209|NCT03748641|64422941|FG001|Overall Study|Ongoing|148|||
23186210|NCT03748641|64422942|FG002|Overall Study|Ongoing|66|||
23186211|NCT03748641|64422943|FG003|Overall Study|Ongoing|79|||
23186212|NCT03748641|64422944|FG004|Overall Study|Ongoing|84|||
23186213|NCT03748641|64422940|FG000|Overall Study|Death|54|||
23186214|NCT03748641|64422941|FG001|Overall Study|Death|59|||
23186215|NCT03748641|64422942|FG002|Overall Study|Death|51|||
23186216|NCT03748641|64422943|FG003|Overall Study|Death|42|||
23466592|NCT01388335|65452071|FG000|Period 2|Sponsor Decision|1|||
23466593|NCT01388335|65452071|FG000|Safety Extension|Progressive Disease|7|||
23466594|NCT04154189|65452072|FG000|Overall Study|Withdrawal by Subject|4|||
23466595|NCT04154189|65452073|FG001|Overall Study|Withdrawal by Subject|6|||
23466596|NCT04154189|65452072|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
23466597|NCT04154189|65452073|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
23466598|NCT04154189|65452072|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
23466599|NCT04154189|65452073|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
23466600|NCT04154189|65452072|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
23466601|NCT04154189|65452073|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
23466602|NCT04154189|65452072|FG000|Overall Study|Death|25|||
23186217|NCT03748641|64422944|FG004|Overall Study|Death|9|||
23186218|NCT03748641|64422940|FG000|Overall Study|Lost to Follow-up|0|||
23186219|NCT03748641|64422941|FG001|Overall Study|Lost to Follow-up|2|||
23186220|NCT03748641|64422942|FG002|Overall Study|Lost to Follow-up|1|||
23186221|NCT03748641|64422943|FG003|Overall Study|Lost to Follow-up|0|||
23186222|NCT03748641|64422944|FG004|Overall Study|Lost to Follow-up|0|||
23244615|NCT00602641|64638853|FG000|Overall Study|Still on treatment at time of analysis|8|||
23186223|NCT03748641|64422940|FG000|Overall Study|Withdrawal by Subject|3|||
23186224|NCT03748641|64422941|FG001|Overall Study|Withdrawal by Subject|2|||
23466603|NCT04154189|65452073|FG001|Overall Study|Death|25|||
23186225|NCT03748641|64422942|FG002|Overall Study|Withdrawal by Subject|5|||
23186226|NCT03748641|64422943|FG003|Overall Study|Withdrawal by Subject|3|||
23186227|NCT03748641|64422944|FG004|Overall Study|Withdrawal by Subject|2|||
23186228|NCT01725165|64422945|FG000|Overall Study|Death|11|||
23186229|NCT01725165|64422946|FG001|Overall Study|Death|18|||
23186230|NCT02936752|64422947|FG000|Overall Study|Death|2|||
23186231|NCT02936752|64422948|FG001|Overall Study|Death|1|||
23186232|NCT02936752|64422947|FG000|Overall Study|Physician Decision|4|||
23186233|NCT02936752|64422948|FG001|Overall Study|Physician Decision|0|||
23186234|NCT02936752|64422947|FG000|Overall Study|Withdrawal by Subject|0|||
23186235|NCT02936752|64422948|FG001|Overall Study|Withdrawal by Subject|2|||
23186236|NCT05139030|64422949|FG000|Overall Study|Withdrawal by Subject|1|||
23186237|NCT05139030|64422950|FG001|Overall Study|Withdrawal by Subject|3|||
23466604|NCT02500797|65452078|FG000|Overall Study|Cancel (rapid disease progression)|0|||
23466605|NCT02500797|65452079|FG001|Overall Study|Cancel (rapid disease progression)|0|||
23466606|NCT02500797|65452080|FG002|Overall Study|Cancel (rapid disease progression)|0|||
23466607|NCT02500797|65452081|FG003|Overall Study|Cancel (rapid disease progression)|0|||
23466608|NCT02500797|65452082|FG004|Overall Study|Cancel (rapid disease progression)|1|||
23586439|NCT01549652|65873073|FG003|Overall Study|Withdrawal by Subject|3|||
23586440|NCT00357396|65873074|FG000|Overall Study|Adverse Event|1|||
23586441|NCT00357396|65873075|FG001|Overall Study|Adverse Event|0|||
23586442|NCT02994654|65876005|FG000|Overall Study|Lost to Follow-up|1|||
23586443|NCT00686517|65876014|FG000|Treatment|Serious Adverse Event|1|||
23586444|NCT00686517|65876015|FG001|Treatment|Serious Adverse Event|2|||
23586445|NCT00686517|65876016|FG002|Treatment|Serious Adverse Event|1|||
23586446|NCT00686517|65876014|FG000|Treatment|Adverse Event|2|||
23586447|NCT00686517|65876015|FG001|Treatment|Adverse Event|0|||
23586448|NCT00686517|65876016|FG002|Treatment|Adverse Event|0|||
23186238|NCT05139030|64422949|FG000|Overall Study|Adverse Event|0|||
23186239|NCT05139030|64422950|FG001|Overall Study|Adverse Event|1|||
23186240|NCT05139030|64422949|FG000|Overall Study|Failure to meet continuation criteria|0|||
23186241|NCT05139030|64422950|FG001|Overall Study|Failure to meet continuation criteria|1|||
23186242|NCT02040142|64422957|FG000|Overall Study|Lost to Follow-up|5|||
23186243|NCT02040142|64422957|FG000|Overall Study|Death|17|||
23186244|NCT02040142|64422957|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
23244616|NCT00602641|64638854|FG001|Overall Study|Still on treatment at time of analysis|15|||
23244617|NCT00602641|64638853|FG000|Overall Study|Adverse Event|62|||
23351414|NCT01593254|65029619|FG000|Overall Study|participant no longer meets study criteria|1|||
23351415|NCT01593254|65029620|FG001|Overall Study|participant no longer meets study criteria|1|||
23351416|NCT01593254|65029619|FG000|Overall Study|Admin reason by sponsor|7|||
23351417|NCT01593254|65029620|FG001|Overall Study|Admin reason by sponsor|3|||
23351418|NCT01593254|65029619|FG000|Overall Study|Imatinib treatment failure|2|||
23351419|NCT01593254|65029620|FG001|Overall Study|Imatinib treatment failure|0|||
23351420|NCT01593254|65029619|FG000|Overall Study|Other Reasons|61|||
23351421|NCT01593254|65029620|FG001|Overall Study|Other Reasons|115|||
23351422|NCT04490018|65029621|FG000|Overall Study|Protocol Violation|0|||
23351423|NCT04490018|65029622|FG001|Overall Study|Protocol Violation|2|||
23351424|NCT04490018|65029623|FG002|Overall Study|Protocol Violation|1|||
23351425|NCT04490018|65029621|FG000|Overall Study|Lost to Follow-up|2|||
23351426|NCT04490018|65029622|FG001|Overall Study|Lost to Follow-up|2|||
23351427|NCT04490018|65029623|FG002|Overall Study|Lost to Follow-up|0|||
23186245|NCT03293680|64422958|FG000|Overall Study|Death|1|||
23186246|NCT03293680|64422958|FG000|Overall Study|Did not meet inclusion criteria|8|||
23186247|NCT03871491|64422959|FG000|Overall Study|Withdrawal by Subject|14|||
23186248|NCT03871491|64422960|FG001|Overall Study|Withdrawal by Subject|14|||
23186249|NCT03871491|64422961|FG002|Overall Study|Withdrawal by Subject|14|||
23186250|NCT03871491|64422962|FG003|Overall Study|Withdrawal by Subject|14|||
23186251|NCT03871491|64422959|FG000|Overall Study|Physician Decision|0|||
23466609|NCT02500797|65452083|FG005|Overall Study|Cancel (rapid disease progression)|1|||
23466610|NCT02500797|65452084|FG006|Overall Study|Cancel (rapid disease progression)|0|||
23466611|NCT02500797|65452085|FG007|Overall Study|Cancel (rapid disease progression)|0|||
23466612|NCT02500797|65452078|FG000|Overall Study|Withdrawal by Subject|1|||
23466613|NCT02500797|65452079|FG001|Overall Study|Withdrawal by Subject|0|||
23466614|NCT02500797|65452080|FG002|Overall Study|Withdrawal by Subject|0|||
23466615|NCT02500797|65452081|FG003|Overall Study|Withdrawal by Subject|0|||
23466616|NCT02500797|65452082|FG004|Overall Study|Withdrawal by Subject|0|||
23466617|NCT02500797|65452083|FG005|Overall Study|Withdrawal by Subject|0|||
23466618|NCT02500797|65452084|FG006|Overall Study|Withdrawal by Subject|0|||
23466619|NCT02500797|65452085|FG007|Overall Study|Withdrawal by Subject|0|||
23466620|NCT00853567|65452086|FG000|Overall Study|Study prematurely terminated|71|||
23466621|NCT00354432|65452087|FG000|Overall Study|Adverse Event|3|||
23466622|NCT00354432|65452088|FG001|Overall Study|Adverse Event|1|||
23466623|NCT00354432|65452089|FG002|Overall Study|Adverse Event|5|||
23466624|NCT00354432|65452090|FG003|Overall Study|Adverse Event|5|||
23466625|NCT00354432|65452087|FG000|Overall Study|Off/Toxicity|3|||
23466626|NCT00354432|65452088|FG001|Overall Study|Off/Toxicity|7|||
23466627|NCT00354432|65452089|FG002|Overall Study|Off/Toxicity|5|||
23466628|NCT00354432|65452090|FG003|Overall Study|Off/Toxicity|5|||
23466629|NCT00706238|65452091|FG000|Overall Study|Disease progression|4|||
23466630|NCT00706238|65452091|FG000|Overall Study|Other|1|||
23466631|NCT00670306|65452094|FG000|Overall Study|Adverse Event|8|||
23466632|NCT00670306|65452094|FG000|Overall Study|Lack of Efficacy|10|||
23466633|NCT00670306|65452094|FG000|Overall Study|Withdrawal by Subject|9|||
23466634|NCT00670306|65452094|FG000|Overall Study|Physician Decision|1|||
23466635|NCT00670306|65452094|FG000|Overall Study|Lost to Follow-up|8|||
23466636|NCT00670306|65452094|FG000|Overall Study|incl/excl criterias did not meet|19|||
23466637|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
23466638|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
23466639|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
23466640|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
23466641|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
23466642|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
23466643|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
23466644|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
23466645|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
23466646|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
23466647|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
23466648|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
23466649|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
23466650|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
23466651|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
23466652|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
23466653|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
23466654|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
23466655|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
23466656|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
23466657|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
23466658|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
23466659|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
23466660|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
23466661|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
23466662|NCT01584440|65452095|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
23466663|NCT01584440|65452096|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
23466664|NCT01584440|65452097|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
23466665|NCT01584440|65452098|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
23466666|NCT01584440|65452099|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
23466667|NCT01584440|65452095|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
23186252|NCT03871491|64422960|FG001|Overall Study|Physician Decision|0|||
23186253|NCT03871491|64422961|FG002|Overall Study|Physician Decision|1|||
23186254|NCT03871491|64422962|FG003|Overall Study|Physician Decision|1|||
23244618|NCT00602641|64638854|FG001|Overall Study|Adverse Event|53|||
23466668|NCT01584440|65452096|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
23466669|NCT01584440|65452097|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
23466670|NCT01584440|65452098|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
23466671|NCT01584440|65452099|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
23186255|NCT03871491|64422959|FG000|Overall Study|Lost to Follow-up|50|||
23466672|NCT01584440|65452095|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
23466673|NCT01584440|65452096|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
23466674|NCT01584440|65452097|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
23466675|NCT01584440|65452098|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
23466676|NCT01584440|65452099|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
23466677|NCT01584440|65452095|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
23466678|NCT01584440|65452096|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
23466679|NCT01584440|65452097|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
23466680|NCT01584440|65452098|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
23466681|NCT01584440|65452099|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
23466682|NCT00131248|65452102|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
23466683|NCT00131248|65452103|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
23466684|NCT01677377|65452104|FG000|Overall Study|Protocol Violation|1|||
23186256|NCT03871491|64422960|FG001|Overall Study|Lost to Follow-up|15|||
23186257|NCT03871491|64422961|FG002|Overall Study|Lost to Follow-up|36|||
23466685|NCT01677377|65452105|FG001|Overall Study|Protocol Violation|0|||
23466686|NCT01677377|65452106|FG002|Overall Study|Protocol Violation|0|||
23466687|NCT01677377|65452104|FG000|Overall Study|Lost to Follow-up|0|||
23466688|NCT01677377|65452105|FG001|Overall Study|Lost to Follow-up|1|||
23466689|NCT01677377|65452106|FG002|Overall Study|Lost to Follow-up|1|||
23466690|NCT01677377|65452104|FG000|Overall Study|Withdrawal by Subject|0|||
23466691|NCT01677377|65452105|FG001|Overall Study|Withdrawal by Subject|0|||
23466692|NCT01677377|65452106|FG002|Overall Study|Withdrawal by Subject|3|||
23466693|NCT01677377|65452104|FG000|Overall Study|Lack of Efficacy|0|||
23466694|NCT01677377|65452105|FG001|Overall Study|Lack of Efficacy|0|||
23466695|NCT01677377|65452106|FG002|Overall Study|Lack of Efficacy|1|||
23466696|NCT01677377|65452104|FG000|Overall Study|Pregnancy|0|||
23466697|NCT01677377|65452105|FG001|Overall Study|Pregnancy|0|||
23466698|NCT01677377|65452106|FG002|Overall Study|Pregnancy|1|||
23466699|NCT01626872|65452107|FG000|Overall Study|Physician Decision|13|||
23466700|NCT01626872|65452108|FG001|Overall Study|Physician Decision|9|||
23466701|NCT01626872|65452109|FG002|Overall Study|Physician Decision|6|||
23466702|NCT01626872|65452107|FG000|Overall Study|Withdrawal by Subject|19|||
23466703|NCT01626872|65452108|FG001|Overall Study|Withdrawal by Subject|27|||
23466704|NCT01626872|65452109|FG002|Overall Study|Withdrawal by Subject|8|||
23466705|NCT01626872|65452107|FG000|Overall Study|Adverse Event (including Death)|20|||
23466706|NCT01626872|65452108|FG001|Overall Study|Adverse Event (including Death)|28|||
23466707|NCT01626872|65452109|FG002|Overall Study|Adverse Event (including Death)|8|||
23466708|NCT01626872|65452107|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
23466709|NCT01626872|65452108|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
23466710|NCT01626872|65452109|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
23466711|NCT01185080|65452111|FG000|Overall Study|Adverse Event|1|||
23466712|NCT01185080|65452112|FG001|Overall Study|Adverse Event|1|||
23466713|NCT01185080|65452113|FG002|Overall Study|Adverse Event|0|||
23466714|NCT01185080|65452111|FG000|Overall Study|Personal reasons|0|||
23466715|NCT01185080|65452112|FG001|Overall Study|Personal reasons|0|||
23466716|NCT01185080|65452113|FG002|Overall Study|Personal reasons|1|||
23466717|NCT01064947|65452115|FG000|Overall Study|negative culture|41|||
23466718|NCT02136069|65452116|FG000|Overall Study|UC flare-up|1|||
23466719|NCT02136069|65452117|FG001|Overall Study|UC flare-up|0|||
23466720|NCT02136069|65452116|FG000|Overall Study|Adverse Event|6|||
23466721|NCT02136069|65452117|FG001|Overall Study|Adverse Event|8|||
23466722|NCT02136069|65452116|FG000|Overall Study|Death|0|||
23466723|NCT02136069|65452117|FG001|Overall Study|Death|1|||
23466724|NCT02136069|65452116|FG000|Overall Study|Lack of Efficacy|10|||
23466725|NCT02136069|65452117|FG001|Overall Study|Lack of Efficacy|4|||
23466726|NCT02136069|65452116|FG000|Overall Study|Lost to Follow-up|1|||
23466727|NCT02136069|65452117|FG001|Overall Study|Lost to Follow-up|0|||
23466728|NCT02136069|65452116|FG000|Overall Study|Non-Compliance|1|||
23466729|NCT02136069|65452117|FG001|Overall Study|Non-Compliance|0|||
23466730|NCT02136069|65452116|FG000|Overall Study|Physician Decision|5|||
23466731|NCT02136069|65452117|FG001|Overall Study|Physician Decision|4|||
23466732|NCT02136069|65452116|FG000|Overall Study|Withdrawal by Subject|10|||
23466733|NCT02136069|65452117|FG001|Overall Study|Withdrawal by Subject|11|||
23466734|NCT00380367|65452118|FG000|Overall Study|Lost to Follow-up|1|||
23466735|NCT00380367|65452118|FG000|Overall Study|Withdrawal by Subject|1|||
23466736|NCT01544335|65452119|FG000|Overall Study|Lost to Follow-up|27|||
23466737|NCT01544335|65452119|FG000|Overall Study|Death|4|||
23466738|NCT01544335|65452119|FG000|Overall Study|Disease progression|3|||
23586449|NCT00686517|65876014|FG000|Treatment|Poor Protocol Compliance|1|||
23586450|NCT00686517|65876015|FG001|Treatment|Poor Protocol Compliance|0|||
23186258|NCT03871491|64422962|FG003|Overall Study|Lost to Follow-up|11|||
23244619|NCT00602641|64638853|FG000|Overall Study|Disease progression|38|||
23466739|NCT01544335|65452119|FG000|Overall Study|Baseline Measurements not Available|19|||
23466740|NCT01821118|65452120|FG000|Overall Study|Death|0|||
23466741|NCT01821118|65452121|FG001|Overall Study|Death|1|||
23466742|NCT01076361|65452122|FG000|Overall Study|22 leads were excluded from analysis|21|||
23466743|NCT00686686|65452123|FG000|Overall Study|Non-compliance|1|||
23466744|NCT00686686|65452123|FG000|Overall Study|Adverse Event|2|||
23466745|NCT00686686|65452123|FG000|Overall Study|Lost to Follow-up|3|||
23466746|NCT01286480|65452125|FG000|Overall Study|Withdrawal by Subject|5|||
23466747|NCT01286480|65452126|FG001|Overall Study|Withdrawal by Subject|3|||
23466748|NCT00755183|65452133|FG000|Overall Study|Adverse Event|5|||
23466749|NCT00755183|65452134|FG001|Overall Study|Adverse Event|2|||
23466750|NCT00755183|65452133|FG000|Overall Study|Protocol Violation|0|||
23466751|NCT00755183|65452134|FG001|Overall Study|Protocol Violation|1|||
23466752|NCT00755183|65452133|FG000|Overall Study|Withdrawal by Subject|0|||
23466753|NCT00755183|65452134|FG001|Overall Study|Withdrawal by Subject|2|||
23466754|NCT00755183|65452133|FG000|Overall Study|Administrative|2|||
23466755|NCT00755183|65452134|FG001|Overall Study|Administrative|1|||
23466756|NCT00803569|65452135|FG000|Overall Study|Progressive Disease|3|||
23466757|NCT00803569|65452135|FG000|Overall Study|Noncompliance|1|||
23466758|NCT03312634|65452136|FG000|Overall Study|Adverse Event|11|||
23466759|NCT03312634|65452137|FG001|Overall Study|Adverse Event|0|||
23466760|NCT03312634|65452136|FG000|Overall Study|Sponsor request|2|||
23466761|NCT03312634|65452137|FG001|Overall Study|Sponsor request|0|||
23466762|NCT03312634|65452136|FG000|Overall Study|Withdrawal by Subject|31|||
23466763|NCT03312634|65452137|FG001|Overall Study|Withdrawal by Subject|9|||
23466764|NCT03312634|65452136|FG000|Overall Study|Enrolled in an interventional study|0|||
23466765|NCT03312634|65452137|FG001|Overall Study|Enrolled in an interventional study|52|||
23466766|NCT03312634|65452136|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
23186259|NCT01275677|64422967|FG000|Overall Study|Not at risk for recurrence.|1|||
23186260|NCT01275677|64422968|FG001|Overall Study|Not at risk for recurrence.|1|||
23186261|NCT01275677|64422967|FG000|Overall Study|No follow-up|26|||
23186262|NCT01275677|64422968|FG001|Overall Study|No follow-up|37|||
23186263|NCT01275677|64422967|FG000|Overall Study|No clinical follow up.|1|||
23186264|NCT01275677|64422968|FG001|Overall Study|No clinical follow up.|4|||
23186265|NCT02642042|64422969|FG000|Overall Study|Adverse Event|22|||
23466767|NCT03312634|65452137|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
23466768|NCT03312634|65452136|FG000|Overall Study|Death|0|||
23466769|NCT03312634|65452137|FG001|Overall Study|Death|1|||
23466770|NCT03312634|65452136|FG000|Overall Study|Non-compliance|0|||
23466771|NCT03312634|65452137|FG001|Overall Study|Non-compliance|2|||
23466772|NCT03312634|65452136|FG000|Overall Study|Lost to Follow-up|0|||
23466773|NCT03312634|65452137|FG001|Overall Study|Lost to Follow-up|1|||
23466774|NCT03312634|65452136|FG000|Overall Study|Enrolled into non-interventional study|0|||
23466775|NCT03312634|65452137|FG001|Overall Study|Enrolled into non-interventional study|5|||
23466776|NCT03312634|65452136|FG000|Overall Study|Worsening clinical condition|0|||
23466777|NCT03312634|65452137|FG001|Overall Study|Worsening clinical condition|1|||
23466778|NCT03312634|65452136|FG000|Overall Study|Participant did not want to travel|0|||
23466779|NCT03312634|65452137|FG001|Overall Study|Participant did not want to travel|1|||
23466780|NCT03312634|65452136|FG000|Overall Study|Physician Decision|1|||
23466781|NCT03312634|65452137|FG001|Overall Study|Physician Decision|0|||
23466782|NCT03312634|65452136|FG000|Overall Study|Other|13|||
23466783|NCT03312634|65452137|FG001|Overall Study|Other|0|||
23466784|NCT00372593|65452138|FG000|Overall Study|Adverse Event|43|||
23466785|NCT00372593|65452139|FG001|Overall Study|Adverse Event|45|||
23466786|NCT00372593|65452140|FG002|Overall Study|Adverse Event|0|||
23466787|NCT00372593|65452138|FG000|Overall Study|Death|16|||
23466788|NCT00372593|65452139|FG001|Overall Study|Death|20|||
23466789|NCT00372593|65452140|FG002|Overall Study|Death|1|||
23466790|NCT00372593|65452138|FG000|Overall Study|Lack of Efficacy|82|||
23466791|NCT00372593|65452139|FG001|Overall Study|Lack of Efficacy|71|||
23466792|NCT00372593|65452140|FG002|Overall Study|Lack of Efficacy|2|||
23466793|NCT00372593|65452138|FG000|Overall Study|Lost to Follow-up|1|||
23466794|NCT00372593|65452139|FG001|Overall Study|Lost to Follow-up|0|||
23466795|NCT00372593|65452140|FG002|Overall Study|Lost to Follow-up|0|||
23466796|NCT00372593|65452138|FG000|Overall Study|Physician Decision|42|||
23466797|NCT00372593|65452139|FG001|Overall Study|Physician Decision|41|||
23466798|NCT00372593|65452140|FG002|Overall Study|Physician Decision|0|||
23466799|NCT00372593|65452138|FG000|Overall Study|Ineligible|20|||
23466800|NCT00372593|65452139|FG001|Overall Study|Ineligible|21|||
23466801|NCT00372593|65452140|FG002|Overall Study|Ineligible|1|||
23466802|NCT00080899|65452141|FG000|Overall Study|Adverse Event|1|||
23186266|NCT02642042|64422969|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23466803|NCT01244893|65452142|FG000|Baseline|Protocol Violation|0|||
23466804|NCT01244893|65452143|FG001|Baseline|Protocol Violation|1|||
23466805|NCT01244893|65452142|FG000|1-Week Follow Up|Lost to Follow-up|1|||
23466806|NCT01244893|65452143|FG001|1-Week Follow Up|Lost to Follow-up|0|||
23466807|NCT00885534|65452144|FG000|Overall Study|Patient deemed ineligible|1|||
23186267|NCT02642042|64422969|FG000|Overall Study|Progression/Relapse|28|||
23466808|NCT01192191|65452145|FG000|Overall Study|Adverse Event|7|||
23466809|NCT01192191|65452146|FG001|Overall Study|Adverse Event|12|||
23466810|NCT01192191|65452145|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
23466811|NCT01192191|65452146|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
23466812|NCT01192191|65452145|FG000|Overall Study|Lost to Follow-up|0|||
23466813|NCT01192191|65452146|FG001|Overall Study|Lost to Follow-up|1|||
23466814|NCT01192191|65452145|FG000|Overall Study|Withdrawal by Subject|1|||
23466815|NCT01192191|65452146|FG001|Overall Study|Withdrawal by Subject|6|||
23466816|NCT03083873|65452148|FG000|Overall Study|Death|6|||
23466817|NCT03083873|65452149|FG001|Overall Study|Death|15|||
23466818|NCT03083873|65452150|FG002|Overall Study|Death|13|||
23466819|NCT03083873|65452151|FG003|Overall Study|Death|9|||
23466820|NCT03083873|65452152|FG004|Overall Study|Death|0|||
23466821|NCT03083873|65452148|FG000|Overall Study|Sponsor Terminated Study|0|||
23466822|NCT03083873|65452149|FG001|Overall Study|Sponsor Terminated Study|1|||
23466823|NCT03083873|65452150|FG002|Overall Study|Sponsor Terminated Study|2|||
23466824|NCT03083873|65452151|FG003|Overall Study|Sponsor Terminated Study|3|||
23466825|NCT03083873|65452152|FG004|Overall Study|Sponsor Terminated Study|0|||
23466826|NCT03083873|65452148|FG000|Overall Study|Lost to Follow-up|0|||
23466827|NCT03083873|65452149|FG001|Overall Study|Lost to Follow-up|1|||
23466828|NCT03083873|65452150|FG002|Overall Study|Lost to Follow-up|1|||
23466829|NCT03083873|65452151|FG003|Overall Study|Lost to Follow-up|0|||
23466830|NCT03083873|65452152|FG004|Overall Study|Lost to Follow-up|0|||
23466831|NCT03083873|65452148|FG000|Overall Study|Withdrawal by Subject|2|||
23466832|NCT03083873|65452149|FG001|Overall Study|Withdrawal by Subject|0|||
23466833|NCT03083873|65452150|FG002|Overall Study|Withdrawal by Subject|0|||
23466834|NCT03083873|65452151|FG003|Overall Study|Withdrawal by Subject|0|||
23466835|NCT03083873|65452152|FG004|Overall Study|Withdrawal by Subject|0|||
23466836|NCT03083873|65452148|FG000|Overall Study|Did Not Receive TIL|2|||
23466837|NCT03083873|65452149|FG001|Overall Study|Did Not Receive TIL|5|||
23466838|NCT03083873|65452150|FG002|Overall Study|Did Not Receive TIL|3|||
23466839|NCT03083873|65452151|FG003|Overall Study|Did Not Receive TIL|1|||
23466840|NCT03083873|65452152|FG004|Overall Study|Did Not Receive TIL|0|||
23466841|NCT03614156|65452153|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
23466842|NCT03614156|65452154|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
23466843|NCT03614156|65452155|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
23466844|NCT03614156|65452156|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
23466845|NCT03614156|65452153|FG000|Open-Label Treatment Period|Adverse Event|7|||
23466846|NCT03614156|65452154|FG001|Open-Label Treatment Period|Adverse Event|0|||
23466847|NCT03614156|65452155|FG002|Open-Label Treatment Period|Adverse Event|0|||
23466848|NCT03614156|65452156|FG003|Open-Label Treatment Period|Adverse Event|0|||
23466849|NCT03614156|65452153|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
23244620|NCT00602641|64638854|FG001|Overall Study|Disease progression|55|||
23466850|NCT03614156|65452154|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
23466851|NCT03614156|65452155|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
23466852|NCT03614156|65452156|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
23466853|NCT03614156|65452153|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
23466854|NCT03614156|65452154|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
23466855|NCT03614156|65452155|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
23466856|NCT03614156|65452156|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
23466857|NCT03614156|65452153|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
23466858|NCT03614156|65452154|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
23466859|NCT03614156|65452155|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
23466860|NCT03614156|65452156|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
23466861|NCT03614156|65452153|FG000|Open-Label Treatment Period|Protocol Violation|2|||
23466862|NCT03614156|65452154|FG001|Open-Label Treatment Period|Protocol Violation|0|||
23466863|NCT03614156|65452155|FG002|Open-Label Treatment Period|Protocol Violation|0|||
23586451|NCT00686517|65876016|FG002|Treatment|Poor Protocol Compliance|0|||
23586452|NCT00686517|65876014|FG000|Treatment|Protocol Violation|2|||
23244621|NCT00602641|64638853|FG000|Overall Study|Death|6|||
23244622|NCT00602641|64638854|FG001|Overall Study|Death|5|||
23466864|NCT03614156|65452156|FG003|Open-Label Treatment Period|Protocol Violation|0|||
23466865|NCT03614156|65452153|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
23466866|NCT03614156|65452154|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
23466867|NCT03614156|65452155|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
23466868|NCT03614156|65452156|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
23466869|NCT03614156|65452153|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
23466870|NCT03614156|65452154|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
23466871|NCT03614156|65452155|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
23466872|NCT03614156|65452156|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
23466873|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
23466874|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
23466875|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
23466876|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
23466877|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23466878|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
23466879|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23586453|NCT00686517|65876015|FG001|Treatment|Protocol Violation|1|||
23244623|NCT00602641|64638853|FG000|Overall Study|Withdrawal by Subject|15|||
23244624|NCT00602641|64638854|FG001|Overall Study|Withdrawal by Subject|12|||
23244625|NCT00602641|64638853|FG000|Overall Study|Alternative therapy|5|||
23244626|NCT00602641|64638854|FG001|Overall Study|Alternative therapy|2|||
23186268|NCT02642042|64422969|FG000|Overall Study|Death|1|||
23186269|NCT02642042|64422969|FG000|Overall Study|Not Protocol Specified|2|||
23186270|NCT05817045|64422976|FG000|Overall Study|Protocol Violation|0|||
23186271|NCT05817045|64422977|FG001|Overall Study|Protocol Violation|3|||
23244627|NCT00602641|64638853|FG000|Overall Study|Other Complicating Disease|5|||
23244628|NCT00602641|64638854|FG001|Overall Study|Other Complicating Disease|2|||
23244629|NCT00602641|64638853|FG000|Overall Study|Physician Decision|5|||
23244630|NCT00602641|64638854|FG001|Overall Study|Physician Decision|4|||
23351428|NCT04490018|65029621|FG000|Overall Study|Withdrawal by Subject|2|||
23351429|NCT04490018|65029622|FG001|Overall Study|Withdrawal by Subject|1|||
23351430|NCT04490018|65029623|FG002|Overall Study|Withdrawal by Subject|0|||
23351431|NCT04490018|65029621|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23351432|NCT04490018|65029622|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23351433|NCT04490018|65029623|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23351434|NCT02920177|65029624|FG000|Overall Study|Withdrawal by Subject|1|||
23186272|NCT05817045|64422976|FG000|Overall Study|Withdrawal by Subject|10|||
23186273|NCT05817045|64422977|FG001|Overall Study|Withdrawal by Subject|7|||
23186274|NCT05817045|64422976|FG000|Overall Study|Physician Decision|3|||
23186275|NCT05817045|64422977|FG001|Overall Study|Physician Decision|0|||
23186276|NCT05817045|64422976|FG000|Overall Study|Lost to Follow-up|0|||
23186277|NCT05817045|64422977|FG001|Overall Study|Lost to Follow-up|1|||
23186278|NCT05817045|64422976|FG000|Overall Study|Device Deficiency|1|||
23186279|NCT05817045|64422977|FG001|Overall Study|Device Deficiency|0|||
23186280|NCT05817045|64422976|FG000|Overall Study|System Error|1|||
23186281|NCT05817045|64422977|FG001|Overall Study|System Error|0|||
23186282|NCT02725788|64422978|FG000|Overall Study|Lost to Follow-up|1|||
23186283|NCT02725788|64422979|FG001|Overall Study|Lost to Follow-up|1|||
23186284|NCT02725788|64422978|FG000|Overall Study|Protocol Violation|0|||
23186285|NCT02725788|64422979|FG001|Overall Study|Protocol Violation|1|||
23186286|NCT01386385|64422980|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
23186287|NCT01386385|64422981|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23186288|NCT01386385|64422982|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23186289|NCT01386385|64422983|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23186290|NCT01386385|64422984|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23186291|NCT01386385|64422985|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23186292|NCT01386385|64422986|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23186293|NCT01386385|64422987|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
23186294|NCT01386385|64422980|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
23186295|NCT01386385|64422981|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23186296|NCT01386385|64422982|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23186297|NCT01386385|64422983|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23186298|NCT01386385|64422984|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23186299|NCT01386385|64422985|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23186300|NCT01386385|64422986|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23186301|NCT01386385|64422987|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
23186302|NCT01386385|64422980|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23186303|NCT01386385|64422981|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23186304|NCT01386385|64422982|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
23186305|NCT01386385|64422983|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23186306|NCT01386385|64422984|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23186307|NCT01386385|64422985|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23186308|NCT01386385|64422986|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23186309|NCT01386385|64422987|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
23186310|NCT01386385|64422980|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23186311|NCT01386385|64422981|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23186312|NCT01386385|64422982|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23186313|NCT01386385|64422983|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23186314|NCT01386385|64422984|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
23186315|NCT01386385|64422985|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23186316|NCT01386385|64422986|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23186317|NCT01386385|64422987|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
23186318|NCT01386385|64422980|FG000|Phase II Concurrent CRT|Adverse Event|0|||
23186319|NCT01386385|64422981|FG001|Phase II Concurrent CRT|Adverse Event|0|||
23351435|NCT02920177|65029625|FG001|Overall Study|Withdrawal by Subject|1|||
23244631|NCT00602641|64638853|FG000|Overall Study|Administrative Closure|1|||
23244632|NCT00602641|64638854|FG001|Overall Study|Administrative Closure|1|||
23244633|NCT00602641|64638853|FG000|Overall Study|Other|3|||
23351436|NCT02920177|65029624|FG000|Overall Study|Physician Decision|1|||
23351437|NCT02920177|65029625|FG001|Overall Study|Physician Decision|0|||
23351438|NCT02920177|65029624|FG000|Overall Study|Lost to Follow-up|0|||
23351439|NCT02920177|65029625|FG001|Overall Study|Lost to Follow-up|1|||
23351440|NCT03564795|65029626|FG000|Overall Study|Withdrawal by Subject|3|||
23351441|NCT03564795|65029626|FG000|Overall Study|Lost to Follow-up|6|||
23351442|NCT03564795|65029626|FG000|Overall Study|Physician Decision|2|||
23351443|NCT02636439|65029627|FG000|Overall Study|Adverse Event|2|||
23351444|NCT02636439|65029628|FG001|Overall Study|Adverse Event|2|||
23351445|NCT02636439|65029627|FG000|Overall Study|Lost to Follow-up|1|||
23351446|NCT02636439|65029628|FG001|Overall Study|Lost to Follow-up|0|||
23351447|NCT02636439|65029627|FG000|Overall Study|Non-compliance|1|||
23351448|NCT02636439|65029628|FG001|Overall Study|Non-compliance|1|||
23466880|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
23466881|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23466882|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23466883|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
23351449|NCT02636439|65029627|FG000|Overall Study|Personal reasons|2|||
23466884|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
23466885|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
23466886|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
23466887|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
23466888|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
23466889|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
23466890|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
23466891|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
23466892|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
23466893|NCT03614156|65452153|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
23466894|NCT03614156|65452154|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
23466895|NCT03614156|65452155|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
23466896|NCT03614156|65452156|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
23466897|NCT03614156|65452153|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
23466898|NCT03614156|65452154|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
23466899|NCT03614156|65452155|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
23466900|NCT03614156|65452156|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
23586454|NCT00686517|65876016|FG002|Treatment|Protocol Violation|0|||
23586455|NCT02918071|65876017|FG000|Overall Study|Withdrawal by Subject|2|||
23586456|NCT02918071|65876017|FG000|Overall Study|Lost to Follow-up|1|||
23586457|NCT00364286|65876018|FG000|Overall Study|Withdrawal by Subject|1|||
23186320|NCT01386385|64422982|FG002|Phase II Concurrent CRT|Adverse Event|0|||
23186321|NCT01386385|64422983|FG003|Phase II Concurrent CRT|Adverse Event|0|||
23586458|NCT00364286|65876018|FG000|Overall Study|Adverse Event|2|||
23586459|NCT00927823|65876024|FG000|Continuous Dosing Period|Death|0|||
23586460|NCT00927823|65876025|FG001|Continuous Dosing Period|Death|0|||
23586461|NCT00927823|65876026|FG002|Continuous Dosing Period|Death|6|||
23586462|NCT00927823|65876027|FG003|Continuous Dosing Period|Death|0|||
23586463|NCT00927823|65876024|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
23586464|NCT00927823|65876025|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
23586465|NCT00927823|65876026|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
23586466|NCT00927823|65876027|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
23586467|NCT00927823|65876024|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
23586468|NCT00927823|65876025|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
23586469|NCT00927823|65876026|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
23586470|NCT00927823|65876027|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
23586471|NCT00927823|65876024|FG000|Continuous Dosing Period|Other|1|||
23586472|NCT00927823|65876025|FG001|Continuous Dosing Period|Other|2|||
23586473|NCT00927823|65876026|FG002|Continuous Dosing Period|Other|9|||
23586474|NCT00927823|65876027|FG003|Continuous Dosing Period|Other|3|||
23586475|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Other|4|||
23586476|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Other|0|||
23586477|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
23586478|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
23586479|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
23586480|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
23586481|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
23586482|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
23351450|NCT02636439|65029628|FG001|Overall Study|Personal reasons|0|||
23351451|NCT01074255|65029633|FG000|Overall Study|Did not receive EMEND|2|||
23351452|NCT02787083|65029634|FG000|Overall Study|Adverse Event|1|||
23351453|NCT02787083|65029635|FG001|Overall Study|Adverse Event|0|||
23466901|NCT03614156|65452153|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
23466902|NCT03614156|65452154|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
23466903|NCT03614156|65452155|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
23244634|NCT00602641|64638854|FG001|Overall Study|Other|1|||
23244635|NCT00944125|64638855|FG000|3 to 6 Months|Withdrawal by Subject|0|||
23244636|NCT00944125|64638856|FG001|3 to 6 Months|Withdrawal by Subject|2|||
23244637|NCT00944125|64638855|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
23244638|NCT00944125|64638856|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
23586483|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
23586484|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
23586485|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
23586486|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
23586487|NCT00853827|65876028|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
23586488|NCT00853827|65876029|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
23586489|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
23586490|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
23586491|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
23586492|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
23586493|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
23586494|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
23586495|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
23586496|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
23586497|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
23586498|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
23586499|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
23586500|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
23586501|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
23586502|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
23586503|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
23244660|NCT01068418|64638866|FG000|Overall Study|Physician Decision|12|||
23244661|NCT02279888|64638867|FG000|Overall Study|Death|326|||
23244662|NCT02279888|64638867|FG000|Overall Study|Withdrawal by Subject|38|||
23244663|NCT02279888|64638867|FG000|Overall Study|Lost to Follow-up|21|||
23244664|NCT02279888|64638867|FG000|Overall Study|Physician Decision|62|||
23244665|NCT02279888|64638867|FG000|Overall Study|Subject Non-compliance|43|||
23244666|NCT02279888|64638867|FG000|Overall Study|Not implanted|14|||
23244667|NCT02279888|64638867|FG000|Overall Study|Visit not performed|26|||
23244668|NCT01036594|64638868|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
23244669|NCT01036594|64638869|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
23244670|NCT01036594|64638868|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
23244671|NCT01036594|64638869|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
23244672|NCT01036594|64638868|FG000|Week 12 Evaluation|Adverse Event|5|||
23244673|NCT01036594|64638869|FG001|Week 12 Evaluation|Adverse Event|0|||
23244674|NCT01036594|64638868|FG000|Week 12 Evaluation|Physician Decision|1|||
23244675|NCT01036594|64638869|FG001|Week 12 Evaluation|Physician Decision|0|||
23244676|NCT01036594|64638868|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
23244677|NCT01036594|64638869|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
23244678|NCT01036594|64638868|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
23244679|NCT01036594|64638869|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
23351454|NCT02787083|65029634|FG000|Overall Study|Withdrawal by Subject|2|||
23586504|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
23586505|NCT00853827|65876028|FG000|Double Blind Period (103 Weeks)|Death|1|||
23586506|NCT00853827|65876029|FG001|Double Blind Period (103 Weeks)|Death|6|||
23586507|NCT03710564|65876030|FG000|Overall Study|Study Terminated by Sponsor|104|||
23586508|NCT03710564|65876031|FG001|Overall Study|Study Terminated by Sponsor|55|||
23586509|NCT03710564|65876030|FG000|Overall Study|Withdrawal by Subject|57|||
23586510|NCT03710564|65876031|FG001|Overall Study|Withdrawal by Subject|25|||
23586511|NCT03710564|65876030|FG000|Overall Study|Death|10|||
23586512|NCT03710564|65876031|FG001|Overall Study|Death|4|||
23586513|NCT03710564|65876030|FG000|Overall Study|Lost to Follow-up|5|||
23586514|NCT03710564|65876031|FG001|Overall Study|Lost to Follow-up|4|||
23586515|NCT03710564|65876030|FG000|Overall Study|Protocol Violation|3|||
23586516|NCT03710564|65876031|FG001|Overall Study|Protocol Violation|2|||
23586517|NCT03710564|65876030|FG000|Overall Study|Adverse Event|3|||
23586518|NCT03710564|65876031|FG001|Overall Study|Adverse Event|0|||
23244680|NCT01036594|64638868|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
23244681|NCT01036594|64638869|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
23244682|NCT01036594|64638868|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
23244683|NCT01036594|64638869|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
23244684|NCT01036594|64638868|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
23244685|NCT01036594|64638869|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
23244686|NCT00408005|64638870|FG000|Induction|Adverse Event|19|||
23244687|NCT00408005|64638871|FG001|Induction|Adverse Event|3|||
23244688|NCT00408005|64638872|FG002|Induction|Adverse Event|0|||
23244689|NCT00408005|64638873|FG003|Induction|Adverse Event|0|||
23244690|NCT00408005|64638874|FG004|Induction|Adverse Event|0|||
23244691|NCT00408005|64638875|FG005|Induction|Adverse Event|0|||
23244692|NCT00408005|64638876|FG006|Induction|Adverse Event|0|||
23244693|NCT00408005|64638877|FG007|Induction|Adverse Event|0|||
23244694|NCT00408005|64638870|FG000|Induction|Death|6|||
23244695|NCT00408005|64638871|FG001|Induction|Death|0|||
23244696|NCT00408005|64638872|FG002|Induction|Death|0|||
23244697|NCT00408005|64638873|FG003|Induction|Death|0|||
23244698|NCT00408005|64638874|FG004|Induction|Death|0|||
23244699|NCT00408005|64638875|FG005|Induction|Death|0|||
23244700|NCT00408005|64638876|FG006|Induction|Death|0|||
23244701|NCT00408005|64638877|FG007|Induction|Death|0|||
23244702|NCT00408005|64638870|FG000|Induction|Physician Decision|83|||
23244703|NCT00408005|64638871|FG001|Induction|Physician Decision|9|||
23244704|NCT00408005|64638872|FG002|Induction|Physician Decision|0|||
23244705|NCT00408005|64638873|FG003|Induction|Physician Decision|0|||
23244706|NCT00408005|64638874|FG004|Induction|Physician Decision|0|||
23244707|NCT00408005|64638875|FG005|Induction|Physician Decision|0|||
23244708|NCT00408005|64638876|FG006|Induction|Physician Decision|0|||
23244709|NCT00408005|64638877|FG007|Induction|Physician Decision|0|||
23244710|NCT00408005|64638870|FG000|Induction|Withdrawal by Subject|2|||
23244711|NCT00408005|64638871|FG001|Induction|Withdrawal by Subject|4|||
23244712|NCT00408005|64638872|FG002|Induction|Withdrawal by Subject|0|||
23244713|NCT00408005|64638873|FG003|Induction|Withdrawal by Subject|0|||
23244714|NCT00408005|64638874|FG004|Induction|Withdrawal by Subject|0|||
23244715|NCT00408005|64638875|FG005|Induction|Withdrawal by Subject|0|||
23244716|NCT00408005|64638876|FG006|Induction|Withdrawal by Subject|0|||
23244717|NCT00408005|64638877|FG007|Induction|Withdrawal by Subject|0|||
23244718|NCT00408005|64638870|FG000|Induction|Ineligible|33|||
23586519|NCT03710564|65876030|FG000|Overall Study|Physician Decision|2|||
23586520|NCT03710564|65876031|FG001|Overall Study|Physician Decision|3|||
23586521|NCT02987543|65876032|FG000|Overall Study|Ongoing study at data cut off|49|||
23586522|NCT02987543|65876033|FG001|Overall Study|Ongoing study at data cut off|21|||
23586523|NCT02987543|65876034|FG002|Overall Study|Ongoing study at data cut off|19|||
23586524|NCT02987543|65876035|FG003|Overall Study|Ongoing study at data cut off|12|||
23586525|NCT02987543|65876032|FG000|Overall Study|Death|88|||
23586526|NCT02987543|65876033|FG001|Overall Study|Death|54|||
23586527|NCT02987543|65876034|FG002|Overall Study|Death|67|||
23586528|NCT02987543|65876035|FG003|Overall Study|Death|28|||
23586529|NCT02987543|65876032|FG000|Overall Study|Lost to Follow-up|3|||
23244719|NCT00408005|64638871|FG001|Induction|Ineligible|14|||
23586530|NCT02987543|65876033|FG001|Overall Study|Lost to Follow-up|0|||
23586531|NCT02987543|65876034|FG002|Overall Study|Lost to Follow-up|1|||
23586532|NCT02987543|65876035|FG003|Overall Study|Lost to Follow-up|0|||
23586533|NCT02987543|65876032|FG000|Overall Study|Screen failure|0|||
23586534|NCT02987543|65876033|FG001|Overall Study|Screen failure|0|||
23586535|NCT02987543|65876034|FG002|Overall Study|Screen failure|0|||
23586536|NCT02987543|65876035|FG003|Overall Study|Screen failure|1|||
23244720|NCT00408005|64638872|FG002|Induction|Ineligible|0|||
23244721|NCT00408005|64638873|FG003|Induction|Ineligible|0|||
23244722|NCT00408005|64638874|FG004|Induction|Ineligible|0|||
23244723|NCT00408005|64638875|FG005|Induction|Ineligible|0|||
23244724|NCT00408005|64638876|FG006|Induction|Ineligible|0|||
23244725|NCT00408005|64638877|FG007|Induction|Ineligible|0|||
23244726|NCT00408005|64638870|FG000|Induction|Refusal of Further Protocol Therapy|225|||
23244727|NCT00408005|64638871|FG001|Induction|Refusal of Further Protocol Therapy|44|||
23244728|NCT00408005|64638872|FG002|Induction|Refusal of Further Protocol Therapy|0|||
23244729|NCT00408005|64638873|FG003|Induction|Refusal of Further Protocol Therapy|0|||
23244730|NCT00408005|64638874|FG004|Induction|Refusal of Further Protocol Therapy|0|||
23586537|NCT02987543|65876032|FG000|Overall Study|Withdrawal by Subject|21|||
23586538|NCT02987543|65876033|FG001|Overall Study|Withdrawal by Subject|7|||
23244731|NCT00408005|64638875|FG005|Induction|Refusal of Further Protocol Therapy|0|||
23244732|NCT00408005|64638876|FG006|Induction|Refusal of Further Protocol Therapy|0|||
23244733|NCT00408005|64638877|FG007|Induction|Refusal of Further Protocol Therapy|0|||
23244734|NCT00408005|64638870|FG000|Induction|Entered another COG therapeutic protocol|4|||
23244735|NCT00408005|64638871|FG001|Induction|Entered another COG therapeutic protocol|0|||
23244736|NCT00408005|64638872|FG002|Induction|Entered another COG therapeutic protocol|0|||
23244737|NCT00408005|64638873|FG003|Induction|Entered another COG therapeutic protocol|0|||
23244738|NCT00408005|64638874|FG004|Induction|Entered another COG therapeutic protocol|0|||
23244739|NCT00408005|64638875|FG005|Induction|Entered another COG therapeutic protocol|0|||
23244740|NCT00408005|64638876|FG006|Induction|Entered another COG therapeutic protocol|0|||
23586539|NCT02987543|65876034|FG002|Overall Study|Withdrawal by Subject|7|||
23586540|NCT02987543|65876035|FG003|Overall Study|Withdrawal by Subject|6|||
23586541|NCT02987543|65876032|FG000|Overall Study|Study terminated by sponsor|1|||
23244741|NCT00408005|64638877|FG007|Induction|Entered another COG therapeutic protocol|0|||
23244742|NCT00408005|64638870|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
23244743|NCT00408005|64638871|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
23244744|NCT00408005|64638872|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
23244745|NCT00408005|64638873|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
23244746|NCT00408005|64638874|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
23244747|NCT00408005|64638875|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
23244748|NCT00408005|64638876|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
23244749|NCT00408005|64638877|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
23244750|NCT00408005|64638870|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
23244751|NCT00408005|64638871|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
23351455|NCT02787083|65029635|FG001|Overall Study|Withdrawal by Subject|2|||
23244752|NCT00408005|64638872|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
23244753|NCT00408005|64638873|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
23244754|NCT00408005|64638874|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
23244755|NCT00408005|64638875|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
23244756|NCT00408005|64638876|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
23244757|NCT00408005|64638877|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
23244758|NCT00408005|64638870|FG000|Induction|Progressive Disease|0|||
23244759|NCT00408005|64638871|FG001|Induction|Progressive Disease|1|||
23244760|NCT00408005|64638872|FG002|Induction|Progressive Disease|0|||
23244761|NCT00408005|64638873|FG003|Induction|Progressive Disease|0|||
23244762|NCT00408005|64638874|FG004|Induction|Progressive Disease|0|||
23244763|NCT00408005|64638875|FG005|Induction|Progressive Disease|0|||
23244764|NCT00408005|64638876|FG006|Induction|Progressive Disease|0|||
23244765|NCT00408005|64638877|FG007|Induction|Progressive Disease|0|||
23244766|NCT00408005|64638870|FG000|Induction|Inevaluable|18|||
23244767|NCT00408005|64638871|FG001|Induction|Inevaluable|14|||
23244768|NCT00408005|64638872|FG002|Induction|Inevaluable|0|||
23244769|NCT00408005|64638873|FG003|Induction|Inevaluable|0|||
23244770|NCT00408005|64638874|FG004|Induction|Inevaluable|0|||
23244771|NCT00408005|64638875|FG005|Induction|Inevaluable|0|||
23244772|NCT00408005|64638876|FG006|Induction|Inevaluable|0|||
23244773|NCT00408005|64638877|FG007|Induction|Inevaluable|0|||
23244774|NCT00408005|64638870|FG000|Induction|Failed to Complete Randomization|3|||
23244775|NCT00408005|64638871|FG001|Induction|Failed to Complete Randomization|2|||
23244776|NCT00408005|64638872|FG002|Induction|Failed to Complete Randomization|0|||
23244777|NCT00408005|64638873|FG003|Induction|Failed to Complete Randomization|0|||
23244778|NCT00408005|64638874|FG004|Induction|Failed to Complete Randomization|0|||
23244779|NCT00408005|64638875|FG005|Induction|Failed to Complete Randomization|0|||
23351456|NCT02588092|65029637|FG000|Overall Study|Death|4|||
23351457|NCT02588092|65029638|FG001|Overall Study|Death|3|||
23351458|NCT02588092|65029639|FG002|Overall Study|Death|3|||
23351459|NCT02588092|65029640|FG003|Overall Study|Death|3|||
23351460|NCT02588092|65029641|FG004|Overall Study|Death|2|||
23351461|NCT02588092|65029642|FG005|Overall Study|Death|2|||
23351462|NCT02588092|65029643|FG006|Overall Study|Death|2|||
23351463|NCT02588092|65029644|FG007|Overall Study|Death|1|||
23351464|NCT02588092|65029645|FG008|Overall Study|Death|5|||
23351465|NCT02588092|65029646|FG009|Overall Study|Death|2|||
23351466|NCT02588092|65029637|FG000|Overall Study|Withdrawal by Subject|0|||
23351467|NCT02588092|65029638|FG001|Overall Study|Withdrawal by Subject|0|||
23351468|NCT02588092|65029639|FG002|Overall Study|Withdrawal by Subject|0|||
23351469|NCT02588092|65029640|FG003|Overall Study|Withdrawal by Subject|0|||
23351470|NCT02588092|65029641|FG004|Overall Study|Withdrawal by Subject|0|||
23351471|NCT02588092|65029642|FG005|Overall Study|Withdrawal by Subject|1|||
23351472|NCT02588092|65029643|FG006|Overall Study|Withdrawal by Subject|1|||
23351473|NCT02588092|65029644|FG007|Overall Study|Withdrawal by Subject|2|||
23351474|NCT02588092|65029645|FG008|Overall Study|Withdrawal by Subject|0|||
23351475|NCT02588092|65029646|FG009|Overall Study|Withdrawal by Subject|0|||
23351476|NCT02588092|65029637|FG000|Overall Study|Started Another Treatment|0|||
23351477|NCT02588092|65029638|FG001|Overall Study|Started Another Treatment|0|||
23351478|NCT02588092|65029639|FG002|Overall Study|Started Another Treatment|0|||
23351479|NCT02588092|65029640|FG003|Overall Study|Started Another Treatment|0|||
23351480|NCT02588092|65029641|FG004|Overall Study|Started Another Treatment|1|||
23351481|NCT02588092|65029642|FG005|Overall Study|Started Another Treatment|0|||
23466904|NCT03614156|65452156|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
23351482|NCT02588092|65029643|FG006|Overall Study|Started Another Treatment|0|||
23351483|NCT02588092|65029644|FG007|Overall Study|Started Another Treatment|1|||
23351484|NCT02588092|65029645|FG008|Overall Study|Started Another Treatment|0|||
23351485|NCT02588092|65029646|FG009|Overall Study|Started Another Treatment|0|||
23351486|NCT02588092|65029637|FG000|Overall Study|Sponsor Decision|0|||
23466905|NCT03614156|65452153|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
23351487|NCT02588092|65029638|FG001|Overall Study|Sponsor Decision|0|||
23244780|NCT00408005|64638876|FG006|Induction|Failed to Complete Randomization|0|||
23244781|NCT00408005|64638877|FG007|Induction|Failed to Complete Randomization|0|||
23244782|NCT00408005|64638870|FG000|Induction|Protocol Deviation|3|||
23244783|NCT00408005|64638871|FG001|Induction|Protocol Deviation|1|||
23244784|NCT00408005|64638872|FG002|Induction|Protocol Deviation|0|||
23244785|NCT00408005|64638873|FG003|Induction|Protocol Deviation|0|||
23244786|NCT00408005|64638874|FG004|Induction|Protocol Deviation|0|||
23244787|NCT00408005|64638875|FG005|Induction|Protocol Deviation|0|||
23244788|NCT00408005|64638876|FG006|Induction|Protocol Deviation|0|||
23244789|NCT00408005|64638877|FG007|Induction|Protocol Deviation|0|||
23244790|NCT00408005|64638870|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
23244791|NCT00408005|64638871|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
23244792|NCT00408005|64638872|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
23244793|NCT00408005|64638873|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
23244794|NCT00408005|64638874|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
23244795|NCT00408005|64638875|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
23244796|NCT00408005|64638876|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
23244797|NCT00408005|64638877|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
23244798|NCT00408005|64638870|FG000|Induction|Recurrent leukemia|1|||
23244799|NCT00408005|64638871|FG001|Induction|Recurrent leukemia|0|||
23244800|NCT00408005|64638872|FG002|Induction|Recurrent leukemia|0|||
23244801|NCT00408005|64638873|FG003|Induction|Recurrent leukemia|0|||
23244802|NCT00408005|64638874|FG004|Induction|Recurrent leukemia|0|||
23244803|NCT00408005|64638875|FG005|Induction|Recurrent leukemia|0|||
23244804|NCT00408005|64638876|FG006|Induction|Recurrent leukemia|0|||
23244805|NCT00408005|64638877|FG007|Induction|Recurrent leukemia|0|||
23244806|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23244807|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23244808|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
23244809|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
23244810|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
23244811|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
23244812|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
23244813|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23244814|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
23244815|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
23244816|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
23244817|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
23244818|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
23244819|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
23244820|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
23244821|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
23244822|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23244823|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23244824|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
23244825|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23244826|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
23244827|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23244828|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23244829|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
23244830|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
23244831|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
23244832|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
23244833|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
23244834|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
23244835|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
23244836|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
23244837|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
23244838|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23244839|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23244840|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
23244841|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
23244842|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23244843|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
23244844|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23244845|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
23244846|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
23351488|NCT02588092|65029639|FG002|Overall Study|Sponsor Decision|0|||
23351489|NCT02588092|65029640|FG003|Overall Study|Sponsor Decision|0|||
23351490|NCT02588092|65029641|FG004|Overall Study|Sponsor Decision|0|||
23351491|NCT02588092|65029642|FG005|Overall Study|Sponsor Decision|0|||
23586542|NCT02987543|65876033|FG001|Overall Study|Study terminated by sponsor|0|||
23586543|NCT02987543|65876034|FG002|Overall Study|Study terminated by sponsor|0|||
23586544|NCT02987543|65876035|FG003|Overall Study|Study terminated by sponsor|0|||
23586545|NCT02987543|65876032|FG000|Overall Study|Investigator decision|0|||
23186322|NCT01386385|64422984|FG004|Phase II Concurrent CRT|Adverse Event|0|||
23186323|NCT01386385|64422985|FG005|Phase II Concurrent CRT|Adverse Event|0|||
23186324|NCT01386385|64422986|FG006|Phase II Concurrent CRT|Adverse Event|3|||
23186325|NCT01386385|64422987|FG007|Phase II Concurrent CRT|Adverse Event|3|||
23186326|NCT01386385|64422980|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23186327|NCT01386385|64422981|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23186328|NCT01386385|64422982|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23186329|NCT01386385|64422983|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23186330|NCT01386385|64422984|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23186331|NCT01386385|64422985|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23186332|NCT01386385|64422986|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
23186333|NCT01386385|64422987|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
23186334|NCT01386385|64422980|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
23186335|NCT01386385|64422981|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
23186336|NCT01386385|64422982|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
23186337|NCT01386385|64422983|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
23186338|NCT01386385|64422984|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
23186339|NCT01386385|64422985|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
23186340|NCT01386385|64422986|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
23186341|NCT01386385|64422987|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
23466906|NCT03614156|65452154|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
23586546|NCT02987543|65876033|FG001|Overall Study|Investigator decision|1|||
23586547|NCT02987543|65876034|FG002|Overall Study|Investigator decision|0|||
23586548|NCT02987543|65876035|FG003|Overall Study|Investigator decision|0|||
23586549|NCT02987543|65876032|FG000|Overall Study|Disease progression|0|||
23586550|NCT02987543|65876033|FG001|Overall Study|Disease progression|0|||
23586551|NCT02987543|65876034|FG002|Overall Study|Disease progression|0|||
23586552|NCT02987543|65876035|FG003|Overall Study|Disease progression|1|||
23586553|NCT00315055|65876036|FG000|Overall Study|Protocol Violation|2|||
23586554|NCT00315055|65876037|FG001|Overall Study|Protocol Violation|4|||
23586555|NCT00315055|65876036|FG000|Overall Study|Lost to Follow-up|1|||
23586556|NCT00315055|65876037|FG001|Overall Study|Lost to Follow-up|1|||
23586557|NCT01786564|65876043|FG000|Overall Study|Lost to Follow-up|47|||
23586558|NCT01786564|65876043|FG000|Overall Study|Ineligible|17|||
23586559|NCT01651949|65876049|FG000|Overall Study|Unknown status|4|||
23586560|NCT01651949|65876050|FG001|Overall Study|Unknown status|4|||
23586561|NCT01651949|65876051|FG002|Overall Study|Unknown status|0|||
23586562|NCT01651949|65876049|FG000|Overall Study|Lost to Follow-up|30|||
23586563|NCT01651949|65876050|FG001|Overall Study|Lost to Follow-up|56|||
23586564|NCT01651949|65876051|FG002|Overall Study|Lost to Follow-up|20|||
23586565|NCT01651949|65876049|FG000|Overall Study|Protocol Violation|0|||
23586566|NCT01651949|65876050|FG001|Overall Study|Protocol Violation|2|||
23586567|NCT01651949|65876051|FG002|Overall Study|Protocol Violation|1|||
23586568|NCT01651949|65876049|FG000|Overall Study|Physician Decision|0|||
23586569|NCT01651949|65876050|FG001|Overall Study|Physician Decision|2|||
23586570|NCT01651949|65876051|FG002|Overall Study|Physician Decision|0|||
23586571|NCT01651949|65876049|FG000|Overall Study|Adverse Event|0|||
23586572|NCT01651949|65876050|FG001|Overall Study|Adverse Event|2|||
23586573|NCT01651949|65876051|FG002|Overall Study|Adverse Event|1|||
23586574|NCT01651949|65876049|FG000|Overall Study|Screen failure|2|||
23586575|NCT01651949|65876050|FG001|Overall Study|Screen failure|2|||
23586576|NCT01651949|65876051|FG002|Overall Study|Screen failure|0|||
23586577|NCT01651949|65876049|FG000|Overall Study|Withdrawal by Subject|17|||
23586578|NCT01651949|65876050|FG001|Overall Study|Withdrawal by Subject|18|||
23586579|NCT01651949|65876051|FG002|Overall Study|Withdrawal by Subject|9|||
23586580|NCT01196988|65876054|FG000|Overall Study|Adverse Event|1|||
23586581|NCT01196988|65876055|FG001|Overall Study|Adverse Event|2|||
23586582|NCT01196988|65876056|FG002|Overall Study|Adverse Event|0|||
23586583|NCT01196988|65876057|FG003|Overall Study|Adverse Event|0|||
23586584|NCT01196988|65876054|FG000|Overall Study|Withdrawal by Subject|5|||
23586585|NCT01196988|65876055|FG001|Overall Study|Withdrawal by Subject|1|||
23586586|NCT01196988|65876056|FG002|Overall Study|Withdrawal by Subject|4|||
23586587|NCT01196988|65876057|FG003|Overall Study|Withdrawal by Subject|0|||
23244847|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
23466907|NCT03614156|65452155|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
23586588|NCT01196988|65876054|FG000|Overall Study|Lost to Follow-up|16|||
23586589|NCT01196988|65876055|FG001|Overall Study|Lost to Follow-up|29|||
23586590|NCT01196988|65876056|FG002|Overall Study|Lost to Follow-up|21|||
23586591|NCT01196988|65876057|FG003|Overall Study|Lost to Follow-up|1|||
23586592|NCT01196988|65876054|FG000|Overall Study|Other|2|||
23586593|NCT01196988|65876055|FG001|Overall Study|Other|0|||
23586594|NCT01196988|65876056|FG002|Overall Study|Other|0|||
23586595|NCT01196988|65876057|FG003|Overall Study|Other|0|||
23244848|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
23244849|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
23244850|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
23244851|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
23244852|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
23351492|NCT02588092|65029643|FG006|Overall Study|Sponsor Decision|0|||
23351493|NCT02588092|65029644|FG007|Overall Study|Sponsor Decision|0|||
23351494|NCT02588092|65029645|FG008|Overall Study|Sponsor Decision|1|||
23351495|NCT02588092|65029646|FG009|Overall Study|Sponsor Decision|1|||
23351496|NCT02440854|65029647|FG000|Overall Study|Relocation of patient|1|||
23351497|NCT02440854|65029647|FG000|Overall Study|Death|6|||
23351498|NCT02440854|65029647|FG000|Overall Study|Lost to Follow-up|10|||
23351499|NCT02440854|65029647|FG000|Overall Study|Afatinib discontinuation|46|||
23186342|NCT01386385|64422980|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23186343|NCT01386385|64422981|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23186344|NCT01386385|64422982|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23186345|NCT01386385|64422983|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23186346|NCT01386385|64422984|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23351500|NCT02440854|65029647|FG000|Overall Study|stopped study at earlier timepoint|14|||
23351501|NCT02440854|65029647|FG000|Overall Study|Study medication not received|1|||
23186347|NCT01386385|64422985|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23186348|NCT01386385|64422986|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
23186349|NCT01386385|64422987|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
23186350|NCT01386385|64422980|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
23186351|NCT01386385|64422981|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
23351502|NCT02440854|65029647|FG000|Overall Study|Violation of inclusion criteria|2|||
23351503|NCT03677934|65029651|FG000|Overall Study|Adverse Event|1|||
23351504|NCT03677934|65029652|FG001|Overall Study|Adverse Event|1|||
23351505|NCT03677934|65029651|FG000|Overall Study|Death|8|||
23351506|NCT03677934|65029652|FG001|Overall Study|Death|4|||
23351507|NCT03677934|65029651|FG000|Overall Study|Lost to Follow-up|3|||
23351508|NCT03677934|65029652|FG001|Overall Study|Lost to Follow-up|0|||
23466908|NCT03614156|65452156|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
23466909|NCT00790842|65452157|FG000|Dose Level 1|Adverse Event|1|||
23466910|NCT00790842|65452158|FG001|Dose Level 1|Adverse Event|0|||
23466911|NCT00790842|65452159|FG002|Dose Level 1|Adverse Event|0|||
23466912|NCT00790842|65452160|FG003|Dose Level 1|Adverse Event|2|||
23466913|NCT00790842|65452161|FG004|Dose Level 1|Adverse Event|0|||
23186352|NCT01386385|64422982|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
23186353|NCT01386385|64422983|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
23186354|NCT01386385|64422984|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
23186355|NCT01386385|64422985|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
23186356|NCT01386385|64422986|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
23186357|NCT01386385|64422987|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
23186358|NCT04246047|64422988|FG000|Overall Study|Death|50|||
23351509|NCT03677934|65029651|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23466914|NCT00790842|65452162|FG005|Dose Level 1|Adverse Event|0|||
23466915|NCT00790842|65452163|FG006|Dose Level 1|Adverse Event|0|||
23466916|NCT00790842|65452164|FG007|Dose Level 1|Adverse Event|1|||
23466917|NCT00790842|65452165|FG008|Dose Level 1|Adverse Event|0|||
23466918|NCT00790842|65452166|FG009|Dose Level 1|Adverse Event|0|||
23466919|NCT00790842|65452167|FG010|Dose Level 1|Adverse Event|0|||
23466920|NCT00790842|65452157|FG000|Dose Level 1|Physician Decision|1|||
23466921|NCT00790842|65452158|FG001|Dose Level 1|Physician Decision|0|||
23466922|NCT00790842|65452159|FG002|Dose Level 1|Physician Decision|0|||
23466923|NCT00790842|65452160|FG003|Dose Level 1|Physician Decision|0|||
23466924|NCT00790842|65452161|FG004|Dose Level 1|Physician Decision|0|||
23466925|NCT00790842|65452162|FG005|Dose Level 1|Physician Decision|0|||
23466926|NCT00790842|65452163|FG006|Dose Level 1|Physician Decision|0|||
23466927|NCT00790842|65452164|FG007|Dose Level 1|Physician Decision|1|||
23466928|NCT00790842|65452165|FG008|Dose Level 1|Physician Decision|0|||
23466929|NCT00790842|65452166|FG009|Dose Level 1|Physician Decision|0|||
23466930|NCT00790842|65452167|FG010|Dose Level 1|Physician Decision|0|||
23466931|NCT00790842|65452157|FG000|Dose Level 1|Withdrawal by Subject|1|||
23466932|NCT00790842|65452158|FG001|Dose Level 1|Withdrawal by Subject|0|||
23466933|NCT00790842|65452159|FG002|Dose Level 1|Withdrawal by Subject|0|||
23466934|NCT00790842|65452160|FG003|Dose Level 1|Withdrawal by Subject|0|||
23466935|NCT00790842|65452161|FG004|Dose Level 1|Withdrawal by Subject|0|||
23466936|NCT00790842|65452162|FG005|Dose Level 1|Withdrawal by Subject|0|||
23466937|NCT00790842|65452163|FG006|Dose Level 1|Withdrawal by Subject|0|||
23466938|NCT00790842|65452164|FG007|Dose Level 1|Withdrawal by Subject|0|||
23466939|NCT00790842|65452165|FG008|Dose Level 1|Withdrawal by Subject|0|||
23466940|NCT00790842|65452166|FG009|Dose Level 1|Withdrawal by Subject|0|||
23466941|NCT00790842|65452167|FG010|Dose Level 1|Withdrawal by Subject|0|||
23466942|NCT00790842|65452157|FG000|Dose Level 2|Death|0|||
23466943|NCT00790842|65452158|FG001|Dose Level 2|Death|1|||
23466944|NCT00790842|65452159|FG002|Dose Level 2|Death|0|||
23466945|NCT00790842|65452160|FG003|Dose Level 2|Death|0|||
23466946|NCT00790842|65452161|FG004|Dose Level 2|Death|1|||
23466947|NCT00790842|65452162|FG005|Dose Level 2|Death|0|||
23466948|NCT00790842|65452163|FG006|Dose Level 2|Death|0|||
23466949|NCT00790842|65452164|FG007|Dose Level 2|Death|0|||
23466950|NCT00790842|65452165|FG008|Dose Level 2|Death|0|||
23466951|NCT00790842|65452166|FG009|Dose Level 2|Death|0|||
23466952|NCT00790842|65452167|FG010|Dose Level 2|Death|0|||
23466953|NCT00790842|65452157|FG000|Dose Level 2|Physician Decision|0|||
23466954|NCT00790842|65452158|FG001|Dose Level 2|Physician Decision|1|||
23466955|NCT00790842|65452159|FG002|Dose Level 2|Physician Decision|0|||
23466956|NCT00790842|65452160|FG003|Dose Level 2|Physician Decision|0|||
23466957|NCT00790842|65452161|FG004|Dose Level 2|Physician Decision|0|||
23466958|NCT00790842|65452162|FG005|Dose Level 2|Physician Decision|0|||
23466959|NCT00790842|65452163|FG006|Dose Level 2|Physician Decision|0|||
23466960|NCT00790842|65452164|FG007|Dose Level 2|Physician Decision|0|||
23466961|NCT00790842|65452165|FG008|Dose Level 2|Physician Decision|0|||
23466962|NCT00790842|65452166|FG009|Dose Level 2|Physician Decision|0|||
23466963|NCT00790842|65452167|FG010|Dose Level 2|Physician Decision|0|||
23466964|NCT00790842|65452157|FG000|Dose Level 2|Withdrawal by Subject|0|||
23466965|NCT00790842|65452158|FG001|Dose Level 2|Withdrawal by Subject|1|||
23466966|NCT00790842|65452159|FG002|Dose Level 2|Withdrawal by Subject|0|||
23466967|NCT00790842|65452160|FG003|Dose Level 2|Withdrawal by Subject|0|||
23466968|NCT00790842|65452161|FG004|Dose Level 2|Withdrawal by Subject|0|||
23466969|NCT00790842|65452162|FG005|Dose Level 2|Withdrawal by Subject|0|||
23466970|NCT00790842|65452163|FG006|Dose Level 2|Withdrawal by Subject|0|||
23466971|NCT00790842|65452164|FG007|Dose Level 2|Withdrawal by Subject|0|||
23466972|NCT00790842|65452165|FG008|Dose Level 2|Withdrawal by Subject|0|||
23466973|NCT00790842|65452166|FG009|Dose Level 2|Withdrawal by Subject|0|||
23466974|NCT00790842|65452167|FG010|Dose Level 2|Withdrawal by Subject|0|||
23466975|NCT00790842|65452157|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466976|NCT00790842|65452158|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466977|NCT00790842|65452159|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466978|NCT00790842|65452160|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466979|NCT00790842|65452161|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23186359|NCT04246047|64422989|FG001|Overall Study|Death|77|||
23186360|NCT04246047|64422988|FG000|Overall Study|Lost to Follow-up|1|||
23186361|NCT04246047|64422989|FG001|Overall Study|Lost to Follow-up|3|||
23466980|NCT00790842|65452162|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23186362|NCT04246047|64422988|FG000|Overall Study|Physician Decision|4|||
23186363|NCT04246047|64422989|FG001|Overall Study|Physician Decision|10|||
23186364|NCT04246047|64422988|FG000|Overall Study|Withdrawal by Subject|19|||
23466981|NCT00790842|65452163|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466982|NCT00790842|65452164|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466983|NCT00790842|65452165|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
23466984|NCT00790842|65452166|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466985|NCT00790842|65452167|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
23466986|NCT00790842|65452157|FG000|Dose Level 3|Adverse Event|0|||
23466987|NCT00790842|65452158|FG001|Dose Level 3|Adverse Event|0|||
23466988|NCT00790842|65452159|FG002|Dose Level 3|Adverse Event|1|||
23186365|NCT04246047|64422989|FG001|Overall Study|Withdrawal by Subject|26|||
23466989|NCT00790842|65452160|FG003|Dose Level 3|Adverse Event|0|||
23186366|NCT04246047|64422988|FG000|Overall Study|Ongoing|169|||
23186367|NCT04246047|64422989|FG001|Overall Study|Ongoing|135|||
23186368|NCT03517436|64422990|FG000|Overall Study|Death|3|||
23186369|NCT03517436|64422990|FG000|Overall Study|Withdrawal by Subject|4|||
23186370|NCT03517436|64422990|FG000|Overall Study|Did not receive study valve.|1|||
23186371|NCT04091217|64422991|FG000|Overall Study|Lost to Follow-up|2|||
23186372|NCT02761057|64422992|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
23186373|NCT02761057|64422993|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
23186374|NCT02761057|64422994|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
23244853|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
23244854|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23466990|NCT00790842|65452161|FG004|Dose Level 3|Adverse Event|0|||
23466991|NCT00790842|65452162|FG005|Dose Level 3|Adverse Event|0|||
23466992|NCT00790842|65452163|FG006|Dose Level 3|Adverse Event|0|||
23466993|NCT00790842|65452164|FG007|Dose Level 3|Adverse Event|0|||
23466994|NCT00790842|65452165|FG008|Dose Level 3|Adverse Event|0|||
23466995|NCT00790842|65452166|FG009|Dose Level 3|Adverse Event|0|||
23466996|NCT00790842|65452167|FG010|Dose Level 3|Adverse Event|0|||
23466997|NCT00790842|65452157|FG000|Dose Level 3|Withdrawal by Subject|0|||
23466998|NCT00790842|65452158|FG001|Dose Level 3|Withdrawal by Subject|0|||
23466999|NCT00790842|65452159|FG002|Dose Level 3|Withdrawal by Subject|3|||
23467000|NCT00790842|65452160|FG003|Dose Level 3|Withdrawal by Subject|0|||
23467001|NCT00790842|65452161|FG004|Dose Level 3|Withdrawal by Subject|0|||
23467002|NCT00790842|65452162|FG005|Dose Level 3|Withdrawal by Subject|0|||
23467003|NCT00790842|65452163|FG006|Dose Level 3|Withdrawal by Subject|0|||
23467004|NCT00790842|65452164|FG007|Dose Level 3|Withdrawal by Subject|0|||
23467005|NCT00790842|65452165|FG008|Dose Level 3|Withdrawal by Subject|0|||
23467006|NCT00790842|65452166|FG009|Dose Level 3|Withdrawal by Subject|2|||
23467007|NCT00790842|65452167|FG010|Dose Level 3|Withdrawal by Subject|0|||
23467008|NCT00790842|65452157|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467009|NCT00790842|65452158|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467010|NCT00790842|65452159|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467011|NCT00790842|65452160|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467012|NCT00790842|65452161|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467013|NCT00790842|65452162|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
23467014|NCT00790842|65452163|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467015|NCT00790842|65452164|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467016|NCT00790842|65452165|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467017|NCT00790842|65452166|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467018|NCT00790842|65452167|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
23467019|NCT00790842|65452157|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467020|NCT00790842|65452158|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467021|NCT00790842|65452159|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
23467022|NCT00790842|65452160|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467023|NCT00790842|65452161|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467024|NCT00790842|65452162|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467025|NCT00790842|65452163|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467026|NCT00790842|65452164|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467027|NCT00790842|65452165|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467028|NCT00790842|65452166|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467029|NCT00790842|65452167|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
23467030|NCT00790842|65452157|FG000|Dose Level 4|Adverse Event|0|||
23467031|NCT00790842|65452158|FG001|Dose Level 4|Adverse Event|0|||
23467032|NCT00790842|65452159|FG002|Dose Level 4|Adverse Event|0|||
23467033|NCT00790842|65452160|FG003|Dose Level 4|Adverse Event|0|||
23467034|NCT00790842|65452161|FG004|Dose Level 4|Adverse Event|0|||
23467035|NCT00790842|65452162|FG005|Dose Level 4|Adverse Event|0|||
23467036|NCT00790842|65452163|FG006|Dose Level 4|Adverse Event|1|||
23186375|NCT02761057|64422995|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
23186376|NCT02761057|64422992|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
23186377|NCT02761057|64422993|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
23186378|NCT02761057|64422994|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
23186379|NCT02761057|64422995|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
23467037|NCT00790842|65452164|FG007|Dose Level 4|Adverse Event|0|||
23467038|NCT00790842|65452165|FG008|Dose Level 4|Adverse Event|0|||
23467039|NCT00790842|65452166|FG009|Dose Level 4|Adverse Event|0|||
23467040|NCT00790842|65452167|FG010|Dose Level 4|Adverse Event|0|||
23467041|NCT00790842|65452157|FG000|Dose Level 4|Physician Decision|0|||
23467042|NCT00790842|65452158|FG001|Dose Level 4|Physician Decision|0|||
23467043|NCT00790842|65452159|FG002|Dose Level 4|Physician Decision|0|||
23186380|NCT02761057|64422992|FG000|Overall Study|Currently On Study Treatment|0|||
23186381|NCT02761057|64422993|FG001|Overall Study|Currently On Study Treatment|3|||
23467044|NCT00790842|65452160|FG003|Dose Level 4|Physician Decision|0|||
23467045|NCT00790842|65452161|FG004|Dose Level 4|Physician Decision|0|||
23467046|NCT00790842|65452162|FG005|Dose Level 4|Physician Decision|0|||
23467047|NCT00790842|65452163|FG006|Dose Level 4|Physician Decision|1|||
23467048|NCT00790842|65452164|FG007|Dose Level 4|Physician Decision|0|||
23467049|NCT00790842|65452165|FG008|Dose Level 4|Physician Decision|0|||
23467050|NCT00790842|65452166|FG009|Dose Level 4|Physician Decision|0|||
23467051|NCT00790842|65452167|FG010|Dose Level 4|Physician Decision|1|||
23467052|NCT00790842|65452157|FG000|Dose Level 4|Withdrawal by Subject|0|||
23467053|NCT00790842|65452158|FG001|Dose Level 4|Withdrawal by Subject|0|||
23467054|NCT00790842|65452159|FG002|Dose Level 4|Withdrawal by Subject|0|||
23467055|NCT00790842|65452160|FG003|Dose Level 4|Withdrawal by Subject|0|||
23467056|NCT00790842|65452161|FG004|Dose Level 4|Withdrawal by Subject|0|||
23467057|NCT00790842|65452162|FG005|Dose Level 4|Withdrawal by Subject|0|||
23467058|NCT00790842|65452163|FG006|Dose Level 4|Withdrawal by Subject|0|||
23467059|NCT00790842|65452164|FG007|Dose Level 4|Withdrawal by Subject|0|||
23467060|NCT00790842|65452165|FG008|Dose Level 4|Withdrawal by Subject|0|||
23467061|NCT00790842|65452166|FG009|Dose Level 4|Withdrawal by Subject|0|||
23467062|NCT00790842|65452167|FG010|Dose Level 4|Withdrawal by Subject|1|||
23467063|NCT00790842|65452157|FG000|Expansion Cohort|Adverse Event|0|||
23467064|NCT00790842|65452158|FG001|Expansion Cohort|Adverse Event|0|||
23467065|NCT00790842|65452159|FG002|Expansion Cohort|Adverse Event|0|||
23467066|NCT00790842|65452160|FG003|Expansion Cohort|Adverse Event|0|||
23467067|NCT00790842|65452161|FG004|Expansion Cohort|Adverse Event|0|||
23467068|NCT00790842|65452162|FG005|Expansion Cohort|Adverse Event|0|||
23467069|NCT00790842|65452163|FG006|Expansion Cohort|Adverse Event|1|||
23467070|NCT00790842|65452164|FG007|Expansion Cohort|Adverse Event|0|||
23467071|NCT00790842|65452165|FG008|Expansion Cohort|Adverse Event|0|||
23467072|NCT00790842|65452166|FG009|Expansion Cohort|Adverse Event|0|||
23467073|NCT00790842|65452167|FG010|Expansion Cohort|Adverse Event|0|||
23467074|NCT00790842|65452157|FG000|Expansion Cohort|Death|0|||
23351510|NCT03677934|65029652|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23467075|NCT00790842|65452158|FG001|Expansion Cohort|Death|0|||
23467076|NCT00790842|65452159|FG002|Expansion Cohort|Death|2|||
23186382|NCT02761057|64422994|FG002|Overall Study|Currently On Study Treatment|0|||
23467077|NCT00790842|65452160|FG003|Expansion Cohort|Death|0|||
23467078|NCT00790842|65452161|FG004|Expansion Cohort|Death|0|||
23467079|NCT00790842|65452162|FG005|Expansion Cohort|Death|0|||
23467080|NCT00790842|65452163|FG006|Expansion Cohort|Death|0|||
23467081|NCT00790842|65452164|FG007|Expansion Cohort|Death|0|||
23467082|NCT00790842|65452165|FG008|Expansion Cohort|Death|0|||
23467083|NCT00790842|65452166|FG009|Expansion Cohort|Death|0|||
23467084|NCT00790842|65452167|FG010|Expansion Cohort|Death|0|||
23467085|NCT00790842|65452157|FG000|Expansion Cohort|Physician Decision|0|||
23467086|NCT00790842|65452158|FG001|Expansion Cohort|Physician Decision|0|||
23467087|NCT00790842|65452159|FG002|Expansion Cohort|Physician Decision|1|||
23467088|NCT00790842|65452160|FG003|Expansion Cohort|Physician Decision|0|||
23467089|NCT00790842|65452161|FG004|Expansion Cohort|Physician Decision|0|||
23467090|NCT00790842|65452162|FG005|Expansion Cohort|Physician Decision|0|||
23467091|NCT00790842|65452163|FG006|Expansion Cohort|Physician Decision|0|||
23467092|NCT00790842|65452164|FG007|Expansion Cohort|Physician Decision|0|||
23467093|NCT00790842|65452165|FG008|Expansion Cohort|Physician Decision|0|||
23467094|NCT00790842|65452166|FG009|Expansion Cohort|Physician Decision|0|||
23467095|NCT00790842|65452167|FG010|Expansion Cohort|Physician Decision|0|||
23467096|NCT00790842|65452157|FG000|Expansion Cohort|Withdrawal by Subject|0|||
23467097|NCT00790842|65452158|FG001|Expansion Cohort|Withdrawal by Subject|0|||
23467098|NCT00790842|65452159|FG002|Expansion Cohort|Withdrawal by Subject|3|||
23467099|NCT00790842|65452160|FG003|Expansion Cohort|Withdrawal by Subject|0|||
23467100|NCT00790842|65452161|FG004|Expansion Cohort|Withdrawal by Subject|0|||
23467101|NCT00790842|65452162|FG005|Expansion Cohort|Withdrawal by Subject|0|||
23467102|NCT00790842|65452163|FG006|Expansion Cohort|Withdrawal by Subject|0|||
23467103|NCT00790842|65452164|FG007|Expansion Cohort|Withdrawal by Subject|0|||
23467104|NCT00790842|65452165|FG008|Expansion Cohort|Withdrawal by Subject|0|||
23467105|NCT00790842|65452166|FG009|Expansion Cohort|Withdrawal by Subject|0|||
23467106|NCT00790842|65452167|FG010|Expansion Cohort|Withdrawal by Subject|0|||
23467107|NCT00790842|65452157|FG000|Expansion Cohort|Study Closure|0|||
23467108|NCT00790842|65452158|FG001|Expansion Cohort|Study Closure|0|||
23186383|NCT02761057|64422995|FG003|Overall Study|Currently On Study Treatment|0|||
23186384|NCT02761057|64422992|FG000|Overall Study|Adverse Event|11|||
23186385|NCT02761057|64422993|FG001|Overall Study|Adverse Event|9|||
23186386|NCT02761057|64422994|FG002|Overall Study|Adverse Event|5|||
23186387|NCT02761057|64422995|FG003|Overall Study|Adverse Event|3|||
23186388|NCT02761057|64422992|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
23186389|NCT02761057|64422993|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
23186390|NCT02761057|64422994|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
23467109|NCT00790842|65452159|FG002|Expansion Cohort|Study Closure|1|||
23467110|NCT00790842|65452160|FG003|Expansion Cohort|Study Closure|0|||
23351511|NCT03677934|65029651|FG000|Overall Study|Physician Decision|0|||
23351512|NCT03677934|65029652|FG001|Overall Study|Physician Decision|1|||
23351513|NCT03677934|65029651|FG000|Overall Study|Withdrawal by Subject|1|||
23351514|NCT03677934|65029652|FG001|Overall Study|Withdrawal by Subject|7|||
23351515|NCT00184093|65029653|FG000|Overall Study|Adverse Event|3|||
23351516|NCT00184093|65029653|FG000|Overall Study|Lost to Follow-up|3|||
23351517|NCT00184093|65029653|FG000|Overall Study|Physician Decision|1|||
23351518|NCT00184093|65029653|FG000|Overall Study|Withdrawal by Subject|2|||
23186391|NCT02761057|64422995|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
23186392|NCT02761057|64422992|FG000|Overall Study|Progression/Relapse|29|||
23186393|NCT02761057|64422993|FG001|Overall Study|Progression/Relapse|27|||
23186394|NCT02761057|64422994|FG002|Overall Study|Progression/Relapse|20|||
23186395|NCT02761057|64422995|FG003|Overall Study|Progression/Relapse|23|||
23186396|NCT02761057|64422992|FG000|Overall Study|Death|2|||
23186397|NCT02761057|64422993|FG001|Overall Study|Death|2|||
23186398|NCT02761057|64422994|FG002|Overall Study|Death|1|||
23186399|NCT02761057|64422995|FG003|Overall Study|Death|1|||
23186400|NCT02761057|64422992|FG000|Overall Study|Other - Not Protocol Specified|2|||
23244855|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23244856|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23244857|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23244858|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
23244859|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23244860|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23244861|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
23244862|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
23244863|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
23244864|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
23244865|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
23244866|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
23244867|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
23244868|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
23244869|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
23244870|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23244871|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23244872|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23244873|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23244874|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
23244875|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
23244876|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
23244877|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
23244878|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23244879|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23244880|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23244881|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23244882|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23244883|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
23244884|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23244885|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
23244886|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
23244887|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
23244888|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
23244889|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
23244890|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
23244891|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
23351519|NCT01618019|65029654|FG000|Overall Study|Withdrawal by Subject|14|||
23351520|NCT01618019|65029655|FG001|Overall Study|Withdrawal by Subject|14|||
23351521|NCT02427802|65029656|FG000|Overall Study|Adverse Event|11|||
23351522|NCT02427802|65029657|FG001|Overall Study|Adverse Event|3|||
23351523|NCT02427802|65029658|FG002|Overall Study|Adverse Event|7|||
23351524|NCT02427802|65029656|FG000|Overall Study|Death|0|||
23351525|NCT02427802|65029657|FG001|Overall Study|Death|4|||
23351526|NCT02427802|65029658|FG002|Overall Study|Death|1|||
23186401|NCT02761057|64422993|FG001|Overall Study|Other - Not Protocol Specified|1|||
23186402|NCT02761057|64422994|FG002|Overall Study|Other - Not Protocol Specified|2|||
23186403|NCT02761057|64422995|FG003|Overall Study|Other - Not Protocol Specified|0|||
23186404|NCT04925570|64422996|FG000|Overall Study|Protocol Violation|24|||
23467111|NCT00790842|65452161|FG004|Expansion Cohort|Study Closure|0|||
23467112|NCT00790842|65452162|FG005|Expansion Cohort|Study Closure|0|||
23467113|NCT00790842|65452163|FG006|Expansion Cohort|Study Closure|0|||
23244892|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
23351527|NCT02427802|65029656|FG000|Overall Study|Lost to Follow-up|13|||
23467114|NCT00790842|65452164|FG007|Expansion Cohort|Study Closure|0|||
23467115|NCT00790842|65452165|FG008|Expansion Cohort|Study Closure|0|||
23467116|NCT00790842|65452166|FG009|Expansion Cohort|Study Closure|0|||
23467117|NCT00790842|65452167|FG010|Expansion Cohort|Study Closure|0|||
23467118|NCT00753649|65452168|FG000|Overall Study|Migrated/moved from study area|1|||
23467119|NCT00753649|65452169|FG001|Overall Study|Migrated/moved from study area|0|||
23467120|NCT00753649|65452168|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
23467121|NCT00753649|65452169|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
23467122|NCT00753649|65452168|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
23467123|NCT00753649|65452169|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
23467124|NCT00753649|65452168|FG000|Overall Study|Protocol Violation|2|||
23467125|NCT00753649|65452169|FG001|Overall Study|Protocol Violation|0|||
23467126|NCT02447003|65452170|FG000|Overall Study|Other|0|||
23467127|NCT02447003|65452171|FG001|Overall Study|Other|4|||
23467128|NCT02447003|65452170|FG000|Overall Study|Site discontinued|0|||
23467129|NCT02447003|65452171|FG001|Overall Study|Site discontinued|2|||
23467130|NCT02447003|65452170|FG000|Overall Study|Physician Decision|0|||
23467131|NCT02447003|65452171|FG001|Overall Study|Physician Decision|1|||
23467132|NCT02447003|65452170|FG000|Overall Study|Withdrawal by Subject|4|||
23467133|NCT02447003|65452171|FG001|Overall Study|Withdrawal by Subject|3|||
23467134|NCT02447003|65452170|FG000|Overall Study|Sponsor Decision|6|||
23467135|NCT02447003|65452171|FG001|Overall Study|Sponsor Decision|11|||
23467136|NCT02447003|65452170|FG000|Overall Study|Progressive Disease|1|||
23467137|NCT02447003|65452171|FG001|Overall Study|Progressive Disease|0|||
23467138|NCT02447003|65452170|FG000|Overall Study|Lost to Follow-up|5|||
23467139|NCT02447003|65452171|FG001|Overall Study|Lost to Follow-up|0|||
23467140|NCT02447003|65452170|FG000|Overall Study|Death|154|||
23467141|NCT02447003|65452171|FG001|Overall Study|Death|63|||
23467142|NCT00346697|65452172|FG000|Overall Study|Lost to Follow-up|0|||
23467143|NCT00346697|65452173|FG001|Overall Study|Lost to Follow-up|1|||
23467144|NCT00357006|65452174|FG000|Overall Study|Lost to Follow-up|1|||
23467145|NCT00357006|65452175|FG001|Overall Study|Lost to Follow-up|2|||
23467146|NCT00357006|65452176|FG002|Overall Study|Lost to Follow-up|1|||
23467147|NCT00357006|65452174|FG000|Overall Study|Withdrawal by Subject|1|||
23467148|NCT00357006|65452175|FG001|Overall Study|Withdrawal by Subject|3|||
23467149|NCT00357006|65452176|FG002|Overall Study|Withdrawal by Subject|2|||
23467150|NCT00396253|65452177|FG000|Overall Study|Protocol Violation|1|||
23467151|NCT00396253|65452177|FG000|Overall Study|Withdrawal by Subject|7|||
23467152|NCT00396253|65452177|FG000|Overall Study|Death|3|||
23467153|NCT00396253|65452177|FG000|Overall Study|Physician Decision|1|||
23467154|NCT00396253|65452177|FG000|Overall Study|Change in eligibility status|1|||
23467155|NCT03212144|65452182|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
23467156|NCT03212144|65452183|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
23467157|NCT03212144|65452182|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
23467158|NCT03212144|65452183|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
23467159|NCT02625909|65452184|FG000|Overall Study|Death|2|||
23467160|NCT02625909|65452185|FG001|Overall Study|Death|0|||
23467161|NCT02625909|65452184|FG000|Overall Study|Lost to Follow-up|3|||
23467162|NCT02625909|65452185|FG001|Overall Study|Lost to Follow-up|5|||
23586596|NCT02962674|65876059|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
23586597|NCT03784963|65876073|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
23586598|NCT03784963|65876074|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
23586599|NCT03784963|65876075|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
23586600|NCT03784963|65876076|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
23586601|NCT02486588|65876077|FG000|Overall Study|Randomized in error- ineligible|738|||
23244893|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
23586602|NCT02486588|65876078|FG001|Overall Study|Randomized in error- ineligible|750|||
23586603|NCT02486588|65876079|FG002|Overall Study|Randomized in error- ineligible|755|||
23467163|NCT02625909|65452184|FG000|Overall Study|Lack of Efficacy|9|||
23467164|NCT02625909|65452185|FG001|Overall Study|Lack of Efficacy|2|||
23467165|NCT02625909|65452184|FG000|Overall Study|Reinfection|3|||
23467166|NCT02625909|65452185|FG001|Overall Study|Reinfection|2|||
23244894|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23244895|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23244896|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23244897|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23467167|NCT03530124|65452189|FG000|Overall Study|Withdrawal by Subject|0|||
23467168|NCT03530124|65452190|FG001|Overall Study|Withdrawal by Subject|1|||
23467169|NCT03530124|65452189|FG000|Overall Study|Protocol Violation|1|||
23467170|NCT03530124|65452190|FG001|Overall Study|Protocol Violation|0|||
23467171|NCT03530124|65452189|FG000|Overall Study|Discharged prior to study completion|1|||
23467172|NCT03530124|65452190|FG001|Overall Study|Discharged prior to study completion|0|||
23467173|NCT02999672|65452196|FG000|Overall Study|Death|0|||
23467174|NCT02999672|65452197|FG001|Overall Study|Death|1|||
23467175|NCT02999672|65452196|FG000|Overall Study|Study Terminated by Sponsor|0|||
23467176|NCT02999672|65452197|FG001|Overall Study|Study Terminated by Sponsor|1|||
23467177|NCT02999672|65452196|FG000|Overall Study|Progressive Disease|9|||
23467178|NCT02999672|65452197|FG001|Overall Study|Progressive Disease|5|||
23467179|NCT02999672|65452196|FG000|Overall Study|Adverse Event|4|||
23467180|NCT02999672|65452197|FG001|Overall Study|Adverse Event|0|||
23467181|NCT01657019|65452202|FG000|Overall Study|Withdrawal by Subject|65|||
23467182|NCT01657019|65452202|FG000|Overall Study|Adverse Event|55|||
23467183|NCT01657019|65452202|FG000|Overall Study|Lost to Follow-up|48|||
23467184|NCT01657019|65452202|FG000|Overall Study|Protocol Violation|6|||
23467185|NCT01657019|65452202|FG000|Overall Study|Lack of Efficacy|3|||
23467186|NCT01657019|65452202|FG000|Overall Study|Other|58|||
23467187|NCT00043979|65452208|FG000|Period 1|recipient with progressive disease|7|||
23467188|NCT00043979|65452209|FG001|Period 1|recipient with progressive disease|4|||
23467189|NCT00043979|65452210|FG002|Period 1|recipient with progressive disease|3|||
23467190|NCT01413204|65452211|FG000|Overall Study|Adverse Event|1|||
23467191|NCT01413204|65452212|FG001|Overall Study|Adverse Event|2|||
23467192|NCT01413204|65452213|FG002|Overall Study|Adverse Event|2|||
23467193|NCT01413204|65452211|FG000|Overall Study|Physician Decision|3|||
23467194|NCT01413204|65452212|FG001|Overall Study|Physician Decision|0|||
23467195|NCT01413204|65452213|FG002|Overall Study|Physician Decision|2|||
23467196|NCT01413204|65452211|FG000|Overall Study|Withdrawal by Subject|1|||
23467197|NCT01413204|65452212|FG001|Overall Study|Withdrawal by Subject|4|||
23467198|NCT01413204|65452213|FG002|Overall Study|Withdrawal by Subject|4|||
23467199|NCT01413204|65452211|FG000|Overall Study|Clearly not eligible for the study|0|||
23467200|NCT01413204|65452212|FG001|Overall Study|Clearly not eligible for the study|0|||
23467201|NCT01413204|65452213|FG002|Overall Study|Clearly not eligible for the study|1|||
23467202|NCT01413204|65452211|FG000|Overall Study|Fasting plasma glucose level increased|1|||
23467203|NCT01413204|65452212|FG001|Overall Study|Fasting plasma glucose level increased|0|||
23467204|NCT01413204|65452213|FG002|Overall Study|Fasting plasma glucose level increased|10|||
23467205|NCT01012440|65452218|FG000|Overall Study|Withdrawal by Subject|2|||
23467206|NCT03714672|65452219|FG000|Overall Study|Adverse Event|0|||
23467207|NCT03714672|65452220|FG001|Overall Study|Adverse Event|0|||
23467208|NCT03714672|65452221|FG002|Overall Study|Adverse Event|3|||
23467209|NCT03714672|65452222|FG003|Overall Study|Adverse Event|0|||
23467210|NCT03714672|65452219|FG000|Overall Study|Physician Decision|0|||
23467211|NCT03714672|65452220|FG001|Overall Study|Physician Decision|1|||
23467212|NCT03714672|65452221|FG002|Overall Study|Physician Decision|0|||
23467213|NCT03714672|65452222|FG003|Overall Study|Physician Decision|0|||
23467214|NCT03714672|65452219|FG000|Overall Study|Other Reason|1|||
23467215|NCT03714672|65452220|FG001|Overall Study|Other Reason|2|||
23467216|NCT03714672|65452221|FG002|Overall Study|Other Reason|1|||
23467217|NCT03714672|65452222|FG003|Overall Study|Other Reason|1|||
23467218|NCT03714672|65452219|FG000|Overall Study|Lost to Follow-up|1|||
23244898|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
23351528|NCT02427802|65029657|FG001|Overall Study|Lost to Follow-up|8|||
23467219|NCT03714672|65452220|FG001|Overall Study|Lost to Follow-up|1|||
23467220|NCT03714672|65452221|FG002|Overall Study|Lost to Follow-up|0|||
23467221|NCT03714672|65452222|FG003|Overall Study|Lost to Follow-up|0|||
23467222|NCT01976741|65452228|FG000|Overall Study|Withdrawal by Subject|1|||
23467223|NCT01976741|65452229|FG001|Overall Study|Withdrawal by Subject|0|||
23467224|NCT01976741|65452230|FG002|Overall Study|Withdrawal by Subject|1|||
23467225|NCT01976741|65452231|FG003|Overall Study|Withdrawal by Subject|1|||
23467226|NCT01976741|65452232|FG004|Overall Study|Withdrawal by Subject|0|||
23467227|NCT01976741|65452233|FG005|Overall Study|Withdrawal by Subject|0|||
23467228|NCT01976741|65452234|FG006|Overall Study|Withdrawal by Subject|1|||
23467229|NCT01976741|65452235|FG007|Overall Study|Withdrawal by Subject|4|||
23467230|NCT01976741|65452236|FG008|Overall Study|Withdrawal by Subject|0|||
23467231|NCT01976741|65452237|FG009|Overall Study|Withdrawal by Subject|0|||
23467232|NCT01976741|65452228|FG000|Overall Study|Adverse Event|0|||
23467233|NCT01976741|65452229|FG001|Overall Study|Adverse Event|0|||
23467234|NCT01976741|65452230|FG002|Overall Study|Adverse Event|2|||
23467235|NCT01976741|65452231|FG003|Overall Study|Adverse Event|0|||
23467236|NCT01976741|65452232|FG004|Overall Study|Adverse Event|0|||
23467237|NCT01976741|65452233|FG005|Overall Study|Adverse Event|0|||
23467238|NCT01976741|65452234|FG006|Overall Study|Adverse Event|3|||
23467239|NCT01976741|65452235|FG007|Overall Study|Adverse Event|8|||
23467240|NCT01976741|65452236|FG008|Overall Study|Adverse Event|1|||
23467241|NCT01976741|65452237|FG009|Overall Study|Adverse Event|4|||
23467242|NCT00828204|65452238|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
23467243|NCT00828204|65452239|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
23467244|NCT00828204|65452238|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
23467245|NCT00828204|65452239|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
23467246|NCT00828204|65452238|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
23467247|NCT00828204|65452239|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
23467248|NCT00828204|65452238|FG000|Main Study: After Study Restart|Adverse Event|0|||
23244899|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
23244900|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23244901|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
23244902|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
23244903|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
23244904|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
23244905|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
23351529|NCT02427802|65029658|FG002|Overall Study|Lost to Follow-up|8|||
23351530|NCT02427802|65029656|FG000|Overall Study|Physician Decision|4|||
23351531|NCT02427802|65029657|FG001|Overall Study|Physician Decision|2|||
23351532|NCT02427802|65029658|FG002|Overall Study|Physician Decision|4|||
23467249|NCT00828204|65452239|FG001|Main Study: After Study Restart|Adverse Event|2|||
23467250|NCT00828204|65452238|FG000|Main Study: After Study Restart|Noncompliance|0|||
23467251|NCT00828204|65452239|FG001|Main Study: After Study Restart|Noncompliance|1|||
23467252|NCT00828204|65452238|FG000|Extension Study|Lost to Follow-up|0|||
23467253|NCT00828204|65452239|FG001|Extension Study|Lost to Follow-up|1|||
23467254|NCT00828204|65452238|FG000|Extension Study|Physician Decision|0|||
23467255|NCT00828204|65452239|FG001|Extension Study|Physician Decision|2|||
23467256|NCT02736578|65452240|FG000|Overall Study|Adverse Event|1|||
23467257|NCT02736578|65452241|FG001|Overall Study|Adverse Event|0|||
23467258|NCT00477386|65452246|FG000|Overall Study|Adverse Event|4|||
23467259|NCT00477386|65452247|FG001|Overall Study|Adverse Event|8|||
23467260|NCT00477386|65452246|FG000|Overall Study|Disease progression, relapse|3|||
23467261|NCT00477386|65452247|FG001|Overall Study|Disease progression, relapse|4|||
23467262|NCT00477386|65452246|FG000|Overall Study|Disease progression, refractory|1|||
23467263|NCT00477386|65452247|FG001|Overall Study|Disease progression, refractory|3|||
23467264|NCT00477386|65452246|FG000|Overall Study|Other|1|||
23467265|NCT00477386|65452247|FG001|Overall Study|Other|2|||
23467266|NCT00477386|65452246|FG000|Overall Study|Physician Decision|1|||
23467267|NCT00477386|65452247|FG001|Overall Study|Physician Decision|0|||
23467268|NCT00477386|65452246|FG000|Overall Study|Withdrawal by Subject|1|||
23467269|NCT00477386|65452247|FG001|Overall Study|Withdrawal by Subject|0|||
23467270|NCT02281383|65452248|FG000|Overall Study|Progressive Disease|1|||
23467271|NCT02281383|65452248|FG000|Overall Study|Withdrawal by Subject|6|||
23467272|NCT02281383|65452248|FG000|Overall Study|Protocol Violation|2|||
23467273|NCT02281383|65452248|FG000|Overall Study|Death|1|||
23467274|NCT02281383|65452248|FG000|Overall Study|Adverse Event|2|||
23467275|NCT00750438|65452249|FG000|Overall Study|Protocol Violation|4|||
23467276|NCT00750438|65452250|FG001|Overall Study|Protocol Violation|1|||
23467277|NCT00750438|65452249|FG000|Overall Study|Physician Decision|2|||
23467278|NCT00750438|65452250|FG001|Overall Study|Physician Decision|2|||
23467279|NCT00750438|65452249|FG000|Overall Study|Withdrawal by Subject|1|||
23351533|NCT02427802|65029656|FG000|Overall Study|Withdrawal by Subject|10|||
23351534|NCT02427802|65029657|FG001|Overall Study|Withdrawal by Subject|5|||
23467280|NCT00750438|65452250|FG001|Overall Study|Withdrawal by Subject|1|||
23467281|NCT01587924|65452251|FG000|Overall Study|Adverse Event|0|||
23467282|NCT01587924|65452252|FG001|Overall Study|Adverse Event|2|||
23467283|NCT01587924|65452253|FG002|Overall Study|Adverse Event|0|||
23467284|NCT01587924|65452254|FG003|Overall Study|Adverse Event|0|||
23467285|NCT01587924|65452251|FG000|Overall Study|Protocol Violation|2|||
23467286|NCT01587924|65452252|FG001|Overall Study|Protocol Violation|1|||
23467287|NCT01587924|65452253|FG002|Overall Study|Protocol Violation|2|||
23467288|NCT01587924|65452254|FG003|Overall Study|Protocol Violation|1|||
23467289|NCT01587924|65452251|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
23467290|NCT01587924|65452252|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
23467291|NCT01587924|65452253|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
23467292|NCT01587924|65452254|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
23467293|NCT01587924|65452251|FG000|Overall Study|Withdrawal by Subject|0|||
23467294|NCT01587924|65452252|FG001|Overall Study|Withdrawal by Subject|1|||
23467295|NCT01587924|65452253|FG002|Overall Study|Withdrawal by Subject|1|||
23467296|NCT01587924|65452254|FG003|Overall Study|Withdrawal by Subject|0|||
23467297|NCT00892099|65452257|FG000|Overall Study|Death|1|||
23467298|NCT00892099|65452258|FG001|Overall Study|Death|0|||
23467299|NCT00892099|65452259|FG002|Overall Study|Death|1|||
23467300|NCT00892099|65452257|FG000|Overall Study|Adverse Event|1|||
23467301|NCT00892099|65452258|FG001|Overall Study|Adverse Event|0|||
23467302|NCT00892099|65452259|FG002|Overall Study|Adverse Event|0|||
23467303|NCT00892099|65452257|FG000|Overall Study|replocated|1|||
23467304|NCT00892099|65452258|FG001|Overall Study|replocated|0|||
23467305|NCT00892099|65452259|FG002|Overall Study|replocated|2|||
23467306|NCT00892099|65452257|FG000|Overall Study|Prolonged hospitalization|1|||
23467307|NCT00892099|65452258|FG001|Overall Study|Prolonged hospitalization|0|||
23467308|NCT00892099|65452259|FG002|Overall Study|Prolonged hospitalization|1|||
23186405|NCT04925570|64422997|FG001|Overall Study|Protocol Violation|30|||
23186406|NCT04925570|64422996|FG000|Overall Study|Withdrawal by Subject|0|||
23186407|NCT04925570|64422997|FG001|Overall Study|Withdrawal by Subject|2|||
23186408|NCT04996797|64422998|FG000|Overall Study|Adverse Event|0|||
23186409|NCT04996797|64422999|FG001|Overall Study|Adverse Event|2|||
23186410|NCT04996797|64423000|FG002|Overall Study|Adverse Event|0|||
23186411|NCT04996797|64423001|FG003|Overall Study|Adverse Event|1|||
23186412|NCT04996797|64422998|FG000|Overall Study|Lack of Efficacy|0|||
23186413|NCT04996797|64422999|FG001|Overall Study|Lack of Efficacy|2|||
23186414|NCT04996797|64423000|FG002|Overall Study|Lack of Efficacy|0|||
23186415|NCT04996797|64423001|FG003|Overall Study|Lack of Efficacy|0|||
23186416|NCT04996797|64422998|FG000|Overall Study|Prohibited Medication|0|||
23186417|NCT04996797|64422999|FG001|Overall Study|Prohibited Medication|1|||
23186418|NCT04996797|64423000|FG002|Overall Study|Prohibited Medication|0|||
23186419|NCT04996797|64423001|FG003|Overall Study|Prohibited Medication|0|||
23186420|NCT04996797|64422998|FG000|Overall Study|Ongoing|68|||
23186421|NCT04996797|64422999|FG001|Overall Study|Ongoing|60|||
23186422|NCT04996797|64423000|FG002|Overall Study|Ongoing|22|||
23186423|NCT04996797|64423001|FG003|Overall Study|Ongoing|20|||
23186424|NCT04996797|64422998|FG000|Overall Study|Withdrawal by Subject|0|||
23186425|NCT04996797|64422999|FG001|Overall Study|Withdrawal by Subject|2|||
23186426|NCT04996797|64423000|FG002|Overall Study|Withdrawal by Subject|0|||
23186427|NCT04996797|64423001|FG003|Overall Study|Withdrawal by Subject|0|||
23186428|NCT04513158|64423009|FG000|Overall Study|Screen Failure|1|||
23186429|NCT02112448|64423010|FG000|Overall Study|lab values precluding use of ketorolac|2|||
23186430|NCT02112448|64423011|FG001|Overall Study|lab values precluding use of ketorolac|2|||
23186431|NCT02112448|64423010|FG000|Overall Study|Protocol Violation|1|||
23186432|NCT02112448|64423011|FG001|Overall Study|Protocol Violation|2|||
23186433|NCT02112448|64423010|FG000|Overall Study|Physician Decision|4|||
23186434|NCT02112448|64423011|FG001|Overall Study|Physician Decision|6|||
23186435|NCT02112448|64423010|FG000|Overall Study|required heparin so could not use ketoro|1|||
23186436|NCT02112448|64423011|FG001|Overall Study|required heparin so could not use ketoro|0|||
23186437|NCT03277196|64423012|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
23186438|NCT03277196|64423012|FG000|Overall Study|Lost to Follow-up|3|||
23186439|NCT03277196|64423012|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
23186440|NCT03277196|64423012|FG000|Overall Study|Other|2|||
23186441|NCT05847881|64423013|FG000|Overall Study|Principal Investigator Decision|8|||
23186442|NCT05847881|64423013|FG000|Overall Study|Withdrawal by Subject|2|||
23186443|NCT03191786|64423014|FG000|Overall Study|Death|236|||
23186444|NCT03191786|64423015|FG001|Overall Study|Death|127|||
23186445|NCT03191786|64423014|FG000|Overall Study|Lost to Follow-up|9|||
23186446|NCT03191786|64423015|FG001|Overall Study|Lost to Follow-up|3|||
23186447|NCT03191786|64423014|FG000|Overall Study|Physician Decision|1|||
23186448|NCT03191786|64423015|FG001|Overall Study|Physician Decision|0|||
23186449|NCT03191786|64423014|FG000|Overall Study|Moved to Post Trial Access Program|30|||
23186450|NCT03191786|64423015|FG001|Overall Study|Moved to Post Trial Access Program|5|||
23186451|NCT03191786|64423014|FG000|Overall Study|Withdrawal by Subject|26|||
23467309|NCT00892099|65452257|FG000|Overall Study|no further details|1|||
23467310|NCT00892099|65452258|FG001|Overall Study|no further details|0|||
23467311|NCT00892099|65452259|FG002|Overall Study|no further details|1|||
23467312|NCT00892099|65452257|FG000|Overall Study|kidney function recovered|0|||
23186452|NCT03191786|64423015|FG001|Overall Study|Withdrawal by Subject|16|||
23186453|NCT04358458|64423020|FG000|Overall Study|Death|1|||
23351535|NCT02427802|65029658|FG002|Overall Study|Withdrawal by Subject|11|||
23351536|NCT02427802|65029656|FG000|Overall Study|Protocol Violation|3|||
23186454|NCT04358458|64423021|FG001|Overall Study|Death|1|||
23186455|NCT04358458|64423022|FG002|Overall Study|Death|3|||
23186456|NCT04358458|64423023|FG003|Overall Study|Death|8|||
23186457|NCT04358458|64423024|FG004|Overall Study|Death|1|||
23467313|NCT00892099|65452258|FG001|Overall Study|kidney function recovered|1|||
23467314|NCT00892099|65452259|FG002|Overall Study|kidney function recovered|0|||
23467315|NCT00892099|65452257|FG000|Overall Study|investigator decision|0|||
23467316|NCT00892099|65452258|FG001|Overall Study|investigator decision|0|||
23467317|NCT00892099|65452259|FG002|Overall Study|investigator decision|1|||
23467318|NCT00892099|65452257|FG000|Overall Study|Lost to Follow-up|0|||
23467319|NCT00892099|65452258|FG001|Overall Study|Lost to Follow-up|0|||
23467320|NCT00892099|65452259|FG002|Overall Study|Lost to Follow-up|1|||
23467321|NCT00622440|65452260|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
23467322|NCT00622440|65452261|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
23467323|NCT00622440|65452260|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
23467324|NCT00622440|65452261|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
23467325|NCT00622440|65452260|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
23467326|NCT00622440|65452261|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
23467327|NCT00622440|65452260|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
23467328|NCT00622440|65452261|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
23467329|NCT00871975|65452263|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
23467330|NCT00871975|65452263|FG000|Overall Study|Catheters could not be inserted|1|||
23467331|NCT00871975|65452263|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
23467332|NCT00871975|65452263|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
23467333|NCT00888940|65452264|FG000|Overall Study|Adverse Event|12|||
23467334|NCT00888940|65452265|FG001|Overall Study|Adverse Event|3|||
23467335|NCT00888940|65452264|FG000|Overall Study|Lost to Follow-up|5|||
23467336|NCT00888940|65452265|FG001|Overall Study|Lost to Follow-up|5|||
23467337|NCT00888940|65452264|FG000|Overall Study|Randomized Not Treated|11|||
23467338|NCT00888940|65452265|FG001|Overall Study|Randomized Not Treated|13|||
23467339|NCT02858362|65452266|FG000|Overall Study|Protocol Violation|0|||
23467340|NCT02858362|65452267|FG001|Overall Study|Protocol Violation|1|||
23467341|NCT02858362|65452268|FG002|Overall Study|Protocol Violation|0|||
23467342|NCT02858362|65452266|FG000|Overall Study|Withdrawal by Subject|1|||
23467343|NCT02858362|65452267|FG001|Overall Study|Withdrawal by Subject|0|||
23467344|NCT02858362|65452268|FG002|Overall Study|Withdrawal by Subject|0|||
23467345|NCT02858362|65452266|FG000|Overall Study|Early Study Termination|0|||
23467346|NCT02858362|65452267|FG001|Overall Study|Early Study Termination|0|||
23467347|NCT02858362|65452268|FG002|Overall Study|Early Study Termination|3|||
23467348|NCT02858362|65452266|FG000|Overall Study|Lost to Follow-up|1|||
23467349|NCT02858362|65452267|FG001|Overall Study|Lost to Follow-up|0|||
23467350|NCT02858362|65452268|FG002|Overall Study|Lost to Follow-up|0|||
23467351|NCT00345358|65452274|FG000|Primary Vaccination Phase|Other|0|||
23467352|NCT00345358|65452275|FG001|Primary Vaccination Phase|Other|1|||
23467353|NCT00345358|65452276|FG002|Primary Vaccination Phase|Other|1|||
23467354|NCT00345358|65452277|FG003|Primary Vaccination Phase|Other|0|||
23467355|NCT00345358|65452274|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
23467356|NCT00345358|65452275|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
23467357|NCT00345358|65452276|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
23467358|NCT00345358|65452277|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
23467359|NCT00345358|65452274|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
23467360|NCT00345358|65452275|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
23467361|NCT00345358|65452276|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
23467362|NCT00345358|65452277|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
23467363|NCT00345358|65452274|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
23467364|NCT00345358|65452275|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
23467365|NCT00345358|65452276|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
23467366|NCT00345358|65452277|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
23467367|NCT00345358|65452274|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
23467368|NCT00345358|65452275|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
23467369|NCT00345358|65452276|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
23467370|NCT00345358|65452277|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
23467371|NCT00345358|65452274|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
23467372|NCT00345358|65452275|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
23467373|NCT00345358|65452276|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
23467374|NCT00345358|65452277|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
23467375|NCT01605799|65452278|FG000|Overall Study|Withdrawal by Subject|2|||
23467376|NCT01605799|65452279|FG001|Overall Study|Withdrawal by Subject|1|||
23467377|NCT00334113|65452282|FG000|Overall Study|Lost to Follow-up|2|||
23467378|NCT00334113|65452283|FG001|Overall Study|Lost to Follow-up|2|||
23467379|NCT00334113|65452282|FG000|Overall Study|Withdrawal by Subject|0|||
23467380|NCT00334113|65452283|FG001|Overall Study|Withdrawal by Subject|1|||
23467381|NCT01421719|65452284|FG000|Overall Study|Withdrawal by Subject|4|||
23467382|NCT01583296|65452286|FG000|Overall Study|Withdrawal by Subject|11|||
23467383|NCT01583296|65452287|FG001|Overall Study|Withdrawal by Subject|10|||
23467384|NCT02873702|65452288|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
23467385|NCT02873702|65452289|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
23467386|NCT02873702|65452290|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
23467387|NCT02873702|65452291|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
23467388|NCT02873702|65452288|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
23467389|NCT02873702|65452289|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
23467390|NCT02873702|65452290|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
23467391|NCT02873702|65452291|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
23467392|NCT02873702|65452288|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
23467393|NCT02873702|65452289|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
23467394|NCT02873702|65452290|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
23467395|NCT02873702|65452291|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
23467396|NCT02873702|65452288|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
23467397|NCT02873702|65452289|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
23467398|NCT02873702|65452290|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
23467399|NCT02873702|65452291|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
23467400|NCT02873702|65452288|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
23467401|NCT02873702|65452289|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
23467402|NCT02873702|65452290|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
23467403|NCT02873702|65452291|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
23467404|NCT00499083|65452292|FG000|Overall Study|Not evaluable|3|||
23586604|NCT02486588|65876080|FG003|Overall Study|Randomized in error- ineligible|738|||
23244906|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
23244907|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
23244908|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
23244909|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
23244910|NCT00408005|64638870|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
23244911|NCT00408005|64638871|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
23244912|NCT00408005|64638872|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
23244913|NCT00408005|64638873|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
23244914|NCT00408005|64638874|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
23244915|NCT00408005|64638875|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
23244916|NCT00408005|64638876|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
23244917|NCT00408005|64638877|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
23244918|NCT04059484|64638878|FG000|Overall Study|Adverse Event|2|||
23244919|NCT04059484|64638879|FG001|Overall Study|Adverse Event|5|||
23244920|NCT04059484|64638878|FG000|Overall Study|Withdrawal by Subject|5|||
23244921|NCT04059484|64638879|FG001|Overall Study|Withdrawal by Subject|3|||
23244922|NCT04059484|64638878|FG000|Overall Study|Progressive disease|112|||
23244923|NCT04059484|64638879|FG001|Overall Study|Progressive disease|112|||
23244924|NCT04059484|64638878|FG000|Overall Study|Other|8|||
23244925|NCT04059484|64638879|FG001|Overall Study|Other|3|||
23244926|NCT04059484|64638878|FG000|Overall Study|Ongoing|20|||
23244927|NCT04059484|64638879|FG001|Overall Study|Ongoing|20|||
23244928|NCT01901393|64638880|FG000|Overall Study|Adverse Event|1|||
23244929|NCT01901393|64638881|FG001|Overall Study|Adverse Event|0|||
23244930|NCT00554788|64638882|FG000|Overall Study|Adverse Event|0|||
23244931|NCT00554788|64638883|FG001|Overall Study|Adverse Event|1|||
23244932|NCT00554788|64638884|FG002|Overall Study|Adverse Event|2|||
23244933|NCT00554788|64638882|FG000|Overall Study|Lost to Follow-up|4|||
23244934|NCT00554788|64638883|FG001|Overall Study|Lost to Follow-up|3|||
23244935|NCT00554788|64638884|FG002|Overall Study|Lost to Follow-up|3|||
23244936|NCT00554788|64638882|FG000|Overall Study|Physician Decision|1|||
23244937|NCT00554788|64638883|FG001|Overall Study|Physician Decision|1|||
23244938|NCT00554788|64638884|FG002|Overall Study|Physician Decision|3|||
23244939|NCT00554788|64638882|FG000|Overall Study|Withdrawal by Subject|0|||
23244940|NCT00554788|64638883|FG001|Overall Study|Withdrawal by Subject|0|||
23244941|NCT00554788|64638884|FG002|Overall Study|Withdrawal by Subject|1|||
23244942|NCT00554788|64638882|FG000|Overall Study|Refusal of further protocol therapy|0|||
23244943|NCT00554788|64638883|FG001|Overall Study|Refusal of further protocol therapy|1|||
23244944|NCT00554788|64638884|FG002|Overall Study|Refusal of further protocol therapy|1|||
23244945|NCT00554788|64638882|FG000|Overall Study|Progressive disease|0|||
23244946|NCT00554788|64638883|FG001|Overall Study|Progressive disease|0|||
23244947|NCT00554788|64638884|FG002|Overall Study|Progressive disease|3|||
23244948|NCT00554788|64638882|FG000|Overall Study|Ineligible|2|||
23467405|NCT02668393|65452293|FG000|Overall Study|Progressive disease|6|||
23186458|NCT04358458|64423025|FG005|Overall Study|Death|6|||
23186459|NCT04358458|64423026|FG006|Overall Study|Death|2|||
23186460|NCT04358458|64423027|FG007|Overall Study|Death|3|||
23186461|NCT04358458|64423020|FG000|Overall Study|Lost to Follow-up|0|||
23186462|NCT04358458|64423021|FG001|Overall Study|Lost to Follow-up|0|||
23186463|NCT04358458|64423022|FG002|Overall Study|Lost to Follow-up|0|||
23186464|NCT04358458|64423023|FG003|Overall Study|Lost to Follow-up|0|||
23244949|NCT00554788|64638883|FG001|Overall Study|Ineligible|0|||
23244950|NCT00554788|64638884|FG002|Overall Study|Ineligible|1|||
23244951|NCT01513759|64638885|FG000|Overall Study|Protocol Violation|4|||
23244952|NCT01513759|64638885|FG000|Overall Study|Death during catheter placement|1|||
23244953|NCT02916056|64638886|FG000|Overall Study|Adverse Event|6|||
23244954|NCT02916056|64638886|FG000|Overall Study|Lost to Follow-up|1|||
23351537|NCT02427802|65029657|FG001|Overall Study|Protocol Violation|1|||
23351538|NCT02427802|65029658|FG002|Overall Study|Protocol Violation|1|||
23351539|NCT02427802|65029656|FG000|Overall Study|protocol specific treatment unrelated|18|||
23351540|NCT02427802|65029657|FG001|Overall Study|protocol specific treatment unrelated|11|||
23351541|NCT02427802|65029658|FG002|Overall Study|protocol specific treatment unrelated|11|||
23351542|NCT03448939|65029659|FG000|Overall Study|Adverse Event|5|||
23244955|NCT02916056|64638886|FG000|Overall Study|Other|12|||
23244956|NCT02916056|64638886|FG000|Overall Study|Protocol Violation|1|||
23244957|NCT02916056|64638886|FG000|Overall Study|Withdrawal by Subject|8|||
23244958|NCT02916056|64638886|FG000|Overall Study|Study Terminated by Sponsor|269|||
23244959|NCT04629534|64638887|FG000|Overall Study|Physician Decision|1|||
23244960|NCT04629534|64638888|FG001|Overall Study|Physician Decision|0|||
23244961|NCT04629534|64638887|FG000|Overall Study|Protocol Violation|0|||
23244962|NCT04629534|64638888|FG001|Overall Study|Protocol Violation|2|||
23244963|NCT02975882|64638889|FG000|Overall Study|Adverse Event|1|||
23244964|NCT02975882|64638890|FG001|Overall Study|Adverse Event|2|||
23244965|NCT02975882|64638891|FG002|Overall Study|Adverse Event|1|||
23244966|NCT02975882|64638892|FG003|Overall Study|Adverse Event|1|||
23244967|NCT02975882|64638889|FG000|Overall Study|Death|0|||
23244968|NCT02975882|64638890|FG001|Overall Study|Death|1|||
23244969|NCT02975882|64638891|FG002|Overall Study|Death|0|||
23244970|NCT02975882|64638892|FG003|Overall Study|Death|0|||
23244971|NCT02975882|64638889|FG000|Overall Study|Lack of Efficacy|3|||
23244972|NCT02975882|64638890|FG001|Overall Study|Lack of Efficacy|7|||
23244973|NCT02975882|64638891|FG002|Overall Study|Lack of Efficacy|4|||
23244974|NCT02975882|64638892|FG003|Overall Study|Lack of Efficacy|3|||
23244975|NCT02975882|64638889|FG000|Overall Study|Physician Decision|0|||
23244976|NCT02975882|64638890|FG001|Overall Study|Physician Decision|2|||
23244977|NCT02975882|64638891|FG002|Overall Study|Physician Decision|4|||
23244978|NCT02975882|64638892|FG003|Overall Study|Physician Decision|2|||
23244979|NCT02975882|64638889|FG000|Overall Study|Ineligible|0|||
23244980|NCT02975882|64638890|FG001|Overall Study|Ineligible|1|||
23244981|NCT02975882|64638891|FG002|Overall Study|Ineligible|0|||
23244982|NCT02975882|64638892|FG003|Overall Study|Ineligible|0|||
23244987|NCT04637815|64638895|FG000|Overall Study|Death|1|||
23244988|NCT04637815|64638896|FG001|Overall Study|Death|0|||
23244989|NCT04637815|64638895|FG000|Overall Study|Lost to Follow-up|5|||
23244990|NCT04637815|64638896|FG001|Overall Study|Lost to Follow-up|2|||
23467406|NCT02668393|65452294|FG001|Overall Study|Progressive disease|3|||
23467407|NCT02668393|65452293|FG000|Overall Study|Adverse Event|0|||
23351543|NCT03448939|65029660|FG001|Overall Study|Adverse Event|1|||
23351544|NCT03448939|65029659|FG000|Overall Study|Lost to Follow-up|6|||
23245007|NCT02526017|64638904|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23245008|NCT02526017|64638905|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23245009|NCT02526017|64638906|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23245010|NCT02526017|64638907|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23245011|NCT02526017|64638908|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
23245012|NCT02526017|64638909|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23467408|NCT02668393|65452294|FG001|Overall Study|Adverse Event|2|||
23467409|NCT02668393|65452293|FG000|Overall Study|Withdrawal from the trial|0|||
23467410|NCT02668393|65452294|FG001|Overall Study|Withdrawal from the trial|1|||
23467411|NCT02668393|65452293|FG000|Overall Study|Lack of benefit and side effects|1|||
23467412|NCT02668393|65452294|FG001|Overall Study|Lack of benefit and side effects|0|||
23467413|NCT00934362|65452295|FG000|Overall Study|Adverse Event|1|||
23467414|NCT00934362|65452296|FG001|Overall Study|Adverse Event|0|||
23467415|NCT02157883|65457032|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
23467416|NCT02157883|65457032|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
23467417|NCT02157883|65457032|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
23467418|NCT02157883|65457032|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
23467419|NCT02157883|65457032|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
23467420|NCT05097963|65457037|FG000|Overall Study|Protocol Violation|13|||
23467421|NCT05097963|65457037|FG000|Overall Study|Withdrawal by Subject|21|||
23467422|NCT00943618|65457038|FG000|Overall Study|Lost to Follow-up|38|||
23467423|NCT00943618|65457039|FG001|Overall Study|Lost to Follow-up|48|||
23467424|NCT00943618|65457040|FG002|Overall Study|Lost to Follow-up|20|||
23467425|NCT00943618|65457038|FG000|Overall Study|Discontinued Medication|17|||
23245013|NCT02526017|64638910|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23245014|NCT02526017|64638911|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23245015|NCT02526017|64638912|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
23245016|NCT00110084|64638917|FG000|Overall Study|Adverse Event|9|||
23245017|NCT00110084|64638917|FG000|Overall Study|Death|1|||
23245018|NCT00110084|64638917|FG000|Overall Study|Patient Refusal|10|||
23245019|NCT00110084|64638917|FG000|Overall Study|Alternate Therapy|5|||
23245020|NCT00110084|64638917|FG000|Overall Study|Intercurrent Illness|1|||
23245021|NCT00110084|64638917|FG000|Overall Study|Other|2|||
23245022|NCT03941860|64638918|FG000|Overall Study|Withdrawal by Subject|0|||
23245023|NCT03941860|64638919|FG001|Overall Study|Withdrawal by Subject|1|||
23586605|NCT02486588|65876081|FG004|Overall Study|Randomized in error- ineligible|746|||
23586606|NCT02486588|65876082|FG005|Overall Study|Randomized in error- ineligible|746|||
23586607|NCT01419717|65876083|FG000|Overall Study|Protocol-specified Criteria|62|||
23586608|NCT01419717|65876083|FG000|Overall Study|Adverse Event|19|||
23586609|NCT01419717|65876083|FG000|Overall Study|Death|17|||
23586610|NCT01419717|65876083|FG000|Overall Study|Withdrawal by Subject|10|||
23586611|NCT01419717|65876083|FG000|Overall Study|Disease Progression|9|||
23586612|NCT01419717|65876083|FG000|Overall Study|Other|4|||
23586613|NCT01419717|65876083|FG000|Overall Study|Lost to Follow-up|2|||
23586614|NCT01419717|65876083|FG000|Overall Study|Administrative Decision|1|||
23586615|NCT01419717|65876083|FG000|Overall Study|Noncompliance|1|||
23586616|NCT00094809|65876085|FG000|Overall Study|Protocol deviation|2|||
23586617|NCT00094809|65876086|FG001|Overall Study|Protocol deviation|2|||
23586618|NCT00094809|65876085|FG000|Overall Study|Noncompliance|1|||
23586619|NCT00094809|65876086|FG001|Overall Study|Noncompliance|0|||
23586620|NCT00094809|65876085|FG000|Overall Study|Adverse Event|3|||
23586621|NCT00094809|65876086|FG001|Overall Study|Adverse Event|1|||
23586622|NCT00094809|65876085|FG000|Overall Study|Withdrawal by Subject|8|||
23586623|NCT00094809|65876086|FG001|Overall Study|Withdrawal by Subject|9|||
23586624|NCT00094809|65876085|FG000|Overall Study|Disease progression|3|||
23586625|NCT00094809|65876086|FG001|Overall Study|Disease progression|3|||
23586626|NCT00094809|65876085|FG000|Overall Study|Physician Decision|3|||
23586627|NCT00094809|65876086|FG001|Overall Study|Physician Decision|5|||
23586628|NCT00094809|65876085|FG000|Overall Study|Lost to Follow-up|6|||
23586629|NCT00094809|65876086|FG001|Overall Study|Lost to Follow-up|6|||
23586630|NCT00094809|65876085|FG000|Overall Study|Death|19|||
23586631|NCT00094809|65876086|FG001|Overall Study|Death|25|||
23586632|NCT00094809|65876085|FG000|Overall Study|Protocol-specified criteria|1|||
23586633|NCT00094809|65876086|FG001|Overall Study|Protocol-specified criteria|1|||
23586634|NCT00094809|65876085|FG000|Overall Study|Other|2|||
23586635|NCT00094809|65876086|FG001|Overall Study|Other|4|||
23586636|NCT00094809|65876085|FG000|Overall Study|Informed consent signed after treatment|1|||
23245056|NCT02842086|64638924|FG000|Overall Study|Randomized but Never Treated|6|||
23245057|NCT02842086|64638925|FG001|Overall Study|Randomized but Never Treated|6|||
23245058|NCT02842086|64638924|FG000|Overall Study|Still in Double-Blind Phase|7|||
23245059|NCT02842086|64638925|FG001|Overall Study|Still in Double-Blind Phase|3|||
23245060|NCT02842086|64638924|FG000|Overall Study|Adverse Event|18|||
23245061|NCT02842086|64638925|FG001|Overall Study|Adverse Event|20|||
23245062|NCT02842086|64638924|FG000|Overall Study|Death|3|||
23245063|NCT02842086|64638925|FG001|Overall Study|Death|3|||
23186465|NCT04358458|64423024|FG004|Overall Study|Lost to Follow-up|0|||
23245064|NCT02842086|64638924|FG000|Overall Study|Investigator's Discretion|9|||
23245065|NCT02842086|64638925|FG001|Overall Study|Investigator's Discretion|13|||
23245066|NCT02842086|64638924|FG000|Overall Study|Non-Compliance with Study Drug|9|||
23245067|NCT02842086|64638925|FG001|Overall Study|Non-Compliance with Study Drug|8|||
23245068|NCT02842086|64638924|FG000|Overall Study|Protocol Violation|8|||
23245069|NCT02842086|64638925|FG001|Overall Study|Protocol Violation|4|||
23245070|NCT02842086|64638924|FG000|Overall Study|Withdrew Consent|205|||
23245071|NCT02842086|64638925|FG001|Overall Study|Withdrew Consent|194|||
23245072|NCT02842086|64638924|FG000|Overall Study|Lost to Follow-up|274|||
23245073|NCT02842086|64638925|FG001|Overall Study|Lost to Follow-up|236|||
23245074|NCT02842086|64638924|FG000|Overall Study|HIV-1 Infection|5|||
23245075|NCT02842086|64638925|FG001|Overall Study|HIV-1 Infection|6|||
23245076|NCT00761735|64638927|FG000|Overall Study|Lost to Follow-up|6|||
23245077|NCT00761735|64638927|FG000|Overall Study|Withdrawal by Subject|6|||
23245078|NCT00761735|64638927|FG000|Overall Study|Non-compliance with protocol|1|||
23351545|NCT03448939|65029660|FG001|Overall Study|Lost to Follow-up|6|||
23245079|NCT00761735|64638927|FG000|Overall Study|Administrative|1|||
23186466|NCT04358458|64423025|FG005|Overall Study|Lost to Follow-up|0|||
23186467|NCT04358458|64423026|FG006|Overall Study|Lost to Follow-up|0|||
23186468|NCT04358458|64423027|FG007|Overall Study|Lost to Follow-up|1|||
23186469|NCT04358458|64423020|FG000|Overall Study|Site is closing study participation|0|||
23186470|NCT04358458|64423021|FG001|Overall Study|Site is closing study participation|0|||
23186471|NCT04358458|64423022|FG002|Overall Study|Site is closing study participation|0|||
23186472|NCT04358458|64423023|FG003|Overall Study|Site is closing study participation|1|||
23186473|NCT04358458|64423024|FG004|Overall Study|Site is closing study participation|0|||
23245080|NCT01251861|64638930|FG000|Overall Study|Disease progression|6|||
23245081|NCT01251861|64638931|FG001|Overall Study|Disease progression|6|||
23245082|NCT01251861|64638930|FG000|Overall Study|Adverse Event|2|||
23245083|NCT01251861|64638931|FG001|Overall Study|Adverse Event|17|||
23245084|NCT01251861|64638930|FG000|Overall Study|Withdrawal by Subject|2|||
23245085|NCT01251861|64638931|FG001|Overall Study|Withdrawal by Subject|2|||
23245086|NCT01251861|64638930|FG000|Overall Study|Alternative therapy|1|||
23245087|NCT01251861|64638931|FG001|Overall Study|Alternative therapy|0|||
23245088|NCT01251861|64638930|FG000|Overall Study|Other complicating disease|0|||
23245089|NCT01251861|64638931|FG001|Overall Study|Other complicating disease|1|||
23245090|NCT01251861|64638930|FG000|Overall Study|Physician Decision|1|||
23245091|NCT01251861|64638931|FG001|Overall Study|Physician Decision|0|||
23245092|NCT01251861|64638930|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
23245093|NCT01251861|64638931|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
23245094|NCT01251861|64638930|FG000|Overall Study|Other|1|||
23245095|NCT01251861|64638931|FG001|Overall Study|Other|0|||
23245096|NCT01251861|64638930|FG000|Overall Study|Never started therapy|4|||
23245097|NCT01251861|64638931|FG001|Overall Study|Never started therapy|1|||
23245098|NCT01251861|64638930|FG000|Overall Study|Potential interaction of drugs|0|||
23245099|NCT01251861|64638931|FG001|Overall Study|Potential interaction of drugs|1|||
23245100|NCT03690206|64638932|FG000|Overall Study|Withdrawal by Subject|2|||
23245101|NCT03690206|64638933|FG001|Overall Study|Withdrawal by Subject|0|||
23245102|NCT03690206|64638934|FG002|Overall Study|Withdrawal by Subject|0|||
23245103|NCT03690206|64638932|FG000|Overall Study|ICF withdrawal|2|||
23245104|NCT03690206|64638933|FG001|Overall Study|ICF withdrawal|0|||
23351546|NCT03448939|65029659|FG000|Overall Study|Pregnancy|1|||
23351547|NCT03448939|65029660|FG001|Overall Study|Pregnancy|1|||
23351548|NCT03448939|65029659|FG000|Overall Study|Withdrawal by Subject|9|||
23351549|NCT03448939|65029660|FG001|Overall Study|Withdrawal by Subject|3|||
23351550|NCT00438256|65029661|FG000|Overall Study|Ineligible for Resection|2|||
23351551|NCT00438256|65029662|FG001|Overall Study|Ineligible for Resection|1|||
23351552|NCT00438256|65029663|FG002|Overall Study|Ineligible for Resection|1|||
23351553|NCT00438256|65029664|FG003|Overall Study|Ineligible for Resection|7|||
23351554|NCT00438256|65029661|FG000|Overall Study|Excluded final Diagnosis|0|||
23351555|NCT00438256|65029662|FG001|Overall Study|Excluded final Diagnosis|0|||
23586637|NCT00094809|65876086|FG001|Overall Study|Informed consent signed after treatment|0|||
23586638|NCT00094809|65876085|FG000|Overall Study|Study drug not received|2|||
23586639|NCT00094809|65876086|FG001|Overall Study|Study drug not received|8|||
23586640|NCT00094809|65876085|FG000|Overall Study|Other|1|||
23586641|NCT00094809|65876086|FG001|Overall Study|Other|1|||
23586642|NCT00208767|65876092|FG000|Overall Study|Adverse Event|9|||
23586643|NCT00208767|65876093|FG001|Overall Study|Adverse Event|1|||
23586644|NCT00208767|65876092|FG000|Overall Study|Withdrawal by Subject|14|||
23586645|NCT00208767|65876093|FG001|Overall Study|Withdrawal by Subject|3|||
23586646|NCT00208767|65876092|FG000|Overall Study|Death|1|||
23586647|NCT00208767|65876093|FG001|Overall Study|Death|0|||
23586648|NCT00208767|65876092|FG000|Overall Study|Lost to Follow-up|3|||
23586649|NCT00208767|65876093|FG001|Overall Study|Lost to Follow-up|3|||
23586650|NCT00367055|65876097|FG000|Overall Study|Adverse Event|6|||
23586651|NCT00367055|65876098|FG001|Overall Study|Adverse Event|3|||
23586652|NCT00367055|65876097|FG000|Overall Study|Patient's Willing|3|||
23586653|NCT00367055|65876098|FG001|Overall Study|Patient's Willing|2|||
23586654|NCT00367055|65876097|FG000|Overall Study|Lack of Efficacy|1|||
23186474|NCT04358458|64423025|FG005|Overall Study|Site is closing study participation|0|||
23186475|NCT04358458|64423026|FG006|Overall Study|Site is closing study participation|0|||
23586655|NCT00367055|65876098|FG001|Overall Study|Lack of Efficacy|2|||
23586656|NCT00367055|65876097|FG000|Overall Study|Lost to Follow-up|1|||
23586657|NCT00367055|65876098|FG001|Overall Study|Lost to Follow-up|1|||
23586658|NCT00367055|65876097|FG000|Overall Study|Protocol Violation|0|||
23186476|NCT04358458|64423027|FG007|Overall Study|Site is closing study participation|0|||
23186477|NCT04358458|64423020|FG000|Overall Study|Sponsor request|2|||
23186478|NCT04358458|64423021|FG001|Overall Study|Sponsor request|3|||
23186479|NCT04358458|64423022|FG002|Overall Study|Sponsor request|3|||
23186480|NCT04358458|64423023|FG003|Overall Study|Sponsor request|0|||
23186481|NCT04358458|64423024|FG004|Overall Study|Sponsor request|2|||
23186482|NCT04358458|64423025|FG005|Overall Study|Sponsor request|3|||
23186483|NCT04358458|64423026|FG006|Overall Study|Sponsor request|1|||
23186484|NCT04358458|64423027|FG007|Overall Study|Sponsor request|1|||
23186485|NCT04358458|64423020|FG000|Overall Study|Withdrawal by Subject|0|||
23186486|NCT04358458|64423021|FG001|Overall Study|Withdrawal by Subject|0|||
23186487|NCT04358458|64423022|FG002|Overall Study|Withdrawal by Subject|1|||
23186488|NCT04358458|64423023|FG003|Overall Study|Withdrawal by Subject|1|||
23186489|NCT04358458|64423024|FG004|Overall Study|Withdrawal by Subject|0|||
23186490|NCT04358458|64423025|FG005|Overall Study|Withdrawal by Subject|1|||
23186491|NCT04358458|64423026|FG006|Overall Study|Withdrawal by Subject|0|||
23186492|NCT04358458|64423027|FG007|Overall Study|Withdrawal by Subject|1|||
23186493|NCT01064648|64423028|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
23186494|NCT01064648|64423029|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
23186495|NCT01064648|64423030|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
23186496|NCT01064648|64423031|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
23186497|NCT01064648|64423028|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
23186498|NCT01064648|64423029|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
23186499|NCT01064648|64423030|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
23186500|NCT01064648|64423031|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
23186501|NCT01064648|64423028|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
23186502|NCT01064648|64423029|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
23186503|NCT01064648|64423030|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
23186504|NCT01064648|64423031|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
23186505|NCT01064648|64423028|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
23186506|NCT01064648|64423029|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
23186507|NCT01064648|64423030|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
23586659|NCT00367055|65876098|FG001|Overall Study|Protocol Violation|1|||
23586660|NCT00367055|65876097|FG000|Overall Study|Stopping Criterion Met|0|||
23351556|NCT00438256|65029663|FG002|Overall Study|Excluded final Diagnosis|0|||
23351557|NCT00438256|65029664|FG003|Overall Study|Excluded final Diagnosis|2|||
23186508|NCT01064648|64423031|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
23186509|NCT01064648|64423028|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
23186510|NCT01064648|64423029|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
23186511|NCT01064648|64423030|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
23351558|NCT00236899|65029665|FG000|Overall Study|Adverse Event (Study Related)|1|||
23586661|NCT00367055|65876098|FG001|Overall Study|Stopping Criterion Met|1|||
23245105|NCT03690206|64638934|FG002|Overall Study|ICF withdrawal|0|||
23245106|NCT05257109|64638935|FG000|Overall Study|Withdrawal by Subject|1|||
23245107|NCT05257109|64638936|FG001|Overall Study|Withdrawal by Subject|0|||
23245108|NCT05257109|64638937|FG002|Overall Study|Withdrawal by Subject|0|||
23245109|NCT05257109|64638938|FG003|Overall Study|Withdrawal by Subject|0|||
23586662|NCT00367055|65876097|FG000|Overall Study|Participant Living too Far from Hospital|0|||
23586663|NCT00367055|65876098|FG001|Overall Study|Participant Living too Far from Hospital|1|||
23586664|NCT01803646|65876099|FG000|Overall Study|Protocol Violation|1|||
23586665|NCT01803646|65876100|FG001|Overall Study|Protocol Violation|0|||
23586666|NCT01803646|65876099|FG000|Overall Study|Adverse Event|1|||
23586667|NCT01803646|65876100|FG001|Overall Study|Adverse Event|1|||
23586668|NCT01803646|65876099|FG000|Overall Study|Withdrawal by Subject|9|||
23586669|NCT01803646|65876100|FG001|Overall Study|Withdrawal by Subject|6|||
23586670|NCT01803646|65876099|FG000|Overall Study|Randomization error|1|||
23586671|NCT01803646|65876100|FG001|Overall Study|Randomization error|2|||
23586672|NCT01803646|65876099|FG000|Overall Study|Lost to Follow-up|5|||
23586673|NCT01803646|65876100|FG001|Overall Study|Lost to Follow-up|1|||
23586674|NCT03861767|65876101|FG000|Overall Study|Withdrawal by Subject|2|||
23586675|NCT03861767|65876102|FG001|Overall Study|Withdrawal by Subject|1|||
23351559|NCT00236899|65029666|FG001|Overall Study|Adverse Event (Study Related)|1|||
23351560|NCT00236899|65029667|FG002|Overall Study|Adverse Event (Study Related)|2|||
23351561|NCT00236899|65029668|FG003|Overall Study|Adverse Event (Study Related)|1|||
23351562|NCT00236899|65029665|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
23351563|NCT00236899|65029666|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
23351564|NCT00236899|65029667|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
23351565|NCT00236899|65029668|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
23351566|NCT00236899|65029665|FG000|Overall Study|Death (Study Disease)|1|||
23351567|NCT00236899|65029666|FG001|Overall Study|Death (Study Disease)|4|||
23586676|NCT03861767|65876103|FG002|Overall Study|Withdrawal by Subject|0|||
23586677|NCT03861767|65876104|FG003|Overall Study|Withdrawal by Subject|5|||
23586678|NCT03861767|65876105|FG004|Overall Study|Withdrawal by Subject|2|||
23586679|NCT03861767|65876106|FG005|Overall Study|Withdrawal by Subject|1|||
23586680|NCT03861767|65876107|FG006|Overall Study|Withdrawal by Subject|3|||
23586681|NCT03861767|65876108|FG007|Overall Study|Withdrawal by Subject|1|||
23586682|NCT03861767|65876109|FG008|Overall Study|Withdrawal by Subject|0|||
23586683|NCT03861767|65876110|FG009|Overall Study|Withdrawal by Subject|5|||
23586684|NCT00957658|65876111|FG000|Overall Study|Death|1|||
23586685|NCT00957658|65876111|FG000|Overall Study|Lost to Follow-up|4|||
23245134|NCT01142388|64638944|FG000|Overall Study|Lack of Efficacy|21|||
23245135|NCT01142388|64638945|FG001|Overall Study|Lack of Efficacy|31|||
23245136|NCT01142388|64638944|FG000|Overall Study|Adverse Event|9|||
23245137|NCT01142388|64638945|FG001|Overall Study|Adverse Event|5|||
23245138|NCT01142388|64638944|FG000|Overall Study|Death|3|||
23245139|NCT01142388|64638945|FG001|Overall Study|Death|2|||
23245140|NCT01142388|64638944|FG000|Overall Study|Withdrawal by Subject|5|||
23245141|NCT01142388|64638945|FG001|Overall Study|Withdrawal by Subject|3|||
23245142|NCT01142388|64638944|FG000|Overall Study|Alternative therapy|1|||
23245143|NCT01142388|64638945|FG001|Overall Study|Alternative therapy|0|||
23245144|NCT01142388|64638944|FG000|Overall Study|Other complications|0|||
23351568|NCT00236899|65029667|FG002|Overall Study|Death (Study Disease)|0|||
23351569|NCT00236899|65029668|FG003|Overall Study|Death (Study Disease)|0|||
23351570|NCT00236899|65029665|FG000|Overall Study|Death (Not Study Related)|2|||
23586686|NCT00957658|65876111|FG000|Overall Study|Withdrawal by Subject|12|||
23586687|NCT00957658|65876111|FG000|Overall Study|Revision|1|||
23586688|NCT00957658|65876111|FG000|Overall Study|Incomplete 2 yr data|28|||
23586689|NCT00957658|65876111|FG000|Overall Study|Site termination|10|||
23586690|NCT00957658|65876111|FG000|Overall Study|unwilling/unable to return|2|||
23586691|NCT00957658|65876111|FG000|Overall Study|surgery cancelled|2|||
23586692|NCT00957658|65876111|FG000|Overall Study|Protocol Violation|5|||
23586693|NCT03055767|65876112|FG000|Open-Label Period|Lost to Follow-up|0|||
23586694|NCT03055767|65876113|FG001|Open-Label Period|Lost to Follow-up|0|||
23245145|NCT01142388|64638945|FG001|Overall Study|Other complications|2|||
23245146|NCT01142388|64638944|FG000|Overall Study|Other|1|||
23245147|NCT01142388|64638945|FG001|Overall Study|Other|1|||
23245148|NCT01142388|64638944|FG000|Overall Study|Never started therapy|7|||
23245149|NCT01142388|64638945|FG001|Overall Study|Never started therapy|3|||
23245150|NCT03382561|64638946|FG000|Overall Study|Disease progression|47|||
23245151|NCT03382561|64638947|FG001|Overall Study|Disease progression|6|||
23245152|NCT03382561|64638946|FG000|Overall Study|Adverse Event|10|||
23245153|NCT03382561|64638947|FG001|Overall Study|Adverse Event|2|||
23245154|NCT03382561|64638946|FG000|Overall Study|Death|8|||
23245155|NCT03382561|64638947|FG001|Overall Study|Death|3|||
23245156|NCT03382561|64638946|FG000|Overall Study|Withdrawal by Subject|6|||
23245157|NCT03382561|64638947|FG001|Overall Study|Withdrawal by Subject|5|||
23245158|NCT03382561|64638946|FG000|Overall Study|Alternative therapy|2|||
23245159|NCT03382561|64638947|FG001|Overall Study|Alternative therapy|8|||
23245160|NCT03382561|64638946|FG000|Overall Study|Never started treatment|3|||
23245161|NCT03382561|64638947|FG001|Overall Study|Never started treatment|6|||
23245162|NCT03382561|64638946|FG000|Overall Study|Lack of Efficacy|0|||
23245163|NCT03382561|64638947|FG001|Overall Study|Lack of Efficacy|1|||
23245164|NCT03382561|64638946|FG000|Overall Study|Physician Decision|0|||
23245165|NCT03382561|64638947|FG001|Overall Study|Physician Decision|1|||
23245166|NCT03382561|64638946|FG000|Overall Study|Other complicating disease|0|||
23245167|NCT03382561|64638947|FG001|Overall Study|Other complicating disease|1|||
23245168|NCT03323034|64638948|FG000|Overall Study|Lack of Efficacy|5|||
23245169|NCT03323034|64638949|FG001|Overall Study|Lack of Efficacy|5|||
23245170|NCT03323034|64638950|FG002|Overall Study|Lack of Efficacy|6|||
23245171|NCT03323034|64638951|FG003|Overall Study|Lack of Efficacy|5|||
23245172|NCT03323034|64638952|FG004|Overall Study|Lack of Efficacy|5|||
23245173|NCT03323034|64638948|FG000|Overall Study|Physician Decision|0|||
23245174|NCT03323034|64638949|FG001|Overall Study|Physician Decision|0|||
23245175|NCT03323034|64638950|FG002|Overall Study|Physician Decision|0|||
23245176|NCT03323034|64638951|FG003|Overall Study|Physician Decision|0|||
23245177|NCT03323034|64638952|FG004|Overall Study|Physician Decision|1|||
23245178|NCT03323034|64638948|FG000|Overall Study|Withdrawal by Subject|1|||
23245179|NCT03323034|64638949|FG001|Overall Study|Withdrawal by Subject|1|||
23351571|NCT00236899|65029666|FG001|Overall Study|Death (Not Study Related)|0|||
23351572|NCT00236899|65029667|FG002|Overall Study|Death (Not Study Related)|0|||
23351573|NCT00236899|65029668|FG003|Overall Study|Death (Not Study Related)|0|||
23351574|NCT00236899|65029665|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
23351575|NCT00236899|65029666|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
23351576|NCT00236899|65029667|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
23351577|NCT00236899|65029668|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
23351578|NCT00236899|65029665|FG000|Overall Study|Lost to Follow-up|0|||
23351579|NCT00236899|65029666|FG001|Overall Study|Lost to Follow-up|1|||
23351580|NCT00236899|65029667|FG002|Overall Study|Lost to Follow-up|0|||
23351581|NCT00236899|65029668|FG003|Overall Study|Lost to Follow-up|0|||
23351582|NCT00236899|65029665|FG000|Overall Study|Entry Criteria Exclusion|0|||
23351583|NCT00236899|65029666|FG001|Overall Study|Entry Criteria Exclusion|1|||
23351584|NCT00236899|65029667|FG002|Overall Study|Entry Criteria Exclusion|1|||
23351585|NCT00236899|65029668|FG003|Overall Study|Entry Criteria Exclusion|0|||
23351586|NCT00236899|65029665|FG000|Overall Study|Protocol Violation|1|||
23351587|NCT00236899|65029666|FG001|Overall Study|Protocol Violation|0|||
23351588|NCT00236899|65029667|FG002|Overall Study|Protocol Violation|0|||
23351589|NCT00236899|65029668|FG003|Overall Study|Protocol Violation|0|||
23351590|NCT00236899|65029665|FG000|Overall Study|Withdrawal by Subject|6|||
23186512|NCT01064648|64423031|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
23186513|NCT01064648|64423028|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
23186514|NCT01064648|64423029|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
23186515|NCT01064648|64423030|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
23186516|NCT01064648|64423031|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
23186517|NCT01064648|64423028|FG000|Phase II|Adverse Event|0|||
23186518|NCT01064648|64423029|FG001|Phase II|Adverse Event|0|||
23186519|NCT01064648|64423030|FG002|Phase II|Adverse Event|15|||
23186520|NCT01064648|64423031|FG003|Phase II|Adverse Event|8|||
23186521|NCT01064648|64423028|FG000|Phase II|Death|0|||
23186522|NCT01064648|64423029|FG001|Phase II|Death|0|||
23186523|NCT01064648|64423030|FG002|Phase II|Death|4|||
23186524|NCT01064648|64423031|FG003|Phase II|Death|5|||
23186525|NCT01064648|64423028|FG000|Phase II|Withdrawal by Subject|0|||
23186526|NCT01064648|64423029|FG001|Phase II|Withdrawal by Subject|0|||
23186527|NCT01064648|64423030|FG002|Phase II|Withdrawal by Subject|2|||
23186528|NCT01064648|64423031|FG003|Phase II|Withdrawal by Subject|5|||
23186529|NCT01064648|64423028|FG000|Phase II|Progression|0|||
23186530|NCT01064648|64423029|FG001|Phase II|Progression|0|||
23351591|NCT00236899|65029666|FG001|Overall Study|Withdrawal by Subject|4|||
23351592|NCT00236899|65029667|FG002|Overall Study|Withdrawal by Subject|5|||
23351593|NCT00236899|65029668|FG003|Overall Study|Withdrawal by Subject|2|||
23351594|NCT00236899|65029665|FG000|Overall Study|Physician Decision|7|||
23186531|NCT01064648|64423030|FG002|Phase II|Progression|21|||
23186532|NCT01064648|64423031|FG003|Phase II|Progression|27|||
23186533|NCT01064648|64423028|FG000|Phase II|Non-protocol specified|0|||
23186534|NCT01064648|64423029|FG001|Phase II|Non-protocol specified|0|||
23186535|NCT01064648|64423030|FG002|Phase II|Non-protocol specified|5|||
23245180|NCT03323034|64638950|FG002|Overall Study|Withdrawal by Subject|0|||
23245181|NCT03323034|64638951|FG003|Overall Study|Withdrawal by Subject|1|||
23245182|NCT03323034|64638952|FG004|Overall Study|Withdrawal by Subject|0|||
23586695|NCT03055767|65876114|FG002|Open-Label Period|Lost to Follow-up|2|||
23586696|NCT03055767|65876115|FG003|Open-Label Period|Lost to Follow-up|0|||
23586697|NCT03055767|65876112|FG000|Open-Label Period|Withdrawal by Subject|0|||
23351595|NCT00236899|65029666|FG001|Overall Study|Physician Decision|8|||
23186536|NCT01064648|64423031|FG003|Phase II|Non-protocol specified|3|||
23186537|NCT01064648|64423028|FG000|Phase II|Under Review|0|||
23586698|NCT03055767|65876113|FG001|Open-Label Period|Withdrawal by Subject|0|||
23351596|NCT00236899|65029667|FG002|Overall Study|Physician Decision|7|||
23351597|NCT00236899|65029668|FG003|Overall Study|Physician Decision|6|||
23351598|NCT00236899|65029665|FG000|Overall Study|Satisfactory Response|2|||
23351599|NCT00236899|65029666|FG001|Overall Study|Satisfactory Response|0|||
23351600|NCT00236899|65029667|FG002|Overall Study|Satisfactory Response|0|||
23351601|NCT00236899|65029668|FG003|Overall Study|Satisfactory Response|1|||
23351602|NCT00236899|65029665|FG000|Overall Study|Lack of Efficacy|18|||
23351603|NCT00236899|65029666|FG001|Overall Study|Lack of Efficacy|18|||
23186538|NCT01064648|64423029|FG001|Phase II|Under Review|0|||
23186539|NCT01064648|64423030|FG002|Phase II|Under Review|2|||
23186540|NCT01064648|64423031|FG003|Phase II|Under Review|0|||
23186541|NCT01877655|64423033|FG000|Overall Study|Death|57|||
23186542|NCT01877655|64423034|FG001|Overall Study|Death|52|||
23186543|NCT01877655|64423033|FG000|Overall Study|Withdrawal by Subject|18|||
23186544|NCT01877655|64423034|FG001|Overall Study|Withdrawal by Subject|26|||
23186545|NCT01877655|64423033|FG000|Overall Study|Physician Decision|11|||
23186546|NCT01877655|64423034|FG001|Overall Study|Physician Decision|10|||
23186547|NCT01877655|64423033|FG000|Overall Study|Miscellaneous|4|||
23186548|NCT01877655|64423034|FG001|Overall Study|Miscellaneous|4|||
23186549|NCT01877655|64423033|FG000|Overall Study|Randomized but Never Received Drug|8|||
23186550|NCT01877655|64423034|FG001|Overall Study|Randomized but Never Received Drug|5|||
23186551|NCT00860470|64423035|FG000|Overall Study|Death|6|||
23186552|NCT00860470|64423036|FG001|Overall Study|Death|10|||
23186553|NCT00860470|64423035|FG000|Overall Study|Moved away|8|||
23186554|NCT00860470|64423036|FG001|Overall Study|Moved away|10|||
23186555|NCT00860470|64423035|FG000|Overall Study|Lost to Follow-up|34|||
23186556|NCT00860470|64423036|FG001|Overall Study|Lost to Follow-up|39|||
23186557|NCT01672892|64423037|FG000|Overall Study|Protocol Violation|7|||
23186558|NCT01672892|64423038|FG001|Overall Study|Protocol Violation|3|||
23186559|NCT01662999|64423039|FG000|Period 3|Withdrawal by Subject|0|||
23186560|NCT01662999|64423040|FG001|Period 3|Withdrawal by Subject|1|||
23186561|NCT01662999|64423041|FG002|Period 3|Withdrawal by Subject|0|||
23186562|NCT01662999|64423042|FG003|Period 3|Withdrawal by Subject|0|||
23186563|NCT01662999|64423043|FG004|Period 3|Withdrawal by Subject|0|||
23186564|NCT01662999|64423044|FG005|Period 3|Withdrawal by Subject|0|||
23186565|NCT01299025|64423046|FG000|Overall Study|Withdrawal by Subject|2|||
23186566|NCT01299025|64423047|FG001|Overall Study|Withdrawal by Subject|1|||
23186567|NCT01299025|64423046|FG000|Overall Study|Lost to Follow-up|1|||
23186568|NCT01299025|64423047|FG001|Overall Study|Lost to Follow-up|0|||
23186569|NCT04433117|64423050|FG000|Overall Study|Withdrawal by Subject|1|||
23186570|NCT04433117|64423051|FG001|Overall Study|Withdrawal by Subject|0|||
23186571|NCT04178590|64423053|FG000|Overall Study|Pregnancy|1|||
23186572|NCT04178590|64423053|FG000|Overall Study|Lost to Follow-up|1|||
23186573|NCT00327444|64423055|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
23186574|NCT00327444|64423056|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
23186575|NCT00327444|64423055|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
23186576|NCT00327444|64423056|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
23186577|NCT00327444|64423055|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
23186578|NCT00327444|64423056|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
23186579|NCT00327444|64423055|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
23186580|NCT00327444|64423056|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
23186581|NCT00327444|64423055|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
23186582|NCT00327444|64423056|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
23186583|NCT00327444|64423055|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
23186584|NCT00327444|64423056|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
23186585|NCT00327444|64423055|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
23186586|NCT00327444|64423056|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
23186587|NCT00327444|64423055|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
23186588|NCT00327444|64423056|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
23186589|NCT02317510|64423057|FG000|Overall Study|Adverse Event|0|||
23186590|NCT02317510|64423058|FG001|Overall Study|Adverse Event|1|||
23186591|NCT02886715|64423059|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23186592|NCT02886715|64423060|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23186593|NCT02886715|64423061|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23186594|NCT02886715|64423059|FG000|Overall Study|Adverse Event|4|||
23186595|NCT02886715|64423060|FG001|Overall Study|Adverse Event|2|||
23586699|NCT03055767|65876114|FG002|Open-Label Period|Withdrawal by Subject|0|||
23586700|NCT03055767|65876115|FG003|Open-Label Period|Withdrawal by Subject|1|||
23186596|NCT02886715|64423061|FG002|Overall Study|Adverse Event|0|||
23186597|NCT02886715|64423059|FG000|Overall Study|Lack of Efficacy|0|||
23586701|NCT01156116|65876117|FG000|Overall Study|Withdrawal by Subject|3|||
23586702|NCT01156116|65876118|FG001|Overall Study|Withdrawal by Subject|1|||
23586703|NCT01156116|65876117|FG000|Overall Study|CPAP intolerance|2|||
23586704|NCT01156116|65876118|FG001|Overall Study|CPAP intolerance|0|||
23186598|NCT02886715|64423060|FG001|Overall Study|Lack of Efficacy|2|||
23351604|NCT00236899|65029667|FG002|Overall Study|Lack of Efficacy|25|||
23351605|NCT00236899|65029668|FG003|Overall Study|Lack of Efficacy|23|||
23586705|NCT01833832|65876120|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
23586706|NCT01499134|65876123|FG000|Overall Study|Withdrawal by Subject|0|||
23586707|NCT01499134|65876124|FG001|Overall Study|Withdrawal by Subject|1|||
23586708|NCT03761784|65876125|FG000|Overall Study|Adverse Event|4|||
23586709|NCT03761784|65876126|FG001|Overall Study|Adverse Event|0|||
23586710|NCT03761784|65876125|FG000|Overall Study|Lost to Follow-up|10|||
23586711|NCT03761784|65876126|FG001|Overall Study|Lost to Follow-up|7|||
23245201|NCT00980460|64641999|FG000|Overall Study|Death|0|||
23245202|NCT00980460|64642000|FG001|Overall Study|Death|0|||
23245203|NCT00980460|64642001|FG002|Overall Study|Death|1|||
23245204|NCT00980460|64642002|FG003|Overall Study|Death|2|||
23245205|NCT00980460|64642003|FG004|Overall Study|Death|1|||
23245206|NCT00980460|64641999|FG000|Overall Study|Lack of Efficacy|0|||
23245207|NCT00980460|64642000|FG001|Overall Study|Lack of Efficacy|0|||
23245208|NCT00980460|64642001|FG002|Overall Study|Lack of Efficacy|10|||
23245209|NCT00980460|64642002|FG003|Overall Study|Lack of Efficacy|6|||
23245210|NCT00980460|64642003|FG004|Overall Study|Lack of Efficacy|8|||
23245211|NCT00980460|64641999|FG000|Overall Study|Lost to Follow-up|0|||
23245212|NCT00980460|64642000|FG001|Overall Study|Lost to Follow-up|0|||
23245213|NCT00980460|64642001|FG002|Overall Study|Lost to Follow-up|0|||
23245214|NCT00980460|64642002|FG003|Overall Study|Lost to Follow-up|1|||
23245215|NCT00980460|64642003|FG004|Overall Study|Lost to Follow-up|0|||
23245216|NCT00980460|64641999|FG000|Overall Study|Physician Decision|0|||
23245217|NCT00980460|64642000|FG001|Overall Study|Physician Decision|0|||
23245218|NCT00980460|64642001|FG002|Overall Study|Physician Decision|11|||
23245219|NCT00980460|64642002|FG003|Overall Study|Physician Decision|5|||
23245220|NCT00980460|64642003|FG004|Overall Study|Physician Decision|3|||
23245221|NCT00980460|64641999|FG000|Overall Study|Withdrawal by Subject|0|||
23245222|NCT00980460|64642000|FG001|Overall Study|Withdrawal by Subject|0|||
23245223|NCT00980460|64642001|FG002|Overall Study|Withdrawal by Subject|1|||
23245224|NCT00980460|64642002|FG003|Overall Study|Withdrawal by Subject|0|||
23245225|NCT00980460|64642003|FG004|Overall Study|Withdrawal by Subject|0|||
23245226|NCT00980460|64641999|FG000|Overall Study|Ineligible|0|||
23245227|NCT00980460|64642000|FG001|Overall Study|Ineligible|2|||
23245228|NCT00980460|64642001|FG002|Overall Study|Ineligible|3|||
23245229|NCT00980460|64642002|FG003|Overall Study|Ineligible|1|||
23351606|NCT04015518|65029669|FG000|Overall Study|Adverse Event|6|||
23245230|NCT00980460|64642003|FG004|Overall Study|Ineligible|4|||
23186599|NCT02886715|64423061|FG002|Overall Study|Lack of Efficacy|1|||
23186600|NCT02886715|64423059|FG000|Overall Study|Lost to Follow-up|29|||
23186601|NCT02886715|64423060|FG001|Overall Study|Lost to Follow-up|26|||
23186602|NCT02886715|64423061|FG002|Overall Study|Lost to Follow-up|10|||
23186603|NCT02886715|64423059|FG000|Overall Study|Pregnancy|1|||
23186604|NCT02886715|64423060|FG001|Overall Study|Pregnancy|1|||
23351607|NCT04015518|65029670|FG001|Overall Study|Adverse Event|1|||
23351608|NCT04015518|65029671|FG002|Overall Study|Adverse Event|1|||
23245231|NCT00980460|64641999|FG000|Overall Study|Refusal of further therapy|0|||
23245232|NCT00980460|64642000|FG001|Overall Study|Refusal of further therapy|2|||
23186605|NCT02886715|64423061|FG002|Overall Study|Pregnancy|1|||
23186606|NCT02886715|64423059|FG000|Overall Study|Protocol Violation|3|||
23186607|NCT02886715|64423060|FG001|Overall Study|Protocol Violation|2|||
23186608|NCT02886715|64423061|FG002|Overall Study|Protocol Violation|1|||
23186609|NCT02886715|64423059|FG000|Overall Study|Withdrawal by Subject|20|||
23186610|NCT02886715|64423060|FG001|Overall Study|Withdrawal by Subject|18|||
23186611|NCT02886715|64423061|FG002|Overall Study|Withdrawal by Subject|5|||
23186612|NCT02886715|64423059|FG000|Overall Study|missing|7|||
23186613|NCT02886715|64423060|FG001|Overall Study|missing|2|||
23186614|NCT02886715|64423061|FG002|Overall Study|missing|2|||
23186615|NCT00503399|64423062|FG000|Overall Study|Death|2|||
23186616|NCT00503399|64423063|FG001|Overall Study|Death|1|||
23186617|NCT00503399|64423062|FG000|Overall Study|Protocol Violation|1|||
23186618|NCT00503399|64423063|FG001|Overall Study|Protocol Violation|0|||
23186619|NCT00503399|64423062|FG000|Overall Study|Withdrawal by Subject|4|||
23186620|NCT00503399|64423063|FG001|Overall Study|Withdrawal by Subject|2|||
23186621|NCT00503399|64423062|FG000|Overall Study|Adverse Event|0|||
23186622|NCT00503399|64423063|FG001|Overall Study|Adverse Event|3|||
23186623|NCT00503399|64423062|FG000|Overall Study|Lost to Follow-up|0|||
23186624|NCT00503399|64423063|FG001|Overall Study|Lost to Follow-up|2|||
23186625|NCT03717922|64423064|FG000|Overall Study|Lost to Follow-up|2|||
23186626|NCT03717922|64423065|FG001|Overall Study|Lost to Follow-up|2|||
23186627|NCT03180736|64423066|FG000|Overall Study|Adverse Event|3|||
23186628|NCT03180736|64423067|FG001|Overall Study|Adverse Event|4|||
23186629|NCT03180736|64423066|FG000|Overall Study|Death|10|||
23186630|NCT03180736|64423067|FG001|Overall Study|Death|7|||
23186631|NCT03180736|64423066|FG000|Overall Study|Withdrawal by Subject|5|||
23186632|NCT03180736|64423067|FG001|Overall Study|Withdrawal by Subject|12|||
23186633|NCT03180736|64423066|FG000|Overall Study|Lost to Follow-up|1|||
23186634|NCT03180736|64423067|FG001|Overall Study|Lost to Follow-up|0|||
23186635|NCT03180736|64423066|FG000|Overall Study|Lack of Efficacy|66|||
23186636|NCT03180736|64423067|FG001|Overall Study|Lack of Efficacy|87|||
23186637|NCT03180736|64423066|FG000|Overall Study|Physician Decision|4|||
23186638|NCT03180736|64423067|FG001|Overall Study|Physician Decision|7|||
23245233|NCT00980460|64642001|FG002|Overall Study|Refusal of further therapy|3|||
23245234|NCT00980460|64642002|FG003|Overall Study|Refusal of further therapy|2|||
23245235|NCT00980460|64642003|FG004|Overall Study|Refusal of further therapy|0|||
23245236|NCT00980460|64641999|FG000|Overall Study|No therapy within 42 days of resection|0|||
23245237|NCT00980460|64642000|FG001|Overall Study|No therapy within 42 days of resection|0|||
23245238|NCT00980460|64642001|FG002|Overall Study|No therapy within 42 days of resection|3|||
23245239|NCT00980460|64642002|FG003|Overall Study|No therapy within 42 days of resection|1|||
23245240|NCT00980460|64642003|FG004|Overall Study|No therapy within 42 days of resection|0|||
23245241|NCT00980460|64641999|FG000|Overall Study|No transplant by protocol timepoints|0|||
23245242|NCT00980460|64642000|FG001|Overall Study|No transplant by protocol timepoints|0|||
23245243|NCT00980460|64642001|FG002|Overall Study|No transplant by protocol timepoints|3|||
23245244|NCT00980460|64642002|FG003|Overall Study|No transplant by protocol timepoints|0|||
23245245|NCT00980460|64642003|FG004|Overall Study|No transplant by protocol timepoints|0|||
23245246|NCT04633434|64642004|FG000|Overall Study|Lost to Follow-up|32|||
23245247|NCT04633434|64642005|FG001|Overall Study|Lost to Follow-up|32|||
23245248|NCT03563716|64642006|FG000|Overall Study|Death|20|||
23245249|NCT03563716|64642007|FG001|Overall Study|Death|14|||
23245250|NCT03563716|64642006|FG000|Overall Study|Withdrawal by Subject|3|||
23245251|NCT03563716|64642007|FG001|Overall Study|Withdrawal by Subject|3|||
23186639|NCT03180736|64423066|FG000|Overall Study|randomized but not treated|2|||
23186640|NCT03180736|64423067|FG001|Overall Study|randomized but not treated|3|||
23186641|NCT00845429|64423069|FG000|Overall Study|Protocol Violation|5|||
23186642|NCT00845429|64423070|FG001|Overall Study|Protocol Violation|4|||
23186643|NCT00845429|64423071|FG002|Overall Study|Protocol Violation|7|||
23186644|NCT00845429|64423069|FG000|Overall Study|Lost to Follow-up|7|||
23186645|NCT00845429|64423070|FG001|Overall Study|Lost to Follow-up|9|||
23186646|NCT00845429|64423071|FG002|Overall Study|Lost to Follow-up|10|||
23186647|NCT00845429|64423069|FG000|Overall Study|Withdrawal by Subject|2|||
23351609|NCT04015518|65029672|FG003|Overall Study|Adverse Event|3|||
23186648|NCT00845429|64423070|FG001|Overall Study|Withdrawal by Subject|2|||
23186649|NCT00845429|64423071|FG002|Overall Study|Withdrawal by Subject|2|||
23245252|NCT03563716|64642006|FG000|Overall Study|Still on Study|45|||
23245253|NCT03563716|64642007|FG001|Overall Study|Still on Study|50|||
23245254|NCT02180867|64642008|FG000|Overall Study|Adverse Event|3|||
23351610|NCT04015518|65029673|FG004|Overall Study|Adverse Event|3|||
23351611|NCT04015518|65029669|FG000|Overall Study|Lack of Efficacy|1|||
23351612|NCT04015518|65029670|FG001|Overall Study|Lack of Efficacy|0|||
23351613|NCT04015518|65029671|FG002|Overall Study|Lack of Efficacy|1|||
23351614|NCT04015518|65029672|FG003|Overall Study|Lack of Efficacy|0|||
23467426|NCT00943618|65457039|FG001|Overall Study|Discontinued Medication|29|||
23245255|NCT02180867|64642009|FG001|Overall Study|Adverse Event|4|||
23245256|NCT02180867|64642010|FG002|Overall Study|Adverse Event|1|||
23245257|NCT02180867|64642011|FG003|Overall Study|Adverse Event|5|||
23245258|NCT02180867|64642012|FG004|Overall Study|Adverse Event|0|||
23467427|NCT00943618|65457040|FG002|Overall Study|Discontinued Medication|11|||
23467428|NCT01254422|65457041|FG000|Overall Study|Protocol Violation|1|||
23186650|NCT00845429|64423069|FG000|Overall Study|Serious adverse event|0|||
23186651|NCT00845429|64423070|FG001|Overall Study|Serious adverse event|0|||
23186652|NCT00845429|64423071|FG002|Overall Study|Serious adverse event|1|||
23186653|NCT00813748|64423074|FG000|Skin Test Substudy|Physician Decision|0|||
23186654|NCT00813748|64423075|FG001|Skin Test Substudy|Physician Decision|1|||
23186655|NCT00886938|64423076|FG000|Overall Study|Adverse Event|1|||
23186656|NCT00886938|64423076|FG000|Overall Study|Withdrawal by Subject|1|||
23186657|NCT01829048|64423079|FG000|Overall Study|Withdrawal by Subject|0|||
23186658|NCT01829048|64423080|FG001|Overall Study|Withdrawal by Subject|0|||
23186659|NCT01829048|64423081|FG002|Overall Study|Withdrawal by Subject|0|||
23186660|NCT01829048|64423082|FG003|Overall Study|Withdrawal by Subject|2|||
23186661|NCT01829048|64423083|FG004|Overall Study|Withdrawal by Subject|0|||
23186662|NCT01974323|64423084|FG000|Overall Study|Other Reasons|25|||
23186663|NCT01974323|64423085|FG001|Overall Study|Other Reasons|28|||
23186664|NCT01974323|64423084|FG000|Overall Study|Protocol Violation|2|||
23186665|NCT01974323|64423085|FG001|Overall Study|Protocol Violation|2|||
23186666|NCT01974323|64423084|FG000|Overall Study|Personal Reasons|15|||
23186667|NCT01974323|64423085|FG001|Overall Study|Personal Reasons|19|||
23186668|NCT01974323|64423084|FG000|Overall Study|Lost to Follow-up|45|||
23186669|NCT01974323|64423085|FG001|Overall Study|Lost to Follow-up|40|||
23186670|NCT01974323|64423084|FG000|Overall Study|Pregnancy|2|||
23186671|NCT01974323|64423085|FG001|Overall Study|Pregnancy|1|||
23186672|NCT01974323|64423084|FG000|Overall Study|Lack of Efficacy|1|||
23186673|NCT01974323|64423085|FG001|Overall Study|Lack of Efficacy|1|||
23186674|NCT01974323|64423084|FG000|Overall Study|Adverse Event|2|||
23186675|NCT01974323|64423085|FG001|Overall Study|Adverse Event|2|||
23186676|NCT05089708|64423086|FG000|Overall Study|Lost to Follow-up|9|||
23186677|NCT05089708|64423087|FG001|Overall Study|Lost to Follow-up|7|||
23186678|NCT05089708|64423086|FG000|Overall Study|Withdrawal by Subject|3|||
23186679|NCT05089708|64423087|FG001|Overall Study|Withdrawal by Subject|1|||
23186680|NCT05089708|64423086|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
23186681|NCT05089708|64423087|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
23186682|NCT05089708|64423086|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
23186683|NCT05089708|64423087|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
23186684|NCT03323749|64423088|FG000|Double-blind Period|Lost to Follow-up|4|||
23186685|NCT03323749|64423089|FG001|Double-blind Period|Lost to Follow-up|5|||
23186686|NCT03323749|64423088|FG000|Double-blind Period|Adverse Event|3|||
23186687|NCT03323749|64423089|FG001|Double-blind Period|Adverse Event|1|||
23186688|NCT03323749|64423088|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
23186689|NCT03323749|64423089|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
23186690|NCT03323749|64423088|FG000|Open-Label Period|Adverse Event|3|||
23186691|NCT03323749|64423089|FG001|Open-Label Period|Adverse Event|10|||
23186692|NCT03323749|64423088|FG000|Open-Label Period|Withdrawal by Subject|7|||
23245259|NCT02180867|64642013|FG005|Overall Study|Adverse Event|0|||
23245260|NCT02180867|64642014|FG006|Overall Study|Adverse Event|0|||
23245261|NCT02180867|64642008|FG000|Overall Study|Death|0|||
23245262|NCT02180867|64642009|FG001|Overall Study|Death|0|||
23245263|NCT02180867|64642010|FG002|Overall Study|Death|0|||
23245264|NCT02180867|64642011|FG003|Overall Study|Death|0|||
23245265|NCT02180867|64642012|FG004|Overall Study|Death|1|||
23351615|NCT04015518|65029673|FG004|Overall Study|Lack of Efficacy|4|||
23467429|NCT01254422|65457042|FG001|Overall Study|Protocol Violation|0|||
23467430|NCT01254422|65457041|FG000|Overall Study|Adverse Event|1|||
23467431|NCT01254422|65457042|FG001|Overall Study|Adverse Event|0|||
23467432|NCT01254422|65457041|FG000|Overall Study|Serious adverse event|0|||
23186693|NCT03323749|64423089|FG001|Open-Label Period|Withdrawal by Subject|5|||
23186694|NCT00775021|64426306|FG000|First Intervention|Lost to Follow-up|1|||
23351616|NCT04015518|65029669|FG000|Overall Study|Lost to Follow-up|0|||
23186695|NCT00775021|64426307|FG001|First Intervention|Lost to Follow-up|0|||
23186696|NCT00775021|64426306|FG000|Second Intervention|Adverse Event|0|||
23186697|NCT00775021|64426307|FG001|Second Intervention|Adverse Event|1|||
23245266|NCT02180867|64642013|FG005|Overall Study|Death|0|||
23245267|NCT02180867|64642014|FG006|Overall Study|Death|0|||
23245268|NCT02180867|64642008|FG000|Overall Study|Lack of Efficacy|0|||
23245269|NCT02180867|64642009|FG001|Overall Study|Lack of Efficacy|2|||
23467433|NCT01254422|65457042|FG001|Overall Study|Serious adverse event|1|||
23467434|NCT01254422|65457041|FG000|Overall Study|Lost to Follow-up|1|||
23467435|NCT01254422|65457042|FG001|Overall Study|Lost to Follow-up|0|||
23467436|NCT01273519|65457043|FG000|Overall Study|Adverse Event|3|||
23467437|NCT01273519|65457044|FG001|Overall Study|Adverse Event|0|||
23467438|NCT01273519|65457045|FG002|Overall Study|Adverse Event|0|||
23467439|NCT01273519|65457043|FG000|Overall Study|Lost to Follow-up|2|||
23467440|NCT01273519|65457044|FG001|Overall Study|Lost to Follow-up|1|||
23467441|NCT01273519|65457045|FG002|Overall Study|Lost to Follow-up|3|||
23467442|NCT01273519|65457043|FG000|Overall Study|Lack of Efficacy|8|||
23467443|NCT01273519|65457044|FG001|Overall Study|Lack of Efficacy|3|||
23467444|NCT01273519|65457045|FG002|Overall Study|Lack of Efficacy|4|||
23467445|NCT01273519|65457043|FG000|Overall Study|Other|6|||
23467446|NCT01273519|65457044|FG001|Overall Study|Other|1|||
23467447|NCT01273519|65457045|FG002|Overall Study|Other|1|||
23467448|NCT00433004|65457046|FG000|Overall Study|Lost to Follow-up|5|||
23467449|NCT00433004|65457047|FG001|Overall Study|Lost to Follow-up|7|||
23467450|NCT00865566|65457048|FG000|Overall Study|Death|1|||
23467451|NCT00865566|65457049|FG001|Overall Study|Death|11|||
23467452|NCT00865566|65457048|FG000|Overall Study|Lost to Follow-up|314|||
23467453|NCT00865566|65457049|FG001|Overall Study|Lost to Follow-up|315|||
23467454|NCT00865566|65457048|FG000|Overall Study|Withdrawal by Subject|45|||
23467455|NCT00865566|65457049|FG001|Overall Study|Withdrawal by Subject|65|||
23467456|NCT00865566|65457048|FG000|Overall Study|Physician Decision|0|||
23467457|NCT00865566|65457049|FG001|Overall Study|Physician Decision|1|||
23467458|NCT00865566|65457048|FG000|Overall Study|Participant relocated|78|||
23467459|NCT00865566|65457049|FG001|Overall Study|Participant relocated|107|||
23467460|NCT00865566|65457048|FG000|Overall Study|Participant unable to adhere|27|||
23467461|NCT00865566|65457049|FG001|Overall Study|Participant unable to adhere|42|||
23467462|NCT00865566|65457048|FG000|Overall Study|Other; N=245 due to early study closure|154|||
23467463|NCT00865566|65457049|FG001|Overall Study|Other; N=245 due to early study closure|139|||
23467464|NCT00865566|65457048|FG000|Overall Study|HIV infection|5|||
23467465|NCT00865566|65457049|FG001|Overall Study|HIV infection|7|||
23467466|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
23467467|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
23467468|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
23467469|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
23467470|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
23467471|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
23467472|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
23467473|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
23467474|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
23186698|NCT01193335|64426308|FG000|After Infant Series|Lost to Follow-up|1|||
23186699|NCT01193335|64426309|FG001|After Infant Series|Lost to Follow-up|2|||
23186700|NCT01193335|64426308|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
23186701|NCT01193335|64426309|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
23186702|NCT01193335|64426308|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
23186703|NCT01193335|64426309|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
23186704|NCT01193335|64426308|FG000|1-Year Follow-up|Lost to Follow-up|4|||
23186705|NCT01193335|64426309|FG001|1-Year Follow-up|Lost to Follow-up|0|||
23186706|NCT01193335|64426308|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
23186707|NCT01193335|64426309|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
23186708|NCT01193335|64426308|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
23186709|NCT01193335|64426309|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
23186710|NCT00659438|64426310|FG000|Overall Study|Withdrawal by Subject|2|||
23186711|NCT00659438|64426311|FG001|Overall Study|Withdrawal by Subject|2|||
23186712|NCT00659438|64426310|FG000|Overall Study|Death|11|||
23186713|NCT00659438|64426311|FG001|Overall Study|Death|6|||
23186714|NCT00659438|64426310|FG000|Overall Study|Lost to Follow-up|1|||
23186715|NCT00659438|64426311|FG001|Overall Study|Lost to Follow-up|0|||
23186716|NCT01295125|64426312|FG000|Overall Study|Study stopped prematurely|9|||
23186717|NCT01564784|64426313|FG000|Overall Study|Other|1|||
23186718|NCT01564784|64426314|FG001|Overall Study|Other|0|||
23186719|NCT01564784|64426313|FG000|Overall Study|Subject refused further follow-up|1|||
23186720|NCT01564784|64426314|FG001|Overall Study|Subject refused further follow-up|6|||
23245270|NCT02180867|64642010|FG002|Overall Study|Lack of Efficacy|0|||
23245271|NCT02180867|64642011|FG003|Overall Study|Lack of Efficacy|1|||
23186721|NCT01564784|64426313|FG000|Overall Study|Lost to Follow-up|1|||
23245272|NCT02180867|64642012|FG004|Overall Study|Lack of Efficacy|6|||
23186722|NCT01564784|64426314|FG001|Overall Study|Lost to Follow-up|1|||
23245273|NCT02180867|64642013|FG005|Overall Study|Lack of Efficacy|0|||
23467475|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
23467476|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467477|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
23467478|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23186723|NCT01564784|64426313|FG000|Overall Study|Death|131|||
23186724|NCT01564784|64426314|FG001|Overall Study|Death|126|||
23186725|NCT03301857|64426315|FG000|Overall Study|Death|0|||
23467479|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467480|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467481|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467482|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467483|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
23467484|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467485|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
23467486|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467487|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467488|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467489|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
23467490|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
23467491|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
23467492|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
23467493|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|Other|0|||
23467494|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|Other|0|||
23467495|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|Other|1|||
23467496|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|Other|1|||
23467497|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|Other|0|||
23467498|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|Other|0|||
23467499|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|Other|0|||
23467500|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|Other|1|||
23467501|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|Other|0|||
23467502|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|Death|0|||
23467503|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|Death|0|||
23467504|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|Death|0|||
23467505|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|Death|0|||
23467506|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|Death|0|||
23467507|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|Death|1|||
23467508|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|Death|0|||
23467509|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|Death|0|||
23467510|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|Death|0|||
23467511|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467512|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467513|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467514|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467515|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467516|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
23467517|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
23467518|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467519|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
23467520|NCT00557856|65457053|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
23467521|NCT00557856|65457054|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467522|NCT00557856|65457055|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467523|NCT00557856|65457056|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467524|NCT00557856|65457057|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467525|NCT00557856|65457058|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467526|NCT00557856|65457059|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467527|NCT00557856|65457060|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467528|NCT00557856|65457061|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
23467529|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467530|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467531|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467532|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467533|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467534|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467535|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
23467536|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
23586712|NCT03761784|65876125|FG000|Overall Study|Pregnancy|1|||
23186726|NCT03301857|64426316|FG001|Overall Study|Death|2|||
23186727|NCT03301857|64426315|FG000|Overall Study|Lost to Follow-up|4|||
23186728|NCT03301857|64426316|FG001|Overall Study|Lost to Follow-up|2|||
23186729|NCT03301857|64426315|FG000|Overall Study|Decision by Sponsor|6|||
23186730|NCT03301857|64426316|FG001|Overall Study|Decision by Sponsor|0|||
23186731|NCT03301857|64426315|FG000|Overall Study|Withdrawal by Subject|12|||
23186732|NCT03301857|64426316|FG001|Overall Study|Withdrawal by Subject|4|||
23467537|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
23467538|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467539|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467540|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467541|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467542|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467543|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467544|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467545|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
23467546|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
23467547|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
23467548|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
23467549|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
23245274|NCT02180867|64642014|FG006|Overall Study|Lack of Efficacy|1|||
23245275|NCT02180867|64642008|FG000|Overall Study|Physician Decision|1|||
23245276|NCT02180867|64642009|FG001|Overall Study|Physician Decision|3|||
23245277|NCT02180867|64642010|FG002|Overall Study|Physician Decision|1|||
23467550|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
23467551|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
23467552|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
23467553|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
23467554|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
23467555|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
23467556|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|Other|0|||
23467557|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|Other|0|||
23467558|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|Other|0|||
23467559|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|Other|0|||
23467560|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|Other|0|||
23467561|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|Other|0|||
23467562|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|Other|0|||
23467563|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|Other|0|||
23467564|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|Other|1|||
23467565|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|Death|0|||
23467566|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|Death|0|||
23467567|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|Death|0|||
23467568|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|Death|0|||
23467569|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|Death|0|||
23467570|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|Death|0|||
23467571|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|Death|0|||
23467572|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|Death|0|||
23467573|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|Death|2|||
23467574|NCT00557856|65457053|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467575|NCT00557856|65457054|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467576|NCT00557856|65457055|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467577|NCT00557856|65457056|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467578|NCT00557856|65457057|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467579|NCT00557856|65457058|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
23186733|NCT03312218|64426317|FG000|Overall Study|Never signed in to access the app|54|||
23186734|NCT03312218|64426318|FG001|Overall Study|Never signed in to access the app|58|||
23186735|NCT05408858|64426322|FG000|Overall Study|no longer met eligibility criteria|1|||
23186736|NCT00466505|64426325|FG000|Overall Study|disease progression|13|||
23186737|NCT00466505|64426325|FG000|Overall Study|Adverse Event|4|||
23186738|NCT04030195|64426326|FG000|Overall Study|Withdrawal by Subject|2|||
23186739|NCT04030195|64426327|FG001|Overall Study|Withdrawal by Subject|0|||
23245278|NCT02180867|64642011|FG003|Overall Study|Physician Decision|10|||
23586713|NCT03761784|65876126|FG001|Overall Study|Pregnancy|0|||
23586714|NCT03761784|65876125|FG000|Overall Study|Protocol Violation|2|||
23586715|NCT03761784|65876126|FG001|Overall Study|Protocol Violation|0|||
23586716|NCT03761784|65876125|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
23586717|NCT03761784|65876126|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
23586718|NCT03761784|65876125|FG000|Overall Study|Withdrawal by Subject|9|||
23245279|NCT02180867|64642012|FG004|Overall Study|Physician Decision|9|||
23245280|NCT02180867|64642013|FG005|Overall Study|Physician Decision|3|||
23245281|NCT02180867|64642014|FG006|Overall Study|Physician Decision|4|||
23467580|NCT00557856|65457059|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467581|NCT00557856|65457060|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
23467582|NCT00557856|65457061|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
23467583|NCT01750229|65457062|FG000|Randomized Crossover Phase|Adverse Event|1|||
23186740|NCT04030195|64426328|FG002|Overall Study|Withdrawal by Subject|0|||
23467584|NCT01750229|65457062|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
23467585|NCT01750229|65457062|FG000|Long-term Follow-up Phase|Adverse Event|2|||
23245282|NCT02180867|64642008|FG000|Overall Study|Withdrawal by Subject|0|||
23467586|NCT01750229|65457062|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
23245283|NCT02180867|64642009|FG001|Overall Study|Withdrawal by Subject|0|||
23245284|NCT02180867|64642010|FG002|Overall Study|Withdrawal by Subject|0|||
23245285|NCT02180867|64642011|FG003|Overall Study|Withdrawal by Subject|1|||
23245286|NCT02180867|64642012|FG004|Overall Study|Withdrawal by Subject|1|||
23245287|NCT02180867|64642013|FG005|Overall Study|Withdrawal by Subject|0|||
23245288|NCT02180867|64642014|FG006|Overall Study|Withdrawal by Subject|0|||
23245289|NCT02180867|64642008|FG000|Overall Study|Ineligible|1|||
23245290|NCT02180867|64642009|FG001|Overall Study|Ineligible|2|||
23245291|NCT02180867|64642010|FG002|Overall Study|Ineligible|0|||
23245292|NCT02180867|64642011|FG003|Overall Study|Ineligible|3|||
23245293|NCT02180867|64642012|FG004|Overall Study|Ineligible|5|||
23245294|NCT02180867|64642013|FG005|Overall Study|Ineligible|0|||
23467587|NCT02357368|65457063|FG000|Overall Study|Lost to Follow-up|0|||
23467588|NCT02357368|65457064|FG001|Overall Study|Lost to Follow-up|0|||
23186741|NCT00075881|64426333|FG000|Overall Study|Lack of Efficacy|18|||
23186742|NCT00075881|64426333|FG000|Overall Study|Adverse Event|7|||
23186743|NCT00075881|64426333|FG000|Overall Study|Death|1|||
23186744|NCT00075881|64426333|FG000|Overall Study|Withdrawal by Subject|2|||
23186745|NCT00075881|64426333|FG000|Overall Study|Protocol Violation|4|||
23186746|NCT00075881|64426333|FG000|Overall Study|other complicating disease|3|||
23186747|NCT00075881|64426333|FG000|Overall Study|other|4|||
23186748|NCT00075881|64426333|FG000|Overall Study|missing data|2|||
23186749|NCT00075881|64426333|FG000|Overall Study|Ineligible|1|||
23186750|NCT00075881|64426333|FG000|Overall Study|never start protocol therapy|1|||
23467589|NCT02357368|65457065|FG002|Overall Study|Lost to Follow-up|0|||
23467590|NCT02357368|65457066|FG003|Overall Study|Lost to Follow-up|1|||
23467591|NCT02357368|65457063|FG000|Overall Study|Pregnancy|3|||
23467592|NCT02357368|65457064|FG001|Overall Study|Pregnancy|2|||
23467593|NCT02357368|65457065|FG002|Overall Study|Pregnancy|0|||
23467594|NCT02357368|65457066|FG003|Overall Study|Pregnancy|0|||
23467595|NCT02357368|65457063|FG000|Overall Study|Withdrawal by Subject|3|||
23467596|NCT02357368|65457064|FG001|Overall Study|Withdrawal by Subject|1|||
23467597|NCT02357368|65457065|FG002|Overall Study|Withdrawal by Subject|1|||
23467598|NCT02357368|65457066|FG003|Overall Study|Withdrawal by Subject|2|||
23467599|NCT04041414|65457067|FG000|Overall Study|Lost to Follow-up|1|||
23186751|NCT00473694|64426339|FG000|Overall Study|Adverse Event|0|||
23186752|NCT00473694|64426340|FG001|Overall Study|Adverse Event|1|||
23186753|NCT00473694|64426341|FG002|Overall Study|Adverse Event|0|||
23186754|NCT00473694|64426342|FG003|Overall Study|Adverse Event|0|||
23186755|NCT00473694|64426339|FG000|Overall Study|Participants did not receive treatment|11|||
23186756|NCT00473694|64426340|FG001|Overall Study|Participants did not receive treatment|3|||
23186757|NCT00473694|64426341|FG002|Overall Study|Participants did not receive treatment|5|||
23186758|NCT00473694|64426342|FG003|Overall Study|Participants did not receive treatment|6|||
23186759|NCT00473694|64426339|FG000|Overall Study|Lost to Follow-up|0|||
23245295|NCT02180867|64642014|FG006|Overall Study|Ineligible|0|||
23245296|NCT02180867|64642008|FG000|Overall Study|Repeat Eligibility Studies|0|||
23245297|NCT02180867|64642009|FG001|Overall Study|Repeat Eligibility Studies|0|||
23245298|NCT02180867|64642010|FG002|Overall Study|Repeat Eligibility Studies|0|||
23245299|NCT02180867|64642011|FG003|Overall Study|Repeat Eligibility Studies|0|||
23186760|NCT00473694|64426340|FG001|Overall Study|Lost to Follow-up|0|||
23186761|NCT00473694|64426341|FG002|Overall Study|Lost to Follow-up|0|||
23186762|NCT00473694|64426342|FG003|Overall Study|Lost to Follow-up|1|||
23186763|NCT03427073|64426346|FG000|Overall Study|Disease Progression|1|||
23186764|NCT03427073|64426347|FG001|Overall Study|Disease Progression|1|||
23245300|NCT02180867|64642012|FG004|Overall Study|Repeat Eligibility Studies|1|||
23245301|NCT02180867|64642013|FG005|Overall Study|Repeat Eligibility Studies|0|||
23245302|NCT02180867|64642014|FG006|Overall Study|Repeat Eligibility Studies|0|||
23245303|NCT02180867|64642008|FG000|Overall Study|Refusal of further protocol therapy|1|||
23245304|NCT02180867|64642009|FG001|Overall Study|Refusal of further protocol therapy|0|||
23245305|NCT02180867|64642010|FG002|Overall Study|Refusal of further protocol therapy|2|||
23245306|NCT02180867|64642011|FG003|Overall Study|Refusal of further protocol therapy|6|||
23245307|NCT02180867|64642012|FG004|Overall Study|Refusal of further protocol therapy|4|||
23467600|NCT04041414|65457068|FG001|Overall Study|Lost to Follow-up|2|||
23467601|NCT01903811|65457069|FG000|Overall Study|No measurable disease|1|||
23467602|NCT01903811|65457070|FG001|Overall Study|No measurable disease|1|||
23245308|NCT02180867|64642013|FG005|Overall Study|Refusal of further protocol therapy|0|||
23245309|NCT02180867|64642014|FG006|Overall Study|Refusal of further protocol therapy|0|||
23586719|NCT03761784|65876126|FG001|Overall Study|Withdrawal by Subject|4|||
23586720|NCT03761784|65876125|FG000|Overall Study|Physician Decision|1|||
23586721|NCT03761784|65876126|FG001|Overall Study|Physician Decision|0|||
23467603|NCT01903811|65457069|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
23186765|NCT03427073|64426348|FG002|Overall Study|Disease Progression|1|||
23586722|NCT03761784|65876125|FG000|Overall Study|Other Than Specified|1|||
23351617|NCT04015518|65029670|FG001|Overall Study|Lost to Follow-up|0|||
23467604|NCT01903811|65457070|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
23186766|NCT03427073|64426349|FG003|Overall Study|Disease Progression|3|||
23186767|NCT03427073|64426350|FG004|Overall Study|Disease Progression|3|||
23186768|NCT03427073|64426351|FG005|Overall Study|Disease Progression|4|||
23186769|NCT03427073|64426352|FG006|Overall Study|Disease Progression|2|||
23186770|NCT03427073|64426353|FG007|Overall Study|Disease Progression|3|||
23186771|NCT03427073|64426346|FG000|Overall Study|Physician Decision|0|||
23186772|NCT03427073|64426347|FG001|Overall Study|Physician Decision|0|||
23186773|NCT03427073|64426348|FG002|Overall Study|Physician Decision|0|||
23186774|NCT03427073|64426349|FG003|Overall Study|Physician Decision|0|||
23467605|NCT01903811|65457069|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
23467606|NCT01903811|65457070|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
23186775|NCT03427073|64426350|FG004|Overall Study|Physician Decision|0|||
23186776|NCT03427073|64426351|FG005|Overall Study|Physician Decision|0|||
23186777|NCT03427073|64426352|FG006|Overall Study|Physician Decision|1|||
23467607|NCT01903811|65457069|FG000|Overall Study|Withdrawal by Subject|0|||
23467608|NCT01903811|65457070|FG001|Overall Study|Withdrawal by Subject|1|||
23467609|NCT00834093|65457071|FG000|Overall Study|Progressive Disease|3|||
23467610|NCT00834093|65457071|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
23467611|NCT02721966|65457072|FG000|Overall Study|Protocol Violation|1|||
23467612|NCT02721966|65457073|FG001|Overall Study|Protocol Violation|0|||
23186778|NCT03427073|64426353|FG007|Overall Study|Physician Decision|1|||
23186779|NCT01073943|64426360|FG000|Overall Study|Withdrawal by Subject|8|||
23186780|NCT01073943|64426361|FG001|Overall Study|Withdrawal by Subject|2|||
23186781|NCT01073943|64426360|FG000|Overall Study|Protocol Violation|2|||
23186782|NCT01073943|64426361|FG001|Overall Study|Protocol Violation|1|||
23186783|NCT01073943|64426360|FG000|Overall Study|Adverse Event|1|||
23186784|NCT01073943|64426361|FG001|Overall Study|Adverse Event|1|||
23186785|NCT01073943|64426360|FG000|Overall Study|Lost to Follow-up|0|||
23186786|NCT01073943|64426361|FG001|Overall Study|Lost to Follow-up|2|||
23186787|NCT01073943|64426360|FG000|Overall Study|Power outage; colonoscopy not done|1|||
23186788|NCT01073943|64426361|FG001|Overall Study|Power outage; colonoscopy not done|0|||
23186789|NCT01073943|64426360|FG000|Overall Study|Subject forgot|0|||
23186790|NCT01073943|64426361|FG001|Overall Study|Subject forgot|1|||
23186791|NCT01073943|64426360|FG000|Overall Study|Unable to return for follow-up|0|||
23186792|NCT01073943|64426361|FG001|Overall Study|Unable to return for follow-up|1|||
23467613|NCT02721966|65457074|FG002|Overall Study|Protocol Violation|0|||
23467614|NCT02721966|65457075|FG003|Overall Study|Protocol Violation|0|||
23467615|NCT02721966|65457076|FG004|Overall Study|Protocol Violation|0|||
23186793|NCT01073943|64426360|FG000|Overall Study|Could not tolerate prep|1|||
23467616|NCT02721966|65457072|FG000|Overall Study|Withdrawal by Subject|9|||
23467617|NCT02721966|65457073|FG001|Overall Study|Withdrawal by Subject|2|||
23467618|NCT02721966|65457074|FG002|Overall Study|Withdrawal by Subject|3|||
23467619|NCT02721966|65457075|FG003|Overall Study|Withdrawal by Subject|7|||
23467620|NCT02721966|65457076|FG004|Overall Study|Withdrawal by Subject|0|||
23467621|NCT02721966|65457072|FG000|Overall Study|Adverse Event|4|||
23186794|NCT01073943|64426361|FG001|Overall Study|Could not tolerate prep|0|||
23186795|NCT03263806|64426364|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
23186796|NCT03263806|64426365|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
23186797|NCT03263806|64426364|FG000|Overall Study|Withdrawal by Subject|0|||
23186798|NCT03263806|64426365|FG001|Overall Study|Withdrawal by Subject|1|||
23186799|NCT03263806|64426364|FG000|Overall Study|Study Termination|5|||
23586723|NCT03761784|65876126|FG001|Overall Study|Other Than Specified|0|||
23586724|NCT02163915|65876127|FG000|Overall Study|Withdrawal by Subject|2|||
23586725|NCT02163915|65876128|FG001|Overall Study|Withdrawal by Subject|0|||
23586726|NCT02163915|65876129|FG002|Overall Study|Withdrawal by Subject|2|||
23586727|NCT02163915|65876130|FG003|Overall Study|Withdrawal by Subject|2|||
23586728|NCT02163915|65876131|FG004|Overall Study|Withdrawal by Subject|2|||
23467622|NCT02721966|65457073|FG001|Overall Study|Adverse Event|4|||
23467623|NCT02721966|65457074|FG002|Overall Study|Adverse Event|3|||
23467624|NCT02721966|65457075|FG003|Overall Study|Adverse Event|0|||
23467625|NCT02721966|65457076|FG004|Overall Study|Adverse Event|0|||
23186800|NCT03263806|64426365|FG001|Overall Study|Study Termination|6|||
23586729|NCT02163915|65876127|FG000|Overall Study|Study termination|1|||
23586730|NCT02163915|65876128|FG001|Overall Study|Study termination|0|||
23586731|NCT02163915|65876129|FG002|Overall Study|Study termination|0|||
23586732|NCT02163915|65876130|FG003|Overall Study|Study termination|0|||
23467626|NCT02721966|65457072|FG000|Overall Study|Death|1|||
23586733|NCT02163915|65876131|FG004|Overall Study|Study termination|2|||
23586734|NCT02163915|65876127|FG000|Overall Study|Physician Decision|0|||
23586735|NCT02163915|65876128|FG001|Overall Study|Physician Decision|0|||
23245328|NCT02252172|64642017|FG000|Overall Study|Lost to Follow-up|3|||
23467627|NCT02721966|65457073|FG001|Overall Study|Death|0|||
23467628|NCT02721966|65457074|FG002|Overall Study|Death|0|||
23467629|NCT02721966|65457075|FG003|Overall Study|Death|0|||
23186801|NCT05502289|64426366|FG000|Period 1|Out Of Window|1|||
23186802|NCT05502289|64426367|FG001|Period 1|Out Of Window|0|||
23186803|NCT01697345|64426370|FG000|Overall Study|Withdrawal by Subject|1|||
23186804|NCT01137435|64426371|FG000|Overall Study|Lost to Follow-up|24|||
23186805|NCT01137435|64426371|FG000|Overall Study|Off label usage|4|||
23186806|NCT02091440|64426372|FG000|Overall Study|Death|2|||
23586736|NCT02163915|65876129|FG002|Overall Study|Physician Decision|0|||
23586737|NCT02163915|65876130|FG003|Overall Study|Physician Decision|1|||
23586738|NCT02163915|65876131|FG004|Overall Study|Physician Decision|0|||
23586739|NCT03942042|65876134|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
23586740|NCT03942042|65876135|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
23586741|NCT03942042|65876134|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
23586742|NCT03942042|65876135|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
23586743|NCT01152190|65876136|FG000|Overall Study|Adverse Event|2|||
23586744|NCT01152190|65876137|FG001|Overall Study|Adverse Event|4|||
23586745|NCT01152190|65876136|FG000|Overall Study|Death|1|||
23586746|NCT01152190|65876137|FG001|Overall Study|Death|0|||
23586747|NCT01152190|65876136|FG000|Overall Study|Protocol Violation|1|||
23586748|NCT01152190|65876137|FG001|Overall Study|Protocol Violation|1|||
23586749|NCT01152190|65876136|FG000|Overall Study|Withdrawal by Subject|1|||
23586750|NCT01152190|65876137|FG001|Overall Study|Withdrawal by Subject|3|||
23586751|NCT03635112|65876138|FG000|Overall Study|Adverse Event|5|||
23586752|NCT03635112|65876139|FG001|Overall Study|Adverse Event|9|||
23586753|NCT03635112|65876140|FG002|Overall Study|Adverse Event|14|||
23586754|NCT03635112|65876138|FG000|Overall Study|Lost to Follow-up|1|||
23586755|NCT03635112|65876139|FG001|Overall Study|Lost to Follow-up|0|||
23586756|NCT03635112|65876140|FG002|Overall Study|Lost to Follow-up|1|||
23586757|NCT03635112|65876138|FG000|Overall Study|Physician Decision|5|||
23586758|NCT03635112|65876139|FG001|Overall Study|Physician Decision|7|||
23586759|NCT03635112|65876140|FG002|Overall Study|Physician Decision|5|||
23586760|NCT03635112|65876138|FG000|Overall Study|Protocol Violation|0|||
23351618|NCT04015518|65029671|FG002|Overall Study|Lost to Follow-up|0|||
23351619|NCT04015518|65029672|FG003|Overall Study|Lost to Follow-up|0|||
23351620|NCT04015518|65029673|FG004|Overall Study|Lost to Follow-up|1|||
23351621|NCT04015518|65029669|FG000|Overall Study|Withdrawal by Subject|0|||
23351622|NCT04015518|65029670|FG001|Overall Study|Withdrawal by Subject|1|||
23351623|NCT04015518|65029671|FG002|Overall Study|Withdrawal by Subject|0|||
23351624|NCT04015518|65029672|FG003|Overall Study|Withdrawal by Subject|1|||
23351625|NCT04015518|65029673|FG004|Overall Study|Withdrawal by Subject|1|||
23351626|NCT04015518|65029669|FG000|Overall Study|Patient did not come for consecutive visits|0|||
23351627|NCT04015518|65029670|FG001|Overall Study|Patient did not come for consecutive visits|1|||
23351628|NCT04015518|65029671|FG002|Overall Study|Patient did not come for consecutive visits|0|||
23351629|NCT04015518|65029672|FG003|Overall Study|Patient did not come for consecutive visits|0|||
23351630|NCT04015518|65029673|FG004|Overall Study|Patient did not come for consecutive visits|0|||
23351631|NCT04015518|65029669|FG000|Overall Study|not willing to travel due to Covid-19|0|||
23351632|NCT04015518|65029670|FG001|Overall Study|not willing to travel due to Covid-19|0|||
23351633|NCT04015518|65029671|FG002|Overall Study|not willing to travel due to Covid-19|1|||
23351634|NCT04015518|65029672|FG003|Overall Study|not willing to travel due to Covid-19|0|||
23351635|NCT04015518|65029673|FG004|Overall Study|not willing to travel due to Covid-19|0|||
23351636|NCT04015518|65029669|FG000|Overall Study|Patient wants to discontinue treatment|0|||
23351637|NCT04015518|65029670|FG001|Overall Study|Patient wants to discontinue treatment|0|||
23351638|NCT04015518|65029671|FG002|Overall Study|Patient wants to discontinue treatment|0|||
23351639|NCT04015518|65029672|FG003|Overall Study|Patient wants to discontinue treatment|1|||
23467630|NCT02721966|65457076|FG004|Overall Study|Death|0|||
23467631|NCT02721966|65457072|FG000|Overall Study|Lack of Efficacy|7|||
23467632|NCT02721966|65457073|FG001|Overall Study|Lack of Efficacy|4|||
23467633|NCT02721966|65457074|FG002|Overall Study|Lack of Efficacy|0|||
23467634|NCT02721966|65457075|FG003|Overall Study|Lack of Efficacy|0|||
23467635|NCT02721966|65457076|FG004|Overall Study|Lack of Efficacy|0|||
23467636|NCT02721966|65457072|FG000|Overall Study|Lost to Follow-up|0|||
23467637|NCT02721966|65457073|FG001|Overall Study|Lost to Follow-up|0|||
23586761|NCT03635112|65876139|FG001|Overall Study|Protocol Violation|0|||
23586762|NCT03635112|65876140|FG002|Overall Study|Protocol Violation|1|||
23586763|NCT03635112|65876138|FG000|Overall Study|Study Terminated by Sponsor|11|||
23186807|NCT02649634|64426373|FG000|Overall Study|Withdrawal by Subject|3|||
23186808|NCT02649634|64426374|FG001|Overall Study|Withdrawal by Subject|5|||
23186809|NCT02649634|64426373|FG000|Overall Study|Lost to Follow-up|0|||
23186810|NCT02649634|64426374|FG001|Overall Study|Lost to Follow-up|1|||
23186811|NCT01526148|64426379|FG000|Overall Study|Adverse Event|6|||
23186812|NCT01526148|64426380|FG001|Overall Study|Adverse Event|5|||
23186813|NCT01526148|64426379|FG000|Overall Study|Lost to Follow-up|3|||
23186814|NCT01526148|64426380|FG001|Overall Study|Lost to Follow-up|6|||
23186815|NCT01526148|64426379|FG000|Overall Study|Withdrawal by Subject|2|||
23186816|NCT01526148|64426380|FG001|Overall Study|Withdrawal by Subject|0|||
23586764|NCT03635112|65876139|FG001|Overall Study|Study Terminated by Sponsor|17|||
23586765|NCT03635112|65876140|FG002|Overall Study|Study Terminated by Sponsor|21|||
23586766|NCT03635112|65876138|FG000|Overall Study|Withdrawal by Subject|4|||
23586767|NCT03635112|65876139|FG001|Overall Study|Withdrawal by Subject|9|||
23186817|NCT01526148|64426379|FG000|Overall Study|Unstable Medical Condition|1|||
23186818|NCT01526148|64426380|FG001|Overall Study|Unstable Medical Condition|0|||
23186819|NCT01526148|64426379|FG000|Overall Study|Unable to discontinue concomitant med|1|||
23467638|NCT02721966|65457074|FG002|Overall Study|Lost to Follow-up|3|||
23351640|NCT04015518|65029673|FG004|Overall Study|Patient wants to discontinue treatment|0|||
23351641|NCT04015518|65029669|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
23351642|NCT04015518|65029670|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
23467639|NCT02721966|65457075|FG003|Overall Study|Lost to Follow-up|0|||
23467640|NCT02721966|65457076|FG004|Overall Study|Lost to Follow-up|0|||
23467641|NCT02721966|65457072|FG000|Overall Study|Physician Decision|1|||
23467642|NCT02721966|65457073|FG001|Overall Study|Physician Decision|1|||
23467643|NCT02721966|65457074|FG002|Overall Study|Physician Decision|0|||
23467644|NCT02721966|65457075|FG003|Overall Study|Physician Decision|0|||
23467645|NCT02721966|65457076|FG004|Overall Study|Physician Decision|0|||
23467646|NCT02721966|65457072|FG000|Overall Study|Pregnancy|1|||
23467647|NCT02721966|65457073|FG001|Overall Study|Pregnancy|0|||
23467648|NCT02721966|65457074|FG002|Overall Study|Pregnancy|0|||
23467649|NCT02721966|65457075|FG003|Overall Study|Pregnancy|0|||
23467650|NCT02721966|65457076|FG004|Overall Study|Pregnancy|0|||
23467651|NCT02721966|65457072|FG000|Overall Study|Did not continue to period 2|5|||
23467652|NCT02721966|65457073|FG001|Overall Study|Did not continue to period 2|12|||
23467653|NCT02721966|65457074|FG002|Overall Study|Did not continue to period 2|0|||
23467654|NCT02721966|65457075|FG003|Overall Study|Did not continue to period 2|0|||
23467655|NCT02721966|65457076|FG004|Overall Study|Did not continue to period 2|5|||
23467656|NCT04540913|65457077|FG000|Overall Study|Withdrawal by Subject|14|||
23467657|NCT04540913|65457078|FG001|Overall Study|Withdrawal by Subject|3|||
23467658|NCT03216226|65457079|FG000|Overall Study|Adverse Event|3|||
23467659|NCT03216226|65457080|FG001|Overall Study|Adverse Event|0|||
23467660|NCT03216226|65457079|FG000|Overall Study|Protocol Violation|1|||
23467661|NCT03216226|65457080|FG001|Overall Study|Protocol Violation|3|||
23467662|NCT03216226|65457079|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
23467663|NCT03216226|65457080|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
23467664|NCT03216226|65457079|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
23467665|NCT03216226|65457080|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
23467666|NCT03216226|65457079|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
23467667|NCT03216226|65457080|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
23467668|NCT00998296|65457081|FG000|Overall Study|Progressive disease|0|||
23467669|NCT00998296|65457082|FG001|Overall Study|Progressive disease|1|||
23467670|NCT00998296|65457083|FG002|Overall Study|Progressive disease|0|||
23467671|NCT00998296|65457084|FG003|Overall Study|Progressive disease|0|||
23467672|NCT00998296|65457085|FG004|Overall Study|Progressive disease|0|||
23467673|NCT00998296|65457086|FG005|Overall Study|Progressive disease|0|||
23467674|NCT00998296|65457087|FG006|Overall Study|Progressive disease|1|||
23467675|NCT00998296|65457088|FG007|Overall Study|Progressive disease|0|||
23467676|NCT00998296|65457089|FG008|Overall Study|Progressive disease|0|||
23467677|NCT00998296|65457090|FG009|Overall Study|Progressive disease|14|||
23467678|NCT00998296|65457091|FG010|Overall Study|Progressive disease|5|||
23467679|NCT00998296|65457081|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467680|NCT00998296|65457082|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467681|NCT00998296|65457083|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467682|NCT00998296|65457084|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467683|NCT00998296|65457085|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
23467684|NCT00998296|65457086|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467685|NCT00998296|65457087|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467686|NCT00998296|65457088|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
23467687|NCT00998296|65457089|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
23467688|NCT00998296|65457090|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467689|NCT00998296|65457091|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
23467690|NCT00998296|65457081|FG000|Overall Study|Other adverse event|0|||
23467691|NCT00998296|65457082|FG001|Overall Study|Other adverse event|0|||
23467692|NCT00998296|65457083|FG002|Overall Study|Other adverse event|0|||
23467693|NCT00998296|65457084|FG003|Overall Study|Other adverse event|0|||
23467694|NCT00998296|65457085|FG004|Overall Study|Other adverse event|1|||
23467695|NCT00998296|65457086|FG005|Overall Study|Other adverse event|0|||
23467696|NCT00998296|65457087|FG006|Overall Study|Other adverse event|0|||
23467697|NCT00998296|65457088|FG007|Overall Study|Other adverse event|0|||
23467698|NCT00998296|65457089|FG008|Overall Study|Other adverse event|0|||
23467699|NCT00998296|65457090|FG009|Overall Study|Other adverse event|1|||
23467700|NCT00998296|65457091|FG010|Overall Study|Other adverse event|2|||
23467701|NCT00998296|65457081|FG000|Overall Study|Refused to continue taking trial med.|0|||
23467702|NCT00998296|65457082|FG001|Overall Study|Refused to continue taking trial med.|0|||
23467703|NCT00998296|65457083|FG002|Overall Study|Refused to continue taking trial med.|0|||
23467704|NCT00998296|65457084|FG003|Overall Study|Refused to continue taking trial med.|0|||
23467705|NCT00998296|65457085|FG004|Overall Study|Refused to continue taking trial med.|0|||
23467706|NCT00998296|65457086|FG005|Overall Study|Refused to continue taking trial med.|0|||
23467707|NCT00998296|65457087|FG006|Overall Study|Refused to continue taking trial med.|0|||
23467708|NCT00998296|65457088|FG007|Overall Study|Refused to continue taking trial med.|0|||
23467709|NCT00998296|65457089|FG008|Overall Study|Refused to continue taking trial med.|0|||
23467710|NCT00998296|65457090|FG009|Overall Study|Refused to continue taking trial med.|2|||
23467711|NCT00998296|65457091|FG010|Overall Study|Refused to continue taking trial med.|0|||
23467712|NCT00998296|65457081|FG000|Overall Study|Reason other than those specified above|0|||
23467713|NCT00998296|65457082|FG001|Overall Study|Reason other than those specified above|0|||
23467714|NCT00998296|65457083|FG002|Overall Study|Reason other than those specified above|0|||
23467715|NCT00998296|65457084|FG003|Overall Study|Reason other than those specified above|0|||
23467716|NCT00998296|65457085|FG004|Overall Study|Reason other than those specified above|0|||
23467717|NCT00998296|65457086|FG005|Overall Study|Reason other than those specified above|0|||
23467718|NCT00998296|65457087|FG006|Overall Study|Reason other than those specified above|0|||
23467719|NCT00998296|65457088|FG007|Overall Study|Reason other than those specified above|0|||
23467720|NCT00998296|65457089|FG008|Overall Study|Reason other than those specified above|0|||
23467721|NCT00998296|65457090|FG009|Overall Study|Reason other than those specified above|1|||
23467722|NCT00998296|65457091|FG010|Overall Study|Reason other than those specified above|0|||
23467723|NCT02637037|65457098|FG000|Overall Study|Positive drug screen at admission|1|||
23467724|NCT02637037|65457099|FG001|Overall Study|Positive drug screen at admission|0|||
23467725|NCT02637037|65457098|FG000|Overall Study|Withdrawal by Subject|2|||
23467726|NCT02637037|65457099|FG001|Overall Study|Withdrawal by Subject|1|||
23467727|NCT02637037|65457098|FG000|Overall Study|Adverse Event|1|||
23467728|NCT02637037|65457099|FG001|Overall Study|Adverse Event|0|||
23467729|NCT02633306|65457104|FG000|Overall Study|Withdrawal by Subject|3|||
23467730|NCT00737672|65457107|FG000|Overall Study|Graft Abandonment|48|||
23467731|NCT00737672|65457108|FG001|Overall Study|Graft Abandonment|56|||
23467732|NCT00737672|65457107|FG000|Overall Study|Death|23|||
23467733|NCT00737672|65457108|FG001|Overall Study|Death|22|||
23467734|NCT00737672|65457107|FG000|Overall Study|Withdrawal by Subject|1|||
23351643|NCT04015518|65029671|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
23351644|NCT04015518|65029672|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
23351645|NCT04015518|65029673|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
23351646|NCT04015518|65029669|FG000|Overall Study|Pregnancy|0|||
23351647|NCT04015518|65029670|FG001|Overall Study|Pregnancy|0|||
23351648|NCT04015518|65029671|FG002|Overall Study|Pregnancy|0|||
23351649|NCT04015518|65029672|FG003|Overall Study|Pregnancy|0|||
23351650|NCT04015518|65029673|FG004|Overall Study|Pregnancy|1|||
23351651|NCT04015518|65029669|FG000|Overall Study|Personal reasons|1|||
23351652|NCT04015518|65029670|FG001|Overall Study|Personal reasons|0|||
23351653|NCT04015518|65029671|FG002|Overall Study|Personal reasons|0|||
23351654|NCT04015518|65029672|FG003|Overall Study|Personal reasons|0|||
23351655|NCT04015518|65029673|FG004|Overall Study|Personal reasons|1|||
23351656|NCT04015518|65029669|FG000|Overall Study|Withdrew consent|1|||
23351657|NCT04015518|65029670|FG001|Overall Study|Withdrew consent|0|||
23351658|NCT04015518|65029671|FG002|Overall Study|Withdrew consent|0|||
23351659|NCT04015518|65029672|FG003|Overall Study|Withdrew consent|0|||
23351660|NCT04015518|65029673|FG004|Overall Study|Withdrew consent|0|||
23351661|NCT04015518|65029669|FG000|Overall Study|Prostate carcinoma|1|||
23351662|NCT04015518|65029670|FG001|Overall Study|Prostate carcinoma|0|||
23351663|NCT04015518|65029671|FG002|Overall Study|Prostate carcinoma|0|||
23351664|NCT04015518|65029672|FG003|Overall Study|Prostate carcinoma|0|||
23351665|NCT04015518|65029673|FG004|Overall Study|Prostate carcinoma|0|||
23351666|NCT04015518|65029669|FG000|Overall Study|Could not keep appointments due to work|1|||
23351667|NCT04015518|65029670|FG001|Overall Study|Could not keep appointments due to work|0|||
23351668|NCT04015518|65029671|FG002|Overall Study|Could not keep appointments due to work|0|||
23351669|NCT04015518|65029672|FG003|Overall Study|Could not keep appointments due to work|0|||
23351670|NCT04015518|65029673|FG004|Overall Study|Could not keep appointments due to work|0|||
23351671|NCT01941537|65029680|FG000|Overall Study|Lack of Efficacy|1|||
23351672|NCT01941537|65029681|FG001|Overall Study|Lack of Efficacy|2|||
23351673|NCT01941537|65029680|FG000|Overall Study|Lost to Follow-up|1|||
23351674|NCT01941537|65029681|FG001|Overall Study|Lost to Follow-up|0|||
23351675|NCT01941537|65029680|FG000|Overall Study|Pregnancy|1|||
23351676|NCT01941537|65029681|FG001|Overall Study|Pregnancy|0|||
23467735|NCT00737672|65457108|FG001|Overall Study|Withdrawal by Subject|2|||
23467736|NCT00737672|65457107|FG000|Overall Study|Lost to Follow-up|1|||
23351677|NCT01941537|65029680|FG000|Overall Study|Adverse Event|1|||
23351678|NCT01941537|65029681|FG001|Overall Study|Adverse Event|0|||
23467737|NCT00737672|65457108|FG001|Overall Study|Lost to Follow-up|0|||
23467738|NCT00737672|65457107|FG000|Overall Study|Miscellaneous|7|||
23351679|NCT01941537|65029680|FG000|Overall Study|Withdrawal by Subject|0|||
23351680|NCT01941537|65029681|FG001|Overall Study|Withdrawal by Subject|1|||
23351681|NCT02457832|65029686|FG000|Training|Lost to Follow-up|10|||
23351682|NCT02457832|65029687|FG001|Training|Lost to Follow-up|6|||
23351683|NCT02457832|65029688|FG002|Training|Lost to Follow-up|3|||
23351684|NCT02457832|65029686|FG000|One Month Washout|Lost to Follow-up|0|||
23351685|NCT02457832|65029687|FG001|One Month Washout|Lost to Follow-up|1|||
23351686|NCT02457832|65029688|FG002|One Month Washout|Lost to Follow-up|1|||
23351687|NCT02073656|65029689|FG000|Primary Study|Lost to Follow-up|6|||
23351688|NCT02073656|65029689|FG000|Primary Study|Death|1|||
23351689|NCT02073656|65029689|FG000|Primary Study|Withdrew Consent|1|||
23351690|NCT00379808|65029690|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
23351691|NCT00379808|65029691|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
23351692|NCT00772005|65029692|FG000|Overall Study|Adverse Event|9|||
23351693|NCT00772005|65029693|FG001|Overall Study|Adverse Event|14|||
23351694|NCT00772005|65029694|FG002|Overall Study|Adverse Event|10|||
23351695|NCT00772005|65029695|FG003|Overall Study|Adverse Event|13|||
23351696|NCT00772005|65029692|FG000|Overall Study|Lack of Efficacy|0|||
23351697|NCT00772005|65029693|FG001|Overall Study|Lack of Efficacy|1|||
23351698|NCT00772005|65029694|FG002|Overall Study|Lack of Efficacy|0|||
23245329|NCT02252172|64642018|FG001|Overall Study|Lost to Follow-up|1|||
23245330|NCT02252172|64642017|FG000|Overall Study|Ongoing|276|||
23245331|NCT02252172|64642018|FG001|Overall Study|Ongoing|298|||
23586768|NCT03635112|65876140|FG002|Overall Study|Withdrawal by Subject|7|||
23586769|NCT03635112|65876138|FG000|Overall Study|Miscellaneous|0|||
23586770|NCT03635112|65876139|FG001|Overall Study|Miscellaneous|0|||
23586771|NCT03635112|65876140|FG002|Overall Study|Miscellaneous|1|||
23586772|NCT00299702|65876141|FG000|Overall Study|Death|1|||
23245337|NCT01286272|64642020|FG000|Overall Study|Ineligible after beginning treatment|1|||
23245338|NCT01286272|64642021|FG001|Overall Study|Ineligible after beginning treatment|3|||
23245339|NCT00026312|64642025|FG000|Overall Study|Adverse Event|0|||
23245340|NCT00026312|64642026|FG001|Overall Study|Adverse Event|32|||
23245341|NCT00026312|64642025|FG000|Overall Study|Death|1|||
23245342|NCT00026312|64642026|FG001|Overall Study|Death|7|||
23245343|NCT00026312|64642025|FG000|Overall Study|Lack of Efficacy|19|||
23351699|NCT00772005|65029695|FG003|Overall Study|Lack of Efficacy|0|||
23351700|NCT00772005|65029692|FG000|Overall Study|Withdrawal by Subject|3|||
23351701|NCT00772005|65029693|FG001|Overall Study|Withdrawal by Subject|7|||
23351702|NCT00772005|65029694|FG002|Overall Study|Withdrawal by Subject|10|||
23351703|NCT00772005|65029695|FG003|Overall Study|Withdrawal by Subject|2|||
23351704|NCT00772005|65029692|FG000|Overall Study|Protocol Violation|2|||
23351705|NCT00772005|65029693|FG001|Overall Study|Protocol Violation|4|||
23351706|NCT00772005|65029694|FG002|Overall Study|Protocol Violation|1|||
23351707|NCT00772005|65029695|FG003|Overall Study|Protocol Violation|6|||
23351708|NCT00772005|65029692|FG000|Overall Study|Lost to Follow-up|7|||
23351709|NCT00772005|65029693|FG001|Overall Study|Lost to Follow-up|3|||
23351710|NCT00772005|65029694|FG002|Overall Study|Lost to Follow-up|6|||
23351711|NCT00772005|65029695|FG003|Overall Study|Lost to Follow-up|3|||
23351712|NCT00772005|65029692|FG000|Overall Study|Non-compliance with study procedures|1|||
23351713|NCT00772005|65029693|FG001|Overall Study|Non-compliance with study procedures|1|||
23351714|NCT00772005|65029694|FG002|Overall Study|Non-compliance with study procedures|0|||
23351715|NCT00772005|65029695|FG003|Overall Study|Non-compliance with study procedures|1|||
23351716|NCT00772005|65029692|FG000|Overall Study|Non-compliance with drug administration|3|||
23351717|NCT00772005|65029693|FG001|Overall Study|Non-compliance with drug administration|0|||
23351718|NCT00772005|65029694|FG002|Overall Study|Non-compliance with drug administration|1|||
23351719|NCT00772005|65029695|FG003|Overall Study|Non-compliance with drug administration|1|||
23351720|NCT00099632|65029698|FG000|Overall Study|Lost to Follow-up|1|||
23351721|NCT00099632|65029699|FG001|Overall Study|Lost to Follow-up|0|||
23351722|NCT00099632|65029700|FG002|Overall Study|Lost to Follow-up|3|||
23351723|NCT00099632|65029701|FG003|Overall Study|Lost to Follow-up|1|||
23351724|NCT00099632|65029702|FG004|Overall Study|Lost to Follow-up|1|||
23351725|NCT00099632|65029703|FG005|Overall Study|Lost to Follow-up|0|||
23351726|NCT00099632|65029698|FG000|Overall Study|Withdrawal by Subject|0|||
23351727|NCT00099632|65029699|FG001|Overall Study|Withdrawal by Subject|1|||
23351728|NCT00099632|65029700|FG002|Overall Study|Withdrawal by Subject|0|||
23351729|NCT00099632|65029701|FG003|Overall Study|Withdrawal by Subject|0|||
23351730|NCT00099632|65029702|FG004|Overall Study|Withdrawal by Subject|0|||
23351731|NCT00099632|65029703|FG005|Overall Study|Withdrawal by Subject|1|||
23351732|NCT00099632|65029698|FG000|Overall Study|Protocol Violation|0|||
23351733|NCT00099632|65029699|FG001|Overall Study|Protocol Violation|0|||
23351734|NCT00099632|65029700|FG002|Overall Study|Protocol Violation|0|||
23351735|NCT00099632|65029701|FG003|Overall Study|Protocol Violation|0|||
23351736|NCT00099632|65029702|FG004|Overall Study|Protocol Violation|0|||
23351737|NCT00099632|65029703|FG005|Overall Study|Protocol Violation|1|||
23351738|NCT03114657|65029705|FG000|Overall Study|Adverse Event|9|||
23245344|NCT00026312|64642026|FG001|Overall Study|Lack of Efficacy|114|||
23351739|NCT03114657|65029706|FG001|Overall Study|Adverse Event|6|||
23351740|NCT03114657|65029705|FG000|Overall Study|Death|4|||
23245345|NCT00026312|64642025|FG000|Overall Study|Lost to Follow-up|0|||
23351741|NCT03114657|65029706|FG001|Overall Study|Death|0|||
23351742|NCT03114657|65029705|FG000|Overall Study|Multiple Reasons|1|||
23351743|NCT03114657|65029706|FG001|Overall Study|Multiple Reasons|2|||
23351744|NCT03114657|65029705|FG000|Overall Study|Physician Decision|2|||
23245346|NCT00026312|64642026|FG001|Overall Study|Lost to Follow-up|5|||
23586773|NCT00299702|65876142|FG001|Overall Study|Death|0|||
23586774|NCT00299702|65876141|FG000|Overall Study|Adverse Event|0|||
23586775|NCT00299702|65876142|FG001|Overall Study|Adverse Event|4|||
23586776|NCT00299702|65876141|FG000|Overall Study|Lost to Follow-up|18|||
23586777|NCT00299702|65876142|FG001|Overall Study|Lost to Follow-up|10|||
23586778|NCT00299702|65876141|FG000|Overall Study|Withdrawal by Subject|25|||
23586779|NCT00299702|65876142|FG001|Overall Study|Withdrawal by Subject|23|||
23586780|NCT00299702|65876141|FG000|Overall Study|Pregnancy|0|||
23586781|NCT00299702|65876142|FG001|Overall Study|Pregnancy|1|||
23586782|NCT00299702|65876141|FG000|Overall Study|Insufficient Response|4|||
23586783|NCT00299702|65876142|FG001|Overall Study|Insufficient Response|3|||
23586784|NCT00299702|65876141|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
23586785|NCT00299702|65876142|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
23245347|NCT00026312|64642025|FG000|Overall Study|Physician Decision|1|||
23245348|NCT00026312|64642026|FG001|Overall Study|Physician Decision|37|||
23245349|NCT00026312|64642025|FG000|Overall Study|Protocol Violation|0|||
23245350|NCT00026312|64642026|FG001|Overall Study|Protocol Violation|3|||
23245351|NCT00026312|64642025|FG000|Overall Study|Withdrawal by Subject|1|||
23245352|NCT00026312|64642026|FG001|Overall Study|Withdrawal by Subject|6|||
23245353|NCT00026312|64642025|FG000|Overall Study|Ineligible|4|||
23245354|NCT00026312|64642026|FG001|Overall Study|Ineligible|5|||
23245355|NCT00026312|64642025|FG000|Overall Study|Entry onto another COG study|0|||
23245356|NCT00026312|64642026|FG001|Overall Study|Entry onto another COG study|1|||
23245357|NCT00026312|64642025|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
23245358|NCT00026312|64642026|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
23245359|NCT04619004|64642029|FG000|Overall Study|Death|114|||
23245360|NCT04619004|64642030|FG001|Overall Study|Death|28|||
23245361|NCT04619004|64642029|FG000|Overall Study|Lost to Follow-up|1|||
23245362|NCT04619004|64642030|FG001|Overall Study|Lost to Follow-up|1|||
23245363|NCT04619004|64642029|FG000|Overall Study|Withdrawal by Subject|24|||
23245364|NCT04619004|64642030|FG001|Overall Study|Withdrawal by Subject|7|||
23245365|NCT04619004|64642029|FG000|Overall Study|Other - Not specified|0|||
23245366|NCT04619004|64642030|FG001|Overall Study|Other - Not specified|1|||
23586786|NCT02512042|65876144|FG000|Overall Study|Adverse Event|0|||
23586787|NCT02512042|65876145|FG001|Overall Study|Adverse Event|4|||
23586788|NCT02512042|65876144|FG000|Overall Study|Withdrawal by Subject|6|||
23245370|NCT05378269|64642034|FG000|Overall Study|Protocol Violation|1|||
23245371|NCT05378269|64642035|FG001|Overall Study|Protocol Violation|0|||
23245372|NCT05378269|64642036|FG002|Overall Study|Protocol Violation|2|||
23245373|NCT05378269|64642037|FG003|Overall Study|Protocol Violation|0|||
23245374|NCT05378269|64642038|FG004|Overall Study|Protocol Violation|0|||
23245375|NCT00770809|64642039|FG000|Overall Study|Adverse Event|9|||
23245376|NCT00770809|64642040|FG001|Overall Study|Adverse Event|1|||
23245377|NCT00770809|64642041|FG002|Overall Study|Adverse Event|12|||
23245378|NCT00770809|64642039|FG000|Overall Study|Death|1|||
23245379|NCT00770809|64642040|FG001|Overall Study|Death|0|||
23245380|NCT00770809|64642041|FG002|Overall Study|Death|0|||
23245381|NCT00770809|64642039|FG000|Overall Study|Withdrawal by Subject|3|||
23245382|NCT00770809|64642040|FG001|Overall Study|Withdrawal by Subject|3|||
23245383|NCT00770809|64642041|FG002|Overall Study|Withdrawal by Subject|7|||
23245384|NCT00770809|64642039|FG000|Overall Study|Progression|2|||
23245385|NCT00770809|64642040|FG001|Overall Study|Progression|2|||
23245386|NCT00770809|64642041|FG002|Overall Study|Progression|0|||
23245387|NCT00770809|64642039|FG000|Overall Study|Complicating illness|0|||
23245388|NCT00770809|64642040|FG001|Overall Study|Complicating illness|0|||
23245389|NCT00770809|64642041|FG002|Overall Study|Complicating illness|1|||
23245390|NCT00770809|64642039|FG000|Overall Study|Other Medical Reasons|2|||
23245391|NCT00770809|64642040|FG001|Overall Study|Other Medical Reasons|4|||
23245392|NCT00770809|64642041|FG002|Overall Study|Other Medical Reasons|3|||
23245393|NCT05299359|64642042|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
23245394|NCT05299359|64642043|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
23245395|NCT05299359|64642042|FG000|Main Part: Day 1 up to Day 366|Other|2|||
23245396|NCT05299359|64642043|FG001|Main Part: Day 1 up to Day 366|Other|0|||
23245397|NCT05299359|64642042|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
23467739|NCT00737672|65457108|FG001|Overall Study|Miscellaneous|1|||
23245398|NCT05299359|64642043|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
23245399|NCT05299359|64642042|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
23245400|NCT05299359|64642043|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
23245401|NCT05299359|64642042|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
23245402|NCT05299359|64642043|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
23245403|NCT05299359|64642042|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
23245404|NCT05299359|64642043|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
23245405|NCT05299359|64642042|FG000|Extension Part: Day 1 to Day 366|Other|0|||
23467740|NCT00737672|65457107|FG000|Overall Study|Physician Decision|0|||
23467741|NCT00737672|65457108|FG001|Overall Study|Physician Decision|2|||
23467742|NCT00950859|65457109|FG000|Overall Study|Adverse Event|3|||
23186820|NCT01526148|64426380|FG001|Overall Study|Unable to discontinue concomitant med|0|||
23186821|NCT01526148|64426379|FG000|Overall Study|Moved out of state|1|||
23186822|NCT01526148|64426380|FG001|Overall Study|Moved out of state|0|||
23186823|NCT01526148|64426379|FG000|Overall Study|Incarcerated|0|||
23186824|NCT01526148|64426380|FG001|Overall Study|Incarcerated|2|||
23186825|NCT01333189|64426381|FG000|Overall Study|Time constraints|1|||
23186826|NCT01333189|64426382|FG001|Overall Study|Time constraints|0|||
23351745|NCT03114657|65029706|FG001|Overall Study|Physician Decision|2|||
23351746|NCT03114657|65029705|FG000|Overall Study|Study Terminated By Sponsor|355|||
23351747|NCT03114657|65029706|FG001|Overall Study|Study Terminated By Sponsor|374|||
23351748|NCT03114657|65029705|FG000|Overall Study|Symptomatic Deterioration|0|||
23245406|NCT05299359|64642043|FG001|Extension Part: Day 1 to Day 366|Other|1|||
23245407|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245408|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245409|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245410|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23245411|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23245412|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245413|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245414|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245415|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245416|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23245417|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245418|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245419|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23245420|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
23245421|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
23245422|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
23245423|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
23245424|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
23245425|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
23245426|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245427|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245428|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245429|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245430|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245431|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
23245432|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245433|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245434|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245435|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
23245436|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245437|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245438|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245439|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
23245440|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
23245441|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
23245442|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
23245443|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
23245444|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
23245445|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
23245446|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245447|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245448|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23351749|NCT03114657|65029706|FG001|Overall Study|Symptomatic Deterioration|1|||
23351750|NCT03114657|65029705|FG000|Overall Study|Withdrawal by Subject|28|||
23351751|NCT03114657|65029706|FG001|Overall Study|Withdrawal by Subject|22|||
23351752|NCT03877224|65029715|FG000|Overall Study|Death|3|||
23351753|NCT03877224|65029716|FG001|Overall Study|Death|2|||
23351754|NCT03877224|65029715|FG000|Overall Study|Withdrawal by Subject|1|||
23351755|NCT03877224|65029716|FG001|Overall Study|Withdrawal by Subject|6|||
23351756|NCT03877224|65029715|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
23186827|NCT01333189|64426381|FG000|Overall Study|Adverse Event|1|||
23186828|NCT01333189|64426382|FG001|Overall Study|Adverse Event|0|||
23245449|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23402773|NCT01446874|65220004|FG001|Overall Study|No surgery/No qualifying surgery|0|||
23186829|NCT01333189|64426381|FG000|Overall Study|Transportation difficulties|0|||
23186830|NCT01333189|64426382|FG001|Overall Study|Transportation difficulties|1|||
23245450|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
23245451|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245452|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245453|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245454|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245455|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245456|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245457|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245458|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245459|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
23245460|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245461|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245462|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
23245463|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
23245464|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245465|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245466|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245467|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23186831|NCT01333189|64426381|FG000|Overall Study|Moved from region|0|||
23186832|NCT01333189|64426382|FG001|Overall Study|Moved from region|1|||
23186833|NCT01856673|64426383|FG000|Overall Study|Withdrawal by Subject|44|||
23186834|NCT01856673|64426384|FG001|Overall Study|Withdrawal by Subject|50|||
23186835|NCT01856673|64426385|FG002|Overall Study|Withdrawal by Subject|33|||
23186836|NCT01856673|64426383|FG000|Overall Study|Lost to Follow-up|31|||
23186837|NCT01856673|64426384|FG001|Overall Study|Lost to Follow-up|34|||
23186838|NCT01856673|64426385|FG002|Overall Study|Lost to Follow-up|0|||
23186839|NCT01856673|64426383|FG000|Overall Study|Unknown reasons|9|||
23245468|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23467743|NCT00950859|65457110|FG001|Overall Study|Adverse Event|3|||
23186840|NCT01856673|64426384|FG001|Overall Study|Unknown reasons|0|||
23186841|NCT01856673|64426385|FG002|Overall Study|Unknown reasons|0|||
23245469|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245470|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245471|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245472|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245473|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245474|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
23245475|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245476|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245477|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
23245478|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245479|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245480|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
23245481|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
23245482|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
23245483|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23245484|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
23245485|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23245486|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23245487|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23245488|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23245489|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23245490|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23245491|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23245492|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23186842|NCT01856673|64426383|FG000|Overall Study|Psychologist decision|1|||
23186843|NCT01856673|64426384|FG001|Overall Study|Psychologist decision|0|||
23186844|NCT01856673|64426385|FG002|Overall Study|Psychologist decision|0|||
23186845|NCT01856673|64426383|FG000|Overall Study|Paperwork errors|8|||
23186846|NCT01856673|64426384|FG001|Overall Study|Paperwork errors|0|||
23186847|NCT01856673|64426385|FG002|Overall Study|Paperwork errors|0|||
23186848|NCT01856673|64426383|FG000|Overall Study|Death|1|||
23186849|NCT01856673|64426384|FG001|Overall Study|Death|1|||
23186850|NCT01856673|64426385|FG002|Overall Study|Death|0|||
23186851|NCT01856673|64426383|FG000|Overall Study|Protocol Violation|1|||
23186852|NCT01856673|64426384|FG001|Overall Study|Protocol Violation|0|||
23186853|NCT01856673|64426385|FG002|Overall Study|Protocol Violation|1|||
23186854|NCT00813995|64426386|FG000|Overall Study|Clinical adverse event|9|||
23186855|NCT00813995|64426387|FG001|Overall Study|Clinical adverse event|3|||
23186856|NCT00813995|64426386|FG000|Overall Study|Laboratory adverse event|0|||
23186857|NCT00813995|64426387|FG001|Overall Study|Laboratory adverse event|2|||
23186858|NCT00813995|64426386|FG000|Overall Study|Lack of Efficacy|1|||
23186859|NCT00813995|64426387|FG001|Overall Study|Lack of Efficacy|0|||
23186860|NCT00813995|64426386|FG000|Overall Study|Lost to Follow-up|4|||
23186861|NCT00813995|64426387|FG001|Overall Study|Lost to Follow-up|2|||
23186862|NCT00813995|64426386|FG000|Overall Study|Other reason|2|||
23186863|NCT00813995|64426387|FG001|Overall Study|Other reason|2|||
23245493|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23245494|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23245495|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
23245496|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
23245497|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
23245498|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
23245499|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
23245500|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
23245501|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
23245502|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23245503|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23245504|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
23467744|NCT00950859|65457109|FG000|Overall Study|Insufficient Viral Load Response|12|||
23467745|NCT00950859|65457110|FG001|Overall Study|Insufficient Viral Load Response|3|||
23467746|NCT00950859|65457109|FG000|Overall Study|Protocol Violation|1|||
23186864|NCT00813995|64426386|FG000|Overall Study|Protocol Violation|3|||
23186865|NCT00813995|64426387|FG001|Overall Study|Protocol Violation|2|||
23186866|NCT00813995|64426386|FG000|Overall Study|Subject moved|4|||
23186867|NCT00813995|64426387|FG001|Overall Study|Subject moved|0|||
23245505|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23245506|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23245507|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23245508|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23245509|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23245510|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23245511|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23245512|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23245513|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23245514|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23245515|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23245516|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23186868|NCT00813995|64426386|FG000|Overall Study|Withdrawal by Subject|0|||
23186869|NCT00813995|64426387|FG001|Overall Study|Withdrawal by Subject|5|||
23245517|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
23245518|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
23245519|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
23245520|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
23245521|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245522|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245523|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245524|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245525|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
23245526|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245527|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245528|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245529|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245530|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
23245531|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245532|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245533|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245534|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245535|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245536|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245537|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245538|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245539|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
23245540|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
23245541|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23245542|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23245543|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23245544|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23245545|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
23245546|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23245547|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23245548|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23245549|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23245550|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
23245551|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23245552|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23245553|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
23245554|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
23186870|NCT04112914|64426388|FG000|Overall Study|Lost to Follow-up|13|||
23186871|NCT04112914|64426389|FG001|Overall Study|Lost to Follow-up|9|||
23186872|NCT04112914|64426388|FG000|Overall Study|Withdrawal by Subject|1|||
23186873|NCT04112914|64426389|FG001|Overall Study|Withdrawal by Subject|0|||
23186877|NCT03022461|64426393|FG000|Overall Study|Death|3|||
23186878|NCT02732951|64426394|FG000|Overall Study|Other than listed|1|||
23186879|NCT02732951|64426395|FG001|Overall Study|Other than listed|0|||
23186880|NCT02732951|64426394|FG000|Overall Study|Lost to Follow-up|0|||
23186881|NCT02732951|64426395|FG001|Overall Study|Lost to Follow-up|1|||
23186882|NCT02732951|64426394|FG000|Overall Study|Adverse Event|4|||
23186883|NCT02732951|64426395|FG001|Overall Study|Adverse Event|4|||
23186884|NCT02732951|64426394|FG000|Overall Study|Protocol Violation|0|||
23186885|NCT02732951|64426395|FG001|Overall Study|Protocol Violation|1|||
23186886|NCT01682044|64426396|FG000|Overall Study|Death|1|||
23351757|NCT03877224|65029716|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
23245555|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
23245556|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
23245557|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
23245558|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
23245559|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245560|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245561|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245562|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245563|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245564|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23351758|NCT01554176|65029717|FG000|Treatment Phase|Protocol Violation|1|||
23467747|NCT00950859|65457110|FG001|Overall Study|Protocol Violation|1|||
23467748|NCT00950859|65457109|FG000|Overall Study|Lost to Follow-up|0|||
23467749|NCT00950859|65457110|FG001|Overall Study|Lost to Follow-up|3|||
23467750|NCT02105961|65457121|FG000|Overall Study|Adverse Event|18|||
23467751|NCT02105961|65457122|FG001|Overall Study|Adverse Event|7|||
23467752|NCT02105961|65457123|FG002|Overall Study|Adverse Event|13|||
23467753|NCT02105961|65457121|FG000|Overall Study|Lack of Efficacy|3|||
23467754|NCT02105961|65457122|FG001|Overall Study|Lack of Efficacy|0|||
23467755|NCT02105961|65457123|FG002|Overall Study|Lack of Efficacy|3|||
23245565|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245566|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245567|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245568|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245569|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
23245570|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245571|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245572|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245573|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245574|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245575|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245576|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245577|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
23245578|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
23245579|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
23245580|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23245581|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23245582|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
23245583|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
23351759|NCT01554176|65029718|FG001|Treatment Phase|Protocol Violation|2|||
23351760|NCT01554176|65029719|FG002|Treatment Phase|Protocol Violation|0|||
23467756|NCT02105961|65457121|FG000|Overall Study|Lost to Follow-up|2|||
23467757|NCT02105961|65457122|FG001|Overall Study|Lost to Follow-up|0|||
23467758|NCT02105961|65457123|FG002|Overall Study|Lost to Follow-up|1|||
23467759|NCT02105961|65457121|FG000|Overall Study|Physician Decision|3|||
23467760|NCT02105961|65457122|FG001|Overall Study|Physician Decision|3|||
23467761|NCT02105961|65457123|FG002|Overall Study|Physician Decision|2|||
23467762|NCT02105961|65457121|FG000|Overall Study|Withdrawal by Subject|15|||
23467763|NCT02105961|65457122|FG001|Overall Study|Withdrawal by Subject|7|||
23467764|NCT02105961|65457123|FG002|Overall Study|Withdrawal by Subject|11|||
23467765|NCT04646044|65457125|FG000|Overall Study|Lost to Follow-up|0|||
23467766|NCT04646044|65457126|FG001|Overall Study|Lost to Follow-up|0|||
23467767|NCT04646044|65457127|FG002|Overall Study|Lost to Follow-up|1|||
23467768|NCT04646044|65457128|FG003|Overall Study|Lost to Follow-up|0|||
23467769|NCT04646044|65457125|FG000|Overall Study|Withdrawal by Subject|0|||
23467770|NCT04646044|65457126|FG001|Overall Study|Withdrawal by Subject|1|||
23467771|NCT04646044|65457127|FG002|Overall Study|Withdrawal by Subject|0|||
23467772|NCT04646044|65457128|FG003|Overall Study|Withdrawal by Subject|0|||
23467773|NCT03038880|65457132|FG000|Overall Study|Death|1|||
23467774|NCT03038880|65457133|FG001|Overall Study|Death|2|||
23467775|NCT03038880|65457134|FG002|Overall Study|Death|0|||
23467776|NCT03038880|65457132|FG000|Overall Study|Physician Decision|2|||
23467777|NCT03038880|65457133|FG001|Overall Study|Physician Decision|1|||
23467778|NCT03038880|65457134|FG002|Overall Study|Physician Decision|0|||
23467779|NCT04555616|65457135|FG000|Overall Study|Death|1|||
23467780|NCT04555616|65457136|FG001|Overall Study|Death|0|||
23467781|NCT04555616|65457137|FG002|Overall Study|Death|1|||
23467782|NCT04555616|65457135|FG000|Overall Study|Withdrawal by Subject|2|||
23467783|NCT04555616|65457136|FG001|Overall Study|Withdrawal by Subject|1|||
23467784|NCT04555616|65457137|FG002|Overall Study|Withdrawal by Subject|0|||
23467785|NCT03345784|65457138|FG000|Overall Study|Withdrawal by Subject|2|||
23467786|NCT03345784|65457139|FG001|Overall Study|Withdrawal by Subject|1|||
23351761|NCT01554176|65029720|FG003|Treatment Phase|Protocol Violation|0|||
23351762|NCT01554176|65029721|FG004|Treatment Phase|Protocol Violation|0|||
23351763|NCT01554176|65029717|FG000|Treatment Phase|Physician Decision|1|||
23351764|NCT01554176|65029718|FG001|Treatment Phase|Physician Decision|1|||
23351765|NCT01554176|65029719|FG002|Treatment Phase|Physician Decision|0|||
23351766|NCT01554176|65029720|FG003|Treatment Phase|Physician Decision|0|||
23351767|NCT01554176|65029721|FG004|Treatment Phase|Physician Decision|0|||
23351768|NCT01554176|65029717|FG000|Treatment Phase|Lack of Efficacy|0|||
23351769|NCT01554176|65029718|FG001|Treatment Phase|Lack of Efficacy|1|||
23351770|NCT01554176|65029719|FG002|Treatment Phase|Lack of Efficacy|0|||
23186887|NCT01682044|64426396|FG000|Overall Study|Progression|3|||
23186888|NCT02900092|64426398|FG000|Overall Study|Adverse Event|1|||
23186889|NCT02088034|64426399|FG000|Overall Study|Lost to Follow-up|1|||
23186890|NCT02088034|64426400|FG001|Overall Study|Lost to Follow-up|1|||
23351771|NCT01554176|65029720|FG003|Treatment Phase|Lack of Efficacy|0|||
23351772|NCT01554176|65029721|FG004|Treatment Phase|Lack of Efficacy|0|||
23351773|NCT01554176|65029717|FG000|Treatment Phase|Adverse event, non-fatal|1|||
23351774|NCT01554176|65029718|FG001|Treatment Phase|Adverse event, non-fatal|1|||
23351775|NCT01554176|65029719|FG002|Treatment Phase|Adverse event, non-fatal|0|||
23351776|NCT01554176|65029720|FG003|Treatment Phase|Adverse event, non-fatal|0|||
23351777|NCT01554176|65029721|FG004|Treatment Phase|Adverse event, non-fatal|0|||
23351778|NCT01554176|65029717|FG000|Treatment Phase|Non-compliance with study drug|1|||
23351779|NCT01554176|65029718|FG001|Treatment Phase|Non-compliance with study drug|0|||
23351780|NCT01554176|65029719|FG002|Treatment Phase|Non-compliance with study drug|0|||
23351781|NCT01554176|65029720|FG003|Treatment Phase|Non-compliance with study drug|0|||
23351782|NCT01554176|65029721|FG004|Treatment Phase|Non-compliance with study drug|0|||
23351783|NCT01554176|65029717|FG000|Treatment Phase|Withdrawal by Subject|1|||
23351784|NCT01554176|65029718|FG001|Treatment Phase|Withdrawal by Subject|0|||
23351785|NCT01554176|65029719|FG002|Treatment Phase|Withdrawal by Subject|0|||
23351786|NCT01554176|65029720|FG003|Treatment Phase|Withdrawal by Subject|0|||
23351787|NCT01554176|65029721|FG004|Treatment Phase|Withdrawal by Subject|0|||
23351788|NCT01554176|65029717|FG000|Treatment Phase|Lost to Follow-up|3|||
23351789|NCT01554176|65029718|FG001|Treatment Phase|Lost to Follow-up|0|||
23351790|NCT01554176|65029719|FG002|Treatment Phase|Lost to Follow-up|0|||
23351791|NCT01554176|65029720|FG003|Treatment Phase|Lost to Follow-up|0|||
23186891|NCT02088034|64426401|FG002|Overall Study|Lost to Follow-up|0|||
23186892|NCT02088034|64426399|FG000|Overall Study|Pregnancy|2|||
23186893|NCT02088034|64426400|FG001|Overall Study|Pregnancy|1|||
23186894|NCT02088034|64426401|FG002|Overall Study|Pregnancy|2|||
23186895|NCT01937312|64426402|FG000|Overall Study|Adverse Event|10|||
23186896|NCT01937312|64426403|FG001|Overall Study|Adverse Event|1|||
23186897|NCT01937312|64426402|FG000|Overall Study|Lack of Efficacy|0|||
23186898|NCT01937312|64426403|FG001|Overall Study|Lack of Efficacy|1|||
23186899|NCT01937312|64426402|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
23245584|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23245585|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
23245586|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23245587|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
23245588|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23245589|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23245590|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
23245591|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
23245592|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
23245593|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
23245594|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
23245595|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
23245596|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
23245597|NCT01915498|64642044|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
23245598|NCT01915498|64642045|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
23245599|NCT01915498|64642046|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
23245600|NCT01915498|64642047|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
23245601|NCT01915498|64642048|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
23245602|NCT01915498|64642049|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
23351792|NCT01554176|65029721|FG004|Treatment Phase|Lost to Follow-up|0|||
23351793|NCT01554176|65029717|FG000|Run-out Phase|Protocol Violation|0|||
23351794|NCT01554176|65029718|FG001|Run-out Phase|Protocol Violation|0|||
23351795|NCT01554176|65029719|FG002|Run-out Phase|Protocol Violation|0|||
23351796|NCT01554176|65029720|FG003|Run-out Phase|Protocol Violation|1|||
23351797|NCT01554176|65029721|FG004|Run-out Phase|Protocol Violation|0|||
23351798|NCT00586508|65029724|FG000|Overall Study|Progressive disease|52|||
23186900|NCT01937312|64426403|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
23186901|NCT01794780|64426404|FG000|Overall Study|Adverse Event|0|||
23186902|NCT01794780|64426405|FG001|Overall Study|Adverse Event|1|||
23351799|NCT00586508|65029725|FG001|Overall Study|Progressive disease|8|||
23351800|NCT00586508|65029724|FG000|Overall Study|Death|0|||
23351801|NCT00586508|65029725|FG001|Overall Study|Death|1|||
23351802|NCT00586508|65029724|FG000|Overall Study|Adverse Event|12|||
23351803|NCT00586508|65029725|FG001|Overall Study|Adverse Event|4|||
23351804|NCT00586508|65029724|FG000|Overall Study|Withdrawal by Subject|4|||
23351805|NCT00586508|65029725|FG001|Overall Study|Withdrawal by Subject|0|||
23402774|NCT01446874|65220005|FG002|Overall Study|No surgery/No qualifying surgery|12|||
23402775|NCT01446874|65220003|FG000|Overall Study|Non-compliance|0|||
23402776|NCT01446874|65220004|FG001|Overall Study|Non-compliance|4|||
23402777|NCT01446874|65220005|FG002|Overall Study|Non-compliance|0|||
23402778|NCT01446874|65220003|FG000|Overall Study|Antibiotics for pre-op infection|0|||
23402779|NCT01446874|65220004|FG001|Overall Study|Antibiotics for pre-op infection|0|||
23402780|NCT01446874|65220005|FG002|Overall Study|Antibiotics for pre-op infection|2|||
23402781|NCT01446874|65220003|FG000|Overall Study|Withdrawal by Subject|0|||
23402782|NCT01446874|65220004|FG001|Overall Study|Withdrawal by Subject|0|||
23402783|NCT01446874|65220005|FG002|Overall Study|Withdrawal by Subject|4|||
23402784|NCT03848416|65220006|FG000|Overall Study|Withdrawal by Subject|1|||
23402785|NCT03848416|65220007|FG001|Overall Study|Withdrawal by Subject|0|||
23402786|NCT03848416|65220008|FG002|Overall Study|Withdrawal by Subject|0|||
23402787|NCT03848416|65220006|FG000|Overall Study|Death|0|||
23402788|NCT03848416|65220007|FG001|Overall Study|Death|0|||
23402789|NCT03848416|65220008|FG002|Overall Study|Death|1|||
23402790|NCT03824392|65220009|FG000|Overall Study|Adverse Event|1|||
23402791|NCT03824392|65220010|FG001|Overall Study|Adverse Event|0|||
23402792|NCT03824392|65220011|FG002|Overall Study|Adverse Event|0|||
23402793|NCT03824392|65220012|FG003|Overall Study|Adverse Event|0|||
23402794|NCT03824392|65220009|FG000|Overall Study|Investigator Decision|0|||
23402795|NCT03824392|65220010|FG001|Overall Study|Investigator Decision|1|||
23402796|NCT03824392|65220011|FG002|Overall Study|Investigator Decision|0|||
23402797|NCT03824392|65220012|FG003|Overall Study|Investigator Decision|0|||
23402798|NCT03824392|65220009|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
23186903|NCT01794780|64426406|FG002|Overall Study|Adverse Event|2|||
23186904|NCT01794780|64426407|FG003|Overall Study|Adverse Event|0|||
23186905|NCT01794780|64426408|FG004|Overall Study|Adverse Event|0|||
23186906|NCT01794780|64426409|FG005|Overall Study|Adverse Event|0|||
23186907|NCT01794780|64426410|FG006|Overall Study|Adverse Event|0|||
23186908|NCT01794780|64426411|FG007|Overall Study|Adverse Event|0|||
23186909|NCT01794780|64426404|FG000|Overall Study|Death|0|||
23402799|NCT03824392|65220010|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
23402800|NCT03824392|65220011|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
23467787|NCT01327482|65457140|FG000|Overall Study|Adverse Event|1|||
23467788|NCT01701674|65457142|FG000|Overall Study|Unable to safely complete treatment|1|||
23402801|NCT03824392|65220012|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
23402802|NCT00560508|65220013|FG000|12 Week Double-blind Period|Adverse Event|3|||
23402803|NCT00560508|65220014|FG001|12 Week Double-blind Period|Adverse Event|2|||
23402804|NCT00560508|65220013|FG000|12 Week Double-blind Period|Protocol Violation|1|||
23402805|NCT00560508|65220014|FG001|12 Week Double-blind Period|Protocol Violation|0|||
23467789|NCT00616759|65457143|FG000|Overall Study|Physician Decision|2|||
23467790|NCT00616759|65457144|FG001|Overall Study|Physician Decision|0|||
23467791|NCT00616759|65457143|FG000|Overall Study|Withdrawal by Subject|1|||
23467792|NCT00616759|65457144|FG001|Overall Study|Withdrawal by Subject|2|||
23467793|NCT02792829|65457145|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467794|NCT02792829|65457146|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
23467795|NCT02792829|65457147|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467796|NCT02792829|65457148|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467797|NCT02792829|65457149|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467798|NCT02792829|65457150|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467799|NCT02792829|65457151|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23186910|NCT01794780|64426405|FG001|Overall Study|Death|2|||
23186911|NCT01794780|64426406|FG002|Overall Study|Death|14|||
23186912|NCT01794780|64426407|FG003|Overall Study|Death|1|||
23186913|NCT01794780|64426408|FG004|Overall Study|Death|0|||
23186914|NCT01794780|64426409|FG005|Overall Study|Death|9|||
23186915|NCT01794780|64426410|FG006|Overall Study|Death|4|||
23186916|NCT01794780|64426411|FG007|Overall Study|Death|0|||
23186917|NCT01794780|64426404|FG000|Overall Study|Lost to Follow-up|10|||
23186918|NCT01794780|64426405|FG001|Overall Study|Lost to Follow-up|64|||
23402806|NCT00560508|65220013|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
23402807|NCT00560508|65220014|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
23402808|NCT00560508|65220013|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
23186919|NCT01794780|64426406|FG002|Overall Study|Lost to Follow-up|165|||
23186920|NCT01794780|64426407|FG003|Overall Study|Lost to Follow-up|53|||
23186921|NCT01794780|64426408|FG004|Overall Study|Lost to Follow-up|2|||
23186922|NCT01794780|64426409|FG005|Overall Study|Lost to Follow-up|99|||
23351806|NCT05052697|65032856|FG000|Substudy A|Lost to Follow-up|0|||
23351807|NCT05052697|65032857|FG001|Substudy A|Lost to Follow-up|0|||
23186923|NCT01794780|64426410|FG006|Overall Study|Lost to Follow-up|30|||
23186924|NCT01794780|64426411|FG007|Overall Study|Lost to Follow-up|5|||
23245603|NCT01915498|64642050|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
23245604|NCT01915498|64642051|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
23351808|NCT05052697|65032858|FG002|Substudy A|Lost to Follow-up|0|||
23351809|NCT05052697|65032859|FG003|Substudy A|Lost to Follow-up|0|||
23351810|NCT05052697|65032860|FG004|Substudy A|Lost to Follow-up|0|||
23351811|NCT05052697|65032861|FG005|Substudy A|Lost to Follow-up|1|||
23351812|NCT05052697|65032862|FG006|Substudy A|Lost to Follow-up|0|||
23351813|NCT05052697|65032863|FG007|Substudy A|Lost to Follow-up|0|||
23351814|NCT05052697|65032864|FG008|Substudy A|Lost to Follow-up|0|||
23351815|NCT05052697|65032865|FG009|Substudy A|Lost to Follow-up|0|||
23351816|NCT05052697|65032866|FG010|Substudy A|Lost to Follow-up|0|||
23351817|NCT05052697|65032867|FG011|Substudy A|Lost to Follow-up|0|||
23351818|NCT05052697|65032868|FG012|Substudy A|Lost to Follow-up|0|||
23351819|NCT05052697|65032869|FG013|Substudy A|Lost to Follow-up|0|||
23351820|NCT05052697|65032870|FG014|Substudy A|Lost to Follow-up|0|||
23351821|NCT05052697|65032871|FG015|Substudy A|Lost to Follow-up|2|||
23351822|NCT05052697|65032872|FG016|Substudy A|Lost to Follow-up|0|||
23351823|NCT05052697|65032873|FG017|Substudy A|Lost to Follow-up|0|||
23351824|NCT05052697|65032874|FG018|Substudy A|Lost to Follow-up|0|||
23351825|NCT05052697|65032875|FG019|Substudy A|Lost to Follow-up|0|||
23351826|NCT05052697|65032876|FG020|Substudy A|Lost to Follow-up|0|||
23351827|NCT05052697|65032877|FG021|Substudy A|Lost to Follow-up|0|||
23351828|NCT05052697|65032878|FG022|Substudy A|Lost to Follow-up|0|||
23351829|NCT05052697|65032879|FG023|Substudy A|Lost to Follow-up|0|||
23351830|NCT05052697|65032880|FG024|Substudy A|Lost to Follow-up|0|||
23186925|NCT01794780|64426404|FG000|Overall Study|Withdrew informed consent|7|||
23186926|NCT01794780|64426405|FG001|Overall Study|Withdrew informed consent|17|||
23186927|NCT01794780|64426406|FG002|Overall Study|Withdrew informed consent|36|||
23186928|NCT01794780|64426407|FG003|Overall Study|Withdrew informed consent|9|||
23186929|NCT01794780|64426408|FG004|Overall Study|Withdrew informed consent|0|||
23186930|NCT01794780|64426409|FG005|Overall Study|Withdrew informed consent|48|||
23186931|NCT01794780|64426410|FG006|Overall Study|Withdrew informed consent|4|||
23186932|NCT01794780|64426411|FG007|Overall Study|Withdrew informed consent|3|||
23245605|NCT01915498|64642052|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
23245606|NCT01915498|64642053|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
23245607|NCT01915498|64642054|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
23245608|NCT01915498|64642055|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
23245609|NCT01915498|64642056|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
23245610|NCT01915498|64642057|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
23245611|NCT01915498|64642058|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
23245612|NCT01915498|64642059|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
23245613|NCT01915498|64642060|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
23245614|NCT01915498|64642061|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
23245615|NCT01915498|64642062|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
23245616|NCT01915498|64642044|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245617|NCT01915498|64642045|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245618|NCT01915498|64642046|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245619|NCT01915498|64642047|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245620|NCT01915498|64642048|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245621|NCT01915498|64642049|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245622|NCT01915498|64642050|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245623|NCT01915498|64642051|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245624|NCT01915498|64642052|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245625|NCT01915498|64642053|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245626|NCT01915498|64642054|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245627|NCT01915498|64642055|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245628|NCT01915498|64642056|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245629|NCT01915498|64642057|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245630|NCT01915498|64642058|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23351831|NCT05052697|65032881|FG025|Substudy A|Lost to Follow-up|0|||
23351832|NCT05052697|65032882|FG026|Substudy A|Lost to Follow-up|0|||
23351833|NCT05052697|65032883|FG027|Substudy A|Lost to Follow-up|0|||
23186933|NCT01794780|64426404|FG000|Overall Study|Other|0|||
23351834|NCT05052697|65032884|FG028|Substudy A|Lost to Follow-up|0|||
23351835|NCT05052697|65032885|FG029|Substudy A|Lost to Follow-up|0|||
23351836|NCT05052697|65032886|FG030|Substudy A|Lost to Follow-up|0|||
23351837|NCT05052697|65032887|FG031|Substudy A|Lost to Follow-up|0|||
23351838|NCT05052697|65032888|FG032|Substudy A|Lost to Follow-up|0|||
23186934|NCT01794780|64426405|FG001|Overall Study|Other|12|||
23186935|NCT01794780|64426406|FG002|Overall Study|Other|25|||
23186936|NCT01794780|64426407|FG003|Overall Study|Other|20|||
23186937|NCT01794780|64426408|FG004|Overall Study|Other|1|||
23186938|NCT01794780|64426409|FG005|Overall Study|Other|24|||
23186939|NCT01794780|64426410|FG006|Overall Study|Other|4|||
23186940|NCT01794780|64426411|FG007|Overall Study|Other|1|||
23186941|NCT00278629|64426412|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
23186942|NCT00587223|64426415|FG000|Overall Study|Adverse Event|1|||
23186943|NCT00826748|64426421|FG000|Overall Study|Withdrawal by Subject|0|||
23186944|NCT00826748|64426422|FG001|Overall Study|Withdrawal by Subject|0|||
23186945|NCT00826748|64426423|FG002|Overall Study|Withdrawal by Subject|2|||
23186946|NCT00826748|64426421|FG000|Overall Study|Physician Decision|0|||
23186947|NCT00826748|64426422|FG001|Overall Study|Physician Decision|0|||
23186948|NCT00826748|64426423|FG002|Overall Study|Physician Decision|1|||
23186949|NCT00826748|64426421|FG000|Overall Study|Samples Did Not pass QC|0|||
23186950|NCT00826748|64426422|FG001|Overall Study|Samples Did Not pass QC|0|||
23186951|NCT00826748|64426423|FG002|Overall Study|Samples Did Not pass QC|1|||
23186952|NCT00609609|64426427|FG000|Overall Study|Withdrawal by Subject|2|||
23186953|NCT00609609|64426428|FG001|Overall Study|Withdrawal by Subject|0|||
23186954|NCT00609609|64426427|FG000|Overall Study|Progression|4|||
23186955|NCT00609609|64426428|FG001|Overall Study|Progression|2|||
23186956|NCT02240706|64426431|FG000|Overall Study|Lack of Efficacy|2|||
23186957|NCT02240706|64426432|FG001|Overall Study|Lack of Efficacy|2|||
23186958|NCT02240706|64426433|FG002|Overall Study|Lack of Efficacy|2|||
23186959|NCT02240706|64426434|FG003|Overall Study|Lack of Efficacy|2|||
23186960|NCT02240706|64426435|FG004|Overall Study|Lack of Efficacy|5|||
23186961|NCT02240706|64426436|FG005|Overall Study|Lack of Efficacy|0|||
23186962|NCT02240706|64426437|FG006|Overall Study|Lack of Efficacy|0|||
23186963|NCT02240706|64426431|FG000|Overall Study|Adverse Event|1|||
23186964|NCT02240706|64426432|FG001|Overall Study|Adverse Event|0|||
23186965|NCT02240706|64426433|FG002|Overall Study|Adverse Event|1|||
23186966|NCT02240706|64426434|FG003|Overall Study|Adverse Event|0|||
23186967|NCT02240706|64426435|FG004|Overall Study|Adverse Event|2|||
23186968|NCT02240706|64426436|FG005|Overall Study|Adverse Event|0|||
23186969|NCT02240706|64426437|FG006|Overall Study|Adverse Event|0|||
23186970|NCT02240706|64426431|FG000|Overall Study|Progressive disease|0|||
23186971|NCT02240706|64426432|FG001|Overall Study|Progressive disease|0|||
23186972|NCT02240706|64426433|FG002|Overall Study|Progressive disease|0|||
23186973|NCT02240706|64426434|FG003|Overall Study|Progressive disease|0|||
23186974|NCT02240706|64426435|FG004|Overall Study|Progressive disease|1|||
23186975|NCT02240706|64426436|FG005|Overall Study|Progressive disease|0|||
23186976|NCT02240706|64426437|FG006|Overall Study|Progressive disease|0|||
23186977|NCT02240706|64426431|FG000|Overall Study|Dose limiting toxicity|0|||
23186978|NCT02240706|64426432|FG001|Overall Study|Dose limiting toxicity|0|||
23186979|NCT02240706|64426433|FG002|Overall Study|Dose limiting toxicity|0|||
23186980|NCT02240706|64426434|FG003|Overall Study|Dose limiting toxicity|0|||
23186981|NCT02240706|64426435|FG004|Overall Study|Dose limiting toxicity|1|||
23186982|NCT02240706|64426436|FG005|Overall Study|Dose limiting toxicity|0|||
23186983|NCT02240706|64426437|FG006|Overall Study|Dose limiting toxicity|0|||
23186984|NCT02240706|64426431|FG000|Overall Study|Refused to continue taking medication|0|||
23186985|NCT02240706|64426432|FG001|Overall Study|Refused to continue taking medication|1|||
23186986|NCT02240706|64426433|FG002|Overall Study|Refused to continue taking medication|3|||
23186987|NCT02240706|64426434|FG003|Overall Study|Refused to continue taking medication|1|||
23186988|NCT02240706|64426435|FG004|Overall Study|Refused to continue taking medication|2|||
23186989|NCT02240706|64426436|FG005|Overall Study|Refused to continue taking medication|0|||
23186990|NCT02240706|64426437|FG006|Overall Study|Refused to continue taking medication|0|||
23186991|NCT02240706|64426431|FG000|Overall Study|Insurance billing concerns|0|||
23186992|NCT02240706|64426432|FG001|Overall Study|Insurance billing concerns|0|||
23186993|NCT02240706|64426433|FG002|Overall Study|Insurance billing concerns|0|||
23186994|NCT02240706|64426434|FG003|Overall Study|Insurance billing concerns|1|||
23186995|NCT02240706|64426435|FG004|Overall Study|Insurance billing concerns|0|||
23186996|NCT02240706|64426436|FG005|Overall Study|Insurance billing concerns|0|||
23186997|NCT02240706|64426437|FG006|Overall Study|Insurance billing concerns|0|||
23186998|NCT00200057|64426438|FG000|Overall Study|Lack of Efficacy|3|||
23186999|NCT00200057|64426438|FG000|Overall Study|Exited due to terminal illness of PI|2|||
23187000|NCT00200057|64426438|FG000|Overall Study|Withdrawal by Subject|1|||
23187001|NCT00200057|64426438|FG000|Overall Study|Change in medical condition|1|||
23187002|NCT00200057|64426438|FG000|Overall Study|Infection|1|||
23187003|NCT00200057|64426438|FG000|Overall Study|Death|1|||
23187004|NCT04321343|64426439|FG000|Overall Study|Adverse Event|0|||
23187005|NCT04321343|64426440|FG001|Overall Study|Adverse Event|0|||
23187006|NCT04321343|64426441|FG002|Overall Study|Adverse Event|1|||
23187007|NCT04321343|64426442|FG003|Overall Study|Adverse Event|0|||
23187008|NCT04321343|64426439|FG000|Overall Study|Death|0|||
23187009|NCT04321343|64426440|FG001|Overall Study|Death|0|||
23187010|NCT04321343|64426441|FG002|Overall Study|Death|0|||
23187011|NCT04321343|64426442|FG003|Overall Study|Death|1|||
23187012|NCT04321343|64426439|FG000|Overall Study|Pregnancy|1|||
23187013|NCT04321343|64426440|FG001|Overall Study|Pregnancy|0|||
23187014|NCT04321343|64426441|FG002|Overall Study|Pregnancy|0|||
23187015|NCT04321343|64426442|FG003|Overall Study|Pregnancy|0|||
23187016|NCT04321343|64426439|FG000|Overall Study|Protocol Violation|1|||
23351839|NCT05052697|65032889|FG033|Substudy A|Lost to Follow-up|0|||
23351840|NCT05052697|65032856|FG000|Substudy A|No longer met eligibility criteria|0|||
23245631|NCT01915498|64642059|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245632|NCT01915498|64642060|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245633|NCT01915498|64642061|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
23245634|NCT01915498|64642062|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
23245635|NCT01915498|64642044|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245636|NCT01915498|64642045|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23187017|NCT04321343|64426440|FG001|Overall Study|Protocol Violation|1|||
23187018|NCT04321343|64426441|FG002|Overall Study|Protocol Violation|1|||
23187019|NCT04321343|64426442|FG003|Overall Study|Protocol Violation|1|||
23187020|NCT04321343|64426439|FG000|Overall Study|Withdrawal by Subject|0|||
23187021|NCT04321343|64426440|FG001|Overall Study|Withdrawal by Subject|6|||
23187022|NCT04321343|64426441|FG002|Overall Study|Withdrawal by Subject|0|||
23187023|NCT04321343|64426442|FG003|Overall Study|Withdrawal by Subject|2|||
23187024|NCT04321343|64426439|FG000|Overall Study|Lost to Follow-up|2|||
23187025|NCT04321343|64426440|FG001|Overall Study|Lost to Follow-up|2|||
23187026|NCT04321343|64426441|FG002|Overall Study|Lost to Follow-up|1|||
23187027|NCT04321343|64426442|FG003|Overall Study|Lost to Follow-up|3|||
23187028|NCT00688688|64426443|FG000|Overall Study|Eligibility criterion not met|7|||
23187029|NCT00688688|64426444|FG001|Overall Study|Eligibility criterion not met|7|||
23187030|NCT00688688|64426445|FG002|Overall Study|Eligibility criterion not met|10|||
23187031|NCT00688688|64426443|FG000|Overall Study|Adverse Event|52|||
23187032|NCT00688688|64426444|FG001|Overall Study|Adverse Event|51|||
23187033|NCT00688688|64426445|FG002|Overall Study|Adverse Event|50|||
23187034|NCT00688688|64426443|FG000|Overall Study|Lack of Efficacy|34|||
23187035|NCT00688688|64426444|FG001|Overall Study|Lack of Efficacy|25|||
23187036|NCT00688688|64426445|FG002|Overall Study|Lack of Efficacy|45|||
23187037|NCT00688688|64426443|FG000|Overall Study|Withdrawal by Subject|66|||
23245637|NCT01915498|64642046|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245638|NCT01915498|64642047|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245639|NCT01915498|64642048|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245640|NCT01915498|64642049|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245641|NCT01915498|64642050|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245642|NCT01915498|64642051|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23351841|NCT05052697|65032857|FG001|Substudy A|No longer met eligibility criteria|0|||
23351842|NCT05052697|65032858|FG002|Substudy A|No longer met eligibility criteria|0|||
23351843|NCT05052697|65032859|FG003|Substudy A|No longer met eligibility criteria|0|||
23351844|NCT05052697|65032860|FG004|Substudy A|No longer met eligibility criteria|0|||
23351845|NCT05052697|65032861|FG005|Substudy A|No longer met eligibility criteria|0|||
23351846|NCT05052697|65032862|FG006|Substudy A|No longer met eligibility criteria|0|||
23351847|NCT05052697|65032863|FG007|Substudy A|No longer met eligibility criteria|0|||
23351848|NCT05052697|65032864|FG008|Substudy A|No longer met eligibility criteria|0|||
23245643|NCT01915498|64642052|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245644|NCT01915498|64642053|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23351849|NCT05052697|65032865|FG009|Substudy A|No longer met eligibility criteria|0|||
23351850|NCT05052697|65032866|FG010|Substudy A|No longer met eligibility criteria|0|||
23351851|NCT05052697|65032867|FG011|Substudy A|No longer met eligibility criteria|0|||
23351852|NCT05052697|65032868|FG012|Substudy A|No longer met eligibility criteria|0|||
23187038|NCT00688688|64426444|FG001|Overall Study|Withdrawal by Subject|75|||
23187039|NCT00688688|64426445|FG002|Overall Study|Withdrawal by Subject|65|||
23187040|NCT00688688|64426443|FG000|Overall Study|Lost to Follow-up|14|||
23187041|NCT00688688|64426444|FG001|Overall Study|Lost to Follow-up|7|||
23187042|NCT00688688|64426445|FG002|Overall Study|Lost to Follow-up|7|||
23187043|NCT00688688|64426443|FG000|Overall Study|Protocol Violation|6|||
23187044|NCT00688688|64426444|FG001|Overall Study|Protocol Violation|9|||
23187045|NCT00688688|64426445|FG002|Overall Study|Protocol Violation|11|||
23245645|NCT01915498|64642054|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23187046|NCT00688688|64426443|FG000|Overall Study|Randomized but never received study drug|1|||
23187047|NCT00688688|64426444|FG001|Overall Study|Randomized but never received study drug|0|||
23187048|NCT00688688|64426445|FG002|Overall Study|Randomized but never received study drug|0|||
23187049|NCT00688688|64426443|FG000|Overall Study|Non-compliance with study procedures|5|||
23187050|NCT00688688|64426444|FG001|Overall Study|Non-compliance with study procedures|3|||
23187051|NCT00688688|64426445|FG002|Overall Study|Non-compliance with study procedures|4|||
23187052|NCT00688688|64426443|FG000|Overall Study|Taking exclusionary medications|1|||
23187053|NCT00688688|64426444|FG001|Overall Study|Taking exclusionary medications|0|||
23187054|NCT00688688|64426445|FG002|Overall Study|Taking exclusionary medications|0|||
23187055|NCT00688688|64426443|FG000|Overall Study|Site closure|0|||
23187056|NCT00688688|64426444|FG001|Overall Study|Site closure|1|||
23187057|NCT00688688|64426445|FG002|Overall Study|Site closure|0|||
23187058|NCT00688688|64426443|FG000|Overall Study|Violation of exclusion criterion|0|||
23187059|NCT00688688|64426444|FG001|Overall Study|Violation of exclusion criterion|1|||
23187060|NCT00688688|64426445|FG002|Overall Study|Violation of exclusion criterion|0|||
23187061|NCT00986349|64426446|FG000|Overall Study|Unsuccessful implant procedure|3|||
23187062|NCT00986349|64426446|FG000|Overall Study|Adverse Event|2|||
23187063|NCT00986349|64426446|FG000|Overall Study|Physician Decision|1|||
23187064|NCT00986349|64426446|FG000|Overall Study|device migration|1|||
23187065|NCT03015532|64426447|FG000|Overall Study|Adverse Event|0|||
23187066|NCT03015532|64426448|FG001|Overall Study|Adverse Event|0|||
23187067|NCT03015532|64426449|FG002|Overall Study|Adverse Event|0|||
23187068|NCT03015532|64426450|FG003|Overall Study|Adverse Event|0|||
23187069|NCT03015532|64426451|FG004|Overall Study|Adverse Event|0|||
23187070|NCT03015532|64426452|FG005|Overall Study|Adverse Event|2|||
23187071|NCT03015532|64426453|FG006|Overall Study|Adverse Event|1|||
23187072|NCT03015532|64426454|FG007|Overall Study|Adverse Event|0|||
23187073|NCT03015532|64426447|FG000|Overall Study|Withdrawal by Subject|0|||
23187074|NCT03015532|64426448|FG001|Overall Study|Withdrawal by Subject|0|||
23187075|NCT03015532|64426449|FG002|Overall Study|Withdrawal by Subject|0|||
23187076|NCT03015532|64426450|FG003|Overall Study|Withdrawal by Subject|0|||
23245646|NCT01915498|64642055|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245647|NCT01915498|64642056|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245648|NCT01915498|64642057|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245649|NCT01915498|64642058|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245650|NCT01915498|64642059|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245651|NCT01915498|64642060|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245652|NCT01915498|64642061|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
23245653|NCT01915498|64642062|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
23245654|NCT01915498|64642044|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245655|NCT01915498|64642045|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245656|NCT01915498|64642046|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245657|NCT01915498|64642047|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245658|NCT01915498|64642048|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23187077|NCT03015532|64426451|FG004|Overall Study|Withdrawal by Subject|0|||
23187078|NCT03015532|64426452|FG005|Overall Study|Withdrawal by Subject|0|||
23187079|NCT03015532|64426453|FG006|Overall Study|Withdrawal by Subject|1|||
23187080|NCT03015532|64426454|FG007|Overall Study|Withdrawal by Subject|0|||
23187081|NCT00488631|64426456|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
23187082|NCT00488631|64426457|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
23245659|NCT01915498|64642049|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245660|NCT01915498|64642050|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245661|NCT01915498|64642051|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245662|NCT01915498|64642052|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245663|NCT01915498|64642053|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23467800|NCT02792829|65457152|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
23467801|NCT02792829|65457145|FG000|Treatment Period 2|Adverse Event|0|||
23467802|NCT02792829|65457146|FG001|Treatment Period 2|Adverse Event|0|||
23245664|NCT01915498|64642054|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245665|NCT01915498|64642055|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245666|NCT01915498|64642056|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245667|NCT01915498|64642057|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245668|NCT01915498|64642058|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245669|NCT01915498|64642059|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245670|NCT01915498|64642060|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245671|NCT01915498|64642061|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
23245672|NCT01915498|64642062|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
23245673|NCT04484805|64642069|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
23245674|NCT04484805|64642070|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
23245675|NCT04484805|64642069|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
23245676|NCT04484805|64642070|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
23586789|NCT02512042|65876145|FG001|Overall Study|Withdrawal by Subject|6|||
23467803|NCT02792829|65457147|FG002|Treatment Period 2|Adverse Event|0|||
23467804|NCT02792829|65457148|FG003|Treatment Period 2|Adverse Event|0|||
23586790|NCT02512042|65876144|FG000|Overall Study|Non-compliance with study drug|1|||
23187083|NCT00488631|64426458|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
23187084|NCT00488631|64426459|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
23187085|NCT00488631|64426460|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
23187086|NCT00488631|64426461|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
23187087|NCT00488631|64426462|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
23187088|NCT00488631|64426463|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
23187089|NCT00488631|64426464|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
23187090|NCT00488631|64426465|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
23187091|NCT00488631|64426456|FG000|Double Blind Period (Week 0-54)|Death|0|||
23187092|NCT00488631|64426457|FG001|Double Blind Period (Week 0-54)|Death|0|||
23187093|NCT00488631|64426458|FG002|Double Blind Period (Week 0-54)|Death|0|||
23187094|NCT00488631|64426459|FG003|Double Blind Period (Week 0-54)|Death|0|||
23187095|NCT00488631|64426460|FG004|Double Blind Period (Week 0-54)|Death|0|||
23187096|NCT00488631|64426461|FG005|Double Blind Period (Week 0-54)|Death|1|||
23187097|NCT00488631|64426462|FG006|Double Blind Period (Week 0-54)|Death|0|||
23187098|NCT00488631|64426463|FG007|Double Blind Period (Week 0-54)|Death|0|||
23187099|NCT00488631|64426464|FG008|Double Blind Period (Week 0-54)|Death|0|||
23187100|NCT00488631|64426465|FG009|Double Blind Period (Week 0-54)|Death|0|||
23187101|NCT00488631|64426456|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
23187102|NCT00488631|64426457|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
23187103|NCT00488631|64426458|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
23187104|NCT00488631|64426459|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
23187105|NCT00488631|64426460|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
23187106|NCT00488631|64426461|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
23187107|NCT00488631|64426462|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
23187108|NCT00488631|64426463|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
23187109|NCT00488631|64426464|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
23586791|NCT02512042|65876145|FG001|Overall Study|Non-compliance with study drug|2|||
23245679|NCT05146999|64642073|FG000|Overall Study|Withdrew consent|6|||
23245680|NCT05146999|64642074|FG001|Overall Study|Withdrew consent|1|||
23245681|NCT05146999|64642073|FG000|Overall Study|Lost to Follow-up|3|||
23245682|NCT05146999|64642074|FG001|Overall Study|Lost to Follow-up|2|||
23245683|NCT05146999|64642073|FG000|Overall Study|Other|1|||
23245684|NCT05146999|64642074|FG001|Overall Study|Other|3|||
23586792|NCT02512042|65876144|FG000|Overall Study|Lost to Follow-up|5|||
23467805|NCT02792829|65457149|FG004|Treatment Period 2|Adverse Event|1|||
23467806|NCT02792829|65457150|FG005|Treatment Period 2|Adverse Event|0|||
23467807|NCT02792829|65457151|FG006|Treatment Period 2|Adverse Event|1|||
23467808|NCT02792829|65457152|FG007|Treatment Period 2|Adverse Event|1|||
23467809|NCT02792829|65457145|FG000|Treatment Period 2|Use of proscribed medications|0|||
23467810|NCT02792829|65457146|FG001|Treatment Period 2|Use of proscribed medications|0|||
23467811|NCT02792829|65457147|FG002|Treatment Period 2|Use of proscribed medications|0|||
23187110|NCT00488631|64426465|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
23187111|NCT00488631|64426456|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
23187112|NCT00488631|64426457|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
23187113|NCT00488631|64426458|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
23187114|NCT00488631|64426459|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23187115|NCT00488631|64426460|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
23187116|NCT00488631|64426461|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
23187117|NCT00488631|64426462|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23187118|NCT00488631|64426463|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23187119|NCT00488631|64426464|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23187120|NCT00488631|64426465|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
23187121|NCT00488631|64426456|FG000|Double Blind Period (Week 0-54)|Other|6|||
23187122|NCT00488631|64426457|FG001|Double Blind Period (Week 0-54)|Other|12|||
23187123|NCT00488631|64426458|FG002|Double Blind Period (Week 0-54)|Other|10|||
23187124|NCT00488631|64426459|FG003|Double Blind Period (Week 0-54)|Other|11|||
23187125|NCT00488631|64426460|FG004|Double Blind Period (Week 0-54)|Other|14|||
23187126|NCT00488631|64426461|FG005|Double Blind Period (Week 0-54)|Other|34|||
23187127|NCT00488631|64426462|FG006|Double Blind Period (Week 0-54)|Other|0|||
23187128|NCT00488631|64426463|FG007|Double Blind Period (Week 0-54)|Other|0|||
23187129|NCT00488631|64426464|FG008|Double Blind Period (Week 0-54)|Other|0|||
23187130|NCT00488631|64426465|FG009|Double Blind Period (Week 0-54)|Other|0|||
23187131|NCT00488631|64426456|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23187132|NCT00488631|64426457|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23187133|NCT00488631|64426458|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23187134|NCT00488631|64426459|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23187135|NCT00488631|64426460|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23187136|NCT00488631|64426461|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23187137|NCT00488631|64426462|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
23187138|NCT00488631|64426463|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
23187139|NCT00488631|64426464|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
23187140|NCT00488631|64426465|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
23187141|NCT00488631|64426456|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
23586793|NCT02512042|65876145|FG001|Overall Study|Lost to Follow-up|2|||
23586794|NCT02512042|65876144|FG000|Overall Study|Other|11|||
23586795|NCT02512042|65876145|FG001|Overall Study|Other|11|||
23586796|NCT02595398|65876150|FG000|Overall Study|Non-compliance|1|||
23586797|NCT02595398|65876151|FG001|Overall Study|Non-compliance|0|||
23467812|NCT02792829|65457148|FG003|Treatment Period 2|Use of proscribed medications|0|||
23467813|NCT02792829|65457149|FG004|Treatment Period 2|Use of proscribed medications|0|||
23467814|NCT02792829|65457150|FG005|Treatment Period 2|Use of proscribed medications|0|||
23467815|NCT02792829|65457151|FG006|Treatment Period 2|Use of proscribed medications|0|||
23467816|NCT02792829|65457152|FG007|Treatment Period 2|Use of proscribed medications|1|||
23467817|NCT00719472|65457159|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
23467818|NCT00719472|65457159|FG000|Enrolled in Study|Subject decision to withdraw|8|||
23467819|NCT00719472|65457159|FG000|Enrolled in Study|Various Reasons|17|||
23467820|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
23467821|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Death|5|||
23467822|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
23467823|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
23467824|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
23467825|NCT00719472|65457159|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
23467826|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
23467827|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Death|6|||
23467828|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Disease progression|3|||
23467829|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
23467830|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
23467831|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
23467832|NCT00719472|65457159|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
23467833|NCT00286468|65457160|FG000|Overall Study|Hyperglycemic Rescue|28|||
23467834|NCT00286468|65457161|FG001|Overall Study|Hyperglycemic Rescue|30|||
23187142|NCT00488631|64426457|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
23586798|NCT02595398|65876150|FG000|Overall Study|Withdrawal by Subject|2|||
23586799|NCT02595398|65876151|FG001|Overall Study|Withdrawal by Subject|1|||
23351853|NCT05052697|65032869|FG013|Substudy A|No longer met eligibility criteria|1|||
23351854|NCT05052697|65032870|FG014|Substudy A|No longer met eligibility criteria|0|||
23467835|NCT00286468|65457162|FG002|Overall Study|Hyperglycemic Rescue|31|||
23467836|NCT00286468|65457160|FG000|Overall Study|Adverse Event|2|||
23467837|NCT00286468|65457161|FG001|Overall Study|Adverse Event|6|||
23586800|NCT02595398|65876150|FG000|Overall Study|Lost to Follow-up|1|||
23467838|NCT00286468|65457162|FG002|Overall Study|Adverse Event|4|||
23467839|NCT00286468|65457160|FG000|Overall Study|Protocol Violation|0|||
23467840|NCT00286468|65457161|FG001|Overall Study|Protocol Violation|3|||
23467841|NCT00286468|65457162|FG002|Overall Study|Protocol Violation|1|||
23467842|NCT00286468|65457160|FG000|Overall Study|Lost to Follow-up|1|||
23467843|NCT00286468|65457161|FG001|Overall Study|Lost to Follow-up|1|||
23467844|NCT00286468|65457162|FG002|Overall Study|Lost to Follow-up|2|||
23467845|NCT00286468|65457160|FG000|Overall Study|Withdrawal by Subject|3|||
23467846|NCT00286468|65457161|FG001|Overall Study|Withdrawal by Subject|8|||
23467847|NCT00286468|65457162|FG002|Overall Study|Withdrawal by Subject|11|||
23467848|NCT00286468|65457160|FG000|Overall Study|Physician Decision|3|||
23467849|NCT00286468|65457161|FG001|Overall Study|Physician Decision|2|||
23467850|NCT00286468|65457162|FG002|Overall Study|Physician Decision|1|||
23467851|NCT03339219|65457163|FG000|Overall Study|Death|12|||
23467852|NCT03339219|65457163|FG000|Overall Study|Site Terminated by Sponsor|22|||
23467853|NCT03339219|65457163|FG000|Overall Study|Withdrawal by Subject|1|||
23467854|NCT01249261|65457164|FG000|Overall Study|Withdrawal by Subject|1|||
23467855|NCT01249261|65457165|FG001|Overall Study|Withdrawal by Subject|0|||
23467856|NCT03763877|65457166|FG000|Overall Study|Withdrawal by Subject|3|||
23467857|NCT03763877|65457167|FG001|Overall Study|Withdrawal by Subject|1|||
23467858|NCT03763877|65457168|FG002|Overall Study|Withdrawal by Subject|3|||
23467859|NCT03763877|65457169|FG003|Overall Study|Withdrawal by Subject|4|||
23467860|NCT03763877|65457166|FG000|Overall Study|Adverse Event|1|||
23467861|NCT03763877|65457167|FG001|Overall Study|Adverse Event|1|||
23467862|NCT03763877|65457168|FG002|Overall Study|Adverse Event|3|||
23467863|NCT03763877|65457169|FG003|Overall Study|Adverse Event|1|||
23467864|NCT03763877|65457166|FG000|Overall Study|Protocol Violation|1|||
23467865|NCT03763877|65457167|FG001|Overall Study|Protocol Violation|1|||
23467866|NCT03763877|65457168|FG002|Overall Study|Protocol Violation|0|||
23467867|NCT03763877|65457169|FG003|Overall Study|Protocol Violation|0|||
23467868|NCT03763877|65457166|FG000|Overall Study|Lost to Follow-up|0|||
23467869|NCT03763877|65457167|FG001|Overall Study|Lost to Follow-up|1|||
23467870|NCT03763877|65457168|FG002|Overall Study|Lost to Follow-up|1|||
23467871|NCT03763877|65457169|FG003|Overall Study|Lost to Follow-up|0|||
23467872|NCT00357552|65457170|FG000|Screening|Did not meet eligibility criteria|84|||
23467873|NCT00357552|65457170|FG000|Weeks 0 to 24|Death|1|||
23467874|NCT00357552|65457170|FG000|Weeks 24 to 104|Death|3|||
23467875|NCT00357552|65457170|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
23467876|NCT01088048|65457171|FG000|Overall Study|Adverse Event|7|||
23467877|NCT01088048|65457172|FG001|Overall Study|Adverse Event|9|||
23467878|NCT01088048|65457173|FG002|Overall Study|Adverse Event|7|||
23467879|NCT01088048|65457174|FG003|Overall Study|Adverse Event|5|||
23467880|NCT01088048|65457175|FG004|Overall Study|Adverse Event|6|||
23467881|NCT01088048|65457176|FG005|Overall Study|Adverse Event|3|||
23467882|NCT01088048|65457177|FG006|Overall Study|Adverse Event|3|||
23467883|NCT01088048|65457178|FG007|Overall Study|Adverse Event|0|||
23187143|NCT00488631|64426458|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
23187144|NCT00488631|64426459|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
23187145|NCT00488631|64426460|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
23187146|NCT00488631|64426461|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
23187147|NCT00488631|64426462|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
23187148|NCT00488631|64426463|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
23187149|NCT00488631|64426464|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
23187150|NCT00488631|64426465|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
23187151|NCT00488631|64426456|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23586801|NCT02595398|65876151|FG001|Overall Study|Lost to Follow-up|0|||
23586802|NCT02680756|65876153|FG000|Overall Study|Adverse Event|10|||
23187152|NCT00488631|64426457|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23187153|NCT00488631|64426458|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23187154|NCT00488631|64426459|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23187155|NCT00488631|64426460|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23187156|NCT00488631|64426461|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
23467884|NCT01088048|65457179|FG008|Overall Study|Adverse Event|2|||
23467885|NCT01088048|65457180|FG009|Overall Study|Adverse Event|2|||
23467886|NCT01088048|65457171|FG000|Overall Study|Withdrew Consent|1|||
23467887|NCT01088048|65457172|FG001|Overall Study|Withdrew Consent|1|||
23467888|NCT01088048|65457173|FG002|Overall Study|Withdrew Consent|1|||
23467889|NCT01088048|65457174|FG003|Overall Study|Withdrew Consent|1|||
23467890|NCT01088048|65457175|FG004|Overall Study|Withdrew Consent|2|||
23467891|NCT01088048|65457176|FG005|Overall Study|Withdrew Consent|1|||
23467892|NCT01088048|65457177|FG006|Overall Study|Withdrew Consent|0|||
23467893|NCT01088048|65457178|FG007|Overall Study|Withdrew Consent|2|||
23467894|NCT01088048|65457179|FG008|Overall Study|Withdrew Consent|2|||
23467895|NCT01088048|65457180|FG009|Overall Study|Withdrew Consent|1|||
23467896|NCT01088048|65457171|FG000|Overall Study|Concomitant Medication Prohibited|1|||
23467897|NCT01088048|65457172|FG001|Overall Study|Concomitant Medication Prohibited|0|||
23467898|NCT01088048|65457173|FG002|Overall Study|Concomitant Medication Prohibited|0|||
23467899|NCT01088048|65457174|FG003|Overall Study|Concomitant Medication Prohibited|0|||
23467900|NCT01088048|65457175|FG004|Overall Study|Concomitant Medication Prohibited|0|||
23467901|NCT01088048|65457176|FG005|Overall Study|Concomitant Medication Prohibited|0|||
23467902|NCT01088048|65457177|FG006|Overall Study|Concomitant Medication Prohibited|0|||
23467903|NCT01088048|65457178|FG007|Overall Study|Concomitant Medication Prohibited|0|||
23467904|NCT01088048|65457179|FG008|Overall Study|Concomitant Medication Prohibited|0|||
23467905|NCT01088048|65457180|FG009|Overall Study|Concomitant Medication Prohibited|0|||
23467906|NCT01088048|65457171|FG000|Overall Study|Investigator Request|2|||
23467907|NCT01088048|65457172|FG001|Overall Study|Investigator Request|2|||
23467908|NCT01088048|65457173|FG002|Overall Study|Investigator Request|0|||
23467909|NCT01088048|65457174|FG003|Overall Study|Investigator Request|0|||
23467910|NCT01088048|65457175|FG004|Overall Study|Investigator Request|3|||
23467911|NCT01088048|65457176|FG005|Overall Study|Investigator Request|1|||
23467912|NCT01088048|65457177|FG006|Overall Study|Investigator Request|1|||
23467913|NCT01088048|65457178|FG007|Overall Study|Investigator Request|0|||
23467914|NCT01088048|65457179|FG008|Overall Study|Investigator Request|0|||
23467915|NCT01088048|65457180|FG009|Overall Study|Investigator Request|0|||
23467916|NCT01088048|65457171|FG000|Overall Study|Patient Non-compliance|0|||
23467917|NCT01088048|65457172|FG001|Overall Study|Patient Non-compliance|1|||
23467918|NCT01088048|65457173|FG002|Overall Study|Patient Non-compliance|0|||
23467919|NCT01088048|65457174|FG003|Overall Study|Patient Non-compliance|0|||
23467920|NCT01088048|65457175|FG004|Overall Study|Patient Non-compliance|0|||
23467921|NCT01088048|65457176|FG005|Overall Study|Patient Non-compliance|0|||
23467922|NCT01088048|65457177|FG006|Overall Study|Patient Non-compliance|0|||
23467923|NCT01088048|65457178|FG007|Overall Study|Patient Non-compliance|0|||
23467924|NCT01088048|65457179|FG008|Overall Study|Patient Non-compliance|0|||
23467925|NCT01088048|65457180|FG009|Overall Study|Patient Non-compliance|0|||
23467926|NCT01088048|65457171|FG000|Overall Study|Disease Progression|7|||
23467927|NCT01088048|65457172|FG001|Overall Study|Disease Progression|4|||
23467928|NCT01088048|65457173|FG002|Overall Study|Disease Progression|3|||
23467929|NCT01088048|65457174|FG003|Overall Study|Disease Progression|5|||
23467930|NCT01088048|65457175|FG004|Overall Study|Disease Progression|3|||
23467931|NCT01088048|65457176|FG005|Overall Study|Disease Progression|3|||
23467932|NCT01088048|65457177|FG006|Overall Study|Disease Progression|2|||
23467933|NCT01088048|65457178|FG007|Overall Study|Disease Progression|1|||
23467934|NCT01088048|65457179|FG008|Overall Study|Disease Progression|0|||
23187157|NCT00488631|64426462|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
23187158|NCT00488631|64426463|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
23187159|NCT00488631|64426464|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
23187160|NCT00488631|64426465|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
23187161|NCT00488631|64426456|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23467935|NCT01088048|65457180|FG009|Overall Study|Disease Progression|0|||
23467936|NCT01088048|65457171|FG000|Overall Study|Death|1|||
23467937|NCT01088048|65457172|FG001|Overall Study|Death|5|||
23467938|NCT01088048|65457173|FG002|Overall Study|Death|3|||
23467939|NCT01088048|65457174|FG003|Overall Study|Death|3|||
23467940|NCT01088048|65457175|FG004|Overall Study|Death|1|||
23467941|NCT01088048|65457176|FG005|Overall Study|Death|3|||
23467942|NCT01088048|65457177|FG006|Overall Study|Death|0|||
23467943|NCT01088048|65457178|FG007|Overall Study|Death|0|||
23467944|NCT01088048|65457179|FG008|Overall Study|Death|3|||
23467945|NCT01088048|65457180|FG009|Overall Study|Death|1|||
23467946|NCT01088048|65457171|FG000|Overall Study|Other|3|||
23351855|NCT05052697|65032871|FG015|Substudy A|No longer met eligibility criteria|0|||
23351856|NCT05052697|65032872|FG016|Substudy A|No longer met eligibility criteria|0|||
23351857|NCT05052697|65032873|FG017|Substudy A|No longer met eligibility criteria|0|||
23351858|NCT05052697|65032874|FG018|Substudy A|No longer met eligibility criteria|0|||
23351859|NCT05052697|65032875|FG019|Substudy A|No longer met eligibility criteria|0|||
23351860|NCT05052697|65032876|FG020|Substudy A|No longer met eligibility criteria|0|||
23351861|NCT05052697|65032877|FG021|Substudy A|No longer met eligibility criteria|0|||
23351862|NCT05052697|65032878|FG022|Substudy A|No longer met eligibility criteria|0|||
23351863|NCT05052697|65032879|FG023|Substudy A|No longer met eligibility criteria|0|||
23351864|NCT05052697|65032880|FG024|Substudy A|No longer met eligibility criteria|0|||
23351865|NCT05052697|65032881|FG025|Substudy A|No longer met eligibility criteria|0|||
23351866|NCT05052697|65032882|FG026|Substudy A|No longer met eligibility criteria|0|||
23351867|NCT05052697|65032883|FG027|Substudy A|No longer met eligibility criteria|0|||
23351868|NCT05052697|65032884|FG028|Substudy A|No longer met eligibility criteria|0|||
23351869|NCT05052697|65032885|FG029|Substudy A|No longer met eligibility criteria|0|||
23351870|NCT05052697|65032886|FG030|Substudy A|No longer met eligibility criteria|0|||
23467947|NCT01088048|65457172|FG001|Overall Study|Other|5|||
23467948|NCT01088048|65457173|FG002|Overall Study|Other|0|||
23467949|NCT01088048|65457174|FG003|Overall Study|Other|0|||
23467950|NCT01088048|65457175|FG004|Overall Study|Other|2|||
23467951|NCT01088048|65457176|FG005|Overall Study|Other|0|||
23467952|NCT01088048|65457177|FG006|Overall Study|Other|0|||
23467953|NCT01088048|65457178|FG007|Overall Study|Other|2|||
23467954|NCT01088048|65457179|FG008|Overall Study|Other|0|||
23467955|NCT01088048|65457180|FG009|Overall Study|Other|0|||
23467956|NCT03847896|65457181|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
23467957|NCT03847896|65457182|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
23467958|NCT03847896|65457183|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
23586803|NCT02680756|65876154|FG001|Overall Study|Adverse Event|2|||
23586804|NCT02680756|65876153|FG000|Overall Study|Lost to Follow-up|7|||
23586805|NCT02680756|65876154|FG001|Overall Study|Lost to Follow-up|6|||
23586806|NCT02680756|65876153|FG000|Overall Study|Withdrawal by Subject|5|||
23467959|NCT03847896|65457184|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
23467960|NCT03847896|65457185|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
23467961|NCT03847896|65457181|FG000|Overall Study|Withdrawal by Subject|2|||
23467962|NCT03847896|65457182|FG001|Overall Study|Withdrawal by Subject|10|||
23467963|NCT03847896|65457183|FG002|Overall Study|Withdrawal by Subject|5|||
23586807|NCT02680756|65876154|FG001|Overall Study|Withdrawal by Subject|5|||
23586808|NCT02680756|65876153|FG000|Overall Study|Physician Decision|4|||
23586809|NCT02680756|65876154|FG001|Overall Study|Physician Decision|1|||
23586810|NCT02680756|65876153|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
23586811|NCT02680756|65876154|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
23586812|NCT02680756|65876153|FG000|Overall Study|Blood transfusion for any reason|0|||
23586813|NCT02680756|65876154|FG001|Overall Study|Blood transfusion for any reason|1|||
23586814|NCT02680756|65876153|FG000|Overall Study|Death|1|||
23586815|NCT02680756|65876154|FG001|Overall Study|Death|0|||
23586816|NCT02680756|65876153|FG000|Overall Study|Protocol Violation|1|||
23586817|NCT02680756|65876154|FG001|Overall Study|Protocol Violation|0|||
23586818|NCT02680756|65876153|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
23586819|NCT02680756|65876154|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
23586820|NCT02680756|65876153|FG000|Overall Study|None of above or not recorded|3|||
23586821|NCT02680756|65876154|FG001|Overall Study|None of above or not recorded|2|||
23586822|NCT04860258|65876155|FG000|Overall Study|Withdrawal by Subject|0|||
23586823|NCT04860258|65876156|FG001|Overall Study|Withdrawal by Subject|0|||
23586824|NCT04860258|65876157|FG002|Overall Study|Withdrawal by Subject|4|||
23187162|NCT00488631|64426457|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23187163|NCT00488631|64426458|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23187164|NCT00488631|64426459|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23351871|NCT05052697|65032887|FG031|Substudy A|No longer met eligibility criteria|0|||
23351872|NCT05052697|65032888|FG032|Substudy A|No longer met eligibility criteria|0|||
23351873|NCT05052697|65032889|FG033|Substudy A|No longer met eligibility criteria|0|||
23351874|NCT05052697|65032856|FG000|Substudy A|Not vaccinated|0|||
23467964|NCT03847896|65457184|FG003|Overall Study|Withdrawal by Subject|9|||
23467965|NCT03847896|65457185|FG004|Overall Study|Withdrawal by Subject|8|||
23467966|NCT03847896|65457181|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23586825|NCT04860258|65876158|FG003|Overall Study|Withdrawal by Subject|1|||
23586826|NCT04860258|65876159|FG004|Overall Study|Withdrawal by Subject|4|||
23586827|NCT04860258|65876160|FG005|Overall Study|Withdrawal by Subject|1|||
23586828|NCT04860258|65876161|FG006|Overall Study|Withdrawal by Subject|0|||
23586829|NCT01466881|65876167|FG000|Overall Study|Ineligible|5|||
23586830|NCT01466881|65876167|FG000|Overall Study|Adverse Event|6|||
23586831|NCT01466881|65876167|FG000|Overall Study|Progression/relapse|20|||
23586832|NCT01466881|65876167|FG000|Overall Study|Death|4|||
23351875|NCT05052697|65032857|FG001|Substudy A|Not vaccinated|0|||
23351876|NCT05052697|65032858|FG002|Substudy A|Not vaccinated|0|||
23586833|NCT01466881|65876167|FG000|Overall Study|Other reason not protocol specified|5|||
23586834|NCT01137292|65876168|FG000|Overall Study|Death|30|||
23586835|NCT01137292|65876168|FG000|Overall Study|Adverse Event|3|||
23586836|NCT01137292|65876168|FG000|Overall Study|Lack of Efficacy|13|||
23586837|NCT01137292|65876168|FG000|Overall Study|Lost to Follow-up|1|||
23586838|NCT01137292|65876168|FG000|Overall Study|Other|7|||
23467967|NCT03847896|65457182|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23467968|NCT03847896|65457183|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23467969|NCT03847896|65457184|FG003|Overall Study|Withdrawal by parent/guardian|0|||
23467970|NCT03847896|65457185|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23467971|NCT03847896|65457181|FG000|Overall Study|Adverse Event|2|||
23467972|NCT03847896|65457182|FG001|Overall Study|Adverse Event|1|||
23467973|NCT03847896|65457183|FG002|Overall Study|Adverse Event|3|||
23467974|NCT03847896|65457184|FG003|Overall Study|Adverse Event|2|||
23467975|NCT03847896|65457185|FG004|Overall Study|Adverse Event|4|||
23467976|NCT03847896|65457181|FG000|Overall Study|A severe exacerbation event|0|||
23586839|NCT01144182|65876171|FG000|Overall Study|Death|5|||
23586840|NCT01144182|65876172|FG001|Overall Study|Death|6|||
23586841|NCT01144182|65876171|FG000|Overall Study|Withdrawal by Subject|3|||
23467977|NCT03847896|65457182|FG001|Overall Study|A severe exacerbation event|0|||
23467978|NCT03847896|65457183|FG002|Overall Study|A severe exacerbation event|0|||
23467979|NCT03847896|65457184|FG003|Overall Study|A severe exacerbation event|0|||
23467980|NCT03847896|65457185|FG004|Overall Study|A severe exacerbation event|3|||
23467981|NCT03847896|65457181|FG000|Overall Study|Protocol Violation|0|||
23467982|NCT03847896|65457182|FG001|Overall Study|Protocol Violation|2|||
23467983|NCT03847896|65457183|FG002|Overall Study|Protocol Violation|1|||
23467984|NCT03847896|65457184|FG003|Overall Study|Protocol Violation|0|||
23467985|NCT03847896|65457185|FG004|Overall Study|Protocol Violation|2|||
23467986|NCT03847896|65457181|FG000|Overall Study|Lost to Follow-up|0|||
23467987|NCT03847896|65457182|FG001|Overall Study|Lost to Follow-up|0|||
23467988|NCT03847896|65457183|FG002|Overall Study|Lost to Follow-up|0|||
23467989|NCT03847896|65457184|FG003|Overall Study|Lost to Follow-up|1|||
23467990|NCT03847896|65457185|FG004|Overall Study|Lost to Follow-up|0|||
23467991|NCT03847896|65457181|FG000|Overall Study|Condition under investigation worsened|0|||
23467992|NCT03847896|65457182|FG001|Overall Study|Condition under investigation worsened|0|||
23467993|NCT03847896|65457183|FG002|Overall Study|Condition under investigation worsened|0|||
23467994|NCT03847896|65457184|FG003|Overall Study|Condition under investigation worsened|1|||
23467995|NCT03847896|65457185|FG004|Overall Study|Condition under investigation worsened|1|||
23467996|NCT03847896|65457181|FG000|Overall Study|Lack of Efficacy|0|||
23467997|NCT03847896|65457182|FG001|Overall Study|Lack of Efficacy|0|||
23467998|NCT03847896|65457183|FG002|Overall Study|Lack of Efficacy|0|||
23467999|NCT03847896|65457184|FG003|Overall Study|Lack of Efficacy|2|||
23468000|NCT03847896|65457185|FG004|Overall Study|Lack of Efficacy|2|||
23468001|NCT03847896|65457181|FG000|Overall Study|Other reasons|3|||
23468002|NCT03847896|65457182|FG001|Overall Study|Other reasons|3|||
23468003|NCT03847896|65457183|FG002|Overall Study|Other reasons|1|||
23468004|NCT03847896|65457184|FG003|Overall Study|Other reasons|2|||
23468005|NCT03847896|65457185|FG004|Overall Study|Other reasons|1|||
23468006|NCT02541604|65457186|FG000|Overall Study|Death|6|||
23468007|NCT02541604|65457187|FG001|Overall Study|Death|5|||
23586842|NCT01144182|65876172|FG001|Overall Study|Withdrawal by Subject|6|||
23586843|NCT01144182|65876171|FG000|Overall Study|Lost to Follow-up|9|||
23586844|NCT01144182|65876172|FG001|Overall Study|Lost to Follow-up|9|||
23586845|NCT04304534|65876175|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
23586846|NCT04304534|65876176|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
23468008|NCT02541604|65457188|FG002|Overall Study|Death|7|||
23468009|NCT02541604|65457189|FG003|Overall Study|Death|2|||
23468010|NCT02541604|65457190|FG004|Overall Study|Death|9|||
23468011|NCT02541604|65457191|FG005|Overall Study|Death|8|||
23586847|NCT04304534|65876177|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
23351877|NCT05052697|65032859|FG003|Substudy A|Not vaccinated|1|||
23468012|NCT02541604|65457192|FG006|Overall Study|Death|9|||
23468013|NCT02541604|65457193|FG007|Overall Study|Death|9|||
23468014|NCT02541604|65457194|FG008|Overall Study|Death|3|||
23468015|NCT02541604|65457195|FG009|Overall Study|Death|4|||
23468016|NCT02541604|65457196|FG010|Overall Study|Death|2|||
23468017|NCT02541604|65457197|FG011|Overall Study|Death|3|||
23468018|NCT02541604|65457186|FG000|Overall Study|Lost to Follow-up|2|||
23586848|NCT04304534|65876178|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
23586849|NCT04304534|65876175|FG000|Overall Study|Non-Compliance with study drug|0|||
23586850|NCT04304534|65876176|FG001|Overall Study|Non-Compliance with study drug|1|||
23586851|NCT04304534|65876177|FG002|Overall Study|Non-Compliance with study drug|1|||
23586852|NCT04304534|65876178|FG003|Overall Study|Non-Compliance with study drug|1|||
23586853|NCT04304534|65876175|FG000|Overall Study|Lost to Follow-up|0|||
23586854|NCT04304534|65876176|FG001|Overall Study|Lost to Follow-up|1|||
23586855|NCT04304534|65876177|FG002|Overall Study|Lost to Follow-up|2|||
23586856|NCT04304534|65876178|FG003|Overall Study|Lost to Follow-up|3|||
23586857|NCT04304534|65876175|FG000|Overall Study|Unspecific|4|||
23586858|NCT04304534|65876176|FG001|Overall Study|Unspecific|2|||
23586859|NCT04304534|65876177|FG002|Overall Study|Unspecific|2|||
23586860|NCT04304534|65876178|FG003|Overall Study|Unspecific|2|||
23586861|NCT04304534|65876175|FG000|Overall Study|Technical Problems|2|||
23586862|NCT04304534|65876176|FG001|Overall Study|Technical Problems|2|||
23586863|NCT04304534|65876177|FG002|Overall Study|Technical Problems|3|||
23586864|NCT04304534|65876178|FG003|Overall Study|Technical Problems|4|||
23586865|NCT04304534|65876175|FG000|Overall Study|Death|7|||
23586866|NCT04304534|65876176|FG001|Overall Study|Death|2|||
23586867|NCT04304534|65876177|FG002|Overall Study|Death|4|||
23586868|NCT04304534|65876178|FG003|Overall Study|Death|3|||
23586869|NCT04304534|65876175|FG000|Overall Study|Withdrawal by Subject|7|||
23586870|NCT04304534|65876176|FG001|Overall Study|Withdrawal by Subject|2|||
23586871|NCT04304534|65876177|FG002|Overall Study|Withdrawal by Subject|7|||
23586872|NCT04304534|65876178|FG003|Overall Study|Withdrawal by Subject|4|||
23586873|NCT04304534|65876175|FG000|Overall Study|Physician Decision|4|||
23586874|NCT04304534|65876176|FG001|Overall Study|Physician Decision|9|||
23586875|NCT04304534|65876177|FG002|Overall Study|Physician Decision|9|||
23586876|NCT04304534|65876178|FG003|Overall Study|Physician Decision|5|||
23586877|NCT04304534|65876175|FG000|Overall Study|Subject Decision|34|||
23187165|NCT00488631|64426460|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23351878|NCT05052697|65032860|FG004|Substudy A|Not vaccinated|0|||
23351879|NCT05052697|65032861|FG005|Substudy A|Not vaccinated|0|||
23351880|NCT05052697|65032862|FG006|Substudy A|Not vaccinated|0|||
23351881|NCT05052697|65032863|FG007|Substudy A|Not vaccinated|0|||
23351882|NCT05052697|65032864|FG008|Substudy A|Not vaccinated|1|||
23351883|NCT05052697|65032865|FG009|Substudy A|Not vaccinated|0|||
23351884|NCT05052697|65032866|FG010|Substudy A|Not vaccinated|0|||
23351885|NCT05052697|65032867|FG011|Substudy A|Not vaccinated|0|||
23351886|NCT05052697|65032868|FG012|Substudy A|Not vaccinated|0|||
23351887|NCT05052697|65032869|FG013|Substudy A|Not vaccinated|0|||
23351888|NCT05052697|65032870|FG014|Substudy A|Not vaccinated|0|||
23351889|NCT05052697|65032871|FG015|Substudy A|Not vaccinated|0|||
23351890|NCT05052697|65032872|FG016|Substudy A|Not vaccinated|0|||
23351891|NCT05052697|65032873|FG017|Substudy A|Not vaccinated|0|||
23351892|NCT05052697|65032874|FG018|Substudy A|Not vaccinated|0|||
23351893|NCT05052697|65032875|FG019|Substudy A|Not vaccinated|0|||
23351894|NCT05052697|65032876|FG020|Substudy A|Not vaccinated|0|||
23351895|NCT05052697|65032877|FG021|Substudy A|Not vaccinated|0|||
23351896|NCT05052697|65032878|FG022|Substudy A|Not vaccinated|0|||
23351897|NCT05052697|65032879|FG023|Substudy A|Not vaccinated|0|||
23351898|NCT05052697|65032880|FG024|Substudy A|Not vaccinated|0|||
23351899|NCT05052697|65032881|FG025|Substudy A|Not vaccinated|0|||
23586878|NCT04304534|65876176|FG001|Overall Study|Subject Decision|25|||
23586879|NCT04304534|65876177|FG002|Overall Study|Subject Decision|25|||
23187166|NCT00488631|64426461|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23187167|NCT00488631|64426462|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
23187168|NCT00488631|64426463|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23187169|NCT00488631|64426464|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
23187170|NCT00488631|64426465|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
23187171|NCT00488631|64426456|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23187172|NCT00488631|64426457|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23187173|NCT00488631|64426458|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23187174|NCT00488631|64426459|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23187175|NCT00488631|64426460|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23187176|NCT00488631|64426461|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23187177|NCT00488631|64426462|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
23187178|NCT00488631|64426463|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
23187179|NCT00488631|64426464|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
23187180|NCT00488631|64426465|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
23187181|NCT02717507|64426466|FG000|Overall Study|Lost to Follow-up|5|||
23586880|NCT04304534|65876178|FG003|Overall Study|Subject Decision|26|||
23351900|NCT05052697|65032882|FG026|Substudy A|Not vaccinated|0|||
23351901|NCT05052697|65032883|FG027|Substudy A|Not vaccinated|0|||
23351902|NCT05052697|65032884|FG028|Substudy A|Not vaccinated|0|||
23586881|NCT04304534|65876175|FG000|Overall Study|Adverse Event|35|||
23351903|NCT05052697|65032885|FG029|Substudy A|Not vaccinated|0|||
23351904|NCT05052697|65032886|FG030|Substudy A|Not vaccinated|0|||
23586882|NCT04304534|65876176|FG001|Overall Study|Adverse Event|40|||
23245707|NCT04512976|64642077|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23245708|NCT04512976|64642078|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23245709|NCT04512976|64642079|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23245710|NCT04512976|64642080|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23245711|NCT04512976|64642081|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
23245712|NCT04512976|64642082|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
23245713|NCT04969263|64642083|FG000|Overall Study|Death|1|||
23245714|NCT04969263|64642083|FG000|Overall Study|Lost to Follow-up|2|||
23245715|NCT04969263|64642083|FG000|Overall Study|Withdrawal by Subject|5|||
23586883|NCT04304534|65876177|FG002|Overall Study|Adverse Event|39|||
23586884|NCT04304534|65876178|FG003|Overall Study|Adverse Event|44|||
23586885|NCT03396835|65876184|FG000|Overall Study|Withdrawn prior to completion|1|||
23586886|NCT03396835|65876184|FG000|Overall Study|Did not meet criteria for data analysis|1|||
23586887|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
23586888|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
23586889|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
23586890|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
23586891|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
23586892|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
23586893|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
23586894|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
23586895|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
23586896|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
23586897|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
23586898|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
23586899|NCT02057718|65876185|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
23586900|NCT02057718|65876186|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
23586901|NCT02057718|65876185|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
23586902|NCT02057718|65876186|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
23586903|NCT02057718|65876185|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
23586904|NCT02057718|65876186|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
23586905|NCT02057718|65876185|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
23586906|NCT02057718|65876186|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
23586907|NCT02057718|65876185|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
23187182|NCT02717507|64426467|FG001|Overall Study|Lost to Follow-up|8|||
23187183|NCT02717507|64426466|FG000|Overall Study|Pregnancy|1|||
23187184|NCT02717507|64426467|FG001|Overall Study|Pregnancy|1|||
23187185|NCT02717507|64426466|FG000|Overall Study|Protocol Violation|2|||
23187186|NCT02717507|64426467|FG001|Overall Study|Protocol Violation|2|||
23187187|NCT02717507|64426466|FG000|Overall Study|Withdrawal by Subject|20|||
23187188|NCT02717507|64426467|FG001|Overall Study|Withdrawal by Subject|20|||
23187189|NCT02717507|64426466|FG000|Overall Study|Relapse|1|||
23187190|NCT02717507|64426467|FG001|Overall Study|Relapse|1|||
23187191|NCT02717507|64426466|FG000|Overall Study|Cardiac Event|2|||
23187192|NCT02717507|64426467|FG001|Overall Study|Cardiac Event|6|||
23187193|NCT00630032|64426468|FG000|Overall Study|Death|55|||
23187194|NCT00630032|64426469|FG001|Overall Study|Death|49|||
23187195|NCT00630032|64426468|FG000|Overall Study|Withdrawal by Subject|3|||
23187196|NCT00630032|64426469|FG001|Overall Study|Withdrawal by Subject|2|||
23187197|NCT00630032|64426468|FG000|Overall Study|Lost to Follow-up|18|||
23187198|NCT00630032|64426469|FG001|Overall Study|Lost to Follow-up|31|||
23187199|NCT00630032|64426468|FG000|Overall Study|Protocol Violation|1|||
23187200|NCT00630032|64426469|FG001|Overall Study|Protocol Violation|0|||
23187201|NCT00630032|64426468|FG000|Overall Study|Patient has moved|1|||
23187202|NCT00630032|64426469|FG001|Overall Study|Patient has moved|1|||
23187203|NCT00630032|64426468|FG000|Overall Study|Disease progression|1|||
23187204|NCT00630032|64426469|FG001|Overall Study|Disease progression|1|||
23187205|NCT00630032|64426468|FG000|Overall Study|End of monitoring in US centers|11|||
23187206|NCT00630032|64426469|FG001|Overall Study|End of monitoring in US centers|11|||
23351905|NCT05052697|65032887|FG031|Substudy A|Not vaccinated|0|||
23351906|NCT05052697|65032888|FG032|Substudy A|Not vaccinated|0|||
23187207|NCT00742781|64426470|FG000|Overall Study|Withdrawal by Subject|3|||
23187208|NCT03853694|64426471|FG000|Overall Study|Protocol Violation|3|||
23187209|NCT03853694|64426472|FG001|Overall Study|Protocol Violation|5|||
23187210|NCT03853694|64426473|FG002|Overall Study|Protocol Violation|3|||
23187211|NCT03853694|64426471|FG000|Overall Study|Delivered early|0|||
23586908|NCT02057718|65876186|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
23586909|NCT00741988|65876187|FG000|Overall Study|Adverse Event|2|||
23586910|NCT00741988|65876188|FG001|Overall Study|Adverse Event|4|||
23586911|NCT00741988|65876187|FG000|Overall Study|Lack of Efficacy|2|||
23245716|NCT04969263|64642083|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
23245717|NCT05993299|64642084|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
23245718|NCT05993299|64642084|FG000|Overall Study|Ongoing|4|||
23245719|NCT04780776|64642085|FG000|Titration Week 1-5|Lost to Follow-up|2|||
23245720|NCT04780776|64642086|FG001|Titration Week 1-5|Lost to Follow-up|8|||
23245721|NCT04780776|64642085|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
23245722|NCT04780776|64642086|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
23245723|NCT04780776|64642085|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
23245724|NCT04780776|64642086|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
23586912|NCT00741988|65876188|FG001|Overall Study|Lack of Efficacy|0|||
23351907|NCT05052697|65032889|FG033|Substudy A|Not vaccinated|0|||
23351908|NCT05052697|65032856|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23586913|NCT01616654|65876189|FG000|Overall Study|Lack of Efficacy|1|||
23586914|NCT01616654|65876190|FG001|Overall Study|Lack of Efficacy|0|||
23586915|NCT01616654|65876191|FG002|Overall Study|Lack of Efficacy|0|||
23586916|NCT01616654|65876192|FG003|Overall Study|Lack of Efficacy|0|||
23586917|NCT01616654|65876193|FG004|Overall Study|Lack of Efficacy|1|||
23586918|NCT01616654|65876189|FG000|Overall Study|Adverse Event|0|||
23586919|NCT01616654|65876190|FG001|Overall Study|Adverse Event|1|||
23586920|NCT01616654|65876191|FG002|Overall Study|Adverse Event|2|||
23586921|NCT01616654|65876192|FG003|Overall Study|Adverse Event|1|||
23586922|NCT01616654|65876193|FG004|Overall Study|Adverse Event|0|||
23586923|NCT01616654|65876189|FG000|Overall Study|Withdrawal by Subject|2|||
23586924|NCT01616654|65876190|FG001|Overall Study|Withdrawal by Subject|2|||
23586925|NCT01616654|65876191|FG002|Overall Study|Withdrawal by Subject|3|||
23586926|NCT01616654|65876192|FG003|Overall Study|Withdrawal by Subject|1|||
23586927|NCT01616654|65876193|FG004|Overall Study|Withdrawal by Subject|5|||
23586928|NCT01616654|65876189|FG000|Overall Study|Protocol Violation|0|||
23586929|NCT01616654|65876190|FG001|Overall Study|Protocol Violation|5|||
23586930|NCT01616654|65876191|FG002|Overall Study|Protocol Violation|2|||
23586931|NCT01616654|65876192|FG003|Overall Study|Protocol Violation|4|||
23586932|NCT01616654|65876193|FG004|Overall Study|Protocol Violation|4|||
23586933|NCT01616654|65876189|FG000|Overall Study|Lost to Follow-up|1|||
23586934|NCT01616654|65876190|FG001|Overall Study|Lost to Follow-up|0|||
23586935|NCT01616654|65876191|FG002|Overall Study|Lost to Follow-up|3|||
23586936|NCT01616654|65876192|FG003|Overall Study|Lost to Follow-up|2|||
23586937|NCT01616654|65876193|FG004|Overall Study|Lost to Follow-up|1|||
23586938|NCT01616654|65876189|FG000|Overall Study|Pregnancy|1|||
23586939|NCT01616654|65876190|FG001|Overall Study|Pregnancy|0|||
23586940|NCT01616654|65876191|FG002|Overall Study|Pregnancy|0|||
23586941|NCT01616654|65876192|FG003|Overall Study|Pregnancy|0|||
23586942|NCT01616654|65876193|FG004|Overall Study|Pregnancy|1|||
23586943|NCT00139737|65876198|FG000|Overall Study|Withdrawal by Subject|190|||
23586944|NCT00139737|65876198|FG000|Overall Study|Adverse Event|58|||
23586945|NCT00139737|65876198|FG000|Overall Study|Lack of Efficacy|40|||
23586946|NCT00139737|65876198|FG000|Overall Study|Lost to Follow-up|8|||
23586947|NCT00139737|65876198|FG000|Overall Study|Death|3|||
23586948|NCT00139737|65876198|FG000|Overall Study|Laboratory Abnormality|2|||
23586949|NCT00139737|65876198|FG000|Overall Study|Protocol Violation|18|||
23586950|NCT00139737|65876198|FG000|Overall Study|Withdrew During Screening Phase|8|||
23586951|NCT00139737|65876198|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23586952|NCT00139737|65876198|FG000|Overall Study|Screened, Not Treated|13|||
23586953|NCT00591838|65876202|FG000|Overall Study|Withdrawal by Subject|0|||
23586954|NCT00591838|65876203|FG001|Overall Study|Withdrawal by Subject|0|||
23586955|NCT00591838|65876204|FG002|Overall Study|Withdrawal by Subject|0|||
23586956|NCT00591838|65876205|FG003|Overall Study|Withdrawal by Subject|1|||
23586957|NCT00591838|65876206|FG004|Overall Study|Withdrawal by Subject|0|||
23586958|NCT00619645|65876207|FG000|Overall Study|Adverse Event|1|||
23586959|NCT02106442|65876208|FG000|Overall Study|Case Report Forms Uncollected|7|||
23586960|NCT02106442|65876208|FG000|Overall Study|Protocol Deviation|30|||
23586961|NCT03255018|65876209|FG000|Overall Study|Death on study|0|||
23586962|NCT03255018|65876210|FG001|Overall Study|Death on study|5|||
23586963|NCT03255018|65876209|FG000|Overall Study|Withdrawal by Subject|0|||
23586964|NCT03255018|65876210|FG001|Overall Study|Withdrawal by Subject|2|||
23586965|NCT01648140|65876213|FG000|Overall Study|Physician Decision|1|||
23586966|NCT01648140|65876214|FG001|Overall Study|Physician Decision|0|||
23586967|NCT01648140|65876215|FG002|Overall Study|Physician Decision|0|||
23586968|NCT01648140|65876216|FG003|Overall Study|Physician Decision|0|||
23586969|NCT01648140|65876213|FG000|Overall Study|Lack of Efficacy|4|||
23586970|NCT01648140|65876214|FG001|Overall Study|Lack of Efficacy|7|||
23586971|NCT01648140|65876215|FG002|Overall Study|Lack of Efficacy|1|||
23586972|NCT01648140|65876216|FG003|Overall Study|Lack of Efficacy|0|||
23586973|NCT01648140|65876213|FG000|Overall Study|Adverse Event|3|||
23586974|NCT01648140|65876214|FG001|Overall Study|Adverse Event|1|||
23586975|NCT01648140|65876215|FG002|Overall Study|Adverse Event|2|||
23586976|NCT01648140|65876216|FG003|Overall Study|Adverse Event|0|||
23586977|NCT01648140|65876213|FG000|Overall Study|Withdrawal by Subject|2|||
23586978|NCT01648140|65876214|FG001|Overall Study|Withdrawal by Subject|3|||
23586979|NCT01648140|65876215|FG002|Overall Study|Withdrawal by Subject|3|||
23586980|NCT01648140|65876216|FG003|Overall Study|Withdrawal by Subject|2|||
23586981|NCT01648140|65876213|FG000|Overall Study|Lost to Follow-up|2|||
23586982|NCT01648140|65876214|FG001|Overall Study|Lost to Follow-up|1|||
23586983|NCT01648140|65876215|FG002|Overall Study|Lost to Follow-up|2|||
23586984|NCT01648140|65876216|FG003|Overall Study|Lost to Follow-up|0|||
23586985|NCT00762463|65876217|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
23586986|NCT00762463|65876218|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
23586987|NCT00762463|65876219|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
23586988|NCT00762463|65876220|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
23586989|NCT00762463|65876217|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
23586990|NCT00762463|65876218|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
23586991|NCT00762463|65876219|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
23586992|NCT00762463|65876220|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
23586993|NCT00762463|65876217|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
23245743|NCT02257736|64642089|FG000|Overall Study|Progressive disease|365|||
23245744|NCT02257736|64642090|FG001|Overall Study|Progressive disease|327|||
23245745|NCT02257736|64642089|FG000|Overall Study|Adverse Event|45|||
23245746|NCT02257736|64642090|FG001|Overall Study|Adverse Event|56|||
23586994|NCT00762463|65876218|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
23586995|NCT00762463|65876219|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
23586996|NCT00762463|65876220|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
23586997|NCT00762463|65876217|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
23586998|NCT00762463|65876218|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
23586999|NCT00762463|65876219|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
23587000|NCT00762463|65876220|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
23587001|NCT00762463|65876217|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
23351909|NCT05052697|65032857|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23245747|NCT02257736|64642089|FG000|Overall Study|Withdrawal by Subject|21|||
23245748|NCT02257736|64642090|FG001|Overall Study|Withdrawal by Subject|38|||
23245749|NCT02257736|64642089|FG000|Overall Study|Death|11|||
23245750|NCT02257736|64642090|FG001|Overall Study|Death|6|||
23245751|NCT02257736|64642089|FG000|Overall Study|Physician Decision|5|||
23245752|NCT02257736|64642090|FG001|Overall Study|Physician Decision|9|||
23245753|NCT02257736|64642089|FG000|Overall Study|Non-Compliance with study drug|1|||
23245754|NCT02257736|64642090|FG001|Overall Study|Non-Compliance with study drug|2|||
23245755|NCT02257736|64642089|FG000|Overall Study|Protocol Violation|1|||
23245756|NCT02257736|64642090|FG001|Overall Study|Protocol Violation|0|||
23245757|NCT02257736|64642089|FG000|Overall Study|Other|1|||
23245758|NCT02257736|64642090|FG001|Overall Study|Other|7|||
23245759|NCT02257736|64642089|FG000|Overall Study|Randomized, not treated|1|||
23245760|NCT02257736|64642090|FG001|Overall Study|Randomized, not treated|2|||
23245761|NCT04888377|64642091|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
23245762|NCT04888377|64642092|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
23245763|NCT04888377|64642091|FG000|Overall Study|Physician Decision|6|||
23245764|NCT04888377|64642092|FG001|Overall Study|Physician Decision|6|||
23245765|NCT04888377|64642091|FG000|Overall Study|Withdrawal by Subject|7|||
23245766|NCT04888377|64642092|FG001|Overall Study|Withdrawal by Subject|3|||
23245767|NCT05637515|64642095|FG000|Overall Study|Withdrawal by Subject|17|||
23245768|NCT05637515|64642096|FG001|Overall Study|Withdrawal by Subject|17|||
23245769|NCT05279807|64642103|FG000|Overall Study|Withdrawal by Subject|1|||
23245770|NCT05279807|64642104|FG001|Overall Study|Withdrawal by Subject|0|||
23245771|NCT05279807|64642103|FG000|Overall Study|Adverse Event|0|||
23245772|NCT05279807|64642104|FG001|Overall Study|Adverse Event|1|||
23245773|NCT05279807|64642103|FG000|Overall Study|Laboratory Abnormal Results|1|||
23245774|NCT05279807|64642104|FG001|Overall Study|Laboratory Abnormal Results|0|||
23245775|NCT01371981|64642105|FG000|Overall Study|Adverse Event|12|||
23245776|NCT01371981|64642106|FG001|Overall Study|Adverse Event|17|||
23245777|NCT01371981|64642107|FG002|Overall Study|Adverse Event|0|||
23245778|NCT01371981|64642108|FG003|Overall Study|Adverse Event|4|||
23245779|NCT01371981|64642109|FG004|Overall Study|Adverse Event|1|||
23245780|NCT01371981|64642110|FG005|Overall Study|Adverse Event|0|||
23245781|NCT01371981|64642105|FG000|Overall Study|Death|22|||
23245782|NCT01371981|64642106|FG001|Overall Study|Death|16|||
23245783|NCT01371981|64642107|FG002|Overall Study|Death|0|||
23245784|NCT01371981|64642108|FG003|Overall Study|Death|0|||
23245785|NCT01371981|64642109|FG004|Overall Study|Death|2|||
23245786|NCT01371981|64642110|FG005|Overall Study|Death|2|||
23351910|NCT05052697|65032858|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351911|NCT05052697|65032859|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23187212|NCT03853694|64426472|FG001|Overall Study|Delivered early|1|||
23187213|NCT03853694|64426473|FG002|Overall Study|Delivered early|0|||
23187214|NCT03853694|64426471|FG000|Overall Study|not suitable to proceed|0|||
23187215|NCT03853694|64426472|FG001|Overall Study|not suitable to proceed|1|||
23187216|NCT03853694|64426473|FG002|Overall Study|not suitable to proceed|0|||
23187217|NCT03853694|64426471|FG000|Overall Study|difficult surgery|0|||
23187218|NCT03853694|64426472|FG001|Overall Study|difficult surgery|0|||
23187219|NCT03853694|64426473|FG002|Overall Study|difficult surgery|1|||
23187220|NCT03853694|64426471|FG000|Overall Study|Lost to Follow-up|0|||
23187221|NCT03853694|64426472|FG001|Overall Study|Lost to Follow-up|1|||
23187222|NCT03853694|64426473|FG002|Overall Study|Lost to Follow-up|0|||
23187223|NCT03853694|64426471|FG000|Overall Study|Withdrawal by Subject|0|||
23187224|NCT03853694|64426472|FG001|Overall Study|Withdrawal by Subject|1|||
23187225|NCT03853694|64426473|FG002|Overall Study|Withdrawal by Subject|0|||
23187226|NCT00892437|64426474|FG000|Randomized Phase|Randomized but not treated|6|||
23187227|NCT00892437|64426475|FG001|Randomized Phase|Randomized but not treated|0|||
23187228|NCT00892437|64426474|FG000|Randomized Phase|Adverse Event|2|||
23187229|NCT00892437|64426475|FG001|Randomized Phase|Adverse Event|2|||
23187230|NCT00892437|64426474|FG000|Randomized Phase|Lost to Follow-up|1|||
23187231|NCT00892437|64426475|FG001|Randomized Phase|Lost to Follow-up|3|||
23187232|NCT00892437|64426474|FG000|Randomized Phase|Investigator's Discretion|1|||
23187233|NCT00892437|64426475|FG001|Randomized Phase|Investigator's Discretion|0|||
23187234|NCT00892437|64426474|FG000|Randomized Phase|Withdrew Consent|1|||
23187235|NCT00892437|64426475|FG001|Randomized Phase|Withdrew Consent|0|||
23187236|NCT00892437|64426474|FG000|Open-Label Extension Phase|Adverse Event|4|||
23187237|NCT00892437|64426475|FG001|Open-Label Extension Phase|Adverse Event|2|||
23187238|NCT00892437|64426474|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
23187239|NCT00892437|64426475|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
23187240|NCT00892437|64426474|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
23187241|NCT00892437|64426475|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
23187242|NCT00892437|64426474|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
23187243|NCT00892437|64426475|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
23187244|NCT00892437|64426474|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
23187245|NCT00892437|64426475|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
23187246|NCT03116113|64426476|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23187247|NCT03116113|64426477|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23187248|NCT03116113|64426478|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23187249|NCT03116113|64426479|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23187250|NCT03116113|64426480|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23187251|NCT03116113|64426481|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23187252|NCT03116113|64426482|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
23187253|NCT03116113|64426483|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
23187254|NCT03116113|64426484|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
23187255|NCT03075839|64426490|FG000|Overall Study|Lost to Follow-up|4|||
23187256|NCT03830281|64426492|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
23187257|NCT03830281|64426493|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
23187258|NCT03830281|64426492|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
23187259|NCT03830281|64426493|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
23187260|NCT03830281|64426492|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
23187261|NCT03830281|64426493|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
23187262|NCT03830281|64426492|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
23187263|NCT03830281|64426493|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
23187264|NCT03830281|64426492|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
23187265|NCT03830281|64426493|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
23187266|NCT03830281|64426492|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
23187267|NCT03830281|64426493|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
23187268|NCT03830281|64426492|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
23187269|NCT03830281|64426493|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
23187270|NCT03830281|64426492|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
23187271|NCT03830281|64426493|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
23187272|NCT03830281|64426492|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
23187273|NCT03830281|64426493|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
23187274|NCT00509106|64426494|FG000|Overall Study|Adverse Event|3|||
23187275|NCT00509106|64426495|FG001|Overall Study|Adverse Event|2|||
23187276|NCT00509106|64426494|FG000|Overall Study|Noncompliance|0|||
23187277|NCT00509106|64426495|FG001|Overall Study|Noncompliance|1|||
23351912|NCT05052697|65032860|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351913|NCT05052697|65032861|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351914|NCT05052697|65032862|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351915|NCT05052697|65032863|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351916|NCT05052697|65032864|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351917|NCT05052697|65032865|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351918|NCT05052697|65032866|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351919|NCT05052697|65032867|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351920|NCT05052697|65032868|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351921|NCT05052697|65032869|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351922|NCT05052697|65032870|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351923|NCT05052697|65032871|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351924|NCT05052697|65032872|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351925|NCT05052697|65032873|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351926|NCT05052697|65032874|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
23351927|NCT05052697|65032875|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
23351928|NCT05052697|65032876|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351929|NCT05052697|65032877|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
23351930|NCT05052697|65032878|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
23351931|NCT05052697|65032879|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351932|NCT05052697|65032880|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351933|NCT05052697|65032881|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351934|NCT05052697|65032882|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351935|NCT05052697|65032883|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351936|NCT05052697|65032884|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351937|NCT05052697|65032885|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351938|NCT05052697|65032886|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351939|NCT05052697|65032887|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351940|NCT05052697|65032888|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351941|NCT05052697|65032889|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
23351942|NCT05052697|65032856|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351943|NCT05052697|65032857|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351944|NCT05052697|65032858|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351945|NCT05052697|65032859|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351946|NCT05052697|65032860|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351947|NCT05052697|65032861|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351948|NCT05052697|65032862|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351949|NCT05052697|65032863|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
23245787|NCT01371981|64642105|FG000|Overall Study|Lack of Efficacy|69|||
23245788|NCT01371981|64642106|FG001|Overall Study|Lack of Efficacy|61|||
23245789|NCT01371981|64642107|FG002|Overall Study|Lack of Efficacy|4|||
23245790|NCT01371981|64642108|FG003|Overall Study|Lack of Efficacy|8|||
23245791|NCT01371981|64642109|FG004|Overall Study|Lack of Efficacy|5|||
23245792|NCT01371981|64642110|FG005|Overall Study|Lack of Efficacy|0|||
23245793|NCT01371981|64642105|FG000|Overall Study|Physician Decision|48|||
23245794|NCT01371981|64642106|FG001|Overall Study|Physician Decision|63|||
23245795|NCT01371981|64642107|FG002|Overall Study|Physician Decision|1|||
23245796|NCT01371981|64642108|FG003|Overall Study|Physician Decision|7|||
23245797|NCT01371981|64642109|FG004|Overall Study|Physician Decision|14|||
23245798|NCT01371981|64642110|FG005|Overall Study|Physician Decision|3|||
23245799|NCT01371981|64642105|FG000|Overall Study|Withdrawal by Subject|12|||
23245800|NCT01371981|64642106|FG001|Overall Study|Withdrawal by Subject|19|||
23245801|NCT01371981|64642107|FG002|Overall Study|Withdrawal by Subject|1|||
23245802|NCT01371981|64642108|FG003|Overall Study|Withdrawal by Subject|2|||
23245803|NCT01371981|64642109|FG004|Overall Study|Withdrawal by Subject|10|||
23245804|NCT01371981|64642110|FG005|Overall Study|Withdrawal by Subject|3|||
23245805|NCT01371981|64642105|FG000|Overall Study|Ineligible|19|||
23245806|NCT01371981|64642106|FG001|Overall Study|Ineligible|13|||
23245807|NCT01371981|64642107|FG002|Overall Study|Ineligible|0|||
23245808|NCT01371981|64642108|FG003|Overall Study|Ineligible|0|||
23351950|NCT05052697|65032864|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351951|NCT05052697|65032865|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351952|NCT05052697|65032866|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351953|NCT05052697|65032867|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351954|NCT05052697|65032868|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351955|NCT05052697|65032869|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
23245809|NCT01371981|64642109|FG004|Overall Study|Ineligible|0|||
23351956|NCT05052697|65032870|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351957|NCT05052697|65032871|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351958|NCT05052697|65032872|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
23245810|NCT01371981|64642110|FG005|Overall Study|Ineligible|4|||
23245811|NCT01371981|64642105|FG000|Overall Study|Did not start treatment|2|||
23245812|NCT01371981|64642106|FG001|Overall Study|Did not start treatment|3|||
23245813|NCT01371981|64642107|FG002|Overall Study|Did not start treatment|0|||
23351959|NCT05052697|65032873|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
23351960|NCT05052697|65032874|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351961|NCT05052697|65032875|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351962|NCT05052697|65032876|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351963|NCT05052697|65032877|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351964|NCT05052697|65032878|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351965|NCT05052697|65032879|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351966|NCT05052697|65032880|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351967|NCT05052697|65032881|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351968|NCT05052697|65032882|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351969|NCT05052697|65032883|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351970|NCT05052697|65032884|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351971|NCT05052697|65032885|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351972|NCT05052697|65032886|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351973|NCT05052697|65032887|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351974|NCT05052697|65032888|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351975|NCT05052697|65032889|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
23351976|NCT05052697|65032856|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351977|NCT05052697|65032857|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351978|NCT05052697|65032858|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351979|NCT05052697|65032859|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351980|NCT05052697|65032860|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351981|NCT05052697|65032861|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351982|NCT05052697|65032862|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351983|NCT05052697|65032863|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351984|NCT05052697|65032864|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351985|NCT05052697|65032865|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351986|NCT05052697|65032866|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351987|NCT05052697|65032867|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351988|NCT05052697|65032868|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351989|NCT05052697|65032869|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351990|NCT05052697|65032870|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351991|NCT05052697|65032871|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351992|NCT05052697|65032872|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351993|NCT05052697|65032873|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351994|NCT05052697|65032874|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351995|NCT05052697|65032875|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
23351996|NCT05052697|65032876|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351997|NCT05052697|65032877|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351998|NCT05052697|65032878|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23351999|NCT05052697|65032879|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352000|NCT05052697|65032880|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352001|NCT05052697|65032881|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352002|NCT05052697|65032882|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352003|NCT05052697|65032883|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352004|NCT05052697|65032884|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352005|NCT05052697|65032885|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352006|NCT05052697|65032886|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352007|NCT05052697|65032887|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352008|NCT05052697|65032888|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352009|NCT05052697|65032889|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
23352010|NCT05052697|65032856|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352011|NCT05052697|65032857|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352012|NCT05052697|65032858|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352013|NCT05052697|65032859|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352014|NCT05052697|65032860|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352015|NCT05052697|65032861|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352016|NCT05052697|65032862|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352017|NCT05052697|65032863|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352018|NCT05052697|65032864|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352019|NCT05052697|65032865|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352020|NCT05052697|65032866|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352021|NCT05052697|65032867|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352022|NCT05052697|65032868|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352023|NCT05052697|65032869|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352024|NCT05052697|65032870|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352025|NCT05052697|65032871|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352026|NCT05052697|65032872|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352027|NCT05052697|65032873|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
23352028|NCT05052697|65032874|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352029|NCT05052697|65032875|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352030|NCT05052697|65032876|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352031|NCT05052697|65032877|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352032|NCT05052697|65032878|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352033|NCT05052697|65032879|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352034|NCT05052697|65032880|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352035|NCT05052697|65032881|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
23352036|NCT05052697|65032882|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352037|NCT05052697|65032883|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
23352038|NCT05052697|65032884|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352039|NCT05052697|65032885|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352040|NCT05052697|65032886|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352041|NCT05052697|65032887|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352042|NCT05052697|65032888|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352043|NCT05052697|65032889|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
23352044|NCT05052697|65032856|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352045|NCT05052697|65032857|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352046|NCT05052697|65032858|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352047|NCT05052697|65032859|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352048|NCT05052697|65032860|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352049|NCT05052697|65032861|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352050|NCT05052697|65032862|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352051|NCT05052697|65032863|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352052|NCT05052697|65032864|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352053|NCT05052697|65032865|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352054|NCT05052697|65032866|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352055|NCT05052697|65032867|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352056|NCT05052697|65032868|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352057|NCT05052697|65032869|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352058|NCT05052697|65032870|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352059|NCT05052697|65032871|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352060|NCT05052697|65032872|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352061|NCT05052697|65032873|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352062|NCT05052697|65032874|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352063|NCT05052697|65032875|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352064|NCT05052697|65032876|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352065|NCT05052697|65032877|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352066|NCT05052697|65032878|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352067|NCT05052697|65032879|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352068|NCT05052697|65032880|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352069|NCT05052697|65032881|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352070|NCT05052697|65032882|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352071|NCT05052697|65032883|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352072|NCT05052697|65032884|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
23352073|NCT05052697|65032885|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352074|NCT05052697|65032886|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
23352075|NCT05052697|65032887|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
23352076|NCT05052697|65032888|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
23352077|NCT05052697|65032889|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
23352078|NCT05052697|65032856|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352079|NCT05052697|65032857|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352080|NCT05052697|65032858|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352081|NCT05052697|65032859|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352082|NCT05052697|65032860|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352083|NCT05052697|65032861|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352084|NCT05052697|65032862|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352085|NCT05052697|65032863|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352086|NCT05052697|65032864|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352087|NCT05052697|65032865|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23187278|NCT00509106|64426494|FG000|Overall Study|At the request of sponsor/investigator|1|||
23187279|NCT00509106|64426495|FG001|Overall Study|At the request of sponsor/investigator|2|||
23187280|NCT00509106|64426494|FG000|Overall Study|Withdrew consent|4|||
23187281|NCT00509106|64426495|FG001|Overall Study|Withdrew consent|8|||
23187282|NCT00509106|64426494|FG000|Overall Study|Lost to Follow-up|16|||
23187283|NCT00509106|64426495|FG001|Overall Study|Lost to Follow-up|10|||
23187284|NCT00509106|64426494|FG000|Overall Study|Other|1|||
23187285|NCT00509106|64426495|FG001|Overall Study|Other|0|||
23352088|NCT05052697|65032866|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352089|NCT05052697|65032867|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352090|NCT05052697|65032868|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352091|NCT05052697|65032869|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352092|NCT05052697|65032870|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352093|NCT05052697|65032871|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352094|NCT05052697|65032872|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352095|NCT05052697|65032873|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352096|NCT05052697|65032874|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352097|NCT05052697|65032875|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352098|NCT05052697|65032876|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352099|NCT05052697|65032877|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352100|NCT05052697|65032878|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352101|NCT05052697|65032879|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352102|NCT05052697|65032880|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352103|NCT05052697|65032881|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352104|NCT05052697|65032882|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352105|NCT05052697|65032883|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352106|NCT05052697|65032884|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
23352107|NCT05052697|65032885|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
23352108|NCT05052697|65032886|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
23352109|NCT05052697|65032887|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
23352110|NCT05052697|65032888|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
23352111|NCT05052697|65032889|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
23352112|NCT05052697|65032856|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352113|NCT05052697|65032857|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352114|NCT05052697|65032858|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352115|NCT05052697|65032859|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352116|NCT05052697|65032860|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352117|NCT05052697|65032861|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352118|NCT05052697|65032862|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352119|NCT05052697|65032863|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352120|NCT05052697|65032864|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352121|NCT05052697|65032865|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352122|NCT05052697|65032866|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352123|NCT05052697|65032867|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352124|NCT05052697|65032868|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352125|NCT05052697|65032869|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352126|NCT05052697|65032870|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352127|NCT05052697|65032871|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352128|NCT05052697|65032872|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352129|NCT05052697|65032873|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352130|NCT05052697|65032874|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352131|NCT05052697|65032875|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352132|NCT05052697|65032876|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352133|NCT05052697|65032877|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352134|NCT05052697|65032878|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352135|NCT05052697|65032879|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352136|NCT05052697|65032880|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23587002|NCT00762463|65876218|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
23587003|NCT00762463|65876219|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
23587004|NCT00762463|65876220|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
23587005|NCT00762463|65876217|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
23587006|NCT00762463|65876218|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
23587007|NCT00762463|65876219|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
23587008|NCT00762463|65876220|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
23587009|NCT00762463|65876217|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
23587010|NCT00762463|65876218|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
23587011|NCT00762463|65876219|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
23587012|NCT00762463|65876220|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
23587013|NCT00762463|65876217|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
23352137|NCT05052697|65032881|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352138|NCT05052697|65032882|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352139|NCT05052697|65032883|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352140|NCT05052697|65032884|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352141|NCT05052697|65032885|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352142|NCT05052697|65032886|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352143|NCT05052697|65032887|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352144|NCT05052697|65032888|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
23352145|NCT05052697|65032889|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
23352146|NCT05052697|65032856|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352147|NCT05052697|65032857|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352148|NCT05052697|65032858|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352149|NCT05052697|65032859|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352150|NCT05052697|65032860|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352151|NCT05052697|65032861|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352152|NCT05052697|65032862|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352153|NCT05052697|65032863|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352154|NCT05052697|65032864|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352155|NCT05052697|65032865|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352156|NCT05052697|65032866|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352157|NCT05052697|65032867|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352158|NCT05052697|65032868|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352159|NCT05052697|65032869|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352160|NCT05052697|65032870|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352161|NCT05052697|65032871|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352162|NCT05052697|65032872|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352163|NCT05052697|65032873|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352164|NCT05052697|65032874|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352165|NCT05052697|65032875|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352166|NCT05052697|65032876|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352167|NCT05052697|65032877|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352168|NCT05052697|65032878|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352169|NCT05052697|65032879|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23187286|NCT00509106|64426494|FG000|Overall Study|Death|6|||
23187287|NCT00509106|64426495|FG001|Overall Study|Death|6|||
23187288|NCT03926143|64426496|FG000|Overall Study|Physician Decision|3|||
23187289|NCT03926143|64426496|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
23187290|NCT03926143|64426496|FG000|Overall Study|Adverse Event|2|||
23187291|NCT03926143|64426496|FG000|Overall Study|Progressive disease|3|||
23187292|NCT00917384|64426502|FG000|Overall Study|Lost to Follow-up|4|||
23352170|NCT05052697|65032880|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352171|NCT05052697|65032881|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352172|NCT05052697|65032882|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352173|NCT05052697|65032883|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352174|NCT05052697|65032884|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
23352175|NCT05052697|65032885|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
23352176|NCT05052697|65032886|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
23352177|NCT05052697|65032887|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352178|NCT05052697|65032888|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352179|NCT05052697|65032889|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
23352180|NCT00096993|65032896|FG000|Overall Study|Death|1|||
23352181|NCT00096993|65032897|FG001|Overall Study|Death|0|||
23352182|NCT00096993|65032896|FG000|Overall Study|Disease progression|56|||
23352183|NCT00096993|65032897|FG001|Overall Study|Disease progression|53|||
23352184|NCT00096993|65032896|FG000|Overall Study|Adverse Event|2|||
23352185|NCT00096993|65032897|FG001|Overall Study|Adverse Event|8|||
23352186|NCT00096993|65032896|FG000|Overall Study|Subject's decision|3|||
23352187|NCT00096993|65032897|FG001|Overall Study|Subject's decision|1|||
23352188|NCT00096993|65032896|FG000|Overall Study|Physician Decision|2|||
23352189|NCT00096993|65032897|FG001|Overall Study|Physician Decision|1|||
23352190|NCT00096993|65032896|FG000|Overall Study|Non-compliance|0|||
23352191|NCT00096993|65032897|FG001|Overall Study|Non-compliance|1|||
23352192|NCT00096993|65032896|FG000|Overall Study|Other unspecified|1|||
23352193|NCT00096993|65032897|FG001|Overall Study|Other unspecified|1|||
23352194|NCT02913105|65032909|FG000|Overall Study|Adverse Event|11|||
23352195|NCT02913105|65032910|FG001|Overall Study|Adverse Event|0|||
23352196|NCT02913105|65032911|FG002|Overall Study|Adverse Event|4|||
23352197|NCT02913105|65032909|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23187293|NCT00917384|64426503|FG001|Overall Study|Lost to Follow-up|2|||
23352198|NCT02913105|65032910|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23352199|NCT02913105|65032911|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23352200|NCT02913105|65032909|FG000|Overall Study|Reason Not Specified|3|||
23352201|NCT02913105|65032910|FG001|Overall Study|Reason Not Specified|1|||
23352202|NCT02913105|65032911|FG002|Overall Study|Reason Not Specified|1|||
23187294|NCT00917384|64426502|FG000|Overall Study|Withdrawal by Subject|10|||
23187295|NCT00917384|64426503|FG001|Overall Study|Withdrawal by Subject|2|||
23187296|NCT02224664|64426504|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
23187297|NCT02224664|64426505|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
23245814|NCT01371981|64642108|FG003|Overall Study|Did not start treatment|0|||
23245815|NCT01371981|64642109|FG004|Overall Study|Did not start treatment|0|||
23245816|NCT01371981|64642110|FG005|Overall Study|Did not start treatment|2|||
23587014|NCT00762463|65876218|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
23587015|NCT00762463|65876219|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
23587016|NCT00762463|65876220|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
23587017|NCT01726023|65876221|FG000|Overall Study|Death|1|||
23587018|NCT01726023|65876222|FG001|Overall Study|Death|1|||
23587019|NCT01726023|65876221|FG000|Overall Study|Lost to Follow-up|5|||
23587020|NCT01726023|65876222|FG001|Overall Study|Lost to Follow-up|10|||
23587021|NCT01726023|65876221|FG000|Overall Study|Other Eligibility criteria|7|||
23587022|NCT01726023|65876222|FG001|Overall Study|Other Eligibility criteria|7|||
23587023|NCT01726023|65876221|FG000|Overall Study|Withdrawal by Subject|16|||
23245827|NCT03901352|64642113|FG000|Double-blind Phase|Adverse Event|6|||
23245828|NCT03901352|64642114|FG001|Double-blind Phase|Adverse Event|4|||
23245829|NCT03901352|64642113|FG000|Double-blind Phase|Death|1|||
23245830|NCT03901352|64642114|FG001|Double-blind Phase|Death|0|||
23245831|NCT03901352|64642113|FG000|Double-blind Phase|Lack of Efficacy|0|||
23187298|NCT02224664|64426506|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
23187299|NCT02224664|64426507|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
23187300|NCT02224664|64426508|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
23187301|NCT02224664|64426504|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
23187302|NCT02224664|64426505|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
23187303|NCT02224664|64426506|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
23187304|NCT02224664|64426507|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
23187305|NCT02224664|64426508|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
23187306|NCT02224664|64426504|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
23187307|NCT02224664|64426505|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
23187308|NCT02224664|64426506|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
23187309|NCT02224664|64426507|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
23187310|NCT02224664|64426508|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
23187311|NCT03240081|64426509|FG000|Overall Study|Withdrawal by Subject|0|||
23187312|NCT03240081|64426510|FG001|Overall Study|Withdrawal by Subject|2|||
23187313|NCT03240081|64426509|FG000|Overall Study|Lost to Follow-up|0|||
23187314|NCT03240081|64426510|FG001|Overall Study|Lost to Follow-up|1|||
23187315|NCT02032524|64426520|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
23187316|NCT02032524|64426521|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
23187317|NCT02032524|64426522|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
23187318|NCT02032524|64426523|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
23187319|NCT02032524|64426524|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
23187320|NCT02032524|64426525|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
23187321|NCT02032524|64426520|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
23187322|NCT02032524|64426521|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
23187323|NCT02032524|64426522|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
23187324|NCT02032524|64426523|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
23187325|NCT02032524|64426524|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
23187326|NCT02032524|64426525|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
23187327|NCT02032524|64426520|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
23187328|NCT02032524|64426521|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
23187329|NCT02032524|64426522|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
23187330|NCT02032524|64426523|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
23187331|NCT02032524|64426524|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
23187332|NCT02032524|64426525|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
23187333|NCT02032524|64426520|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
23187334|NCT02032524|64426521|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
23187335|NCT02032524|64426522|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
23187336|NCT02032524|64426523|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
23187337|NCT02032524|64426524|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
23187338|NCT02032524|64426525|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
23187339|NCT02032524|64426520|FG000|Period 2: LTS13769 Study|Other|0|||
23187340|NCT02032524|64426521|FG001|Period 2: LTS13769 Study|Other|0|||
23187341|NCT02032524|64426522|FG002|Period 2: LTS13769 Study|Other|0|||
23187342|NCT02032524|64426523|FG003|Period 2: LTS13769 Study|Other|0|||
23187343|NCT02032524|64426524|FG004|Period 2: LTS13769 Study|Other|0|||
23187344|NCT02032524|64426525|FG005|Period 2: LTS13769 Study|Other|1|||
23187345|NCT02698410|64426531|FG000|Overall Study|Adverse Event|2|||
23187346|NCT02698410|64426531|FG000|Overall Study|Withdrawal by Subject|1|||
23245832|NCT03901352|64642114|FG001|Double-blind Phase|Lack of Efficacy|1|||
23245833|NCT03901352|64642113|FG000|Double-blind Phase|Protocol Violation|0|||
23245834|NCT03901352|64642114|FG001|Double-blind Phase|Protocol Violation|1|||
23245835|NCT03901352|64642113|FG000|Double-blind Phase|Withdrawal by Subject|10|||
23245836|NCT03901352|64642114|FG001|Double-blind Phase|Withdrawal by Subject|8|||
23468019|NCT02541604|65457187|FG001|Overall Study|Lost to Follow-up|0|||
23468020|NCT02541604|65457188|FG002|Overall Study|Lost to Follow-up|1|||
23468021|NCT02541604|65457189|FG003|Overall Study|Lost to Follow-up|0|||
23468022|NCT02541604|65457190|FG004|Overall Study|Lost to Follow-up|0|||
23468023|NCT02541604|65457191|FG005|Overall Study|Lost to Follow-up|1|||
23468024|NCT02541604|65457192|FG006|Overall Study|Lost to Follow-up|1|||
23468025|NCT02541604|65457193|FG007|Overall Study|Lost to Follow-up|0|||
23468026|NCT02541604|65457194|FG008|Overall Study|Lost to Follow-up|0|||
23468027|NCT02541604|65457195|FG009|Overall Study|Lost to Follow-up|0|||
23468028|NCT02541604|65457196|FG010|Overall Study|Lost to Follow-up|0|||
23468029|NCT02541604|65457197|FG011|Overall Study|Lost to Follow-up|0|||
23468030|NCT02541604|65457186|FG000|Overall Study|Withdrawal by Subject|2|||
23468031|NCT02541604|65457187|FG001|Overall Study|Withdrawal by Subject|0|||
23468032|NCT02541604|65457188|FG002|Overall Study|Withdrawal by Subject|1|||
23587024|NCT01726023|65876222|FG001|Overall Study|Withdrawal by Subject|8|||
23587025|NCT01145885|65876223|FG000|Overall Study|Progressive Disease|7|||
23587026|NCT02072226|65876225|FG000|Overall Study|Lost to Follow-up|11|||
23587027|NCT02072226|65876226|FG001|Overall Study|Lost to Follow-up|7|||
23587028|NCT02072226|65876225|FG000|Overall Study|Patient Non-compliance|2|||
23587029|NCT02072226|65876226|FG001|Overall Study|Patient Non-compliance|3|||
23587030|NCT02072226|65876225|FG000|Overall Study|Death|1|||
23587031|NCT02072226|65876226|FG001|Overall Study|Death|0|||
23587032|NCT02072226|65876225|FG000|Overall Study|Patient Withdrawal of Consent|1|||
23587033|NCT02072226|65876226|FG001|Overall Study|Patient Withdrawal of Consent|0|||
23587034|NCT03061474|65876227|FG000|Overall Study|Adverse Event|2|||
23587035|NCT03061474|65876228|FG001|Overall Study|Adverse Event|0|||
23587036|NCT03061474|65876227|FG000|Overall Study|Safety Risk|0|||
23587037|NCT03061474|65876228|FG001|Overall Study|Safety Risk|1|||
23587038|NCT03061474|65876227|FG000|Overall Study|Participant unwilling or unable to participate|0|||
23587039|NCT03061474|65876228|FG001|Overall Study|Participant unwilling or unable to participate|2|||
23587040|NCT03061474|65876227|FG000|Overall Study|Lost to Follow-up|0|||
23587041|NCT03061474|65876228|FG001|Overall Study|Lost to Follow-up|1|||
23587042|NCT01908634|65876232|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
23587043|NCT01908634|65876232|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
23587044|NCT01801930|65876233|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
23587045|NCT01801930|65876234|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
23587046|NCT01801930|65876235|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
23587047|NCT01801930|65876236|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
23587048|NCT01801930|65876233|FG000|Overall Study|DLT occurs|0|||
23587049|NCT01801930|65876234|FG001|Overall Study|DLT occurs|1|||
23587050|NCT01801930|65876235|FG002|Overall Study|DLT occurs|0|||
23187347|NCT02698410|64426531|FG000|Overall Study|Other|1|||
23187348|NCT02951052|64426538|FG000|Overall Study|Adverse Event|13|||
23187349|NCT02951052|64426539|FG001|Overall Study|Adverse Event|5|||
23187350|NCT02951052|64426538|FG000|Overall Study|Withdrawal by Subject|1|||
23187351|NCT02951052|64426539|FG001|Overall Study|Withdrawal by Subject|5|||
23187352|NCT02951052|64426538|FG000|Overall Study|Physician Decision|2|||
23187353|NCT02951052|64426539|FG001|Overall Study|Physician Decision|0|||
23187354|NCT02951052|64426538|FG000|Overall Study|Lost to Follow-up|1|||
23187355|NCT02951052|64426539|FG001|Overall Study|Lost to Follow-up|1|||
23187356|NCT02951052|64426538|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
23187357|NCT02951052|64426539|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
23187358|NCT02951052|64426538|FG000|Overall Study|Protocol Violation|5|||
23187359|NCT02951052|64426539|FG001|Overall Study|Protocol Violation|3|||
23187360|NCT02951052|64426538|FG000|Overall Study|Lack of Efficacy|3|||
23187361|NCT02951052|64426539|FG001|Overall Study|Lack of Efficacy|4|||
23187362|NCT02951052|64426538|FG000|Overall Study|Ongoing|1|||
23187363|NCT02951052|64426539|FG001|Overall Study|Ongoing|0|||
23187364|NCT03065530|64426541|FG000|Overall Study|Lack of Efficacy|1|||
23187365|NCT03065530|64426542|FG001|Overall Study|Lack of Efficacy|1|||
23187366|NCT03065530|64426543|FG002|Overall Study|Lack of Efficacy|0|||
23187367|NCT03065530|64426544|FG003|Overall Study|Lack of Efficacy|1|||
23187368|NCT03065530|64426541|FG000|Overall Study|Protocol Violation|1|||
23187369|NCT03065530|64426542|FG001|Overall Study|Protocol Violation|0|||
23187370|NCT03065530|64426543|FG002|Overall Study|Protocol Violation|1|||
23187371|NCT03065530|64426544|FG003|Overall Study|Protocol Violation|1|||
23187372|NCT01123889|64426546|FG000|Overall Study|Lost to Follow-up|3|||
23187373|NCT01123889|64426547|FG001|Overall Study|Lost to Follow-up|1|||
23187374|NCT03406962|64426549|FG000|Overall Study|Death|2|||
23187375|NCT03406962|64426549|FG000|Overall Study|Adverse Event|1|||
23187376|NCT01360996|64426550|FG000|Overall Study|Withdrawal by Subject|4|||
23352203|NCT02913105|65032909|FG000|Overall Study|Physician Decision|1|||
23587051|NCT01801930|65876236|FG003|Overall Study|DLT occurs|0|||
23587052|NCT00612586|65876237|FG000|Overall Study|Adverse Event|6|||
23187377|NCT01360996|64426551|FG001|Overall Study|Withdrawal by Subject|3|||
23468033|NCT02541604|65457189|FG003|Overall Study|Withdrawal by Subject|0|||
23468034|NCT02541604|65457190|FG004|Overall Study|Withdrawal by Subject|1|||
23352204|NCT02913105|65032910|FG001|Overall Study|Physician Decision|1|||
23352205|NCT02913105|65032911|FG002|Overall Study|Physician Decision|0|||
23352206|NCT02913105|65032909|FG000|Overall Study|Withdrawal by Subject|0|||
23352207|NCT02913105|65032910|FG001|Overall Study|Withdrawal by Subject|3|||
23352208|NCT02913105|65032911|FG002|Overall Study|Withdrawal by Subject|1|||
23352209|NCT02603107|65032912|FG000|Randomized Phase|Withdrew consent|8|||
23352210|NCT02603107|65032913|FG001|Randomized Phase|Withdrew consent|15|||
23352211|NCT02603107|65032912|FG000|Randomized Phase|Lost to Follow-up|1|||
23352212|NCT02603107|65032913|FG001|Randomized Phase|Lost to Follow-up|3|||
23352213|NCT02603107|65032912|FG000|Randomized Phase|Adverse Event|2|||
23352214|NCT02603107|65032913|FG001|Randomized Phase|Adverse Event|0|||
23352215|NCT02603107|65032912|FG000|Randomized Phase|Death|1|||
23352216|NCT02603107|65032913|FG001|Randomized Phase|Death|1|||
23352217|NCT02603107|65032912|FG000|Randomized Phase|Non-compliance with study drug|1|||
23352218|NCT02603107|65032913|FG001|Randomized Phase|Non-compliance with study drug|1|||
23352219|NCT02603107|65032912|FG000|Randomized Phase|Investigator's discretion|0|||
23352220|NCT02603107|65032913|FG001|Randomized Phase|Investigator's discretion|1|||
23352221|NCT02603107|65032912|FG000|Randomized Phase|Lack of Efficacy|1|||
23352222|NCT02603107|65032913|FG001|Randomized Phase|Lack of Efficacy|0|||
23352223|NCT02603107|65032912|FG000|Randomized Phase|Protocol Violation|1|||
23352224|NCT02603107|65032913|FG001|Randomized Phase|Protocol Violation|0|||
23352225|NCT02603107|65032912|FG000|Optional Extension Phase|Lost to Follow-up|3|||
23352226|NCT02603107|65032913|FG001|Optional Extension Phase|Lost to Follow-up|3|||
23352227|NCT02603107|65032912|FG000|Optional Extension Phase|Withdrew consent|3|||
23352228|NCT02603107|65032913|FG001|Optional Extension Phase|Withdrew consent|2|||
23352229|NCT02603107|65032912|FG000|Optional Extension Phase|Investigator's discretion|2|||
23352230|NCT02603107|65032913|FG001|Optional Extension Phase|Investigator's discretion|2|||
23352231|NCT02603107|65032912|FG000|Optional Extension Phase|Pregnancy|0|||
23352232|NCT02603107|65032913|FG001|Optional Extension Phase|Pregnancy|3|||
23352233|NCT02603107|65032912|FG000|Optional Extension Phase|Adverse Event|0|||
23352234|NCT02603107|65032913|FG001|Optional Extension Phase|Adverse Event|2|||
23352235|NCT02603107|65032912|FG000|Optional Extension Phase|Not treated in extension phase|0|||
23352236|NCT02603107|65032913|FG001|Optional Extension Phase|Not treated in extension phase|1|||
23352237|NCT02603107|65032912|FG000|Optional Extension Phase|Protocol Violation|1|||
23352238|NCT02603107|65032913|FG001|Optional Extension Phase|Protocol Violation|0|||
23352239|NCT03796676|65032914|FG000|Overall Study|Adverse Event|2|||
23352240|NCT03796676|65032915|FG001|Overall Study|Adverse Event|1|||
23352241|NCT03796676|65032916|FG002|Overall Study|Adverse Event|2|||
23352242|NCT03796676|65032914|FG000|Overall Study|Lost to Follow-up|2|||
23352243|NCT03796676|65032915|FG001|Overall Study|Lost to Follow-up|1|||
23352244|NCT03796676|65032916|FG002|Overall Study|Lost to Follow-up|0|||
23352245|NCT03796676|65032914|FG000|Overall Study|Protocol Violation|0|||
23352246|NCT03796676|65032915|FG001|Overall Study|Protocol Violation|0|||
23352247|NCT03796676|65032916|FG002|Overall Study|Protocol Violation|1|||
23352248|NCT03796676|65032914|FG000|Overall Study|Withdrawal by Subject|1|||
23352249|NCT03796676|65032915|FG001|Overall Study|Withdrawal by Subject|1|||
23352250|NCT03796676|65032916|FG002|Overall Study|Withdrawal by Subject|0|||
23352251|NCT03796676|65032914|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
23352252|NCT03796676|65032915|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
23352253|NCT03796676|65032916|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
23352254|NCT00539032|65032917|FG000|Overall Study|Withdrawal by Subject|2|||
23352255|NCT00539032|65032918|FG001|Overall Study|Withdrawal by Subject|1|||
23352256|NCT02003963|65032920|FG000|Overall Study|Lost to Follow-up|2|||
23352257|NCT02003963|65032921|FG001|Overall Study|Lost to Follow-up|1|||
23352258|NCT04933617|65032924|FG000|Dose Escalation|Early closure of study|0|||
23352259|NCT04933617|65032925|FG001|Dose Escalation|Early closure of study|3|||
23352260|NCT04933617|65032926|FG002|Dose Escalation|Early closure of study|0|||
23352261|NCT04933617|65032927|FG003|Dose Escalation|Early closure of study|0|||
23187378|NCT01360996|64426552|FG002|Overall Study|Withdrawal by Subject|2|||
23187379|NCT01360996|64426550|FG000|Overall Study|Noncompliant|2|||
23187380|NCT01360996|64426551|FG001|Overall Study|Noncompliant|0|||
23187381|NCT01360996|64426552|FG002|Overall Study|Noncompliant|0|||
23187382|NCT01982630|64426553|FG000|Overall Study|Adverse Event|2|||
23187383|NCT01982630|64426554|FG001|Overall Study|Adverse Event|0|||
23187384|NCT01982630|64426555|FG002|Overall Study|Adverse Event|1|||
23187385|NCT01982630|64426556|FG003|Overall Study|Adverse Event|0|||
23187386|NCT01982630|64426557|FG004|Overall Study|Adverse Event|1|||
23187387|NCT01982630|64426558|FG005|Overall Study|Adverse Event|2|||
23187388|NCT01982630|64426559|FG006|Overall Study|Adverse Event|1|||
23187389|NCT01982630|64426560|FG007|Overall Study|Adverse Event|0|||
23245837|NCT03901352|64642113|FG000|Open-label Extension Phase|Adverse Event|24|||
23187390|NCT01982630|64426553|FG000|Overall Study|Physician Decision|1|||
23245838|NCT03901352|64642114|FG001|Open-label Extension Phase|Adverse Event|0|||
23352262|NCT04933617|65032928|FG004|Dose Escalation|Early closure of study|0|||
23352263|NCT03309696|65032933|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
23587053|NCT00612586|65876238|FG001|Overall Study|Adverse Event|2|||
23587054|NCT00612586|65876237|FG000|Overall Study|Death|1|||
23587055|NCT00612586|65876238|FG001|Overall Study|Death|0|||
23245839|NCT03901352|64642113|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
23245840|NCT03901352|64642114|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
23245841|NCT03901352|64642113|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
23187391|NCT01982630|64426554|FG001|Overall Study|Physician Decision|0|||
23187392|NCT01982630|64426555|FG002|Overall Study|Physician Decision|2|||
23187393|NCT01982630|64426556|FG003|Overall Study|Physician Decision|1|||
23187394|NCT01982630|64426557|FG004|Overall Study|Physician Decision|2|||
23187395|NCT01982630|64426558|FG005|Overall Study|Physician Decision|0|||
23187396|NCT01982630|64426559|FG006|Overall Study|Physician Decision|0|||
23187397|NCT01982630|64426560|FG007|Overall Study|Physician Decision|0|||
23245842|NCT03901352|64642114|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
23245843|NCT03901352|64642113|FG000|Open-label Extension Phase|Other|1|||
23245844|NCT03901352|64642114|FG001|Open-label Extension Phase|Other|0|||
23245845|NCT03747939|64642115|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
23468035|NCT02541604|65457191|FG005|Overall Study|Withdrawal by Subject|1|||
23468036|NCT02541604|65457192|FG006|Overall Study|Withdrawal by Subject|0|||
23468037|NCT02541604|65457193|FG007|Overall Study|Withdrawal by Subject|0|||
23468038|NCT02541604|65457194|FG008|Overall Study|Withdrawal by Subject|1|||
23468039|NCT02541604|65457195|FG009|Overall Study|Withdrawal by Subject|0|||
23468040|NCT02541604|65457196|FG010|Overall Study|Withdrawal by Subject|0|||
23468041|NCT02541604|65457197|FG011|Overall Study|Withdrawal by Subject|0|||
23468042|NCT02541604|65457186|FG000|Overall Study|Study Terminated by Sponsor|1|||
23468043|NCT02541604|65457187|FG001|Overall Study|Study Terminated by Sponsor|4|||
23468044|NCT02541604|65457188|FG002|Overall Study|Study Terminated by Sponsor|2|||
23468045|NCT02541604|65457189|FG003|Overall Study|Study Terminated by Sponsor|1|||
23468046|NCT02541604|65457190|FG004|Overall Study|Study Terminated by Sponsor|0|||
23468047|NCT02541604|65457191|FG005|Overall Study|Study Terminated by Sponsor|0|||
23468048|NCT02541604|65457192|FG006|Overall Study|Study Terminated by Sponsor|0|||
23468049|NCT02541604|65457193|FG007|Overall Study|Study Terminated by Sponsor|0|||
23468050|NCT02541604|65457194|FG008|Overall Study|Study Terminated by Sponsor|0|||
23468051|NCT02541604|65457195|FG009|Overall Study|Study Terminated by Sponsor|0|||
23468052|NCT02541604|65457196|FG010|Overall Study|Study Terminated by Sponsor|0|||
23468053|NCT02541604|65457197|FG011|Overall Study|Study Terminated by Sponsor|0|||
23468054|NCT02541604|65457186|FG000|Overall Study|Medical condition may jeopardize safety|0|||
23468055|NCT02541604|65457187|FG001|Overall Study|Medical condition may jeopardize safety|0|||
23468056|NCT02541604|65457188|FG002|Overall Study|Medical condition may jeopardize safety|0|||
23468057|NCT02541604|65457189|FG003|Overall Study|Medical condition may jeopardize safety|0|||
23468058|NCT02541604|65457190|FG004|Overall Study|Medical condition may jeopardize safety|0|||
23468059|NCT02541604|65457191|FG005|Overall Study|Medical condition may jeopardize safety|0|||
23468060|NCT02541604|65457192|FG006|Overall Study|Medical condition may jeopardize safety|0|||
23468061|NCT02541604|65457193|FG007|Overall Study|Medical condition may jeopardize safety|1|||
23468062|NCT02541604|65457194|FG008|Overall Study|Medical condition may jeopardize safety|0|||
23468063|NCT02541604|65457195|FG009|Overall Study|Medical condition may jeopardize safety|0|||
23468064|NCT02541604|65457196|FG010|Overall Study|Medical condition may jeopardize safety|0|||
23468065|NCT02541604|65457197|FG011|Overall Study|Medical condition may jeopardize safety|0|||
23468066|NCT03196349|65457198|FG000|Overall Study|Did not receive study drug|0|||
23468067|NCT03196349|65457199|FG001|Overall Study|Did not receive study drug|1|||
23468068|NCT03196349|65457200|FG002|Overall Study|Did not receive study drug|2|||
23468069|NCT03196349|65457198|FG000|Overall Study|No data entered|2|||
23468070|NCT03196349|65457199|FG001|Overall Study|No data entered|4|||
23468071|NCT03196349|65457200|FG002|Overall Study|No data entered|0|||
23468072|NCT03196349|65457198|FG000|Overall Study|Study Terminated early|15|||
23468073|NCT03196349|65457199|FG001|Overall Study|Study Terminated early|9|||
23587056|NCT00612586|65876237|FG000|Overall Study|Entry Criteria Not Met|0|||
23587057|NCT00612586|65876238|FG001|Overall Study|Entry Criteria Not Met|2|||
23587058|NCT00612586|65876237|FG000|Overall Study|Withdrawal by Subject|7|||
23587059|NCT00612586|65876238|FG001|Overall Study|Withdrawal by Subject|9|||
23187398|NCT01982630|64426553|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23245846|NCT03747939|64642116|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
23245847|NCT03747939|64642117|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
23245848|NCT03747939|64642118|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
23245849|NCT03747939|64642115|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
23352264|NCT03309696|65032934|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
23468074|NCT03196349|65457200|FG002|Overall Study|Study Terminated early|11|||
23587060|NCT00612586|65876237|FG000|Overall Study|Physician Decision|1|||
23187399|NCT01982630|64426554|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23187400|NCT01982630|64426555|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
23187401|NCT01982630|64426556|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23187402|NCT01982630|64426557|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23468075|NCT01039519|65457201|FG000|Treatment|Progressive disease|20|||
23587061|NCT00612586|65876238|FG001|Overall Study|Physician Decision|2|||
23468076|NCT01039519|65457201|FG000|Treatment|Treatment failure|2|||
23468077|NCT01039519|65457201|FG000|Treatment|Adverse Event|3|||
23468078|NCT01039519|65457201|FG000|Treatment|Physician Decision|2|||
23468079|NCT01039519|65457201|FG000|Survival Follow-up|Death|23|||
23468080|NCT01039519|65457201|FG000|Survival Follow-up|Sponsor decision|4|||
23468081|NCT01623050|65457202|FG000|Overall Study|Lost to Follow-up|9|||
23468082|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
23468083|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
23468084|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
23468085|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
23468086|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
23468087|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
23468088|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
23468089|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
23468090|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
23468091|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
23468092|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
23468093|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
23468094|NCT03158285|65457205|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
23468095|NCT03158285|65457206|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
23468096|NCT03158285|65457207|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
23468097|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
23468098|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
23468099|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
23468100|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
23468101|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
23468102|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
23468103|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
23468104|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
23468105|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
23468106|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
23468107|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
23468108|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
23468109|NCT03158285|65457205|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
23468110|NCT03158285|65457206|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
23468111|NCT03158285|65457207|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
23468112|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
23468113|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
23468114|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
23468115|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
23468116|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
23468117|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
23468118|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
23468119|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
23468120|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
23468121|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
23468122|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
23468123|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
23468124|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Death|1|||
23468125|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Death|0|||
23468126|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Death|0|||
23468127|NCT03158285|65457205|FG000|Active Treatment Period: Week 52-100|Other|4|||
23468128|NCT03158285|65457206|FG001|Active Treatment Period: Week 52-100|Other|1|||
23468129|NCT03158285|65457207|FG002|Active Treatment Period: Week 52-100|Other|0|||
23468130|NCT00295880|65457209|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
23468131|NCT00295880|65457209|FG000|Overall Study|Unit randomization did not occur|1|||
23468132|NCT01104311|65457210|FG000|Overall Study|Withdrawal by Subject|6|||
23468133|NCT01104311|65457211|FG001|Overall Study|Withdrawal by Subject|6|||
23468134|NCT01104311|65457210|FG000|Overall Study|Protocol Violation|0|||
23468135|NCT01104311|65457211|FG001|Overall Study|Protocol Violation|1|||
23468136|NCT01104311|65457210|FG000|Overall Study|Physician Decision|2|||
23468137|NCT01104311|65457211|FG001|Overall Study|Physician Decision|2|||
23468138|NCT01104311|65457210|FG000|Overall Study|low compliance|1|||
23468139|NCT01104311|65457211|FG001|Overall Study|low compliance|1|||
23245850|NCT03747939|64642116|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
23245851|NCT03747939|64642117|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
23245852|NCT03747939|64642118|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
23245853|NCT03747939|64642115|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
23468140|NCT01104311|65457210|FG000|Overall Study|Adverse Event|1|||
23245854|NCT03747939|64642116|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
23468141|NCT01104311|65457211|FG001|Overall Study|Adverse Event|2|||
23468142|NCT02803580|65457217|FG000|Overall Study|Death|13|||
23468143|NCT02803580|65457217|FG000|Overall Study|Lost to Follow-up|19|||
23468144|NCT02803580|65457217|FG000|Overall Study|Withdrawal by Subject|3|||
23468145|NCT02803580|65457217|FG000|Overall Study|Inclusion in clinical trial|1|||
23468146|NCT02379637|65457218|FG000|Overall Study|Protocol Violation|0|||
23468147|NCT02379637|65457219|FG001|Overall Study|Protocol Violation|1|||
23468148|NCT02379637|65457218|FG000|Overall Study|Adverse Event|1|||
23468149|NCT02379637|65457219|FG001|Overall Study|Adverse Event|0|||
23468150|NCT02379637|65457218|FG000|Overall Study|Withdrawal by Subject|1|||
23468151|NCT02379637|65457219|FG001|Overall Study|Withdrawal by Subject|0|||
23468152|NCT02536963|65457220|FG000|Overall Study|Withdrawal by Subject|18|||
23468153|NCT04816669|65457221|FG000|Part 1|Adverse Event|1|||
23468154|NCT04816669|65457222|FG001|Part 1|Adverse Event|1|||
23468155|NCT04816669|65457223|FG002|Part 1|Adverse Event|0|||
23468156|NCT04816669|65457224|FG003|Part 1|Adverse Event|0|||
23468157|NCT04816669|65457221|FG000|Part 1|Lost to Follow-up|2|||
23468158|NCT04816669|65457222|FG001|Part 1|Lost to Follow-up|2|||
23468159|NCT04816669|65457223|FG002|Part 1|Lost to Follow-up|0|||
23468160|NCT04816669|65457224|FG003|Part 1|Lost to Follow-up|0|||
23468161|NCT04816669|65457221|FG000|Part 1|Protocol Violation|0|||
23468162|NCT04816669|65457222|FG001|Part 1|Protocol Violation|1|||
23468163|NCT04816669|65457223|FG002|Part 1|Protocol Violation|0|||
23468164|NCT04816669|65457224|FG003|Part 1|Protocol Violation|0|||
23468165|NCT04816669|65457221|FG000|Part 1|Withdrawal by Subject|1|||
23468166|NCT04816669|65457222|FG001|Part 1|Withdrawal by Subject|2|||
23468167|NCT04816669|65457223|FG002|Part 1|Withdrawal by Subject|0|||
23468168|NCT04816669|65457224|FG003|Part 1|Withdrawal by Subject|0|||
23468169|NCT04816669|65457221|FG000|Part 2|Other|0|||
23468170|NCT04816669|65457222|FG001|Part 2|Other|0|||
23468171|NCT04816669|65457223|FG002|Part 2|Other|1|||
23468172|NCT04816669|65457224|FG003|Part 2|Other|0|||
23468173|NCT04816669|65457221|FG000|Part 2|Withdrawal by Subject|0|||
23468174|NCT04816669|65457222|FG001|Part 2|Withdrawal by Subject|0|||
23187403|NCT01982630|64426558|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23187404|NCT01982630|64426559|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23187405|NCT01982630|64426560|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
23187406|NCT01982630|64426553|FG000|Overall Study|Withdrawal by Subject|0|||
23187407|NCT01982630|64426554|FG001|Overall Study|Withdrawal by Subject|0|||
23187408|NCT01982630|64426555|FG002|Overall Study|Withdrawal by Subject|0|||
23187409|NCT01982630|64426556|FG003|Overall Study|Withdrawal by Subject|0|||
23187410|NCT01982630|64426557|FG004|Overall Study|Withdrawal by Subject|0|||
23187411|NCT01982630|64426558|FG005|Overall Study|Withdrawal by Subject|1|||
23187412|NCT01982630|64426559|FG006|Overall Study|Withdrawal by Subject|0|||
23187413|NCT01982630|64426560|FG007|Overall Study|Withdrawal by Subject|0|||
23187414|NCT00942409|64426561|FG000|Overall Study|Lack of Efficacy|1|||
23187415|NCT00942409|64426561|FG000|Overall Study|study drug unavailable|2|||
23187416|NCT02111811|64426562|FG000|Treatment Phase|Lost to Follow-up|22|||
23187417|NCT02111811|64426563|FG001|Treatment Phase|Lost to Follow-up|18|||
23187418|NCT02111811|64426562|FG000|Treatment Phase|Death|2|||
23187419|NCT02111811|64426563|FG001|Treatment Phase|Death|0|||
23187420|NCT02111811|64426562|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
23187421|NCT02111811|64426563|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
23187422|NCT02111811|64426562|FG000|Follow up Period (Aim 2)|Death|2|||
23187423|NCT02111811|64426563|FG001|Follow up Period (Aim 2)|Death|0|||
23187424|NCT03455543|64426564|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
23187425|NCT03455543|64426565|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
23187426|NCT03455543|64426566|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
23187427|NCT03455543|64426564|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
23187428|NCT03455543|64426565|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
23187429|NCT03455543|64426566|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
23187430|NCT03455543|64426564|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
23245855|NCT03747939|64642117|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
23245856|NCT03747939|64642118|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
23468175|NCT04816669|65457223|FG002|Part 2|Withdrawal by Subject|0|||
23468176|NCT04816669|65457224|FG003|Part 2|Withdrawal by Subject|1|||
23468177|NCT04816669|65457221|FG000|Part 2|Lost to Follow-up|0|||
23468178|NCT04816669|65457222|FG001|Part 2|Lost to Follow-up|0|||
23468179|NCT04816669|65457223|FG002|Part 2|Lost to Follow-up|1|||
23468180|NCT04816669|65457224|FG003|Part 2|Lost to Follow-up|0|||
23187431|NCT03455543|64426565|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
23468181|NCT02318706|65457226|FG000|Double-blind Phase|Adverse Event|7|||
23468182|NCT02318706|65457227|FG001|Double-blind Phase|Adverse Event|4|||
23468183|NCT02318706|65457228|FG002|Double-blind Phase|Adverse Event|3|||
23468184|NCT02318706|65457229|FG003|Double-blind Phase|Adverse Event|10|||
23468185|NCT02318706|65457230|FG004|Double-blind Phase|Adverse Event|0|||
23468186|NCT02318706|65457226|FG000|Double-blind Phase|Lost to Follow-up|1|||
23468187|NCT02318706|65457227|FG001|Double-blind Phase|Lost to Follow-up|0|||
23187432|NCT03455543|64426566|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
23187433|NCT03455543|64426564|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
23187434|NCT03455543|64426565|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
23187435|NCT03455543|64426566|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
23187436|NCT03455543|64426564|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
23187437|NCT03455543|64426565|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
23187438|NCT03455543|64426566|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
23187439|NCT03455543|64426564|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
23187440|NCT03455543|64426565|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
23187441|NCT03455543|64426566|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
23187442|NCT03455543|64426564|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
23187443|NCT03455543|64426565|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
23187444|NCT03455543|64426566|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
23187445|NCT03455543|64426564|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
23187446|NCT03455543|64426565|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
23187447|NCT03455543|64426566|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
23187448|NCT03455543|64426564|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
23187449|NCT03455543|64426565|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
23187450|NCT03455543|64426566|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
23187451|NCT01440101|64426568|FG000|Overall Study|Adverse Event|2|||
23187452|NCT01440101|64426569|FG001|Overall Study|Adverse Event|0|||
23187453|NCT01440101|64426570|FG002|Overall Study|Adverse Event|0|||
23187454|NCT01440101|64426568|FG000|Overall Study|Withdrawal by Subject|0|||
23187455|NCT01440101|64426569|FG001|Overall Study|Withdrawal by Subject|3|||
23187456|NCT01440101|64426570|FG002|Overall Study|Withdrawal by Subject|1|||
23187457|NCT01440101|64426568|FG000|Overall Study|Other|0|||
23187458|NCT01440101|64426569|FG001|Overall Study|Other|1|||
23187459|NCT01440101|64426570|FG002|Overall Study|Other|0|||
23187460|NCT02500550|64426573|FG000|Overall Study|Death|7|||
23187461|NCT00957853|64426574|FG000|Overall Study|Withdrawal by Subject|1|||
23245857|NCT03747939|64642115|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
23245858|NCT03747939|64642116|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
23245859|NCT03747939|64642117|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
23245860|NCT03747939|64642118|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
23245861|NCT03747939|64642115|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
23245862|NCT03747939|64642116|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
23245863|NCT03747939|64642117|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
23245864|NCT03747939|64642118|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
23245865|NCT03747939|64642115|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
23245866|NCT03747939|64642116|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
23245867|NCT03747939|64642117|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
23245868|NCT03747939|64642118|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
23245869|NCT03747939|64642115|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
23245870|NCT03747939|64642116|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
23245871|NCT03747939|64642117|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
23245872|NCT03747939|64642118|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
23245873|NCT03747939|64642115|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
23245874|NCT03747939|64642116|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
23245875|NCT03747939|64642117|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
23245876|NCT03747939|64642118|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
23468188|NCT02318706|65457228|FG002|Double-blind Phase|Lost to Follow-up|0|||
23468189|NCT02318706|65457229|FG003|Double-blind Phase|Lost to Follow-up|0|||
23468190|NCT02318706|65457230|FG004|Double-blind Phase|Lost to Follow-up|0|||
23187462|NCT00957853|64426575|FG001|Overall Study|Withdrawal by Subject|0|||
23187463|NCT00957853|64426576|FG002|Overall Study|Withdrawal by Subject|0|||
23187464|NCT03233048|64426577|FG000|Overall Study|Withdrawal by Subject|1|||
23187465|NCT05299892|64426578|FG000|Overall Study|Withdrawal by Subject|2|||
23187466|NCT02782715|64426581|FG000|Overall Study|Withdrawal by Subject|1|||
23187467|NCT01503021|64426584|FG000|Overall Study|Adverse Event|7|||
23187468|NCT01503021|64426585|FG001|Overall Study|Adverse Event|6|||
23187469|NCT01503021|64426584|FG000|Overall Study|Death|0|||
23187470|NCT01503021|64426585|FG001|Overall Study|Death|2|||
23187471|NCT01503021|64426584|FG000|Overall Study|Lost to Follow-up|2|||
23187472|NCT01503021|64426585|FG001|Overall Study|Lost to Follow-up|0|||
23187473|NCT01503021|64426584|FG000|Overall Study|Physician Decision|3|||
23468191|NCT02318706|65457226|FG000|Double-blind Phase|Protocol Violation|4|||
23187474|NCT01503021|64426585|FG001|Overall Study|Physician Decision|0|||
23187475|NCT01503021|64426584|FG000|Overall Study|Protocol Violation|1|||
23187476|NCT01503021|64426585|FG001|Overall Study|Protocol Violation|3|||
23187477|NCT01503021|64426584|FG000|Overall Study|Withdrawal by Subject|9|||
23187478|NCT01503021|64426585|FG001|Overall Study|Withdrawal by Subject|8|||
23187479|NCT01503021|64426584|FG000|Overall Study|Moved, received transplant, etc.|5|||
23187480|NCT01503021|64426585|FG001|Overall Study|Moved, received transplant, etc.|7|||
23187481|NCT02704429|64426586|FG000|Part A: 24 Weeks|Adverse Event|3|||
23187482|NCT02704429|64426587|FG001|Part A: 24 Weeks|Adverse Event|0|||
23468192|NCT02318706|65457227|FG001|Double-blind Phase|Protocol Violation|2|||
23468193|NCT02318706|65457228|FG002|Double-blind Phase|Protocol Violation|4|||
23468194|NCT02318706|65457229|FG003|Double-blind Phase|Protocol Violation|3|||
23468195|NCT02318706|65457230|FG004|Double-blind Phase|Protocol Violation|0|||
23468196|NCT02318706|65457226|FG000|Double-blind Phase|Withdrawal by Subject|9|||
23468197|NCT02318706|65457227|FG001|Double-blind Phase|Withdrawal by Subject|5|||
23468198|NCT02318706|65457228|FG002|Double-blind Phase|Withdrawal by Subject|7|||
23468199|NCT02318706|65457229|FG003|Double-blind Phase|Withdrawal by Subject|10|||
23468200|NCT02318706|65457230|FG004|Double-blind Phase|Withdrawal by Subject|0|||
23468201|NCT02318706|65457226|FG000|Double-blind Phase|Other|4|||
23468202|NCT02318706|65457227|FG001|Double-blind Phase|Other|1|||
23468203|NCT02318706|65457228|FG002|Double-blind Phase|Other|2|||
23468204|NCT02318706|65457229|FG003|Double-blind Phase|Other|1|||
23468205|NCT02318706|65457230|FG004|Double-blind Phase|Other|0|||
23468206|NCT02318706|65457226|FG000|Double-blind Phase|Death|0|||
23468207|NCT02318706|65457227|FG001|Double-blind Phase|Death|0|||
23468208|NCT02318706|65457228|FG002|Double-blind Phase|Death|2|||
23468209|NCT02318706|65457229|FG003|Double-blind Phase|Death|0|||
23468210|NCT02318706|65457230|FG004|Double-blind Phase|Death|0|||
23468211|NCT02318706|65457226|FG000|Open-label Extension Phase|Adverse Event|0|||
23468212|NCT02318706|65457227|FG001|Open-label Extension Phase|Adverse Event|0|||
23468213|NCT02318706|65457228|FG002|Open-label Extension Phase|Adverse Event|0|||
23468214|NCT02318706|65457229|FG003|Open-label Extension Phase|Adverse Event|0|||
23468215|NCT02318706|65457230|FG004|Open-label Extension Phase|Adverse Event|21|||
23468216|NCT02318706|65457226|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
23468217|NCT02318706|65457227|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
23468218|NCT02318706|65457228|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
23468219|NCT02318706|65457229|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
23468220|NCT02318706|65457230|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
23468221|NCT02318706|65457226|FG000|Open-label Extension Phase|Death|0|||
23468222|NCT02318706|65457227|FG001|Open-label Extension Phase|Death|0|||
23468223|NCT02318706|65457228|FG002|Open-label Extension Phase|Death|0|||
23468224|NCT02318706|65457229|FG003|Open-label Extension Phase|Death|0|||
23468225|NCT02318706|65457230|FG004|Open-label Extension Phase|Death|1|||
23468226|NCT02318706|65457226|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
23468227|NCT02318706|65457227|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
23468228|NCT02318706|65457228|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
23468229|NCT02318706|65457229|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
23468230|NCT02318706|65457230|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
23468231|NCT01528969|65457231|FG000|Overall Study|absent from the school at baseline|2|||
23468232|NCT01528969|65457232|FG001|Overall Study|absent from the school at baseline|0|||
23468233|NCT01523366|65457237|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23468234|NCT01523366|65457238|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23468235|NCT01523366|65457237|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
23468236|NCT01523366|65457238|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
23468237|NCT00470275|65457239|FG000|Overall Study|Death|1|||
23468238|NCT00470275|65457239|FG000|Overall Study|Lack of Efficacy|7|||
23468239|NCT00470275|65457239|FG000|Overall Study|Withdrawal by Subject|2|||
23468240|NCT00602472|65457240|FG000|Overall Study|Adverse Event|5|||
23187483|NCT02704429|64426586|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
23187484|NCT02704429|64426587|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
23187485|NCT00586690|64426588|FG000|Overall Study|Death|2|||
23187486|NCT00586690|64426589|FG001|Overall Study|Death|0|||
23187487|NCT00586690|64426588|FG000|Overall Study|Disease Progression|10|||
23187488|NCT00586690|64426589|FG001|Overall Study|Disease Progression|0|||
23187489|NCT00586690|64426588|FG000|Overall Study|Adverse Event|1|||
23187490|NCT00586690|64426589|FG001|Overall Study|Adverse Event|0|||
23468241|NCT00602472|65457241|FG001|Overall Study|Adverse Event|23|||
23468242|NCT00602472|65457240|FG000|Overall Study|Protocol Violation|4|||
23468243|NCT00602472|65457241|FG001|Overall Study|Protocol Violation|19|||
23468244|NCT00602472|65457240|FG000|Overall Study|Withdrawal by Subject|8|||
23187491|NCT00586690|64426588|FG000|Overall Study|Lack of Efficacy|2|||
23245877|NCT03747939|64642115|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
23187492|NCT00586690|64426589|FG001|Overall Study|Lack of Efficacy|0|||
23245878|NCT03747939|64642116|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
23468245|NCT00602472|65457241|FG001|Overall Study|Withdrawal by Subject|14|||
23468246|NCT00602472|65457240|FG000|Overall Study|Other incl. lack of efficacy|4|||
23468247|NCT00602472|65457241|FG001|Overall Study|Other incl. lack of efficacy|2|||
23468248|NCT00220636|65457242|FG000|Overall Study|Withdrawal by Subject|4|||
23468249|NCT03252925|65457243|FG000|Overall Study|Withdrawal by Subject|1|||
23245879|NCT03747939|64642117|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
23468250|NCT03252925|65457244|FG001|Overall Study|Withdrawal by Subject|0|||
23245880|NCT03747939|64642118|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
23245881|NCT03747939|64642115|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
23245882|NCT03747939|64642116|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
23187493|NCT00586690|64426588|FG000|Overall Study|Lab can't accommodate|1|||
23245883|NCT03747939|64642117|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
23245884|NCT03747939|64642118|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
23245885|NCT03747939|64642115|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
23245886|NCT03747939|64642116|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
23245887|NCT03747939|64642117|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
23245888|NCT03747939|64642118|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
23245889|NCT03747939|64642115|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
23245890|NCT03747939|64642116|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
23245891|NCT03747939|64642117|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
23245892|NCT03747939|64642118|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
23245893|NCT03747939|64642115|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
23245894|NCT03747939|64642116|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
23245895|NCT03747939|64642117|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
23245896|NCT03747939|64642118|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
23468251|NCT03252925|65457243|FG000|Overall Study|Protocol Violation|6|||
23468252|NCT03252925|65457244|FG001|Overall Study|Protocol Violation|0|||
23468253|NCT03252925|65457243|FG000|Overall Study|Adverse Event|1|||
23468254|NCT03252925|65457244|FG001|Overall Study|Adverse Event|0|||
23468255|NCT03252925|65457243|FG000|Overall Study|Lost to Follow-up|6|||
23468256|NCT03252925|65457244|FG001|Overall Study|Lost to Follow-up|6|||
23468257|NCT03584789|65457246|FG000|Overall Study|refused EHR permission|19|||
23468258|NCT03584789|65457247|FG001|Overall Study|refused EHR permission|28|||
23468259|NCT03584789|65457248|FG002|Overall Study|refused EHR permission|23|||
23187494|NCT00586690|64426589|FG001|Overall Study|Lab can't accommodate|0|||
23187495|NCT01154101|64426590|FG000|Overall Study|Adverse Event|0|||
23187496|NCT01154101|64426591|FG001|Overall Study|Adverse Event|2|||
23187497|NCT01154101|64426592|FG002|Overall Study|Adverse Event|1|||
23187498|NCT01154101|64426593|FG003|Overall Study|Adverse Event|1|||
23187499|NCT01154101|64426594|FG004|Overall Study|Adverse Event|0|||
23187500|NCT01154101|64426590|FG000|Overall Study|Lost to Follow-up|0|||
23187501|NCT01154101|64426591|FG001|Overall Study|Lost to Follow-up|1|||
23187502|NCT01154101|64426592|FG002|Overall Study|Lost to Follow-up|0|||
23187503|NCT01154101|64426593|FG003|Overall Study|Lost to Follow-up|1|||
23187504|NCT01154101|64426594|FG004|Overall Study|Lost to Follow-up|0|||
23187505|NCT01154101|64426590|FG000|Overall Study|Withdrawal by Subject|0|||
23187506|NCT01154101|64426591|FG001|Overall Study|Withdrawal by Subject|1|||
23187507|NCT01154101|64426592|FG002|Overall Study|Withdrawal by Subject|2|||
23187508|NCT01154101|64426593|FG003|Overall Study|Withdrawal by Subject|0|||
23187509|NCT01154101|64426594|FG004|Overall Study|Withdrawal by Subject|1|||
23187510|NCT01739595|64426595|FG000|Overall Study|Adverse Event|3|||
23187511|NCT01739595|64426596|FG001|Overall Study|Adverse Event|0|||
23187512|NCT01739595|64426597|FG002|Overall Study|Adverse Event|0|||
23187513|NCT01739595|64426595|FG000|Overall Study|Lost to Follow-up|2|||
23187514|NCT01739595|64426596|FG001|Overall Study|Lost to Follow-up|0|||
23187515|NCT01739595|64426597|FG002|Overall Study|Lost to Follow-up|0|||
23187516|NCT01739595|64426595|FG000|Overall Study|Withdrawal by Subject|2|||
23187517|NCT01739595|64426596|FG001|Overall Study|Withdrawal by Subject|1|||
23187518|NCT01739595|64426597|FG002|Overall Study|Withdrawal by Subject|2|||
23187519|NCT01739595|64426595|FG000|Overall Study|Eligibility issue|3|||
23187520|NCT01739595|64426596|FG001|Overall Study|Eligibility issue|0|||
23187521|NCT01739595|64426597|FG002|Overall Study|Eligibility issue|0|||
23187522|NCT01739595|64426595|FG000|Overall Study|Protocol Violation|1|||
23187523|NCT01739595|64426596|FG001|Overall Study|Protocol Violation|0|||
23187524|NCT01739595|64426597|FG002|Overall Study|Protocol Violation|0|||
23187525|NCT01739595|64426595|FG000|Overall Study|Lab assessment|1|||
23187526|NCT01739595|64426596|FG001|Overall Study|Lab assessment|0|||
23187527|NCT01739595|64426597|FG002|Overall Study|Lab assessment|0|||
23187528|NCT01739595|64426595|FG000|Overall Study|Drug discrepancy|1|||
23187529|NCT01739595|64426596|FG001|Overall Study|Drug discrepancy|0|||
23187530|NCT01739595|64426597|FG002|Overall Study|Drug discrepancy|0|||
23187531|NCT03545282|64426598|FG000|Overall Study|Lost to Follow-up|15|||
23187532|NCT03545282|64426599|FG001|Overall Study|Lost to Follow-up|10|||
23187533|NCT03545282|64426598|FG000|Overall Study|Withdrawal by Subject|2|||
23468260|NCT03584789|65457246|FG000|Overall Study|patients tied to a provider who retired|0|||
23187534|NCT03545282|64426599|FG001|Overall Study|Withdrawal by Subject|2|||
23468261|NCT03584789|65457247|FG001|Overall Study|patients tied to a provider who retired|0|||
23587062|NCT00612586|65876237|FG000|Overall Study|Sponsor Decision|1|||
23352265|NCT03309696|65032935|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
23352266|NCT03309696|65032936|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
23352267|NCT02432144|65032937|FG000|Overall Study|Participant Non-Compliance|1|||
23352268|NCT03885999|65032938|FG000|Overall Study|Adverse Event|1|||
23352269|NCT03391232|65032939|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
23352270|NCT03391232|65032940|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
23352271|NCT03391232|65032939|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
23352272|NCT03391232|65032940|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
23352273|NCT01926197|65032943|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
23352274|NCT01926197|65032944|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
23352275|NCT01926197|65032943|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
23352276|NCT01926197|65032944|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
23352277|NCT00938587|65032945|FG000|Overall Study|Adverse Event|2|||
23352278|NCT00938587|65032946|FG001|Overall Study|Adverse Event|0|||
23352279|NCT00938587|65032947|FG002|Overall Study|Adverse Event|0|||
23352280|NCT00938587|65032948|FG003|Overall Study|Adverse Event|2|||
23352281|NCT00938587|65032945|FG000|Overall Study|Did not meet entrance criteria|0|||
23352282|NCT00938587|65032946|FG001|Overall Study|Did not meet entrance criteria|0|||
23352283|NCT00938587|65032947|FG002|Overall Study|Did not meet entrance criteria|1|||
23352284|NCT00938587|65032948|FG003|Overall Study|Did not meet entrance criteria|0|||
23352285|NCT00938587|65032945|FG000|Overall Study|Withdrawal by Subject|1|||
23352286|NCT00938587|65032946|FG001|Overall Study|Withdrawal by Subject|1|||
23352287|NCT00938587|65032947|FG002|Overall Study|Withdrawal by Subject|0|||
23352288|NCT00938587|65032948|FG003|Overall Study|Withdrawal by Subject|0|||
23352289|NCT00089635|65032953|FG000|Overall Study|Adverse Event|2|||
23352290|NCT00089635|65032953|FG000|Overall Study|Death|17|||
23352291|NCT00089635|65032953|FG000|Overall Study|Disease Progression|12|||
23352292|NCT00089635|65032953|FG000|Overall Study|Lost to Follow-up|3|||
23245897|NCT03747939|64642115|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
23245898|NCT03747939|64642116|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
23245899|NCT03747939|64642117|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
23245900|NCT03747939|64642118|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
23245901|NCT04469465|64642119|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
23245902|NCT04469465|64642120|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
23352293|NCT00089635|65032953|FG000|Overall Study|Withdrawal by Subject|6|||
23352294|NCT00089635|65032953|FG000|Overall Study|Ineligibility determined|1|||
23352295|NCT00089635|65032953|FG000|Overall Study|Other|2|||
23352296|NCT02971800|65032954|FG000|Overall Study|Protocol Violation|1|||
23352297|NCT02971800|65032954|FG000|Overall Study|Withdrawal by Subject|1|||
23352298|NCT02971800|65032954|FG000|Overall Study|Exclusion criteria prior intervention|1|||
23352299|NCT02971800|65032954|FG000|Overall Study|Number evaluable participant already reached|4|||
23352300|NCT01092637|65032955|FG000|Overall Study|Death|47|||
23352301|NCT01092637|65032956|FG001|Overall Study|Death|49|||
23352302|NCT01672294|65032957|FG000|Overall Study|Withdrawal by Subject|4|||
23352303|NCT01672294|65032958|FG001|Overall Study|Withdrawal by Subject|4|||
23352304|NCT01672294|65032959|FG002|Overall Study|Withdrawal by Subject|4|||
23468262|NCT03584789|65457248|FG002|Overall Study|patients tied to a provider who retired|3|||
23245903|NCT04469465|64642119|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
23245904|NCT04469465|64642120|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
23245905|NCT04469465|64642119|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
23245906|NCT04469465|64642120|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
23245907|NCT04469465|64642119|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
23245908|NCT04469465|64642120|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
23245909|NCT04469465|64642119|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
23245910|NCT04469465|64642120|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
23245911|NCT04469465|64642119|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
23245912|NCT04469465|64642120|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
23245913|NCT04469465|64642119|FG000|Long-Term Extension (LTE)|Death|0|||
23245914|NCT04469465|64642120|FG001|Long-Term Extension (LTE)|Death|1|||
23587063|NCT00612586|65876238|FG001|Overall Study|Sponsor Decision|1|||
23587064|NCT00612586|65876237|FG000|Overall Study|Progressive Disease|26|||
23587065|NCT00612586|65876238|FG001|Overall Study|Progressive Disease|24|||
23587066|NCT00612586|65876237|FG000|Overall Study|Randomized and Not Treated|1|||
23587067|NCT00612586|65876238|FG001|Overall Study|Randomized and Not Treated|1|||
23587068|NCT03603717|65876239|FG000|Overall Study|Lost to Follow-up|20|||
23587069|NCT03603717|65876240|FG001|Overall Study|Lost to Follow-up|20|||
23587070|NCT03603717|65876239|FG000|Overall Study|Withdrawal by Subject|16|||
23245915|NCT04469465|64642119|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
23245916|NCT04469465|64642120|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
23468263|NCT01383356|65457252|FG000|Period 1|Adverse Event|5|||
23587071|NCT03603717|65876240|FG001|Overall Study|Withdrawal by Subject|10|||
23245917|NCT03971422|64642124|FG000|Overall Study|Lost to Follow-up|0|||
23587072|NCT02357784|65876241|FG000|Overall Study|Withdrawal by Subject|1|||
23587073|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Death|1|||
23587074|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Death|1|||
23245918|NCT03971422|64642125|FG001|Overall Study|Lost to Follow-up|1|||
23245919|NCT03971422|64642126|FG002|Overall Study|Lost to Follow-up|0|||
23245920|NCT03971422|64642124|FG000|Overall Study|Lack of Efficacy|5|||
23245921|NCT03971422|64642125|FG001|Overall Study|Lack of Efficacy|1|||
23245922|NCT03971422|64642126|FG002|Overall Study|Lack of Efficacy|1|||
23245923|NCT03971422|64642124|FG000|Overall Study|Adverse event, not fatal|2|||
23352305|NCT01672294|65032960|FG003|Overall Study|Withdrawal by Subject|4|||
23245924|NCT03971422|64642125|FG001|Overall Study|Adverse event, not fatal|2|||
23245925|NCT03971422|64642126|FG002|Overall Study|Adverse event, not fatal|5|||
23245926|NCT03971422|64642124|FG000|Overall Study|Worsening of MG Symptoms|1|||
23352306|NCT01672294|65032957|FG000|Overall Study|Excluded by study|1|||
23352307|NCT01672294|65032958|FG001|Overall Study|Excluded by study|1|||
23352308|NCT01672294|65032959|FG002|Overall Study|Excluded by study|0|||
23352309|NCT01672294|65032960|FG003|Overall Study|Excluded by study|0|||
23352310|NCT01672294|65032957|FG000|Overall Study|Lost to Follow-up|1|||
23352311|NCT01672294|65032958|FG001|Overall Study|Lost to Follow-up|16|||
23352312|NCT01672294|65032959|FG002|Overall Study|Lost to Follow-up|7|||
23587075|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Death|0|||
23587076|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Death|0|||
23587077|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Death|0|||
23587078|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
23587079|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
23587080|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
23587081|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
23587082|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
23587083|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Physician Decision|0|||
23587084|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Physician Decision|0|||
23587085|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Physician Decision|0|||
23587086|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Physician Decision|0|||
23587087|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Physician Decision|1|||
23587088|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
23587089|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
23587090|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
23587091|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
23187535|NCT02424149|64426600|FG000|Overall Study|surgery cancelled|2|||
23187536|NCT02424149|64426601|FG001|Overall Study|surgery cancelled|0|||
23187537|NCT02424149|64426600|FG000|Overall Study|Withdrawal by Subject|0|||
23352313|NCT01672294|65032960|FG003|Overall Study|Lost to Follow-up|9|||
23352314|NCT03383692|65032961|FG000|Overall Study|Progressive disease as per RECIST|3|||
23587092|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
23187538|NCT02424149|64426601|FG001|Overall Study|Withdrawal by Subject|1|||
23187539|NCT00195351|64426602|FG000|Overall Study|Lost to Follow-up|9|||
23187540|NCT00195351|64426603|FG001|Overall Study|Lost to Follow-up|9|||
23187541|NCT00195351|64426602|FG000|Overall Study|Withdrawal by Subject|6|||
23187542|NCT00195351|64426603|FG001|Overall Study|Withdrawal by Subject|3|||
23187543|NCT00195351|64426602|FG000|Overall Study|Protocol Deviation|3|||
23187544|NCT00195351|64426603|FG001|Overall Study|Protocol Deviation|2|||
23187545|NCT00195351|64426602|FG000|Overall Study|Death|3|||
23187546|NCT00195351|64426603|FG001|Overall Study|Death|1|||
23187547|NCT00195351|64426602|FG000|Overall Study|Lack of Efficacy|0|||
23187548|NCT00195351|64426603|FG001|Overall Study|Lack of Efficacy|1|||
23187549|NCT00592683|64426605|FG000|Overall Study|Found ineligible|0|||
23187550|NCT00592683|64426606|FG001|Overall Study|Found ineligible|1|||
23187551|NCT00592683|64426605|FG000|Overall Study|Withdrawal by Subject|1|||
23187552|NCT00592683|64426606|FG001|Overall Study|Withdrawal by Subject|0|||
23187553|NCT00592683|64426605|FG000|Overall Study|Adverse Event|0|||
23187554|NCT00592683|64426606|FG001|Overall Study|Adverse Event|2|||
23187555|NCT00592683|64426605|FG000|Overall Study|Protocol Violation|1|||
23187556|NCT00592683|64426606|FG001|Overall Study|Protocol Violation|0|||
23187557|NCT00592683|64426605|FG000|Overall Study|Study drug expired|1|||
23187558|NCT00592683|64426606|FG001|Overall Study|Study drug expired|0|||
23187559|NCT00592683|64426605|FG000|Overall Study|Other|1|||
23187560|NCT00592683|64426606|FG001|Overall Study|Other|0|||
23187561|NCT00592683|64426605|FG000|Overall Study|Lost to Follow-up|0|||
23187562|NCT00592683|64426606|FG001|Overall Study|Lost to Follow-up|1|||
23187563|NCT02498652|64426615|FG000|Overall Study|Protocol Violation|0|||
23187564|NCT02498652|64426616|FG001|Overall Study|Protocol Violation|1|||
23187565|NCT02111369|64429895|FG000|Overall Study|Lost to Follow-up|2|||
23187566|NCT02111369|64429895|FG000|Overall Study|Withdrawal by Subject|1|||
23187567|NCT03815175|64429896|FG000|Overall Study|Subject Lost to Follow-up|6|||
23187568|NCT03815175|64429896|FG000|Overall Study|Subject Withdrew Consent|48|||
23587093|NCT02503202|65876244|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
23187569|NCT03815175|64429896|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
23245927|NCT03971422|64642125|FG001|Overall Study|Worsening of MG Symptoms|4|||
23187570|NCT03815175|64429896|FG000|Overall Study|Death|86|||
23352315|NCT03383692|65032962|FG001|Overall Study|Progressive disease as per RECIST|3|||
23245928|NCT03971422|64642126|FG002|Overall Study|Worsening of MG Symptoms|2|||
23245929|NCT03971422|64642124|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
23245930|NCT03971422|64642125|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
23245931|NCT03971422|64642126|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
23245932|NCT03971422|64642124|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
23468264|NCT01383356|65457253|FG001|Period 1|Adverse Event|3|||
23245933|NCT03971422|64642125|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
23245934|NCT03971422|64642126|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
23468265|NCT01383356|65457252|FG000|Period 1|Non-compliance|3|||
23468266|NCT01383356|65457253|FG001|Period 1|Non-compliance|0|||
23468267|NCT01383356|65457252|FG000|Period 1|Out of Range Mid-study-Test|0|||
23468268|NCT01383356|65457253|FG001|Period 1|Out of Range Mid-study-Test|1|||
23468269|NCT01383356|65457252|FG000|Period 1|Personal|0|||
23468270|NCT01383356|65457253|FG001|Period 1|Personal|2|||
23468271|NCT03436082|65457256|FG000|Overall Study|Did not undergo procedure|1|||
23468272|NCT03436082|65457257|FG001|Overall Study|Did not undergo procedure|0|||
23468273|NCT00214201|65457262|FG000|Overall Study|Withdrawal by Subject|2|||
23468274|NCT00214201|65457263|FG001|Overall Study|Withdrawal by Subject|0|||
23468275|NCT00214201|65457262|FG000|Overall Study|Death|0|||
23468276|NCT00214201|65457263|FG001|Overall Study|Death|2|||
23468277|NCT02533453|65457264|FG000|Overall Study|Adverse Event|6|||
23468278|NCT02533453|65457264|FG000|Overall Study|Protocol Violation|1|||
23468279|NCT02533453|65457264|FG000|Overall Study|Withdrawal by Subject|2|||
23468280|NCT00594815|65457265|FG000|Overall Study|Never Treated|3|||
23468281|NCT00594815|65457265|FG000|Overall Study|Withdrawal by Subject|2|||
23468282|NCT00594815|65457265|FG000|Overall Study|Toxicity|4|||
23468283|NCT02819804|65457266|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
23468284|NCT03848832|65457267|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
23468285|NCT03848832|65457268|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
23468286|NCT03848832|65457269|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
23468287|NCT03848832|65457267|FG000|Overall Study|Withdrawal by Subject|0|||
23468288|NCT03848832|65457268|FG001|Overall Study|Withdrawal by Subject|0|||
23468289|NCT03848832|65457269|FG002|Overall Study|Withdrawal by Subject|1|||
23468290|NCT03848832|65457267|FG000|Overall Study|Withdrawal (Covid-19)|0|||
23468291|NCT03848832|65457268|FG001|Overall Study|Withdrawal (Covid-19)|2|||
23468292|NCT03848832|65457269|FG002|Overall Study|Withdrawal (Covid-19)|0|||
23468293|NCT03848832|65457267|FG000|Overall Study|Physician Decision|2|||
23468294|NCT03848832|65457268|FG001|Overall Study|Physician Decision|1|||
23468295|NCT03848832|65457269|FG002|Overall Study|Physician Decision|3|||
23468296|NCT03848832|65457267|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
23468297|NCT03848832|65457268|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
23468298|NCT03848832|65457269|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
23468299|NCT03848832|65457267|FG000|Overall Study|Adverse Event|1|||
23468300|NCT03848832|65457268|FG001|Overall Study|Adverse Event|0|||
23468301|NCT03848832|65457269|FG002|Overall Study|Adverse Event|0|||
23468302|NCT00423917|65457274|FG000|Overall Study|Cancel|2|||
23468303|NCT00423917|65457274|FG000|Overall Study|Ineligible|1|||
23468304|NCT02461758|65457275|FG000|Overall Study|Lost to Follow-up|0|||
23468305|NCT02461758|65457276|FG001|Overall Study|Lost to Follow-up|1|||
23245935|NCT03971422|64642124|FG000|Overall Study|Due to COVID-19 pandemic|0|||
23245936|NCT03971422|64642125|FG001|Overall Study|Due to COVID-19 pandemic|1|||
23245937|NCT03971422|64642126|FG002|Overall Study|Due to COVID-19 pandemic|1|||
23245938|NCT02152631|64642127|FG000|Overall Study|Adverse Event|32|||
23245939|NCT02152631|64642128|FG001|Overall Study|Adverse Event|4|||
23245940|NCT02152631|64642127|FG000|Overall Study|Withdrawal by Subject|13|||
23245941|NCT02152631|64642128|FG001|Overall Study|Withdrawal by Subject|16|||
23245942|NCT02152631|64642127|FG000|Overall Study|Noncompliance with study drug|1|||
23245943|NCT02152631|64642128|FG001|Overall Study|Noncompliance with study drug|0|||
23245944|NCT02152631|64642127|FG000|Overall Study|Physician Decision|1|||
23245945|NCT02152631|64642128|FG001|Overall Study|Physician Decision|2|||
23245946|NCT02152631|64642127|FG000|Overall Study|Lost to Follow-up|0|||
23245947|NCT02152631|64642128|FG001|Overall Study|Lost to Follow-up|1|||
23245948|NCT02152631|64642127|FG000|Overall Study|On Treatment|19|||
23245949|NCT02152631|64642128|FG001|Overall Study|On Treatment|3|||
23245950|NCT00679042|64642129|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
23245951|NCT00679042|64642129|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
23468306|NCT02461758|65457277|FG002|Overall Study|Lost to Follow-up|1|||
23468307|NCT02461758|65457278|FG003|Overall Study|Lost to Follow-up|0|||
23468308|NCT00118417|65457280|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
23468309|NCT00118417|65457281|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
23245952|NCT00679042|64642129|FG000|5-Year Follow Up|Death|1|||
23245953|NCT00679042|64642129|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
23245954|NCT00679042|64642129|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
23245955|NCT03239340|64642130|FG000|Overall Study|Other|26|||
23468310|NCT00118417|65457280|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
23468311|NCT00118417|65457281|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
23468312|NCT00118417|65457280|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
23468313|NCT00118417|65457281|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
23468314|NCT00118417|65457280|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
23468315|NCT00118417|65457281|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
23468316|NCT00118417|65457280|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
23468317|NCT00118417|65457281|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
23468318|NCT02175030|65457282|FG000|Overall Study|Failed screen after consent|7|||
23468319|NCT02175030|65457283|FG001|Overall Study|Failed screen after consent|6|||
23468320|NCT02175030|65457282|FG000|Overall Study|Failed IUD Insertion|20|||
23468321|NCT02175030|65457283|FG001|Overall Study|Failed IUD Insertion|21|||
23468322|NCT02175030|65457282|FG000|Overall Study|Physician Decision|1|||
23468323|NCT02175030|65457283|FG001|Overall Study|Physician Decision|1|||
23468324|NCT02175030|65457282|FG000|Overall Study|Lost to Follow-up|6|||
23352316|NCT03383692|65032961|FG000|Overall Study|Clinical progression|0|||
23352317|NCT03383692|65032962|FG001|Overall Study|Clinical progression|1|||
23352318|NCT03383692|65032961|FG000|Overall Study|Adverse Event|3|||
23352319|NCT03383692|65032962|FG001|Overall Study|Adverse Event|0|||
23468325|NCT02175030|65457283|FG001|Overall Study|Lost to Follow-up|6|||
23468326|NCT02175030|65457282|FG000|Overall Study|Withdrawal by Subject|1|||
23468327|NCT02175030|65457283|FG001|Overall Study|Withdrawal by Subject|4|||
23468328|NCT00996333|65457284|FG000|Overall Study|Screen failure|1|||
23468329|NCT00996333|65457284|FG000|Overall Study|Withdrawal by Subject|1|||
23468330|NCT00996333|65457284|FG000|Overall Study|Death|4|||
23468331|NCT00996333|65457284|FG000|Overall Study|Adverse Event|1|||
23468332|NCT00996333|65457284|FG000|Overall Study|Physician Decision|1|||
23468333|NCT00996333|65457284|FG000|Overall Study|Other|5|||
23468334|NCT04413617|65457285|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
23468335|NCT04413617|65457286|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
23468336|NCT04413617|65457287|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
23468337|NCT04413617|65457288|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
23468338|NCT04413617|65457289|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
23468339|NCT04413617|65457285|FG000|Overall Study|Protocol Violation|0|||
23187571|NCT03815175|64429896|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
23187572|NCT03815175|64429896|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
23352320|NCT02223364|65032963|FG000|Overall Study|Protocol Violation|3|||
23352321|NCT02223364|65032964|FG001|Overall Study|Protocol Violation|0|||
23352322|NCT02223364|65032965|FG002|Overall Study|Protocol Violation|3|||
23352323|NCT02223364|65032963|FG000|Overall Study|subject expired before surgery|1|||
23352324|NCT02223364|65032964|FG001|Overall Study|subject expired before surgery|0|||
23352325|NCT02223364|65032965|FG002|Overall Study|subject expired before surgery|0|||
23352326|NCT02223364|65032963|FG000|Overall Study|Physician Decision|1|||
23352327|NCT02223364|65032964|FG001|Overall Study|Physician Decision|0|||
23352328|NCT02223364|65032965|FG002|Overall Study|Physician Decision|0|||
23352329|NCT00577005|65032968|FG000|Overall Study|Lost to Follow-up|3|||
23352330|NCT00577005|65032969|FG001|Overall Study|Lost to Follow-up|2|||
23352331|NCT00577005|65032968|FG000|Overall Study|Withdrawal by Subject|2|||
23352332|NCT00577005|65032969|FG001|Overall Study|Withdrawal by Subject|1|||
23468340|NCT04413617|65457286|FG001|Overall Study|Protocol Violation|1|||
23468341|NCT04413617|65457287|FG002|Overall Study|Protocol Violation|0|||
23468342|NCT04413617|65457288|FG003|Overall Study|Protocol Violation|0|||
23468343|NCT04413617|65457289|FG004|Overall Study|Protocol Violation|1|||
23187573|NCT03815175|64429896|FG000|Overall Study|Other Status Change Reason|1|||
23187574|NCT03815175|64429896|FG000|Overall Study|Missed Visit|12|||
23187575|NCT02582515|64429897|FG000|Overall Study|Withdrawal by Subject|0|||
23187576|NCT02582515|64429898|FG001|Overall Study|Withdrawal by Subject|1|||
23187577|NCT01938625|64429904|FG000|Overall Study|Withdrawal by Subject|0|||
23187578|NCT01938625|64429905|FG001|Overall Study|Withdrawal by Subject|1|||
23187579|NCT01938625|64429904|FG000|Overall Study|Adverse Event|0|||
23187580|NCT01938625|64429905|FG001|Overall Study|Adverse Event|1|||
23187581|NCT01719757|64429906|FG000|Overall Study|Adverse Event|38|||
23187582|NCT01719757|64429906|FG000|Overall Study|Withdrawal by Subject|15|||
23187583|NCT01719757|64429906|FG000|Overall Study|Lost to Follow-up|20|||
23187584|NCT01719757|64429906|FG000|Overall Study|Protocol Violation|1|||
23187585|NCT01719757|64429906|FG000|Overall Study|well controlled pain|27|||
23187586|NCT00561353|64429912|FG000|Overall Study|Subject reached a virologic endpoint|2|||
23187587|NCT00561353|64429913|FG001|Overall Study|Subject reached a virologic endpoint|1|||
23187588|NCT00561353|64429914|FG002|Overall Study|Subject reached a virologic endpoint|1|||
23187589|NCT00561353|64429915|FG003|Overall Study|Subject reached a virologic endpoint|4|||
23245956|NCT03239340|64642130|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
23187590|NCT00561353|64429916|FG004|Overall Study|Subject reached a virologic endpoint|1|||
23352333|NCT00441363|65032971|FG000|Overall Study|Adverse Event|4|||
23352334|NCT00441363|65032972|FG001|Overall Study|Adverse Event|2|||
23352335|NCT00441363|65032971|FG000|Overall Study|Withdrawal by Subject|3|||
23352336|NCT00441363|65032972|FG001|Overall Study|Withdrawal by Subject|4|||
23245957|NCT03239340|64642130|FG000|Overall Study|Death|40|||
23245958|NCT03239340|64642130|FG000|Overall Study|Lost to Follow-up|2|||
23245959|NCT03239340|64642130|FG000|Overall Study|Physician Decision|16|||
23245960|NCT03239340|64642130|FG000|Overall Study|Withdrawal by Subject|27|||
23245961|NCT02666768|64642131|FG000|Overall Study|Withdrawal by Subject|4|||
23245962|NCT03901339|64642132|FG000|Overall Study|Death|220|||
23245963|NCT03901339|64642133|FG001|Overall Study|Death|192|||
23245964|NCT03901339|64642132|FG000|Overall Study|Informed consent withdrawn|13|||
23245965|NCT03901339|64642133|FG001|Overall Study|Informed consent withdrawn|40|||
23245966|NCT03901339|64642132|FG000|Overall Study|Sponsor request|30|||
23245967|NCT03901339|64642133|FG001|Overall Study|Sponsor request|23|||
23245968|NCT03901339|64642132|FG000|Overall Study|Reason not specified|5|||
23245969|NCT03901339|64642133|FG001|Overall Study|Reason not specified|7|||
23245970|NCT03901339|64642132|FG000|Overall Study|Lost to Follow-up|4|||
23245971|NCT03901339|64642133|FG001|Overall Study|Lost to Follow-up|7|||
23245972|NCT03901339|64642132|FG000|Overall Study|Covid19|0|||
23245973|NCT03901339|64642133|FG001|Overall Study|Covid19|2|||
23245974|NCT06067191|64642135|FG000|Overall Study|Withdrawal by Subject|0|||
23245975|NCT06067191|64642136|FG001|Overall Study|Withdrawal by Subject|1|||
23245976|NCT04882085|64642137|FG000|Overall Study|Death|6|||
23245977|NCT04882085|64642138|FG001|Overall Study|Death|9|||
23245978|NCT04882085|64642137|FG000|Overall Study|Withdrawal by Subject|0|||
23245979|NCT04882085|64642138|FG001|Overall Study|Withdrawal by Subject|3|||
23245980|NCT04882085|64642137|FG000|Overall Study|Randomized not treated|1|||
23245981|NCT04882085|64642138|FG001|Overall Study|Randomized not treated|0|||
23245982|NCT02867592|64642139|FG000|Overall Study|Adverse Event|3|||
23245983|NCT02867592|64642140|FG001|Overall Study|Adverse Event|0|||
23245984|NCT02867592|64642141|FG002|Overall Study|Adverse Event|2|||
23245985|NCT02867592|64642142|FG003|Overall Study|Adverse Event|1|||
23245986|NCT02867592|64642143|FG004|Overall Study|Adverse Event|1|||
23245987|NCT02867592|64642144|FG005|Overall Study|Adverse Event|5|||
23245988|NCT02867592|64642139|FG000|Overall Study|Death|0|||
23245989|NCT02867592|64642140|FG001|Overall Study|Death|0|||
23245990|NCT02867592|64642141|FG002|Overall Study|Death|0|||
23245991|NCT02867592|64642142|FG003|Overall Study|Death|1|||
23245992|NCT02867592|64642143|FG004|Overall Study|Death|0|||
23245993|NCT02867592|64642144|FG005|Overall Study|Death|1|||
23245994|NCT02867592|64642139|FG000|Overall Study|Lack of Efficacy|8|||
23245995|NCT02867592|64642140|FG001|Overall Study|Lack of Efficacy|10|||
23245996|NCT02867592|64642141|FG002|Overall Study|Lack of Efficacy|8|||
23245997|NCT02867592|64642142|FG003|Overall Study|Lack of Efficacy|8|||
23245998|NCT02867592|64642143|FG004|Overall Study|Lack of Efficacy|12|||
23245999|NCT02867592|64642144|FG005|Overall Study|Lack of Efficacy|17|||
23246000|NCT02867592|64642139|FG000|Overall Study|Physician Decision|1|||
23246001|NCT02867592|64642140|FG001|Overall Study|Physician Decision|2|||
23246002|NCT02867592|64642141|FG002|Overall Study|Physician Decision|2|||
23246003|NCT02867592|64642142|FG003|Overall Study|Physician Decision|0|||
23246004|NCT02867592|64642143|FG004|Overall Study|Physician Decision|5|||
23246005|NCT02867592|64642144|FG005|Overall Study|Physician Decision|1|||
23246006|NCT02867592|64642139|FG000|Overall Study|Protocol Violation|0|||
23246007|NCT02867592|64642140|FG001|Overall Study|Protocol Violation|0|||
23246008|NCT02867592|64642141|FG002|Overall Study|Protocol Violation|0|||
23246009|NCT02867592|64642142|FG003|Overall Study|Protocol Violation|0|||
23246010|NCT02867592|64642143|FG004|Overall Study|Protocol Violation|1|||
23246011|NCT02867592|64642144|FG005|Overall Study|Protocol Violation|1|||
23352337|NCT00441363|65032971|FG000|Overall Study|Physician Decision|6|||
23352338|NCT00441363|65032972|FG001|Overall Study|Physician Decision|7|||
23352339|NCT00441363|65032971|FG000|Overall Study|Lost to Follow-up|2|||
23352340|NCT00441363|65032972|FG001|Overall Study|Lost to Follow-up|2|||
23352341|NCT00441363|65032971|FG000|Overall Study|Other|2|||
23352342|NCT00441363|65032972|FG001|Overall Study|Other|0|||
23352343|NCT02651688|65032973|FG000|Overall Study|Non-compliance|0|||
23352344|NCT02651688|65032974|FG001|Overall Study|Non-compliance|0|||
23352345|NCT02651688|65032975|FG002|Overall Study|Non-compliance|1|||
23352346|NCT02651688|65032973|FG000|Overall Study|Principal Investigator (PI) decision|0|||
23352347|NCT02651688|65032974|FG001|Overall Study|Principal Investigator (PI) decision|2|||
23468344|NCT04413617|65457285|FG000|Overall Study|Lack of Efficacy|2|||
23468345|NCT04413617|65457286|FG001|Overall Study|Lack of Efficacy|0|||
23352348|NCT02651688|65032975|FG002|Overall Study|Principal Investigator (PI) decision|0|||
23352349|NCT02651688|65032973|FG000|Overall Study|Lost to Follow-up|1|||
23246012|NCT02867592|64642139|FG000|Overall Study|Withdrawal by Subject|0|||
23468346|NCT04413617|65457287|FG002|Overall Study|Lack of Efficacy|2|||
23246013|NCT02867592|64642140|FG001|Overall Study|Withdrawal by Subject|1|||
23246014|NCT02867592|64642141|FG002|Overall Study|Withdrawal by Subject|0|||
23246015|NCT02867592|64642142|FG003|Overall Study|Withdrawal by Subject|1|||
23352350|NCT02651688|65032974|FG001|Overall Study|Lost to Follow-up|3|||
23246016|NCT02867592|64642143|FG004|Overall Study|Withdrawal by Subject|3|||
23246017|NCT02867592|64642144|FG005|Overall Study|Withdrawal by Subject|3|||
23352351|NCT02651688|65032975|FG002|Overall Study|Lost to Follow-up|0|||
23352352|NCT02651688|65032973|FG000|Overall Study|Withdrawal by Subject|1|||
23246018|NCT02867592|64642139|FG000|Overall Study|Ineligible|1|||
23246019|NCT02867592|64642140|FG001|Overall Study|Ineligible|1|||
23246020|NCT02867592|64642141|FG002|Overall Study|Ineligible|0|||
23246021|NCT02867592|64642142|FG003|Overall Study|Ineligible|0|||
23246022|NCT02867592|64642143|FG004|Overall Study|Ineligible|2|||
23246023|NCT02867592|64642144|FG005|Overall Study|Ineligible|0|||
23246024|NCT02867592|64642139|FG000|Overall Study|No Treatment|1|||
23246025|NCT02867592|64642140|FG001|Overall Study|No Treatment|0|||
23246026|NCT02867592|64642141|FG002|Overall Study|No Treatment|0|||
23246027|NCT02867592|64642142|FG003|Overall Study|No Treatment|0|||
23246028|NCT02867592|64642143|FG004|Overall Study|No Treatment|0|||
23352353|NCT02651688|65032974|FG001|Overall Study|Withdrawal by Subject|0|||
23352354|NCT02651688|65032975|FG002|Overall Study|Withdrawal by Subject|2|||
23352355|NCT02554318|65032976|FG000|Overall Study|Withdrawal by Subject|10|||
23352356|NCT02554318|65032977|FG001|Overall Study|Withdrawal by Subject|8|||
23352357|NCT03816007|65032978|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
23352358|NCT03816007|65032979|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
23352359|NCT03816007|65032978|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
23352360|NCT03816007|65032979|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
23352361|NCT03816007|65032978|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
23352362|NCT03816007|65032979|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
23352363|NCT00520767|65032980|FG000|Overall Study|Death|2|||
23187591|NCT00561353|64429917|FG005|Overall Study|Subject reached a virologic endpoint|3|||
23187592|NCT00561353|64429918|FG006|Overall Study|Subject reached a virologic endpoint|4|||
23187593|NCT00561353|64429919|FG007|Overall Study|Subject reached a virologic endpoint|4|||
23187594|NCT00561353|64429920|FG008|Overall Study|Subject reached a virologic endpoint|5|||
23187595|NCT00561353|64429921|FG009|Overall Study|Subject reached a virologic endpoint|0|||
23187596|NCT00561353|64429912|FG000|Overall Study|Subject ineligible to continue the trial|0|||
23187597|NCT00561353|64429913|FG001|Overall Study|Subject ineligible to continue the trial|0|||
23187598|NCT00561353|64429914|FG002|Overall Study|Subject ineligible to continue the trial|0|||
23187599|NCT00561353|64429915|FG003|Overall Study|Subject ineligible to continue the trial|0|||
23187600|NCT00561353|64429916|FG004|Overall Study|Subject ineligible to continue the trial|0|||
23187601|NCT00561353|64429917|FG005|Overall Study|Subject ineligible to continue the trial|1|||
23187602|NCT00561353|64429918|FG006|Overall Study|Subject ineligible to continue the trial|1|||
23187603|NCT00561353|64429919|FG007|Overall Study|Subject ineligible to continue the trial|0|||
23187604|NCT00561353|64429920|FG008|Overall Study|Subject ineligible to continue the trial|2|||
23187605|NCT00561353|64429921|FG009|Overall Study|Subject ineligible to continue the trial|1|||
23187606|NCT00561353|64429912|FG000|Overall Study|Other|1|||
23187607|NCT00561353|64429913|FG001|Overall Study|Other|0|||
23187608|NCT00561353|64429914|FG002|Overall Study|Other|1|||
23187609|NCT00561353|64429915|FG003|Overall Study|Other|0|||
23187610|NCT00561353|64429916|FG004|Overall Study|Other|0|||
23187611|NCT00561353|64429917|FG005|Overall Study|Other|2|||
23187612|NCT00561353|64429918|FG006|Overall Study|Other|0|||
23187613|NCT00561353|64429919|FG007|Overall Study|Other|0|||
23187614|NCT00561353|64429920|FG008|Overall Study|Other|0|||
23187615|NCT00561353|64429921|FG009|Overall Study|Other|0|||
23187616|NCT00561353|64429912|FG000|Overall Study|Adverse Event|0|||
23187617|NCT00561353|64429913|FG001|Overall Study|Adverse Event|0|||
23187618|NCT00561353|64429914|FG002|Overall Study|Adverse Event|0|||
23187619|NCT00561353|64429915|FG003|Overall Study|Adverse Event|2|||
23187620|NCT00561353|64429916|FG004|Overall Study|Adverse Event|0|||
23187621|NCT00561353|64429917|FG005|Overall Study|Adverse Event|0|||
23187622|NCT00561353|64429918|FG006|Overall Study|Adverse Event|1|||
23187623|NCT00561353|64429919|FG007|Overall Study|Adverse Event|0|||
23187624|NCT00561353|64429920|FG008|Overall Study|Adverse Event|0|||
23187625|NCT00561353|64429921|FG009|Overall Study|Adverse Event|1|||
23187626|NCT00561353|64429912|FG000|Overall Study|Lost to Follow-up|2|||
23187627|NCT00561353|64429913|FG001|Overall Study|Lost to Follow-up|0|||
23187628|NCT00561353|64429914|FG002|Overall Study|Lost to Follow-up|1|||
23187629|NCT00561353|64429915|FG003|Overall Study|Lost to Follow-up|0|||
23187630|NCT00561353|64429916|FG004|Overall Study|Lost to Follow-up|0|||
23187631|NCT00561353|64429917|FG005|Overall Study|Lost to Follow-up|0|||
23187632|NCT00561353|64429918|FG006|Overall Study|Lost to Follow-up|0|||
23187633|NCT00561353|64429919|FG007|Overall Study|Lost to Follow-up|0|||
23187634|NCT00561353|64429920|FG008|Overall Study|Lost to Follow-up|0|||
23187635|NCT00561353|64429921|FG009|Overall Study|Lost to Follow-up|0|||
23187636|NCT00561353|64429912|FG000|Overall Study|Withdrawal by Subject|0|||
23187637|NCT00561353|64429913|FG001|Overall Study|Withdrawal by Subject|2|||
23187638|NCT00561353|64429914|FG002|Overall Study|Withdrawal by Subject|0|||
23187639|NCT00561353|64429915|FG003|Overall Study|Withdrawal by Subject|0|||
23246029|NCT02867592|64642144|FG005|Overall Study|No Treatment|0|||
23246030|NCT02867592|64642139|FG000|Overall Study|Still on Therapy|0|||
23352364|NCT01259375|65032986|FG000|Overall Study|Adverse Event|1|||
23187640|NCT00561353|64429916|FG004|Overall Study|Withdrawal by Subject|0|||
23187641|NCT00561353|64429917|FG005|Overall Study|Withdrawal by Subject|0|||
23246031|NCT02867592|64642140|FG001|Overall Study|Still on Therapy|0|||
23587094|NCT02503202|65876245|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
23587095|NCT02503202|65876246|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
23246032|NCT02867592|64642141|FG002|Overall Study|Still on Therapy|0|||
23246033|NCT02867592|64642142|FG003|Overall Study|Still on Therapy|0|||
23246034|NCT02867592|64642143|FG004|Overall Study|Still on Therapy|1|||
23246035|NCT02867592|64642144|FG005|Overall Study|Still on Therapy|0|||
23246036|NCT02867592|64642139|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23246037|NCT02867592|64642140|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23246038|NCT02867592|64642141|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23246039|NCT02867592|64642142|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23246040|NCT02867592|64642143|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
23246041|NCT02867592|64642144|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
23246042|NCT02867592|64642139|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
23246043|NCT02867592|64642140|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
23246044|NCT02867592|64642141|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
23246045|NCT02867592|64642142|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
23246046|NCT02867592|64642143|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
23246047|NCT02867592|64642144|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
23246048|NCT03737994|64642145|FG000|Overall Study|Withdrawal by Subject|0|||
23246049|NCT03737994|64642146|FG001|Overall Study|Withdrawal by Subject|0|||
23246050|NCT03737994|64642147|FG002|Overall Study|Withdrawal by Subject|0|||
23246051|NCT03737994|64642148|FG003|Overall Study|Withdrawal by Subject|0|||
23246052|NCT03737994|64642149|FG004|Overall Study|Withdrawal by Subject|0|||
23246053|NCT03737994|64642150|FG005|Overall Study|Withdrawal by Subject|0|||
23246054|NCT03737994|64642151|FG006|Overall Study|Withdrawal by Subject|1|||
23246055|NCT03973918|64642152|FG000|Overall Study|Adverse Event|0|||
23246056|NCT03973918|64642153|FG001|Overall Study|Adverse Event|0|||
23246057|NCT03973918|64642154|FG002|Overall Study|Adverse Event|0|||
23246058|NCT03973918|64642155|FG003|Overall Study|Adverse Event|1|||
23246059|NCT03973918|64642152|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
23246060|NCT03973918|64642153|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
23246061|NCT03973918|64642154|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
23246062|NCT03973918|64642155|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
23246063|NCT04812548|64642158|FG000|Overall Study|Adverse Event|2|||
23246064|NCT04812548|64642159|FG001|Overall Study|Adverse Event|7|||
23246065|NCT04812548|64642158|FG000|Overall Study|HSCT Planned|2|||
23246066|NCT04812548|64642159|FG001|Overall Study|HSCT Planned|3|||
23246067|NCT04812548|64642158|FG000|Overall Study|Progressive Disease|0|||
23246068|NCT04812548|64642159|FG001|Overall Study|Progressive Disease|2|||
23246069|NCT04812548|64642158|FG000|Overall Study|Death|0|||
23246070|NCT04812548|64642159|FG001|Overall Study|Death|1|||
23246071|NCT04812548|64642158|FG000|Overall Study|Post Study Access to Treatment|0|||
23246072|NCT04812548|64642159|FG001|Overall Study|Post Study Access to Treatment|1|||
23246073|NCT04812548|64642158|FG000|Overall Study|Withdrawal by Subject|0|||
23246074|NCT04812548|64642159|FG001|Overall Study|Withdrawal by Subject|1|||
23246075|NCT04812548|64642158|FG000|Overall Study|Physician Decision|1|||
23246076|NCT04812548|64642159|FG001|Overall Study|Physician Decision|0|||
23246077|NCT04775953|64642162|FG000|Overall Study|Lost to Follow-up|6|||
23246078|NCT04775953|64642163|FG001|Overall Study|Lost to Follow-up|11|||
23246079|NCT04775953|64642162|FG000|Overall Study|Death|5|||
23246080|NCT04775953|64642163|FG001|Overall Study|Death|4|||
23246081|NCT04775953|64642162|FG000|Overall Study|Withdrawal by Subject|3|||
23246082|NCT04775953|64642163|FG001|Overall Study|Withdrawal by Subject|3|||
23246083|NCT04775953|64642162|FG000|Overall Study|Protocol Violation|2|||
23246084|NCT04775953|64642163|FG001|Overall Study|Protocol Violation|0|||
23246085|NCT04775953|64642162|FG000|Overall Study|Participant non-compliance|0|||
23246086|NCT04775953|64642163|FG001|Overall Study|Participant non-compliance|1|||
23246087|NCT02965716|64642164|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23246088|NCT02965716|64642165|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
23246089|NCT02965716|64642164|FG000|Overall Study|Progression/Relapse|8|||
23246090|NCT02965716|64642165|FG001|Overall Study|Progression/Relapse|16|||
23246091|NCT02965716|64642164|FG000|Overall Study|Death|1|||
23246092|NCT02965716|64642165|FG001|Overall Study|Death|0|||
23246093|NCT02965716|64642164|FG000|Overall Study|Not Protocol Specified|1|||
23246094|NCT02965716|64642165|FG001|Overall Study|Not Protocol Specified|3|||
23352365|NCT03403621|65032987|FG000|Overall Study|Withdrawal by Subject|2|||
23246095|NCT01015118|64642166|FG000|Overall Study|Protocol Violation|5|||
23352366|NCT03403621|65032988|FG001|Overall Study|Withdrawal by Subject|2|||
23352367|NCT00723697|65032989|FG000|Overall Study|Physician questionnaires not received|2|||
23352368|NCT00723697|65032989|FG000|Overall Study|Missing Informed Consent Form|10|||
23352369|NCT00723697|65032989|FG000|Overall Study|Other exclusion criteria applied|6|||
23352370|NCT03853291|65032991|FG000|Overall Study|Lost to Follow-up|1|||
23352371|NCT03853291|65032992|FG001|Overall Study|Lost to Follow-up|2|||
23352372|NCT03853291|65032993|FG002|Overall Study|Lost to Follow-up|0|||
23352373|NCT03853291|65032994|FG003|Overall Study|Lost to Follow-up|0|||
23352374|NCT03853291|65032995|FG004|Overall Study|Lost to Follow-up|0|||
23352375|NCT03853291|65032996|FG005|Overall Study|Lost to Follow-up|0|||
23352376|NCT03853291|65032991|FG000|Overall Study|Determined to be ineligible|1|||
23352377|NCT03853291|65032992|FG001|Overall Study|Determined to be ineligible|1|||
23352378|NCT03853291|65032993|FG002|Overall Study|Determined to be ineligible|0|||
23352379|NCT03853291|65032994|FG003|Overall Study|Determined to be ineligible|0|||
23352380|NCT03853291|65032995|FG004|Overall Study|Determined to be ineligible|0|||
23352381|NCT03853291|65032996|FG005|Overall Study|Determined to be ineligible|0|||
23352382|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
23352383|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
23352384|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
23352385|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
23352386|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
23352387|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
23352388|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
23352389|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
23352390|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
23352391|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
23352392|NCT00455520|65032998|FG000|Open Label Tapentadol Extended Release|All other|33|||
23352393|NCT00455520|65032999|FG001|Open Label Tapentadol Extended Release|All other|0|||
23352394|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
23352395|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
23352396|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
23352397|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
23352398|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
23352399|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
23352400|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
23352401|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
23352402|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
23352403|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
23352404|NCT00455520|65032998|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
23352405|NCT00455520|65032999|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
23468347|NCT04413617|65457288|FG003|Overall Study|Lack of Efficacy|1|||
23468348|NCT04413617|65457289|FG004|Overall Study|Lack of Efficacy|0|||
23187642|NCT00561353|64429918|FG006|Overall Study|Withdrawal by Subject|0|||
23187643|NCT00561353|64429919|FG007|Overall Study|Withdrawal by Subject|0|||
23187644|NCT00561353|64429920|FG008|Overall Study|Withdrawal by Subject|0|||
23187645|NCT00561353|64429921|FG009|Overall Study|Withdrawal by Subject|0|||
23187646|NCT01773473|64429925|FG000|Overall Study|Adverse Event|3|||
23187647|NCT01773473|64429926|FG001|Overall Study|Adverse Event|2|||
23187648|NCT01773473|64429925|FG000|Overall Study|Protocol Violation|0|||
23187649|NCT01773473|64429926|FG001|Overall Study|Protocol Violation|4|||
23187650|NCT01773473|64429925|FG000|Overall Study|Physician Decision|3|||
23187651|NCT01773473|64429926|FG001|Overall Study|Physician Decision|5|||
23246096|NCT01015118|64642167|FG001|Overall Study|Protocol Violation|6|||
23246097|NCT01015118|64642166|FG000|Overall Study|Withdrawal by Subject|103|||
23246098|NCT01015118|64642167|FG001|Overall Study|Withdrawal by Subject|27|||
23246099|NCT01015118|64642166|FG000|Overall Study|Other Adverse Event (AE)|141|||
23246100|NCT01015118|64642167|FG001|Overall Study|Other Adverse Event (AE)|33|||
23246101|NCT01015118|64642166|FG000|Overall Study|Worsening or AE of underlying disease|5|||
23246102|NCT01015118|64642167|FG001|Overall Study|Worsening or AE of underlying disease|4|||
23246103|NCT01015118|64642166|FG000|Overall Study|Progressive disease|364|||
23246104|NCT01015118|64642167|FG001|Overall Study|Progressive disease|229|||
23246105|NCT01015118|64642166|FG000|Overall Study|Not treated|9|||
23246106|NCT01015118|64642167|FG001|Overall Study|Not treated|5|||
23352406|NCT00006305|65033007|FG000|Overall Study|Withdrawal by Subject|17|||
23352407|NCT00006305|65033008|FG001|Overall Study|Withdrawal by Subject|10|||
23352408|NCT00006305|65033009|FG002|Overall Study|Withdrawal by Subject|15|||
23468349|NCT04413617|65457285|FG000|Overall Study|Withdrawal by Subject|3|||
23468350|NCT04413617|65457286|FG001|Overall Study|Withdrawal by Subject|4|||
23187652|NCT01773473|64429925|FG000|Overall Study|Sponsor Decision|2|||
23187653|NCT01773473|64429926|FG001|Overall Study|Sponsor Decision|0|||
23246107|NCT01015118|64642166|FG000|Overall Study|Other than stated above|42|||
23187654|NCT01773473|64429925|FG000|Overall Study|Lack of Efficacy|0|||
23187655|NCT01773473|64429926|FG001|Overall Study|Lack of Efficacy|1|||
23187656|NCT01773473|64429925|FG000|Overall Study|Non-Compliance with study drug|1|||
23246108|NCT01015118|64642167|FG001|Overall Study|Other than stated above|23|||
23246109|NCT03743571|64642168|FG000|Overall Study|Withdrawal by Subject|1|||
23246110|NCT03743571|64642169|FG001|Overall Study|Withdrawal by Subject|1|||
23246111|NCT03743571|64642168|FG000|Overall Study|Lost to Follow-up|1|||
23246112|NCT03743571|64642169|FG001|Overall Study|Lost to Follow-up|2|||
23246113|NCT00585468|64642171|FG000|First Intervention|Withdrawal by Subject|1|||
23246114|NCT00585468|64642172|FG001|First Intervention|Withdrawal by Subject|1|||
23246115|NCT05153629|64642180|FG000|Overall Study|Withdrawal by Subject|0|||
23246116|NCT05153629|64642181|FG001|Overall Study|Withdrawal by Subject|2|||
23246117|NCT02304302|64642182|FG000|Overall Study|Adverse Event|2|||
23246118|NCT02304302|64642183|FG001|Overall Study|Adverse Event|3|||
23246119|NCT02304302|64642182|FG000|Overall Study|Lost to Follow-up|1|||
23246120|NCT02304302|64642183|FG001|Overall Study|Lost to Follow-up|4|||
23246121|NCT02304302|64642182|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
23246122|NCT02304302|64642183|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
23246123|NCT03985293|64642188|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
23246124|NCT03985293|64642189|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
23246125|NCT03985293|64642190|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
23246126|NCT03985293|64642191|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
23246127|NCT03985293|64642192|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
23246128|NCT03985293|64642193|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
23246129|NCT03985293|64642188|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
23246130|NCT03985293|64642189|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
23246131|NCT03985293|64642190|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
23246132|NCT03985293|64642191|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
23246133|NCT03985293|64642192|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
23246134|NCT03985293|64642193|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
23246135|NCT03985293|64642188|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
23246136|NCT03985293|64642189|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
23246137|NCT03985293|64642190|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
23246138|NCT03985293|64642191|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
23246139|NCT03985293|64642192|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
23246140|NCT03985293|64642193|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
23246141|NCT03985293|64642188|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
23246142|NCT03985293|64642189|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
23246143|NCT03985293|64642190|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
23246144|NCT03985293|64642191|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
23246145|NCT03985293|64642192|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
23246146|NCT03985293|64642193|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
23246147|NCT03985293|64642188|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
23246148|NCT03985293|64642189|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
23246149|NCT03985293|64642190|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
23246150|NCT03985293|64642191|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
23246151|NCT03985293|64642192|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
23246152|NCT03985293|64642193|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
23246153|NCT03985293|64642188|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
23246154|NCT03985293|64642189|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
23246155|NCT03985293|64642190|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
23246156|NCT03985293|64642191|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
23246157|NCT03985293|64642192|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
23246158|NCT03985293|64642193|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
23246159|NCT03985293|64642188|FG000|FOLLOW-UP|Lost to Follow-up|0|||
23246160|NCT03985293|64642189|FG001|FOLLOW-UP|Lost to Follow-up|0|||
23246161|NCT03985293|64642190|FG002|FOLLOW-UP|Lost to Follow-up|1|||
23246162|NCT03985293|64642191|FG003|FOLLOW-UP|Lost to Follow-up|0|||
23246163|NCT03985293|64642192|FG004|FOLLOW-UP|Lost to Follow-up|0|||
23246164|NCT03985293|64642193|FG005|FOLLOW-UP|Lost to Follow-up|0|||
23246165|NCT00938392|64642194|FG000|Overall Study|Adverse Event|0|||
23246166|NCT00938392|64642195|FG001|Overall Study|Adverse Event|1|||
23246167|NCT00938392|64642194|FG000|Overall Study|Withdrawal by Subject|0|||
23246168|NCT00938392|64642195|FG001|Overall Study|Withdrawal by Subject|1|||
23246169|NCT00938392|64642194|FG000|Overall Study|Lost to Follow-up|2|||
23246170|NCT00938392|64642195|FG001|Overall Study|Lost to Follow-up|2|||
23246171|NCT00270205|64642196|FG000|Overall Study|Lost to Follow-up|1|||
23246172|NCT00270205|64642197|FG001|Overall Study|Lost to Follow-up|0|||
23246173|NCT00270205|64642198|FG002|Overall Study|Lost to Follow-up|0|||
23246174|NCT00270205|64642199|FG003|Overall Study|Lost to Follow-up|1|||
23587096|NCT02503202|65876247|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
23587097|NCT02503202|65876248|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
23587098|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
23587099|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
23587100|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
23587101|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
23587102|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
23587103|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Death|1|||
23587104|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Death|0|||
23587105|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Death|0|||
23587106|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Death|0|||
23587107|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Death|0|||
23587108|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
23587109|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
23587110|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
23587111|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
23587112|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
23587113|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Physician Decision|1|||
23587114|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Physician Decision|0|||
23587115|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Physician Decision|1|||
23587116|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Physician Decision|3|||
23587117|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Physician Decision|0|||
23587118|NCT02503202|65876244|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
23587119|NCT02503202|65876245|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
23587120|NCT02503202|65876246|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
23352409|NCT00006305|65033010|FG003|Overall Study|Withdrawal by Subject|14|||
23352410|NCT00473824|65033011|FG000|Overall Study|Virologic Breakthrough|1|||
23352411|NCT00473824|65033012|FG001|Overall Study|Virologic Breakthrough|0|||
23352412|NCT00473824|65033011|FG000|Overall Study|Adverse Event|1|||
23352413|NCT00473824|65033012|FG001|Overall Study|Adverse Event|0|||
23352414|NCT00473824|65033011|FG000|Overall Study|Death|1|||
23352415|NCT00473824|65033012|FG001|Overall Study|Death|0|||
23352416|NCT00473824|65033011|FG000|Overall Study|Lost to Follow-up|1|||
23352417|NCT00473824|65033012|FG001|Overall Study|Lost to Follow-up|0|||
23352418|NCT00473824|65033011|FG000|Overall Study|Withdrawal by physician|1|||
23352419|NCT00473824|65033012|FG001|Overall Study|Withdrawal by physician|0|||
23352420|NCT00382109|65033016|FG000|Overall Study|Adverse Event|3|||
23352421|NCT00382109|65033017|FG001|Overall Study|Adverse Event|0|||
23352422|NCT00382109|65033016|FG000|Overall Study|Physician Decision|6|||
23352423|NCT00382109|65033017|FG001|Overall Study|Physician Decision|1|||
23352424|NCT00382109|65033016|FG000|Overall Study|Withdrawal by Subject|1|||
23352425|NCT00382109|65033017|FG001|Overall Study|Withdrawal by Subject|0|||
23352426|NCT00382109|65033016|FG000|Overall Study|ineligible|2|||
23352427|NCT00382109|65033017|FG001|Overall Study|ineligible|0|||
23352428|NCT00382109|65033016|FG000|Overall Study|Other|0|||
23352429|NCT00382109|65033017|FG001|Overall Study|Other|2|||
23352430|NCT00382109|65033016|FG000|Overall Study|consent withdrawal|0|||
23352431|NCT00382109|65033017|FG001|Overall Study|consent withdrawal|1|||
23352432|NCT05095311|65033018|FG000|Overall Study|Lost to Follow-up|7|||
23352433|NCT05095311|65033019|FG001|Overall Study|Lost to Follow-up|0|||
23352434|NCT05095311|65033020|FG002|Overall Study|Lost to Follow-up|0|||
23352435|NCT01903993|65033023|FG000|Overall Study|Death|118|||
23352436|NCT01903993|65033024|FG001|Overall Study|Death|121|||
23352437|NCT01903993|65033023|FG000|Overall Study|Withdrawal by Subject|15|||
23352438|NCT01903993|65033024|FG001|Overall Study|Withdrawal by Subject|4|||
23352439|NCT01903993|65033023|FG000|Overall Study|Lost to Follow-up|2|||
23352440|NCT01903993|65033024|FG001|Overall Study|Lost to Follow-up|3|||
23352441|NCT01903993|65033023|FG000|Overall Study|Study Terminated by Sponsor|8|||
23352442|NCT01903993|65033024|FG001|Overall Study|Study Terminated by Sponsor|14|||
23587121|NCT02503202|65876247|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
23587122|NCT02503202|65876248|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
23587123|NCT02049866|65876251|FG000|Overall Study|Withdrawal by Subject|1|||
23587124|NCT00961636|65876252|FG000|Overall Study|Adverse Event|35|||
23587125|NCT00961636|65876253|FG001|Overall Study|Adverse Event|54|||
23587126|NCT00961636|65876254|FG002|Overall Study|Adverse Event|13|||
23352443|NCT01903993|65033023|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
23352444|NCT01903993|65033024|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
23352445|NCT02907619|65033026|FG000|Overall Study|Study terminated by sponsor|18|||
23352446|NCT02907619|65033027|FG001|Overall Study|Study terminated by sponsor|18|||
23352447|NCT02907619|65033028|FG002|Overall Study|Study terminated by sponsor|19|||
23352448|NCT02907619|65033026|FG000|Overall Study|Death|0|||
23352449|NCT02907619|65033027|FG001|Overall Study|Death|0|||
23352450|NCT02907619|65033028|FG002|Overall Study|Death|1|||
23352451|NCT02907619|65033026|FG000|Overall Study|Withdrawal by Subject|1|||
23352452|NCT02907619|65033027|FG001|Overall Study|Withdrawal by Subject|1|||
23352453|NCT02907619|65033028|FG002|Overall Study|Withdrawal by Subject|0|||
23352454|NCT02907619|65033026|FG000|Overall Study|Other|0|||
23352455|NCT02907619|65033027|FG001|Overall Study|Other|1|||
23352456|NCT02907619|65033028|FG002|Overall Study|Other|0|||
23352457|NCT00269477|65033033|FG000|Overall Study|Protocol Violation|5|||
23468351|NCT04413617|65457287|FG002|Overall Study|Withdrawal by Subject|2|||
23468352|NCT04413617|65457288|FG003|Overall Study|Withdrawal by Subject|5|||
23468353|NCT04413617|65457289|FG004|Overall Study|Withdrawal by Subject|3|||
23187657|NCT01773473|64429926|FG001|Overall Study|Non-Compliance with study drug|4|||
23187658|NCT01773473|64429925|FG000|Overall Study|Withdrawal by Subject|5|||
23187659|NCT01773473|64429926|FG001|Overall Study|Withdrawal by Subject|3|||
23187660|NCT01773473|64429925|FG000|Overall Study|Lost to Follow-up|2|||
23187661|NCT01773473|64429926|FG001|Overall Study|Lost to Follow-up|0|||
23187662|NCT01241786|64429927|FG000|Overall Study|Lack of Efficacy|5|||
23187663|NCT00023322|64429928|FG000|Overall Study|Lost to Follow-up|1|||
23187664|NCT03019549|64429929|FG000|Washout|DId not meet genotype criteria|11|||
23187665|NCT03019549|64429929|FG000|Period 2|Adverse Event|2|||
23187666|NCT03019549|64429929|FG000|Period 2|Physician Decision|2|||
23187667|NCT03019549|64429929|FG000|Period 2|Withdrawal by Subject|1|||
23187668|NCT01750918|64429930|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
23187669|NCT01750918|64429931|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
23187670|NCT01750918|64429932|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
23187671|NCT01750918|64429933|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
23187672|NCT01750918|64429934|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
23187673|NCT01750918|64429935|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
23187674|NCT01750918|64429936|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
23187675|NCT01750918|64429937|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
23187676|NCT01750918|64429930|FG000|Overall Study|Lost to Follow-up|0|||
23187677|NCT01750918|64429931|FG001|Overall Study|Lost to Follow-up|0|||
23187678|NCT01750918|64429932|FG002|Overall Study|Lost to Follow-up|2|||
23187679|NCT01750918|64429933|FG003|Overall Study|Lost to Follow-up|2|||
23187680|NCT01750918|64429934|FG004|Overall Study|Lost to Follow-up|0|||
23187681|NCT01750918|64429935|FG005|Overall Study|Lost to Follow-up|0|||
23187682|NCT01750918|64429936|FG006|Overall Study|Lost to Follow-up|0|||
23187683|NCT01750918|64429937|FG007|Overall Study|Lost to Follow-up|1|||
23187684|NCT01750918|64429930|FG000|Overall Study|Withdrawal by Subject|0|||
23187685|NCT01750918|64429931|FG001|Overall Study|Withdrawal by Subject|0|||
23187686|NCT01750918|64429932|FG002|Overall Study|Withdrawal by Subject|1|||
23187687|NCT01750918|64429933|FG003|Overall Study|Withdrawal by Subject|2|||
23187688|NCT01750918|64429934|FG004|Overall Study|Withdrawal by Subject|1|||
23187689|NCT01750918|64429935|FG005|Overall Study|Withdrawal by Subject|1|||
23187690|NCT01750918|64429936|FG006|Overall Study|Withdrawal by Subject|2|||
23187691|NCT01750918|64429937|FG007|Overall Study|Withdrawal by Subject|2|||
23187692|NCT02468193|64429939|FG000|Overall Study|Adverse Event|4|||
23187693|NCT02468193|64429939|FG000|Overall Study|Subject/ Guardian decision|2|||
23187694|NCT01076179|64429944|FG000|Overall Study|Withdrawal by Subject|1|||
23187695|NCT03401749|64429945|FG000|Overall Study|Lost to Follow-up|20|||
23187696|NCT03401749|64429946|FG001|Overall Study|Lost to Follow-up|16|||
23187697|NCT03401749|64429947|FG002|Overall Study|Lost to Follow-up|26|||
23187698|NCT04285723|64429950|FG000|Overall Study|Subject decision|1|||
23187699|NCT04285723|64429951|FG001|Overall Study|Subject decision|2|||
23352458|NCT00269477|65033034|FG001|Overall Study|Protocol Violation|5|||
23352459|NCT00269477|65033035|FG002|Overall Study|Protocol Violation|1|||
23187700|NCT04285723|64429950|FG000|Overall Study|Physician Decision|1|||
23187701|NCT04285723|64429951|FG001|Overall Study|Physician Decision|0|||
23187702|NCT04285723|64429950|FG000|Overall Study|No efficiency|1|||
23187703|NCT04285723|64429951|FG001|Overall Study|No efficiency|0|||
23187704|NCT02579603|64429952|FG000|Overall Study|Not treated|1|||
23187705|NCT02579603|64429953|FG001|Overall Study|Not treated|0|||
23187706|NCT02579603|64429952|FG000|Overall Study|Adverse Event|2|||
23352460|NCT00269477|65033036|FG003|Overall Study|Protocol Violation|0|||
23352461|NCT00269477|65033033|FG000|Overall Study|Missed post-vaccination blood draw|0|||
23468354|NCT04413617|65457285|FG000|Overall Study|Death|1|||
23468355|NCT04413617|65457286|FG001|Overall Study|Death|0|||
23468356|NCT04413617|65457287|FG002|Overall Study|Death|0|||
23468357|NCT04413617|65457288|FG003|Overall Study|Death|0|||
23468358|NCT04413617|65457289|FG004|Overall Study|Death|0|||
23468359|NCT04413617|65457285|FG000|Overall Study|Adverse Event|1|||
23468360|NCT04413617|65457286|FG001|Overall Study|Adverse Event|0|||
23468361|NCT04413617|65457287|FG002|Overall Study|Adverse Event|0|||
23468362|NCT04413617|65457288|FG003|Overall Study|Adverse Event|1|||
23468363|NCT04413617|65457289|FG004|Overall Study|Adverse Event|1|||
23468364|NCT04413617|65457285|FG000|Overall Study|COVID-19|0|||
23587127|NCT00961636|65876252|FG000|Overall Study|Flushing Symptoms|29|||
23587128|NCT00961636|65876253|FG001|Overall Study|Flushing Symptoms|46|||
23587129|NCT00961636|65876254|FG002|Overall Study|Flushing Symptoms|3|||
23587130|NCT00961636|65876252|FG000|Overall Study|Lost to Follow-up|2|||
23587131|NCT00961636|65876253|FG001|Overall Study|Lost to Follow-up|3|||
23587132|NCT00961636|65876254|FG002|Overall Study|Lost to Follow-up|1|||
23587133|NCT00961636|65876252|FG000|Overall Study|Physician Decision|3|||
23587134|NCT00961636|65876253|FG001|Overall Study|Physician Decision|1|||
23587135|NCT00961636|65876254|FG002|Overall Study|Physician Decision|1|||
23587136|NCT00961636|65876252|FG000|Overall Study|Protocol Violation|9|||
23587137|NCT00961636|65876253|FG001|Overall Study|Protocol Violation|5|||
23587138|NCT00961636|65876254|FG002|Overall Study|Protocol Violation|1|||
23587139|NCT00961636|65876252|FG000|Overall Study|Withdrawal by Subject|29|||
23587140|NCT00961636|65876253|FG001|Overall Study|Withdrawal by Subject|22|||
23587141|NCT00961636|65876254|FG002|Overall Study|Withdrawal by Subject|13|||
23587142|NCT00646451|65876258|FG000|Overall Study|Adverse Event|3|||
23587143|NCT00646451|65876259|FG001|Overall Study|Adverse Event|0|||
23246235|NCT02353572|64642206|FG000|Overall Study|Withdrawal by Subject|1|||
23246236|NCT02353572|64642206|FG000|Overall Study|Study terminated|2|||
23246237|NCT01569594|64642207|FG000|Overall Study|Physician Decision|4|||
23246238|NCT01569594|64642207|FG000|Overall Study|Death|13|||
23246239|NCT01569594|64642207|FG000|Overall Study|Lost to Follow-up|22|||
23246240|NCT01569594|64642207|FG000|Overall Study|Adverse Event|2|||
23246241|NCT01569594|64642207|FG000|Overall Study|Withdrawal by Subject|13|||
23246242|NCT01569594|64642207|FG000|Overall Study|Other|4|||
23246243|NCT01569594|64642207|FG000|Overall Study|No ECM used|9|||
23246244|NCT03170271|64642208|FG000|Overall Study|Adverse Event|7|||
23246245|NCT03170271|64642209|FG001|Overall Study|Adverse Event|2|||
23246246|NCT03170271|64642208|FG000|Overall Study|Lost to Follow-up|0|||
23246247|NCT03170271|64642209|FG001|Overall Study|Lost to Follow-up|1|||
23246248|NCT03170271|64642208|FG000|Overall Study|Physician Decision|1|||
23246249|NCT03170271|64642209|FG001|Overall Study|Physician Decision|0|||
23246250|NCT03170271|64642208|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
23246251|NCT03170271|64642209|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
23246252|NCT03170271|64642208|FG000|Overall Study|Withdrawal by Subject|17|||
23246253|NCT03170271|64642209|FG001|Overall Study|Withdrawal by Subject|5|||
23246254|NCT03170271|64642208|FG000|Overall Study|Other|2|||
23246255|NCT03170271|64642209|FG001|Overall Study|Other|2|||
23246256|NCT03170271|64642208|FG000|Overall Study|Randomized in error|4|||
23246257|NCT03170271|64642209|FG001|Overall Study|Randomized in error|0|||
23246258|NCT03231709|64642210|FG000|Treatment Period 1|Reason not Specified|0|||
23246259|NCT03231709|64642211|FG001|Treatment Period 1|Reason not Specified|1|||
23246260|NCT03231709|64642210|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
23246261|NCT03231709|64642211|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
23587144|NCT00646451|65876258|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
23187707|NCT02579603|64429953|FG001|Overall Study|Adverse Event|2|||
23187708|NCT02579603|64429952|FG000|Overall Study|Other than stated|1|||
23187709|NCT02579603|64429953|FG001|Overall Study|Other than stated|0|||
23187710|NCT02209766|64429954|FG000|Overall Study|Withdrawal by Subject|0|||
23187711|NCT02209766|64429955|FG001|Overall Study|Withdrawal by Subject|0|||
23187712|NCT02209766|64429956|FG002|Overall Study|Withdrawal by Subject|0|||
23187713|NCT02209766|64429957|FG003|Overall Study|Withdrawal by Subject|1|||
23187714|NCT02209766|64429958|FG004|Overall Study|Withdrawal by Subject|0|||
23187715|NCT02609399|64429959|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
23187716|NCT02609399|64429960|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
23187717|NCT02609399|64429959|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
23187718|NCT02609399|64429960|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
23187719|NCT02609399|64429959|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
23187720|NCT02609399|64429960|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
23187721|NCT05127486|64429962|FG000|Overall Study|Adverse Event|2|||
23187722|NCT05127486|64429963|FG001|Overall Study|Adverse Event|4|||
23187723|NCT05127486|64429962|FG000|Overall Study|Lack of Efficacy|1|||
23187724|NCT05127486|64429963|FG001|Overall Study|Lack of Efficacy|0|||
23187725|NCT05127486|64429962|FG000|Overall Study|Pregnancy|0|||
23187726|NCT05127486|64429963|FG001|Overall Study|Pregnancy|1|||
23187727|NCT05127486|64429962|FG000|Overall Study|Physician Decision|4|||
23187728|NCT05127486|64429963|FG001|Overall Study|Physician Decision|1|||
23187729|NCT05127486|64429962|FG000|Overall Study|Withdrawal by Subject|14|||
23246262|NCT01898884|64642213|FG000|Multiple Dose Period|Adverse Event|0|||
23246263|NCT01898884|64642214|FG001|Multiple Dose Period|Adverse Event|0|||
23246264|NCT01898884|64642215|FG002|Multiple Dose Period|Adverse Event|0|||
23187730|NCT05127486|64429963|FG001|Overall Study|Withdrawal by Subject|13|||
23187731|NCT05127486|64429962|FG000|Overall Study|Lost to Follow-up|5|||
23187732|NCT05127486|64429963|FG001|Overall Study|Lost to Follow-up|8|||
23187733|NCT03716726|64429964|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
23187734|NCT03716726|64429965|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
23246265|NCT01898884|64642216|FG003|Multiple Dose Period|Adverse Event|0|||
23352462|NCT00269477|65033034|FG001|Overall Study|Missed post-vaccination blood draw|1|||
23352463|NCT00269477|65033035|FG002|Overall Study|Missed post-vaccination blood draw|0|||
23352464|NCT00269477|65033036|FG003|Overall Study|Missed post-vaccination blood draw|0|||
23352465|NCT00423813|65033039|FG000|Overall Study|Adverse Event|11|||
23352466|NCT00423813|65033040|FG001|Overall Study|Adverse Event|30|||
23352467|NCT00423813|65033041|FG002|Overall Study|Adverse Event|40|||
23352468|NCT00423813|65033039|FG000|Overall Study|Withdrawal by Subject|6|||
23352469|NCT00423813|65033040|FG001|Overall Study|Withdrawal by Subject|8|||
23352470|NCT00423813|65033041|FG002|Overall Study|Withdrawal by Subject|5|||
23352471|NCT00423813|65033039|FG000|Overall Study|Lost to Follow-up|5|||
23352472|NCT00423813|65033040|FG001|Overall Study|Lost to Follow-up|4|||
23352473|NCT00423813|65033041|FG002|Overall Study|Lost to Follow-up|4|||
23352474|NCT00423813|65033039|FG000|Overall Study|Lack of Efficacy|23|||
23352475|NCT00423813|65033040|FG001|Overall Study|Lack of Efficacy|18|||
23352476|NCT00423813|65033041|FG002|Overall Study|Lack of Efficacy|19|||
23352477|NCT00423813|65033039|FG000|Overall Study|Physician Decision|2|||
23352478|NCT00423813|65033040|FG001|Overall Study|Physician Decision|0|||
23352479|NCT00423813|65033041|FG002|Overall Study|Physician Decision|0|||
23352480|NCT00423813|65033039|FG000|Overall Study|Sponsor Decision|0|||
23352481|NCT00423813|65033040|FG001|Overall Study|Sponsor Decision|1|||
23352482|NCT00423813|65033041|FG002|Overall Study|Sponsor Decision|0|||
23352483|NCT00423813|65033039|FG000|Overall Study|Protocol Violation|9|||
23352484|NCT00423813|65033040|FG001|Overall Study|Protocol Violation|4|||
23352485|NCT00423813|65033041|FG002|Overall Study|Protocol Violation|4|||
23352486|NCT00423813|65033039|FG000|Overall Study|Pregnancy|0|||
23352487|NCT00423813|65033040|FG001|Overall Study|Pregnancy|0|||
23352488|NCT00423813|65033041|FG002|Overall Study|Pregnancy|1|||
23352489|NCT00423813|65033039|FG000|Overall Study|Subject started night shift work|1|||
23352490|NCT00423813|65033040|FG001|Overall Study|Subject started night shift work|0|||
23352491|NCT00423813|65033041|FG002|Overall Study|Subject started night shift work|0|||
23352492|NCT00423813|65033039|FG000|Overall Study|Will start exclusionary medications|0|||
23352493|NCT00423813|65033040|FG001|Overall Study|Will start exclusionary medications|1|||
23352494|NCT00423813|65033041|FG002|Overall Study|Will start exclusionary medications|0|||
23352495|NCT00423813|65033039|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
23352496|NCT00423813|65033040|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
23352497|NCT00423813|65033041|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
23352498|NCT01254721|65033043|FG000|Overall Study|Lost to Follow-up|0|||
23352499|NCT01254721|65033044|FG001|Overall Study|Lost to Follow-up|4|||
23352500|NCT01254721|65033043|FG000|Overall Study|Lack of Efficacy|4|||
23352501|NCT01254721|65033044|FG001|Overall Study|Lack of Efficacy|2|||
23352502|NCT01254721|65033043|FG000|Overall Study|Death|0|||
23352503|NCT01254721|65033044|FG001|Overall Study|Death|1|||
23352504|NCT01254721|65033043|FG000|Overall Study|technical problum|1|||
23352505|NCT01254721|65033044|FG001|Overall Study|technical problum|0|||
23352506|NCT01254721|65033043|FG000|Overall Study|Adverse Event|2|||
23352507|NCT01254721|65033044|FG001|Overall Study|Adverse Event|3|||
23352508|NCT01254721|65033043|FG000|Overall Study|Withdrawal by Subject|8|||
23352509|NCT01254721|65033044|FG001|Overall Study|Withdrawal by Subject|11|||
23352510|NCT01254721|65033043|FG000|Overall Study|Wrongly randomization|0|||
23352511|NCT01254721|65033044|FG001|Overall Study|Wrongly randomization|1|||
23352512|NCT03209518|65033046|FG000|Overall Study|Case Report Forms Uncollected|1|||
23352513|NCT03209518|65033046|FG000|Overall Study|Protocol Deviation|1|||
23352514|NCT03769194|65033048|FG000|Overall Study|Withdrawal by Subject|0|||
23352515|NCT03769194|65033049|FG001|Overall Study|Withdrawal by Subject|7|||
23352516|NCT03769194|65033050|FG002|Overall Study|Withdrawal by Subject|4|||
23352517|NCT03769194|65033051|FG003|Overall Study|Withdrawal by Subject|1|||
23352518|NCT03769194|65033048|FG000|Overall Study|moved from study area|0|||
23352519|NCT03769194|65033049|FG001|Overall Study|moved from study area|2|||
23352520|NCT03769194|65033050|FG002|Overall Study|moved from study area|1|||
23352521|NCT03769194|65033051|FG003|Overall Study|moved from study area|1|||
23352522|NCT03769194|65033048|FG000|Overall Study|Lost to Follow-up|3|||
23352523|NCT03769194|65033049|FG001|Overall Study|Lost to Follow-up|6|||
23352524|NCT03769194|65033050|FG002|Overall Study|Lost to Follow-up|3|||
23352525|NCT03769194|65033051|FG003|Overall Study|Lost to Follow-up|6|||
23352526|NCT03769194|65033048|FG000|Overall Study|other|1|||
23352527|NCT03769194|65033049|FG001|Overall Study|other|3|||
23352528|NCT03769194|65033050|FG002|Overall Study|other|0|||
23352529|NCT03769194|65033051|FG003|Overall Study|other|1|||
23352530|NCT00869557|65033057|FG000|Randomized Phase|Lost to Follow-up|2|||
23352531|NCT00869557|65033058|FG001|Randomized Phase|Lost to Follow-up|1|||
23352532|NCT00869557|65033057|FG000|Randomized Phase|Investigator's Discretion|1|||
23352533|NCT00869557|65033058|FG001|Randomized Phase|Investigator's Discretion|0|||
23352534|NCT00869557|65033057|FG000|Randomized Phase|Withdrew Consent|0|||
23352535|NCT00869557|65033058|FG001|Randomized Phase|Withdrew Consent|1|||
23352536|NCT00869557|65033057|FG000|Extension Phase|Adverse Event|2|||
23352537|NCT00869557|65033058|FG001|Extension Phase|Adverse Event|2|||
23352538|NCT00869557|65033057|FG000|Extension Phase|Lack of Efficacy|1|||
23352539|NCT00869557|65033058|FG001|Extension Phase|Lack of Efficacy|0|||
23352540|NCT00869557|65033057|FG000|Extension Phase|Lost to Follow-up|3|||
23352541|NCT00869557|65033058|FG001|Extension Phase|Lost to Follow-up|1|||
23352542|NCT00869557|65033057|FG000|Extension Phase|Investigator's Discretion|2|||
23352543|NCT00869557|65033058|FG001|Extension Phase|Investigator's Discretion|0|||
23352544|NCT00869557|65033057|FG000|Extension Phase|Withdrew Consent|2|||
23352545|NCT00869557|65033058|FG001|Extension Phase|Withdrew Consent|0|||
23352546|NCT02578940|65033061|FG000|Overall Study|Screening failure|5|||
23352547|NCT02578940|65033061|FG000|Overall Study|Lost to Follow-up|1|||
23352548|NCT02431806|65033063|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
23352549|NCT02431806|65033064|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
23352550|NCT02431806|65033065|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
23352551|NCT02431806|65033066|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
23352552|NCT02431806|65033063|FG000|Double-blind Treatment Period|Adverse Event|4|||
23352553|NCT02431806|65033064|FG001|Double-blind Treatment Period|Adverse Event|7|||
23352554|NCT02431806|65033065|FG002|Double-blind Treatment Period|Adverse Event|11|||
23352555|NCT02431806|65033066|FG003|Double-blind Treatment Period|Adverse Event|7|||
23352556|NCT02431806|65033063|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
23352557|NCT02431806|65033064|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
23352558|NCT02431806|65033065|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
23352559|NCT02431806|65033066|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
23352560|NCT02431806|65033063|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
23352561|NCT02431806|65033064|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
23352562|NCT02431806|65033065|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
23352563|NCT02431806|65033066|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
23352564|NCT02431806|65033063|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
23352565|NCT02431806|65033064|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
23187735|NCT03716726|64429964|FG000|12 Months Followup|Lost to Follow-up|10|||
23187736|NCT03716726|64429965|FG001|12 Months Followup|Lost to Follow-up|17|||
23187737|NCT01748760|64429966|FG000|Overall Study|Withdrawal by Subject|1|||
23187738|NCT01748760|64429967|FG001|Overall Study|Withdrawal by Subject|1|||
23187739|NCT01748760|64429966|FG000|Overall Study|Lost to Follow-up|5|||
23187740|NCT01748760|64429967|FG001|Overall Study|Lost to Follow-up|1|||
23187741|NCT01325493|64429968|FG000|Overall Study|Protocol Violation|0|||
23187742|NCT01325493|64429969|FG001|Overall Study|Protocol Violation|1|||
23352566|NCT02431806|65033065|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
23352567|NCT02431806|65033066|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
23352568|NCT02431806|65033063|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
23352569|NCT02431806|65033064|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
23352570|NCT02431806|65033065|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
23352571|NCT02431806|65033066|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
23352572|NCT02431806|65033063|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
23352573|NCT02431806|65033064|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
23352574|NCT02431806|65033065|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
23352575|NCT02431806|65033066|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
23352576|NCT02561455|65033067|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
23352577|NCT02561455|65033068|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
23352578|NCT02561455|65033069|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
23352579|NCT02561455|65033070|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
23352580|NCT02561455|65033067|FG000|Overall Study|Withdrawal by Subject|1|||
23352581|NCT02561455|65033068|FG001|Overall Study|Withdrawal by Subject|0|||
23352582|NCT02561455|65033069|FG002|Overall Study|Withdrawal by Subject|1|||
23352583|NCT02561455|65033070|FG003|Overall Study|Withdrawal by Subject|0|||
23352584|NCT02561455|65033067|FG000|Overall Study|Disease Progression|0|||
23352585|NCT02561455|65033068|FG001|Overall Study|Disease Progression|1|||
23352586|NCT02561455|65033069|FG002|Overall Study|Disease Progression|0|||
23352587|NCT02561455|65033070|FG003|Overall Study|Disease Progression|0|||
23352588|NCT01810783|65033071|FG000|Overall Study|Adverse Event|32|||
23187743|NCT01325493|64429968|FG000|Overall Study|loss of neuromonitoring signals|0|||
23187744|NCT01325493|64429969|FG001|Overall Study|loss of neuromonitoring signals|2|||
23187745|NCT01325493|64429968|FG000|Overall Study|Allergy|1|||
23187746|NCT01325493|64429969|FG001|Overall Study|Allergy|0|||
23187747|NCT02251743|64429970|FG000|Overall Study|Withdrawal by Subject|1|||
23187748|NCT02251743|64429971|FG001|Overall Study|Withdrawal by Subject|1|||
23352589|NCT01810783|65033071|FG000|Overall Study|Withdrawal by Subject|22|||
23352590|NCT01810783|65033071|FG000|Overall Study|Lack of Efficacy|12|||
23468365|NCT04413617|65457286|FG001|Overall Study|COVID-19|1|||
23468366|NCT04413617|65457287|FG002|Overall Study|COVID-19|0|||
23187749|NCT02868892|64429972|FG000|Overall Study|Investigator left site and no follow-up|6|||
23187750|NCT03633331|64429973|FG000|Overall Study|Withdrawal by Subject|1|||
23187751|NCT01122927|64429974|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
23187752|NCT01122927|64429975|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
23187753|NCT01122927|64429974|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
23187754|NCT01122927|64429975|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
23187755|NCT01122927|64429974|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
23187756|NCT01122927|64429975|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
23187757|NCT01122927|64429974|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
23187758|NCT01122927|64429975|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
23187759|NCT01122927|64429974|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
23187760|NCT01122927|64429975|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
23187761|NCT01122927|64429974|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
23187762|NCT01122927|64429975|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
23187763|NCT01122927|64429974|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
23468367|NCT04413617|65457288|FG003|Overall Study|COVID-19|0|||
23468368|NCT04413617|65457289|FG004|Overall Study|COVID-19|0|||
23468369|NCT01671319|65457291|FG000|Overall Study|Withdrawal by Subject|1|||
23468370|NCT00930046|65457295|FG000|Overall Study|Wound catheter malfunctioned|1|||
23468371|NCT00930046|65457296|FG001|Overall Study|Wound catheter malfunctioned|2|||
23468372|NCT00248040|65457301|FG000|Overall Study|transplantectomy|2|||
23468373|NCT00248040|65457302|FG001|Overall Study|transplantectomy|1|||
23468374|NCT00248040|65457303|FG002|Overall Study|transplantectomy|3|||
23468375|NCT00248040|65457301|FG000|Overall Study|transplant cancelled post treat start|1|||
23468376|NCT00248040|65457302|FG001|Overall Study|transplant cancelled post treat start|0|||
23468377|NCT00248040|65457303|FG002|Overall Study|transplant cancelled post treat start|0|||
23468378|NCT00248040|65457301|FG000|Overall Study|Death|0|||
23468379|NCT00248040|65457302|FG001|Overall Study|Death|0|||
23468380|NCT00248040|65457303|FG002|Overall Study|Death|1|||
23468381|NCT04233216|65457304|FG000|Overall Study|Lost to Follow-up|0|||
23468382|NCT04233216|65457305|FG001|Overall Study|Lost to Follow-up|0|||
23468383|NCT04233216|65457306|FG002|Overall Study|Lost to Follow-up|2|||
23468384|NCT04233216|65457307|FG003|Overall Study|Lost to Follow-up|0|||
23468385|NCT04233216|65457304|FG000|Overall Study|Physician Decision|0|||
23468386|NCT04233216|65457305|FG001|Overall Study|Physician Decision|1|||
23468387|NCT04233216|65457306|FG002|Overall Study|Physician Decision|0|||
23468388|NCT04233216|65457307|FG003|Overall Study|Physician Decision|0|||
23468389|NCT04233216|65457304|FG000|Overall Study|Withdrawal by Subject|0|||
23468390|NCT04233216|65457305|FG001|Overall Study|Withdrawal by Subject|1|||
23468391|NCT04233216|65457306|FG002|Overall Study|Withdrawal by Subject|1|||
23468392|NCT04233216|65457307|FG003|Overall Study|Withdrawal by Subject|0|||
23246266|NCT01898884|64642217|FG004|Multiple Dose Period|Adverse Event|0|||
23246267|NCT01898884|64642218|FG005|Multiple Dose Period|Adverse Event|0|||
23246268|NCT01898884|64642219|FG006|Multiple Dose Period|Adverse Event|1|||
23246269|NCT01898884|64642220|FG007|Multiple Dose Period|Adverse Event|0|||
23468393|NCT04233216|65457304|FG000|Overall Study|Ongoing participation in study|7|||
23468394|NCT04233216|65457305|FG001|Overall Study|Ongoing participation in study|12|||
23468395|NCT04233216|65457306|FG002|Overall Study|Ongoing participation in study|4|||
23468396|NCT04233216|65457307|FG003|Overall Study|Ongoing participation in study|7|||
23468397|NCT02872935|65457312|FG000|Overall Study|Other|0|||
23468398|NCT02872935|65457313|FG001|Overall Study|Other|1|||
23468399|NCT02817464|65457314|FG000|Overall Study|Lost to Follow-up|1|||
23468400|NCT02817464|65457315|FG001|Overall Study|Lost to Follow-up|0|||
23468401|NCT02817464|65457314|FG000|Overall Study|Discontinued early due to personal decision|1|||
23187764|NCT01122927|64429975|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
23187765|NCT01122927|64429974|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
23246270|NCT01898884|64642221|FG008|Multiple Dose Period|Adverse Event|0|||
23246271|NCT01898884|64642213|FG000|Multiple Dose Period|Randomized Not Treated|0|||
23246272|NCT01898884|64642214|FG001|Multiple Dose Period|Randomized Not Treated|0|||
23246273|NCT01898884|64642215|FG002|Multiple Dose Period|Randomized Not Treated|0|||
23246274|NCT01898884|64642216|FG003|Multiple Dose Period|Randomized Not Treated|0|||
23246275|NCT01898884|64642217|FG004|Multiple Dose Period|Randomized Not Treated|0|||
23246276|NCT01898884|64642218|FG005|Multiple Dose Period|Randomized Not Treated|0|||
23246277|NCT01898884|64642219|FG006|Multiple Dose Period|Randomized Not Treated|0|||
23246278|NCT01898884|64642220|FG007|Multiple Dose Period|Randomized Not Treated|0|||
23246279|NCT01898884|64642221|FG008|Multiple Dose Period|Randomized Not Treated|1|||
23246280|NCT01728376|64642223|FG000|Overall Study|Adverse Event|1|||
23246281|NCT01728376|64642224|FG001|Overall Study|Adverse Event|1|||
23246282|NCT01728376|64642225|FG002|Overall Study|Adverse Event|1|||
23246283|NCT01728376|64642226|FG003|Overall Study|Adverse Event|1|||
23468402|NCT02817464|65457315|FG001|Overall Study|Discontinued early due to personal decision|1|||
23468403|NCT01524796|65457316|FG000|Overall Study|Adverse Event|13|||
23468404|NCT01524796|65457316|FG000|Overall Study|Lack of Efficacy|3|||
23468405|NCT01524796|65457316|FG000|Overall Study|Lost to Follow-up|1|||
23468406|NCT01524796|65457316|FG000|Overall Study|The price|1|||
23468407|NCT01524796|65457316|FG000|Overall Study|Withdrawal by Subject|4|||
23468408|NCT01524796|65457316|FG000|Overall Study|Move|1|||
23468409|NCT01524796|65457316|FG000|Overall Study|Deterioration of pains|1|||
23468410|NCT01524796|65457316|FG000|Overall Study|Gall stone surgery|1|||
23187766|NCT01122927|64429975|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
23468411|NCT01524796|65457316|FG000|Overall Study|Nervous about confidentiality|1|||
23468412|NCT01524796|65457316|FG000|Overall Study|Switch to carbamazapine|1|||
23468413|NCT01524796|65457316|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
23468414|NCT02876601|65457319|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
23468415|NCT02876601|65457320|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
23468416|NCT02876601|65457321|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
23468417|NCT02876601|65457322|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
23468418|NCT02427464|65457323|FG000|Overall Study|Adverse Event|6|||
23468419|NCT02427464|65457324|FG001|Overall Study|Adverse Event|1|||
23468420|NCT02427464|65457323|FG000|Overall Study|Lost to Follow-up|16|||
23468421|NCT02427464|65457324|FG001|Overall Study|Lost to Follow-up|5|||
23468422|NCT02427464|65457323|FG000|Overall Study|Physician Decision|2|||
23468423|NCT02427464|65457324|FG001|Overall Study|Physician Decision|0|||
23468424|NCT02427464|65457323|FG000|Overall Study|Withdrawal by Subject|10|||
23468425|NCT02427464|65457324|FG001|Overall Study|Withdrawal by Subject|8|||
23468426|NCT02427464|65457323|FG000|Overall Study|Noncompliance|16|||
23468427|NCT02427464|65457324|FG001|Overall Study|Noncompliance|10|||
23468428|NCT02453711|65457325|FG000|Overall Study|Withdrawal by Subject|5|||
23468429|NCT02453711|65457326|FG001|Overall Study|Withdrawal by Subject|4|||
23468430|NCT02453711|65457327|FG002|Overall Study|Withdrawal by Subject|6|||
23468431|NCT02453711|65457328|FG003|Overall Study|Withdrawal by Subject|4|||
23468432|NCT02453711|65457329|FG004|Overall Study|Withdrawal by Subject|1|||
23352591|NCT01810783|65033071|FG000|Overall Study|Lost to Follow-up|10|||
23352592|NCT01810783|65033071|FG000|Overall Study|Protocol Violation|5|||
23352593|NCT01810783|65033071|FG000|Overall Study|Non-compliance with IMP|4|||
23468433|NCT02453711|65457330|FG005|Overall Study|Withdrawal by Subject|1|||
23468434|NCT02453711|65457331|FG006|Overall Study|Withdrawal by Subject|0|||
23468435|NCT02453711|65457332|FG007|Overall Study|Withdrawal by Subject|1|||
23468436|NCT02453711|65457333|FG008|Overall Study|Withdrawal by Subject|7|||
23468437|NCT02453711|65457325|FG000|Overall Study|Lost to Follow-up|5|||
23468438|NCT02453711|65457326|FG001|Overall Study|Lost to Follow-up|3|||
23468439|NCT02453711|65457327|FG002|Overall Study|Lost to Follow-up|2|||
23187767|NCT01122927|64429974|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
23187768|NCT01122927|64429975|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
23468440|NCT02453711|65457328|FG003|Overall Study|Lost to Follow-up|3|||
23468441|NCT02453711|65457329|FG004|Overall Study|Lost to Follow-up|1|||
23468442|NCT02453711|65457330|FG005|Overall Study|Lost to Follow-up|5|||
23468443|NCT02453711|65457331|FG006|Overall Study|Lost to Follow-up|2|||
23468444|NCT02453711|65457332|FG007|Overall Study|Lost to Follow-up|6|||
23468445|NCT02453711|65457333|FG008|Overall Study|Lost to Follow-up|6|||
23468446|NCT02453711|65457325|FG000|Overall Study|Death|0|||
23468447|NCT02453711|65457326|FG001|Overall Study|Death|0|||
23468448|NCT02453711|65457327|FG002|Overall Study|Death|0|||
23468449|NCT02453711|65457328|FG003|Overall Study|Death|0|||
23468450|NCT02453711|65457329|FG004|Overall Study|Death|0|||
23468451|NCT02453711|65457330|FG005|Overall Study|Death|0|||
23468452|NCT02453711|65457331|FG006|Overall Study|Death|1|||
23468453|NCT02453711|65457332|FG007|Overall Study|Death|0|||
23468454|NCT02453711|65457333|FG008|Overall Study|Death|0|||
23468455|NCT02453711|65457325|FG000|Overall Study|Unclassified|1|||
23468456|NCT02453711|65457326|FG001|Overall Study|Unclassified|0|||
23468457|NCT02453711|65457327|FG002|Overall Study|Unclassified|1|||
23468458|NCT02453711|65457328|FG003|Overall Study|Unclassified|0|||
23468459|NCT02453711|65457329|FG004|Overall Study|Unclassified|0|||
23468460|NCT02453711|65457330|FG005|Overall Study|Unclassified|0|||
23468461|NCT02453711|65457331|FG006|Overall Study|Unclassified|0|||
23468462|NCT02453711|65457332|FG007|Overall Study|Unclassified|0|||
23587145|NCT00646451|65876259|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
23187769|NCT01122927|64429974|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
23187770|NCT01122927|64429975|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
23187771|NCT01122927|64429974|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
23187772|NCT01122927|64429975|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
23187773|NCT01122927|64429974|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
23352594|NCT01810783|65033071|FG000|Overall Study|Adminstrative or other reason(s)|23|||
23468463|NCT02453711|65457333|FG008|Overall Study|Unclassified|0|||
23468464|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
23468465|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
23468466|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
23468467|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
23468468|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
23468469|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
23468470|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
23468471|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
23468472|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
23187774|NCT01122927|64429975|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
23246284|NCT01728376|64642227|FG004|Overall Study|Adverse Event|1|||
23246285|NCT01728376|64642228|FG005|Overall Study|Adverse Event|0|||
23246286|NCT01728376|64642223|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
23246287|NCT01728376|64642224|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
23246288|NCT01728376|64642225|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
23246289|NCT01728376|64642226|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
23246290|NCT01728376|64642227|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
23246291|NCT01728376|64642228|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
23246292|NCT01728376|64642223|FG000|Overall Study|No relevant bacteria|2|||
23246293|NCT01728376|64642224|FG001|Overall Study|No relevant bacteria|0|||
23246294|NCT01728376|64642225|FG002|Overall Study|No relevant bacteria|0|||
23246295|NCT01728376|64642226|FG003|Overall Study|No relevant bacteria|0|||
23246296|NCT01728376|64642227|FG004|Overall Study|No relevant bacteria|1|||
23246297|NCT01728376|64642228|FG005|Overall Study|No relevant bacteria|1|||
23246298|NCT01728376|64642223|FG000|Overall Study|Did not receive treatment|0|||
23246299|NCT01728376|64642224|FG001|Overall Study|Did not receive treatment|1|||
23246300|NCT01728376|64642225|FG002|Overall Study|Did not receive treatment|0|||
23246301|NCT01728376|64642226|FG003|Overall Study|Did not receive treatment|0|||
23246302|NCT01728376|64642227|FG004|Overall Study|Did not receive treatment|0|||
23246303|NCT01728376|64642228|FG005|Overall Study|Did not receive treatment|0|||
23246304|NCT01728376|64642223|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
23246305|NCT01728376|64642224|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
23246306|NCT01728376|64642225|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
23246307|NCT01728376|64642226|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
23468473|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
23468474|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
23468475|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
23468476|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
23468477|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
23468478|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
23468479|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
23468480|NCT02834793|65457334|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
23468481|NCT02834793|65457335|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
23468482|NCT02834793|65457336|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
23468483|NCT02834793|65457337|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
23468484|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
23468485|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
23468486|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
23468487|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
23468488|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
23468489|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
23468490|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
23468491|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
23468492|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
23468493|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
23468494|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
23468495|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
23468496|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
23468497|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
23468498|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
23468499|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
23468500|NCT02834793|65457334|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
23468501|NCT02834793|65457335|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
23468502|NCT02834793|65457336|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
23468503|NCT02834793|65457337|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
23468504|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
23468505|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
23468506|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
23468507|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
23468508|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
23587146|NCT00919763|65876260|FG000|Overall Study|Adverse Event|7|||
23587147|NCT00919763|65876261|FG001|Overall Study|Adverse Event|1|||
23587148|NCT00919763|65876260|FG000|Overall Study|Lost to Follow-up|1|||
23246308|NCT01728376|64642227|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
23246309|NCT01728376|64642228|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
23246310|NCT00449761|64642233|FG000|Overall Study|Disease progression|12|||
23246311|NCT00449761|64642233|FG000|Overall Study|Death|5|||
23246312|NCT00449761|64642233|FG000|Overall Study|New cancer therapy|1|||
23468509|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
23587149|NCT00919763|65876261|FG001|Overall Study|Lost to Follow-up|0|||
23587150|NCT00919763|65876260|FG000|Overall Study|Protocol Violation|1|||
23468510|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
23468511|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
23468512|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
23468513|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
23468514|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
23468515|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
23468516|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
23468517|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
23468518|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
23468519|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
23468520|NCT02834793|65457334|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
23468521|NCT02834793|65457335|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
23468522|NCT02834793|65457336|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
23468523|NCT02834793|65457337|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
23352595|NCT01810783|65033071|FG000|Overall Study|Enrolled, not treated|1|||
23352596|NCT00494221|65033072|FG000|Overall Study|Death|15|||
23352597|NCT00494221|65033073|FG001|Overall Study|Death|9|||
23468524|NCT00555061|65457338|FG000|Overall Study|Adverse Event|3|||
23468525|NCT00555061|65457338|FG000|Overall Study|Protocol Violation|1|||
23468526|NCT00555061|65457338|FG000|Overall Study|Lost to Follow-up|2|||
23468527|NCT00555061|65457338|FG000|Overall Study|Withdrawal by Subject|2|||
23468528|NCT00555061|65457338|FG000|Overall Study|Participant enrolled, but never treated|1|||
23468529|NCT01379508|65457339|FG000|Treatment to Week 104|Adverse Event|2|||
23468530|NCT01379508|65457340|FG001|Treatment to Week 104|Adverse Event|0|||
23468531|NCT01379508|65457341|FG002|Treatment to Week 104|Adverse Event|5|||
23468532|NCT01379508|65457342|FG003|Treatment to Week 104|Adverse Event|0|||
23468533|NCT01379508|65457339|FG000|Treatment to Week 104|Abnormal lab value|1|||
23468534|NCT01379508|65457340|FG001|Treatment to Week 104|Abnormal lab value|0|||
23468535|NCT01379508|65457341|FG002|Treatment to Week 104|Abnormal lab value|0|||
23468536|NCT01379508|65457342|FG003|Treatment to Week 104|Abnormal lab value|0|||
23468537|NCT01379508|65457339|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
23468538|NCT01379508|65457340|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
23468539|NCT01379508|65457341|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
23468540|NCT01379508|65457342|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
23468541|NCT01379508|65457339|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
23468542|NCT01379508|65457340|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
23468543|NCT01379508|65457341|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
23468544|NCT01379508|65457342|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
23468545|NCT01379508|65457339|FG000|Treatment to Week 104|Lost to Follow-up|5|||
23468546|NCT01379508|65457340|FG001|Treatment to Week 104|Lost to Follow-up|0|||
23468547|NCT01379508|65457341|FG002|Treatment to Week 104|Lost to Follow-up|3|||
23468548|NCT01379508|65457342|FG003|Treatment to Week 104|Lost to Follow-up|0|||
23468549|NCT01379508|65457339|FG000|Treatment to Week 104|Administrative problems|3|||
23468550|NCT01379508|65457340|FG001|Treatment to Week 104|Administrative problems|1|||
23468551|NCT01379508|65457341|FG002|Treatment to Week 104|Administrative problems|0|||
23468552|NCT01379508|65457342|FG003|Treatment to Week 104|Administrative problems|0|||
23246313|NCT04936334|64642240|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
23246314|NCT02181673|64642244|FG000|Up to Week 24|Adverse Event|2|||
23352598|NCT00494221|65033074|FG002|Overall Study|Death|14|||
23352599|NCT00494221|65033072|FG000|Overall Study|Withdrawal by Subject|1|||
23352600|NCT00494221|65033073|FG001|Overall Study|Withdrawal by Subject|2|||
23468553|NCT01379508|65457339|FG000|Treatment to Week 104|Protocol Violation|1|||
23468554|NCT01379508|65457340|FG001|Treatment to Week 104|Protocol Violation|1|||
23468555|NCT01379508|65457341|FG002|Treatment to Week 104|Protocol Violation|1|||
23468556|NCT01379508|65457342|FG003|Treatment to Week 104|Protocol Violation|0|||
23468557|NCT01379508|65457339|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
23468558|NCT01379508|65457340|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
23468559|NCT01379508|65457341|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
23468560|NCT01379508|65457342|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
23468561|NCT01379508|65457339|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
23468562|NCT01379508|65457340|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
23468563|NCT01379508|65457341|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
23468564|NCT01379508|65457342|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
23468565|NCT01379508|65457339|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
23468566|NCT01379508|65457340|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
23468567|NCT01379508|65457341|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
23468568|NCT01379508|65457342|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
23468569|NCT01379508|65457339|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
23468570|NCT01379508|65457340|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
23352601|NCT00494221|65033074|FG002|Overall Study|Withdrawal by Subject|0|||
23468571|NCT01379508|65457341|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
23468572|NCT01379508|65457342|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
23468573|NCT01616693|65457343|FG000|Evaluated for Safety|Physician Decision|1|||
23468574|NCT01616693|65457344|FG001|Evaluated for Safety|Physician Decision|0|||
23468575|NCT01616693|65457345|FG002|Evaluated for Safety|Physician Decision|1|||
23468576|NCT01616693|65457346|FG003|Evaluated for Safety|Physician Decision|0|||
23468577|NCT01616693|65457343|FG000|Received Both Vaccines|Adverse Event|2|||
23468578|NCT01616693|65457344|FG001|Received Both Vaccines|Adverse Event|0|||
23468579|NCT01616693|65457345|FG002|Received Both Vaccines|Adverse Event|0|||
23468580|NCT01616693|65457346|FG003|Received Both Vaccines|Adverse Event|0|||
23468581|NCT01616693|65457343|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
23468582|NCT01616693|65457344|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
23468583|NCT01616693|65457345|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
23468584|NCT01616693|65457346|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
23468585|NCT01616693|65457343|FG000|Received Both Vaccines|Lost to Follow-up|4|||
23468586|NCT01616693|65457344|FG001|Received Both Vaccines|Lost to Follow-up|3|||
23468587|NCT01616693|65457345|FG002|Received Both Vaccines|Lost to Follow-up|4|||
23187775|NCT01733329|64429976|FG000|Overall Study|Protocol Violation|1|||
23187776|NCT01733329|64429977|FG001|Overall Study|Protocol Violation|1|||
23187777|NCT01733329|64429976|FG000|Overall Study|Uterine artery injury|1|||
23187778|NCT01733329|64429977|FG001|Overall Study|Uterine artery injury|0|||
23187779|NCT01173653|64429980|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
23187780|NCT01173653|64429981|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
23187781|NCT01287117|64429982|FG000|Overall Study|Adverse Event|2|||
23187782|NCT01287117|64429983|FG001|Overall Study|Adverse Event|1|||
23187783|NCT01287117|64429984|FG002|Overall Study|Adverse Event|1|||
23187784|NCT01287117|64429985|FG003|Overall Study|Adverse Event|1|||
23187785|NCT01287117|64429982|FG000|Overall Study|Lost to Follow-up|1|||
23187786|NCT01287117|64429983|FG001|Overall Study|Lost to Follow-up|1|||
23187787|NCT01287117|64429984|FG002|Overall Study|Lost to Follow-up|0|||
23187788|NCT01287117|64429985|FG003|Overall Study|Lost to Follow-up|0|||
23352602|NCT01522235|65033075|FG000|Overall Study|Physician Decision|1|||
23468588|NCT01616693|65457346|FG003|Received Both Vaccines|Lost to Follow-up|4|||
23468589|NCT01616693|65457343|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
23468590|NCT01616693|65457344|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
23468591|NCT01616693|65457345|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
23468592|NCT01616693|65457346|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
23468593|NCT02167139|65457347|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
23468594|NCT02167139|65457348|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
23468595|NCT02167139|65457349|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
23468596|NCT02167139|65457350|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
23468597|NCT02167139|65457347|FG000|Randomised, Double-blind|Adverse Event|2|||
23468598|NCT02167139|65457348|FG001|Randomised, Double-blind|Adverse Event|9|||
23468599|NCT02167139|65457349|FG002|Randomised, Double-blind|Adverse Event|0|||
23468600|NCT02167139|65457350|FG003|Randomised, Double-blind|Adverse Event|0|||
23468601|NCT02167139|65457347|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
23468602|NCT02167139|65457348|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
23468603|NCT02167139|65457349|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
23468604|NCT02167139|65457350|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
23468605|NCT02167139|65457347|FG000|Randomised, Double-blind|Other|3|||
23468606|NCT02167139|65457348|FG001|Randomised, Double-blind|Other|0|||
23468607|NCT02167139|65457349|FG002|Randomised, Double-blind|Other|0|||
23468608|NCT02167139|65457350|FG003|Randomised, Double-blind|Other|0|||
23468609|NCT02167139|65457347|FG000|Transition-extension|Adverse Event|2|||
23468610|NCT02167139|65457348|FG001|Transition-extension|Adverse Event|0|||
23468611|NCT02167139|65457349|FG002|Transition-extension|Adverse Event|2|||
23187789|NCT01287117|64429982|FG000|Overall Study|Physician Decision|0|||
23246315|NCT02181673|64642245|FG001|Up to Week 24|Adverse Event|0|||
23352603|NCT01522235|65033076|FG001|Overall Study|Physician Decision|1|||
23468612|NCT02167139|65457350|FG003|Transition-extension|Adverse Event|3|||
23468613|NCT02167139|65457347|FG000|Transition-extension|Withdrawal by Subject|2|||
23587151|NCT00919763|65876261|FG001|Overall Study|Protocol Violation|1|||
23587152|NCT00919763|65876260|FG000|Overall Study|Withdrawal by Subject|3|||
23587153|NCT00919763|65876261|FG001|Overall Study|Withdrawal by Subject|1|||
23587154|NCT00919763|65876260|FG000|Overall Study|Non-compliance|0|||
23587155|NCT00919763|65876261|FG001|Overall Study|Non-compliance|1|||
23587156|NCT03121950|65876262|FG000|Overall Study|Withdrawal by Subject|11|||
23187790|NCT01287117|64429983|FG001|Overall Study|Physician Decision|1|||
23468614|NCT02167139|65457348|FG001|Transition-extension|Withdrawal by Subject|0|||
23468615|NCT02167139|65457349|FG002|Transition-extension|Withdrawal by Subject|4|||
23468616|NCT02167139|65457350|FG003|Transition-extension|Withdrawal by Subject|1|||
23468617|NCT02167139|65457347|FG000|Transition-extension|Lack of Efficacy|0|||
23468618|NCT02167139|65457348|FG001|Transition-extension|Lack of Efficacy|0|||
23468619|NCT02167139|65457349|FG002|Transition-extension|Lack of Efficacy|1|||
23468620|NCT02167139|65457350|FG003|Transition-extension|Lack of Efficacy|1|||
23468621|NCT02167139|65457347|FG000|Transition-extension|Other|1|||
23468622|NCT02167139|65457348|FG001|Transition-extension|Other|0|||
23468623|NCT02167139|65457349|FG002|Transition-extension|Other|1|||
23468624|NCT02167139|65457350|FG003|Transition-extension|Other|0|||
23468625|NCT02167139|65457347|FG000|Transition-extension|Lost to Follow-up|1|||
23468626|NCT02167139|65457348|FG001|Transition-extension|Lost to Follow-up|0|||
23468627|NCT02167139|65457349|FG002|Transition-extension|Lost to Follow-up|0|||
23468628|NCT02167139|65457350|FG003|Transition-extension|Lost to Follow-up|0|||
23468629|NCT01967576|65457353|FG000|Overall Study|Withdrawal by Subject|3|||
23468630|NCT01967576|65457353|FG000|Overall Study|Progressed/Removed from treatment|1|||
23468631|NCT01967576|65457353|FG000|Overall Study|Study closing at site|1|||
23468632|NCT01967576|65457353|FG000|Overall Study|Adverse Event|1|||
23468633|NCT01967576|65457353|FG000|Overall Study|Refused further treatment|1|||
23468634|NCT01157234|65457358|FG000|Overall Study|Withdrawal by Subject|1|||
23468635|NCT01157234|65457359|FG001|Overall Study|Withdrawal by Subject|0|||
23468636|NCT03599089|65457360|FG000|Overall Study|Lost to Follow-up|1|||
23468637|NCT03599089|65457361|FG001|Overall Study|Lost to Follow-up|0|||
23468638|NCT03599089|65457362|FG002|Overall Study|Lost to Follow-up|0|||
23468639|NCT03599089|65457363|FG003|Overall Study|Lost to Follow-up|0|||
23468640|NCT03599089|65457360|FG000|Overall Study|Withdrawal by Subject|2|||
23468641|NCT03599089|65457361|FG001|Overall Study|Withdrawal by Subject|1|||
23468642|NCT03599089|65457362|FG002|Overall Study|Withdrawal by Subject|0|||
23468643|NCT03599089|65457363|FG003|Overall Study|Withdrawal by Subject|0|||
23468644|NCT03599089|65457360|FG000|Overall Study|Lack of Efficacy|0|||
23468645|NCT03599089|65457361|FG001|Overall Study|Lack of Efficacy|0|||
23468646|NCT03599089|65457362|FG002|Overall Study|Lack of Efficacy|1|||
23468647|NCT03599089|65457363|FG003|Overall Study|Lack of Efficacy|2|||
23468648|NCT01621802|65457364|FG000|Overall Study|Protocol Violation|0|||
23468649|NCT01621802|65457365|FG001|Overall Study|Protocol Violation|0|||
23468650|NCT01621802|65457366|FG002|Overall Study|Protocol Violation|0|||
23468651|NCT01621802|65457367|FG003|Overall Study|Protocol Violation|0|||
23468652|NCT01621802|65457368|FG004|Overall Study|Protocol Violation|0|||
23468653|NCT01621802|65457369|FG005|Overall Study|Protocol Violation|1|||
23468654|NCT01621802|65457364|FG000|Overall Study|Withdrawal by Subject|8|||
23468655|NCT01621802|65457365|FG001|Overall Study|Withdrawal by Subject|4|||
23468656|NCT01621802|65457366|FG002|Overall Study|Withdrawal by Subject|4|||
23468657|NCT01621802|65457367|FG003|Overall Study|Withdrawal by Subject|2|||
23468658|NCT01621802|65457368|FG004|Overall Study|Withdrawal by Subject|2|||
23468659|NCT01621802|65457369|FG005|Overall Study|Withdrawal by Subject|0|||
23468660|NCT01621802|65457364|FG000|Overall Study|Migrated/moved from study area|0|||
23468661|NCT01621802|65457365|FG001|Overall Study|Migrated/moved from study area|0|||
23468662|NCT01621802|65457366|FG002|Overall Study|Migrated/moved from study area|2|||
23468663|NCT01621802|65457367|FG003|Overall Study|Migrated/moved from study area|0|||
23187791|NCT01287117|64429984|FG002|Overall Study|Physician Decision|1|||
23187792|NCT01287117|64429985|FG003|Overall Study|Physician Decision|1|||
23187793|NCT01287117|64429982|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
23187794|NCT01287117|64429983|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
23187795|NCT01287117|64429984|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
23187796|NCT01287117|64429985|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
23187797|NCT01287117|64429982|FG000|Overall Study|Disease Progression|10|||
23187798|NCT01287117|64429983|FG001|Overall Study|Disease Progression|5|||
23187799|NCT01287117|64429984|FG002|Overall Study|Disease Progression|6|||
23187800|NCT01287117|64429985|FG003|Overall Study|Disease Progression|5|||
23187801|NCT02120417|64429986|FG000|Overall Study|Death|5|||
23187802|NCT02120417|64429987|FG001|Overall Study|Death|1|||
23187803|NCT02120417|64429986|FG000|Overall Study|Adverse Event|3|||
23187804|NCT02120417|64429987|FG001|Overall Study|Adverse Event|9|||
23187805|NCT02120417|64429986|FG000|Overall Study|Participant decision|4|||
23187806|NCT02120417|64429987|FG001|Overall Study|Participant decision|4|||
23187807|NCT02120417|64429986|FG000|Overall Study|Disease progression|41|||
23187808|NCT02120417|64429987|FG001|Overall Study|Disease progression|45|||
23187809|NCT02120417|64429986|FG000|Overall Study|Noncompliance with study treatment|0|||
23187810|NCT02120417|64429987|FG001|Overall Study|Noncompliance with study treatment|2|||
23187811|NCT02120417|64429986|FG000|Overall Study|Physician Decision|2|||
23187812|NCT02120417|64429987|FG001|Overall Study|Physician Decision|3|||
23468664|NCT01621802|65457368|FG004|Overall Study|Migrated/moved from study area|1|||
23468665|NCT01621802|65457369|FG005|Overall Study|Migrated/moved from study area|0|||
23468666|NCT01621802|65457364|FG000|Overall Study|Others|3|||
23468667|NCT01621802|65457365|FG001|Overall Study|Others|3|||
23468668|NCT01621802|65457366|FG002|Overall Study|Others|3|||
23468669|NCT01621802|65457367|FG003|Overall Study|Others|2|||
23468670|NCT01621802|65457368|FG004|Overall Study|Others|1|||
23468671|NCT01621802|65457369|FG005|Overall Study|Others|0|||
23246316|NCT02181673|64642246|FG002|Up to Week 24|Adverse Event|3|||
23246317|NCT02181673|64642244|FG000|Up to Week 24|Death|1|||
23246318|NCT02181673|64642245|FG001|Up to Week 24|Death|0|||
23246319|NCT02181673|64642246|FG002|Up to Week 24|Death|0|||
23246320|NCT02181673|64642244|FG000|Up to Week 24|Lack of Efficacy|1|||
23246321|NCT02181673|64642245|FG001|Up to Week 24|Lack of Efficacy|0|||
23246322|NCT02181673|64642246|FG002|Up to Week 24|Lack of Efficacy|0|||
23246323|NCT02181673|64642244|FG000|Up to Week 24|Lost to Follow-up|1|||
23246324|NCT02181673|64642245|FG001|Up to Week 24|Lost to Follow-up|0|||
23246325|NCT02181673|64642246|FG002|Up to Week 24|Lost to Follow-up|0|||
23246326|NCT02181673|64642244|FG000|Up to Week 24|Physician Decision|0|||
23246327|NCT02181673|64642245|FG001|Up to Week 24|Physician Decision|0|||
23246328|NCT02181673|64642246|FG002|Up to Week 24|Physician Decision|3|||
23246329|NCT02181673|64642244|FG000|Up to Week 24|Withdrawal by Subject|10|||
23246330|NCT02181673|64642245|FG001|Up to Week 24|Withdrawal by Subject|0|||
23246331|NCT02181673|64642246|FG002|Up to Week 24|Withdrawal by Subject|1|||
23246332|NCT02181673|64642244|FG000|Up to Week 24|Other|2|||
23246333|NCT02181673|64642245|FG001|Up to Week 24|Other|0|||
23246334|NCT02181673|64642246|FG002|Up to Week 24|Other|3|||
23246335|NCT02181673|64642244|FG000|Up to Week 24|Randomized not Treated|0|||
23246336|NCT02181673|64642245|FG001|Up to Week 24|Randomized not Treated|0|||
23246337|NCT02181673|64642246|FG002|Up to Week 24|Randomized not Treated|1|||
23246338|NCT02181673|64642244|FG000|Week 24-Week 60|Adverse Event|0|||
23246339|NCT02181673|64642245|FG001|Week 24-Week 60|Adverse Event|4|||
23246340|NCT02181673|64642246|FG002|Week 24-Week 60|Adverse Event|10|||
23246341|NCT02181673|64642244|FG000|Week 24-Week 60|Other|0|||
23246342|NCT02181673|64642245|FG001|Week 24-Week 60|Other|2|||
23246343|NCT02181673|64642246|FG002|Week 24-Week 60|Other|1|||
23246344|NCT02181673|64642244|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
23246345|NCT02181673|64642245|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
23246346|NCT02181673|64642246|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
23246347|NCT02181673|64642244|FG000|Week 24-Week 60|Pregnancy|0|||
23352604|NCT02305446|65033078|FG000|Overall Study|Adverse Event|1|||
23352605|NCT02368210|65033079|FG000|Overall Study|Withdrawal by Subject|1|||
23587157|NCT03121950|65876263|FG001|Overall Study|Withdrawal by Subject|2|||
23587158|NCT01227707|65876266|FG000|Overall Study|Adverse Event|10|||
23246348|NCT02181673|64642245|FG001|Week 24-Week 60|Pregnancy|0|||
23246349|NCT02181673|64642246|FG002|Week 24-Week 60|Pregnancy|1|||
23246350|NCT02181673|64642244|FG000|Week 24-Week 60|Lack of Efficacy|0|||
23246351|NCT02181673|64642245|FG001|Week 24-Week 60|Lack of Efficacy|0|||
23246352|NCT02181673|64642246|FG002|Week 24-Week 60|Lack of Efficacy|1|||
23246353|NCT02181673|64642244|FG000|Week 24-Week 60|Lost to Follow-up|0|||
23246354|NCT02181673|64642245|FG001|Week 24-Week 60|Lost to Follow-up|0|||
23587159|NCT01227707|65876266|FG000|Overall Study|Progression of disease|3|||
23187813|NCT02120417|64429986|FG000|Overall Study|Other unspecified|5|||
23187814|NCT02120417|64429987|FG001|Overall Study|Other unspecified|4|||
23587160|NCT01227707|65876266|FG000|Overall Study|Withdrawal by Subject|1|||
23587161|NCT01227707|65876266|FG000|Overall Study|Patient non-compliance|3|||
23187815|NCT01966731|64429988|FG000|Overall Study|Death|2|||
23187816|NCT01966731|64429988|FG000|Overall Study|Lost to Follow-up|1|||
23587162|NCT01227707|65876266|FG000|Overall Study|Medical decision|6|||
23587163|NCT01227707|65876266|FG000|Overall Study|Death|1|||
23187817|NCT01966731|64429988|FG000|Overall Study|Physician Decision|2|||
23187818|NCT01966731|64429988|FG000|Overall Study|Follow up is not complete|600|||
23187819|NCT01966731|64429988|FG000|Overall Study|Screening Failure|29|||
23187820|NCT01966731|64429988|FG000|Overall Study|Found to be ineligible|1|||
23187821|NCT00472303|64429989|FG000|Titration Phase|Adverse Event|22|||
23187822|NCT00472303|64429990|FG001|Titration Phase|Adverse Event|12|||
23187823|NCT00472303|64429991|FG002|Titration Phase|Adverse Event|0|||
23187824|NCT00472303|64429989|FG000|Titration Phase|Death|4|||
23187825|NCT00472303|64429990|FG001|Titration Phase|Death|2|||
23187826|NCT00472303|64429991|FG002|Titration Phase|Death|0|||
23187827|NCT00472303|64429989|FG000|Titration Phase|Lack of Efficacy|10|||
23187828|NCT00472303|64429990|FG001|Titration Phase|Lack of Efficacy|0|||
23187829|NCT00472303|64429991|FG002|Titration Phase|Lack of Efficacy|0|||
23187830|NCT00472303|64429989|FG000|Titration Phase|Withdrawal by Subject|16|||
23187831|NCT00472303|64429990|FG001|Titration Phase|Withdrawal by Subject|13|||
23246355|NCT02181673|64642246|FG002|Week 24-Week 60|Lost to Follow-up|1|||
23246356|NCT02181673|64642244|FG000|Week 24-Week 60|Physician Decision|0|||
23246357|NCT02181673|64642245|FG001|Week 24-Week 60|Physician Decision|0|||
23246358|NCT02181673|64642246|FG002|Week 24-Week 60|Physician Decision|1|||
23246359|NCT04359758|64642247|FG000|Overall Study|Protocol Violation|3|||
23246360|NCT04359758|64642248|FG001|Overall Study|Protocol Violation|2|||
23187832|NCT00472303|64429991|FG002|Titration Phase|Withdrawal by Subject|0|||
23246361|NCT00278473|64642249|FG000|Overall Study|drop out|4|||
23246362|NCT00278473|64642250|FG001|Overall Study|drop out|3|||
23187833|NCT00472303|64429989|FG000|Titration Phase|Trial Medication non-compliant|4|||
23187834|NCT00472303|64429990|FG001|Titration Phase|Trial Medication non-compliant|1|||
23246363|NCT03083639|64642258|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
23246364|NCT03083639|64642259|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
23352606|NCT02368210|65033080|FG001|Overall Study|Withdrawal by Subject|0|||
23187835|NCT00472303|64429991|FG002|Titration Phase|Trial Medication non-compliant|0|||
23352607|NCT02368210|65033079|FG000|Overall Study|Adverse Event|0|||
23352608|NCT02368210|65033080|FG001|Overall Study|Adverse Event|1|||
23352609|NCT00369161|65033096|FG000|Overall Study|Adverse Event|15|||
23352610|NCT00369161|65033097|FG001|Overall Study|Adverse Event|13|||
23352611|NCT00369161|65033096|FG000|Overall Study|Abnormal laboratory value|0|||
23352612|NCT00369161|65033097|FG001|Overall Study|Abnormal laboratory value|1|||
23352613|NCT00369161|65033096|FG000|Overall Study|Lack of Efficacy|3|||
23352614|NCT00369161|65033097|FG001|Overall Study|Lack of Efficacy|1|||
23187836|NCT00472303|64429989|FG000|Titration Phase|Other|3|||
23187837|NCT00472303|64429990|FG001|Titration Phase|Other|1|||
23187838|NCT00472303|64429991|FG002|Titration Phase|Other|0|||
23187839|NCT00472303|64429989|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
23187840|NCT00472303|64429990|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
23187841|NCT00472303|64429991|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
23187842|NCT00472303|64429989|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
23187843|NCT00472303|64429990|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
23187844|NCT00472303|64429991|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
23187845|NCT00472303|64429989|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
23187846|NCT00472303|64429990|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
23187847|NCT00472303|64429991|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
23187848|NCT00472303|64429989|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
23187849|NCT00472303|64429990|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
23187850|NCT00472303|64429991|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
23187851|NCT00472303|64429989|FG000|Discontinuations After Titration Phase|Other|5|||
23187852|NCT00472303|64429990|FG001|Discontinuations After Titration Phase|Other|0|||
23187853|NCT00472303|64429991|FG002|Discontinuations After Titration Phase|Other|0|||
23187854|NCT00472303|64429989|FG000|Maintenance Phase|Adverse Event|5|||
23187855|NCT00472303|64429990|FG001|Maintenance Phase|Adverse Event|6|||
23187856|NCT00472303|64429991|FG002|Maintenance Phase|Adverse Event|6|||
23187857|NCT00472303|64429989|FG000|Maintenance Phase|Death|3|||
23187858|NCT00472303|64429990|FG001|Maintenance Phase|Death|0|||
23187859|NCT00472303|64429991|FG002|Maintenance Phase|Death|2|||
23187860|NCT00472303|64429989|FG000|Maintenance Phase|Lack of Efficacy|2|||
23187861|NCT00472303|64429990|FG001|Maintenance Phase|Lack of Efficacy|2|||
23187862|NCT00472303|64429991|FG002|Maintenance Phase|Lack of Efficacy|4|||
23187863|NCT00472303|64429989|FG000|Maintenance Phase|Withdrawal by Subject|6|||
23187864|NCT00472303|64429990|FG001|Maintenance Phase|Withdrawal by Subject|7|||
23187865|NCT00472303|64429991|FG002|Maintenance Phase|Withdrawal by Subject|3|||
23187866|NCT00472303|64429989|FG000|Maintenance Phase|Trial medication non-compliant|0|||
23187867|NCT00472303|64429990|FG001|Maintenance Phase|Trial medication non-compliant|0|||
23187868|NCT00472303|64429991|FG002|Maintenance Phase|Trial medication non-compliant|1|||
23187869|NCT00472303|64429989|FG000|Maintenance Phase|Resolution of pain|0|||
23187870|NCT00472303|64429990|FG001|Maintenance Phase|Resolution of pain|0|||
23187871|NCT00472303|64429991|FG002|Maintenance Phase|Resolution of pain|1|||
23187872|NCT00472303|64429989|FG000|Maintenance Phase|Other|1|||
23187873|NCT00472303|64429990|FG001|Maintenance Phase|Other|1|||
23187874|NCT00472303|64429991|FG002|Maintenance Phase|Other|0|||
23187875|NCT05029622|64429992|FG000|Overall Study|Lost to Follow-up|1|||
23187876|NCT04938648|64429997|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
23187877|NCT04938648|64429998|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
23187878|NCT04938648|64429997|FG000|Overall Study|Patient too ill|0|||
23187879|NCT04938648|64429998|FG001|Overall Study|Patient too ill|1|||
23187880|NCT04938648|64429997|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
23187881|NCT04938648|64429998|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
23187882|NCT04938648|64429997|FG000|Overall Study|Patient did not have memory problems|1|||
23187883|NCT04938648|64429998|FG001|Overall Study|Patient did not have memory problems|1|||
23187884|NCT04938648|64429997|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
23187885|NCT04938648|64429998|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
23187886|NCT04938648|64429997|FG000|Overall Study|Care partner could not be reached|0|||
23187887|NCT04938648|64429998|FG001|Overall Study|Care partner could not be reached|1|||
23187888|NCT04938648|64429997|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
23187889|NCT04938648|64429998|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
23352615|NCT00369161|65033096|FG000|Overall Study|Protocol Violation|0|||
23468672|NCT01621802|65457364|FG000|Overall Study|Lost to Follow-up|36|||
23187890|NCT04938648|64429997|FG000|Overall Study|Withdrawal by Subject|2|||
23187891|NCT04938648|64429998|FG001|Overall Study|Withdrawal by Subject|1|||
23352616|NCT00369161|65033097|FG001|Overall Study|Protocol Violation|2|||
23352617|NCT00369161|65033096|FG000|Overall Study|Withdrawal by Subject|2|||
23468673|NCT01621802|65457365|FG001|Overall Study|Lost to Follow-up|16|||
23352618|NCT00369161|65033097|FG001|Overall Study|Withdrawal by Subject|3|||
23468674|NCT01621802|65457366|FG002|Overall Study|Lost to Follow-up|24|||
23246365|NCT03083639|64642258|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
23246366|NCT03083639|64642259|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
23246367|NCT01308762|64642260|FG000|Overall Study|Protocol Violation|0|||
23246368|NCT01308762|64642261|FG001|Overall Study|Protocol Violation|1|||
23246369|NCT01308762|64642262|FG002|Overall Study|Protocol Violation|0|||
23246370|NCT02660489|64642263|FG000|Overall Study|Lost to Follow-up|1|||
23246371|NCT02660489|64642264|FG001|Overall Study|Lost to Follow-up|1|||
23246372|NCT02660489|64642263|FG000|Overall Study|Adverse Event|1|||
23246373|NCT02660489|64642264|FG001|Overall Study|Adverse Event|3|||
23246374|NCT02660489|64642263|FG000|Overall Study|no rhinovirus infection|4|||
23246375|NCT02660489|64642264|FG001|Overall Study|no rhinovirus infection|4|||
23246376|NCT05000931|64642265|FG000|Overall Study|Lost to Follow-up|1|||
23246377|NCT03151707|64642266|FG000|Overall Study|Lost to Follow-up|6|||
23246378|NCT01265875|64642267|FG000|Overall Study|Uncooperative/unreliable|1|||
23246379|NCT03733301|64642268|FG000|Overall Study|Screen Fail|1|||
23246380|NCT03733301|64642269|FG001|Overall Study|Screen Fail|0|||
23246381|NCT03733301|64642270|FG002|Overall Study|Screen Fail|0|||
23246382|NCT03733301|64642268|FG000|Overall Study|Non-compliance|1|||
23246383|NCT03733301|64642269|FG001|Overall Study|Non-compliance|0|||
23246384|NCT03733301|64642270|FG002|Overall Study|Non-compliance|0|||
23352619|NCT00369161|65033096|FG000|Overall Study|Death|1|||
23468675|NCT01621802|65457367|FG003|Overall Study|Lost to Follow-up|7|||
23468676|NCT01621802|65457368|FG004|Overall Study|Lost to Follow-up|31|||
23468677|NCT01621802|65457369|FG005|Overall Study|Lost to Follow-up|11|||
23468678|NCT00670748|65460577|FG000|Overall Study|Death during treatment|1|||
23468679|NCT00670748|65460578|FG001|Overall Study|Death during treatment|1|||
23468680|NCT00670748|65460579|FG002|Overall Study|Death during treatment|1|||
23468681|NCT00670748|65460580|FG003|Overall Study|Death during treatment|0|||
23187892|NCT04840667|64430002|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
23187893|NCT00356915|64430003|FG000|Overall Study|Non compliance|1|||
23187894|NCT00356915|64430004|FG001|Overall Study|Non compliance|2|||
23187895|NCT00356915|64430005|FG002|Overall Study|Non compliance|1|||
23187896|NCT00356915|64430003|FG000|Overall Study|Protocol Violation|2|||
23187897|NCT00356915|64430004|FG001|Overall Study|Protocol Violation|3|||
23187898|NCT00356915|64430005|FG002|Overall Study|Protocol Violation|2|||
23187899|NCT00356915|64430003|FG000|Overall Study|Withdrawal by Subject|14|||
23187900|NCT00356915|64430004|FG001|Overall Study|Withdrawal by Subject|14|||
23187901|NCT00356915|64430005|FG002|Overall Study|Withdrawal by Subject|10|||
23187902|NCT00356915|64430003|FG000|Overall Study|Lack of Efficacy|0|||
23187903|NCT00356915|64430004|FG001|Overall Study|Lack of Efficacy|0|||
23187904|NCT00356915|64430005|FG002|Overall Study|Lack of Efficacy|3|||
23187905|NCT00356915|64430003|FG000|Overall Study|Lost to Follow-up|27|||
23187906|NCT00356915|64430004|FG001|Overall Study|Lost to Follow-up|34|||
23187907|NCT00356915|64430005|FG002|Overall Study|Lost to Follow-up|14|||
23187908|NCT00356915|64430003|FG000|Overall Study|Administrative Decision|0|||
23187909|NCT00356915|64430004|FG001|Overall Study|Administrative Decision|0|||
23187910|NCT00356915|64430005|FG002|Overall Study|Administrative Decision|1|||
23187911|NCT00356915|64430003|FG000|Overall Study|Physician Decision|0|||
23187912|NCT00356915|64430004|FG001|Overall Study|Physician Decision|2|||
23187913|NCT00356915|64430005|FG002|Overall Study|Physician Decision|0|||
23187914|NCT00356915|64430003|FG000|Overall Study|Adverse Event|21|||
23187915|NCT00356915|64430004|FG001|Overall Study|Adverse Event|31|||
23187916|NCT00356915|64430005|FG002|Overall Study|Adverse Event|8|||
23187917|NCT00356915|64430003|FG000|Overall Study|Miscellaneous reasons|11|||
23187918|NCT00356915|64430004|FG001|Overall Study|Miscellaneous reasons|8|||
23187919|NCT00356915|64430005|FG002|Overall Study|Miscellaneous reasons|3|||
23187920|NCT01331161|64430006|FG000|Overall Study|Physician Decision|1|||
23187921|NCT01331161|64430007|FG001|Overall Study|Physician Decision|0|||
23187922|NCT01331161|64430006|FG000|Overall Study|Lost to Follow-up|0|||
23187923|NCT01331161|64430007|FG001|Overall Study|Lost to Follow-up|1|||
23187924|NCT01331161|64430006|FG000|Overall Study|Pregnancy|0|||
23187925|NCT01331161|64430007|FG001|Overall Study|Pregnancy|1|||
23187926|NCT00761215|64430008|FG000|Overall Study|Randomized but didn't receive drug|1|||
23246385|NCT03733301|64642268|FG000|Overall Study|Lack of Efficacy|2|||
23246386|NCT03733301|64642269|FG001|Overall Study|Lack of Efficacy|3|||
23246387|NCT03733301|64642270|FG002|Overall Study|Lack of Efficacy|0|||
23352620|NCT00369161|65033097|FG001|Overall Study|Death|2|||
23352621|NCT00369161|65033096|FG000|Overall Study|Graft loss|4|||
23187927|NCT00761215|64430009|FG001|Overall Study|Randomized but didn't receive drug|1|||
23187928|NCT00761215|64430010|FG002|Overall Study|Randomized but didn't receive drug|2|||
23187929|NCT00761215|64430008|FG000|Overall Study|Lost to Follow-up|6|||
23187930|NCT00761215|64430009|FG001|Overall Study|Lost to Follow-up|3|||
23187931|NCT00761215|64430010|FG002|Overall Study|Lost to Follow-up|6|||
23187932|NCT00761215|64430008|FG000|Overall Study|Withdrawal by Subject|1|||
23187933|NCT00761215|64430009|FG001|Overall Study|Withdrawal by Subject|0|||
23246388|NCT03733301|64642268|FG000|Overall Study|Adverse Event|0|||
23246389|NCT03733301|64642269|FG001|Overall Study|Adverse Event|1|||
23246390|NCT03733301|64642270|FG002|Overall Study|Adverse Event|3|||
23246391|NCT03733301|64642268|FG000|Overall Study|Withdrawal by Subject|3|||
23246392|NCT03733301|64642269|FG001|Overall Study|Withdrawal by Subject|5|||
23246393|NCT03733301|64642270|FG002|Overall Study|Withdrawal by Subject|1|||
23246394|NCT02575807|64645501|FG000|Overall Study|Death|8|||
23246395|NCT02575807|64645502|FG001|Overall Study|Death|3|||
23246396|NCT02575807|64645503|FG002|Overall Study|Death|7|||
23246397|NCT02575807|64645504|FG003|Overall Study|Death|0|||
23246398|NCT02575807|64645505|FG004|Overall Study|Death|1|||
23246399|NCT02575807|64645501|FG000|Overall Study|Study terminated by Sponsor|0|||
23246400|NCT02575807|64645502|FG001|Overall Study|Study terminated by Sponsor|1|||
23246401|NCT02575807|64645503|FG002|Overall Study|Study terminated by Sponsor|7|||
23246402|NCT02575807|64645504|FG003|Overall Study|Study terminated by Sponsor|0|||
23246403|NCT02575807|64645505|FG004|Overall Study|Study terminated by Sponsor|1|||
23246404|NCT02575807|64645501|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
23246405|NCT02575807|64645502|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
23246406|NCT02575807|64645503|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
23246407|NCT02575807|64645504|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
23246408|NCT02575807|64645505|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
23246409|NCT02575807|64645501|FG000|Overall Study|Terminated due to physician decision|0|||
23246410|NCT02575807|64645502|FG001|Overall Study|Terminated due to physician decision|0|||
23246411|NCT02575807|64645503|FG002|Overall Study|Terminated due to physician decision|1|||
23246412|NCT02575807|64645504|FG003|Overall Study|Terminated due to physician decision|0|||
23246413|NCT02575807|64645505|FG004|Overall Study|Terminated due to physician decision|0|||
23246414|NCT02575807|64645501|FG000|Overall Study|Subject ineligible - medical implant|0|||
23246415|NCT02575807|64645502|FG001|Overall Study|Subject ineligible - medical implant|0|||
23246416|NCT02575807|64645503|FG002|Overall Study|Subject ineligible - medical implant|0|||
23246417|NCT02575807|64645504|FG003|Overall Study|Subject ineligible - medical implant|1|||
23246418|NCT02575807|64645505|FG004|Overall Study|Subject ineligible - medical implant|0|||
23352622|NCT00369161|65033097|FG001|Overall Study|Graft loss|0|||
23352623|NCT00369161|65033096|FG000|Overall Study|Administrative Problem|2|||
23246419|NCT02575807|64645501|FG000|Overall Study|Withdrawal by Subject|0|||
23246420|NCT02575807|64645502|FG001|Overall Study|Withdrawal by Subject|0|||
23246421|NCT02575807|64645503|FG002|Overall Study|Withdrawal by Subject|1|||
23187934|NCT00761215|64430010|FG002|Overall Study|Withdrawal by Subject|0|||
23187935|NCT00761215|64430008|FG000|Overall Study|Bacteremia|1|||
23187936|NCT00761215|64430009|FG001|Overall Study|Bacteremia|0|||
23187937|NCT00761215|64430010|FG002|Overall Study|Bacteremia|0|||
23187938|NCT00636818|64430011|FG000|Overall Study|Adverse Event|1|||
23187939|NCT00636818|64430011|FG000|Overall Study|Lost to Follow-up|2|||
23187940|NCT00636818|64430011|FG000|Overall Study|Entry Criteria Exclusion|3|||
23187941|NCT00636818|64430011|FG000|Overall Study|Protocol Violation|1|||
23187942|NCT00636818|64430011|FG000|Overall Study|Withdrawal by Subject|4|||
23187943|NCT01051739|64430014|FG000|Overall Study|Death|3|||
23187944|NCT01051739|64430015|FG001|Overall Study|Death|3|||
23187945|NCT01051739|64430014|FG000|Overall Study|Withdrawal by Subject|25|||
23246422|NCT02575807|64645504|FG003|Overall Study|Withdrawal by Subject|1|||
23246423|NCT02575807|64645505|FG004|Overall Study|Withdrawal by Subject|2|||
23246424|NCT04101721|64645506|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
23246425|NCT04101721|64645507|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
23246426|NCT04101721|64645506|FG000|Overall Study|Death|0|||
23246427|NCT04101721|64645507|FG001|Overall Study|Death|1|||
23246428|NCT04101721|64645506|FG000|Overall Study|Lost to Follow-up|0|||
23246429|NCT04101721|64645507|FG001|Overall Study|Lost to Follow-up|3|||
23246430|NCT00962013|64645508|FG000|Overall Study|Did not have surgery|1|||
23246431|NCT00962013|64645508|FG000|Overall Study|Death|8|||
23246432|NCT00962013|64645508|FG000|Overall Study|Lost to Follow-up|12|||
23246433|NCT00962013|64645508|FG000|Overall Study|Unable/Unwilling to return|6|||
23246434|NCT00962013|64645508|FG000|Overall Study|Withdrawal by Subject|8|||
23246435|NCT00962013|64645508|FG000|Overall Study|Removal of study device|3|||
23246436|NCT00962013|64645508|FG000|Overall Study|Site Termination|24|||
23246437|NCT00962013|64645508|FG000|Overall Study|No 5 year evaluation|6|||
23246438|NCT00398632|64645516|FG000|Overall Study|Withdrawal by Subject|1|||
23468682|NCT00670748|65460577|FG000|Overall Study|Not off study|2|||
23352624|NCT00369161|65033097|FG001|Overall Study|Administrative Problem|2|||
23187946|NCT01051739|64430015|FG001|Overall Study|Withdrawal by Subject|10|||
23246439|NCT00398632|64645516|FG000|Overall Study|Lack of Efficacy|1|||
23246440|NCT04881448|64645519|FG000|Overall Study|Study cancelled by sponsor|220|||
23246441|NCT04881448|64645519|FG000|Overall Study|Withdrawal by Subject|2|||
23352625|NCT01556932|65033100|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
23352626|NCT01556932|65033101|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
23187947|NCT01896232|64430016|FG000|Overall Study|Death|6|||
23187948|NCT01896232|64430017|FG001|Overall Study|Death|10|||
23187949|NCT01896232|64430016|FG000|Overall Study|Withdrawal by Subject|32|||
23187950|NCT01896232|64430017|FG001|Overall Study|Withdrawal by Subject|31|||
23246442|NCT04881448|64645519|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
23246443|NCT03039686|64645520|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
23246444|NCT03039686|64645521|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
23246445|NCT03039686|64645522|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
23246446|NCT03039686|64645520|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
23246447|NCT03039686|64645521|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
23246448|NCT03039686|64645522|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
23246449|NCT03039686|64645520|FG000|Double-blind Period|Withdrawal by Subject|2|||
23352627|NCT01797094|65033102|FG000|Overall Study|Adverse Event|1|||
23352628|NCT01797094|65033103|FG001|Overall Study|Adverse Event|1|||
23352629|NCT01797094|65033102|FG000|Overall Study|Personal Reasons|4|||
23352630|NCT01797094|65033103|FG001|Overall Study|Personal Reasons|0|||
23352631|NCT01797094|65033102|FG000|Overall Study|Protocol Violation|0|||
23352632|NCT01797094|65033103|FG001|Overall Study|Protocol Violation|1|||
23352633|NCT01797094|65033102|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23352634|NCT01797094|65033103|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23352635|NCT00345878|65033107|FG000|Overall Study|Adverse Event|1|||
23352636|NCT00345878|65033108|FG001|Overall Study|Adverse Event|0|||
23352637|NCT00345878|65033107|FG000|Overall Study|Lost to Follow-up|2|||
23352638|NCT00345878|65033108|FG001|Overall Study|Lost to Follow-up|1|||
23352639|NCT00345878|65033107|FG000|Overall Study|Other|1|||
23352640|NCT00345878|65033108|FG001|Overall Study|Other|0|||
23352641|NCT04527978|65033109|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
23352642|NCT04527978|65033110|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
23352643|NCT00662558|65033111|FG000|Overall Study|Adverse Event|21|||
23352644|NCT00662558|65033112|FG001|Overall Study|Adverse Event|59|||
23352645|NCT00662558|65033111|FG000|Overall Study|Lack of Efficacy|4|||
23352646|NCT00662558|65033112|FG001|Overall Study|Lack of Efficacy|7|||
23352647|NCT00662558|65033111|FG000|Overall Study|Lost to Follow-up|13|||
23352648|NCT00662558|65033112|FG001|Overall Study|Lost to Follow-up|10|||
23352649|NCT00662558|65033111|FG000|Overall Study|Other|9|||
23352650|NCT00662558|65033112|FG001|Overall Study|Other|14|||
23352651|NCT00662558|65033111|FG000|Overall Study|Withdrawal by Subject|7|||
23352652|NCT00662558|65033112|FG001|Overall Study|Withdrawal by Subject|12|||
23352653|NCT00662558|65033111|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
23352654|NCT00662558|65033112|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
23352655|NCT02669667|65033114|FG000|Overall Study|Lost to Follow-up|0|||
23352656|NCT02669667|65033115|FG001|Overall Study|Lost to Follow-up|0|||
23352657|NCT02669667|65033116|FG002|Overall Study|Lost to Follow-up|0|||
23352658|NCT02669667|65033117|FG003|Overall Study|Lost to Follow-up|0|||
23352659|NCT02669667|65033118|FG004|Overall Study|Lost to Follow-up|0|||
23352660|NCT02669667|65033119|FG005|Overall Study|Lost to Follow-up|1|||
23352661|NCT02669667|65033120|FG006|Overall Study|Lost to Follow-up|0|||
23352662|NCT02469168|65033126|FG000|Overall Study|Trial closed|1|||
23352663|NCT02469168|65033127|FG001|Overall Study|Trial closed|0|||
23352664|NCT00448812|65033128|FG000|Year 2|Missed visit but remained in study|4|||
23352665|NCT00448812|65033129|FG001|Year 2|Missed visit but remained in study|1|||
23352666|NCT00448812|65033128|FG000|Year 3|Withdrawal by Subject|1|||
23352667|NCT00448812|65033129|FG001|Year 3|Withdrawal by Subject|3|||
23352668|NCT00448812|65033128|FG000|Year 3|Lost to Follow-up|1|||
23352669|NCT00448812|65033129|FG001|Year 3|Lost to Follow-up|0|||
23352670|NCT00448812|65033128|FG000|Year 3|Missed visit but remained in study|2|||
23352671|NCT00448812|65033129|FG001|Year 3|Missed visit but remained in study|0|||
23352672|NCT00448812|65033128|FG000|Year 5|Missed visit but remained in study|1|||
23352673|NCT00448812|65033129|FG001|Year 5|Missed visit but remained in study|0|||
23352674|NCT04318132|65033130|FG000|Overall Study|Protocol Violation|0|||
23352675|NCT04318132|65033131|FG001|Overall Study|Protocol Violation|0|||
23352676|NCT04318132|65033132|FG002|Overall Study|Protocol Violation|3|||
23352677|NCT04318132|65033133|FG003|Overall Study|Protocol Violation|0|||
23352678|NCT00575510|65033134|FG000|Overall Study|Lost to Follow-up|4|||
23246450|NCT03039686|64645521|FG001|Double-blind Period|Withdrawal by Subject|2|||
23246451|NCT03039686|64645522|FG002|Double-blind Period|Withdrawal by Subject|1|||
23352679|NCT00575510|65033135|FG001|Overall Study|Lost to Follow-up|6|||
23352680|NCT00575510|65033136|FG002|Overall Study|Lost to Follow-up|9|||
23352681|NCT00575510|65033134|FG000|Overall Study|Withdrawal by Subject|1|||
23352682|NCT00575510|65033135|FG001|Overall Study|Withdrawal by Subject|0|||
23352683|NCT00575510|65033136|FG002|Overall Study|Withdrawal by Subject|0|||
23352684|NCT00575510|65033134|FG000|Overall Study|Clinic Called Patient|7|||
23587164|NCT01352507|65876269|FG000|Treatment Period 1|Adverse Event|3|||
23246452|NCT03039686|64645520|FG000|Double-blind Period|Death|0|||
23246453|NCT03039686|64645521|FG001|Double-blind Period|Death|0|||
23468683|NCT00670748|65460578|FG001|Overall Study|Not off study|1|||
23468684|NCT00670748|65460579|FG002|Overall Study|Not off study|1|||
23468685|NCT00670748|65460580|FG003|Overall Study|Not off study|1|||
23468686|NCT02991040|65460581|FG000|Overall Study|Withdrawal by Subject|2|||
23468687|NCT02991040|65460581|FG000|Overall Study|Lost to Follow-up|2|||
23352685|NCT00575510|65033135|FG001|Overall Study|Clinic Called Patient|7|||
23352686|NCT00575510|65033136|FG002|Overall Study|Clinic Called Patient|7|||
23352687|NCT00575510|65033134|FG000|Overall Study|Pregnancy|0|||
23352688|NCT00575510|65033135|FG001|Overall Study|Pregnancy|0|||
23352689|NCT00575510|65033136|FG002|Overall Study|Pregnancy|1|||
23587165|NCT01352507|65876270|FG001|Treatment Period 1|Adverse Event|0|||
23246454|NCT03039686|64645522|FG002|Double-blind Period|Death|1|||
23468688|NCT00775593|65460582|FG000|Overall Study|Unmet eligibility criteria|6|||
23468689|NCT00775593|65460582|FG000|Overall Study|Death|1|||
23468690|NCT02249832|65460583|FG000|Overall Study|Withdrawal by Subject|3|||
23246455|NCT03039686|64645520|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
23246456|NCT03039686|64645521|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
23246457|NCT03039686|64645522|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
23246458|NCT03039686|64645520|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
23246459|NCT03039686|64645521|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
23246460|NCT03039686|64645522|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
23246461|NCT03039686|64645520|FG000|Open Label Period|Withdrawal by Subject|0|||
23246462|NCT03039686|64645521|FG001|Open Label Period|Withdrawal by Subject|3|||
23246463|NCT03039686|64645522|FG002|Open Label Period|Withdrawal by Subject|1|||
23246464|NCT03280628|64645523|FG000|Overall Study|Lost to Follow-up|8|||
23246465|NCT03280628|64645524|FG001|Overall Study|Lost to Follow-up|6|||
23246466|NCT03280628|64645525|FG002|Overall Study|Lost to Follow-up|11|||
23246467|NCT01876082|64645526|FG000|Overall Study|Withdrawal by Subject|0|||
23587166|NCT01352507|65876269|FG000|Treatment Period 1|Lost to Follow-up|3|||
23587167|NCT01352507|65876270|FG001|Treatment Period 1|Lost to Follow-up|4|||
23587168|NCT01352507|65876269|FG000|Treatment Period 1|Withdrawal by Subject|7|||
23587169|NCT01352507|65876270|FG001|Treatment Period 1|Withdrawal by Subject|5|||
23587170|NCT01352507|65876269|FG000|Treatment Period 1|Physician Decision|1|||
23587171|NCT01352507|65876270|FG001|Treatment Period 1|Physician Decision|0|||
23587172|NCT01352507|65876269|FG000|Washout Period|Withdrawal by Subject|0|||
23587173|NCT01352507|65876270|FG001|Washout Period|Withdrawal by Subject|1|||
23587174|NCT01352507|65876269|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
23587175|NCT01352507|65876270|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
23587176|NCT01352507|65876269|FG000|Treatment Period 2|Withdrawal by Subject|4|||
23587177|NCT01352507|65876270|FG001|Treatment Period 2|Withdrawal by Subject|3|||
23587178|NCT01352507|65876269|FG000|Treatment Period 2|Lack of Efficacy|1|||
23587179|NCT01352507|65876270|FG001|Treatment Period 2|Lack of Efficacy|0|||
23587180|NCT04176458|65876271|FG000|Overall Study|Covid 19|4|||
23587181|NCT01193153|65876272|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
23587182|NCT01193153|65876273|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
23587183|NCT01193153|65876272|FG000|Open-label Lead in Period|Pregnancy|1|||
23587184|NCT01193153|65876273|FG001|Open-label Lead in Period|Pregnancy|0|||
23587185|NCT01193153|65876272|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
23587186|NCT01193153|65876273|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
23587187|NCT01193153|65876272|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
23587188|NCT01193153|65876273|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
23587189|NCT01193153|65876272|FG000|Open-label Lead in Period|Other|14|||
23587190|NCT01193153|65876273|FG001|Open-label Lead in Period|Other|0|||
23587191|NCT01193153|65876272|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
23587192|NCT01193153|65876273|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
23587193|NCT01193153|65876272|FG000|Open-label Lead in Period|Adverse Event|41|||
23587194|NCT01193153|65876273|FG001|Open-label Lead in Period|Adverse Event|0|||
23587195|NCT01193153|65876272|FG000|Open-label Lead in Period|Death|1|||
23246468|NCT01876082|64645527|FG001|Overall Study|Withdrawal by Subject|2|||
23246469|NCT01876082|64645526|FG000|Overall Study|Protocol Violation|1|||
23246470|NCT01876082|64645527|FG001|Overall Study|Protocol Violation|0|||
23246471|NCT01876082|64645526|FG000|Overall Study|Adverse Event|1|||
23246472|NCT01876082|64645527|FG001|Overall Study|Adverse Event|1|||
23246473|NCT01876082|64645526|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
23246474|NCT01876082|64645527|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
23246475|NCT00326118|64645528|FG000|Active Phase|Withdrawal by Subject|4|||
23246476|NCT00326118|64645529|FG001|Active Phase|Withdrawal by Subject|1|||
23246477|NCT00474994|64645530|FG000|Overall Study|Patient Not treated|1|||
23246478|NCT00474994|64645530|FG000|Overall Study|Patient evaluable for toxicity only|3|||
23246479|NCT00474994|64645530|FG000|Overall Study|Patient found to be ineligible|1|||
23246480|NCT01777191|64645531|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
23352690|NCT02772809|65033140|FG000|Overall Study|not completed some tasks|6|||
23468691|NCT02249832|65460583|FG000|Overall Study|Lost to Follow-up|10|||
23468692|NCT00223080|65460585|FG000|Overall Study|Withdrawal by Subject|253|||
23468693|NCT00223080|65460586|FG001|Overall Study|Withdrawal by Subject|232|||
23468694|NCT00223080|65460585|FG000|Overall Study|Required contraindicated med|0|||
23468695|NCT00223080|65460586|FG001|Overall Study|Required contraindicated med|1|||
23468696|NCT00223080|65460585|FG000|Overall Study|Non-compliant|7|||
23468697|NCT00223080|65460586|FG001|Overall Study|Non-compliant|7|||
23468698|NCT00223080|65460585|FG000|Overall Study|Moved from study area|37|||
23468699|NCT00223080|65460586|FG001|Overall Study|Moved from study area|47|||
23587196|NCT01193153|65876273|FG001|Open-label Lead in Period|Death|0|||
23587197|NCT01193153|65876272|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
23352691|NCT02649426|65033143|FG000|Overall Study|Follow-up on going|1|||
23352692|NCT02649426|65033144|FG001|Overall Study|Follow-up on going|26|||
23352693|NCT02649426|65033145|FG002|Overall Study|Follow-up on going|28|||
23352694|NCT02649426|65033146|FG003|Overall Study|Follow-up on going|31|||
23352695|NCT00481767|65033147|FG000|Overall Study|Withdrawal by Subject|16|||
23352696|NCT00481767|65033148|FG001|Overall Study|Withdrawal by Subject|11|||
23352697|NCT00481767|65033147|FG000|Overall Study|Lost to Follow-up|16|||
23352698|NCT00481767|65033148|FG001|Overall Study|Lost to Follow-up|10|||
23352699|NCT02697734|65037326|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
23352700|NCT02697734|65037327|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
23352701|NCT02697734|65037326|FG000|Core Phase - up to Week 48|Adverse Event|1|||
23352702|NCT02697734|65037327|FG001|Core Phase - up to Week 48|Adverse Event|2|||
23352703|NCT02697734|65037326|FG000|Core Phase - up to Week 48|Physician Decision|1|||
23352704|NCT02697734|65037327|FG001|Core Phase - up to Week 48|Physician Decision|0|||
23352705|NCT02697734|65037326|FG000|Optional Extension Phase|Adverse Event|5|||
23352706|NCT02697734|65037327|FG001|Optional Extension Phase|Adverse Event|1|||
23352707|NCT02697734|65037326|FG000|Optional Extension Phase|Physician Decision|0|||
23352708|NCT02697734|65037327|FG001|Optional Extension Phase|Physician Decision|1|||
23352709|NCT02028169|65037328|FG000|Overall Study|Lost to Follow-up|21|||
23352710|NCT02028169|65037328|FG000|Overall Study|Lack of Efficacy|2|||
23352711|NCT02028169|65037328|FG000|Overall Study|Withdrawal by Subject|2|||
23352712|NCT02028169|65037328|FG000|Overall Study|Adverse Event|1|||
23352713|NCT02028169|65037328|FG000|Overall Study|Cessation of Drug|1|||
23352714|NCT02028169|65037328|FG000|Overall Study|Concomitant Medication Usage|1|||
23352715|NCT00792116|65037331|FG000|Overall Study|Lost to Follow-up|0|||
23352716|NCT00792116|65037332|FG001|Overall Study|Lost to Follow-up|1|||
23352717|NCT00792116|65037331|FG000|Overall Study|Discontnued intervention|1|||
23352718|NCT00792116|65037332|FG001|Overall Study|Discontnued intervention|0|||
23352719|NCT01690299|65037339|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
23352720|NCT01690299|65037340|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
23352721|NCT01690299|65037341|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
23352722|NCT01690299|65037342|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
23352723|NCT01690299|65037343|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
23352724|NCT01690299|65037344|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
23352725|NCT01690299|65037339|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
23352726|NCT01690299|65037340|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352727|NCT01690299|65037341|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352728|NCT01690299|65037342|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352729|NCT01690299|65037343|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352730|NCT01690299|65037344|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23352731|NCT01690299|65037339|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
23352732|NCT01690299|65037340|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
23352733|NCT01690299|65037341|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23352734|NCT01690299|65037342|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23352735|NCT01690299|65037343|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23352736|NCT01690299|65037344|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23352737|NCT01690299|65037339|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
23352738|NCT01690299|65037340|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
23352739|NCT01690299|65037341|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
23352740|NCT01690299|65037342|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
23352741|NCT01690299|65037343|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
23352742|NCT01690299|65037344|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
23352743|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
23352744|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
23352745|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
23352746|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
23352747|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
23352748|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
23352749|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
23352750|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
23352751|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
23352752|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
23352753|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
23352754|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
23587198|NCT01193153|65876273|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
23587199|NCT01193153|65876272|FG000|Open-label Stabilization Period|Adverse Event|9|||
23587200|NCT01193153|65876273|FG001|Open-label Stabilization Period|Adverse Event|0|||
23352755|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
23352756|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
23352757|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
23352758|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
23352759|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
23352760|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
23352761|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
23352762|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
23352763|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
23352764|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
23352765|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
23352766|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
23352767|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
23352768|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
23352769|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
23352770|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
23352771|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
23352772|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
23352773|NCT01690299|65037339|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352774|NCT01690299|65037340|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352775|NCT01690299|65037341|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352776|NCT01690299|65037342|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352777|NCT01690299|65037343|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
23352778|NCT01690299|65037344|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
23352779|NCT01285492|65037347|FG000|Overall Study|Adverse Event|11|||
23352780|NCT01285492|65037348|FG001|Overall Study|Adverse Event|0|||
23352781|NCT01285492|65037347|FG000|Overall Study|Protocol Violation|3|||
23352782|NCT01285492|65037348|FG001|Overall Study|Protocol Violation|0|||
23352783|NCT01285492|65037347|FG000|Overall Study|Withdrawal by Subject|2|||
23352784|NCT01285492|65037348|FG001|Overall Study|Withdrawal by Subject|1|||
23352785|NCT01285492|65037347|FG000|Overall Study|Death|1|||
23352786|NCT01285492|65037348|FG001|Overall Study|Death|0|||
23352787|NCT01857102|65037349|FG000|Period 1|No longer meets Eligibility Criteria|0|||
23352788|NCT01857102|65037350|FG001|Period 1|No longer meets Eligibility Criteria|2|||
23468700|NCT00223080|65460585|FG000|Overall Study|Lost to Follow-up|259|||
23468701|NCT00223080|65460586|FG001|Overall Study|Lost to Follow-up|284|||
23468702|NCT00223080|65460585|FG000|Overall Study|Death|85|||
23468703|NCT00223080|65460586|FG001|Overall Study|Death|74|||
23468704|NCT00223080|65460585|FG000|Overall Study|Other|14|||
23468705|NCT00223080|65460586|FG001|Overall Study|Other|11|||
23468706|NCT00223080|65460585|FG000|Overall Study|Reason not provided|141|||
23468707|NCT00223080|65460586|FG001|Overall Study|Reason not provided|140|||
23468708|NCT00223080|65460585|FG000|Overall Study|Adverse Event|0|||
23587201|NCT01193153|65876272|FG000|Open-label Stabilization Period|Death|2|||
23187951|NCT01896232|64430016|FG000|Overall Study|Sponsor Decision|2|||
23187952|NCT01896232|64430017|FG001|Overall Study|Sponsor Decision|0|||
23187953|NCT01896232|64430016|FG000|Overall Study|Lost to Follow-up|9|||
23187954|NCT01896232|64430017|FG001|Overall Study|Lost to Follow-up|12|||
23187955|NCT02104180|64430018|FG000|Overall Study|Protocol Violation|1|||
23187956|NCT02104180|64430019|FG001|Overall Study|Protocol Violation|0|||
23187957|NCT03040024|64430027|FG000|Overall Study|Adverse Event|0|||
23187958|NCT03040024|64430028|FG001|Overall Study|Adverse Event|1|||
23187959|NCT03040024|64430029|FG002|Overall Study|Adverse Event|0|||
23187960|NCT03040024|64430027|FG000|Overall Study|Death|0|||
23187961|NCT03040024|64430028|FG001|Overall Study|Death|1|||
23187962|NCT03040024|64430029|FG002|Overall Study|Death|0|||
23187963|NCT03040024|64430027|FG000|Overall Study|Physician Decision|0|||
23246481|NCT01777191|64645532|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
23246482|NCT01777191|64645531|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
23246483|NCT01777191|64645532|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
23246484|NCT01777191|64645531|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
23246485|NCT01777191|64645532|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
23246486|NCT01777191|64645531|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
23246487|NCT01777191|64645532|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
23246488|NCT01777191|64645531|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
23246489|NCT01777191|64645532|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
23468709|NCT00223080|65460586|FG001|Overall Study|Adverse Event|1|||
23187964|NCT03040024|64430028|FG001|Overall Study|Physician Decision|0|||
23187965|NCT03040024|64430029|FG002|Overall Study|Physician Decision|1|||
23187966|NCT02561156|64430030|FG000|Part 2|Adverse Event|0|||
23187967|NCT02561156|64430031|FG001|Part 2|Adverse Event|0|||
23187968|NCT02561156|64430032|FG002|Part 2|Adverse Event|0|||
23187969|NCT02561156|64430033|FG003|Part 2|Adverse Event|0|||
23246490|NCT01777191|64645531|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
23246491|NCT01777191|64645532|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
23246492|NCT01777191|64645531|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
23246493|NCT01777191|64645532|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
23187970|NCT02561156|64430034|FG004|Part 2|Adverse Event|0|||
23187971|NCT02561156|64430035|FG005|Part 2|Adverse Event|0|||
23246494|NCT01777191|64645531|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
23352789|NCT01857102|65037349|FG000|Period 1|Lost to Follow-up|0|||
23187972|NCT02561156|64430036|FG006|Part 2|Adverse Event|0|||
23246495|NCT01777191|64645532|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
23246496|NCT01777191|64645531|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
23246497|NCT01777191|64645532|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
23246498|NCT01777191|64645531|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
23246499|NCT01777191|64645532|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
23246500|NCT01777191|64645531|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
23246501|NCT01777191|64645532|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
23246502|NCT00761761|64645533|FG000|Overall Study|Lost to Follow-up|3|||
23246503|NCT00761761|64645534|FG001|Overall Study|Lost to Follow-up|1|||
23246504|NCT00761761|64645533|FG000|Overall Study|Withdrawal by Subject|3|||
23246505|NCT00761761|64645534|FG001|Overall Study|Withdrawal by Subject|0|||
23246506|NCT01414062|64645535|FG000|Overall Study|Lost to Follow-up|3|||
23246507|NCT01414062|64645536|FG001|Overall Study|Lost to Follow-up|2|||
23246508|NCT01414062|64645535|FG000|Overall Study|Left Country|1|||
23246509|NCT01414062|64645536|FG001|Overall Study|Left Country|1|||
23246510|NCT01414062|64645535|FG000|Overall Study|Family Disapproval|1|||
23246511|NCT01414062|64645536|FG001|Overall Study|Family Disapproval|0|||
23246512|NCT01414062|64645535|FG000|Overall Study|Withdrawal by Subject|0|||
23246513|NCT01414062|64645536|FG001|Overall Study|Withdrawal by Subject|1|||
23246514|NCT03425331|64645537|FG000|Overall Study|Withdrawal by Subject|1|||
23352790|NCT01857102|65037350|FG001|Period 1|Lost to Follow-up|3|||
23352791|NCT01857102|65037349|FG000|Period 1|Unsatisfactory Lens Fit|1|||
23187973|NCT02561156|64430037|FG007|Part 2|Adverse Event|0|||
23187974|NCT02561156|64430038|FG008|Part 2|Adverse Event|0|||
23187975|NCT02561156|64430039|FG009|Part 2|Adverse Event|0|||
23187976|NCT02561156|64430040|FG010|Part 2|Adverse Event|0|||
23187977|NCT02561156|64430041|FG011|Part 2|Adverse Event|1|||
23352792|NCT01857102|65037350|FG001|Period 1|Unsatisfactory Lens Fit|0|||
23352793|NCT01857102|65037349|FG000|Period 1|Unsatisfactory Visual Response|1|||
23187978|NCT02561156|64430042|FG012|Part 2|Adverse Event|0|||
23187979|NCT00844883|64430051|FG000|Overall Study|Bridged to liver transplant|3|||
23352794|NCT01857102|65037350|FG001|Period 1|Unsatisfactory Visual Response|0|||
23352795|NCT01857102|65037349|FG000|Period 1|Physician Decision|1|||
23352796|NCT01857102|65037350|FG001|Period 1|Physician Decision|0|||
23352797|NCT01857102|65037349|FG000|Period 2|Lens Discomfort|1|||
23352798|NCT01857102|65037350|FG001|Period 2|Lens Discomfort|0|||
23352799|NCT01857102|65037349|FG000|Period 2|Unsatisfactory Lens Fit|1|||
23352800|NCT01857102|65037350|FG001|Period 2|Unsatisfactory Lens Fit|0|||
23352801|NCT01900899|65037353|FG000|Overall Study|Withdrawal by Subject|7|||
23352802|NCT01900899|65037354|FG001|Overall Study|Withdrawal by Subject|1|||
23352803|NCT01900899|65037353|FG000|Overall Study|Migrated from study area|2|||
23352804|NCT01900899|65037354|FG001|Overall Study|Migrated from study area|0|||
23352805|NCT00957905|65037356|FG000|Part B|Not Treated|0|||
23187980|NCT00844883|64430051|FG000|Overall Study|Bridged to resection|1|||
23187981|NCT00754390|64430052|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
23187982|NCT00754390|64430052|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
23246515|NCT03425331|64645537|FG000|Overall Study|Death|1|||
23246516|NCT03425331|64645537|FG000|Overall Study|Adverse Event|1|||
23246517|NCT03425331|64645537|FG000|Overall Study|Disease Progression|2|||
23246518|NCT03992456|64645538|FG000|Overall Study|Withdrawal by Subject|1|||
23246519|NCT03992456|64645539|FG001|Overall Study|Withdrawal by Subject|0|||
23352806|NCT00957905|65037357|FG001|Part B|Not Treated|1|||
23352807|NCT00957905|65037356|FG000|Part B|Physician Decision|0|||
23352808|NCT00957905|65037357|FG001|Part B|Physician Decision|1|||
23352809|NCT00957905|65037356|FG000|Part B|Death|0|||
23468710|NCT01474239|65460587|FG000|Overall Study|Disease Progression|37|||
23468711|NCT01474239|65460588|FG001|Overall Study|Disease Progression|25|||
23468712|NCT01474239|65460587|FG000|Overall Study|Adverse Event|12|||
23468713|NCT01474239|65460588|FG001|Overall Study|Adverse Event|3|||
23468714|NCT01474239|65460587|FG000|Overall Study|Withdrawal by Subject|1|||
23468715|NCT01474239|65460588|FG001|Overall Study|Withdrawal by Subject|2|||
23468716|NCT01474239|65460587|FG000|Overall Study|Death|1|||
23468717|NCT01474239|65460588|FG001|Overall Study|Death|1|||
23468718|NCT01474239|65460587|FG000|Overall Study|Clinical Disease Progression|7|||
23468719|NCT01474239|65460588|FG001|Overall Study|Clinical Disease Progression|1|||
23468720|NCT01474239|65460587|FG000|Overall Study|Withdrawal for Economic Reason|1|||
23468721|NCT01474239|65460588|FG001|Overall Study|Withdrawal for Economic Reason|0|||
23468722|NCT02106390|65460595|FG000|Overall Study|Withdrawal by Subject|15|||
23468723|NCT02106390|65460596|FG001|Overall Study|Withdrawal by Subject|16|||
23468724|NCT02106390|65460597|FG002|Overall Study|Withdrawal by Subject|15|||
23468725|NCT02106390|65460595|FG000|Overall Study|Lost to Follow-up|25|||
23468726|NCT02106390|65460596|FG001|Overall Study|Lost to Follow-up|20|||
23468727|NCT02106390|65460597|FG002|Overall Study|Lost to Follow-up|13|||
23468728|NCT02106390|65460595|FG000|Overall Study|Other: Administrative Reason|8|||
23187983|NCT00754390|64430052|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
23187984|NCT00754390|64430052|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
23468729|NCT02106390|65460596|FG001|Overall Study|Other: Administrative Reason|5|||
23468730|NCT02106390|65460597|FG002|Overall Study|Other: Administrative Reason|12|||
23468731|NCT02106390|65460595|FG000|Overall Study|Other: Unspecified|1|||
23468732|NCT02106390|65460596|FG001|Overall Study|Other: Unspecified|4|||
23468733|NCT02106390|65460597|FG002|Overall Study|Other: Unspecified|2|||
23468734|NCT02106390|65460595|FG000|Overall Study|Adverse Event|0|||
23468735|NCT02106390|65460596|FG001|Overall Study|Adverse Event|2|||
23468736|NCT02106390|65460597|FG002|Overall Study|Adverse Event|1|||
23468737|NCT02106390|65460595|FG000|Overall Study|Protocol Violation|0|||
23468738|NCT02106390|65460596|FG001|Overall Study|Protocol Violation|1|||
23468739|NCT02106390|65460597|FG002|Overall Study|Protocol Violation|0|||
23468740|NCT00611026|65460598|FG000|Randomized to Double-blind Treatment|Not treated|2|||
23468741|NCT00611026|65460599|FG001|Randomized to Double-blind Treatment|Not treated|1|||
23468742|NCT00611026|65460600|FG002|Randomized to Double-blind Treatment|Not treated|3|||
23468743|NCT00611026|65460598|FG000|Double-blind Treatment Period|Death|1|||
23468744|NCT00611026|65460599|FG001|Double-blind Treatment Period|Death|0|||
23468745|NCT00611026|65460600|FG002|Double-blind Treatment Period|Death|0|||
23468746|NCT00611026|65460598|FG000|Double-blind Treatment Period|Adverse Event|9|||
23468747|NCT00611026|65460599|FG001|Double-blind Treatment Period|Adverse Event|28|||
23468748|NCT00611026|65460600|FG002|Double-blind Treatment Period|Adverse Event|46|||
23468749|NCT00611026|65460598|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
23468750|NCT00611026|65460599|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
23468751|NCT00611026|65460600|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
23468752|NCT00611026|65460598|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
23468753|NCT00611026|65460599|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
23468754|NCT00611026|65460600|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
23468755|NCT00611026|65460598|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
23468756|NCT00611026|65460599|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
23468757|NCT00611026|65460600|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
23468758|NCT00611026|65460598|FG000|Double-blind Treatment Period|Other|13|||
23468759|NCT00611026|65460599|FG001|Double-blind Treatment Period|Other|20|||
23468760|NCT00611026|65460600|FG002|Double-blind Treatment Period|Other|18|||
23468761|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
23468762|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
23468763|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
23468764|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
23468765|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
23187985|NCT00784758|64430053|FG000|Overall Study|Withdrawal by Subject|3|||
23187986|NCT00784758|64430054|FG001|Overall Study|Withdrawal by Subject|0|||
23187987|NCT00784758|64430053|FG000|Overall Study|Adverse Event|1|||
23187988|NCT00784758|64430054|FG001|Overall Study|Adverse Event|0|||
23187989|NCT00826514|64430055|FG000|Overall Study|Adverse Event|1|||
23246520|NCT03992456|64645538|FG000|Overall Study|Disease progression|4|||
23246521|NCT03992456|64645539|FG001|Overall Study|Disease progression|5|||
23468766|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
23468767|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
23468768|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
23468769|NCT02283762|65460602|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
23468770|NCT02283762|65460603|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
23468771|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
23468772|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
23468773|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
23468774|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
23468775|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
23468776|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
23468777|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
23468778|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
23468779|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
23468780|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
23468781|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
23468782|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
23468783|NCT02283762|65460602|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
23468784|NCT02283762|65460603|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
23468785|NCT05343624|65460604|FG000|Overall Study|Chart review not completed|1|||
23468786|NCT01376804|65460611|FG000|Treatment Period|Withdrawal by Subject|1|||
23468787|NCT01376804|65460611|FG000|Treatment Period|Adverse Event|6|||
23468788|NCT01376804|65460611|FG000|Treatment Period|Patient did not receive study drug|1|||
23468789|NCT00882557|65460612|FG000|Overall Study|Withdrawal by Subject|1|||
23468790|NCT00882557|65460613|FG001|Overall Study|Withdrawal by Subject|0|||
23468791|NCT00882557|65460612|FG000|Overall Study|Trouble with Vein Access|1|||
23468792|NCT00882557|65460613|FG001|Overall Study|Trouble with Vein Access|0|||
23468793|NCT00882557|65460612|FG000|Overall Study|Randomized Not Treated|0|||
23468794|NCT00882557|65460613|FG001|Overall Study|Randomized Not Treated|1|||
23187990|NCT00826514|64430056|FG001|Overall Study|Adverse Event|1|||
23187991|NCT00826514|64430055|FG000|Overall Study|Lack of Efficacy|0|||
23187992|NCT00826514|64430056|FG001|Overall Study|Lack of Efficacy|1|||
23187993|NCT00826514|64430055|FG000|Overall Study|Withdrawal by Subject|2|||
23468795|NCT02399163|65460617|FG000|Overall Study|Adverse Event|2|||
23468796|NCT02399163|65460617|FG000|Overall Study|Protocol Deviation|2|||
23468797|NCT02399163|65460617|FG000|Overall Study|Withdrawal by Participant|5|||
23468798|NCT04195893|65460618|FG000|Second Intervention|Withdrawal by Subject|1|||
23468799|NCT04195893|65460619|FG001|Second Intervention|Withdrawal by Subject|0|||
23468800|NCT01063283|65460623|FG000|Cycle 1|Adverse Event|2|||
23468801|NCT01063283|65460624|FG001|Cycle 1|Adverse Event|0|||
23468802|NCT01063283|65460625|FG002|Cycle 1|Adverse Event|0|||
23468803|NCT01063283|65460623|FG000|Cycle 1|Technical failure in data collection|1|||
23468804|NCT01063283|65460624|FG001|Cycle 1|Technical failure in data collection|0|||
23468805|NCT01063283|65460625|FG002|Cycle 1|Technical failure in data collection|0|||
23468806|NCT03436290|65460626|FG000|Overall Study|Post-randomization Exclusion|1|||
23468807|NCT03436290|65460627|FG001|Overall Study|Post-randomization Exclusion|0|||
23468808|NCT03436290|65460626|FG000|Overall Study|Death|6|||
23468809|NCT03436290|65460627|FG001|Overall Study|Death|0|||
23468810|NCT03436290|65460626|FG000|Overall Study|Withdrawal by Subject|4|||
23468811|NCT03436290|65460627|FG001|Overall Study|Withdrawal by Subject|0|||
23468812|NCT03436290|65460626|FG000|Overall Study|Protocol Violation|30|||
23468813|NCT03436290|65460627|FG001|Overall Study|Protocol Violation|0|||
23468814|NCT04294680|65460628|FG000|Overall Study|Withdrawal by Subject|2|||
23468815|NCT04294680|65460629|FG001|Overall Study|Withdrawal by Subject|1|||
23468816|NCT04294680|65460628|FG000|Overall Study|Follow-up visits completed outside of window|1|||
23468817|NCT04294680|65460629|FG001|Overall Study|Follow-up visits completed outside of window|0|||
23468818|NCT01209689|65460630|FG000|Overall Study|Insufficient Therapeutic Response|7|||
23468819|NCT01209689|65460631|FG001|Overall Study|Insufficient Therapeutic Response|2|||
23468820|NCT01209689|65460630|FG000|Overall Study|Refused Treatment|8|||
23468821|NCT01209689|65460631|FG001|Overall Study|Refused Treatment|3|||
23468822|NCT01209689|65460630|FG000|Overall Study|Adverse Event|4|||
23468823|NCT01209689|65460631|FG001|Overall Study|Adverse Event|0|||
23468824|NCT01209689|65460630|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
23468825|NCT01209689|65460631|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
23468826|NCT01209689|65460630|FG000|Overall Study|Failure to Return|3|||
23468827|NCT01209689|65460631|FG001|Overall Study|Failure to Return|0|||
23468828|NCT01209689|65460630|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
23468829|NCT01209689|65460631|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
23468830|NCT01663103|65460632|FG000|Overall Study|Withdrawal by Subject|1|||
23468831|NCT01663103|65460633|FG001|Overall Study|Withdrawal by Subject|2|||
23468832|NCT01663103|65460632|FG000|Overall Study|Adverse Event|1|||
23468833|NCT01663103|65460633|FG001|Overall Study|Adverse Event|0|||
23468834|NCT01663103|65460632|FG000|Overall Study|dog bite|1|||
23468835|NCT01663103|65460633|FG001|Overall Study|dog bite|0|||
23468836|NCT02346721|65460644|FG000|Overall Study|Withdrew Consent|3|||
23468837|NCT02346721|65460644|FG000|Overall Study|Lack of Efficacy|1|||
23187994|NCT00826514|64430056|FG001|Overall Study|Withdrawal by Subject|3|||
23468838|NCT02722304|65460645|FG000|Overall Study|Study Terminated by Sponsor|1|||
23187995|NCT00201201|64430064|FG000|Overall Study|Death|0|||
23187996|NCT00201201|64430065|FG001|Overall Study|Death|2|||
23468839|NCT02722304|65460646|FG001|Overall Study|Study Terminated by Sponsor|0|||
23468840|NCT02722304|65460647|FG002|Overall Study|Study Terminated by Sponsor|2|||
23468841|NCT02722304|65460648|FG003|Overall Study|Study Terminated by Sponsor|1|||
23468842|NCT02722304|65460649|FG004|Overall Study|Study Terminated by Sponsor|1|||
23468843|NCT02722304|65460645|FG000|Overall Study|Other|0|||
23468844|NCT02722304|65460646|FG001|Overall Study|Other|0|||
23468845|NCT02722304|65460647|FG002|Overall Study|Other|0|||
23468846|NCT02722304|65460648|FG003|Overall Study|Other|1|||
23468847|NCT02722304|65460649|FG004|Overall Study|Other|1|||
23468848|NCT00473382|65460650|FG000|Core Study|Adverse Event|3|||
23468849|NCT00473382|65460651|FG001|Core Study|Adverse Event|1|||
23468850|NCT00473382|65460652|FG002|Core Study|Adverse Event|1|||
23468851|NCT00473382|65460650|FG000|Core Study|Death|3|||
23468852|NCT00473382|65460651|FG001|Core Study|Death|5|||
23468853|NCT00473382|65460652|FG002|Core Study|Death|10|||
23468854|NCT00473382|65460650|FG000|Core Study|Lost to Follow-up|3|||
23468855|NCT00473382|65460651|FG001|Core Study|Lost to Follow-up|3|||
23468856|NCT00473382|65460652|FG002|Core Study|Lost to Follow-up|3|||
23468857|NCT00473382|65460650|FG000|Core Study|Physician Decision|1|||
23468858|NCT00473382|65460651|FG001|Core Study|Physician Decision|2|||
23468859|NCT00473382|65460652|FG002|Core Study|Physician Decision|2|||
23468860|NCT00473382|65460650|FG000|Core Study|Subject non-compliance|5|||
23468861|NCT00473382|65460651|FG001|Core Study|Subject non-compliance|2|||
23468862|NCT00473382|65460652|FG002|Core Study|Subject non-compliance|1|||
23468863|NCT00473382|65460650|FG000|Core Study|Subject needed other treatment|1|||
23468864|NCT00473382|65460651|FG001|Core Study|Subject needed other treatment|3|||
23468865|NCT00473382|65460652|FG002|Core Study|Subject needed other treatment|2|||
23468866|NCT00473382|65460650|FG000|Core Study|Subject's decision|12|||
23468867|NCT00473382|65460651|FG001|Core Study|Subject's decision|11|||
23468868|NCT00473382|65460652|FG002|Core Study|Subject's decision|10|||
23468869|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
23468870|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
23468871|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
23468872|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Death|1|||
23468873|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Death|3|||
23468874|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Death|3|||
23468875|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
23468876|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
23468877|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
23468878|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
23468879|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
23468880|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
23468881|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
23246522|NCT03992456|64645538|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
23246523|NCT03992456|64645539|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
23246524|NCT01071083|64645540|FG000|Overall Study|Adverse Event|1|||
23246525|NCT01071083|64645541|FG001|Overall Study|Adverse Event|0|||
23246526|NCT01071083|64645542|FG002|Overall Study|Adverse Event|1|||
23468882|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
23468883|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
23468884|NCT00473382|65460650|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
23468885|NCT00473382|65460651|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
23468886|NCT00473382|65460652|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
23468887|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
23468888|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
23468889|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
23468890|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Death|1|||
23587202|NCT01193153|65876273|FG001|Open-label Stabilization Period|Death|0|||
23587203|NCT01193153|65876272|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
23587204|NCT01193153|65876273|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
23587205|NCT01193153|65876272|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
23587206|NCT01193153|65876273|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
23587207|NCT01193153|65876272|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
23246527|NCT01071083|64645543|FG003|Overall Study|Adverse Event|0|||
23246528|NCT01071083|64645544|FG004|Overall Study|Adverse Event|1|||
23246529|NCT01071083|64645540|FG000|Overall Study|Withdrawal by Subject|3|||
23246530|NCT01071083|64645541|FG001|Overall Study|Withdrawal by Subject|0|||
23246531|NCT01071083|64645542|FG002|Overall Study|Withdrawal by Subject|2|||
23246532|NCT01071083|64645543|FG003|Overall Study|Withdrawal by Subject|0|||
23468891|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Death|7|||
23468892|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Death|4|||
23468893|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
23468894|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
23468895|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
23587208|NCT01193153|65876273|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
23246533|NCT01071083|64645544|FG004|Overall Study|Withdrawal by Subject|3|||
23246534|NCT01071083|64645540|FG000|Overall Study|Physician Decision|1|||
23246535|NCT01071083|64645541|FG001|Overall Study|Physician Decision|0|||
23246536|NCT01071083|64645542|FG002|Overall Study|Physician Decision|0|||
23246537|NCT01071083|64645543|FG003|Overall Study|Physician Decision|1|||
23246538|NCT01071083|64645544|FG004|Overall Study|Physician Decision|1|||
23246539|NCT01071083|64645540|FG000|Overall Study|Early Rescue|1|||
23246540|NCT01071083|64645541|FG001|Overall Study|Early Rescue|0|||
23246541|NCT01071083|64645542|FG002|Overall Study|Early Rescue|0|||
23246542|NCT01071083|64645543|FG003|Overall Study|Early Rescue|0|||
23246543|NCT01071083|64645544|FG004|Overall Study|Early Rescue|1|||
23246544|NCT01071083|64645540|FG000|Overall Study|Subject Moved|0|||
23246545|NCT01071083|64645541|FG001|Overall Study|Subject Moved|1|||
23246546|NCT01071083|64645542|FG002|Overall Study|Subject Moved|0|||
23246547|NCT01071083|64645543|FG003|Overall Study|Subject Moved|0|||
23246548|NCT01071083|64645544|FG004|Overall Study|Subject Moved|0|||
23246549|NCT01071083|64645540|FG000|Overall Study|Images Not Usable (Motion)|0|||
23246550|NCT01071083|64645541|FG001|Overall Study|Images Not Usable (Motion)|1|||
23246551|NCT01071083|64645542|FG002|Overall Study|Images Not Usable (Motion)|0|||
23246552|NCT01071083|64645543|FG003|Overall Study|Images Not Usable (Motion)|0|||
23246553|NCT01071083|64645544|FG004|Overall Study|Images Not Usable (Motion)|0|||
23246554|NCT01071083|64645540|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
23246555|NCT01071083|64645541|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
23246556|NCT01071083|64645542|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
23246557|NCT01071083|64645543|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
23246558|NCT01071083|64645544|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
23246559|NCT01071083|64645540|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
23246560|NCT01071083|64645541|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
23246561|NCT01071083|64645542|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
23246562|NCT01071083|64645543|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
23246563|NCT01071083|64645544|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
23246564|NCT01071083|64645540|FG000|Overall Study|Subject Refused to Continue|1|||
23246565|NCT01071083|64645541|FG001|Overall Study|Subject Refused to Continue|0|||
23246566|NCT01071083|64645542|FG002|Overall Study|Subject Refused to Continue|0|||
23246567|NCT01071083|64645543|FG003|Overall Study|Subject Refused to Continue|0|||
23246568|NCT01071083|64645544|FG004|Overall Study|Subject Refused to Continue|0|||
23246569|NCT02181634|64645552|FG000|Overall Study|Lack of Efficacy|33|||
23246570|NCT02181634|64645552|FG000|Overall Study|Adverse Event|17|||
23246571|NCT02181634|64645552|FG000|Overall Study|Physician Decision|8|||
23246572|NCT02181634|64645552|FG000|Overall Study|Withdrawal by Subject|5|||
23246573|NCT02181634|64645552|FG000|Overall Study|Death|2|||
23246574|NCT02181634|64645552|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
23246575|NCT02181634|64645552|FG000|Overall Study|Ineligible|1|||
23246576|NCT02181634|64645552|FG000|Overall Study|Max number of dose reduction|1|||
23246577|NCT02181634|64645552|FG000|Overall Study|Symptomatic progression|1|||
23246578|NCT02181634|64645552|FG000|Overall Study|Patient opted to proceed to surgery|1|||
23246579|NCT00819091|64645553|FG000|Overall Study|Adverse Event|3|||
23246580|NCT00819091|64645554|FG001|Overall Study|Adverse Event|5|||
23246581|NCT00819091|64645553|FG000|Overall Study|Protocol Violation|0|||
23246582|NCT00819091|64645554|FG001|Overall Study|Protocol Violation|1|||
23246583|NCT00819091|64645553|FG000|Overall Study|Lost to Follow-up|2|||
23246584|NCT00819091|64645554|FG001|Overall Study|Lost to Follow-up|0|||
23352810|NCT00957905|65037357|FG001|Part B|Death|1|||
23352811|NCT00957905|65037356|FG000|Part B|Protocol Violation|0|||
23352812|NCT00957905|65037357|FG001|Part B|Protocol Violation|1|||
23587209|NCT01193153|65876272|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
23587210|NCT01193153|65876273|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
23587211|NCT01193153|65876272|FG000|Open-label Stabilization Period|Other|8|||
23246585|NCT00819091|64645553|FG000|Overall Study|Withdrawal by Subject|1|||
23246586|NCT00819091|64645554|FG001|Overall Study|Withdrawal by Subject|2|||
23246587|NCT00819091|64645553|FG000|Overall Study|Other|1|||
23587212|NCT01193153|65876273|FG001|Open-label Stabilization Period|Other|0|||
23587213|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Other|2|||
23587214|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Other|3|||
23246588|NCT00819091|64645554|FG001|Overall Study|Other|2|||
23246589|NCT01371006|64645561|FG000|Overall Study|Adverse Event|1|||
23246590|NCT01371006|64645562|FG001|Overall Study|Adverse Event|0|||
23246591|NCT00530621|64645563|FG000|Overall Study|Adverse Event|11|||
23246592|NCT00530621|64645564|FG001|Overall Study|Adverse Event|8|||
23246593|NCT00530621|64645563|FG000|Overall Study|Physician Decision|2|||
23246594|NCT00530621|64645564|FG001|Overall Study|Physician Decision|4|||
23587215|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
23246595|NCT00530621|64645563|FG000|Overall Study|Progressive Disease (PD)|47|||
23246596|NCT00530621|64645564|FG001|Overall Study|Progressive Disease (PD)|40|||
23246597|NCT00530621|64645563|FG000|Overall Study|Sponsor Decision|12|||
23246598|NCT00530621|64645564|FG001|Overall Study|Sponsor Decision|15|||
23246599|NCT00530621|64645563|FG000|Overall Study|Subject Decision|4|||
23246600|NCT00530621|64645564|FG001|Overall Study|Subject Decision|7|||
23246601|NCT00530621|64645563|FG000|Overall Study|Death|3|||
23352813|NCT00534105|65037358|FG000|Overall Study|Lost to Follow-up|23|||
23352814|NCT00534105|65037359|FG001|Overall Study|Lost to Follow-up|39|||
23352815|NCT00195494|65037361|FG000|Year 1|Adverse Event|0|||
23352816|NCT00195494|65037362|FG001|Year 1|Adverse Event|0|||
23352817|NCT00195494|65037363|FG002|Year 1|Adverse Event|0|||
23352818|NCT00195494|65037364|FG003|Year 1|Adverse Event|0|||
23352819|NCT00195494|65037365|FG004|Year 1|Adverse Event|34|||
23352820|NCT00195494|65037366|FG005|Year 1|Adverse Event|27|||
23352821|NCT00195494|65037361|FG000|Year 1|System Toxicity|0|||
23352822|NCT00195494|65037362|FG001|Year 1|System Toxicity|0|||
23352823|NCT00195494|65037363|FG002|Year 1|System Toxicity|0|||
23352824|NCT00195494|65037364|FG003|Year 1|System Toxicity|0|||
23352825|NCT00195494|65037365|FG004|Year 1|System Toxicity|0|||
23352826|NCT00195494|65037366|FG005|Year 1|System Toxicity|1|||
23352827|NCT00195494|65037361|FG000|Year 1|Lack of Efficacy|0|||
23352828|NCT00195494|65037362|FG001|Year 1|Lack of Efficacy|0|||
23352829|NCT00195494|65037363|FG002|Year 1|Lack of Efficacy|0|||
23352830|NCT00195494|65037364|FG003|Year 1|Lack of Efficacy|0|||
23352831|NCT00195494|65037365|FG004|Year 1|Lack of Efficacy|24|||
23246602|NCT00530621|64645564|FG001|Overall Study|Death|6|||
23246603|NCT00530621|64645563|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
23246604|NCT00530621|64645564|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
23246605|NCT00463385|64645565|FG000|Overall Study|Other|4|||
23246606|NCT00463385|64645566|FG001|Overall Study|Other|3|||
23246607|NCT00463385|64645567|FG002|Overall Study|Other|6|||
23246608|NCT00463385|64645568|FG003|Overall Study|Other|4|||
23352832|NCT00195494|65037366|FG005|Year 1|Lack of Efficacy|9|||
23352833|NCT00195494|65037361|FG000|Year 1|Compliance|0|||
23352834|NCT00195494|65037362|FG001|Year 1|Compliance|0|||
23352835|NCT00195494|65037363|FG002|Year 1|Compliance|0|||
23352836|NCT00195494|65037364|FG003|Year 1|Compliance|0|||
23352837|NCT00195494|65037365|FG004|Year 1|Compliance|5|||
23352838|NCT00195494|65037366|FG005|Year 1|Compliance|1|||
23352839|NCT00195494|65037361|FG000|Year 1|Lost to Follow-up|0|||
23352840|NCT00195494|65037362|FG001|Year 1|Lost to Follow-up|0|||
23352841|NCT00195494|65037363|FG002|Year 1|Lost to Follow-up|0|||
23352842|NCT00195494|65037364|FG003|Year 1|Lost to Follow-up|0|||
23352843|NCT00195494|65037365|FG004|Year 1|Lost to Follow-up|1|||
23352844|NCT00195494|65037366|FG005|Year 1|Lost to Follow-up|0|||
23352845|NCT00195494|65037361|FG000|Year 1|Missed >4 consecutive doses|0|||
23352846|NCT00195494|65037362|FG001|Year 1|Missed >4 consecutive doses|0|||
23352847|NCT00195494|65037363|FG002|Year 1|Missed >4 consecutive doses|0|||
23352848|NCT00195494|65037364|FG003|Year 1|Missed >4 consecutive doses|0|||
23352849|NCT00195494|65037365|FG004|Year 1|Missed >4 consecutive doses|3|||
23352850|NCT00195494|65037366|FG005|Year 1|Missed >4 consecutive doses|2|||
23352851|NCT00195494|65037361|FG000|Year 1|Protocol deviation|0|||
23352852|NCT00195494|65037362|FG001|Year 1|Protocol deviation|0|||
23352853|NCT00195494|65037363|FG002|Year 1|Protocol deviation|0|||
23352854|NCT00195494|65037364|FG003|Year 1|Protocol deviation|0|||
23352855|NCT00195494|65037365|FG004|Year 1|Protocol deviation|2|||
23187997|NCT00201201|64430064|FG000|Overall Study|Withdrawal by Subject|5|||
23187998|NCT00201201|64430065|FG001|Overall Study|Withdrawal by Subject|5|||
23187999|NCT00686127|64430068|FG000|Overall Study|Withdrawal by Subject|14|||
23188000|NCT00686127|64430069|FG001|Overall Study|Withdrawal by Subject|6|||
23188001|NCT02902809|64430074|FG000|Overall Study|Discontinuation of asthma program|28|||
23188002|NCT01531725|64430075|FG000|Overall Study|Protocol Violation|5|||
23188003|NCT00840463|64430079|FG000|Overall Study|Adverse Event|1|||
23188004|NCT00840463|64430080|FG001|Overall Study|Adverse Event|0|||
23188005|NCT00004980|64430081|FG000|Overall Study|Withdrawal by Subject|1|||
23246609|NCT00463385|64645565|FG000|Overall Study|Adverse Event|5|||
23246610|NCT00463385|64645566|FG001|Overall Study|Adverse Event|8|||
23246611|NCT00463385|64645567|FG002|Overall Study|Adverse Event|4|||
23246612|NCT00463385|64645568|FG003|Overall Study|Adverse Event|2|||
23246613|NCT00463385|64645565|FG000|Overall Study|Lack of Efficacy|6|||
23246614|NCT00463385|64645566|FG001|Overall Study|Lack of Efficacy|6|||
23246615|NCT00463385|64645567|FG002|Overall Study|Lack of Efficacy|7|||
23246616|NCT00463385|64645568|FG003|Overall Study|Lack of Efficacy|9|||
23246617|NCT00463385|64645565|FG000|Overall Study|Withdrawal by Subject|3|||
23246618|NCT00463385|64645566|FG001|Overall Study|Withdrawal by Subject|3|||
23246619|NCT00463385|64645567|FG002|Overall Study|Withdrawal by Subject|3|||
23352856|NCT00195494|65037366|FG005|Year 1|Protocol deviation|3|||
23352857|NCT00195494|65037361|FG000|Year 1|Physician Decision|0|||
23352858|NCT00195494|65037362|FG001|Year 1|Physician Decision|0|||
23352859|NCT00195494|65037363|FG002|Year 1|Physician Decision|0|||
23352860|NCT00195494|65037364|FG003|Year 1|Physician Decision|0|||
23352861|NCT00195494|65037365|FG004|Year 1|Physician Decision|1|||
23352862|NCT00195494|65037366|FG005|Year 1|Physician Decision|0|||
23352863|NCT00195494|65037361|FG000|Year 1|Withdrawal by Subject|0|||
23352864|NCT00195494|65037362|FG001|Year 1|Withdrawal by Subject|0|||
23352865|NCT00195494|65037363|FG002|Year 1|Withdrawal by Subject|0|||
23352866|NCT00195494|65037364|FG003|Year 1|Withdrawal by Subject|0|||
23352867|NCT00195494|65037365|FG004|Year 1|Withdrawal by Subject|8|||
23352868|NCT00195494|65037366|FG005|Year 1|Withdrawal by Subject|9|||
23468896|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
23188006|NCT00004980|64430082|FG001|Overall Study|Withdrawal by Subject|0|||
23188007|NCT00004980|64430081|FG000|Overall Study|memory difficulties|1|||
23188008|NCT00004980|64430082|FG001|Overall Study|memory difficulties|1|||
23188009|NCT00004980|64430081|FG000|Overall Study|Physician Decision|0|||
23188010|NCT00004980|64430082|FG001|Overall Study|Physician Decision|1|||
23188011|NCT00847613|64430089|FG000|Overall Study|Ongoing at cut-off date|250|||
23188012|NCT00847613|64430090|FG001|Overall Study|Ongoing at cut-off date|265|||
23188013|NCT00847613|64430091|FG002|Overall Study|Ongoing at cut-off date|64|||
23188014|NCT00847613|64430092|FG003|Overall Study|Ongoing at cut-off date|64|||
23188015|NCT00847613|64430089|FG000|Overall Study|Death|1|||
23188016|NCT00847613|64430090|FG001|Overall Study|Death|1|||
23188017|NCT00847613|64430091|FG002|Overall Study|Death|0|||
23188018|NCT00847613|64430092|FG003|Overall Study|Death|0|||
23188019|NCT00847613|64430089|FG000|Overall Study|Adverse Event|36|||
23246620|NCT00463385|64645568|FG003|Overall Study|Withdrawal by Subject|4|||
23468897|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
23468898|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
23468899|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
23246621|NCT00463385|64645565|FG000|Overall Study|Lost to Follow-up|0|||
23468900|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
23468901|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
23468902|NCT00473382|65460650|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
23468903|NCT00473382|65460651|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
23468904|NCT00473382|65460652|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
23468905|NCT01746901|65460653|FG000|Naloxone Challenge Phase|Adverse Event|2|||
23468906|NCT01746901|65460654|FG001|Naloxone Challenge Phase|Adverse Event|0|||
23468907|NCT01746901|65460655|FG002|Naloxone Challenge Phase|Adverse Event|0|||
23468908|NCT01746901|65460656|FG003|Naloxone Challenge Phase|Adverse Event|0|||
23468909|NCT01746901|65460657|FG004|Naloxone Challenge Phase|Adverse Event|0|||
23468910|NCT01746901|65460658|FG005|Naloxone Challenge Phase|Adverse Event|0|||
23468911|NCT01746901|65460659|FG006|Naloxone Challenge Phase|Adverse Event|0|||
23468912|NCT01746901|65460660|FG007|Naloxone Challenge Phase|Adverse Event|0|||
23468913|NCT01746901|65460661|FG008|Naloxone Challenge Phase|Adverse Event|0|||
23468914|NCT01746901|65460653|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
23468915|NCT01746901|65460654|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468916|NCT01746901|65460655|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468917|NCT01746901|65460656|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468918|NCT01746901|65460657|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23246622|NCT00463385|64645566|FG001|Overall Study|Lost to Follow-up|0|||
23246623|NCT00463385|64645567|FG002|Overall Study|Lost to Follow-up|0|||
23246624|NCT00463385|64645568|FG003|Overall Study|Lost to Follow-up|1|||
23246625|NCT00463385|64645565|FG000|Overall Study|Death|2|||
23246626|NCT00463385|64645566|FG001|Overall Study|Death|1|||
23246627|NCT00463385|64645567|FG002|Overall Study|Death|2|||
23246628|NCT00463385|64645568|FG003|Overall Study|Death|0|||
23246629|NCT00463385|64645565|FG000|Overall Study|Missing|2|||
23246630|NCT00463385|64645566|FG001|Overall Study|Missing|0|||
23246631|NCT00463385|64645567|FG002|Overall Study|Missing|0|||
23246632|NCT00463385|64645568|FG003|Overall Study|Missing|2|||
23246633|NCT00463385|64645565|FG000|Overall Study|1 participant received commercial drug|0|||
23246634|NCT00463385|64645566|FG001|Overall Study|1 participant received commercial drug|1|||
23246635|NCT00463385|64645567|FG002|Overall Study|1 participant received commercial drug|0|||
23246636|NCT00463385|64645568|FG003|Overall Study|1 participant received commercial drug|0|||
23246637|NCT01306968|64645569|FG000|Overall Study|Lost to Follow-up|1|||
23246638|NCT01306968|64645570|FG001|Overall Study|Lost to Follow-up|1|||
23246639|NCT01306968|64645571|FG002|Overall Study|Lost to Follow-up|0|||
23246640|NCT01306968|64645572|FG003|Overall Study|Lost to Follow-up|0|||
23246641|NCT01306968|64645569|FG000|Overall Study|Physician Decision|0|||
23246642|NCT01306968|64645570|FG001|Overall Study|Physician Decision|1|||
23246643|NCT01306968|64645571|FG002|Overall Study|Physician Decision|0|||
23246644|NCT01306968|64645572|FG003|Overall Study|Physician Decision|0|||
23246645|NCT01306968|64645569|FG000|Overall Study|Relocated and left active duty|0|||
23246646|NCT01306968|64645570|FG001|Overall Study|Relocated and left active duty|1|||
23246647|NCT01306968|64645571|FG002|Overall Study|Relocated and left active duty|1|||
23188020|NCT00847613|64430090|FG001|Overall Study|Adverse Event|26|||
23188021|NCT00847613|64430091|FG002|Overall Study|Adverse Event|5|||
23188022|NCT00847613|64430092|FG003|Overall Study|Adverse Event|6|||
23188023|NCT00847613|64430089|FG000|Overall Study|Lack of Efficacy|7|||
23246648|NCT01306968|64645572|FG003|Overall Study|Relocated and left active duty|1|||
23246649|NCT01306968|64645569|FG000|Overall Study|Withdrew - time commitment|0|||
23246650|NCT01306968|64645570|FG001|Overall Study|Withdrew - time commitment|0|||
23246651|NCT01306968|64645571|FG002|Overall Study|Withdrew - time commitment|0|||
23188024|NCT00847613|64430090|FG001|Overall Study|Lack of Efficacy|3|||
23352869|NCT00195494|65037361|FG000|Year 1|Protocol Violation|0|||
23352870|NCT00195494|65037362|FG001|Year 1|Protocol Violation|0|||
23352871|NCT00195494|65037363|FG002|Year 1|Protocol Violation|0|||
23352872|NCT00195494|65037364|FG003|Year 1|Protocol Violation|0|||
23352873|NCT00195494|65037365|FG004|Year 1|Protocol Violation|1|||
23352874|NCT00195494|65037366|FG005|Year 1|Protocol Violation|1|||
23352875|NCT00195494|65037361|FG000|Year 2|Adverse Event|3|||
23352876|NCT00195494|65037362|FG001|Year 2|Adverse Event|7|||
23246652|NCT01306968|64645572|FG003|Overall Study|Withdrew - time commitment|2|||
23246653|NCT01306968|64645569|FG000|Overall Study|Withdrew over privacy concerns|0|||
23246654|NCT01306968|64645570|FG001|Overall Study|Withdrew over privacy concerns|0|||
23246655|NCT01306968|64645571|FG002|Overall Study|Withdrew over privacy concerns|0|||
23352877|NCT00195494|65037363|FG002|Year 2|Adverse Event|5|||
23352878|NCT00195494|65037364|FG003|Year 2|Adverse Event|9|||
23352879|NCT00195494|65037365|FG004|Year 2|Adverse Event|0|||
23352880|NCT00195494|65037366|FG005|Year 2|Adverse Event|0|||
23352881|NCT00195494|65037361|FG000|Year 2|Lack of Efficacy|0|||
23352882|NCT00195494|65037362|FG001|Year 2|Lack of Efficacy|1|||
23352883|NCT00195494|65037363|FG002|Year 2|Lack of Efficacy|7|||
23468919|NCT01746901|65460658|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468920|NCT01746901|65460659|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468921|NCT01746901|65460660|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468922|NCT01746901|65460661|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
23468923|NCT01746901|65460653|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23188025|NCT00847613|64430091|FG002|Overall Study|Lack of Efficacy|3|||
23188026|NCT00847613|64430092|FG003|Overall Study|Lack of Efficacy|1|||
23188027|NCT00847613|64430089|FG000|Overall Study|Study terminated by Sponsor|1|||
23188028|NCT00847613|64430090|FG001|Overall Study|Study terminated by Sponsor|0|||
23188029|NCT00847613|64430091|FG002|Overall Study|Study terminated by Sponsor|2|||
23188030|NCT00847613|64430092|FG003|Overall Study|Study terminated by Sponsor|1|||
23188031|NCT00847613|64430089|FG000|Overall Study|Lost to Follow-up|5|||
23188032|NCT00847613|64430090|FG001|Overall Study|Lost to Follow-up|0|||
23188033|NCT00847613|64430091|FG002|Overall Study|Lost to Follow-up|0|||
23246656|NCT01306968|64645572|FG003|Overall Study|Withdrew over privacy concerns|1|||
23246657|NCT04285983|64645577|FG000|Overall Study|Protocol Violation|6|||
23246658|NCT00518531|64645578|FG000|Treatment Period 1|Adverse Event|5|||
23246659|NCT00518531|64645579|FG001|Treatment Period 1|Adverse Event|0|||
23246660|NCT00518531|64645578|FG000|Treatment Period 1|Lost to Follow-up|5|||
23246661|NCT00518531|64645579|FG001|Treatment Period 1|Lost to Follow-up|3|||
23246662|NCT00518531|64645578|FG000|Treatment Period 1|Physician Decision|1|||
23246663|NCT00518531|64645579|FG001|Treatment Period 1|Physician Decision|0|||
23246664|NCT00518531|64645578|FG000|Treatment Period 1|Protocol Violation|2|||
23246665|NCT00518531|64645579|FG001|Treatment Period 1|Protocol Violation|0|||
23246666|NCT00518531|64645578|FG000|Treatment Period 1|Withdrawal by Subject|4|||
23246667|NCT00518531|64645579|FG001|Treatment Period 1|Withdrawal by Subject|6|||
23246668|NCT00518531|64645578|FG000|Treatment Period 1|Early crossover|1|||
23246669|NCT00518531|64645579|FG001|Treatment Period 1|Early crossover|3|||
23246670|NCT00518531|64645578|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23246671|NCT00518531|64645579|FG001|Treatment Period 2|Withdrawal by Subject|8|||
23246672|NCT00518531|64645578|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
23246673|NCT00518531|64645579|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
23246674|NCT00518531|64645578|FG000|Treatment Period 2|Adverse Event|1|||
23246675|NCT00518531|64645579|FG001|Treatment Period 2|Adverse Event|7|||
23246676|NCT00518531|64645578|FG000|Treatment Period 2|Protocol-specified criteria|0|||
23246677|NCT00518531|64645579|FG001|Treatment Period 2|Protocol-specified criteria|1|||
23246678|NCT00518531|64645578|FG000|Treatment Period 2|Non-compliance|1|||
23246679|NCT00518531|64645579|FG001|Treatment Period 2|Non-compliance|2|||
23246680|NCT01023815|64645583|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
23246681|NCT01023815|64645584|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
23246682|NCT01023815|64645585|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
23246683|NCT01023815|64645586|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
23246684|NCT01023815|64645583|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
23246685|NCT01023815|64645584|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
23246686|NCT01023815|64645585|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
23352884|NCT00195494|65037364|FG003|Year 2|Lack of Efficacy|7|||
23352885|NCT00195494|65037365|FG004|Year 2|Lack of Efficacy|0|||
23188034|NCT00847613|64430092|FG003|Overall Study|Lost to Follow-up|3|||
23188035|NCT00847613|64430089|FG000|Overall Study|Protocol Violation|6|||
23352886|NCT00195494|65037366|FG005|Year 2|Lack of Efficacy|0|||
23352887|NCT00195494|65037361|FG000|Year 2|Compliance|1|||
23352888|NCT00195494|65037362|FG001|Year 2|Compliance|0|||
23188036|NCT00847613|64430090|FG001|Overall Study|Protocol Violation|6|||
23352889|NCT00195494|65037363|FG002|Year 2|Compliance|0|||
23352890|NCT00195494|65037364|FG003|Year 2|Compliance|2|||
23352891|NCT00195494|65037365|FG004|Year 2|Compliance|0|||
23352892|NCT00195494|65037366|FG005|Year 2|Compliance|0|||
23352893|NCT00195494|65037361|FG000|Year 2|Lost to Follow-up|0|||
23352894|NCT00195494|65037362|FG001|Year 2|Lost to Follow-up|0|||
23352895|NCT00195494|65037363|FG002|Year 2|Lost to Follow-up|1|||
23352896|NCT00195494|65037364|FG003|Year 2|Lost to Follow-up|1|||
23352897|NCT00195494|65037365|FG004|Year 2|Lost to Follow-up|0|||
23352898|NCT00195494|65037366|FG005|Year 2|Lost to Follow-up|0|||
23352899|NCT00195494|65037361|FG000|Year 2|Missed >4 consecutive doses|1|||
23352900|NCT00195494|65037362|FG001|Year 2|Missed >4 consecutive doses|1|||
23352901|NCT00195494|65037363|FG002|Year 2|Missed >4 consecutive doses|1|||
23352902|NCT00195494|65037364|FG003|Year 2|Missed >4 consecutive doses|0|||
23352903|NCT00195494|65037365|FG004|Year 2|Missed >4 consecutive doses|0|||
23352904|NCT00195494|65037366|FG005|Year 2|Missed >4 consecutive doses|0|||
23352905|NCT00195494|65037361|FG000|Year 2|Protocol deviation|0|||
23352906|NCT00195494|65037362|FG001|Year 2|Protocol deviation|1|||
23352907|NCT00195494|65037363|FG002|Year 2|Protocol deviation|0|||
23352908|NCT00195494|65037364|FG003|Year 2|Protocol deviation|0|||
23352909|NCT00195494|65037365|FG004|Year 2|Protocol deviation|0|||
23352910|NCT00195494|65037366|FG005|Year 2|Protocol deviation|0|||
23352911|NCT00195494|65037361|FG000|Year 2|Physician Decision|1|||
23352912|NCT00195494|65037362|FG001|Year 2|Physician Decision|1|||
23352913|NCT00195494|65037363|FG002|Year 2|Physician Decision|0|||
23352914|NCT00195494|65037364|FG003|Year 2|Physician Decision|0|||
23188037|NCT00847613|64430091|FG002|Overall Study|Protocol Violation|3|||
23188038|NCT00847613|64430092|FG003|Overall Study|Protocol Violation|1|||
23188039|NCT00847613|64430089|FG000|Overall Study|Pregnancy|1|||
23352915|NCT00195494|65037365|FG004|Year 2|Physician Decision|0|||
23352916|NCT00195494|65037366|FG005|Year 2|Physician Decision|0|||
23468924|NCT01746901|65460654|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
23468925|NCT01746901|65460655|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468926|NCT01746901|65460656|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468927|NCT01746901|65460657|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468928|NCT01746901|65460658|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468929|NCT01746901|65460659|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468930|NCT01746901|65460660|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468931|NCT01746901|65460661|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
23468932|NCT01746901|65460653|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468933|NCT01746901|65460654|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
23468934|NCT01746901|65460655|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
23468935|NCT01746901|65460656|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468936|NCT01746901|65460657|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23352917|NCT00195494|65037361|FG000|Year 2|Withdrawal by Subject|1|||
23352918|NCT00195494|65037362|FG001|Year 2|Withdrawal by Subject|5|||
23352919|NCT00195494|65037363|FG002|Year 2|Withdrawal by Subject|4|||
23352920|NCT00195494|65037364|FG003|Year 2|Withdrawal by Subject|3|||
23352921|NCT00195494|65037365|FG004|Year 2|Withdrawal by Subject|0|||
23352922|NCT00195494|65037366|FG005|Year 2|Withdrawal by Subject|0|||
23352923|NCT00195494|65037361|FG000|Year 2|System toxicity|0|||
23352924|NCT00195494|65037362|FG001|Year 2|System toxicity|0|||
23188040|NCT00847613|64430090|FG001|Overall Study|Pregnancy|1|||
23188041|NCT00847613|64430091|FG002|Overall Study|Pregnancy|0|||
23188042|NCT00847613|64430092|FG003|Overall Study|Pregnancy|0|||
23188043|NCT00847613|64430089|FG000|Overall Study|Site closure|1|||
23188044|NCT00847613|64430090|FG001|Overall Study|Site closure|0|||
23188045|NCT00847613|64430091|FG002|Overall Study|Site closure|0|||
23188046|NCT00847613|64430092|FG003|Overall Study|Site closure|1|||
23188047|NCT00847613|64430089|FG000|Overall Study|Withdrawal by Subject|8|||
23188048|NCT00847613|64430090|FG001|Overall Study|Withdrawal by Subject|11|||
23188049|NCT00847613|64430091|FG002|Overall Study|Withdrawal by Subject|2|||
23188050|NCT00847613|64430092|FG003|Overall Study|Withdrawal by Subject|2|||
23188051|NCT00847613|64430089|FG000|Overall Study|Participant moved|4|||
23188052|NCT00847613|64430090|FG001|Overall Study|Participant moved|1|||
23188053|NCT00847613|64430091|FG002|Overall Study|Participant moved|0|||
23188054|NCT00847613|64430092|FG003|Overall Study|Participant moved|0|||
23188055|NCT00847613|64430089|FG000|Overall Study|Sponsor request|0|||
23188056|NCT00847613|64430090|FG001|Overall Study|Sponsor request|1|||
23188057|NCT00847613|64430091|FG002|Overall Study|Sponsor request|0|||
23188058|NCT00847613|64430092|FG003|Overall Study|Sponsor request|0|||
23188059|NCT00847613|64430089|FG000|Overall Study|Randomized, but not treated|0|||
23188060|NCT00847613|64430090|FG001|Overall Study|Randomized, but not treated|3|||
23352925|NCT00195494|65037363|FG002|Year 2|System toxicity|0|||
23352926|NCT00195494|65037364|FG003|Year 2|System toxicity|1|||
23352927|NCT00195494|65037365|FG004|Year 2|System toxicity|0|||
23352928|NCT00195494|65037366|FG005|Year 2|System toxicity|0|||
23352929|NCT00750919|65037367|FG000|Overall Study|Adverse Event|9|||
23352930|NCT00750919|65037367|FG000|Overall Study|Withdrawal by Subject|1|||
23468937|NCT01746901|65460658|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468938|NCT01746901|65460659|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468939|NCT01746901|65460660|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468940|NCT01746901|65460661|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
23468941|NCT01746901|65460653|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468942|NCT01746901|65460654|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
23468943|NCT01746901|65460655|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
23468944|NCT01746901|65460656|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468945|NCT01746901|65460657|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468946|NCT01746901|65460658|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468947|NCT01746901|65460659|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468948|NCT01746901|65460660|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468949|NCT01746901|65460661|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
23468950|NCT01746901|65460653|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468951|NCT01746901|65460654|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
23468952|NCT01746901|65460655|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
23468953|NCT01746901|65460656|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468954|NCT01746901|65460657|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468955|NCT01746901|65460658|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468956|NCT01746901|65460659|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468957|NCT01746901|65460660|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468958|NCT01746901|65460661|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
23468959|NCT01746901|65460653|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
23246687|NCT01023815|64645586|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
23246688|NCT01023815|64645583|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
23246689|NCT01023815|64645584|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
23246690|NCT01023815|64645585|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
23246691|NCT01023815|64645586|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
23246692|NCT01023815|64645583|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
23246693|NCT01023815|64645584|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
23246694|NCT01023815|64645585|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
23246695|NCT01023815|64645586|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
23246696|NCT01023815|64645583|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
23246697|NCT01023815|64645584|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
23246698|NCT01023815|64645585|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
23246699|NCT01023815|64645586|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
23246700|NCT02610842|64645587|FG000|Overall Study|Lost to Follow-up|5|||
23246701|NCT03996694|64645588|FG000|First Washout (7 Days)|positive urine drug screen|0|||
23246702|NCT03996694|64645589|FG001|First Washout (7 Days)|positive urine drug screen|0|||
23246703|NCT03996694|64645590|FG002|First Washout (7 Days)|positive urine drug screen|1|||
23246704|NCT03996694|64645591|FG003|First Washout (7 Days)|positive urine drug screen|0|||
23246705|NCT03996694|64645592|FG004|First Washout (7 Days)|positive urine drug screen|0|||
23246706|NCT03996694|64645593|FG005|First Washout (7 Days)|positive urine drug screen|0|||
23246707|NCT03996694|64645588|FG000|First Washout (7 Days)|Adverse Event|0|||
23246708|NCT03996694|64645589|FG001|First Washout (7 Days)|Adverse Event|1|||
23246709|NCT03996694|64645590|FG002|First Washout (7 Days)|Adverse Event|0|||
23246710|NCT03996694|64645591|FG003|First Washout (7 Days)|Adverse Event|0|||
23246711|NCT03996694|64645592|FG004|First Washout (7 Days)|Adverse Event|0|||
23246712|NCT03996694|64645593|FG005|First Washout (7 Days)|Adverse Event|0|||
23246713|NCT03996694|64645588|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
23246714|NCT03996694|64645589|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
23246715|NCT03996694|64645590|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
23246716|NCT03996694|64645591|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
23246717|NCT03996694|64645592|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
23246718|NCT03996694|64645593|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
23246719|NCT03996694|64645588|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
23246720|NCT03996694|64645589|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
23246721|NCT03996694|64645590|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
23246722|NCT03996694|64645591|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
23246723|NCT03996694|64645592|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
23246724|NCT03996694|64645593|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
23246725|NCT01125358|64645594|FG000|Overall Study|Adverse Event|3|||
23246726|NCT01125358|64645595|FG001|Overall Study|Adverse Event|0|||
23246727|NCT01125358|64645596|FG002|Overall Study|Adverse Event|0|||
23246728|NCT01125358|64645597|FG003|Overall Study|Adverse Event|2|||
23246729|NCT01125358|64645594|FG000|Overall Study|Perceived Lack of Efficacy|6|||
23246730|NCT01125358|64645595|FG001|Overall Study|Perceived Lack of Efficacy|3|||
23246731|NCT01125358|64645596|FG002|Overall Study|Perceived Lack of Efficacy|7|||
23246732|NCT01125358|64645597|FG003|Overall Study|Perceived Lack of Efficacy|4|||
23352931|NCT00750919|65037367|FG000|Overall Study|Lack of Efficacy|8|||
23468960|NCT01746901|65460654|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
23468961|NCT01746901|65460655|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
23468962|NCT01746901|65460656|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
23468963|NCT01746901|65460657|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
23468964|NCT01746901|65460658|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
23468965|NCT01746901|65460659|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
23468966|NCT01746901|65460660|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
23468967|NCT01746901|65460661|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
23468968|NCT01746901|65460653|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468969|NCT01746901|65460654|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468970|NCT01746901|65460655|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468971|NCT01746901|65460656|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468972|NCT01746901|65460657|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468973|NCT01746901|65460658|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468974|NCT01746901|65460659|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468975|NCT01746901|65460660|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
23468976|NCT01746901|65460661|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
23468977|NCT01746901|65460653|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468978|NCT01746901|65460654|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468979|NCT01746901|65460655|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
23246733|NCT01125358|64645594|FG000|Overall Study|Protocol Violation|1|||
23246734|NCT01125358|64645595|FG001|Overall Study|Protocol Violation|0|||
23246735|NCT01125358|64645596|FG002|Overall Study|Protocol Violation|0|||
23246736|NCT01125358|64645597|FG003|Overall Study|Protocol Violation|0|||
23246737|NCT01125358|64645594|FG000|Overall Study|Sponsor Decision|0|||
23246738|NCT01125358|64645595|FG001|Overall Study|Sponsor Decision|0|||
23468980|NCT01746901|65460656|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468981|NCT01746901|65460657|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468982|NCT01746901|65460658|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
23468983|NCT01746901|65460659|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
23468984|NCT01746901|65460660|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468985|NCT01746901|65460661|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
23468986|NCT01746901|65460653|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468987|NCT01746901|65460654|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468988|NCT01746901|65460655|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468989|NCT01746901|65460656|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
23468990|NCT01746901|65460657|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468991|NCT01746901|65460658|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468992|NCT01746901|65460659|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468993|NCT01746901|65460660|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468994|NCT01746901|65460661|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
23468995|NCT01746901|65460653|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23468996|NCT01746901|65460654|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23468997|NCT01746901|65460655|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23468998|NCT01746901|65460656|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23468999|NCT01746901|65460657|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23469000|NCT01746901|65460658|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
23469001|NCT01746901|65460659|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23469002|NCT01746901|65460660|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
23469003|NCT01746901|65460661|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
23469004|NCT01746901|65460653|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469005|NCT01746901|65460654|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469006|NCT01746901|65460655|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469007|NCT01746901|65460656|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469008|NCT01746901|65460657|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469009|NCT01746901|65460658|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23188061|NCT00847613|64430091|FG002|Overall Study|Randomized, but not treated|0|||
23246739|NCT01125358|64645596|FG002|Overall Study|Sponsor Decision|1|||
23246740|NCT01125358|64645597|FG003|Overall Study|Sponsor Decision|1|||
23246741|NCT01125358|64645594|FG000|Overall Study|Withdrawal by Subject|2|||
23246742|NCT01125358|64645595|FG001|Overall Study|Withdrawal by Subject|1|||
23246743|NCT01125358|64645596|FG002|Overall Study|Withdrawal by Subject|1|||
23246744|NCT01125358|64645597|FG003|Overall Study|Withdrawal by Subject|1|||
23246745|NCT01257737|64645605|FG000|Overall Study|Lost to Follow-up|1|||
23246746|NCT01257737|64645606|FG001|Overall Study|Lost to Follow-up|2|||
23469010|NCT01746901|65460659|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
23469011|NCT01746901|65460660|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
23469012|NCT01746901|65460661|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
23469013|NCT01047553|65460667|FG000|Overall Study|Adverse Event|10|||
23469014|NCT01047553|65460668|FG001|Overall Study|Adverse Event|5|||
23469015|NCT01047553|65460667|FG000|Overall Study|Withdrawal by Subject|4|||
23469016|NCT01047553|65460668|FG001|Overall Study|Withdrawal by Subject|2|||
23469017|NCT01047553|65460667|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
23469018|NCT01047553|65460668|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
23469019|NCT01047553|65460667|FG000|Overall Study|Lost to Follow-up|1|||
23469020|NCT01047553|65460668|FG001|Overall Study|Lost to Follow-up|0|||
23469021|NCT01047553|65460667|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
23469022|NCT01047553|65460668|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
23469023|NCT01047553|65460667|FG000|Overall Study|PI's decision|0|||
23469024|NCT01047553|65460668|FG001|Overall Study|PI's decision|1|||
23469025|NCT00993967|65460669|FG000|Overall Study|Adverse Event|8|||
23469026|NCT00993967|65460669|FG000|Overall Study|Death|1|||
23469027|NCT00993967|65460669|FG000|Overall Study|Lost to Follow-up|14|||
23469028|NCT00993967|65460669|FG000|Overall Study|Withdrawal by Subject|36|||
23469029|NCT00993967|65460669|FG000|Overall Study|Protocol Violation|2|||
23469030|NCT03710161|65460670|FG000|Overall Study|Study halted due to COVID pandemic|3|||
23469031|NCT03710161|65460671|FG001|Overall Study|Study halted due to COVID pandemic|2|||
23469032|NCT04200352|65460672|FG000|Overall Study|Death|1|||
23469033|NCT04200352|65460672|FG000|Overall Study|Adverse Event|6|||
23469034|NCT04200352|65460672|FG000|Overall Study|Withdrawal by parent/guardian|6|||
23469035|NCT04200352|65460672|FG000|Overall Study|Lack of Efficacy|1|||
23469036|NCT04200352|65460672|FG000|Overall Study|Other than specified|6|||
23469037|NCT01075685|65460674|FG000|Overall Study|Protocol Violation|9|||
23469038|NCT01075685|65460675|FG001|Overall Study|Protocol Violation|1|||
23469039|NCT01075685|65460674|FG000|Overall Study|Withdrawal by Subject|20|||
23469040|NCT01075685|65460675|FG001|Overall Study|Withdrawal by Subject|5|||
23469041|NCT01075685|65460674|FG000|Overall Study|Lost to Follow-up|563|||
23469042|NCT01075685|65460675|FG001|Overall Study|Lost to Follow-up|220|||
23469043|NCT03179319|65460676|FG000|Overall Study|Lost to Follow-up|6|||
23469044|NCT03179319|65460677|FG001|Overall Study|Lost to Follow-up|0|||
23469045|NCT01763996|65460678|FG000|Treatment Period 2|Adverse Event|0|||
23469046|NCT01763996|65460679|FG001|Treatment Period 2|Adverse Event|1|||
23469047|NCT02395471|65460694|FG000|Overall Study|Lost to Follow-up|2|||
23469048|NCT02395471|65460695|FG001|Overall Study|Lost to Follow-up|0|||
23469049|NCT02395471|65460694|FG000|Overall Study|Withdrawal by Subject|2|||
23469050|NCT02395471|65460695|FG001|Overall Study|Withdrawal by Subject|1|||
23469051|NCT02395471|65460694|FG000|Overall Study|Physician Decision|1|||
23188062|NCT00847613|64430092|FG003|Overall Study|Randomized, but not treated|0|||
23469052|NCT02395471|65460695|FG001|Overall Study|Physician Decision|0|||
23469053|NCT02395471|65460694|FG000|Overall Study|Protocol Violation|0|||
23469054|NCT02395471|65460695|FG001|Overall Study|Protocol Violation|1|||
23469055|NCT02395471|65460694|FG000|Overall Study|Failure to swollow sponge twice|1|||
23469056|NCT02395471|65460695|FG001|Overall Study|Failure to swollow sponge twice|0|||
23188063|NCT00847613|64430089|FG000|Overall Study|Other|1|||
23188064|NCT00847613|64430090|FG001|Overall Study|Other|1|||
23188065|NCT00847613|64430091|FG002|Overall Study|Other|2|||
23188066|NCT00847613|64430092|FG003|Overall Study|Other|0|||
23188067|NCT00998738|64430093|FG000|Overall Study|Uknown|1|||
23188068|NCT01844076|64430094|FG000|Overall Study|Adverse Event|1|||
23188069|NCT01844076|64430095|FG001|Overall Study|Adverse Event|0|||
23188070|NCT01844076|64430096|FG002|Overall Study|Adverse Event|0|||
23188071|NCT01844076|64430097|FG003|Overall Study|Adverse Event|0|||
23188072|NCT01844076|64430094|FG000|Overall Study|Withdrawal by Subject|1|||
23188073|NCT01844076|64430095|FG001|Overall Study|Withdrawal by Subject|0|||
23188074|NCT01844076|64430096|FG002|Overall Study|Withdrawal by Subject|0|||
23188075|NCT01844076|64430097|FG003|Overall Study|Withdrawal by Subject|0|||
23188076|NCT04919564|64430102|FG000|Overall Study|Lost to Follow-up|1|||
23188077|NCT04919564|64430103|FG001|Overall Study|Lost to Follow-up|0|||
23469057|NCT02395471|65460694|FG000|Overall Study|Patient did not return for procedure|0|||
23469058|NCT02395471|65460695|FG001|Overall Study|Patient did not return for procedure|1|||
23188078|NCT04919564|64430102|FG000|Overall Study|Physician Decision|1|||
23188079|NCT04919564|64430103|FG001|Overall Study|Physician Decision|1|||
23188080|NCT02863848|64430107|FG000|Overall Study|Lost to Follow-up|1|||
23188081|NCT02863848|64430108|FG001|Overall Study|Lost to Follow-up|1|||
23188082|NCT02863848|64430107|FG000|Overall Study|Protocol Violation|1|||
23188083|NCT02863848|64430108|FG001|Overall Study|Protocol Violation|2|||
23188084|NCT02017444|64430109|FG000|Overall Study|Physician Decision|1|||
23188085|NCT02017444|64430110|FG001|Overall Study|Physician Decision|0|||
23469059|NCT02395471|65460694|FG000|Overall Study|Subject not eligible|1|||
23469060|NCT02395471|65460695|FG001|Overall Study|Subject not eligible|0|||
23469061|NCT00811018|65460701|FG000|Overall Study|Additional Chronic Treatment|31|||
23469062|NCT00811018|65460701|FG000|Overall Study|Adverse Event|79|||
23469063|NCT00811018|65460701|FG000|Overall Study|Death|147|||
23469064|NCT00811018|65460701|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
23469065|NCT00811018|65460701|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
23469066|NCT00811018|65460701|FG000|Overall Study|Investigator Decision|57|||
23469067|NCT00811018|65460701|FG000|Overall Study|Lost to Follow-up|19|||
23469068|NCT00811018|65460701|FG000|Overall Study|Pregnancy|6|||
23469069|NCT00811018|65460701|FG000|Overall Study|Sponsor Decision|450|||
23469070|NCT00811018|65460701|FG000|Overall Study|Withdrawal by Subject|70|||
23469071|NCT00811018|65460701|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
23469072|NCT00811018|65460701|FG000|Overall Study|Other|26|||
23469073|NCT00363480|65460702|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
23469074|NCT00363480|65460702|FG000|Overall Study|Adverse Event|4|||
23469075|NCT00363480|65460702|FG000|Overall Study|Lost to Follow-up|5|||
23469076|NCT00363480|65460702|FG000|Overall Study|Withdrawal by Subject|5|||
23469077|NCT00363480|65460702|FG000|Overall Study|Non-compliance of subject|1|||
23469078|NCT00363480|65460702|FG000|Overall Study|Participant discontinued on its own|1|||
23469079|NCT02598583|65460703|FG000|Extension Period|Withdrawal by Subject|1|||
23469080|NCT02598583|65460704|FG001|Extension Period|Withdrawal by Subject|0|||
23469081|NCT01310075|65460705|FG000|Overall Study|Lost to Follow-up|1|||
23469082|NCT01310075|65460706|FG001|Overall Study|Lost to Follow-up|0|||
23469083|NCT01310075|65460705|FG000|Overall Study|Physician Decision|10|||
23469084|NCT01310075|65460706|FG001|Overall Study|Physician Decision|7|||
23469085|NCT01310075|65460705|FG000|Overall Study|Protocol Violation|2|||
23469086|NCT01310075|65460706|FG001|Overall Study|Protocol Violation|2|||
23469087|NCT01310075|65460705|FG000|Overall Study|Withdrawal by Subject|1|||
23469088|NCT01310075|65460706|FG001|Overall Study|Withdrawal by Subject|1|||
23469089|NCT03636893|65460707|FG000|Overall Study|Death|0|||
23469090|NCT03636893|65460708|FG001|Overall Study|Death|1|||
23469091|NCT03636893|65460707|FG000|Overall Study|Protocol Violation|0|||
23469092|NCT03636893|65460708|FG001|Overall Study|Protocol Violation|3|||
23469093|NCT03636893|65460707|FG000|Overall Study|Withdrawal by Subject|1|||
23469094|NCT03636893|65460708|FG001|Overall Study|Withdrawal by Subject|2|||
23469095|NCT03636893|65460707|FG000|Overall Study|Refusal to surgery|4|||
23469096|NCT03636893|65460708|FG001|Overall Study|Refusal to surgery|3|||
23188086|NCT02017444|64430109|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
23188087|NCT02017444|64430110|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
23188088|NCT01826214|64430113|FG000|Overall Study|Adverse Event|7|||
23188089|NCT01826214|64430114|FG001|Overall Study|Adverse Event|6|||
23188090|NCT01826214|64430113|FG000|Overall Study|Death|3|||
23188091|NCT01826214|64430114|FG001|Overall Study|Death|1|||
23188092|NCT01826214|64430113|FG000|Overall Study|Lost to Follow-up|1|||
23246747|NCT01257737|64645605|FG000|Overall Study|Liver transplant|1|||
23246748|NCT01257737|64645606|FG001|Overall Study|Liver transplant|0|||
23246749|NCT01257737|64645605|FG000|Overall Study|Relocation out of the country|0|||
23246750|NCT01257737|64645606|FG001|Overall Study|Relocation out of the country|1|||
23246751|NCT01257737|64645605|FG000|Overall Study|Withdrew from study|0|||
23469097|NCT03636893|65460707|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
23469098|NCT03636893|65460708|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
23469099|NCT03636893|65460707|FG000|Overall Study|Adverse Event|1|||
23352932|NCT00750919|65037367|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
23352933|NCT00750919|65037367|FG000|Overall Study|Other|36|||
23352934|NCT01085084|65037376|FG000|Overall Study|Withdrawal by Subject|1|||
23352935|NCT01085084|65037377|FG001|Overall Study|Withdrawal by Subject|0|||
23352936|NCT01085084|65037378|FG002|Overall Study|Withdrawal by Subject|0|||
23352937|NCT01085084|65037376|FG000|Overall Study|Lost to Follow-up|2|||
23352938|NCT01085084|65037377|FG001|Overall Study|Lost to Follow-up|1|||
23246752|NCT01257737|64645606|FG001|Overall Study|Withdrew from study|1|||
23246753|NCT03252756|64645607|FG000|Overall Study|Protocol Violation|2|||
23246754|NCT03252756|64645608|FG001|Overall Study|Protocol Violation|4|||
23246755|NCT03252756|64645607|FG000|Overall Study|COVID-19 Pandemic|1|||
23246756|NCT03252756|64645608|FG001|Overall Study|COVID-19 Pandemic|1|||
23246757|NCT03252756|64645607|FG000|Overall Study|Study Drug Expiration|0|||
23246758|NCT03252756|64645608|FG001|Overall Study|Study Drug Expiration|1|||
23246759|NCT00713830|64645609|FG000|Overall Study|Adverse Event|23|||
23246760|NCT00713830|64645610|FG001|Overall Study|Adverse Event|71|||
23246761|NCT00713830|64645609|FG000|Overall Study|Lack of Efficacy|24|||
23246762|NCT00713830|64645610|FG001|Overall Study|Lack of Efficacy|16|||
23352939|NCT01085084|65037378|FG002|Overall Study|Lost to Follow-up|1|||
23352940|NCT01085084|65037376|FG000|Overall Study|Adverse Event|4|||
23352941|NCT01085084|65037377|FG001|Overall Study|Adverse Event|3|||
23352942|NCT01085084|65037378|FG002|Overall Study|Adverse Event|6|||
23469100|NCT03636893|65460708|FG001|Overall Study|Adverse Event|1|||
23246763|NCT00713830|64645609|FG000|Overall Study|Lost to Follow-up|2|||
23246764|NCT00713830|64645610|FG001|Overall Study|Lost to Follow-up|9|||
23469101|NCT02597478|65460719|FG000|Overall Study|Withdrawal by Subject|2|||
23469102|NCT02597478|65460720|FG001|Overall Study|Withdrawal by Subject|0|||
23469103|NCT02597478|65460719|FG000|Overall Study|Change of opioid dose|1|||
23469104|NCT02597478|65460720|FG001|Overall Study|Change of opioid dose|0|||
23469105|NCT02597478|65460719|FG000|Overall Study|Insufficient exertional dyspnea|0|||
23469106|NCT02597478|65460720|FG001|Overall Study|Insufficient exertional dyspnea|1|||
23246765|NCT00713830|64645609|FG000|Overall Study|Withdrawal by Subject|13|||
23246766|NCT00713830|64645610|FG001|Overall Study|Withdrawal by Subject|23|||
23246767|NCT00713830|64645609|FG000|Overall Study|Poor Compliance to Protocol|7|||
23246768|NCT00713830|64645610|FG001|Overall Study|Poor Compliance to Protocol|14|||
23246769|NCT00713830|64645609|FG000|Overall Study|Familial and Personal Reasons|9|||
23246770|NCT00713830|64645610|FG001|Overall Study|Familial and Personal Reasons|34|||
23246771|NCT00713830|64645609|FG000|Overall Study|Sponsor Decision|4|||
23246772|NCT00713830|64645610|FG001|Overall Study|Sponsor Decision|10|||
23246773|NCT02704130|64645612|FG000|Overall Study|Physician Decision|5|||
23246774|NCT02704130|64645613|FG001|Overall Study|Physician Decision|3|||
23246775|NCT04341727|64645616|FG000|Overall Study|Withdrawal by Subject|0|||
23246776|NCT04341727|64645617|FG001|Overall Study|Withdrawal by Subject|0|||
23246777|NCT04341727|64645618|FG002|Overall Study|Withdrawal by Subject|1|||
23246778|NCT04341727|64645619|FG003|Overall Study|Withdrawal by Subject|0|||
23246779|NCT04341727|64645616|FG000|Overall Study|Lost to Follow-up|0|||
23246780|NCT04341727|64645617|FG001|Overall Study|Lost to Follow-up|0|||
23246781|NCT04341727|64645618|FG002|Overall Study|Lost to Follow-up|0|||
23246782|NCT04341727|64645619|FG003|Overall Study|Lost to Follow-up|1|||
23246783|NCT02866695|64645620|FG000|Overall Study|Adverse Event|1|||
23246784|NCT02866695|64645620|FG000|Overall Study|Lost to Follow-up|1|||
23246785|NCT01721200|64645621|FG000|Overall Study|Lost to Follow-up|3|||
23246786|NCT01721200|64645622|FG001|Overall Study|Lost to Follow-up|5|||
23246787|NCT02086968|64645623|FG000|Overall Study|Adverse Event|1|||
23246788|NCT02086968|64645624|FG001|Overall Study|Adverse Event|5|||
23246789|NCT02086968|64645623|FG000|Overall Study|Lost to Follow-up|2|||
23246790|NCT02086968|64645624|FG001|Overall Study|Lost to Follow-up|3|||
23246791|NCT02086968|64645623|FG000|Overall Study|Study drug received outside protocol|0|||
23246792|NCT02086968|64645624|FG001|Overall Study|Study drug received outside protocol|1|||
23246793|NCT02086968|64645623|FG000|Overall Study|Physician Decision|4|||
23246794|NCT02086968|64645624|FG001|Overall Study|Physician Decision|0|||
23352943|NCT01085084|65037376|FG000|Overall Study|Treatment Failure|0|||
23352944|NCT01085084|65037377|FG001|Overall Study|Treatment Failure|1|||
23352945|NCT01085084|65037378|FG002|Overall Study|Treatment Failure|2|||
23352946|NCT00926536|65037406|FG000|Overall Study|Physician Decision|1|||
23352947|NCT00926536|65037407|FG001|Overall Study|Physician Decision|2|||
23352948|NCT03420222|65037408|FG000|Overall Study|Withdrawal by Subject|5|||
23352949|NCT03420222|65037409|FG001|Overall Study|Withdrawal by Subject|0|||
23352950|NCT03420222|65037408|FG000|Overall Study|Physician Decision|0|||
23352951|NCT03420222|65037409|FG001|Overall Study|Physician Decision|1|||
23352952|NCT03092791|65037411|FG000|Overall Study|Lost to Follow-up|0|||
23352953|NCT03092791|65037412|FG001|Overall Study|Lost to Follow-up|0|||
23352954|NCT03092791|65037413|FG002|Overall Study|Lost to Follow-up|0|||
23469107|NCT01396057|65460722|FG000|Overall Study|Adverse Event|2|||
23469108|NCT01396057|65460723|FG001|Overall Study|Adverse Event|6|||
23469109|NCT01396057|65460722|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23469110|NCT01396057|65460723|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
23469111|NCT01396057|65460722|FG000|Overall Study|Protocol deviation|4|||
23469112|NCT01396057|65460723|FG001|Overall Study|Protocol deviation|4|||
23469113|NCT01396057|65460722|FG000|Overall Study|Consent withdrawn|3|||
23469114|NCT01396057|65460723|FG001|Overall Study|Consent withdrawn|2|||
23469115|NCT03967444|65460731|FG000|Overall Study|Lost to Follow-up|1|||
23469116|NCT03967444|65460732|FG001|Overall Study|Lost to Follow-up|2|||
23469117|NCT01938716|65460736|FG000|Overall Study|Physician Decision|2|||
23469118|NCT01938716|65460736|FG000|Overall Study|Withdrawal by Subject|2|||
23469119|NCT01519869|65460737|FG000|Overall Study|Lost to Follow-up|1|||
23469120|NCT03894813|65460745|FG000|Overall Study|Adverse Event|1|||
23469121|NCT03894813|65460746|FG001|Overall Study|Adverse Event|1|||
23469122|NCT03894813|65460745|FG000|Overall Study|Lack of Efficacy|3|||
23469123|NCT03894813|65460746|FG001|Overall Study|Lack of Efficacy|3|||
23587216|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
23587217|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Death|2|||
23587218|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Death|0|||
23587219|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
23587220|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
23587221|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
23587222|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
23587223|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
23587224|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
23587225|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
23587226|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
23587227|NCT01193153|65876272|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
23246795|NCT02086968|64645623|FG000|Overall Study|Withdrawal by Subject|1|||
23246796|NCT02086968|64645624|FG001|Overall Study|Withdrawal by Subject|4|||
23469124|NCT03894813|65460745|FG000|Overall Study|Lost to Follow-up|1|||
23469125|NCT03894813|65460746|FG001|Overall Study|Lost to Follow-up|0|||
23469126|NCT03894813|65460745|FG000|Overall Study|Pregnancy|2|||
23469127|NCT03894813|65460746|FG001|Overall Study|Pregnancy|1|||
23469128|NCT03894813|65460745|FG000|Overall Study|Protocol Violation|3|||
23469129|NCT03894813|65460746|FG001|Overall Study|Protocol Violation|7|||
23469130|NCT03894813|65460745|FG000|Overall Study|Withdrawal by Subject|1|||
23469131|NCT03894813|65460746|FG001|Overall Study|Withdrawal by Subject|3|||
23469132|NCT03894813|65460745|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
23469133|NCT03894813|65460746|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
23469134|NCT02888119|65460752|FG000|Overall Study|Lost to Follow-up|5|||
23469135|NCT02888119|65460753|FG001|Overall Study|Lost to Follow-up|4|||
23469136|NCT02888119|65460754|FG002|Overall Study|Lost to Follow-up|0|||
23469137|NCT03527732|65460755|FG000|Overall Study|Lost to Follow-up|21|||
23469138|NCT03527732|65460756|FG001|Overall Study|Lost to Follow-up|23|||
23469139|NCT03527732|65460757|FG002|Overall Study|Lost to Follow-up|80|||
23469140|NCT03527732|65460758|FG003|Overall Study|Lost to Follow-up|62|||
23469141|NCT03527732|65460759|FG004|Overall Study|Lost to Follow-up|12|||
23246797|NCT00390572|64645625|FG000|Overall Study|Lost to Follow-up|8|||
23246798|NCT00390572|64645626|FG001|Overall Study|Lost to Follow-up|4|||
23246799|NCT00390572|64645625|FG000|Overall Study|health condition|0|||
23469142|NCT03527732|65460760|FG005|Overall Study|Lost to Follow-up|20|||
23469143|NCT03116152|65460763|FG000|Overall Study|Disease Progression|49|||
23469144|NCT03116152|65460764|FG001|Overall Study|Disease Progression|47|||
23469145|NCT03116152|65460763|FG000|Overall Study|Death|5|||
23469146|NCT03116152|65460764|FG001|Overall Study|Death|2|||
23469147|NCT03116152|65460763|FG000|Overall Study|Adverse Event|21|||
23469148|NCT03116152|65460764|FG001|Overall Study|Adverse Event|7|||
23469149|NCT03116152|65460763|FG000|Overall Study|Protocol Violation|2|||
23469150|NCT03116152|65460764|FG001|Overall Study|Protocol Violation|2|||
23469151|NCT03116152|65460763|FG000|Overall Study|Withdrawal by Subject|0|||
23469152|NCT03116152|65460764|FG001|Overall Study|Withdrawal by Subject|1|||
23469153|NCT03116152|65460763|FG000|Overall Study|Physician Decision|3|||
23469154|NCT03116152|65460764|FG001|Overall Study|Physician Decision|2|||
23469155|NCT03116152|65460763|FG000|Overall Study|other|11|||
23246800|NCT00390572|64645626|FG001|Overall Study|health condition|1|||
23246801|NCT04797637|64645627|FG000|Overall Study|Lost to Follow-up|23|||
23246802|NCT04797637|64645628|FG001|Overall Study|Lost to Follow-up|32|||
23246803|NCT04797637|64645627|FG000|Overall Study|Withdrawal by Subject|0|||
23246804|NCT04797637|64645628|FG001|Overall Study|Withdrawal by Subject|1|||
23246805|NCT03976076|64645629|FG000|Overall Study|Withdrawal by Subject|2|||
23246806|NCT03359473|64645631|FG000|Overall Study|Adverse Event|0|||
23246807|NCT03359473|64645632|FG001|Overall Study|Adverse Event|2|||
23246808|NCT03359473|64645633|FG002|Overall Study|Adverse Event|5|||
23246809|NCT03359473|64645634|FG003|Overall Study|Adverse Event|3|||
23246810|NCT03359473|64645631|FG000|Overall Study|Lost to Follow-up|0|||
23246811|NCT03359473|64645632|FG001|Overall Study|Lost to Follow-up|1|||
23246812|NCT03359473|64645633|FG002|Overall Study|Lost to Follow-up|0|||
23246813|NCT03359473|64645634|FG003|Overall Study|Lost to Follow-up|0|||
23246814|NCT03359473|64645631|FG000|Overall Study|Physician Decision|0|||
23246815|NCT03359473|64645632|FG001|Overall Study|Physician Decision|1|||
23246816|NCT03359473|64645633|FG002|Overall Study|Physician Decision|0|||
23246817|NCT03359473|64645634|FG003|Overall Study|Physician Decision|1|||
23246818|NCT03359473|64645631|FG000|Overall Study|Withdrawal by Subject|1|||
23246819|NCT03359473|64645632|FG001|Overall Study|Withdrawal by Subject|2|||
23246820|NCT03359473|64645633|FG002|Overall Study|Withdrawal by Subject|1|||
23246821|NCT03359473|64645634|FG003|Overall Study|Withdrawal by Subject|0|||
23246822|NCT03359473|64645631|FG000|Overall Study|Protocol-defined stopping criteria|1|||
23246823|NCT03359473|64645632|FG001|Overall Study|Protocol-defined stopping criteria|0|||
23246824|NCT03359473|64645633|FG002|Overall Study|Protocol-defined stopping criteria|0|||
23246825|NCT03359473|64645634|FG003|Overall Study|Protocol-defined stopping criteria|1|||
23246826|NCT00299546|64645635|FG000|Overall Study|Death|3|||
23246827|NCT00299546|64645636|FG001|Overall Study|Death|2|||
23469156|NCT03116152|65460764|FG001|Overall Study|other|34|||
23246828|NCT00299546|64645637|FG002|Overall Study|Death|0|||
23246829|NCT00299546|64645635|FG000|Overall Study|Lost to Follow-up|2|||
23246830|NCT00299546|64645636|FG001|Overall Study|Lost to Follow-up|2|||
23246831|NCT00299546|64645637|FG002|Overall Study|Lost to Follow-up|5|||
23246832|NCT00299546|64645635|FG000|Overall Study|Adverse Event|37|||
23246833|NCT00299546|64645636|FG001|Overall Study|Adverse Event|22|||
23469157|NCT00948441|65460767|FG000|Overall Study|no longer meet inclusion criteria|1|||
23469158|NCT00948441|65460768|FG001|Overall Study|no longer meet inclusion criteria|4|||
23469159|NCT00750152|65460771|FG000|Overall Study|Adverse Event|2|||
23469160|NCT00750152|65460772|FG001|Overall Study|Adverse Event|1|||
23469161|NCT00750152|65460771|FG000|Overall Study|Lost to Follow-up|8|||
23469162|NCT00750152|65460772|FG001|Overall Study|Lost to Follow-up|13|||
23469163|NCT00750152|65460771|FG000|Overall Study|Withdrawal by Subject|3|||
23469164|NCT00750152|65460772|FG001|Overall Study|Withdrawal by Subject|3|||
23469165|NCT00750152|65460771|FG000|Overall Study|Physician Decision|1|||
23469166|NCT00750152|65460772|FG001|Overall Study|Physician Decision|1|||
23469167|NCT00750152|65460771|FG000|Overall Study|Non-compliance|0|||
23469168|NCT00750152|65460772|FG001|Overall Study|Non-compliance|1|||
23469169|NCT00750152|65460771|FG000|Overall Study|Termination by sponsor|1|||
23469170|NCT00750152|65460772|FG001|Overall Study|Termination by sponsor|0|||
23469171|NCT00750152|65460771|FG000|Overall Study|Other|7|||
23469172|NCT00750152|65460772|FG001|Overall Study|Other|8|||
23469173|NCT00843284|65460773|FG000|Overall Study|Adverse Event|39|||
23469174|NCT00843284|65460773|FG000|Overall Study|Lack of Efficacy|5|||
23469175|NCT00843284|65460773|FG000|Overall Study|Lost to Follow-up|11|||
23469176|NCT00843284|65460773|FG000|Overall Study|Other|10|||
23469177|NCT00843284|65460773|FG000|Overall Study|Withdrawal by Subject|4|||
23469178|NCT00843284|65460773|FG000|Overall Study|Death|3|||
23469179|NCT00526071|65460774|FG000|Overall Study|Adverse Event|1|||
23469180|NCT00526071|65460774|FG000|Overall Study|Withdrawal by Subject|1|||
23469181|NCT00526071|65460774|FG000|Overall Study|Lack of Response to Study Drug|4|||
23469182|NCT01696188|65460775|FG000|Overall Study|Protocol Violation|1|||
23469183|NCT01696188|65460776|FG001|Overall Study|Protocol Violation|1|||
23469184|NCT01229267|65460779|FG000|Overall Study|Adverse Event|4|||
23469185|NCT01229267|65460780|FG001|Overall Study|Adverse Event|6|||
23469186|NCT01229267|65460781|FG002|Overall Study|Adverse Event|3|||
23469187|NCT01229267|65460782|FG003|Overall Study|Adverse Event|2|||
23469188|NCT01229267|65460783|FG004|Overall Study|Adverse Event|10|||
23469189|NCT01229267|65460779|FG000|Overall Study|Death|40|||
23469190|NCT01229267|65460780|FG001|Overall Study|Death|37|||
23469191|NCT01229267|65460781|FG002|Overall Study|Death|35|||
23469192|NCT01229267|65460782|FG003|Overall Study|Death|13|||
23469193|NCT01229267|65460783|FG004|Overall Study|Death|103|||
23469194|NCT01229267|65460779|FG000|Overall Study|Withdrawal by Subject|23|||
23469195|NCT01229267|65460780|FG001|Overall Study|Withdrawal by Subject|22|||
23469196|NCT01229267|65460781|FG002|Overall Study|Withdrawal by Subject|32|||
23469197|NCT01229267|65460782|FG003|Overall Study|Withdrawal by Subject|14|||
23469198|NCT01229267|65460783|FG004|Overall Study|Withdrawal by Subject|59|||
23469199|NCT01229267|65460779|FG000|Overall Study|Protocol Violation|0|||
23469200|NCT01229267|65460780|FG001|Overall Study|Protocol Violation|1|||
23469201|NCT01229267|65460781|FG002|Overall Study|Protocol Violation|0|||
23469202|NCT01229267|65460782|FG003|Overall Study|Protocol Violation|0|||
23469203|NCT01229267|65460783|FG004|Overall Study|Protocol Violation|0|||
23469204|NCT01229267|65460779|FG000|Overall Study|Progressive disease|0|||
23469205|NCT01229267|65460780|FG001|Overall Study|Progressive disease|0|||
23469206|NCT01229267|65460781|FG002|Overall Study|Progressive disease|0|||
23469207|NCT01229267|65460782|FG003|Overall Study|Progressive disease|0|||
23469208|NCT01229267|65460783|FG004|Overall Study|Progressive disease|1|||
23469209|NCT01229267|65460779|FG000|Overall Study|Physician Decision|8|||
23469210|NCT01229267|65460780|FG001|Overall Study|Physician Decision|11|||
23469211|NCT01229267|65460781|FG002|Overall Study|Physician Decision|8|||
23469212|NCT01229267|65460782|FG003|Overall Study|Physician Decision|3|||
23469213|NCT01229267|65460783|FG004|Overall Study|Physician Decision|25|||
23469214|NCT01229267|65460779|FG000|Overall Study|Lost to Follow-up|6|||
23469215|NCT01229267|65460780|FG001|Overall Study|Lost to Follow-up|5|||
23469216|NCT01229267|65460781|FG002|Overall Study|Lost to Follow-up|8|||
23352955|NCT03092791|65037414|FG003|Overall Study|Lost to Follow-up|0|||
23469217|NCT01229267|65460782|FG003|Overall Study|Lost to Follow-up|3|||
23469218|NCT01229267|65460783|FG004|Overall Study|Lost to Follow-up|22|||
23469219|NCT00329797|65460784|FG000|Overall Study|Protocol Violation|1|||
23469220|NCT00329797|65460785|FG001|Overall Study|Protocol Violation|0|||
23469221|NCT00329797|65460784|FG000|Overall Study|Withdrawal by Subject|6|||
23469222|NCT00329797|65460785|FG001|Overall Study|Withdrawal by Subject|6|||
23469223|NCT01869764|65460786|FG000|Overall Study|Withdrawal by Subject|0|||
23469224|NCT01869764|65460787|FG001|Overall Study|Withdrawal by Subject|2|||
23469225|NCT00845897|65460792|FG000|Overall Study|Lost to Follow-up|1|||
23469226|NCT00845897|65460793|FG001|Overall Study|Lost to Follow-up|1|||
23469227|NCT00845897|65460794|FG002|Overall Study|Lost to Follow-up|0|||
23352956|NCT03092791|65037415|FG004|Overall Study|Lost to Follow-up|0|||
23352957|NCT03092791|65037416|FG005|Overall Study|Lost to Follow-up|0|||
23352958|NCT03092791|65037417|FG006|Overall Study|Lost to Follow-up|1|||
23469228|NCT00845897|65460792|FG000|Overall Study|Withdrawal by Subject|0|||
23469229|NCT00845897|65460793|FG001|Overall Study|Withdrawal by Subject|3|||
23469230|NCT00845897|65460794|FG002|Overall Study|Withdrawal by Subject|2|||
23469231|NCT00845897|65460792|FG000|Overall Study|Ulcer did not heal|1|||
23469232|NCT00845897|65460793|FG001|Overall Study|Ulcer did not heal|0|||
23469233|NCT00845897|65460794|FG002|Overall Study|Ulcer did not heal|1|||
23469234|NCT00845897|65460792|FG000|Overall Study|Too ill to participate|0|||
23469235|NCT00845897|65460793|FG001|Overall Study|Too ill to participate|1|||
23469236|NCT00845897|65460794|FG002|Overall Study|Too ill to participate|0|||
23469237|NCT04270370|65460795|FG000|Overall Study|Lost to Follow-up|1|||
23469238|NCT04270370|65460796|FG001|Overall Study|Lost to Follow-up|0|||
23469239|NCT04270370|65460797|FG002|Overall Study|Lost to Follow-up|0|||
23469240|NCT04270370|65460798|FG003|Overall Study|Lost to Follow-up|0|||
23469241|NCT04270370|65460799|FG004|Overall Study|Lost to Follow-up|0|||
23246834|NCT00299546|64645637|FG002|Overall Study|Adverse Event|27|||
23246835|NCT00299546|64645635|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
23246836|NCT00299546|64645636|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
23246837|NCT00299546|64645637|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
23246838|NCT00299546|64645635|FG000|Overall Study|Other|24|||
23246839|NCT00299546|64645636|FG001|Overall Study|Other|26|||
23246840|NCT00299546|64645637|FG002|Overall Study|Other|19|||
23246841|NCT00299546|64645635|FG000|Overall Study|Not treated|0|||
23246842|NCT00299546|64645636|FG001|Overall Study|Not treated|1|||
23246843|NCT00299546|64645637|FG002|Overall Study|Not treated|1|||
23352959|NCT03092791|65037418|FG007|Overall Study|Lost to Follow-up|0|||
23352960|NCT03092791|65037411|FG000|Overall Study|Withdrawal of Consent|0|||
23352961|NCT03092791|65037412|FG001|Overall Study|Withdrawal of Consent|0|||
23352962|NCT03092791|65037413|FG002|Overall Study|Withdrawal of Consent|0|||
23352963|NCT03092791|65037414|FG003|Overall Study|Withdrawal of Consent|0|||
23352964|NCT03092791|65037415|FG004|Overall Study|Withdrawal of Consent|4|||
23352965|NCT03092791|65037416|FG005|Overall Study|Withdrawal of Consent|12|||
23352966|NCT03092791|65037417|FG006|Overall Study|Withdrawal of Consent|6|||
23352967|NCT03092791|65037418|FG007|Overall Study|Withdrawal of Consent|4|||
23352968|NCT03092791|65037411|FG000|Overall Study|Study Termination|0|||
23352969|NCT03092791|65037412|FG001|Overall Study|Study Termination|0|||
23352970|NCT03092791|65037413|FG002|Overall Study|Study Termination|0|||
23352971|NCT03092791|65037414|FG003|Overall Study|Study Termination|0|||
23352972|NCT03092791|65037415|FG004|Overall Study|Study Termination|55|||
23352973|NCT03092791|65037416|FG005|Overall Study|Study Termination|46|||
23352974|NCT03092791|65037417|FG006|Overall Study|Study Termination|53|||
23352975|NCT03092791|65037418|FG007|Overall Study|Study Termination|55|||
23352976|NCT03092791|65037411|FG000|Overall Study|Death|0|||
23352977|NCT03092791|65037412|FG001|Overall Study|Death|0|||
23352978|NCT03092791|65037413|FG002|Overall Study|Death|0|||
23352979|NCT03092791|65037414|FG003|Overall Study|Death|0|||
23352980|NCT03092791|65037415|FG004|Overall Study|Death|0|||
23352981|NCT03092791|65037416|FG005|Overall Study|Death|1|||
23352982|NCT03092791|65037417|FG006|Overall Study|Death|0|||
23352983|NCT03092791|65037418|FG007|Overall Study|Death|1|||
23352984|NCT03092791|65037411|FG000|Overall Study|Reason Not Specified|0|||
23352985|NCT03092791|65037412|FG001|Overall Study|Reason Not Specified|0|||
23352986|NCT03092791|65037413|FG002|Overall Study|Reason Not Specified|0|||
23352987|NCT03092791|65037414|FG003|Overall Study|Reason Not Specified|0|||
23352988|NCT03092791|65037415|FG004|Overall Study|Reason Not Specified|1|||
23352989|NCT03092791|65037416|FG005|Overall Study|Reason Not Specified|1|||
23352990|NCT03092791|65037417|FG006|Overall Study|Reason Not Specified|0|||
23352991|NCT03092791|65037418|FG007|Overall Study|Reason Not Specified|0|||
23352992|NCT04521114|65037419|FG000|Overall Study|Lost to Follow-up|1|||
23352993|NCT04521114|65037420|FG001|Overall Study|Lost to Follow-up|2|||
23352994|NCT04521114|65037421|FG002|Overall Study|Lost to Follow-up|0|||
23352995|NCT04521114|65037419|FG000|Overall Study|Withdrawal by Subject|1|||
23352996|NCT04521114|65037420|FG001|Overall Study|Withdrawal by Subject|2|||
23352997|NCT04521114|65037421|FG002|Overall Study|Withdrawal by Subject|2|||
23352998|NCT04521114|65037419|FG000|Overall Study|Adverse Event|1|||
23352999|NCT04521114|65037420|FG001|Overall Study|Adverse Event|0|||
23353000|NCT04521114|65037421|FG002|Overall Study|Adverse Event|0|||
23353001|NCT04521114|65037419|FG000|Overall Study|Sponsor Wish|1|||
23353002|NCT04521114|65037420|FG001|Overall Study|Sponsor Wish|0|||
23353003|NCT04521114|65037421|FG002|Overall Study|Sponsor Wish|0|||
23353004|NCT04521114|65037419|FG000|Overall Study|Withdrawal of Consent|2|||
23353005|NCT04521114|65037420|FG001|Overall Study|Withdrawal of Consent|2|||
23353006|NCT04521114|65037421|FG002|Overall Study|Withdrawal of Consent|0|||
23353007|NCT03326518|65037423|FG000|Overall Study|Protocol Violation|1|||
23353008|NCT03326518|65037424|FG001|Overall Study|Protocol Violation|0|||
23353009|NCT03326518|65037425|FG002|Overall Study|Protocol Violation|0|||
23353010|NCT03326518|65037423|FG000|Overall Study|Withdrawal by Subject|1|||
23353011|NCT03326518|65037424|FG001|Overall Study|Withdrawal by Subject|0|||
23353012|NCT03326518|65037425|FG002|Overall Study|Withdrawal by Subject|0|||
23353013|NCT03326518|65037423|FG000|Overall Study|Lost to Follow-up|1|||
23353014|NCT03326518|65037424|FG001|Overall Study|Lost to Follow-up|0|||
23353015|NCT03326518|65037425|FG002|Overall Study|Lost to Follow-up|1|||
23353016|NCT01094782|65037435|FG000|Overall Study|Withdrawal by Subject|5|||
23353017|NCT01094782|65037436|FG001|Overall Study|Withdrawal by Subject|5|||
23353018|NCT01094782|65037437|FG002|Overall Study|Withdrawal by Subject|1|||
23246844|NCT01100073|64645638|FG000|Overall Study|Lack of Efficacy|4|||
23246845|NCT01100073|64645638|FG000|Overall Study|Insufficient Tolerability|21|||
23353019|NCT01094782|65037438|FG003|Overall Study|Withdrawal by Subject|5|||
23353020|NCT01094782|65037439|FG004|Overall Study|Withdrawal by Subject|5|||
23353021|NCT01094782|65037440|FG005|Overall Study|Withdrawal by Subject|0|||
23353022|NCT01094782|65037435|FG000|Overall Study|Lost to Follow-up|1|||
23246846|NCT01100073|64645638|FG000|Overall Study|Withdrawal by Subject|13|||
23246847|NCT01100073|64645638|FG000|Overall Study|Lost to Follow-up|39|||
23353023|NCT01094782|65037436|FG001|Overall Study|Lost to Follow-up|0|||
23246848|NCT01100073|64645638|FG000|Overall Study|Lack of effect + patient's wish|2|||
23246849|NCT01100073|64645638|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
23246850|NCT01100073|64645638|FG000|Overall Study|Other|8|||
23246851|NCT01100073|64645638|FG000|Overall Study|Missing|5|||
23246852|NCT05037409|64645639|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
23246853|NCT05037409|64645640|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
23246854|NCT05037409|64645641|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
23246855|NCT02628418|64645642|FG000|Overall Study|Lost to Follow-up|1|||
23469242|NCT04270370|65460800|FG005|Overall Study|Lost to Follow-up|0|||
23469243|NCT04270370|65460801|FG006|Overall Study|Lost to Follow-up|0|||
23469244|NCT04270370|65460802|FG007|Overall Study|Lost to Follow-up|0|||
23469245|NCT04270370|65460803|FG008|Overall Study|Lost to Follow-up|1|||
23469246|NCT04270370|65460804|FG009|Overall Study|Lost to Follow-up|0|||
23469247|NCT04270370|65460805|FG010|Overall Study|Lost to Follow-up|0|||
23469248|NCT04270370|65460806|FG011|Overall Study|Lost to Follow-up|0|||
23469249|NCT04343235|65460808|FG000|Overall Study|Lost to Follow-up|3|||
23469250|NCT04343235|65460809|FG001|Overall Study|Lost to Follow-up|2|||
23469251|NCT00796419|65460810|FG000|Overall Study|Death|0|||
23469252|NCT00796419|65460811|FG001|Overall Study|Death|1|||
23469253|NCT03224819|65460813|FG000|Overall Study|Withdrawal by Subject|0|||
23469254|NCT03224819|65460814|FG001|Overall Study|Withdrawal by Subject|0|||
23469255|NCT03224819|65460815|FG002|Overall Study|Withdrawal by Subject|0|||
23469256|NCT03224819|65460816|FG003|Overall Study|Withdrawal by Subject|0|||
23469257|NCT03224819|65460817|FG004|Overall Study|Withdrawal by Subject|0|||
23469258|NCT03224819|65460818|FG005|Overall Study|Withdrawal by Subject|0|||
23469259|NCT03224819|65460819|FG006|Overall Study|Withdrawal by Subject|0|||
23469260|NCT03224819|65460820|FG007|Overall Study|Withdrawal by Subject|0|||
23469261|NCT03224819|65460821|FG008|Overall Study|Withdrawal by Subject|0|||
23469262|NCT03224819|65460822|FG009|Overall Study|Withdrawal by Subject|0|||
23469263|NCT03224819|65460823|FG010|Overall Study|Withdrawal by Subject|0|||
23469264|NCT03224819|65460824|FG011|Overall Study|Withdrawal by Subject|0|||
23469265|NCT03224819|65460825|FG012|Overall Study|Withdrawal by Subject|1|||
23469266|NCT03224819|65460826|FG013|Overall Study|Withdrawal by Subject|0|||
23469267|NCT03224819|65460813|FG000|Overall Study|Sponsor Decision|0|||
23469268|NCT03224819|65460814|FG001|Overall Study|Sponsor Decision|0|||
23469269|NCT03224819|65460815|FG002|Overall Study|Sponsor Decision|0|||
23469270|NCT03224819|65460816|FG003|Overall Study|Sponsor Decision|1|||
23469271|NCT03224819|65460817|FG004|Overall Study|Sponsor Decision|1|||
23469272|NCT03224819|65460818|FG005|Overall Study|Sponsor Decision|2|||
23469273|NCT03224819|65460819|FG006|Overall Study|Sponsor Decision|1|||
23469274|NCT03224819|65460820|FG007|Overall Study|Sponsor Decision|1|||
23469275|NCT03224819|65460821|FG008|Overall Study|Sponsor Decision|1|||
23469276|NCT03224819|65460822|FG009|Overall Study|Sponsor Decision|2|||
23469277|NCT03224819|65460823|FG010|Overall Study|Sponsor Decision|1|||
23469278|NCT03224819|65460824|FG011|Overall Study|Sponsor Decision|1|||
23469279|NCT03224819|65460825|FG012|Overall Study|Sponsor Decision|1|||
23469280|NCT03224819|65460826|FG013|Overall Study|Sponsor Decision|0|||
23469281|NCT03224819|65460813|FG000|Overall Study|Lost to Follow-up|0|||
23469282|NCT03224819|65460814|FG001|Overall Study|Lost to Follow-up|0|||
23469283|NCT03224819|65460815|FG002|Overall Study|Lost to Follow-up|0|||
23469284|NCT03224819|65460816|FG003|Overall Study|Lost to Follow-up|0|||
23469285|NCT03224819|65460817|FG004|Overall Study|Lost to Follow-up|0|||
23469286|NCT03224819|65460818|FG005|Overall Study|Lost to Follow-up|0|||
23469287|NCT03224819|65460819|FG006|Overall Study|Lost to Follow-up|0|||
23469288|NCT03224819|65460820|FG007|Overall Study|Lost to Follow-up|0|||
23469289|NCT03224819|65460821|FG008|Overall Study|Lost to Follow-up|1|||
23469290|NCT03224819|65460822|FG009|Overall Study|Lost to Follow-up|0|||
23469291|NCT03224819|65460823|FG010|Overall Study|Lost to Follow-up|0|||
23469292|NCT03224819|65460824|FG011|Overall Study|Lost to Follow-up|0|||
23469293|NCT03224819|65460825|FG012|Overall Study|Lost to Follow-up|0|||
23469294|NCT03224819|65460826|FG013|Overall Study|Lost to Follow-up|0|||
23469295|NCT03224819|65460813|FG000|Overall Study|Death|0|||
23469296|NCT03224819|65460814|FG001|Overall Study|Death|1|||
23469297|NCT03224819|65460815|FG002|Overall Study|Death|0|||
23469298|NCT03224819|65460816|FG003|Overall Study|Death|0|||
23246856|NCT02628418|64645643|FG001|Overall Study|Lost to Follow-up|2|||
23469299|NCT03224819|65460817|FG004|Overall Study|Death|0|||
23469300|NCT03224819|65460818|FG005|Overall Study|Death|0|||
23469301|NCT03224819|65460819|FG006|Overall Study|Death|0|||
23246857|NCT00391118|64645644|FG000|Overall Study|Adverse Event|3|||
23469302|NCT03224819|65460820|FG007|Overall Study|Death|1|||
23469303|NCT03224819|65460821|FG008|Overall Study|Death|0|||
23469304|NCT03224819|65460822|FG009|Overall Study|Death|0|||
23469305|NCT03224819|65460823|FG010|Overall Study|Death|0|||
23469306|NCT03224819|65460824|FG011|Overall Study|Death|1|||
23469307|NCT03224819|65460825|FG012|Overall Study|Death|0|||
23469308|NCT03224819|65460826|FG013|Overall Study|Death|0|||
23469309|NCT01467960|65460835|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
23469310|NCT01467960|65460836|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
23246858|NCT00391118|64645645|FG001|Overall Study|Adverse Event|10|||
23246859|NCT00391118|64645646|FG002|Overall Study|Adverse Event|7|||
23246860|NCT00391118|64645644|FG000|Overall Study|Lost to Follow-up|0|||
23246861|NCT00391118|64645645|FG001|Overall Study|Lost to Follow-up|2|||
23246862|NCT00391118|64645646|FG002|Overall Study|Lost to Follow-up|3|||
23246863|NCT00391118|64645644|FG000|Overall Study|Withdrawal by Subject|0|||
23246864|NCT00391118|64645645|FG001|Overall Study|Withdrawal by Subject|9|||
23246865|NCT00391118|64645646|FG002|Overall Study|Withdrawal by Subject|1|||
23246866|NCT00391118|64645644|FG000|Overall Study|Death|0|||
23246867|NCT00391118|64645645|FG001|Overall Study|Death|1|||
23246868|NCT00391118|64645646|FG002|Overall Study|Death|0|||
23246869|NCT00391118|64645644|FG000|Overall Study|Physician Decision|0|||
23246870|NCT00391118|64645645|FG001|Overall Study|Physician Decision|3|||
23246871|NCT00391118|64645646|FG002|Overall Study|Physician Decision|0|||
23246872|NCT00391118|64645644|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
23246873|NCT00391118|64645645|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
23246874|NCT00391118|64645646|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
23246875|NCT00391118|64645644|FG000|Overall Study|Progressive Disease|7|||
23246876|NCT00391118|64645645|FG001|Overall Study|Progressive Disease|26|||
23246877|NCT00391118|64645646|FG002|Overall Study|Progressive Disease|43|||
23353024|NCT01094782|65037437|FG002|Overall Study|Lost to Follow-up|0|||
23353025|NCT01094782|65037438|FG003|Overall Study|Lost to Follow-up|2|||
23353026|NCT01094782|65037439|FG004|Overall Study|Lost to Follow-up|1|||
23353027|NCT01094782|65037440|FG005|Overall Study|Lost to Follow-up|4|||
23353028|NCT01094782|65037435|FG000|Overall Study|Positive Drug Screen|2|||
23353029|NCT01094782|65037436|FG001|Overall Study|Positive Drug Screen|2|||
23353030|NCT01094782|65037437|FG002|Overall Study|Positive Drug Screen|1|||
23353031|NCT01094782|65037438|FG003|Overall Study|Positive Drug Screen|1|||
23353032|NCT01094782|65037439|FG004|Overall Study|Positive Drug Screen|3|||
23353033|NCT01094782|65037440|FG005|Overall Study|Positive Drug Screen|2|||
23353034|NCT01094782|65037435|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
23353035|NCT01094782|65037436|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
23353036|NCT01094782|65037437|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
23353037|NCT01094782|65037438|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
23353038|NCT01094782|65037439|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
23353039|NCT01094782|65037440|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
23353040|NCT01094782|65037435|FG000|Overall Study|Unable to Complete Questionnaires|0|||
23353041|NCT01094782|65037436|FG001|Overall Study|Unable to Complete Questionnaires|1|||
23353042|NCT01094782|65037437|FG002|Overall Study|Unable to Complete Questionnaires|0|||
23353043|NCT01094782|65037438|FG003|Overall Study|Unable to Complete Questionnaires|0|||
23353044|NCT01094782|65037439|FG004|Overall Study|Unable to Complete Questionnaires|0|||
23353045|NCT01094782|65037440|FG005|Overall Study|Unable to Complete Questionnaires|0|||
23353046|NCT01094782|65037435|FG000|Overall Study|Healthy Subject Had Pain|0|||
23353047|NCT01094782|65037436|FG001|Overall Study|Healthy Subject Had Pain|1|||
23353048|NCT01094782|65037437|FG002|Overall Study|Healthy Subject Had Pain|0|||
23353049|NCT01094782|65037438|FG003|Overall Study|Healthy Subject Had Pain|0|||
23353050|NCT01094782|65037439|FG004|Overall Study|Healthy Subject Had Pain|0|||
23353051|NCT01094782|65037440|FG005|Overall Study|Healthy Subject Had Pain|0|||
23353052|NCT01094782|65037435|FG000|Overall Study|Hypertension|0|||
23353053|NCT01094782|65037436|FG001|Overall Study|Hypertension|0|||
23353054|NCT01094782|65037437|FG002|Overall Study|Hypertension|1|||
23353055|NCT01094782|65037438|FG003|Overall Study|Hypertension|0|||
23353056|NCT01094782|65037439|FG004|Overall Study|Hypertension|0|||
23353057|NCT01094782|65037440|FG005|Overall Study|Hypertension|0|||
23353058|NCT01094782|65037435|FG000|Overall Study|Wrong Pain Condition|0|||
23353059|NCT01094782|65037436|FG001|Overall Study|Wrong Pain Condition|0|||
23353060|NCT01094782|65037437|FG002|Overall Study|Wrong Pain Condition|0|||
23353061|NCT01094782|65037438|FG003|Overall Study|Wrong Pain Condition|2|||
23353062|NCT01094782|65037439|FG004|Overall Study|Wrong Pain Condition|1|||
23353063|NCT01094782|65037440|FG005|Overall Study|Wrong Pain Condition|1|||
23353064|NCT01094782|65037435|FG000|Overall Study|Recent Interventional Injection|0|||
23353065|NCT01094782|65037436|FG001|Overall Study|Recent Interventional Injection|0|||
23353066|NCT01094782|65037437|FG002|Overall Study|Recent Interventional Injection|0|||
23353067|NCT01094782|65037438|FG003|Overall Study|Recent Interventional Injection|0|||
23353068|NCT01094782|65037439|FG004|Overall Study|Recent Interventional Injection|0|||
23353069|NCT01094782|65037440|FG005|Overall Study|Recent Interventional Injection|1|||
23353070|NCT01094782|65037435|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23246878|NCT00391118|64645644|FG000|Overall Study|Sponsor Decision|0|||
23246879|NCT00391118|64645645|FG001|Overall Study|Sponsor Decision|1|||
23353071|NCT01094782|65037436|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23353072|NCT01094782|65037437|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23246880|NCT00391118|64645646|FG002|Overall Study|Sponsor Decision|3|||
23246881|NCT00391118|64645644|FG000|Overall Study|Protocol Violation|1|||
23353073|NCT01094782|65037438|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23246882|NCT00391118|64645645|FG001|Overall Study|Protocol Violation|0|||
23246883|NCT00391118|64645646|FG002|Overall Study|Protocol Violation|0|||
23246884|NCT01473589|64645647|FG000|Overall Study|Adverse Event|1|||
23246885|NCT01473589|64645648|FG001|Overall Study|Adverse Event|1|||
23246886|NCT01473589|64645647|FG000|Overall Study|Death|2|||
23246887|NCT01473589|64645648|FG001|Overall Study|Death|0|||
23246888|NCT01473589|64645647|FG000|Overall Study|Lost to Follow-up|2|||
23246889|NCT01473589|64645648|FG001|Overall Study|Lost to Follow-up|2|||
23246890|NCT01473589|64645647|FG000|Overall Study|Protocol Violation|1|||
23246891|NCT01473589|64645648|FG001|Overall Study|Protocol Violation|0|||
23246892|NCT01473589|64645647|FG000|Overall Study|Withdrawal by Subject|5|||
23246893|NCT01473589|64645648|FG001|Overall Study|Withdrawal by Subject|11|||
23246894|NCT01473589|64645647|FG000|Overall Study|Physician Decision|0|||
23246895|NCT01473589|64645648|FG001|Overall Study|Physician Decision|1|||
23246896|NCT01473589|64645647|FG000|Overall Study|Entry criteria not met|0|||
23246897|NCT01473589|64645648|FG001|Overall Study|Entry criteria not met|1|||
23246898|NCT00769132|64645650|FG000|Period 1|Adverse Event|1|||
23246899|NCT00769132|64645651|FG001|Period 1|Adverse Event|0|||
23246900|NCT00769132|64645652|FG002|Period 1|Adverse Event|0|||
23246901|NCT00769132|64645653|FG003|Period 1|Adverse Event|1|||
23246902|NCT00769132|64645650|FG000|Period 2|Withdrawal by Subject|0|||
23246903|NCT00769132|64645651|FG001|Period 2|Withdrawal by Subject|0|||
23246904|NCT00769132|64645652|FG002|Period 2|Withdrawal by Subject|0|||
23246905|NCT00769132|64645653|FG003|Period 2|Withdrawal by Subject|1|||
23246906|NCT00769132|64645650|FG000|Period 3|Withdrawal by Subject|1|||
23246907|NCT00769132|64645651|FG001|Period 3|Withdrawal by Subject|0|||
23246908|NCT00769132|64645652|FG002|Period 3|Withdrawal by Subject|0|||
23246909|NCT00769132|64645653|FG003|Period 3|Withdrawal by Subject|0|||
23246910|NCT00769132|64645650|FG000|Period 4|Withdrawal by Subject|0|||
23246911|NCT00769132|64645651|FG001|Period 4|Withdrawal by Subject|1|||
23246912|NCT00769132|64645652|FG002|Period 4|Withdrawal by Subject|0|||
23246913|NCT00769132|64645653|FG003|Period 4|Withdrawal by Subject|0|||
23246914|NCT02815540|64645658|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
23246915|NCT04362761|64645659|FG000|Part A (48 Weeks)|Adverse Event|2|||
23246916|NCT04362761|64645659|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
23246917|NCT04362761|64645659|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
23246918|NCT04362761|64645659|FG000|Part A (48 Weeks)|Other|5|||
23246919|NCT04362761|64645659|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
23246920|NCT04362761|64645659|FG000|Part B (86 Weeks)|Other|4|||
23246921|NCT01211613|64645660|FG000|Overall Study|Lost to Follow-up|2|||
23246922|NCT01211613|64645661|FG001|Overall Study|Lost to Follow-up|2|||
23246923|NCT01211613|64645662|FG002|Overall Study|Lost to Follow-up|2|||
23246924|NCT01211613|64645660|FG000|Overall Study|Withdrawal by Subject|1|||
23246925|NCT01211613|64645661|FG001|Overall Study|Withdrawal by Subject|0|||
23246926|NCT01211613|64645662|FG002|Overall Study|Withdrawal by Subject|0|||
23246927|NCT03224234|64645665|FG000|Main Study|Lost to Follow-up|5|||
23246928|NCT03224234|64645666|FG001|Main Study|Lost to Follow-up|5|||
23246929|NCT04682639|64645667|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
23246930|NCT04682639|64645668|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
23246931|NCT04682639|64645669|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
23246932|NCT04682639|64645670|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
23246933|NCT04682639|64645671|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
23246934|NCT04682639|64645667|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
23246935|NCT04682639|64645668|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
23246936|NCT04682639|64645669|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
23246937|NCT04682639|64645670|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23246938|NCT04682639|64645671|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23246939|NCT04682639|64645667|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
23246940|NCT04682639|64645668|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23246941|NCT04682639|64645669|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23246942|NCT04682639|64645670|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23246943|NCT04682639|64645671|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23246944|NCT04682639|64645667|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
23246945|NCT04682639|64645668|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
23246946|NCT04682639|64645669|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
23246947|NCT04682639|64645670|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
23246948|NCT04682639|64645671|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
23246949|NCT04682639|64645667|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
23246950|NCT04682639|64645668|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
23246951|NCT04682639|64645669|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
23246952|NCT04682639|64645670|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
23246953|NCT04682639|64645671|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
23246954|NCT04682639|64645667|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
23246955|NCT04682639|64645668|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
23246956|NCT04682639|64645669|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
23246957|NCT04682639|64645670|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23246958|NCT04682639|64645671|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23246959|NCT04682639|64645667|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
23246960|NCT04682639|64645668|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
23246961|NCT04682639|64645669|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
23246962|NCT04682639|64645670|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
23246963|NCT04682639|64645671|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
23246964|NCT04682639|64645667|FG000|OLE Period (28 Weeks)|Other|1|||
23246965|NCT04682639|64645668|FG001|OLE Period (28 Weeks)|Other|2|||
23246966|NCT04682639|64645669|FG002|OLE Period (28 Weeks)|Other|0|||
23246967|NCT04682639|64645670|FG003|OLE Period (28 Weeks)|Other|0|||
23246968|NCT04682639|64645671|FG004|OLE Period (28 Weeks)|Other|1|||
23246969|NCT04682639|64645667|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
23246970|NCT04682639|64645668|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
23246971|NCT04682639|64645669|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
23246972|NCT04682639|64645670|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
23246973|NCT04682639|64645671|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
23246974|NCT04682639|64645667|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
23246975|NCT04682639|64645668|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
23246976|NCT04682639|64645669|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23246977|NCT04682639|64645670|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23246978|NCT04682639|64645671|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23246979|NCT04682639|64645667|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
23246980|NCT04682639|64645668|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
23246981|NCT04682639|64645669|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23246982|NCT04682639|64645670|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23246983|NCT04682639|64645671|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23246984|NCT04682639|64645667|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
23246985|NCT04682639|64645668|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
23246986|NCT04682639|64645669|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
23246987|NCT04682639|64645670|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
23246988|NCT04682639|64645671|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
23246989|NCT02362646|64645672|FG000|Overall Study|Death|15|||
23246990|NCT02362646|64645673|FG001|Overall Study|Death|8|||
23246991|NCT02362646|64645672|FG000|Overall Study|Withdrawal by Subject|2|||
23246992|NCT02362646|64645673|FG001|Overall Study|Withdrawal by Subject|2|||
23353074|NCT01094782|65037439|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
23246993|NCT02362646|64645672|FG000|Overall Study|received transplant|21|||
23246994|NCT02362646|64645673|FG001|Overall Study|received transplant|14|||
23246995|NCT03972709|64645674|FG000|Overall Study|Withdrawal by Subject|18|||
23246996|NCT03972709|64645675|FG001|Overall Study|Withdrawal by Subject|7|||
23246997|NCT03972709|64645676|FG002|Overall Study|Withdrawal by Subject|14|||
23246998|NCT03972709|64645674|FG000|Overall Study|Study Terminated by Sponsor|48|||
23246999|NCT03972709|64645675|FG001|Overall Study|Study Terminated by Sponsor|25|||
23247000|NCT03972709|64645676|FG002|Overall Study|Study Terminated by Sponsor|50|||
23247001|NCT03972709|64645674|FG000|Overall Study|Physician Decision|1|||
23247002|NCT03972709|64645675|FG001|Overall Study|Physician Decision|0|||
23353075|NCT01094782|65037440|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
23353076|NCT01094782|65037435|FG000|Overall Study|Noncompliance With Study Schedule|0|||
23353077|NCT01094782|65037436|FG001|Overall Study|Noncompliance With Study Schedule|0|||
23353078|NCT01094782|65037437|FG002|Overall Study|Noncompliance With Study Schedule|0|||
23353079|NCT01094782|65037438|FG003|Overall Study|Noncompliance With Study Schedule|1|||
23353080|NCT01094782|65037439|FG004|Overall Study|Noncompliance With Study Schedule|0|||
23353081|NCT01094782|65037440|FG005|Overall Study|Noncompliance With Study Schedule|0|||
23587228|NCT01193153|65876273|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
23587229|NCT00930813|65876274|FG000|Overall Study|Death|4|||
23247003|NCT03972709|64645676|FG002|Overall Study|Physician Decision|0|||
23247004|NCT03972709|64645674|FG000|Overall Study|COVID-19|0|||
23247005|NCT03972709|64645675|FG001|Overall Study|COVID-19|1|||
23247006|NCT03972709|64645676|FG002|Overall Study|COVID-19|1|||
23247007|NCT03972709|64645674|FG000|Overall Study|Lost to Follow-up|6|||
23247008|NCT03972709|64645675|FG001|Overall Study|Lost to Follow-up|1|||
23353082|NCT03913104|65037441|FG000|Overall Study|Lost to Follow-up|20|||
23353083|NCT03913104|65037441|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
23587230|NCT00930813|65876275|FG001|Overall Study|Death|5|||
23247009|NCT03972709|64645676|FG002|Overall Study|Lost to Follow-up|2|||
23247010|NCT03972709|64645674|FG000|Overall Study|Death|5|||
23587231|NCT00930813|65876274|FG000|Overall Study|Withdrawal by Subject|2|||
23247011|NCT03972709|64645675|FG001|Overall Study|Death|1|||
23247012|NCT03972709|64645676|FG002|Overall Study|Death|4|||
23247013|NCT03972709|64645674|FG000|Overall Study|Adverse Event|3|||
23247014|NCT03972709|64645675|FG001|Overall Study|Adverse Event|1|||
23247015|NCT03972709|64645676|FG002|Overall Study|Adverse Event|4|||
23247016|NCT03972709|64645674|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
23247017|NCT03972709|64645675|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
23353084|NCT03913104|65037441|FG000|Overall Study|Withdrawal by Subject|2|||
23353085|NCT00513357|65037442|FG000|Overall Study|did not receive allocated placebo|2|||
23353086|NCT00513357|65037443|FG001|Overall Study|did not receive allocated placebo|3|||
23353087|NCT00513357|65037442|FG000|Overall Study|Adverse Event|4|||
23247018|NCT03972709|64645676|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
23247019|NCT03972709|64645674|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
23247020|NCT03972709|64645675|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
23247021|NCT03972709|64645676|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
23247022|NCT03972709|64645674|FG000|Overall Study|Subject Unable to be Contacted|0|||
23247023|NCT03972709|64645675|FG001|Overall Study|Subject Unable to be Contacted|1|||
23247024|NCT03972709|64645676|FG002|Overall Study|Subject Unable to be Contacted|0|||
23247025|NCT03972709|64645674|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
23247026|NCT03972709|64645675|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
23247027|NCT03972709|64645676|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
23247028|NCT03972709|64645674|FG000|Overall Study|Subject Moved|0|||
23247029|NCT03972709|64645675|FG001|Overall Study|Subject Moved|1|||
23247030|NCT03972709|64645676|FG002|Overall Study|Subject Moved|0|||
23247031|NCT03972709|64645674|FG000|Overall Study|Missed Study Visits|1|||
23247032|NCT03972709|64645675|FG001|Overall Study|Missed Study Visits|0|||
23247033|NCT03972709|64645676|FG002|Overall Study|Missed Study Visits|0|||
23247034|NCT01856257|64645682|FG000|Overall Study|Death|2|||
23247035|NCT01856257|64645683|FG001|Overall Study|Death|0|||
23247036|NCT01856257|64645684|FG002|Overall Study|Death|0|||
23247037|NCT01856257|64645685|FG003|Overall Study|Death|0|||
23247038|NCT01856257|64645682|FG000|Overall Study|Physician Decision|0|||
23247039|NCT01856257|64645683|FG001|Overall Study|Physician Decision|0|||
23247040|NCT01856257|64645684|FG002|Overall Study|Physician Decision|0|||
23247041|NCT01856257|64645685|FG003|Overall Study|Physician Decision|1|||
23247042|NCT01856257|64645682|FG000|Overall Study|Withdrawal by Subject|1|||
23247043|NCT01856257|64645683|FG001|Overall Study|Withdrawal by Subject|1|||
23247044|NCT01856257|64645684|FG002|Overall Study|Withdrawal by Subject|0|||
23247045|NCT01856257|64645685|FG003|Overall Study|Withdrawal by Subject|0|||
23247046|NCT01856257|64645682|FG000|Overall Study|Donor complication|0|||
23247047|NCT01856257|64645683|FG001|Overall Study|Donor complication|0|||
23247048|NCT01856257|64645684|FG002|Overall Study|Donor complication|0|||
23247049|NCT01856257|64645685|FG003|Overall Study|Donor complication|1|||
23247050|NCT02998645|64645688|FG000|Treatment Period 1|Adverse Event|6|||
23247051|NCT02998645|64645688|FG000|Treatment Period 1|Death|5|||
23247052|NCT02998645|64645688|FG000|Treatment Period 1|Technical Problems|4|||
23247053|NCT02998645|64645688|FG000|Treatment Period 1|Lack of Efficacy|2|||
23247054|NCT02998645|64645688|FG000|Treatment Period 1|Progressive disease|1|||
23247055|NCT02998645|64645688|FG000|Treatment Period 1|Subject/guardian decision|1|||
23247056|NCT02998645|64645688|FG000|Treatment Period 2|Lack of Efficacy|5|||
23247057|NCT02998645|64645688|FG000|Treatment Period 2|Adverse Event|2|||
23247058|NCT02998645|64645688|FG000|Treatment Period 2|Progressive disease|2|||
23247059|NCT02998645|64645688|FG000|Treatment Period 2|Physician Decision|1|||
23247060|NCT00605839|64645689|FG000|Overall Study|Protocol Violation|1|||
23247061|NCT00605839|64645690|FG001|Overall Study|Protocol Violation|0|||
23247062|NCT00605839|64645691|FG002|Overall Study|Protocol Violation|0|||
23247063|NCT02780115|64645692|FG000|Overall Study|Withdrawal by Subject|0|||
23247064|NCT02780115|64645693|FG001|Overall Study|Withdrawal by Subject|1|||
23247065|NCT02780115|64645694|FG002|Overall Study|Withdrawal by Subject|1|||
23247066|NCT02780115|64645695|FG003|Overall Study|Withdrawal by Subject|0|||
23247067|NCT02780115|64645696|FG004|Overall Study|Withdrawal by Subject|0|||
23247068|NCT02780115|64645692|FG000|Overall Study|Adverse Event|0|||
23247069|NCT02780115|64645693|FG001|Overall Study|Adverse Event|0|||
23247070|NCT02780115|64645694|FG002|Overall Study|Adverse Event|0|||
23247071|NCT02780115|64645695|FG003|Overall Study|Adverse Event|1|||
23247072|NCT02780115|64645696|FG004|Overall Study|Adverse Event|1|||
23247073|NCT01500434|64645706|FG000|Overall Study|Death|1|||
23247074|NCT01500434|64645706|FG000|Overall Study|Withdrawal by Subject|1|||
23247075|NCT01500434|64645706|FG000|Overall Study|Missed 12-month follow-up|5|||
23247076|NCT04057118|64645707|FG000|Overall Study|Adverse Event|1|||
23353088|NCT00513357|65037443|FG001|Overall Study|Adverse Event|2|||
23469311|NCT01467960|65460837|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
23247077|NCT04057118|64645708|FG001|Overall Study|Adverse Event|0|||
23247078|NCT04057118|64645709|FG002|Overall Study|Adverse Event|1|||
23247079|NCT04057118|64645710|FG003|Overall Study|Adverse Event|1|||
23247080|NCT04057118|64645707|FG000|Overall Study|Physician Decision|0|||
23247081|NCT04057118|64645708|FG001|Overall Study|Physician Decision|0|||
23469312|NCT01467960|65460838|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
23247082|NCT04057118|64645709|FG002|Overall Study|Physician Decision|1|||
23247083|NCT04057118|64645710|FG003|Overall Study|Physician Decision|1|||
23247084|NCT04057118|64645707|FG000|Overall Study|Withdrawal by Subject|2|||
23247085|NCT04057118|64645708|FG001|Overall Study|Withdrawal by Subject|2|||
23247086|NCT04057118|64645709|FG002|Overall Study|Withdrawal by Subject|0|||
23247087|NCT04057118|64645710|FG003|Overall Study|Withdrawal by Subject|2|||
23247088|NCT04057118|64645707|FG000|Overall Study|Not Specific|0|||
23247089|NCT04057118|64645708|FG001|Overall Study|Not Specific|0|||
23247090|NCT04057118|64645709|FG002|Overall Study|Not Specific|1|||
23247091|NCT04057118|64645710|FG003|Overall Study|Not Specific|1|||
23247092|NCT00491322|64645711|FG000|Overall Study|Protocol Violation|1|||
23247093|NCT00491322|64645712|FG001|Overall Study|Protocol Violation|0|||
23247094|NCT00491322|64645711|FG000|Overall Study|Pregnancy|0|||
23247095|NCT00491322|64645712|FG001|Overall Study|Pregnancy|1|||
23247096|NCT01615822|64645713|FG000|Period 1|Withdrawal by Subject|0|||
23247097|NCT01615822|64645714|FG001|Period 1|Withdrawal by Subject|1|||
23247098|NCT01615822|64645715|FG002|Period 1|Withdrawal by Subject|0|||
23247099|NCT01615822|64645713|FG000|Period 1|Adverse Event|1|||
23247100|NCT01615822|64645714|FG001|Period 1|Adverse Event|1|||
23247101|NCT01615822|64645715|FG002|Period 1|Adverse Event|0|||
23247102|NCT01615822|64645713|FG000|Period 2|Lost to Follow-up|0|||
23247103|NCT01615822|64645714|FG001|Period 2|Lost to Follow-up|1|||
23247104|NCT01615822|64645715|FG002|Period 2|Lost to Follow-up|2|||
23247105|NCT03099161|64645730|FG000|Overall Study|Adverse Event|0|||
23353089|NCT00513357|65037442|FG000|Overall Study|Death|2|||
23353090|NCT00513357|65037443|FG001|Overall Study|Death|0|||
23353091|NCT00513357|65037442|FG000|Overall Study|Withdrawal by Subject|5|||
23353092|NCT00513357|65037443|FG001|Overall Study|Withdrawal by Subject|4|||
23353093|NCT00513357|65037442|FG000|Overall Study|Disease Progression|2|||
23353094|NCT00513357|65037443|FG001|Overall Study|Disease Progression|1|||
23247106|NCT03099161|64645731|FG001|Overall Study|Adverse Event|0|||
23247107|NCT03099161|64645732|FG002|Overall Study|Adverse Event|2|||
23247108|NCT03099161|64645730|FG000|Overall Study|Physician Decision|2|||
23247109|NCT03099161|64645731|FG001|Overall Study|Physician Decision|0|||
23247110|NCT03099161|64645732|FG002|Overall Study|Physician Decision|0|||
23247111|NCT03099161|64645730|FG000|Overall Study|Progressive Disease|1|||
23247112|NCT03099161|64645731|FG001|Overall Study|Progressive Disease|4|||
23247113|NCT03099161|64645732|FG002|Overall Study|Progressive Disease|1|||
23247114|NCT03022799|64645741|FG000|Overall Study|Adverse Event|0|||
23247115|NCT03022799|64645742|FG001|Overall Study|Adverse Event|0|||
23247116|NCT03022799|64645743|FG002|Overall Study|Adverse Event|0|||
23247117|NCT03022799|64645744|FG003|Overall Study|Adverse Event|0|||
23247118|NCT03022799|64645745|FG004|Overall Study|Adverse Event|0|||
23247119|NCT03022799|64645746|FG005|Overall Study|Adverse Event|0|||
23247120|NCT03022799|64645747|FG006|Overall Study|Adverse Event|0|||
23247121|NCT03022799|64645748|FG007|Overall Study|Adverse Event|0|||
23247122|NCT03022799|64645749|FG008|Overall Study|Adverse Event|0|||
23247123|NCT03022799|64645750|FG009|Overall Study|Adverse Event|1|||
23247124|NCT03022799|64645751|FG010|Overall Study|Adverse Event|1|||
23247125|NCT03022799|64645752|FG011|Overall Study|Adverse Event|0|||
23247126|NCT03022799|64645753|FG012|Overall Study|Adverse Event|0|||
23469313|NCT01467960|65460839|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
23247127|NCT03751124|64645754|FG000|Overall Study|Adverse Event|4|||
23247128|NCT03751124|64645755|FG001|Overall Study|Adverse Event|3|||
23353095|NCT02864316|65037444|FG000|Overall Study|Progressive Disease|2|||
23353096|NCT02864316|65037445|FG001|Overall Study|Progressive Disease|1|||
23353097|NCT02864316|65037444|FG000|Overall Study|Adverse Event|0|||
23353098|NCT02864316|65037445|FG001|Overall Study|Adverse Event|1|||
23353099|NCT03810235|65037462|FG000|Overall Study|Withdrawal by Subject|2|||
23353100|NCT03810235|65037463|FG001|Overall Study|Withdrawal by Subject|0|||
23353101|NCT02510820|65037464|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23353102|NCT02510820|65037465|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23353103|NCT02510820|65037464|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23353104|NCT02510820|65037465|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23353105|NCT01832818|65037467|FG000|Overall Study|Lost to Follow-up|6|||
23353106|NCT02417961|65037468|FG000|Overall Study|Adverse Event|1|||
23353107|NCT02417961|65037468|FG000|Overall Study|Lost to Follow-up|1|||
23247129|NCT03751124|64645754|FG000|Overall Study|Protocol Deviation|0|||
23247130|NCT03751124|64645755|FG001|Overall Study|Protocol Deviation|1|||
23247131|NCT03751124|64645754|FG000|Overall Study|Lost to Follow-up|6|||
23247132|NCT03751124|64645755|FG001|Overall Study|Lost to Follow-up|4|||
23247133|NCT03751124|64645754|FG000|Overall Study|Withdrawal by Subject|6|||
23247134|NCT03751124|64645755|FG001|Overall Study|Withdrawal by Subject|8|||
23247135|NCT03751124|64645754|FG000|Overall Study|Lack of Efficacy|1|||
23353108|NCT02417961|65037468|FG000|Overall Study|Withdrawal by Subject|2|||
23353109|NCT01108237|65037469|FG000|Overall Study|No alignment data|2|||
23353110|NCT01108237|65037470|FG001|Overall Study|No alignment data|15|||
23247136|NCT03751124|64645755|FG001|Overall Study|Lack of Efficacy|1|||
23247137|NCT03751124|64645754|FG000|Overall Study|Pregnancy|0|||
23247138|NCT03751124|64645755|FG001|Overall Study|Pregnancy|1|||
23247139|NCT03751124|64645754|FG000|Overall Study|Other|9|||
23247140|NCT03751124|64645755|FG001|Overall Study|Other|9|||
23247141|NCT03751124|64645754|FG000|Overall Study|Participants who did not receive any study drug|0|||
23247142|NCT03751124|64645755|FG001|Overall Study|Participants who did not receive any study drug|1|||
23247143|NCT00903409|64645756|FG000|Overall Study|Adverse Event|11|||
23247144|NCT00903409|64645757|FG001|Overall Study|Adverse Event|9|||
23247145|NCT00903409|64645756|FG000|Overall Study|Non-compliance with Protocol|1|||
23247146|NCT00903409|64645757|FG001|Overall Study|Non-compliance with Protocol|1|||
23247147|NCT00903409|64645756|FG000|Overall Study|Laboratory Abnormality|2|||
23247148|NCT00903409|64645757|FG001|Overall Study|Laboratory Abnormality|0|||
23247149|NCT00903409|64645756|FG000|Overall Study|Withdrawal by Subject|8|||
23247150|NCT00903409|64645757|FG001|Overall Study|Withdrawal by Subject|8|||
23247151|NCT00903409|64645756|FG000|Overall Study|Other|2|||
23247152|NCT00903409|64645757|FG001|Overall Study|Other|3|||
23247153|NCT00903409|64645756|FG000|Overall Study|Lost to Follow-up|2|||
23247154|NCT00903409|64645757|FG001|Overall Study|Lost to Follow-up|6|||
23247155|NCT01689649|64645758|FG000|Overall Study|Lack of Efficacy|3|||
23247156|NCT01689649|64645758|FG000|Overall Study|Non-compliance|11|||
23247157|NCT01689649|64645758|FG000|Overall Study|Protocol Violation|3|||
23247158|NCT01689649|64645758|FG000|Overall Study|Lost to Follow-up|5|||
23247159|NCT02900976|64645759|FG000|Overall Study|Adverse Event|0|||
23247160|NCT02900976|64645760|FG001|Overall Study|Adverse Event|1|||
23247161|NCT02900976|64645759|FG000|Overall Study|Physician Decision|0|||
23247162|NCT02900976|64645760|FG001|Overall Study|Physician Decision|2|||
23247163|NCT02900976|64645759|FG000|Overall Study|Progressive disease|0|||
23247164|NCT02900976|64645760|FG001|Overall Study|Progressive disease|6|||
23247165|NCT02873195|64645761|FG000|Overall Study|Ineligible|5|||
23247166|NCT02873195|64645762|FG001|Overall Study|Ineligible|0|||
23247167|NCT04798027|64645763|FG000|Overall Study|Protocol Violation|0|||
23247168|NCT04798027|64645764|FG001|Overall Study|Protocol Violation|0|||
23247169|NCT04798027|64645765|FG002|Overall Study|Protocol Violation|0|||
23247170|NCT04798027|64645766|FG003|Overall Study|Protocol Violation|0|||
23247171|NCT04798027|64645767|FG004|Overall Study|Protocol Violation|1|||
23247172|NCT04798027|64645768|FG005|Overall Study|Protocol Violation|0|||
23247173|NCT04798027|64645769|FG006|Overall Study|Protocol Violation|0|||
23247174|NCT04798027|64645770|FG007|Overall Study|Protocol Violation|1|||
23247175|NCT04798027|64645771|FG008|Overall Study|Protocol Violation|0|||
23247176|NCT04798027|64645763|FG000|Overall Study|Withdrawal by Subject|1|||
23247177|NCT04798027|64645764|FG001|Overall Study|Withdrawal by Subject|0|||
23247178|NCT04798027|64645765|FG002|Overall Study|Withdrawal by Subject|1|||
23247179|NCT04798027|64645766|FG003|Overall Study|Withdrawal by Subject|1|||
23247180|NCT04798027|64645767|FG004|Overall Study|Withdrawal by Subject|1|||
23247181|NCT04798027|64645768|FG005|Overall Study|Withdrawal by Subject|1|||
23353111|NCT01108237|65037469|FG000|Overall Study|Did not meet criteria for analysis|7|||
23353112|NCT01108237|65037470|FG001|Overall Study|Did not meet criteria for analysis|0|||
23353113|NCT02509078|65037473|FG000|Overall Study|Protocol Violation|1|||
23353114|NCT02509078|65037474|FG001|Overall Study|Protocol Violation|1|||
23353115|NCT01451164|65037477|FG000|Overall Study|Adverse Event|19|||
23353116|NCT01451164|65037478|FG001|Overall Study|Adverse Event|12|||
23353117|NCT01451164|65037479|FG002|Overall Study|Adverse Event|18|||
23353118|NCT01451164|65037480|FG003|Overall Study|Adverse Event|21|||
23353119|NCT01451164|65037477|FG000|Overall Study|Withdrawal Criteria|1|||
23353120|NCT01451164|65037478|FG001|Overall Study|Withdrawal Criteria|1|||
23353121|NCT01451164|65037479|FG002|Overall Study|Withdrawal Criteria|1|||
23353122|NCT01451164|65037480|FG003|Overall Study|Withdrawal Criteria|1|||
23587232|NCT00930813|65876275|FG001|Overall Study|Withdrawal by Subject|5|||
23587233|NCT00930813|65876274|FG000|Overall Study|Lost to Follow-up|2|||
23587234|NCT00930813|65876275|FG001|Overall Study|Lost to Follow-up|4|||
23587235|NCT00906035|65876276|FG000|Overall Study|Withdrawal by Subject|2|||
23587236|NCT00906035|65876277|FG001|Overall Study|Withdrawal by Subject|3|||
23587237|NCT00906035|65876278|FG002|Overall Study|Withdrawal by Subject|0|||
23587238|NCT01185522|65876279|FG000|Overall Study|Lack of Efficacy|28|||
23587239|NCT01185522|65876279|FG000|Overall Study|Lost to Follow-up|19|||
23587240|NCT01185522|65876279|FG000|Overall Study|Withdrawal by Subject|10|||
23587241|NCT01185522|65876279|FG000|Overall Study|Poor tolerance|39|||
23587242|NCT01185522|65876279|FG000|Overall Study|Other reasons|12|||
23587243|NCT00909363|65876280|FG000|Overall Study|Withdrawal by Subject|1|||
23587244|NCT00909363|65876281|FG001|Overall Study|Withdrawal by Subject|0|||
23587245|NCT00909363|65876282|FG002|Overall Study|Withdrawal by Subject|0|||
23587246|NCT00909363|65876280|FG000|Overall Study|Lack of Efficacy|1|||
23587247|NCT00909363|65876281|FG001|Overall Study|Lack of Efficacy|0|||
23587248|NCT00909363|65876282|FG002|Overall Study|Lack of Efficacy|0|||
23587249|NCT01792830|65876285|FG000|Overall Study|Withdrawal by Subject|22|||
23587250|NCT01792830|65876286|FG001|Overall Study|Withdrawal by Subject|0|||
23247182|NCT04798027|64645769|FG006|Overall Study|Withdrawal by Subject|3|||
23353123|NCT01451164|65037477|FG000|Overall Study|Physician Decision|2|||
23353124|NCT01451164|65037478|FG001|Overall Study|Physician Decision|0|||
23587251|NCT01792830|65876287|FG002|Overall Study|Withdrawal by Subject|0|||
23188093|NCT01826214|64430114|FG001|Overall Study|Lost to Follow-up|0|||
23188094|NCT01826214|64430113|FG000|Overall Study|Physician Decision|0|||
23188095|NCT01826214|64430114|FG001|Overall Study|Physician Decision|2|||
23188096|NCT01826214|64430113|FG000|Overall Study|Progressive disease|22|||
23188097|NCT01826214|64430114|FG001|Overall Study|Progressive disease|21|||
23188098|NCT01826214|64430113|FG000|Overall Study|Study terminated by Sponsor|0|||
23188099|NCT01826214|64430114|FG001|Overall Study|Study terminated by Sponsor|1|||
23188100|NCT01826214|64430113|FG000|Overall Study|Subject/guardian decision|2|||
23188101|NCT01826214|64430114|FG001|Overall Study|Subject/guardian decision|3|||
23188102|NCT00538681|64430117|FG000|Overall Study|Progressive Disease|7|||
23188103|NCT00538681|64430118|FG001|Overall Study|Progressive Disease|0|||
23188104|NCT00538681|64430119|FG002|Overall Study|Progressive Disease|1|||
23188105|NCT00538681|64430120|FG003|Overall Study|Progressive Disease|0|||
23188106|NCT00538681|64430117|FG000|Overall Study|Sponsor Decision|1|||
23188107|NCT00538681|64430118|FG001|Overall Study|Sponsor Decision|3|||
23188108|NCT00538681|64430119|FG002|Overall Study|Sponsor Decision|8|||
23188109|NCT00538681|64430120|FG003|Overall Study|Sponsor Decision|9|||
23188110|NCT00538681|64430117|FG000|Overall Study|Adverse Event|1|||
23188111|NCT00538681|64430118|FG001|Overall Study|Adverse Event|1|||
23188112|NCT00538681|64430119|FG002|Overall Study|Adverse Event|1|||
23188113|NCT00538681|64430120|FG003|Overall Study|Adverse Event|0|||
23188114|NCT00538681|64430117|FG000|Overall Study|Death|0|||
23188115|NCT00538681|64430118|FG001|Overall Study|Death|0|||
23188116|NCT00538681|64430119|FG002|Overall Study|Death|1|||
23188117|NCT00538681|64430120|FG003|Overall Study|Death|1|||
23188118|NCT00538681|64430117|FG000|Overall Study|Investigator Decision|0|||
23188119|NCT00538681|64430118|FG001|Overall Study|Investigator Decision|0|||
23188120|NCT00538681|64430119|FG002|Overall Study|Investigator Decision|0|||
23188121|NCT00538681|64430120|FG003|Overall Study|Investigator Decision|1|||
23188122|NCT03577990|64430121|FG000|Overall Study|Lost to Follow-up|4|||
23188123|NCT03577990|64430122|FG001|Overall Study|Lost to Follow-up|6|||
23188124|NCT03577990|64430121|FG000|Overall Study|Withdrawal by Subject|4|||
23188125|NCT03577990|64430122|FG001|Overall Study|Withdrawal by Subject|7|||
23188126|NCT00144170|64430124|FG000|Overall Study|Adverse Event|84|||
23188127|NCT00144170|64430125|FG001|Overall Study|Adverse Event|41|||
23188128|NCT00144170|64430124|FG000|Overall Study|Protocol Violation|23|||
23188129|NCT00144170|64430125|FG001|Overall Study|Protocol Violation|16|||
23188130|NCT00144170|64430124|FG000|Overall Study|Lost to Follow-up|5|||
23247183|NCT04798027|64645770|FG007|Overall Study|Withdrawal by Subject|2|||
23247184|NCT04798027|64645771|FG008|Overall Study|Withdrawal by Subject|2|||
23247185|NCT04798027|64645763|FG000|Overall Study|Lost to Follow-up|1|||
23247186|NCT04798027|64645764|FG001|Overall Study|Lost to Follow-up|3|||
23247187|NCT04798027|64645765|FG002|Overall Study|Lost to Follow-up|0|||
23247188|NCT04798027|64645766|FG003|Overall Study|Lost to Follow-up|0|||
23247189|NCT04798027|64645767|FG004|Overall Study|Lost to Follow-up|0|||
23247190|NCT04798027|64645768|FG005|Overall Study|Lost to Follow-up|1|||
23247191|NCT04798027|64645769|FG006|Overall Study|Lost to Follow-up|0|||
23247192|NCT04798027|64645770|FG007|Overall Study|Lost to Follow-up|0|||
23247193|NCT04798027|64645771|FG008|Overall Study|Lost to Follow-up|1|||
23247194|NCT04798027|64645763|FG000|Overall Study|Withdrawal by Sponsor|8|||
23247195|NCT04798027|64645764|FG001|Overall Study|Withdrawal by Sponsor|22|||
23247196|NCT04798027|64645765|FG002|Overall Study|Withdrawal by Sponsor|9|||
23247197|NCT04798027|64645766|FG003|Overall Study|Withdrawal by Sponsor|26|||
23247198|NCT04798027|64645767|FG004|Overall Study|Withdrawal by Sponsor|24|||
23247199|NCT04798027|64645768|FG005|Overall Study|Withdrawal by Sponsor|11|||
23247200|NCT04798027|64645769|FG006|Overall Study|Withdrawal by Sponsor|25|||
23247201|NCT04798027|64645770|FG007|Overall Study|Withdrawal by Sponsor|26|||
23247202|NCT04798027|64645771|FG008|Overall Study|Withdrawal by Sponsor|11|||
23247203|NCT04163991|64645776|FG000|Overall Study|Adverse Event|0|||
23247204|NCT04163991|64645777|FG001|Overall Study|Adverse Event|0|||
23247205|NCT04163991|64645778|FG002|Overall Study|Adverse Event|0|||
23247206|NCT04163991|64645779|FG003|Overall Study|Adverse Event|1|||
23247207|NCT04163991|64645780|FG004|Overall Study|Adverse Event|0|||
23247208|NCT04163991|64645776|FG000|Overall Study|Death|0|||
23247209|NCT04163991|64645777|FG001|Overall Study|Death|0|||
23247210|NCT04163991|64645778|FG002|Overall Study|Death|1|||
23247211|NCT04163991|64645779|FG003|Overall Study|Death|0|||
23247212|NCT04163991|64645780|FG004|Overall Study|Death|0|||
23188131|NCT00144170|64430125|FG001|Overall Study|Lost to Follow-up|10|||
23188132|NCT00144170|64430124|FG000|Overall Study|Withdrawal by Subject|29|||
23188133|NCT00144170|64430125|FG001|Overall Study|Withdrawal by Subject|13|||
23188134|NCT00144170|64430124|FG000|Overall Study|Other reason not defined above|211|||
23188135|NCT00144170|64430125|FG001|Overall Study|Other reason not defined above|316|||
23188136|NCT01772134|64430131|FG000|Overall Study|Adverse Event|6|||
23188137|NCT01772134|64430132|FG001|Overall Study|Adverse Event|5|||
23247213|NCT04163991|64645776|FG000|Overall Study|Lost to Follow-up|0|||
23188138|NCT01772134|64430133|FG002|Overall Study|Adverse Event|10|||
23247214|NCT04163991|64645777|FG001|Overall Study|Lost to Follow-up|1|||
23247215|NCT04163991|64645778|FG002|Overall Study|Lost to Follow-up|0|||
23353125|NCT01451164|65037479|FG002|Overall Study|Physician Decision|1|||
23353126|NCT01451164|65037480|FG003|Overall Study|Physician Decision|0|||
23353127|NCT01451164|65037477|FG000|Overall Study|Withdrawal by Subject|14|||
23353128|NCT01451164|65037478|FG001|Overall Study|Withdrawal by Subject|11|||
23353129|NCT01451164|65037479|FG002|Overall Study|Withdrawal by Subject|16|||
23353130|NCT01451164|65037480|FG003|Overall Study|Withdrawal by Subject|17|||
23353131|NCT01451164|65037477|FG000|Overall Study|Protocol Violation|0|||
23353132|NCT01451164|65037478|FG001|Overall Study|Protocol Violation|1|||
23353133|NCT01451164|65037479|FG002|Overall Study|Protocol Violation|0|||
23188139|NCT01772134|64430131|FG000|Overall Study|Withdrew Consent|3|||
23188140|NCT01772134|64430132|FG001|Overall Study|Withdrew Consent|1|||
23188141|NCT01772134|64430133|FG002|Overall Study|Withdrew Consent|5|||
23188142|NCT01772134|64430131|FG000|Overall Study|Lost to Follow-up|2|||
23188143|NCT01772134|64430132|FG001|Overall Study|Lost to Follow-up|0|||
23188144|NCT01772134|64430133|FG002|Overall Study|Lost to Follow-up|0|||
23188145|NCT01772134|64430131|FG000|Overall Study|Protocol Deviation|4|||
23188146|NCT01772134|64430132|FG001|Overall Study|Protocol Deviation|3|||
23188147|NCT01772134|64430133|FG002|Overall Study|Protocol Deviation|3|||
23188148|NCT01772134|64430131|FG000|Overall Study|Lack of Efficacy|11|||
23188149|NCT01772134|64430132|FG001|Overall Study|Lack of Efficacy|5|||
23188150|NCT01772134|64430133|FG002|Overall Study|Lack of Efficacy|3|||
23188151|NCT01772134|64430131|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
23188152|NCT01772134|64430132|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
23353134|NCT01451164|65037480|FG003|Overall Study|Protocol Violation|0|||
23353135|NCT01451164|65037477|FG000|Overall Study|Lack of Efficacy|7|||
23353136|NCT01451164|65037478|FG001|Overall Study|Lack of Efficacy|9|||
23353137|NCT01451164|65037479|FG002|Overall Study|Lack of Efficacy|9|||
23353138|NCT01451164|65037480|FG003|Overall Study|Lack of Efficacy|7|||
23353139|NCT00350779|65037483|FG000|Overall Study|Adverse Event|4|||
23353140|NCT00350779|65037484|FG001|Overall Study|Adverse Event|2|||
23353141|NCT00350779|65037483|FG000|Overall Study|Lack of Efficacy|0|||
23353142|NCT00350779|65037484|FG001|Overall Study|Lack of Efficacy|4|||
23353143|NCT00350779|65037483|FG000|Overall Study|Lost to Follow-up|2|||
23353144|NCT00350779|65037484|FG001|Overall Study|Lost to Follow-up|0|||
23353145|NCT00350779|65037483|FG000|Overall Study|Physician Decision|2|||
23353146|NCT00350779|65037484|FG001|Overall Study|Physician Decision|4|||
23353147|NCT00350779|65037483|FG000|Overall Study|Protocol Violation|3|||
23353148|NCT00350779|65037484|FG001|Overall Study|Protocol Violation|1|||
23353149|NCT00350779|65037483|FG000|Overall Study|Withdrawal by Subject|9|||
23353150|NCT00350779|65037484|FG001|Overall Study|Withdrawal by Subject|8|||
23353151|NCT00350779|65037483|FG000|Overall Study|Patient Moved|2|||
23353152|NCT00350779|65037484|FG001|Overall Study|Patient Moved|1|||
23353153|NCT00350779|65037483|FG000|Overall Study|Non-compliance with study procedures|0|||
23353154|NCT00350779|65037484|FG001|Overall Study|Non-compliance with study procedures|1|||
23188153|NCT01772134|64430133|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
23188154|NCT01772134|64430131|FG000|Overall Study|Randomized Study Medication Not Received|2|||
23188155|NCT01772134|64430132|FG001|Overall Study|Randomized Study Medication Not Received|0|||
23188156|NCT01772134|64430133|FG002|Overall Study|Randomized Study Medication Not Received|1|||
23188157|NCT03212261|64430137|FG000|Overall Study|Became ineligible d/t tech|2|||
23188158|NCT03212261|64430137|FG000|Overall Study|Tech Trouble- No first study visit|1|||
23353155|NCT02208050|65037492|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
23353156|NCT02208050|65037493|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
23353157|NCT01937715|65037497|FG000|Overall Study|Death|0|||
23353158|NCT01937715|65037498|FG001|Overall Study|Death|0|||
23353159|NCT01937715|65037499|FG002|Overall Study|Death|0|||
23353160|NCT01937715|65037500|FG003|Overall Study|Death|1|||
23353161|NCT01937715|65037501|FG004|Overall Study|Death|0|||
23353162|NCT01937715|65037497|FG000|Overall Study|Withdrawal by Subject|0|||
23353163|NCT01937715|65037498|FG001|Overall Study|Withdrawal by Subject|1|||
23353164|NCT01937715|65037499|FG002|Overall Study|Withdrawal by Subject|0|||
23353165|NCT01937715|65037500|FG003|Overall Study|Withdrawal by Subject|0|||
23353166|NCT01937715|65037501|FG004|Overall Study|Withdrawal by Subject|2|||
23188159|NCT03212261|64430137|FG000|Overall Study|Lost to Follow-up|7|||
23188160|NCT03212261|64430137|FG000|Overall Study|Family Emergency|1|||
23188161|NCT03212261|64430137|FG000|Overall Study|Too busy/ No time|5|||
23188162|NCT00730236|64430138|FG000|Overall Study|Adverse Event|4|||
23188163|NCT00730236|64430138|FG000|Overall Study|Withdrawal by Subject|1|||
23188164|NCT00730236|64430138|FG000|Overall Study|Non-compliance|1|||
23188165|NCT02638012|64430139|FG000|Overall Study|Lost to Follow-up|1|||
23353167|NCT01937715|65037497|FG000|Overall Study|Other|0|||
23353168|NCT01937715|65037498|FG001|Overall Study|Other|0|||
23353169|NCT01937715|65037499|FG002|Overall Study|Other|0|||
23353170|NCT01937715|65037500|FG003|Overall Study|Other|3|||
23353171|NCT01937715|65037501|FG004|Overall Study|Other|0|||
23353172|NCT00594386|65037502|FG000|Overall Study|Major protocol violation|2|||
23353173|NCT00594386|65037502|FG000|Overall Study|Lack of Efficacy|12|||
23353174|NCT00594386|65037502|FG000|Overall Study|Adverse Event|68|||
23353175|NCT00594386|65037502|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
23469314|NCT01467960|65460840|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
23469315|NCT03524118|65460845|FG000|Overall Study|Lost to Follow-up|0|||
23469316|NCT03524118|65460846|FG001|Overall Study|Lost to Follow-up|0|||
23469317|NCT03524118|65460847|FG002|Overall Study|Lost to Follow-up|0|||
23469318|NCT03524118|65460848|FG003|Overall Study|Lost to Follow-up|0|||
23469319|NCT03524118|65460849|FG004|Overall Study|Lost to Follow-up|1|||
23469320|NCT03524118|65460850|FG005|Overall Study|Lost to Follow-up|0|||
23469321|NCT03524118|65460845|FG000|Overall Study|Other|0|||
23469322|NCT03524118|65460846|FG001|Overall Study|Other|1|||
23469323|NCT03524118|65460847|FG002|Overall Study|Other|0|||
23469324|NCT03524118|65460848|FG003|Overall Study|Other|0|||
23469325|NCT03524118|65460849|FG004|Overall Study|Other|1|||
23469326|NCT03524118|65460850|FG005|Overall Study|Other|1|||
23469327|NCT03524118|65460845|FG000|Overall Study|Physician Decision|0|||
23469328|NCT03524118|65460846|FG001|Overall Study|Physician Decision|0|||
23469329|NCT03524118|65460847|FG002|Overall Study|Physician Decision|0|||
23469330|NCT03524118|65460848|FG003|Overall Study|Physician Decision|0|||
23469331|NCT03524118|65460849|FG004|Overall Study|Physician Decision|1|||
23469332|NCT03524118|65460850|FG005|Overall Study|Physician Decision|0|||
23469333|NCT03524118|65460845|FG000|Overall Study|Protocol Violation|0|||
23469334|NCT03524118|65460846|FG001|Overall Study|Protocol Violation|0|||
23188166|NCT03215277|64430140|FG000|Overall Study|Adverse Event|2|||
23188167|NCT03215277|64430141|FG001|Overall Study|Adverse Event|3|||
23188168|NCT03215277|64430140|FG000|Overall Study|Death|1|||
23188169|NCT03215277|64430141|FG001|Overall Study|Death|0|||
23188170|NCT03215277|64430140|FG000|Overall Study|Lost to Follow-up|0|||
23188171|NCT03215277|64430141|FG001|Overall Study|Lost to Follow-up|1|||
23188172|NCT03215277|64430140|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
23188173|NCT03215277|64430141|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
23188174|NCT00805207|64430142|FG000|Overall Study|Protocol Violation|0|||
23188175|NCT00805207|64430143|FG001|Overall Study|Protocol Violation|0|||
23188176|NCT00805207|64430144|FG002|Overall Study|Protocol Violation|1|||
23188177|NCT00805207|64430145|FG003|Overall Study|Protocol Violation|0|||
23188178|NCT00805207|64430146|FG004|Overall Study|Protocol Violation|0|||
23247216|NCT04163991|64645779|FG003|Overall Study|Lost to Follow-up|0|||
23247217|NCT04163991|64645780|FG004|Overall Study|Lost to Follow-up|0|||
23247218|NCT04163991|64645776|FG000|Overall Study|Withdrawal by Subject|1|||
23469335|NCT03524118|65460847|FG002|Overall Study|Protocol Violation|1|||
23469336|NCT03524118|65460848|FG003|Overall Study|Protocol Violation|0|||
23469337|NCT03524118|65460849|FG004|Overall Study|Protocol Violation|1|||
23469338|NCT03524118|65460850|FG005|Overall Study|Protocol Violation|0|||
23469339|NCT03524118|65460845|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23469340|NCT03524118|65460846|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23469341|NCT03524118|65460847|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23469342|NCT03524118|65460848|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
23469343|NCT03524118|65460849|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
23469344|NCT03524118|65460850|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23469345|NCT02447302|65460857|FG000|Overall Study|Physician Decision|1|||
23469346|NCT02447302|65460858|FG001|Overall Study|Physician Decision|0|||
23469347|NCT02447302|65460859|FG002|Overall Study|Physician Decision|0|||
23469348|NCT02447302|65460857|FG000|Overall Study|Adverse Event|4|||
23469349|NCT02447302|65460858|FG001|Overall Study|Adverse Event|3|||
23469350|NCT02447302|65460859|FG002|Overall Study|Adverse Event|0|||
23469351|NCT02447302|65460857|FG000|Overall Study|Withdrawal by Subject|0|||
23469352|NCT02447302|65460858|FG001|Overall Study|Withdrawal by Subject|1|||
23469353|NCT02447302|65460859|FG002|Overall Study|Withdrawal by Subject|5|||
23469354|NCT02447302|65460857|FG000|Overall Study|Sponsor Decision|0|||
23469355|NCT02447302|65460858|FG001|Overall Study|Sponsor Decision|0|||
23469356|NCT02447302|65460859|FG002|Overall Study|Sponsor Decision|1|||
23587252|NCT01792830|65876288|FG003|Overall Study|Withdrawal by Subject|2|||
23469357|NCT01391546|65460862|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
23469358|NCT01391546|65460863|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
23469359|NCT00804908|65460864|FG000|Overall Study|Other|115|||
23469360|NCT00804908|65460865|FG001|Overall Study|Other|116|||
23469361|NCT00804908|65460866|FG002|Overall Study|Other|114|||
23188179|NCT00805207|64430147|FG005|Overall Study|Protocol Violation|0|||
23469362|NCT01590888|65460867|FG000|Overall Study|Adverse Event|3|||
23469363|NCT01590888|65460868|FG001|Overall Study|Adverse Event|0|||
23469364|NCT01590888|65460869|FG002|Overall Study|Adverse Event|1|||
23469365|NCT01590888|65460867|FG000|Overall Study|Lost to Follow-up|1|||
23188180|NCT00805207|64430148|FG006|Overall Study|Protocol Violation|0|||
23188181|NCT00805207|64430149|FG007|Overall Study|Protocol Violation|0|||
23188182|NCT00805207|64430150|FG008|Overall Study|Protocol Violation|0|||
23188183|NCT00805207|64430142|FG000|Overall Study|Physician Decision|0|||
23188184|NCT00805207|64430143|FG001|Overall Study|Physician Decision|1|||
23469366|NCT01590888|65460868|FG001|Overall Study|Lost to Follow-up|0|||
23469367|NCT01590888|65460869|FG002|Overall Study|Lost to Follow-up|0|||
23353176|NCT00594386|65037502|FG000|Overall Study|Subject withdrew consent|35|||
23353177|NCT00594386|65037502|FG000|Overall Study|Study ended per sponsor|115|||
23188185|NCT00805207|64430144|FG002|Overall Study|Physician Decision|0|||
23188186|NCT00805207|64430145|FG003|Overall Study|Physician Decision|0|||
23188187|NCT00805207|64430146|FG004|Overall Study|Physician Decision|0|||
23188188|NCT00805207|64430147|FG005|Overall Study|Physician Decision|1|||
23188189|NCT00805207|64430148|FG006|Overall Study|Physician Decision|0|||
23188190|NCT00805207|64430149|FG007|Overall Study|Physician Decision|0|||
23353178|NCT00594386|65037502|FG000|Overall Study|Lost to Follow-up|6|||
23353179|NCT00594386|65037502|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
23353180|NCT00594386|65037502|FG000|Overall Study|Other: Subject moved to Seattle|1|||
23353181|NCT00594386|65037502|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
23188191|NCT00805207|64430150|FG008|Overall Study|Physician Decision|0|||
23188192|NCT00805207|64430142|FG000|Overall Study|Withdrawal by Subject|0|||
23188193|NCT00805207|64430143|FG001|Overall Study|Withdrawal by Subject|1|||
23188194|NCT00805207|64430144|FG002|Overall Study|Withdrawal by Subject|0|||
23188195|NCT00805207|64430145|FG003|Overall Study|Withdrawal by Subject|0|||
23188196|NCT00805207|64430146|FG004|Overall Study|Withdrawal by Subject|1|||
23188197|NCT00805207|64430147|FG005|Overall Study|Withdrawal by Subject|2|||
23188198|NCT00805207|64430148|FG006|Overall Study|Withdrawal by Subject|0|||
23188199|NCT00805207|64430149|FG007|Overall Study|Withdrawal by Subject|0|||
23188200|NCT00805207|64430150|FG008|Overall Study|Withdrawal by Subject|0|||
23188201|NCT01901224|64430156|FG000|Overall Study|study was not funded and terminated|2|||
23188202|NCT00308620|64430159|FG000|Overall Study|Death|1|||
23188203|NCT00308620|64430160|FG001|Overall Study|Death|1|||
23188204|NCT00308620|64430161|FG002|Overall Study|Death|0|||
23188205|NCT00308620|64430159|FG000|Overall Study|Lost to Follow-up|0|||
23188206|NCT00308620|64430160|FG001|Overall Study|Lost to Follow-up|0|||
23188207|NCT00308620|64430161|FG002|Overall Study|Lost to Follow-up|1|||
23188208|NCT01676116|64430162|FG000|Overall Study|Withdrawal criteria|2|||
23188209|NCT01676116|64430163|FG001|Overall Study|Withdrawal criteria|14|||
23188210|NCT01676116|64430162|FG000|Overall Study|Adverse Event|1|||
23188211|NCT01676116|64430163|FG001|Overall Study|Adverse Event|2|||
23188212|NCT01676116|64430162|FG000|Overall Study|Unclassified|4|||
23188213|NCT01676116|64430163|FG001|Overall Study|Unclassified|10|||
23188214|NCT01676116|64430162|FG000|Overall Study|Protocol Violation|9|||
23188215|NCT01676116|64430163|FG001|Overall Study|Protocol Violation|3|||
23188216|NCT01548638|64430173|FG000|Overall Study|Protocol Violation|3|||
23188217|NCT01548638|64430173|FG000|Overall Study|Withdrawal by Subject|1|||
23188218|NCT00963807|64430174|FG000|Overall Study|Physician Decision|2|||
23469368|NCT03534180|65460871|FG000|Overall Study|Withdrawal by Subject|1|||
23469369|NCT00802945|65460872|FG000|Overall Study|Death|27|||
23469370|NCT00802945|65460873|FG001|Overall Study|Death|23|||
23469371|NCT00802945|65460872|FG000|Overall Study|Terminated by sponsor|8|||
23469372|NCT00802945|65460873|FG001|Overall Study|Terminated by sponsor|12|||
23469373|NCT01330108|65460874|FG000|Overall Study|Withdrawal by Subject|4|||
23469374|NCT01255436|65460875|FG000|Overall Study|Lost to Follow-up|178|||
23469375|NCT01255436|65460876|FG001|Overall Study|Lost to Follow-up|191|||
23469376|NCT01255436|65460875|FG000|Overall Study|Death, stroke, or MI|4|||
23469377|NCT01255436|65460876|FG001|Overall Study|Death, stroke, or MI|3|||
23469378|NCT00865280|65460880|FG000|Overall Study|Withdrawal by Subject|4|||
23469379|NCT00865280|65460881|FG001|Overall Study|Withdrawal by Subject|1|||
23469380|NCT00865280|65460880|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
23469381|NCT00865280|65460881|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
23469382|NCT00865280|65460880|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
23469383|NCT00865280|65460881|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
23469384|NCT00865280|65460880|FG000|Overall Study|Exclusion Condition|1|||
23469385|NCT00865280|65460881|FG001|Overall Study|Exclusion Condition|0|||
23469386|NCT00865280|65460880|FG000|Overall Study|Adverse Event|0|||
23469387|NCT00865280|65460881|FG001|Overall Study|Adverse Event|1|||
23469388|NCT02280408|65460882|FG000|Overall Study|Lost to Follow-up|0|||
23188219|NCT00963807|64430174|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
23188220|NCT00963807|64430174|FG000|Overall Study|Disease progression|15|||
23188221|NCT00364793|64430175|FG000|Overall Study|Adverse Event|2|||
23188222|NCT00364793|64430176|FG001|Overall Study|Adverse Event|0|||
23188223|NCT00364793|64430177|FG002|Overall Study|Adverse Event|0|||
23188224|NCT00364793|64430178|FG003|Overall Study|Adverse Event|0|||
23188225|NCT00364793|64430175|FG000|Overall Study|Death|1|||
23188226|NCT00364793|64430176|FG001|Overall Study|Death|0|||
23353182|NCT00594386|65037502|FG000|Overall Study|Other: Study terminated per investigator|2|||
23353183|NCT00594386|65037502|FG000|Overall Study|Other: Sponsor closure of study|1|||
23469389|NCT02280408|65460883|FG001|Overall Study|Lost to Follow-up|2|||
23469390|NCT02280408|65460884|FG002|Overall Study|Lost to Follow-up|0|||
23469391|NCT02280408|65460885|FG003|Overall Study|Lost to Follow-up|0|||
23188227|NCT00364793|64430177|FG002|Overall Study|Death|1|||
23353184|NCT00594386|65037502|FG000|Overall Study|Other: Site terminated participation|1|||
23353185|NCT00594386|65037502|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
23353186|NCT00594386|65037502|FG000|Overall Study|Other: Loss of drivers license|1|||
23353187|NCT02155322|65037504|FG000|Overall Study|Adverse Event|1|||
23353188|NCT02155322|65037504|FG000|Overall Study|Physician Decision|1|||
23353189|NCT02155322|65037504|FG000|Overall Study|Relapse/Recurrence|8|||
23353190|NCT02155322|65037504|FG000|Overall Study|Withdrawal by Subject|4|||
23353191|NCT01375374|65037505|FG000|Overall Study|Adverse Event|1|||
23353192|NCT01964716|65037506|FG000|Overall Study|Withdrawal by Subject|2|||
23353193|NCT01964716|65037507|FG001|Overall Study|Withdrawal by Subject|3|||
23353194|NCT01964716|65037506|FG000|Overall Study|Lost to Follow-up|1|||
23353195|NCT01964716|65037507|FG001|Overall Study|Lost to Follow-up|2|||
23353196|NCT01964716|65037506|FG000|Overall Study|No longer met eligibility criteria|1|||
23353197|NCT01964716|65037507|FG001|Overall Study|No longer met eligibility criteria|1|||
23353198|NCT01964716|65037506|FG000|Overall Study|Death|1|||
23353199|NCT01964716|65037507|FG001|Overall Study|Death|0|||
23353200|NCT01754766|65037508|FG000|Overall Study|Personal reasons|1|||
23353201|NCT01754766|65037509|FG001|Overall Study|Personal reasons|1|||
23353202|NCT01754766|65037510|FG002|Overall Study|Personal reasons|0|||
23353203|NCT01080391|65037515|FG000|Overall Study|Randomized but not treated|7|||
23353204|NCT01080391|65037516|FG001|Overall Study|Randomized but not treated|4|||
23188228|NCT00364793|64430178|FG003|Overall Study|Death|0|||
23188229|NCT00364793|64430175|FG000|Overall Study|Lack of Efficacy|3|||
23188230|NCT00364793|64430176|FG001|Overall Study|Lack of Efficacy|3|||
23188231|NCT00364793|64430177|FG002|Overall Study|Lack of Efficacy|1|||
23247219|NCT04163991|64645777|FG001|Overall Study|Withdrawal by Subject|1|||
23353205|NCT03301831|65037520|FG000|Overall Study|Lost to Follow-up|5|||
23353206|NCT03301831|65037521|FG001|Overall Study|Lost to Follow-up|3|||
23353207|NCT03301831|65037520|FG000|Overall Study|Protocol Violation|4|||
23353208|NCT03301831|65037521|FG001|Overall Study|Protocol Violation|0|||
23353209|NCT03301831|65037520|FG000|Overall Study|Withdrawal by Subject|11|||
23353210|NCT03301831|65037521|FG001|Overall Study|Withdrawal by Subject|0|||
23353211|NCT00508157|65037524|FG000|Overall Study|Adverse Event|0|||
23353212|NCT00508157|65037525|FG001|Overall Study|Adverse Event|1|||
23469392|NCT00541385|65460886|FG000|Overall Study|Adverse Event|6|||
23469393|NCT00541385|65460887|FG001|Overall Study|Adverse Event|3|||
23469394|NCT00541385|65460886|FG000|Overall Study|Withdrawal by Subject|2|||
23469395|NCT00541385|65460887|FG001|Overall Study|Withdrawal by Subject|2|||
23469396|NCT00541385|65460886|FG000|Overall Study|Lost to Follow-up|6|||
23469397|NCT00541385|65460887|FG001|Overall Study|Lost to Follow-up|1|||
23469398|NCT00541385|65460886|FG000|Overall Study|Parasite reappearance/malaria|67|||
23469399|NCT00541385|65460887|FG001|Overall Study|Parasite reappearance/malaria|32|||
23469400|NCT04455815|65460890|FG000|Randomisation Phase|Adverse Event|1|||
23469401|NCT04455815|65460891|FG001|Randomisation Phase|Adverse Event|0|||
23469402|NCT04455815|65460890|FG000|Treatment Phase|Adverse Event|0|||
23469403|NCT04455815|65460891|FG001|Treatment Phase|Adverse Event|1|||
23469404|NCT04455815|65460890|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
23469405|NCT04455815|65460891|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
23469406|NCT04455815|65460890|FG000|Treatment Phase|Withdrawal by Subject|1|||
23469407|NCT04455815|65460891|FG001|Treatment Phase|Withdrawal by Subject|1|||
23188232|NCT00364793|64430178|FG003|Overall Study|Lack of Efficacy|1|||
23188233|NCT00364793|64430175|FG000|Overall Study|Lost to Follow-up|1|||
23188234|NCT00364793|64430176|FG001|Overall Study|Lost to Follow-up|0|||
23188235|NCT00364793|64430177|FG002|Overall Study|Lost to Follow-up|2|||
23188236|NCT00364793|64430178|FG003|Overall Study|Lost to Follow-up|0|||
23247220|NCT04163991|64645778|FG002|Overall Study|Withdrawal by Subject|3|||
23247221|NCT04163991|64645779|FG003|Overall Study|Withdrawal by Subject|1|||
23247222|NCT04163991|64645780|FG004|Overall Study|Withdrawal by Subject|1|||
23247223|NCT04163991|64645776|FG000|Overall Study|Other, Not Specified|0|||
23247224|NCT04163991|64645777|FG001|Overall Study|Other, Not Specified|1|||
23247225|NCT04163991|64645778|FG002|Overall Study|Other, Not Specified|1|||
23247226|NCT04163991|64645779|FG003|Overall Study|Other, Not Specified|1|||
23247227|NCT04163991|64645780|FG004|Overall Study|Other, Not Specified|0|||
23247228|NCT01432600|64645781|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
23247229|NCT01432600|64645782|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
23353213|NCT00508157|65037524|FG000|Overall Study|Subject Withdrew Consent|1|||
23353214|NCT00508157|65037525|FG001|Overall Study|Subject Withdrew Consent|0|||
23353215|NCT00508157|65037524|FG000|Overall Study|Lost to Follow-up|1|||
23353216|NCT00508157|65037525|FG001|Overall Study|Lost to Follow-up|0|||
23353217|NCT00508157|65037524|FG000|Overall Study|Subject no longer met study criteria|0|||
23469408|NCT01033448|65460893|FG000|Overall Study|Withdrawal by Subject|4|||
23469409|NCT01033448|65460893|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
23188237|NCT00364793|64430175|FG000|Overall Study|Poor or non-compliance|1|||
23469410|NCT01033448|65460893|FG000|Overall Study|Lost to Follow-up|3|||
23247230|NCT01432600|64645783|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
23247231|NCT01591499|64645784|FG000|Baseline Visit|Withdrawal by Subject|0|||
23469411|NCT01033448|65460893|FG000|Overall Study|Withdrew due to other reasons|3|||
23469412|NCT01033448|65460893|FG000|Overall Study|Unknown disposition|1|||
23469413|NCT03048578|65460894|FG000|Overall Study|Withdrawal by Subject|5|||
23247232|NCT01591499|64645785|FG001|Baseline Visit|Withdrawal by Subject|2|||
23247233|NCT01591499|64645786|FG002|Baseline Visit|Withdrawal by Subject|0|||
23247234|NCT01591499|64645787|FG003|Baseline Visit|Withdrawal by Subject|2|||
23247235|NCT01591499|64645784|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
23247236|NCT01591499|64645785|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
23247237|NCT01591499|64645786|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
23247238|NCT01591499|64645787|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
23247239|NCT01591499|64645784|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
23247240|NCT01591499|64645785|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
23469414|NCT03048578|65460895|FG001|Overall Study|Withdrawal by Subject|6|||
23469415|NCT03048578|65460894|FG000|Overall Study|Lost to Follow-up|22|||
23469416|NCT03048578|65460895|FG001|Overall Study|Lost to Follow-up|10|||
23469417|NCT03048578|65460894|FG000|Overall Study|Adverse Event|1|||
23469418|NCT03048578|65460895|FG001|Overall Study|Adverse Event|2|||
23469419|NCT03048578|65460894|FG000|Overall Study|Terminated|3|||
23469420|NCT03048578|65460895|FG001|Overall Study|Terminated|2|||
23469421|NCT00599339|65460896|FG000|Overall Study|Adverse Event|79|||
23469422|NCT00599339|65460896|FG000|Overall Study|Withdrawal by Subject|137|||
23469423|NCT00599339|65460896|FG000|Overall Study|Other Reason|179|||
23469424|NCT00599339|65460896|FG000|Overall Study|Lost to Follow-up|221|||
23469425|NCT00599339|65460896|FG000|Overall Study|No valid data consent|36|||
23469426|NCT00599339|65460896|FG000|Overall Study|Study Termination Status Unknown|12|||
23469427|NCT03070964|65460897|FG000|Overall Study|Progressive disease|8|||
23469428|NCT03070964|65460897|FG000|Overall Study|Treatment-unrelated adverse event|2|||
23469429|NCT03070964|65460897|FG000|Overall Study|Never treated|1|||
23469430|NCT03070964|65460897|FG000|Overall Study|Physician Decision|1|||
23469431|NCT03070964|65460897|FG000|Overall Study|Withdrawal by Subject|1|||
23469432|NCT03070964|65460897|FG000|Overall Study|Adverse Event|1|||
23469433|NCT00829504|65460898|FG000|First Intervention|Adverse Event|1|||
23469434|NCT00829504|65460899|FG001|First Intervention|Adverse Event|0|||
23469435|NCT00829504|65460898|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23469436|NCT00829504|65460899|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23469437|NCT00829504|65460898|FG000|Second Intervention|Physician Decision|1|||
23469438|NCT00829504|65460899|FG001|Second Intervention|Physician Decision|0|||
23469439|NCT00387790|65464228|FG000|Overall Study|Adverse Event|5|||
23469440|NCT00387790|65464228|FG000|Overall Study|Lack of Efficacy|2|||
23469441|NCT00387790|65464228|FG000|Overall Study|Physician Decision|2|||
23469442|NCT00387790|65464228|FG000|Overall Study|Withdrawal by Subject|3|||
23469443|NCT00387790|65464228|FG000|Overall Study|Ineligible for study|2|||
23469444|NCT02970942|65464229|FG000|Overall Study|Death|0|||
23469445|NCT02970942|65464230|FG001|Overall Study|Death|1|||
23469446|NCT02970942|65464231|FG002|Overall Study|Death|0|||
23469447|NCT02970942|65464232|FG003|Overall Study|Death|0|||
23469448|NCT02970942|65464229|FG000|Overall Study|Lost to Follow-up|1|||
23469449|NCT02970942|65464230|FG001|Overall Study|Lost to Follow-up|0|||
23247241|NCT01591499|64645786|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
23247242|NCT01591499|64645787|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
23247243|NCT04935931|64645788|FG000|Overall Study|Withdrawal by Subject|1|||
23247244|NCT03867500|64645789|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
23247245|NCT00689273|64645792|FG000|Overall Study|Adverse Event|3|||
23247246|NCT00689273|64645793|FG001|Overall Study|Adverse Event|1|||
23247247|NCT00689273|64645792|FG000|Overall Study|Lack of Efficacy|3|||
23247248|NCT00689273|64645793|FG001|Overall Study|Lack of Efficacy|0|||
23247249|NCT00689273|64645792|FG000|Overall Study|Lost to Follow-up|0|||
23247250|NCT00689273|64645793|FG001|Overall Study|Lost to Follow-up|2|||
23247251|NCT00689273|64645792|FG000|Overall Study|Other|6|||
23469450|NCT02970942|65464231|FG002|Overall Study|Lost to Follow-up|2|||
23469451|NCT02970942|65464232|FG003|Overall Study|Lost to Follow-up|1|||
23469452|NCT02970942|65464229|FG000|Overall Study|Withdrawal by Subject|3|||
23469453|NCT02970942|65464230|FG001|Overall Study|Withdrawal by Subject|5|||
23469454|NCT02970942|65464231|FG002|Overall Study|Withdrawal by Subject|3|||
23469455|NCT02970942|65464232|FG003|Overall Study|Withdrawal by Subject|2|||
23587253|NCT01792830|65876289|FG004|Overall Study|Withdrawal by Subject|1|||
23587254|NCT01792830|65876290|FG005|Overall Study|Withdrawal by Subject|1|||
23247252|NCT00689273|64645793|FG001|Overall Study|Other|2|||
23247253|NCT00689273|64645792|FG000|Overall Study|Randomized but not Treated|1|||
23247254|NCT00689273|64645793|FG001|Overall Study|Randomized but not Treated|0|||
23247255|NCT01067339|64645794|FG000|Overall Study|Withdrawal by Subject|6|||
23247256|NCT01067339|64645795|FG001|Overall Study|Withdrawal by Subject|5|||
23469456|NCT05300763|65464233|FG000|Overall Study|Adverse Event|0|||
23469457|NCT05300763|65464234|FG001|Overall Study|Adverse Event|1|||
23469458|NCT05300763|65464233|FG000|Overall Study|Major Protocol Deviation|1|||
23469459|NCT05300763|65464234|FG001|Overall Study|Major Protocol Deviation|0|||
23587255|NCT01792830|65876291|FG006|Overall Study|Withdrawal by Subject|1|||
23469460|NCT05300763|65464233|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
23469461|NCT05300763|65464234|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
23469462|NCT02259088|65464235|FG000|Overall Study|Adverse Event|6|||
23469463|NCT02259088|65464236|FG001|Overall Study|Adverse Event|4|||
23469464|NCT02259088|65464235|FG000|Overall Study|Lost to Follow-up|2|||
23469465|NCT02259088|65464236|FG001|Overall Study|Lost to Follow-up|0|||
23469466|NCT02259088|65464235|FG000|Overall Study|Death|2|||
23469467|NCT02259088|65464236|FG001|Overall Study|Death|0|||
23469468|NCT02259088|65464235|FG000|Overall Study|Physician Decision|5|||
23469469|NCT02259088|65464236|FG001|Overall Study|Physician Decision|2|||
23469470|NCT02259088|65464235|FG000|Overall Study|Protocol deviation|5|||
23469471|NCT02259088|65464236|FG001|Overall Study|Protocol deviation|0|||
23469472|NCT02259088|65464235|FG000|Overall Study|Subject/guardian decision|8|||
23469473|NCT02259088|65464236|FG001|Overall Study|Subject/guardian decision|8|||
23469474|NCT00643162|65464239|FG000|Overall Study|Withdrawal by Subject|1|||
23188238|NCT00364793|64430176|FG001|Overall Study|Poor or non-compliance|1|||
23469475|NCT00643162|65464240|FG001|Overall Study|Withdrawal by Subject|1|||
23469476|NCT00467753|65464241|FG000|Overall Study|Lost to Follow-up|1|||
23469477|NCT00467753|65464242|FG001|Overall Study|Lost to Follow-up|2|||
23469478|NCT00467753|65464241|FG000|Overall Study|Adverse Event|2|||
23469479|NCT00467753|65464242|FG001|Overall Study|Adverse Event|0|||
23469480|NCT01276054|65464244|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
23469481|NCT01276054|65464245|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
23469482|NCT02141204|65464246|FG000|Overall Study|Lost to Follow-up|2|||
23469483|NCT02141204|65464247|FG001|Overall Study|Lost to Follow-up|1|||
23469484|NCT02141204|65464246|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
23469485|NCT02141204|65464247|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
23469486|NCT02141204|65464246|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
23469487|NCT02141204|65464247|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
23469488|NCT02141204|65464246|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
23469489|NCT02141204|65464247|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
23469490|NCT01215097|65464248|FG000|Overall Study|Adverse Event|1|||
23469491|NCT01215097|65464249|FG001|Overall Study|Adverse Event|3|||
23469492|NCT01215097|65464248|FG000|Overall Study|Protocol Violation|0|||
23469493|NCT01215097|65464249|FG001|Overall Study|Protocol Violation|2|||
23469494|NCT01215097|65464248|FG000|Overall Study|Lost to Follow-up|2|||
23469495|NCT01215097|65464249|FG001|Overall Study|Lost to Follow-up|0|||
23469496|NCT01215097|65464248|FG000|Overall Study|Withdrawal by Subject|6|||
23469497|NCT01215097|65464249|FG001|Overall Study|Withdrawal by Subject|3|||
23469498|NCT01215097|65464248|FG000|Overall Study|Lack of Efficacy|0|||
23469499|NCT01215097|65464249|FG001|Overall Study|Lack of Efficacy|3|||
23188239|NCT00364793|64430177|FG002|Overall Study|Poor or non-compliance|0|||
23188240|NCT00364793|64430178|FG003|Overall Study|Poor or non-compliance|1|||
23188241|NCT00364793|64430175|FG000|Overall Study|No longer meets criteria|0|||
23188242|NCT00364793|64430176|FG001|Overall Study|No longer meets criteria|0|||
23188243|NCT00364793|64430177|FG002|Overall Study|No longer meets criteria|0|||
23188244|NCT00364793|64430178|FG003|Overall Study|No longer meets criteria|1|||
23188245|NCT00364793|64430175|FG000|Overall Study|Withdrawal by Subject|0|||
23188246|NCT00364793|64430176|FG001|Overall Study|Withdrawal by Subject|1|||
23188247|NCT00364793|64430177|FG002|Overall Study|Withdrawal by Subject|0|||
23188248|NCT00364793|64430178|FG003|Overall Study|Withdrawal by Subject|0|||
23188249|NCT00594399|64430180|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
23188250|NCT00594399|64430181|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
23188251|NCT00594399|64430182|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
23188252|NCT00594399|64430180|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
23188253|NCT00594399|64430181|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
23188254|NCT00594399|64430182|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
23188255|NCT00594399|64430180|FG000|Initial 3 Month Counseling|Personal issues|2|||
23469500|NCT01215097|65464248|FG000|Overall Study|patient's refusal to come|2|||
23469501|NCT01215097|65464249|FG001|Overall Study|patient's refusal to come|2|||
23469502|NCT01215097|65464248|FG000|Overall Study|patient's private reason|1|||
23469503|NCT01215097|65464249|FG001|Overall Study|patient's private reason|1|||
23469504|NCT02656693|65464251|FG000|Overall Study|Pregnancy|1|||
23469505|NCT02656693|65464252|FG001|Overall Study|Pregnancy|1|||
23469506|NCT02656693|65464253|FG002|Overall Study|Pregnancy|1|||
23469507|NCT02656693|65464251|FG000|Overall Study|Bariatric surgery|0|||
23587256|NCT01792830|65876292|FG007|Overall Study|Withdrawal by Subject|1|||
23188256|NCT00594399|64430181|FG001|Initial 3 Month Counseling|Personal issues|0|||
23188257|NCT00594399|64430182|FG002|Initial 3 Month Counseling|Personal issues|0|||
23188258|NCT00594399|64430180|FG000|Initial 3 Month Counseling|Too busy|7|||
23469508|NCT02656693|65464252|FG001|Overall Study|Bariatric surgery|1|||
23469509|NCT02656693|65464253|FG002|Overall Study|Bariatric surgery|2|||
23469510|NCT00114517|65464254|FG000|Overall Study|Adverse Event|6|||
23469511|NCT00114517|65464255|FG001|Overall Study|Adverse Event|1|||
23469512|NCT00114517|65464256|FG002|Overall Study|Adverse Event|6|||
23469513|NCT00114517|65464257|FG003|Overall Study|Adverse Event|3|||
23469514|NCT00114517|65464254|FG000|Overall Study|Lost to Follow-up|2|||
23469515|NCT00114517|65464255|FG001|Overall Study|Lost to Follow-up|2|||
23469516|NCT00114517|65464256|FG002|Overall Study|Lost to Follow-up|2|||
23469517|NCT00114517|65464257|FG003|Overall Study|Lost to Follow-up|1|||
23469518|NCT00114517|65464254|FG000|Overall Study|Too busy|3|||
23469519|NCT00114517|65464255|FG001|Overall Study|Too busy|1|||
23469520|NCT00114517|65464256|FG002|Overall Study|Too busy|1|||
23469521|NCT00114517|65464257|FG003|Overall Study|Too busy|2|||
23469522|NCT00114517|65464254|FG000|Overall Study|Moved from area|0|||
23469523|NCT00114517|65464255|FG001|Overall Study|Moved from area|3|||
23469524|NCT00114517|65464256|FG002|Overall Study|Moved from area|2|||
23469525|NCT00114517|65464257|FG003|Overall Study|Moved from area|1|||
23469526|NCT00114517|65464254|FG000|Overall Study|Did not want estradiol|1|||
23469527|NCT00114517|65464255|FG001|Overall Study|Did not want estradiol|1|||
23469528|NCT00114517|65464256|FG002|Overall Study|Did not want estradiol|0|||
23469529|NCT00114517|65464257|FG003|Overall Study|Did not want estradiol|0|||
23469530|NCT00114517|65464254|FG000|Overall Study|Armed-services duty|0|||
23469531|NCT00114517|65464255|FG001|Overall Study|Armed-services duty|1|||
23469532|NCT00114517|65464256|FG002|Overall Study|Armed-services duty|0|||
23469533|NCT00114517|65464257|FG003|Overall Study|Armed-services duty|1|||
23469534|NCT00114517|65464254|FG000|Overall Study|Competing family issue|0|||
23469535|NCT00114517|65464255|FG001|Overall Study|Competing family issue|1|||
23469536|NCT00114517|65464256|FG002|Overall Study|Competing family issue|0|||
23469537|NCT00114517|65464257|FG003|Overall Study|Competing family issue|1|||
23469538|NCT00114517|65464254|FG000|Overall Study|Physician Decision|0|||
23469539|NCT00114517|65464255|FG001|Overall Study|Physician Decision|1|||
23469540|NCT00114517|65464256|FG002|Overall Study|Physician Decision|0|||
23469541|NCT00114517|65464257|FG003|Overall Study|Physician Decision|0|||
23469542|NCT00114517|65464254|FG000|Overall Study|Lost interest|0|||
23469543|NCT00114517|65464255|FG001|Overall Study|Lost interest|0|||
23469544|NCT00114517|65464256|FG002|Overall Study|Lost interest|1|||
23469545|NCT00114517|65464257|FG003|Overall Study|Lost interest|0|||
23469546|NCT00114517|65464254|FG000|Overall Study|Weight increase|0|||
23469547|NCT00114517|65464255|FG001|Overall Study|Weight increase|0|||
23469548|NCT00114517|65464256|FG002|Overall Study|Weight increase|1|||
23469549|NCT00114517|65464257|FG003|Overall Study|Weight increase|0|||
23469550|NCT00114517|65464254|FG000|Overall Study|Concern about blood clots|0|||
23469551|NCT00114517|65464255|FG001|Overall Study|Concern about blood clots|0|||
23469552|NCT00114517|65464256|FG002|Overall Study|Concern about blood clots|1|||
23469553|NCT00114517|65464257|FG003|Overall Study|Concern about blood clots|0|||
23469554|NCT00114517|65464254|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
23469555|NCT00114517|65464255|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
23469556|NCT00114517|65464256|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
23469557|NCT00114517|65464257|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
23469558|NCT03052426|65464258|FG000|Overall Study|Withdrawal by Subject|0|||
23469559|NCT03052426|65464259|FG001|Overall Study|Withdrawal by Subject|1|||
23469560|NCT03052426|65464260|FG002|Overall Study|Withdrawal by Subject|0|||
23587257|NCT01792830|65876293|FG008|Overall Study|Withdrawal by Subject|7|||
23587258|NCT01792830|65876294|FG009|Overall Study|Withdrawal by Subject|0|||
23587259|NCT01792830|65876295|FG010|Overall Study|Withdrawal by Subject|2|||
23587260|NCT01792830|65876285|FG000|Overall Study|Death|3|||
23587261|NCT01792830|65876286|FG001|Overall Study|Death|0|||
23587262|NCT01792830|65876287|FG002|Overall Study|Death|0|||
23587263|NCT01792830|65876288|FG003|Overall Study|Death|1|||
23587264|NCT01792830|65876289|FG004|Overall Study|Death|0|||
23587265|NCT01792830|65876290|FG005|Overall Study|Death|0|||
23587266|NCT01792830|65876291|FG006|Overall Study|Death|1|||
23587267|NCT01792830|65876292|FG007|Overall Study|Death|0|||
23587268|NCT01792830|65876293|FG008|Overall Study|Death|1|||
23587269|NCT01792830|65876294|FG009|Overall Study|Death|0|||
23587270|NCT01792830|65876295|FG010|Overall Study|Death|1|||
23587271|NCT01792830|65876285|FG000|Overall Study|Adverse Event|0|||
23587272|NCT01792830|65876286|FG001|Overall Study|Adverse Event|0|||
23587273|NCT01792830|65876287|FG002|Overall Study|Adverse Event|0|||
23587274|NCT01792830|65876288|FG003|Overall Study|Adverse Event|0|||
23469561|NCT03052426|65464258|FG000|Overall Study|Lost to Follow-up|2|||
23469562|NCT03052426|65464259|FG001|Overall Study|Lost to Follow-up|0|||
23469563|NCT03052426|65464260|FG002|Overall Study|Lost to Follow-up|1|||
23587275|NCT01792830|65876289|FG004|Overall Study|Adverse Event|0|||
23587276|NCT01792830|65876290|FG005|Overall Study|Adverse Event|0|||
23587277|NCT01792830|65876291|FG006|Overall Study|Adverse Event|0|||
23469564|NCT03710083|65464262|FG000|Overall Study|Withdrawal by Subject|2|||
23469565|NCT03710083|65464262|FG000|Overall Study|Unsuccessful Procedure|1|||
23469566|NCT02269267|65464263|FG000|Overall Study|Death|5|||
23587278|NCT01792830|65876292|FG007|Overall Study|Adverse Event|0|||
23587279|NCT01792830|65876293|FG008|Overall Study|Adverse Event|1|||
23587280|NCT01792830|65876294|FG009|Overall Study|Adverse Event|0|||
23587281|NCT01792830|65876295|FG010|Overall Study|Adverse Event|0|||
23587282|NCT01649791|65876296|FG000|Overall Study|Disease Progression|2|||
23469567|NCT00993148|65464266|FG000|Overall Study|Lost to Follow-up|2|||
23469568|NCT00993148|65464266|FG000|Overall Study|never initiated treatment|1|||
23469569|NCT04080167|65464267|FG000|Overall Study|Lost to Follow-up-Patients|7|||
23469570|NCT04080167|65464268|FG001|Overall Study|Lost to Follow-up-Patients|14|||
23469571|NCT04080167|65464269|FG002|Overall Study|Lost to Follow-up-Patients|0|||
23469572|NCT04080167|65464267|FG000|Overall Study|Lost to Follow-up-Providers|2|||
23469573|NCT04080167|65464268|FG001|Overall Study|Lost to Follow-up-Providers|2|||
23469574|NCT04080167|65464269|FG002|Overall Study|Lost to Follow-up-Providers|0|||
23469575|NCT04080167|65464267|FG000|Overall Study|Withdrawal by Subject|1|||
23469576|NCT04080167|65464268|FG001|Overall Study|Withdrawal by Subject|2|||
23469577|NCT04080167|65464269|FG002|Overall Study|Withdrawal by Subject|0|||
23469578|NCT04080167|65464267|FG000|Overall Study|Withdrawal by Provider|0|||
23469579|NCT04080167|65464268|FG001|Overall Study|Withdrawal by Provider|0|||
23469580|NCT04080167|65464269|FG002|Overall Study|Withdrawal by Provider|4|||
23469581|NCT04080167|65464267|FG000|Overall Study|Death-Patient|2|||
23469582|NCT04080167|65464268|FG001|Overall Study|Death-Patient|1|||
23469583|NCT04080167|65464269|FG002|Overall Study|Death-Patient|0|||
23469584|NCT04080167|65464267|FG000|Overall Study|Hydroxyurea New Starts|0|||
23469585|NCT04080167|65464268|FG001|Overall Study|Hydroxyurea New Starts|0|||
23469586|NCT04080167|65464269|FG002|Overall Study|Hydroxyurea New Starts|1|||
23469587|NCT04080167|65464267|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
23469588|NCT04080167|65464268|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
23469589|NCT04080167|65464269|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
23469590|NCT03583385|65464270|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23469591|NCT03583385|65464271|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23469592|NCT03583385|65464270|FG000|Treatment Period 2|Adverse Event|1|||
23469593|NCT03583385|65464271|FG001|Treatment Period 2|Adverse Event|0|||
23469594|NCT00441116|65464277|FG000|Overall Study|Adverse Event|1|||
23469595|NCT00441116|65464278|FG001|Overall Study|Adverse Event|1|||
23469596|NCT00441116|65464277|FG000|Overall Study|Withdrawal by Subject|1|||
23469597|NCT00441116|65464278|FG001|Overall Study|Withdrawal by Subject|0|||
23469598|NCT00441116|65464277|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
23469599|NCT00441116|65464278|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
23469600|NCT03554486|65464284|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
23469601|NCT03554486|65464285|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
23469602|NCT03554486|65464286|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
23469603|NCT03554486|65464284|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
23469604|NCT03554486|65464285|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
23469605|NCT03554486|65464286|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
23469606|NCT03554486|65464284|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23469607|NCT03554486|65464285|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
23469608|NCT03554486|65464286|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
23469609|NCT02282605|65464295|FG000|Overall Study|negative SA result on Day -1|3|||
23469610|NCT02282605|65464296|FG001|Overall Study|negative SA result on Day -1|0|||
23469611|NCT02282605|65464297|FG002|Overall Study|negative SA result on Day -1|0|||
23469612|NCT00241839|65464298|FG000|Overall Study|Withdrawal by Subject|18|||
23469613|NCT00241839|65464299|FG001|Overall Study|Withdrawal by Subject|17|||
23469614|NCT00241839|65464298|FG000|Overall Study|Adverse Event|1|||
23469615|NCT00241839|65464299|FG001|Overall Study|Adverse Event|1|||
23469616|NCT01296672|65464300|FG000|Overall Study|Lost to Follow-up|73|||
23469617|NCT01296672|65464301|FG001|Overall Study|Lost to Follow-up|18|||
23469618|NCT00775190|65464304|FG000|Overall Study|Lost to Follow-up|2|||
23469619|NCT00775190|65464305|FG001|Overall Study|Lost to Follow-up|3|||
23469620|NCT00775190|65464304|FG000|Overall Study|Withdrawal by Subject|1|||
23469621|NCT00775190|65464305|FG001|Overall Study|Withdrawal by Subject|2|||
23469622|NCT00775190|65464304|FG000|Overall Study|Protocol Violation|1|||
23469623|NCT00775190|65464305|FG001|Overall Study|Protocol Violation|0|||
23469624|NCT04629066|65464311|FG000|Overall Study|Lost to Follow-up|3|||
23469625|NCT04629066|65464312|FG001|Overall Study|Lost to Follow-up|2|||
23469626|NCT03565497|65464313|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
23469627|NCT03565497|65464314|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
23469628|NCT03565497|65464315|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
23469629|NCT03565497|65464313|FG000|Overall Study|Lost to Follow-up|1|||
23469630|NCT03565497|65464314|FG001|Overall Study|Lost to Follow-up|1|||
23469631|NCT03565497|65464315|FG002|Overall Study|Lost to Follow-up|2|||
23469632|NCT03565497|65464313|FG000|Overall Study|Withdrawal by Subject|1|||
23469633|NCT03565497|65464314|FG001|Overall Study|Withdrawal by Subject|1|||
23469634|NCT03565497|65464315|FG002|Overall Study|Withdrawal by Subject|1|||
23469635|NCT00939393|65464316|FG000|Overall Study|Withdrawal by Subject|1|||
23188259|NCT00594399|64430181|FG001|Initial 3 Month Counseling|Too busy|1|||
23469636|NCT00939393|65464317|FG001|Overall Study|Withdrawal by Subject|0|||
23469637|NCT00939393|65464316|FG000|Overall Study|Lost to Follow-up|3|||
23469638|NCT00939393|65464317|FG001|Overall Study|Lost to Follow-up|0|||
23587283|NCT01649791|65876296|FG000|Overall Study|Adverse Event|1|||
23469639|NCT01146795|65464324|FG000|Overall Study|Withdrawal by Subject|4|||
23469640|NCT01146795|65464324|FG000|Overall Study|Adverse Event|6|||
23188260|NCT00594399|64430182|FG002|Initial 3 Month Counseling|Too busy|0|||
23469641|NCT01146795|65464324|FG000|Overall Study|Still in treatment at study closure|10|||
23469642|NCT00441064|65464325|FG000|Overall Study|Adverse Event|1|||
23469643|NCT00441064|65464326|FG001|Overall Study|Adverse Event|0|||
23469644|NCT00441064|65464325|FG000|Overall Study|Abnormal laboratory values|0|||
23469645|NCT00441064|65464326|FG001|Overall Study|Abnormal laboratory values|2|||
23469646|NCT00441064|65464325|FG000|Overall Study|Abnormal test procedure results|0|||
23469647|NCT00441064|65464326|FG001|Overall Study|Abnormal test procedure results|1|||
23469648|NCT00441064|65464325|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23469649|NCT00441064|65464326|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23469650|NCT00441064|65464325|FG000|Overall Study|Protocol Deviation|3|||
23469651|NCT00441064|65464326|FG001|Overall Study|Protocol Deviation|2|||
23469652|NCT00441064|65464325|FG000|Overall Study|Patient withdrew consent|5|||
23469653|NCT00441064|65464326|FG001|Overall Study|Patient withdrew consent|2|||
23469654|NCT00606593|65464327|FG000|Overall Study|Adverse Event|0|||
23469655|NCT00606593|65464328|FG001|Overall Study|Adverse Event|0|||
23469656|NCT00606593|65464329|FG002|Overall Study|Adverse Event|0|||
23469657|NCT00606593|65464330|FG003|Overall Study|Adverse Event|1|||
23469658|NCT00606593|65464331|FG004|Overall Study|Adverse Event|1|||
23469659|NCT00606593|65464332|FG005|Overall Study|Adverse Event|0|||
23469660|NCT00606593|65464333|FG006|Overall Study|Adverse Event|1|||
23469661|NCT00606593|65464334|FG007|Overall Study|Adverse Event|2|||
23469662|NCT00606593|65464335|FG008|Overall Study|Adverse Event|1|||
23469663|NCT00606593|65464336|FG009|Overall Study|Adverse Event|0|||
23469664|NCT00606593|65464327|FG000|Overall Study|Withdrawal of consent|1|||
23469665|NCT00606593|65464328|FG001|Overall Study|Withdrawal of consent|0|||
23469666|NCT00606593|65464329|FG002|Overall Study|Withdrawal of consent|1|||
23469667|NCT00606593|65464330|FG003|Overall Study|Withdrawal of consent|0|||
23469668|NCT00606593|65464331|FG004|Overall Study|Withdrawal of consent|0|||
23469669|NCT00606593|65464332|FG005|Overall Study|Withdrawal of consent|0|||
23469670|NCT00606593|65464333|FG006|Overall Study|Withdrawal of consent|0|||
23469671|NCT00606593|65464334|FG007|Overall Study|Withdrawal of consent|0|||
23469672|NCT00606593|65464335|FG008|Overall Study|Withdrawal of consent|0|||
23469673|NCT00606593|65464336|FG009|Overall Study|Withdrawal of consent|0|||
23469674|NCT00606593|65464327|FG000|Overall Study|Administrative/Other|0|||
23469675|NCT00606593|65464328|FG001|Overall Study|Administrative/Other|0|||
23469676|NCT00606593|65464329|FG002|Overall Study|Administrative/Other|1|||
23469677|NCT00606593|65464330|FG003|Overall Study|Administrative/Other|0|||
23469678|NCT00606593|65464331|FG004|Overall Study|Administrative/Other|0|||
23188261|NCT00594399|64430180|FG000|Initial 3 Month Counseling|Pain|2|||
23188262|NCT00594399|64430181|FG001|Initial 3 Month Counseling|Pain|0|||
23188263|NCT00594399|64430182|FG002|Initial 3 Month Counseling|Pain|0|||
23188264|NCT00594399|64430180|FG000|Initial 3 Month Counseling|Moved|1|||
23188265|NCT00594399|64430181|FG001|Initial 3 Month Counseling|Moved|0|||
23469679|NCT00606593|65464332|FG005|Overall Study|Administrative/Other|0|||
23188266|NCT00594399|64430182|FG002|Initial 3 Month Counseling|Moved|0|||
23469680|NCT00606593|65464333|FG006|Overall Study|Administrative/Other|0|||
23469681|NCT00606593|65464334|FG007|Overall Study|Administrative/Other|0|||
23469682|NCT00606593|65464335|FG008|Overall Study|Administrative/Other|0|||
23469683|NCT00606593|65464336|FG009|Overall Study|Administrative/Other|0|||
23469684|NCT04040933|65464338|FG000|Overall Study|Protocol Violation|1|||
23469685|NCT04040933|65464338|FG000|Overall Study|Withdrawal by Subject|2|||
23469686|NCT02379091|65464340|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23469687|NCT02379091|65464341|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
23469688|NCT02379091|65464342|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23469689|NCT02379091|65464343|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
23469690|NCT02379091|65464340|FG000|Overall Study|Principal Investigator Discretion|0|||
23469691|NCT02379091|65464341|FG001|Overall Study|Principal Investigator Discretion|1|||
23469692|NCT02379091|65464342|FG002|Overall Study|Principal Investigator Discretion|0|||
23469693|NCT02379091|65464343|FG003|Overall Study|Principal Investigator Discretion|0|||
23469694|NCT02379091|65464340|FG000|Overall Study|Lost to Follow-up|0|||
23469695|NCT02379091|65464341|FG001|Overall Study|Lost to Follow-up|0|||
23469696|NCT02379091|65464342|FG002|Overall Study|Lost to Follow-up|0|||
23469697|NCT02379091|65464343|FG003|Overall Study|Lost to Follow-up|1|||
23469698|NCT02379091|65464340|FG000|Overall Study|Voluntary Withdrawal|2|||
23469699|NCT02379091|65464341|FG001|Overall Study|Voluntary Withdrawal|5|||
23469700|NCT02379091|65464342|FG002|Overall Study|Voluntary Withdrawal|2|||
23469701|NCT02379091|65464343|FG003|Overall Study|Voluntary Withdrawal|4|||
23469702|NCT02379091|65464340|FG000|Overall Study|Study Termination|7|||
23469703|NCT02379091|65464341|FG001|Overall Study|Study Termination|2|||
23469704|NCT02379091|65464342|FG002|Overall Study|Study Termination|5|||
23469705|NCT02379091|65464343|FG003|Overall Study|Study Termination|8|||
23469706|NCT02379091|65464340|FG000|Overall Study|Lack of Efficacy|3|||
23469707|NCT02379091|65464341|FG001|Overall Study|Lack of Efficacy|0|||
23469708|NCT02379091|65464342|FG002|Overall Study|Lack of Efficacy|0|||
23469709|NCT02379091|65464343|FG003|Overall Study|Lack of Efficacy|0|||
23469710|NCT00122980|65464344|FG000|Overall Study|Death|0|||
23469711|NCT00122980|65464345|FG001|Overall Study|Death|1|||
23469712|NCT00122980|65464344|FG000|Overall Study|Physician Decision|2|||
23469713|NCT00122980|65464345|FG001|Overall Study|Physician Decision|0|||
23469714|NCT00122980|65464344|FG000|Overall Study|Protocol Violation|5|||
23469715|NCT00122980|65464345|FG001|Overall Study|Protocol Violation|1|||
23469716|NCT00122980|65464344|FG000|Overall Study|Withdrawal by Subject|2|||
23469717|NCT00122980|65464345|FG001|Overall Study|Withdrawal by Subject|3|||
23469718|NCT00122980|65464344|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
23469719|NCT00122980|65464345|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
23469720|NCT00122980|65464344|FG000|Overall Study|Study termination|27|||
23469721|NCT00122980|65464345|FG001|Overall Study|Study termination|35|||
23469722|NCT02709538|65464346|FG000|Overall Study|Adverse Event|13|||
23469723|NCT02709538|65464347|FG001|Overall Study|Adverse Event|2|||
23469724|NCT02709538|65464348|FG002|Overall Study|Adverse Event|3|||
23469725|NCT02709538|65464346|FG000|Overall Study|Lack of Efficacy|1|||
23469726|NCT02709538|65464347|FG001|Overall Study|Lack of Efficacy|0|||
23469727|NCT02709538|65464348|FG002|Overall Study|Lack of Efficacy|0|||
23469728|NCT02709538|65464346|FG000|Overall Study|Lost to Follow-up|24|||
23469729|NCT02709538|65464347|FG001|Overall Study|Lost to Follow-up|8|||
23469730|NCT02709538|65464348|FG002|Overall Study|Lost to Follow-up|4|||
23469731|NCT02709538|65464346|FG000|Overall Study|Physician Decision|1|||
23469732|NCT02709538|65464347|FG001|Overall Study|Physician Decision|0|||
23469733|NCT02709538|65464348|FG002|Overall Study|Physician Decision|0|||
23469734|NCT02709538|65464346|FG000|Overall Study|Withdrawal by Subject|40|||
23469735|NCT02709538|65464347|FG001|Overall Study|Withdrawal by Subject|7|||
23469736|NCT02709538|65464348|FG002|Overall Study|Withdrawal by Subject|4|||
23469737|NCT02709538|65464346|FG000|Overall Study|Non-compliance with study procedures|5|||
23469738|NCT02709538|65464347|FG001|Overall Study|Non-compliance with study procedures|0|||
23469739|NCT02709538|65464348|FG002|Overall Study|Non-compliance with study procedures|0|||
23469740|NCT02709538|65464346|FG000|Overall Study|Non-compliance with study drug|2|||
23469741|NCT02709538|65464347|FG001|Overall Study|Non-compliance with study drug|0|||
23469742|NCT02709538|65464348|FG002|Overall Study|Non-compliance with study drug|0|||
23469743|NCT02709538|65464346|FG000|Overall Study|Protocol deviation|10|||
23469744|NCT02709538|65464347|FG001|Overall Study|Protocol deviation|4|||
23469745|NCT02709538|65464348|FG002|Overall Study|Protocol deviation|4|||
23469746|NCT02709538|65464346|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
23469747|NCT02709538|65464347|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
23469748|NCT02709538|65464348|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
23469749|NCT02709538|65464346|FG000|Overall Study|Other|16|||
23469750|NCT02709538|65464347|FG001|Overall Study|Other|7|||
23469751|NCT02709538|65464348|FG002|Overall Study|Other|5|||
23469752|NCT01399372|65464350|FG000|Overall Study|Protocol Violation|3|||
23469753|NCT01399372|65464351|FG001|Overall Study|Protocol Violation|1|||
23587284|NCT03939819|65878977|FG000|Overall Study|Death|2|||
23587285|NCT03939819|65878978|FG001|Overall Study|Death|0|||
23469754|NCT00485134|65464352|FG000|Overall Study|Lost to Follow-up|1|||
23469755|NCT00485134|65464353|FG001|Overall Study|Lost to Follow-up|0|||
23469756|NCT00485134|65464354|FG002|Overall Study|Lost to Follow-up|0|||
23469757|NCT00485134|65464355|FG003|Overall Study|Lost to Follow-up|0|||
23469758|NCT00485134|65464356|FG004|Overall Study|Lost to Follow-up|0|||
23469759|NCT00485134|65464357|FG005|Overall Study|Lost to Follow-up|0|||
23469760|NCT00485134|65464358|FG006|Overall Study|Lost to Follow-up|0|||
23469761|NCT00485134|65464359|FG007|Overall Study|Lost to Follow-up|0|||
23587286|NCT01134562|65878979|FG000|Overall Study|Adverse Event|0|||
23469762|NCT00485134|65464352|FG000|Overall Study|Withdrawal by Subject|0|||
23469763|NCT00485134|65464353|FG001|Overall Study|Withdrawal by Subject|1|||
23469764|NCT00485134|65464354|FG002|Overall Study|Withdrawal by Subject|0|||
23469765|NCT00485134|65464355|FG003|Overall Study|Withdrawal by Subject|0|||
23469766|NCT00485134|65464356|FG004|Overall Study|Withdrawal by Subject|0|||
23469767|NCT00485134|65464357|FG005|Overall Study|Withdrawal by Subject|0|||
23469768|NCT00485134|65464358|FG006|Overall Study|Withdrawal by Subject|0|||
23469769|NCT00485134|65464359|FG007|Overall Study|Withdrawal by Subject|0|||
23469770|NCT00485134|65464352|FG000|Overall Study|Change in health status|0|||
23469771|NCT00485134|65464353|FG001|Overall Study|Change in health status|1|||
23469772|NCT00485134|65464354|FG002|Overall Study|Change in health status|2|||
23469773|NCT00485134|65464355|FG003|Overall Study|Change in health status|1|||
23469774|NCT00485134|65464356|FG004|Overall Study|Change in health status|0|||
23469775|NCT00485134|65464357|FG005|Overall Study|Change in health status|1|||
23469776|NCT00485134|65464358|FG006|Overall Study|Change in health status|0|||
23469777|NCT00485134|65464359|FG007|Overall Study|Change in health status|0|||
23469778|NCT00485134|65464352|FG000|Overall Study|Withdrew for adverse event|0|||
23469779|NCT00485134|65464353|FG001|Overall Study|Withdrew for adverse event|0|||
23469780|NCT00485134|65464354|FG002|Overall Study|Withdrew for adverse event|1|||
23469781|NCT00485134|65464355|FG003|Overall Study|Withdrew for adverse event|0|||
23469782|NCT00485134|65464356|FG004|Overall Study|Withdrew for adverse event|0|||
23469783|NCT00485134|65464357|FG005|Overall Study|Withdrew for adverse event|0|||
23469784|NCT00485134|65464358|FG006|Overall Study|Withdrew for adverse event|0|||
23469785|NCT00485134|65464359|FG007|Overall Study|Withdrew for adverse event|0|||
23469786|NCT00485134|65464352|FG000|Overall Study|Positive drug test|0|||
23469787|NCT00485134|65464353|FG001|Overall Study|Positive drug test|0|||
23469788|NCT00485134|65464354|FG002|Overall Study|Positive drug test|0|||
23469789|NCT00485134|65464355|FG003|Overall Study|Positive drug test|0|||
23469790|NCT00485134|65464356|FG004|Overall Study|Positive drug test|2|||
23469791|NCT00485134|65464357|FG005|Overall Study|Positive drug test|1|||
23469792|NCT00485134|65464358|FG006|Overall Study|Positive drug test|0|||
23469793|NCT00485134|65464359|FG007|Overall Study|Positive drug test|0|||
23469794|NCT00485134|65464352|FG000|Overall Study|Non-compliance|0|||
23469795|NCT00485134|65464353|FG001|Overall Study|Non-compliance|0|||
23469796|NCT00485134|65464354|FG002|Overall Study|Non-compliance|0|||
23469797|NCT00485134|65464355|FG003|Overall Study|Non-compliance|0|||
23469798|NCT00485134|65464356|FG004|Overall Study|Non-compliance|1|||
23469799|NCT00485134|65464357|FG005|Overall Study|Non-compliance|2|||
23469800|NCT00485134|65464358|FG006|Overall Study|Non-compliance|2|||
23469801|NCT00485134|65464359|FG007|Overall Study|Non-compliance|0|||
23469802|NCT00485134|65464352|FG000|Overall Study|Unable to comply with study schedule|0|||
23469803|NCT00485134|65464353|FG001|Overall Study|Unable to comply with study schedule|0|||
23469804|NCT00485134|65464354|FG002|Overall Study|Unable to comply with study schedule|0|||
23469805|NCT00485134|65464355|FG003|Overall Study|Unable to comply with study schedule|0|||
23469806|NCT00485134|65464356|FG004|Overall Study|Unable to comply with study schedule|0|||
23469807|NCT00485134|65464357|FG005|Overall Study|Unable to comply with study schedule|0|||
23469808|NCT00485134|65464358|FG006|Overall Study|Unable to comply with study schedule|0|||
23469809|NCT00485134|65464359|FG007|Overall Study|Unable to comply with study schedule|1|||
23188267|NCT00594399|64430180|FG000|Initial 3 Month Counseling|Family illness|1|||
23188268|NCT00594399|64430181|FG001|Initial 3 Month Counseling|Family illness|0|||
23188269|NCT00594399|64430182|FG002|Initial 3 Month Counseling|Family illness|0|||
23188270|NCT00594399|64430180|FG000|Rerandomization Arm 1 Only|Death|2|||
23188271|NCT00594399|64430181|FG001|Rerandomization Arm 1 Only|Death|1|||
23188272|NCT00594399|64430182|FG002|Rerandomization Arm 1 Only|Death|0|||
23188273|NCT00594399|64430180|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
23188274|NCT00594399|64430181|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
23188275|NCT00594399|64430182|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
23188276|NCT00670111|64430183|FG000|Enrollment to One Month|Testing Failure|0|||
23188277|NCT00670111|64430184|FG001|Enrollment to One Month|Testing Failure|0|||
23188278|NCT00670111|64430185|FG002|Enrollment to One Month|Testing Failure|13|||
23188279|NCT00670111|64430183|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
23188280|NCT00670111|64430184|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
23188281|NCT00670111|64430185|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
23188282|NCT00670111|64430183|FG000|Enrollment to One Month|Physician Decision|1|||
23469810|NCT00485134|65464352|FG000|Overall Study|Pregnancy|0|||
23469811|NCT00485134|65464353|FG001|Overall Study|Pregnancy|0|||
23469812|NCT00485134|65464354|FG002|Overall Study|Pregnancy|0|||
23469813|NCT00485134|65464355|FG003|Overall Study|Pregnancy|0|||
23469814|NCT00485134|65464356|FG004|Overall Study|Pregnancy|0|||
23469815|NCT00485134|65464357|FG005|Overall Study|Pregnancy|0|||
23469816|NCT00485134|65464358|FG006|Overall Study|Pregnancy|1|||
23469817|NCT00485134|65464359|FG007|Overall Study|Pregnancy|0|||
23469818|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
23469819|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
23469820|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
23469821|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
23469822|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
23469823|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
23469824|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
23469825|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
23469826|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
23469827|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
23469828|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
23469829|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
23469830|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
23469831|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
23469832|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
23469833|NCT01235741|65464360|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
23469834|NCT01235741|65464361|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
23469835|NCT01235741|65464362|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
23469836|NCT01235741|65464360|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
23469837|NCT01235741|65464361|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
23469838|NCT01235741|65464362|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
23469839|NCT01235741|65464360|FG000|Randomized to Treatment|Adverse Event|0|||
23469840|NCT01235741|65464361|FG001|Randomized to Treatment|Adverse Event|1|||
23469841|NCT01235741|65464362|FG002|Randomized to Treatment|Adverse Event|1|||
23469842|NCT01235741|65464360|FG000|Randomized to Treatment|Sponsor terminated study|0|||
23469843|NCT01235741|65464361|FG001|Randomized to Treatment|Sponsor terminated study|35|||
23469844|NCT01235741|65464362|FG002|Randomized to Treatment|Sponsor terminated study|34|||
23469845|NCT01235741|65464360|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
23469846|NCT01235741|65464361|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
23469847|NCT01235741|65464362|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
23469848|NCT01235741|65464360|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
23469849|NCT01235741|65464361|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
23188283|NCT00670111|64430184|FG001|Enrollment to One Month|Physician Decision|0|||
23469850|NCT01235741|65464362|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
23469851|NCT01235741|65464360|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
23469852|NCT01235741|65464361|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
23469853|NCT01235741|65464362|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
23469854|NCT01716052|65464363|FG000|Overall Study|Withdrawal of funding|1|||
23469855|NCT01716052|65464364|FG001|Overall Study|Withdrawal of funding|1|||
23469856|NCT01120717|65464367|FG000|Overall Study|Withdrawal by Subject|11|||
23469857|NCT01120717|65464368|FG001|Overall Study|Withdrawal by Subject|6|||
23469858|NCT01120717|65464367|FG000|Overall Study|Adverse Event|10|||
23469859|NCT01120717|65464368|FG001|Overall Study|Adverse Event|6|||
23469860|NCT01120717|65464367|FG000|Overall Study|Protocol Deviation|2|||
23469861|NCT01120717|65464368|FG001|Overall Study|Protocol Deviation|5|||
23469862|NCT01120717|65464367|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23469863|NCT01120717|65464368|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23469864|NCT01120717|65464367|FG000|Overall Study|Lost to Follow-up|2|||
23469865|NCT01120717|65464368|FG001|Overall Study|Lost to Follow-up|3|||
23469866|NCT01120717|65464367|FG000|Overall Study|Death|3|||
23469867|NCT01120717|65464368|FG001|Overall Study|Death|1|||
23469868|NCT01120717|65464367|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
23469869|NCT01120717|65464368|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
23469870|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
23469871|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
23469872|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
23469873|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
23469874|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
23469875|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
23469876|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
23469877|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
23469878|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
23469879|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
23469880|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
23188284|NCT00670111|64430185|FG002|Enrollment to One Month|Physician Decision|0|||
23469881|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
23469882|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
23469883|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
23469884|NCT04173494|65464371|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
23469885|NCT04173494|65464372|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
23469886|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
23469887|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
23247257|NCT03862807|64645796|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
23247258|NCT00916617|64648922|FG000|Overall Study|Adverse Event|3|||
23247259|NCT00916617|64648923|FG001|Overall Study|Adverse Event|2|||
23247260|NCT00916617|64648924|FG002|Overall Study|Adverse Event|6|||
23247261|NCT00916617|64648925|FG003|Overall Study|Adverse Event|3|||
23247262|NCT00916617|64648922|FG000|Overall Study|Withdrawal by Subject|3|||
23247263|NCT00916617|64648923|FG001|Overall Study|Withdrawal by Subject|2|||
23247264|NCT00916617|64648924|FG002|Overall Study|Withdrawal by Subject|0|||
23247265|NCT00916617|64648925|FG003|Overall Study|Withdrawal by Subject|1|||
23247266|NCT00916617|64648922|FG000|Overall Study|Caregiver Request|3|||
23247267|NCT00916617|64648923|FG001|Overall Study|Caregiver Request|2|||
23247268|NCT00916617|64648924|FG002|Overall Study|Caregiver Request|1|||
23247269|NCT00916617|64648925|FG003|Overall Study|Caregiver Request|0|||
23247270|NCT00916617|64648922|FG000|Overall Study|Physician Decision|1|||
23247271|NCT00916617|64648923|FG001|Overall Study|Physician Decision|1|||
23247272|NCT00916617|64648924|FG002|Overall Study|Physician Decision|0|||
23247273|NCT00916617|64648925|FG003|Overall Study|Physician Decision|0|||
23247274|NCT00916617|64648922|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
23247275|NCT00916617|64648923|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
23247276|NCT00916617|64648924|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
23247277|NCT00916617|64648925|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
23247278|NCT00916617|64648922|FG000|Overall Study|Lost to Follow-up|2|||
23247279|NCT00916617|64648923|FG001|Overall Study|Lost to Follow-up|1|||
23247280|NCT00916617|64648924|FG002|Overall Study|Lost to Follow-up|0|||
23469888|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
23469889|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
23469890|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
23469891|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
23469892|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
23469893|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
23469894|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
23469895|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
23469896|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
23469897|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
23469898|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
23469899|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
23469900|NCT04173494|65464371|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
23469901|NCT04173494|65464372|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
23469902|NCT02474069|65464376|FG000|Selection Phase (SP)|Adverse Event|8|||
23469903|NCT02474069|65464377|FG001|Selection Phase (SP)|Adverse Event|0|||
23469904|NCT02474069|65464378|FG002|Selection Phase (SP)|Adverse Event|0|||
23469905|NCT02474069|65464376|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
23469906|NCT02474069|65464377|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
23469907|NCT02474069|65464378|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
23469908|NCT02474069|65464376|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
23469909|NCT02474069|65464377|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
23469910|NCT02474069|65464378|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
23469911|NCT02474069|65464376|FG000|Selection Phase (SP)|Physician Decision|1|||
23469912|NCT02474069|65464377|FG001|Selection Phase (SP)|Physician Decision|0|||
23469913|NCT02474069|65464378|FG002|Selection Phase (SP)|Physician Decision|0|||
23469914|NCT02474069|65464376|FG000|Selection Phase (SP)|Protocol Violation|1|||
23469915|NCT02474069|65464377|FG001|Selection Phase (SP)|Protocol Violation|0|||
23587287|NCT01134562|65878980|FG001|Overall Study|Adverse Event|1|||
23587288|NCT01134562|65878981|FG002|Overall Study|Adverse Event|0|||
23247281|NCT00916617|64648925|FG003|Overall Study|Lost to Follow-up|0|||
23247282|NCT00916617|64648922|FG000|Overall Study|Lack of Efficacy|1|||
23247283|NCT00916617|64648923|FG001|Overall Study|Lack of Efficacy|0|||
23247284|NCT00916617|64648924|FG002|Overall Study|Lack of Efficacy|0|||
23247285|NCT00916617|64648925|FG003|Overall Study|Lack of Efficacy|0|||
23247286|NCT00916617|64648922|FG000|Overall Study|Other|2|||
23247287|NCT00916617|64648923|FG001|Overall Study|Other|0|||
23247288|NCT00916617|64648924|FG002|Overall Study|Other|0|||
23247289|NCT00916617|64648925|FG003|Overall Study|Other|2|||
23247290|NCT02803138|64648926|FG000|Overall Study|Failure to return|38|||
23247291|NCT02803138|64648926|FG000|Overall Study|Insufficient virological response|2|||
23247292|NCT02803138|64648926|FG000|Overall Study|Withdrawn consent|1|||
23247293|NCT02803138|64648926|FG000|Overall Study|Death|1|||
23247294|NCT02803138|64648926|FG000|Overall Study|Other, not specified|28|||
23247295|NCT01017731|64648927|FG000|Overall Study|Lost to Follow-up|2|||
23247296|NCT01017731|64648927|FG000|Overall Study|Withdrawal by Subject|3|||
23247297|NCT01017731|64648927|FG000|Overall Study|Physician Decision|2|||
23247298|NCT01017731|64648927|FG000|Overall Study|Adverse Event|1|||
23247299|NCT00530088|64648928|FG000|Overall Study|Disease Progression|4|||
23247300|NCT00530088|64648928|FG000|Overall Study|Physician Decision|4|||
23247301|NCT00530088|64648928|FG000|Overall Study|Other Not Specified|2|||
23247302|NCT00038467|64648931|FG000|Overall Study|Adverse Event|170|||
23247303|NCT00038467|64648932|FG001|Overall Study|Adverse Event|145|||
23247304|NCT00038467|64648931|FG000|Overall Study|Withdrawal by Subject|150|||
23247305|NCT00038467|64648932|FG001|Overall Study|Withdrawal by Subject|107|||
23247306|NCT00038467|64648931|FG000|Overall Study|Protocol Violation|19|||
23247307|NCT00038467|64648932|FG001|Overall Study|Protocol Violation|22|||
23247308|NCT00038467|64648931|FG000|Overall Study|Death|22|||
23247309|NCT00038467|64648932|FG001|Overall Study|Death|16|||
23247310|NCT00038467|64648931|FG000|Overall Study|Lost to Follow-up|15|||
23247311|NCT00038467|64648932|FG001|Overall Study|Lost to Follow-up|10|||
23247312|NCT00038467|64648931|FG000|Overall Study|Recurrence|109|||
23247313|NCT00038467|64648932|FG001|Overall Study|Recurrence|179|||
23247314|NCT00038467|64648931|FG000|Overall Study|Randomized, but not treated|31|||
23247315|NCT00038467|64648932|FG001|Overall Study|Randomized, but not treated|35|||
23247316|NCT00038467|64648931|FG000|Overall Study|Other|26|||
23247317|NCT00038467|64648932|FG001|Overall Study|Other|28|||
23247318|NCT00138658|64648935|FG000|Overall Study|Adverse Event|23|||
23469916|NCT02474069|65464378|FG002|Selection Phase (SP)|Protocol Violation|0|||
23469917|NCT02474069|65464376|FG000|Selection Phase (SP)|No longer requires treatment|1|||
23469918|NCT02474069|65464377|FG001|Selection Phase (SP)|No longer requires treatment|0|||
23469919|NCT02474069|65464378|FG002|Selection Phase (SP)|No longer requires treatment|0|||
23469920|NCT02474069|65464376|FG000|Selection Phase (SP)|Technical Problem|1|||
23469921|NCT02474069|65464377|FG001|Selection Phase (SP)|Technical Problem|0|||
23469922|NCT02474069|65464378|FG002|Selection Phase (SP)|Technical Problem|0|||
23469923|NCT02474069|65464376|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
23469924|NCT02474069|65464377|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
23469925|NCT02474069|65464378|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
23469926|NCT02474069|65464376|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
23469927|NCT02474069|65464377|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
23469928|NCT02474069|65464378|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
23469929|NCT02474069|65464376|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
23469930|NCT02474069|65464377|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
23469931|NCT02474069|65464378|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
23469932|NCT02474069|65464376|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
23469933|NCT02474069|65464377|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
23469934|NCT02474069|65464378|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
23469935|NCT02474069|65464376|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
23469936|NCT02474069|65464377|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
23469937|NCT02474069|65464378|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
23469938|NCT02474069|65464376|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
23469939|NCT02474069|65464377|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
23469940|NCT02474069|65464378|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
23469941|NCT01509053|65464379|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
23469942|NCT01509053|65464379|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
23469943|NCT01509053|65464379|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
23469944|NCT01509053|65464379|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
23469945|NCT01509053|65464379|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
23469946|NCT01509053|65464379|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
23469947|NCT00123422|65464380|FG000|Overall Study|Physician Decision|2|||
23188285|NCT02015819|64432889|FG000|Overall Study|Rickham catheter was misaligned|0|||
23188286|NCT02015819|64432890|FG001|Overall Study|Rickham catheter was misaligned|0|||
23188287|NCT02015819|64432891|FG002|Overall Study|Rickham catheter was misaligned|0|||
23188288|NCT02015819|64432892|FG003|Overall Study|Rickham catheter was misaligned|1|||
23188289|NCT01450540|64432896|FG000|Overall Study|Withdrawal by Subject|19|||
23188290|NCT01450540|64432897|FG001|Overall Study|Withdrawal by Subject|13|||
23188291|NCT01450540|64432896|FG000|Overall Study|protocol deviation|3|||
23188292|NCT01450540|64432897|FG001|Overall Study|protocol deviation|23|||
23188293|NCT00440401|64432898|FG000|Overall Study|Adverse Event|2|||
23188294|NCT00440401|64432899|FG001|Overall Study|Adverse Event|1|||
23188295|NCT00440401|64432898|FG000|Overall Study|Other|2|||
23188296|NCT00440401|64432899|FG001|Overall Study|Other|5|||
23188297|NCT01450137|64432903|FG000|Up to Week 12|Adverse Event|2|||
23188298|NCT01450137|64432904|FG001|Up to Week 12|Adverse Event|1|||
23247319|NCT00138658|64648935|FG000|Overall Study|Death|1|||
23188299|NCT01450137|64432903|FG000|Up to Week 12|Withdrawal by Subject|0|||
23188300|NCT01450137|64432904|FG001|Up to Week 12|Withdrawal by Subject|2|||
23247320|NCT00138658|64648935|FG000|Overall Study|Disease Progression|21|||
23247321|NCT00138658|64648935|FG000|Overall Study|Physician Decision|11|||
23247322|NCT00138658|64648935|FG000|Overall Study|Withdrawal by Subject|5|||
23247323|NCT02940392|64648936|FG000|Overall Study|Lost to Follow-up|3|||
23247324|NCT02940392|64648936|FG000|Overall Study|Retreatment|3|||
23188301|NCT01450137|64432903|FG000|Week 12 to Study End|Death|0|||
23188302|NCT01450137|64432904|FG001|Week 12 to Study End|Death|1|||
23188303|NCT01450137|64432903|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
23188304|NCT01450137|64432904|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
23188305|NCT00853905|64432911|FG000|Overall Study|Lost to Follow-up|1|||
23188306|NCT00853905|64432912|FG001|Overall Study|Lost to Follow-up|3|||
23188307|NCT00853905|64432911|FG000|Overall Study|Withdrawal by Subject|0|||
23188308|NCT00853905|64432912|FG001|Overall Study|Withdrawal by Subject|1|||
23188309|NCT00853905|64432911|FG000|Overall Study|never had surgery|1|||
23188310|NCT00853905|64432912|FG001|Overall Study|never had surgery|0|||
23188311|NCT04734873|64432914|FG000|Overall Study|Lost to Follow-up|1|||
23188312|NCT04734873|64432915|FG001|Overall Study|Lost to Follow-up|3|||
23188313|NCT04734873|64432916|FG002|Overall Study|Lost to Follow-up|2|||
23188314|NCT04734873|64432914|FG000|Overall Study|Randomized but not dosed|1|||
23188315|NCT04734873|64432915|FG001|Overall Study|Randomized but not dosed|0|||
23188316|NCT04734873|64432916|FG002|Overall Study|Randomized but not dosed|1|||
23188317|NCT02707757|64432917|FG000|Overall Study|Protocol Violation|3|||
23188318|NCT02707757|64432918|FG001|Overall Study|Protocol Violation|2|||
23188319|NCT02707757|64432917|FG000|Overall Study|Withdrawal by Subject|2|||
23188320|NCT02707757|64432918|FG001|Overall Study|Withdrawal by Subject|0|||
23188321|NCT02707757|64432917|FG000|Overall Study|Death|0|||
23188322|NCT02707757|64432918|FG001|Overall Study|Death|1|||
23188323|NCT02707757|64432917|FG000|Overall Study|Adverse Event|6|||
23188324|NCT02707757|64432918|FG001|Overall Study|Adverse Event|4|||
23188325|NCT02707757|64432917|FG000|Overall Study|Renal transplant/elective operation|1|||
23188326|NCT02707757|64432918|FG001|Overall Study|Renal transplant/elective operation|5|||
23188327|NCT00231478|64432919|FG000|Overall Study|Protocol Violation|3|||
23188328|NCT00231478|64432920|FG001|Overall Study|Protocol Violation|2|||
23188329|NCT00231478|64432919|FG000|Overall Study|Refused Treatment|1|||
23188330|NCT00231478|64432920|FG001|Overall Study|Refused Treatment|1|||
23188331|NCT00231478|64432919|FG000|Overall Study|Withdrawal by Subject|1|||
23188332|NCT00231478|64432920|FG001|Overall Study|Withdrawal by Subject|0|||
23188333|NCT00231478|64432919|FG000|Overall Study|Adverse Event|0|||
23188334|NCT00231478|64432920|FG001|Overall Study|Adverse Event|1|||
23188335|NCT00231478|64432919|FG000|Overall Study|Administrative|3|||
23188336|NCT00231478|64432920|FG001|Overall Study|Administrative|2|||
23247325|NCT02940392|64648936|FG000|Overall Study|Death|2|||
23247326|NCT00297882|64648937|FG000|Day 14|Lack of Efficacy|12|||
23247327|NCT00297882|64648938|FG001|Day 14|Lack of Efficacy|49|||
23247328|NCT00297882|64648937|FG000|Day 28|Lost to Follow-up|13|||
23247329|NCT00297882|64648938|FG001|Day 28|Lost to Follow-up|23|||
23247330|NCT00297882|64648937|FG000|Day 28|Lack of Efficacy|3|||
23247331|NCT00297882|64648938|FG001|Day 28|Lack of Efficacy|0|||
23247332|NCT03256526|64648939|FG000|Overall Study|Adverse Event|1|||
23247333|NCT03256526|64648940|FG001|Overall Study|Adverse Event|0|||
23247334|NCT03256526|64648941|FG002|Overall Study|Adverse Event|1|||
23247335|NCT03256526|64648939|FG000|Overall Study|Lost to Follow-up|1|||
23247336|NCT03256526|64648940|FG001|Overall Study|Lost to Follow-up|0|||
23247337|NCT03256526|64648941|FG002|Overall Study|Lost to Follow-up|2|||
23247338|NCT01652872|64648950|FG000|Overall Study|Death|36|||
23247339|NCT01652872|64648951|FG001|Overall Study|Death|39|||
23247340|NCT01652872|64648950|FG000|Overall Study|Lost to Follow-up|28|||
23247341|NCT01652872|64648951|FG001|Overall Study|Lost to Follow-up|23|||
23247342|NCT01652872|64648950|FG000|Overall Study|Decision by sponsor|5|||
23247343|NCT01652872|64648951|FG001|Overall Study|Decision by sponsor|7|||
23247344|NCT01652872|64648950|FG000|Overall Study|Withdrawal by Subject|76|||
23247345|NCT01652872|64648951|FG001|Overall Study|Withdrawal by Subject|84|||
23247346|NCT04639310|64648952|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
23188337|NCT03952650|64432921|FG000|Overall Study|TRAVEL|0|||
23188338|NCT03952650|64432922|FG001|Overall Study|TRAVEL|4|||
23247347|NCT04639310|64648953|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
23247348|NCT03087773|64648955|FG000|Overall Study|Withdrawal by Subject|8|||
23247349|NCT03087773|64648956|FG001|Overall Study|Withdrawal by Subject|4|||
23188339|NCT03952650|64432923|FG002|Overall Study|TRAVEL|0|||
23188340|NCT03952650|64432924|FG003|Overall Study|TRAVEL|4|||
23188341|NCT03952650|64432925|FG004|Overall Study|TRAVEL|0|||
23188342|NCT03952650|64432926|FG005|Overall Study|TRAVEL|3|||
23188343|NCT03952650|64432927|FG006|Overall Study|TRAVEL|2|||
23188344|NCT03952650|64432921|FG000|Overall Study|Withdrawal by Subject|0|||
23188345|NCT03952650|64432922|FG001|Overall Study|Withdrawal by Subject|2|||
23188346|NCT03952650|64432923|FG002|Overall Study|Withdrawal by Subject|0|||
23188347|NCT03952650|64432924|FG003|Overall Study|Withdrawal by Subject|3|||
23188348|NCT03952650|64432925|FG004|Overall Study|Withdrawal by Subject|0|||
23188349|NCT03952650|64432926|FG005|Overall Study|Withdrawal by Subject|1|||
23247350|NCT03087773|64648955|FG000|Overall Study|Lost to Follow-up|12|||
23247351|NCT03087773|64648956|FG001|Overall Study|Lost to Follow-up|8|||
23247352|NCT00826176|64648957|FG000|Overall Study|Lost to Follow-up|1|||
23247353|NCT00826176|64648958|FG001|Overall Study|Lost to Follow-up|0|||
23247354|NCT00826176|64648957|FG000|Overall Study|Subject Withdrew Consent|3|||
23247355|NCT00826176|64648958|FG001|Overall Study|Subject Withdrew Consent|0|||
23247356|NCT00826176|64648957|FG000|Overall Study|Administrative|9|||
23247357|NCT00826176|64648958|FG001|Overall Study|Administrative|0|||
23247358|NCT00883740|64648959|FG000|First Intervention|Lost to Follow-up|1|||
23247359|NCT00883740|64648960|FG001|First Intervention|Lost to Follow-up|0|||
23247360|NCT00883740|64648959|FG000|First Intervention|No longer willing to participate|2|||
23247361|NCT00883740|64648960|FG001|First Intervention|No longer willing to participate|0|||
23247362|NCT00883740|64648959|FG000|First Intervention|Protocol Violation|3|||
23247363|NCT00883740|64648960|FG001|First Intervention|Protocol Violation|6|||
23247364|NCT00883740|64648959|FG000|First Intervention|Adverse Event|1|||
23247365|NCT00883740|64648960|FG001|First Intervention|Adverse Event|2|||
23247366|NCT00883740|64648959|FG000|Second Intervention|Protocol Violation|1|||
23247367|NCT00883740|64648960|FG001|Second Intervention|Protocol Violation|0|||
23247368|NCT00883740|64648959|FG000|Second Intervention|No longer willing to participate|0|||
23247369|NCT00883740|64648960|FG001|Second Intervention|No longer willing to participate|1|||
23247370|NCT02703454|64648961|FG000|Overall Study|Not treated|1|||
23247371|NCT02703454|64648962|FG001|Overall Study|Not treated|3|||
23247372|NCT02703454|64648961|FG000|Overall Study|Withdrawal by Subject|4|||
23247373|NCT02703454|64648962|FG001|Overall Study|Withdrawal by Subject|3|||
23247374|NCT02703454|64648961|FG000|Overall Study|Lost to Follow-up|1|||
23247375|NCT02703454|64648962|FG001|Overall Study|Lost to Follow-up|2|||
23247376|NCT02703454|64648961|FG000|Overall Study|Study discontinuation|5|||
23247377|NCT02703454|64648962|FG001|Overall Study|Study discontinuation|8|||
23247378|NCT00806416|64648966|FG000|Period 1 - Part I|Adverse Event|0|||
23247379|NCT00806416|64648967|FG001|Period 1 - Part I|Adverse Event|1|||
23247380|NCT00806416|64648968|FG002|Period 1 - Part I|Adverse Event|0|||
23247381|NCT00806416|64648969|FG003|Period 1 - Part I|Adverse Event|0|||
23247382|NCT00806416|64648966|FG000|Period 1 - Part I|Lost to Follow-up|0|||
23247383|NCT00806416|64648967|FG001|Period 1 - Part I|Lost to Follow-up|2|||
23247384|NCT00806416|64648968|FG002|Period 1 - Part I|Lost to Follow-up|0|||
23247385|NCT00806416|64648969|FG003|Period 1 - Part I|Lost to Follow-up|0|||
23469948|NCT00123422|65464381|FG001|Overall Study|Physician Decision|2|||
23469949|NCT00123422|65464382|FG002|Overall Study|Physician Decision|6|||
23469950|NCT00123422|65464380|FG000|Overall Study|Withdrawal by Subject|1|||
23469951|NCT00123422|65464381|FG001|Overall Study|Withdrawal by Subject|2|||
23469952|NCT00123422|65464382|FG002|Overall Study|Withdrawal by Subject|2|||
23469953|NCT00123422|65464380|FG000|Overall Study|Lost to Follow-up|1|||
23469954|NCT00123422|65464381|FG001|Overall Study|Lost to Follow-up|2|||
23469955|NCT00123422|65464382|FG002|Overall Study|Lost to Follow-up|2|||
23469956|NCT01950013|65464383|FG000|Overall Study|Withdrawal by Subject|0|||
23469957|NCT01950013|65464384|FG001|Overall Study|Withdrawal by Subject|2|||
23469958|NCT01950013|65464385|FG002|Overall Study|Withdrawal by Subject|0|||
23469959|NCT03926611|65464388|FG000|Overall Study|Adverse Event|0|||
23469960|NCT03926611|65464389|FG001|Overall Study|Adverse Event|0|||
23469961|NCT03926611|65464390|FG002|Overall Study|Adverse Event|0|||
23469962|NCT03926611|65464391|FG003|Overall Study|Adverse Event|3|||
23469963|NCT03926611|65464392|FG004|Overall Study|Adverse Event|1|||
23469964|NCT03926611|65464393|FG005|Overall Study|Adverse Event|3|||
23469965|NCT03926611|65464394|FG006|Overall Study|Adverse Event|0|||
23469966|NCT03926611|65464388|FG000|Overall Study|Lack of Efficacy|1|||
23469967|NCT03926611|65464389|FG001|Overall Study|Lack of Efficacy|2|||
23469968|NCT03926611|65464390|FG002|Overall Study|Lack of Efficacy|0|||
23469969|NCT03926611|65464391|FG003|Overall Study|Lack of Efficacy|0|||
23469970|NCT03926611|65464392|FG004|Overall Study|Lack of Efficacy|1|||
23469971|NCT03926611|65464393|FG005|Overall Study|Lack of Efficacy|0|||
23469972|NCT03926611|65464394|FG006|Overall Study|Lack of Efficacy|1|||
23469973|NCT03926611|65464388|FG000|Overall Study|Physician Decision|0|||
23469974|NCT03926611|65464389|FG001|Overall Study|Physician Decision|0|||
23469975|NCT03926611|65464390|FG002|Overall Study|Physician Decision|0|||
23469976|NCT03926611|65464391|FG003|Overall Study|Physician Decision|0|||
23469977|NCT03926611|65464392|FG004|Overall Study|Physician Decision|0|||
23469978|NCT03926611|65464393|FG005|Overall Study|Physician Decision|1|||
23469979|NCT03926611|65464394|FG006|Overall Study|Physician Decision|0|||
23469980|NCT03926611|65464388|FG000|Overall Study|Protocol Violation|1|||
23469981|NCT03926611|65464389|FG001|Overall Study|Protocol Violation|0|||
23469982|NCT03926611|65464390|FG002|Overall Study|Protocol Violation|0|||
23469983|NCT03926611|65464391|FG003|Overall Study|Protocol Violation|1|||
23469984|NCT03926611|65464392|FG004|Overall Study|Protocol Violation|1|||
23469985|NCT03926611|65464393|FG005|Overall Study|Protocol Violation|1|||
23247386|NCT00806416|64648966|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
23247387|NCT00806416|64648967|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
23247388|NCT00806416|64648968|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
23247389|NCT00806416|64648969|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
23247390|NCT00806416|64648966|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
23469986|NCT03926611|65464394|FG006|Overall Study|Protocol Violation|1|||
23469987|NCT03926611|65464388|FG000|Overall Study|Technical problems|0|||
23469988|NCT03926611|65464389|FG001|Overall Study|Technical problems|0|||
23469989|NCT03926611|65464390|FG002|Overall Study|Technical problems|0|||
23353218|NCT00508157|65037525|FG001|Overall Study|Subject no longer met study criteria|1|||
23353219|NCT00508157|65037524|FG000|Overall Study|Other known cause|0|||
23353220|NCT00508157|65037525|FG001|Overall Study|Other known cause|1|||
23353221|NCT01658904|65037528|FG000|Overall Study|Principal Investigator discretion|2|||
23353222|NCT01658904|65037529|FG001|Overall Study|Principal Investigator discretion|0|||
23353223|NCT01658904|65037530|FG002|Overall Study|Principal Investigator discretion|0|||
23353224|NCT00530790|65037531|FG000|Overall Study|Adverse Event|2|||
23353225|NCT00530790|65037531|FG000|Overall Study|Withdrawal by Subject|2|||
23353226|NCT00530790|65037531|FG000|Overall Study|Physician Decision|1|||
23353227|NCT01348100|65037532|FG000|Overall Study|Subject Withdrew Consent|0|||
23353228|NCT01348100|65037533|FG001|Overall Study|Subject Withdrew Consent|0|||
23353229|NCT01348100|65037534|FG002|Overall Study|Subject Withdrew Consent|2|||
23353230|NCT01348100|65037535|FG003|Overall Study|Subject Withdrew Consent|0|||
23353231|NCT01348100|65037536|FG004|Overall Study|Subject Withdrew Consent|1|||
23353232|NCT01348100|65037537|FG005|Overall Study|Subject Withdrew Consent|0|||
23353233|NCT01348100|65037538|FG006|Overall Study|Subject Withdrew Consent|1|||
23353234|NCT01348100|65037532|FG000|Overall Study|Protocol Deviation|0|||
23353235|NCT01348100|65037533|FG001|Overall Study|Protocol Deviation|0|||
23353236|NCT01348100|65037534|FG002|Overall Study|Protocol Deviation|0|||
23353237|NCT01348100|65037535|FG003|Overall Study|Protocol Deviation|1|||
23353238|NCT01348100|65037536|FG004|Overall Study|Protocol Deviation|0|||
23353239|NCT01348100|65037537|FG005|Overall Study|Protocol Deviation|0|||
23353240|NCT01348100|65037538|FG006|Overall Study|Protocol Deviation|0|||
23353241|NCT01348100|65037532|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23247391|NCT00806416|64648967|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
23247392|NCT00806416|64648968|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
23247393|NCT00806416|64648969|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
23247394|NCT00244881|64648970|FG000|Overall Study|Withdrawal by Subject|3|||
23247395|NCT00447265|64648971|FG000|Overall Study|Physician Decision|1|||
23247396|NCT00447265|64648972|FG001|Overall Study|Physician Decision|0|||
23247397|NCT02856282|64648980|FG000|Overall Study|Withdrawal by Subject|1|||
23247398|NCT01035229|64648981|FG000|Overall Study|Adverse Event|61|||
23247399|NCT01035229|64648982|FG001|Overall Study|Adverse Event|14|||
23247400|NCT01035229|64648981|FG000|Overall Study|Withdrawal by Subject|20|||
23247401|NCT01035229|64648982|FG001|Overall Study|Withdrawal by Subject|7|||
23247402|NCT01035229|64648981|FG000|Overall Study|Lost to Follow-up|1|||
23247403|NCT01035229|64648982|FG001|Overall Study|Lost to Follow-up|0|||
23247404|NCT01035229|64648981|FG000|Overall Study|Administrative problems|1|||
23247405|NCT01035229|64648982|FG001|Overall Study|Administrative problems|1|||
23247406|NCT01035229|64648981|FG000|Overall Study|Death|13|||
23247407|NCT01035229|64648982|FG001|Overall Study|Death|5|||
23247408|NCT01035229|64648981|FG000|Overall Study|New cancer therapy|2|||
23247409|NCT01035229|64648982|FG001|Overall Study|New cancer therapy|0|||
23247410|NCT01035229|64648981|FG000|Overall Study|Protocol Violation|0|||
23353242|NCT01348100|65037533|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23469990|NCT03926611|65464391|FG003|Overall Study|Technical problems|0|||
23247411|NCT01035229|64648982|FG001|Overall Study|Protocol Violation|2|||
23247412|NCT01035229|64648981|FG000|Overall Study|Sponsor's decision to end study|3|||
23247413|NCT01035229|64648982|FG001|Overall Study|Sponsor's decision to end study|3|||
23247414|NCT01035229|64648981|FG000|Overall Study|Disease Progression|261|||
23247415|NCT01035229|64648982|FG001|Overall Study|Disease Progression|152|||
23247416|NCT00320801|64648983|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
23247417|NCT00320801|64648984|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
23247418|NCT00320801|64648985|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
23247419|NCT00320801|64648986|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
23247420|NCT00320801|64648983|FG000|Open-label Run-in Period|Adverse Event|33|||
23247421|NCT00320801|64648984|FG001|Open-label Run-in Period|Adverse Event|0|||
23247422|NCT00320801|64648985|FG002|Open-label Run-in Period|Adverse Event|0|||
23247423|NCT00320801|64648986|FG003|Open-label Run-in Period|Adverse Event|0|||
23247424|NCT00320801|64648983|FG000|Open-label Run-in Period|Administrative|10|||
23247425|NCT00320801|64648984|FG001|Open-label Run-in Period|Administrative|0|||
23247426|NCT00320801|64648985|FG002|Open-label Run-in Period|Administrative|0|||
23247427|NCT00320801|64648986|FG003|Open-label Run-in Period|Administrative|0|||
23247428|NCT00320801|64648983|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
23247429|NCT00320801|64648984|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
23353243|NCT01348100|65037534|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23353244|NCT01348100|65037535|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23353245|NCT01348100|65037536|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23353246|NCT01348100|65037537|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
23353247|NCT01348100|65037538|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23247430|NCT00320801|64648985|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
23469991|NCT03926611|65464392|FG004|Overall Study|Technical problems|0|||
23247431|NCT00320801|64648986|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
23247432|NCT00320801|64648983|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
23247433|NCT00320801|64648984|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
23247434|NCT00320801|64648985|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
23469992|NCT03926611|65464393|FG005|Overall Study|Technical problems|1|||
23469993|NCT03926611|65464394|FG006|Overall Study|Technical problems|0|||
23469994|NCT03926611|65464388|FG000|Overall Study|Withdrawal by Subject|1|||
23353248|NCT01348100|65037532|FG000|Overall Study|Lost to Follow-up|0|||
23353249|NCT01348100|65037533|FG001|Overall Study|Lost to Follow-up|0|||
23353250|NCT01348100|65037534|FG002|Overall Study|Lost to Follow-up|0|||
23353251|NCT01348100|65037535|FG003|Overall Study|Lost to Follow-up|0|||
23247435|NCT00320801|64648986|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
23247436|NCT00320801|64648983|FG000|Open-label Run-in Period|Did not qualify|1|||
23247437|NCT00320801|64648984|FG001|Open-label Run-in Period|Did not qualify|0|||
23247438|NCT00320801|64648985|FG002|Open-label Run-in Period|Did not qualify|0|||
23247439|NCT00320801|64648986|FG003|Open-label Run-in Period|Did not qualify|0|||
23247440|NCT00320801|64648983|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23247441|NCT00320801|64648984|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23247442|NCT00320801|64648985|FG002|Double-blind Phase|Withdrawal by Subject|1|||
23247443|NCT00320801|64648986|FG003|Double-blind Phase|Withdrawal by Subject|0|||
23247444|NCT00320801|64648983|FG000|Double-blind Phase|Adverse Event|0|||
23247445|NCT00320801|64648984|FG001|Double-blind Phase|Adverse Event|2|||
23247446|NCT00320801|64648985|FG002|Double-blind Phase|Adverse Event|8|||
23247447|NCT00320801|64648986|FG003|Double-blind Phase|Adverse Event|0|||
23247448|NCT00320801|64648983|FG000|Double-blind Phase|Administrative|0|||
23247449|NCT00320801|64648984|FG001|Double-blind Phase|Administrative|0|||
23247450|NCT00320801|64648985|FG002|Double-blind Phase|Administrative|4|||
23247451|NCT00320801|64648986|FG003|Double-blind Phase|Administrative|0|||
23247452|NCT00320801|64648983|FG000|Double-blind Phase|Lack of Efficacy|0|||
23247453|NCT00320801|64648984|FG001|Double-blind Phase|Lack of Efficacy|9|||
23247454|NCT00320801|64648985|FG002|Double-blind Phase|Lack of Efficacy|1|||
23247455|NCT00320801|64648986|FG003|Double-blind Phase|Lack of Efficacy|0|||
23247456|NCT00320801|64648983|FG000|Extension Phase|Withdrawal by Subject|0|||
23247457|NCT00320801|64648984|FG001|Extension Phase|Withdrawal by Subject|0|||
23247458|NCT00320801|64648985|FG002|Extension Phase|Withdrawal by Subject|0|||
23247459|NCT00320801|64648986|FG003|Extension Phase|Withdrawal by Subject|6|||
23247460|NCT00320801|64648983|FG000|Extension Phase|Adverse Event|0|||
23247461|NCT00320801|64648984|FG001|Extension Phase|Adverse Event|0|||
23247462|NCT00320801|64648985|FG002|Extension Phase|Adverse Event|0|||
23247463|NCT00320801|64648986|FG003|Extension Phase|Adverse Event|8|||
23247464|NCT00320801|64648983|FG000|Extension Phase|Administrative|0|||
23247465|NCT00320801|64648984|FG001|Extension Phase|Administrative|0|||
23247466|NCT00320801|64648985|FG002|Extension Phase|Administrative|0|||
23247467|NCT00320801|64648986|FG003|Extension Phase|Administrative|29|||
23247468|NCT00320801|64648983|FG000|Extension Phase|Lack of Efficacy|0|||
23469995|NCT03926611|65464389|FG001|Overall Study|Withdrawal by Subject|1|||
23469996|NCT03926611|65464390|FG002|Overall Study|Withdrawal by Subject|1|||
23247469|NCT00320801|64648984|FG001|Extension Phase|Lack of Efficacy|0|||
23353252|NCT01348100|65037536|FG004|Overall Study|Lost to Follow-up|0|||
23353253|NCT01348100|65037537|FG005|Overall Study|Lost to Follow-up|0|||
23353254|NCT01348100|65037538|FG006|Overall Study|Lost to Follow-up|1|||
23353255|NCT01348100|65037532|FG000|Overall Study|Administrative Problems|0|||
23353256|NCT01348100|65037533|FG001|Overall Study|Administrative Problems|0|||
23353257|NCT01348100|65037534|FG002|Overall Study|Administrative Problems|0|||
23353258|NCT01348100|65037535|FG003|Overall Study|Administrative Problems|0|||
23353259|NCT01348100|65037536|FG004|Overall Study|Administrative Problems|0|||
23353260|NCT01348100|65037537|FG005|Overall Study|Administrative Problems|1|||
23353261|NCT01348100|65037538|FG006|Overall Study|Administrative Problems|1|||
23353262|NCT02453256|65037539|FG000|Double Blind Period|Death|1|||
23353263|NCT02453256|65037540|FG001|Double Blind Period|Death|1|||
23469997|NCT03926611|65464391|FG003|Overall Study|Withdrawal by Subject|0|||
23469998|NCT03926611|65464392|FG004|Overall Study|Withdrawal by Subject|0|||
23469999|NCT03926611|65464393|FG005|Overall Study|Withdrawal by Subject|1|||
23470000|NCT03926611|65464394|FG006|Overall Study|Withdrawal by Subject|3|||
23470001|NCT03926611|65464388|FG000|Overall Study|Covid-19 pandemic|0|||
23587289|NCT01134562|65878982|FG003|Overall Study|Adverse Event|0|||
23247470|NCT00320801|64648985|FG002|Extension Phase|Lack of Efficacy|0|||
23247471|NCT00320801|64648986|FG003|Extension Phase|Lack of Efficacy|2|||
23247472|NCT00320801|64648983|FG000|Extension Phase|Lost to Follow-up|0|||
23353264|NCT02453256|65037539|FG000|Double Blind Period|Adverse Event|3|||
23353265|NCT02453256|65037540|FG001|Double Blind Period|Adverse Event|2|||
23470002|NCT03926611|65464389|FG001|Overall Study|Covid-19 pandemic|0|||
23587290|NCT01134562|65878983|FG004|Overall Study|Adverse Event|0|||
23247473|NCT00320801|64648984|FG001|Extension Phase|Lost to Follow-up|0|||
23247474|NCT00320801|64648985|FG002|Extension Phase|Lost to Follow-up|0|||
23247475|NCT00320801|64648986|FG003|Extension Phase|Lost to Follow-up|3|||
23247476|NCT02723786|64648990|FG000|Overall Study|Lost to Follow-up|1|||
23247477|NCT04635631|64648994|FG000|Overall Study|Adverse Event|1|||
23247478|NCT04635631|64648994|FG000|Overall Study|Progressive disease|13|||
23353266|NCT02453256|65037539|FG000|Double Blind Period|Withdrawal by Subject|9|||
23470003|NCT03926611|65464390|FG002|Overall Study|Covid-19 pandemic|1|||
23470004|NCT03926611|65464391|FG003|Overall Study|Covid-19 pandemic|0|||
23470005|NCT03926611|65464392|FG004|Overall Study|Covid-19 pandemic|1|||
23353267|NCT02453256|65037540|FG001|Double Blind Period|Withdrawal by Subject|5|||
23353268|NCT02453256|65037539|FG000|Double Blind Period|Other|0|||
23353269|NCT02453256|65037540|FG001|Double Blind Period|Other|1|||
23353270|NCT02453256|65037539|FG000|Open Label Period|Adverse Event|1|||
23353271|NCT02453256|65037540|FG001|Open Label Period|Adverse Event|3|||
23353272|NCT02453256|65037539|FG000|Open Label Period|Death|0|||
23353273|NCT02453256|65037540|FG001|Open Label Period|Death|1|||
23353274|NCT02453256|65037539|FG000|Open Label Period|Lost to Follow-up|1|||
23353275|NCT02453256|65037540|FG001|Open Label Period|Lost to Follow-up|0|||
23353276|NCT02453256|65037539|FG000|Open Label Period|Other|0|||
23353277|NCT02453256|65037540|FG001|Open Label Period|Other|2|||
23353278|NCT02453256|65037539|FG000|Open Label Period|Withdrawal by Subject|5|||
23353279|NCT02453256|65037540|FG001|Open Label Period|Withdrawal by Subject|1|||
23353280|NCT02086448|65037543|FG000|Overall Study|Withdrawal by Subject|1|||
23353281|NCT02086448|65037544|FG001|Overall Study|Withdrawal by Subject|0|||
23353282|NCT02086448|65037545|FG002|Overall Study|Withdrawal by Subject|0|||
23353283|NCT02086448|65037546|FG003|Overall Study|Withdrawal by Subject|2|||
23353284|NCT01492101|65037547|FG000|Overall Study|Death|323|||
23353285|NCT01492101|65037548|FG001|Overall Study|Death|322|||
23353286|NCT01492101|65037547|FG000|Overall Study|Withdrawal by Subject|14|||
23353287|NCT01492101|65037548|FG001|Overall Study|Withdrawal by Subject|18|||
23353288|NCT01492101|65037547|FG000|Overall Study|Lost to Follow-up|0|||
23353289|NCT01492101|65037548|FG001|Overall Study|Lost to Follow-up|2|||
23353290|NCT03275389|65037549|FG000|Overall Study|Lost to Follow-up|10|||
23353291|NCT03275389|65037550|FG001|Overall Study|Lost to Follow-up|10|||
23353292|NCT03275389|65037551|FG002|Overall Study|Lost to Follow-up|19|||
23353293|NCT03275389|65037552|FG003|Overall Study|Lost to Follow-up|12|||
23353294|NCT03275389|65037553|FG004|Overall Study|Lost to Follow-up|11|||
23353295|NCT03275389|65037554|FG005|Overall Study|Lost to Follow-up|12|||
23353296|NCT03275389|65037555|FG006|Overall Study|Lost to Follow-up|21|||
23353297|NCT03275389|65037556|FG007|Overall Study|Lost to Follow-up|15|||
23353298|NCT03275389|65037557|FG008|Overall Study|Lost to Follow-up|12|||
23353299|NCT03275389|65037558|FG009|Overall Study|Lost to Follow-up|14|||
23353300|NCT03275389|65037549|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353301|NCT03275389|65037550|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353302|NCT03275389|65037551|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353303|NCT03275389|65037552|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353304|NCT03275389|65037553|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23247479|NCT04635631|64648994|FG000|Overall Study|Withdrawal by Subject|1|||
23247480|NCT00518011|64648995|FG000|Overall Study|Death|1|||
23247481|NCT00518011|64648996|FG001|Overall Study|Death|1|||
23247482|NCT00518011|64648995|FG000|Overall Study|Adverse Event|2|||
23247483|NCT00518011|64648996|FG001|Overall Study|Adverse Event|3|||
23247484|NCT00518011|64648995|FG000|Overall Study|Disease Progression|2|||
23247485|NCT00518011|64648996|FG001|Overall Study|Disease Progression|2|||
23247486|NCT00518011|64648995|FG000|Overall Study|Other Reasons|3|||
23247487|NCT00518011|64648996|FG001|Overall Study|Other Reasons|2|||
23247488|NCT00518011|64648995|FG000|Overall Study|Withdrawal by Subject|1|||
23247489|NCT00518011|64648996|FG001|Overall Study|Withdrawal by Subject|0|||
23247490|NCT02284373|64649001|FG000|Overall Study|Withdrawal by Subject|0|||
23247491|NCT02284373|64649002|FG001|Overall Study|Withdrawal by Subject|1|||
23247492|NCT02284373|64649003|FG002|Overall Study|Withdrawal by Subject|0|||
23247493|NCT02284373|64649001|FG000|Overall Study|Other|0|||
23247494|NCT02284373|64649002|FG001|Overall Study|Other|1|||
23247495|NCT02284373|64649003|FG002|Overall Study|Other|0|||
23247496|NCT02284373|64649001|FG000|Overall Study|Lost to Follow-up|0|||
23247497|NCT02284373|64649002|FG001|Overall Study|Lost to Follow-up|1|||
23247498|NCT02284373|64649003|FG002|Overall Study|Lost to Follow-up|0|||
23247499|NCT00203892|64649004|FG000|Overall Study|Physician Decision|1|||
23247500|NCT00203892|64649005|FG001|Overall Study|Physician Decision|2|||
23247501|NCT00203892|64649006|FG002|Overall Study|Physician Decision|0|||
23247502|NCT00203892|64649004|FG000|Overall Study|Death|1|||
23247503|NCT00203892|64649005|FG001|Overall Study|Death|0|||
23247504|NCT00203892|64649006|FG002|Overall Study|Death|0|||
23247505|NCT05083559|64649011|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
23247506|NCT05083559|64649012|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
23247507|NCT05083559|64649011|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
23247508|NCT05083559|64649012|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
23247509|NCT05083559|64649011|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
23247510|NCT05083559|64649012|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
23247511|NCT04578548|64649013|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
23353305|NCT03275389|65037554|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
23353306|NCT03275389|65037555|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353307|NCT03275389|65037556|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353308|NCT03275389|65037557|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
23353309|NCT03275389|65037558|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
23353310|NCT03275389|65037549|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
23353311|NCT03275389|65037550|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23353312|NCT03275389|65037551|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23353313|NCT03275389|65037552|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
23353314|NCT03275389|65037553|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
23353315|NCT03275389|65037554|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
23353316|NCT03275389|65037555|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
23353317|NCT03275389|65037556|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
23353318|NCT03275389|65037557|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
23353319|NCT03275389|65037558|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
23353320|NCT03275389|65037549|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353321|NCT03275389|65037550|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23353322|NCT03275389|65037551|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353323|NCT03275389|65037552|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
23353324|NCT03275389|65037553|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353325|NCT03275389|65037554|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353326|NCT03275389|65037555|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23353327|NCT03275389|65037556|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353328|NCT03275389|65037557|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353329|NCT03275389|65037558|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
23353330|NCT03275389|65037549|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353331|NCT03275389|65037550|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353332|NCT03275389|65037551|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
23353333|NCT03275389|65037552|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353334|NCT03275389|65037553|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353335|NCT03275389|65037554|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353336|NCT03275389|65037555|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353337|NCT03275389|65037556|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353338|NCT03275389|65037557|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
23353339|NCT03275389|65037558|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
23353340|NCT03275389|65037549|FG000|Overall Study|Other|0|||
23353341|NCT03275389|65037550|FG001|Overall Study|Other|4|||
23353342|NCT03275389|65037551|FG002|Overall Study|Other|3|||
23353343|NCT03275389|65037552|FG003|Overall Study|Other|2|||
23353344|NCT03275389|65037553|FG004|Overall Study|Other|2|||
23353345|NCT03275389|65037554|FG005|Overall Study|Other|2|||
23353346|NCT03275389|65037555|FG006|Overall Study|Other|0|||
23353347|NCT03275389|65037556|FG007|Overall Study|Other|0|||
23353348|NCT03275389|65037557|FG008|Overall Study|Other|1|||
23353349|NCT03275389|65037558|FG009|Overall Study|Other|0|||
23353350|NCT02661061|65037560|FG000|Overall Study|Lack of Efficacy|1|||
23353351|NCT02661061|65037561|FG001|Overall Study|Lack of Efficacy|1|||
23353352|NCT02661061|65037560|FG000|Overall Study|Withdrawal by Subject|1|||
23353353|NCT02661061|65037561|FG001|Overall Study|Withdrawal by Subject|1|||
23353354|NCT01366638|65037562|FG000|Overall Study|Withdrawal by Subject|0|||
23353355|NCT01366638|65037563|FG001|Overall Study|Withdrawal by Subject|0|||
23353356|NCT01366638|65037564|FG002|Overall Study|Withdrawal by Subject|6|||
23353357|NCT01366638|65037562|FG000|Overall Study|Other|1|||
23353358|NCT01366638|65037563|FG001|Overall Study|Other|0|||
23353359|NCT01366638|65037564|FG002|Overall Study|Other|0|||
23353360|NCT02172040|65037565|FG000|Overall Study|Adverse Event|0|||
23353361|NCT02172040|65037566|FG001|Overall Study|Adverse Event|2|||
23353362|NCT02172040|65037567|FG002|Overall Study|Adverse Event|0|||
23353363|NCT02172040|65037568|FG003|Overall Study|Adverse Event|0|||
23353364|NCT02172040|65037565|FG000|Overall Study|Protocol Violation|0|||
23353365|NCT02172040|65037566|FG001|Overall Study|Protocol Violation|1|||
23353366|NCT02172040|65037567|FG002|Overall Study|Protocol Violation|0|||
23353367|NCT02172040|65037568|FG003|Overall Study|Protocol Violation|0|||
23353368|NCT02172040|65037565|FG000|Overall Study|Withdrawal by Subject|0|||
23353369|NCT02172040|65037566|FG001|Overall Study|Withdrawal by Subject|0|||
23353370|NCT02172040|65037567|FG002|Overall Study|Withdrawal by Subject|1|||
23353371|NCT02172040|65037568|FG003|Overall Study|Withdrawal by Subject|0|||
23353372|NCT02172040|65037565|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
23353373|NCT02172040|65037566|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
23353374|NCT02172040|65037567|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
23353375|NCT02172040|65037568|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
23353376|NCT02172040|65037565|FG000|Overall Study|Family emergency abroad|0|||
23353377|NCT02172040|65037566|FG001|Overall Study|Family emergency abroad|0|||
23353378|NCT02172040|65037567|FG002|Overall Study|Family emergency abroad|0|||
23353379|NCT02172040|65037568|FG003|Overall Study|Family emergency abroad|1|||
23353380|NCT00359294|65037569|FG000|Overall Study|Progressive disease|1|||
23353381|NCT00359294|65037570|FG001|Overall Study|Progressive disease|1|||
23353382|NCT00359294|65037571|FG002|Overall Study|Progressive disease|2|||
23353383|NCT00359294|65037572|FG003|Overall Study|Progressive disease|3|||
23353384|NCT00359294|65037573|FG004|Overall Study|Progressive disease|2|||
23353385|NCT00359294|65037569|FG000|Overall Study|Withdrawal by Subject|0|||
23353386|NCT00359294|65037570|FG001|Overall Study|Withdrawal by Subject|0|||
23353387|NCT00359294|65037571|FG002|Overall Study|Withdrawal by Subject|0|||
23353388|NCT00359294|65037572|FG003|Overall Study|Withdrawal by Subject|0|||
23353389|NCT00359294|65037573|FG004|Overall Study|Withdrawal by Subject|1|||
23353390|NCT00359294|65037569|FG000|Overall Study|Not treated|0|||
23353391|NCT00359294|65037570|FG001|Overall Study|Not treated|0|||
23353392|NCT00359294|65037571|FG002|Overall Study|Not treated|0|||
23353393|NCT00359294|65037572|FG003|Overall Study|Not treated|1|||
23353394|NCT00359294|65037573|FG004|Overall Study|Not treated|0|||
23353395|NCT00359294|65037569|FG000|Overall Study|Physician Decision|0|||
23353396|NCT00359294|65037570|FG001|Overall Study|Physician Decision|0|||
23353397|NCT00359294|65037571|FG002|Overall Study|Physician Decision|1|||
23353398|NCT00359294|65037572|FG003|Overall Study|Physician Decision|0|||
23353399|NCT00359294|65037573|FG004|Overall Study|Physician Decision|0|||
23353400|NCT00830518|65037574|FG000|Overall Study|Progressive Disease|18|||
23353401|NCT00830518|65037575|FG001|Overall Study|Progressive Disease|8|||
23353402|NCT00830518|65037574|FG000|Overall Study|Symptomatic Deterioration|4|||
23353403|NCT00830518|65037575|FG001|Overall Study|Symptomatic Deterioration|1|||
23353404|NCT00830518|65037574|FG000|Overall Study|Adverse Event|14|||
23353405|NCT00830518|65037575|FG001|Overall Study|Adverse Event|1|||
23353406|NCT00830518|65037574|FG000|Overall Study|Withdrawal by Patient|2|||
23353407|NCT00830518|65037575|FG001|Overall Study|Withdrawal by Patient|0|||
23353408|NCT00830518|65037574|FG000|Overall Study|Reason not Specified|8|||
23353409|NCT00830518|65037575|FG001|Overall Study|Reason not Specified|1|||
23353410|NCT01210352|65037582|FG000|Overall Study|Adverse Event|0|||
23353411|NCT01210352|65037583|FG001|Overall Study|Adverse Event|0|||
23353412|NCT01210352|65037584|FG002|Overall Study|Adverse Event|0|||
23353413|NCT01210352|65037585|FG003|Overall Study|Adverse Event|0|||
23353414|NCT01210352|65037586|FG004|Overall Study|Adverse Event|0|||
23353415|NCT01210352|65037587|FG005|Overall Study|Adverse Event|0|||
23353416|NCT01210352|65037588|FG006|Overall Study|Adverse Event|0|||
23353417|NCT01210352|65037589|FG007|Overall Study|Adverse Event|2|||
23353418|NCT01210352|65037590|FG008|Overall Study|Adverse Event|1|||
23353419|NCT01210352|65037582|FG000|Overall Study|Lack of Efficacy|0|||
23353420|NCT01210352|65037583|FG001|Overall Study|Lack of Efficacy|0|||
23353421|NCT01210352|65037584|FG002|Overall Study|Lack of Efficacy|0|||
23353422|NCT01210352|65037585|FG003|Overall Study|Lack of Efficacy|0|||
23353423|NCT01210352|65037586|FG004|Overall Study|Lack of Efficacy|0|||
23353424|NCT01210352|65037587|FG005|Overall Study|Lack of Efficacy|0|||
23353425|NCT01210352|65037588|FG006|Overall Study|Lack of Efficacy|1|||
23353426|NCT01210352|65037589|FG007|Overall Study|Lack of Efficacy|0|||
23353427|NCT01210352|65037590|FG008|Overall Study|Lack of Efficacy|0|||
23353428|NCT01210352|65037582|FG000|Overall Study|Physician Decision|0|||
23353429|NCT01210352|65037583|FG001|Overall Study|Physician Decision|0|||
23353430|NCT01210352|65037584|FG002|Overall Study|Physician Decision|0|||
23353431|NCT01210352|65037585|FG003|Overall Study|Physician Decision|0|||
23353432|NCT01210352|65037586|FG004|Overall Study|Physician Decision|0|||
23353433|NCT01210352|65037587|FG005|Overall Study|Physician Decision|0|||
23353434|NCT01210352|65037588|FG006|Overall Study|Physician Decision|0|||
23353435|NCT01210352|65037589|FG007|Overall Study|Physician Decision|1|||
23353436|NCT01210352|65037590|FG008|Overall Study|Physician Decision|2|||
23353437|NCT01210352|65037582|FG000|Overall Study|Withdrawal by Subject|0|||
23353438|NCT01210352|65037583|FG001|Overall Study|Withdrawal by Subject|0|||
23353439|NCT01210352|65037584|FG002|Overall Study|Withdrawal by Subject|1|||
23353440|NCT01210352|65037585|FG003|Overall Study|Withdrawal by Subject|0|||
23353441|NCT01210352|65037586|FG004|Overall Study|Withdrawal by Subject|0|||
23353442|NCT01210352|65037587|FG005|Overall Study|Withdrawal by Subject|0|||
23353443|NCT01210352|65037588|FG006|Overall Study|Withdrawal by Subject|1|||
23353444|NCT01210352|65037589|FG007|Overall Study|Withdrawal by Subject|0|||
23353445|NCT01210352|65037590|FG008|Overall Study|Withdrawal by Subject|1|||
23353446|NCT01210352|65037582|FG000|Overall Study|Patient Discharged Early|0|||
23353447|NCT01210352|65037583|FG001|Overall Study|Patient Discharged Early|0|||
23353448|NCT01210352|65037584|FG002|Overall Study|Patient Discharged Early|1|||
23353449|NCT01210352|65037585|FG003|Overall Study|Patient Discharged Early|0|||
23353450|NCT01210352|65037586|FG004|Overall Study|Patient Discharged Early|0|||
23353451|NCT01210352|65037587|FG005|Overall Study|Patient Discharged Early|0|||
23353452|NCT01210352|65037588|FG006|Overall Study|Patient Discharged Early|0|||
23353453|NCT01210352|65037589|FG007|Overall Study|Patient Discharged Early|0|||
23353454|NCT01210352|65037590|FG008|Overall Study|Patient Discharged Early|0|||
23353455|NCT04686266|65037591|FG000|Overall Study|Withdrawal by Subject|0|||
23353456|NCT04686266|65037592|FG001|Overall Study|Withdrawal by Subject|1|||
23353457|NCT03430856|65037593|FG000|Overall Study|Adverse Event|0|||
23353458|NCT03430856|65037594|FG001|Overall Study|Adverse Event|1|||
23353459|NCT03430856|65037595|FG002|Overall Study|Adverse Event|0|||
23353460|NCT03430856|65037593|FG000|Overall Study|Rescue criteria|1|||
23353461|NCT03430856|65037594|FG001|Overall Study|Rescue criteria|1|||
23353462|NCT03430856|65037595|FG002|Overall Study|Rescue criteria|0|||
23353463|NCT03430856|65037593|FG000|Overall Study|Voluntary withdrawal of consent|1|||
23353464|NCT03430856|65037594|FG001|Overall Study|Voluntary withdrawal of consent|1|||
23353465|NCT03430856|65037595|FG002|Overall Study|Voluntary withdrawal of consent|1|||
23353466|NCT00731731|65037596|FG000|Overall Study|Protocol Violation|0|||
23188350|NCT03952650|64432927|FG006|Overall Study|Withdrawal by Subject|1|||
23353467|NCT00731731|65037597|FG001|Overall Study|Protocol Violation|0|||
23353468|NCT00731731|65037598|FG002|Overall Study|Protocol Violation|1|||
23353469|NCT00731731|65037596|FG000|Overall Study|Cancel prior to treatment|0|||
23353470|NCT00731731|65037597|FG001|Overall Study|Cancel prior to treatment|0|||
23353471|NCT00731731|65037598|FG002|Overall Study|Cancel prior to treatment|2|||
23353472|NCT03681184|65037599|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
23353473|NCT03681184|65037600|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
23353474|NCT02688764|65037603|FG000|Overall Study|Adverse Event|3|||
23353475|NCT02688764|65037604|FG001|Overall Study|Adverse Event|3|||
23353476|NCT02688764|65037603|FG000|Overall Study|AE/Kidney transplant|1|||
23353477|NCT02688764|65037604|FG001|Overall Study|AE/Kidney transplant|0|||
23353478|NCT02688764|65037603|FG000|Overall Study|AE/Lack of efficacy|1|||
23188351|NCT03952650|64432921|FG000|Overall Study|Lost to Follow-up|0|||
23188352|NCT03952650|64432922|FG001|Overall Study|Lost to Follow-up|1|||
23188353|NCT03952650|64432923|FG002|Overall Study|Lost to Follow-up|0|||
23353479|NCT02688764|65037604|FG001|Overall Study|AE/Lack of efficacy|0|||
23353480|NCT02688764|65037603|FG000|Overall Study|AE/Non-compl.|1|||
23353481|NCT02688764|65037604|FG001|Overall Study|AE/Non-compl.|0|||
23353482|NCT02688764|65037603|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
23353483|NCT02688764|65037604|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
23353484|NCT02688764|65037603|FG000|Overall Study|AE/Other|0|||
23353485|NCT02688764|65037604|FG001|Overall Study|AE/Other|1|||
23353486|NCT02688764|65037603|FG000|Overall Study|AE/Physician decision|1|||
23353487|NCT02688764|65037604|FG001|Overall Study|AE/Physician decision|0|||
23353488|NCT02688764|65037603|FG000|Overall Study|AE/Withd. parent|3|||
23353489|NCT02688764|65037604|FG001|Overall Study|AE/Withd. parent|0|||
23353490|NCT02688764|65037603|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
23353491|NCT02688764|65037604|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
23353492|NCT02688764|65037603|FG000|Overall Study|AE/Withd. subject|1|||
23353493|NCT02688764|65037604|FG001|Overall Study|AE/Withd. subject|0|||
23353494|NCT02688764|65037603|FG000|Overall Study|Kidney transplant|10|||
23353495|NCT02688764|65037604|FG001|Overall Study|Kidney transplant|4|||
23353496|NCT02688764|65037603|FG000|Overall Study|Lack of Efficacy|3|||
23353497|NCT02688764|65037604|FG001|Overall Study|Lack of Efficacy|2|||
23353498|NCT02688764|65037603|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
23353499|NCT02688764|65037604|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
23353500|NCT02688764|65037603|FG000|Overall Study|Non-compliance with study drug|4|||
23353501|NCT02688764|65037604|FG001|Overall Study|Non-compliance with study drug|0|||
23353502|NCT02688764|65037603|FG000|Overall Study|Non-compl./Physician decision|2|||
23353503|NCT02688764|65037604|FG001|Overall Study|Non-compl./Physician decision|0|||
23353504|NCT02688764|65037603|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
23353505|NCT02688764|65037604|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
23353506|NCT02688764|65037603|FG000|Overall Study|Non-compl./Withd. subject|0|||
23353507|NCT02688764|65037604|FG001|Overall Study|Non-compl./Withd. subject|2|||
23353508|NCT02688764|65037603|FG000|Overall Study|Phosphorus level outside safe range|0|||
23353509|NCT02688764|65037604|FG001|Overall Study|Phosphorus level outside safe range|1|||
23353510|NCT02688764|65037603|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
23353511|NCT02688764|65037604|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
23353512|NCT02688764|65037603|FG000|Overall Study|Study drug taste/Withd. parent|1|||
23353513|NCT02688764|65037604|FG001|Overall Study|Study drug taste/Withd. parent|0|||
23353514|NCT02688764|65037603|FG000|Overall Study|Subject moving out|2|||
23247512|NCT04578548|64649014|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
23353515|NCT02688764|65037604|FG001|Overall Study|Subject moving out|0|||
23353516|NCT02688764|65037603|FG000|Overall Study|Subject taken off dialysis|1|||
23353517|NCT02688764|65037604|FG001|Overall Study|Subject taken off dialysis|0|||
23353518|NCT02688764|65037603|FG000|Overall Study|Withdrawal by parent|3|||
23353519|NCT02688764|65037604|FG001|Overall Study|Withdrawal by parent|0|||
23188354|NCT03952650|64432924|FG003|Overall Study|Lost to Follow-up|0|||
23188355|NCT03952650|64432925|FG004|Overall Study|Lost to Follow-up|0|||
23353520|NCT00483704|65037605|FG000|Randomization|Withdrawal by Subject|19|||
23353521|NCT00483704|65037606|FG001|Randomization|Withdrawal by Subject|28|||
23353522|NCT00483704|65037607|FG002|Randomization|Withdrawal by Subject|18|||
23353523|NCT00483704|65037605|FG000|Randomization|Protocol Violation|14|||
23353524|NCT00483704|65037606|FG001|Randomization|Protocol Violation|25|||
23353525|NCT00483704|65037607|FG002|Randomization|Protocol Violation|22|||
23353526|NCT00483704|65037605|FG000|Randomization|Lost to Follow-up|14|||
23353527|NCT00483704|65037606|FG001|Randomization|Lost to Follow-up|14|||
23353528|NCT00483704|65037607|FG002|Randomization|Lost to Follow-up|19|||
23353529|NCT00483704|65037605|FG000|Randomization|Pregnancy|1|||
23353530|NCT00483704|65037606|FG001|Randomization|Pregnancy|0|||
23353531|NCT00483704|65037607|FG002|Randomization|Pregnancy|0|||
23353532|NCT00483704|65037605|FG000|Randomization|Physician Decision|2|||
23353533|NCT00483704|65037606|FG001|Randomization|Physician Decision|4|||
23353534|NCT00483704|65037607|FG002|Randomization|Physician Decision|0|||
23353535|NCT00483704|65037605|FG000|Randomization|Progressive disease|0|||
23353536|NCT00483704|65037606|FG001|Randomization|Progressive disease|0|||
23353537|NCT00483704|65037607|FG002|Randomization|Progressive disease|1|||
23353538|NCT00483704|65037605|FG000|Randomization|Lack of qualifying migraines|21|||
23353539|NCT00483704|65037606|FG001|Randomization|Lack of qualifying migraines|25|||
23247513|NCT04578548|64649013|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
23247514|NCT04578548|64649014|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
23247515|NCT04578548|64649013|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
23247516|NCT04578548|64649014|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
23247517|NCT04578548|64649013|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
23247518|NCT04578548|64649014|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
23247519|NCT04578548|64649013|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
23247520|NCT04578548|64649014|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
23353540|NCT00483704|65037607|FG002|Randomization|Lack of qualifying migraines|31|||
23353541|NCT00483704|65037605|FG000|Treatment|Lack of qualifying migraines|101|||
23353542|NCT00483704|65037606|FG001|Treatment|Lack of qualifying migraines|99|||
23353543|NCT00483704|65037607|FG002|Treatment|Lack of qualifying migraines|116|||
23353544|NCT00483704|65037605|FG000|Treatment|Adverse Event|3|||
23247521|NCT04578548|64649013|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
23247522|NCT04578548|64649014|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
23247523|NCT03332212|64649015|FG000|Overall Study|Not treated|0|||
23247524|NCT03332212|64649016|FG001|Overall Study|Not treated|1|||
23247525|NCT03332212|64649017|FG002|Overall Study|Not treated|0|||
23247526|NCT03332212|64649018|FG003|Overall Study|Not treated|0|||
23247527|NCT03332212|64649015|FG000|Overall Study|Adverse Event|0|||
23247528|NCT03332212|64649016|FG001|Overall Study|Adverse Event|0|||
23247529|NCT03332212|64649017|FG002|Overall Study|Adverse Event|0|||
23247530|NCT03332212|64649018|FG003|Overall Study|Adverse Event|1|||
23247531|NCT03332212|64649015|FG000|Overall Study|worsening of disease under study|1|||
23247532|NCT03332212|64649016|FG001|Overall Study|worsening of disease under study|1|||
23247533|NCT03332212|64649017|FG002|Overall Study|worsening of disease under study|0|||
23247534|NCT03332212|64649018|FG003|Overall Study|worsening of disease under study|0|||
23247535|NCT01643928|64649025|FG000|Overall Study|Lost to Follow-up|1|||
23247536|NCT01643928|64649026|FG001|Overall Study|Lost to Follow-up|0|||
23247537|NCT01643928|64649027|FG002|Overall Study|Lost to Follow-up|2|||
23247538|NCT01643928|64649028|FG003|Overall Study|Lost to Follow-up|0|||
23247539|NCT01643928|64649029|FG004|Overall Study|Lost to Follow-up|0|||
23247540|NCT01643928|64649025|FG000|Overall Study|Withdrawal by Subject|2|||
23247541|NCT01643928|64649026|FG001|Overall Study|Withdrawal by Subject|0|||
23247542|NCT01643928|64649027|FG002|Overall Study|Withdrawal by Subject|0|||
23247543|NCT01643928|64649028|FG003|Overall Study|Withdrawal by Subject|1|||
23247544|NCT01643928|64649029|FG004|Overall Study|Withdrawal by Subject|0|||
23247545|NCT01643928|64649025|FG000|Overall Study|Pregnancy|0|||
23247546|NCT01643928|64649026|FG001|Overall Study|Pregnancy|0|||
23247547|NCT01643928|64649027|FG002|Overall Study|Pregnancy|0|||
23247548|NCT01643928|64649028|FG003|Overall Study|Pregnancy|1|||
23247549|NCT01643928|64649029|FG004|Overall Study|Pregnancy|0|||
23247550|NCT01643928|64649025|FG000|Overall Study|Other|5|||
23247551|NCT01643928|64649026|FG001|Overall Study|Other|1|||
23247552|NCT01643928|64649027|FG002|Overall Study|Other|1|||
23247553|NCT01643928|64649028|FG003|Overall Study|Other|0|||
23247554|NCT01643928|64649029|FG004|Overall Study|Other|0|||
23247555|NCT01643928|64649025|FG000|Overall Study|Adverse Event|2|||
23247556|NCT01643928|64649026|FG001|Overall Study|Adverse Event|1|||
23247557|NCT01643928|64649027|FG002|Overall Study|Adverse Event|0|||
23247558|NCT01643928|64649028|FG003|Overall Study|Adverse Event|1|||
23247559|NCT01643928|64649029|FG004|Overall Study|Adverse Event|2|||
23353545|NCT00483704|65037606|FG001|Treatment|Adverse Event|5|||
23353546|NCT00483704|65037607|FG002|Treatment|Adverse Event|4|||
23353547|NCT00483704|65037605|FG000|Treatment|Withdrawal by Subject|16|||
23353548|NCT00483704|65037606|FG001|Treatment|Withdrawal by Subject|12|||
23247560|NCT04527549|64649030|FG000|Overall Study|Withdrawal by Subject|1|||
23353549|NCT00483704|65037607|FG002|Treatment|Withdrawal by Subject|21|||
23353550|NCT00483704|65037605|FG000|Treatment|Protocol Violation|6|||
23353551|NCT00483704|65037606|FG001|Treatment|Protocol Violation|3|||
23353552|NCT00483704|65037607|FG002|Treatment|Protocol Violation|5|||
23353553|NCT00483704|65037605|FG000|Treatment|Lost to Follow-up|2|||
23353554|NCT00483704|65037606|FG001|Treatment|Lost to Follow-up|7|||
23353555|NCT00483704|65037607|FG002|Treatment|Lost to Follow-up|5|||
23353556|NCT00483704|65037605|FG000|Treatment|Lack of Efficacy|1|||
23353557|NCT00483704|65037606|FG001|Treatment|Lack of Efficacy|1|||
23353558|NCT00483704|65037607|FG002|Treatment|Lack of Efficacy|1|||
23353559|NCT00483704|65037605|FG000|Treatment|Pregnancy|0|||
23353560|NCT00483704|65037606|FG001|Treatment|Pregnancy|1|||
23353561|NCT00483704|65037607|FG002|Treatment|Pregnancy|0|||
23353562|NCT00483704|65037605|FG000|Treatment|Physician Decision|0|||
23353563|NCT00483704|65037606|FG001|Treatment|Physician Decision|1|||
23353564|NCT00483704|65037607|FG002|Treatment|Physician Decision|4|||
23353565|NCT01027897|65037610|FG000|Overall Study|Protocol Violation|1|||
23353566|NCT01027897|65037610|FG000|Overall Study|Withdrawal by Subject|1|||
23353567|NCT00985426|65037616|FG000|Overall Study|Adverse Event|0|||
23353568|NCT00985426|65037617|FG001|Overall Study|Adverse Event|1|||
23587291|NCT03621761|65878984|FG000|Overall Study|Lost to Follow-up|1|||
23587292|NCT03621761|65878985|FG001|Overall Study|Lost to Follow-up|1|||
23587293|NCT03621761|65878986|FG002|Overall Study|Lost to Follow-up|2|||
23587294|NCT03621761|65878984|FG000|Overall Study|Withdrawal by Subject|2|||
23353569|NCT00985426|65037616|FG000|Overall Study|Subject Non-Compliance|3|||
23353570|NCT00985426|65037617|FG001|Overall Study|Subject Non-Compliance|3|||
23353571|NCT00985426|65037616|FG000|Overall Study|Withdrawal by Subject|12|||
23353572|NCT00985426|65037617|FG001|Overall Study|Withdrawal by Subject|16|||
23353573|NCT00985426|65037616|FG000|Overall Study|Lost to Follow-up|8|||
23353574|NCT00985426|65037617|FG001|Overall Study|Lost to Follow-up|10|||
23353575|NCT00985426|65037616|FG000|Overall Study|Death|7|||
23353576|NCT00985426|65037617|FG001|Overall Study|Death|3|||
23353577|NCT00985426|65037616|FG000|Overall Study|Protocol Violation|2|||
23353578|NCT00985426|65037617|FG001|Overall Study|Protocol Violation|0|||
23353579|NCT00985426|65037616|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
23353580|NCT00985426|65037617|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
23353581|NCT02565706|65037618|FG000|Overall Study|Withdrawal by Subject|5|||
23353582|NCT02565706|65037619|FG001|Overall Study|Withdrawal by Subject|7|||
23353583|NCT02565706|65037620|FG002|Overall Study|Withdrawal by Subject|7|||
23353584|NCT02565706|65037621|FG003|Overall Study|Withdrawal by Subject|11|||
23353585|NCT02565706|65037618|FG000|Overall Study|Lost to Follow-up|72|||
23353586|NCT02565706|65037619|FG001|Overall Study|Lost to Follow-up|75|||
23353587|NCT02565706|65037620|FG002|Overall Study|Lost to Follow-up|82|||
23353588|NCT02565706|65037621|FG003|Overall Study|Lost to Follow-up|74|||
23353589|NCT01243177|65037622|FG000|Overall Study|Lack of Efficacy|47|||
23353590|NCT01243177|65037623|FG001|Overall Study|Lack of Efficacy|31|||
23353591|NCT01243177|65037622|FG000|Overall Study|Protocol Violation|11|||
23353592|NCT01243177|65037623|FG001|Overall Study|Protocol Violation|10|||
23353593|NCT01243177|65037622|FG000|Overall Study|Lost to Follow-up|15|||
23353594|NCT01243177|65037623|FG001|Overall Study|Lost to Follow-up|18|||
23353595|NCT01243177|65037622|FG000|Overall Study|Withdrawal by Subject|46|||
23353596|NCT01243177|65037623|FG001|Overall Study|Withdrawal by Subject|38|||
23353597|NCT01243177|65037622|FG000|Overall Study|AE, serious fatal|0|||
23353598|NCT01243177|65037623|FG001|Overall Study|AE, serious fatal|1|||
23353599|NCT01243177|65037622|FG000|Overall Study|SAE, non-fatal|7|||
23353600|NCT01243177|65037623|FG001|Overall Study|SAE, non-fatal|9|||
23353601|NCT01243177|65037622|FG000|Overall Study|AE, non-serious non-fatal|40|||
23353602|NCT01243177|65037623|FG001|Overall Study|AE, non-serious non-fatal|58|||
23353603|NCT01243177|65037622|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
23353604|NCT01243177|65037623|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
23353605|NCT01243177|65037622|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23353606|NCT01243177|65037623|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
23353607|NCT01243177|65037622|FG000|Overall Study|Other Reason|11|||
23353608|NCT01243177|65037623|FG001|Overall Study|Other Reason|12|||
23353609|NCT03170609|65037627|FG000|Overall Study|Death|0|||
23470006|NCT03926611|65464393|FG005|Overall Study|Covid-19 pandemic|2|||
23470007|NCT03926611|65464394|FG006|Overall Study|Covid-19 pandemic|0|||
23353610|NCT03170609|65037628|FG001|Overall Study|Death|0|||
23587295|NCT03621761|65878985|FG001|Overall Study|Withdrawal by Subject|1|||
23353611|NCT03170609|65037629|FG002|Overall Study|Death|1|||
23353612|NCT03170609|65037630|FG003|Overall Study|Death|0|||
23353613|NCT03170609|65037631|FG004|Overall Study|Death|0|||
23353614|NCT03170609|65037632|FG005|Overall Study|Death|0|||
23353615|NCT03170609|65037633|FG006|Overall Study|Death|0|||
23353616|NCT03170609|65037627|FG000|Overall Study|Withdrawal by Subject|1|||
23353617|NCT03170609|65037628|FG001|Overall Study|Withdrawal by Subject|2|||
23353618|NCT03170609|65037629|FG002|Overall Study|Withdrawal by Subject|0|||
23353619|NCT03170609|65037630|FG003|Overall Study|Withdrawal by Subject|0|||
23353620|NCT03170609|65037631|FG004|Overall Study|Withdrawal by Subject|0|||
23470008|NCT03237286|65464395|FG000|Overall Study|Withdrawal by Subject|1|||
23470009|NCT03237286|65464396|FG001|Overall Study|Withdrawal by Subject|0|||
23470010|NCT03237286|65464397|FG002|Overall Study|Withdrawal by Subject|2|||
23470011|NCT03237286|65464395|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
23470012|NCT03237286|65464396|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
23470013|NCT03237286|65464397|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
23470014|NCT00436345|65464404|FG000|Overall Study|ICU resident beyond follow-up period|3|||
23470015|NCT00436345|65464405|FG001|Overall Study|ICU resident beyond follow-up period|0|||
23470016|NCT02722499|65464406|FG000|Overall Study|Lost to Follow-up|2|||
23470017|NCT02722499|65464407|FG001|Overall Study|Lost to Follow-up|0|||
23470018|NCT02722499|65464408|FG002|Overall Study|Lost to Follow-up|1|||
23470019|NCT02779556|65464411|FG000|Baseline|Partial baseline interview completed|1|||
23470020|NCT02779556|65464412|FG001|Baseline|Partial baseline interview completed|0|||
23470021|NCT02779556|65464411|FG000|3 Months|Lost to Follow-up|40|||
23470022|NCT02779556|65464412|FG001|3 Months|Lost to Follow-up|29|||
23470023|NCT02779556|65464411|FG000|3 Months|Missed 3 month clinic visit|27|||
23470024|NCT02779556|65464412|FG001|3 Months|Missed 3 month clinic visit|19|||
23470025|NCT02779556|65464411|FG000|6 Month|Lost to Follow-up|33|||
23188356|NCT03952650|64432926|FG005|Overall Study|Lost to Follow-up|1|||
23188357|NCT03952650|64432927|FG006|Overall Study|Lost to Follow-up|1|||
23188358|NCT03952650|64432921|FG000|Overall Study|Received wrong vaccine and travelled|0|||
23188359|NCT03952650|64432922|FG001|Overall Study|Received wrong vaccine and travelled|0|||
23188360|NCT03952650|64432923|FG002|Overall Study|Received wrong vaccine and travelled|0|||
23188361|NCT03952650|64432924|FG003|Overall Study|Received wrong vaccine and travelled|0|||
23188362|NCT03952650|64432925|FG004|Overall Study|Received wrong vaccine and travelled|0|||
23188363|NCT03952650|64432926|FG005|Overall Study|Received wrong vaccine and travelled|1|||
23188364|NCT03952650|64432927|FG006|Overall Study|Received wrong vaccine and travelled|0|||
23188365|NCT03952650|64432921|FG000|Overall Study|Unable to make study visit|0|||
23188366|NCT03952650|64432922|FG001|Overall Study|Unable to make study visit|0|||
23188367|NCT03952650|64432923|FG002|Overall Study|Unable to make study visit|0|||
23188368|NCT03952650|64432924|FG003|Overall Study|Unable to make study visit|0|||
23188369|NCT03952650|64432925|FG004|Overall Study|Unable to make study visit|0|||
23188370|NCT03952650|64432926|FG005|Overall Study|Unable to make study visit|1|||
23188371|NCT03952650|64432927|FG006|Overall Study|Unable to make study visit|0|||
23188372|NCT01645930|64432928|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
23188373|NCT01645930|64432928|FG000|Overall Study|Progressive Disease|12|||
23188374|NCT01645930|64432928|FG000|Overall Study|Adverse Event|4|||
23188375|NCT01645930|64432928|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
23188376|NCT01645930|64432928|FG000|Overall Study|Withdrawal by Participant|2|||
23188377|NCT01645930|64432928|FG000|Overall Study|Reason not Defined|1|||
23188378|NCT00408681|64432929|FG000|Overall Study|Lack of Efficacy|2|||
23188379|NCT00408681|64432929|FG000|Overall Study|Adverse Event|7|||
23188380|NCT00957372|64432930|FG000|PART I|Lost to Follow-up|0|||
23188381|NCT00957372|64432931|FG001|PART I|Lost to Follow-up|0|||
23188382|NCT00957372|64432932|FG002|PART I|Lost to Follow-up|1|||
23188383|NCT00957372|64432933|FG003|PART I|Lost to Follow-up|0|||
23188384|NCT00957372|64432930|FG000|PART II|Withdrawal by Subject|0|||
23188385|NCT00957372|64432931|FG001|PART II|Withdrawal by Subject|0|||
23188386|NCT00957372|64432932|FG002|PART II|Withdrawal by Subject|0|||
23188387|NCT00957372|64432933|FG003|PART II|Withdrawal by Subject|8|||
23188388|NCT00957372|64432930|FG000|PART II|Physician Decision|0|||
23188389|NCT00957372|64432931|FG001|PART II|Physician Decision|0|||
23188390|NCT00957372|64432932|FG002|PART II|Physician Decision|0|||
23188391|NCT00957372|64432933|FG003|PART II|Physician Decision|1|||
23188392|NCT00957372|64432930|FG000|PART II|Pregnancy|0|||
23188393|NCT00957372|64432931|FG001|PART II|Pregnancy|0|||
23188394|NCT00957372|64432932|FG002|PART II|Pregnancy|0|||
23188395|NCT00957372|64432933|FG003|PART II|Pregnancy|1|||
23188396|NCT00957372|64432930|FG000|PART II|Not Know|0|||
23188397|NCT00957372|64432931|FG001|PART II|Not Know|0|||
23188398|NCT00957372|64432932|FG002|PART II|Not Know|0|||
23188399|NCT00957372|64432933|FG003|PART II|Not Know|20|||
23188400|NCT00957372|64432930|FG000|PART II|Adverse Event|0|||
23188401|NCT00957372|64432931|FG001|PART II|Adverse Event|0|||
23247561|NCT04527549|64649031|FG001|Overall Study|Withdrawal by Subject|1|||
23188402|NCT00957372|64432932|FG002|PART II|Adverse Event|0|||
23188403|NCT00957372|64432933|FG003|PART II|Adverse Event|10|||
23188404|NCT00957372|64432930|FG000|PART II|Patient non-compliance|0|||
23188405|NCT00957372|64432931|FG001|PART II|Patient non-compliance|0|||
23188406|NCT00957372|64432932|FG002|PART II|Patient non-compliance|0|||
23188407|NCT00957372|64432933|FG003|PART II|Patient non-compliance|4|||
23188408|NCT01845025|64432936|FG000|Overall Study|Adverse Event|6|||
23470026|NCT02779556|65464412|FG001|6 Month|Lost to Follow-up|39|||
23470027|NCT02779556|65464411|FG000|6 Month HbA1c|No value collected during window|69|||
23470028|NCT02779556|65464412|FG001|6 Month HbA1c|No value collected during window|50|||
23247562|NCT01215955|64649033|FG000|Overall Study|Adverse Event|1|||
23247563|NCT01215955|64649034|FG001|Overall Study|Adverse Event|4|||
23247564|NCT01215955|64649035|FG002|Overall Study|Adverse Event|2|||
23247565|NCT01215955|64649036|FG003|Overall Study|Adverse Event|3|||
23247566|NCT01215955|64649033|FG000|Overall Study|Death|2|||
23247567|NCT01215955|64649034|FG001|Overall Study|Death|0|||
23247568|NCT01215955|64649035|FG002|Overall Study|Death|1|||
23247569|NCT01215955|64649036|FG003|Overall Study|Death|3|||
23247570|NCT01215955|64649033|FG000|Overall Study|Entry Criteria Not Met|1|||
23247571|NCT01215955|64649034|FG001|Overall Study|Entry Criteria Not Met|3|||
23247572|NCT01215955|64649035|FG002|Overall Study|Entry Criteria Not Met|4|||
23247573|NCT01215955|64649036|FG003|Overall Study|Entry Criteria Not Met|7|||
23247574|NCT01215955|64649033|FG000|Overall Study|Lack of Efficacy|1|||
23247575|NCT01215955|64649034|FG001|Overall Study|Lack of Efficacy|2|||
23247576|NCT01215955|64649035|FG002|Overall Study|Lack of Efficacy|1|||
23247577|NCT01215955|64649036|FG003|Overall Study|Lack of Efficacy|0|||
23247578|NCT01215955|64649033|FG000|Overall Study|Lost to Follow-up|4|||
23247579|NCT01215955|64649034|FG001|Overall Study|Lost to Follow-up|4|||
23247580|NCT01215955|64649035|FG002|Overall Study|Lost to Follow-up|8|||
23247581|NCT01215955|64649036|FG003|Overall Study|Lost to Follow-up|9|||
23247582|NCT01215955|64649033|FG000|Overall Study|Physician Decision|4|||
23353621|NCT03170609|65037632|FG005|Overall Study|Withdrawal by Subject|0|||
23353622|NCT03170609|65037633|FG006|Overall Study|Withdrawal by Subject|1|||
23353623|NCT03170609|65037627|FG000|Overall Study|Lost to Follow-up|1|||
23353624|NCT03170609|65037628|FG001|Overall Study|Lost to Follow-up|0|||
23353625|NCT03170609|65037629|FG002|Overall Study|Lost to Follow-up|5|||
23353626|NCT03170609|65037630|FG003|Overall Study|Lost to Follow-up|2|||
23353627|NCT03170609|65037631|FG004|Overall Study|Lost to Follow-up|1|||
23587296|NCT03621761|65878986|FG002|Overall Study|Withdrawal by Subject|1|||
23587297|NCT03621761|65878984|FG000|Overall Study|Became Ineligible|0|||
23587298|NCT03621761|65878985|FG001|Overall Study|Became Ineligible|2|||
23587299|NCT03621761|65878986|FG002|Overall Study|Became Ineligible|0|||
23587300|NCT00762606|65878987|FG000|Overall Study|Lost to Follow-up|18|||
23587301|NCT00762606|65878988|FG001|Overall Study|Lost to Follow-up|13|||
23587302|NCT00309452|65878989|FG000|Overall Study|Withdrawal by Subject|3|||
23587303|NCT00309452|65878990|FG001|Overall Study|Withdrawal by Subject|0|||
23247583|NCT01215955|64649034|FG001|Overall Study|Physician Decision|10|||
23247584|NCT01215955|64649035|FG002|Overall Study|Physician Decision|8|||
23587304|NCT01768676|65879000|FG000|Overall Study|Adverse Event|3|||
23247585|NCT01215955|64649036|FG003|Overall Study|Physician Decision|11|||
23247586|NCT01215955|64649033|FG000|Overall Study|Protocol Violation|17|||
23247587|NCT01215955|64649034|FG001|Overall Study|Protocol Violation|13|||
23587305|NCT01768676|65879001|FG001|Overall Study|Adverse Event|3|||
23247588|NCT01215955|64649035|FG002|Overall Study|Protocol Violation|8|||
23353628|NCT03170609|65037632|FG005|Overall Study|Lost to Follow-up|1|||
23353629|NCT03170609|65037633|FG006|Overall Study|Lost to Follow-up|0|||
23353630|NCT03170609|65037627|FG000|Overall Study|Other|1|||
23353631|NCT03170609|65037628|FG001|Overall Study|Other|0|||
23353632|NCT03170609|65037629|FG002|Overall Study|Other|0|||
23353633|NCT03170609|65037630|FG003|Overall Study|Other|0|||
23353634|NCT03170609|65037631|FG004|Overall Study|Other|0|||
23353635|NCT03170609|65037632|FG005|Overall Study|Other|1|||
23353636|NCT03170609|65037633|FG006|Overall Study|Other|0|||
23353637|NCT01038752|65037638|FG000|Overall Study|Tumor Progression|2|||
23353638|NCT01038752|65037639|FG001|Overall Study|Tumor Progression|2|||
23353639|NCT01038752|65037638|FG000|Overall Study|Lost to Follow-up|3|||
23353640|NCT01038752|65037639|FG001|Overall Study|Lost to Follow-up|3|||
23353641|NCT03251482|65037642|FG000|Overall Study|Withdrawal by Subject|0|||
23353642|NCT03251482|65037643|FG001|Overall Study|Withdrawal by Subject|1|||
23353643|NCT03251482|65037644|FG002|Overall Study|Withdrawal by Subject|0|||
23353644|NCT03251482|65037645|FG003|Overall Study|Withdrawal by Subject|0|||
23353645|NCT03251482|65037646|FG004|Overall Study|Withdrawal by Subject|0|||
23353646|NCT01709409|65037647|FG000|Overall Study|Protocol Violation|1|||
23353647|NCT01709409|65037648|FG001|Overall Study|Protocol Violation|0|||
23353648|NCT02131636|65037655|FG000|Overall Study|Personal Reasons|4|||
23353649|NCT02131636|65037656|FG001|Overall Study|Personal Reasons|4|||
23353650|NCT02131636|65037655|FG000|Overall Study|Lost to Follow-up|4|||
23353651|NCT02131636|65037656|FG001|Overall Study|Lost to Follow-up|0|||
23353652|NCT02131636|65037655|FG000|Overall Study|Adverse Event|4|||
23353653|NCT02131636|65037656|FG001|Overall Study|Adverse Event|1|||
23353654|NCT01533688|65037657|FG000|Overall Study|Withdrawal by Subject|5|||
23353655|NCT01533688|65037658|FG001|Overall Study|Withdrawal by Subject|4|||
23353656|NCT01533688|65037659|FG002|Overall Study|Withdrawal by Subject|3|||
23353657|NCT01533688|65037657|FG000|Overall Study|Medically unstable|1|||
23353658|NCT01533688|65037658|FG001|Overall Study|Medically unstable|3|||
23353659|NCT01533688|65037659|FG002|Overall Study|Medically unstable|3|||
23353660|NCT01533688|65037657|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
23353661|NCT01533688|65037658|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
23353662|NCT01533688|65037659|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
23353663|NCT03749109|65037660|FG000|Overall Study|Adverse Event|2|||
23353664|NCT03749109|65037661|FG001|Overall Study|Adverse Event|0|||
23353665|NCT02187861|65037666|FG000|Overall Study|Adverse Event|2|||
23353666|NCT02187861|65037667|FG001|Overall Study|Adverse Event|1|||
23353667|NCT02187861|65037668|FG002|Overall Study|Adverse Event|2|||
23353668|NCT02187861|65037669|FG003|Overall Study|Adverse Event|1|||
23353669|NCT02187861|65037666|FG000|Overall Study|Death|0|||
23353670|NCT02187861|65037667|FG001|Overall Study|Death|3|||
23353671|NCT02187861|65037668|FG002|Overall Study|Death|1|||
23353672|NCT02187861|65037669|FG003|Overall Study|Death|2|||
23353673|NCT02187861|65037666|FG000|Overall Study|Physician Decision|0|||
23353674|NCT02187861|65037667|FG001|Overall Study|Physician Decision|1|||
23353675|NCT02187861|65037668|FG002|Overall Study|Physician Decision|0|||
23353676|NCT02187861|65037669|FG003|Overall Study|Physician Decision|3|||
23353677|NCT02187861|65037666|FG000|Overall Study|Progressive Disease|4|||
23353678|NCT02187861|65037667|FG001|Overall Study|Progressive Disease|42|||
23353679|NCT02187861|65037668|FG002|Overall Study|Progressive Disease|19|||
23353680|NCT02187861|65037669|FG003|Overall Study|Progressive Disease|22|||
23353681|NCT02187861|65037666|FG000|Overall Study|Withdrawal by Subject|0|||
23353682|NCT02187861|65037667|FG001|Overall Study|Withdrawal by Subject|0|||
23353683|NCT02187861|65037668|FG002|Overall Study|Withdrawal by Subject|3|||
23353684|NCT02187861|65037669|FG003|Overall Study|Withdrawal by Subject|3|||
23353685|NCT02187861|65037666|FG000|Overall Study|Other|0|||
23353686|NCT02187861|65037667|FG001|Overall Study|Other|1|||
23353687|NCT02187861|65037668|FG002|Overall Study|Other|7|||
23353688|NCT02187861|65037669|FG003|Overall Study|Other|1|||
23353689|NCT01994902|65037670|FG000|Test Period 1|Withdrawal by Subject|3|||
23353690|NCT01994902|65037671|FG001|Test Period 1|Withdrawal by Subject|0|||
23353691|NCT01994902|65037670|FG000|Test Period 1|device deficiency with adverse event|0|||
23353692|NCT01994902|65037671|FG001|Test Period 1|device deficiency with adverse event|1|||
23353693|NCT01994902|65037670|FG000|Test Period 1|Adverse Event|2|||
23353694|NCT01994902|65037671|FG001|Test Period 1|Adverse Event|1|||
23353695|NCT01994902|65037670|FG000|Test Period 1|Lack of Efficacy|0|||
23587306|NCT01768676|65879000|FG000|Overall Study|Lost to Follow-up|13|||
23587307|NCT01768676|65879001|FG001|Overall Study|Lost to Follow-up|16|||
23353696|NCT01994902|65037671|FG001|Test Period 1|Lack of Efficacy|1|||
23353697|NCT01994902|65037670|FG000|Test Period 1|bag too small|1|||
23353698|NCT01994902|65037671|FG001|Test Period 1|bag too small|0|||
23353699|NCT01994902|65037670|FG000|Test Period 2|Withdrawal by Subject|0|||
23353700|NCT01994902|65037671|FG001|Test Period 2|Withdrawal by Subject|2|||
23353701|NCT01994902|65037670|FG000|Test Period 2|Lack of Efficacy|0|||
23353702|NCT01994902|65037671|FG001|Test Period 2|Lack of Efficacy|1|||
23353703|NCT01994902|65037670|FG000|Test Period 2|Other|0|||
23353704|NCT01994902|65037671|FG001|Test Period 2|Other|3|||
23353705|NCT01119846|65037672|FG000|Overall Study|Adverse Event|1|||
23470029|NCT02779556|65464411|FG000|12 Month HbA1c|No value collected during window|138|||
23353706|NCT01119846|65037673|FG001|Overall Study|Adverse Event|0|||
23353707|NCT01119846|65037674|FG002|Overall Study|Adverse Event|6|||
23353708|NCT01119846|65037672|FG000|Overall Study|Physician Decision|1|||
23353709|NCT01119846|65037673|FG001|Overall Study|Physician Decision|0|||
23353710|NCT01119846|65037674|FG002|Overall Study|Physician Decision|0|||
23353711|NCT01119846|65037672|FG000|Overall Study|Protocol Violation|0|||
23353712|NCT01119846|65037673|FG001|Overall Study|Protocol Violation|0|||
23353713|NCT01119846|65037674|FG002|Overall Study|Protocol Violation|1|||
23353714|NCT01119846|65037672|FG000|Overall Study|Withdrawal by Subject|0|||
23188409|NCT01845025|64432937|FG001|Overall Study|Adverse Event|3|||
23188410|NCT01845025|64432936|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23188411|NCT01845025|64432937|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23188412|NCT01845025|64432936|FG000|Overall Study|Withdrawal by Subject|48|||
23188413|NCT01845025|64432937|FG001|Overall Study|Withdrawal by Subject|44|||
23188414|NCT01845025|64432936|FG000|Overall Study|Lost to Follow-up|13|||
23188415|NCT01845025|64432937|FG001|Overall Study|Lost to Follow-up|13|||
23188416|NCT01845025|64432936|FG000|Overall Study|Administrative problems|8|||
23353715|NCT01119846|65037673|FG001|Overall Study|Withdrawal by Subject|0|||
23353716|NCT01119846|65037674|FG002|Overall Study|Withdrawal by Subject|4|||
23353717|NCT04750278|65037679|FG000|Overall Study|Death|9|||
23353718|NCT04750278|65037680|FG001|Overall Study|Death|10|||
23353719|NCT04750278|65037681|FG002|Overall Study|Death|10|||
23353720|NCT04750278|65037679|FG000|Overall Study|Withdrawal by Subject|4|||
23353721|NCT04750278|65037680|FG001|Overall Study|Withdrawal by Subject|1|||
23353722|NCT04750278|65037681|FG002|Overall Study|Withdrawal by Subject|2|||
23353723|NCT04750278|65037679|FG000|Overall Study|Lost to Follow-up|1|||
23470030|NCT02779556|65464412|FG001|12 Month HbA1c|No value collected during window|102|||
23188417|NCT01845025|64432937|FG001|Overall Study|Administrative problems|8|||
23188418|NCT01845025|64432936|FG000|Overall Study|Death|2|||
23470031|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
23353724|NCT04750278|65037680|FG001|Overall Study|Lost to Follow-up|1|||
23353725|NCT04750278|65037681|FG002|Overall Study|Lost to Follow-up|1|||
23353726|NCT04750278|65037679|FG000|Overall Study|Pregnancy|1|||
23353727|NCT04750278|65037680|FG001|Overall Study|Pregnancy|0|||
23188419|NCT01845025|64432937|FG001|Overall Study|Death|0|||
23470032|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
23353728|NCT04750278|65037681|FG002|Overall Study|Pregnancy|0|||
23353729|NCT04750278|65037679|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
23353730|NCT04750278|65037680|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
23353731|NCT04750278|65037681|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
23353732|NCT04750278|65037679|FG000|Overall Study|Non-compliance|0|||
23353733|NCT04750278|65037680|FG001|Overall Study|Non-compliance|0|||
23353734|NCT04750278|65037681|FG002|Overall Study|Non-compliance|1|||
23353735|NCT04750278|65037679|FG000|Overall Study|Transfer to Outside Facility|0|||
23353736|NCT04750278|65037680|FG001|Overall Study|Transfer to Outside Facility|2|||
23353737|NCT04750278|65037681|FG002|Overall Study|Transfer to Outside Facility|1|||
23353738|NCT04750278|65037679|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
23353739|NCT04750278|65037680|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
23353740|NCT04750278|65037681|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
23353741|NCT04750278|65037679|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
23353742|NCT04750278|65037680|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
23353743|NCT04750278|65037681|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
23353744|NCT01653327|65037682|FG000|Overall Study|Withdrawal by Subject|1|||
23353745|NCT01030718|65037683|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
23353746|NCT01030718|65037684|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
23353747|NCT01030718|65037685|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
23353748|NCT01030718|65037683|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
23353749|NCT01030718|65037684|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
23353750|NCT01030718|65037685|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
23353751|NCT01030718|65037683|FG000|Studies CA180-031 and -036 Combined|Death|0|||
23353752|NCT01030718|65037684|FG001|Studies CA180-031 and -036 Combined|Death|1|||
23353753|NCT01030718|65037685|FG002|Studies CA180-031 and -036 Combined|Death|0|||
23353754|NCT01030718|65037683|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
23353755|NCT01030718|65037684|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
23353756|NCT01030718|65037685|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
23188420|NCT01845025|64432936|FG000|Overall Study|Protocol deviation|3|||
23188421|NCT01845025|64432937|FG001|Overall Study|Protocol deviation|6|||
23188422|NCT01845025|64432936|FG000|Overall Study|Missing|1|||
23188423|NCT01845025|64432937|FG001|Overall Study|Missing|1|||
23188424|NCT04375878|64432939|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
23188425|NCT04375878|64432940|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
23188426|NCT04375878|64432941|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
23188427|NCT04375878|64432942|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
23188428|NCT04375878|64432943|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
23188429|NCT04375878|64432944|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
23188430|NCT04375878|64432939|FG000|Crossover First and Second Interventions|Adverse Event|0|||
23188431|NCT04375878|64432940|FG001|Crossover First and Second Interventions|Adverse Event|0|||
23188432|NCT04375878|64432941|FG002|Crossover First and Second Interventions|Adverse Event|1|||
23188433|NCT04375878|64432942|FG003|Crossover First and Second Interventions|Adverse Event|0|||
23188434|NCT04375878|64432943|FG004|Crossover First and Second Interventions|Adverse Event|0|||
23188435|NCT04375878|64432944|FG005|Crossover First and Second Interventions|Adverse Event|0|||
23188436|NCT04375878|64432939|FG000|Extension Phase|Withdrawal by Subject|0|||
23188437|NCT04375878|64432940|FG001|Extension Phase|Withdrawal by Subject|0|||
23188438|NCT04375878|64432941|FG002|Extension Phase|Withdrawal by Subject|0|||
23188439|NCT04375878|64432942|FG003|Extension Phase|Withdrawal by Subject|0|||
23188440|NCT04375878|64432943|FG004|Extension Phase|Withdrawal by Subject|1|||
23188441|NCT04375878|64432944|FG005|Extension Phase|Withdrawal by Subject|0|||
23188442|NCT01006356|64432945|FG000|Overall Study|Adverse Event|6|||
23188443|NCT01006356|64432945|FG000|Overall Study|Physician Decision|1|||
23188444|NCT01006356|64432945|FG000|Overall Study|Paticipants did not cooperate|6|||
23188445|NCT01006356|64432945|FG000|Overall Study|Withdrawal by Subject|1|||
23188446|NCT01006356|64432945|FG000|Overall Study|Choice by participants|2|||
23188447|NCT01006356|64432945|FG000|Overall Study|Protocol Violation|3|||
23188448|NCT01006356|64432945|FG000|Overall Study|Other|23|||
23188449|NCT00756002|64432946|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
23188450|NCT00756002|64432947|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
23188451|NCT00756002|64432946|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23188452|NCT00756002|64432947|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
23188453|NCT00756002|64432946|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
23188454|NCT00756002|64432947|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
23353757|NCT01030718|65037683|FG000|Study CA180-036 Only|insufficient effect|1|||
23353758|NCT01030718|65037684|FG001|Study CA180-036 Only|insufficient effect|1|||
23353759|NCT01030718|65037685|FG002|Study CA180-036 Only|insufficient effect|5|||
23353760|NCT01030718|65037683|FG000|Study CA180-036 Only|Adverse Event|2|||
23353761|NCT01030718|65037684|FG001|Study CA180-036 Only|Adverse Event|3|||
23188455|NCT00756002|64432946|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
23188456|NCT00756002|64432947|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
23188457|NCT00756002|64432946|FG000|Double-Blind Treatment Period|Other|2|||
23188458|NCT00756002|64432947|FG001|Double-Blind Treatment Period|Other|2|||
23188459|NCT00095121|64432955|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
23188460|NCT00095121|64432956|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
23188461|NCT00095121|64432955|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
23587308|NCT01768676|65879000|FG000|Overall Study|Protocol Violation|1|||
23587309|NCT01768676|65879001|FG001|Overall Study|Protocol Violation|1|||
23587310|NCT01768676|65879000|FG000|Overall Study|Physician Decision|4|||
23587311|NCT01768676|65879001|FG001|Overall Study|Physician Decision|1|||
23587312|NCT01768676|65879000|FG000|Overall Study|Withdrawal by Subject|3|||
23587313|NCT01768676|65879001|FG001|Overall Study|Withdrawal by Subject|10|||
23587314|NCT00269399|65879004|FG000|Overall Study|Lack of Efficacy|27|||
23587315|NCT00269399|65879005|FG001|Overall Study|Lack of Efficacy|10|||
23587316|NCT00269399|65879004|FG000|Overall Study|Adverse Event|10|||
23587317|NCT00269399|65879005|FG001|Overall Study|Adverse Event|4|||
23587318|NCT00269399|65879004|FG000|Overall Study|Withdrawal by Subject|2|||
23188462|NCT00095121|64432956|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
23188463|NCT00377962|64432959|FG000|Core Study: 0-12 Months|Adverse Event|18|||
23188464|NCT00377962|64432960|FG001|Core Study: 0-12 Months|Adverse Event|2|||
23247589|NCT01215955|64649036|FG003|Overall Study|Protocol Violation|8|||
23247590|NCT01215955|64649033|FG000|Overall Study|Sponsor Decision|1|||
23470033|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Patient requirement|20|||
23470034|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Death|5|||
23470035|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Change of therapy|6|||
23470036|NCT01071798|65464414|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
23470037|NCT01071798|65464414|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
23470038|NCT01071798|65464414|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
23470039|NCT01071798|65464414|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
23470040|NCT01071798|65464414|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
23470041|NCT01711216|65464421|FG000|Overall Study|Adverse Event|4|||
23470042|NCT01711216|65464421|FG000|Overall Study|Pregnancy|56|||
23470043|NCT01711216|65464421|FG000|Overall Study|Withdrawal by Subject|6|||
23470044|NCT01711216|65464421|FG000|Overall Study|Lost to Follow-up|46|||
23470045|NCT01711216|65464421|FG000|Overall Study|variety of other minor reasons|83|||
23470046|NCT01711216|65464421|FG000|Overall Study|no reason specified|22|||
23470047|NCT02228980|65464422|FG000|Overall Study|Adverse Event|14|||
23470048|NCT02228980|65464423|FG001|Overall Study|Adverse Event|0|||
23470049|NCT02228980|65464424|FG002|Overall Study|Adverse Event|0|||
23470050|NCT02228980|65464425|FG003|Overall Study|Adverse Event|0|||
23470051|NCT02228980|65464422|FG000|Overall Study|Protocol Violation|7|||
23470052|NCT02228980|65464423|FG001|Overall Study|Protocol Violation|0|||
23470053|NCT02228980|65464424|FG002|Overall Study|Protocol Violation|0|||
23470054|NCT02228980|65464425|FG003|Overall Study|Protocol Violation|0|||
23470055|NCT02228980|65464422|FG000|Overall Study|Withdrawal by Subject|3|||
23470056|NCT02228980|65464423|FG001|Overall Study|Withdrawal by Subject|3|||
23470057|NCT02228980|65464424|FG002|Overall Study|Withdrawal by Subject|2|||
23470058|NCT02228980|65464425|FG003|Overall Study|Withdrawal by Subject|3|||
23470059|NCT02660983|65464435|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
23470060|NCT02660983|65464436|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
23470061|NCT02660983|65464435|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
23470062|NCT02660983|65464436|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
23470063|NCT02660983|65464435|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
23470064|NCT02660983|65464436|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
23470065|NCT02660983|65464435|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
23470066|NCT02660983|65464436|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
23587319|NCT00269399|65879005|FG001|Overall Study|Withdrawal by Subject|5|||
23587320|NCT00269399|65879004|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
23587321|NCT00269399|65879005|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
23587322|NCT00269399|65879004|FG000|Overall Study|Other|0|||
23247591|NCT01215955|64649034|FG001|Overall Study|Sponsor Decision|2|||
23188465|NCT00377962|64432959|FG000|Core Study: 0-12 Months|Death|3|||
23188466|NCT00377962|64432960|FG001|Core Study: 0-12 Months|Death|0|||
23188467|NCT00377962|64432959|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
23188468|NCT00377962|64432960|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
23247592|NCT01215955|64649035|FG002|Overall Study|Sponsor Decision|0|||
23470067|NCT02660983|65464435|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
23470068|NCT02660983|65464436|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
23470069|NCT02660983|65464435|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
23470070|NCT02660983|65464436|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
23470071|NCT02660983|65464435|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
23470072|NCT02660983|65464436|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
23470073|NCT00634101|65464437|FG000|Overall Study|Study Terminated|3|||
23470074|NCT00634101|65464438|FG001|Overall Study|Study Terminated|3|||
23470075|NCT00634101|65464437|FG000|Overall Study|Lost to Follow-up|2|||
23470076|NCT00634101|65464438|FG001|Overall Study|Lost to Follow-up|0|||
23470077|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
23470078|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
23470079|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
23470080|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
23470081|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
23470082|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
23470083|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
23470084|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
23470085|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
23470086|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
23470087|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
23470088|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
23470089|NCT00479687|65464439|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
23470090|NCT00479687|65464440|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
23470091|NCT00479687|65464441|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
23470092|NCT00479687|65464439|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
23470093|NCT00479687|65464440|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
23470094|NCT00479687|65464441|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
23470095|NCT00479687|65464439|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
23470096|NCT00479687|65464440|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
23470097|NCT00479687|65464441|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
23470098|NCT00479687|65464439|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
23470099|NCT00479687|65464440|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
23470100|NCT00479687|65464441|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
23470101|NCT00479687|65464439|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
23470102|NCT00479687|65464440|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
23470103|NCT00479687|65464441|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
23470104|NCT00808080|65464446|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
23470105|NCT00867815|65464454|FG000|Overall Study|Lost to Follow-up|1|||
23470106|NCT02223858|65464455|FG000|Overall Study|Death|1|||
23470107|NCT02223858|65464456|FG001|Overall Study|Death|1|||
23470108|NCT02223858|65464455|FG000|Overall Study|Lost to Follow-up|6|||
23470109|NCT02223858|65464456|FG001|Overall Study|Lost to Follow-up|11|||
23470110|NCT02223858|65464455|FG000|Overall Study|Withdrawal by Subject|8|||
23470111|NCT02223858|65464456|FG001|Overall Study|Withdrawal by Subject|5|||
23470112|NCT02223858|65464455|FG000|Overall Study|Refused|9|||
23470113|NCT02223858|65464456|FG001|Overall Study|Refused|9|||
23470114|NCT01469377|65464457|FG000|Overall Study|Protocol Deviation|7|||
23470115|NCT01469377|65464458|FG001|Overall Study|Protocol Deviation|10|||
23470116|NCT01469377|65464459|FG002|Overall Study|Protocol Deviation|10|||
23470117|NCT01469377|65464457|FG000|Overall Study|Lost to Follow-up|3|||
23470118|NCT01469377|65464458|FG001|Overall Study|Lost to Follow-up|2|||
23470119|NCT01469377|65464459|FG002|Overall Study|Lost to Follow-up|5|||
23587323|NCT00269399|65879005|FG001|Overall Study|Other|4|||
23587324|NCT00269399|65879004|FG000|Overall Study|Development of exclusion criteria|0|||
23587325|NCT00269399|65879005|FG001|Overall Study|Development of exclusion criteria|1|||
23587326|NCT00197236|65879010|FG000|Overall Study|Adverse Event|1|||
23587327|NCT00197236|65879011|FG001|Overall Study|Adverse Event|0|||
23587328|NCT00197236|65879012|FG002|Overall Study|Adverse Event|1|||
23587329|NCT00197236|65879010|FG000|Overall Study|Lost to Follow-up|5|||
23587330|NCT00197236|65879011|FG001|Overall Study|Lost to Follow-up|14|||
23587331|NCT00197236|65879012|FG002|Overall Study|Lost to Follow-up|6|||
23587332|NCT00197236|65879010|FG000|Overall Study|Protocol Violation|0|||
23247593|NCT01215955|64649036|FG003|Overall Study|Sponsor Decision|1|||
23247594|NCT01215955|64649033|FG000|Overall Study|Withdrawal by Subject|14|||
23470120|NCT01469377|65464457|FG000|Overall Study|Withdrawal of Consent|12|||
23470121|NCT01469377|65464458|FG001|Overall Study|Withdrawal of Consent|14|||
23587333|NCT00197236|65879011|FG001|Overall Study|Protocol Violation|0|||
23587334|NCT00197236|65879012|FG002|Overall Study|Protocol Violation|1|||
23587335|NCT00197236|65879010|FG000|Overall Study|Withdrawal by Subject|7|||
23587336|NCT00197236|65879011|FG001|Overall Study|Withdrawal by Subject|3|||
23587337|NCT00197236|65879012|FG002|Overall Study|Withdrawal by Subject|11|||
23470122|NCT01469377|65464459|FG002|Overall Study|Withdrawal of Consent|15|||
23470123|NCT01469377|65464457|FG000|Overall Study|Adverse Event|8|||
23470124|NCT01469377|65464458|FG001|Overall Study|Adverse Event|18|||
23470125|NCT01469377|65464459|FG002|Overall Study|Adverse Event|36|||
23470126|NCT01469377|65464457|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23470127|NCT01469377|65464458|FG001|Overall Study|Insufficient Therapeutic Response|4|||
23470128|NCT01469377|65464459|FG002|Overall Study|Insufficient Therapeutic Response|0|||
23247595|NCT01215955|64649034|FG001|Overall Study|Withdrawal by Subject|15|||
23247596|NCT01215955|64649035|FG002|Overall Study|Withdrawal by Subject|13|||
23247597|NCT01215955|64649036|FG003|Overall Study|Withdrawal by Subject|9|||
23247598|NCT01215955|64649033|FG000|Overall Study|Quality Issues|0|||
23247599|NCT01215955|64649034|FG001|Overall Study|Quality Issues|0|||
23247600|NCT01215955|64649035|FG002|Overall Study|Quality Issues|3|||
23247601|NCT01215955|64649036|FG003|Overall Study|Quality Issues|2|||
23470129|NCT01469377|65464457|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23247602|NCT03683719|64649039|FG000|Overall Study|Lack of Efficacy|1|||
23470130|NCT01469377|65464458|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23470131|NCT01469377|65464459|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23470132|NCT01006291|65464460|FG000|Overall Study|Adverse Event|2|||
23470133|NCT01006291|65464461|FG001|Overall Study|Adverse Event|1|||
23470134|NCT01006291|65464462|FG002|Overall Study|Adverse Event|2|||
23470135|NCT01006291|65464460|FG000|Overall Study|Lack of Efficacy|2|||
23470136|NCT01006291|65464461|FG001|Overall Study|Lack of Efficacy|2|||
23470137|NCT01006291|65464462|FG002|Overall Study|Lack of Efficacy|1|||
23470138|NCT01006291|65464460|FG000|Overall Study|Protocol Violation|3|||
23470139|NCT01006291|65464461|FG001|Overall Study|Protocol Violation|3|||
23470140|NCT01006291|65464462|FG002|Overall Study|Protocol Violation|3|||
23470141|NCT01006291|65464460|FG000|Overall Study|Withdrawal criteria|5|||
23470142|NCT01006291|65464461|FG001|Overall Study|Withdrawal criteria|4|||
23470143|NCT01006291|65464462|FG002|Overall Study|Withdrawal criteria|4|||
23470144|NCT01006291|65464460|FG000|Overall Study|Other|14|||
23470145|NCT01006291|65464461|FG001|Overall Study|Other|14|||
23470146|NCT01006291|65464462|FG002|Overall Study|Other|17|||
23470147|NCT00098813|65464463|FG000|Overall Study|Death|8|||
23470148|NCT00098813|65464463|FG000|Overall Study|Protocol Violation|1|||
23470149|NCT00098813|65464463|FG000|Overall Study|Withdrawal by Subject|7|||
23470150|NCT00098813|65464463|FG000|Overall Study|Progression of Disease|1|||
23470151|NCT00098813|65464463|FG000|Overall Study|Other complicating disease|1|||
23470152|NCT00098813|65464463|FG000|Overall Study|Reversal of RAI resistance|1|||
23470153|NCT02405442|65464464|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
23470154|NCT02405442|65464465|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
23470155|NCT02405442|65464466|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
23470156|NCT02405442|65464467|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
23470157|NCT02405442|65464464|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
23470158|NCT02405442|65464465|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
23470159|NCT02405442|65464466|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
23470160|NCT02405442|65464467|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
23470161|NCT02405442|65464464|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
23470162|NCT02405442|65464465|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
23470163|NCT02405442|65464466|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
23470164|NCT02405442|65464467|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
23470165|NCT02405442|65464464|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
23470166|NCT02405442|65464465|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
23470167|NCT02405442|65464466|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
23470168|NCT02405442|65464467|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
23470169|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
23470170|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
23470171|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
23470172|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
23470173|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
23470174|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
23470175|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
23470176|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
23470177|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
23470178|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
23470179|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
23587338|NCT00197236|65879010|FG000|Overall Study|Study drug/medication expiration|1|||
23247603|NCT03683719|64649040|FG001|Overall Study|Lack of Efficacy|3|||
23247604|NCT03683719|64649041|FG002|Overall Study|Lack of Efficacy|4|||
23247605|NCT03683719|64649042|FG003|Overall Study|Lack of Efficacy|0|||
23247606|NCT03683719|64649043|FG004|Overall Study|Lack of Efficacy|4|||
23247607|NCT03683719|64649039|FG000|Overall Study|Adverse Event|6|||
23247608|NCT03683719|64649040|FG001|Overall Study|Adverse Event|6|||
23353762|NCT01030718|65037685|FG002|Study CA180-036 Only|Adverse Event|0|||
23470180|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
23470181|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
23470182|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
23470183|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
23470184|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
23470185|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
23470186|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
23470187|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
23470188|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
23470189|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
23470190|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
23470191|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
23470192|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
23470193|NCT02405442|65464464|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
23470194|NCT02405442|65464465|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
23470195|NCT02405442|65464466|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
23470196|NCT02405442|65464467|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
23470197|NCT02405442|65464464|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
23470198|NCT02405442|65464465|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
23470199|NCT02405442|65464466|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
23470200|NCT02405442|65464467|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
23470201|NCT02405442|65464464|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
23470202|NCT02405442|65464465|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
23247609|NCT03683719|64649041|FG002|Overall Study|Adverse Event|0|||
23247610|NCT03683719|64649042|FG003|Overall Study|Adverse Event|1|||
23247611|NCT03683719|64649043|FG004|Overall Study|Adverse Event|3|||
23247612|NCT03683719|64649039|FG000|Overall Study|Withdrawal by Subject|4|||
23247613|NCT03683719|64649040|FG001|Overall Study|Withdrawal by Subject|4|||
23247614|NCT03683719|64649041|FG002|Overall Study|Withdrawal by Subject|3|||
23247615|NCT03683719|64649042|FG003|Overall Study|Withdrawal by Subject|5|||
23188469|NCT00377962|64432959|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
23247616|NCT03683719|64649043|FG004|Overall Study|Withdrawal by Subject|5|||
23247617|NCT03683719|64649039|FG000|Overall Study|Lost to Follow-up|1|||
23247618|NCT03683719|64649040|FG001|Overall Study|Lost to Follow-up|0|||
23353763|NCT01030718|65037683|FG000|Study CA180-036 Only|Death|0|||
23470203|NCT02405442|65464466|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
23470204|NCT02405442|65464467|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
23470205|NCT02405442|65464464|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
23470206|NCT02405442|65464465|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
23470207|NCT02405442|65464466|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
23587339|NCT00197236|65879011|FG001|Overall Study|Study drug/medication expiration|0|||
23587340|NCT00197236|65879012|FG002|Overall Study|Study drug/medication expiration|3|||
23587341|NCT00197236|65879010|FG000|Overall Study|Returned out of specified time window|0|||
23587342|NCT00197236|65879011|FG001|Overall Study|Returned out of specified time window|0|||
23587343|NCT00197236|65879012|FG002|Overall Study|Returned out of specified time window|1|||
23587344|NCT03006341|65879013|FG000|Overall Study|Not linked in the EMR|25069|||
23587345|NCT03006341|65879014|FG001|Overall Study|Not linked in the EMR|67505|||
23587346|NCT03006341|65879015|FG002|Overall Study|Not linked in the EMR|30993|||
23587347|NCT03006341|65879016|FG003|Overall Study|Not linked in the EMR|10685|||
23587348|NCT01876511|65879017|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
23587349|NCT01876511|65879018|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
23587350|NCT01876511|65879019|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
23587351|NCT01876511|65879017|FG000|Overall Study|Death (unrelated)|3|||
23587352|NCT01876511|65879018|FG001|Overall Study|Death (unrelated)|0|||
23587353|NCT01876511|65879019|FG002|Overall Study|Death (unrelated)|2|||
23587354|NCT01876511|65879017|FG000|Overall Study|Drug-related Toxicity|5|||
23587355|NCT01876511|65879018|FG001|Overall Study|Drug-related Toxicity|1|||
23587356|NCT01876511|65879019|FG002|Overall Study|Drug-related Toxicity|6|||
23587357|NCT01876511|65879017|FG000|Overall Study|Patient Decision|3|||
23587358|NCT01876511|65879018|FG001|Overall Study|Patient Decision|0|||
23587359|NCT01876511|65879019|FG002|Overall Study|Patient Decision|6|||
23188470|NCT00377962|64432960|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
23188471|NCT00377962|64432959|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
23188472|NCT00377962|64432960|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
23188473|NCT00377962|64432959|FG000|Extension Study: 12-24 Months|Death|1|||
23188474|NCT00377962|64432960|FG001|Extension Study: 12-24 Months|Death|1|||
23188475|NCT00377962|64432959|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
23188476|NCT00377962|64432960|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
23188477|NCT00377962|64432959|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
23353764|NCT01030718|65037684|FG001|Study CA180-036 Only|Death|1|||
23353765|NCT01030718|65037685|FG002|Study CA180-036 Only|Death|0|||
23353766|NCT01030718|65037683|FG000|Study CA180-036 Only|Other Reasons|0|||
23188478|NCT00377962|64432960|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
23188479|NCT00377962|64432959|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
23188480|NCT00377962|64432960|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
23470208|NCT02405442|65464467|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
23470209|NCT01160822|65464472|FG000|Overall Study|Adverse Event|0|||
23470210|NCT01160822|65464473|FG001|Overall Study|Adverse Event|0|||
23470211|NCT01160822|65464474|FG002|Overall Study|Adverse Event|0|||
23470212|NCT01160822|65464475|FG003|Overall Study|Adverse Event|0|||
23470213|NCT01160822|65464476|FG004|Overall Study|Adverse Event|1|||
23470214|NCT01160822|65464477|FG005|Overall Study|Adverse Event|2|||
23470215|NCT01160822|65464478|FG006|Overall Study|Adverse Event|5|||
23470216|NCT01160822|65464472|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23470217|NCT01160822|65464473|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23470218|NCT01160822|65464474|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23470219|NCT01160822|65464475|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
23470220|NCT01160822|65464476|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
23470221|NCT01160822|65464477|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
23470222|NCT01160822|65464478|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
23470223|NCT01160822|65464472|FG000|Overall Study|Withdrawal by Subject|0|||
23470224|NCT01160822|65464473|FG001|Overall Study|Withdrawal by Subject|0|||
23470225|NCT01160822|65464474|FG002|Overall Study|Withdrawal by Subject|0|||
23470226|NCT01160822|65464475|FG003|Overall Study|Withdrawal by Subject|0|||
23470227|NCT01160822|65464476|FG004|Overall Study|Withdrawal by Subject|0|||
23470228|NCT01160822|65464477|FG005|Overall Study|Withdrawal by Subject|0|||
23470229|NCT01160822|65464478|FG006|Overall Study|Withdrawal by Subject|1|||
23470230|NCT01160822|65464472|FG000|Overall Study|Lost to Follow-up|0|||
23470231|NCT01160822|65464473|FG001|Overall Study|Lost to Follow-up|0|||
23470232|NCT01160822|65464474|FG002|Overall Study|Lost to Follow-up|0|||
23470233|NCT01160822|65464475|FG003|Overall Study|Lost to Follow-up|0|||
23470234|NCT01160822|65464476|FG004|Overall Study|Lost to Follow-up|1|||
23470235|NCT01160822|65464477|FG005|Overall Study|Lost to Follow-up|0|||
23470236|NCT01160822|65464478|FG006|Overall Study|Lost to Follow-up|0|||
23188481|NCT02919306|64432964|FG000|Overall Study|Withdrawal by Subject|1|||
23353767|NCT01030718|65037684|FG001|Study CA180-036 Only|Other Reasons|2|||
23587360|NCT01876511|65879017|FG000|Overall Study|Physician Decision|1|||
23587361|NCT01876511|65879018|FG001|Overall Study|Physician Decision|0|||
23587362|NCT01876511|65879019|FG002|Overall Study|Physician Decision|1|||
23587363|NCT00244855|65879023|FG000|Overall Study|Withdrawal by Subject|0|||
23587364|NCT00244855|65879024|FG001|Overall Study|Withdrawal by Subject|1|||
23587365|NCT00464672|65879025|FG000|Overall Study|withdrawal of consent|0|||
23188482|NCT02919306|64432965|FG001|Overall Study|Withdrawal by Subject|0|||
23188483|NCT02919306|64432964|FG000|Overall Study|Protocol Violation|1|||
23188484|NCT02919306|64432965|FG001|Overall Study|Protocol Violation|0|||
23188485|NCT00206518|64432966|FG000|Overall Study|Lack of Efficacy|6|||
23188486|NCT00206518|64432967|FG001|Overall Study|Lack of Efficacy|4|||
23247619|NCT03683719|64649041|FG002|Overall Study|Lost to Follow-up|0|||
23353768|NCT01030718|65037685|FG002|Study CA180-036 Only|Other Reasons|0|||
23353769|NCT01578499|65037686|FG000|Overall Study|Reason not Specified|0|||
23470237|NCT01160822|65464472|FG000|Overall Study|Administrative problems|0|||
23470238|NCT01160822|65464473|FG001|Overall Study|Administrative problems|0|||
23470239|NCT01160822|65464474|FG002|Overall Study|Administrative problems|0|||
23587366|NCT00464672|65879026|FG001|Overall Study|withdrawal of consent|0|||
23587367|NCT00464672|65879027|FG002|Overall Study|withdrawal of consent|0|||
23188487|NCT00206518|64432966|FG000|Overall Study|Adverse Event|2|||
23188488|NCT00206518|64432967|FG001|Overall Study|Adverse Event|1|||
23188489|NCT00206518|64432966|FG000|Overall Study|Physician Decision|1|||
23353770|NCT01578499|65037687|FG001|Overall Study|Reason not Specified|1|||
23353771|NCT01578499|65037686|FG000|Overall Study|Lost to Follow-up|2|||
23587368|NCT00464672|65879028|FG003|Overall Study|withdrawal of consent|1|||
23470240|NCT01160822|65464475|FG003|Overall Study|Administrative problems|0|||
23470241|NCT01160822|65464476|FG004|Overall Study|Administrative problems|1|||
23587369|NCT00464672|65879029|FG004|Overall Study|withdrawal of consent|9|||
23470242|NCT01160822|65464477|FG005|Overall Study|Administrative problems|0|||
23247620|NCT03683719|64649042|FG003|Overall Study|Lost to Follow-up|1|||
23247621|NCT03683719|64649043|FG004|Overall Study|Lost to Follow-up|1|||
23353772|NCT01578499|65037687|FG001|Overall Study|Lost to Follow-up|1|||
23353773|NCT01578499|65037686|FG000|Overall Study|Withdrawal by Subject|10|||
23353774|NCT01578499|65037687|FG001|Overall Study|Withdrawal by Subject|16|||
23353775|NCT01578499|65037686|FG000|Overall Study|Death|20|||
23353776|NCT01578499|65037687|FG001|Overall Study|Death|25|||
23188490|NCT00206518|64432967|FG001|Overall Study|Physician Decision|0|||
23353777|NCT01578499|65037686|FG000|Overall Study|Died and End of Study Page not Completed|2|||
23353778|NCT01578499|65037687|FG001|Overall Study|Died and End of Study Page not Completed|0|||
23353779|NCT01739764|65037689|FG000|Overall Study|Adverse Event|0|||
23353780|NCT01739764|65037690|FG001|Overall Study|Adverse Event|3|||
23353781|NCT01739764|65037691|FG002|Overall Study|Adverse Event|4|||
23353782|NCT01739764|65037689|FG000|Overall Study|Death|4|||
23353783|NCT01739764|65037690|FG001|Overall Study|Death|6|||
23353784|NCT01739764|65037691|FG002|Overall Study|Death|38|||
23353785|NCT01739764|65037689|FG000|Overall Study|Lost to Follow-up|0|||
23353786|NCT01739764|65037690|FG001|Overall Study|Lost to Follow-up|0|||
23353787|NCT01739764|65037691|FG002|Overall Study|Lost to Follow-up|5|||
23470243|NCT01160822|65464478|FG006|Overall Study|Administrative problems|0|||
23470244|NCT01160822|65464472|FG000|Overall Study|Protocol deviation|0|||
23470245|NCT01160822|65464473|FG001|Overall Study|Protocol deviation|0|||
23470246|NCT01160822|65464474|FG002|Overall Study|Protocol deviation|0|||
23470247|NCT01160822|65464475|FG003|Overall Study|Protocol deviation|0|||
23470248|NCT01160822|65464476|FG004|Overall Study|Protocol deviation|2|||
23470249|NCT01160822|65464477|FG005|Overall Study|Protocol deviation|0|||
23470250|NCT01160822|65464478|FG006|Overall Study|Protocol deviation|0|||
23470251|NCT01908803|65464479|FG000|Overall Study|Adverse Event|1|||
23470252|NCT01908803|65464480|FG001|Overall Study|Adverse Event|0|||
23470253|NCT01908803|65464479|FG000|Overall Study|Physician Decision|0|||
23470254|NCT01908803|65464480|FG001|Overall Study|Physician Decision|1|||
23470255|NCT01908803|65464479|FG000|Overall Study|Withdrawal by Subject|1|||
23470256|NCT01908803|65464480|FG001|Overall Study|Withdrawal by Subject|0|||
23470257|NCT01908803|65464479|FG000|Overall Study|Randomization Error|1|||
23188491|NCT00206518|64432966|FG000|Overall Study|Protocol Violation|1|||
23188492|NCT00206518|64432967|FG001|Overall Study|Protocol Violation|1|||
23188493|NCT00465569|64432968|FG000|Overall Study|persistent eczema during dose escalation|1|||
23188494|NCT00465569|64432969|FG001|Overall Study|persistent eczema during dose escalation|0|||
23188495|NCT00995371|64432970|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
23188496|NCT00995371|64432971|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
23188497|NCT04329949|64432976|FG000|Overall Study|Death|36|||
23188498|NCT04329949|64432976|FG000|Overall Study|Withdrawal by Subject|4|||
23188499|NCT04329949|64432976|FG000|Overall Study|Termination of study by sponsor|3|||
23188500|NCT01025635|64432977|FG000|Overall Study|Withdrawal by Subject|6|||
23188501|NCT01025635|64432978|FG001|Overall Study|Withdrawal by Subject|7|||
23188502|NCT01025635|64432977|FG000|Overall Study|Protocol Violation|4|||
23188503|NCT01025635|64432978|FG001|Overall Study|Protocol Violation|2|||
23188504|NCT01025635|64432977|FG000|Overall Study|Lack of Efficacy|0|||
23188505|NCT01025635|64432978|FG001|Overall Study|Lack of Efficacy|1|||
23188506|NCT01025635|64432977|FG000|Overall Study|Lost to Follow-up|9|||
23188507|NCT01025635|64432978|FG001|Overall Study|Lost to Follow-up|13|||
23188508|NCT01025635|64432977|FG000|Overall Study|Reason not known|4|||
23188509|NCT01025635|64432978|FG001|Overall Study|Reason not known|2|||
23188510|NCT02286960|64432979|FG000|Overall Study|Lost to Follow-up|3|||
23188511|NCT02286960|64432980|FG001|Overall Study|Lost to Follow-up|3|||
23188512|NCT02286102|64432981|FG000|Overall Study|Screen Failure|1|||
23188513|NCT02286102|64432982|FG001|Overall Study|Screen Failure|1|||
23247622|NCT03683719|64649039|FG000|Overall Study|Other personal reasons|0|||
23247623|NCT03683719|64649040|FG001|Overall Study|Other personal reasons|0|||
23247624|NCT03683719|64649041|FG002|Overall Study|Other personal reasons|1|||
23470258|NCT01908803|65464480|FG001|Overall Study|Randomization Error|0|||
23188514|NCT00996840|64432983|FG000|Overall Study|Adverse Event|0|||
23247625|NCT03683719|64649042|FG003|Overall Study|Other personal reasons|0|||
23353788|NCT01739764|65037689|FG000|Overall Study|Non-Compliance|0|||
23353789|NCT01739764|65037690|FG001|Overall Study|Non-Compliance|0|||
23353790|NCT01739764|65037691|FG002|Overall Study|Non-Compliance|1|||
23470259|NCT01908803|65464479|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
23353791|NCT01739764|65037689|FG000|Overall Study|Multiple Reasons|3|||
23353792|NCT01739764|65037690|FG001|Overall Study|Multiple Reasons|2|||
23353793|NCT01739764|65037691|FG002|Overall Study|Multiple Reasons|3|||
23353794|NCT01739764|65037689|FG000|Overall Study|Physician Decision|2|||
23353795|NCT01739764|65037690|FG001|Overall Study|Physician Decision|2|||
23353796|NCT01739764|65037691|FG002|Overall Study|Physician Decision|4|||
23247626|NCT03683719|64649043|FG004|Overall Study|Other personal reasons|1|||
23247627|NCT04854421|64649044|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
23247628|NCT04854421|64649045|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
23247629|NCT00057330|64649046|FG000|Overall Study|Adverse Event|9|||
23247630|NCT00057330|64649047|FG001|Overall Study|Adverse Event|12|||
23247631|NCT00057330|64649046|FG000|Overall Study|Death|1|||
23247632|NCT00057330|64649047|FG001|Overall Study|Death|0|||
23247633|NCT00057330|64649046|FG000|Overall Study|Protocol Violation|1|||
23247634|NCT00057330|64649047|FG001|Overall Study|Protocol Violation|1|||
23247635|NCT00057330|64649046|FG000|Overall Study|Withdrawal by Subject|115|||
23247636|NCT00057330|64649047|FG001|Overall Study|Withdrawal by Subject|84|||
23247637|NCT00057330|64649046|FG000|Overall Study|Lost to Follow-up|745|||
23247638|NCT00057330|64649047|FG001|Overall Study|Lost to Follow-up|617|||
23247639|NCT00057330|64649046|FG000|Overall Study|Physician Decision|1|||
23247640|NCT00057330|64649047|FG001|Overall Study|Physician Decision|0|||
23247641|NCT00057330|64649046|FG000|Overall Study|Other|260|||
23247642|NCT00057330|64649047|FG001|Overall Study|Other|206|||
23247643|NCT05144477|64649048|FG000|Overall Study|Withdrawal by Subject|1|||
23247644|NCT05144477|64649049|FG001|Overall Study|Withdrawal by Subject|1|||
23247645|NCT00630994|64649050|FG000|Overall Study|Adverse Event|1|||
23247646|NCT00630994|64649050|FG000|Overall Study|Disease Progression|1|||
23247647|NCT00630994|64649050|FG000|Overall Study|Lack of Efficacy|1|||
23247648|NCT00630994|64649050|FG000|Overall Study|Other|1|||
23247649|NCT02861534|64649051|FG000|Overall Study|Death|541|||
23247650|NCT02861534|64649052|FG001|Overall Study|Death|552|||
23247651|NCT02861534|64649051|FG000|Overall Study|Lost to Follow-up|14|||
23353797|NCT01739764|65037689|FG000|Overall Study|Progressive Disease|3|||
23188515|NCT00996840|64432984|FG001|Overall Study|Adverse Event|1|||
23188516|NCT00996840|64432985|FG002|Overall Study|Adverse Event|0|||
23188517|NCT00996840|64432986|FG003|Overall Study|Adverse Event|0|||
23188518|NCT00996840|64432987|FG004|Overall Study|Adverse Event|0|||
23188519|NCT00996840|64432983|FG000|Overall Study|Physician Decision|0|||
23188520|NCT00996840|64432984|FG001|Overall Study|Physician Decision|0|||
23188521|NCT00996840|64432985|FG002|Overall Study|Physician Decision|1|||
23188522|NCT00996840|64432986|FG003|Overall Study|Physician Decision|1|||
23188523|NCT00996840|64432987|FG004|Overall Study|Physician Decision|2|||
23188524|NCT00996840|64432983|FG000|Overall Study|Withdrawal by Subject|1|||
23188525|NCT00996840|64432984|FG001|Overall Study|Withdrawal by Subject|1|||
23188526|NCT00996840|64432985|FG002|Overall Study|Withdrawal by Subject|0|||
23188527|NCT00996840|64432986|FG003|Overall Study|Withdrawal by Subject|0|||
23188528|NCT00996840|64432987|FG004|Overall Study|Withdrawal by Subject|0|||
23188529|NCT01633060|64432988|FG000|Randomization Phase|Protocol deviation|1|||
23188530|NCT01633060|64432989|FG001|Randomization Phase|Protocol deviation|2|||
23188531|NCT01633060|64432988|FG000|Randomization Phase|Technical problem|0|||
23188532|NCT01633060|64432989|FG001|Randomization Phase|Technical problem|1|||
23188533|NCT01633060|64432988|FG000|Treatment Phase|Adverse Event|24|||
23188534|NCT01633060|64432989|FG001|Treatment Phase|Adverse Event|3|||
23188535|NCT01633060|64432988|FG000|Treatment Phase|Lost to Follow-up|1|||
23188536|NCT01633060|64432989|FG001|Treatment Phase|Lost to Follow-up|0|||
23188537|NCT01633060|64432988|FG000|Treatment Phase|Physician Decision|16|||
23188538|NCT01633060|64432989|FG001|Treatment Phase|Physician Decision|7|||
23188539|NCT01633060|64432988|FG000|Treatment Phase|Progressive Disease|210|||
23188540|NCT01633060|64432989|FG001|Treatment Phase|Progressive Disease|120|||
23188541|NCT01633060|64432988|FG000|Treatment Phase|Protocol Deviation|1|||
23188542|NCT01633060|64432989|FG001|Treatment Phase|Protocol Deviation|0|||
23188543|NCT01633060|64432988|FG000|Treatment Phase|Study Terminated by sponsor|7|||
23188544|NCT01633060|64432989|FG001|Treatment Phase|Study Terminated by sponsor|3|||
23353798|NCT01739764|65037690|FG001|Overall Study|Progressive Disease|5|||
23188545|NCT01633060|64432988|FG000|Treatment Phase|Subject/guardian decision|25|||
23188546|NCT01633060|64432989|FG001|Treatment Phase|Subject/guardian decision|4|||
23188547|NCT01633060|64432988|FG000|Treatment Phase|Death|4|||
23247652|NCT02861534|64649052|FG001|Overall Study|Lost to Follow-up|14|||
23247653|NCT02861534|64649051|FG000|Overall Study|Site Terminated by Sponsor|4|||
23247654|NCT02861534|64649052|FG001|Overall Study|Site Terminated by Sponsor|3|||
23247655|NCT02861534|64649051|FG000|Overall Study|Withdrawal by Subject|15|||
23353799|NCT01739764|65037691|FG002|Overall Study|Progressive Disease|16|||
23188548|NCT01633060|64432989|FG001|Treatment Phase|Death|3|||
23247656|NCT02861534|64649052|FG001|Overall Study|Withdrawal by Subject|18|||
23247657|NCT00798707|64649057|FG000|Overall Study|Adverse Event|6|||
23247658|NCT00798707|64649058|FG001|Overall Study|Adverse Event|8|||
23247659|NCT00798707|64649059|FG002|Overall Study|Adverse Event|8|||
23247660|NCT00798707|64649057|FG000|Overall Study|Failed to return|2|||
23247661|NCT00798707|64649058|FG001|Overall Study|Failed to return|2|||
23247662|NCT00798707|64649059|FG002|Overall Study|Failed to return|0|||
23247663|NCT00798707|64649057|FG000|Overall Study|Investigator|0|||
23247664|NCT00798707|64649058|FG001|Overall Study|Investigator|1|||
23247665|NCT00798707|64649059|FG002|Overall Study|Investigator|2|||
23247666|NCT00798707|64649057|FG000|Overall Study|Lack of Efficacy|2|||
23247667|NCT00798707|64649058|FG001|Overall Study|Lack of Efficacy|2|||
23247668|NCT00798707|64649059|FG002|Overall Study|Lack of Efficacy|1|||
23353800|NCT01739764|65037689|FG000|Overall Study|Protocol Violation|0|||
23353801|NCT01739764|65037690|FG001|Overall Study|Protocol Violation|0|||
23353802|NCT01739764|65037691|FG002|Overall Study|Protocol Violation|2|||
23353803|NCT01739764|65037689|FG000|Overall Study|Study Terminated by Sponsor|8|||
23353804|NCT01739764|65037690|FG001|Overall Study|Study Terminated by Sponsor|13|||
23353805|NCT01739764|65037691|FG002|Overall Study|Study Terminated by Sponsor|26|||
23353806|NCT01739764|65037689|FG000|Overall Study|Withdrawal by Subject|6|||
23353807|NCT01739764|65037690|FG001|Overall Study|Withdrawal by Subject|5|||
23353808|NCT01739764|65037691|FG002|Overall Study|Withdrawal by Subject|27|||
23353809|NCT03617861|65037692|FG000|Second Intervention (1 Day)|Adverse Event|0|||
23353810|NCT03617861|65037693|FG001|Second Intervention (1 Day)|Adverse Event|0|||
23353811|NCT03617861|65037694|FG002|Second Intervention (1 Day)|Adverse Event|1|||
23353812|NCT03617861|65037695|FG003|Second Intervention (1 Day)|Adverse Event|0|||
23353813|NCT02000882|65037696|FG000|Overall Study|Adverse Event|3|||
23353814|NCT02000882|65037696|FG000|Overall Study|Physician Decision|2|||
23353815|NCT02000882|65037696|FG000|Overall Study|Withdrawal by Subject|1|||
23353816|NCT03747302|65037697|FG000|Overall Study|Withdrawal by Subject|1|||
23353817|NCT03747302|65037698|FG001|Overall Study|Withdrawal by Subject|2|||
23353818|NCT00463840|65041262|FG000|Overall Study|Disease progression|7|||
23353819|NCT00463840|65041262|FG000|Overall Study|Withdrawal by Subject|2|||
23188549|NCT01633060|64432988|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
23188550|NCT01633060|64432989|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23188551|NCT01633060|64432988|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
23188552|NCT01633060|64432989|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
23188553|NCT01633060|64432988|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
23188554|NCT01633060|64432989|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
23188555|NCT01633060|64432988|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
23188556|NCT01633060|64432989|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
23188557|NCT01633060|64432988|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
23188558|NCT01633060|64432989|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
23188559|NCT01633060|64432988|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
23188560|NCT01633060|64432989|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
23188561|NCT00215150|64432990|FG000|Open Label Phase|Lost to Follow-up|7|||
23188562|NCT00215150|64432990|FG000|Open Label Phase|Withdrawal by Subject|1|||
23188563|NCT00215150|64432990|FG000|Open Label Phase|Did not complete a post base visit|13|||
23188564|NCT00215150|64432990|FG000|Open Label Phase|Did not meet randomization criteria|9|||
23188565|NCT00215150|64432990|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
23188566|NCT00215150|64432990|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
23188567|NCT00215150|64432990|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
23188568|NCT01967225|64432991|FG000|Overall Study|Adverse Event|3|||
23188569|NCT01967225|64432992|FG001|Overall Study|Adverse Event|1|||
23188570|NCT01967225|64432991|FG000|Overall Study|Withdrawal by Subject|2|||
23188571|NCT01967225|64432992|FG001|Overall Study|Withdrawal by Subject|1|||
23188572|NCT01967225|64432991|FG000|Overall Study|Lack of Efficacy|1|||
23188573|NCT01967225|64432992|FG001|Overall Study|Lack of Efficacy|1|||
23188574|NCT01967225|64432991|FG000|Overall Study|Switching to other therapy|2|||
23188575|NCT01967225|64432992|FG001|Overall Study|Switching to other therapy|0|||
23188576|NCT01967225|64432991|FG000|Overall Study|Protocol driven decision point|1|||
23188577|NCT01967225|64432992|FG001|Overall Study|Protocol driven decision point|0|||
23188578|NCT01967225|64432991|FG000|Overall Study|Logistical difficulties|1|||
23188579|NCT01967225|64432992|FG001|Overall Study|Logistical difficulties|0|||
23188580|NCT01967225|64432991|FG000|Overall Study|Protocol Violation|2|||
23188581|NCT01967225|64432992|FG001|Overall Study|Protocol Violation|0|||
23188582|NCT02623361|64432994|FG000|Overall Study|Protocol Violation|0|||
23188583|NCT02623361|64432995|FG001|Overall Study|Protocol Violation|1|||
23188584|NCT02623361|64432994|FG000|Overall Study|Withdrawal by Subject|0|||
23188585|NCT02623361|64432995|FG001|Overall Study|Withdrawal by Subject|1|||
23188586|NCT00504257|64432998|FG000|Overall Study|Withdrawal by Subject|2|||
23188587|NCT00504257|64432998|FG000|Overall Study|ineligible histology|2|||
23353820|NCT00463840|65041262|FG000|Overall Study|Adverse Event|3|||
23353821|NCT03484403|65041263|FG000|Overall Study|Withdrawal by Subject|6|||
23353822|NCT03484403|65041264|FG001|Overall Study|Withdrawal by Subject|4|||
23353823|NCT04126317|65041265|FG000|Overall Study|Adverse Event|0|||
23353824|NCT04126317|65041266|FG001|Overall Study|Adverse Event|1|||
23353825|NCT04126317|65041265|FG000|Overall Study|Withdrawal by Subject|4|||
23353826|NCT04126317|65041266|FG001|Overall Study|Withdrawal by Subject|1|||
23353827|NCT02700698|65041267|FG000|Overall Study|Withdrawal by Subject|1|||
23353828|NCT02700698|65041268|FG001|Overall Study|Withdrawal by Subject|0|||
23353829|NCT01410240|65041269|FG000|Overall Study|Physician Decision|0|||
23353830|NCT01410240|65041270|FG001|Overall Study|Physician Decision|0|||
23353831|NCT01410240|65041271|FG002|Overall Study|Physician Decision|1|||
23353832|NCT01410240|65041269|FG000|Overall Study|Missed week 6 assessments|1|||
23353833|NCT01410240|65041270|FG001|Overall Study|Missed week 6 assessments|1|||
23353834|NCT01410240|65041271|FG002|Overall Study|Missed week 6 assessments|1|||
23353835|NCT01588405|65041273|FG000|Overall Study|Adverse Event|1|||
23353836|NCT01588405|65041273|FG000|Overall Study|Clinical Worsening|1|||
23353837|NCT01260584|65041276|FG000|Period 1|Protocol Violation|0|||
23470260|NCT01908803|65464480|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
23470261|NCT00990704|65464481|FG000|Overall Study|Adverse Event|1|||
23470262|NCT00990704|65464482|FG001|Overall Study|Adverse Event|1|||
23247669|NCT00798707|64649057|FG000|Overall Study|Lost to Follow-up|5|||
23353838|NCT01260584|65041277|FG001|Period 1|Protocol Violation|0|||
23353839|NCT01260584|65041278|FG002|Period 1|Protocol Violation|1|||
23353840|NCT01260584|65041279|FG003|Period 1|Protocol Violation|1|||
23353841|NCT01260584|65041276|FG000|Period 1|Adverse Event|0|||
23353842|NCT01260584|65041277|FG001|Period 1|Adverse Event|0|||
23353843|NCT01260584|65041278|FG002|Period 1|Adverse Event|1|||
23353844|NCT01260584|65041279|FG003|Period 1|Adverse Event|0|||
23353845|NCT01260584|65041276|FG000|Period 2|Protocol Violation|0|||
23353846|NCT01260584|65041277|FG001|Period 2|Protocol Violation|2|||
23353847|NCT01260584|65041278|FG002|Period 2|Protocol Violation|3|||
23353848|NCT01260584|65041279|FG003|Period 2|Protocol Violation|1|||
23353849|NCT01260584|65041276|FG000|Period 2|Adverse Event|1|||
23353850|NCT01260584|65041277|FG001|Period 2|Adverse Event|0|||
23353851|NCT01260584|65041278|FG002|Period 2|Adverse Event|2|||
23353852|NCT01260584|65041279|FG003|Period 2|Adverse Event|0|||
23353853|NCT01260584|65041276|FG000|Period 2|Withdrawal by Subject|0|||
23353854|NCT01260584|65041277|FG001|Period 2|Withdrawal by Subject|1|||
23353855|NCT01260584|65041278|FG002|Period 2|Withdrawal by Subject|0|||
23353856|NCT01260584|65041279|FG003|Period 2|Withdrawal by Subject|0|||
23353857|NCT01737879|65041280|FG000|Overall Study|Death|1|||
23353858|NCT01737879|65041280|FG000|Overall Study|Sponsor decision|40|||
23353859|NCT00642954|65041282|FG000|Overall Study|Progressive Disease|3|||
23353860|NCT00642954|65041283|FG001|Overall Study|Progressive Disease|3|||
23353861|NCT00642954|65041284|FG002|Overall Study|Progressive Disease|3|||
23353862|NCT00642954|65041285|FG003|Overall Study|Progressive Disease|3|||
23353863|NCT00642954|65041286|FG004|Overall Study|Progressive Disease|9|||
23353864|NCT00642954|65041282|FG000|Overall Study|Withdrawal by Subject|0|||
23353865|NCT00642954|65041283|FG001|Overall Study|Withdrawal by Subject|0|||
23353866|NCT00642954|65041284|FG002|Overall Study|Withdrawal by Subject|0|||
23353867|NCT00642954|65041285|FG003|Overall Study|Withdrawal by Subject|0|||
23353868|NCT00642954|65041286|FG004|Overall Study|Withdrawal by Subject|1|||
23188588|NCT01252966|64433000|FG000|Overall Study|Lost to Follow-up|16|||
23188589|NCT01252966|64433001|FG001|Overall Study|Lost to Follow-up|10|||
23188590|NCT01252966|64433000|FG000|Overall Study|Withdrawal by Subject|7|||
23188591|NCT01252966|64433001|FG001|Overall Study|Withdrawal by Subject|3|||
23188592|NCT02299934|64433004|FG000|Overall Study|Termination of study|13|||
23188593|NCT03486314|64433005|FG000|Part A|Adverse Event|1|||
23188594|NCT03486314|64433006|FG001|Part A|Adverse Event|0|||
23188595|NCT03486314|64433007|FG002|Part A|Adverse Event|0|||
23188596|NCT03486314|64433005|FG000|Part A|Symptomatic Deterioration|2|||
23188597|NCT03486314|64433006|FG001|Part A|Symptomatic Deterioration|0|||
23188598|NCT03486314|64433007|FG002|Part A|Symptomatic Deterioration|0|||
23188599|NCT00613314|64433013|FG000|Overall Study|Adverse Event|5|||
23188600|NCT00613314|64433013|FG000|Overall Study|Protocol Violation|14|||
23470263|NCT00990704|65464481|FG000|Overall Study|Physician Decision|0|||
23247670|NCT00798707|64649058|FG001|Overall Study|Lost to Follow-up|6|||
23188601|NCT00613314|64433013|FG000|Overall Study|Lost to Follow-up|46|||
23188602|NCT00613314|64433013|FG000|Overall Study|Other reason not defined above|90|||
23353869|NCT00642954|65041282|FG000|Overall Study|Adverse Event|1|||
23353870|NCT00642954|65041283|FG001|Overall Study|Adverse Event|1|||
23470264|NCT00990704|65464482|FG001|Overall Study|Physician Decision|1|||
23470265|NCT00899431|65464483|FG000|Overall Study|Physician Decision|1|||
23353871|NCT00642954|65041284|FG002|Overall Study|Adverse Event|0|||
23353872|NCT00642954|65041285|FG003|Overall Study|Adverse Event|0|||
23353873|NCT00642954|65041286|FG004|Overall Study|Adverse Event|6|||
23470266|NCT00899431|65464484|FG001|Overall Study|Physician Decision|0|||
23353874|NCT01017601|65041287|FG000|Overall Study|Disease Progression|12|||
23353875|NCT01017601|65041288|FG001|Overall Study|Disease Progression|12|||
23353876|NCT01017601|65041287|FG000|Overall Study|Withdrawal by Subject|0|||
23353877|NCT01017601|65041288|FG001|Overall Study|Withdrawal by Subject|1|||
23353878|NCT02065518|65041289|FG000|Overall Study|Lost to Follow-up|3|||
23353879|NCT02065518|65041290|FG001|Overall Study|Lost to Follow-up|4|||
23353880|NCT02065518|65041291|FG002|Overall Study|Lost to Follow-up|0|||
23353881|NCT02065518|65041292|FG003|Overall Study|Lost to Follow-up|3|||
23353882|NCT02065518|65041289|FG000|Overall Study|Withdrawal by Subject|3|||
23353883|NCT02065518|65041290|FG001|Overall Study|Withdrawal by Subject|4|||
23353884|NCT02065518|65041291|FG002|Overall Study|Withdrawal by Subject|9|||
23353885|NCT02065518|65041292|FG003|Overall Study|Withdrawal by Subject|2|||
23353886|NCT01438814|65041293|FG000|Overall Study|Adverse Event|3|||
23353887|NCT01438814|65041294|FG001|Overall Study|Adverse Event|3|||
23353888|NCT01438814|65041293|FG000|Overall Study|Protocol Violation|1|||
23353889|NCT01438814|65041294|FG001|Overall Study|Protocol Violation|2|||
23353890|NCT01438814|65041293|FG000|Overall Study|Lost to Follow-up|4|||
23353891|NCT01438814|65041294|FG001|Overall Study|Lost to Follow-up|3|||
23353892|NCT01438814|65041293|FG000|Overall Study|Withdrawal by Subject|4|||
23353893|NCT01438814|65041294|FG001|Overall Study|Withdrawal by Subject|2|||
23353894|NCT01438814|65041293|FG000|Overall Study|Other|2|||
23353895|NCT01438814|65041294|FG001|Overall Study|Other|4|||
23353896|NCT00135356|65041295|FG000|Overall Study|Adverse Event|6|||
23353897|NCT00135356|65041296|FG001|Overall Study|Adverse Event|2|||
23353898|NCT00135356|65041295|FG000|Overall Study|Lack of Efficacy|2|||
23353899|NCT00135356|65041296|FG001|Overall Study|Lack of Efficacy|0|||
23353900|NCT00135356|65041295|FG000|Overall Study|Lost to Follow-up|3|||
23353901|NCT00135356|65041296|FG001|Overall Study|Lost to Follow-up|1|||
23353902|NCT00135356|65041295|FG000|Overall Study|Surgery for abdominal fat|1|||
23353903|NCT00135356|65041296|FG001|Overall Study|Surgery for abdominal fat|0|||
23353904|NCT00135356|65041295|FG000|Overall Study|Change in antiviral regimen|0|||
23353905|NCT00135356|65041296|FG001|Overall Study|Change in antiviral regimen|1|||
23353906|NCT00135356|65041295|FG000|Overall Study|Poor/noncompliance|1|||
23353907|NCT00135356|65041296|FG001|Overall Study|Poor/noncompliance|1|||
23353908|NCT00135356|65041295|FG000|Overall Study|No longer meets study criteria|2|||
23353909|NCT00135356|65041296|FG001|Overall Study|No longer meets study criteria|0|||
23353910|NCT00135356|65041295|FG000|Overall Study|Withdrawal by Subject|2|||
23353911|NCT00135356|65041296|FG001|Overall Study|Withdrawal by Subject|4|||
23353912|NCT02014558|65041297|FG000|Overall Study|Never Received Study Drug|0|||
23353913|NCT02014558|65041298|FG001|Overall Study|Never Received Study Drug|0|||
23353914|NCT02014558|65041299|FG002|Overall Study|Never Received Study Drug|0|||
23353915|NCT02014558|65041300|FG003|Overall Study|Never Received Study Drug|0|||
23188603|NCT03185130|64433014|FG000|Overall Study|Withdrawal by Subject|0|||
23188604|NCT03185130|64433015|FG001|Overall Study|Withdrawal by Subject|2|||
23353916|NCT02014558|65041301|FG004|Overall Study|Never Received Study Drug|1|||
23353917|NCT02014558|65041302|FG005|Overall Study|Never Received Study Drug|0|||
23353918|NCT02014558|65041303|FG006|Overall Study|Never Received Study Drug|1|||
23353919|NCT02014558|65041304|FG007|Overall Study|Never Received Study Drug|0|||
23353920|NCT02014558|65041305|FG008|Overall Study|Never Received Study Drug|2|||
23353921|NCT02014558|65041306|FG009|Overall Study|Never Received Study Drug|0|||
23353922|NCT02014558|65041307|FG010|Overall Study|Never Received Study Drug|2|||
23353923|NCT02014558|65041308|FG011|Overall Study|Never Received Study Drug|2|||
23353924|NCT02014558|65041309|FG012|Overall Study|Never Received Study Drug|0|||
23353925|NCT02014558|65041297|FG000|Overall Study|Adverse Event|0|||
23353926|NCT02014558|65041298|FG001|Overall Study|Adverse Event|0|||
23353927|NCT02014558|65041299|FG002|Overall Study|Adverse Event|0|||
23353928|NCT02014558|65041300|FG003|Overall Study|Adverse Event|0|||
23353929|NCT02014558|65041301|FG004|Overall Study|Adverse Event|1|||
23353930|NCT02014558|65041302|FG005|Overall Study|Adverse Event|0|||
23353931|NCT02014558|65041303|FG006|Overall Study|Adverse Event|0|||
23353932|NCT02014558|65041304|FG007|Overall Study|Adverse Event|0|||
23470267|NCT00899431|65464485|FG002|Overall Study|Physician Decision|0|||
23188605|NCT01282814|64433016|FG000|First Intervention|Emesis During Dosing Interval|0|||
23188606|NCT01282814|64433017|FG001|First Intervention|Emesis During Dosing Interval|3|||
23353933|NCT02014558|65041305|FG008|Overall Study|Adverse Event|2|||
23353934|NCT02014558|65041306|FG009|Overall Study|Adverse Event|2|||
23353935|NCT02014558|65041307|FG010|Overall Study|Adverse Event|5|||
23353936|NCT02014558|65041308|FG011|Overall Study|Adverse Event|21|||
23353937|NCT02014558|65041309|FG012|Overall Study|Adverse Event|3|||
23470268|NCT02998268|65464486|FG000|Overall Study|Adverse Event|0|||
23188607|NCT01282814|64433016|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
23353938|NCT02014558|65041297|FG000|Overall Study|Death|1|||
23470269|NCT02998268|65464487|FG001|Overall Study|Adverse Event|2|||
23188608|NCT01282814|64433017|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23353939|NCT02014558|65041298|FG001|Overall Study|Death|0|||
23353940|NCT02014558|65041299|FG002|Overall Study|Death|0|||
23353941|NCT02014558|65041300|FG003|Overall Study|Death|0|||
23353942|NCT02014558|65041301|FG004|Overall Study|Death|0|||
23470270|NCT02998268|65464486|FG000|Overall Study|Withdrawal by Subject|0|||
23353943|NCT02014558|65041302|FG005|Overall Study|Death|0|||
23470271|NCT02998268|65464487|FG001|Overall Study|Withdrawal by Subject|1|||
23353944|NCT02014558|65041303|FG006|Overall Study|Death|1|||
23353945|NCT02014558|65041304|FG007|Overall Study|Death|1|||
23353946|NCT02014558|65041305|FG008|Overall Study|Death|2|||
23353947|NCT02014558|65041306|FG009|Overall Study|Death|5|||
23353948|NCT02014558|65041307|FG010|Overall Study|Death|5|||
23353949|NCT02014558|65041308|FG011|Overall Study|Death|19|||
23353950|NCT02014558|65041309|FG012|Overall Study|Death|2|||
23353951|NCT02014558|65041297|FG000|Overall Study|Lack of Efficacy|1|||
23587370|NCT00464672|65879030|FG005|Overall Study|withdrawal of consent|4|||
23188609|NCT00793585|64433018|FG000|Overall Study|Adverse Event|1|||
23188610|NCT00793585|64433019|FG001|Overall Study|Adverse Event|1|||
23188611|NCT00793585|64433018|FG000|Overall Study|Protocol Violation|1|||
23188612|NCT00793585|64433019|FG001|Overall Study|Protocol Violation|2|||
23188623|NCT01919307|64433022|FG000|Overall Study|Withdrawal by Subject|9|||
23188624|NCT02626338|64433028|FG000|Overall Study|Lack of Efficacy|3|||
23188625|NCT02626338|64433029|FG001|Overall Study|Lack of Efficacy|2|||
23188626|NCT02626338|64433030|FG002|Overall Study|Lack of Efficacy|0|||
23188627|NCT04655586|64433031|FG000|Overall Study|Physician Decision|1|||
23188628|NCT04655586|64433032|FG001|Overall Study|Physician Decision|3|||
23188629|NCT04655586|64433033|FG002|Overall Study|Physician Decision|4|||
23188630|NCT04655586|64433031|FG000|Overall Study|Withdrawal by Subject|1|||
23188631|NCT04655586|64433032|FG001|Overall Study|Withdrawal by Subject|3|||
23188632|NCT04655586|64433033|FG002|Overall Study|Withdrawal by Subject|1|||
23188633|NCT02397655|64433037|FG000|Overall Study|data not completed|1301|||
23188634|NCT01584024|64433038|FG000|Overall Study|Lost to Follow-up|10|||
23188635|NCT01584024|64433038|FG000|Overall Study|Withdrawal by Subject|3|||
23188636|NCT02629393|64433041|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
23188637|NCT02629393|64433041|FG000|Overall Study|Physician Decision|1|||
23188638|NCT00546351|64433042|FG000|Overall Study|Adverse Event|76|||
23188639|NCT00546351|64433042|FG000|Overall Study|Lack of Efficacy|15|||
23188640|NCT00546351|64433042|FG000|Overall Study|Withdrawal by Subject|109|||
23188641|NCT00546351|64433042|FG000|Overall Study|Lost to Follow-up|9|||
23188642|NCT00546351|64433042|FG000|Overall Study|Protocol Deviation|1|||
23188643|NCT00546351|64433042|FG000|Overall Study|Unsatisfactory compliance|9|||
23188644|NCT00546351|64433042|FG000|Overall Study|Other reasons for premature termination|17|||
23188645|NCT03478683|64433049|FG000|Overall Study|Adverse Event|5|||
23188646|NCT03478683|64433050|FG001|Overall Study|Adverse Event|3|||
23188647|NCT03478683|64433049|FG000|Overall Study|Lost to Follow-up|0|||
23188648|NCT03478683|64433050|FG001|Overall Study|Lost to Follow-up|5|||
23188649|NCT03478683|64433049|FG000|Overall Study|Physician Decision|1|||
23188650|NCT03478683|64433050|FG001|Overall Study|Physician Decision|3|||
23188651|NCT03478683|64433049|FG000|Overall Study|Withdrawal by Subject|7|||
23188652|NCT03478683|64433050|FG001|Overall Study|Withdrawal by Subject|7|||
23188653|NCT02489630|64433051|FG000|Overall Study|Oversedation|1|||
23188654|NCT02489630|64433052|FG001|Overall Study|Oversedation|1|||
23188655|NCT02489630|64433051|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
23188656|NCT02489630|64433052|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
23188657|NCT01926886|64433053|FG000|Overall Study|Administrative/other|1|||
23188658|NCT01926886|64433054|FG001|Overall Study|Administrative/other|0|||
23188659|NCT01926886|64433053|FG000|Overall Study|Adverse event/intercurrent illness|4|||
23188660|NCT01926886|64433054|FG001|Overall Study|Adverse event/intercurrent illness|0|||
23188661|NCT01926886|64433053|FG000|Overall Study|Disease progression/recurrence|4|||
23587371|NCT00464672|65879025|FG000|Overall Study|Lost to Follow-up|25|||
23188662|NCT01926886|64433054|FG001|Overall Study|Disease progression/recurrence|0|||
23188663|NCT01926886|64433053|FG000|Overall Study|Withdrawal by Subject|15|||
23188664|NCT01926886|64433054|FG001|Overall Study|Withdrawal by Subject|0|||
23188665|NCT01926886|64433053|FG000|Overall Study|Failure to return|3|||
23188666|NCT01926886|64433054|FG001|Overall Study|Failure to return|0|||
23188667|NCT01926886|64433053|FG000|Overall Study|Recurrence of disease|1|||
23188668|NCT01926886|64433054|FG001|Overall Study|Recurrence of disease|0|||
23188669|NCT01926886|64433053|FG000|Overall Study|Progression of disease|2|||
23188670|NCT01926886|64433054|FG001|Overall Study|Progression of disease|0|||
23188671|NCT01926886|64433053|FG000|Overall Study|Death|1|||
23188672|NCT01926886|64433054|FG001|Overall Study|Death|0|||
23188673|NCT01926886|64433053|FG000|Overall Study|Did not cooperate|1|||
23188674|NCT01926886|64433054|FG001|Overall Study|Did not cooperate|0|||
23353952|NCT02014558|65041298|FG001|Overall Study|Lack of Efficacy|2|||
23353953|NCT02014558|65041299|FG002|Overall Study|Lack of Efficacy|1|||
23353954|NCT02014558|65041300|FG003|Overall Study|Lack of Efficacy|1|||
23587372|NCT00464672|65879026|FG001|Overall Study|Lost to Follow-up|10|||
23587373|NCT00464672|65879027|FG002|Overall Study|Lost to Follow-up|0|||
23587374|NCT00464672|65879028|FG003|Overall Study|Lost to Follow-up|0|||
23587375|NCT00464672|65879029|FG004|Overall Study|Lost to Follow-up|1|||
23587376|NCT00464672|65879030|FG005|Overall Study|Lost to Follow-up|0|||
23587377|NCT04148937|65879051|FG000|Overall Study|Withdrawal by Subject|0|||
23587378|NCT04148937|65879052|FG001|Overall Study|Withdrawal by Subject|0|||
23587379|NCT04148937|65879053|FG002|Overall Study|Withdrawal by Subject|0|||
23587380|NCT04148937|65879054|FG003|Overall Study|Withdrawal by Subject|1|||
23247671|NCT00798707|64649059|FG002|Overall Study|Lost to Follow-up|6|||
23587381|NCT04148937|65879055|FG004|Overall Study|Withdrawal by Subject|0|||
23587382|NCT04148937|65879056|FG005|Overall Study|Withdrawal by Subject|1|||
23247672|NCT00798707|64649057|FG000|Overall Study|Other|0|||
23247673|NCT00798707|64649058|FG001|Overall Study|Other|1|||
23247674|NCT00798707|64649059|FG002|Overall Study|Other|0|||
23247675|NCT00798707|64649057|FG000|Overall Study|Protocol Violation|4|||
23247676|NCT00798707|64649058|FG001|Overall Study|Protocol Violation|0|||
23353955|NCT02014558|65041301|FG004|Overall Study|Lack of Efficacy|0|||
23353956|NCT02014558|65041302|FG005|Overall Study|Lack of Efficacy|0|||
23353957|NCT02014558|65041303|FG006|Overall Study|Lack of Efficacy|1|||
23353958|NCT02014558|65041304|FG007|Overall Study|Lack of Efficacy|3|||
23353959|NCT02014558|65041305|FG008|Overall Study|Lack of Efficacy|3|||
23353960|NCT02014558|65041306|FG009|Overall Study|Lack of Efficacy|3|||
23353961|NCT02014558|65041307|FG010|Overall Study|Lack of Efficacy|16|||
23353962|NCT02014558|65041308|FG011|Overall Study|Lack of Efficacy|8|||
23353963|NCT02014558|65041309|FG012|Overall Study|Lack of Efficacy|5|||
23353964|NCT02014558|65041297|FG000|Overall Study|Lost to Follow-up|0|||
23353965|NCT02014558|65041298|FG001|Overall Study|Lost to Follow-up|0|||
23353966|NCT02014558|65041299|FG002|Overall Study|Lost to Follow-up|0|||
23353967|NCT02014558|65041300|FG003|Overall Study|Lost to Follow-up|0|||
23353968|NCT02014558|65041301|FG004|Overall Study|Lost to Follow-up|0|||
23353969|NCT02014558|65041302|FG005|Overall Study|Lost to Follow-up|0|||
23353970|NCT02014558|65041303|FG006|Overall Study|Lost to Follow-up|0|||
23353971|NCT02014558|65041304|FG007|Overall Study|Lost to Follow-up|0|||
23353972|NCT02014558|65041305|FG008|Overall Study|Lost to Follow-up|0|||
23353973|NCT02014558|65041306|FG009|Overall Study|Lost to Follow-up|0|||
23353974|NCT02014558|65041307|FG010|Overall Study|Lost to Follow-up|1|||
23353975|NCT02014558|65041308|FG011|Overall Study|Lost to Follow-up|0|||
23353976|NCT02014558|65041309|FG012|Overall Study|Lost to Follow-up|0|||
23353977|NCT02014558|65041297|FG000|Overall Study|Progressive Disease|1|||
23353978|NCT02014558|65041298|FG001|Overall Study|Progressive Disease|0|||
23353979|NCT02014558|65041299|FG002|Overall Study|Progressive Disease|1|||
23353980|NCT02014558|65041300|FG003|Overall Study|Progressive Disease|1|||
23353981|NCT02014558|65041301|FG004|Overall Study|Progressive Disease|1|||
23353982|NCT02014558|65041302|FG005|Overall Study|Progressive Disease|2|||
23353983|NCT02014558|65041303|FG006|Overall Study|Progressive Disease|1|||
23353984|NCT02014558|65041304|FG007|Overall Study|Progressive Disease|6|||
23587383|NCT04148937|65879057|FG006|Overall Study|Withdrawal by Subject|1|||
23587384|NCT04148937|65879058|FG007|Overall Study|Withdrawal by Subject|0|||
23587385|NCT04148937|65879051|FG000|Overall Study|Lost to Follow-up|0|||
23587386|NCT04148937|65879052|FG001|Overall Study|Lost to Follow-up|0|||
23587387|NCT04148937|65879053|FG002|Overall Study|Lost to Follow-up|1|||
23587388|NCT04148937|65879054|FG003|Overall Study|Lost to Follow-up|0|||
23587389|NCT04148937|65879055|FG004|Overall Study|Lost to Follow-up|0|||
23587390|NCT04148937|65879056|FG005|Overall Study|Lost to Follow-up|2|||
23587391|NCT04148937|65879057|FG006|Overall Study|Lost to Follow-up|0|||
23587392|NCT04148937|65879058|FG007|Overall Study|Lost to Follow-up|0|||
23587393|NCT03987451|65879061|FG000|Overall Study|Lost to Follow-up|1|||
23587394|NCT03987451|65879062|FG001|Overall Study|Lost to Follow-up|0|||
23587395|NCT03987451|65879061|FG000|Overall Study|Withdrawal by Subject|1|||
23587396|NCT03987451|65879062|FG001|Overall Study|Withdrawal by Subject|1|||
23587397|NCT01977612|65879065|FG000|Overall Study|Lost to Follow-up|1|||
23587398|NCT01977612|65879066|FG001|Overall Study|Lost to Follow-up|1|||
23587399|NCT01149681|65879067|FG000|Overall Study|Withdrawal by Subject|7|||
23587400|NCT01149681|65879067|FG000|Overall Study|Progressive disease|1|||
23587401|NCT01149681|65879067|FG000|Overall Study|Physician Decision|2|||
23587402|NCT01149681|65879067|FG000|Overall Study|adverse events nonrelated study drug|2|||
23587403|NCT02317016|65879068|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
23247677|NCT00798707|64649059|FG002|Overall Study|Protocol Violation|2|||
23353985|NCT02014558|65041305|FG008|Overall Study|Progressive Disease|5|||
23353986|NCT02014558|65041306|FG009|Overall Study|Progressive Disease|6|||
23353987|NCT02014558|65041307|FG010|Overall Study|Progressive Disease|22|||
23353988|NCT02014558|65041308|FG011|Overall Study|Progressive Disease|31|||
23353989|NCT02014558|65041309|FG012|Overall Study|Progressive Disease|6|||
23353990|NCT02014558|65041297|FG000|Overall Study|Withdrawal by Subject|0|||
23353991|NCT02014558|65041298|FG001|Overall Study|Withdrawal by Subject|0|||
23587404|NCT02317016|65879068|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
23587405|NCT02317016|65879068|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
23587406|NCT02317016|65879068|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
23587407|NCT02317016|65879068|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
23587408|NCT02317016|65879068|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
23587409|NCT02317016|65879068|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
23587410|NCT01190150|65879071|FG000|First Treatment|Withdrawal by Subject|1|||
23587411|NCT01190150|65879072|FG001|First Treatment|Withdrawal by Subject|0|||
23247678|NCT00798707|64649057|FG000|Overall Study|Withdrawal by Subject|3|||
23247679|NCT00798707|64649058|FG001|Overall Study|Withdrawal by Subject|8|||
23353992|NCT02014558|65041299|FG002|Overall Study|Withdrawal by Subject|0|||
23353993|NCT02014558|65041300|FG003|Overall Study|Withdrawal by Subject|0|||
23353994|NCT02014558|65041301|FG004|Overall Study|Withdrawal by Subject|1|||
23353995|NCT02014558|65041302|FG005|Overall Study|Withdrawal by Subject|0|||
23353996|NCT02014558|65041303|FG006|Overall Study|Withdrawal by Subject|0|||
23353997|NCT02014558|65041304|FG007|Overall Study|Withdrawal by Subject|0|||
23353998|NCT02014558|65041305|FG008|Overall Study|Withdrawal by Subject|0|||
23353999|NCT02014558|65041306|FG009|Overall Study|Withdrawal by Subject|2|||
23354000|NCT02014558|65041307|FG010|Overall Study|Withdrawal by Subject|6|||
23247680|NCT00798707|64649059|FG002|Overall Study|Withdrawal by Subject|2|||
23247681|NCT00798707|64649057|FG000|Overall Study|Randomized not treated|4|||
23247682|NCT00798707|64649058|FG001|Overall Study|Randomized not treated|5|||
23247683|NCT00798707|64649059|FG002|Overall Study|Randomized not treated|1|||
23247684|NCT00558831|64649060|FG000|Overall Study|Lost to Follow-up|1|||
23247685|NCT04980391|64649061|FG000|Overall Study|Death|0|||
23247686|NCT04980391|64649062|FG001|Overall Study|Death|0|||
23247687|NCT04980391|64649063|FG002|Overall Study|Death|1|||
23247688|NCT04980391|64649064|FG003|Overall Study|Death|1|||
23247689|NCT04980391|64649061|FG000|Overall Study|Lost to Follow-up|3|||
23247690|NCT04980391|64649062|FG001|Overall Study|Lost to Follow-up|3|||
23247691|NCT04980391|64649063|FG002|Overall Study|Lost to Follow-up|2|||
23247692|NCT04980391|64649064|FG003|Overall Study|Lost to Follow-up|3|||
23247693|NCT04980391|64649061|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
23247694|NCT04980391|64649062|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
23247695|NCT04980391|64649063|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
23247696|NCT04980391|64649064|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
23247697|NCT04980391|64649061|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23247698|NCT04980391|64649062|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23247699|NCT04980391|64649063|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
23247700|NCT04980391|64649064|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23247701|NCT04980391|64649061|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
23247702|NCT04980391|64649062|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
23247703|NCT04980391|64649063|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
23247704|NCT04980391|64649064|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
23247705|NCT02787746|64649067|FG000|Overall Study|Adverse Event|42|||
23247706|NCT02787746|64649067|FG000|Overall Study|Withdrawal by Subject|65|||
23247707|NCT02787746|64649067|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
23247708|NCT03911960|64649070|FG000|Overall Study|Lost to Follow-up|5|||
23247709|NCT03911960|64649071|FG001|Overall Study|Lost to Follow-up|3|||
23247710|NCT03725722|64649073|FG000|Overall Study|Lack of Efficacy|2|||
23247711|NCT03725722|64649074|FG001|Overall Study|Lack of Efficacy|1|||
23247712|NCT03725722|64649075|FG002|Overall Study|Lack of Efficacy|2|||
23247713|NCT03725722|64649076|FG003|Overall Study|Lack of Efficacy|0|||
23247714|NCT03725722|64649077|FG004|Overall Study|Lack of Efficacy|2|||
23247715|NCT03725722|64649073|FG000|Overall Study|Adverse Event|2|||
23247716|NCT03725722|64649074|FG001|Overall Study|Adverse Event|2|||
23247717|NCT03725722|64649075|FG002|Overall Study|Adverse Event|1|||
23247718|NCT03725722|64649076|FG003|Overall Study|Adverse Event|0|||
23247719|NCT03725722|64649077|FG004|Overall Study|Adverse Event|6|||
23247720|NCT03725722|64649073|FG000|Overall Study|Withdrawal by Subject|4|||
23247721|NCT03725722|64649074|FG001|Overall Study|Withdrawal by Subject|1|||
23247722|NCT03725722|64649075|FG002|Overall Study|Withdrawal by Subject|0|||
23247723|NCT03725722|64649076|FG003|Overall Study|Withdrawal by Subject|4|||
23247724|NCT03725722|64649077|FG004|Overall Study|Withdrawal by Subject|4|||
23247725|NCT03725722|64649073|FG000|Overall Study|Lost to Follow-up|3|||
23247726|NCT03725722|64649074|FG001|Overall Study|Lost to Follow-up|1|||
23247727|NCT03725722|64649075|FG002|Overall Study|Lost to Follow-up|2|||
23247728|NCT03725722|64649076|FG003|Overall Study|Lost to Follow-up|2|||
23247729|NCT03725722|64649077|FG004|Overall Study|Lost to Follow-up|1|||
23247730|NCT03725722|64649073|FG000|Overall Study|Personal reasons|0|||
23247731|NCT03725722|64649074|FG001|Overall Study|Personal reasons|0|||
23247732|NCT03725722|64649075|FG002|Overall Study|Personal reasons|1|||
23354001|NCT02014558|65041308|FG011|Overall Study|Withdrawal by Subject|10|||
23354002|NCT02014558|65041309|FG012|Overall Study|Withdrawal by Subject|0|||
23354003|NCT02014558|65041297|FG000|Overall Study|Miscellaneous|2|||
23354004|NCT02014558|65041298|FG001|Overall Study|Miscellaneous|1|||
23247733|NCT03725722|64649076|FG003|Overall Study|Personal reasons|0|||
23354005|NCT02014558|65041299|FG002|Overall Study|Miscellaneous|1|||
23354006|NCT02014558|65041300|FG003|Overall Study|Miscellaneous|1|||
23247734|NCT03725722|64649077|FG004|Overall Study|Personal reasons|1|||
23247735|NCT03725722|64649073|FG000|Overall Study|COVID-19 situation|0|||
23247736|NCT03725722|64649074|FG001|Overall Study|COVID-19 situation|1|||
23354007|NCT02014558|65041301|FG004|Overall Study|Miscellaneous|0|||
23354008|NCT02014558|65041302|FG005|Overall Study|Miscellaneous|1|||
23354009|NCT02014558|65041303|FG006|Overall Study|Miscellaneous|0|||
23354010|NCT02014558|65041304|FG007|Overall Study|Miscellaneous|1|||
23354011|NCT02014558|65041305|FG008|Overall Study|Miscellaneous|1|||
23354012|NCT02014558|65041306|FG009|Overall Study|Miscellaneous|3|||
23354013|NCT02014558|65041307|FG010|Overall Study|Miscellaneous|12|||
23354014|NCT02014558|65041308|FG011|Overall Study|Miscellaneous|11|||
23354015|NCT02014558|65041309|FG012|Overall Study|Miscellaneous|1|||
23354016|NCT01324570|65041310|FG000|Overall Study|Adverse Event|4|||
23354017|NCT01324570|65041311|FG001|Overall Study|Adverse Event|7|||
23354018|NCT01324570|65041310|FG000|Overall Study|Withdrawal by Subject|0|||
23354019|NCT01324570|65041311|FG001|Overall Study|Withdrawal by Subject|3|||
23354020|NCT01324570|65041310|FG000|Overall Study|Lack of Efficacy|0|||
23354021|NCT01324570|65041311|FG001|Overall Study|Lack of Efficacy|1|||
23354022|NCT01324570|65041310|FG000|Overall Study|Confirmed or suspected diversion|0|||
23354023|NCT01324570|65041311|FG001|Overall Study|Confirmed or suspected diversion|1|||
23354024|NCT01324570|65041310|FG000|Overall Study|Administrative|0|||
23354025|NCT01324570|65041311|FG001|Overall Study|Administrative|2|||
23354026|NCT00282152|65041312|FG000|Overall Study|Withdrawal by Subject|1|||
23354027|NCT00282152|65041313|FG001|Overall Study|Withdrawal by Subject|0|||
23354028|NCT00253370|65041314|FG000|Overall Study|Adverse Event|18|||
23354029|NCT00253370|65041314|FG000|Overall Study|Disease progression|13|||
23354030|NCT00253370|65041314|FG000|Overall Study|Death|2|||
23354031|NCT00253370|65041314|FG000|Overall Study|Withdrawal by Subject|6|||
23354032|NCT00253370|65041314|FG000|Overall Study|Non-protocol therapy|1|||
23354033|NCT00253370|65041314|FG000|Overall Study|Physician Decision|1|||
23354034|NCT00253370|65041314|FG000|Overall Study|Protocol Violation|1|||
23354035|NCT00253370|65041314|FG000|Overall Study|Abdominal pain due to disease|1|||
23354036|NCT00791492|65041317|FG000|Overall Study|Withdrawal by Subject|1|||
23354037|NCT00791492|65041318|FG001|Overall Study|Withdrawal by Subject|2|||
23354038|NCT00791492|65041317|FG000|Overall Study|Liver transplantation|5|||
23354039|NCT00791492|65041318|FG001|Overall Study|Liver transplantation|1|||
23354040|NCT00422422|65041321|FG000|Overall Study|Lack of Efficacy|1|||
23354041|NCT00422422|65041321|FG000|Overall Study|Protocol Violation|1|||
23354042|NCT00422422|65041321|FG000|Overall Study|Withdrawal by Subject|2|||
23354043|NCT00422422|65041321|FG000|Overall Study|SAE, non-fatal|1|||
23354044|NCT00422422|65041321|FG000|Overall Study|AE, non-serious non-fatal|5|||
23354045|NCT01313221|65041322|FG000|Overall Study|Protocol Violation|0|||
23354046|NCT01313221|65041323|FG001|Overall Study|Protocol Violation|1|||
23354047|NCT01313221|65041324|FG002|Overall Study|Protocol Violation|1|||
23354048|NCT01313221|65041322|FG000|Overall Study|Non-compliance|3|||
23354049|NCT01313221|65041323|FG001|Overall Study|Non-compliance|0|||
23354050|NCT01313221|65041324|FG002|Overall Study|Non-compliance|2|||
23470272|NCT00357903|65464488|FG000|Overall Study|Adverse Event|87|||
23470273|NCT00357903|65464489|FG001|Overall Study|Adverse Event|4|||
23470274|NCT00357903|65464488|FG000|Overall Study|Death|33|||
23470275|NCT00357903|65464489|FG001|Overall Study|Death|0|||
23470276|NCT00357903|65464488|FG000|Overall Study|Lost to Follow-up|23|||
23470277|NCT00357903|65464489|FG001|Overall Study|Lost to Follow-up|4|||
23470278|NCT00357903|65464488|FG000|Overall Study|Physician Decision|39|||
23470279|NCT00357903|65464489|FG001|Overall Study|Physician Decision|5|||
23470280|NCT00357903|65464488|FG000|Overall Study|Withdrawal by Subject|57|||
23470281|NCT00357903|65464489|FG001|Overall Study|Withdrawal by Subject|7|||
23470282|NCT00357903|65464488|FG000|Overall Study|Completed month 12 only|0|||
23470283|NCT00357903|65464489|FG001|Overall Study|Completed month 12 only|1|||
23470284|NCT00357903|65464488|FG000|Overall Study|Protocol issues|14|||
23470285|NCT00357903|65464489|FG001|Overall Study|Protocol issues|3|||
23470286|NCT00357903|65464488|FG000|Overall Study|Response status|61|||
23470287|NCT00357903|65464489|FG001|Overall Study|Response status|9|||
23470288|NCT00357903|65464488|FG000|Overall Study|Other|49|||
23470289|NCT00357903|65464489|FG001|Overall Study|Other|10|||
23470290|NCT00706342|65464490|FG000|Overall Study|Adverse Event|3|||
23470291|NCT00706342|65464490|FG000|Overall Study|Not responding to treatment|2|||
23354051|NCT01313221|65041322|FG000|Overall Study|Withdrawal by Subject|2|||
23354052|NCT01313221|65041323|FG001|Overall Study|Withdrawal by Subject|3|||
23354053|NCT01313221|65041324|FG002|Overall Study|Withdrawal by Subject|5|||
23354054|NCT01313221|65041322|FG000|Overall Study|Requirement for alternative therapy|0|||
23354055|NCT01313221|65041323|FG001|Overall Study|Requirement for alternative therapy|1|||
23354056|NCT01313221|65041324|FG002|Overall Study|Requirement for alternative therapy|1|||
23354057|NCT01313221|65041322|FG000|Overall Study|Lost to Follow-up|6|||
23354058|NCT01313221|65041323|FG001|Overall Study|Lost to Follow-up|3|||
23354059|NCT01313221|65041324|FG002|Overall Study|Lost to Follow-up|1|||
23470292|NCT00706342|65464490|FG000|Overall Study|Withdrawn due to failure to respond|1|||
23470293|NCT00706342|65464490|FG000|Overall Study|Death|1|||
23354060|NCT01313221|65041322|FG000|Overall Study|Other|1|||
23354061|NCT01313221|65041323|FG001|Overall Study|Other|0|||
23470294|NCT00706342|65464490|FG000|Overall Study|Withdrew from the study on his own.|1|||
23470295|NCT00706342|65464490|FG000|Overall Study|Investigator discretion|2|||
23470296|NCT00706342|65464490|FG000|Overall Study|Non-responder Week 12|1|||
23470297|NCT00706342|65464490|FG000|Overall Study|Ongoing|6|||
23470298|NCT00706342|65464490|FG000|Overall Study|WIthdrawal of consent|1|||
23470299|NCT03091348|65464491|FG000|Overall Study|Lost to Follow-up|2|||
23470300|NCT03091348|65464492|FG001|Overall Study|Lost to Follow-up|1|||
23470301|NCT02425943|65464494|FG000|Overall Study|Adverse Event|3|||
23470302|NCT02425943|65464495|FG001|Overall Study|Adverse Event|1|||
23470303|NCT02425943|65464494|FG000|Overall Study|Lost to Follow-up|59|||
23470304|NCT02425943|65464495|FG001|Overall Study|Lost to Follow-up|37|||
23470305|NCT02425943|65464494|FG000|Overall Study|Protocol Violation|4|||
23470306|NCT02425943|65464495|FG001|Overall Study|Protocol Violation|1|||
23470307|NCT02425943|65464494|FG000|Overall Study|Withdrawal by Subject|64|||
23470308|NCT02425943|65464495|FG001|Overall Study|Withdrawal by Subject|31|||
23470309|NCT02425943|65464494|FG000|Overall Study|Other|6|||
23470310|NCT02425943|65464495|FG001|Overall Study|Other|0|||
23470311|NCT02978781|65464499|FG000|Part A|Adverse Event|1|||
23470312|NCT02978781|65464500|FG001|Part A|Adverse Event|1|||
23470313|NCT02978781|65464501|FG002|Part A|Adverse Event|0|||
23470314|NCT02978781|65464502|FG003|Part A|Adverse Event|0|||
23470315|NCT02978781|65464503|FG004|Part A|Adverse Event|0|||
23470316|NCT02978781|65464499|FG000|Part A|Withdrawal by Subject|0|||
23470317|NCT02978781|65464500|FG001|Part A|Withdrawal by Subject|1|||
23470318|NCT02978781|65464501|FG002|Part A|Withdrawal by Subject|0|||
23470319|NCT02978781|65464502|FG003|Part A|Withdrawal by Subject|0|||
23470320|NCT02978781|65464503|FG004|Part A|Withdrawal by Subject|0|||
23470321|NCT02978781|65464499|FG000|Part B|Withdrawal by Subject|0|||
23470322|NCT02978781|65464500|FG001|Part B|Withdrawal by Subject|0|||
23470323|NCT02978781|65464501|FG002|Part B|Withdrawal by Subject|0|||
23470324|NCT02978781|65464502|FG003|Part B|Withdrawal by Subject|1|||
23470325|NCT02978781|65464503|FG004|Part B|Withdrawal by Subject|0|||
23470326|NCT02978781|65464499|FG000|Part C|Adverse Event|0|||
23470327|NCT02978781|65464500|FG001|Part C|Adverse Event|0|||
23470328|NCT02978781|65464501|FG002|Part C|Adverse Event|0|||
23470329|NCT02978781|65464502|FG003|Part C|Adverse Event|0|||
23587412|NCT01190150|65879071|FG000|Washout|Withdrawal by Subject|0|||
23587413|NCT01190150|65879072|FG001|Washout|Withdrawal by Subject|1|||
23587414|NCT01190150|65879071|FG000|Washout|Difficulty in adherence|0|||
23587415|NCT01190150|65879072|FG001|Washout|Difficulty in adherence|1|||
23587416|NCT04173572|65879075|FG000|Overall Study|Withdrawal by Subject|1|||
23587417|NCT04173572|65879076|FG001|Overall Study|Withdrawal by Subject|5|||
23587418|NCT04173572|65879075|FG000|Overall Study|Lost to Follow-up|3|||
23587419|NCT04173572|65879076|FG001|Overall Study|Lost to Follow-up|1|||
23587420|NCT01695317|65879077|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
23587421|NCT01695317|65879078|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
23587422|NCT01695317|65879077|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
23587423|NCT01695317|65879078|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
23587424|NCT01838200|65879079|FG000|Overall Study|Adverse Event|0|||
23587425|NCT01838200|65879080|FG001|Overall Study|Adverse Event|2|||
23587426|NCT01838200|65879079|FG000|Overall Study|Progressive disease|3|||
23247737|NCT03725722|64649075|FG002|Overall Study|COVID-19 situation|0|||
23247738|NCT03725722|64649076|FG003|Overall Study|COVID-19 situation|0|||
23247739|NCT03725722|64649077|FG004|Overall Study|COVID-19 situation|0|||
23247740|NCT02662556|64649079|FG000|Overall Study|Adverse Event|4|||
23247741|NCT02662556|64649079|FG000|Overall Study|Lack of Efficacy|4|||
23247742|NCT00396318|64649082|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
23354062|NCT01313221|65041324|FG002|Overall Study|Other|0|||
23470330|NCT02978781|65464503|FG004|Part C|Adverse Event|2|||
23470331|NCT02978781|65464499|FG000|Part C|Withdrawal by Subject|0|||
23470332|NCT02978781|65464500|FG001|Part C|Withdrawal by Subject|0|||
23470333|NCT02978781|65464501|FG002|Part C|Withdrawal by Subject|0|||
23470334|NCT02978781|65464502|FG003|Part C|Withdrawal by Subject|0|||
23470335|NCT02978781|65464503|FG004|Part C|Withdrawal by Subject|1|||
23470336|NCT02978781|65464499|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
23470337|NCT02978781|65464500|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
23470338|NCT02978781|65464501|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
23470339|NCT02978781|65464502|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
23587427|NCT01838200|65879080|FG001|Overall Study|Progressive disease|0|||
23587428|NCT00109967|65879082|FG000|Overall Study|Cancel Prior to Treatment|2|||
23188675|NCT01059812|64433060|FG000|Overall Study|Adverse Event|9|||
23188676|NCT01059812|64433061|FG001|Overall Study|Adverse Event|5|||
23188677|NCT01059812|64433060|FG000|Overall Study|Lack of Efficacy|2|||
23188678|NCT01059812|64433061|FG001|Overall Study|Lack of Efficacy|2|||
23188679|NCT01059812|64433060|FG000|Overall Study|Protocol Violation|3|||
23188680|NCT01059812|64433061|FG001|Overall Study|Protocol Violation|1|||
23188681|NCT01059812|64433060|FG000|Overall Study|Withdrawal Criteria|9|||
23188682|NCT01059812|64433061|FG001|Overall Study|Withdrawal Criteria|4|||
23188683|NCT01059812|64433060|FG000|Overall Study|Unclassified|14|||
23188684|NCT01059812|64433061|FG001|Overall Study|Unclassified|4|||
23188685|NCT00391976|64433062|FG000|Overall Study|Adverse Event|0|||
23354063|NCT01313221|65041322|FG000|Overall Study|Adverse Event|0|||
23354064|NCT01313221|65041323|FG001|Overall Study|Adverse Event|0|||
23354065|NCT01313221|65041324|FG002|Overall Study|Adverse Event|7|||
23354066|NCT01313221|65041322|FG000|Overall Study|Disease progression|0|||
23354067|NCT01313221|65041323|FG001|Overall Study|Disease progression|0|||
23354068|NCT01313221|65041324|FG002|Overall Study|Disease progression|2|||
23354069|NCT01313221|65041322|FG000|Overall Study|Physician Decision|0|||
23354070|NCT01313221|65041323|FG001|Overall Study|Physician Decision|0|||
23354071|NCT01313221|65041324|FG002|Overall Study|Physician Decision|2|||
23354072|NCT01313221|65041322|FG000|Overall Study|Pregnancy|0|||
23354073|NCT01313221|65041323|FG001|Overall Study|Pregnancy|0|||
23354074|NCT01313221|65041324|FG002|Overall Study|Pregnancy|2|||
23354075|NCT01402986|65041325|FG000|Overall Study|Withdrawal by Subject|7|||
23354076|NCT01402986|65041326|FG001|Overall Study|Withdrawal by Subject|10|||
23354077|NCT01402986|65041327|FG002|Overall Study|Withdrawal by Subject|7|||
23354078|NCT01402986|65041328|FG003|Overall Study|Withdrawal by Subject|13|||
23354079|NCT01402986|65041325|FG000|Overall Study|Death|0|||
23354080|NCT01402986|65041326|FG001|Overall Study|Death|0|||
23354081|NCT01402986|65041327|FG002|Overall Study|Death|0|||
23354082|NCT01402986|65041328|FG003|Overall Study|Death|2|||
23354083|NCT01402986|65041325|FG000|Overall Study|Lost to Follow-up|0|||
23354084|NCT01402986|65041326|FG001|Overall Study|Lost to Follow-up|0|||
23354085|NCT01402986|65041327|FG002|Overall Study|Lost to Follow-up|0|||
23354086|NCT01402986|65041328|FG003|Overall Study|Lost to Follow-up|1|||
23354087|NCT01402986|65041325|FG000|Overall Study|Other|2|||
23354088|NCT01402986|65041326|FG001|Overall Study|Other|5|||
23354089|NCT01402986|65041327|FG002|Overall Study|Other|1|||
23354090|NCT01402986|65041328|FG003|Overall Study|Other|6|||
23354091|NCT02069093|65041329|FG000|Overall Study|Disease progression|14|||
23354092|NCT02069093|65041329|FG000|Overall Study|New cancer therapy|1|||
23354093|NCT02069093|65041329|FG000|Overall Study|Death|1|||
23354094|NCT02069093|65041329|FG000|Overall Study|Administrative problems|1|||
23354095|NCT02069093|65041329|FG000|Overall Study|Withdrawal by Subject|2|||
23354096|NCT02069093|65041329|FG000|Overall Study|Abnormal laboratory values|1|||
23354097|NCT02069093|65041329|FG000|Overall Study|Adverse Event|10|||
23354098|NCT02380859|65041332|FG000|Overall Study|Withdrawal by Subject|2|||
23354099|NCT02380859|65041333|FG001|Overall Study|Withdrawal by Subject|0|||
23354100|NCT02109445|65041334|FG000|Overall Study|Symptomatic deterioration|2|||
23354101|NCT02109445|65041334|FG000|Overall Study|Adverse Event|1|||
23354102|NCT01603394|65041336|FG000|Overall Study|Adverse Event|1|||
23354103|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
23188686|NCT00391976|64433063|FG001|Overall Study|Adverse Event|0|||
23188687|NCT00391976|64433064|FG002|Overall Study|Adverse Event|1|||
23188688|NCT00391976|64433062|FG000|Overall Study|Withdrawal of consent|0|||
23188689|NCT00391976|64433063|FG001|Overall Study|Withdrawal of consent|1|||
23188690|NCT00391976|64433064|FG002|Overall Study|Withdrawal of consent|1|||
23188691|NCT00391976|64433062|FG000|Overall Study|Lost to Follow-up|1|||
23247743|NCT02058368|64649083|FG000|Overall Study|Adverse Event|15|||
23247744|NCT02058368|64649084|FG001|Overall Study|Adverse Event|20|||
23247745|NCT02058368|64649083|FG000|Overall Study|Lack of Efficacy|0|||
23247746|NCT02058368|64649084|FG001|Overall Study|Lack of Efficacy|1|||
23247747|NCT02058368|64649083|FG000|Overall Study|Protocol Violation|0|||
23247748|NCT02058368|64649084|FG001|Overall Study|Protocol Violation|4|||
23354104|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
23354105|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
23188692|NCT00391976|64433063|FG001|Overall Study|Lost to Follow-up|2|||
23188693|NCT00391976|64433064|FG002|Overall Study|Lost to Follow-up|0|||
23188694|NCT00391976|64433062|FG000|Overall Study|Inappropriate enrollment|1|||
23188695|NCT00391976|64433063|FG001|Overall Study|Inappropriate enrollment|1|||
23354106|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
23354107|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
23354108|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
23354109|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
23354110|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
23188696|NCT00391976|64433064|FG002|Overall Study|Inappropriate enrollment|0|||
23188697|NCT00391976|64433062|FG000|Overall Study|Protocol deviation/violation|4|||
23188698|NCT00391976|64433063|FG001|Overall Study|Protocol deviation/violation|2|||
23247749|NCT02058368|64649083|FG000|Overall Study|Lost to Follow-up|2|||
23354111|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
23354112|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
23354113|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
23354114|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
23354115|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
23354116|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
23354117|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
23354118|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
23354119|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
23354120|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
23188699|NCT00391976|64433064|FG002|Overall Study|Protocol deviation/violation|1|||
23188700|NCT00391976|64433062|FG000|Overall Study|Recurrence/no eradication of infection|21|||
23188701|NCT00391976|64433063|FG001|Overall Study|Recurrence/no eradication of infection|19|||
23188702|NCT00391976|64433064|FG002|Overall Study|Recurrence/no eradication of infection|0|||
23188703|NCT00391976|64433062|FG000|Overall Study|Unable to classify|0|||
23188704|NCT00391976|64433063|FG001|Overall Study|Unable to classify|0|||
23188705|NCT00391976|64433064|FG002|Overall Study|Unable to classify|1|||
23188706|NCT00391976|64433062|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
23188707|NCT00391976|64433063|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
23188708|NCT00391976|64433064|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
23188709|NCT02580058|64433065|FG000|Overall Study|Adverse Event|16|||
23188710|NCT02580058|64433066|FG001|Overall Study|Adverse Event|30|||
23354121|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
23354122|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
23354123|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
23354124|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
23354125|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
23354126|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
23354127|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
23354128|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
23354129|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
23354130|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
23354131|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
23354132|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
23354133|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
23354134|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
23247750|NCT02058368|64649084|FG001|Overall Study|Lost to Follow-up|0|||
23247751|NCT02058368|64649083|FG000|Overall Study|Physician Decision|2|||
23247752|NCT02058368|64649084|FG001|Overall Study|Physician Decision|3|||
23354135|NCT03538691|65041339|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
23354136|NCT03538691|65041340|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
23354137|NCT03538691|65041341|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
23188711|NCT02580058|64433067|FG002|Overall Study|Adverse Event|20|||
23188712|NCT02580058|64433065|FG000|Overall Study|Death|4|||
23188713|NCT02580058|64433066|FG001|Overall Study|Death|4|||
23188714|NCT02580058|64433067|FG002|Overall Study|Death|5|||
23188715|NCT02580058|64433065|FG000|Overall Study|Physician Decision|1|||
23188716|NCT02580058|64433066|FG001|Overall Study|Physician Decision|3|||
23188717|NCT02580058|64433067|FG002|Overall Study|Physician Decision|11|||
23188718|NCT02580058|64433065|FG000|Overall Study|Other|5|||
23188719|NCT02580058|64433066|FG001|Overall Study|Other|1|||
23247753|NCT02058368|64649083|FG000|Overall Study|Withdrawal by Subject|22|||
23247754|NCT02058368|64649084|FG001|Overall Study|Withdrawal by Subject|26|||
23247755|NCT01126359|64649085|FG000|First Intervention (20-minutes)|Physician Decision|0|||
23247756|NCT01126359|64649086|FG001|First Intervention (20-minutes)|Physician Decision|1|||
23247757|NCT00499252|64649087|FG000|Overall Study|Adverse Event|3|||
23247758|NCT00499252|64649087|FG000|Overall Study|Refused further treatment|2|||
23247759|NCT00499252|64649087|FG000|Overall Study|Ineligible|4|||
23247760|NCT00499252|64649087|FG000|Overall Study|<no further label>|3|||
23247761|NCT01523301|64649096|FG000|Overall Study|Adverse Event|25|||
23247762|NCT01523301|64649097|FG001|Overall Study|Adverse Event|16|||
23247763|NCT01523301|64649096|FG000|Overall Study|Lack of Efficacy|0|||
23188720|NCT02580058|64433067|FG002|Overall Study|Other|3|||
23188721|NCT02580058|64433065|FG000|Overall Study|Withdrawal by Subject|4|||
23188722|NCT02580058|64433066|FG001|Overall Study|Withdrawal by Subject|7|||
23188723|NCT02580058|64433067|FG002|Overall Study|Withdrawal by Subject|31|||
23188724|NCT02580058|64433065|FG000|Overall Study|Global Deterioration of Health Status|19|||
23247764|NCT01523301|64649097|FG001|Overall Study|Lack of Efficacy|2|||
23247765|NCT01523301|64649096|FG000|Overall Study|Protocol Violation|3|||
23247766|NCT01523301|64649097|FG001|Overall Study|Protocol Violation|4|||
23247767|NCT01523301|64649096|FG000|Overall Study|Lost to Follow-up|1|||
23247768|NCT01523301|64649097|FG001|Overall Study|Lost to Follow-up|0|||
23247769|NCT01523301|64649096|FG000|Overall Study|Withdrawal by Subject|6|||
23247770|NCT01523301|64649097|FG001|Overall Study|Withdrawal by Subject|8|||
23247771|NCT01523301|64649096|FG000|Overall Study|Other Reason|0|||
23247772|NCT01523301|64649097|FG001|Overall Study|Other Reason|2|||
23188725|NCT02580058|64433066|FG001|Overall Study|Global Deterioration of Health Status|18|||
23188726|NCT02580058|64433067|FG002|Overall Study|Global Deterioration of Health Status|24|||
23188727|NCT02580058|64433065|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
23188728|NCT02580058|64433066|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23188729|NCT02580058|64433067|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
23188730|NCT02580058|64433065|FG000|Overall Study|Progressive Disease|137|||
23188731|NCT02580058|64433066|FG001|Overall Study|Progressive Disease|125|||
23247773|NCT00424632|64649103|FG000|Overall Study|Death|0|||
23247774|NCT00424632|64649104|FG001|Overall Study|Death|0|||
23354138|NCT03538691|65041342|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
23470340|NCT02978781|65464503|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
23470341|NCT01262820|65464504|FG000|Overall Study|Adverse Event|5|||
23470342|NCT01262820|65464504|FG000|Overall Study|Lack of Efficacy|9|||
23470343|NCT01262820|65464504|FG000|Overall Study|Drug held for 21+ days|1|||
23470344|NCT00960570|65464505|FG000|21 Day Washout Period|Adverse Event|1|||
23470345|NCT00960570|65464505|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
23470346|NCT00960570|65464505|FG000|1 Day Period Between Dosing|Adverse Event|2|||
23470347|NCT00960570|65464505|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
23470348|NCT01011309|65464506|FG000|Overall Study|Adverse Event|2|||
23470349|NCT01011309|65464507|FG001|Overall Study|Adverse Event|1|||
23470350|NCT01011309|65464508|FG002|Overall Study|Adverse Event|2|||
23470351|NCT01011309|65464506|FG000|Overall Study|Lack of Efficacy|0|||
23470352|NCT01011309|65464507|FG001|Overall Study|Lack of Efficacy|1|||
23470353|NCT01011309|65464508|FG002|Overall Study|Lack of Efficacy|0|||
23470354|NCT01011309|65464506|FG000|Overall Study|Protocol Violation|0|||
23470355|NCT01011309|65464507|FG001|Overall Study|Protocol Violation|1|||
23470356|NCT01011309|65464508|FG002|Overall Study|Protocol Violation|3|||
23470357|NCT00515619|65464511|FG000|Overall Study|Adverse Event|34|||
23470358|NCT00515619|65464511|FG000|Overall Study|Lack of Efficacy|92|||
23470359|NCT00515619|65464511|FG000|Overall Study|Withdrawal by Subject|66|||
23470360|NCT00515619|65464511|FG000|Overall Study|Protocol Violation|3|||
23470361|NCT00515619|65464511|FG000|Overall Study|Lost to Follow-up|4|||
23470362|NCT00515619|65464511|FG000|Overall Study|Unsatisfactory compliance|6|||
23470363|NCT00515619|65464511|FG000|Overall Study|Other: Site discontinuing trials|2|||
23470364|NCT00515619|65464511|FG000|Overall Study|Other: Subject cannot attend visits|2|||
23188732|NCT02580058|64433067|FG002|Overall Study|Progressive Disease|94|||
23188733|NCT02580058|64433065|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23188734|NCT02580058|64433066|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23188735|NCT02580058|64433067|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23188736|NCT00658333|64433070|FG000|Overall Study|Adverse Event|2|||
23188737|NCT00658333|64433071|FG001|Overall Study|Adverse Event|1|||
23188738|NCT00824564|64433072|FG000|Overall Study|Lost to Follow-up|5|||
23188739|NCT00824564|64433073|FG001|Overall Study|Lost to Follow-up|7|||
23188740|NCT00824564|64433072|FG000|Overall Study|Withdrawal by Subject|1|||
23188741|NCT00824564|64433073|FG001|Overall Study|Withdrawal by Subject|1|||
23188742|NCT00824564|64433072|FG000|Overall Study|Other|1|||
23188743|NCT00824564|64433073|FG001|Overall Study|Other|2|||
23188744|NCT00824564|64433072|FG000|Overall Study|Randomized, but not treated|1|||
23188745|NCT00824564|64433073|FG001|Overall Study|Randomized, but not treated|0|||
23188746|NCT01357239|64433076|FG000|Stratum: All Patients|Adverse Event|0|||
23188747|NCT01357239|64433077|FG001|Stratum: All Patients|Adverse Event|0|||
23188748|NCT01357239|64433078|FG002|Stratum: All Patients|Adverse Event|1|||
23188749|NCT01357239|64433079|FG003|Stratum: All Patients|Adverse Event|1|||
23188750|NCT01357239|64433076|FG000|Stratum: All Patients|Subject withdrew consent|0|||
23188751|NCT01357239|64433077|FG001|Stratum: All Patients|Subject withdrew consent|0|||
23188752|NCT01357239|64433078|FG002|Stratum: All Patients|Subject withdrew consent|1|||
23188753|NCT01357239|64433079|FG003|Stratum: All Patients|Subject withdrew consent|1|||
23188754|NCT01357239|64433076|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
23188755|NCT01357239|64433077|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
23470365|NCT00515619|65464511|FG000|Overall Study|Other: Subject required surgery|1|||
23470366|NCT00515619|65464511|FG000|Overall Study|Other: Subject moved to another country|1|||
23470367|NCT00515619|65464511|FG000|Overall Study|Other: Investigator decision|1|||
23470368|NCT00515619|65464511|FG000|Overall Study|Other: Subject became pregnant|1|||
23470369|NCT00515619|65464511|FG000|Overall Study|Other: Request from sponsor|1|||
23188756|NCT01357239|64433078|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
23188757|NCT01357239|64433079|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
23188758|NCT01357239|64433076|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
23188759|NCT01357239|64433077|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
23188760|NCT01357239|64433078|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
23247775|NCT00424632|64649105|FG002|Overall Study|Death|0|||
23470370|NCT00515619|65464511|FG000|Overall Study|Other: Drug available on license|1|||
23470371|NCT00515619|65464511|FG000|Overall Study|Other: Subject interested in other AED|1|||
23470372|NCT01262989|65464513|FG000|Period 1|Lost to Follow-up|1|||
23470373|NCT01262989|65464514|FG001|Period 1|Lost to Follow-up|1|||
23470374|NCT01262989|65464513|FG000|Period 1|Intercurrent disease|0|||
23470375|NCT01262989|65464514|FG001|Period 1|Intercurrent disease|1|||
23470376|NCT01262989|65464513|FG000|Period 1|Positive answer for exclusion criteria|0|||
23470377|NCT01262989|65464514|FG001|Period 1|Positive answer for exclusion criteria|1|||
23470378|NCT01262989|65464513|FG000|Period 2|Intercurrent disease|0|||
23470379|NCT01262989|65464514|FG001|Period 2|Intercurrent disease|1|||
23470380|NCT00806819|65464517|FG000|Overall Study|progressive disease (modified RECIST )|217|||
23470381|NCT00806819|65464518|FG001|Overall Study|progressive disease (modified RECIST )|216|||
23470382|NCT00806819|65464517|FG000|Overall Study|Worsening or AE of underlying disease|18|||
23470383|NCT00806819|65464518|FG001|Overall Study|Worsening or AE of underlying disease|25|||
23470384|NCT00806819|65464517|FG000|Overall Study|Other AE|38|||
23470385|NCT00806819|65464518|FG001|Overall Study|Other AE|40|||
23470386|NCT00806819|65464517|FG000|Overall Study|Protocol Violation|9|||
23470387|NCT00806819|65464518|FG001|Overall Study|Protocol Violation|4|||
23470388|NCT00806819|65464517|FG000|Overall Study|Lost to Follow-up|1|||
23470389|NCT00806819|65464518|FG001|Overall Study|Lost to Follow-up|0|||
23470390|NCT00806819|65464517|FG000|Overall Study|Withdrawal by Subject|32|||
23470391|NCT00806819|65464518|FG001|Overall Study|Withdrawal by Subject|29|||
23470392|NCT00806819|65464517|FG000|Overall Study|Not treated|6|||
23470393|NCT00806819|65464518|FG001|Overall Study|Not treated|3|||
23470394|NCT00806819|65464517|FG000|Overall Study|Reasons other than stated above|25|||
23470395|NCT00806819|65464518|FG001|Overall Study|Reasons other than stated above|41|||
23470396|NCT00661427|65464519|FG000|Overall Study|Adverse Event|5|||
23470397|NCT00661427|65464520|FG001|Overall Study|Adverse Event|5|||
23470398|NCT00661427|65464519|FG000|Overall Study|Patient not treated|0|||
23470399|NCT00661427|65464520|FG001|Overall Study|Patient not treated|2|||
23470400|NCT04075734|65464521|FG000|Overall Study|Lost to Follow-up|1|||
23470401|NCT04075734|65464522|FG001|Overall Study|Lost to Follow-up|1|||
23470402|NCT04075734|65464523|FG002|Overall Study|Lost to Follow-up|0|||
23470403|NCT04075734|65464521|FG000|Overall Study|Withdrawal by Subject|3|||
23470404|NCT04075734|65464522|FG001|Overall Study|Withdrawal by Subject|0|||
23470405|NCT04075734|65464523|FG002|Overall Study|Withdrawal by Subject|0|||
23470406|NCT00787267|65464544|FG000|Overall Study|Screen failure/Ineligible|10|||
23470407|NCT00787267|65464544|FG000|Overall Study|No Reason Provided|1|||
23470408|NCT00787267|65464544|FG000|Overall Study|Withdrawal by Subject|1|||
23587429|NCT00109967|65879083|FG001|Overall Study|Cancel Prior to Treatment|0|||
23587430|NCT00109967|65879082|FG000|Overall Study|Adverse Event|12|||
23587431|NCT00109967|65879083|FG001|Overall Study|Adverse Event|1|||
23587432|NCT00109967|65879082|FG000|Overall Study|Withdrawal by Subject|5|||
23587433|NCT00109967|65879083|FG001|Overall Study|Withdrawal by Subject|0|||
23587434|NCT00109967|65879082|FG000|Overall Study|Physician Decision|1|||
23587435|NCT00109967|65879083|FG001|Overall Study|Physician Decision|3|||
23587436|NCT00109967|65879082|FG000|Overall Study|Death|0|||
23587437|NCT00109967|65879083|FG001|Overall Study|Death|2|||
23587438|NCT01451814|65879085|FG000|Overall Study|Withdrawal by Subject|1|||
23587439|NCT01451814|65879086|FG001|Overall Study|Withdrawal by Subject|1|||
23587440|NCT01451814|65879085|FG000|Overall Study|Lost to Follow-up|5|||
23587441|NCT01451814|65879086|FG001|Overall Study|Lost to Follow-up|4|||
23587442|NCT01020838|65879095|FG000|Overall Study|Death|90|||
23587443|NCT01020838|65879095|FG000|Overall Study|Adverse Event|1|||
23587444|NCT01020838|65879095|FG000|Overall Study|Withdrawal by Subject|9|||
23587445|NCT01020838|65879095|FG000|Overall Study|Lost to Follow-up|6|||
23587446|NCT01020838|65879095|FG000|Overall Study|Most common: Study ended by sponsor|77|||
23587447|NCT01831791|65879097|FG000|Overall Study|Withdrawal by Subject|10|||
23587448|NCT00954707|65879104|FG000|Overall Study|Death|34|||
23587449|NCT00954707|65879104|FG000|Overall Study|Withdrawal by Subject|100|||
23587450|NCT00954707|65879104|FG000|Overall Study|Lost to Follow-up|33|||
23470409|NCT02704143|65466499|FG000|Overall Study|disease progression|10|||
23470410|NCT03671148|65466503|FG000|Overall Study|Adverse Event|3|||
23470411|NCT03671148|65466504|FG001|Overall Study|Adverse Event|2|||
23470412|NCT03671148|65466503|FG000|Overall Study|Withdrawal by Subject|8|||
23470413|NCT03671148|65466504|FG001|Overall Study|Withdrawal by Subject|2|||
23470414|NCT03671148|65466503|FG000|Overall Study|Lost to Follow-up|1|||
23470415|NCT03671148|65466504|FG001|Overall Study|Lost to Follow-up|2|||
23470416|NCT03671148|65466503|FG000|Overall Study|Lack of Efficacy|7|||
23470417|NCT03671148|65466504|FG001|Overall Study|Lack of Efficacy|2|||
23470418|NCT03671148|65466503|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
23587451|NCT01570751|65879105|FG000|Period A (16 Weeks)|Protocol Violation|1|||
23587452|NCT01570751|65879106|FG001|Period A (16 Weeks)|Protocol Violation|1|||
23587453|NCT01570751|65879105|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
23587454|NCT01570751|65879106|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
23587455|NCT01570751|65879105|FG000|Period A (16 Weeks)|Unclassified|2|||
23587456|NCT01570751|65879106|FG001|Period A (16 Weeks)|Unclassified|3|||
23470419|NCT03671148|65466504|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
23470420|NCT03671148|65466503|FG000|Overall Study|Other|1|||
23470421|NCT03671148|65466504|FG001|Overall Study|Other|0|||
23470422|NCT03671148|65466503|FG000|Overall Study|Incomplete Randomization Visit|1|||
23470423|NCT03671148|65466504|FG001|Overall Study|Incomplete Randomization Visit|0|||
23470424|NCT01419197|65466505|FG000|Overall Study|Death|247|||
23470425|NCT01419197|65466506|FG001|Overall Study|Death|122|||
23470426|NCT01419197|65466505|FG000|Overall Study|Physician Decision|4|||
23470427|NCT01419197|65466506|FG001|Overall Study|Physician Decision|4|||
23470428|NCT01419197|65466505|FG000|Overall Study|Non-compliance|3|||
23470429|NCT01419197|65466506|FG001|Overall Study|Non-compliance|1|||
23470430|NCT01419197|65466505|FG000|Overall Study|Withdrawal by Subject|33|||
23470431|NCT01419197|65466506|FG001|Overall Study|Withdrawal by Subject|32|||
23470432|NCT01419197|65466505|FG000|Overall Study|Study Completed by Sponsor|103|||
23470433|NCT01419197|65466506|FG001|Overall Study|Study Completed by Sponsor|34|||
23470434|NCT01419197|65466505|FG000|Overall Study|Reason Not Specified|0|||
23470435|NCT01419197|65466506|FG001|Overall Study|Reason Not Specified|1|||
23470436|NCT01419197|65466505|FG000|Overall Study|Lost to Follow-up|14|||
23470437|NCT01419197|65466506|FG001|Overall Study|Lost to Follow-up|4|||
23470438|NCT01106248|65466508|FG000|Overall Study|Adverse Event|1|||
23470439|NCT01106248|65466508|FG000|Overall Study|Administrative|2|||
23470440|NCT00312195|65466511|FG000|Overall Study|Adverse Event|4|||
23470441|NCT00312195|65466512|FG001|Overall Study|Adverse Event|6|||
23470442|NCT00312195|65466511|FG000|Overall Study|Lost to Follow-up|1|||
23470443|NCT00312195|65466512|FG001|Overall Study|Lost to Follow-up|0|||
23470444|NCT00312195|65466511|FG000|Overall Study|Protocol Violation|1|||
23470445|NCT00312195|65466512|FG001|Overall Study|Protocol Violation|0|||
23470446|NCT00392769|65466513|FG000|Overall Study|Clinical Deterioration|9|||
23470447|NCT00392769|65466513|FG000|Overall Study|Adverse Event|1|||
23470448|NCT02930018|65466514|FG000|Overall Study|Lost to Follow-up|1|||
23470449|NCT02930018|65466515|FG001|Overall Study|Lost to Follow-up|1|||
23470450|NCT02930018|65466514|FG000|Overall Study|Withdrawal by Subject|5|||
23470451|NCT02930018|65466515|FG001|Overall Study|Withdrawal by Subject|2|||
23470452|NCT02252939|65466516|FG000|Overall Study|Lost to Follow-up|3|||
23470453|NCT00393861|65466517|FG000|Overall Study|Adverse Event|2|||
23470454|NCT00393861|65466517|FG000|Overall Study|Disease Progression|24|||
23470455|NCT01301027|65466518|FG000|Overall Study|Physician Decision|2|||
23470456|NCT01301027|65466519|FG001|Overall Study|Physician Decision|0|||
23470457|NCT01301027|65466518|FG000|Overall Study|Withdrawal by Subject|2|||
23470458|NCT01301027|65466519|FG001|Overall Study|Withdrawal by Subject|3|||
23470459|NCT01301027|65466518|FG000|Overall Study|Adverse Event|0|||
23470460|NCT01301027|65466519|FG001|Overall Study|Adverse Event|2|||
23470461|NCT01301027|65466518|FG000|Overall Study|Fracture|1|||
23470462|NCT01301027|65466519|FG001|Overall Study|Fracture|3|||
23470463|NCT01301027|65466518|FG000|Overall Study|Transplant|0|||
23470464|NCT01301027|65466519|FG001|Overall Study|Transplant|2|||
23470465|NCT01301027|65466518|FG000|Overall Study|Volume Overload|3|||
23470466|NCT01301027|65466519|FG001|Overall Study|Volume Overload|0|||
23470467|NCT03783078|65466522|FG000|Overall Study|Participants Ongoing|29|||
23470468|NCT03783078|65466522|FG000|Overall Study|Death|26|||
23470469|NCT03085797|65466523|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
23470470|NCT03085797|65466524|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
23470471|NCT03085797|65466523|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
23470472|NCT03085797|65466524|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
23470473|NCT03085797|65466523|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
23470474|NCT03085797|65466524|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
23470475|NCT04328077|65466525|FG000|Overall Study|Lost to Follow-up|0|||
23470476|NCT04328077|65466526|FG001|Overall Study|Lost to Follow-up|1|||
23470477|NCT04328077|65466527|FG002|Overall Study|Lost to Follow-up|0|||
23470478|NCT04328077|65466528|FG003|Overall Study|Lost to Follow-up|0|||
23470479|NCT04328077|65466525|FG000|Overall Study|Withdrawal by Subject|0|||
23470480|NCT04328077|65466526|FG001|Overall Study|Withdrawal by Subject|1|||
23470481|NCT04328077|65466527|FG002|Overall Study|Withdrawal by Subject|1|||
23470482|NCT04328077|65466528|FG003|Overall Study|Withdrawal by Subject|3|||
23470483|NCT03704636|65466529|FG000|Overall Study|Inadequate Venous Flow|3|||
23470484|NCT00452361|65466530|FG000|Overall Study|Adverse Event|8|||
23470485|NCT00452361|65466531|FG001|Overall Study|Adverse Event|0|||
23470486|NCT00452361|65466530|FG000|Overall Study|Withdrawal by Subject|0|||
23470487|NCT00452361|65466531|FG001|Overall Study|Withdrawal by Subject|1|||
23470488|NCT00452361|65466530|FG000|Overall Study|Premature termination|13|||
23470489|NCT00452361|65466531|FG001|Overall Study|Premature termination|9|||
23470490|NCT00641667|65466532|FG000|Overall Study|Withdrawal by Subject|1|||
23470491|NCT00641667|65466532|FG000|Overall Study|Adverse Event|1|||
23470492|NCT00641667|65466532|FG000|Overall Study|Physician Decision|1|||
23470493|NCT00641667|65466532|FG000|Overall Study|Worsening of underlying disease|3|||
23470494|NCT05366738|65466533|FG000|Overall Study|Adverse Event|0|||
23470495|NCT05366738|65466534|FG001|Overall Study|Adverse Event|1|||
23470496|NCT05366738|65466535|FG002|Overall Study|Adverse Event|0|||
23470497|NCT04463069|65466539|FG000|Overall Study|Withdrawal by Subject|2|||
23470498|NCT04463069|65466540|FG001|Overall Study|Withdrawal by Subject|10|||
23470499|NCT04463069|65466539|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
23470500|NCT04463069|65466540|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
23470501|NCT02067676|65466543|FG000|Overall Study|Withdrawal by Subject|1|||
23470502|NCT02067676|65466544|FG001|Overall Study|Withdrawal by Subject|0|||
23470503|NCT02067676|65466545|FG002|Overall Study|Withdrawal by Subject|0|||
23470504|NCT02067676|65466546|FG003|Overall Study|Withdrawal by Subject|0|||
23470505|NCT02067676|65466547|FG004|Overall Study|Withdrawal by Subject|0|||
23470506|NCT02067676|65466548|FG005|Overall Study|Withdrawal by Subject|0|||
23470507|NCT01358721|65466551|FG000|Overall Study|Withdrawal by Subject|0|||
23470508|NCT01358721|65466552|FG001|Overall Study|Withdrawal by Subject|0|||
23470509|NCT01358721|65466553|FG002|Overall Study|Withdrawal by Subject|0|||
23470510|NCT01358721|65466554|FG003|Overall Study|Withdrawal by Subject|1|||
23470511|NCT01358721|65466551|FG000|Overall Study|Death|0|||
23470512|NCT01358721|65466552|FG001|Overall Study|Death|2|||
23470513|NCT01358721|65466553|FG002|Overall Study|Death|0|||
23470514|NCT01358721|65466554|FG003|Overall Study|Death|0|||
23470515|NCT01358721|65466551|FG000|Overall Study|Study Drug Toxicity|1|||
23470516|NCT01358721|65466552|FG001|Overall Study|Study Drug Toxicity|3|||
23470517|NCT01358721|65466553|FG002|Overall Study|Study Drug Toxicity|4|||
23470518|NCT01358721|65466554|FG003|Overall Study|Study Drug Toxicity|5|||
23470519|NCT01358721|65466551|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
23470520|NCT01358721|65466552|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
23470521|NCT01358721|65466553|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
23470522|NCT01358721|65466554|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
23470523|NCT01358721|65466551|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
23470524|NCT01358721|65466552|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
23470525|NCT01358721|65466553|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
23470526|NCT01358721|65466554|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
23470527|NCT01358721|65466551|FG000|Overall Study|Adverse Event related to study drug|1|||
23188761|NCT01357239|64433079|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
23188762|NCT01357239|64433076|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
23188763|NCT01357239|64433077|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
23247776|NCT00424632|64649106|FG003|Overall Study|Death|0|||
23247777|NCT00424632|64649107|FG004|Overall Study|Death|0|||
23247778|NCT00424632|64649108|FG005|Overall Study|Death|2|||
23247779|NCT00424632|64649109|FG006|Overall Study|Death|0|||
23247780|NCT00424632|64649110|FG007|Overall Study|Death|0|||
23247781|NCT00424632|64649111|FG008|Overall Study|Death|0|||
23247782|NCT00424632|64649112|FG009|Overall Study|Death|0|||
23247783|NCT00424632|64649103|FG000|Overall Study|Adverse Event|0|||
23247784|NCT00424632|64649104|FG001|Overall Study|Adverse Event|0|||
23247785|NCT00424632|64649105|FG002|Overall Study|Adverse Event|0|||
23247786|NCT00424632|64649106|FG003|Overall Study|Adverse Event|0|||
23247787|NCT00424632|64649107|FG004|Overall Study|Adverse Event|0|||
23247788|NCT00424632|64649108|FG005|Overall Study|Adverse Event|0|||
23188764|NCT01357239|64433078|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
23188765|NCT01357239|64433079|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
23188766|NCT02986373|64433080|FG000|Overall Study|Adverse Event|4|||
23188767|NCT02986373|64433080|FG000|Overall Study|Lost to Follow-up|1|||
23188768|NCT02986373|64433080|FG000|Overall Study|Withdrawal by Subject|10|||
23188769|NCT02986373|64433080|FG000|Overall Study|Other|24|||
23188770|NCT01071070|64433084|FG000|Overall Study|Adverse Event|0|||
23188771|NCT01071070|64433085|FG001|Overall Study|Adverse Event|3|||
23188772|NCT01071070|64433084|FG000|Overall Study|Withdrawal by Subject|1|||
23188773|NCT01071070|64433085|FG001|Overall Study|Withdrawal by Subject|0|||
23247789|NCT00424632|64649109|FG006|Overall Study|Adverse Event|0|||
23247790|NCT00424632|64649110|FG007|Overall Study|Adverse Event|0|||
23247791|NCT00424632|64649111|FG008|Overall Study|Adverse Event|3|||
23247792|NCT00424632|64649112|FG009|Overall Study|Adverse Event|2|||
23247793|NCT00424632|64649103|FG000|Overall Study|Global deterioration of health status|0|||
23247794|NCT00424632|64649104|FG001|Overall Study|Global deterioration of health status|0|||
23470528|NCT01358721|65466552|FG001|Overall Study|Adverse Event related to study drug|0|||
23247795|NCT00424632|64649105|FG002|Overall Study|Global deterioration of health status|0|||
23247796|NCT00424632|64649106|FG003|Overall Study|Global deterioration of health status|1|||
23247797|NCT00424632|64649107|FG004|Overall Study|Global deterioration of health status|1|||
23188774|NCT01071070|64433084|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
23247798|NCT00424632|64649108|FG005|Overall Study|Global deterioration of health status|0|||
23247799|NCT00424632|64649109|FG006|Overall Study|Global deterioration of health status|0|||
23247800|NCT00424632|64649110|FG007|Overall Study|Global deterioration of health status|0|||
23470529|NCT01358721|65466553|FG002|Overall Study|Adverse Event related to study drug|0|||
23470530|NCT01358721|65466554|FG003|Overall Study|Adverse Event related to study drug|1|||
23188775|NCT01071070|64433085|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
23247801|NCT00424632|64649111|FG008|Overall Study|Global deterioration of health status|0|||
23247802|NCT00424632|64649112|FG009|Overall Study|Global deterioration of health status|0|||
23247803|NCT00424632|64649103|FG000|Overall Study|Objective progression or relapse|1|||
23247804|NCT00424632|64649104|FG001|Overall Study|Objective progression or relapse|1|||
23247805|NCT00424632|64649105|FG002|Overall Study|Objective progression or relapse|1|||
23247806|NCT00424632|64649106|FG003|Overall Study|Objective progression or relapse|2|||
23247807|NCT00424632|64649107|FG004|Overall Study|Objective progression or relapse|2|||
23247808|NCT00424632|64649108|FG005|Overall Study|Objective progression or relapse|13|||
23188776|NCT01071070|64433084|FG000|Overall Study|Hypercalcemia|1|||
23188777|NCT01071070|64433085|FG001|Overall Study|Hypercalcemia|0|||
23188778|NCT02499952|64433086|FG000|Overall Study|Lost to Follow-up|1|||
23188779|NCT02499952|64433086|FG000|Overall Study|Death|9|||
23188780|NCT00532259|64433087|FG000|Overall Study|Withdrawal by Subject|2|||
23188781|NCT00532259|64433087|FG000|Overall Study|Adverse Event|1|||
23188782|NCT00532259|64433087|FG000|Overall Study|Death|1|||
23188783|NCT00532259|64433087|FG000|Overall Study|Lack of Efficacy|21|||
23188784|NCT00532259|64433087|FG000|Overall Study|Lost to Follow-up|3|||
23188785|NCT00532259|64433087|FG000|Overall Study|Physician Decision|3|||
23188786|NCT00532259|64433087|FG000|Overall Study|Protocol Violation|1|||
23188787|NCT00524303|64433090|FG000|Overall Study|Lost to Follow-up|6|||
23188788|NCT00524303|64433091|FG001|Overall Study|Lost to Follow-up|0|||
23188789|NCT00524303|64433092|FG002|Overall Study|Lost to Follow-up|3|||
23188790|NCT00524303|64433090|FG000|Overall Study|Protocol Violation|0|||
23188791|NCT00524303|64433091|FG001|Overall Study|Protocol Violation|1|||
23188792|NCT00524303|64433092|FG002|Overall Study|Protocol Violation|1|||
23188793|NCT00524303|64433090|FG000|Overall Study|Withdrawal by Subject|3|||
23188794|NCT00524303|64433091|FG001|Overall Study|Withdrawal by Subject|0|||
23188795|NCT00524303|64433092|FG002|Overall Study|Withdrawal by Subject|4|||
23188796|NCT00524303|64433090|FG000|Overall Study|Death|0|||
23188797|NCT00524303|64433091|FG001|Overall Study|Death|2|||
23188798|NCT00524303|64433092|FG002|Overall Study|Death|3|||
23188799|NCT00524303|64433090|FG000|Overall Study|Adverse Event|1|||
23188800|NCT00524303|64433091|FG001|Overall Study|Adverse Event|2|||
23188801|NCT00524303|64433092|FG002|Overall Study|Adverse Event|3|||
23188802|NCT00524303|64433090|FG000|Overall Study|Did not Complete Study Dosing|1|||
23188803|NCT00524303|64433091|FG001|Overall Study|Did not Complete Study Dosing|0|||
23188804|NCT00524303|64433092|FG002|Overall Study|Did not Complete Study Dosing|0|||
23188805|NCT00524303|64433090|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
23188806|NCT00524303|64433091|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
23188807|NCT00524303|64433092|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
23188808|NCT00524303|64433090|FG000|Overall Study|Disease Progression|0|||
23188809|NCT00524303|64433091|FG001|Overall Study|Disease Progression|4|||
23188810|NCT00524303|64433092|FG002|Overall Study|Disease Progression|1|||
23188811|NCT00524303|64433090|FG000|Overall Study|Disease Recurrence|0|||
23188812|NCT00524303|64433091|FG001|Overall Study|Disease Recurrence|1|||
23188813|NCT00524303|64433092|FG002|Overall Study|Disease Recurrence|0|||
23188814|NCT00524303|64433090|FG000|Overall Study|Sponsor Request|0|||
23188815|NCT00524303|64433091|FG001|Overall Study|Sponsor Request|0|||
23188816|NCT00524303|64433092|FG002|Overall Study|Sponsor Request|1|||
23188817|NCT00524303|64433090|FG000|Overall Study|Physician Decision|0|||
23188818|NCT00524303|64433091|FG001|Overall Study|Physician Decision|0|||
23188819|NCT00524303|64433092|FG002|Overall Study|Physician Decision|1|||
23188820|NCT00524303|64433090|FG000|Overall Study|Completed 5 years|0|||
23188821|NCT00524303|64433091|FG001|Overall Study|Completed 5 years|0|||
23188822|NCT00524303|64433092|FG002|Overall Study|Completed 5 years|1|||
23188823|NCT01389128|64433094|FG000|Overall Study|Fetal distress|1|||
23188824|NCT01389128|64433095|FG001|Overall Study|Fetal distress|0|||
23247809|NCT00424632|64649109|FG006|Overall Study|Objective progression or relapse|7|||
23354139|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
23470531|NCT01358721|65466551|FG000|Overall Study|Disease Progression|19|||
23587457|NCT01570751|65879105|FG000|Period B (16 Weeks)|Adverse Event|1|||
23587458|NCT01570751|65879106|FG001|Period B (16 Weeks)|Adverse Event|0|||
23587459|NCT01570751|65879105|FG000|Period B (16 Weeks)|Protocol Violation|0|||
23188825|NCT01389128|64433094|FG000|Overall Study|Cervix dilation stop|1|||
23188826|NCT01389128|64433095|FG001|Overall Study|Cervix dilation stop|2|||
23188827|NCT01389128|64433094|FG000|Overall Study|Rapid labor evolution|3|||
23188828|NCT01389128|64433095|FG001|Overall Study|Rapid labor evolution|2|||
23188829|NCT01389128|64433094|FG000|Overall Study|Intolerance to procedure|0|||
23188830|NCT01389128|64433095|FG001|Overall Study|Intolerance to procedure|2|||
23188831|NCT00847561|64433098|FG000|Overall Study|Withdrawal by Subject|4|||
23188832|NCT00847561|64433099|FG001|Overall Study|Withdrawal by Subject|3|||
23188833|NCT00847561|64433098|FG000|Overall Study|Unable to schedule|9|||
23188834|NCT00847561|64433099|FG001|Overall Study|Unable to schedule|1|||
23188835|NCT03846947|64433100|FG000|Overall Study|technical issues with imaging sequence|2|||
23188836|NCT05480514|64433105|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
23188837|NCT05480514|64433106|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
23247810|NCT00424632|64649110|FG007|Overall Study|Objective progression or relapse|3|||
23247811|NCT00424632|64649111|FG008|Overall Study|Objective progression or relapse|12|||
23587460|NCT01570751|65879106|FG001|Period B (16 Weeks)|Protocol Violation|1|||
23247812|NCT00424632|64649112|FG009|Overall Study|Objective progression or relapse|4|||
23247813|NCT00424632|64649103|FG000|Overall Study|Other|0|||
23247814|NCT00424632|64649104|FG001|Overall Study|Other|0|||
23247815|NCT00424632|64649105|FG002|Overall Study|Other|0|||
23247816|NCT00424632|64649106|FG003|Overall Study|Other|1|||
23247817|NCT00424632|64649107|FG004|Overall Study|Other|0|||
23247818|NCT00424632|64649108|FG005|Overall Study|Other|0|||
23247819|NCT00424632|64649109|FG006|Overall Study|Other|0|||
23247820|NCT00424632|64649110|FG007|Overall Study|Other|0|||
23247821|NCT00424632|64649111|FG008|Overall Study|Other|1|||
23247822|NCT00424632|64649112|FG009|Overall Study|Other|0|||
23247823|NCT01977482|64649113|FG000|Overall Study|Adverse Event|0|||
23247824|NCT01977482|64649114|FG001|Overall Study|Adverse Event|1|||
23247825|NCT01977482|64649115|FG002|Overall Study|Adverse Event|1|||
23247826|NCT01977482|64649116|FG003|Overall Study|Adverse Event|0|||
23247827|NCT01977482|64649117|FG004|Overall Study|Adverse Event|2|||
23247828|NCT01977482|64649118|FG005|Overall Study|Adverse Event|0|||
23247829|NCT01977482|64649113|FG000|Overall Study|Lost to Follow-up|1|||
23247830|NCT01977482|64649114|FG001|Overall Study|Lost to Follow-up|0|||
23247831|NCT01977482|64649115|FG002|Overall Study|Lost to Follow-up|0|||
23247832|NCT01977482|64649116|FG003|Overall Study|Lost to Follow-up|0|||
23247833|NCT01977482|64649117|FG004|Overall Study|Lost to Follow-up|0|||
23247834|NCT01977482|64649118|FG005|Overall Study|Lost to Follow-up|0|||
23247835|NCT01977482|64649113|FG000|Overall Study|Physician Decision|0|||
23247836|NCT01977482|64649114|FG001|Overall Study|Physician Decision|1|||
23247837|NCT01977482|64649115|FG002|Overall Study|Physician Decision|0|||
23247838|NCT01977482|64649116|FG003|Overall Study|Physician Decision|0|||
23247839|NCT01977482|64649117|FG004|Overall Study|Physician Decision|0|||
23247840|NCT01977482|64649118|FG005|Overall Study|Physician Decision|0|||
23247841|NCT01977482|64649113|FG000|Overall Study|Protocol Violation|0|||
23247842|NCT01977482|64649114|FG001|Overall Study|Protocol Violation|0|||
23247843|NCT01977482|64649115|FG002|Overall Study|Protocol Violation|1|||
23247844|NCT01977482|64649116|FG003|Overall Study|Protocol Violation|0|||
23247845|NCT01977482|64649117|FG004|Overall Study|Protocol Violation|0|||
23247846|NCT01977482|64649118|FG005|Overall Study|Protocol Violation|0|||
23247847|NCT01977482|64649113|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
23247848|NCT01977482|64649114|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
23247849|NCT01977482|64649115|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
23247850|NCT01977482|64649116|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
23247851|NCT01977482|64649117|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
23247852|NCT01977482|64649118|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
23247853|NCT01977482|64649113|FG000|Overall Study|Withdrawal by Subject|2|||
23247854|NCT01977482|64649114|FG001|Overall Study|Withdrawal by Subject|4|||
23247855|NCT01977482|64649115|FG002|Overall Study|Withdrawal by Subject|1|||
23247856|NCT01977482|64649116|FG003|Overall Study|Withdrawal by Subject|3|||
23247857|NCT01977482|64649117|FG004|Overall Study|Withdrawal by Subject|1|||
23247858|NCT01977482|64649118|FG005|Overall Study|Withdrawal by Subject|5|||
23247859|NCT04278872|64649119|FG000|Overall Study|Adverse Event|1|||
23247860|NCT04278872|64649120|FG001|Overall Study|Adverse Event|0|||
23247861|NCT04278872|64649119|FG000|Overall Study|Protocol Violation|0|||
23247862|NCT04278872|64649120|FG001|Overall Study|Protocol Violation|1|||
23354140|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
23587461|NCT00487578|65879107|FG000|Overall Study|Adverse Event|1|||
23587462|NCT00487578|65879108|FG001|Overall Study|Adverse Event|2|||
23587463|NCT00487578|65879107|FG000|Overall Study|Lack of Efficacy|0|||
23587464|NCT00487578|65879108|FG001|Overall Study|Lack of Efficacy|1|||
23587465|NCT00487578|65879107|FG000|Overall Study|Lost to Follow-up|0|||
23587466|NCT00487578|65879108|FG001|Overall Study|Lost to Follow-up|1|||
23247863|NCT04278872|64649119|FG000|Overall Study|Study Termination|2|||
23247864|NCT04278872|64649120|FG001|Overall Study|Study Termination|0|||
23354141|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
23587467|NCT03395353|65879110|FG000|Overall Study|Adverse Event|20|||
23354142|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
23354143|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
23587468|NCT03395353|65879110|FG000|Overall Study|Protocol Violation|1|||
23587469|NCT03395353|65879110|FG000|Overall Study|Lack of Efficacy|3|||
23247865|NCT01833897|64649121|FG000|Overall Study|Lack of Efficacy|1|||
23247866|NCT01612780|64649128|FG000|Overall Study|Treatment not completed|1|||
23247867|NCT01612780|64649128|FG000|Overall Study|Withdrawal by Subject|5|||
23247868|NCT00782275|64649129|FG000|Overall Study|Adverse Event|11|||
23247869|NCT00782275|64649129|FG000|Overall Study|Withdrawal by Subject|1|||
23247870|NCT00782275|64649129|FG000|Overall Study|Progressive Disease|21|||
23247871|NCT00782275|64649129|FG000|Overall Study|Physician Decision|4|||
23247872|NCT00782275|64649129|FG000|Overall Study|Not started treatment|1|||
23247873|NCT00782275|64649129|FG000|Overall Study|Other|3|||
23247874|NCT00555399|64649130|FG000|Overall Study|Withdrawal by Subject|0|||
23470532|NCT01358721|65466552|FG001|Overall Study|Disease Progression|15|||
23470533|NCT01358721|65466553|FG002|Overall Study|Disease Progression|17|||
23470534|NCT01358721|65466554|FG003|Overall Study|Disease Progression|15|||
23470535|NCT01358721|65466551|FG000|Overall Study|Out of State/Unmet Criteria|0|||
23470536|NCT01358721|65466552|FG001|Overall Study|Out of State/Unmet Criteria|0|||
23470537|NCT01358721|65466553|FG002|Overall Study|Out of State/Unmet Criteria|1|||
23247875|NCT00555399|64649131|FG001|Overall Study|Withdrawal by Subject|0|||
23247876|NCT00555399|64649132|FG002|Overall Study|Withdrawal by Subject|1|||
23247877|NCT00555399|64649133|FG003|Overall Study|Withdrawal by Subject|0|||
23247878|NCT00555399|64649134|FG004|Overall Study|Withdrawal by Subject|0|||
23247879|NCT00555399|64649135|FG005|Overall Study|Withdrawal by Subject|0|||
23247880|NCT00555399|64649136|FG006|Overall Study|Withdrawal by Subject|0|||
23247881|NCT00555399|64649137|FG007|Overall Study|Withdrawal by Subject|0|||
23247882|NCT00555399|64649138|FG008|Overall Study|Withdrawal by Subject|0|||
23247883|NCT00555399|64649139|FG009|Overall Study|Withdrawal by Subject|0|||
23247884|NCT00555399|64649140|FG010|Overall Study|Withdrawal by Subject|0|||
23247885|NCT00555399|64649141|FG011|Overall Study|Withdrawal by Subject|1|||
23247886|NCT00555399|64649130|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
23247887|NCT00555399|64649131|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
23247888|NCT00555399|64649132|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
23247889|NCT00555399|64649133|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
23247890|NCT00555399|64649134|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
23247891|NCT00555399|64649135|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
23247892|NCT00555399|64649136|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
23247893|NCT00555399|64649137|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
23247894|NCT00555399|64649138|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
23247895|NCT00555399|64649139|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
23247896|NCT00555399|64649140|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
23470538|NCT01358721|65466554|FG003|Overall Study|Out of State/Unmet Criteria|0|||
23470539|NCT00068419|65466555|FG000|Overall Study|Adverse Event|3|||
23470540|NCT00068419|65466555|FG000|Overall Study|Lack of Efficacy|24|||
23470541|NCT00068419|65466555|FG000|Overall Study|Lost to Follow-up|1|||
23470542|NCT00068419|65466555|FG000|Overall Study|Physician Decision|7|||
23247897|NCT00555399|64649141|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
23247898|NCT01861717|64649142|FG000|Overall Study|Lost to Follow-up|1|||
23247899|NCT01861717|64649142|FG000|Overall Study|Withdrawal by Subject|1|||
23247900|NCT02787785|64649146|FG000|Overall Study|Death|3|||
23247901|NCT02787785|64649147|FG001|Overall Study|Death|4|||
23247902|NCT02787785|64649146|FG000|Overall Study|Lost to Follow-up|1|||
23247903|NCT02787785|64649147|FG001|Overall Study|Lost to Follow-up|1|||
23247904|NCT02787785|64649146|FG000|Overall Study|Withdrawal by Subject|0|||
23587470|NCT03395353|65879110|FG000|Overall Study|Withdrawal by Subject|24|||
23354144|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
23354145|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
23587471|NCT03395353|65879110|FG000|Overall Study|Discontinued visit|1|||
23587472|NCT03395353|65879110|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
23587473|NCT03395353|65879110|FG000|Overall Study|Physician Decision|4|||
23587474|NCT03395353|65879110|FG000|Overall Study|Early termination of overall study|33|||
23587475|NCT04842604|65879114|FG000|Overall Study|Death|1|||
23587476|NCT04842604|65879115|FG001|Overall Study|Death|0|||
23247905|NCT02787785|64649147|FG001|Overall Study|Withdrawal by Subject|5|||
23247906|NCT00358670|64649148|FG000|Overall Study|Adverse Event|26|||
23247907|NCT00358670|64649149|FG001|Overall Study|Adverse Event|29|||
23247908|NCT00358670|64649148|FG000|Overall Study|Lack of Efficacy|20|||
23247909|NCT00358670|64649149|FG001|Overall Study|Lack of Efficacy|23|||
23247910|NCT00358670|64649148|FG000|Overall Study|Protocol Violation|6|||
23247911|NCT00358670|64649149|FG001|Overall Study|Protocol Violation|9|||
23247912|NCT00358670|64649148|FG000|Overall Study|Lost to Follow-up|4|||
23247913|NCT00358670|64649149|FG001|Overall Study|Lost to Follow-up|5|||
23247914|NCT00358670|64649148|FG000|Overall Study|Withdrawal by Subject|13|||
23247915|NCT00358670|64649149|FG001|Overall Study|Withdrawal by Subject|24|||
23247916|NCT00358670|64649148|FG000|Overall Study|Protocol Defined Clinical Event|0|||
23247917|NCT00358670|64649149|FG001|Overall Study|Protocol Defined Clinical Event|1|||
23247918|NCT00358670|64649148|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
23247919|NCT00358670|64649149|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
23247920|NCT00358670|64649148|FG000|Overall Study|Administrative|153|||
23247921|NCT00358670|64649149|FG001|Overall Study|Administrative|125|||
23247922|NCT03981614|64649150|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
23247923|NCT03981614|64649151|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
23247924|NCT03981614|64649152|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
23247925|NCT02076113|64649153|FG000|Overall Study|Lost to Follow-up|4|||
23247926|NCT02076113|64649154|FG001|Overall Study|Lost to Follow-up|1|||
23247927|NCT02076113|64649153|FG000|Overall Study|Withdrawal by Subject|2|||
23247928|NCT02076113|64649154|FG001|Overall Study|Withdrawal by Subject|3|||
23247929|NCT02076113|64649153|FG000|Overall Study|Death|1|||
23247930|NCT02076113|64649154|FG001|Overall Study|Death|3|||
23247931|NCT01266642|64649155|FG000|Overall Study|Protocol Violation|0|||
23247932|NCT01266642|64649156|FG001|Overall Study|Protocol Violation|1|||
23247933|NCT01843660|64649162|FG000|Overall Study|Other|30|||
23247934|NCT00503035|64649164|FG000|Overall Study|Lost to Follow-up|2|||
23247935|NCT00503035|64649164|FG000|Overall Study|Physician Decision|3|||
23247936|NCT00503035|64649164|FG000|Overall Study|Ineligible|15|||
23247937|NCT03606109|64649168|FG000|Overall Study|Lost to Follow-up|2|||
23247938|NCT03606109|64649169|FG001|Overall Study|Lost to Follow-up|1|||
23247939|NCT00902486|64649170|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
23247940|NCT00902486|64649171|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
23247941|NCT00902486|64649172|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
23247942|NCT00902486|64649173|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
23247943|NCT00902486|64649174|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
23247944|NCT00902486|64649175|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
23247945|NCT00902486|64649170|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
23247946|NCT00902486|64649171|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
23247947|NCT00902486|64649172|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
23247948|NCT00902486|64649173|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
23247949|NCT00902486|64649174|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
23247950|NCT00902486|64649175|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
23247951|NCT00902486|64649170|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
23247952|NCT00902486|64649171|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
23247953|NCT00902486|64649172|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
23247954|NCT00902486|64649173|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
23247955|NCT00902486|64649174|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
23354146|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
23247956|NCT00902486|64649175|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
23587477|NCT04842604|65879114|FG000|Overall Study|Other|4|||
23587478|NCT04842604|65879115|FG001|Overall Study|Other|4|||
23354147|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
23354148|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
23354149|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
23354150|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
23354151|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
23587479|NCT04842604|65879114|FG000|Overall Study|Randomized but not treated|1|||
23188838|NCT05480514|64433105|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
23188839|NCT05480514|64433106|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
23188840|NCT05480514|64433105|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
23188841|NCT05480514|64433106|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
23188842|NCT05480514|64433105|FG000|Period 1|Covid-19 Related|1|||
23188843|NCT05480514|64433106|FG001|Period 1|Covid-19 Related|0|||
23188844|NCT05480514|64433105|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
23188845|NCT05480514|64433106|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
23188846|NCT02452359|64433114|FG000|Overall Study|Adverse Event|1|||
23188847|NCT02452359|64433114|FG000|Overall Study|Lost to Follow-up|15|||
23188848|NCT02452359|64433114|FG000|Overall Study|Pregnancy|1|||
23188849|NCT02452359|64433114|FG000|Overall Study|Withdrawal by Subject|4|||
23188850|NCT03443024|64433115|FG000|Overall Study|Adverse Event|2|||
23188851|NCT03443024|64433116|FG001|Overall Study|Adverse Event|4|||
23188852|NCT03443024|64433117|FG002|Overall Study|Adverse Event|3|||
23188853|NCT03443024|64433118|FG003|Overall Study|Adverse Event|1|||
23188854|NCT03443024|64433115|FG000|Overall Study|Lost to Follow-up|9|||
23188855|NCT03443024|64433116|FG001|Overall Study|Lost to Follow-up|9|||
23188856|NCT03443024|64433117|FG002|Overall Study|Lost to Follow-up|7|||
23188857|NCT03443024|64433118|FG003|Overall Study|Lost to Follow-up|5|||
23188858|NCT03443024|64433115|FG000|Overall Study|Withdrawal by Subject|8|||
23188859|NCT03443024|64433116|FG001|Overall Study|Withdrawal by Subject|15|||
23188860|NCT03443024|64433117|FG002|Overall Study|Withdrawal by Subject|9|||
23587480|NCT04842604|65879115|FG001|Overall Study|Randomized but not treated|0|||
23587481|NCT00408928|65879122|FG000|Overall Study|Withdrawal by Subject|1|||
23587482|NCT00408928|65879122|FG000|Overall Study|Death|1|||
23188861|NCT03443024|64433118|FG003|Overall Study|Withdrawal by Subject|23|||
23188862|NCT03443024|64433115|FG000|Overall Study|Physician Decision|1|||
23188863|NCT03443024|64433116|FG001|Overall Study|Physician Decision|2|||
23188864|NCT03443024|64433117|FG002|Overall Study|Physician Decision|0|||
23188865|NCT03443024|64433118|FG003|Overall Study|Physician Decision|1|||
23188866|NCT03443024|64433115|FG000|Overall Study|Sponsor Decision|1|||
23188867|NCT03443024|64433116|FG001|Overall Study|Sponsor Decision|1|||
23188868|NCT03443024|64433117|FG002|Overall Study|Sponsor Decision|0|||
23188869|NCT03443024|64433118|FG003|Overall Study|Sponsor Decision|0|||
23188870|NCT03443024|64433115|FG000|Overall Study|Protocol Deviation|0|||
23188871|NCT03443024|64433116|FG001|Overall Study|Protocol Deviation|0|||
23188872|NCT03443024|64433117|FG002|Overall Study|Protocol Deviation|0|||
23188873|NCT03443024|64433118|FG003|Overall Study|Protocol Deviation|2|||
23188874|NCT03167619|64433121|FG000|Overall Study|Death|11|||
23587483|NCT00408928|65879122|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
23587484|NCT03125382|65879133|FG000|Randomization|screening failure|1|||
23587485|NCT03125382|65879134|FG001|Randomization|screening failure|4|||
23587486|NCT03125382|65879135|FG002|Randomization|screening failure|2|||
23587487|NCT03125382|65879136|FG003|Randomization|screening failure|0|||
23587488|NCT03125382|65879133|FG000|Follow-up|Death|1|||
23587489|NCT03125382|65879134|FG001|Follow-up|Death|2|||
23587490|NCT03125382|65879135|FG002|Follow-up|Death|1|||
23587491|NCT03125382|65879136|FG003|Follow-up|Death|2|||
23587492|NCT03125382|65879133|FG000|Follow-up|Lost to Follow-up|1|||
23587493|NCT03125382|65879134|FG001|Follow-up|Lost to Follow-up|4|||
23587494|NCT03125382|65879135|FG002|Follow-up|Lost to Follow-up|3|||
23587495|NCT03125382|65879136|FG003|Follow-up|Lost to Follow-up|1|||
23587496|NCT02674750|65879145|FG000|Overall Study|Death|4|||
23587497|NCT02674750|65879146|FG001|Overall Study|Death|5|||
23587498|NCT02674750|65879147|FG002|Overall Study|Death|8|||
23188875|NCT03167619|64433122|FG001|Overall Study|Death|8|||
23188876|NCT03167619|64433121|FG000|Overall Study|Withdrawal by Subject|1|||
23188877|NCT03167619|64433122|FG001|Overall Study|Withdrawal by Subject|2|||
23188878|NCT03167619|64433121|FG000|Overall Study|Physician Decision|0|||
23188879|NCT03167619|64433122|FG001|Overall Study|Physician Decision|1|||
23188880|NCT01451515|64433123|FG000|Overall Study|Death|0|||
23188881|NCT01451515|64433124|FG001|Overall Study|Death|1|||
23188882|NCT01451515|64433125|FG002|Overall Study|Death|0|||
23188883|NCT01451515|64433123|FG000|Overall Study|Withdrawal by Subject|0|||
23188884|NCT01451515|64433124|FG001|Overall Study|Withdrawal by Subject|1|||
23188885|NCT01451515|64433125|FG002|Overall Study|Withdrawal by Subject|0|||
23587499|NCT02674750|65879145|FG000|Overall Study|Lost to Follow-up|0|||
23587500|NCT02674750|65879146|FG001|Overall Study|Lost to Follow-up|8|||
23587501|NCT02674750|65879147|FG002|Overall Study|Lost to Follow-up|0|||
23587502|NCT02674750|65879145|FG000|Overall Study|Lack of Efficacy|1|||
23587503|NCT02674750|65879146|FG001|Overall Study|Lack of Efficacy|17|||
23587504|NCT02674750|65879147|FG002|Overall Study|Lack of Efficacy|3|||
23587505|NCT02674750|65879145|FG000|Overall Study|Withdrawal by Subject|0|||
23587506|NCT02674750|65879146|FG001|Overall Study|Withdrawal by Subject|7|||
23587507|NCT02674750|65879147|FG002|Overall Study|Withdrawal by Subject|1|||
23587508|NCT02674750|65879145|FG000|Overall Study|Other|0|||
23587509|NCT02674750|65879146|FG001|Overall Study|Other|8|||
23587510|NCT02674750|65879147|FG002|Overall Study|Other|0|||
23587511|NCT00878722|65879152|FG000|Overall Study|Progressive disease|3|||
23587512|NCT00878722|65879153|FG001|Overall Study|Progressive disease|3|||
23587513|NCT00878722|65879154|FG002|Overall Study|Progressive disease|3|||
23587514|NCT00878722|65879155|FG003|Overall Study|Progressive disease|7|||
23587515|NCT00878722|65879156|FG004|Overall Study|Progressive disease|7|||
23587516|NCT00878722|65879157|FG005|Overall Study|Progressive disease|1|||
23587517|NCT00878722|65879158|FG006|Overall Study|Progressive disease|4|||
23587518|NCT00878722|65879159|FG007|Overall Study|Progressive disease|3|||
23587519|NCT00878722|65879152|FG000|Overall Study|Death|0|||
23587520|NCT00878722|65879153|FG001|Overall Study|Death|0|||
23587521|NCT00878722|65879154|FG002|Overall Study|Death|0|||
23587522|NCT00878722|65879155|FG003|Overall Study|Death|1|||
23354152|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
23354153|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
23354154|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
23354155|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
23354156|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
23354157|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
23354158|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
23354159|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
23354160|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
23354161|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
23354162|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
23354163|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
23354164|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
23354165|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
23354166|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
23354167|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
23354168|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
23354169|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
23354170|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
23354171|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
23354172|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
23354173|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
23354174|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
23354175|NCT03538691|65041339|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23587523|NCT00878722|65879156|FG004|Overall Study|Death|0|||
23587524|NCT00878722|65879157|FG005|Overall Study|Death|1|||
23587525|NCT00878722|65879158|FG006|Overall Study|Death|0|||
23587526|NCT00878722|65879159|FG007|Overall Study|Death|2|||
23587527|NCT00878722|65879152|FG000|Overall Study|Adverse Event|0|||
23587528|NCT00878722|65879153|FG001|Overall Study|Adverse Event|0|||
23188886|NCT01451515|64433123|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
23188887|NCT01451515|64433124|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
23188888|NCT01451515|64433125|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
23188889|NCT01451515|64433123|FG000|Overall Study|Relapse (except CNS)|1|||
23188890|NCT01451515|64433124|FG001|Overall Study|Relapse (except CNS)|1|||
23188891|NCT01451515|64433125|FG002|Overall Study|Relapse (except CNS)|0|||
23188892|NCT01676961|64433126|FG000|Overall Study|Death|3|||
23188893|NCT01676961|64433126|FG000|Overall Study|Lost to Follow-up|1|||
23188894|NCT01676961|64433126|FG000|Overall Study|Withdrawal by Subject|1|||
23188895|NCT01985321|64433127|FG000|Overall Study|Protocol Violation|4|||
23188896|NCT01985321|64433128|FG001|Overall Study|Protocol Violation|3|||
23188897|NCT01985321|64433127|FG000|Overall Study|Withdrawal by Subject|1|||
23188898|NCT01985321|64433128|FG001|Overall Study|Withdrawal by Subject|0|||
23188899|NCT01985321|64433127|FG000|Overall Study|Lost to Follow-up|5|||
23354176|NCT03538691|65041340|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
23354177|NCT03538691|65041341|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23354178|NCT03538691|65041342|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23354179|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
23354180|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
23354181|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
23354182|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
23354183|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
23354184|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
23587529|NCT00878722|65879154|FG002|Overall Study|Adverse Event|0|||
23188900|NCT01985321|64433128|FG001|Overall Study|Lost to Follow-up|2|||
23188901|NCT01985321|64433127|FG000|Overall Study|Subject treated wrong type of sore|1|||
23188902|NCT01985321|64433128|FG001|Overall Study|Subject treated wrong type of sore|0|||
23188903|NCT00104104|64433137|FG000|Overall Study|Adverse Event|8|||
23188904|NCT00104104|64433138|FG001|Overall Study|Adverse Event|8|||
23188905|NCT00104104|64433137|FG000|Overall Study|Abnormal laboratory value(s)|20|||
23188906|NCT00104104|64433138|FG001|Overall Study|Abnormal laboratory value(s)|14|||
23188907|NCT00104104|64433137|FG000|Overall Study|Lack of Efficacy|0|||
23188908|NCT00104104|64433138|FG001|Overall Study|Lack of Efficacy|3|||
23188909|NCT00104104|64433137|FG000|Overall Study|Condition no longer requires study drug|7|||
23188910|NCT00104104|64433138|FG001|Overall Study|Condition no longer requires study drug|4|||
23188911|NCT00104104|64433137|FG000|Overall Study|Protocol Violation|5|||
23188912|NCT00104104|64433138|FG001|Overall Study|Protocol Violation|2|||
23188913|NCT00104104|64433137|FG000|Overall Study|Withdrawal by Subject|11|||
23188914|NCT00104104|64433138|FG001|Overall Study|Withdrawal by Subject|15|||
23188915|NCT00104104|64433137|FG000|Overall Study|Lost to Follow-up|3|||
23188916|NCT00104104|64433138|FG001|Overall Study|Lost to Follow-up|7|||
23188917|NCT00104104|64433137|FG000|Overall Study|Administrative problems|12|||
23247957|NCT00902486|64649170|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23247958|NCT00902486|64649171|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23247959|NCT00902486|64649172|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23247960|NCT00902486|64649173|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
23247961|NCT00902486|64649174|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23247962|NCT00902486|64649175|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
23247963|NCT00902486|64649170|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23247964|NCT00902486|64649171|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23247965|NCT00902486|64649172|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23247966|NCT00902486|64649173|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
23247967|NCT00902486|64649174|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23354185|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
23354186|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
23354187|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
23587530|NCT00878722|65879155|FG003|Overall Study|Adverse Event|0|||
23587531|NCT00878722|65879156|FG004|Overall Study|Adverse Event|0|||
23587532|NCT00878722|65879157|FG005|Overall Study|Adverse Event|0|||
23587533|NCT00878722|65879158|FG006|Overall Study|Adverse Event|2|||
23587534|NCT00878722|65879159|FG007|Overall Study|Adverse Event|0|||
23587535|NCT00878722|65879152|FG000|Overall Study|Withdrawal by Subject|0|||
23587536|NCT00878722|65879153|FG001|Overall Study|Withdrawal by Subject|0|||
23188918|NCT00104104|64433138|FG001|Overall Study|Administrative problems|13|||
23188919|NCT00104104|64433137|FG000|Overall Study|Death|9|||
23188920|NCT00104104|64433138|FG001|Overall Study|Death|6|||
23188921|NCT02519231|64433139|FG000|Overall Study|Lost to Follow-up|2|||
23188922|NCT02519231|64433140|FG001|Overall Study|Lost to Follow-up|5|||
23188923|NCT02519231|64433139|FG000|Overall Study|Withdrawal by Subject|0|||
23188924|NCT02519231|64433140|FG001|Overall Study|Withdrawal by Subject|1|||
23354188|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
23354189|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
23354190|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
23188925|NCT04538950|64433148|FG000|Overall Study|Pulmonary Issues|2|||
23188926|NCT04538950|64433148|FG000|Overall Study|illness|2|||
23188927|NCT03794986|64433149|FG000|Overall Study|0 Sessions Attended|34|||
23354191|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
23354192|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
23354193|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
23354194|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
23188928|NCT03794986|64433150|FG001|Overall Study|0 Sessions Attended|37|||
23188929|NCT03794986|64433149|FG000|Overall Study|Withdrawal by Subject|4|||
23247968|NCT00902486|64649175|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
23247969|NCT00902486|64649170|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
23247970|NCT00902486|64649171|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
23354195|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
23247971|NCT00902486|64649172|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
23247972|NCT00902486|64649173|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
23247973|NCT00902486|64649174|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
23247974|NCT00902486|64649175|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
23247975|NCT00902486|64649170|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
23354196|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
23354197|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
23354198|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
23354199|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
23354200|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
23354201|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
23354202|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
23354203|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
23470543|NCT00068419|65466555|FG000|Overall Study|Withdrawal by Subject|14|||
23470544|NCT00068419|65466555|FG000|Overall Study|Ineligible|11|||
23470545|NCT02194985|65466556|FG000|Overall Study|Adverse Event|1|||
23470546|NCT02194985|65466556|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
23470547|NCT02194985|65466556|FG000|Overall Study|Physician Decision|4|||
23470548|NCT02194985|65466556|FG000|Overall Study|Lost to Follow-up|1|||
23470549|NCT02194985|65466556|FG000|Overall Study|Withdrawal by Subject|2|||
23470550|NCT03120351|65466557|FG000|Overall Study|Physician Decision|1|||
23470551|NCT03120351|65466558|FG001|Overall Study|Physician Decision|1|||
23470552|NCT01818752|65466562|FG000|Overall Study|Adverse Event|64|||
23470553|NCT01818752|65466563|FG001|Overall Study|Adverse Event|74|||
23470554|NCT01818752|65466562|FG000|Overall Study|Death|14|||
23470555|NCT01818752|65466563|FG001|Overall Study|Death|18|||
23188930|NCT03794986|64433150|FG001|Overall Study|Withdrawal by Subject|6|||
23470556|NCT01818752|65466562|FG000|Overall Study|Non-compliance|16|||
23188931|NCT03794986|64433149|FG000|Overall Study|Protocol Violation|1|||
23470557|NCT01818752|65466563|FG001|Overall Study|Non-compliance|20|||
23470558|NCT01818752|65466562|FG000|Overall Study|Withdrawal by Subject|15|||
23470559|NCT01818752|65466563|FG001|Overall Study|Withdrawal by Subject|14|||
23470560|NCT01818752|65466562|FG000|Overall Study|Physician Decision|9|||
23470561|NCT01818752|65466563|FG001|Overall Study|Physician Decision|8|||
23470562|NCT01818752|65466562|FG000|Overall Study|Disease Progression|54|||
23470563|NCT01818752|65466563|FG001|Overall Study|Disease Progression|48|||
23470564|NCT01818752|65466562|FG000|Overall Study|Other|7|||
23470565|NCT01818752|65466563|FG001|Overall Study|Other|8|||
23470566|NCT01818752|65466562|FG000|Overall Study|Continuing Treatment|1|||
23470567|NCT01818752|65466563|FG001|Overall Study|Continuing Treatment|4|||
23470568|NCT01818752|65466562|FG000|Overall Study|Randomized but not Dosed|7|||
23470569|NCT01818752|65466563|FG001|Overall Study|Randomized but not Dosed|4|||
23470570|NCT02504216|65466564|FG000|Overall Study|Lost to Follow-up|3|||
23470571|NCT02504216|65466565|FG001|Overall Study|Lost to Follow-up|3|||
23470572|NCT02504216|65466564|FG000|Overall Study|Withdrawal by Subject|8|||
23470573|NCT02504216|65466565|FG001|Overall Study|Withdrawal by Subject|12|||
23470574|NCT00476229|65466566|FG000|Overall Study|Progressive shortness of breath|1|||
23470575|NCT02657408|65466567|FG000|Overall Study|Adverse Event|3|||
23470576|NCT02657408|65466568|FG001|Overall Study|Adverse Event|7|||
23470577|NCT01733680|65466569|FG000|Overall Study|Withdrawal by Subject|0|||
23470578|NCT01733680|65466570|FG001|Overall Study|Withdrawal by Subject|1|||
23470579|NCT01297491|65466572|FG000|Overall Study|Adverse Event|11|||
23470580|NCT01297491|65466573|FG001|Overall Study|Adverse Event|6|||
23470581|NCT01297491|65466572|FG000|Overall Study|Physician Decision|3|||
23470582|NCT01297491|65466573|FG001|Overall Study|Physician Decision|2|||
23470583|NCT01297491|65466572|FG000|Overall Study|Progressive disease|11|||
23470584|NCT01297491|65466573|FG001|Overall Study|Progressive disease|20|||
23470585|NCT01297491|65466572|FG000|Overall Study|Patient/Guardian decision|3|||
23470586|NCT01297491|65466573|FG001|Overall Study|Patient/Guardian decision|4|||
23470587|NCT01297491|65466572|FG000|Overall Study|Death|2|||
23470588|NCT01297491|65466573|FG001|Overall Study|Death|1|||
23470589|NCT03313037|65466574|FG000|Overall Study|Protocol Violation|4|||
23470590|NCT03313037|65466575|FG001|Overall Study|Protocol Violation|1|||
23470591|NCT03313037|65466574|FG000|Overall Study|Other|1|||
23470592|NCT03313037|65466575|FG001|Overall Study|Other|1|||
23470593|NCT03313037|65466574|FG000|Overall Study|Withdrawal by Subject|4|||
23470594|NCT03313037|65466575|FG001|Overall Study|Withdrawal by Subject|3|||
23470595|NCT03313037|65466574|FG000|Overall Study|No longer meets eligibility criteria|1|||
23470596|NCT03313037|65466575|FG001|Overall Study|No longer meets eligibility criteria|7|||
23470597|NCT03313037|65466574|FG000|Overall Study|Lost to Follow-up|9|||
23470598|NCT03313037|65466575|FG001|Overall Study|Lost to Follow-up|8|||
23470599|NCT03313037|65466574|FG000|Overall Study|Randomized but not treated|1|||
23470600|NCT03313037|65466575|FG001|Overall Study|Randomized but not treated|0|||
23470601|NCT02054104|65466578|FG000|Overall Study|Did not want to continue due to college classes|1|||
23470602|NCT02054104|65466579|FG001|Overall Study|Did not want to continue due to college classes|0|||
23470603|NCT02054104|65466578|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
23470604|NCT02054104|65466579|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
23470605|NCT02054104|65466578|FG000|Overall Study|No evidence of immunologic response|2|||
23470606|NCT02054104|65466579|FG001|Overall Study|No evidence of immunologic response|2|||
23470607|NCT02054104|65466578|FG000|Overall Study|Disease Progression On Study|4|||
23470608|NCT02054104|65466579|FG001|Overall Study|Disease Progression On Study|5|||
23470609|NCT02054104|65466578|FG000|Overall Study|Diagnosis of lymphoma|0|||
23470610|NCT02054104|65466579|FG001|Overall Study|Diagnosis of lymphoma|1|||
23470611|NCT02054104|65466578|FG000|Overall Study|Inconclusive response|0|||
23470612|NCT02054104|65466579|FG001|Overall Study|Inconclusive response|1|||
23470613|NCT00419952|65466580|FG000|Overall Study|Adverse Event|8|||
23470614|NCT00419952|65466581|FG001|Overall Study|Adverse Event|10|||
23470615|NCT00419952|65466580|FG000|Overall Study|Withdrawal by Subject|44|||
23470616|NCT00419952|65466581|FG001|Overall Study|Withdrawal by Subject|43|||
23470617|NCT00419952|65466580|FG000|Overall Study|Lost to Follow-up|43|||
23470618|NCT00419952|65466581|FG001|Overall Study|Lost to Follow-up|34|||
23470619|NCT00419952|65466580|FG000|Overall Study|Protocol Violation|32|||
23470620|NCT00419952|65466581|FG001|Overall Study|Protocol Violation|24|||
23470621|NCT00419952|65466580|FG000|Overall Study|Pregnancy|4|||
23470622|NCT00419952|65466581|FG001|Overall Study|Pregnancy|2|||
23470623|NCT00419952|65466580|FG000|Overall Study|Physician Decision|1|||
23470624|NCT00419952|65466581|FG001|Overall Study|Physician Decision|3|||
23470625|NCT00419952|65466580|FG000|Overall Study|Incorrectly enrolled|10|||
23470626|NCT00419952|65466581|FG001|Overall Study|Incorrectly enrolled|3|||
23470627|NCT00419952|65466580|FG000|Overall Study|Intake of prohibited medication|2|||
23470628|NCT00419952|65466581|FG001|Overall Study|Intake of prohibited medication|2|||
23470629|NCT00419952|65466580|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
23470630|NCT00419952|65466581|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
23470631|NCT00419952|65466580|FG000|Overall Study|Diary or medication non-compliance|2|||
23470632|NCT00419952|65466581|FG001|Overall Study|Diary or medication non-compliance|4|||
23587537|NCT00878722|65879154|FG002|Overall Study|Withdrawal by Subject|0|||
23587538|NCT00878722|65879155|FG003|Overall Study|Withdrawal by Subject|0|||
23587539|NCT00878722|65879156|FG004|Overall Study|Withdrawal by Subject|0|||
23587540|NCT00878722|65879157|FG005|Overall Study|Withdrawal by Subject|0|||
23587541|NCT00878722|65879158|FG006|Overall Study|Withdrawal by Subject|0|||
23354204|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
23354205|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
23354206|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
23354207|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
23354208|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
23354209|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
23354210|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
23354211|NCT03538691|65041339|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23354212|NCT03538691|65041340|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
23354213|NCT03538691|65041341|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
23354214|NCT03538691|65041342|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
23354215|NCT00703326|65041348|FG000|Overall Study|Lost to Follow-up|47|||
23354216|NCT00703326|65041349|FG001|Overall Study|Lost to Follow-up|18|||
23354217|NCT00703326|65041348|FG000|Overall Study|Withdrawal by Subject|54|||
23354218|NCT00703326|65041349|FG001|Overall Study|Withdrawal by Subject|20|||
23354219|NCT00703326|65041348|FG000|Overall Study|Adverse Event|1|||
23354220|NCT00703326|65041349|FG001|Overall Study|Adverse Event|0|||
23354221|NCT02412878|65041350|FG000|Overall Study|Withdrawal by Subject|19|||
23354222|NCT02412878|65041351|FG001|Overall Study|Withdrawal by Subject|10|||
23354223|NCT02412878|65041350|FG000|Overall Study|Lost to Follow-up|2|||
23354224|NCT02412878|65041351|FG001|Overall Study|Lost to Follow-up|3|||
23354225|NCT03013985|65041352|FG000|Overall Study|Protocol Violation|2|||
23354226|NCT03013985|65041353|FG001|Overall Study|Protocol Violation|2|||
23354227|NCT03013985|65041352|FG000|Overall Study|Withdrawal by Subject|14|||
23354228|NCT03013985|65041353|FG001|Overall Study|Withdrawal by Subject|17|||
23354229|NCT04424914|65041354|FG000|Overall Study|Other|0|||
23354230|NCT04424914|65041355|FG001|Overall Study|Other|0|||
23354231|NCT04424914|65041356|FG002|Overall Study|Other|28|||
23354232|NCT04424914|65041354|FG000|Overall Study|Withdrawal by Subject|3|||
23354233|NCT04424914|65041355|FG001|Overall Study|Withdrawal by Subject|0|||
23354234|NCT04424914|65041356|FG002|Overall Study|Withdrawal by Subject|0|||
23354235|NCT04424914|65041354|FG000|Overall Study|Study terminated by sponsor|23|||
23354236|NCT04424914|65041355|FG001|Overall Study|Study terminated by sponsor|7|||
23354237|NCT04424914|65041356|FG002|Overall Study|Study terminated by sponsor|0|||
23354238|NCT04424914|65041354|FG000|Overall Study|Lost to Follow-up|0|||
23354239|NCT04424914|65041355|FG001|Overall Study|Lost to Follow-up|0|||
23354240|NCT04424914|65041356|FG002|Overall Study|Lost to Follow-up|1|||
23354241|NCT04424914|65041354|FG000|Overall Study|Death|3|||
23354242|NCT04424914|65041355|FG001|Overall Study|Death|1|||
23354243|NCT04424914|65041356|FG002|Overall Study|Death|0|||
23354244|NCT04122625|65041357|FG000|Part A (up to 2.92 Years)|Death|2|||
23354245|NCT04122625|65041358|FG001|Part A (up to 2.92 Years)|Death|4|||
23354246|NCT04122625|65041359|FG002|Part A (up to 2.92 Years)|Death|0|||
23354247|NCT04122625|65041360|FG003|Part A (up to 2.92 Years)|Death|0|||
23354248|NCT04122625|65041361|FG004|Part A (up to 2.92 Years)|Death|0|||
23354249|NCT04122625|65041362|FG005|Part A (up to 2.92 Years)|Death|0|||
23354250|NCT04122625|65041357|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
23354251|NCT04122625|65041358|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
23354252|NCT04122625|65041359|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
23354253|NCT04122625|65041360|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
23354254|NCT04122625|65041361|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
23354255|NCT04122625|65041362|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
23354256|NCT04122625|65041357|FG000|Part B (up to 2.33 Years)|Death|0|||
23354257|NCT04122625|65041358|FG001|Part B (up to 2.33 Years)|Death|0|||
23354258|NCT04122625|65041359|FG002|Part B (up to 2.33 Years)|Death|5|||
23354259|NCT04122625|65041360|FG003|Part B (up to 2.33 Years)|Death|7|||
23354260|NCT04122625|65041361|FG004|Part B (up to 2.33 Years)|Death|6|||
23354261|NCT04122625|65041362|FG005|Part B (up to 2.33 Years)|Death|7|||
23354262|NCT02347072|65041366|FG000|Overall Study|Adverse Event|2|||
23354263|NCT02347072|65041366|FG000|Overall Study|Withdrawal by Subject|6|||
23354264|NCT02347072|65041366|FG000|Overall Study|Physician Decision|1|||
23354265|NCT02347072|65041366|FG000|Overall Study|Lost to Follow-up|2|||
23354266|NCT02347072|65041366|FG000|Overall Study|Protocol Violation|1|||
23354267|NCT02347072|65041366|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
23354268|NCT02756819|65041368|FG000|Overall Study|Lost for observation|23|||
23354269|NCT02756819|65041368|FG000|Overall Study|Patient's unwillingness|16|||
23354270|NCT02756819|65041368|FG000|Overall Study|Insufficient efficacy|2|||
23587542|NCT00878722|65879159|FG007|Overall Study|Withdrawal by Subject|2|||
23470633|NCT00419952|65466580|FG000|Overall Study|Abnormal ECG|1|||
23470634|NCT00419952|65466581|FG001|Overall Study|Abnormal ECG|0|||
23470635|NCT00074490|65466582|FG000|Overall Study|Progressive malignancy|0|||
23470636|NCT00074490|65466583|FG001|Overall Study|Progressive malignancy|7|||
23470637|NCT00074490|65466584|FG002|Overall Study|Progressive malignancy|0|||
23470638|NCT00074490|65466585|FG003|Overall Study|Progressive malignancy|0|||
23470639|NCT00074490|65466586|FG004|Overall Study|Progressive malignancy|3|||
23470640|NCT00074490|65466587|FG005|Overall Study|Progressive malignancy|0|||
23470641|NCT00947882|65466588|FG000|Overall Study|Adverse Event|0|||
23470642|NCT00947882|65466589|FG001|Overall Study|Adverse Event|1|||
23587543|NCT00878722|65879152|FG000|Overall Study|Relapse|0|||
23587544|NCT00878722|65879153|FG001|Overall Study|Relapse|0|||
23587545|NCT00878722|65879154|FG002|Overall Study|Relapse|0|||
23587546|NCT00878722|65879155|FG003|Overall Study|Relapse|1|||
23587547|NCT00878722|65879156|FG004|Overall Study|Relapse|0|||
23587548|NCT00878722|65879157|FG005|Overall Study|Relapse|0|||
23587549|NCT00878722|65879158|FG006|Overall Study|Relapse|0|||
23587550|NCT00878722|65879159|FG007|Overall Study|Relapse|0|||
23587551|NCT01689519|65879160|FG000|Intent to Treat|Death|157|||
23587552|NCT01689519|65879161|FG001|Intent to Treat|Death|167|||
23470643|NCT00947882|65466590|FG002|Overall Study|Adverse Event|4|||
23470644|NCT00947882|65466591|FG003|Overall Study|Adverse Event|4|||
23470645|NCT00947882|65466588|FG000|Overall Study|Withdrawal by Subject|2|||
23470646|NCT00947882|65466589|FG001|Overall Study|Withdrawal by Subject|0|||
23470647|NCT00947882|65466590|FG002|Overall Study|Withdrawal by Subject|8|||
23470648|NCT00947882|65466591|FG003|Overall Study|Withdrawal by Subject|2|||
23470649|NCT00947882|65466588|FG000|Overall Study|Protocol Violation|0|||
23470650|NCT00947882|65466589|FG001|Overall Study|Protocol Violation|0|||
23470651|NCT00947882|65466590|FG002|Overall Study|Protocol Violation|1|||
23470652|NCT00947882|65466591|FG003|Overall Study|Protocol Violation|0|||
23470653|NCT00947882|65466588|FG000|Overall Study|Lost to Follow-up|0|||
23470654|NCT00947882|65466589|FG001|Overall Study|Lost to Follow-up|2|||
23470655|NCT00947882|65466590|FG002|Overall Study|Lost to Follow-up|1|||
23470656|NCT00947882|65466591|FG003|Overall Study|Lost to Follow-up|0|||
23470657|NCT00947882|65466588|FG000|Overall Study|Other/Unknown|10|||
23470658|NCT00947882|65466589|FG001|Overall Study|Other/Unknown|13|||
23587553|NCT01689519|65879160|FG000|Intent to Treat|Lost to Follow-up|4|||
23587554|NCT01689519|65879161|FG001|Intent to Treat|Lost to Follow-up|8|||
23188932|NCT03794986|64433150|FG001|Overall Study|Protocol Violation|0|||
23188933|NCT05309083|64433154|FG000|Overall Study|Withdrawal by Subject|2|||
23188934|NCT01242111|64433160|FG000|Overall Study|Adverse Event|1|||
23188935|NCT01242111|64433160|FG000|Overall Study|Withdrawal by Subject|1|||
23188936|NCT01242111|64433160|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
23188937|NCT00519077|64433161|FG000|Overall Study|Death|6|||
23188938|NCT00519077|64433161|FG000|Overall Study|Other|2|||
23188939|NCT01158950|64433164|FG000|1st Intervention (1 Day)|Physician Decision|1|||
23188940|NCT01158950|64433165|FG001|1st Intervention (1 Day)|Physician Decision|2|||
23188941|NCT01096667|64433166|FG000|Overall Study|Lost to Follow-up|1|||
23188942|NCT01096667|64433167|FG001|Overall Study|Lost to Follow-up|1|||
23188943|NCT01096667|64433168|FG002|Overall Study|Lost to Follow-up|1|||
23188944|NCT01096667|64433169|FG003|Overall Study|Lost to Follow-up|0|||
23188945|NCT01096667|64433170|FG004|Overall Study|Lost to Follow-up|0|||
23188946|NCT01096667|64433166|FG000|Overall Study|Withdrawal by Subject|1|||
23188947|NCT01096667|64433167|FG001|Overall Study|Withdrawal by Subject|0|||
23188948|NCT01096667|64433168|FG002|Overall Study|Withdrawal by Subject|0|||
23188949|NCT01096667|64433169|FG003|Overall Study|Withdrawal by Subject|1|||
23188950|NCT01096667|64433170|FG004|Overall Study|Withdrawal by Subject|0|||
23470659|NCT00947882|65466590|FG002|Overall Study|Other/Unknown|3|||
23470660|NCT00947882|65466591|FG003|Overall Study|Other/Unknown|6|||
23470661|NCT00947882|65466588|FG000|Overall Study|Trial Terminated by Sponsor|62|||
23470662|NCT00947882|65466589|FG001|Overall Study|Trial Terminated by Sponsor|61|||
23470663|NCT00947882|65466590|FG002|Overall Study|Trial Terminated by Sponsor|62|||
23470664|NCT00947882|65466591|FG003|Overall Study|Trial Terminated by Sponsor|70|||
23470665|NCT01646125|65466598|FG000|Overall Study|Untreated|2|||
23470666|NCT01646125|65466599|FG001|Overall Study|Untreated|5|||
23247976|NCT00902486|64649171|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
23587555|NCT01689519|65879160|FG000|Intent to Treat|Other|2|||
23587556|NCT01689519|65879161|FG001|Intent to Treat|Other|4|||
23587557|NCT01689519|65879160|FG000|Intent to Treat|Physician Decision|4|||
23587558|NCT01689519|65879161|FG001|Intent to Treat|Physician Decision|1|||
23188951|NCT01096667|64433166|FG000|Overall Study|Reason not available|0|||
23188952|NCT01096667|64433167|FG001|Overall Study|Reason not available|1|||
23188953|NCT01096667|64433168|FG002|Overall Study|Reason not available|1|||
23470667|NCT01646125|65466598|FG000|Overall Study|Adverse Event|2|||
23587559|NCT01689519|65879160|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
23587560|NCT01689519|65879161|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
23188954|NCT01096667|64433169|FG003|Overall Study|Reason not available|1|||
23188955|NCT01096667|64433170|FG004|Overall Study|Reason not available|0|||
23188956|NCT01096667|64433166|FG000|Overall Study|Protocol Violation|0|||
23188957|NCT01096667|64433167|FG001|Overall Study|Protocol Violation|0|||
23188958|NCT01096667|64433168|FG002|Overall Study|Protocol Violation|0|||
23188959|NCT01096667|64433169|FG003|Overall Study|Protocol Violation|1|||
23188960|NCT01096667|64433170|FG004|Overall Study|Protocol Violation|0|||
23188961|NCT01096667|64433166|FG000|Overall Study|Not treated|1|||
23188962|NCT01096667|64433167|FG001|Overall Study|Not treated|0|||
23188963|NCT01096667|64433168|FG002|Overall Study|Not treated|0|||
23188964|NCT01096667|64433169|FG003|Overall Study|Not treated|0|||
23188965|NCT01096667|64433170|FG004|Overall Study|Not treated|0|||
23188966|NCT02240628|64433171|FG000|Overall Study|Physician Decision|6|||
23188967|NCT02240628|64433172|FG001|Overall Study|Physician Decision|5|||
23188968|NCT03497689|64433173|FG000|Overall Study|Adverse Event|2|||
23188969|NCT03497689|64433173|FG000|Overall Study|Death|1|||
23188970|NCT03497689|64433173|FG000|Overall Study|Physician Decision|1|||
23188971|NCT03497689|64433173|FG000|Overall Study|Withdrawal by Subject|1|||
23188972|NCT03497689|64433173|FG000|Overall Study|Protocol Violation|2|||
23188973|NCT01687673|64433174|FG000|Overall Study|Physician Decision|1|||
23188974|NCT00553787|64433179|FG000|Overall Study|Adverse Event|34|||
23188975|NCT00553787|64433180|FG001|Overall Study|Adverse Event|21|||
23247977|NCT00902486|64649172|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
23470668|NCT01646125|65466599|FG001|Overall Study|Adverse Event|1|||
23470669|NCT01646125|65466598|FG000|Overall Study|Death|1|||
23470670|NCT01646125|65466599|FG001|Overall Study|Death|1|||
23188976|NCT00553787|64433181|FG002|Overall Study|Adverse Event|67|||
23470671|NCT01646125|65466598|FG000|Overall Study|Physician Decision|1|||
23470672|NCT01646125|65466599|FG001|Overall Study|Physician Decision|3|||
23470673|NCT01646125|65466598|FG000|Overall Study|Progressive disease|22|||
23470674|NCT01646125|65466599|FG001|Overall Study|Progressive disease|16|||
23470675|NCT01646125|65466598|FG000|Overall Study|Study terminated by sponsor|2|||
23470676|NCT01646125|65466599|FG001|Overall Study|Study terminated by sponsor|1|||
23470677|NCT01646125|65466598|FG000|Overall Study|Subject/Guardian decision|1|||
23470678|NCT01646125|65466599|FG001|Overall Study|Subject/Guardian decision|1|||
23470679|NCT01554241|65466601|FG000|Overall Study|Death|3|||
23470680|NCT01554241|65466602|FG001|Overall Study|Death|1|||
23470681|NCT01554241|65466603|FG002|Overall Study|Death|1|||
23470682|NCT01554241|65466604|FG003|Overall Study|Death|0|||
23470683|NCT01554241|65466601|FG000|Overall Study|protocol specified renal stone|0|||
23470684|NCT01554241|65466602|FG001|Overall Study|protocol specified renal stone|0|||
23470685|NCT01554241|65466603|FG002|Overall Study|protocol specified renal stone|0|||
23470686|NCT01554241|65466604|FG003|Overall Study|protocol specified renal stone|1|||
23470687|NCT01554241|65466601|FG000|Overall Study|protocol specified change in eGFR|0|||
23470688|NCT01554241|65466602|FG001|Overall Study|protocol specified change in eGFR|0|||
23470689|NCT01554241|65466603|FG002|Overall Study|protocol specified change in eGFR|1|||
23470690|NCT01554241|65466604|FG003|Overall Study|protocol specified change in eGFR|0|||
23470691|NCT01554241|65466601|FG000|Overall Study|Withdrawal by Subject|0|||
23470692|NCT01554241|65466602|FG001|Overall Study|Withdrawal by Subject|0|||
23470693|NCT01554241|65466603|FG002|Overall Study|Withdrawal by Subject|2|||
23470694|NCT01554241|65466604|FG003|Overall Study|Withdrawal by Subject|0|||
23470695|NCT03695367|65466605|FG000|Overall Study|Missed the Day 28 visit.|1|||
23470696|NCT03695367|65466606|FG001|Overall Study|Missed the Day 28 visit.|0|||
23470697|NCT03695367|65466605|FG000|Overall Study|Lost to Follow-up|0|||
23470698|NCT03695367|65466606|FG001|Overall Study|Lost to Follow-up|1|||
23470699|NCT03695367|65466605|FG000|Overall Study|Withdrawal by Subject|0|||
23470700|NCT03695367|65466606|FG001|Overall Study|Withdrawal by Subject|1|||
23470701|NCT03695367|65466605|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
23470702|NCT03695367|65466606|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
23470703|NCT02636361|65466609|FG000|Period 4|Physician Decision|0|||
23470704|NCT02636361|65466610|FG001|Period 4|Physician Decision|0|||
23470705|NCT02636361|65466611|FG002|Period 4|Physician Decision|0|||
23470706|NCT02636361|65466612|FG003|Period 4|Physician Decision|1|||
23354271|NCT02756819|65041368|FG000|Overall Study|Adverse Event|2|||
23470707|NCT02636361|65466613|FG004|Period 4|Physician Decision|0|||
23470708|NCT00233064|65466617|FG000|Overall Study|Lost to Follow-up|7|||
23470709|NCT00233064|65466618|FG001|Overall Study|Lost to Follow-up|7|||
23188977|NCT00553787|64433179|FG000|Overall Study|Lost to Follow-up|132|||
23188978|NCT00553787|64433180|FG001|Overall Study|Lost to Follow-up|44|||
23188979|NCT00553787|64433181|FG002|Overall Study|Lost to Follow-up|78|||
23188980|NCT00553787|64433179|FG000|Overall Study|Withdrawal by Subject|151|||
23188981|NCT00553787|64433180|FG001|Overall Study|Withdrawal by Subject|40|||
23188982|NCT00553787|64433181|FG002|Overall Study|Withdrawal by Subject|83|||
23247978|NCT00902486|64649173|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
23470710|NCT00233064|65466617|FG000|Overall Study|Withdrawal by Subject|5|||
23470711|NCT00233064|65466618|FG001|Overall Study|Withdrawal by Subject|3|||
23470712|NCT00233064|65466617|FG000|Overall Study|Death|0|||
23470713|NCT00233064|65466618|FG001|Overall Study|Death|1|||
23470714|NCT00233064|65466617|FG000|Overall Study|Relocation|0|||
23470715|NCT00233064|65466618|FG001|Overall Study|Relocation|1|||
23470716|NCT00233064|65466617|FG000|Overall Study|Protocol Violation|1|||
23470717|NCT00233064|65466618|FG001|Overall Study|Protocol Violation|0|||
23470718|NCT00233064|65466617|FG000|Overall Study|Moved to Dom. Republic|1|||
23470719|NCT00233064|65466618|FG001|Overall Study|Moved to Dom. Republic|0|||
23470720|NCT00721968|65466619|FG000|Overall Study|Lost to Follow-up|2|||
23470721|NCT00721968|65466620|FG001|Overall Study|Lost to Follow-up|0|||
23470722|NCT00862082|65466621|FG000|Overall Study|Sponsor decision to terminate the study|5|||
23470723|NCT00862082|65466622|FG001|Overall Study|Sponsor decision to terminate the study|0|||
23470724|NCT00862082|65466621|FG000|Overall Study|Withdrawal by Subject|0|||
23470725|NCT00862082|65466622|FG001|Overall Study|Withdrawal by Subject|1|||
23470726|NCT01092117|65466625|FG000|Index Procedure to 1 Month|Death|1|||
23470727|NCT01092117|65466625|FG000|1 Month|Death|1|||
23470728|NCT01092117|65466625|FG000|1 Month|Withdrawal by Subject|1|||
23470729|NCT01092117|65466625|FG000|1 Month|Lost to Follow-up|1|||
23470730|NCT01092117|65466625|FG000|6 Months|Death|2|||
23470731|NCT01092117|65466625|FG000|6 Months|Withdrawal by Subject|3|||
23470732|NCT01092117|65466625|FG000|12 Month|Death|11|||
23470733|NCT01092117|65466625|FG000|12 Month|Withdrawal by Subject|2|||
23470734|NCT01092117|65466625|FG000|12 Month|Lost to Follow-up|1|||
23470735|NCT01092117|65466625|FG000|Year 2|Death|5|||
23470736|NCT01092117|65466625|FG000|Year 2|Withdrawal by Subject|4|||
23470737|NCT01092117|65466625|FG000|Year 2|Lost to Follow-up|1|||
23470738|NCT01092117|65466625|FG000|Year 3|Death|7|||
23470739|NCT01092117|65466625|FG000|Year 3|Withdrawal by Subject|9|||
23470740|NCT01092117|65466625|FG000|Year 3|Lost to Follow-up|3|||
23470741|NCT01092117|65466625|FG000|Year 4|Death|8|||
23470742|NCT01092117|65466625|FG000|Year 4|Withdrawal by Subject|4|||
23470743|NCT01092117|65466625|FG000|Year 4|Lost to Follow-up|4|||
23470744|NCT00859456|65466626|FG000|Overall Study|Adverse Event|3|||
23470745|NCT00859456|65466626|FG000|Overall Study|Progressive disease|2|||
23470746|NCT00859456|65466626|FG000|Overall Study|Non-compliance|3|||
23470747|NCT02537015|65466631|FG000|Overall Study|Adverse Event|3|||
23470748|NCT02537015|65466631|FG000|Overall Study|Withdrawal by Subject|2|||
23188983|NCT00553787|64433179|FG000|Overall Study|Lack of Efficacy|31|||
23188984|NCT00553787|64433180|FG001|Overall Study|Lack of Efficacy|1|||
23188985|NCT00553787|64433181|FG002|Overall Study|Lack of Efficacy|3|||
23188986|NCT00553787|64433179|FG000|Overall Study|Pregnancy|0|||
23188987|NCT00553787|64433180|FG001|Overall Study|Pregnancy|1|||
23188988|NCT00553787|64433181|FG002|Overall Study|Pregnancy|2|||
23188989|NCT00553787|64433179|FG000|Overall Study|non compliance|4|||
23188990|NCT00553787|64433180|FG001|Overall Study|non compliance|0|||
23470749|NCT02537015|65466631|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23470750|NCT01738477|65466634|FG000|Overall Study|Lost to Follow-up|1|||
23470751|NCT01738477|65466635|FG001|Overall Study|Lost to Follow-up|4|||
23470752|NCT00831493|65466636|FG000|Overall Study|Intractable nausea and vomiting|1|||
23470753|NCT03181529|65466637|FG000|Overall Study|Withdrawal by Subject|1|||
23470754|NCT03181529|65466638|FG001|Overall Study|Withdrawal by Subject|1|||
23470755|NCT03181529|65466637|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
23470756|NCT03181529|65466638|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
23470757|NCT03023813|65466639|FG000|Overall Study|Lost to Follow-up|1|||
23470758|NCT03023813|65466640|FG001|Overall Study|Lost to Follow-up|2|||
23470759|NCT03023813|65466641|FG002|Overall Study|Lost to Follow-up|0|||
23188991|NCT00553787|64433181|FG002|Overall Study|non compliance|11|||
23188992|NCT00553787|64433179|FG000|Overall Study|Requirement for restricted medication|8|||
23188993|NCT00553787|64433180|FG001|Overall Study|Requirement for restricted medication|7|||
23188994|NCT00553787|64433181|FG002|Overall Study|Requirement for restricted medication|5|||
23188995|NCT00553787|64433179|FG000|Overall Study|Other|18|||
23188996|NCT00553787|64433180|FG001|Overall Study|Other|10|||
23188997|NCT00553787|64433181|FG002|Overall Study|Other|13|||
23188998|NCT01524289|64433183|FG000|Overall Study|Lost to Follow-up|0|||
23188999|NCT01524289|64433184|FG001|Overall Study|Lost to Follow-up|1|||
23189000|NCT01524289|64433183|FG000|Overall Study|Physician Decision|1|||
23189001|NCT01524289|64433184|FG001|Overall Study|Physician Decision|0|||
23189002|NCT01524289|64433183|FG000|Overall Study|Protocol Violation|5|||
23189003|NCT01524289|64433184|FG001|Overall Study|Protocol Violation|1|||
23354272|NCT02756819|65041368|FG000|Overall Study|Reason not Specified|9|||
23189004|NCT01524289|64433183|FG000|Overall Study|Withdrawal by Subject|11|||
23189005|NCT01524289|64433184|FG001|Overall Study|Withdrawal by Subject|7|||
23470760|NCT03544333|65466642|FG000|Overall Study|Withdrawal by Subject|1|||
23470761|NCT03544333|65466643|FG001|Overall Study|Withdrawal by Subject|0|||
23470762|NCT03773796|65466646|FG000|Overall Study|Adverse Event|1|||
23470763|NCT03773796|65466646|FG000|Overall Study|Withdrawal by Subject|1|||
23470764|NCT03773796|65466646|FG000|Overall Study|Lack of Efficacy|1|||
23189006|NCT01524289|64433183|FG000|Overall Study|Adverse Event|12|||
23470765|NCT01918306|65466647|FG000|Overall Study|progresive disease|4|||
23470766|NCT01918306|65466648|FG001|Overall Study|progresive disease|0|||
23470767|NCT01918306|65466649|FG002|Overall Study|progresive disease|1|||
23470768|NCT01918306|65466650|FG003|Overall Study|progresive disease|1|||
23470769|NCT01918306|65466647|FG000|Overall Study|Withdrawal by Subject|0|||
23470770|NCT01918306|65466648|FG001|Overall Study|Withdrawal by Subject|0|||
23470771|NCT01918306|65466649|FG002|Overall Study|Withdrawal by Subject|0|||
23470772|NCT01918306|65466650|FG003|Overall Study|Withdrawal by Subject|2|||
23470773|NCT01918306|65466647|FG000|Overall Study|neutropenia|1|||
23470774|NCT01918306|65466648|FG001|Overall Study|neutropenia|0|||
23470775|NCT01918306|65466649|FG002|Overall Study|neutropenia|0|||
23470776|NCT01918306|65466650|FG003|Overall Study|neutropenia|0|||
23470777|NCT01918306|65466647|FG000|Overall Study|Lack of Efficacy|1|||
23470778|NCT01918306|65466648|FG001|Overall Study|Lack of Efficacy|0|||
23470779|NCT01918306|65466649|FG002|Overall Study|Lack of Efficacy|0|||
23470780|NCT01918306|65466650|FG003|Overall Study|Lack of Efficacy|0|||
23470781|NCT01918306|65466647|FG000|Overall Study|progress disease, crossover|0|||
23470782|NCT01918306|65466648|FG001|Overall Study|progress disease, crossover|0|||
23470783|NCT01918306|65466649|FG002|Overall Study|progress disease, crossover|1|||
23470784|NCT01918306|65466650|FG003|Overall Study|progress disease, crossover|0|||
23470785|NCT02023697|65466653|FG000|Treatment Period|Radiological progression|13|||
23470786|NCT02023697|65466654|FG001|Treatment Period|Radiological progression|17|||
23470787|NCT02023697|65466655|FG002|Treatment Period|Radiological progression|26|||
23470788|NCT02023697|65466653|FG000|Treatment Period|Never Treated|5|||
23470789|NCT02023697|65466654|FG001|Treatment Period|Never Treated|6|||
23470790|NCT02023697|65466655|FG002|Treatment Period|Never Treated|10|||
23470791|NCT02023697|65466653|FG000|Treatment Period|Adverse Event|13|||
23470792|NCT02023697|65466654|FG001|Treatment Period|Adverse Event|25|||
23470793|NCT02023697|65466655|FG002|Treatment Period|Adverse Event|23|||
23470794|NCT02023697|65466653|FG000|Treatment Period|Logistical difficulties|1|||
23470795|NCT02023697|65466654|FG001|Treatment Period|Logistical difficulties|1|||
23470796|NCT02023697|65466655|FG002|Treatment Period|Logistical difficulties|1|||
23470797|NCT02023697|65466653|FG000|Treatment Period|Clinical progression|10|||
23470798|NCT02023697|65466654|FG001|Treatment Period|Clinical progression|8|||
23470799|NCT02023697|65466655|FG002|Treatment Period|Clinical progression|28|||
23470800|NCT02023697|65466653|FG000|Treatment Period|Withdrawal by Subject|4|||
23470801|NCT02023697|65466654|FG001|Treatment Period|Withdrawal by Subject|5|||
23470802|NCT02023697|65466655|FG002|Treatment Period|Withdrawal by Subject|13|||
23470803|NCT02023697|65466653|FG000|Treatment Period|Safety outcome reached|0|||
23470804|NCT02023697|65466654|FG001|Treatment Period|Safety outcome reached|1|||
23470805|NCT02023697|65466655|FG002|Treatment Period|Safety outcome reached|0|||
23470806|NCT02023697|65466653|FG000|Treatment Period|Physician Decision|0|||
23470807|NCT02023697|65466654|FG001|Treatment Period|Physician Decision|0|||
23470808|NCT02023697|65466655|FG002|Treatment Period|Physician Decision|1|||
23470809|NCT02023697|65466653|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
23470810|NCT02023697|65466654|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
23470811|NCT02023697|65466655|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
23470812|NCT02023697|65466653|FG000|Active Follow-up Period|Lost to Follow-up|1|||
23470813|NCT02023697|65466654|FG001|Active Follow-up Period|Lost to Follow-up|1|||
23470814|NCT02023697|65466655|FG002|Active Follow-up Period|Lost to Follow-up|1|||
23470815|NCT02023697|65466653|FG000|Active Follow-up Period|Deterioration of general condition|1|||
23470816|NCT02023697|65466654|FG001|Active Follow-up Period|Deterioration of general condition|1|||
23470817|NCT02023697|65466655|FG002|Active Follow-up Period|Deterioration of general condition|1|||
23470818|NCT02023697|65466653|FG000|Active Follow-up Period|Other unspecified|2|||
23470819|NCT02023697|65466654|FG001|Active Follow-up Period|Other unspecified|0|||
23189007|NCT01524289|64433184|FG001|Overall Study|Adverse Event|5|||
23247979|NCT00902486|64649174|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
23470820|NCT02023697|65466655|FG002|Active Follow-up Period|Other unspecified|1|||
23470821|NCT02023697|65466653|FG000|Active Follow-up Period|Clinical progression|0|||
23470822|NCT02023697|65466654|FG001|Active Follow-up Period|Clinical progression|2|||
23470823|NCT02023697|65466655|FG002|Active Follow-up Period|Clinical progression|1|||
23470824|NCT02023697|65466653|FG000|Active Follow-up Period|Radiological progression|0|||
23470825|NCT02023697|65466654|FG001|Active Follow-up Period|Radiological progression|0|||
23470826|NCT02023697|65466655|FG002|Active Follow-up Period|Radiological progression|1|||
23470827|NCT02023697|65466653|FG000|Active Follow-up Period|Death|83|||
23470828|NCT02023697|65466654|FG001|Active Follow-up Period|Death|82|||
23470829|NCT02023697|65466655|FG002|Active Follow-up Period|Death|87|||
23470830|NCT02023697|65466653|FG000|Long-term Follow-up Period|Death|9|||
23470831|NCT02023697|65466654|FG001|Long-term Follow-up Period|Death|6|||
23470832|NCT02023697|65466655|FG002|Long-term Follow-up Period|Death|4|||
23470833|NCT02023697|65466653|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
23470834|NCT02023697|65466654|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
23470835|NCT02023697|65466655|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
23470836|NCT02023697|65466653|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
23470837|NCT02023697|65466654|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
23470838|NCT02023697|65466655|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
23470839|NCT02023697|65466653|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
23470840|NCT02023697|65466654|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
23470841|NCT02023697|65466655|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
23470842|NCT02023697|65466653|FG000|Long-term Follow-up Period|Technical problems|0|||
23470843|NCT02023697|65466654|FG001|Long-term Follow-up Period|Technical problems|0|||
23470844|NCT02023697|65466655|FG002|Long-term Follow-up Period|Technical problems|1|||
23470845|NCT02023697|65466653|FG000|Long-term Follow-up Period|Other unspecified|6|||
23470846|NCT02023697|65466654|FG001|Long-term Follow-up Period|Other unspecified|3|||
23470847|NCT02023697|65466655|FG002|Long-term Follow-up Period|Other unspecified|5|||
23470848|NCT00092443|65466656|FG000|Overall Study|Adverse Event|9|||
23470849|NCT00092443|65466657|FG001|Overall Study|Adverse Event|13|||
23470850|NCT00092443|65466656|FG000|Overall Study|Lost to Follow-up|7|||
23470851|NCT00092443|65466657|FG001|Overall Study|Lost to Follow-up|3|||
23470852|NCT00092443|65466656|FG000|Overall Study|Protocol Violation|11|||
23470853|NCT00092443|65466657|FG001|Overall Study|Protocol Violation|9|||
23470854|NCT00092443|65466656|FG000|Overall Study|Withdrawal by Subject|9|||
23470855|NCT00092443|65466657|FG001|Overall Study|Withdrawal by Subject|11|||
23470856|NCT00092443|65466656|FG000|Overall Study|Moved|5|||
23470857|NCT00092443|65466657|FG001|Overall Study|Moved|5|||
23470858|NCT00092443|65466656|FG000|Overall Study|Other|17|||
23470859|NCT00092443|65466657|FG001|Overall Study|Other|13|||
23470860|NCT01253577|65466658|FG000|Overall Study|Lost to Follow-up|3|||
23470861|NCT05334212|65466659|FG000|Overall Study|Study terminated prematurely|7|||
23470862|NCT01781299|65466660|FG000|Overall Study|Withdrawal by Subject|0|||
23470863|NCT01781299|65466661|FG001|Overall Study|Withdrawal by Subject|1|||
23470864|NCT02954172|65466663|FG000|Overall Study|Protocol Violation|3|||
23470865|NCT02954172|65466664|FG001|Overall Study|Protocol Violation|0|||
23470866|NCT02954172|65466663|FG000|Overall Study|allergic reaction|2|||
23470867|NCT02954172|65466664|FG001|Overall Study|allergic reaction|1|||
23470868|NCT02954172|65466663|FG000|Overall Study|non-measurable lesions at baseline|1|||
23470869|NCT02954172|65466664|FG001|Overall Study|non-measurable lesions at baseline|2|||
23470870|NCT02527421|65466665|FG000|Overall Study|Withdrawal by Subject|1|||
23470871|NCT02527421|65466666|FG001|Overall Study|Withdrawal by Subject|0|||
23470872|NCT01499277|65466667|FG000|Overall Study|Adverse Event|3|||
23470873|NCT01499277|65466668|FG001|Overall Study|Adverse Event|6|||
23470874|NCT01499277|65466667|FG000|Overall Study|Death|3|||
23470875|NCT01499277|65466668|FG001|Overall Study|Death|2|||
23470876|NCT01499277|65466667|FG000|Overall Study|Lost to Follow-up|15|||
23470877|NCT01499277|65466668|FG001|Overall Study|Lost to Follow-up|8|||
23470878|NCT01499277|65466667|FG000|Overall Study|Protocol Violation|2|||
23470879|NCT01499277|65466668|FG001|Overall Study|Protocol Violation|3|||
23470880|NCT01499277|65466667|FG000|Overall Study|Withdrawal by Subject|16|||
23470881|NCT01499277|65466668|FG001|Overall Study|Withdrawal by Subject|6|||
23470882|NCT01499277|65466667|FG000|Overall Study|Lack of therapeutic response and other|8|||
23470883|NCT01499277|65466668|FG001|Overall Study|Lack of therapeutic response and other|7|||
23470884|NCT03198507|65466669|FG000|Overall Study|Withdrawal by Subject|1|||
23470885|NCT03198507|65466670|FG001|Overall Study|Withdrawal by Subject|0|||
23470886|NCT01026324|65466671|FG000|Follow up/Survival|Withdrawal by Subject|1|||
23470887|NCT01026324|65466672|FG001|Follow up/Survival|Withdrawal by Subject|0|||
23354273|NCT01607346|65041372|FG000|Overall Study|Adverse Event|3|||
23354274|NCT01738191|65041375|FG000|Overall Study|Withdrawal by Subject|4|||
23354275|NCT01738191|65041376|FG001|Overall Study|Withdrawal by Subject|1|||
23354276|NCT02557516|65041377|FG000|Overall Study|Adverse Event|1|||
23470888|NCT01026324|65466673|FG002|Follow up/Survival|Withdrawal by Subject|0|||
23470889|NCT02974543|65466674|FG000|Overall Study|Withdrawal by Subject|1|||
23470890|NCT02974543|65466675|FG001|Overall Study|Withdrawal by Subject|0|||
23470891|NCT01456897|65466676|FG000|Overall Study|Adverse Event|19|||
23470892|NCT01456897|65466677|FG001|Overall Study|Adverse Event|22|||
23470893|NCT01456897|65466676|FG000|Overall Study|Protocol Violation|3|||
23470894|NCT01456897|65466677|FG001|Overall Study|Protocol Violation|4|||
23470895|NCT01456897|65466676|FG000|Overall Study|Physician Decision|5|||
23470896|NCT01456897|65466677|FG001|Overall Study|Physician Decision|3|||
23470897|NCT01456897|65466676|FG000|Overall Study|Withdrawal by Subject|44|||
23470898|NCT01456897|65466677|FG001|Overall Study|Withdrawal by Subject|17|||
23470899|NCT01456897|65466676|FG000|Overall Study|Lack of Efficacy|4|||
23470900|NCT01456897|65466677|FG001|Overall Study|Lack of Efficacy|11|||
23470901|NCT01243242|65466678|FG000|Overall Study|Adverse Event|1|||
23470902|NCT01243242|65466679|FG001|Overall Study|Adverse Event|1|||
23470903|NCT01243242|65466678|FG000|Overall Study|Withdrawal by Subject|1|||
23470904|NCT01243242|65466679|FG001|Overall Study|Withdrawal by Subject|1|||
23470905|NCT01243242|65466678|FG000|Overall Study|Physician Decision|0|||
23470906|NCT01243242|65466679|FG001|Overall Study|Physician Decision|1|||
23470907|NCT01243242|65466678|FG000|Overall Study|sponsor decision|0|||
23470908|NCT01243242|65466679|FG001|Overall Study|sponsor decision|1|||
23470909|NCT01243242|65466678|FG000|Overall Study|non compliance|1|||
23470910|NCT01243242|65466679|FG001|Overall Study|non compliance|0|||
23470911|NCT01474018|65466683|FG000|Overall Study|Lost to Follow-up|0|||
23470912|NCT01474018|65466684|FG001|Overall Study|Lost to Follow-up|1|||
23470913|NCT01474018|65466683|FG000|Overall Study|Withdrawal by Subject|0|||
23189008|NCT01524289|64433183|FG000|Overall Study|Did not take study medication|1|||
23189009|NCT01524289|64433184|FG001|Overall Study|Did not take study medication|0|||
23189010|NCT02981472|64433185|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
23189011|NCT02981472|64433186|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
23189012|NCT02981472|64433185|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23189013|NCT02981472|64433186|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23189014|NCT02981472|64433185|FG000|Treatment Period|Adverse Event|6|||
23189015|NCT02981472|64433186|FG001|Treatment Period|Adverse Event|1|||
23189016|NCT02981472|64433185|FG000|Treatment Period|Participant withdrew consent|1|||
23247980|NCT00902486|64649175|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
23470914|NCT01474018|65466684|FG001|Overall Study|Withdrawal by Subject|2|||
23470915|NCT00711477|65466687|FG000|Overall Study|Adverse Event|3|||
23470916|NCT00711477|65466688|FG001|Overall Study|Adverse Event|1|||
23470917|NCT00711477|65466687|FG000|Overall Study|Lost to Follow-up|0|||
23470918|NCT00711477|65466688|FG001|Overall Study|Lost to Follow-up|1|||
23470919|NCT00711477|65466687|FG000|Overall Study|Noncompliance|0|||
23470920|NCT00711477|65466688|FG001|Overall Study|Noncompliance|1|||
23470921|NCT05083585|65466694|FG000|Overall Study|Death|1|||
23470922|NCT05083585|65466695|FG001|Overall Study|Death|1|||
23470923|NCT05083585|65466694|FG000|Overall Study|Lost to Follow-up|1|||
23470924|NCT05083585|65466695|FG001|Overall Study|Lost to Follow-up|1|||
23470925|NCT05083585|65466694|FG000|Overall Study|Withdrawal by Subject|2|||
23470926|NCT05083585|65466695|FG001|Overall Study|Withdrawal by Subject|0|||
23470927|NCT05083585|65466694|FG000|Overall Study|Randomized but not vaccinated|2|||
23470928|NCT05083585|65466695|FG001|Overall Study|Randomized but not vaccinated|0|||
23470929|NCT04254913|65466696|FG000|Overall Study|Adverse Event|1|||
23470930|NCT00256997|65466698|FG000|Overall Study|Protocol Violation|1|||
23470931|NCT00256997|65466699|FG001|Overall Study|Protocol Violation|4|||
23470932|NCT00256997|65466698|FG000|Overall Study|Lack of Efficacy|1|||
23470933|NCT00256997|65466699|FG001|Overall Study|Lack of Efficacy|4|||
23470934|NCT00256997|65466698|FG000|Overall Study|Death|2|||
23470935|NCT00256997|65466699|FG001|Overall Study|Death|0|||
23470936|NCT00256997|65466698|FG000|Overall Study|Adverse Event|4|||
23470937|NCT00256997|65466699|FG001|Overall Study|Adverse Event|0|||
23470938|NCT00256997|65466698|FG000|Overall Study|Lost to Follow-up|3|||
23470939|NCT00256997|65466699|FG001|Overall Study|Lost to Follow-up|5|||
23470940|NCT00256997|65466698|FG000|Overall Study|Withdrawal by Subject|13|||
23470941|NCT00256997|65466699|FG001|Overall Study|Withdrawal by Subject|3|||
23470942|NCT00256997|65466698|FG000|Overall Study|Started but not treated|2|||
23470943|NCT00256997|65466699|FG001|Overall Study|Started but not treated|0|||
23470944|NCT00256997|65466698|FG000|Overall Study|Other|5|||
23470945|NCT00256997|65466699|FG001|Overall Study|Other|8|||
23470946|NCT00256997|65466698|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
23470947|NCT00256997|65466699|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
23470948|NCT00256997|65466698|FG000|Overall Study|Participant Non-compliant|3|||
23470949|NCT00256997|65466699|FG001|Overall Study|Participant Non-compliant|6|||
23470950|NCT00256997|65466698|FG000|Overall Study|Investigator Withdrew Participant|2|||
23470951|NCT00256997|65466699|FG001|Overall Study|Investigator Withdrew Participant|1|||
23470952|NCT00006289|65466700|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
23470953|NCT00006289|65466701|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
23247981|NCT00902486|64649170|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23470954|NCT00006289|65466700|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
23470955|NCT00006289|65466701|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
23470956|NCT00554216|65466704|FG000|Overall Study|Lost to Follow-up|92|||
23470957|NCT00554216|65466705|FG001|Overall Study|Lost to Follow-up|31|||
23470958|NCT00554216|65466706|FG002|Overall Study|Lost to Follow-up|63|||
23470959|NCT00554216|65466704|FG000|Overall Study|Adverse Event|16|||
23470960|NCT00554216|65466705|FG001|Overall Study|Adverse Event|16|||
23470961|NCT00554216|65466706|FG002|Overall Study|Adverse Event|36|||
23470962|NCT00554216|65466704|FG000|Overall Study|Withdrawal by Subject|92|||
23470963|NCT00554216|65466705|FG001|Overall Study|Withdrawal by Subject|31|||
23470964|NCT00554216|65466706|FG002|Overall Study|Withdrawal by Subject|43|||
23470965|NCT00554216|65466704|FG000|Overall Study|Non compliance|10|||
23470966|NCT00554216|65466705|FG001|Overall Study|Non compliance|4|||
23470967|NCT00554216|65466706|FG002|Overall Study|Non compliance|5|||
23470968|NCT00554216|65466704|FG000|Overall Study|Pregnancy|2|||
23470969|NCT00554216|65466705|FG001|Overall Study|Pregnancy|1|||
23470970|NCT00554216|65466706|FG002|Overall Study|Pregnancy|14|||
23470971|NCT00554216|65466704|FG000|Overall Study|Restricted med|3|||
23470972|NCT00554216|65466705|FG001|Overall Study|Restricted med|1|||
23470973|NCT00554216|65466706|FG002|Overall Study|Restricted med|1|||
23470974|NCT00554216|65466704|FG000|Overall Study|Other|12|||
23470975|NCT00554216|65466705|FG001|Overall Study|Other|7|||
23470976|NCT00554216|65466706|FG002|Overall Study|Other|10|||
23470977|NCT00554216|65466704|FG000|Overall Study|Lack of Efficacy|15|||
23470978|NCT00554216|65466705|FG001|Overall Study|Lack of Efficacy|3|||
23470979|NCT00554216|65466706|FG002|Overall Study|Lack of Efficacy|0|||
23470980|NCT00636363|65470547|FG000|Overall Study|Conjunctivitis|0|||
23470981|NCT00636363|65470548|FG001|Overall Study|Conjunctivitis|0|||
23470982|NCT00636363|65470549|FG002|Overall Study|Conjunctivitis|1|||
23470983|NCT00636363|65470547|FG000|Overall Study|Adverse Event|0|||
23470984|NCT00636363|65470548|FG001|Overall Study|Adverse Event|0|||
23470985|NCT00636363|65470549|FG002|Overall Study|Adverse Event|1|||
23470986|NCT00636363|65470547|FG000|Overall Study|Positive slit lamp finding|0|||
23470987|NCT00636363|65470548|FG001|Overall Study|Positive slit lamp finding|2|||
23470988|NCT00636363|65470549|FG002|Overall Study|Positive slit lamp finding|1|||
23470989|NCT00636363|65470547|FG000|Overall Study|Study related symptoms/complaints|8|||
23470990|NCT00636363|65470548|FG001|Overall Study|Study related symptoms/complaints|7|||
23470991|NCT00636363|65470549|FG002|Overall Study|Study related symptoms/complaints|4|||
23470992|NCT00636363|65470547|FG000|Overall Study|Met ineligibility criteria|0|||
23470993|NCT00636363|65470548|FG001|Overall Study|Met ineligibility criteria|0|||
23470994|NCT00636363|65470549|FG002|Overall Study|Met ineligibility criteria|3|||
23470995|NCT00636363|65470547|FG000|Overall Study|Missed > 1 visit|0|||
23470996|NCT00636363|65470548|FG001|Overall Study|Missed > 1 visit|1|||
23470997|NCT00636363|65470549|FG002|Overall Study|Missed > 1 visit|3|||
23470998|NCT00636363|65470547|FG000|Overall Study|Lack of motivation|1|||
23470999|NCT00636363|65470548|FG001|Overall Study|Lack of motivation|0|||
23471000|NCT00636363|65470549|FG002|Overall Study|Lack of motivation|1|||
23471001|NCT00636363|65470547|FG000|Overall Study|Protocol Violation|0|||
23471002|NCT00636363|65470548|FG001|Overall Study|Protocol Violation|3|||
23471003|NCT00636363|65470549|FG002|Overall Study|Protocol Violation|0|||
23471004|NCT00636363|65470547|FG000|Overall Study|Lost to Follow-up|3|||
23471005|NCT00636363|65470548|FG001|Overall Study|Lost to Follow-up|4|||
23471006|NCT00636363|65470549|FG002|Overall Study|Lost to Follow-up|2|||
23471007|NCT00636363|65470547|FG000|Overall Study|Withdrawal by Subject|1|||
23471008|NCT00636363|65470548|FG001|Overall Study|Withdrawal by Subject|3|||
23471009|NCT00636363|65470549|FG002|Overall Study|Withdrawal by Subject|2|||
23471010|NCT00724867|65470550|FG000|Overall Study|Adverse Event|25|||
23471011|NCT00724867|65470550|FG000|Overall Study|Lack of Efficacy|14|||
23471012|NCT00724867|65470550|FG000|Overall Study|Lost to Follow-up|12|||
23471013|NCT00724867|65470550|FG000|Overall Study|Non-compliance with study drug|6|||
23471014|NCT00724867|65470550|FG000|Overall Study|Physician Decision|17|||
23471015|NCT00724867|65470550|FG000|Overall Study|Protocol Violation|1|||
23471016|NCT00724867|65470550|FG000|Overall Study|Withdrawal by Subject|31|||
23471017|NCT00724867|65470550|FG000|Overall Study|Sponsor decision to end study|14|||
23471018|NCT00724867|65470550|FG000|Overall Study|Subject incarcerated|1|||
23471019|NCT00724867|65470550|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
23471020|NCT00724867|65470550|FG000|Overall Study|Subject moved out of state|1|||
23471021|NCT00724867|65470550|FG000|Overall Study|Elected to exit due to site closure|2|||
23471022|NCT00834080|65470551|FG000|Overall Study|Adverse Event|7|||
23471023|NCT00834080|65470551|FG000|Overall Study|Lost to Follow-up|7|||
23471024|NCT00834080|65470551|FG000|Overall Study|Withdrawal by Subject|5|||
23471025|NCT00834080|65470551|FG000|Overall Study|Other - Pregnancy|1|||
23587561|NCT01689519|65879160|FG000|Intent to Treat|Withdrawal by Subject|21|||
23587562|NCT01689519|65879161|FG001|Intent to Treat|Withdrawal by Subject|20|||
23587563|NCT01689519|65879160|FG000|Safety Population|Death|158|||
23587564|NCT01689519|65879161|FG001|Safety Population|Death|165|||
23587565|NCT01689519|65879160|FG000|Safety Population|Lost to Follow-up|4|||
23471026|NCT00834080|65470551|FG000|Overall Study|Other - False positive tests of the UDS|1|||
23471027|NCT00834080|65470551|FG000|Overall Study|Physician Decision|1|||
23471028|NCT00834080|65470551|FG000|Overall Study|Subject Relocated|1|||
23471029|NCT02118961|65470553|FG000|Overall Study|Withdrawal by Subject|1|||
23471030|NCT02118961|65470554|FG001|Overall Study|Withdrawal by Subject|0|||
23471031|NCT03698591|65470555|FG000|Overall Study|Withdrawal by Subject|2|||
23471032|NCT03698591|65470556|FG001|Overall Study|Withdrawal by Subject|2|||
23471033|NCT03698591|65470555|FG000|Overall Study|Failed drug screen|1|||
23471034|NCT03698591|65470556|FG001|Overall Study|Failed drug screen|1|||
23471035|NCT03698591|65470555|FG000|Overall Study|Failed health screen|0|||
23471036|NCT03698591|65470556|FG001|Overall Study|Failed health screen|1|||
23471037|NCT03698591|65470555|FG000|Overall Study|Ineligible for financial compensation|1|||
23189017|NCT02981472|64433186|FG001|Treatment Period|Participant withdrew consent|0|||
23189018|NCT02981472|64433185|FG000|Treatment Period|Lost to Follow-up|0|||
23189019|NCT02981472|64433186|FG001|Treatment Period|Lost to Follow-up|1|||
23354277|NCT02557516|65041378|FG001|Overall Study|Adverse Event|0|||
23354278|NCT02557516|65041379|FG002|Overall Study|Adverse Event|2|||
23354279|NCT02557516|65041380|FG003|Overall Study|Adverse Event|1|||
23354280|NCT02557516|65041377|FG000|Overall Study|Disease progression|0|||
23354281|NCT02557516|65041378|FG001|Overall Study|Disease progression|2|||
23354282|NCT02557516|65041379|FG002|Overall Study|Disease progression|0|||
23587566|NCT01689519|65879161|FG001|Safety Population|Lost to Follow-up|8|||
23587567|NCT01689519|65879160|FG000|Safety Population|Other|2|||
23587568|NCT01689519|65879161|FG001|Safety Population|Other|4|||
23587569|NCT01689519|65879160|FG000|Safety Population|Physician Decision|4|||
23587570|NCT01689519|65879161|FG001|Safety Population|Physician Decision|1|||
23587571|NCT01689519|65879160|FG000|Safety Population|Study Terminated By Sponsor|60|||
23587572|NCT01689519|65879161|FG001|Safety Population|Study Terminated By Sponsor|47|||
23587573|NCT01689519|65879160|FG000|Safety Population|Withdrawal by Subject|20|||
23587574|NCT01689519|65879161|FG001|Safety Population|Withdrawal by Subject|20|||
23587575|NCT00831415|65879162|FG000|Overall Study|Adverse Event|14|||
23587576|NCT00831415|65879162|FG000|Overall Study|Failed to return|3|||
23587577|NCT00831415|65879162|FG000|Overall Study|Physician Decision|6|||
23587578|NCT00831415|65879162|FG000|Overall Study|Lost to Follow-up|9|||
23587579|NCT00831415|65879162|FG000|Overall Study|Protocol Violation|3|||
23587580|NCT00831415|65879162|FG000|Overall Study|Withdrawal by Subject|35|||
23587581|NCT00831415|65879162|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
23587582|NCT00831415|65879162|FG000|Overall Study|Death|1|||
23587583|NCT05179837|65879163|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
23587584|NCT05179837|65879163|FG000|Overall Study|Device malfunctioned|1|||
23587585|NCT05179837|65879163|FG000|Overall Study|Image quality too low|2|||
23587586|NCT01048788|65879164|FG000|Overall Study|Adverse Event|5|||
23587587|NCT01048788|65879165|FG001|Overall Study|Adverse Event|1|||
23587588|NCT01048788|65879166|FG002|Overall Study|Adverse Event|1|||
23587589|NCT01048788|65879164|FG000|Overall Study|Lack of Efficacy|0|||
23587590|NCT01048788|65879165|FG001|Overall Study|Lack of Efficacy|0|||
23587591|NCT01048788|65879166|FG002|Overall Study|Lack of Efficacy|1|||
23587592|NCT01048788|65879164|FG000|Overall Study|Withdrawal by Subject|0|||
23587593|NCT01048788|65879165|FG001|Overall Study|Withdrawal by Subject|1|||
23587594|NCT01048788|65879166|FG002|Overall Study|Withdrawal by Subject|0|||
23587595|NCT01460342|65879169|FG000|Overall Study|Adverse Event|5|||
23587596|NCT01460342|65879170|FG001|Overall Study|Adverse Event|4|||
23587597|NCT01460342|65879169|FG000|Overall Study|Lost to Follow-up|1|||
23587598|NCT01460342|65879170|FG001|Overall Study|Lost to Follow-up|2|||
23587599|NCT01460342|65879169|FG000|Overall Study|Protocol Violation|0|||
23587600|NCT01460342|65879170|FG001|Overall Study|Protocol Violation|1|||
23587601|NCT01460342|65879169|FG000|Overall Study|Withdrawal by Subject|3|||
23587602|NCT01460342|65879170|FG001|Overall Study|Withdrawal by Subject|4|||
23587603|NCT01460342|65879169|FG000|Overall Study|Physician Decision|1|||
23587604|NCT01460342|65879170|FG001|Overall Study|Physician Decision|3|||
23587605|NCT01460342|65879169|FG000|Overall Study|Lack of Efficacy|1|||
23587606|NCT01460342|65879170|FG001|Overall Study|Lack of Efficacy|0|||
23587607|NCT00157014|65879171|FG000|Overall Study|Death|4|||
23587608|NCT00157014|65879172|FG001|Overall Study|Death|2|||
23587609|NCT00157014|65879173|FG002|Overall Study|Death|1|||
23587610|NCT00157014|65879174|FG003|Overall Study|Death|1|||
23587611|NCT00157014|65879171|FG000|Overall Study|Physician Decision|0|||
23587612|NCT00157014|65879172|FG001|Overall Study|Physician Decision|1|||
23587613|NCT00157014|65879173|FG002|Overall Study|Physician Decision|0|||
23587614|NCT00157014|65879174|FG003|Overall Study|Physician Decision|0|||
23587615|NCT00157014|65879171|FG000|Overall Study|Medications withdrawn on family request|0|||
23587616|NCT00157014|65879172|FG001|Overall Study|Medications withdrawn on family request|1|||
23587617|NCT00157014|65879173|FG002|Overall Study|Medications withdrawn on family request|0|||
23587618|NCT00157014|65879174|FG003|Overall Study|Medications withdrawn on family request|0|||
23587619|NCT00157014|65879171|FG000|Overall Study|Patient withdrawn by investigator|1|||
23587620|NCT00157014|65879172|FG001|Overall Study|Patient withdrawn by investigator|0|||
23587621|NCT00157014|65879173|FG002|Overall Study|Patient withdrawn by investigator|0|||
23587622|NCT00157014|65879174|FG003|Overall Study|Patient withdrawn by investigator|0|||
23587623|NCT00157014|65879171|FG000|Overall Study|Patient unable to return in nursing home|1|||
23587624|NCT00157014|65879172|FG001|Overall Study|Patient unable to return in nursing home|0|||
23587625|NCT00157014|65879173|FG002|Overall Study|Patient unable to return in nursing home|0|||
23587626|NCT00157014|65879174|FG003|Overall Study|Patient unable to return in nursing home|0|||
23189020|NCT04651777|64435973|FG000|Overall Study|Adverse Event|1|||
23189021|NCT04651777|64435973|FG000|Overall Study|Withdrawal by Subject|2|||
23189022|NCT01061008|64435974|FG000|Overall Study|Badiocephalic fistula failed|3|||
23189023|NCT01061008|64435975|FG001|Overall Study|Badiocephalic fistula failed|2|||
23354283|NCT02557516|65041380|FG003|Overall Study|Disease progression|0|||
23354284|NCT02557516|65041377|FG000|Overall Study|Physician Decision|0|||
23247982|NCT00902486|64649171|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23471038|NCT03698591|65470556|FG001|Overall Study|Ineligible for financial compensation|0|||
23471039|NCT03698591|65470555|FG000|Overall Study|Equipment Error|1|||
23471040|NCT03698591|65470556|FG001|Overall Study|Equipment Error|0|||
23189024|NCT01061008|64435974|FG000|Overall Study|Death|1|||
23189025|NCT01061008|64435975|FG001|Overall Study|Death|0|||
23189026|NCT01061008|64435974|FG000|Overall Study|Withdrawal by Subject|1|||
23189027|NCT01061008|64435975|FG001|Overall Study|Withdrawal by Subject|3|||
23189028|NCT01061008|64435974|FG000|Overall Study|Unable to exercise following surgery|1|||
23189029|NCT01061008|64435975|FG001|Overall Study|Unable to exercise following surgery|0|||
23189030|NCT01061008|64435974|FG000|Overall Study|Adverse Event|0|||
23189031|NCT01061008|64435975|FG001|Overall Study|Adverse Event|1|||
23189032|NCT05421754|64435979|FG000|Overall Study|Technical issue with sensor|1|||
23189033|NCT04272606|64435980|FG000|Overall Study|Protocol Violation|1|||
23189034|NCT04272606|64435981|FG001|Overall Study|Protocol Violation|1|||
23189035|NCT04272606|64435980|FG000|Overall Study|Physician Decision|0|||
23189036|NCT04272606|64435981|FG001|Overall Study|Physician Decision|1|||
23189037|NCT00479466|64435984|FG000|Overall Study|Adverse Event|5|||
23471041|NCT03698591|65470555|FG000|Overall Study|Could not establish TMS dosage|0|||
23471042|NCT03698591|65470556|FG001|Overall Study|Could not establish TMS dosage|1|||
23471043|NCT03083990|65470557|FG000|Overall Study|Adverse Event|1|||
23471044|NCT03083990|65470558|FG001|Overall Study|Adverse Event|0|||
23471045|NCT00640224|65470561|FG000|Overall Study|Lost to Follow-up|5|||
23471046|NCT00640224|65470562|FG001|Overall Study|Lost to Follow-up|2|||
23471047|NCT00640224|65470563|FG002|Overall Study|Lost to Follow-up|0|||
23471048|NCT00640224|65470564|FG003|Overall Study|Lost to Follow-up|0|||
23471049|NCT00640224|65470561|FG000|Overall Study|Withdrawal by Subject|1|||
23471050|NCT00640224|65470562|FG001|Overall Study|Withdrawal by Subject|0|||
23471051|NCT00640224|65470563|FG002|Overall Study|Withdrawal by Subject|0|||
23189038|NCT00479466|64435985|FG001|Overall Study|Adverse Event|1|||
23189039|NCT00479466|64435986|FG002|Overall Study|Adverse Event|0|||
23189040|NCT00479466|64435987|FG003|Overall Study|Adverse Event|1|||
23189041|NCT00479466|64435988|FG004|Overall Study|Adverse Event|2|||
23189042|NCT00479466|64435989|FG005|Overall Study|Adverse Event|0|||
23189043|NCT00479466|64435984|FG000|Overall Study|Hyperglycemia|0|||
23189044|NCT00479466|64435985|FG001|Overall Study|Hyperglycemia|0|||
23189045|NCT00479466|64435986|FG002|Overall Study|Hyperglycemia|0|||
23189046|NCT00479466|64435987|FG003|Overall Study|Hyperglycemia|0|||
23189047|NCT00479466|64435988|FG004|Overall Study|Hyperglycemia|0|||
23189048|NCT00479466|64435989|FG005|Overall Study|Hyperglycemia|1|||
23189049|NCT00479466|64435984|FG000|Overall Study|Lack of Efficacy|2|||
23189050|NCT00479466|64435985|FG001|Overall Study|Lack of Efficacy|0|||
23189051|NCT00479466|64435986|FG002|Overall Study|Lack of Efficacy|1|||
23247983|NCT00902486|64649172|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23189052|NCT00479466|64435987|FG003|Overall Study|Lack of Efficacy|0|||
23189053|NCT00479466|64435988|FG004|Overall Study|Lack of Efficacy|0|||
23189054|NCT00479466|64435989|FG005|Overall Study|Lack of Efficacy|0|||
23189055|NCT00479466|64435984|FG000|Overall Study|Lost to Follow-up|0|||
23189056|NCT00479466|64435985|FG001|Overall Study|Lost to Follow-up|1|||
23189057|NCT00479466|64435986|FG002|Overall Study|Lost to Follow-up|1|||
23189058|NCT00479466|64435987|FG003|Overall Study|Lost to Follow-up|0|||
23189059|NCT00479466|64435988|FG004|Overall Study|Lost to Follow-up|2|||
23189060|NCT00479466|64435989|FG005|Overall Study|Lost to Follow-up|2|||
23189061|NCT00479466|64435984|FG000|Overall Study|Physician Decision|2|||
23189062|NCT00479466|64435985|FG001|Overall Study|Physician Decision|1|||
23189063|NCT00479466|64435986|FG002|Overall Study|Physician Decision|1|||
23189064|NCT00479466|64435987|FG003|Overall Study|Physician Decision|0|||
23189065|NCT00479466|64435988|FG004|Overall Study|Physician Decision|0|||
23471052|NCT00640224|65470564|FG003|Overall Study|Withdrawal by Subject|0|||
23587627|NCT00157014|65879171|FG000|Overall Study|Patient would not receive transplant|0|||
23587628|NCT00157014|65879172|FG001|Overall Study|Patient would not receive transplant|1|||
23471053|NCT00640224|65470561|FG000|Overall Study|Headaches|0|||
23587629|NCT00157014|65879173|FG002|Overall Study|Patient would not receive transplant|0|||
23587630|NCT00157014|65879174|FG003|Overall Study|Patient would not receive transplant|0|||
23587631|NCT00157014|65879171|FG000|Overall Study|Withdrawal by Subject|1|||
23587632|NCT00157014|65879172|FG001|Overall Study|Withdrawal by Subject|0|||
23189066|NCT00479466|64435989|FG005|Overall Study|Physician Decision|0|||
23189067|NCT00479466|64435984|FG000|Overall Study|Pregnancy|0|||
23189068|NCT00479466|64435985|FG001|Overall Study|Pregnancy|0|||
23189069|NCT00479466|64435986|FG002|Overall Study|Pregnancy|0|||
23189070|NCT00479466|64435987|FG003|Overall Study|Pregnancy|0|||
23189071|NCT00479466|64435988|FG004|Overall Study|Pregnancy|1|||
23471054|NCT00640224|65470562|FG001|Overall Study|Headaches|1|||
23471055|NCT00640224|65470563|FG002|Overall Study|Headaches|0|||
23471056|NCT00640224|65470564|FG003|Overall Study|Headaches|0|||
23471057|NCT04556383|65470565|FG000|PCP|Lack of Efficacy|28|||
23471058|NCT04556383|65470566|FG001|PCP|Lack of Efficacy|23|||
23471059|NCT04556383|65470567|FG002|PCP|Lack of Efficacy|23|||
23471060|NCT04556383|65470568|FG003|PCP|Lack of Efficacy|0|||
23471061|NCT04556383|65470565|FG000|PCP|Study terminated by sponsor|15|||
23471062|NCT04556383|65470566|FG001|PCP|Study terminated by sponsor|13|||
23471063|NCT04556383|65470567|FG002|PCP|Study terminated by sponsor|16|||
23471064|NCT04556383|65470568|FG003|PCP|Study terminated by sponsor|0|||
23189072|NCT00479466|64435989|FG005|Overall Study|Pregnancy|0|||
23189073|NCT00479466|64435984|FG000|Overall Study|Protocol Violation|1|||
23189074|NCT00479466|64435985|FG001|Overall Study|Protocol Violation|0|||
23189075|NCT00479466|64435986|FG002|Overall Study|Protocol Violation|0|||
23189076|NCT00479466|64435987|FG003|Overall Study|Protocol Violation|0|||
23189077|NCT00479466|64435988|FG004|Overall Study|Protocol Violation|0|||
23189078|NCT00479466|64435989|FG005|Overall Study|Protocol Violation|0|||
23189079|NCT00479466|64435984|FG000|Overall Study|Withdrawal by Subject|3|||
23189080|NCT00479466|64435985|FG001|Overall Study|Withdrawal by Subject|5|||
23189081|NCT00479466|64435986|FG002|Overall Study|Withdrawal by Subject|0|||
23189082|NCT00479466|64435987|FG003|Overall Study|Withdrawal by Subject|2|||
23189083|NCT00479466|64435988|FG004|Overall Study|Withdrawal by Subject|3|||
23189084|NCT00479466|64435989|FG005|Overall Study|Withdrawal by Subject|1|||
23189085|NCT00871858|64435992|FG000|Overall Study|Protocol Violation|3|||
23189086|NCT00871858|64435993|FG001|Overall Study|Protocol Violation|4|||
23189087|NCT00871858|64435992|FG000|Overall Study|Adverse Event|1|||
23189088|NCT00871858|64435993|FG001|Overall Study|Adverse Event|1|||
23189089|NCT00871858|64435992|FG000|Overall Study|Withdrawal by Subject|1|||
23189090|NCT00871858|64435993|FG001|Overall Study|Withdrawal by Subject|1|||
23189091|NCT00871858|64435992|FG000|Overall Study|Lost to Follow-up|0|||
23189092|NCT00871858|64435993|FG001|Overall Study|Lost to Follow-up|1|||
23189093|NCT02201940|64435994|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
23189094|NCT02201940|64435995|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
23189095|NCT02201940|64435994|FG000|Overall Study|Lack of Efficacy|2|||
23247984|NCT00902486|64649173|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23247985|NCT00902486|64649174|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
23247986|NCT00902486|64649175|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
23471065|NCT04556383|65470565|FG000|PCP|Withdrawal by Subject|8|||
23471066|NCT04556383|65470566|FG001|PCP|Withdrawal by Subject|6|||
23471067|NCT04556383|65470567|FG002|PCP|Withdrawal by Subject|6|||
23471068|NCT04556383|65470568|FG003|PCP|Withdrawal by Subject|0|||
23471069|NCT04556383|65470565|FG000|PCP|Adverse Event|1|||
23471070|NCT04556383|65470566|FG001|PCP|Adverse Event|7|||
23471071|NCT04556383|65470567|FG002|PCP|Adverse Event|7|||
23471072|NCT04556383|65470568|FG003|PCP|Adverse Event|0|||
23471073|NCT04556383|65470565|FG000|PCP|Other, Not Specified|1|||
23471074|NCT04556383|65470566|FG001|PCP|Other, Not Specified|2|||
23471075|NCT04556383|65470567|FG002|PCP|Other, Not Specified|1|||
23471076|NCT04556383|65470568|FG003|PCP|Other, Not Specified|0|||
23471077|NCT04556383|65470565|FG000|PCP|Protocol Violation|1|||
23471078|NCT04556383|65470566|FG001|PCP|Protocol Violation|0|||
23471079|NCT04556383|65470567|FG002|PCP|Protocol Violation|1|||
23471080|NCT04556383|65470568|FG003|PCP|Protocol Violation|0|||
23471081|NCT04556383|65470565|FG000|PCP|Lost to Follow-up|1|||
23471082|NCT04556383|65470566|FG001|PCP|Lost to Follow-up|0|||
23471083|NCT04556383|65470567|FG002|PCP|Lost to Follow-up|0|||
23471084|NCT04556383|65470568|FG003|PCP|Lost to Follow-up|0|||
23471085|NCT04556383|65470565|FG000|PCP|Physician Decision|0|||
23587633|NCT00157014|65879173|FG002|Overall Study|Withdrawal by Subject|0|||
23587634|NCT00157014|65879174|FG003|Overall Study|Withdrawal by Subject|0|||
23587635|NCT01713530|65879176|FG000|Overall Study|Adverse Event|0|||
23587636|NCT01713530|65879177|FG001|Overall Study|Adverse Event|5|||
23587637|NCT01713530|65879176|FG000|Overall Study|Withdrawal criteria|21|||
23587638|NCT01713530|65879177|FG001|Overall Study|Withdrawal criteria|12|||
23587639|NCT01713530|65879176|FG000|Overall Study|Unclassified|4|||
23587640|NCT01713530|65879177|FG001|Overall Study|Unclassified|2|||
23189096|NCT02201940|64435995|FG001|Overall Study|Lack of Efficacy|113|||
23189097|NCT02201940|64435994|FG000|Overall Study|Lost to Follow-up|5|||
23189098|NCT02201940|64435995|FG001|Overall Study|Lost to Follow-up|0|||
23189099|NCT02201940|64435994|FG000|Overall Study|Withdrew Consent|2|||
23189100|NCT02201940|64435995|FG001|Overall Study|Withdrew Consent|1|||
23354285|NCT02557516|65041378|FG001|Overall Study|Physician Decision|2|||
23471086|NCT04556383|65470566|FG001|PCP|Physician Decision|1|||
23471087|NCT04556383|65470567|FG002|PCP|Physician Decision|0|||
23471088|NCT04556383|65470568|FG003|PCP|Physician Decision|0|||
23471089|NCT04556383|65470565|FG000|PCP|Site terminated by sponsor|0|||
23471090|NCT04556383|65470566|FG001|PCP|Site terminated by sponsor|1|||
23471091|NCT04556383|65470567|FG002|PCP|Site terminated by sponsor|0|||
23471092|NCT04556383|65470568|FG003|PCP|Site terminated by sponsor|0|||
23471093|NCT04556383|65470565|FG000|OLE|Study terminated by sponsor|0|||
23471094|NCT04556383|65470566|FG001|OLE|Study terminated by sponsor|0|||
23471095|NCT04556383|65470567|FG002|OLE|Study terminated by sponsor|0|||
23587641|NCT00217672|65879183|FG000|Allocation|Ineligible|2|||
23471096|NCT04556383|65470568|FG003|OLE|Study terminated by sponsor|68|||
23471097|NCT04556383|65470565|FG000|OLE|Withdrawal by Subject|0|||
23471098|NCT04556383|65470566|FG001|OLE|Withdrawal by Subject|0|||
23471099|NCT04556383|65470567|FG002|OLE|Withdrawal by Subject|0|||
23471100|NCT04556383|65470568|FG003|OLE|Withdrawal by Subject|10|||
23471101|NCT04556383|65470565|FG000|OLE|Lack of Efficacy|0|||
23471102|NCT04556383|65470566|FG001|OLE|Lack of Efficacy|0|||
23471103|NCT04556383|65470567|FG002|OLE|Lack of Efficacy|0|||
23471104|NCT04556383|65470568|FG003|OLE|Lack of Efficacy|7|||
23471105|NCT04556383|65470565|FG000|OLE|Adverse Event|0|||
23471106|NCT04556383|65470566|FG001|OLE|Adverse Event|0|||
23471107|NCT04556383|65470567|FG002|OLE|Adverse Event|0|||
23471108|NCT04556383|65470568|FG003|OLE|Adverse Event|2|||
23471109|NCT04556383|65470565|FG000|OLE|Other, Not Specified|0|||
23471110|NCT04556383|65470566|FG001|OLE|Other, Not Specified|0|||
23471111|NCT04556383|65470567|FG002|OLE|Other, Not Specified|0|||
23471112|NCT04556383|65470568|FG003|OLE|Other, Not Specified|2|||
23471113|NCT04556383|65470565|FG000|OLE|Death|0|||
23471114|NCT04556383|65470566|FG001|OLE|Death|0|||
23471115|NCT04556383|65470567|FG002|OLE|Death|0|||
23471116|NCT04556383|65470568|FG003|OLE|Death|1|||
23471117|NCT04556383|65470565|FG000|OLE|Lost to Follow-up|0|||
23471118|NCT04556383|65470566|FG001|OLE|Lost to Follow-up|0|||
23471119|NCT04556383|65470567|FG002|OLE|Lost to Follow-up|0|||
23471120|NCT04556383|65470568|FG003|OLE|Lost to Follow-up|1|||
23471121|NCT01587898|65470569|FG000|Overall Study|Adverse Event|1|||
23471122|NCT01587898|65470570|FG001|Overall Study|Adverse Event|1|||
23471123|NCT01587898|65470571|FG002|Overall Study|Adverse Event|0|||
23471124|NCT01587898|65470572|FG003|Overall Study|Adverse Event|0|||
23471125|NCT01587898|65470569|FG000|Overall Study|Protocol Violation|0|||
23471126|NCT01587898|65470570|FG001|Overall Study|Protocol Violation|2|||
23471127|NCT01587898|65470571|FG002|Overall Study|Protocol Violation|1|||
23471128|NCT01587898|65470572|FG003|Overall Study|Protocol Violation|1|||
23471129|NCT01587898|65470569|FG000|Overall Study|Lost to Follow-up|0|||
23471130|NCT01587898|65470570|FG001|Overall Study|Lost to Follow-up|0|||
23471131|NCT01587898|65470571|FG002|Overall Study|Lost to Follow-up|0|||
23471132|NCT01587898|65470572|FG003|Overall Study|Lost to Follow-up|1|||
23471133|NCT01587898|65470569|FG000|Overall Study|Withdrawal by Subject|2|||
23471134|NCT01587898|65470570|FG001|Overall Study|Withdrawal by Subject|1|||
23471135|NCT01587898|65470571|FG002|Overall Study|Withdrawal by Subject|0|||
23471136|NCT01587898|65470572|FG003|Overall Study|Withdrawal by Subject|0|||
23471137|NCT01587898|65470569|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
23471138|NCT01587898|65470570|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
23471139|NCT01587898|65470571|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
23471140|NCT01587898|65470572|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
23471141|NCT04027608|65470576|FG000|Overall Study|Withdrawal by Subject|13|||
23471142|NCT04027608|65470577|FG001|Overall Study|Withdrawal by Subject|2|||
23471143|NCT04027608|65470576|FG000|Overall Study|Protocol Violation|2|||
23471144|NCT04027608|65470577|FG001|Overall Study|Protocol Violation|1|||
23471145|NCT04027608|65470576|FG000|Overall Study|Physician Decision|1|||
23471146|NCT04027608|65470577|FG001|Overall Study|Physician Decision|0|||
23471147|NCT04027608|65470576|FG000|Overall Study|Lost to Follow-up|20|||
23471148|NCT04027608|65470577|FG001|Overall Study|Lost to Follow-up|4|||
23471149|NCT01994889|65470591|FG000|Overall Study|Adverse Event|5|||
23471150|NCT01994889|65470592|FG001|Overall Study|Adverse Event|12|||
23471151|NCT01994889|65470593|FG002|Overall Study|Adverse Event|11|||
23471152|NCT01994889|65470591|FG000|Overall Study|Cardiac Device Implantation|0|||
23471153|NCT01994889|65470592|FG001|Overall Study|Cardiac Device Implantation|2|||
23471154|NCT01994889|65470593|FG002|Overall Study|Cardiac Device Implantation|0|||
23471155|NCT01994889|65470591|FG000|Overall Study|Organ Transplantation|1|||
23354286|NCT02557516|65041379|FG002|Overall Study|Physician Decision|0|||
23471156|NCT01994889|65470592|FG001|Overall Study|Organ Transplantation|5|||
23471157|NCT01994889|65470593|FG002|Overall Study|Organ Transplantation|5|||
23471158|NCT01994889|65470591|FG000|Overall Study|No longer willing to participate|8|||
23471159|NCT01994889|65470592|FG001|Overall Study|No longer willing to participate|17|||
23471160|NCT01994889|65470593|FG002|Overall Study|No longer willing to participate|37|||
23471161|NCT01994889|65470591|FG000|Overall Study|Lost to Follow-up|0|||
23471162|NCT01994889|65470592|FG001|Overall Study|Lost to Follow-up|1|||
23471163|NCT01994889|65470593|FG002|Overall Study|Lost to Follow-up|0|||
23471164|NCT01994889|65470591|FG000|Overall Study|Protocol Violation|0|||
23471165|NCT01994889|65470592|FG001|Overall Study|Protocol Violation|1|||
23471166|NCT01994889|65470593|FG002|Overall Study|Protocol Violation|1|||
23471167|NCT01994889|65470591|FG000|Overall Study|Death|14|||
23471168|NCT01994889|65470592|FG001|Overall Study|Death|25|||
23587642|NCT00217672|65879184|FG001|Allocation|Ineligible|0|||
23354287|NCT02557516|65041380|FG003|Overall Study|Physician Decision|0|||
23354288|NCT02557516|65041377|FG000|Overall Study|Sponsor decision|0|||
23247987|NCT00902486|64649170|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23247988|NCT00902486|64649171|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23247989|NCT00902486|64649172|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23247990|NCT00902486|64649173|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
23587643|NCT00217672|65879183|FG000|Treatment|disease progression|33|||
23587644|NCT00217672|65879184|FG001|Treatment|disease progression|4|||
23587645|NCT00217672|65879183|FG000|Treatment|Adverse Event|18|||
23587646|NCT00217672|65879184|FG001|Treatment|Adverse Event|2|||
23587647|NCT00217672|65879183|FG000|Treatment|reqd treatment not permitted by protocol|6|||
23587648|NCT00217672|65879184|FG001|Treatment|reqd treatment not permitted by protocol|0|||
23587649|NCT00217672|65879183|FG000|Treatment|Physician Decision|6|||
23587650|NCT00217672|65879184|FG001|Treatment|Physician Decision|0|||
23587651|NCT00217672|65879183|FG000|Treatment|insurance issues|1|||
23247991|NCT00902486|64649174|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23247992|NCT00902486|64649175|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
23247993|NCT00902486|64649170|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23247994|NCT00902486|64649171|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23247995|NCT00902486|64649172|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
23247996|NCT00902486|64649173|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23247997|NCT00902486|64649174|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23247998|NCT00902486|64649175|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
23247999|NCT00902486|64649170|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
23248000|NCT00902486|64649171|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
23248001|NCT00902486|64649172|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
23248002|NCT00902486|64649173|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
23248003|NCT00902486|64649174|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
23248004|NCT00902486|64649175|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
23248005|NCT03130777|64649176|FG000|Overall Study|Death|0|||
23248006|NCT03130777|64649177|FG001|Overall Study|Death|1|||
23248007|NCT03130777|64649176|FG000|Overall Study|Did not meet eligibility criteria|1|||
23248008|NCT03130777|64649177|FG001|Overall Study|Did not meet eligibility criteria|0|||
23248009|NCT00440193|64649180|FG000|Treatment Period|Adverse Event|74|||
23587652|NCT00217672|65879184|FG001|Treatment|insurance issues|1|||
23587653|NCT00217672|65879183|FG000|Treatment|Death|2|||
23587654|NCT00217672|65879184|FG001|Treatment|Death|0|||
23587655|NCT00217672|65879183|FG000|Treatment|secondary malignancy|1|||
23587656|NCT00217672|65879184|FG001|Treatment|secondary malignancy|0|||
23189101|NCT02201940|64435994|FG000|Overall Study|Investigator's Discretion|1|||
23189102|NCT02201940|64435995|FG001|Overall Study|Investigator's Discretion|1|||
23189103|NCT02201940|64435994|FG000|Overall Study|Death|1|||
23189104|NCT02201940|64435995|FG001|Overall Study|Death|0|||
23189105|NCT02201940|64435994|FG000|Overall Study|Adverse Event|0|||
23189106|NCT02201940|64435995|FG001|Overall Study|Adverse Event|1|||
23189107|NCT00491530|64435996|FG000|Overall Study|Adverse Event|6|||
23189108|NCT00491530|64435997|FG001|Overall Study|Adverse Event|1|||
23189109|NCT00491530|64435998|FG002|Overall Study|Adverse Event|2|||
23189110|NCT00491530|64435996|FG000|Overall Study|Withdrawal by Subject|3|||
23248010|NCT00440193|64649181|FG001|Treatment Period|Adverse Event|67|||
23587657|NCT00217672|65879183|FG000|Follow-up|Withdrawal by Subject|4|||
23587658|NCT00217672|65879184|FG001|Follow-up|Withdrawal by Subject|0|||
23248011|NCT00440193|64649180|FG000|Treatment Period|Death|19|||
23248012|NCT00440193|64649181|FG001|Treatment Period|Death|22|||
23248013|NCT00440193|64649180|FG000|Treatment Period|Lack of Efficacy|0|||
23248014|NCT00440193|64649181|FG001|Treatment Period|Lack of Efficacy|1|||
23248015|NCT00440193|64649180|FG000|Treatment Period|Lost to Follow-up|12|||
23248016|NCT00440193|64649181|FG001|Treatment Period|Lost to Follow-up|18|||
23248017|NCT00440193|64649180|FG000|Treatment Period|Physician Decision|3|||
23248018|NCT00440193|64649181|FG001|Treatment Period|Physician Decision|6|||
23248019|NCT00440193|64649180|FG000|Treatment Period|Protocol Violation|16|||
23248020|NCT00440193|64649181|FG001|Treatment Period|Protocol Violation|19|||
23248021|NCT00440193|64649180|FG000|Treatment Period|Withdrawal by Subject|36|||
23248022|NCT00440193|64649181|FG001|Treatment Period|Withdrawal by Subject|77|||
23248023|NCT00440193|64649180|FG000|Treatment Period|Clinical endpoint reached|28|||
23248024|NCT00440193|64649181|FG001|Treatment Period|Clinical endpoint reached|25|||
23248025|NCT00440193|64649180|FG000|Treatment Period|Study terminated by sponsor|102|||
23248026|NCT00440193|64649181|FG001|Treatment Period|Study terminated by sponsor|94|||
23248027|NCT00440193|64649180|FG000|Treatment Period|Protocol driven decision point|2|||
23248028|NCT00440193|64649181|FG001|Treatment Period|Protocol driven decision point|2|||
23248029|NCT00440193|64649180|FG000|Treatment Period|Switch to commercial drug|0|||
23248030|NCT00440193|64649181|FG001|Treatment Period|Switch to commercial drug|2|||
23248031|NCT00440193|64649180|FG000|Treatment Period|Technical problems|1|||
23354289|NCT02557516|65041378|FG001|Overall Study|Sponsor decision|1|||
23354290|NCT02557516|65041379|FG002|Overall Study|Sponsor decision|2|||
23354291|NCT02557516|65041380|FG003|Overall Study|Sponsor decision|8|||
23354292|NCT01483599|65041382|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
23354293|NCT01483599|65041383|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354294|NCT01483599|65041384|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354295|NCT01483599|65041385|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
23354296|NCT01483599|65041386|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
23354297|NCT01483599|65041387|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
23354298|NCT01483599|65041388|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
23354299|NCT01483599|65041389|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354300|NCT01483599|65041390|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354301|NCT01483599|65041391|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354302|NCT01483599|65041392|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354303|NCT01483599|65041393|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354304|NCT01483599|65041394|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354305|NCT01483599|65041395|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
23354306|NCT01483599|65041382|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354307|NCT01483599|65041383|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
23354308|NCT01483599|65041384|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354309|NCT01483599|65041385|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
23354310|NCT01483599|65041386|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354311|NCT01483599|65041387|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354312|NCT01483599|65041388|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
23354313|NCT01483599|65041389|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354314|NCT01483599|65041390|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354315|NCT01483599|65041391|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354316|NCT01483599|65041392|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354317|NCT01483599|65041393|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354318|NCT01483599|65041394|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23354319|NCT01483599|65041395|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
23471169|NCT01994889|65470593|FG002|Overall Study|Death|38|||
23471170|NCT00001213|65470594|FG000|Overall Study|Death|18|||
23471171|NCT01657461|65470598|FG000|Overall Study|Death|9|||
23471172|NCT01657461|65470599|FG001|Overall Study|Death|12|||
23471173|NCT01657461|65470598|FG000|Overall Study|Lost to Follow-up|0|||
23471174|NCT01657461|65470599|FG001|Overall Study|Lost to Follow-up|3|||
23471175|NCT01657461|65470598|FG000|Overall Study|Physician Decision|0|||
23471176|NCT01657461|65470599|FG001|Overall Study|Physician Decision|2|||
23471177|NCT01657461|65470598|FG000|Overall Study|Withdrawal by Subject|1|||
23471178|NCT01657461|65470599|FG001|Overall Study|Withdrawal by Subject|3|||
23354320|NCT01483599|65041382|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
23471179|NCT04543279|65470602|FG000|Overall Study|Withdrawal by Subject|1|||
23471180|NCT04543279|65470603|FG001|Overall Study|Withdrawal by Subject|0|||
23471181|NCT04543279|65470602|FG000|Overall Study|Adverse Event|1|||
23471182|NCT04543279|65470603|FG001|Overall Study|Adverse Event|0|||
23471183|NCT04543279|65470602|FG000|Overall Study|Physician Decision|1|||
23248032|NCT00440193|64649181|FG001|Treatment Period|Technical problems|1|||
23248033|NCT00440193|64649180|FG000|Treatment Period|Participant convenience|5|||
23248034|NCT00440193|64649181|FG001|Treatment Period|Participant convenience|2|||
23248035|NCT00440193|64649180|FG000|Treatment Period|Participant did not receive treatment|7|||
23248036|NCT00440193|64649181|FG001|Treatment Period|Participant did not receive treatment|13|||
23248037|NCT00440193|64649180|FG000|Treatment Period|Site closed by investigator|0|||
23248038|NCT00440193|64649181|FG001|Treatment Period|Site closed by investigator|2|||
23248039|NCT00440193|64649180|FG000|Observational Period|Adverse Event|2|||
23248040|NCT00440193|64649181|FG001|Observational Period|Adverse Event|2|||
23248041|NCT00440193|64649180|FG000|Observational Period|Death|15|||
23248042|NCT00440193|64649181|FG001|Observational Period|Death|20|||
23248043|NCT00440193|64649180|FG000|Observational Period|Lost to Follow-up|12|||
23248044|NCT00440193|64649181|FG001|Observational Period|Lost to Follow-up|8|||
23248045|NCT00440193|64649180|FG000|Observational Period|Protocol Violation|1|||
23248046|NCT00440193|64649181|FG001|Observational Period|Protocol Violation|0|||
23248047|NCT00440193|64649180|FG000|Observational Period|Withdrawal by Subject|11|||
23248048|NCT00440193|64649181|FG001|Observational Period|Withdrawal by Subject|8|||
23248049|NCT00440193|64649180|FG000|Observational Period|Physician Decision|1|||
23248050|NCT00440193|64649181|FG001|Observational Period|Physician Decision|0|||
23248051|NCT00440193|64649180|FG000|Observational Period|Clinical endpoint reached|1|||
23248052|NCT00440193|64649181|FG001|Observational Period|Clinical endpoint reached|0|||
23248053|NCT00440193|64649180|FG000|Observational Period|Participant convenience|2|||
23248054|NCT00440193|64649181|FG001|Observational Period|Participant convenience|0|||
23248055|NCT03519386|64649182|FG000|Overall Study|Withdrawal by Subject|4|||
23248056|NCT03519386|64649183|FG001|Overall Study|Withdrawal by Subject|1|||
23248057|NCT03519386|64649184|FG002|Overall Study|Withdrawal by Subject|2|||
23248058|NCT03519386|64649182|FG000|Overall Study|Physician Decision|1|||
23248059|NCT03519386|64649183|FG001|Overall Study|Physician Decision|1|||
23248060|NCT03519386|64649184|FG002|Overall Study|Physician Decision|1|||
23248061|NCT03519386|64649182|FG000|Overall Study|Lost to Follow-up|0|||
23248062|NCT03519386|64649183|FG001|Overall Study|Lost to Follow-up|1|||
23248063|NCT03519386|64649184|FG002|Overall Study|Lost to Follow-up|1|||
23248064|NCT03519386|64649182|FG000|Overall Study|Death|1|||
23248065|NCT03519386|64649183|FG001|Overall Study|Death|0|||
23248066|NCT03519386|64649184|FG002|Overall Study|Death|4|||
23248067|NCT03519386|64649182|FG000|Overall Study|Adverse Event|2|||
23248068|NCT03519386|64649183|FG001|Overall Study|Adverse Event|1|||
23248069|NCT03519386|64649184|FG002|Overall Study|Adverse Event|2|||
23248070|NCT03519386|64649182|FG000|Overall Study|Explanted|2|||
23587659|NCT00217672|65879183|FG000|Follow-up|Lost to Follow-up|1|||
23587660|NCT00217672|65879184|FG001|Follow-up|Lost to Follow-up|0|||
23587661|NCT03999554|65879187|FG000|Overall Study|Lost to Follow-up|4|||
23248071|NCT03519386|64649183|FG001|Overall Study|Explanted|1|||
23248072|NCT03519386|64649184|FG002|Overall Study|Explanted|0|||
23248073|NCT03519386|64649182|FG000|Overall Study|Ongoing in study|190|||
23248074|NCT03519386|64649183|FG001|Overall Study|Ongoing in study|192|||
23248075|NCT03519386|64649184|FG002|Overall Study|Ongoing in study|183|||
23248076|NCT00359073|64649185|FG000|Overall Study|Withdrawal by Subject|1|||
23248077|NCT00359073|64649186|FG001|Overall Study|Withdrawal by Subject|1|||
23248078|NCT00359073|64649185|FG000|Overall Study|Eligibility criteria no longer met|3|||
23248079|NCT00359073|64649186|FG001|Overall Study|Eligibility criteria no longer met|0|||
23248080|NCT00359073|64649185|FG000|Overall Study|developed RV16 antibody|0|||
23248081|NCT00359073|64649186|FG001|Overall Study|developed RV16 antibody|1|||
23248082|NCT00455923|64649187|FG000|Overall Study|Pregnancy|0|||
23248083|NCT00455923|64649188|FG001|Overall Study|Pregnancy|2|||
23248084|NCT00455923|64649187|FG000|Overall Study|Other|3|||
23248085|NCT00455923|64649188|FG001|Overall Study|Other|1|||
23248086|NCT02204449|64649189|FG000|Overall Study|Lost to Follow-up|7|||
23248087|NCT02204449|64649190|FG001|Overall Study|Lost to Follow-up|9|||
23248088|NCT02204449|64649189|FG000|Overall Study|Death|0|||
23248089|NCT02204449|64649190|FG001|Overall Study|Death|1|||
23248090|NCT02204449|64649189|FG000|Overall Study|Withdrawal by Subject|0|||
23248091|NCT02204449|64649190|FG001|Overall Study|Withdrawal by Subject|1|||
23248092|NCT04764669|64649191|FG000|Overall Study|Adverse Event|1|||
23248093|NCT04764669|64649192|FG001|Overall Study|Adverse Event|0|||
23248094|NCT04764669|64649193|FG002|Overall Study|Adverse Event|1|||
23248095|NCT04764669|64649194|FG003|Overall Study|Adverse Event|0|||
23248096|NCT04764669|64649191|FG000|Overall Study|Subject Choice|0|||
23471184|NCT04543279|65470603|FG001|Overall Study|Physician Decision|0|||
23471185|NCT00530504|65470606|FG000|Overall Study|Death|54|||
23248097|NCT04764669|64649192|FG001|Overall Study|Subject Choice|0|||
23248098|NCT04764669|64649193|FG002|Overall Study|Subject Choice|1|||
23248099|NCT04764669|64649194|FG003|Overall Study|Subject Choice|0|||
23248100|NCT04764669|64649191|FG000|Overall Study|Withdrawal by Subject|2|||
23248101|NCT04764669|64649192|FG001|Overall Study|Withdrawal by Subject|0|||
23248102|NCT04764669|64649193|FG002|Overall Study|Withdrawal by Subject|0|||
23248103|NCT04764669|64649194|FG003|Overall Study|Withdrawal by Subject|0|||
23248104|NCT01525407|64649195|FG000|Overall Study|Change in recipient treatment plan|2|||
23248105|NCT01525407|64649196|FG001|Overall Study|Change in recipient treatment plan|2|||
23248106|NCT01525407|64649195|FG000|Overall Study|Withdrawal by Subject|0|||
23248107|NCT01525407|64649196|FG001|Overall Study|Withdrawal by Subject|1|||
23248108|NCT01525407|64649195|FG000|Overall Study|Transplant was delayed|0|||
23248109|NCT01525407|64649196|FG001|Overall Study|Transplant was delayed|1|||
23248110|NCT01525407|64649195|FG000|Overall Study|Delay in Transplant|1|||
23248111|NCT01525407|64649196|FG001|Overall Study|Delay in Transplant|0|||
23248112|NCT03252015|64649197|FG000|Overall Study|Withdrawal by Subject|0|||
23248113|NCT03252015|64649198|FG001|Overall Study|Withdrawal by Subject|1|||
23248114|NCT03252015|64649199|FG002|Overall Study|Withdrawal by Subject|1|||
23248115|NCT03252015|64649200|FG003|Overall Study|Withdrawal by Subject|0|||
23248116|NCT03252015|64649197|FG000|Overall Study|Adverse Event|1|||
23248117|NCT03252015|64649198|FG001|Overall Study|Adverse Event|0|||
23248118|NCT03252015|64649199|FG002|Overall Study|Adverse Event|0|||
23248119|NCT03252015|64649200|FG003|Overall Study|Adverse Event|1|||
23248120|NCT01447628|64649201|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
23248121|NCT01447628|64649202|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
23248122|NCT01447628|64649203|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
23248123|NCT01447628|64649204|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
23248124|NCT00602927|64649206|FG000|Period 1: 13 Days|Protocol Violation|2|||
23248125|NCT00602927|64649207|FG001|Period 1: 13 Days|Protocol Violation|4|||
23248126|NCT00602927|64649206|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
23248127|NCT00602927|64649207|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
23248128|NCT00602927|64649206|FG000|Period 1: 13 Days|Time|1|||
23248129|NCT00602927|64649207|FG001|Period 1: 13 Days|Time|0|||
23248130|NCT00602927|64649206|FG000|Period 1: 13 Days|Claustrophobia|0|||
23248131|NCT00602927|64649207|FG001|Period 1: 13 Days|Claustrophobia|1|||
23248132|NCT00602927|64649206|FG000|Period 2: 14 Days|Protocol Violation|0|||
23248133|NCT00602927|64649207|FG001|Period 2: 14 Days|Protocol Violation|2|||
23248134|NCT00602927|64649206|FG000|Period 3: 13 Days|Protocol Violation|0|||
23248135|NCT00602927|64649207|FG001|Period 3: 13 Days|Protocol Violation|1|||
23248136|NCT00602927|64649206|FG000|Period 3: 13 Days|MRI data quality|2|||
23248137|NCT00602927|64649207|FG001|Period 3: 13 Days|MRI data quality|2|||
23248138|NCT01976663|64649210|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
23248139|NCT01976663|64649210|FG000|Overall Study|Personal Reasons|6|||
23248140|NCT01976663|64649210|FG000|Overall Study|Withdrawal by Subject|4|||
23248141|NCT01976663|64649210|FG000|Overall Study|Screen Failure|3|||
23248142|NCT01976663|64649210|FG000|Overall Study|Adverse Event|2|||
23248143|NCT01976663|64649210|FG000|Overall Study|Lost to Follow-up|3|||
23248144|NCT00391092|64649213|FG000|Overall Study|Death|78|||
23248145|NCT00391092|64649214|FG001|Overall Study|Death|81|||
23248146|NCT00391092|64649213|FG000|Overall Study|Lost to Follow-up|13|||
23248147|NCT00391092|64649214|FG001|Overall Study|Lost to Follow-up|18|||
23248148|NCT00391092|64649213|FG000|Overall Study|Alive on treatment|29|||
23248149|NCT00391092|64649214|FG001|Overall Study|Alive on treatment|33|||
23248150|NCT00391092|64649213|FG000|Overall Study|Alive in follow-up|88|||
23248151|NCT00391092|64649214|FG001|Overall Study|Alive in follow-up|84|||
23248152|NCT01102972|64649219|FG000|Overall Study|Adverse Event|8|||
23248153|NCT01102972|64649220|FG001|Overall Study|Adverse Event|2|||
23248154|NCT01102972|64649219|FG000|Overall Study|Lack of Efficacy|2|||
23248155|NCT01102972|64649220|FG001|Overall Study|Lack of Efficacy|1|||
23248156|NCT01102972|64649219|FG000|Overall Study|Protocol Violation|1|||
23248157|NCT01102972|64649220|FG001|Overall Study|Protocol Violation|0|||
23248158|NCT01102972|64649219|FG000|Overall Study|Lost to Follow-up|10|||
23248159|NCT01102972|64649220|FG001|Overall Study|Lost to Follow-up|5|||
23248160|NCT01102972|64649219|FG000|Overall Study|Investigator Discretion|2|||
23248161|NCT01102972|64649220|FG001|Overall Study|Investigator Discretion|0|||
23248162|NCT01102972|64649219|FG000|Overall Study|Withdrawal by Subject|6|||
23248163|NCT01102972|64649220|FG001|Overall Study|Withdrawal by Subject|6|||
23248164|NCT03875235|64649221|FG000|Overall Study|Ongoing study treatment|63|||
23248165|NCT03875235|64649222|FG001|Overall Study|Ongoing study treatment|20|||
23471186|NCT00530504|65470606|FG000|Overall Study|Lost to Follow-up|26|||
23471187|NCT00530504|65470606|FG000|Overall Study|Withdrawal by Subject|39|||
23587662|NCT03999554|65879188|FG001|Overall Study|Lost to Follow-up|5|||
23587663|NCT03999554|65879189|FG002|Overall Study|Lost to Follow-up|4|||
23248166|NCT03875235|64649221|FG000|Overall Study|Off treatment|77|||
23248167|NCT03875235|64649222|FG001|Overall Study|Off treatment|91|||
23587664|NCT03999554|65879190|FG003|Overall Study|Lost to Follow-up|5|||
23248168|NCT03875235|64649221|FG000|Overall Study|Withdrawal by Subject|3|||
23248169|NCT03875235|64649222|FG001|Overall Study|Withdrawal by Subject|10|||
23248170|NCT03875235|64649221|FG000|Overall Study|Death|198|||
23248171|NCT03875235|64649222|FG001|Overall Study|Death|223|||
23248172|NCT00433771|64649225|FG000|Overall Study|screen fail|14|||
23248173|NCT00433771|64649225|FG000|Overall Study|Treated and later found to be ineligible|2|||
23248174|NCT00433771|64649225|FG000|Overall Study|Death|2|||
23248175|NCT00433771|64649225|FG000|Overall Study|Failure to deploy stent|1|||
23354321|NCT01483599|65041383|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354322|NCT01483599|65041384|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23248176|NCT00589693|64652450|FG000|Overall Study|randomized in error|12|||
23248177|NCT00589693|64652451|FG001|Overall Study|randomized in error|6|||
23248178|NCT00589693|64652450|FG000|Overall Study|Adverse Event|4|||
23248179|NCT00589693|64652451|FG001|Overall Study|Adverse Event|4|||
23248180|NCT00589693|64652450|FG000|Overall Study|Death|26|||
23248181|NCT00589693|64652451|FG001|Overall Study|Death|16|||
23248182|NCT00589693|64652450|FG000|Overall Study|Lack of Efficacy|0|||
23248183|NCT00589693|64652451|FG001|Overall Study|Lack of Efficacy|1|||
23248184|NCT00589693|64652450|FG000|Overall Study|Lost to Follow-up|1|||
23248185|NCT00589693|64652451|FG001|Overall Study|Lost to Follow-up|0|||
23248186|NCT00589693|64652450|FG000|Overall Study|Physician Decision|0|||
23248187|NCT00589693|64652451|FG001|Overall Study|Physician Decision|1|||
23587665|NCT03999554|65879191|FG004|Overall Study|Lost to Follow-up|8|||
23587666|NCT03999554|65879187|FG000|Overall Study|Protocol Violation|0|||
23248188|NCT00589693|64652450|FG000|Overall Study|Protocol Violation|1|||
23587667|NCT03999554|65879188|FG001|Overall Study|Protocol Violation|0|||
23587668|NCT03999554|65879189|FG002|Overall Study|Protocol Violation|5|||
23587669|NCT03999554|65879190|FG003|Overall Study|Protocol Violation|0|||
23587670|NCT03999554|65879191|FG004|Overall Study|Protocol Violation|0|||
23587671|NCT03999554|65879187|FG000|Overall Study|Pregnancy|0|||
23587672|NCT03999554|65879188|FG001|Overall Study|Pregnancy|0|||
23587673|NCT03999554|65879189|FG002|Overall Study|Pregnancy|1|||
23587674|NCT03999554|65879190|FG003|Overall Study|Pregnancy|0|||
23587675|NCT03999554|65879191|FG004|Overall Study|Pregnancy|0|||
23587676|NCT03999554|65879187|FG000|Overall Study|Withdrawal by Subject|2|||
23587677|NCT03999554|65879188|FG001|Overall Study|Withdrawal by Subject|2|||
23587678|NCT03999554|65879189|FG002|Overall Study|Withdrawal by Subject|2|||
23587679|NCT03999554|65879190|FG003|Overall Study|Withdrawal by Subject|1|||
23587680|NCT03999554|65879191|FG004|Overall Study|Withdrawal by Subject|1|||
23587681|NCT03999554|65879187|FG000|Overall Study|failure to comply with protocol requirements|0|||
23587682|NCT03999554|65879188|FG001|Overall Study|failure to comply with protocol requirements|0|||
23587683|NCT03999554|65879189|FG002|Overall Study|failure to comply with protocol requirements|0|||
23587684|NCT03999554|65879190|FG003|Overall Study|failure to comply with protocol requirements|1|||
23587685|NCT03999554|65879191|FG004|Overall Study|failure to comply with protocol requirements|0|||
23587686|NCT03184558|65879192|FG000|Overall Study|Withdrawal by Subject|2|||
23587687|NCT03184558|65879192|FG000|Overall Study|Death|16|||
23587688|NCT03184558|65879192|FG000|Overall Study|Lost to Follow-up|2|||
23587689|NCT03184558|65879192|FG000|Overall Study|Other|9|||
23587690|NCT02030028|65879197|FG000|Overall Study|Withdrawal by Subject|4|||
23189111|NCT00491530|64435997|FG001|Overall Study|Withdrawal by Subject|0|||
23471188|NCT00530504|65470606|FG000|Overall Study|Exited study due to other reasons|33|||
23587691|NCT02030028|65879197|FG000|Overall Study|lack of transportation|1|||
23587692|NCT04880733|65879198|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
23587693|NCT04880733|65879199|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
23189112|NCT00491530|64435998|FG002|Overall Study|Withdrawal by Subject|0|||
23248189|NCT00589693|64652451|FG001|Overall Study|Protocol Violation|1|||
23248190|NCT00567996|64652457|FG000|Overall Study|Adverse Event|18|||
23248191|NCT00567996|64652458|FG001|Overall Study|Adverse Event|16|||
23248192|NCT00567996|64652459|FG002|Overall Study|Adverse Event|13|||
23248193|NCT00567996|64652457|FG000|Overall Study|Protocol Deviation|9|||
23248194|NCT00567996|64652458|FG001|Overall Study|Protocol Deviation|11|||
23248195|NCT00567996|64652459|FG002|Overall Study|Protocol Deviation|13|||
23248196|NCT00567996|64652457|FG000|Overall Study|Withdrawal by Subject|8|||
23248197|NCT00567996|64652458|FG001|Overall Study|Withdrawal by Subject|12|||
23248198|NCT00567996|64652459|FG002|Overall Study|Withdrawal by Subject|22|||
23248199|NCT00567996|64652457|FG000|Overall Study|Abnormal Lab value(s)|2|||
23248200|NCT00567996|64652458|FG001|Overall Study|Abnormal Lab value(s)|1|||
23248201|NCT00567996|64652459|FG002|Overall Study|Abnormal Lab value(s)|2|||
23248202|NCT00567996|64652457|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23248203|NCT00567996|64652458|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23248204|NCT00567996|64652459|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23248205|NCT00567996|64652457|FG000|Overall Study|Lost to Follow-up|2|||
23248206|NCT00567996|64652458|FG001|Overall Study|Lost to Follow-up|5|||
23248207|NCT00567996|64652459|FG002|Overall Study|Lost to Follow-up|2|||
23248208|NCT00567996|64652457|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23248209|NCT00567996|64652458|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23248210|NCT00567996|64652459|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
23248211|NCT00567996|64652457|FG000|Overall Study|Administrative problems|1|||
23248212|NCT00567996|64652458|FG001|Overall Study|Administrative problems|1|||
23248213|NCT00567996|64652459|FG002|Overall Study|Administrative problems|0|||
23248214|NCT00567996|64652457|FG000|Overall Study|Death|1|||
23248215|NCT00567996|64652458|FG001|Overall Study|Death|0|||
23248216|NCT00567996|64652459|FG002|Overall Study|Death|2|||
23248217|NCT00567996|64652457|FG000|Overall Study|Patient's inability to use the device|0|||
23248218|NCT00567996|64652458|FG001|Overall Study|Patient's inability to use the device|1|||
23248219|NCT00567996|64652459|FG002|Overall Study|Patient's inability to use the device|0|||
23248220|NCT02426125|64652460|FG000|Overall Study|Lost to Follow-up|14|||
23248221|NCT02426125|64652461|FG001|Overall Study|Lost to Follow-up|12|||
23248222|NCT02426125|64652460|FG000|Overall Study|Withdrawal by Subject|13|||
23248223|NCT02426125|64652461|FG001|Overall Study|Withdrawal by Subject|14|||
23248224|NCT02426125|64652460|FG000|Overall Study|Death|185|||
23248225|NCT02426125|64652461|FG001|Overall Study|Death|200|||
23248226|NCT02426125|64652460|FG000|Overall Study|Randomized, But Never Treated|5|||
23248227|NCT02426125|64652461|FG001|Overall Study|Randomized, But Never Treated|2|||
23248228|NCT02545868|64652465|FG000|Overall Study|Lack of Efficacy|1|||
23248229|NCT02545868|64652466|FG001|Overall Study|Lack of Efficacy|1|||
23248230|NCT02545868|64652467|FG002|Overall Study|Lack of Efficacy|0|||
23354323|NCT01483599|65041385|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354324|NCT01483599|65041386|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23471189|NCT00275340|65470607|FG000|Overall Study|Lost to Follow-up|2|||
23471190|NCT00275340|65470608|FG001|Overall Study|Lost to Follow-up|4|||
23471191|NCT00548184|65470609|FG000|Overall Study|Adverse Event|3|||
23471192|NCT00548184|65470609|FG000|Overall Study|took other drug|1|||
23471193|NCT00548184|65470609|FG000|Overall Study|Found Her2 negative|1|||
23471194|NCT01788215|65470610|FG000|Overall Study|Withdrawal by Subject|0|||
23471195|NCT01788215|65470611|FG001|Overall Study|Withdrawal by Subject|1|||
23471196|NCT01788215|65470610|FG000|Overall Study|Lost to Follow-up|2|||
23471197|NCT01788215|65470611|FG001|Overall Study|Lost to Follow-up|0|||
23471198|NCT00502203|65470612|FG000|Overall Study|Inevaluable|1|||
23471199|NCT02563067|65470613|FG000|Overall Study|Subject/guardian decision|14|||
23471200|NCT02563067|65470614|FG001|Overall Study|Subject/guardian decision|20|||
23471201|NCT02563067|65470615|FG002|Overall Study|Subject/guardian decision|16|||
23471202|NCT02563067|65470613|FG000|Overall Study|Physician Decision|0|||
23471203|NCT02563067|65470614|FG001|Overall Study|Physician Decision|1|||
23471204|NCT02563067|65470615|FG002|Overall Study|Physician Decision|3|||
23471205|NCT02563067|65470613|FG000|Overall Study|Lost to Follow-up|1|||
23471206|NCT02563067|65470614|FG001|Overall Study|Lost to Follow-up|2|||
23471207|NCT02563067|65470615|FG002|Overall Study|Lost to Follow-up|0|||
23471208|NCT02563067|65470613|FG000|Overall Study|Technical problems|0|||
23471209|NCT02563067|65470614|FG001|Overall Study|Technical problems|1|||
23471210|NCT02563067|65470615|FG002|Overall Study|Technical problems|0|||
23248231|NCT02545868|64652465|FG000|Overall Study|Lost to Follow-up|1|||
23248232|NCT02545868|64652466|FG001|Overall Study|Lost to Follow-up|5|||
23354325|NCT01483599|65041387|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354326|NCT01483599|65041388|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23471211|NCT02563067|65470613|FG000|Overall Study|Lack of Efficacy|1|||
23471212|NCT02563067|65470614|FG001|Overall Study|Lack of Efficacy|0|||
23248233|NCT02545868|64652467|FG002|Overall Study|Lost to Follow-up|1|||
23248234|NCT02545868|64652465|FG000|Overall Study|Non-compliance|1|||
23248235|NCT02545868|64652466|FG001|Overall Study|Non-compliance|1|||
23354327|NCT01483599|65041389|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23471213|NCT02563067|65470615|FG002|Overall Study|Lack of Efficacy|0|||
23587694|NCT04880733|65879200|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
23587695|NCT04880733|65879198|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
23587696|NCT04880733|65879199|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
23587697|NCT04880733|65879200|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
23587698|NCT04880733|65879198|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
23587699|NCT04880733|65879199|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
23587700|NCT04880733|65879200|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
23587701|NCT04880733|65879198|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
23587702|NCT04880733|65879199|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
23587703|NCT04880733|65879200|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
23587704|NCT04880733|65879198|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
23189113|NCT00491530|64435996|FG000|Overall Study|Lost to Follow-up|3|||
23189114|NCT00491530|64435997|FG001|Overall Study|Lost to Follow-up|2|||
23189115|NCT00491530|64435998|FG002|Overall Study|Lost to Follow-up|2|||
23189116|NCT00491530|64435996|FG000|Overall Study|Lack of Efficacy|0|||
23189117|NCT00491530|64435997|FG001|Overall Study|Lack of Efficacy|1|||
23189118|NCT00491530|64435998|FG002|Overall Study|Lack of Efficacy|0|||
23189119|NCT00491530|64435996|FG000|Overall Study|Investigator Discretion|0|||
23189120|NCT00491530|64435997|FG001|Overall Study|Investigator Discretion|1|||
23189121|NCT00491530|64435998|FG002|Overall Study|Investigator Discretion|0|||
23189122|NCT00491530|64435996|FG000|Overall Study|Patient Request|0|||
23248236|NCT02545868|64652467|FG002|Overall Study|Non-compliance|1|||
23248237|NCT02545868|64652465|FG000|Overall Study|Treatment change|21|||
23248238|NCT02545868|64652466|FG001|Overall Study|Treatment change|19|||
23248239|NCT02545868|64652467|FG002|Overall Study|Treatment change|22|||
23248240|NCT02545868|64652465|FG000|Overall Study|Physician Decision|1|||
23248241|NCT02545868|64652466|FG001|Overall Study|Physician Decision|1|||
23248242|NCT02545868|64652467|FG002|Overall Study|Physician Decision|1|||
23248243|NCT02545868|64652465|FG000|Overall Study|Withdrawal by Subject|6|||
23248244|NCT02545868|64652466|FG001|Overall Study|Withdrawal by Subject|7|||
23354328|NCT01483599|65041390|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23189123|NCT00491530|64435997|FG001|Overall Study|Patient Request|1|||
23189124|NCT00491530|64435998|FG002|Overall Study|Patient Request|0|||
23189125|NCT00491530|64435996|FG000|Overall Study|Use of Prohibited Medication|0|||
23471214|NCT02563067|65470613|FG000|Overall Study|Death|0|||
23189126|NCT00491530|64435997|FG001|Overall Study|Use of Prohibited Medication|0|||
23189127|NCT00491530|64435998|FG002|Overall Study|Use of Prohibited Medication|1|||
23189128|NCT00174941|64436002|FG000|Overall Study|Adverse Event|1|||
23189129|NCT00174941|64436003|FG001|Overall Study|Adverse Event|10|||
23189130|NCT00174941|64436004|FG002|Overall Study|Adverse Event|2|||
23248245|NCT02545868|64652467|FG002|Overall Study|Withdrawal by Subject|9|||
23471215|NCT02563067|65470614|FG001|Overall Study|Death|1|||
23471216|NCT02563067|65470615|FG002|Overall Study|Death|1|||
23471217|NCT02563067|65470613|FG000|Overall Study|Adverse Event|2|||
23471218|NCT02563067|65470614|FG001|Overall Study|Adverse Event|1|||
23471219|NCT02563067|65470615|FG002|Overall Study|Adverse Event|0|||
23471220|NCT02563067|65470613|FG000|Overall Study|Death post Treatment/safety period|1|||
23471221|NCT02563067|65470614|FG001|Overall Study|Death post Treatment/safety period|0|||
23471222|NCT02563067|65470615|FG002|Overall Study|Death post Treatment/safety period|0|||
23471223|NCT01915303|65470616|FG000|Core Phase|Adverse Event|7|||
23471224|NCT01915303|65470616|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
23471225|NCT01915303|65470616|FG000|Core Phase|Death|2|||
23471226|NCT01915303|65470616|FG000|Core Phase|Protocol Violation|2|||
23471227|NCT01915303|65470616|FG000|Core Phase|Abnormal lab value|1|||
23587705|NCT04880733|65879199|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
23587706|NCT04880733|65879200|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
23587707|NCT04072822|65879201|FG000|Treatment|Adverse Event|9|||
23189131|NCT00174941|64436005|FG003|Overall Study|Adverse Event|13|||
23189132|NCT00174941|64436002|FG000|Overall Study|Protocol Violation|0|||
23189133|NCT00174941|64436003|FG001|Overall Study|Protocol Violation|1|||
23189134|NCT00174941|64436004|FG002|Overall Study|Protocol Violation|0|||
23189135|NCT00174941|64436005|FG003|Overall Study|Protocol Violation|1|||
23189136|NCT00174941|64436002|FG000|Overall Study|Lost to Follow-up|0|||
23248246|NCT02531698|64652468|FG000|Overall Study|Adverse Event|2|||
23248247|NCT02531698|64652469|FG001|Overall Study|Adverse Event|1|||
23248248|NCT02531698|64652468|FG000|Overall Study|Withdrawal by Subject|6|||
23471228|NCT01915303|65470616|FG000|Core Phase|Withdrawal by Subject|1|||
23354329|NCT01483599|65041391|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354330|NCT01483599|65041392|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354331|NCT01483599|65041393|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354332|NCT01483599|65041394|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354333|NCT01483599|65041395|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
23354334|NCT01483599|65041382|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
23354335|NCT01483599|65041383|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
23354336|NCT01483599|65041384|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
23354337|NCT01483599|65041385|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
23354338|NCT01483599|65041386|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
23354339|NCT01483599|65041387|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
23354340|NCT01483599|65041388|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
23354341|NCT01483599|65041389|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
23354342|NCT01483599|65041390|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
23354343|NCT01483599|65041391|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
23354344|NCT01483599|65041392|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
23354345|NCT01483599|65041393|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
23354346|NCT01483599|65041394|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
23354347|NCT01483599|65041395|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
23354348|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
23354349|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
23354350|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
23354351|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
23354352|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
23354353|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
23354354|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
23354355|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
23354356|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
23354357|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
23354358|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
23354359|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
23354360|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
23354361|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
23354362|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354363|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354364|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354365|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354366|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354367|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354368|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354369|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
23354370|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
23354371|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354372|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354373|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
23354374|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
23354375|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
23354376|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354377|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354378|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354379|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354380|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354381|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354382|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23471229|NCT01915303|65470616|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
23471230|NCT01915303|65470616|FG000|Extension Phase|Withdrawal by Subject|4|||
23248249|NCT02531698|64652469|FG001|Overall Study|Withdrawal by Subject|1|||
23248250|NCT02531698|64652468|FG000|Overall Study|Protocol Violation|2|||
23248251|NCT02531698|64652469|FG001|Overall Study|Protocol Violation|0|||
23248252|NCT02531698|64652468|FG000|Overall Study|Lost to Follow-up|1|||
23248253|NCT02531698|64652469|FG001|Overall Study|Lost to Follow-up|0|||
23248254|NCT00981019|64652472|FG000|Overall Study|Did not respond|65|||
23248255|NCT00981019|64652472|FG000|Overall Study|Did not match target population|94|||
23248256|NCT00981019|64652472|FG000|Overall Study|Inadvertent exclusion|239|||
23248257|NCT00981019|64652472|FG000|Overall Study|Hit the survey after closure|79|||
23471231|NCT01915303|65470616|FG000|Extension Phase|Adverse Event|3|||
23471232|NCT01915303|65470616|FG000|Extension Phase|Death|1|||
23248258|NCT01467570|64652473|FG000|Overall Study|Lost to Follow-up|8|||
23248259|NCT01467570|64652474|FG001|Overall Study|Lost to Follow-up|9|||
23189137|NCT00174941|64436003|FG001|Overall Study|Lost to Follow-up|3|||
23189138|NCT00174941|64436004|FG002|Overall Study|Lost to Follow-up|2|||
23189139|NCT00174941|64436005|FG003|Overall Study|Lost to Follow-up|5|||
23189140|NCT00174941|64436002|FG000|Overall Study|Personal Reason(s)|0|||
23189141|NCT00174941|64436003|FG001|Overall Study|Personal Reason(s)|14|||
23189142|NCT00174941|64436004|FG002|Overall Study|Personal Reason(s)|8|||
23189143|NCT00174941|64436005|FG003|Overall Study|Personal Reason(s)|22|||
23189144|NCT00174941|64436002|FG000|Overall Study|Gout Flare|0|||
23189145|NCT00174941|64436003|FG001|Overall Study|Gout Flare|4|||
23189146|NCT00174941|64436004|FG002|Overall Study|Gout Flare|4|||
23189147|NCT00174941|64436005|FG003|Overall Study|Gout Flare|8|||
23189148|NCT00174941|64436002|FG000|Overall Study|Reason Not Specified|1|||
23189149|NCT00174941|64436003|FG001|Overall Study|Reason Not Specified|6|||
23189150|NCT00174941|64436004|FG002|Overall Study|Reason Not Specified|2|||
23189151|NCT00174941|64436005|FG003|Overall Study|Reason Not Specified|9|||
23189152|NCT01981187|64436008|FG000|Overall Study|Participant/guardian decision|2|||
23189153|NCT01981187|64436008|FG000|Overall Study|Physician Decision|1|||
23189154|NCT01981187|64436008|FG000|Overall Study|Disease progression|2|||
23189155|NCT01981187|64436008|FG000|Overall Study|Adverse Event|7|||
23189156|NCT01480180|64436009|FG000|Main Phase|Withdrawal criteria|12|||
23189157|NCT01480180|64436010|FG001|Main Phase|Withdrawal criteria|1|||
23189158|NCT01480180|64436011|FG002|Main Phase|Withdrawal criteria|0|||
23189159|NCT01480180|64436012|FG003|Main Phase|Withdrawal criteria|0|||
23189160|NCT01480180|64436013|FG004|Main Phase|Withdrawal criteria|0|||
23189161|NCT01480180|64436014|FG005|Main Phase|Withdrawal criteria|0|||
23189162|NCT01480180|64436009|FG000|Main Phase|Lack of Efficacy|1|||
23189163|NCT01480180|64436010|FG001|Main Phase|Lack of Efficacy|0|||
23189164|NCT01480180|64436011|FG002|Main Phase|Lack of Efficacy|0|||
23189165|NCT01480180|64436012|FG003|Main Phase|Lack of Efficacy|0|||
23189166|NCT01480180|64436013|FG004|Main Phase|Lack of Efficacy|0|||
23189167|NCT01480180|64436014|FG005|Main Phase|Lack of Efficacy|0|||
23189168|NCT01480180|64436009|FG000|Main Phase|Non-compliance|3|||
23189169|NCT01480180|64436010|FG001|Main Phase|Non-compliance|0|||
23189170|NCT01480180|64436011|FG002|Main Phase|Non-compliance|0|||
23189171|NCT01480180|64436012|FG003|Main Phase|Non-compliance|0|||
23189172|NCT01480180|64436013|FG004|Main Phase|Non-compliance|0|||
23189173|NCT01480180|64436014|FG005|Main Phase|Non-compliance|0|||
23189174|NCT01480180|64436009|FG000|Main Phase|Unclassified|3|||
23189175|NCT01480180|64436010|FG001|Main Phase|Unclassified|0|||
23189176|NCT01480180|64436011|FG002|Main Phase|Unclassified|0|||
23189177|NCT01480180|64436012|FG003|Main Phase|Unclassified|0|||
23189178|NCT01480180|64436013|FG004|Main Phase|Unclassified|0|||
23189179|NCT01480180|64436014|FG005|Main Phase|Unclassified|0|||
23189180|NCT01480180|64436009|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
23189181|NCT01480180|64436010|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
23189182|NCT01480180|64436011|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
23189183|NCT01480180|64436012|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
23189184|NCT01480180|64436013|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
23189185|NCT01480180|64436014|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
23189186|NCT01480180|64436009|FG000|Extension Phase, Part 1|Unclassified|0|||
23189187|NCT01480180|64436010|FG001|Extension Phase, Part 1|Unclassified|0|||
23189188|NCT01480180|64436011|FG002|Extension Phase, Part 1|Unclassified|1|||
23189189|NCT01480180|64436012|FG003|Extension Phase, Part 1|Unclassified|0|||
23189190|NCT01480180|64436013|FG004|Extension Phase, Part 1|Unclassified|0|||
23189191|NCT01480180|64436014|FG005|Extension Phase, Part 1|Unclassified|0|||
23248260|NCT00817778|64652480|FG000|Overall Study|Adverse Event|1|||
23248261|NCT00817778|64652481|FG001|Overall Study|Adverse Event|0|||
23248262|NCT00817778|64652480|FG000|Overall Study|Withdrawal by Subject|1|||
23248263|NCT00817778|64652481|FG001|Overall Study|Withdrawal by Subject|1|||
23248264|NCT00817778|64652480|FG000|Overall Study|Protocol Violation|0|||
23248265|NCT00817778|64652481|FG001|Overall Study|Protocol Violation|1|||
23248266|NCT00817778|64652480|FG000|Overall Study|Study-specific discontinuation criteria|0|||
23248267|NCT00817778|64652481|FG001|Overall Study|Study-specific discontinuation criteria|1|||
23471233|NCT01915303|65470616|FG000|Extension Phase|Protocol Violation|1|||
23189192|NCT01480180|64436009|FG000|Extension Phase, Part 1|Adverse Event|0|||
23189193|NCT01480180|64436010|FG001|Extension Phase, Part 1|Adverse Event|0|||
23189194|NCT01480180|64436011|FG002|Extension Phase, Part 1|Adverse Event|4|||
23189195|NCT01480180|64436012|FG003|Extension Phase, Part 1|Adverse Event|1|||
23471234|NCT02175199|65470617|FG000|Overall Study|Withdrawal by Subject|1|||
23189196|NCT01480180|64436013|FG004|Extension Phase, Part 1|Adverse Event|0|||
23189197|NCT01480180|64436014|FG005|Extension Phase, Part 1|Adverse Event|0|||
23189198|NCT01480180|64436009|FG000|Extension Phase, Part 1|Change of treatment|0|||
23189199|NCT01480180|64436010|FG001|Extension Phase, Part 1|Change of treatment|0|||
23248268|NCT00817778|64652480|FG000|Overall Study|Poor venous access|1|||
23248269|NCT00817778|64652481|FG001|Overall Study|Poor venous access|0|||
23354383|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354384|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
23354385|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354386|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354387|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
23354388|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
23354389|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
23189200|NCT01480180|64436011|FG002|Extension Phase, Part 1|Change of treatment|0|||
23189201|NCT01480180|64436012|FG003|Extension Phase, Part 1|Change of treatment|9|||
23189202|NCT01480180|64436013|FG004|Extension Phase, Part 1|Change of treatment|0|||
23248270|NCT00557830|64652491|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
23354390|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354391|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354392|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354393|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354394|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354395|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354396|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354397|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354398|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
23354399|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354400|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
23354401|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354402|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
23354403|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
23354404|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354405|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354406|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23587708|NCT04072822|65879202|FG001|Treatment|Adverse Event|5|||
23587709|NCT04072822|65879201|FG000|Treatment|Met Stopping Criteria|13|||
23587710|NCT04072822|65879202|FG001|Treatment|Met Stopping Criteria|24|||
23587711|NCT04072822|65879201|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
23587712|NCT04072822|65879202|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
23587713|NCT04072822|65879201|FG000|Treatment|Withdrawal by Subject|0|||
23587714|NCT04072822|65879202|FG001|Treatment|Withdrawal by Subject|2|||
23587715|NCT04072822|65879201|FG000|Treatment|Death|0|||
23587716|NCT04072822|65879202|FG001|Treatment|Death|2|||
23587717|NCT04072822|65879201|FG000|Treatment|Lost to Follow-up|11|||
23587718|NCT04072822|65879202|FG001|Treatment|Lost to Follow-up|3|||
23587719|NCT04072822|65879201|FG000|Treatment|Physician Decision|1|||
23587720|NCT04072822|65879202|FG001|Treatment|Physician Decision|0|||
23587721|NCT04072822|65879201|FG000|Treatment|Other|7|||
23587722|NCT04072822|65879202|FG001|Treatment|Other|9|||
23189203|NCT01480180|64436014|FG005|Extension Phase, Part 1|Change of treatment|0|||
23189204|NCT01480180|64436009|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
23189205|NCT01480180|64436010|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
23189206|NCT01480180|64436011|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
23189207|NCT01480180|64436012|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
23189208|NCT01480180|64436013|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
23189209|NCT01480180|64436014|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
23189210|NCT01480180|64436009|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
23189211|NCT01480180|64436010|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
23189212|NCT01480180|64436011|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
23189213|NCT01480180|64436012|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
23189214|NCT01480180|64436013|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
23248271|NCT00557830|64652492|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
23248272|NCT00557830|64652493|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
23587723|NCT04072822|65879201|FG000|Follow-up|Withdrawal by Subject|1|||
23587724|NCT04072822|65879202|FG001|Follow-up|Withdrawal by Subject|0|||
23189215|NCT01480180|64436014|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
23189216|NCT01480180|64436009|FG000|Extension Phase, Part 2|Unclassified|0|||
23189217|NCT01480180|64436010|FG001|Extension Phase, Part 2|Unclassified|0|||
23189218|NCT01480180|64436011|FG002|Extension Phase, Part 2|Unclassified|3|||
23189219|NCT01480180|64436012|FG003|Extension Phase, Part 2|Unclassified|1|||
23189220|NCT01480180|64436013|FG004|Extension Phase, Part 2|Unclassified|1|||
23189221|NCT01480180|64436014|FG005|Extension Phase, Part 2|Unclassified|0|||
23189222|NCT01273818|64436018|FG000|Overall Study|Physician Decision|13|||
23189223|NCT01273818|64436019|FG001|Overall Study|Physician Decision|2|||
23189224|NCT01273818|64436020|FG002|Overall Study|Physician Decision|9|||
23189225|NCT01040832|64436021|FG000|Overall Study|Adverse Event|4|||
23189226|NCT01040832|64436022|FG001|Overall Study|Adverse Event|5|||
23189227|NCT01040832|64436021|FG000|Overall Study|Death|4|||
23189228|NCT01040832|64436022|FG001|Overall Study|Death|6|||
23189229|NCT01040832|64436021|FG000|Overall Study|Withdrawal by Subject|2|||
23189230|NCT01040832|64436022|FG001|Overall Study|Withdrawal by Subject|3|||
23189231|NCT01040832|64436021|FG000|Overall Study|Progressive disease|32|||
23189232|NCT01040832|64436022|FG001|Overall Study|Progressive disease|17|||
23189233|NCT01040832|64436021|FG000|Overall Study|Symptomatic deterioration|2|||
23189234|NCT01040832|64436022|FG001|Overall Study|Symptomatic deterioration|5|||
23189235|NCT01040832|64436021|FG000|Overall Study|Other|2|||
23248273|NCT00557830|64652491|FG000|Screening Treatment Phase|Adverse Event|2|||
23248274|NCT00557830|64652492|FG001|Screening Treatment Phase|Adverse Event|0|||
23248275|NCT00557830|64652493|FG002|Screening Treatment Phase|Adverse Event|0|||
23248276|NCT00557830|64652491|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
23248277|NCT00557830|64652492|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
23248278|NCT00557830|64652493|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
23248279|NCT02886494|64652494|FG000|Overall Study|Adverse Event|1|||
23354407|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354408|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354409|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354410|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354411|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354412|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
23354413|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354414|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354415|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
23354416|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
23354417|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
23354418|NCT01483599|65041382|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
23354419|NCT01483599|65041383|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
23354420|NCT01483599|65041384|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
23354421|NCT01483599|65041385|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
23248280|NCT02886494|64652495|FG001|Overall Study|Adverse Event|0|||
23248281|NCT02886494|64652494|FG000|Overall Study|Withdrawal by Subject|12|||
23248282|NCT02886494|64652495|FG001|Overall Study|Withdrawal by Subject|3|||
23248283|NCT02886494|64652494|FG000|Overall Study|Protocol Violation|4|||
23248284|NCT02886494|64652495|FG001|Overall Study|Protocol Violation|1|||
23248285|NCT00960687|64652496|FG000|Washout Period of 7 Days|Adverse Event|3|||
23354422|NCT01483599|65041386|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
23354423|NCT01483599|65041387|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
23354424|NCT01483599|65041388|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
23354425|NCT01483599|65041389|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
23354426|NCT01483599|65041390|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
23354427|NCT01483599|65041391|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
23354428|NCT01483599|65041392|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
23354429|NCT01483599|65041393|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
23354430|NCT01483599|65041394|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
23354431|NCT01483599|65041395|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
23354432|NCT03268005|65041399|FG000|Overall Study|Death|2|||
23354433|NCT03268005|65041400|FG001|Overall Study|Death|1|||
23354434|NCT03268005|65041399|FG000|Overall Study|Lost to Follow-up|2|||
23354435|NCT03268005|65041400|FG001|Overall Study|Lost to Follow-up|2|||
23354436|NCT03268005|65041399|FG000|Overall Study|Withdrawal by Subject|11|||
23471235|NCT02175199|65470618|FG001|Overall Study|Withdrawal by Subject|5|||
23189236|NCT01040832|64436022|FG001|Overall Study|Other|1|||
23189237|NCT00500071|64436025|FG000|Screening and Washout Phase|Protocol Violation|1|||
23189238|NCT00500071|64436025|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
23189239|NCT00500071|64436025|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
23354437|NCT03268005|65041400|FG001|Overall Study|Withdrawal by Subject|11|||
23354438|NCT01935128|65041401|FG000|Overall Study|Death|1|||
23248286|NCT00960687|64652497|FG001|Washout Period of 7 Days|Adverse Event|2|||
23248287|NCT00960687|64652496|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
23471236|NCT02175199|65470617|FG000|Overall Study|Randomized in Error|1|||
23471237|NCT02175199|65470618|FG001|Overall Study|Randomized in Error|0|||
23471238|NCT02175199|65470617|FG000|Overall Study|Sponsor Decision|1|||
23471239|NCT02175199|65470618|FG001|Overall Study|Sponsor Decision|0|||
23471240|NCT03214666|65470627|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471241|NCT03214666|65470628|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471242|NCT03214666|65470629|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471243|NCT03214666|65470630|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471244|NCT03214666|65470631|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
23471245|NCT03214666|65470632|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
23471246|NCT00314795|65470633|FG000|Overall Study|Adverse Event|8|||
23471247|NCT00314795|65470633|FG000|Overall Study|Death|4|||
23471248|NCT00314795|65470633|FG000|Overall Study|Reason not Specified|3|||
23471249|NCT00314795|65470633|FG000|Overall Study|Renal Transplant|3|||
23471250|NCT00314795|65470633|FG000|Overall Study|Participants Withdrew Consent|2|||
23471251|NCT02100696|65470634|FG000|Induction Phase|Adverse Event|0|||
23471252|NCT02100696|65470635|FG001|Induction Phase|Adverse Event|0|||
23471253|NCT02100696|65470636|FG002|Induction Phase|Adverse Event|1|||
23471254|NCT02100696|65470637|FG003|Induction Phase|Adverse Event|0|||
23471255|NCT02100696|65470638|FG004|Induction Phase|Adverse Event|0|||
23471256|NCT02100696|65470639|FG005|Induction Phase|Adverse Event|0|||
23471257|NCT02100696|65470634|FG000|Induction Phase|Lost to Follow-up|1|||
23471258|NCT02100696|65470635|FG001|Induction Phase|Lost to Follow-up|0|||
23471259|NCT02100696|65470636|FG002|Induction Phase|Lost to Follow-up|1|||
23471260|NCT02100696|65470637|FG003|Induction Phase|Lost to Follow-up|0|||
23471261|NCT02100696|65470638|FG004|Induction Phase|Lost to Follow-up|0|||
23471262|NCT02100696|65470639|FG005|Induction Phase|Lost to Follow-up|0|||
23471263|NCT02100696|65470634|FG000|Induction Phase|Protocol Violation|0|||
23471264|NCT02100696|65470635|FG001|Induction Phase|Protocol Violation|1|||
23471265|NCT02100696|65470636|FG002|Induction Phase|Protocol Violation|1|||
23471266|NCT02100696|65470637|FG003|Induction Phase|Protocol Violation|0|||
23471267|NCT02100696|65470638|FG004|Induction Phase|Protocol Violation|0|||
23471268|NCT02100696|65470639|FG005|Induction Phase|Protocol Violation|0|||
23471269|NCT02100696|65470634|FG000|Induction Phase|Withdrawal by Subject|8|||
23471270|NCT02100696|65470635|FG001|Induction Phase|Withdrawal by Subject|2|||
23471271|NCT02100696|65470636|FG002|Induction Phase|Withdrawal by Subject|13|||
23471272|NCT02100696|65470637|FG003|Induction Phase|Withdrawal by Subject|0|||
23471273|NCT02100696|65470638|FG004|Induction Phase|Withdrawal by Subject|0|||
23471274|NCT02100696|65470639|FG005|Induction Phase|Withdrawal by Subject|0|||
23471275|NCT02100696|65470634|FG000|Induction Phase|Physician Decision|1|||
23471276|NCT02100696|65470635|FG001|Induction Phase|Physician Decision|0|||
23471277|NCT02100696|65470636|FG002|Induction Phase|Physician Decision|2|||
23471278|NCT02100696|65470637|FG003|Induction Phase|Physician Decision|0|||
23471279|NCT02100696|65470638|FG004|Induction Phase|Physician Decision|0|||
23471280|NCT02100696|65470639|FG005|Induction Phase|Physician Decision|0|||
23471281|NCT02100696|65470634|FG000|Induction Phase|Multiple Reasons|5|||
23471282|NCT02100696|65470635|FG001|Induction Phase|Multiple Reasons|2|||
23471283|NCT02100696|65470636|FG002|Induction Phase|Multiple Reasons|8|||
23471284|NCT02100696|65470637|FG003|Induction Phase|Multiple Reasons|0|||
23471285|NCT02100696|65470638|FG004|Induction Phase|Multiple Reasons|0|||
23471286|NCT02100696|65470639|FG005|Induction Phase|Multiple Reasons|0|||
23471287|NCT02100696|65470634|FG000|Maintenance Phase|Adverse Event|0|||
23471288|NCT02100696|65470635|FG001|Maintenance Phase|Adverse Event|0|||
23471289|NCT02100696|65470636|FG002|Maintenance Phase|Adverse Event|0|||
23471290|NCT02100696|65470637|FG003|Maintenance Phase|Adverse Event|0|||
23471291|NCT02100696|65470638|FG004|Maintenance Phase|Adverse Event|0|||
23471292|NCT02100696|65470639|FG005|Maintenance Phase|Adverse Event|2|||
23471293|NCT02100696|65470634|FG000|Maintenance Phase|Lost to Follow-up|0|||
23587725|NCT04072822|65879201|FG000|Follow-up|Lost to Follow-up|5|||
23587726|NCT04072822|65879202|FG001|Follow-up|Lost to Follow-up|4|||
23587727|NCT01909336|65879208|FG000|Overall Study|Lost to Follow-up|4|||
23587728|NCT01909336|65879209|FG001|Overall Study|Lost to Follow-up|2|||
23587729|NCT01909336|65879210|FG002|Overall Study|Lost to Follow-up|2|||
23587730|NCT01909336|65879208|FG000|Overall Study|Physician Decision|0|||
23587731|NCT01909336|65879209|FG001|Overall Study|Physician Decision|1|||
23471294|NCT02100696|65470635|FG001|Maintenance Phase|Lost to Follow-up|0|||
23471295|NCT02100696|65470636|FG002|Maintenance Phase|Lost to Follow-up|0|||
23587732|NCT01909336|65879210|FG002|Overall Study|Physician Decision|1|||
23587733|NCT03179787|65879211|FG000|Overall Study|Lost to Follow-up|15|||
23587734|NCT03179787|65879211|FG000|Overall Study|Case report failures|2|||
23587735|NCT03179787|65879211|FG000|Overall Study|Treatment not administered|1|||
23587736|NCT02918968|65879219|FG000|1st Line AAT|Progressive disease|9|||
23471296|NCT02100696|65470637|FG003|Maintenance Phase|Lost to Follow-up|0|||
23471297|NCT02100696|65470638|FG004|Maintenance Phase|Lost to Follow-up|1|||
23471298|NCT02100696|65470639|FG005|Maintenance Phase|Lost to Follow-up|0|||
23471299|NCT02100696|65470634|FG000|Maintenance Phase|Protocol Violation|0|||
23248288|NCT00960687|64652497|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23248289|NCT03387735|64652499|FG000|Overall Study|Lost to Follow-up|4|||
23248290|NCT03387735|64652500|FG001|Overall Study|Lost to Follow-up|8|||
23248291|NCT03387735|64652499|FG000|Overall Study|Death|4|||
23248292|NCT03387735|64652500|FG001|Overall Study|Death|8|||
23248293|NCT02487979|64652501|FG000|Overall Study|Physician Decision|2|||
23248294|NCT02487979|64652501|FG000|Overall Study|Withdrawal by Subject|2|||
23248295|NCT02487979|64652501|FG000|Overall Study|Progressive Disease|17|||
23248296|NCT03869684|64652502|FG000|Overall Study|Adverse Event|0|||
23248297|NCT03869684|64652503|FG001|Overall Study|Adverse Event|3|||
23354439|NCT01935128|65041401|FG000|Overall Study|Adverse Event|6|||
23354440|NCT04702997|65041402|FG000|Overall Study|Withdrawal by Subject|1|||
23354441|NCT04702997|65041403|FG001|Overall Study|Withdrawal by Subject|1|||
23354442|NCT01870297|65041406|FG000|Overall Study|Adverse Event|0|||
23354443|NCT01870297|65041407|FG001|Overall Study|Adverse Event|0|||
23354444|NCT01870297|65041408|FG002|Overall Study|Adverse Event|0|||
23354445|NCT01870297|65041409|FG003|Overall Study|Adverse Event|0|||
23354446|NCT01870297|65041410|FG004|Overall Study|Adverse Event|2|||
23354447|NCT01870297|65041411|FG005|Overall Study|Adverse Event|0|||
23354448|NCT01870297|65041412|FG006|Overall Study|Adverse Event|0|||
23354449|NCT01870297|65041406|FG000|Overall Study|Lost to Follow-up|0|||
23471300|NCT02100696|65470635|FG001|Maintenance Phase|Protocol Violation|0|||
23471301|NCT02100696|65470636|FG002|Maintenance Phase|Protocol Violation|0|||
23471302|NCT02100696|65470637|FG003|Maintenance Phase|Protocol Violation|0|||
23471303|NCT02100696|65470638|FG004|Maintenance Phase|Protocol Violation|1|||
23471304|NCT02100696|65470639|FG005|Maintenance Phase|Protocol Violation|0|||
23471305|NCT02100696|65470634|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23471306|NCT02100696|65470635|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23471307|NCT02100696|65470636|FG002|Maintenance Phase|Withdrawal by Subject|0|||
23471308|NCT02100696|65470637|FG003|Maintenance Phase|Withdrawal by Subject|1|||
23471309|NCT02100696|65470638|FG004|Maintenance Phase|Withdrawal by Subject|4|||
23471310|NCT02100696|65470639|FG005|Maintenance Phase|Withdrawal by Subject|2|||
23471311|NCT02100696|65470634|FG000|Maintenance Phase|Physician Decision|0|||
23471312|NCT02100696|65470635|FG001|Maintenance Phase|Physician Decision|0|||
23471313|NCT02100696|65470636|FG002|Maintenance Phase|Physician Decision|0|||
23471314|NCT02100696|65470637|FG003|Maintenance Phase|Physician Decision|0|||
23471315|NCT02100696|65470638|FG004|Maintenance Phase|Physician Decision|1|||
23471316|NCT02100696|65470639|FG005|Maintenance Phase|Physician Decision|0|||
23587737|NCT02918968|65879220|FG001|1st Line AAT|Progressive disease|4|||
23587738|NCT02918968|65879219|FG000|1st Line AAT|Adverse Event|12|||
23587739|NCT02918968|65879220|FG001|1st Line AAT|Adverse Event|3|||
23354450|NCT01870297|65041407|FG001|Overall Study|Lost to Follow-up|1|||
23471317|NCT02100696|65470634|FG000|Maintenance Phase|Multiple Reasons|0|||
23471318|NCT02100696|65470635|FG001|Maintenance Phase|Multiple Reasons|0|||
23471319|NCT02100696|65470636|FG002|Maintenance Phase|Multiple Reasons|0|||
23587740|NCT02918968|65879219|FG000|1st Line AAT|Physician Decision|4|||
23587741|NCT02918968|65879220|FG001|1st Line AAT|Physician Decision|2|||
23587742|NCT02918968|65879219|FG000|1st Line AAT|Withdrawal by Subject|2|||
23587743|NCT02918968|65879220|FG001|1st Line AAT|Withdrawal by Subject|1|||
23587744|NCT02918968|65879219|FG000|1st Line AAT|Lost to Follow-up|0|||
23587745|NCT02918968|65879220|FG001|1st Line AAT|Lost to Follow-up|1|||
23587746|NCT02918968|65879219|FG000|1st Line AAT|Death|1|||
23587747|NCT02918968|65879220|FG001|1st Line AAT|Death|0|||
23248298|NCT03869684|64652504|FG002|Overall Study|Adverse Event|1|||
23354451|NCT01870297|65041408|FG002|Overall Study|Lost to Follow-up|1|||
23354452|NCT01870297|65041409|FG003|Overall Study|Lost to Follow-up|0|||
23587748|NCT02918968|65879219|FG000|1st Line AAT|Miscellaneous|1|||
23587749|NCT02918968|65879220|FG001|1st Line AAT|Miscellaneous|0|||
23248299|NCT03869684|64652502|FG000|Overall Study|Withdrawal by Subject|1|||
23248300|NCT03869684|64652503|FG001|Overall Study|Withdrawal by Subject|0|||
23248301|NCT03869684|64652504|FG002|Overall Study|Withdrawal by Subject|0|||
23354453|NCT01870297|65041410|FG004|Overall Study|Lost to Follow-up|0|||
23471320|NCT02100696|65470637|FG003|Maintenance Phase|Multiple Reasons|0|||
23471321|NCT02100696|65470638|FG004|Maintenance Phase|Multiple Reasons|2|||
23471322|NCT02100696|65470639|FG005|Maintenance Phase|Multiple Reasons|1|||
23248302|NCT03869684|64652502|FG000|Overall Study|Lost to Follow-up|1|||
23248303|NCT03869684|64652503|FG001|Overall Study|Lost to Follow-up|0|||
23248304|NCT03869684|64652504|FG002|Overall Study|Lost to Follow-up|0|||
23248305|NCT03869684|64652502|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
23248306|NCT03869684|64652503|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
23248307|NCT03869684|64652504|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
23248308|NCT03069365|64652508|FG000|Overall Study|Adverse Event|1|||
23248309|NCT02392559|64652511|FG000|Overall Study|Withdrawal by Subject|0|||
23248310|NCT02392559|64652512|FG001|Overall Study|Withdrawal by Subject|1|||
23248311|NCT01311505|64652514|FG000|First Intervention Period|Protocol Violation|0|||
23248312|NCT01311505|64652515|FG001|First Intervention Period|Protocol Violation|1|||
23248313|NCT01741259|64652516|FG000|Overall Study|Protocol Violation|6|||
23248314|NCT01741259|64652517|FG001|Overall Study|Protocol Violation|4|||
23248315|NCT01741259|64652516|FG000|Overall Study|Withdrawal by Subject|0|||
23248316|NCT01741259|64652517|FG001|Overall Study|Withdrawal by Subject|2|||
23248317|NCT01491737|64652520|FG000|Overall Study|Withdrawal by Subject|20|||
23248318|NCT01491737|64652521|FG001|Overall Study|Withdrawal by Subject|17|||
23248319|NCT01491737|64652520|FG000|Overall Study|Lost to Follow-up|2|||
23248320|NCT01491737|64652521|FG001|Overall Study|Lost to Follow-up|10|||
23248321|NCT01491737|64652520|FG000|Overall Study|Death|63|||
23248322|NCT01491737|64652521|FG001|Overall Study|Death|57|||
23248323|NCT01491737|64652520|FG000|Overall Study|Study Termination by Sponsor|36|||
23248324|NCT01491737|64652521|FG001|Overall Study|Study Termination by Sponsor|36|||
23248325|NCT01491737|64652520|FG000|Overall Study|Reason Not Specified|8|||
23248326|NCT01491737|64652521|FG001|Overall Study|Reason Not Specified|9|||
23248327|NCT03079869|64652529|FG000|Overall Study|Adverse Event|6|||
23248328|NCT03079869|64652530|FG001|Overall Study|Adverse Event|8|||
23248329|NCT03079869|64652529|FG000|Overall Study|Withdrawal by Subject|4|||
23248330|NCT03079869|64652530|FG001|Overall Study|Withdrawal by Subject|1|||
23471323|NCT02238080|65470642|FG000|Overall Study|Death|13|||
23471324|NCT02238080|65470642|FG000|Overall Study|Treatment interrupted|6|||
23471325|NCT02238080|65470642|FG000|Overall Study|Withdrawal by Subject|2|||
23471326|NCT02238080|65470642|FG000|Overall Study|Other|4|||
23471327|NCT02302339|65470643|FG000|Overall Study|Lost to Follow-up|1|||
23471328|NCT02302339|65470644|FG001|Overall Study|Lost to Follow-up|0|||
23471329|NCT02302339|65470645|FG002|Overall Study|Lost to Follow-up|0|||
23471330|NCT02302339|65470646|FG003|Overall Study|Lost to Follow-up|0|||
23471331|NCT02302339|65470643|FG000|Overall Study|Withdrawal by Subject|0|||
23471332|NCT02302339|65470644|FG001|Overall Study|Withdrawal by Subject|2|||
23471333|NCT02302339|65470645|FG002|Overall Study|Withdrawal by Subject|1|||
23471334|NCT02302339|65470646|FG003|Overall Study|Withdrawal by Subject|0|||
23471335|NCT00373113|65470650|FG000|Overall Study|Death|1|||
23471336|NCT00373113|65470651|FG001|Overall Study|Death|7|||
23471337|NCT00373113|65470650|FG000|Overall Study|Adverse Event|38|||
23471338|NCT00373113|65470651|FG001|Overall Study|Adverse Event|24|||
23471339|NCT00373113|65470650|FG000|Overall Study|Study terminated by sponsor|9|||
23471340|NCT00373113|65470651|FG001|Overall Study|Study terminated by sponsor|1|||
23471341|NCT00373113|65470650|FG000|Overall Study|Global deterioration of health status|10|||
23471342|NCT00373113|65470651|FG001|Overall Study|Global deterioration of health status|7|||
23471343|NCT00373113|65470650|FG000|Overall Study|Lost to Follow-up|1|||
23471344|NCT00373113|65470651|FG001|Overall Study|Lost to Follow-up|3|||
23471345|NCT00373113|65470650|FG000|Overall Study|Objective progression or relapse|150|||
23471346|NCT00373113|65470651|FG001|Overall Study|Objective progression or relapse|169|||
23471347|NCT00373113|65470650|FG000|Overall Study|Other|14|||
23471348|NCT00373113|65470651|FG001|Overall Study|Other|17|||
23471349|NCT00373113|65470650|FG000|Overall Study|Protocol Violation|5|||
23471350|NCT00373113|65470651|FG001|Overall Study|Protocol Violation|1|||
23471351|NCT00373113|65470650|FG000|Overall Study|Withdrawal by Subject|10|||
23471352|NCT00373113|65470651|FG001|Overall Study|Withdrawal by Subject|15|||
23248331|NCT03079869|64652529|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
23248332|NCT03079869|64652530|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
23248333|NCT01186744|64652531|FG000|Overall Study|Lack of Efficacy|156|||
23248334|NCT01186744|64652532|FG001|Overall Study|Lack of Efficacy|99|||
23248335|NCT01186744|64652533|FG002|Overall Study|Lack of Efficacy|0|||
23248336|NCT01186744|64652534|FG003|Overall Study|Lack of Efficacy|2|||
23354454|NCT01870297|65041411|FG005|Overall Study|Lost to Follow-up|0|||
23248337|NCT01186744|64652535|FG004|Overall Study|Lack of Efficacy|2|||
23354455|NCT01870297|65041412|FG006|Overall Study|Lost to Follow-up|0|||
23248338|NCT01186744|64652536|FG005|Overall Study|Lack of Efficacy|5|||
23248339|NCT01186744|64652531|FG000|Overall Study|Protocol Violation|1|||
23471353|NCT01432730|65470652|FG000|Period 1|Adverse Event|2|||
23471354|NCT01432730|65470653|FG001|Period 1|Adverse Event|0|||
23471355|NCT01432730|65470652|FG000|Period 2|Adverse Event|0|||
23471356|NCT01432730|65470653|FG001|Period 2|Adverse Event|4|||
23471357|NCT01516034|65470654|FG000|Overall Study|Physician Decision|1|||
23471358|NCT01516034|65470654|FG000|Overall Study|Lack of Efficacy|7|||
23471359|NCT00567398|65470657|FG000|Overall Study|Adverse Event|6|||
23471360|NCT00567398|65470658|FG001|Overall Study|Adverse Event|14|||
23189240|NCT00500071|64436025|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
23354456|NCT01870297|65041406|FG000|Overall Study|Withdrawal by Subject|0|||
23354457|NCT01870297|65041407|FG001|Overall Study|Withdrawal by Subject|0|||
23354458|NCT01870297|65041408|FG002|Overall Study|Withdrawal by Subject|0|||
23354459|NCT01870297|65041409|FG003|Overall Study|Withdrawal by Subject|0|||
23354460|NCT01870297|65041410|FG004|Overall Study|Withdrawal by Subject|1|||
23471361|NCT00567398|65470657|FG000|Overall Study|Physician Decision|0|||
23471362|NCT00567398|65470658|FG001|Overall Study|Physician Decision|4|||
23354461|NCT01870297|65041411|FG005|Overall Study|Withdrawal by Subject|1|||
23354462|NCT01870297|65041412|FG006|Overall Study|Withdrawal by Subject|1|||
23354463|NCT01870297|65041406|FG000|Overall Study|Sponsor Decision|0|||
23354464|NCT01870297|65041407|FG001|Overall Study|Sponsor Decision|6|||
23354465|NCT01870297|65041408|FG002|Overall Study|Sponsor Decision|0|||
23354466|NCT01870297|65041409|FG003|Overall Study|Sponsor Decision|0|||
23354467|NCT01870297|65041410|FG004|Overall Study|Sponsor Decision|0|||
23354468|NCT01870297|65041411|FG005|Overall Study|Sponsor Decision|0|||
23354469|NCT01870297|65041412|FG006|Overall Study|Sponsor Decision|1|||
23354470|NCT00840034|65041417|FG000|Acute Treatment Phase|Adverse Event|6|||
23354471|NCT00840034|65041418|FG001|Acute Treatment Phase|Adverse Event|8|||
23354472|NCT00840034|65041417|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
23471363|NCT00567398|65470657|FG000|Overall Study|Withdrawal by Subject|0|||
23471364|NCT00567398|65470658|FG001|Overall Study|Withdrawal by Subject|2|||
23354473|NCT00840034|65041418|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
23354474|NCT00840034|65041417|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
23354475|NCT00840034|65041418|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
23471365|NCT00567398|65470657|FG000|Overall Study|Renal Transplantation|0|||
23354476|NCT00840034|65041417|FG000|Acute Treatment Phase|Physician Decision|0|||
23354477|NCT00840034|65041418|FG001|Acute Treatment Phase|Physician Decision|1|||
23354478|NCT00840034|65041417|FG000|Acute Treatment Phase|Protocol Violation|2|||
23354479|NCT00840034|65041418|FG001|Acute Treatment Phase|Protocol Violation|4|||
23354480|NCT00840034|65041417|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
23354481|NCT00840034|65041418|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
23354482|NCT00840034|65041417|FG000|Taper Phase|Adverse Event|1|||
23354483|NCT00840034|65041418|FG001|Taper Phase|Adverse Event|0|||
23354484|NCT00840034|65041417|FG000|Taper Phase|Lost to Follow-up|1|||
23354485|NCT00840034|65041418|FG001|Taper Phase|Lost to Follow-up|1|||
23354486|NCT00840034|65041417|FG000|Taper Phase|Withdrawal by Subject|1|||
23354487|NCT00840034|65041418|FG001|Taper Phase|Withdrawal by Subject|1|||
23354488|NCT04631107|65041420|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
23354489|NCT04631107|65041420|FG000|Second Intervention (1 Night)|Adverse Event|1|||
23354490|NCT04631107|65041420|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
23189241|NCT00500071|64436025|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
23189242|NCT00500071|64436025|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
23189243|NCT00500071|64436025|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
23189244|NCT04430348|64436031|FG000|Overall Study|Death|3|||
23189245|NCT04430348|64436032|FG001|Overall Study|Death|2|||
23189246|NCT04430348|64436033|FG002|Overall Study|Death|2|||
23189247|NCT04430348|64436034|FG003|Overall Study|Death|2|||
23189248|NCT04430348|64436035|FG004|Overall Study|Death|2|||
23189249|NCT04430348|64436036|FG005|Overall Study|Death|3|||
23189250|NCT04430348|64436031|FG000|Overall Study|Lost to Follow-up|0|||
23189251|NCT04430348|64436032|FG001|Overall Study|Lost to Follow-up|0|||
23248340|NCT01186744|64652532|FG001|Overall Study|Protocol Violation|2|||
23248341|NCT01186744|64652533|FG002|Overall Study|Protocol Violation|0|||
23248342|NCT01186744|64652534|FG003|Overall Study|Protocol Violation|1|||
23248343|NCT01186744|64652535|FG004|Overall Study|Protocol Violation|1|||
23248344|NCT01186744|64652536|FG005|Overall Study|Protocol Violation|2|||
23248345|NCT01186744|64652531|FG000|Overall Study|Lost to Follow-up|15|||
23248346|NCT01186744|64652532|FG001|Overall Study|Lost to Follow-up|16|||
23248347|NCT01186744|64652533|FG002|Overall Study|Lost to Follow-up|2|||
23248348|NCT01186744|64652534|FG003|Overall Study|Lost to Follow-up|1|||
23248349|NCT01186744|64652535|FG004|Overall Study|Lost to Follow-up|1|||
23248350|NCT01186744|64652536|FG005|Overall Study|Lost to Follow-up|4|||
23248351|NCT01186744|64652531|FG000|Overall Study|Screen failure|1|||
23248352|NCT01186744|64652532|FG001|Overall Study|Screen failure|1|||
23248353|NCT01186744|64652533|FG002|Overall Study|Screen failure|0|||
23248354|NCT01186744|64652534|FG003|Overall Study|Screen failure|1|||
23248355|NCT01186744|64652535|FG004|Overall Study|Screen failure|0|||
23248356|NCT01186744|64652536|FG005|Overall Study|Screen failure|0|||
23248357|NCT01186744|64652531|FG000|Overall Study|Withdrawal by Subject|14|||
23248358|NCT01186744|64652532|FG001|Overall Study|Withdrawal by Subject|10|||
23248359|NCT01186744|64652533|FG002|Overall Study|Withdrawal by Subject|2|||
23248360|NCT01186744|64652534|FG003|Overall Study|Withdrawal by Subject|5|||
23248361|NCT01186744|64652535|FG004|Overall Study|Withdrawal by Subject|0|||
23248362|NCT01186744|64652536|FG005|Overall Study|Withdrawal by Subject|6|||
23248363|NCT01186744|64652531|FG000|Overall Study|Study terminated by Sponsor|1|||
23248364|NCT01186744|64652532|FG001|Overall Study|Study terminated by Sponsor|0|||
23248365|NCT01186744|64652533|FG002|Overall Study|Study terminated by Sponsor|0|||
23354491|NCT04631107|65041420|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
23354492|NCT02107313|65041421|FG000|Overall Study|One participant did not do the FED cohor|0|||
23354493|NCT02107313|65041422|FG001|Overall Study|One participant did not do the FED cohor|1|||
23354494|NCT00957424|65041430|FG000|Overall Study|Lost to Follow-up|19|||
23354495|NCT00957424|65041430|FG000|Overall Study|Protocol Violation|3|||
23471366|NCT00567398|65470658|FG001|Overall Study|Renal Transplantation|3|||
23471367|NCT00567398|65470657|FG000|Overall Study|Other|1|||
23471368|NCT00567398|65470658|FG001|Overall Study|Other|0|||
23471369|NCT01776307|65470659|FG000|Overall Study|Not dosed|0|||
23471370|NCT01776307|65470660|FG001|Overall Study|Not dosed|0|||
23354496|NCT00957424|65041430|FG000|Overall Study|Withdrawal by Subject|1|||
23354497|NCT02634983|65041431|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
23354498|NCT02634983|65041432|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
23471371|NCT01776307|65470661|FG002|Overall Study|Not dosed|1|||
23189252|NCT04430348|64436033|FG002|Overall Study|Lost to Follow-up|0|||
23248366|NCT01186744|64652534|FG003|Overall Study|Study terminated by Sponsor|0|||
23471372|NCT00228553|65470662|FG000|Overall Study|Adverse Event|112|||
23248367|NCT01186744|64652535|FG004|Overall Study|Study terminated by Sponsor|0|||
23248368|NCT01186744|64652536|FG005|Overall Study|Study terminated by Sponsor|0|||
23248369|NCT01186744|64652531|FG000|Overall Study|Other|9|||
23248370|NCT01186744|64652532|FG001|Overall Study|Other|10|||
23354499|NCT01616758|65041445|FG000|Overall Study|Adverse Event|1|||
23354500|NCT01616758|65041445|FG000|Overall Study|Withdrawal by Subject|2|||
23189253|NCT04430348|64436034|FG003|Overall Study|Lost to Follow-up|1|||
23189254|NCT04430348|64436035|FG004|Overall Study|Lost to Follow-up|0|||
23471373|NCT00228553|65470662|FG000|Overall Study|Lack of Efficacy|34|||
23471374|NCT00228553|65470662|FG000|Overall Study|Lost to Follow-up|67|||
23471375|NCT00228553|65470662|FG000|Overall Study|Physician Decision|48|||
23471376|NCT00228553|65470662|FG000|Overall Study|Protocol Violation|6|||
23471377|NCT00228553|65470662|FG000|Overall Study|Withdrawal by Subject|115|||
23471378|NCT00228553|65470662|FG000|Overall Study|Pregnancy|2|||
23354501|NCT01616758|65041445|FG000|Overall Study|Disease progression|18|||
23354502|NCT01616758|65041445|FG000|Overall Study|Study termination by Sponsor|1|||
23354503|NCT00908596|65041453|FG000|Overall Study|Other reasons|46|||
23354504|NCT00908596|65041454|FG001|Overall Study|Other reasons|6|||
23354505|NCT00908596|65041455|FG002|Overall Study|Other reasons|2|||
23354506|NCT00908596|65041456|FG003|Overall Study|Other reasons|0|||
23354507|NCT00908596|65041453|FG000|Overall Study|Lost to Follow-up|0|||
23354508|NCT00908596|65041454|FG001|Overall Study|Lost to Follow-up|1|||
23354509|NCT00908596|65041455|FG002|Overall Study|Lost to Follow-up|12|||
23354510|NCT00908596|65041456|FG003|Overall Study|Lost to Follow-up|4|||
23354511|NCT00908596|65041453|FG000|Overall Study|Death|0|||
23354512|NCT00908596|65041454|FG001|Overall Study|Death|5|||
23354513|NCT00908596|65041455|FG002|Overall Study|Death|57|||
23354514|NCT00908596|65041456|FG003|Overall Study|Death|32|||
23354515|NCT00908596|65041453|FG000|Overall Study|Protocol Violation|1|||
23354516|NCT00908596|65041454|FG001|Overall Study|Protocol Violation|0|||
23354517|NCT00908596|65041455|FG002|Overall Study|Protocol Violation|0|||
23354518|NCT00908596|65041456|FG003|Overall Study|Protocol Violation|0|||
23354519|NCT00908596|65041453|FG000|Overall Study|Withdrawal by Subject|0|||
23354520|NCT00908596|65041454|FG001|Overall Study|Withdrawal by Subject|1|||
23354521|NCT00908596|65041455|FG002|Overall Study|Withdrawal by Subject|3|||
23471379|NCT00228553|65470662|FG000|Overall Study|Miscellaneous|46|||
23471380|NCT04380519|65470663|FG000|Overall Study|Withdrawal by Subject|4|||
23471381|NCT04380519|65470664|FG001|Overall Study|Withdrawal by Subject|0|||
23471382|NCT04380519|65470665|FG002|Overall Study|Withdrawal by Subject|1|||
23471383|NCT04380519|65470663|FG000|Overall Study|Death|14|||
23471384|NCT04380519|65470664|FG001|Overall Study|Death|9|||
23471385|NCT04380519|65470665|FG002|Overall Study|Death|6|||
23471386|NCT04380519|65470663|FG000|Overall Study|Adverse Event|0|||
23471387|NCT04380519|65470664|FG001|Overall Study|Adverse Event|1|||
23471388|NCT04380519|65470665|FG002|Overall Study|Adverse Event|0|||
23471389|NCT04380519|65470663|FG000|Overall Study|relatives' decision|0|||
23471390|NCT04380519|65470664|FG001|Overall Study|relatives' decision|1|||
23471391|NCT04380519|65470665|FG002|Overall Study|relatives' decision|0|||
23471392|NCT02164461|65470666|FG000|Overall Study|Adverse Event|0|||
23471393|NCT02164461|65470667|FG001|Overall Study|Adverse Event|0|||
23471394|NCT02164461|65470668|FG002|Overall Study|Adverse Event|1|||
23471395|NCT02164461|65470666|FG000|Overall Study|Disease Progression|1|||
23471396|NCT02164461|65470667|FG001|Overall Study|Disease Progression|3|||
23471397|NCT02164461|65470668|FG002|Overall Study|Disease Progression|4|||
23471398|NCT02164461|65470666|FG000|Overall Study|Withdrawal by Subject|0|||
23471399|NCT02164461|65470667|FG001|Overall Study|Withdrawal by Subject|3|||
23471400|NCT02164461|65470668|FG002|Overall Study|Withdrawal by Subject|0|||
23471401|NCT00101452|65470669|FG000|Overall Study|Adverse Event|2|||
23471402|NCT00101452|65470670|FG001|Overall Study|Adverse Event|0|||
23471403|NCT00101452|65470671|FG002|Overall Study|Adverse Event|1|||
23471404|NCT00101452|65470669|FG000|Overall Study|Lost to Follow-up|13|||
23471405|NCT00101452|65470670|FG001|Overall Study|Lost to Follow-up|8|||
23471406|NCT00101452|65470671|FG002|Overall Study|Lost to Follow-up|14|||
23471407|NCT00101452|65470669|FG000|Overall Study|Withdrawal by Subject|10|||
23471408|NCT00101452|65470670|FG001|Overall Study|Withdrawal by Subject|14|||
23471409|NCT00101452|65470671|FG002|Overall Study|Withdrawal by Subject|9|||
23471410|NCT00101452|65470669|FG000|Overall Study|Baseline Fail|2|||
23471411|NCT00101452|65470670|FG001|Overall Study|Baseline Fail|1|||
23471412|NCT00101452|65470671|FG002|Overall Study|Baseline Fail|2|||
23471413|NCT00101452|65470669|FG000|Overall Study|Physician Decision|0|||
23471414|NCT00101452|65470670|FG001|Overall Study|Physician Decision|3|||
23471415|NCT00101452|65470671|FG002|Overall Study|Physician Decision|2|||
23471416|NCT00101452|65470669|FG000|Overall Study|Protocol Violation|2|||
23471417|NCT00101452|65470670|FG001|Overall Study|Protocol Violation|1|||
23471418|NCT00101452|65470671|FG002|Overall Study|Protocol Violation|3|||
23471419|NCT00101452|65470669|FG000|Overall Study|Other|15|||
23471420|NCT00101452|65470670|FG001|Overall Study|Other|16|||
23354522|NCT00908596|65041456|FG003|Overall Study|Withdrawal by Subject|1|||
23354523|NCT01915771|65041457|FG000|Day 1|Withdrawal by Subject|1|||
23354524|NCT01915771|65041457|FG000|Day 15|Withdrawal by Subject|1|||
23354525|NCT00153816|65041460|FG000|Overall Study|Death|6|||
23354526|NCT00153816|65041461|FG001|Overall Study|Death|5|||
23354527|NCT00153816|65041462|FG002|Overall Study|Death|4|||
23354528|NCT00153816|65041463|FG003|Overall Study|Death|6|||
23471421|NCT00101452|65470671|FG002|Overall Study|Other|12|||
23354529|NCT00153816|65041464|FG004|Overall Study|Death|0|||
23354530|NCT00153816|65041465|FG005|Overall Study|Death|2|||
23471422|NCT00635219|65470672|FG000|Overall Study|Adverse Event|12|||
23471423|NCT00635219|65470673|FG001|Overall Study|Adverse Event|10|||
23354531|NCT00153816|65041460|FG000|Overall Study|Lost to Follow-up|7|||
23354532|NCT00153816|65041461|FG001|Overall Study|Lost to Follow-up|8|||
23354533|NCT00153816|65041462|FG002|Overall Study|Lost to Follow-up|5|||
23354534|NCT00153816|65041463|FG003|Overall Study|Lost to Follow-up|8|||
23354535|NCT00153816|65041464|FG004|Overall Study|Lost to Follow-up|7|||
23354536|NCT00153816|65041465|FG005|Overall Study|Lost to Follow-up|9|||
23354537|NCT00153816|65041460|FG000|Overall Study|Withdrawal by Subject|9|||
23354538|NCT00153816|65041461|FG001|Overall Study|Withdrawal by Subject|9|||
23354539|NCT00153816|65041462|FG002|Overall Study|Withdrawal by Subject|9|||
23354540|NCT00153816|65041463|FG003|Overall Study|Withdrawal by Subject|4|||
23354541|NCT00153816|65041464|FG004|Overall Study|Withdrawal by Subject|1|||
23354542|NCT00153816|65041465|FG005|Overall Study|Withdrawal by Subject|5|||
23354543|NCT00153816|65041460|FG000|Overall Study|Follow-up exam not done|8|||
23354544|NCT00153816|65041461|FG001|Overall Study|Follow-up exam not done|7|||
23354545|NCT00153816|65041462|FG002|Overall Study|Follow-up exam not done|11|||
23354546|NCT00153816|65041463|FG003|Overall Study|Follow-up exam not done|10|||
23354547|NCT00153816|65041464|FG004|Overall Study|Follow-up exam not done|8|||
23354548|NCT00153816|65041465|FG005|Overall Study|Follow-up exam not done|9|||
23354549|NCT00153816|65041460|FG000|Overall Study|Follow-up exam done, histology missing|2|||
23354550|NCT00153816|65041461|FG001|Overall Study|Follow-up exam done, histology missing|3|||
23354551|NCT00153816|65041462|FG002|Overall Study|Follow-up exam done, histology missing|3|||
23354552|NCT00153816|65041463|FG003|Overall Study|Follow-up exam done, histology missing|3|||
23354553|NCT00153816|65041464|FG004|Overall Study|Follow-up exam done, histology missing|1|||
23354554|NCT00153816|65041465|FG005|Overall Study|Follow-up exam done, histology missing|2|||
23354555|NCT02191046|65041466|FG000|Overall Study|low compliance|5|||
23354556|NCT02191046|65041467|FG001|Overall Study|low compliance|1|||
23354557|NCT00435188|65041468|FG000|Overall Study|Death|1|||
23354558|NCT00435188|65041469|FG001|Overall Study|Death|6|||
23354559|NCT00435188|65041468|FG000|Overall Study|Withdrawal by Subject|16|||
23354560|NCT00435188|65041469|FG001|Overall Study|Withdrawal by Subject|11|||
23354561|NCT00435188|65041468|FG000|Overall Study|Lost to Follow-up|5|||
23354562|NCT00435188|65041469|FG001|Overall Study|Lost to Follow-up|6|||
23354563|NCT02007278|65041472|FG000|Overall Study|Failure to comply with an eligibility|0|||
23354564|NCT02007278|65041473|FG001|Overall Study|Failure to comply with an eligibility|1|||
23354565|NCT02007278|65041472|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
23587750|NCT02918968|65879219|FG000|2nd Line AAT|Progressive disease|21|||
23587751|NCT02918968|65879220|FG001|2nd Line AAT|Progressive disease|3|||
23587752|NCT02918968|65879219|FG000|2nd Line AAT|Adverse Event|2|||
23587753|NCT02918968|65879220|FG001|2nd Line AAT|Adverse Event|5|||
23248371|NCT01186744|64652533|FG002|Overall Study|Other|1|||
23248372|NCT01186744|64652534|FG003|Overall Study|Other|2|||
23248373|NCT01186744|64652535|FG004|Overall Study|Other|1|||
23248374|NCT01186744|64652536|FG005|Overall Study|Other|5|||
23248375|NCT01186744|64652531|FG000|Overall Study|Adverse Event|10|||
23248376|NCT01186744|64652532|FG001|Overall Study|Adverse Event|14|||
23248377|NCT01186744|64652533|FG002|Overall Study|Adverse Event|1|||
23248378|NCT01186744|64652534|FG003|Overall Study|Adverse Event|0|||
23248379|NCT01186744|64652535|FG004|Overall Study|Adverse Event|1|||
23248380|NCT01186744|64652536|FG005|Overall Study|Adverse Event|4|||
23248381|NCT01186744|64652531|FG000|Overall Study|Death|1|||
23248382|NCT01186744|64652532|FG001|Overall Study|Death|0|||
23248383|NCT01186744|64652533|FG002|Overall Study|Death|0|||
23248384|NCT01186744|64652534|FG003|Overall Study|Death|0|||
23248385|NCT01186744|64652535|FG004|Overall Study|Death|0|||
23248386|NCT01186744|64652536|FG005|Overall Study|Death|0|||
23248387|NCT00061945|64652537|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
23587754|NCT02918968|65879219|FG000|2nd Line AAT|Physician Decision|0|||
23587755|NCT02918968|65879220|FG001|2nd Line AAT|Physician Decision|1|||
23587756|NCT02918968|65879219|FG000|2nd Line AAT|Withdrawal by Subject|2|||
23587757|NCT02918968|65879220|FG001|2nd Line AAT|Withdrawal by Subject|2|||
23587758|NCT02918968|65879219|FG000|2nd Line AAT|Death|0|||
23587759|NCT02918968|65879220|FG001|2nd Line AAT|Death|1|||
23587760|NCT02174562|65879223|FG000|Overall Study|Withdrawal by Subject|7|||
23587761|NCT02174562|65879224|FG001|Overall Study|Withdrawal by Subject|2|||
23248388|NCT00061945|64652538|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
23248389|NCT00061945|64652537|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
23248390|NCT00061945|64652538|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
23248391|NCT00061945|64652537|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
23354566|NCT02007278|65041473|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
23354567|NCT02007278|65041472|FG000|Overall Study|Incorrect medication administration|1|||
23354568|NCT02007278|65041473|FG001|Overall Study|Incorrect medication administration|0|||
23354569|NCT02007278|65041472|FG000|Overall Study|Mis-randomization|1|||
23354570|NCT02007278|65041473|FG001|Overall Study|Mis-randomization|1|||
23354571|NCT01554163|65041474|FG000|Overall Study|Adverse Event|3|||
23354572|NCT01554163|65041475|FG001|Overall Study|Adverse Event|0|||
23354573|NCT01554163|65041474|FG000|Overall Study|Lack of Efficacy|1|||
23587762|NCT02174562|65879223|FG000|Overall Study|Death|2|||
23189255|NCT04430348|64436036|FG005|Overall Study|Lost to Follow-up|0|||
23189256|NCT04430348|64436031|FG000|Overall Study|Adverse Event|0|||
23354574|NCT01554163|65041475|FG001|Overall Study|Lack of Efficacy|0|||
23354575|NCT01554163|65041474|FG000|Overall Study|Lost to Follow-up|1|||
23354576|NCT01554163|65041475|FG001|Overall Study|Lost to Follow-up|0|||
23354577|NCT01554163|65041474|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23354578|NCT01554163|65041475|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23354579|NCT01554163|65041474|FG000|Overall Study|Protocol Violation|0|||
23354580|NCT01554163|65041475|FG001|Overall Study|Protocol Violation|4|||
23354581|NCT01554163|65041474|FG000|Overall Study|Withdrawal by Subject|1|||
23354582|NCT01554163|65041475|FG001|Overall Study|Withdrawal by Subject|5|||
23354583|NCT01554163|65041474|FG000|Overall Study|Not Treated|1|||
23354584|NCT01554163|65041475|FG001|Overall Study|Not Treated|0|||
23354585|NCT01250171|65041479|FG000|Overall Study|Administrative reasons|1|||
23354586|NCT01250171|65041480|FG001|Overall Study|Administrative reasons|0|||
23354587|NCT01250171|65041481|FG002|Overall Study|Administrative reasons|0|||
23354588|NCT01289574|65041482|FG000|Overall Study|Lack of Efficacy|4|||
23354589|NCT01289574|65041483|FG001|Overall Study|Lack of Efficacy|0|||
23471424|NCT00635219|65470674|FG002|Overall Study|Adverse Event|18|||
23471425|NCT00635219|65470675|FG003|Overall Study|Adverse Event|15|||
23471426|NCT00635219|65470676|FG004|Overall Study|Adverse Event|19|||
23471427|NCT00635219|65470672|FG000|Overall Study|Lack of Efficacy|5|||
23471428|NCT00635219|65470673|FG001|Overall Study|Lack of Efficacy|6|||
23471429|NCT00635219|65470674|FG002|Overall Study|Lack of Efficacy|3|||
23471430|NCT00635219|65470675|FG003|Overall Study|Lack of Efficacy|4|||
23471431|NCT00635219|65470676|FG004|Overall Study|Lack of Efficacy|6|||
23471432|NCT00635219|65470672|FG000|Overall Study|Non-compliance With Study Product|0|||
23471433|NCT00635219|65470673|FG001|Overall Study|Non-compliance With Study Product|0|||
23471434|NCT00635219|65470674|FG002|Overall Study|Non-compliance With Study Product|0|||
23471435|NCT00635219|65470675|FG003|Overall Study|Non-compliance With Study Product|2|||
23471436|NCT00635219|65470676|FG004|Overall Study|Non-compliance With Study Product|1|||
23471437|NCT00635219|65470672|FG000|Overall Study|Protocol Violation|0|||
23471438|NCT00635219|65470673|FG001|Overall Study|Protocol Violation|2|||
23471439|NCT00635219|65470674|FG002|Overall Study|Protocol Violation|3|||
23471440|NCT00635219|65470675|FG003|Overall Study|Protocol Violation|2|||
23471441|NCT00635219|65470676|FG004|Overall Study|Protocol Violation|4|||
23471442|NCT00635219|65470672|FG000|Overall Study|Withdrawal of Consent|8|||
23471443|NCT00635219|65470673|FG001|Overall Study|Withdrawal of Consent|6|||
23471444|NCT00635219|65470674|FG002|Overall Study|Withdrawal of Consent|8|||
23471445|NCT00635219|65470675|FG003|Overall Study|Withdrawal of Consent|11|||
23471446|NCT00635219|65470676|FG004|Overall Study|Withdrawal of Consent|8|||
23471447|NCT00635219|65470672|FG000|Overall Study|Lost to Follow-up|0|||
23471448|NCT00635219|65470673|FG001|Overall Study|Lost to Follow-up|0|||
23471449|NCT00635219|65470674|FG002|Overall Study|Lost to Follow-up|2|||
23471450|NCT00635219|65470675|FG003|Overall Study|Lost to Follow-up|0|||
23587763|NCT02174562|65879224|FG001|Overall Study|Death|0|||
23587764|NCT02174562|65879223|FG000|Overall Study|Lost to Follow-up|0|||
23587765|NCT02174562|65879224|FG001|Overall Study|Lost to Follow-up|3|||
23587766|NCT05019729|65879231|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587767|NCT05019729|65879232|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587768|NCT05019729|65879233|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587769|NCT05019729|65879234|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587770|NCT05019729|65879235|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
23587771|NCT05019729|65879236|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
23587772|NCT02736799|65879238|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
23587773|NCT02736799|65879239|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
23587774|NCT02736799|65879240|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
23587775|NCT02736799|65879241|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
23587776|NCT00395018|65879244|FG000|On-Treatment|Death|4|||
23587777|NCT00395018|65879244|FG000|On-Treatment|Other Reason|2|||
23587778|NCT00395018|65879244|FG000|On-Treatment|Poor/non-compliance|2|||
23587779|NCT00395018|65879244|FG000|On-Treatment|Subject no longer meets study criteria|2|||
23587780|NCT00395018|65879244|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
23354590|NCT01289574|65041484|FG002|Overall Study|Lack of Efficacy|1|||
23354591|NCT01289574|65041482|FG000|Overall Study|Lost to Follow-up|2|||
23471451|NCT00635219|65470676|FG004|Overall Study|Lost to Follow-up|3|||
23471452|NCT00635219|65470672|FG000|Overall Study|Administrative or Other Reasons|0|||
23471453|NCT00635219|65470673|FG001|Overall Study|Administrative or Other Reasons|1|||
23471454|NCT00635219|65470674|FG002|Overall Study|Administrative or Other Reasons|1|||
23354592|NCT01289574|65041483|FG001|Overall Study|Lost to Follow-up|0|||
23354593|NCT01289574|65041484|FG002|Overall Study|Lost to Follow-up|1|||
23354594|NCT01289574|65041482|FG000|Overall Study|Withdrawal by Subject|1|||
23471455|NCT00635219|65470675|FG003|Overall Study|Administrative or Other Reasons|0|||
23471456|NCT00635219|65470676|FG004|Overall Study|Administrative or Other Reasons|1|||
23471457|NCT00539864|65470678|FG000|Overall Study|Lost to Follow-up|0|||
23471458|NCT00539864|65470679|FG001|Overall Study|Lost to Follow-up|1|||
23471459|NCT00539864|65470678|FG000|Overall Study|Withdrawal by Subject|1|||
23471460|NCT00539864|65470679|FG001|Overall Study|Withdrawal by Subject|1|||
23471461|NCT01864603|65470685|FG000|Stage 2|DSMB design modification|86056|||
23471462|NCT01864603|65470686|FG001|Stage 2|DSMB design modification|92558|||
23248392|NCT00061945|64652538|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
23248393|NCT00061945|64652537|FG000|Course IV: Alemtuzumab|Early exits|6|||
23248394|NCT00061945|64652538|FG001|Course IV: Alemtuzumab|Early exits|15|||
23248395|NCT00915473|64652539|FG000|Screening|Withdrawal by Subject|1|||
23248396|NCT00915473|64652540|FG001|Screening|Withdrawal by Subject|0|||
23248397|NCT00915473|64652539|FG000|4-week Follow Up|Lost to Follow-up|1|||
23248398|NCT00915473|64652540|FG001|4-week Follow Up|Lost to Follow-up|5|||
23248399|NCT02594384|64652541|FG000|Overall Study|Disease Progression|3|||
23248400|NCT02594384|64652542|FG001|Overall Study|Disease Progression|7|||
23248401|NCT02594384|64652543|FG002|Overall Study|Disease Progression|0|||
23248402|NCT02594384|64652544|FG003|Overall Study|Disease Progression|2|||
23248403|NCT02594384|64652545|FG004|Overall Study|Disease Progression|2|||
23248404|NCT02594384|64652546|FG005|Overall Study|Disease Progression|12|||
23248405|NCT02594384|64652547|FG006|Overall Study|Disease Progression|5|||
23248406|NCT02594384|64652548|FG007|Overall Study|Disease Progression|5|||
23248407|NCT02594384|64652541|FG000|Overall Study|Adverse Event|0|||
23248408|NCT02594384|64652542|FG001|Overall Study|Adverse Event|1|||
23248409|NCT02594384|64652543|FG002|Overall Study|Adverse Event|4|||
23248410|NCT02594384|64652544|FG003|Overall Study|Adverse Event|1|||
23248411|NCT02594384|64652545|FG004|Overall Study|Adverse Event|0|||
23248412|NCT02594384|64652546|FG005|Overall Study|Adverse Event|6|||
23248413|NCT02594384|64652547|FG006|Overall Study|Adverse Event|1|||
23248414|NCT02594384|64652548|FG007|Overall Study|Adverse Event|1|||
23248415|NCT02594384|64652541|FG000|Overall Study|Withdrawal by Subject|0|||
23248416|NCT02594384|64652542|FG001|Overall Study|Withdrawal by Subject|0|||
23248417|NCT02594384|64652543|FG002|Overall Study|Withdrawal by Subject|0|||
23248418|NCT02594384|64652544|FG003|Overall Study|Withdrawal by Subject|1|||
23248419|NCT02594384|64652545|FG004|Overall Study|Withdrawal by Subject|0|||
23248420|NCT02594384|64652546|FG005|Overall Study|Withdrawal by Subject|0|||
23248421|NCT02594384|64652547|FG006|Overall Study|Withdrawal by Subject|0|||
23248422|NCT02594384|64652548|FG007|Overall Study|Withdrawal by Subject|1|||
23248423|NCT02594384|64652541|FG000|Overall Study|Physician Decision|0|||
23248424|NCT02594384|64652542|FG001|Overall Study|Physician Decision|0|||
23248425|NCT02594384|64652543|FG002|Overall Study|Physician Decision|0|||
23471463|NCT03500224|65470691|FG000|Overall Study|Withdrawal by Subject|2|||
23471464|NCT01124006|65470692|FG000|Overall Study|Withdrawal by Subject|2|||
23471465|NCT01124006|65470693|FG001|Overall Study|Withdrawal by Subject|2|||
23471466|NCT01124006|65470694|FG002|Overall Study|Withdrawal by Subject|0|||
23471467|NCT01124006|65470692|FG000|Overall Study|Lost to Follow-up|1|||
23471468|NCT01124006|65470693|FG001|Overall Study|Lost to Follow-up|0|||
23471469|NCT01124006|65470694|FG002|Overall Study|Lost to Follow-up|1|||
23471470|NCT01124006|65470692|FG000|Overall Study|Other|0|||
23471471|NCT01124006|65470693|FG001|Overall Study|Other|0|||
23471472|NCT01124006|65470694|FG002|Overall Study|Other|1|||
23471473|NCT00499590|65470697|FG000|Overall Study|Study Terminated|112|||
23471474|NCT00499590|65470698|FG001|Overall Study|Study Terminated|112|||
23471475|NCT00499590|65470699|FG002|Overall Study|Study Terminated|112|||
23471476|NCT00499590|65470697|FG000|Overall Study|Not treated|1|||
23471477|NCT00499590|65470698|FG001|Overall Study|Not treated|0|||
23471478|NCT00499590|65470699|FG002|Overall Study|Not treated|1|||
23471479|NCT02920242|65470700|FG000|Overall Study|Withdrawal by Subject|1|||
23471480|NCT02920242|65470701|FG001|Overall Study|Withdrawal by Subject|0|||
23471481|NCT02920242|65470702|FG002|Overall Study|Withdrawal by Subject|1|||
23471482|NCT02920242|65470700|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
23471483|NCT02920242|65470701|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
23471484|NCT02920242|65470702|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
23471485|NCT03110770|65470703|FG000|Overall Study|Death|1|||
23471486|NCT03110770|65470704|FG001|Overall Study|Death|0|||
23471487|NCT03110770|65470705|FG002|Overall Study|Death|0|||
23471488|NCT03110770|65470706|FG003|Overall Study|Death|1|||
23471489|NCT03110770|65470707|FG004|Overall Study|Death|0|||
23248426|NCT02594384|64652544|FG003|Overall Study|Physician Decision|0|||
23248427|NCT02594384|64652545|FG004|Overall Study|Physician Decision|0|||
23248428|NCT02594384|64652546|FG005|Overall Study|Physician Decision|1|||
23248429|NCT02594384|64652547|FG006|Overall Study|Physician Decision|2|||
23248430|NCT02594384|64652548|FG007|Overall Study|Physician Decision|0|||
23248431|NCT02594384|64652541|FG000|Overall Study|Progressive Leukocytosis|0|||
23248432|NCT02594384|64652542|FG001|Overall Study|Progressive Leukocytosis|0|||
23248433|NCT02594384|64652543|FG002|Overall Study|Progressive Leukocytosis|1|||
23248434|NCT02594384|64652544|FG003|Overall Study|Progressive Leukocytosis|0|||
23248435|NCT02594384|64652545|FG004|Overall Study|Progressive Leukocytosis|0|||
23471490|NCT03110770|65470703|FG000|Overall Study|Enrolled but did not receive product|0|||
23471491|NCT03110770|65470704|FG001|Overall Study|Enrolled but did not receive product|0|||
23471492|NCT03110770|65470705|FG002|Overall Study|Enrolled but did not receive product|0|||
23471493|NCT03110770|65470706|FG003|Overall Study|Enrolled but did not receive product|8|||
23471494|NCT03110770|65470707|FG004|Overall Study|Enrolled but did not receive product|7|||
23471495|NCT03110770|65470703|FG000|Overall Study|Lost to Follow-up|0|||
23471496|NCT03110770|65470704|FG001|Overall Study|Lost to Follow-up|0|||
23471497|NCT03110770|65470705|FG002|Overall Study|Lost to Follow-up|0|||
23471498|NCT03110770|65470706|FG003|Overall Study|Lost to Follow-up|53|||
23471499|NCT03110770|65470707|FG004|Overall Study|Lost to Follow-up|45|||
23471500|NCT03110770|65470703|FG000|Overall Study|Investigator Decision|0|||
23471501|NCT03110770|65470704|FG001|Overall Study|Investigator Decision|0|||
23471502|NCT03110770|65470705|FG002|Overall Study|Investigator Decision|0|||
23471503|NCT03110770|65470706|FG003|Overall Study|Investigator Decision|5|||
23471504|NCT03110770|65470707|FG004|Overall Study|Investigator Decision|3|||
23471505|NCT03110770|65470703|FG000|Overall Study|Withdrawal by Subject|0|||
23471506|NCT03110770|65470704|FG001|Overall Study|Withdrawal by Subject|0|||
23471507|NCT03110770|65470705|FG002|Overall Study|Withdrawal by Subject|0|||
23471508|NCT03110770|65470706|FG003|Overall Study|Withdrawal by Subject|24|||
23471509|NCT03110770|65470707|FG004|Overall Study|Withdrawal by Subject|24|||
23471510|NCT03110770|65470703|FG000|Overall Study|Moved from area|5|||
23471511|NCT03110770|65470704|FG001|Overall Study|Moved from area|0|||
23471512|NCT03110770|65470705|FG002|Overall Study|Moved from area|2|||
23471513|NCT03110770|65470706|FG003|Overall Study|Moved from area|42|||
23471514|NCT03110770|65470707|FG004|Overall Study|Moved from area|43|||
23471515|NCT03110770|65470703|FG000|Overall Study|Illness/Injury unrelated to product|0|||
23471516|NCT03110770|65470704|FG001|Overall Study|Illness/Injury unrelated to product|0|||
23471517|NCT03110770|65470705|FG002|Overall Study|Illness/Injury unrelated to product|0|||
23471518|NCT03110770|65470706|FG003|Overall Study|Illness/Injury unrelated to product|0|||
23471519|NCT03110770|65470707|FG004|Overall Study|Illness/Injury unrelated to product|1|||
23471520|NCT02644109|65470711|FG000|Overall Study|Adverse Event|0|||
23471521|NCT02644109|65470712|FG001|Overall Study|Adverse Event|4|||
23471522|NCT01191762|65470713|FG000|Overall Study|Adverse Event|1|||
23471523|NCT01191762|65470714|FG001|Overall Study|Adverse Event|0|||
23471524|NCT02703337|65470715|FG000|Period One (Part A)|Withdrawal by Subject|0|||
23471525|NCT02703337|65470716|FG001|Period One (Part A)|Withdrawal by Subject|0|||
23471526|NCT02703337|65470717|FG002|Period One (Part A)|Withdrawal by Subject|0|||
23471527|NCT02703337|65470718|FG003|Period One (Part A)|Withdrawal by Subject|0|||
23471528|NCT02703337|65470719|FG004|Period One (Part A)|Withdrawal by Subject|1|||
23471529|NCT02703337|65470720|FG005|Period One (Part A)|Withdrawal by Subject|0|||
23471530|NCT02703337|65470721|FG006|Period One (Part A)|Withdrawal by Subject|0|||
23471531|NCT02703337|65470722|FG007|Period One (Part A)|Withdrawal by Subject|0|||
23471532|NCT02446899|65470726|FG000|Overall Study|Adverse Event|4|||
23189257|NCT04430348|64436032|FG001|Overall Study|Adverse Event|0|||
23189258|NCT04430348|64436033|FG002|Overall Study|Adverse Event|0|||
23189259|NCT04430348|64436034|FG003|Overall Study|Adverse Event|0|||
23189260|NCT04430348|64436035|FG004|Overall Study|Adverse Event|0|||
23189261|NCT04430348|64436036|FG005|Overall Study|Adverse Event|1|||
23189262|NCT04430348|64436031|FG000|Overall Study|Withdrawal by Subject|0|||
23189263|NCT04430348|64436032|FG001|Overall Study|Withdrawal by Subject|1|||
23189264|NCT04430348|64436033|FG002|Overall Study|Withdrawal by Subject|0|||
23189265|NCT04430348|64436034|FG003|Overall Study|Withdrawal by Subject|0|||
23189266|NCT04430348|64436035|FG004|Overall Study|Withdrawal by Subject|0|||
23189267|NCT04430348|64436036|FG005|Overall Study|Withdrawal by Subject|1|||
23354595|NCT01289574|65041483|FG001|Overall Study|Withdrawal by Subject|1|||
23354596|NCT01289574|65041484|FG002|Overall Study|Withdrawal by Subject|1|||
23354597|NCT01289574|65041482|FG000|Overall Study|Adverse Event|0|||
23354598|NCT01289574|65041483|FG001|Overall Study|Adverse Event|1|||
23354599|NCT01289574|65041484|FG002|Overall Study|Adverse Event|0|||
23354600|NCT01289574|65041482|FG000|Overall Study|Subject wanted alternate treatment|0|||
23471533|NCT02446899|65470727|FG001|Overall Study|Adverse Event|7|||
23471534|NCT02446899|65470726|FG000|Overall Study|Condition Under Investigation Worsened|1|||
23471535|NCT02446899|65470727|FG001|Overall Study|Condition Under Investigation Worsened|4|||
23471536|NCT02446899|65470726|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
23471537|NCT02446899|65470727|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
23587781|NCT00395018|65879244|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
23587782|NCT00395018|65879244|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
23189268|NCT04430348|64436031|FG000|Overall Study|Study Terminated by Sponsor|0|||
23189269|NCT04430348|64436032|FG001|Overall Study|Study Terminated by Sponsor|0|||
23189270|NCT04430348|64436033|FG002|Overall Study|Study Terminated by Sponsor|2|||
23189271|NCT04430348|64436034|FG003|Overall Study|Study Terminated by Sponsor|0|||
23354601|NCT01289574|65041483|FG001|Overall Study|Subject wanted alternate treatment|1|||
23354602|NCT01289574|65041484|FG002|Overall Study|Subject wanted alternate treatment|0|||
23189272|NCT04430348|64436035|FG004|Overall Study|Study Terminated by Sponsor|1|||
23354603|NCT04710368|65041485|FG000|Overall Study|Withdrawal by Subject|9|||
23471538|NCT02446899|65470726|FG000|Overall Study|Lack of Efficacy|2|||
23471539|NCT02446899|65470727|FG001|Overall Study|Lack of Efficacy|8|||
23471540|NCT02446899|65470726|FG000|Overall Study|Lost to Follow-up|1|||
23471541|NCT02446899|65470727|FG001|Overall Study|Lost to Follow-up|3|||
23471542|NCT02446899|65470726|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
23471543|NCT02446899|65470727|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
23471544|NCT02446899|65470726|FG000|Overall Study|Withdrawal by Subject|11|||
23471545|NCT02446899|65470727|FG001|Overall Study|Withdrawal by Subject|19|||
23471546|NCT02446899|65470726|FG000|Overall Study|Miscellaneous|5|||
23471547|NCT02446899|65470727|FG001|Overall Study|Miscellaneous|4|||
23471548|NCT02446899|65470726|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
23471549|NCT02446899|65470727|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
23471550|NCT00509145|65470729|FG000|Overall Study|Death|0|||
23471551|NCT00509145|65470730|FG001|Overall Study|Death|2|||
23471552|NCT00509145|65470729|FG000|Overall Study|Adverse Event|42|||
23471553|NCT00509145|65470730|FG001|Overall Study|Adverse Event|28|||
23471554|NCT00509145|65470729|FG000|Overall Study|Withdrawal by Subject|32|||
23471555|NCT00509145|65470730|FG001|Overall Study|Withdrawal by Subject|38|||
23471556|NCT00509145|65470729|FG000|Overall Study|Physician Decision|11|||
23471557|NCT00509145|65470730|FG001|Overall Study|Physician Decision|14|||
23471558|NCT00509145|65470729|FG000|Overall Study|Protocol Violation|1|||
23471559|NCT00509145|65470730|FG001|Overall Study|Protocol Violation|6|||
23471560|NCT00509145|65470729|FG000|Overall Study|Pregnancy|3|||
23471561|NCT00509145|65470730|FG001|Overall Study|Pregnancy|8|||
23471562|NCT00509145|65470729|FG000|Overall Study|Lost to Follow-up|6|||
23471563|NCT00509145|65470730|FG001|Overall Study|Lost to Follow-up|5|||
23471564|NCT00509145|65470729|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
23471565|NCT00509145|65470730|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
23471566|NCT00509145|65470729|FG000|Overall Study|Other|6|||
23471567|NCT00509145|65470730|FG001|Overall Study|Other|6|||
23471568|NCT02762370|65470732|FG000|Overall Study|Protocol Violation|1|||
23471569|NCT02762370|65470733|FG001|Overall Study|Protocol Violation|0|||
23471570|NCT02934503|65470734|FG000|Overall Study|progression of disease|3|||
23471571|NCT02934503|65470734|FG000|Overall Study|Withdrawal by Subject|1|||
23471572|NCT00916929|65470735|FG000|Overall Study|Lost to Follow-up|1|||
23471573|NCT00916929|65470736|FG001|Overall Study|Lost to Follow-up|3|||
23471574|NCT00916929|65470735|FG000|Overall Study|Death|5|||
23471575|NCT00916929|65470736|FG001|Overall Study|Death|10|||
23471576|NCT00916929|65470735|FG000|Overall Study|Withdrawal by Subject|1|||
23471577|NCT00916929|65470736|FG001|Overall Study|Withdrawal by Subject|5|||
23471578|NCT00916929|65470735|FG000|Overall Study|Left ventricular epicardial lead|1|||
23471579|NCT00916929|65470736|FG001|Overall Study|Left ventricular epicardial lead|2|||
23471580|NCT00916929|65470735|FG000|Overall Study|Transferred to hospice care|1|||
23471581|NCT00916929|65470736|FG001|Overall Study|Transferred to hospice care|1|||
23471582|NCT00916929|65470735|FG000|Overall Study|System explant|1|||
23587783|NCT03192046|65879245|FG000|Overall Study|Withdrawal by Subject|1|||
23587784|NCT03192046|65879246|FG001|Overall Study|Withdrawal by Subject|1|||
23471583|NCT00916929|65470736|FG001|Overall Study|System explant|0|||
23471584|NCT00916929|65470735|FG000|Overall Study|Moved to another state|0|||
23471585|NCT00916929|65470736|FG001|Overall Study|Moved to another state|1|||
23471586|NCT00916929|65470735|FG000|Overall Study|Device unable to process impedance data|0|||
23471587|NCT00916929|65470736|FG001|Overall Study|Device unable to process impedance data|7|||
23471588|NCT00486291|65470740|FG000|Overall Study|Adverse Event|3|||
23471589|NCT00486291|65470741|FG001|Overall Study|Adverse Event|4|||
23587785|NCT01186848|65879247|FG000|Overall Study|Lost to Follow-up|4|||
23587786|NCT01186848|65879247|FG000|Overall Study|Withdrawal by Subject|2|||
23587787|NCT01186848|65879247|FG000|Overall Study|Adverse Event|2|||
23587788|NCT01988233|65879250|FG000|Overall Study|Lost to Follow-up|64|||
23587789|NCT01988233|65879251|FG001|Overall Study|Lost to Follow-up|51|||
23587790|NCT00751036|65879252|FG000|Overall Study|Disease Progression|28|||
23587791|NCT00751036|65879253|FG001|Overall Study|Disease Progression|29|||
23587792|NCT00751036|65879252|FG000|Overall Study|Adverse Event|6|||
23587793|NCT00751036|65879253|FG001|Overall Study|Adverse Event|4|||
23471590|NCT00486291|65470740|FG000|Overall Study|Lost to Follow-up|3|||
23471591|NCT00486291|65470741|FG001|Overall Study|Lost to Follow-up|7|||
23471592|NCT00486291|65470740|FG000|Overall Study|protocol non-compliance|10|||
23471593|NCT00486291|65470741|FG001|Overall Study|protocol non-compliance|15|||
23587794|NCT00751036|65879252|FG000|Overall Study|Administrative Problems|3|||
23471594|NCT00486291|65470740|FG000|Overall Study|requirement for restricted medication|0|||
23471595|NCT00486291|65470741|FG001|Overall Study|requirement for restricted medication|3|||
23471596|NCT02207088|65470742|FG000|Overall Study|Adverse Event|2|||
23471597|NCT00607373|65470745|FG000|Treatment Period|Adverse Event|0|||
23471598|NCT00607373|65470746|FG001|Treatment Period|Adverse Event|4|||
23471599|NCT00607373|65470745|FG000|Treatment Period|Physician Decision|0|||
23471600|NCT00607373|65470746|FG001|Treatment Period|Physician Decision|1|||
23587795|NCT00751036|65879253|FG001|Overall Study|Administrative Problems|4|||
23587796|NCT00751036|65879252|FG000|Overall Study|Withdrawal by Subject|5|||
23471601|NCT00607373|65470745|FG000|Treatment Period|Withdrawal by Subject|0|||
23471602|NCT00607373|65470746|FG001|Treatment Period|Withdrawal by Subject|1|||
23471603|NCT00607373|65470745|FG000|Follow-up Period|Other|0|||
23471604|NCT00607373|65470746|FG001|Follow-up Period|Other|1|||
23471605|NCT00607373|65470745|FG000|Follow-up Period|Protocol Violation|0|||
23471606|NCT00607373|65470746|FG001|Follow-up Period|Protocol Violation|1|||
23471607|NCT00607373|65470745|FG000|Follow-up Period|Withdrawal by Subject|1|||
23471608|NCT00607373|65470746|FG001|Follow-up Period|Withdrawal by Subject|3|||
23471609|NCT03052400|65470750|FG000|Overall Study|Lost to Follow-up|1|||
23471610|NCT03052400|65470751|FG001|Overall Study|Lost to Follow-up|0|||
23471611|NCT03052400|65470750|FG000|Overall Study|Withdrawal by Subject|0|||
23471612|NCT03052400|65470751|FG001|Overall Study|Withdrawal by Subject|1|||
23471613|NCT00947193|65470755|FG000|Overall Study|Lost to Follow-up|1|||
23471614|NCT00947193|65470756|FG001|Overall Study|Lost to Follow-up|0|||
23471615|NCT00947193|65470755|FG000|Overall Study|Withdrawal by Subject|1|||
23471616|NCT00947193|65470756|FG001|Overall Study|Withdrawal by Subject|0|||
23471617|NCT00947193|65470755|FG000|Overall Study|Factor VIII >1%|1|||
23471618|NCT00947193|65470756|FG001|Overall Study|Factor VIII >1%|0|||
23471619|NCT00488683|65470757|FG000|Overall Study|Withdrawal by Subject|1|||
23471620|NCT00488683|65470758|FG001|Overall Study|Withdrawal by Subject|2|||
23471621|NCT00488683|65470759|FG002|Overall Study|Withdrawal by Subject|2|||
23471622|NCT00488683|65470757|FG000|Overall Study|Lost to Follow-up|5|||
23471623|NCT00488683|65470758|FG001|Overall Study|Lost to Follow-up|3|||
23471624|NCT00488683|65470759|FG002|Overall Study|Lost to Follow-up|0|||
23471625|NCT00488683|65470757|FG000|Overall Study|Protocol Violation|5|||
23248436|NCT02594384|64652546|FG005|Overall Study|Progressive Leukocytosis|0|||
23471626|NCT00488683|65470758|FG001|Overall Study|Protocol Violation|1|||
23248437|NCT02594384|64652547|FG006|Overall Study|Progressive Leukocytosis|0|||
23248438|NCT02594384|64652548|FG007|Overall Study|Progressive Leukocytosis|0|||
23248439|NCT02594384|64652541|FG000|Overall Study|Lack of Efficacy|0|||
23248440|NCT02594384|64652542|FG001|Overall Study|Lack of Efficacy|0|||
23248441|NCT02594384|64652543|FG002|Overall Study|Lack of Efficacy|0|||
23248442|NCT02594384|64652544|FG003|Overall Study|Lack of Efficacy|0|||
23471627|NCT00488683|65470759|FG002|Overall Study|Protocol Violation|0|||
23471628|NCT00488683|65470757|FG000|Overall Study|Unable to Classify|1|||
23471629|NCT00488683|65470758|FG001|Overall Study|Unable to Classify|0|||
23471630|NCT00488683|65470759|FG002|Overall Study|Unable to Classify|0|||
23471631|NCT01712399|65470761|FG000|Overall Study|Lost to Follow-up|1|||
23471632|NCT01712399|65470761|FG000|Overall Study|Withdrawal by Subject|39|||
23471633|NCT01712399|65470761|FG000|Overall Study|Death|1|||
23471634|NCT01712399|65470761|FG000|Overall Study|Adverse Event|11|||
23471635|NCT01712399|65470761|FG000|Overall Study|Study closure|345|||
23471636|NCT03073733|65470763|FG000|Overall Study|Lost to Follow-up|1|||
23471637|NCT03073733|65470764|FG001|Overall Study|Lost to Follow-up|0|||
23471638|NCT03073733|65470765|FG002|Overall Study|Lost to Follow-up|0|||
23471639|NCT03073733|65470763|FG000|Overall Study|Physician Decision|0|||
23471640|NCT03073733|65470764|FG001|Overall Study|Physician Decision|1|||
23471641|NCT03073733|65470765|FG002|Overall Study|Physician Decision|0|||
23471642|NCT03073733|65470763|FG000|Overall Study|Withdrawal by Subject|0|||
23471643|NCT03073733|65470764|FG001|Overall Study|Withdrawal by Subject|0|||
23471644|NCT03073733|65470765|FG002|Overall Study|Withdrawal by Subject|1|||
23471645|NCT02840799|65470766|FG000|Phase 1|Physician Decision|1|||
23471646|NCT02840799|65470767|FG001|Phase 1|Physician Decision|3|||
23471647|NCT02840799|65470766|FG000|Phase 1|Withdrawal by Subject|4|||
23471648|NCT02840799|65470767|FG001|Phase 1|Withdrawal by Subject|0|||
23471649|NCT02840799|65470766|FG000|Phase 2 (Crossover)|Adverse Event|0|||
23471650|NCT02840799|65470767|FG001|Phase 2 (Crossover)|Adverse Event|1|||
23471651|NCT02840799|65470766|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
23471652|NCT02840799|65470767|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
23471653|NCT00740857|65470768|FG000|Overall Study|Withdrawal by Subject|1|||
23471654|NCT00740857|65470769|FG001|Overall Study|Withdrawal by Subject|0|||
23471655|NCT00740857|65470770|FG002|Overall Study|Withdrawal by Subject|0|||
23471656|NCT02433080|65470771|FG000|Overall Study|Lost to Follow-up|1|||
23471657|NCT02433080|65470772|FG001|Overall Study|Lost to Follow-up|2|||
23471658|NCT02433080|65470771|FG000|Overall Study|Withdrawal by Subject|0|||
23471659|NCT02433080|65470772|FG001|Overall Study|Withdrawal by Subject|2|||
23471660|NCT01525225|65470773|FG000|Enrollment|No longer met study criteria|1|||
23471661|NCT01525225|65470773|FG000|Enrollment|Other|1|||
23471662|NCT00459186|65470774|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
23471663|NCT00459186|65470774|FG000|PET Imaging and Assessment|Adverse Event|3|||
23471664|NCT00744042|65470775|FG000|Overall Study|Withdrawal by Subject|1|||
23248443|NCT02594384|64652545|FG004|Overall Study|Lack of Efficacy|1|||
23248444|NCT02594384|64652546|FG005|Overall Study|Lack of Efficacy|0|||
23471665|NCT00823615|65470780|FG000|Period 2|Lost to Follow-up|2|||
23471666|NCT00823615|65470781|FG001|Period 2|Lost to Follow-up|0|||
23471667|NCT00823615|65470780|FG000|Period 2|Time/Job Conflict|1|||
23471668|NCT00823615|65470781|FG001|Period 2|Time/Job Conflict|2|||
23471669|NCT01798849|65470782|FG000|Overall Study|Physician Decision|0|||
23471670|NCT01798849|65470783|FG001|Overall Study|Physician Decision|0|||
23471671|NCT01798849|65470784|FG002|Overall Study|Physician Decision|1|||
23471672|NCT01068600|65470786|FG000|Overall Study|Withdrawal by Subject|5|||
23471673|NCT01068600|65470787|FG001|Overall Study|Withdrawal by Subject|6|||
23471674|NCT01068600|65470786|FG000|Overall Study|Adverse Event|3|||
23471675|NCT01068600|65470787|FG001|Overall Study|Adverse Event|3|||
23471676|NCT01068600|65470786|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23471677|NCT01068600|65470787|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23471678|NCT01068600|65470786|FG000|Overall Study|Lost to Follow-up|1|||
23471679|NCT01068600|65470787|FG001|Overall Study|Lost to Follow-up|2|||
23471680|NCT01068600|65470786|FG000|Overall Study|Protocol deviation|1|||
23471681|NCT01068600|65470787|FG001|Overall Study|Protocol deviation|1|||
23471682|NCT01068600|65470786|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23471683|NCT01068600|65470787|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23471684|NCT01068600|65470786|FG000|Overall Study|Administrative problems|0|||
23471685|NCT01068600|65470787|FG001|Overall Study|Administrative problems|1|||
23471686|NCT01409811|65470788|FG000|Overall Study|Insurance denial|1|||
23471687|NCT01598129|65470792|FG000|Overall Study|Disease progression|6|||
23471688|NCT01598129|65470792|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
23471689|NCT01598129|65470792|FG000|Overall Study|Withdrawal by Subject|1|||
23471690|NCT01015638|65470793|FG000|Overall Study|Withdrawal by Subject|1|||
23471691|NCT01015638|65470794|FG001|Overall Study|Withdrawal by Subject|0|||
23471692|NCT00481091|65470796|FG000|Overall Study|Withdrawal by Subject|0|||
23471693|NCT00481091|65470797|FG001|Overall Study|Withdrawal by Subject|1|||
23471694|NCT00481091|65470798|FG002|Overall Study|Withdrawal by Subject|1|||
23471695|NCT00481091|65470799|FG003|Overall Study|Withdrawal by Subject|0|||
23471696|NCT00481091|65470800|FG004|Overall Study|Withdrawal by Subject|0|||
23471697|NCT00481091|65470801|FG005|Overall Study|Withdrawal by Subject|0|||
23471698|NCT00481091|65470802|FG006|Overall Study|Withdrawal by Subject|0|||
23471699|NCT00481091|65470803|FG007|Overall Study|Withdrawal by Subject|0|||
23248445|NCT02594384|64652547|FG006|Overall Study|Lack of Efficacy|0|||
23248446|NCT02594384|64652548|FG007|Overall Study|Lack of Efficacy|0|||
23248447|NCT02594384|64652541|FG000|Overall Study|Substantial noncompliance|0|||
23471700|NCT00481091|65470804|FG008|Overall Study|Withdrawal by Subject|1|||
23471701|NCT00481091|65470805|FG009|Overall Study|Withdrawal by Subject|6|||
23471702|NCT00481091|65470796|FG000|Overall Study|Other, Not Specified|0|||
23471703|NCT00481091|65470797|FG001|Overall Study|Other, Not Specified|1|||
23471704|NCT00481091|65470798|FG002|Overall Study|Other, Not Specified|1|||
23471705|NCT00481091|65470799|FG003|Overall Study|Other, Not Specified|0|||
23471706|NCT00481091|65470800|FG004|Overall Study|Other, Not Specified|0|||
23471707|NCT00481091|65470801|FG005|Overall Study|Other, Not Specified|1|||
23471708|NCT00481091|65470802|FG006|Overall Study|Other, Not Specified|0|||
23471709|NCT00481091|65470803|FG007|Overall Study|Other, Not Specified|0|||
23471710|NCT00481091|65470804|FG008|Overall Study|Other, Not Specified|0|||
23587797|NCT00751036|65879253|FG001|Overall Study|Withdrawal by Subject|2|||
23587798|NCT00751036|65879252|FG000|Overall Study|Death|3|||
23189273|NCT04430348|64436036|FG005|Overall Study|Study Terminated by Sponsor|1|||
23248448|NCT02594384|64652542|FG001|Overall Study|Substantial noncompliance|0|||
23248449|NCT02594384|64652543|FG002|Overall Study|Substantial noncompliance|0|||
23248450|NCT02594384|64652544|FG003|Overall Study|Substantial noncompliance|0|||
23248451|NCT02594384|64652545|FG004|Overall Study|Substantial noncompliance|0|||
23248452|NCT02594384|64652546|FG005|Overall Study|Substantial noncompliance|0|||
23471711|NCT00481091|65470805|FG009|Overall Study|Other, Not Specified|4|||
23471712|NCT00481091|65470796|FG000|Overall Study|Adverse Event|1|||
23471713|NCT00481091|65470797|FG001|Overall Study|Adverse Event|2|||
23471714|NCT00481091|65470798|FG002|Overall Study|Adverse Event|0|||
23471715|NCT00481091|65470799|FG003|Overall Study|Adverse Event|1|||
23471716|NCT00481091|65470800|FG004|Overall Study|Adverse Event|1|||
23471717|NCT00481091|65470801|FG005|Overall Study|Adverse Event|1|||
23189274|NCT02158533|64436040|FG000|Stage 1|Adverse Event|6|||
23189275|NCT02158533|64436041|FG001|Stage 1|Adverse Event|4|||
23189276|NCT02158533|64436042|FG002|Stage 1|Adverse Event|7|||
23189277|NCT02158533|64436043|FG003|Stage 1|Adverse Event|0|||
23189278|NCT02158533|64436044|FG004|Stage 1|Adverse Event|0|||
23189279|NCT02158533|64436045|FG005|Stage 1|Adverse Event|0|||
23189280|NCT02158533|64436040|FG000|Stage 1|Withdrawal by Subject|3|||
23189281|NCT02158533|64436041|FG001|Stage 1|Withdrawal by Subject|2|||
23189282|NCT02158533|64436042|FG002|Stage 1|Withdrawal by Subject|1|||
23189283|NCT02158533|64436043|FG003|Stage 1|Withdrawal by Subject|0|||
23248453|NCT02594384|64652547|FG006|Overall Study|Substantial noncompliance|1|||
23189284|NCT02158533|64436044|FG004|Stage 1|Withdrawal by Subject|0|||
23189285|NCT02158533|64436045|FG005|Stage 1|Withdrawal by Subject|0|||
23248454|NCT02594384|64652548|FG007|Overall Study|Substantial noncompliance|0|||
23354604|NCT04710368|65041485|FG000|Overall Study|Lost to Follow-up|4|||
23471718|NCT00481091|65470802|FG006|Overall Study|Adverse Event|2|||
23471719|NCT00481091|65470803|FG007|Overall Study|Adverse Event|1|||
23354605|NCT04710368|65041485|FG000|Overall Study|Death|2|||
23354606|NCT04710368|65041485|FG000|Overall Study|Patient preference|11|||
23354607|NCT04710368|65041485|FG000|Overall Study|Treatment discontinuation|1|||
23354608|NCT01342445|65041486|FG000|Overall Study|Experienced side effects|0|||
23354609|NCT01342445|65041487|FG001|Overall Study|Experienced side effects|2|||
23354610|NCT03882957|65041488|FG000|Overall Study|Did not complete all three arms|1|||
23354611|NCT02452554|65041489|FG000|Overall Study|Death|2|||
23354612|NCT02452554|65041490|FG001|Overall Study|Death|1|||
23354613|NCT02452554|65041491|FG002|Overall Study|Death|0|||
23354614|NCT02452554|65041492|FG003|Overall Study|Death|0|||
23354615|NCT02452554|65041493|FG004|Overall Study|Death|0|||
23354616|NCT02452554|65041494|FG005|Overall Study|Death|0|||
23471720|NCT00481091|65470804|FG008|Overall Study|Adverse Event|1|||
23471721|NCT00481091|65470805|FG009|Overall Study|Adverse Event|6|||
23248455|NCT00890409|64652551|FG000|Overall Study|Lost to Follow-up|20|||
23354617|NCT02452554|65041489|FG000|Overall Study|Lack of Efficacy|13|||
23354618|NCT02452554|65041490|FG001|Overall Study|Lack of Efficacy|14|||
23471722|NCT00481091|65470796|FG000|Overall Study|Progressive disease clinical|0|||
23471723|NCT00481091|65470797|FG001|Overall Study|Progressive disease clinical|0|||
23471724|NCT00481091|65470798|FG002|Overall Study|Progressive disease clinical|0|||
23471725|NCT00481091|65470799|FG003|Overall Study|Progressive disease clinical|0|||
23471726|NCT00481091|65470800|FG004|Overall Study|Progressive disease clinical|0|||
23354619|NCT02452554|65041491|FG002|Overall Study|Lack of Efficacy|9|||
23354620|NCT02452554|65041492|FG003|Overall Study|Lack of Efficacy|1|||
23354621|NCT02452554|65041493|FG004|Overall Study|Lack of Efficacy|5|||
23354622|NCT02452554|65041494|FG005|Overall Study|Lack of Efficacy|8|||
23354623|NCT02452554|65041489|FG000|Overall Study|Physician Decision|0|||
23354624|NCT02452554|65041490|FG001|Overall Study|Physician Decision|1|||
23354625|NCT02452554|65041491|FG002|Overall Study|Physician Decision|0|||
23354626|NCT02452554|65041492|FG003|Overall Study|Physician Decision|0|||
23354627|NCT02452554|65041493|FG004|Overall Study|Physician Decision|0|||
23354628|NCT02452554|65041494|FG005|Overall Study|Physician Decision|0|||
23354629|NCT02452554|65041489|FG000|Overall Study|Withdrawal by Subject|1|||
23354630|NCT02452554|65041490|FG001|Overall Study|Withdrawal by Subject|0|||
23354631|NCT02452554|65041491|FG002|Overall Study|Withdrawal by Subject|2|||
23354632|NCT02452554|65041492|FG003|Overall Study|Withdrawal by Subject|0|||
23354633|NCT02452554|65041493|FG004|Overall Study|Withdrawal by Subject|0|||
23354634|NCT02452554|65041494|FG005|Overall Study|Withdrawal by Subject|1|||
23471727|NCT00481091|65470801|FG005|Overall Study|Progressive disease clinical|0|||
23587799|NCT00751036|65879253|FG001|Overall Study|Death|3|||
23587800|NCT00751036|65879252|FG000|Overall Study|Lost to Follow-up|0|||
23587801|NCT00751036|65879253|FG001|Overall Study|Lost to Follow-up|1|||
23587802|NCT00751036|65879252|FG000|Overall Study|Protocol Violation|1|||
23587803|NCT00751036|65879253|FG001|Overall Study|Protocol Violation|0|||
23587804|NCT00751036|65879252|FG000|Overall Study|Missing end of Treatment Page|2|||
23587805|NCT00751036|65879253|FG001|Overall Study|Missing end of Treatment Page|3|||
23587806|NCT00603538|65879254|FG000|Overall Study|Adverse Event|0|||
23587807|NCT00603538|65879255|FG001|Overall Study|Adverse Event|4|||
23587808|NCT00603538|65879256|FG002|Overall Study|Adverse Event|2|||
23587809|NCT00603538|65879254|FG000|Overall Study|Objective progression or relapse|3|||
23587810|NCT00603538|65879255|FG001|Overall Study|Objective progression or relapse|0|||
23587811|NCT00603538|65879256|FG002|Overall Study|Objective progression or relapse|0|||
23587812|NCT00324038|65879257|FG000|Overall Study|Adverse Event|38|||
23587813|NCT00324038|65879258|FG001|Overall Study|Adverse Event|23|||
23587814|NCT00324038|65879257|FG000|Overall Study|Lack of Efficacy|5|||
23587815|NCT00324038|65879258|FG001|Overall Study|Lack of Efficacy|13|||
23587816|NCT00324038|65879257|FG000|Overall Study|Lost to Follow-up|0|||
23587817|NCT00324038|65879258|FG001|Overall Study|Lost to Follow-up|2|||
23587818|NCT00324038|65879257|FG000|Overall Study|Other|6|||
23587819|NCT00324038|65879258|FG001|Overall Study|Other|13|||
23587820|NCT00770965|65882022|FG000|Safety Set|Withdrawal by Subject|0|||
23587821|NCT00770965|65882023|FG001|Safety Set|Withdrawal by Subject|0|||
23587822|NCT00770965|65882024|FG002|Safety Set|Withdrawal by Subject|0|||
23189286|NCT02158533|64436040|FG000|Stage 1|Lack of Efficacy|1|||
23189287|NCT02158533|64436041|FG001|Stage 1|Lack of Efficacy|0|||
23189288|NCT02158533|64436042|FG002|Stage 1|Lack of Efficacy|0|||
23189289|NCT02158533|64436043|FG003|Stage 1|Lack of Efficacy|0|||
23189290|NCT02158533|64436044|FG004|Stage 1|Lack of Efficacy|0|||
23189291|NCT02158533|64436045|FG005|Stage 1|Lack of Efficacy|0|||
23189292|NCT02158533|64436040|FG000|Stage 1|Lost to Follow-up|3|||
23189293|NCT02158533|64436041|FG001|Stage 1|Lost to Follow-up|1|||
23189294|NCT02158533|64436042|FG002|Stage 1|Lost to Follow-up|0|||
23189295|NCT02158533|64436043|FG003|Stage 1|Lost to Follow-up|0|||
23189296|NCT02158533|64436044|FG004|Stage 1|Lost to Follow-up|0|||
23189297|NCT02158533|64436045|FG005|Stage 1|Lost to Follow-up|0|||
23189298|NCT02158533|64436040|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
23189299|NCT02158533|64436041|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
23471728|NCT00481091|65470802|FG006|Overall Study|Progressive disease clinical|0|||
23471729|NCT00481091|65470803|FG007|Overall Study|Progressive disease clinical|0|||
23471730|NCT00481091|65470804|FG008|Overall Study|Progressive disease clinical|1|||
23471731|NCT00481091|65470805|FG009|Overall Study|Progressive disease clinical|7|||
23471732|NCT00481091|65470796|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
23471733|NCT00481091|65470797|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
23471734|NCT00481091|65470798|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471735|NCT00481091|65470799|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471736|NCT00481091|65470800|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471737|NCT00481091|65470801|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
23471738|NCT00481091|65470802|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471739|NCT00481091|65470803|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471740|NCT00481091|65470804|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23471741|NCT00481091|65470805|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
23189300|NCT02158533|64436042|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
23189301|NCT02158533|64436043|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
23189302|NCT02158533|64436044|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
23189303|NCT02158533|64436045|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
23189304|NCT02158533|64436040|FG000|Stage 1|Non-compliance with study visits|1|||
23189305|NCT02158533|64436041|FG001|Stage 1|Non-compliance with study visits|0|||
23189306|NCT02158533|64436042|FG002|Stage 1|Non-compliance with study visits|0|||
23189307|NCT02158533|64436043|FG003|Stage 1|Non-compliance with study visits|0|||
23189308|NCT02158533|64436044|FG004|Stage 1|Non-compliance with study visits|0|||
23189309|NCT02158533|64436045|FG005|Stage 1|Non-compliance with study visits|0|||
23189310|NCT02158533|64436040|FG000|Stage 2|Adverse Event|0|||
23248456|NCT00890409|64652552|FG001|Overall Study|Lost to Follow-up|21|||
23248457|NCT03123120|64652554|FG000|Overall Study|Lost to Follow-up|0|||
23248458|NCT03123120|64652555|FG001|Overall Study|Lost to Follow-up|1|||
23471742|NCT00481091|65470796|FG000|Overall Study|Progressive disease other|1|||
23587823|NCT00770965|65882025|FG003|Safety Set|Withdrawal by Subject|1|||
23587824|NCT00770965|65882022|FG000|Safety Set|Protocol deviation|0|||
23248459|NCT03123120|64652554|FG000|Overall Study|Withdrawal by Subject|0|||
23354635|NCT02452554|65041489|FG000|Overall Study|Ineligible|0|||
23354636|NCT02452554|65041490|FG001|Overall Study|Ineligible|1|||
23354637|NCT02452554|65041491|FG002|Overall Study|Ineligible|0|||
23354638|NCT02452554|65041492|FG003|Overall Study|Ineligible|0|||
23354639|NCT02452554|65041493|FG004|Overall Study|Ineligible|0|||
23354640|NCT02452554|65041494|FG005|Overall Study|Ineligible|0|||
23587825|NCT00770965|65882023|FG001|Safety Set|Protocol deviation|0|||
23587826|NCT00770965|65882024|FG002|Safety Set|Protocol deviation|1|||
23587827|NCT00770965|65882025|FG003|Safety Set|Protocol deviation|0|||
23587828|NCT00770965|65882022|FG000|Excluded Set|Administrative problems|14|||
23587829|NCT00770965|65882023|FG001|Excluded Set|Administrative problems|12|||
23587830|NCT00770965|65882024|FG002|Excluded Set|Administrative problems|12|||
23189311|NCT02158533|64436041|FG001|Stage 2|Adverse Event|0|||
23189312|NCT02158533|64436042|FG002|Stage 2|Adverse Event|0|||
23189313|NCT02158533|64436043|FG003|Stage 2|Adverse Event|0|||
23189314|NCT02158533|64436044|FG004|Stage 2|Adverse Event|0|||
23189315|NCT02158533|64436045|FG005|Stage 2|Adverse Event|1|||
23189316|NCT02158533|64436040|FG000|Stage 2|Lack of Efficacy|0|||
23189317|NCT02158533|64436041|FG001|Stage 2|Lack of Efficacy|0|||
23189318|NCT02158533|64436042|FG002|Stage 2|Lack of Efficacy|0|||
23189319|NCT02158533|64436043|FG003|Stage 2|Lack of Efficacy|0|||
23189320|NCT02158533|64436044|FG004|Stage 2|Lack of Efficacy|1|||
23587831|NCT00770965|65882025|FG003|Excluded Set|Administrative problems|10|||
23587832|NCT00770965|65882022|FG000|Excluded Set|Withdrawal by Subject|1|||
23587833|NCT00770965|65882023|FG001|Excluded Set|Withdrawal by Subject|1|||
23587834|NCT00770965|65882024|FG002|Excluded Set|Withdrawal by Subject|2|||
23587835|NCT00770965|65882025|FG003|Excluded Set|Withdrawal by Subject|3|||
23587836|NCT04012853|65882026|FG000|Overall Study|Withdrawal by Subject|1|||
23587837|NCT04012853|65882027|FG001|Overall Study|Withdrawal by Subject|1|||
23587838|NCT04012853|65882026|FG000|Overall Study|Protocol Violation|1|||
23587839|NCT04012853|65882027|FG001|Overall Study|Protocol Violation|0|||
23189321|NCT02158533|64436045|FG005|Stage 2|Lack of Efficacy|0|||
23248460|NCT03123120|64652555|FG001|Overall Study|Withdrawal by Subject|1|||
23248461|NCT00414011|64652564|FG000|Overall Study|Physician Decision|3|||
23248462|NCT00414011|64652564|FG000|Overall Study|Withdrawal by Subject|2|||
23189322|NCT02158533|64436040|FG000|Stage 2|Lost to Follow-up|0|||
23189323|NCT02158533|64436041|FG001|Stage 2|Lost to Follow-up|0|||
23189324|NCT02158533|64436042|FG002|Stage 2|Lost to Follow-up|0|||
23189325|NCT02158533|64436043|FG003|Stage 2|Lost to Follow-up|1|||
23248463|NCT04856917|64652565|FG000|Overall Study|Withdrawal by Subject|4|||
23354641|NCT02452554|65041489|FG000|Overall Study|Never Received Treatment|1|||
23354642|NCT02452554|65041490|FG001|Overall Study|Never Received Treatment|0|||
23189326|NCT02158533|64436044|FG004|Stage 2|Lost to Follow-up|1|||
23189327|NCT02158533|64436045|FG005|Stage 2|Lost to Follow-up|2|||
23248464|NCT04856917|64652566|FG001|Overall Study|Withdrawal by Subject|3|||
23248465|NCT04856917|64652567|FG002|Overall Study|Withdrawal by Subject|1|||
23248466|NCT04856917|64652565|FG000|Overall Study|Lost to Follow-up|3|||
23248467|NCT04856917|64652566|FG001|Overall Study|Lost to Follow-up|1|||
23248468|NCT04856917|64652567|FG002|Overall Study|Lost to Follow-up|1|||
23248469|NCT04856917|64652565|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
23248470|NCT04856917|64652566|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
23248471|NCT04856917|64652567|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
23248472|NCT04856917|64652565|FG000|Overall Study|Other|1|||
23248473|NCT04856917|64652566|FG001|Overall Study|Other|1|||
23248474|NCT04856917|64652567|FG002|Overall Study|Other|0|||
23248475|NCT02949219|64652569|FG000|Overall Study|Withdrawal by Subject|1|||
23248476|NCT03125915|64652572|FG000|1 Month Follow up|Lost to Follow-up|3|||
23248477|NCT03125915|64652573|FG001|1 Month Follow up|Lost to Follow-up|3|||
23248478|NCT03125915|64652574|FG002|1 Month Follow up|Lost to Follow-up|2|||
23248479|NCT03125915|64652575|FG003|1 Month Follow up|Lost to Follow-up|3|||
23248480|NCT03125915|64652572|FG000|3 Month Follow-up|Lost to Follow-up|6|||
23248481|NCT03125915|64652573|FG001|3 Month Follow-up|Lost to Follow-up|4|||
23248482|NCT03125915|64652574|FG002|3 Month Follow-up|Lost to Follow-up|4|||
23248483|NCT03125915|64652575|FG003|3 Month Follow-up|Lost to Follow-up|2|||
23248484|NCT03125915|64652572|FG000|6 Month Follow-up|Lost to Follow-up|7|||
23248485|NCT03125915|64652573|FG001|6 Month Follow-up|Lost to Follow-up|3|||
23248486|NCT03125915|64652574|FG002|6 Month Follow-up|Lost to Follow-up|6|||
23248487|NCT03125915|64652575|FG003|6 Month Follow-up|Lost to Follow-up|3|||
23248488|NCT01988337|64652582|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
23248489|NCT00902278|64652583|FG000|Overall Study|Physician Decision|1|||
23248490|NCT00902278|64652584|FG001|Overall Study|Physician Decision|0|||
23248491|NCT00902278|64652585|FG002|Overall Study|Physician Decision|2|||
23248492|NCT00902278|64652586|FG003|Overall Study|Physician Decision|0|||
23471743|NCT00481091|65470797|FG001|Overall Study|Progressive disease other|1|||
23471744|NCT00481091|65470798|FG002|Overall Study|Progressive disease other|0|||
23471745|NCT00481091|65470799|FG003|Overall Study|Progressive disease other|1|||
23471746|NCT00481091|65470800|FG004|Overall Study|Progressive disease other|1|||
23471747|NCT00481091|65470801|FG005|Overall Study|Progressive disease other|1|||
23189328|NCT02158533|64436040|FG000|Stage 2|Withdrawal by Subject|0|||
23189329|NCT02158533|64436041|FG001|Stage 2|Withdrawal by Subject|0|||
23189330|NCT02158533|64436042|FG002|Stage 2|Withdrawal by Subject|0|||
23189331|NCT02158533|64436043|FG003|Stage 2|Withdrawal by Subject|0|||
23189332|NCT02158533|64436044|FG004|Stage 2|Withdrawal by Subject|1|||
23189333|NCT02158533|64436045|FG005|Stage 2|Withdrawal by Subject|2|||
23189334|NCT02158533|64436040|FG000|Stage 2|Physician Decision|0|||
23189335|NCT02158533|64436041|FG001|Stage 2|Physician Decision|0|||
23189336|NCT02158533|64436042|FG002|Stage 2|Physician Decision|0|||
23189337|NCT02158533|64436043|FG003|Stage 2|Physician Decision|0|||
23189338|NCT02158533|64436044|FG004|Stage 2|Physician Decision|1|||
23189339|NCT02158533|64436045|FG005|Stage 2|Physician Decision|0|||
23189340|NCT02158533|64436040|FG000|Stage 2|Pregnancy|0|||
23189341|NCT02158533|64436041|FG001|Stage 2|Pregnancy|0|||
23189342|NCT02158533|64436042|FG002|Stage 2|Pregnancy|0|||
23471748|NCT00481091|65470802|FG006|Overall Study|Progressive disease other|0|||
23189343|NCT02158533|64436043|FG003|Stage 2|Pregnancy|1|||
23189344|NCT02158533|64436044|FG004|Stage 2|Pregnancy|0|||
23189345|NCT02158533|64436045|FG005|Stage 2|Pregnancy|0|||
23189346|NCT02158533|64436040|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
23248493|NCT00902278|64652587|FG004|Overall Study|Physician Decision|1|||
23248494|NCT00902278|64652583|FG000|Overall Study|Lost to Follow-up|3|||
23248495|NCT00902278|64652584|FG001|Overall Study|Lost to Follow-up|2|||
23248496|NCT00902278|64652585|FG002|Overall Study|Lost to Follow-up|3|||
23471749|NCT00481091|65470803|FG007|Overall Study|Progressive disease other|2|||
23189347|NCT02158533|64436041|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
23189348|NCT02158533|64436042|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
23189349|NCT02158533|64436043|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
23471750|NCT00481091|65470804|FG008|Overall Study|Progressive disease other|0|||
23189350|NCT02158533|64436044|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
23189351|NCT02158533|64436045|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
23471751|NCT00481091|65470805|FG009|Overall Study|Progressive disease other|0|||
23471752|NCT00481091|65470796|FG000|Overall Study|No reason given|0|||
23471753|NCT00481091|65470797|FG001|Overall Study|No reason given|0|||
23471754|NCT00481091|65470798|FG002|Overall Study|No reason given|1|||
23471755|NCT00481091|65470799|FG003|Overall Study|No reason given|1|||
23471756|NCT00481091|65470800|FG004|Overall Study|No reason given|1|||
23471757|NCT00481091|65470801|FG005|Overall Study|No reason given|0|||
23471758|NCT00481091|65470802|FG006|Overall Study|No reason given|1|||
23471759|NCT00481091|65470803|FG007|Overall Study|No reason given|1|||
23471760|NCT00481091|65470804|FG008|Overall Study|No reason given|1|||
23471761|NCT00481091|65470805|FG009|Overall Study|No reason given|4|||
23471762|NCT01874340|65470807|FG000|Overall Study|Study terminated by Sponsor|6|||
23471763|NCT01874340|65470808|FG001|Overall Study|Study terminated by Sponsor|8|||
23471764|NCT01874340|65470809|FG002|Overall Study|Study terminated by Sponsor|8|||
23471765|NCT01874340|65470810|FG003|Overall Study|Study terminated by Sponsor|4|||
23471766|NCT01874340|65470807|FG000|Overall Study|Withdrawal by Subject|0|||
23471767|NCT01874340|65470808|FG001|Overall Study|Withdrawal by Subject|0|||
23471768|NCT01874340|65470809|FG002|Overall Study|Withdrawal by Subject|0|||
23471769|NCT01874340|65470810|FG003|Overall Study|Withdrawal by Subject|1|||
23471770|NCT00330967|65470811|FG000|Overall Study|Withdrawal by Subject|0|||
23471771|NCT00330967|65470812|FG001|Overall Study|Withdrawal by Subject|5|||
23471772|NCT00330967|65470811|FG000|Overall Study|Physician Decision|0|||
23471773|NCT00330967|65470812|FG001|Overall Study|Physician Decision|9|||
23471774|NCT02036853|65470813|FG000|Overall Study|Adverse Event|0|||
23471775|NCT02036853|65470814|FG001|Overall Study|Adverse Event|2|||
23471776|NCT02036853|65470813|FG000|Overall Study|Lack of Efficacy|0|||
23471777|NCT02036853|65470814|FG001|Overall Study|Lack of Efficacy|2|||
23471778|NCT02036853|65470813|FG000|Overall Study|Physician Decision|0|||
23471779|NCT02036853|65470814|FG001|Overall Study|Physician Decision|1|||
23471780|NCT02036853|65470813|FG000|Overall Study|Withdrawal by Subject|0|||
23471781|NCT02036853|65470814|FG001|Overall Study|Withdrawal by Subject|1|||
23471782|NCT00126490|65470815|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
23471783|NCT01500720|65470826|FG000|Overall Study|Randomized But Not Treated|1|||
23471784|NCT01500720|65470827|FG001|Overall Study|Randomized But Not Treated|1|||
23471785|NCT01500720|65470826|FG000|Overall Study|Other|4|||
23471786|NCT01500720|65470827|FG001|Overall Study|Other|8|||
23471787|NCT00578292|65470828|FG000|Overall Study|Death|1|||
23471788|NCT00578292|65470828|FG000|Overall Study|Graft failure|2|||
23471789|NCT03304249|65470829|FG000|Overall Study|Lost to Follow-up|8|||
23471790|NCT03304249|65470830|FG001|Overall Study|Lost to Follow-up|10|||
23471791|NCT03304249|65470829|FG000|Overall Study|Withdrawal by Subject|12|||
23471792|NCT03304249|65470830|FG001|Overall Study|Withdrawal by Subject|2|||
23471793|NCT03304249|65470829|FG000|Overall Study|Moved Out of District|4|||
23471794|NCT03304249|65470830|FG001|Overall Study|Moved Out of District|2|||
23471795|NCT00531427|65470831|FG000|Overall Study|Withdrawal by Subject|7|||
23471796|NCT00531427|65470832|FG001|Overall Study|Withdrawal by Subject|13|||
23471797|NCT00531427|65470831|FG000|Overall Study|Adverse Event|44|||
23189352|NCT02158533|64436040|FG000|Stage 2|Non-adherence with study visits|0|||
23189353|NCT02158533|64436041|FG001|Stage 2|Non-adherence with study visits|0|||
23189354|NCT02158533|64436042|FG002|Stage 2|Non-adherence with study visits|0|||
23189355|NCT02158533|64436043|FG003|Stage 2|Non-adherence with study visits|0|||
23189356|NCT02158533|64436044|FG004|Stage 2|Non-adherence with study visits|0|||
23471798|NCT00531427|65470832|FG001|Overall Study|Adverse Event|30|||
23587840|NCT04012853|65882026|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
23587841|NCT04012853|65882027|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
23189357|NCT02158533|64436045|FG005|Stage 2|Non-adherence with study visits|1|||
23189358|NCT02300129|64436046|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
23189359|NCT02300129|64436047|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
23189360|NCT02300129|64436048|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
23189361|NCT02300129|64436049|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
23189362|NCT02300129|64436046|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
23189363|NCT02300129|64436047|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
23248497|NCT00902278|64652586|FG003|Overall Study|Lost to Follow-up|0|||
23471799|NCT00531427|65470831|FG000|Overall Study|Lost to Follow-up|4|||
23471800|NCT00531427|65470832|FG001|Overall Study|Lost to Follow-up|3|||
23471801|NCT00531427|65470831|FG000|Overall Study|Lack of Efficacy|14|||
23471802|NCT00531427|65470832|FG001|Overall Study|Lack of Efficacy|39|||
23471803|NCT00531427|65470831|FG000|Overall Study|Administrative|4|||
23471804|NCT00531427|65470832|FG001|Overall Study|Administrative|9|||
23471805|NCT01396070|65470833|FG000|Overall Study|Withdrawal by Subject|2|||
23471806|NCT01396070|65470833|FG000|Overall Study|Death|2|||
23471807|NCT01396070|65470833|FG000|Overall Study|Adverse Event|8|||
23471808|NCT01396070|65470833|FG000|Overall Study|Physician Decision|3|||
23471809|NCT01396070|65470833|FG000|Overall Study|Lack of Efficacy|4|||
23354643|NCT02452554|65041491|FG002|Overall Study|Never Received Treatment|0|||
23471810|NCT03037580|65470834|FG000|Overall Study|Withdrawal by Subject|3|||
23471811|NCT03037580|65470835|FG001|Overall Study|Withdrawal by Subject|0|||
23471812|NCT03037580|65470834|FG000|Overall Study|Adverse Event|1|||
23471813|NCT03037580|65470835|FG001|Overall Study|Adverse Event|0|||
23471814|NCT03037580|65470834|FG000|Overall Study|Study Terminated by Sponsor|12|||
23471815|NCT03037580|65470835|FG001|Overall Study|Study Terminated by Sponsor|15|||
23471816|NCT03037580|65470834|FG000|Overall Study|Death|0|||
23471817|NCT03037580|65470835|FG001|Overall Study|Death|1|||
23471818|NCT02687191|65470836|FG000|Overall Study|Death|0|||
23471819|NCT02687191|65470837|FG001|Overall Study|Death|1|||
23471820|NCT02687191|65470838|FG002|Overall Study|Death|1|||
23471821|NCT02687191|65470839|FG003|Overall Study|Death|0|||
23471822|NCT02687191|65470840|FG004|Overall Study|Death|1|||
23471823|NCT02687191|65470841|FG005|Overall Study|Death|1|||
23471824|NCT02687191|65470836|FG000|Overall Study|Withdrawal by Subject|0|||
23471825|NCT02687191|65470837|FG001|Overall Study|Withdrawal by Subject|0|||
23471826|NCT02687191|65470838|FG002|Overall Study|Withdrawal by Subject|0|||
23471827|NCT02687191|65470839|FG003|Overall Study|Withdrawal by Subject|1|||
23471828|NCT02687191|65470840|FG004|Overall Study|Withdrawal by Subject|0|||
23471829|NCT02687191|65470841|FG005|Overall Study|Withdrawal by Subject|0|||
23471830|NCT01354899|65470842|FG000|Overall Study|discharge from the hospital|2|||
23471831|NCT01354899|65470842|FG000|Overall Study|Protocol Violation|1|||
23471832|NCT03566485|65470843|FG000|Overall Study|Disease progression|5|||
23471833|NCT03566485|65470844|FG001|Overall Study|Disease progression|4|||
23471834|NCT03566485|65470843|FG000|Overall Study|Clinical progression|0|||
23471835|NCT03566485|65470844|FG001|Overall Study|Clinical progression|1|||
23471836|NCT03566485|65470843|FG000|Overall Study|Toxicity|0|||
23471837|NCT03566485|65470844|FG001|Overall Study|Toxicity|2|||
23471838|NCT01387542|65470854|FG000|Overall Study|Adverse Event|3|||
23471839|NCT01387542|65470854|FG000|Overall Study|Withdrawal by Subject|1|||
23471840|NCT01387542|65470854|FG000|Overall Study|Changed diagnosis|1|||
23471841|NCT01387542|65470854|FG000|Overall Study|Insufficient response|1|||
23471842|NCT01387542|65470854|FG000|Overall Study|Non-compliant|1|||
23471843|NCT01387542|65470854|FG000|Overall Study|Lost to Follow-up|1|||
23471844|NCT01761240|65470855|FG000|Overall Study|Progressive disease:radiology assessment|3|||
23471845|NCT01761240|65470856|FG001|Overall Study|Progressive disease:radiology assessment|3|||
23471846|NCT01761240|65470857|FG002|Overall Study|Progressive disease:radiology assessment|0|||
23471847|NCT01761240|65470858|FG003|Overall Study|Progressive disease:radiology assessment|0|||
23471848|NCT01761240|65470859|FG004|Overall Study|Progressive disease:radiology assessment|0|||
23471849|NCT01761240|65470855|FG000|Overall Study|Progressive disease:clinical assessment|0|||
23471850|NCT01761240|65470856|FG001|Overall Study|Progressive disease:clinical assessment|0|||
23471851|NCT01761240|65470857|FG002|Overall Study|Progressive disease:clinical assessment|3|||
23471852|NCT01761240|65470858|FG003|Overall Study|Progressive disease:clinical assessment|1|||
23587842|NCT02314117|65882030|FG000|Overall Study|Lost to Follow-up|9|||
23587843|NCT02314117|65882031|FG001|Overall Study|Lost to Follow-up|14|||
23587844|NCT02314117|65882030|FG000|Overall Study|Withdrawal by Subject|3|||
23587845|NCT02314117|65882031|FG001|Overall Study|Withdrawal by Subject|2|||
23587846|NCT02488980|65882039|FG000|Overall Study|Protocol Violation|2|||
23587847|NCT02488980|65882040|FG001|Overall Study|Protocol Violation|2|||
23587848|NCT02488980|65882041|FG002|Overall Study|Protocol Violation|2|||
23587849|NCT00708032|65882045|FG000|Overall Study|Adverse Event|0|||
23587850|NCT00708032|65882046|FG001|Overall Study|Adverse Event|2|||
23587851|NCT00708032|65882045|FG000|Overall Study|Lost to Follow-up|1|||
23587852|NCT00708032|65882046|FG001|Overall Study|Lost to Follow-up|2|||
23587853|NCT00708032|65882045|FG000|Overall Study|Pregnancy|0|||
23189364|NCT02300129|64436048|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
23471853|NCT01761240|65470859|FG004|Overall Study|Progressive disease:clinical assessment|0|||
23471854|NCT01761240|65470855|FG000|Overall Study|Withdrawal by Subject|0|||
23471855|NCT01761240|65470856|FG001|Overall Study|Withdrawal by Subject|0|||
23471856|NCT01761240|65470857|FG002|Overall Study|Withdrawal by Subject|0|||
23471857|NCT01761240|65470858|FG003|Overall Study|Withdrawal by Subject|3|||
23471858|NCT01761240|65470859|FG004|Overall Study|Withdrawal by Subject|1|||
23471859|NCT01761240|65470855|FG000|Overall Study|Adverse Event|0|||
23471860|NCT01761240|65470856|FG001|Overall Study|Adverse Event|0|||
23587854|NCT00708032|65882046|FG001|Overall Study|Pregnancy|1|||
23471861|NCT01761240|65470857|FG002|Overall Study|Adverse Event|0|||
23471862|NCT01761240|65470858|FG003|Overall Study|Adverse Event|1|||
23471863|NCT01761240|65470859|FG004|Overall Study|Adverse Event|6|||
23471864|NCT01761240|65470855|FG000|Overall Study|Death|0|||
23471865|NCT01761240|65470856|FG001|Overall Study|Death|1|||
23471866|NCT01761240|65470857|FG002|Overall Study|Death|1|||
23471867|NCT01761240|65470858|FG003|Overall Study|Death|2|||
23471868|NCT01761240|65470859|FG004|Overall Study|Death|1|||
23471869|NCT01761240|65470855|FG000|Overall Study|Non-compliance|0|||
23471870|NCT01761240|65470856|FG001|Overall Study|Non-compliance|0|||
23471871|NCT01761240|65470857|FG002|Overall Study|Non-compliance|1|||
23587855|NCT00708032|65882045|FG000|Overall Study|Poor vision|0|||
23471872|NCT01761240|65470858|FG003|Overall Study|Non-compliance|0|||
23471873|NCT01761240|65470859|FG004|Overall Study|Non-compliance|0|||
23471874|NCT02442804|65470860|FG000|Overall Study|Withdrawal by Subject|0|||
23471875|NCT02442804|65470861|FG001|Overall Study|Withdrawal by Subject|1|||
23471876|NCT02442804|65470860|FG000|Overall Study|Adverse Event|1|||
23471877|NCT02442804|65470861|FG001|Overall Study|Adverse Event|0|||
23471878|NCT02969655|65470862|FG000|Overall Study|Withdrawal by Subject|3|||
23471879|NCT02969655|65470863|FG001|Overall Study|Withdrawal by Subject|2|||
23471880|NCT02969655|65470862|FG000|Overall Study|Physician Decision|4|||
23471881|NCT02969655|65470863|FG001|Overall Study|Physician Decision|3|||
23471882|NCT02969655|65470862|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
23471883|NCT02969655|65470863|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
23471884|NCT02969655|65470862|FG000|Overall Study|Adverse Event|10|||
23471885|NCT02969655|65470863|FG001|Overall Study|Adverse Event|8|||
23471886|NCT00790088|65470864|FG000|Overall Study|Protocol Violation|11|||
23471887|NCT00790088|65470864|FG000|Overall Study|Withdrawal by Subject|17|||
23189365|NCT02300129|64436049|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
23189366|NCT02300129|64436046|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
23189367|NCT02300129|64436047|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
23189368|NCT02300129|64436048|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
23471888|NCT00790088|65470864|FG000|Overall Study|Lost to Follow-up|7|||
23471889|NCT00790088|65470864|FG000|Overall Study|Physician Decision|4|||
23471890|NCT02152956|65470865|FG000|Overall Study|Adverse Event|0|||
23471891|NCT02152956|65470866|FG001|Overall Study|Adverse Event|0|||
23471892|NCT02152956|65470867|FG002|Overall Study|Adverse Event|0|||
23471893|NCT02152956|65470868|FG003|Overall Study|Adverse Event|0|||
23471894|NCT02152956|65470869|FG004|Overall Study|Adverse Event|0|||
23471895|NCT02152956|65470870|FG005|Overall Study|Adverse Event|0|||
23471896|NCT02152956|65470871|FG006|Overall Study|Adverse Event|0|||
23471897|NCT02152956|65470872|FG007|Overall Study|Adverse Event|0|||
23471898|NCT02152956|65470873|FG008|Overall Study|Adverse Event|0|||
23471899|NCT02152956|65470874|FG009|Overall Study|Adverse Event|0|||
23471900|NCT02152956|65470875|FG010|Overall Study|Adverse Event|0|||
23471901|NCT02152956|65470876|FG011|Overall Study|Adverse Event|4|||
23471902|NCT02152956|65470877|FG012|Overall Study|Adverse Event|0|||
23471903|NCT02152956|65470865|FG000|Overall Study|Death|0|||
23471904|NCT02152956|65470866|FG001|Overall Study|Death|3|||
23471905|NCT02152956|65470867|FG002|Overall Study|Death|3|||
23471906|NCT02152956|65470868|FG003|Overall Study|Death|4|||
23587856|NCT00708032|65882046|FG001|Overall Study|Poor vision|6|||
23587857|NCT00708032|65882045|FG000|Overall Study|Visit out of range at month 12|4|||
23587858|NCT00708032|65882046|FG001|Overall Study|Visit out of range at month 12|1|||
23587859|NCT00708032|65882045|FG000|Overall Study|Did not meet protocol criteria|1|||
23587860|NCT00708032|65882046|FG001|Overall Study|Did not meet protocol criteria|2|||
23587861|NCT00708032|65882045|FG000|Overall Study|Protocol Violation|4|||
23189369|NCT02300129|64436049|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
23354644|NCT02452554|65041492|FG003|Overall Study|Never Received Treatment|0|||
23189370|NCT02453841|64436050|FG000|Overall Study|Protocol Violation|1|||
23189371|NCT02453841|64436050|FG000|Overall Study|Unable to obtain blood samples|2|||
23189372|NCT00117312|64436051|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
23354645|NCT02452554|65041493|FG004|Overall Study|Never Received Treatment|0|||
23354646|NCT02452554|65041494|FG005|Overall Study|Never Received Treatment|0|||
23354647|NCT02327013|65041495|FG000|Overall Study|Adverse Event|4|||
23354648|NCT02327013|65041496|FG001|Overall Study|Adverse Event|4|||
23354649|NCT02327013|65041497|FG002|Overall Study|Adverse Event|3|||
23354650|NCT02327013|65041498|FG003|Overall Study|Adverse Event|0|||
23354651|NCT02327013|65041499|FG004|Overall Study|Adverse Event|1|||
23354652|NCT02327013|65041495|FG000|Overall Study|Lack of Efficacy|2|||
23354653|NCT02327013|65041496|FG001|Overall Study|Lack of Efficacy|0|||
23354654|NCT02327013|65041497|FG002|Overall Study|Lack of Efficacy|5|||
23354655|NCT02327013|65041498|FG003|Overall Study|Lack of Efficacy|0|||
23354656|NCT02327013|65041499|FG004|Overall Study|Lack of Efficacy|1|||
23354657|NCT02327013|65041495|FG000|Overall Study|Non-compliance with IMP|1|||
23471907|NCT02152956|65470869|FG004|Overall Study|Death|1|||
23471908|NCT02152956|65470870|FG005|Overall Study|Death|2|||
23354658|NCT02327013|65041496|FG001|Overall Study|Non-compliance with IMP|2|||
23354659|NCT02327013|65041497|FG002|Overall Study|Non-compliance with IMP|7|||
23354660|NCT02327013|65041498|FG003|Overall Study|Non-compliance with IMP|0|||
23471909|NCT02152956|65470871|FG006|Overall Study|Death|6|||
23471910|NCT02152956|65470872|FG007|Overall Study|Death|6|||
23471911|NCT02152956|65470873|FG008|Overall Study|Death|4|||
23471912|NCT02152956|65470874|FG009|Overall Study|Death|5|||
23587862|NCT00708032|65882046|FG001|Overall Study|Protocol Violation|1|||
23189373|NCT00117312|64436052|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
23587863|NCT00708032|65882045|FG000|Overall Study|Withdrawal by Subject|0|||
23587864|NCT00708032|65882046|FG001|Overall Study|Withdrawal by Subject|1|||
23471913|NCT02152956|65470875|FG010|Overall Study|Death|3|||
23471914|NCT02152956|65470876|FG011|Overall Study|Death|143|||
23471915|NCT02152956|65470877|FG012|Overall Study|Death|12|||
23189374|NCT00117312|64436053|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
23189375|NCT00117312|64436054|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
23189376|NCT00117312|64436051|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
23189377|NCT00117312|64436052|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
23189378|NCT00117312|64436053|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
23189379|NCT00117312|64436054|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
23189380|NCT00117312|64436051|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
23189381|NCT00117312|64436052|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
23189382|NCT00117312|64436053|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
23189383|NCT00117312|64436054|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
23189384|NCT00117312|64436051|FG000|Overall Study|Other|0|||
23189385|NCT00117312|64436052|FG001|Overall Study|Other|1|||
23189386|NCT00117312|64436053|FG002|Overall Study|Other|3|||
23189387|NCT00117312|64436054|FG003|Overall Study|Other|1|||
23189388|NCT00117312|64436051|FG000|Overall Study|Patient choice|0|||
23189389|NCT00117312|64436052|FG001|Overall Study|Patient choice|0|||
23189390|NCT00117312|64436053|FG002|Overall Study|Patient choice|2|||
23189391|NCT00117312|64436054|FG003|Overall Study|Patient choice|1|||
23189392|NCT00117312|64436051|FG000|Overall Study|Adverse Event|0|||
23189393|NCT00117312|64436052|FG001|Overall Study|Adverse Event|2|||
23189394|NCT00117312|64436053|FG002|Overall Study|Adverse Event|0|||
23189395|NCT00117312|64436054|FG003|Overall Study|Adverse Event|0|||
23189396|NCT00117312|64436051|FG000|Overall Study|Protocol Violation|0|||
23189397|NCT00117312|64436052|FG001|Overall Study|Protocol Violation|1|||
23189398|NCT00117312|64436053|FG002|Overall Study|Protocol Violation|3|||
23189399|NCT00117312|64436054|FG003|Overall Study|Protocol Violation|0|||
23248498|NCT00902278|64652587|FG004|Overall Study|Lost to Follow-up|1|||
23248499|NCT00981409|64652588|FG000|Overall Study|Adverse Event|4|||
23248500|NCT00981409|64652589|FG001|Overall Study|Adverse Event|0|||
23248501|NCT00981409|64652588|FG000|Overall Study|Protocol Violation|0|||
23248502|NCT00981409|64652589|FG001|Overall Study|Protocol Violation|1|||
23248503|NCT00981409|64652588|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
23248504|NCT00981409|64652589|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
23248505|NCT00447694|64652590|FG000|Overall Study|Adverse Event|2|||
23248506|NCT00447694|64652590|FG000|Overall Study|Abnormal laboratory value|1|||
23248507|NCT00447694|64652590|FG000|Overall Study|Abnormal test procedure result|1|||
23248508|NCT00447694|64652590|FG000|Overall Study|Withdrawal by Subject|2|||
23248509|NCT03669640|64652593|FG000|Overall Study|Study Terminated by Sponsor|0|||
23248510|NCT03669640|64652594|FG001|Overall Study|Study Terminated by Sponsor|0|||
23248511|NCT03669640|64652595|FG002|Overall Study|Study Terminated by Sponsor|0|||
23248512|NCT03669640|64652596|FG003|Overall Study|Study Terminated by Sponsor|0|||
23248513|NCT03669640|64652597|FG004|Overall Study|Study Terminated by Sponsor|1|||
23248514|NCT03669640|64652598|FG005|Overall Study|Study Terminated by Sponsor|0|||
23248515|NCT03669640|64652593|FG000|Overall Study|Lost to Follow-up|0|||
23248516|NCT03669640|64652594|FG001|Overall Study|Lost to Follow-up|0|||
23248517|NCT03669640|64652595|FG002|Overall Study|Lost to Follow-up|2|||
23248518|NCT03669640|64652596|FG003|Overall Study|Lost to Follow-up|0|||
23248519|NCT03669640|64652597|FG004|Overall Study|Lost to Follow-up|0|||
23248520|NCT03669640|64652598|FG005|Overall Study|Lost to Follow-up|0|||
23248521|NCT03669640|64652593|FG000|Overall Study|Death|0|||
23248522|NCT03669640|64652594|FG001|Overall Study|Death|0|||
23248523|NCT03669640|64652595|FG002|Overall Study|Death|1|||
23248524|NCT03669640|64652596|FG003|Overall Study|Death|0|||
23248525|NCT03669640|64652597|FG004|Overall Study|Death|0|||
23248526|NCT03669640|64652598|FG005|Overall Study|Death|0|||
23248527|NCT03669640|64652593|FG000|Overall Study|Withdrawal by Subject|1|||
23248528|NCT03669640|64652594|FG001|Overall Study|Withdrawal by Subject|2|||
23248529|NCT03669640|64652595|FG002|Overall Study|Withdrawal by Subject|1|||
23248530|NCT03669640|64652596|FG003|Overall Study|Withdrawal by Subject|0|||
23248531|NCT03669640|64652597|FG004|Overall Study|Withdrawal by Subject|1|||
23354661|NCT02327013|65041499|FG004|Overall Study|Non-compliance with IMP|0|||
23354662|NCT02327013|65041495|FG000|Overall Study|Withdrawal of Consent|1|||
23354663|NCT02327013|65041496|FG001|Overall Study|Withdrawal of Consent|0|||
23354664|NCT02327013|65041497|FG002|Overall Study|Withdrawal of Consent|3|||
23354665|NCT02327013|65041498|FG003|Overall Study|Withdrawal of Consent|0|||
23587865|NCT03441360|65882047|FG000|Overall Study|Radiological disease progression|5|||
23587866|NCT03441360|65882048|FG001|Overall Study|Radiological disease progression|6|||
23587867|NCT03441360|65882049|FG002|Overall Study|Radiological disease progression|4|||
23587868|NCT03441360|65882047|FG000|Overall Study|Clinical disease progression|2|||
23587869|NCT03441360|65882048|FG001|Overall Study|Clinical disease progression|2|||
23189400|NCT00117312|64436051|FG000|Overall Study|PSA decrease <=50%|0|||
23189401|NCT00117312|64436052|FG001|Overall Study|PSA decrease <=50%|2|||
23248532|NCT03669640|64652598|FG005|Overall Study|Withdrawal by Subject|3|||
23248533|NCT03669640|64652593|FG000|Overall Study|Protocol Violation|1|||
23248534|NCT03669640|64652594|FG001|Overall Study|Protocol Violation|0|||
23248535|NCT03669640|64652595|FG002|Overall Study|Protocol Violation|0|||
23248536|NCT03669640|64652596|FG003|Overall Study|Protocol Violation|0|||
23248537|NCT03669640|64652597|FG004|Overall Study|Protocol Violation|0|||
23248538|NCT03669640|64652598|FG005|Overall Study|Protocol Violation|0|||
23248539|NCT03669640|64652593|FG000|Overall Study|Physician Decision|0|||
23587870|NCT03441360|65882049|FG002|Overall Study|Clinical disease progression|0|||
23587871|NCT03441360|65882047|FG000|Overall Study|Adverse Event|1|||
23587872|NCT03441360|65882048|FG001|Overall Study|Adverse Event|0|||
23587873|NCT03441360|65882049|FG002|Overall Study|Adverse Event|1|||
23587874|NCT03885596|65882051|FG000|Overall Study|Withdrawal by Subject|2|||
23587875|NCT03885596|65882052|FG001|Overall Study|Withdrawal by Subject|1|||
23587876|NCT03885596|65882053|FG002|Overall Study|Withdrawal by Subject|0|||
23587877|NCT03885596|65882054|FG003|Overall Study|Withdrawal by Subject|0|||
23587878|NCT00957229|65882055|FG000|Study Start|Adverse Event|0|||
23587879|NCT00957229|65882056|FG001|Study Start|Adverse Event|3|||
23587880|NCT00957229|65882055|FG000|Study Start|Disease Progression|1|||
23587881|NCT00957229|65882056|FG001|Study Start|Disease Progression|0|||
23587882|NCT00957229|65882055|FG000|Reallocated to or Continued Vismodegib|Death|1|||
23587883|NCT00957229|65882056|FG001|Reallocated to or Continued Vismodegib|Death|1|||
23587884|NCT00957229|65882055|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
23587885|NCT00957229|65882056|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
23587886|NCT01050569|65882057|FG000|Overall Study|Lost to Follow-up|20|||
23587887|NCT01050569|65882058|FG001|Overall Study|Lost to Follow-up|14|||
23587888|NCT01050569|65882059|FG002|Overall Study|Lost to Follow-up|16|||
23587889|NCT01050569|65882057|FG000|Overall Study|Withdrawal by Subject|9|||
23587890|NCT01050569|65882058|FG001|Overall Study|Withdrawal by Subject|3|||
23587891|NCT01050569|65882059|FG002|Overall Study|Withdrawal by Subject|11|||
23248540|NCT03669640|64652594|FG001|Overall Study|Physician Decision|2|||
23587892|NCT01050569|65882057|FG000|Overall Study|Lack of Efficacy|5|||
23587893|NCT01050569|65882058|FG001|Overall Study|Lack of Efficacy|4|||
23189402|NCT00117312|64436053|FG002|Overall Study|PSA decrease <=50%|2|||
23248541|NCT03669640|64652595|FG002|Overall Study|Physician Decision|0|||
23587894|NCT01050569|65882059|FG002|Overall Study|Lack of Efficacy|3|||
23587895|NCT01050569|65882057|FG000|Overall Study|Adverse Event|1|||
23248542|NCT03669640|64652596|FG003|Overall Study|Physician Decision|0|||
23248543|NCT03669640|64652597|FG004|Overall Study|Physician Decision|0|||
23248544|NCT03669640|64652598|FG005|Overall Study|Physician Decision|0|||
23248545|NCT03669640|64652593|FG000|Overall Study|Disease Relapse|1|||
23248546|NCT03669640|64652594|FG001|Overall Study|Disease Relapse|0|||
23248547|NCT03669640|64652595|FG002|Overall Study|Disease Relapse|0|||
23248548|NCT03669640|64652596|FG003|Overall Study|Disease Relapse|0|||
23248549|NCT03669640|64652597|FG004|Overall Study|Disease Relapse|0|||
23248550|NCT03669640|64652598|FG005|Overall Study|Disease Relapse|0|||
23248551|NCT03669640|64652593|FG000|Overall Study|Adverse Event|2|||
23248552|NCT03669640|64652594|FG001|Overall Study|Adverse Event|1|||
23248553|NCT03669640|64652595|FG002|Overall Study|Adverse Event|0|||
23248554|NCT03669640|64652596|FG003|Overall Study|Adverse Event|0|||
23248555|NCT03669640|64652597|FG004|Overall Study|Adverse Event|1|||
23248556|NCT03669640|64652598|FG005|Overall Study|Adverse Event|0|||
23354666|NCT02327013|65041499|FG004|Overall Study|Withdrawal of Consent|0|||
23354667|NCT02327013|65041495|FG000|Overall Study|Lost to Follow-up|2|||
23354668|NCT02327013|65041496|FG001|Overall Study|Lost to Follow-up|4|||
23354669|NCT02327013|65041497|FG002|Overall Study|Lost to Follow-up|5|||
23354670|NCT02327013|65041498|FG003|Overall Study|Lost to Follow-up|0|||
23354671|NCT02327013|65041499|FG004|Overall Study|Lost to Follow-up|0|||
23354672|NCT02327013|65041495|FG000|Overall Study|Administrative or other reason(s)|1|||
23354673|NCT02327013|65041496|FG001|Overall Study|Administrative or other reason(s)|5|||
23354674|NCT02327013|65041497|FG002|Overall Study|Administrative or other reason(s)|11|||
23354675|NCT02327013|65041498|FG003|Overall Study|Administrative or other reason(s)|1|||
23471916|NCT02152956|65470865|FG000|Overall Study|Lost to Follow-up|0|||
23471917|NCT02152956|65470866|FG001|Overall Study|Lost to Follow-up|1|||
23471918|NCT02152956|65470867|FG002|Overall Study|Lost to Follow-up|0|||
23471919|NCT02152956|65470868|FG003|Overall Study|Lost to Follow-up|0|||
23471920|NCT02152956|65470869|FG004|Overall Study|Lost to Follow-up|0|||
23471921|NCT02152956|65470870|FG005|Overall Study|Lost to Follow-up|0|||
23471922|NCT02152956|65470871|FG006|Overall Study|Lost to Follow-up|0|||
23471923|NCT02152956|65470872|FG007|Overall Study|Lost to Follow-up|0|||
23471924|NCT02152956|65470873|FG008|Overall Study|Lost to Follow-up|0|||
23471925|NCT02152956|65470874|FG009|Overall Study|Lost to Follow-up|0|||
23471926|NCT02152956|65470875|FG010|Overall Study|Lost to Follow-up|0|||
23354676|NCT02327013|65041499|FG004|Overall Study|Administrative or other reason(s)|1|||
23354677|NCT02327013|65041495|FG000|Overall Study|Protocol Violation|0|||
23471927|NCT02152956|65470876|FG011|Overall Study|Lost to Follow-up|3|||
23354678|NCT02327013|65041496|FG001|Overall Study|Protocol Violation|0|||
23471928|NCT02152956|65470877|FG012|Overall Study|Lost to Follow-up|0|||
23248557|NCT03533608|64652599|FG000|Overall Study|Withdrawal by Subject|3|||
23248558|NCT03533608|64652599|FG000|Overall Study|Physician Decision|2|||
23248559|NCT01956123|64652603|FG000|COS Cycle 2|Protocol Violation|8|||
23248560|NCT01956123|64652604|FG001|COS Cycle 2|Protocol Violation|3|||
23248561|NCT01956123|64652605|FG002|COS Cycle 2|Protocol Violation|0|||
23248562|NCT01956123|64652606|FG003|COS Cycle 2|Protocol Violation|0|||
23248563|NCT01956123|64652603|FG000|COS Cycle 2|Adverse Event|3|||
23248564|NCT01956123|64652604|FG001|COS Cycle 2|Adverse Event|4|||
23248565|NCT01956123|64652605|FG002|COS Cycle 2|Adverse Event|0|||
23248566|NCT01956123|64652606|FG003|COS Cycle 2|Adverse Event|0|||
23248567|NCT01956123|64652603|FG000|COS Cycle 2|Personal Reasons|2|||
23248568|NCT01956123|64652604|FG001|COS Cycle 2|Personal Reasons|0|||
23248569|NCT01956123|64652605|FG002|COS Cycle 2|Personal Reasons|0|||
23248570|NCT01956123|64652606|FG003|COS Cycle 2|Personal Reasons|0|||
23248571|NCT01956123|64652603|FG000|COS Cycle 2|Withdrawal by Subject|1|||
23189403|NCT00117312|64436054|FG003|Overall Study|PSA decrease <=50%|4|||
23189404|NCT00117312|64436051|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
23189405|NCT00117312|64436052|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
23189406|NCT00117312|64436053|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
23189407|NCT00117312|64436054|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
23189408|NCT00117312|64436051|FG000|Overall Study|Hepatic abnormality|0|||
23189409|NCT00117312|64436052|FG001|Overall Study|Hepatic abnormality|1|||
23189410|NCT00117312|64436053|FG002|Overall Study|Hepatic abnormality|0|||
23189411|NCT00117312|64436054|FG003|Overall Study|Hepatic abnormality|1|||
23189412|NCT00117312|64436051|FG000|Overall Study|Withdrawal by Subject|0|||
23189413|NCT00117312|64436052|FG001|Overall Study|Withdrawal by Subject|2|||
23189414|NCT00117312|64436053|FG002|Overall Study|Withdrawal by Subject|0|||
23471929|NCT02152956|65470865|FG000|Overall Study|Withdrawal by Subject|1|||
23471930|NCT02152956|65470866|FG001|Overall Study|Withdrawal by Subject|0|||
23471931|NCT02152956|65470867|FG002|Overall Study|Withdrawal by Subject|1|||
23471932|NCT02152956|65470868|FG003|Overall Study|Withdrawal by Subject|0|||
23189415|NCT00117312|64436054|FG003|Overall Study|Withdrawal by Subject|0|||
23471933|NCT02152956|65470869|FG004|Overall Study|Withdrawal by Subject|2|||
23471934|NCT02152956|65470870|FG005|Overall Study|Withdrawal by Subject|2|||
23471935|NCT02152956|65470871|FG006|Overall Study|Withdrawal by Subject|0|||
23471936|NCT02152956|65470872|FG007|Overall Study|Withdrawal by Subject|0|||
23471937|NCT02152956|65470873|FG008|Overall Study|Withdrawal by Subject|1|||
23248572|NCT01956123|64652604|FG001|COS Cycle 2|Withdrawal by Subject|0|||
23248573|NCT01956123|64652605|FG002|COS Cycle 2|Withdrawal by Subject|0|||
23248574|NCT01956123|64652606|FG003|COS Cycle 2|Withdrawal by Subject|0|||
23354679|NCT02327013|65041497|FG002|Overall Study|Protocol Violation|3|||
23354680|NCT02327013|65041498|FG003|Overall Study|Protocol Violation|0|||
23354681|NCT02327013|65041499|FG004|Overall Study|Protocol Violation|1|||
23354682|NCT02327013|65041495|FG000|Overall Study|Withdrawal before treatment|2|||
23354683|NCT02327013|65041496|FG001|Overall Study|Withdrawal before treatment|1|||
23354684|NCT02327013|65041497|FG002|Overall Study|Withdrawal before treatment|5|||
23354685|NCT02327013|65041498|FG003|Overall Study|Withdrawal before treatment|0|||
23354686|NCT02327013|65041499|FG004|Overall Study|Withdrawal before treatment|0|||
23471938|NCT02152956|65470874|FG009|Overall Study|Withdrawal by Subject|0|||
23189416|NCT00638846|64436055|FG000|Overall Study|Adverse Event|0|||
23248575|NCT01956123|64652603|FG000|COS Cycle 3|Protocol Violation|0|||
23248576|NCT01956123|64652604|FG001|COS Cycle 3|Protocol Violation|0|||
23248577|NCT01956123|64652605|FG002|COS Cycle 3|Protocol Violation|2|||
23248578|NCT01956123|64652606|FG003|COS Cycle 3|Protocol Violation|1|||
23248579|NCT01956123|64652603|FG000|COS Cycle 3|Adverse Event|0|||
23248580|NCT01956123|64652604|FG001|COS Cycle 3|Adverse Event|0|||
23248581|NCT01956123|64652605|FG002|COS Cycle 3|Adverse Event|3|||
23248582|NCT01956123|64652606|FG003|COS Cycle 3|Adverse Event|0|||
23248583|NCT01956123|64652603|FG000|COS Cycle 3|Personal Reasons|0|||
23248584|NCT01956123|64652604|FG001|COS Cycle 3|Personal Reasons|0|||
23248585|NCT01956123|64652605|FG002|COS Cycle 3|Personal Reasons|1|||
23248586|NCT01956123|64652606|FG003|COS Cycle 3|Personal Reasons|0|||
23248587|NCT01956123|64652603|FG000|COS Cycle 3|Withdrawal by Subject|0|||
23471939|NCT02152956|65470875|FG010|Overall Study|Withdrawal by Subject|0|||
23189417|NCT00638846|64436056|FG001|Overall Study|Adverse Event|1|||
23189418|NCT00638846|64436055|FG000|Overall Study|Lost to Follow-up|3|||
23248588|NCT01956123|64652604|FG001|COS Cycle 3|Withdrawal by Subject|0|||
23248589|NCT01956123|64652605|FG002|COS Cycle 3|Withdrawal by Subject|0|||
23248590|NCT01956123|64652606|FG003|COS Cycle 3|Withdrawal by Subject|1|||
23248591|NCT02525627|64652609|FG000|Overall Study|Revision|1|||
23354687|NCT02584959|65041500|FG000|Period 1|Withdrawn from study|3|||
23354688|NCT02584959|65041501|FG001|Period 1|Withdrawn from study|4|||
23471940|NCT02152956|65470876|FG011|Overall Study|Withdrawal by Subject|4|||
23189419|NCT00638846|64436056|FG001|Overall Study|Lost to Follow-up|2|||
23189420|NCT00638846|64436055|FG000|Overall Study|lens issue|1|||
23248592|NCT02525627|64652610|FG001|Overall Study|Revision|1|||
23248593|NCT02525627|64652609|FG000|Overall Study|Withdrawal by Subject|1|||
23248594|NCT02525627|64652610|FG001|Overall Study|Withdrawal by Subject|2|||
23354689|NCT02584959|65041502|FG002|Period 1|Withdrawn from study|0|||
23354690|NCT02584959|65041500|FG000|Period 2|Withdrawn from study|6|||
23248595|NCT02525627|64652609|FG000|Overall Study|Death|1|||
23248596|NCT02525627|64652610|FG001|Overall Study|Death|0|||
23248597|NCT02525627|64652609|FG000|Overall Study|Site terminated|11|||
23248598|NCT02525627|64652610|FG001|Overall Study|Site terminated|10|||
23248599|NCT02163694|64652611|FG000|Overall Study|Adverse event- related to progression|3|||
23248600|NCT02163694|64652612|FG001|Overall Study|Adverse event- related to progression|8|||
23248601|NCT02163694|64652611|FG000|Overall Study|Adverse event- not related to progression|7|||
23248602|NCT02163694|64652612|FG001|Overall Study|Adverse event- not related to progression|17|||
23248603|NCT02163694|64652611|FG000|Overall Study|Withdrew consent|8|||
23248604|NCT02163694|64652612|FG001|Overall Study|Withdrew consent|21|||
23248605|NCT02163694|64652611|FG000|Overall Study|Lost to Follow-up|1|||
23248606|NCT02163694|64652612|FG001|Overall Study|Lost to Follow-up|2|||
23248607|NCT02163694|64652611|FG000|Overall Study|Progressive disease per protocol|122|||
23248608|NCT02163694|64652612|FG001|Overall Study|Progressive disease per protocol|197|||
23248609|NCT02163694|64652611|FG000|Overall Study|Other, not specified|13|||
23248610|NCT02163694|64652612|FG001|Overall Study|Other, not specified|22|||
23248611|NCT04342390|64652613|FG000|Overall Study|Lost to Follow-up|3|||
23248612|NCT04342390|64652614|FG001|Overall Study|Lost to Follow-up|0|||
23248613|NCT00595127|64652619|FG000|Overall Study|Death|6|||
23248614|NCT00595127|64652619|FG000|Overall Study|Relapsed|3|||
23248615|NCT00595127|64652619|FG000|Overall Study|joined another trial|1|||
23248616|NCT01856686|64652620|FG000|Overall Study|Lost to Follow-up|5|||
23248617|NCT01856686|64652621|FG001|Overall Study|Lost to Follow-up|11|||
23248618|NCT04993339|64652623|FG000|Overall Study|Lost to Follow-up|0|||
23248619|NCT04993339|64652624|FG001|Overall Study|Lost to Follow-up|1|||
23248620|NCT04993339|64652623|FG000|Overall Study|no MRI scan|3|||
23248621|NCT04993339|64652624|FG001|Overall Study|no MRI scan|1|||
23248622|NCT03993288|64652625|FG000|Overall Study|Lost to Follow-up|2|||
23248623|NCT03993288|64652626|FG001|Overall Study|Lost to Follow-up|1|||
23248624|NCT03993288|64652625|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
23248625|NCT03993288|64652626|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
23248626|NCT03993288|64652625|FG000|Overall Study|wrong randomization|0|||
23248627|NCT03993288|64652626|FG001|Overall Study|wrong randomization|1|||
23248628|NCT03993288|64652625|FG000|Overall Study|improper enrollment|0|||
23248629|NCT03993288|64652626|FG001|Overall Study|improper enrollment|1|||
23248630|NCT03993288|64652625|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
23248631|NCT03993288|64652626|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
23248632|NCT03993288|64652625|FG000|Overall Study|developed SAE|2|||
23248633|NCT03993288|64652626|FG001|Overall Study|developed SAE|0|||
23248634|NCT03993288|64652625|FG000|Overall Study|consent withdrawal|1|||
23248635|NCT03993288|64652626|FG001|Overall Study|consent withdrawal|0|||
23248636|NCT03993288|64652625|FG000|Overall Study|did not follow the treatment schedule|1|||
23248637|NCT03993288|64652626|FG001|Overall Study|did not follow the treatment schedule|0|||
23248638|NCT03993288|64652625|FG000|Overall Study|did not follow the treatment regimen|1|||
23248639|NCT03993288|64652626|FG001|Overall Study|did not follow the treatment regimen|0|||
23248640|NCT03993288|64652625|FG000|Overall Study|Adverse Event|1|||
23248641|NCT03993288|64652626|FG001|Overall Study|Adverse Event|0|||
23248642|NCT03993288|64652625|FG000|Overall Study|Withdrawal by Subject|1|||
23248643|NCT03993288|64652626|FG001|Overall Study|Withdrawal by Subject|1|||
23248644|NCT03853213|64652630|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
23248645|NCT03853213|64652631|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
23354691|NCT02584959|65041501|FG001|Period 2|Withdrawn from study|1|||
23248646|NCT03853213|64652630|FG000|Overall Study|Other (e.g., too busy)|0|||
23248647|NCT03853213|64652631|FG001|Overall Study|Other (e.g., too busy)|2|||
23248648|NCT04199104|64652634|FG000|Overall Study|Death|148|||
23248649|NCT04199104|64652635|FG001|Overall Study|Death|134|||
23248650|NCT04199104|64652634|FG000|Overall Study|Lost to Follow-up|1|||
23248651|NCT04199104|64652635|FG001|Overall Study|Lost to Follow-up|1|||
23248652|NCT04199104|64652634|FG000|Overall Study|Withdrawal by Subject|4|||
23248653|NCT04199104|64652635|FG001|Overall Study|Withdrawal by Subject|4|||
23248654|NCT04199104|64652634|FG000|Overall Study|Participants Ongoing|103|||
23354692|NCT02584959|65041502|FG002|Period 2|Withdrawn from study|2|||
23248655|NCT04199104|64652635|FG001|Overall Study|Participants Ongoing|116|||
23248656|NCT03286426|64652638|FG000|Overall Study|Physician Decision|3|||
23248657|NCT00185731|64652639|FG000|Overall Study|Withdrawal by Subject|1|||
23248658|NCT00185731|64652639|FG000|Overall Study|Not Eligible|1|||
23248659|NCT03205163|64652640|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
23248660|NCT03205163|64652641|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
23248661|NCT00996918|64652642|FG000|Overall Study|Lack of Efficacy|1|||
23248662|NCT00996918|64652643|FG001|Overall Study|Lack of Efficacy|1|||
23248663|NCT00996918|64652644|FG002|Overall Study|Lack of Efficacy|2|||
23354693|NCT03230838|65041503|FG000|Overall Study|Withdrawal by Subject|3|||
23471941|NCT02152956|65470877|FG012|Overall Study|Withdrawal by Subject|0|||
23248664|NCT00996918|64652645|FG003|Overall Study|Lack of Efficacy|2|||
23248665|NCT00996918|64652646|FG004|Overall Study|Lack of Efficacy|0|||
23248666|NCT00996918|64652642|FG000|Overall Study|Adverse Event|2|||
23248667|NCT00996918|64652643|FG001|Overall Study|Adverse Event|5|||
23248668|NCT00996918|64652644|FG002|Overall Study|Adverse Event|2|||
23248669|NCT00996918|64652645|FG003|Overall Study|Adverse Event|6|||
23248670|NCT00996918|64652646|FG004|Overall Study|Adverse Event|0|||
23248671|NCT00996918|64652642|FG000|Overall Study|Withdrawal by Subject|1|||
23248672|NCT00996918|64652643|FG001|Overall Study|Withdrawal by Subject|4|||
23248673|NCT00996918|64652644|FG002|Overall Study|Withdrawal by Subject|3|||
23248674|NCT00996918|64652645|FG003|Overall Study|Withdrawal by Subject|3|||
23248675|NCT00996918|64652646|FG004|Overall Study|Withdrawal by Subject|2|||
23248676|NCT00996918|64652642|FG000|Overall Study|Physician Decision|1|||
23248677|NCT00996918|64652643|FG001|Overall Study|Physician Decision|0|||
23248678|NCT00996918|64652644|FG002|Overall Study|Physician Decision|0|||
23248679|NCT00996918|64652645|FG003|Overall Study|Physician Decision|0|||
23248680|NCT00996918|64652646|FG004|Overall Study|Physician Decision|0|||
23248681|NCT00996918|64652642|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
23248682|NCT00996918|64652643|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
23248683|NCT00996918|64652644|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
23248684|NCT00996918|64652645|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
23248685|NCT00996918|64652646|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
23248686|NCT00996918|64652642|FG000|Overall Study|Loss of Caregiver|0|||
23248687|NCT00996918|64652643|FG001|Overall Study|Loss of Caregiver|1|||
23248688|NCT00996918|64652644|FG002|Overall Study|Loss of Caregiver|0|||
23248689|NCT00996918|64652645|FG003|Overall Study|Loss of Caregiver|0|||
23248690|NCT00996918|64652646|FG004|Overall Study|Loss of Caregiver|0|||
23248691|NCT00996918|64652642|FG000|Overall Study|Other|3|||
23248692|NCT00996918|64652643|FG001|Overall Study|Other|1|||
23248693|NCT00996918|64652644|FG002|Overall Study|Other|0|||
23248694|NCT00996918|64652645|FG003|Overall Study|Other|0|||
23248695|NCT00996918|64652646|FG004|Overall Study|Other|0|||
23248696|NCT03674827|64652649|FG000|Treatment Phase|Adverse Event|0|||
23248697|NCT03674827|64652650|FG001|Treatment Phase|Adverse Event|0|||
23248698|NCT03674827|64652651|FG002|Treatment Phase|Adverse Event|0|||
23248699|NCT03674827|64652652|FG003|Treatment Phase|Adverse Event|0|||
23248700|NCT03674827|64652653|FG004|Treatment Phase|Adverse Event|0|||
23248701|NCT03674827|64652654|FG005|Treatment Phase|Adverse Event|2|||
23248702|NCT03674827|64652649|FG000|Treatment Phase|Death|2|||
23248703|NCT03674827|64652650|FG001|Treatment Phase|Death|0|||
23248704|NCT03674827|64652651|FG002|Treatment Phase|Death|0|||
23248705|NCT03674827|64652652|FG003|Treatment Phase|Death|0|||
23248706|NCT03674827|64652653|FG004|Treatment Phase|Death|1|||
23248707|NCT03674827|64652654|FG005|Treatment Phase|Death|0|||
23248708|NCT03674827|64652649|FG000|Treatment Phase|Progressive Disease|0|||
23248709|NCT03674827|64652650|FG001|Treatment Phase|Progressive Disease|4|||
23248710|NCT03674827|64652651|FG002|Treatment Phase|Progressive Disease|3|||
23248711|NCT03674827|64652652|FG003|Treatment Phase|Progressive Disease|4|||
23248712|NCT03674827|64652653|FG004|Treatment Phase|Progressive Disease|4|||
23248713|NCT03674827|64652654|FG005|Treatment Phase|Progressive Disease|9|||
23248714|NCT03674827|64652649|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
23248715|NCT03674827|64652650|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
23248716|NCT03674827|64652651|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
23248717|NCT03674827|64652652|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
23248718|NCT03674827|64652653|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
23248719|NCT03674827|64652654|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
23248720|NCT03674827|64652649|FG000|Treatment Phase|Withdrawal by Subject|0|||
23248721|NCT03674827|64652650|FG001|Treatment Phase|Withdrawal by Subject|0|||
23248722|NCT03674827|64652651|FG002|Treatment Phase|Withdrawal by Subject|0|||
23248723|NCT03674827|64652652|FG003|Treatment Phase|Withdrawal by Subject|0|||
23248724|NCT03674827|64652653|FG004|Treatment Phase|Withdrawal by Subject|0|||
23189421|NCT00638846|64436056|FG001|Overall Study|lens issue|3|||
23248725|NCT03674827|64652654|FG005|Treatment Phase|Withdrawal by Subject|1|||
23248726|NCT03674827|64652649|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
23248727|NCT03674827|64652650|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
23248728|NCT03674827|64652651|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
23248729|NCT03674827|64652652|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
23248730|NCT03674827|64652653|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
23248731|NCT03674827|64652654|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
23248732|NCT03674827|64652649|FG000|Treatment Phase|Other|0|||
23248733|NCT03674827|64652650|FG001|Treatment Phase|Other|1|||
23248734|NCT03674827|64652651|FG002|Treatment Phase|Other|0|||
23248735|NCT03674827|64652652|FG003|Treatment Phase|Other|0|||
23248736|NCT03674827|64652653|FG004|Treatment Phase|Other|0|||
23248737|NCT03674827|64652654|FG005|Treatment Phase|Other|1|||
23248738|NCT03674827|64652649|FG000|Long-Term Follow-up Phase|Death|2|||
23248739|NCT03674827|64652650|FG001|Long-Term Follow-up Phase|Death|4|||
23248740|NCT03674827|64652651|FG002|Long-Term Follow-up Phase|Death|2|||
23248741|NCT03674827|64652652|FG003|Long-Term Follow-up Phase|Death|3|||
23248742|NCT03674827|64652653|FG004|Long-Term Follow-up Phase|Death|2|||
23248743|NCT03674827|64652654|FG005|Long-Term Follow-up Phase|Death|6|||
23248744|NCT03674827|64652649|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
23248745|NCT03674827|64652650|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
23248746|NCT03674827|64652651|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
23248747|NCT03674827|64652652|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
23248748|NCT03674827|64652653|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
23248749|NCT03674827|64652654|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
23248750|NCT03674827|64652649|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
23248751|NCT03674827|64652650|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
23248752|NCT03674827|64652651|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
23248753|NCT03674827|64652652|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
23248754|NCT03674827|64652653|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
23248755|NCT03674827|64652654|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
23248756|NCT00742859|64652655|FG000|Overall Study|Adverse Event|5|||
23248757|NCT00742859|64652656|FG001|Overall Study|Adverse Event|6|||
23248758|NCT00742859|64652657|FG002|Overall Study|Adverse Event|3|||
23248759|NCT00742859|64652658|FG003|Overall Study|Adverse Event|1|||
23248760|NCT00742859|64652655|FG000|Overall Study|Death|1|||
23248761|NCT00742859|64652656|FG001|Overall Study|Death|0|||
23248762|NCT00742859|64652657|FG002|Overall Study|Death|0|||
23248763|NCT00742859|64652658|FG003|Overall Study|Death|1|||
23248764|NCT00742859|64652655|FG000|Overall Study|Physician Decision|1|||
23248765|NCT00742859|64652656|FG001|Overall Study|Physician Decision|2|||
23248766|NCT00742859|64652657|FG002|Overall Study|Physician Decision|0|||
23248767|NCT00742859|64652658|FG003|Overall Study|Physician Decision|0|||
23248768|NCT00742859|64652655|FG000|Overall Study|Withdrawal by Subject|4|||
23248769|NCT00742859|64652656|FG001|Overall Study|Withdrawal by Subject|2|||
23248770|NCT00742859|64652657|FG002|Overall Study|Withdrawal by Subject|4|||
23248771|NCT00742859|64652658|FG003|Overall Study|Withdrawal by Subject|1|||
23248772|NCT00742859|64652655|FG000|Overall Study|Endpoint|0|||
23248773|NCT00742859|64652656|FG001|Overall Study|Endpoint|1|||
23248774|NCT00742859|64652657|FG002|Overall Study|Endpoint|1|||
23248775|NCT00742859|64652658|FG003|Overall Study|Endpoint|2|||
23248776|NCT00742859|64652655|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
23248777|NCT00742859|64652656|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
23248778|NCT00742859|64652657|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
23248779|NCT00742859|64652658|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
23248780|NCT00742859|64652655|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
23248781|NCT00742859|64652656|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
23248782|NCT00742859|64652657|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
23248783|NCT00742859|64652658|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
23248784|NCT00742859|64652655|FG000|Overall Study|Sponsor request patient out of town|0|||
23248785|NCT00742859|64652656|FG001|Overall Study|Sponsor request patient out of town|0|||
23248786|NCT00742859|64652657|FG002|Overall Study|Sponsor request patient out of town|1|||
23248787|NCT00742859|64652658|FG003|Overall Study|Sponsor request patient out of town|1|||
23248788|NCT00742859|64652655|FG000|Overall Study|Site error|0|||
23354694|NCT03230838|65041504|FG001|Overall Study|Withdrawal by Subject|0|||
23354695|NCT03230838|65041503|FG000|Overall Study|Temperature excursion|1|||
23354696|NCT03230838|65041504|FG001|Overall Study|Temperature excursion|0|||
23354697|NCT00845676|65041505|FG000|Overall Study|Virologic breakthrough at week 20|1|||
23354698|NCT00845676|65041505|FG000|Overall Study|Adverse Event|1|||
23354699|NCT00715520|65041506|FG000|Overall Study|Screen failure|8|||
23354700|NCT00715520|65041507|FG001|Overall Study|Screen failure|1|||
23354701|NCT00715520|65041508|FG002|Overall Study|Screen failure|1|||
23354702|NCT00715520|65041506|FG000|Overall Study|Withdrawal by Subject|2|||
23354703|NCT00715520|65041507|FG001|Overall Study|Withdrawal by Subject|0|||
23354704|NCT00715520|65041508|FG002|Overall Study|Withdrawal by Subject|1|||
23354705|NCT02005627|65041512|FG000|Overall Study|Lost to Follow-up|1|||
23354706|NCT02005627|65041513|FG001|Overall Study|Lost to Follow-up|2|||
23587896|NCT01050569|65882058|FG001|Overall Study|Adverse Event|0|||
23248789|NCT00742859|64652656|FG001|Overall Study|Site error|0|||
23248790|NCT00742859|64652657|FG002|Overall Study|Site error|1|||
23248791|NCT00742859|64652658|FG003|Overall Study|Site error|1|||
23248792|NCT03914469|64652659|FG000|Overall Study|Lost to Follow-up|1|||
23248793|NCT03914469|64652660|FG001|Overall Study|Lost to Follow-up|4|||
23248794|NCT02395536|64652663|FG000|Overall Study|Lost to Follow-up|4|||
23248795|NCT02395536|64652664|FG001|Overall Study|Lost to Follow-up|4|||
23248796|NCT02395536|64652663|FG000|Overall Study|Death|2|||
23248797|NCT02395536|64652664|FG001|Overall Study|Death|0|||
23248798|NCT02395536|64652663|FG000|Overall Study|Physician Decision|4|||
23354707|NCT02005627|65041512|FG000|Overall Study|Withdrawal by Subject|1|||
23354708|NCT02005627|65041513|FG001|Overall Study|Withdrawal by Subject|2|||
23354709|NCT01390428|65041514|FG000|Overall Study|Elective Surgery|0|||
23354710|NCT01390428|65041515|FG001|Overall Study|Elective Surgery|0|||
23354711|NCT01390428|65041516|FG002|Overall Study|Elective Surgery|0|||
23354712|NCT01390428|65041517|FG003|Overall Study|Elective Surgery|0|||
23354713|NCT01390428|65041518|FG004|Overall Study|Elective Surgery|1|||
23587897|NCT01050569|65882059|FG002|Overall Study|Adverse Event|0|||
23587898|NCT01050569|65882057|FG000|Overall Study|Physician Decision|3|||
23587899|NCT01050569|65882058|FG001|Overall Study|Physician Decision|3|||
23587900|NCT01050569|65882059|FG002|Overall Study|Physician Decision|3|||
23587901|NCT00337818|65882060|FG000|Overall Study|Lost to Follow-up|289|||
23587902|NCT00337818|65882061|FG001|Overall Study|Lost to Follow-up|91|||
23587903|NCT00337818|65882062|FG002|Overall Study|Lost to Follow-up|107|||
23587904|NCT01810263|65882063|FG000|Overall Study|Lost to Follow-up|8|||
23587905|NCT01810263|65882064|FG001|Overall Study|Lost to Follow-up|7|||
23587906|NCT03478696|65882065|FG000|Overall Study|Adverse Event|1|||
23587907|NCT03478696|65882066|FG001|Overall Study|Adverse Event|5|||
23587908|NCT03478696|65882065|FG000|Overall Study|Lost to Follow-up|1|||
23587909|NCT03478696|65882066|FG001|Overall Study|Lost to Follow-up|0|||
23587910|NCT03478696|65882065|FG000|Overall Study|Physician Decision|6|||
23587911|NCT03478696|65882066|FG001|Overall Study|Physician Decision|3|||
23587912|NCT03478696|65882065|FG000|Overall Study|Withdrawal by Subject|9|||
23587913|NCT03478696|65882066|FG001|Overall Study|Withdrawal by Subject|4|||
23248799|NCT02395536|64652664|FG001|Overall Study|Physician Decision|6|||
23248800|NCT02395536|64652663|FG000|Overall Study|Withdrawal by Subject|9|||
23248801|NCT02395536|64652664|FG001|Overall Study|Withdrawal by Subject|17|||
23248802|NCT02395536|64652663|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
23248803|NCT02395536|64652664|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
23248804|NCT02395536|64652663|FG000|Overall Study|Insurance issue|0|||
23248805|NCT02395536|64652664|FG001|Overall Study|Insurance issue|1|||
23248806|NCT04611152|64652665|FG000|Overall Study|Adverse Event|9|||
23248807|NCT04611152|64652666|FG001|Overall Study|Adverse Event|8|||
23248808|NCT04611152|64652665|FG000|Overall Study|Non-compliance with study schedule|1|||
23248809|NCT04611152|64652666|FG001|Overall Study|Non-compliance with study schedule|3|||
23248810|NCT04611152|64652665|FG000|Overall Study|Withdrawal by Subject|5|||
23248811|NCT04611152|64652666|FG001|Overall Study|Withdrawal by Subject|6|||
23248812|NCT04611152|64652665|FG000|Overall Study|Lost to Follow-up|11|||
23248813|NCT04611152|64652666|FG001|Overall Study|Lost to Follow-up|2|||
23248814|NCT01260194|64652667|FG000|Overall Study|Withdrawal of Consent|1|||
23248815|NCT04854707|64652669|FG000|Overall Study|Lack of Efficacy|78|||
23248816|NCT04854707|64652670|FG001|Overall Study|Lack of Efficacy|59|||
23248817|NCT04854707|64652671|FG002|Overall Study|Lack of Efficacy|30|||
23248818|NCT01610284|64652672|FG000|Randomization Phase|Adverse Event|1|||
23248819|NCT01610284|64652673|FG001|Randomization Phase|Adverse Event|0|||
23248820|NCT01610284|64652672|FG000|Randomization Phase|Physician Decision|1|||
23248821|NCT01610284|64652673|FG001|Randomization Phase|Physician Decision|1|||
23248822|NCT01610284|64652672|FG000|Randomization Phase|Death|0|||
23248823|NCT01610284|64652673|FG001|Randomization Phase|Death|1|||
23248824|NCT01610284|64652672|FG000|Treatment Phase|Adverse Event|80|||
23248825|NCT01610284|64652673|FG001|Treatment Phase|Adverse Event|12|||
23248826|NCT01610284|64652672|FG000|Treatment Phase|Lost to Follow-up|1|||
23248827|NCT01610284|64652673|FG001|Treatment Phase|Lost to Follow-up|0|||
23248828|NCT01610284|64652672|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
23248829|NCT01610284|64652673|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
23248830|NCT01610284|64652672|FG000|Treatment Phase|Physician Decision|27|||
23248831|NCT01610284|64652673|FG001|Treatment Phase|Physician Decision|24|||
23248832|NCT01610284|64652672|FG000|Treatment Phase|Progressive Disease|377|||
23248833|NCT01610284|64652673|FG001|Treatment Phase|Progressive Disease|486|||
23248834|NCT01610284|64652672|FG000|Treatment Phase|Protocol Deviation|2|||
23248835|NCT01610284|64652673|FG001|Treatment Phase|Protocol Deviation|3|||
23248836|NCT01610284|64652672|FG000|Treatment Phase|Study terminated by Sponsor|18|||
23248837|NCT01610284|64652673|FG001|Treatment Phase|Study terminated by Sponsor|15|||
23248838|NCT01610284|64652672|FG000|Treatment Phase|Subject/Guardian Decision|55|||
23248839|NCT01610284|64652673|FG001|Treatment Phase|Subject/Guardian Decision|23|||
23248840|NCT01610284|64652672|FG000|Treatment Phase|Death|6|||
23248841|NCT01610284|64652673|FG001|Treatment Phase|Death|5|||
23248842|NCT01610284|64652672|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
23248843|NCT01610284|64652673|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
23248844|NCT01610284|64652672|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
23248845|NCT01610284|64652673|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
23248846|NCT01610284|64652672|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
23248847|NCT01610284|64652673|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
23248848|NCT01610284|64652672|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
23248849|NCT01610284|64652673|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
23248850|NCT01610284|64652672|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
23248851|NCT01610284|64652673|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
23248852|NCT01610284|64652672|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
23471942|NCT02152956|65470865|FG000|Overall Study|Physician Decision|0|||
23587914|NCT04107805|65882067|FG000|Overall Study|Adverse Event|0|||
23587915|NCT04107805|65882068|FG001|Overall Study|Adverse Event|0|||
23354714|NCT01390428|65041519|FG005|Overall Study|Elective Surgery|0|||
23354715|NCT01390428|65041514|FG000|Overall Study|Withdrawal by Subject|0|||
23354716|NCT01390428|65041515|FG001|Overall Study|Withdrawal by Subject|0|||
23354717|NCT01390428|65041516|FG002|Overall Study|Withdrawal by Subject|1|||
23354718|NCT01390428|65041517|FG003|Overall Study|Withdrawal by Subject|0|||
23354719|NCT01390428|65041518|FG004|Overall Study|Withdrawal by Subject|0|||
23354720|NCT01390428|65041519|FG005|Overall Study|Withdrawal by Subject|0|||
23354721|NCT01897571|65041520|FG000|Overall Study|Lost to Follow-up|3|||
23354722|NCT01897571|65041521|FG001|Overall Study|Lost to Follow-up|0|||
23354723|NCT01897571|65041522|FG002|Overall Study|Lost to Follow-up|0|||
23354724|NCT01897571|65041523|FG003|Overall Study|Lost to Follow-up|0|||
23354725|NCT01897571|65041524|FG004|Overall Study|Lost to Follow-up|2|||
23354726|NCT01897571|65041525|FG005|Overall Study|Lost to Follow-up|0|||
23354727|NCT01897571|65041526|FG006|Overall Study|Lost to Follow-up|0|||
23354728|NCT01897571|65041527|FG007|Overall Study|Lost to Follow-up|0|||
23354729|NCT01897571|65041528|FG008|Overall Study|Lost to Follow-up|1|||
23354730|NCT01897571|65041529|FG009|Overall Study|Lost to Follow-up|2|||
23354731|NCT01897571|65041530|FG010|Overall Study|Lost to Follow-up|4|||
23354732|NCT01897571|65041520|FG000|Overall Study|Withdrawal by Subject|0|||
23354733|NCT01897571|65041521|FG001|Overall Study|Withdrawal by Subject|0|||
23354734|NCT01897571|65041522|FG002|Overall Study|Withdrawal by Subject|0|||
23354735|NCT01897571|65041523|FG003|Overall Study|Withdrawal by Subject|0|||
23354736|NCT01897571|65041524|FG004|Overall Study|Withdrawal by Subject|0|||
23354737|NCT01897571|65041525|FG005|Overall Study|Withdrawal by Subject|0|||
23354738|NCT01897571|65041526|FG006|Overall Study|Withdrawal by Subject|0|||
23354739|NCT01897571|65041527|FG007|Overall Study|Withdrawal by Subject|1|||
23354740|NCT01897571|65041528|FG008|Overall Study|Withdrawal by Subject|4|||
23189422|NCT05370157|64436057|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
23189423|NCT05370157|64436058|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
23189424|NCT05370157|64436057|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
23189425|NCT05370157|64436058|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
23189426|NCT02243176|64436059|FG000|Overall Study|Other reason|1|||
23189427|NCT02243176|64436060|FG001|Overall Study|Other reason|2|||
23189428|NCT02243176|64436059|FG000|Overall Study|protocol specified withdrawal critera|1|||
23189429|NCT02243176|64436060|FG001|Overall Study|protocol specified withdrawal critera|3|||
23189430|NCT02243176|64436059|FG000|Overall Study|Protocol Violation|2|||
23189431|NCT02243176|64436060|FG001|Overall Study|Protocol Violation|1|||
23189432|NCT02243176|64436059|FG000|Overall Study|Withdrawal by Subject|8|||
23189433|NCT02243176|64436060|FG001|Overall Study|Withdrawal by Subject|7|||
23189434|NCT02243176|64436059|FG000|Overall Study|Adverse Event|2|||
23189435|NCT02243176|64436060|FG001|Overall Study|Adverse Event|2|||
23189436|NCT03476239|64436061|FG000|Overall Study|Withdrawal by Subject|10|||
23189437|NCT03476239|64436061|FG000|Overall Study|Death|80|||
23189438|NCT03476239|64436061|FG000|Overall Study|Lost to Follow-up|8|||
23189439|NCT00707577|64436062|FG000|Overall Study|Withdrawal by Subject|3|||
23189440|NCT00707577|64436063|FG001|Overall Study|Withdrawal by Subject|2|||
23189441|NCT00707577|64436062|FG000|Overall Study|Lost to Follow-up|34|||
23189442|NCT00707577|64436063|FG001|Overall Study|Lost to Follow-up|25|||
23189443|NCT00707577|64436062|FG000|Overall Study|Left employment|13|||
23189444|NCT00707577|64436063|FG001|Overall Study|Left employment|10|||
23189445|NCT00707577|64436062|FG000|Overall Study|Pregnancy|4|||
23354741|NCT01897571|65041529|FG009|Overall Study|Withdrawal by Subject|3|||
23354742|NCT01897571|65041530|FG010|Overall Study|Withdrawal by Subject|1|||
23354743|NCT01897571|65041520|FG000|Overall Study|Other|1|||
23354744|NCT01897571|65041521|FG001|Overall Study|Other|0|||
23354745|NCT01897571|65041522|FG002|Overall Study|Other|0|||
23354746|NCT01897571|65041523|FG003|Overall Study|Other|3|||
23354747|NCT01897571|65041524|FG004|Overall Study|Other|3|||
23354748|NCT01897571|65041525|FG005|Overall Study|Other|4|||
23354749|NCT01897571|65041526|FG006|Overall Study|Other|7|||
23354750|NCT01897571|65041527|FG007|Overall Study|Other|0|||
23354751|NCT01897571|65041528|FG008|Overall Study|Other|0|||
23354752|NCT01897571|65041529|FG009|Overall Study|Other|0|||
23354753|NCT01897571|65041530|FG010|Overall Study|Other|0|||
23354754|NCT01897571|65041520|FG000|Overall Study|Enrolled in rollover study|0|||
23354755|NCT01897571|65041521|FG001|Overall Study|Enrolled in rollover study|0|||
23354756|NCT01897571|65041522|FG002|Overall Study|Enrolled in rollover study|0|||
23354757|NCT01897571|65041523|FG003|Overall Study|Enrolled in rollover study|0|||
23354758|NCT01897571|65041524|FG004|Overall Study|Enrolled in rollover study|0|||
23354759|NCT01897571|65041525|FG005|Overall Study|Enrolled in rollover study|0|||
23587916|NCT04107805|65882069|FG002|Overall Study|Adverse Event|0|||
23587917|NCT04107805|65882070|FG003|Overall Study|Adverse Event|1|||
23587918|NCT04107805|65882071|FG004|Overall Study|Adverse Event|0|||
23587919|NCT04107805|65882072|FG005|Overall Study|Adverse Event|1|||
23587920|NCT04107805|65882073|FG006|Overall Study|Adverse Event|0|||
23587921|NCT04107805|65882074|FG007|Overall Study|Adverse Event|0|||
23587922|NCT04107805|65882075|FG008|Overall Study|Adverse Event|1|||
23587923|NCT04364269|65882079|FG000|Overall Study|Adverse Event|1|||
23189446|NCT00707577|64436063|FG001|Overall Study|Pregnancy|1|||
23189447|NCT01507246|64436064|FG000|Overall Study|Required different surgical procedures|2|||
23189448|NCT01507246|64436065|FG001|Overall Study|Required different surgical procedures|1|||
23189449|NCT02053246|64436074|FG000|Overall Study|Withdrawal by Subject|3|||
23189450|NCT02053246|64436074|FG000|Overall Study|Physician Decision|1|||
23189451|NCT00117338|64436075|FG000|Overall Study|Adverse Event|0|||
23189452|NCT00117338|64436076|FG001|Overall Study|Adverse Event|1|||
23189453|NCT00117338|64436075|FG000|Overall Study|Protocol Violation|3|||
23189454|NCT00117338|64436076|FG001|Overall Study|Protocol Violation|2|||
23189455|NCT00117338|64436075|FG000|Overall Study|Withdrawal by Subject|1|||
23189456|NCT00117338|64436076|FG001|Overall Study|Withdrawal by Subject|0|||
23189457|NCT00117338|64436075|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
23189458|NCT00117338|64436076|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
23189459|NCT00117338|64436075|FG000|Overall Study|Lack of Efficacy|0|||
23189460|NCT00117338|64436076|FG001|Overall Study|Lack of Efficacy|1|||
23189461|NCT03414359|64436077|FG000|Overall Study|Lack of Efficacy|1|||
23189462|NCT03414359|64436078|FG001|Overall Study|Lack of Efficacy|1|||
23189463|NCT03414359|64436077|FG000|Overall Study|Protocol Violation|0|||
23189464|NCT03414359|64436078|FG001|Overall Study|Protocol Violation|1|||
23189465|NCT00814710|64436079|FG000|Overall Study|Adverse Event|1|||
23189466|NCT00814710|64436080|FG001|Overall Study|Adverse Event|0|||
23189467|NCT00814710|64436079|FG000|Overall Study|Lost to Follow-up|7|||
23189468|NCT00814710|64436080|FG001|Overall Study|Lost to Follow-up|3|||
23189469|NCT01121406|64436082|FG000|Overall Study|Progressive disease RECIST|44|||
23248853|NCT01610284|64652673|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
23248854|NCT01289990|64652675|FG000|Overall Study|Death|0|||
23248855|NCT01289990|64652676|FG001|Overall Study|Death|0|||
23248856|NCT01289990|64652677|FG002|Overall Study|Death|0|||
23248857|NCT01289990|64652678|FG003|Overall Study|Death|1|||
23248858|NCT01289990|64652679|FG004|Overall Study|Death|2|||
23248859|NCT01289990|64652680|FG005|Overall Study|Death|1|||
23248860|NCT01289990|64652681|FG006|Overall Study|Death|0|||
23248861|NCT01289990|64652682|FG007|Overall Study|Death|0|||
23354760|NCT01897571|65041526|FG006|Overall Study|Enrolled in rollover study|0|||
23354761|NCT01897571|65041527|FG007|Overall Study|Enrolled in rollover study|9|||
23354762|NCT01897571|65041528|FG008|Overall Study|Enrolled in rollover study|7|||
23354763|NCT01897571|65041529|FG009|Overall Study|Enrolled in rollover study|9|||
23354764|NCT01897571|65041530|FG010|Overall Study|Enrolled in rollover study|1|||
23189470|NCT01121406|64436083|FG001|Overall Study|Progressive disease RECIST|28|||
23189471|NCT01121406|64436082|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
23248862|NCT01289990|64652683|FG008|Overall Study|Death|0|||
23354765|NCT01897571|65041520|FG000|Overall Study|Death|2|||
23354766|NCT01897571|65041521|FG001|Overall Study|Death|2|||
23587924|NCT04364269|65882080|FG001|Overall Study|Adverse Event|0|||
23354767|NCT01897571|65041522|FG002|Overall Study|Death|3|||
23354768|NCT01897571|65041523|FG003|Overall Study|Death|6|||
23354769|NCT01897571|65041524|FG004|Overall Study|Death|7|||
23354770|NCT01897571|65041525|FG005|Overall Study|Death|9|||
23354771|NCT01897571|65041526|FG006|Overall Study|Death|5|||
23354772|NCT01897571|65041527|FG007|Overall Study|Death|22|||
23354773|NCT01897571|65041528|FG008|Overall Study|Death|23|||
23354774|NCT01897571|65041529|FG009|Overall Study|Death|129|||
23354775|NCT01897571|65041530|FG010|Overall Study|Death|59|||
23354776|NCT02588664|65041531|FG000|Overall Study|Death|56|||
23354777|NCT02588664|65041532|FG001|Overall Study|Death|55|||
23354778|NCT02588664|65041531|FG000|Overall Study|Lost to Follow-up|1305|||
23354779|NCT02588664|65041532|FG001|Overall Study|Lost to Follow-up|990|||
23354780|NCT00966355|65041533|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
23354781|NCT00966355|65041534|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
23354782|NCT00966355|65041535|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
23354783|NCT00966355|65041533|FG000|Overall Study|newly diagnosed advanced HCC|11|||
23354784|NCT00966355|65041534|FG001|Overall Study|newly diagnosed advanced HCC|12|||
23354785|NCT00966355|65041535|FG002|Overall Study|newly diagnosed advanced HCC|10|||
23354786|NCT00966355|65041533|FG000|Overall Study|Lost to Follow-up|5|||
23354787|NCT00966355|65041534|FG001|Overall Study|Lost to Follow-up|4|||
23354788|NCT00966355|65041535|FG002|Overall Study|Lost to Follow-up|3|||
23354789|NCT00621517|65041536|FG000|Overall Study|Lost to Follow-up|3|||
23354790|NCT00621517|65041537|FG001|Overall Study|Lost to Follow-up|3|||
23354791|NCT00621517|65041536|FG000|Overall Study|Withdrawal by Subject|3|||
23354792|NCT00621517|65041537|FG001|Overall Study|Withdrawal by Subject|4|||
23471943|NCT02152956|65470866|FG001|Overall Study|Physician Decision|0|||
23471944|NCT02152956|65470867|FG002|Overall Study|Physician Decision|0|||
23354793|NCT00621517|65041536|FG000|Overall Study|Adverse Event|1|||
23189472|NCT01121406|64436083|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
23189473|NCT01121406|64436082|FG000|Overall Study|Other AE|3|||
23354794|NCT00621517|65041537|FG001|Overall Study|Adverse Event|0|||
23354795|NCT00303472|65041538|FG000|Treatment Period|Adverse Event|0|||
23354796|NCT00303472|65041539|FG001|Treatment Period|Adverse Event|0|||
23354797|NCT00303472|65041540|FG002|Treatment Period|Adverse Event|0|||
23354798|NCT00303472|65041541|FG003|Treatment Period|Adverse Event|0|||
23471945|NCT02152956|65470868|FG003|Overall Study|Physician Decision|0|||
23471946|NCT02152956|65470869|FG004|Overall Study|Physician Decision|0|||
23471947|NCT02152956|65470870|FG005|Overall Study|Physician Decision|0|||
23471948|NCT02152956|65470871|FG006|Overall Study|Physician Decision|0|||
23471949|NCT02152956|65470872|FG007|Overall Study|Physician Decision|0|||
23471950|NCT02152956|65470873|FG008|Overall Study|Physician Decision|0|||
23471951|NCT02152956|65470874|FG009|Overall Study|Physician Decision|0|||
23471952|NCT02152956|65470875|FG010|Overall Study|Physician Decision|0|||
23471953|NCT02152956|65470876|FG011|Overall Study|Physician Decision|1|||
23189474|NCT01121406|64436083|FG001|Overall Study|Other AE|10|||
23189475|NCT01121406|64436082|FG000|Overall Study|Non-compliant with protocol|0|||
23189476|NCT01121406|64436083|FG001|Overall Study|Non-compliant with protocol|2|||
23189477|NCT01121406|64436082|FG000|Overall Study|Lost to Follow-up|0|||
23189478|NCT01121406|64436083|FG001|Overall Study|Lost to Follow-up|1|||
23189479|NCT01121406|64436082|FG000|Overall Study|Refused continuation of study med.|1|||
23354799|NCT00303472|65041542|FG004|Treatment Period|Adverse Event|1|||
23354800|NCT00303472|65041543|FG005|Treatment Period|Adverse Event|0|||
23354801|NCT00303472|65041544|FG006|Treatment Period|Adverse Event|0|||
23354802|NCT00303472|65041538|FG000|Treatment Period|Death|0|||
23354803|NCT00303472|65041539|FG001|Treatment Period|Death|0|||
23354804|NCT00303472|65041540|FG002|Treatment Period|Death|0|||
23354805|NCT00303472|65041541|FG003|Treatment Period|Death|1|||
23354806|NCT00303472|65041542|FG004|Treatment Period|Death|0|||
23189480|NCT01121406|64436083|FG001|Overall Study|Refused continuation of study med.|2|||
23189481|NCT01121406|64436082|FG000|Overall Study|Reason other than specified above|2|||
23189482|NCT01121406|64436083|FG001|Overall Study|Reason other than specified above|6|||
23189483|NCT01121406|64436082|FG000|Overall Study|Not treated|1|||
23189484|NCT01121406|64436083|FG001|Overall Study|Not treated|0|||
23189485|NCT01887912|64436085|FG000|Overall Study|Serious adverse event|400|||
23189486|NCT01887912|64436086|FG001|Overall Study|Serious adverse event|198|||
23189487|NCT01887912|64436085|FG000|Overall Study|Other Adverse Event|34|||
23189488|NCT01887912|64436086|FG001|Overall Study|Other Adverse Event|15|||
23189489|NCT01887912|64436085|FG000|Overall Study|Protocol Violation|67|||
23354807|NCT00303472|65041543|FG005|Treatment Period|Death|0|||
23354808|NCT00303472|65041544|FG006|Treatment Period|Death|1|||
23354809|NCT00303472|65041538|FG000|Treatment Period|Withdrawal by Subject|0|||
23354810|NCT00303472|65041539|FG001|Treatment Period|Withdrawal by Subject|0|||
23354811|NCT00303472|65041540|FG002|Treatment Period|Withdrawal by Subject|0|||
23471954|NCT02152956|65470877|FG012|Overall Study|Physician Decision|0|||
23471955|NCT02152956|65470865|FG000|Overall Study|Study terminated by sponsor|0|||
23471956|NCT02152956|65470866|FG001|Overall Study|Study terminated by sponsor|0|||
23354812|NCT00303472|65041541|FG003|Treatment Period|Withdrawal by Subject|1|||
23354813|NCT00303472|65041542|FG004|Treatment Period|Withdrawal by Subject|0|||
23354814|NCT00303472|65041543|FG005|Treatment Period|Withdrawal by Subject|1|||
23248863|NCT01289990|64652684|FG009|Overall Study|Death|0|||
23248864|NCT01289990|64652685|FG010|Overall Study|Death|0|||
23248865|NCT01289990|64652686|FG011|Overall Study|Death|1|||
23248866|NCT01289990|64652687|FG012|Overall Study|Death|0|||
23248867|NCT01289990|64652675|FG000|Overall Study|Lost to Follow-up|3|||
23248868|NCT01289990|64652676|FG001|Overall Study|Lost to Follow-up|2|||
23248869|NCT01289990|64652677|FG002|Overall Study|Lost to Follow-up|5|||
23248870|NCT01289990|64652678|FG003|Overall Study|Lost to Follow-up|5|||
23471957|NCT02152956|65470867|FG002|Overall Study|Study terminated by sponsor|0|||
23471958|NCT02152956|65470868|FG003|Overall Study|Study terminated by sponsor|0|||
23471959|NCT02152956|65470869|FG004|Overall Study|Study terminated by sponsor|0|||
23471960|NCT02152956|65470870|FG005|Overall Study|Study terminated by sponsor|0|||
23471961|NCT02152956|65470871|FG006|Overall Study|Study terminated by sponsor|0|||
23471962|NCT02152956|65470872|FG007|Overall Study|Study terminated by sponsor|0|||
23471963|NCT02152956|65470873|FG008|Overall Study|Study terminated by sponsor|0|||
23471964|NCT02152956|65470874|FG009|Overall Study|Study terminated by sponsor|0|||
23471965|NCT02152956|65470875|FG010|Overall Study|Study terminated by sponsor|0|||
23471966|NCT02152956|65470876|FG011|Overall Study|Study terminated by sponsor|29|||
23471967|NCT02152956|65470877|FG012|Overall Study|Study terminated by sponsor|0|||
23471968|NCT02152956|65470865|FG000|Overall Study|progressive disease|0|||
23471969|NCT02152956|65470866|FG001|Overall Study|progressive disease|0|||
23471970|NCT02152956|65470867|FG002|Overall Study|progressive disease|0|||
23471971|NCT02152956|65470868|FG003|Overall Study|progressive disease|0|||
23471972|NCT02152956|65470869|FG004|Overall Study|progressive disease|0|||
23471973|NCT02152956|65470870|FG005|Overall Study|progressive disease|0|||
23471974|NCT02152956|65470871|FG006|Overall Study|progressive disease|0|||
23471975|NCT02152956|65470872|FG007|Overall Study|progressive disease|0|||
23471976|NCT02152956|65470873|FG008|Overall Study|progressive disease|1|||
23189490|NCT01887912|64436086|FG001|Overall Study|Protocol Violation|37|||
23189491|NCT01887912|64436085|FG000|Overall Study|Lost to Follow-up|163|||
23189492|NCT01887912|64436086|FG001|Overall Study|Lost to Follow-up|74|||
23189493|NCT01887912|64436085|FG000|Overall Study|Withdrawal by Subject|606|||
23189494|NCT01887912|64436086|FG001|Overall Study|Withdrawal by Subject|349|||
23189495|NCT01887912|64436085|FG000|Overall Study|Other|122|||
23248871|NCT01289990|64652679|FG004|Overall Study|Lost to Follow-up|3|||
23471977|NCT02152956|65470874|FG009|Overall Study|progressive disease|0|||
23471978|NCT02152956|65470875|FG010|Overall Study|progressive disease|0|||
23471979|NCT02152956|65470876|FG011|Overall Study|progressive disease|1|||
23471980|NCT02152956|65470877|FG012|Overall Study|progressive disease|0|||
23471981|NCT01069900|65470878|FG000|Overall Study|Technical problems|0|||
23189496|NCT01887912|64436086|FG001|Overall Study|Other|58|||
23189497|NCT01845077|64436089|FG000|Washout Period|Lost to Follow-up|0|||
23189498|NCT01845077|64436090|FG001|Washout Period|Lost to Follow-up|1|||
23189499|NCT01845077|64436091|FG002|Washout Period|Lost to Follow-up|0|||
23189500|NCT01845077|64436092|FG003|Washout Period|Lost to Follow-up|1|||
23189501|NCT01845077|64436093|FG004|Washout Period|Lost to Follow-up|0|||
23189502|NCT01845077|64436094|FG005|Washout Period|Lost to Follow-up|1|||
23189503|NCT01845077|64436089|FG000|Washout Period|Adverse Event|1|||
23189504|NCT01845077|64436090|FG001|Washout Period|Adverse Event|0|||
23189505|NCT01845077|64436091|FG002|Washout Period|Adverse Event|0|||
23189506|NCT01845077|64436092|FG003|Washout Period|Adverse Event|0|||
23189507|NCT01845077|64436093|FG004|Washout Period|Adverse Event|0|||
23248872|NCT01289990|64652680|FG005|Overall Study|Lost to Follow-up|4|||
23248873|NCT01289990|64652681|FG006|Overall Study|Lost to Follow-up|2|||
23471982|NCT01069900|65470879|FG001|Overall Study|Technical problems|1|||
23471983|NCT01069900|65470878|FG000|Overall Study|Lost to Follow-up|7|||
23189508|NCT01845077|64436094|FG005|Washout Period|Adverse Event|0|||
23189509|NCT01845077|64436089|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
23189510|NCT01845077|64436090|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
23248874|NCT01289990|64652682|FG007|Overall Study|Lost to Follow-up|2|||
23248875|NCT01289990|64652683|FG008|Overall Study|Lost to Follow-up|1|||
23248876|NCT01289990|64652684|FG009|Overall Study|Lost to Follow-up|4|||
23248877|NCT01289990|64652685|FG010|Overall Study|Lost to Follow-up|2|||
23248878|NCT01289990|64652686|FG011|Overall Study|Lost to Follow-up|1|||
23471984|NCT01069900|65470879|FG001|Overall Study|Lost to Follow-up|1|||
23587925|NCT04364269|65882081|FG002|Overall Study|Adverse Event|0|||
23587926|NCT04364269|65882079|FG000|Overall Study|Withdrawal by Subject|0|||
23587927|NCT04364269|65882080|FG001|Overall Study|Withdrawal by Subject|1|||
23587928|NCT04364269|65882081|FG002|Overall Study|Withdrawal by Subject|0|||
23587929|NCT00606580|65882084|FG000|Overall Study|Lost to Follow-up|1|||
23587930|NCT00606580|65882085|FG001|Overall Study|Lost to Follow-up|1|||
23587931|NCT00606580|65882086|FG002|Overall Study|Lost to Follow-up|4|||
23587932|NCT00606580|65882084|FG000|Overall Study|Clinical failures|1|||
23587933|NCT00606580|65882085|FG001|Overall Study|Clinical failures|0|||
23248879|NCT01289990|64652687|FG012|Overall Study|Lost to Follow-up|2|||
23471985|NCT01069900|65470878|FG000|Overall Study|Withdrawal by Subject|6|||
23471986|NCT01069900|65470879|FG001|Overall Study|Withdrawal by Subject|1|||
23471987|NCT01069900|65470878|FG000|Overall Study|Protocol Violation|4|||
23471988|NCT01069900|65470879|FG001|Overall Study|Protocol Violation|1|||
23471989|NCT01069900|65470878|FG000|Overall Study|Insufficient Therapeutic effect|1|||
23471990|NCT01069900|65470879|FG001|Overall Study|Insufficient Therapeutic effect|0|||
23471991|NCT01942733|65470884|FG000|Overall Study|Lost to Follow-up|1|||
23471992|NCT01942733|65470884|FG000|Overall Study|Non-compliance with IMP|1|||
23471993|NCT01942733|65470884|FG000|Overall Study|Administrative|1|||
23471994|NCT04050202|65470885|FG000|Overall Study|Lost to Follow-up|2|||
23471995|NCT00918736|65470887|FG000|Overall Study|Withdrawal by Subject|4|||
23471996|NCT02654717|65470899|FG000|Overall Study|Adverse Event|2|||
23471997|NCT02654717|65470900|FG001|Overall Study|Adverse Event|2|||
23471998|NCT02654717|65470899|FG000|Overall Study|Protocol Violation|1|||
23471999|NCT02654717|65470900|FG001|Overall Study|Protocol Violation|2|||
23472000|NCT02654717|65470899|FG000|Overall Study|Withdrawal by Subject|0|||
23472001|NCT02654717|65470900|FG001|Overall Study|Withdrawal by Subject|1|||
23472002|NCT02654717|65470899|FG000|Overall Study|Non-permitted medication|3|||
23472003|NCT02654717|65470900|FG001|Overall Study|Non-permitted medication|0|||
23472004|NCT03983317|65470902|FG000|Overall Study|Physician Decision|5|||
23472005|NCT00856518|65470903|FG000|Overall Study|Lost to Follow-up|4|||
23472006|NCT00856518|65470904|FG001|Overall Study|Lost to Follow-up|2|||
23472007|NCT00615901|65470906|FG000|Overall Study|Withdrawal by Subject|2|||
23472008|NCT00615901|65470906|FG000|Overall Study|Adverse Event|7|||
23472009|NCT01765218|65470907|FG000|Overall Study|Protocol Violation|1|||
23472010|NCT01765218|65470908|FG001|Overall Study|Protocol Violation|2|||
23472011|NCT02267317|65473804|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
23472012|NCT02267317|65473805|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472013|NCT02267317|65473806|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472014|NCT02267317|65473807|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472015|NCT02267317|65473808|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472016|NCT02267317|65473809|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
23472017|NCT02267317|65473804|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
23472018|NCT02267317|65473805|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23248880|NCT01289990|64652675|FG000|Overall Study|Withdrawal by Subject|15|||
23248881|NCT01289990|64652676|FG001|Overall Study|Withdrawal by Subject|14|||
23472019|NCT02267317|65473806|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23248882|NCT01289990|64652677|FG002|Overall Study|Withdrawal by Subject|12|||
23472020|NCT02267317|65473807|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23472021|NCT02267317|65473808|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23472022|NCT02267317|65473809|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
23472023|NCT02864862|65473816|FG000|Overall Study|Lost to Follow-up|1|||
23472024|NCT02864862|65473817|FG001|Overall Study|Lost to Follow-up|0|||
23472025|NCT02864862|65473818|FG002|Overall Study|Lost to Follow-up|1|||
23472026|NCT02864862|65473816|FG000|Overall Study|Protocol Violation|0|||
23472027|NCT02864862|65473817|FG001|Overall Study|Protocol Violation|0|||
23472028|NCT02864862|65473818|FG002|Overall Study|Protocol Violation|1|||
23472029|NCT00647270|65473819|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
23472030|NCT00647270|65473820|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
23472031|NCT00647270|65473821|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
23472032|NCT00647270|65473819|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
23472033|NCT00647270|65473820|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
23472034|NCT00647270|65473821|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
23472035|NCT00647270|65473819|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
23472036|NCT00647270|65473820|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
23472037|NCT00647270|65473821|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
23472038|NCT00647270|65473819|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
23472039|NCT00647270|65473820|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
23472040|NCT00647270|65473821|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
23472041|NCT00647270|65473819|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
23472042|NCT00647270|65473820|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
23472043|NCT00647270|65473821|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
23472044|NCT00647270|65473819|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
23472045|NCT00647270|65473820|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
23472046|NCT00647270|65473821|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
23472047|NCT00647270|65473819|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
23472048|NCT00647270|65473820|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
23472049|NCT00647270|65473821|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
23472050|NCT00402740|65473836|FG000|Overall Study|Withdrawal by Subject|18|||
23472051|NCT00402740|65473836|FG000|Overall Study|Death|50|||
23472052|NCT00402740|65473836|FG000|Overall Study|Lost to Follow-up|6|||
23472053|NCT00402740|65473836|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
23472054|NCT00402740|65473836|FG000|Overall Study|Subject disposition unknown.|1|||
23472055|NCT00742235|65473841|FG000|Overall Study|Lost to Follow-up|0|||
23472056|NCT00742235|65473842|FG001|Overall Study|Lost to Follow-up|31|||
23472057|NCT00125164|65473843|FG000|Overall Study|Adverse Event|0|||
23472058|NCT00125164|65473844|FG001|Overall Study|Adverse Event|0|||
23472059|NCT00125164|65473845|FG002|Overall Study|Adverse Event|2|||
23472060|NCT00125164|65473846|FG003|Overall Study|Adverse Event|4|||
23472061|NCT00125164|65473843|FG000|Overall Study|Lost to Follow-up|0|||
23248883|NCT01289990|64652678|FG003|Overall Study|Withdrawal by Subject|13|||
23248884|NCT01289990|64652679|FG004|Overall Study|Withdrawal by Subject|8|||
23248885|NCT01289990|64652680|FG005|Overall Study|Withdrawal by Subject|7|||
23248886|NCT01289990|64652681|FG006|Overall Study|Withdrawal by Subject|13|||
23248887|NCT01289990|64652682|FG007|Overall Study|Withdrawal by Subject|9|||
23472062|NCT00125164|65473844|FG001|Overall Study|Lost to Follow-up|0|||
23472063|NCT00125164|65473845|FG002|Overall Study|Lost to Follow-up|1|||
23472064|NCT00125164|65473846|FG003|Overall Study|Lost to Follow-up|1|||
23472065|NCT00125164|65473843|FG000|Overall Study|Withdrawal by Subject|2|||
23472066|NCT00125164|65473844|FG001|Overall Study|Withdrawal by Subject|0|||
23472067|NCT00125164|65473845|FG002|Overall Study|Withdrawal by Subject|1|||
23472068|NCT00125164|65473846|FG003|Overall Study|Withdrawal by Subject|1|||
23472069|NCT04450381|65473851|FG000|Overall Study|Protocol Violation|4|||
23472070|NCT04450381|65473851|FG000|Overall Study|Wrong device setting|2|||
23472071|NCT00771953|65473856|FG000|Overall Study|Adverse Event|5|||
23472072|NCT00771953|65473857|FG001|Overall Study|Adverse Event|3|||
23472073|NCT00771953|65473856|FG000|Overall Study|Death|2|||
23472074|NCT00771953|65473857|FG001|Overall Study|Death|2|||
23472075|NCT00771953|65473856|FG000|Overall Study|Progression before active Tx|1|||
23472076|NCT00771953|65473857|FG001|Overall Study|Progression before active Tx|2|||
23472077|NCT00771953|65473856|FG000|Overall Study|Sponsor decision|1|||
23189511|NCT01845077|64436091|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
23189512|NCT01845077|64436092|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
23189513|NCT01845077|64436093|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
23189514|NCT01845077|64436094|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
23189515|NCT01845077|64436089|FG000|Washout Period|Protocol Violation|0|||
23189516|NCT01845077|64436090|FG001|Washout Period|Protocol Violation|0|||
23189517|NCT01845077|64436091|FG002|Washout Period|Protocol Violation|0|||
23189518|NCT01845077|64436092|FG003|Washout Period|Protocol Violation|1|||
23189519|NCT01845077|64436093|FG004|Washout Period|Protocol Violation|1|||
23189520|NCT01845077|64436094|FG005|Washout Period|Protocol Violation|0|||
23189521|NCT02403206|64436095|FG000|Overall Study|Lost to Follow-up|4|||
23189522|NCT02403206|64436096|FG001|Overall Study|Lost to Follow-up|3|||
23189523|NCT02403206|64436095|FG000|Overall Study|Physician Decision|2|||
23189524|NCT02403206|64436096|FG001|Overall Study|Physician Decision|0|||
23189525|NCT02403206|64436095|FG000|Overall Study|Withdrawal by Subject|3|||
23189526|NCT02403206|64436096|FG001|Overall Study|Withdrawal by Subject|3|||
23189527|NCT02403206|64436095|FG000|Overall Study|Reason not given|2|||
23248888|NCT01289990|64652683|FG008|Overall Study|Withdrawal by Subject|12|||
23248889|NCT01289990|64652684|FG009|Overall Study|Withdrawal by Subject|13|||
23472078|NCT00771953|65473857|FG001|Overall Study|Sponsor decision|0|||
23472079|NCT00771953|65473856|FG000|Overall Study|Other complicating disease|1|||
23472080|NCT00771953|65473857|FG001|Overall Study|Other complicating disease|0|||
23472081|NCT00771953|65473856|FG000|Overall Study|Withdrawal by Subject|0|||
23472082|NCT00771953|65473857|FG001|Overall Study|Withdrawal by Subject|3|||
23472083|NCT00777153|65473858|FG000|Overall Study|Lost to Follow-up|1|||
23472084|NCT00777153|65473859|FG001|Overall Study|Lost to Follow-up|1|||
23472085|NCT00777153|65473860|FG002|Overall Study|Lost to Follow-up|0|||
23472086|NCT00777153|65473858|FG000|Overall Study|Death|85|||
23189528|NCT02403206|64436096|FG001|Overall Study|Reason not given|4|||
23189529|NCT02124798|64436097|FG000|Overall Study|Adverse Event|3|||
23189530|NCT02124798|64436097|FG000|Overall Study|Lost to Follow-up|1|||
23189531|NCT01025336|64436100|FG000|Overall Study|Protocol Violation|0|||
23189532|NCT01025336|64436101|FG001|Overall Study|Protocol Violation|0|||
23189533|NCT01025336|64436102|FG002|Overall Study|Protocol Violation|0|||
23189534|NCT01025336|64436103|FG003|Overall Study|Protocol Violation|2|||
23189535|NCT01025336|64436104|FG004|Overall Study|Protocol Violation|0|||
23189536|NCT00376688|64436106|FG000|Overall Study|Adverse Event|3|||
23189537|NCT00376688|64436106|FG000|Overall Study|Death|1|||
23189538|NCT03518840|64436107|FG000|Overall Study|Lost to Follow-up|6|||
23189539|NCT00815308|64436108|FG000|Overall Study|Adverse Event|4|||
23189540|NCT00815308|64436108|FG000|Overall Study|Withdrawal by Subject|0|||
23189541|NCT00815308|64436108|FG000|Overall Study|Protocol Violation|6|||
23189542|NCT02128490|64436109|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
23189543|NCT02128490|64436110|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23189544|NCT02128490|64436111|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
23189545|NCT02128490|64436112|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
23189546|NCT02128490|64436113|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
23189547|NCT02128490|64436109|FG000|Overall Study|Major Protocol Deviation|1|||
23189548|NCT02128490|64436110|FG001|Overall Study|Major Protocol Deviation|2|||
23189549|NCT02128490|64436111|FG002|Overall Study|Major Protocol Deviation|0|||
23189550|NCT02128490|64436112|FG003|Overall Study|Major Protocol Deviation|2|||
23189551|NCT02128490|64436113|FG004|Overall Study|Major Protocol Deviation|2|||
23189552|NCT02128490|64436109|FG000|Overall Study|Lost to Follow-up|0|||
23189553|NCT02128490|64436110|FG001|Overall Study|Lost to Follow-up|0|||
23189554|NCT02128490|64436111|FG002|Overall Study|Lost to Follow-up|1|||
23189555|NCT02128490|64436112|FG003|Overall Study|Lost to Follow-up|1|||
23189556|NCT02128490|64436113|FG004|Overall Study|Lost to Follow-up|1|||
23189557|NCT02128490|64436109|FG000|Overall Study|Voluntary Withdrawal|3|||
23472087|NCT00777153|65473859|FG001|Overall Study|Death|73|||
23472088|NCT00777153|65473860|FG002|Overall Study|Death|33|||
23472089|NCT00777153|65473858|FG000|Overall Study|Withdrawal by Subject|3|||
23472090|NCT00777153|65473859|FG001|Overall Study|Withdrawal by Subject|4|||
23472091|NCT00777153|65473860|FG002|Overall Study|Withdrawal by Subject|3|||
23472092|NCT00777153|65473858|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
23472093|NCT00777153|65473859|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
23472094|NCT00777153|65473860|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
23472095|NCT02139592|65473864|FG000|Overall Study|Case Report Forms Uncollected|8|||
23472096|NCT01497366|65473866|FG000|Overall Study|Virologic failure|2|||
23472097|NCT01497366|65473867|FG001|Overall Study|Virologic failure|50|||
23472098|NCT01497366|65473866|FG000|Overall Study|Lost to Follow-up|11|||
23587934|NCT00606580|65882086|FG002|Overall Study|Clinical failures|12|||
23587935|NCT00606580|65882084|FG000|Overall Study|Withdrawal by investigator|0|||
23587936|NCT00606580|65882085|FG001|Overall Study|Withdrawal by investigator|1|||
23587937|NCT00606580|65882086|FG002|Overall Study|Withdrawal by investigator|6|||
23587938|NCT00606580|65882084|FG000|Overall Study|Withdrawal by Subject|0|||
23587939|NCT00606580|65882085|FG001|Overall Study|Withdrawal by Subject|1|||
23587940|NCT00606580|65882086|FG002|Overall Study|Withdrawal by Subject|0|||
23587941|NCT03478956|65882087|FG000|Overall Study|Adverse Event|1|||
23587942|NCT03478956|65882088|FG001|Overall Study|Adverse Event|0|||
23587943|NCT03478956|65882087|FG000|Overall Study|Withdrawal by Subject|0|||
23587944|NCT03478956|65882088|FG001|Overall Study|Withdrawal by Subject|1|||
23587945|NCT03478956|65882087|FG000|Overall Study|Ongoing in the Study|11|||
23587946|NCT03478956|65882088|FG001|Overall Study|Ongoing in the Study|11|||
23587947|NCT00305695|65882089|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
23587948|NCT00305695|65882090|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
23587949|NCT00305695|65882089|FG000|Overall Study|Did not have baseline scan|1|||
23587950|NCT00305695|65882090|FG001|Overall Study|Did not have baseline scan|1|||
23587951|NCT00377455|65882094|FG000|Overall Study|Withdrawal by Subject|1|||
23587952|NCT04439799|65882101|FG000|Overall Study|Lost to Follow-up|6|||
23587953|NCT04439799|65882102|FG001|Overall Study|Lost to Follow-up|6|||
23587954|NCT04439799|65882101|FG000|Overall Study|Withdrawal by Subject|2|||
23587955|NCT04439799|65882102|FG001|Overall Study|Withdrawal by Subject|6|||
23587956|NCT04439799|65882101|FG000|Overall Study|Adverse Event|2|||
23189558|NCT02128490|64436110|FG001|Overall Study|Voluntary Withdrawal|3|||
23189559|NCT02128490|64436111|FG002|Overall Study|Voluntary Withdrawal|1|||
23189560|NCT02128490|64436112|FG003|Overall Study|Voluntary Withdrawal|1|||
23587957|NCT04439799|65882102|FG001|Overall Study|Adverse Event|5|||
23189561|NCT02128490|64436113|FG004|Overall Study|Voluntary Withdrawal|2|||
23189562|NCT02128490|64436109|FG000|Overall Study|Lack of Efficacy|0|||
23189563|NCT02128490|64436110|FG001|Overall Study|Lack of Efficacy|1|||
23248890|NCT01289990|64652685|FG010|Overall Study|Withdrawal by Subject|11|||
23189564|NCT02128490|64436111|FG002|Overall Study|Lack of Efficacy|0|||
23472099|NCT01497366|65473867|FG001|Overall Study|Lost to Follow-up|10|||
23472100|NCT01497366|65473866|FG000|Overall Study|Withdrawal by Subject|6|||
23472101|NCT01497366|65473867|FG001|Overall Study|Withdrawal by Subject|6|||
23587958|NCT02982213|65882105|FG000|Overall Study|Did not complete follow up questionnaire|5|||
23587959|NCT02982213|65882106|FG001|Overall Study|Did not complete follow up questionnaire|1|||
23587960|NCT01289119|65882107|FG000|Overall Study|Adverse Event|2|||
23587961|NCT01289119|65882108|FG001|Overall Study|Adverse Event|1|||
23587962|NCT01289119|65882109|FG002|Overall Study|Adverse Event|0|||
23587963|NCT01289119|65882110|FG003|Overall Study|Adverse Event|2|||
23472102|NCT01497366|65473866|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
23472103|NCT01497366|65473867|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
23472104|NCT01497366|65473866|FG000|Overall Study|Other|5|||
23472105|NCT01497366|65473867|FG001|Overall Study|Other|0|||
23472106|NCT01497366|65473866|FG000|Overall Study|Death|1|||
23472107|NCT01497366|65473867|FG001|Overall Study|Death|1|||
23472108|NCT01497366|65473866|FG000|Overall Study|Randomized but not treated|7|||
23472109|NCT01497366|65473867|FG001|Overall Study|Randomized but not treated|21|||
23472110|NCT02260180|65473870|FG000|Overall Study|Adverse Event|2|||
23472111|NCT02260180|65473871|FG001|Overall Study|Adverse Event|0|||
23472112|NCT02260180|65473872|FG002|Overall Study|Adverse Event|1|||
23472113|NCT00243269|65473873|FG000|Overall Study|Protocol Violation|2|||
23472114|NCT00243269|65473874|FG001|Overall Study|Protocol Violation|1|||
23472115|NCT00243269|65473875|FG002|Overall Study|Protocol Violation|0|||
23472116|NCT00243269|65473876|FG003|Overall Study|Protocol Violation|1|||
23472117|NCT00243269|65473873|FG000|Overall Study|Lost to Follow-up|1|||
23472118|NCT00243269|65473874|FG001|Overall Study|Lost to Follow-up|0|||
23472119|NCT00243269|65473875|FG002|Overall Study|Lost to Follow-up|1|||
23472120|NCT00243269|65473876|FG003|Overall Study|Lost to Follow-up|3|||
23472121|NCT00280748|65473877|FG000|Overall Study|Decline in performance|3|||
23472122|NCT00280748|65473877|FG000|Overall Study|Extra-cranial disease progression|1|||
23472123|NCT04530136|65473878|FG000|Overall Study|Lost to Follow-up|2|||
23472124|NCT04530136|65473879|FG001|Overall Study|Lost to Follow-up|3|||
23472125|NCT04530136|65473878|FG000|Overall Study|Withdrawal by Subject|1|||
23472126|NCT04530136|65473879|FG001|Overall Study|Withdrawal by Subject|0|||
23472127|NCT04530136|65473878|FG000|Overall Study|Death|0|||
23472128|NCT04530136|65473879|FG001|Overall Study|Death|1|||
23472129|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
23472130|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
23472131|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
23472132|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
23472133|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
23472134|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
23472135|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
23472136|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
23472137|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
23472138|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
23472139|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Death|0|||
23472140|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Death|0|||
23472141|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Death|0|||
23472142|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Death|0|||
23472143|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Death|0|||
23472144|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Death|0|||
23472145|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Death|0|||
23587964|NCT01289119|65882111|FG004|Overall Study|Adverse Event|1|||
23587965|NCT01289119|65882112|FG005|Overall Study|Adverse Event|0|||
23587966|NCT01289119|65882107|FG000|Overall Study|Major Protocol Deviation|2|||
23587967|NCT01289119|65882108|FG001|Overall Study|Major Protocol Deviation|1|||
23587968|NCT01289119|65882109|FG002|Overall Study|Major Protocol Deviation|3|||
23587969|NCT01289119|65882110|FG003|Overall Study|Major Protocol Deviation|0|||
23587970|NCT01289119|65882111|FG004|Overall Study|Major Protocol Deviation|2|||
23248891|NCT01289990|64652686|FG011|Overall Study|Withdrawal by Subject|13|||
23248892|NCT01289990|64652687|FG012|Overall Study|Withdrawal by Subject|16|||
23248893|NCT01289990|64652675|FG000|Overall Study|discontinued in preceding trial|18|||
23248894|NCT01289990|64652676|FG001|Overall Study|discontinued in preceding trial|20|||
23248895|NCT01289990|64652677|FG002|Overall Study|discontinued in preceding trial|41|||
23354815|NCT00303472|65041544|FG006|Treatment Period|Withdrawal by Subject|0|||
23472146|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Death|0|||
23472147|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Death|1|||
23472148|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Death|0|||
23354816|NCT00303472|65041538|FG000|Treatment Period|Other|0|||
23354817|NCT00303472|65041539|FG001|Treatment Period|Other|0|||
23587971|NCT01289119|65882112|FG005|Overall Study|Major Protocol Deviation|1|||
23587972|NCT01289119|65882107|FG000|Overall Study|Lost to Follow-up|0|||
23472149|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
23472150|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472151|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
23587973|NCT01289119|65882108|FG001|Overall Study|Lost to Follow-up|3|||
23587974|NCT01289119|65882109|FG002|Overall Study|Lost to Follow-up|0|||
23354818|NCT00303472|65041540|FG002|Treatment Period|Other|0|||
23472152|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472153|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472154|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472155|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472156|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472157|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
23472158|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
23472159|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472160|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472161|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472162|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472163|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
23472164|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472165|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472166|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
23472167|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
23472168|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
23472169|NCT02036970|65473880|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472170|NCT02036970|65473881|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472171|NCT02036970|65473882|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472172|NCT02036970|65473883|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
23472173|NCT02036970|65473884|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472174|NCT02036970|65473885|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472175|NCT02036970|65473886|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472176|NCT02036970|65473887|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23472177|NCT02036970|65473888|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23248896|NCT01289990|64652678|FG003|Overall Study|discontinued in preceding trial|17|||
23248897|NCT01289990|64652679|FG004|Overall Study|discontinued in preceding trial|11|||
23248898|NCT01289990|64652680|FG005|Overall Study|discontinued in preceding trial|12|||
23248899|NCT01289990|64652681|FG006|Overall Study|discontinued in preceding trial|18|||
23248900|NCT01289990|64652682|FG007|Overall Study|discontinued in preceding trial|8|||
23248901|NCT01289990|64652683|FG008|Overall Study|discontinued in preceding trial|17|||
23248902|NCT01289990|64652684|FG009|Overall Study|discontinued in preceding trial|21|||
23248903|NCT01289990|64652685|FG010|Overall Study|discontinued in preceding trial|17|||
23472178|NCT02036970|65473889|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
23248904|NCT01289990|64652686|FG011|Overall Study|discontinued in preceding trial|17|||
23248905|NCT01289990|64652687|FG012|Overall Study|discontinued in preceding trial|24|||
23248906|NCT01289990|64652675|FG000|Overall Study|did not continue in extension|41|||
23248907|NCT01289990|64652676|FG001|Overall Study|did not continue in extension|45|||
23248908|NCT01289990|64652677|FG002|Overall Study|did not continue in extension|51|||
23248909|NCT01289990|64652678|FG003|Overall Study|did not continue in extension|51|||
23248910|NCT01289990|64652679|FG004|Overall Study|did not continue in extension|48|||
23248911|NCT01289990|64652680|FG005|Overall Study|did not continue in extension|50|||
23248912|NCT01289990|64652681|FG006|Overall Study|did not continue in extension|54|||
23248913|NCT01289990|64652682|FG007|Overall Study|did not continue in extension|36|||
23248914|NCT01289990|64652683|FG008|Overall Study|did not continue in extension|44|||
23248915|NCT01289990|64652684|FG009|Overall Study|did not continue in extension|48|||
23248916|NCT01289990|64652685|FG010|Overall Study|did not continue in extension|45|||
23248917|NCT01289990|64652686|FG011|Overall Study|did not continue in extension|34|||
23248918|NCT01289990|64652687|FG012|Overall Study|did not continue in extension|56|||
23354819|NCT00303472|65041541|FG003|Treatment Period|Other|0|||
23472179|NCT02036970|65473880|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
23472180|NCT02036970|65473881|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
23472181|NCT02036970|65473882|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
23472182|NCT02036970|65473883|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
23472183|NCT02036970|65473884|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
23472184|NCT02036970|65473885|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
23472185|NCT02036970|65473886|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
23587975|NCT01289119|65882110|FG003|Overall Study|Lost to Follow-up|0|||
23587976|NCT01289119|65882111|FG004|Overall Study|Lost to Follow-up|0|||
23248919|NCT01289990|64652675|FG000|Overall Study|Not treated|0|||
23248920|NCT01289990|64652676|FG001|Overall Study|Not treated|0|||
23248921|NCT01289990|64652677|FG002|Overall Study|Not treated|0|||
23248922|NCT01289990|64652678|FG003|Overall Study|Not treated|0|||
23248923|NCT01289990|64652679|FG004|Overall Study|Not treated|0|||
23354820|NCT00303472|65041542|FG004|Treatment Period|Other|1|||
23472186|NCT02036970|65473887|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
23472187|NCT02036970|65473888|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
23472188|NCT02036970|65473889|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
23472189|NCT02036970|65473880|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472190|NCT02036970|65473881|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472191|NCT02036970|65473882|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472192|NCT02036970|65473883|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472193|NCT02036970|65473884|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472194|NCT02036970|65473885|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472195|NCT02036970|65473886|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472196|NCT02036970|65473887|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
23587977|NCT01289119|65882112|FG005|Overall Study|Lost to Follow-up|1|||
23189565|NCT02128490|64436112|FG003|Overall Study|Lack of Efficacy|0|||
23189566|NCT02128490|64436113|FG004|Overall Study|Lack of Efficacy|0|||
23587978|NCT01289119|65882107|FG000|Overall Study|Withdrawal by Subject|4|||
23587979|NCT01289119|65882108|FG001|Overall Study|Withdrawal by Subject|2|||
23587980|NCT01289119|65882109|FG002|Overall Study|Withdrawal by Subject|4|||
23248924|NCT01289990|64652680|FG005|Overall Study|Not treated|0|||
23248925|NCT01289990|64652681|FG006|Overall Study|Not treated|1|||
23587981|NCT01289119|65882110|FG003|Overall Study|Withdrawal by Subject|3|||
23587982|NCT01289119|65882111|FG004|Overall Study|Withdrawal by Subject|1|||
23587983|NCT01289119|65882112|FG005|Overall Study|Withdrawal by Subject|1|||
23587984|NCT01289119|65882107|FG000|Overall Study|Pregnancy|0|||
23587985|NCT01289119|65882108|FG001|Overall Study|Pregnancy|1|||
23587986|NCT01289119|65882109|FG002|Overall Study|Pregnancy|0|||
23587987|NCT01289119|65882110|FG003|Overall Study|Pregnancy|0|||
23587988|NCT01289119|65882111|FG004|Overall Study|Pregnancy|0|||
23587989|NCT01289119|65882112|FG005|Overall Study|Pregnancy|0|||
23587990|NCT01289119|65882107|FG000|Overall Study|Lack of Efficacy|0|||
23587991|NCT01289119|65882108|FG001|Overall Study|Lack of Efficacy|1|||
23587992|NCT01289119|65882109|FG002|Overall Study|Lack of Efficacy|1|||
23587993|NCT01289119|65882110|FG003|Overall Study|Lack of Efficacy|1|||
23587994|NCT01289119|65882111|FG004|Overall Study|Lack of Efficacy|1|||
23587995|NCT01289119|65882112|FG005|Overall Study|Lack of Efficacy|1|||
23587996|NCT01289119|65882107|FG000|Overall Study|Other|1|||
23587997|NCT01289119|65882108|FG001|Overall Study|Other|0|||
23587998|NCT01289119|65882109|FG002|Overall Study|Other|1|||
23587999|NCT01289119|65882110|FG003|Overall Study|Other|0|||
23588000|NCT01289119|65882111|FG004|Overall Study|Other|0|||
23588001|NCT01289119|65882112|FG005|Overall Study|Other|0|||
23588002|NCT01685606|65882117|FG000|Overall Study|Withdrawal by Subject|1|||
23588003|NCT00964366|65882118|FG000|Overall Study|Did not qualify at Day 1|1|||
23588004|NCT00964366|65882119|FG001|Overall Study|Did not qualify at Day 1|0|||
23588005|NCT00964366|65882118|FG000|Overall Study|Withdrawal by Subject|0|||
23588006|NCT00964366|65882119|FG001|Overall Study|Withdrawal by Subject|1|||
23588007|NCT00943605|65882120|FG000|Overall Study|Study termination|30|||
23588008|NCT00943605|65882121|FG001|Overall Study|Study termination|30|||
23588009|NCT00530842|65882122|FG000|Overall Study|Adverse Event|10|||
23588010|NCT00530842|65882123|FG001|Overall Study|Adverse Event|6|||
23588011|NCT00530842|65882122|FG000|Overall Study|Lack of Efficacy|2|||
23588012|NCT00530842|65882123|FG001|Overall Study|Lack of Efficacy|1|||
23588013|NCT00530842|65882122|FG000|Overall Study|Lost to Follow-up|0|||
23588014|NCT00530842|65882123|FG001|Overall Study|Lost to Follow-up|4|||
23588015|NCT00530842|65882122|FG000|Overall Study|Protocol Violation|3|||
23588016|NCT00530842|65882123|FG001|Overall Study|Protocol Violation|2|||
23588017|NCT00530842|65882122|FG000|Overall Study|Withdrawal by Subject|4|||
23588018|NCT00530842|65882123|FG001|Overall Study|Withdrawal by Subject|5|||
23588019|NCT00530842|65882122|FG000|Overall Study|Individual different reasons|4|||
23588020|NCT00530842|65882123|FG001|Overall Study|Individual different reasons|3|||
23588021|NCT00530842|65882122|FG000|Period 1|Adverse Event|7|||
23248926|NCT01289990|64652682|FG007|Overall Study|Not treated|0|||
23354821|NCT00303472|65041543|FG005|Treatment Period|Other|0|||
23588022|NCT00530842|65882123|FG001|Period 1|Adverse Event|3|||
23588023|NCT00530842|65882122|FG000|Period 1|Lack of Efficacy|1|||
23588024|NCT00530842|65882123|FG001|Period 1|Lack of Efficacy|1|||
23588025|NCT00530842|65882122|FG000|Period 1|Protocol Violation|2|||
23472197|NCT02036970|65473888|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
23588026|NCT00530842|65882123|FG001|Period 1|Protocol Violation|1|||
23588027|NCT00530842|65882122|FG000|Period 1|Withdrawal by Subject|2|||
23588028|NCT00530842|65882123|FG001|Period 1|Withdrawal by Subject|3|||
23588029|NCT00530842|65882122|FG000|Period 1|Individual different reasons|2|||
23588030|NCT00530842|65882123|FG001|Period 1|Individual different reasons|3|||
23189567|NCT02128490|64436109|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
23189568|NCT02128490|64436110|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
23588031|NCT00530842|65882122|FG000|Period 2|Adverse Event|3|||
23588032|NCT00530842|65882123|FG001|Period 2|Adverse Event|3|||
23588033|NCT00530842|65882122|FG000|Period 2|Lack of Efficacy|1|||
23588034|NCT00530842|65882123|FG001|Period 2|Lack of Efficacy|0|||
23588035|NCT00530842|65882122|FG000|Period 2|Lost to Follow-up|0|||
23588036|NCT00530842|65882123|FG001|Period 2|Lost to Follow-up|4|||
23588037|NCT00530842|65882122|FG000|Period 2|Protocol Violation|1|||
23588038|NCT00530842|65882123|FG001|Period 2|Protocol Violation|0|||
23588039|NCT00530842|65882122|FG000|Period 2|Withdrawal by Subject|1|||
23588040|NCT00530842|65882123|FG001|Period 2|Withdrawal by Subject|2|||
23588041|NCT00530842|65882122|FG000|Period 2|Individual different reasons|2|||
23588042|NCT00530842|65882123|FG001|Period 2|Individual different reasons|0|||
23588043|NCT04588480|65882126|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
23588044|NCT04588480|65882127|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
23588045|NCT04588480|65882128|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
23588046|NCT04588480|65882126|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
23588047|NCT04588480|65882127|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
23588048|NCT04588480|65882128|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
23588049|NCT00597519|65882129|FG000|Overall Study|Death|1|||
23588050|NCT00678795|65882130|FG000|Overall Study|Adverse Event|7|||
23588051|NCT00678795|65882131|FG001|Overall Study|Adverse Event|3|||
23588052|NCT00678795|65882130|FG000|Overall Study|Withdrawal by Subject|3|||
23588053|NCT00678795|65882131|FG001|Overall Study|Withdrawal by Subject|0|||
23588054|NCT00678795|65882130|FG000|Overall Study|Protocol Violation|0|||
23588055|NCT00678795|65882131|FG001|Overall Study|Protocol Violation|1|||
23588056|NCT00678795|65882130|FG000|Overall Study|Lost to Follow-up|0|||
23588057|NCT00678795|65882131|FG001|Overall Study|Lost to Follow-up|1|||
23588058|NCT00678795|65882130|FG000|Overall Study|Lack of Efficacy|1|||
23588059|NCT00678795|65882131|FG001|Overall Study|Lack of Efficacy|1|||
23588060|NCT03823911|65882133|FG000|Overall Study|Lost to Follow-up|1|||
23588061|NCT03823911|65882134|FG001|Overall Study|Lost to Follow-up|5|||
23588062|NCT03823911|65882135|FG002|Overall Study|Lost to Follow-up|2|||
23588063|NCT03823911|65882133|FG000|Overall Study|Did not meet eligibility criteria|13|||
23588064|NCT03823911|65882134|FG001|Overall Study|Did not meet eligibility criteria|7|||
23588065|NCT03823911|65882135|FG002|Overall Study|Did not meet eligibility criteria|4|||
23588066|NCT03823911|65882133|FG000|Overall Study|Death|0|||
23588067|NCT03823911|65882134|FG001|Overall Study|Death|1|||
23588068|NCT03823911|65882135|FG002|Overall Study|Death|0|||
23588069|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
23588070|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
23588071|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
23588072|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
23588073|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
23588074|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
23588075|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
23588076|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
23588077|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
23588078|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
23588079|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
23588080|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
23588081|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
23588082|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
23588083|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
23588084|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
23588085|NCT03185819|65882136|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
23588086|NCT03185819|65882137|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
23588087|NCT03185819|65882138|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
23588088|NCT03185819|65882139|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
23588089|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
23588090|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
23588091|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
23588092|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
23588093|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
23588094|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
23588095|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
23588096|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
23588097|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
23588098|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
23588099|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
23588100|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
23588101|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
23588102|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
23588103|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
23588104|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
23354822|NCT00303472|65041544|FG006|Treatment Period|Other|1|||
23354823|NCT00303472|65041538|FG000|Treatment Period|Disease Progression (to AML)|0|||
23354824|NCT00303472|65041539|FG001|Treatment Period|Disease Progression (to AML)|0|||
23588105|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
23588106|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
23588107|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
23588108|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
23588109|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
23588110|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
23588111|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
23588112|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
23588113|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
23588114|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
23354825|NCT00303472|65041540|FG002|Treatment Period|Disease Progression (to AML)|0|||
23354826|NCT00303472|65041541|FG003|Treatment Period|Disease Progression (to AML)|0|||
23354827|NCT00303472|65041542|FG004|Treatment Period|Disease Progression (to AML)|1|||
23354828|NCT00303472|65041543|FG005|Treatment Period|Disease Progression (to AML)|0|||
23354829|NCT00303472|65041544|FG006|Treatment Period|Disease Progression (to AML)|0|||
23354830|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Adverse Event|1|||
23354831|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Adverse Event|0|||
23354832|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Adverse Event|1|||
23354833|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Adverse Event|0|||
23354834|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Adverse Event|0|||
23354835|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Adverse Event|0|||
23354836|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Adverse Event|0|||
23354837|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Death|2|||
23354838|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Death|0|||
23354839|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Death|1|||
23354840|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Death|0|||
23354841|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Death|0|||
23354842|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Death|0|||
23354843|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Death|0|||
23354844|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354845|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354846|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354847|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
23354848|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354849|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
23189569|NCT02128490|64436111|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
23189570|NCT02128490|64436112|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
23189571|NCT02128490|64436113|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
23189572|NCT02128490|64436109|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23189573|NCT02128490|64436110|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23189574|NCT02128490|64436111|FG002|Overall Study|Other Miscellaneous Reasons|2|||
23189575|NCT02128490|64436112|FG003|Overall Study|Other Miscellaneous Reasons|1|||
23189576|NCT02128490|64436113|FG004|Overall Study|Other Miscellaneous Reasons|1|||
23189577|NCT00883753|64436116|FG000|Overall Study|Adverse Event|37|||
23248927|NCT01289990|64652683|FG008|Overall Study|Not treated|1|||
23248928|NCT01289990|64652684|FG009|Overall Study|Not treated|0|||
23189578|NCT00883753|64436116|FG000|Overall Study|Death|2|||
23248929|NCT01289990|64652685|FG010|Overall Study|Not treated|1|||
23354850|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
23354851|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Physician Decision|0|||
23189579|NCT00883753|64436116|FG000|Overall Study|Insufficient therapeutic response|16|||
23189580|NCT00883753|64436116|FG000|Overall Study|Lost to Follow-up|4|||
23248930|NCT01289990|64652686|FG011|Overall Study|Not treated|2|||
23248931|NCT01289990|64652687|FG012|Overall Study|Not treated|0|||
23248932|NCT00537056|64652689|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
23248933|NCT03020966|64652690|FG000|Overall Study|Withdrawal by Subject|2|||
23354852|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Physician Decision|4|||
23354853|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Physician Decision|2|||
23354854|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Physician Decision|3|||
23354855|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Physician Decision|2|||
23354856|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Physician Decision|0|||
23354857|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Physician Decision|0|||
23248934|NCT03020966|64652691|FG001|Overall Study|Withdrawal by Subject|0|||
23248935|NCT01333475|64652692|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
23248936|NCT01333475|64652693|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
23248937|NCT01333475|64652692|FG000|Overall Study|Toxicity|1|||
23248938|NCT01333475|64652693|FG001|Overall Study|Toxicity|3|||
23248939|NCT00242567|64652698|FG000|Overall Study|Adverse Event|70|||
23248940|NCT00242567|64652699|FG001|Overall Study|Adverse Event|43|||
23248941|NCT00242567|64652698|FG000|Overall Study|Disease Progression|17|||
23248942|NCT00242567|64652699|FG001|Overall Study|Disease Progression|22|||
23248943|NCT00242567|64652698|FG000|Overall Study|Symptomatic deterioration|9|||
23248944|NCT00242567|64652699|FG001|Overall Study|Symptomatic deterioration|3|||
23248945|NCT00242567|64652698|FG000|Overall Study|Lack of Efficacy|2|||
23248946|NCT00242567|64652699|FG001|Overall Study|Lack of Efficacy|2|||
23248947|NCT00242567|64652698|FG000|Overall Study|Lost to Follow-up|9|||
23248948|NCT00242567|64652699|FG001|Overall Study|Lost to Follow-up|19|||
23248949|NCT00242567|64652698|FG000|Overall Study|Withdrawal by Subject|33|||
23248950|NCT00242567|64652699|FG001|Overall Study|Withdrawal by Subject|28|||
23354858|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
23354859|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
23354860|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
23354861|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
23354862|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
23354863|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
23354864|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
23354865|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Other|0|||
23354866|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Other|2|||
23354867|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Other|4|||
23354868|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Other|2|||
23354869|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Other|1|||
23354870|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Other|0|||
23354871|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Other|0|||
23472198|NCT02036970|65473889|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
23472199|NCT02036970|65473880|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472200|NCT02036970|65473881|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
23472201|NCT02036970|65473882|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
23472202|NCT02036970|65473883|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472203|NCT02036970|65473884|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472204|NCT02036970|65473885|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472205|NCT02036970|65473886|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472206|NCT02036970|65473887|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472207|NCT02036970|65473888|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
23472208|NCT02036970|65473889|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
23472209|NCT02036970|65473880|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
23472210|NCT02036970|65473881|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
23472211|NCT02036970|65473882|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
23472212|NCT02036970|65473883|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
23472213|NCT02036970|65473884|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
23472214|NCT02036970|65473885|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
23472215|NCT02036970|65473886|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
23588115|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
23588116|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
23588117|NCT03185819|65882136|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
23588118|NCT03185819|65882137|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
23189581|NCT00883753|64436116|FG000|Overall Study|Violation of selection criteria at entry|7|||
23248951|NCT00242567|64652698|FG000|Overall Study|Protocol Violation|12|||
23248952|NCT00242567|64652699|FG001|Overall Study|Protocol Violation|12|||
23248953|NCT00242567|64652698|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
23472216|NCT02036970|65473887|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
23472217|NCT02036970|65473888|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
23248954|NCT00242567|64652699|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
23248955|NCT00242567|64652698|FG000|Overall Study|Other|14|||
23189582|NCT00883753|64436116|FG000|Overall Study|Protocol Violation|2|||
23354872|NCT00303472|65041538|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
23354873|NCT00303472|65041539|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354874|NCT00303472|65041540|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354875|NCT00303472|65041541|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354876|NCT00303472|65041542|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354877|NCT00303472|65041543|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
23189583|NCT00883753|64436116|FG000|Overall Study|Refused treatment|4|||
23189584|NCT00883753|64436116|FG000|Overall Study|Withdrew consent|10|||
23189585|NCT00883753|64436116|FG000|Overall Study|Investigator's decision|17|||
23189586|NCT00883753|64436116|FG000|Overall Study|Administrative/Other|8|||
23189587|NCT00363415|64436124|FG000|Overall Study|Progressive Disease|196|||
23189588|NCT00363415|64436125|FG001|Overall Study|Progressive Disease|107|||
23189589|NCT00363415|64436124|FG000|Overall Study|Sponsor Decision|67|||
23189590|NCT00363415|64436125|FG001|Overall Study|Sponsor Decision|31|||
23189591|NCT00363415|64436124|FG000|Overall Study|Death|32|||
23189592|NCT00363415|64436125|FG001|Overall Study|Death|29|||
23189593|NCT00363415|64436124|FG000|Overall Study|Adverse Event|24|||
23248956|NCT00242567|64652699|FG001|Overall Study|Other|9|||
23248957|NCT02032823|64652701|FG000|Overall Study|Death|75|||
23248958|NCT02032823|64652702|FG001|Overall Study|Death|109|||
23248959|NCT02032823|64652701|FG000|Overall Study|Lost to Follow-up|18|||
23248960|NCT02032823|64652702|FG001|Overall Study|Lost to Follow-up|17|||
23248961|NCT02032823|64652701|FG000|Overall Study|Withdrawal by Subject|70|||
23248962|NCT02032823|64652702|FG001|Overall Study|Withdrawal by Subject|53|||
23248963|NCT02032823|64652701|FG000|Overall Study|Ongoing study at data cut-off|755|||
23248964|NCT02032823|64652702|FG001|Overall Study|Ongoing study at data cut-off|731|||
23248965|NCT02032823|64652701|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
23248966|NCT02032823|64652702|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
23248967|NCT01548573|64652705|FG000|Overall Study|Death|3|||
23248968|NCT01548573|64652705|FG000|Overall Study|Withdrawal by Subject|2|||
23248969|NCT00445458|64652706|FG000|Overall Study|Disease Progression|3|||
23248970|NCT00445458|64652707|FG001|Overall Study|Disease Progression|4|||
23248971|NCT00445458|64652708|FG002|Overall Study|Disease Progression|54|||
23248972|NCT00445458|64652709|FG003|Overall Study|Disease Progression|27|||
23248973|NCT00445458|64652706|FG000|Overall Study|Withdrawal by Subject|0|||
23248974|NCT00445458|64652707|FG001|Overall Study|Withdrawal by Subject|0|||
23248975|NCT00445458|64652708|FG002|Overall Study|Withdrawal by Subject|7|||
23248976|NCT00445458|64652709|FG003|Overall Study|Withdrawal by Subject|0|||
23472218|NCT02036970|65473889|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
23472219|NCT00854113|65473890|FG000|Overall Study|Adverse Event|0|||
23472220|NCT00854113|65473891|FG001|Overall Study|Adverse Event|0|||
23472221|NCT00854113|65473892|FG002|Overall Study|Adverse Event|0|||
23472222|NCT00854113|65473893|FG003|Overall Study|Adverse Event|0|||
23472223|NCT00854113|65473894|FG004|Overall Study|Adverse Event|0|||
23472224|NCT00854113|65473895|FG005|Overall Study|Adverse Event|0|||
23472225|NCT00854113|65473896|FG006|Overall Study|Adverse Event|0|||
23472226|NCT00854113|65473897|FG007|Overall Study|Adverse Event|2|||
23472227|NCT00854113|65473898|FG008|Overall Study|Adverse Event|0|||
23472228|NCT00854113|65473899|FG009|Overall Study|Adverse Event|0|||
23472229|NCT00854113|65473900|FG010|Overall Study|Adverse Event|0|||
23588119|NCT03185819|65882138|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
23588120|NCT03185819|65882139|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
23588121|NCT03265210|65882140|FG000|Overall Study|Withdrawal by Subject|7|||
23588122|NCT03265210|65882141|FG001|Overall Study|Withdrawal by Subject|9|||
23588123|NCT03265210|65882140|FG000|Overall Study|Lost to Follow-up|2|||
23588124|NCT03265210|65882141|FG001|Overall Study|Lost to Follow-up|0|||
23588125|NCT03265210|65882140|FG000|Overall Study|Physician Decision|2|||
23588126|NCT03265210|65882141|FG001|Overall Study|Physician Decision|0|||
23588127|NCT03265210|65882140|FG000|Overall Study|Adverse Event|1|||
23588128|NCT03265210|65882141|FG001|Overall Study|Adverse Event|0|||
23588129|NCT03068468|65882142|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
23588130|NCT03068468|65882143|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
23588131|NCT03068468|65882144|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
23588132|NCT03068468|65882145|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
23588133|NCT03068468|65882142|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
23588134|NCT03068468|65882143|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
23189594|NCT00363415|64436125|FG001|Overall Study|Adverse Event|15|||
23189595|NCT00363415|64436124|FG000|Overall Study|Physician Decision|18|||
23248977|NCT00445458|64652706|FG000|Overall Study|Adverse Event|0|||
23248978|NCT00445458|64652707|FG001|Overall Study|Adverse Event|0|||
23248979|NCT00445458|64652708|FG002|Overall Study|Adverse Event|3|||
23472230|NCT00854113|65473890|FG000|Overall Study|Withdrawal by Subject|0|||
23588135|NCT03068468|65882144|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
23588136|NCT03068468|65882145|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
23189596|NCT00363415|64436125|FG001|Overall Study|Physician Decision|35|||
23189597|NCT00363415|64436124|FG000|Overall Study|Entry Criteria Not Met|11|||
23189598|NCT00363415|64436125|FG001|Overall Study|Entry Criteria Not Met|10|||
23189599|NCT00363415|64436124|FG000|Overall Study|Withdrawal by Subject|9|||
23189600|NCT00363415|64436125|FG001|Overall Study|Withdrawal by Subject|15|||
23189601|NCT00363415|64436124|FG000|Overall Study|Lost to Follow-up|3|||
23189602|NCT00363415|64436125|FG001|Overall Study|Lost to Follow-up|3|||
23189603|NCT00363415|64436124|FG000|Overall Study|Protocol Violation|1|||
23189604|NCT00363415|64436125|FG001|Overall Study|Protocol Violation|4|||
23189605|NCT02517515|64436126|FG000|Overall Study|Adverse Event|0|||
23189606|NCT02517515|64436127|FG001|Overall Study|Adverse Event|1|||
23189607|NCT02517515|64436126|FG000|Overall Study|Withdrew Consent|0|||
23189608|NCT02517515|64436127|FG001|Overall Study|Withdrew Consent|1|||
23189609|NCT02517515|64436126|FG000|Overall Study|Lost to Follow-up|1|||
23189610|NCT02517515|64436127|FG001|Overall Study|Lost to Follow-up|0|||
23189611|NCT02517515|64436126|FG000|Overall Study|Other|1|||
23189612|NCT02517515|64436127|FG001|Overall Study|Other|0|||
23189613|NCT01174784|64436128|FG000|Overall Study|Screen fails|4|||
23189614|NCT03227861|64436130|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
23189615|NCT03227861|64436130|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
23189616|NCT03227861|64436130|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
23248980|NCT00445458|64652709|FG003|Overall Study|Adverse Event|0|||
23248981|NCT00445458|64652706|FG000|Overall Study|Death|0|||
23248982|NCT00445458|64652707|FG001|Overall Study|Death|1|||
23248983|NCT00445458|64652708|FG002|Overall Study|Death|2|||
23189617|NCT03227861|64436130|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
23248984|NCT00445458|64652709|FG003|Overall Study|Death|0|||
23354878|NCT00303472|65041544|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
23354879|NCT00551525|65041545|FG000|Overall Study|Protocol Violation|5|||
23354880|NCT01162122|65041547|FG000|Overall Study|Withdrawal by Subject|52|||
23354881|NCT01162122|65041548|FG001|Overall Study|Withdrawal by Subject|43|||
23354882|NCT01162122|65041547|FG000|Overall Study|Lost to Follow-up|73|||
23354883|NCT01162122|65041548|FG001|Overall Study|Lost to Follow-up|91|||
23354884|NCT01162122|65041547|FG000|Overall Study|Adverse Event|3|||
23354885|NCT01162122|65041548|FG001|Overall Study|Adverse Event|2|||
23354886|NCT01162122|65041547|FG000|Overall Study|Death|51|||
23354887|NCT01162122|65041548|FG001|Overall Study|Death|46|||
23354888|NCT01162122|65041547|FG000|Overall Study|Protocol Violation|2|||
23354889|NCT01162122|65041548|FG001|Overall Study|Protocol Violation|2|||
23354890|NCT01162122|65041547|FG000|Overall Study|Inappropriate enrollment|5|||
23248985|NCT00445458|64652706|FG000|Overall Study|Physician Decision|0|||
23248986|NCT00445458|64652707|FG001|Overall Study|Physician Decision|0|||
23248987|NCT00445458|64652708|FG002|Overall Study|Physician Decision|1|||
23248988|NCT00445458|64652709|FG003|Overall Study|Physician Decision|1|||
23248989|NCT00445458|64652706|FG000|Overall Study|Surgery|0|||
23248990|NCT00445458|64652707|FG001|Overall Study|Surgery|0|||
23248991|NCT00445458|64652708|FG002|Overall Study|Surgery|1|||
23248992|NCT00445458|64652709|FG003|Overall Study|Surgery|0|||
23248993|NCT03099265|64652710|FG000|Overall Study|Adverse Event|1|||
23248994|NCT00430638|64652711|FG000|Overall Study|Adverse Event|15|||
23248995|NCT00430638|64652712|FG001|Overall Study|Adverse Event|15|||
23248996|NCT00430638|64652711|FG000|Overall Study|Uncontrolled blood pressure|48|||
23248997|NCT00430638|64652712|FG001|Overall Study|Uncontrolled blood pressure|13|||
23248998|NCT00430638|64652711|FG000|Overall Study|Lost to Follow-up|1|||
23248999|NCT00430638|64652712|FG001|Overall Study|Lost to Follow-up|7|||
23249000|NCT00430638|64652711|FG000|Overall Study|Protocol Violation|6|||
23249001|NCT00430638|64652712|FG001|Overall Study|Protocol Violation|4|||
23249002|NCT00430638|64652711|FG000|Overall Study|Withdrawal by Subject|4|||
23249003|NCT00430638|64652712|FG001|Overall Study|Withdrawal by Subject|6|||
23249004|NCT00430638|64652711|FG000|Overall Study|Non-compliant|2|||
23249005|NCT00430638|64652712|FG001|Overall Study|Non-compliant|1|||
23249006|NCT00430638|64652711|FG000|Overall Study|Other|2|||
23249007|NCT00430638|64652712|FG001|Overall Study|Other|2|||
23249008|NCT01844986|64652713|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
23354891|NCT01162122|65041548|FG001|Overall Study|Inappropriate enrollment|4|||
23354892|NCT01162122|65041547|FG000|Overall Study|Administrative reason|1|||
23189618|NCT03227861|64436130|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
23249009|NCT01844986|64652714|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
23249010|NCT01844986|64652713|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
23249011|NCT01844986|64652714|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
23249012|NCT01844986|64652713|FG000|Overall Study (Global Cohort)|Death|55|||
23249013|NCT01844986|64652714|FG001|Overall Study (Global Cohort)|Death|26|||
23249014|NCT01844986|64652713|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
23249015|NCT01844986|64652714|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
23249016|NCT01844986|64652713|FG000|Overall Study (China Cohort)|Death|10|||
23249017|NCT01844986|64652714|FG001|Overall Study (China Cohort)|Death|6|||
23249018|NCT00685763|64652720|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
23249019|NCT00685763|64652720|FG000|Overall Study|Protocol Violation|1|||
23249020|NCT03926728|64652721|FG000|Overall Study|Withdrawal by Subject|0|||
23249021|NCT03926728|64652722|FG001|Overall Study|Withdrawal by Subject|1|||
23249022|NCT03926728|64652723|FG002|Overall Study|Withdrawal by Subject|1|||
23249023|NCT03926728|64652724|FG003|Overall Study|Withdrawal by Subject|0|||
23249024|NCT03926728|64652725|FG004|Overall Study|Withdrawal by Subject|0|||
23249025|NCT03926728|64652726|FG005|Overall Study|Withdrawal by Subject|1|||
23249026|NCT03926728|64652727|FG006|Overall Study|Withdrawal by Subject|1|||
23249027|NCT03926728|64652728|FG007|Overall Study|Withdrawal by Subject|0|||
23249028|NCT03926728|64652729|FG008|Overall Study|Withdrawal by Subject|0|||
23249029|NCT03926728|64652730|FG009|Overall Study|Withdrawal by Subject|1|||
23249030|NCT03926728|64652731|FG010|Overall Study|Withdrawal by Subject|0|||
23249031|NCT03926728|64652732|FG011|Overall Study|Withdrawal by Subject|0|||
23249032|NCT01965431|64655529|FG000|Overall Study|Adverse Event|0|||
23249033|NCT01965431|64655530|FG001|Overall Study|Adverse Event|1|||
23249034|NCT01965431|64655531|FG002|Overall Study|Adverse Event|0|||
23249035|NCT01965431|64655532|FG003|Overall Study|Adverse Event|0|||
23249036|NCT01965431|64655533|FG004|Overall Study|Adverse Event|0|||
23249037|NCT01965431|64655534|FG005|Overall Study|Adverse Event|0|||
23249038|NCT01965431|64655529|FG000|Overall Study|Other than stated above|6|||
23249039|NCT01965431|64655530|FG001|Overall Study|Other than stated above|5|||
23249040|NCT01965431|64655531|FG002|Overall Study|Other than stated above|6|||
23249041|NCT01965431|64655532|FG003|Overall Study|Other than stated above|6|||
23249042|NCT01965431|64655533|FG004|Overall Study|Other than stated above|6|||
23249043|NCT01965431|64655534|FG005|Overall Study|Other than stated above|6|||
23249044|NCT00965263|64655535|FG000|Overall Study|Physician Decision|2|||
23249045|NCT00965263|64655536|FG001|Overall Study|Physician Decision|0|||
23249046|NCT00965263|64655535|FG000|Overall Study|Family emergency|0|||
23249047|NCT00965263|64655536|FG001|Overall Study|Family emergency|1|||
23249048|NCT00965263|64655535|FG000|Overall Study|Protocol Violation|0|||
23249049|NCT00965263|64655536|FG001|Overall Study|Protocol Violation|2|||
23249050|NCT01393626|64655542|FG000|Overall Study|Adverse Event|2|||
23249051|NCT01393626|64655543|FG001|Overall Study|Adverse Event|1|||
23249052|NCT01393626|64655544|FG002|Overall Study|Adverse Event|5|||
23354893|NCT01162122|65041548|FG001|Overall Study|Administrative reason|1|||
23354894|NCT01162122|65041547|FG000|Overall Study|Unable to classify|3|||
23354895|NCT01162122|65041548|FG001|Overall Study|Unable to classify|7|||
23354896|NCT01162122|65041547|FG000|Overall Study|Missing primary reason|1|||
23354897|NCT01162122|65041548|FG001|Overall Study|Missing primary reason|0|||
23354898|NCT03000530|65041549|FG000|Overall Study|Adverse Event|0|||
23354899|NCT03000530|65041550|FG001|Overall Study|Adverse Event|0|||
23354900|NCT03000530|65041551|FG002|Overall Study|Adverse Event|2|||
23354901|NCT03000530|65041549|FG000|Overall Study|Lost to Follow-up|0|||
23354902|NCT03000530|65041550|FG001|Overall Study|Lost to Follow-up|3|||
23354903|NCT03000530|65041551|FG002|Overall Study|Lost to Follow-up|1|||
23354904|NCT03000530|65041549|FG000|Overall Study|Withdrawal by Subject|0|||
23354905|NCT03000530|65041550|FG001|Overall Study|Withdrawal by Subject|2|||
23354906|NCT03000530|65041551|FG002|Overall Study|Withdrawal by Subject|1|||
23354907|NCT03084315|65041552|FG000|Overall Study|Lost to Follow-up|8|||
23249053|NCT01393626|64655545|FG003|Overall Study|Adverse Event|0|||
23249054|NCT01393626|64655542|FG000|Overall Study|Did not meet entrance criteria|1|||
23249055|NCT01393626|64655543|FG001|Overall Study|Did not meet entrance criteria|0|||
23249056|NCT01393626|64655544|FG002|Overall Study|Did not meet entrance criteria|0|||
23249057|NCT01393626|64655545|FG003|Overall Study|Did not meet entrance criteria|0|||
23249058|NCT01393626|64655542|FG000|Overall Study|Lack of Efficacy|6|||
23249059|NCT01393626|64655543|FG001|Overall Study|Lack of Efficacy|6|||
23249060|NCT01393626|64655544|FG002|Overall Study|Lack of Efficacy|4|||
23249061|NCT01393626|64655545|FG003|Overall Study|Lack of Efficacy|1|||
23249062|NCT01393626|64655542|FG000|Overall Study|Lost to Follow-up|1|||
23354908|NCT03084315|65041553|FG001|Overall Study|Lost to Follow-up|7|||
23588137|NCT03068468|65882142|FG000|Placebo-Controlled Period|Adverse Event|16|||
23588138|NCT03068468|65882143|FG001|Placebo-Controlled Period|Adverse Event|21|||
23249063|NCT01393626|64655543|FG001|Overall Study|Lost to Follow-up|1|||
23249064|NCT01393626|64655544|FG002|Overall Study|Lost to Follow-up|1|||
23249065|NCT01393626|64655545|FG003|Overall Study|Lost to Follow-up|0|||
23249066|NCT01393626|64655542|FG000|Overall Study|Withdrawal by Subject|6|||
23249067|NCT01393626|64655543|FG001|Overall Study|Withdrawal by Subject|4|||
23354909|NCT03084315|65041552|FG000|Overall Study|Withdrawal by Subject|2|||
23249068|NCT01393626|64655544|FG002|Overall Study|Withdrawal by Subject|0|||
23249069|NCT01393626|64655545|FG003|Overall Study|Withdrawal by Subject|0|||
23249070|NCT01393626|64655542|FG000|Overall Study|Other|1|||
23249071|NCT01393626|64655543|FG001|Overall Study|Other|0|||
23249072|NCT01393626|64655544|FG002|Overall Study|Other|0|||
23249073|NCT01393626|64655545|FG003|Overall Study|Other|0|||
23249074|NCT01393626|64655542|FG000|Overall Study|Protocol Violation|1|||
23354910|NCT03084315|65041553|FG001|Overall Study|Withdrawal by Subject|2|||
23354911|NCT01026818|65041554|FG000|Screening Period|Entry Criteria Not Met|105|||
23354912|NCT01026818|65041555|FG001|Screening Period|Entry Criteria Not Met|0|||
23189619|NCT03227861|64436130|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
23189620|NCT03227861|64436130|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
23249075|NCT01393626|64655543|FG001|Overall Study|Protocol Violation|0|||
23354913|NCT01026818|65041556|FG002|Screening Period|Entry Criteria Not Met|0|||
23354914|NCT01026818|65041557|FG003|Screening Period|Entry Criteria Not Met|0|||
23354915|NCT01026818|65041554|FG000|Screening Period|Withdrawal by Subject|49|||
23354916|NCT01026818|65041555|FG001|Screening Period|Withdrawal by Subject|0|||
23354917|NCT01026818|65041556|FG002|Screening Period|Withdrawal by Subject|0|||
23354918|NCT01026818|65041557|FG003|Screening Period|Withdrawal by Subject|0|||
23354919|NCT01026818|65041554|FG000|Screening Period|Protocol Deviation|3|||
23354920|NCT01026818|65041555|FG001|Screening Period|Protocol Deviation|0|||
23354921|NCT01026818|65041556|FG002|Screening Period|Protocol Deviation|0|||
23354922|NCT01026818|65041557|FG003|Screening Period|Protocol Deviation|0|||
23354923|NCT01026818|65041554|FG000|Screening Period|Adverse Event|2|||
23354924|NCT01026818|65041555|FG001|Screening Period|Adverse Event|0|||
23354925|NCT01026818|65041556|FG002|Screening Period|Adverse Event|0|||
23354926|NCT01026818|65041557|FG003|Screening Period|Adverse Event|0|||
23354927|NCT01026818|65041554|FG000|Screening Period|Physician Decision|1|||
23354928|NCT01026818|65041555|FG001|Screening Period|Physician Decision|0|||
23354929|NCT01026818|65041556|FG002|Screening Period|Physician Decision|0|||
23354930|NCT01026818|65041557|FG003|Screening Period|Physician Decision|0|||
23354931|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
23354932|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
23354933|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
23354934|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
23354935|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
23354936|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
23354937|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
23354938|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
23354939|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
23354940|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
23354941|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
23354942|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
23354943|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
23354944|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
23354945|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
23354946|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
23354947|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
23354948|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
23354949|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
23354950|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
23354951|NCT01026818|65041554|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
23354952|NCT01026818|65041555|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
23354953|NCT01026818|65041556|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
23354954|NCT01026818|65041557|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
23354955|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
23354956|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
23354957|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
23354958|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
23354959|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
23354960|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
23354961|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
23354962|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
23354963|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
23354964|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
23354965|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
23354966|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
23354967|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
23354968|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
23354969|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
23354970|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
23354971|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
23472231|NCT00854113|65473891|FG001|Overall Study|Withdrawal by Subject|0|||
23472232|NCT00854113|65473892|FG002|Overall Study|Withdrawal by Subject|0|||
23472233|NCT00854113|65473893|FG003|Overall Study|Withdrawal by Subject|0|||
23472234|NCT00854113|65473894|FG004|Overall Study|Withdrawal by Subject|0|||
23472235|NCT00854113|65473895|FG005|Overall Study|Withdrawal by Subject|0|||
23189621|NCT03227861|64436130|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
23189622|NCT03227861|64436130|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
23472236|NCT00854113|65473896|FG006|Overall Study|Withdrawal by Subject|0|||
23472237|NCT00854113|65473897|FG007|Overall Study|Withdrawal by Subject|1|||
23189623|NCT03227861|64436130|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
23189624|NCT01259466|64436132|FG000|Overall Study|Withdrawal by Subject|1|||
23189625|NCT01259466|64436133|FG001|Overall Study|Withdrawal by Subject|9|||
23189626|NCT03825042|64436134|FG000|Overall Study|Adverse Event|1|||
23189627|NCT03825042|64436135|FG001|Overall Study|Adverse Event|0|||
23189628|NCT03825042|64436134|FG000|Overall Study|Withdrawal by Subject|1|||
23189629|NCT03825042|64436135|FG001|Overall Study|Withdrawal by Subject|0|||
23189630|NCT00618956|64436136|FG000|Overall Study|Adverse Event|10|||
23189631|NCT00618956|64436137|FG001|Overall Study|Adverse Event|34|||
23189632|NCT00618956|64436136|FG000|Overall Study|Lack of Efficacy|2|||
23189633|NCT00618956|64436137|FG001|Overall Study|Lack of Efficacy|1|||
23249076|NCT01393626|64655544|FG002|Overall Study|Protocol Violation|2|||
23249077|NCT01393626|64655545|FG003|Overall Study|Protocol Violation|0|||
23249078|NCT03402126|64655546|FG000|Overall Study|Lost to Follow-up|6|||
23249079|NCT03402126|64655546|FG000|Overall Study|Protocol Violation|10|||
23249080|NCT03402126|64655546|FG000|Overall Study|Sponsor request/Study termination|29|||
23249081|NCT03402126|64655546|FG000|Overall Study|Study product no longer in use|1|||
23249082|NCT03402126|64655546|FG000|Overall Study|Technical problems|1|||
23472238|NCT00854113|65473898|FG008|Overall Study|Withdrawal by Subject|1|||
23472239|NCT00854113|65473899|FG009|Overall Study|Withdrawal by Subject|0|||
23472240|NCT00854113|65473900|FG010|Overall Study|Withdrawal by Subject|0|||
23472241|NCT01209325|65473901|FG000|Overall Study|Lost to Follow-up|24|||
23472242|NCT01209325|65473901|FG000|Overall Study|Adverse Event|1|||
23472243|NCT01209325|65473901|FG000|Overall Study|Relocated|3|||
23472244|NCT01209325|65473901|FG000|Overall Study|Refusal after starting therapy|8|||
23472245|NCT01209325|65473901|FG000|Overall Study|Protocol Violation|4|||
23472246|NCT01209325|65473901|FG000|Overall Study|Refusal prior to therapy|1|||
23472247|NCT01209325|65473901|FG000|Overall Study|Incarceration|2|||
23472248|NCT00029146|65473902|FG000|Overall Study|Lost to Follow-up|2|||
23472249|NCT00029146|65473903|FG001|Overall Study|Lost to Follow-up|1|||
23472250|NCT04335136|65473911|FG000|Overall Study|Death|8|||
23472251|NCT04335136|65473912|FG001|Overall Study|Death|4|||
23472252|NCT04335136|65473911|FG000|Overall Study|Lost to Follow-up|2|||
23472253|NCT04335136|65473912|FG001|Overall Study|Lost to Follow-up|0|||
23472254|NCT04335136|65473911|FG000|Overall Study|Protocol Violation|1|||
23472255|NCT04335136|65473912|FG001|Overall Study|Protocol Violation|0|||
23472256|NCT04335136|65473911|FG000|Overall Study|Withdrawal by Subject|1|||
23472257|NCT04335136|65473912|FG001|Overall Study|Withdrawal by Subject|1|||
23472258|NCT04335136|65473911|FG000|Overall Study|Health-threatening condition|0|||
23472259|NCT04335136|65473912|FG001|Overall Study|Health-threatening condition|1|||
23472260|NCT04335136|65473911|FG000|Overall Study|Adverse Event|0|||
23472261|NCT04335136|65473912|FG001|Overall Study|Adverse Event|1|||
23472262|NCT04335136|65473911|FG000|Overall Study|Erroneously randomized|2|||
23472263|NCT04335136|65473912|FG001|Overall Study|Erroneously randomized|0|||
23472264|NCT00942994|65473914|FG000|Overall Study|Adverse Event|7|||
23472265|NCT00942994|65473915|FG001|Overall Study|Adverse Event|4|||
23472266|NCT00942994|65473914|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23472267|NCT00942994|65473915|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23472268|NCT00942994|65473914|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23472269|NCT00942994|65473915|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23472270|NCT00942994|65473914|FG000|Overall Study|Patient withdrew consent|5|||
23249083|NCT03402126|64655546|FG000|Overall Study|Withdrawal by Subject|6|||
23249084|NCT03402126|64655546|FG000|Overall Study|Physician Decision|2|||
23249085|NCT03402126|64655546|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
23249086|NCT03402126|64655546|FG000|Overall Study|Death|4|||
23249087|NCT01875991|64655547|FG000|Overall Study|Withdrawal by Subject|6|||
23472271|NCT00942994|65473915|FG001|Overall Study|Patient withdrew consent|8|||
23472272|NCT00942994|65473914|FG000|Overall Study|Lost to Follow-up|1|||
23472273|NCT00942994|65473915|FG001|Overall Study|Lost to Follow-up|4|||
23189634|NCT00618956|64436136|FG000|Overall Study|Withdrawal by Subject|5|||
23189635|NCT00618956|64436137|FG001|Overall Study|Withdrawal by Subject|7|||
23249088|NCT01875991|64655548|FG001|Overall Study|Withdrawal by Subject|6|||
23472274|NCT00942994|65473914|FG000|Overall Study|Protocol deviation|1|||
23189636|NCT00618956|64436136|FG000|Overall Study|Lost to Follow-up|4|||
23189637|NCT00618956|64436137|FG001|Overall Study|Lost to Follow-up|5|||
23189638|NCT00618956|64436136|FG000|Overall Study|Protocol Violation|2|||
23249089|NCT01875991|64655547|FG000|Overall Study|Sponsor Decision|1|||
23249090|NCT01875991|64655548|FG001|Overall Study|Sponsor Decision|0|||
23354972|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
23354973|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
23354974|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
23354975|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
23354976|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
23354977|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
23354978|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
23354979|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
23354980|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
23354981|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
23354982|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
23354983|NCT01026818|65041554|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
23354984|NCT01026818|65041555|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
23354985|NCT01026818|65041556|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
23354986|NCT01026818|65041557|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
23354987|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
23354988|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
23354989|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
23354990|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
23354991|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
23354992|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
23354993|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
23354994|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
23354995|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
23354996|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
23354997|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
23354998|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
23354999|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
23355000|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
23355001|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
23355002|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
23355003|NCT01026818|65041554|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
23355004|NCT01026818|65041555|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
23355005|NCT01026818|65041556|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
23355006|NCT01026818|65041557|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
23355007|NCT00496587|65041558|FG000|Overall Study|Adverse Event|2|||
23355008|NCT00496587|65041558|FG000|Overall Study|Progressive Disease|24|||
23355009|NCT00496587|65041558|FG000|Overall Study|Withdrawal by Subject|2|||
23355010|NCT00496587|65041558|FG000|Overall Study|Death|1|||
23355011|NCT00496587|65041558|FG000|Overall Study|Complications unrelated|2|||
23355012|NCT03055494|65041559|FG000|Overall Study|Lost to Follow-up|6|||
23355013|NCT03055494|65041560|FG001|Overall Study|Lost to Follow-up|0|||
23355014|NCT03055494|65041559|FG000|Overall Study|Physician Decision|2|||
23355015|NCT03055494|65041560|FG001|Overall Study|Physician Decision|0|||
23355016|NCT03055494|65041559|FG000|Overall Study|Withdrawal by Subject|1|||
23355017|NCT03055494|65041560|FG001|Overall Study|Withdrawal by Subject|0|||
23355018|NCT03055494|65041559|FG000|Overall Study|Adverse Event|0|||
23355019|NCT03055494|65041560|FG001|Overall Study|Adverse Event|1|||
23355020|NCT03055494|65041559|FG000|Overall Study|Non-compliance with study treatment|1|||
23355021|NCT03055494|65041560|FG001|Overall Study|Non-compliance with study treatment|0|||
23355022|NCT04114656|65041561|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
23355023|NCT04114656|65041562|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
23355024|NCT04114656|65041561|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
23355025|NCT04114656|65041562|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
23355026|NCT04114656|65041561|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
23355027|NCT04114656|65041562|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
23355028|NCT04114656|65041561|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
23355029|NCT04114656|65041562|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
23355030|NCT04114656|65041561|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
23355031|NCT04114656|65041562|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
23355032|NCT01270321|65044810|FG000|Overall Study|Death|3|||
23355033|NCT01270321|65044811|FG001|Overall Study|Death|1|||
23355034|NCT01270321|65044812|FG002|Overall Study|Death|4|||
23355035|NCT01270321|65044810|FG000|Overall Study|Adverse Event|7|||
23355036|NCT01270321|65044811|FG001|Overall Study|Adverse Event|9|||
23355037|NCT01270321|65044812|FG002|Overall Study|Adverse Event|5|||
23355038|NCT04336475|65044814|FG000|Overall Study|pain|1|||
23355039|NCT04336475|65044815|FG001|Overall Study|pain|0|||
23355040|NCT04336475|65044814|FG000|Overall Study|upper respiratory infection|1|||
23355041|NCT04336475|65044815|FG001|Overall Study|upper respiratory infection|0|||
23355042|NCT04336475|65044814|FG000|Overall Study|Lost to Follow-up|0|||
23355043|NCT04336475|65044815|FG001|Overall Study|Lost to Follow-up|2|||
23355044|NCT01066793|65044818|FG000|Overall Study|Death|4|||
23355045|NCT01066793|65044819|FG001|Overall Study|Death|1|||
23355046|NCT01066793|65044820|FG002|Overall Study|Death|1|||
23355047|NCT01066793|65044821|FG003|Overall Study|Death|0|||
23355048|NCT01066793|65044822|FG004|Overall Study|Death|0|||
23355049|NCT01066793|65044823|FG005|Overall Study|Death|0|||
23355050|NCT01066793|65044818|FG000|Overall Study|Lack of Efficacy|2|||
23355051|NCT01066793|65044819|FG001|Overall Study|Lack of Efficacy|1|||
23355052|NCT01066793|65044820|FG002|Overall Study|Lack of Efficacy|0|||
23355053|NCT01066793|65044821|FG003|Overall Study|Lack of Efficacy|0|||
23355054|NCT01066793|65044822|FG004|Overall Study|Lack of Efficacy|0|||
23355055|NCT01066793|65044823|FG005|Overall Study|Lack of Efficacy|0|||
23355056|NCT01066793|65044818|FG000|Overall Study|Lost to Follow-up|180|||
23355057|NCT01066793|65044819|FG001|Overall Study|Lost to Follow-up|39|||
23355058|NCT01066793|65044820|FG002|Overall Study|Lost to Follow-up|82|||
23355059|NCT01066793|65044821|FG003|Overall Study|Lost to Follow-up|16|||
23355060|NCT01066793|65044822|FG004|Overall Study|Lost to Follow-up|0|||
23355061|NCT01066793|65044823|FG005|Overall Study|Lost to Follow-up|1|||
23355062|NCT01066793|65044818|FG000|Overall Study|Physician Decision|3|||
23355063|NCT01066793|65044819|FG001|Overall Study|Physician Decision|0|||
23355064|NCT01066793|65044820|FG002|Overall Study|Physician Decision|0|||
23355065|NCT01066793|65044821|FG003|Overall Study|Physician Decision|0|||
23355066|NCT01066793|65044822|FG004|Overall Study|Physician Decision|0|||
23355067|NCT01066793|65044823|FG005|Overall Study|Physician Decision|0|||
23355068|NCT01066793|65044818|FG000|Overall Study|Protocol Violation|3|||
23355069|NCT01066793|65044819|FG001|Overall Study|Protocol Violation|2|||
23355070|NCT01066793|65044820|FG002|Overall Study|Protocol Violation|2|||
23355071|NCT01066793|65044821|FG003|Overall Study|Protocol Violation|0|||
23355072|NCT01066793|65044822|FG004|Overall Study|Protocol Violation|0|||
23355073|NCT01066793|65044823|FG005|Overall Study|Protocol Violation|0|||
23355074|NCT01066793|65044818|FG000|Overall Study|Withdrawal by Subject|7|||
23355075|NCT01066793|65044819|FG001|Overall Study|Withdrawal by Subject|4|||
23355076|NCT01066793|65044820|FG002|Overall Study|Withdrawal by Subject|1|||
23355077|NCT01066793|65044821|FG003|Overall Study|Withdrawal by Subject|0|||
23355078|NCT01066793|65044822|FG004|Overall Study|Withdrawal by Subject|0|||
23355079|NCT01066793|65044823|FG005|Overall Study|Withdrawal by Subject|0|||
23355080|NCT01066793|65044818|FG000|Overall Study|Early Termination|3|||
23355081|NCT01066793|65044819|FG001|Overall Study|Early Termination|0|||
23355082|NCT01066793|65044820|FG002|Overall Study|Early Termination|0|||
23355083|NCT01066793|65044821|FG003|Overall Study|Early Termination|0|||
23355084|NCT01066793|65044822|FG004|Overall Study|Early Termination|0|||
23355085|NCT01066793|65044823|FG005|Overall Study|Early Termination|0|||
23355086|NCT01066793|65044818|FG000|Overall Study|Lab test not done|7|||
23355087|NCT01066793|65044819|FG001|Overall Study|Lab test not done|0|||
23355088|NCT01066793|65044820|FG002|Overall Study|Lab test not done|0|||
23355089|NCT01066793|65044821|FG003|Overall Study|Lab test not done|1|||
23355090|NCT01066793|65044822|FG004|Overall Study|Lab test not done|0|||
23355091|NCT01066793|65044823|FG005|Overall Study|Lab test not done|0|||
23355092|NCT01066793|65044818|FG000|Overall Study|Miscellaneous|4|||
23355093|NCT01066793|65044819|FG001|Overall Study|Miscellaneous|5|||
23355094|NCT01066793|65044820|FG002|Overall Study|Miscellaneous|6|||
23355095|NCT01066793|65044821|FG003|Overall Study|Miscellaneous|0|||
23355096|NCT01066793|65044822|FG004|Overall Study|Miscellaneous|0|||
23355097|NCT01066793|65044823|FG005|Overall Study|Miscellaneous|0|||
23355098|NCT01066793|65044818|FG000|Overall Study|Non-responders|104|||
23355099|NCT01066793|65044819|FG001|Overall Study|Non-responders|5|||
23189639|NCT00618956|64436137|FG001|Overall Study|Protocol Violation|2|||
23355100|NCT01066793|65044820|FG002|Overall Study|Non-responders|11|||
23355101|NCT01066793|65044821|FG003|Overall Study|Non-responders|25|||
23355102|NCT01066793|65044822|FG004|Overall Study|Non-responders|0|||
23355103|NCT01066793|65044823|FG005|Overall Study|Non-responders|0|||
23355104|NCT01066793|65044818|FG000|Overall Study|Other|15|||
23355105|NCT01066793|65044819|FG001|Overall Study|Other|5|||
23355106|NCT01066793|65044820|FG002|Overall Study|Other|6|||
23355107|NCT01066793|65044821|FG003|Overall Study|Other|2|||
23355108|NCT01066793|65044822|FG004|Overall Study|Other|0|||
23355109|NCT01066793|65044823|FG005|Overall Study|Other|0|||
23355110|NCT01066793|65044818|FG000|Overall Study|Relapse|20|||
23355111|NCT01066793|65044819|FG001|Overall Study|Relapse|8|||
23355112|NCT01066793|65044820|FG002|Overall Study|Relapse|2|||
23355113|NCT01066793|65044821|FG003|Overall Study|Relapse|3|||
23355114|NCT01066793|65044822|FG004|Overall Study|Relapse|0|||
23355115|NCT01066793|65044823|FG005|Overall Study|Relapse|0|||
23355116|NCT01066793|65044818|FG000|Overall Study|Result Not Available|1|||
23355117|NCT01066793|65044819|FG001|Overall Study|Result Not Available|0|||
23588139|NCT03068468|65882144|FG002|Placebo-Controlled Period|Adverse Event|0|||
23588140|NCT03068468|65882145|FG003|Placebo-Controlled Period|Adverse Event|0|||
23249091|NCT02996448|64655549|FG000|Overall Study|Study terminated due to adverse effects|3|||
23249092|NCT00759759|64655554|FG000|Overall Study|didn't return for period 2|1|||
23355118|NCT01066793|65044820|FG002|Overall Study|Result Not Available|0|||
23355119|NCT01066793|65044821|FG003|Overall Study|Result Not Available|0|||
23355120|NCT01066793|65044822|FG004|Overall Study|Result Not Available|0|||
23355121|NCT01066793|65044823|FG005|Overall Study|Result Not Available|0|||
23355122|NCT01066793|65044818|FG000|Overall Study|Treatment Interrupted|1|||
23355123|NCT01066793|65044819|FG001|Overall Study|Treatment Interrupted|1|||
23355124|NCT01066793|65044820|FG002|Overall Study|Treatment Interrupted|0|||
23355125|NCT01066793|65044821|FG003|Overall Study|Treatment Interrupted|0|||
23355126|NCT01066793|65044822|FG004|Overall Study|Treatment Interrupted|0|||
23355127|NCT01066793|65044823|FG005|Overall Study|Treatment Interrupted|0|||
23355128|NCT01066793|65044818|FG000|Overall Study|Treatment Never Started|18|||
23355129|NCT01066793|65044819|FG001|Overall Study|Treatment Never Started|5|||
23355130|NCT01066793|65044820|FG002|Overall Study|Treatment Never Started|4|||
23355131|NCT01066793|65044821|FG003|Overall Study|Treatment Never Started|1|||
23355132|NCT01066793|65044822|FG004|Overall Study|Treatment Never Started|0|||
23355133|NCT01066793|65044823|FG005|Overall Study|Treatment Never Started|0|||
23355134|NCT01066793|65044818|FG000|Overall Study|Treatment Stopped|2|||
23355135|NCT01066793|65044819|FG001|Overall Study|Treatment Stopped|1|||
23355136|NCT01066793|65044820|FG002|Overall Study|Treatment Stopped|0|||
23355137|NCT01066793|65044821|FG003|Overall Study|Treatment Stopped|1|||
23355138|NCT01066793|65044822|FG004|Overall Study|Treatment Stopped|0|||
23355139|NCT01066793|65044823|FG005|Overall Study|Treatment Stopped|0|||
23355140|NCT03762681|65044824|FG000|Part 1|Withdrawal by Subject|0|||
23355141|NCT03762681|65044825|FG001|Part 1|Withdrawal by Subject|0|||
23355142|NCT03762681|65044826|FG002|Part 1|Withdrawal by Subject|0|||
23355143|NCT03762681|65044827|FG003|Part 1|Withdrawal by Subject|1|||
23355144|NCT03762681|65044828|FG004|Part 1|Withdrawal by Subject|0|||
23355145|NCT03762681|65044829|FG005|Part 1|Withdrawal by Subject|0|||
23355146|NCT03762681|65044830|FG006|Part 1|Withdrawal by Subject|0|||
23355147|NCT03762681|65044831|FG007|Part 1|Withdrawal by Subject|0|||
23355148|NCT03762681|65044824|FG000|Part 2a|Pandemic Travel Restrictions|0|||
23355149|NCT03762681|65044825|FG001|Part 2a|Pandemic Travel Restrictions|0|||
23355150|NCT03762681|65044826|FG002|Part 2a|Pandemic Travel Restrictions|0|||
23355151|NCT03762681|65044827|FG003|Part 2a|Pandemic Travel Restrictions|0|||
23355152|NCT03762681|65044828|FG004|Part 2a|Pandemic Travel Restrictions|0|||
23355153|NCT03762681|65044829|FG005|Part 2a|Pandemic Travel Restrictions|0|||
23355154|NCT03762681|65044830|FG006|Part 2a|Pandemic Travel Restrictions|0|||
23355155|NCT03762681|65044831|FG007|Part 2a|Pandemic Travel Restrictions|1|||
23355156|NCT01908582|65044833|FG000|Period 2|Physician Decision|1|||
23355157|NCT01908582|65044833|FG000|Period 2|Withdrawal by Subject|1|||
23355158|NCT02769312|65044834|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
23355159|NCT02769312|65044835|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
23355160|NCT02769312|65044834|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
23355161|NCT02769312|65044835|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
23355162|NCT02769312|65044834|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
23355163|NCT02769312|65044835|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
23355164|NCT02769312|65044834|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
23355165|NCT02769312|65044835|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
23355166|NCT02769312|65044834|FG000|Follow-up|Lost to Follow-up|1|||
23355167|NCT02769312|65044835|FG001|Follow-up|Lost to Follow-up|1|||
23355168|NCT01905592|65044836|FG000|Overall Study|Disease Progression|51|||
23355169|NCT01905592|65044837|FG001|Overall Study|Disease Progression|110|||
23355170|NCT01905592|65044836|FG000|Overall Study|Toxicity|1|||
23355171|NCT01905592|65044837|FG001|Overall Study|Toxicity|16|||
23355172|NCT01905592|65044836|FG000|Overall Study|Physician Decision|0|||
23588141|NCT03068468|65882142|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
23189640|NCT00618956|64436136|FG000|Overall Study|did not meet criteria, non-compliance|2|||
23189641|NCT00618956|64436137|FG001|Overall Study|did not meet criteria, non-compliance|1|||
23189642|NCT02285010|64436140|FG000|Overall Study|not abdominal hysterectomy|2|||
23189643|NCT02285010|64436141|FG001|Overall Study|not abdominal hysterectomy|0|||
23355173|NCT01905592|65044837|FG001|Overall Study|Physician Decision|2|||
23355174|NCT01905592|65044836|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
23355175|NCT01905592|65044837|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
23355176|NCT01905592|65044836|FG000|Overall Study|Protocol Violation|0|||
23355177|NCT01905592|65044837|FG001|Overall Study|Protocol Violation|1|||
23189644|NCT02285010|64436140|FG000|Overall Study|Not spinal anesthesia|3|||
23189645|NCT02285010|64436141|FG001|Overall Study|Not spinal anesthesia|1|||
23189646|NCT01416181|64436144|FG000|Part 1|Other|10|||
23189647|NCT01416181|64436145|FG001|Part 1|Other|24|||
23355178|NCT01905592|65044836|FG000|Overall Study|Sponsor's decision|1|||
23355179|NCT01905592|65044837|FG001|Overall Study|Sponsor's decision|1|||
23355180|NCT01905592|65044836|FG000|Overall Study|Not treated|7|||
23355181|NCT01905592|65044837|FG001|Overall Study|Not treated|3|||
23588142|NCT03068468|65882143|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
23588143|NCT03068468|65882144|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
23588144|NCT03068468|65882145|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
23588145|NCT03068468|65882142|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
23588146|NCT03068468|65882143|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
23588147|NCT03068468|65882144|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23588148|NCT03068468|65882145|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
23588149|NCT03068468|65882142|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
23249093|NCT00759759|64655555|FG001|Overall Study|didn't return for period 2|0|||
23249094|NCT00759759|64655554|FG000|Overall Study|Didn't receive drug in period 2|1|||
23249095|NCT00759759|64655555|FG001|Overall Study|Didn't receive drug in period 2|0|||
23249096|NCT00759759|64655554|FG000|Overall Study|Withdrawal by Subject|2|||
23249097|NCT00759759|64655555|FG001|Overall Study|Withdrawal by Subject|1|||
23249098|NCT01256398|64655556|FG000|Overall Study|Withdrawal by Subject|1|||
23249099|NCT02602080|64655557|FG000|Overall Study|Protocol Violation|6|||
23249100|NCT02602080|64655558|FG001|Overall Study|Protocol Violation|1|||
23249101|NCT02602080|64655559|FG002|Overall Study|Protocol Violation|3|||
23249102|NCT04311411|64655560|FG000|Overall Study|Adverse Event|2|||
23249103|NCT04311411|64655561|FG001|Overall Study|Adverse Event|3|||
23249104|NCT04311411|64655562|FG002|Overall Study|Adverse Event|2|||
23249105|NCT04311411|64655560|FG000|Overall Study|Withdrawal by Subject|3|||
23249106|NCT04311411|64655561|FG001|Overall Study|Withdrawal by Subject|3|||
23355182|NCT01905592|65044836|FG000|Overall Study|Withdrawal by Subject|10|||
23355183|NCT01905592|65044837|FG001|Overall Study|Withdrawal by Subject|2|||
23355184|NCT00549601|65044838|FG000|Randomized|Protocol Violation|0|||
23355185|NCT00549601|65044839|FG001|Randomized|Protocol Violation|0|||
23355186|NCT00549601|65044840|FG002|Randomized|Protocol Violation|1|||
23355187|NCT00549601|65044838|FG000|Randomized|Withdrawal by Subject|0|||
23355188|NCT00549601|65044839|FG001|Randomized|Withdrawal by Subject|1|||
23355189|NCT00549601|65044840|FG002|Randomized|Withdrawal by Subject|1|||
23355190|NCT00549601|65044838|FG000|Received Study Drug|Adverse Event|2|||
23355191|NCT00549601|65044839|FG001|Received Study Drug|Adverse Event|5|||
23355192|NCT00549601|65044840|FG002|Received Study Drug|Adverse Event|1|||
23355193|NCT00549601|65044838|FG000|Received Study Drug|Death|0|||
23355194|NCT00549601|65044839|FG001|Received Study Drug|Death|1|||
23355195|NCT00549601|65044840|FG002|Received Study Drug|Death|0|||
23355196|NCT00549601|65044838|FG000|Received Study Drug|Lost to Follow-up|0|||
23355197|NCT00549601|65044839|FG001|Received Study Drug|Lost to Follow-up|1|||
23355198|NCT00549601|65044840|FG002|Received Study Drug|Lost to Follow-up|1|||
23355199|NCT00549601|65044838|FG000|Received Study Drug|Protocol Violation|3|||
23355200|NCT00549601|65044839|FG001|Received Study Drug|Protocol Violation|4|||
23355201|NCT00549601|65044840|FG002|Received Study Drug|Protocol Violation|1|||
23355202|NCT00549601|65044838|FG000|Received Study Drug|Withdrawal by Subject|2|||
23355203|NCT00549601|65044839|FG001|Received Study Drug|Withdrawal by Subject|0|||
23355204|NCT00549601|65044840|FG002|Received Study Drug|Withdrawal by Subject|1|||
23355205|NCT00419159|65044843|FG000|Overall Study|Adverse Event|7|||
23355206|NCT00419159|65044844|FG001|Overall Study|Adverse Event|15|||
23355207|NCT00419159|65044843|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23355208|NCT00419159|65044844|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23588150|NCT03068468|65882143|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
23588151|NCT03068468|65882144|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
23355209|NCT00419159|65044843|FG000|Overall Study|Subject's no longer requires study drug|0|||
23355210|NCT00419159|65044844|FG001|Overall Study|Subject's no longer requires study drug|1|||
23355211|NCT00419159|65044843|FG000|Overall Study|Protocol Violation|1|||
23355212|NCT00419159|65044844|FG001|Overall Study|Protocol Violation|0|||
23249107|NCT04311411|64655562|FG002|Overall Study|Withdrawal by Subject|0|||
23249108|NCT02453282|64655563|FG000|Overall Study|Death|275|||
23249109|NCT02453282|64655564|FG001|Overall Study|Death|277|||
23472275|NCT00942994|65473915|FG001|Overall Study|Protocol deviation|2|||
23472276|NCT00422513|65473916|FG000|Overall Study|Lack of Efficacy|4|||
23472277|NCT00422513|65473917|FG001|Overall Study|Lack of Efficacy|5|||
23472278|NCT00422513|65473916|FG000|Overall Study|Protocol Violation|23|||
23472279|NCT00422513|65473917|FG001|Overall Study|Protocol Violation|7|||
23472280|NCT00422513|65473916|FG000|Overall Study|Refused Treatment|4|||
23472281|NCT00422513|65473917|FG001|Overall Study|Refused Treatment|2|||
23472282|NCT00422513|65473916|FG000|Overall Study|Withdrawal by Subject|2|||
23472283|NCT00422513|65473917|FG001|Overall Study|Withdrawal by Subject|1|||
23472284|NCT00422513|65473916|FG000|Overall Study|early termination of the study|67|||
23472285|NCT00422513|65473917|FG001|Overall Study|early termination of the study|80|||
23472286|NCT00422513|65473916|FG000|Overall Study|Adverse Event|4|||
23472287|NCT00422513|65473917|FG001|Overall Study|Adverse Event|4|||
23472288|NCT00422513|65473916|FG000|Overall Study|Death|3|||
23588152|NCT03068468|65882145|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
23588153|NCT03068468|65882142|FG000|Placebo-Controlled Period|Death|0|||
23588154|NCT03068468|65882143|FG001|Placebo-Controlled Period|Death|1|||
23588155|NCT03068468|65882144|FG002|Placebo-Controlled Period|Death|0|||
23588156|NCT03068468|65882145|FG003|Placebo-Controlled Period|Death|0|||
23588157|NCT03068468|65882142|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
23588158|NCT03068468|65882143|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
23588159|NCT03068468|65882144|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
23588160|NCT03068468|65882145|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
23588161|NCT03068468|65882142|FG000|Open-Label Extension Period|Adverse Event|0|||
23588162|NCT03068468|65882143|FG001|Open-Label Extension Period|Adverse Event|0|||
23588163|NCT03068468|65882144|FG002|Open-Label Extension Period|Adverse Event|13|||
23588164|NCT03068468|65882145|FG003|Open-Label Extension Period|Adverse Event|17|||
23588165|NCT03068468|65882142|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
23588166|NCT03068468|65882143|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
23588167|NCT03068468|65882144|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
23588168|NCT03068468|65882145|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
23588169|NCT03068468|65882142|FG000|Open-Label Extension Period|Death|0|||
23588170|NCT03068468|65882143|FG001|Open-Label Extension Period|Death|0|||
23588171|NCT03068468|65882144|FG002|Open-Label Extension Period|Death|0|||
23588172|NCT03068468|65882145|FG003|Open-Label Extension Period|Death|1|||
23588173|NCT03068468|65882142|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
23588174|NCT03068468|65882143|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
23588175|NCT03068468|65882144|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
23249110|NCT02453282|64655565|FG002|Overall Study|Death|296|||
23249111|NCT02453282|64655563|FG000|Overall Study|Lost to Follow-up|1|||
23249112|NCT02453282|64655564|FG001|Overall Study|Lost to Follow-up|0|||
23249113|NCT02453282|64655565|FG002|Overall Study|Lost to Follow-up|2|||
23249114|NCT02453282|64655563|FG000|Overall Study|Withdrawal by Subject|12|||
23472289|NCT00422513|65473917|FG001|Overall Study|Death|7|||
23472290|NCT03179605|65473927|FG000|Overall Study|Withdrawal by Subject|1|||
23588176|NCT03068468|65882145|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
23588177|NCT03068468|65882142|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
23588178|NCT03068468|65882143|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
23189648|NCT01416181|64436144|FG000|Part 1|Death|0|||
23472291|NCT00104520|65473928|FG000|Overall Study|Unrelated adverse event|34|||
23472292|NCT00104520|65473929|FG001|Overall Study|Unrelated adverse event|47|||
23249115|NCT02453282|64655564|FG001|Overall Study|Withdrawal by Subject|10|||
23472293|NCT00104520|65473928|FG000|Overall Study|Study drug intolerance|0|||
23249116|NCT02453282|64655565|FG002|Overall Study|Withdrawal by Subject|11|||
23249117|NCT02453282|64655563|FG000|Overall Study|Participants ongoing at data cut-off|85|||
23249118|NCT02453282|64655564|FG001|Overall Study|Participants ongoing at data cut-off|84|||
23249119|NCT02453282|64655565|FG002|Overall Study|Participants ongoing at data cut-off|62|||
23249120|NCT02453282|64655563|FG000|Overall Study|Other|1|||
23249121|NCT02453282|64655564|FG001|Overall Study|Other|1|||
23249122|NCT02453282|64655565|FG002|Overall Study|Other|1|||
23249123|NCT00265239|64655568|FG000|Overall Study|Adverse Event|2|||
23249124|NCT00265239|64655569|FG001|Overall Study|Adverse Event|1|||
23249125|NCT01870921|64655570|FG000|Overall Study|Subject decision|80|||
23249126|NCT01870921|64655570|FG000|Overall Study|Severe non-compliance to protocol|7|||
23355213|NCT00419159|65044843|FG000|Overall Study|Withdrawal by Subject|10|||
23355214|NCT00419159|65044844|FG001|Overall Study|Withdrawal by Subject|3|||
23355215|NCT00419159|65044843|FG000|Overall Study|Lost to Follow-up|0|||
23355216|NCT00419159|65044844|FG001|Overall Study|Lost to Follow-up|1|||
23355217|NCT00419159|65044843|FG000|Overall Study|Death|2|||
23355218|NCT00419159|65044844|FG001|Overall Study|Death|2|||
23355219|NCT00419159|65044843|FG000|Overall Study|Disease progression|79|||
23249127|NCT01870921|64655570|FG000|Overall Study|Subject Lost to Follow up|2|||
23249128|NCT01870921|64655570|FG000|Overall Study|Other|1|||
23249129|NCT01966107|64655575|FG000|Overall Study|excluded from FAS|21|||
23249130|NCT01966107|64655576|FG001|Overall Study|excluded from FAS|20|||
23249131|NCT01966107|64655575|FG000|Overall Study|discontinued treatment|345|||
23249132|NCT01966107|64655576|FG001|Overall Study|discontinued treatment|372|||
23249133|NCT01966107|64655575|FG000|Overall Study|due to study closure|164|||
23249134|NCT01966107|64655576|FG001|Overall Study|due to study closure|186|||
23249135|NCT01966107|64655575|FG000|Overall Study|withdrew from the study|272|||
23249136|NCT01966107|64655576|FG001|Overall Study|withdrew from the study|303|||
23355220|NCT00419159|65044844|FG001|Overall Study|Disease progression|76|||
23355221|NCT01709864|65044847|FG000|Overall Study|Physician Decision|0|||
23355222|NCT01709864|65044848|FG001|Overall Study|Physician Decision|1|||
23355223|NCT01709864|65044847|FG000|Overall Study|subject/guardian decision|5|||
23355224|NCT01709864|65044848|FG001|Overall Study|subject/guardian decision|6|||
23355225|NCT01709864|65044847|FG000|Overall Study|Lost to Follow-up|1|||
23355226|NCT01709864|65044848|FG001|Overall Study|Lost to Follow-up|0|||
23355227|NCT01709864|65044847|FG000|Overall Study|non-compliance with study treatment|1|||
23355228|NCT01709864|65044848|FG001|Overall Study|non-compliance with study treatment|1|||
23355229|NCT01709864|65044847|FG000|Overall Study|Adverse Event|0|||
23355230|NCT01709864|65044848|FG001|Overall Study|Adverse Event|2|||
23355231|NCT01709864|65044847|FG000|Overall Study|Death|0|||
23355232|NCT01709864|65044848|FG001|Overall Study|Death|1|||
23355233|NCT04575584|65044849|FG000|Overall Study|Death|6|||
23355234|NCT04575584|65044850|FG001|Overall Study|Death|4|||
23355235|NCT04575584|65044851|FG002|Overall Study|Death|6|||
23355236|NCT04575584|65044852|FG003|Overall Study|Death|2|||
23355237|NCT04575584|65044853|FG004|Overall Study|Death|0|||
23355238|NCT04575584|65044854|FG005|Overall Study|Death|0|||
23355239|NCT04575584|65044849|FG000|Overall Study|Lost to Follow-up|1|||
23249137|NCT00929201|64655577|FG000|Period 1|Withdrawal by Subject|0|||
23249138|NCT00929201|64655578|FG001|Period 1|Withdrawal by Subject|1|||
23249139|NCT02050373|64655579|FG000|Overall Study|Adverse Event|4|||
23249140|NCT02050373|64655580|FG001|Overall Study|Adverse Event|7|||
23249141|NCT02050373|64655579|FG000|Overall Study|Death|3|||
23355240|NCT04575584|65044850|FG001|Overall Study|Lost to Follow-up|1|||
23355241|NCT04575584|65044851|FG002|Overall Study|Lost to Follow-up|1|||
23355242|NCT04575584|65044852|FG003|Overall Study|Lost to Follow-up|1|||
23355243|NCT04575584|65044853|FG004|Overall Study|Lost to Follow-up|0|||
23355244|NCT04575584|65044854|FG005|Overall Study|Lost to Follow-up|0|||
23355245|NCT04575584|65044849|FG000|Overall Study|Physician Decision|0|||
23355246|NCT04575584|65044850|FG001|Overall Study|Physician Decision|1|||
23355247|NCT04575584|65044851|FG002|Overall Study|Physician Decision|1|||
23355248|NCT04575584|65044852|FG003|Overall Study|Physician Decision|1|||
23355249|NCT04575584|65044853|FG004|Overall Study|Physician Decision|0|||
23355250|NCT04575584|65044854|FG005|Overall Study|Physician Decision|0|||
23355251|NCT04575584|65044849|FG000|Overall Study|Withdrawal by Subject|7|||
23355252|NCT04575584|65044850|FG001|Overall Study|Withdrawal by Subject|9|||
23355253|NCT04575584|65044851|FG002|Overall Study|Withdrawal by Subject|5|||
23355254|NCT04575584|65044852|FG003|Overall Study|Withdrawal by Subject|3|||
23355255|NCT04575584|65044853|FG004|Overall Study|Withdrawal by Subject|0|||
23355256|NCT04575584|65044854|FG005|Overall Study|Withdrawal by Subject|0|||
23355257|NCT04575584|65044849|FG000|Overall Study|Not recorded|0|||
23355258|NCT04575584|65044850|FG001|Overall Study|Not recorded|0|||
23355259|NCT04575584|65044851|FG002|Overall Study|Not recorded|0|||
23355260|NCT04575584|65044852|FG003|Overall Study|Not recorded|1|||
23355261|NCT04575584|65044853|FG004|Overall Study|Not recorded|0|||
23355262|NCT04575584|65044854|FG005|Overall Study|Not recorded|0|||
23355263|NCT02886884|65044855|FG000|Follow-up|Withdrawal by Subject|0|||
23355264|NCT02886884|65044856|FG001|Follow-up|Withdrawal by Subject|0|||
23355265|NCT02886884|65044857|FG002|Follow-up|Withdrawal by Subject|0|||
23355266|NCT02886884|65044858|FG003|Follow-up|Withdrawal by Subject|1|||
23355267|NCT01118663|65044865|FG000|Overall Study|Adverse Event|2|||
23355268|NCT01118663|65044866|FG001|Overall Study|Adverse Event|1|||
23355269|NCT01118663|65044865|FG000|Overall Study|Withdrawal by Subject|0|||
23355270|NCT01118663|65044866|FG001|Overall Study|Withdrawal by Subject|1|||
23355271|NCT00585325|65044867|FG000|Overall Study|Withdrawal by Subject|1|||
23355272|NCT00585325|65044868|FG001|Overall Study|Withdrawal by Subject|1|||
23472294|NCT00104520|65473929|FG001|Overall Study|Study drug intolerance|1|||
23472295|NCT00104520|65473928|FG000|Overall Study|Related adverse event|13|||
23472296|NCT00104520|65473929|FG001|Overall Study|Related adverse event|15|||
23249142|NCT02050373|64655580|FG001|Overall Study|Death|3|||
23249143|NCT01466673|64655583|FG000|Overall Study|Non-compliance with study treatment|2|||
23249144|NCT01466673|64655584|FG001|Overall Study|Non-compliance with study treatment|0|||
23249145|NCT01466673|64655583|FG000|Overall Study|Lost to Follow-up|3|||
23249146|NCT01466673|64655584|FG001|Overall Study|Lost to Follow-up|5|||
23249147|NCT01466673|64655583|FG000|Overall Study|Adverse Event|2|||
23249148|NCT01466673|64655584|FG001|Overall Study|Adverse Event|1|||
23249149|NCT00457418|64655585|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
23249150|NCT00457418|64655585|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
23249151|NCT00457418|64655585|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
23249152|NCT00457418|64655585|FG000|Post PK Maintenance|Adverse Event|10|||
23249153|NCT00457418|64655585|FG000|Post PK Maintenance|Progression of Disease|6|||
23249154|NCT00457418|64655585|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
23249155|NCT00457418|64655585|FG000|Post PK Maintenance|Lost to Follow-up|1|||
23249156|NCT03159611|64655590|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
23249157|NCT03159611|64655591|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
23249158|NCT03159611|64655590|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
23249159|NCT03159611|64655591|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
23249160|NCT03159611|64655590|FG000|Overall Study|Protocol Violation|7|||
23249161|NCT03159611|64655591|FG001|Overall Study|Protocol Violation|4|||
23249162|NCT03159611|64655590|FG000|Overall Study|Adverse Event|1|||
23249163|NCT03159611|64655591|FG001|Overall Study|Adverse Event|0|||
23249164|NCT03159611|64655590|FG000|Overall Study|Withdrawal by Subject|1|||
23249165|NCT03159611|64655591|FG001|Overall Study|Withdrawal by Subject|1|||
23249166|NCT03159611|64655590|FG000|Overall Study|Non-compliance with protocol requirement|3|||
23249167|NCT03159611|64655591|FG001|Overall Study|Non-compliance with protocol requirement|2|||
23249168|NCT03159611|64655590|FG000|Overall Study|Inability to perform procedures|1|||
23249169|NCT03159611|64655591|FG001|Overall Study|Inability to perform procedures|0|||
23355273|NCT01146561|65044869|FG000|Overall Study|Withdrawal by Subject|1|||
23355274|NCT01146561|65044869|FG000|Overall Study|Lost to Follow-up|1|||
23355275|NCT02324699|65044872|FG000|Overall Study|study terminated|1|||
23189649|NCT01416181|64436145|FG001|Part 1|Death|1|||
23355276|NCT00893971|65044875|FG000|Overall Study|Physician Decision|3|||
23355277|NCT01796301|65044876|FG000|Overall Study|Withdrawal by Subject|15|||
23472297|NCT00104520|65473928|FG000|Overall Study|Lost to Follow-up|1|||
23472298|NCT00104520|65473929|FG001|Overall Study|Lost to Follow-up|0|||
23249170|NCT00424515|64655595|FG000|Overall Study|Progressive Disease|10|||
23249171|NCT00424515|64655596|FG001|Overall Study|Progressive Disease|11|||
23355278|NCT01796301|65044877|FG001|Overall Study|Withdrawal by Subject|15|||
23355279|NCT01796301|65044876|FG000|Overall Study|Lost to Follow-up|3|||
23355280|NCT01796301|65044877|FG001|Overall Study|Lost to Follow-up|3|||
23249172|NCT00424515|64655595|FG000|Overall Study|Adverse Event|0|||
23249173|NCT00424515|64655596|FG001|Overall Study|Adverse Event|1|||
23249174|NCT00424515|64655595|FG000|Overall Study|Intercurrent Illness|0|||
23249175|NCT00424515|64655596|FG001|Overall Study|Intercurrent Illness|1|||
23249176|NCT00424515|64655595|FG000|Overall Study|Withdrawal by Subject|1|||
23249177|NCT00424515|64655596|FG001|Overall Study|Withdrawal by Subject|0|||
23249178|NCT03047031|64655597|FG000|Overall Study|Other than listed|1|||
23249179|NCT03047031|64655598|FG001|Overall Study|Other than listed|0|||
23249180|NCT03047031|64655599|FG002|Overall Study|Other than listed|0|||
23249181|NCT03047031|64655597|FG000|Overall Study|Lost to Follow-up|4|||
23249182|NCT03047031|64655598|FG001|Overall Study|Lost to Follow-up|0|||
23249183|NCT03047031|64655599|FG002|Overall Study|Lost to Follow-up|0|||
23249184|NCT03047031|64655597|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
23249185|NCT03047031|64655598|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
23249186|NCT03047031|64655599|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
23355281|NCT01796301|65044876|FG000|Overall Study|Death|0|||
23355282|NCT01796301|65044877|FG001|Overall Study|Death|1|||
23355283|NCT01796301|65044876|FG000|Overall Study|Decision by Sponsor|0|||
23355284|NCT01796301|65044877|FG001|Overall Study|Decision by Sponsor|1|||
23355285|NCT02869893|65044882|FG000|Overall Study|participant aversion to IV|5|||
23355286|NCT02869893|65044882|FG000|Overall Study|participant fear of MRI scanner|2|||
23355287|NCT03774394|65044883|FG000|Overall Study|Withdrawal by Subject|2|||
23355288|NCT03774394|65044884|FG001|Overall Study|Withdrawal by Subject|0|||
23355289|NCT03297021|65044885|FG000|Overall Study|Incomplete/illegible data sheet|4|||
23355290|NCT03297021|65044886|FG001|Overall Study|Incomplete/illegible data sheet|2|||
23355291|NCT03297021|65044887|FG002|Overall Study|Incomplete/illegible data sheet|3|||
23355292|NCT03297021|65044885|FG000|Overall Study|Missing Post-Op Data|1|||
23355293|NCT03297021|65044886|FG001|Overall Study|Missing Post-Op Data|2|||
23355294|NCT03297021|65044887|FG002|Overall Study|Missing Post-Op Data|1|||
23355295|NCT01180049|65044888|FG000|Overall Study|Other|9|||
23355296|NCT01180049|65044889|FG001|Overall Study|Other|7|||
23355297|NCT01180049|65044888|FG000|Overall Study|Lost to Follow-up|8|||
23355298|NCT01180049|65044889|FG001|Overall Study|Lost to Follow-up|6|||
23355299|NCT01180049|65044888|FG000|Overall Study|Death|36|||
23355300|NCT01180049|65044889|FG001|Overall Study|Death|35|||
23355301|NCT02263729|65044890|FG000|Overall Study|Lost to Follow-up|1|||
23355302|NCT02263729|65044891|FG001|Overall Study|Lost to Follow-up|1|||
23355303|NCT04186221|65044892|FG000|Overall Study|Death|1|||
23355304|NCT03396822|65044894|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
23355305|NCT03396822|65044894|FG000|Overall Study|Physician Decision|1|||
23355306|NCT01636947|65044896|FG000|Overall Study|Not Treated|2|||
23355307|NCT01636947|65044897|FG001|Overall Study|Not Treated|2|||
23472299|NCT00104520|65473928|FG000|Overall Study|Noncompliance|0|||
23472300|NCT00104520|65473929|FG001|Overall Study|Noncompliance|2|||
23472301|NCT00104520|65473928|FG000|Overall Study|Personal/administrative|1|||
23588179|NCT03068468|65882144|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
23588180|NCT03068468|65882145|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
23588181|NCT03068468|65882142|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
23588182|NCT03068468|65882143|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
23588183|NCT03068468|65882144|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
23588184|NCT03068468|65882145|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
23588185|NCT03068468|65882142|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
23588186|NCT03068468|65882143|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
23588187|NCT03068468|65882144|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
23588188|NCT03068468|65882145|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
23588189|NCT03068468|65882142|FG000|Open-Label Extension Period|Reason not Specified|0|||
23588190|NCT03068468|65882143|FG001|Open-Label Extension Period|Reason not Specified|0|||
23588191|NCT03068468|65882144|FG002|Open-Label Extension Period|Reason not Specified|1|||
23588192|NCT03068468|65882145|FG003|Open-Label Extension Period|Reason not Specified|4|||
23588193|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
23588194|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
23588195|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
23588196|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23588197|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23588198|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23588199|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23588200|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23249187|NCT03047031|64655597|FG000|Overall Study|Adverse Event|1|||
23355308|NCT01636947|65044896|FG000|Overall Study|Lost to Follow-up|4|||
23355309|NCT01636947|65044897|FG001|Overall Study|Lost to Follow-up|0|||
23355310|NCT01636947|65044896|FG000|Overall Study|Protocol Violation|1|||
23588201|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
23355311|NCT01636947|65044897|FG001|Overall Study|Protocol Violation|1|||
23355312|NCT01636947|65044896|FG000|Overall Study|Withdrawal by Subject|3|||
23355313|NCT01636947|65044897|FG001|Overall Study|Withdrawal by Subject|3|||
23249188|NCT03047031|64655598|FG001|Overall Study|Adverse Event|0|||
23249189|NCT03047031|64655599|FG002|Overall Study|Adverse Event|0|||
23249190|NCT03047031|64655597|FG000|Overall Study|Withdrawal by Subject|2|||
23249191|NCT03047031|64655598|FG001|Overall Study|Withdrawal by Subject|0|||
23249192|NCT03047031|64655599|FG002|Overall Study|Withdrawal by Subject|0|||
23249193|NCT03047031|64655597|FG000|Overall Study|Change to other medication|2|||
23249194|NCT03047031|64655598|FG001|Overall Study|Change to other medication|0|||
23249195|NCT03047031|64655599|FG002|Overall Study|Change to other medication|0|||
23249196|NCT03047031|64655597|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
23249197|NCT03047031|64655598|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
23249198|NCT03047031|64655599|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
23249199|NCT02989610|64655600|FG000|Overall Study|Withdrawal by Subject|20|||
23249200|NCT02989610|64655600|FG000|Overall Study|Departure of PI from Site|8|||
23249201|NCT02989610|64655600|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
23249202|NCT02989610|64655600|FG000|Overall Study|Lost to Follow-up|3|||
23249203|NCT02989610|64655600|FG000|Overall Study|Death|3|||
23249204|NCT02989610|64655600|FG000|Overall Study|System Explant|3|||
23249205|NCT02989610|64655600|FG000|Overall Study|Subject Non-Compliance|2|||
23249206|NCT02989610|64655600|FG000|Overall Study|System Revision|2|||
23249207|NCT02989610|64655600|FG000|Overall Study|PI Left, Study Closing|1|||
23249208|NCT02989610|64655600|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
23249209|NCT02989610|64655600|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
23249210|NCT03575325|64655605|FG000|Overall Study|Death|1|||
23249211|NCT01788163|64655606|FG000|Overall Study|Other|53|||
23249212|NCT01788163|64655607|FG001|Overall Study|Other|0|||
23249213|NCT01788163|64655608|FG002|Overall Study|Other|0|||
23249214|NCT01788163|64655609|FG003|Overall Study|Other|0|||
23249215|NCT01788163|64655610|FG004|Overall Study|Other|0|||
23249216|NCT01788163|64655611|FG005|Overall Study|Other|7|||
23249217|NCT01788163|64655612|FG006|Overall Study|Other|1|||
23249218|NCT01788163|64655613|FG007|Overall Study|Other|48|||
23249219|NCT01788163|64655614|FG008|Overall Study|Other|15|||
23249220|NCT01788163|64655606|FG000|Overall Study|Withdrawal by Subject|2|||
23249221|NCT01788163|64655607|FG001|Overall Study|Withdrawal by Subject|0|||
23249222|NCT01788163|64655608|FG002|Overall Study|Withdrawal by Subject|0|||
23249223|NCT01788163|64655609|FG003|Overall Study|Withdrawal by Subject|0|||
23249224|NCT01788163|64655610|FG004|Overall Study|Withdrawal by Subject|0|||
23249225|NCT01788163|64655611|FG005|Overall Study|Withdrawal by Subject|0|||
23249226|NCT01788163|64655612|FG006|Overall Study|Withdrawal by Subject|0|||
23249227|NCT01788163|64655613|FG007|Overall Study|Withdrawal by Subject|0|||
23249228|NCT01788163|64655614|FG008|Overall Study|Withdrawal by Subject|1|||
23249229|NCT03664024|64655617|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
23249230|NCT03664024|64655617|FG000|Overall Study|Lost to Follow-up|2|||
23249231|NCT03664024|64655617|FG000|Overall Study|Withdrawal by Subject|2|||
23249232|NCT03664024|64655617|FG000|Overall Study|Death|80|||
23249233|NCT03494816|64655621|FG000|Overall Study|Protocol Violation|2|||
23249234|NCT03494816|64655621|FG000|Overall Study|Physician Decision|2|||
23249235|NCT03494816|64655621|FG000|Overall Study|Did not start trial treatment|1|||
23249236|NCT03494816|64655621|FG000|Overall Study|Adverse Event|1|||
23249237|NCT00759174|64655622|FG000|Overall Study|Other|0|||
23249238|NCT00759174|64655623|FG001|Overall Study|Other|2|||
23249239|NCT03722849|64655624|FG000|Overall Study|Withdrawal by Subject|1|||
23249240|NCT03722849|64655625|FG001|Overall Study|Withdrawal by Subject|1|||
23249241|NCT00810615|64655626|FG000|Overall Study|Withdrawal by Subject|1|||
23249242|NCT00810615|64655627|FG001|Overall Study|Withdrawal by Subject|1|||
23249243|NCT01892020|64655628|FG000|Period 1|Adverse Event|1|||
23249244|NCT01892020|64655629|FG001|Period 1|Adverse Event|1|||
23249245|NCT01892020|64655628|FG000|Period 1|Protocol Violation|2|||
23355314|NCT01636947|65044896|FG000|Overall Study|Adverse Event|1|||
23588202|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
23355315|NCT01636947|65044897|FG001|Overall Study|Adverse Event|1|||
23588203|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
23588204|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
23588205|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23249246|NCT01892020|64655629|FG001|Period 1|Protocol Violation|4|||
23249247|NCT01892020|64655628|FG000|Period 1|Unclassified|0|||
23249248|NCT01892020|64655629|FG001|Period 1|Unclassified|1|||
23249249|NCT01892020|64655628|FG000|Period 2|Protocol Violation|1|||
23249250|NCT01892020|64655629|FG001|Period 2|Protocol Violation|0|||
23249251|NCT05349188|64655630|FG000|Overall Study|Withdrawal by Subject|1|||
23355316|NCT01636947|65044896|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
23249252|NCT05349188|64655631|FG001|Overall Study|Withdrawal by Subject|0|||
23249253|NCT02237118|64655632|FG000|Overall Study|Protocol Violation|0|||
23249254|NCT02237118|64655633|FG001|Overall Study|Protocol Violation|1|||
23249255|NCT02237118|64655632|FG000|Overall Study|consent withdrawn|1|||
23249256|NCT02237118|64655633|FG001|Overall Study|consent withdrawn|0|||
23249257|NCT00411762|64655634|FG000|Overall Study|Withdrawal by Subject|5|||
23249258|NCT03594175|64655635|FG000|Overall Study|Not treated|8|||
23249259|NCT03594175|64655636|FG001|Overall Study|Not treated|1|||
23355317|NCT01636947|65044897|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
23355318|NCT01464619|65044898|FG000|Overall Study|Lost to Follow-up|3|||
23355319|NCT01464619|65044899|FG001|Overall Study|Lost to Follow-up|4|||
23355320|NCT02385110|65044900|FG000|Overall Study|Early Death|1|||
23355321|NCT02385110|65044901|FG001|Overall Study|Early Death|0|||
23355322|NCT01308463|65044902|FG000|Overall Study|Study Discontinued|23|||
23355323|NCT01308463|65044902|FG000|Overall Study|Death|4|||
23355324|NCT01308463|65044902|FG000|Overall Study|Revision|2|||
23355325|NCT00076999|65044903|FG000|Overall Study|Adverse Event|2|||
23355326|NCT00076999|65044904|FG001|Overall Study|Adverse Event|8|||
23355327|NCT00076999|65044905|FG002|Overall Study|Adverse Event|6|||
23355328|NCT00076999|65044906|FG003|Overall Study|Adverse Event|0|||
23355329|NCT00076999|65044907|FG004|Overall Study|Adverse Event|2|||
23355330|NCT00076999|65044903|FG000|Overall Study|Protocol Violation|0|||
23355331|NCT00076999|65044904|FG001|Overall Study|Protocol Violation|3|||
23355332|NCT00076999|65044905|FG002|Overall Study|Protocol Violation|4|||
23355333|NCT00076999|65044906|FG003|Overall Study|Protocol Violation|0|||
23355334|NCT00076999|65044907|FG004|Overall Study|Protocol Violation|9|||
23355335|NCT00076999|65044903|FG000|Overall Study|Lost to Follow-up|2|||
23355336|NCT00076999|65044904|FG001|Overall Study|Lost to Follow-up|1|||
23355337|NCT00076999|65044905|FG002|Overall Study|Lost to Follow-up|0|||
23355338|NCT00076999|65044906|FG003|Overall Study|Lost to Follow-up|0|||
23355339|NCT00076999|65044907|FG004|Overall Study|Lost to Follow-up|0|||
23355340|NCT00076999|65044903|FG000|Overall Study|Withdrawal by Subject|0|||
23355341|NCT00076999|65044904|FG001|Overall Study|Withdrawal by Subject|4|||
23355342|NCT00076999|65044905|FG002|Overall Study|Withdrawal by Subject|3|||
23355343|NCT00076999|65044906|FG003|Overall Study|Withdrawal by Subject|0|||
23355344|NCT00076999|65044907|FG004|Overall Study|Withdrawal by Subject|1|||
23355345|NCT00076999|65044903|FG000|Overall Study|Other reason (not specified)|8|||
23355346|NCT00076999|65044904|FG001|Overall Study|Other reason (not specified)|8|||
23355347|NCT00076999|65044905|FG002|Overall Study|Other reason (not specified)|4|||
23355348|NCT00076999|65044906|FG003|Overall Study|Other reason (not specified)|1|||
23355349|NCT00076999|65044907|FG004|Overall Study|Other reason (not specified)|13|||
23355350|NCT02626000|65044912|FG000|Overall Study|Decision by Sponsor|1|||
23355351|NCT02626000|65044912|FG000|Overall Study|Death|29|||
23355352|NCT01424241|65044913|FG000|Overall Study|Withdrawal by Subject|1|||
23355353|NCT01424241|65044913|FG000|Overall Study|Time constraints|2|||
23355354|NCT01863732|65044914|FG000|Overall Study|Adverse Event|2|||
23355355|NCT01863732|65044915|FG001|Overall Study|Adverse Event|0|||
23355356|NCT01863732|65044916|FG002|Overall Study|Adverse Event|3|||
23355357|NCT01863732|65044917|FG003|Overall Study|Adverse Event|3|||
23355358|NCT01863732|65044914|FG000|Overall Study|Lack of Efficacy|1|||
23355359|NCT01863732|65044915|FG001|Overall Study|Lack of Efficacy|0|||
23355360|NCT01863732|65044916|FG002|Overall Study|Lack of Efficacy|2|||
23355361|NCT01863732|65044917|FG003|Overall Study|Lack of Efficacy|1|||
23355362|NCT01863732|65044914|FG000|Overall Study|Lost to Follow-up|2|||
23355363|NCT01863732|65044915|FG001|Overall Study|Lost to Follow-up|2|||
23355364|NCT01863732|65044916|FG002|Overall Study|Lost to Follow-up|1|||
23355365|NCT01863732|65044917|FG003|Overall Study|Lost to Follow-up|1|||
23355366|NCT01863732|65044914|FG000|Overall Study|Physician Decision|1|||
23355367|NCT01863732|65044915|FG001|Overall Study|Physician Decision|0|||
23355368|NCT01863732|65044916|FG002|Overall Study|Physician Decision|1|||
23355369|NCT01863732|65044917|FG003|Overall Study|Physician Decision|0|||
23355370|NCT01863732|65044914|FG000|Overall Study|Pregnancy|0|||
23588206|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588207|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588208|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588209|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588210|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
23588211|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
23588212|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
23355371|NCT01863732|65044915|FG001|Overall Study|Pregnancy|0|||
23355372|NCT01863732|65044916|FG002|Overall Study|Pregnancy|0|||
23355373|NCT01863732|65044917|FG003|Overall Study|Pregnancy|1|||
23355374|NCT01863732|65044914|FG000|Overall Study|Technical problems|0|||
23355375|NCT01863732|65044915|FG001|Overall Study|Technical problems|1|||
23355376|NCT01863732|65044916|FG002|Overall Study|Technical problems|1|||
23355377|NCT01863732|65044917|FG003|Overall Study|Technical problems|0|||
23355378|NCT01863732|65044914|FG000|Overall Study|Subject/guardian decision|6|||
23355379|NCT01863732|65044915|FG001|Overall Study|Subject/guardian decision|9|||
23189650|NCT01416181|64436144|FG000|Part 1|Investigator Decision|7|||
23355380|NCT01863732|65044916|FG002|Overall Study|Subject/guardian decision|3|||
23355381|NCT01863732|65044917|FG003|Overall Study|Subject/guardian decision|1|||
23355382|NCT01863732|65044914|FG000|Overall Study|Death|1|||
23355383|NCT01863732|65044915|FG001|Overall Study|Death|0|||
23355384|NCT01863732|65044916|FG002|Overall Study|Death|0|||
23355385|NCT01863732|65044917|FG003|Overall Study|Death|1|||
23355386|NCT05268016|65044918|FG000|Overall Study|Unacceptable toxicity or AE|2|||
23355387|NCT05268016|65044919|FG001|Overall Study|Unacceptable toxicity or AE|2|||
23355388|NCT05268016|65044920|FG002|Overall Study|Unacceptable toxicity or AE|4|||
23355389|NCT05268016|65044921|FG003|Overall Study|Unacceptable toxicity or AE|3|||
23355390|NCT05268016|65044922|FG004|Overall Study|Unacceptable toxicity or AE|1|||
23355391|NCT05268016|65044918|FG000|Overall Study|Withdrawal by Subject|1|||
23355392|NCT05268016|65044919|FG001|Overall Study|Withdrawal by Subject|3|||
23355393|NCT05268016|65044920|FG002|Overall Study|Withdrawal by Subject|2|||
23355394|NCT05268016|65044921|FG003|Overall Study|Withdrawal by Subject|2|||
23355395|NCT05268016|65044922|FG004|Overall Study|Withdrawal by Subject|1|||
23355396|NCT05268016|65044918|FG000|Overall Study|Lost to Follow-up|4|||
23355397|NCT05268016|65044919|FG001|Overall Study|Lost to Follow-up|7|||
23355398|NCT05268016|65044920|FG002|Overall Study|Lost to Follow-up|1|||
23355399|NCT05268016|65044921|FG003|Overall Study|Lost to Follow-up|3|||
23355400|NCT05268016|65044922|FG004|Overall Study|Lost to Follow-up|5|||
23355401|NCT05268016|65044918|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
23355402|NCT05268016|65044919|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
23355403|NCT05268016|65044920|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
23355404|NCT05268016|65044921|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
23355405|NCT05268016|65044922|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
23355406|NCT05268016|65044918|FG000|Overall Study|Lack of Efficacy|0|||
23355407|NCT05268016|65044919|FG001|Overall Study|Lack of Efficacy|0|||
23355408|NCT05268016|65044920|FG002|Overall Study|Lack of Efficacy|0|||
23355409|NCT05268016|65044921|FG003|Overall Study|Lack of Efficacy|0|||
23355410|NCT05268016|65044922|FG004|Overall Study|Lack of Efficacy|4|||
23355411|NCT05268016|65044918|FG000|Overall Study|Physician Decision|0|||
23355412|NCT05268016|65044919|FG001|Overall Study|Physician Decision|0|||
23355413|NCT05268016|65044920|FG002|Overall Study|Physician Decision|0|||
23355414|NCT05268016|65044921|FG003|Overall Study|Physician Decision|1|||
23355415|NCT05268016|65044922|FG004|Overall Study|Physician Decision|0|||
23588213|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
23588214|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23588215|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23588216|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23588217|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23355416|NCT05268016|65044918|FG000|Overall Study|Other|1|||
23355417|NCT05268016|65044919|FG001|Overall Study|Other|0|||
23355418|NCT05268016|65044920|FG002|Overall Study|Other|1|||
23355419|NCT05268016|65044921|FG003|Overall Study|Other|2|||
23355420|NCT05268016|65044922|FG004|Overall Study|Other|0|||
23355421|NCT03594955|65044923|FG000|Overall Study|Adverse Event|1|||
23355422|NCT03594955|65044923|FG000|Overall Study|Progressive disease|5|||
23355423|NCT03594955|65044923|FG000|Overall Study|Sponsor's decision|1|||
23355424|NCT03373461|65044924|FG000|Part 2|Adverse Event|0|||
23355425|NCT03373461|65044925|FG001|Part 2|Adverse Event|1|||
23355426|NCT03373461|65044926|FG002|Part 2|Adverse Event|0|||
23355427|NCT03373461|65044927|FG003|Part 2|Adverse Event|0|||
23355428|NCT03373461|65044928|FG004|Part 2|Adverse Event|1|||
23355429|NCT00404924|65044932|FG000|Overall Study|Adverse Event|75|||
23355430|NCT00404924|65044933|FG001|Overall Study|Adverse Event|16|||
23355431|NCT00404924|65044932|FG000|Overall Study|Condition under investigation worsened|475|||
23355432|NCT00404924|65044933|FG001|Overall Study|Condition under investigation worsened|264|||
23355433|NCT00404924|65044932|FG000|Overall Study|Lost to Follow-up|1|||
23355434|NCT00404924|65044933|FG001|Overall Study|Lost to Follow-up|1|||
23355435|NCT00404924|65044932|FG000|Overall Study|Withdrawal by Subject|26|||
23355436|NCT00404924|65044933|FG001|Overall Study|Withdrawal by Subject|13|||
23355437|NCT00404924|65044932|FG000|Overall Study|Other|25|||
23355438|NCT00404924|65044933|FG001|Overall Study|Other|11|||
23355439|NCT00404924|65044932|FG000|Overall Study|Randomised but not received treatment|1|||
23355440|NCT00404924|65044933|FG001|Overall Study|Randomised but not received treatment|1|||
23355441|NCT03887117|65044934|FG000|Overall Study|Discontinued prematurely|0|||
23355442|NCT03887117|65044935|FG001|Overall Study|Discontinued prematurely|1|||
23588218|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23355443|NCT03887117|65044936|FG002|Overall Study|Discontinued prematurely|1|||
23355444|NCT03887117|65044937|FG003|Overall Study|Discontinued prematurely|2|||
23588219|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
23588220|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
23355445|NCT01133288|65044938|FG000|Eligibility Assessment|met exclusion criteria|5|||
23355446|NCT01133288|65044938|FG000|Intervention Allocation|study terminated|2|||
23355447|NCT02824562|65044945|FG000|Overall Study|Lost to Follow-up|3|||
23355448|NCT02824562|65044946|FG001|Overall Study|Lost to Follow-up|4|||
23355449|NCT02824562|65044945|FG000|Overall Study|Death|0|||
23355450|NCT02824562|65044946|FG001|Overall Study|Death|1|||
23355451|NCT00433017|65044951|FG000|Overall Study|Adverse Event|5|||
23355452|NCT00433017|65044952|FG001|Overall Study|Adverse Event|3|||
23355453|NCT00433017|65044951|FG000|Overall Study|Withdrawal by Subject|4|||
23355454|NCT00433017|65044952|FG001|Overall Study|Withdrawal by Subject|5|||
23355455|NCT00433017|65044951|FG000|Overall Study|Lost to Follow-up|3|||
23355456|NCT00433017|65044952|FG001|Overall Study|Lost to Follow-up|4|||
23355457|NCT00433017|65044951|FG000|Overall Study|Administrative problems|80|||
23355458|NCT00433017|65044952|FG001|Overall Study|Administrative problems|86|||
23355459|NCT00433017|65044951|FG000|Overall Study|Protocol Violation|1|||
23355460|NCT00433017|65044952|FG001|Overall Study|Protocol Violation|0|||
23355461|NCT00433017|65044951|FG000|Overall Study|Death|2|||
23355462|NCT00433017|65044952|FG001|Overall Study|Death|2|||
23355463|NCT00433017|65044951|FG000|Overall Study|Subject no longer requires study drug|1|||
23355464|NCT00433017|65044952|FG001|Overall Study|Subject no longer requires study drug|1|||
23355465|NCT02442206|65044953|FG000|Period 1|Adverse Event|1|||
23355466|NCT02442206|65044954|FG001|Period 1|Adverse Event|1|||
23355467|NCT02442206|65044953|FG000|Period 1|withdrew consent|0|||
23355468|NCT02442206|65044954|FG001|Period 1|withdrew consent|1|||
23355469|NCT02442206|65044953|FG000|Period 1|COPD exacerbation|0|||
23355470|NCT02442206|65044954|FG001|Period 1|COPD exacerbation|1|||
23355471|NCT02442206|65044953|FG000|Period 2|Adverse Event|1|||
23355472|NCT02442206|65044954|FG001|Period 2|Adverse Event|0|||
23355473|NCT02849171|65044961|FG000|Overall Study|Withdrawal by Subject|1|||
23355474|NCT02849171|65044961|FG000|Overall Study|Not treated|1|||
23355475|NCT00396877|65044964|FG000|Overall Study|Lost to Follow-up|2|||
23355476|NCT00396877|65044965|FG001|Overall Study|Lost to Follow-up|1|||
23355477|NCT00396877|65044964|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
23355478|NCT00396877|65044965|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
23355479|NCT04165135|65044966|FG000|Overall Study|Protocol Violation|10|||
23355480|NCT04165135|65044966|FG000|Overall Study|Participants withdrawal of consent|5|||
23355481|NCT01470144|65044969|FG000|Overall Study|Adverse Event|2|||
23355482|NCT01470144|65044969|FG000|Overall Study|Death|1|||
23355483|NCT01470144|65044969|FG000|Overall Study|Lung transplant|6|||
23355484|NCT01470144|65044969|FG000|Overall Study|Patient's and investigator's decision|1|||
23355485|NCT03035916|65044970|FG000|Overall Study|Puncture failed|0|||
23355486|NCT03035916|65044971|FG001|Overall Study|Puncture failed|2|||
23355487|NCT03035916|65044972|FG002|Overall Study|Puncture failed|0|||
23355488|NCT03034135|65044973|FG000|Overall Study|Withdrawal by Subject|2|||
23355489|NCT01884545|65044975|FG000|Overall Study|Lost to Follow-up|6|||
23355490|NCT01884545|65044976|FG001|Overall Study|Lost to Follow-up|4|||
23355491|NCT01884545|65044977|FG002|Overall Study|Lost to Follow-up|9|||
23355492|NCT01884545|65044978|FG003|Overall Study|Lost to Follow-up|4|||
23355493|NCT01884545|65044975|FG000|Overall Study|Patient withdrawn|7|||
23355494|NCT01884545|65044976|FG001|Overall Study|Patient withdrawn|12|||
23355495|NCT01884545|65044977|FG002|Overall Study|Patient withdrawn|5|||
23355496|NCT01884545|65044978|FG003|Overall Study|Patient withdrawn|5|||
23355497|NCT01884545|65044975|FG000|Overall Study|Non-adherence|0|||
23355498|NCT01884545|65044976|FG001|Overall Study|Non-adherence|2|||
23355499|NCT01884545|65044977|FG002|Overall Study|Non-adherence|0|||
23355500|NCT01884545|65044978|FG003|Overall Study|Non-adherence|0|||
23355501|NCT02304380|65044982|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23355502|NCT02304380|65044983|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23355503|NCT02304380|65044984|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23355504|NCT02304380|65044985|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
23355505|NCT02304380|65044986|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23472302|NCT00104520|65473929|FG001|Overall Study|Personal/administrative|1|||
23355506|NCT02304380|65044987|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
23355507|NCT00048165|65044988|FG000|Completed 6 Months Study|Administration/Other|8|||
23472303|NCT00104520|65473928|FG000|Overall Study|Other|1|||
23472304|NCT00104520|65473929|FG001|Overall Study|Other|5|||
23189651|NCT01416181|64436145|FG001|Part 1|Investigator Decision|6|||
23355508|NCT00048165|65044989|FG001|Completed 6 Months Study|Administration/Other|8|||
23355509|NCT00048165|65044988|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
23355510|NCT00048165|65044989|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
23355511|NCT00048165|65044988|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
23355512|NCT00048165|65044989|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
23355513|NCT00048165|65044988|FG000|Completed 6 Months Study|Death|12|||
23355514|NCT00048165|65044989|FG001|Completed 6 Months Study|Death|6|||
23355515|NCT00048165|65044988|FG000|Completed 6 Months Study|Insufficient therapy|1|||
23355516|NCT00048165|65044989|FG001|Completed 6 Months Study|Insufficient therapy|4|||
23249260|NCT03594175|64655637|FG002|Overall Study|Not treated|5|||
23249261|NCT03594175|64655635|FG000|Overall Study|Adverse Event|3|||
23249262|NCT03594175|64655636|FG001|Overall Study|Adverse Event|0|||
23249263|NCT03594175|64655637|FG002|Overall Study|Adverse Event|0|||
23249264|NCT03594175|64655635|FG000|Overall Study|Withdrawal by Subject|3|||
23355517|NCT00048165|65044988|FG000|Completed 6 Months Study|Other violation|4|||
23355518|NCT00048165|65044989|FG001|Completed 6 Months Study|Other violation|6|||
23355519|NCT00048165|65044988|FG000|Completed 6 Months Study|Refused treatment|5|||
23355520|NCT00048165|65044989|FG001|Completed 6 Months Study|Refused treatment|5|||
23355521|NCT00048165|65044988|FG000|Completed 6 Months Study|Violation criteria|0|||
23355522|NCT00048165|65044989|FG001|Completed 6 Months Study|Violation criteria|2|||
23355523|NCT00048165|65044988|FG000|Completed 6 Months Study|Did not receive study drug|6|||
23355524|NCT00048165|65044989|FG001|Completed 6 Months Study|Did not receive study drug|6|||
23355525|NCT00048165|65044988|FG000|Completed 12 Months Study|Administration/Other|0|||
23355526|NCT00048165|65044989|FG001|Completed 12 Months Study|Administration/Other|2|||
23355527|NCT00048165|65044988|FG000|Completed 12 Months Study|Death|2|||
23355528|NCT00048165|65044989|FG001|Completed 12 Months Study|Death|1|||
23355529|NCT00048165|65044988|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
23355530|NCT00048165|65044989|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
23355531|NCT04202965|65044992|FG000|Overall Study|Adverse Event|3|||
23355532|NCT04202965|65044992|FG000|Overall Study|Did not meet inclusion criteria|1|||
23355533|NCT02937636|65044994|FG000|Overall Study|Other (Not specified)|3|||
23355534|NCT02937636|65044995|FG001|Overall Study|Other (Not specified)|2|||
23355535|NCT00272844|65044998|FG000|Overall Study|Withdrawal by Subject|5|||
23355536|NCT04348500|65045000|FG000|Overall Study|Death|2|||
23355537|NCT04348500|65045001|FG001|Overall Study|Death|2|||
23355538|NCT04348500|65045000|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
23355539|NCT04348500|65045001|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
23355540|NCT01125813|65045009|FG000|Overall Study|Death|1|||
23355541|NCT01125813|65045009|FG000|Overall Study|Withdrawal by Subject|1|||
23355542|NCT01125813|65045009|FG000|Overall Study|Screen Failures|4|||
23355543|NCT00073008|65045011|FG000|Overall Study|Missing|6|||
23355544|NCT00073008|65045012|FG001|Overall Study|Missing|6|||
23355545|NCT00073008|65045011|FG000|Overall Study|Withdrawal by Subject|2|||
23189652|NCT01416181|64436144|FG000|Part 1|Withdrawal by Subject|74|||
23189653|NCT01416181|64436145|FG001|Part 1|Withdrawal by Subject|48|||
23189654|NCT01416181|64436144|FG000|Part 1|Lack of Efficacy|16|||
23189655|NCT01416181|64436145|FG001|Part 1|Lack of Efficacy|8|||
23189656|NCT01416181|64436144|FG000|Part 1|Lost to Follow-up|1|||
23189657|NCT01416181|64436145|FG001|Part 1|Lost to Follow-up|1|||
23189658|NCT01416181|64436144|FG000|Part 1|Adverse Event|15|||
23189659|NCT01416181|64436145|FG001|Part 1|Adverse Event|18|||
23189660|NCT01416181|64436144|FG000|Part 1|Ongoing in Follow-Up|14|||
23189661|NCT01416181|64436145|FG001|Part 1|Ongoing in Follow-Up|8|||
23189662|NCT01416181|64436144|FG000|Part 2|Adverse Event|11|||
23189663|NCT01416181|64436145|FG001|Part 2|Adverse Event|4|||
23189664|NCT01416181|64436144|FG000|Part 2|Other|234|||
23189665|NCT01416181|64436145|FG001|Part 2|Other|267|||
23189666|NCT01416181|64436144|FG000|Part 2|Investigator Decision|6|||
23189667|NCT01416181|64436145|FG001|Part 2|Investigator Decision|7|||
23189668|NCT01416181|64436144|FG000|Part 2|Withdrawal by Subject|14|||
23189669|NCT01416181|64436145|FG001|Part 2|Withdrawal by Subject|5|||
23189670|NCT01416181|64436144|FG000|Part 2|Lack of Efficacy|4|||
23189671|NCT01416181|64436145|FG001|Part 2|Lack of Efficacy|1|||
23189672|NCT01416181|64436144|FG000|Part 2|Lost to Follow-up|2|||
23189673|NCT01416181|64436145|FG001|Part 2|Lost to Follow-up|2|||
23189674|NCT02873221|64436152|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
23189675|NCT02873221|64436153|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
23189676|NCT02873221|64436154|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
23189677|NCT02873221|64436152|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
23189678|NCT02873221|64436153|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
23189679|NCT02873221|64436154|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
23189680|NCT02873221|64436152|FG000|Treatment Period|Protocol Violation|2|||
23189681|NCT02873221|64436153|FG001|Treatment Period|Protocol Violation|5|||
23249265|NCT03594175|64655636|FG001|Overall Study|Withdrawal by Subject|0|||
23189682|NCT02873221|64436154|FG002|Treatment Period|Protocol Violation|8|||
23189683|NCT02873221|64436152|FG000|Treatment Period|Pregnancy|4|||
23189684|NCT02873221|64436153|FG001|Treatment Period|Pregnancy|6|||
23249266|NCT03594175|64655637|FG002|Overall Study|Withdrawal by Subject|0|||
23249267|NCT03594175|64655635|FG000|Overall Study|Protocol Violation|2|||
23249268|NCT03594175|64655636|FG001|Overall Study|Protocol Violation|2|||
23355546|NCT00073008|65045012|FG001|Overall Study|Withdrawal by Subject|2|||
23472305|NCT01727024|65473933|FG000|Period 1|Lost to Follow-up|1|||
23588221|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588222|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
23588223|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588224|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588225|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588226|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588227|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588228|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
23588229|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23588230|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
23588231|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
23588232|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588233|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588234|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23249269|NCT03594175|64655637|FG002|Overall Study|Protocol Violation|2|||
23249270|NCT01396161|64655638|FG000|Overall Study|Withdrawal by Subject|0|||
23249271|NCT01396161|64655639|FG001|Overall Study|Withdrawal by Subject|0|||
23249272|NCT01396161|64655640|FG002|Overall Study|Withdrawal by Subject|0|||
23249273|NCT01396161|64655641|FG003|Overall Study|Withdrawal by Subject|0|||
23249274|NCT01396161|64655642|FG004|Overall Study|Withdrawal by Subject|1|||
23249275|NCT01396161|64655643|FG005|Overall Study|Withdrawal by Subject|0|||
23588235|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588236|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588237|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
23588238|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588239|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23588240|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
23588241|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588242|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588243|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588244|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588245|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588246|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
23588247|NCT01212757|65882156|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
23588248|NCT01212757|65882157|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
23588249|NCT01212757|65882158|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23249276|NCT01396161|64655644|FG006|Overall Study|Withdrawal by Subject|0|||
23249277|NCT01396161|64655638|FG000|Overall Study|Other|0|||
23355547|NCT00073008|65045011|FG000|Overall Study|Lost to Follow-up|1|||
23249278|NCT01396161|64655639|FG001|Overall Study|Other|0|||
23472306|NCT01727024|65473934|FG001|Period 1|Lost to Follow-up|1|||
23472307|NCT01727024|65473933|FG000|Period 1|Withdrawal by Subject|2|||
23472308|NCT01727024|65473934|FG001|Period 1|Withdrawal by Subject|3|||
23472309|NCT02855541|65473935|FG000|Overall Study|Change in health status|2|||
23472310|NCT02855541|65473935|FG000|Overall Study|Withdrawal by Subject|2|||
23472311|NCT02404025|65473938|FG000|Overall Study|Adverse Event|1|||
23472312|NCT02404025|65473938|FG000|Overall Study|Lack of Efficacy|3|||
23472313|NCT00202878|65473939|FG000|Overall Study|Death|964|||
23472314|NCT00202878|65473940|FG001|Overall Study|Death|968|||
23472315|NCT00202878|65473939|FG000|Overall Study|Only Vital Status Known|357|||
23472316|NCT00202878|65473940|FG001|Overall Study|Only Vital Status Known|356|||
23472317|NCT00202878|65473939|FG000|Overall Study|Lost to Follow-up|44|||
23472318|NCT00202878|65473940|FG001|Overall Study|Lost to Follow-up|49|||
23472319|NCT00202878|65473939|FG000|Overall Study|Site Closure|39|||
23472320|NCT00202878|65473940|FG001|Overall Study|Site Closure|36|||
23472321|NCT00202878|65473939|FG000|Overall Study|Withdrawal by Subject|795|||
23472322|NCT00202878|65473940|FG001|Overall Study|Withdrawal by Subject|808|||
23472323|NCT03805659|65473941|FG000|Overall Study|Withdrawal by Subject|0|||
23472324|NCT03805659|65473942|FG001|Overall Study|Withdrawal by Subject|1|||
23472325|NCT01105767|65473945|FG000|Overall Study|Lost to Follow-up|1160|||
23472326|NCT01105767|65473946|FG001|Overall Study|Lost to Follow-up|1614|||
23472327|NCT01105767|65473947|FG002|Overall Study|Lost to Follow-up|1184|||
23472328|NCT01454778|65473950|FG000|Overall Study|Lost to Follow-up|2|||
23472329|NCT01454778|65473950|FG000|Overall Study|Death|1|||
23472330|NCT03672097|65473951|FG000|Period 1|Withdrawal by Subject|2|||
23472331|NCT03672097|65473951|FG000|Period 1|Adverse Event|1|||
23472332|NCT03672097|65473951|FG000|Period 1|Did not receive treatment|1|||
23472333|NCT03672097|65473951|FG000|Period 2|Withdrawal by Subject|3|||
23472334|NCT03672097|65473951|FG000|Period 2|Other|1|||
23472335|NCT01057589|65473952|FG000|Overall Study|Disease Progression|35|||
23472336|NCT01057589|65473952|FG000|Overall Study|Adverse Event|10|||
23472337|NCT01057589|65473952|FG000|Overall Study|Physician Decision|8|||
23472338|NCT01057589|65473952|FG000|Overall Study|Withdrawal by Subject|3|||
23472339|NCT01057589|65473952|FG000|Overall Study|Sponsor Decision|1|||
23472340|NCT01057589|65473952|FG000|Overall Study|Death|8|||
23472341|NCT01057589|65473952|FG000|Overall Study|Lost to Follow-up|1|||
23472342|NCT00635999|65473955|FG000|Overall Study|Withdrawal by Subject|4|||
23472343|NCT00635999|65473956|FG001|Overall Study|Withdrawal by Subject|2|||
23472344|NCT00635999|65473957|FG002|Overall Study|Withdrawal by Subject|1|||
23472345|NCT02929407|65473958|FG000|Overall Study|Adverse Event|1|||
23472346|NCT01802073|65473961|FG000|Overall Study|Lost to Follow-up|0|||
23472347|NCT01802073|65473962|FG001|Overall Study|Lost to Follow-up|1|||
23472348|NCT01802073|65473961|FG000|Overall Study|Non-compliant|4|||
23472349|NCT01802073|65473962|FG001|Overall Study|Non-compliant|2|||
23472350|NCT01802073|65473961|FG000|Overall Study|Withdrawal by Subject|1|||
23472351|NCT01802073|65473962|FG001|Overall Study|Withdrawal by Subject|1|||
23472352|NCT01802073|65473961|FG000|Overall Study|Physician Decision|0|||
23472353|NCT01802073|65473962|FG001|Overall Study|Physician Decision|7|||
23472354|NCT01159431|65473969|FG000|Overall Study|Adverse Event|1|||
23472355|NCT01159431|65473970|FG001|Overall Study|Adverse Event|2|||
23472356|NCT01159431|65473969|FG000|Overall Study|non-compliance|1|||
23472357|NCT01159431|65473970|FG001|Overall Study|non-compliance|1|||
23472358|NCT01159431|65473969|FG000|Overall Study|Lack of Efficacy|0|||
23472359|NCT01159431|65473970|FG001|Overall Study|Lack of Efficacy|3|||
23472360|NCT02791763|65473971|FG000|Overall Study|Protocol Violation|0|||
23472361|NCT02791763|65473972|FG001|Overall Study|Protocol Violation|0|||
23472362|NCT02791763|65473973|FG002|Overall Study|Protocol Violation|1|||
23472363|NCT02791763|65473971|FG000|Overall Study|Withdrawal by Subject|5|||
23472364|NCT02791763|65473972|FG001|Overall Study|Withdrawal by Subject|1|||
23472365|NCT02791763|65473973|FG002|Overall Study|Withdrawal by Subject|0|||
23472366|NCT02791763|65473971|FG000|Overall Study|Physician Decision|0|||
23472367|NCT02791763|65473972|FG001|Overall Study|Physician Decision|1|||
23472368|NCT02791763|65473973|FG002|Overall Study|Physician Decision|0|||
23472369|NCT02791763|65473971|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
23472370|NCT02791763|65473972|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
23472371|NCT02791763|65473973|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
23472372|NCT02791763|65473971|FG000|Overall Study|Cancer event|1|||
23472373|NCT02791763|65473972|FG001|Overall Study|Cancer event|3|||
23472374|NCT02791763|65473973|FG002|Overall Study|Cancer event|0|||
23472375|NCT02791763|65473971|FG000|Overall Study|Participant had renal transplant|3|||
23588250|NCT01212757|65882159|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23472376|NCT02791763|65473972|FG001|Overall Study|Participant had renal transplant|0|||
23472377|NCT02791763|65473973|FG002|Overall Study|Participant had renal transplant|0|||
23472378|NCT02791763|65473971|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
23472379|NCT02791763|65473972|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
23472380|NCT02791763|65473973|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
23472381|NCT02791763|65473971|FG000|Overall Study|Adverse Event|12|||
23472382|NCT02791763|65473972|FG001|Overall Study|Adverse Event|13|||
23472383|NCT02791763|65473973|FG002|Overall Study|Adverse Event|7|||
23472384|NCT01148979|65473974|FG000|Overall Study|Lost to Follow-up|0|||
23472385|NCT01148979|65473975|FG001|Overall Study|Lost to Follow-up|1|||
23472386|NCT01640314|65473976|FG000|Overall Study|Protocol Violation|0|||
23472387|NCT01640314|65473977|FG001|Overall Study|Protocol Violation|1|||
23472388|NCT01689532|65473978|FG000|Overall Study|Adverse Event|9|||
23472389|NCT01689532|65473979|FG001|Overall Study|Adverse Event|5|||
23472390|NCT01689532|65473978|FG000|Overall Study|Lack of Efficacy|2|||
23472391|NCT01689532|65473979|FG001|Overall Study|Lack of Efficacy|2|||
23472392|NCT01689532|65473978|FG000|Overall Study|Withdrawal by Subject|1|||
23472393|NCT01689532|65473979|FG001|Overall Study|Withdrawal by Subject|2|||
23472394|NCT01689532|65473978|FG000|Overall Study|Physician Decision|2|||
23472395|NCT01689532|65473979|FG001|Overall Study|Physician Decision|0|||
23472396|NCT00782834|65473987|FG000|Treatment Phase|fibrous tumor not GIST|1|||
23472397|NCT02744040|65473992|FG000|Overall Study|Withdrawal by Subject|3|||
23472398|NCT02744040|65473993|FG001|Overall Study|Withdrawal by Subject|2|||
23472399|NCT02744040|65473994|FG002|Overall Study|Withdrawal by Subject|2|||
23472400|NCT02744040|65473992|FG000|Overall Study|Physician Decision|0|||
23472401|NCT02744040|65473993|FG001|Overall Study|Physician Decision|8|||
23472402|NCT02744040|65473994|FG002|Overall Study|Physician Decision|13|||
23472403|NCT02744040|65473992|FG000|Overall Study|Lost to Follow-up|3|||
23472404|NCT02744040|65473993|FG001|Overall Study|Lost to Follow-up|1|||
23472405|NCT02744040|65473994|FG002|Overall Study|Lost to Follow-up|7|||
23472406|NCT01510769|65473995|FG000|Overall Study|Adverse Event|7|||
23472407|NCT01510769|65473996|FG001|Overall Study|Adverse Event|6|||
23472408|NCT01510769|65473997|FG002|Overall Study|Adverse Event|4|||
23472409|NCT01510769|65473995|FG000|Overall Study|Gout Flare|0|||
23472410|NCT01510769|65473996|FG001|Overall Study|Gout Flare|3|||
23472411|NCT01510769|65473997|FG002|Overall Study|Gout Flare|1|||
23472412|NCT01510769|65473995|FG000|Overall Study|Protocol Violation|11|||
23472413|NCT01510769|65473996|FG001|Overall Study|Protocol Violation|10|||
23472414|NCT01510769|65473997|FG002|Overall Study|Protocol Violation|9|||
23472415|NCT01510769|65473995|FG000|Overall Study|Lost to Follow-up|5|||
23472416|NCT01510769|65473996|FG001|Overall Study|Lost to Follow-up|1|||
23472417|NCT01510769|65473997|FG002|Overall Study|Lost to Follow-up|5|||
23472418|NCT01510769|65473995|FG000|Overall Study|Withdrawal by Subject|3|||
23472419|NCT01510769|65473996|FG001|Overall Study|Withdrawal by Subject|4|||
23472420|NCT01510769|65473997|FG002|Overall Study|Withdrawal by Subject|3|||
23472421|NCT01510769|65473995|FG000|Overall Study|Death|1|||
23472422|NCT01510769|65473996|FG001|Overall Study|Death|1|||
23472423|NCT01510769|65473997|FG002|Overall Study|Death|0|||
23472424|NCT01338298|65473998|FG000|Overall Study|Withdrawal by Subject|1|||
23472425|NCT01338298|65473999|FG001|Overall Study|Withdrawal by Subject|1|||
23472426|NCT01338298|65473998|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
23472427|NCT01338298|65473999|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
23472428|NCT01338298|65473998|FG000|Overall Study|Administrative error|0|||
23472429|NCT01338298|65473999|FG001|Overall Study|Administrative error|1|||
23472430|NCT01338298|65473998|FG000|Overall Study|Positive symptom worsening|1|||
23472431|NCT01338298|65473999|FG001|Overall Study|Positive symptom worsening|0|||
23472432|NCT01338298|65473998|FG000|Overall Study|Depressive symptoms and nausea|1|||
23472433|NCT01338298|65473999|FG001|Overall Study|Depressive symptoms and nausea|0|||
23472434|NCT01338298|65473998|FG000|Overall Study|Non-adherence|1|||
23472435|NCT01338298|65473999|FG001|Overall Study|Non-adherence|0|||
23249279|NCT01396161|64655640|FG002|Overall Study|Other|0|||
23249280|NCT01396161|64655641|FG003|Overall Study|Other|0|||
23249281|NCT01396161|64655642|FG004|Overall Study|Other|0|||
23249282|NCT01396161|64655643|FG005|Overall Study|Other|0|||
23249283|NCT01396161|64655644|FG006|Overall Study|Other|1|||
23249284|NCT00874757|64655646|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
23249285|NCT01508325|64655650|FG000|Overall Study|Withdrawal by Subject|8|||
23249286|NCT01508325|64655651|FG001|Overall Study|Withdrawal by Subject|9|||
23249287|NCT01508325|64655650|FG000|Overall Study|Protocol Violation|0|||
23249288|NCT01508325|64655651|FG001|Overall Study|Protocol Violation|3|||
23472436|NCT01587014|65474000|FG000|Overall Study|Death|2|||
23472437|NCT00475982|65474001|FG000|Overall Study|surgery rescheduled|7|||
23249289|NCT01508325|64655650|FG000|Overall Study|Physician Decision|2|||
23472438|NCT00475982|65474002|FG001|Overall Study|surgery rescheduled|3|||
23472439|NCT02123472|65474004|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
23472440|NCT02123472|65474005|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
23472441|NCT01864005|65474008|FG000|Overall Study|Protocol Violation|0|||
23472442|NCT01864005|65474009|FG001|Overall Study|Protocol Violation|1|||
23472443|NCT01864005|65474008|FG000|Overall Study|Withdrawal by Subject|0|||
23472444|NCT01864005|65474009|FG001|Overall Study|Withdrawal by Subject|1|||
23249290|NCT01508325|64655651|FG001|Overall Study|Physician Decision|1|||
23249291|NCT01508325|64655650|FG000|Overall Study|Adverse Event|1|||
23472445|NCT01864005|65474008|FG000|Overall Study|Incorrect enrolment|1|||
23472446|NCT01864005|65474009|FG001|Overall Study|Incorrect enrolment|0|||
23472447|NCT01864005|65474008|FG000|Overall Study|Disease need|1|||
23472448|NCT01864005|65474009|FG001|Overall Study|Disease need|1|||
23472449|NCT01864005|65474008|FG000|Overall Study|Need GP IIb/IIIa|1|||
23472450|NCT01864005|65474009|FG001|Overall Study|Need GP IIb/IIIa|3|||
23472451|NCT01837823|65474012|FG000|Overall Study|Lost to Follow-up|6|||
23472452|NCT01324401|65474013|FG000|Overall Study|Withdrawn before any treatment|0|||
23249292|NCT01508325|64655651|FG001|Overall Study|Adverse Event|0|||
23249293|NCT01508325|64655650|FG000|Overall Study|Lost to Follow-up|5|||
23249294|NCT01508325|64655651|FG001|Overall Study|Lost to Follow-up|6|||
23249295|NCT01508325|64655650|FG000|Overall Study|Other|2|||
23249296|NCT01508325|64655651|FG001|Overall Study|Other|2|||
23249297|NCT00378482|64655656|FG000|Overall Study|Lost to Follow-up|1|||
23249298|NCT00378482|64655656|FG000|Overall Study|Lack of Efficacy|8|||
23249299|NCT00378482|64655656|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
23249300|NCT00378482|64655656|FG000|Overall Study|Withdrawal by Subject|4|||
23472453|NCT01324401|65474014|FG001|Overall Study|Withdrawn before any treatment|3|||
23472454|NCT01324401|65474013|FG000|Overall Study|Adverse Event|1|||
23472455|NCT01324401|65474014|FG001|Overall Study|Adverse Event|3|||
23472456|NCT02032238|65474015|FG000|Overall Study|Lost to Follow-up|2|||
23472457|NCT02032238|65474016|FG001|Overall Study|Lost to Follow-up|0|||
23472458|NCT00970684|65474020|FG000|Overall Study|Lack of Efficacy|5|||
23472459|NCT00970684|65474020|FG000|Overall Study|Adverse Event|4|||
23472460|NCT00970684|65474020|FG000|Overall Study|Withdrawal by Subject|1|||
23472461|NCT02695420|65474021|FG000|Overall Study|Death|0|||
23472462|NCT02695420|65474022|FG001|Overall Study|Death|1|||
23472463|NCT02695420|65474023|FG002|Overall Study|Death|0|||
23588251|NCT01212757|65882160|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588252|NCT01212757|65882161|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588253|NCT01212757|65882162|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588254|NCT01212757|65882163|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588255|NCT01212757|65882164|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
23588256|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588257|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
23588258|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
23588259|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
23588260|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588261|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
23588262|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588263|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588264|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
23588265|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23588266|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
23588267|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
23588268|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
23588269|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23588270|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
23588271|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23189685|NCT02873221|64436154|FG002|Treatment Period|Pregnancy|3|||
23189686|NCT02873221|64436152|FG000|Treatment Period|Lack of Qualifying Event|0|||
23189687|NCT02873221|64436153|FG001|Treatment Period|Lack of Qualifying Event|3|||
23189688|NCT02873221|64436154|FG002|Treatment Period|Lack of Qualifying Event|1|||
23189689|NCT02873221|64436152|FG000|Treatment Period|Withdrawal of Consent|52|||
23189690|NCT02873221|64436153|FG001|Treatment Period|Withdrawal of Consent|51|||
23189691|NCT02873221|64436154|FG002|Treatment Period|Withdrawal of Consent|41|||
23189692|NCT02873221|64436152|FG000|Treatment Period|Lack of Efficacy|0|||
23189693|NCT02873221|64436153|FG001|Treatment Period|Lack of Efficacy|17|||
23189694|NCT02873221|64436154|FG002|Treatment Period|Lack of Efficacy|12|||
23189695|NCT02873221|64436152|FG000|Treatment Period|Adverse Event|4|||
23189696|NCT02873221|64436153|FG001|Treatment Period|Adverse Event|9|||
23189697|NCT02873221|64436154|FG002|Treatment Period|Adverse Event|11|||
23189698|NCT02873221|64436152|FG000|Treatment Period|Lost to Follow-up|26|||
23189699|NCT02873221|64436153|FG001|Treatment Period|Lost to Follow-up|30|||
23189700|NCT02873221|64436154|FG002|Treatment Period|Lost to Follow-up|26|||
23189701|NCT02873221|64436152|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
23189702|NCT02873221|64436153|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
23189703|NCT02873221|64436154|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
23189704|NCT02873221|64436152|FG000|Safety Follow-up Period|Protocol Violation|0|||
23189705|NCT02873221|64436153|FG001|Safety Follow-up Period|Protocol Violation|0|||
23189706|NCT02873221|64436154|FG002|Safety Follow-up Period|Protocol Violation|1|||
23249301|NCT00378482|64655656|FG000|Overall Study|Adverse Event|9|||
23249302|NCT01890109|64655659|FG000|Overall Study|Withdrawal by Subject|0|||
23249303|NCT01890109|64655660|FG001|Overall Study|Withdrawal by Subject|3|||
23472464|NCT02695420|65474024|FG003|Overall Study|Death|0|||
23189707|NCT02873221|64436152|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
23472465|NCT02605122|65474025|FG000|Overall Study|Withdrawal by Subject|4|||
23472466|NCT02605122|65474026|FG001|Overall Study|Withdrawal by Subject|1|||
23472467|NCT02605122|65474025|FG000|Overall Study|Lost to Follow-up|1|||
23472468|NCT02605122|65474026|FG001|Overall Study|Lost to Follow-up|1|||
23472469|NCT00145158|65474035|FG000|Overall Study|premature withdrawal|2|||
23472470|NCT00145158|65474036|FG001|Overall Study|premature withdrawal|3|||
23472471|NCT02314637|65474037|FG000|Overall Study|Adverse Event|4|||
23472472|NCT02314637|65474038|FG001|Overall Study|Adverse Event|8|||
23472473|NCT02314637|65474037|FG000|Overall Study|Lack of Efficacy|1|||
23472474|NCT02314637|65474038|FG001|Overall Study|Lack of Efficacy|0|||
23472475|NCT02314637|65474037|FG000|Overall Study|Physician Decision|5|||
23472476|NCT02314637|65474038|FG001|Overall Study|Physician Decision|2|||
23472477|NCT02314637|65474037|FG000|Overall Study|Withdrawal by Subject|5|||
23472478|NCT02314637|65474038|FG001|Overall Study|Withdrawal by Subject|4|||
23472479|NCT02314637|65474037|FG000|Overall Study|Other Reason|1|||
23472480|NCT02314637|65474038|FG001|Overall Study|Other Reason|0|||
23472481|NCT01821560|65474039|FG000|Overall Study|Lost to Follow-up|5|||
23189708|NCT02873221|64436153|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
23189709|NCT02873221|64436154|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
23189710|NCT02873221|64436152|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
23189711|NCT02873221|64436153|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
23189712|NCT02873221|64436154|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
23189713|NCT01208181|64436155|FG000|Part 1|Withdrawal by Subject|11|||
23189714|NCT01208181|64436156|FG001|Part 1|Withdrawal by Subject|10|||
23189715|NCT01208181|64436157|FG002|Part 1|Withdrawal by Subject|0|||
23189716|NCT01208181|64436158|FG003|Part 1|Withdrawal by Subject|0|||
23189717|NCT01208181|64436159|FG004|Part 1|Withdrawal by Subject|0|||
23189718|NCT01208181|64436155|FG000|Part 1|Technical problem|5|||
23472482|NCT01821560|65474040|FG001|Overall Study|Lost to Follow-up|5|||
23472483|NCT01821560|65474039|FG000|Overall Study|Withdrawal by Subject|1|||
23189719|NCT01208181|64436156|FG001|Part 1|Technical problem|0|||
23189720|NCT01208181|64436157|FG002|Part 1|Technical problem|0|||
23472484|NCT01821560|65474040|FG001|Overall Study|Withdrawal by Subject|1|||
23189721|NCT01208181|64436158|FG003|Part 1|Technical problem|0|||
23189722|NCT01208181|64436159|FG004|Part 1|Technical problem|0|||
23189723|NCT01208181|64436155|FG000|Part 1|Protocol Violation|10|||
23189724|NCT01208181|64436156|FG001|Part 1|Protocol Violation|5|||
23189725|NCT01208181|64436157|FG002|Part 1|Protocol Violation|0|||
23472485|NCT01821560|65474039|FG000|Overall Study|Protocol Violation|0|||
23472486|NCT01821560|65474040|FG001|Overall Study|Protocol Violation|1|||
23189726|NCT01208181|64436158|FG003|Part 1|Protocol Violation|0|||
23189727|NCT01208181|64436159|FG004|Part 1|Protocol Violation|0|||
23189728|NCT01208181|64436155|FG000|Part 1|Physician Decision|4|||
23189729|NCT01208181|64436156|FG001|Part 1|Physician Decision|0|||
23189730|NCT01208181|64436157|FG002|Part 1|Physician Decision|0|||
23189731|NCT01208181|64436158|FG003|Part 1|Physician Decision|0|||
23189732|NCT01208181|64436159|FG004|Part 1|Physician Decision|0|||
23189733|NCT01208181|64436155|FG000|Part 1|Non-compliance with study drug|1|||
23189734|NCT01208181|64436156|FG001|Part 1|Non-compliance with study drug|1|||
23189735|NCT01208181|64436157|FG002|Part 1|Non-compliance with study drug|0|||
23472487|NCT01012219|65474041|FG000|Period 1|Withdrawal by Subject|1|||
23472488|NCT01012219|65474041|FG000|Period 2|Withdrawal by Subject|1|||
23472489|NCT01305577|65474049|FG000|Overall Study|Adverse Event|2|||
23472490|NCT01305577|65474050|FG001|Overall Study|Adverse Event|2|||
23472491|NCT01305577|65474051|FG002|Overall Study|Adverse Event|1|||
23472492|NCT01305577|65474049|FG000|Overall Study|Withdrawal by Subject|7|||
23472493|NCT01305577|65474050|FG001|Overall Study|Withdrawal by Subject|5|||
23472494|NCT01305577|65474051|FG002|Overall Study|Withdrawal by Subject|6|||
23472495|NCT01305577|65474049|FG000|Overall Study|Lost to Follow-up|4|||
23472496|NCT01305577|65474050|FG001|Overall Study|Lost to Follow-up|3|||
23472497|NCT01305577|65474051|FG002|Overall Study|Lost to Follow-up|2|||
23472498|NCT01305577|65474049|FG000|Overall Study|Protocol Deviation|0|||
23472499|NCT01305577|65474050|FG001|Overall Study|Protocol Deviation|1|||
23472500|NCT01305577|65474051|FG002|Overall Study|Protocol Deviation|1|||
23472501|NCT00776919|65474052|FG000|Overall Study|Withdrawal by Subject|16|||
23472502|NCT00776919|65474053|FG001|Overall Study|Withdrawal by Subject|14|||
23472503|NCT00776919|65474054|FG002|Overall Study|Withdrawal by Subject|15|||
23472504|NCT00776919|65474055|FG003|Overall Study|Withdrawal by Subject|26|||
23472505|NCT00776919|65474052|FG000|Overall Study|Lost to Follow-up|8|||
23472506|NCT00776919|65474053|FG001|Overall Study|Lost to Follow-up|12|||
23472507|NCT00776919|65474054|FG002|Overall Study|Lost to Follow-up|11|||
23472508|NCT00776919|65474055|FG003|Overall Study|Lost to Follow-up|8|||
23472509|NCT00776919|65474052|FG000|Overall Study|Adverse Event|1|||
23472510|NCT00776919|65474053|FG001|Overall Study|Adverse Event|0|||
23472511|NCT00776919|65474054|FG002|Overall Study|Adverse Event|2|||
23472512|NCT00776919|65474055|FG003|Overall Study|Adverse Event|2|||
23472513|NCT00776919|65474052|FG000|Overall Study|Protocol Violation|1|||
23472514|NCT00776919|65474053|FG001|Overall Study|Protocol Violation|2|||
23472515|NCT00776919|65474054|FG002|Overall Study|Protocol Violation|0|||
23472516|NCT00776919|65474055|FG003|Overall Study|Protocol Violation|1|||
23472517|NCT00776919|65474052|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
23472518|NCT00776919|65474053|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
23472519|NCT00776919|65474054|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
23472520|NCT00776919|65474055|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
23472521|NCT00271505|65474056|FG000|Overall Study|Screen Failure|3|||
23472522|NCT00271505|65474056|FG000|Overall Study|Adverse Event|1|||
23472523|NCT00271505|65474056|FG000|Overall Study|Death|1|||
23472524|NCT00534599|65474057|FG000|Overall Study|Adverse Event|25|||
23472525|NCT00534599|65474058|FG001|Overall Study|Adverse Event|4|||
23472526|NCT00534599|65474057|FG000|Overall Study|Incorrect enrollment|2|||
23472527|NCT00534599|65474058|FG001|Overall Study|Incorrect enrollment|1|||
23472528|NCT00534599|65474057|FG000|Overall Study|Mis-randomization|2|||
23472529|NCT00534599|65474058|FG001|Overall Study|Mis-randomization|2|||
23472530|NCT00534599|65474057|FG000|Overall Study|Developed study-specific d/c criteria|5|||
23472531|NCT00534599|65474058|FG001|Overall Study|Developed study-specific d/c criteria|0|||
23472532|NCT00534599|65474057|FG000|Overall Study|Lack of Efficacy|0|||
23472533|NCT00534599|65474058|FG001|Overall Study|Lack of Efficacy|1|||
23472534|NCT00534599|65474057|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
23472535|NCT00534599|65474058|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
23472536|NCT00534599|65474057|FG000|Overall Study|Protocol Violation|1|||
23472537|NCT00534599|65474058|FG001|Overall Study|Protocol Violation|3|||
23472538|NCT00534599|65474057|FG000|Overall Study|Lost to Follow-up|11|||
23472539|NCT00534599|65474058|FG001|Overall Study|Lost to Follow-up|14|||
23472540|NCT00534599|65474057|FG000|Overall Study|Withdrawal by Subject|4|||
23472541|NCT00534599|65474058|FG001|Overall Study|Withdrawal by Subject|6|||
23472542|NCT00534599|65474057|FG000|Overall Study|Other|7|||
23472543|NCT00534599|65474058|FG001|Overall Study|Other|0|||
23189736|NCT01208181|64436158|FG003|Part 1|Non-compliance with study drug|0|||
23472544|NCT04248491|65474064|FG000|Overall Study|Lost to Follow-up|1|||
23472545|NCT04248491|65474065|FG001|Overall Study|Lost to Follow-up|0|||
23472546|NCT00929643|65474068|FG000|Overall Study|Protocol Violation|2|||
23472547|NCT00336856|65474069|FG000|Overall Study|Withdrawal by Subject|3|||
23472548|NCT00336856|65474069|FG000|Overall Study|Found ineligible at time of analysis|1|||
23472549|NCT00545272|65474072|FG000|Overall Study|Protocol deviation|0|||
23189737|NCT01208181|64436159|FG004|Part 1|Non-compliance with study drug|0|||
23189738|NCT01208181|64436155|FG000|Part 1|Lost to Follow-up|5|||
23355548|NCT00073008|65045012|FG001|Overall Study|Lost to Follow-up|3|||
23355549|NCT00073008|65045011|FG000|Overall Study|Death|46|||
23355550|NCT00073008|65045012|FG001|Overall Study|Death|47|||
23355551|NCT00073008|65045011|FG000|Overall Study|"Other selected on Case Report Form"|7|||
23355552|NCT00073008|65045012|FG001|Overall Study|"Other selected on Case Report Form"|5|||
23355553|NCT03272347|65045015|FG000|Overall Study|Death|0|||
23355554|NCT03272347|65045016|FG001|Overall Study|Death|0|||
23355555|NCT03272347|65045017|FG002|Overall Study|Death|0|||
23355556|NCT03272347|65045018|FG003|Overall Study|Death|1|||
23355557|NCT03272347|65045015|FG000|Overall Study|Lost to Follow-up|1|||
23355558|NCT03272347|65045016|FG001|Overall Study|Lost to Follow-up|3|||
23355559|NCT03272347|65045017|FG002|Overall Study|Lost to Follow-up|5|||
23355560|NCT03272347|65045018|FG003|Overall Study|Lost to Follow-up|1|||
23355561|NCT03272347|65045015|FG000|Overall Study|Physician Decision|4|||
23355562|NCT03272347|65045016|FG001|Overall Study|Physician Decision|2|||
23355563|NCT03272347|65045017|FG002|Overall Study|Physician Decision|5|||
23355564|NCT03272347|65045018|FG003|Overall Study|Physician Decision|4|||
23355565|NCT03272347|65045015|FG000|Overall Study|Screen Failure|1|||
23355566|NCT03272347|65045016|FG001|Overall Study|Screen Failure|0|||
23355567|NCT03272347|65045017|FG002|Overall Study|Screen Failure|0|||
23355568|NCT03272347|65045018|FG003|Overall Study|Screen Failure|0|||
23355569|NCT03272347|65045015|FG000|Overall Study|Withdrawal by Subject|5|||
23355570|NCT03272347|65045016|FG001|Overall Study|Withdrawal by Subject|1|||
23189739|NCT01208181|64436156|FG001|Part 1|Lost to Follow-up|3|||
23189740|NCT01208181|64436157|FG002|Part 1|Lost to Follow-up|0|||
23189741|NCT01208181|64436158|FG003|Part 1|Lost to Follow-up|0|||
23189742|NCT01208181|64436159|FG004|Part 1|Lost to Follow-up|1|||
23189743|NCT01208181|64436155|FG000|Part 1|Lack of Efficacy|37|||
23189744|NCT01208181|64436156|FG001|Part 1|Lack of Efficacy|12|||
23189745|NCT01208181|64436157|FG002|Part 1|Lack of Efficacy|0|||
23189746|NCT01208181|64436158|FG003|Part 1|Lack of Efficacy|0|||
23189747|NCT01208181|64436159|FG004|Part 1|Lack of Efficacy|17|||
23189748|NCT01208181|64436155|FG000|Part 1|Adverse Event|26|||
23249304|NCT01890109|64655659|FG000|Overall Study|Lost to Follow-up|1|||
23249305|NCT01890109|64655660|FG001|Overall Study|Lost to Follow-up|2|||
23249306|NCT02367781|64655669|FG000|Overall Study|Withdrawal by Subject|20|||
23249307|NCT02367781|64655670|FG001|Overall Study|Withdrawal by Subject|13|||
23249308|NCT02367781|64655669|FG000|Overall Study|Protocol Violation|0|||
23249309|NCT02367781|64655670|FG001|Overall Study|Protocol Violation|1|||
23249310|NCT02367781|64655669|FG000|Overall Study|Physician Decision|7|||
23249311|NCT02367781|64655670|FG001|Overall Study|Physician Decision|0|||
23249312|NCT02367781|64655669|FG000|Overall Study|Randomized in Error|5|||
23249313|NCT02367781|64655670|FG001|Overall Study|Randomized in Error|4|||
23249314|NCT02367781|64655669|FG000|Overall Study|Non-Compliance|1|||
23249315|NCT02367781|64655670|FG001|Overall Study|Non-Compliance|0|||
23249316|NCT02367781|64655669|FG000|Overall Study|Lost to Follow-up|1|||
23249317|NCT02367781|64655670|FG001|Overall Study|Lost to Follow-up|2|||
23249318|NCT02367781|64655669|FG000|Overall Study|Death|330|||
23249319|NCT02367781|64655670|FG001|Overall Study|Death|176|||
23249320|NCT02367781|64655669|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
23249321|NCT02367781|64655670|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
23249322|NCT02367781|64655669|FG000|Overall Study|Prolonged Hospitalization|1|||
23249323|NCT02367781|64655670|FG001|Overall Study|Prolonged Hospitalization|0|||
23249324|NCT02367781|64655669|FG000|Overall Study|Death Prior First Dose|1|||
23249325|NCT02367781|64655670|FG001|Overall Study|Death Prior First Dose|0|||
23249326|NCT02367781|64655669|FG000|Overall Study|Administrative-Change Facility|1|||
23249327|NCT02367781|64655670|FG001|Overall Study|Administrative-Change Facility|0|||
23249328|NCT02367781|64655669|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
23249329|NCT02367781|64655670|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
23249330|NCT02367781|64655669|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
23249331|NCT02367781|64655670|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
23249332|NCT02367781|64655669|FG000|Overall Study|Study Terminated by Sponsor|3|||
23249333|NCT02367781|64655670|FG001|Overall Study|Study Terminated by Sponsor|1|||
23249334|NCT02367781|64655669|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
23355571|NCT03272347|65045017|FG002|Overall Study|Withdrawal by Subject|2|||
23355572|NCT03272347|65045018|FG003|Overall Study|Withdrawal by Subject|1|||
23355573|NCT01216332|65045023|FG000|Overall Study|Withdrawal by Subject|4|||
23189749|NCT01208181|64436156|FG001|Part 1|Adverse Event|24|||
23189750|NCT01208181|64436157|FG002|Part 1|Adverse Event|0|||
23189751|NCT01208181|64436158|FG003|Part 1|Adverse Event|0|||
23189752|NCT01208181|64436159|FG004|Part 1|Adverse Event|4|||
23249335|NCT02367781|64655670|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
23249336|NCT02367781|64655669|FG000|Overall Study|Sponsor Decision|2|||
23355574|NCT01216332|65045024|FG001|Overall Study|Withdrawal by Subject|0|||
23355575|NCT04769739|65045025|FG000|Overall Study|Colorectal cancer obstruction|2|||
23355576|NCT04769739|65045026|FG001|Overall Study|Colorectal cancer obstruction|0|||
23355577|NCT04769739|65045027|FG002|Overall Study|Colorectal cancer obstruction|0|||
23355578|NCT04769739|65045028|FG003|Overall Study|Colorectal cancer obstruction|0|||
23472550|NCT00545272|65474073|FG001|Overall Study|Protocol deviation|1|||
23472551|NCT00545272|65474074|FG002|Overall Study|Protocol deviation|0|||
23472552|NCT00545272|65474075|FG003|Overall Study|Protocol deviation|1|||
23472553|NCT00545272|65474076|FG004|Overall Study|Protocol deviation|0|||
23472554|NCT00545272|65474077|FG005|Overall Study|Protocol deviation|1|||
23472555|NCT00545272|65474072|FG000|Overall Study|Adverse Event|0|||
23472556|NCT00545272|65474073|FG001|Overall Study|Adverse Event|0|||
23189753|NCT01208181|64436155|FG000|Part 2|Adverse Event|0|||
23189754|NCT01208181|64436156|FG001|Part 2|Adverse Event|0|||
23189755|NCT01208181|64436157|FG002|Part 2|Adverse Event|6|||
23189756|NCT01208181|64436158|FG003|Part 2|Adverse Event|7|||
23189757|NCT01208181|64436159|FG004|Part 2|Adverse Event|0|||
23189758|NCT01208181|64436155|FG000|Part 2|Withdrawal by Subject|0|||
23189759|NCT01208181|64436156|FG001|Part 2|Withdrawal by Subject|0|||
23189760|NCT01208181|64436157|FG002|Part 2|Withdrawal by Subject|1|||
23472557|NCT00545272|65474074|FG002|Overall Study|Adverse Event|1|||
23472558|NCT00545272|65474075|FG003|Overall Study|Adverse Event|0|||
23472559|NCT00545272|65474076|FG004|Overall Study|Adverse Event|0|||
23472560|NCT00545272|65474077|FG005|Overall Study|Adverse Event|1|||
23472561|NCT00545272|65474072|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23472562|NCT00545272|65474073|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23472563|NCT00545272|65474074|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23472564|NCT00545272|65474075|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23588272|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23588273|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
23189761|NCT01208181|64436158|FG003|Part 2|Withdrawal by Subject|1|||
23249337|NCT02367781|64655670|FG001|Overall Study|Sponsor Decision|0|||
23249338|NCT02367781|64655669|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
23249339|NCT02367781|64655670|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
23249340|NCT03338673|64655671|FG000|Overall Study|Lost to Follow-up|1|||
23249341|NCT03338673|64655672|FG001|Overall Study|Lost to Follow-up|1|||
23249342|NCT03255226|64655673|FG000|Overall Study|Adverse Event|2|||
23249343|NCT03255226|64655673|FG000|Overall Study|Physician Decision|3|||
23249344|NCT03255226|64655673|FG000|Overall Study|Withdrawal by Subject|1|||
23249345|NCT03255226|64655673|FG000|Overall Study|Serum or blood sodium increased|4|||
23249346|NCT03255226|64655673|FG000|Overall Study|Serum or blood potassium increased|4|||
23249347|NCT00833976|64655675|FG000|Overall Study|Withdrawal by Subject|5|||
23249348|NCT00833976|64655675|FG000|Overall Study|Lost to Follow-up|4|||
23249349|NCT00833976|64655675|FG000|Overall Study|Did not meet eligibility criteria|41|||
23189762|NCT01208181|64436159|FG004|Part 2|Withdrawal by Subject|0|||
23189763|NCT01208181|64436155|FG000|Part 2|Protocol Violation|0|||
23189764|NCT01208181|64436156|FG001|Part 2|Protocol Violation|0|||
23189765|NCT01208181|64436157|FG002|Part 2|Protocol Violation|1|||
23189766|NCT01208181|64436158|FG003|Part 2|Protocol Violation|0|||
23189767|NCT01208181|64436159|FG004|Part 2|Protocol Violation|0|||
23189768|NCT01208181|64436155|FG000|Part 2|Physician Decision|0|||
23189769|NCT01208181|64436156|FG001|Part 2|Physician Decision|0|||
23249350|NCT00833976|64655675|FG000|Overall Study|Physician Decision|1|||
23249351|NCT05674721|64655676|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
23249352|NCT05674721|64655677|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
23249353|NCT05674721|64655676|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
23249354|NCT05674721|64655677|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
23249355|NCT00953927|64655679|FG000|Overall Study|Lost to Follow-up|61|||
23249356|NCT00953927|64655680|FG001|Overall Study|Lost to Follow-up|65|||
23249357|NCT00953927|64655679|FG000|Overall Study|Withdrawal by Subject|36|||
23249358|NCT00953927|64655680|FG001|Overall Study|Withdrawal by Subject|25|||
23249359|NCT00953927|64655679|FG000|Overall Study|Death|7|||
23588274|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588275|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588276|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
23249360|NCT00953927|64655680|FG001|Overall Study|Death|4|||
23249361|NCT00953927|64655679|FG000|Overall Study|Other study discontinuation|1|||
23249362|NCT00953927|64655680|FG001|Overall Study|Other study discontinuation|1|||
23355579|NCT04769739|65045025|FG000|Overall Study|Failed cecal intubation|1|||
23472565|NCT00545272|65474076|FG004|Overall Study|Abnormal laboratory value(s)|0|||
23189770|NCT01208181|64436157|FG002|Part 2|Physician Decision|1|||
23189771|NCT01208181|64436158|FG003|Part 2|Physician Decision|2|||
23189772|NCT01208181|64436159|FG004|Part 2|Physician Decision|0|||
23472566|NCT00545272|65474077|FG005|Overall Study|Abnormal laboratory value(s)|1|||
23472567|NCT00545272|65474072|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23472568|NCT00545272|65474073|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23189773|NCT01208181|64436155|FG000|Part 2|Non-compliance with study drug|0|||
23189774|NCT01208181|64436156|FG001|Part 2|Non-compliance with study drug|0|||
23189775|NCT01208181|64436157|FG002|Part 2|Non-compliance with study drug|1|||
23588277|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588278|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588279|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588280|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588281|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23588282|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
23189776|NCT01208181|64436158|FG003|Part 2|Non-compliance with study drug|1|||
23189777|NCT01208181|64436159|FG004|Part 2|Non-compliance with study drug|0|||
23189778|NCT01208181|64436155|FG000|Part 2|Lost to Follow-up|0|||
23189779|NCT01208181|64436156|FG001|Part 2|Lost to Follow-up|0|||
23189780|NCT01208181|64436157|FG002|Part 2|Lost to Follow-up|1|||
23189781|NCT01208181|64436158|FG003|Part 2|Lost to Follow-up|2|||
23189782|NCT01208181|64436159|FG004|Part 2|Lost to Follow-up|0|||
23189783|NCT01208181|64436155|FG000|Part 2|Lack of Efficacy|0|||
23189784|NCT01208181|64436156|FG001|Part 2|Lack of Efficacy|0|||
23355580|NCT04769739|65045026|FG001|Overall Study|Failed cecal intubation|0|||
23588283|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23588284|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
23588285|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
23588286|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
23588287|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
23588288|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
23588289|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23588290|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23588291|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
23588292|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588293|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
23588294|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588295|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588296|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
23588297|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588298|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588299|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588300|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
23588301|NCT01212757|65882156|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588302|NCT01212757|65882157|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
23588303|NCT01212757|65882158|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
23588304|NCT01212757|65882159|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588305|NCT01212757|65882160|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588306|NCT01212757|65882161|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588307|NCT01212757|65882162|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588308|NCT01212757|65882163|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588309|NCT01212757|65882164|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
23588310|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588311|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588312|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588313|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588314|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588315|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588316|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588317|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
23588318|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
23588319|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588320|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
23588321|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
23588322|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588323|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588324|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588325|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
23588326|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
23588327|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
23588328|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588329|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
23588330|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
23588331|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588332|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588333|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23189785|NCT01208181|64436157|FG002|Part 2|Lack of Efficacy|5|||
23189786|NCT01208181|64436158|FG003|Part 2|Lack of Efficacy|7|||
23588334|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588335|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
23588336|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
23588337|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588338|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
23588339|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
23588340|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588341|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588342|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588343|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
23588344|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
23588345|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
23588346|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588347|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588348|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
23588349|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588350|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588351|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588352|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588353|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588354|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
23588355|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588356|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
23588357|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
23588358|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588359|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588360|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588361|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588362|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
23588363|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
23588364|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588365|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
23588366|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
23588367|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588368|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588369|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588370|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
23588371|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
23588372|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
23588373|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23588374|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23588375|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
23588376|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23588377|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23249363|NCT03443973|64655681|FG000|Double-blind Treatment Period|Adverse Event|5|||
23249364|NCT03443973|64655682|FG001|Double-blind Treatment Period|Adverse Event|19|||
23249365|NCT03443973|64655683|FG002|Double-blind Treatment Period|Adverse Event|0|||
23249366|NCT03443973|64655684|FG003|Double-blind Treatment Period|Adverse Event|0|||
23249367|NCT03443973|64655681|FG000|Double-blind Treatment Period|Death|5|||
23588378|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23588379|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23249368|NCT03443973|64655682|FG001|Double-blind Treatment Period|Death|7|||
23588380|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23249369|NCT03443973|64655683|FG002|Double-blind Treatment Period|Death|0|||
23249370|NCT03443973|64655684|FG003|Double-blind Treatment Period|Death|0|||
23355581|NCT04769739|65045027|FG002|Overall Study|Failed cecal intubation|0|||
23355582|NCT04769739|65045028|FG003|Overall Study|Failed cecal intubation|1|||
23355583|NCT04769739|65045025|FG000|Overall Study|Poor bowel preparation|0|||
23355584|NCT04769739|65045026|FG001|Overall Study|Poor bowel preparation|0|||
23355585|NCT04769739|65045027|FG002|Overall Study|Poor bowel preparation|0|||
23355586|NCT04769739|65045028|FG003|Overall Study|Poor bowel preparation|1|||
23355587|NCT02334384|65045029|FG000|Overall Study|Lost to Follow-up|1|||
23355588|NCT02334384|65045030|FG001|Overall Study|Lost to Follow-up|1|||
23355589|NCT04003623|65045036|FG000|Overall Study|Withdrawal by Subject|1|||
23355590|NCT04003623|65045037|FG001|Overall Study|Withdrawal by Subject|0|||
23355591|NCT02075008|65045038|FG000|Overall Study|Technical problems|1|||
23355592|NCT02075008|65045038|FG000|Overall Study|Pregnancy|1|||
23355593|NCT02075008|65045038|FG000|Overall Study|Physician Decision|1|||
23355594|NCT02075008|65045038|FG000|Overall Study|Lost to Follow-up|1|||
23355595|NCT02075008|65045038|FG000|Overall Study|Lack of Efficacy|1|||
23355596|NCT02075008|65045038|FG000|Overall Study|Death|1|||
23355597|NCT02075008|65045038|FG000|Overall Study|Adverse Event|5|||
23355598|NCT02075008|65045038|FG000|Overall Study|Withdrawal by Subject|6|||
23355599|NCT02075008|65045038|FG000|Overall Study|Study terminated by Sponsor|159|||
23355600|NCT03824366|65045041|FG000|Overall Study|Death|1|||
23355601|NCT03824366|65045041|FG000|Overall Study|Previously unidentified metal artifact|1|||
23355602|NCT03824366|65045041|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
23355603|NCT03824366|65045041|FG000|Overall Study|Withdrawal by Subject|1|||
23355604|NCT02732327|65045042|FG000|Overall Study|Protocol Violation|0|||
23355605|NCT02732327|65045043|FG001|Overall Study|Protocol Violation|1|||
23249371|NCT03443973|64655681|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
23249372|NCT03443973|64655682|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
23249373|NCT03443973|64655683|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
23249374|NCT03443973|64655684|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
23249375|NCT03443973|64655681|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23249376|NCT03443973|64655682|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
23355606|NCT00204477|65045046|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
23355607|NCT00204477|65045047|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
23355608|NCT00204477|65045046|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
23355609|NCT00204477|65045047|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
23355610|NCT01256385|65045050|FG000|Overall Study|Physician Decision|1|||
23355611|NCT01256385|65045051|FG001|Overall Study|Physician Decision|1|||
23355612|NCT01256385|65045050|FG000|Overall Study|Withdrawal by Subject|2|||
23355613|NCT01256385|65045051|FG001|Overall Study|Withdrawal by Subject|2|||
23355614|NCT00913770|65045053|FG000|Overall Study|Unable to contact|24|||
23355615|NCT00913770|65045054|FG001|Overall Study|Unable to contact|19|||
23355616|NCT00913770|65045055|FG002|Overall Study|Unable to contact|13|||
23355617|NCT00913770|65045053|FG000|Overall Study|Refused|11|||
23355618|NCT00913770|65045054|FG001|Overall Study|Refused|10|||
23355619|NCT00913770|65045055|FG002|Overall Study|Refused|8|||
23355620|NCT00734656|65045056|FG000|Lab Session 1|Withdrawal by Subject|2|||
23355621|NCT00734656|65045057|FG001|Lab Session 1|Withdrawal by Subject|0|||
23355622|NCT00734656|65045058|FG002|Lab Session 1|Withdrawal by Subject|0|||
23355623|NCT00734656|65045059|FG003|Lab Session 1|Withdrawal by Subject|0|||
23355624|NCT00734656|65045056|FG000|Washout 1|Withdrawal by Subject|1|||
23355625|NCT00734656|65045057|FG001|Washout 1|Withdrawal by Subject|5|||
23355626|NCT00734656|65045058|FG002|Washout 1|Withdrawal by Subject|2|||
23355627|NCT00734656|65045059|FG003|Washout 1|Withdrawal by Subject|3|||
23355628|NCT00734656|65045056|FG000|Lab Session 2|Withdrawal by Subject|1|||
23355629|NCT00734656|65045057|FG001|Lab Session 2|Withdrawal by Subject|0|||
23355630|NCT00734656|65045058|FG002|Lab Session 2|Withdrawal by Subject|0|||
23355631|NCT00734656|65045059|FG003|Lab Session 2|Withdrawal by Subject|1|||
23355632|NCT00734656|65045056|FG000|Washout 2|Withdrawal by Subject|1|||
23355633|NCT00734656|65045057|FG001|Washout 2|Withdrawal by Subject|1|||
23355634|NCT00734656|65045058|FG002|Washout 2|Withdrawal by Subject|1|||
23355635|NCT00734656|65045059|FG003|Washout 2|Withdrawal by Subject|0|||
23588381|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
23355636|NCT00734656|65045056|FG000|Washout 3|Withdrawal by Subject|1|||
23588382|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23249377|NCT03443973|64655683|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23355637|NCT00734656|65045057|FG001|Washout 3|Withdrawal by Subject|0|||
23355638|NCT00734656|65045058|FG002|Washout 3|Withdrawal by Subject|0|||
23355639|NCT00734656|65045059|FG003|Washout 3|Withdrawal by Subject|1|||
23355640|NCT00734656|65045056|FG000|Lab Session 4|Withdrawal by Subject|0|||
23355641|NCT00734656|65045057|FG001|Lab Session 4|Withdrawal by Subject|0|||
23355642|NCT00734656|65045058|FG002|Lab Session 4|Withdrawal by Subject|0|||
23355643|NCT00734656|65045059|FG003|Lab Session 4|Withdrawal by Subject|1|||
23355644|NCT03173456|65045068|FG000|Baseline|Medication dispensing system malfunction'|0|||
23355645|NCT03173456|65045069|FG001|Baseline|Medication dispensing system malfunction'|1|||
23355646|NCT03173456|65045070|FG002|Baseline|Medication dispensing system malfunction'|0|||
23355647|NCT03173456|65045071|FG003|Baseline|Medication dispensing system malfunction'|0|||
23355648|NCT03173456|65045072|FG004|Baseline|Medication dispensing system malfunction'|2|||
23355649|NCT03173456|65045068|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
23355650|NCT03173456|65045069|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
23355651|NCT03173456|65045070|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
23355652|NCT03173456|65045071|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
23249378|NCT03443973|64655684|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23249379|NCT03443973|64655681|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
23249380|NCT03443973|64655682|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
23249381|NCT03443973|64655683|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
23249382|NCT03443973|64655684|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
23355653|NCT03173456|65045072|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
23355654|NCT02282163|65048620|FG000|Overall Study|Protocol Violation|1|||
23355655|NCT03597139|65048623|FG000|Overall Study|Adverse Event|3|||
23355656|NCT03597139|65048624|FG001|Overall Study|Adverse Event|0|||
23355657|NCT03597139|65048623|FG000|Overall Study|Protocol Non-compliance|1|||
23355658|NCT03597139|65048624|FG001|Overall Study|Protocol Non-compliance|0|||
23355659|NCT01031004|65048625|FG000|Overall Study|Protocol Violation|0|||
23355660|NCT01031004|65048626|FG001|Overall Study|Protocol Violation|1|||
23355661|NCT01031004|65048625|FG000|Overall Study|Lost to Follow-up|1|||
23355662|NCT01031004|65048626|FG001|Overall Study|Lost to Follow-up|0|||
23355663|NCT01210222|65048627|FG000|Overall Study|Ineligible|2|||
23355664|NCT01210222|65048627|FG000|Overall Study|Never treated|1|||
23355665|NCT03465709|65048628|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
23189787|NCT01208181|64436159|FG004|Part 2|Lack of Efficacy|0|||
23189788|NCT02723630|64436161|FG000|Intervention Period 1|Adverse Event|1|||
23189789|NCT02723630|64436162|FG001|Intervention Period 1|Adverse Event|0|||
23189790|NCT02723630|64436163|FG002|Intervention Period 1|Adverse Event|0|||
23189791|NCT02723630|64436164|FG003|Intervention Period 1|Adverse Event|0|||
23189792|NCT02723630|64436165|FG004|Intervention Period 1|Adverse Event|0|||
23189793|NCT02723630|64436166|FG005|Intervention Period 1|Adverse Event|0|||
23189794|NCT02723630|64436161|FG000|Intervention Period 3|consumption of restricted item|0|||
23189795|NCT02723630|64436162|FG001|Intervention Period 3|consumption of restricted item|1|||
23189796|NCT02723630|64436163|FG002|Intervention Period 3|consumption of restricted item|0|||
23189797|NCT02723630|64436164|FG003|Intervention Period 3|consumption of restricted item|0|||
23189798|NCT02723630|64436165|FG004|Intervention Period 3|consumption of restricted item|0|||
23189799|NCT02723630|64436166|FG005|Intervention Period 3|consumption of restricted item|0|||
23189800|NCT03658889|64436170|FG000|Overall Study|Protocol Violation|2|||
23189801|NCT03658889|64436171|FG001|Overall Study|Protocol Violation|0|||
23189802|NCT01444391|64436174|FG000|Overall Study|Death|1|||
23189803|NCT01318902|64436178|FG000|Overall Study|Symptomatic Deterioration|0|||
23189804|NCT01318902|64436179|FG001|Overall Study|Symptomatic Deterioration|1|||
23189805|NCT01318902|64436180|FG002|Overall Study|Symptomatic Deterioration|1|||
23189806|NCT01318902|64436181|FG003|Overall Study|Symptomatic Deterioration|2|||
23189807|NCT01318902|64436178|FG000|Overall Study|Withdrawal by Patient|0|||
23189808|NCT01318902|64436179|FG001|Overall Study|Withdrawal by Patient|1|||
23249383|NCT03443973|64655681|FG000|Double-blind Treatment Period|Physician Decision|5|||
23249384|NCT03443973|64655682|FG001|Double-blind Treatment Period|Physician Decision|6|||
23249385|NCT03443973|64655683|FG002|Double-blind Treatment Period|Physician Decision|0|||
23249386|NCT03443973|64655684|FG003|Double-blind Treatment Period|Physician Decision|0|||
23249387|NCT03443973|64655681|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
23249388|NCT03443973|64655682|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
23249389|NCT03443973|64655683|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
23249390|NCT03443973|64655684|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
23249391|NCT03443973|64655681|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
23249392|NCT03443973|64655682|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
23249393|NCT03443973|64655683|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23249394|NCT03443973|64655684|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
23249395|NCT03443973|64655681|FG000|Open-label Extension Period|Reason Not Specified|0|||
23249396|NCT03443973|64655682|FG001|Open-label Extension Period|Reason Not Specified|0|||
23249397|NCT03443973|64655683|FG002|Open-label Extension Period|Reason Not Specified|3|||
23249398|NCT03443973|64655684|FG003|Open-label Extension Period|Reason Not Specified|0|||
23249399|NCT03443973|64655681|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
23249400|NCT03443973|64655682|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
23355666|NCT03465709|65048628|FG000|Overall Study|Withdrawal by Subject|3|||
23355667|NCT02697591|65048631|FG000|Overall Study|Lost to Follow-up|0|||
23472569|NCT00545272|65474074|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23588383|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
23189809|NCT01318902|64436180|FG002|Overall Study|Withdrawal by Patient|0|||
23249401|NCT03443973|64655683|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
23249402|NCT03443973|64655684|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
23249403|NCT01494649|64655685|FG000|Overall Study|Lost to Follow-up|0|||
23249404|NCT01494649|64655686|FG001|Overall Study|Lost to Follow-up|1|||
23249405|NCT01682512|64655694|FG000|Overall Study|Adverse Event|6|||
23249406|NCT01682512|64655695|FG001|Overall Study|Adverse Event|5|||
23249407|NCT01682512|64655696|FG002|Overall Study|Adverse Event|2|||
23249408|NCT01682512|64655694|FG000|Overall Study|Withdrawal by Subject|2|||
23249409|NCT01682512|64655695|FG001|Overall Study|Withdrawal by Subject|6|||
23249410|NCT01682512|64655696|FG002|Overall Study|Withdrawal by Subject|3|||
23249411|NCT01682512|64655694|FG000|Overall Study|Physician Decision|0|||
23249412|NCT01682512|64655695|FG001|Overall Study|Physician Decision|2|||
23249413|NCT01682512|64655696|FG002|Overall Study|Physician Decision|0|||
23249414|NCT01682512|64655694|FG000|Overall Study|Study terminated by sponsor|46|||
23355668|NCT02697591|65048632|FG001|Overall Study|Lost to Follow-up|0|||
23355669|NCT02697591|65048633|FG002|Overall Study|Lost to Follow-up|0|||
23355670|NCT02697591|65048634|FG003|Overall Study|Lost to Follow-up|0|||
23355671|NCT02697591|65048635|FG004|Overall Study|Lost to Follow-up|0|||
23355672|NCT02697591|65048636|FG005|Overall Study|Lost to Follow-up|1|||
23355673|NCT02697591|65048637|FG006|Overall Study|Lost to Follow-up|1|||
23355674|NCT02697591|65048638|FG007|Overall Study|Lost to Follow-up|0|||
23355675|NCT02697591|65048639|FG008|Overall Study|Lost to Follow-up|0|||
23355676|NCT02697591|65048640|FG009|Overall Study|Lost to Follow-up|1|||
23355677|NCT02697591|65048631|FG000|Overall Study|Withdrawal by Subject|1|||
23355678|NCT02697591|65048632|FG001|Overall Study|Withdrawal by Subject|1|||
23355679|NCT02697591|65048633|FG002|Overall Study|Withdrawal by Subject|2|||
23355680|NCT02697591|65048634|FG003|Overall Study|Withdrawal by Subject|1|||
23355681|NCT02697591|65048635|FG004|Overall Study|Withdrawal by Subject|7|||
23355682|NCT02697591|65048636|FG005|Overall Study|Withdrawal by Subject|6|||
23355683|NCT02697591|65048637|FG006|Overall Study|Withdrawal by Subject|9|||
23355684|NCT02697591|65048638|FG007|Overall Study|Withdrawal by Subject|1|||
23355685|NCT02697591|65048639|FG008|Overall Study|Withdrawal by Subject|6|||
23355686|NCT02697591|65048640|FG009|Overall Study|Withdrawal by Subject|10|||
23355687|NCT02697591|65048631|FG000|Overall Study|Physician Decision|1|||
23355688|NCT02697591|65048632|FG001|Overall Study|Physician Decision|0|||
23355689|NCT02697591|65048633|FG002|Overall Study|Physician Decision|0|||
23355690|NCT02697591|65048634|FG003|Overall Study|Physician Decision|0|||
23355691|NCT02697591|65048635|FG004|Overall Study|Physician Decision|1|||
23355692|NCT02697591|65048636|FG005|Overall Study|Physician Decision|2|||
23355693|NCT02697591|65048637|FG006|Overall Study|Physician Decision|0|||
23355694|NCT02697591|65048638|FG007|Overall Study|Physician Decision|0|||
23355695|NCT02697591|65048639|FG008|Overall Study|Physician Decision|1|||
23355696|NCT02697591|65048640|FG009|Overall Study|Physician Decision|1|||
23355697|NCT02697591|65048631|FG000|Overall Study|Death|2|||
23355698|NCT02697591|65048632|FG001|Overall Study|Death|3|||
23355699|NCT02697591|65048633|FG002|Overall Study|Death|1|||
23355700|NCT02697591|65048634|FG003|Overall Study|Death|1|||
23355701|NCT02697591|65048635|FG004|Overall Study|Death|4|||
23249415|NCT01682512|64655695|FG001|Overall Study|Study terminated by sponsor|43|||
23249416|NCT01682512|64655696|FG002|Overall Study|Study terminated by sponsor|0|||
23249417|NCT01682512|64655694|FG000|Overall Study|Lost to Follow-up|3|||
23249418|NCT01682512|64655695|FG001|Overall Study|Lost to Follow-up|0|||
23249419|NCT01682512|64655696|FG002|Overall Study|Lost to Follow-up|2|||
23249420|NCT01682512|64655694|FG000|Overall Study|Protocol Violation|2|||
23249421|NCT01682512|64655695|FG001|Overall Study|Protocol Violation|3|||
23249422|NCT01682512|64655696|FG002|Overall Study|Protocol Violation|2|||
23249423|NCT01682512|64655694|FG000|Overall Study|Primary lack of efficacy|10|||
23249424|NCT01682512|64655695|FG001|Overall Study|Primary lack of efficacy|7|||
23249425|NCT01682512|64655696|FG002|Overall Study|Primary lack of efficacy|7|||
23249426|NCT01682512|64655694|FG000|Overall Study|Secondary lack of efficacy|1|||
23249427|NCT01682512|64655695|FG001|Overall Study|Secondary lack of efficacy|1|||
23355702|NCT02697591|65048636|FG005|Overall Study|Death|5|||
23355703|NCT02697591|65048637|FG006|Overall Study|Death|3|||
23249428|NCT01682512|64655696|FG002|Overall Study|Secondary lack of efficacy|0|||
23249429|NCT01682512|64655694|FG000|Overall Study|Other than stated above|2|||
23249430|NCT01682512|64655695|FG001|Overall Study|Other than stated above|4|||
23249431|NCT01682512|64655696|FG002|Overall Study|Other than stated above|2|||
23249432|NCT03343054|64655697|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
23249433|NCT03343054|64655698|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
23355704|NCT02697591|65048638|FG007|Overall Study|Death|1|||
23355705|NCT02697591|65048639|FG008|Overall Study|Death|1|||
23355706|NCT02697591|65048640|FG009|Overall Study|Death|5|||
23355707|NCT02697591|65048631|FG000|Overall Study|Reason not Specified|0|||
23355708|NCT02697591|65048632|FG001|Overall Study|Reason not Specified|0|||
23355709|NCT02697591|65048633|FG002|Overall Study|Reason not Specified|0|||
23249434|NCT03343054|64655699|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
23355710|NCT02697591|65048634|FG003|Overall Study|Reason not Specified|1|||
23355711|NCT02697591|65048635|FG004|Overall Study|Reason not Specified|1|||
23355712|NCT02697591|65048636|FG005|Overall Study|Reason not Specified|2|||
23355713|NCT02697591|65048637|FG006|Overall Study|Reason not Specified|3|||
23355714|NCT02697591|65048638|FG007|Overall Study|Reason not Specified|1|||
23355715|NCT02697591|65048639|FG008|Overall Study|Reason not Specified|1|||
23355716|NCT02697591|65048640|FG009|Overall Study|Reason not Specified|3|||
23355717|NCT04571385|65048647|FG000|Overall Study|Participant non-compliance|1|||
23355718|NCT04571385|65048648|FG001|Overall Study|Participant non-compliance|0|||
23355719|NCT04571385|65048649|FG002|Overall Study|Participant non-compliance|0|||
23355720|NCT04571385|65048647|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
23355721|NCT04571385|65048648|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
23588384|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23588385|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23588386|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23355722|NCT04571385|65048649|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
23355723|NCT04571385|65048647|FG000|Overall Study|Screen failure|0|||
23355724|NCT04571385|65048648|FG001|Overall Study|Screen failure|0|||
23355725|NCT04571385|65048649|FG002|Overall Study|Screen failure|1|||
23355726|NCT01048099|65048650|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
23355727|NCT01048099|65048650|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
23355728|NCT02985021|65048652|FG000|Overall Study|Inability to comply with study procedures|1|||
23355729|NCT00298363|65048653|FG000|Overall Study|Lost to Follow-up|0|||
23355730|NCT00298363|65048654|FG001|Overall Study|Lost to Follow-up|0|||
23355731|NCT00298363|65048655|FG002|Overall Study|Lost to Follow-up|1|||
23355732|NCT00298363|65048653|FG000|Overall Study|Physician Decision|4|||
23355733|NCT00298363|65048654|FG001|Overall Study|Physician Decision|1|||
23355734|NCT00298363|65048655|FG002|Overall Study|Physician Decision|0|||
23355735|NCT00298363|65048653|FG000|Overall Study|Protocol Violation|1|||
23355736|NCT00298363|65048654|FG001|Overall Study|Protocol Violation|1|||
23588387|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23588388|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
23588389|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23588390|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
23588391|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588392|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588393|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588394|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588395|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588396|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588397|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23355737|NCT00298363|65048655|FG002|Overall Study|Protocol Violation|0|||
23355738|NCT00298363|65048653|FG000|Overall Study|Withdrawal by Subject|5|||
23355739|NCT00298363|65048654|FG001|Overall Study|Withdrawal by Subject|1|||
23355740|NCT00298363|65048655|FG002|Overall Study|Withdrawal by Subject|3|||
23355741|NCT00298363|65048653|FG000|Overall Study|Adverse Event|5|||
23355742|NCT00298363|65048654|FG001|Overall Study|Adverse Event|2|||
23355743|NCT00298363|65048655|FG002|Overall Study|Adverse Event|2|||
23355744|NCT00298363|65048653|FG000|Overall Study|Lack of Efficacy|2|||
23355745|NCT00298363|65048654|FG001|Overall Study|Lack of Efficacy|3|||
23355746|NCT00298363|65048655|FG002|Overall Study|Lack of Efficacy|0|||
23355747|NCT03951753|65048656|FG000|Overall Study|Adverse Event|1|||
23355748|NCT03951753|65048657|FG001|Overall Study|Adverse Event|0|||
23355749|NCT03951753|65048658|FG002|Overall Study|Adverse Event|3|||
23355750|NCT03951753|65048656|FG000|Overall Study|Withdrawal by Subject|3|||
23355751|NCT03951753|65048657|FG001|Overall Study|Withdrawal by Subject|1|||
23355752|NCT03951753|65048658|FG002|Overall Study|Withdrawal by Subject|0|||
23355753|NCT03951753|65048656|FG000|Overall Study|Lost to Follow-up|0|||
23355754|NCT03951753|65048657|FG001|Overall Study|Lost to Follow-up|0|||
23355755|NCT03951753|65048658|FG002|Overall Study|Lost to Follow-up|1|||
23355756|NCT01190189|65048661|FG000|Overall Study|Lost to Follow-up|4|||
23355757|NCT01190189|65048661|FG000|Overall Study|Withdrawal by Subject|1|||
23355758|NCT01190189|65048661|FG000|Overall Study|Migrated/moved from study area|1|||
23355759|NCT03046056|65048662|FG000|Overall Study|Non-responder at Week 10|6|||
23355760|NCT03046056|65048663|FG001|Overall Study|Non-responder at Week 10|6|||
23355761|NCT03046056|65048664|FG002|Overall Study|Non-responder at Week 10|4|||
23355762|NCT03046056|65048662|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
23355763|NCT03046056|65048663|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
23355764|NCT03046056|65048664|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
23355765|NCT03046056|65048662|FG000|Overall Study|Adverse Event|1|||
23355766|NCT03046056|65048663|FG001|Overall Study|Adverse Event|5|||
23355767|NCT03046056|65048664|FG002|Overall Study|Adverse Event|0|||
23355768|NCT03046056|65048662|FG000|Overall Study|Non-compliance With Study Drug|0|||
23355769|NCT03046056|65048663|FG001|Overall Study|Non-compliance With Study Drug|0|||
23355770|NCT03046056|65048664|FG002|Overall Study|Non-compliance With Study Drug|2|||
23355771|NCT03046056|65048662|FG000|Overall Study|Protocol Violation|1|||
23355772|NCT03046056|65048663|FG001|Overall Study|Protocol Violation|1|||
23355773|NCT03046056|65048664|FG002|Overall Study|Protocol Violation|0|||
23355774|NCT03046056|65048662|FG000|Overall Study|Investigator's Discretion|0|||
23355775|NCT03046056|65048663|FG001|Overall Study|Investigator's Discretion|1|||
23355776|NCT03046056|65048664|FG002|Overall Study|Investigator's Discretion|0|||
23355777|NCT03046056|65048662|FG000|Overall Study|Withdrew Consent|1|||
23355778|NCT03046056|65048663|FG001|Overall Study|Withdrew Consent|0|||
23355779|NCT03046056|65048664|FG002|Overall Study|Withdrew Consent|0|||
23355780|NCT00741598|65048665|FG000|Overall Study|Lost to Follow-up|3|||
23355781|NCT00741598|65048666|FG001|Overall Study|Lost to Follow-up|4|||
23355782|NCT00741598|65048665|FG000|Overall Study|Lack of Efficacy|1|||
23355783|NCT00741598|65048666|FG001|Overall Study|Lack of Efficacy|2|||
23355784|NCT00741598|65048665|FG000|Overall Study|Physician Decision|1|||
23355785|NCT00741598|65048666|FG001|Overall Study|Physician Decision|1|||
23355786|NCT00741598|65048665|FG000|Overall Study|Pregnancy|1|||
23355787|NCT00741598|65048666|FG001|Overall Study|Pregnancy|0|||
23355788|NCT00741598|65048665|FG000|Overall Study|Withdrawal by Subject|3|||
23355789|NCT00741598|65048666|FG001|Overall Study|Withdrawal by Subject|2|||
23355790|NCT01084538|65048670|FG000|Overall Study|Drug not available|30|||
23355791|NCT01084538|65048670|FG000|Overall Study|Adverse Event|9|||
23355792|NCT01084538|65048670|FG000|Overall Study|Kidney transplant|6|||
23355793|NCT01084538|65048670|FG000|Overall Study|Serious Adverse Event|3|||
23355794|NCT01084538|65048670|FG000|Overall Study|Lack of effectiveness|2|||
23355795|NCT01084538|65048670|FG000|Overall Study|Patient noncompliance|2|||
23355796|NCT01084538|65048670|FG000|Overall Study|Hyperphosphatemia|2|||
23355797|NCT01084538|65048670|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
23355798|NCT01084538|65048670|FG000|Overall Study|Change of residence|2|||
23355799|NCT01084538|65048670|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
23472570|NCT00545272|65474075|FG003|Overall Study|Abnormal test procedure result(s)|0|||
23189810|NCT01318902|64436181|FG003|Overall Study|Withdrawal by Patient|3|||
23355800|NCT01084538|65048670|FG000|Overall Study|Reason unknown|8|||
23355801|NCT03883477|65048677|FG000|Overall Study|Death|1|||
23355802|NCT03883477|65048678|FG001|Overall Study|Death|0|||
23355803|NCT03883477|65048677|FG000|Overall Study|Protocol Violation|0|||
23355804|NCT03883477|65048678|FG001|Overall Study|Protocol Violation|1|||
23355805|NCT02187029|65048687|FG000|Overall Study|Adverse Event|0|||
23355806|NCT02187029|65048688|FG001|Overall Study|Adverse Event|1|||
23355807|NCT02187029|65048689|FG002|Overall Study|Adverse Event|1|||
23355808|NCT02187029|65048690|FG003|Overall Study|Adverse Event|0|||
23355809|NCT02187029|65048687|FG000|Overall Study|Study Terminated by Sponsor|0|||
23355810|NCT02187029|65048688|FG001|Overall Study|Study Terminated by Sponsor|0|||
23355811|NCT02187029|65048689|FG002|Overall Study|Study Terminated by Sponsor|10|||
23355812|NCT02187029|65048690|FG003|Overall Study|Study Terminated by Sponsor|3|||
23355813|NCT02187029|65048687|FG000|Overall Study|Withdrawal by Subject|1|||
23355814|NCT02187029|65048688|FG001|Overall Study|Withdrawal by Subject|0|||
23355815|NCT02187029|65048689|FG002|Overall Study|Withdrawal by Subject|0|||
23355816|NCT02187029|65048690|FG003|Overall Study|Withdrawal by Subject|0|||
23355817|NCT00548249|65048691|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
23355818|NCT00548249|65048692|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
23355819|NCT00548249|65048693|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
23588398|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
23588399|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
23588400|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23588401|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
23588402|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23249435|NCT03343054|64655697|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
23249436|NCT03343054|64655698|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
23249437|NCT03343054|64655699|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
23249438|NCT03343054|64655697|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
23249439|NCT03343054|64655698|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
23249440|NCT03343054|64655699|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
23249441|NCT03343054|64655697|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
23249442|NCT03343054|64655698|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
23249443|NCT03343054|64655699|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
23249444|NCT00532779|64655706|FG000|Overall Study|Adverse Event|122|||
23249445|NCT00532779|64655707|FG001|Overall Study|Adverse Event|112|||
23249446|NCT00532779|64655708|FG002|Overall Study|Adverse Event|56|||
23249447|NCT00532779|64655706|FG000|Overall Study|Lost to Follow-up|76|||
23249448|NCT00532779|64655707|FG001|Overall Study|Lost to Follow-up|65|||
23249449|NCT00532779|64655708|FG002|Overall Study|Lost to Follow-up|66|||
23249450|NCT00532779|64655706|FG000|Overall Study|Withdrawal by Subject|63|||
23249451|NCT00532779|64655707|FG001|Overall Study|Withdrawal by Subject|60|||
23249452|NCT00532779|64655708|FG002|Overall Study|Withdrawal by Subject|90|||
23249453|NCT00532779|64655706|FG000|Overall Study|Lack of Efficacy|12|||
23249454|NCT00532779|64655707|FG001|Overall Study|Lack of Efficacy|12|||
23249455|NCT00532779|64655708|FG002|Overall Study|Lack of Efficacy|40|||
23249456|NCT00532779|64655706|FG000|Overall Study|Protocol Violation|5|||
23249457|NCT00532779|64655707|FG001|Overall Study|Protocol Violation|9|||
23249458|NCT00532779|64655708|FG002|Overall Study|Protocol Violation|7|||
23249459|NCT00532779|64655706|FG000|Overall Study|Pregnancy|2|||
23249460|NCT00532779|64655707|FG001|Overall Study|Pregnancy|5|||
23249461|NCT00532779|64655708|FG002|Overall Study|Pregnancy|3|||
23249462|NCT00532779|64655706|FG000|Overall Study|Death|0|||
23249463|NCT00532779|64655707|FG001|Overall Study|Death|1|||
23249464|NCT00532779|64655708|FG002|Overall Study|Death|0|||
23249465|NCT00532779|64655706|FG000|Overall Study|Drug noncompliance, moved, other|14|||
23249466|NCT00532779|64655707|FG001|Overall Study|Drug noncompliance, moved, other|23|||
23249467|NCT00532779|64655708|FG002|Overall Study|Drug noncompliance, moved, other|29|||
23249468|NCT04939701|64655719|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
23249469|NCT04939701|64655720|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
23249470|NCT04939701|64655721|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
23249471|NCT04939701|64655719|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
23249472|NCT04939701|64655720|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
23249473|NCT04939701|64655721|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
23249474|NCT04939701|64655719|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
23249475|NCT04939701|64655720|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
23249476|NCT04939701|64655721|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
23249477|NCT04939701|64655719|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
23249478|NCT04939701|64655720|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
23249479|NCT04939701|64655721|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
23249480|NCT04939701|64655719|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
23249481|NCT04939701|64655720|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
23249482|NCT04939701|64655721|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
23249483|NCT04939701|64655719|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
23249484|NCT04939701|64655720|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
23249485|NCT04939701|64655721|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
23355820|NCT00548249|65048694|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
23588403|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23249486|NCT04939701|64655719|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
23355821|NCT00548249|65048695|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
23355822|NCT00548249|65048691|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
23249487|NCT04939701|64655720|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
23249488|NCT04939701|64655721|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
23355823|NCT00548249|65048692|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
23355824|NCT00548249|65048693|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
23355825|NCT00548249|65048694|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
23355826|NCT00548249|65048695|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
23355827|NCT00548249|65048691|FG000|Overall Study|Protocol Violation|1|||
23355828|NCT00548249|65048692|FG001|Overall Study|Protocol Violation|1|||
23355829|NCT00548249|65048693|FG002|Overall Study|Protocol Violation|4|||
23355830|NCT00548249|65048694|FG003|Overall Study|Protocol Violation|0|||
23355831|NCT00548249|65048695|FG004|Overall Study|Protocol Violation|3|||
23355832|NCT00548249|65048691|FG000|Overall Study|Miscellaneous|2|||
23355833|NCT00548249|65048692|FG001|Overall Study|Miscellaneous|3|||
23355834|NCT00548249|65048693|FG002|Overall Study|Miscellaneous|2|||
23355835|NCT00548249|65048694|FG003|Overall Study|Miscellaneous|0|||
23355836|NCT00548249|65048695|FG004|Overall Study|Miscellaneous|2|||
23355837|NCT00548249|65048691|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
23355838|NCT00548249|65048692|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
23355839|NCT00548249|65048693|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
23355840|NCT00548249|65048694|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
23355841|NCT00548249|65048695|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
23355842|NCT00548249|65048691|FG000|Overall Study|Adverse Event|2|||
23355843|NCT00548249|65048692|FG001|Overall Study|Adverse Event|2|||
23355844|NCT00548249|65048693|FG002|Overall Study|Adverse Event|0|||
23355845|NCT00548249|65048694|FG003|Overall Study|Adverse Event|1|||
23355846|NCT00548249|65048695|FG004|Overall Study|Adverse Event|1|||
23355847|NCT00548249|65048691|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
23355848|NCT00548249|65048692|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
23355849|NCT00548249|65048693|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
23355850|NCT00548249|65048694|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
23355851|NCT00548249|65048695|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
23355852|NCT00548249|65048691|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
23355853|NCT00548249|65048692|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
23355854|NCT00548249|65048693|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
23355855|NCT00548249|65048694|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
23355856|NCT00548249|65048695|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
23355857|NCT00548249|65048691|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
23355858|NCT00548249|65048692|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
23355859|NCT00548249|65048693|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
23355860|NCT00548249|65048694|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
23355861|NCT00548249|65048695|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
23355862|NCT00548249|65048691|FG000|Overall Study|Prolonged hospitalization|0|||
23355863|NCT00548249|65048692|FG001|Overall Study|Prolonged hospitalization|0|||
23355864|NCT00548249|65048693|FG002|Overall Study|Prolonged hospitalization|2|||
23355865|NCT00548249|65048694|FG003|Overall Study|Prolonged hospitalization|1|||
23355866|NCT00548249|65048695|FG004|Overall Study|Prolonged hospitalization|0|||
23355867|NCT00548249|65048691|FG000|Overall Study|Withdrawal by Subject|2|||
23355868|NCT00548249|65048692|FG001|Overall Study|Withdrawal by Subject|0|||
23355869|NCT00548249|65048693|FG002|Overall Study|Withdrawal by Subject|0|||
23355870|NCT00548249|65048694|FG003|Overall Study|Withdrawal by Subject|0|||
23355871|NCT00548249|65048695|FG004|Overall Study|Withdrawal by Subject|0|||
23355872|NCT00548249|65048691|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
23355873|NCT00548249|65048692|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
23355874|NCT00548249|65048693|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
23355875|NCT00548249|65048694|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
23355876|NCT00548249|65048695|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
23355877|NCT00548249|65048691|FG000|Overall Study|Sponsor's request|0|||
23355878|NCT00548249|65048692|FG001|Overall Study|Sponsor's request|0|||
23355879|NCT00548249|65048693|FG002|Overall Study|Sponsor's request|0|||
23355880|NCT00548249|65048694|FG003|Overall Study|Sponsor's request|1|||
23355881|NCT00548249|65048695|FG004|Overall Study|Sponsor's request|0|||
23355882|NCT01281956|65048696|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
23355883|NCT01281956|65048697|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
23355884|NCT01882803|65048698|FG000|Overall Study|Disease Progression|1|||
23355885|NCT01882803|65048698|FG000|Overall Study|Withdrawal by Subject|9|||
23588404|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23588405|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23355886|NCT01882803|65048698|FG000|Overall Study|Death|68|||
23355887|NCT01882803|65048698|FG000|Overall Study|Physician Decision|3|||
23355888|NCT01882803|65048698|FG000|Overall Study|Lost to Follow-up|3|||
23355889|NCT01882803|65048698|FG000|Overall Study|Follow-up Completed|39|||
23355890|NCT01882803|65048698|FG000|Overall Study|Study Terminated by the Sponsor|6|||
23355891|NCT02190721|65048699|FG000|Overall Study|Patient was out of the city|0|||
23588406|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23472571|NCT00545272|65474076|FG004|Overall Study|Abnormal test procedure result(s)|1|||
23249489|NCT00797316|64655722|FG000|Overall Study|Administrative problems|1|||
23249490|NCT00797316|64655723|FG001|Overall Study|Administrative problems|0|||
23249491|NCT00797316|64655722|FG000|Overall Study|Adverse Event|5|||
23249492|NCT00797316|64655723|FG001|Overall Study|Adverse Event|3|||
23249493|NCT00797316|64655722|FG000|Overall Study|Lost to Follow-up|4|||
23249494|NCT00797316|64655723|FG001|Overall Study|Lost to Follow-up|8|||
23249495|NCT00797316|64655722|FG000|Overall Study|Protocol Deviation|1|||
23249496|NCT00797316|64655723|FG001|Overall Study|Protocol Deviation|2|||
23249497|NCT00797316|64655722|FG000|Overall Study|Patient withdrew consent|12|||
23249498|NCT00797316|64655723|FG001|Overall Study|Patient withdrew consent|6|||
23249499|NCT00797316|64655722|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23249500|NCT00797316|64655723|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
23249501|NCT01346501|64655726|FG000|Overall Study|Initiated Other Biological Agents|3|||
23249502|NCT01346501|64655727|FG001|Overall Study|Initiated Other Biological Agents|1|||
23249503|NCT01346501|64655726|FG000|Overall Study|Other|8|||
23249504|NCT01346501|64655727|FG001|Overall Study|Other|12|||
23249505|NCT00755937|64655728|FG000|Recruitment|Unknown if infliximab received|164|||
23249506|NCT00755937|64655728|FG000|Observational Follow-up|Lost to Follow-up|148|||
23249507|NCT01238172|64655729|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
23249508|NCT01238172|64655730|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
23249509|NCT01238172|64655729|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
23249510|NCT01238172|64655730|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
23249511|NCT00560573|64655731|FG000|Overall Study|Death|4|||
23249512|NCT00560573|64655732|FG001|Overall Study|Death|1|||
23249513|NCT00560573|64655733|FG002|Overall Study|Death|4|||
23249514|NCT00560573|64655734|FG003|Overall Study|Death|5|||
23249515|NCT00560573|64655735|FG004|Overall Study|Death|1|||
23249516|NCT00560573|64655736|FG005|Overall Study|Death|10|||
23249517|NCT00560573|64655731|FG000|Overall Study|Lost to Follow-up|0|||
23249518|NCT00560573|64655732|FG001|Overall Study|Lost to Follow-up|0|||
23249519|NCT00560573|64655733|FG002|Overall Study|Lost to Follow-up|0|||
23249520|NCT00560573|64655734|FG003|Overall Study|Lost to Follow-up|1|||
23249521|NCT00560573|64655735|FG004|Overall Study|Lost to Follow-up|1|||
23249522|NCT00560573|64655736|FG005|Overall Study|Lost to Follow-up|0|||
23249523|NCT00560573|64655731|FG000|Overall Study|Withdrawal by Subject|0|||
23249524|NCT00560573|64655732|FG001|Overall Study|Withdrawal by Subject|0|||
23249525|NCT00560573|64655733|FG002|Overall Study|Withdrawal by Subject|0|||
23249526|NCT00560573|64655734|FG003|Overall Study|Withdrawal by Subject|1|||
23249527|NCT00560573|64655735|FG004|Overall Study|Withdrawal by Subject|1|||
23249528|NCT00560573|64655736|FG005|Overall Study|Withdrawal by Subject|0|||
23249529|NCT00560573|64655731|FG000|Overall Study|Other|2|||
23249530|NCT00560573|64655732|FG001|Overall Study|Other|2|||
23249531|NCT00560573|64655733|FG002|Overall Study|Other|2|||
23249532|NCT00560573|64655734|FG003|Overall Study|Other|3|||
23249533|NCT00560573|64655735|FG004|Overall Study|Other|3|||
23249534|NCT00560573|64655736|FG005|Overall Study|Other|3|||
23249535|NCT00560573|64655731|FG000|Overall Study|Enrolled, not treated|0|||
23249536|NCT00560573|64655732|FG001|Overall Study|Enrolled, not treated|0|||
23249537|NCT00560573|64655733|FG002|Overall Study|Enrolled, not treated|0|||
23249538|NCT00560573|64655734|FG003|Overall Study|Enrolled, not treated|0|||
23249539|NCT00560573|64655735|FG004|Overall Study|Enrolled, not treated|1|||
23249540|NCT00560573|64655736|FG005|Overall Study|Enrolled, not treated|0|||
23249541|NCT03033069|64655737|FG000|Overall Study|Adverse Event|6|||
23249542|NCT03033069|64655738|FG001|Overall Study|Adverse Event|7|||
23249543|NCT03033069|64655739|FG002|Overall Study|Adverse Event|4|||
23249544|NCT03033069|64655740|FG003|Overall Study|Adverse Event|6|||
23249545|NCT03033069|64655737|FG000|Overall Study|Lack of Efficacy|0|||
23249546|NCT03033069|64655738|FG001|Overall Study|Lack of Efficacy|0|||
23249547|NCT03033069|64655739|FG002|Overall Study|Lack of Efficacy|1|||
23249548|NCT03033069|64655740|FG003|Overall Study|Lack of Efficacy|0|||
23249549|NCT03033069|64655737|FG000|Overall Study|Lost to Follow-up|6|||
23249550|NCT03033069|64655738|FG001|Overall Study|Lost to Follow-up|5|||
23249551|NCT03033069|64655739|FG002|Overall Study|Lost to Follow-up|5|||
23472572|NCT00545272|65474077|FG005|Overall Study|Abnormal test procedure result(s)|0|||
23249552|NCT03033069|64655740|FG003|Overall Study|Lost to Follow-up|6|||
23249553|NCT03033069|64655737|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23249554|NCT03033069|64655738|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23249555|NCT03033069|64655739|FG002|Overall Study|Non-Compliance With Study Drug|1|||
23355892|NCT02190721|65048700|FG001|Overall Study|Patient was out of the city|1|||
23355893|NCT02190721|65048701|FG002|Overall Study|Patient was out of the city|0|||
23355894|NCT02227368|65048702|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
23355895|NCT02227368|65048703|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
23355896|NCT02227368|65048702|FG000|Overall Study|Lost to Follow-up|1|||
23355897|NCT02227368|65048703|FG001|Overall Study|Lost to Follow-up|0|||
23355898|NCT02227368|65048702|FG000|Overall Study|Adverse Event|1|||
23355899|NCT02227368|65048703|FG001|Overall Study|Adverse Event|0|||
23355900|NCT00632125|65048704|FG000|Overall Study|Death|82|||
23355901|NCT00632125|65048704|FG000|Overall Study|Withdrawal by Subject|44|||
23355902|NCT00632125|65048704|FG000|Overall Study|Adverse Event|36|||
23355903|NCT00632125|65048704|FG000|Overall Study|Renal transplantation|17|||
23355904|NCT00632125|65048704|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
23189811|NCT01318902|64436178|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
23189812|NCT01318902|64436179|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
23189813|NCT01318902|64436180|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23189814|NCT01318902|64436181|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
23189815|NCT01318902|64436178|FG000|Overall Study|Adverse Event|0|||
23189816|NCT01318902|64436179|FG001|Overall Study|Adverse Event|1|||
23189817|NCT01318902|64436180|FG002|Overall Study|Adverse Event|0|||
23189818|NCT01318902|64436181|FG003|Overall Study|Adverse Event|0|||
23189819|NCT01318902|64436178|FG000|Overall Study|Terminated by Sponsor|0|||
23189820|NCT01318902|64436179|FG001|Overall Study|Terminated by Sponsor|0|||
23355905|NCT00632125|65048704|FG000|Overall Study|Non-compliance|8|||
23355906|NCT00632125|65048704|FG000|Overall Study|Development of uncontrolled hypertension|5|||
23355907|NCT00632125|65048704|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
23189821|NCT01318902|64436180|FG002|Overall Study|Terminated by Sponsor|1|||
23355908|NCT01931397|65048709|FG000|Overall Study|Physician Decision|2|||
23355909|NCT01931397|65048709|FG000|Overall Study|Withdrawal by Subject|8|||
23189822|NCT01318902|64436181|FG003|Overall Study|Terminated by Sponsor|0|||
23189823|NCT02109029|64436182|FG000|Part B|Adverse Event|0|||
23189824|NCT02109029|64436183|FG001|Part B|Adverse Event|0|||
23189825|NCT02109029|64436184|FG002|Part B|Adverse Event|0|||
23189826|NCT02109029|64436185|FG003|Part B|Adverse Event|0|||
23189827|NCT02109029|64436186|FG004|Part B|Adverse Event|1|||
23189828|NCT02109029|64436187|FG005|Part B|Adverse Event|1|||
23189829|NCT02273973|64436188|FG000|Overall Study|Adverse Event|4|||
23189830|NCT02273973|64436189|FG001|Overall Study|Adverse Event|0|||
23189831|NCT02273973|64436188|FG000|Overall Study|Withdrawal by Subject|2|||
23189832|NCT02273973|64436189|FG001|Overall Study|Withdrawal by Subject|3|||
23189833|NCT02273973|64436188|FG000|Overall Study|Death|1|||
23189834|NCT02273973|64436189|FG001|Overall Study|Death|0|||
23189835|NCT02273973|64436188|FG000|Overall Study|Non-compliance|1|||
23189836|NCT02273973|64436189|FG001|Overall Study|Non-compliance|0|||
23355910|NCT01931397|65048709|FG000|Overall Study|moved out of state|1|||
23355911|NCT03699540|65048712|FG000|Overall Study|Lost to Follow-up|1|||
23355912|NCT01317004|65048713|FG000|Overall Study|Withdrawal by Subject|1|||
23355913|NCT01317004|65048714|FG001|Overall Study|Withdrawal by Subject|4|||
23355914|NCT01317004|65048713|FG000|Overall Study|Protocol Violation|0|||
23355915|NCT01317004|65048714|FG001|Overall Study|Protocol Violation|2|||
23355916|NCT01317004|65048713|FG000|Overall Study|Adverse Event|3|||
23355917|NCT01317004|65048714|FG001|Overall Study|Adverse Event|3|||
23355918|NCT01306214|65048715|FG000|Overall Study|Death|0|||
23355919|NCT01306214|65048716|FG001|Overall Study|Death|0|||
23355920|NCT01306214|65048717|FG002|Overall Study|Death|1|||
23355921|NCT01306214|65048715|FG000|Overall Study|Lost to Follow-up|3|||
23355922|NCT01306214|65048716|FG001|Overall Study|Lost to Follow-up|5|||
23355923|NCT01306214|65048717|FG002|Overall Study|Lost to Follow-up|4|||
23355924|NCT01306214|65048715|FG000|Overall Study|Withdrawal by Subject|24|||
23355925|NCT01306214|65048716|FG001|Overall Study|Withdrawal by Subject|22|||
23355926|NCT01306214|65048717|FG002|Overall Study|Withdrawal by Subject|16|||
23355927|NCT01306214|65048715|FG000|Overall Study|Not treated|1|||
23355928|NCT01306214|65048716|FG001|Overall Study|Not treated|1|||
23355929|NCT01306214|65048717|FG002|Overall Study|Not treated|1|||
23355930|NCT00593918|65048718|FG000|Overall Study|Withdrawal by Subject|5|||
23355931|NCT00593918|65048719|FG001|Overall Study|Withdrawal by Subject|24|||
23355932|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
23355933|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
23355934|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
23355935|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
23355936|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
23355937|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
23355938|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
23355939|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
23355940|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
23355941|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
23355942|NCT01777139|65048720|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
23355943|NCT01777139|65048721|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
23355944|NCT01777139|65048720|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
23355945|NCT01777139|65048721|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
23355946|NCT01777139|65048720|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
23355947|NCT01777139|65048721|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
23355948|NCT00262002|65048725|FG000|Overall Study|Adverse Event|2|||
23355949|NCT00262002|65048726|FG001|Overall Study|Adverse Event|1|||
23355950|NCT00262002|65048727|FG002|Overall Study|Adverse Event|0|||
23355951|NCT00262002|65048728|FG003|Overall Study|Adverse Event|0|||
23355952|NCT00262002|65048729|FG004|Overall Study|Adverse Event|0|||
23355953|NCT00262002|65048730|FG005|Overall Study|Adverse Event|1|||
23355954|NCT00262002|65048731|FG006|Overall Study|Adverse Event|0|||
23355955|NCT00262002|65048725|FG000|Overall Study|Withdrawal by Subject|4|||
23355956|NCT00262002|65048726|FG001|Overall Study|Withdrawal by Subject|2|||
23355957|NCT00262002|65048727|FG002|Overall Study|Withdrawal by Subject|0|||
23355958|NCT00262002|65048728|FG003|Overall Study|Withdrawal by Subject|1|||
23355959|NCT00262002|65048729|FG004|Overall Study|Withdrawal by Subject|2|||
23355960|NCT00262002|65048730|FG005|Overall Study|Withdrawal by Subject|2|||
23355961|NCT00262002|65048731|FG006|Overall Study|Withdrawal by Subject|2|||
23355962|NCT00262002|65048725|FG000|Overall Study|Lost to Follow-up|2|||
23355963|NCT00262002|65048726|FG001|Overall Study|Lost to Follow-up|0|||
23355964|NCT00262002|65048727|FG002|Overall Study|Lost to Follow-up|0|||
23355965|NCT00262002|65048728|FG003|Overall Study|Lost to Follow-up|2|||
23355966|NCT00262002|65048729|FG004|Overall Study|Lost to Follow-up|0|||
23355967|NCT00262002|65048730|FG005|Overall Study|Lost to Follow-up|1|||
23355968|NCT00262002|65048731|FG006|Overall Study|Lost to Follow-up|0|||
23355969|NCT00262002|65048725|FG000|Overall Study|Inapropriate enrollment|0|||
23355970|NCT00262002|65048726|FG001|Overall Study|Inapropriate enrollment|1|||
23355971|NCT00262002|65048727|FG002|Overall Study|Inapropriate enrollment|0|||
23355972|NCT00262002|65048728|FG003|Overall Study|Inapropriate enrollment|0|||
23355973|NCT00262002|65048729|FG004|Overall Study|Inapropriate enrollment|0|||
23355974|NCT00262002|65048730|FG005|Overall Study|Inapropriate enrollment|0|||
23472573|NCT00545272|65474072|FG000|Overall Study|Lost to Follow-up|0|||
23249556|NCT03033069|64655740|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23249557|NCT03033069|64655737|FG000|Overall Study|Protocol Deviation|0|||
23249558|NCT03033069|64655738|FG001|Overall Study|Protocol Deviation|1|||
23249559|NCT03033069|64655739|FG002|Overall Study|Protocol Deviation|0|||
23249560|NCT03033069|64655740|FG003|Overall Study|Protocol Deviation|0|||
23249561|NCT03033069|64655737|FG000|Overall Study|Withdrawal by Subject|10|||
23249562|NCT03033069|64655738|FG001|Overall Study|Withdrawal by Subject|10|||
23249563|NCT03033069|64655739|FG002|Overall Study|Withdrawal by Subject|11|||
23249564|NCT03033069|64655740|FG003|Overall Study|Withdrawal by Subject|6|||
23249565|NCT03033069|64655737|FG000|Overall Study|Withdrawal By Caregiver|1|||
23249566|NCT03033069|64655738|FG001|Overall Study|Withdrawal By Caregiver|0|||
23249567|NCT03033069|64655739|FG002|Overall Study|Withdrawal By Caregiver|0|||
23249568|NCT03033069|64655740|FG003|Overall Study|Withdrawal By Caregiver|0|||
23249569|NCT03033069|64655737|FG000|Overall Study|Reason not Specified|0|||
23249570|NCT03033069|64655738|FG001|Overall Study|Reason not Specified|1|||
23249571|NCT03033069|64655739|FG002|Overall Study|Reason not Specified|0|||
23249572|NCT03033069|64655740|FG003|Overall Study|Reason not Specified|1|||
23249573|NCT00725725|64655741|FG000|Overall Study|Adverse Event|1|||
23249574|NCT00725725|64655742|FG001|Overall Study|Adverse Event|3|||
23249575|NCT00725725|64655743|FG002|Overall Study|Adverse Event|2|||
23249576|NCT00725725|64655741|FG000|Overall Study|Lost to Follow-up|2|||
23355975|NCT00262002|65048731|FG006|Overall Study|Inapropriate enrollment|0|||
23355976|NCT00262002|65048725|FG000|Overall Study|Protocol Violation|3|||
23355977|NCT00262002|65048726|FG001|Overall Study|Protocol Violation|2|||
23355978|NCT00262002|65048727|FG002|Overall Study|Protocol Violation|0|||
23355979|NCT00262002|65048728|FG003|Overall Study|Protocol Violation|2|||
23355980|NCT00262002|65048729|FG004|Overall Study|Protocol Violation|5|||
23355981|NCT00262002|65048730|FG005|Overall Study|Protocol Violation|3|||
23355982|NCT00262002|65048731|FG006|Overall Study|Protocol Violation|2|||
23355983|NCT00262002|65048725|FG000|Overall Study|Unable to classify|0|||
23355984|NCT00262002|65048726|FG001|Overall Study|Unable to classify|0|||
23355985|NCT00262002|65048727|FG002|Overall Study|Unable to classify|0|||
23355986|NCT00262002|65048728|FG003|Overall Study|Unable to classify|0|||
23355987|NCT00262002|65048729|FG004|Overall Study|Unable to classify|0|||
23355988|NCT00262002|65048730|FG005|Overall Study|Unable to classify|0|||
23355989|NCT00262002|65048731|FG006|Overall Study|Unable to classify|2|||
23355990|NCT01204918|65048732|FG000|Overall Study|Withdrawal by Subject|4|||
23355991|NCT01204918|65048733|FG001|Overall Study|Withdrawal by Subject|10|||
23355992|NCT01204918|65048734|FG002|Overall Study|Withdrawal by Subject|5|||
23355993|NCT02437188|65048739|FG000|Overall Study|Randomized but did not receive surgery|4|||
23355994|NCT02437188|65048740|FG001|Overall Study|Randomized but did not receive surgery|8|||
23355995|NCT02437188|65048739|FG000|Overall Study|Adverse Event|0|||
23355996|NCT02437188|65048740|FG001|Overall Study|Adverse Event|1|||
23355997|NCT03488563|65048741|FG000|Overall Study|Lost to Follow-up|7|||
23355998|NCT03488563|65048742|FG001|Overall Study|Lost to Follow-up|6|||
23355999|NCT03488563|65048743|FG002|Overall Study|Lost to Follow-up|7|||
23356000|NCT03488563|65048741|FG000|Overall Study|Withdrawal by Subject|8|||
23356001|NCT03488563|65048742|FG001|Overall Study|Withdrawal by Subject|7|||
23588407|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23356002|NCT03488563|65048743|FG002|Overall Study|Withdrawal by Subject|7|||
23356003|NCT03488563|65048741|FG000|Overall Study|Physician Decision|0|||
23356004|NCT03488563|65048742|FG001|Overall Study|Physician Decision|0|||
23588408|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
23588409|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588410|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588411|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
23588412|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588413|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588414|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588415|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588416|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
23588417|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
23588418|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588419|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
23249577|NCT00725725|64655742|FG001|Overall Study|Lost to Follow-up|0|||
23249578|NCT00725725|64655743|FG002|Overall Study|Lost to Follow-up|2|||
23249579|NCT00725725|64655741|FG000|Overall Study|Withdrawal by Subject|1|||
23249580|NCT00725725|64655742|FG001|Overall Study|Withdrawal by Subject|0|||
23249581|NCT00725725|64655743|FG002|Overall Study|Withdrawal by Subject|1|||
23249582|NCT00725725|64655741|FG000|Overall Study|Protocol Violation|0|||
23249583|NCT00725725|64655742|FG001|Overall Study|Protocol Violation|1|||
23249584|NCT00725725|64655743|FG002|Overall Study|Protocol Violation|0|||
23249585|NCT00656019|64655744|FG000|Overall Study|Not Eligible|10|||
23249586|NCT00656019|64655745|FG001|Overall Study|Not Eligible|0|||
23356005|NCT03488563|65048743|FG002|Overall Study|Physician Decision|1|||
23588420|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23189837|NCT02273973|64436188|FG000|Overall Study|Protocol Violation|1|||
23189838|NCT02273973|64436189|FG001|Overall Study|Protocol Violation|0|||
23189839|NCT02273973|64436188|FG000|Overall Study|Progression of disease|0|||
23189840|NCT02273973|64436189|FG001|Overall Study|Progression of disease|2|||
23189841|NCT02273973|64436188|FG000|Overall Study|Lost to Follow-up|0|||
23189842|NCT02273973|64436189|FG001|Overall Study|Lost to Follow-up|1|||
23189843|NCT02273973|64436188|FG000|Overall Study|Physician Decision|0|||
23189844|NCT02273973|64436189|FG001|Overall Study|Physician Decision|1|||
23588421|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588422|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588423|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588424|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588425|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
23588426|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
23588427|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588428|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
23588429|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
23588430|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588431|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588432|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588433|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
23588434|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
23588435|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
23588436|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23189845|NCT02273973|64436188|FG000|Overall Study|Reason not specified|0|||
23189846|NCT02273973|64436189|FG001|Overall Study|Reason not specified|1|||
23588437|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
23588438|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
23588439|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23189847|NCT00149214|64436190|FG000|Overall Study|Adverse Event|12|||
23189848|NCT00149214|64436191|FG001|Overall Study|Adverse Event|9|||
23189849|NCT00149214|64436190|FG000|Overall Study|Withdrawal by Subject|4|||
23189850|NCT00149214|64436191|FG001|Overall Study|Withdrawal by Subject|1|||
23356006|NCT03488563|65048741|FG000|Overall Study|Protocol Violation|3|||
23356007|NCT03488563|65048742|FG001|Overall Study|Protocol Violation|2|||
23356008|NCT03488563|65048743|FG002|Overall Study|Protocol Violation|6|||
23356009|NCT03488563|65048741|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
23356010|NCT03488563|65048742|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
23356011|NCT03488563|65048743|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
23356012|NCT03488563|65048741|FG000|Overall Study|Use of prohibited medication|2|||
23356013|NCT03488563|65048742|FG001|Overall Study|Use of prohibited medication|0|||
23588440|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23588441|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23588442|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
23588443|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
23588444|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
23588445|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23356014|NCT03488563|65048743|FG002|Overall Study|Use of prohibited medication|0|||
23356015|NCT03488563|65048741|FG000|Overall Study|Adverse Event|1|||
23356016|NCT03488563|65048742|FG001|Overall Study|Adverse Event|0|||
23356017|NCT03488563|65048743|FG002|Overall Study|Adverse Event|1|||
23356018|NCT03488563|65048741|FG000|Overall Study|Subject returned for ET visit|0|||
23356019|NCT03488563|65048742|FG001|Overall Study|Subject returned for ET visit|1|||
23356020|NCT03488563|65048743|FG002|Overall Study|Subject returned for ET visit|0|||
23588446|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
23588447|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
23356021|NCT03488563|65048741|FG000|Overall Study|Sponsor's decision|0|||
23356022|NCT03488563|65048742|FG001|Overall Study|Sponsor's decision|0|||
23356023|NCT03488563|65048743|FG002|Overall Study|Sponsor's decision|1|||
23356024|NCT02070978|65048744|FG000|Overall Study|Adverse Event|6|||
23356025|NCT02070978|65048745|FG001|Overall Study|Adverse Event|2|||
23356026|NCT02070978|65048746|FG002|Overall Study|Adverse Event|0|||
23356027|NCT02070978|65048744|FG000|Overall Study|Lost to Follow-up|1|||
23356028|NCT02070978|65048745|FG001|Overall Study|Lost to Follow-up|3|||
23356029|NCT02070978|65048746|FG002|Overall Study|Lost to Follow-up|4|||
23356030|NCT02070978|65048744|FG000|Overall Study|Withdrawal by Subject|3|||
23356031|NCT02070978|65048745|FG001|Overall Study|Withdrawal by Subject|5|||
23356032|NCT02070978|65048746|FG002|Overall Study|Withdrawal by Subject|3|||
23472574|NCT00545272|65474073|FG001|Overall Study|Lost to Follow-up|0|||
23472575|NCT00545272|65474074|FG002|Overall Study|Lost to Follow-up|0|||
23472576|NCT00545272|65474075|FG003|Overall Study|Lost to Follow-up|0|||
23472577|NCT00545272|65474076|FG004|Overall Study|Lost to Follow-up|1|||
23189851|NCT00149214|64436190|FG000|Overall Study|Physician Decision|3|||
23189852|NCT00149214|64436191|FG001|Overall Study|Physician Decision|3|||
23189853|NCT00149214|64436190|FG000|Overall Study|Sponsor Decision|0|||
23189854|NCT00149214|64436191|FG001|Overall Study|Sponsor Decision|1|||
23189855|NCT00149214|64436190|FG000|Overall Study|Progressive Disease|7|||
23189856|NCT00149214|64436191|FG001|Overall Study|Progressive Disease|3|||
23189857|NCT00467649|64436194|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
23189858|NCT00467649|64436195|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
23189859|NCT00467649|64436196|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
23472578|NCT00545272|65474077|FG005|Overall Study|Lost to Follow-up|0|||
23472579|NCT00539188|65474083|FG000|Overall Study|Withdrawal by Subject|1|||
23472580|NCT00539188|65474084|FG001|Overall Study|Withdrawal by Subject|0|||
23472581|NCT00539188|65474083|FG000|Overall Study|Lost to Follow-up|2|||
23472582|NCT00539188|65474084|FG001|Overall Study|Lost to Follow-up|1|||
23472583|NCT01010867|65474087|FG000|Overall Study|< 50% adherence to probiotic|1|||
23472584|NCT03275350|65474091|FG000|Overall Study|Lost to Follow-up|4|||
23472585|NCT03275350|65474092|FG001|Overall Study|Lost to Follow-up|6|||
23472586|NCT03275350|65474091|FG000|Overall Study|Death|2|||
23472587|NCT03275350|65474092|FG001|Overall Study|Death|1|||
23189860|NCT00467649|64436197|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
23189861|NCT00467649|64436198|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
23189862|NCT00467649|64436199|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
23189863|NCT00467649|64436194|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
23189864|NCT00467649|64436195|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
23189865|NCT00467649|64436196|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
23189866|NCT00467649|64436197|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
23189867|NCT00467649|64436198|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
23189868|NCT00467649|64436199|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
23189869|NCT00467649|64436194|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
23189870|NCT00467649|64436195|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
23189871|NCT00467649|64436196|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
23189872|NCT00467649|64436197|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
23189873|NCT00467649|64436198|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
23189874|NCT00467649|64436199|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
23189875|NCT00467649|64436194|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
23189876|NCT00467649|64436195|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
23189877|NCT00467649|64436196|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
23189878|NCT00467649|64436197|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
23189879|NCT00467649|64436198|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
23189880|NCT00467649|64436199|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
23189881|NCT00467649|64436194|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23189882|NCT00467649|64436195|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23189883|NCT00467649|64436196|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23189884|NCT00467649|64436197|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
23189885|NCT00467649|64436198|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23189886|NCT00467649|64436199|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
23189887|NCT00467649|64436194|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23189888|NCT00467649|64436195|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23189889|NCT00467649|64436196|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23189890|NCT00467649|64436197|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
23189891|NCT00467649|64436198|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23189892|NCT00467649|64436199|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
23356033|NCT02070978|65048744|FG000|Overall Study|Protocol Violation|1|||
23356034|NCT02070978|65048745|FG001|Overall Study|Protocol Violation|0|||
23356035|NCT02070978|65048746|FG002|Overall Study|Protocol Violation|3|||
23356036|NCT02070978|65048744|FG000|Overall Study|Lack of Efficacy|0|||
23472588|NCT03275350|65474091|FG000|Overall Study|Physician Decision|1|||
23249587|NCT00656019|64655746|FG002|Overall Study|Not Eligible|0|||
23249588|NCT00656019|64655747|FG003|Overall Study|Not Eligible|0|||
23249589|NCT00656019|64655744|FG000|Overall Study|Withdrawal by Subject|2|||
23249590|NCT00656019|64655745|FG001|Overall Study|Withdrawal by Subject|0|||
23249591|NCT00656019|64655746|FG002|Overall Study|Withdrawal by Subject|0|||
23249592|NCT00656019|64655747|FG003|Overall Study|Withdrawal by Subject|0|||
23249593|NCT00656019|64655744|FG000|Overall Study|Lost to Follow-up|2|||
23249594|NCT00656019|64655745|FG001|Overall Study|Lost to Follow-up|1|||
23249595|NCT00656019|64655746|FG002|Overall Study|Lost to Follow-up|0|||
23249596|NCT00656019|64655747|FG003|Overall Study|Lost to Follow-up|0|||
23249597|NCT00577031|64655749|FG000|Overall Study|Adverse Event|52|||
23249598|NCT00577031|64655749|FG000|Overall Study|Progression of disease|93|||
23249599|NCT00577031|64655749|FG000|Overall Study|Protocol Violation|5|||
23249600|NCT00577031|64655749|FG000|Overall Study|Participant withdrew consent|13|||
23249601|NCT00577031|64655749|FG000|Overall Study|Participant non-compliance|5|||
23249602|NCT00577031|64655749|FG000|Overall Study|Need for surgery|17|||
23249603|NCT00577031|64655749|FG000|Overall Study|Medical decision|14|||
23356037|NCT02070978|65048745|FG001|Overall Study|Lack of Efficacy|1|||
23356038|NCT02070978|65048746|FG002|Overall Study|Lack of Efficacy|0|||
23356039|NCT02070978|65048744|FG000|Overall Study|Death|0|||
23356040|NCT02070978|65048745|FG001|Overall Study|Death|0|||
23356041|NCT02070978|65048746|FG002|Overall Study|Death|2|||
23356042|NCT02070978|65048744|FG000|Overall Study|Un-specified|3|||
23356043|NCT02070978|65048745|FG001|Overall Study|Un-specified|2|||
23356044|NCT02070978|65048746|FG002|Overall Study|Un-specified|2|||
23356045|NCT02070978|65048744|FG000|Overall Study|Terminated by Sponsor|33|||
23356046|NCT02070978|65048745|FG001|Overall Study|Terminated by Sponsor|40|||
23356047|NCT02070978|65048746|FG002|Overall Study|Terminated by Sponsor|39|||
23356048|NCT00313586|65048747|FG000|Overall Study|Disease progression|14|||
23356049|NCT00313586|65048748|FG001|Overall Study|Disease progression|19|||
23356050|NCT00313586|65048749|FG002|Overall Study|Disease progression|10|||
23356051|NCT00313586|65048750|FG003|Overall Study|Disease progression|3|||
23356052|NCT00313586|65048747|FG000|Overall Study|Adverse Event|12|||
23356053|NCT00313586|65048748|FG001|Overall Study|Adverse Event|18|||
23356054|NCT00313586|65048749|FG002|Overall Study|Adverse Event|3|||
23356055|NCT00313586|65048750|FG003|Overall Study|Adverse Event|10|||
23356056|NCT00313586|65048747|FG000|Overall Study|Death|11|||
23356057|NCT00313586|65048748|FG001|Overall Study|Death|8|||
23356058|NCT00313586|65048749|FG002|Overall Study|Death|1|||
23356059|NCT00313586|65048750|FG003|Overall Study|Death|7|||
23356060|NCT00313586|65048747|FG000|Overall Study|Withdrawal by Subject|13|||
23356061|NCT00313586|65048748|FG001|Overall Study|Withdrawal by Subject|6|||
23356062|NCT00313586|65048749|FG002|Overall Study|Withdrawal by Subject|6|||
23356063|NCT00313586|65048750|FG003|Overall Study|Withdrawal by Subject|2|||
23356064|NCT00313586|65048747|FG000|Overall Study|Alternative therapy|3|||
23356065|NCT00313586|65048748|FG001|Overall Study|Alternative therapy|6|||
23356066|NCT00313586|65048749|FG002|Overall Study|Alternative therapy|2|||
23356067|NCT00313586|65048750|FG003|Overall Study|Alternative therapy|0|||
23356068|NCT00313586|65048747|FG000|Overall Study|Other complicating disease|2|||
23356069|NCT00313586|65048748|FG001|Overall Study|Other complicating disease|2|||
23356070|NCT00313586|65048749|FG002|Overall Study|Other complicating disease|0|||
23356071|NCT00313586|65048750|FG003|Overall Study|Other complicating disease|0|||
23356072|NCT00313586|65048747|FG000|Overall Study|Did not achieve HI-major/better response|10|||
23356073|NCT00313586|65048748|FG001|Overall Study|Did not achieve HI-major/better response|7|||
23356074|NCT00313586|65048749|FG002|Overall Study|Did not achieve HI-major/better response|2|||
23356075|NCT00313586|65048750|FG003|Overall Study|Did not achieve HI-major/better response|1|||
23356076|NCT00313586|65048747|FG000|Overall Study|Physician Decision|2|||
23356077|NCT00313586|65048748|FG001|Overall Study|Physician Decision|1|||
23356078|NCT00313586|65048749|FG002|Overall Study|Physician Decision|0|||
23356079|NCT00313586|65048750|FG003|Overall Study|Physician Decision|0|||
23356080|NCT00313586|65048747|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
23356081|NCT00313586|65048748|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
23356082|NCT00313586|65048749|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
23472589|NCT03275350|65474092|FG001|Overall Study|Physician Decision|0|||
23472590|NCT03275350|65474091|FG000|Overall Study|Incarcerated|1|||
23472591|NCT03275350|65474092|FG001|Overall Study|Incarcerated|1|||
23249604|NCT00577031|64655749|FG000|Overall Study|Death|6|||
23249605|NCT00996632|64655757|FG000|Overall Study|Physician Decision|0|||
23356083|NCT00313586|65048750|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
23356084|NCT00313586|65048747|FG000|Overall Study|Lost insurance|0|||
23356085|NCT00313586|65048748|FG001|Overall Study|Lost insurance|1|||
23356086|NCT00313586|65048749|FG002|Overall Study|Lost insurance|0|||
23356087|NCT00313586|65048750|FG003|Overall Study|Lost insurance|0|||
23356088|NCT00313586|65048747|FG000|Overall Study|Moved|0|||
23356089|NCT00313586|65048748|FG001|Overall Study|Moved|1|||
23356090|NCT00313586|65048749|FG002|Overall Study|Moved|0|||
23472592|NCT01309282|65474097|FG000|Overall Study|Lost to Follow-up|1|||
23249606|NCT00996632|64655758|FG001|Overall Study|Physician Decision|0|||
23249607|NCT01248130|64655761|FG000|Overall Study|Protocol Violation|1|||
23356091|NCT00313586|65048750|FG003|Overall Study|Moved|0|||
23356092|NCT00313586|65048747|FG000|Overall Study|Death before starting treatment|1|||
23356093|NCT00313586|65048748|FG001|Overall Study|Death before starting treatment|0|||
23356094|NCT00313586|65048749|FG002|Overall Study|Death before starting treatment|0|||
23356095|NCT00313586|65048750|FG003|Overall Study|Death before starting treatment|0|||
23356096|NCT03134911|65048756|FG000|Overall Study|Screen failure|31|||
23356097|NCT03134911|65048756|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
23356098|NCT01502033|65048757|FG000|Overall Study|1 participant had scalp discomfort|1|||
23356099|NCT01502033|65048757|FG000|Overall Study|1 participant had worsening depression|1|||
23356100|NCT01502033|65048757|FG000|Overall Study|1 participant went back to school|1|||
23356101|NCT01048944|65048759|FG000|Overall Study|Protocol Violation|8|||
23356102|NCT01048944|65048760|FG001|Overall Study|Protocol Violation|10|||
23356103|NCT01048944|65048761|FG002|Overall Study|Protocol Violation|10|||
23356104|NCT01048944|65048762|FG003|Overall Study|Protocol Violation|2|||
23249608|NCT01248130|64655762|FG001|Overall Study|Protocol Violation|0|||
23249609|NCT01248130|64655761|FG000|Overall Study|Ineligible|1|||
23249610|NCT01248130|64655762|FG001|Overall Study|Ineligible|0|||
23249611|NCT04723173|64655765|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
23249612|NCT03576131|64655768|FG000|Overall Study|Investigator decision|0|||
23249613|NCT03576131|64655769|FG001|Overall Study|Investigator decision|0|||
23249614|NCT03576131|64655770|FG002|Overall Study|Investigator decision|0|||
23249615|NCT03576131|64655771|FG003|Overall Study|Investigator decision|1|||
23249616|NCT03576131|64655772|FG004|Overall Study|Investigator decision|0|||
23249617|NCT03576131|64655773|FG005|Overall Study|Investigator decision|1|||
23249618|NCT03576131|64655774|FG006|Overall Study|Investigator decision|0|||
23249619|NCT03576131|64655775|FG007|Overall Study|Investigator decision|0|||
23249620|NCT03576131|64655768|FG000|Overall Study|Withdrawal by Subject|1|||
23249621|NCT03576131|64655769|FG001|Overall Study|Withdrawal by Subject|1|||
23249622|NCT03576131|64655770|FG002|Overall Study|Withdrawal by Subject|0|||
23249623|NCT03576131|64655771|FG003|Overall Study|Withdrawal by Subject|1|||
23249624|NCT03576131|64655772|FG004|Overall Study|Withdrawal by Subject|2|||
23249625|NCT03576131|64655773|FG005|Overall Study|Withdrawal by Subject|3|||
23249626|NCT03576131|64655774|FG006|Overall Study|Withdrawal by Subject|1|||
23249627|NCT03576131|64655775|FG007|Overall Study|Withdrawal by Subject|0|||
23249628|NCT03576131|64655768|FG000|Overall Study|Death|3|||
23249629|NCT03576131|64655769|FG001|Overall Study|Death|3|||
23249630|NCT03576131|64655770|FG002|Overall Study|Death|1|||
23249631|NCT03576131|64655771|FG003|Overall Study|Death|5|||
23249632|NCT03576131|64655772|FG004|Overall Study|Death|4|||
23249633|NCT03576131|64655773|FG005|Overall Study|Death|1|||
23249634|NCT03576131|64655774|FG006|Overall Study|Death|0|||
23356105|NCT00802672|65048765|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
23356106|NCT00802672|65048766|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
23356107|NCT00802672|65048767|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
23356108|NCT00802672|65048765|FG000|Overall Study|Adverse Event|1|||
23356109|NCT00802672|65048766|FG001|Overall Study|Adverse Event|1|||
23356110|NCT00802672|65048767|FG002|Overall Study|Adverse Event|1|||
23356111|NCT00802672|65048765|FG000|Overall Study|Protocol Violation|2|||
23356112|NCT00802672|65048766|FG001|Overall Study|Protocol Violation|1|||
23356113|NCT00802672|65048767|FG002|Overall Study|Protocol Violation|1|||
23356114|NCT00802672|65048765|FG000|Overall Study|Lost to Follow-up|5|||
23356115|NCT00802672|65048766|FG001|Overall Study|Lost to Follow-up|5|||
23356116|NCT00802672|65048767|FG002|Overall Study|Lost to Follow-up|3|||
23356117|NCT00802672|65048765|FG000|Overall Study|Withdrawal by Subject|1|||
23356118|NCT00802672|65048766|FG001|Overall Study|Withdrawal by Subject|1|||
23356119|NCT00802672|65048767|FG002|Overall Study|Withdrawal by Subject|2|||
23356120|NCT00802672|65048765|FG000|Overall Study|other|3|||
23356121|NCT00802672|65048766|FG001|Overall Study|other|1|||
23356122|NCT00802672|65048767|FG002|Overall Study|other|2|||
23356123|NCT00055497|65048784|FG000|Overall Study|Adverse Event|1|||
23356124|NCT00055497|65048785|FG001|Overall Study|Adverse Event|1|||
23249635|NCT03576131|64655775|FG007|Overall Study|Death|1|||
23249636|NCT03576131|64655768|FG000|Overall Study|New anti-cancer treatment|5|||
23356125|NCT00055497|65048786|FG002|Overall Study|Adverse Event|1|||
23356126|NCT00055497|65048787|FG003|Overall Study|Adverse Event|28|||
23356127|NCT00055497|65048784|FG000|Overall Study|Withdrawal by Subject|3|||
23356128|NCT00055497|65048785|FG001|Overall Study|Withdrawal by Subject|1|||
23356129|NCT00055497|65048786|FG002|Overall Study|Withdrawal by Subject|1|||
23356130|NCT00055497|65048787|FG003|Overall Study|Withdrawal by Subject|15|||
23356131|NCT00055497|65048784|FG000|Overall Study|Lost to Follow-up|0|||
23356132|NCT00055497|65048785|FG001|Overall Study|Lost to Follow-up|1|||
23356133|NCT00055497|65048786|FG002|Overall Study|Lost to Follow-up|0|||
23249637|NCT03576131|64655769|FG001|Overall Study|New anti-cancer treatment|1|||
23249638|NCT03576131|64655770|FG002|Overall Study|New anti-cancer treatment|2|||
23249639|NCT03576131|64655771|FG003|Overall Study|New anti-cancer treatment|3|||
23249640|NCT03576131|64655772|FG004|Overall Study|New anti-cancer treatment|0|||
23356134|NCT00055497|65048787|FG003|Overall Study|Lost to Follow-up|5|||
23249641|NCT03576131|64655773|FG005|Overall Study|New anti-cancer treatment|0|||
23249642|NCT03576131|64655774|FG006|Overall Study|New anti-cancer treatment|0|||
23249643|NCT03576131|64655775|FG007|Overall Study|New anti-cancer treatment|0|||
23249644|NCT03576131|64655768|FG000|Overall Study|Unspecified reason|0|||
23249645|NCT03576131|64655769|FG001|Overall Study|Unspecified reason|0|||
23249646|NCT03576131|64655770|FG002|Overall Study|Unspecified reason|1|||
23249647|NCT03576131|64655771|FG003|Overall Study|Unspecified reason|1|||
23249648|NCT03576131|64655772|FG004|Overall Study|Unspecified reason|1|||
23249649|NCT03576131|64655773|FG005|Overall Study|Unspecified reason|1|||
23249650|NCT03576131|64655774|FG006|Overall Study|Unspecified reason|0|||
23249651|NCT03576131|64655775|FG007|Overall Study|Unspecified reason|0|||
23249652|NCT03576131|64655768|FG000|Overall Study|Subject non-compliance|0|||
23249653|NCT03576131|64655769|FG001|Overall Study|Subject non-compliance|0|||
23249654|NCT03576131|64655770|FG002|Overall Study|Subject non-compliance|0|||
23249655|NCT03576131|64655771|FG003|Overall Study|Subject non-compliance|0|||
23249656|NCT03576131|64655772|FG004|Overall Study|Subject non-compliance|0|||
23249657|NCT03576131|64655773|FG005|Overall Study|Subject non-compliance|1|||
23249658|NCT03576131|64655774|FG006|Overall Study|Subject non-compliance|0|||
23249659|NCT03576131|64655775|FG007|Overall Study|Subject non-compliance|0|||
23249660|NCT02332655|64655776|FG000|Overall Study|Lack of Efficacy|1|||
23249661|NCT03237481|64655777|FG000|Overall Study|Lost to Follow-up|1|||
23249662|NCT03237481|64655778|FG001|Overall Study|Lost to Follow-up|0|||
23249663|NCT03237481|64655779|FG002|Overall Study|Lost to Follow-up|0|||
23249664|NCT03237481|64655777|FG000|Overall Study|Protocol Violation|1|||
23249665|NCT03237481|64655778|FG001|Overall Study|Protocol Violation|0|||
23249666|NCT03237481|64655779|FG002|Overall Study|Protocol Violation|0|||
23249667|NCT03237481|64655777|FG000|Overall Study|Withdrawal by Subject|3|||
23249668|NCT03237481|64655778|FG001|Overall Study|Withdrawal by Subject|2|||
23249669|NCT03237481|64655779|FG002|Overall Study|Withdrawal by Subject|1|||
23249670|NCT00478673|64655780|FG000|30-Days Post-Procedure|Death|2|||
23189893|NCT00467649|64436194|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23189894|NCT00467649|64436195|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23189895|NCT00467649|64436196|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23189896|NCT00467649|64436197|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23189897|NCT00467649|64436198|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
23189898|NCT00467649|64436199|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
23189899|NCT01157169|64436200|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
23189900|NCT01157169|64436201|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
23189901|NCT01157169|64436200|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
23189902|NCT01157169|64436201|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
23189903|NCT01415440|64436202|FG000|Overall Study|Lost to Follow-up|0|||
23189904|NCT01415440|64436203|FG001|Overall Study|Lost to Follow-up|1|||
23189905|NCT01415440|64436204|FG002|Overall Study|Lost to Follow-up|2|||
23189906|NCT01415440|64436202|FG000|Overall Study|Physician Decision|3|||
23189907|NCT01415440|64436203|FG001|Overall Study|Physician Decision|0|||
23189908|NCT01415440|64436204|FG002|Overall Study|Physician Decision|0|||
23189909|NCT01415440|64436202|FG000|Overall Study|Withdrawal by Subject|1|||
23189910|NCT01415440|64436203|FG001|Overall Study|Withdrawal by Subject|0|||
23189911|NCT01415440|64436204|FG002|Overall Study|Withdrawal by Subject|0|||
23189912|NCT00820040|64436205|FG000|Overall Study|Death|1|||
23189913|NCT00820040|64436205|FG000|Overall Study|Sponsor terminated study|1|||
23189914|NCT00820040|64436205|FG000|Overall Study|Screen failure|1|||
23189915|NCT03088605|64436206|FG000|Overall Study|Withdrawal by Subject|1|||
23189916|NCT03088605|64436207|FG001|Overall Study|Withdrawal by Subject|0|||
23189917|NCT01609933|64436210|FG000|Overall Study|Adverse Event|1|||
23189918|NCT01609933|64436210|FG000|Overall Study|Withdrawal by Subject|3|||
23189919|NCT02493751|64436211|FG000|Overall Study|Withdrawal by Subject|2|||
23189920|NCT02493751|64436212|FG001|Overall Study|Withdrawal by Subject|8|||
23189921|NCT02493751|64436211|FG000|Overall Study|Death|6|||
23189922|NCT02493751|64436212|FG001|Overall Study|Death|13|||
23189923|NCT02493751|64436211|FG000|Overall Study|Lost to Follow-up|2|||
23189924|NCT02493751|64436212|FG001|Overall Study|Lost to Follow-up|3|||
23189925|NCT02493751|64436211|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
23189926|NCT02493751|64436212|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
23189927|NCT00641147|64436217|FG000|Completed 4 Months.|Physician Decision|1|||
23189928|NCT00641147|64436218|FG001|Completed 4 Months.|Physician Decision|0|||
23189929|NCT00641147|64436217|FG000|Completed 4 Months.|Adverse Event|1|||
23189930|NCT00641147|64436218|FG001|Completed 4 Months.|Adverse Event|0|||
23249671|NCT00478673|64655780|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
23249672|NCT00478673|64655780|FG000|30-Days Post-Procedure|Missed Visit|7|||
23249673|NCT00478673|64655780|FG000|12-Months Post-Procedure|Death|23|||
23249674|NCT00478673|64655780|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
23249675|NCT00478673|64655780|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
23249676|NCT00478673|64655780|FG000|12-Months Post-Procedure|Missed Visit|25|||
23249677|NCT00478673|64655780|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
23249678|NCT00743119|64655781|FG000|Overall Study|unreliable|3|||
23249679|NCT00743119|64655781|FG000|Overall Study|Withdrawal by Subject|1|||
23356135|NCT00055497|65048784|FG000|Overall Study|Protocol Violation|0|||
23356136|NCT00055497|65048785|FG001|Overall Study|Protocol Violation|0|||
23356137|NCT00055497|65048786|FG002|Overall Study|Protocol Violation|0|||
23356138|NCT00055497|65048787|FG003|Overall Study|Protocol Violation|3|||
23356139|NCT00055497|65048784|FG000|Overall Study|Lack of Efficacy|1|||
23356140|NCT00055497|65048785|FG001|Overall Study|Lack of Efficacy|0|||
23356141|NCT00055497|65048786|FG002|Overall Study|Lack of Efficacy|0|||
23356142|NCT00055497|65048787|FG003|Overall Study|Lack of Efficacy|27|||
23356143|NCT00055497|65048784|FG000|Overall Study|Administrative Reasons|0|||
23356144|NCT00055497|65048785|FG001|Overall Study|Administrative Reasons|0|||
23356145|NCT00055497|65048786|FG002|Overall Study|Administrative Reasons|0|||
23356146|NCT00055497|65048787|FG003|Overall Study|Administrative Reasons|1|||
23356147|NCT00055497|65048784|FG000|Overall Study|Other|0|||
23356148|NCT00055497|65048785|FG001|Overall Study|Other|0|||
23356149|NCT00055497|65048786|FG002|Overall Study|Other|0|||
23356150|NCT00055497|65048787|FG003|Overall Study|Other|11|||
23356151|NCT00742027|65048789|FG000|Overall Study|Disease Progression|76|||
23356152|NCT00742027|65048789|FG000|Overall Study|New Cancer Therapy|19|||
23356153|NCT00742027|65048789|FG000|Overall Study|Withdrawal by Subject|18|||
23356154|NCT00742027|65048789|FG000|Overall Study|Death|7|||
23356155|NCT00742027|65048789|FG000|Overall Study|Lost to Follow-up|4|||
23356156|NCT00742027|65048789|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
23356157|NCT00742027|65048789|FG000|Overall Study|Missing|2|||
23356158|NCT00742027|65048789|FG000|Overall Study|Administrative Problems|1|||
23356159|NCT01698268|65048790|FG000|Overall Study|Physician Decision|2|||
23356160|NCT01698268|65048791|FG001|Overall Study|Physician Decision|1|||
23356161|NCT00849290|65048792|FG000|Overall Study|Adverse Event|3|||
23356162|NCT00849290|65048792|FG000|Overall Study|Death|14|||
23356163|NCT00849290|65048792|FG000|Overall Study|Withdrawal by Subject|11|||
23356164|NCT00849290|65048792|FG000|Overall Study|Lost to Follow-up|2|||
23356165|NCT00849290|65048792|FG000|Overall Study|Protocol Violation|5|||
23588448|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23588449|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23189931|NCT00641147|64436217|FG000|Completed 8 Months.|Physician Decision|2|||
23189932|NCT00641147|64436218|FG001|Completed 8 Months.|Physician Decision|1|||
23189933|NCT00641147|64436217|FG000|Completed 8 Months.|non compliance|1|||
23189934|NCT00641147|64436218|FG001|Completed 8 Months.|non compliance|0|||
23189935|NCT00641147|64436217|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
23189936|NCT00641147|64436218|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
23189937|NCT00641147|64436217|FG000|Completed 12 Months.|Physician Decision|1|||
23189938|NCT00641147|64436218|FG001|Completed 12 Months.|Physician Decision|1|||
23189939|NCT00641147|64436217|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
23189940|NCT00641147|64436218|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
23189941|NCT00641147|64436217|FG000|Completed 16 Months.|Physician Decision|1|||
23189942|NCT00641147|64436218|FG001|Completed 16 Months.|Physician Decision|0|||
23189943|NCT00641147|64436217|FG000|Completed 16 Months.|Lost to Follow-up|1|||
23189944|NCT00641147|64436218|FG001|Completed 16 Months.|Lost to Follow-up|0|||
23189945|NCT00542815|64436224|FG000|Overall Study|Adverse Event|19|||
23189946|NCT00542815|64436225|FG001|Overall Study|Adverse Event|6|||
23189947|NCT00542815|64436226|FG002|Overall Study|Adverse Event|9|||
23189948|NCT00542815|64436224|FG000|Overall Study|Death|10|||
23189949|NCT00542815|64436225|FG001|Overall Study|Death|7|||
23189950|NCT00542815|64436226|FG002|Overall Study|Death|3|||
23189951|NCT00542815|64436224|FG000|Overall Study|Lack of Efficacy|9|||
23189952|NCT00542815|64436225|FG001|Overall Study|Lack of Efficacy|2|||
23189953|NCT00542815|64436226|FG002|Overall Study|Lack of Efficacy|0|||
23249680|NCT00975884|64655784|FG000|Overall Study|Adverse Event|1|||
23249681|NCT00975884|64655785|FG001|Overall Study|Adverse Event|0|||
23249682|NCT00975884|64655784|FG000|Overall Study|Lost to Follow-up|5|||
23356166|NCT00849290|65048792|FG000|Overall Study|Disease Progression|20|||
23356167|NCT00940888|65048793|FG000|Overall Study|Unsuccessful Implant|4|||
23356168|NCT00940888|65048793|FG000|Overall Study|Death|461|||
23356169|NCT00940888|65048793|FG000|Overall Study|Withdrawn - Non-Death|364|||
23356170|NCT00940888|65048793|FG000|Overall Study|Lost to Follow-up|6|||
23356171|NCT01386944|65048794|FG000|Overall Study|Adverse Event|26|||
23588450|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23588451|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
23189954|NCT00542815|64436224|FG000|Overall Study|Physician Decision|2|||
23189955|NCT00542815|64436225|FG001|Overall Study|Physician Decision|1|||
23189956|NCT00542815|64436226|FG002|Overall Study|Physician Decision|0|||
23189957|NCT00542815|64436224|FG000|Overall Study|Protocol Violation|1|||
23249683|NCT00975884|64655785|FG001|Overall Study|Lost to Follow-up|3|||
23356172|NCT01386944|65048794|FG000|Overall Study|Lack of Efficacy|14|||
23356173|NCT01386944|65048794|FG000|Overall Study|Lost to Follow-up|8|||
23356174|NCT01386944|65048794|FG000|Overall Study|Unspecified reason|8|||
23588452|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
23588453|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
23588454|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
23356175|NCT03544281|65048795|FG000|Overall Study|Death|3|||
23356176|NCT03544281|65048796|FG001|Overall Study|Death|2|||
23356177|NCT03544281|65048797|FG002|Overall Study|Death|6|||
23356178|NCT03544281|65048798|FG003|Overall Study|Death|8|||
23356179|NCT03544281|65048799|FG004|Overall Study|Death|4|||
23356180|NCT03544281|65048800|FG005|Overall Study|Death|2|||
23356181|NCT03544281|65048801|FG006|Overall Study|Death|4|||
23356182|NCT03544281|65048802|FG007|Overall Study|Death|5|||
23356183|NCT03544281|65048803|FG008|Overall Study|Death|5|||
23356184|NCT03544281|65048804|FG009|Overall Study|Death|8|||
23356185|NCT03544281|65048805|FG010|Overall Study|Death|6|||
23356186|NCT03544281|65048806|FG011|Overall Study|Death|4|||
23356187|NCT03544281|65048795|FG000|Overall Study|Lost to Follow-up|0|||
23356188|NCT03544281|65048796|FG001|Overall Study|Lost to Follow-up|0|||
23588455|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
23588456|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
23588457|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
23249684|NCT00975884|64655784|FG000|Overall Study|Withdrawal by Subject|9|||
23249685|NCT00975884|64655785|FG001|Overall Study|Withdrawal by Subject|9|||
23249686|NCT00975884|64655784|FG000|Overall Study|Other|1|||
23249687|NCT00975884|64655785|FG001|Overall Study|Other|3|||
23249688|NCT02617446|64655789|FG000|Overall Study|Withdrawal by Subject|0|||
23249689|NCT02617446|64655790|FG001|Overall Study|Withdrawal by Subject|2|||
23249690|NCT02617446|64655791|FG002|Overall Study|Withdrawal by Subject|0|||
23249691|NCT02617446|64655789|FG000|Overall Study|Adverse Event|1|||
23249692|NCT02617446|64655790|FG001|Overall Study|Adverse Event|0|||
23249693|NCT02617446|64655791|FG002|Overall Study|Adverse Event|5|||
23249694|NCT02617446|64655789|FG000|Overall Study|Lost to Follow-up|3|||
23249695|NCT02617446|64655790|FG001|Overall Study|Lost to Follow-up|0|||
23356189|NCT03544281|65048797|FG002|Overall Study|Lost to Follow-up|0|||
23356190|NCT03544281|65048798|FG003|Overall Study|Lost to Follow-up|0|||
23588458|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
23588459|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
23588460|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
23588461|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
23588462|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
23588463|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588464|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588465|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588466|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588467|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588468|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588469|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588470|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
23588471|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
23588472|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588473|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
23588474|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
23588475|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588476|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588477|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588478|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
23588479|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23588480|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
23588481|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23588482|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
23356191|NCT03544281|65048799|FG004|Overall Study|Lost to Follow-up|0|||
23356192|NCT03544281|65048800|FG005|Overall Study|Lost to Follow-up|0|||
23588483|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
23588484|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23356193|NCT03544281|65048801|FG006|Overall Study|Lost to Follow-up|0|||
23588485|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23588486|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23588487|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23249696|NCT02617446|64655791|FG002|Overall Study|Lost to Follow-up|0|||
23249697|NCT02617446|64655789|FG000|Overall Study|Death|0|||
23356194|NCT03544281|65048802|FG007|Overall Study|Lost to Follow-up|0|||
23356195|NCT03544281|65048803|FG008|Overall Study|Lost to Follow-up|0|||
23356196|NCT03544281|65048804|FG009|Overall Study|Lost to Follow-up|0|||
23356197|NCT03544281|65048805|FG010|Overall Study|Lost to Follow-up|1|||
23356198|NCT03544281|65048806|FG011|Overall Study|Lost to Follow-up|0|||
23356199|NCT03544281|65048795|FG000|Overall Study|Physician Decision|0|||
23356200|NCT03544281|65048796|FG001|Overall Study|Physician Decision|0|||
23356201|NCT03544281|65048797|FG002|Overall Study|Physician Decision|0|||
23356202|NCT03544281|65048798|FG003|Overall Study|Physician Decision|0|||
23356203|NCT03544281|65048799|FG004|Overall Study|Physician Decision|0|||
23249698|NCT02617446|64655790|FG001|Overall Study|Death|0|||
23249699|NCT02617446|64655791|FG002|Overall Study|Death|2|||
23189958|NCT00542815|64436225|FG001|Overall Study|Protocol Violation|1|||
23189959|NCT00542815|64436226|FG002|Overall Study|Protocol Violation|2|||
23189960|NCT00542815|64436224|FG000|Overall Study|Withdrawal by Subject|41|||
23189961|NCT00542815|64436225|FG001|Overall Study|Withdrawal by Subject|5|||
23249700|NCT03428217|64659532|FG000|Overall Study|Death|89|||
23249701|NCT03428217|64659533|FG001|Overall Study|Death|93|||
23249702|NCT03428217|64659532|FG000|Overall Study|Withdrawal by Subject|8|||
23249703|NCT03428217|64659533|FG001|Overall Study|Withdrawal by Subject|7|||
23249704|NCT03428217|64659532|FG000|Overall Study|Lost to Follow-up|1|||
23249705|NCT03428217|64659533|FG001|Overall Study|Lost to Follow-up|3|||
23249706|NCT03428217|64659532|FG000|Overall Study|Study terminated by sponsor|124|||
23249707|NCT03428217|64659533|FG001|Overall Study|Study terminated by sponsor|118|||
23249708|NCT03428217|64659532|FG000|Overall Study|Other, Not Specified|1|||
23249709|NCT03428217|64659533|FG001|Overall Study|Other, Not Specified|0|||
23249710|NCT02773446|64659534|FG000|First Admission|Withdrawal by Subject|0|||
23249711|NCT02773446|64659535|FG001|First Admission|Withdrawal by Subject|0|||
23249712|NCT02773446|64659536|FG002|First Admission|Withdrawal by Subject|0|||
23249713|NCT02773446|64659537|FG003|First Admission|Withdrawal by Subject|1|||
23249714|NCT02773446|64659538|FG004|First Admission|Withdrawal by Subject|0|||
23249715|NCT02773446|64659539|FG005|First Admission|Withdrawal by Subject|0|||
23249716|NCT02773446|64659534|FG000|First Admission|Lost to Follow-up|1|||
23249717|NCT02773446|64659535|FG001|First Admission|Lost to Follow-up|0|||
23249718|NCT02773446|64659536|FG002|First Admission|Lost to Follow-up|0|||
23249719|NCT02773446|64659537|FG003|First Admission|Lost to Follow-up|0|||
23249720|NCT02773446|64659538|FG004|First Admission|Lost to Follow-up|0|||
23249721|NCT02773446|64659539|FG005|First Admission|Lost to Follow-up|0|||
23249722|NCT02748616|64659540|FG000|Overall Study|Lost to Follow-up|1|||
23249723|NCT02748616|64659540|FG000|Overall Study|Withdrawal by Subject|2|||
23249724|NCT02748616|64659540|FG000|Overall Study|Physician Decision|2|||
23249725|NCT02748616|64659540|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
23249726|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
23249727|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
23249728|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
23249729|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
23356204|NCT03544281|65048800|FG005|Overall Study|Physician Decision|0|||
23356205|NCT03544281|65048801|FG006|Overall Study|Physician Decision|0|||
23356206|NCT03544281|65048802|FG007|Overall Study|Physician Decision|1|||
23356207|NCT03544281|65048803|FG008|Overall Study|Physician Decision|0|||
23189962|NCT00542815|64436226|FG002|Overall Study|Withdrawal by Subject|8|||
23189963|NCT00542815|64436224|FG000|Overall Study|Other reasons|24|||
23189964|NCT00542815|64436225|FG001|Overall Study|Other reasons|10|||
23189965|NCT00542815|64436226|FG002|Overall Study|Other reasons|10|||
23189966|NCT01380093|64436227|FG000|Naloxone Challenge Phase|Screen failures|21|||
23189967|NCT01380093|64436228|FG001|Naloxone Challenge Phase|Screen failures|0|||
23189968|NCT01380093|64436229|FG002|Naloxone Challenge Phase|Screen failures|0|||
23189969|NCT01380093|64436230|FG003|Naloxone Challenge Phase|Screen failures|0|||
23189970|NCT01380093|64436231|FG004|Naloxone Challenge Phase|Screen failures|0|||
23189971|NCT01380093|64436232|FG005|Naloxone Challenge Phase|Screen failures|0|||
23189972|NCT01380093|64436233|FG006|Naloxone Challenge Phase|Screen failures|0|||
23189973|NCT01380093|64436234|FG007|Naloxone Challenge Phase|Screen failures|0|||
23189974|NCT01380093|64436235|FG008|Naloxone Challenge Phase|Screen failures|0|||
23189975|NCT01380093|64436227|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23189976|NCT01380093|64436228|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
23249730|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
23356208|NCT03544281|65048804|FG009|Overall Study|Physician Decision|0|||
23249731|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
23249732|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
23249733|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
23249734|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23249735|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23249736|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23249737|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
23356209|NCT03544281|65048805|FG010|Overall Study|Physician Decision|0|||
23356210|NCT03544281|65048806|FG011|Overall Study|Physician Decision|0|||
23189977|NCT01380093|64436229|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23189978|NCT01380093|64436230|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23189979|NCT01380093|64436231|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23189980|NCT01380093|64436232|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23189981|NCT01380093|64436233|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23189982|NCT01380093|64436234|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23189983|NCT01380093|64436235|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
23189984|NCT01380093|64436227|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23189985|NCT01380093|64436228|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
23189986|NCT01380093|64436229|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
23189987|NCT01380093|64436230|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23189988|NCT01380093|64436231|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23189989|NCT01380093|64436232|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23189990|NCT01380093|64436233|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23189991|NCT01380093|64436234|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23189992|NCT01380093|64436235|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
23189993|NCT01380093|64436227|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23189994|NCT01380093|64436228|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
23189995|NCT01380093|64436229|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23189996|NCT01380093|64436230|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23189997|NCT01380093|64436231|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23189998|NCT01380093|64436232|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23189999|NCT01380093|64436233|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23190000|NCT01380093|64436234|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23190001|NCT01380093|64436235|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
23190002|NCT01380093|64436227|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23190003|NCT01380093|64436228|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
23190004|NCT01380093|64436229|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
23190005|NCT01380093|64436230|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23190006|NCT01380093|64436231|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23190007|NCT01380093|64436232|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23190008|NCT01380093|64436233|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23190009|NCT01380093|64436234|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23190010|NCT01380093|64436235|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
23190011|NCT01380093|64436227|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23249738|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
23249739|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23249740|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23249741|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
23249742|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
23249743|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
23356211|NCT03544281|65048795|FG000|Overall Study|Withdrawal by Subject|2|||
23356212|NCT03544281|65048796|FG001|Overall Study|Withdrawal by Subject|0|||
23356213|NCT03544281|65048797|FG002|Overall Study|Withdrawal by Subject|1|||
23356214|NCT03544281|65048798|FG003|Overall Study|Withdrawal by Subject|2|||
23356215|NCT03544281|65048799|FG004|Overall Study|Withdrawal by Subject|0|||
23356216|NCT03544281|65048800|FG005|Overall Study|Withdrawal by Subject|0|||
23356217|NCT03544281|65048801|FG006|Overall Study|Withdrawal by Subject|0|||
23356218|NCT03544281|65048802|FG007|Overall Study|Withdrawal by Subject|0|||
23356219|NCT03544281|65048803|FG008|Overall Study|Withdrawal by Subject|2|||
23356220|NCT03544281|65048804|FG009|Overall Study|Withdrawal by Subject|3|||
23249744|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
23249745|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
23249746|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
23249747|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
23249748|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
23249749|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
23249750|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
23249751|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23249752|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
23249753|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23356221|NCT03544281|65048805|FG010|Overall Study|Withdrawal by Subject|0|||
23356222|NCT03544281|65048806|FG011|Overall Study|Withdrawal by Subject|4|||
23356223|NCT03544281|65048795|FG000|Overall Study|Ongoing at the time of analysis|7|||
23356224|NCT03544281|65048796|FG001|Overall Study|Ongoing at the time of analysis|2|||
23356225|NCT03544281|65048797|FG002|Overall Study|Ongoing at the time of analysis|6|||
23356226|NCT03544281|65048798|FG003|Overall Study|Ongoing at the time of analysis|6|||
23472593|NCT00734539|65474100|FG000|Main Study|Death|33|||
23356227|NCT03544281|65048799|FG004|Overall Study|Ongoing at the time of analysis|8|||
23356228|NCT03544281|65048800|FG005|Overall Study|Ongoing at the time of analysis|10|||
23356229|NCT03544281|65048801|FG006|Overall Study|Ongoing at the time of analysis|8|||
23356230|NCT03544281|65048802|FG007|Overall Study|Ongoing at the time of analysis|6|||
23356231|NCT03544281|65048803|FG008|Overall Study|Ongoing at the time of analysis|6|||
23356232|NCT03544281|65048804|FG009|Overall Study|Ongoing at the time of analysis|6|||
23249754|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
23249755|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23249756|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23249757|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
23249758|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
23249759|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
23249760|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
23249761|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
23472594|NCT00734539|65474101|FG001|Main Study|Death|32|||
23472595|NCT00734539|65474100|FG000|Main Study|Physician Decision|2|||
23472596|NCT00734539|65474101|FG001|Main Study|Physician Decision|0|||
23472597|NCT00734539|65474100|FG000|Main Study|Withdrawal by Subject|1|||
23472598|NCT00734539|65474101|FG001|Main Study|Withdrawal by Subject|3|||
23472599|NCT00734539|65474100|FG000|Main Study|Enrolled in error; ineligible|1|||
23472600|NCT00734539|65474101|FG001|Main Study|Enrolled in error; ineligible|0|||
23472601|NCT00899392|65474102|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
23472602|NCT00899392|65474103|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
23472603|NCT01738646|65474104|FG000|Overall Study|Still Receiving Treatment|2|||
23472604|NCT02331277|65474105|FG000|Overall Study|Withdrawal by Subject|1|||
23472605|NCT02331277|65474106|FG001|Overall Study|Withdrawal by Subject|0|||
23472606|NCT00003590|65474109|FG000|Overall Study|Ineligible Patient|1|||
23472607|NCT00003590|65474109|FG000|Overall Study|Adverse Event|7|||
23472608|NCT00003590|65474109|FG000|Overall Study|Withdrawal by Subject|1|||
23472609|NCT00003590|65474109|FG000|Overall Study|Lack of Efficacy|11|||
23472610|NCT00003590|65474109|FG000|Overall Study|Death|1|||
23472611|NCT00003590|65474109|FG000|Overall Study|Physician Decision|1|||
23472612|NCT02745080|65474110|FG000|Overall Study|Adverse Event|13|||
23472613|NCT02745080|65474111|FG001|Overall Study|Adverse Event|21|||
23472614|NCT02745080|65474110|FG000|Overall Study|Lack of Efficacy|11|||
23472615|NCT02745080|65474111|FG001|Overall Study|Lack of Efficacy|23|||
23472616|NCT02745080|65474110|FG000|Overall Study|Lost to Follow-up|3|||
23472617|NCT02745080|65474111|FG001|Overall Study|Lost to Follow-up|3|||
23472618|NCT02745080|65474110|FG000|Overall Study|Physician Decision|3|||
23472619|NCT02745080|65474111|FG001|Overall Study|Physician Decision|0|||
23472620|NCT02745080|65474110|FG000|Overall Study|Protocol Violation|3|||
23472621|NCT02745080|65474111|FG001|Overall Study|Protocol Violation|1|||
23472622|NCT02745080|65474110|FG000|Overall Study|Withdrawal by Subject|22|||
23472623|NCT02745080|65474111|FG001|Overall Study|Withdrawal by Subject|41|||
23472624|NCT04849559|65474114|FG000|Overall Study|Withdrawal by Subject|2|||
23472625|NCT04849559|65474115|FG001|Overall Study|Withdrawal by Subject|1|||
23472626|NCT01396447|65474116|FG000|Overall Study|Did Not Receive Treatment|3|||
23472627|NCT01396447|65474117|FG001|Overall Study|Did Not Receive Treatment|2|||
23472628|NCT01396447|65474118|FG002|Overall Study|Did Not Receive Treatment|1|||
23472629|NCT01396447|65474119|FG003|Overall Study|Did Not Receive Treatment|0|||
23472630|NCT01396447|65474116|FG000|Overall Study|Adverse Event|15|||
23472631|NCT01396447|65474117|FG001|Overall Study|Adverse Event|12|||
23249762|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
23249763|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
23356233|NCT03544281|65048805|FG010|Overall Study|Ongoing at the time of analysis|5|||
23472632|NCT01396447|65474118|FG002|Overall Study|Adverse Event|12|||
23472633|NCT01396447|65474119|FG003|Overall Study|Adverse Event|17|||
23472634|NCT01396447|65474116|FG000|Overall Study|Insufficient Therapeutic Response|5|||
23472635|NCT01396447|65474117|FG001|Overall Study|Insufficient Therapeutic Response|5|||
23472636|NCT01396447|65474118|FG002|Overall Study|Insufficient Therapeutic Response|2|||
23588488|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
23588489|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
23588490|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588491|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
23588492|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
23588493|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588494|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588495|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588496|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
23588497|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
23588498|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
23588499|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23472637|NCT01396447|65474119|FG003|Overall Study|Insufficient Therapeutic Response|4|||
23472638|NCT01396447|65474116|FG000|Overall Study|Protocol Violation|5|||
23472639|NCT01396447|65474117|FG001|Overall Study|Protocol Violation|2|||
23472640|NCT01396447|65474118|FG002|Overall Study|Protocol Violation|3|||
23472641|NCT01396447|65474119|FG003|Overall Study|Protocol Violation|7|||
23472642|NCT01396447|65474116|FG000|Overall Study|Withdrawal of Consent|11|||
23472643|NCT01396447|65474117|FG001|Overall Study|Withdrawal of Consent|9|||
23472644|NCT01396447|65474118|FG002|Overall Study|Withdrawal of Consent|4|||
23472645|NCT01396447|65474119|FG003|Overall Study|Withdrawal of Consent|15|||
23472646|NCT01396447|65474116|FG000|Overall Study|Lost to Follow-up|4|||
23472647|NCT01396447|65474117|FG001|Overall Study|Lost to Follow-up|8|||
23472648|NCT01396447|65474118|FG002|Overall Study|Lost to Follow-up|7|||
23472649|NCT01396447|65474119|FG003|Overall Study|Lost to Follow-up|9|||
23472650|NCT01396447|65474116|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23472651|NCT01396447|65474117|FG001|Overall Study|Other Miscellaneous Reasons|2|||
23472652|NCT01396447|65474118|FG002|Overall Study|Other Miscellaneous Reasons|1|||
23472653|NCT01396447|65474119|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23472654|NCT03241368|65474120|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
23472655|NCT03241368|65474120|FG000|Overall Study|Lost to Follow-up|1|||
23472656|NCT03241368|65474120|FG000|Overall Study|Physician Decision|6|||
23472657|NCT03241368|65474120|FG000|Overall Study|Withdrawal by Subject|6|||
23472658|NCT03241368|65474120|FG000|Overall Study|Protocol Violation|1|||
23472659|NCT02424578|65474124|FG000|Overall Study|Withdrawal by Subject|0|||
23472660|NCT02424578|65474125|FG001|Overall Study|Withdrawal by Subject|1|||
23472661|NCT02034409|65474126|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
23472662|NCT02034409|65474127|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
23472663|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
23472664|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
23472665|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
23472666|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
23472667|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
23472668|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
23472669|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
23472670|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
23472671|NCT02034409|65474126|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
23472672|NCT02034409|65474127|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
23472673|NCT01311024|65474128|FG000|Overall Study|Protocol Violation|35|||
23472674|NCT01311024|65474129|FG001|Overall Study|Protocol Violation|22|||
23472675|NCT01112306|65474130|FG000|Overall Study|Death|175|||
23472676|NCT01112306|65474130|FG000|Overall Study|Lost to Follow-up|9|||
23472677|NCT01112306|65474130|FG000|Overall Study|Withdrawal by Subject|31|||
23472678|NCT01112306|65474130|FG000|Overall Study|Other|70|||
23472679|NCT04681352|65474131|FG000|Overall Study|Lost to Follow-up|2|||
23472680|NCT04681352|65474131|FG000|Overall Study|Withdrawal by Subject|22|||
23472681|NCT02116205|65474132|FG000|Overall Study|Withdrawal by Subject|2|||
23472682|NCT02116205|65474133|FG001|Overall Study|Withdrawal by Subject|4|||
23472683|NCT02116205|65474134|FG002|Overall Study|Withdrawal by Subject|1|||
23472684|NCT02116205|65474135|FG003|Overall Study|Withdrawal by Subject|3|||
23472685|NCT02116205|65474132|FG000|Overall Study|Lost to Follow-up|0|||
23472686|NCT02116205|65474133|FG001|Overall Study|Lost to Follow-up|2|||
23472687|NCT02116205|65474134|FG002|Overall Study|Lost to Follow-up|1|||
23588500|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
23588501|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588502|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588503|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588504|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588505|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588506|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588507|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
23588508|NCT01212757|65882156|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588509|NCT01212757|65882157|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
23588510|NCT01212757|65882158|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
23588511|NCT01212757|65882159|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588512|NCT01212757|65882160|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23472688|NCT02116205|65474135|FG003|Overall Study|Lost to Follow-up|2|||
23588513|NCT01212757|65882161|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23472689|NCT02116205|65474132|FG000|Overall Study|Physician Decision|0|||
23472690|NCT02116205|65474133|FG001|Overall Study|Physician Decision|1|||
23472691|NCT02116205|65474134|FG002|Overall Study|Physician Decision|1|||
23472692|NCT02116205|65474135|FG003|Overall Study|Physician Decision|1|||
23472693|NCT02116205|65474132|FG000|Overall Study|Exclusion criteria|0|||
23472694|NCT02116205|65474133|FG001|Overall Study|Exclusion criteria|0|||
23472695|NCT02116205|65474134|FG002|Overall Study|Exclusion criteria|1|||
23472696|NCT02116205|65474135|FG003|Overall Study|Exclusion criteria|0|||
23472697|NCT01561313|65474139|FG000|Overall Study|Withdrawal by Subject|1|||
23472698|NCT01561313|65474140|FG001|Overall Study|Withdrawal by Subject|0|||
23472699|NCT01561313|65474139|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
23472700|NCT01561313|65474140|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
23472701|NCT00832624|65477440|FG000|Overall Study|Study Terminated|10|||
23472702|NCT01325337|65477448|FG000|Overall Study|Adverse Event|0|||
23249764|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
23472703|NCT01325337|65477449|FG001|Overall Study|Adverse Event|2|||
23472704|NCT01325337|65477450|FG002|Overall Study|Adverse Event|2|||
23472705|NCT01325337|65477451|FG003|Overall Study|Adverse Event|1|||
23472706|NCT01325337|65477452|FG004|Overall Study|Adverse Event|2|||
23472707|NCT01325337|65477448|FG000|Overall Study|Lost to Follow-up|2|||
23472708|NCT01325337|65477449|FG001|Overall Study|Lost to Follow-up|2|||
23472709|NCT01325337|65477450|FG002|Overall Study|Lost to Follow-up|2|||
23472710|NCT01325337|65477451|FG003|Overall Study|Lost to Follow-up|1|||
23249765|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
23249766|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
23249767|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
23249768|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
23249769|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
23249770|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
23249771|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
23249772|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
23249773|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
23249774|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
23249775|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
23249776|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23249777|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
23249778|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23249779|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23249780|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23249781|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
23249782|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
23249783|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
23249784|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
23249785|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
23249786|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
23249787|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
23249788|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
23249789|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
23249790|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
23249791|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
23249792|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
23249793|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
23249794|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
23249795|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
23249796|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
23249797|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
23249798|NCT04440163|64659548|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
23249799|NCT04440163|64659549|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
23249800|NCT04440163|64659550|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
23249801|NCT04440163|64659551|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
23249802|NCT04440163|64659552|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
23249803|NCT04440163|64659553|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
23249804|NCT04440163|64659554|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
23249805|NCT04440163|64659555|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
23249806|NCT04440163|64659548|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
23249807|NCT04440163|64659549|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
23249808|NCT04440163|64659550|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
23249809|NCT04440163|64659551|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
23249810|NCT04440163|64659552|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
23249811|NCT04440163|64659553|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
23249812|NCT04440163|64659554|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
23249813|NCT04440163|64659555|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
23249814|NCT04440163|64659548|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23249815|NCT04440163|64659549|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23249816|NCT04440163|64659550|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23249817|NCT04440163|64659551|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
23249818|NCT04440163|64659552|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23249819|NCT04440163|64659553|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23249820|NCT04440163|64659554|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23249821|NCT04440163|64659555|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
23249822|NCT00563524|64659556|FG000|Overall Study|Adverse Event|0|||
23249823|NCT00563524|64659557|FG001|Overall Study|Adverse Event|1|||
23472711|NCT01325337|65477452|FG004|Overall Study|Lost to Follow-up|2|||
23249824|NCT00563524|64659558|FG002|Overall Study|Adverse Event|0|||
23249825|NCT00563524|64659559|FG003|Overall Study|Adverse Event|0|||
23249826|NCT00563524|64659560|FG004|Overall Study|Adverse Event|2|||
23249827|NCT00563524|64659561|FG005|Overall Study|Adverse Event|0|||
23249828|NCT00563524|64659556|FG000|Overall Study|Lost to Follow-up|1|||
23249829|NCT00563524|64659557|FG001|Overall Study|Lost to Follow-up|0|||
23249830|NCT00563524|64659558|FG002|Overall Study|Lost to Follow-up|0|||
23249831|NCT00563524|64659559|FG003|Overall Study|Lost to Follow-up|0|||
23249832|NCT00563524|64659560|FG004|Overall Study|Lost to Follow-up|0|||
23249833|NCT00563524|64659561|FG005|Overall Study|Lost to Follow-up|0|||
23249834|NCT00563524|64659556|FG000|Overall Study|Protocol Violation|0|||
23249835|NCT00563524|64659557|FG001|Overall Study|Protocol Violation|1|||
23249836|NCT00563524|64659558|FG002|Overall Study|Protocol Violation|0|||
23249837|NCT00563524|64659559|FG003|Overall Study|Protocol Violation|0|||
23249838|NCT00563524|64659560|FG004|Overall Study|Protocol Violation|0|||
23356234|NCT03544281|65048806|FG011|Overall Study|Ongoing at the time of analysis|8|||
23356235|NCT03544281|65048795|FG000|Overall Study|Investigator Site Closed|0|||
23356236|NCT03544281|65048796|FG001|Overall Study|Investigator Site Closed|0|||
23356237|NCT03544281|65048797|FG002|Overall Study|Investigator Site Closed|0|||
23356238|NCT03544281|65048798|FG003|Overall Study|Investigator Site Closed|0|||
23356239|NCT03544281|65048799|FG004|Overall Study|Investigator Site Closed|0|||
23356240|NCT03544281|65048800|FG005|Overall Study|Investigator Site Closed|0|||
23356241|NCT03544281|65048801|FG006|Overall Study|Investigator Site Closed|0|||
23356242|NCT03544281|65048802|FG007|Overall Study|Investigator Site Closed|0|||
23356243|NCT03544281|65048803|FG008|Overall Study|Investigator Site Closed|0|||
23249839|NCT00563524|64659561|FG005|Overall Study|Protocol Violation|0|||
23249840|NCT00563524|64659556|FG000|Overall Study|Withdrawal by Subject|1|||
23249841|NCT00563524|64659557|FG001|Overall Study|Withdrawal by Subject|1|||
23249842|NCT00563524|64659558|FG002|Overall Study|Withdrawal by Subject|3|||
23356244|NCT03544281|65048804|FG009|Overall Study|Investigator Site Closed|1|||
23356245|NCT03544281|65048805|FG010|Overall Study|Investigator Site Closed|0|||
23356246|NCT03544281|65048806|FG011|Overall Study|Investigator Site Closed|0|||
23356247|NCT03544281|65048795|FG000|Overall Study|Did not receive study treatment|0|||
23356248|NCT03544281|65048796|FG001|Overall Study|Did not receive study treatment|0|||
23356249|NCT03544281|65048797|FG002|Overall Study|Did not receive study treatment|0|||
23356250|NCT03544281|65048798|FG003|Overall Study|Did not receive study treatment|0|||
23356251|NCT03544281|65048799|FG004|Overall Study|Did not receive study treatment|0|||
23356252|NCT03544281|65048800|FG005|Overall Study|Did not receive study treatment|0|||
23356253|NCT03544281|65048801|FG006|Overall Study|Did not receive study treatment|1|||
23356254|NCT03544281|65048802|FG007|Overall Study|Did not receive study treatment|0|||
23356255|NCT03544281|65048803|FG008|Overall Study|Did not receive study treatment|0|||
23356256|NCT03544281|65048804|FG009|Overall Study|Did not receive study treatment|0|||
23356257|NCT03544281|65048805|FG010|Overall Study|Did not receive study treatment|0|||
23356258|NCT03544281|65048806|FG011|Overall Study|Did not receive study treatment|0|||
23356259|NCT00534638|65048807|FG000|Overall Study|Withdrawal by Subject|3|||
23356260|NCT00534638|65048808|FG001|Overall Study|Withdrawal by Subject|4|||
23356261|NCT00534638|65048807|FG000|Overall Study|Migrated/moved from study area|13|||
23356262|NCT00534638|65048808|FG001|Overall Study|Migrated/moved from study area|11|||
23356263|NCT00534638|65048807|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
23249843|NCT00563524|64659559|FG003|Overall Study|Withdrawal by Subject|0|||
23249844|NCT00563524|64659560|FG004|Overall Study|Withdrawal by Subject|0|||
23249845|NCT00563524|64659561|FG005|Overall Study|Withdrawal by Subject|1|||
23249846|NCT00720304|64659568|FG000|Overall Study|Withdrawal by Subject|14|||
23249847|NCT00720304|64659569|FG001|Overall Study|Withdrawal by Subject|1|||
23249848|NCT00720304|64659568|FG000|Overall Study|Death|1|||
23249849|NCT00720304|64659569|FG001|Overall Study|Death|0|||
23356264|NCT00534638|65048808|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
23356265|NCT00534638|65048807|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
23356266|NCT00534638|65048808|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
23356267|NCT00534638|65048807|FG000|Overall Study|Other|1685|||
23356268|NCT00534638|65048808|FG001|Overall Study|Other|902|||
23356269|NCT01172808|65048809|FG000|Overall Study|Adverse Event|8|||
23356270|NCT01172808|65048810|FG001|Overall Study|Adverse Event|4|||
23472712|NCT01325337|65477448|FG000|Overall Study|Personal Reasons|2|||
23472713|NCT01325337|65477449|FG001|Overall Study|Personal Reasons|5|||
23249850|NCT00720304|64659568|FG000|Overall Study|Physician Decision|5|||
23356271|NCT01172808|65048811|FG002|Overall Study|Adverse Event|8|||
23356272|NCT01172808|65048812|FG003|Overall Study|Adverse Event|3|||
23356273|NCT01172808|65048809|FG000|Overall Study|Lack of Efficacy|1|||
23356274|NCT01172808|65048810|FG001|Overall Study|Lack of Efficacy|0|||
23356275|NCT01172808|65048811|FG002|Overall Study|Lack of Efficacy|0|||
23249851|NCT00720304|64659569|FG001|Overall Study|Physician Decision|2|||
23249852|NCT00720304|64659568|FG000|Overall Study|Adverse Event|3|||
23249853|NCT00720304|64659569|FG001|Overall Study|Adverse Event|1|||
23249854|NCT00720304|64659568|FG000|Overall Study|Disease progression|6|||
23249855|NCT00720304|64659569|FG001|Overall Study|Disease progression|1|||
23356276|NCT01172808|65048812|FG003|Overall Study|Lack of Efficacy|0|||
23356277|NCT01172808|65048809|FG000|Overall Study|Protocol Violation|2|||
23356278|NCT01172808|65048810|FG001|Overall Study|Protocol Violation|2|||
23356279|NCT01172808|65048811|FG002|Overall Study|Protocol Violation|2|||
23356280|NCT01172808|65048812|FG003|Overall Study|Protocol Violation|0|||
23356281|NCT01172808|65048809|FG000|Overall Study|Lost to Follow-up|0|||
23356282|NCT01172808|65048810|FG001|Overall Study|Lost to Follow-up|1|||
23356283|NCT01172808|65048811|FG002|Overall Study|Lost to Follow-up|1|||
23356284|NCT01172808|65048812|FG003|Overall Study|Lost to Follow-up|3|||
23356285|NCT01172808|65048809|FG000|Overall Study|Withdrawal by Subject|4|||
23356286|NCT01172808|65048810|FG001|Overall Study|Withdrawal by Subject|1|||
23356287|NCT01172808|65048811|FG002|Overall Study|Withdrawal by Subject|3|||
23356288|NCT01172808|65048812|FG003|Overall Study|Withdrawal by Subject|2|||
23356289|NCT01172808|65048809|FG000|Overall Study|Other|6|||
23356290|NCT01172808|65048810|FG001|Overall Study|Other|5|||
23356291|NCT01172808|65048811|FG002|Overall Study|Other|9|||
23356292|NCT01172808|65048812|FG003|Overall Study|Other|7|||
23356293|NCT03959488|65048813|FG000|Season 1|Other|6|||
23356294|NCT03959488|65048814|FG001|Season 1|Other|7|||
23249856|NCT01052038|64659572|FG000|Overall Study|Lost to Follow-up|2|||
23249857|NCT01052038|64659573|FG001|Overall Study|Lost to Follow-up|3|||
23249858|NCT01052038|64659574|FG002|Overall Study|Lost to Follow-up|1|||
23249859|NCT01052038|64659572|FG000|Overall Study|Protocol Violation|2|||
23249860|NCT01052038|64659573|FG001|Overall Study|Protocol Violation|3|||
23249861|NCT01052038|64659574|FG002|Overall Study|Protocol Violation|3|||
23249862|NCT01383954|64659575|FG000|Overall Study|Lack of Efficacy|2|||
23249863|NCT01383954|64659575|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
23249864|NCT01383954|64659575|FG000|Overall Study|Adverse Event|1|||
23249865|NCT01383954|64659575|FG000|Overall Study|Reason Not Specified|9|||
23249866|NCT01614925|64659576|FG000|Overall Study|Withdrawal by Subject|1|||
23249867|NCT01614925|64659577|FG001|Overall Study|Withdrawal by Subject|0|||
23249868|NCT01614925|64659576|FG000|Overall Study|Protocol Violation|3|||
23249869|NCT01614925|64659577|FG001|Overall Study|Protocol Violation|2|||
23249870|NCT02038959|64659578|FG000|Overall Study|Withdrawal by Subject|6|||
23249871|NCT02038959|64659579|FG001|Overall Study|Withdrawal by Subject|8|||
23249872|NCT03940586|64659581|FG000|Overall Study|Death|3|||
23249873|NCT03940586|64659582|FG001|Overall Study|Death|2|||
23249874|NCT03940586|64659583|FG002|Overall Study|Death|0|||
23249875|NCT03940586|64659581|FG000|Overall Study|Physician Decision|1|||
23356295|NCT03959488|65048815|FG002|Season 1|Other|0|||
23356296|NCT03959488|65048816|FG003|Season 1|Other|0|||
23356297|NCT03959488|65048817|FG004|Season 1|Other|0|||
23356298|NCT03959488|65048813|FG000|Season 1|Withdrawal by parent/guardian|43|||
23356299|NCT03959488|65048814|FG001|Season 1|Withdrawal by parent/guardian|28|||
23356300|NCT03959488|65048815|FG002|Season 1|Withdrawal by parent/guardian|0|||
23356301|NCT03959488|65048816|FG003|Season 1|Withdrawal by parent/guardian|0|||
23356302|NCT03959488|65048817|FG004|Season 1|Withdrawal by parent/guardian|0|||
23356303|NCT03959488|65048813|FG000|Season 1|Due to COVID-19 pandemic|2|||
23356304|NCT03959488|65048814|FG001|Season 1|Due to COVID-19 pandemic|3|||
23356305|NCT03959488|65048815|FG002|Season 1|Due to COVID-19 pandemic|0|||
23356306|NCT03959488|65048816|FG003|Season 1|Due to COVID-19 pandemic|0|||
23356307|NCT03959488|65048817|FG004|Season 1|Due to COVID-19 pandemic|0|||
23356308|NCT03959488|65048813|FG000|Season 1|Lost to Follow-up|17|||
23356309|NCT03959488|65048814|FG001|Season 1|Lost to Follow-up|7|||
23356310|NCT03959488|65048815|FG002|Season 1|Lost to Follow-up|0|||
23356311|NCT03959488|65048816|FG003|Season 1|Lost to Follow-up|0|||
23356312|NCT03959488|65048817|FG004|Season 1|Lost to Follow-up|0|||
23249876|NCT03940586|64659582|FG001|Overall Study|Physician Decision|0|||
23249877|NCT03940586|64659583|FG002|Overall Study|Physician Decision|1|||
23249878|NCT03940586|64659581|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
23249879|NCT03940586|64659582|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
23249880|NCT03940586|64659583|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
23249881|NCT03940586|64659581|FG000|Overall Study|Not Treated|0|||
23249882|NCT03940586|64659582|FG001|Overall Study|Not Treated|2|||
23249883|NCT03940586|64659583|FG002|Overall Study|Not Treated|0|||
23249884|NCT02756078|64659584|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
23356313|NCT03959488|65048813|FG000|Season 1|Death|5|||
23356314|NCT03959488|65048814|FG001|Season 1|Death|1|||
23356315|NCT03959488|65048815|FG002|Season 1|Death|0|||
23356316|NCT03959488|65048816|FG003|Season 1|Death|0|||
23356317|NCT03959488|65048817|FG004|Season 1|Death|0|||
23356318|NCT03959488|65048813|FG000|Season 2|Other|0|||
23356319|NCT03959488|65048814|FG001|Season 2|Other|0|||
23190012|NCT01380093|64436228|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
23190013|NCT01380093|64436229|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
23190014|NCT01380093|64436230|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23249885|NCT02756078|64659585|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
23356320|NCT03959488|65048815|FG002|Season 2|Other|2|||
23356321|NCT03959488|65048816|FG003|Season 2|Other|0|||
23356322|NCT03959488|65048817|FG004|Season 2|Other|0|||
23356323|NCT03959488|65048813|FG000|Season 2|Withdrawal by parent/guardian|0|||
23249886|NCT02756078|64659584|FG000|Period 1|Lost to Follow-up|0|||
23249887|NCT02756078|64659585|FG001|Period 1|Lost to Follow-up|2|||
23249888|NCT02756078|64659584|FG000|Period 1|Protocol Violation|0|||
23249889|NCT02756078|64659585|FG001|Period 1|Protocol Violation|1|||
23249890|NCT02756078|64659584|FG000|Period 1|Adverse Event|1|||
23249891|NCT02756078|64659585|FG001|Period 1|Adverse Event|10|||
23249892|NCT02756078|64659584|FG000|Period 1|Withdrawal by Subject|6|||
23249893|NCT02756078|64659585|FG001|Period 1|Withdrawal by Subject|6|||
23249894|NCT02756078|64659584|FG000|Period 1|Lens Discomfort|2|||
23249895|NCT02756078|64659585|FG001|Period 1|Lens Discomfort|2|||
23249896|NCT02756078|64659584|FG000|Period 2|Adverse Event|3|||
23249897|NCT02756078|64659585|FG001|Period 2|Adverse Event|5|||
23249898|NCT02756078|64659584|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
23249899|NCT02756078|64659585|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
23249900|NCT02756078|64659584|FG000|Period 2|Withdrawal by Subject|3|||
23249901|NCT02756078|64659585|FG001|Period 2|Withdrawal by Subject|1|||
23356324|NCT03959488|65048814|FG001|Season 2|Withdrawal by parent/guardian|0|||
23356325|NCT03959488|65048815|FG002|Season 2|Withdrawal by parent/guardian|3|||
23249902|NCT05478603|64659589|FG000|Overall Study|Withdrawal by Subject|0|||
23249903|NCT05478603|64659590|FG001|Overall Study|Withdrawal by Subject|1|||
23249904|NCT05478603|64659591|FG002|Overall Study|Withdrawal by Subject|0|||
23249905|NCT05478603|64659592|FG003|Overall Study|Withdrawal by Subject|0|||
23249906|NCT04529096|64659593|FG000|Overall Study|Adverse Event|6|||
23249907|NCT04529096|64659594|FG001|Overall Study|Adverse Event|1|||
23249908|NCT04529096|64659593|FG000|Overall Study|Lack of Efficacy|1|||
23249909|NCT04529096|64659594|FG001|Overall Study|Lack of Efficacy|0|||
23249910|NCT04529096|64659593|FG000|Overall Study|Lost to Follow-up|1|||
23249911|NCT04529096|64659594|FG001|Overall Study|Lost to Follow-up|1|||
23190015|NCT01380093|64436231|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23190016|NCT01380093|64436232|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23190017|NCT01380093|64436233|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23190018|NCT01380093|64436234|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23190019|NCT01380093|64436235|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
23190020|NCT01380093|64436227|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
23190021|NCT01380093|64436228|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
23190022|NCT01380093|64436229|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
23190023|NCT01380093|64436230|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
23190024|NCT01380093|64436231|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
23190025|NCT01380093|64436232|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
23190026|NCT01380093|64436233|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
23190027|NCT01380093|64436234|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
23190028|NCT01380093|64436235|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
23190029|NCT01380093|64436227|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23190030|NCT01380093|64436228|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23190031|NCT01380093|64436229|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
23190032|NCT01380093|64436230|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23190033|NCT01380093|64436231|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23190034|NCT01380093|64436232|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23190035|NCT01380093|64436233|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23190036|NCT01380093|64436234|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23190037|NCT01380093|64436235|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
23190038|NCT01380093|64436227|FG000|Treatment Phase: Second Intervention|Other|0|||
23190039|NCT01380093|64436228|FG001|Treatment Phase: Second Intervention|Other|0|||
23249912|NCT04529096|64659593|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23249913|NCT04529096|64659594|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23249914|NCT04529096|64659593|FG000|Overall Study|Physician Decision|1|||
23356326|NCT03959488|65048816|FG003|Season 2|Withdrawal by parent/guardian|1|||
23249915|NCT04529096|64659594|FG001|Overall Study|Physician Decision|3|||
23249916|NCT04529096|64659593|FG000|Overall Study|Withdrawal by Subject|5|||
23249917|NCT04529096|64659594|FG001|Overall Study|Withdrawal by Subject|0|||
23249918|NCT00343642|64659595|FG000|Overall Study|Lost to Follow-up|0|||
23249919|NCT00343642|64659596|FG001|Overall Study|Lost to Follow-up|1|||
23356327|NCT03959488|65048817|FG004|Season 2|Withdrawal by parent/guardian|1|||
23249920|NCT00343642|64659597|FG002|Overall Study|Lost to Follow-up|0|||
23356328|NCT03959488|65048813|FG000|Season 2|Lost to Follow-up|0|||
23249921|NCT00343642|64659595|FG000|Overall Study|Pregnancy|1|||
23249922|NCT00343642|64659596|FG001|Overall Study|Pregnancy|0|||
23249923|NCT00343642|64659597|FG002|Overall Study|Pregnancy|2|||
23249924|NCT00343642|64659595|FG000|Overall Study|Withdrawal by Subject|2|||
23249925|NCT00343642|64659596|FG001|Overall Study|Withdrawal by Subject|3|||
23249926|NCT00343642|64659597|FG002|Overall Study|Withdrawal by Subject|4|||
23249927|NCT00343642|64659595|FG000|Overall Study|Adverse Event|0|||
23249928|NCT00343642|64659596|FG001|Overall Study|Adverse Event|0|||
23249929|NCT00343642|64659597|FG002|Overall Study|Adverse Event|1|||
23249930|NCT00343642|64659595|FG000|Overall Study|Flare up|6|||
23249931|NCT00343642|64659596|FG001|Overall Study|Flare up|4|||
23249932|NCT00343642|64659597|FG002|Overall Study|Flare up|0|||
23249933|NCT05180630|64659598|FG000|First Intervention|Physician Decision|0|||
23249934|NCT05180630|64659599|FG001|First Intervention|Physician Decision|0|||
23249935|NCT05180630|64659600|FG002|First Intervention|Physician Decision|3|||
23249936|NCT00792948|64659605|FG000|Overall Study|Adverse Event|6|||
23249937|NCT00792948|64659605|FG000|Overall Study|Death|4|||
23249938|NCT00792948|64659605|FG000|Overall Study|Withdrawal by Subject|3|||
23249939|NCT00792948|64659605|FG000|Overall Study|Ineligible|2|||
23249940|NCT00792948|64659605|FG000|Overall Study|Insurance denial - not treated|1|||
23249941|NCT00792948|64659605|FG000|Overall Study|Physician Decision|11|||
23249942|NCT00792948|64659605|FG000|Overall Study|Protocol Violation|1|||
23249943|NCT00849524|64659606|FG000|Overall Study|Lack of Efficacy|3|||
23249944|NCT01791127|64659620|FG000|Overall Study|Death|356|||
23249945|NCT01791127|64659620|FG000|Overall Study|Patient has withdrawn from study|293|||
23249946|NCT01791127|64659620|FG000|Overall Study|Lost to Follow-up|42|||
23249947|NCT01791127|64659620|FG000|Overall Study|All Siello leads are explanted|31|||
23249948|NCT01791127|64659620|FG000|Overall Study|Completion of 30 day safety registry|1|||
23249949|NCT01791127|64659620|FG000|Overall Study|Study terminated for EP Passion|749|||
23249950|NCT00306852|64659621|FG000|Overall Study|Death|14|||
23249951|NCT00306852|64659622|FG001|Overall Study|Death|14|||
23249952|NCT00306852|64659621|FG000|Overall Study|Lost to Follow-up|15|||
23249953|NCT00306852|64659622|FG001|Overall Study|Lost to Follow-up|24|||
23249954|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Adverse Event|2|||
23249955|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Adverse Event|0|||
23249956|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Adverse Event|0|||
23249957|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Adverse Event|0|||
23249958|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
23249959|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
23249960|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
23249961|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
23249962|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
23249963|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
23249964|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
23249965|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
23249966|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Physician Decision|1|||
23356329|NCT03959488|65048814|FG001|Season 2|Lost to Follow-up|0|||
23249967|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Physician Decision|0|||
23249968|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Physician Decision|0|||
23249969|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Physician Decision|0|||
23249970|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Pregnancy|1|||
23249971|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Pregnancy|0|||
23249972|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Pregnancy|0|||
23249973|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Pregnancy|0|||
23249974|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
23249975|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
23249976|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
23249977|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
23249978|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
23249979|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
23249980|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
23249981|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
23249982|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
23249983|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
23249984|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
23249985|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
23249986|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
23249987|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
23249988|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
23249989|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
23249990|NCT04057573|64659623|FG000|24-Week Double-Blind Period|Not Treated|1|||
23249991|NCT04057573|64659624|FG001|24-Week Double-Blind Period|Not Treated|0|||
23249992|NCT04057573|64659625|FG002|24-Week Double-Blind Period|Not Treated|0|||
23249993|NCT04057573|64659626|FG003|24-Week Double-Blind Period|Not Treated|0|||
23249994|NCT04057573|64659623|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
23249995|NCT04057573|64659624|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
23249996|NCT04057573|64659625|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
23249997|NCT04057573|64659626|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
23249998|NCT04057573|64659623|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
23249999|NCT04057573|64659624|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
23250000|NCT04057573|64659625|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
23250001|NCT04057573|64659626|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
23250002|NCT04057573|64659623|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
23250003|NCT04057573|64659624|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
23250004|NCT04057573|64659625|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
23250005|NCT04057573|64659626|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
23250006|NCT04057573|64659623|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
23250007|NCT04057573|64659624|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
23250008|NCT04057573|64659625|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
23250009|NCT04057573|64659626|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
23250010|NCT04057573|64659623|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
23250011|NCT04057573|64659624|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
23250012|NCT04057573|64659625|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
23250013|NCT04057573|64659626|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
23250014|NCT00572156|64659627|FG000|Overall Study|Adverse Event|3|||
23250015|NCT00572156|64659628|FG001|Overall Study|Adverse Event|1|||
23250016|NCT00572156|64659629|FG002|Overall Study|Adverse Event|5|||
23250017|NCT00572156|64659630|FG003|Overall Study|Adverse Event|1|||
23250018|NCT00572156|64659627|FG000|Overall Study|Lost to Follow-up|1|||
23250019|NCT00572156|64659628|FG001|Overall Study|Lost to Follow-up|1|||
23472714|NCT01325337|65477450|FG002|Overall Study|Personal Reasons|4|||
23472715|NCT01325337|65477451|FG003|Overall Study|Personal Reasons|8|||
23190040|NCT01380093|64436229|FG002|Treatment Phase: Second Intervention|Other|0|||
23190041|NCT01380093|64436230|FG003|Treatment Phase: Second Intervention|Other|1|||
23190042|NCT01380093|64436231|FG004|Treatment Phase: Second Intervention|Other|0|||
23190043|NCT01380093|64436232|FG005|Treatment Phase: Second Intervention|Other|0|||
23190044|NCT01380093|64436233|FG006|Treatment Phase: Second Intervention|Other|0|||
23190045|NCT01380093|64436234|FG007|Treatment Phase: Second Intervention|Other|0|||
23190046|NCT01380093|64436235|FG008|Treatment Phase: Second Intervention|Other|0|||
23190047|NCT01380093|64436227|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
23190048|NCT01380093|64436228|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
23190049|NCT01380093|64436229|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
23190050|NCT01380093|64436230|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
23190051|NCT01380093|64436231|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
23190052|NCT01380093|64436232|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
23190053|NCT01380093|64436233|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
23190054|NCT01380093|64436234|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
23190055|NCT01380093|64436235|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
23190056|NCT01380093|64436227|FG000|Treatment Phase: Third Intervention|Other|0|||
23250020|NCT00572156|64659629|FG002|Overall Study|Lost to Follow-up|1|||
23250021|NCT00572156|64659630|FG003|Overall Study|Lost to Follow-up|0|||
23250022|NCT00572156|64659627|FG000|Overall Study|Protocol Violation|1|||
23250023|NCT00572156|64659628|FG001|Overall Study|Protocol Violation|2|||
23250024|NCT00572156|64659629|FG002|Overall Study|Protocol Violation|0|||
23250025|NCT00572156|64659630|FG003|Overall Study|Protocol Violation|2|||
23250026|NCT00572156|64659627|FG000|Overall Study|Patient/Parent Decision|1|||
23250027|NCT00572156|64659628|FG001|Overall Study|Patient/Parent Decision|6|||
23250028|NCT00572156|64659629|FG002|Overall Study|Patient/Parent Decision|4|||
23250029|NCT00572156|64659630|FG003|Overall Study|Patient/Parent Decision|3|||
23250030|NCT00572156|64659627|FG000|Overall Study|Sponsor Decision|20|||
23250031|NCT00572156|64659628|FG001|Overall Study|Sponsor Decision|16|||
23250032|NCT00572156|64659629|FG002|Overall Study|Sponsor Decision|17|||
23250033|NCT00572156|64659630|FG003|Overall Study|Sponsor Decision|19|||
23250034|NCT01610167|64659631|FG000|Overall Study|Scheduling conflict.|0|||
23250035|NCT01610167|64659632|FG001|Overall Study|Scheduling conflict.|0|||
23250036|NCT01610167|64659633|FG002|Overall Study|Scheduling conflict.|2|||
23250037|NCT01220128|64659634|FG000|Overall Study|Progressive disease|0|||
23250038|NCT01220128|64659635|FG001|Overall Study|Progressive disease|0|||
23250039|NCT01220128|64659636|FG002|Overall Study|Progressive disease|2|||
23250040|NCT01220128|64659637|FG003|Overall Study|Progressive disease|0|||
23250041|NCT01220128|64659638|FG004|Overall Study|Progressive disease|0|||
23250042|NCT01220128|64659639|FG005|Overall Study|Progressive disease|0|||
23250043|NCT01220128|64659640|FG006|Overall Study|Progressive disease|0|||
23250044|NCT01220128|64659634|FG000|Overall Study|Sponsor study termination|0|||
23250045|NCT01220128|64659635|FG001|Overall Study|Sponsor study termination|1|||
23250046|NCT01220128|64659636|FG002|Overall Study|Sponsor study termination|0|||
23250047|NCT01220128|64659637|FG003|Overall Study|Sponsor study termination|0|||
23250048|NCT01220128|64659638|FG004|Overall Study|Sponsor study termination|0|||
23250049|NCT01220128|64659639|FG005|Overall Study|Sponsor study termination|0|||
23250050|NCT01220128|64659640|FG006|Overall Study|Sponsor study termination|1|||
23250051|NCT01220128|64659634|FG000|Overall Study|Adverse event, serious fatal|2|||
23250052|NCT01220128|64659635|FG001|Overall Study|Adverse event, serious fatal|0|||
23250053|NCT01220128|64659636|FG002|Overall Study|Adverse event, serious fatal|0|||
23250054|NCT01220128|64659637|FG003|Overall Study|Adverse event, serious fatal|0|||
23250055|NCT01220128|64659638|FG004|Overall Study|Adverse event, serious fatal|0|||
23250056|NCT01220128|64659639|FG005|Overall Study|Adverse event, serious fatal|0|||
23250057|NCT01220128|64659640|FG006|Overall Study|Adverse event, serious fatal|1|||
23250058|NCT01220128|64659634|FG000|Overall Study|Adverse event, non-fatal|1|||
23250059|NCT01220128|64659635|FG001|Overall Study|Adverse event, non-fatal|0|||
23250060|NCT01220128|64659636|FG002|Overall Study|Adverse event, non-fatal|0|||
23250061|NCT01220128|64659637|FG003|Overall Study|Adverse event, non-fatal|0|||
23250062|NCT01220128|64659638|FG004|Overall Study|Adverse event, non-fatal|0|||
23250063|NCT01220128|64659639|FG005|Overall Study|Adverse event, non-fatal|0|||
23250064|NCT01220128|64659640|FG006|Overall Study|Adverse event, non-fatal|3|||
23588514|NCT01212757|65882162|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588515|NCT01212757|65882163|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588516|NCT01212757|65882164|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
23588517|NCT00811057|65882165|FG000|Overall Study|Protocol Violation|5|||
23588518|NCT00811057|65882166|FG001|Overall Study|Protocol Violation|10|||
23588519|NCT00811057|65882167|FG002|Overall Study|Protocol Violation|10|||
23588520|NCT03525119|65882171|FG000|Overall Study|Adverse Event|0|||
23588521|NCT03525119|65882172|FG001|Overall Study|Adverse Event|1|||
23588522|NCT03525119|65882173|FG002|Overall Study|Adverse Event|0|||
23588523|NCT03525119|65882171|FG000|Overall Study|Lost to Follow-up|32|||
23588524|NCT03525119|65882172|FG001|Overall Study|Lost to Follow-up|33|||
23588525|NCT03525119|65882173|FG002|Overall Study|Lost to Follow-up|37|||
23588526|NCT03525119|65882171|FG000|Overall Study|Withdrawal by Subject|5|||
23250065|NCT01220128|64659634|FG000|Overall Study|Other|0|||
23588527|NCT03525119|65882172|FG001|Overall Study|Withdrawal by Subject|4|||
23588528|NCT03525119|65882173|FG002|Overall Study|Withdrawal by Subject|2|||
23588529|NCT03525119|65882171|FG000|Overall Study|Reason not Specified|2|||
23588530|NCT03525119|65882172|FG001|Overall Study|Reason not Specified|1|||
23588531|NCT03525119|65882173|FG002|Overall Study|Reason not Specified|2|||
23588532|NCT03525119|65882171|FG000|Overall Study|Randomized but not Vaccinated|1|||
23588533|NCT03525119|65882172|FG001|Overall Study|Randomized but not Vaccinated|0|||
23588534|NCT03525119|65882173|FG002|Overall Study|Randomized but not Vaccinated|2|||
23588535|NCT03691428|65882176|FG000|Overall Study|Withdrawal by Subject|6|||
23588536|NCT03691428|65882177|FG001|Overall Study|Withdrawal by Subject|8|||
23588537|NCT00486759|65882178|FG000|Treatment|Adverse event/intercurrent illness|86|||
23588538|NCT00486759|65882179|FG001|Treatment|Adverse event/intercurrent illness|39|||
23588539|NCT00486759|65882178|FG000|Treatment|Insufficient therapeutic response|37|||
23588540|NCT00486759|65882179|FG001|Treatment|Insufficient therapeutic response|39|||
23588541|NCT00486759|65882178|FG000|Treatment|Death|17|||
23588542|NCT00486759|65882179|FG001|Treatment|Death|10|||
23588543|NCT00486759|65882178|FG000|Treatment|Withdrew consent|15|||
23588544|NCT00486759|65882179|FG001|Treatment|Withdrew consent|12|||
23588545|NCT00486759|65882178|FG000|Treatment|Administrative/reason not specified|17|||
23588546|NCT00486759|65882179|FG001|Treatment|Administrative/reason not specified|21|||
23588547|NCT00486759|65882178|FG000|Treatment|Refused treatment|10|||
23588548|NCT00486759|65882179|FG001|Treatment|Refused treatment|7|||
23588549|NCT00486759|65882178|FG000|Treatment|Violation of selection criteria at entry|3|||
23588550|NCT00486759|65882179|FG001|Treatment|Violation of selection criteria at entry|3|||
23588551|NCT00486759|65882178|FG000|Treatment|Other protocol violation|1|||
23588552|NCT00486759|65882179|FG001|Treatment|Other protocol violation|5|||
23588553|NCT00486759|65882178|FG000|Treatment|Failure to return|1|||
23588554|NCT00486759|65882179|FG001|Treatment|Failure to return|1|||
23588555|NCT00486759|65882178|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
23588556|NCT00486759|65882179|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
23588557|NCT00486759|65882178|FG000|Safety Follow-up|Death|40|||
23588558|NCT00486759|65882179|FG001|Safety Follow-up|Death|29|||
23588559|NCT00486759|65882178|FG000|Safety Follow-up|Withdrew consent|32|||
23588560|NCT00486759|65882179|FG001|Safety Follow-up|Withdrew consent|23|||
23588561|NCT00486759|65882178|FG000|Safety Follow-up|Failure to return|9|||
23588562|NCT00486759|65882179|FG001|Safety Follow-up|Failure to return|6|||
23588563|NCT00486759|65882178|FG000|Safety Follow-up|Administrative/not specified|8|||
23588564|NCT00486759|65882179|FG001|Safety Follow-up|Administrative/not specified|6|||
23588565|NCT00486759|65882178|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
23250066|NCT01220128|64659635|FG001|Overall Study|Other|0|||
23588566|NCT00486759|65882179|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
23588567|NCT00486759|65882178|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
23588568|NCT00486759|65882179|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
23588569|NCT01368406|65882180|FG000|Overall Study|Lost to Follow-up|8|||
23588570|NCT01368406|65882181|FG001|Overall Study|Lost to Follow-up|4|||
23588571|NCT01368406|65882180|FG000|Overall Study|Withdrawal by Subject|8|||
23588572|NCT01368406|65882181|FG001|Overall Study|Withdrawal by Subject|4|||
23588573|NCT01368406|65882180|FG000|Overall Study|relapse of the disease|3|||
23588574|NCT01368406|65882181|FG001|Overall Study|relapse of the disease|2|||
23588575|NCT01368406|65882180|FG000|Overall Study|started working|2|||
23588576|NCT01368406|65882181|FG001|Overall Study|started working|3|||
23588577|NCT05046132|65882186|FG000|Overall Study|Adverse Event|4|||
23588578|NCT05046132|65882187|FG001|Overall Study|Adverse Event|0|||
23588579|NCT05046132|65882188|FG002|Overall Study|Adverse Event|0|||
23588580|NCT05046132|65882186|FG000|Overall Study|Withdrawal by Subject|3|||
23588581|NCT05046132|65882187|FG001|Overall Study|Withdrawal by Subject|0|||
23588582|NCT05046132|65882188|FG002|Overall Study|Withdrawal by Subject|0|||
23588583|NCT05046132|65882186|FG000|Overall Study|Positive Covid19 Result.|0|||
23588584|NCT05046132|65882187|FG001|Overall Study|Positive Covid19 Result.|1|||
23588585|NCT05046132|65882188|FG002|Overall Study|Positive Covid19 Result.|0|||
23588586|NCT01595321|65882189|FG000|Overall Study|Adverse Event|1|||
23588587|NCT01595321|65882190|FG001|Overall Study|Adverse Event|1|||
23588588|NCT01595321|65882191|FG002|Overall Study|Adverse Event|1|||
23588589|NCT01595321|65882189|FG000|Overall Study|Lack of Efficacy|0|||
23588590|NCT01595321|65882190|FG001|Overall Study|Lack of Efficacy|0|||
23588591|NCT01595321|65882191|FG002|Overall Study|Lack of Efficacy|4|||
23588592|NCT00798096|65882192|FG000|Overall Study|Ongoing|2|||
23588593|NCT00117988|65882193|FG000|Overall Study|Death|3|||
23588594|NCT00117988|65882193|FG000|Overall Study|Adverse Event|1|||
23588595|NCT00509769|65882194|FG000|Overall Study|Progressive disease|77|||
23588596|NCT00509769|65882194|FG000|Overall Study|Adverse Event|4|||
23588597|NCT00509769|65882194|FG000|Overall Study|Patient's decision|1|||
23588598|NCT00509769|65882194|FG000|Overall Study|Physician Decision|8|||
23588599|NCT00509769|65882194|FG000|Overall Study|Use of prohibited therapies during study|1|||
23588600|NCT00758602|65882196|FG000|Overall Study|Adverse Event|11|||
23588601|NCT00758602|65882197|FG001|Overall Study|Adverse Event|10|||
23588602|NCT00758602|65882196|FG000|Overall Study|Lost to Follow-up|4|||
23588603|NCT00758602|65882197|FG001|Overall Study|Lost to Follow-up|3|||
23588604|NCT00758602|65882196|FG000|Overall Study|Withdrawal by Subject|1|||
23588605|NCT00758602|65882197|FG001|Overall Study|Withdrawal by Subject|3|||
23588606|NCT00758602|65882196|FG000|Overall Study|Protocol Violation|0|||
23588607|NCT00758602|65882197|FG001|Overall Study|Protocol Violation|2|||
23588608|NCT00758602|65882196|FG000|Overall Study|Death|0|||
23588609|NCT00758602|65882197|FG001|Overall Study|Death|1|||
23588610|NCT00758602|65882196|FG000|Overall Study|Reason not specified|3|||
23588611|NCT00758602|65882197|FG001|Overall Study|Reason not specified|3|||
23588612|NCT03418324|65882198|FG000|Overall Study|Death|0|||
23588613|NCT03418324|65882199|FG001|Overall Study|Death|1|||
23588614|NCT03418324|65882198|FG000|Overall Study|Physician Decision|1|||
23588615|NCT03418324|65882199|FG001|Overall Study|Physician Decision|1|||
23588616|NCT02459899|65882200|FG000|Overall Study|Adverse Event|1|||
23588617|NCT02459899|65882201|FG001|Overall Study|Adverse Event|1|||
23588618|NCT02459899|65882202|FG002|Overall Study|Adverse Event|0|||
23588619|NCT02459899|65882203|FG003|Overall Study|Adverse Event|0|||
23588620|NCT02459899|65882200|FG000|Overall Study|Lost to Follow-up|1|||
23588621|NCT02459899|65882201|FG001|Overall Study|Lost to Follow-up|2|||
23588622|NCT02459899|65882202|FG002|Overall Study|Lost to Follow-up|0|||
23588623|NCT02459899|65882203|FG003|Overall Study|Lost to Follow-up|1|||
23588624|NCT02459899|65882200|FG000|Overall Study|Non-compliance with the treatment|0|||
23588625|NCT02459899|65882201|FG001|Overall Study|Non-compliance with the treatment|0|||
23588626|NCT02459899|65882202|FG002|Overall Study|Non-compliance with the treatment|0|||
23588627|NCT02459899|65882203|FG003|Overall Study|Non-compliance with the treatment|1|||
23588628|NCT02459899|65882200|FG000|Overall Study|Withdrawal by Subject|1|||
23588629|NCT02459899|65882201|FG001|Overall Study|Withdrawal by Subject|3|||
23588630|NCT02459899|65882202|FG002|Overall Study|Withdrawal by Subject|0|||
23588631|NCT02459899|65882203|FG003|Overall Study|Withdrawal by Subject|0|||
23588632|NCT02148133|65882204|FG000|Overall Study|Investigator discretion|1|||
23588633|NCT02148133|65882204|FG000|Overall Study|Lack of Efficacy|1|||
23588634|NCT02148133|65882204|FG000|Overall Study|Protocol deviation|1|||
23588635|NCT02148133|65882204|FG000|Overall Study|Protocol-defined stopping criteria|2|||
23588636|NCT00001575|65882208|FG000|Overall Study|Screening failures-Ph I portion|22|||
23356330|NCT03959488|65048815|FG002|Season 2|Lost to Follow-up|1|||
23356331|NCT03959488|65048816|FG003|Season 2|Lost to Follow-up|0|||
23356332|NCT03959488|65048817|FG004|Season 2|Lost to Follow-up|1|||
23472716|NCT01325337|65477452|FG004|Overall Study|Personal Reasons|3|||
23472717|NCT01325337|65477448|FG000|Overall Study|Withdrawal by Subject|1|||
23472718|NCT01325337|65477449|FG001|Overall Study|Withdrawal by Subject|0|||
23472719|NCT01325337|65477450|FG002|Overall Study|Withdrawal by Subject|1|||
23472720|NCT01325337|65477451|FG003|Overall Study|Withdrawal by Subject|0|||
23472721|NCT01325337|65477452|FG004|Overall Study|Withdrawal by Subject|1|||
23472722|NCT02948088|65477453|FG000|Overall Study|Lost to Follow-up|8|||
23472723|NCT02948088|65477453|FG000|Overall Study|Death|1|||
23472724|NCT02948088|65477453|FG000|Overall Study|Withdrawal by Subject|4|||
23472725|NCT02948088|65477453|FG000|Overall Study|Other|2|||
23472726|NCT00773838|65477454|FG000|Overall Study|Adverse Event|29|||
23472727|NCT00773838|65477454|FG000|Overall Study|Lost to Follow-up|1|||
23472728|NCT00773838|65477454|FG000|Overall Study|Physician Decision|8|||
23472729|NCT00773838|65477454|FG000|Overall Study|Progressive Disease|82|||
23472730|NCT00773838|65477454|FG000|Overall Study|Protocol Violation|2|||
23472731|NCT00773838|65477454|FG000|Overall Study|Withdrawal by Subject|21|||
23472732|NCT01290796|65477455|FG000|Overall Study|Lost to Follow-up|21|||
23472733|NCT01290796|65477455|FG000|Overall Study|Withdrawal by Subject|4|||
23472734|NCT01290796|65477455|FG000|Overall Study|Physician Decision|2|||
23472735|NCT01290796|65477455|FG000|Overall Study|Secondary Surgical Intervention|2|||
23472736|NCT01290796|65477455|FG000|Overall Study|Withdrawal by Sponsor|1|||
23472737|NCT01478048|65477457|FG000|Overall Study|Disease Progression|52|||
23472738|NCT01478048|65477458|FG001|Overall Study|Disease Progression|35|||
23472739|NCT01478048|65477457|FG000|Overall Study|study drug toxicity|11|||
23472740|NCT01478048|65477458|FG001|Overall Study|study drug toxicity|14|||
23472741|NCT01478048|65477457|FG000|Overall Study|Adverse Event|2|||
23472742|NCT01478048|65477458|FG001|Overall Study|Adverse Event|11|||
23472743|NCT01478048|65477457|FG000|Overall Study|subject request to discontinue treatment|3|||
23190057|NCT01380093|64436228|FG001|Treatment Phase: Third Intervention|Other|0|||
23588637|NCT00001575|65882208|FG000|Overall Study|Withdrawn/deaths|23|||
23588638|NCT02299336|65882209|FG000|Overall Study|Withdrawal by Subject|11|||
23588639|NCT02299336|65882209|FG000|Overall Study|Adverse Event|1|||
23356333|NCT01563913|65048818|FG000|Overall Study|Physician Decision|1|||
23356334|NCT01563913|65048819|FG001|Overall Study|Physician Decision|0|||
23356335|NCT01563913|65048818|FG000|Overall Study|Spouse Passed Away|1|||
23356336|NCT01563913|65048819|FG001|Overall Study|Spouse Passed Away|0|||
23356337|NCT00162097|65048820|FG000|Overall Study|Participant no longer met study criteria|0|||
23356338|NCT00162097|65048821|FG001|Overall Study|Participant no longer met study criteria|0|||
23356339|NCT00162097|65048822|FG002|Overall Study|Participant no longer met study criteria|0|||
23356340|NCT00162097|65048823|FG003|Overall Study|Participant no longer met study criteria|1|||
23356341|NCT00703677|65048824|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
23356342|NCT02496039|65048826|FG000|Overall Study|Adverse Event|3|||
23356343|NCT02496039|65048826|FG000|Overall Study|Protocol Violation|1|||
23356344|NCT02178358|65048827|FG000|Overall Study|Withdrawal by Subject|0|||
23356345|NCT02178358|65048828|FG001|Overall Study|Withdrawal by Subject|2|||
23356346|NCT02178358|65048829|FG002|Overall Study|Withdrawal by Subject|2|||
23356347|NCT02178358|65048827|FG000|Overall Study|Lost to Follow-up|1|||
23356348|NCT02178358|65048828|FG001|Overall Study|Lost to Follow-up|0|||
23356349|NCT02178358|65048829|FG002|Overall Study|Lost to Follow-up|0|||
23356350|NCT03333486|65048835|FG000|Overall Study|Withdrawal by Subject|1|||
23356351|NCT03333486|65048835|FG000|Overall Study|Lost to Follow-up|1|||
23356352|NCT00002525|65048838|FG000|Overall Study|Adverse Event|36|||
23356353|NCT00002525|65048839|FG001|Overall Study|Adverse Event|0|||
23356354|NCT00002525|65048838|FG000|Overall Study|Death|5|||
23356355|NCT00002525|65048839|FG001|Overall Study|Death|0|||
23356356|NCT00002525|65048838|FG000|Overall Study|Withdrawal by Subject|11|||
23356357|NCT00002525|65048839|FG001|Overall Study|Withdrawal by Subject|0|||
23356358|NCT00002525|65048838|FG000|Overall Study|Start non-protocol therapy|1|||
23356359|NCT00002525|65048839|FG001|Overall Study|Start non-protocol therapy|0|||
23356360|NCT00002525|65048838|FG000|Overall Study|Other complicating disease|1|||
23356361|NCT00002525|65048839|FG001|Overall Study|Other complicating disease|0|||
23356362|NCT00002525|65048838|FG000|Overall Study|Duke's A, B1, D disease|92|||
23356363|NCT00002525|65048839|FG001|Overall Study|Duke's A, B1, D disease|0|||
23356364|NCT00002525|65048838|FG000|Overall Study|Error|6|||
23356365|NCT00002525|65048839|FG001|Overall Study|Error|0|||
23356366|NCT00002525|65048838|FG000|Overall Study|Other|26|||
23356367|NCT00002525|65048839|FG001|Overall Study|Other|0|||
23356368|NCT00002525|65048838|FG000|Overall Study|Never start protocol therapy|8|||
23356369|NCT00002525|65048839|FG001|Overall Study|Never start protocol therapy|0|||
23356370|NCT01090050|65048848|FG000|Overall Study|Lost to Follow-up|0|||
23356371|NCT01090050|65048849|FG001|Overall Study|Lost to Follow-up|1|||
23356372|NCT01090050|65048848|FG000|Overall Study|Lack of Efficacy|1|||
23356373|NCT01090050|65048849|FG001|Overall Study|Lack of Efficacy|5|||
23356374|NCT01090050|65048848|FG000|Overall Study|Physician Decision|0|||
23356375|NCT01090050|65048849|FG001|Overall Study|Physician Decision|1|||
23356376|NCT03332095|65048850|FG000|Overall Study|Lost to Follow-up|1|||
23356377|NCT03332095|65048851|FG001|Overall Study|Lost to Follow-up|0|||
23356378|NCT03332095|65048850|FG000|Overall Study|Pregnancy|0|||
23356379|NCT03332095|65048851|FG001|Overall Study|Pregnancy|1|||
23356380|NCT01641471|65048855|FG000|Overall Study|Withdrawal by Subject|19|||
23356381|NCT01641471|65048856|FG001|Overall Study|Withdrawal by Subject|19|||
23356382|NCT01641471|65048855|FG000|Overall Study|Lost to Follow-up|2|||
23356383|NCT01641471|65048856|FG001|Overall Study|Lost to Follow-up|4|||
23356384|NCT01641471|65048855|FG000|Overall Study|Protocol Violation|2|||
23356385|NCT01641471|65048856|FG001|Overall Study|Protocol Violation|4|||
23190058|NCT01380093|64436229|FG002|Treatment Phase: Third Intervention|Other|0|||
23190059|NCT01380093|64436230|FG003|Treatment Phase: Third Intervention|Other|0|||
23190060|NCT01380093|64436231|FG004|Treatment Phase: Third Intervention|Other|0|||
23190061|NCT01380093|64436232|FG005|Treatment Phase: Third Intervention|Other|0|||
23356386|NCT00395642|65048857|FG000|Overall Study|Death|4|||
23356387|NCT00395642|65048857|FG000|Overall Study|Lost to Follow-up|1|||
23356388|NCT00395642|65048857|FG000|Overall Study|Physician Decision|7|||
23356389|NCT00395642|65048857|FG000|Overall Study|Withdrawal by Subject|1|||
23356390|NCT01775787|65048858|FG000|First 7-10 Days|Adverse Event|0|||
23190062|NCT01380093|64436233|FG006|Treatment Phase: Third Intervention|Other|0|||
23588640|NCT02299336|65882209|FG000|Overall Study|Death|1|||
23356391|NCT01775787|65048859|FG001|First 7-10 Days|Adverse Event|1|||
23356392|NCT01775787|65048858|FG000|First 7-10 Days|family emergency|0|||
23356393|NCT01775787|65048859|FG001|First 7-10 Days|family emergency|1|||
23356394|NCT01775787|65048858|FG000|First 7-10 Days|time commitment|0|||
23356395|NCT01775787|65048859|FG001|First 7-10 Days|time commitment|2|||
23356396|NCT01775787|65048858|FG000|First 7-10 Days|concerns with using IV|1|||
23356397|NCT01775787|65048859|FG001|First 7-10 Days|concerns with using IV|2|||
23356398|NCT01775787|65048858|FG000|Second 7-10 Days|time commitment|0|||
23356399|NCT01775787|65048859|FG001|Second 7-10 Days|time commitment|1|||
23356400|NCT01775787|65048858|FG000|Second 7-10 Days|concerns with using IV|0|||
23356401|NCT01775787|65048859|FG001|Second 7-10 Days|concerns with using IV|1|||
23356402|NCT03246061|65048860|FG000|Overall Study|Still in follow-up|15|||
23356403|NCT03246061|65048861|FG001|Overall Study|Still in follow-up|21|||
23472744|NCT01478048|65477458|FG001|Overall Study|subject request to discontinue treatment|5|||
23472745|NCT01478048|65477457|FG000|Overall Study|Withdrawal by Subject|2|||
23472746|NCT01478048|65477458|FG001|Overall Study|Withdrawal by Subject|5|||
23472747|NCT01478048|65477457|FG000|Overall Study|non-specified|6|||
23472748|NCT01478048|65477458|FG001|Overall Study|non-specified|4|||
23472749|NCT01478048|65477457|FG000|Overall Study|poor/non-compliance|0|||
23472750|NCT01478048|65477458|FG001|Overall Study|poor/non-compliance|1|||
23190063|NCT01380093|64436234|FG007|Treatment Phase: Third Intervention|Other|0|||
23190064|NCT01380093|64436235|FG008|Treatment Phase: Third Intervention|Other|1|||
23472751|NCT01478048|65477457|FG000|Overall Study|no longer meets study criteria|1|||
23472752|NCT01478048|65477458|FG001|Overall Study|no longer meets study criteria|0|||
23472753|NCT00701662|65477459|FG000|Overall Study|Lack of Efficacy|1|||
23472754|NCT03425253|65477464|FG000|Overall Study|Adverse Event|2|||
23472755|NCT03425253|65477464|FG000|Overall Study|Lost to Follow-up|3|||
23472756|NCT03425253|65477464|FG000|Overall Study|Withdrew Consent|6|||
23190065|NCT02591615|64436236|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
23190066|NCT02591615|64436237|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
23190067|NCT02591615|64436238|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
23190068|NCT02591615|64436239|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
23190069|NCT02591615|64436236|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
23190070|NCT02591615|64436237|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
23190071|NCT02591615|64436238|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
23190072|NCT02591615|64436239|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
23190073|NCT02591615|64436236|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
23190074|NCT02591615|64436237|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
23190075|NCT02591615|64436238|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
23190076|NCT02591615|64436239|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
23190077|NCT02591615|64436236|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
23190078|NCT02591615|64436237|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
23190079|NCT02591615|64436238|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
23190080|NCT02591615|64436239|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
23190081|NCT02591615|64436236|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
23190082|NCT02591615|64436237|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
23190083|NCT02591615|64436238|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
23190084|NCT02591615|64436239|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
23190085|NCT02591615|64436236|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
23356404|NCT03504189|65048862|FG000|Overall Study|Withdrawal by Subject|1|||
23356405|NCT03504189|65048862|FG000|Overall Study|Screening Failure|1|||
23356406|NCT03504189|65048862|FG000|Overall Study|Device Failure|2|||
23472757|NCT03425253|65477464|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
23472758|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
23356407|NCT02749799|65048864|FG000|Overall Study|Adverse Event|2|||
23356408|NCT02749799|65048864|FG000|Overall Study|Lost to Follow-up|4|||
23472759|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
23588641|NCT02299336|65882209|FG000|Overall Study|Lost to Follow-up|1|||
23588642|NCT00420316|65882210|FG000|Overall Study|Withdrawal by Subject|0|||
23588643|NCT00420316|65882211|FG001|Overall Study|Withdrawal by Subject|1|||
23588644|NCT00420316|65882210|FG000|Overall Study|Lost to Follow-up|12|||
23588645|NCT00420316|65882211|FG001|Overall Study|Lost to Follow-up|8|||
23588646|NCT00723450|65882212|FG000|Open-Label Phase|Adverse Event|26|||
23588647|NCT00723450|65882213|FG001|Open-Label Phase|Adverse Event|0|||
23588648|NCT00723450|65882214|FG002|Open-Label Phase|Adverse Event|0|||
23588649|NCT00723450|65882212|FG000|Open-Label Phase|Lack of Efficacy|18|||
23588650|NCT00723450|65882213|FG001|Open-Label Phase|Lack of Efficacy|0|||
23472760|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
23472761|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
23472762|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Death|3|||
23472763|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Death|0|||
23472764|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Death|0|||
23472765|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Death|0|||
23472766|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
23472767|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
23472768|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
23472769|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
23472770|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
23588651|NCT00723450|65882214|FG002|Open-Label Phase|Lack of Efficacy|0|||
23588652|NCT00723450|65882212|FG000|Open-Label Phase|Protocol Violation|35|||
23190086|NCT02591615|64436237|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
23190087|NCT02591615|64436238|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
23190088|NCT02591615|64436239|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
23190089|NCT02591615|64436236|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
23190090|NCT02591615|64436237|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
23190091|NCT02591615|64436238|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
23190092|NCT02591615|64436239|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
23190093|NCT02591615|64436236|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
23190094|NCT02591615|64436237|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
23190095|NCT02591615|64436238|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
23190096|NCT02591615|64436239|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
23190097|NCT02591615|64436236|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
23190098|NCT02591615|64436237|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
23190099|NCT02591615|64436238|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
23190100|NCT02591615|64436239|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
23190101|NCT02591615|64436236|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
23190102|NCT02591615|64436237|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
23190103|NCT02591615|64436238|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
23190104|NCT02591615|64436239|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
23190105|NCT02591615|64436236|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
23190106|NCT02591615|64436237|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
23190107|NCT02591615|64436238|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
23190108|NCT02591615|64436239|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
23190109|NCT02591615|64436236|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
23190110|NCT02591615|64436237|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
23190111|NCT02591615|64436238|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
23190112|NCT02591615|64436239|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
23190113|NCT02591615|64436236|FG000|Maintenance MK-3475|Adverse Event|0|||
23190114|NCT02591615|64436237|FG001|Maintenance MK-3475|Adverse Event|3|||
23190115|NCT02591615|64436238|FG002|Maintenance MK-3475|Adverse Event|1|||
23190116|NCT02591615|64436239|FG003|Maintenance MK-3475|Adverse Event|2|||
23190117|NCT02591615|64436236|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
23190118|NCT02591615|64436237|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
23190119|NCT02591615|64436238|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
23190120|NCT02591615|64436239|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
23190121|NCT02591615|64436236|FG000|Maintenance MK-3475|Death|0|||
23588653|NCT00723450|65882213|FG001|Open-Label Phase|Protocol Violation|0|||
23190122|NCT02591615|64436237|FG001|Maintenance MK-3475|Death|1|||
23190123|NCT02591615|64436238|FG002|Maintenance MK-3475|Death|1|||
23190124|NCT02591615|64436239|FG003|Maintenance MK-3475|Death|0|||
23190125|NCT02591615|64436236|FG000|Maintenance MK-3475|Physician discretion|0|||
23472771|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
23472772|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
23588654|NCT00723450|65882214|FG002|Open-Label Phase|Protocol Violation|0|||
23588655|NCT00723450|65882212|FG000|Open-Label Phase|Lost to Follow-up|7|||
23190126|NCT02591615|64436237|FG001|Maintenance MK-3475|Physician discretion|0|||
23190127|NCT02591615|64436238|FG002|Maintenance MK-3475|Physician discretion|1|||
23190128|NCT02591615|64436239|FG003|Maintenance MK-3475|Physician discretion|0|||
23472773|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
23472774|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
23472775|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
23472776|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
23472777|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
23472778|NCT00884741|65477465|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
23472779|NCT00884741|65477466|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
23472780|NCT00884741|65477467|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
23472781|NCT00884741|65477468|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
23472782|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
23472783|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
23472784|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
23472785|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
23472786|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
23472787|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
23472788|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
23472789|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
23472790|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
23472791|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
23472792|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
23472793|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
23472794|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
23472795|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
23472796|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
23472797|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
23472798|NCT00884741|65477465|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
23472799|NCT00884741|65477466|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
23472800|NCT00884741|65477467|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
23190129|NCT02591615|64436236|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
23190130|NCT02591615|64436237|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
23190131|NCT02591615|64436238|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
23190132|NCT02591615|64436239|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
23588656|NCT00723450|65882213|FG001|Open-Label Phase|Lost to Follow-up|0|||
23588657|NCT00723450|65882214|FG002|Open-Label Phase|Lost to Follow-up|0|||
23588658|NCT00723450|65882212|FG000|Open-Label Phase|Physician Decision|2|||
23588659|NCT00723450|65882213|FG001|Open-Label Phase|Physician Decision|0|||
23472801|NCT00884741|65477468|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
23472802|NCT00884741|65477465|FG000|Randomization|Protocol Violation|0|||
23588660|NCT00723450|65882214|FG002|Open-Label Phase|Physician Decision|0|||
23356409|NCT02749799|65048864|FG000|Overall Study|Protocol Violation|1|||
23356410|NCT02749799|65048864|FG000|Overall Study|Withdrawal by Subject|1|||
23356411|NCT01491841|65048865|FG000|Overall Study|Screen Failure|10|||
23472803|NCT00884741|65477466|FG001|Randomization|Protocol Violation|0|||
23472804|NCT00884741|65477467|FG002|Randomization|Protocol Violation|8|||
23472805|NCT00884741|65477468|FG003|Randomization|Protocol Violation|8|||
23472806|NCT01767142|65477470|FG000|Overall Study|Lost to Follow-up|3|||
23472807|NCT00084136|65477471|FG000|PI Comparison|Death|10|||
23472808|NCT00084136|65477472|FG001|PI Comparison|Death|9|||
23472809|NCT00084136|65477473|FG002|PI Comparison|Death|0|||
23472810|NCT00084136|65477471|FG000|PI Comparison|Lost to Follow-up|11|||
23472811|NCT00084136|65477472|FG001|PI Comparison|Lost to Follow-up|8|||
23472812|NCT00084136|65477473|FG002|PI Comparison|Lost to Follow-up|0|||
23472813|NCT00084136|65477471|FG000|PI Comparison|Withdrawal by Subject|33|||
23472814|NCT00084136|65477472|FG001|PI Comparison|Withdrawal by Subject|30|||
23472815|NCT00084136|65477473|FG002|PI Comparison|Withdrawal by Subject|0|||
23190133|NCT02591615|64436236|FG000|Maintenance MK-3475|In active treatment|2|||
23190134|NCT02591615|64436237|FG001|Maintenance MK-3475|In active treatment|0|||
23190135|NCT02591615|64436238|FG002|Maintenance MK-3475|In active treatment|0|||
23190136|NCT02591615|64436239|FG003|Maintenance MK-3475|In active treatment|1|||
23472816|NCT00084136|65477471|FG000|PI Comparison|Clinic site closed|1|||
23472817|NCT00084136|65477472|FG001|PI Comparison|Clinic site closed|0|||
23472818|NCT00084136|65477473|FG002|PI Comparison|Clinic site closed|0|||
23472819|NCT00084136|65477471|FG000|NRTI Comparison|Death|20|||
23472820|NCT00084136|65477472|FG001|NRTI Comparison|Death|0|||
23472821|NCT00084136|65477473|FG002|NRTI Comparison|Death|18|||
23472822|NCT00084136|65477471|FG000|NRTI Comparison|Lost to Follow-up|14|||
23472823|NCT00084136|65477472|FG001|NRTI Comparison|Lost to Follow-up|0|||
23472824|NCT00084136|65477473|FG002|NRTI Comparison|Lost to Follow-up|12|||
23472825|NCT00084136|65477471|FG000|NRTI Comparison|Withdrawal by Subject|54|||
23472826|NCT00084136|65477472|FG001|NRTI Comparison|Withdrawal by Subject|0|||
23472827|NCT00084136|65477473|FG002|NRTI Comparison|Withdrawal by Subject|38|||
23472828|NCT00084136|65477471|FG000|NRTI Comparison|Clinic site closed|12|||
23472829|NCT00084136|65477472|FG001|NRTI Comparison|Clinic site closed|0|||
23472830|NCT00084136|65477473|FG002|NRTI Comparison|Clinic site closed|14|||
23472831|NCT00084136|65477471|FG000|NRTI Comparison|Not reason above|1|||
23472832|NCT00084136|65477472|FG001|NRTI Comparison|Not reason above|0|||
23472833|NCT00084136|65477473|FG002|NRTI Comparison|Not reason above|0|||
23472834|NCT00835211|65477476|FG000|First Intervention|Withdrawal by Subject|0|||
23472835|NCT00835211|65477477|FG001|First Intervention|Withdrawal by Subject|1|||
23472836|NCT00835211|65477476|FG000|Washout: 7 Days|Adverse Event|2|||
23472837|NCT00835211|65477477|FG001|Washout: 7 Days|Adverse Event|1|||
23472838|NCT00835211|65477476|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23472839|NCT00835211|65477477|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23472840|NCT00838513|65477478|FG000|Screening Period|Screen Failure|3|||
23472841|NCT00838513|65477478|FG000|Extension Treatment Period|Death|1|||
23472842|NCT00838513|65477478|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
23472843|NCT00145119|65477479|FG000|Overall Study|Death|45|||
23588661|NCT00723450|65882212|FG000|Open-Label Phase|Withdrawal by Subject|37|||
23190137|NCT00224016|64436246|FG000|Titration Period|Withdrawal by Subject|0|||
23190138|NCT00224016|64436247|FG001|Titration Period|Withdrawal by Subject|1|||
23190139|NCT00224016|64436246|FG000|Titration Period|Lost to Follow-up|1|||
23190140|NCT00224016|64436247|FG001|Titration Period|Lost to Follow-up|0|||
23190141|NCT00224016|64436246|FG000|Maintenance Period|Withdrawal by Subject|2|||
23190142|NCT00224016|64436247|FG001|Maintenance Period|Withdrawal by Subject|0|||
23190143|NCT00224016|64436246|FG000|Maintenance Period|Lost to Follow-up|0|||
23190144|NCT00224016|64436247|FG001|Maintenance Period|Lost to Follow-up|1|||
23190145|NCT03826914|64436251|FG000|Overall Study|Withdrawal by Subject|1|||
23190146|NCT03826914|64436252|FG001|Overall Study|Withdrawal by Subject|1|||
23190147|NCT00772967|64436257|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
23190148|NCT00772967|64436258|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
23588662|NCT00723450|65882213|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23588663|NCT00723450|65882214|FG002|Open-Label Phase|Withdrawal by Subject|0|||
23588664|NCT00723450|65882212|FG000|Randomized Phase|Adverse Event|0|||
23588665|NCT00723450|65882213|FG001|Randomized Phase|Adverse Event|26|||
23588666|NCT00723450|65882214|FG002|Randomized Phase|Adverse Event|17|||
23190149|NCT00772967|64436259|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
23588667|NCT00723450|65882212|FG000|Randomized Phase|Lack of Efficacy|0|||
23588668|NCT00723450|65882213|FG001|Randomized Phase|Lack of Efficacy|11|||
23588669|NCT00723450|65882214|FG002|Randomized Phase|Lack of Efficacy|11|||
23190150|NCT00772967|64436260|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
23588670|NCT00723450|65882212|FG000|Randomized Phase|Protocol Violation|0|||
23588671|NCT00723450|65882213|FG001|Randomized Phase|Protocol Violation|9|||
23588672|NCT00723450|65882214|FG002|Randomized Phase|Protocol Violation|13|||
23588673|NCT00723450|65882212|FG000|Randomized Phase|Lost to Follow-up|0|||
23588674|NCT00723450|65882213|FG001|Randomized Phase|Lost to Follow-up|2|||
23588675|NCT00723450|65882214|FG002|Randomized Phase|Lost to Follow-up|3|||
23588676|NCT00723450|65882212|FG000|Randomized Phase|Physician Decision|0|||
23588677|NCT00723450|65882213|FG001|Randomized Phase|Physician Decision|3|||
23588678|NCT00723450|65882214|FG002|Randomized Phase|Physician Decision|1|||
23588679|NCT00723450|65882212|FG000|Randomized Phase|Withdrawal by Subject|0|||
23356412|NCT01491841|65048865|FG000|Overall Study|Withdrawal by Subject|1|||
23472844|NCT02238067|65477480|FG000|Overall Study|Not completed survey at Month 6|45|||
23472845|NCT00943072|65477485|FG000|Overall Study|Adverse Event|0|||
23472846|NCT00943072|65477486|FG001|Overall Study|Adverse Event|3|||
23472847|NCT00943072|65477485|FG000|Overall Study|Death|0|||
23588680|NCT00723450|65882213|FG001|Randomized Phase|Withdrawal by Subject|14|||
23588681|NCT00723450|65882214|FG002|Randomized Phase|Withdrawal by Subject|22|||
23588682|NCT01131494|65882215|FG000|Overall Study|Withdrawal by Subject|2|||
23190151|NCT00772967|64436261|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
23588683|NCT01981850|65882216|FG000|Main Phase Stage 1|Death|2|||
23190152|NCT00772967|64436262|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
23356413|NCT03337048|65048866|FG000|Overall Study|Withdrawal by Subject|2|||
23472848|NCT00943072|65477486|FG001|Overall Study|Death|2|||
23472849|NCT00943072|65477485|FG000|Overall Study|Withdrawal by Subject|3|||
23472850|NCT00943072|65477486|FG001|Overall Study|Withdrawal by Subject|1|||
23588684|NCT01981850|65882217|FG001|Main Phase Stage 1|Death|0|||
23472851|NCT00943072|65477485|FG000|Overall Study|Protocol Violation|0|||
23472852|NCT00943072|65477486|FG001|Overall Study|Protocol Violation|1|||
23472853|NCT00943072|65477485|FG000|Overall Study|Lost to Follow-up|1|||
23472854|NCT00943072|65477486|FG001|Overall Study|Lost to Follow-up|2|||
23472855|NCT00943072|65477485|FG000|Overall Study|Lack of Efficacy|0|||
23472856|NCT00943072|65477486|FG001|Overall Study|Lack of Efficacy|4|||
23472857|NCT00943072|65477485|FG000|Overall Study|Other|1|||
23472858|NCT00943072|65477486|FG001|Overall Study|Other|1|||
23472859|NCT00505076|65477487|FG000|Overall Study|Adverse Event|1|||
23472860|NCT00505076|65477488|FG001|Overall Study|Adverse Event|0|||
23472861|NCT00505076|65477489|FG002|Overall Study|Adverse Event|1|||
23472862|NCT00505076|65477487|FG000|Overall Study|Protocol Violation|2|||
23472863|NCT00505076|65477488|FG001|Overall Study|Protocol Violation|1|||
23472864|NCT00505076|65477489|FG002|Overall Study|Protocol Violation|2|||
23472865|NCT00505076|65477487|FG000|Overall Study|Withdrawal by Subject|0|||
23472866|NCT00505076|65477488|FG001|Overall Study|Withdrawal by Subject|1|||
23472867|NCT00505076|65477489|FG002|Overall Study|Withdrawal by Subject|2|||
23472868|NCT02273596|65477490|FG000|24-Week Treatment Period|Adverse Event|3|||
23472869|NCT02273596|65477490|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
23472870|NCT02273596|65477490|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
23472871|NCT02273596|65477490|FG000|24-Week Treatment Period|Physician Decision|1|||
23472872|NCT02273596|65477490|FG000|24-Week Treatment Period|Protocol Deviation|1|||
23472873|NCT02273596|65477490|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
23472874|NCT02273596|65477490|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
23472875|NCT02273596|65477490|FG000|Extension Period|Lost to Follow-up|1|||
23472876|NCT02273596|65477490|FG000|Extension Period|Protocol Deviation|1|||
23472877|NCT04093024|65477491|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
23472878|NCT04093024|65477492|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
23472879|NCT04093024|65477491|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
23472880|NCT04093024|65477492|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
23472881|NCT04093024|65477491|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
23472882|NCT04093024|65477492|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
23472883|NCT04093024|65477491|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
23472884|NCT04093024|65477492|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
23472885|NCT02395172|65477493|FG000|Overall Study|Participants randomized but not treated|3|||
23472886|NCT02395172|65477494|FG001|Overall Study|Participants randomized but not treated|31|||
23472887|NCT00119678|65477495|FG000|Double-blind Treatment Period|Death|1|||
23472888|NCT00119678|65477496|FG001|Double-blind Treatment Period|Death|0|||
23472889|NCT00119678|65477495|FG000|Double-blind Treatment Period|Adverse Event|7|||
23472890|NCT00119678|65477496|FG001|Double-blind Treatment Period|Adverse Event|1|||
23472891|NCT00119678|65477495|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
23472892|NCT00119678|65477496|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
23472893|NCT00119678|65477495|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
23472894|NCT00119678|65477496|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
23472895|NCT00119678|65477495|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
23472896|NCT00119678|65477496|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
23472897|NCT00119678|65477495|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
23472898|NCT00119678|65477496|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
23472899|NCT00119678|65477495|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
23472900|NCT00119678|65477496|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
23472901|NCT00119678|65477495|FG000|Double-blind Treatment Period|Pregnancy|0|||
23472902|NCT00119678|65477496|FG001|Double-blind Treatment Period|Pregnancy|2|||
23472903|NCT00119678|65477495|FG000|Double-blind Treatment Period|Not treated|1|||
23472904|NCT00119678|65477496|FG001|Double-blind Treatment Period|Not treated|2|||
23472905|NCT00119678|65477495|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
23472906|NCT00119678|65477496|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
23472907|NCT00119678|65477495|FG000|Open-label Treatment Period|Death|1|||
23472908|NCT00119678|65477496|FG001|Open-label Treatment Period|Death|0|||
23472909|NCT00119678|65477495|FG000|Open-label Treatment Period|Adverse Event|3|||
23472910|NCT00119678|65477496|FG001|Open-label Treatment Period|Adverse Event|0|||
23472911|NCT00119678|65477495|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
23472912|NCT00119678|65477496|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
23472913|NCT00119678|65477495|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
23472914|NCT00119678|65477496|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
23472915|NCT00119678|65477495|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
23472916|NCT00119678|65477496|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
23472917|NCT00119678|65477495|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
23472918|NCT00119678|65477496|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
23472919|NCT00119678|65477495|FG000|Open-label Treatment Period|Pregnancy|1|||
23472920|NCT00119678|65477496|FG001|Open-label Treatment Period|Pregnancy|0|||
23472921|NCT00119678|65477495|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
23472922|NCT00119678|65477496|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
23250067|NCT01220128|64659636|FG002|Overall Study|Other|1|||
23250068|NCT01220128|64659637|FG003|Overall Study|Other|0|||
23250069|NCT01220128|64659638|FG004|Overall Study|Other|0|||
23250070|NCT01220128|64659639|FG005|Overall Study|Other|0|||
23250071|NCT01220128|64659640|FG006|Overall Study|Other|0|||
23250072|NCT01220128|64659634|FG000|Overall Study|Consent withdrawn by subject|1|||
23250073|NCT01220128|64659635|FG001|Overall Study|Consent withdrawn by subject|0|||
23250074|NCT01220128|64659636|FG002|Overall Study|Consent withdrawn by subject|0|||
23250075|NCT01220128|64659637|FG003|Overall Study|Consent withdrawn by subject|0|||
23250076|NCT01220128|64659638|FG004|Overall Study|Consent withdrawn by subject|0|||
23250077|NCT01220128|64659639|FG005|Overall Study|Consent withdrawn by subject|0|||
23250078|NCT01220128|64659640|FG006|Overall Study|Consent withdrawn by subject|0|||
23250079|NCT01020773|64659641|FG000|Overall Study|Withdrawal by Subject|4|||
23250080|NCT01020773|64659642|FG001|Overall Study|Withdrawal by Subject|3|||
23250081|NCT03276962|64659646|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
23250082|NCT03276962|64659647|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
23250083|NCT03276962|64659648|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
23250084|NCT03276962|64659649|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
23250085|NCT03276962|64659650|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
23250086|NCT03276962|64659646|FG000|Overall Study|Protocol Deviation|2|||
23250087|NCT03276962|64659647|FG001|Overall Study|Protocol Deviation|0|||
23250088|NCT03276962|64659648|FG002|Overall Study|Protocol Deviation|1|||
23250089|NCT03276962|64659649|FG003|Overall Study|Protocol Deviation|2|||
23250090|NCT03276962|64659650|FG004|Overall Study|Protocol Deviation|1|||
23250091|NCT03276962|64659646|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
23250092|NCT03276962|64659647|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
23250093|NCT03276962|64659648|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
23472923|NCT02560025|65477501|FG000|Overall Study|Ineligible after consent/ registration|3|||
23472924|NCT00796978|65477502|FG000|Overall Study|Cardiac adverse event|5|||
23472925|NCT00796978|65477502|FG000|Overall Study|Adverse Event|4|||
23472926|NCT00796978|65477502|FG000|Overall Study|Withdrawal by Subject|3|||
23472927|NCT01181986|65477503|FG000|Phase 1|Lost to Follow-up|0|||
23472928|NCT01181986|65477504|FG001|Phase 1|Lost to Follow-up|1|||
23472929|NCT01181986|65477505|FG002|Phase 1|Lost to Follow-up|1|||
23472930|NCT01181986|65477503|FG000|Phase 1|Adverse Event|0|||
23472931|NCT01181986|65477504|FG001|Phase 1|Adverse Event|0|||
23472932|NCT01181986|65477505|FG002|Phase 1|Adverse Event|1|||
23472933|NCT01181986|65477503|FG000|Phase 1|Protocol Violation|1|||
23472934|NCT01181986|65477504|FG001|Phase 1|Protocol Violation|0|||
23472935|NCT01181986|65477505|FG002|Phase 1|Protocol Violation|0|||
23472936|NCT01181986|65477503|FG000|Phase 2|Adverse Event|0|||
23472937|NCT01181986|65477504|FG001|Phase 2|Adverse Event|3|||
23472938|NCT01181986|65477505|FG002|Phase 2|Adverse Event|0|||
23472939|NCT01181986|65477503|FG000|Phase 2|Medical condition|0|||
23472940|NCT01181986|65477504|FG001|Phase 2|Medical condition|1|||
23472941|NCT01181986|65477505|FG002|Phase 2|Medical condition|0|||
23472942|NCT00463567|65477506|FG000|Overall Study|Adverse Event|29|||
23472943|NCT00463567|65477507|FG001|Overall Study|Adverse Event|26|||
23472944|NCT00463567|65477508|FG002|Overall Study|Adverse Event|17|||
23472945|NCT00463567|65477509|FG003|Overall Study|Adverse Event|46|||
23472946|NCT00463567|65477510|FG004|Overall Study|Adverse Event|10|||
23472947|NCT00463567|65477511|FG005|Overall Study|Adverse Event|10|||
23472948|NCT00463567|65477512|FG006|Overall Study|Adverse Event|4|||
23472949|NCT00463567|65477506|FG000|Overall Study|Withdrawal by Subject|29|||
23472950|NCT00463567|65477507|FG001|Overall Study|Withdrawal by Subject|22|||
23472951|NCT00463567|65477508|FG002|Overall Study|Withdrawal by Subject|20|||
23472952|NCT00463567|65477509|FG003|Overall Study|Withdrawal by Subject|37|||
23472953|NCT00463567|65477510|FG004|Overall Study|Withdrawal by Subject|6|||
23472954|NCT00463567|65477511|FG005|Overall Study|Withdrawal by Subject|5|||
23472955|NCT00463567|65477512|FG006|Overall Study|Withdrawal by Subject|1|||
23472956|NCT00463567|65477506|FG000|Overall Study|Protocol Deviation|13|||
23472957|NCT00463567|65477507|FG001|Overall Study|Protocol Deviation|9|||
23472958|NCT00463567|65477508|FG002|Overall Study|Protocol Deviation|14|||
23472959|NCT00463567|65477509|FG003|Overall Study|Protocol Deviation|11|||
23472960|NCT00463567|65477510|FG004|Overall Study|Protocol Deviation|1|||
23472961|NCT00463567|65477511|FG005|Overall Study|Protocol Deviation|1|||
23472962|NCT00463567|65477512|FG006|Overall Study|Protocol Deviation|2|||
23472963|NCT00463567|65477506|FG000|Overall Study|Lost to Follow-up|12|||
23472964|NCT00463567|65477507|FG001|Overall Study|Lost to Follow-up|6|||
23472965|NCT00463567|65477508|FG002|Overall Study|Lost to Follow-up|13|||
23472966|NCT00463567|65477509|FG003|Overall Study|Lost to Follow-up|8|||
23472967|NCT00463567|65477510|FG004|Overall Study|Lost to Follow-up|1|||
23472968|NCT00463567|65477511|FG005|Overall Study|Lost to Follow-up|1|||
23472969|NCT00463567|65477512|FG006|Overall Study|Lost to Follow-up|1|||
23250094|NCT03276962|64659649|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
23250095|NCT03276962|64659650|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
23250096|NCT03276962|64659646|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
23250097|NCT03276962|64659647|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
23250098|NCT03276962|64659648|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
23250099|NCT03276962|64659649|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
23250100|NCT03276962|64659650|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
23250101|NCT03276962|64659646|FG000|Overall Study|Lost to Follow-up|10|||
23250102|NCT03276962|64659647|FG001|Overall Study|Lost to Follow-up|10|||
23250103|NCT03276962|64659648|FG002|Overall Study|Lost to Follow-up|4|||
23250104|NCT03276962|64659649|FG003|Overall Study|Lost to Follow-up|6|||
23472970|NCT00463567|65477506|FG000|Overall Study|Administrative problems|5|||
23472971|NCT00463567|65477507|FG001|Overall Study|Administrative problems|3|||
23472972|NCT00463567|65477508|FG002|Overall Study|Administrative problems|6|||
23472973|NCT00463567|65477509|FG003|Overall Study|Administrative problems|9|||
23472974|NCT00463567|65477510|FG004|Overall Study|Administrative problems|3|||
23472975|NCT00463567|65477511|FG005|Overall Study|Administrative problems|2|||
23472976|NCT00463567|65477512|FG006|Overall Study|Administrative problems|2|||
23472977|NCT00463567|65477506|FG000|Overall Study|Lack of Efficacy|4|||
23472978|NCT00463567|65477507|FG001|Overall Study|Lack of Efficacy|9|||
23472979|NCT00463567|65477508|FG002|Overall Study|Lack of Efficacy|9|||
23472980|NCT00463567|65477509|FG003|Overall Study|Lack of Efficacy|17|||
23472981|NCT00463567|65477510|FG004|Overall Study|Lack of Efficacy|1|||
23472982|NCT00463567|65477511|FG005|Overall Study|Lack of Efficacy|0|||
23472983|NCT00463567|65477512|FG006|Overall Study|Lack of Efficacy|1|||
23472984|NCT00463567|65477506|FG000|Overall Study|Abnormal lab value(s)|1|||
23472985|NCT00463567|65477507|FG001|Overall Study|Abnormal lab value(s)|1|||
23472986|NCT00463567|65477508|FG002|Overall Study|Abnormal lab value(s)|2|||
23472987|NCT00463567|65477509|FG003|Overall Study|Abnormal lab value(s)|1|||
23472988|NCT00463567|65477510|FG004|Overall Study|Abnormal lab value(s)|1|||
23472989|NCT00463567|65477511|FG005|Overall Study|Abnormal lab value(s)|0|||
23472990|NCT00463567|65477512|FG006|Overall Study|Abnormal lab value(s)|0|||
23472991|NCT00463567|65477506|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23472992|NCT00463567|65477507|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23472993|NCT00463567|65477508|FG002|Overall Study|Abnormal test procedure result(s)|6|||
23472994|NCT00463567|65477509|FG003|Overall Study|Abnormal test procedure result(s)|2|||
23472995|NCT00463567|65477510|FG004|Overall Study|Abnormal test procedure result(s)|0|||
23472996|NCT00463567|65477511|FG005|Overall Study|Abnormal test procedure result(s)|2|||
23472997|NCT00463567|65477512|FG006|Overall Study|Abnormal test procedure result(s)|0|||
23472998|NCT00463567|65477506|FG000|Overall Study|Death|1|||
23472999|NCT00463567|65477507|FG001|Overall Study|Death|0|||
23473000|NCT00463567|65477508|FG002|Overall Study|Death|2|||
23473001|NCT00463567|65477509|FG003|Overall Study|Death|0|||
23473002|NCT00463567|65477510|FG004|Overall Study|Death|0|||
23250105|NCT03276962|64659650|FG004|Overall Study|Lost to Follow-up|10|||
23250106|NCT03276962|64659646|FG000|Overall Study|Other|0|||
23250107|NCT03276962|64659647|FG001|Overall Study|Other|2|||
23250108|NCT03276962|64659648|FG002|Overall Study|Other|0|||
23250109|NCT03276962|64659649|FG003|Overall Study|Other|2|||
23250110|NCT03276962|64659650|FG004|Overall Study|Other|1|||
23473003|NCT00463567|65477511|FG005|Overall Study|Death|0|||
23473004|NCT00463567|65477512|FG006|Overall Study|Death|0|||
23473005|NCT02147561|65477513|FG000|Overall Study|Lost to Follow-up|3|||
23473006|NCT02147561|65477513|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
23473007|NCT01742286|65477514|FG000|Escalation Phase|Administrative problems|1|||
23473008|NCT01742286|65477515|FG001|Escalation Phase|Administrative problems|1|||
23473009|NCT01742286|65477516|FG002|Escalation Phase|Administrative problems|0|||
23473010|NCT01742286|65477517|FG003|Escalation Phase|Administrative problems|0|||
23473011|NCT01742286|65477518|FG004|Escalation Phase|Administrative problems|0|||
23473012|NCT01742286|65477519|FG005|Escalation Phase|Administrative problems|0|||
23473013|NCT01742286|65477520|FG006|Escalation Phase|Administrative problems|2|||
23473014|NCT01742286|65477514|FG000|Escalation Phase|Adverse Event|0|||
23473015|NCT01742286|65477515|FG001|Escalation Phase|Adverse Event|1|||
23473016|NCT01742286|65477516|FG002|Escalation Phase|Adverse Event|2|||
23473017|NCT01742286|65477517|FG003|Escalation Phase|Adverse Event|0|||
23473018|NCT01742286|65477518|FG004|Escalation Phase|Adverse Event|0|||
23473019|NCT01742286|65477519|FG005|Escalation Phase|Adverse Event|1|||
23473020|NCT01742286|65477520|FG006|Escalation Phase|Adverse Event|0|||
23473021|NCT01742286|65477514|FG000|Escalation Phase|Disease progression|3|||
23473022|NCT01742286|65477515|FG001|Escalation Phase|Disease progression|7|||
23473023|NCT01742286|65477516|FG002|Escalation Phase|Disease progression|4|||
23473024|NCT01742286|65477517|FG003|Escalation Phase|Disease progression|1|||
23473025|NCT01742286|65477518|FG004|Escalation Phase|Disease progression|4|||
23473026|NCT01742286|65477519|FG005|Escalation Phase|Disease progression|3|||
23473027|NCT01742286|65477520|FG006|Escalation Phase|Disease progression|2|||
23473028|NCT01742286|65477514|FG000|Escalation Phase|Death|0|||
23250111|NCT00683904|64659651|FG000|Dose Level 1|Disease progression|2|||
23250112|NCT00683904|64659652|FG001|Dose Level 1|Disease progression|0|||
23250113|NCT00683904|64659651|FG000|Dose Level 1|Adverse Event|1|||
23250114|NCT00683904|64659652|FG001|Dose Level 1|Adverse Event|0|||
23250115|NCT00683904|64659651|FG000|Dose Level 2|Adverse Event|0|||
23250116|NCT00683904|64659652|FG001|Dose Level 2|Adverse Event|2|||
23250117|NCT03506425|64659653|FG000|Overall Study|Adverse Event|1|||
23250118|NCT03506425|64659654|FG001|Overall Study|Adverse Event|3|||
23250119|NCT03506425|64659655|FG002|Overall Study|Adverse Event|0|||
23250120|NCT03506425|64659653|FG000|Overall Study|Death|1|||
23250121|NCT03506425|64659654|FG001|Overall Study|Death|0|||
23250122|NCT03506425|64659655|FG002|Overall Study|Death|0|||
23250123|NCT03506425|64659653|FG000|Overall Study|Withdrawal by Subject|0|||
23250124|NCT03506425|64659654|FG001|Overall Study|Withdrawal by Subject|0|||
23250125|NCT03506425|64659655|FG002|Overall Study|Withdrawal by Subject|1|||
23250126|NCT04476017|64659656|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
23250127|NCT04476017|64659657|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
23250128|NCT02094573|64659662|FG000|Overall Study|Adverse Event|4|||
23250129|NCT02094573|64659663|FG001|Overall Study|Adverse Event|14|||
23250130|NCT02094573|64659662|FG000|Overall Study|Clinical Progressive Disease|9|||
23250131|NCT02094573|64659663|FG001|Overall Study|Clinical Progressive Disease|13|||
23250132|NCT02094573|64659662|FG000|Overall Study|Death|11|||
23250133|NCT02094573|64659663|FG001|Overall Study|Death|3|||
23250134|NCT02094573|64659662|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
23250135|NCT02094573|64659663|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
23250136|NCT02094573|64659662|FG000|Overall Study|Non-compliance with Study Drug|1|||
23356414|NCT03337048|65048867|FG001|Overall Study|Withdrawal by Subject|0|||
23356415|NCT03337048|65048868|FG002|Overall Study|Withdrawal by Subject|0|||
23356416|NCT00791700|65048869|FG000|Overall Study|Insufficient clinical response|1|||
23356417|NCT00791700|65048870|FG001|Overall Study|Insufficient clinical response|4|||
23356418|NCT00791700|65048871|FG002|Overall Study|Insufficient clinical response|1|||
23356419|NCT00791700|65048872|FG003|Overall Study|Insufficient clinical response|8|||
23356420|NCT00791700|65048869|FG000|Overall Study|No longer willing to participate|1|||
23356421|NCT00791700|65048870|FG001|Overall Study|No longer willing to participate|1|||
23356422|NCT00791700|65048871|FG002|Overall Study|No longer willing to participate|0|||
23356423|NCT00791700|65048872|FG003|Overall Study|No longer willing to participate|8|||
23356424|NCT00791700|65048869|FG000|Overall Study|Non-compliance with study treatment|0|||
23356425|NCT00791700|65048870|FG001|Overall Study|Non-compliance with study treatment|2|||
23356426|NCT00791700|65048871|FG002|Overall Study|Non-compliance with study treatment|0|||
23356427|NCT00791700|65048872|FG003|Overall Study|Non-compliance with study treatment|4|||
23356428|NCT00791700|65048869|FG000|Overall Study|Withdrawn due to pregnancy|0|||
23356429|NCT00791700|65048870|FG001|Overall Study|Withdrawn due to pregnancy|0|||
23356430|NCT00791700|65048871|FG002|Overall Study|Withdrawn due to pregnancy|0|||
23356431|NCT00791700|65048872|FG003|Overall Study|Withdrawn due to pregnancy|1|||
23356432|NCT00791700|65048869|FG000|Overall Study|Other|0|||
23356433|NCT00791700|65048870|FG001|Overall Study|Other|1|||
23356434|NCT00791700|65048871|FG002|Overall Study|Other|0|||
23356435|NCT00791700|65048872|FG003|Overall Study|Other|1|||
23356436|NCT00791700|65048869|FG000|Overall Study|Death|0|||
23356437|NCT00791700|65048870|FG001|Overall Study|Death|0|||
23356438|NCT00791700|65048871|FG002|Overall Study|Death|0|||
23356439|NCT00791700|65048872|FG003|Overall Study|Death|1|||
23356440|NCT00791700|65048869|FG000|Overall Study|Lost to Follow-up|4|||
23356441|NCT00791700|65048870|FG001|Overall Study|Lost to Follow-up|3|||
23473029|NCT01742286|65477515|FG001|Escalation Phase|Death|0|||
23190153|NCT00772967|64436257|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23190154|NCT00772967|64436258|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
23190155|NCT00772967|64436259|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23190156|NCT00772967|64436260|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23190157|NCT00772967|64436261|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23190158|NCT00772967|64436262|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
23190159|NCT00772967|64436257|FG000|Crossover Treatment 3|Adverse Event|0|||
23190160|NCT00772967|64436258|FG001|Crossover Treatment 3|Adverse Event|0|||
23190161|NCT00772967|64436259|FG002|Crossover Treatment 3|Adverse Event|0|||
23190162|NCT00772967|64436260|FG003|Crossover Treatment 3|Adverse Event|0|||
23190163|NCT00772967|64436261|FG004|Crossover Treatment 3|Adverse Event|1|||
23190164|NCT00772967|64436262|FG005|Crossover Treatment 3|Adverse Event|0|||
23356442|NCT00791700|65048871|FG002|Overall Study|Lost to Follow-up|4|||
23356443|NCT00791700|65048872|FG003|Overall Study|Lost to Follow-up|6|||
23356444|NCT00791700|65048869|FG000|Overall Study|Adverse Event|0|||
23190165|NCT00201851|64436263|FG000|Overall Study|Lost to Follow-up|2|||
23190166|NCT00201851|64436264|FG001|Overall Study|Lost to Follow-up|1|||
23250137|NCT02094573|64659663|FG001|Overall Study|Non-compliance with Study Drug|1|||
23356445|NCT00791700|65048870|FG001|Overall Study|Adverse Event|0|||
23250138|NCT02094573|64659662|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
23250139|NCT02094573|64659663|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
23250140|NCT02094573|64659662|FG000|Overall Study|Physician Decision|4|||
23250141|NCT02094573|64659663|FG001|Overall Study|Physician Decision|4|||
23250142|NCT02094573|64659662|FG000|Overall Study|Site Terminated by Sponsor|10|||
23250143|NCT02094573|64659663|FG001|Overall Study|Site Terminated by Sponsor|17|||
23250144|NCT02094573|64659662|FG000|Overall Study|Withdrawal by Subject|6|||
23250145|NCT02094573|64659663|FG001|Overall Study|Withdrawal by Subject|8|||
23250146|NCT02094573|64659662|FG000|Overall Study|Randomized but not Treated|3|||
23356446|NCT00791700|65048871|FG002|Overall Study|Adverse Event|1|||
23356447|NCT00791700|65048872|FG003|Overall Study|Adverse Event|1|||
23356448|NCT00316914|65048873|FG000|Overall Study|Withdrawal by Subject|5|||
23356449|NCT00316914|65048874|FG001|Overall Study|Withdrawal by Subject|3|||
23356450|NCT00316914|65048873|FG000|Overall Study|Adverse Event|8|||
23356451|NCT00316914|65048874|FG001|Overall Study|Adverse Event|7|||
23356452|NCT00316914|65048873|FG000|Overall Study|Other Problems|6|||
23356453|NCT00316914|65048874|FG001|Overall Study|Other Problems|11|||
23356454|NCT00316914|65048873|FG000|Overall Study|Missing end of treatment documentation|14|||
23356455|NCT00316914|65048874|FG001|Overall Study|Missing end of treatment documentation|15|||
23356456|NCT01711619|65048875|FG000|Overall Study|Early study termination|10|||
23356457|NCT01711619|65048876|FG001|Overall Study|Early study termination|14|||
23356458|NCT01711619|65048875|FG000|Overall Study|Withdrawal by Subject|3|||
23250147|NCT02094573|64659663|FG001|Overall Study|Randomized but not Treated|0|||
23250148|NCT00545441|64659666|FG000|Overall Study|Fistula draining at 6 months|2|||
23250149|NCT00545441|64659667|FG001|Overall Study|Fistula draining at 6 months|4|||
23250150|NCT00545441|64659666|FG000|Overall Study|Lost to Follow-up|9|||
23250151|NCT00545441|64659667|FG001|Overall Study|Lost to Follow-up|5|||
23250152|NCT00545441|64659666|FG000|Overall Study|Technical failure|0|||
23250153|NCT00545441|64659667|FG001|Overall Study|Technical failure|1|||
23250154|NCT00545441|64659666|FG000|Overall Study|Withdrawal by Subject|1|||
23250155|NCT00545441|64659667|FG001|Overall Study|Withdrawal by Subject|1|||
23250156|NCT00545441|64659666|FG000|Overall Study|Persistence or recurrence of fistula|5|||
23250157|NCT00545441|64659667|FG001|Overall Study|Persistence or recurrence of fistula|2|||
23250158|NCT00545441|64659666|FG000|Overall Study|Patients were not treated|1|||
23250159|NCT00545441|64659667|FG001|Overall Study|Patients were not treated|3|||
23250160|NCT04333199|64659668|FG000|Evaluated Patients|Lost to Follow-up|0|||
23250161|NCT04333199|64659669|FG001|Evaluated Patients|Lost to Follow-up|1|||
23250162|NCT04333199|64659670|FG002|Evaluated Patients|Lost to Follow-up|2|||
23250163|NCT03349437|64659675|FG000|Screening|Screen Fail|4|||
23250164|NCT03349437|64659676|FG001|Screening|Screen Fail|0|||
23250165|NCT03349437|64659677|FG002|Screening|Screen Fail|0|||
23250166|NCT03349437|64659675|FG000|Screening|Withdrawn|1|||
23250167|NCT03349437|64659676|FG001|Screening|Withdrawn|0|||
23250168|NCT03349437|64659677|FG002|Screening|Withdrawn|0|||
23250169|NCT01286207|64659678|FG000|Overall Study|Adverse Event|27|||
23250170|NCT01286207|64659679|FG001|Overall Study|Adverse Event|41|||
23250171|NCT01286207|64659680|FG002|Overall Study|Adverse Event|8|||
23250172|NCT01286207|64659678|FG000|Overall Study|Lost to Follow-up|49|||
23250173|NCT01286207|64659679|FG001|Overall Study|Lost to Follow-up|43|||
23250174|NCT01286207|64659680|FG002|Overall Study|Lost to Follow-up|20|||
23250175|NCT01286207|64659678|FG000|Overall Study|Withdrawal by Subject|93|||
23250176|NCT01286207|64659679|FG001|Overall Study|Withdrawal by Subject|79|||
23250177|NCT01286207|64659680|FG002|Overall Study|Withdrawal by Subject|41|||
23356459|NCT01711619|65048876|FG001|Overall Study|Withdrawal by Subject|7|||
23356460|NCT01711619|65048875|FG000|Overall Study|Protocol Violation|2|||
23356461|NCT01711619|65048876|FG001|Overall Study|Protocol Violation|3|||
23356462|NCT01711619|65048875|FG000|Overall Study|Adverse Event|2|||
23356463|NCT01711619|65048876|FG001|Overall Study|Adverse Event|0|||
23356464|NCT01711619|65048875|FG000|Overall Study|Lost to Follow-up|1|||
23356465|NCT01711619|65048876|FG001|Overall Study|Lost to Follow-up|0|||
23356466|NCT01121536|65048879|FG000|Overall Study|Adverse Event|63|||
23356467|NCT01121536|65048879|FG000|Overall Study|Lack of Efficacy|35|||
23356468|NCT01121536|65048879|FG000|Overall Study|Withdrawal by Subject|65|||
23356469|NCT01121536|65048879|FG000|Overall Study|Protocol Violation|20|||
23356470|NCT01121536|65048879|FG000|Overall Study|Noncompliance with study medication|12|||
23356471|NCT01121536|65048879|FG000|Overall Study|Noncompliance with study procedures|9|||
23356472|NCT01121536|65048879|FG000|Overall Study|Lost to Follow-up|39|||
23356473|NCT01121536|65048879|FG000|Overall Study|Other|118|||
23356474|NCT01605825|65048880|FG000|Overall Study|Adverse Event|4|||
23356475|NCT01605825|65048881|FG001|Overall Study|Adverse Event|2|||
23473030|NCT01742286|65477516|FG002|Escalation Phase|Death|0|||
23356476|NCT01605825|65048880|FG000|Overall Study|Withdrawal by Subject|0|||
23473031|NCT01742286|65477517|FG003|Escalation Phase|Death|0|||
23250178|NCT01286207|64659678|FG000|Overall Study|Lack of Response|92|||
23356477|NCT01605825|65048881|FG001|Overall Study|Withdrawal by Subject|1|||
23473032|NCT01742286|65477518|FG004|Escalation Phase|Death|0|||
23250179|NCT01286207|64659679|FG001|Overall Study|Lack of Response|38|||
23250180|NCT01286207|64659680|FG002|Overall Study|Lack of Response|8|||
23250181|NCT01286207|64659678|FG000|Overall Study|Other|37|||
23250182|NCT01286207|64659679|FG001|Overall Study|Other|47|||
23250183|NCT01286207|64659680|FG002|Overall Study|Other|13|||
23250184|NCT00791154|64659682|FG000|Overall Study|Noncompliance|0|||
23356478|NCT01605825|65048880|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
23356479|NCT01605825|65048881|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
23356480|NCT01605825|65048880|FG000|Overall Study|Non-Compliance with Protocol|3|||
23356481|NCT01605825|65048881|FG001|Overall Study|Non-Compliance with Protocol|0|||
23356482|NCT01677182|65048882|FG000|Overall Study|Adverse Event|2|||
23356483|NCT01677182|65048883|FG001|Overall Study|Adverse Event|1|||
23356484|NCT01677182|65048884|FG002|Overall Study|Adverse Event|8|||
23356485|NCT01677182|65048882|FG000|Overall Study|Protocol Violation|5|||
23356486|NCT01677182|65048883|FG001|Overall Study|Protocol Violation|1|||
23356487|NCT01677182|65048884|FG002|Overall Study|Protocol Violation|4|||
23356488|NCT01677182|65048882|FG000|Overall Study|Lost to Follow-up|4|||
23356489|NCT01677182|65048883|FG001|Overall Study|Lost to Follow-up|0|||
23356490|NCT01677182|65048884|FG002|Overall Study|Lost to Follow-up|3|||
23356491|NCT01677182|65048882|FG000|Overall Study|Withdrawal by Subject|7|||
23356492|NCT01677182|65048883|FG001|Overall Study|Withdrawal by Subject|12|||
23356493|NCT01677182|65048884|FG002|Overall Study|Withdrawal by Subject|10|||
23356494|NCT01677182|65048882|FG000|Overall Study|Study termination|12|||
23356495|NCT01677182|65048883|FG001|Overall Study|Study termination|9|||
23356496|NCT01677182|65048884|FG002|Overall Study|Study termination|11|||
23356497|NCT01677182|65048882|FG000|Overall Study|Lack of Efficacy|3|||
23473033|NCT01742286|65477519|FG005|Escalation Phase|Death|1|||
23473034|NCT01742286|65477520|FG006|Escalation Phase|Death|0|||
23473035|NCT01742286|65477514|FG000|Escalation Phase|Physician Decision|0|||
23473036|NCT01742286|65477515|FG001|Escalation Phase|Physician Decision|3|||
23473037|NCT01742286|65477516|FG002|Escalation Phase|Physician Decision|0|||
23473038|NCT01742286|65477517|FG003|Escalation Phase|Physician Decision|1|||
23473039|NCT01742286|65477518|FG004|Escalation Phase|Physician Decision|0|||
23473040|NCT01742286|65477519|FG005|Escalation Phase|Physician Decision|0|||
23473041|NCT01742286|65477520|FG006|Escalation Phase|Physician Decision|2|||
23473042|NCT01742286|65477514|FG000|Escalation Phase|Subject/guardian decision|1|||
23473043|NCT01742286|65477515|FG001|Escalation Phase|Subject/guardian decision|0|||
23473044|NCT01742286|65477516|FG002|Escalation Phase|Subject/guardian decision|0|||
23473045|NCT01742286|65477517|FG003|Escalation Phase|Subject/guardian decision|0|||
23473046|NCT01742286|65477518|FG004|Escalation Phase|Subject/guardian decision|0|||
23473047|NCT01742286|65477519|FG005|Escalation Phase|Subject/guardian decision|0|||
23473048|NCT01742286|65477520|FG006|Escalation Phase|Subject/guardian decision|0|||
23588685|NCT01981850|65882218|FG002|Main Phase Stage 1|Death|0|||
23473049|NCT01742286|65477514|FG000|Expansion Phase|Administrative problems|0|||
23473050|NCT01742286|65477515|FG001|Expansion Phase|Administrative problems|0|||
23473051|NCT01742286|65477516|FG002|Expansion Phase|Administrative problems|0|||
23473052|NCT01742286|65477517|FG003|Expansion Phase|Administrative problems|0|||
23473053|NCT01742286|65477518|FG004|Expansion Phase|Administrative problems|0|||
23473054|NCT01742286|65477519|FG005|Expansion Phase|Administrative problems|0|||
23473055|NCT01742286|65477520|FG006|Expansion Phase|Administrative problems|5|||
23473056|NCT01742286|65477514|FG000|Expansion Phase|Physician Decision|0|||
23473057|NCT01742286|65477515|FG001|Expansion Phase|Physician Decision|0|||
23473058|NCT01742286|65477516|FG002|Expansion Phase|Physician Decision|4|||
23588686|NCT01981850|65882219|FG003|Main Phase Stage 1|Death|0|||
23588687|NCT01981850|65882220|FG004|Main Phase Stage 1|Death|0|||
23588688|NCT01981850|65882221|FG005|Main Phase Stage 1|Death|0|||
23588689|NCT01981850|65882222|FG006|Main Phase Stage 1|Death|0|||
23588690|NCT01981850|65882223|FG007|Main Phase Stage 1|Death|0|||
23588691|NCT01981850|65882224|FG008|Main Phase Stage 1|Death|0|||
23588692|NCT01981850|65882225|FG009|Main Phase Stage 1|Death|0|||
23588693|NCT01981850|65882216|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
23588694|NCT01981850|65882217|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588695|NCT01981850|65882218|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23473059|NCT01742286|65477517|FG003|Expansion Phase|Physician Decision|0|||
23473060|NCT01742286|65477518|FG004|Expansion Phase|Physician Decision|0|||
23473061|NCT01742286|65477519|FG005|Expansion Phase|Physician Decision|0|||
23588696|NCT01981850|65882219|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23356498|NCT01677182|65048883|FG001|Overall Study|Lack of Efficacy|0|||
23356499|NCT01677182|65048884|FG002|Overall Study|Lack of Efficacy|1|||
23356500|NCT01677182|65048882|FG000|Overall Study|Other reasons|1|||
23356501|NCT01677182|65048883|FG001|Overall Study|Other reasons|5|||
23356502|NCT01677182|65048884|FG002|Overall Study|Other reasons|2|||
23356503|NCT02328937|65048887|FG000|Period 1|Lost to Follow-up|0|||
23356504|NCT02328937|65048888|FG001|Period 1|Lost to Follow-up|0|||
23356505|NCT02328937|65048889|FG002|Period 1|Lost to Follow-up|0|||
23356506|NCT02328937|65048890|FG003|Period 1|Lost to Follow-up|1|||
23356507|NCT02328937|65048891|FG004|Period 1|Lost to Follow-up|0|||
23356508|NCT02328937|65048892|FG005|Period 1|Lost to Follow-up|0|||
23356509|NCT02328937|65048887|FG000|Period 2|Adverse Event|0|||
23356510|NCT02328937|65048888|FG001|Period 2|Adverse Event|0|||
23356511|NCT02328937|65048889|FG002|Period 2|Adverse Event|1|||
23356512|NCT02328937|65048890|FG003|Period 2|Adverse Event|0|||
23356513|NCT02328937|65048891|FG004|Period 2|Adverse Event|0|||
23356514|NCT02328937|65048892|FG005|Period 2|Adverse Event|0|||
23356515|NCT01778751|65048893|FG000|Overall Study|Lost to Follow-up|1|||
23356516|NCT01778751|65048894|FG001|Overall Study|Lost to Follow-up|0|||
23356517|NCT01778751|65048893|FG000|Overall Study|Withdrawal by Subject|0|||
23356518|NCT01778751|65048894|FG001|Overall Study|Withdrawal by Subject|2|||
23356519|NCT01778751|65048893|FG000|Overall Study|Transfered care|1|||
23356520|NCT01778751|65048894|FG001|Overall Study|Transfered care|0|||
23356521|NCT03089853|65048895|FG000|Overall Study|Lost to Follow-up|2|||
23356522|NCT03089853|65048896|FG001|Overall Study|Lost to Follow-up|1|||
23356523|NCT02290925|65048898|FG000|First Period of Three Months|Lost to Follow-up|2|||
23356524|NCT02290925|65048899|FG001|First Period of Three Months|Lost to Follow-up|1|||
23356525|NCT02290925|65048898|FG000|First Period of Three Months|Death|1|||
23356526|NCT02290925|65048899|FG001|First Period of Three Months|Death|0|||
23356527|NCT02290925|65048898|FG000|First Period of Three Months|Insulin Started|1|||
23356528|NCT02290925|65048899|FG001|First Period of Three Months|Insulin Started|1|||
23356529|NCT02290925|65048898|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
23356530|NCT02290925|65048899|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
23356531|NCT02290925|65048898|FG000|Second Period of 3 Months|insulin started|0|||
23356532|NCT02290925|65048899|FG001|Second Period of 3 Months|insulin started|1|||
23356533|NCT00321906|65048900|FG000|Overall Study|Adverse Event|36|||
23356534|NCT00321906|65048901|FG001|Overall Study|Adverse Event|44|||
23356535|NCT00321906|65048900|FG000|Overall Study|Death|9|||
23356536|NCT00321906|65048901|FG001|Overall Study|Death|6|||
23356537|NCT00321906|65048900|FG000|Overall Study|Lost to Follow-up|1|||
23356538|NCT00321906|65048901|FG001|Overall Study|Lost to Follow-up|2|||
23356539|NCT00321906|65048900|FG000|Overall Study|Withdrawal by Subject|0|||
23356540|NCT00321906|65048901|FG001|Overall Study|Withdrawal by Subject|4|||
23356541|NCT00572455|65048904|FG000|Stage I (14 Days)|Adverse Event|0|||
23356542|NCT00572455|65048905|FG001|Stage I (14 Days)|Adverse Event|0|||
23356543|NCT00572455|65048906|FG002|Stage I (14 Days)|Adverse Event|0|||
23356544|NCT00572455|65048907|FG003|Stage I (14 Days)|Adverse Event|0|||
23356545|NCT00572455|65048908|FG004|Stage I (14 Days)|Adverse Event|0|||
23356546|NCT00572455|65048909|FG005|Stage I (14 Days)|Adverse Event|3|||
23356547|NCT00572455|65048910|FG006|Stage I (14 Days)|Adverse Event|0|||
23356548|NCT00572455|65048911|FG007|Stage I (14 Days)|Adverse Event|0|||
23356549|NCT00572455|65048912|FG008|Stage I (14 Days)|Adverse Event|0|||
23356550|NCT00572455|65048913|FG009|Stage I (14 Days)|Adverse Event|0|||
23356551|NCT00572455|65048914|FG010|Stage I (14 Days)|Adverse Event|0|||
23356552|NCT00572455|65048915|FG011|Stage I (14 Days)|Adverse Event|0|||
23588697|NCT01981850|65882220|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23356553|NCT00572455|65048916|FG012|Stage I (14 Days)|Adverse Event|0|||
23356554|NCT00572455|65048917|FG013|Stage I (14 Days)|Adverse Event|0|||
23356555|NCT00572455|65048904|FG000|Stage I (14 Days)|Other|0|||
23356556|NCT00572455|65048905|FG001|Stage I (14 Days)|Other|0|||
23356557|NCT00572455|65048906|FG002|Stage I (14 Days)|Other|0|||
23356558|NCT00572455|65048907|FG003|Stage I (14 Days)|Other|0|||
23356559|NCT00572455|65048908|FG004|Stage I (14 Days)|Other|1|||
23356560|NCT00572455|65048909|FG005|Stage I (14 Days)|Other|0|||
23356561|NCT00572455|65048910|FG006|Stage I (14 Days)|Other|0|||
23356562|NCT00572455|65048911|FG007|Stage I (14 Days)|Other|0|||
23356563|NCT00572455|65048912|FG008|Stage I (14 Days)|Other|0|||
23356564|NCT00572455|65048913|FG009|Stage I (14 Days)|Other|0|||
23356565|NCT00572455|65048914|FG010|Stage I (14 Days)|Other|0|||
23356566|NCT00572455|65048915|FG011|Stage I (14 Days)|Other|0|||
23356567|NCT00572455|65048916|FG012|Stage I (14 Days)|Other|0|||
23356568|NCT00572455|65048917|FG013|Stage I (14 Days)|Other|0|||
23356569|NCT00572455|65048904|FG000|Stage II (28 Days)|Adverse Event|0|||
23356570|NCT00572455|65048905|FG001|Stage II (28 Days)|Adverse Event|0|||
23356571|NCT00572455|65048906|FG002|Stage II (28 Days)|Adverse Event|0|||
23356572|NCT00572455|65048907|FG003|Stage II (28 Days)|Adverse Event|0|||
23356573|NCT00572455|65048908|FG004|Stage II (28 Days)|Adverse Event|0|||
23356574|NCT00572455|65048909|FG005|Stage II (28 Days)|Adverse Event|0|||
23356575|NCT00572455|65048910|FG006|Stage II (28 Days)|Adverse Event|0|||
23356576|NCT00572455|65048911|FG007|Stage II (28 Days)|Adverse Event|0|||
23356577|NCT00572455|65048912|FG008|Stage II (28 Days)|Adverse Event|1|||
23356578|NCT00572455|65048913|FG009|Stage II (28 Days)|Adverse Event|3|||
23356579|NCT00572455|65048914|FG010|Stage II (28 Days)|Adverse Event|3|||
23356580|NCT00572455|65048915|FG011|Stage II (28 Days)|Adverse Event|4|||
23356581|NCT00572455|65048916|FG012|Stage II (28 Days)|Adverse Event|5|||
23356582|NCT00572455|65048917|FG013|Stage II (28 Days)|Adverse Event|1|||
23356583|NCT00572455|65048904|FG000|Stage II (28 Days)|Death|0|||
23356584|NCT00572455|65048905|FG001|Stage II (28 Days)|Death|0|||
23356585|NCT00572455|65048906|FG002|Stage II (28 Days)|Death|0|||
23356586|NCT00572455|65048907|FG003|Stage II (28 Days)|Death|0|||
23356587|NCT00572455|65048908|FG004|Stage II (28 Days)|Death|0|||
23356588|NCT00572455|65048909|FG005|Stage II (28 Days)|Death|0|||
23356589|NCT00572455|65048910|FG006|Stage II (28 Days)|Death|0|||
23356590|NCT00572455|65048911|FG007|Stage II (28 Days)|Death|0|||
23356591|NCT00572455|65048912|FG008|Stage II (28 Days)|Death|1|||
23356592|NCT00572455|65048913|FG009|Stage II (28 Days)|Death|0|||
23356593|NCT00572455|65048914|FG010|Stage II (28 Days)|Death|0|||
23356594|NCT00572455|65048915|FG011|Stage II (28 Days)|Death|0|||
23356595|NCT00572455|65048916|FG012|Stage II (28 Days)|Death|0|||
23356596|NCT00572455|65048917|FG013|Stage II (28 Days)|Death|0|||
23356597|NCT00572455|65048904|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
23356598|NCT00572455|65048905|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
23356599|NCT00572455|65048906|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
23356600|NCT00572455|65048907|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
23356601|NCT00572455|65048908|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
23356602|NCT00572455|65048909|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
23356603|NCT00572455|65048910|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
23356604|NCT00572455|65048911|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
23356605|NCT00572455|65048912|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
23250185|NCT00791154|64659683|FG001|Overall Study|Noncompliance|1|||
23250186|NCT00791154|64659684|FG002|Overall Study|Noncompliance|0|||
23356606|NCT00572455|65048913|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
23356607|NCT00572455|65048914|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
23356608|NCT00572455|65048915|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
23356609|NCT00572455|65048916|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
23356610|NCT00572455|65048917|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
23356611|NCT00572455|65048904|FG000|Stage II (28 Days)|Other|0|||
23356612|NCT00572455|65048905|FG001|Stage II (28 Days)|Other|0|||
23356613|NCT00572455|65048906|FG002|Stage II (28 Days)|Other|0|||
23356614|NCT00572455|65048907|FG003|Stage II (28 Days)|Other|0|||
23356615|NCT00572455|65048908|FG004|Stage II (28 Days)|Other|0|||
23356616|NCT00572455|65048909|FG005|Stage II (28 Days)|Other|0|||
23356617|NCT00572455|65048910|FG006|Stage II (28 Days)|Other|0|||
23356618|NCT00572455|65048911|FG007|Stage II (28 Days)|Other|0|||
23356619|NCT00572455|65048912|FG008|Stage II (28 Days)|Other|1|||
23356620|NCT00572455|65048913|FG009|Stage II (28 Days)|Other|0|||
23356621|NCT00572455|65048914|FG010|Stage II (28 Days)|Other|0|||
23356622|NCT00572455|65048915|FG011|Stage II (28 Days)|Other|0|||
23356623|NCT00572455|65048916|FG012|Stage II (28 Days)|Other|0|||
23356624|NCT00572455|65048917|FG013|Stage II (28 Days)|Other|0|||
23356625|NCT00572455|65048904|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
23356626|NCT00572455|65048905|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
23356627|NCT00572455|65048906|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
23190167|NCT00201851|64436265|FG002|Overall Study|Lost to Follow-up|0|||
23190168|NCT00201851|64436263|FG000|Overall Study|Ineligible post enrollment|6|||
23190169|NCT00201851|64436264|FG001|Overall Study|Ineligible post enrollment|1|||
23190170|NCT00201851|64436265|FG002|Overall Study|Ineligible post enrollment|1|||
23190171|NCT01901328|64436266|FG000|Overall Study|Lost to Follow-up|1|||
23190172|NCT01901328|64436267|FG001|Overall Study|Lost to Follow-up|0|||
23190173|NCT01901328|64436266|FG000|Overall Study|Physician Decision|0|||
23190174|NCT01901328|64436267|FG001|Overall Study|Physician Decision|1|||
23190175|NCT01901328|64436266|FG000|Overall Study|Protocol Violation|1|||
23250187|NCT00791154|64659685|FG003|Overall Study|Noncompliance|0|||
23250188|NCT00791154|64659686|FG004|Overall Study|Noncompliance|1|||
23250189|NCT00791154|64659687|FG005|Overall Study|Noncompliance|1|||
23356628|NCT00572455|65048907|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
23356629|NCT00572455|65048908|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
23356630|NCT00572455|65048909|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
23356631|NCT00572455|65048910|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
23356632|NCT00572455|65048911|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
23356633|NCT00572455|65048912|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
23356634|NCT00572455|65048913|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
23356635|NCT00572455|65048914|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
23356636|NCT00572455|65048915|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
23356637|NCT00572455|65048916|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
23356638|NCT00572455|65048917|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
23356639|NCT03026283|65048918|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
23356640|NCT03026283|65048919|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
23356641|NCT03026283|65048920|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
23356642|NCT03026283|65048921|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
23356643|NCT03026283|65048922|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
23356644|NCT03026283|65048923|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
23356645|NCT03026283|65048924|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
23356646|NCT03026283|65048925|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
23356647|NCT03026283|65048918|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
23356648|NCT03026283|65048919|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
23356649|NCT03026283|65048920|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
23356650|NCT03026283|65048921|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
23356651|NCT03026283|65048922|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
23356652|NCT03026283|65048923|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
23356653|NCT03026283|65048924|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
23356654|NCT03026283|65048925|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
23356655|NCT03026283|65048918|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356656|NCT03026283|65048919|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
23356657|NCT03026283|65048920|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356658|NCT03026283|65048921|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356659|NCT03026283|65048922|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356660|NCT03026283|65048923|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356661|NCT03026283|65048924|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356662|NCT03026283|65048925|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
23356663|NCT03026283|65048918|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356664|NCT03026283|65048919|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356665|NCT03026283|65048920|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
23356666|NCT03026283|65048921|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356667|NCT03026283|65048922|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356668|NCT03026283|65048923|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356669|NCT03026283|65048924|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23473062|NCT01742286|65477520|FG006|Expansion Phase|Physician Decision|9|||
23473063|NCT01742286|65477514|FG000|Expansion Phase|Adverse Event|0|||
23588698|NCT01981850|65882221|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23250190|NCT00791154|64659688|FG006|Overall Study|Noncompliance|1|||
23250191|NCT00791154|64659682|FG000|Overall Study|Adverse Event|0|||
23250192|NCT00791154|64659683|FG001|Overall Study|Adverse Event|0|||
23250193|NCT00791154|64659684|FG002|Overall Study|Adverse Event|0|||
23250194|NCT00791154|64659685|FG003|Overall Study|Adverse Event|0|||
23250195|NCT00791154|64659686|FG004|Overall Study|Adverse Event|2|||
23250196|NCT00791154|64659687|FG005|Overall Study|Adverse Event|0|||
23250197|NCT00791154|64659688|FG006|Overall Study|Adverse Event|1|||
23250198|NCT00791154|64659682|FG000|Overall Study|Full Consent withdrawn|1|||
23250199|NCT00791154|64659683|FG001|Overall Study|Full Consent withdrawn|3|||
23250200|NCT00791154|64659684|FG002|Overall Study|Full Consent withdrawn|0|||
23250201|NCT00791154|64659685|FG003|Overall Study|Full Consent withdrawn|0|||
23250202|NCT00791154|64659686|FG004|Overall Study|Full Consent withdrawn|1|||
23250203|NCT00791154|64659687|FG005|Overall Study|Full Consent withdrawn|3|||
23250204|NCT00791154|64659688|FG006|Overall Study|Full Consent withdrawn|1|||
23250205|NCT00791154|64659682|FG000|Overall Study|Lost to Follow-up|0|||
23250206|NCT00791154|64659683|FG001|Overall Study|Lost to Follow-up|0|||
23250207|NCT00791154|64659684|FG002|Overall Study|Lost to Follow-up|0|||
23250208|NCT00791154|64659685|FG003|Overall Study|Lost to Follow-up|1|||
23250209|NCT00791154|64659686|FG004|Overall Study|Lost to Follow-up|2|||
23250210|NCT00791154|64659687|FG005|Overall Study|Lost to Follow-up|0|||
23250211|NCT00791154|64659688|FG006|Overall Study|Lost to Follow-up|4|||
23250212|NCT00791154|64659682|FG000|Overall Study|Death|5|||
23250213|NCT00791154|64659683|FG001|Overall Study|Death|4|||
23356670|NCT03026283|65048925|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
23356671|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356672|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356673|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356674|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
23356675|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
23356676|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356677|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356678|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
23356679|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356680|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356681|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356682|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
23356683|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
23250214|NCT00791154|64659684|FG002|Overall Study|Death|4|||
23250215|NCT00791154|64659685|FG003|Overall Study|Death|7|||
23250216|NCT00791154|64659686|FG004|Overall Study|Death|54|||
23250217|NCT00791154|64659687|FG005|Overall Study|Death|54|||
23250218|NCT00791154|64659688|FG006|Overall Study|Death|52|||
23250219|NCT00791154|64659682|FG000|Overall Study|Other event|0|||
23356684|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
23356685|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356686|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
23356687|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356688|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356689|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23250220|NCT00791154|64659683|FG001|Overall Study|Other event|0|||
23356690|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
23356691|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356692|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
23356693|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356694|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
23356695|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23250221|NCT00791154|64659684|FG002|Overall Study|Other event|2|||
23250222|NCT00791154|64659685|FG003|Overall Study|Other event|0|||
23250223|NCT00791154|64659686|FG004|Overall Study|Other event|2|||
23250224|NCT00791154|64659687|FG005|Overall Study|Other event|4|||
23250225|NCT00791154|64659688|FG006|Overall Study|Other event|2|||
23250226|NCT01977625|64659698|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
23250227|NCT01977625|64659699|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23250228|NCT01977625|64659698|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
23356696|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356697|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23473064|NCT01742286|65477515|FG001|Expansion Phase|Adverse Event|0|||
23473065|NCT01742286|65477516|FG002|Expansion Phase|Adverse Event|0|||
23190176|NCT01901328|64436267|FG001|Overall Study|Protocol Violation|1|||
23250229|NCT01977625|64659699|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23250230|NCT00434148|64659700|FG000|Overall Study|Adverse Event|18|||
23250231|NCT00434148|64659701|FG001|Overall Study|Adverse Event|18|||
23473066|NCT01742286|65477517|FG003|Expansion Phase|Adverse Event|0|||
23250232|NCT00434148|64659700|FG000|Overall Study|Lack of Efficacy|25|||
23356698|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
23356699|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356700|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356701|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356702|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
23356703|NCT03026283|65048918|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356704|NCT03026283|65048919|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356705|NCT03026283|65048920|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356706|NCT03026283|65048921|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356707|NCT03026283|65048922|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
23356708|NCT03026283|65048923|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
23356709|NCT03026283|65048924|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23356710|NCT03026283|65048925|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
23250233|NCT00434148|64659701|FG001|Overall Study|Lack of Efficacy|28|||
23250234|NCT00434148|64659700|FG000|Overall Study|Withdrawal by Subject|15|||
23250235|NCT00434148|64659701|FG001|Overall Study|Withdrawal by Subject|15|||
23250236|NCT00434148|64659700|FG000|Overall Study|Protocol Violation|4|||
23250237|NCT00434148|64659701|FG001|Overall Study|Protocol Violation|0|||
23250238|NCT00434148|64659700|FG000|Overall Study|Administrative problems|6|||
23250239|NCT00434148|64659701|FG001|Overall Study|Administrative problems|10|||
23250240|NCT00434148|64659700|FG000|Overall Study|Lost to Follow-up|0|||
23250241|NCT00434148|64659701|FG001|Overall Study|Lost to Follow-up|1|||
23250242|NCT00434148|64659700|FG000|Overall Study|Condition no longer requires study drug|1|||
23250243|NCT00434148|64659701|FG001|Overall Study|Condition no longer requires study drug|0|||
23356711|NCT03313310|65048926|FG000|Phase 2|Lost to Follow-up|4|||
23356712|NCT03313310|65048927|FG001|Phase 2|Lost to Follow-up|0|||
23250244|NCT00434148|64659700|FG000|Overall Study|Abnormal test procedure result|0|||
23250245|NCT00434148|64659701|FG001|Overall Study|Abnormal test procedure result|1|||
23250246|NCT03454672|64659702|FG000|Overall Study|Adverse Event|1|||
23473067|NCT01742286|65477518|FG004|Expansion Phase|Adverse Event|0|||
23473068|NCT01742286|65477519|FG005|Expansion Phase|Adverse Event|0|||
23473069|NCT01742286|65477520|FG006|Expansion Phase|Adverse Event|6|||
23473070|NCT01742286|65477514|FG000|Expansion Phase|Disease progression|0|||
23473071|NCT01742286|65477515|FG001|Expansion Phase|Disease progression|0|||
23190177|NCT01901328|64436266|FG000|Overall Study|Study Terminated by Sponsor|19|||
23190178|NCT01901328|64436267|FG001|Overall Study|Study Terminated by Sponsor|16|||
23190179|NCT01901328|64436266|FG000|Overall Study|Withdrawal by Subject|1|||
23190180|NCT01901328|64436267|FG001|Overall Study|Withdrawal by Subject|2|||
23190181|NCT01901328|64436266|FG000|Overall Study|Lack of Efficacy|0|||
23190182|NCT01901328|64436267|FG001|Overall Study|Lack of Efficacy|1|||
23190183|NCT00003641|64439344|FG000|Overall Study|Withdrawal by Subject|0|||
23190184|NCT00003641|64439345|FG001|Overall Study|Withdrawal by Subject|100|||
23190185|NCT00003641|64439344|FG000|Overall Study|Adverse Event|0|||
23190186|NCT00003641|64439345|FG001|Overall Study|Adverse Event|38|||
23190187|NCT00003641|64439344|FG000|Overall Study|Disease progression|0|||
23190188|NCT00003641|64439345|FG001|Overall Study|Disease progression|2|||
23190189|NCT00003641|64439344|FG000|Overall Study|Unknown/missing|0|||
23190190|NCT00003641|64439345|FG001|Overall Study|Unknown/missing|22|||
23190191|NCT00003641|64439344|FG000|Overall Study|Should not receive interferon therapy|2|||
23190192|NCT00003641|64439345|FG001|Overall Study|Should not receive interferon therapy|0|||
23190193|NCT00003641|64439344|FG000|Overall Study|Never started interferon|567|||
23190194|NCT00003641|64439345|FG001|Overall Study|Never started interferon|12|||
23250247|NCT03454672|64659703|FG001|Overall Study|Adverse Event|1|||
23250248|NCT03454672|64659702|FG000|Overall Study|Lost to Follow-up|1|||
23356713|NCT03313310|65048926|FG000|Phase 3|Lost to Follow-up|0|||
23356714|NCT03313310|65048927|FG001|Phase 3|Lost to Follow-up|1|||
23356715|NCT00660595|65048928|FG000|Overall Study|Lost to Follow-up|0|||
23356716|NCT00660595|65048929|FG001|Overall Study|Lost to Follow-up|1|||
23356717|NCT00660595|65048928|FG000|Overall Study|Did not consent to participate in study|12|||
23473072|NCT01742286|65477516|FG002|Expansion Phase|Disease progression|3|||
23473073|NCT01742286|65477517|FG003|Expansion Phase|Disease progression|0|||
23473074|NCT01742286|65477518|FG004|Expansion Phase|Disease progression|0|||
23473075|NCT01742286|65477519|FG005|Expansion Phase|Disease progression|0|||
23473076|NCT01742286|65477520|FG006|Expansion Phase|Disease progression|15|||
23473077|NCT01742286|65477514|FG000|Expansion Phase|Withdrawal by Subject|0|||
23190195|NCT01457339|64439346|FG000|Period 3 (100 mg)|Adverse Event|0|||
23190196|NCT01457339|64439347|FG001|Period 3 (100 mg)|Adverse Event|1|||
23190197|NCT01457339|64439346|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
23190198|NCT01457339|64439347|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
23190199|NCT01457339|64439346|FG000|Period 6 (250 mg)|Family Emergency|1|||
23250249|NCT03454672|64659703|FG001|Overall Study|Lost to Follow-up|3|||
23250250|NCT03454672|64659702|FG000|Overall Study|painful|1|||
23190200|NCT01457339|64439347|FG001|Period 6 (250 mg)|Family Emergency|0|||
23190201|NCT01457339|64439346|FG000|Period 6 (250 mg)|Personal appointment|0|||
23190202|NCT01457339|64439347|FG001|Period 6 (250 mg)|Personal appointment|1|||
23190203|NCT00971321|64439348|FG000|Up to Month 7|Withdrawal by Subject|1|||
23190204|NCT00971321|64439349|FG001|Up to Month 7|Withdrawal by Subject|0|||
23190205|NCT00971321|64439348|FG000|Up to Month 7|Migrated/moved from study area|3|||
23190206|NCT00971321|64439349|FG001|Up to Month 7|Migrated/moved from study area|2|||
23356718|NCT00660595|65048929|FG001|Overall Study|Did not consent to participate in study|8|||
23356719|NCT00660595|65048928|FG000|Overall Study|Participant left hospital|1|||
23356720|NCT00660595|65048929|FG001|Overall Study|Participant left hospital|0|||
23356721|NCT00660595|65048928|FG000|Overall Study|Non Specified reasons|5|||
23190207|NCT00971321|64439348|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
23190208|NCT00971321|64439349|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
23190209|NCT00971321|64439348|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
23190210|NCT00971321|64439349|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
23190211|NCT00971321|64439348|FG000|Up to Month 11-12|Lost to Follow-up|1|||
23190212|NCT00971321|64439349|FG001|Up to Month 11-12|Lost to Follow-up|0|||
23190213|NCT00852930|64439350|FG000|Overall Study|Withdrawal by Subject|1|||
23190214|NCT00852930|64439351|FG001|Overall Study|Withdrawal by Subject|1|||
23190215|NCT00852930|64439352|FG002|Overall Study|Withdrawal by Subject|1|||
23588699|NCT01981850|65882222|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588700|NCT01981850|65882223|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588701|NCT01981850|65882224|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588702|NCT01981850|65882225|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
23588703|NCT01981850|65882216|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
23588704|NCT01981850|65882217|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
23190216|NCT00852930|64439350|FG000|Overall Study|Physician Decision|0|||
23190217|NCT00852930|64439351|FG001|Overall Study|Physician Decision|0|||
23190218|NCT00852930|64439352|FG002|Overall Study|Physician Decision|1|||
23190219|NCT00283712|64439354|FG000|Overall Study|Death|0|||
23190220|NCT00283712|64439355|FG001|Overall Study|Death|1|||
23190221|NCT00673673|64439356|FG000|Overall Study|Progressive disease|27|||
23190222|NCT00673673|64439356|FG000|Overall Study|Adverse Event|4|||
23190223|NCT00673673|64439356|FG000|Overall Study|Withdrawal by Subject|3|||
23190224|NCT00673673|64439356|FG000|Overall Study|Investigators' discretion|2|||
23190225|NCT00550238|64439357|FG000|Overall Study|Adverse Event|88|||
23190226|NCT00550238|64439357|FG000|Overall Study|Death|34|||
23356722|NCT00660595|65048929|FG001|Overall Study|Non Specified reasons|0|||
23356723|NCT01911793|65048930|FG000|Overall Study|Physician Decision|1|||
23356724|NCT01911793|65048931|FG001|Overall Study|Physician Decision|5|||
23356725|NCT01299896|65048933|FG000|Overall Study|Withdrawal by Subject|1|||
23356726|NCT01299896|65048934|FG001|Overall Study|Withdrawal by Subject|7|||
23356727|NCT01299896|65048933|FG000|Overall Study|Lost to Follow-up|0|||
23588705|NCT01981850|65882218|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
23588706|NCT01981850|65882219|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
23588707|NCT01981850|65882220|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
23588708|NCT01981850|65882221|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
23190227|NCT00550238|64439357|FG000|Overall Study|Disease progression|46|||
23190228|NCT00550238|64439357|FG000|Overall Study|Withdrawal by Subject|167|||
23190229|NCT00550238|64439357|FG000|Overall Study|Physician Decision|31|||
23190230|NCT00550238|64439357|FG000|Overall Study|Patient noncompliance|25|||
23190231|NCT00550238|64439357|FG000|Overall Study|Lost to Follow-up|13|||
23190232|NCT00550238|64439357|FG000|Overall Study|Sponsor decision|55|||
23190233|NCT00964795|64439358|FG000|Overall Study|Withdrawal by Subject|79|||
23190234|NCT00964795|64439358|FG000|Overall Study|Adverse Event|12|||
23190235|NCT00964795|64439358|FG000|Overall Study|Death|14|||
23356728|NCT01299896|65048934|FG001|Overall Study|Lost to Follow-up|11|||
23588709|NCT01981850|65882222|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
23190236|NCT00964795|64439358|FG000|Overall Study|Lost to Follow-up|7|||
23190237|NCT00964795|64439358|FG000|Overall Study|Termination of Study by Sponsor|169|||
23190238|NCT00964795|64439358|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
23190239|NCT00964795|64439358|FG000|Overall Study|Other|23|||
23190240|NCT00969618|64439361|FG000|Overall Study|Adverse Event|29|||
23190241|NCT00969618|64439361|FG000|Overall Study|Entry Criteria Not Met|3|||
23190242|NCT00969618|64439361|FG000|Overall Study|Lack of Efficacy|2|||
23190243|NCT00969618|64439361|FG000|Overall Study|Lost to Follow-up|7|||
23190244|NCT00969618|64439361|FG000|Overall Study|Physician Decision|1|||
23190245|NCT00969618|64439361|FG000|Overall Study|Protocol Violation|9|||
23356729|NCT02776670|65048935|FG000|Overall Study|Adverse Event|0|||
23356730|NCT02776670|65048936|FG001|Overall Study|Adverse Event|2|||
23356731|NCT02776670|65048935|FG000|Overall Study|Protocol Violation|0|||
23588710|NCT01981850|65882223|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
23588711|NCT01981850|65882224|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
23588712|NCT01981850|65882225|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
23588713|NCT01981850|65882216|FG000|Main Phase Stage 1|Various reasons|0|||
23588714|NCT01981850|65882217|FG001|Main Phase Stage 1|Various reasons|0|||
23588715|NCT01981850|65882218|FG002|Main Phase Stage 1|Various reasons|2|||
23588716|NCT01981850|65882219|FG003|Main Phase Stage 1|Various reasons|0|||
23588717|NCT01981850|65882220|FG004|Main Phase Stage 1|Various reasons|0|||
23588718|NCT01981850|65882221|FG005|Main Phase Stage 1|Various reasons|0|||
23588719|NCT01981850|65882222|FG006|Main Phase Stage 1|Various reasons|0|||
23588720|NCT01981850|65882223|FG007|Main Phase Stage 1|Various reasons|0|||
23588721|NCT01981850|65882224|FG008|Main Phase Stage 1|Various reasons|0|||
23588722|NCT01981850|65882225|FG009|Main Phase Stage 1|Various reasons|0|||
23588723|NCT01981850|65882216|FG000|Main Phase Stage 2|Adverse Event|0|||
23588724|NCT01981850|65882217|FG001|Main Phase Stage 2|Adverse Event|0|||
23588725|NCT01981850|65882218|FG002|Main Phase Stage 2|Adverse Event|0|||
23588726|NCT01981850|65882219|FG003|Main Phase Stage 2|Adverse Event|0|||
23588727|NCT01981850|65882220|FG004|Main Phase Stage 2|Adverse Event|6|||
23588728|NCT01981850|65882221|FG005|Main Phase Stage 2|Adverse Event|5|||
23588729|NCT01981850|65882222|FG006|Main Phase Stage 2|Adverse Event|7|||
23588730|NCT01981850|65882223|FG007|Main Phase Stage 2|Adverse Event|0|||
23588731|NCT01981850|65882224|FG008|Main Phase Stage 2|Adverse Event|0|||
23588732|NCT01981850|65882225|FG009|Main Phase Stage 2|Adverse Event|0|||
23588733|NCT01981850|65882216|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588734|NCT01981850|65882217|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588735|NCT01981850|65882218|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588736|NCT01981850|65882219|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588737|NCT01981850|65882220|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
23588738|NCT01981850|65882221|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
23588739|NCT01981850|65882222|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
23588740|NCT01981850|65882223|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588741|NCT01981850|65882224|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588742|NCT01981850|65882225|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
23588743|NCT01981850|65882216|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
23588744|NCT01981850|65882217|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
23588745|NCT01981850|65882218|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
23190246|NCT00969618|64439361|FG000|Overall Study|Withdrawal by Subject|27|||
23190247|NCT02032875|64439363|FG000|Treatment Period|Adverse Event|1|||
23190248|NCT02032875|64439364|FG001|Treatment Period|Adverse Event|0|||
23190249|NCT02032875|64439363|FG000|Treatment Period|Liver transplant, No extension needed|0|||
23190250|NCT02032875|64439364|FG001|Treatment Period|Liver transplant, No extension needed|1|||
23190251|NCT02032875|64439363|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
23190252|NCT02032875|64439364|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
23190253|NCT02032875|64439363|FG000|Follow-up Period|Death|0|||
23190254|NCT02032875|64439364|FG001|Follow-up Period|Death|1|||
23190255|NCT02032875|64439363|FG000|Follow-up Period|Virologic Relapse|3|||
23190256|NCT02032875|64439364|FG001|Follow-up Period|Virologic Relapse|10|||
23190257|NCT01707147|64439371|FG000|Overall Study|Administered Trajenta prior to contract|5|||
23190258|NCT01707147|64439371|FG000|Overall Study|Patients who have not taken Trajenta|1|||
23190259|NCT01707147|64439371|FG000|Overall Study|Follow-up failure|17|||
23190260|NCT01707147|64439371|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
23190261|NCT02725177|64439378|FG000|Overall Study|Physician Decision|4|||
23190262|NCT02725177|64439378|FG000|Overall Study|Adverse Event|1|||
23190263|NCT00090285|64439379|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
23190264|NCT00090285|64439380|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
23190265|NCT00090285|64439381|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23190266|NCT00090285|64439382|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23473078|NCT01742286|65477515|FG001|Expansion Phase|Withdrawal by Subject|0|||
23473079|NCT01742286|65477516|FG002|Expansion Phase|Withdrawal by Subject|0|||
23473080|NCT01742286|65477517|FG003|Expansion Phase|Withdrawal by Subject|0|||
23473081|NCT01742286|65477518|FG004|Expansion Phase|Withdrawal by Subject|0|||
23473082|NCT01742286|65477519|FG005|Expansion Phase|Withdrawal by Subject|0|||
23473083|NCT01742286|65477520|FG006|Expansion Phase|Withdrawal by Subject|1|||
23473084|NCT01964755|65477524|FG000|Overall Study|Death|2|||
23473085|NCT00095940|65477525|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
23473086|NCT00095940|65477526|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
23473087|NCT00095940|65477527|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
23473088|NCT00095940|65477528|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
23473089|NCT00095940|65477529|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
23473090|NCT00095940|65477530|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
23473091|NCT00095940|65477531|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
23473092|NCT00095940|65477532|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
23473093|NCT00095940|65477533|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
23473094|NCT00095940|65477525|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
23473095|NCT00095940|65477526|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
23473096|NCT00095940|65477527|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
23473097|NCT00095940|65477528|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23473098|NCT00095940|65477529|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23473099|NCT00095940|65477530|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23473100|NCT00095940|65477531|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23473101|NCT00095940|65477532|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
23588746|NCT01981850|65882219|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
23588747|NCT01981850|65882220|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
23588748|NCT01981850|65882221|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
23588749|NCT01981850|65882222|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
23588750|NCT01981850|65882223|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
23588751|NCT01981850|65882224|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
23588752|NCT01981850|65882225|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
23588753|NCT01981850|65882216|FG000|Main Phase Stage 2|Various reasons|0|||
23588754|NCT01981850|65882217|FG001|Main Phase Stage 2|Various reasons|0|||
23588755|NCT01981850|65882218|FG002|Main Phase Stage 2|Various reasons|0|||
23588756|NCT01981850|65882219|FG003|Main Phase Stage 2|Various reasons|0|||
23588757|NCT01981850|65882220|FG004|Main Phase Stage 2|Various reasons|2|||
23588758|NCT01981850|65882221|FG005|Main Phase Stage 2|Various reasons|0|||
23588759|NCT01981850|65882222|FG006|Main Phase Stage 2|Various reasons|1|||
23588760|NCT01981850|65882223|FG007|Main Phase Stage 2|Various reasons|0|||
23588761|NCT01981850|65882224|FG008|Main Phase Stage 2|Various reasons|0|||
23588762|NCT01981850|65882225|FG009|Main Phase Stage 2|Various reasons|0|||
23588763|NCT01981850|65882216|FG000|Main Phase Stage 2|Progressive Disease|0|||
23588764|NCT01981850|65882217|FG001|Main Phase Stage 2|Progressive Disease|0|||
23588765|NCT01981850|65882218|FG002|Main Phase Stage 2|Progressive Disease|0|||
23588766|NCT01981850|65882219|FG003|Main Phase Stage 2|Progressive Disease|0|||
23588767|NCT01981850|65882220|FG004|Main Phase Stage 2|Progressive Disease|0|||
23588768|NCT01981850|65882221|FG005|Main Phase Stage 2|Progressive Disease|6|||
23588769|NCT01981850|65882222|FG006|Main Phase Stage 2|Progressive Disease|6|||
23190267|NCT00090285|64439383|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23190268|NCT00090285|64439384|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
23190269|NCT00090285|64439379|FG000|Base Study Vaccination Period|Adverse Event|2|||
23190270|NCT00090285|64439380|FG001|Base Study Vaccination Period|Adverse Event|4|||
23588770|NCT01981850|65882223|FG007|Main Phase Stage 2|Progressive Disease|0|||
23588771|NCT01981850|65882224|FG008|Main Phase Stage 2|Progressive Disease|0|||
23588772|NCT01981850|65882225|FG009|Main Phase Stage 2|Progressive Disease|0|||
23250251|NCT03454672|64659703|FG001|Overall Study|painful|2|||
23250252|NCT03454672|64659702|FG000|Overall Study|Non-compliance|2|||
23250253|NCT03454672|64659703|FG001|Overall Study|Non-compliance|4|||
23250254|NCT03454672|64659702|FG000|Overall Study|personal reasons|3|||
23250255|NCT03454672|64659703|FG001|Overall Study|personal reasons|2|||
23250256|NCT03454672|64659702|FG000|Overall Study|Withdrawal by Subject|1|||
23250257|NCT03454672|64659703|FG001|Overall Study|Withdrawal by Subject|0|||
23250258|NCT01461369|64659708|FG000|Overall Study|Lack of Efficacy|2|||
23250259|NCT01461369|64659709|FG001|Overall Study|Lack of Efficacy|0|||
23356732|NCT02776670|65048936|FG001|Overall Study|Protocol Violation|2|||
23588773|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Adverse Event|0|||
23588774|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Adverse Event|0|||
23588775|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Adverse Event|0|||
23588776|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Adverse Event|0|||
23588777|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Adverse Event|0|||
23588778|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Adverse Event|0|||
23588779|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Adverse Event|0|||
23588780|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Adverse Event|2|||
23588781|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Adverse Event|1|||
23473102|NCT00095940|65477533|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
23588782|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Adverse Event|8|||
23588783|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588784|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588785|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
23250260|NCT01461369|64659710|FG002|Overall Study|Lack of Efficacy|6|||
23588786|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588787|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
23250261|NCT01461369|64659708|FG000|Overall Study|Lost to Follow-up|0|||
23250262|NCT01461369|64659709|FG001|Overall Study|Lost to Follow-up|0|||
23190271|NCT00090285|64439381|FG002|Base Study Vaccination Period|Adverse Event|0|||
23190272|NCT00090285|64439382|FG003|Base Study Vaccination Period|Adverse Event|0|||
23190273|NCT00090285|64439383|FG004|Base Study Vaccination Period|Adverse Event|0|||
23190274|NCT00090285|64439384|FG005|Base Study Vaccination Period|Adverse Event|0|||
23190275|NCT00090285|64439379|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
23190276|NCT00090285|64439380|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
23190277|NCT00090285|64439381|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
23250263|NCT01461369|64659710|FG002|Overall Study|Lost to Follow-up|3|||
23356733|NCT02776670|65048935|FG000|Overall Study|Withdrawal by Subject|0|||
23356734|NCT02776670|65048936|FG001|Overall Study|Withdrawal by Subject|1|||
23356735|NCT02776670|65048935|FG000|Overall Study|Other - Reason not given|0|||
23356736|NCT02776670|65048936|FG001|Overall Study|Other - Reason not given|1|||
23356737|NCT05459558|65052546|FG000|Overall Study|Adverse Event|1|||
23356738|NCT05459558|65052547|FG001|Overall Study|Adverse Event|0|||
23356739|NCT05459558|65052548|FG002|Overall Study|Adverse Event|0|||
23356740|NCT05459558|65052546|FG000|Overall Study|Scheduling issue|0|||
23356741|NCT05459558|65052547|FG001|Overall Study|Scheduling issue|1|||
23356742|NCT05459558|65052548|FG002|Overall Study|Scheduling issue|3|||
23356743|NCT05459558|65052546|FG000|Overall Study|Withdrawal by Subject|0|||
23356744|NCT05459558|65052547|FG001|Overall Study|Withdrawal by Subject|0|||
23356745|NCT05459558|65052548|FG002|Overall Study|Withdrawal by Subject|2|||
23356746|NCT01887678|65052551|FG000|Overall Study|Adverse Event|4|||
23356747|NCT01887678|65052552|FG001|Overall Study|Adverse Event|6|||
23473103|NCT00095940|65477525|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473104|NCT00095940|65477526|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
23588788|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588789|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
23588790|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
23588791|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
23588792|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
23588793|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Various reasons|0|||
23588794|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Various reasons|0|||
23588795|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Various reasons|0|||
23250264|NCT01461369|64659708|FG000|Overall Study|Adverse Event|9|||
23250265|NCT01461369|64659709|FG001|Overall Study|Adverse Event|12|||
23250266|NCT01461369|64659710|FG002|Overall Study|Adverse Event|4|||
23250267|NCT01461369|64659708|FG000|Overall Study|Protocol Violation|1|||
23250268|NCT01461369|64659709|FG001|Overall Study|Protocol Violation|2|||
23250269|NCT01461369|64659710|FG002|Overall Study|Protocol Violation|2|||
23250270|NCT01461369|64659708|FG000|Overall Study|Withdrawal by Subject|1|||
23250271|NCT01461369|64659709|FG001|Overall Study|Withdrawal by Subject|3|||
23250272|NCT01461369|64659710|FG002|Overall Study|Withdrawal by Subject|2|||
23250273|NCT02858076|64659719|FG000|Overall Study|Death|6|||
23250274|NCT02858076|64659720|FG001|Overall Study|Death|3|||
23250275|NCT02858076|64659719|FG000|Overall Study|Withdrawal by Subject|1|||
23250276|NCT02858076|64659720|FG001|Overall Study|Withdrawal by Subject|5|||
23250277|NCT02858076|64659719|FG000|Overall Study|Lost to Follow-up|2|||
23250278|NCT02858076|64659720|FG001|Overall Study|Lost to Follow-up|7|||
23250279|NCT02858076|64659719|FG000|Overall Study|Completed Out of Window|1|||
23250280|NCT02858076|64659720|FG001|Overall Study|Completed Out of Window|3|||
23250281|NCT00808015|64659721|FG000|Overall Study|Death|1|||
23250282|NCT00808015|64659721|FG000|Overall Study|Lack of Efficacy|58|||
23250283|NCT00808015|64659721|FG000|Overall Study|Lost to Follow-up|76|||
23250284|NCT00808015|64659721|FG000|Overall Study|Participants not willing to participate|158|||
23250285|NCT00808015|64659721|FG000|Overall Study|Adverse Event|22|||
23250286|NCT00808015|64659721|FG000|Overall Study|Other|25|||
23250287|NCT00808015|64659721|FG000|Overall Study|Enrolled but not treated|4|||
23250288|NCT03543046|64659722|FG000|Overall Study|Adverse Event|1|||
23250289|NCT03543046|64659723|FG001|Overall Study|Adverse Event|1|||
23250290|NCT03543046|64659722|FG000|Overall Study|Physician Decision|1|||
23250291|NCT03543046|64659723|FG001|Overall Study|Physician Decision|1|||
23356748|NCT01887678|65052551|FG000|Overall Study|Exceeded rescue medication dosage|4|||
23356749|NCT01887678|65052552|FG001|Overall Study|Exceeded rescue medication dosage|5|||
23250292|NCT03543046|64659722|FG000|Overall Study|Protocol Violation|1|||
23250293|NCT03543046|64659723|FG001|Overall Study|Protocol Violation|0|||
23250294|NCT00550420|64659724|FG000|Overall Study|Adverse Event|28|||
23250295|NCT00550420|64659724|FG000|Overall Study|Lost to Follow-up|8|||
23356750|NCT01887678|65052551|FG000|Overall Study|Withdrawal of consent|3|||
23356751|NCT01887678|65052552|FG001|Overall Study|Withdrawal of consent|4|||
23250296|NCT00550420|64659724|FG000|Overall Study|Protocol Violation|11|||
23250297|NCT00550420|64659724|FG000|Overall Study|Withdrawal by Subject|30|||
23356752|NCT01887678|65052551|FG000|Overall Study|Lost to Follow-up|4|||
23356753|NCT01887678|65052552|FG001|Overall Study|Lost to Follow-up|2|||
23356754|NCT01887678|65052551|FG000|Overall Study|Deterioration of clinical condition|0|||
23473105|NCT00095940|65477527|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473106|NCT00095940|65477528|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473107|NCT00095940|65477529|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473108|NCT00095940|65477530|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473109|NCT00095940|65477531|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473110|NCT00095940|65477532|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
23473111|NCT00095940|65477533|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
23473112|NCT01175083|65477540|FG000|Primary Epoch|Withdrawal by Subject|0|||
23473113|NCT01175083|65477541|FG001|Primary Epoch|Withdrawal by Subject|0|||
23588796|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Various reasons|0|||
23588797|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Various reasons|0|||
23588798|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Various reasons|0|||
23190278|NCT00090285|64439382|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
23588799|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Various reasons|0|||
23190279|NCT00090285|64439383|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
23190280|NCT00090285|64439384|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
23190281|NCT00090285|64439379|FG000|Base Study Vaccination Period|Protocol Violation|2|||
23190282|NCT00090285|64439380|FG001|Base Study Vaccination Period|Protocol Violation|3|||
23190283|NCT00090285|64439381|FG002|Base Study Vaccination Period|Protocol Violation|0|||
23190284|NCT00090285|64439382|FG003|Base Study Vaccination Period|Protocol Violation|0|||
23190285|NCT00090285|64439383|FG004|Base Study Vaccination Period|Protocol Violation|0|||
23190286|NCT00090285|64439384|FG005|Base Study Vaccination Period|Protocol Violation|0|||
23190287|NCT00090285|64439379|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
23190288|NCT00090285|64439380|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
23588800|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Various reasons|3|||
23588801|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Various reasons|1|||
23588802|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Various reasons|3|||
23588803|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
23588804|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
23190289|NCT00090285|64439381|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
23190290|NCT00090285|64439382|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
23190291|NCT00090285|64439383|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
23190292|NCT00090285|64439384|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
23190293|NCT00090285|64439379|FG000|Base Study Vaccination Period|Uncooperative|2|||
23190294|NCT00090285|64439380|FG001|Base Study Vaccination Period|Uncooperative|2|||
23190295|NCT00090285|64439381|FG002|Base Study Vaccination Period|Uncooperative|0|||
23190296|NCT00090285|64439382|FG003|Base Study Vaccination Period|Uncooperative|0|||
23190297|NCT00090285|64439383|FG004|Base Study Vaccination Period|Uncooperative|0|||
23190298|NCT00090285|64439384|FG005|Base Study Vaccination Period|Uncooperative|0|||
23190299|NCT00090285|64439379|FG000|Base Study Vaccination Period|Moved|20|||
23190300|NCT00090285|64439380|FG001|Base Study Vaccination Period|Moved|21|||
23190301|NCT00090285|64439381|FG002|Base Study Vaccination Period|Moved|0|||
23356755|NCT01887678|65052552|FG001|Overall Study|Deterioration of clinical condition|4|||
23356756|NCT01887678|65052551|FG000|Overall Study|Lack of Efficacy|1|||
23356757|NCT01887678|65052552|FG001|Overall Study|Lack of Efficacy|2|||
23356758|NCT01887678|65052551|FG000|Overall Study|Non-compliance|0|||
23356759|NCT01887678|65052552|FG001|Overall Study|Non-compliance|3|||
23356760|NCT01887678|65052551|FG000|Overall Study|Specified|1|||
23356761|NCT01887678|65052552|FG001|Overall Study|Specified|2|||
23356762|NCT01693185|65052554|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
23356763|NCT01693185|65052555|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
23356764|NCT03131687|65052557|FG000|Overall Study|Adverse Event|0|||
23356765|NCT03131687|65052558|FG001|Overall Study|Adverse Event|1|||
23356766|NCT03131687|65052559|FG002|Overall Study|Adverse Event|0|||
23356767|NCT03131687|65052560|FG003|Overall Study|Adverse Event|1|||
23356768|NCT03131687|65052561|FG004|Overall Study|Adverse Event|2|||
23356769|NCT03131687|65052562|FG005|Overall Study|Adverse Event|2|||
23356770|NCT03131687|65052557|FG000|Overall Study|Death|1|||
23356771|NCT03131687|65052558|FG001|Overall Study|Death|0|||
23356772|NCT03131687|65052559|FG002|Overall Study|Death|0|||
23473114|NCT01175083|65477542|FG002|Primary Epoch|Withdrawal by Subject|0|||
23588805|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
23588806|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
23588807|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
23190302|NCT00090285|64439382|FG003|Base Study Vaccination Period|Moved|0|||
23190303|NCT00090285|64439383|FG004|Base Study Vaccination Period|Moved|0|||
23356773|NCT03131687|65052560|FG003|Overall Study|Death|0|||
23356774|NCT03131687|65052561|FG004|Overall Study|Death|0|||
23356775|NCT03131687|65052562|FG005|Overall Study|Death|0|||
23356776|NCT03131687|65052557|FG000|Overall Study|Withdrawal by Subject|3|||
23190304|NCT00090285|64439384|FG005|Base Study Vaccination Period|Moved|0|||
23190305|NCT00090285|64439379|FG000|Base Study Vaccination Period|Site Terminated|1|||
23190306|NCT00090285|64439380|FG001|Base Study Vaccination Period|Site Terminated|0|||
23190307|NCT00090285|64439381|FG002|Base Study Vaccination Period|Site Terminated|0|||
23473115|NCT01175083|65477543|FG003|Primary Epoch|Withdrawal by Subject|0|||
23473116|NCT01175083|65477544|FG004|Primary Epoch|Withdrawal by Subject|0|||
23473117|NCT01175083|65477545|FG005|Primary Epoch|Withdrawal by Subject|2|||
23473118|NCT01175083|65477540|FG000|Primary Epoch|Lost to Follow-up|0|||
23473119|NCT01175083|65477541|FG001|Primary Epoch|Lost to Follow-up|0|||
23473120|NCT01175083|65477542|FG002|Primary Epoch|Lost to Follow-up|0|||
23473121|NCT01175083|65477543|FG003|Primary Epoch|Lost to Follow-up|0|||
23473122|NCT01175083|65477544|FG004|Primary Epoch|Lost to Follow-up|0|||
23473123|NCT01175083|65477545|FG005|Primary Epoch|Lost to Follow-up|1|||
23473124|NCT01175083|65477540|FG000|Booster Epoch|Death|0|||
23473125|NCT01175083|65477541|FG001|Booster Epoch|Death|0|||
23473126|NCT01175083|65477542|FG002|Booster Epoch|Death|1|||
23473127|NCT01175083|65477543|FG003|Booster Epoch|Death|0|||
23473128|NCT01175083|65477544|FG004|Booster Epoch|Death|0|||
23473129|NCT01175083|65477545|FG005|Booster Epoch|Death|0|||
23473130|NCT01175083|65477540|FG000|Booster Epoch|Withdrawal by Subject|0|||
23473131|NCT01175083|65477541|FG001|Booster Epoch|Withdrawal by Subject|0|||
23473132|NCT01175083|65477542|FG002|Booster Epoch|Withdrawal by Subject|0|||
23473133|NCT01175083|65477543|FG003|Booster Epoch|Withdrawal by Subject|1|||
23473134|NCT01175083|65477544|FG004|Booster Epoch|Withdrawal by Subject|0|||
23473135|NCT01175083|65477545|FG005|Booster Epoch|Withdrawal by Subject|0|||
23473136|NCT01536067|65477546|FG000|Overall Study|Disease Progression|1|||
23473137|NCT00324961|65477548|FG000|Overall Study|Adverse Event|5|||
23473138|NCT00324961|65477548|FG000|Overall Study|Consent Withdrawn|11|||
23473139|NCT00324961|65477548|FG000|Overall Study|Lost to Follow-up|22|||
23473140|NCT00324961|65477548|FG000|Overall Study|Protocol Violation|3|||
23473141|NCT00324961|65477548|FG000|Overall Study|Other|2|||
23473142|NCT01523275|65477549|FG000|Overall Study|Lost to Follow-up|1|||
23473143|NCT01523275|65477550|FG001|Overall Study|Lost to Follow-up|2|||
23473144|NCT01523275|65477549|FG000|Overall Study|Withdrawal by Subject|1|||
23473145|NCT01523275|65477550|FG001|Overall Study|Withdrawal by Subject|0|||
23473146|NCT01761162|65477556|FG000|Overall Study|Withdrawal by Subject|3|||
23190308|NCT00090285|64439382|FG003|Base Study Vaccination Period|Site Terminated|0|||
23190309|NCT00090285|64439383|FG004|Base Study Vaccination Period|Site Terminated|0|||
23190310|NCT00090285|64439384|FG005|Base Study Vaccination Period|Site Terminated|0|||
23190311|NCT00090285|64439379|FG000|Base Study Vaccination Period|Other|2|||
23190312|NCT00090285|64439380|FG001|Base Study Vaccination Period|Other|2|||
23190313|NCT00090285|64439381|FG002|Base Study Vaccination Period|Other|0|||
23190314|NCT00090285|64439382|FG003|Base Study Vaccination Period|Other|0|||
23473147|NCT01124864|65477557|FG000|Overall Study|Follow up phase competed as per protocol|18|||
23473148|NCT01124864|65477558|FG001|Overall Study|Follow up phase competed as per protocol|22|||
23473149|NCT01124864|65477559|FG002|Overall Study|Follow up phase competed as per protocol|24|||
23473150|NCT01124864|65477560|FG003|Overall Study|Follow up phase competed as per protocol|18|||
23473151|NCT01124864|65477561|FG004|Overall Study|Follow up phase competed as per protocol|26|||
23473152|NCT01124864|65477562|FG005|Overall Study|Follow up phase competed as per protocol|2|||
23473153|NCT01124864|65477557|FG000|Overall Study|Death|6|||
23473154|NCT01124864|65477558|FG001|Overall Study|Death|9|||
23473155|NCT01124864|65477559|FG002|Overall Study|Death|6|||
23473156|NCT01124864|65477560|FG003|Overall Study|Death|2|||
23473157|NCT01124864|65477561|FG004|Overall Study|Death|1|||
23473158|NCT01124864|65477562|FG005|Overall Study|Death|0|||
23473159|NCT01124864|65477557|FG000|Overall Study|Withdrawal by Subject|2|||
23473160|NCT01124864|65477558|FG001|Overall Study|Withdrawal by Subject|3|||
23473161|NCT01124864|65477559|FG002|Overall Study|Withdrawal by Subject|4|||
23473162|NCT01124864|65477560|FG003|Overall Study|Withdrawal by Subject|0|||
23473163|NCT01124864|65477561|FG004|Overall Study|Withdrawal by Subject|2|||
23473164|NCT01124864|65477562|FG005|Overall Study|Withdrawal by Subject|1|||
23473165|NCT01124864|65477557|FG000|Overall Study|Lost to Follow-up|1|||
23473166|NCT01124864|65477558|FG001|Overall Study|Lost to Follow-up|1|||
23473167|NCT01124864|65477559|FG002|Overall Study|Lost to Follow-up|0|||
23473168|NCT01124864|65477560|FG003|Overall Study|Lost to Follow-up|1|||
23473169|NCT01124864|65477561|FG004|Overall Study|Lost to Follow-up|0|||
23473170|NCT01124864|65477562|FG005|Overall Study|Lost to Follow-up|0|||
23473171|NCT01124864|65477557|FG000|Overall Study|Protocol Violation|1|||
23473172|NCT01124864|65477558|FG001|Overall Study|Protocol Violation|0|||
23473173|NCT01124864|65477559|FG002|Overall Study|Protocol Violation|0|||
23473174|NCT01124864|65477560|FG003|Overall Study|Protocol Violation|0|||
23473175|NCT01124864|65477561|FG004|Overall Study|Protocol Violation|1|||
23473176|NCT01124864|65477562|FG005|Overall Study|Protocol Violation|0|||
23473177|NCT02059291|65477563|FG000|Epoch 2|Lack of Efficacy|0|||
23190315|NCT00090285|64439383|FG004|Base Study Vaccination Period|Other|0|||
23190316|NCT00090285|64439384|FG005|Base Study Vaccination Period|Other|0|||
23473178|NCT02059291|65477564|FG001|Epoch 2|Lack of Efficacy|0|||
23473179|NCT02059291|65477565|FG002|Epoch 2|Lack of Efficacy|0|||
23473180|NCT02059291|65477566|FG003|Epoch 2|Lack of Efficacy|1|||
23473181|NCT02059291|65477567|FG004|Epoch 2|Lack of Efficacy|0|||
23473182|NCT02059291|65477568|FG005|Epoch 2|Lack of Efficacy|1|||
23473183|NCT02059291|65477569|FG006|Epoch 2|Lack of Efficacy|0|||
23473184|NCT02059291|65477570|FG007|Epoch 2|Lack of Efficacy|0|||
23473185|NCT02059291|65477571|FG008|Epoch 2|Lack of Efficacy|0|||
23473186|NCT02059291|65477572|FG009|Epoch 2|Lack of Efficacy|0|||
23473187|NCT02059291|65477573|FG010|Epoch 2|Lack of Efficacy|0|||
23473188|NCT02059291|65477574|FG011|Epoch 2|Lack of Efficacy|0|||
23473189|NCT02059291|65477575|FG012|Epoch 2|Lack of Efficacy|0|||
23473190|NCT02059291|65477576|FG013|Epoch 2|Lack of Efficacy|0|||
23473191|NCT02059291|65477577|FG014|Epoch 2|Lack of Efficacy|0|||
23473192|NCT02059291|65477578|FG015|Epoch 2|Lack of Efficacy|0|||
23473193|NCT02059291|65477579|FG016|Epoch 2|Lack of Efficacy|0|||
23473194|NCT02059291|65477580|FG017|Epoch 2|Lack of Efficacy|0|||
23473195|NCT02059291|65477581|FG018|Epoch 2|Lack of Efficacy|0|||
23473196|NCT02059291|65477582|FG019|Epoch 2|Lack of Efficacy|0|||
23473197|NCT02059291|65477583|FG020|Epoch 2|Lack of Efficacy|0|||
23473198|NCT02059291|65477584|FG021|Epoch 2|Lack of Efficacy|0|||
23473199|NCT02059291|65477585|FG022|Epoch 2|Lack of Efficacy|0|||
23473200|NCT02059291|65477586|FG023|Epoch 2|Lack of Efficacy|0|||
23473201|NCT02059291|65477587|FG024|Epoch 2|Lack of Efficacy|0|||
23473202|NCT02059291|65477563|FG000|Epoch 2|Adverse Event|0|||
23473203|NCT02059291|65477564|FG001|Epoch 2|Adverse Event|0|||
23473204|NCT02059291|65477565|FG002|Epoch 2|Adverse Event|1|||
23473205|NCT02059291|65477566|FG003|Epoch 2|Adverse Event|1|||
23473206|NCT02059291|65477567|FG004|Epoch 2|Adverse Event|0|||
23473207|NCT02059291|65477568|FG005|Epoch 2|Adverse Event|0|||
23473208|NCT02059291|65477569|FG006|Epoch 2|Adverse Event|0|||
23473209|NCT02059291|65477570|FG007|Epoch 2|Adverse Event|1|||
23473210|NCT02059291|65477571|FG008|Epoch 2|Adverse Event|1|||
23473211|NCT02059291|65477572|FG009|Epoch 2|Adverse Event|0|||
23473212|NCT02059291|65477573|FG010|Epoch 2|Adverse Event|0|||
23473213|NCT02059291|65477574|FG011|Epoch 2|Adverse Event|0|||
23473214|NCT02059291|65477575|FG012|Epoch 2|Adverse Event|0|||
23473215|NCT02059291|65477576|FG013|Epoch 2|Adverse Event|0|||
23473216|NCT02059291|65477577|FG014|Epoch 2|Adverse Event|0|||
23473217|NCT02059291|65477578|FG015|Epoch 2|Adverse Event|0|||
23473218|NCT02059291|65477579|FG016|Epoch 2|Adverse Event|0|||
23473219|NCT02059291|65477580|FG017|Epoch 2|Adverse Event|0|||
23473220|NCT02059291|65477581|FG018|Epoch 2|Adverse Event|0|||
23473221|NCT02059291|65477582|FG019|Epoch 2|Adverse Event|0|||
23473222|NCT02059291|65477583|FG020|Epoch 2|Adverse Event|0|||
23473223|NCT02059291|65477584|FG021|Epoch 2|Adverse Event|0|||
23473224|NCT02059291|65477585|FG022|Epoch 2|Adverse Event|0|||
23473225|NCT02059291|65477586|FG023|Epoch 2|Adverse Event|0|||
23473226|NCT02059291|65477587|FG024|Epoch 2|Adverse Event|0|||
23473227|NCT02059291|65477563|FG000|Epoch 2|Withdrawal by Subject|0|||
23473228|NCT02059291|65477564|FG001|Epoch 2|Withdrawal by Subject|1|||
23473229|NCT02059291|65477565|FG002|Epoch 2|Withdrawal by Subject|0|||
23473230|NCT02059291|65477566|FG003|Epoch 2|Withdrawal by Subject|0|||
23473231|NCT02059291|65477567|FG004|Epoch 2|Withdrawal by Subject|0|||
23473232|NCT02059291|65477568|FG005|Epoch 2|Withdrawal by Subject|1|||
23473233|NCT02059291|65477569|FG006|Epoch 2|Withdrawal by Subject|0|||
23473234|NCT02059291|65477570|FG007|Epoch 2|Withdrawal by Subject|0|||
23250298|NCT00550420|64659724|FG000|Overall Study|Still in study at termination|206|||
23250299|NCT00550420|64659724|FG000|Overall Study|Missing|2|||
23250300|NCT00550420|64659724|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
23250301|NCT00550420|64659724|FG000|Overall Study|Investigators opinion|1|||
23473235|NCT02059291|65477571|FG008|Epoch 2|Withdrawal by Subject|1|||
23473236|NCT02059291|65477572|FG009|Epoch 2|Withdrawal by Subject|0|||
23473237|NCT02059291|65477573|FG010|Epoch 2|Withdrawal by Subject|0|||
23473238|NCT02059291|65477574|FG011|Epoch 2|Withdrawal by Subject|0|||
23473239|NCT02059291|65477575|FG012|Epoch 2|Withdrawal by Subject|0|||
23473240|NCT02059291|65477576|FG013|Epoch 2|Withdrawal by Subject|0|||
23588808|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
23588809|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
23588810|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
23588811|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
23473241|NCT02059291|65477577|FG014|Epoch 2|Withdrawal by Subject|0|||
23473242|NCT02059291|65477578|FG015|Epoch 2|Withdrawal by Subject|0|||
23473243|NCT02059291|65477579|FG016|Epoch 2|Withdrawal by Subject|0|||
23473244|NCT02059291|65477580|FG017|Epoch 2|Withdrawal by Subject|0|||
23473245|NCT02059291|65477581|FG018|Epoch 2|Withdrawal by Subject|0|||
23473246|NCT02059291|65477582|FG019|Epoch 2|Withdrawal by Subject|0|||
23473247|NCT02059291|65477583|FG020|Epoch 2|Withdrawal by Subject|0|||
23473248|NCT02059291|65477584|FG021|Epoch 2|Withdrawal by Subject|0|||
23473249|NCT02059291|65477585|FG022|Epoch 2|Withdrawal by Subject|0|||
23473250|NCT02059291|65477586|FG023|Epoch 2|Withdrawal by Subject|0|||
23473251|NCT02059291|65477587|FG024|Epoch 2|Withdrawal by Subject|0|||
23473252|NCT02059291|65477563|FG000|Epoch 3|Physician Decision|0|||
23473253|NCT02059291|65477564|FG001|Epoch 3|Physician Decision|0|||
23473254|NCT02059291|65477565|FG002|Epoch 3|Physician Decision|0|||
23473255|NCT02059291|65477566|FG003|Epoch 3|Physician Decision|0|||
23473256|NCT02059291|65477567|FG004|Epoch 3|Physician Decision|0|||
23473257|NCT02059291|65477568|FG005|Epoch 3|Physician Decision|0|||
23473258|NCT02059291|65477569|FG006|Epoch 3|Physician Decision|0|||
23473259|NCT02059291|65477570|FG007|Epoch 3|Physician Decision|0|||
23473260|NCT02059291|65477571|FG008|Epoch 3|Physician Decision|0|||
23473261|NCT02059291|65477572|FG009|Epoch 3|Physician Decision|0|||
23473262|NCT02059291|65477573|FG010|Epoch 3|Physician Decision|0|||
23473263|NCT02059291|65477574|FG011|Epoch 3|Physician Decision|0|||
23473264|NCT02059291|65477575|FG012|Epoch 3|Physician Decision|0|||
23473265|NCT02059291|65477576|FG013|Epoch 3|Physician Decision|1|||
23473266|NCT02059291|65477577|FG014|Epoch 3|Physician Decision|0|||
23473267|NCT02059291|65477578|FG015|Epoch 3|Physician Decision|1|||
23473268|NCT02059291|65477579|FG016|Epoch 3|Physician Decision|0|||
23473269|NCT02059291|65477580|FG017|Epoch 3|Physician Decision|0|||
23473270|NCT02059291|65477581|FG018|Epoch 3|Physician Decision|0|||
23473271|NCT02059291|65477582|FG019|Epoch 3|Physician Decision|0|||
23473272|NCT02059291|65477583|FG020|Epoch 3|Physician Decision|0|||
23473273|NCT02059291|65477584|FG021|Epoch 3|Physician Decision|0|||
23473274|NCT02059291|65477585|FG022|Epoch 3|Physician Decision|0|||
23473275|NCT02059291|65477586|FG023|Epoch 3|Physician Decision|0|||
23473276|NCT02059291|65477587|FG024|Epoch 3|Physician Decision|0|||
23473277|NCT02059291|65477563|FG000|Epoch 3|Adverse Event|0|||
23473278|NCT02059291|65477564|FG001|Epoch 3|Adverse Event|0|||
23473279|NCT02059291|65477565|FG002|Epoch 3|Adverse Event|0|||
23473280|NCT02059291|65477566|FG003|Epoch 3|Adverse Event|0|||
23473281|NCT02059291|65477567|FG004|Epoch 3|Adverse Event|0|||
23473282|NCT02059291|65477568|FG005|Epoch 3|Adverse Event|0|||
23473283|NCT02059291|65477569|FG006|Epoch 3|Adverse Event|0|||
23473284|NCT02059291|65477570|FG007|Epoch 3|Adverse Event|0|||
23473285|NCT02059291|65477571|FG008|Epoch 3|Adverse Event|0|||
23473286|NCT02059291|65477572|FG009|Epoch 3|Adverse Event|0|||
23473287|NCT02059291|65477573|FG010|Epoch 3|Adverse Event|0|||
23473288|NCT02059291|65477574|FG011|Epoch 3|Adverse Event|0|||
23588812|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
23588813|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588814|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588815|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588816|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588817|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588818|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588819|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588820|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588821|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
23588822|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
23588823|NCT01981850|65882216|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
23190317|NCT00090285|64439379|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
23250302|NCT00550420|64659724|FG000|Overall Study|Lack of curative effect|1|||
23473289|NCT02059291|65477575|FG012|Epoch 3|Adverse Event|0|||
23473290|NCT02059291|65477576|FG013|Epoch 3|Adverse Event|0|||
23473291|NCT02059291|65477577|FG014|Epoch 3|Adverse Event|0|||
23473292|NCT02059291|65477578|FG015|Epoch 3|Adverse Event|1|||
23473293|NCT02059291|65477579|FG016|Epoch 3|Adverse Event|0|||
23473294|NCT02059291|65477580|FG017|Epoch 3|Adverse Event|0|||
23473295|NCT02059291|65477581|FG018|Epoch 3|Adverse Event|0|||
23473296|NCT02059291|65477582|FG019|Epoch 3|Adverse Event|0|||
23473297|NCT02059291|65477583|FG020|Epoch 3|Adverse Event|0|||
23190318|NCT00090285|64439380|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
23190319|NCT00090285|64439381|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
23190320|NCT00090285|64439382|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
23190321|NCT00090285|64439383|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
23190322|NCT00090285|64439384|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
23190323|NCT00090285|64439379|FG000|Base Study Vaccination Period|HIV positive|1|||
23473298|NCT02059291|65477584|FG021|Epoch 3|Adverse Event|0|||
23473299|NCT02059291|65477585|FG022|Epoch 3|Adverse Event|0|||
23473300|NCT02059291|65477586|FG023|Epoch 3|Adverse Event|0|||
23473301|NCT02059291|65477587|FG024|Epoch 3|Adverse Event|0|||
23473302|NCT02059291|65477563|FG000|Epoch 3|Lack of Efficacy|0|||
23473303|NCT02059291|65477564|FG001|Epoch 3|Lack of Efficacy|0|||
23588824|NCT01981850|65882217|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588825|NCT01981850|65882218|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
23473304|NCT02059291|65477565|FG002|Epoch 3|Lack of Efficacy|0|||
23250303|NCT00550420|64659724|FG000|Overall Study|Unethical stop of enrollment|2|||
23473305|NCT02059291|65477566|FG003|Epoch 3|Lack of Efficacy|0|||
23473306|NCT02059291|65477567|FG004|Epoch 3|Lack of Efficacy|0|||
23473307|NCT02059291|65477568|FG005|Epoch 3|Lack of Efficacy|0|||
23473308|NCT02059291|65477569|FG006|Epoch 3|Lack of Efficacy|0|||
23473309|NCT02059291|65477570|FG007|Epoch 3|Lack of Efficacy|0|||
23473310|NCT02059291|65477571|FG008|Epoch 3|Lack of Efficacy|0|||
23473311|NCT02059291|65477572|FG009|Epoch 3|Lack of Efficacy|0|||
23190324|NCT00090285|64439380|FG001|Base Study Vaccination Period|HIV positive|1|||
23190325|NCT00090285|64439381|FG002|Base Study Vaccination Period|HIV positive|0|||
23190326|NCT00090285|64439382|FG003|Base Study Vaccination Period|HIV positive|0|||
23190327|NCT00090285|64439383|FG004|Base Study Vaccination Period|HIV positive|0|||
23190328|NCT00090285|64439384|FG005|Base Study Vaccination Period|HIV positive|0|||
23190329|NCT00090285|64439379|FG000|Base Study Follow-up Period|Adverse Event|3|||
23190330|NCT00090285|64439380|FG001|Base Study Follow-up Period|Adverse Event|10|||
23190331|NCT00090285|64439381|FG002|Base Study Follow-up Period|Adverse Event|0|||
23190332|NCT00090285|64439382|FG003|Base Study Follow-up Period|Adverse Event|0|||
23190333|NCT00090285|64439383|FG004|Base Study Follow-up Period|Adverse Event|0|||
23190334|NCT00090285|64439384|FG005|Base Study Follow-up Period|Adverse Event|0|||
23190335|NCT00090285|64439379|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
23190336|NCT00090285|64439380|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
23190337|NCT00090285|64439381|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
23250304|NCT00550420|64659724|FG000|Overall Study|Caregiver's decision to withdraw|1|||
23588826|NCT01981850|65882219|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
23250305|NCT00550420|64659724|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
23250306|NCT00550420|64659724|FG000|Overall Study|Exclusion criteria|1|||
23250307|NCT00550420|64659724|FG000|Overall Study|Prohibited medicine|1|||
23250308|NCT01999322|64659725|FG000|Overall Study|Adverse Event|1|||
23250309|NCT01999322|64659726|FG001|Overall Study|Adverse Event|0|||
23250310|NCT04388527|64659727|FG000|Overall Study|Death|14|||
23250311|NCT04388527|64659727|FG000|Overall Study|Withdrawal by Subject|2|||
23250312|NCT04388527|64659727|FG000|Overall Study|Lost to Follow-up|1|||
23250313|NCT00529802|64659730|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
23250314|NCT00529802|64659730|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
23250315|NCT00529802|64659730|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
23250316|NCT00529802|64659730|FG000|Evaluable for Primary Endpoint|Death|1|||
23250317|NCT00529802|64659730|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
23250318|NCT00529802|64659730|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
23250319|NCT00529802|64659730|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
23250320|NCT03746080|64659731|FG000|Overall Study|In follow up|2|||
23356777|NCT03131687|65052558|FG001|Overall Study|Withdrawal by Subject|3|||
23356778|NCT03131687|65052559|FG002|Overall Study|Withdrawal by Subject|3|||
23356779|NCT03131687|65052560|FG003|Overall Study|Withdrawal by Subject|1|||
23588827|NCT01981850|65882220|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
23356780|NCT03131687|65052561|FG004|Overall Study|Withdrawal by Subject|2|||
23356781|NCT03131687|65052562|FG005|Overall Study|Withdrawal by Subject|1|||
23356782|NCT03131687|65052557|FG000|Overall Study|Lost to Follow-up|1|||
23356783|NCT03131687|65052558|FG001|Overall Study|Lost to Follow-up|4|||
23356784|NCT03131687|65052559|FG002|Overall Study|Lost to Follow-up|0|||
23356785|NCT03131687|65052560|FG003|Overall Study|Lost to Follow-up|1|||
23356786|NCT03131687|65052561|FG004|Overall Study|Lost to Follow-up|4|||
23356787|NCT03131687|65052562|FG005|Overall Study|Lost to Follow-up|2|||
23356788|NCT03131687|65052557|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
23356789|NCT03131687|65052558|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
23356790|NCT03131687|65052559|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
23356791|NCT03131687|65052560|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
23588828|NCT01981850|65882221|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588829|NCT01981850|65882222|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588830|NCT01981850|65882223|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588831|NCT01981850|65882224|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
23588832|NCT01981850|65882225|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
23356792|NCT03131687|65052561|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
23356793|NCT03131687|65052562|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
23588833|NCT03781336|65882226|FG000|Overall Study|Withdrawal by Subject|2|||
23588834|NCT03781336|65882227|FG001|Overall Study|Withdrawal by Subject|2|||
23588835|NCT01393119|65882228|FG000|Overall Study|Adverse Event|1|||
23588836|NCT01393119|65882229|FG001|Overall Study|Adverse Event|1|||
23588837|NCT01393119|65882230|FG002|Overall Study|Adverse Event|0|||
23588838|NCT01393119|65882231|FG003|Overall Study|Adverse Event|1|||
23588839|NCT01393119|65882228|FG000|Overall Study|Withdrawal by Subject|0|||
23588840|NCT01393119|65882229|FG001|Overall Study|Withdrawal by Subject|1|||
23588841|NCT01393119|65882230|FG002|Overall Study|Withdrawal by Subject|1|||
23588842|NCT01393119|65882231|FG003|Overall Study|Withdrawal by Subject|0|||
23588843|NCT01393119|65882228|FG000|Overall Study|Lack of Efficacy|1|||
23190338|NCT00090285|64439382|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
23250321|NCT03746080|64659731|FG000|Overall Study|Death|15|||
23190339|NCT00090285|64439383|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
23190340|NCT00090285|64439384|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
23250322|NCT05553600|64659736|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
23356794|NCT03131687|65052557|FG000|Overall Study|Principle Investigator Decision|0|||
23473312|NCT02059291|65477573|FG010|Epoch 3|Lack of Efficacy|0|||
23356795|NCT03131687|65052558|FG001|Overall Study|Principle Investigator Decision|1|||
23356796|NCT03131687|65052559|FG002|Overall Study|Principle Investigator Decision|0|||
23356797|NCT03131687|65052560|FG003|Overall Study|Principle Investigator Decision|0|||
23356798|NCT03131687|65052561|FG004|Overall Study|Principle Investigator Decision|0|||
23356799|NCT03131687|65052562|FG005|Overall Study|Principle Investigator Decision|0|||
23356800|NCT03131687|65052557|FG000|Overall Study|Inadvertent Enrollment|0|||
23356801|NCT03131687|65052558|FG001|Overall Study|Inadvertent Enrollment|0|||
23356802|NCT03131687|65052559|FG002|Overall Study|Inadvertent Enrollment|0|||
23356803|NCT03131687|65052560|FG003|Overall Study|Inadvertent Enrollment|1|||
23356804|NCT03131687|65052561|FG004|Overall Study|Inadvertent Enrollment|0|||
23356805|NCT03131687|65052562|FG005|Overall Study|Inadvertent Enrollment|0|||
23356806|NCT01300247|65052563|FG000|Overall Study|Death|1|||
23356807|NCT01300247|65052564|FG001|Overall Study|Death|1|||
23356808|NCT01300247|65052563|FG000|Overall Study|Lost to Follow-up|2|||
23356809|NCT01300247|65052564|FG001|Overall Study|Lost to Follow-up|0|||
23356810|NCT01300247|65052563|FG000|Overall Study|Withdrawal by Subject|1|||
23356811|NCT01300247|65052564|FG001|Overall Study|Withdrawal by Subject|0|||
23356812|NCT01300247|65052563|FG000|Overall Study|Non-Compliance|0|||
23356813|NCT01300247|65052564|FG001|Overall Study|Non-Compliance|1|||
23356814|NCT02683239|65052565|FG000|Overall Study|Protocol Violation|35|||
23356815|NCT02683239|65052566|FG001|Overall Study|Protocol Violation|23|||
23190341|NCT00090285|64439379|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
23190342|NCT00090285|64439380|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
23190343|NCT00090285|64439381|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
23190344|NCT00090285|64439382|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
23190345|NCT00090285|64439383|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
23190346|NCT00090285|64439384|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
23190347|NCT00090285|64439379|FG000|Base Study Follow-up Period|Moved|41|||
23190348|NCT00090285|64439380|FG001|Base Study Follow-up Period|Moved|36|||
23190349|NCT00090285|64439381|FG002|Base Study Follow-up Period|Moved|0|||
23190350|NCT00090285|64439382|FG003|Base Study Follow-up Period|Moved|0|||
23190351|NCT00090285|64439383|FG004|Base Study Follow-up Period|Moved|0|||
23190352|NCT00090285|64439384|FG005|Base Study Follow-up Period|Moved|0|||
23190353|NCT00090285|64439379|FG000|Base Study Follow-up Period|Other|2|||
23190354|NCT00090285|64439380|FG001|Base Study Follow-up Period|Other|0|||
23190355|NCT00090285|64439381|FG002|Base Study Follow-up Period|Other|0|||
23190356|NCT00090285|64439382|FG003|Base Study Follow-up Period|Other|0|||
23190357|NCT00090285|64439383|FG004|Base Study Follow-up Period|Other|0|||
23190358|NCT00090285|64439384|FG005|Base Study Follow-up Period|Other|0|||
23190359|NCT00090285|64439379|FG000|Base Study Follow-up Period|Protocol Violation|1|||
23190360|NCT00090285|64439380|FG001|Base Study Follow-up Period|Protocol Violation|0|||
23190361|NCT00090285|64439381|FG002|Base Study Follow-up Period|Protocol Violation|0|||
23190362|NCT00090285|64439382|FG003|Base Study Follow-up Period|Protocol Violation|0|||
23190363|NCT00090285|64439383|FG004|Base Study Follow-up Period|Protocol Violation|0|||
23190364|NCT00090285|64439384|FG005|Base Study Follow-up Period|Protocol Violation|0|||
23190365|NCT00090285|64439379|FG000|Base Study Follow-up Period|Uncooperative|3|||
23190366|NCT00090285|64439380|FG001|Base Study Follow-up Period|Uncooperative|4|||
23190367|NCT00090285|64439381|FG002|Base Study Follow-up Period|Uncooperative|0|||
23190368|NCT00090285|64439382|FG003|Base Study Follow-up Period|Uncooperative|0|||
23190369|NCT00090285|64439383|FG004|Base Study Follow-up Period|Uncooperative|0|||
23190370|NCT00090285|64439384|FG005|Base Study Follow-up Period|Uncooperative|0|||
23190371|NCT00090285|64439379|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
23190372|NCT00090285|64439380|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
23190373|NCT00090285|64439381|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
23190374|NCT00090285|64439382|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
23190375|NCT00090285|64439383|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
23190376|NCT00090285|64439384|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
23190377|NCT00090285|64439379|FG000|Extension 1|Adverse Event|0|||
23190378|NCT00090285|64439380|FG001|Extension 1|Adverse Event|0|||
23190379|NCT00090285|64439381|FG002|Extension 1|Adverse Event|2|||
23190380|NCT00090285|64439382|FG003|Extension 1|Adverse Event|0|||
23190381|NCT00090285|64439383|FG004|Extension 1|Adverse Event|0|||
23190382|NCT00090285|64439384|FG005|Extension 1|Adverse Event|0|||
23190383|NCT00090285|64439379|FG000|Extension 1|Lost to Follow-up|0|||
23190384|NCT00090285|64439380|FG001|Extension 1|Lost to Follow-up|0|||
23190385|NCT00090285|64439381|FG002|Extension 1|Lost to Follow-up|35|||
23190386|NCT00090285|64439382|FG003|Extension 1|Lost to Follow-up|0|||
23190387|NCT00090285|64439383|FG004|Extension 1|Lost to Follow-up|0|||
23190388|NCT00090285|64439384|FG005|Extension 1|Lost to Follow-up|0|||
23190389|NCT00090285|64439379|FG000|Extension 1|Withdrawal by Subject|0|||
23190390|NCT00090285|64439380|FG001|Extension 1|Withdrawal by Subject|0|||
23190391|NCT00090285|64439381|FG002|Extension 1|Withdrawal by Subject|13|||
23190392|NCT00090285|64439382|FG003|Extension 1|Withdrawal by Subject|1|||
23190393|NCT00090285|64439383|FG004|Extension 1|Withdrawal by Subject|0|||
23190394|NCT00090285|64439384|FG005|Extension 1|Withdrawal by Subject|0|||
23356816|NCT02683239|65052567|FG002|Overall Study|Protocol Violation|26|||
23356817|NCT02683239|65052568|FG003|Overall Study|Protocol Violation|4|||
23356818|NCT02683239|65052569|FG004|Overall Study|Protocol Violation|35|||
23356819|NCT02683239|65052570|FG005|Overall Study|Protocol Violation|4|||
23356820|NCT02683239|65052571|FG006|Overall Study|Protocol Violation|5|||
23356821|NCT02683239|65052565|FG000|Overall Study|Adverse Event|64|||
23356822|NCT02683239|65052566|FG001|Overall Study|Adverse Event|39|||
23356823|NCT02683239|65052567|FG002|Overall Study|Adverse Event|42|||
23356824|NCT02683239|65052568|FG003|Overall Study|Adverse Event|16|||
23356825|NCT02683239|65052569|FG004|Overall Study|Adverse Event|189|||
23356826|NCT02683239|65052570|FG005|Overall Study|Adverse Event|9|||
23356827|NCT02683239|65052571|FG006|Overall Study|Adverse Event|9|||
23356828|NCT02683239|65052565|FG000|Overall Study|Physician Decision|38|||
23356829|NCT02683239|65052566|FG001|Overall Study|Physician Decision|19|||
23356830|NCT02683239|65052567|FG002|Overall Study|Physician Decision|14|||
23356831|NCT02683239|65052568|FG003|Overall Study|Physician Decision|73|||
23356832|NCT02683239|65052569|FG004|Overall Study|Physician Decision|143|||
23356833|NCT02683239|65052570|FG005|Overall Study|Physician Decision|14|||
23356834|NCT02683239|65052571|FG006|Overall Study|Physician Decision|15|||
23356835|NCT02683239|65052565|FG000|Overall Study|Withdrawal by Subject|187|||
23356836|NCT02683239|65052566|FG001|Overall Study|Withdrawal by Subject|99|||
23356837|NCT02683239|65052567|FG002|Overall Study|Withdrawal by Subject|91|||
23356838|NCT02683239|65052568|FG003|Overall Study|Withdrawal by Subject|18|||
23356839|NCT02683239|65052569|FG004|Overall Study|Withdrawal by Subject|248|||
23356840|NCT02683239|65052570|FG005|Overall Study|Withdrawal by Subject|22|||
23356841|NCT02683239|65052571|FG006|Overall Study|Withdrawal by Subject|28|||
23356842|NCT02683239|65052565|FG000|Overall Study|Lost to Follow-up|77|||
23356843|NCT02683239|65052566|FG001|Overall Study|Lost to Follow-up|24|||
23356844|NCT02683239|65052567|FG002|Overall Study|Lost to Follow-up|25|||
23356845|NCT02683239|65052568|FG003|Overall Study|Lost to Follow-up|7|||
23356846|NCT02683239|65052569|FG004|Overall Study|Lost to Follow-up|88|||
23356847|NCT02683239|65052570|FG005|Overall Study|Lost to Follow-up|8|||
23356848|NCT02683239|65052571|FG006|Overall Study|Lost to Follow-up|11|||
23356849|NCT02683239|65052565|FG000|Overall Study|Death|9|||
23356850|NCT02683239|65052566|FG001|Overall Study|Death|5|||
23356851|NCT02683239|65052567|FG002|Overall Study|Death|8|||
23356852|NCT02683239|65052568|FG003|Overall Study|Death|0|||
23356853|NCT02683239|65052569|FG004|Overall Study|Death|12|||
23250323|NCT05553600|64659737|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
23250324|NCT05553600|64659738|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
23250325|NCT05553600|64659739|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
23250326|NCT05553600|64659736|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
23250327|NCT05553600|64659737|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
23250328|NCT05553600|64659738|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
23250329|NCT05553600|64659739|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
23250330|NCT05553600|64659736|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
23250331|NCT05553600|64659737|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
23250332|NCT05553600|64659738|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
23250333|NCT05553600|64659739|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
23250334|NCT05553600|64659736|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
23250335|NCT05553600|64659737|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
23250336|NCT05553600|64659738|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
23250337|NCT05553600|64659739|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
23250338|NCT05553600|64659736|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
23250339|NCT05553600|64659737|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
23250340|NCT05553600|64659738|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
23250341|NCT05553600|64659739|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
23250342|NCT05553600|64659736|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
23250343|NCT05553600|64659737|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
23250344|NCT05553600|64659738|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
23356854|NCT02683239|65052570|FG005|Overall Study|Death|1|||
23588844|NCT01393119|65882229|FG001|Overall Study|Lack of Efficacy|0|||
23356855|NCT02683239|65052571|FG006|Overall Study|Death|0|||
23356856|NCT02683239|65052565|FG000|Overall Study|Lack of Efficacy|50|||
23356857|NCT02683239|65052566|FG001|Overall Study|Lack of Efficacy|23|||
23356858|NCT02683239|65052567|FG002|Overall Study|Lack of Efficacy|12|||
23356859|NCT02683239|65052568|FG003|Overall Study|Lack of Efficacy|2|||
23356860|NCT02683239|65052569|FG004|Overall Study|Lack of Efficacy|29|||
23356861|NCT02683239|65052570|FG005|Overall Study|Lack of Efficacy|2|||
23356862|NCT02683239|65052571|FG006|Overall Study|Lack of Efficacy|3|||
23356863|NCT02683239|65052565|FG000|Overall Study|Missing data|0|||
23356864|NCT02683239|65052566|FG001|Overall Study|Missing data|1|||
23356865|NCT02683239|65052567|FG002|Overall Study|Missing data|1|||
23356866|NCT02683239|65052568|FG003|Overall Study|Missing data|0|||
23356867|NCT02683239|65052569|FG004|Overall Study|Missing data|1|||
23356868|NCT02683239|65052570|FG005|Overall Study|Missing data|0|||
23356869|NCT02683239|65052571|FG006|Overall Study|Missing data|0|||
23356870|NCT01429441|65052573|FG000|Overall Study|Adverse Event|5|||
23356871|NCT01429441|65052574|FG001|Overall Study|Adverse Event|1|||
23356872|NCT01429441|65052573|FG000|Overall Study|Death|0|||
23356873|NCT01429441|65052574|FG001|Overall Study|Death|2|||
23356874|NCT01429441|65052573|FG000|Overall Study|Lost to Follow-up|5|||
23356875|NCT01429441|65052574|FG001|Overall Study|Lost to Follow-up|2|||
23356876|NCT01429441|65052573|FG000|Overall Study|Physician Decision|1|||
23356877|NCT01429441|65052574|FG001|Overall Study|Physician Decision|0|||
23356878|NCT01429441|65052573|FG000|Overall Study|Withdrawal by Subject|27|||
23356879|NCT01429441|65052574|FG001|Overall Study|Withdrawal by Subject|18|||
23356880|NCT01808222|65052575|FG000|Overall Study|mpMR scan was not performed|1|||
23356881|NCT02797678|65052576|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
23356882|NCT02797678|65052577|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
23356883|NCT02797678|65052578|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
23356884|NCT02797678|65052579|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
23356885|NCT02797678|65052576|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
23356886|NCT02797678|65052577|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
23356887|NCT02797678|65052578|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
23356888|NCT02797678|65052579|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
23356889|NCT02797678|65052576|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
23356890|NCT02797678|65052577|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
23356891|NCT02797678|65052578|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
23356892|NCT02797678|65052579|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
23356893|NCT00460746|65052582|FG000|Overall Study|Adverse Event|1|||
23356894|NCT00460746|65052582|FG000|Overall Study|Lost to Follow-up|1|||
23356895|NCT02840474|65052583|FG000|Overall Study|Lost to Follow-up|1|||
23356896|NCT02840474|65052584|FG001|Overall Study|Lost to Follow-up|0|||
23356897|NCT01398358|65052585|FG000|Overall Study|Lost to Follow-up|11|||
23356898|NCT01398358|65052586|FG001|Overall Study|Lost to Follow-up|21|||
23356899|NCT01398358|65052587|FG002|Overall Study|Lost to Follow-up|18|||
23356900|NCT01398358|65052585|FG000|Overall Study|Withdrawal by Subject|3|||
23356901|NCT01398358|65052586|FG001|Overall Study|Withdrawal by Subject|2|||
23356902|NCT01398358|65052587|FG002|Overall Study|Withdrawal by Subject|2|||
23356903|NCT01398358|65052585|FG000|Overall Study|no longer eligible|1|||
23356904|NCT01398358|65052586|FG001|Overall Study|no longer eligible|0|||
23356905|NCT01398358|65052587|FG002|Overall Study|no longer eligible|1|||
23356906|NCT00564278|65052590|FG000|Overall Study|Lost to Follow-up|35|||
23356907|NCT00564278|65052591|FG001|Overall Study|Lost to Follow-up|33|||
23356908|NCT00564278|65052590|FG000|Overall Study|Physician Decision|1|||
23356909|NCT00564278|65052591|FG001|Overall Study|Physician Decision|2|||
23356910|NCT00564278|65052590|FG000|Overall Study|Withdrawal by Subject|11|||
23356911|NCT00564278|65052591|FG001|Overall Study|Withdrawal by Subject|7|||
23588845|NCT01393119|65882230|FG002|Overall Study|Lack of Efficacy|2|||
23190395|NCT00090285|64439379|FG000|Extension 1|Other|0|||
23190396|NCT00090285|64439380|FG001|Extension 1|Other|0|||
23190397|NCT00090285|64439381|FG002|Extension 1|Other|4|||
23190398|NCT00090285|64439382|FG003|Extension 1|Other|0|||
23190399|NCT00090285|64439383|FG004|Extension 1|Other|0|||
23190400|NCT00090285|64439384|FG005|Extension 1|Other|0|||
23190401|NCT00090285|64439379|FG000|Extension 1|Moved|0|||
23190402|NCT00090285|64439380|FG001|Extension 1|Moved|0|||
23190403|NCT00090285|64439381|FG002|Extension 1|Moved|3|||
23190404|NCT00090285|64439382|FG003|Extension 1|Moved|0|||
23190405|NCT00090285|64439383|FG004|Extension 1|Moved|0|||
23250345|NCT05553600|64659739|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
23356912|NCT02226120|65052592|FG000|Overall Study|Adverse Event|60|||
23356913|NCT02226120|65052592|FG000|Overall Study|Death|172|||
23356914|NCT02226120|65052592|FG000|Overall Study|Study terminated by sponsor|1|||
23356915|NCT02226120|65052592|FG000|Overall Study|Technical problems|4|||
23356916|NCT02226120|65052592|FG000|Overall Study|Lost to Follow-up|13|||
23356917|NCT02226120|65052592|FG000|Overall Study|Physician Decision|21|||
23356918|NCT02226120|65052592|FG000|Overall Study|Withdrawal by parent/guardian|36|||
23356919|NCT02226120|65052592|FG000|Overall Study|Non-compliance with study drug|10|||
23356920|NCT02226120|65052592|FG000|Overall Study|Protocol deviation|1|||
23356921|NCT02226120|65052592|FG000|Overall Study|missing treatment disposition pages|2|||
23190406|NCT00090285|64439384|FG005|Extension 1|Moved|0|||
23190407|NCT00090285|64439379|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
23190408|NCT00090285|64439380|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
23190409|NCT00090285|64439381|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
23356922|NCT03859648|65052593|FG000|Overall Study|Lost to Follow-up|1|||
23356923|NCT03859648|65052593|FG000|Overall Study|Adverse Event|1|||
23356924|NCT02716779|65052597|FG000|Monotherapy|Adverse Event|0|||
23356925|NCT02716779|65052598|FG001|Monotherapy|Adverse Event|1|||
23356926|NCT02716779|65052599|FG002|Monotherapy|Adverse Event|1|||
23356927|NCT02716779|65052597|FG000|Combination Therapy|Adverse Event|0|||
23356928|NCT02716779|65052598|FG001|Combination Therapy|Adverse Event|2|||
23356929|NCT02716779|65052599|FG002|Combination Therapy|Adverse Event|1|||
23356930|NCT02579382|65052606|FG000|Main Study Phase|Lost to Follow-up|0|||
23356931|NCT02579382|65052607|FG001|Main Study Phase|Lost to Follow-up|0|||
23356932|NCT02579382|65052608|FG002|Main Study Phase|Lost to Follow-up|2|||
23356933|NCT02579382|65052609|FG003|Main Study Phase|Lost to Follow-up|0|||
23356934|NCT02579382|65052606|FG000|Main Study Phase|Withdrew Consent|0|||
23356935|NCT02579382|65052607|FG001|Main Study Phase|Withdrew Consent|0|||
23356936|NCT02579382|65052608|FG002|Main Study Phase|Withdrew Consent|0|||
23356937|NCT02579382|65052609|FG003|Main Study Phase|Withdrew Consent|2|||
23356938|NCT02579382|65052606|FG000|Main Study Phase|Lack of Efficacy|0|||
23356939|NCT02579382|65052607|FG001|Main Study Phase|Lack of Efficacy|0|||
23356940|NCT02579382|65052608|FG002|Main Study Phase|Lack of Efficacy|0|||
23356941|NCT02579382|65052609|FG003|Main Study Phase|Lack of Efficacy|1|||
23356942|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
23356943|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
23356944|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
23356945|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
23356946|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
23356947|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
23356948|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
23356949|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
23356950|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
23356951|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
23356952|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
23356953|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
23356954|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
23356955|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
23356956|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
23356957|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
23356958|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
23356959|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
23356960|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
23356961|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
23356962|NCT02579382|65052606|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
23356963|NCT02579382|65052607|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
23356964|NCT02579382|65052608|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
23356965|NCT02579382|65052609|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
23356966|NCT04152083|65052610|FG000|Overall Study|Lost to Follow-up|2|||
23356967|NCT04152083|65052611|FG001|Overall Study|Lost to Follow-up|1|||
23356968|NCT04152083|65052610|FG000|Overall Study|Adverse Event|1|||
23356969|NCT04152083|65052611|FG001|Overall Study|Adverse Event|0|||
23356970|NCT04152083|65052610|FG000|Overall Study|Randomized but not treated|3|||
23356971|NCT04152083|65052611|FG001|Overall Study|Randomized but not treated|2|||
23356972|NCT00885378|65052612|FG000|Overall Study|Lack of Efficacy|2|||
23356973|NCT00885378|65052613|FG001|Overall Study|Lack of Efficacy|2|||
23356974|NCT00885378|65052612|FG000|Overall Study|Withdrawal by Subject|1|||
23356975|NCT00885378|65052613|FG001|Overall Study|Withdrawal by Subject|2|||
23356976|NCT00885378|65052612|FG000|Overall Study|Lost to Follow-up|1|||
23356977|NCT00885378|65052613|FG001|Overall Study|Lost to Follow-up|2|||
23356978|NCT00885378|65052612|FG000|Overall Study|Poor/Noncompliance|2|||
23356979|NCT00885378|65052613|FG001|Overall Study|Poor/Noncompliance|2|||
23356980|NCT00885378|65052612|FG000|Overall Study|Protocol Violation|2|||
23356981|NCT00885378|65052613|FG001|Overall Study|Protocol Violation|0|||
23356982|NCT04727528|65052628|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
23356983|NCT04727528|65052629|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
23356984|NCT04727528|65052628|FG000|Open-label Period|Randomized who did not receive treatment|1|||
23356985|NCT04727528|65052629|FG001|Open-label Period|Randomized who did not receive treatment|0|||
23356986|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23356987|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Adverse Event|1|||
23356988|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Death|0|||
23356989|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Death|1|||
23356990|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
23473313|NCT02059291|65477574|FG011|Epoch 3|Lack of Efficacy|0|||
23473314|NCT02059291|65477575|FG012|Epoch 3|Lack of Efficacy|0|||
23473315|NCT02059291|65477576|FG013|Epoch 3|Lack of Efficacy|0|||
23473316|NCT02059291|65477577|FG014|Epoch 3|Lack of Efficacy|0|||
23473317|NCT02059291|65477578|FG015|Epoch 3|Lack of Efficacy|3|||
23473318|NCT02059291|65477579|FG016|Epoch 3|Lack of Efficacy|0|||
23473319|NCT02059291|65477580|FG017|Epoch 3|Lack of Efficacy|0|||
23473320|NCT02059291|65477581|FG018|Epoch 3|Lack of Efficacy|0|||
23473321|NCT02059291|65477582|FG019|Epoch 3|Lack of Efficacy|0|||
23473322|NCT02059291|65477583|FG020|Epoch 3|Lack of Efficacy|0|||
23473323|NCT02059291|65477584|FG021|Epoch 3|Lack of Efficacy|0|||
23473324|NCT02059291|65477585|FG022|Epoch 3|Lack of Efficacy|0|||
23473325|NCT02059291|65477586|FG023|Epoch 3|Lack of Efficacy|0|||
23473326|NCT02059291|65477587|FG024|Epoch 3|Lack of Efficacy|0|||
23473327|NCT02059291|65477563|FG000|Epoch 3|Withdrawal by Subject|0|||
23473328|NCT02059291|65477564|FG001|Epoch 3|Withdrawal by Subject|0|||
23473329|NCT02059291|65477565|FG002|Epoch 3|Withdrawal by Subject|0|||
23473330|NCT02059291|65477566|FG003|Epoch 3|Withdrawal by Subject|0|||
23473331|NCT02059291|65477567|FG004|Epoch 3|Withdrawal by Subject|0|||
23473332|NCT02059291|65477568|FG005|Epoch 3|Withdrawal by Subject|0|||
23473333|NCT02059291|65477569|FG006|Epoch 3|Withdrawal by Subject|0|||
23473334|NCT02059291|65477570|FG007|Epoch 3|Withdrawal by Subject|0|||
23588846|NCT01393119|65882231|FG003|Overall Study|Lack of Efficacy|1|||
23588847|NCT01393119|65882228|FG000|Overall Study|Protocol Violation|0|||
23588848|NCT01393119|65882229|FG001|Overall Study|Protocol Violation|0|||
23588849|NCT01393119|65882230|FG002|Overall Study|Protocol Violation|1|||
23588850|NCT01393119|65882231|FG003|Overall Study|Protocol Violation|0|||
23588851|NCT01393119|65882228|FG000|Overall Study|Death|0|||
23588852|NCT01393119|65882229|FG001|Overall Study|Death|0|||
23588853|NCT01393119|65882230|FG002|Overall Study|Death|0|||
23473335|NCT02059291|65477571|FG008|Epoch 3|Withdrawal by Subject|0|||
23473336|NCT02059291|65477572|FG009|Epoch 3|Withdrawal by Subject|0|||
23473337|NCT02059291|65477573|FG010|Epoch 3|Withdrawal by Subject|0|||
23588854|NCT01393119|65882231|FG003|Overall Study|Death|1|||
23473338|NCT02059291|65477574|FG011|Epoch 3|Withdrawal by Subject|0|||
23473339|NCT02059291|65477575|FG012|Epoch 3|Withdrawal by Subject|0|||
23473340|NCT02059291|65477576|FG013|Epoch 3|Withdrawal by Subject|0|||
23473341|NCT02059291|65477577|FG014|Epoch 3|Withdrawal by Subject|0|||
23588855|NCT01393119|65882228|FG000|Overall Study|Randomized but Not treated|1|||
23250346|NCT05553600|64659736|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
23250347|NCT05553600|64659737|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
23250348|NCT05553600|64659738|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
23250349|NCT05553600|64659739|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
23250350|NCT05553600|64659736|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
23356991|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
23356992|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
23356993|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
23356994|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Physician Decision|0|||
23356995|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Physician Decision|1|||
23356996|NCT04727528|65052628|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
23356997|NCT04727528|65052629|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23356998|NCT00705341|65052630|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
23356999|NCT00705341|65052631|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
23357000|NCT00705341|65052632|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
23357001|NCT00705341|65052633|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
23357002|NCT00705341|65052630|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
23357003|NCT00705341|65052631|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
23357004|NCT00705341|65052632|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
23357005|NCT00705341|65052633|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
23357006|NCT00593606|65052634|FG000|Overall Study|Adverse Event|13|||
23357007|NCT00593606|65052634|FG000|Overall Study|Withdrawal by Subject|1|||
23357008|NCT00593606|65052634|FG000|Overall Study|Protocol Violation|3|||
23357009|NCT00593606|65052634|FG000|Overall Study|Lost to Follow-up|2|||
23357010|NCT00593606|65052634|FG000|Overall Study|Run-In Failure|5|||
23357011|NCT00593606|65052634|FG000|Overall Study|Screen Failure|3|||
23473342|NCT02059291|65477578|FG015|Epoch 3|Withdrawal by Subject|1|||
23250351|NCT05553600|64659737|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
23250352|NCT05553600|64659738|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
23250353|NCT05553600|64659739|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
23250354|NCT05553600|64659736|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
23250355|NCT05553600|64659737|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
23250356|NCT05553600|64659738|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
23250357|NCT05553600|64659739|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
23250358|NCT05553600|64659736|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
23250359|NCT05553600|64659737|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
23250360|NCT05553600|64659738|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
23250361|NCT05553600|64659739|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
23250362|NCT05553600|64659736|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
23250363|NCT05553600|64659737|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
23250364|NCT05553600|64659738|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
23250365|NCT05553600|64659739|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
23250366|NCT05553600|64659736|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
23250367|NCT05553600|64659737|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
23250368|NCT05553600|64659738|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
23250369|NCT05553600|64659739|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
23250370|NCT01179191|64659742|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
23250371|NCT01179191|64659742|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
23250372|NCT01179191|64659742|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
23250373|NCT01179191|64659742|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
23250374|NCT01179191|64659742|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
23250375|NCT01179191|64659742|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
23250376|NCT01179191|64659742|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
23250377|NCT01179191|64659742|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
23250378|NCT01179191|64659742|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
23250379|NCT01179191|64659742|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
23250380|NCT01179191|64659742|FG000|Maintenance Phase (8 Weeks)|Other|66|||
23250381|NCT01216319|64659743|FG000|Overall Study|Lost to Follow-up|2|||
23250382|NCT01216319|64659743|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
23250383|NCT04440007|64659744|FG000|Overall Study|Adverse Event|0|||
23250384|NCT04440007|64659745|FG001|Overall Study|Adverse Event|1|||
23250385|NCT04440007|64659744|FG000|Overall Study|Lost to Follow-up|1|||
23250386|NCT04440007|64659745|FG001|Overall Study|Lost to Follow-up|3|||
23250387|NCT04440007|64659744|FG000|Overall Study|Death|7|||
23357012|NCT01212159|65052640|FG000|Overall Study|Withdrawal by Subject|12|||
23357013|NCT01212159|65052641|FG001|Overall Study|Withdrawal by Subject|12|||
23357014|NCT00869128|65052644|FG000|Overall Study|lack of Compliance|6|||
23357015|NCT00869128|65052645|FG001|Overall Study|lack of Compliance|6|||
23357016|NCT00264290|65052646|FG000|Intervention (8 Weeks)|Adverse Event|1|||
23357017|NCT00264290|65052647|FG001|Intervention (8 Weeks)|Adverse Event|0|||
23357018|NCT03124537|65052648|FG000|Overall Study|Lost to Follow-up|3|||
23357019|NCT03124537|65052649|FG001|Overall Study|Lost to Follow-up|5|||
23357020|NCT03124537|65052648|FG000|Overall Study|App Crash, Incomplete Data|7|||
23357021|NCT03124537|65052649|FG001|Overall Study|App Crash, Incomplete Data|8|||
23357022|NCT03162328|65052652|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
23357023|NCT03162328|65052653|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
23357024|NCT03162328|65052654|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
23357025|NCT03162328|65052652|FG000|Screening Period|Withdrawal by Subject|1|||
23357026|NCT03162328|65052653|FG001|Screening Period|Withdrawal by Subject|0|||
23357027|NCT03162328|65052654|FG002|Screening Period|Withdrawal by Subject|0|||
23357028|NCT03162328|65052652|FG000|Study Period|Withdrawal by Subject|0|||
23357029|NCT03162328|65052653|FG001|Study Period|Withdrawal by Subject|0|||
23357030|NCT03162328|65052654|FG002|Study Period|Withdrawal by Subject|1|||
23357031|NCT02784288|65052655|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
23357032|NCT01972464|65052656|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
23357033|NCT01972464|65052657|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
23357034|NCT01972464|65052656|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
23357035|NCT01972464|65052657|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
23357036|NCT01972464|65052656|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
23357037|NCT01972464|65052657|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
23357038|NCT01972464|65052656|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
23357039|NCT01972464|65052657|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
23357040|NCT03307837|65052663|FG000|Overall Study|Withdrawal by Subject|0|||
23357041|NCT03307837|65052664|FG001|Overall Study|Withdrawal by Subject|0|||
23357042|NCT03307837|65052665|FG002|Overall Study|Withdrawal by Subject|1|||
23357043|NCT03307837|65052666|FG003|Overall Study|Withdrawal by Subject|0|||
23357044|NCT03307837|65052667|FG004|Overall Study|Withdrawal by Subject|0|||
23357045|NCT03307837|65052668|FG005|Overall Study|Withdrawal by Subject|1|||
23357046|NCT03307837|65052663|FG000|Overall Study|Lost to Follow-up|1|||
23357047|NCT03307837|65052664|FG001|Overall Study|Lost to Follow-up|1|||
23357048|NCT03307837|65052665|FG002|Overall Study|Lost to Follow-up|0|||
23357049|NCT03307837|65052666|FG003|Overall Study|Lost to Follow-up|0|||
23357050|NCT03307837|65052667|FG004|Overall Study|Lost to Follow-up|0|||
23357051|NCT03307837|65052668|FG005|Overall Study|Lost to Follow-up|1|||
23357052|NCT04105842|65052669|FG000|Overall Study|Withdrawal by Subject|2|||
23357053|NCT00985686|65052670|FG000|Overall Study|Lost to Follow-up|1|||
23357054|NCT00985686|65052671|FG001|Overall Study|Lost to Follow-up|1|||
23357055|NCT00985686|65052672|FG002|Overall Study|Lost to Follow-up|0|||
23357056|NCT00985686|65052673|FG003|Overall Study|Lost to Follow-up|2|||
23357057|NCT04227405|65052674|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
23357058|NCT04227405|65052675|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
23357059|NCT04227405|65052674|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
23357060|NCT04227405|65052675|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
23357061|NCT04227405|65052674|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
23357062|NCT04227405|65052675|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
23357063|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
23357064|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
23357065|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
23357066|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
23357067|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
23357068|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
23357069|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
23357070|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
23357071|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
23357072|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
23357073|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
23357074|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
23357075|NCT02634801|65052677|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
23357076|NCT02634801|65052678|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
23357077|NCT02634801|65052679|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
23357078|NCT02634801|65052677|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
23190410|NCT00090285|64439382|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
23250388|NCT04440007|64659745|FG001|Overall Study|Death|2|||
23357079|NCT02634801|65052678|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
23357080|NCT02634801|65052679|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
23357081|NCT02634801|65052677|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
23357082|NCT02634801|65052678|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
23357083|NCT02634801|65052679|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
23357084|NCT02634801|65052677|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
23357085|NCT02634801|65052678|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
23357086|NCT02634801|65052679|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
23357087|NCT02634801|65052677|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
23357088|NCT02634801|65052678|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
23357089|NCT02634801|65052679|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
23357090|NCT02634801|65052677|FG000|Follow-up Period|Lost to Follow-up|3|||
23357091|NCT02634801|65052678|FG001|Follow-up Period|Lost to Follow-up|1|||
23357092|NCT02634801|65052679|FG002|Follow-up Period|Lost to Follow-up|2|||
23357093|NCT02634801|65052677|FG000|Follow-up Period|Physician Decision|0|||
23357094|NCT02634801|65052678|FG001|Follow-up Period|Physician Decision|0|||
23357095|NCT02634801|65052679|FG002|Follow-up Period|Physician Decision|1|||
23357096|NCT02634801|65052677|FG000|Follow-up Period|Withdrawal by Subject|1|||
23357097|NCT02634801|65052678|FG001|Follow-up Period|Withdrawal by Subject|2|||
23357098|NCT02634801|65052679|FG002|Follow-up Period|Withdrawal by Subject|5|||
23357099|NCT02634801|65052677|FG000|Follow-up Period|Adverse Event|1|||
23357100|NCT02634801|65052678|FG001|Follow-up Period|Adverse Event|5|||
23357101|NCT02634801|65052679|FG002|Follow-up Period|Adverse Event|0|||
23357102|NCT01928199|65052683|FG000|Overall Study|Lost to Follow-up|2|||
23357103|NCT01928199|65052684|FG001|Overall Study|Lost to Follow-up|1|||
23357104|NCT01928199|65052683|FG000|Overall Study|Withdrawal by Subject|3|||
23357105|NCT01928199|65052684|FG001|Overall Study|Withdrawal by Subject|5|||
23357106|NCT03041467|65052685|FG000|Overall Study|Death|46|||
23357107|NCT03041467|65052686|FG001|Overall Study|Death|39|||
23357108|NCT03041467|65052685|FG000|Overall Study|Withdrawal by Subject|36|||
23357109|NCT03041467|65052686|FG001|Overall Study|Withdrawal by Subject|37|||
23357110|NCT03041467|65052685|FG000|Overall Study|Lost to Follow-up|6|||
23357111|NCT03041467|65052686|FG001|Overall Study|Lost to Follow-up|8|||
23357112|NCT03041467|65052685|FG000|Overall Study|Declined consent for study extension|21|||
23357113|NCT03041467|65052686|FG001|Overall Study|Declined consent for study extension|33|||
23357114|NCT03041467|65052685|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
23357115|NCT03041467|65052686|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
23357116|NCT03469999|65052687|FG000|Overall Study|Lost to Follow-up|2|||
23357117|NCT00154375|65052688|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
23357118|NCT00154375|65052689|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
23357119|NCT00154375|65052688|FG000|Overall Study|Adverse Event|18|||
23357120|NCT00154375|65052689|FG001|Overall Study|Adverse Event|20|||
23357121|NCT00154375|65052688|FG000|Overall Study|Withdrawal by Subject|14|||
23357122|NCT00154375|65052689|FG001|Overall Study|Withdrawal by Subject|10|||
23357123|NCT00154375|65052688|FG000|Overall Study|Death|5|||
23190411|NCT00090285|64439383|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
23190412|NCT00090285|64439384|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
23190413|NCT00090285|64439379|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23190414|NCT00090285|64439380|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23190415|NCT00090285|64439381|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23357124|NCT00154375|65052689|FG001|Overall Study|Death|13|||
23357125|NCT00154375|65052688|FG000|Overall Study|Study drug no longer required|5|||
23473343|NCT02059291|65477579|FG016|Epoch 3|Withdrawal by Subject|0|||
23588856|NCT01393119|65882229|FG001|Overall Study|Randomized but Not treated|0|||
23588857|NCT01393119|65882230|FG002|Overall Study|Randomized but Not treated|1|||
23588858|NCT01393119|65882231|FG003|Overall Study|Randomized but Not treated|1|||
23588859|NCT01393119|65882228|FG000|Overall Study|Sponsor Termination of Study|11|||
23190416|NCT00090285|64439382|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
23190417|NCT00090285|64439383|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
23190418|NCT00090285|64439384|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
23190419|NCT00090285|64439379|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23190420|NCT00090285|64439380|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23357126|NCT00154375|65052689|FG001|Overall Study|Study drug no longer required|3|||
23357127|NCT00154375|65052688|FG000|Overall Study|Lost to Follow-up|2|||
23357128|NCT00154375|65052689|FG001|Overall Study|Lost to Follow-up|1|||
23357129|NCT00154375|65052688|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23357130|NCT00154375|65052689|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23357131|NCT00154375|65052688|FG000|Overall Study|Protocol Violation|0|||
23357132|NCT00154375|65052689|FG001|Overall Study|Protocol Violation|1|||
23357133|NCT00154375|65052688|FG000|Overall Study|Suspected progression of disease|44|||
23357134|NCT00154375|65052689|FG001|Overall Study|Suspected progression of disease|30|||
23357135|NCT01687283|65052690|FG000|Overall Study|Adverse Event|11|||
23473344|NCT02059291|65477580|FG017|Epoch 3|Withdrawal by Subject|0|||
23473345|NCT02059291|65477581|FG018|Epoch 3|Withdrawal by Subject|0|||
23473346|NCT02059291|65477582|FG019|Epoch 3|Withdrawal by Subject|0|||
23473347|NCT02059291|65477583|FG020|Epoch 3|Withdrawal by Subject|0|||
23473348|NCT02059291|65477584|FG021|Epoch 3|Withdrawal by Subject|0|||
23473349|NCT02059291|65477585|FG022|Epoch 3|Withdrawal by Subject|0|||
23473350|NCT02059291|65477586|FG023|Epoch 3|Withdrawal by Subject|0|||
23473351|NCT02059291|65477587|FG024|Epoch 3|Withdrawal by Subject|0|||
23473352|NCT02059291|65477563|FG000|Epoch 4|Adverse Event|0|||
23473353|NCT02059291|65477564|FG001|Epoch 4|Adverse Event|0|||
23473354|NCT02059291|65477565|FG002|Epoch 4|Adverse Event|0|||
23473355|NCT02059291|65477566|FG003|Epoch 4|Adverse Event|0|||
23473356|NCT02059291|65477567|FG004|Epoch 4|Adverse Event|0|||
23473357|NCT02059291|65477568|FG005|Epoch 4|Adverse Event|0|||
23473358|NCT02059291|65477569|FG006|Epoch 4|Adverse Event|0|||
23473359|NCT02059291|65477570|FG007|Epoch 4|Adverse Event|0|||
23250389|NCT04440007|64659744|FG000|Overall Study|Physician Decision|1|||
23190421|NCT00090285|64439381|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23190422|NCT00090285|64439382|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
23190423|NCT00090285|64439383|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
23190424|NCT00090285|64439384|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
23190425|NCT00090285|64439379|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
23190426|NCT00090285|64439380|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
23190427|NCT00090285|64439381|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
23190428|NCT00090285|64439382|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
23190429|NCT00090285|64439383|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
23190430|NCT00090285|64439384|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
23190431|NCT02799381|64439385|FG000|Overall Study|Withdrew consent|3|||
23190432|NCT02799381|64439386|FG001|Overall Study|Withdrew consent|2|||
23250390|NCT04440007|64659745|FG001|Overall Study|Physician Decision|1|||
23250391|NCT04440007|64659744|FG000|Overall Study|Withdrawal by Subject|2|||
23473360|NCT02059291|65477571|FG008|Epoch 4|Adverse Event|0|||
23473361|NCT02059291|65477572|FG009|Epoch 4|Adverse Event|0|||
23473362|NCT02059291|65477573|FG010|Epoch 4|Adverse Event|0|||
23473363|NCT02059291|65477574|FG011|Epoch 4|Adverse Event|0|||
23473364|NCT02059291|65477575|FG012|Epoch 4|Adverse Event|0|||
23473365|NCT02059291|65477576|FG013|Epoch 4|Adverse Event|0|||
23473366|NCT02059291|65477577|FG014|Epoch 4|Adverse Event|0|||
23473367|NCT02059291|65477578|FG015|Epoch 4|Adverse Event|0|||
23473368|NCT02059291|65477579|FG016|Epoch 4|Adverse Event|1|||
23473369|NCT02059291|65477580|FG017|Epoch 4|Adverse Event|0|||
23473370|NCT02059291|65477581|FG018|Epoch 4|Adverse Event|0|||
23473371|NCT02059291|65477582|FG019|Epoch 4|Adverse Event|0|||
23473372|NCT02059291|65477583|FG020|Epoch 4|Adverse Event|0|||
23473373|NCT02059291|65477584|FG021|Epoch 4|Adverse Event|0|||
23473374|NCT02059291|65477585|FG022|Epoch 4|Adverse Event|1|||
23473375|NCT02059291|65477586|FG023|Epoch 4|Adverse Event|0|||
23473376|NCT02059291|65477587|FG024|Epoch 4|Adverse Event|0|||
23190433|NCT02799381|64439385|FG000|Overall Study|Adverse Event|0|||
23250392|NCT04440007|64659745|FG001|Overall Study|Withdrawal by Subject|1|||
23250393|NCT04440007|64659744|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
23250394|NCT04440007|64659745|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
23250395|NCT04440007|64659744|FG000|Overall Study|Discontinued prior to dosing|0|||
23250396|NCT04440007|64659745|FG001|Overall Study|Discontinued prior to dosing|2|||
23250397|NCT01817764|64659746|FG000|Overall Study|Adverse Event|7|||
23250398|NCT01817764|64659747|FG001|Overall Study|Adverse Event|10|||
23250399|NCT01817764|64659746|FG000|Overall Study|Lack of Efficacy|9|||
23250400|NCT01817764|64659747|FG001|Overall Study|Lack of Efficacy|7|||
23250401|NCT01817764|64659746|FG000|Overall Study|Protocol Violation|7|||
23250402|NCT01817764|64659747|FG001|Overall Study|Protocol Violation|5|||
23250403|NCT01817764|64659746|FG000|Overall Study|Lost to Follow-up|1|||
23250404|NCT01817764|64659747|FG001|Overall Study|Lost to Follow-up|4|||
23473377|NCT02059291|65477563|FG000|Epoch 4|Pregnancy|0|||
23473378|NCT02059291|65477564|FG001|Epoch 4|Pregnancy|0|||
23250405|NCT01817764|64659746|FG000|Overall Study|Withdrawal by Subject|10|||
23473379|NCT02059291|65477565|FG002|Epoch 4|Pregnancy|0|||
23473380|NCT02059291|65477566|FG003|Epoch 4|Pregnancy|0|||
23473381|NCT02059291|65477567|FG004|Epoch 4|Pregnancy|0|||
23473382|NCT02059291|65477568|FG005|Epoch 4|Pregnancy|0|||
23473383|NCT02059291|65477569|FG006|Epoch 4|Pregnancy|0|||
23473384|NCT02059291|65477570|FG007|Epoch 4|Pregnancy|0|||
23473385|NCT02059291|65477571|FG008|Epoch 4|Pregnancy|0|||
23473386|NCT02059291|65477572|FG009|Epoch 4|Pregnancy|0|||
23473387|NCT02059291|65477573|FG010|Epoch 4|Pregnancy|0|||
23588860|NCT01393119|65882229|FG001|Overall Study|Sponsor Termination of Study|12|||
23190434|NCT02799381|64439386|FG001|Overall Study|Adverse Event|1|||
23473388|NCT02059291|65477574|FG011|Epoch 4|Pregnancy|0|||
23473389|NCT02059291|65477575|FG012|Epoch 4|Pregnancy|0|||
23473390|NCT02059291|65477576|FG013|Epoch 4|Pregnancy|0|||
23473391|NCT02059291|65477577|FG014|Epoch 4|Pregnancy|0|||
23473392|NCT02059291|65477578|FG015|Epoch 4|Pregnancy|0|||
23473393|NCT02059291|65477579|FG016|Epoch 4|Pregnancy|1|||
23473394|NCT02059291|65477580|FG017|Epoch 4|Pregnancy|0|||
23473395|NCT02059291|65477581|FG018|Epoch 4|Pregnancy|0|||
23473396|NCT02059291|65477582|FG019|Epoch 4|Pregnancy|0|||
23473397|NCT02059291|65477583|FG020|Epoch 4|Pregnancy|0|||
23473398|NCT02059291|65477584|FG021|Epoch 4|Pregnancy|0|||
23473399|NCT02059291|65477585|FG022|Epoch 4|Pregnancy|0|||
23473400|NCT02059291|65477586|FG023|Epoch 4|Pregnancy|0|||
23473401|NCT02059291|65477587|FG024|Epoch 4|Pregnancy|0|||
23473402|NCT02059291|65477563|FG000|Epoch 4|Withdrawal by Subject|0|||
23473403|NCT02059291|65477564|FG001|Epoch 4|Withdrawal by Subject|0|||
23473404|NCT02059291|65477565|FG002|Epoch 4|Withdrawal by Subject|0|||
23473405|NCT02059291|65477566|FG003|Epoch 4|Withdrawal by Subject|0|||
23473406|NCT02059291|65477567|FG004|Epoch 4|Withdrawal by Subject|0|||
23473407|NCT02059291|65477568|FG005|Epoch 4|Withdrawal by Subject|0|||
23473408|NCT02059291|65477569|FG006|Epoch 4|Withdrawal by Subject|0|||
23473409|NCT02059291|65477570|FG007|Epoch 4|Withdrawal by Subject|0|||
23473410|NCT02059291|65477571|FG008|Epoch 4|Withdrawal by Subject|0|||
23473411|NCT02059291|65477572|FG009|Epoch 4|Withdrawal by Subject|0|||
23473412|NCT02059291|65477573|FG010|Epoch 4|Withdrawal by Subject|0|||
23473413|NCT02059291|65477574|FG011|Epoch 4|Withdrawal by Subject|0|||
23473414|NCT02059291|65477575|FG012|Epoch 4|Withdrawal by Subject|0|||
23473415|NCT02059291|65477576|FG013|Epoch 4|Withdrawal by Subject|0|||
23473416|NCT02059291|65477577|FG014|Epoch 4|Withdrawal by Subject|0|||
23473417|NCT02059291|65477578|FG015|Epoch 4|Withdrawal by Subject|0|||
23473418|NCT02059291|65477579|FG016|Epoch 4|Withdrawal by Subject|0|||
23473419|NCT02059291|65477580|FG017|Epoch 4|Withdrawal by Subject|0|||
23473420|NCT02059291|65477581|FG018|Epoch 4|Withdrawal by Subject|0|||
23473421|NCT02059291|65477582|FG019|Epoch 4|Withdrawal by Subject|0|||
23473422|NCT02059291|65477583|FG020|Epoch 4|Withdrawal by Subject|1|||
23473423|NCT02059291|65477584|FG021|Epoch 4|Withdrawal by Subject|0|||
23473424|NCT02059291|65477585|FG022|Epoch 4|Withdrawal by Subject|0|||
23473425|NCT02059291|65477586|FG023|Epoch 4|Withdrawal by Subject|0|||
23473426|NCT02059291|65477587|FG024|Epoch 4|Withdrawal by Subject|0|||
23473427|NCT02059291|65477563|FG000|Epoch 4|Lack of Efficacy|0|||
23473428|NCT02059291|65477564|FG001|Epoch 4|Lack of Efficacy|0|||
23473429|NCT02059291|65477565|FG002|Epoch 4|Lack of Efficacy|0|||
23473430|NCT02059291|65477566|FG003|Epoch 4|Lack of Efficacy|0|||
23473431|NCT02059291|65477567|FG004|Epoch 4|Lack of Efficacy|0|||
23473432|NCT02059291|65477568|FG005|Epoch 4|Lack of Efficacy|0|||
23473433|NCT02059291|65477569|FG006|Epoch 4|Lack of Efficacy|0|||
23473434|NCT02059291|65477570|FG007|Epoch 4|Lack of Efficacy|0|||
23473435|NCT02059291|65477571|FG008|Epoch 4|Lack of Efficacy|0|||
23473436|NCT02059291|65477572|FG009|Epoch 4|Lack of Efficacy|0|||
23473437|NCT02059291|65477573|FG010|Epoch 4|Lack of Efficacy|0|||
23473438|NCT02059291|65477574|FG011|Epoch 4|Lack of Efficacy|0|||
23473439|NCT02059291|65477575|FG012|Epoch 4|Lack of Efficacy|0|||
23473440|NCT02059291|65477576|FG013|Epoch 4|Lack of Efficacy|0|||
23473441|NCT02059291|65477577|FG014|Epoch 4|Lack of Efficacy|0|||
23473442|NCT02059291|65477578|FG015|Epoch 4|Lack of Efficacy|0|||
23473443|NCT02059291|65477579|FG016|Epoch 4|Lack of Efficacy|0|||
23473444|NCT02059291|65477580|FG017|Epoch 4|Lack of Efficacy|0|||
23473445|NCT02059291|65477581|FG018|Epoch 4|Lack of Efficacy|0|||
23473446|NCT02059291|65477582|FG019|Epoch 4|Lack of Efficacy|0|||
23473447|NCT02059291|65477583|FG020|Epoch 4|Lack of Efficacy|0|||
23473448|NCT02059291|65477584|FG021|Epoch 4|Lack of Efficacy|0|||
23190435|NCT02799381|64439385|FG000|Overall Study|Participant did not take any study drug|1|||
23473449|NCT02059291|65477585|FG022|Epoch 4|Lack of Efficacy|0|||
23473450|NCT02059291|65477586|FG023|Epoch 4|Lack of Efficacy|1|||
23473451|NCT02059291|65477587|FG024|Epoch 4|Lack of Efficacy|0|||
23473452|NCT03865381|65477593|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
23473453|NCT03865381|65477593|FG000|Overall Study|Withdrawal by Subject|2|||
23473454|NCT01097005|65477596|FG000|Overall Study|Case Report Form not collected|18|||
23473455|NCT01097005|65477596|FG000|Overall Study|Subjects cannot visit the hospital|1|||
23473456|NCT01097005|65477596|FG000|Overall Study|Poor medication compliance|1|||
23473457|NCT01097005|65477596|FG000|Overall Study|No examination data available|244|||
23473458|NCT01097005|65477596|FG000|Overall Study|Deviation from exclusion criteria|37|||
23473459|NCT01097005|65477596|FG000|Overall Study|Adverse Event|14|||
23473460|NCT01097005|65477596|FG000|Overall Study|Discontinuance by complication|50|||
23473461|NCT03844945|65477597|FG000|Overall Study|Adverse Event|1|||
23473462|NCT03844945|65477598|FG001|Overall Study|Adverse Event|1|||
23473463|NCT03844945|65477599|FG002|Overall Study|Adverse Event|4|||
23473464|NCT03844945|65477600|FG003|Overall Study|Adverse Event|0|||
23473465|NCT03844945|65477597|FG000|Overall Study|Withdrawal by Subject|0|||
23473466|NCT03844945|65477598|FG001|Overall Study|Withdrawal by Subject|0|||
23473467|NCT03844945|65477599|FG002|Overall Study|Withdrawal by Subject|1|||
23473468|NCT03844945|65477600|FG003|Overall Study|Withdrawal by Subject|0|||
23473469|NCT03844945|65477597|FG000|Overall Study|Lack of Efficacy|0|||
23473470|NCT03844945|65477598|FG001|Overall Study|Lack of Efficacy|0|||
23473471|NCT03844945|65477599|FG002|Overall Study|Lack of Efficacy|0|||
23473472|NCT03844945|65477600|FG003|Overall Study|Lack of Efficacy|1|||
23473473|NCT00612807|65477601|FG000|Overall Study|Withdrawal by Subject|2|||
23473474|NCT00612807|65477602|FG001|Overall Study|Withdrawal by Subject|0|||
23473475|NCT00689117|65477603|FG000|Overall Study|Adverse Event|6|||
23473476|NCT00689117|65477604|FG001|Overall Study|Adverse Event|0|||
23473477|NCT00689117|65477605|FG002|Overall Study|Adverse Event|5|||
23473478|NCT00689117|65477606|FG003|Overall Study|Adverse Event|0|||
23473479|NCT00689117|65477603|FG000|Overall Study|Lost to Follow-up|26|||
23473480|NCT00689117|65477604|FG001|Overall Study|Lost to Follow-up|19|||
23473481|NCT00689117|65477605|FG002|Overall Study|Lost to Follow-up|17|||
23473482|NCT00689117|65477606|FG003|Overall Study|Lost to Follow-up|11|||
23473483|NCT00689117|65477603|FG000|Overall Study|Lack of Efficacy|1|||
23473484|NCT00689117|65477604|FG001|Overall Study|Lack of Efficacy|2|||
23473485|NCT00689117|65477605|FG002|Overall Study|Lack of Efficacy|2|||
23473486|NCT00689117|65477606|FG003|Overall Study|Lack of Efficacy|2|||
23473487|NCT00689117|65477603|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
23473488|NCT00689117|65477604|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
23473489|NCT00689117|65477605|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
23473490|NCT00689117|65477606|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
23473491|NCT00689117|65477603|FG000|Overall Study|Withdrawal by Subject|19|||
23473492|NCT00689117|65477604|FG001|Overall Study|Withdrawal by Subject|18|||
23473493|NCT00689117|65477605|FG002|Overall Study|Withdrawal by Subject|26|||
23473494|NCT00689117|65477606|FG003|Overall Study|Withdrawal by Subject|13|||
23473495|NCT00689117|65477603|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
23473496|NCT00689117|65477604|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
23473497|NCT00689117|65477605|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
23473498|NCT00689117|65477606|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
23473499|NCT00689117|65477603|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23473500|NCT00689117|65477604|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
23473501|NCT00689117|65477605|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23473502|NCT00689117|65477606|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23473503|NCT00689117|65477603|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
23473504|NCT00689117|65477604|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
23473505|NCT00689117|65477605|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
23473506|NCT00689117|65477606|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
23473507|NCT00689117|65477603|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
23473508|NCT00689117|65477604|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
23473509|NCT00689117|65477605|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
23473510|NCT00689117|65477606|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
23473511|NCT00689117|65477603|FG000|Overall Study|Use of Prohibitive Medication|2|||
23473512|NCT00689117|65477604|FG001|Overall Study|Use of Prohibitive Medication|1|||
23473513|NCT00689117|65477605|FG002|Overall Study|Use of Prohibitive Medication|3|||
23473514|NCT00689117|65477606|FG003|Overall Study|Use of Prohibitive Medication|0|||
23473515|NCT00689117|65477603|FG000|Overall Study|Pregnancy|0|||
23588861|NCT01393119|65882230|FG002|Overall Study|Sponsor Termination of Study|9|||
23190436|NCT02799381|64439386|FG001|Overall Study|Participant did not take any study drug|0|||
23190437|NCT00947154|64439387|FG000|Overall Study|Lost to Follow-up|1|||
23190438|NCT02714205|64439393|FG000|Overall Study|Cannot tolerate medication|1|||
23190439|NCT02714205|64439394|FG001|Overall Study|Cannot tolerate medication|0|||
23190440|NCT02714205|64439393|FG000|Overall Study|Adverse Event|2|||
23190441|NCT02714205|64439394|FG001|Overall Study|Adverse Event|0|||
23190442|NCT02714205|64439393|FG000|Overall Study|Too busy|1|||
23190443|NCT02714205|64439394|FG001|Overall Study|Too busy|0|||
23190444|NCT02714205|64439393|FG000|Overall Study|Incomplete outcome data|0|||
23190445|NCT02714205|64439394|FG001|Overall Study|Incomplete outcome data|1|||
23190446|NCT00465738|64439397|FG000|Overall Study|Lost to Follow-up|2|||
23190447|NCT00465738|64439398|FG001|Overall Study|Lost to Follow-up|0|||
23190448|NCT00465738|64439397|FG000|Overall Study|Adverse Event|0|||
23190449|NCT00465738|64439398|FG001|Overall Study|Adverse Event|1|||
23473516|NCT00689117|65477604|FG001|Overall Study|Pregnancy|2|||
23473517|NCT00689117|65477605|FG002|Overall Study|Pregnancy|0|||
23473518|NCT00689117|65477606|FG003|Overall Study|Pregnancy|2|||
23473519|NCT00689117|65477603|FG000|Overall Study|Incarceration|2|||
23473520|NCT00689117|65477604|FG001|Overall Study|Incarceration|0|||
23473521|NCT00689117|65477605|FG002|Overall Study|Incarceration|0|||
23473522|NCT00689117|65477606|FG003|Overall Study|Incarceration|0|||
23473523|NCT00689117|65477603|FG000|Overall Study|Fear of Birth Defects|0|||
23473524|NCT00689117|65477604|FG001|Overall Study|Fear of Birth Defects|0|||
23190450|NCT00465738|64439397|FG000|Overall Study|Withdrawal by Subject|2|||
23190451|NCT00465738|64439398|FG001|Overall Study|Withdrawal by Subject|0|||
23190452|NCT00465738|64439397|FG000|Overall Study|Other|2|||
23190453|NCT00465738|64439398|FG001|Overall Study|Other|5|||
23190454|NCT02259231|64439399|FG000|Overall Study|Adverse Event|1|||
23473525|NCT00689117|65477605|FG002|Overall Study|Fear of Birth Defects|1|||
23473526|NCT00689117|65477606|FG003|Overall Study|Fear of Birth Defects|0|||
23473527|NCT00689117|65477603|FG000|Overall Study|Transportation|1|||
23473528|NCT00689117|65477604|FG001|Overall Study|Transportation|0|||
23473529|NCT00689117|65477605|FG002|Overall Study|Transportation|0|||
23473530|NCT00689117|65477606|FG003|Overall Study|Transportation|0|||
23473531|NCT00689117|65477603|FG000|Overall Study|Patient Withdrew from Study|0|||
23473532|NCT00689117|65477604|FG001|Overall Study|Patient Withdrew from Study|0|||
23473533|NCT00689117|65477605|FG002|Overall Study|Patient Withdrew from Study|0|||
23473534|NCT00689117|65477606|FG003|Overall Study|Patient Withdrew from Study|1|||
23473535|NCT00689117|65477603|FG000|Overall Study|Personal Reason|0|||
23473536|NCT00689117|65477604|FG001|Overall Study|Personal Reason|1|||
23473537|NCT00689117|65477605|FG002|Overall Study|Personal Reason|0|||
23473538|NCT00689117|65477606|FG003|Overall Study|Personal Reason|0|||
23473539|NCT00689117|65477603|FG000|Overall Study|Dispensing Error|0|||
23473540|NCT00689117|65477604|FG001|Overall Study|Dispensing Error|1|||
23473541|NCT00689117|65477605|FG002|Overall Study|Dispensing Error|0|||
23473542|NCT00689117|65477606|FG003|Overall Study|Dispensing Error|0|||
23473543|NCT04605991|65477607|FG000|Overall Study|Adverse Event|5|||
23473544|NCT04605991|65477607|FG000|Overall Study|Lack of Efficacy|1|||
23473545|NCT04605991|65477607|FG000|Overall Study|Lost to Follow-up|8|||
23473546|NCT04605991|65477607|FG000|Overall Study|Physician Decision|4|||
23473547|NCT04605991|65477607|FG000|Overall Study|Withdrawal by Subject|14|||
23473548|NCT04605991|65477607|FG000|Overall Study|Non-compliance with study|1|||
23473549|NCT02873429|65477608|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
23473550|NCT02873429|65477609|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
23473551|NCT02873429|65477608|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
23473552|NCT02873429|65477609|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
23473553|NCT02873429|65477608|FG000|16 Weeks|Lost to Follow-up|3|||
23473554|NCT02873429|65477609|FG001|16 Weeks|Lost to Follow-up|0|||
23473555|NCT01932437|65477611|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473556|NCT01932437|65477612|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473557|NCT01932437|65477613|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473558|NCT01932437|65477614|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473559|NCT01932437|65477615|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
23473560|NCT01932437|65477616|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
23473561|NCT00096356|65477620|FG000|Overall Study|Adverse Event|11|||
23473562|NCT00096356|65477621|FG001|Overall Study|Adverse Event|9|||
23473563|NCT00096356|65477620|FG000|Overall Study|Physician Decision|5|||
23473564|NCT00096356|65477621|FG001|Overall Study|Physician Decision|3|||
23473565|NCT00096356|65477620|FG000|Overall Study|Withdrawal by Subject|17|||
23473566|NCT00096356|65477621|FG001|Overall Study|Withdrawal by Subject|23|||
23473567|NCT00096356|65477620|FG000|Overall Study|Lack of Efficacy|1|||
23473568|NCT00096356|65477621|FG001|Overall Study|Lack of Efficacy|0|||
23473569|NCT00096356|65477620|FG000|Overall Study|multiple reasons|10|||
23473570|NCT00096356|65477621|FG001|Overall Study|multiple reasons|18|||
23473571|NCT00715910|65477623|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
23473572|NCT00715910|65477624|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
23473573|NCT00715910|65477625|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
23473574|NCT00715910|65477626|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
23473575|NCT00715910|65477627|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
23473576|NCT00715910|65477628|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
23473577|NCT00715910|65477623|FG000|Booster and ESFU Phase|Other|0|||
23250406|NCT01817764|64659747|FG001|Overall Study|Withdrawal by Subject|12|||
23250407|NCT04701658|64659750|FG000|Overall Study|Lost to Follow-up|6|||
23250408|NCT00289731|64659755|FG000|Overall Study|Adverse Event|1|||
23250409|NCT00289731|64659756|FG001|Overall Study|Adverse Event|2|||
23250410|NCT00289731|64659757|FG002|Overall Study|Adverse Event|2|||
23250411|NCT00289731|64659755|FG000|Overall Study|Other|1|||
23473578|NCT00715910|65477624|FG001|Booster and ESFU Phase|Other|0|||
23473579|NCT00715910|65477625|FG002|Booster and ESFU Phase|Other|0|||
23473580|NCT00715910|65477626|FG003|Booster and ESFU Phase|Other|5|||
23473581|NCT00715910|65477627|FG004|Booster and ESFU Phase|Other|1|||
23473582|NCT00715910|65477628|FG005|Booster and ESFU Phase|Other|0|||
23473583|NCT01596062|65477632|FG000|Overall Study|Adverse Event|1|||
23473584|NCT01596062|65477633|FG001|Overall Study|Adverse Event|0|||
23473585|NCT01596062|65477634|FG002|Overall Study|Adverse Event|2|||
23473586|NCT01596062|65477632|FG000|Overall Study|Lack of Efficacy|0|||
23473587|NCT01596062|65477633|FG001|Overall Study|Lack of Efficacy|0|||
23473588|NCT01596062|65477634|FG002|Overall Study|Lack of Efficacy|1|||
23473589|NCT00486811|65477635|FG000|Overall Study|Adverse Event|28|||
23473590|NCT00486811|65477636|FG001|Overall Study|Adverse Event|60|||
23250412|NCT00289731|64659756|FG001|Overall Study|Other|0|||
23473591|NCT00486811|65477637|FG002|Overall Study|Adverse Event|135|||
23473592|NCT00486811|65477635|FG000|Overall Study|Lack of Efficacy|34|||
23473593|NCT00486811|65477636|FG001|Overall Study|Lack of Efficacy|14|||
23190455|NCT02259231|64439400|FG001|Overall Study|Adverse Event|1|||
23190456|NCT02259231|64439401|FG002|Overall Study|Adverse Event|2|||
23190457|NCT02259231|64439402|FG003|Overall Study|Adverse Event|0|||
23190458|NCT02259231|64439403|FG004|Overall Study|Adverse Event|0|||
23190459|NCT02259231|64439404|FG005|Overall Study|Adverse Event|0|||
23190460|NCT02259231|64439405|FG006|Overall Study|Adverse Event|0|||
23190461|NCT02259231|64439399|FG000|Overall Study|Progressive Disease|4|||
23190462|NCT02259231|64439400|FG001|Overall Study|Progressive Disease|5|||
23190463|NCT02259231|64439401|FG002|Overall Study|Progressive Disease|4|||
23473594|NCT00486811|65477637|FG002|Overall Study|Lack of Efficacy|7|||
23473595|NCT00486811|65477635|FG000|Overall Study|Lost to Follow-up|4|||
23473596|NCT00486811|65477636|FG001|Overall Study|Lost to Follow-up|6|||
23473597|NCT00486811|65477637|FG002|Overall Study|Lost to Follow-up|4|||
23473598|NCT00486811|65477635|FG000|Overall Study|Withdrawal by Subject|33|||
23190464|NCT02259231|64439402|FG003|Overall Study|Progressive Disease|5|||
23190465|NCT02259231|64439403|FG004|Overall Study|Progressive Disease|4|||
23190466|NCT02259231|64439404|FG005|Overall Study|Progressive Disease|5|||
23190467|NCT02259231|64439405|FG006|Overall Study|Progressive Disease|4|||
23190468|NCT02259231|64439399|FG000|Overall Study|Sponsor termination of study|1|||
23190469|NCT02259231|64439400|FG001|Overall Study|Sponsor termination of study|0|||
23473599|NCT00486811|65477636|FG001|Overall Study|Withdrawal by Subject|44|||
23473600|NCT00486811|65477637|FG002|Overall Study|Withdrawal by Subject|58|||
23473601|NCT00486811|65477635|FG000|Overall Study|Study drug non-compliant|5|||
23473602|NCT00486811|65477636|FG001|Overall Study|Study drug non-compliant|6|||
23473603|NCT00486811|65477637|FG002|Overall Study|Study drug non-compliant|3|||
23473604|NCT00486811|65477635|FG000|Overall Study|All other|18|||
23473605|NCT00486811|65477636|FG001|Overall Study|All other|11|||
23473606|NCT00486811|65477637|FG002|Overall Study|All other|7|||
23473607|NCT01808092|65477642|FG000|Overall Study|Death|39|||
23473608|NCT01808092|65477643|FG001|Overall Study|Death|29|||
23473609|NCT01808092|65477642|FG000|Overall Study|Lost to Follow-up|3|||
23473610|NCT01808092|65477643|FG001|Overall Study|Lost to Follow-up|7|||
23473611|NCT01808092|65477642|FG000|Overall Study|Withdrawal by Subject|9|||
23473612|NCT01808092|65477643|FG001|Overall Study|Withdrawal by Subject|4|||
23473613|NCT01808092|65477642|FG000|Overall Study|Other Eligibility criteria|3|||
23473614|NCT01808092|65477643|FG001|Overall Study|Other Eligibility criteria|5|||
23473615|NCT02102204|65477644|FG000|Overall Study|Withdrawal by Subject|137|||
23473616|NCT02102204|65477644|FG000|Overall Study|Death|92|||
23473617|NCT02102204|65477644|FG000|Overall Study|Lost to Follow-up|65|||
23473618|NCT02102204|65477644|FG000|Overall Study|Sponsor Decision|5|||
23473619|NCT02102204|65477644|FG000|Overall Study|Ongoing|5|||
23473620|NCT00955305|65477646|FG000|Overall Study|Disease progression|39|||
23473621|NCT00955305|65477647|FG001|Overall Study|Disease progression|41|||
23473622|NCT00955305|65477646|FG000|Overall Study|Adverse Event|22|||
23473623|NCT00955305|65477647|FG001|Overall Study|Adverse Event|22|||
23473624|NCT00955305|65477646|FG000|Overall Study|Death|2|||
23588862|NCT01393119|65882231|FG003|Overall Study|Sponsor Termination of Study|12|||
23588863|NCT05136443|65882236|FG000|Overall Study|Lost to Follow-up|2|||
23588864|NCT05136443|65882236|FG000|Overall Study|Adverse Event|2|||
23588865|NCT02248480|65882240|FG000|Overall Study|Lack of Efficacy|4|||
23588866|NCT02248480|65882241|FG001|Overall Study|Lack of Efficacy|6|||
23588867|NCT02248480|65882240|FG000|Overall Study|Adverse Event|11|||
23588868|NCT02248480|65882241|FG001|Overall Study|Adverse Event|2|||
23588869|NCT02248480|65882240|FG000|Overall Study|Withdrawal by Subject|2|||
23588870|NCT02248480|65882241|FG001|Overall Study|Withdrawal by Subject|4|||
23588871|NCT02248480|65882240|FG000|Overall Study|Entry Criteria Not Met|0|||
23588872|NCT02248480|65882241|FG001|Overall Study|Entry Criteria Not Met|1|||
23588873|NCT02248480|65882240|FG000|Overall Study|Other:Physician Decision|0|||
23473625|NCT00955305|65477647|FG001|Overall Study|Death|1|||
23473626|NCT00955305|65477646|FG000|Overall Study|Withdrawal by Subject|5|||
23473627|NCT00955305|65477647|FG001|Overall Study|Withdrawal by Subject|4|||
23473628|NCT00955305|65477646|FG000|Overall Study|Alternative therapy|4|||
23473629|NCT00955305|65477647|FG001|Overall Study|Alternative therapy|0|||
23473630|NCT00955305|65477646|FG000|Overall Study|Other complicating disease|2|||
23473631|NCT00955305|65477647|FG001|Overall Study|Other complicating disease|4|||
23588874|NCT02248480|65882241|FG001|Overall Study|Other:Physician Decision|1|||
23588875|NCT02770248|65882242|FG000|Overall Study|Adverse Event|0|||
23250413|NCT00289731|64659757|FG002|Overall Study|Other|0|||
23473632|NCT00955305|65477646|FG000|Overall Study|Physician Decision|1|||
23473633|NCT00955305|65477647|FG001|Overall Study|Physician Decision|0|||
23473634|NCT00955305|65477646|FG000|Overall Study|Continued presence of residual disease|0|||
23190470|NCT02259231|64439401|FG002|Overall Study|Sponsor termination of study|0|||
23190471|NCT02259231|64439402|FG003|Overall Study|Sponsor termination of study|1|||
23190472|NCT02259231|64439403|FG004|Overall Study|Sponsor termination of study|2|||
23190473|NCT02259231|64439404|FG005|Overall Study|Sponsor termination of study|1|||
23190474|NCT02259231|64439405|FG006|Overall Study|Sponsor termination of study|1|||
23190475|NCT01491945|64439406|FG000|Overall Study|Death|30|||
23473635|NCT00955305|65477647|FG001|Overall Study|Continued presence of residual disease|1|||
23473636|NCT00955305|65477646|FG000|Overall Study|Functional decline|2|||
23473637|NCT00955305|65477647|FG001|Overall Study|Functional decline|0|||
23473638|NCT00955305|65477646|FG000|Overall Study|Maximum response achieved|0|||
23473639|NCT00955305|65477647|FG001|Overall Study|Maximum response achieved|1|||
23473640|NCT00955305|65477646|FG000|Overall Study|Lost to Follow-up|0|||
23473641|NCT00955305|65477647|FG001|Overall Study|Lost to Follow-up|1|||
23473642|NCT00955305|65477646|FG000|Overall Study|No off-treatment reason submitted|1|||
23190476|NCT01491945|64439406|FG000|Overall Study|Withdrwan/LTF|16|||
23190477|NCT01491945|64439406|FG000|Overall Study|Conversion|4|||
23190478|NCT01491945|64439406|FG000|Overall Study|Missed Visit|1|||
23190479|NCT01520922|64439407|FG000|Treatment Phase|Physician Decision|2|||
23190480|NCT01520922|64439408|FG001|Treatment Phase|Physician Decision|1|||
23190481|NCT01520922|64439407|FG000|Treatment Phase|Progression|0|||
23190482|NCT01520922|64439408|FG001|Treatment Phase|Progression|2|||
23190483|NCT01520922|64439407|FG000|Treatment Phase|Adverse Event|3|||
23190484|NCT01520922|64439408|FG001|Treatment Phase|Adverse Event|5|||
23190485|NCT01520922|64439407|FG000|Follow up|Lost to Follow-up|0|||
23190486|NCT01520922|64439408|FG001|Follow up|Lost to Follow-up|1|||
23190487|NCT01520922|64439407|FG000|Survival Follow-up|Withdrawal by Subject|1|||
23190488|NCT01520922|64439408|FG001|Survival Follow-up|Withdrawal by Subject|0|||
23473643|NCT00955305|65477647|FG001|Overall Study|No off-treatment reason submitted|0|||
23473644|NCT00955305|65477646|FG000|Overall Study|Never started protocol treatment|5|||
23473645|NCT00955305|65477647|FG001|Overall Study|Never started protocol treatment|5|||
23473646|NCT00955305|65477646|FG000|Overall Study|Ineligible|5|||
23473647|NCT00955305|65477647|FG001|Overall Study|Ineligible|7|||
23473648|NCT00702715|65477648|FG000|Overall Study|Lost to Follow-up|1|||
23473649|NCT00702715|65477649|FG001|Overall Study|Lost to Follow-up|0|||
23473650|NCT01546623|65477650|FG000|Overall Study|Adverse Event|2|||
23473651|NCT01546623|65477651|FG001|Overall Study|Adverse Event|3|||
23473652|NCT01546623|65477650|FG000|Overall Study|Major Protocol Deviation|1|||
23473653|NCT01546623|65477651|FG001|Overall Study|Major Protocol Deviation|1|||
23473654|NCT01546623|65477650|FG000|Overall Study|High Prostate specific antigen|2|||
23473655|NCT01546623|65477651|FG001|Overall Study|High Prostate specific antigen|1|||
23473656|NCT01546623|65477650|FG000|Overall Study|Did Not Receive Study Drug|1|||
23190489|NCT00728416|64439411|FG000|Overall Study|Adverse Event|1|||
23190490|NCT00728416|64439412|FG001|Overall Study|Adverse Event|1|||
23190491|NCT00728416|64439411|FG000|Overall Study|Treatment Failure|0|||
23473657|NCT01546623|65477651|FG001|Overall Study|Did Not Receive Study Drug|1|||
23190492|NCT00728416|64439412|FG001|Overall Study|Treatment Failure|1|||
23190493|NCT00728416|64439411|FG000|Overall Study|Withdrawal by Subject|1|||
23250414|NCT00929864|64659760|FG000|Overall Study|Death|1|||
23250415|NCT00929864|64659761|FG001|Overall Study|Death|1|||
23250416|NCT00929864|64659760|FG000|Overall Study|Adverse Event|11|||
23250417|NCT00929864|64659761|FG001|Overall Study|Adverse Event|30|||
23250418|NCT00929864|64659760|FG000|Overall Study|Lack of Efficacy|19|||
23473658|NCT00862641|65477654|FG000|Overall Study|Randomized, but drug not received|1|||
23473659|NCT00862641|65477655|FG001|Overall Study|Randomized, but drug not received|4|||
23473660|NCT00862641|65477656|FG002|Overall Study|Randomized, but drug not received|1|||
23473661|NCT00862641|65477657|FG003|Overall Study|Randomized, but drug not received|4|||
23473662|NCT00246740|65477660|FG000|Initial Enrollment|Death|1|||
23473663|NCT00246740|65477661|FG001|Initial Enrollment|Death|0|||
23473664|NCT00246740|65477660|FG000|Initial Enrollment|Additional surgery scheduled|0|||
23473665|NCT00246740|65477661|FG001|Initial Enrollment|Additional surgery scheduled|2|||
23473666|NCT00246740|65477660|FG000|Initial Enrollment|Surgery schedule change|4|||
23473667|NCT00246740|65477661|FG001|Initial Enrollment|Surgery schedule change|4|||
23473668|NCT00246740|65477660|FG000|Initial Enrollment|Other|1|||
23473669|NCT00246740|65477661|FG001|Initial Enrollment|Other|2|||
23473670|NCT02365480|65477662|FG000|Overall Study|Withdrawal by Subject|2|||
23473671|NCT02365480|65477663|FG001|Overall Study|Withdrawal by Subject|0|||
23473672|NCT01137604|65477666|FG000|Overall Study|Adverse Event|3|||
23473673|NCT01137604|65477667|FG001|Overall Study|Adverse Event|6|||
23473674|NCT01137604|65477668|FG002|Overall Study|Adverse Event|9|||
23473675|NCT01137604|65477669|FG003|Overall Study|Adverse Event|9|||
23473676|NCT01137604|65477666|FG000|Overall Study|Participant Choice|0|||
23473677|NCT01137604|65477667|FG001|Overall Study|Participant Choice|2|||
23473678|NCT01137604|65477668|FG002|Overall Study|Participant Choice|2|||
23473679|NCT01137604|65477669|FG003|Overall Study|Participant Choice|0|||
23473680|NCT01137604|65477666|FG000|Overall Study|Withdrawal of consent|0|||
23473681|NCT01137604|65477667|FG001|Overall Study|Withdrawal of consent|0|||
23473682|NCT01137604|65477668|FG002|Overall Study|Withdrawal of consent|0|||
23473683|NCT01137604|65477669|FG003|Overall Study|Withdrawal of consent|2|||
23473684|NCT01137604|65477666|FG000|Overall Study|Clinical progression/deterioration|1|||
23473685|NCT01137604|65477667|FG001|Overall Study|Clinical progression/deterioration|2|||
23473686|NCT01137604|65477668|FG002|Overall Study|Clinical progression/deterioration|2|||
23473687|NCT01137604|65477669|FG003|Overall Study|Clinical progression/deterioration|0|||
23473688|NCT01388985|65477672|FG000|Overall Study|Death|0|||
23473689|NCT01388985|65477673|FG001|Overall Study|Death|1|||
23473690|NCT01388985|65477672|FG000|Overall Study|Lost to Follow-up|30|||
23473691|NCT01388985|65477673|FG001|Overall Study|Lost to Follow-up|30|||
23473692|NCT01388985|65477672|FG000|Overall Study|Withdrawal by Subject|13|||
23473693|NCT01388985|65477673|FG001|Overall Study|Withdrawal by Subject|4|||
23473694|NCT01388985|65477672|FG000|Overall Study|Subject unavailable|1|||
23473695|NCT01388985|65477673|FG001|Overall Study|Subject unavailable|1|||
23473696|NCT01388985|65477672|FG000|Overall Study|Other (no reason)|0|||
23473697|NCT01388985|65477673|FG001|Overall Study|Other (no reason)|1|||
23473698|NCT01388985|65477672|FG000|Overall Study|Error of nurse|5|||
23250419|NCT00929864|64659761|FG001|Overall Study|Lack of Efficacy|16|||
23250420|NCT00929864|64659760|FG000|Overall Study|Lost to Follow-up|7|||
23250421|NCT00929864|64659761|FG001|Overall Study|Lost to Follow-up|12|||
23357136|NCT01687283|65052691|FG001|Overall Study|Adverse Event|4|||
23357137|NCT01687283|65052690|FG000|Overall Study|Lack of Efficacy|3|||
23357138|NCT01687283|65052691|FG001|Overall Study|Lack of Efficacy|1|||
23357139|NCT01687283|65052690|FG000|Overall Study|Protocol Violation|1|||
23357140|NCT01687283|65052691|FG001|Overall Study|Protocol Violation|3|||
23357141|NCT01687283|65052690|FG000|Overall Study|protocol defined stopping criteria|8|||
23357142|NCT01687283|65052691|FG001|Overall Study|protocol defined stopping criteria|10|||
23357143|NCT01687283|65052690|FG000|Overall Study|Lost to Follow-up|1|||
23357144|NCT01687283|65052691|FG001|Overall Study|Lost to Follow-up|1|||
23357145|NCT01687283|65052690|FG000|Overall Study|Investigator discretion|2|||
23357146|NCT01687283|65052691|FG001|Overall Study|Investigator discretion|0|||
23357147|NCT01687283|65052690|FG000|Overall Study|Withdrawal by Subject|9|||
23357148|NCT01687283|65052691|FG001|Overall Study|Withdrawal by Subject|8|||
23357149|NCT01148459|65052692|FG000|Overall Study|Serious Adverse Event|5|||
23357150|NCT01148459|65052693|FG001|Overall Study|Serious Adverse Event|4|||
23357151|NCT01148459|65052692|FG000|Overall Study|Withdrawal by Subject|1|||
23357152|NCT01148459|65052693|FG001|Overall Study|Withdrawal by Subject|0|||
23357153|NCT01148459|65052692|FG000|Overall Study|Migrated/moved from study area|3|||
23357154|NCT01148459|65052693|FG001|Overall Study|Migrated/moved from study area|6|||
23357155|NCT01148459|65052692|FG000|Overall Study|Lost to Follow-up|2|||
23357156|NCT01148459|65052693|FG001|Overall Study|Lost to Follow-up|0|||
23357157|NCT01148459|65052692|FG000|Overall Study|Refusal|1|||
23357158|NCT01148459|65052693|FG001|Overall Study|Refusal|0|||
23357159|NCT01148459|65052692|FG000|Overall Study|Failure to comply with study procedures|0|||
23357160|NCT01148459|65052693|FG001|Overall Study|Failure to comply with study procedures|1|||
23357161|NCT00493311|65052702|FG000|Overall Study|Need for rescue medication|2|||
23357162|NCT00493311|65052703|FG001|Overall Study|Need for rescue medication|2|||
23357163|NCT04854057|65052704|FG000|Overall Study|Adverse Event|0|||
23357164|NCT04854057|65052705|FG001|Overall Study|Adverse Event|1|||
23357165|NCT03423147|65052706|FG000|Overall Study|Lost to Follow-up|5|||
23357166|NCT03423147|65052707|FG001|Overall Study|Lost to Follow-up|8|||
23357167|NCT03423147|65052706|FG000|Overall Study|Withdrawal by Subject|1|||
23357168|NCT03423147|65052707|FG001|Overall Study|Withdrawal by Subject|0|||
23357169|NCT03423147|65052706|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
23357170|NCT03423147|65052707|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
23357171|NCT03423147|65052706|FG000|Overall Study|Age < 18|1|||
23357172|NCT03423147|65052707|FG001|Overall Study|Age < 18|0|||
23357173|NCT03423147|65052706|FG000|Overall Study|No Trial of Labor|0|||
23357174|NCT03423147|65052707|FG001|Overall Study|No Trial of Labor|1|||
23473699|NCT01388985|65477673|FG001|Overall Study|Error of nurse|1|||
23473700|NCT01134705|65477674|FG000|Overall Study|Adverse Event|1|||
23190494|NCT00728416|64439412|FG001|Overall Study|Withdrawal by Subject|0|||
23190495|NCT00064701|64439416|FG000|One Year Post-transplant|Did not receive study drug|7|||
23190496|NCT00064701|64439417|FG001|One Year Post-transplant|Did not receive study drug|12|||
23190497|NCT00064701|64439418|FG002|One Year Post-transplant|Did not receive study drug|11|||
23190498|NCT00064701|64439416|FG000|One Year Post-transplant|Adverse Event|23|||
23190499|NCT00064701|64439417|FG001|One Year Post-transplant|Adverse Event|19|||
23190500|NCT00064701|64439418|FG002|One Year Post-transplant|Adverse Event|37|||
23190501|NCT00064701|64439416|FG000|One Year Post-transplant|Rejection|0|||
23190502|NCT00064701|64439417|FG001|One Year Post-transplant|Rejection|1|||
23190503|NCT00064701|64439418|FG002|One Year Post-transplant|Rejection|16|||
23190504|NCT00064701|64439416|FG000|One Year Post-transplant|Non-compliance|4|||
23190505|NCT00064701|64439417|FG001|One Year Post-transplant|Non-compliance|2|||
23190506|NCT00064701|64439418|FG002|One Year Post-transplant|Non-compliance|5|||
23190507|NCT00064701|64439416|FG000|One Year Post-transplant|Graft Failure|3|||
23190508|NCT00064701|64439417|FG001|One Year Post-transplant|Graft Failure|2|||
23190509|NCT00064701|64439418|FG002|One Year Post-transplant|Graft Failure|1|||
23190510|NCT00064701|64439416|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
23190511|NCT00064701|64439417|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
23190512|NCT00064701|64439418|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
23190513|NCT00064701|64439416|FG000|One Year Post-transplant|Lost to Follow-up|1|||
23190514|NCT00064701|64439417|FG001|One Year Post-transplant|Lost to Follow-up|0|||
23190515|NCT00064701|64439418|FG002|One Year Post-transplant|Lost to Follow-up|0|||
23190516|NCT00064701|64439416|FG000|One Year Post-transplant|Converted to rapamycin|1|||
23190517|NCT00064701|64439417|FG001|One Year Post-transplant|Converted to rapamycin|0|||
23473701|NCT01134705|65477675|FG001|Overall Study|Adverse Event|7|||
23190518|NCT00064701|64439418|FG002|One Year Post-transplant|Converted to rapamycin|0|||
23190519|NCT00064701|64439416|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
23190520|NCT00064701|64439417|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
23190521|NCT00064701|64439418|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
23190522|NCT00064701|64439416|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
23357175|NCT00069823|65052712|FG000|Overall Study|Did not have follow-up diary cards|6|||
23357176|NCT00069823|65052713|FG001|Overall Study|Did not have follow-up diary cards|3|||
23357177|NCT01370616|65052714|FG000|Overall Study|Adverse Event|11|||
23357178|NCT01370616|65052715|FG001|Overall Study|Adverse Event|16|||
23250422|NCT00929864|64659760|FG000|Overall Study|Withdrawal by Subject|20|||
23250423|NCT00929864|64659761|FG001|Overall Study|Withdrawal by Subject|9|||
23588876|NCT02770248|65882243|FG001|Overall Study|Adverse Event|1|||
23357179|NCT01370616|65052714|FG000|Overall Study|Death|1|||
23357180|NCT01370616|65052715|FG001|Overall Study|Death|0|||
23357181|NCT01370616|65052714|FG000|Overall Study|Lack of Efficacy|6|||
23357182|NCT01370616|65052715|FG001|Overall Study|Lack of Efficacy|2|||
23357183|NCT01370616|65052714|FG000|Overall Study|Lost to Follow-up|0|||
23357184|NCT01370616|65052715|FG001|Overall Study|Lost to Follow-up|3|||
23357185|NCT01370616|65052714|FG000|Overall Study|Physician Decision|6|||
23357186|NCT01370616|65052715|FG001|Overall Study|Physician Decision|6|||
23357187|NCT01370616|65052714|FG000|Overall Study|Progressive Disease|0|||
23357188|NCT01370616|65052715|FG001|Overall Study|Progressive Disease|1|||
23357189|NCT01370616|65052714|FG000|Overall Study|Recovery|1|||
23357190|NCT01370616|65052715|FG001|Overall Study|Recovery|0|||
23357191|NCT01370616|65052714|FG000|Overall Study|Technical Problems|3|||
23357192|NCT01370616|65052715|FG001|Overall Study|Technical Problems|5|||
23357193|NCT01370616|65052714|FG000|Overall Study|Withdrawal by Subject|34|||
23357194|NCT01370616|65052715|FG001|Overall Study|Withdrawal by Subject|34|||
23357195|NCT02020512|65052717|FG000|Overall Study|Adverse Event|1|||
23357196|NCT02020512|65052717|FG000|Overall Study|Lost to Follow-up|3|||
23357197|NCT02020512|65052717|FG000|Overall Study|Protocol Violation|4|||
23357198|NCT02933528|65052718|FG000|Overall Study|Lost to Follow-up|2|||
23357199|NCT03628716|65052719|FG000|Overall Study|Adverse Event|1|||
23357200|NCT03628716|65052720|FG001|Overall Study|Adverse Event|1|||
23357201|NCT03628716|65052719|FG000|Overall Study|Death|1|||
23357202|NCT03628716|65052720|FG001|Overall Study|Death|0|||
23357203|NCT03628716|65052719|FG000|Overall Study|Lack of Efficacy|15|||
23357204|NCT03628716|65052720|FG001|Overall Study|Lack of Efficacy|20|||
23357205|NCT03628716|65052719|FG000|Overall Study|Withdrawal by Subject|1|||
23357206|NCT03628716|65052720|FG001|Overall Study|Withdrawal by Subject|2|||
23588877|NCT02770248|65882242|FG000|Overall Study|Randomized in error, prior to treatment|0|||
23588878|NCT02770248|65882243|FG001|Overall Study|Randomized in error, prior to treatment|1|||
23588879|NCT03993392|65882249|FG000|Overall Study|Withdrawal by Subject|3|||
23588880|NCT03993392|65882249|FG000|Overall Study|Lost to Follow-up|2|||
23588881|NCT03993392|65882249|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
23588882|NCT01183780|65882253|FG000|Overall Study|Withdrawal by Subject|25|||
23588883|NCT01183780|65882254|FG001|Overall Study|Withdrawal by Subject|14|||
23588884|NCT01183780|65882253|FG000|Overall Study|Lost to Follow-up|6|||
23588885|NCT01183780|65882254|FG001|Overall Study|Lost to Follow-up|11|||
23588886|NCT01196429|65882255|FG000|Overall Study|Ineligible - inadequate pathology|1|||
23588887|NCT01196429|65882256|FG001|Overall Study|Ineligible - inadequate pathology|0|||
23588888|NCT01196429|65882255|FG000|Overall Study|Ineligible - wrong cell type|1|||
23190523|NCT00064701|64439417|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
23190524|NCT00064701|64439418|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
23250424|NCT00929864|64659760|FG000|Overall Study|No longer met criteria|2|||
23250425|NCT00929864|64659761|FG001|Overall Study|No longer met criteria|1|||
23250426|NCT00929864|64659760|FG000|Overall Study|Poor or non-compliance|3|||
23588889|NCT01196429|65882256|FG001|Overall Study|Ineligible - wrong cell type|0|||
23190525|NCT00064701|64439416|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
23190526|NCT00064701|64439417|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
23190527|NCT00064701|64439418|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
23190528|NCT00064701|64439416|FG000|One Year Post-transplant|Poor absorption|0|||
23190529|NCT00064701|64439417|FG001|One Year Post-transplant|Poor absorption|1|||
23190530|NCT00064701|64439418|FG002|One Year Post-transplant|Poor absorption|0|||
23190531|NCT00064701|64439416|FG000|One Year Post-transplant|Pancreas transplant|0|||
23190532|NCT00064701|64439417|FG001|One Year Post-transplant|Pancreas transplant|0|||
23190533|NCT00064701|64439418|FG002|One Year Post-transplant|Pancreas transplant|1|||
23190534|NCT00064701|64439416|FG000|Clinical Continuation Phase|Adverse Event|12|||
23190535|NCT00064701|64439417|FG001|Clinical Continuation Phase|Adverse Event|21|||
23190536|NCT00064701|64439418|FG002|Clinical Continuation Phase|Adverse Event|14|||
23190537|NCT00064701|64439416|FG000|Clinical Continuation Phase|Non-compliance|8|||
23190538|NCT00064701|64439417|FG001|Clinical Continuation Phase|Non-compliance|6|||
23190539|NCT00064701|64439418|FG002|Clinical Continuation Phase|Non-compliance|7|||
23357207|NCT03628716|65052719|FG000|Overall Study|Study Terminated by Sponsor|1|||
23357208|NCT03628716|65052720|FG001|Overall Study|Study Terminated by Sponsor|0|||
23190540|NCT00064701|64439416|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
23190541|NCT00064701|64439417|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
23250427|NCT00929864|64659761|FG001|Overall Study|Poor or non-compliance|3|||
23250428|NCT00929864|64659760|FG000|Overall Study|Pregnancy|0|||
23357209|NCT01502956|65052722|FG000|Overall Study|Death|0|||
23357210|NCT01502956|65052723|FG001|Overall Study|Death|2|||
23357211|NCT01502956|65052722|FG000|Overall Study|Lost to Follow-up|14|||
23357212|NCT01502956|65052723|FG001|Overall Study|Lost to Follow-up|11|||
23357213|NCT01502956|65052722|FG000|Overall Study|Physician Decision|2|||
23190542|NCT00064701|64439418|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
23190543|NCT00064701|64439416|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
23190544|NCT00064701|64439417|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
23190545|NCT00064701|64439418|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
23357214|NCT01502956|65052723|FG001|Overall Study|Physician Decision|3|||
23357215|NCT01502956|65052722|FG000|Overall Study|Withdrawal by Subject|8|||
23357216|NCT01502956|65052723|FG001|Overall Study|Withdrawal by Subject|10|||
23190546|NCT00064701|64439416|FG000|Clinical Continuation Phase|Graft Failure|5|||
23190547|NCT00064701|64439417|FG001|Clinical Continuation Phase|Graft Failure|5|||
23190548|NCT00064701|64439418|FG002|Clinical Continuation Phase|Graft Failure|2|||
23357217|NCT05114564|65052724|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
23357218|NCT05114564|65052725|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
23357219|NCT05114564|65052724|FG000|First Intervention|Adverse Event|0|||
23588890|NCT01196429|65882255|FG000|Overall Study|Refused - Never Treated|1|||
23588891|NCT01196429|65882256|FG001|Overall Study|Refused - Never Treated|0|||
23588892|NCT01697319|65882257|FG000|Primary Phase|Withdrawal by Subject|1|||
23588893|NCT01697319|65882257|FG000|Extension Phase|Terminated by Sponsor|15|||
23588894|NCT01560949|65882258|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
23588895|NCT01560949|65882258|FG000|Surgery Phase|Physician Decision|3|||
23588896|NCT00880906|65882259|FG000|Overall Study|Lost to Follow-up|0|||
23588897|NCT00880906|65882260|FG001|Overall Study|Lost to Follow-up|1|||
23588898|NCT00880906|65882259|FG000|Overall Study|Did not meet criteria following patholog|12|||
23588899|NCT00880906|65882260|FG001|Overall Study|Did not meet criteria following patholog|6|||
23588900|NCT03181958|65882264|FG000|Overall Study|Lost to Follow-up|17|||
23588901|NCT03181958|65882265|FG001|Overall Study|Lost to Follow-up|21|||
23588902|NCT03181958|65882266|FG002|Overall Study|Lost to Follow-up|15|||
23588903|NCT03394027|65882267|FG000|Overall Study|Ineligible|3|||
23190549|NCT00064701|64439416|FG000|Clinical Continuation Phase|Rejection|1|||
23190550|NCT00064701|64439417|FG001|Clinical Continuation Phase|Rejection|2|||
23190551|NCT00064701|64439418|FG002|Clinical Continuation Phase|Rejection|2|||
23250429|NCT00929864|64659761|FG001|Overall Study|Pregnancy|3|||
23250430|NCT00929864|64659760|FG000|Overall Study|Administrative reason by Sponsor|1|||
23250431|NCT00929864|64659761|FG001|Overall Study|Administrative reason by Sponsor|1|||
23588904|NCT03394027|65882268|FG001|Overall Study|Ineligible|1|||
23357220|NCT05114564|65052725|FG001|First Intervention|Adverse Event|1|||
23357221|NCT01134393|65052727|FG000|Overall Study|Adverse Event|18|||
23357222|NCT01134393|65052727|FG000|Overall Study|Lack of Efficacy|2|||
23357223|NCT01134393|65052727|FG000|Overall Study|Protocol Violation|12|||
23357224|NCT01134393|65052727|FG000|Overall Study|Lost to Follow-up|3|||
23357225|NCT01134393|65052727|FG000|Overall Study|Withdrawal by Subject|11|||
23357226|NCT01134393|65052727|FG000|Overall Study|Other|6|||
23357227|NCT00703118|65052728|FG000|Overall Study|Adverse Event|1|||
23357228|NCT00703118|65052729|FG001|Overall Study|Adverse Event|2|||
23357229|NCT00703118|65052730|FG002|Overall Study|Adverse Event|2|||
23357230|NCT00703118|65052728|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
23357231|NCT00703118|65052729|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
23357232|NCT00703118|65052730|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
23357233|NCT00703118|65052728|FG000|Overall Study|Lost to Follow-up|6|||
23357234|NCT00703118|65052729|FG001|Overall Study|Lost to Follow-up|4|||
23357235|NCT00703118|65052730|FG002|Overall Study|Lost to Follow-up|4|||
23357236|NCT00703118|65052728|FG000|Overall Study|Withdrawal by Subject|8|||
23357237|NCT00703118|65052729|FG001|Overall Study|Withdrawal by Subject|7|||
23357238|NCT00703118|65052730|FG002|Overall Study|Withdrawal by Subject|13|||
23357239|NCT00703118|65052728|FG000|Overall Study|Other|0|||
23357240|NCT00703118|65052729|FG001|Overall Study|Other|0|||
23357241|NCT00703118|65052730|FG002|Overall Study|Other|1|||
23357242|NCT02401035|65052733|FG000|Overall Study|Withdrawal by Subject|1|||
23357243|NCT02401035|65052734|FG001|Overall Study|Withdrawal by Subject|0|||
23357244|NCT03754972|65052735|FG000|Overall Study|Protocol Violation|25|||
23357245|NCT03539484|65052736|FG000|Overall Study|Death|1|||
23357246|NCT03539484|65052737|FG001|Overall Study|Death|0|||
23357247|NCT03539484|65052738|FG002|Overall Study|Death|0|||
23357248|NCT03539484|65052739|FG003|Overall Study|Death|2|||
23250432|NCT00929864|64659760|FG000|Overall Study|Non-specified|2|||
23250433|NCT00929864|64659761|FG001|Overall Study|Non-specified|7|||
23250434|NCT00990093|64659770|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
23250435|NCT00990093|64659771|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
23250436|NCT00990093|64659770|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
23250437|NCT00990093|64659771|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
23250438|NCT00990093|64659770|FG000|Test Period 1 (1-14 Days)|Other|1|||
23250439|NCT00990093|64659771|FG001|Test Period 1 (1-14 Days)|Other|0|||
23250440|NCT00990093|64659770|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
23250441|NCT00990093|64659771|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
23250442|NCT00990093|64659770|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
23250443|NCT00990093|64659771|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
23250444|NCT00990093|64659770|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
23250445|NCT00990093|64659771|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
23250446|NCT00990093|64659770|FG000|Test Period 2 (15-28 Days)|Other|0|||
23250447|NCT00990093|64659771|FG001|Test Period 2 (15-28 Days)|Other|1|||
23250448|NCT03496207|64659774|FG000|Base Study|Adverse Event|0|||
23250449|NCT03496207|64659775|FG001|Base Study|Adverse Event|0|||
23250450|NCT03496207|64659776|FG002|Base Study|Adverse Event|1|||
23250451|NCT03496207|64659777|FG003|Base Study|Adverse Event|1|||
23250452|NCT03496207|64659778|FG004|Base Study|Adverse Event|4|||
23250453|NCT03496207|64659774|FG000|Base Study|Death|0|||
23250454|NCT03496207|64659775|FG001|Base Study|Death|0|||
23250455|NCT03496207|64659776|FG002|Base Study|Death|0|||
23250456|NCT03496207|64659777|FG003|Base Study|Death|0|||
23250457|NCT03496207|64659778|FG004|Base Study|Death|1|||
23250458|NCT03496207|64659774|FG000|Base Study|Withdrawal by Subject|0|||
23250459|NCT03496207|64659775|FG001|Base Study|Withdrawal by Subject|0|||
23250460|NCT03496207|64659776|FG002|Base Study|Withdrawal by Subject|1|||
23250461|NCT03496207|64659777|FG003|Base Study|Withdrawal by Subject|0|||
23250462|NCT03496207|64659778|FG004|Base Study|Withdrawal by Subject|1|||
23250463|NCT03496207|64659774|FG000|Extension Period|Adverse Event|0|||
23588905|NCT03394027|65882269|FG002|Overall Study|Ineligible|3|||
23250464|NCT03496207|64659775|FG001|Extension Period|Adverse Event|0|||
23250465|NCT03496207|64659776|FG002|Extension Period|Adverse Event|0|||
23250466|NCT03496207|64659777|FG003|Extension Period|Adverse Event|1|||
23250467|NCT03496207|64659778|FG004|Extension Period|Adverse Event|1|||
23250468|NCT03496207|64659774|FG000|Extension Period|Death|1|||
23250469|NCT03496207|64659775|FG001|Extension Period|Death|0|||
23250470|NCT03496207|64659776|FG002|Extension Period|Death|0|||
23250471|NCT03496207|64659777|FG003|Extension Period|Death|1|||
23250472|NCT03496207|64659778|FG004|Extension Period|Death|2|||
23250473|NCT03496207|64659774|FG000|Extension Period|Withdrawal by Subject|1|||
23250474|NCT03496207|64659775|FG001|Extension Period|Withdrawal by Subject|0|||
23250475|NCT03496207|64659776|FG002|Extension Period|Withdrawal by Subject|0|||
23250476|NCT03496207|64659777|FG003|Extension Period|Withdrawal by Subject|1|||
23357249|NCT03539484|65052740|FG004|Overall Study|Death|8|||
23357250|NCT03539484|65052741|FG005|Overall Study|Death|3|||
23357251|NCT03539484|65052742|FG006|Overall Study|Death|0|||
23357252|NCT03539484|65052736|FG000|Overall Study|Lost to Follow-up|0|||
23357253|NCT03539484|65052737|FG001|Overall Study|Lost to Follow-up|1|||
23357254|NCT03539484|65052738|FG002|Overall Study|Lost to Follow-up|0|||
23250477|NCT03496207|64659778|FG004|Extension Period|Withdrawal by Subject|1|||
23250478|NCT03496207|64659774|FG000|Extension Period|Elevated hemoglobin levels|0|||
23250479|NCT03496207|64659775|FG001|Extension Period|Elevated hemoglobin levels|0|||
23250480|NCT03496207|64659776|FG002|Extension Period|Elevated hemoglobin levels|0|||
23357255|NCT03539484|65052739|FG003|Overall Study|Lost to Follow-up|0|||
23190552|NCT00064701|64439416|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
23190553|NCT00064701|64439417|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
23190554|NCT00064701|64439418|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
23190555|NCT00064701|64439416|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
23190556|NCT00064701|64439417|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
23190557|NCT00064701|64439418|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
23190558|NCT00064701|64439416|FG000|Clinical Continuation Phase|Physician Decision|1|||
23190559|NCT00064701|64439417|FG001|Clinical Continuation Phase|Physician Decision|3|||
23190560|NCT00064701|64439418|FG002|Clinical Continuation Phase|Physician Decision|0|||
23190561|NCT00064701|64439416|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
23190562|NCT00064701|64439417|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
23190563|NCT00064701|64439418|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
23190564|NCT00064701|64439416|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
23190565|NCT00064701|64439417|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
23190566|NCT00064701|64439418|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
23473702|NCT01134705|65477674|FG000|Overall Study|Withdrawal by Subject|6|||
23190567|NCT00064701|64439416|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
23190568|NCT00064701|64439417|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
23190569|NCT00064701|64439418|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
23190570|NCT00064701|64439416|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
23190571|NCT00064701|64439417|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
23190572|NCT00064701|64439418|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
23190573|NCT00064701|64439416|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
23190574|NCT00064701|64439417|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
23190575|NCT00064701|64439418|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
23190576|NCT00064701|64439416|FG000|Clinical Continuation Phase|Patient opted out|0|||
23473703|NCT01134705|65477675|FG001|Overall Study|Withdrawal by Subject|6|||
23473704|NCT01134705|65477674|FG000|Overall Study|Pregnancy|1|||
23473705|NCT01134705|65477675|FG001|Overall Study|Pregnancy|0|||
23473706|NCT01134705|65477674|FG000|Overall Study|Lost to Follow-up|5|||
23473707|NCT01134705|65477675|FG001|Overall Study|Lost to Follow-up|2|||
23473708|NCT01134705|65477674|FG000|Overall Study|Protocol Violation|1|||
23473709|NCT01134705|65477675|FG001|Overall Study|Protocol Violation|1|||
23473710|NCT01134705|65477674|FG000|Overall Study|Other|1|||
23190577|NCT00064701|64439417|FG001|Clinical Continuation Phase|Patient opted out|0|||
23190578|NCT00064701|64439418|FG002|Clinical Continuation Phase|Patient opted out|1|||
23190579|NCT02138110|64439423|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
23190580|NCT02138110|64439423|FG000|Overall Scaffold Implantation|Death|3|||
23190581|NCT04332419|64439424|FG000|Overall Study|Withdrawal by Subject|1|||
23190582|NCT02955186|64439425|FG000|Overall Study|Withdrawal by Subject|6|||
23473711|NCT01134705|65477675|FG001|Overall Study|Other|6|||
23473712|NCT00344487|65477677|FG000|Overall Study|immunologic failure|1|||
23190583|NCT02955186|64439426|FG001|Overall Study|Withdrawal by Subject|2|||
23190584|NCT02955186|64439425|FG000|Overall Study|Protocol Violation|1|||
23190585|NCT02955186|64439426|FG001|Overall Study|Protocol Violation|0|||
23190586|NCT03060577|64439437|FG000|Overall Study|Withdrawal by Subject|25|||
23190587|NCT03060577|64439438|FG001|Overall Study|Withdrawal by Subject|5|||
23190588|NCT03060577|64439437|FG000|Overall Study|Physician Decision|4|||
23190589|NCT03060577|64439438|FG001|Overall Study|Physician Decision|3|||
23190590|NCT03060577|64439437|FG000|Overall Study|Lost to Follow-up|3|||
23190591|NCT03060577|64439438|FG001|Overall Study|Lost to Follow-up|0|||
23190592|NCT03060577|64439437|FG000|Overall Study|Death|7|||
23190593|NCT03060577|64439438|FG001|Overall Study|Death|1|||
23190594|NCT03060577|64439437|FG000|Overall Study|Adverse Event|9|||
23190595|NCT03060577|64439438|FG001|Overall Study|Adverse Event|1|||
23190596|NCT03060577|64439437|FG000|Overall Study|Inclusion/Exclusion|1|||
23190597|NCT03060577|64439438|FG001|Overall Study|Inclusion/Exclusion|0|||
23190598|NCT03060577|64439437|FG000|Overall Study|Other|8|||
23190599|NCT03060577|64439438|FG001|Overall Study|Other|2|||
23190600|NCT01088412|64439439|FG000|Overall Study|Adverse Event|38|||
23190601|NCT01088412|64439440|FG001|Overall Study|Adverse Event|0|||
23190602|NCT01088412|64439441|FG002|Overall Study|Adverse Event|0|||
23190603|NCT01088412|64439439|FG000|Overall Study|Death|42|||
23190604|NCT01088412|64439440|FG001|Overall Study|Death|6|||
23190605|NCT01088412|64439441|FG002|Overall Study|Death|0|||
23190606|NCT01088412|64439439|FG000|Overall Study|Other Reason per Case Report Form|2089|||
23473713|NCT00335764|65477678|FG000|Overall Study|wrong histology|1|||
23473714|NCT00335764|65477679|FG001|Overall Study|wrong histology|0|||
23473715|NCT00335764|65477680|FG002|Overall Study|wrong histology|0|||
23473716|NCT00335764|65477681|FG003|Overall Study|wrong histology|0|||
23473717|NCT00335764|65477682|FG004|Overall Study|wrong histology|1|||
23473718|NCT00934440|65477683|FG000|Overall Study|Lost to Follow-up|1|||
23473719|NCT01363349|65477693|FG000|Overall Study|Adverse Event|6|||
23190607|NCT01088412|64439440|FG001|Overall Study|Other Reason per Case Report Form|103|||
23473720|NCT01363349|65477694|FG001|Overall Study|Adverse Event|7|||
23473721|NCT01363349|65477693|FG000|Overall Study|Lack of Efficacy|3|||
23473722|NCT01363349|65477694|FG001|Overall Study|Lack of Efficacy|10|||
23190608|NCT01088412|64439441|FG002|Overall Study|Other Reason per Case Report Form|9|||
23190609|NCT01088412|64439439|FG000|Overall Study|Withdrawal by Subject|1761|||
23473723|NCT01363349|65477693|FG000|Overall Study|Non compliance/Protocol deviations|2|||
23473724|NCT01363349|65477694|FG001|Overall Study|Non compliance/Protocol deviations|2|||
23473725|NCT01363349|65477693|FG000|Overall Study|Withdrawal by Subject|14|||
23473726|NCT01363349|65477694|FG001|Overall Study|Withdrawal by Subject|6|||
23473727|NCT01363349|65477693|FG000|Overall Study|Lost to Follow-up|5|||
23190610|NCT01088412|64439440|FG001|Overall Study|Withdrawal by Subject|25|||
23190611|NCT01088412|64439441|FG002|Overall Study|Withdrawal by Subject|1|||
23190612|NCT01088412|64439439|FG000|Overall Study|Received Another GH Product|79|||
23190613|NCT01088412|64439440|FG001|Overall Study|Received Another GH Product|0|||
23190614|NCT01088412|64439441|FG002|Overall Study|Received Another GH Product|0|||
23190615|NCT01088412|64439439|FG000|Overall Study|Participant Moved|601|||
23190616|NCT01088412|64439440|FG001|Overall Study|Participant Moved|21|||
23190617|NCT01088412|64439441|FG002|Overall Study|Participant Moved|2|||
23190618|NCT01088412|64439439|FG000|Overall Study|Physician Decision|1041|||
23473728|NCT01363349|65477694|FG001|Overall Study|Lost to Follow-up|6|||
23473729|NCT01363349|65477693|FG000|Overall Study|Not reported|36|||
23473730|NCT01363349|65477694|FG001|Overall Study|Not reported|37|||
23473731|NCT01363349|65477693|FG000|Overall Study|missing|1|||
23473732|NCT01363349|65477694|FG001|Overall Study|missing|2|||
23473733|NCT00552188|65477695|FG000|Overall Study|Adverse Event|0|||
23473734|NCT00552188|65477696|FG001|Overall Study|Adverse Event|2|||
23473735|NCT00552188|65477695|FG000|Overall Study|Lost to Follow-up|2|||
23473736|NCT00552188|65477696|FG001|Overall Study|Lost to Follow-up|1|||
23473737|NCT00552188|65477695|FG000|Overall Study|Withdrawal of consent|0|||
23473738|NCT00552188|65477696|FG001|Overall Study|Withdrawal of consent|1|||
23473739|NCT00552188|65477695|FG000|Overall Study|Subject returned to home country|0|||
23473740|NCT00552188|65477696|FG001|Overall Study|Subject returned to home country|1|||
23473741|NCT01868542|65477697|FG000|Overall Study|Protocol Violation|0|||
23473742|NCT01868542|65477698|FG001|Overall Study|Protocol Violation|1|||
23473743|NCT01868542|65477697|FG000|Overall Study|Unclassified|0|||
23473744|NCT01868542|65477698|FG001|Overall Study|Unclassified|1|||
23473745|NCT03180840|65477702|FG000|Overall Study|Withdrawal by Subject|1|||
23473746|NCT00475306|65477703|FG000|Overall Study|Protocol Violation|1|||
23473747|NCT00475306|65477704|FG001|Overall Study|Protocol Violation|1|||
23473748|NCT00475306|65477705|FG002|Overall Study|Protocol Violation|0|||
23473749|NCT00475306|65477706|FG003|Overall Study|Protocol Violation|1|||
23473750|NCT00743106|65477707|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
23473751|NCT00743106|65477708|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
23473752|NCT04491604|65477709|FG000|Overall Study|Withdrawal by Subject|3|||
23473753|NCT02105662|65477710|FG000|Overall Study|Lost to Follow-up|5|||
23473754|NCT02105662|65477710|FG000|Overall Study|Withdrawal by Subject|1|||
23473755|NCT03087617|65477711|FG000|Overall Study|Lost to Follow-up|32|||
23473756|NCT03087617|65477712|FG001|Overall Study|Lost to Follow-up|30|||
23473757|NCT03087617|65477713|FG002|Overall Study|Lost to Follow-up|30|||
23473758|NCT03087617|65477714|FG003|Overall Study|Lost to Follow-up|39|||
23473759|NCT02565784|65477715|FG000|First Treatment|Adverse Event|1|||
23473760|NCT02565784|65477715|FG000|First Treatment|Withdrawal by Subject|1|||
23473761|NCT02565784|65477715|FG000|Second Treatment|Withdrawal by Subject|2|||
23473762|NCT02160899|65477716|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
23473763|NCT02160899|65477717|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
23473764|NCT02160899|65477718|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
23473765|NCT02160899|65477719|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
23473766|NCT02160899|65477720|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
23473767|NCT02160899|65477721|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
23190619|NCT01088412|64439440|FG001|Overall Study|Physician Decision|8|||
23190620|NCT01088412|64439441|FG002|Overall Study|Physician Decision|4|||
23190621|NCT01088412|64439439|FG000|Overall Study|Sponsor Decision|4467|||
23190622|NCT01088412|64439440|FG001|Overall Study|Sponsor Decision|79|||
23473768|NCT02720042|65477722|FG000|Overall Study|Death|3|||
23473769|NCT02720042|65477722|FG000|Overall Study|Lost to Follow-up|4|||
23473770|NCT02720042|65477722|FG000|Overall Study|Withdrawal by Subject|1|||
23473771|NCT02720042|65477722|FG000|Overall Study|Physician Decision|3|||
23473772|NCT02720042|65477722|FG000|Overall Study|Phasix Mesh explanted|1|||
23473773|NCT02720042|65477722|FG000|Overall Study|unable due to non-study-related illness|3|||
23190623|NCT01088412|64439441|FG002|Overall Study|Sponsor Decision|23|||
23190624|NCT01088412|64439439|FG000|Overall Study|Third Party Required to Change Brand|487|||
23190625|NCT01088412|64439440|FG001|Overall Study|Third Party Required to Change Brand|0|||
23190626|NCT01088412|64439441|FG002|Overall Study|Third Party Required to Change Brand|0|||
23250481|NCT03496207|64659777|FG003|Extension Period|Elevated hemoglobin levels|0|||
23250482|NCT03496207|64659778|FG004|Extension Period|Elevated hemoglobin levels|1|||
23250483|NCT01954082|64659779|FG000|Overall Study|Study Suspension|42|||
23250484|NCT01954082|64659780|FG001|Overall Study|Study Suspension|36|||
23250485|NCT01954082|64659779|FG000|Overall Study|Adverse Event|10|||
23250486|NCT01954082|64659780|FG001|Overall Study|Adverse Event|4|||
23250487|NCT01954082|64659779|FG000|Overall Study|Intolerance|0|||
23250488|NCT01954082|64659780|FG001|Overall Study|Intolerance|1|||
23250489|NCT01954082|64659779|FG000|Overall Study|Non-compliance|6|||
23250490|NCT01954082|64659780|FG001|Overall Study|Non-compliance|4|||
23250491|NCT01954082|64659779|FG000|Overall Study|Physician Decision|2|||
23250492|NCT01954082|64659780|FG001|Overall Study|Physician Decision|0|||
23250493|NCT01954082|64659779|FG000|Overall Study|Parent Decision|1|||
23250494|NCT01954082|64659780|FG001|Overall Study|Parent Decision|0|||
23357256|NCT03539484|65052740|FG004|Overall Study|Lost to Follow-up|1|||
23357257|NCT03539484|65052741|FG005|Overall Study|Lost to Follow-up|0|||
23357258|NCT03539484|65052742|FG006|Overall Study|Lost to Follow-up|0|||
23190627|NCT01088412|64439439|FG000|Overall Study|Lost to Follow-up|3052|||
23190628|NCT01088412|64439440|FG001|Overall Study|Lost to Follow-up|130|||
23190629|NCT01088412|64439441|FG002|Overall Study|Lost to Follow-up|11|||
23190630|NCT01088412|64439439|FG000|Overall Study|Study Summary Not Completed|4360|||
23190631|NCT01088412|64439440|FG001|Overall Study|Study Summary Not Completed|64|||
23190632|NCT01088412|64439441|FG002|Overall Study|Study Summary Not Completed|22|||
23190633|NCT00942708|64439447|FG000|Overall Study|Withdrawal by Subject|1|||
23190634|NCT02750410|64439448|FG000|Double-Blind Treatment Period|Adverse Event|2|||
23190635|NCT02750410|64439449|FG001|Double-Blind Treatment Period|Adverse Event|2|||
23190636|NCT02750410|64439448|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23190637|NCT02750410|64439449|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23190638|NCT02750410|64439448|FG000|Open-Label Extension Period|Adverse Event|5|||
23190639|NCT02750410|64439449|FG001|Open-Label Extension Period|Adverse Event|3|||
23190640|NCT02750410|64439448|FG000|Open-Label Extension Period|Protocol Violation|0|||
23357259|NCT03539484|65052736|FG000|Overall Study|Withdrawal by Subject|0|||
23357260|NCT03539484|65052737|FG001|Overall Study|Withdrawal by Subject|0|||
23190641|NCT02750410|64439449|FG001|Open-Label Extension Period|Protocol Violation|1|||
23250495|NCT01954082|64659779|FG000|Overall Study|Withdrawal by Subject|0|||
23250496|NCT01954082|64659780|FG001|Overall Study|Withdrawal by Subject|1|||
23250497|NCT01954082|64659779|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
23250498|NCT01954082|64659780|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
23357261|NCT03539484|65052738|FG002|Overall Study|Withdrawal by Subject|0|||
23190642|NCT02750410|64439448|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
23190643|NCT02750410|64439449|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
23190644|NCT02263365|64439450|FG000|Overall Study|Physician Decision|22|||
23473774|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
23473775|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
23473776|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
23473777|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
23473778|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
23473779|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
23250499|NCT01954082|64659779|FG000|Overall Study|Redirection of Care|0|||
23250500|NCT01954082|64659780|FG001|Overall Study|Redirection of Care|2|||
23250501|NCT01954082|64659779|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
23250502|NCT01954082|64659780|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
23250503|NCT01954082|64659779|FG000|Overall Study|Comfort Care|0|||
23250504|NCT01954082|64659780|FG001|Overall Study|Comfort Care|1|||
23250505|NCT01954082|64659779|FG000|Overall Study|Infant Moved|0|||
23250506|NCT01954082|64659780|FG001|Overall Study|Infant Moved|1|||
23190645|NCT02263365|64439451|FG001|Overall Study|Physician Decision|18|||
23190646|NCT00501852|64439452|FG000|Overall Study|Adverse Event|3|||
23190647|NCT00501852|64439452|FG000|Overall Study|Withdrawal by Subject|2|||
23190648|NCT01165229|64439456|FG000|Overall Study|Serious Adverse Event|456|||
23190649|NCT01165229|64439457|FG001|Overall Study|Serious Adverse Event|487|||
23190650|NCT01165229|64439456|FG000|Overall Study|Non-Serious Adverse Event|47|||
23190651|NCT01165229|64439457|FG001|Overall Study|Non-Serious Adverse Event|15|||
23190652|NCT01165229|64439456|FG000|Overall Study|Protocol Violation|6|||
23190653|NCT01165229|64439457|FG001|Overall Study|Protocol Violation|8|||
23250507|NCT01954082|64659779|FG000|Overall Study|Randomized not Treated|4|||
23473780|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
23473781|NCT00946985|65477723|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
23473782|NCT00946985|65477723|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
23473783|NCT02078960|65477729|FG000|Treatment Period|Other|0|||
23473784|NCT02078960|65477730|FG001|Treatment Period|Other|0|||
23473785|NCT02078960|65477731|FG002|Treatment Period|Other|1|||
23473786|NCT02078960|65477729|FG000|Treatment Period|Lack of Efficacy|0|||
23473787|NCT02078960|65477730|FG001|Treatment Period|Lack of Efficacy|1|||
23473788|NCT02078960|65477731|FG002|Treatment Period|Lack of Efficacy|0|||
23473789|NCT02078960|65477729|FG000|Treatment Period|Disease progression - accelerated phase|0|||
23473790|NCT02078960|65477730|FG001|Treatment Period|Disease progression - accelerated phase|1|||
23473791|NCT02078960|65477731|FG002|Treatment Period|Disease progression - accelerated phase|0|||
23473792|NCT02078960|65477729|FG000|Treatment Period|Disease progression - blast phase|1|||
23473793|NCT02078960|65477730|FG001|Treatment Period|Disease progression - blast phase|0|||
23473794|NCT02078960|65477731|FG002|Treatment Period|Disease progression - blast phase|0|||
23473795|NCT02078960|65477729|FG000|Treatment Period|Withdrawal by Subject|0|||
23473796|NCT02078960|65477730|FG001|Treatment Period|Withdrawal by Subject|1|||
23473797|NCT02078960|65477731|FG002|Treatment Period|Withdrawal by Subject|1|||
23473798|NCT02078960|65477729|FG000|Treatment Period|Adverse Event|1|||
23473799|NCT02078960|65477730|FG001|Treatment Period|Adverse Event|0|||
23473800|NCT02078960|65477731|FG002|Treatment Period|Adverse Event|0|||
23473801|NCT02078960|65477729|FG000|Treatment Period|Death|0|||
23473802|NCT02078960|65477730|FG001|Treatment Period|Death|0|||
23473803|NCT02078960|65477731|FG002|Treatment Period|Death|1|||
23473804|NCT02078960|65477729|FG000|Follow-up Period|Death|2|||
23473805|NCT02078960|65477730|FG001|Follow-up Period|Death|0|||
23473806|NCT02078960|65477731|FG002|Follow-up Period|Death|0|||
23473807|NCT02078960|65477729|FG000|Follow-up Period|Lost to Follow-up|0|||
23473808|NCT02078960|65477730|FG001|Follow-up Period|Lost to Follow-up|1|||
23473809|NCT02078960|65477731|FG002|Follow-up Period|Lost to Follow-up|0|||
23473810|NCT01705509|65477734|FG000|Inclusion CPET|Screen Failure|5|||
23473811|NCT01705509|65477734|FG000|Inclusion CPET|Withdrawal by Subject|2|||
23473812|NCT01705509|65477734|FG000|CPET w/ Ranexa|Screen Failure|2|||
23473813|NCT04889118|65477735|FG000|Overall Study|Death|33|||
23473814|NCT04889118|65477736|FG001|Overall Study|Death|37|||
23588906|NCT03394027|65882267|FG000|Overall Study|Participant declined to participate before treatment started|0|||
23588907|NCT03394027|65882268|FG001|Overall Study|Participant declined to participate before treatment started|0|||
23250508|NCT01954082|64659780|FG001|Overall Study|Randomized not Treated|2|||
23473815|NCT04889118|65477735|FG000|Overall Study|Ongoing in Study|31|||
23473816|NCT04889118|65477736|FG001|Overall Study|Ongoing in Study|30|||
23473817|NCT01601652|65477737|FG000|Overall Study|Death|1|||
23473818|NCT02925338|65477738|FG000|Overall Study|Death|0|||
23473819|NCT02925338|65477739|FG001|Overall Study|Death|2|||
23190654|NCT01165229|64439456|FG000|Overall Study|Withdrawal by Subject|387|||
23473820|NCT02925338|65477740|FG002|Overall Study|Death|1|||
23473821|NCT02925338|65477741|FG003|Overall Study|Death|0|||
23473822|NCT02925338|65477742|FG004|Overall Study|Death|0|||
23473823|NCT02925338|65477738|FG000|Overall Study|Lost to Follow-up|30|||
23473824|NCT02925338|65477739|FG001|Overall Study|Lost to Follow-up|10|||
23473825|NCT02925338|65477740|FG002|Overall Study|Lost to Follow-up|1|||
23473826|NCT02925338|65477741|FG003|Overall Study|Lost to Follow-up|16|||
23473827|NCT02925338|65477742|FG004|Overall Study|Lost to Follow-up|3|||
23473828|NCT02925338|65477738|FG000|Overall Study|Withdrawal by Subject|3|||
23473829|NCT02925338|65477739|FG001|Overall Study|Withdrawal by Subject|0|||
23473830|NCT02925338|65477740|FG002|Overall Study|Withdrawal by Subject|3|||
23473831|NCT02925338|65477741|FG003|Overall Study|Withdrawal by Subject|2|||
23473832|NCT02925338|65477742|FG004|Overall Study|Withdrawal by Subject|2|||
23473833|NCT02925338|65477738|FG000|Overall Study|Missing|38|||
23473834|NCT02925338|65477739|FG001|Overall Study|Missing|27|||
23473835|NCT02925338|65477740|FG002|Overall Study|Missing|0|||
23473836|NCT02925338|65477741|FG003|Overall Study|Missing|3|||
23473837|NCT02925338|65477742|FG004|Overall Study|Missing|2|||
23473838|NCT02925338|65477738|FG000|Overall Study|Participant's Decision|11|||
23473839|NCT02925338|65477739|FG001|Overall Study|Participant's Decision|7|||
23473840|NCT02925338|65477740|FG002|Overall Study|Participant's Decision|3|||
23473841|NCT02925338|65477741|FG003|Overall Study|Participant's Decision|8|||
23473842|NCT02925338|65477742|FG004|Overall Study|Participant's Decision|1|||
23473843|NCT02925338|65477738|FG000|Overall Study|Treatment Discontinuation|144|||
23473844|NCT02925338|65477739|FG001|Overall Study|Treatment Discontinuation|65|||
23473845|NCT02925338|65477740|FG002|Overall Study|Treatment Discontinuation|56|||
23473846|NCT02925338|65477741|FG003|Overall Study|Treatment Discontinuation|131|||
23473847|NCT02925338|65477742|FG004|Overall Study|Treatment Discontinuation|22|||
23473848|NCT02039843|65477743|FG000|Randomization and Observation Period|Adverse Event|2|||
23473849|NCT02039843|65477744|FG001|Randomization and Observation Period|Adverse Event|0|||
23473850|NCT02039843|65477743|FG000|Randomization and Observation Period|Death|1|||
23473851|NCT02039843|65477744|FG001|Randomization and Observation Period|Death|0|||
23473852|NCT02039843|65477743|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
23473853|NCT02039843|65477744|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
23473854|NCT02039843|65477743|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
23473855|NCT02039843|65477744|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
23473856|NCT02039843|65477743|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
23473857|NCT02039843|65477744|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
23588908|NCT03394027|65882269|FG002|Overall Study|Participant declined to participate before treatment started|1|||
23190655|NCT01165229|64439457|FG001|Overall Study|Withdrawal by Subject|396|||
23190656|NCT01165229|64439456|FG000|Overall Study|Migrated/moved from study area|51|||
23190657|NCT01165229|64439457|FG001|Overall Study|Migrated/moved from study area|46|||
23190658|NCT01165229|64439456|FG000|Overall Study|Lost to Follow-up|123|||
23190659|NCT01165229|64439457|FG001|Overall Study|Lost to Follow-up|133|||
23190660|NCT01165229|64439456|FG000|Overall Study|Suspected HZ Episode|2|||
23190661|NCT01165229|64439457|FG001|Overall Study|Suspected HZ Episode|2|||
23190662|NCT01165229|64439456|FG000|Overall Study|No reason from the subject|108|||
23190663|NCT01165229|64439457|FG001|Overall Study|No reason from the subject|102|||
23190664|NCT01165229|64439456|FG000|Overall Study|Unknown completion status|0|||
23190665|NCT01165229|64439457|FG001|Overall Study|Unknown completion status|1|||
23190666|NCT04024228|64439458|FG000|Overall Study|Adverse Event|1|||
23190667|NCT04024228|64439459|FG001|Overall Study|Adverse Event|0|||
23190668|NCT04024228|64439458|FG000|Overall Study|Protocol Deviation|0|||
23190669|NCT04024228|64439459|FG001|Overall Study|Protocol Deviation|2|||
23190670|NCT04024228|64439458|FG000|Overall Study|Withdrawal by Subject|3|||
23190671|NCT04024228|64439459|FG001|Overall Study|Withdrawal by Subject|4|||
23190672|NCT03429556|64439464|FG000|Overall Study|Lost to Follow-up|0|||
23190673|NCT03429556|64439465|FG001|Overall Study|Lost to Follow-up|1|||
23190674|NCT03429556|64439466|FG002|Overall Study|Lost to Follow-up|0|||
23190675|NCT03429556|64439467|FG003|Overall Study|Lost to Follow-up|0|||
23250509|NCT01988493|64659781|FG000|Overall Study|Randomized but not treated|0|||
23250510|NCT01988493|64659782|FG001|Overall Study|Randomized but not treated|0|||
23473858|NCT02039843|65477743|FG000|Pairing With a Study Dog|Death|1|||
23473859|NCT02039843|65477744|FG001|Pairing With a Study Dog|Death|0|||
23473860|NCT02039843|65477743|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
23473861|NCT02039843|65477744|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
23473862|NCT02039843|65477743|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
23473863|NCT02039843|65477744|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
23473864|NCT02039843|65477743|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
23588909|NCT01360840|65882270|FG000|Overall Study|Ongoing at data cut-off|10|||
23588910|NCT01360840|65882271|FG001|Overall Study|Ongoing at data cut-off|10|||
23588911|NCT01360840|65882272|FG002|Overall Study|Ongoing at data cut-off|9|||
23588912|NCT01069341|65882273|FG000|Overall Study|Lost to Follow-up|1|||
23588913|NCT02385669|65882274|FG000|Overall Study|Adverse Event|2|||
23588914|NCT00559949|65882275|FG000|Overall Study|Progressive Disease during cycle 1|1|||
23250511|NCT01988493|64659783|FG002|Overall Study|Randomized but not treated|0|||
23190676|NCT03067311|64439468|FG000|Overall Study|Lost to Follow-up|1|||
23190677|NCT03067311|64439469|FG001|Overall Study|Lost to Follow-up|1|||
23190678|NCT03067311|64439468|FG000|Overall Study|Moved away|1|||
23588915|NCT00559949|65882275|FG000|Overall Study|Adverse Event|1|||
23588916|NCT00559949|65882275|FG000|Overall Study|Withdrawal by Subject|4|||
23588917|NCT00559949|65882275|FG000|Overall Study|No disease evaluation per protocol|1|||
23588918|NCT01467700|65882276|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
23588919|NCT01467700|65882277|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
23588920|NCT01467700|65882278|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
23588921|NCT01467700|65882279|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
23588922|NCT01467700|65882276|FG000|Overall Study|Major Protocol Deviation|3|||
23588923|NCT01467700|65882277|FG001|Overall Study|Major Protocol Deviation|3|||
23588924|NCT01467700|65882278|FG002|Overall Study|Major Protocol Deviation|2|||
23588925|NCT01467700|65882279|FG003|Overall Study|Major Protocol Deviation|3|||
23250512|NCT01988493|64659784|FG003|Overall Study|Randomized but not treated|0|||
23250513|NCT01988493|64659785|FG004|Overall Study|Randomized but not treated|1|||
23250514|NCT00865306|64659786|FG000|Controlled Trial|Lost to Follow-up|1|||
23250515|NCT00865306|64659787|FG001|Controlled Trial|Lost to Follow-up|1|||
23250516|NCT00865306|64659786|FG000|Controlled Trial|Difficulty commuting|2|||
23250517|NCT00865306|64659787|FG001|Controlled Trial|Difficulty commuting|0|||
23250518|NCT00865306|64659786|FG000|Controlled Trial|Improved btw baseline and first session|1|||
23250519|NCT00865306|64659787|FG001|Controlled Trial|Improved btw baseline and first session|0|||
23250520|NCT00865306|64659786|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
23250521|NCT00865306|64659787|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
23250522|NCT00865306|64659786|FG000|Controlled Trial|Withdrawal by Subject|0|||
23250523|NCT00865306|64659787|FG001|Controlled Trial|Withdrawal by Subject|1|||
23250524|NCT04347161|64659788|FG000|Overall Study|Death|0|||
23250525|NCT04347161|64659789|FG001|Overall Study|Death|2|||
23250526|NCT04347161|64659788|FG000|Overall Study|Withdrawal by Subject|1|||
23250527|NCT04347161|64659789|FG001|Overall Study|Withdrawal by Subject|0|||
23250528|NCT04347161|64659788|FG000|Overall Study|Lost to Follow-up|0|||
23250529|NCT04347161|64659789|FG001|Overall Study|Lost to Follow-up|1|||
23250530|NCT04347161|64659788|FG000|Overall Study|No longer on study medication|1|||
23250531|NCT04347161|64659789|FG001|Overall Study|No longer on study medication|1|||
23250532|NCT01342367|64659791|FG000|Overall Study|Death|1|||
23250533|NCT01342367|64659792|FG001|Overall Study|Death|0|||
23250534|NCT01342367|64659791|FG000|Overall Study|Withdrawal by Subject|1|||
23250535|NCT01342367|64659792|FG001|Overall Study|Withdrawal by Subject|2|||
23250536|NCT03286400|64659793|FG000|Overall Study|Death|10|||
23250537|NCT03286400|64659793|FG000|Overall Study|Lost to Follow-up|10|||
23250538|NCT03286400|64659793|FG000|Overall Study|Physician Decision|1|||
23250539|NCT03286400|64659793|FG000|Overall Study|Scheduling difficulty|4|||
23250540|NCT02494583|64659799|FG000|Overall Study|Death|224|||
23250541|NCT02494583|64659800|FG001|Overall Study|Death|214|||
23250542|NCT02494583|64659801|FG002|Overall Study|Death|225|||
23250543|NCT02494583|64659799|FG000|Overall Study|Lost to Follow-up|1|||
23250544|NCT02494583|64659800|FG001|Overall Study|Lost to Follow-up|0|||
23250545|NCT02494583|64659801|FG002|Overall Study|Lost to Follow-up|0|||
23250546|NCT02494583|64659799|FG000|Overall Study|Protocol Violation|1|||
23250547|NCT02494583|64659800|FG001|Overall Study|Protocol Violation|2|||
23250548|NCT02494583|64659801|FG002|Overall Study|Protocol Violation|0|||
23250549|NCT02494583|64659799|FG000|Overall Study|Screen Failure|0|||
23250550|NCT02494583|64659800|FG001|Overall Study|Screen Failure|1|||
23250551|NCT02494583|64659801|FG002|Overall Study|Screen Failure|0|||
23588926|NCT01467700|65882276|FG000|Overall Study|Lost to Follow-up|6|||
23588927|NCT01467700|65882277|FG001|Overall Study|Lost to Follow-up|5|||
23190679|NCT03067311|64439469|FG001|Overall Study|Moved away|1|||
23250552|NCT02494583|64659799|FG000|Overall Study|Transferred to Extension Study|15|||
23250553|NCT02494583|64659800|FG001|Overall Study|Transferred to Extension Study|15|||
23588928|NCT01467700|65882278|FG002|Overall Study|Lost to Follow-up|2|||
23250554|NCT02494583|64659801|FG002|Overall Study|Transferred to Extension Study|6|||
23250555|NCT02494583|64659799|FG000|Overall Study|Did Not Continue on Extension Study|8|||
23250556|NCT02494583|64659800|FG001|Overall Study|Did Not Continue on Extension Study|10|||
23588929|NCT01467700|65882279|FG003|Overall Study|Lost to Follow-up|3|||
23357262|NCT03539484|65052739|FG003|Overall Study|Withdrawal by Subject|0|||
23357263|NCT03539484|65052740|FG004|Overall Study|Withdrawal by Subject|2|||
23357264|NCT03539484|65052741|FG005|Overall Study|Withdrawal by Subject|0|||
23357265|NCT03539484|65052742|FG006|Overall Study|Withdrawal by Subject|1|||
23357266|NCT03539484|65052736|FG000|Overall Study|Study Terminated by Sponsor|0|||
23357267|NCT03539484|65052737|FG001|Overall Study|Study Terminated by Sponsor|0|||
23357268|NCT03539484|65052738|FG002|Overall Study|Study Terminated by Sponsor|1|||
23357269|NCT03539484|65052739|FG003|Overall Study|Study Terminated by Sponsor|1|||
23357270|NCT03539484|65052740|FG004|Overall Study|Study Terminated by Sponsor|2|||
23357271|NCT03539484|65052741|FG005|Overall Study|Study Terminated by Sponsor|2|||
23357272|NCT03539484|65052742|FG006|Overall Study|Study Terminated by Sponsor|1|||
23357273|NCT03076515|65052743|FG000|Overall Study|DMC decision based on interim analysis|25|||
23357274|NCT03076515|65052744|FG001|Overall Study|DMC decision based on interim analysis|29|||
23357275|NCT02686814|65052745|FG000|Overall Study|Physician Decision|14|||
23357276|NCT02686814|65052745|FG000|Overall Study|Withdrawal by Subject|4|||
23357277|NCT02686814|65052745|FG000|Overall Study|Death|1|||
23357278|NCT02560623|65052746|FG000|Overall Study|Unable to swallow sponge|0|||
23357279|NCT02560623|65052747|FG001|Overall Study|Unable to swallow sponge|1|||
23357280|NCT02560623|65052748|FG002|Overall Study|Unable to swallow sponge|0|||
23357281|NCT02560623|65052749|FG003|Overall Study|Unable to swallow sponge|0|||
23357282|NCT02560623|65052746|FG000|Overall Study|Intervention prior to sponge administration|0|||
23357283|NCT02560623|65052747|FG001|Overall Study|Intervention prior to sponge administration|1|||
23357284|NCT02560623|65052748|FG002|Overall Study|Intervention prior to sponge administration|0|||
23357285|NCT02560623|65052749|FG003|Overall Study|Intervention prior to sponge administration|0|||
23357286|NCT01133704|65052750|FG000|Overall Study|Death|44|||
23357287|NCT01133704|65052751|FG001|Overall Study|Death|26|||
23357288|NCT01133704|65052750|FG000|Overall Study|Patient refused to continue|4|||
23357289|NCT01133704|65052751|FG001|Overall Study|Patient refused to continue|0|||
23588930|NCT01467700|65882276|FG000|Overall Study|Voluntary Withdrawal|5|||
23588931|NCT01467700|65882277|FG001|Overall Study|Voluntary Withdrawal|7|||
23588932|NCT01467700|65882278|FG002|Overall Study|Voluntary Withdrawal|6|||
23588933|NCT01467700|65882279|FG003|Overall Study|Voluntary Withdrawal|2|||
23588934|NCT01467700|65882276|FG000|Overall Study|Study Termination|6|||
23588935|NCT01467700|65882277|FG001|Overall Study|Study Termination|5|||
23588936|NCT01467700|65882278|FG002|Overall Study|Study Termination|10|||
23588937|NCT01467700|65882279|FG003|Overall Study|Study Termination|7|||
23588938|NCT01467700|65882276|FG000|Overall Study|Pregnancy|0|||
23588939|NCT01467700|65882277|FG001|Overall Study|Pregnancy|1|||
23588940|NCT01467700|65882278|FG002|Overall Study|Pregnancy|1|||
23588941|NCT01467700|65882279|FG003|Overall Study|Pregnancy|0|||
23357290|NCT01133704|65052750|FG000|Overall Study|Study Closure|1|||
23357291|NCT01133704|65052751|FG001|Overall Study|Study Closure|0|||
23357292|NCT01760447|65052752|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
23357293|NCT01760447|65052753|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
23357294|NCT01760447|65052754|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
23357295|NCT01760447|65052755|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
23357296|NCT01760447|65052752|FG000|Weeks 0-20|Withdrawal by Subject|2|||
23357297|NCT01760447|65052753|FG001|Weeks 0-20|Withdrawal by Subject|0|||
23357298|NCT01760447|65052754|FG002|Weeks 0-20|Withdrawal by Subject|1|||
23357299|NCT01760447|65052755|FG003|Weeks 0-20|Withdrawal by Subject|0|||
23357300|NCT01760447|65052752|FG000|Weeks 0-20|Lost to Follow-up|1|||
23357301|NCT01760447|65052753|FG001|Weeks 0-20|Lost to Follow-up|0|||
23357302|NCT01760447|65052754|FG002|Weeks 0-20|Lost to Follow-up|1|||
23357303|NCT01760447|65052755|FG003|Weeks 0-20|Lost to Follow-up|1|||
23357304|NCT01760447|65052752|FG000|Weeks 0-20|Randomized but not treated|0|||
23357305|NCT01760447|65052753|FG001|Weeks 0-20|Randomized but not treated|0|||
23357306|NCT01760447|65052754|FG002|Weeks 0-20|Randomized but not treated|2|||
23357307|NCT01760447|65052755|FG003|Weeks 0-20|Randomized but not treated|0|||
23357308|NCT01760447|65052752|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
23357309|NCT01760447|65052753|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
23357310|NCT01760447|65052754|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
23357311|NCT01760447|65052755|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
23357312|NCT01760447|65052752|FG000|Weeks 20-54|Withdrawal by Subject|2|||
23357313|NCT01760447|65052753|FG001|Weeks 20-54|Withdrawal by Subject|1|||
23190680|NCT03941548|64439472|FG000|Overall Study|Adverse Event|0|||
23190681|NCT03941548|64439473|FG001|Overall Study|Adverse Event|1|||
23190682|NCT03941548|64439472|FG000|Overall Study|Lost to Follow-up|0|||
23190683|NCT03941548|64439473|FG001|Overall Study|Lost to Follow-up|1|||
23190684|NCT03941548|64439472|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
23357314|NCT01760447|65052754|FG002|Weeks 20-54|Withdrawal by Subject|1|||
23357315|NCT01760447|65052755|FG003|Weeks 20-54|Withdrawal by Subject|2|||
23357316|NCT01760447|65052752|FG000|Weeks 20-54|Lost to Follow-up|0|||
23357317|NCT01760447|65052753|FG001|Weeks 20-54|Lost to Follow-up|0|||
23357318|NCT01760447|65052754|FG002|Weeks 20-54|Lost to Follow-up|1|||
23357319|NCT01760447|65052755|FG003|Weeks 20-54|Lost to Follow-up|2|||
23357320|NCT03334188|65052758|FG000|Overall Study|Withdrawal by Subject|0|||
23357321|NCT03334188|65052759|FG001|Overall Study|Withdrawal by Subject|1|||
23357322|NCT03334188|65052758|FG000|Overall Study|Death|1|||
23357323|NCT03334188|65052759|FG001|Overall Study|Death|0|||
23357324|NCT03334188|65052758|FG000|Overall Study|Never had qualifying clinic visit|7|||
23357325|NCT03334188|65052759|FG001|Overall Study|Never had qualifying clinic visit|7|||
23357326|NCT00376532|65052760|FG000|Overall Study|Lack sufficient blood sample|6|||
23357327|NCT00376532|65052761|FG001|Overall Study|Lack sufficient blood sample|6|||
23357328|NCT01301079|65052762|FG000|Overall Study|Lost to Follow-up|2|||
23357329|NCT01301079|65052763|FG001|Overall Study|Lost to Follow-up|2|||
23357330|NCT04391842|65052764|FG000|Overall Study|Withdrawal by Subject|2|||
23357331|NCT01937884|65052765|FG000|Overall Study|Withdrawal by Subject|1|||
23357332|NCT01937884|65052766|FG001|Overall Study|Withdrawal by Subject|0|||
23357333|NCT02315664|65052767|FG000|Overall Study|Lost to Follow-up|1|||
23357334|NCT02315664|65052768|FG001|Overall Study|Lost to Follow-up|1|||
23357335|NCT02315664|65052767|FG000|Overall Study|Withdrawal by Subject|0|||
23357336|NCT02315664|65052768|FG001|Overall Study|Withdrawal by Subject|3|||
23357337|NCT01808261|65052769|FG000|Overall Study|Physician Decision|0|||
23190685|NCT03941548|64439473|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
23190686|NCT02190591|64439479|FG000|Overall Study|Withdrawal by Subject|1|||
23190687|NCT02190591|64439480|FG001|Overall Study|Withdrawal by Subject|8|||
23190688|NCT02190591|64439479|FG000|Overall Study|Protocol Violation|1|||
23190689|NCT02190591|64439480|FG001|Overall Study|Protocol Violation|0|||
23190690|NCT02190591|64439479|FG000|Overall Study|did not use peanut ball as instructed|0|||
23357338|NCT01808261|65052770|FG001|Overall Study|Physician Decision|2|||
23357339|NCT01808261|65052769|FG000|Overall Study|Study Closed/Terminated|25|||
23357340|NCT01808261|65052770|FG001|Overall Study|Study Closed/Terminated|23|||
23357341|NCT01808261|65052769|FG000|Overall Study|Adverse event, non-fatal|2|||
23357342|NCT01808261|65052770|FG001|Overall Study|Adverse event, non-fatal|0|||
23357343|NCT01808261|65052769|FG000|Overall Study|Consent withdrawn by subject|6|||
23190691|NCT02190591|64439480|FG001|Overall Study|did not use peanut ball as instructed|2|||
23357344|NCT01808261|65052770|FG001|Overall Study|Consent withdrawn by subject|7|||
23250557|NCT02494583|64659801|FG002|Overall Study|Did Not Continue on Extension Study|4|||
23250558|NCT02494583|64659799|FG000|Overall Study|Withdrawal by Subject|7|||
23250559|NCT02494583|64659800|FG001|Overall Study|Withdrawal by Subject|15|||
23250560|NCT02494583|64659801|FG002|Overall Study|Withdrawal by Subject|15|||
23250561|NCT03457727|64659803|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
23250562|NCT03457727|64659804|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
23250563|NCT03457727|64659805|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
23250564|NCT03457727|64659806|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
23250565|NCT00530439|64659812|FG000|Overall Study|GDM|9|||
23250566|NCT00530439|64659813|FG001|Overall Study|GDM|3|||
23250567|NCT00530439|64659812|FG000|Overall Study|Withdraw|18|||
23250568|NCT00530439|64659813|FG001|Overall Study|Withdraw|14|||
23250569|NCT00530439|64659812|FG000|Overall Study|Missed abortion|1|||
23250570|NCT00530439|64659813|FG001|Overall Study|Missed abortion|4|||
23250571|NCT00530439|64659812|FG000|Overall Study|Misclassification|2|||
23250572|NCT00530439|64659813|FG001|Overall Study|Misclassification|0|||
23250573|NCT00530439|64659812|FG000|Overall Study|Twin pregnancy|0|||
23250574|NCT00530439|64659813|FG001|Overall Study|Twin pregnancy|2|||
23250575|NCT00530439|64659812|FG000|Overall Study|Severe malformation/abortion|0|||
23250576|NCT00530439|64659813|FG001|Overall Study|Severe malformation/abortion|3|||
23250577|NCT02181842|64659814|FG000|Overall Study|Case Report Forms Uncollected|2|||
23250578|NCT03333382|64659815|FG000|Overall Study|Lost to Follow-up|1|||
23250579|NCT03333382|64659816|FG001|Overall Study|Lost to Follow-up|0|||
23250580|NCT01227954|64659817|FG000|Overall Study|Protocol Violation|6|||
23250581|NCT01227954|64659817|FG000|Overall Study|No protocol treatment|7|||
23250582|NCT00828516|64659818|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
23250583|NCT02499406|64659819|FG000|Overall Study|missed 3 treatment sessions|4|||
23250584|NCT01422720|64659820|FG000|Overall Study|Adverse Event|16|||
23250585|NCT01422720|64659820|FG000|Overall Study|Lack of Efficacy|1|||
23250586|NCT01422720|64659820|FG000|Overall Study|Withdrawal by Subject|4|||
23588942|NCT01467700|65882276|FG000|Overall Study|Lack of Efficacy|2|||
23588943|NCT01467700|65882277|FG001|Overall Study|Lack of Efficacy|0|||
23588944|NCT01467700|65882278|FG002|Overall Study|Lack of Efficacy|2|||
23588945|NCT01467700|65882279|FG003|Overall Study|Lack of Efficacy|1|||
23588946|NCT01467700|65882276|FG000|Overall Study|Reason not Specified|1|||
23588947|NCT01467700|65882277|FG001|Overall Study|Reason not Specified|3|||
23588948|NCT01467700|65882278|FG002|Overall Study|Reason not Specified|2|||
23588949|NCT01467700|65882279|FG003|Overall Study|Reason not Specified|8|||
23588950|NCT04849416|65882280|FG000|Overall Study|Ongoing Treatment|12|||
23588951|NCT04849416|65882281|FG001|Overall Study|Ongoing Treatment|5|||
23588952|NCT04849416|65882282|FG002|Overall Study|Ongoing Treatment|3|||
23588953|NCT04849416|65882280|FG000|Overall Study|On Post-Treatment Follow-up|8|||
23588954|NCT04849416|65882281|FG001|Overall Study|On Post-Treatment Follow-up|9|||
23588955|NCT04849416|65882282|FG002|Overall Study|On Post-Treatment Follow-up|10|||
23588956|NCT04849416|65882280|FG000|Overall Study|Withdrawal by Subject|0|||
23588957|NCT04849416|65882281|FG001|Overall Study|Withdrawal by Subject|0|||
23588958|NCT04849416|65882282|FG002|Overall Study|Withdrawal by Subject|1|||
23588959|NCT04849416|65882280|FG000|Overall Study|Lost to Follow-up|1|||
23588960|NCT04849416|65882281|FG001|Overall Study|Lost to Follow-up|0|||
23588961|NCT04849416|65882282|FG002|Overall Study|Lost to Follow-up|0|||
23190692|NCT02190591|64439479|FG000|Overall Study|face presentation so she was ineligible|0|||
23190693|NCT02190591|64439480|FG001|Overall Study|face presentation so she was ineligible|1|||
23190694|NCT03241173|64439482|FG000|Overall Study|Death|3|||
23190695|NCT03241173|64439483|FG001|Overall Study|Death|2|||
23190696|NCT03241173|64439484|FG002|Overall Study|Death|4|||
23190697|NCT03241173|64439485|FG003|Overall Study|Death|4|||
23190698|NCT03241173|64439486|FG004|Overall Study|Death|2|||
23190699|NCT03241173|64439487|FG005|Overall Study|Death|2|||
23190700|NCT03241173|64439488|FG006|Overall Study|Death|3|||
23190701|NCT03241173|64439489|FG007|Overall Study|Death|1|||
23190702|NCT03241173|64439490|FG008|Overall Study|Death|0|||
23190703|NCT03241173|64439491|FG009|Overall Study|Death|5|||
23190704|NCT03241173|64439492|FG010|Overall Study|Death|4|||
23190705|NCT03241173|64439493|FG011|Overall Study|Death|3|||
23190706|NCT03241173|64439494|FG012|Overall Study|Death|0|||
23190707|NCT03241173|64439495|FG013|Overall Study|Death|0|||
23190708|NCT03241173|64439496|FG014|Overall Study|Death|0|||
23190709|NCT03241173|64439482|FG000|Overall Study|Withdrawal by Subject|0|||
23190710|NCT03241173|64439483|FG001|Overall Study|Withdrawal by Subject|0|||
23190711|NCT03241173|64439484|FG002|Overall Study|Withdrawal by Subject|1|||
23190712|NCT03241173|64439485|FG003|Overall Study|Withdrawal by Subject|0|||
23190713|NCT03241173|64439486|FG004|Overall Study|Withdrawal by Subject|0|||
23190714|NCT03241173|64439487|FG005|Overall Study|Withdrawal by Subject|1|||
23190715|NCT03241173|64439488|FG006|Overall Study|Withdrawal by Subject|0|||
23190716|NCT03241173|64439489|FG007|Overall Study|Withdrawal by Subject|0|||
23190717|NCT03241173|64439490|FG008|Overall Study|Withdrawal by Subject|0|||
23250587|NCT01422720|64659820|FG000|Overall Study|Ineligibility|1|||
23588962|NCT01140048|65882286|FG000|Overall Study|Physician Decision|1|||
23190718|NCT03241173|64439491|FG009|Overall Study|Withdrawal by Subject|0|||
23250588|NCT01850108|64659821|FG000|Overall Study|Lost to Follow-up|4|||
23250589|NCT01850108|64659821|FG000|Overall Study|Not eligible|1|||
23250590|NCT01850108|64659821|FG000|Overall Study|Failed engraftment|2|||
23250591|NCT01850108|64659821|FG000|Overall Study|Physician Decision|1|||
23250592|NCT02983227|64659824|FG000|Overall Study|Adverse Event|21|||
23250593|NCT02983227|64659825|FG001|Overall Study|Adverse Event|3|||
23250594|NCT02983227|64659824|FG000|Overall Study|Death|3|||
23250595|NCT02983227|64659825|FG001|Overall Study|Death|0|||
23250596|NCT02983227|64659824|FG000|Overall Study|Lack of Efficacy|8|||
23250597|NCT02983227|64659825|FG001|Overall Study|Lack of Efficacy|1|||
23250598|NCT02983227|64659824|FG000|Overall Study|Lost to Follow-up|3|||
23250599|NCT02983227|64659825|FG001|Overall Study|Lost to Follow-up|0|||
23250600|NCT02983227|64659824|FG000|Overall Study|Multiple Reasons|2|||
23250601|NCT02983227|64659825|FG001|Overall Study|Multiple Reasons|1|||
23250602|NCT02983227|64659824|FG000|Overall Study|Physician Decision|3|||
23250603|NCT02983227|64659825|FG001|Overall Study|Physician Decision|1|||
23250604|NCT02983227|64659824|FG000|Overall Study|Withdrawal by Subject|19|||
23250605|NCT02983227|64659825|FG001|Overall Study|Withdrawal by Subject|8|||
23250606|NCT00666718|64659826|FG000|Overall Study|Adverse Event|0|||
23250607|NCT00666718|64659827|FG001|Overall Study|Adverse Event|1|||
23250608|NCT00666718|64659826|FG000|Overall Study|Death|1|||
23250609|NCT00666718|64659827|FG001|Overall Study|Death|0|||
23250610|NCT00666718|64659826|FG000|Overall Study|Lost to Follow-up|1|||
23250611|NCT00666718|64659827|FG001|Overall Study|Lost to Follow-up|0|||
23250612|NCT00666718|64659826|FG000|Overall Study|Entry Criteria Not Met|2|||
23250613|NCT00666718|64659827|FG001|Overall Study|Entry Criteria Not Met|0|||
23250614|NCT00666718|64659826|FG000|Overall Study|Protocol Violation|1|||
23250615|NCT00666718|64659827|FG001|Overall Study|Protocol Violation|3|||
23250616|NCT00666718|64659826|FG000|Overall Study|Withdrawal by Subject|7|||
23250617|NCT00666718|64659827|FG001|Overall Study|Withdrawal by Subject|12|||
23250618|NCT00666718|64659826|FG000|Overall Study|Physician Decision|0|||
23250619|NCT00666718|64659827|FG001|Overall Study|Physician Decision|2|||
23250620|NCT00765999|64659828|FG000|Overall Study|Adverse Event|203|||
23250621|NCT00765999|64659828|FG000|Overall Study|Insufficient Therapeutic Response|100|||
23250622|NCT00765999|64659828|FG000|Overall Study|Protocol Violation|95|||
23250623|NCT00765999|64659828|FG000|Overall Study|Consent Withdrawn|202|||
23250624|NCT00765999|64659828|FG000|Overall Study|Lost to Follow-up|131|||
23250625|NCT00765999|64659828|FG000|Overall Study|Study Terminated by Sponsor|2|||
23250626|NCT00765999|64659828|FG000|Overall Study|Other Miscellaneous Reasons|51|||
23250627|NCT00005879|64659829|FG000|Overall Study|Withdrawal by Subject|8|||
23250628|NCT00005879|64659830|FG001|Overall Study|Withdrawal by Subject|10|||
23250629|NCT00386100|64659833|FG000|Overall Study|Did not receive study medication|6|||
23250630|NCT00386100|64659834|FG001|Overall Study|Did not receive study medication|4|||
23250631|NCT00386100|64659833|FG000|Overall Study|Adverse Event|15|||
23250632|NCT00386100|64659834|FG001|Overall Study|Adverse Event|25|||
23250633|NCT00386100|64659833|FG000|Overall Study|Death|0|||
23250634|NCT00386100|64659834|FG001|Overall Study|Death|1|||
23250635|NCT00386100|64659833|FG000|Overall Study|Insufficient therapeutic effect|30|||
23250636|NCT00386100|64659834|FG001|Overall Study|Insufficient therapeutic effect|6|||
23250637|NCT00386100|64659833|FG000|Overall Study|Lost to Follow-up|29|||
23250638|NCT00386100|64659834|FG001|Overall Study|Lost to Follow-up|29|||
23250639|NCT00386100|64659833|FG000|Overall Study|Non-compliance|18|||
23250640|NCT00386100|64659834|FG001|Overall Study|Non-compliance|19|||
23250641|NCT00386100|64659833|FG000|Overall Study|Protocol Violation|5|||
23250642|NCT00386100|64659834|FG001|Overall Study|Protocol Violation|3|||
23250643|NCT00386100|64659833|FG000|Overall Study|Withdrawal by Subject|32|||
23250644|NCT00386100|64659834|FG001|Overall Study|Withdrawal by Subject|31|||
23250645|NCT00386100|64659833|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
23250646|NCT00386100|64659834|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
23250647|NCT00386100|64659833|FG000|Overall Study|BMD <2.5|1|||
23250648|NCT00386100|64659834|FG001|Overall Study|BMD <2.5|0|||
23250649|NCT00386100|64659833|FG000|Overall Study|Consecutive elevated Hba1C|1|||
23250650|NCT00386100|64659834|FG001|Overall Study|Consecutive elevated Hba1C|0|||
23250651|NCT00386100|64659833|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
23357345|NCT01808261|65052769|FG000|Overall Study|Lost to Follow-up|3|||
23357346|NCT01808261|65052770|FG001|Overall Study|Lost to Follow-up|1|||
23357347|NCT00080483|65052771|FG000|Overall Study|Lost to Follow-up|1|||
23357348|NCT00080483|65052772|FG001|Overall Study|Lost to Follow-up|1|||
23357349|NCT00080483|65052771|FG000|Overall Study|Physician Decision|1|||
23357350|NCT00080483|65052772|FG001|Overall Study|Physician Decision|1|||
23357351|NCT01887288|65052774|FG000|Overall Study|The study was terminated and the PI has|16|||
23588963|NCT01140048|65882286|FG000|Overall Study|Withdrawal by Subject|13|||
23250652|NCT00386100|64659834|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
23250653|NCT00386100|64659833|FG000|Overall Study|Laboratory findings|1|||
23250654|NCT00386100|64659834|FG001|Overall Study|Laboratory findings|0|||
23250655|NCT00386100|64659833|FG000|Overall Study|Participant's concern due to CPK levels|1|||
23250656|NCT00386100|64659834|FG001|Overall Study|Participant's concern due to CPK levels|0|||
23250657|NCT00386100|64659833|FG000|Overall Study|Participant moving out of state|2|||
23357352|NCT03585712|65052775|FG000|Treatment Period 1|Protocol Violation|1|||
23357353|NCT03585712|65052776|FG001|Treatment Period 1|Protocol Violation|0|||
23357354|NCT03585712|65052777|FG002|Treatment Period 1|Protocol Violation|0|||
23357355|NCT03585712|65052775|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
23357356|NCT03585712|65052776|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
23357357|NCT03585712|65052777|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
23357358|NCT03585712|65052775|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
23250658|NCT00386100|64659834|FG001|Overall Study|Participant moving out of state|0|||
23250659|NCT00386100|64659833|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
23250660|NCT00386100|64659834|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
23250661|NCT00386100|64659833|FG000|Overall Study|Didn't meet entry criteria|1|||
23250662|NCT00386100|64659834|FG001|Overall Study|Didn't meet entry criteria|1|||
23250663|NCT00386100|64659833|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
23250664|NCT00386100|64659834|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
23250665|NCT00386100|64659833|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
23250666|NCT00386100|64659834|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
23250667|NCT00386100|64659833|FG000|Overall Study|Bad metabolic control & patient security|1|||
23250668|NCT00386100|64659834|FG001|Overall Study|Bad metabolic control & patient security|0|||
23250669|NCT00386100|64659833|FG000|Overall Study|Bone loss by DXA bone scan|1|||
23250670|NCT00386100|64659834|FG001|Overall Study|Bone loss by DXA bone scan|0|||
23250671|NCT00386100|64659833|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
23250672|NCT00386100|64659834|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
23250673|NCT00386100|64659833|FG000|Overall Study|7.6% bone loss|1|||
23250674|NCT00386100|64659834|FG001|Overall Study|7.6% bone loss|0|||
23250675|NCT00386100|64659833|FG000|Overall Study|Osteoporosis|0|||
23250676|NCT00386100|64659834|FG001|Overall Study|Osteoporosis|1|||
23250677|NCT00386100|64659833|FG000|Overall Study|Positive pregnancy test|1|||
23250678|NCT00386100|64659834|FG001|Overall Study|Positive pregnancy test|3|||
23250679|NCT00386100|64659833|FG000|Overall Study|Out of country for 5 months|1|||
23250680|NCT00386100|64659834|FG001|Overall Study|Out of country for 5 months|0|||
23250681|NCT00386100|64659833|FG000|Overall Study|Hb1Ac >8%|0|||
23250682|NCT00386100|64659834|FG001|Overall Study|Hb1Ac >8%|1|||
23250683|NCT00386100|64659833|FG000|Overall Study|Participant randomized in error|1|||
23250684|NCT00386100|64659834|FG001|Overall Study|Participant randomized in error|0|||
23250685|NCT03273712|64659837|FG000|Overall Study|Death|5|||
23250686|NCT03273712|64659837|FG000|Overall Study|Adverse Event|1|||
23250687|NCT03273712|64659837|FG000|Overall Study|Disease Progression|1|||
23250688|NCT00928135|64659838|FG000|Overall Study|Withdrawal by Subject|1|||
23250689|NCT00928135|64659839|FG001|Overall Study|Withdrawal by Subject|0|||
23250690|NCT01154673|64659840|FG000|Overall Study|Lost to Follow-up|1|||
23250691|NCT01154673|64659841|FG001|Overall Study|Lost to Follow-up|0|||
23250692|NCT01154673|64659840|FG000|Overall Study|moved out of province|1|||
23250693|NCT01154673|64659841|FG001|Overall Study|moved out of province|0|||
23250694|NCT01066039|64659842|FG000|Overall Study|Adverse Event|6|||
23250695|NCT01066039|64659842|FG000|Overall Study|Withdrawal by Subject|17|||
23250696|NCT01066039|64659842|FG000|Overall Study|Protocol Violation|2|||
23250697|NCT01066039|64659842|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
23250698|NCT01066039|64659842|FG000|Overall Study|Investigator's Request|1|||
23250699|NCT01066039|64659842|FG000|Overall Study|Dropout due to Insulin Administration|1|||
23250700|NCT01066039|64659842|FG000|Overall Study|Additional Antihypertensive Required|4|||
23250701|NCT01066039|64659842|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
23250702|NCT01066039|64659842|FG000|Overall Study|Failure to Control Blood Pressure|1|||
23250703|NCT01066039|64659842|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
23250704|NCT00450177|64659843|FG000|Overall Study|Adverse Event|7|||
23250705|NCT00450177|64659844|FG001|Overall Study|Adverse Event|4|||
23250706|NCT00450177|64659843|FG000|Overall Study|Withdrawal by Subject|1|||
23250707|NCT00450177|64659844|FG001|Overall Study|Withdrawal by Subject|6|||
23250708|NCT00450177|64659843|FG000|Overall Study|Withdrawal by Primary Team|1|||
23250709|NCT00450177|64659844|FG001|Overall Study|Withdrawal by Primary Team|1|||
23250710|NCT00728988|64659847|FG000|Overall Study|Not Treated|2|||
23250711|NCT00728988|64659848|FG001|Overall Study|Not Treated|2|||
23250712|NCT00728988|64659847|FG000|Overall Study|Death|1|||
23250713|NCT00728988|64659848|FG001|Overall Study|Death|1|||
23250714|NCT00728988|64659847|FG000|Overall Study|Adverse Event|3|||
23250715|NCT00728988|64659848|FG001|Overall Study|Adverse Event|2|||
23250716|NCT00728988|64659847|FG000|Overall Study|Other|85|||
23250717|NCT00728988|64659848|FG001|Overall Study|Other|77|||
23250718|NCT00728988|64659847|FG000|Overall Study|Withdrawal by Subject|2|||
23250719|NCT00728988|64659848|FG001|Overall Study|Withdrawal by Subject|6|||
23250720|NCT02200614|64662496|FG000|Double Blind Treatment|Adverse Event|86|||
23357359|NCT03585712|65052776|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
23588964|NCT01140048|65882286|FG000|Overall Study|Lost to Follow-up|31|||
23250721|NCT02200614|64662497|FG001|Double Blind Treatment|Adverse Event|48|||
23250722|NCT02200614|64662496|FG000|Double Blind Treatment|Confirmed metastasis|120|||
23250723|NCT02200614|64662497|FG001|Double Blind Treatment|Confirmed metastasis|140|||
23250724|NCT02200614|64662496|FG000|Double Blind Treatment|Judgment of the investigator|59|||
23250725|NCT02200614|64662497|FG001|Double Blind Treatment|Judgment of the investigator|99|||
23250726|NCT02200614|64662496|FG000|Double Blind Treatment|Metastasis by local reading|1|||
23250727|NCT02200614|64662497|FG001|Double Blind Treatment|Metastasis by local reading|3|||
23250728|NCT02200614|64662496|FG000|Double Blind Treatment|Other reason|6|||
23250729|NCT02200614|64662497|FG001|Double Blind Treatment|Other reason|2|||
23250730|NCT02200614|64662496|FG000|Double Blind Treatment|Personal reason|77|||
23250731|NCT02200614|64662497|FG001|Double Blind Treatment|Personal reason|85|||
23250732|NCT02200614|64662496|FG000|Double Blind Treatment|Protocol deviation|14|||
23250733|NCT02200614|64662497|FG001|Double Blind Treatment|Protocol deviation|7|||
23250734|NCT02200614|64662496|FG000|Double Blind Treatment|Not treated|1|||
23250735|NCT02200614|64662497|FG001|Double Blind Treatment|Not treated|0|||
23250736|NCT02200614|64662496|FG000|Open Label|Adverse Event|41|||
23250737|NCT02200614|64662497|FG001|Open Label|Adverse Event|11|||
23250738|NCT02200614|64662496|FG000|Open Label|Confirmed metastasis|1|||
23250739|NCT02200614|64662497|FG001|Open Label|Confirmed metastasis|0|||
23357360|NCT03585712|65052777|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
23357361|NCT03585712|65052775|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
23357362|NCT03585712|65052776|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
23357363|NCT03585712|65052777|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
23357364|NCT01597492|65052778|FG000|Overall Study|Withdrawal by Subject|1|||
23250740|NCT02200614|64662496|FG000|Open Label|Judgment of the investigator|29|||
23250741|NCT02200614|64662497|FG001|Open Label|Judgment of the investigator|2|||
23250742|NCT02200614|64662496|FG000|Open Label|Metastasis by local reading|138|||
23250743|NCT02200614|64662497|FG001|Open Label|Metastasis by local reading|27|||
23357365|NCT01597492|65052779|FG001|Overall Study|Withdrawal by Subject|2|||
23357366|NCT01597492|65052778|FG000|Overall Study|Adverse Event|3|||
23357367|NCT01597492|65052779|FG001|Overall Study|Adverse Event|0|||
23357368|NCT01597492|65052778|FG000|Overall Study|Lost to Follow-up|0|||
23357369|NCT01597492|65052779|FG001|Overall Study|Lost to Follow-up|2|||
23357370|NCT01597492|65052778|FG000|Overall Study|Other Reason|2|||
23357371|NCT01597492|65052779|FG001|Overall Study|Other Reason|0|||
23357372|NCT02131233|65052784|FG000|Overall Study|Not Treated|2|||
23357373|NCT02131233|65052785|FG001|Overall Study|Not Treated|3|||
23357374|NCT02131233|65052784|FG000|Overall Study|Adverse Event|7|||
23357375|NCT02131233|65052785|FG001|Overall Study|Adverse Event|6|||
23357376|NCT02131233|65052784|FG000|Overall Study|Death|0|||
23357377|NCT02131233|65052785|FG001|Overall Study|Death|1|||
23357378|NCT02131233|65052784|FG000|Overall Study|Lack of Efficacy|6|||
23357379|NCT02131233|65052785|FG001|Overall Study|Lack of Efficacy|3|||
23357380|NCT02131233|65052784|FG000|Overall Study|Lost to Follow-up|14|||
23357381|NCT02131233|65052785|FG001|Overall Study|Lost to Follow-up|13|||
23357382|NCT02131233|65052784|FG000|Overall Study|Non-Compliance With Study Drug|8|||
23357383|NCT02131233|65052785|FG001|Overall Study|Non-Compliance With Study Drug|5|||
23357384|NCT02131233|65052784|FG000|Overall Study|Physician Decision|7|||
23357385|NCT02131233|65052785|FG001|Overall Study|Physician Decision|0|||
23357386|NCT02131233|65052784|FG000|Overall Study|Pregnancy|4|||
23357387|NCT02131233|65052785|FG001|Overall Study|Pregnancy|0|||
23357388|NCT02131233|65052784|FG000|Overall Study|Withdrawal by Subject|18|||
23357389|NCT02131233|65052785|FG001|Overall Study|Withdrawal by Subject|11|||
23357390|NCT02756364|65052786|FG000|Overall Study|Site Terminated by Sponsor|24|||
23357391|NCT02756364|65052787|FG001|Overall Study|Site Terminated by Sponsor|30|||
23357392|NCT02756364|65052788|FG002|Overall Study|Site Terminated by Sponsor|21|||
23357393|NCT02756364|65052786|FG000|Overall Study|Death|20|||
23250744|NCT02200614|64662496|FG000|Open Label|Other reason|22|||
23250745|NCT02200614|64662497|FG001|Open Label|Other reason|4|||
23250746|NCT02200614|64662496|FG000|Open Label|Personal reason|60|||
23250747|NCT02200614|64662497|FG001|Open Label|Personal reason|8|||
23250748|NCT02200614|64662496|FG000|Open Label|Protocol deviation|3|||
23250749|NCT02200614|64662497|FG001|Open Label|Protocol deviation|2|||
23250750|NCT02200614|64662496|FG000|Open Label|Missing|2|||
23250751|NCT02200614|64662497|FG001|Open Label|Missing|2|||
23250752|NCT01339000|64662505|FG000|Overall Study|study closed due to lack of drug supply|1|||
23357394|NCT02756364|65052787|FG001|Overall Study|Death|15|||
23357395|NCT02756364|65052788|FG002|Overall Study|Death|18|||
23357396|NCT02756364|65052786|FG000|Overall Study|Withdrawal by Patient|2|||
23357397|NCT02756364|65052787|FG001|Overall Study|Withdrawal by Patient|1|||
23357398|NCT02756364|65052788|FG002|Overall Study|Withdrawal by Patient|8|||
23250753|NCT01339000|64662506|FG001|Overall Study|study closed due to lack of drug supply|0|||
23357399|NCT02756364|65052786|FG000|Overall Study|Lost to Follow-up|0|||
23250754|NCT00943384|64662507|FG000|Overall Study|Dispositioned prior to treatment|23|||
23357400|NCT02756364|65052787|FG001|Overall Study|Lost to Follow-up|1|||
23357401|NCT02756364|65052788|FG002|Overall Study|Lost to Follow-up|1|||
23357402|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
23357403|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
23357404|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
23250755|NCT00943384|64662507|FG000|Overall Study|Treated off protocol-protocol violation|5|||
23250756|NCT00943384|64662507|FG000|Overall Study|Lost to Follow-up|16|||
23250757|NCT00943384|64662507|FG000|Overall Study|Withdrawal by Subject|5|||
23357405|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
23357406|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
23357407|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
23357408|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
23357409|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
23357410|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
23357411|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
23357412|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
23357413|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
23357414|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
23357415|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
23357416|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
23357417|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
23357418|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
23357419|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
23357420|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
23357421|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
23357422|NCT02087943|65052789|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
23357423|NCT02087943|65052790|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
23357424|NCT02087943|65052791|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
23357425|NCT02087943|65052792|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
23357426|NCT02087943|65052793|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
23357427|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
23588965|NCT00845832|65882287|FG000|Treatment Period|Adverse Event|0|||
23250758|NCT02125734|64662508|FG000|Period 2|Adverse Event|0|||
23250759|NCT02125734|64662509|FG001|Period 2|Adverse Event|1|||
23250760|NCT00827359|64662510|FG000|Overall Study|Progressive Diseas|19|||
23250761|NCT00827359|64662510|FG000|Overall Study|Unacceptable Toxicity|5|||
23250762|NCT00827359|64662510|FG000|Overall Study|Ineligible|1|||
23250763|NCT01625286|64662511|FG000|Overall Study|Adverse Event|0|||
23250764|NCT01625286|64662512|FG001|Overall Study|Adverse Event|0|||
23250765|NCT01625286|64662513|FG002|Overall Study|Adverse Event|0|||
23250766|NCT01625286|64662514|FG003|Overall Study|Adverse Event|0|||
23250767|NCT01625286|64662515|FG004|Overall Study|Adverse Event|1|||
23250768|NCT01625286|64662516|FG005|Overall Study|Adverse Event|2|||
23250769|NCT01625286|64662517|FG006|Overall Study|Adverse Event|1|||
23250770|NCT01625286|64662511|FG000|Overall Study|Death|0|||
23250771|NCT01625286|64662512|FG001|Overall Study|Death|0|||
23250772|NCT01625286|64662513|FG002|Overall Study|Death|1|||
23250773|NCT01625286|64662514|FG003|Overall Study|Death|1|||
23250774|NCT01625286|64662515|FG004|Overall Study|Death|0|||
23250775|NCT01625286|64662516|FG005|Overall Study|Death|11|||
23250776|NCT01625286|64662517|FG006|Overall Study|Death|16|||
23250777|NCT01625286|64662511|FG000|Overall Study|Withdrawal by Subject|0|||
23250778|NCT01625286|64662512|FG001|Overall Study|Withdrawal by Subject|1|||
23250779|NCT01625286|64662513|FG002|Overall Study|Withdrawal by Subject|0|||
23250780|NCT01625286|64662514|FG003|Overall Study|Withdrawal by Subject|1|||
23250781|NCT01625286|64662515|FG004|Overall Study|Withdrawal by Subject|0|||
23250782|NCT01625286|64662516|FG005|Overall Study|Withdrawal by Subject|0|||
23250783|NCT01625286|64662517|FG006|Overall Study|Withdrawal by Subject|1|||
23250784|NCT01625286|64662511|FG000|Overall Study|Any reason not specifically recorded|0|||
23250785|NCT01625286|64662512|FG001|Overall Study|Any reason not specifically recorded|0|||
23250786|NCT01625286|64662513|FG002|Overall Study|Any reason not specifically recorded|0|||
23250787|NCT01625286|64662514|FG003|Overall Study|Any reason not specifically recorded|0|||
23250788|NCT01625286|64662515|FG004|Overall Study|Any reason not specifically recorded|0|||
23250789|NCT01625286|64662516|FG005|Overall Study|Any reason not specifically recorded|1|||
23250790|NCT01625286|64662517|FG006|Overall Study|Any reason not specifically recorded|0|||
23250791|NCT01625286|64662511|FG000|Overall Study|Progressive disease|6|||
23250792|NCT01625286|64662512|FG001|Overall Study|Progressive disease|3|||
23250793|NCT01625286|64662513|FG002|Overall Study|Progressive disease|4|||
23250794|NCT01625286|64662514|FG003|Overall Study|Progressive disease|5|||
23250795|NCT01625286|64662515|FG004|Overall Study|Progressive disease|5|||
23357428|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
23250796|NCT01625286|64662516|FG005|Overall Study|Progressive disease|0|||
23250797|NCT01625286|64662517|FG006|Overall Study|Progressive disease|0|||
23250798|NCT01625286|64662511|FG000|Overall Study|Lost to Follow-up|0|||
23250799|NCT01625286|64662512|FG001|Overall Study|Lost to Follow-up|0|||
23250800|NCT01625286|64662513|FG002|Overall Study|Lost to Follow-up|0|||
23250801|NCT01625286|64662514|FG003|Overall Study|Lost to Follow-up|0|||
23250802|NCT01625286|64662515|FG004|Overall Study|Lost to Follow-up|0|||
23250803|NCT01625286|64662516|FG005|Overall Study|Lost to Follow-up|0|||
23357429|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
23357430|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
23190719|NCT03241173|64439492|FG010|Overall Study|Withdrawal by Subject|0|||
23190720|NCT03241173|64439493|FG011|Overall Study|Withdrawal by Subject|0|||
23357431|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
23357432|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
23357433|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
23357434|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
23357435|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
23190721|NCT03241173|64439494|FG012|Overall Study|Withdrawal by Subject|0|||
23190722|NCT03241173|64439495|FG013|Overall Study|Withdrawal by Subject|0|||
23190723|NCT03241173|64439496|FG014|Overall Study|Withdrawal by Subject|0|||
23190724|NCT03241173|64439482|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
23190725|NCT03241173|64439483|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
23190726|NCT03241173|64439484|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23190727|NCT03241173|64439485|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
23190728|NCT03241173|64439486|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
23190729|NCT03241173|64439487|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
23190730|NCT03241173|64439488|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
23190731|NCT03241173|64439489|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
23190732|NCT03241173|64439490|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23190733|NCT03241173|64439491|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23190734|NCT03241173|64439492|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
23250804|NCT01625286|64662517|FG006|Overall Study|Lost to Follow-up|1|||
23250805|NCT02574260|64662521|FG000|Overall Study|Disease Progression|1|||
23250806|NCT03174925|64662522|FG000|Overall Study|Elastographic images not retrievable|2|||
23250807|NCT03174925|64662522|FG000|Overall Study|Elastography image not interpretable|1|||
23250808|NCT02475980|64662523|FG000|Overall Study|Lost to Follow-up|4|||
23250809|NCT02475980|64662523|FG000|Overall Study|Withdrawal by Subject|1|||
23250810|NCT00934622|64662524|FG000|Overall Study|Lost to Follow-up|7|||
23357436|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
23357437|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
23357438|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
23357439|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
23357440|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
23357441|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
23250811|NCT00934622|64662524|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
23357442|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
23190735|NCT03241173|64439493|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
23250812|NCT03547531|64662525|FG000|Overall Study|not coming in data collection : sick|2|||
23250813|NCT03547531|64662526|FG001|Overall Study|not coming in data collection : sick|2|||
23357443|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
23357444|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
23250814|NCT03547531|64662525|FG000|Overall Study|having family occasion|0|||
23250815|NCT03547531|64662526|FG001|Overall Study|having family occasion|2|||
23250816|NCT00420290|64662529|FG000|Overall Study|Adverse Event|3|||
23250817|NCT00420290|64662530|FG001|Overall Study|Adverse Event|1|||
23250818|NCT00420290|64662529|FG000|Overall Study|Withdrawal by Subject|0|||
23250819|NCT00420290|64662530|FG001|Overall Study|Withdrawal by Subject|2|||
23250820|NCT00420290|64662529|FG000|Overall Study|did not meet inclusion/exclusion|1|||
23473865|NCT02039843|65477744|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
23473866|NCT01214395|65477745|FG000|Overall Study|All patients had infection|5|||
23473867|NCT00684060|65477747|FG000|Overall Study|Lost to Follow-up|1|||
23473868|NCT00684060|65477748|FG001|Overall Study|Lost to Follow-up|0|||
23190736|NCT03241173|64439494|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23190737|NCT03241173|64439495|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23190738|NCT03241173|64439496|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
23473869|NCT00684060|65477747|FG000|Overall Study|New stenosis identified|1|||
23473870|NCT00684060|65477748|FG001|Overall Study|New stenosis identified|0|||
23473871|NCT00684060|65477747|FG000|Overall Study|Unable to collect MRI|1|||
23473872|NCT00684060|65477748|FG001|Overall Study|Unable to collect MRI|2|||
23473873|NCT00684060|65477747|FG000|Overall Study|Death|0|||
23473874|NCT00684060|65477748|FG001|Overall Study|Death|1|||
23473875|NCT02604160|65477749|FG000|Overall Study|Protocol Violation|0|||
23473876|NCT02604160|65477750|FG001|Overall Study|Protocol Violation|1|||
23473877|NCT02604160|65477749|FG000|Overall Study|Physician Decision|0|||
23473878|NCT02604160|65477750|FG001|Overall Study|Physician Decision|1|||
23473879|NCT02878798|65477751|FG000|Overall Study|Withdrawal by Subject|5|||
23473880|NCT02878798|65477752|FG001|Overall Study|Withdrawal by Subject|4|||
23190739|NCT03241173|64439482|FG000|Overall Study|Lost to Follow-up|0|||
23190740|NCT03241173|64439483|FG001|Overall Study|Lost to Follow-up|0|||
23473881|NCT02878798|65477751|FG000|Overall Study|Lost to Follow-up|2|||
23473882|NCT02878798|65477752|FG001|Overall Study|Lost to Follow-up|2|||
23473883|NCT02878798|65477751|FG000|Overall Study|Protocol Violation|0|||
23473884|NCT02878798|65477752|FG001|Overall Study|Protocol Violation|1|||
23473885|NCT01410357|65477753|FG000|Overall Study|Death|2|||
23473886|NCT01410357|65477754|FG001|Overall Study|Death|1|||
23473887|NCT01410357|65477753|FG000|Overall Study|Withdrawal by Subject|1|||
23473888|NCT01410357|65477754|FG001|Overall Study|Withdrawal by Subject|2|||
23473889|NCT01410357|65477753|FG000|Overall Study|Lost to Follow-up|23|||
23473890|NCT01410357|65477754|FG001|Overall Study|Lost to Follow-up|21|||
23473891|NCT00146848|65477755|FG000|Pre-randomization|Death|19|||
23473892|NCT00146848|65477756|FG001|Pre-randomization|Death|0|||
23473893|NCT00146848|65477757|FG002|Pre-randomization|Death|0|||
23473894|NCT00146848|65477755|FG000|Pre-randomization|Lost to Follow-up|70|||
23473895|NCT00146848|65477756|FG001|Pre-randomization|Lost to Follow-up|0|||
23473896|NCT00146848|65477757|FG002|Pre-randomization|Lost to Follow-up|0|||
23473897|NCT00146848|65477755|FG000|Pre-randomization|Physician Decision|8|||
23473898|NCT00146848|65477756|FG001|Pre-randomization|Physician Decision|0|||
23473899|NCT00146848|65477757|FG002|Pre-randomization|Physician Decision|0|||
23473900|NCT00146848|65477755|FG000|Pre-randomization|Protocol Violation|172|||
23473901|NCT00146848|65477756|FG001|Pre-randomization|Protocol Violation|0|||
23473902|NCT00146848|65477757|FG002|Pre-randomization|Protocol Violation|0|||
23473903|NCT00146848|65477755|FG000|Pre-randomization|Withdrawal by Subject|40|||
23473904|NCT00146848|65477756|FG001|Pre-randomization|Withdrawal by Subject|0|||
23473905|NCT00146848|65477757|FG002|Pre-randomization|Withdrawal by Subject|0|||
23473906|NCT00146848|65477755|FG000|Post-randomization|Lost to Follow-up|12|||
23473907|NCT00146848|65477756|FG001|Post-randomization|Lost to Follow-up|15|||
23473908|NCT00146848|65477757|FG002|Post-randomization|Lost to Follow-up|12|||
23250821|NCT00420290|64662530|FG001|Overall Study|did not meet inclusion/exclusion|1|||
23250822|NCT02962739|64662532|FG000|Overall Study|Withdrawal by Subject|0|||
23250823|NCT02962739|64662533|FG001|Overall Study|Withdrawal by Subject|1|||
23250824|NCT02962739|64662534|FG002|Overall Study|Withdrawal by Subject|0|||
23250825|NCT02962739|64662535|FG003|Overall Study|Withdrawal by Subject|0|||
23250826|NCT02962739|64662536|FG004|Overall Study|Withdrawal by Subject|0|||
23250827|NCT02962739|64662537|FG005|Overall Study|Withdrawal by Subject|0|||
23250828|NCT02962739|64662532|FG000|Overall Study|Protocol Violation|0|||
23250829|NCT02962739|64662533|FG001|Overall Study|Protocol Violation|0|||
23250830|NCT02962739|64662534|FG002|Overall Study|Protocol Violation|1|||
23250831|NCT02962739|64662535|FG003|Overall Study|Protocol Violation|0|||
23250832|NCT02962739|64662536|FG004|Overall Study|Protocol Violation|1|||
23473909|NCT00146848|65477755|FG000|Post-randomization|Withdrawn|26|||
23588966|NCT00845832|65882288|FG001|Treatment Period|Adverse Event|2|||
23250833|NCT02962739|64662537|FG005|Overall Study|Protocol Violation|0|||
23473910|NCT00146848|65477756|FG001|Post-randomization|Withdrawn|32|||
23473911|NCT00146848|65477757|FG002|Post-randomization|Withdrawn|27|||
23473912|NCT03207763|65481601|FG000|Overall Study|Lost to Follow-up|1|||
23588967|NCT00845832|65882289|FG002|Treatment Period|Adverse Event|0|||
23250834|NCT01896700|64662538|FG000|Overall Study|Adverse Event|4|||
23473913|NCT03207763|65481602|FG001|Overall Study|Lost to Follow-up|0|||
23473914|NCT04145219|65481603|FG000|Overall Study|Adverse Event|18|||
23473915|NCT04145219|65481604|FG001|Overall Study|Adverse Event|6|||
23473916|NCT04145219|65481603|FG000|Overall Study|Lost to Follow-up|2|||
23473917|NCT04145219|65481604|FG001|Overall Study|Lost to Follow-up|3|||
23473918|NCT04145219|65481603|FG000|Overall Study|Physician Decision|0|||
23473919|NCT04145219|65481604|FG001|Overall Study|Physician Decision|2|||
23473920|NCT04145219|65481603|FG000|Overall Study|Withdrawal by Subject|12|||
23473921|NCT04145219|65481604|FG001|Overall Study|Withdrawal by Subject|8|||
23473922|NCT04145219|65481603|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
23473923|NCT04145219|65481604|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
23473924|NCT01206322|65481607|FG000|Overall Study|Adverse Event|0|||
23473925|NCT01206322|65481608|FG001|Overall Study|Adverse Event|0|||
23473926|NCT01206322|65481609|FG002|Overall Study|Adverse Event|0|||
23473927|NCT01206322|65481610|FG003|Overall Study|Adverse Event|1|||
23473928|NCT00763698|65481614|FG000|Overall Study|Unsuccessful Implant|5|||
23473929|NCT00763698|65481614|FG000|Overall Study|Death|4|||
23473930|NCT00763698|65481614|FG000|Overall Study|Withdrawal by Subject|1|||
23473931|NCT01675544|65481618|FG000|Overall Study|Withdrawal by Subject|2|||
23473932|NCT01182844|65481619|FG000|Overall Study|Withdrawal by Subject|0|||
23473933|NCT01182844|65481620|FG001|Overall Study|Withdrawal by Subject|2|||
23473934|NCT01136785|65481621|FG000|Overall Study|Protocol Violation|2|||
23473935|NCT01136785|65481622|FG001|Overall Study|Protocol Violation|1|||
23473936|NCT03288142|65481623|FG000|Overall Study|Lost to Follow-up|22|||
23473937|NCT03288142|65481624|FG001|Overall Study|Lost to Follow-up|15|||
23473938|NCT00530816|65481625|FG000|Overall Study|Progressive Disease|16|||
23473939|NCT00530816|65481626|FG001|Overall Study|Progressive Disease|24|||
23473940|NCT00530816|65481627|FG002|Overall Study|Progressive Disease|24|||
23190741|NCT03241173|64439484|FG002|Overall Study|Lost to Follow-up|0|||
23190742|NCT03241173|64439485|FG003|Overall Study|Lost to Follow-up|0|||
23357445|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
23473941|NCT00530816|65481625|FG000|Overall Study|Adverse Event|6|||
23473942|NCT00530816|65481626|FG001|Overall Study|Adverse Event|13|||
23473943|NCT00530816|65481627|FG002|Overall Study|Adverse Event|7|||
23473944|NCT00530816|65481625|FG000|Overall Study|Other|3|||
23473945|NCT00530816|65481626|FG001|Overall Study|Other|3|||
23473946|NCT00530816|65481627|FG002|Overall Study|Other|4|||
23473947|NCT00530816|65481625|FG000|Overall Study|Withdrawal by Subject|1|||
23473948|NCT00530816|65481626|FG001|Overall Study|Withdrawal by Subject|2|||
23473949|NCT00530816|65481627|FG002|Overall Study|Withdrawal by Subject|6|||
23473950|NCT00783198|65481628|FG000|Overall Study|Adverse Event|15|||
23473951|NCT00783198|65481629|FG001|Overall Study|Adverse Event|19|||
23473952|NCT00783198|65481630|FG002|Overall Study|Adverse Event|3|||
23473953|NCT00783198|65481628|FG000|Overall Study|Lost to Follow-up|11|||
23473954|NCT00783198|65481629|FG001|Overall Study|Lost to Follow-up|1|||
23473955|NCT00783198|65481630|FG002|Overall Study|Lost to Follow-up|7|||
23473956|NCT00783198|65481628|FG000|Overall Study|Withdrawal by Subject|22|||
23473957|NCT00783198|65481629|FG001|Overall Study|Withdrawal by Subject|14|||
23473958|NCT00783198|65481630|FG002|Overall Study|Withdrawal by Subject|20|||
23473959|NCT00783198|65481628|FG000|Overall Study|Noncompliance with protocol|7|||
23473960|NCT00783198|65481629|FG001|Overall Study|Noncompliance with protocol|7|||
23473961|NCT00783198|65481630|FG002|Overall Study|Noncompliance with protocol|10|||
23473962|NCT00783198|65481628|FG000|Overall Study|Did not meet protocol eligibility|0|||
23473963|NCT00783198|65481629|FG001|Overall Study|Did not meet protocol eligibility|1|||
23473964|NCT00783198|65481630|FG002|Overall Study|Did not meet protocol eligibility|0|||
23473965|NCT00783198|65481628|FG000|Overall Study|Administrative|2|||
23473966|NCT00783198|65481629|FG001|Overall Study|Administrative|1|||
23473967|NCT00783198|65481630|FG002|Overall Study|Administrative|2|||
23357446|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
23357447|NCT02087943|65052789|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
23357448|NCT02087943|65052790|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
23357449|NCT02087943|65052791|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
23357450|NCT02087943|65052792|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
23357451|NCT02087943|65052793|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
23357452|NCT00385827|65052794|FG000|Part 1|Adverse Event|1|||
23357453|NCT00385827|65052795|FG001|Part 1|Adverse Event|0|||
23357454|NCT00385827|65052796|FG002|Part 1|Adverse Event|0|||
23190743|NCT03241173|64439486|FG004|Overall Study|Lost to Follow-up|1|||
23190744|NCT03241173|64439487|FG005|Overall Study|Lost to Follow-up|0|||
23190745|NCT03241173|64439488|FG006|Overall Study|Lost to Follow-up|0|||
23190746|NCT03241173|64439489|FG007|Overall Study|Lost to Follow-up|0|||
23190747|NCT03241173|64439490|FG008|Overall Study|Lost to Follow-up|0|||
23190748|NCT03241173|64439491|FG009|Overall Study|Lost to Follow-up|1|||
23473968|NCT00160667|65481631|FG000|Overall Study|Adverse Event|3|||
23473969|NCT00160667|65481632|FG001|Overall Study|Adverse Event|1|||
23190749|NCT03241173|64439492|FG010|Overall Study|Lost to Follow-up|0|||
23473970|NCT00160667|65481633|FG002|Overall Study|Adverse Event|4|||
23473971|NCT00160667|65481631|FG000|Overall Study|Withdrawal by Subject|2|||
23190750|NCT03241173|64439493|FG011|Overall Study|Lost to Follow-up|0|||
23190751|NCT03241173|64439494|FG012|Overall Study|Lost to Follow-up|0|||
23250835|NCT01896700|64662539|FG001|Overall Study|Adverse Event|5|||
23473972|NCT00160667|65481632|FG001|Overall Study|Withdrawal by Subject|0|||
23473973|NCT00160667|65481633|FG002|Overall Study|Withdrawal by Subject|1|||
23473974|NCT00160667|65481631|FG000|Overall Study|Lack of Efficacy|0|||
23473975|NCT00160667|65481632|FG001|Overall Study|Lack of Efficacy|1|||
23473976|NCT00160667|65481633|FG002|Overall Study|Lack of Efficacy|0|||
23473977|NCT00160667|65481631|FG000|Overall Study|Protocol Violation|0|||
23473978|NCT00160667|65481632|FG001|Overall Study|Protocol Violation|1|||
23473979|NCT00160667|65481633|FG002|Overall Study|Protocol Violation|0|||
23473980|NCT00160667|65481631|FG000|Overall Study|Patient decision|0|||
23473981|NCT00160667|65481632|FG001|Overall Study|Patient decision|0|||
23473982|NCT00160667|65481633|FG002|Overall Study|Patient decision|1|||
23473983|NCT00796991|65481634|FG000|Overall Study|Adverse Event|0|||
23473984|NCT00796991|65481635|FG001|Overall Study|Adverse Event|0|||
23473985|NCT00796991|65481636|FG002|Overall Study|Adverse Event|1|||
23473986|NCT00796991|65481634|FG000|Overall Study|Death|2|||
23473987|NCT00796991|65481635|FG001|Overall Study|Death|0|||
23473988|NCT00796991|65481636|FG002|Overall Study|Death|0|||
23473989|NCT00796991|65481634|FG000|Overall Study|Disease Progression|10|||
23473990|NCT00796991|65481635|FG001|Overall Study|Disease Progression|9|||
23473991|NCT00796991|65481636|FG002|Overall Study|Disease Progression|7|||
23473992|NCT00796991|65481634|FG000|Overall Study|Study Drug Toxicity|3|||
23473993|NCT00796991|65481635|FG001|Overall Study|Study Drug Toxicity|3|||
23250836|NCT01896700|64662538|FG000|Overall Study|Withdrawal by Subject|0|||
23250837|NCT01896700|64662539|FG001|Overall Study|Withdrawal by Subject|1|||
23250838|NCT01246986|64662540|FG000|Overall Study|Lost to Follow-up|0|||
23250839|NCT01246986|64662541|FG001|Overall Study|Lost to Follow-up|1|||
23250840|NCT01246986|64662542|FG002|Overall Study|Lost to Follow-up|3|||
23250841|NCT01246986|64662543|FG003|Overall Study|Lost to Follow-up|0|||
23250842|NCT01246986|64662544|FG004|Overall Study|Lost to Follow-up|0|||
23250843|NCT01246986|64662545|FG005|Overall Study|Lost to Follow-up|1|||
23250844|NCT01246986|64662546|FG006|Overall Study|Lost to Follow-up|0|||
23250845|NCT01246986|64662540|FG000|Overall Study|Withdrawal by Subject|3|||
23250846|NCT01246986|64662541|FG001|Overall Study|Withdrawal by Subject|4|||
23250847|NCT01246986|64662542|FG002|Overall Study|Withdrawal by Subject|3|||
23250848|NCT01246986|64662543|FG003|Overall Study|Withdrawal by Subject|0|||
23250849|NCT01246986|64662544|FG004|Overall Study|Withdrawal by Subject|4|||
23250850|NCT01246986|64662545|FG005|Overall Study|Withdrawal by Subject|0|||
23250851|NCT01246986|64662546|FG006|Overall Study|Withdrawal by Subject|0|||
23473994|NCT00796991|65481636|FG002|Overall Study|Study Drug Toxicity|5|||
23473995|NCT00796991|65481634|FG000|Overall Study|Withdrawal by Subject|0|||
23473996|NCT00796991|65481635|FG001|Overall Study|Withdrawal by Subject|0|||
23473997|NCT00796991|65481636|FG002|Overall Study|Withdrawal by Subject|1|||
23473998|NCT04784442|65481639|FG000|Overall Study|Adverse Event|1|||
23473999|NCT04784442|65481640|FG001|Overall Study|Adverse Event|0|||
23474000|NCT04784442|65481641|FG002|Overall Study|Adverse Event|2|||
23474001|NCT04784442|65481642|FG003|Overall Study|Adverse Event|1|||
23474002|NCT04784442|65481639|FG000|Overall Study|Protocol Violation|1|||
23474003|NCT04784442|65481640|FG001|Overall Study|Protocol Violation|0|||
23474004|NCT04784442|65481641|FG002|Overall Study|Protocol Violation|0|||
23474005|NCT04784442|65481642|FG003|Overall Study|Protocol Violation|0|||
23474006|NCT04784442|65481639|FG000|Overall Study|Non-compliance with study drug|1|||
23474007|NCT04784442|65481640|FG001|Overall Study|Non-compliance with study drug|0|||
23474008|NCT04784442|65481641|FG002|Overall Study|Non-compliance with study drug|0|||
23474009|NCT04784442|65481642|FG003|Overall Study|Non-compliance with study drug|0|||
23474010|NCT04525885|65481643|FG000|Overall Study|Screen Failure|1|||
23474011|NCT04525885|65481644|FG001|Overall Study|Screen Failure|0|||
23474012|NCT04525885|65481645|FG002|Overall Study|Screen Failure|0|||
23474013|NCT04525885|65481643|FG000|Overall Study|Withdrawal by Subject|14|||
23474014|NCT04525885|65481644|FG001|Overall Study|Withdrawal by Subject|6|||
23474015|NCT04525885|65481645|FG002|Overall Study|Withdrawal by Subject|20|||
23474016|NCT04525885|65481643|FG000|Overall Study|Physician Decision|1|||
23474017|NCT04525885|65481644|FG001|Overall Study|Physician Decision|0|||
23474018|NCT04525885|65481645|FG002|Overall Study|Physician Decision|1|||
23474019|NCT03085914|65481646|FG000|Overall Study|Death|6|||
23474020|NCT03085914|65481647|FG001|Overall Study|Death|6|||
23474021|NCT03085914|65481648|FG002|Overall Study|Death|4|||
23250852|NCT03091400|64662547|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
23250853|NCT03091400|64662548|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
23474022|NCT03085914|65481649|FG003|Overall Study|Death|1|||
23474023|NCT03085914|65481650|FG004|Overall Study|Death|5|||
23190752|NCT03241173|64439495|FG013|Overall Study|Lost to Follow-up|0|||
23474024|NCT03085914|65481651|FG005|Overall Study|Death|2|||
23474025|NCT03085914|65481652|FG006|Overall Study|Death|2|||
23474026|NCT03085914|65481646|FG000|Overall Study|Withdrawal by Subject|1|||
23474027|NCT03085914|65481647|FG001|Overall Study|Withdrawal by Subject|1|||
23474028|NCT03085914|65481648|FG002|Overall Study|Withdrawal by Subject|2|||
23474029|NCT03085914|65481649|FG003|Overall Study|Withdrawal by Subject|2|||
23474030|NCT03085914|65481650|FG004|Overall Study|Withdrawal by Subject|2|||
23474031|NCT03085914|65481651|FG005|Overall Study|Withdrawal by Subject|0|||
23474032|NCT03085914|65481652|FG006|Overall Study|Withdrawal by Subject|1|||
23474033|NCT03085914|65481646|FG000|Overall Study|Lost to Follow-up|0|||
23474034|NCT03085914|65481647|FG001|Overall Study|Lost to Follow-up|0|||
23474035|NCT03085914|65481648|FG002|Overall Study|Lost to Follow-up|1|||
23474036|NCT03085914|65481649|FG003|Overall Study|Lost to Follow-up|0|||
23474037|NCT03085914|65481650|FG004|Overall Study|Lost to Follow-up|0|||
23474038|NCT03085914|65481651|FG005|Overall Study|Lost to Follow-up|1|||
23474039|NCT03085914|65481652|FG006|Overall Study|Lost to Follow-up|1|||
23474040|NCT03085914|65481646|FG000|Overall Study|Reason was not specified,|2|||
23474041|NCT03085914|65481647|FG001|Overall Study|Reason was not specified,|2|||
23474042|NCT03085914|65481648|FG002|Overall Study|Reason was not specified,|2|||
23474043|NCT03085914|65481649|FG003|Overall Study|Reason was not specified,|3|||
23474044|NCT03085914|65481650|FG004|Overall Study|Reason was not specified,|3|||
23474045|NCT03085914|65481651|FG005|Overall Study|Reason was not specified,|3|||
23474046|NCT03085914|65481652|FG006|Overall Study|Reason was not specified,|6|||
23474047|NCT03085914|65481646|FG000|Overall Study|Progressive Disease|0|||
23474048|NCT03085914|65481647|FG001|Overall Study|Progressive Disease|0|||
23474049|NCT03085914|65481648|FG002|Overall Study|Progressive Disease|2|||
23474050|NCT03085914|65481649|FG003|Overall Study|Progressive Disease|2|||
23474051|NCT03085914|65481650|FG004|Overall Study|Progressive Disease|1|||
23474052|NCT03085914|65481651|FG005|Overall Study|Progressive Disease|1|||
23474053|NCT03085914|65481652|FG006|Overall Study|Progressive Disease|1|||
23474054|NCT03085914|65481646|FG000|Overall Study|Study Terminated by the Sponsor|0|||
23474055|NCT03085914|65481647|FG001|Overall Study|Study Terminated by the Sponsor|0|||
23474056|NCT03085914|65481648|FG002|Overall Study|Study Terminated by the Sponsor|0|||
23474057|NCT03085914|65481649|FG003|Overall Study|Study Terminated by the Sponsor|1|||
23474058|NCT03085914|65481650|FG004|Overall Study|Study Terminated by the Sponsor|2|||
23474059|NCT03085914|65481651|FG005|Overall Study|Study Terminated by the Sponsor|1|||
23474060|NCT03085914|65481652|FG006|Overall Study|Study Terminated by the Sponsor|0|||
23474061|NCT01008423|65481653|FG000|Overall Study|Adverse Event|13|||
23474062|NCT01008423|65481654|FG001|Overall Study|Adverse Event|6|||
23474063|NCT01008423|65481653|FG000|Overall Study|Withdrawal by Subject|4|||
23474064|NCT01008423|65481654|FG001|Overall Study|Withdrawal by Subject|7|||
23474065|NCT01008423|65481653|FG000|Overall Study|Lost to Follow-up|0|||
23474066|NCT01008423|65481654|FG001|Overall Study|Lost to Follow-up|2|||
23588968|NCT00845832|65882287|FG000|Treatment Period|Protocol Violation|1|||
23588969|NCT00845832|65882288|FG001|Treatment Period|Protocol Violation|1|||
23588970|NCT00845832|65882289|FG002|Treatment Period|Protocol Violation|0|||
23588971|NCT00845832|65882287|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
23588972|NCT00845832|65882288|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
23588973|NCT00845832|65882289|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
23588974|NCT00845832|65882287|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
23588975|NCT00845832|65882288|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
23588976|NCT00845832|65882289|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
23588977|NCT00605033|65882290|FG000|Overall Study|Adverse Event|2|||
23588978|NCT00605033|65882291|FG001|Overall Study|Adverse Event|2|||
23588979|NCT00605033|65882290|FG000|Overall Study|Lost to Follow-up|1|||
23588980|NCT00605033|65882291|FG001|Overall Study|Lost to Follow-up|1|||
23588981|NCT00605033|65882290|FG000|Overall Study|Withdrawal by Subject|3|||
23588982|NCT00605033|65882291|FG001|Overall Study|Withdrawal by Subject|4|||
23588983|NCT00605033|65882290|FG000|Overall Study|Protocol Violation|1|||
23588984|NCT00605033|65882291|FG001|Overall Study|Protocol Violation|1|||
23588985|NCT02131324|65882292|FG000|Overall Study|Withdrawal by Subject|1|||
23588986|NCT02131324|65882293|FG001|Overall Study|Withdrawal by Subject|2|||
23588987|NCT02131324|65882292|FG000|Overall Study|Lost to Follow-up|1|||
23588988|NCT02131324|65882293|FG001|Overall Study|Lost to Follow-up|1|||
23588989|NCT01194258|65882297|FG000|Titration Period|Withdrawal by Subject|6|||
23588990|NCT01194258|65882298|FG001|Titration Period|Withdrawal by Subject|0|||
23588991|NCT01194258|65882299|FG002|Titration Period|Withdrawal by Subject|0|||
23588992|NCT01194258|65882300|FG003|Titration Period|Withdrawal by Subject|0|||
23588993|NCT01194258|65882301|FG004|Titration Period|Withdrawal by Subject|0|||
23588994|NCT01194258|65882297|FG000|Titration Period|Lost to Follow-up|2|||
23588995|NCT01194258|65882298|FG001|Titration Period|Lost to Follow-up|0|||
23588996|NCT01194258|65882299|FG002|Titration Period|Lost to Follow-up|0|||
23588997|NCT01194258|65882300|FG003|Titration Period|Lost to Follow-up|0|||
23588998|NCT01194258|65882301|FG004|Titration Period|Lost to Follow-up|0|||
23474067|NCT01008423|65481653|FG000|Overall Study|Low Cortisol|0|||
23474068|NCT01008423|65481654|FG001|Overall Study|Low Cortisol|1|||
23474069|NCT01008423|65481653|FG000|Overall Study|Lack of Efficacy|0|||
23474070|NCT01008423|65481654|FG001|Overall Study|Lack of Efficacy|5|||
23474071|NCT01008423|65481653|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
23474072|NCT01008423|65481654|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
23588999|NCT01194258|65882297|FG000|Titration Period|Titration failure|3|||
23589000|NCT01194258|65882298|FG001|Titration Period|Titration failure|0|||
23589001|NCT01194258|65882299|FG002|Titration Period|Titration failure|0|||
23589002|NCT01194258|65882300|FG003|Titration Period|Titration failure|0|||
23474073|NCT01008423|65481653|FG000|Overall Study|Personal Conflict|1|||
23474074|NCT01008423|65481654|FG001|Overall Study|Personal Conflict|0|||
23474075|NCT01008423|65481653|FG000|Overall Study|Other|0|||
23474076|NCT01008423|65481654|FG001|Overall Study|Other|1|||
23474077|NCT01667419|65481655|FG000|Overall Study|Reason Not Specified|1|||
23474078|NCT01667419|65481656|FG001|Overall Study|Reason Not Specified|0|||
23474079|NCT01667419|65481657|FG002|Overall Study|Reason Not Specified|0|||
23474080|NCT01667419|65481658|FG003|Overall Study|Reason Not Specified|0|||
23474081|NCT01667419|65481655|FG000|Overall Study|Withdrawal by Subject|16|||
23474082|NCT01667419|65481656|FG001|Overall Study|Withdrawal by Subject|8|||
23474083|NCT01667419|65481657|FG002|Overall Study|Withdrawal by Subject|9|||
23474084|NCT01667419|65481658|FG003|Overall Study|Withdrawal by Subject|8|||
23474085|NCT01667419|65481655|FG000|Overall Study|Non-compliance|0|||
23474086|NCT01667419|65481656|FG001|Overall Study|Non-compliance|0|||
23474087|NCT01667419|65481657|FG002|Overall Study|Non-compliance|0|||
23474088|NCT01667419|65481658|FG003|Overall Study|Non-compliance|1|||
23474089|NCT01667419|65481655|FG000|Overall Study|Protocol Violation|1|||
23474090|NCT01667419|65481656|FG001|Overall Study|Protocol Violation|0|||
23474091|NCT01667419|65481657|FG002|Overall Study|Protocol Violation|0|||
23474092|NCT01667419|65481658|FG003|Overall Study|Protocol Violation|0|||
23474093|NCT01667419|65481655|FG000|Overall Study|Lost to Follow-up|7|||
23474094|NCT01667419|65481656|FG001|Overall Study|Lost to Follow-up|6|||
23474095|NCT01667419|65481657|FG002|Overall Study|Lost to Follow-up|2|||
23474096|NCT01667419|65481658|FG003|Overall Study|Lost to Follow-up|4|||
23474097|NCT01667419|65481655|FG000|Overall Study|Death|18|||
23474098|NCT01667419|65481656|FG001|Overall Study|Death|33|||
23474099|NCT01667419|65481657|FG002|Overall Study|Death|25|||
23474100|NCT01667419|65481658|FG003|Overall Study|Death|26|||
23474101|NCT03976648|65481659|FG000|Overall Study|Adverse Event|0|||
23474102|NCT03976648|65481660|FG001|Overall Study|Adverse Event|2|||
23474103|NCT03976648|65481659|FG000|Overall Study|Study terminated by sponsor|21|||
23474104|NCT03976648|65481660|FG001|Overall Study|Study terminated by sponsor|8|||
23474105|NCT02043899|65481661|FG000|Overall Study|Adverse Event|3|||
23474106|NCT02043899|65481661|FG000|Overall Study|Physician Decision|1|||
23474107|NCT02043899|65481661|FG000|Overall Study|Withdrawal by Subject|2|||
23474108|NCT02043899|65481661|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
23474109|NCT02043899|65481661|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
23474110|NCT02043899|65481661|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
23357455|NCT00385827|65052794|FG000|Part 1|Death|2|||
23357456|NCT00385827|65052795|FG001|Part 1|Death|0|||
23357457|NCT00385827|65052796|FG002|Part 1|Death|0|||
23357458|NCT00385827|65052794|FG000|Part 1|Lack of Efficacy|5|||
23357459|NCT00385827|65052795|FG001|Part 1|Lack of Efficacy|0|||
23357460|NCT00385827|65052796|FG002|Part 1|Lack of Efficacy|0|||
23357461|NCT00385827|65052794|FG000|Part 1|Other|1|||
23357462|NCT00385827|65052795|FG001|Part 1|Other|0|||
23357463|NCT00385827|65052796|FG002|Part 1|Other|0|||
23474111|NCT02043899|65481661|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
23474112|NCT02043899|65481661|FG000|Overall Study|Treatment delayed|1|||
23474113|NCT00243841|65481662|FG000|Overall Study|Physician Decision|0|||
23589003|NCT01194258|65882301|FG004|Titration Period|Titration failure|0|||
23589004|NCT01194258|65882297|FG000|Period 1 (12 Weeks)|Death|0|||
23589005|NCT01194258|65882298|FG001|Period 1 (12 Weeks)|Death|0|||
23589006|NCT01194258|65882299|FG002|Period 1 (12 Weeks)|Death|0|||
23589007|NCT01194258|65882300|FG003|Period 1 (12 Weeks)|Death|0|||
23589008|NCT01194258|65882301|FG004|Period 1 (12 Weeks)|Death|1|||
23357464|NCT00385827|65052794|FG000|Part 2|Adverse Event|0|||
23357465|NCT00385827|65052795|FG001|Part 2|Adverse Event|6|||
23474114|NCT00243841|65481663|FG001|Overall Study|Physician Decision|0|||
23474115|NCT00243841|65481664|FG002|Overall Study|Physician Decision|1|||
23474116|NCT00243841|65481665|FG003|Overall Study|Physician Decision|0|||
23474117|NCT00243841|65481666|FG004|Overall Study|Physician Decision|0|||
23474118|NCT00243841|65481667|FG005|Overall Study|Physician Decision|2|||
23589009|NCT01194258|65882297|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23474119|NCT01018810|65481668|FG000|Overall Study|Withdrawal by Subject|0|||
23474120|NCT01018810|65481669|FG001|Overall Study|Withdrawal by Subject|1|||
23474121|NCT01018810|65481670|FG002|Overall Study|Withdrawal by Subject|0|||
23474122|NCT01018810|65481671|FG003|Overall Study|Withdrawal by Subject|0|||
23474123|NCT01018810|65481672|FG004|Overall Study|Withdrawal by Subject|0|||
23474124|NCT01018810|65481668|FG000|Overall Study|Sponsor Decision|2|||
23474125|NCT01018810|65481669|FG001|Overall Study|Sponsor Decision|0|||
23474126|NCT01018810|65481670|FG002|Overall Study|Sponsor Decision|1|||
23589010|NCT01194258|65882298|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23357466|NCT00385827|65052796|FG002|Part 2|Adverse Event|10|||
23357467|NCT00385827|65052794|FG000|Part 2|Death|0|||
23589011|NCT01194258|65882299|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23589012|NCT01194258|65882300|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23589013|NCT01194258|65882301|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
23589014|NCT01194258|65882297|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
23589015|NCT01194258|65882298|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
23589016|NCT01194258|65882299|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
23589017|NCT01194258|65882300|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
23589018|NCT01194258|65882301|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
23589019|NCT01194258|65882297|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23589020|NCT01194258|65882298|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23589021|NCT01194258|65882299|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23589022|NCT01194258|65882300|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23589023|NCT01194258|65882301|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23589024|NCT00854906|65882302|FG000|Overall Study|One person had no ocular history|1|||
23589025|NCT00344019|65882304|FG000|Overall Study|did not meet final inclusion criteria|0|||
23589026|NCT00344019|65882305|FG001|Overall Study|did not meet final inclusion criteria|0|||
23589027|NCT00344019|65882306|FG002|Overall Study|did not meet final inclusion criteria|74|||
23589028|NCT01390402|65882307|FG000|Overall Study|Death|1|||
23589029|NCT01390402|65882307|FG000|Overall Study|Disease Progression|4|||
23589030|NCT01460290|65882308|FG000|Overall Study|Adverse Event|3|||
23589031|NCT01460290|65882308|FG000|Overall Study|Elevated liver function|1|||
23589032|NCT00547118|65882311|FG000|Overall Study|Did not qualify prior to starting drug|1|||
23589033|NCT00547118|65882312|FG001|Overall Study|Did not qualify prior to starting drug|1|||
23589034|NCT00547118|65882311|FG000|Overall Study|Study suspended|7|||
23589035|NCT00547118|65882312|FG001|Overall Study|Study suspended|8|||
23589036|NCT02261467|65882313|FG000|Overall Study|Enrolled in Error|1|||
23589037|NCT02261467|65882314|FG001|Overall Study|Enrolled in Error|0|||
23589038|NCT02261467|65882313|FG000|Overall Study|Protocol Violation|0|||
23589039|NCT02261467|65882314|FG001|Overall Study|Protocol Violation|1|||
23589040|NCT02261467|65882313|FG000|Overall Study|Personal Reasons|17|||
23589041|NCT02261467|65882314|FG001|Overall Study|Personal Reasons|22|||
23589042|NCT02261467|65882313|FG000|Overall Study|Lost to Follow-up|2|||
23589043|NCT02261467|65882314|FG001|Overall Study|Lost to Follow-up|13|||
23589044|NCT02261467|65882313|FG000|Overall Study|Adverse Event|1|||
23589045|NCT02261467|65882314|FG001|Overall Study|Adverse Event|1|||
23589046|NCT02482233|65882320|FG000|Overall Study|Lost to Follow-up|1|||
23589047|NCT02482233|65882321|FG001|Overall Study|Lost to Follow-up|1|||
23589048|NCT00130637|65882322|FG000|Overall Study|Adverse Event|2|||
23589049|NCT00130637|65882322|FG000|Overall Study|Withdrawal by Subject|1|||
23589050|NCT02281318|65882323|FG000|Overall Study|Adverse Event|2|||
23589051|NCT02281318|65882324|FG001|Overall Study|Adverse Event|2|||
23589052|NCT02281318|65882323|FG000|Overall Study|Lack of Efficacy|2|||
23589053|NCT02281318|65882324|FG001|Overall Study|Lack of Efficacy|0|||
23589054|NCT02281318|65882323|FG000|Overall Study|Lost to Follow-up|2|||
23589055|NCT02281318|65882324|FG001|Overall Study|Lost to Follow-up|1|||
23589056|NCT02281318|65882323|FG000|Overall Study|Physician Decision|2|||
23589057|NCT02281318|65882324|FG001|Overall Study|Physician Decision|0|||
23589058|NCT02281318|65882323|FG000|Overall Study|Withdrawal by Subject|6|||
23589059|NCT02281318|65882324|FG001|Overall Study|Withdrawal by Subject|2|||
23589060|NCT00922207|65885948|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
23589061|NCT00922207|65885949|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
23589062|NCT00922207|65885950|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
23589063|NCT00922207|65885948|FG000|Overall Study|Insufficient Therapeutic Response|0|||
23589064|NCT00922207|65885949|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23589065|NCT00922207|65885950|FG002|Overall Study|Insufficient Therapeutic Response|1|||
23589066|NCT00922207|65885948|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
23589067|NCT00922207|65885949|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23589068|NCT00922207|65885950|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
23589069|NCT00922207|65885948|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
23589070|NCT00922207|65885949|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
23589071|NCT00922207|65885950|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
23589072|NCT00922207|65885948|FG000|Overall Study|Withdrew Consent|2|||
23589073|NCT00922207|65885949|FG001|Overall Study|Withdrew Consent|5|||
23589074|NCT00922207|65885950|FG002|Overall Study|Withdrew Consent|2|||
23589075|NCT00922207|65885948|FG000|Overall Study|Abnormality of Laboratory Test|0|||
23589076|NCT00922207|65885949|FG001|Overall Study|Abnormality of Laboratory Test|1|||
23589077|NCT00922207|65885950|FG002|Overall Study|Abnormality of Laboratory Test|1|||
23589078|NCT02537522|65885957|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
23589079|NCT02537522|65885958|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
23589080|NCT02537522|65885959|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
23589081|NCT02537522|65885960|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
23589082|NCT02537522|65885957|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
23589083|NCT02537522|65885958|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
23589084|NCT02537522|65885959|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
23589085|NCT02537522|65885960|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
23589086|NCT02537522|65885957|FG000|Phase I - Contralateral|incorrect randomization|0|||
23589087|NCT02537522|65885958|FG001|Phase I - Contralateral|incorrect randomization|1|||
23589088|NCT02537522|65885959|FG002|Phase I - Contralateral|incorrect randomization|0|||
23589089|NCT02537522|65885960|FG003|Phase I - Contralateral|incorrect randomization|0|||
23589090|NCT02537522|65885957|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
23589091|NCT02537522|65885958|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
23589092|NCT02537522|65885959|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
23589093|NCT02537522|65885960|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
23589094|NCT02537522|65885957|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
23589095|NCT02537522|65885958|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
23589096|NCT02537522|65885959|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
23589097|NCT02537522|65885960|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
23589098|NCT00544440|65885961|FG000|Overall Study|Other|1|||
23589099|NCT00544440|65885961|FG000|Overall Study|Adverse Event|1|||
23589100|NCT00544440|65885961|FG000|Overall Study|Withdrawal by Subject|2|||
23589101|NCT00544440|65885961|FG000|Overall Study|Subject Non-compliance|1|||
23589102|NCT00544440|65885961|FG000|Overall Study|Progressive Disease|47|||
23589103|NCT00544440|65885961|FG000|Overall Study|Other|5|||
23589104|NCT00732381|65885964|FG000|Overall Study|Adverse Event|1|||
23589105|NCT00732381|65885965|FG001|Overall Study|Adverse Event|0|||
23589106|NCT00732381|65885964|FG000|Overall Study|Treatment Failure|1|||
23589107|NCT00732381|65885965|FG001|Overall Study|Treatment Failure|1|||
23589108|NCT00003656|65885966|FG000|Overall Study|Adverse Event|0|||
23589109|NCT00003656|65885967|FG001|Overall Study|Adverse Event|1|||
23589110|NCT03439124|65885968|FG000|Overall Study|Adverse Event|2|||
23589111|NCT03439124|65885969|FG001|Overall Study|Adverse Event|0|||
23589112|NCT03439124|65885968|FG000|Overall Study|Lost to Follow-up|1|||
23589113|NCT03439124|65885969|FG001|Overall Study|Lost to Follow-up|0|||
23589114|NCT03439124|65885968|FG000|Overall Study|Other reasons|1|||
23589115|NCT03439124|65885969|FG001|Overall Study|Other reasons|0|||
23589116|NCT01591616|65885970|FG000|Overall Study|Withdrawal by Subject|1|||
23589117|NCT02045836|65885971|FG000|Overall Study|Adverse Event|4|||
23589118|NCT02045836|65885972|FG001|Overall Study|Adverse Event|4|||
23589119|NCT02045836|65885971|FG000|Overall Study|Withdrawal by Subject|1|||
23589120|NCT02045836|65885972|FG001|Overall Study|Withdrawal by Subject|1|||
23589121|NCT02045836|65885971|FG000|Overall Study|Lost to Follow-up|4|||
23589122|NCT02045836|65885972|FG001|Overall Study|Lost to Follow-up|7|||
23589123|NCT02045836|65885971|FG000|Overall Study|Migrated from study area|0|||
23589124|NCT02045836|65885972|FG001|Overall Study|Migrated from study area|2|||
23589125|NCT02000817|65885973|FG000|Overall Study|Withdrawal by Subject|2|||
23589126|NCT02000817|65885974|FG001|Overall Study|Withdrawal by Subject|0|||
23589127|NCT02000817|65885975|FG002|Overall Study|Withdrawal by Subject|0|||
23589128|NCT02000817|65885976|FG003|Overall Study|Withdrawal by Subject|0|||
23589129|NCT02000817|65885973|FG000|Overall Study|Adverse Event|0|||
23589130|NCT02000817|65885974|FG001|Overall Study|Adverse Event|1|||
23589131|NCT02000817|65885975|FG002|Overall Study|Adverse Event|0|||
23589132|NCT02000817|65885976|FG003|Overall Study|Adverse Event|0|||
23589133|NCT02000817|65885973|FG000|Overall Study|Lost to Follow-up|0|||
23589134|NCT02000817|65885974|FG001|Overall Study|Lost to Follow-up|0|||
23589135|NCT02000817|65885975|FG002|Overall Study|Lost to Follow-up|1|||
23589136|NCT02000817|65885976|FG003|Overall Study|Lost to Follow-up|0|||
23250854|NCT02149199|64662549|FG000|Overall Study|Study specific withdrawal criteria|4|||
23250855|NCT02149199|64662550|FG001|Overall Study|Study specific withdrawal criteria|21|||
23250856|NCT02149199|64662551|FG002|Overall Study|Study specific withdrawal criteria|6|||
23250857|NCT02149199|64662549|FG000|Overall Study|Other|20|||
23250858|NCT02149199|64662550|FG001|Overall Study|Other|25|||
23250859|NCT02149199|64662551|FG002|Overall Study|Other|20|||
23250860|NCT02149199|64662549|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
23250861|NCT02149199|64662550|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
23250862|NCT02149199|64662551|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
23250863|NCT02149199|64662549|FG000|Overall Study|Withdrawal by Subject|75|||
23250864|NCT02149199|64662550|FG001|Overall Study|Withdrawal by Subject|93|||
23250865|NCT02149199|64662551|FG002|Overall Study|Withdrawal by Subject|77|||
23357468|NCT00385827|65052795|FG001|Part 2|Death|0|||
23357469|NCT00385827|65052796|FG002|Part 2|Death|2|||
23357470|NCT00385827|65052794|FG000|Part 2|Lack of Efficacy|0|||
23357471|NCT00385827|65052795|FG001|Part 2|Lack of Efficacy|14|||
23357472|NCT00385827|65052796|FG002|Part 2|Lack of Efficacy|13|||
23357473|NCT00385827|65052794|FG000|Part 2|Randomized but not treated|0|||
23357474|NCT00385827|65052795|FG001|Part 2|Randomized but not treated|2|||
23357475|NCT00385827|65052796|FG002|Part 2|Randomized but not treated|2|||
23357476|NCT00385827|65052794|FG000|Part 2|Other|0|||
23357477|NCT00385827|65052795|FG001|Part 2|Other|11|||
23357478|NCT00385827|65052796|FG002|Part 2|Other|21|||
23357479|NCT02559570|65052798|FG000|Overall Study|Adverse Event|0|||
23357480|NCT02559570|65052799|FG001|Overall Study|Adverse Event|2|||
23357481|NCT02559570|65052800|FG002|Overall Study|Adverse Event|0|||
23357482|NCT02559570|65052801|FG003|Overall Study|Adverse Event|1|||
23357483|NCT02559570|65052802|FG004|Overall Study|Adverse Event|0|||
23357484|NCT02559570|65052798|FG000|Overall Study|Withdrawal of Consent|0|||
23357485|NCT02559570|65052799|FG001|Overall Study|Withdrawal of Consent|0|||
23357486|NCT02559570|65052800|FG002|Overall Study|Withdrawal of Consent|1|||
23357487|NCT02559570|65052801|FG003|Overall Study|Withdrawal of Consent|2|||
23357488|NCT02559570|65052802|FG004|Overall Study|Withdrawal of Consent|1|||
23357489|NCT02559570|65052798|FG000|Overall Study|Lost to Follow-up|1|||
23589137|NCT05257798|65885977|FG000|Follow-up Phase|Lost to Follow-up|1|||
23589138|NCT05257798|65885978|FG001|Follow-up Phase|Lost to Follow-up|0|||
23190753|NCT03241173|64439496|FG014|Overall Study|Lost to Follow-up|0|||
23190754|NCT03894540|64439497|FG000|Overall Study|Adverse Event|0|||
23190755|NCT03894540|64439498|FG001|Overall Study|Adverse Event|0|||
23190756|NCT03894540|64439499|FG002|Overall Study|Adverse Event|0|||
23190757|NCT03894540|64439500|FG003|Overall Study|Adverse Event|0|||
23190758|NCT03894540|64439501|FG004|Overall Study|Adverse Event|1|||
23190759|NCT03894540|64439502|FG005|Overall Study|Adverse Event|0|||
23190760|NCT03894540|64439497|FG000|Overall Study|Withdrawal by Subject|0|||
23190761|NCT03894540|64439498|FG001|Overall Study|Withdrawal by Subject|0|||
23190762|NCT03894540|64439499|FG002|Overall Study|Withdrawal by Subject|0|||
23250866|NCT02149199|64662549|FG000|Overall Study|Protocol Violation|16|||
23250867|NCT02149199|64662550|FG001|Overall Study|Protocol Violation|13|||
23250868|NCT02149199|64662551|FG002|Overall Study|Protocol Violation|15|||
23250869|NCT02149199|64662549|FG000|Overall Study|Lost to Follow-up|3|||
23250870|NCT02149199|64662550|FG001|Overall Study|Lost to Follow-up|12|||
23250871|NCT02149199|64662551|FG002|Overall Study|Lost to Follow-up|11|||
23250872|NCT02149199|64662549|FG000|Overall Study|Death|0|||
23250873|NCT02149199|64662550|FG001|Overall Study|Death|0|||
23250874|NCT02149199|64662551|FG002|Overall Study|Death|1|||
23250875|NCT02149199|64662549|FG000|Overall Study|Adverse Event|6|||
23250876|NCT02149199|64662550|FG001|Overall Study|Adverse Event|15|||
23250877|NCT02149199|64662551|FG002|Overall Study|Adverse Event|9|||
23250878|NCT04508621|64662552|FG000|Overall Study|Adverse Event|39|||
23250879|NCT04508621|64662553|FG001|Overall Study|Adverse Event|16|||
23250880|NCT04508621|64662552|FG000|Overall Study|Lack of Efficacy|2|||
23250881|NCT04508621|64662553|FG001|Overall Study|Lack of Efficacy|8|||
23357490|NCT02559570|65052799|FG001|Overall Study|Lost to Follow-up|0|||
23357491|NCT02559570|65052800|FG002|Overall Study|Lost to Follow-up|0|||
23589139|NCT01835899|65885994|FG000|Overall Study|Adverse Event|0|||
23589140|NCT01835899|65885995|FG001|Overall Study|Adverse Event|0|||
23589141|NCT01835899|65885996|FG002|Overall Study|Adverse Event|1|||
23589142|NCT01835899|65885994|FG000|Overall Study|Other than stated above|0|||
23357492|NCT02559570|65052801|FG003|Overall Study|Lost to Follow-up|0|||
23357493|NCT02559570|65052802|FG004|Overall Study|Lost to Follow-up|0|||
23357494|NCT02559570|65052798|FG000|Overall Study|Protocol Violation|1|||
23589143|NCT01835899|65885995|FG001|Overall Study|Other than stated above|1|||
23190763|NCT03894540|64439500|FG003|Overall Study|Withdrawal by Subject|0|||
23190764|NCT03894540|64439501|FG004|Overall Study|Withdrawal by Subject|1|||
23190765|NCT03894540|64439502|FG005|Overall Study|Withdrawal by Subject|0|||
23357495|NCT02559570|65052799|FG001|Overall Study|Protocol Violation|0|||
23357496|NCT02559570|65052800|FG002|Overall Study|Protocol Violation|0|||
23357497|NCT02559570|65052801|FG003|Overall Study|Protocol Violation|0|||
23357498|NCT02559570|65052802|FG004|Overall Study|Protocol Violation|1|||
23357499|NCT02559570|65052798|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23250882|NCT04508621|64662552|FG000|Overall Study|Physician Decision|0|||
23250883|NCT04508621|64662553|FG001|Overall Study|Physician Decision|1|||
23190766|NCT03894540|64439497|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
23190767|NCT03894540|64439498|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
23190768|NCT03894540|64439499|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
23190769|NCT03894540|64439500|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
23190770|NCT03894540|64439501|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
23190771|NCT03894540|64439502|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
23190772|NCT03894540|64439497|FG000|Overall Study|Progressive Disease Clinical|1|||
23190773|NCT03894540|64439498|FG001|Overall Study|Progressive Disease Clinical|1|||
23190774|NCT03894540|64439499|FG002|Overall Study|Progressive Disease Clinical|0|||
23190775|NCT03894540|64439500|FG003|Overall Study|Progressive Disease Clinical|1|||
23190776|NCT03894540|64439501|FG004|Overall Study|Progressive Disease Clinical|5|||
23250884|NCT04508621|64662552|FG000|Overall Study|Withdrawal by Subject|10|||
23250885|NCT04508621|64662553|FG001|Overall Study|Withdrawal by Subject|14|||
23357500|NCT02559570|65052799|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23357501|NCT02559570|65052800|FG002|Overall Study|Other Miscellaneous Reasons|1|||
23357502|NCT02559570|65052801|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23357503|NCT02559570|65052802|FG004|Overall Study|Other Miscellaneous Reasons|0|||
23357504|NCT00624832|65052803|FG000|Overall Study|Adverse Event|0|||
23357505|NCT00624832|65052804|FG001|Overall Study|Adverse Event|1|||
23589144|NCT01835899|65885996|FG002|Overall Study|Other than stated above|0|||
23589145|NCT01596504|65885998|FG000|Overall Study|Participant's Private Reason|0|||
23190777|NCT03894540|64439502|FG005|Overall Study|Progressive Disease Clinical|1|||
23190778|NCT03894540|64439497|FG000|Overall Study|Study termination by sponsor|0|||
23190779|NCT03894540|64439498|FG001|Overall Study|Study termination by sponsor|0|||
23190780|NCT03894540|64439499|FG002|Overall Study|Study termination by sponsor|0|||
23190781|NCT03894540|64439500|FG003|Overall Study|Study termination by sponsor|0|||
23190782|NCT03894540|64439501|FG004|Overall Study|Study termination by sponsor|2|||
23250886|NCT04508621|64662552|FG000|Overall Study|Lost to Follow-up|12|||
23250887|NCT04508621|64662553|FG001|Overall Study|Lost to Follow-up|9|||
23250888|NCT04508621|64662552|FG000|Overall Study|COVID-19 related crisis|3|||
23250889|NCT04508621|64662553|FG001|Overall Study|COVID-19 related crisis|0|||
23250890|NCT04508621|64662552|FG000|Overall Study|Subject non-compliance|1|||
23250891|NCT04508621|64662553|FG001|Overall Study|Subject non-compliance|0|||
23250892|NCT02702271|64662561|FG000|Overall Study|Death|36|||
23250893|NCT02702271|64662562|FG001|Overall Study|Death|7|||
23250894|NCT02702271|64662561|FG000|Overall Study|Lost to Follow-up|12|||
23250895|NCT02702271|64662562|FG001|Overall Study|Lost to Follow-up|0|||
23250896|NCT02702271|64662561|FG000|Overall Study|Withdrawal by Subject|8|||
23250897|NCT02702271|64662562|FG001|Overall Study|Withdrawal by Subject|1|||
23250898|NCT02702271|64662561|FG000|Overall Study|Physician Decision|2|||
23250899|NCT02702271|64662562|FG001|Overall Study|Physician Decision|0|||
23250900|NCT02702271|64662561|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
23250901|NCT02702271|64662562|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
23250902|NCT03701516|64662565|FG000|Period 1|Lost to Follow-up|0|||
23250903|NCT03701516|64662566|FG001|Period 1|Lost to Follow-up|1|||
23250904|NCT03701516|64662565|FG000|Period 1|Adverse Event|0|||
23250905|NCT03701516|64662566|FG001|Period 1|Adverse Event|2|||
23250906|NCT03701516|64662565|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
23250907|NCT03701516|64662566|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
23589146|NCT01596504|65885999|FG001|Overall Study|Participant's Private Reason|1|||
23589147|NCT01596504|65886000|FG002|Overall Study|Participant's Private Reason|0|||
23589148|NCT01596504|65885998|FG000|Overall Study|Adverse Event|1|||
23589149|NCT01596504|65885999|FG001|Overall Study|Adverse Event|2|||
23589150|NCT01596504|65886000|FG002|Overall Study|Adverse Event|1|||
23357506|NCT00624832|65052805|FG002|Overall Study|Adverse Event|0|||
23357507|NCT00624832|65052806|FG003|Overall Study|Adverse Event|1|||
23589151|NCT01596504|65885998|FG000|Overall Study|Withdrawal by Subject|1|||
23589152|NCT01596504|65885999|FG001|Overall Study|Withdrawal by Subject|0|||
23250908|NCT03701516|64662565|FG000|Period 1|Non Compliance to Protocol|2|||
23250909|NCT03701516|64662566|FG001|Period 1|Non Compliance to Protocol|1|||
23250910|NCT03701516|64662565|FG000|Period 1|Withdrawal by Subject|0|||
23250911|NCT03701516|64662566|FG001|Period 1|Withdrawal by Subject|1|||
23250912|NCT03701516|64662565|FG000|Period 2|failed to meet all eligibility creiteria|1|||
23250913|NCT03701516|64662566|FG001|Period 2|failed to meet all eligibility creiteria|0|||
23250914|NCT03701516|64662565|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
23250915|NCT03701516|64662566|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
23250916|NCT04380701|64662567|FG000|Overall Study|Pregnancy|0|||
23357508|NCT00624832|65052803|FG000|Overall Study|Abnormal Laboratory Value|2|||
23357509|NCT00624832|65052804|FG001|Overall Study|Abnormal Laboratory Value|0|||
23357510|NCT00624832|65052805|FG002|Overall Study|Abnormal Laboratory Value|0|||
23357511|NCT00624832|65052806|FG003|Overall Study|Abnormal Laboratory Value|0|||
23357512|NCT00625183|65052808|FG000|Overall Study|Disease Progression|1|||
23357513|NCT02469961|65052813|FG000|Overall Study|Physician Decision|4|||
23357514|NCT02469961|65052814|FG001|Overall Study|Physician Decision|1|||
23357515|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
23357516|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
23357517|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
23357518|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
23357519|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
23357520|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
23357521|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
23357522|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
23357523|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
23357524|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
23357525|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
23357526|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
23357527|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
23357528|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
23357529|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
23357530|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
23357531|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
23357532|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
23357533|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
23357534|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
23357535|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357536|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357537|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
23357538|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357539|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357540|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357541|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357542|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357543|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357544|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
23357545|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357546|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357547|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357548|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357549|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357550|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
23357551|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357552|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
23357553|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357554|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
23357555|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
23357556|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
23250917|NCT04380701|64662568|FG001|Overall Study|Pregnancy|0|||
23250918|NCT04380701|64662569|FG002|Overall Study|Pregnancy|0|||
23190783|NCT03894540|64439502|FG005|Overall Study|Study termination by sponsor|0|||
23250919|NCT04380701|64662570|FG003|Overall Study|Pregnancy|0|||
23250920|NCT04380701|64662571|FG004|Overall Study|Pregnancy|0|||
23250921|NCT04380701|64662572|FG005|Overall Study|Pregnancy|0|||
23250922|NCT04380701|64662573|FG006|Overall Study|Pregnancy|0|||
23250923|NCT04380701|64662574|FG007|Overall Study|Pregnancy|0|||
23250924|NCT04380701|64662575|FG008|Overall Study|Pregnancy|0|||
23250925|NCT04380701|64662576|FG009|Overall Study|Pregnancy|0|||
23250926|NCT04380701|64662577|FG010|Overall Study|Pregnancy|0|||
23250927|NCT04380701|64662578|FG011|Overall Study|Pregnancy|0|||
23250928|NCT04380701|64662579|FG012|Overall Study|Pregnancy|0|||
23250929|NCT04380701|64662580|FG013|Overall Study|Pregnancy|0|||
23250930|NCT04380701|64662581|FG014|Overall Study|Pregnancy|0|||
23250931|NCT04380701|64662582|FG015|Overall Study|Pregnancy|0|||
23250932|NCT04380701|64662583|FG016|Overall Study|Pregnancy|0|||
23250933|NCT04380701|64662584|FG017|Overall Study|Pregnancy|0|||
23250934|NCT04380701|64662585|FG018|Overall Study|Pregnancy|0|||
23250935|NCT04380701|64662586|FG019|Overall Study|Pregnancy|0|||
23250936|NCT04380701|64662587|FG020|Overall Study|Pregnancy|0|||
23250937|NCT04380701|64662588|FG021|Overall Study|Pregnancy|0|||
23250938|NCT04380701|64662589|FG022|Overall Study|Pregnancy|0|||
23250939|NCT04380701|64662590|FG023|Overall Study|Pregnancy|0|||
23250940|NCT04380701|64662591|FG024|Overall Study|Pregnancy|0|||
23250941|NCT04380701|64662592|FG025|Overall Study|Pregnancy|0|||
23357557|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
23357558|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23357559|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
23357560|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
23357561|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23589153|NCT01596504|65886000|FG002|Overall Study|Withdrawal by Subject|0|||
23589154|NCT00246012|65886001|FG000|Overall Study|Adverse Event|0|||
23190784|NCT02469246|64439503|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
23190785|NCT02469246|64439504|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
23190786|NCT02469246|64439503|FG000|Double-Blind Phase|Adverse Event|12|||
23190787|NCT02469246|64439504|FG001|Double-Blind Phase|Adverse Event|9|||
23190788|NCT02469246|64439503|FG000|Double-Blind Phase|Death|2|||
23190789|NCT02469246|64439504|FG001|Double-Blind Phase|Death|0|||
23190790|NCT02469246|64439503|FG000|Double-Blind Phase|Lack of Efficacy|2|||
23190791|NCT02469246|64439504|FG001|Double-Blind Phase|Lack of Efficacy|1|||
23190792|NCT02469246|64439503|FG000|Double-Blind Phase|Investigator's Discretion|8|||
23250942|NCT04380701|64662593|FG026|Overall Study|Pregnancy|0|||
23250943|NCT04380701|64662594|FG027|Overall Study|Pregnancy|0|||
23250944|NCT04380701|64662595|FG028|Overall Study|Pregnancy|0|||
23250945|NCT04380701|64662596|FG029|Overall Study|Pregnancy|0|||
23250946|NCT04380701|64662597|FG030|Overall Study|Pregnancy|0|||
23589155|NCT00246012|65886002|FG001|Overall Study|Adverse Event|0|||
23589156|NCT00246012|65886003|FG002|Overall Study|Adverse Event|0|||
23589157|NCT00246012|65886004|FG003|Overall Study|Adverse Event|0|||
23589158|NCT00246012|65886005|FG004|Overall Study|Adverse Event|0|||
23589159|NCT00246012|65886006|FG005|Overall Study|Adverse Event|1|||
23589160|NCT00246012|65886007|FG006|Overall Study|Adverse Event|0|||
23589161|NCT00246012|65886008|FG007|Overall Study|Adverse Event|0|||
23589162|NCT00246012|65886009|FG008|Overall Study|Adverse Event|2|||
23589163|NCT00246012|65886001|FG000|Overall Study|Withdrawal by Subject|0|||
23589164|NCT00246012|65886002|FG001|Overall Study|Withdrawal by Subject|0|||
23589165|NCT00246012|65886003|FG002|Overall Study|Withdrawal by Subject|0|||
23589166|NCT00246012|65886004|FG003|Overall Study|Withdrawal by Subject|0|||
23589167|NCT00246012|65886005|FG004|Overall Study|Withdrawal by Subject|0|||
23589168|NCT00246012|65886006|FG005|Overall Study|Withdrawal by Subject|1|||
23589169|NCT00246012|65886007|FG006|Overall Study|Withdrawal by Subject|0|||
23589170|NCT00246012|65886008|FG007|Overall Study|Withdrawal by Subject|0|||
23250947|NCT04380701|64662598|FG031|Overall Study|Pregnancy|0|||
23250948|NCT04380701|64662599|FG032|Overall Study|Pregnancy|1|||
23250949|NCT04380701|64662600|FG033|Overall Study|Pregnancy|0|||
23250950|NCT04380701|64662567|FG000|Overall Study|Lost to Follow-up|0|||
23250951|NCT04380701|64662568|FG001|Overall Study|Lost to Follow-up|0|||
23250952|NCT04380701|64662569|FG002|Overall Study|Lost to Follow-up|0|||
23250953|NCT04380701|64662570|FG003|Overall Study|Lost to Follow-up|0|||
23250954|NCT04380701|64662571|FG004|Overall Study|Lost to Follow-up|0|||
23250955|NCT04380701|64662572|FG005|Overall Study|Lost to Follow-up|0|||
23250956|NCT04380701|64662573|FG006|Overall Study|Lost to Follow-up|0|||
23250957|NCT04380701|64662574|FG007|Overall Study|Lost to Follow-up|0|||
23250958|NCT04380701|64662575|FG008|Overall Study|Lost to Follow-up|0|||
23250959|NCT04380701|64662576|FG009|Overall Study|Lost to Follow-up|0|||
23250960|NCT04380701|64662577|FG010|Overall Study|Lost to Follow-up|0|||
23250961|NCT04380701|64662578|FG011|Overall Study|Lost to Follow-up|0|||
23250962|NCT04380701|64662579|FG012|Overall Study|Lost to Follow-up|0|||
23250963|NCT04380701|64662580|FG013|Overall Study|Lost to Follow-up|0|||
23250964|NCT04380701|64662581|FG014|Overall Study|Lost to Follow-up|0|||
23250965|NCT04380701|64662582|FG015|Overall Study|Lost to Follow-up|0|||
23250966|NCT04380701|64662583|FG016|Overall Study|Lost to Follow-up|0|||
23250967|NCT04380701|64662584|FG017|Overall Study|Lost to Follow-up|0|||
23250968|NCT04380701|64662585|FG018|Overall Study|Lost to Follow-up|0|||
23250969|NCT04380701|64662586|FG019|Overall Study|Lost to Follow-up|0|||
23250970|NCT04380701|64662587|FG020|Overall Study|Lost to Follow-up|1|||
23250971|NCT04380701|64662588|FG021|Overall Study|Lost to Follow-up|0|||
23250972|NCT04380701|64662589|FG022|Overall Study|Lost to Follow-up|0|||
23250973|NCT04380701|64662590|FG023|Overall Study|Lost to Follow-up|1|||
23250974|NCT04380701|64662591|FG024|Overall Study|Lost to Follow-up|0|||
23250975|NCT04380701|64662592|FG025|Overall Study|Lost to Follow-up|0|||
23250976|NCT04380701|64662593|FG026|Overall Study|Lost to Follow-up|0|||
23250977|NCT04380701|64662594|FG027|Overall Study|Lost to Follow-up|0|||
23250978|NCT04380701|64662595|FG028|Overall Study|Lost to Follow-up|0|||
23250979|NCT04380701|64662596|FG029|Overall Study|Lost to Follow-up|1|||
23250980|NCT04380701|64662597|FG030|Overall Study|Lost to Follow-up|0|||
23250981|NCT04380701|64662598|FG031|Overall Study|Lost to Follow-up|0|||
23250982|NCT04380701|64662599|FG032|Overall Study|Lost to Follow-up|0|||
23250983|NCT04380701|64662600|FG033|Overall Study|Lost to Follow-up|1|||
23250984|NCT04380701|64662567|FG000|Overall Study|Private reason(s)|0|||
23250985|NCT04380701|64662568|FG001|Overall Study|Private reason(s)|0|||
23250986|NCT04380701|64662569|FG002|Overall Study|Private reason(s)|0|||
23250987|NCT04380701|64662570|FG003|Overall Study|Private reason(s)|0|||
23250988|NCT04380701|64662571|FG004|Overall Study|Private reason(s)|0|||
23250989|NCT04380701|64662572|FG005|Overall Study|Private reason(s)|0|||
23250990|NCT04380701|64662573|FG006|Overall Study|Private reason(s)|1|||
23250991|NCT04380701|64662574|FG007|Overall Study|Private reason(s)|0|||
23250992|NCT04380701|64662575|FG008|Overall Study|Private reason(s)|1|||
23250993|NCT04380701|64662576|FG009|Overall Study|Private reason(s)|1|||
23250994|NCT04380701|64662577|FG010|Overall Study|Private reason(s)|0|||
23250995|NCT04380701|64662578|FG011|Overall Study|Private reason(s)|0|||
23250996|NCT04380701|64662579|FG012|Overall Study|Private reason(s)|0|||
23250997|NCT04380701|64662580|FG013|Overall Study|Private reason(s)|0|||
23250998|NCT04380701|64662581|FG014|Overall Study|Private reason(s)|0|||
23250999|NCT04380701|64662582|FG015|Overall Study|Private reason(s)|0|||
23251000|NCT04380701|64662583|FG016|Overall Study|Private reason(s)|0|||
23251001|NCT04380701|64662584|FG017|Overall Study|Private reason(s)|0|||
23251002|NCT04380701|64662585|FG018|Overall Study|Private reason(s)|0|||
23251003|NCT04380701|64662586|FG019|Overall Study|Private reason(s)|0|||
23251004|NCT04380701|64662587|FG020|Overall Study|Private reason(s)|0|||
23251005|NCT04380701|64662588|FG021|Overall Study|Private reason(s)|0|||
23251006|NCT04380701|64662589|FG022|Overall Study|Private reason(s)|0|||
23251007|NCT04380701|64662590|FG023|Overall Study|Private reason(s)|1|||
23251008|NCT04380701|64662591|FG024|Overall Study|Private reason(s)|0|||
23251009|NCT04380701|64662592|FG025|Overall Study|Private reason(s)|0|||
23251010|NCT04380701|64662593|FG026|Overall Study|Private reason(s)|0|||
23251011|NCT04380701|64662594|FG027|Overall Study|Private reason(s)|0|||
23251012|NCT04380701|64662595|FG028|Overall Study|Private reason(s)|0|||
23251013|NCT04380701|64662596|FG029|Overall Study|Private reason(s)|1|||
23251014|NCT04380701|64662597|FG030|Overall Study|Private reason(s)|0|||
23251015|NCT04380701|64662598|FG031|Overall Study|Private reason(s)|0|||
23251016|NCT04380701|64662599|FG032|Overall Study|Private reason(s)|0|||
23251017|NCT04380701|64662600|FG033|Overall Study|Private reason(s)|0|||
23251018|NCT04380701|64662567|FG000|Overall Study|Withdrawal by Subject|0|||
23251019|NCT04380701|64662568|FG001|Overall Study|Withdrawal by Subject|0|||
23251020|NCT04380701|64662569|FG002|Overall Study|Withdrawal by Subject|0|||
23251021|NCT04380701|64662570|FG003|Overall Study|Withdrawal by Subject|0|||
23251022|NCT04380701|64662571|FG004|Overall Study|Withdrawal by Subject|0|||
23251023|NCT04380701|64662572|FG005|Overall Study|Withdrawal by Subject|0|||
23251024|NCT04380701|64662573|FG006|Overall Study|Withdrawal by Subject|1|||
23251025|NCT04380701|64662574|FG007|Overall Study|Withdrawal by Subject|1|||
23251026|NCT04380701|64662575|FG008|Overall Study|Withdrawal by Subject|0|||
23251027|NCT04380701|64662576|FG009|Overall Study|Withdrawal by Subject|0|||
23251028|NCT04380701|64662577|FG010|Overall Study|Withdrawal by Subject|0|||
23251029|NCT04380701|64662578|FG011|Overall Study|Withdrawal by Subject|1|||
23251030|NCT04380701|64662579|FG012|Overall Study|Withdrawal by Subject|0|||
23251031|NCT04380701|64662580|FG013|Overall Study|Withdrawal by Subject|1|||
23251032|NCT04380701|64662581|FG014|Overall Study|Withdrawal by Subject|0|||
23357562|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23357563|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23357564|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
23357565|NCT04074330|65052815|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357566|NCT04074330|65052816|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
23357567|NCT04074330|65052817|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
23357568|NCT04074330|65052818|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
23357569|NCT04074330|65052819|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357570|NCT04074330|65052820|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
23357571|NCT04074330|65052821|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357572|NCT04074330|65052822|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357573|NCT04074330|65052823|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357574|NCT04074330|65052824|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
23357575|NCT04074330|65052815|FG000|Dose Expansion (up to 42 Months)|Death|0|||
23357576|NCT04074330|65052816|FG001|Dose Expansion (up to 42 Months)|Death|0|||
23357577|NCT04074330|65052817|FG002|Dose Expansion (up to 42 Months)|Death|0|||
23357578|NCT04074330|65052818|FG003|Dose Expansion (up to 42 Months)|Death|0|||
23357579|NCT04074330|65052819|FG004|Dose Expansion (up to 42 Months)|Death|0|||
23357580|NCT04074330|65052820|FG005|Dose Expansion (up to 42 Months)|Death|0|||
23357581|NCT04074330|65052821|FG006|Dose Expansion (up to 42 Months)|Death|0|||
23357582|NCT04074330|65052822|FG007|Dose Expansion (up to 42 Months)|Death|0|||
23357583|NCT04074330|65052823|FG008|Dose Expansion (up to 42 Months)|Death|1|||
23357584|NCT04074330|65052824|FG009|Dose Expansion (up to 42 Months)|Death|0|||
23357585|NCT04074330|65052815|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357586|NCT04074330|65052816|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357587|NCT04074330|65052817|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357588|NCT04074330|65052818|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357589|NCT04074330|65052819|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357590|NCT04074330|65052820|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357591|NCT04074330|65052821|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357592|NCT04074330|65052822|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
23357593|NCT04074330|65052823|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
23357594|NCT04074330|65052824|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
23357595|NCT01909973|65052825|FG000|Overall Study|Lost to Follow-up|1|||
23357596|NCT01909973|65052826|FG001|Overall Study|Lost to Follow-up|0|||
23357597|NCT02383355|65052827|FG000|Overall Study|Adverse Event|2|||
23357598|NCT02383355|65052828|FG001|Overall Study|Adverse Event|0|||
23357599|NCT04625413|65052829|FG000|Overall Study|Hospice|2|||
23357600|NCT04625413|65052829|FG000|Overall Study|Distress|1|||
23589171|NCT00246012|65886009|FG008|Overall Study|Withdrawal by Subject|0|||
23589172|NCT00246012|65886001|FG000|Overall Study|Disease progression|3|||
23190793|NCT02469246|64439504|FG001|Double-Blind Phase|Investigator's Discretion|8|||
23190794|NCT02469246|64439503|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
23190795|NCT02469246|64439504|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
23190796|NCT02469246|64439503|FG000|Double-Blind Phase|Protocol Violation|1|||
23190797|NCT02469246|64439504|FG001|Double-Blind Phase|Protocol Violation|1|||
23190798|NCT02469246|64439503|FG000|Double-Blind Phase|Withdrew Consent|25|||
23190799|NCT02469246|64439504|FG001|Double-Blind Phase|Withdrew Consent|25|||
23190800|NCT02469246|64439503|FG000|Double-Blind Phase|Lost to Follow-up|9|||
23190801|NCT02469246|64439504|FG001|Double-Blind Phase|Lost to Follow-up|5|||
23190802|NCT00685178|64439505|FG000|Overall Study|Adverse Event|1|||
23190803|NCT00685178|64439506|FG001|Overall Study|Adverse Event|5|||
23190804|NCT00685178|64439507|FG002|Overall Study|Adverse Event|2|||
23190805|NCT00685178|64439508|FG003|Overall Study|Adverse Event|4|||
23190806|NCT00685178|64439505|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
23190807|NCT00685178|64439506|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
23190808|NCT00685178|64439507|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
23190809|NCT00685178|64439508|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
23190810|NCT00685178|64439505|FG000|Overall Study|voluntary study discharge|4|||
23190811|NCT00685178|64439506|FG001|Overall Study|voluntary study discharge|5|||
23190812|NCT00685178|64439507|FG002|Overall Study|voluntary study discharge|1|||
23589173|NCT00246012|65886002|FG001|Overall Study|Disease progression|1|||
23190813|NCT00685178|64439508|FG003|Overall Study|voluntary study discharge|1|||
23190814|NCT00685178|64439505|FG000|Overall Study|incarcerated|1|||
23357601|NCT04625413|65052829|FG000|Overall Study|Not feeling well|1|||
23357602|NCT00560703|65052834|FG000|Overall Study|Adverse Event|0|||
23357603|NCT00560703|65052835|FG001|Overall Study|Adverse Event|2|||
23357604|NCT00560703|65052834|FG000|Overall Study|Protocol Violation|0|||
23190815|NCT00685178|64439506|FG001|Overall Study|incarcerated|3|||
23190816|NCT00685178|64439507|FG002|Overall Study|incarcerated|7|||
23190817|NCT00685178|64439508|FG003|Overall Study|incarcerated|0|||
23357605|NCT00560703|65052835|FG001|Overall Study|Protocol Violation|2|||
23357606|NCT00560703|65052834|FG000|Overall Study|Withdrawal by Subject|0|||
23357607|NCT00560703|65052835|FG001|Overall Study|Withdrawal by Subject|1|||
23357608|NCT00560703|65052834|FG000|Overall Study|non-compliance|0|||
23357609|NCT00560703|65052835|FG001|Overall Study|non-compliance|1|||
23357610|NCT01763203|65052836|FG000|Overall Study|Death|4|||
23357611|NCT01763203|65052837|FG001|Overall Study|Death|7|||
23357612|NCT01763203|65052836|FG000|Overall Study|Lost to Follow-up|12|||
23357613|NCT01763203|65052837|FG001|Overall Study|Lost to Follow-up|12|||
23357614|NCT01763203|65052836|FG000|Overall Study|Withdrawal by Subject|8|||
23357615|NCT01763203|65052837|FG001|Overall Study|Withdrawal by Subject|12|||
23357616|NCT01763203|65052836|FG000|Overall Study|Moved out of study region|7|||
23357617|NCT01763203|65052837|FG001|Overall Study|Moved out of study region|10|||
23357618|NCT01763203|65052836|FG000|Overall Study|Physician Decision|2|||
23251033|NCT04380701|64662582|FG015|Overall Study|Withdrawal by Subject|0|||
23251034|NCT04380701|64662583|FG016|Overall Study|Withdrawal by Subject|1|||
23251035|NCT04380701|64662584|FG017|Overall Study|Withdrawal by Subject|0|||
23251036|NCT04380701|64662585|FG018|Overall Study|Withdrawal by Subject|0|||
23251037|NCT04380701|64662586|FG019|Overall Study|Withdrawal by Subject|0|||
23251038|NCT04380701|64662587|FG020|Overall Study|Withdrawal by Subject|0|||
23251039|NCT04380701|64662588|FG021|Overall Study|Withdrawal by Subject|0|||
23251040|NCT04380701|64662589|FG022|Overall Study|Withdrawal by Subject|2|||
23251041|NCT04380701|64662590|FG023|Overall Study|Withdrawal by Subject|2|||
23251042|NCT04380701|64662591|FG024|Overall Study|Withdrawal by Subject|1|||
23251043|NCT04380701|64662592|FG025|Overall Study|Withdrawal by Subject|1|||
23251044|NCT04380701|64662593|FG026|Overall Study|Withdrawal by Subject|0|||
23251045|NCT04380701|64662594|FG027|Overall Study|Withdrawal by Subject|0|||
23251046|NCT04380701|64662595|FG028|Overall Study|Withdrawal by Subject|0|||
23251047|NCT04380701|64662596|FG029|Overall Study|Withdrawal by Subject|0|||
23251048|NCT04380701|64662597|FG030|Overall Study|Withdrawal by Subject|0|||
23251049|NCT04380701|64662598|FG031|Overall Study|Withdrawal by Subject|0|||
23251050|NCT04380701|64662599|FG032|Overall Study|Withdrawal by Subject|0|||
23251051|NCT04380701|64662600|FG033|Overall Study|Withdrawal by Subject|0|||
23251052|NCT04380701|64662567|FG000|Overall Study|Adverse Event|0|||
23251053|NCT04380701|64662568|FG001|Overall Study|Adverse Event|0|||
23251054|NCT04380701|64662569|FG002|Overall Study|Adverse Event|0|||
23251055|NCT04380701|64662570|FG003|Overall Study|Adverse Event|0|||
23251056|NCT04380701|64662571|FG004|Overall Study|Adverse Event|0|||
23251057|NCT04380701|64662572|FG005|Overall Study|Adverse Event|1|||
23251058|NCT04380701|64662573|FG006|Overall Study|Adverse Event|0|||
23251059|NCT04380701|64662574|FG007|Overall Study|Adverse Event|0|||
23251060|NCT04380701|64662575|FG008|Overall Study|Adverse Event|0|||
23251061|NCT04380701|64662576|FG009|Overall Study|Adverse Event|0|||
23251062|NCT04380701|64662577|FG010|Overall Study|Adverse Event|0|||
23251063|NCT04380701|64662578|FG011|Overall Study|Adverse Event|0|||
23251064|NCT04380701|64662579|FG012|Overall Study|Adverse Event|0|||
23251065|NCT04380701|64662580|FG013|Overall Study|Adverse Event|0|||
23251066|NCT04380701|64662581|FG014|Overall Study|Adverse Event|0|||
23251067|NCT04380701|64662582|FG015|Overall Study|Adverse Event|1|||
23357619|NCT01763203|65052837|FG001|Overall Study|Physician Decision|1|||
23357620|NCT01904032|65052838|FG000|Overall Study|Adverse Event|3|||
23251068|NCT04380701|64662583|FG016|Overall Study|Adverse Event|0|||
23251069|NCT04380701|64662584|FG017|Overall Study|Adverse Event|0|||
23251070|NCT04380701|64662585|FG018|Overall Study|Adverse Event|0|||
23251071|NCT04380701|64662586|FG019|Overall Study|Adverse Event|1|||
23357621|NCT01904032|65052839|FG001|Overall Study|Adverse Event|1|||
23190818|NCT00685178|64439505|FG000|Overall Study|administrative (disciplinary) discharge|0|||
23190819|NCT00685178|64439506|FG001|Overall Study|administrative (disciplinary) discharge|1|||
23190820|NCT00685178|64439507|FG002|Overall Study|administrative (disciplinary) discharge|0|||
23190821|NCT00685178|64439508|FG003|Overall Study|administrative (disciplinary) discharge|2|||
23190822|NCT00685178|64439505|FG000|Overall Study|Pregnancy|0|||
23190823|NCT00685178|64439506|FG001|Overall Study|Pregnancy|0|||
23190824|NCT00685178|64439507|FG002|Overall Study|Pregnancy|0|||
23190825|NCT00685178|64439508|FG003|Overall Study|Pregnancy|1|||
23190826|NCT04331899|64439517|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
23190827|NCT04331899|64439518|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
23190828|NCT01635933|64439526|FG000|Overall Study|Adverse Event|1|||
23251072|NCT04380701|64662587|FG020|Overall Study|Adverse Event|0|||
23251073|NCT04380701|64662588|FG021|Overall Study|Adverse Event|0|||
23251074|NCT04380701|64662589|FG022|Overall Study|Adverse Event|0|||
23251075|NCT04380701|64662590|FG023|Overall Study|Adverse Event|0|||
23251076|NCT04380701|64662591|FG024|Overall Study|Adverse Event|0|||
23357622|NCT01904032|65052838|FG000|Overall Study|Lost to Follow-up|4|||
23190829|NCT01635933|64439527|FG001|Overall Study|Adverse Event|0|||
23190830|NCT01635933|64439526|FG000|Overall Study|Lost to Follow-up|0|||
23251077|NCT04380701|64662592|FG025|Overall Study|Adverse Event|0|||
23190831|NCT01635933|64439527|FG001|Overall Study|Lost to Follow-up|5|||
23251078|NCT04380701|64662593|FG026|Overall Study|Adverse Event|0|||
23251079|NCT04380701|64662594|FG027|Overall Study|Adverse Event|0|||
23190832|NCT01635933|64439526|FG000|Overall Study|Subject decision|1|||
23251080|NCT04380701|64662595|FG028|Overall Study|Adverse Event|0|||
23474127|NCT01018810|65481671|FG003|Overall Study|Sponsor Decision|1|||
23474128|NCT01018810|65481672|FG004|Overall Study|Sponsor Decision|1|||
23474129|NCT02509117|65481673|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474130|NCT02509117|65481674|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
23474131|NCT02509117|65481675|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474132|NCT02509117|65481676|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474133|NCT02509117|65481677|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474134|NCT02509117|65481678|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474135|NCT02509117|65481679|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474136|NCT02509117|65481680|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474137|NCT02509117|65481681|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23357623|NCT01904032|65052839|FG001|Overall Study|Lost to Follow-up|2|||
23357624|NCT01006590|65052840|FG000|Overall Study|Adverse Event|2|||
23474138|NCT02509117|65481682|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
23474139|NCT02509117|65481673|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474140|NCT02509117|65481674|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474141|NCT02509117|65481675|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474142|NCT02509117|65481676|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474143|NCT02509117|65481677|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474144|NCT02509117|65481678|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474145|NCT02509117|65481679|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474146|NCT02509117|65481680|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474147|NCT02509117|65481681|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
23474148|NCT02509117|65481682|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
23474149|NCT02509117|65481673|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474150|NCT02509117|65481674|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474151|NCT02509117|65481675|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474152|NCT02509117|65481676|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474153|NCT02509117|65481677|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474154|NCT02509117|65481678|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474155|NCT02509117|65481679|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474156|NCT02509117|65481680|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474157|NCT02509117|65481681|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
23474158|NCT02509117|65481682|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
23474159|NCT01227018|65481684|FG000|Overall Study|Disease progression|9|||
23474160|NCT01227018|65481684|FG000|Overall Study|Toxicity|2|||
23474161|NCT01227018|65481684|FG000|Overall Study|Withdrew after beginning treatment|4|||
23474162|NCT01541397|65481689|FG000|Overall Study|Study ended prior to data collection|4|||
23474163|NCT01541397|65481690|FG001|Overall Study|Study ended prior to data collection|2|||
23474164|NCT00881868|65481692|FG000|Overall Study|Adverse Event|0|||
23474165|NCT00881868|65481693|FG001|Overall Study|Adverse Event|1|||
23474166|NCT00881868|65481692|FG000|Overall Study|Lost to Follow-up|2|||
23474167|NCT00881868|65481693|FG001|Overall Study|Lost to Follow-up|1|||
23474168|NCT00881868|65481692|FG000|Overall Study|Physician Decision|4|||
23474169|NCT00881868|65481693|FG001|Overall Study|Physician Decision|0|||
23474170|NCT00881868|65481692|FG000|Overall Study|Protocol Violation|2|||
23474171|NCT00881868|65481693|FG001|Overall Study|Protocol Violation|0|||
23474172|NCT01086358|65481694|FG000|First Intervention|Lost to Follow-up|9|||
23474173|NCT01086358|65481695|FG001|First Intervention|Lost to Follow-up|4|||
23474174|NCT01086358|65481694|FG000|First Intervention|Withdrawal by Subject|0|||
23474175|NCT01086358|65481695|FG001|First Intervention|Withdrawal by Subject|1|||
23474176|NCT01086358|65481694|FG000|Second Intervention|Lost to Follow-up|4|||
23474177|NCT01086358|65481695|FG001|Second Intervention|Lost to Follow-up|4|||
23474178|NCT03753789|65481696|FG000|Overall Study|Withdrawal by Subject|2|||
23474179|NCT04881942|65481697|FG000|Overall Study|Adverse Event|0|||
23474180|NCT04881942|65481698|FG001|Overall Study|Adverse Event|0|||
23474181|NCT04881942|65481699|FG002|Overall Study|Adverse Event|0|||
23474182|NCT04881942|65481700|FG003|Overall Study|Adverse Event|0|||
23474183|NCT04881942|65481701|FG004|Overall Study|Adverse Event|1|||
23474184|NCT04881942|65481697|FG000|Overall Study|Alternates|0|||
23474185|NCT04881942|65481698|FG001|Overall Study|Alternates|0|||
23474186|NCT04881942|65481699|FG002|Overall Study|Alternates|0|||
23251081|NCT04380701|64662596|FG029|Overall Study|Adverse Event|0|||
23474187|NCT04881942|65481700|FG003|Overall Study|Alternates|0|||
23474188|NCT04881942|65481701|FG004|Overall Study|Alternates|2|||
23474189|NCT03255083|65481703|FG000|Overall Study|Clinical progression|1|||
23474190|NCT03255083|65481704|FG001|Overall Study|Clinical progression|0|||
23251082|NCT04380701|64662597|FG030|Overall Study|Adverse Event|0|||
23474191|NCT03255083|65481705|FG002|Overall Study|Clinical progression|0|||
23474192|NCT03255083|65481706|FG003|Overall Study|Clinical progression|0|||
23474193|NCT03255083|65481703|FG000|Overall Study|Adverse Event|0|||
23474194|NCT03255083|65481704|FG001|Overall Study|Adverse Event|1|||
23474195|NCT03255083|65481705|FG002|Overall Study|Adverse Event|0|||
23474196|NCT03255083|65481706|FG003|Overall Study|Adverse Event|0|||
23474197|NCT03255083|65481703|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
23474198|NCT03255083|65481704|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
23474199|NCT03255083|65481705|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
23589174|NCT00246012|65886003|FG002|Overall Study|Disease progression|2|||
23589175|NCT00246012|65886004|FG003|Overall Study|Disease progression|3|||
23589176|NCT00246012|65886005|FG004|Overall Study|Disease progression|3|||
23589177|NCT00246012|65886006|FG005|Overall Study|Disease progression|25|||
23589178|NCT00246012|65886007|FG006|Overall Study|Disease progression|30|||
23589179|NCT00246012|65886008|FG007|Overall Study|Disease progression|27|||
23589180|NCT00246012|65886009|FG008|Overall Study|Disease progression|26|||
23589181|NCT00246012|65886001|FG000|Overall Study|Other|0|||
23589182|NCT00246012|65886002|FG001|Overall Study|Other|0|||
23589183|NCT00246012|65886003|FG002|Overall Study|Other|0|||
23589184|NCT00246012|65886004|FG003|Overall Study|Other|0|||
23589185|NCT00246012|65886005|FG004|Overall Study|Other|0|||
23589186|NCT00246012|65886006|FG005|Overall Study|Other|0|||
23589187|NCT00246012|65886007|FG006|Overall Study|Other|0|||
23589188|NCT00246012|65886008|FG007|Overall Study|Other|1|||
23589189|NCT00246012|65886009|FG008|Overall Study|Other|0|||
23589190|NCT00246012|65886001|FG000|Overall Study|Randomly assigned but not treated|0|||
23589191|NCT00246012|65886002|FG001|Overall Study|Randomly assigned but not treated|0|||
23589192|NCT00246012|65886003|FG002|Overall Study|Randomly assigned but not treated|0|||
23589193|NCT00246012|65886004|FG003|Overall Study|Randomly assigned but not treated|0|||
23589194|NCT00246012|65886005|FG004|Overall Study|Randomly assigned but not treated|0|||
23589195|NCT00246012|65886006|FG005|Overall Study|Randomly assigned but not treated|1|||
23589196|NCT00246012|65886007|FG006|Overall Study|Randomly assigned but not treated|1|||
23589197|NCT00246012|65886008|FG007|Overall Study|Randomly assigned but not treated|0|||
23589198|NCT00246012|65886009|FG008|Overall Study|Randomly assigned but not treated|0|||
23589199|NCT01490580|65886010|FG000|Overall Study|Parents withdrew consent|0|||
23589200|NCT01490580|65886011|FG001|Overall Study|Parents withdrew consent|2|||
23589201|NCT02026258|65886012|FG000|Randomized|Did not start treatment|2|||
23589202|NCT02026258|65886013|FG001|Randomized|Did not start treatment|1|||
23589203|NCT02026258|65886012|FG000|Randomized|Change in treatment plan|1|||
23589204|NCT02026258|65886013|FG001|Randomized|Change in treatment plan|0|||
23589205|NCT02026258|65886012|FG000|Randomized|Presence of periodontal disease|1|||
23589206|NCT02026258|65886013|FG001|Randomized|Presence of periodontal disease|1|||
23589207|NCT02026258|65886012|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
23589208|NCT02026258|65886013|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
23589209|NCT02026258|65886012|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
23589210|NCT02026258|65886013|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
23589211|NCT03743246|65886018|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
23589212|NCT03743246|65886019|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
23589213|NCT03743246|65886020|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
23589214|NCT03743246|65886021|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
23589215|NCT03743246|65886018|FG000|Pre-Treatment Period|Death|0|||
23589216|NCT03743246|65886019|FG001|Pre-Treatment Period|Death|1|||
23589217|NCT03743246|65886020|FG002|Pre-Treatment Period|Death|0|||
23589218|NCT03743246|65886021|FG003|Pre-Treatment Period|Death|1|||
23190833|NCT01635933|64439527|FG001|Overall Study|Subject decision|1|||
23589219|NCT03743246|65886018|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
23589220|NCT03743246|65886019|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
23190834|NCT01635933|64439526|FG000|Overall Study|Noncompliance|0|||
23251083|NCT04380701|64662598|FG031|Overall Study|Adverse Event|0|||
23251084|NCT04380701|64662599|FG032|Overall Study|Adverse Event|0|||
23589221|NCT03743246|65886020|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
23589222|NCT03743246|65886021|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
23589223|NCT03743246|65886018|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
23589224|NCT03743246|65886019|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
23589225|NCT03743246|65886020|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
23474200|NCT03255083|65481706|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
23474201|NCT03255083|65481703|FG000|Overall Study|Withdrawal by Subject|1|||
23474202|NCT03255083|65481704|FG001|Overall Study|Withdrawal by Subject|1|||
23474203|NCT03255083|65481705|FG002|Overall Study|Withdrawal by Subject|1|||
23474204|NCT03255083|65481706|FG003|Overall Study|Withdrawal by Subject|0|||
23474205|NCT01754402|65481707|FG000|Overall Study|Death|0|||
23474206|NCT01754402|65481708|FG001|Overall Study|Death|0|||
23474207|NCT01754402|65481709|FG002|Overall Study|Death|1|||
23474208|NCT01754402|65481707|FG000|Overall Study|Adverse Event|2|||
23474209|NCT01754402|65481708|FG001|Overall Study|Adverse Event|2|||
23474210|NCT01754402|65481709|FG002|Overall Study|Adverse Event|1|||
23474211|NCT01754402|65481707|FG000|Overall Study|Withdrawal by Subject|0|||
23474212|NCT01754402|65481708|FG001|Overall Study|Withdrawal by Subject|0|||
23474213|NCT01754402|65481709|FG002|Overall Study|Withdrawal by Subject|1|||
23474214|NCT01754402|65481707|FG000|Overall Study|Lack of Efficacy|0|||
23474215|NCT01754402|65481708|FG001|Overall Study|Lack of Efficacy|0|||
23474216|NCT01754402|65481709|FG002|Overall Study|Lack of Efficacy|1|||
23474217|NCT01451437|65481710|FG000|Overall Study|Adverse Event|0|||
23474218|NCT01451437|65481711|FG001|Overall Study|Adverse Event|0|||
23474219|NCT01451437|65481712|FG002|Overall Study|Adverse Event|0|||
23474220|NCT01451437|65481713|FG003|Overall Study|Adverse Event|0|||
23474221|NCT01451437|65481714|FG004|Overall Study|Adverse Event|0|||
23474222|NCT01451437|65481715|FG005|Overall Study|Adverse Event|1|||
23190835|NCT01635933|64439527|FG001|Overall Study|Noncompliance|1|||
23190836|NCT01635933|64439526|FG000|Overall Study|No longer had transportation|0|||
23190837|NCT01635933|64439527|FG001|Overall Study|No longer had transportation|1|||
23190838|NCT02795156|64439528|FG000|Overall Study|Progressive Disease|22|||
23190839|NCT02795156|64439529|FG001|Overall Study|Progressive Disease|7|||
23190840|NCT02795156|64439530|FG002|Overall Study|Progressive Disease|34|||
23190841|NCT02795156|64439531|FG003|Overall Study|Progressive Disease|7|||
23190842|NCT02795156|64439528|FG000|Overall Study|Adverse Event|13|||
23190843|NCT02795156|64439529|FG001|Overall Study|Adverse Event|2|||
23474223|NCT01451437|65481716|FG006|Overall Study|Adverse Event|1|||
23474224|NCT01451437|65481717|FG007|Overall Study|Adverse Event|2|||
23190844|NCT02795156|64439530|FG002|Overall Study|Adverse Event|3|||
23190845|NCT02795156|64439531|FG003|Overall Study|Adverse Event|2|||
23190846|NCT02795156|64439528|FG000|Overall Study|Death|1|||
23190847|NCT02795156|64439529|FG001|Overall Study|Death|1|||
23190848|NCT02795156|64439530|FG002|Overall Study|Death|1|||
23190849|NCT02795156|64439531|FG003|Overall Study|Death|0|||
23190850|NCT02795156|64439528|FG000|Overall Study|Physician Decision|1|||
23190851|NCT02795156|64439529|FG001|Overall Study|Physician Decision|0|||
23190852|NCT02795156|64439530|FG002|Overall Study|Physician Decision|1|||
23251085|NCT04380701|64662600|FG033|Overall Study|Adverse Event|0|||
23251086|NCT04380701|64662567|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
23251087|NCT04380701|64662568|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
23251088|NCT04380701|64662569|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
23251089|NCT04380701|64662570|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
23251090|NCT04380701|64662571|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
23251091|NCT04380701|64662572|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
23251092|NCT04380701|64662573|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
23251093|NCT04380701|64662574|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
23251094|NCT04380701|64662575|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
23474225|NCT01451437|65481718|FG008|Overall Study|Adverse Event|1|||
23474226|NCT01451437|65481710|FG000|Overall Study|Physician Decision|1|||
23474227|NCT01451437|65481711|FG001|Overall Study|Physician Decision|1|||
23589226|NCT03743246|65886021|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
23251095|NCT04380701|64662576|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
23357625|NCT01006590|65052841|FG001|Overall Study|Adverse Event|3|||
23357626|NCT01006590|65052840|FG000|Overall Study|Death|1|||
23589227|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
23589228|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
23589229|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
23589230|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
23190853|NCT02795156|64439531|FG003|Overall Study|Physician Decision|0|||
23190854|NCT02795156|64439528|FG000|Overall Study|Withdrawal by Subject|2|||
23251096|NCT04380701|64662577|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
23251097|NCT04380701|64662578|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
23190855|NCT02795156|64439529|FG001|Overall Study|Withdrawal by Subject|0|||
23190856|NCT02795156|64439530|FG002|Overall Study|Withdrawal by Subject|3|||
23190857|NCT02795156|64439531|FG003|Overall Study|Withdrawal by Subject|0|||
23474228|NCT01451437|65481712|FG002|Overall Study|Physician Decision|2|||
23474229|NCT01451437|65481713|FG003|Overall Study|Physician Decision|0|||
23474230|NCT01451437|65481714|FG004|Overall Study|Physician Decision|0|||
23474231|NCT01451437|65481715|FG005|Overall Study|Physician Decision|0|||
23474232|NCT01451437|65481716|FG006|Overall Study|Physician Decision|0|||
23190858|NCT03368859|64439532|FG000|Overall Study|Withdrew Consent|5|||
23190859|NCT03368859|64439533|FG001|Overall Study|Withdrew Consent|4|||
23190860|NCT03368859|64439532|FG000|Overall Study|Death|12|||
23357627|NCT01006590|65052841|FG001|Overall Study|Death|1|||
23474233|NCT01451437|65481717|FG007|Overall Study|Physician Decision|0|||
23474234|NCT01451437|65481718|FG008|Overall Study|Physician Decision|0|||
23474235|NCT01451437|65481710|FG000|Overall Study|Disease Progression|0|||
23474236|NCT01451437|65481711|FG001|Overall Study|Disease Progression|0|||
23474237|NCT01451437|65481712|FG002|Overall Study|Disease Progression|1|||
23474238|NCT01451437|65481713|FG003|Overall Study|Disease Progression|1|||
23474239|NCT01451437|65481714|FG004|Overall Study|Disease Progression|3|||
23474240|NCT01451437|65481715|FG005|Overall Study|Disease Progression|2|||
23474241|NCT01451437|65481716|FG006|Overall Study|Disease Progression|3|||
23474242|NCT01451437|65481717|FG007|Overall Study|Disease Progression|1|||
23474243|NCT01451437|65481718|FG008|Overall Study|Disease Progression|3|||
23474244|NCT01451437|65481710|FG000|Overall Study|Protocol Violation|0|||
23474245|NCT01451437|65481711|FG001|Overall Study|Protocol Violation|0|||
23474246|NCT01451437|65481712|FG002|Overall Study|Protocol Violation|0|||
23474247|NCT01451437|65481713|FG003|Overall Study|Protocol Violation|0|||
23474248|NCT01451437|65481714|FG004|Overall Study|Protocol Violation|0|||
23474249|NCT01451437|65481715|FG005|Overall Study|Protocol Violation|0|||
23474250|NCT01451437|65481716|FG006|Overall Study|Protocol Violation|1|||
23474251|NCT01451437|65481717|FG007|Overall Study|Protocol Violation|0|||
23474252|NCT01451437|65481718|FG008|Overall Study|Protocol Violation|0|||
23474253|NCT01451437|65481710|FG000|Overall Study|Withdrawal by Subject|0|||
23474254|NCT01451437|65481711|FG001|Overall Study|Withdrawal by Subject|0|||
23474255|NCT01451437|65481712|FG002|Overall Study|Withdrawal by Subject|0|||
23474256|NCT01451437|65481713|FG003|Overall Study|Withdrawal by Subject|0|||
23474257|NCT01451437|65481714|FG004|Overall Study|Withdrawal by Subject|1|||
23474258|NCT01451437|65481715|FG005|Overall Study|Withdrawal by Subject|0|||
23474259|NCT01451437|65481716|FG006|Overall Study|Withdrawal by Subject|1|||
23474260|NCT01451437|65481717|FG007|Overall Study|Withdrawal by Subject|0|||
23474261|NCT01451437|65481718|FG008|Overall Study|Withdrawal by Subject|0|||
23474262|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
23474263|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
23474264|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
23474265|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
23474266|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
23474267|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
23474268|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
23474269|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
23474270|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
23474271|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
23474272|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
23474273|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
23474274|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
23474275|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
23474276|NCT00612105|65481721|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
23474277|NCT00612105|65481722|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
23474278|NCT00612105|65481721|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
23474279|NCT00612105|65481722|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
23474280|NCT00612105|65481721|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
23474281|NCT00612105|65481722|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
23474282|NCT00612105|65481721|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
23474283|NCT00612105|65481722|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
23474284|NCT00612105|65481721|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
23474285|NCT00612105|65481722|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
23474286|NCT02870933|65481725|FG000|Overall Study|Death|2|||
23474287|NCT02870933|65481726|FG001|Overall Study|Death|1|||
23589231|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
23589232|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
23589233|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
23589234|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
23474288|NCT02870933|65481725|FG000|Overall Study|Withdrawal by Subject|0|||
23589235|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
23474289|NCT02870933|65481726|FG001|Overall Study|Withdrawal by Subject|1|||
23474290|NCT02547363|65481727|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
23474291|NCT02547363|65481728|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
23190861|NCT03368859|64439533|FG001|Overall Study|Death|6|||
23474292|NCT02547363|65481727|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
23474293|NCT02547363|65481728|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
23474294|NCT02547363|65481727|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
23474295|NCT02547363|65481728|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
23474296|NCT02547363|65481727|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
23474297|NCT02547363|65481728|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
23474298|NCT02547363|65481727|FG000|12-month Follow-up|Withdrawal by Subject|4|||
23474299|NCT02547363|65481728|FG001|12-month Follow-up|Withdrawal by Subject|3|||
23474300|NCT02547363|65481727|FG000|12-month Follow-up|Lost to Follow-up|4|||
23474301|NCT02547363|65481728|FG001|12-month Follow-up|Lost to Follow-up|1|||
23474302|NCT02547363|65481727|FG000|12-month Follow-up|Lack of Efficacy|1|||
23474303|NCT02547363|65481728|FG001|12-month Follow-up|Lack of Efficacy|1|||
23474304|NCT02547363|65481727|FG000|12-month Follow-up|Other|1|||
23474305|NCT02547363|65481728|FG001|12-month Follow-up|Other|0|||
23474306|NCT01090323|65481729|FG000|Overall Study|Adverse Event|12|||
23474307|NCT01090323|65481730|FG001|Overall Study|Adverse Event|2|||
23474308|NCT01090323|65481729|FG000|Overall Study|Abnormal Lab Values|3|||
23474309|NCT01090323|65481730|FG001|Overall Study|Abnormal Lab Values|1|||
23474310|NCT01090323|65481729|FG000|Overall Study|Abnormal Test Procedure Results|2|||
23474311|NCT01090323|65481730|FG001|Overall Study|Abnormal Test Procedure Results|0|||
23474312|NCT01090323|65481729|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23474313|NCT01090323|65481730|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23474314|NCT01090323|65481729|FG000|Overall Study|Condition no longer requires drug|5|||
23474315|NCT01090323|65481730|FG001|Overall Study|Condition no longer requires drug|4|||
23474316|NCT01090323|65481729|FG000|Overall Study|Protocol Violation|2|||
23474317|NCT01090323|65481730|FG001|Overall Study|Protocol Violation|1|||
23474318|NCT01090323|65481729|FG000|Overall Study|Withdrew consent|33|||
23474319|NCT01090323|65481730|FG001|Overall Study|Withdrew consent|11|||
23474320|NCT01090323|65481729|FG000|Overall Study|Lost to Follow-up|11|||
23474321|NCT01090323|65481730|FG001|Overall Study|Lost to Follow-up|6|||
23474322|NCT01090323|65481729|FG000|Overall Study|Administrative problems|6|||
23474323|NCT01090323|65481730|FG001|Overall Study|Administrative problems|4|||
23474324|NCT01090323|65481729|FG000|Overall Study|Death|1|||
23474325|NCT01090323|65481730|FG001|Overall Study|Death|2|||
23474326|NCT01090323|65481729|FG000|Overall Study|Stopped end of core|7|||
23474327|NCT01090323|65481730|FG001|Overall Study|Stopped end of core|0|||
23474328|NCT01090323|65481729|FG000|Overall Study|Stopped end of extension 1#|3|||
23474329|NCT01090323|65481730|FG001|Overall Study|Stopped end of extension 1#|1|||
23474330|NCT05194579|65481731|FG000|Overall Study|Lost to Follow-up|2|||
23474331|NCT05194579|65481732|FG001|Overall Study|Lost to Follow-up|3|||
23474332|NCT05194579|65481731|FG000|Overall Study|Withdrawal by Subject|3|||
23474333|NCT05194579|65481732|FG001|Overall Study|Withdrawal by Subject|4|||
23474334|NCT05194579|65481731|FG000|Overall Study|Refused further study procedures|0|||
23474335|NCT05194579|65481732|FG001|Overall Study|Refused further study procedures|1|||
23474336|NCT05194579|65481731|FG000|Overall Study|Protocol deviation|1|||
23474337|NCT05194579|65481732|FG001|Overall Study|Protocol deviation|0|||
23474338|NCT00006409|65481735|FG000|Baseline|Protocol Violation|48|||
23474339|NCT00006409|65481736|FG001|Baseline|Protocol Violation|70|||
23474340|NCT00006409|65481737|FG002|Baseline|Protocol Violation|0|||
23474341|NCT00006409|65481738|FG003|Baseline|Protocol Violation|0|||
23474342|NCT00006409|65481739|FG004|Baseline|Protocol Violation|0|||
23474343|NCT00006409|65481740|FG005|Baseline|Protocol Violation|0|||
23474344|NCT00006409|65481735|FG000|Post-2 Year Intervention|Protocol Violation|0|||
23474345|NCT00006409|65481736|FG001|Post-2 Year Intervention|Protocol Violation|0|||
23474346|NCT00006409|65481737|FG002|Post-2 Year Intervention|Protocol Violation|251|||
23474347|NCT00006409|65481738|FG003|Post-2 Year Intervention|Protocol Violation|168|||
23474348|NCT00006409|65481739|FG004|Post-2 Year Intervention|Protocol Violation|0|||
23190862|NCT03368859|64439532|FG000|Overall Study|Study terminated by Sponsor|18|||
23190863|NCT03368859|64439533|FG001|Overall Study|Study terminated by Sponsor|23|||
23474349|NCT00006409|65481740|FG005|Post-2 Year Intervention|Protocol Violation|0|||
23474350|NCT00006409|65481735|FG000|Post-3 Year Intervention|Protocol Violation|0|||
23474351|NCT00006409|65481736|FG001|Post-3 Year Intervention|Protocol Violation|0|||
23190864|NCT03368859|64439532|FG000|Overall Study|Other|1|||
23190865|NCT03368859|64439533|FG001|Overall Study|Other|1|||
23190866|NCT02522377|64439534|FG000|Overall Study|Withdrawal by Subject|1|||
23190867|NCT02522377|64439535|FG001|Overall Study|Withdrawal by Subject|0|||
23190868|NCT02522377|64439534|FG000|Overall Study|Remission Achieved|3|||
23190869|NCT02522377|64439535|FG001|Overall Study|Remission Achieved|0|||
23190870|NCT00824421|64439536|FG000|Overall Study|Adverse Event|6|||
23190871|NCT00824421|64439537|FG001|Overall Study|Adverse Event|6|||
23190872|NCT00824421|64439538|FG002|Overall Study|Adverse Event|6|||
23474352|NCT00006409|65481737|FG002|Post-3 Year Intervention|Protocol Violation|0|||
23474353|NCT00006409|65481738|FG003|Post-3 Year Intervention|Protocol Violation|0|||
23474354|NCT00006409|65481739|FG004|Post-3 Year Intervention|Protocol Violation|62|||
23474355|NCT00006409|65481740|FG005|Post-3 Year Intervention|Protocol Violation|62|||
23474356|NCT01501955|65481744|FG000|Overall Study|Withdrawal by Subject|1|||
23474357|NCT01501955|65481745|FG001|Overall Study|Withdrawal by Subject|0|||
23474358|NCT01501955|65481744|FG000|Overall Study|Adverse Event|1|||
23474359|NCT01501955|65481745|FG001|Overall Study|Adverse Event|3|||
23474360|NCT01590758|65481751|FG000|Overall Study|Withdrawal by Subject|0|||
23474361|NCT01590758|65481752|FG001|Overall Study|Withdrawal by Subject|3|||
23190873|NCT00824421|64439536|FG000|Overall Study|Death|0|||
23190874|NCT00824421|64439537|FG001|Overall Study|Death|1|||
23190875|NCT00824421|64439538|FG002|Overall Study|Death|0|||
23190876|NCT00824421|64439536|FG000|Overall Study|Lack of Efficacy|5|||
23190877|NCT00824421|64439537|FG001|Overall Study|Lack of Efficacy|7|||
23190878|NCT00824421|64439538|FG002|Overall Study|Lack of Efficacy|4|||
23190879|NCT00824421|64439536|FG000|Overall Study|Lost to Follow-up|2|||
23190880|NCT00824421|64439537|FG001|Overall Study|Lost to Follow-up|3|||
23190881|NCT00824421|64439538|FG002|Overall Study|Lost to Follow-up|0|||
23190882|NCT00824421|64439536|FG000|Overall Study|Pregnancy|1|||
23190883|NCT00824421|64439537|FG001|Overall Study|Pregnancy|0|||
23190884|NCT00824421|64439538|FG002|Overall Study|Pregnancy|1|||
23474362|NCT01590758|65481751|FG000|Overall Study|Physician Decision|1|||
23474363|NCT01590758|65481752|FG001|Overall Study|Physician Decision|2|||
23474364|NCT01590758|65481751|FG000|Overall Study|Lost to Follow-up|4|||
23474365|NCT01590758|65481752|FG001|Overall Study|Lost to Follow-up|2|||
23474366|NCT02813577|65481753|FG000|Overall Study|Study terminated|4|||
23474367|NCT02160041|65481755|FG000|Overall Study|Adverse Event|11|||
23474368|NCT02160041|65481755|FG000|Overall Study|Death|2|||
23474369|NCT02160041|65481755|FG000|Overall Study|disease progression|57|||
23474370|NCT02160041|65481755|FG000|Overall Study|Protocol Violation|1|||
23190885|NCT00824421|64439536|FG000|Overall Study|Withdrawal by Subject|2|||
23190886|NCT00824421|64439537|FG001|Overall Study|Withdrawal by Subject|3|||
23190887|NCT00824421|64439538|FG002|Overall Study|Withdrawal by Subject|3|||
23190888|NCT00824421|64439536|FG000|Overall Study|Randomized but not Treated|1|||
23190889|NCT00824421|64439537|FG001|Overall Study|Randomized but not Treated|1|||
23190890|NCT00824421|64439538|FG002|Overall Study|Randomized but not Treated|0|||
23190891|NCT00824421|64439536|FG000|Overall Study|Other|0|||
23190892|NCT00824421|64439537|FG001|Overall Study|Other|1|||
23190893|NCT00824421|64439538|FG002|Overall Study|Other|0|||
23190894|NCT00907738|64439539|FG000|Overall Study|Adverse Event|2|||
23357628|NCT01006590|65052840|FG000|Overall Study|Lost to Follow-up|1|||
23357629|NCT01006590|65052841|FG001|Overall Study|Lost to Follow-up|1|||
23474371|NCT02160041|65481755|FG000|Overall Study|non-compliance with study|1|||
23190895|NCT00907738|64439540|FG001|Overall Study|Adverse Event|0|||
23474372|NCT02160041|65481755|FG000|Overall Study|Physician Decision|3|||
23474373|NCT02160041|65481755|FG000|Overall Study|Withdrawal by Subject|8|||
23474374|NCT02160041|65481755|FG000|Overall Study|study terminated by by sponsor|1|||
23474375|NCT01519167|65481756|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
23190896|NCT00907738|64439541|FG002|Overall Study|Adverse Event|1|||
23190897|NCT00907738|64439542|FG003|Overall Study|Adverse Event|0|||
23190898|NCT00907738|64439543|FG004|Overall Study|Adverse Event|0|||
23357630|NCT01006590|65052840|FG000|Overall Study|Protocol Violation|1|||
23190899|NCT00907738|64439539|FG000|Overall Study|not specified or withdrew consent|3|||
23190900|NCT00907738|64439540|FG001|Overall Study|not specified or withdrew consent|0|||
23357631|NCT01006590|65052841|FG001|Overall Study|Protocol Violation|0|||
23190901|NCT00907738|64439541|FG002|Overall Study|not specified or withdrew consent|0|||
23190902|NCT00907738|64439542|FG003|Overall Study|not specified or withdrew consent|0|||
23190903|NCT00907738|64439543|FG004|Overall Study|not specified or withdrew consent|0|||
23190904|NCT00907738|64439539|FG000|Overall Study|Disease progression|8|||
23190905|NCT00907738|64439540|FG001|Overall Study|Disease progression|1|||
23190906|NCT00907738|64439541|FG002|Overall Study|Disease progression|6|||
23190907|NCT00907738|64439542|FG003|Overall Study|Disease progression|4|||
23190908|NCT00907738|64439543|FG004|Overall Study|Disease progression|2|||
23190909|NCT02371629|64439546|FG000|Overall Study|Patient decision|14|||
23190910|NCT02371629|64439547|FG001|Overall Study|Patient decision|10|||
23190911|NCT02371629|64439546|FG000|Overall Study|Adverse Event|8|||
23190912|NCT02371629|64439547|FG001|Overall Study|Adverse Event|8|||
23190913|NCT02371629|64439546|FG000|Overall Study|Physician Decision|2|||
23190914|NCT02371629|64439547|FG001|Overall Study|Physician Decision|3|||
23190915|NCT02371629|64439546|FG000|Overall Study|Death|1|||
23190916|NCT02371629|64439547|FG001|Overall Study|Death|1|||
23190917|NCT02371629|64439546|FG000|Overall Study|Noncompliance with study treatment|1|||
23190918|NCT02371629|64439547|FG001|Overall Study|Noncompliance with study treatment|0|||
23190919|NCT02371629|64439546|FG000|Overall Study|Lack of Efficacy|0|||
23190920|NCT02371629|64439547|FG001|Overall Study|Lack of Efficacy|2|||
23190921|NCT02371629|64439546|FG000|Overall Study|Protocol deviation|0|||
23190922|NCT02371629|64439547|FG001|Overall Study|Protocol deviation|1|||
23190923|NCT02767570|64439548|FG000|Overall Study|Lost to Follow-up|3|||
23190924|NCT02767570|64439549|FG001|Overall Study|Lost to Follow-up|0|||
23190925|NCT02767570|64439548|FG000|Overall Study|COVID shutdown|2|||
23190926|NCT02767570|64439549|FG001|Overall Study|COVID shutdown|5|||
23190927|NCT02767570|64439548|FG000|Overall Study|Increased pain|2|||
23190928|NCT02767570|64439549|FG001|Overall Study|Increased pain|0|||
23190929|NCT02767570|64439548|FG000|Overall Study|Withdrawal by Subject|1|||
23190930|NCT02767570|64439549|FG001|Overall Study|Withdrawal by Subject|3|||
23190931|NCT02767570|64439548|FG000|Overall Study|Unrelated medical issue|1|||
23190932|NCT02767570|64439549|FG001|Overall Study|Unrelated medical issue|1|||
23190933|NCT02767570|64439548|FG000|Overall Study|Received intra-articular injection|0|||
23190934|NCT02767570|64439549|FG001|Overall Study|Received intra-articular injection|1|||
23190935|NCT00949650|64439552|FG000|Overall Study|Progressive disease|188|||
23190936|NCT00949650|64439553|FG001|Overall Study|Progressive disease|19|||
23190937|NCT00949650|64439552|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
23190938|NCT00949650|64439553|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
23190939|NCT00949650|64439552|FG000|Overall Study|Other Adverse Event (AE)|28|||
23190940|NCT00949650|64439553|FG001|Overall Study|Other Adverse Event (AE)|17|||
23190941|NCT00949650|64439552|FG000|Overall Study|Protocol Violation|1|||
23190942|NCT00949650|64439553|FG001|Overall Study|Protocol Violation|4|||
23190943|NCT00949650|64439552|FG000|Overall Study|Refusal to continue medication|7|||
23190944|NCT00949650|64439553|FG001|Overall Study|Refusal to continue medication|11|||
23190945|NCT00949650|64439552|FG000|Overall Study|Not treated|1|||
23190946|NCT00949650|64439553|FG001|Overall Study|Not treated|4|||
23190947|NCT00949650|64439552|FG000|Overall Study|Other not specified above|5|||
23190948|NCT00949650|64439553|FG001|Overall Study|Other not specified above|0|||
23190949|NCT04083222|64439555|FG000|Overall Study|Voluntary Withdrawal|0|||
23190950|NCT04083222|64439556|FG001|Overall Study|Voluntary Withdrawal|1|||
23190951|NCT04083222|64439555|FG000|Overall Study|Reason not Specified|0|||
23190952|NCT04083222|64439556|FG001|Overall Study|Reason not Specified|1|||
23190953|NCT03461289|64439557|FG000|Overall Study|Death|1|||
23190954|NCT01821963|64439558|FG000|Overall Study|Adverse Event|1|||
23190955|NCT02179398|64439561|FG000|Overall Study|Lack of obligatory data|3|||
23190956|NCT02179398|64439562|FG001|Overall Study|Lack of obligatory data|3|||
23190957|NCT02179398|64439561|FG000|Overall Study|Lost to Follow-up|0|||
23190958|NCT02179398|64439562|FG001|Overall Study|Lost to Follow-up|1|||
23357632|NCT01006590|65052840|FG000|Overall Study|Withdrawal by Subject|4|||
23190959|NCT00891657|64439569|FG000|Overall Study|Withdrawal by Subject|1|||
23190960|NCT00891657|64439570|FG001|Overall Study|Withdrawal by Subject|1|||
23357633|NCT01006590|65052841|FG001|Overall Study|Withdrawal by Subject|2|||
23357634|NCT01006590|65052840|FG000|Overall Study|Study specific discontinuation criteria|16|||
23357635|NCT01006590|65052841|FG001|Overall Study|Study specific discontinuation criteria|23|||
23357636|NCT01006590|65052840|FG000|Overall Study|Other|3|||
23357637|NCT01006590|65052841|FG001|Overall Study|Other|2|||
23357638|NCT01990768|65052842|FG000|Intervention Started|Found to be ineligible|14|||
23357639|NCT01990768|65052843|FG001|Intervention Started|Found to be ineligible|13|||
23357640|NCT01990768|65052844|FG002|Intervention Started|Found to be ineligible|11|||
23357641|NCT01990768|65052842|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
23357642|NCT01990768|65052843|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
23357643|NCT01990768|65052844|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
23357644|NCT01990768|65052842|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
23357645|NCT01990768|65052843|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
23357646|NCT01990768|65052844|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
23357647|NCT01990768|65052842|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
23357648|NCT01990768|65052843|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
23357649|NCT01990768|65052844|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
23357650|NCT01990768|65052842|FG000|Intervention Started|Patient care priority|1|||
23357651|NCT01990768|65052843|FG001|Intervention Started|Patient care priority|2|||
23357652|NCT01990768|65052844|FG002|Intervention Started|Patient care priority|3|||
23357653|NCT01990768|65052842|FG000|Intervention Started|IV lost|2|||
23357654|NCT01990768|65052843|FG001|Intervention Started|IV lost|2|||
23357655|NCT01990768|65052844|FG002|Intervention Started|IV lost|2|||
23357656|NCT01990768|65052842|FG000|Intervention Started|Required CPR|1|||
23357657|NCT01990768|65052843|FG001|Intervention Started|Required CPR|1|||
23357658|NCT01990768|65052844|FG002|Intervention Started|Required CPR|0|||
23357659|NCT01990768|65052842|FG000|Intervention Started|Seizure or hx of seizure|0|||
23357660|NCT01990768|65052843|FG001|Intervention Started|Seizure or hx of seizure|0|||
23357661|NCT01990768|65052844|FG002|Intervention Started|Seizure or hx of seizure|2|||
23357662|NCT01990768|65052842|FG000|Intervention Started|Discovered to be pregnant|0|||
23357663|NCT01990768|65052843|FG001|Intervention Started|Discovered to be pregnant|1|||
23357664|NCT01990768|65052844|FG002|Intervention Started|Discovered to be pregnant|0|||
23357665|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
23357666|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
23357667|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
23357668|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
23357669|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
23357670|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
23357671|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
23357672|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
23357673|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
23357674|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
23357675|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
23474376|NCT01519167|65481757|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
23190961|NCT04075604|64439576|FG000|Overall Study|Adverse Event|0|||
23190962|NCT04075604|64439577|FG001|Overall Study|Adverse Event|0|||
23190963|NCT04075604|64439578|FG002|Overall Study|Adverse Event|3|||
23190964|NCT04075604|64439576|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23474377|NCT01519167|65481756|FG000|Overall Study|Adverse Event|0|||
23190965|NCT04075604|64439577|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23190966|NCT04075604|64439578|FG002|Overall Study|Participant request to discontinue study treatment|1|||
23190967|NCT04075604|64439576|FG000|Overall Study|Participant withdrew consent|0|||
23190968|NCT04075604|64439577|FG001|Overall Study|Participant withdrew consent|0|||
23474378|NCT01519167|65481757|FG001|Overall Study|Adverse Event|1|||
23474379|NCT01519167|65481756|FG000|Overall Study|Lack of Efficacy|0|||
23474380|NCT01519167|65481757|FG001|Overall Study|Lack of Efficacy|1|||
23474381|NCT01519167|65481756|FG000|Overall Study|Medical condition changes&deep sedation|0|||
23474382|NCT01519167|65481757|FG001|Overall Study|Medical condition changes&deep sedation|2|||
23474383|NCT01519167|65481756|FG000|Overall Study|Physician Decision|0|||
23474384|NCT01519167|65481757|FG001|Overall Study|Physician Decision|1|||
23474385|NCT02500056|65481761|FG000|Overall Study|Lost to Follow-up|3|||
23190969|NCT04075604|64439578|FG002|Overall Study|Participant withdrew consent|1|||
23190970|NCT04075604|64439576|FG000|Overall Study|Other reasons|1|||
23190971|NCT04075604|64439577|FG001|Overall Study|Other reasons|0|||
23251098|NCT04380701|64662579|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
23474386|NCT02500056|65481762|FG001|Overall Study|Lost to Follow-up|7|||
23474387|NCT02500056|65481761|FG000|Overall Study|Recurrence|1|||
23474388|NCT02500056|65481762|FG001|Overall Study|Recurrence|0|||
23190972|NCT04075604|64439578|FG002|Overall Study|Other reasons|0|||
23190973|NCT04075604|64439576|FG000|Overall Study|Disease progression|0|||
23474389|NCT02500056|65481761|FG000|Overall Study|Death|3|||
23474390|NCT02500056|65481762|FG001|Overall Study|Death|1|||
23251099|NCT04380701|64662580|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
23251100|NCT04380701|64662581|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
23251101|NCT04380701|64662582|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
23251102|NCT04380701|64662583|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
23251103|NCT04380701|64662584|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
23251104|NCT04380701|64662585|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
23251105|NCT04380701|64662586|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
23251106|NCT04380701|64662587|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
23251107|NCT04380701|64662588|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
23190974|NCT04075604|64439577|FG001|Overall Study|Disease progression|1|||
23190975|NCT04075604|64439578|FG002|Overall Study|Disease progression|0|||
23190976|NCT04075604|64439576|FG000|Overall Study|Study drug toxicity|0|||
23190977|NCT04075604|64439577|FG001|Overall Study|Study drug toxicity|5|||
23190978|NCT04075604|64439578|FG002|Overall Study|Study drug toxicity|1|||
23190979|NCT02424539|64439579|FG000|Overall Study|Adverse Event|0|||
23190980|NCT02424539|64439580|FG001|Overall Study|Adverse Event|0|||
23190981|NCT02424539|64439581|FG002|Overall Study|Adverse Event|1|||
23190982|NCT02424539|64439579|FG000|Overall Study|Physician Decision|0|||
23190983|NCT02424539|64439580|FG001|Overall Study|Physician Decision|0|||
23190984|NCT02424539|64439581|FG002|Overall Study|Physician Decision|1|||
23190985|NCT02424539|64439579|FG000|Overall Study|Withdrawal by Subject|3|||
23190986|NCT02424539|64439580|FG001|Overall Study|Withdrawal by Subject|1|||
23190987|NCT02424539|64439581|FG002|Overall Study|Withdrawal by Subject|0|||
23190988|NCT02424539|64439579|FG000|Overall Study|Other: Reached stopping criteria|11|||
23190989|NCT02424539|64439580|FG001|Overall Study|Other: Reached stopping criteria|7|||
23190990|NCT02424539|64439581|FG002|Overall Study|Other: Reached stopping criteria|6|||
23190991|NCT00793104|64439582|FG000|Overall Study|Lost to Follow-up|1|||
23190992|NCT00492921|64439583|FG000|Overall Study|Death|1|||
23190993|NCT00492921|64439584|FG001|Overall Study|Death|0|||
23190994|NCT00492921|64439585|FG002|Overall Study|Death|1|||
23190995|NCT00850499|64439586|FG000|Overall Study|Adverse Event|3|||
23190996|NCT00850499|64439587|FG001|Overall Study|Adverse Event|1|||
23251108|NCT04380701|64662589|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
23251109|NCT04380701|64662590|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
23251110|NCT04380701|64662591|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
23251111|NCT04380701|64662592|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
23251112|NCT04380701|64662593|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
23251113|NCT04380701|64662594|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
23251114|NCT04380701|64662595|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
23251115|NCT04380701|64662596|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
23251116|NCT04380701|64662597|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
23251117|NCT04380701|64662598|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
23251118|NCT04380701|64662599|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
23251119|NCT04380701|64662600|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
23251120|NCT04380701|64662567|FG000|Overall Study|Physician Decision|0|||
23251121|NCT04380701|64662568|FG001|Overall Study|Physician Decision|0|||
23251122|NCT04380701|64662569|FG002|Overall Study|Physician Decision|0|||
23251123|NCT04380701|64662570|FG003|Overall Study|Physician Decision|0|||
23357676|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
23357677|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Death|3|||
23357678|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Death|1|||
23357679|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Death|1|||
23251124|NCT04380701|64662571|FG004|Overall Study|Physician Decision|0|||
23251125|NCT04380701|64662572|FG005|Overall Study|Physician Decision|0|||
23251126|NCT04380701|64662573|FG006|Overall Study|Physician Decision|0|||
23251127|NCT04380701|64662574|FG007|Overall Study|Physician Decision|0|||
23251128|NCT04380701|64662575|FG008|Overall Study|Physician Decision|0|||
23251129|NCT04380701|64662576|FG009|Overall Study|Physician Decision|0|||
23190997|NCT00850499|64439586|FG000|Overall Study|Lack of Efficacy|0|||
23190998|NCT00850499|64439587|FG001|Overall Study|Lack of Efficacy|1|||
23190999|NCT01499576|64439588|FG000|Overall Study|Physician Decision|12|||
23474391|NCT01343693|65481763|FG000|Overall Study|Lost to Follow-up|9|||
23474392|NCT03615040|65481764|FG000|Overall Study|Withdrawal by Subject|2|||
23251130|NCT04380701|64662577|FG010|Overall Study|Physician Decision|0|||
23251131|NCT04380701|64662578|FG011|Overall Study|Physician Decision|0|||
23251132|NCT04380701|64662579|FG012|Overall Study|Physician Decision|0|||
23251133|NCT04380701|64662580|FG013|Overall Study|Physician Decision|0|||
23251134|NCT04380701|64662581|FG014|Overall Study|Physician Decision|0|||
23251135|NCT04380701|64662582|FG015|Overall Study|Physician Decision|0|||
23251136|NCT04380701|64662583|FG016|Overall Study|Physician Decision|0|||
23251137|NCT04380701|64662584|FG017|Overall Study|Physician Decision|0|||
23251138|NCT04380701|64662585|FG018|Overall Study|Physician Decision|0|||
23251139|NCT04380701|64662586|FG019|Overall Study|Physician Decision|0|||
23251140|NCT04380701|64662587|FG020|Overall Study|Physician Decision|0|||
23251141|NCT04380701|64662588|FG021|Overall Study|Physician Decision|0|||
23251142|NCT04380701|64662589|FG022|Overall Study|Physician Decision|0|||
23251143|NCT04380701|64662590|FG023|Overall Study|Physician Decision|0|||
23251144|NCT04380701|64662591|FG024|Overall Study|Physician Decision|2|||
23251145|NCT04380701|64662592|FG025|Overall Study|Physician Decision|0|||
23251146|NCT04380701|64662593|FG026|Overall Study|Physician Decision|0|||
23251147|NCT04380701|64662594|FG027|Overall Study|Physician Decision|0|||
23474393|NCT03615040|65481765|FG001|Overall Study|Withdrawal by Subject|1|||
23474394|NCT03615040|65481764|FG000|Overall Study|Physician Decision|2|||
23589236|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
23589237|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
23589238|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
23589239|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
23589240|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
23589241|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
23589242|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
23589243|NCT03743246|65886018|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
23474395|NCT03615040|65481765|FG001|Overall Study|Physician Decision|2|||
23474396|NCT03615040|65481764|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
23474397|NCT03615040|65481765|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
23474398|NCT03615040|65481764|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
23474399|NCT03615040|65481765|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
23474400|NCT03615040|65481764|FG000|Overall Study|Death|0|||
23474401|NCT03615040|65481765|FG001|Overall Study|Death|2|||
23474402|NCT01332799|65481772|FG000|Overall Study|Insufficient funding|10|||
23474403|NCT01332799|65481773|FG001|Overall Study|Insufficient funding|10|||
23474404|NCT00499616|65481774|FG000|Overall Study|Death|1|||
23474405|NCT00499616|65481775|FG001|Overall Study|Death|5|||
23474406|NCT00499616|65481776|FG002|Overall Study|Death|3|||
23474407|NCT00499616|65481777|FG003|Overall Study|Death|1|||
23474408|NCT00499616|65481774|FG000|Overall Study|Lack of Efficacy|5|||
23474409|NCT00499616|65481775|FG001|Overall Study|Lack of Efficacy|0|||
23474410|NCT00499616|65481776|FG002|Overall Study|Lack of Efficacy|19|||
23474411|NCT00499616|65481777|FG003|Overall Study|Lack of Efficacy|0|||
23474412|NCT00499616|65481774|FG000|Overall Study|Lost to Follow-up|0|||
23474413|NCT00499616|65481775|FG001|Overall Study|Lost to Follow-up|0|||
23474414|NCT00499616|65481776|FG002|Overall Study|Lost to Follow-up|1|||
23474415|NCT00499616|65481777|FG003|Overall Study|Lost to Follow-up|0|||
23251148|NCT04380701|64662595|FG028|Overall Study|Physician Decision|0|||
23251149|NCT04380701|64662596|FG029|Overall Study|Physician Decision|0|||
23251150|NCT04380701|64662597|FG030|Overall Study|Physician Decision|0|||
23251151|NCT04380701|64662598|FG031|Overall Study|Physician Decision|0|||
23474416|NCT00499616|65481774|FG000|Overall Study|Physician Decision|6|||
23589244|NCT03743246|65886019|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
23251152|NCT04380701|64662599|FG032|Overall Study|Physician Decision|0|||
23251153|NCT04380701|64662600|FG033|Overall Study|Physician Decision|0|||
23251154|NCT04380701|64662567|FG000|Overall Study|Death|0|||
23251155|NCT04380701|64662568|FG001|Overall Study|Death|0|||
23251156|NCT04380701|64662569|FG002|Overall Study|Death|0|||
23251157|NCT04380701|64662570|FG003|Overall Study|Death|0|||
23251158|NCT04380701|64662571|FG004|Overall Study|Death|0|||
23251159|NCT04380701|64662572|FG005|Overall Study|Death|0|||
23251160|NCT04380701|64662573|FG006|Overall Study|Death|0|||
23251161|NCT04380701|64662574|FG007|Overall Study|Death|0|||
23251162|NCT04380701|64662575|FG008|Overall Study|Death|0|||
23251163|NCT04380701|64662576|FG009|Overall Study|Death|0|||
23251164|NCT04380701|64662577|FG010|Overall Study|Death|0|||
23251165|NCT04380701|64662578|FG011|Overall Study|Death|0|||
23251166|NCT04380701|64662579|FG012|Overall Study|Death|0|||
23251167|NCT04380701|64662580|FG013|Overall Study|Death|0|||
23251168|NCT04380701|64662581|FG014|Overall Study|Death|0|||
23251169|NCT04380701|64662582|FG015|Overall Study|Death|0|||
23251170|NCT04380701|64662583|FG016|Overall Study|Death|0|||
23251171|NCT04380701|64662584|FG017|Overall Study|Death|0|||
23251172|NCT04380701|64662585|FG018|Overall Study|Death|0|||
23251173|NCT04380701|64662586|FG019|Overall Study|Death|0|||
23251174|NCT04380701|64662587|FG020|Overall Study|Death|0|||
23251175|NCT04380701|64662588|FG021|Overall Study|Death|0|||
23251176|NCT04380701|64662589|FG022|Overall Study|Death|0|||
23251177|NCT04380701|64662590|FG023|Overall Study|Death|0|||
23251178|NCT04380701|64662591|FG024|Overall Study|Death|1|||
23251179|NCT04380701|64662592|FG025|Overall Study|Death|0|||
23251180|NCT04380701|64662593|FG026|Overall Study|Death|0|||
23251181|NCT04380701|64662594|FG027|Overall Study|Death|0|||
23251182|NCT04380701|64662595|FG028|Overall Study|Death|0|||
23251183|NCT04380701|64662596|FG029|Overall Study|Death|0|||
23251184|NCT04380701|64662597|FG030|Overall Study|Death|0|||
23251185|NCT04380701|64662598|FG031|Overall Study|Death|0|||
23251186|NCT04380701|64662599|FG032|Overall Study|Death|0|||
23251187|NCT04380701|64662600|FG033|Overall Study|Death|0|||
23251188|NCT04380701|64662567|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251189|NCT04380701|64662568|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251190|NCT04380701|64662569|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251191|NCT04380701|64662570|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23474417|NCT00499616|65481775|FG001|Overall Study|Physician Decision|16|||
23251192|NCT04380701|64662571|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251193|NCT04380701|64662572|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251194|NCT04380701|64662573|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251195|NCT04380701|64662574|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251196|NCT04380701|64662575|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251197|NCT04380701|64662576|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251198|NCT04380701|64662577|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251199|NCT04380701|64662578|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251200|NCT04380701|64662579|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23357680|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Discharged|2|||
23357681|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Discharged|1|||
23357682|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Discharged|0|||
23357683|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
23357684|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
23357685|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
23357686|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
23357687|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
23357688|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
23357689|NCT01990768|65052842|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
23357690|NCT01990768|65052843|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
23357691|NCT01990768|65052844|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
23357692|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
23357693|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
23357694|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
23357695|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
23357696|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
23357697|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
23357698|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
23357699|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
23357700|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
23357701|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
23357702|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
23357703|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
23357704|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
23357705|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
23357706|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
23357707|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
23357708|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
23357709|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
23251201|NCT04380701|64662580|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251202|NCT04380701|64662581|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23357710|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
23357711|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
23357712|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
23357713|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
23357714|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
23357715|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
23357716|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
23589245|NCT03743246|65886020|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
23589246|NCT03743246|65886021|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
23251203|NCT04380701|64662582|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251204|NCT04380701|64662583|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251205|NCT04380701|64662584|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251206|NCT04380701|64662585|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251207|NCT04380701|64662586|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251208|NCT04380701|64662587|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251209|NCT04380701|64662588|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
23251210|NCT04380701|64662589|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
23251211|NCT04380701|64662590|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
23251212|NCT04380701|64662591|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
23251213|NCT04380701|64662592|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251214|NCT04380701|64662593|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251215|NCT04380701|64662594|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251216|NCT04380701|64662595|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251217|NCT04380701|64662596|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23357717|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
23357718|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
23357719|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
23357720|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
23357721|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
23357722|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
23357723|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
23357724|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
23474418|NCT00499616|65481776|FG002|Overall Study|Physician Decision|9|||
23474419|NCT00499616|65481777|FG003|Overall Study|Physician Decision|0|||
23474420|NCT00499616|65481774|FG000|Overall Study|Withdrawal by Subject|1|||
23474421|NCT00499616|65481775|FG001|Overall Study|Withdrawal by Subject|0|||
23474422|NCT00499616|65481776|FG002|Overall Study|Withdrawal by Subject|1|||
23474423|NCT00499616|65481777|FG003|Overall Study|Withdrawal by Subject|0|||
23474424|NCT00499616|65481774|FG000|Overall Study|Ineligible|1|||
23474425|NCT00499616|65481775|FG001|Overall Study|Ineligible|2|||
23474426|NCT00499616|65481776|FG002|Overall Study|Ineligible|0|||
23474427|NCT00499616|65481777|FG003|Overall Study|Ineligible|15|||
23589247|NCT02596035|65886026|FG000|Overall Study|Disease Progression|64|||
23589248|NCT02596035|65886027|FG001|Overall Study|Disease Progression|32|||
23589249|NCT02596035|65886028|FG002|Overall Study|Disease Progression|1|||
23474428|NCT00499616|65481774|FG000|Overall Study|Not evaluable|0|||
23589250|NCT02596035|65886026|FG000|Overall Study|study drug toxicity|12|||
23589251|NCT02596035|65886027|FG001|Overall Study|study drug toxicity|3|||
23589252|NCT02596035|65886028|FG002|Overall Study|study drug toxicity|0|||
23589253|NCT02596035|65886026|FG000|Overall Study|AE unrelated to study drug|5|||
23589254|NCT02596035|65886027|FG001|Overall Study|AE unrelated to study drug|2|||
23589255|NCT02596035|65886028|FG002|Overall Study|AE unrelated to study drug|0|||
23191000|NCT01499576|64439588|FG000|Overall Study|Withdrawal by Subject|9|||
23191001|NCT02559505|64439589|FG000|Overall Study|Lost to Follow-up|23|||
23191002|NCT02559505|64439590|FG001|Overall Study|Lost to Follow-up|20|||
23191003|NCT02559505|64439589|FG000|Overall Study|Withdrawal by Subject|4|||
23191004|NCT02559505|64439590|FG001|Overall Study|Withdrawal by Subject|2|||
23191005|NCT01089725|64439592|FG000|Overall Study|Adverse Event|1|||
23191006|NCT01089725|64439593|FG001|Overall Study|Adverse Event|1|||
23191007|NCT01089725|64439594|FG002|Overall Study|Adverse Event|0|||
23191008|NCT01089725|64439595|FG003|Overall Study|Adverse Event|0|||
23191009|NCT01089725|64439596|FG004|Overall Study|Adverse Event|2|||
23191010|NCT01089725|64439592|FG000|Overall Study|Lack of Efficacy|4|||
23191011|NCT01089725|64439593|FG001|Overall Study|Lack of Efficacy|3|||
23191012|NCT01089725|64439594|FG002|Overall Study|Lack of Efficacy|1|||
23191013|NCT01089725|64439595|FG003|Overall Study|Lack of Efficacy|0|||
23251218|NCT04380701|64662597|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251219|NCT04380701|64662598|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251220|NCT04380701|64662599|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251221|NCT04380701|64662600|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
23251222|NCT04128696|64662608|FG000|Overall Study|Lost to Follow-up|3|||
23474429|NCT00499616|65481775|FG001|Overall Study|Not evaluable|0|||
23474430|NCT00499616|65481776|FG002|Overall Study|Not evaluable|0|||
23474431|NCT00499616|65481777|FG003|Overall Study|Not evaluable|41|||
23474432|NCT00499616|65481774|FG000|Overall Study|Patient/Parent Refusal|1|||
23474433|NCT00499616|65481775|FG001|Overall Study|Patient/Parent Refusal|5|||
23474434|NCT00499616|65481776|FG002|Overall Study|Patient/Parent Refusal|3|||
23589256|NCT02596035|65886026|FG000|Overall Study|participant request to discontinue study treatment|2|||
23589257|NCT02596035|65886027|FG001|Overall Study|participant request to discontinue study treatment|0|||
23589258|NCT02596035|65886028|FG002|Overall Study|participant request to discontinue study treatment|0|||
23589259|NCT02596035|65886026|FG000|Overall Study|participant withdrew consent|2|||
23589260|NCT02596035|65886027|FG001|Overall Study|participant withdrew consent|2|||
23589261|NCT02596035|65886028|FG002|Overall Study|participant withdrew consent|0|||
23589262|NCT02596035|65886026|FG000|Overall Study|Poor/Non Comlpiance|0|||
23589263|NCT02596035|65886027|FG001|Overall Study|Poor/Non Comlpiance|1|||
23589264|NCT02596035|65886028|FG002|Overall Study|Poor/Non Comlpiance|0|||
23589265|NCT02596035|65886026|FG000|Overall Study|participant no longer meets study criteria|1|||
23589266|NCT02596035|65886027|FG001|Overall Study|participant no longer meets study criteria|0|||
23589267|NCT02596035|65886028|FG002|Overall Study|participant no longer meets study criteria|0|||
23251223|NCT04128696|64662609|FG001|Overall Study|Lost to Follow-up|7|||
23251224|NCT04128696|64662608|FG000|Overall Study|Withdrawal by Subject|12|||
23251225|NCT04128696|64662609|FG001|Overall Study|Withdrawal by Subject|11|||
23474435|NCT00499616|65481777|FG003|Overall Study|Patient/Parent Refusal|0|||
23474436|NCT00171834|65481778|FG000|Overall Study|Adverse Event|2|||
23589268|NCT02596035|65886026|FG000|Overall Study|other reasons|11|||
23589269|NCT02596035|65886027|FG001|Overall Study|other reasons|4|||
23191014|NCT01089725|64439596|FG004|Overall Study|Lack of Efficacy|4|||
23191015|NCT01089725|64439592|FG000|Overall Study|Lost to Follow-up|2|||
23474437|NCT00171834|65481779|FG001|Overall Study|Adverse Event|1|||
23191016|NCT01089725|64439593|FG001|Overall Study|Lost to Follow-up|2|||
23191017|NCT01089725|64439594|FG002|Overall Study|Lost to Follow-up|0|||
23474438|NCT00171834|65481780|FG002|Overall Study|Adverse Event|3|||
23474439|NCT00171834|65481781|FG003|Overall Study|Adverse Event|2|||
23191018|NCT01089725|64439595|FG003|Overall Study|Lost to Follow-up|3|||
23191019|NCT01089725|64439596|FG004|Overall Study|Lost to Follow-up|0|||
23191020|NCT01089725|64439592|FG000|Overall Study|Protocol Violation|0|||
23191021|NCT01089725|64439593|FG001|Overall Study|Protocol Violation|0|||
23589270|NCT02596035|65886028|FG002|Overall Study|other reasons|0|||
23191022|NCT01089725|64439594|FG002|Overall Study|Protocol Violation|1|||
23357725|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
23357726|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
23191023|NCT01089725|64439595|FG003|Overall Study|Protocol Violation|1|||
23191024|NCT01089725|64439596|FG004|Overall Study|Protocol Violation|0|||
23191025|NCT01089725|64439592|FG000|Overall Study|Withdrawal by Subject|5|||
23191026|NCT01089725|64439593|FG001|Overall Study|Withdrawal by Subject|5|||
23357727|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
23357728|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
23357729|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
23357730|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
23357731|NCT01990768|65052842|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
23357732|NCT01990768|65052843|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
23357733|NCT01990768|65052844|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
23357734|NCT01990768|65052842|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
23357735|NCT01990768|65052843|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
23357736|NCT01990768|65052844|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
23357737|NCT01990768|65052842|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
23357738|NCT01990768|65052843|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
23357739|NCT01990768|65052844|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
23474440|NCT00171834|65481782|FG004|Overall Study|Adverse Event|2|||
23191027|NCT01089725|64439594|FG002|Overall Study|Withdrawal by Subject|4|||
23191028|NCT01089725|64439595|FG003|Overall Study|Withdrawal by Subject|5|||
23191029|NCT01089725|64439596|FG004|Overall Study|Withdrawal by Subject|4|||
23191030|NCT01089725|64439592|FG000|Overall Study|Study Terminated by Sponsor|51|||
23191031|NCT01089725|64439593|FG001|Overall Study|Study Terminated by Sponsor|56|||
23191032|NCT01089725|64439594|FG002|Overall Study|Study Terminated by Sponsor|53|||
23191033|NCT01089725|64439595|FG003|Overall Study|Study Terminated by Sponsor|68|||
23191034|NCT01089725|64439596|FG004|Overall Study|Study Terminated by Sponsor|68|||
23191035|NCT01089725|64439592|FG000|Overall Study|Randomized, but not treated|0|||
23191036|NCT01089725|64439593|FG001|Overall Study|Randomized, but not treated|1|||
23191037|NCT01089725|64439594|FG002|Overall Study|Randomized, but not treated|2|||
23191038|NCT01089725|64439595|FG003|Overall Study|Randomized, but not treated|1|||
23191039|NCT01089725|64439596|FG004|Overall Study|Randomized, but not treated|2|||
23191040|NCT01089725|64439592|FG000|Overall Study|Other|3|||
23191041|NCT01089725|64439593|FG001|Overall Study|Other|0|||
23191042|NCT01089725|64439594|FG002|Overall Study|Other|0|||
23191043|NCT01089725|64439595|FG003|Overall Study|Other|1|||
23191044|NCT01089725|64439596|FG004|Overall Study|Other|0|||
23191045|NCT00506389|64439597|FG000|In-treatment Period|Other|3|||
23191046|NCT00506389|64439598|FG001|In-treatment Period|Other|3|||
23251226|NCT04128696|64662608|FG000|Overall Study|Study Closed/Terminated|26|||
23251227|NCT04128696|64662609|FG001|Overall Study|Study Closed/Terminated|38|||
23251228|NCT04128696|64662608|FG000|Overall Study|Physician Decision|2|||
23251229|NCT04128696|64662609|FG001|Overall Study|Physician Decision|3|||
23251230|NCT01123980|64662615|FG000|Overall Study|Adverse Event|1|||
23251231|NCT01123980|64662616|FG001|Overall Study|Adverse Event|1|||
23251232|NCT01123980|64662615|FG000|Overall Study|Lack of Efficacy|1|||
23251233|NCT01123980|64662616|FG001|Overall Study|Lack of Efficacy|0|||
23251234|NCT01123980|64662615|FG000|Overall Study|Physician Decision|0|||
23251235|NCT01123980|64662616|FG001|Overall Study|Physician Decision|1|||
23251236|NCT01123980|64662615|FG000|Overall Study|Lost to Follow-up|0|||
23251237|NCT01123980|64662616|FG001|Overall Study|Lost to Follow-up|6|||
23251238|NCT01123980|64662615|FG000|Overall Study|Protocol Violation|6|||
23251239|NCT01123980|64662616|FG001|Overall Study|Protocol Violation|6|||
23251240|NCT01123980|64662615|FG000|Overall Study|Withdrawal by Subject|5|||
23251241|NCT01123980|64662616|FG001|Overall Study|Withdrawal by Subject|3|||
23251242|NCT01123980|64662615|FG000|Overall Study|Unclassified|6|||
23251243|NCT01123980|64662616|FG001|Overall Study|Unclassified|7|||
23251244|NCT01345058|64662619|FG000|Overall Study|Withdrawal by Subject|1|||
23251245|NCT01345058|64662620|FG001|Overall Study|Withdrawal by Subject|0|||
23251246|NCT01345058|64662619|FG000|Overall Study|Participant Reported Increase in Events|1|||
23251247|NCT01345058|64662620|FG001|Overall Study|Participant Reported Increase in Events|0|||
23251248|NCT01345058|64662619|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
23357740|NCT01990768|65052842|FG000|6-Month Follow-up|No contact information|5|||
23357741|NCT01990768|65052843|FG001|6-Month Follow-up|No contact information|6|||
23191047|NCT00506389|64439599|FG002|In-treatment Period|Other|4|||
23191048|NCT00506389|64439597|FG000|In-treatment Period|Lost to Follow-up|0|||
23191049|NCT00506389|64439598|FG001|In-treatment Period|Lost to Follow-up|0|||
23191050|NCT00506389|64439599|FG002|In-treatment Period|Lost to Follow-up|1|||
23251249|NCT01345058|64662620|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
23251250|NCT01345058|64662619|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
23191051|NCT00506389|64439597|FG000|In-treatment Period|Lack of compliance|1|||
23251251|NCT01345058|64662620|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
23251252|NCT01345058|64662619|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
23191052|NCT00506389|64439598|FG001|In-treatment Period|Lack of compliance|0|||
23191053|NCT00506389|64439599|FG002|In-treatment Period|Lack of compliance|0|||
23191054|NCT00506389|64439597|FG000|In-treatment Period|Reasons not related to trial|4|||
23191055|NCT00506389|64439598|FG001|In-treatment Period|Reasons not related to trial|1|||
23191056|NCT00506389|64439599|FG002|In-treatment Period|Reasons not related to trial|0|||
23191057|NCT00506389|64439597|FG000|In-treatment Period|Withdrawal by Subject|3|||
23191058|NCT00506389|64439598|FG001|In-treatment Period|Withdrawal by Subject|3|||
23191059|NCT00506389|64439599|FG002|In-treatment Period|Withdrawal by Subject|4|||
23191060|NCT00506389|64439597|FG000|In-treatment Period|Lack of Efficacy|0|||
23191061|NCT00506389|64439598|FG001|In-treatment Period|Lack of Efficacy|2|||
23191062|NCT00506389|64439599|FG002|In-treatment Period|Lack of Efficacy|0|||
23191063|NCT00506389|64439597|FG000|In-treatment Period|Adverse Event|11|||
23191064|NCT00506389|64439598|FG001|In-treatment Period|Adverse Event|5|||
23251253|NCT01345058|64662620|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
23191065|NCT00506389|64439599|FG002|In-treatment Period|Adverse Event|2|||
23191066|NCT00506389|64439597|FG000|In-treatment Period|Randomized but not treated|4|||
23191067|NCT00506389|64439598|FG001|In-treatment Period|Randomized but not treated|1|||
23191068|NCT00506389|64439599|FG002|In-treatment Period|Randomized but not treated|1|||
23191069|NCT00849212|64439602|FG000|Overall Study|Lack of Efficacy|1|||
23251254|NCT00585039|64662624|FG000|Overall Study|medication spilled|2|||
23251255|NCT00585039|64662625|FG001|Overall Study|medication spilled|0|||
23251256|NCT03876873|64662626|FG000|Overall Study|Physician Decision|0|||
23251257|NCT03876873|64662627|FG001|Overall Study|Physician Decision|1|||
23251258|NCT02956005|64662629|FG000|Overall Study|Not eligible|1|||
23251259|NCT02956005|64662629|FG000|Overall Study|Withdrawal by Subject|3|||
23251260|NCT02956005|64662629|FG000|Overall Study|Physician Decision|12|||
23251261|NCT02524665|64662630|FG000|Overall Study|Lost to Follow-up|1|||
23251262|NCT01785472|64662631|FG000|Overall Study|Adverse Event|5|||
23251263|NCT01785472|64662632|FG001|Overall Study|Adverse Event|4|||
23251264|NCT01785472|64662633|FG002|Overall Study|Adverse Event|6|||
23251265|NCT01785472|64662631|FG000|Overall Study|Lack of Efficacy|2|||
23251266|NCT01785472|64662632|FG001|Overall Study|Lack of Efficacy|0|||
23251267|NCT01785472|64662633|FG002|Overall Study|Lack of Efficacy|1|||
23251268|NCT01785472|64662631|FG000|Overall Study|Lost to Follow-up|1|||
23251269|NCT01785472|64662632|FG001|Overall Study|Lost to Follow-up|2|||
23251270|NCT01785472|64662633|FG002|Overall Study|Lost to Follow-up|0|||
23251271|NCT01785472|64662631|FG000|Overall Study|Physician Decision|1|||
23251272|NCT01785472|64662632|FG001|Overall Study|Physician Decision|1|||
23251273|NCT01785472|64662633|FG002|Overall Study|Physician Decision|1|||
23251274|NCT01785472|64662631|FG000|Overall Study|Protocol deviation|0|||
23251275|NCT01785472|64662632|FG001|Overall Study|Protocol deviation|2|||
23251276|NCT01785472|64662633|FG002|Overall Study|Protocol deviation|2|||
23251277|NCT01785472|64662631|FG000|Overall Study|Subject/guardian decision|15|||
23251278|NCT01785472|64662632|FG001|Overall Study|Subject/guardian decision|10|||
23251279|NCT01785472|64662633|FG002|Overall Study|Subject/guardian decision|11|||
23251280|NCT01785472|64662631|FG000|Overall Study|Technical problems|0|||
23251281|NCT01785472|64662632|FG001|Overall Study|Technical problems|0|||
23251282|NCT01785472|64662633|FG002|Overall Study|Technical problems|1|||
23251283|NCT00734617|64662634|FG000|Overall Study|Adverse Event|4|||
23251284|NCT00734617|64662635|FG001|Overall Study|Adverse Event|7|||
23251285|NCT00734617|64662634|FG000|Overall Study|Withdrawal by Subject|103|||
23251286|NCT00734617|64662635|FG001|Overall Study|Withdrawal by Subject|95|||
23251287|NCT04651218|64662636|FG000|Overall Study|Withdrawal by Subject|0|||
23251288|NCT04651218|64662637|FG001|Overall Study|Withdrawal by Subject|2|||
23251289|NCT03284424|64662638|FG000|Overall Study|Death|70|||
23251290|NCT03284424|64662639|FG001|Overall Study|Death|24|||
23251291|NCT03284424|64662638|FG000|Overall Study|Lost to Follow-up|3|||
23251292|NCT03284424|64662639|FG001|Overall Study|Lost to Follow-up|1|||
23357742|NCT01990768|65052844|FG002|6-Month Follow-up|No contact information|5|||
23474441|NCT00171834|65481783|FG005|Overall Study|Adverse Event|15|||
23191070|NCT00849212|64439602|FG000|Overall Study|Withdrawal by Subject|3|||
23191071|NCT00849212|64439602|FG000|Overall Study|Adverse Event|2|||
23191072|NCT00849212|64439602|FG000|Overall Study|Miscellaneous|1|||
23191073|NCT01849848|64439603|FG000|Overall Study|Physician Decision|1|||
23251293|NCT03284424|64662638|FG000|Overall Study|Physician Decision|1|||
23251294|NCT03284424|64662639|FG001|Overall Study|Physician Decision|2|||
23251295|NCT03284424|64662638|FG000|Overall Study|Withdrawal by Subject|4|||
23251296|NCT03284424|64662639|FG001|Overall Study|Withdrawal by Subject|5|||
23251297|NCT03284424|64662638|FG000|Overall Study|Sponsor's decision|27|||
23191074|NCT01849848|64439603|FG000|Overall Study|Progression of the primary disease|3|||
23251298|NCT03284424|64662639|FG001|Overall Study|Sponsor's decision|22|||
23251299|NCT02595528|64662640|FG000|Overall Study|Withdrawal by Subject|1|||
23251300|NCT02595528|64662641|FG001|Overall Study|Withdrawal by Subject|2|||
23191075|NCT05372315|64439604|FG000|Overall Study|Withdrawal by Subject|1|||
23191076|NCT05372315|64439605|FG001|Overall Study|Withdrawal by Subject|0|||
23191077|NCT03671369|64439606|FG000|Overall Study|Other|1|||
23357743|NCT01990768|65052842|FG000|6-Month Follow-up|Homeless|4|||
23357744|NCT01990768|65052843|FG001|6-Month Follow-up|Homeless|3|||
23357745|NCT01990768|65052844|FG002|6-Month Follow-up|Homeless|6|||
23357746|NCT01990768|65052842|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
23357747|NCT01990768|65052843|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
23357748|NCT01990768|65052844|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
23357749|NCT01990768|65052842|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
23357750|NCT01990768|65052843|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
23357751|NCT01990768|65052844|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
23357752|NCT01990768|65052842|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
23357753|NCT01990768|65052843|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
23357754|NCT01990768|65052844|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
23357755|NCT01393106|65052849|FG000|Overall Study|Adverse Event|3|||
23357756|NCT01393106|65052849|FG000|Overall Study|Withdrawal by Subject|1|||
23357757|NCT01393106|65052849|FG000|Overall Study|Lack of Efficacy|1|||
23357758|NCT03472521|65052850|FG000|Overall Study|Lost to Follow-up|3|||
23357759|NCT03472521|65052851|FG001|Overall Study|Lost to Follow-up|2|||
23474442|NCT00171834|65481784|FG006|Overall Study|Adverse Event|1|||
23474443|NCT00171834|65481778|FG000|Overall Study|Withdrawal by Subject|0|||
23474444|NCT00171834|65481779|FG001|Overall Study|Withdrawal by Subject|2|||
23474445|NCT00171834|65481780|FG002|Overall Study|Withdrawal by Subject|0|||
23474446|NCT00171834|65481781|FG003|Overall Study|Withdrawal by Subject|1|||
23474447|NCT00171834|65481782|FG004|Overall Study|Withdrawal by Subject|1|||
23474448|NCT00171834|65481783|FG005|Overall Study|Withdrawal by Subject|1|||
23474449|NCT00171834|65481784|FG006|Overall Study|Withdrawal by Subject|0|||
23474450|NCT00171834|65481778|FG000|Overall Study|Death from study indication|0|||
23474451|NCT00171834|65481779|FG001|Overall Study|Death from study indication|1|||
23191078|NCT03671369|64439606|FG000|Overall Study|Withdrawal by Subject|289|||
23191079|NCT03671369|64439606|FG000|Overall Study|Not willing to be vaccinated|1|||
23191080|NCT01570491|64439607|FG000|Overall Study|Lost to Follow-up|3|||
23191081|NCT01570491|64439608|FG001|Overall Study|Lost to Follow-up|1|||
23191082|NCT01570491|64439607|FG000|Overall Study|treatment: not given or discontinued|2|||
23191083|NCT01570491|64439608|FG001|Overall Study|treatment: not given or discontinued|0|||
23191084|NCT01756157|64439611|FG000|First Intervention Period|Withdrawal by Subject|1|||
23191085|NCT01756157|64439612|FG001|First Intervention Period|Withdrawal by Subject|0|||
23191086|NCT01756157|64439611|FG000|First Intervention Period|Lost to Follow-up|0|||
23191087|NCT01756157|64439612|FG001|First Intervention Period|Lost to Follow-up|2|||
23357760|NCT03472521|65052850|FG000|Overall Study|Discontinued intervention|3|||
23357761|NCT03472521|65052851|FG001|Overall Study|Discontinued intervention|1|||
23357762|NCT01066871|65052852|FG000|Overall Study|Lost to Follow-up|0|||
23357763|NCT01066871|65052853|FG001|Overall Study|Lost to Follow-up|2|||
23474452|NCT00171834|65481780|FG002|Overall Study|Death from study indication|0|||
23474453|NCT00171834|65481781|FG003|Overall Study|Death from study indication|0|||
23191088|NCT00095303|64439615|FG000|Main Study|Lost to Follow-up|91|||
23191089|NCT00095303|64439616|FG001|Main Study|Lost to Follow-up|87|||
23357764|NCT01066871|65052854|FG002|Overall Study|Lost to Follow-up|2|||
23357765|NCT01066871|65052855|FG003|Overall Study|Lost to Follow-up|0|||
23191090|NCT00095303|64439615|FG000|Follow Up Study|Lost to Follow-up|59|||
23191091|NCT00095303|64439616|FG001|Follow Up Study|Lost to Follow-up|58|||
23191092|NCT03575468|64442189|FG000|Overall Study|Withdrawal by Subject|3|||
23191093|NCT03575468|64442190|FG001|Overall Study|Withdrawal by Subject|0|||
23191094|NCT03575468|64442189|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
23191095|NCT03575468|64442190|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
23191096|NCT03575468|64442189|FG000|Overall Study|Lost to Follow-up|13|||
23251301|NCT02595528|64662642|FG002|Overall Study|Withdrawal by Subject|1|||
23251302|NCT02595528|64662643|FG003|Overall Study|Withdrawal by Subject|3|||
23474454|NCT00171834|65481782|FG004|Overall Study|Death from study indication|1|||
23474455|NCT00171834|65481783|FG005|Overall Study|Death from study indication|0|||
23474456|NCT00171834|65481784|FG006|Overall Study|Death from study indication|0|||
23474457|NCT00171834|65481778|FG000|Overall Study|Disease Progression|4|||
23474458|NCT00171834|65481779|FG001|Overall Study|Disease Progression|8|||
23474459|NCT00171834|65481780|FG002|Overall Study|Disease Progression|8|||
23474460|NCT00171834|65481781|FG003|Overall Study|Disease Progression|9|||
23474461|NCT00171834|65481782|FG004|Overall Study|Disease Progression|2|||
23474462|NCT00171834|65481783|FG005|Overall Study|Disease Progression|18|||
23474463|NCT00171834|65481784|FG006|Overall Study|Disease Progression|3|||
23474464|NCT00171834|65481778|FG000|Overall Study|Treatment Duration Completed|0|||
23474465|NCT00171834|65481779|FG001|Overall Study|Treatment Duration Completed|0|||
23474466|NCT00171834|65481780|FG002|Overall Study|Treatment Duration Completed|1|||
23474467|NCT00171834|65481781|FG003|Overall Study|Treatment Duration Completed|0|||
23474468|NCT00171834|65481782|FG004|Overall Study|Treatment Duration Completed|2|||
23474469|NCT00171834|65481783|FG005|Overall Study|Treatment Duration Completed|1|||
23474470|NCT00171834|65481784|FG006|Overall Study|Treatment Duration Completed|0|||
23474471|NCT00781885|65481785|FG000|Overall Study|Physician Decision|1|||
23474472|NCT02741518|65481786|FG000|Overall Study|Withdrawal by Subject|1|||
23474473|NCT02741518|65481787|FG001|Overall Study|Withdrawal by Subject|1|||
23474474|NCT00904033|65481788|FG000|Overall Study|Withdrawal by Subject|1|||
23251303|NCT02595528|64662640|FG000|Overall Study|Lost to Follow-up|1|||
23251304|NCT02595528|64662641|FG001|Overall Study|Lost to Follow-up|1|||
23251305|NCT02595528|64662642|FG002|Overall Study|Lost to Follow-up|0|||
23251306|NCT02595528|64662643|FG003|Overall Study|Lost to Follow-up|1|||
23474475|NCT00904033|65481789|FG001|Overall Study|Withdrawal by Subject|1|||
23474476|NCT00904033|65481790|FG002|Overall Study|Withdrawal by Subject|0|||
23474477|NCT00904033|65481791|FG003|Overall Study|Withdrawal by Subject|0|||
23474478|NCT00904033|65481788|FG000|Overall Study|Physician Decision|0|||
23474479|NCT00904033|65481789|FG001|Overall Study|Physician Decision|0|||
23474480|NCT00904033|65481790|FG002|Overall Study|Physician Decision|1|||
23474481|NCT00904033|65481791|FG003|Overall Study|Physician Decision|0|||
23251307|NCT03151226|64662651|FG000|Overall Study|Withdrawal by Subject|2|||
23251308|NCT03151226|64662651|FG000|Overall Study|not wear device correctly|1|||
23251309|NCT02441179|64662652|FG000|Overall Study|Withdrawal by Subject|1|||
23251310|NCT02441179|64662653|FG001|Overall Study|Withdrawal by Subject|1|||
23251311|NCT02406742|64662654|FG000|Overall Study|Progression of Disease|5|||
23251312|NCT02406742|64662655|FG001|Overall Study|Progression of Disease|1|||
23251313|NCT02406742|64662656|FG002|Overall Study|Progression of Disease|6|||
23251314|NCT02406742|64662654|FG000|Overall Study|Adverse Event|3|||
23251315|NCT02406742|64662655|FG001|Overall Study|Adverse Event|0|||
23251316|NCT02406742|64662656|FG002|Overall Study|Adverse Event|2|||
23251317|NCT02406742|64662654|FG000|Overall Study|Death|1|||
23251318|NCT02406742|64662655|FG001|Overall Study|Death|0|||
23251319|NCT02406742|64662656|FG002|Overall Study|Death|0|||
23251320|NCT02406742|64662654|FG000|Overall Study|Lack of Efficacy|0|||
23357766|NCT01066871|65052852|FG000|Overall Study|Protocol Violation|1|||
23474482|NCT00904033|65481788|FG000|Overall Study|Unable to obtain final blood draw|0|||
23474483|NCT00904033|65481789|FG001|Overall Study|Unable to obtain final blood draw|0|||
23474484|NCT00904033|65481790|FG002|Overall Study|Unable to obtain final blood draw|0|||
23474485|NCT00904033|65481791|FG003|Overall Study|Unable to obtain final blood draw|2|||
23474486|NCT00439738|65481796|FG000|Overall Study|Withdrawal by Subject|16|||
23474487|NCT00439738|65481797|FG001|Overall Study|Withdrawal by Subject|13|||
23474488|NCT00439738|65481796|FG000|Overall Study|Adverse Event|6|||
23474489|NCT00439738|65481797|FG001|Overall Study|Adverse Event|4|||
23474490|NCT00439738|65481796|FG000|Overall Study|Lost to Follow-up|5|||
23474491|NCT00439738|65481797|FG001|Overall Study|Lost to Follow-up|6|||
23251321|NCT02406742|64662655|FG001|Overall Study|Lack of Efficacy|0|||
23251322|NCT02406742|64662656|FG002|Overall Study|Lack of Efficacy|1|||
23251323|NCT02406742|64662654|FG000|Overall Study|Withdrawal by Participant|1|||
23251324|NCT02406742|64662655|FG001|Overall Study|Withdrawal by Participant|2|||
23474492|NCT00439738|65481796|FG000|Overall Study|Protocol Violation|6|||
23474493|NCT00439738|65481797|FG001|Overall Study|Protocol Violation|3|||
23474494|NCT00439738|65481796|FG000|Overall Study|Lack of Efficacy|2|||
23474495|NCT00439738|65481797|FG001|Overall Study|Lack of Efficacy|2|||
23474496|NCT00439738|65481796|FG000|Overall Study|Abnormal Lab Values|1|||
23474497|NCT00439738|65481797|FG001|Overall Study|Abnormal Lab Values|0|||
23474498|NCT02082340|65481800|FG000|Overall Study|Lost to Follow-up|1|||
23474499|NCT02082340|65481801|FG001|Overall Study|Lost to Follow-up|1|||
23474500|NCT00573144|65481802|FG000|Overall Study|Withdrawal by Subject|2|||
23474501|NCT00573144|65481803|FG001|Overall Study|Withdrawal by Subject|3|||
23474502|NCT00759564|65481804|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
23474503|NCT00759564|65481805|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
23251325|NCT02406742|64662656|FG002|Overall Study|Withdrawal by Participant|0|||
23251326|NCT02406742|64662654|FG000|Overall Study|Physician Decision|1|||
23251327|NCT02406742|64662655|FG001|Overall Study|Physician Decision|2|||
23251328|NCT02406742|64662656|FG002|Overall Study|Physician Decision|1|||
23251329|NCT02406742|64662654|FG000|Overall Study|Transition to other treatment|2|||
23251330|NCT02406742|64662655|FG001|Overall Study|Transition to other treatment|0|||
23251331|NCT02406742|64662656|FG002|Overall Study|Transition to other treatment|1|||
23251332|NCT02406742|64662654|FG000|Overall Study|Other Reasons|1|||
23251333|NCT02406742|64662655|FG001|Overall Study|Other Reasons|11|||
23251334|NCT02406742|64662656|FG002|Overall Study|Other Reasons|5|||
23251335|NCT01678924|64662659|FG000|Overall Study|Adverse Event|1|||
23251336|NCT01678924|64662660|FG001|Overall Study|Adverse Event|1|||
23251337|NCT01678924|64662661|FG002|Overall Study|Adverse Event|0|||
23251338|NCT01678924|64662662|FG003|Overall Study|Adverse Event|1|||
23251339|NCT01678924|64662659|FG000|Overall Study|Lack of Efficacy|7|||
23251340|NCT01678924|64662660|FG001|Overall Study|Lack of Efficacy|2|||
23251341|NCT01678924|64662661|FG002|Overall Study|Lack of Efficacy|0|||
23251342|NCT01678924|64662662|FG003|Overall Study|Lack of Efficacy|5|||
23251343|NCT01678924|64662659|FG000|Overall Study|Lost to Follow-up|0|||
23251344|NCT01678924|64662660|FG001|Overall Study|Lost to Follow-up|4|||
23251345|NCT01678924|64662661|FG002|Overall Study|Lost to Follow-up|0|||
23251346|NCT01678924|64662662|FG003|Overall Study|Lost to Follow-up|2|||
23251347|NCT01678924|64662659|FG000|Overall Study|Personal Reasons|2|||
23251348|NCT01678924|64662660|FG001|Overall Study|Personal Reasons|2|||
23251349|NCT01678924|64662661|FG002|Overall Study|Personal Reasons|2|||
23251350|NCT01678924|64662662|FG003|Overall Study|Personal Reasons|7|||
23251351|NCT01678924|64662659|FG000|Overall Study|Withdrawal by Subject|0|||
23251352|NCT01678924|64662660|FG001|Overall Study|Withdrawal by Subject|3|||
23251353|NCT01678924|64662661|FG002|Overall Study|Withdrawal by Subject|0|||
23251354|NCT01678924|64662662|FG003|Overall Study|Withdrawal by Subject|2|||
23251355|NCT01678924|64662659|FG000|Overall Study|Unable to attend scheduled visits|0|||
23251356|NCT01678924|64662660|FG001|Overall Study|Unable to attend scheduled visits|0|||
23251357|NCT01678924|64662661|FG002|Overall Study|Unable to attend scheduled visits|0|||
23251358|NCT01678924|64662662|FG003|Overall Study|Unable to attend scheduled visits|1|||
23251359|NCT02729545|64662663|FG000|Overall Study|Pregnancy|1|||
23251360|NCT02729545|64662664|FG001|Overall Study|Pregnancy|1|||
23251361|NCT02729545|64662663|FG000|Overall Study|Lost to Follow-up|0|||
23251362|NCT02729545|64662664|FG001|Overall Study|Lost to Follow-up|1|||
23251363|NCT02729545|64662663|FG000|Overall Study|Withdrawal by Subject|2|||
23251364|NCT02729545|64662664|FG001|Overall Study|Withdrawal by Subject|3|||
23251365|NCT00479765|64662665|FG000|Overall Study|study terminated|4|||
23251366|NCT00858234|64662668|FG000|Overall Study|Adverse Event|6|||
23251367|NCT00858234|64662668|FG000|Overall Study|Progressive disease|2|||
23251368|NCT00858234|64662668|FG000|Overall Study|Status unknown|1|||
23251369|NCT00291330|64662669|FG000|Overall Study|Adverse Event|47|||
23474504|NCT00759564|65481806|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
23474505|NCT00759564|65481807|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
23474506|NCT00759564|65481808|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
23474507|NCT00375609|65481811|FG000|Overall Study|Did not receive treatment|1|||
23589271|NCT00457691|65886029|FG000|Overall Study|Adverse Event|4|||
23589272|NCT00457691|65886030|FG001|Overall Study|Adverse Event|1|||
23589273|NCT00457691|65886029|FG000|Overall Study|Death|163|||
23589274|NCT00457691|65886030|FG001|Overall Study|Death|148|||
23589275|NCT00457691|65886029|FG000|Overall Study|Protocol Violation|1|||
23589276|NCT00457691|65886030|FG001|Overall Study|Protocol Violation|3|||
23589277|NCT00457691|65886029|FG000|Overall Study|Lost to Follow-up|23|||
23589278|NCT00457691|65886030|FG001|Overall Study|Lost to Follow-up|14|||
23251370|NCT00291330|64662670|FG001|Overall Study|Adverse Event|40|||
23251371|NCT00291330|64662669|FG000|Overall Study|Protocol Violation|13|||
23251372|NCT00291330|64662670|FG001|Overall Study|Protocol Violation|20|||
23251373|NCT00291330|64662669|FG000|Overall Study|Lost to Follow-up|16|||
23251374|NCT00291330|64662670|FG001|Overall Study|Lost to Follow-up|11|||
23251375|NCT00291330|64662669|FG000|Overall Study|Withdrawal by Subject|22|||
23251376|NCT00291330|64662670|FG001|Overall Study|Withdrawal by Subject|25|||
23251377|NCT00291330|64662669|FG000|Overall Study|Other|3|||
23474508|NCT00375609|65481812|FG001|Overall Study|Did not receive treatment|0|||
23589279|NCT00457691|65886029|FG000|Overall Study|Study terminated by Sponsor|1|||
23474509|NCT00375609|65481813|FG002|Overall Study|Did not receive treatment|0|||
23474510|NCT00375609|65481811|FG000|Overall Study|Adverse Event|0|||
23474511|NCT00375609|65481812|FG001|Overall Study|Adverse Event|3|||
23474512|NCT00375609|65481813|FG002|Overall Study|Adverse Event|0|||
23474513|NCT00375609|65481811|FG000|Overall Study|Lost to Follow-up|1|||
23474514|NCT00375609|65481812|FG001|Overall Study|Lost to Follow-up|0|||
23474515|NCT00375609|65481813|FG002|Overall Study|Lost to Follow-up|0|||
23474516|NCT00375609|65481811|FG000|Overall Study|Physician Decision|0|||
23474517|NCT00375609|65481812|FG001|Overall Study|Physician Decision|0|||
23474518|NCT00375609|65481813|FG002|Overall Study|Physician Decision|1|||
23474519|NCT00375609|65481811|FG000|Overall Study|Withdrawal by Subject|1|||
23474520|NCT00375609|65481812|FG001|Overall Study|Withdrawal by Subject|4|||
23474521|NCT00375609|65481813|FG002|Overall Study|Withdrawal by Subject|0|||
23474522|NCT00375609|65481811|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
23474523|NCT00375609|65481812|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
23474524|NCT00375609|65481813|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
23474525|NCT00975689|65481814|FG000|Overall Study|Adverse Event|0|||
23191097|NCT03575468|64442190|FG001|Overall Study|Lost to Follow-up|17|||
23191098|NCT00035815|64442191|FG000|Overall Study|Withdrawal by Subject|17|||
23357767|NCT01066871|65052853|FG001|Overall Study|Protocol Violation|0|||
23357768|NCT01066871|65052854|FG002|Overall Study|Protocol Violation|3|||
23357769|NCT01066871|65052855|FG003|Overall Study|Protocol Violation|2|||
23357770|NCT01066871|65052852|FG000|Overall Study|Lack of Efficacy|0|||
23357771|NCT01066871|65052853|FG001|Overall Study|Lack of Efficacy|0|||
23357772|NCT01066871|65052854|FG002|Overall Study|Lack of Efficacy|0|||
23357773|NCT01066871|65052855|FG003|Overall Study|Lack of Efficacy|1|||
23357774|NCT01066871|65052852|FG000|Overall Study|Withdrawal by Subject|3|||
23357775|NCT01066871|65052853|FG001|Overall Study|Withdrawal by Subject|1|||
23357776|NCT01066871|65052854|FG002|Overall Study|Withdrawal by Subject|0|||
23474526|NCT00975689|65481815|FG001|Overall Study|Adverse Event|3|||
23474527|NCT00975689|65481814|FG000|Overall Study|Withdrawal by Subject|1|||
23191099|NCT00035815|64442192|FG001|Overall Study|Withdrawal by Subject|11|||
23474528|NCT00975689|65481815|FG001|Overall Study|Withdrawal by Subject|0|||
23474529|NCT00975689|65481814|FG000|Overall Study|Physician Decision|1|||
23474530|NCT00975689|65481815|FG001|Overall Study|Physician Decision|0|||
23474531|NCT04129151|65481817|FG000|Overall Study|Adverse Event|1|||
23474532|NCT04129151|65481817|FG000|Overall Study|Disease Progression|7|||
23474533|NCT04129151|65481817|FG000|Overall Study|Study closure|1|||
23474534|NCT01978938|65481818|FG000|Overall Study|Lost to Follow-up|12|||
23474535|NCT01978938|65481819|FG001|Overall Study|Lost to Follow-up|6|||
23474536|NCT01978938|65481818|FG000|Overall Study|Withdrawal by Subject|8|||
23474537|NCT01978938|65481819|FG001|Overall Study|Withdrawal by Subject|4|||
23474538|NCT01978938|65481818|FG000|Overall Study|Adverse Event, non-fatal|2|||
23474539|NCT01978938|65481819|FG001|Overall Study|Adverse Event, non-fatal|1|||
23474540|NCT01978938|65481818|FG000|Overall Study|Participant noncompliance|1|||
23474541|NCT01978938|65481819|FG001|Overall Study|Participant noncompliance|1|||
23474542|NCT01978938|65481818|FG000|Overall Study|Did not meet inclusion criteria|0|||
23474543|NCT01978938|65481819|FG001|Overall Study|Did not meet inclusion criteria|1|||
23474544|NCT01978938|65481818|FG000|Overall Study|Previously scheduled procedure|0|||
23474545|NCT01978938|65481819|FG001|Overall Study|Previously scheduled procedure|1|||
23474546|NCT02343549|65481820|FG000|Overall Study|Death|11|||
23474547|NCT02343549|65481820|FG000|Overall Study|Withdrawal by Subject|2|||
23474548|NCT00653939|65481821|FG000|Overall Study|Adverse Event|1|||
23474549|NCT00653939|65481822|FG001|Overall Study|Adverse Event|3|||
23474550|NCT00653939|65481821|FG000|Overall Study|Withdrawal by Subject|3|||
23191100|NCT02515669|64442196|FG000|228 Week Open-Label Phase|Other|0|||
23191101|NCT02515669|64442197|FG001|228 Week Open-Label Phase|Other|0|||
23191102|NCT02515669|64442198|FG002|228 Week Open-Label Phase|Other|1|||
23191103|NCT02515669|64442199|FG003|228 Week Open-Label Phase|Other|4|||
23191104|NCT02515669|64442196|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
23191105|NCT02515669|64442197|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
23191106|NCT02515669|64442198|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
23357777|NCT01066871|65052855|FG003|Overall Study|Withdrawal by Subject|0|||
23474551|NCT00653939|65481822|FG001|Overall Study|Withdrawal by Subject|3|||
23474552|NCT00653939|65481821|FG000|Overall Study|Physician Decision|4|||
23474553|NCT00653939|65481822|FG001|Overall Study|Physician Decision|0|||
23474554|NCT00653939|65481821|FG000|Overall Study|Disease Progression|2|||
23474555|NCT00653939|65481822|FG001|Overall Study|Disease Progression|3|||
23474556|NCT00653939|65481821|FG000|Overall Study|Other|2|||
23191107|NCT02515669|64442199|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
23474557|NCT00653939|65481822|FG001|Overall Study|Other|6|||
23474558|NCT03645434|65481823|FG000|Period 1|Adverse Event|0|||
23474559|NCT03645434|65481824|FG001|Period 1|Adverse Event|0|||
23357778|NCT01066871|65052852|FG000|Overall Study|Other|0|||
23474560|NCT03645434|65481825|FG002|Period 1|Adverse Event|0|||
23474561|NCT03645434|65481826|FG003|Period 1|Adverse Event|1|||
23474562|NCT03645434|65481827|FG004|Period 1|Adverse Event|0|||
23474563|NCT03645434|65481828|FG005|Period 1|Adverse Event|0|||
23474564|NCT03645434|65481823|FG000|Period 1|COPD exacerbation|0|||
23474565|NCT03645434|65481824|FG001|Period 1|COPD exacerbation|0|||
23474566|NCT03645434|65481825|FG002|Period 1|COPD exacerbation|0|||
23474567|NCT03645434|65481826|FG003|Period 1|COPD exacerbation|0|||
23474568|NCT03645434|65481827|FG004|Period 1|COPD exacerbation|1|||
23474569|NCT03645434|65481828|FG005|Period 1|COPD exacerbation|0|||
23474570|NCT01731938|65481829|FG000|Preliminary Part I|Withdrawal by Subject|2|||
23474571|NCT01731938|65481830|FG001|Preliminary Part I|Withdrawal by Subject|2|||
23474572|NCT01731938|65481829|FG000|Preliminary Part I|Physician Decision|1|||
23474573|NCT01731938|65481830|FG001|Preliminary Part I|Physician Decision|0|||
23474574|NCT01731938|65481829|FG000|Preliminary Part I|Lost to Follow-up|0|||
23474575|NCT01731938|65481830|FG001|Preliminary Part I|Lost to Follow-up|3|||
23474576|NCT01731938|65481829|FG000|Preliminary Part I|Missed Week 6 visit|0|||
23474577|NCT01731938|65481830|FG001|Preliminary Part I|Missed Week 6 visit|3|||
23474578|NCT01731938|65481829|FG000|Primary Part II|Withdrawal by Subject|5|||
23474579|NCT01731938|65481830|FG001|Primary Part II|Withdrawal by Subject|4|||
23474580|NCT01731938|65481829|FG000|Primary Part II|Lost to Follow-up|4|||
23474581|NCT01731938|65481830|FG001|Primary Part II|Lost to Follow-up|5|||
23474582|NCT01731938|65481829|FG000|Primary Part II|Death|2|||
23474583|NCT01731938|65481830|FG001|Primary Part II|Death|1|||
23474584|NCT01731938|65481829|FG000|Primary Part II|Missed Week 6 visit|2|||
23474585|NCT01731938|65481830|FG001|Primary Part II|Missed Week 6 visit|3|||
23474586|NCT02674204|65481831|FG000|Overall Study|Adverse Event|1|||
23474587|NCT02674204|65481832|FG001|Overall Study|Adverse Event|0|||
23474588|NCT04074161|65481833|FG000|Overall Study|Withdrawal by Subject|2|||
23474589|NCT04074161|65481834|FG001|Overall Study|Withdrawal by Subject|4|||
23474590|NCT04074161|65481835|FG002|Overall Study|Withdrawal by Subject|1|||
23474591|NCT04074161|65481833|FG000|Overall Study|Lost to Follow-up|4|||
23474592|NCT04074161|65481834|FG001|Overall Study|Lost to Follow-up|5|||
23474593|NCT04074161|65481835|FG002|Overall Study|Lost to Follow-up|3|||
23474594|NCT01282463|65481836|FG000|Overall Study|Lost to Follow-up|1|||
23474595|NCT01282463|65481837|FG001|Overall Study|Lost to Follow-up|0|||
23474596|NCT01282463|65481838|FG002|Overall Study|Lost to Follow-up|0|||
23474597|NCT01282463|65481836|FG000|Overall Study|Withdrawal by Subject|6|||
23474598|NCT01282463|65481837|FG001|Overall Study|Withdrawal by Subject|2|||
23474599|NCT01282463|65481838|FG002|Overall Study|Withdrawal by Subject|3|||
23474600|NCT01282463|65481836|FG000|Overall Study|"Never Treated Death"|0|||
23474601|NCT01282463|65481837|FG001|Overall Study|"Never Treated Death"|1|||
23474602|NCT01282463|65481838|FG002|Overall Study|"Never Treated Death"|0|||
23474603|NCT01282463|65481836|FG000|Overall Study|"Never Treated PD"|0|||
23474604|NCT01282463|65481837|FG001|Overall Study|"Never Treated PD"|1|||
23474605|NCT01282463|65481838|FG002|Overall Study|"Never Treated PD"|0|||
23474606|NCT01282463|65481836|FG000|Overall Study|Protocol Violation|0|||
23474607|NCT01282463|65481837|FG001|Overall Study|Protocol Violation|0|||
23474608|NCT01282463|65481838|FG002|Overall Study|Protocol Violation|1|||
23474609|NCT01282463|65481836|FG000|Overall Study|Physician Decision|1|||
23474610|NCT01282463|65481837|FG001|Overall Study|Physician Decision|0|||
23474611|NCT01282463|65481838|FG002|Overall Study|Physician Decision|0|||
23474612|NCT04493892|65481839|FG000|Overall Study|Withdrawal by Subject|15|||
23251378|NCT00291330|64662670|FG001|Overall Study|Other|1|||
23251379|NCT02367729|64662671|FG000|Overall Study|Organic disorder diagnosed|2|||
23251380|NCT02367729|64662672|FG001|Overall Study|Organic disorder diagnosed|1|||
23251381|NCT02367729|64662671|FG000|Overall Study|Adverse Event|1|||
23251382|NCT02367729|64662672|FG001|Overall Study|Adverse Event|2|||
23251383|NCT02367729|64662671|FG000|Overall Study|Withdrawal by Subject|0|||
23251384|NCT02367729|64662672|FG001|Overall Study|Withdrawal by Subject|5|||
23251385|NCT03959423|64662673|FG000|Overall Study|Withdrawal by Subject|2|||
23251386|NCT03959423|64662674|FG001|Overall Study|Withdrawal by Subject|3|||
23251387|NCT03959423|64662673|FG000|Overall Study|Physician Decision|0|||
23251388|NCT03959423|64662674|FG001|Overall Study|Physician Decision|1|||
23251389|NCT03959423|64662673|FG000|Overall Study|Lost to Follow-up|1|||
23251390|NCT03959423|64662674|FG001|Overall Study|Lost to Follow-up|0|||
23251391|NCT03959423|64662673|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
23589280|NCT00457691|65886030|FG001|Overall Study|Study terminated by Sponsor|1|||
23251392|NCT03959423|64662674|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23251393|NCT00435825|64662675|FG000|Overall Study|Abnormality of Laboratory Test|0|||
23357779|NCT01066871|65052853|FG001|Overall Study|Other|2|||
23357780|NCT01066871|65052854|FG002|Overall Study|Other|1|||
23357781|NCT01066871|65052855|FG003|Overall Study|Other|2|||
23474613|NCT01433289|65481841|FG000|Overall Study|Pregnancy|0|||
23474614|NCT01433289|65481842|FG001|Overall Study|Pregnancy|1|||
23474615|NCT01433289|65481843|FG002|Overall Study|Pregnancy|0|||
23474616|NCT01433289|65481844|FG003|Overall Study|Pregnancy|0|||
23474617|NCT00139477|65481845|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
23474618|NCT00139477|65481846|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
23474619|NCT00139477|65481845|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
23474620|NCT00139477|65481846|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
23357782|NCT02182830|65052856|FG000|Overall Study|Not Treated|1|||
23251394|NCT00435825|64662676|FG001|Overall Study|Abnormality of Laboratory Test|1|||
23251395|NCT00435825|64662677|FG002|Overall Study|Abnormality of Laboratory Test|0|||
23251396|NCT00435825|64662678|FG003|Overall Study|Abnormality of Laboratory Test|0|||
23251397|NCT00435825|64662675|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23251398|NCT00435825|64662676|FG001|Overall Study|Insufficient Therapeutic Response|1|||
23251399|NCT00435825|64662677|FG002|Overall Study|Insufficient Therapeutic Response|0|||
23251400|NCT00435825|64662678|FG003|Overall Study|Insufficient Therapeutic Response|3|||
23251401|NCT00435825|64662675|FG000|Overall Study|Other Protocol Violation|1|||
23251402|NCT00435825|64662676|FG001|Overall Study|Other Protocol Violation|0|||
23251403|NCT00435825|64662677|FG002|Overall Study|Other Protocol Violation|0|||
23251404|NCT00435825|64662678|FG003|Overall Study|Other Protocol Violation|0|||
23251405|NCT00435825|64662675|FG000|Overall Study|Refused treatment|2|||
23251406|NCT00435825|64662676|FG001|Overall Study|Refused treatment|0|||
23251407|NCT00435825|64662677|FG002|Overall Study|Refused treatment|0|||
23251408|NCT00435825|64662678|FG003|Overall Study|Refused treatment|5|||
23251409|NCT00435825|64662675|FG000|Overall Study|Failure to return|5|||
23251410|NCT00435825|64662676|FG001|Overall Study|Failure to return|0|||
23251411|NCT00435825|64662677|FG002|Overall Study|Failure to return|4|||
23251412|NCT00435825|64662678|FG003|Overall Study|Failure to return|0|||
23251413|NCT00435825|64662675|FG000|Overall Study|Did not receive study drug|1|||
23251414|NCT00435825|64662676|FG001|Overall Study|Did not receive study drug|0|||
23251415|NCT00435825|64662677|FG002|Overall Study|Did not receive study drug|2|||
23251416|NCT00435825|64662678|FG003|Overall Study|Did not receive study drug|0|||
23251417|NCT00435825|64662675|FG000|Overall Study|Did not enter follow-up|0|||
23251418|NCT00435825|64662676|FG001|Overall Study|Did not enter follow-up|4|||
23251419|NCT00435825|64662677|FG002|Overall Study|Did not enter follow-up|1|||
23251420|NCT00435825|64662678|FG003|Overall Study|Did not enter follow-up|3|||
23589281|NCT00457691|65886029|FG000|Overall Study|Subject refused (reason other than AE)|14|||
23589282|NCT00457691|65886030|FG001|Overall Study|Subject refused (reason other than AE)|19|||
23589283|NCT00457691|65886029|FG000|Overall Study|Disease progression, study terminated|180|||
23589284|NCT00457691|65886030|FG001|Overall Study|Disease progression, study terminated|196|||
23589285|NCT03235349|65886033|FG000|Overall Study|Adverse Event|1|||
23589286|NCT03235349|65886033|FG000|Overall Study|Other|1|||
23589287|NCT02954848|65886034|FG000|Overall Study|Randomized but Not Treated|0|||
23589288|NCT02954848|65886035|FG001|Overall Study|Randomized but Not Treated|1|||
23589289|NCT02954848|65886034|FG000|Overall Study|Adverse Event|2|||
23589290|NCT02954848|65886035|FG001|Overall Study|Adverse Event|3|||
23589291|NCT02954848|65886034|FG000|Overall Study|Withdrawal by Participant|0|||
23251421|NCT00435825|64662675|FG000|Overall Study|Did not complete full follow-up period|6|||
23251422|NCT00435825|64662676|FG001|Overall Study|Did not complete full follow-up period|6|||
23251423|NCT00435825|64662677|FG002|Overall Study|Did not complete full follow-up period|4|||
23357783|NCT02182830|65052857|FG001|Overall Study|Not Treated|1|||
23474621|NCT00139477|65481845|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
23474622|NCT00139477|65481846|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
23474623|NCT00139477|65481845|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
23474624|NCT00139477|65481846|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
23474625|NCT00139477|65481845|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
23474626|NCT00139477|65481846|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
23474627|NCT00139477|65481845|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
23474628|NCT00139477|65481846|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
23474629|NCT00139477|65481845|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
23474630|NCT00139477|65481846|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
23474631|NCT03189524|65481852|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
23474632|NCT03189524|65481853|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
23474633|NCT03189524|65481854|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
23474634|NCT03189524|65481852|FG000|Overall Study|Death|2|||
23474635|NCT03189524|65481853|FG001|Overall Study|Death|2|||
23589292|NCT02954848|65886035|FG001|Overall Study|Withdrawal by Participant|1|||
23589293|NCT02001623|65886040|FG000|Overall Study|Disease Progression|2|||
23589294|NCT02001623|65886041|FG001|Overall Study|Disease Progression|2|||
23251424|NCT00435825|64662678|FG003|Overall Study|Did not complete full follow-up period|5|||
23251425|NCT00297492|64662679|FG000|Set Quit Date|Lost to Follow-up|7|||
23251426|NCT00297492|64662680|FG001|Set Quit Date|Lost to Follow-up|13|||
23251427|NCT00297492|64662681|FG002|Set Quit Date|Lost to Follow-up|5|||
23251428|NCT00297492|64662679|FG000|6 Month Follow-up|Lost to Follow-up|63|||
23251429|NCT00297492|64662680|FG001|6 Month Follow-up|Lost to Follow-up|49|||
23251430|NCT00297492|64662681|FG002|6 Month Follow-up|Lost to Follow-up|27|||
23251431|NCT02162511|64662682|FG000|Overall Study|Lack of Efficacy|0|||
23251432|NCT02162511|64662683|FG001|Overall Study|Lack of Efficacy|0|||
23251433|NCT02162511|64662684|FG002|Overall Study|Lack of Efficacy|2|||
23357784|NCT02182830|65052856|FG000|Overall Study|Trial stopped, reason missing|3|||
23474636|NCT03189524|65481854|FG002|Overall Study|Death|1|||
23474637|NCT03189524|65481852|FG000|Overall Study|Lost to Follow-up|1|||
23474638|NCT03189524|65481853|FG001|Overall Study|Lost to Follow-up|0|||
23474639|NCT03189524|65481854|FG002|Overall Study|Lost to Follow-up|8|||
23191108|NCT02515669|64442196|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
23191109|NCT02515669|64442197|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
23191110|NCT02515669|64442198|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
23191111|NCT02515669|64442199|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
23191112|NCT02515669|64442196|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
23191113|NCT02515669|64442197|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
23191114|NCT02515669|64442198|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
23191115|NCT02515669|64442199|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
23191116|NCT02515669|64442196|FG000|228 Week Open-Label Phase|Missing|0|||
23191117|NCT02515669|64442197|FG001|228 Week Open-Label Phase|Missing|2|||
23191118|NCT02515669|64442198|FG002|228 Week Open-Label Phase|Missing|2|||
23474640|NCT03189524|65481852|FG000|Overall Study|Withdrawal by Subject|1|||
23474641|NCT03189524|65481853|FG001|Overall Study|Withdrawal by Subject|1|||
23474642|NCT03189524|65481854|FG002|Overall Study|Withdrawal by Subject|3|||
23474643|NCT03189524|65481852|FG000|Overall Study|Progressive Disease|0|||
23474644|NCT03189524|65481853|FG001|Overall Study|Progressive Disease|2|||
23474645|NCT03189524|65481854|FG002|Overall Study|Progressive Disease|0|||
23474646|NCT02445794|65481860|FG000|Overall Study|Adverse Event|0|||
23474647|NCT02445794|65481861|FG001|Overall Study|Adverse Event|0|||
23474648|NCT02445794|65481862|FG002|Overall Study|Adverse Event|2|||
23589295|NCT02001623|65886042|FG002|Overall Study|Disease Progression|3|||
23589296|NCT02001623|65886043|FG003|Overall Study|Disease Progression|2|||
23589297|NCT02001623|65886044|FG004|Overall Study|Disease Progression|3|||
23589298|NCT02001623|65886045|FG005|Overall Study|Disease Progression|2|||
23589299|NCT02001623|65886046|FG006|Overall Study|Disease Progression|3|||
23589300|NCT02001623|65886047|FG007|Overall Study|Disease Progression|3|||
23589301|NCT02001623|65886048|FG008|Overall Study|Disease Progression|7|||
23589302|NCT02001623|65886049|FG009|Overall Study|Disease Progression|40|||
23589303|NCT02001623|65886050|FG010|Overall Study|Disease Progression|5|||
23589304|NCT02001623|65886051|FG011|Overall Study|Disease Progression|9|||
23589305|NCT02001623|65886052|FG012|Overall Study|Disease Progression|9|||
23589306|NCT02001623|65886053|FG013|Overall Study|Disease Progression|20|||
23589307|NCT02001623|65886054|FG014|Overall Study|Disease Progression|9|||
23589308|NCT02001623|65886040|FG000|Overall Study|Physician Decision|0|||
23589309|NCT02001623|65886041|FG001|Overall Study|Physician Decision|0|||
23589310|NCT02001623|65886042|FG002|Overall Study|Physician Decision|0|||
23589311|NCT02001623|65886043|FG003|Overall Study|Physician Decision|0|||
23589312|NCT02001623|65886044|FG004|Overall Study|Physician Decision|0|||
23589313|NCT02001623|65886045|FG005|Overall Study|Physician Decision|0|||
23589314|NCT02001623|65886046|FG006|Overall Study|Physician Decision|0|||
23589315|NCT02001623|65886047|FG007|Overall Study|Physician Decision|0|||
23589316|NCT02001623|65886048|FG008|Overall Study|Physician Decision|3|||
23589317|NCT02001623|65886049|FG009|Overall Study|Physician Decision|2|||
23589318|NCT02001623|65886050|FG010|Overall Study|Physician Decision|3|||
23589319|NCT02001623|65886051|FG011|Overall Study|Physician Decision|3|||
23589320|NCT02001623|65886052|FG012|Overall Study|Physician Decision|1|||
23589321|NCT02001623|65886053|FG013|Overall Study|Physician Decision|2|||
23589322|NCT02001623|65886054|FG014|Overall Study|Physician Decision|1|||
23589323|NCT02001623|65886040|FG000|Overall Study|Death|0|||
23589324|NCT02001623|65886041|FG001|Overall Study|Death|1|||
23589325|NCT02001623|65886042|FG002|Overall Study|Death|0|||
23589326|NCT02001623|65886043|FG003|Overall Study|Death|0|||
23589327|NCT02001623|65886044|FG004|Overall Study|Death|0|||
23589328|NCT02001623|65886045|FG005|Overall Study|Death|0|||
23589329|NCT02001623|65886046|FG006|Overall Study|Death|0|||
23589330|NCT02001623|65886047|FG007|Overall Study|Death|0|||
23589331|NCT02001623|65886048|FG008|Overall Study|Death|0|||
23589332|NCT02001623|65886049|FG009|Overall Study|Death|0|||
23589333|NCT02001623|65886050|FG010|Overall Study|Death|0|||
23589334|NCT02001623|65886051|FG011|Overall Study|Death|0|||
23589335|NCT02001623|65886052|FG012|Overall Study|Death|0|||
23589336|NCT02001623|65886053|FG013|Overall Study|Death|0|||
23191119|NCT02515669|64442199|FG003|228 Week Open-Label Phase|Missing|2|||
23474649|NCT02445794|65481863|FG003|Overall Study|Adverse Event|0|||
23474650|NCT03567343|65481866|FG000|Overall Study|Lost to Follow-up|2|||
23474651|NCT03567343|65481867|FG001|Overall Study|Lost to Follow-up|1|||
23474652|NCT03567343|65481866|FG000|Overall Study|No longer eligible|2|||
23589337|NCT02001623|65886054|FG014|Overall Study|Death|0|||
23589338|NCT02001623|65886040|FG000|Overall Study|Adverse Event|0|||
23589339|NCT02001623|65886041|FG001|Overall Study|Adverse Event|0|||
23589340|NCT02001623|65886042|FG002|Overall Study|Adverse Event|0|||
23589341|NCT02001623|65886043|FG003|Overall Study|Adverse Event|0|||
23589342|NCT02001623|65886044|FG004|Overall Study|Adverse Event|0|||
23589343|NCT02001623|65886045|FG005|Overall Study|Adverse Event|1|||
23589344|NCT02001623|65886046|FG006|Overall Study|Adverse Event|0|||
23474653|NCT03567343|65481867|FG001|Overall Study|No longer eligible|1|||
23474654|NCT03567343|65481866|FG000|Overall Study|Adverse Event|1|||
23474655|NCT03567343|65481867|FG001|Overall Study|Adverse Event|0|||
23474656|NCT03567343|65481866|FG000|Overall Study|Protocol Violation|1|||
23474657|NCT03567343|65481867|FG001|Overall Study|Protocol Violation|1|||
23474658|NCT04535453|65481868|FG000|Overall Study|Death|0|||
23474659|NCT04535453|65481869|FG001|Overall Study|Death|1|||
23474660|NCT04535453|65481870|FG002|Overall Study|Death|0|||
23474661|NCT04535453|65481871|FG003|Overall Study|Death|0|||
23474662|NCT04535453|65481872|FG004|Overall Study|Death|0|||
23474663|NCT04535453|65481873|FG005|Overall Study|Death|0|||
23474664|NCT04535453|65481874|FG006|Overall Study|Death|0|||
23474665|NCT04535453|65481875|FG007|Overall Study|Death|0|||
23474666|NCT04535453|65481876|FG008|Overall Study|Death|0|||
23474667|NCT04535453|65481877|FG009|Overall Study|Death|0|||
23474668|NCT04535453|65481878|FG010|Overall Study|Death|0|||
23474669|NCT04535453|65481879|FG011|Overall Study|Death|0|||
23474670|NCT04535453|65481868|FG000|Overall Study|Lost to Follow-up|1|||
23474671|NCT04535453|65481869|FG001|Overall Study|Lost to Follow-up|1|||
23474672|NCT04535453|65481870|FG002|Overall Study|Lost to Follow-up|1|||
23474673|NCT04535453|65481871|FG003|Overall Study|Lost to Follow-up|0|||
23474674|NCT04535453|65481872|FG004|Overall Study|Lost to Follow-up|3|||
23474675|NCT04535453|65481873|FG005|Overall Study|Lost to Follow-up|1|||
23474676|NCT04535453|65481874|FG006|Overall Study|Lost to Follow-up|0|||
23474677|NCT04535453|65481875|FG007|Overall Study|Lost to Follow-up|0|||
23474678|NCT04535453|65481876|FG008|Overall Study|Lost to Follow-up|1|||
23474679|NCT04535453|65481877|FG009|Overall Study|Lost to Follow-up|1|||
23474680|NCT04535453|65481878|FG010|Overall Study|Lost to Follow-up|0|||
23474681|NCT04535453|65481879|FG011|Overall Study|Lost to Follow-up|0|||
23474682|NCT04535453|65481868|FG000|Overall Study|Physician Decision|0|||
23474683|NCT04535453|65481869|FG001|Overall Study|Physician Decision|0|||
23474684|NCT04535453|65481870|FG002|Overall Study|Physician Decision|0|||
23191120|NCT03937986|64442200|FG000|Overall Study|COVID-19 Pandemic|1|||
23191121|NCT01618656|64442201|FG000|Overall Study|Withdrawal by Subject|7|||
23191122|NCT01618656|64442202|FG001|Overall Study|Withdrawal by Subject|3|||
23191123|NCT01618656|64442201|FG000|Overall Study|Physician Decision|1|||
23474685|NCT04535453|65481871|FG003|Overall Study|Physician Decision|1|||
23474686|NCT04535453|65481872|FG004|Overall Study|Physician Decision|0|||
23474687|NCT04535453|65481873|FG005|Overall Study|Physician Decision|0|||
23474688|NCT04535453|65481874|FG006|Overall Study|Physician Decision|0|||
23474689|NCT04535453|65481875|FG007|Overall Study|Physician Decision|0|||
23474690|NCT04535453|65481876|FG008|Overall Study|Physician Decision|0|||
23474691|NCT04535453|65481877|FG009|Overall Study|Physician Decision|0|||
23474692|NCT04535453|65481878|FG010|Overall Study|Physician Decision|0|||
23474693|NCT04535453|65481879|FG011|Overall Study|Physician Decision|0|||
23474694|NCT04535453|65481868|FG000|Overall Study|Withdrawal by Subject|3|||
23474695|NCT04535453|65481869|FG001|Overall Study|Withdrawal by Subject|6|||
23474696|NCT04535453|65481870|FG002|Overall Study|Withdrawal by Subject|3|||
23474697|NCT04535453|65481871|FG003|Overall Study|Withdrawal by Subject|3|||
23474698|NCT04535453|65481872|FG004|Overall Study|Withdrawal by Subject|2|||
23474699|NCT04535453|65481873|FG005|Overall Study|Withdrawal by Subject|1|||
23474700|NCT04535453|65481874|FG006|Overall Study|Withdrawal by Subject|1|||
23474701|NCT04535453|65481875|FG007|Overall Study|Withdrawal by Subject|1|||
23474702|NCT04535453|65481876|FG008|Overall Study|Withdrawal by Subject|1|||
23474703|NCT04535453|65481877|FG009|Overall Study|Withdrawal by Subject|1|||
23474704|NCT04535453|65481878|FG010|Overall Study|Withdrawal by Subject|0|||
23474705|NCT04535453|65481879|FG011|Overall Study|Withdrawal by Subject|1|||
23474706|NCT04535453|65481868|FG000|Overall Study|Other|0|||
23474707|NCT04535453|65481869|FG001|Overall Study|Other|0|||
23474708|NCT04535453|65481870|FG002|Overall Study|Other|1|||
23474709|NCT04535453|65481871|FG003|Overall Study|Other|0|||
23474710|NCT04535453|65481872|FG004|Overall Study|Other|1|||
23589345|NCT02001623|65886047|FG007|Overall Study|Adverse Event|3|||
23589346|NCT02001623|65886048|FG008|Overall Study|Adverse Event|4|||
23589347|NCT02001623|65886049|FG009|Overall Study|Adverse Event|6|||
23474711|NCT04535453|65481873|FG005|Overall Study|Other|0|||
23474712|NCT04535453|65481874|FG006|Overall Study|Other|1|||
23474713|NCT04535453|65481875|FG007|Overall Study|Other|1|||
23474714|NCT04535453|65481876|FG008|Overall Study|Other|1|||
23474715|NCT04535453|65481877|FG009|Overall Study|Other|0|||
23474716|NCT04535453|65481878|FG010|Overall Study|Other|0|||
23474717|NCT04535453|65481879|FG011|Overall Study|Other|0|||
23474718|NCT00992589|65481880|FG000|Open-Label Phase|Adverse Event|4|||
23474719|NCT00992589|65481881|FG001|Open-Label Phase|Adverse Event|0|||
23474720|NCT00992589|65481882|FG002|Open-Label Phase|Adverse Event|0|||
23589348|NCT02001623|65886050|FG010|Overall Study|Adverse Event|4|||
23191124|NCT01618656|64442202|FG001|Overall Study|Physician Decision|1|||
23474721|NCT00992589|65481883|FG003|Open-Label Phase|Adverse Event|0|||
23474722|NCT00992589|65481880|FG000|Open-Label Phase|Withdrawal by Subject|20|||
23474723|NCT00992589|65481881|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23589349|NCT02001623|65886051|FG011|Overall Study|Adverse Event|0|||
23474724|NCT00992589|65481882|FG002|Open-Label Phase|Withdrawal by Subject|0|||
23474725|NCT00992589|65481883|FG003|Open-Label Phase|Withdrawal by Subject|0|||
23474726|NCT00992589|65481880|FG000|Open-Label Phase|Lost to Follow-up|1|||
23474727|NCT00992589|65481881|FG001|Open-Label Phase|Lost to Follow-up|0|||
23474728|NCT00992589|65481882|FG002|Open-Label Phase|Lost to Follow-up|0|||
23474729|NCT00992589|65481883|FG003|Open-Label Phase|Lost to Follow-up|0|||
23474730|NCT00992589|65481880|FG000|Open-Label Phase|Protocol Violation|3|||
23474731|NCT00992589|65481881|FG001|Open-Label Phase|Protocol Violation|0|||
23474732|NCT00992589|65481882|FG002|Open-Label Phase|Protocol Violation|0|||
23474733|NCT00992589|65481883|FG003|Open-Label Phase|Protocol Violation|0|||
23474734|NCT00992589|65481880|FG000|Open-Label Phase|Physician Decision|4|||
23474735|NCT00992589|65481881|FG001|Open-Label Phase|Physician Decision|0|||
23474736|NCT00992589|65481882|FG002|Open-Label Phase|Physician Decision|0|||
23474737|NCT00992589|65481883|FG003|Open-Label Phase|Physician Decision|0|||
23474738|NCT00992589|65481880|FG000|Open-Label Phase|Other|45|||
23191125|NCT01824602|64442211|FG000|Overall Study|Withdrawal by Subject|0|||
23191126|NCT01824602|64442212|FG001|Overall Study|Withdrawal by Subject|0|||
23191127|NCT01824602|64442213|FG002|Overall Study|Withdrawal by Subject|1|||
23191128|NCT01824602|64442214|FG003|Overall Study|Withdrawal by Subject|2|||
23191129|NCT01824602|64442211|FG000|Overall Study|Patient non-compliance|0|||
23191130|NCT01824602|64442212|FG001|Overall Study|Patient non-compliance|0|||
23191131|NCT01824602|64442213|FG002|Overall Study|Patient non-compliance|1|||
23191132|NCT01824602|64442214|FG003|Overall Study|Patient non-compliance|0|||
23251434|NCT01784419|64662685|FG000|Overall Study|Adverse Event|3|||
23251435|NCT03591107|64662686|FG000|Overall Study|Same patient in both arms|1|||
23251436|NCT03591107|64662687|FG001|Overall Study|Same patient in both arms|1|||
23474739|NCT00992589|65481881|FG001|Open-Label Phase|Other|0|||
23474740|NCT00992589|65481882|FG002|Open-Label Phase|Other|0|||
23474741|NCT00992589|65481883|FG003|Open-Label Phase|Other|0|||
23474742|NCT00992589|65481880|FG000|Double-Blind Phase|Adverse Event|0|||
23474743|NCT00992589|65481881|FG001|Double-Blind Phase|Adverse Event|6|||
23589350|NCT02001623|65886052|FG012|Overall Study|Adverse Event|3|||
23589351|NCT02001623|65886053|FG013|Overall Study|Adverse Event|5|||
23589352|NCT02001623|65886054|FG014|Overall Study|Adverse Event|6|||
23589353|NCT02001623|65886040|FG000|Overall Study|Other - Miscellaneous|0|||
23589354|NCT02001623|65886041|FG001|Overall Study|Other - Miscellaneous|0|||
23589355|NCT02001623|65886042|FG002|Overall Study|Other - Miscellaneous|0|||
23589356|NCT02001623|65886043|FG003|Overall Study|Other - Miscellaneous|0|||
23589357|NCT02001623|65886044|FG004|Overall Study|Other - Miscellaneous|0|||
23589358|NCT02001623|65886045|FG005|Overall Study|Other - Miscellaneous|0|||
23589359|NCT02001623|65886046|FG006|Overall Study|Other - Miscellaneous|0|||
23589360|NCT02001623|65886047|FG007|Overall Study|Other - Miscellaneous|0|||
23589361|NCT02001623|65886048|FG008|Overall Study|Other - Miscellaneous|0|||
23589362|NCT02001623|65886049|FG009|Overall Study|Other - Miscellaneous|1|||
23589363|NCT02001623|65886050|FG010|Overall Study|Other - Miscellaneous|0|||
23589364|NCT02001623|65886051|FG011|Overall Study|Other - Miscellaneous|0|||
23589365|NCT02001623|65886052|FG012|Overall Study|Other - Miscellaneous|0|||
23589366|NCT02001623|65886053|FG013|Overall Study|Other - Miscellaneous|1|||
23589367|NCT02001623|65886054|FG014|Overall Study|Other - Miscellaneous|0|||
23589368|NCT02001623|65886040|FG000|Overall Study|Withdrawal by Subject|1|||
23589369|NCT02001623|65886041|FG001|Overall Study|Withdrawal by Subject|0|||
23589370|NCT02001623|65886042|FG002|Overall Study|Withdrawal by Subject|0|||
23589371|NCT02001623|65886043|FG003|Overall Study|Withdrawal by Subject|0|||
23589372|NCT02001623|65886044|FG004|Overall Study|Withdrawal by Subject|0|||
23589373|NCT02001623|65886045|FG005|Overall Study|Withdrawal by Subject|0|||
23589374|NCT02001623|65886046|FG006|Overall Study|Withdrawal by Subject|0|||
23589375|NCT02001623|65886047|FG007|Overall Study|Withdrawal by Subject|0|||
23589376|NCT02001623|65886048|FG008|Overall Study|Withdrawal by Subject|1|||
23589377|NCT02001623|65886049|FG009|Overall Study|Withdrawal by Subject|3|||
23589378|NCT02001623|65886050|FG010|Overall Study|Withdrawal by Subject|2|||
23191133|NCT01824602|64442211|FG000|Overall Study|Adverse Event|1|||
23191134|NCT01824602|64442212|FG001|Overall Study|Adverse Event|0|||
23474744|NCT00992589|65481882|FG002|Double-Blind Phase|Adverse Event|2|||
23191135|NCT01824602|64442213|FG002|Overall Study|Adverse Event|2|||
23251437|NCT03591107|64662686|FG000|Overall Study|Sought care at other clinics|0|||
23251438|NCT03591107|64662687|FG001|Overall Study|Sought care at other clinics|2|||
23357785|NCT02182830|65052857|FG001|Overall Study|Trial stopped, reason missing|3|||
23474745|NCT00992589|65481883|FG003|Double-Blind Phase|Adverse Event|3|||
23474746|NCT00992589|65481880|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23474747|NCT00992589|65481881|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
23474748|NCT00992589|65481882|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
23589379|NCT02001623|65886051|FG011|Overall Study|Withdrawal by Subject|2|||
23589380|NCT02001623|65886052|FG012|Overall Study|Withdrawal by Subject|1|||
23589381|NCT02001623|65886053|FG013|Overall Study|Withdrawal by Subject|5|||
23589382|NCT02001623|65886054|FG014|Overall Study|Withdrawal by Subject|2|||
23589383|NCT02001623|65886040|FG000|Overall Study|Lost to Follow-up|0|||
23251439|NCT03591107|64662686|FG000|Overall Study|Discharged from clinic|0|||
23357786|NCT02182830|65052856|FG000|Overall Study|Consent withdrawn|8|||
23357787|NCT02182830|65052857|FG001|Overall Study|Consent withdrawn|8|||
23357788|NCT02182830|65052856|FG000|Overall Study|Lost to Follow-up|3|||
23357789|NCT02182830|65052857|FG001|Overall Study|Lost to Follow-up|3|||
23357790|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
23357791|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
23357792|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
23357793|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
23357794|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
23357795|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
23357796|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
23357797|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
23251440|NCT03591107|64662687|FG001|Overall Study|Discharged from clinic|1|||
23251441|NCT03591107|64662686|FG000|Overall Study|Withdrawal by Subject|0|||
23251442|NCT03591107|64662687|FG001|Overall Study|Withdrawal by Subject|1|||
23251443|NCT01556165|64662688|FG000|Overall Study|Adverse Event|5|||
23251444|NCT01556165|64662689|FG001|Overall Study|Adverse Event|3|||
23251445|NCT01556165|64662688|FG000|Overall Study|Protocol Violation|0|||
23251446|NCT01556165|64662689|FG001|Overall Study|Protocol Violation|3|||
23251447|NCT01556165|64662688|FG000|Overall Study|Withdrawal of Consent|7|||
23251448|NCT01556165|64662689|FG001|Overall Study|Withdrawal of Consent|1|||
23251449|NCT01328054|64662690|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
23251450|NCT01328054|64662691|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
23251451|NCT01328054|64662690|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
23251452|NCT01328054|64662691|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
23251453|NCT01328054|64662690|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
23251454|NCT01328054|64662691|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
23251455|NCT02525562|64662712|FG000|Overall Study|Death|9|||
23251456|NCT02525562|64662713|FG001|Overall Study|Death|0|||
23251457|NCT02525562|64662714|FG002|Overall Study|Death|0|||
23251458|NCT02525562|64662712|FG000|Overall Study|Lost to Follow-up|19|||
23251459|NCT02525562|64662713|FG001|Overall Study|Lost to Follow-up|0|||
23251460|NCT02525562|64662714|FG002|Overall Study|Lost to Follow-up|0|||
23251461|NCT02525562|64662712|FG000|Overall Study|Withdrawal by Subject|37|||
23251462|NCT02525562|64662713|FG001|Overall Study|Withdrawal by Subject|0|||
23251463|NCT02525562|64662714|FG002|Overall Study|Withdrawal by Subject|0|||
23251464|NCT02525562|64662712|FG000|Overall Study|Revision/Removal of Study Device|4|||
23251465|NCT02525562|64662713|FG001|Overall Study|Revision/Removal of Study Device|0|||
23251466|NCT02525562|64662714|FG002|Overall Study|Revision/Removal of Study Device|0|||
23251467|NCT02525562|64662712|FG000|Overall Study|Study Closed by Sponsor|154|||
23251468|NCT02525562|64662713|FG001|Overall Study|Study Closed by Sponsor|0|||
23251469|NCT02525562|64662714|FG002|Overall Study|Study Closed by Sponsor|0|||
23251470|NCT02428231|64662715|FG000|Overall Study|Other|10|||
23251471|NCT02428231|64662716|FG001|Overall Study|Other|16|||
23251472|NCT02428231|64662715|FG000|Overall Study|Required Symptomatic Therapy|0|||
23251473|NCT02428231|64662716|FG001|Overall Study|Required Symptomatic Therapy|1|||
23251474|NCT02428231|64662715|FG000|Overall Study|Adverse Event|3|||
23251475|NCT02428231|64662716|FG001|Overall Study|Adverse Event|0|||
23251476|NCT01238211|64662717|FG000|Overall Study|Continues active treatment|31|||
23251477|NCT01238211|64662717|FG000|Overall Study|Adverse Event|7|||
23251478|NCT01238211|64662717|FG000|Overall Study|Death|4|||
23251479|NCT01238211|64662717|FG000|Overall Study|Relapse/Progression|2|||
23251480|NCT01238211|64662717|FG000|Overall Study|Withdrawal by Subject|7|||
23251481|NCT01238211|64662717|FG000|Overall Study|Non-protocol treatment|4|||
23251482|NCT01238211|64662717|FG000|Overall Study|Investigator/Patient Decision|3|||
23251483|NCT00835068|64662721|FG000|Overall Study|Death|1|||
23251484|NCT00835068|64662722|FG001|Overall Study|Death|0|||
23251485|NCT00835068|64662721|FG000|Overall Study|Adverse Event|0|||
23251486|NCT00835068|64662722|FG001|Overall Study|Adverse Event|1|||
23251487|NCT00835068|64662721|FG000|Overall Study|Other|8|||
23251488|NCT00835068|64662722|FG001|Overall Study|Other|0|||
23251489|NCT00835068|64662721|FG000|Overall Study|Withdrawal by Subject|1|||
23357798|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
23251490|NCT00835068|64662722|FG001|Overall Study|Withdrawal by Subject|0|||
23251491|NCT02766088|64662723|FG000|Overall Study|Sponsor study termination|498|||
23251492|NCT02766088|64662723|FG000|Overall Study|Migrated/moved from the study area|1|||
23251493|NCT02766088|64662723|FG000|Overall Study|Lost to Follow-up|5|||
23357799|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
23357800|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
23357801|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
23357802|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
23357803|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
23357804|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
23357805|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
23357806|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
23357807|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
23357808|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
23357809|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
23357810|NCT01004432|65052870|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
23357811|NCT01004432|65052871|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
23357812|NCT01004432|65052872|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
23357813|NCT01004432|65052873|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
23357814|NCT01004432|65052874|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
23357815|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
23357816|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
23357817|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
23357818|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
23357819|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
23357820|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
23357821|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
23357822|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
23357823|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
23357824|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
23357825|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
23357826|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
23357827|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
23357828|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
23357829|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
23251494|NCT02766088|64662723|FG000|Overall Study|Other|1|||
23251495|NCT02766088|64662723|FG000|Overall Study|Death|1|||
23251496|NCT00640614|64662724|FG000|Overall Study|Lost to Follow-up|1|||
23251497|NCT00640614|64662725|FG001|Overall Study|Lost to Follow-up|0|||
23251498|NCT01005680|64662726|FG000|Overall Study|Lost to Follow-up|4|||
23251499|NCT01005680|64662727|FG001|Overall Study|Lost to Follow-up|6|||
23251500|NCT01005680|64662726|FG000|Overall Study|Withdrawal by Subject|1|||
23251501|NCT01005680|64662727|FG001|Overall Study|Withdrawal by Subject|4|||
23251502|NCT01005680|64662726|FG000|Overall Study|Physician Decision|1|||
23251503|NCT01005680|64662727|FG001|Overall Study|Physician Decision|1|||
23251504|NCT00829439|64662728|FG000|Overall Study|Adverse Event|0|||
23251505|NCT00829439|64662729|FG001|Overall Study|Adverse Event|0|||
23251506|NCT00829439|64662730|FG002|Overall Study|Adverse Event|1|||
23251507|NCT00829439|64662731|FG003|Overall Study|Adverse Event|0|||
23251508|NCT00665626|64662737|FG000|Overall Study|Lack of Efficacy|8|||
23251509|NCT00665626|64662738|FG001|Overall Study|Lack of Efficacy|5|||
23251510|NCT00665626|64662737|FG000|Overall Study|Lost to Follow-up|0|||
23251511|NCT00665626|64662738|FG001|Overall Study|Lost to Follow-up|2|||
23251512|NCT00665626|64662737|FG000|Overall Study|Withdrawal by Subject|0|||
23251513|NCT00665626|64662738|FG001|Overall Study|Withdrawal by Subject|1|||
23251514|NCT00665626|64662737|FG000|Overall Study|Protocol Violation|0|||
23251515|NCT00665626|64662738|FG001|Overall Study|Protocol Violation|2|||
23251516|NCT00665626|64662737|FG000|Overall Study|Adverse Event|1|||
23251517|NCT00665626|64662738|FG001|Overall Study|Adverse Event|9|||
23251518|NCT00665626|64662737|FG000|Overall Study|Due to exclusion criteria|0|||
23251519|NCT00665626|64662738|FG001|Overall Study|Due to exclusion criteria|1|||
23251520|NCT00665626|64662737|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
23589384|NCT02001623|65886041|FG001|Overall Study|Lost to Follow-up|0|||
23589385|NCT02001623|65886042|FG002|Overall Study|Lost to Follow-up|0|||
23589386|NCT02001623|65886043|FG003|Overall Study|Lost to Follow-up|0|||
23589387|NCT02001623|65886044|FG004|Overall Study|Lost to Follow-up|0|||
23589388|NCT02001623|65886045|FG005|Overall Study|Lost to Follow-up|0|||
23251521|NCT00665626|64662738|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
23251522|NCT00665626|64662737|FG000|Overall Study|Unably to comply with dosing regimen|0|||
23589389|NCT02001623|65886046|FG006|Overall Study|Lost to Follow-up|0|||
23251523|NCT00665626|64662738|FG001|Overall Study|Unably to comply with dosing regimen|1|||
23251524|NCT00665626|64662737|FG000|Overall Study|Death|1|||
23251525|NCT00665626|64662738|FG001|Overall Study|Death|0|||
23251526|NCT01244516|64662740|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
23251527|NCT01244516|64662741|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
23251528|NCT01244516|64662742|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
23251529|NCT01244516|64662740|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
23251530|NCT01244516|64662741|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
23251531|NCT01244516|64662742|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
23251532|NCT01244516|64662740|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
23251533|NCT01244516|64662741|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
23251534|NCT01244516|64662742|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
23251535|NCT01244516|64662740|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
23251536|NCT01244516|64662741|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
23251537|NCT01244516|64662742|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
23251538|NCT01244516|64662740|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
23251539|NCT01244516|64662741|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
23251540|NCT01244516|64662742|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
23251541|NCT01244516|64662740|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
23251542|NCT01244516|64662741|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
23251543|NCT01244516|64662742|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
23251544|NCT01244516|64662740|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
23251545|NCT01244516|64662741|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
23251546|NCT01244516|64662742|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
23251547|NCT02564952|64662743|FG000|Overall Study|Adverse Event|6|||
23251548|NCT02564952|64662743|FG000|Overall Study|Lost to Follow-up|1|||
23251549|NCT02564952|64662743|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
23251550|NCT02564952|64662743|FG000|Overall Study|Withdrawal by Subject|1|||
23251551|NCT02564952|64662743|FG000|Overall Study|Low Efficacy|1|||
23251552|NCT02564952|64662743|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
23251553|NCT01205529|64662744|FG000|Overall Study|Procedure Cancelled|4|||
23251554|NCT01205529|64662744|FG000|Overall Study|Withdrawal by Subject|2|||
23251555|NCT01205529|64662744|FG000|Overall Study|Physician Decision|4|||
23251556|NCT01205529|64662744|FG000|Overall Study|Unstable post op|15|||
23251557|NCT01205529|64662744|FG000|Overall Study|No longer met criteria|30|||
23251558|NCT04523831|64662749|FG000|Overall Study|Lost to Follow-up|15|||
23251559|NCT04523831|64662750|FG001|Overall Study|Lost to Follow-up|17|||
23251560|NCT04523831|64662749|FG000|Overall Study|Death|0|||
23251561|NCT04523831|64662750|FG001|Overall Study|Death|3|||
23251562|NCT04523831|64662749|FG000|Overall Study|Adverse Event|2|||
23251563|NCT04523831|64662750|FG001|Overall Study|Adverse Event|0|||
23251564|NCT00963599|64662751|FG000|Overall Study|Adverse Event|2|||
23251565|NCT00963599|64662752|FG001|Overall Study|Adverse Event|0|||
23251566|NCT00963599|64662753|FG002|Overall Study|Adverse Event|1|||
23251567|NCT00963599|64662754|FG003|Overall Study|Adverse Event|2|||
23251568|NCT00963599|64662751|FG000|Overall Study|Lack of Efficacy|0|||
23251569|NCT00963599|64662752|FG001|Overall Study|Lack of Efficacy|2|||
23251570|NCT00963599|64662753|FG002|Overall Study|Lack of Efficacy|1|||
23251571|NCT00963599|64662754|FG003|Overall Study|Lack of Efficacy|4|||
23251572|NCT00963599|64662751|FG000|Overall Study|Lost to Follow-up|0|||
23251573|NCT00963599|64662752|FG001|Overall Study|Lost to Follow-up|1|||
23251574|NCT00963599|64662753|FG002|Overall Study|Lost to Follow-up|1|||
23251575|NCT00963599|64662754|FG003|Overall Study|Lost to Follow-up|1|||
23251576|NCT00963599|64662751|FG000|Overall Study|Protocol Violation|2|||
23251577|NCT00963599|64662752|FG001|Overall Study|Protocol Violation|2|||
23251578|NCT00963599|64662753|FG002|Overall Study|Protocol Violation|3|||
23251579|NCT00963599|64662754|FG003|Overall Study|Protocol Violation|4|||
23251580|NCT00963599|64662751|FG000|Overall Study|Withdrawal by Subject|2|||
23251581|NCT00963599|64662752|FG001|Overall Study|Withdrawal by Subject|1|||
23251582|NCT00963599|64662753|FG002|Overall Study|Withdrawal by Subject|3|||
23251583|NCT00963599|64662754|FG003|Overall Study|Withdrawal by Subject|3|||
23251584|NCT04465916|64662757|FG000|Overall Study|Withdrawal by Subject|0|||
23251585|NCT04465916|64662758|FG001|Overall Study|Withdrawal by Subject|1|||
23251586|NCT02411110|64662761|FG000|Treatment Period 1|Adverse Event|4|||
23251587|NCT02411110|64662762|FG001|Treatment Period 1|Adverse Event|2|||
23251588|NCT02411110|64662761|FG000|Treatment Period 1|Lost to Follow-up|1|||
23251589|NCT02411110|64662762|FG001|Treatment Period 1|Lost to Follow-up|0|||
23251590|NCT02411110|64662761|FG000|Treatment Period 1|Personal Reasons|2|||
23251591|NCT02411110|64662762|FG001|Treatment Period 1|Personal Reasons|5|||
23251592|NCT02411110|64662761|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
23251593|NCT02411110|64662762|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
23251594|NCT02411110|64662761|FG000|Treatment Period 2|Adverse Event|1|||
23251595|NCT02411110|64662762|FG001|Treatment Period 2|Adverse Event|0|||
23251596|NCT02411110|64662761|FG000|Treatment Period 2|Lost to Follow-up|0|||
23251597|NCT02411110|64662762|FG001|Treatment Period 2|Lost to Follow-up|2|||
23251598|NCT02411110|64662761|FG000|Treatment Period 2|Personal Reasons|0|||
23251599|NCT02411110|64662762|FG001|Treatment Period 2|Personal Reasons|2|||
23251600|NCT00068445|64662763|FG000|Randomization|Cancel|1|||
23251601|NCT00068445|64662764|FG001|Randomization|Cancel|3|||
23357830|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
23251602|NCT00068445|64662763|FG000|Randomization|Ineligible|1|||
23251603|NCT00068445|64662764|FG001|Randomization|Ineligible|1|||
23357831|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
23357832|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
23357833|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
23357834|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
23357835|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
23357836|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
23357837|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
23357838|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
23357839|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
23357840|NCT01004432|65052870|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
23357841|NCT01004432|65052871|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
23357842|NCT01004432|65052872|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
23357843|NCT01004432|65052873|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
23357844|NCT01004432|65052874|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
23357845|NCT01004432|65052870|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
23357846|NCT01004432|65052871|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
23357847|NCT01004432|65052872|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
23357848|NCT01004432|65052873|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
23357849|NCT01004432|65052874|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
23357850|NCT01004432|65052870|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
23357851|NCT01004432|65052871|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
23357852|NCT01004432|65052872|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
23357853|NCT01004432|65052873|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
23357854|NCT01004432|65052874|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
23357855|NCT01004432|65052870|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
23357856|NCT01004432|65052871|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
23357857|NCT01004432|65052872|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
23357858|NCT01004432|65052873|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
23357859|NCT01004432|65052874|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
23357860|NCT01004432|65052870|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
23357861|NCT01004432|65052871|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
23357862|NCT01004432|65052872|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
23357863|NCT01004432|65052873|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
23357864|NCT01004432|65052874|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
23357865|NCT03066778|65052875|FG000|Overall Study|Death|195|||
23357866|NCT03066778|65052876|FG001|Overall Study|Death|205|||
23357867|NCT03066778|65052875|FG000|Overall Study|Withdrawal by Subject|5|||
23357868|NCT03066778|65052876|FG001|Overall Study|Withdrawal by Subject|7|||
23357869|NCT02983045|65056130|FG000|Overall Study|Withdrawal by Subject|0|||
23357870|NCT02983045|65056131|FG001|Overall Study|Withdrawal by Subject|1|||
23357871|NCT02983045|65056132|FG002|Overall Study|Withdrawal by Subject|0|||
23357872|NCT02983045|65056133|FG003|Overall Study|Withdrawal by Subject|5|||
23357873|NCT02983045|65056134|FG004|Overall Study|Withdrawal by Subject|0|||
23191136|NCT01824602|64442214|FG003|Overall Study|Adverse Event|2|||
23191137|NCT01824602|64442211|FG000|Overall Study|Treatment failure|0|||
23357874|NCT02983045|65056135|FG005|Overall Study|Withdrawal by Subject|72|||
23191138|NCT01824602|64442212|FG001|Overall Study|Treatment failure|0|||
23357875|NCT02983045|65056136|FG006|Overall Study|Withdrawal by Subject|0|||
23357876|NCT02983045|65056137|FG007|Overall Study|Withdrawal by Subject|0|||
23191139|NCT01824602|64442213|FG002|Overall Study|Treatment failure|0|||
23251604|NCT00068445|64662763|FG000|Treatment|Refused Further Treatment|13|||
23251605|NCT00068445|64662764|FG001|Treatment|Refused Further Treatment|10|||
23251606|NCT00068445|64662763|FG000|Treatment|Adverse Event|7|||
23251607|NCT00068445|64662764|FG001|Treatment|Adverse Event|1|||
23251608|NCT00068445|64662763|FG000|Treatment|Other (Specifics not available)|9|||
23251609|NCT00068445|64662764|FG001|Treatment|Other (Specifics not available)|5|||
23251610|NCT01010230|64662765|FG000|Overall Study|Withdrawal by Subject|6|||
23251611|NCT01010230|64662766|FG001|Overall Study|Withdrawal by Subject|5|||
23251612|NCT01010230|64662765|FG000|Overall Study|Lost to Follow-up|4|||
23251613|NCT01010230|64662766|FG001|Overall Study|Lost to Follow-up|2|||
23251614|NCT03634488|64662771|FG000|Overall Study|Death|1|||
23251615|NCT03634488|64662772|FG001|Overall Study|Death|0|||
23251616|NCT03634488|64662773|FG002|Overall Study|Death|0|||
23251617|NCT03634488|64662771|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
23251618|NCT03634488|64662772|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
23251619|NCT03634488|64662773|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
23251620|NCT01652573|64662786|FG000|Overall Study|Adverse Event|0|||
23251621|NCT01652573|64662787|FG001|Overall Study|Adverse Event|1|||
23251622|NCT02643394|64662794|FG000|Overall Study|Protocol Violation|4|||
23251623|NCT02643394|64662795|FG001|Overall Study|Protocol Violation|5|||
23251624|NCT02173301|64662801|FG000|Overall Study|Adverse Event|7|||
23251625|NCT02173301|64662802|FG001|Overall Study|Adverse Event|8|||
23251626|NCT02173301|64662803|FG002|Overall Study|Adverse Event|13|||
23251627|NCT02173301|64662804|FG003|Overall Study|Adverse Event|5|||
23251628|NCT02173301|64662801|FG000|Overall Study|Withdrawal by Subject|8|||
23251629|NCT02173301|64662802|FG001|Overall Study|Withdrawal by Subject|10|||
23251630|NCT02173301|64662803|FG002|Overall Study|Withdrawal by Subject|4|||
23251631|NCT02173301|64662804|FG003|Overall Study|Withdrawal by Subject|8|||
23251632|NCT02173301|64662801|FG000|Overall Study|Lost to Follow-up|4|||
23251633|NCT02173301|64662802|FG001|Overall Study|Lost to Follow-up|4|||
23251634|NCT02173301|64662803|FG002|Overall Study|Lost to Follow-up|2|||
23251635|NCT02173301|64662804|FG003|Overall Study|Lost to Follow-up|2|||
23251636|NCT02173301|64662801|FG000|Overall Study|Protocol Violation|0|||
23251637|NCT02173301|64662802|FG001|Overall Study|Protocol Violation|1|||
23251638|NCT02173301|64662803|FG002|Overall Study|Protocol Violation|0|||
23251639|NCT02173301|64662804|FG003|Overall Study|Protocol Violation|0|||
23251640|NCT02173301|64662801|FG000|Overall Study|Physician Decision|0|||
23251641|NCT02173301|64662802|FG001|Overall Study|Physician Decision|0|||
23251642|NCT02173301|64662803|FG002|Overall Study|Physician Decision|1|||
23474749|NCT00992589|65481883|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
23474750|NCT00992589|65481880|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23474751|NCT00992589|65481881|FG001|Double-Blind Phase|Lost to Follow-up|0|||
23474752|NCT00992589|65481882|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23251643|NCT02173301|64662804|FG003|Overall Study|Physician Decision|0|||
23251644|NCT02173301|64662801|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
23251645|NCT02173301|64662802|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
23251646|NCT02173301|64662803|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
23357877|NCT02983045|65056138|FG008|Overall Study|Withdrawal by Subject|0|||
23474753|NCT00992589|65481883|FG003|Double-Blind Phase|Lost to Follow-up|2|||
23191140|NCT01824602|64442214|FG003|Overall Study|Treatment failure|1|||
23191141|NCT04382651|64442218|FG000|Overall Study|Death|26|||
23191142|NCT04382651|64442219|FG001|Overall Study|Death|23|||
23191143|NCT04382651|64442218|FG000|Overall Study|Lost to Follow-up|3|||
23191144|NCT04382651|64442219|FG001|Overall Study|Lost to Follow-up|4|||
23191145|NCT04382651|64442218|FG000|Overall Study|Withdrawal by Subject|2|||
23191146|NCT04382651|64442219|FG001|Overall Study|Withdrawal by Subject|0|||
23251647|NCT02173301|64662804|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
23251648|NCT04098068|64662807|FG000|Overall Study|Disease Progression|7|||
23589390|NCT02001623|65886047|FG007|Overall Study|Lost to Follow-up|0|||
23589391|NCT02001623|65886048|FG008|Overall Study|Lost to Follow-up|0|||
23589392|NCT02001623|65886049|FG009|Overall Study|Lost to Follow-up|1|||
23589393|NCT02001623|65886050|FG010|Overall Study|Lost to Follow-up|0|||
23357878|NCT02983045|65056139|FG009|Overall Study|Withdrawal by Subject|2|||
23357879|NCT02983045|65056130|FG000|Overall Study|Lost to Follow-up|0|||
23474754|NCT00992589|65481880|FG000|Double-Blind Phase|Other|0|||
23474755|NCT00992589|65481881|FG001|Double-Blind Phase|Other|1|||
23474756|NCT00992589|65481882|FG002|Double-Blind Phase|Other|6|||
23474757|NCT00992589|65481883|FG003|Double-Blind Phase|Other|3|||
23474758|NCT04345367|65481884|FG000|Overall Study|Other|3|||
23474759|NCT04345367|65481885|FG001|Overall Study|Other|4|||
23474760|NCT04345367|65481884|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
23474761|NCT04345367|65481885|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
23474762|NCT04345367|65481884|FG000|Overall Study|Withdrawal by Subject|11|||
23474763|NCT04345367|65481885|FG001|Overall Study|Withdrawal by Subject|11|||
23251649|NCT04098068|64662807|FG000|Overall Study|Withdrawal by Subject|2|||
23251650|NCT04098068|64662807|FG000|Overall Study|New Cancer Diagnosis|1|||
23251651|NCT00701558|64662808|FG000|Overall Study|Death|7|||
23251652|NCT00701558|64662808|FG000|Overall Study|Lost to Follow-up|8|||
23251653|NCT00566631|64662809|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
23474764|NCT04345367|65481884|FG000|Overall Study|Protocol Violation|4|||
23474765|NCT04345367|65481885|FG001|Overall Study|Protocol Violation|3|||
23474766|NCT04345367|65481884|FG000|Overall Study|Lost to Follow-up|2|||
23589394|NCT02001623|65886051|FG011|Overall Study|Lost to Follow-up|0|||
23251654|NCT00566631|64662809|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
23251655|NCT00566631|64662809|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
23251656|NCT00566631|64662809|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
23251657|NCT00566631|64662809|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
23251658|NCT00566631|64662809|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
23251659|NCT00566631|64662809|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
23251660|NCT00566631|64662809|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
23251661|NCT00566631|64662809|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
23251662|NCT00566631|64662809|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
23251663|NCT00566631|64662809|FG000|Part 2: Extension Phase|Adverse Event|11|||
23251664|NCT00566631|64662809|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
23251665|NCT00566631|64662809|FG000|Part 2: Extension Phase|Death|1|||
23251666|NCT00566631|64662809|FG000|Part 2: Extension Phase|Other|5|||
23251667|NCT00190684|64662810|FG000|Overall Study|Adverse Event|86|||
23251668|NCT00190684|64662810|FG000|Overall Study|Satisfactory response|80|||
23251669|NCT00190684|64662810|FG000|Overall Study|Lack of efficacy|204|||
23251670|NCT00190684|64662810|FG000|Overall Study|Lost to Follow-up|232|||
23251671|NCT00190684|64662810|FG000|Overall Study|Patient moved|60|||
23251672|NCT00190684|64662810|FG000|Overall Study|Patient Decision|432|||
23251673|NCT00190684|64662810|FG000|Overall Study|Clinical relapse|67|||
23251674|NCT00190684|64662810|FG000|Overall Study|Sponsor's decision|17|||
23251675|NCT00190684|64662810|FG000|Overall Study|Physician Decision|84|||
23251676|NCT00190684|64662810|FG000|Overall Study|Protocol Violation|123|||
23251677|NCT00190684|64662810|FG000|Overall Study|Study Period III Completed|103|||
23357880|NCT02983045|65056131|FG001|Overall Study|Lost to Follow-up|0|||
23357881|NCT02983045|65056132|FG002|Overall Study|Lost to Follow-up|0|||
23589395|NCT02001623|65886052|FG012|Overall Study|Lost to Follow-up|0|||
23589396|NCT02001623|65886053|FG013|Overall Study|Lost to Follow-up|0|||
23589397|NCT02001623|65886054|FG014|Overall Study|Lost to Follow-up|0|||
23589398|NCT02001623|65886040|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
23589399|NCT02001623|65886041|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
23589400|NCT02001623|65886042|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
23191147|NCT04382651|64442218|FG000|Overall Study|Physician Decision|0|||
23474767|NCT04345367|65481885|FG001|Overall Study|Lost to Follow-up|4|||
23474768|NCT04345367|65481884|FG000|Overall Study|Lack of Efficacy|2|||
23589401|NCT02001623|65886043|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
23589402|NCT02001623|65886044|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
23589403|NCT02001623|65886045|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
23357882|NCT02983045|65056133|FG003|Overall Study|Lost to Follow-up|0|||
23357883|NCT02983045|65056134|FG004|Overall Study|Lost to Follow-up|0|||
23357884|NCT02983045|65056135|FG005|Overall Study|Lost to Follow-up|10|||
23357885|NCT02983045|65056136|FG006|Overall Study|Lost to Follow-up|0|||
23357886|NCT02983045|65056137|FG007|Overall Study|Lost to Follow-up|0|||
23357887|NCT02983045|65056138|FG008|Overall Study|Lost to Follow-up|0|||
23357888|NCT02983045|65056139|FG009|Overall Study|Lost to Follow-up|0|||
23357889|NCT02447328|65056143|FG000|Overall Study|Withdrawal by Subject|1|||
23357890|NCT01962948|65056144|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
23357891|NCT01962948|65056145|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
23357892|NCT01962948|65056146|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
23357893|NCT01962948|65056147|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
23357894|NCT00564395|65056148|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
23357895|NCT00564395|65056149|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
23357896|NCT00564395|65056148|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
23357897|NCT00564395|65056149|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
23357898|NCT01358578|65056150|FG000|Induction Period|Adverse Event|2|||
23357899|NCT01358578|65056151|FG001|Induction Period|Adverse Event|4|||
23357900|NCT01358578|65056152|FG002|Induction Period|Adverse Event|2|||
23357901|NCT01358578|65056153|FG003|Induction Period|Adverse Event|6|||
23357902|NCT01358578|65056154|FG004|Induction Period|Adverse Event|0|||
23357903|NCT01358578|65056155|FG005|Induction Period|Adverse Event|0|||
23357904|NCT01358578|65056150|FG000|Induction Period|Lack of Efficacy|0|||
23357905|NCT01358578|65056151|FG001|Induction Period|Lack of Efficacy|0|||
23357906|NCT01358578|65056152|FG002|Induction Period|Lack of Efficacy|9|||
23357907|NCT01358578|65056153|FG003|Induction Period|Lack of Efficacy|1|||
23357908|NCT01358578|65056154|FG004|Induction Period|Lack of Efficacy|0|||
23357909|NCT01358578|65056155|FG005|Induction Period|Lack of Efficacy|0|||
23357910|NCT01358578|65056150|FG000|Induction Period|Lost to Follow-up|0|||
23357911|NCT01358578|65056151|FG001|Induction Period|Lost to Follow-up|0|||
23357912|NCT01358578|65056152|FG002|Induction Period|Lost to Follow-up|1|||
23357913|NCT01358578|65056153|FG003|Induction Period|Lost to Follow-up|4|||
23357914|NCT01358578|65056154|FG004|Induction Period|Lost to Follow-up|0|||
23357915|NCT01358578|65056155|FG005|Induction Period|Lost to Follow-up|0|||
23357916|NCT01358578|65056150|FG000|Induction Period|Physician Decision|2|||
23357917|NCT01358578|65056151|FG001|Induction Period|Physician Decision|1|||
23357918|NCT01358578|65056152|FG002|Induction Period|Physician Decision|2|||
23191148|NCT04382651|64442219|FG001|Overall Study|Physician Decision|1|||
23191149|NCT01736683|64442222|FG000|Overall Study|Disease Relapse|0|||
23191150|NCT01736683|64442223|FG001|Overall Study|Disease Relapse|0|||
23191151|NCT01736683|64442224|FG002|Overall Study|Disease Relapse|2|||
23357919|NCT01358578|65056153|FG003|Induction Period|Physician Decision|0|||
23191152|NCT01736683|64442225|FG003|Overall Study|Disease Relapse|1|||
23191153|NCT01736683|64442226|FG004|Overall Study|Disease Relapse|0|||
23191154|NCT01736683|64442222|FG000|Overall Study|Adverse Event|0|||
23191155|NCT01736683|64442223|FG001|Overall Study|Adverse Event|2|||
23191156|NCT01736683|64442224|FG002|Overall Study|Adverse Event|2|||
23191157|NCT01736683|64442225|FG003|Overall Study|Adverse Event|3|||
23191158|NCT01736683|64442226|FG004|Overall Study|Adverse Event|2|||
23191159|NCT01736683|64442222|FG000|Overall Study|Withdrawal by Subject|0|||
23191160|NCT01736683|64442223|FG001|Overall Study|Withdrawal by Subject|0|||
23191161|NCT01736683|64442224|FG002|Overall Study|Withdrawal by Subject|3|||
23191162|NCT01736683|64442225|FG003|Overall Study|Withdrawal by Subject|1|||
23191163|NCT01736683|64442226|FG004|Overall Study|Withdrawal by Subject|1|||
23191164|NCT01736683|64442222|FG000|Overall Study|Lack of Therapeutic Effect|7|||
23191165|NCT01736683|64442223|FG001|Overall Study|Lack of Therapeutic Effect|4|||
23191166|NCT01736683|64442224|FG002|Overall Study|Lack of Therapeutic Effect|13|||
23191167|NCT01736683|64442225|FG003|Overall Study|Lack of Therapeutic Effect|20|||
23191168|NCT01736683|64442226|FG004|Overall Study|Lack of Therapeutic Effect|1|||
23191169|NCT01736683|64442222|FG000|Overall Study|Progressive Disease|0|||
23191170|NCT01736683|64442223|FG001|Overall Study|Progressive Disease|0|||
23191171|NCT01736683|64442224|FG002|Overall Study|Progressive Disease|0|||
23191172|NCT01736683|64442225|FG003|Overall Study|Progressive Disease|1|||
23191173|NCT01736683|64442226|FG004|Overall Study|Progressive Disease|0|||
23191174|NCT01736683|64442222|FG000|Overall Study|Other|0|||
23357920|NCT01358578|65056154|FG004|Induction Period|Physician Decision|0|||
23357921|NCT01358578|65056155|FG005|Induction Period|Physician Decision|0|||
23474769|NCT04345367|65481885|FG001|Overall Study|Lack of Efficacy|0|||
23191175|NCT01736683|64442223|FG001|Overall Study|Other|0|||
23191176|NCT01736683|64442224|FG002|Overall Study|Other|1|||
23191177|NCT01736683|64442225|FG003|Overall Study|Other|9|||
23191178|NCT01736683|64442226|FG004|Overall Study|Other|1|||
23191179|NCT03607682|64442227|FG000|Overall Study|Withdrawal by Subject|1|||
23191180|NCT03607682|64442227|FG000|Overall Study|Disease progression|1|||
23191181|NCT00858832|64442228|FG000|Overall Study|became ineligible: delivered vaginally|1|||
23357922|NCT01358578|65056150|FG000|Induction Period|Protocol Deviation|3|||
23357923|NCT01358578|65056151|FG001|Induction Period|Protocol Deviation|5|||
23357924|NCT01358578|65056152|FG002|Induction Period|Protocol Deviation|0|||
23357925|NCT01358578|65056153|FG003|Induction Period|Protocol Deviation|3|||
23357926|NCT01358578|65056154|FG004|Induction Period|Protocol Deviation|0|||
23357927|NCT01358578|65056155|FG005|Induction Period|Protocol Deviation|0|||
23357928|NCT01358578|65056150|FG000|Induction Period|technical problems|0|||
23357929|NCT01358578|65056151|FG001|Induction Period|technical problems|0|||
23357930|NCT01358578|65056152|FG002|Induction Period|technical problems|1|||
23357931|NCT01358578|65056153|FG003|Induction Period|technical problems|1|||
23357932|NCT01358578|65056154|FG004|Induction Period|technical problems|0|||
23357933|NCT01358578|65056155|FG005|Induction Period|technical problems|0|||
23357934|NCT01358578|65056150|FG000|Induction Period|Withdrawal by Subject|5|||
23357935|NCT01358578|65056151|FG001|Induction Period|Withdrawal by Subject|5|||
23357936|NCT01358578|65056152|FG002|Induction Period|Withdrawal by Subject|10|||
23357937|NCT01358578|65056153|FG003|Induction Period|Withdrawal by Subject|6|||
23357938|NCT01358578|65056154|FG004|Induction Period|Withdrawal by Subject|0|||
23357939|NCT01358578|65056155|FG005|Induction Period|Withdrawal by Subject|0|||
23357940|NCT01358578|65056150|FG000|Maintenance Period|Adverse Event|2|||
23357941|NCT01358578|65056151|FG001|Maintenance Period|Adverse Event|7|||
23251678|NCT00190684|64662810|FG000|Overall Study|Study Period V Completed|1|||
23251679|NCT00078819|64665336|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
23251680|NCT00078819|64665337|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
23251681|NCT00078819|64665338|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
23251682|NCT00078819|64665339|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
23251683|NCT00078819|64665336|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
23251684|NCT00078819|64665337|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
23251685|NCT00078819|64665338|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
23357942|NCT01358578|65056152|FG002|Maintenance Period|Adverse Event|0|||
23357943|NCT01358578|65056153|FG003|Maintenance Period|Adverse Event|6|||
23357944|NCT01358578|65056154|FG004|Maintenance Period|Adverse Event|4|||
23357945|NCT01358578|65056155|FG005|Maintenance Period|Adverse Event|3|||
23357946|NCT01358578|65056150|FG000|Maintenance Period|Lack of Efficacy|10|||
23357947|NCT01358578|65056151|FG001|Maintenance Period|Lack of Efficacy|2|||
23357948|NCT01358578|65056152|FG002|Maintenance Period|Lack of Efficacy|0|||
23357949|NCT01358578|65056153|FG003|Maintenance Period|Lack of Efficacy|11|||
23357950|NCT01358578|65056154|FG004|Maintenance Period|Lack of Efficacy|3|||
23357951|NCT01358578|65056155|FG005|Maintenance Period|Lack of Efficacy|0|||
23357952|NCT01358578|65056150|FG000|Maintenance Period|Lost to Follow-up|4|||
23357953|NCT01358578|65056151|FG001|Maintenance Period|Lost to Follow-up|0|||
23251686|NCT00078819|64665339|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
23251687|NCT00078819|64665336|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
23251688|NCT00078819|64665337|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
23251689|NCT00078819|64665338|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
23251690|NCT00078819|64665339|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
23251691|NCT00078819|64665336|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
23251692|NCT00078819|64665337|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
23251693|NCT00078819|64665338|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
23251694|NCT00078819|64665339|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
23251695|NCT00078819|64665336|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
23251696|NCT00078819|64665337|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
23251697|NCT00078819|64665338|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
23251698|NCT00078819|64665339|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
23251699|NCT00078819|64665336|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
23251700|NCT00078819|64665337|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
23251701|NCT00078819|64665338|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
23251702|NCT00078819|64665339|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
23357954|NCT01358578|65056152|FG002|Maintenance Period|Lost to Follow-up|0|||
23357955|NCT01358578|65056153|FG003|Maintenance Period|Lost to Follow-up|5|||
23357956|NCT01358578|65056154|FG004|Maintenance Period|Lost to Follow-up|1|||
23357957|NCT01358578|65056155|FG005|Maintenance Period|Lost to Follow-up|1|||
23357958|NCT01358578|65056150|FG000|Maintenance Period|Non-compliance with study treatment|3|||
23357959|NCT01358578|65056151|FG001|Maintenance Period|Non-compliance with study treatment|1|||
23357960|NCT01358578|65056152|FG002|Maintenance Period|Non-compliance with study treatment|0|||
23357961|NCT01358578|65056153|FG003|Maintenance Period|Non-compliance with study treatment|2|||
23589404|NCT02001623|65886046|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
23589405|NCT02001623|65886047|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
23357962|NCT01358578|65056154|FG004|Maintenance Period|Non-compliance with study treatment|1|||
23357963|NCT01358578|65056155|FG005|Maintenance Period|Non-compliance with study treatment|2|||
23589406|NCT02001623|65886048|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
23474770|NCT04345367|65481884|FG000|Overall Study|Death|2|||
23474771|NCT04345367|65481885|FG001|Overall Study|Death|0|||
23474772|NCT04345367|65481884|FG000|Overall Study|Adverse Event|10|||
23474773|NCT04345367|65481885|FG001|Overall Study|Adverse Event|9|||
23474774|NCT01032889|65481886|FG000|Overall Study|Adverse Event|2|||
23474775|NCT01032889|65481887|FG001|Overall Study|Adverse Event|2|||
23474776|NCT01032889|65481888|FG002|Overall Study|Adverse Event|0|||
23474777|NCT01032889|65481886|FG000|Overall Study|Withdrawal of Consent|1|||
23474778|NCT01032889|65481887|FG001|Overall Study|Withdrawal of Consent|2|||
23474779|NCT01032889|65481888|FG002|Overall Study|Withdrawal of Consent|1|||
23474780|NCT01032889|65481886|FG000|Overall Study|Patient Request|0|||
23474781|NCT01032889|65481887|FG001|Overall Study|Patient Request|1|||
23474782|NCT01032889|65481888|FG002|Overall Study|Patient Request|0|||
23474783|NCT01032889|65481886|FG000|Overall Study|Lost to Follow-up|1|||
23474784|NCT01032889|65481887|FG001|Overall Study|Lost to Follow-up|1|||
23474785|NCT01032889|65481888|FG002|Overall Study|Lost to Follow-up|0|||
23474786|NCT01032889|65481886|FG000|Overall Study|Lack of Submental Fat|2|||
23474787|NCT01032889|65481887|FG001|Overall Study|Lack of Submental Fat|8|||
23474788|NCT01032889|65481888|FG002|Overall Study|Lack of Submental Fat|1|||
23589407|NCT02001623|65886049|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
23589408|NCT02001623|65886050|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
23589409|NCT02001623|65886051|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
23251703|NCT00078819|64665336|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
23251704|NCT00078819|64665337|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
23251705|NCT00078819|64665338|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
23251706|NCT00078819|64665339|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
23251707|NCT00078819|64665336|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
23251708|NCT00078819|64665337|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
23251709|NCT00078819|64665338|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
23251710|NCT00078819|64665339|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
23251711|NCT01358708|64665340|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
23251712|NCT01358708|64665341|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23251713|NCT01358708|64665340|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
23251714|NCT01358708|64665341|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
23251715|NCT01984229|64665342|FG000|Safety Follow-up Period|Adverse Event|1|||
23251716|NCT01984229|64665343|FG001|Safety Follow-up Period|Adverse Event|1|||
23251717|NCT01984229|64665342|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
23251718|NCT01984229|64665343|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
23251719|NCT02295280|64665346|FG000|Overall Study|Adverse Event|0|||
23251720|NCT02295280|64665347|FG001|Overall Study|Adverse Event|1|||
23251721|NCT00647426|64665348|FG000|Overall Study|Withdrawal by Subject|2|||
23251722|NCT04529499|64665350|FG000|Overall Study|Withdrawal by Subject|9|||
23251723|NCT04529499|64665351|FG001|Overall Study|Withdrawal by Subject|11|||
23251724|NCT04529499|64665350|FG000|Overall Study|Physician Decision|1|||
23251725|NCT04529499|64665351|FG001|Overall Study|Physician Decision|2|||
23251726|NCT04529499|64665350|FG000|Overall Study|Adverse Event|4|||
23251727|NCT04529499|64665351|FG001|Overall Study|Adverse Event|4|||
23251728|NCT04529499|64665350|FG000|Overall Study|Death|14|||
23251729|NCT04529499|64665351|FG001|Overall Study|Death|11|||
23251730|NCT04529499|64665350|FG000|Overall Study|Lost to Follow-up|1|||
23251731|NCT04529499|64665351|FG001|Overall Study|Lost to Follow-up|1|||
23474789|NCT01032889|65481886|FG000|Overall Study|Miscellaneous Reasons|2|||
23474790|NCT01032889|65481887|FG001|Overall Study|Miscellaneous Reasons|1|||
23474791|NCT01032889|65481888|FG002|Overall Study|Miscellaneous Reasons|1|||
23474792|NCT00282308|65481892|FG000|Treatment Period|Lost to Follow-up|1|||
23474793|NCT00282308|65481893|FG001|Treatment Period|Lost to Follow-up|0|||
23589410|NCT02001623|65886052|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
23589411|NCT02001623|65886053|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
23589412|NCT02001623|65886054|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
23589413|NCT02001623|65886040|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
23589414|NCT02001623|65886041|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
23589415|NCT02001623|65886042|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
23589416|NCT02001623|65886043|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
23589417|NCT02001623|65886044|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
23589418|NCT02001623|65886045|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
23589419|NCT02001623|65886046|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
23251732|NCT04529499|64665350|FG000|Overall Study|Others|7|||
23251733|NCT04529499|64665351|FG001|Overall Study|Others|11|||
23251734|NCT01977352|64665353|FG000|Overall Study|Lost to Follow-up|1|||
23251735|NCT01977352|64665354|FG001|Overall Study|Lost to Follow-up|2|||
23251736|NCT00021229|64665355|FG000|Overall Study|Adverse Event|10|||
23251737|NCT00021229|64665356|FG001|Overall Study|Adverse Event|5|||
23474794|NCT00282308|65481894|FG002|Treatment Period|Lost to Follow-up|0|||
23474795|NCT00282308|65481892|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
23251738|NCT00021229|64665357|FG002|Overall Study|Adverse Event|2|||
23251739|NCT00021229|64665355|FG000|Overall Study|Death|0|||
23251740|NCT00021229|64665356|FG001|Overall Study|Death|1|||
23251741|NCT00021229|64665357|FG002|Overall Study|Death|0|||
23251742|NCT00021229|64665355|FG000|Overall Study|Withdrawal by Subject|7|||
23251743|NCT00021229|64665356|FG001|Overall Study|Withdrawal by Subject|7|||
23251744|NCT00021229|64665357|FG002|Overall Study|Withdrawal by Subject|1|||
23251745|NCT00021229|64665355|FG000|Overall Study|Progressive Disease|15|||
23251746|NCT00021229|64665356|FG001|Overall Study|Progressive Disease|19|||
23251747|NCT00021229|64665357|FG002|Overall Study|Progressive Disease|12|||
23251748|NCT00021229|64665355|FG000|Overall Study|Protocol Violation|1|||
23251749|NCT00021229|64665356|FG001|Overall Study|Protocol Violation|1|||
23251750|NCT00021229|64665357|FG002|Overall Study|Protocol Violation|0|||
23251751|NCT00021229|64665355|FG000|Overall Study|Physician Decision|0|||
23251752|NCT00021229|64665356|FG001|Overall Study|Physician Decision|0|||
23251753|NCT00021229|64665357|FG002|Overall Study|Physician Decision|1|||
23357964|NCT01358578|65056150|FG000|Maintenance Period|Physician Decision|0|||
23357965|NCT01358578|65056151|FG001|Maintenance Period|Physician Decision|1|||
23357966|NCT01358578|65056152|FG002|Maintenance Period|Physician Decision|0|||
23357967|NCT01358578|65056153|FG003|Maintenance Period|Physician Decision|1|||
23357968|NCT01358578|65056154|FG004|Maintenance Period|Physician Decision|0|||
23357969|NCT01358578|65056155|FG005|Maintenance Period|Physician Decision|0|||
23357970|NCT01358578|65056150|FG000|Maintenance Period|Pregnancy|1|||
23357971|NCT01358578|65056151|FG001|Maintenance Period|Pregnancy|0|||
23357972|NCT01358578|65056152|FG002|Maintenance Period|Pregnancy|0|||
23357973|NCT01358578|65056153|FG003|Maintenance Period|Pregnancy|0|||
23357974|NCT01358578|65056154|FG004|Maintenance Period|Pregnancy|0|||
23357975|NCT01358578|65056155|FG005|Maintenance Period|Pregnancy|0|||
23357976|NCT01358578|65056150|FG000|Maintenance Period|Protocol deviation|7|||
23357977|NCT01358578|65056151|FG001|Maintenance Period|Protocol deviation|4|||
23357978|NCT01358578|65056152|FG002|Maintenance Period|Protocol deviation|0|||
23357979|NCT01358578|65056153|FG003|Maintenance Period|Protocol deviation|2|||
23357980|NCT01358578|65056154|FG004|Maintenance Period|Protocol deviation|2|||
23357981|NCT01358578|65056155|FG005|Maintenance Period|Protocol deviation|2|||
23357982|NCT01358578|65056150|FG000|Maintenance Period|Withdrawal by Subject|12|||
23357983|NCT01358578|65056151|FG001|Maintenance Period|Withdrawal by Subject|7|||
23357984|NCT01358578|65056152|FG002|Maintenance Period|Withdrawal by Subject|2|||
23357985|NCT01358578|65056153|FG003|Maintenance Period|Withdrawal by Subject|15|||
23357986|NCT01358578|65056154|FG004|Maintenance Period|Withdrawal by Subject|6|||
23357987|NCT01358578|65056155|FG005|Maintenance Period|Withdrawal by Subject|3|||
23357988|NCT01358578|65056150|FG000|Follow-up Period|Adverse Event|1|||
23357989|NCT01358578|65056151|FG001|Follow-up Period|Adverse Event|1|||
23357990|NCT01358578|65056152|FG002|Follow-up Period|Adverse Event|0|||
23357991|NCT01358578|65056153|FG003|Follow-up Period|Adverse Event|0|||
23251754|NCT00021229|64665355|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
23251755|NCT00021229|64665356|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
23251756|NCT00021229|64665357|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
23251757|NCT02713243|64665358|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
23251758|NCT02713243|64665359|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
23357992|NCT01358578|65056154|FG004|Follow-up Period|Adverse Event|0|||
23357993|NCT01358578|65056155|FG005|Follow-up Period|Adverse Event|0|||
23357994|NCT01358578|65056150|FG000|Follow-up Period|Lack of Efficacy|3|||
23357995|NCT01358578|65056151|FG001|Follow-up Period|Lack of Efficacy|0|||
23357996|NCT01358578|65056152|FG002|Follow-up Period|Lack of Efficacy|4|||
23357997|NCT01358578|65056153|FG003|Follow-up Period|Lack of Efficacy|1|||
23357998|NCT01358578|65056154|FG004|Follow-up Period|Lack of Efficacy|0|||
23474796|NCT00282308|65481893|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
23474797|NCT00282308|65481894|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
23474798|NCT00282308|65481892|FG000|Treatment Period|Adverse Event|0|||
23474799|NCT00282308|65481893|FG001|Treatment Period|Adverse Event|2|||
23474800|NCT00282308|65481894|FG002|Treatment Period|Adverse Event|0|||
23474801|NCT00282308|65481892|FG000|Treatment Period|Not Treated with Study Drug|1|||
23474802|NCT00282308|65481893|FG001|Treatment Period|Not Treated with Study Drug|0|||
23474803|NCT00282308|65481894|FG002|Treatment Period|Not Treated with Study Drug|0|||
23474804|NCT00282308|65481892|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
23474805|NCT00282308|65481893|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
23474806|NCT00282308|65481894|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
23474807|NCT00282308|65481892|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
23474808|NCT00282308|65481893|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
23474809|NCT00282308|65481894|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
23474810|NCT00282308|65481892|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
23474811|NCT00282308|65481893|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
23474812|NCT00282308|65481894|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
23474813|NCT00282308|65481892|FG000|Safety Follow-up Period|Adverse Event|0|||
23474814|NCT00282308|65481893|FG001|Safety Follow-up Period|Adverse Event|0|||
23474815|NCT00282308|65481894|FG002|Safety Follow-up Period|Adverse Event|1|||
23474816|NCT00282308|65481892|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
23474817|NCT00282308|65481893|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
23474818|NCT00282308|65481894|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
23474819|NCT00282308|65481892|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
23474820|NCT00282308|65481893|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
23474821|NCT00282308|65481894|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
23474822|NCT00282308|65481892|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
23474823|NCT00282308|65481893|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
23474824|NCT00282308|65481894|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
23474825|NCT03079102|65481895|FG000|Overall Study|Physician Decision|0|||
23474826|NCT03079102|65481896|FG001|Overall Study|Physician Decision|1|||
23474827|NCT02872285|65481897|FG000|Overall Study|Withdrawal by Subject|2|||
23474828|NCT02872285|65481898|FG001|Overall Study|Withdrawal by Subject|0|||
23474829|NCT02872285|65481897|FG000|Overall Study|Lost to Follow-up|2|||
23474830|NCT02872285|65481898|FG001|Overall Study|Lost to Follow-up|2|||
23474831|NCT02872285|65481897|FG000|Overall Study|Discontinued due to back surgery|1|||
23474832|NCT02872285|65481898|FG001|Overall Study|Discontinued due to back surgery|0|||
23474833|NCT03887702|65481899|FG000|Overall Study|Study terminated|0|||
23474834|NCT03887702|65481900|FG001|Overall Study|Study terminated|0|||
23474835|NCT03887702|65481901|FG002|Overall Study|Study terminated|2|||
23474836|NCT03887702|65481902|FG003|Overall Study|Study terminated|2|||
23474837|NCT03830892|65481903|FG000|Overall Study|Physician Decision|2|||
23474838|NCT03830892|65481904|FG001|Overall Study|Physician Decision|3|||
23474839|NCT03830892|65481903|FG000|Overall Study|Study terminated due to COVID|4|||
23474840|NCT03830892|65481904|FG001|Overall Study|Study terminated due to COVID|0|||
23474841|NCT03830892|65481903|FG000|Overall Study|Protocol Violation|0|||
23474842|NCT03830892|65481904|FG001|Overall Study|Protocol Violation|1|||
23474843|NCT03830892|65481903|FG000|Overall Study|Withdrawal by Subject|0|||
23474844|NCT03830892|65481904|FG001|Overall Study|Withdrawal by Subject|2|||
23474845|NCT02466659|65481907|FG000|Overall Study|Lost to Follow-up|5|||
23474846|NCT02466659|65481908|FG001|Overall Study|Lost to Follow-up|2|||
23474847|NCT00966875|65481910|FG000|Part A|Adverse Event|2|||
23474848|NCT00966875|65481911|FG001|Part A|Adverse Event|1|||
23474849|NCT00966875|65481912|FG002|Part A|Adverse Event|0|||
23474850|NCT00966875|65481913|FG003|Part A|Adverse Event|1|||
23474851|NCT00966875|65481914|FG004|Part A|Adverse Event|0|||
23474852|NCT00966875|65481915|FG005|Part A|Adverse Event|1|||
23474853|NCT00966875|65481916|FG006|Part A|Adverse Event|0|||
23474854|NCT00966875|65481917|FG007|Part A|Adverse Event|3|||
23474855|NCT00966875|65481918|FG008|Part A|Adverse Event|3|||
23474856|NCT00966875|65481910|FG000|Part A|Entry Criteria|0|||
23474857|NCT00966875|65481911|FG001|Part A|Entry Criteria|0|||
23474858|NCT00966875|65481912|FG002|Part A|Entry Criteria|0|||
23474859|NCT00966875|65481913|FG003|Part A|Entry Criteria|0|||
23474860|NCT00966875|65481914|FG004|Part A|Entry Criteria|0|||
23589420|NCT02001623|65886047|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
23474861|NCT00966875|65481915|FG005|Part A|Entry Criteria|2|||
23357999|NCT01358578|65056155|FG005|Follow-up Period|Lack of Efficacy|0|||
23474862|NCT00966875|65481916|FG006|Part A|Entry Criteria|0|||
23474863|NCT00966875|65481917|FG007|Part A|Entry Criteria|0|||
23474864|NCT00966875|65481918|FG008|Part A|Entry Criteria|0|||
23474865|NCT00966875|65481910|FG000|Part A|Lack of Efficacy|0|||
23474866|NCT00966875|65481911|FG001|Part A|Lack of Efficacy|1|||
23474867|NCT00966875|65481912|FG002|Part A|Lack of Efficacy|0|||
23474868|NCT00966875|65481913|FG003|Part A|Lack of Efficacy|0|||
23474869|NCT00966875|65481914|FG004|Part A|Lack of Efficacy|0|||
23474870|NCT00966875|65481915|FG005|Part A|Lack of Efficacy|0|||
23474871|NCT00966875|65481916|FG006|Part A|Lack of Efficacy|4|||
23474872|NCT00966875|65481917|FG007|Part A|Lack of Efficacy|0|||
23474873|NCT00966875|65481918|FG008|Part A|Lack of Efficacy|0|||
23474874|NCT00966875|65481910|FG000|Part A|Lost to Follow-up|2|||
23474875|NCT00966875|65481911|FG001|Part A|Lost to Follow-up|0|||
23474876|NCT00966875|65481912|FG002|Part A|Lost to Follow-up|0|||
23474877|NCT00966875|65481913|FG003|Part A|Lost to Follow-up|0|||
23474878|NCT00966875|65481914|FG004|Part A|Lost to Follow-up|0|||
23474879|NCT00966875|65481915|FG005|Part A|Lost to Follow-up|1|||
23474880|NCT00966875|65481916|FG006|Part A|Lost to Follow-up|0|||
23474881|NCT00966875|65481917|FG007|Part A|Lost to Follow-up|0|||
23474882|NCT00966875|65481918|FG008|Part A|Lost to Follow-up|0|||
23474883|NCT00966875|65481910|FG000|Part A|Parent/Caregiver Decision|0|||
23474884|NCT00966875|65481911|FG001|Part A|Parent/Caregiver Decision|0|||
23474885|NCT00966875|65481912|FG002|Part A|Parent/Caregiver Decision|0|||
23474886|NCT00966875|65481913|FG003|Part A|Parent/Caregiver Decision|1|||
23474887|NCT00966875|65481914|FG004|Part A|Parent/Caregiver Decision|0|||
23474888|NCT00966875|65481915|FG005|Part A|Parent/Caregiver Decision|0|||
23474889|NCT00966875|65481916|FG006|Part A|Parent/Caregiver Decision|0|||
23474890|NCT00966875|65481917|FG007|Part A|Parent/Caregiver Decision|0|||
23474891|NCT00966875|65481918|FG008|Part A|Parent/Caregiver Decision|0|||
23474892|NCT00966875|65481910|FG000|Part A|Physician Decision|0|||
23474893|NCT00966875|65481911|FG001|Part A|Physician Decision|0|||
23474894|NCT00966875|65481912|FG002|Part A|Physician Decision|0|||
23474895|NCT00966875|65481913|FG003|Part A|Physician Decision|0|||
23474896|NCT00966875|65481914|FG004|Part A|Physician Decision|1|||
23474897|NCT00966875|65481915|FG005|Part A|Physician Decision|0|||
23474898|NCT00966875|65481916|FG006|Part A|Physician Decision|1|||
23474899|NCT00966875|65481917|FG007|Part A|Physician Decision|0|||
23474900|NCT00966875|65481918|FG008|Part A|Physician Decision|2|||
23474901|NCT00966875|65481910|FG000|Part A|Sponsor Decision|0|||
23474902|NCT00966875|65481911|FG001|Part A|Sponsor Decision|0|||
23474903|NCT00966875|65481912|FG002|Part A|Sponsor Decision|1|||
23474904|NCT00966875|65481913|FG003|Part A|Sponsor Decision|0|||
23474905|NCT00966875|65481914|FG004|Part A|Sponsor Decision|1|||
23474906|NCT00966875|65481915|FG005|Part A|Sponsor Decision|0|||
23474907|NCT00966875|65481916|FG006|Part A|Sponsor Decision|0|||
23474908|NCT00966875|65481917|FG007|Part A|Sponsor Decision|2|||
23474909|NCT00966875|65481918|FG008|Part A|Sponsor Decision|1|||
23474910|NCT00966875|65481910|FG000|Part A|Withdrawal by Subject|2|||
23474911|NCT00966875|65481911|FG001|Part A|Withdrawal by Subject|2|||
23474912|NCT00966875|65481912|FG002|Part A|Withdrawal by Subject|1|||
23474913|NCT00966875|65481913|FG003|Part A|Withdrawal by Subject|1|||
23474914|NCT00966875|65481914|FG004|Part A|Withdrawal by Subject|3|||
23474915|NCT00966875|65481915|FG005|Part A|Withdrawal by Subject|0|||
23474916|NCT00966875|65481916|FG006|Part A|Withdrawal by Subject|5|||
23474917|NCT00966875|65481917|FG007|Part A|Withdrawal by Subject|1|||
23474918|NCT00966875|65481918|FG008|Part A|Withdrawal by Subject|1|||
23474919|NCT00966875|65481910|FG000|Part A|Protocol Violation|0|||
23474920|NCT00966875|65481911|FG001|Part A|Protocol Violation|0|||
23474921|NCT00966875|65481912|FG002|Part A|Protocol Violation|0|||
23474922|NCT00966875|65481913|FG003|Part A|Protocol Violation|0|||
23474923|NCT00966875|65481914|FG004|Part A|Protocol Violation|0|||
23474924|NCT00966875|65481915|FG005|Part A|Protocol Violation|0|||
23474925|NCT00966875|65481916|FG006|Part A|Protocol Violation|2|||
23474926|NCT00966875|65481917|FG007|Part A|Protocol Violation|1|||
23474927|NCT00966875|65481918|FG008|Part A|Protocol Violation|1|||
23474928|NCT00966875|65481910|FG000|Part B|Adverse Event|0|||
23474929|NCT00966875|65481911|FG001|Part B|Adverse Event|1|||
23474930|NCT00966875|65481912|FG002|Part B|Adverse Event|1|||
23474931|NCT00966875|65481913|FG003|Part B|Adverse Event|0|||
23474932|NCT00966875|65481914|FG004|Part B|Adverse Event|1|||
23474933|NCT00966875|65481915|FG005|Part B|Adverse Event|0|||
23474934|NCT00966875|65481916|FG006|Part B|Adverse Event|5|||
23474935|NCT00966875|65481917|FG007|Part B|Adverse Event|2|||
23474936|NCT00966875|65481918|FG008|Part B|Adverse Event|2|||
23474937|NCT00966875|65481910|FG000|Part B|Death|0|||
23474938|NCT00966875|65481911|FG001|Part B|Death|0|||
23474939|NCT00966875|65481912|FG002|Part B|Death|1|||
23474940|NCT00966875|65481913|FG003|Part B|Death|0|||
23474941|NCT00966875|65481914|FG004|Part B|Death|0|||
23474942|NCT00966875|65481915|FG005|Part B|Death|0|||
23474943|NCT00966875|65481916|FG006|Part B|Death|0|||
23474944|NCT00966875|65481917|FG007|Part B|Death|1|||
23474945|NCT00966875|65481918|FG008|Part B|Death|0|||
23474946|NCT00966875|65481910|FG000|Part B|Lack of Efficacy|2|||
23474947|NCT00966875|65481911|FG001|Part B|Lack of Efficacy|1|||
23474948|NCT00966875|65481912|FG002|Part B|Lack of Efficacy|1|||
23474949|NCT00966875|65481913|FG003|Part B|Lack of Efficacy|1|||
23474950|NCT00966875|65481914|FG004|Part B|Lack of Efficacy|2|||
23474951|NCT00966875|65481915|FG005|Part B|Lack of Efficacy|3|||
23474952|NCT00966875|65481916|FG006|Part B|Lack of Efficacy|12|||
23474953|NCT00966875|65481917|FG007|Part B|Lack of Efficacy|9|||
23474954|NCT00966875|65481918|FG008|Part B|Lack of Efficacy|6|||
23474955|NCT00966875|65481910|FG000|Part B|Lost to Follow-up|0|||
23474956|NCT00966875|65481911|FG001|Part B|Lost to Follow-up|0|||
23474957|NCT00966875|65481912|FG002|Part B|Lost to Follow-up|0|||
23474958|NCT00966875|65481913|FG003|Part B|Lost to Follow-up|1|||
23474959|NCT00966875|65481914|FG004|Part B|Lost to Follow-up|0|||
23474960|NCT00966875|65481915|FG005|Part B|Lost to Follow-up|0|||
23474961|NCT00966875|65481916|FG006|Part B|Lost to Follow-up|0|||
23474962|NCT00966875|65481917|FG007|Part B|Lost to Follow-up|0|||
23474963|NCT00966875|65481918|FG008|Part B|Lost to Follow-up|1|||
23474964|NCT00966875|65481910|FG000|Part B|Physician Decision|0|||
23474965|NCT00966875|65481911|FG001|Part B|Physician Decision|0|||
23474966|NCT00966875|65481912|FG002|Part B|Physician Decision|1|||
23474967|NCT00966875|65481913|FG003|Part B|Physician Decision|0|||
23474968|NCT00966875|65481914|FG004|Part B|Physician Decision|2|||
23474969|NCT00966875|65481915|FG005|Part B|Physician Decision|1|||
23474970|NCT00966875|65481916|FG006|Part B|Physician Decision|0|||
23474971|NCT00966875|65481917|FG007|Part B|Physician Decision|0|||
23474972|NCT00966875|65481918|FG008|Part B|Physician Decision|2|||
23474973|NCT00966875|65481910|FG000|Part B|Sponsor Decision|1|||
23474974|NCT00966875|65481911|FG001|Part B|Sponsor Decision|0|||
23474975|NCT00966875|65481912|FG002|Part B|Sponsor Decision|0|||
23474976|NCT00966875|65481913|FG003|Part B|Sponsor Decision|0|||
23474977|NCT00966875|65481914|FG004|Part B|Sponsor Decision|0|||
23474978|NCT00966875|65481915|FG005|Part B|Sponsor Decision|1|||
23474979|NCT00966875|65481916|FG006|Part B|Sponsor Decision|0|||
23474980|NCT00966875|65481917|FG007|Part B|Sponsor Decision|2|||
23474981|NCT00966875|65481918|FG008|Part B|Sponsor Decision|1|||
23474982|NCT00966875|65481910|FG000|Part B|Withdrawal by Subject|2|||
23474983|NCT00966875|65481911|FG001|Part B|Withdrawal by Subject|1|||
23474984|NCT00966875|65481912|FG002|Part B|Withdrawal by Subject|2|||
23474985|NCT00966875|65481913|FG003|Part B|Withdrawal by Subject|1|||
23474986|NCT00966875|65481914|FG004|Part B|Withdrawal by Subject|2|||
23251759|NCT02713243|64665358|FG000|Overall Study|Administrative problems|0|||
23251760|NCT02713243|64665359|FG001|Overall Study|Administrative problems|1|||
23251761|NCT02713243|64665358|FG000|Overall Study|Protocol deviation|0|||
23251762|NCT02713243|64665359|FG001|Overall Study|Protocol deviation|1|||
23474987|NCT00966875|65481915|FG005|Part B|Withdrawal by Subject|1|||
23474988|NCT00966875|65481916|FG006|Part B|Withdrawal by Subject|4|||
23474989|NCT00966875|65481917|FG007|Part B|Withdrawal by Subject|5|||
23474990|NCT00966875|65481918|FG008|Part B|Withdrawal by Subject|5|||
23474991|NCT00966875|65481910|FG000|Part B|Entry Criteria|0|||
23474992|NCT00966875|65481911|FG001|Part B|Entry Criteria|0|||
23474993|NCT00966875|65481912|FG002|Part B|Entry Criteria|0|||
23474994|NCT00966875|65481913|FG003|Part B|Entry Criteria|0|||
23474995|NCT00966875|65481914|FG004|Part B|Entry Criteria|0|||
23474996|NCT00966875|65481915|FG005|Part B|Entry Criteria|0|||
23474997|NCT00966875|65481916|FG006|Part B|Entry Criteria|1|||
23474998|NCT00966875|65481917|FG007|Part B|Entry Criteria|0|||
23191182|NCT00858832|64442229|FG001|Overall Study|became ineligible: delivered vaginally|0|||
23191183|NCT00858832|64442228|FG000|Overall Study|Adverse Event|0|||
23191184|NCT00858832|64442229|FG001|Overall Study|Adverse Event|1|||
23191185|NCT04786210|64442232|FG000|Overall Study|Lost to Follow-up|2|||
23191186|NCT04786210|64442232|FG000|Overall Study|Withdrawal by Subject|4|||
23191187|NCT00072189|64442233|FG000|Overall Study|Withdrawal by Subject|1|||
23191188|NCT03133481|64442237|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
23191189|NCT03133481|64442238|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
23191190|NCT01614457|64442239|FG000|Overall Study|Non-Compliance|1|||
23191191|NCT01614457|64442240|FG001|Overall Study|Non-Compliance|0|||
23191192|NCT01614457|64442239|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
23191193|NCT01614457|64442240|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
23191194|NCT00091793|64442243|FG000|Overall Study|Adverse Event|1|||
23191195|NCT00091793|64442244|FG001|Overall Study|Adverse Event|2|||
23191196|NCT00091793|64442243|FG000|Overall Study|Withdrawal by Subject|10|||
23474999|NCT00966875|65481918|FG008|Part B|Entry Criteria|1|||
23191197|NCT00091793|64442244|FG001|Overall Study|Withdrawal by Subject|15|||
23251763|NCT00350519|64665360|FG000|Overall Study|Death|0|||
23251764|NCT00350519|64665361|FG001|Overall Study|Death|1|||
23251765|NCT00350519|64665360|FG000|Overall Study|Physician Decision|0|||
23475000|NCT00348881|65481919|FG000|Overall Study|Lost to Follow-up|12|||
23475001|NCT00348881|65481920|FG001|Overall Study|Lost to Follow-up|6|||
23475002|NCT00348881|65481919|FG000|Overall Study|Withdrawal by Subject|3|||
23475003|NCT00348881|65481920|FG001|Overall Study|Withdrawal by Subject|4|||
23475004|NCT00348881|65481919|FG000|Overall Study|Adverse Event|2|||
23475005|NCT00348881|65481920|FG001|Overall Study|Adverse Event|0|||
23475006|NCT00348881|65481919|FG000|Overall Study|Serious Adverse Event|0|||
23475007|NCT00348881|65481920|FG001|Overall Study|Serious Adverse Event|2|||
23475008|NCT01675167|65481925|FG000|Open-label Titration Phase|Adverse Event|81|||
23475009|NCT01675167|65481926|FG001|Open-label Titration Phase|Adverse Event|0|||
23475010|NCT01675167|65481927|FG002|Open-label Titration Phase|Adverse Event|0|||
23475011|NCT01675167|65481925|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
23475012|NCT01675167|65481926|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
23475013|NCT01675167|65481927|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
23475014|NCT01675167|65481925|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
23475015|NCT01675167|65481926|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
23475016|NCT01675167|65481927|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
23475017|NCT01675167|65481925|FG000|Open-label Titration Phase|Protocol Violation|43|||
23475018|NCT01675167|65481926|FG001|Open-label Titration Phase|Protocol Violation|0|||
23475019|NCT01675167|65481927|FG002|Open-label Titration Phase|Protocol Violation|0|||
23475020|NCT01675167|65481925|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
23475021|NCT01675167|65481926|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
23475022|NCT01675167|65481927|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
23475023|NCT01675167|65481925|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
23475024|NCT01675167|65481926|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
23475025|NCT01675167|65481927|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
23475026|NCT01675167|65481925|FG000|Open-label Titration Phase|Other|55|||
23475027|NCT01675167|65481926|FG001|Open-label Titration Phase|Other|0|||
23475028|NCT01675167|65481927|FG002|Open-label Titration Phase|Other|0|||
23475029|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
23475030|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
23475031|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
23475032|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23475033|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
23475034|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
23475035|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23475036|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Adverse Event|5|||
23475037|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Adverse Event|13|||
23475038|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
23475039|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
23475040|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
23475041|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23475042|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
23475043|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
23475044|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
23475045|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
23475046|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
23475047|NCT01675167|65481925|FG000|Double-blind Treatment Phase|Other|0|||
23475048|NCT01675167|65481926|FG001|Double-blind Treatment Phase|Other|7|||
23475049|NCT01675167|65481927|FG002|Double-blind Treatment Phase|Other|5|||
23475050|NCT03531632|65481928|FG000|Overall Study|Adverse Event|0|||
23475051|NCT03531632|65481929|FG001|Overall Study|Adverse Event|0|||
23475052|NCT03531632|65481930|FG002|Overall Study|Adverse Event|1|||
23475053|NCT03531632|65481928|FG000|Overall Study|Death|4|||
23475054|NCT03531632|65481929|FG001|Overall Study|Death|0|||
23475055|NCT03531632|65481930|FG002|Overall Study|Death|14|||
23475056|NCT03531632|65481928|FG000|Overall Study|Study Terminated|1|||
23475057|NCT03531632|65481929|FG001|Overall Study|Study Terminated|3|||
23475058|NCT03531632|65481930|FG002|Overall Study|Study Terminated|11|||
23475059|NCT02894502|65481933|FG000|Baseline|Withdrawal by Subject|24|||
23475060|NCT02894502|65481934|FG001|Baseline|Withdrawal by Subject|31|||
23475061|NCT02894502|65481935|FG002|Baseline|Withdrawal by Subject|36|||
23475062|NCT02894502|65481933|FG000|Baseline|Death|3|||
23475063|NCT02894502|65481934|FG001|Baseline|Death|1|||
23475064|NCT02894502|65481935|FG002|Baseline|Death|9|||
23475065|NCT02894502|65481933|FG000|First Follow up|Withdrawal by Subject|32|||
23475066|NCT02894502|65481934|FG001|First Follow up|Withdrawal by Subject|29|||
23475067|NCT02894502|65481935|FG002|First Follow up|Withdrawal by Subject|37|||
23475068|NCT02894502|65481933|FG000|First Follow up|Death|2|||
23475069|NCT02894502|65481934|FG001|First Follow up|Death|2|||
23475070|NCT02894502|65481935|FG002|First Follow up|Death|3|||
23475071|NCT02894502|65481933|FG000|Second Follow up|Withdrawal by Subject|13|||
23475072|NCT02894502|65481934|FG001|Second Follow up|Withdrawal by Subject|15|||
23475073|NCT02894502|65481935|FG002|Second Follow up|Withdrawal by Subject|13|||
23475074|NCT02894502|65481933|FG000|Second Follow up|Death|2|||
23475075|NCT02894502|65481934|FG001|Second Follow up|Death|3|||
23475076|NCT02894502|65481935|FG002|Second Follow up|Death|1|||
23475077|NCT02894502|65481933|FG000|Third Follow up|Withdrawal by Subject|5|||
23475078|NCT02894502|65481934|FG001|Third Follow up|Withdrawal by Subject|6|||
23475079|NCT02894502|65481935|FG002|Third Follow up|Withdrawal by Subject|3|||
23475080|NCT02894502|65481933|FG000|Third Follow up|Death|1|||
23475081|NCT02894502|65481934|FG001|Third Follow up|Death|1|||
23475082|NCT02894502|65481935|FG002|Third Follow up|Death|0|||
23475083|NCT03137069|65485308|FG000|Overall Study|Withdrawal by Subject|1|||
23475084|NCT03137069|65485309|FG001|Overall Study|Withdrawal by Subject|2|||
23475085|NCT03137069|65485310|FG002|Overall Study|Withdrawal by Subject|2|||
23475086|NCT03137069|65485311|FG003|Overall Study|Withdrawal by Subject|2|||
23475087|NCT03137069|65485312|FG004|Overall Study|Withdrawal by Subject|0|||
23475088|NCT03137069|65485313|FG005|Overall Study|Withdrawal by Subject|0|||
23475089|NCT03137069|65485308|FG000|Overall Study|Adverse Event|0|||
23475090|NCT03137069|65485309|FG001|Overall Study|Adverse Event|3|||
23475091|NCT03137069|65485310|FG002|Overall Study|Adverse Event|1|||
23191198|NCT00091793|64442243|FG000|Overall Study|Ineligibility determined|2|||
23191199|NCT00091793|64442244|FG001|Overall Study|Ineligibility determined|0|||
23475092|NCT03137069|65485311|FG003|Overall Study|Adverse Event|1|||
23475093|NCT03137069|65485312|FG004|Overall Study|Adverse Event|0|||
23475094|NCT03137069|65485313|FG005|Overall Study|Adverse Event|1|||
23475095|NCT03137069|65485308|FG000|Overall Study|Protocol Violation|0|||
23475096|NCT03137069|65485309|FG001|Overall Study|Protocol Violation|1|||
23475097|NCT03137069|65485310|FG002|Overall Study|Protocol Violation|0|||
23475098|NCT03137069|65485311|FG003|Overall Study|Protocol Violation|1|||
23475099|NCT03137069|65485312|FG004|Overall Study|Protocol Violation|1|||
23475100|NCT03137069|65485313|FG005|Overall Study|Protocol Violation|1|||
23251766|NCT00350519|64665361|FG001|Overall Study|Physician Decision|1|||
23251767|NCT00350519|64665360|FG000|Overall Study|Protocol Violation|1|||
23251768|NCT00350519|64665361|FG001|Overall Study|Protocol Violation|2|||
23251769|NCT00350519|64665360|FG000|Overall Study|Withdrawal by Subject|3|||
23251770|NCT00350519|64665361|FG001|Overall Study|Withdrawal by Subject|2|||
23251771|NCT03959137|64665365|FG000|Overall Study|Protocol Violation|6|||
23251772|NCT01418352|64665370|FG000|Overall Study|Lost to Follow-up|2|||
23251773|NCT01418352|64665371|FG001|Overall Study|Lost to Follow-up|0|||
23251774|NCT01418352|64665372|FG002|Overall Study|Lost to Follow-up|0|||
23251775|NCT01418352|64665373|FG003|Overall Study|Lost to Follow-up|0|||
23251776|NCT01418352|64665370|FG000|Overall Study|Adverse Event|0|||
23251777|NCT01418352|64665371|FG001|Overall Study|Adverse Event|1|||
23251778|NCT01418352|64665372|FG002|Overall Study|Adverse Event|0|||
23251779|NCT01418352|64665373|FG003|Overall Study|Adverse Event|0|||
23251780|NCT01418352|64665370|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
23251781|NCT01418352|64665371|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
23251782|NCT01418352|64665372|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
23251783|NCT01418352|64665373|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
23251784|NCT01418352|64665370|FG000|Overall Study|Subject Withdrew Consent|0|||
23251785|NCT01418352|64665371|FG001|Overall Study|Subject Withdrew Consent|1|||
23475101|NCT03137069|65485308|FG000|Overall Study|Physician Decision|0|||
23475102|NCT03137069|65485309|FG001|Overall Study|Physician Decision|0|||
23191200|NCT00091793|64442243|FG000|Overall Study|Lost to Follow-up|7|||
23191201|NCT00091793|64442244|FG001|Overall Study|Lost to Follow-up|5|||
23191202|NCT00091793|64442243|FG000|Overall Study|Noncompliance|2|||
23191203|NCT00091793|64442244|FG001|Overall Study|Noncompliance|0|||
23251786|NCT01418352|64665372|FG002|Overall Study|Subject Withdrew Consent|2|||
23251787|NCT01418352|64665373|FG003|Overall Study|Subject Withdrew Consent|1|||
23475103|NCT03137069|65485310|FG002|Overall Study|Physician Decision|0|||
23475104|NCT03137069|65485311|FG003|Overall Study|Physician Decision|1|||
23475105|NCT03137069|65485312|FG004|Overall Study|Physician Decision|0|||
23475106|NCT03137069|65485313|FG005|Overall Study|Physician Decision|0|||
23475107|NCT03137069|65485308|FG000|Overall Study|Study Terminated by Sponsor|0|||
23475108|NCT03137069|65485309|FG001|Overall Study|Study Terminated by Sponsor|0|||
23475109|NCT03137069|65485310|FG002|Overall Study|Study Terminated by Sponsor|0|||
23475110|NCT03137069|65485311|FG003|Overall Study|Study Terminated by Sponsor|0|||
23475111|NCT03137069|65485312|FG004|Overall Study|Study Terminated by Sponsor|1|||
23475112|NCT03137069|65485313|FG005|Overall Study|Study Terminated by Sponsor|0|||
23475113|NCT03137069|65485308|FG000|Overall Study|Data Entry Error|0|||
23475114|NCT03137069|65485309|FG001|Overall Study|Data Entry Error|0|||
23475115|NCT03137069|65485310|FG002|Overall Study|Data Entry Error|0|||
23475116|NCT03137069|65485311|FG003|Overall Study|Data Entry Error|1|||
23475117|NCT03137069|65485312|FG004|Overall Study|Data Entry Error|0|||
23475118|NCT03137069|65485313|FG005|Overall Study|Data Entry Error|0|||
23475119|NCT02255435|65485314|FG000|Overall Study|Patient's Limited Time Availability|0|||
23475120|NCT02255435|65485315|FG001|Overall Study|Patient's Limited Time Availability|0|||
23251788|NCT01418352|64665370|FG000|Overall Study|Protocol Deviation|0|||
23191204|NCT00091793|64442243|FG000|Overall Study|Other|2|||
23191205|NCT00091793|64442244|FG001|Overall Study|Other|0|||
23191206|NCT02345161|64442249|FG000|Overall Study|Withdrawal by Subject|25|||
23475121|NCT02255435|65485316|FG002|Overall Study|Patient's Limited Time Availability|0|||
23475122|NCT02255435|65485317|FG003|Overall Study|Patient's Limited Time Availability|0|||
23475123|NCT02255435|65485318|FG004|Overall Study|Patient's Limited Time Availability|0|||
23475124|NCT02255435|65485319|FG005|Overall Study|Patient's Limited Time Availability|0|||
23475125|NCT02255435|65485320|FG006|Overall Study|Patient's Limited Time Availability|0|||
23475126|NCT02255435|65485321|FG007|Overall Study|Patient's Limited Time Availability|1|||
23475127|NCT02255435|65485322|FG008|Overall Study|Patient's Limited Time Availability|0|||
23475128|NCT02255435|65485323|FG009|Overall Study|Patient's Limited Time Availability|0|||
23475129|NCT02255435|65485314|FG000|Overall Study|Withdrawal by Subject|0|||
23475130|NCT02255435|65485315|FG001|Overall Study|Withdrawal by Subject|0|||
23475131|NCT02255435|65485316|FG002|Overall Study|Withdrawal by Subject|0|||
23475132|NCT02255435|65485317|FG003|Overall Study|Withdrawal by Subject|0|||
23475133|NCT02255435|65485318|FG004|Overall Study|Withdrawal by Subject|0|||
23475134|NCT02255435|65485319|FG005|Overall Study|Withdrawal by Subject|0|||
23251789|NCT01418352|64665371|FG001|Overall Study|Protocol Deviation|0|||
23251790|NCT01418352|64665372|FG002|Overall Study|Protocol Deviation|1|||
23251791|NCT01418352|64665373|FG003|Overall Study|Protocol Deviation|0|||
23251792|NCT01418352|64665370|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
23475135|NCT02255435|65485320|FG006|Overall Study|Withdrawal by Subject|0|||
23475136|NCT02255435|65485321|FG007|Overall Study|Withdrawal by Subject|0|||
23475137|NCT02255435|65485322|FG008|Overall Study|Withdrawal by Subject|1|||
23475138|NCT02255435|65485323|FG009|Overall Study|Withdrawal by Subject|4|||
23475139|NCT02255435|65485314|FG000|Overall Study|Administrative reasons|0|||
23475140|NCT02255435|65485315|FG001|Overall Study|Administrative reasons|0|||
23475141|NCT02255435|65485316|FG002|Overall Study|Administrative reasons|0|||
23475142|NCT02255435|65485317|FG003|Overall Study|Administrative reasons|0|||
23475143|NCT02255435|65485318|FG004|Overall Study|Administrative reasons|0|||
23475144|NCT02255435|65485319|FG005|Overall Study|Administrative reasons|0|||
23475145|NCT02255435|65485320|FG006|Overall Study|Administrative reasons|0|||
23475146|NCT02255435|65485321|FG007|Overall Study|Administrative reasons|0|||
23475147|NCT02255435|65485322|FG008|Overall Study|Administrative reasons|0|||
23475148|NCT02255435|65485323|FG009|Overall Study|Administrative reasons|2|||
23475149|NCT01242813|65485324|FG000|Overall Study|Lost to Follow-up|2|||
23475150|NCT03539549|65485329|FG000|Overall Study|Adverse Event|12|||
23475151|NCT03539549|65485329|FG000|Overall Study|Lost to Follow-up|1|||
23475152|NCT03539549|65485329|FG000|Overall Study|Death|2|||
23475153|NCT03539549|65485329|FG000|Overall Study|Progressive Disease|1|||
23475154|NCT03539549|65485329|FG000|Overall Study|Reason not Specified|1|||
23475155|NCT03135119|65485330|FG000|Overall Study|Lost to Follow-up|2|||
23475156|NCT03135119|65485331|FG001|Overall Study|Lost to Follow-up|0|||
23475157|NCT03135119|65485330|FG000|Overall Study|Physician Decision|1|||
23475158|NCT03135119|65485331|FG001|Overall Study|Physician Decision|1|||
23475159|NCT03135119|65485330|FG000|Overall Study|COVID-19 Shutdown|2|||
23475160|NCT03135119|65485331|FG001|Overall Study|COVID-19 Shutdown|2|||
23475161|NCT02230670|65485332|FG000|Overall Study|Adverse Event|1|||
23475162|NCT02230670|65485333|FG001|Overall Study|Adverse Event|2|||
23475163|NCT02230670|65485332|FG000|Overall Study|Withdrawal by Subject|2|||
23475164|NCT02230670|65485333|FG001|Overall Study|Withdrawal by Subject|2|||
23475165|NCT02230670|65485332|FG000|Overall Study|Physician Decision|0|||
23475166|NCT02230670|65485333|FG001|Overall Study|Physician Decision|1|||
23475167|NCT02230670|65485332|FG000|Overall Study|Protocol Violation|0|||
23475168|NCT02230670|65485333|FG001|Overall Study|Protocol Violation|1|||
23589421|NCT02001623|65886048|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
23589422|NCT02001623|65886049|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
23589423|NCT02001623|65886050|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
23589424|NCT02001623|65886051|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
23191207|NCT02345161|64442250|FG001|Overall Study|Withdrawal by Subject|33|||
23191208|NCT02345161|64442249|FG000|Overall Study|Adverse Event|16|||
23191209|NCT02345161|64442250|FG001|Overall Study|Adverse Event|19|||
23191210|NCT02345161|64442249|FG000|Overall Study|Physician Decision|4|||
23191211|NCT02345161|64442250|FG001|Overall Study|Physician Decision|4|||
23191212|NCT02345161|64442249|FG000|Overall Study|Lost to Follow-up|0|||
23191213|NCT02345161|64442250|FG001|Overall Study|Lost to Follow-up|1|||
23191214|NCT00474253|64442251|FG000|Overall Study|Withdrew consent|2|||
23191215|NCT00474253|64442252|FG001|Overall Study|Withdrew consent|0|||
23191216|NCT00474253|64442251|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
23191217|NCT00474253|64442252|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
23191218|NCT00474253|64442251|FG000|Overall Study|Lost to Follow-up|1|||
23191219|NCT00474253|64442252|FG001|Overall Study|Lost to Follow-up|0|||
23191220|NCT00474253|64442251|FG000|Overall Study|Discharged prior to study completion|0|||
23191221|NCT00474253|64442252|FG001|Overall Study|Discharged prior to study completion|1|||
23191222|NCT00624338|64442253|FG000|Overall Study|Adverse Event|14|||
23191223|NCT00624338|64442254|FG001|Overall Study|Adverse Event|14|||
23191224|NCT00624338|64442255|FG002|Overall Study|Adverse Event|18|||
23191225|NCT00624338|64442253|FG000|Overall Study|Lost to Follow-up|1|||
23191226|NCT00624338|64442254|FG001|Overall Study|Lost to Follow-up|0|||
23191227|NCT00624338|64442255|FG002|Overall Study|Lost to Follow-up|0|||
23191228|NCT00624338|64442253|FG000|Overall Study|Lack of Efficacy|11|||
23251793|NCT01418352|64665371|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
23475169|NCT02230670|65485332|FG000|Overall Study|Progression to Child-Pugh C|1|||
23475170|NCT02230670|65485333|FG001|Overall Study|Progression to Child-Pugh C|2|||
23475171|NCT00363545|65485334|FG000|Overall Study|Serious Adverse Event|0|||
23475172|NCT00363545|65485335|FG001|Overall Study|Serious Adverse Event|1|||
23475173|NCT00363545|65485334|FG000|Overall Study|Withdrawal by Subject|12|||
23589425|NCT02001623|65886052|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
23589426|NCT02001623|65886053|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
23589427|NCT02001623|65886054|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
23589428|NCT02517307|65886055|FG000|Overall Study|Withdrawal by Subject|1|||
23589429|NCT02517307|65886056|FG001|Overall Study|Withdrawal by Subject|0|||
23589430|NCT02517307|65886057|FG002|Overall Study|Withdrawal by Subject|1|||
23589431|NCT02517307|65886058|FG003|Overall Study|Withdrawal by Subject|0|||
23589432|NCT02517307|65886055|FG000|Overall Study|Protocol Violation|0|||
23589433|NCT02517307|65886056|FG001|Overall Study|Protocol Violation|0|||
23589434|NCT02517307|65886057|FG002|Overall Study|Protocol Violation|1|||
23589435|NCT02517307|65886058|FG003|Overall Study|Protocol Violation|1|||
23589436|NCT01693614|65886059|FG000|Overall Study|Adverse Event|7|||
23589437|NCT01693614|65886060|FG001|Overall Study|Adverse Event|11|||
23589438|NCT01693614|65886061|FG002|Overall Study|Adverse Event|5|||
23589439|NCT01693614|65886059|FG000|Overall Study|Disease progression|11|||
23191229|NCT00624338|64442254|FG001|Overall Study|Lack of Efficacy|3|||
23191230|NCT00624338|64442255|FG002|Overall Study|Lack of Efficacy|14|||
23191231|NCT00624338|64442253|FG000|Overall Study|Protocol Violation|3|||
23191232|NCT00624338|64442254|FG001|Overall Study|Protocol Violation|3|||
23191233|NCT00624338|64442255|FG002|Overall Study|Protocol Violation|2|||
23191234|NCT00624338|64442253|FG000|Overall Study|Death|0|||
23191235|NCT00624338|64442254|FG001|Overall Study|Death|2|||
23191236|NCT00624338|64442255|FG002|Overall Study|Death|0|||
23191237|NCT00624338|64442253|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
23191238|NCT00624338|64442254|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
23191239|NCT00624338|64442255|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
23191240|NCT00624338|64442253|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
23191241|NCT00624338|64442254|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
23191242|NCT00624338|64442255|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
23251794|NCT01418352|64665372|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
23251795|NCT01418352|64665373|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
23589440|NCT01693614|65886060|FG001|Overall Study|Disease progression|8|||
23589441|NCT01693614|65886061|FG002|Overall Study|Disease progression|7|||
23589442|NCT01693614|65886059|FG000|Overall Study|Protocol Violation|5|||
23589443|NCT01693614|65886060|FG001|Overall Study|Protocol Violation|2|||
23589444|NCT01693614|65886061|FG002|Overall Study|Protocol Violation|1|||
23589445|NCT01693614|65886059|FG000|Overall Study|Death|1|||
23589446|NCT01693614|65886060|FG001|Overall Study|Death|0|||
23589447|NCT01693614|65886061|FG002|Overall Study|Death|0|||
23589448|NCT01693614|65886059|FG000|Overall Study|Physician Decision|1|||
23589449|NCT01693614|65886060|FG001|Overall Study|Physician Decision|1|||
23589450|NCT01693614|65886061|FG002|Overall Study|Physician Decision|4|||
23589451|NCT01693614|65886059|FG000|Overall Study|Withdrawal by subject/guardian|0|||
23589452|NCT01693614|65886060|FG001|Overall Study|Withdrawal by subject/guardian|0|||
23589453|NCT01693614|65886061|FG002|Overall Study|Withdrawal by subject/guardian|2|||
23589454|NCT01693614|65886059|FG000|Overall Study|Withdrawal by Subject|1|||
23589455|NCT01693614|65886060|FG001|Overall Study|Withdrawal by Subject|0|||
23589456|NCT01693614|65886061|FG002|Overall Study|Withdrawal by Subject|5|||
23589457|NCT01254019|65886062|FG000|Overall Study|Adverse Event|0|||
23589458|NCT01254019|65886063|FG001|Overall Study|Adverse Event|2|||
23589459|NCT01254019|65886062|FG000|Overall Study|Protocol Violation|1|||
23589460|NCT01254019|65886063|FG001|Overall Study|Protocol Violation|0|||
23589461|NCT01254019|65886062|FG000|Overall Study|Withdrawal by Subject|0|||
23589462|NCT01254019|65886063|FG001|Overall Study|Withdrawal by Subject|2|||
23191243|NCT00624338|64442253|FG000|Overall Study|Other|15|||
23251796|NCT03120520|64665375|FG000|Overall Study|Lost to Follow-up|1|||
23251797|NCT03120520|64665376|FG001|Overall Study|Lost to Follow-up|1|||
23251798|NCT03120520|64665377|FG002|Overall Study|Lost to Follow-up|1|||
23251799|NCT03120520|64665378|FG003|Overall Study|Lost to Follow-up|1|||
23251800|NCT03120520|64665375|FG000|Overall Study|Withdrawal by Subject|3|||
23251801|NCT03120520|64665376|FG001|Overall Study|Withdrawal by Subject|2|||
23251802|NCT03120520|64665377|FG002|Overall Study|Withdrawal by Subject|3|||
23251803|NCT03120520|64665378|FG003|Overall Study|Withdrawal by Subject|2|||
23251804|NCT03120520|64665375|FG000|Overall Study|Other|0|||
23589463|NCT00814346|65886064|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
23589464|NCT00814346|65886065|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
23589465|NCT00814346|65886064|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
23589466|NCT00814346|65886065|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
23191244|NCT00624338|64442254|FG001|Overall Study|Other|5|||
23589467|NCT00814346|65886064|FG000|Open Phase (17 Months)|Adverse Event|5|||
23191245|NCT00624338|64442255|FG002|Overall Study|Other|9|||
23191246|NCT00624338|64442253|FG000|Overall Study|Randomized but not treated|2|||
23251805|NCT03120520|64665376|FG001|Overall Study|Other|1|||
23251806|NCT03120520|64665377|FG002|Overall Study|Other|0|||
23589468|NCT00814346|65886065|FG001|Open Phase (17 Months)|Adverse Event|0|||
23589469|NCT00814346|65886064|FG000|Open Phase (17 Months)|Consent|2|||
23589470|NCT00814346|65886065|FG001|Open Phase (17 Months)|Consent|0|||
23589471|NCT00814346|65886064|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
23589472|NCT00814346|65886065|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
23589473|NCT00814346|65886064|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
23589474|NCT00814346|65886065|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
23589475|NCT00517933|65886066|FG000|Period 1|Death|2|||
23589476|NCT00517933|65886067|FG001|Period 1|Death|1|||
23589477|NCT00517933|65886066|FG000|Period 1|Adverse Event|4|||
23589478|NCT00517933|65886067|FG001|Period 1|Adverse Event|4|||
23589479|NCT00517933|65886066|FG000|Period 1|Lost to Follow-up|2|||
23589480|NCT00517933|65886067|FG001|Period 1|Lost to Follow-up|0|||
23589481|NCT00517933|65886066|FG000|Period 1|Underwent lung transplant|0|||
23589482|NCT00517933|65886067|FG001|Period 1|Underwent lung transplant|1|||
23589483|NCT00517933|65886066|FG000|Period 2|Death|2|||
23589484|NCT00517933|65886067|FG001|Period 2|Death|4|||
23589485|NCT00517933|65886066|FG000|Period 2|Adverse Event|2|||
23589486|NCT00517933|65886067|FG001|Period 2|Adverse Event|4|||
23251807|NCT03120520|64665378|FG003|Overall Study|Other|0|||
23251808|NCT01174368|64665380|FG000|Overall Study|Withdrawal by Subject|1|||
23251809|NCT00854607|64665386|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
23251810|NCT02913261|64665387|FG000|Overall Study|Technical problems|0|||
23251811|NCT02913261|64665388|FG001|Overall Study|Technical problems|1|||
23251812|NCT02913261|64665387|FG000|Overall Study|Lack of Efficacy|32|||
23251813|NCT02913261|64665388|FG001|Overall Study|Lack of Efficacy|69|||
23251814|NCT02913261|64665387|FG000|Overall Study|Adverse Event|27|||
23251815|NCT02913261|64665388|FG001|Overall Study|Adverse Event|5|||
23251816|NCT02913261|64665387|FG000|Overall Study|Death|25|||
23251817|NCT02913261|64665388|FG001|Overall Study|Death|22|||
23251818|NCT02913261|64665387|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
23251819|NCT02913261|64665388|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
23251820|NCT02913261|64665387|FG000|Overall Study|Disease relapse|8|||
23251821|NCT02913261|64665388|FG001|Overall Study|Disease relapse|13|||
23251822|NCT02913261|64665387|FG000|Overall Study|Physician Decision|8|||
23251823|NCT02913261|64665388|FG001|Overall Study|Physician Decision|9|||
23251824|NCT02913261|64665387|FG000|Overall Study|Subject/guardian decision|4|||
23251825|NCT02913261|64665388|FG001|Overall Study|Subject/guardian decision|6|||
23251826|NCT02913261|64665387|FG000|Overall Study|Graft loss|2|||
23251827|NCT02913261|64665388|FG001|Overall Study|Graft loss|0|||
23251828|NCT00366678|64665389|FG000|Infant Series|Withdrawal by Subject|8|||
23251829|NCT00366678|64665390|FG001|Infant Series|Withdrawal by Subject|6|||
23589487|NCT00517933|65886066|FG000|Period 2|Physician Decision|1|||
23251830|NCT00366678|64665391|FG002|Infant Series|Withdrawal by Subject|0|||
23251831|NCT00366678|64665389|FG000|Infant Series|Protocol Violation|4|||
23589488|NCT00517933|65886067|FG001|Period 2|Physician Decision|0|||
23589489|NCT00517933|65886066|FG000|Period 2|Withdrawal by Subject|1|||
23589490|NCT00517933|65886067|FG001|Period 2|Withdrawal by Subject|3|||
23251832|NCT00366678|64665390|FG001|Infant Series|Protocol Violation|3|||
23589491|NCT00517933|65886066|FG000|Period 2|Underwent lung transplant|0|||
23589492|NCT00517933|65886067|FG001|Period 2|Underwent lung transplant|2|||
23589493|NCT00801983|65886068|FG000|Period 1|Lost to Follow-up|2|||
23358000|NCT01358578|65056150|FG000|Follow-up Period|Lost to Follow-up|0|||
23358001|NCT01358578|65056151|FG001|Follow-up Period|Lost to Follow-up|1|||
23358002|NCT01358578|65056152|FG002|Follow-up Period|Lost to Follow-up|0|||
23358003|NCT01358578|65056153|FG003|Follow-up Period|Lost to Follow-up|4|||
23358004|NCT01358578|65056154|FG004|Follow-up Period|Lost to Follow-up|0|||
23358005|NCT01358578|65056155|FG005|Follow-up Period|Lost to Follow-up|0|||
23358006|NCT01358578|65056150|FG000|Follow-up Period|non- compliance with study treatment|1|||
23358007|NCT01358578|65056151|FG001|Follow-up Period|non- compliance with study treatment|0|||
23358008|NCT01358578|65056152|FG002|Follow-up Period|non- compliance with study treatment|0|||
23358009|NCT01358578|65056153|FG003|Follow-up Period|non- compliance with study treatment|0|||
23358010|NCT01358578|65056154|FG004|Follow-up Period|non- compliance with study treatment|0|||
23358011|NCT01358578|65056155|FG005|Follow-up Period|non- compliance with study treatment|0|||
23358012|NCT01358578|65056150|FG000|Follow-up Period|Pregnancy|1|||
23358013|NCT01358578|65056151|FG001|Follow-up Period|Pregnancy|0|||
23358014|NCT01358578|65056152|FG002|Follow-up Period|Pregnancy|0|||
23358015|NCT01358578|65056153|FG003|Follow-up Period|Pregnancy|0|||
23358016|NCT01358578|65056154|FG004|Follow-up Period|Pregnancy|0|||
23358017|NCT01358578|65056155|FG005|Follow-up Period|Pregnancy|0|||
23358018|NCT01358578|65056150|FG000|Follow-up Period|Withdrawal by Subject|3|||
23251833|NCT00366678|64665391|FG002|Infant Series|Protocol Violation|0|||
23251834|NCT00366678|64665389|FG000|Infant Series|Failed to return|1|||
23251835|NCT00366678|64665390|FG001|Infant Series|Failed to return|1|||
23251836|NCT00366678|64665391|FG002|Infant Series|Failed to return|0|||
23251837|NCT00366678|64665389|FG000|Infant Series|Adverse Event|1|||
23251838|NCT00366678|64665390|FG001|Infant Series|Adverse Event|0|||
23251839|NCT00366678|64665391|FG002|Infant Series|Adverse Event|0|||
23251840|NCT00366678|64665389|FG000|After Infant|Withdrawal by Subject|8|||
23251841|NCT00366678|64665390|FG001|After Infant|Withdrawal by Subject|4|||
23251842|NCT00366678|64665391|FG002|After Infant|Withdrawal by Subject|0|||
23251843|NCT00366678|64665389|FG000|After Infant|Lost to Follow-up|2|||
23251844|NCT00366678|64665390|FG001|After Infant|Lost to Follow-up|1|||
23251845|NCT00366678|64665391|FG002|After Infant|Lost to Follow-up|0|||
23251846|NCT00366678|64665389|FG000|After Infant|Failed to return|5|||
23251847|NCT00366678|64665390|FG001|After Infant|Failed to return|5|||
23251848|NCT00366678|64665391|FG002|After Infant|Failed to return|0|||
23251849|NCT00366678|64665389|FG000|After Infant|Adverse Event|1|||
23251850|NCT00366678|64665390|FG001|After Infant|Adverse Event|0|||
23251851|NCT00366678|64665391|FG002|After Infant|Adverse Event|0|||
23251852|NCT00366678|64665389|FG000|After Infant|Protocol Violation|1|||
23251853|NCT00366678|64665390|FG001|After Infant|Protocol Violation|0|||
23251854|NCT00366678|64665391|FG002|After Infant|Protocol Violation|0|||
23251855|NCT00366678|64665389|FG000|Toddler Dose|Protocol Violation|2|||
23251856|NCT00366678|64665390|FG001|Toddler Dose|Protocol Violation|1|||
23251857|NCT00366678|64665391|FG002|Toddler Dose|Protocol Violation|0|||
23251858|NCT00366678|64665389|FG000|Toddler Dose|Failed to return|1|||
23251859|NCT00366678|64665390|FG001|Toddler Dose|Failed to return|0|||
23251860|NCT00366678|64665391|FG002|Toddler Dose|Failed to return|0|||
23251861|NCT00366678|64665389|FG000|Toddler Dose|Withdrawal by Subject|1|||
23251862|NCT00366678|64665390|FG001|Toddler Dose|Withdrawal by Subject|0|||
23251863|NCT00366678|64665391|FG002|Toddler Dose|Withdrawal by Subject|0|||
23251864|NCT00366678|64665389|FG000|Toddler Dose|protocol deviation|1|||
23251865|NCT00366678|64665390|FG001|Toddler Dose|protocol deviation|0|||
23251866|NCT00366678|64665391|FG002|Toddler Dose|protocol deviation|0|||
23589494|NCT00801983|65886069|FG001|Period 1|Lost to Follow-up|0|||
23589495|NCT00801983|65886068|FG000|Period 1|Withdrawal by Subject|2|||
23589496|NCT00801983|65886069|FG001|Period 1|Withdrawal by Subject|8|||
23589497|NCT00801983|65886068|FG000|Period 2|Withdrawal by Subject|2|||
23589498|NCT00801983|65886069|FG001|Period 2|Withdrawal by Subject|1|||
23589499|NCT00430300|65886074|FG000|Overall Study|Adverse Event|0|||
23589500|NCT00430300|65886075|FG001|Overall Study|Adverse Event|2|||
23589501|NCT00430300|65886076|FG002|Overall Study|Adverse Event|1|||
23589502|NCT00430300|65886077|FG003|Overall Study|Adverse Event|1|||
23589503|NCT00430300|65886074|FG000|Overall Study|Withdrawal by Subject|1|||
23589504|NCT00430300|65886075|FG001|Overall Study|Withdrawal by Subject|0|||
23589505|NCT00430300|65886076|FG002|Overall Study|Withdrawal by Subject|5|||
23251879|NCT03044431|64665399|FG000|Overall Study|Lost to Follow-up|59|||
23251880|NCT00627458|64665400|FG000|Overall Study|Migrated from study area|1|||
23251881|NCT00627458|64665401|FG001|Overall Study|Migrated from study area|0|||
23251882|NCT00627458|64665402|FG002|Overall Study|Migrated from study area|1|||
23251883|NCT00627458|64665400|FG000|Overall Study|Withdrawal by Subject|2|||
23251884|NCT00627458|64665401|FG001|Overall Study|Withdrawal by Subject|6|||
23251885|NCT00627458|64665402|FG002|Overall Study|Withdrawal by Subject|5|||
23251886|NCT00627458|64665400|FG000|Overall Study|Lost to Follow-up|1|||
23251887|NCT00627458|64665401|FG001|Overall Study|Lost to Follow-up|1|||
23358019|NCT01358578|65056151|FG001|Follow-up Period|Withdrawal by Subject|3|||
23358020|NCT01358578|65056152|FG002|Follow-up Period|Withdrawal by Subject|1|||
23358021|NCT01358578|65056153|FG003|Follow-up Period|Withdrawal by Subject|12|||
23358022|NCT01358578|65056154|FG004|Follow-up Period|Withdrawal by Subject|0|||
23358023|NCT01358578|65056155|FG005|Follow-up Period|Withdrawal by Subject|0|||
23358024|NCT01358578|65056150|FG000|Follow-up Period|Physician Decision|1|||
23589506|NCT00430300|65886077|FG003|Overall Study|Withdrawal by Subject|0|||
23251888|NCT00627458|64665402|FG002|Overall Study|Lost to Follow-up|0|||
23251889|NCT01571635|64665403|FG000|Overall Study|Adverse Event|3|||
23251890|NCT01571635|64665404|FG001|Overall Study|Adverse Event|0|||
23251891|NCT01571635|64665405|FG002|Overall Study|Adverse Event|2|||
23251892|NCT01571635|64665406|FG003|Overall Study|Adverse Event|3|||
23251893|NCT01571635|64665407|FG004|Overall Study|Adverse Event|5|||
23251894|NCT01571635|64665403|FG000|Overall Study|Other reasons|2|||
23251895|NCT01571635|64665404|FG001|Overall Study|Other reasons|1|||
23251896|NCT01571635|64665405|FG002|Overall Study|Other reasons|2|||
23251897|NCT01571635|64665406|FG003|Overall Study|Other reasons|2|||
23251898|NCT01571635|64665407|FG004|Overall Study|Other reasons|1|||
23251899|NCT01571635|64665403|FG000|Overall Study|Study terminated by sponsor|0|||
23358025|NCT01358578|65056151|FG001|Follow-up Period|Physician Decision|1|||
23358026|NCT01358578|65056152|FG002|Follow-up Period|Physician Decision|0|||
23358027|NCT01358578|65056153|FG003|Follow-up Period|Physician Decision|2|||
23358028|NCT01358578|65056154|FG004|Follow-up Period|Physician Decision|0|||
23358029|NCT01358578|65056155|FG005|Follow-up Period|Physician Decision|0|||
23358030|NCT02849704|65056161|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
23358031|NCT02849704|65056162|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
23358032|NCT02849704|65056161|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
23358033|NCT02849704|65056162|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
23358034|NCT02849704|65056161|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
23358035|NCT02849704|65056162|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
23358036|NCT00809094|65056164|FG000|Overall Study|Lost to Follow-up|0|||
23251900|NCT01571635|64665404|FG001|Overall Study|Study terminated by sponsor|4|||
23251901|NCT01571635|64665405|FG002|Overall Study|Study terminated by sponsor|1|||
23251902|NCT01571635|64665406|FG003|Overall Study|Study terminated by sponsor|3|||
23251903|NCT01571635|64665407|FG004|Overall Study|Study terminated by sponsor|1|||
23251904|NCT01571635|64665403|FG000|Overall Study|Withdrew consent|1|||
23251905|NCT01571635|64665404|FG001|Overall Study|Withdrew consent|1|||
23251906|NCT01571635|64665405|FG002|Overall Study|Withdrew consent|2|||
23251907|NCT01571635|64665406|FG003|Overall Study|Withdrew consent|3|||
23251908|NCT01571635|64665407|FG004|Overall Study|Withdrew consent|0|||
23251909|NCT01571635|64665403|FG000|Overall Study|Lack of Efficacy|0|||
23251910|NCT01571635|64665404|FG001|Overall Study|Lack of Efficacy|2|||
23251911|NCT01571635|64665405|FG002|Overall Study|Lack of Efficacy|0|||
23251912|NCT01571635|64665406|FG003|Overall Study|Lack of Efficacy|1|||
23251913|NCT01571635|64665407|FG004|Overall Study|Lack of Efficacy|2|||
23251914|NCT03056001|64665408|FG000|Overall Study|Death|24|||
23251915|NCT02875067|64665409|FG000|Overall Study|Withdrawal by Subject|1|||
23251916|NCT02875067|64665409|FG000|Overall Study|Withdrawal by Termination of Study|5|||
23251917|NCT00995930|64665410|FG000|Overall Study|Protocol deviation|2|||
23251918|NCT00995930|64665411|FG001|Overall Study|Protocol deviation|5|||
23251919|NCT00995930|64665410|FG000|Overall Study|Death|0|||
23251920|NCT00995930|64665411|FG001|Overall Study|Death|1|||
23251921|NCT00995930|64665410|FG000|Overall Study|Administrative problems|4|||
23251922|NCT00995930|64665411|FG001|Overall Study|Administrative problems|2|||
23191247|NCT00624338|64442254|FG001|Overall Study|Randomized but not treated|1|||
23191248|NCT00624338|64442255|FG002|Overall Study|Randomized but not treated|3|||
23191249|NCT01041573|64442256|FG000|Overall Study|Withdrawal by Subject|2|||
23191250|NCT01041573|64442257|FG001|Overall Study|Withdrawal by Subject|5|||
23251923|NCT00995930|64665410|FG000|Overall Study|Lost to Follow-up|1|||
23251924|NCT00995930|64665411|FG001|Overall Study|Lost to Follow-up|2|||
23251925|NCT00995930|64665410|FG000|Overall Study|Withdrawal by Subject|3|||
23251926|NCT00995930|64665411|FG001|Overall Study|Withdrawal by Subject|4|||
23251927|NCT00995930|64665410|FG000|Overall Study|Adverse Event|11|||
23251928|NCT00995930|64665411|FG001|Overall Study|Adverse Event|14|||
23358037|NCT00809094|65056165|FG001|Overall Study|Lost to Follow-up|1|||
23358038|NCT03411902|65056166|FG000|Overall Study|Lost to Follow-up|3|||
23358039|NCT03411902|65056167|FG001|Overall Study|Lost to Follow-up|0|||
23358040|NCT04676724|65056168|FG000|Overall Study|Adverse Event|2|||
23191251|NCT01041573|64442258|FG002|Overall Study|Withdrawal by Subject|2|||
23191252|NCT01041573|64442259|FG003|Overall Study|Withdrawal by Subject|0|||
23191253|NCT01041573|64442256|FG000|Overall Study|Death|1|||
23191254|NCT01041573|64442257|FG001|Overall Study|Death|0|||
23191255|NCT01041573|64442258|FG002|Overall Study|Death|0|||
23191256|NCT01041573|64442259|FG003|Overall Study|Death|0|||
23191257|NCT01041573|64442256|FG000|Overall Study|Lost to Follow-up|0|||
23191258|NCT01041573|64442257|FG001|Overall Study|Lost to Follow-up|1|||
23191259|NCT01041573|64442258|FG002|Overall Study|Lost to Follow-up|2|||
23191260|NCT01041573|64442259|FG003|Overall Study|Lost to Follow-up|1|||
23191261|NCT01041573|64442256|FG000|Overall Study|Adverse Event|0|||
23191262|NCT01041573|64442257|FG001|Overall Study|Adverse Event|2|||
23191263|NCT01041573|64442258|FG002|Overall Study|Adverse Event|0|||
23191264|NCT01041573|64442259|FG003|Overall Study|Adverse Event|0|||
23191265|NCT01041573|64442256|FG000|Overall Study|relocation|1|||
23191266|NCT01041573|64442257|FG001|Overall Study|relocation|4|||
23191267|NCT01041573|64442258|FG002|Overall Study|relocation|3|||
23191268|NCT01041573|64442259|FG003|Overall Study|relocation|1|||
23191269|NCT01041573|64442256|FG000|Overall Study|further blood extraction|0|||
23191270|NCT01041573|64442257|FG001|Overall Study|further blood extraction|1|||
23191271|NCT01041573|64442258|FG002|Overall Study|further blood extraction|0|||
23191272|NCT01041573|64442259|FG003|Overall Study|further blood extraction|0|||
23191273|NCT01041573|64442256|FG000|Overall Study|positive to anti-HCV|1|||
23191274|NCT01041573|64442257|FG001|Overall Study|positive to anti-HCV|0|||
23191275|NCT01041573|64442258|FG002|Overall Study|positive to anti-HCV|0|||
23191276|NCT01041573|64442259|FG003|Overall Study|positive to anti-HCV|0|||
23191277|NCT03634072|64442264|FG000|Overall Study|Early termination of overall study|1|||
23251929|NCT01612702|64665412|FG000|Overall Study|Protocol Violation|11|||
23251930|NCT01612702|64665413|FG001|Overall Study|Protocol Violation|11|||
23251931|NCT00529568|64665414|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
23358041|NCT04676724|65056169|FG001|Overall Study|Adverse Event|0|||
23358042|NCT04676724|65056168|FG000|Overall Study|Lost to Follow-up|1|||
23358043|NCT04676724|65056169|FG001|Overall Study|Lost to Follow-up|0|||
23358044|NCT04676724|65056168|FG000|Overall Study|Physician Decision|0|||
23358045|NCT04676724|65056169|FG001|Overall Study|Physician Decision|1|||
23358046|NCT04676724|65056168|FG000|Overall Study|Withdrawal by Subject|3|||
23358047|NCT04676724|65056169|FG001|Overall Study|Withdrawal by Subject|2|||
23358048|NCT04153565|65056170|FG000|Overall Study|Death|13|||
23358049|NCT03130959|65056174|FG000|Overall Study|Disease progression|19|||
23358050|NCT03130959|65056175|FG001|Overall Study|Disease progression|7|||
23358051|NCT03130959|65056176|FG002|Overall Study|Disease progression|12|||
23358052|NCT03130959|65056177|FG003|Overall Study|Disease progression|7|||
23358053|NCT03130959|65056178|FG004|Overall Study|Disease progression|12|||
23358054|NCT03130959|65056179|FG005|Overall Study|Disease progression|3|||
23358055|NCT03130959|65056180|FG006|Overall Study|Disease progression|6|||
23358056|NCT03130959|65056181|FG007|Overall Study|Disease progression|3|||
23251932|NCT00529568|64665415|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
23251933|NCT00529568|64665416|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
23251934|NCT00529568|64665414|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
23251935|NCT00529568|64665415|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
23251936|NCT00529568|64665416|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
23251937|NCT00529568|64665414|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
23251938|NCT00529568|64665415|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
23251939|NCT00529568|64665416|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
23251940|NCT00529568|64665414|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
23251941|NCT00529568|64665415|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
23251942|NCT00529568|64665416|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
23251943|NCT00529568|64665414|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
23251944|NCT00529568|64665415|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
23251945|NCT00529568|64665416|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
23251946|NCT00529568|64665414|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
23251947|NCT00529568|64665415|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
23251948|NCT00529568|64665416|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
23251949|NCT00529568|64665414|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
23251950|NCT00529568|64665415|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
23251951|NCT00529568|64665416|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
23251952|NCT00529568|64665414|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
23251953|NCT00529568|64665415|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
23251954|NCT00529568|64665416|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
23251955|NCT00529568|64665414|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
23251956|NCT00529568|64665415|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
23251957|NCT00529568|64665416|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
23251958|NCT00529568|64665414|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
23251959|NCT00529568|64665415|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
23251960|NCT00529568|64665416|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
23251961|NCT00529568|64665414|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
23251962|NCT00529568|64665415|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
23251963|NCT00529568|64665416|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
23251964|NCT01106352|64665421|FG000|Overall Study|Subjects untreated|0|||
23251965|NCT01106352|64665422|FG001|Overall Study|Subjects untreated|0|||
23251966|NCT01106352|64665423|FG002|Overall Study|Subjects untreated|0|||
23251967|NCT01106352|64665424|FG003|Overall Study|Subjects untreated|3|||
23251968|NCT01106352|64665425|FG004|Overall Study|Subjects untreated|4|||
23251969|NCT01106352|64665421|FG000|Overall Study|Sponsor Decision|1|||
23251970|NCT01106352|64665422|FG001|Overall Study|Sponsor Decision|0|||
23251971|NCT01106352|64665423|FG002|Overall Study|Sponsor Decision|0|||
23251972|NCT01106352|64665424|FG003|Overall Study|Sponsor Decision|0|||
23251973|NCT01106352|64665425|FG004|Overall Study|Sponsor Decision|0|||
23251974|NCT01106352|64665421|FG000|Overall Study|Too ill to come in for the visit|0|||
23251975|NCT01106352|64665422|FG001|Overall Study|Too ill to come in for the visit|0|||
23251976|NCT01106352|64665423|FG002|Overall Study|Too ill to come in for the visit|1|||
23251977|NCT01106352|64665424|FG003|Overall Study|Too ill to come in for the visit|0|||
23251978|NCT01106352|64665425|FG004|Overall Study|Too ill to come in for the visit|0|||
23251979|NCT01106352|64665421|FG000|Overall Study|Lost to Follow-up|0|||
23251980|NCT01106352|64665422|FG001|Overall Study|Lost to Follow-up|0|||
23251981|NCT01106352|64665423|FG002|Overall Study|Lost to Follow-up|0|||
23251982|NCT01106352|64665424|FG003|Overall Study|Lost to Follow-up|0|||
23251983|NCT01106352|64665425|FG004|Overall Study|Lost to Follow-up|1|||
23358057|NCT03130959|65056182|FG008|Overall Study|Disease progression|15|||
23358058|NCT03130959|65056183|FG009|Overall Study|Disease progression|8|||
23358059|NCT03130959|65056174|FG000|Overall Study|Study drug toxicity|2|||
23191278|NCT03634072|64442265|FG001|Overall Study|Early termination of overall study|0|||
23191279|NCT01919411|64442268|FG000|Overall Study|Lost to Follow-up|2|||
23191280|NCT01919411|64442269|FG001|Overall Study|Lost to Follow-up|4|||
23191281|NCT01919411|64442268|FG000|Overall Study|Physician Decision|1|||
23191282|NCT01919411|64442269|FG001|Overall Study|Physician Decision|0|||
23191283|NCT01919411|64442268|FG000|Overall Study|Protocol Violation|2|||
23191284|NCT01919411|64442269|FG001|Overall Study|Protocol Violation|1|||
23191285|NCT02522481|64442270|FG000|Overall Study|discontinued|1|||
23191286|NCT02522481|64442270|FG000|Overall Study|Not dosed|2|||
23191287|NCT00866294|64442278|FG000|Overall Study|Adverse Event|12|||
23191288|NCT00866294|64442279|FG001|Overall Study|Adverse Event|13|||
23191289|NCT00866294|64442280|FG002|Overall Study|Adverse Event|9|||
23191290|NCT00866294|64442278|FG000|Overall Study|Lack of Efficacy|7|||
23191291|NCT00866294|64442279|FG001|Overall Study|Lack of Efficacy|1|||
23191292|NCT00866294|64442280|FG002|Overall Study|Lack of Efficacy|0|||
23191293|NCT00866294|64442278|FG000|Overall Study|Protocol Violation|2|||
23191294|NCT00866294|64442279|FG001|Overall Study|Protocol Violation|0|||
23191295|NCT00866294|64442280|FG002|Overall Study|Protocol Violation|0|||
23191296|NCT00866294|64442278|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
23191297|NCT00866294|64442279|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23191298|NCT00866294|64442280|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
23191299|NCT00866294|64442278|FG000|Overall Study|Lost to Follow-up|1|||
23191300|NCT00866294|64442279|FG001|Overall Study|Lost to Follow-up|3|||
23191301|NCT00866294|64442280|FG002|Overall Study|Lost to Follow-up|0|||
23191302|NCT00866294|64442278|FG000|Overall Study|Physician Decision|6|||
23191303|NCT00866294|64442279|FG001|Overall Study|Physician Decision|2|||
23191304|NCT00866294|64442280|FG002|Overall Study|Physician Decision|1|||
23191305|NCT02082184|64442284|FG000|Overall Study|Adverse Event|1|||
23191306|NCT02082184|64442285|FG001|Overall Study|Adverse Event|0|||
23191307|NCT02082184|64442284|FG000|Overall Study|Medical diagnosis|1|||
23191308|NCT02082184|64442285|FG001|Overall Study|Medical diagnosis|2|||
23191309|NCT02082184|64442284|FG000|Overall Study|Device associated symptoms|5|||
23191310|NCT02082184|64442285|FG001|Overall Study|Device associated symptoms|0|||
23191311|NCT02082184|64442284|FG000|Overall Study|Withdrawal by Subject|3|||
23191312|NCT02082184|64442285|FG001|Overall Study|Withdrawal by Subject|2|||
23191313|NCT02082184|64442284|FG000|Overall Study|Protocol Violation|0|||
23191314|NCT02082184|64442285|FG001|Overall Study|Protocol Violation|6|||
23191315|NCT02082184|64442284|FG000|Overall Study|Lost to Follow-up|0|||
23191316|NCT02082184|64442285|FG001|Overall Study|Lost to Follow-up|2|||
23191317|NCT02082184|64442284|FG000|Overall Study|Subject non-compliance|0|||
23191318|NCT02082184|64442285|FG001|Overall Study|Subject non-compliance|1|||
23191319|NCT04090164|64442286|FG000|Overall Study|incomplete data on file|245|||
23191320|NCT04090164|64442287|FG001|Overall Study|incomplete data on file|0|||
23191321|NCT00538733|64442290|FG000|Overall Study|Adverse Event|8|||
23191322|NCT00538733|64442290|FG000|Overall Study|Death|1|||
23191323|NCT00538733|64442290|FG000|Overall Study|declined to participate|2|||
23191324|NCT00538733|64442290|FG000|Overall Study|still on therapy|1|||
23191325|NCT01172288|64442291|FG000|Overall Study|Adverse Event|1|||
23191326|NCT01172288|64442292|FG001|Overall Study|Adverse Event|0|||
23191327|NCT01172288|64442291|FG000|Overall Study|Protocol Violation|0|||
23191328|NCT01172288|64442292|FG001|Overall Study|Protocol Violation|1|||
23191329|NCT01716169|64442294|FG000|Overall Study|Adverse Event|1|||
23191330|NCT01716169|64442294|FG000|Overall Study|Lost to Follow-up|1|||
23191331|NCT01716169|64442294|FG000|Overall Study|Withdrawal by Subject|1|||
23191332|NCT01716169|64442294|FG000|Overall Study|inconsistent dressing application|1|||
23191333|NCT02333331|64442299|FG000|Overall Study|Adverse Event|1|||
23191334|NCT02333331|64442300|FG001|Overall Study|Adverse Event|0|||
23191335|NCT02333331|64442301|FG002|Overall Study|Adverse Event|4|||
23191336|NCT02333331|64442302|FG003|Overall Study|Adverse Event|1|||
23191337|NCT02333331|64442299|FG000|Overall Study|Death|0|||
23191338|NCT02333331|64442300|FG001|Overall Study|Death|0|||
23191339|NCT02333331|64442301|FG002|Overall Study|Death|2|||
23191340|NCT02333331|64442302|FG003|Overall Study|Death|0|||
23191341|NCT02333331|64442299|FG000|Overall Study|Lost to Follow-up|0|||
23191342|NCT02333331|64442300|FG001|Overall Study|Lost to Follow-up|0|||
23251984|NCT01106352|64665421|FG000|Overall Study|Death|0|||
23251985|NCT01106352|64665422|FG001|Overall Study|Death|0|||
23191343|NCT02333331|64442301|FG002|Overall Study|Lost to Follow-up|1|||
23191344|NCT02333331|64442302|FG003|Overall Study|Lost to Follow-up|0|||
23191345|NCT02333331|64442299|FG000|Overall Study|Physician Decision|0|||
23191346|NCT02333331|64442300|FG001|Overall Study|Physician Decision|1|||
23191347|NCT02333331|64442301|FG002|Overall Study|Physician Decision|0|||
23191348|NCT02333331|64442302|FG003|Overall Study|Physician Decision|0|||
23191349|NCT02333331|64442299|FG000|Overall Study|Protocol Deviation|0|||
23191350|NCT02333331|64442300|FG001|Overall Study|Protocol Deviation|3|||
23191351|NCT02333331|64442301|FG002|Overall Study|Protocol Deviation|2|||
23191352|NCT02333331|64442302|FG003|Overall Study|Protocol Deviation|1|||
23191353|NCT02333331|64442299|FG000|Overall Study|Patient/Guardian Decision|1|||
23191354|NCT02333331|64442300|FG001|Overall Study|Patient/Guardian Decision|2|||
23191355|NCT02333331|64442301|FG002|Overall Study|Patient/Guardian Decision|9|||
23358060|NCT03130959|65056175|FG001|Overall Study|Study drug toxicity|2|||
23358061|NCT03130959|65056176|FG002|Overall Study|Study drug toxicity|1|||
23358062|NCT03130959|65056177|FG003|Overall Study|Study drug toxicity|2|||
23358063|NCT03130959|65056178|FG004|Overall Study|Study drug toxicity|1|||
23358064|NCT03130959|65056179|FG005|Overall Study|Study drug toxicity|1|||
23358065|NCT03130959|65056180|FG006|Overall Study|Study drug toxicity|3|||
23358066|NCT03130959|65056181|FG007|Overall Study|Study drug toxicity|0|||
23358067|NCT03130959|65056182|FG008|Overall Study|Study drug toxicity|3|||
23251986|NCT01106352|64665423|FG002|Overall Study|Death|1|||
23251987|NCT01106352|64665424|FG003|Overall Study|Death|3|||
23251988|NCT01106352|64665425|FG004|Overall Study|Death|1|||
23251989|NCT01106352|64665421|FG000|Overall Study|Disease progression|0|||
23251990|NCT01106352|64665422|FG001|Overall Study|Disease progression|0|||
23251991|NCT01106352|64665423|FG002|Overall Study|Disease progression|0|||
23251992|NCT01106352|64665424|FG003|Overall Study|Disease progression|1|||
23251993|NCT01106352|64665425|FG004|Overall Study|Disease progression|0|||
23251994|NCT01106352|64665421|FG000|Overall Study|Withdrawal by Subject|0|||
23251995|NCT01106352|64665422|FG001|Overall Study|Withdrawal by Subject|0|||
23251996|NCT01106352|64665423|FG002|Overall Study|Withdrawal by Subject|0|||
23251997|NCT01106352|64665424|FG003|Overall Study|Withdrawal by Subject|3|||
23251998|NCT01106352|64665425|FG004|Overall Study|Withdrawal by Subject|2|||
23251999|NCT01106352|64665421|FG000|Overall Study|Went on hospice|0|||
23252000|NCT01106352|64665422|FG001|Overall Study|Went on hospice|0|||
23252001|NCT01106352|64665423|FG002|Overall Study|Went on hospice|0|||
23252002|NCT01106352|64665424|FG003|Overall Study|Went on hospice|1|||
23252003|NCT01106352|64665425|FG004|Overall Study|Went on hospice|0|||
23252004|NCT01106352|64665421|FG000|Overall Study|Subject entered hospice|0|||
23252005|NCT01106352|64665422|FG001|Overall Study|Subject entered hospice|0|||
23252006|NCT01106352|64665423|FG002|Overall Study|Subject entered hospice|0|||
23252007|NCT01106352|64665424|FG003|Overall Study|Subject entered hospice|1|||
23252008|NCT01106352|64665425|FG004|Overall Study|Subject entered hospice|0|||
23252009|NCT01106352|64665421|FG000|Overall Study|Home hospice since July 2013|0|||
23252010|NCT01106352|64665422|FG001|Overall Study|Home hospice since July 2013|0|||
23252011|NCT01106352|64665423|FG002|Overall Study|Home hospice since July 2013|0|||
23252012|NCT01106352|64665424|FG003|Overall Study|Home hospice since July 2013|1|||
23252013|NCT01106352|64665425|FG004|Overall Study|Home hospice since July 2013|0|||
23252014|NCT01835470|64665430|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
23252015|NCT01835470|64665430|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
23252016|NCT01325701|64665435|FG000|Overall Study|Adverse Event|12|||
23252017|NCT01325701|64665436|FG001|Overall Study|Adverse Event|0|||
23252018|NCT01325701|64665435|FG000|Overall Study|Protocol Violation|1|||
23358068|NCT03130959|65056183|FG009|Overall Study|Study drug toxicity|3|||
23358069|NCT03130959|65056174|FG000|Overall Study|Other reasons|0|||
23358070|NCT03130959|65056175|FG001|Overall Study|Other reasons|0|||
23358071|NCT03130959|65056176|FG002|Overall Study|Other reasons|0|||
23358072|NCT03130959|65056177|FG003|Overall Study|Other reasons|0|||
23358073|NCT03130959|65056178|FG004|Overall Study|Other reasons|0|||
23358074|NCT03130959|65056179|FG005|Overall Study|Other reasons|1|||
23358075|NCT03130959|65056180|FG006|Overall Study|Other reasons|1|||
23358076|NCT03130959|65056181|FG007|Overall Study|Other reasons|0|||
23358077|NCT03130959|65056182|FG008|Overall Study|Other reasons|0|||
23358078|NCT03130959|65056183|FG009|Overall Study|Other reasons|0|||
23358079|NCT03130959|65056174|FG000|Overall Study|Subject request to discontinue therapy|0|||
23358080|NCT03130959|65056175|FG001|Overall Study|Subject request to discontinue therapy|0|||
23358081|NCT03130959|65056176|FG002|Overall Study|Subject request to discontinue therapy|1|||
23358082|NCT03130959|65056177|FG003|Overall Study|Subject request to discontinue therapy|1|||
23358083|NCT03130959|65056178|FG004|Overall Study|Subject request to discontinue therapy|0|||
23358084|NCT03130959|65056179|FG005|Overall Study|Subject request to discontinue therapy|0|||
23358085|NCT03130959|65056180|FG006|Overall Study|Subject request to discontinue therapy|1|||
23358086|NCT03130959|65056181|FG007|Overall Study|Subject request to discontinue therapy|1|||
23358087|NCT03130959|65056182|FG008|Overall Study|Subject request to discontinue therapy|0|||
23358088|NCT03130959|65056183|FG009|Overall Study|Subject request to discontinue therapy|0|||
23358089|NCT03130959|65056174|FG000|Overall Study|Not reported|0|||
23358090|NCT03130959|65056175|FG001|Overall Study|Not reported|0|||
23252019|NCT01325701|64665436|FG001|Overall Study|Protocol Violation|0|||
23252020|NCT01325701|64665435|FG000|Overall Study|Physician Decision|2|||
23358091|NCT03130959|65056176|FG002|Overall Study|Not reported|0|||
23252021|NCT01325701|64665436|FG001|Overall Study|Physician Decision|2|||
23252022|NCT01325701|64665435|FG000|Overall Study|Withdrawal by Subject|2|||
23252023|NCT01325701|64665436|FG001|Overall Study|Withdrawal by Subject|1|||
23252024|NCT01325701|64665435|FG000|Overall Study|Rollerover Extension Study|4|||
23252025|NCT01325701|64665436|FG001|Overall Study|Rollerover Extension Study|0|||
23252026|NCT00267007|64665437|FG000|Overall Study|Withdrawal by Subject|6|||
23358092|NCT03130959|65056177|FG003|Overall Study|Not reported|1|||
23358093|NCT03130959|65056178|FG004|Overall Study|Not reported|0|||
23252027|NCT00267007|64665438|FG001|Overall Study|Withdrawal by Subject|0|||
23252028|NCT00267007|64665437|FG000|Overall Study|Lost to Follow-up|1|||
23252029|NCT00267007|64665438|FG001|Overall Study|Lost to Follow-up|0|||
23252030|NCT00267007|64665437|FG000|Overall Study|Non-compliance|0|||
23358094|NCT03130959|65056179|FG005|Overall Study|Not reported|1|||
23358095|NCT03130959|65056180|FG006|Overall Study|Not reported|0|||
23358096|NCT03130959|65056181|FG007|Overall Study|Not reported|0|||
23358097|NCT03130959|65056182|FG008|Overall Study|Not reported|0|||
23358098|NCT03130959|65056183|FG009|Overall Study|Not reported|1|||
23358099|NCT03130959|65056174|FG000|Overall Study|Adverse Event unrelated to drug|0|||
23358100|NCT03130959|65056175|FG001|Overall Study|Adverse Event unrelated to drug|0|||
23358101|NCT03130959|65056176|FG002|Overall Study|Adverse Event unrelated to drug|1|||
23358102|NCT03130959|65056177|FG003|Overall Study|Adverse Event unrelated to drug|1|||
23358103|NCT03130959|65056178|FG004|Overall Study|Adverse Event unrelated to drug|1|||
23252031|NCT00267007|64665438|FG001|Overall Study|Non-compliance|1|||
23252032|NCT00267007|64665437|FG000|Overall Study|Adverse Event|1|||
23252033|NCT00267007|64665438|FG001|Overall Study|Adverse Event|0|||
23252034|NCT01529749|64665439|FG000|Overall Study|Lost to Follow-up|0|||
23252035|NCT01529749|64665440|FG001|Overall Study|Lost to Follow-up|1|||
23252036|NCT01529749|64665441|FG002|Overall Study|Lost to Follow-up|1|||
23252037|NCT01529749|64665442|FG003|Overall Study|Lost to Follow-up|0|||
23252038|NCT01529749|64665439|FG000|Overall Study|Physician Decision|0|||
23252039|NCT01529749|64665440|FG001|Overall Study|Physician Decision|0|||
23252040|NCT01529749|64665441|FG002|Overall Study|Physician Decision|0|||
23252041|NCT01529749|64665442|FG003|Overall Study|Physician Decision|1|||
23252042|NCT01529749|64665439|FG000|Overall Study|Withdrawal by Subject|0|||
23252043|NCT01529749|64665440|FG001|Overall Study|Withdrawal by Subject|1|||
23252044|NCT01529749|64665441|FG002|Overall Study|Withdrawal by Subject|1|||
23252045|NCT01529749|64665442|FG003|Overall Study|Withdrawal by Subject|0|||
23252046|NCT01529749|64665439|FG000|Overall Study|Protocol Violation|0|||
23252047|NCT01529749|64665440|FG001|Overall Study|Protocol Violation|0|||
23252048|NCT01529749|64665441|FG002|Overall Study|Protocol Violation|0|||
23252049|NCT01529749|64665442|FG003|Overall Study|Protocol Violation|1|||
23252050|NCT01458132|64665447|FG000|Overall Study|Other|15|||
23252051|NCT01458132|64665448|FG001|Overall Study|Other|3|||
23252052|NCT00837577|64665449|FG000|Double-blind Period|Clinical Adverse Event|1|||
23252053|NCT00837577|64665450|FG001|Double-blind Period|Clinical Adverse Event|0|||
23252054|NCT00837577|64665449|FG000|Double-blind Period|Withdrawal by Subject|1|||
23252055|NCT00837577|64665450|FG001|Double-blind Period|Withdrawal by Subject|0|||
23252056|NCT00837577|64665449|FG000|Open-label Period|Clinical Adverse Event|2|||
23252057|NCT00837577|64665450|FG001|Open-label Period|Clinical Adverse Event|2|||
23252058|NCT00837577|64665449|FG000|Open-label Period|Laboratory Adverse Event|0|||
23252059|NCT00837577|64665450|FG001|Open-label Period|Laboratory Adverse Event|1|||
23252060|NCT00837577|64665449|FG000|Open-label Period|Lack of Efficacy|4|||
23252061|NCT00837577|64665450|FG001|Open-label Period|Lack of Efficacy|3|||
23252062|NCT00837577|64665449|FG000|Open-label Period|Withdrawal by Subject|1|||
23252063|NCT00837577|64665450|FG001|Open-label Period|Withdrawal by Subject|2|||
23252064|NCT00837577|64665449|FG000|Open-label Period|Other Reason|1|||
23252065|NCT00837577|64665450|FG001|Open-label Period|Other Reason|1|||
23252066|NCT01858558|64665451|FG000|Overall Study|Death|1|||
23358104|NCT03130959|65056179|FG005|Overall Study|Adverse Event unrelated to drug|0|||
23475174|NCT00363545|65485335|FG001|Overall Study|Withdrawal by Subject|15|||
23191356|NCT02333331|64442302|FG003|Overall Study|Patient/Guardian Decision|1|||
23191357|NCT01887210|64442303|FG000|Overall Study|Withdrawal by Subject|1|||
23191358|NCT01887210|64442304|FG001|Overall Study|Withdrawal by Subject|3|||
23191359|NCT01887210|64442303|FG000|Overall Study|Lost to Follow-up|0|||
23191360|NCT01887210|64442304|FG001|Overall Study|Lost to Follow-up|1|||
23191361|NCT01326962|64442306|FG000|Overall Study|Adverse Event|1|||
23191362|NCT01326962|64442306|FG000|Overall Study|Withdrawal by Subject|1|||
23191363|NCT01326962|64442306|FG000|Overall Study|Lost to Follow-up|3|||
23191364|NCT01326962|64442306|FG000|Overall Study|Other|2|||
23191365|NCT00642616|64442321|FG000|Overall Study|Adverse Event|2|||
23252067|NCT01858558|64665452|FG001|Overall Study|Death|1|||
23252068|NCT01858558|64665451|FG000|Overall Study|Lost to Follow-up|1|||
23252069|NCT01858558|64665452|FG001|Overall Study|Lost to Follow-up|0|||
23252070|NCT01858558|64665451|FG000|Overall Study|Disease progression|3|||
23252071|NCT01858558|64665452|FG001|Overall Study|Disease progression|1|||
23191366|NCT00642616|64442322|FG001|Overall Study|Adverse Event|0|||
23191367|NCT00642616|64442323|FG002|Overall Study|Adverse Event|1|||
23191368|NCT00642616|64442324|FG003|Overall Study|Adverse Event|0|||
23191369|NCT00642616|64442321|FG000|Overall Study|Study Terminated by Sponsor|7|||
23191370|NCT00642616|64442322|FG001|Overall Study|Study Terminated by Sponsor|6|||
23191371|NCT00642616|64442323|FG002|Overall Study|Study Terminated by Sponsor|4|||
23191372|NCT00642616|64442324|FG003|Overall Study|Study Terminated by Sponsor|5|||
23252072|NCT01858558|64665451|FG000|Overall Study|Product contamination|2|||
23252073|NCT01858558|64665452|FG001|Overall Study|Product contamination|0|||
23252074|NCT01858558|64665451|FG000|Overall Study|Failed expansion of cell product|2|||
23252075|NCT01858558|64665452|FG001|Overall Study|Failed expansion of cell product|0|||
23252076|NCT00402779|64665453|FG000|Overall Study|Screen Failure|77|||
23358105|NCT03130959|65056180|FG006|Overall Study|Adverse Event unrelated to drug|1|||
23358106|NCT03130959|65056181|FG007|Overall Study|Adverse Event unrelated to drug|0|||
23358107|NCT03130959|65056182|FG008|Overall Study|Adverse Event unrelated to drug|1|||
23358108|NCT03130959|65056183|FG009|Overall Study|Adverse Event unrelated to drug|1|||
23358109|NCT03130959|65056174|FG000|Overall Study|Participant withdrew consent|0|||
23358110|NCT03130959|65056175|FG001|Overall Study|Participant withdrew consent|1|||
23358111|NCT03130959|65056176|FG002|Overall Study|Participant withdrew consent|0|||
23358112|NCT03130959|65056177|FG003|Overall Study|Participant withdrew consent|2|||
23358113|NCT03130959|65056178|FG004|Overall Study|Participant withdrew consent|1|||
23358114|NCT03130959|65056179|FG005|Overall Study|Participant withdrew consent|0|||
23358115|NCT03130959|65056180|FG006|Overall Study|Participant withdrew consent|0|||
23358116|NCT03130959|65056181|FG007|Overall Study|Participant withdrew consent|0|||
23358117|NCT03130959|65056182|FG008|Overall Study|Participant withdrew consent|0|||
23358118|NCT03130959|65056183|FG009|Overall Study|Participant withdrew consent|2|||
23358119|NCT03130959|65056174|FG000|Overall Study|Administrative reason by sponsor|1|||
23191373|NCT00642616|64442321|FG000|Overall Study|Withdrawal by Subject|0|||
23191374|NCT00642616|64442322|FG001|Overall Study|Withdrawal by Subject|1|||
23191375|NCT00642616|64442323|FG002|Overall Study|Withdrawal by Subject|1|||
23191376|NCT00642616|64442324|FG003|Overall Study|Withdrawal by Subject|1|||
23191377|NCT00642616|64442321|FG000|Overall Study|Protocol Violation|0|||
23191378|NCT00642616|64442322|FG001|Overall Study|Protocol Violation|0|||
23191379|NCT00642616|64442323|FG002|Overall Study|Protocol Violation|2|||
23191380|NCT00642616|64442324|FG003|Overall Study|Protocol Violation|0|||
23191381|NCT00642616|64442321|FG000|Overall Study|Physician Decision|0|||
23191382|NCT00642616|64442322|FG001|Overall Study|Physician Decision|0|||
23191383|NCT00642616|64442323|FG002|Overall Study|Physician Decision|1|||
23191384|NCT00642616|64442324|FG003|Overall Study|Physician Decision|1|||
23191385|NCT02903511|64442329|FG000|Overall Study|Withdrawal by Subject|1|||
23191386|NCT02903511|64442330|FG001|Overall Study|Withdrawal by Subject|0|||
23252077|NCT00402779|64665454|FG001|Overall Study|Screen Failure|76|||
23252078|NCT01559818|64665455|FG000|Overall Study|Physician Decision|1|||
23252079|NCT01559818|64665455|FG000|Overall Study|Pregnancy|1|||
23252080|NCT01559818|64665455|FG000|Overall Study|Study terminated by Sponsor|4|||
23252081|NCT01559818|64665455|FG000|Overall Study|Withdrawal by Subject|1|||
23358120|NCT03130959|65056175|FG001|Overall Study|Administrative reason by sponsor|0|||
23358121|NCT03130959|65056176|FG002|Overall Study|Administrative reason by sponsor|1|||
23358122|NCT03130959|65056177|FG003|Overall Study|Administrative reason by sponsor|0|||
23358123|NCT03130959|65056178|FG004|Overall Study|Administrative reason by sponsor|0|||
23589507|NCT00430300|65886074|FG000|Overall Study|Laboratory abnormality|1|||
23191387|NCT02903511|64442329|FG000|Overall Study|Lost to Follow-up|3|||
23191388|NCT02903511|64442330|FG001|Overall Study|Lost to Follow-up|2|||
23252082|NCT02561000|64665456|FG000|Overall Study|Withdrawal by Subject|2|||
23252083|NCT02561000|64665457|FG001|Overall Study|Withdrawal by Subject|3|||
23252084|NCT02561000|64665458|FG002|Overall Study|Withdrawal by Subject|0|||
23252085|NCT02561000|64665456|FG000|Overall Study|Adverse Event|0|||
23252086|NCT02561000|64665457|FG001|Overall Study|Adverse Event|1|||
23252087|NCT02561000|64665458|FG002|Overall Study|Adverse Event|0|||
23252088|NCT01271933|64665459|FG000|Single-Blind Phase|Lack of Efficacy|37|||
23252089|NCT01271933|64665460|FG001|Single-Blind Phase|Lack of Efficacy|0|||
23252090|NCT01271933|64665461|FG002|Single-Blind Phase|Lack of Efficacy|0|||
23252091|NCT01271933|64665459|FG000|Single-Blind Phase|Lost to Follow-up|10|||
23252092|NCT01271933|64665460|FG001|Single-Blind Phase|Lost to Follow-up|0|||
23252093|NCT01271933|64665461|FG002|Single-Blind Phase|Lost to Follow-up|0|||
23252094|NCT01271933|64665459|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
23252095|NCT01271933|64665460|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
23252096|NCT01271933|64665461|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
23252097|NCT01271933|64665459|FG000|Single-Blind Phase|Protocol Violation|3|||
23252098|NCT01271933|64665460|FG001|Single-Blind Phase|Protocol Violation|0|||
23252099|NCT01271933|64665461|FG002|Single-Blind Phase|Protocol Violation|0|||
23252100|NCT01271933|64665459|FG000|Single-Blind Phase|Adverse Event|52|||
23252101|NCT01271933|64665460|FG001|Single-Blind Phase|Adverse Event|0|||
23252102|NCT01271933|64665461|FG002|Single-Blind Phase|Adverse Event|0|||
23252103|NCT01271933|64665459|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
23252104|NCT01271933|64665460|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
23252105|NCT01271933|64665461|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
23252106|NCT01271933|64665459|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
23252107|NCT01271933|64665460|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
23252108|NCT01271933|64665461|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
23252109|NCT01271933|64665459|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
23252110|NCT01271933|64665460|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
23252111|NCT01271933|64665461|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
23252112|NCT01271933|64665459|FG000|Double-Blind Phase|Randomized but not treated|0|||
23252113|NCT01271933|64665460|FG001|Double-Blind Phase|Randomized but not treated|0|||
23252114|NCT01271933|64665461|FG002|Double-Blind Phase|Randomized but not treated|1|||
23252115|NCT01271933|64665459|FG000|Double-Blind Phase|Lack of Efficacy|0|||
23252116|NCT01271933|64665460|FG001|Double-Blind Phase|Lack of Efficacy|6|||
23252117|NCT01271933|64665461|FG002|Double-Blind Phase|Lack of Efficacy|9|||
23252118|NCT01271933|64665459|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23252119|NCT01271933|64665460|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23252120|NCT01271933|64665461|FG002|Double-Blind Phase|Lost to Follow-up|1|||
23252121|NCT01271933|64665459|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23252122|NCT01271933|64665460|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
23252123|NCT01271933|64665461|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
23252124|NCT01271933|64665459|FG000|Double-Blind Phase|Adverse Event|0|||
23252125|NCT01271933|64665460|FG001|Double-Blind Phase|Adverse Event|3|||
23589508|NCT00430300|65886075|FG001|Overall Study|Laboratory abnormality|0|||
23589509|NCT00430300|65886076|FG002|Overall Study|Laboratory abnormality|0|||
23589510|NCT00430300|65886077|FG003|Overall Study|Laboratory abnormality|0|||
23589511|NCT00430300|65886074|FG000|Overall Study|Other|0|||
23589512|NCT00430300|65886075|FG001|Overall Study|Other|0|||
23589513|NCT00430300|65886076|FG002|Overall Study|Other|0|||
23589514|NCT00430300|65886077|FG003|Overall Study|Other|1|||
23589515|NCT01546155|65886078|FG000|Overall Study|could not tolerate long scan duration|3|||
23589516|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Adverse Event|1|||
23589517|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
23589518|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
23589519|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
23589520|NCT01063036|65886079|FG000|Participants Treated With Study Drug|Pregnancy|1|||
23589521|NCT01063036|65886079|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
23589522|NCT01063036|65886079|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
23589523|NCT01063036|65886079|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
23589524|NCT01924767|65886080|FG000|Overall Study|Adverse Event|1|||
23589525|NCT01924767|65886081|FG001|Overall Study|Adverse Event|0|||
23589526|NCT01924767|65886082|FG002|Overall Study|Adverse Event|1|||
23589527|NCT01924767|65886083|FG003|Overall Study|Adverse Event|0|||
23589528|NCT01924767|65886084|FG004|Overall Study|Adverse Event|0|||
23589529|NCT04347954|65886085|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
23589530|NCT04347954|65886086|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
23589531|NCT04347954|65886087|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
23589532|NCT04347954|65886085|FG000|Overall Study|Lost to Follow-up|0|||
23589533|NCT04347954|65886086|FG001|Overall Study|Lost to Follow-up|1|||
23589534|NCT04347954|65886087|FG002|Overall Study|Lost to Follow-up|0|||
23589535|NCT05193318|65886091|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
23589536|NCT05193318|65886091|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
23252126|NCT01271933|64665461|FG002|Double-Blind Phase|Adverse Event|0|||
23252127|NCT01271933|64665459|FG000|Double-Blind Phase|Participant request-personal reason|0|||
23252128|NCT01271933|64665460|FG001|Double-Blind Phase|Participant request-personal reason|1|||
23252129|NCT01271933|64665461|FG002|Double-Blind Phase|Participant request-personal reason|0|||
23252130|NCT01011907|64665462|FG000|Overall Study|Withdrawal by Subject|13|||
23252131|NCT01011907|64665463|FG001|Overall Study|Withdrawal by Subject|11|||
23252132|NCT01011907|64665462|FG000|Overall Study|Adverse Event|1|||
23252133|NCT01011907|64665463|FG001|Overall Study|Adverse Event|4|||
23191389|NCT00530712|64442331|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
23191390|NCT00530712|64442331|FG000|30 Day Follow-up Visit|Missed Visit|5|||
23191391|NCT00530712|64442331|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
23191392|NCT00530712|64442331|FG000|6 Month Follow-up Visit|Missed Visit|3|||
23252134|NCT00995488|64665466|FG000|Overall Study|Withdrawal by Subject|1|||
23252135|NCT03724916|64665468|FG000|Overall Study|Withdrawal by Subject|0|||
23252136|NCT03724916|64665469|FG001|Overall Study|Withdrawal by Subject|1|||
23252137|NCT03724916|64665470|FG002|Overall Study|Withdrawal by Subject|1|||
23252138|NCT03724916|64665471|FG003|Overall Study|Withdrawal by Subject|2|||
23252139|NCT03724916|64665468|FG000|Overall Study|Randomized but not Treated|1|||
23252140|NCT03724916|64665469|FG001|Overall Study|Randomized but not Treated|0|||
23252141|NCT03724916|64665470|FG002|Overall Study|Randomized but not Treated|0|||
23252142|NCT03724916|64665471|FG003|Overall Study|Randomized but not Treated|0|||
23252143|NCT03471182|64665472|FG000|Overall Study|Withdrawal by Subject|1|||
23358124|NCT03130959|65056179|FG005|Overall Study|Administrative reason by sponsor|0|||
23358125|NCT03130959|65056180|FG006|Overall Study|Administrative reason by sponsor|0|||
23358126|NCT03130959|65056181|FG007|Overall Study|Administrative reason by sponsor|0|||
23589537|NCT01070888|65886093|FG000|First Intervention (14 Days)|Adverse Event|0|||
23191393|NCT00530712|64442331|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
23191394|NCT00530712|64442331|FG000|6 Month Follow-up Visit|Death|2|||
23191395|NCT00530712|64442331|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
23191396|NCT00530712|64442331|FG000|12 Month Follow-up Visit|Missed Visit|3|||
23191397|NCT00530712|64442331|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
23191398|NCT00530712|64442331|FG000|12 Month Follow-up Visit|Death|9|||
23191399|NCT00652093|64442333|FG000|Overall Study|Withdrawal by Subject|0|||
23191400|NCT00652093|64442334|FG001|Overall Study|Withdrawal by Subject|0|||
23191401|NCT00652093|64442335|FG002|Overall Study|Withdrawal by Subject|1|||
23191402|NCT00652093|64442336|FG003|Overall Study|Withdrawal by Subject|0|||
23191403|NCT00652093|64442337|FG004|Overall Study|Withdrawal by Subject|1|||
23191404|NCT00652093|64442338|FG005|Overall Study|Withdrawal by Subject|0|||
23191405|NCT00652093|64442333|FG000|Overall Study|Physician Decision|0|||
23191406|NCT00652093|64442334|FG001|Overall Study|Physician Decision|0|||
23191407|NCT00652093|64442335|FG002|Overall Study|Physician Decision|0|||
23191408|NCT00652093|64442336|FG003|Overall Study|Physician Decision|0|||
23252144|NCT03471182|64665473|FG001|Overall Study|Withdrawal by Subject|1|||
23252145|NCT03471182|64665474|FG002|Overall Study|Withdrawal by Subject|0|||
23252146|NCT03471182|64665472|FG000|Overall Study|Technical failure|2|||
23252147|NCT03471182|64665473|FG001|Overall Study|Technical failure|0|||
23191409|NCT00652093|64442337|FG004|Overall Study|Physician Decision|1|||
23191410|NCT00652093|64442338|FG005|Overall Study|Physician Decision|0|||
23191411|NCT01899144|64442339|FG000|Treatment Period 2|Other|1|||
23191412|NCT01899144|64442339|FG000|Treatment Period 3|Other|2|||
23191413|NCT01899144|64442339|FG000|Treatment Period 5|Other|1|||
23191414|NCT01342640|64442342|FG000|Overall Study|Adverse Event|3|||
23191415|NCT01342640|64442342|FG000|Overall Study|Protocol Violation|16|||
23191416|NCT01342640|64442342|FG000|Overall Study|Lost to Follow-up|21|||
23191417|NCT01342640|64442342|FG000|Overall Study|Other|1|||
23191418|NCT01720667|64442343|FG000|Overall Study|Adverse Event|1|||
23191419|NCT01720667|64442344|FG001|Overall Study|Adverse Event|1|||
23191420|NCT01720667|64442343|FG000|Overall Study|Withdrawal by Subject|3|||
23191421|NCT01720667|64442344|FG001|Overall Study|Withdrawal by Subject|0|||
23252148|NCT03471182|64665474|FG002|Overall Study|Technical failure|0|||
23252149|NCT03672396|64665476|FG000|Overall Study|Withdrawal by Subject|4|||
23252150|NCT03672396|64665476|FG000|Overall Study|Physician Decision|1|||
23252151|NCT03672396|64665476|FG000|Overall Study|Adverse Event|1|||
23252152|NCT02598622|64665482|FG000|Overall Study|Withdrawal by Subject|3|||
23252153|NCT02598622|64665483|FG001|Overall Study|Withdrawal by Subject|0|||
23252154|NCT02598622|64665482|FG000|Overall Study|Physician Decision|3|||
23252155|NCT02598622|64665483|FG001|Overall Study|Physician Decision|0|||
23252156|NCT04603937|64665488|FG000|Overall Study|Adverse Event|9|||
23252157|NCT04603937|64665489|FG001|Overall Study|Adverse Event|10|||
23358127|NCT03130959|65056182|FG008|Overall Study|Administrative reason by sponsor|0|||
23358128|NCT03130959|65056183|FG009|Overall Study|Administrative reason by sponsor|0|||
23358129|NCT03130959|65056174|FG000|Overall Study|Lost to Follow-up|1|||
23191422|NCT03750838|64442348|FG000|Overall Study|Lost to Follow-up|10|||
23191423|NCT03750838|64442349|FG001|Overall Study|Lost to Follow-up|6|||
23191424|NCT00447421|64442352|FG000|Overall Study|Lack of Efficacy|1|||
23191425|NCT00447421|64442352|FG000|Overall Study|Adverse Event|3|||
23191426|NCT00447421|64442352|FG000|Overall Study|Sponsor Decision|2|||
23191427|NCT03976401|64442355|FG000|Overall Study|Adverse Event|2|||
23191428|NCT03976401|64442356|FG001|Overall Study|Adverse Event|0|||
23358130|NCT03130959|65056175|FG001|Overall Study|Lost to Follow-up|0|||
23358131|NCT03130959|65056176|FG002|Overall Study|Lost to Follow-up|0|||
23358132|NCT03130959|65056177|FG003|Overall Study|Lost to Follow-up|0|||
23358133|NCT03130959|65056178|FG004|Overall Study|Lost to Follow-up|0|||
23358134|NCT03130959|65056179|FG005|Overall Study|Lost to Follow-up|0|||
23358135|NCT03130959|65056180|FG006|Overall Study|Lost to Follow-up|0|||
23358136|NCT03130959|65056181|FG007|Overall Study|Lost to Follow-up|0|||
23358137|NCT03130959|65056182|FG008|Overall Study|Lost to Follow-up|0|||
23358138|NCT03130959|65056183|FG009|Overall Study|Lost to Follow-up|0|||
23358139|NCT00824655|65056186|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
23358140|NCT00824655|65056187|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
23358141|NCT00824655|65056186|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
23358142|NCT00824655|65056187|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
23358143|NCT03665077|65056188|FG000|Overall Study|Lost to Follow-up|2|||
23358144|NCT03665077|65056188|FG000|Overall Study|Physician Decision|2|||
23358145|NCT01215435|65056191|FG000|Overall Study|Adverse Event|1|||
23358146|NCT01215435|65056192|FG001|Overall Study|Adverse Event|0|||
23358147|NCT01215435|65056191|FG000|Overall Study|Protocol Violation|2|||
23358148|NCT01215435|65056192|FG001|Overall Study|Protocol Violation|0|||
23358149|NCT01215435|65056191|FG000|Overall Study|Withdrawal Criteria|8|||
23358150|NCT01215435|65056192|FG001|Overall Study|Withdrawal Criteria|11|||
23358151|NCT01215435|65056191|FG000|Overall Study|Lost to Follow-up|3|||
23358152|NCT01215435|65056192|FG001|Overall Study|Lost to Follow-up|0|||
23358153|NCT01215435|65056191|FG000|Overall Study|Unclassified|5|||
23358154|NCT01215435|65056192|FG001|Overall Study|Unclassified|5|||
23358155|NCT02499263|65056193|FG000|Overall Study|Lost to Follow-up|9|||
23358156|NCT02499263|65056193|FG000|Overall Study|Participant's withdrawal of consent|4|||
23358157|NCT02499263|65056193|FG000|Overall Study|Lack of Efficacy|22|||
23475175|NCT00363545|65485334|FG000|Overall Study|Migrated/moved from study area|3|||
23475176|NCT00363545|65485335|FG001|Overall Study|Migrated/moved from study area|6|||
23475177|NCT00363545|65485334|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
23475178|NCT00363545|65485335|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
23475179|NCT00363545|65485334|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
23475180|NCT00363545|65485335|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
23475181|NCT00363545|65485334|FG000|Overall Study|Others|1|||
23475182|NCT00363545|65485335|FG001|Overall Study|Others|0|||
23475183|NCT00109590|65485336|FG000|Overall Study|Lost to Follow-up|1|||
23475184|NCT00109590|65485337|FG001|Overall Study|Lost to Follow-up|0|||
23475185|NCT00109590|65485338|FG002|Overall Study|Lost to Follow-up|1|||
23475186|NCT00109590|65485336|FG000|Overall Study|Never Started Treatment|1|||
23475187|NCT00109590|65485337|FG001|Overall Study|Never Started Treatment|2|||
23475188|NCT00109590|65485338|FG002|Overall Study|Never Started Treatment|3|||
23475189|NCT01485172|65485339|FG000|Overall Study|Adverse Event|2|||
23475190|NCT01485172|65485340|FG001|Overall Study|Adverse Event|1|||
23475191|NCT01485172|65485341|FG002|Overall Study|Adverse Event|2|||
23475192|NCT01485172|65485342|FG003|Overall Study|Adverse Event|2|||
23475193|NCT01485172|65485343|FG004|Overall Study|Adverse Event|1|||
23475194|NCT01485172|65485344|FG005|Overall Study|Adverse Event|2|||
23475195|NCT01485172|65485339|FG000|Overall Study|Lack of Efficacy|2|||
23475196|NCT01485172|65485340|FG001|Overall Study|Lack of Efficacy|0|||
23475197|NCT01485172|65485341|FG002|Overall Study|Lack of Efficacy|0|||
23475198|NCT01485172|65485342|FG003|Overall Study|Lack of Efficacy|0|||
23475199|NCT01485172|65485343|FG004|Overall Study|Lack of Efficacy|0|||
23475200|NCT01485172|65485344|FG005|Overall Study|Lack of Efficacy|0|||
23475201|NCT01485172|65485339|FG000|Overall Study|Protocol Violation|0|||
23589538|NCT01070888|65886094|FG001|First Intervention (14 Days)|Adverse Event|1|||
23589539|NCT01070888|65886093|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
23589540|NCT01070888|65886094|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
23589541|NCT01070888|65886093|FG000|Washout (14 Days)|Physician Decision|1|||
23589542|NCT01070888|65886094|FG001|Washout (14 Days)|Physician Decision|0|||
23589543|NCT01373346|65886095|FG000|Overall Study|Death|1|||
23589544|NCT00189202|65886096|FG000|Overall Study|Physician Decision|5|||
23589545|NCT02145182|65886097|FG000|Overall Study|Adverse Event|4|||
23589546|NCT02145182|65886098|FG001|Overall Study|Adverse Event|1|||
23589547|NCT02145182|65886097|FG000|Overall Study|Death|7|||
23589548|NCT02145182|65886098|FG001|Overall Study|Death|7|||
23589549|NCT02145182|65886097|FG000|Overall Study|Lost to Follow-up|2|||
23589550|NCT02145182|65886098|FG001|Overall Study|Lost to Follow-up|2|||
23358158|NCT02499263|65056193|FG000|Overall Study|investigator's judgment|12|||
23358159|NCT02499263|65056193|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
23358160|NCT02499263|65056193|FG000|Overall Study|Participant's decision|3|||
23358161|NCT02499263|65056193|FG000|Overall Study|Pregnancy|1|||
23358162|NCT02299388|65056196|FG000|Overall Study|Withdrawal by Subject|0|||
23358163|NCT02299388|65056197|FG001|Overall Study|Withdrawal by Subject|1|||
23475202|NCT01485172|65485340|FG001|Overall Study|Protocol Violation|0|||
23589551|NCT02145182|65886097|FG000|Overall Study|Pre-transplant Withdrawal|0|||
23358164|NCT02173379|65056198|FG000|Overall Study|Lost to Follow-up|89|||
23358165|NCT02173379|65056199|FG001|Overall Study|Lost to Follow-up|81|||
23475203|NCT01485172|65485341|FG002|Overall Study|Protocol Violation|4|||
23475204|NCT01485172|65485342|FG003|Overall Study|Protocol Violation|5|||
23475205|NCT01485172|65485343|FG004|Overall Study|Protocol Violation|1|||
23475206|NCT01485172|65485344|FG005|Overall Study|Protocol Violation|0|||
23475207|NCT01485172|65485339|FG000|Overall Study|Protocol defined stopping criteria|1|||
23475208|NCT01485172|65485340|FG001|Overall Study|Protocol defined stopping criteria|0|||
23475209|NCT01485172|65485341|FG002|Overall Study|Protocol defined stopping criteria|0|||
23475210|NCT01485172|65485342|FG003|Overall Study|Protocol defined stopping criteria|0|||
23475211|NCT01485172|65485343|FG004|Overall Study|Protocol defined stopping criteria|1|||
23475212|NCT01485172|65485344|FG005|Overall Study|Protocol defined stopping criteria|0|||
23475213|NCT01485172|65485339|FG000|Overall Study|Lost to Follow-up|0|||
23475214|NCT01485172|65485340|FG001|Overall Study|Lost to Follow-up|0|||
23475215|NCT01485172|65485341|FG002|Overall Study|Lost to Follow-up|1|||
23475216|NCT01485172|65485342|FG003|Overall Study|Lost to Follow-up|0|||
23475217|NCT01485172|65485343|FG004|Overall Study|Lost to Follow-up|0|||
23475218|NCT01485172|65485344|FG005|Overall Study|Lost to Follow-up|1|||
23475219|NCT01485172|65485339|FG000|Overall Study|Physician Decision|0|||
23475220|NCT01485172|65485340|FG001|Overall Study|Physician Decision|0|||
23475221|NCT01485172|65485341|FG002|Overall Study|Physician Decision|0|||
23475222|NCT01485172|65485342|FG003|Overall Study|Physician Decision|0|||
23475223|NCT01485172|65485343|FG004|Overall Study|Physician Decision|1|||
23475224|NCT01485172|65485344|FG005|Overall Study|Physician Decision|0|||
23475225|NCT01485172|65485339|FG000|Overall Study|Withdrawal by Subject|2|||
23475226|NCT01485172|65485340|FG001|Overall Study|Withdrawal by Subject|0|||
23475227|NCT01485172|65485341|FG002|Overall Study|Withdrawal by Subject|0|||
23475228|NCT01485172|65485342|FG003|Overall Study|Withdrawal by Subject|1|||
23475229|NCT01485172|65485343|FG004|Overall Study|Withdrawal by Subject|1|||
23475230|NCT01485172|65485344|FG005|Overall Study|Withdrawal by Subject|1|||
23475231|NCT01349049|65485353|FG000|Overall Study|Disease progression|3|||
23475232|NCT01349049|65485354|FG001|Overall Study|Disease progression|5|||
23475233|NCT01349049|65485355|FG002|Overall Study|Disease progression|3|||
23475234|NCT01349049|65485356|FG003|Overall Study|Disease progression|2|||
23475235|NCT01349049|65485357|FG004|Overall Study|Disease progression|2|||
23475236|NCT01349049|65485358|FG005|Overall Study|Disease progression|2|||
23475237|NCT01349049|65485359|FG006|Overall Study|Disease progression|3|||
23475238|NCT01349049|65485360|FG007|Overall Study|Disease progression|2|||
23475239|NCT01349049|65485361|FG008|Overall Study|Disease progression|33|||
23475240|NCT01349049|65485353|FG000|Overall Study|Adverse Event|0|||
23475241|NCT01349049|65485354|FG001|Overall Study|Adverse Event|1|||
23475242|NCT01349049|65485355|FG002|Overall Study|Adverse Event|0|||
23475243|NCT01349049|65485356|FG003|Overall Study|Adverse Event|0|||
23475244|NCT01349049|65485357|FG004|Overall Study|Adverse Event|0|||
23475245|NCT01349049|65485358|FG005|Overall Study|Adverse Event|3|||
23475246|NCT01349049|65485359|FG006|Overall Study|Adverse Event|1|||
23475247|NCT01349049|65485360|FG007|Overall Study|Adverse Event|0|||
23475248|NCT01349049|65485361|FG008|Overall Study|Adverse Event|4|||
23475249|NCT01349049|65485353|FG000|Overall Study|Physician Decision|0|||
23475250|NCT01349049|65485354|FG001|Overall Study|Physician Decision|1|||
23475251|NCT01349049|65485355|FG002|Overall Study|Physician Decision|0|||
23475252|NCT01349049|65485356|FG003|Overall Study|Physician Decision|0|||
23475253|NCT01349049|65485357|FG004|Overall Study|Physician Decision|0|||
23475254|NCT01349049|65485358|FG005|Overall Study|Physician Decision|0|||
23475255|NCT01349049|65485359|FG006|Overall Study|Physician Decision|0|||
23475256|NCT01349049|65485360|FG007|Overall Study|Physician Decision|0|||
23475257|NCT01349049|65485361|FG008|Overall Study|Physician Decision|2|||
23475258|NCT01349049|65485353|FG000|Overall Study|Protocol Violation|0|||
23475259|NCT01349049|65485354|FG001|Overall Study|Protocol Violation|0|||
23475260|NCT01349049|65485355|FG002|Overall Study|Protocol Violation|0|||
23475261|NCT01349049|65485356|FG003|Overall Study|Protocol Violation|0|||
23475262|NCT01349049|65485357|FG004|Overall Study|Protocol Violation|0|||
23475263|NCT01349049|65485358|FG005|Overall Study|Protocol Violation|0|||
23475264|NCT01349049|65485359|FG006|Overall Study|Protocol Violation|0|||
23475265|NCT01349049|65485360|FG007|Overall Study|Protocol Violation|0|||
23475266|NCT01349049|65485361|FG008|Overall Study|Protocol Violation|1|||
23475267|NCT01349049|65485353|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
23475268|NCT01349049|65485354|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
23475269|NCT01349049|65485355|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
23475270|NCT01349049|65485356|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
23475271|NCT01349049|65485357|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
23475272|NCT01349049|65485358|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
23475273|NCT01349049|65485359|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
23475274|NCT01349049|65485360|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
23475275|NCT01349049|65485361|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
23475276|NCT01349049|65485353|FG000|Overall Study|Other|0|||
23191429|NCT03976401|64442357|FG002|Overall Study|Adverse Event|4|||
23475277|NCT01349049|65485354|FG001|Overall Study|Other|0|||
23475278|NCT01349049|65485355|FG002|Overall Study|Other|0|||
23475279|NCT01349049|65485356|FG003|Overall Study|Other|0|||
23475280|NCT01349049|65485357|FG004|Overall Study|Other|0|||
23475281|NCT01349049|65485358|FG005|Overall Study|Other|1|||
23475282|NCT01349049|65485359|FG006|Overall Study|Other|0|||
23475283|NCT01349049|65485360|FG007|Overall Study|Other|0|||
23475284|NCT01349049|65485361|FG008|Overall Study|Other|4|||
23475285|NCT01349049|65485353|FG000|Overall Study|Death|0|||
23475286|NCT01349049|65485354|FG001|Overall Study|Death|0|||
23475287|NCT01349049|65485355|FG002|Overall Study|Death|0|||
23475288|NCT01349049|65485356|FG003|Overall Study|Death|0|||
23475289|NCT01349049|65485357|FG004|Overall Study|Death|0|||
23475290|NCT01349049|65485358|FG005|Overall Study|Death|0|||
23475291|NCT01349049|65485359|FG006|Overall Study|Death|0|||
23475292|NCT01349049|65485360|FG007|Overall Study|Death|1|||
23475293|NCT01349049|65485361|FG008|Overall Study|Death|5|||
23475294|NCT01349049|65485353|FG000|Overall Study|Non-compliance|0|||
23475295|NCT01349049|65485354|FG001|Overall Study|Non-compliance|0|||
23475296|NCT01349049|65485355|FG002|Overall Study|Non-compliance|0|||
23475297|NCT01349049|65485356|FG003|Overall Study|Non-compliance|1|||
23475298|NCT01349049|65485357|FG004|Overall Study|Non-compliance|0|||
23475299|NCT01349049|65485358|FG005|Overall Study|Non-compliance|0|||
23475300|NCT01349049|65485359|FG006|Overall Study|Non-compliance|0|||
23475301|NCT01349049|65485360|FG007|Overall Study|Non-compliance|0|||
23475302|NCT01349049|65485361|FG008|Overall Study|Non-compliance|0|||
23475303|NCT01349049|65485353|FG000|Overall Study|Withdrawal by Subject|0|||
23475304|NCT01349049|65485354|FG001|Overall Study|Withdrawal by Subject|0|||
23475305|NCT01349049|65485355|FG002|Overall Study|Withdrawal by Subject|0|||
23475306|NCT01349049|65485356|FG003|Overall Study|Withdrawal by Subject|0|||
23475307|NCT01349049|65485357|FG004|Overall Study|Withdrawal by Subject|0|||
23475308|NCT01349049|65485358|FG005|Overall Study|Withdrawal by Subject|0|||
23475309|NCT01349049|65485359|FG006|Overall Study|Withdrawal by Subject|0|||
23475310|NCT01349049|65485360|FG007|Overall Study|Withdrawal by Subject|0|||
23475311|NCT01349049|65485361|FG008|Overall Study|Withdrawal by Subject|6|||
23475312|NCT00313781|65485362|FG000|Before Crossover|Death|22|||
23475313|NCT00313781|65485363|FG001|Before Crossover|Death|8|||
23475314|NCT00313781|65485364|FG002|Before Crossover|Death|0|||
23475315|NCT00313781|65485362|FG000|Before Crossover|Lost to Follow-up|0|||
23475316|NCT00313781|65485363|FG001|Before Crossover|Lost to Follow-up|3|||
23475317|NCT00313781|65485364|FG002|Before Crossover|Lost to Follow-up|0|||
23475318|NCT00313781|65485362|FG000|Before Crossover|Withdrawal by Subject|3|||
23475319|NCT00313781|65485363|FG001|Before Crossover|Withdrawal by Subject|1|||
23475320|NCT00313781|65485364|FG002|Before Crossover|Withdrawal by Subject|0|||
23475321|NCT00313781|65485362|FG000|Before Crossover|Other|45|||
23475322|NCT00313781|65485363|FG001|Before Crossover|Other|30|||
23475323|NCT00313781|65485364|FG002|Before Crossover|Other|0|||
23475324|NCT00313781|65485362|FG000|Before Crossover|Crossover|0|||
23475325|NCT00313781|65485363|FG001|Before Crossover|Crossover|37|||
23475326|NCT00313781|65485364|FG002|Before Crossover|Crossover|0|||
23475327|NCT00313781|65485362|FG000|Before Crossover|Randomized, not treated|5|||
23475328|NCT00313781|65485363|FG001|Before Crossover|Randomized, not treated|0|||
23475329|NCT00313781|65485364|FG002|Before Crossover|Randomized, not treated|0|||
23475330|NCT00313781|65485362|FG000|After Crossover|Death|0|||
23475331|NCT00313781|65485363|FG001|After Crossover|Death|0|||
23475332|NCT00313781|65485364|FG002|After Crossover|Death|6|||
23475333|NCT00313781|65485362|FG000|After Crossover|Withdrawal by Subject|0|||
23475334|NCT00313781|65485363|FG001|After Crossover|Withdrawal by Subject|0|||
23475335|NCT00313781|65485364|FG002|After Crossover|Withdrawal by Subject|3|||
23475336|NCT00313781|65485362|FG000|After Crossover|Other|0|||
23475337|NCT00313781|65485363|FG001|After Crossover|Other|0|||
23475338|NCT00313781|65485364|FG002|After Crossover|Other|18|||
23475339|NCT01087736|65485365|FG000|Overall Study|Lost to Follow-up|1|||
23475340|NCT01087736|65485366|FG001|Overall Study|Lost to Follow-up|0|||
23589552|NCT02145182|65886098|FG001|Overall Study|Pre-transplant Withdrawal|2|||
23589553|NCT02145182|65886097|FG000|Overall Study|Withdrawal by Subject|5|||
23252158|NCT04603937|64665488|FG000|Overall Study|Withdrawal by Subject|7|||
23252159|NCT04603937|64665489|FG001|Overall Study|Withdrawal by Subject|6|||
23475341|NCT01087736|65485365|FG000|Overall Study|Death|0|||
23475342|NCT01087736|65485366|FG001|Overall Study|Death|1|||
23475343|NCT01087736|65485365|FG000|Overall Study|Withdrawal by Subject|0|||
23475344|NCT01087736|65485366|FG001|Overall Study|Withdrawal by Subject|1|||
23475345|NCT03836001|65485367|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
23475346|NCT03836001|65485368|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
23475347|NCT03836001|65485369|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
23475348|NCT03836001|65485367|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
23475349|NCT03836001|65485368|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
23475350|NCT03836001|65485369|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
23191430|NCT03976401|64442358|FG003|Overall Study|Adverse Event|1|||
23475351|NCT03836001|65485367|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
23475352|NCT03836001|65485368|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
23475353|NCT03836001|65485369|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
23475354|NCT03836001|65485367|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
23475355|NCT03836001|65485368|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
23475356|NCT03836001|65485369|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
23589554|NCT02145182|65886098|FG001|Overall Study|Withdrawal by Subject|4|||
23589555|NCT00573833|65886099|FG000|Overall Study|Not Treated|2|||
23589556|NCT00768651|65886100|FG000|Overall Study|Withdrawal by Subject|1|||
23589557|NCT04581824|65886104|FG000|Overall Study|Ongoing|75|||
23589558|NCT04581824|65886105|FG001|Overall Study|Ongoing|69|||
23589559|NCT04581824|65886104|FG000|Overall Study|Withdrawal by Subject|3|||
23589560|NCT04581824|65886105|FG001|Overall Study|Withdrawal by Subject|5|||
23589561|NCT04581824|65886104|FG000|Overall Study|Lost to Follow-up|1|||
23589562|NCT04581824|65886105|FG001|Overall Study|Lost to Follow-up|0|||
23589563|NCT02751580|65886109|FG000|Overall Study|Lost to Follow-up|4|||
23589564|NCT02751580|65886109|FG000|Overall Study|Death|2|||
23589565|NCT03058991|65886110|FG000|Overall Study|Lost to Follow-up|17|||
23589566|NCT03058991|65886111|FG001|Overall Study|Lost to Follow-up|12|||
23589567|NCT03058991|65886112|FG002|Overall Study|Lost to Follow-up|12|||
23589568|NCT03058991|65886110|FG000|Overall Study|Withdrawal by Subject|1|||
23589569|NCT03058991|65886111|FG001|Overall Study|Withdrawal by Subject|0|||
23589570|NCT03058991|65886112|FG002|Overall Study|Withdrawal by Subject|0|||
23589571|NCT01897233|65886113|FG000|Part B (24 Weeks)|Adverse Event|1|||
23589572|NCT01897233|65886113|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
23191431|NCT03976401|64442359|FG004|Overall Study|Adverse Event|1|||
23475357|NCT01237899|65485373|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
23475358|NCT01237899|65485374|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
23475359|NCT01237899|65485375|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
23475360|NCT01237899|65485376|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
23475361|NCT01237899|65485377|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
23475362|NCT01237899|65485378|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
23475363|NCT01237899|65485379|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
23475364|NCT01237899|65485380|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
23475365|NCT01237899|65485381|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
23475366|NCT01237899|65485382|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
23475367|NCT01237899|65485383|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
23475368|NCT03337490|65485385|FG000|Overall Study|Withdrawal by Subject|1|||
23475369|NCT03337490|65485386|FG001|Overall Study|Withdrawal by Subject|0|||
23475370|NCT03337490|65485387|FG002|Overall Study|Withdrawal by Subject|0|||
23475371|NCT03337490|65485385|FG000|Overall Study|Lack of Efficacy|10|||
23475372|NCT03337490|65485386|FG001|Overall Study|Lack of Efficacy|12|||
23475373|NCT03337490|65485387|FG002|Overall Study|Lack of Efficacy|35|||
23475374|NCT03337490|65485385|FG000|Overall Study|Physician Decision|0|||
23475375|NCT03337490|65485386|FG001|Overall Study|Physician Decision|1|||
23475376|NCT03337490|65485387|FG002|Overall Study|Physician Decision|0|||
23475377|NCT03337490|65485385|FG000|Overall Study|Lost to Follow-up|0|||
23475378|NCT03337490|65485386|FG001|Overall Study|Lost to Follow-up|1|||
23475379|NCT03337490|65485387|FG002|Overall Study|Lost to Follow-up|0|||
23475380|NCT01536392|65485393|FG000|Overall Study|Adverse Event|2|||
23475381|NCT01536392|65485394|FG001|Overall Study|Adverse Event|2|||
23475382|NCT01536392|65485393|FG000|Overall Study|Physician Decision|2|||
23475383|NCT01536392|65485394|FG001|Overall Study|Physician Decision|3|||
23475384|NCT01536392|65485393|FG000|Overall Study|Withdrawal by Subject|3|||
23475385|NCT01536392|65485394|FG001|Overall Study|Withdrawal by Subject|6|||
23475386|NCT01536392|65485393|FG000|Overall Study|Non Compliance|3|||
23475387|NCT01536392|65485394|FG001|Overall Study|Non Compliance|4|||
23475388|NCT01536392|65485393|FG000|Overall Study|Completed therapy early|3|||
23475389|NCT01536392|65485394|FG001|Overall Study|Completed therapy early|0|||
23475390|NCT01433250|65485395|FG000|Overall Study|Protocol Violation|0|||
23475391|NCT01433250|65485396|FG001|Overall Study|Protocol Violation|1|||
23475392|NCT01433250|65485395|FG000|Overall Study|Withdrawal by Subject|3|||
23475393|NCT01433250|65485396|FG001|Overall Study|Withdrawal by Subject|2|||
23191432|NCT03976401|64442360|FG005|Overall Study|Adverse Event|0|||
23191433|NCT03976401|64442355|FG000|Overall Study|Withdrawal by Subject|0|||
23475394|NCT00003472|65485405|FG000|Overall Study|Not evaluable|3|||
23475395|NCT04359901|65485406|FG000|Overall Study|Withdrawal by Subject|0|||
23475396|NCT04359901|65485407|FG001|Overall Study|Withdrawal by Subject|1|||
23191434|NCT03976401|64442356|FG001|Overall Study|Withdrawal by Subject|1|||
23475397|NCT04359901|65485406|FG000|Overall Study|Death|6|||
23475398|NCT04359901|65485407|FG001|Overall Study|Death|2|||
23475399|NCT02577887|65485408|FG000|Overall Study|Death|93|||
23475400|NCT02577887|65485408|FG000|Overall Study|Protocol Violation|125|||
23589573|NCT01897233|65886113|FG000|Part B (24 Weeks)|Physician Decision|1|||
23589574|NCT02685033|65886114|FG000|Overall Study|Withdrawal of Consent|0|||
23589575|NCT02685033|65886115|FG001|Overall Study|Withdrawal of Consent|1|||
23589576|NCT02685033|65886114|FG000|Overall Study|Lost to Follow-up|2|||
23589577|NCT02685033|65886115|FG001|Overall Study|Lost to Follow-up|1|||
23589578|NCT02685033|65886114|FG000|Overall Study|Adverse Event|1|||
23589579|NCT02685033|65886115|FG001|Overall Study|Adverse Event|0|||
23589580|NCT01241292|65886116|FG000|Overall Study|Administrative Reason by Sponsor|1|||
23589581|NCT01241292|65886117|FG001|Overall Study|Administrative Reason by Sponsor|0|||
23589582|NCT01241292|65886116|FG000|Overall Study|Disease Progression|2|||
23589583|NCT01241292|65886117|FG001|Overall Study|Disease Progression|0|||
23589584|NCT01241292|65886116|FG000|Overall Study|Study Drug Toxicity|0|||
23589585|NCT01241292|65886117|FG001|Overall Study|Study Drug Toxicity|1|||
23589586|NCT01241292|65886116|FG000|Overall Study|Participant Discontinued Treatment|0|||
23589587|NCT01241292|65886117|FG001|Overall Study|Participant Discontinued Treatment|2|||
23589588|NCT05274217|65886122|FG000|Overall Study|Study terminated.|11|||
23589589|NCT05274217|65886123|FG001|Overall Study|Study terminated.|0|||
23589590|NCT04033432|65886124|FG000|Overall Study|Progressive Disease|8|||
23589591|NCT04033432|65886124|FG000|Overall Study|Adverse Event|4|||
23589592|NCT04033432|65886124|FG000|Overall Study|Death|1|||
23589593|NCT02104765|65886127|FG000|Overall Study|Lost to Follow-up|0|||
23589594|NCT02104765|65886128|FG001|Overall Study|Lost to Follow-up|0|||
23589595|NCT02104765|65886129|FG002|Overall Study|Lost to Follow-up|1|||
23589596|NCT02104765|65886130|FG003|Overall Study|Lost to Follow-up|0|||
23589597|NCT02104765|65886131|FG004|Overall Study|Lost to Follow-up|0|||
23589598|NCT02104765|65886132|FG005|Overall Study|Lost to Follow-up|0|||
23191435|NCT03976401|64442357|FG002|Overall Study|Withdrawal by Subject|0|||
23191436|NCT03976401|64442358|FG003|Overall Study|Withdrawal by Subject|0|||
23191437|NCT03976401|64442359|FG004|Overall Study|Withdrawal by Subject|0|||
23191438|NCT03976401|64442360|FG005|Overall Study|Withdrawal by Subject|1|||
23252160|NCT04603937|64665488|FG000|Overall Study|Lost to Follow-up|5|||
23252161|NCT04603937|64665489|FG001|Overall Study|Lost to Follow-up|6|||
23252162|NCT04603937|64665488|FG000|Overall Study|Physician Decision|0|||
23358166|NCT02173379|65056198|FG000|Overall Study|Withdrawal by Subject|24|||
23358167|NCT02173379|65056199|FG001|Overall Study|Withdrawal by Subject|29|||
23358168|NCT02173379|65056198|FG000|Overall Study|Physician Decision|8|||
23358169|NCT02173379|65056199|FG001|Overall Study|Physician Decision|8|||
23358170|NCT02173379|65056198|FG000|Overall Study|Death|75|||
23358171|NCT02173379|65056199|FG001|Overall Study|Death|72|||
23358172|NCT02173379|65056198|FG000|Overall Study|Other Reason|1|||
23358173|NCT02173379|65056199|FG001|Overall Study|Other Reason|0|||
23358174|NCT00531947|65056202|FG000|Overall Study|Adverse Event|5|||
23358175|NCT00531947|65056203|FG001|Overall Study|Adverse Event|10|||
23358176|NCT00531947|65056202|FG000|Overall Study|Lost to Follow-up|12|||
23358177|NCT00531947|65056203|FG001|Overall Study|Lost to Follow-up|9|||
23358178|NCT00531947|65056202|FG000|Overall Study|Withdrawal by Subject|14|||
23358179|NCT00531947|65056203|FG001|Overall Study|Withdrawal by Subject|19|||
23358180|NCT00531947|65056202|FG000|Overall Study|Protocol Violation|2|||
23358181|NCT00531947|65056203|FG001|Overall Study|Protocol Violation|1|||
23358182|NCT00531947|65056202|FG000|Overall Study|Non-Compliance|4|||
23358183|NCT00531947|65056203|FG001|Overall Study|Non-Compliance|7|||
23358184|NCT00531947|65056202|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
23358185|NCT00531947|65056203|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
23358186|NCT02942277|65056207|FG000|Year 1|Withdrawal by Subject|0|||
23358187|NCT02942277|65056208|FG001|Year 1|Withdrawal by Subject|0|||
23358188|NCT02942277|65056209|FG002|Year 1|Withdrawal by Subject|0|||
23358189|NCT02942277|65056210|FG003|Year 1|Withdrawal by Subject|0|||
23358190|NCT02942277|65056211|FG004|Year 1|Withdrawal by Subject|1|||
23358191|NCT02942277|65056212|FG005|Year 1|Withdrawal by Subject|3|||
23358192|NCT02942277|65056213|FG006|Year 1|Withdrawal by Subject|0|||
23358193|NCT02942277|65056214|FG007|Year 1|Withdrawal by Subject|1|||
23358194|NCT02942277|65056215|FG008|Year 1|Withdrawal by Subject|0|||
23358195|NCT02942277|65056216|FG009|Year 1|Withdrawal by Subject|0|||
23358196|NCT02942277|65056217|FG010|Year 1|Withdrawal by Subject|3|||
23358197|NCT02942277|65056207|FG000|Year 1|Travel|0|||
23358198|NCT02942277|65056208|FG001|Year 1|Travel|1|||
23358199|NCT02942277|65056209|FG002|Year 1|Travel|0|||
23358200|NCT02942277|65056210|FG003|Year 1|Travel|0|||
23358201|NCT02942277|65056211|FG004|Year 1|Travel|4|||
23358202|NCT02942277|65056212|FG005|Year 1|Travel|5|||
23358203|NCT02942277|65056213|FG006|Year 1|Travel|0|||
23358204|NCT02942277|65056214|FG007|Year 1|Travel|0|||
23358205|NCT02942277|65056215|FG008|Year 1|Travel|0|||
23358206|NCT02942277|65056216|FG009|Year 1|Travel|0|||
23358207|NCT02942277|65056217|FG010|Year 1|Travel|8|||
23358208|NCT02942277|65056207|FG000|Year 1|Joined Army|0|||
23589599|NCT02104765|65886133|FG006|Overall Study|Lost to Follow-up|0|||
23589600|NCT02104765|65886127|FG000|Overall Study|Withdrawal by Subject|0|||
23589601|NCT02104765|65886128|FG001|Overall Study|Withdrawal by Subject|0|||
23589602|NCT02104765|65886129|FG002|Overall Study|Withdrawal by Subject|0|||
23589603|NCT02104765|65886130|FG003|Overall Study|Withdrawal by Subject|1|||
23589604|NCT02104765|65886131|FG004|Overall Study|Withdrawal by Subject|1|||
23589605|NCT02104765|65886132|FG005|Overall Study|Withdrawal by Subject|0|||
23589606|NCT02104765|65886133|FG006|Overall Study|Withdrawal by Subject|1|||
23589607|NCT00082810|65886134|FG000|Overall Study|Adverse Event|3|||
23589608|NCT00082810|65886134|FG000|Overall Study|Progressive disease|24|||
23589609|NCT00082810|65886134|FG000|Overall Study|Withdrawal by Subject|4|||
23589610|NCT02232178|65886135|FG000|Overall Study|Lost to Follow-up|0|||
23589611|NCT02232178|65886136|FG001|Overall Study|Lost to Follow-up|1|||
23589612|NCT02232178|65886137|FG002|Overall Study|Lost to Follow-up|0|||
23589613|NCT02232178|65886135|FG000|Overall Study|ineligibility|0|||
23589614|NCT02232178|65886136|FG001|Overall Study|ineligibility|0|||
23589615|NCT02232178|65886137|FG002|Overall Study|ineligibility|1|||
23191439|NCT03976401|64442355|FG000|Overall Study|Physician Decision|0|||
23191440|NCT03976401|64442356|FG001|Overall Study|Physician Decision|0|||
23191441|NCT03976401|64442357|FG002|Overall Study|Physician Decision|1|||
23252163|NCT04603937|64665489|FG001|Overall Study|Physician Decision|1|||
23475401|NCT02577887|65485408|FG000|Overall Study|Withdrawal by Subject|80|||
23475402|NCT00796523|65485409|FG000|Overall Study|Lost to Follow-up|9|||
23475403|NCT00796523|65485410|FG001|Overall Study|Lost to Follow-up|7|||
23475404|NCT04268823|65485413|FG000|Overall Study|Adverse Event|1|||
23475405|NCT04268823|65485414|FG001|Overall Study|Adverse Event|0|||
23475406|NCT04268823|65485413|FG000|Overall Study|Participant Decision|1|||
23475407|NCT04268823|65485414|FG001|Overall Study|Participant Decision|0|||
23475408|NCT01865552|65485415|FG000|Period 1|Adverse Event|1|||
23475409|NCT01865552|65485416|FG001|Period 1|Adverse Event|0|||
23475410|NCT01865552|65485417|FG002|Period 1|Adverse Event|0|||
23475411|NCT01865552|65485418|FG003|Period 1|Adverse Event|1|||
23475412|NCT01865552|65485419|FG004|Period 1|Adverse Event|1|||
23475413|NCT01865552|65485420|FG005|Period 1|Adverse Event|1|||
23475414|NCT01865552|65485415|FG000|Period 1|Pathological lab|0|||
23475415|NCT01865552|65485416|FG001|Period 1|Pathological lab|0|||
23475416|NCT01865552|65485417|FG002|Period 1|Pathological lab|0|||
23475417|NCT01865552|65485418|FG003|Period 1|Pathological lab|0|||
23475418|NCT01865552|65485419|FG004|Period 1|Pathological lab|1|||
23475419|NCT01865552|65485420|FG005|Period 1|Pathological lab|0|||
23475420|NCT01865552|65485415|FG000|Period 1|Other|0|||
23475421|NCT01865552|65485416|FG001|Period 1|Other|0|||
23475422|NCT01865552|65485417|FG002|Period 1|Other|0|||
23475423|NCT01865552|65485418|FG003|Period 1|Other|0|||
23475424|NCT01865552|65485419|FG004|Period 1|Other|1|||
23475425|NCT01865552|65485420|FG005|Period 1|Other|0|||
23475426|NCT01284491|65485421|FG000|Overall Study|Study termination|13|||
23475427|NCT00717236|65485422|FG000|Double-Blind Period|Adverse Event|33|||
23475428|NCT00717236|65485423|FG001|Double-Blind Period|Adverse Event|6|||
23475429|NCT00717236|65485422|FG000|Double-Blind Period|Lack of Efficacy|6|||
23475430|NCT00717236|65485423|FG001|Double-Blind Period|Lack of Efficacy|6|||
23475431|NCT00717236|65485422|FG000|Double-Blind Period|Lost to Follow-up|3|||
23475432|NCT00717236|65485423|FG001|Double-Blind Period|Lost to Follow-up|5|||
23475433|NCT00717236|65485422|FG000|Double-Blind Period|Withdrawal by Subject|10|||
23475434|NCT00717236|65485423|FG001|Double-Blind Period|Withdrawal by Subject|2|||
23475435|NCT00717236|65485422|FG000|Double-Blind Period|Loss of efficacy|3|||
23475436|NCT00717236|65485423|FG001|Double-Blind Period|Loss of efficacy|0|||
23475437|NCT00717236|65485422|FG000|Double-Blind Period|Other: Death|1|||
23475438|NCT00717236|65485423|FG001|Double-Blind Period|Other: Death|0|||
23475439|NCT00717236|65485422|FG000|Double-Blind Period|Other: Pregnancy|1|||
23475440|NCT00717236|65485423|FG001|Double-Blind Period|Other: Pregnancy|0|||
23475441|NCT00717236|65485422|FG000|Double-Blind Period|Other: Protocol Violation|2|||
23475442|NCT00717236|65485423|FG001|Double-Blind Period|Other: Protocol Violation|0|||
23475443|NCT00717236|65485422|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
23475444|NCT00717236|65485423|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
23475445|NCT00717236|65485422|FG000|Double-Blind Period|Other: Site withdrew|2|||
23475446|NCT00717236|65485423|FG001|Double-Blind Period|Other: Site withdrew|0|||
23589616|NCT02232178|65886135|FG000|Overall Study|surgical complication|1|||
23589617|NCT02232178|65886136|FG001|Overall Study|surgical complication|0|||
23589618|NCT02232178|65886137|FG002|Overall Study|surgical complication|0|||
23191442|NCT03976401|64442358|FG003|Overall Study|Physician Decision|0|||
23191443|NCT03976401|64442359|FG004|Overall Study|Physician Decision|0|||
23191444|NCT03976401|64442360|FG005|Overall Study|Physician Decision|0|||
23191445|NCT03976401|64442355|FG000|Overall Study|Lost to Follow-up|1|||
23191446|NCT03976401|64442356|FG001|Overall Study|Lost to Follow-up|2|||
23191447|NCT03976401|64442357|FG002|Overall Study|Lost to Follow-up|0|||
23191448|NCT03976401|64442358|FG003|Overall Study|Lost to Follow-up|0|||
23191449|NCT03976401|64442359|FG004|Overall Study|Lost to Follow-up|0|||
23191450|NCT03976401|64442360|FG005|Overall Study|Lost to Follow-up|0|||
23191451|NCT03976401|64442355|FG000|Overall Study|Protocol Violation|0|||
23191452|NCT03976401|64442356|FG001|Overall Study|Protocol Violation|1|||
23191453|NCT03976401|64442357|FG002|Overall Study|Protocol Violation|0|||
23191454|NCT03976401|64442358|FG003|Overall Study|Protocol Violation|0|||
23191455|NCT03976401|64442359|FG004|Overall Study|Protocol Violation|0|||
23191456|NCT03976401|64442360|FG005|Overall Study|Protocol Violation|0|||
23191457|NCT03976401|64442355|FG000|Overall Study|Withdrew Consent|0|||
23191458|NCT03976401|64442356|FG001|Overall Study|Withdrew Consent|0|||
23191459|NCT03976401|64442357|FG002|Overall Study|Withdrew Consent|0|||
23191460|NCT03976401|64442358|FG003|Overall Study|Withdrew Consent|1|||
23589619|NCT02551055|65886138|FG000|Overall Study|Death|2|||
23589620|NCT02551055|65886139|FG001|Overall Study|Death|4|||
23589621|NCT02551055|65886140|FG002|Overall Study|Death|2|||
23589622|NCT02551055|65886141|FG003|Overall Study|Death|2|||
23589623|NCT02551055|65886142|FG004|Overall Study|Death|2|||
23589624|NCT02551055|65886143|FG005|Overall Study|Death|1|||
23252164|NCT04603937|64665488|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
23252165|NCT04603937|64665489|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
23252166|NCT00738920|64665493|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
23252167|NCT00738920|64665494|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
23252168|NCT00738920|64665495|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
23252169|NCT00738920|64665493|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
23252170|NCT00738920|64665494|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
23252171|NCT00738920|64665495|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
23252172|NCT00738920|64665493|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
23252173|NCT00738920|64665494|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
23252174|NCT00738920|64665495|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
23252175|NCT00738920|64665493|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
23252176|NCT00738920|64665494|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
23252177|NCT00738920|64665495|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
23252178|NCT00738920|64665493|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
23252179|NCT00738920|64665494|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
23252180|NCT00738920|64665495|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
23252181|NCT00738920|64665493|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
23252182|NCT00738920|64665494|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
23252183|NCT00738920|64665495|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
23252184|NCT00738920|64665493|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
23252185|NCT00738920|64665494|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
23252186|NCT00738920|64665495|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
23252187|NCT00738920|64665493|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
23252188|NCT00738920|64665494|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
23252189|NCT00738920|64665495|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
23252190|NCT00738920|64665493|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
23252191|NCT00738920|64665494|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
23252192|NCT00738920|64665495|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
23252193|NCT00738920|64665493|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
23252194|NCT00738920|64665494|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
23252195|NCT00738920|64665495|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
23252196|NCT02567266|64665500|FG000|Overall Study|Withdrawal by Subject|10|||
23252197|NCT02567266|64665501|FG001|Overall Study|Withdrawal by Subject|7|||
23252198|NCT02567266|64665502|FG002|Overall Study|Withdrawal by Subject|6|||
23252199|NCT02567266|64665500|FG000|Overall Study|Lost to Follow-up|13|||
23252200|NCT02567266|64665501|FG001|Overall Study|Lost to Follow-up|8|||
23252201|NCT02567266|64665502|FG002|Overall Study|Lost to Follow-up|10|||
23252202|NCT01864525|64665503|FG000|Overall Study|Adverse Event|1|||
23252203|NCT01864525|64665504|FG001|Overall Study|Adverse Event|0|||
23252204|NCT01563029|64665505|FG000|Overall Study|Adverse Event|1|||
23252205|NCT01563029|64665506|FG001|Overall Study|Adverse Event|0|||
23252206|NCT01563029|64665507|FG002|Overall Study|Adverse Event|1|||
23252207|NCT01563029|64665508|FG003|Overall Study|Adverse Event|2|||
23252208|NCT01563029|64665509|FG004|Overall Study|Adverse Event|1|||
23252209|NCT01563029|64665505|FG000|Overall Study|Lack of Efficacy|42|||
23252210|NCT01563029|64665506|FG001|Overall Study|Lack of Efficacy|16|||
23252211|NCT01563029|64665507|FG002|Overall Study|Lack of Efficacy|23|||
23252212|NCT01563029|64665508|FG003|Overall Study|Lack of Efficacy|21|||
23252213|NCT01563029|64665509|FG004|Overall Study|Lack of Efficacy|19|||
23252214|NCT01563029|64665505|FG000|Overall Study|Protocol Violation|1|||
23252215|NCT01563029|64665506|FG001|Overall Study|Protocol Violation|2|||
23252216|NCT01563029|64665507|FG002|Overall Study|Protocol Violation|3|||
23252217|NCT01563029|64665508|FG003|Overall Study|Protocol Violation|1|||
23252218|NCT01563029|64665509|FG004|Overall Study|Protocol Violation|3|||
23252219|NCT01563029|64665505|FG000|Overall Study|Protocol defined stopping criteria|1|||
23252220|NCT01563029|64665506|FG001|Overall Study|Protocol defined stopping criteria|0|||
23252221|NCT01563029|64665507|FG002|Overall Study|Protocol defined stopping criteria|0|||
23252222|NCT01563029|64665508|FG003|Overall Study|Protocol defined stopping criteria|0|||
23252223|NCT01563029|64665509|FG004|Overall Study|Protocol defined stopping criteria|0|||
23252224|NCT01563029|64665505|FG000|Overall Study|Lost to Follow-up|1|||
23252225|NCT01563029|64665506|FG001|Overall Study|Lost to Follow-up|0|||
23252226|NCT01563029|64665507|FG002|Overall Study|Lost to Follow-up|1|||
23252227|NCT01563029|64665508|FG003|Overall Study|Lost to Follow-up|1|||
23589625|NCT02551055|65886144|FG006|Overall Study|Death|2|||
23589626|NCT02551055|65886145|FG007|Overall Study|Death|0|||
23252228|NCT01563029|64665509|FG004|Overall Study|Lost to Follow-up|1|||
23252229|NCT01563029|64665505|FG000|Overall Study|Physician Decision|3|||
23252230|NCT01563029|64665506|FG001|Overall Study|Physician Decision|5|||
23252231|NCT01563029|64665507|FG002|Overall Study|Physician Decision|2|||
23252232|NCT01563029|64665508|FG003|Overall Study|Physician Decision|4|||
23252233|NCT01563029|64665509|FG004|Overall Study|Physician Decision|2|||
23358209|NCT02942277|65056208|FG001|Year 1|Joined Army|1|||
23358210|NCT02942277|65056209|FG002|Year 1|Joined Army|0|||
23358211|NCT02942277|65056210|FG003|Year 1|Joined Army|0|||
23358212|NCT02942277|65056211|FG004|Year 1|Joined Army|0|||
23358213|NCT02942277|65056212|FG005|Year 1|Joined Army|0|||
23358214|NCT02942277|65056213|FG006|Year 1|Joined Army|0|||
23358215|NCT02942277|65056214|FG007|Year 1|Joined Army|0|||
23358216|NCT02942277|65056215|FG008|Year 1|Joined Army|0|||
23358217|NCT02942277|65056216|FG009|Year 1|Joined Army|0|||
23358218|NCT02942277|65056217|FG010|Year 1|Joined Army|0|||
23358219|NCT02942277|65056207|FG000|Year 1|Subject met withdrawal criteria|0|||
23358220|NCT02942277|65056208|FG001|Year 1|Subject met withdrawal criteria|0|||
23358221|NCT02942277|65056209|FG002|Year 1|Subject met withdrawal criteria|0|||
23358222|NCT02942277|65056210|FG003|Year 1|Subject met withdrawal criteria|1|||
23358223|NCT02942277|65056211|FG004|Year 1|Subject met withdrawal criteria|0|||
23358224|NCT02942277|65056212|FG005|Year 1|Subject met withdrawal criteria|0|||
23358225|NCT02942277|65056213|FG006|Year 1|Subject met withdrawal criteria|0|||
23475447|NCT00717236|65485422|FG000|Double-Blind Period|Other: Screening failure|1|||
23475448|NCT00717236|65485423|FG001|Double-Blind Period|Other: Screening failure|0|||
23475449|NCT00717236|65485422|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
23475450|NCT00717236|65485423|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
23475451|NCT00717236|65485422|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
23475452|NCT00717236|65485423|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
23475453|NCT00717236|65485422|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
23475454|NCT00717236|65485423|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
23475455|NCT00717236|65485422|FG000|Double-Blind Period|Other: History of cancer|1|||
23475456|NCT00717236|65485423|FG001|Double-Blind Period|Other: History of cancer|0|||
23475457|NCT00717236|65485422|FG000|Double-Blind Period|Other: Sponsor request|1|||
23475458|NCT00717236|65485423|FG001|Double-Blind Period|Other: Sponsor request|0|||
23475459|NCT00717236|65485422|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
23475460|NCT00717236|65485423|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
23475461|NCT00717236|65485422|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
23475462|NCT00717236|65485423|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
23475463|NCT00717236|65485422|FG000|Double-Blind Period|Other: Subject moved|1|||
23475464|NCT00717236|65485423|FG001|Double-Blind Period|Other: Subject moved|1|||
23475465|NCT00717236|65485422|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
23475466|NCT00717236|65485423|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
23475467|NCT00717236|65485422|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
23475468|NCT00717236|65485423|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
23475469|NCT00717236|65485422|FG000|Double-Blind Period|Other: Transportation problems|0|||
23475470|NCT00717236|65485423|FG001|Double-Blind Period|Other: Transportation problems|1|||
23475471|NCT00717236|65485422|FG000|Double-Blind Period|Other: Investigator Decision|0|||
23252234|NCT01563029|64665505|FG000|Overall Study|Withdrawal by Subject|4|||
23252235|NCT01563029|64665506|FG001|Overall Study|Withdrawal by Subject|1|||
23252236|NCT01563029|64665507|FG002|Overall Study|Withdrawal by Subject|3|||
23252237|NCT01563029|64665508|FG003|Overall Study|Withdrawal by Subject|4|||
23252238|NCT01563029|64665509|FG004|Overall Study|Withdrawal by Subject|3|||
23252239|NCT01299272|64665510|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
23252240|NCT01299272|64665511|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
23252241|NCT01299272|64665512|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
23252242|NCT01299272|64665513|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
23252243|NCT01299272|64665510|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
23252244|NCT01299272|64665511|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
23252245|NCT01299272|64665512|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
23252246|NCT01299272|64665513|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
23252247|NCT01299272|64665510|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
23252248|NCT01299272|64665511|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
23252249|NCT01299272|64665512|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
23358226|NCT02942277|65056214|FG007|Year 1|Subject met withdrawal criteria|0|||
23475472|NCT00717236|65485423|FG001|Double-Blind Period|Other: Investigator Decision|1|||
23475473|NCT00717236|65485422|FG000|Open-Label Period|Adverse Event|29|||
23475474|NCT00717236|65485423|FG001|Open-Label Period|Adverse Event|4|||
23358227|NCT02942277|65056215|FG008|Year 1|Subject met withdrawal criteria|0|||
23358228|NCT02942277|65056216|FG009|Year 1|Subject met withdrawal criteria|0|||
23475475|NCT00717236|65485422|FG000|Open-Label Period|Lack of Efficacy|30|||
23358229|NCT02942277|65056217|FG010|Year 1|Subject met withdrawal criteria|0|||
23252250|NCT01299272|64665513|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
23358230|NCT02942277|65056207|FG000|Year 1|Lost to Follow-up|0|||
23358231|NCT02942277|65056208|FG001|Year 1|Lost to Follow-up|0|||
23358232|NCT02942277|65056209|FG002|Year 1|Lost to Follow-up|0|||
23358233|NCT02942277|65056210|FG003|Year 1|Lost to Follow-up|0|||
23358234|NCT02942277|65056211|FG004|Year 1|Lost to Follow-up|1|||
23358235|NCT02942277|65056212|FG005|Year 1|Lost to Follow-up|0|||
23358236|NCT02942277|65056213|FG006|Year 1|Lost to Follow-up|0|||
23358237|NCT02942277|65056214|FG007|Year 1|Lost to Follow-up|0|||
23358238|NCT02942277|65056215|FG008|Year 1|Lost to Follow-up|0|||
23358239|NCT02942277|65056216|FG009|Year 1|Lost to Follow-up|0|||
23358240|NCT02942277|65056217|FG010|Year 1|Lost to Follow-up|2|||
23358241|NCT02942277|65056207|FG000|Year 1|Protocol Violation|0|||
23358242|NCT02942277|65056208|FG001|Year 1|Protocol Violation|0|||
23358243|NCT02942277|65056209|FG002|Year 1|Protocol Violation|0|||
23358244|NCT02942277|65056210|FG003|Year 1|Protocol Violation|0|||
23358245|NCT02942277|65056211|FG004|Year 1|Protocol Violation|1|||
23358246|NCT02942277|65056212|FG005|Year 1|Protocol Violation|1|||
23358247|NCT02942277|65056213|FG006|Year 1|Protocol Violation|0|||
23358248|NCT02942277|65056214|FG007|Year 1|Protocol Violation|0|||
23358249|NCT02942277|65056215|FG008|Year 1|Protocol Violation|0|||
23358250|NCT02942277|65056216|FG009|Year 1|Protocol Violation|0|||
23358251|NCT02942277|65056217|FG010|Year 1|Protocol Violation|2|||
23358252|NCT02942277|65056207|FG000|Year 1|Pregnancy|0|||
23358253|NCT02942277|65056208|FG001|Year 1|Pregnancy|0|||
23358254|NCT02942277|65056209|FG002|Year 1|Pregnancy|0|||
23589627|NCT02551055|65886138|FG000|Overall Study|Study Terminated by Sponsor|1|||
23252251|NCT01299272|64665510|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
23252252|NCT01299272|64665511|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
23252253|NCT01299272|64665512|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
23252254|NCT01299272|64665513|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
23252255|NCT01299272|64665510|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
23252256|NCT01299272|64665511|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
23252257|NCT01299272|64665512|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
23252258|NCT01299272|64665513|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
23252259|NCT01299272|64665510|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
23252260|NCT01299272|64665511|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
23252261|NCT01299272|64665512|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
23252262|NCT01299272|64665513|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
23252263|NCT01299272|64665510|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
23252264|NCT01299272|64665511|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
23252265|NCT01299272|64665512|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
23252266|NCT01299272|64665513|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
23252267|NCT01299272|64665510|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
23252268|NCT01299272|64665511|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
23252269|NCT01299272|64665512|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
23252270|NCT01299272|64665513|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
23252271|NCT01299272|64665510|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
23252272|NCT01299272|64665511|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
23252273|NCT01299272|64665512|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
23252274|NCT01299272|64665513|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
23252275|NCT01299272|64665510|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
23252276|NCT01299272|64665511|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
23252277|NCT01299272|64665512|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
23252278|NCT01299272|64665513|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
23252279|NCT01299272|64665510|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
23252280|NCT01299272|64665511|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
23252281|NCT01299272|64665512|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
23252282|NCT01299272|64665513|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
23252283|NCT01299272|64665510|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
23252284|NCT01299272|64665511|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
23252285|NCT01299272|64665512|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
23252286|NCT01299272|64665513|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
23252287|NCT01299272|64665510|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
23252288|NCT01299272|64665511|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
23252289|NCT01299272|64665512|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
23252290|NCT01299272|64665513|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
23358255|NCT02942277|65056210|FG003|Year 1|Pregnancy|0|||
23358256|NCT02942277|65056211|FG004|Year 1|Pregnancy|0|||
23358257|NCT02942277|65056212|FG005|Year 1|Pregnancy|1|||
23358258|NCT02942277|65056213|FG006|Year 1|Pregnancy|0|||
23358259|NCT02942277|65056214|FG007|Year 1|Pregnancy|0|||
23358260|NCT02942277|65056215|FG008|Year 1|Pregnancy|0|||
23358261|NCT02942277|65056216|FG009|Year 1|Pregnancy|0|||
23358262|NCT02942277|65056217|FG010|Year 1|Pregnancy|0|||
23358263|NCT02942277|65056207|FG000|Year 2|Lost to Follow-up|0|||
23358264|NCT02942277|65056208|FG001|Year 2|Lost to Follow-up|0|||
23358265|NCT02942277|65056209|FG002|Year 2|Lost to Follow-up|0|||
23358266|NCT02942277|65056210|FG003|Year 2|Lost to Follow-up|0|||
23358267|NCT02942277|65056211|FG004|Year 2|Lost to Follow-up|2|||
23358268|NCT02942277|65056212|FG005|Year 2|Lost to Follow-up|1|||
23358269|NCT02942277|65056213|FG006|Year 2|Lost to Follow-up|0|||
23358270|NCT02942277|65056214|FG007|Year 2|Lost to Follow-up|0|||
23358271|NCT02942277|65056215|FG008|Year 2|Lost to Follow-up|0|||
23358272|NCT02942277|65056216|FG009|Year 2|Lost to Follow-up|0|||
23358273|NCT02942277|65056217|FG010|Year 2|Lost to Follow-up|0|||
23358274|NCT02942277|65056207|FG000|Year 2|Did not rescreen|0|||
23358275|NCT02942277|65056208|FG001|Year 2|Did not rescreen|0|||
23358276|NCT02942277|65056209|FG002|Year 2|Did not rescreen|1|||
23358277|NCT02942277|65056210|FG003|Year 2|Did not rescreen|1|||
23358278|NCT02942277|65056211|FG004|Year 2|Did not rescreen|9|||
23358279|NCT02942277|65056212|FG005|Year 2|Did not rescreen|6|||
23358280|NCT02942277|65056213|FG006|Year 2|Did not rescreen|0|||
23358281|NCT02942277|65056214|FG007|Year 2|Did not rescreen|1|||
23358282|NCT02942277|65056215|FG008|Year 2|Did not rescreen|0|||
23358283|NCT02942277|65056216|FG009|Year 2|Did not rescreen|0|||
23358284|NCT02942277|65056217|FG010|Year 2|Did not rescreen|21|||
23358285|NCT02942277|65056207|FG000|Year 2|Met withdrawal criteria|0|||
23358286|NCT02942277|65056208|FG001|Year 2|Met withdrawal criteria|0|||
23358287|NCT02942277|65056209|FG002|Year 2|Met withdrawal criteria|0|||
23252291|NCT01299272|64665510|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
23252292|NCT01299272|64665511|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
23358288|NCT02942277|65056210|FG003|Year 2|Met withdrawal criteria|0|||
23358289|NCT02942277|65056211|FG004|Year 2|Met withdrawal criteria|1|||
23358290|NCT02942277|65056212|FG005|Year 2|Met withdrawal criteria|2|||
23358291|NCT02942277|65056213|FG006|Year 2|Met withdrawal criteria|0|||
23589628|NCT02551055|65886139|FG001|Overall Study|Study Terminated by Sponsor|1|||
23589629|NCT02551055|65886140|FG002|Overall Study|Study Terminated by Sponsor|0|||
23589630|NCT02551055|65886141|FG003|Overall Study|Study Terminated by Sponsor|2|||
23589631|NCT02551055|65886142|FG004|Overall Study|Study Terminated by Sponsor|2|||
23358292|NCT02942277|65056214|FG007|Year 2|Met withdrawal criteria|0|||
23358293|NCT02942277|65056215|FG008|Year 2|Met withdrawal criteria|0|||
23358294|NCT02942277|65056216|FG009|Year 2|Met withdrawal criteria|0|||
23358295|NCT02942277|65056217|FG010|Year 2|Met withdrawal criteria|1|||
23589632|NCT02551055|65886143|FG005|Overall Study|Study Terminated by Sponsor|0|||
23589633|NCT02551055|65886144|FG006|Overall Study|Study Terminated by Sponsor|0|||
23589634|NCT02551055|65886145|FG007|Overall Study|Study Terminated by Sponsor|0|||
23589635|NCT02551055|65886138|FG000|Overall Study|Withdrawal by Subject|1|||
23589636|NCT02551055|65886139|FG001|Overall Study|Withdrawal by Subject|1|||
23191461|NCT03976401|64442359|FG004|Overall Study|Withdrew Consent|0|||
23358296|NCT02942277|65056207|FG000|Year 2|Travel|0|||
23358297|NCT02942277|65056208|FG001|Year 2|Travel|1|||
23358298|NCT02942277|65056209|FG002|Year 2|Travel|0|||
23358299|NCT02942277|65056210|FG003|Year 2|Travel|0|||
23358300|NCT02942277|65056211|FG004|Year 2|Travel|0|||
23358301|NCT02942277|65056212|FG005|Year 2|Travel|1|||
23358302|NCT02942277|65056213|FG006|Year 2|Travel|0|||
23358303|NCT02942277|65056214|FG007|Year 2|Travel|0|||
23358304|NCT02942277|65056215|FG008|Year 2|Travel|0|||
23358305|NCT02942277|65056216|FG009|Year 2|Travel|1|||
23358306|NCT02942277|65056217|FG010|Year 2|Travel|3|||
23475476|NCT00717236|65485423|FG001|Open-Label Period|Lack of Efficacy|8|||
23475477|NCT00717236|65485422|FG000|Open-Label Period|Lost to Follow-up|28|||
23475478|NCT00717236|65485423|FG001|Open-Label Period|Lost to Follow-up|4|||
23475479|NCT00717236|65485422|FG000|Open-Label Period|Withdrawal by Subject|20|||
23475480|NCT00717236|65485423|FG001|Open-Label Period|Withdrawal by Subject|2|||
23589637|NCT02551055|65886140|FG002|Overall Study|Withdrawal by Subject|0|||
23589638|NCT02551055|65886141|FG003|Overall Study|Withdrawal by Subject|1|||
23589639|NCT02551055|65886142|FG004|Overall Study|Withdrawal by Subject|2|||
23191462|NCT03976401|64442360|FG005|Overall Study|Withdrew Consent|0|||
23358307|NCT02942277|65056207|FG000|Year 2|Non-compliant|0|||
23358308|NCT02942277|65056208|FG001|Year 2|Non-compliant|0|||
23358309|NCT02942277|65056209|FG002|Year 2|Non-compliant|0|||
23358310|NCT02942277|65056210|FG003|Year 2|Non-compliant|0|||
23358311|NCT02942277|65056211|FG004|Year 2|Non-compliant|1|||
23358312|NCT02942277|65056212|FG005|Year 2|Non-compliant|1|||
23358313|NCT02942277|65056213|FG006|Year 2|Non-compliant|0|||
23358314|NCT02942277|65056214|FG007|Year 2|Non-compliant|0|||
23358315|NCT02942277|65056215|FG008|Year 2|Non-compliant|0|||
23358316|NCT02942277|65056216|FG009|Year 2|Non-compliant|0|||
23358317|NCT02942277|65056217|FG010|Year 2|Non-compliant|0|||
23358318|NCT02942277|65056207|FG000|Year 2|Withdrawal by Subject|0|||
23589640|NCT02551055|65886143|FG005|Overall Study|Withdrawal by Subject|0|||
23191463|NCT02436239|64442363|FG000|Open-Lable Treatment Period|Adverse Event|12|||
23191464|NCT02436239|64442364|FG001|Open-Lable Treatment Period|Adverse Event|3|||
23191465|NCT02436239|64442365|FG002|Open-Lable Treatment Period|Adverse Event|4|||
23191466|NCT02436239|64442366|FG003|Open-Lable Treatment Period|Adverse Event|2|||
23191467|NCT02436239|64442363|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
23191468|NCT02436239|64442364|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
23191469|NCT02436239|64442365|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
23358319|NCT02942277|65056208|FG001|Year 2|Withdrawal by Subject|0|||
23358320|NCT02942277|65056209|FG002|Year 2|Withdrawal by Subject|0|||
23358321|NCT02942277|65056210|FG003|Year 2|Withdrawal by Subject|0|||
23358322|NCT02942277|65056211|FG004|Year 2|Withdrawal by Subject|0|||
23358323|NCT02942277|65056212|FG005|Year 2|Withdrawal by Subject|0|||
23358324|NCT02942277|65056213|FG006|Year 2|Withdrawal by Subject|1|||
23589641|NCT02551055|65886144|FG006|Overall Study|Withdrawal by Subject|0|||
23589642|NCT02551055|65886145|FG007|Overall Study|Withdrawal by Subject|0|||
23589643|NCT02551055|65886138|FG000|Overall Study|Reason not specified|0|||
23589644|NCT02551055|65886139|FG001|Overall Study|Reason not specified|0|||
23589645|NCT02551055|65886140|FG002|Overall Study|Reason not specified|0|||
23589646|NCT02551055|65886141|FG003|Overall Study|Reason not specified|0|||
23589647|NCT02551055|65886142|FG004|Overall Study|Reason not specified|1|||
23358325|NCT02942277|65056214|FG007|Year 2|Withdrawal by Subject|0|||
23358326|NCT02942277|65056215|FG008|Year 2|Withdrawal by Subject|0|||
23358327|NCT02942277|65056216|FG009|Year 2|Withdrawal by Subject|0|||
23358328|NCT02942277|65056217|FG010|Year 2|Withdrawal by Subject|0|||
23358329|NCT02782377|65056220|FG000|Overall Study|Physician Decision|5|||
23358330|NCT04399538|65056221|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
23358331|NCT04399538|65056222|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
23358332|NCT04399538|65056223|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
23358333|NCT04399538|65056224|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
23358334|NCT04399538|65056225|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
23358335|NCT04399538|65056221|FG000|Double-Blind Treatment|Adverse Event|0|||
23358336|NCT04399538|65056222|FG001|Double-Blind Treatment|Adverse Event|0|||
23358337|NCT04399538|65056223|FG002|Double-Blind Treatment|Adverse Event|0|||
23358338|NCT04399538|65056224|FG003|Double-Blind Treatment|Adverse Event|0|||
23358339|NCT04399538|65056225|FG004|Double-Blind Treatment|Adverse Event|1|||
23358340|NCT04399538|65056221|FG000|Follow-Up|Adverse Event|0|||
23358341|NCT04399538|65056222|FG001|Follow-Up|Adverse Event|0|||
23358342|NCT04399538|65056223|FG002|Follow-Up|Adverse Event|0|||
23358343|NCT04399538|65056224|FG003|Follow-Up|Adverse Event|0|||
23358344|NCT04399538|65056225|FG004|Follow-Up|Adverse Event|1|||
23358345|NCT04399538|65056221|FG000|Follow-Up|Withdrawal by Subject|0|||
23358346|NCT04399538|65056222|FG001|Follow-Up|Withdrawal by Subject|0|||
23358347|NCT04399538|65056223|FG002|Follow-Up|Withdrawal by Subject|0|||
23358348|NCT04399538|65056224|FG003|Follow-Up|Withdrawal by Subject|2|||
23358349|NCT04399538|65056225|FG004|Follow-Up|Withdrawal by Subject|0|||
23358350|NCT02669043|65056233|FG000|Overall Study|Didn't meet I/E criteria|4|||
23358351|NCT00948922|65056236|FG000|Overall Study|Did not start study treatment|2|||
23358352|NCT00948922|65056237|FG001|Overall Study|Did not start study treatment|5|||
23358353|NCT00948922|65056238|FG002|Overall Study|Did not start study treatment|0|||
23358354|NCT00948922|65056236|FG000|Overall Study|Withdrawal by Subject|0|||
23358355|NCT00948922|65056237|FG001|Overall Study|Withdrawal by Subject|2|||
23358356|NCT00948922|65056238|FG002|Overall Study|Withdrawal by Subject|1|||
23358357|NCT00948922|65056236|FG000|Overall Study|Death|3|||
23358358|NCT00948922|65056237|FG001|Overall Study|Death|0|||
23358359|NCT00948922|65056238|FG002|Overall Study|Death|0|||
23358360|NCT00948922|65056236|FG000|Overall Study|Disease progression|0|||
23358361|NCT00948922|65056237|FG001|Overall Study|Disease progression|1|||
23358362|NCT00948922|65056238|FG002|Overall Study|Disease progression|0|||
23358363|NCT00948922|65056236|FG000|Overall Study|Insurance issues|1|||
23358364|NCT00948922|65056237|FG001|Overall Study|Insurance issues|0|||
23358365|NCT00948922|65056238|FG002|Overall Study|Insurance issues|0|||
23358366|NCT00948922|65056236|FG000|Overall Study|Transplant eligibility issues|2|||
23358367|NCT00948922|65056237|FG001|Overall Study|Transplant eligibility issues|3|||
23358368|NCT00948922|65056238|FG002|Overall Study|Transplant eligibility issues|0|||
23358369|NCT00948922|65056236|FG000|Overall Study|Not evaluable at time of analysis|0|||
23358370|NCT00948922|65056237|FG001|Overall Study|Not evaluable at time of analysis|3|||
23358371|NCT00948922|65056238|FG002|Overall Study|Not evaluable at time of analysis|0|||
23358372|NCT00255164|65056239|FG000|Overall Study|Adverse Event|10|||
23358373|NCT00255164|65056240|FG001|Overall Study|Adverse Event|6|||
23589648|NCT02551055|65886143|FG005|Overall Study|Reason not specified|0|||
23589649|NCT02551055|65886144|FG006|Overall Study|Reason not specified|1|||
23589650|NCT02551055|65886145|FG007|Overall Study|Reason not specified|0|||
23589651|NCT01233050|65886147|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
23358374|NCT00255164|65056241|FG002|Overall Study|Adverse Event|9|||
23358375|NCT00255164|65056239|FG000|Overall Study|Lost to Follow-up|4|||
23358376|NCT00255164|65056240|FG001|Overall Study|Lost to Follow-up|3|||
23358377|NCT00255164|65056241|FG002|Overall Study|Lost to Follow-up|4|||
23589652|NCT01233050|65886148|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
23589653|NCT02698891|65886151|FG000|Overall Study|Withdrawal by Subject|2|||
23358378|NCT00255164|65056239|FG000|Overall Study|Withdrawal by Subject|18|||
23358379|NCT00255164|65056240|FG001|Overall Study|Withdrawal by Subject|17|||
23358380|NCT00255164|65056241|FG002|Overall Study|Withdrawal by Subject|8|||
23358381|NCT00255164|65056239|FG000|Overall Study|Noncompliance|0|||
23358382|NCT00255164|65056240|FG001|Overall Study|Noncompliance|1|||
23358383|NCT00255164|65056241|FG002|Overall Study|Noncompliance|2|||
23358384|NCT00255164|65056239|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
23358385|NCT00255164|65056240|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
23358386|NCT00255164|65056241|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
23358387|NCT00255164|65056239|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
23358388|NCT00255164|65056240|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
23358389|NCT00255164|65056241|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
23358390|NCT00255164|65056239|FG000|Overall Study|Possible Barrett's Esophagus|1|||
23358391|NCT00255164|65056240|FG001|Overall Study|Possible Barrett's Esophagus|3|||
23358392|NCT00255164|65056241|FG002|Overall Study|Possible Barrett's Esophagus|8|||
23358393|NCT00255164|65056239|FG000|Overall Study|Esophageal Stricture|0|||
23358394|NCT00255164|65056240|FG001|Overall Study|Esophageal Stricture|0|||
23358395|NCT00255164|65056241|FG002|Overall Study|Esophageal Stricture|1|||
23358396|NCT00255164|65056239|FG000|Overall Study|Therapeutic Failure|11|||
23358397|NCT00255164|65056240|FG001|Overall Study|Therapeutic Failure|2|||
23252293|NCT01299272|64665512|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
23252294|NCT01299272|64665513|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
23358398|NCT00255164|65056241|FG002|Overall Study|Therapeutic Failure|3|||
23358399|NCT01670045|65056242|FG000|Overall Study|Withdrawal by Subject|3|||
23358400|NCT01670045|65056242|FG000|Overall Study|Adverse Event|1|||
23358401|NCT01670045|65056242|FG000|Overall Study|Death|1|||
23252295|NCT01299272|64665510|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
23252296|NCT01299272|64665511|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
23252297|NCT01299272|64665512|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
23252298|NCT01299272|64665513|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
23252299|NCT01299272|64665510|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
23252300|NCT01299272|64665511|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
23252301|NCT01299272|64665512|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
23252302|NCT01299272|64665513|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
23252303|NCT01299272|64665510|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
23252304|NCT01299272|64665511|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
23252305|NCT01299272|64665512|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
23252306|NCT01299272|64665513|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
23252307|NCT01299272|64665510|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
23252308|NCT01299272|64665511|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
23252309|NCT01299272|64665512|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
23252310|NCT01299272|64665513|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
23252311|NCT01299272|64665510|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
23252312|NCT01299272|64665511|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
23252313|NCT01299272|64665512|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
23252314|NCT01299272|64665513|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
23252315|NCT01299272|64665510|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
23252316|NCT01299272|64665511|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
23252317|NCT01299272|64665512|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
23252318|NCT01299272|64665513|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
23252319|NCT01299272|64665510|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
23252320|NCT01299272|64665511|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
23252321|NCT01299272|64665512|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
23252322|NCT01299272|64665513|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
23252323|NCT01299272|64665510|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
23252324|NCT01299272|64665511|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
23252325|NCT01299272|64665512|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
23252326|NCT01299272|64665513|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
23252327|NCT01299272|64665510|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
23252328|NCT01299272|64665511|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
23252329|NCT01299272|64665512|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
23252330|NCT01299272|64665513|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
23252331|NCT01299272|64665510|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
23252332|NCT01299272|64665511|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
23252333|NCT01299272|64665512|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
23252334|NCT01299272|64665513|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
23358402|NCT01670045|65056242|FG000|Overall Study|Lost to Follow-up|11|||
23358403|NCT02113007|65056245|FG000|Overall Study|Progressive disease|2|||
23358404|NCT00645671|65056246|FG000|Overall Study|Protocol Violation|1|||
23358405|NCT00645671|65056247|FG001|Overall Study|Protocol Violation|0|||
23358406|NCT00645671|65056246|FG000|Overall Study|Withdrawal by Subject|0|||
23358407|NCT00645671|65056247|FG001|Overall Study|Withdrawal by Subject|4|||
23358408|NCT00645671|65056246|FG000|Overall Study|Adverse Event|0|||
23475481|NCT00717236|65485422|FG000|Open-Label Period|Loss of Efficacy|6|||
23475482|NCT00717236|65485423|FG001|Open-Label Period|Loss of Efficacy|1|||
23475483|NCT00717236|65485422|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
23475484|NCT00717236|65485423|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
23475485|NCT00717236|65485422|FG000|Open-Label Period|Other: Lack of Compliance|1|||
23475486|NCT00717236|65485423|FG001|Open-Label Period|Other: Lack of Compliance|1|||
23475487|NCT00717236|65485422|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
23475488|NCT00717236|65485423|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
23252335|NCT01299272|64665510|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
23475489|NCT00717236|65485422|FG000|Open-Label Period|Other: Moved|1|||
23589654|NCT02698891|65886151|FG000|Overall Study|deemed ineligible|1|||
23589655|NCT02698891|65886151|FG000|Overall Study|Adverse Event|9|||
23589656|NCT00768664|65886153|FG000|Overall Study|Death|57|||
23589657|NCT00768664|65886153|FG000|Overall Study|Lost to Follow-up|2|||
23589658|NCT00768664|65886153|FG000|Overall Study|Other|9|||
23589659|NCT00768664|65886153|FG000|Overall Study|Participant refused|1|||
23589660|NCT02057692|65886157|FG000|Overall Study|Adverse Event|1|||
23589661|NCT02057692|65886158|FG001|Overall Study|Adverse Event|0|||
23589662|NCT02057692|65886159|FG002|Overall Study|Adverse Event|0|||
23589663|NCT02057692|65886160|FG003|Overall Study|Adverse Event|0|||
23589664|NCT02057692|65886157|FG000|Overall Study|Lost to Follow-up|0|||
23589665|NCT02057692|65886158|FG001|Overall Study|Lost to Follow-up|0|||
23589666|NCT02057692|65886159|FG002|Overall Study|Lost to Follow-up|0|||
23589667|NCT02057692|65886160|FG003|Overall Study|Lost to Follow-up|1|||
23589668|NCT00172185|65886161|FG000|Overall Study|Adverse Event|0|||
23589669|NCT00172185|65886162|FG001|Overall Study|Adverse Event|1|||
23589670|NCT00172185|65886163|FG002|Overall Study|Adverse Event|3|||
23589671|NCT00172185|65886164|FG003|Overall Study|Adverse Event|4|||
23589672|NCT00172185|65886161|FG000|Overall Study|Physician Decision|0|||
23589673|NCT00172185|65886162|FG001|Overall Study|Physician Decision|0|||
23589674|NCT00172185|65886163|FG002|Overall Study|Physician Decision|1|||
23589675|NCT00172185|65886164|FG003|Overall Study|Physician Decision|0|||
23589676|NCT00172185|65886161|FG000|Overall Study|SPONSOR Decision|0|||
23589677|NCT00172185|65886162|FG001|Overall Study|SPONSOR Decision|1|||
23589678|NCT00172185|65886163|FG002|Overall Study|SPONSOR Decision|0|||
23589679|NCT00172185|65886164|FG003|Overall Study|SPONSOR Decision|0|||
23589680|NCT00172185|65886161|FG000|Overall Study|Withdrawal by Subject|0|||
23589681|NCT00172185|65886162|FG001|Overall Study|Withdrawal by Subject|0|||
23589682|NCT00172185|65886163|FG002|Overall Study|Withdrawal by Subject|1|||
23589683|NCT00172185|65886164|FG003|Overall Study|Withdrawal by Subject|0|||
23589684|NCT00842257|65886165|FG000|Overall Study|Adverse Event|1|||
23252336|NCT01299272|64665511|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
23252337|NCT01299272|64665512|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
23252338|NCT01299272|64665513|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
23252339|NCT02609178|64665514|FG000|First Crown|Withdrawal by Subject|0|||
23252340|NCT02609178|64665515|FG001|First Crown|Withdrawal by Subject|0|||
23252341|NCT02609178|64665516|FG002|First Crown|Withdrawal by Subject|1|||
23589685|NCT00383188|65886166|FG000|Overall Study|Adverse Event|4|||
23589686|NCT00383188|65886167|FG001|Overall Study|Adverse Event|7|||
23589687|NCT00383188|65886168|FG002|Overall Study|Adverse Event|9|||
23589688|NCT00383188|65886169|FG003|Overall Study|Adverse Event|8|||
23589689|NCT00383188|65886170|FG004|Overall Study|Adverse Event|8|||
23589690|NCT00383188|65886166|FG000|Overall Study|Lack of Efficacy|9|||
23589691|NCT00383188|65886167|FG001|Overall Study|Lack of Efficacy|3|||
23589692|NCT00383188|65886168|FG002|Overall Study|Lack of Efficacy|3|||
23589693|NCT00383188|65886169|FG003|Overall Study|Lack of Efficacy|2|||
23589694|NCT00383188|65886170|FG004|Overall Study|Lack of Efficacy|6|||
23589695|NCT00383188|65886166|FG000|Overall Study|Other|3|||
23589696|NCT00383188|65886167|FG001|Overall Study|Other|1|||
23589697|NCT00383188|65886168|FG002|Overall Study|Other|0|||
23589698|NCT00383188|65886169|FG003|Overall Study|Other|2|||
23589699|NCT00383188|65886170|FG004|Overall Study|Other|6|||
23589700|NCT00383188|65886166|FG000|Overall Study|No longer willing to participate|1|||
23589701|NCT00383188|65886167|FG001|Overall Study|No longer willing to participate|0|||
23589702|NCT00383188|65886168|FG002|Overall Study|No longer willing to participate|1|||
23589703|NCT00383188|65886169|FG003|Overall Study|No longer willing to participate|0|||
23589704|NCT00383188|65886170|FG004|Overall Study|No longer willing to participate|2|||
23589705|NCT00383188|65886166|FG000|Overall Study|Lost to Follow-up|0|||
23589706|NCT00383188|65886167|FG001|Overall Study|Lost to Follow-up|0|||
23589707|NCT00383188|65886168|FG002|Overall Study|Lost to Follow-up|0|||
23589708|NCT00383188|65886169|FG003|Overall Study|Lost to Follow-up|0|||
23589709|NCT00383188|65886170|FG004|Overall Study|Lost to Follow-up|1|||
23589710|NCT02957539|65886175|FG000|Baseline to Week 16|Lost to Follow-up|8|||
23589711|NCT02957539|65886176|FG001|Baseline to Week 16|Lost to Follow-up|10|||
23358409|NCT00645671|65056247|FG001|Overall Study|Adverse Event|1|||
23358410|NCT00645671|65056246|FG000|Overall Study|Physician Decision|0|||
23358411|NCT00645671|65056247|FG001|Overall Study|Physician Decision|1|||
23358412|NCT01134263|65056248|FG000|Overall Study|Serious adverse event|2|||
23358413|NCT01134263|65056249|FG001|Overall Study|Serious adverse event|1|||
23358414|NCT01134263|65056250|FG002|Overall Study|Serious adverse event|1|||
23358415|NCT01134263|65056251|FG003|Overall Study|Serious adverse event|1|||
23358416|NCT01134263|65056252|FG004|Overall Study|Serious adverse event|1|||
23358417|NCT01134263|65056248|FG000|Overall Study|Other adverse event|1|||
23358418|NCT01134263|65056249|FG001|Overall Study|Other adverse event|2|||
23358419|NCT01134263|65056250|FG002|Overall Study|Other adverse event|5|||
23358420|NCT01134263|65056251|FG003|Overall Study|Other adverse event|3|||
23358421|NCT01134263|65056252|FG004|Overall Study|Other adverse event|0|||
23358422|NCT01134263|65056248|FG000|Overall Study|Protocol Violation|8|||
23358423|NCT01134263|65056249|FG001|Overall Study|Protocol Violation|7|||
23358424|NCT01134263|65056250|FG002|Overall Study|Protocol Violation|2|||
23252342|NCT02609178|64665517|FG003|First Crown|Withdrawal by Subject|1|||
23252343|NCT02609178|64665518|FG004|First Crown|Withdrawal by Subject|0|||
23252344|NCT02609178|64665519|FG005|First Crown|Withdrawal by Subject|0|||
23252345|NCT00068406|64665520|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
23252346|NCT00068406|64665520|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
23252347|NCT04247594|64665524|FG000|Overall Study|Withdrawal by Subject|4|||
23252348|NCT02742818|64665530|FG000|Overall Study|Adverse Event|0|||
23252349|NCT02742818|64665531|FG001|Overall Study|Adverse Event|1|||
23252350|NCT02742818|64665530|FG000|Overall Study|Protocol Violation|0|||
23252351|NCT02742818|64665531|FG001|Overall Study|Protocol Violation|1|||
23252352|NCT00449930|64665534|FG000|Overall Study|Adverse Event|9|||
23252353|NCT00449930|64665535|FG001|Overall Study|Adverse Event|19|||
23252354|NCT00449930|64665534|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
23252355|NCT00449930|64665535|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
23252356|NCT00449930|64665534|FG000|Overall Study|Lack of Efficacy|10|||
23358425|NCT01134263|65056251|FG003|Overall Study|Protocol Violation|4|||
23358426|NCT01134263|65056252|FG004|Overall Study|Protocol Violation|2|||
23358427|NCT01134263|65056248|FG000|Overall Study|Lost to Follow-up|4|||
23358428|NCT01134263|65056249|FG001|Overall Study|Lost to Follow-up|3|||
23358429|NCT01134263|65056250|FG002|Overall Study|Lost to Follow-up|5|||
23358430|NCT01134263|65056251|FG003|Overall Study|Lost to Follow-up|3|||
23358431|NCT01134263|65056252|FG004|Overall Study|Lost to Follow-up|1|||
23358432|NCT01134263|65056248|FG000|Overall Study|Withdrawal by Subject|8|||
23358433|NCT01134263|65056249|FG001|Overall Study|Withdrawal by Subject|6|||
23358434|NCT01134263|65056250|FG002|Overall Study|Withdrawal by Subject|16|||
23358435|NCT01134263|65056251|FG003|Overall Study|Withdrawal by Subject|7|||
23358436|NCT01134263|65056252|FG004|Overall Study|Withdrawal by Subject|5|||
23358437|NCT01134263|65056248|FG000|Overall Study|Enrolled, but not treated|1|||
23358438|NCT01134263|65056249|FG001|Overall Study|Enrolled, but not treated|1|||
23358439|NCT01134263|65056250|FG002|Overall Study|Enrolled, but not treated|0|||
23358440|NCT01134263|65056251|FG003|Overall Study|Enrolled, but not treated|1|||
23358441|NCT01134263|65056252|FG004|Overall Study|Enrolled, but not treated|0|||
23358442|NCT01471444|65056253|FG000|Overall Study|Physician Decision|3|||
23358443|NCT01471444|65056254|FG001|Overall Study|Physician Decision|2|||
23358444|NCT01471444|65056253|FG000|Overall Study|Withdrawal by Subject|0|||
23358445|NCT01471444|65056254|FG001|Overall Study|Withdrawal by Subject|1|||
23358446|NCT01911780|65056256|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
23358447|NCT01911780|65056257|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
23358448|NCT01911780|65056256|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
23358449|NCT01911780|65056257|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
23358450|NCT01911780|65056256|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
23358451|NCT01911780|65056257|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
23358452|NCT01911780|65056256|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
23358453|NCT01911780|65056257|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
23252357|NCT00449930|64665535|FG001|Overall Study|Lack of Efficacy|1|||
23252358|NCT00449930|64665534|FG000|Overall Study|Lost to Follow-up|9|||
23252359|NCT00449930|64665535|FG001|Overall Study|Lost to Follow-up|14|||
23252360|NCT00449930|64665534|FG000|Overall Study|Physician Decision|1|||
23252361|NCT00449930|64665535|FG001|Overall Study|Physician Decision|2|||
23358454|NCT01911780|65056256|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
23358455|NCT01911780|65056257|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
23358456|NCT01911780|65056256|FG000|Extension Period (52 Weeks)|Personal reason|1|||
23358457|NCT01911780|65056257|FG001|Extension Period (52 Weeks)|Personal reason|1|||
23358458|NCT01765569|65056258|FG000|Period B|Withdrawal by Subject|1|||
23358459|NCT01765569|65056258|FG000|Period C|Death|1|||
23358460|NCT00314808|65056263|FG000|Overall Study|Disease Progression without AE|4|||
23358461|NCT00314808|65056263|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
23358462|NCT01859949|65056265|FG000|Overall Study|Family Matters|0|||
23358463|NCT01859949|65056266|FG001|Overall Study|Family Matters|1|||
23358464|NCT01859949|65056265|FG000|Overall Study|Physician Decision|2|||
23358465|NCT01859949|65056266|FG001|Overall Study|Physician Decision|4|||
23358466|NCT01859949|65056265|FG000|Overall Study|Withdrawal by Subject|11|||
23358467|NCT01859949|65056266|FG001|Overall Study|Withdrawal by Subject|10|||
23358468|NCT01859949|65056265|FG000|Overall Study|Protocol Violation|1|||
23358469|NCT01859949|65056266|FG001|Overall Study|Protocol Violation|1|||
23358470|NCT01859949|65056265|FG000|Overall Study|Adverse Event|0|||
23358471|NCT01859949|65056266|FG001|Overall Study|Adverse Event|1|||
23358472|NCT03060291|65056267|FG000|3-month Follow-up|Declined to respond|8|||
23358473|NCT03060291|65056268|FG001|3-month Follow-up|Declined to respond|10|||
23358474|NCT03060291|65056269|FG002|3-month Follow-up|Declined to respond|2|||
23358475|NCT03060291|65056267|FG000|6-month Follow-up|Declined to respond|7|||
23358476|NCT03060291|65056268|FG001|6-month Follow-up|Declined to respond|13|||
23358477|NCT03060291|65056269|FG002|6-month Follow-up|Declined to respond|4|||
23358478|NCT03060291|65056267|FG000|12-month Follow-up|Declined to respond|7|||
23358479|NCT03060291|65056268|FG001|12-month Follow-up|Declined to respond|16|||
23358480|NCT03060291|65056269|FG002|12-month Follow-up|Declined to respond|6|||
23358481|NCT00978341|65056270|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
23358482|NCT00978341|65056271|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
23358483|NCT00187278|65056280|FG000|Overall Study|Protocol Violation|10|||
23358484|NCT00187278|65056281|FG001|Overall Study|Protocol Violation|13|||
23358485|NCT02906579|65056282|FG000|Overall Study|Adverse Event|1|||
23358486|NCT02906579|65056282|FG000|Overall Study|Physician Decision|1|||
23358487|NCT02168777|65056283|FG000|Overall Study|Withdrawal by Subject|1|||
23358488|NCT02168777|65056284|FG001|Overall Study|Withdrawal by Subject|0|||
23358489|NCT02168777|65056285|FG002|Overall Study|Withdrawal by Subject|2|||
23358490|NCT02168777|65056283|FG000|Overall Study|Adverse Event|1|||
23358491|NCT02168777|65056284|FG001|Overall Study|Adverse Event|0|||
23358492|NCT02168777|65056285|FG002|Overall Study|Adverse Event|1|||
23358493|NCT02168777|65056283|FG000|Overall Study|Disease recurrence|0|||
23358494|NCT02168777|65056284|FG001|Overall Study|Disease recurrence|0|||
23358495|NCT02168777|65056285|FG002|Overall Study|Disease recurrence|1|||
23358496|NCT02168777|65056283|FG000|Overall Study|Radiological disease progression|0|||
23358497|NCT02168777|65056284|FG001|Overall Study|Radiological disease progression|5|||
23358498|NCT02168777|65056285|FG002|Overall Study|Radiological disease progression|5|||
23358499|NCT02168777|65056283|FG000|Overall Study|Clinical disease progression|0|||
23358500|NCT02168777|65056284|FG001|Overall Study|Clinical disease progression|1|||
23358501|NCT02168777|65056285|FG002|Overall Study|Clinical disease progression|2|||
23358502|NCT02168777|65056283|FG000|Overall Study|Other reason|0|||
23358503|NCT02168777|65056284|FG001|Overall Study|Other reason|1|||
23358504|NCT02168777|65056285|FG002|Overall Study|Other reason|0|||
23358505|NCT01548768|65056286|FG000|Overall Study|Withdrawal by Subject|0|||
23358506|NCT01548768|65056287|FG001|Overall Study|Withdrawal by Subject|2|||
23252362|NCT00449930|64665534|FG000|Overall Study|Protocol Violation|14|||
23252363|NCT00449930|64665535|FG001|Overall Study|Protocol Violation|15|||
23252364|NCT00449930|64665534|FG000|Overall Study|Withdrawal by Subject|16|||
23252365|NCT00449930|64665535|FG001|Overall Study|Withdrawal by Subject|23|||
23252366|NCT00449930|64665534|FG000|Overall Study|Glycemic discontinuation criteria|1|||
23252367|NCT00449930|64665535|FG001|Overall Study|Glycemic discontinuation criteria|1|||
23252368|NCT04288115|64665539|FG000|Overall Study|Withdrawal by Subject|0|||
23252369|NCT04288115|64665540|FG001|Overall Study|Withdrawal by Subject|1|||
23252370|NCT04288115|64665539|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
23252371|NCT04288115|64665540|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
23252372|NCT02156466|64665541|FG000|Overall Study|Adverse Event|0|||
23252373|NCT02156466|64665542|FG001|Overall Study|Adverse Event|0|||
23252374|NCT02156466|64665543|FG002|Overall Study|Adverse Event|1|||
23252375|NCT02156466|64665544|FG003|Overall Study|Adverse Event|1|||
23252376|NCT02156466|64665545|FG004|Overall Study|Adverse Event|0|||
23252377|NCT02156466|64665541|FG000|Overall Study|Quantiferon Positivity|0|||
23252378|NCT02156466|64665542|FG001|Overall Study|Quantiferon Positivity|0|||
23252379|NCT02156466|64665543|FG002|Overall Study|Quantiferon Positivity|0|||
23252380|NCT02156466|64665544|FG003|Overall Study|Quantiferon Positivity|1|||
23252381|NCT02156466|64665545|FG004|Overall Study|Quantiferon Positivity|0|||
23358507|NCT01548768|65056288|FG002|Overall Study|Withdrawal by Subject|1|||
23358508|NCT01548768|65056289|FG003|Overall Study|Withdrawal by Subject|0|||
23358509|NCT01548768|65056286|FG000|Overall Study|Physician Decision|1|||
23358510|NCT01548768|65056287|FG001|Overall Study|Physician Decision|0|||
23358511|NCT01548768|65056288|FG002|Overall Study|Physician Decision|0|||
23358512|NCT01548768|65056289|FG003|Overall Study|Physician Decision|0|||
23252382|NCT00602979|64665548|FG000|Overall Study|Lost to Follow-up|3|||
23252383|NCT00602979|64665549|FG001|Overall Study|Lost to Follow-up|2|||
23252384|NCT00602979|64665550|FG002|Overall Study|Lost to Follow-up|3|||
23358513|NCT01548768|65056286|FG000|Overall Study|Adverse Event|0|||
23358514|NCT01548768|65056287|FG001|Overall Study|Adverse Event|0|||
23358515|NCT01548768|65056288|FG002|Overall Study|Adverse Event|0|||
23358516|NCT01548768|65056289|FG003|Overall Study|Adverse Event|1|||
23358517|NCT01548768|65056286|FG000|Overall Study|Non-Compliance|0|||
23358518|NCT01548768|65056287|FG001|Overall Study|Non-Compliance|0|||
23358519|NCT01548768|65056288|FG002|Overall Study|Non-Compliance|0|||
23358520|NCT01548768|65056289|FG003|Overall Study|Non-Compliance|3|||
23358521|NCT00694356|65056297|FG000|Overall Study|Adverse Event|1|||
23358522|NCT00694356|65056298|FG001|Overall Study|Adverse Event|0|||
23358523|NCT00694356|65056299|FG002|Overall Study|Adverse Event|0|||
23358524|NCT00694356|65056297|FG000|Overall Study|Progressive Disease|2|||
23358525|NCT00694356|65056298|FG001|Overall Study|Progressive Disease|6|||
23358526|NCT00694356|65056299|FG002|Overall Study|Progressive Disease|6|||
23358527|NCT03743025|65056300|FG000|Overall Study|Surgery was cancelled|2|||
23358528|NCT03743025|65056301|FG001|Overall Study|Surgery was cancelled|1|||
23252385|NCT00602979|64665551|FG003|Overall Study|Lost to Follow-up|2|||
23252386|NCT00602979|64665552|FG004|Overall Study|Lost to Follow-up|3|||
23252387|NCT00602979|64665548|FG000|Overall Study|Failed Intubation|0|||
23252388|NCT00602979|64665549|FG001|Overall Study|Failed Intubation|1|||
23252389|NCT00602979|64665550|FG002|Overall Study|Failed Intubation|0|||
23252390|NCT00602979|64665551|FG003|Overall Study|Failed Intubation|1|||
23252391|NCT00602979|64665552|FG004|Overall Study|Failed Intubation|0|||
23252392|NCT01959230|64665554|FG000|Overall Study|Failure to follow study procedures|0|||
23252393|NCT01959230|64665555|FG001|Overall Study|Failure to follow study procedures|1|||
23252394|NCT01959230|64665554|FG000|Overall Study|Administrative reasons|2|||
23252395|NCT01959230|64665555|FG001|Overall Study|Administrative reasons|0|||
23252396|NCT01959230|64665554|FG000|Overall Study|Withdrawal by Subject|2|||
23252397|NCT01959230|64665555|FG001|Overall Study|Withdrawal by Subject|0|||
23252398|NCT00468312|64665556|FG000|Overall Study|Adverse Event|2|||
23252399|NCT00468312|64665557|FG001|Overall Study|Adverse Event|1|||
23252400|NCT00468312|64665556|FG000|Overall Study|Lack of Efficacy|0|||
23252401|NCT00468312|64665557|FG001|Overall Study|Lack of Efficacy|1|||
23252402|NCT00468312|64665556|FG000|Overall Study|Withdrawal by Subject|0|||
23252403|NCT00468312|64665557|FG001|Overall Study|Withdrawal by Subject|1|||
23252404|NCT00468312|64665556|FG000|Overall Study|Protocol Violation|2|||
23252405|NCT00468312|64665557|FG001|Overall Study|Protocol Violation|1|||
23252406|NCT00468312|64665556|FG000|Overall Study|Did not meet protocol eligibility|0|||
23252407|NCT00468312|64665557|FG001|Overall Study|Did not meet protocol eligibility|1|||
23252408|NCT00000135|64665558|FG000|Overall Study|Death|27|||
23358529|NCT03148067|65056308|FG000|Overall Study|Lost to Follow-up|3|||
23358530|NCT03148067|65056308|FG000|Overall Study|Death|1|||
23358531|NCT00759655|65056316|FG000|Overall Study|Termination of the study by sponsor|1|||
23358532|NCT00003896|65056319|FG000|Overall Study|Adverse Event|16|||
23358533|NCT00003896|65056319|FG000|Overall Study|Withdrawal by Subject|1|||
23358534|NCT00003896|65056319|FG000|Overall Study|Lack of Efficacy|1|||
23358535|NCT00003896|65056319|FG000|Overall Study|Death|3|||
23358536|NCT00003896|65056319|FG000|Overall Study|not protocol specified|3|||
23358537|NCT00003896|65056319|FG000|Overall Study|ineligible|5|||
23358538|NCT01066663|65056320|FG000|Overall Study|Adverse Event|0|||
23358539|NCT01066663|65056321|FG001|Overall Study|Adverse Event|0|||
23358540|NCT01066663|65056322|FG002|Overall Study|Adverse Event|1|||
23358541|NCT00662311|65056323|FG000|Overall Study|Respiratory Infection|1|||
23358542|NCT00662311|65056324|FG001|Overall Study|Respiratory Infection|0|||
23358543|NCT00662311|65056325|FG002|Overall Study|Respiratory Infection|0|||
23358544|NCT03373760|65056328|FG000|Overall Study|Adverse Event|8|||
23358545|NCT03373760|65056328|FG000|Overall Study|Disease Progression|46|||
23358546|NCT03373760|65056328|FG000|Overall Study|Death|4|||
23358547|NCT01189461|65056329|FG000|Overall Study|Lack of Efficacy|13|||
23589712|NCT02957539|65886177|FG002|Baseline to Week 16|Lost to Follow-up|16|||
23589713|NCT02957539|65886175|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
23589714|NCT02957539|65886176|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
23589715|NCT02957539|65886177|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
23589716|NCT02957539|65886175|FG000|Week 16 to 32|Withdrawal by Subject|3|||
23589717|NCT02957539|65886176|FG001|Week 16 to 32|Withdrawal by Subject|3|||
23589718|NCT02957539|65886177|FG002|Week 16 to 32|Withdrawal by Subject|1|||
23589719|NCT02957539|65886175|FG000|Week 16 to 32|Lost to Follow-up|8|||
23589720|NCT02957539|65886176|FG001|Week 16 to 32|Lost to Follow-up|7|||
23358548|NCT01189461|65056329|FG000|Overall Study|Lost to Follow-up|1|||
23589721|NCT02957539|65886177|FG002|Week 16 to 32|Lost to Follow-up|5|||
23252409|NCT00000135|64665559|FG001|Overall Study|Death|14|||
23252410|NCT03891875|64665560|FG000|Overall Study|Withdrawal by Subject|20|||
23358549|NCT01189461|65056329|FG000|Overall Study|Withdrawal by Subject|6|||
23358550|NCT01189461|65056329|FG000|Overall Study|Protocol Violation|1|||
23358551|NCT01189461|65056329|FG000|Overall Study|Adverse Event|2|||
23358552|NCT01189461|65056329|FG000|Overall Study|Did not meet entrance criteria|3|||
23358553|NCT01189461|65056329|FG000|Overall Study|Other|8|||
23358554|NCT00199849|65056330|FG000|Overall Study|Unrelated illness or complication|0|||
23252411|NCT03891875|64665561|FG001|Overall Study|Withdrawal by Subject|3|||
23252412|NCT03891875|64665560|FG000|Overall Study|Adverse Event|10|||
23252413|NCT03891875|64665561|FG001|Overall Study|Adverse Event|4|||
23358555|NCT00199849|65056331|FG001|Overall Study|Unrelated illness or complication|1|||
23358556|NCT00199849|65056332|FG002|Overall Study|Unrelated illness or complication|0|||
23252414|NCT03891875|64665560|FG000|Overall Study|Physician Decision|1|||
23358557|NCT00199849|65056330|FG000|Overall Study|Progressive disease requiring intervention|0|||
23358558|NCT00199849|65056331|FG001|Overall Study|Progressive disease requiring intervention|0|||
23358559|NCT00199849|65056332|FG002|Overall Study|Progressive disease requiring intervention|1|||
23358560|NCT00199849|65056330|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
23358561|NCT00199849|65056331|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
23358562|NCT00199849|65056332|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
23358563|NCT00329745|65056333|FG000|Overall Study|Protocol Violation|1|||
23358564|NCT00329745|65056334|FG001|Overall Study|Protocol Violation|0|||
23358565|NCT00329745|65056333|FG000|Overall Study|Withdrawal by Subject|0|||
23358566|NCT00329745|65056334|FG001|Overall Study|Withdrawal by Subject|1|||
23358567|NCT00329745|65056333|FG000|Overall Study|Lost to Follow-up|86|||
23358568|NCT00329745|65056334|FG001|Overall Study|Lost to Follow-up|101|||
23358569|NCT03253744|65056335|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
23358570|NCT03253744|65056336|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
23358571|NCT03253744|65056337|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
23252415|NCT03891875|64665561|FG001|Overall Study|Physician Decision|1|||
23252416|NCT03891875|64665560|FG000|Overall Study|Protocol Violation|1|||
23252417|NCT03891875|64665561|FG001|Overall Study|Protocol Violation|0|||
23252418|NCT03891875|64665560|FG000|Overall Study|Lost to Follow-up|1|||
23252419|NCT03891875|64665561|FG001|Overall Study|Lost to Follow-up|0|||
23252420|NCT03891875|64665560|FG000|Overall Study|COVID-19 infection|1|||
23252421|NCT03891875|64665561|FG001|Overall Study|COVID-19 infection|0|||
23252422|NCT01825876|64665563|FG000|Period 2|Withdrawal by Subject|0|||
23252423|NCT01825876|64665564|FG001|Period 2|Withdrawal by Subject|1|||
23252424|NCT02862535|64665565|FG000|Overall Study|Death|7|||
23252425|NCT02862535|64665566|FG001|Overall Study|Death|3|||
23252426|NCT02862535|64665567|FG002|Overall Study|Death|2|||
23252427|NCT02862535|64665568|FG003|Overall Study|Death|5|||
23252428|NCT02862535|64665565|FG000|Overall Study|Study Terminated by Sponsor|1|||
23252429|NCT02862535|64665566|FG001|Overall Study|Study Terminated by Sponsor|3|||
23252430|NCT02862535|64665567|FG002|Overall Study|Study Terminated by Sponsor|8|||
23252431|NCT02862535|64665568|FG003|Overall Study|Study Terminated by Sponsor|5|||
23252432|NCT02862535|64665565|FG000|Overall Study|Enrolled, not Treated|1|||
23252433|NCT02862535|64665566|FG001|Overall Study|Enrolled, not Treated|0|||
23252434|NCT02862535|64665567|FG002|Overall Study|Enrolled, not Treated|0|||
23252435|NCT02862535|64665568|FG003|Overall Study|Enrolled, not Treated|1|||
23252436|NCT00337129|64665571|FG000|Overall Study|Adverse Event|4|||
23252437|NCT00337129|64665571|FG000|Overall Study|Withdrawal by Subject|1|||
23252438|NCT00337129|64665571|FG000|Overall Study|Lack of Efficacy|32|||
23252439|NCT00337129|64665571|FG000|Overall Study|Death|2|||
23252440|NCT00337129|64665571|FG000|Overall Study|not protocol specified|1|||
23252441|NCT00423488|64665572|FG000|Overall Study|No evidence of study drug intake|2|||
23252442|NCT00423488|64665573|FG001|Overall Study|No evidence of study drug intake|1|||
23252443|NCT00423488|64665572|FG000|Overall Study|No post baseline data|3|||
23252444|NCT00423488|64665573|FG001|Overall Study|No post baseline data|0|||
23252445|NCT00763269|64665575|FG000|Overall Study|Lost to Follow-up|12|||
23252446|NCT00763269|64665576|FG001|Overall Study|Lost to Follow-up|13|||
23252447|NCT01162135|64665577|FG000|Overall Study|Withdrawal by Subject|1|||
23252448|NCT01162135|64665577|FG000|Overall Study|Severe back pain|1|||
23252449|NCT01162135|64665577|FG000|Overall Study|Ineligible|1|||
23252450|NCT02380248|64665580|FG000|Overall Study|Lost to Follow-up|11|||
23252451|NCT02380248|64665580|FG000|Overall Study|Withdrawal by Subject|3|||
23252452|NCT02476851|64665581|FG000|Overall Study|Protocol Violation|1|||
23252453|NCT02476851|64665582|FG001|Overall Study|Protocol Violation|1|||
23252454|NCT00527397|64665583|FG000|Overall Study|Adverse Event|3|||
23252455|NCT00527397|64665583|FG000|Overall Study|Lack of Efficacy|1|||
23252456|NCT00527397|64665583|FG000|Overall Study|Protocol Violation|1|||
23358572|NCT03253744|65056338|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
23358573|NCT00582426|65056340|FG000|Overall Study|Lost to Follow-up|0|||
23475490|NCT00717236|65485423|FG001|Open-Label Period|Other: Moved|0|||
23252457|NCT00527397|64665583|FG000|Overall Study|Withdrawal by Subject|6|||
23252458|NCT00527397|64665583|FG000|Overall Study|Study terminated by sponsor|13|||
23252459|NCT01374906|64665587|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23252460|NCT01374906|64665588|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23252461|NCT01374906|64665587|FG000|Overall Study|Administrative problems|2|||
23252462|NCT01374906|64665588|FG001|Overall Study|Administrative problems|2|||
23252463|NCT01374906|64665587|FG000|Overall Study|Adverse Event|10|||
23252464|NCT01374906|64665588|FG001|Overall Study|Adverse Event|11|||
23252465|NCT01374906|64665587|FG000|Overall Study|Death|0|||
23252466|NCT01374906|64665588|FG001|Overall Study|Death|2|||
23252467|NCT01374906|64665587|FG000|Overall Study|Protocol Violation|2|||
23252468|NCT01374906|64665588|FG001|Overall Study|Protocol Violation|2|||
23252469|NCT01374906|64665587|FG000|Overall Study|Withdrawal by Subject|15|||
23358574|NCT00582426|65056341|FG001|Overall Study|Lost to Follow-up|2|||
23358575|NCT00582426|65056340|FG000|Overall Study|Adverse Event|4|||
23358576|NCT00582426|65056341|FG001|Overall Study|Adverse Event|2|||
23358577|NCT00582426|65056340|FG000|Overall Study|Protocol Violation|6|||
23358578|NCT00582426|65056341|FG001|Overall Study|Protocol Violation|2|||
23358579|NCT00582426|65056340|FG000|Overall Study|Death|4|||
23358580|NCT00582426|65056341|FG001|Overall Study|Death|3|||
23358581|NCT00582426|65056340|FG000|Overall Study|Withdrawal by Subject|3|||
23358582|NCT00582426|65056341|FG001|Overall Study|Withdrawal by Subject|2|||
23358583|NCT00582426|65056340|FG000|Overall Study|Disease Progression|2|||
23358584|NCT00582426|65056341|FG001|Overall Study|Disease Progression|2|||
23358585|NCT00582426|65056340|FG000|Overall Study|Use of illicit drugs|1|||
23358586|NCT00582426|65056341|FG001|Overall Study|Use of illicit drugs|0|||
23358587|NCT03042910|65056343|FG000|Overall Study|Adverse Event|1|||
23358588|NCT03042910|65056343|FG000|Overall Study|Disease Progression|2|||
23358589|NCT03042910|65056343|FG000|Overall Study|Withdrawal by Subject|3|||
23191470|NCT02436239|64442366|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
23191471|NCT02436239|64442363|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
23191472|NCT02436239|64442364|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
23191473|NCT02436239|64442365|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
23191474|NCT02436239|64442366|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
23252470|NCT01374906|64665588|FG001|Overall Study|Withdrawal by Subject|9|||
23252471|NCT01374906|64665587|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
23252472|NCT01374906|64665588|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
23252473|NCT00331773|64665589|FG000|Overall Study|Withdrawal by Subject|6|||
23252474|NCT00331773|64665590|FG001|Overall Study|Withdrawal by Subject|4|||
23252475|NCT00331773|64665589|FG000|Overall Study|Protocol Violation|10|||
23191475|NCT02436239|64442363|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
23191476|NCT02436239|64442364|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
23191477|NCT02436239|64442365|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
23191478|NCT02436239|64442366|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
23191479|NCT02436239|64442363|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
23191480|NCT02436239|64442364|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
23252476|NCT00331773|64665590|FG001|Overall Study|Protocol Violation|3|||
23252477|NCT03550794|64667771|FG000|Overall Study|No longer met inclusion criteria|1|||
23252478|NCT03550794|64667772|FG001|Overall Study|No longer met inclusion criteria|2|||
23252479|NCT03550794|64667771|FG000|Overall Study|Goals of care changed|1|||
23252480|NCT03550794|64667772|FG001|Overall Study|Goals of care changed|0|||
23252481|NCT03550794|64667771|FG000|Overall Study|Withdrawal by Subject|2|||
23252482|NCT03550794|64667772|FG001|Overall Study|Withdrawal by Subject|0|||
23252483|NCT03550794|64667771|FG000|Overall Study|Death|0|||
23252484|NCT03550794|64667772|FG001|Overall Study|Death|1|||
23252485|NCT01222715|64667773|FG000|Overall Study|Adverse Event|0|||
23252486|NCT01222715|64667774|FG001|Overall Study|Adverse Event|4|||
23252487|NCT01222715|64667773|FG000|Overall Study|Death|0|||
23252488|NCT01222715|64667774|FG001|Overall Study|Death|1|||
23252489|NCT01222715|64667773|FG000|Overall Study|Lack of Efficacy|22|||
23252490|NCT01222715|64667774|FG001|Overall Study|Lack of Efficacy|14|||
23252491|NCT01222715|64667773|FG000|Overall Study|Physician Decision|12|||
23252492|NCT01222715|64667774|FG001|Overall Study|Physician Decision|2|||
23252493|NCT01222715|64667773|FG000|Overall Study|Refusal of further protocol therapy|0|||
23252494|NCT01222715|64667774|FG001|Overall Study|Refusal of further protocol therapy|4|||
23252495|NCT01222715|64667773|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
23252496|NCT01222715|64667774|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
23252497|NCT01222715|64667773|FG000|Overall Study|Ineligible|0|||
23252498|NCT01222715|64667774|FG001|Overall Study|Ineligible|1|||
23252499|NCT01222715|64667773|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
23358590|NCT03042910|65056343|FG000|Overall Study|Enrolled but not treated|1|||
23358591|NCT04304508|65056344|FG000|Overall Study|Subject Decision|29|||
23358592|NCT04304508|65056345|FG001|Overall Study|Subject Decision|39|||
23358593|NCT04304508|65056346|FG002|Overall Study|Subject Decision|37|||
23475491|NCT00717236|65485422|FG000|Open-Label Period|Other: Investigator Decision|1|||
23589722|NCT02957539|65886175|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
23589723|NCT02957539|65886176|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
23589724|NCT02957539|65886177|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
23589725|NCT02957539|65886175|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
23589726|NCT02957539|65886176|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
23589727|NCT02957539|65886177|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
23589728|NCT00972504|65886182|FG000|Overall Study|Adverse Event|2|||
23589729|NCT00972504|65886182|FG000|Overall Study|Investigator discretion|1|||
23589730|NCT02299635|65886183|FG000|Overall Study|Adverse Event|2|||
23191481|NCT02436239|64442365|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
23191482|NCT02436239|64442366|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
23252500|NCT01222715|64667774|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
23358594|NCT04304508|65056347|FG003|Overall Study|Subject Decision|48|||
23589731|NCT02299635|65886183|FG000|Overall Study|Death|1|||
23191483|NCT02436239|64442363|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
23191484|NCT02436239|64442364|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
23358595|NCT04304508|65056344|FG000|Overall Study|Death|6|||
23358596|NCT04304508|65056345|FG001|Overall Study|Death|1|||
23191485|NCT02436239|64442365|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
23252501|NCT00295620|64667775|FG000|Overall Study|Lost to Follow-up|9|||
23358597|NCT04304508|65056346|FG002|Overall Study|Death|8|||
23358598|NCT04304508|65056347|FG003|Overall Study|Death|5|||
23358599|NCT04304508|65056344|FG000|Overall Study|Non-compliance With Study Drug|3|||
23358600|NCT04304508|65056345|FG001|Overall Study|Non-compliance With Study Drug|1|||
23358601|NCT04304508|65056346|FG002|Overall Study|Non-compliance With Study Drug|2|||
23358602|NCT04304508|65056347|FG003|Overall Study|Non-compliance With Study Drug|0|||
23358603|NCT04304508|65056344|FG000|Overall Study|Switching To Other Therapy|1|||
23358604|NCT04304508|65056345|FG001|Overall Study|Switching To Other Therapy|1|||
23358605|NCT04304508|65056346|FG002|Overall Study|Switching To Other Therapy|1|||
23358606|NCT04304508|65056347|FG003|Overall Study|Switching To Other Therapy|2|||
23358607|NCT04304508|65056344|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
23358608|NCT04304508|65056345|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
23358609|NCT04304508|65056346|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
23358610|NCT04304508|65056347|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
23358611|NCT04304508|65056344|FG000|Overall Study|Withdrawal by Subject|7|||
23358612|NCT04304508|65056345|FG001|Overall Study|Withdrawal by Subject|5|||
23358613|NCT04304508|65056346|FG002|Overall Study|Withdrawal by Subject|11|||
23358614|NCT04304508|65056347|FG003|Overall Study|Withdrawal by Subject|6|||
23358615|NCT04304508|65056344|FG000|Overall Study|Logistical Difficulties|2|||
23358616|NCT04304508|65056345|FG001|Overall Study|Logistical Difficulties|2|||
23358617|NCT04304508|65056346|FG002|Overall Study|Logistical Difficulties|3|||
23358618|NCT04304508|65056347|FG003|Overall Study|Logistical Difficulties|2|||
23358619|NCT04304508|65056344|FG000|Overall Study|Missing Information|1|||
23358620|NCT04304508|65056345|FG001|Overall Study|Missing Information|2|||
23358621|NCT04304508|65056346|FG002|Overall Study|Missing Information|1|||
23358622|NCT04304508|65056347|FG003|Overall Study|Missing Information|3|||
23358623|NCT04304508|65056344|FG000|Overall Study|Other|7|||
23358624|NCT04304508|65056345|FG001|Overall Study|Other|6|||
23358625|NCT04304508|65056346|FG002|Overall Study|Other|5|||
23358626|NCT04304508|65056347|FG003|Overall Study|Other|4|||
23358627|NCT04304508|65056344|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
23191486|NCT02436239|64442366|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
23252502|NCT00295620|64667776|FG001|Overall Study|Lost to Follow-up|5|||
23358628|NCT04304508|65056345|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
23358629|NCT04304508|65056346|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
23358630|NCT04304508|65056347|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
23358631|NCT04304508|65056344|FG000|Overall Study|Physician Decision|3|||
23358632|NCT04304508|65056345|FG001|Overall Study|Physician Decision|4|||
23358633|NCT04304508|65056346|FG002|Overall Study|Physician Decision|9|||
23358634|NCT04304508|65056347|FG003|Overall Study|Physician Decision|7|||
23358635|NCT04304508|65056344|FG000|Overall Study|Study drug never administered|10|||
23358636|NCT04304508|65056345|FG001|Overall Study|Study drug never administered|4|||
23358637|NCT04304508|65056346|FG002|Overall Study|Study drug never administered|4|||
23358638|NCT04304508|65056347|FG003|Overall Study|Study drug never administered|4|||
23358639|NCT04304508|65056344|FG000|Overall Study|Adverse Event|49|||
23191487|NCT02436239|64442363|FG000|Open-Lable Treatment Period|Other Reason|1|||
23191488|NCT02436239|64442364|FG001|Open-Lable Treatment Period|Other Reason|1|||
23475492|NCT00717236|65485423|FG001|Open-Label Period|Other: Investigator Decision|0|||
23475493|NCT00717236|65485422|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
23475494|NCT00717236|65485423|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
23475495|NCT00717236|65485422|FG000|Open-Label Period|Other: Sponsor Request|3|||
23475496|NCT00717236|65485423|FG001|Open-Label Period|Other: Sponsor Request|0|||
23475497|NCT00717236|65485422|FG000|Open-Label Period|Other: Cataract Surgery|1|||
23475498|NCT00717236|65485423|FG001|Open-Label Period|Other: Cataract Surgery|0|||
23475499|NCT00717236|65485422|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
23475500|NCT00717236|65485423|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
23475501|NCT00717236|65485422|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
23475502|NCT00717236|65485423|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
23475503|NCT00717236|65485422|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
23475504|NCT00717236|65485423|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
23475505|NCT03642132|65485424|FG000|Chemotherapy Period|Adverse Event|1|||
23475506|NCT03642132|65485425|FG001|Chemotherapy Period|Adverse Event|1|||
23475507|NCT03642132|65485426|FG002|Chemotherapy Period|Adverse Event|0|||
23475508|NCT03642132|65485424|FG000|Chemotherapy Period|Physician's decision|4|||
23475509|NCT03642132|65485425|FG001|Chemotherapy Period|Physician's decision|1|||
23475510|NCT03642132|65485426|FG002|Chemotherapy Period|Physician's decision|0|||
23475511|NCT03642132|65485424|FG000|Chemotherapy Period|Progressive disease|0|||
23475512|NCT03642132|65485425|FG001|Chemotherapy Period|Progressive disease|0|||
23475513|NCT03642132|65485426|FG002|Chemotherapy Period|Progressive disease|1|||
23475514|NCT03642132|65485424|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
23252503|NCT00295620|64667775|FG000|Overall Study|Withdrawal by Subject|37|||
23252504|NCT00295620|64667776|FG001|Overall Study|Withdrawal by Subject|50|||
23475515|NCT03642132|65485425|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
23475516|NCT03642132|65485426|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
23475517|NCT03642132|65485424|FG000|Chemotherapy Period|Other|1|||
23475518|NCT03642132|65485425|FG001|Chemotherapy Period|Other|0|||
23475519|NCT03642132|65485426|FG002|Chemotherapy Period|Other|2|||
23475520|NCT03642132|65485424|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
23475521|NCT03642132|65485425|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
23475522|NCT03642132|65485426|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
23475523|NCT03642132|65485424|FG000|Maintenance Period|Adverse Event|1|||
23475524|NCT03642132|65485425|FG001|Maintenance Period|Adverse Event|2|||
23475525|NCT03642132|65485426|FG002|Maintenance Period|Adverse Event|0|||
23475526|NCT03642132|65485424|FG000|Maintenance Period|Non-compliance with study drug|0|||
23475527|NCT03642132|65485425|FG001|Maintenance Period|Non-compliance with study drug|0|||
23475528|NCT03642132|65485426|FG002|Maintenance Period|Non-compliance with study drug|1|||
23475529|NCT03642132|65485424|FG000|Maintenance Period|Physician's decision|2|||
23475530|NCT03642132|65485425|FG001|Maintenance Period|Physician's decision|2|||
23475531|NCT03642132|65485426|FG002|Maintenance Period|Physician's decision|2|||
23475532|NCT03642132|65485424|FG000|Maintenance Period|Progressive disease|9|||
23475533|NCT03642132|65485425|FG001|Maintenance Period|Progressive disease|3|||
23475534|NCT03642132|65485426|FG002|Maintenance Period|Progressive disease|6|||
23475535|NCT03642132|65485424|FG000|Maintenance Period|Other|0|||
23475536|NCT03642132|65485425|FG001|Maintenance Period|Other|0|||
23475537|NCT03642132|65485426|FG002|Maintenance Period|Other|3|||
23475538|NCT03642132|65485424|FG000|Maintenance Period|Withdrawal by Subject|1|||
23475539|NCT03642132|65485425|FG001|Maintenance Period|Withdrawal by Subject|1|||
23475540|NCT03642132|65485426|FG002|Maintenance Period|Withdrawal by Subject|2|||
23475541|NCT03642132|65485424|FG000|Follow-up Period|Other|0|||
23475542|NCT03642132|65485425|FG001|Follow-up Period|Other|0|||
23475543|NCT03642132|65485426|FG002|Follow-up Period|Other|1|||
23475544|NCT03642132|65485424|FG000|Follow-up Period|Withdrawal by Subject|1|||
23475545|NCT03642132|65485425|FG001|Follow-up Period|Withdrawal by Subject|2|||
23475546|NCT03642132|65485426|FG002|Follow-up Period|Withdrawal by Subject|0|||
23475547|NCT03642132|65485424|FG000|Follow-up Period|Study terminated by sponsor|1|||
23475548|NCT03642132|65485425|FG001|Follow-up Period|Study terminated by sponsor|0|||
23475549|NCT03642132|65485426|FG002|Follow-up Period|Study terminated by sponsor|1|||
23475550|NCT03642132|65485424|FG000|Follow-up Period|Lack of Efficacy|1|||
23475551|NCT03642132|65485425|FG001|Follow-up Period|Lack of Efficacy|0|||
23475552|NCT03642132|65485426|FG002|Follow-up Period|Lack of Efficacy|0|||
23475553|NCT03642132|65485424|FG000|Follow-up Period|Death|1|||
23475554|NCT03642132|65485425|FG001|Follow-up Period|Death|0|||
23475555|NCT03642132|65485426|FG002|Follow-up Period|Death|2|||
23475556|NCT03642132|65485424|FG000|Follow-up Period|Adverse Event|1|||
23475557|NCT03642132|65485425|FG001|Follow-up Period|Adverse Event|0|||
23475558|NCT03642132|65485426|FG002|Follow-up Period|Adverse Event|0|||
23475559|NCT02410343|65485427|FG000|Core Period (24 Weeks)|Adverse Event|1|||
23475560|NCT02410343|65485428|FG001|Core Period (24 Weeks)|Adverse Event|0|||
23475561|NCT02410343|65485427|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
23475562|NCT02410343|65485428|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
23475563|NCT02410343|65485427|FG000|Extension Period (12 Months)|Adverse Event|1|||
23475564|NCT02410343|65485428|FG001|Extension Period (12 Months)|Adverse Event|0|||
23475565|NCT02410343|65485427|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
23475566|NCT02410343|65485428|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
23475567|NCT02576145|65485429|FG000|Overall Study|Adverse Event|1|||
23475568|NCT02576145|65485430|FG001|Overall Study|Adverse Event|0|||
23475569|NCT02576145|65485429|FG000|Overall Study|Withdrawal by Subject|1|||
23475570|NCT02576145|65485430|FG001|Overall Study|Withdrawal by Subject|0|||
23475571|NCT02576145|65485429|FG000|Overall Study|Acute rejection|1|||
23475572|NCT02576145|65485430|FG001|Overall Study|Acute rejection|0|||
23475573|NCT02576145|65485429|FG000|Overall Study|Tetanus Titers Decreased|0|||
23475574|NCT02576145|65485430|FG001|Overall Study|Tetanus Titers Decreased|1|||
23475575|NCT03148691|65485431|FG000|Overall Study|Protocol Violation|1|||
23475576|NCT03148691|65485432|FG001|Overall Study|Protocol Violation|2|||
23475577|NCT03148691|65485433|FG002|Overall Study|Protocol Violation|7|||
23475578|NCT03148691|65485431|FG000|Overall Study|Lost to Follow-up|0|||
23475579|NCT03148691|65485432|FG001|Overall Study|Lost to Follow-up|0|||
23475580|NCT03148691|65485433|FG002|Overall Study|Lost to Follow-up|1|||
23475581|NCT03148691|65485431|FG000|Overall Study|Other|1|||
23475582|NCT03148691|65485432|FG001|Overall Study|Other|0|||
23475583|NCT03148691|65485433|FG002|Overall Study|Other|0|||
23475584|NCT03148691|65485431|FG000|Overall Study|Withdrawal by Subject|1|||
23475585|NCT03148691|65485432|FG001|Overall Study|Withdrawal by Subject|0|||
23475586|NCT03148691|65485433|FG002|Overall Study|Withdrawal by Subject|0|||
23475587|NCT00294762|65485443|FG000|Overall Study|Did not receive study treatment|3|||
23475588|NCT00294762|65485444|FG001|Overall Study|Did not receive study treatment|3|||
23475589|NCT00668733|65485448|FG000|Overall Study|Lost to Follow-up|2|||
23475590|NCT00668733|65485449|FG001|Overall Study|Lost to Follow-up|3|||
23475591|NCT00668733|65485448|FG000|Overall Study|Withdrawal by Subject|0|||
23475592|NCT00668733|65485449|FG001|Overall Study|Withdrawal by Subject|4|||
23475593|NCT01256294|65485453|FG000|Overall Study|Adverse Event|1|||
23475594|NCT01256294|65485454|FG001|Overall Study|Adverse Event|0|||
23475595|NCT01256294|65485453|FG000|Overall Study|Withdrawal by Subject|1|||
23191489|NCT02436239|64442365|FG002|Open-Lable Treatment Period|Other Reason|0|||
23191490|NCT02436239|64442366|FG003|Open-Lable Treatment Period|Other Reason|0|||
23191491|NCT02436239|64442363|FG000|Down-Taper Period|Withdrawal by Subject|4|||
23252505|NCT00295620|64667775|FG000|Overall Study|Death|206|||
23252506|NCT00295620|64667776|FG001|Overall Study|Death|207|||
23191492|NCT02436239|64442364|FG001|Down-Taper Period|Withdrawal by Subject|4|||
23252507|NCT00295620|64667775|FG000|Overall Study|Other reasons|10|||
23475596|NCT01256294|65485454|FG001|Overall Study|Withdrawal by Subject|1|||
23589732|NCT02299635|65886183|FG000|Overall Study|Global deterioration of health status|1|||
23589733|NCT02299635|65886183|FG000|Overall Study|Objective progression or relapse|10|||
23589734|NCT02299635|65886183|FG000|Overall Study|Withdrawal by Subject|2|||
23589735|NCT02299635|65886183|FG000|Overall Study|Other|3|||
23589736|NCT01391130|65886189|FG000|Overall Study|Withdrawal by Subject|3|||
23589737|NCT01391130|65886190|FG001|Overall Study|Withdrawal by Subject|2|||
23589738|NCT01391130|65886189|FG000|Overall Study|Physician Decision|2|||
23589739|NCT01391130|65886190|FG001|Overall Study|Physician Decision|3|||
23589740|NCT01391130|65886189|FG000|Overall Study|Did not Receive Drug|1|||
23589741|NCT01391130|65886190|FG001|Overall Study|Did not Receive Drug|1|||
23589742|NCT01253226|65886193|FG000|Overall Study|Adverse Event|0|||
23589743|NCT01253226|65886194|FG001|Overall Study|Adverse Event|0|||
23589744|NCT01253226|65886195|FG002|Overall Study|Adverse Event|1|||
23589745|NCT01253226|65886196|FG003|Overall Study|Adverse Event|0|||
23589746|NCT01253226|65886197|FG004|Overall Study|Adverse Event|0|||
23589747|NCT01253226|65886193|FG000|Overall Study|Death|0|||
23589748|NCT01253226|65886194|FG001|Overall Study|Death|1|||
23589749|NCT01253226|65886195|FG002|Overall Study|Death|0|||
23589750|NCT01253226|65886196|FG003|Overall Study|Death|0|||
23589751|NCT01253226|65886197|FG004|Overall Study|Death|0|||
23589752|NCT01253226|65886193|FG000|Overall Study|Physician Decision|0|||
23589753|NCT01253226|65886194|FG001|Overall Study|Physician Decision|0|||
23589754|NCT01253226|65886195|FG002|Overall Study|Physician Decision|0|||
23589755|NCT01253226|65886196|FG003|Overall Study|Physician Decision|0|||
23589756|NCT01253226|65886197|FG004|Overall Study|Physician Decision|2|||
23589757|NCT01253226|65886193|FG000|Overall Study|Withdrawal by Subject|0|||
23589758|NCT01253226|65886194|FG001|Overall Study|Withdrawal by Subject|0|||
23589759|NCT01253226|65886195|FG002|Overall Study|Withdrawal by Subject|0|||
23358640|NCT04304508|65056345|FG001|Overall Study|Adverse Event|50|||
23358641|NCT04304508|65056346|FG002|Overall Study|Adverse Event|51|||
23358642|NCT04304508|65056347|FG003|Overall Study|Adverse Event|56|||
23358643|NCT04304508|65056344|FG000|Overall Study|Lost to Follow-up|1|||
23358644|NCT04304508|65056345|FG001|Overall Study|Lost to Follow-up|5|||
23358645|NCT04304508|65056346|FG002|Overall Study|Lost to Follow-up|2|||
23358646|NCT04304508|65056347|FG003|Overall Study|Lost to Follow-up|3|||
23358647|NCT03442088|65056348|FG000|Overall Study|Adverse Event|1|||
23358648|NCT03442088|65056348|FG000|Overall Study|Lack of Efficacy|2|||
23358649|NCT03442088|65056348|FG000|Overall Study|Lost to Follow-up|2|||
23358650|NCT01844817|65056349|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
23358651|NCT01844817|65056350|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
23358652|NCT01844817|65056349|FG000|Treatment|Progressive Disease|27|||
23358653|NCT01844817|65056350|FG001|Treatment|Progressive Disease|36|||
23358654|NCT01844817|65056349|FG000|Treatment|Adverse Event|17|||
23358655|NCT01844817|65056350|FG001|Treatment|Adverse Event|9|||
23358656|NCT01844817|65056349|FG000|Treatment|Withdrawal by Subject|10|||
23358657|NCT01844817|65056350|FG001|Treatment|Withdrawal by Subject|6|||
23358658|NCT01844817|65056349|FG000|Treatment|Death|10|||
23358659|NCT01844817|65056350|FG001|Treatment|Death|8|||
23358660|NCT01844817|65056349|FG000|Treatment|Lost to Follow-up|0|||
23358661|NCT01844817|65056350|FG001|Treatment|Lost to Follow-up|1|||
23358662|NCT01844817|65056349|FG000|Treatment|Other|0|||
23358663|NCT01844817|65056350|FG001|Treatment|Other|3|||
23358664|NCT04446429|65056351|FG000|Overall Study|Lost to Follow-up|6|||
23358665|NCT04446429|65056352|FG001|Overall Study|Lost to Follow-up|0|||
23358666|NCT00805129|65056353|FG000|Overall Study|Not treated|1|||
23358667|NCT00255840|65056366|FG000|Overall Study|Lost to Follow-up|10|||
23358668|NCT00255840|65056367|FG001|Overall Study|Lost to Follow-up|14|||
23358669|NCT00255840|65056366|FG000|Overall Study|Discontinued intervention|53|||
23358670|NCT00255840|65056367|FG001|Overall Study|Discontinued intervention|56|||
23589760|NCT01253226|65886196|FG003|Overall Study|Withdrawal by Subject|1|||
23358671|NCT00627926|65056370|FG000|Overall Study|Adverse Event|26|||
23358672|NCT00627926|65056371|FG001|Overall Study|Adverse Event|37|||
23358673|NCT00627926|65056372|FG002|Overall Study|Adverse Event|36|||
23358674|NCT00627926|65056370|FG000|Overall Study|Death|1|||
23358675|NCT00627926|65056371|FG001|Overall Study|Death|0|||
23589761|NCT01253226|65886197|FG004|Overall Study|Withdrawal by Subject|0|||
23589762|NCT00442117|65886198|FG000|Overall Study|Adverse Event|3|||
23589763|NCT00442117|65886199|FG001|Overall Study|Adverse Event|2|||
23589764|NCT00442117|65886198|FG000|Overall Study|Lack of Efficacy|2|||
23358676|NCT00627926|65056372|FG002|Overall Study|Death|0|||
23589765|NCT00442117|65886199|FG001|Overall Study|Lack of Efficacy|6|||
23589766|NCT00442117|65886198|FG000|Overall Study|Lost to Follow-up|1|||
23589767|NCT00442117|65886199|FG001|Overall Study|Lost to Follow-up|2|||
23589768|NCT00442117|65886198|FG000|Overall Study|Withdrawal by Subject|2|||
23589769|NCT00442117|65886199|FG001|Overall Study|Withdrawal by Subject|2|||
23589770|NCT00442117|65886198|FG000|Overall Study|Major Deviation|25|||
23589771|NCT00442117|65886199|FG001|Overall Study|Major Deviation|20|||
23589772|NCT00442117|65886198|FG000|Overall Study|Non compliance with protocol|3|||
23589773|NCT00442117|65886199|FG001|Overall Study|Non compliance with protocol|5|||
23589774|NCT00442117|65886198|FG000|Overall Study|Met Withdrawal Criteria|2|||
23589775|NCT00442117|65886199|FG001|Overall Study|Met Withdrawal Criteria|1|||
23589776|NCT01353963|65886202|FG000|Overall Study|Adverse Event|2|||
23589777|NCT04246762|65886203|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
23589778|NCT02873754|65886209|FG000|Overall Study|Lost to Follow-up|5|||
23589779|NCT02873754|65886209|FG000|Overall Study|Couldn't complete study procedures|1|||
23589780|NCT03008915|65886210|FG000|Treatment 1|Withdrawal by Subject|0|||
23589781|NCT03008915|65886211|FG001|Treatment 1|Withdrawal by Subject|1|||
23589782|NCT01909778|65886212|FG000|Overall Study|failed screening|1|||
23589783|NCT01456936|65886213|FG000|Overall Study|Other reason|41|||
23589784|NCT01456936|65886214|FG001|Overall Study|Other reason|30|||
23589785|NCT01456936|65886215|FG002|Overall Study|Other reason|36|||
23589786|NCT01456936|65886216|FG003|Overall Study|Other reason|33|||
23589787|NCT01456936|65886213|FG000|Overall Study|No longer meets eligibility criteria|4|||
23589788|NCT01456936|65886214|FG001|Overall Study|No longer meets eligibility criteria|8|||
23589789|NCT01456936|65886215|FG002|Overall Study|No longer meets eligibility criteria|6|||
23589790|NCT01456936|65886216|FG003|Overall Study|No longer meets eligibility criteria|5|||
23589791|NCT01456936|65886213|FG000|Overall Study|Protocol Violation|4|||
23589792|NCT01456936|65886214|FG001|Overall Study|Protocol Violation|2|||
23589793|NCT01456936|65886215|FG002|Overall Study|Protocol Violation|5|||
23589794|NCT01456936|65886216|FG003|Overall Study|Protocol Violation|5|||
23589795|NCT01456936|65886213|FG000|Overall Study|Pregnancy|1|||
23589796|NCT01456936|65886214|FG001|Overall Study|Pregnancy|0|||
23589797|NCT01456936|65886215|FG002|Overall Study|Pregnancy|0|||
23589798|NCT01456936|65886216|FG003|Overall Study|Pregnancy|1|||
23589799|NCT01456936|65886213|FG000|Overall Study|Insufficient clinical response|4|||
23589800|NCT01456936|65886214|FG001|Overall Study|Insufficient clinical response|4|||
23589801|NCT01456936|65886215|FG002|Overall Study|Insufficient clinical response|14|||
23589802|NCT01456936|65886216|FG003|Overall Study|Insufficient clinical response|13|||
23589803|NCT01456936|65886213|FG000|Overall Study|No longer willing to participate|195|||
23589804|NCT01456936|65886214|FG001|Overall Study|No longer willing to participate|218|||
23589805|NCT01456936|65886215|FG002|Overall Study|No longer willing to participate|224|||
23191493|NCT02436239|64442365|FG002|Down-Taper Period|Withdrawal by Subject|1|||
23191494|NCT02436239|64442366|FG003|Down-Taper Period|Withdrawal by Subject|2|||
23191495|NCT00783289|64442367|FG000|Overall Study|Protocol Violation|0|||
23191496|NCT00783289|64442368|FG001|Overall Study|Protocol Violation|1|||
23191497|NCT00783289|64442369|FG002|Overall Study|Protocol Violation|0|||
23191498|NCT00783289|64442370|FG003|Overall Study|Protocol Violation|0|||
23191499|NCT00881205|64442371|FG000|Overall Study|Adverse Event|8|||
23191500|NCT00881205|64442372|FG001|Overall Study|Adverse Event|3|||
23191501|NCT00881205|64442371|FG000|Overall Study|Withdrawal by Subject|1|||
23191502|NCT00881205|64442372|FG001|Overall Study|Withdrawal by Subject|2|||
23191503|NCT00881205|64442371|FG000|Overall Study|Lost to Follow-up|0|||
23191504|NCT00881205|64442372|FG001|Overall Study|Lost to Follow-up|1|||
23191505|NCT00881205|64442371|FG000|Overall Study|Administrative problems|1|||
23191506|NCT00881205|64442372|FG001|Overall Study|Administrative problems|1|||
23191507|NCT00881205|64442371|FG000|Overall Study|Condition no longer requires drug|1|||
23191508|NCT00881205|64442372|FG001|Overall Study|Condition no longer requires drug|0|||
23191509|NCT03494725|64442373|FG000|Overall Study|Withdrawal by Subject|0|||
23191510|NCT03494725|64442374|FG001|Overall Study|Withdrawal by Subject|2|||
23191511|NCT03494725|64442373|FG000|Overall Study|Antibiotic use|1|||
23191512|NCT03494725|64442374|FG001|Overall Study|Antibiotic use|0|||
23191513|NCT02873715|64442375|FG000|Overall Study|Lost to Follow-up|84|||
23191514|NCT02873715|64442376|FG001|Overall Study|Lost to Follow-up|94|||
23191515|NCT02873715|64442375|FG000|Overall Study|Withdrawal by Subject|7|||
23191516|NCT02873715|64442376|FG001|Overall Study|Withdrawal by Subject|26|||
23191517|NCT01508676|64442377|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
23475597|NCT01256294|65485453|FG000|Overall Study|Protocol deviation|2|||
23589806|NCT01456936|65886216|FG003|Overall Study|No longer willing to participate|248|||
23589807|NCT01456936|65886213|FG000|Overall Study|Lost to Follow-up|135|||
23589808|NCT01456936|65886214|FG001|Overall Study|Lost to Follow-up|126|||
23589809|NCT01456936|65886215|FG002|Overall Study|Lost to Follow-up|144|||
23589810|NCT01456936|65886216|FG003|Overall Study|Lost to Follow-up|127|||
23589811|NCT01456936|65886213|FG000|Overall Study|Medication error|0|||
23589812|NCT01456936|65886214|FG001|Overall Study|Medication error|1|||
23191518|NCT01508676|64442378|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
23191519|NCT01508676|64442377|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
23191520|NCT01508676|64442378|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
23191521|NCT01508676|64442377|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
23191522|NCT01508676|64442378|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
23475598|NCT01256294|65485454|FG001|Overall Study|Protocol deviation|1|||
23589813|NCT01456936|65886215|FG002|Overall Study|Medication error|0|||
23358677|NCT00627926|65056370|FG000|Overall Study|Lost to Follow-up|4|||
23358678|NCT00627926|65056371|FG001|Overall Study|Lost to Follow-up|3|||
23358679|NCT00627926|65056372|FG002|Overall Study|Lost to Follow-up|4|||
23358680|NCT00627926|65056370|FG000|Overall Study|Withdrawal by Subject|2|||
23358681|NCT00627926|65056371|FG001|Overall Study|Withdrawal by Subject|1|||
23358682|NCT00627926|65056372|FG002|Overall Study|Withdrawal by Subject|0|||
23358683|NCT00627926|65056370|FG000|Overall Study|Lack of Efficacy|118|||
23358684|NCT00627926|65056371|FG001|Overall Study|Lack of Efficacy|40|||
23358685|NCT00627926|65056372|FG002|Overall Study|Lack of Efficacy|38|||
23358686|NCT00627926|65056370|FG000|Overall Study|Noncompliance/unspecified|8|||
23358687|NCT00627926|65056371|FG001|Overall Study|Noncompliance/unspecified|23|||
23358688|NCT00627926|65056372|FG002|Overall Study|Noncompliance/unspecified|17|||
23358689|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
23358690|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
23589814|NCT01456936|65886216|FG003|Overall Study|Medication error|1|||
23589815|NCT01456936|65886213|FG000|Overall Study|Adverse event (study drug)|25|||
23589816|NCT01456936|65886214|FG001|Overall Study|Adverse event (study drug)|21|||
23589817|NCT01456936|65886215|FG002|Overall Study|Adverse event (study drug)|26|||
23589818|NCT01456936|65886216|FG003|Overall Study|Adverse event (study drug)|17|||
23589819|NCT01456936|65886213|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
23589820|NCT01456936|65886214|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
23589821|NCT01456936|65886215|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
23589822|NCT01456936|65886216|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
23589823|NCT01456936|65886213|FG000|Overall Study|Death|0|||
23589824|NCT01456936|65886214|FG001|Overall Study|Death|3|||
23589825|NCT01456936|65886215|FG002|Overall Study|Death|1|||
23589826|NCT01456936|65886216|FG003|Overall Study|Death|3|||
23589827|NCT01456936|65886213|FG000|Overall Study|Randomized but not treated|21|||
23589828|NCT01456936|65886214|FG001|Overall Study|Randomized but not treated|28|||
23589829|NCT01456936|65886215|FG002|Overall Study|Randomized but not treated|16|||
23589830|NCT01456936|65886216|FG003|Overall Study|Randomized but not treated|21|||
23589831|NCT01190007|65886223|FG000|Overall Study|Withdrawal by Subject|4|||
23589832|NCT01190007|65886223|FG000|Overall Study|Adverse Event|8|||
23589833|NCT01190007|65886223|FG000|Overall Study|Difficulty of visit for complications|1|||
23589834|NCT01190007|65886223|FG000|Overall Study|Participant was arrested|1|||
23589835|NCT04381494|65886224|FG000|Overall Study|Early termination of trial|19|||
23589836|NCT04381494|65886224|FG000|Overall Study|Investigator's discretion|1|||
23589837|NCT04381494|65886224|FG000|Overall Study|Withdrawal by Subject|9|||
23589838|NCT04381494|65886224|FG000|Overall Study|NSCLC disease progression|4|||
23589839|NCT04381494|65886224|FG000|Overall Study|Device-Related Adverse Event|2|||
23589840|NCT04567888|65886227|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
23589841|NCT04567888|65886228|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
23589842|NCT04567888|65886227|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
23589843|NCT04567888|65886228|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
23589844|NCT04567888|65886227|FG000|Overall Study|Reported Unusual Birth Year|2|||
23589845|NCT04567888|65886228|FG001|Overall Study|Reported Unusual Birth Year|3|||
23589846|NCT04567888|65886227|FG000|Overall Study|Duplicate Responses|0|||
23589847|NCT04567888|65886228|FG001|Overall Study|Duplicate Responses|1|||
23589848|NCT03920215|65886229|FG000|Overall Study|Lost to Follow-up|1|||
23589849|NCT03920215|65886230|FG001|Overall Study|Lost to Follow-up|2|||
23589850|NCT03920215|65886231|FG002|Overall Study|Lost to Follow-up|0|||
23589851|NCT03920215|65886232|FG003|Overall Study|Lost to Follow-up|0|||
23589852|NCT03920215|65886229|FG000|Overall Study|Death|0|||
23589853|NCT03920215|65886230|FG001|Overall Study|Death|0|||
23589854|NCT03920215|65886231|FG002|Overall Study|Death|0|||
23589855|NCT03920215|65886232|FG003|Overall Study|Death|1|||
23589856|NCT01597258|65886233|FG000|Overall Study|No Drug Administration|1|||
23589857|NCT02614560|65886236|FG000|Overall Study|Death|6|||
23358691|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
23358692|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
23589858|NCT02614560|65886237|FG001|Overall Study|Death|2|||
23589859|NCT02975934|65886238|FG000|Treatment Phase|Ongoing at data-analysis|33|||
23589860|NCT02975934|65886239|FG001|Treatment Phase|Ongoing at data-analysis|5|||
23589861|NCT02975934|65886238|FG000|Treatment Phase|Discontinued prior to study drug|0|||
23191523|NCT01508676|64442377|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
23358693|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
23358694|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
23358695|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
23358696|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
23358697|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
23358698|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
23358699|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
23358700|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
23358701|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
23358702|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
23358703|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
23358704|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
23358705|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
23358706|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
23358707|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
23358708|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
23358709|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
23358710|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
23358711|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
23358712|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
23358713|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
23358714|NCT02137226|65056373|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
23358715|NCT02137226|65056374|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
23358716|NCT02137226|65056375|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
23358717|NCT02137226|65056376|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
23358718|NCT02137226|65056377|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
23358719|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
23358720|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
23358721|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
23358722|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
23358723|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
23358724|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
23358725|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
23358726|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
23358727|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
23358728|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
23358729|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
23358730|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
23358731|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
23358732|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
23191524|NCT01508676|64442378|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
23358733|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
23358734|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
23358735|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
23358736|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
23358737|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
23358738|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
23358739|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
23358740|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
23358741|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
23358742|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
23358743|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
23358744|NCT02137226|65056373|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
23358745|NCT02137226|65056374|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
23358746|NCT02137226|65056375|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
23358747|NCT02137226|65056376|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
23358748|NCT02137226|65056377|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
23358749|NCT00631163|65056378|FG000|Number of Participants in Year 1|Adverse Event|12|||
23358750|NCT00631163|65056378|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
23358751|NCT00631163|65056378|FG000|Number of Participants in Year 1|Death|6|||
23358752|NCT00631163|65056378|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
23358753|NCT00631163|65056378|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
23358754|NCT00631163|65056378|FG000|Number of Participants in Year 1|Administrative problems|6|||
23358755|NCT00631163|65056378|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
23358756|NCT00631163|65056378|FG000|Number of Participants in Year 2|Adverse Event|1|||
23358757|NCT00631163|65056378|FG000|Number of Participants in Year 2|Protocol Violation|1|||
23358758|NCT00631163|65056378|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
23589862|NCT02975934|65886239|FG001|Treatment Phase|Discontinued prior to study drug|5|||
23589863|NCT02975934|65886238|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
23589864|NCT02975934|65886239|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
23589865|NCT02263508|65889461|FG000|Overall Study|Withdrawal by Subject|1|||
23589866|NCT02263508|65889462|FG001|Overall Study|Withdrawal by Subject|23|||
23589867|NCT02263508|65889463|FG002|Overall Study|Withdrawal by Subject|17|||
23589868|NCT02263508|65889461|FG000|Overall Study|Sponsor Decision|12|||
23589869|NCT02263508|65889462|FG001|Overall Study|Sponsor Decision|165|||
23589870|NCT02263508|65889463|FG002|Overall Study|Sponsor Decision|182|||
23589871|NCT02263508|65889461|FG000|Overall Study|Lost to Follow-up|2|||
23589872|NCT02263508|65889462|FG001|Overall Study|Lost to Follow-up|7|||
23589873|NCT02263508|65889463|FG002|Overall Study|Lost to Follow-up|7|||
23589874|NCT02263508|65889461|FG000|Overall Study|Death|6|||
23589875|NCT02263508|65889462|FG001|Overall Study|Death|151|||
23589876|NCT02263508|65889463|FG002|Overall Study|Death|140|||
23589877|NCT04379713|65889465|FG000|Overall Study|Adverse Event|2|||
23589878|NCT04379713|65889466|FG001|Overall Study|Adverse Event|0|||
23589879|NCT04379713|65889465|FG000|Overall Study|Physician Decision|2|||
23589880|NCT04379713|65889466|FG001|Overall Study|Physician Decision|1|||
23589881|NCT04379713|65889465|FG000|Overall Study|Protocol Violation|11|||
23589882|NCT04379713|65889466|FG001|Overall Study|Protocol Violation|6|||
23589883|NCT04379713|65889465|FG000|Overall Study|No longer met eligibility criteria|14|||
23589884|NCT04379713|65889466|FG001|Overall Study|No longer met eligibility criteria|11|||
23589885|NCT04379713|65889465|FG000|Overall Study|Withdrawal by parent/guardian|36|||
23589886|NCT04379713|65889466|FG001|Overall Study|Withdrawal by parent/guardian|15|||
23589887|NCT04379713|65889465|FG000|Overall Study|Lost to Follow-up|31|||
23589888|NCT04379713|65889466|FG001|Overall Study|Lost to Follow-up|21|||
23589889|NCT00868192|65889467|FG000|Overall Study|Ineligible|4|||
23589890|NCT00258895|65889475|FG000|Overall Study|Lost to Follow-up|3|||
23589891|NCT00258895|65889476|FG001|Overall Study|Lost to Follow-up|1|||
23589892|NCT00258895|65889475|FG000|Overall Study|Protocol Violation|6|||
23589893|NCT00258895|65889476|FG001|Overall Study|Protocol Violation|2|||
23589894|NCT00258895|65889475|FG000|Overall Study|Withdrawal by Subject|1|||
23589895|NCT00258895|65889476|FG001|Overall Study|Withdrawal by Subject|0|||
23589896|NCT03808883|65889477|FG000|Overall Study|Withdrawal by Subject|2|||
23589897|NCT03808883|65889478|FG001|Overall Study|Withdrawal by Subject|0|||
23589898|NCT03808883|65889477|FG000|Overall Study|Did not complete pre test or post test survey|4|||
23589899|NCT03808883|65889478|FG001|Overall Study|Did not complete pre test or post test survey|3|||
23589900|NCT02950558|65889479|FG000|Overall Study|Lost to Follow-up|2|||
23589901|NCT02950558|65889480|FG001|Overall Study|Lost to Follow-up|0|||
23589902|NCT00158054|65889483|FG000|Overall Study|Refused to continue|3|||
23589903|NCT00158054|65889484|FG001|Overall Study|Refused to continue|0|||
23589904|NCT00158054|65889483|FG000|Overall Study|Unavailable for follow up|7|||
23589905|NCT00158054|65889484|FG001|Overall Study|Unavailable for follow up|3|||
23589906|NCT03615924|65889488|FG000|Overall Study|Withdrawal by Subject|2|||
23589907|NCT03615924|65889489|FG001|Overall Study|Withdrawal by Subject|5|||
23358759|NCT02779075|65056381|FG000|Overall Study|Withdrawal by Subject|1|||
23358760|NCT02779075|65056382|FG001|Overall Study|Withdrawal by Subject|3|||
23358761|NCT02779075|65056381|FG000|Overall Study|IV lost during 2nd study|1|||
23358762|NCT02779075|65056382|FG001|Overall Study|IV lost during 2nd study|0|||
23358763|NCT00045734|65056397|FG000|Overall Study|Protocol Violation|1|||
23358764|NCT01663857|65056398|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
23358765|NCT01663857|65056399|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
23358766|NCT01663857|65056400|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
23358767|NCT01663857|65056401|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
23358768|NCT01663857|65056398|FG000|Overall Study|Lost to Follow-up|0|||
23358769|NCT01663857|65056399|FG001|Overall Study|Lost to Follow-up|0|||
23358770|NCT01663857|65056400|FG002|Overall Study|Lost to Follow-up|3|||
23358771|NCT01663857|65056401|FG003|Overall Study|Lost to Follow-up|1|||
23589908|NCT03615924|65889488|FG000|Overall Study|Death|3|||
23589909|NCT03615924|65889489|FG001|Overall Study|Death|1|||
23191525|NCT01508676|64442377|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
23191526|NCT01508676|64442378|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
23191527|NCT01024244|64442389|FG000|Overall Study|Adverse Event|1|||
23191528|NCT01024244|64442390|FG001|Overall Study|Adverse Event|2|||
23191529|NCT01024244|64442391|FG002|Overall Study|Adverse Event|0|||
23191530|NCT01024244|64442392|FG003|Overall Study|Adverse Event|1|||
23191531|NCT01024244|64442393|FG004|Overall Study|Adverse Event|2|||
23191532|NCT01024244|64442389|FG000|Overall Study|Entry Criteria Not Met|0|||
23191533|NCT01024244|64442390|FG001|Overall Study|Entry Criteria Not Met|1|||
23191534|NCT01024244|64442391|FG002|Overall Study|Entry Criteria Not Met|0|||
23191535|NCT01024244|64442392|FG003|Overall Study|Entry Criteria Not Met|0|||
23191536|NCT01024244|64442393|FG004|Overall Study|Entry Criteria Not Met|0|||
23191537|NCT01024244|64442389|FG000|Overall Study|Lack of Efficacy|1|||
23191538|NCT01024244|64442390|FG001|Overall Study|Lack of Efficacy|0|||
23191539|NCT01024244|64442391|FG002|Overall Study|Lack of Efficacy|0|||
23191540|NCT01024244|64442392|FG003|Overall Study|Lack of Efficacy|0|||
23191541|NCT01024244|64442393|FG004|Overall Study|Lack of Efficacy|0|||
23191542|NCT01024244|64442389|FG000|Overall Study|Protocol Violation|1|||
23191543|NCT01024244|64442390|FG001|Overall Study|Protocol Violation|0|||
23191544|NCT01024244|64442391|FG002|Overall Study|Protocol Violation|0|||
23191545|NCT01024244|64442392|FG003|Overall Study|Protocol Violation|0|||
23191546|NCT01024244|64442393|FG004|Overall Study|Protocol Violation|2|||
23191547|NCT01024244|64442389|FG000|Overall Study|Sponsor Decision|14|||
23191548|NCT01024244|64442390|FG001|Overall Study|Sponsor Decision|7|||
23191549|NCT01024244|64442391|FG002|Overall Study|Sponsor Decision|14|||
23191550|NCT01024244|64442392|FG003|Overall Study|Sponsor Decision|12|||
23191551|NCT01024244|64442393|FG004|Overall Study|Sponsor Decision|10|||
23191552|NCT01024244|64442389|FG000|Overall Study|Withdrawal by Subject|0|||
23191553|NCT01024244|64442390|FG001|Overall Study|Withdrawal by Subject|1|||
23191554|NCT01024244|64442391|FG002|Overall Study|Withdrawal by Subject|0|||
23191555|NCT01024244|64442392|FG003|Overall Study|Withdrawal by Subject|0|||
23191556|NCT01024244|64442393|FG004|Overall Study|Withdrawal by Subject|0|||
23191557|NCT00545818|64442394|FG000|Overall Study|Protocol Violation|1|||
23191558|NCT00545818|64442395|FG001|Overall Study|Protocol Violation|0|||
23252508|NCT00295620|64667776|FG001|Overall Study|Other reasons|9|||
23252509|NCT00295620|64667775|FG000|Overall Study|Discontinuation by sponsor|580|||
23252510|NCT00295620|64667776|FG001|Overall Study|Discontinuation by sponsor|593|||
23252511|NCT00295620|64667775|FG000|Overall Study|Protocol Violation|30|||
23191559|NCT00545818|64442394|FG000|Overall Study|Adverse Event|1|||
23191560|NCT00545818|64442395|FG001|Overall Study|Adverse Event|1|||
23191561|NCT00545818|64442394|FG000|Overall Study|Lost to Follow-up|1|||
23191562|NCT00545818|64442395|FG001|Overall Study|Lost to Follow-up|6|||
23191563|NCT00069121|64442396|FG000|Overall Study|Death|286|||
23191564|NCT00069121|64442397|FG001|Overall Study|Death|242|||
23191565|NCT00069121|64442396|FG000|Overall Study|Withdrawal by Subject|18|||
23191566|NCT00069121|64442397|FG001|Overall Study|Withdrawal by Subject|20|||
23191567|NCT00069121|64442396|FG000|Overall Study|Lost to Follow-up|63|||
23252512|NCT00295620|64667776|FG001|Overall Study|Protocol Violation|32|||
23252513|NCT01964898|64667777|FG000|Overall Study|ineligible post-randomization|1|||
23358772|NCT02757625|65056402|FG000|Overall Study|Investigator's discretion|0|||
23358773|NCT02757625|65056403|FG001|Overall Study|Investigator's discretion|0|||
23589910|NCT03615924|65889488|FG000|Overall Study|Lost to Follow-up|1|||
23191568|NCT00069121|64442397|FG001|Overall Study|Lost to Follow-up|63|||
23191569|NCT03694522|64442398|FG000|Overall Study|Withdrawal by Subject|8|||
23252514|NCT01964898|64667778|FG001|Overall Study|ineligible post-randomization|1|||
23252515|NCT01964898|64667777|FG000|Overall Study|did not receive the allocated interventi|2|||
23358774|NCT02757625|65056404|FG002|Overall Study|Investigator's discretion|1|||
23191570|NCT03694522|64442399|FG001|Overall Study|Withdrawal by Subject|10|||
23191571|NCT03694522|64442398|FG000|Overall Study|Physician Decision|53|||
23191572|NCT03694522|64442399|FG001|Overall Study|Physician Decision|54|||
23191573|NCT03694522|64442398|FG000|Overall Study|Other|1|||
23191574|NCT03694522|64442399|FG001|Overall Study|Other|1|||
23191575|NCT03694522|64442398|FG000|Overall Study|Lost to Follow-up|0|||
23191576|NCT03694522|64442399|FG001|Overall Study|Lost to Follow-up|1|||
23358775|NCT02757625|65056405|FG003|Overall Study|Investigator's discretion|0|||
23191577|NCT00650585|64442404|FG000|Overall Study|Lost to Follow-up|505|||
23191578|NCT00650585|64442405|FG001|Overall Study|Lost to Follow-up|482|||
23191579|NCT00650585|64442404|FG000|Overall Study|No parental consent|935|||
23191580|NCT00650585|64442405|FG001|Overall Study|No parental consent|866|||
23191581|NCT00650585|64442404|FG000|Overall Study|Excluded/ruled ineligible|357|||
23191582|NCT00650585|64442405|FG001|Overall Study|Excluded/ruled ineligible|129|||
23191583|NCT00393458|64442408|FG000|Overall Study|Adverse Event|35|||
23191584|NCT00393458|64442409|FG001|Overall Study|Adverse Event|24|||
23191585|NCT00393458|64442410|FG002|Overall Study|Adverse Event|40|||
23191586|NCT00393458|64442411|FG003|Overall Study|Adverse Event|35|||
23191587|NCT00393458|64442408|FG000|Overall Study|Subject withdrew consent|27|||
23191588|NCT00393458|64442409|FG001|Overall Study|Subject withdrew consent|40|||
23191589|NCT00393458|64442410|FG002|Overall Study|Subject withdrew consent|33|||
23191590|NCT00393458|64442411|FG003|Overall Study|Subject withdrew consent|50|||
23191591|NCT00393458|64442408|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
23191592|NCT00393458|64442409|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
23191593|NCT00393458|64442410|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
23191594|NCT00393458|64442411|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
23191595|NCT00393458|64442408|FG000|Overall Study|Protocol deviation|11|||
23191596|NCT00393458|64442409|FG001|Overall Study|Protocol deviation|11|||
23191597|NCT00393458|64442410|FG002|Overall Study|Protocol deviation|11|||
23191598|NCT00393458|64442411|FG003|Overall Study|Protocol deviation|10|||
23191599|NCT00393458|64442408|FG000|Overall Study|Administrative problems|7|||
23191600|NCT00393458|64442409|FG001|Overall Study|Administrative problems|8|||
23191601|NCT00393458|64442410|FG002|Overall Study|Administrative problems|5|||
23191602|NCT00393458|64442411|FG003|Overall Study|Administrative problems|2|||
23191603|NCT00393458|64442408|FG000|Overall Study|Lost to Follow-up|5|||
23191604|NCT00393458|64442409|FG001|Overall Study|Lost to Follow-up|6|||
23191605|NCT00393458|64442410|FG002|Overall Study|Lost to Follow-up|5|||
23191606|NCT00393458|64442411|FG003|Overall Study|Lost to Follow-up|3|||
23191607|NCT00393458|64442408|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23191608|NCT00393458|64442409|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23191609|NCT00393458|64442410|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23191610|NCT00393458|64442411|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23191611|NCT00393458|64442408|FG000|Overall Study|Death|1|||
23191612|NCT00393458|64442409|FG001|Overall Study|Death|1|||
23191613|NCT00393458|64442410|FG002|Overall Study|Death|5|||
23191614|NCT00393458|64442411|FG003|Overall Study|Death|5|||
23191615|NCT00393458|64442408|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23191616|NCT00393458|64442409|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23191617|NCT00393458|64442410|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23191618|NCT00393458|64442411|FG003|Overall Study|Abnormal test procedure result(s)|2|||
23191619|NCT00393458|64442408|FG000|Overall Study|Subject no longer requires study drug|0|||
23191620|NCT00393458|64442409|FG001|Overall Study|Subject no longer requires study drug|1|||
23191621|NCT00393458|64442410|FG002|Overall Study|Subject no longer requires study drug|0|||
23191622|NCT00393458|64442411|FG003|Overall Study|Subject no longer requires study drug|0|||
23191623|NCT02786537|64442412|FG000|As Randomized|Adverse Event|0|||
23191624|NCT02786537|64442413|FG001|As Randomized|Adverse Event|11|||
23191625|NCT02786537|64442414|FG002|As Randomized|Adverse Event|0|||
23191626|NCT02786537|64442415|FG003|As Randomized|Adverse Event|4|||
23191627|NCT02786537|64442416|FG004|As Randomized|Adverse Event|6|||
23191628|NCT02786537|64442417|FG005|As Randomized|Adverse Event|2|||
23191629|NCT02786537|64442412|FG000|As Randomized|Lack of Efficacy|0|||
23191630|NCT02786537|64442413|FG001|As Randomized|Lack of Efficacy|0|||
23252516|NCT01964898|64667778|FG001|Overall Study|did not receive the allocated interventi|1|||
23252517|NCT01964898|64667777|FG000|Overall Study|Lost to Follow-up|3|||
23475599|NCT03232333|65485455|FG000|Overall Study|Infection or Osteomyelitis|9|||
23191631|NCT02786537|64442414|FG002|As Randomized|Lack of Efficacy|0|||
23191632|NCT02786537|64442415|FG003|As Randomized|Lack of Efficacy|1|||
23191633|NCT02786537|64442416|FG004|As Randomized|Lack of Efficacy|0|||
23191634|NCT02786537|64442417|FG005|As Randomized|Lack of Efficacy|0|||
23191635|NCT02786537|64442412|FG000|As Randomized|Withdrawal by Subject|1|||
23191636|NCT02786537|64442413|FG001|As Randomized|Withdrawal by Subject|2|||
23191637|NCT02786537|64442414|FG002|As Randomized|Withdrawal by Subject|0|||
23191638|NCT02786537|64442415|FG003|As Randomized|Withdrawal by Subject|1|||
23191639|NCT02786537|64442416|FG004|As Randomized|Withdrawal by Subject|1|||
23191640|NCT02786537|64442417|FG005|As Randomized|Withdrawal by Subject|0|||
23191641|NCT02786537|64442412|FG000|As Randomized|Death|0|||
23252518|NCT01964898|64667778|FG001|Overall Study|Lost to Follow-up|5|||
23252519|NCT01964898|64667777|FG000|Overall Study|Withdrawal by Subject|1|||
23252520|NCT01964898|64667778|FG001|Overall Study|Withdrawal by Subject|0|||
23252521|NCT03944707|64667786|FG000|Overall Study|Adverse Event|0|||
23252522|NCT03944707|64667787|FG001|Overall Study|Adverse Event|2|||
23252523|NCT03944707|64667786|FG000|Overall Study|Study terminated by sponsor|12|||
23252524|NCT03944707|64667787|FG001|Overall Study|Study terminated by sponsor|7|||
23252525|NCT03944707|64667786|FG000|Overall Study|Subject decision|0|||
23252526|NCT03944707|64667787|FG001|Overall Study|Subject decision|1|||
23252527|NCT00479401|64667788|FG000|Overall Study|Adverse Event|24|||
23252528|NCT00479401|64667789|FG001|Overall Study|Adverse Event|20|||
23252529|NCT00479401|64667790|FG002|Overall Study|Adverse Event|4|||
23252530|NCT00479401|64667788|FG000|Overall Study|Lack of Efficacy|2|||
23252531|NCT00479401|64667789|FG001|Overall Study|Lack of Efficacy|2|||
23252532|NCT00479401|64667790|FG002|Overall Study|Lack of Efficacy|4|||
23252533|NCT00479401|64667788|FG000|Overall Study|Protocol Violation|2|||
23475600|NCT03232333|65485455|FG000|Overall Study|Lost to Follow-up|4|||
23252534|NCT00479401|64667789|FG001|Overall Study|Protocol Violation|1|||
23475601|NCT03232333|65485455|FG000|Overall Study|Withdrawal by Subject|2|||
23475602|NCT00732940|65485458|FG000|Overall Study|Withdrawal by Subject|1|||
23475603|NCT00732940|65485459|FG001|Overall Study|Withdrawal by Subject|2|||
23191642|NCT02786537|64442413|FG001|As Randomized|Death|2|||
23191643|NCT02786537|64442414|FG002|As Randomized|Death|0|||
23191644|NCT02786537|64442415|FG003|As Randomized|Death|3|||
23191645|NCT02786537|64442416|FG004|As Randomized|Death|1|||
23191646|NCT02786537|64442417|FG005|As Randomized|Death|0|||
23191647|NCT02786537|64442412|FG000|As Randomized|Non-compliance with study drug|1|||
23191648|NCT02786537|64442413|FG001|As Randomized|Non-compliance with study drug|11|||
23191649|NCT02786537|64442414|FG002|As Randomized|Non-compliance with study drug|0|||
23475604|NCT00732940|65485458|FG000|Overall Study|Adverse Event|0|||
23475605|NCT00732940|65485459|FG001|Overall Study|Adverse Event|1|||
23475606|NCT00732940|65485458|FG000|Overall Study|Lost to Follow-up|1|||
23589911|NCT03615924|65889489|FG001|Overall Study|Lost to Follow-up|0|||
23589912|NCT03615924|65889488|FG000|Overall Study|Randomized in error|1|||
23191650|NCT02786537|64442415|FG003|As Randomized|Non-compliance with study drug|1|||
23191651|NCT02786537|64442416|FG004|As Randomized|Non-compliance with study drug|0|||
23191652|NCT02786537|64442417|FG005|As Randomized|Non-compliance with study drug|1|||
23191653|NCT02786537|64442412|FG000|As Randomized|Lost to treatment follow-up|4|||
23191654|NCT02786537|64442413|FG001|As Randomized|Lost to treatment follow-up|32|||
23191655|NCT02786537|64442414|FG002|As Randomized|Lost to treatment follow-up|0|||
23191656|NCT02786537|64442415|FG003|As Randomized|Lost to treatment follow-up|24|||
23191657|NCT02786537|64442416|FG004|As Randomized|Lost to treatment follow-up|4|||
23191658|NCT02786537|64442417|FG005|As Randomized|Lost to treatment follow-up|4|||
23191659|NCT02786537|64442412|FG000|As Randomized|Incarceration|0|||
23191660|NCT02786537|64442413|FG001|As Randomized|Incarceration|1|||
23191661|NCT02786537|64442414|FG002|As Randomized|Incarceration|0|||
23191662|NCT02786537|64442415|FG003|As Randomized|Incarceration|0|||
23191663|NCT02786537|64442416|FG004|As Randomized|Incarceration|0|||
23191664|NCT02786537|64442417|FG005|As Randomized|Incarceration|0|||
23191665|NCT02786537|64442412|FG000|As Randomized|Opiate Dependency Relapse|0|||
23191666|NCT02786537|64442413|FG001|As Randomized|Opiate Dependency Relapse|1|||
23191667|NCT02786537|64442414|FG002|As Randomized|Opiate Dependency Relapse|0|||
23191668|NCT02786537|64442415|FG003|As Randomized|Opiate Dependency Relapse|0|||
23475607|NCT00732940|65485459|FG001|Overall Study|Lost to Follow-up|0|||
23475608|NCT01217307|65485460|FG000|Overall Study|Withdrawal by Subject|0|||
23475609|NCT01217307|65485461|FG001|Overall Study|Withdrawal by Subject|1|||
23475610|NCT00311584|65485462|FG000|Overall Study|Death|1|||
23475611|NCT00311584|65485463|FG001|Overall Study|Death|0|||
23589913|NCT03615924|65889489|FG001|Overall Study|Randomized in error|0|||
23589914|NCT03615924|65889488|FG000|Overall Study|Study termination by Sponsor|94|||
23475612|NCT00311584|65485462|FG000|Overall Study|Lack of Efficacy|12|||
23589915|NCT03615924|65889489|FG001|Overall Study|Study termination by Sponsor|86|||
23589916|NCT00494442|65889490|FG000|Overall Study|Death|1|||
23191669|NCT02786537|64442416|FG004|As Randomized|Opiate Dependency Relapse|0|||
23191670|NCT02786537|64442417|FG005|As Randomized|Opiate Dependency Relapse|0|||
23191671|NCT02786537|64442412|FG000|As Randomized|HCV drugs stolen from pt|0|||
23252535|NCT00479401|64667790|FG002|Overall Study|Protocol Violation|1|||
23252536|NCT00479401|64667788|FG000|Overall Study|Lost to Follow-up|1|||
23252537|NCT00479401|64667789|FG001|Overall Study|Lost to Follow-up|1|||
23475613|NCT00311584|65485463|FG001|Overall Study|Lack of Efficacy|15|||
23589917|NCT00494442|65889491|FG001|Overall Study|Death|1|||
23252538|NCT00479401|64667790|FG002|Overall Study|Lost to Follow-up|1|||
23252539|NCT00479401|64667788|FG000|Overall Study|Withdrawal by Subject|16|||
23252540|NCT00479401|64667789|FG001|Overall Study|Withdrawal by Subject|10|||
23252541|NCT00479401|64667790|FG002|Overall Study|Withdrawal by Subject|2|||
23475614|NCT00311584|65485462|FG000|Overall Study|Physician Decision|4|||
23191672|NCT02786537|64442413|FG001|As Randomized|HCV drugs stolen from pt|1|||
23191673|NCT02786537|64442414|FG002|As Randomized|HCV drugs stolen from pt|0|||
23252542|NCT00479401|64667788|FG000|Overall Study|Exclusion criteria, relocation|4|||
23252543|NCT00479401|64667789|FG001|Overall Study|Exclusion criteria, relocation|3|||
23252544|NCT00479401|64667790|FG002|Overall Study|Exclusion criteria, relocation|0|||
23252545|NCT01586624|64667791|FG000|Overall Study|Adverse Event|3|||
23252546|NCT01586624|64667792|FG001|Overall Study|Adverse Event|0|||
23252547|NCT01586624|64667793|FG002|Overall Study|Adverse Event|2|||
23252548|NCT01586624|64667794|FG003|Overall Study|Adverse Event|1|||
23252549|NCT01586624|64667795|FG004|Overall Study|Adverse Event|3|||
23191674|NCT02786537|64442415|FG003|As Randomized|HCV drugs stolen from pt|0|||
23191675|NCT02786537|64442416|FG004|As Randomized|HCV drugs stolen from pt|0|||
23191676|NCT02786537|64442417|FG005|As Randomized|HCV drugs stolen from pt|0|||
23191677|NCT02786537|64442412|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
23191678|NCT02786537|64442413|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
23191679|NCT02786537|64442414|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
23191680|NCT02786537|64442415|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
23191681|NCT02786537|64442416|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
23191682|NCT02786537|64442417|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
23191683|NCT02786537|64442412|FG000|As Randomized|Subject lost insurance|0|||
23191684|NCT02786537|64442413|FG001|As Randomized|Subject lost insurance|0|||
23191685|NCT02786537|64442414|FG002|As Randomized|Subject lost insurance|0|||
23191686|NCT02786537|64442415|FG003|As Randomized|Subject lost insurance|1|||
23191687|NCT02786537|64442416|FG004|As Randomized|Subject lost insurance|0|||
23191688|NCT02786537|64442417|FG005|As Randomized|Subject lost insurance|0|||
23191689|NCT02786537|64442412|FG000|As Treated|Adverse Event|0|||
23191690|NCT02786537|64442413|FG001|As Treated|Adverse Event|11|||
23191691|NCT02786537|64442414|FG002|As Treated|Adverse Event|0|||
23191692|NCT02786537|64442415|FG003|As Treated|Adverse Event|4|||
23191693|NCT02786537|64442416|FG004|As Treated|Adverse Event|6|||
23191694|NCT02786537|64442417|FG005|As Treated|Adverse Event|2|||
23191695|NCT02786537|64442412|FG000|As Treated|Death|0|||
23191696|NCT02786537|64442413|FG001|As Treated|Death|2|||
23191697|NCT02786537|64442414|FG002|As Treated|Death|0|||
23191698|NCT02786537|64442415|FG003|As Treated|Death|3|||
23191699|NCT02786537|64442416|FG004|As Treated|Death|1|||
23191700|NCT02786537|64442417|FG005|As Treated|Death|0|||
23191701|NCT02786537|64442412|FG000|As Treated|Lack of Efficacy|0|||
23191702|NCT02786537|64442413|FG001|As Treated|Lack of Efficacy|0|||
23191703|NCT02786537|64442414|FG002|As Treated|Lack of Efficacy|0|||
23191704|NCT02786537|64442415|FG003|As Treated|Lack of Efficacy|1|||
23191705|NCT02786537|64442416|FG004|As Treated|Lack of Efficacy|0|||
23191706|NCT02786537|64442417|FG005|As Treated|Lack of Efficacy|0|||
23191707|NCT02786537|64442412|FG000|As Treated|Lost to Follow-up|4|||
23191708|NCT02786537|64442413|FG001|As Treated|Lost to Follow-up|32|||
23191709|NCT02786537|64442414|FG002|As Treated|Lost to Follow-up|0|||
23191710|NCT02786537|64442415|FG003|As Treated|Lost to Follow-up|25|||
23191711|NCT02786537|64442416|FG004|As Treated|Lost to Follow-up|4|||
23191712|NCT02786537|64442417|FG005|As Treated|Lost to Follow-up|4|||
23191713|NCT02786537|64442412|FG000|As Treated|Non-compliance with study drug|1|||
23191714|NCT02786537|64442413|FG001|As Treated|Non-compliance with study drug|11|||
23191715|NCT02786537|64442414|FG002|As Treated|Non-compliance with study drug|0|||
23191716|NCT02786537|64442415|FG003|As Treated|Non-compliance with study drug|1|||
23191717|NCT02786537|64442416|FG004|As Treated|Non-compliance with study drug|0|||
23191718|NCT02786537|64442417|FG005|As Treated|Non-compliance with study drug|1|||
23191719|NCT02786537|64442412|FG000|As Treated|Lost insurance|0|||
23191720|NCT02786537|64442413|FG001|As Treated|Lost insurance|0|||
23191721|NCT02786537|64442414|FG002|As Treated|Lost insurance|0|||
23191722|NCT02786537|64442415|FG003|As Treated|Lost insurance|1|||
23358776|NCT02757625|65056402|FG000|Overall Study|Adverse Event|0|||
23191723|NCT02786537|64442416|FG004|As Treated|Lost insurance|0|||
23191724|NCT02786537|64442417|FG005|As Treated|Lost insurance|0|||
23191725|NCT02786537|64442412|FG000|As Treated|Withdrawal by Subject|1|||
23191726|NCT02786537|64442413|FG001|As Treated|Withdrawal by Subject|2|||
23191727|NCT02786537|64442414|FG002|As Treated|Withdrawal by Subject|0|||
23191728|NCT02786537|64442415|FG003|As Treated|Withdrawal by Subject|0|||
23191729|NCT02786537|64442416|FG004|As Treated|Withdrawal by Subject|1|||
23191730|NCT02786537|64442417|FG005|As Treated|Withdrawal by Subject|0|||
23191731|NCT02786537|64442412|FG000|As Treated|Incarceration|0|||
23191732|NCT02786537|64442413|FG001|As Treated|Incarceration|1|||
23191733|NCT02786537|64442414|FG002|As Treated|Incarceration|0|||
23191734|NCT02786537|64442415|FG003|As Treated|Incarceration|0|||
23252550|NCT01586624|64667796|FG005|Overall Study|Adverse Event|3|||
23191735|NCT02786537|64442416|FG004|As Treated|Incarceration|0|||
23191736|NCT02786537|64442417|FG005|As Treated|Incarceration|0|||
23191737|NCT02786537|64442412|FG000|As Treated|Opiate dependency relapse|0|||
23191738|NCT02786537|64442413|FG001|As Treated|Opiate dependency relapse|1|||
23191739|NCT02786537|64442414|FG002|As Treated|Opiate dependency relapse|0|||
23191740|NCT02786537|64442415|FG003|As Treated|Opiate dependency relapse|0|||
23191741|NCT02786537|64442416|FG004|As Treated|Opiate dependency relapse|0|||
23191742|NCT02786537|64442417|FG005|As Treated|Opiate dependency relapse|0|||
23191743|NCT02786537|64442412|FG000|As Treated|Drugs stolen from patient|0|||
23191744|NCT02786537|64442413|FG001|As Treated|Drugs stolen from patient|1|||
23191745|NCT02786537|64442414|FG002|As Treated|Drugs stolen from patient|0|||
23191746|NCT02786537|64442415|FG003|As Treated|Drugs stolen from patient|0|||
23191747|NCT02786537|64442416|FG004|As Treated|Drugs stolen from patient|0|||
23191748|NCT02786537|64442417|FG005|As Treated|Drugs stolen from patient|0|||
23191749|NCT02786537|64442412|FG000|As Treated|Advised to stop tx after loss of meds|0|||
23191750|NCT02786537|64442413|FG001|As Treated|Advised to stop tx after loss of meds|1|||
23191751|NCT02786537|64442414|FG002|As Treated|Advised to stop tx after loss of meds|0|||
23191752|NCT02786537|64442415|FG003|As Treated|Advised to stop tx after loss of meds|0|||
23191753|NCT02786537|64442416|FG004|As Treated|Advised to stop tx after loss of meds|0|||
23191754|NCT02786537|64442417|FG005|As Treated|Advised to stop tx after loss of meds|0|||
23191755|NCT01300286|64442423|FG000|Overall Study|did not get dosed|1|||
23191756|NCT04723537|64442425|FG000|Overall Study|Withdrawal by Subject|3|||
23191757|NCT04723537|64442426|FG001|Overall Study|Withdrawal by Subject|0|||
23191758|NCT04723537|64442427|FG002|Overall Study|Withdrawal by Subject|0|||
23191759|NCT04723537|64442425|FG000|Overall Study|Physician Decision|0|||
23191760|NCT04723537|64442426|FG001|Overall Study|Physician Decision|0|||
23191761|NCT04723537|64442427|FG002|Overall Study|Physician Decision|1|||
23191762|NCT04723537|64442425|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
23191763|NCT04723537|64442426|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
23191764|NCT04723537|64442427|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
23191765|NCT02024464|64442429|FG000|Overall Study|Discontinued|5|||
23191766|NCT02024464|64442430|FG001|Overall Study|Discontinued|4|||
23191767|NCT02024464|64442429|FG000|Overall Study|Missed Visits|1|||
23191768|NCT02024464|64442430|FG001|Overall Study|Missed Visits|0|||
23191769|NCT02024464|64442429|FG000|Overall Study|Lost to Follow-up|4|||
23191770|NCT02024464|64442430|FG001|Overall Study|Lost to Follow-up|7|||
23191771|NCT00686205|64442431|FG000|Overall Study|Protocol Violation|127|||
23191772|NCT00686205|64442432|FG001|Overall Study|Protocol Violation|0|||
23191773|NCT00686205|64442431|FG000|Overall Study|Withdrawal by Subject|2|||
23191774|NCT00686205|64442432|FG001|Overall Study|Withdrawal by Subject|0|||
23191775|NCT00686205|64442431|FG000|Overall Study|Specimen handling procedure altered|5878|||
23191776|NCT00686205|64442432|FG001|Overall Study|Specimen handling procedure altered|0|||
23191777|NCT00686205|64442431|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
23191778|NCT00686205|64442432|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
23191779|NCT00753922|64442433|FG000|Overall Study|Lost to Follow-up|155|||
23191780|NCT00753922|64442434|FG001|Overall Study|Lost to Follow-up|24|||
23191781|NCT00753922|64442435|FG002|Overall Study|Lost to Follow-up|28|||
23191782|NCT00753922|64442436|FG003|Overall Study|Lost to Follow-up|5|||
23191783|NCT00753922|64442433|FG000|Overall Study|Withdrawal by Subject|9|||
23191784|NCT00753922|64442434|FG001|Overall Study|Withdrawal by Subject|11|||
23191785|NCT00753922|64442435|FG002|Overall Study|Withdrawal by Subject|4|||
23191786|NCT00753922|64442436|FG003|Overall Study|Withdrawal by Subject|2|||
23191787|NCT00753922|64442433|FG000|Overall Study|Patient Non-compliance|55|||
23191788|NCT00753922|64442434|FG001|Overall Study|Patient Non-compliance|22|||
23191789|NCT00753922|64442435|FG002|Overall Study|Patient Non-compliance|14|||
23191790|NCT00753922|64442436|FG003|Overall Study|Patient Non-compliance|11|||
23191791|NCT00753922|64442433|FG000|Overall Study|Patients Not Completing Visit|11|||
23191792|NCT00753922|64442434|FG001|Overall Study|Patients Not Completing Visit|0|||
23191793|NCT00753922|64442435|FG002|Overall Study|Patients Not Completing Visit|1|||
23191794|NCT00753922|64442436|FG003|Overall Study|Patients Not Completing Visit|0|||
23191795|NCT00753922|64442433|FG000|Overall Study|Death|2|||
23191796|NCT00753922|64442434|FG001|Overall Study|Death|23|||
23191797|NCT00753922|64442435|FG002|Overall Study|Death|2|||
23191798|NCT00753922|64442436|FG003|Overall Study|Death|1|||
23191799|NCT00753922|64442433|FG000|Overall Study|Discontinuation Due to Explantation|14|||
23191800|NCT00753922|64442434|FG001|Overall Study|Discontinuation Due to Explantation|14|||
23191801|NCT00753922|64442435|FG002|Overall Study|Discontinuation Due to Explantation|14|||
23191802|NCT00753922|64442436|FG003|Overall Study|Discontinuation Due to Explantation|4|||
23191803|NCT03228186|64442437|FG000|Overall Study|Patient never started treatment|1|||
23191804|NCT00414440|64442441|FG000|Core Period|Withdrawal by Subject|70|||
23191805|NCT00414440|64442442|FG001|Core Period|Withdrawal by Subject|32|||
23191806|NCT00414440|64442441|FG000|Extension Period|Lost to Follow-up|44|||
23191807|NCT00414440|64442442|FG001|Extension Period|Lost to Follow-up|52|||
23191808|NCT00414440|64442441|FG000|Extension Period|Did not consent to continue follow up|61|||
23191809|NCT00414440|64442442|FG001|Extension Period|Did not consent to continue follow up|54|||
23191810|NCT00414440|64442441|FG000|Extension Period|Other|1|||
23191811|NCT00414440|64442442|FG001|Extension Period|Other|1|||
23191812|NCT00414440|64442441|FG000|Extension Period|Administrative|16|||
23252551|NCT01586624|64667797|FG006|Overall Study|Adverse Event|2|||
23191813|NCT00414440|64442442|FG001|Extension Period|Administrative|16|||
23252552|NCT01586624|64667798|FG007|Overall Study|Adverse Event|3|||
23252553|NCT01586624|64667791|FG000|Overall Study|Physician Decision|0|||
23252554|NCT01586624|64667792|FG001|Overall Study|Physician Decision|1|||
23252555|NCT01586624|64667793|FG002|Overall Study|Physician Decision|1|||
23252556|NCT01586624|64667794|FG003|Overall Study|Physician Decision|0|||
23252557|NCT01586624|64667795|FG004|Overall Study|Physician Decision|2|||
23252558|NCT01586624|64667796|FG005|Overall Study|Physician Decision|0|||
23252559|NCT01586624|64667797|FG006|Overall Study|Physician Decision|1|||
23252560|NCT01586624|64667798|FG007|Overall Study|Physician Decision|1|||
23252561|NCT01586624|64667791|FG000|Overall Study|Withdrawal by Subject|0|||
23252562|NCT01586624|64667792|FG001|Overall Study|Withdrawal by Subject|0|||
23252563|NCT01586624|64667793|FG002|Overall Study|Withdrawal by Subject|0|||
23358777|NCT02757625|65056403|FG001|Overall Study|Adverse Event|0|||
23358778|NCT02757625|65056404|FG002|Overall Study|Adverse Event|1|||
23358779|NCT02757625|65056405|FG003|Overall Study|Adverse Event|0|||
23358780|NCT02112877|65056406|FG000|Overall Study|Withdrawal by Subject|1|||
23191814|NCT00414440|64442441|FG000|Extension Period|Death|1|||
23191815|NCT00414440|64442442|FG001|Extension Period|Death|2|||
23191816|NCT00414440|64442441|FG000|Extension Period|Withdrawal by Subject|9|||
23191817|NCT00414440|64442442|FG001|Extension Period|Withdrawal by Subject|7|||
23191818|NCT00414440|64442441|FG000|Extension Period|Not included in follow up period|18|||
23191819|NCT00414440|64442442|FG001|Extension Period|Not included in follow up period|8|||
23191820|NCT01269125|64442443|FG000|Overall Study|Adverse Event|3|||
23191821|NCT01269125|64442444|FG001|Overall Study|Adverse Event|5|||
23191822|NCT01269125|64442445|FG002|Overall Study|Adverse Event|0|||
23191823|NCT01269125|64442443|FG000|Overall Study|Lost to Follow-up|4|||
23191824|NCT01269125|64442444|FG001|Overall Study|Lost to Follow-up|0|||
23191825|NCT01269125|64442445|FG002|Overall Study|Lost to Follow-up|0|||
23191826|NCT01426386|64442450|FG000|Overall Study|Adverse Event|0|||
23191827|NCT01426386|64442451|FG001|Overall Study|Adverse Event|1|||
23191828|NCT01426386|64442452|FG002|Overall Study|Adverse Event|0|||
23191829|NCT01426386|64442453|FG003|Overall Study|Adverse Event|0|||
23191830|NCT01426386|64442454|FG004|Overall Study|Adverse Event|0|||
23191831|NCT01426386|64442455|FG005|Overall Study|Adverse Event|0|||
23191832|NCT01426386|64442450|FG000|Overall Study|Did not attend scheduled visit|1|||
23191833|NCT01426386|64442451|FG001|Overall Study|Did not attend scheduled visit|4|||
23191834|NCT01426386|64442452|FG002|Overall Study|Did not attend scheduled visit|0|||
23191835|NCT01426386|64442453|FG003|Overall Study|Did not attend scheduled visit|0|||
23191836|NCT01426386|64442454|FG004|Overall Study|Did not attend scheduled visit|2|||
23191837|NCT01426386|64442455|FG005|Overall Study|Did not attend scheduled visit|1|||
23191838|NCT01426386|64442450|FG000|Overall Study|Poor response|2|||
23191839|NCT01426386|64442451|FG001|Overall Study|Poor response|1|||
23191840|NCT01426386|64442452|FG002|Overall Study|Poor response|2|||
23191841|NCT01426386|64442453|FG003|Overall Study|Poor response|0|||
23191842|NCT01426386|64442454|FG004|Overall Study|Poor response|1|||
23191843|NCT01426386|64442455|FG005|Overall Study|Poor response|0|||
23358781|NCT02112877|65056407|FG001|Overall Study|Withdrawal by Subject|7|||
23358782|NCT02112877|65056406|FG000|Overall Study|Visit Missed|1|||
23358783|NCT02112877|65056407|FG001|Overall Study|Visit Missed|6|||
23358784|NCT01716520|65056410|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
23358785|NCT01716520|65056411|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
23358786|NCT01716520|65056412|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
23358787|NCT01716520|65056413|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
23358788|NCT01716520|65056414|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
23589918|NCT00494442|65889490|FG000|Overall Study|Lack of Efficacy|16|||
23191844|NCT01426386|64442450|FG000|Overall Study|Personal reasons|0|||
23191845|NCT01426386|64442451|FG001|Overall Study|Personal reasons|0|||
23191846|NCT01426386|64442452|FG002|Overall Study|Personal reasons|0|||
23191847|NCT01426386|64442453|FG003|Overall Study|Personal reasons|0|||
23191848|NCT01426386|64442454|FG004|Overall Study|Personal reasons|1|||
23191849|NCT01426386|64442455|FG005|Overall Study|Personal reasons|0|||
23589919|NCT00494442|65889491|FG001|Overall Study|Lack of Efficacy|10|||
23191850|NCT01522651|64442456|FG000|Overall Study|Adverse Event|3|||
23191851|NCT01522651|64442457|FG001|Overall Study|Adverse Event|4|||
23191852|NCT01522651|64442458|FG002|Overall Study|Adverse Event|4|||
23252564|NCT01586624|64667794|FG003|Overall Study|Withdrawal by Subject|1|||
23252565|NCT01586624|64667795|FG004|Overall Study|Withdrawal by Subject|0|||
23589920|NCT00494442|65889490|FG000|Overall Study|Adverse Event|0|||
23475615|NCT00311584|65485463|FG001|Overall Study|Physician Decision|5|||
23475616|NCT00311584|65485462|FG000|Overall Study|Withdrawal by Subject|1|||
23475617|NCT00311584|65485463|FG001|Overall Study|Withdrawal by Subject|1|||
23475618|NCT00311584|65485462|FG000|Overall Study|ineligible|2|||
23475619|NCT00311584|65485463|FG001|Overall Study|ineligible|2|||
23475620|NCT03180619|65485464|FG000|Overall Study|Withdrew Consent|5|||
23475621|NCT03180619|65485465|FG001|Overall Study|Withdrew Consent|0|||
23475622|NCT03180619|65485466|FG002|Overall Study|Withdrew Consent|2|||
23475623|NCT03180619|65485464|FG000|Overall Study|Death|2|||
23475624|NCT03180619|65485465|FG001|Overall Study|Death|1|||
23475625|NCT03180619|65485466|FG002|Overall Study|Death|2|||
23475626|NCT03180619|65485464|FG000|Overall Study|Adverse Event|2|||
23475627|NCT03180619|65485465|FG001|Overall Study|Adverse Event|0|||
23475628|NCT03180619|65485466|FG002|Overall Study|Adverse Event|1|||
23475629|NCT03180619|65485464|FG000|Overall Study|Investigator's discretion|2|||
23475630|NCT03180619|65485465|FG001|Overall Study|Investigator's discretion|0|||
23475631|NCT03180619|65485466|FG002|Overall Study|Investigator's discretion|1|||
23475632|NCT01947855|65485470|FG000|Overall Study|Withdrawal by Subject|1|||
23475633|NCT01947855|65485471|FG001|Overall Study|Withdrawal by Subject|0|||
23589921|NCT00494442|65889491|FG001|Overall Study|Adverse Event|2|||
23589922|NCT00494442|65889490|FG000|Overall Study|Physician Decision|0|||
23589923|NCT00494442|65889491|FG001|Overall Study|Physician Decision|1|||
23252566|NCT01586624|64667796|FG005|Overall Study|Withdrawal by Subject|0|||
23252567|NCT01586624|64667797|FG006|Overall Study|Withdrawal by Subject|0|||
23252568|NCT01586624|64667798|FG007|Overall Study|Withdrawal by Subject|0|||
23252569|NCT01586624|64667791|FG000|Overall Study|Evidence of disease progression|1|||
23252570|NCT01586624|64667792|FG001|Overall Study|Evidence of disease progression|3|||
23252571|NCT01586624|64667793|FG002|Overall Study|Evidence of disease progression|2|||
23252572|NCT01586624|64667794|FG003|Overall Study|Evidence of disease progression|5|||
23252573|NCT01586624|64667795|FG004|Overall Study|Evidence of disease progression|3|||
23252574|NCT01586624|64667796|FG005|Overall Study|Evidence of disease progression|5|||
23252575|NCT01586624|64667797|FG006|Overall Study|Evidence of disease progression|4|||
23252576|NCT01586624|64667798|FG007|Overall Study|Evidence of disease progression|6|||
23252577|NCT01586624|64667791|FG000|Overall Study|Screen failure (no treatment received)|0|||
23252578|NCT01586624|64667792|FG001|Overall Study|Screen failure (no treatment received)|0|||
23252579|NCT01586624|64667793|FG002|Overall Study|Screen failure (no treatment received)|0|||
23252580|NCT01586624|64667794|FG003|Overall Study|Screen failure (no treatment received)|0|||
23252581|NCT01586624|64667795|FG004|Overall Study|Screen failure (no treatment received)|0|||
23252582|NCT01586624|64667796|FG005|Overall Study|Screen failure (no treatment received)|0|||
23252583|NCT01586624|64667797|FG006|Overall Study|Screen failure (no treatment received)|1|||
23191853|NCT01522651|64442459|FG003|Overall Study|Adverse Event|5|||
23191854|NCT01522651|64442460|FG004|Overall Study|Adverse Event|4|||
23191855|NCT01522651|64442456|FG000|Overall Study|Cardioversion|1|||
23191856|NCT01522651|64442457|FG001|Overall Study|Cardioversion|0|||
23191857|NCT01522651|64442458|FG002|Overall Study|Cardioversion|0|||
23191858|NCT01522651|64442459|FG003|Overall Study|Cardioversion|0|||
23191859|NCT01522651|64442460|FG004|Overall Study|Cardioversion|0|||
23191860|NCT01522651|64442456|FG000|Overall Study|Device Malfunction|0|||
23191861|NCT01522651|64442457|FG001|Overall Study|Device Malfunction|1|||
23191862|NCT01522651|64442458|FG002|Overall Study|Device Malfunction|0|||
23191863|NCT01522651|64442459|FG003|Overall Study|Device Malfunction|0|||
23191864|NCT01522651|64442460|FG004|Overall Study|Device Malfunction|0|||
23252584|NCT01586624|64667798|FG007|Overall Study|Screen failure (no treatment received)|0|||
23252585|NCT00552617|64667799|FG000|Overall Study|Not Treated|0|||
23252586|NCT00552617|64667800|FG001|Overall Study|Not Treated|0|||
23252587|NCT00552617|64667801|FG002|Overall Study|Not Treated|1|||
23252588|NCT00552617|64667802|FG003|Overall Study|Not Treated|0|||
23252589|NCT00552617|64667803|FG004|Overall Study|Not Treated|0|||
23589924|NCT00494442|65889490|FG000|Overall Study|Non-compliance|0|||
23589925|NCT00494442|65889491|FG001|Overall Study|Non-compliance|1|||
23589926|NCT00494442|65889490|FG000|Overall Study|Intercurrent illness|0|||
23589927|NCT00494442|65889491|FG001|Overall Study|Intercurrent illness|1|||
23589928|NCT03257813|65889492|FG000|Overall Study|Protocol Violation|6|||
23475634|NCT01947855|65485472|FG002|Overall Study|Withdrawal by Subject|0|||
23475635|NCT03263702|65485491|FG000|Overall Study|Lost to Follow-up|2|||
23475636|NCT03263702|65485492|FG001|Overall Study|Lost to Follow-up|2|||
23589929|NCT03257813|65889493|FG001|Overall Study|Protocol Violation|3|||
23589930|NCT00754936|65889495|FG000|Overall Study|Lost to Follow-up|3|||
23191865|NCT01522651|64442456|FG000|Overall Study|Investigator's Discretion|0|||
23191866|NCT01522651|64442457|FG001|Overall Study|Investigator's Discretion|1|||
23475637|NCT03263702|65485491|FG000|Overall Study|Withdrawal by Subject|1|||
23475638|NCT03263702|65485492|FG001|Overall Study|Withdrawal by Subject|2|||
23589931|NCT00754936|65889495|FG000|Overall Study|Physician Decision|1|||
23191867|NCT01522651|64442458|FG002|Overall Study|Investigator's Discretion|0|||
23252590|NCT00552617|64667804|FG005|Overall Study|Not Treated|0|||
23252591|NCT00552617|64667805|FG006|Overall Study|Not Treated|0|||
23252592|NCT00552617|64667806|FG007|Overall Study|Not Treated|0|||
23252593|NCT00552617|64667807|FG008|Overall Study|Not Treated|0|||
23252594|NCT00552617|64667808|FG009|Overall Study|Not Treated|1|||
23252595|NCT00552617|64667799|FG000|Overall Study|Lost to Follow-up|0|||
23252596|NCT00552617|64667800|FG001|Overall Study|Lost to Follow-up|0|||
23252597|NCT00552617|64667801|FG002|Overall Study|Lost to Follow-up|0|||
23252598|NCT00552617|64667802|FG003|Overall Study|Lost to Follow-up|1|||
23252599|NCT00552617|64667803|FG004|Overall Study|Lost to Follow-up|0|||
23252600|NCT00552617|64667804|FG005|Overall Study|Lost to Follow-up|2|||
23252601|NCT00552617|64667805|FG006|Overall Study|Lost to Follow-up|0|||
23252602|NCT00552617|64667806|FG007|Overall Study|Lost to Follow-up|0|||
23252603|NCT00552617|64667807|FG008|Overall Study|Lost to Follow-up|2|||
23252604|NCT00552617|64667808|FG009|Overall Study|Lost to Follow-up|0|||
23252605|NCT01364298|64667809|FG000|Overall Study|Adverse Event|3|||
23252606|NCT01364298|64667810|FG001|Overall Study|Adverse Event|4|||
23252607|NCT01364298|64667809|FG000|Overall Study|Lack of adherence to treatment|1|||
23252608|NCT01364298|64667810|FG001|Overall Study|Lack of adherence to treatment|3|||
23252609|NCT01364298|64667809|FG000|Overall Study|Lack of Efficacy|1|||
23589932|NCT00754936|65889495|FG000|Overall Study|Withdrawal by Subject|2|||
23191868|NCT01522651|64442459|FG003|Overall Study|Investigator's Discretion|0|||
23358789|NCT01716520|65056415|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
23589933|NCT00754936|65889495|FG000|Overall Study|Side Effects|3|||
23252610|NCT01364298|64667810|FG001|Overall Study|Lack of Efficacy|0|||
23252611|NCT01364298|64667809|FG000|Overall Study|Lost to Follow-up|5|||
23252612|NCT01364298|64667810|FG001|Overall Study|Lost to Follow-up|10|||
23252613|NCT01364298|64667809|FG000|Overall Study|Withdrawal by Subject|3|||
23252614|NCT01364298|64667810|FG001|Overall Study|Withdrawal by Subject|3|||
23252615|NCT01364298|64667809|FG000|Overall Study|Other|1|||
23252616|NCT01364298|64667810|FG001|Overall Study|Other|3|||
23252617|NCT02239601|64667813|FG000|Overall Study|Withdrawal by Subject|3|||
23252618|NCT02239601|64667814|FG001|Overall Study|Withdrawal by Subject|4|||
23252619|NCT02239601|64667813|FG000|Overall Study|Protocol Violation|4|||
23252620|NCT02239601|64667814|FG001|Overall Study|Protocol Violation|2|||
23252621|NCT00667719|64667815|FG000|Overall Study|Adverse Event|39|||
23252622|NCT00667719|64667815|FG000|Overall Study|Abnormal Test Procedure|1|||
23252623|NCT00667719|64667815|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23252624|NCT00667719|64667815|FG000|Overall Study|Protocol Violation|3|||
23252625|NCT00667719|64667815|FG000|Overall Study|Withdrawal by Subject|17|||
23252626|NCT00667719|64667815|FG000|Overall Study|Lost to Follow-up|8|||
23252627|NCT01493531|64667816|FG000|Overall Study|Adverse Event|4|||
23252628|NCT01493531|64667817|FG001|Overall Study|Adverse Event|12|||
23252629|NCT01493531|64667818|FG002|Overall Study|Adverse Event|9|||
23252630|NCT01493531|64667816|FG000|Overall Study|Gout flare|3|||
23252631|NCT01493531|64667817|FG001|Overall Study|Gout flare|0|||
23252632|NCT01493531|64667818|FG002|Overall Study|Gout flare|2|||
23252633|NCT01493531|64667816|FG000|Overall Study|Protocol Violation|8|||
23252634|NCT01493531|64667817|FG001|Overall Study|Protocol Violation|15|||
23252635|NCT01493531|64667818|FG002|Overall Study|Protocol Violation|12|||
23252636|NCT01493531|64667816|FG000|Overall Study|Sponsor terminated study|5|||
23252637|NCT01493531|64667817|FG001|Overall Study|Sponsor terminated study|2|||
23252638|NCT01493531|64667818|FG002|Overall Study|Sponsor terminated study|3|||
23252639|NCT01493531|64667816|FG000|Overall Study|Lost to Follow-up|5|||
23252640|NCT01493531|64667817|FG001|Overall Study|Lost to Follow-up|7|||
23252641|NCT01493531|64667818|FG002|Overall Study|Lost to Follow-up|11|||
23252642|NCT01493531|64667816|FG000|Overall Study|Withdrawal by Subject|16|||
23252643|NCT01493531|64667817|FG001|Overall Study|Withdrawal by Subject|13|||
23252644|NCT01493531|64667818|FG002|Overall Study|Withdrawal by Subject|11|||
23252645|NCT01493531|64667816|FG000|Overall Study|Death|0|||
23252646|NCT01493531|64667817|FG001|Overall Study|Death|1|||
23252647|NCT01493531|64667818|FG002|Overall Study|Death|0|||
23252648|NCT01399125|64667819|FG000|Overall Study|Adverse Event|32|||
23252649|NCT01399125|64667820|FG001|Overall Study|Adverse Event|30|||
23252650|NCT01399125|64667819|FG000|Overall Study|Abnormal Lab values|0|||
23252651|NCT01399125|64667820|FG001|Overall Study|Abnormal Lab values|1|||
23252652|NCT01399125|64667819|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23252653|NCT01399125|64667820|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
23252654|NCT01399125|64667819|FG000|Overall Study|Withdrawal by Subject|5|||
23252655|NCT01399125|64667820|FG001|Overall Study|Withdrawal by Subject|8|||
23252656|NCT01399125|64667819|FG000|Overall Study|Lost to Follow-up|2|||
23252657|NCT01399125|64667820|FG001|Overall Study|Lost to Follow-up|3|||
23252658|NCT01399125|64667819|FG000|Overall Study|Administrative Problems|7|||
23252659|NCT01399125|64667820|FG001|Overall Study|Administrative Problems|11|||
23475639|NCT01324141|65485493|FG000|Overall Study|Declined to participate before treatment started|1|||
23475640|NCT01324141|65485493|FG000|Overall Study|Disease progression on study|1|||
23475641|NCT01652469|65485495|FG000|Overall Study|Withdrawal by Subject|1|||
23475642|NCT01652469|65485496|FG001|Overall Study|Withdrawal by Subject|4|||
23475643|NCT01652469|65485495|FG000|Overall Study|Lost to Follow-up|0|||
23475644|NCT01652469|65485496|FG001|Overall Study|Lost to Follow-up|2|||
23475645|NCT04661579|65485505|FG000|Overall Study|Lost to Follow-up|19|||
23475646|NCT04661579|65485506|FG001|Overall Study|Lost to Follow-up|10|||
23475647|NCT04661579|65485507|FG002|Overall Study|Lost to Follow-up|2|||
23475648|NCT04661579|65485508|FG003|Overall Study|Lost to Follow-up|7|||
23475649|NCT04661579|65485509|FG004|Overall Study|Lost to Follow-up|11|||
23252660|NCT01399125|64667819|FG000|Overall Study|Death|0|||
23252661|NCT01399125|64667820|FG001|Overall Study|Death|1|||
23252662|NCT01399125|64667819|FG000|Overall Study|Protocol Deviation|5|||
23252663|NCT01399125|64667820|FG001|Overall Study|Protocol Deviation|2|||
23252664|NCT01169844|64667821|FG000|Overall Study|Adverse Event|0|||
23252665|NCT01169844|64667822|FG001|Overall Study|Adverse Event|1|||
23252666|NCT01169844|64667821|FG000|Overall Study|Patient withdrew consent|4|||
23252667|NCT01169844|64667822|FG001|Overall Study|Patient withdrew consent|0|||
23252668|NCT01169844|64667821|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23252669|NCT01169844|64667822|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23252670|NCT02482571|64667825|FG000|Overall Study|Adverse Event|1|||
23358790|NCT01716520|65056410|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
23358791|NCT01716520|65056411|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358792|NCT01716520|65056412|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
23358793|NCT01716520|65056413|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
23358794|NCT01716520|65056414|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358795|NCT01716520|65056415|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
23358796|NCT01716520|65056410|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23358797|NCT01716520|65056411|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23358798|NCT01716520|65056412|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23475650|NCT04661579|65485505|FG000|Overall Study|Physician Decision|2|||
23475651|NCT04661579|65485506|FG001|Overall Study|Physician Decision|0|||
23475652|NCT04661579|65485507|FG002|Overall Study|Physician Decision|0|||
23475653|NCT04661579|65485508|FG003|Overall Study|Physician Decision|1|||
23475654|NCT04661579|65485509|FG004|Overall Study|Physician Decision|0|||
23475655|NCT04661579|65485505|FG000|Overall Study|Withdrawal by Subject|1|||
23475656|NCT04661579|65485506|FG001|Overall Study|Withdrawal by Subject|4|||
23475657|NCT04661579|65485507|FG002|Overall Study|Withdrawal by Subject|0|||
23475658|NCT04661579|65485508|FG003|Overall Study|Withdrawal by Subject|2|||
23475659|NCT04661579|65485509|FG004|Overall Study|Withdrawal by Subject|0|||
23358799|NCT01716520|65056413|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23358800|NCT01716520|65056414|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23358801|NCT01716520|65056415|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23358802|NCT01716520|65056410|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358803|NCT01716520|65056411|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
23358804|NCT01716520|65056412|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358805|NCT01716520|65056413|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358806|NCT01716520|65056414|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358807|NCT01716520|65056415|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
23358808|NCT01716520|65056410|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23358809|NCT01716520|65056411|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23358810|NCT01716520|65056412|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23475660|NCT04661579|65485505|FG000|Overall Study|Death|1|||
23475661|NCT04661579|65485506|FG001|Overall Study|Death|0|||
23475662|NCT04661579|65485507|FG002|Overall Study|Death|0|||
23475663|NCT04661579|65485508|FG003|Overall Study|Death|0|||
23475664|NCT04661579|65485509|FG004|Overall Study|Death|0|||
23475665|NCT04661579|65485505|FG000|Overall Study|Other|1|||
23475666|NCT04661579|65485506|FG001|Overall Study|Other|2|||
23475667|NCT04661579|65485507|FG002|Overall Study|Other|1|||
23475668|NCT04661579|65485508|FG003|Overall Study|Other|1|||
23475669|NCT04661579|65485509|FG004|Overall Study|Other|1|||
23252671|NCT02482571|64667825|FG000|Overall Study|Scanner or Respiract failure|3|||
23252672|NCT02482571|64667825|FG000|Overall Study|Withdrawal by Subject|4|||
23252673|NCT02176642|64667826|FG000|Overall Study|Withdrawal by Subject|0|||
23252674|NCT02176642|64667827|FG001|Overall Study|Withdrawal by Subject|1|||
23475670|NCT04661579|65485505|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
23475671|NCT04661579|65485506|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
23475672|NCT04661579|65485507|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
23475673|NCT04661579|65485508|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
23475674|NCT04661579|65485509|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
23475675|NCT00337675|65485510|FG000|Overall Study|Adverse Event|10|||
23475676|NCT00337675|65485511|FG001|Overall Study|Adverse Event|9|||
23475677|NCT00337675|65485512|FG002|Overall Study|Adverse Event|19|||
23475678|NCT00337675|65485510|FG000|Overall Study|Lack of Efficacy|10|||
23475679|NCT00337675|65485511|FG001|Overall Study|Lack of Efficacy|7|||
23589934|NCT00754936|65889495|FG000|Overall Study|Inter-current medical events|3|||
23589935|NCT00628862|65889496|FG000|Overall Study|Adverse Event|6|||
23589936|NCT00628862|65889497|FG001|Overall Study|Adverse Event|8|||
23589937|NCT00628862|65889498|FG002|Overall Study|Adverse Event|10|||
23589938|NCT00628862|65889496|FG000|Overall Study|Withdrawal by Subject|4|||
23589939|NCT00628862|65889497|FG001|Overall Study|Withdrawal by Subject|6|||
23589940|NCT00628862|65889498|FG002|Overall Study|Withdrawal by Subject|11|||
23475680|NCT00337675|65485512|FG002|Overall Study|Lack of Efficacy|9|||
23475681|NCT00337675|65485510|FG000|Overall Study|Lost to Follow-up|22|||
23475682|NCT00337675|65485511|FG001|Overall Study|Lost to Follow-up|19|||
23475683|NCT00337675|65485512|FG002|Overall Study|Lost to Follow-up|17|||
23475684|NCT00337675|65485510|FG000|Overall Study|Physician Decision|9|||
23475685|NCT00337675|65485511|FG001|Overall Study|Physician Decision|17|||
23475686|NCT00337675|65485512|FG002|Overall Study|Physician Decision|14|||
23475687|NCT00337675|65485510|FG000|Overall Study|Protocol Violation|21|||
23475688|NCT00337675|65485511|FG001|Overall Study|Protocol Violation|24|||
23475689|NCT00337675|65485512|FG002|Overall Study|Protocol Violation|19|||
23475690|NCT00337675|65485510|FG000|Overall Study|Withdrawal by Subject|25|||
23475691|NCT00337675|65485511|FG001|Overall Study|Withdrawal by Subject|25|||
23475692|NCT00337675|65485512|FG002|Overall Study|Withdrawal by Subject|19|||
23475693|NCT00337675|65485510|FG000|Overall Study|Progressive Disease|0|||
23475694|NCT00337675|65485511|FG001|Overall Study|Progressive Disease|2|||
23475695|NCT00337675|65485512|FG002|Overall Study|Progressive Disease|0|||
23475696|NCT00337675|65485510|FG000|Overall Study|Trial Terminated|0|||
23475697|NCT00337675|65485511|FG001|Overall Study|Trial Terminated|0|||
23475698|NCT00337675|65485512|FG002|Overall Study|Trial Terminated|2|||
23475699|NCT02881567|65485513|FG000|Overall Study|Adverse Event|1|||
23475700|NCT02881567|65485513|FG000|Overall Study|Lost to Follow-up|3|||
23589941|NCT00628862|65889496|FG000|Overall Study|Lost to Follow-up|0|||
23589942|NCT00628862|65889497|FG001|Overall Study|Lost to Follow-up|2|||
23589943|NCT00628862|65889498|FG002|Overall Study|Lost to Follow-up|1|||
23589944|NCT00628862|65889496|FG000|Overall Study|Protocol Violation|1|||
23589945|NCT00628862|65889497|FG001|Overall Study|Protocol Violation|0|||
23589946|NCT00628862|65889498|FG002|Overall Study|Protocol Violation|0|||
23589947|NCT00628862|65889496|FG000|Overall Study|COPD Exacerbation|0|||
23589948|NCT00628862|65889497|FG001|Overall Study|COPD Exacerbation|1|||
23589949|NCT00628862|65889498|FG002|Overall Study|COPD Exacerbation|0|||
23589950|NCT01505881|65889499|FG000|Overall Study|Adverse Event|0|||
23589951|NCT01505881|65889500|FG001|Overall Study|Adverse Event|1|||
23589952|NCT01505881|65889499|FG000|Overall Study|Lost to Follow-up|2|||
23589953|NCT01505881|65889500|FG001|Overall Study|Lost to Follow-up|0|||
23589954|NCT01505881|65889499|FG000|Overall Study|Withdrawal by Subject|2|||
23589955|NCT01505881|65889500|FG001|Overall Study|Withdrawal by Subject|0|||
23589956|NCT04678830|65889501|FG000|Overall Study|Lack of Efficacy|2|||
23589957|NCT04678830|65889502|FG001|Overall Study|Lack of Efficacy|0|||
23589958|NCT04678830|65889501|FG000|Overall Study|Withdrawal by Subject|0|||
23589959|NCT04678830|65889502|FG001|Overall Study|Withdrawal by Subject|1|||
23589960|NCT01251354|65889517|FG000|Overall Study|Adverse Event|1|||
23589961|NCT01251354|65889517|FG000|Overall Study|Investigator's Decision|1|||
23589962|NCT01251354|65889517|FG000|Overall Study|Disease Progression|4|||
23589963|NCT01370694|65889518|FG000|Overall Study|Switched to rituximab|4|||
23589964|NCT01370694|65889518|FG000|Overall Study|Progressive disease|2|||
23589965|NCT00970307|65889519|FG000|Overall Study|Serious Adverse Event|1|||
23589966|NCT00970307|65889520|FG001|Overall Study|Serious Adverse Event|0|||
23589967|NCT00970307|65889521|FG002|Overall Study|Serious Adverse Event|0|||
23475701|NCT02881567|65485513|FG000|Overall Study|Consent withdrawn|1|||
23589968|NCT00970307|65889519|FG000|Overall Study|Withdrawal by Subject|2|||
23589969|NCT00970307|65889520|FG001|Overall Study|Withdrawal by Subject|3|||
23475702|NCT02881567|65485513|FG000|Overall Study|Investigator decision|1|||
23475703|NCT02881567|65485513|FG000|Overall Study|Study terminated by sponsor|9|||
23475704|NCT02881567|65485513|FG000|Overall Study|Reason not Specified|3|||
23475705|NCT02270944|65485516|FG000|Overall Study|Lost to Follow-up|9|||
23475706|NCT02270944|65485517|FG001|Overall Study|Lost to Follow-up|4|||
23475707|NCT02270944|65485516|FG000|Overall Study|Withdrawal by Subject|2|||
23475708|NCT02270944|65485517|FG001|Overall Study|Withdrawal by Subject|1|||
23589970|NCT00970307|65889521|FG002|Overall Study|Withdrawal by Subject|2|||
23589971|NCT01025843|65889522|FG000|Washout 4|Withdrawal by Subject|0|||
23475709|NCT02891070|65485518|FG000|Overall Study|Adverse Event|1|||
23475710|NCT02891070|65485519|FG001|Overall Study|Adverse Event|0|||
23475711|NCT02891070|65485518|FG000|Overall Study|Physician Decision|0|||
23475712|NCT02891070|65485519|FG001|Overall Study|Physician Decision|1|||
23475713|NCT02891070|65485518|FG000|Overall Study|Lost to Follow-up|4|||
23475714|NCT02891070|65485519|FG001|Overall Study|Lost to Follow-up|4|||
23252675|NCT05028751|64667828|FG000|Overall Study|Study Terminated by Sponsor|3|||
23252676|NCT05028751|64667829|FG001|Overall Study|Study Terminated by Sponsor|0|||
23252677|NCT05028751|64667830|FG002|Overall Study|Study Terminated by Sponsor|0|||
23252678|NCT05028751|64667831|FG003|Overall Study|Study Terminated by Sponsor|0|||
23252679|NCT05028751|64667828|FG000|Overall Study|Death|9|||
23252680|NCT05028751|64667829|FG001|Overall Study|Death|3|||
23252681|NCT05028751|64667830|FG002|Overall Study|Death|2|||
23252682|NCT05028751|64667831|FG003|Overall Study|Death|4|||
23252683|NCT05028751|64667828|FG000|Overall Study|Withdrawal by Subject|0|||
23252684|NCT05028751|64667829|FG001|Overall Study|Withdrawal by Subject|0|||
23252685|NCT05028751|64667830|FG002|Overall Study|Withdrawal by Subject|1|||
23358811|NCT01716520|65056413|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23358812|NCT01716520|65056414|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
23475715|NCT02891070|65485518|FG000|Overall Study|Other|1|||
23475716|NCT02891070|65485519|FG001|Overall Study|Other|0|||
23475717|NCT02891070|65485518|FG000|Overall Study|Protocol Violation|0|||
23475718|NCT02891070|65485519|FG001|Overall Study|Protocol Violation|1|||
23475719|NCT02891070|65485518|FG000|Overall Study|Withdrawal by Subject|1|||
23475720|NCT02891070|65485519|FG001|Overall Study|Withdrawal by Subject|2|||
23475721|NCT02891070|65485518|FG000|Overall Study|Death|3|||
23191869|NCT01522651|64442460|FG004|Overall Study|Investigator's Discretion|0|||
23191870|NCT01522651|64442456|FG000|Overall Study|Protocol Violation|3|||
23191871|NCT01522651|64442457|FG001|Overall Study|Protocol Violation|0|||
23191872|NCT01522651|64442458|FG002|Overall Study|Protocol Violation|0|||
23191873|NCT01522651|64442459|FG003|Overall Study|Protocol Violation|0|||
23191874|NCT01522651|64442460|FG004|Overall Study|Protocol Violation|0|||
23191875|NCT01522651|64442456|FG000|Overall Study|Reason Not Specified|0|||
23191876|NCT01522651|64442457|FG001|Overall Study|Reason Not Specified|0|||
23191877|NCT01522651|64442458|FG002|Overall Study|Reason Not Specified|0|||
23191878|NCT01522651|64442459|FG003|Overall Study|Reason Not Specified|1|||
23191879|NCT01522651|64442460|FG004|Overall Study|Reason Not Specified|0|||
23191880|NCT01522651|64442456|FG000|Overall Study|Participant Non-Compliance|1|||
23358813|NCT01716520|65056415|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
23475722|NCT02891070|65485519|FG001|Overall Study|Death|0|||
23475723|NCT01168219|65485520|FG000|Overall Study|off study before starting treatment|2|||
23475724|NCT01168219|65485520|FG000|Overall Study|withdrew before transplant|1|||
23475725|NCT01168219|65485520|FG000|Overall Study|ineligible due to CML|2|||
23475726|NCT01395524|65485521|FG000|Overall Study|Non-compliance with study schedule|1|||
23475727|NCT01395524|65485522|FG001|Overall Study|Non-compliance with study schedule|0|||
23475728|NCT01395524|65485523|FG002|Overall Study|Non-compliance with study schedule|1|||
23475729|NCT01395524|65485521|FG000|Overall Study|Lost to Follow-up|3|||
23475730|NCT01395524|65485522|FG001|Overall Study|Lost to Follow-up|1|||
23475731|NCT01395524|65485523|FG002|Overall Study|Lost to Follow-up|1|||
23475732|NCT01395524|65485521|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
23475733|NCT01395524|65485522|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
23475734|NCT01395524|65485523|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
23475735|NCT01395524|65485521|FG000|Overall Study|Severe noncompliance with protocol|1|||
23475736|NCT01395524|65485522|FG001|Overall Study|Severe noncompliance with protocol|0|||
23191881|NCT01522651|64442457|FG001|Overall Study|Participant Non-Compliance|0|||
23191882|NCT01522651|64442458|FG002|Overall Study|Participant Non-Compliance|0|||
23191883|NCT01522651|64442459|FG003|Overall Study|Participant Non-Compliance|0|||
23252686|NCT05028751|64667831|FG003|Overall Study|Withdrawal by Subject|0|||
23252687|NCT05028751|64667828|FG000|Overall Study|Miscellaneous|2|||
23475737|NCT01395524|65485523|FG002|Overall Study|Severe noncompliance with protocol|0|||
23191884|NCT01522651|64442460|FG004|Overall Study|Participant Non-Compliance|0|||
23475738|NCT01395524|65485521|FG000|Overall Study|Adverse Event|4|||
23475739|NCT01395524|65485522|FG001|Overall Study|Adverse Event|4|||
23475740|NCT01395524|65485523|FG002|Overall Study|Adverse Event|3|||
23475741|NCT01395524|65485521|FG000|Overall Study|Death|1|||
23475742|NCT01395524|65485522|FG001|Overall Study|Death|0|||
23475743|NCT01395524|65485523|FG002|Overall Study|Death|0|||
23475744|NCT01395524|65485521|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
23475745|NCT01395524|65485522|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23475746|NCT01395524|65485523|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23475747|NCT01395524|65485521|FG000|Overall Study|Withdrawal by Subject|4|||
23589972|NCT01025843|65889523|FG001|Washout 4|Withdrawal by Subject|0|||
23589973|NCT01025843|65889524|FG002|Washout 4|Withdrawal by Subject|1|||
23589974|NCT01025843|65889525|FG003|Washout 4|Withdrawal by Subject|1|||
23589975|NCT01025843|65889526|FG004|Washout 4|Withdrawal by Subject|0|||
23589976|NCT01025843|65889527|FG005|Washout 4|Withdrawal by Subject|0|||
23589977|NCT01025843|65889528|FG006|Washout 4|Withdrawal by Subject|0|||
23589978|NCT01025843|65889529|FG007|Washout 4|Withdrawal by Subject|0|||
23589979|NCT01025843|65889530|FG008|Washout 4|Withdrawal by Subject|0|||
23589980|NCT01025843|65889531|FG009|Washout 4|Withdrawal by Subject|0|||
23589981|NCT00843193|65889533|FG000|Overall Study|Adverse Event|2|||
23589982|NCT00843193|65889534|FG001|Overall Study|Adverse Event|4|||
23589983|NCT00843193|65889533|FG000|Overall Study|Lack of Efficacy|1|||
23589984|NCT00843193|65889534|FG001|Overall Study|Lack of Efficacy|1|||
23589985|NCT00843193|65889533|FG000|Overall Study|Protocol Violation|1|||
23589986|NCT00843193|65889534|FG001|Overall Study|Protocol Violation|2|||
23589987|NCT00843193|65889533|FG000|Overall Study|Lost to Follow-up|1|||
23589988|NCT00843193|65889534|FG001|Overall Study|Lost to Follow-up|0|||
23589989|NCT00843193|65889533|FG000|Overall Study|Physician Decision|0|||
23589990|NCT00843193|65889534|FG001|Overall Study|Physician Decision|1|||
23589991|NCT00843193|65889533|FG000|Overall Study|Withdrawal by Subject|3|||
23589992|NCT00843193|65889534|FG001|Overall Study|Withdrawal by Subject|3|||
23589993|NCT01072357|65889537|FG000|Overall Study|Lost to Follow-up|0|||
23589994|NCT01072357|65889538|FG001|Overall Study|Lost to Follow-up|1|||
23589995|NCT01121549|65889539|FG000|Overall Study|Adverse Event|10|||
23589996|NCT01121549|65889539|FG000|Overall Study|Lack of Efficacy|11|||
23589997|NCT01121549|65889539|FG000|Overall Study|Lost to Follow-up|12|||
23358814|NCT01716520|65056410|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
23358815|NCT01716520|65056411|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
23589998|NCT01121549|65889539|FG000|Overall Study|Did not meet entrance criteria|9|||
23358816|NCT01716520|65056412|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
23358817|NCT01716520|65056413|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
23358818|NCT01716520|65056414|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
23358819|NCT01716520|65056415|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
23358820|NCT01716520|65056410|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358821|NCT01716520|65056411|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358822|NCT01716520|65056412|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358823|NCT01716520|65056413|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358824|NCT01716520|65056414|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
23358825|NCT01716520|65056415|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
23358826|NCT01716520|65056410|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23358827|NCT01716520|65056411|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23358828|NCT01716520|65056412|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23358829|NCT01716520|65056413|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23358830|NCT01716520|65056414|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
23358831|NCT01716520|65056415|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
23475748|NCT01395524|65485522|FG001|Overall Study|Withdrawal by Subject|8|||
23475749|NCT01395524|65485523|FG002|Overall Study|Withdrawal by Subject|8|||
23475750|NCT01395524|65485521|FG000|Overall Study|Did not receive treatment|1|||
23589999|NCT01121549|65889539|FG000|Overall Study|Study terminated by sponsor|197|||
23590000|NCT01121549|65889539|FG000|Overall Study|Pregnancy|1|||
23590001|NCT01121549|65889539|FG000|Overall Study|Protocol Violation|33|||
23590002|NCT01121549|65889539|FG000|Overall Study|Withdrawal by Subject|16|||
23590003|NCT01121549|65889539|FG000|Overall Study|Other|58|||
23590004|NCT01075217|65889540|FG000|Overall Study|Adverse Event|1|||
23590005|NCT01075217|65889541|FG001|Overall Study|Adverse Event|1|||
23590006|NCT01075217|65889540|FG000|Overall Study|Physician Decision|1|||
23590007|NCT01075217|65889541|FG001|Overall Study|Physician Decision|0|||
23590008|NCT02371746|65889543|FG000|Overall Study|Consent withdrawn|0|||
23590009|NCT02371746|65889544|FG001|Overall Study|Consent withdrawn|0|||
23590010|NCT02371746|65889545|FG002|Overall Study|Consent withdrawn|0|||
23590011|NCT02371746|65889546|FG003|Overall Study|Consent withdrawn|0|||
23475751|NCT01395524|65485522|FG001|Overall Study|Did not receive treatment|1|||
23475752|NCT01395524|65485523|FG002|Overall Study|Did not receive treatment|3|||
23475753|NCT01395524|65485521|FG000|Overall Study|Subject had spinal surgery|0|||
23358832|NCT01716520|65056410|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23475754|NCT01395524|65485522|FG001|Overall Study|Subject had spinal surgery|0|||
23475755|NCT01395524|65485523|FG002|Overall Study|Subject had spinal surgery|1|||
23475756|NCT01794338|65485524|FG000|Overall Study|Death|2|||
23475757|NCT01794338|65485525|FG001|Overall Study|Death|0|||
23475758|NCT01794338|65485524|FG000|Overall Study|Lost to Follow-up|6|||
23475759|NCT01794338|65485525|FG001|Overall Study|Lost to Follow-up|9|||
23475760|NCT02350764|65485526|FG000|Overall Study|Adverse Event|4|||
23475761|NCT02350764|65485526|FG000|Overall Study|Death|3|||
23358833|NCT01716520|65056411|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358834|NCT01716520|65056412|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23252688|NCT05028751|64667829|FG001|Overall Study|Miscellaneous|0|||
23252689|NCT05028751|64667830|FG002|Overall Study|Miscellaneous|0|||
23252690|NCT05028751|64667831|FG003|Overall Study|Miscellaneous|0|||
23252691|NCT00267020|64667832|FG000|Overall Study|Adverse Event|22|||
23252692|NCT00267020|64667833|FG001|Overall Study|Adverse Event|5|||
23252693|NCT00267020|64667832|FG000|Overall Study|Death|2|||
23475762|NCT02350764|65485526|FG000|Overall Study|Physician Decision|2|||
23475763|NCT02350764|65485526|FG000|Overall Study|Withdrawal by Subject|2|||
23475764|NCT01250496|65485529|FG000|Overall Study|Study terminated|124|||
23475765|NCT01250496|65485530|FG001|Overall Study|Study terminated|124|||
23475766|NCT00591318|65485531|FG000|Overall Study|Lack of Efficacy|2|||
23475767|NCT00591318|65485532|FG001|Overall Study|Lack of Efficacy|0|||
23475768|NCT00591318|65485531|FG000|Overall Study|Adverse Event|2|||
23475769|NCT00591318|65485532|FG001|Overall Study|Adverse Event|0|||
23252694|NCT00267020|64667833|FG001|Overall Study|Death|1|||
23252695|NCT00267020|64667832|FG000|Overall Study|Withdrawal by Subject|17|||
23252696|NCT00267020|64667833|FG001|Overall Study|Withdrawal by Subject|7|||
23252697|NCT00267020|64667832|FG000|Overall Study|Physician Decision|3|||
23252698|NCT00267020|64667833|FG001|Overall Study|Physician Decision|2|||
23252699|NCT00267020|64667832|FG000|Overall Study|Disease Progression|39|||
23358835|NCT01716520|65056413|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
23358836|NCT01716520|65056414|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358837|NCT01716520|65056415|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
23358838|NCT01716520|65056410|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
23358839|NCT01716520|65056411|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
23358840|NCT01716520|65056412|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
23358841|NCT01716520|65056413|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
23358842|NCT01716520|65056414|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
23358843|NCT01716520|65056415|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
23358844|NCT01716520|65056410|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
23358845|NCT01716520|65056411|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358846|NCT01716520|65056412|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358847|NCT01716520|65056413|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358848|NCT01716520|65056414|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358849|NCT01716520|65056415|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
23358850|NCT01716520|65056410|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23358851|NCT01716520|65056411|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23358852|NCT01716520|65056412|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23358853|NCT01716520|65056413|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23475770|NCT01402102|65485533|FG000|Overall Study|Protocol Violation|1|||
23475771|NCT01402102|65485534|FG001|Overall Study|Protocol Violation|0|||
23475772|NCT01402102|65485533|FG000|Overall Study|Insufficiency of compliance|1|||
23475773|NCT01402102|65485534|FG001|Overall Study|Insufficiency of compliance|1|||
23475774|NCT01402102|65485533|FG000|Overall Study|Withdrawal by Subject|0|||
23475775|NCT01402102|65485534|FG001|Overall Study|Withdrawal by Subject|2|||
23475776|NCT00200356|65485535|FG000|Overall Study|Lack of Efficacy|3|||
23475777|NCT00200356|65485536|FG001|Overall Study|Lack of Efficacy|3|||
23475778|NCT00200356|65485535|FG000|Overall Study|Protocol Violation|4|||
23475779|NCT00200356|65485536|FG001|Overall Study|Protocol Violation|4|||
23475780|NCT00200356|65485535|FG000|Overall Study|Nontreatment|1|||
23475781|NCT00200356|65485536|FG001|Overall Study|Nontreatment|0|||
23475782|NCT02756806|65485537|FG000|Overall Study|Study terminated early|5|||
23358854|NCT01716520|65056414|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
23475783|NCT00905645|65485540|FG000|Overall Study|Death (not device related)|10|||
23475784|NCT00905645|65485541|FG001|Overall Study|Death (not device related)|4|||
23475785|NCT00905645|65485542|FG002|Overall Study|Death (not device related)|15|||
23475786|NCT00905645|65485543|FG003|Overall Study|Death (not device related)|8|||
23475787|NCT00905645|65485540|FG000|Overall Study|Explantation of study device(s)|78|||
23252700|NCT00267020|64667833|FG001|Overall Study|Disease Progression|25|||
23252701|NCT00267020|64667832|FG000|Overall Study|Unrelated Complication|1|||
23358855|NCT01716520|65056415|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
23358856|NCT01716520|65056410|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358857|NCT01716520|65056411|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
23358858|NCT01716520|65056412|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358859|NCT01716520|65056413|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358860|NCT01716520|65056414|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358861|NCT01716520|65056415|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
23358862|NCT01716520|65056410|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358863|NCT01716520|65056411|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358864|NCT01716520|65056412|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358865|NCT01716520|65056413|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358866|NCT01716520|65056414|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
23358867|NCT01716520|65056415|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
23358868|NCT01716520|65056410|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358869|NCT01716520|65056411|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358870|NCT01716520|65056412|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
23358871|NCT01716520|65056413|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358872|NCT01716520|65056414|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358873|NCT01716520|65056415|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
23358874|NCT03519919|65056416|FG000|Overall Study|Withdrawal by Subject|1|||
23358875|NCT03519919|65056416|FG000|Overall Study|Lack of Efficacy|1|||
23358876|NCT03519919|65056416|FG000|Overall Study|Screen Failure|1|||
23358877|NCT02144077|65056421|FG000|Overall Study|Withdrawal by Subject|3|||
23358878|NCT02144077|65056422|FG001|Overall Study|Withdrawal by Subject|3|||
23358879|NCT02144077|65056421|FG000|Overall Study|Adverse Event|2|||
23358880|NCT02144077|65056422|FG001|Overall Study|Adverse Event|3|||
23358881|NCT02144077|65056421|FG000|Overall Study|Lost to Follow-up|2|||
23358882|NCT02144077|65056422|FG001|Overall Study|Lost to Follow-up|2|||
23358883|NCT02144077|65056421|FG000|Overall Study|Protocol Violation|1|||
23358884|NCT02144077|65056422|FG001|Overall Study|Protocol Violation|2|||
23358885|NCT02144077|65056421|FG000|Overall Study|Death|0|||
23358886|NCT02144077|65056422|FG001|Overall Study|Death|1|||
23358887|NCT02144077|65056421|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
23358888|NCT02144077|65056422|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
23358889|NCT00765817|65056429|FG000|Overall Study|Adverse Event|13|||
23358890|NCT00765817|65056430|FG001|Overall Study|Adverse Event|1|||
23358891|NCT00765817|65056429|FG000|Overall Study|Death|0|||
23358892|NCT00765817|65056430|FG001|Overall Study|Death|1|||
23358893|NCT00765817|65056429|FG000|Overall Study|Entry criteria not met|2|||
23358894|NCT00765817|65056430|FG001|Overall Study|Entry criteria not met|2|||
23358895|NCT00765817|65056429|FG000|Overall Study|Loss of glucose control|0|||
23358896|NCT00765817|65056430|FG001|Overall Study|Loss of glucose control|2|||
23358897|NCT00765817|65056429|FG000|Overall Study|Lost to Follow-up|1|||
23358898|NCT00765817|65056430|FG001|Overall Study|Lost to Follow-up|3|||
23358899|NCT00765817|65056429|FG000|Overall Study|Physician Decision|2|||
23252702|NCT00267020|64667833|FG001|Overall Study|Unrelated Complication|1|||
23252703|NCT00267020|64667832|FG000|Overall Study|Sponsor Request|1|||
23252704|NCT00267020|64667833|FG001|Overall Study|Sponsor Request|0|||
23252705|NCT00267020|64667832|FG000|Overall Study|Other|1|||
23252706|NCT00267020|64667833|FG001|Overall Study|Other|2|||
23252707|NCT04056299|64667837|FG000|Overall Study|Sponsor discontinued study|3|||
23252708|NCT04056299|64667838|FG001|Overall Study|Sponsor discontinued study|3|||
23252709|NCT01406873|64667841|FG000|Overall Study|Withdrawal by Subject|1|||
23252710|NCT01406873|64667842|FG001|Overall Study|Withdrawal by Subject|1|||
23252711|NCT01726335|64667843|FG000|Overall Study|Lost to Follow-up|2|||
23252712|NCT01726335|64667843|FG000|Overall Study|Withdrawal by Subject|15|||
23252713|NCT01726335|64667843|FG000|Overall Study|Adverse Event|4|||
23252714|NCT01726335|64667843|FG000|Overall Study|Lost to Follow-up|2|||
23252715|NCT01726335|64667843|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
23252716|NCT01050673|64667844|FG000|Overall Study|Physician Decision|4|||
23252717|NCT01050673|64667845|FG001|Overall Study|Physician Decision|5|||
23252718|NCT03302299|64667846|FG000|Overall Study|Protocol Violation|1|||
23252719|NCT00319020|64667847|FG000|Overall Study|Death|2|||
23252720|NCT00319020|64667848|FG001|Overall Study|Death|2|||
23252721|NCT00319020|64667847|FG000|Overall Study|Withdrawal by Subject|4|||
23252722|NCT00319020|64667848|FG001|Overall Study|Withdrawal by Subject|1|||
23358900|NCT00765817|65056430|FG001|Overall Study|Physician Decision|1|||
23358901|NCT00765817|65056429|FG000|Overall Study|Protocol Violation|1|||
23358902|NCT00765817|65056430|FG001|Overall Study|Protocol Violation|1|||
23358903|NCT00765817|65056429|FG000|Overall Study|Subject decision|7|||
23358904|NCT00765817|65056430|FG001|Overall Study|Subject decision|11|||
23252723|NCT00319020|64667847|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
23252724|NCT00319020|64667848|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
23252725|NCT00319020|64667847|FG000|Overall Study|Administrative reason|0|||
23358905|NCT04035499|65059905|FG000|Overall Study|Death|2|||
23475788|NCT00905645|65485541|FG001|Overall Study|Explantation of study device(s)|47|||
23252726|NCT00319020|64667848|FG001|Overall Study|Administrative reason|5|||
23252727|NCT00319020|64667847|FG000|Overall Study|Disease progression|0|||
23252728|NCT00319020|64667848|FG001|Overall Study|Disease progression|2|||
23252729|NCT00319020|64667847|FG000|Overall Study|Transplant|0|||
23252730|NCT00319020|64667848|FG001|Overall Study|Transplant|1|||
23252731|NCT00319020|64667847|FG000|Overall Study|Treatment failure|0|||
23252732|NCT00319020|64667848|FG001|Overall Study|Treatment failure|1|||
23252733|NCT00319020|64667847|FG000|Overall Study|Adverse Event|0|||
23252734|NCT00319020|64667848|FG001|Overall Study|Adverse Event|1|||
23252735|NCT01335399|64667849|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
23252736|NCT01335399|64667850|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
23252737|NCT01335399|64667849|FG000|Pre-treatment Period|Participant request to discontinue|0|||
23252738|NCT01335399|64667850|FG001|Pre-treatment Period|Participant request to discontinue|1|||
23252739|NCT01335399|64667849|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
23252740|NCT01335399|64667850|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
23252741|NCT01335399|64667849|FG000|Pre-treatment Period|Consent withdrawal|3|||
23252742|NCT01335399|64667850|FG001|Pre-treatment Period|Consent withdrawal|0|||
23252743|NCT01335399|64667849|FG000|Treatment Period|Disease progression|117|||
23252744|NCT01335399|64667850|FG001|Treatment Period|Disease progression|145|||
23252745|NCT01335399|64667849|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
23252746|NCT01335399|64667850|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
23252747|NCT01335399|64667849|FG000|Treatment Period|Study drug toxicity|52|||
23252748|NCT01335399|64667850|FG001|Treatment Period|Study drug toxicity|64|||
23252749|NCT01335399|64667849|FG000|Treatment Period|Participant request to discontinue|30|||
23252750|NCT01335399|64667850|FG001|Treatment Period|Participant request to discontinue|22|||
23252751|NCT01335399|64667849|FG000|Treatment Period|Other reasons|30|||
23252752|NCT01335399|64667850|FG001|Treatment Period|Other reasons|30|||
23252753|NCT01335399|64667849|FG000|Treatment Period|Consent withdrawal|10|||
23252754|NCT01335399|64667850|FG001|Treatment Period|Consent withdrawal|7|||
23252755|NCT01335399|64667849|FG000|Treatment Period|Death|7|||
23252756|NCT01335399|64667850|FG001|Treatment Period|Death|6|||
23252757|NCT01335399|64667849|FG000|Treatment Period|Poor/Non-compliance|3|||
23252758|NCT01335399|64667850|FG001|Treatment Period|Poor/Non-compliance|4|||
23252759|NCT01335399|64667849|FG000|Treatment Period|Lost to Follow-up|2|||
23252760|NCT01335399|64667850|FG001|Treatment Period|Lost to Follow-up|2|||
23252761|NCT01335399|64667849|FG000|Treatment Period|Maximum clinical benefit|1|||
23252762|NCT01335399|64667850|FG001|Treatment Period|Maximum clinical benefit|1|||
23252763|NCT01335399|64667849|FG000|Treatment Period|No longer meet study criteria|1|||
23252764|NCT01335399|64667850|FG001|Treatment Period|No longer meet study criteria|1|||
23252765|NCT01335399|64667849|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
23252766|NCT01335399|64667850|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
23252767|NCT01092702|64667853|FG000|Overall Study|Withdrawal by Subject|7|||
23252768|NCT01092702|64667853|FG000|Overall Study|Lost to Follow-up|2|||
23252769|NCT01185639|64667854|FG000|Overall Study|Progressed and didn't receive therapy|2|||
23252770|NCT01902134|64667855|FG000|Overall Study|Adverse Event|3|||
23252771|NCT01902134|64667856|FG001|Overall Study|Adverse Event|1|||
23252772|NCT01902134|64667857|FG002|Overall Study|Adverse Event|2|||
23252773|NCT01902134|64667858|FG003|Overall Study|Adverse Event|1|||
23252774|NCT01902134|64667859|FG004|Overall Study|Adverse Event|1|||
23252775|NCT01902134|64667860|FG005|Overall Study|Adverse Event|3|||
23252776|NCT01902134|64667855|FG000|Overall Study|Lack of Efficacy|0|||
23252777|NCT01902134|64667856|FG001|Overall Study|Lack of Efficacy|0|||
23252778|NCT01902134|64667857|FG002|Overall Study|Lack of Efficacy|2|||
23252779|NCT01902134|64667858|FG003|Overall Study|Lack of Efficacy|0|||
23252780|NCT01902134|64667859|FG004|Overall Study|Lack of Efficacy|0|||
23252781|NCT01902134|64667860|FG005|Overall Study|Lack of Efficacy|1|||
23252782|NCT01902134|64667855|FG000|Overall Study|Physician Decision|0|||
23252783|NCT01902134|64667856|FG001|Overall Study|Physician Decision|1|||
23252784|NCT01902134|64667857|FG002|Overall Study|Physician Decision|0|||
23252785|NCT01902134|64667858|FG003|Overall Study|Physician Decision|0|||
23252786|NCT01902134|64667859|FG004|Overall Study|Physician Decision|0|||
23252787|NCT01902134|64667860|FG005|Overall Study|Physician Decision|0|||
23252788|NCT01902134|64667855|FG000|Overall Study|Protocol Violation|0|||
23252789|NCT01902134|64667856|FG001|Overall Study|Protocol Violation|0|||
23252790|NCT01902134|64667857|FG002|Overall Study|Protocol Violation|0|||
23252791|NCT01902134|64667858|FG003|Overall Study|Protocol Violation|0|||
23475789|NCT00905645|65485542|FG002|Overall Study|Explantation of study device(s)|28|||
23590012|NCT02371746|65889547|FG004|Overall Study|Consent withdrawn|0|||
23590013|NCT02371746|65889548|FG005|Overall Study|Consent withdrawn|0|||
23252792|NCT01902134|64667859|FG004|Overall Study|Protocol Violation|0|||
23252793|NCT01902134|64667860|FG005|Overall Study|Protocol Violation|1|||
23252794|NCT01902134|64667855|FG000|Overall Study|Withdrawal by Subject|4|||
23252795|NCT01902134|64667856|FG001|Overall Study|Withdrawal by Subject|8|||
23252796|NCT01902134|64667857|FG002|Overall Study|Withdrawal by Subject|9|||
23252797|NCT01902134|64667858|FG003|Overall Study|Withdrawal by Subject|1|||
23358906|NCT04035499|65059905|FG000|Overall Study|Withdrawal by Subject|1|||
23358907|NCT02998996|65059906|FG000|Overall Study|Lost to Follow-up|0|||
23358908|NCT02998996|65059907|FG001|Overall Study|Lost to Follow-up|0|||
23358909|NCT02998996|65059908|FG002|Overall Study|Lost to Follow-up|1|||
23358910|NCT02998996|65059909|FG003|Overall Study|Lost to Follow-up|0|||
23358911|NCT02998996|65059910|FG004|Overall Study|Lost to Follow-up|0|||
23358912|NCT02998996|65059911|FG005|Overall Study|Lost to Follow-up|0|||
23358913|NCT02998996|65059906|FG000|Overall Study|Pregnancy|0|||
23358914|NCT02998996|65059907|FG001|Overall Study|Pregnancy|1|||
23358915|NCT02998996|65059908|FG002|Overall Study|Pregnancy|0|||
23358916|NCT02998996|65059909|FG003|Overall Study|Pregnancy|0|||
23358917|NCT02998996|65059910|FG004|Overall Study|Pregnancy|0|||
23358918|NCT02998996|65059911|FG005|Overall Study|Pregnancy|0|||
23358919|NCT02998996|65059906|FG000|Overall Study|Family reasons|0|||
23358920|NCT02998996|65059907|FG001|Overall Study|Family reasons|0|||
23358921|NCT02998996|65059908|FG002|Overall Study|Family reasons|0|||
23358922|NCT02998996|65059909|FG003|Overall Study|Family reasons|0|||
23358923|NCT02998996|65059910|FG004|Overall Study|Family reasons|1|||
23358924|NCT02998996|65059911|FG005|Overall Study|Family reasons|0|||
23358925|NCT01121263|65059912|FG000|Overall Study|Death|3|||
23358926|NCT01121263|65059913|FG001|Overall Study|Death|2|||
23358927|NCT01121263|65059912|FG000|Overall Study|Lost to Follow-up|22|||
23358928|NCT01121263|65059913|FG001|Overall Study|Lost to Follow-up|12|||
23358929|NCT01121263|65059912|FG000|Overall Study|Withdrawal by Subject|0|||
23358930|NCT01121263|65059913|FG001|Overall Study|Withdrawal by Subject|1|||
23358931|NCT00762762|65059914|FG000|Overall Study|Did not return for appointments|6|||
23358932|NCT00762762|65059915|FG001|Overall Study|Did not return for appointments|8|||
23358933|NCT03076996|65059916|FG000|Overall Study|Withdrawal by Subject|2|||
23358934|NCT03076996|65059916|FG000|Overall Study|Lost to Follow-up|3|||
23358935|NCT03076996|65059916|FG000|Overall Study|Literacy precluded participation|1|||
23358936|NCT02098395|65059917|FG000|Overall Study|Protocol Violation|2|||
23358937|NCT02098395|65059918|FG001|Overall Study|Protocol Violation|2|||
23358938|NCT02098395|65059919|FG002|Overall Study|Protocol Violation|0|||
23358939|NCT02098395|65059920|FG003|Overall Study|Protocol Violation|7|||
23358940|NCT02098395|65059917|FG000|Overall Study|Withdrawal by Subject|10|||
23358941|NCT02098395|65059918|FG001|Overall Study|Withdrawal by Subject|10|||
23358942|NCT02098395|65059919|FG002|Overall Study|Withdrawal by Subject|5|||
23358943|NCT02098395|65059920|FG003|Overall Study|Withdrawal by Subject|13|||
23358944|NCT02098395|65059917|FG000|Overall Study|Adverse Event|12|||
23358945|NCT02098395|65059918|FG001|Overall Study|Adverse Event|19|||
23358946|NCT02098395|65059919|FG002|Overall Study|Adverse Event|34|||
23358947|NCT02098395|65059920|FG003|Overall Study|Adverse Event|2|||
23358948|NCT02098395|65059917|FG000|Overall Study|Lost to Follow-up|2|||
23358949|NCT02098395|65059918|FG001|Overall Study|Lost to Follow-up|1|||
23358950|NCT02098395|65059919|FG002|Overall Study|Lost to Follow-up|0|||
23358951|NCT02098395|65059920|FG003|Overall Study|Lost to Follow-up|3|||
23358952|NCT02098395|65059917|FG000|Overall Study|Unclassified|0|||
23358953|NCT02098395|65059918|FG001|Overall Study|Unclassified|0|||
23358954|NCT02098395|65059919|FG002|Overall Study|Unclassified|3|||
23358955|NCT02098395|65059920|FG003|Overall Study|Unclassified|2|||
23358956|NCT02501161|65059921|FG000|Overall Study|Adverse Event|2|||
23358957|NCT02501161|65059922|FG001|Overall Study|Adverse Event|6|||
23358958|NCT02501161|65059921|FG000|Overall Study|Lost to Follow-up|7|||
23358959|NCT02501161|65059922|FG001|Overall Study|Lost to Follow-up|4|||
23358960|NCT02501161|65059921|FG000|Overall Study|Withdrawal by Subject|10|||
23358961|NCT02501161|65059922|FG001|Overall Study|Withdrawal by Subject|15|||
23358962|NCT02501161|65059921|FG000|Overall Study|Other|3|||
23358963|NCT02501161|65059922|FG001|Overall Study|Other|0|||
23358964|NCT01744483|65059923|FG000|Overall Study|Death|9|||
23358965|NCT01744483|65059924|FG001|Overall Study|Death|4|||
23358966|NCT01744483|65059925|FG002|Overall Study|Death|11|||
23358967|NCT01744483|65059923|FG000|Overall Study|Lost to Follow-up|8|||
23358968|NCT01744483|65059924|FG001|Overall Study|Lost to Follow-up|9|||
23358969|NCT01744483|65059925|FG002|Overall Study|Lost to Follow-up|11|||
23358970|NCT01744483|65059923|FG000|Overall Study|Protocol Violation|1|||
23358971|NCT01744483|65059924|FG001|Overall Study|Protocol Violation|2|||
23358972|NCT01744483|65059925|FG002|Overall Study|Protocol Violation|1|||
23358973|NCT01744483|65059923|FG000|Overall Study|Withdrawal by Subject|4|||
23358974|NCT01744483|65059924|FG001|Overall Study|Withdrawal by Subject|6|||
23358975|NCT01744483|65059925|FG002|Overall Study|Withdrawal by Subject|2|||
23358976|NCT01744483|65059923|FG000|Overall Study|No ICU Admit|5|||
23358977|NCT01744483|65059924|FG001|Overall Study|No ICU Admit|1|||
23590014|NCT02371746|65889549|FG006|Overall Study|Consent withdrawn|1|||
23358978|NCT01744483|65059925|FG002|Overall Study|No ICU Admit|2|||
23358979|NCT01744483|65059923|FG000|Overall Study|Routed to OSH|2|||
23358980|NCT01744483|65059924|FG001|Overall Study|Routed to OSH|0|||
23358981|NCT01744483|65059925|FG002|Overall Study|Routed to OSH|1|||
23358982|NCT01516736|65059929|FG000|Overall Study|Withdrawal by Subject|10|||
23358983|NCT01516736|65059930|FG001|Overall Study|Withdrawal by Subject|4|||
23358984|NCT01516736|65059929|FG000|Overall Study|Adverse Event|4|||
23358985|NCT01516736|65059930|FG001|Overall Study|Adverse Event|5|||
23358986|NCT01516736|65059929|FG000|Overall Study|Death|3|||
23358987|NCT01516736|65059930|FG001|Overall Study|Death|1|||
23358988|NCT01516736|65059929|FG000|Overall Study|Physician Decision|2|||
23358989|NCT01516736|65059930|FG001|Overall Study|Physician Decision|1|||
23358990|NCT01516736|65059929|FG000|Overall Study|Lack of Efficacy|1|||
23358991|NCT01516736|65059930|FG001|Overall Study|Lack of Efficacy|0|||
23358992|NCT01516736|65059929|FG000|Overall Study|Protocol Violation|0|||
23358993|NCT01516736|65059930|FG001|Overall Study|Protocol Violation|1|||
23358994|NCT01516736|65059929|FG000|Overall Study|Other (not specified)|0|||
23358995|NCT01516736|65059930|FG001|Overall Study|Other (not specified)|1|||
23358996|NCT01951573|65059931|FG000|Washout Period|Adverse Event|0|||
23358997|NCT01951573|65059932|FG001|Washout Period|Adverse Event|1|||
23358998|NCT03727841|65059933|FG000|Overall Study|Physician Decision|3|||
23358999|NCT03727841|65059934|FG001|Overall Study|Physician Decision|1|||
23359000|NCT00048997|65059935|FG000|Overall Study|Protocol Violation|7|||
23590015|NCT00880048|65889552|FG000|Overall Study|Adverse Event|2|||
23590016|NCT00880048|65889553|FG001|Overall Study|Adverse Event|3|||
23590017|NCT00880048|65889554|FG002|Overall Study|Adverse Event|5|||
23590018|NCT00880048|65889552|FG000|Overall Study|Lack of Efficacy|1|||
23590019|NCT00880048|65889553|FG001|Overall Study|Lack of Efficacy|2|||
23590020|NCT00880048|65889554|FG002|Overall Study|Lack of Efficacy|2|||
23252798|NCT01902134|64667859|FG004|Overall Study|Withdrawal by Subject|5|||
23252799|NCT01902134|64667860|FG005|Overall Study|Withdrawal by Subject|4|||
23252800|NCT01902134|64667855|FG000|Overall Study|no compliance|1|||
23252801|NCT01902134|64667856|FG001|Overall Study|no compliance|0|||
23252802|NCT01902134|64667857|FG002|Overall Study|no compliance|0|||
23252803|NCT01902134|64667858|FG003|Overall Study|no compliance|0|||
23252804|NCT01902134|64667859|FG004|Overall Study|no compliance|0|||
23252805|NCT01902134|64667860|FG005|Overall Study|no compliance|0|||
23359001|NCT00048997|65059936|FG001|Overall Study|Protocol Violation|2|||
23359002|NCT00048997|65059935|FG000|Overall Study|Withdrawal by Subject|6|||
23359003|NCT00048997|65059936|FG001|Overall Study|Withdrawal by Subject|1|||
23359004|NCT02256917|65059937|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
23359005|NCT02256917|65059937|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
23359006|NCT02256917|65059937|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
23359007|NCT02256917|65059937|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
23359008|NCT02256917|65059937|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
23359009|NCT02821416|65059942|FG000|Overall Study|Adverse Event|0|||
23359010|NCT02821416|65059943|FG001|Overall Study|Adverse Event|1|||
23359011|NCT02821416|65059942|FG000|Overall Study|Withdrawal by Subject|2|||
23359012|NCT02821416|65059943|FG001|Overall Study|Withdrawal by Subject|0|||
23359013|NCT02821416|65059942|FG000|Overall Study|Lost to Follow-up|1|||
23359014|NCT02821416|65059943|FG001|Overall Study|Lost to Follow-up|0|||
23359015|NCT01087203|65059948|FG000|Overall Study|Lost to Follow-up|2|||
23359016|NCT01087203|65059949|FG001|Overall Study|Lost to Follow-up|0|||
23359017|NCT01087203|65059948|FG000|Overall Study|Withdrawal by Subject|2|||
23359018|NCT01087203|65059949|FG001|Overall Study|Withdrawal by Subject|6|||
23359019|NCT01087203|65059948|FG000|Overall Study|Lack of Efficacy|1|||
23359020|NCT01087203|65059949|FG001|Overall Study|Lack of Efficacy|2|||
23359021|NCT01087203|65059948|FG000|Overall Study|Study terminated by sponsor|27|||
23359022|NCT01087203|65059949|FG001|Overall Study|Study terminated by sponsor|27|||
23359023|NCT00103662|65059950|FG000|Overall Study|Entered Rescue Procedure|0|||
23359024|NCT00103662|65059951|FG001|Overall Study|Entered Rescue Procedure|7|||
23359025|NCT00103662|65059950|FG000|Overall Study|Death|7|||
23590021|NCT00880048|65889552|FG000|Overall Study|Protocol Violation|4|||
23252806|NCT01902134|64667855|FG000|Overall Study|Other|0|||
23252807|NCT01902134|64667856|FG001|Overall Study|Other|1|||
23252808|NCT01902134|64667857|FG002|Overall Study|Other|2|||
23252809|NCT01902134|64667858|FG003|Overall Study|Other|0|||
23252810|NCT01902134|64667859|FG004|Overall Study|Other|1|||
23252811|NCT01902134|64667860|FG005|Overall Study|Other|0|||
23590022|NCT00880048|65889553|FG001|Overall Study|Protocol Violation|6|||
23590023|NCT00880048|65889554|FG002|Overall Study|Protocol Violation|5|||
23590024|NCT00880048|65889552|FG000|Overall Study|Lost to Follow-up|6|||
23590025|NCT00880048|65889553|FG001|Overall Study|Lost to Follow-up|6|||
23590026|NCT00880048|65889554|FG002|Overall Study|Lost to Follow-up|5|||
23252812|NCT00033631|64667862|FG000|Overall Study|Protocol Violation|14|||
23252813|NCT00033631|64667863|FG001|Overall Study|Protocol Violation|11|||
23252814|NCT00033631|64667862|FG000|Overall Study|Withdrawal by Subject|4|||
23252815|NCT00033631|64667863|FG001|Overall Study|Withdrawal by Subject|4|||
23252816|NCT02239692|64667873|FG000|Overall Study|Incomplete colonoscopy|1|||
23359026|NCT00103662|65059951|FG001|Overall Study|Death|7|||
23359027|NCT00103662|65059950|FG000|Overall Study|Elective Withdrawal|5|||
23359028|NCT00103662|65059951|FG001|Overall Study|Elective Withdrawal|5|||
23359029|NCT00103662|65059950|FG000|Overall Study|Lost to Follow-up|0|||
23359030|NCT00103662|65059951|FG001|Overall Study|Lost to Follow-up|1|||
23359031|NCT00103662|65059950|FG000|Overall Study|Other|6|||
23590027|NCT00880048|65889552|FG000|Overall Study|Physician Decision|1|||
23590028|NCT00880048|65889553|FG001|Overall Study|Physician Decision|1|||
23590029|NCT00880048|65889554|FG002|Overall Study|Physician Decision|7|||
23252817|NCT02239692|64667874|FG001|Overall Study|Incomplete colonoscopy|2|||
23252818|NCT02239692|64667873|FG000|Overall Study|Adverse Event|0|||
23252819|NCT02239692|64667874|FG001|Overall Study|Adverse Event|1|||
23252820|NCT02239692|64667873|FG000|Overall Study|Physician Decision|0|||
23252821|NCT02239692|64667874|FG001|Overall Study|Physician Decision|1|||
23252822|NCT02239692|64667873|FG000|Overall Study|Lost to Follow-up|1|||
23252823|NCT02239692|64667874|FG001|Overall Study|Lost to Follow-up|4|||
23252824|NCT02239692|64667873|FG000|Overall Study|Withdrawal by Subject|3|||
23252825|NCT02239692|64667874|FG001|Overall Study|Withdrawal by Subject|5|||
23252826|NCT02239692|64667873|FG000|Overall Study|Other reason|1|||
23252827|NCT02239692|64667874|FG001|Overall Study|Other reason|0|||
23252828|NCT01440647|64667877|FG000|Overall Study|Death|2|||
23252829|NCT01440647|64667878|FG001|Overall Study|Death|3|||
23252830|NCT01120600|64667879|FG000|Overall Study|Adverse Event|7|||
23252831|NCT01120600|64667880|FG001|Overall Study|Adverse Event|7|||
23252832|NCT01120600|64667879|FG000|Overall Study|Excessive Bone Loss|0|||
23252833|NCT01120600|64667880|FG001|Overall Study|Excessive Bone Loss|4|||
23252834|NCT01120600|64667879|FG000|Overall Study|Lost to Follow-up|1|||
23252835|NCT01120600|64667880|FG001|Overall Study|Lost to Follow-up|3|||
23252836|NCT01120600|64667879|FG000|Overall Study|Physician Decision|1|||
23252837|NCT01120600|64667880|FG001|Overall Study|Physician Decision|3|||
23252838|NCT01120600|64667879|FG000|Overall Study|Protocol Violation|0|||
23252839|NCT01120600|64667880|FG001|Overall Study|Protocol Violation|4|||
23252840|NCT01120600|64667879|FG000|Overall Study|Withdrawal by Subject|10|||
23252841|NCT01120600|64667880|FG001|Overall Study|Withdrawal by Subject|11|||
23252842|NCT01715415|64667882|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
23359032|NCT00103662|65059951|FG001|Overall Study|Other|9|||
23359033|NCT00103662|65059950|FG000|Overall Study|Failed mobilization|0|||
23359034|NCT00103662|65059951|FG001|Overall Study|Failed mobilization|4|||
23359035|NCT00103662|65059950|FG000|Overall Study|Intercurrent illness|1|||
23359036|NCT00103662|65059951|FG001|Overall Study|Intercurrent illness|0|||
23359037|NCT02819440|65059954|FG000|Overall Study|Adverse Event|3|||
23359038|NCT02819440|65059955|FG001|Overall Study|Adverse Event|1|||
23359039|NCT02819440|65059954|FG000|Overall Study|Lost to Follow-up|1|||
23359040|NCT02819440|65059955|FG001|Overall Study|Lost to Follow-up|3|||
23359041|NCT02819440|65059954|FG000|Overall Study|Withdrawal by Subject|9|||
23359042|NCT02819440|65059955|FG001|Overall Study|Withdrawal by Subject|8|||
23359043|NCT00992017|65059958|FG000|Overall Study|Lost to Follow-up|2|||
23359044|NCT00992017|65059958|FG000|Overall Study|Withdrawal by Subject|2|||
23359045|NCT00992017|65059958|FG000|Overall Study|Unable to get to clinic|5|||
23359046|NCT00992017|65059958|FG000|Overall Study|Not adhere to study requirements|1|||
23359047|NCT02734862|65059963|FG000|Part A|Death|3|||
23359048|NCT02734862|65059964|FG001|Part A|Death|4|||
23359049|NCT02734862|65059965|FG002|Part A|Death|6|||
23359050|NCT02734862|65059963|FG000|Part A|Lost to Follow-up|2|||
23359051|NCT02734862|65059964|FG001|Part A|Lost to Follow-up|1|||
23252843|NCT01715415|64667883|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
23252844|NCT01715415|64667882|FG000|Double-blind Treatment|Adverse Event|3|||
23252845|NCT01715415|64667883|FG001|Double-blind Treatment|Adverse Event|0|||
23359052|NCT02734862|65059965|FG002|Part A|Lost to Follow-up|1|||
23359053|NCT02734862|65059963|FG000|Part A|Withdrawal by Subject|1|||
23359054|NCT02734862|65059964|FG001|Part A|Withdrawal by Subject|1|||
23359055|NCT02734862|65059965|FG002|Part A|Withdrawal by Subject|2|||
23359056|NCT02734862|65059963|FG000|Part A|Physician Decision|2|||
23359057|NCT02734862|65059964|FG001|Part A|Physician Decision|0|||
23359058|NCT02734862|65059965|FG002|Part A|Physician Decision|1|||
23359059|NCT02734862|65059963|FG000|Part A|Adverse Event|2|||
23359060|NCT02734862|65059964|FG001|Part A|Adverse Event|0|||
23359061|NCT02734862|65059965|FG002|Part A|Adverse Event|1|||
23359062|NCT02734862|65059963|FG000|Part A|Noncompliance|1|||
23359063|NCT02734862|65059964|FG001|Part A|Noncompliance|1|||
23475790|NCT00905645|65485543|FG003|Overall Study|Explantation of study device(s)|21|||
23475791|NCT00905645|65485540|FG000|Overall Study|Subject Request|41|||
23252846|NCT01715415|64667882|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
23359064|NCT02734862|65059965|FG002|Part A|Noncompliance|0|||
23359065|NCT02734862|65059963|FG000|Part A|Other|1|||
23359066|NCT02734862|65059964|FG001|Part A|Other|1|||
23252847|NCT01715415|64667883|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
23252848|NCT01715415|64667882|FG000|Double-blind Treatment|Other|1|||
23252849|NCT01715415|64667883|FG001|Double-blind Treatment|Other|0|||
23359067|NCT02734862|65059965|FG002|Part A|Other|3|||
23252850|NCT01715415|64667882|FG000|Open-label Treatment|Adverse Event|0|||
23252851|NCT01715415|64667883|FG001|Open-label Treatment|Adverse Event|1|||
23359068|NCT02734862|65059963|FG000|Part B|Death|8|||
23252852|NCT01715415|64667882|FG000|Open-label Treatment|Subject Noncompliant|0|||
23359069|NCT02734862|65059964|FG001|Part B|Death|3|||
23359070|NCT02734862|65059965|FG002|Part B|Death|5|||
23359071|NCT02734862|65059963|FG000|Part B|Lost to Follow-up|2|||
23359072|NCT02734862|65059964|FG001|Part B|Lost to Follow-up|2|||
23359073|NCT02734862|65059965|FG002|Part B|Lost to Follow-up|0|||
23359074|NCT02734862|65059963|FG000|Part B|Withdrawal by Subject|3|||
23359075|NCT02734862|65059964|FG001|Part B|Withdrawal by Subject|1|||
23475792|NCT00905645|65485541|FG001|Overall Study|Subject Request|17|||
23475793|NCT00905645|65485542|FG002|Overall Study|Subject Request|13|||
23475794|NCT00905645|65485543|FG003|Overall Study|Subject Request|11|||
23475795|NCT00905645|65485540|FG000|Overall Study|Lost to Follow-up|299|||
23475796|NCT00905645|65485541|FG001|Overall Study|Lost to Follow-up|103|||
23475797|NCT00905645|65485542|FG002|Overall Study|Lost to Follow-up|51|||
23475798|NCT00905645|65485543|FG003|Overall Study|Lost to Follow-up|12|||
23475799|NCT03801031|65485544|FG000|Overall Study|Lost to Follow-up|1|||
23475800|NCT03801031|65485545|FG001|Overall Study|Lost to Follow-up|0|||
23475801|NCT03801031|65485544|FG000|Overall Study|Unable to comply|1|||
23475802|NCT03801031|65485545|FG001|Overall Study|Unable to comply|0|||
23475803|NCT03801031|65485544|FG000|Overall Study|Withdrawal by Subject|0|||
23475804|NCT03801031|65485545|FG001|Overall Study|Withdrawal by Subject|1|||
23475805|NCT02880956|65485546|FG000|Overall Study|Adverse Event|3|||
23475806|NCT02880956|65485547|FG001|Overall Study|Adverse Event|6|||
23475807|NCT02880956|65485548|FG002|Overall Study|Adverse Event|5|||
23475808|NCT02880956|65485549|FG003|Overall Study|Adverse Event|4|||
23475809|NCT02880956|65485546|FG000|Overall Study|Withdrawal by Subject|9|||
23475810|NCT02880956|65485547|FG001|Overall Study|Withdrawal by Subject|4|||
23475811|NCT02880956|65485548|FG002|Overall Study|Withdrawal by Subject|6|||
23475812|NCT02880956|65485549|FG003|Overall Study|Withdrawal by Subject|11|||
23475813|NCT02880956|65485546|FG000|Overall Study|Lost to Follow-up|0|||
23475814|NCT02880956|65485547|FG001|Overall Study|Lost to Follow-up|1|||
23475815|NCT02880956|65485548|FG002|Overall Study|Lost to Follow-up|0|||
23475816|NCT02880956|65485549|FG003|Overall Study|Lost to Follow-up|0|||
23475817|NCT02880956|65485546|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
23475818|NCT02880956|65485547|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
23475819|NCT02880956|65485548|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
23475820|NCT02880956|65485549|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
23475821|NCT02880956|65485546|FG000|Overall Study|Other, Not Specified|4|||
23475822|NCT02880956|65485547|FG001|Overall Study|Other, Not Specified|2|||
23475823|NCT02880956|65485548|FG002|Overall Study|Other, Not Specified|0|||
23475824|NCT02880956|65485549|FG003|Overall Study|Other, Not Specified|3|||
23475825|NCT02116530|65485550|FG000|Overall Study|Withdrawal by Subject|1|||
23475826|NCT02116530|65485551|FG001|Overall Study|Withdrawal by Subject|2|||
23475827|NCT02116530|65485550|FG000|Overall Study|Adverse Event|4|||
23475828|NCT02116530|65485551|FG001|Overall Study|Adverse Event|0|||
23475829|NCT02116530|65485550|FG000|Overall Study|Physician Decision|1|||
23475830|NCT02116530|65485551|FG001|Overall Study|Physician Decision|0|||
23475831|NCT02116530|65485550|FG000|Overall Study|Lost to Follow-up|1|||
23475832|NCT02116530|65485551|FG001|Overall Study|Lost to Follow-up|0|||
23475833|NCT02116530|65485550|FG000|Overall Study|Other Medical Problems|2|||
23475834|NCT02116530|65485551|FG001|Overall Study|Other Medical Problems|2|||
23475835|NCT01024309|65485556|FG000|Overall Study|Physician Decision|4|||
23475836|NCT01024309|65485557|FG001|Overall Study|Physician Decision|0|||
23475837|NCT01024309|65485556|FG000|Overall Study|Withdrawal by Subject|4|||
23475838|NCT01024309|65485557|FG001|Overall Study|Withdrawal by Subject|4|||
23475839|NCT01981551|65485560|FG000|Overall Study|Refused further treatment|8|||
23475840|NCT01981551|65485560|FG000|Overall Study|Adverse Event|1|||
23475841|NCT01754727|65485561|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
23475842|NCT00638183|65485564|FG000|Overall Study|Adverse Event|23|||
23475843|NCT00638183|65485564|FG000|Overall Study|Lack of Efficacy|14|||
23475844|NCT00638183|65485564|FG000|Overall Study|Physician Decision|9|||
23475845|NCT00638183|65485564|FG000|Overall Study|Lost to Follow-up|46|||
23475846|NCT00638183|65485564|FG000|Overall Study|Other reason not defined above|27|||
23475847|NCT03720652|65485565|FG000|Overall Study|Withdrawal by Subject|2|||
23475848|NCT03720652|65485566|FG001|Overall Study|Withdrawal by Subject|7|||
23475849|NCT03720652|65485565|FG000|Overall Study|Lost to Follow-up|0|||
23475850|NCT03720652|65485566|FG001|Overall Study|Lost to Follow-up|4|||
23475851|NCT02529553|65485567|FG000|Overall Study|Progressive Disease|1|||
23475852|NCT02529553|65485568|FG001|Overall Study|Progressive Disease|0|||
23475853|NCT02529553|65485569|FG002|Overall Study|Progressive Disease|1|||
23475854|NCT02529553|65485570|FG003|Overall Study|Progressive Disease|3|||
23475855|NCT02529553|65485571|FG004|Overall Study|Progressive Disease|2|||
23475856|NCT02529553|65485572|FG005|Overall Study|Progressive Disease|3|||
23475857|NCT02529553|65485573|FG006|Overall Study|Progressive Disease|3|||
23475858|NCT02529553|65485574|FG007|Overall Study|Progressive Disease|5|||
23475859|NCT02529553|65485575|FG008|Overall Study|Progressive Disease|3|||
23475860|NCT02529553|65485567|FG000|Overall Study|Physician Decision|0|||
23475861|NCT02529553|65485568|FG001|Overall Study|Physician Decision|1|||
23475862|NCT02529553|65485569|FG002|Overall Study|Physician Decision|0|||
23475863|NCT02529553|65485570|FG003|Overall Study|Physician Decision|0|||
23475864|NCT02529553|65485571|FG004|Overall Study|Physician Decision|1|||
23475865|NCT02529553|65485572|FG005|Overall Study|Physician Decision|0|||
23475866|NCT02529553|65485573|FG006|Overall Study|Physician Decision|0|||
23359076|NCT02734862|65059965|FG002|Part B|Withdrawal by Subject|0|||
23359077|NCT02734862|65059963|FG000|Part B|Other|0|||
23359078|NCT02734862|65059964|FG001|Part B|Other|1|||
23359079|NCT02734862|65059965|FG002|Part B|Other|0|||
23359080|NCT01344759|65059966|FG000|Overall Study|Patients failed to reach sedation level|0|||
23359081|NCT01344759|65059967|FG001|Overall Study|Patients failed to reach sedation level|2|||
23359082|NCT02348008|65059968|FG000|Overall Study|Adverse Event|2|||
23359083|NCT02348008|65059969|FG001|Overall Study|Adverse Event|3|||
23359084|NCT02348008|65059970|FG002|Overall Study|Adverse Event|3|||
23359085|NCT02348008|65059968|FG000|Overall Study|Disease Progression|1|||
23359086|NCT02348008|65059969|FG001|Overall Study|Disease Progression|5|||
23359087|NCT02348008|65059970|FG002|Overall Study|Disease Progression|16|||
23359088|NCT02348008|65059968|FG000|Overall Study|Withdrawal by Subject|0|||
23359089|NCT02348008|65059969|FG001|Overall Study|Withdrawal by Subject|1|||
23359090|NCT02348008|65059970|FG002|Overall Study|Withdrawal by Subject|0|||
23359091|NCT02348008|65059968|FG000|Overall Study|Symptomatic Deterioration|0|||
23359092|NCT02348008|65059969|FG001|Overall Study|Symptomatic Deterioration|1|||
23359093|NCT02348008|65059970|FG002|Overall Study|Symptomatic Deterioration|0|||
23359094|NCT04888494|65059971|FG000|Overall Study|Lost to Follow-up|2|||
23359095|NCT04888494|65059972|FG001|Overall Study|Lost to Follow-up|3|||
23359096|NCT04888494|65059971|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
23359097|NCT04888494|65059972|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
23359098|NCT01877668|65059976|FG000|Overall Study|Death|0|||
23252853|NCT01715415|64667883|FG001|Open-label Treatment|Subject Noncompliant|1|||
23252854|NCT03797222|64667884|FG000|Overall Study|Withdrawal by Subject|1|||
23252855|NCT01963676|64667885|FG000|Overall Study|Withdrawal by Subject|1|||
23252856|NCT01963676|64667886|FG001|Overall Study|Withdrawal by Subject|0|||
23359099|NCT01877668|65059977|FG001|Overall Study|Death|0|||
23359100|NCT01877668|65059978|FG002|Overall Study|Death|0|||
23359101|NCT01877668|65059979|FG003|Overall Study|Death|1|||
23359102|NCT01877668|65059980|FG004|Overall Study|Death|0|||
23359103|NCT01877668|65059976|FG000|Overall Study|No longer met study criteria|1|||
23359104|NCT01877668|65059977|FG001|Overall Study|No longer met study criteria|0|||
23359105|NCT01877668|65059978|FG002|Overall Study|No longer met study criteria|1|||
23359106|NCT01877668|65059979|FG003|Overall Study|No longer met study criteria|0|||
23359107|NCT01877668|65059980|FG004|Overall Study|No longer met study criteria|0|||
23475867|NCT02529553|65485574|FG007|Overall Study|Physician Decision|0|||
23475868|NCT02529553|65485575|FG008|Overall Study|Physician Decision|0|||
23475869|NCT02529553|65485567|FG000|Overall Study|Withdrawal by Subject|0|||
23475870|NCT02529553|65485568|FG001|Overall Study|Withdrawal by Subject|0|||
23475871|NCT02529553|65485569|FG002|Overall Study|Withdrawal by Subject|0|||
23475872|NCT02529553|65485570|FG003|Overall Study|Withdrawal by Subject|0|||
23475873|NCT02529553|65485571|FG004|Overall Study|Withdrawal by Subject|0|||
23475874|NCT02529553|65485572|FG005|Overall Study|Withdrawal by Subject|1|||
23475875|NCT02529553|65485573|FG006|Overall Study|Withdrawal by Subject|0|||
23475876|NCT02529553|65485574|FG007|Overall Study|Withdrawal by Subject|1|||
23475877|NCT02529553|65485575|FG008|Overall Study|Withdrawal by Subject|0|||
23475878|NCT04657666|65485578|FG000|Period 1|Withdrawal of participant consent|2|||
23475879|NCT04657666|65485579|FG001|Period 1|Withdrawal of participant consent|1|||
23475880|NCT04657666|65485578|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
23475881|NCT04657666|65485579|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
23475882|NCT04657666|65485578|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
23475883|NCT04657666|65485579|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
23475884|NCT04657666|65485578|FG000|Period 2|Other|2|||
23475885|NCT04657666|65485579|FG001|Period 2|Other|0|||
23475886|NCT04657666|65485578|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
23475887|NCT04657666|65485579|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
23475888|NCT01715857|65485580|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
23475889|NCT00946153|65485581|FG000|Phase 2|Adverse Event|0|||
23475890|NCT00946153|65485582|FG001|Phase 2|Adverse Event|0|||
23475891|NCT00946153|65485583|FG002|Phase 2|Adverse Event|0|||
23475892|NCT00946153|65485584|FG003|Phase 2|Adverse Event|0|||
23475893|NCT00946153|65485585|FG004|Phase 2|Adverse Event|6|||
23475894|NCT00946153|65485581|FG000|Phase 2|Need more reduction of dose|0|||
23475895|NCT00946153|65485582|FG001|Phase 2|Need more reduction of dose|0|||
23475896|NCT00946153|65485583|FG002|Phase 2|Need more reduction of dose|0|||
23475897|NCT00946153|65485584|FG003|Phase 2|Need more reduction of dose|0|||
23359108|NCT01877668|65059976|FG000|Overall Study|Insufficient clinical response|0|||
23359109|NCT01877668|65059977|FG001|Overall Study|Insufficient clinical response|1|||
23359110|NCT01877668|65059978|FG002|Overall Study|Insufficient clinical response|2|||
23475898|NCT00946153|65485585|FG004|Phase 2|Need more reduction of dose|2|||
23191885|NCT01522651|64442456|FG000|Overall Study|Withdrew Consent|1|||
23191886|NCT01522651|64442457|FG001|Overall Study|Withdrew Consent|1|||
23359111|NCT01877668|65059979|FG003|Overall Study|Insufficient clinical response|2|||
23475899|NCT00946153|65485581|FG000|Phase 2|Physician Decision|0|||
23475900|NCT00946153|65485582|FG001|Phase 2|Physician Decision|0|||
23359112|NCT01877668|65059980|FG004|Overall Study|Insufficient clinical response|0|||
23359113|NCT01877668|65059976|FG000|Overall Study|Lost to Follow-up|0|||
23359114|NCT01877668|65059977|FG001|Overall Study|Lost to Follow-up|2|||
23359115|NCT01877668|65059978|FG002|Overall Study|Lost to Follow-up|1|||
23359116|NCT01877668|65059979|FG003|Overall Study|Lost to Follow-up|0|||
23359117|NCT01877668|65059980|FG004|Overall Study|Lost to Follow-up|0|||
23359118|NCT01877668|65059976|FG000|Overall Study|Withdrawal by Subject|2|||
23359119|NCT01877668|65059977|FG001|Overall Study|Withdrawal by Subject|0|||
23359120|NCT01877668|65059978|FG002|Overall Study|Withdrawal by Subject|3|||
23359121|NCT01877668|65059979|FG003|Overall Study|Withdrawal by Subject|2|||
23359122|NCT01877668|65059980|FG004|Overall Study|Withdrawal by Subject|2|||
23475901|NCT00946153|65485583|FG002|Phase 2|Physician Decision|0|||
23475902|NCT00946153|65485584|FG003|Phase 2|Physician Decision|0|||
23475903|NCT00946153|65485585|FG004|Phase 2|Physician Decision|1|||
23475904|NCT00946153|65485581|FG000|Phase 2|14 days washout for recovery due to AE|0|||
23475905|NCT00946153|65485582|FG001|Phase 2|14 days washout for recovery due to AE|0|||
23475906|NCT00946153|65485583|FG002|Phase 2|14 days washout for recovery due to AE|0|||
23475907|NCT00946153|65485584|FG003|Phase 2|14 days washout for recovery due to AE|0|||
23475908|NCT00946153|65485585|FG004|Phase 2|14 days washout for recovery due to AE|4|||
23475909|NCT03060551|65485590|FG000|Overall Study|Withdrawal by Subject|1|||
23475910|NCT03060551|65485590|FG000|Overall Study|Adverse Event|1|||
23475911|NCT03113136|65485591|FG000|Overall Study|Lost to Follow-up|22|||
23475912|NCT03113136|65485592|FG001|Overall Study|Lost to Follow-up|47|||
23475913|NCT03113136|65485593|FG002|Overall Study|Lost to Follow-up|54|||
23475914|NCT03113136|65485591|FG000|Overall Study|Withdrawal by Subject|4|||
23475915|NCT03113136|65485592|FG001|Overall Study|Withdrawal by Subject|13|||
23475916|NCT03113136|65485593|FG002|Overall Study|Withdrawal by Subject|14|||
23475917|NCT03113136|65485591|FG000|Overall Study|Ineligible|0|||
23475918|NCT03113136|65485592|FG001|Overall Study|Ineligible|2|||
23475919|NCT03113136|65485593|FG002|Overall Study|Ineligible|1|||
23475920|NCT03113136|65485591|FG000|Overall Study|Study Team Decision|1|||
23475921|NCT03113136|65485592|FG001|Overall Study|Study Team Decision|4|||
23475922|NCT03113136|65485593|FG002|Overall Study|Study Team Decision|0|||
23475923|NCT03595228|65485594|FG000|Overall Study|Death|2|||
23475924|NCT03595228|65485594|FG000|Overall Study|Lack of Efficacy|13|||
23475925|NCT03595228|65485594|FG000|Overall Study|Withdrawal by Subject|3|||
23475926|NCT03595228|65485594|FG000|Overall Study|Withdrawal by Sponsor|1|||
23475927|NCT01155011|65485596|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
23475928|NCT01155011|65485597|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
23475929|NCT01155011|65485596|FG000|Baseline to 6 Months|investigator decision, moved|4|||
23475930|NCT01155011|65485597|FG001|Baseline to 6 Months|investigator decision, moved|5|||
23475931|NCT01155011|65485596|FG000|Baseline to 6 Months|Death|0|||
23475932|NCT01155011|65485597|FG001|Baseline to 6 Months|Death|1|||
23475933|NCT01155011|65485596|FG000|6 to 12 Months|Withdrawal by Subject|8|||
23475934|NCT01155011|65485597|FG001|6 to 12 Months|Withdrawal by Subject|5|||
23475935|NCT01155011|65485596|FG000|6 to 12 Months|Death|1|||
23475936|NCT01155011|65485597|FG001|6 to 12 Months|Death|5|||
23475937|NCT03179202|65485598|FG000|Overall Study|Screen Failure|67|||
23252857|NCT03182686|64667887|FG000|Overall Study|Lost to Follow-up|2|||
23359123|NCT01877668|65059976|FG000|Overall Study|Other|1|||
23475938|NCT03179202|65485598|FG000|Overall Study|Subject Lost to Follow Up|12|||
23475939|NCT03179202|65485598|FG000|Overall Study|Withdrawal by Subject|7|||
23475940|NCT03179202|65485598|FG000|Overall Study|Adverse Event|3|||
23475941|NCT03179202|65485598|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
23475942|NCT03179202|65485598|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
23475943|NCT02366091|65485601|FG000|Overall Study|Withdrawal by Subject|3|||
23475944|NCT02366091|65485602|FG001|Overall Study|Withdrawal by Subject|7|||
23475945|NCT02366091|65485603|FG002|Overall Study|Withdrawal by Subject|3|||
23475946|NCT02366091|65485604|FG003|Overall Study|Withdrawal by Subject|1|||
23475947|NCT01958489|65485605|FG000|Period 2|Adverse Event|0|||
23475948|NCT01958489|65485606|FG001|Period 2|Adverse Event|1|||
23475949|NCT01381562|65485607|FG000|Overall Study|Adverse Event|0|||
23475950|NCT01381562|65485608|FG001|Overall Study|Adverse Event|1|||
23475951|NCT01381562|65485609|FG002|Overall Study|Adverse Event|0|||
23475952|NCT01014910|65485610|FG000|Overall Study|Withdrawal by Subject|0|||
23252858|NCT03182686|64667888|FG001|Overall Study|Lost to Follow-up|0|||
23359124|NCT01877668|65059977|FG001|Overall Study|Other|1|||
23475953|NCT01014910|65485611|FG001|Overall Study|Withdrawal by Subject|2|||
23475954|NCT01250145|65485618|FG000|Overall Study|Adverse Event|2|||
23475955|NCT01250145|65485619|FG001|Overall Study|Adverse Event|1|||
23475956|NCT01250145|65485618|FG000|Overall Study|Withdrawal by Subject|0|||
23475957|NCT01250145|65485619|FG001|Overall Study|Withdrawal by Subject|4|||
23475958|NCT02051933|65485620|FG000|Overall Study|Physician Decision|0|||
23475959|NCT02051933|65485621|FG001|Overall Study|Physician Decision|1|||
23475960|NCT01252667|65485622|FG000|Overall Study|Transplant aborted post-conditioning|0|||
23475961|NCT01252667|65485623|FG001|Overall Study|Transplant aborted post-conditioning|0|||
23475962|NCT01252667|65485624|FG002|Overall Study|Transplant aborted post-conditioning|0|||
23475963|NCT01252667|65485625|FG003|Overall Study|Transplant aborted post-conditioning|0|||
23475964|NCT01252667|65485626|FG004|Overall Study|Transplant aborted post-conditioning|0|||
23475965|NCT01252667|65485627|FG005|Overall Study|Transplant aborted post-conditioning|1|||
23475966|NCT02874144|65485629|FG000|Overall Study|Lost to Follow-up|3|||
23475967|NCT02874144|65485630|FG001|Overall Study|Lost to Follow-up|5|||
23475968|NCT02365233|65485635|FG000|Overall Study|IRB withheld the data|1|||
23252859|NCT03182686|64667887|FG000|Overall Study|Adverse Event|2|||
23252860|NCT03182686|64667888|FG001|Overall Study|Adverse Event|0|||
23252861|NCT03182686|64667887|FG000|Overall Study|Withdrawal by Subject|3|||
23252862|NCT03182686|64667888|FG001|Overall Study|Withdrawal by Subject|0|||
23252863|NCT04330482|64667891|FG000|Overall Study|Lost to Follow-up|2|||
23252864|NCT04330482|64667892|FG001|Overall Study|Lost to Follow-up|1|||
23252865|NCT04330482|64667891|FG000|Overall Study|Withdrawal by Subject|0|||
23252866|NCT04330482|64667892|FG001|Overall Study|Withdrawal by Subject|3|||
23252867|NCT02556632|64667893|FG000|Overall Study|Lost to Follow-up|1|||
23252868|NCT02556632|64667894|FG001|Overall Study|Lost to Follow-up|0|||
23252869|NCT02556632|64667895|FG002|Overall Study|Lost to Follow-up|0|||
23252870|NCT02556632|64667893|FG000|Overall Study|Disliked Intervention|1|||
23252871|NCT02556632|64667894|FG001|Overall Study|Disliked Intervention|1|||
23252872|NCT02556632|64667895|FG002|Overall Study|Disliked Intervention|1|||
23252873|NCT02556632|64667893|FG000|Overall Study|No Reason|1|||
23252874|NCT02556632|64667894|FG001|Overall Study|No Reason|0|||
23359125|NCT01877668|65059978|FG002|Overall Study|Other|1|||
23359126|NCT01877668|65059979|FG003|Overall Study|Other|1|||
23359127|NCT01877668|65059980|FG004|Overall Study|Other|3|||
23359128|NCT01877668|65059976|FG000|Overall Study|Protocol Violation|1|||
23359129|NCT01877668|65059977|FG001|Overall Study|Protocol Violation|1|||
23359130|NCT01877668|65059978|FG002|Overall Study|Protocol Violation|0|||
23359131|NCT01877668|65059979|FG003|Overall Study|Protocol Violation|0|||
23359132|NCT01877668|65059980|FG004|Overall Study|Protocol Violation|3|||
23359133|NCT01877668|65059976|FG000|Overall Study|Adverse event related to study drug|2|||
23359134|NCT01877668|65059977|FG001|Overall Study|Adverse event related to study drug|2|||
23359135|NCT01877668|65059978|FG002|Overall Study|Adverse event related to study drug|2|||
23359136|NCT01877668|65059979|FG003|Overall Study|Adverse event related to study drug|2|||
23359137|NCT01877668|65059980|FG004|Overall Study|Adverse event related to study drug|1|||
23359138|NCT01877668|65059976|FG000|Overall Study|Adverse event unrelated to study drug|4|||
23359139|NCT01877668|65059977|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23359140|NCT01877668|65059978|FG002|Overall Study|Adverse event unrelated to study drug|2|||
23359141|NCT01877668|65059979|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23359142|NCT01877668|65059980|FG004|Overall Study|Adverse event unrelated to study drug|1|||
23359143|NCT00003483|65059981|FG000|Overall Study|Not evaluable|1|||
23359144|NCT01763827|65059982|FG000|Overall Study|Withdrawal by Subject|1|||
23359145|NCT01763827|65059983|FG001|Overall Study|Withdrawal by Subject|0|||
23359146|NCT01763827|65059984|FG002|Overall Study|Withdrawal by Subject|0|||
23359147|NCT01763827|65059985|FG003|Overall Study|Withdrawal by Subject|0|||
23359148|NCT01763827|65059986|FG004|Overall Study|Withdrawal by Subject|2|||
23359149|NCT01763827|65059987|FG005|Overall Study|Withdrawal by Subject|0|||
23359150|NCT01763827|65059982|FG000|Overall Study|Decision by sponsor|2|||
23359151|NCT01763827|65059983|FG001|Overall Study|Decision by sponsor|0|||
23359152|NCT01763827|65059984|FG002|Overall Study|Decision by sponsor|3|||
23359153|NCT01763827|65059985|FG003|Overall Study|Decision by sponsor|0|||
23359154|NCT01763827|65059986|FG004|Overall Study|Decision by sponsor|2|||
23359155|NCT01763827|65059987|FG005|Overall Study|Decision by sponsor|1|||
23359156|NCT01763827|65059982|FG000|Overall Study|Lost to Follow-up|0|||
23359157|NCT01763827|65059983|FG001|Overall Study|Lost to Follow-up|1|||
23359158|NCT01763827|65059984|FG002|Overall Study|Lost to Follow-up|1|||
23359159|NCT01763827|65059985|FG003|Overall Study|Lost to Follow-up|1|||
23359160|NCT01763827|65059986|FG004|Overall Study|Lost to Follow-up|2|||
23475969|NCT02365233|65485636|FG001|Overall Study|IRB withheld the data|2|||
23475970|NCT02365233|65485637|FG002|Overall Study|IRB withheld the data|2|||
23475971|NCT02437110|65485638|FG000|Screening|Lost to Follow-up|3|||
23191887|NCT01522651|64442458|FG002|Overall Study|Withdrew Consent|0|||
23191888|NCT01522651|64442459|FG003|Overall Study|Withdrew Consent|1|||
23359161|NCT01763827|65059987|FG005|Overall Study|Lost to Follow-up|1|||
23359162|NCT02815267|65059988|FG000|Double-Blind Phase|Adverse Event|0|||
23359163|NCT02815267|65059989|FG001|Double-Blind Phase|Adverse Event|3|||
23475972|NCT02437110|65485638|FG000|Screening|Physician Decision|1|||
23359164|NCT02815267|65059988|FG000|Double-Blind Phase|Lost to Follow-up|17|||
23359165|NCT02815267|65059989|FG001|Double-Blind Phase|Lost to Follow-up|9|||
23359166|NCT02815267|65059988|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
23252875|NCT02556632|64667895|FG002|Overall Study|No Reason|1|||
23252876|NCT02556632|64667893|FG000|Overall Study|Personal Issues|0|||
23252877|NCT02556632|64667894|FG001|Overall Study|Personal Issues|1|||
23252878|NCT02556632|64667895|FG002|Overall Study|Personal Issues|1|||
23252879|NCT02556632|64667893|FG000|Overall Study|Changed Mind|0|||
23252880|NCT02556632|64667894|FG001|Overall Study|Changed Mind|1|||
23252881|NCT02556632|64667895|FG002|Overall Study|Changed Mind|0|||
23252882|NCT02556632|64667893|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
23252883|NCT02556632|64667894|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
23252884|NCT02556632|64667895|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
23252885|NCT02556632|64667893|FG000|Overall Study|Unrelated Adverse Event|1|||
23252886|NCT02556632|64667894|FG001|Overall Study|Unrelated Adverse Event|0|||
23252887|NCT02556632|64667895|FG002|Overall Study|Unrelated Adverse Event|3|||
23252888|NCT02556632|64667893|FG000|Overall Study|Related Adverse Event|0|||
23252889|NCT02556632|64667894|FG001|Overall Study|Related Adverse Event|1|||
23252890|NCT02556632|64667895|FG002|Overall Study|Related Adverse Event|0|||
23252891|NCT02556632|64667893|FG000|Overall Study|Possibly Related Adverse Event|0|||
23252892|NCT02556632|64667894|FG001|Overall Study|Possibly Related Adverse Event|0|||
23252893|NCT02556632|64667895|FG002|Overall Study|Possibly Related Adverse Event|1|||
23252894|NCT02556632|64667893|FG000|Overall Study|Did Not Start RT|0|||
23252895|NCT02556632|64667894|FG001|Overall Study|Did Not Start RT|1|||
23252896|NCT02556632|64667895|FG002|Overall Study|Did Not Start RT|0|||
23252897|NCT02556632|64667893|FG000|Overall Study|Ineligible|0|||
23252898|NCT02556632|64667894|FG001|Overall Study|Ineligible|1|||
23252899|NCT02556632|64667895|FG002|Overall Study|Ineligible|0|||
23252900|NCT02556632|64667893|FG000|Overall Study|Disliked Study Procedures|0|||
23252901|NCT02556632|64667894|FG001|Overall Study|Disliked Study Procedures|0|||
23252902|NCT02556632|64667895|FG002|Overall Study|Disliked Study Procedures|1|||
23252903|NCT02556632|64667893|FG000|Overall Study|Treatment or Change Delay|0|||
23252904|NCT02556632|64667894|FG001|Overall Study|Treatment or Change Delay|0|||
23252905|NCT02556632|64667895|FG002|Overall Study|Treatment or Change Delay|1|||
23252906|NCT02164539|64667898|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
23252907|NCT02164539|64667899|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
23252908|NCT02164539|64667900|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
23252909|NCT02164539|64667901|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
23252910|NCT02164539|64667902|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
23252911|NCT02164539|64667903|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
23252912|NCT02164539|64667904|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
23252913|NCT02164539|64667898|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
23252914|NCT02164539|64667899|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
23252915|NCT02164539|64667900|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
23252916|NCT02164539|64667901|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
23252917|NCT02164539|64667902|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
23252918|NCT02164539|64667903|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
23252919|NCT02164539|64667904|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
23252920|NCT02164539|64667898|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
23252921|NCT02164539|64667899|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
23252922|NCT02164539|64667900|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
23252923|NCT02164539|64667901|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
23252924|NCT02164539|64667902|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
23252925|NCT02164539|64667903|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
23252926|NCT02164539|64667904|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
23252927|NCT02164539|64667898|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
23252928|NCT02164539|64667899|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23252929|NCT02164539|64667900|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23252930|NCT02164539|64667901|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23252931|NCT02164539|64667902|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23252932|NCT02164539|64667903|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23252933|NCT02164539|64667904|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
23252934|NCT02164539|64667898|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
23252935|NCT02164539|64667899|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
23252936|NCT02164539|64667900|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
23252937|NCT02164539|64667901|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
23252938|NCT02164539|64667902|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
23252939|NCT02164539|64667903|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
23252940|NCT02164539|64667904|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
23252941|NCT02164539|64667898|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
23252942|NCT02164539|64667899|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
23252943|NCT02164539|64667900|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
23252944|NCT02164539|64667901|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
23252945|NCT02164539|64667902|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
23252946|NCT02164539|64667903|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
23252947|NCT02164539|64667904|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
23252948|NCT01430104|64667909|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
23252949|NCT00766506|64667911|FG000|Overall Study|Use rescue medication after 3 hours|3|||
23252950|NCT00766506|64667912|FG001|Overall Study|Use rescue medication after 3 hours|0|||
23191889|NCT01522651|64442460|FG004|Overall Study|Withdrew Consent|1|||
23475973|NCT02437110|65485638|FG000|ART|Adverse Event|3|||
23475974|NCT02437110|65485638|FG000|ART|Protocol Violation|3|||
23475975|NCT02437110|65485638|FG000|ART|Withdrawal by Subject|4|||
23475976|NCT02437110|65485638|FG000|ART|Lost to follow-up prior to start of intervention|1|||
23475977|NCT02437110|65485638|FG000|ART|Physician decision prior to start of intervention|2|||
23475978|NCT02437110|65485638|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
23475979|NCT02437110|65485638|FG000|Post-ART|Lost to Follow-up|3|||
23475980|NCT02437110|65485638|FG000|Post-ART|Protocol Violation|4|||
23475981|NCT02437110|65485638|FG000|Post-ART|Withdrawal by Subject|3|||
23475982|NCT03890666|65485639|FG000|Overall Study|Withdrawal by Subject|0|||
23475983|NCT03890666|65485640|FG001|Overall Study|Withdrawal by Subject|1|||
23475984|NCT03890666|65485639|FG000|Overall Study|Protocol deviation|1|||
23475985|NCT03890666|65485640|FG001|Overall Study|Protocol deviation|4|||
23475986|NCT03890666|65485639|FG000|Overall Study|Lost to Follow-up|2|||
23475987|NCT03890666|65485640|FG001|Overall Study|Lost to Follow-up|5|||
23475988|NCT03890666|65485639|FG000|Overall Study|Other than specified|1|||
23475989|NCT03890666|65485640|FG001|Overall Study|Other than specified|8|||
23475990|NCT03353740|65485641|FG000|Overall Study|Images for these participants not viable|52|||
23475991|NCT03560518|65485642|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
23475992|NCT03560518|65485643|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
23475993|NCT03560518|65485644|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
23475994|NCT03560518|65485642|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
23475995|NCT03560518|65485643|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
23475996|NCT03560518|65485644|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
23475997|NCT03560518|65485642|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23475998|NCT03560518|65485643|FG001|Double Blind Treatment Period|Protocol Violation|2|||
23475999|NCT03560518|65485644|FG002|Double Blind Treatment Period|Protocol Violation|0|||
23476000|NCT03560518|65485642|FG000|Double Blind Treatment Period|Pregnancy|0|||
23476001|NCT03560518|65485643|FG001|Double Blind Treatment Period|Pregnancy|2|||
23476002|NCT03560518|65485644|FG002|Double Blind Treatment Period|Pregnancy|0|||
23476003|NCT03560518|65485642|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
23476004|NCT03560518|65485643|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
23590030|NCT00880048|65889552|FG000|Overall Study|Withdrawal by Subject|5|||
23590031|NCT00880048|65889553|FG001|Overall Study|Withdrawal by Subject|8|||
23590032|NCT00880048|65889554|FG002|Overall Study|Withdrawal by Subject|5|||
23590033|NCT00880048|65889552|FG000|Overall Study|Study closed/terminated|9|||
23590034|NCT00880048|65889553|FG001|Overall Study|Study closed/terminated|7|||
23590035|NCT00880048|65889554|FG002|Overall Study|Study closed/terminated|6|||
23590036|NCT02955069|65889557|FG000|Overall Study|Adverse Event|7|||
23590037|NCT02955069|65889558|FG001|Overall Study|Adverse Event|2|||
23590038|NCT02955069|65889557|FG000|Overall Study|Death|7|||
23590039|NCT02955069|65889558|FG001|Overall Study|Death|3|||
23590040|NCT02955069|65889557|FG000|Overall Study|Physician Decision|10|||
23590041|NCT02955069|65889558|FG001|Overall Study|Physician Decision|2|||
23590042|NCT02955069|65889557|FG000|Overall Study|Progressive disease|64|||
23590043|NCT02955069|65889558|FG001|Overall Study|Progressive disease|13|||
23590044|NCT02955069|65889557|FG000|Overall Study|Study terminated by sponsor|4|||
23590045|NCT02955069|65889558|FG001|Overall Study|Study terminated by sponsor|0|||
23590046|NCT02955069|65889557|FG000|Overall Study|Subject/Guardian decision|3|||
23590047|NCT02955069|65889558|FG001|Overall Study|Subject/Guardian decision|1|||
23476005|NCT03560518|65485644|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
23476006|NCT03560518|65485642|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
23590048|NCT03070483|65889559|FG000|Overall Study|Lost to Follow-up|2|||
23590049|NCT03895034|65889560|FG000|Overall Study|Lost to Follow-up|2|||
23590050|NCT00828672|65889561|FG000|Study Treatment|Lost to Follow-up|1|||
23476007|NCT03560518|65485643|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
23590051|NCT00828672|65889562|FG001|Study Treatment|Lost to Follow-up|0|||
23590052|NCT00828672|65889561|FG000|Study Treatment|Adverse Event|0|||
23590053|NCT00828672|65889562|FG001|Study Treatment|Adverse Event|1|||
23476008|NCT03560518|65485644|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
23476009|NCT03560518|65485642|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
23476010|NCT03560518|65485643|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
23191890|NCT01522651|64442456|FG000|Overall Study|Randomized but Never Treated|0|||
23191891|NCT01522651|64442457|FG001|Overall Study|Randomized but Never Treated|1|||
23191892|NCT01522651|64442458|FG002|Overall Study|Randomized but Never Treated|0|||
23191893|NCT01522651|64442459|FG003|Overall Study|Randomized but Never Treated|1|||
23252951|NCT00766506|64667911|FG000|Overall Study|Other|2|||
23476011|NCT03560518|65485644|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
23476012|NCT03560518|65485642|FG000|Double Blind Treatment Period|Adverse Event|0|||
23476013|NCT03560518|65485643|FG001|Double Blind Treatment Period|Adverse Event|3|||
23476014|NCT03560518|65485644|FG002|Double Blind Treatment Period|Adverse Event|1|||
23476015|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
23476016|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
23476017|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
23476018|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
23476019|NCT00490529|65485645|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
23476020|NCT00490529|65485645|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
23590054|NCT00828672|65889561|FG000|Study Treatment|Complete response, no surgery|1|||
23590055|NCT00828672|65889562|FG001|Study Treatment|Complete response, no surgery|1|||
23191894|NCT01522651|64442460|FG004|Overall Study|Randomized but Never Treated|1|||
23590056|NCT00828672|65889561|FG000|Post-surgery (<30 Days)|No central review materials|0|||
23590057|NCT00828672|65889562|FG001|Post-surgery (<30 Days)|No central review materials|1|||
23590058|NCT01930045|65889563|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590059|NCT01930045|65889564|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590060|NCT01930045|65889565|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590061|NCT01930045|65889566|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590062|NCT01930045|65889567|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
23590063|NCT01930045|65889568|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
23590064|NCT01930045|65889563|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
23590065|NCT01930045|65889564|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
23252952|NCT00766506|64667912|FG001|Overall Study|Other|2|||
23252953|NCT00370396|64667917|FG000|Overall Study|Withdrawal by Subject|0|||
23252954|NCT00370396|64667918|FG001|Overall Study|Withdrawal by Subject|0|||
23252955|NCT00370396|64667919|FG002|Overall Study|Withdrawal by Subject|1|||
23252956|NCT00370396|64667917|FG000|Overall Study|Lost to Follow-up|11|||
23252957|NCT00370396|64667918|FG001|Overall Study|Lost to Follow-up|1|||
23252958|NCT00370396|64667919|FG002|Overall Study|Lost to Follow-up|0|||
23252959|NCT00096200|64667920|FG000|Overall Study|Adverse Event|0|||
23252960|NCT00096200|64667921|FG001|Overall Study|Adverse Event|4|||
23252961|NCT00096200|64667922|FG002|Overall Study|Adverse Event|0|||
23252962|NCT00096200|64667920|FG000|Overall Study|Withdrawal by Subject|1|||
23252963|NCT00096200|64667921|FG001|Overall Study|Withdrawal by Subject|2|||
23252964|NCT00096200|64667922|FG002|Overall Study|Withdrawal by Subject|0|||
23252965|NCT00096200|64667920|FG000|Overall Study|Ineligible pathology|0|||
23252966|NCT00096200|64667921|FG001|Overall Study|Ineligible pathology|1|||
23252967|NCT00096200|64667922|FG002|Overall Study|Ineligible pathology|0|||
23252968|NCT00078312|64667923|FG000|Overall Study|Adverse Event|43|||
23252969|NCT00078312|64667923|FG000|Overall Study|Lack of Efficacy|15|||
23252970|NCT00078312|64667923|FG000|Overall Study|Lost to Follow-up|41|||
23252971|NCT00078312|64667923|FG000|Overall Study|Physician Decision|9|||
23252972|NCT00078312|64667923|FG000|Overall Study|Protocol Violation|3|||
23252973|NCT00078312|64667923|FG000|Overall Study|Withdrawal by Subject|33|||
23252974|NCT00078312|64667923|FG000|Overall Study|Miscellaneous|33|||
23252975|NCT00802529|64667924|FG000|Overall Study|Lost to Follow-up|0|||
23252976|NCT00802529|64667925|FG001|Overall Study|Lost to Follow-up|1|||
23252977|NCT02261974|64667927|FG000|Overall Study|Withdrawal by Subject|3|||
23252978|NCT02261974|64667928|FG001|Overall Study|Withdrawal by Subject|2|||
23252979|NCT02261974|64667927|FG000|Overall Study|Pregnancy|0|||
23252980|NCT02261974|64667928|FG001|Overall Study|Pregnancy|1|||
23252981|NCT02261974|64667927|FG000|Overall Study|Missed treatment cut-off date|6|||
23252982|NCT02261974|64667928|FG001|Overall Study|Missed treatment cut-off date|3|||
23252983|NCT02261974|64667927|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
23252984|NCT02261974|64667928|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
23252985|NCT02261974|64667927|FG000|Overall Study|Lost to Follow-up|2|||
23252986|NCT02261974|64667928|FG001|Overall Study|Lost to Follow-up|0|||
23252987|NCT02261974|64667927|FG000|Overall Study|Adverse Event|1|||
23252988|NCT02261974|64667928|FG001|Overall Study|Adverse Event|0|||
23252989|NCT00869089|64667929|FG000|Overall Study|Lost to Follow-up|1|||
23252990|NCT00869089|64667929|FG000|Overall Study|Withdrawal by Subject|1|||
23252991|NCT00869089|64667929|FG000|Overall Study|Screen Fail|1|||
23252992|NCT02059187|64667930|FG000|Overall Study|Adverse Event|0|||
23252993|NCT02059187|64667931|FG001|Overall Study|Adverse Event|3|||
23252994|NCT02059187|64667930|FG000|Overall Study|Death|1|||
23252995|NCT02059187|64667931|FG001|Overall Study|Death|1|||
23252996|NCT02059187|64667930|FG000|Overall Study|Lost to Follow-up|9|||
23252997|NCT02059187|64667931|FG001|Overall Study|Lost to Follow-up|8|||
23252998|NCT02059187|64667930|FG000|Overall Study|Non-compliance with study drug|1|||
23252999|NCT02059187|64667931|FG001|Overall Study|Non-compliance with study drug|0|||
23253000|NCT02059187|64667930|FG000|Overall Study|Physician Decision|1|||
23253001|NCT02059187|64667931|FG001|Overall Study|Physician Decision|2|||
23253002|NCT02059187|64667930|FG000|Overall Study|Protocol Violation|1|||
23253003|NCT02059187|64667931|FG001|Overall Study|Protocol Violation|0|||
23253004|NCT02059187|64667930|FG000|Overall Study|Withdrawal by Subject|12|||
23253005|NCT02059187|64667931|FG001|Overall Study|Withdrawal by Subject|8|||
23253006|NCT01336608|64667932|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
23253007|NCT01336608|64667933|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23253008|NCT01336608|64667934|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23359167|NCT02815267|65059989|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
23359168|NCT02815267|65059988|FG000|Double-Blind Phase|Protocol Violation|3|||
23359169|NCT02815267|65059989|FG001|Double-Blind Phase|Protocol Violation|2|||
23476021|NCT01499368|65487976|FG000|Overall Study|Did not meet I/E criteria|8|||
23253009|NCT01336608|64667935|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
23253010|NCT01336608|64667932|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
23253011|NCT01336608|64667933|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23253012|NCT01336608|64667934|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23253013|NCT01336608|64667935|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
23253014|NCT01336608|64667932|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
23253015|NCT01336608|64667933|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
23253016|NCT01336608|64667934|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
23253017|NCT01336608|64667935|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
23253018|NCT01336608|64667932|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
23253019|NCT01336608|64667933|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
23253020|NCT01336608|64667934|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
23253021|NCT01336608|64667935|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
23359170|NCT02815267|65059988|FG000|Double-Blind Phase|Site withdrawal|1|||
23253022|NCT01336608|64667932|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
23253023|NCT01336608|64667933|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23253024|NCT01336608|64667934|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23253025|NCT01336608|64667935|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
23253026|NCT01336608|64667932|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
23253027|NCT01336608|64667933|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
23253028|NCT01336608|64667934|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
23253029|NCT01336608|64667935|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
23253030|NCT01336608|64667932|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23253031|NCT01336608|64667933|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
23253032|NCT01336608|64667934|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23253033|NCT01336608|64667935|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
23253034|NCT01336608|64667932|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
23253035|NCT01336608|64667933|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
23253036|NCT01336608|64667934|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
23253037|NCT01336608|64667935|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
23253038|NCT01336608|64667932|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
23253039|NCT01336608|64667933|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
23253040|NCT01336608|64667934|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
23253041|NCT01336608|64667935|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
23359171|NCT02815267|65059989|FG001|Double-Blind Phase|Site withdrawal|6|||
23359172|NCT02815267|65059988|FG000|Double-Blind Phase|Received a disallowed medication|1|||
23359173|NCT02815267|65059989|FG001|Double-Blind Phase|Received a disallowed medication|1|||
23359174|NCT02815267|65059988|FG000|Open-Label Phase|Adverse Event|1|||
23359175|NCT02815267|65059989|FG001|Open-Label Phase|Adverse Event|1|||
23359176|NCT02815267|65059988|FG000|Open-Label Phase|Lost to Follow-up|23|||
23359177|NCT02815267|65059989|FG001|Open-Label Phase|Lost to Follow-up|9|||
23359178|NCT02815267|65059988|FG000|Open-Label Phase|Withdrawal by Subject|24|||
23359179|NCT02815267|65059989|FG001|Open-Label Phase|Withdrawal by Subject|13|||
23359180|NCT02815267|65059988|FG000|Open-Label Phase|Protocol Violation|0|||
23359181|NCT02815267|65059989|FG001|Open-Label Phase|Protocol Violation|1|||
23359182|NCT02815267|65059988|FG000|Open-Label Phase|Administrative|21|||
23359183|NCT02815267|65059989|FG001|Open-Label Phase|Administrative|12|||
23359184|NCT02815267|65059988|FG000|Open-Label Phase|Other|2|||
23359185|NCT02815267|65059989|FG001|Open-Label Phase|Other|5|||
23359186|NCT02029274|65059990|FG000|Overall Study|Adverse Event|1|||
23359187|NCT02029274|65059991|FG001|Overall Study|Adverse Event|0|||
23359188|NCT02029274|65059992|FG002|Overall Study|Adverse Event|2|||
23359189|NCT02029274|65059993|FG003|Overall Study|Adverse Event|2|||
23359190|NCT04676152|65059994|FG000|Overall Study|screen fail|9|||
23359191|NCT00565604|65059995|FG000|Overall Study|Failure to treat|2|||
23359192|NCT00565604|65059995|FG000|Overall Study|Lost to Follow-up|2|||
23359193|NCT02080364|65059996|FG000|Baseline Period|Protocol Violation|2|||
23359194|NCT02080364|65059997|FG001|Baseline Period|Protocol Violation|1|||
23359195|NCT02080364|65059998|FG002|Baseline Period|Protocol Violation|0|||
23359196|NCT02080364|65059999|FG003|Baseline Period|Protocol Violation|0|||
23359197|NCT02080364|65059996|FG000|Baseline Period|Other|0|||
23359198|NCT02080364|65059997|FG001|Baseline Period|Other|1|||
23359199|NCT02080364|65059998|FG002|Baseline Period|Other|1|||
23359200|NCT02080364|65059999|FG003|Baseline Period|Other|0|||
23359201|NCT02080364|65059996|FG000|Treatment Period|Adverse Event|10|||
23359202|NCT02080364|65059997|FG001|Treatment Period|Adverse Event|15|||
23359203|NCT02080364|65059998|FG002|Treatment Period|Adverse Event|11|||
23359204|NCT02080364|65059999|FG003|Treatment Period|Adverse Event|14|||
23359205|NCT02080364|65059996|FG000|Treatment Period|Lost to Follow-up|2|||
23359206|NCT02080364|65059997|FG001|Treatment Period|Lost to Follow-up|3|||
23359207|NCT02080364|65059998|FG002|Treatment Period|Lost to Follow-up|5|||
23359208|NCT02080364|65059999|FG003|Treatment Period|Lost to Follow-up|0|||
23359209|NCT02080364|65059996|FG000|Treatment Period|Protocol Violation|5|||
23359210|NCT02080364|65059997|FG001|Treatment Period|Protocol Violation|3|||
23359211|NCT02080364|65059998|FG002|Treatment Period|Protocol Violation|5|||
23359212|NCT02080364|65059999|FG003|Treatment Period|Protocol Violation|1|||
23359213|NCT02080364|65059996|FG000|Treatment Period|Withdrawal by Subject|16|||
23359214|NCT02080364|65059997|FG001|Treatment Period|Withdrawal by Subject|16|||
23359215|NCT02080364|65059998|FG002|Treatment Period|Withdrawal by Subject|15|||
23359216|NCT02080364|65059999|FG003|Treatment Period|Withdrawal by Subject|10|||
23359217|NCT02080364|65059996|FG000|Treatment Period|Study Terminated by Sponsor|0|||
23359218|NCT02080364|65059997|FG001|Treatment Period|Study Terminated by Sponsor|0|||
23359219|NCT02080364|65059998|FG002|Treatment Period|Study Terminated by Sponsor|180|||
23359220|NCT02080364|65059999|FG003|Treatment Period|Study Terminated by Sponsor|183|||
23359221|NCT02080364|65059996|FG000|Treatment Period|Other|14|||
23590066|NCT01930045|65889565|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
23253042|NCT01336608|64667932|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
23253043|NCT01336608|64667933|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
23253044|NCT01336608|64667934|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
23253045|NCT01336608|64667935|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
23253046|NCT01336608|64667932|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23253047|NCT01336608|64667933|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
23253048|NCT01336608|64667934|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23253049|NCT01336608|64667935|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23253050|NCT01336608|64667932|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
23253051|NCT01336608|64667933|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
23253052|NCT01336608|64667934|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
23253053|NCT01336608|64667935|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
23253054|NCT01336608|64667932|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23253055|NCT01336608|64667933|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
23253056|NCT01336608|64667934|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
23253057|NCT01336608|64667935|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
23253058|NCT01360632|64667936|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
23253059|NCT01360632|64667937|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
23253060|NCT01360632|64667938|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
23253061|NCT01360632|64667939|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
23253062|NCT01360632|64667940|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
23253063|NCT01360632|64667936|FG000|Phase A (8 Weeks)|Adverse Event|60|||
23253064|NCT01360632|64667937|FG001|Phase A (8 Weeks)|Adverse Event|0|||
23253065|NCT01360632|64667938|FG002|Phase A (8 Weeks)|Adverse Event|0|||
23253066|NCT01360632|64667939|FG003|Phase A (8 Weeks)|Adverse Event|0|||
23253067|NCT01360632|64667940|FG004|Phase A (8 Weeks)|Adverse Event|0|||
23253068|NCT01360632|64667936|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
23253069|NCT01360632|64667937|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
23253070|NCT01360632|64667938|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
23253071|NCT01360632|64667939|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
23253072|NCT01360632|64667940|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
23253073|NCT01360632|64667936|FG000|Phase A (8 Weeks)|Physician Decision|10|||
23253074|NCT01360632|64667937|FG001|Phase A (8 Weeks)|Physician Decision|0|||
23253075|NCT01360632|64667938|FG002|Phase A (8 Weeks)|Physician Decision|0|||
23253076|NCT01360632|64667939|FG003|Phase A (8 Weeks)|Physician Decision|0|||
23253077|NCT01360632|64667940|FG004|Phase A (8 Weeks)|Physician Decision|0|||
23253078|NCT01360632|64667936|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
23253079|NCT01360632|64667937|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
23253080|NCT01360632|64667938|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
23253081|NCT01360632|64667939|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
23253082|NCT01360632|64667940|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
23253083|NCT01360632|64667936|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
23253084|NCT01360632|64667937|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
23253085|NCT01360632|64667938|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
23253086|NCT01360632|64667939|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
23253087|NCT01360632|64667940|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
23253088|NCT01360632|64667936|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
23253089|NCT01360632|64667937|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
23253090|NCT01360632|64667938|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
23253091|NCT01360632|64667939|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
23253092|NCT01360632|64667940|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
23253093|NCT01360632|64667936|FG000|Phase B (6 Weeks)|Adverse Event|0|||
23253094|NCT01360632|64667937|FG001|Phase B (6 Weeks)|Adverse Event|3|||
23253095|NCT01360632|64667938|FG002|Phase B (6 Weeks)|Adverse Event|9|||
23253096|NCT01360632|64667939|FG003|Phase B (6 Weeks)|Adverse Event|3|||
23253097|NCT01360632|64667940|FG004|Phase B (6 Weeks)|Adverse Event|0|||
23253098|NCT01360632|64667936|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23253099|NCT01360632|64667937|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23253100|NCT01360632|64667938|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
23253101|NCT01360632|64667939|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
23253102|NCT01360632|64667940|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
23253103|NCT01360632|64667936|FG000|Phase B (6 Weeks)|Physician Decision|0|||
23253104|NCT01360632|64667937|FG001|Phase B (6 Weeks)|Physician Decision|0|||
23253105|NCT01360632|64667938|FG002|Phase B (6 Weeks)|Physician Decision|0|||
23253106|NCT01360632|64667939|FG003|Phase B (6 Weeks)|Physician Decision|1|||
23253107|NCT01360632|64667940|FG004|Phase B (6 Weeks)|Physician Decision|0|||
23253108|NCT01360632|64667936|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
23253109|NCT01360632|64667937|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
23253110|NCT01360632|64667938|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
23253111|NCT01360632|64667939|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
23253112|NCT01360632|64667940|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
23253113|NCT01360632|64667936|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
23253114|NCT01360632|64667937|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
23253115|NCT01360632|64667938|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
23191895|NCT00510692|64442463|FG000|Overall Study|Adverse Event|1|||
23191896|NCT00510692|64442464|FG001|Overall Study|Adverse Event|3|||
23191897|NCT00510692|64442463|FG000|Overall Study|Withdrawal by Subject|1|||
23191898|NCT00510692|64442464|FG001|Overall Study|Withdrawal by Subject|0|||
23191899|NCT00744055|64442467|FG000|Overall Study|Withdrawal by Subject|6|||
23191900|NCT00744055|64442468|FG001|Overall Study|Withdrawal by Subject|9|||
23191901|NCT00744055|64442467|FG000|Overall Study|Lack of Efficacy|0|||
23253116|NCT01360632|64667939|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
23253117|NCT01360632|64667940|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
23253118|NCT01360632|64667936|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
23253119|NCT01360632|64667937|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
23253120|NCT01360632|64667938|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
23253121|NCT01360632|64667939|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
23253122|NCT01360632|64667940|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
23253123|NCT01360632|64667936|FG000|Phase A+|Lost to Follow-up|0|||
23253124|NCT01360632|64667937|FG001|Phase A+|Lost to Follow-up|0|||
23253125|NCT01360632|64667938|FG002|Phase A+|Lost to Follow-up|0|||
23590067|NCT01930045|65889566|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
23590068|NCT01930045|65889567|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
23590069|NCT01930045|65889568|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
23590070|NCT02020616|65889570|FG000|Overall Study|Adverse Event|0|||
23590071|NCT02020616|65889571|FG001|Overall Study|Adverse Event|0|||
23590072|NCT02020616|65889572|FG002|Overall Study|Adverse Event|0|||
23590073|NCT02020616|65889573|FG003|Overall Study|Adverse Event|0|||
23590074|NCT02020616|65889574|FG004|Overall Study|Adverse Event|0|||
23590075|NCT02020616|65889575|FG005|Overall Study|Adverse Event|1|||
23590076|NCT02020616|65889576|FG006|Overall Study|Adverse Event|1|||
23590077|NCT02020616|65889570|FG000|Overall Study|Physician Decision|0|||
23590078|NCT02020616|65889571|FG001|Overall Study|Physician Decision|0|||
23590079|NCT02020616|65889572|FG002|Overall Study|Physician Decision|0|||
23590080|NCT02020616|65889573|FG003|Overall Study|Physician Decision|0|||
23590081|NCT02020616|65889574|FG004|Overall Study|Physician Decision|0|||
23590082|NCT02020616|65889575|FG005|Overall Study|Physician Decision|1|||
23590083|NCT02020616|65889576|FG006|Overall Study|Physician Decision|2|||
23590084|NCT02020616|65889570|FG000|Overall Study|Withdrawal by Subject|0|||
23590085|NCT02020616|65889571|FG001|Overall Study|Withdrawal by Subject|0|||
23590086|NCT02020616|65889572|FG002|Overall Study|Withdrawal by Subject|1|||
23590087|NCT02020616|65889573|FG003|Overall Study|Withdrawal by Subject|0|||
23590088|NCT02020616|65889574|FG004|Overall Study|Withdrawal by Subject|0|||
23590089|NCT02020616|65889575|FG005|Overall Study|Withdrawal by Subject|1|||
23590090|NCT02020616|65889576|FG006|Overall Study|Withdrawal by Subject|1|||
23590091|NCT02020616|65889570|FG000|Overall Study|Lost to Follow-up|0|||
23590092|NCT02020616|65889571|FG001|Overall Study|Lost to Follow-up|1|||
23590093|NCT02020616|65889572|FG002|Overall Study|Lost to Follow-up|0|||
23590094|NCT02020616|65889573|FG003|Overall Study|Lost to Follow-up|1|||
23590095|NCT02020616|65889574|FG004|Overall Study|Lost to Follow-up|1|||
23590096|NCT02020616|65889575|FG005|Overall Study|Lost to Follow-up|1|||
23590097|NCT02020616|65889576|FG006|Overall Study|Lost to Follow-up|0|||
23590098|NCT02020616|65889570|FG000|Overall Study|Early Termination Criteria Met|0|||
23191902|NCT00744055|64442468|FG001|Overall Study|Lack of Efficacy|1|||
23191903|NCT00744055|64442467|FG000|Overall Study|Physician Decision|0|||
23253126|NCT01360632|64667939|FG003|Phase A+|Lost to Follow-up|0|||
23253127|NCT01360632|64667940|FG004|Phase A+|Lost to Follow-up|2|||
23590099|NCT02020616|65889571|FG001|Overall Study|Early Termination Criteria Met|0|||
23590100|NCT02020616|65889572|FG002|Overall Study|Early Termination Criteria Met|1|||
23191904|NCT00744055|64442468|FG001|Overall Study|Physician Decision|2|||
23359222|NCT02080364|65059997|FG001|Treatment Period|Other|12|||
23359223|NCT02080364|65059998|FG002|Treatment Period|Other|21|||
23359224|NCT02080364|65059999|FG003|Treatment Period|Other|16|||
23359225|NCT02500719|65060000|FG000|Overall Study|Lost to Follow-up|2|||
23359226|NCT02500719|65060001|FG001|Overall Study|Lost to Follow-up|3|||
23359227|NCT02500719|65060000|FG000|Overall Study|Trauma history|1|||
23359228|NCT02500719|65060001|FG001|Overall Study|Trauma history|0|||
23359229|NCT02500719|65060000|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
23359230|NCT02500719|65060001|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
23359231|NCT02500719|65060000|FG000|Overall Study|Did not meet criteria for PTSD|0|||
23359232|NCT02500719|65060001|FG001|Overall Study|Did not meet criteria for PTSD|1|||
23359233|NCT02500719|65060000|FG000|Overall Study|Claustrophobia|0|||
23359234|NCT02500719|65060001|FG001|Overall Study|Claustrophobia|1|||
23359235|NCT02500719|65060000|FG000|Overall Study|History of head trauma|0|||
23359236|NCT02500719|65060001|FG001|Overall Study|History of head trauma|1|||
23359237|NCT00977613|65060002|FG000|Overall Study|Lost to Follow-up|16|||
23359238|NCT01153009|65060011|FG000|Overall Study|Adverse Event|4|||
23359239|NCT01153009|65060012|FG001|Overall Study|Adverse Event|14|||
23359240|NCT01153009|65060013|FG002|Overall Study|Adverse Event|14|||
23359241|NCT01153009|65060014|FG003|Overall Study|Adverse Event|10|||
23359242|NCT01153009|65060011|FG000|Overall Study|Lack of Efficacy|9|||
23359243|NCT01153009|65060012|FG001|Overall Study|Lack of Efficacy|0|||
23359244|NCT01153009|65060013|FG002|Overall Study|Lack of Efficacy|2|||
23359245|NCT01153009|65060014|FG003|Overall Study|Lack of Efficacy|1|||
23359246|NCT01153009|65060011|FG000|Overall Study|Noncompliance with Study Medication|1|||
23359247|NCT01153009|65060012|FG001|Overall Study|Noncompliance with Study Medication|3|||
23590101|NCT02020616|65889573|FG003|Overall Study|Early Termination Criteria Met|0|||
23359248|NCT01153009|65060013|FG002|Overall Study|Noncompliance with Study Medication|4|||
23359249|NCT01153009|65060014|FG003|Overall Study|Noncompliance with Study Medication|1|||
23359250|NCT01153009|65060011|FG000|Overall Study|Protocol Deviations|4|||
23359251|NCT01153009|65060012|FG001|Overall Study|Protocol Deviations|3|||
23359252|NCT01153009|65060013|FG002|Overall Study|Protocol Deviations|3|||
23359253|NCT01153009|65060014|FG003|Overall Study|Protocol Deviations|2|||
23359254|NCT01153009|65060011|FG000|Overall Study|Withdrawal of Consent|5|||
23359255|NCT01153009|65060012|FG001|Overall Study|Withdrawal of Consent|5|||
23359256|NCT01153009|65060013|FG002|Overall Study|Withdrawal of Consent|4|||
23359257|NCT01153009|65060014|FG003|Overall Study|Withdrawal of Consent|6|||
23359258|NCT01153009|65060011|FG000|Overall Study|Lost to Follow-up|8|||
23359259|NCT01153009|65060012|FG001|Overall Study|Lost to Follow-up|8|||
23359260|NCT01153009|65060013|FG002|Overall Study|Lost to Follow-up|11|||
23359261|NCT01153009|65060014|FG003|Overall Study|Lost to Follow-up|15|||
23359262|NCT01153009|65060011|FG000|Overall Study|Other|1|||
23359263|NCT01153009|65060012|FG001|Overall Study|Other|1|||
23359264|NCT01153009|65060013|FG002|Overall Study|Other|3|||
23359265|NCT01153009|65060014|FG003|Overall Study|Other|2|||
23359266|NCT02609984|65060018|FG000|Overall Study|Death|29|||
23359267|NCT02609984|65060019|FG001|Overall Study|Death|26|||
23359268|NCT02609984|65060018|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
23359269|NCT02609984|65060019|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
23359270|NCT02609984|65060018|FG000|Overall Study|Lost to Follow-up|1|||
23359271|NCT02609984|65060019|FG001|Overall Study|Lost to Follow-up|2|||
23359272|NCT02609984|65060018|FG000|Overall Study|Withdrawal by Subject|0|||
23359273|NCT02609984|65060019|FG001|Overall Study|Withdrawal by Subject|1|||
23359274|NCT02609984|65060018|FG000|Overall Study|Disease Progression|2|||
23359275|NCT02609984|65060019|FG001|Overall Study|Disease Progression|0|||
23359276|NCT00856999|65060022|FG000|Overall Study|Withdrawal by Subject|5|||
23359277|NCT04999085|65060027|FG000|Overall Study|Death|1|||
23359278|NCT01054222|65060030|FG000|Overall Study|Lack of Efficacy|1|||
23359279|NCT01054222|65060030|FG000|Overall Study|Lost to Follow-up|4|||
23359280|NCT01054222|65060030|FG000|Overall Study|Withdrawal by Subject|6|||
23359281|NCT00070564|65060031|FG000|Overall Study|Progression|2|||
23359282|NCT00070564|65060032|FG001|Overall Study|Progression|4|||
23359283|NCT00070564|65060033|FG002|Overall Study|Progression|7|||
23359284|NCT00070564|65060034|FG003|Overall Study|Progression|7|||
23359285|NCT00070564|65060035|FG004|Overall Study|Progression|1|||
23359286|NCT00070564|65060036|FG005|Overall Study|Progression|0|||
23359287|NCT00070564|65060031|FG000|Overall Study|Delinquent|1|||
23359288|NCT00070564|65060032|FG001|Overall Study|Delinquent|4|||
23359289|NCT00070564|65060033|FG002|Overall Study|Delinquent|2|||
23359290|NCT00070564|65060034|FG003|Overall Study|Delinquent|0|||
23359291|NCT00070564|65060035|FG004|Overall Study|Delinquent|0|||
23253128|NCT01360632|64667936|FG000|Phase A+|Adverse Event|0|||
23359292|NCT00070564|65060036|FG005|Overall Study|Delinquent|0|||
23359293|NCT00070564|65060031|FG000|Overall Study|Adverse Event|150|||
23359294|NCT00070564|65060032|FG001|Overall Study|Adverse Event|142|||
23359295|NCT00070564|65060033|FG002|Overall Study|Adverse Event|120|||
23590102|NCT02020616|65889574|FG004|Overall Study|Early Termination Criteria Met|0|||
23253129|NCT01360632|64667937|FG001|Phase A+|Adverse Event|0|||
23359296|NCT00070564|65060034|FG003|Overall Study|Adverse Event|108|||
23359297|NCT00070564|65060035|FG004|Overall Study|Adverse Event|63|||
23359298|NCT00070564|65060036|FG005|Overall Study|Adverse Event|36|||
23359299|NCT00070564|65060031|FG000|Overall Study|Death|4|||
23359300|NCT00070564|65060032|FG001|Overall Study|Death|1|||
23359301|NCT00070564|65060033|FG002|Overall Study|Death|5|||
23253130|NCT01360632|64667938|FG002|Phase A+|Adverse Event|0|||
23253131|NCT01360632|64667939|FG003|Phase A+|Adverse Event|0|||
23253132|NCT01360632|64667940|FG004|Phase A+|Adverse Event|2|||
23253133|NCT01360632|64667936|FG000|Phase A+|Met Withdrawal Criteria|0|||
23253134|NCT01360632|64667937|FG001|Phase A+|Met Withdrawal Criteria|0|||
23253135|NCT01360632|64667938|FG002|Phase A+|Met Withdrawal Criteria|0|||
23253136|NCT01360632|64667939|FG003|Phase A+|Met Withdrawal Criteria|0|||
23253137|NCT01360632|64667940|FG004|Phase A+|Met Withdrawal Criteria|7|||
23359302|NCT00070564|65060034|FG003|Overall Study|Death|3|||
23359303|NCT00070564|65060035|FG004|Overall Study|Death|0|||
23359304|NCT00070564|65060036|FG005|Overall Study|Death|1|||
23359305|NCT00070564|65060031|FG000|Overall Study|Other, not protocol specified|17|||
23359306|NCT00070564|65060032|FG001|Overall Study|Other, not protocol specified|15|||
23359307|NCT00070564|65060033|FG002|Overall Study|Other, not protocol specified|14|||
23359308|NCT00070564|65060034|FG003|Overall Study|Other, not protocol specified|19|||
23359309|NCT00070564|65060035|FG004|Overall Study|Other, not protocol specified|6|||
23359310|NCT00070564|65060036|FG005|Overall Study|Other, not protocol specified|7|||
23359311|NCT00070564|65060031|FG000|Overall Study|Withdrawal by Subject|26|||
23359312|NCT00070564|65060032|FG001|Overall Study|Withdrawal by Subject|37|||
23359313|NCT00070564|65060033|FG002|Overall Study|Withdrawal by Subject|23|||
23359314|NCT00070564|65060034|FG003|Overall Study|Withdrawal by Subject|30|||
23359315|NCT00070564|65060035|FG004|Overall Study|Withdrawal by Subject|8|||
23359316|NCT00070564|65060036|FG005|Overall Study|Withdrawal by Subject|8|||
23359317|NCT00070564|65060031|FG000|Overall Study|Not reported|0|||
23359318|NCT00070564|65060032|FG001|Overall Study|Not reported|0|||
23359319|NCT00070564|65060033|FG002|Overall Study|Not reported|0|||
23359320|NCT00070564|65060034|FG003|Overall Study|Not reported|0|||
23359321|NCT00070564|65060035|FG004|Overall Study|Not reported|1|||
23359322|NCT00070564|65060036|FG005|Overall Study|Not reported|0|||
23359323|NCT01990573|65060037|FG000|Overall Study|Physician Decision|0|||
23359324|NCT01990573|65060038|FG001|Overall Study|Physician Decision|0|||
23359325|NCT01990573|65060039|FG002|Overall Study|Physician Decision|1|||
23359326|NCT00571103|65060040|FG000|Overall Study|Withdrawal by Subject|1|||
23359327|NCT00571103|65060040|FG000|Overall Study|Lost to Follow-up|1|||
23359328|NCT05446142|65060046|FG000|Period 2|Adverse Event|1|||
23359329|NCT05446142|65060047|FG001|Period 2|Adverse Event|0|||
23359330|NCT05446142|65060048|FG002|Period 2|Adverse Event|0|||
23359331|NCT05446142|65060049|FG003|Period 2|Adverse Event|0|||
23359332|NCT05446142|65060050|FG004|Period 2|Adverse Event|0|||
23359333|NCT05446142|65060051|FG005|Period 2|Adverse Event|0|||
23359334|NCT02585713|65060052|FG000|Overall Study|Withdrew prior to treatment|2|||
23590103|NCT02020616|65889575|FG005|Overall Study|Early Termination Criteria Met|1|||
23590104|NCT02020616|65889576|FG006|Overall Study|Early Termination Criteria Met|0|||
23590105|NCT02020616|65889570|FG000|Overall Study|Randomized in Error|0|||
23590106|NCT02020616|65889571|FG001|Overall Study|Randomized in Error|0|||
23590107|NCT02020616|65889572|FG002|Overall Study|Randomized in Error|0|||
23590108|NCT02020616|65889573|FG003|Overall Study|Randomized in Error|1|||
23590109|NCT02020616|65889574|FG004|Overall Study|Randomized in Error|0|||
23253138|NCT01360632|64667936|FG000|Phase A+|Physician Decision|0|||
23359335|NCT02585713|65060053|FG001|Overall Study|Withdrew prior to treatment|7|||
23359336|NCT02585713|65060052|FG000|Overall Study|Other|3|||
23359337|NCT02585713|65060053|FG001|Overall Study|Other|1|||
23253139|NCT01360632|64667937|FG001|Phase A+|Physician Decision|0|||
23359338|NCT02095197|65060057|FG000|Overall Study|Lost to Follow-up|0|||
23359339|NCT02095197|65060058|FG001|Overall Study|Lost to Follow-up|3|||
23359340|NCT03077607|65060059|FG000|Period 1 (15 Days)|Adverse Event|1|||
23359341|NCT03077607|65060060|FG001|Period 1 (15 Days)|Adverse Event|0|||
23359342|NCT03077607|65060059|FG000|Period 1 (15 Days)|Death|1|||
23253140|NCT01360632|64667938|FG002|Phase A+|Physician Decision|0|||
23253141|NCT01360632|64667939|FG003|Phase A+|Physician Decision|0|||
23359343|NCT03077607|65060060|FG001|Period 1 (15 Days)|Death|0|||
23359344|NCT03077607|65060059|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
23359345|NCT03077607|65060060|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
23359346|NCT03077607|65060059|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
23590110|NCT02020616|65889575|FG005|Overall Study|Randomized in Error|0|||
23590111|NCT02020616|65889576|FG006|Overall Study|Randomized in Error|0|||
23253142|NCT01360632|64667940|FG004|Phase A+|Physician Decision|3|||
23359347|NCT03077607|65060060|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
23359348|NCT03782571|65060061|FG000|Period 1|Withdrawal by Subject|1|||
23191905|NCT00744055|64442467|FG000|Overall Study|Protocol Violation|1|||
23191906|NCT00744055|64442468|FG001|Overall Study|Protocol Violation|1|||
23191907|NCT00744055|64442467|FG000|Overall Study|Lost to Follow-up|0|||
23191908|NCT00744055|64442468|FG001|Overall Study|Lost to Follow-up|1|||
23191909|NCT03952130|64442469|FG000|Overall Study|Adverse Event|0|||
23191910|NCT03952130|64442470|FG001|Overall Study|Adverse Event|1|||
23191911|NCT03952130|64442469|FG000|Overall Study|Lost to Follow-up|1|||
23191912|NCT03952130|64442470|FG001|Overall Study|Lost to Follow-up|0|||
23191913|NCT03952130|64442469|FG000|Overall Study|Withdrawal by Subject|1|||
23191914|NCT03952130|64442470|FG001|Overall Study|Withdrawal by Subject|5|||
23191915|NCT01416610|64442478|FG000|Overall Study|Adverse Event|4|||
23191916|NCT01416610|64442478|FG000|Overall Study|Adverse Event -Patient decision|3|||
23191917|NCT01416610|64442478|FG000|Overall Study|Lack of Efficacy|4|||
23191918|NCT01416610|64442478|FG000|Overall Study|No reason given|5|||
23191919|NCT01416610|64442478|FG000|Overall Study|Withdrawal by Subject|13|||
23191920|NCT01416610|64442478|FG000|Overall Study|Lost to Follow-up|7|||
23191921|NCT01416610|64442478|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
23191922|NCT01634243|64442480|FG000|Overall Study|Adverse Event|5|||
23191923|NCT01634243|64442481|FG001|Overall Study|Adverse Event|5|||
23191924|NCT01634243|64442480|FG000|Overall Study|Lack of Efficacy|1|||
23191925|NCT01634243|64442481|FG001|Overall Study|Lack of Efficacy|0|||
23191926|NCT00336492|64445741|FG000|Overall Study|Adverse Event|4|||
23191927|NCT00336492|64445742|FG001|Overall Study|Adverse Event|3|||
23191928|NCT00336492|64445743|FG002|Overall Study|Adverse Event|6|||
23191929|NCT00336492|64445741|FG000|Overall Study|Lack of Efficacy|6|||
23191930|NCT00336492|64445742|FG001|Overall Study|Lack of Efficacy|1|||
23191931|NCT00336492|64445743|FG002|Overall Study|Lack of Efficacy|4|||
23191932|NCT00336492|64445741|FG000|Overall Study|Other|5|||
23191933|NCT00336492|64445742|FG001|Overall Study|Other|0|||
23191934|NCT00336492|64445743|FG002|Overall Study|Other|1|||
23191935|NCT03280550|64445744|FG000|Overall Study|Withdrawal by Subject|2|||
23191936|NCT03280550|64445745|FG001|Overall Study|Withdrawal by Subject|2|||
23191937|NCT03280550|64445744|FG000|Overall Study|Physician Decision|0|||
23191938|NCT03280550|64445745|FG001|Overall Study|Physician Decision|1|||
23253143|NCT01360632|64667936|FG000|Phase A+|Withdrawal by Subject|0|||
23253144|NCT01360632|64667937|FG001|Phase A+|Withdrawal by Subject|0|||
23253145|NCT01360632|64667938|FG002|Phase A+|Withdrawal by Subject|0|||
23253146|NCT01360632|64667939|FG003|Phase A+|Withdrawal by Subject|0|||
23191939|NCT02961764|64445746|FG000|Overall Study|Protocol Violation|0|||
23191940|NCT02961764|64445747|FG001|Overall Study|Protocol Violation|1|||
23191941|NCT02961764|64445746|FG000|Overall Study|Death|2|||
23191942|NCT02961764|64445747|FG001|Overall Study|Death|0|||
23191943|NCT02961764|64445746|FG000|Overall Study|Lost to Follow-up|35|||
23191944|NCT02961764|64445747|FG001|Overall Study|Lost to Follow-up|24|||
23191945|NCT02961764|64445746|FG000|Overall Study|Withdrawal by Subject|2|||
23191946|NCT02961764|64445747|FG001|Overall Study|Withdrawal by Subject|0|||
23253147|NCT01360632|64667940|FG004|Phase A+|Withdrawal by Subject|8|||
23253148|NCT01360632|64667936|FG000|Phase A+|Protocol Deviation|0|||
23253149|NCT01360632|64667937|FG001|Phase A+|Protocol Deviation|0|||
23253150|NCT01360632|64667938|FG002|Phase A+|Protocol Deviation|0|||
23253151|NCT01360632|64667939|FG003|Phase A+|Protocol Deviation|0|||
23253152|NCT01360632|64667940|FG004|Phase A+|Protocol Deviation|3|||
23253153|NCT01783730|64667941|FG000|Overall Study|Failed to meet inclusion criteria|6|||
23253154|NCT00678379|64667944|FG000|Overall Study|Injection performed after tonsillectomy|2|||
23253155|NCT00678379|64667945|FG001|Overall Study|Injection performed after tonsillectomy|0|||
23253156|NCT00678379|64667946|FG002|Overall Study|Injection performed after tonsillectomy|1|||
23253157|NCT00678379|64667944|FG000|Overall Study|Incomplete Data|4|||
23253158|NCT00678379|64667945|FG001|Overall Study|Incomplete Data|3|||
23253159|NCT00678379|64667946|FG002|Overall Study|Incomplete Data|3|||
23253160|NCT03499249|64667947|FG000|Overall Study|Physician Decision|1|||
23253161|NCT05288673|64667948|FG000|Overall Study|Consent withdrawn by subject|0|||
23253162|NCT05288673|64667949|FG001|Overall Study|Consent withdrawn by subject|0|||
23253163|NCT05288673|64667950|FG002|Overall Study|Consent withdrawn by subject|1|||
23253164|NCT00756652|64667951|FG000|Original Phase|Withdrawal by Subject|864|||
23253165|NCT00756652|64667952|FG001|Original Phase|Withdrawal by Subject|23|||
23191947|NCT04172831|64445748|FG000|Overall Study|Adverse Event|21|||
23253166|NCT00756652|64667951|FG000|Original Phase|Lost to Follow-up|601|||
23191948|NCT04172831|64445749|FG001|Overall Study|Adverse Event|9|||
23191949|NCT04172831|64445748|FG000|Overall Study|Lack of Efficacy|2|||
23191950|NCT04172831|64445749|FG001|Overall Study|Lack of Efficacy|8|||
23191951|NCT04172831|64445748|FG000|Overall Study|Physician Decision|0|||
23191952|NCT04172831|64445749|FG001|Overall Study|Physician Decision|1|||
23191953|NCT04172831|64445748|FG000|Overall Study|Withdrawal by Subject|12|||
23191954|NCT04172831|64445749|FG001|Overall Study|Withdrawal by Subject|11|||
23191955|NCT04172831|64445748|FG000|Overall Study|Lost to Follow-up|4|||
23191956|NCT04172831|64445749|FG001|Overall Study|Lost to Follow-up|9|||
23253167|NCT00756652|64667952|FG001|Original Phase|Lost to Follow-up|0|||
23253168|NCT00756652|64667951|FG000|Original Phase|Other Discontinuation|797|||
23253169|NCT00756652|64667952|FG001|Original Phase|Other Discontinuation|5|||
23191957|NCT04172831|64445748|FG000|Overall Study|COVID-19 related crisis|3|||
23191958|NCT04172831|64445749|FG001|Overall Study|COVID-19 related crisis|3|||
23191959|NCT04172831|64445748|FG000|Overall Study|Subject non-compliance|1|||
23191960|NCT04172831|64445749|FG001|Overall Study|Subject non-compliance|1|||
23191961|NCT04172831|64445748|FG000|Overall Study|Family emergency|1|||
23191962|NCT04172831|64445749|FG001|Overall Study|Family emergency|0|||
23191963|NCT01927562|64445750|FG000|Overall Study|Lost to Follow-up|30|||
23191964|NCT01927562|64445750|FG000|Overall Study|Withdrawal by Subject|3|||
23191965|NCT01927562|64445750|FG000|Overall Study|Physician Decision|5|||
23359349|NCT03782571|65060062|FG001|Period 1|Withdrawal by Subject|0|||
23359350|NCT03782571|65060063|FG002|Period 1|Withdrawal by Subject|0|||
23359351|NCT03782571|65060064|FG003|Period 1|Withdrawal by Subject|0|||
23359352|NCT03782571|65060061|FG000|Period 3|Subject Unable to Attend V5|1|||
23359353|NCT03782571|65060062|FG001|Period 3|Subject Unable to Attend V5|0|||
23359354|NCT03782571|65060063|FG002|Period 3|Subject Unable to Attend V5|0|||
23191966|NCT02973815|64445754|FG000|Post Intervention|Death|1|||
23191967|NCT02973815|64445755|FG001|Post Intervention|Death|0|||
23191968|NCT02973815|64445754|FG000|Post Intervention|Lost to Follow-up|7|||
23191969|NCT02973815|64445755|FG001|Post Intervention|Lost to Follow-up|24|||
23191970|NCT02973815|64445754|FG000|Follow-up|Lost to Follow-up|2|||
23191971|NCT02973815|64445755|FG001|Follow-up|Lost to Follow-up|0|||
23191972|NCT01164501|64445756|FG000|Overall Study|Not treated|2|||
23191973|NCT01164501|64445757|FG001|Overall Study|Not treated|0|||
23191974|NCT01164501|64445758|FG002|Overall Study|Not treated|1|||
23191975|NCT01164501|64445756|FG000|Overall Study|Adverse Event|18|||
23359355|NCT03782571|65060064|FG003|Period 3|Subject Unable to Attend V5|0|||
23359356|NCT03782571|65060061|FG000|Period 3|Adverse Event|1|||
23359357|NCT03782571|65060062|FG001|Period 3|Adverse Event|0|||
23359358|NCT03782571|65060063|FG002|Period 3|Adverse Event|0|||
23359359|NCT03782571|65060064|FG003|Period 3|Adverse Event|0|||
23359360|NCT04547140|65060065|FG000|Overall Study|Adverse Event|0|||
23359361|NCT04547140|65060066|FG001|Overall Study|Adverse Event|1|||
23359362|NCT04547140|65060065|FG000|Overall Study|Withdrawal by Subject|0|||
23359363|NCT04547140|65060066|FG001|Overall Study|Withdrawal by Subject|1|||
23359364|NCT04547140|65060065|FG000|Overall Study|Lost to Follow-up|3|||
23359365|NCT04547140|65060066|FG001|Overall Study|Lost to Follow-up|1|||
23359366|NCT04547140|65060065|FG000|Overall Study|Death|2|||
23359367|NCT04547140|65060066|FG001|Overall Study|Death|1|||
23359368|NCT04547140|65060065|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
23359369|NCT04547140|65060066|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
23191976|NCT01164501|64445757|FG001|Overall Study|Adverse Event|4|||
23191977|NCT01164501|64445758|FG002|Overall Study|Adverse Event|21|||
23253170|NCT00756652|64667951|FG000|Original Phase|Participant Noncompliance|18622|||
23253171|NCT00756652|64667952|FG001|Original Phase|Participant Noncompliance|424|||
23253172|NCT00756652|64667951|FG000|Original Phase|Unknown Discontinuation Reason|2|||
23253173|NCT00756652|64667952|FG001|Original Phase|Unknown Discontinuation Reason|0|||
23253174|NCT00756652|64667951|FG000|Original Phase|Participants without data|3259|||
23253175|NCT00756652|64667952|FG001|Original Phase|Participants without data|466|||
23476022|NCT01499368|65487977|FG001|Overall Study|Did not meet I/E criteria|4|||
23476023|NCT01499368|65487978|FG002|Overall Study|Did not meet I/E criteria|4|||
23476024|NCT01499368|65487976|FG000|Overall Study|Prohibited Concomitant medication|1|||
23253176|NCT00756652|64667951|FG000|Original Phase|Death|168|||
23253177|NCT00756652|64667952|FG001|Original Phase|Death|1|||
23253178|NCT00756652|64667951|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
23253179|NCT00756652|64667952|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
23253180|NCT00756652|64667951|FG000|Re-Op Phase|Withdrawal by Subject|62|||
23253181|NCT00756652|64667952|FG001|Re-Op Phase|Withdrawal by Subject|0|||
23253182|NCT00756652|64667951|FG000|Re-Op Phase|Death|6|||
23359370|NCT04547140|65060065|FG000|Overall Study|Pregnancy|1|||
23359371|NCT04547140|65060066|FG001|Overall Study|Pregnancy|0|||
23359372|NCT04547140|65060065|FG000|Overall Study|Reason Not Specified|4|||
23359373|NCT04547140|65060066|FG001|Overall Study|Reason Not Specified|1|||
23359374|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
23359375|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
23476025|NCT01499368|65487977|FG001|Overall Study|Prohibited Concomitant medication|1|||
23476026|NCT01499368|65487978|FG002|Overall Study|Prohibited Concomitant medication|0|||
23359376|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
23476027|NCT01499368|65487976|FG000|Overall Study|Withdrawal by Subject|11|||
23191978|NCT01164501|64445756|FG000|Overall Study|Lack of Efficacy|0|||
23191979|NCT01164501|64445757|FG001|Overall Study|Lack of Efficacy|0|||
23476028|NCT01499368|65487977|FG001|Overall Study|Withdrawal by Subject|10|||
23191980|NCT01164501|64445758|FG002|Overall Study|Lack of Efficacy|1|||
23253183|NCT00756652|64667952|FG001|Re-Op Phase|Death|0|||
23253184|NCT00756652|64667951|FG000|Re-Op Phase|Lost to Follow-up|340|||
23253185|NCT00756652|64667952|FG001|Re-Op Phase|Lost to Follow-up|0|||
23253186|NCT00756652|64667951|FG000|Re-Op Phase|Site Closed|2454|||
23253187|NCT00756652|64667952|FG001|Re-Op Phase|Site Closed|0|||
23476029|NCT01499368|65487978|FG002|Overall Study|Withdrawal by Subject|8|||
23476030|NCT01499368|65487976|FG000|Overall Study|Lost to Follow-up|3|||
23476031|NCT01499368|65487977|FG001|Overall Study|Lost to Follow-up|2|||
23476032|NCT01499368|65487978|FG002|Overall Study|Lost to Follow-up|5|||
23476033|NCT01499368|65487976|FG000|Overall Study|Adverse Event|4|||
23476034|NCT01499368|65487977|FG001|Overall Study|Adverse Event|0|||
23476035|NCT01499368|65487978|FG002|Overall Study|Adverse Event|2|||
23476036|NCT01499368|65487976|FG000|Overall Study|Physician Decision|0|||
23476037|NCT01499368|65487977|FG001|Overall Study|Physician Decision|1|||
23476038|NCT01499368|65487978|FG002|Overall Study|Physician Decision|0|||
23476039|NCT01499368|65487976|FG000|Overall Study|Deviation from visit window|0|||
23476040|NCT01499368|65487977|FG001|Overall Study|Deviation from visit window|0|||
23476041|NCT01499368|65487978|FG002|Overall Study|Deviation from visit window|1|||
23476042|NCT01499368|65487976|FG000|Overall Study|Error of Prescriptions|0|||
23476043|NCT01499368|65487977|FG001|Overall Study|Error of Prescriptions|0|||
23476044|NCT01499368|65487978|FG002|Overall Study|Error of Prescriptions|1|||
23476045|NCT00910299|65487979|FG000|Overall Study|Withdrawal by Subject|16|||
23476046|NCT00910299|65487980|FG001|Overall Study|Withdrawal by Subject|13|||
23476047|NCT00910299|65487979|FG000|Overall Study|Sponsor Decision|58|||
23476048|NCT00910299|65487980|FG001|Overall Study|Sponsor Decision|60|||
23476049|NCT00910299|65487979|FG000|Overall Study|Didn't receive any study drug|2|||
23476050|NCT00910299|65487980|FG001|Overall Study|Didn't receive any study drug|1|||
23476051|NCT02717832|65487983|FG000|Overall Study|Inability to place IV|3|||
23476052|NCT01643772|65487984|FG000|Overall Study|Protocol Violation|0|||
23476053|NCT01643772|65487985|FG001|Overall Study|Protocol Violation|0|||
23476054|NCT01643772|65487986|FG002|Overall Study|Protocol Violation|0|||
23476055|NCT01643772|65487987|FG003|Overall Study|Protocol Violation|1|||
23476056|NCT01643772|65487984|FG000|Overall Study|Adverse Event|0|||
23476057|NCT01643772|65487985|FG001|Overall Study|Adverse Event|0|||
23476058|NCT01643772|65487986|FG002|Overall Study|Adverse Event|0|||
23476059|NCT01643772|65487987|FG003|Overall Study|Adverse Event|1|||
23476060|NCT01233232|65487988|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
23191981|NCT01164501|64445756|FG000|Overall Study|Non compliant with protocol|1|||
23191982|NCT01164501|64445757|FG001|Overall Study|Non compliant with protocol|1|||
23191983|NCT01164501|64445758|FG002|Overall Study|Non compliant with protocol|4|||
23191984|NCT01164501|64445756|FG000|Overall Study|Lost to Follow-up|3|||
23191985|NCT01164501|64445757|FG001|Overall Study|Lost to Follow-up|0|||
23191986|NCT01164501|64445758|FG002|Overall Study|Lost to Follow-up|3|||
23191987|NCT01164501|64445756|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
23191988|NCT01164501|64445757|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
23191989|NCT01164501|64445758|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
23191990|NCT01164501|64445756|FG000|Overall Study|Other reason not defined above|9|||
23191991|NCT01164501|64445757|FG001|Overall Study|Other reason not defined above|1|||
23191992|NCT01164501|64445758|FG002|Overall Study|Other reason not defined above|4|||
23253188|NCT00756652|64667951|FG000|Re-Op Phase|Withdrawn after explant|14|||
23253189|NCT00756652|64667952|FG001|Re-Op Phase|Withdrawn after explant|0|||
23253190|NCT01309828|64667953|FG000|Overall Study|Adverse Event|10|||
23253191|NCT01309828|64667954|FG001|Overall Study|Adverse Event|11|||
23253192|NCT01309828|64667953|FG000|Overall Study|Voluntary Withdrawal|5|||
23253193|NCT01309828|64667954|FG001|Overall Study|Voluntary Withdrawal|4|||
23253194|NCT01309828|64667953|FG000|Overall Study|Major Protocol Deviation|0|||
23253195|NCT01309828|64667954|FG001|Overall Study|Major Protocol Deviation|1|||
23253196|NCT01309828|64667953|FG000|Overall Study|Other|1|||
23253197|NCT01309828|64667954|FG001|Overall Study|Other|0|||
23253198|NCT01074307|64667955|FG000|Overall Study|No primary endpoint evaluation|14|||
23253199|NCT01074307|64667956|FG001|Overall Study|No primary endpoint evaluation|6|||
23253200|NCT01074307|64667955|FG000|Overall Study|Exclusion criterion|0|||
23253201|NCT01074307|64667956|FG001|Overall Study|Exclusion criterion|1|||
23476061|NCT01233232|65487989|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
23476062|NCT01233232|65487990|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
23476063|NCT03658876|65487991|FG000|Overall Study|Protocol Violation|3|||
23476064|NCT03658876|65487992|FG001|Overall Study|Protocol Violation|2|||
23476065|NCT03658876|65487991|FG000|Overall Study|Withdrawal by Subject|2|||
23191993|NCT04419506|64445759|FG000|Overall Study|Adverse Event|0|||
23191994|NCT04419506|64445760|FG001|Overall Study|Adverse Event|10|||
23191995|NCT04419506|64445761|FG002|Overall Study|Adverse Event|0|||
23253202|NCT01074307|64667955|FG000|Overall Study|Protocol Violation|8|||
23476066|NCT03658876|65487992|FG001|Overall Study|Withdrawal by Subject|0|||
23476067|NCT03658876|65487991|FG000|Overall Study|Death|0|||
23476068|NCT03658876|65487992|FG001|Overall Study|Death|1|||
23476069|NCT03658876|65487991|FG000|Overall Study|Intercurrent illness|6|||
23476070|NCT03658876|65487992|FG001|Overall Study|Intercurrent illness|4|||
23253203|NCT01074307|64667956|FG001|Overall Study|Protocol Violation|5|||
23253204|NCT03611751|64667957|FG000|Pre-treatment|Randomized but not treated|1|||
23253205|NCT03611751|64667958|FG001|Pre-treatment|Randomized but not treated|1|||
23476071|NCT03658876|65487991|FG000|Overall Study|Transplantation/other operation|1|||
23191996|NCT04419506|64445762|FG003|Overall Study|Adverse Event|3|||
23191997|NCT04419506|64445759|FG000|Overall Study|Withdrawal by Subject|0|||
23191998|NCT04419506|64445760|FG001|Overall Study|Withdrawal by Subject|0|||
23191999|NCT04419506|64445761|FG002|Overall Study|Withdrawal by Subject|0|||
23192000|NCT04419506|64445762|FG003|Overall Study|Withdrawal by Subject|1|||
23192001|NCT04419506|64445759|FG000|Overall Study|poor-compliance|0|||
23192002|NCT04419506|64445760|FG001|Overall Study|poor-compliance|0|||
23192003|NCT04419506|64445761|FG002|Overall Study|poor-compliance|0|||
23192004|NCT04419506|64445762|FG003|Overall Study|poor-compliance|1|||
23192005|NCT02990338|64445763|FG000|Overall Study|Ongoing|30|||
23192006|NCT02990338|64445764|FG001|Overall Study|Ongoing|36|||
23192007|NCT00417612|64445768|FG000|Overall Study|Errant diagnosis|0|||
23192008|NCT00417612|64445769|FG001|Overall Study|Errant diagnosis|1|||
23192009|NCT00417612|64445768|FG000|Overall Study|Adverse Event|2|||
23192010|NCT00417612|64445769|FG001|Overall Study|Adverse Event|0|||
23192011|NCT00417612|64445768|FG000|Overall Study|Protocol Violation|0|||
23192012|NCT00417612|64445769|FG001|Overall Study|Protocol Violation|2|||
23192013|NCT00417612|64445768|FG000|Overall Study|Lost to Follow-up|1|||
23476072|NCT03658876|65487992|FG001|Overall Study|Transplantation/other operation|5|||
23476073|NCT03598114|65487998|FG000|Overall Study|Staff turnover/left the program|3|||
23476074|NCT03598114|65487999|FG001|Overall Study|Staff turnover/left the program|39|||
23476075|NCT01788358|65488000|FG000|Overall Study|Other|11|||
23476076|NCT01788358|65488000|FG000|Overall Study|Logistical difficulties|1|||
23476077|NCT01788358|65488000|FG000|Overall Study|Lost to Follow-up|5|||
23476078|NCT01788358|65488000|FG000|Overall Study|Protocol Violation|3|||
23476079|NCT01788358|65488000|FG000|Overall Study|Withdrawal by Subject|26|||
23476080|NCT01788358|65488000|FG000|Overall Study|Lack of Efficacy|1|||
23476081|NCT01788358|65488000|FG000|Overall Study|Adverse Event|51|||
23476082|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
23476083|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
23476084|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
23476085|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
23476086|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
23476087|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
23192014|NCT00417612|64445769|FG001|Overall Study|Lost to Follow-up|0|||
23192015|NCT02586207|64445771|FG000|Overall Study|Physician Decision|1|||
23192016|NCT02586207|64445771|FG000|Overall Study|Withdrawal by Subject|1|||
23253206|NCT03611751|64667959|FG002|Pre-treatment|Randomized but not treated|0|||
23476088|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
23476089|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
23476090|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
23590112|NCT02020616|65889570|FG000|Overall Study|Lack of Efficacy|0|||
23590113|NCT02020616|65889571|FG001|Overall Study|Lack of Efficacy|0|||
23590114|NCT02020616|65889572|FG002|Overall Study|Lack of Efficacy|0|||
23590115|NCT02020616|65889573|FG003|Overall Study|Lack of Efficacy|0|||
23590116|NCT02020616|65889574|FG004|Overall Study|Lack of Efficacy|1|||
23590117|NCT02020616|65889575|FG005|Overall Study|Lack of Efficacy|0|||
23590118|NCT02020616|65889576|FG006|Overall Study|Lack of Efficacy|0|||
23590119|NCT03959241|65889577|FG000|Overall Study|Withdrawal by Subject|7|||
23590120|NCT03959241|65889578|FG001|Overall Study|Withdrawal by Subject|8|||
23590121|NCT03959241|65889577|FG000|Overall Study|Lost to Follow-up|1|||
23590122|NCT03959241|65889578|FG001|Overall Study|Lost to Follow-up|0|||
23590123|NCT03959241|65889577|FG000|Overall Study|Move to Hospice Care|1|||
23590124|NCT03959241|65889578|FG001|Overall Study|Move to Hospice Care|0|||
23590125|NCT03959241|65889577|FG000|Overall Study|Screen Failure|1|||
23192017|NCT01362322|64445772|FG000|Overall Study|Withdrawal by Subject|3|||
23192018|NCT01362322|64445773|FG001|Overall Study|Withdrawal by Subject|1|||
23192019|NCT01362322|64445772|FG000|Overall Study|Lost to Follow-up|2|||
23192020|NCT01362322|64445773|FG001|Overall Study|Lost to Follow-up|6|||
23192021|NCT03270085|64445774|FG000|Overall Study|Withdrawal by Subject|1|||
23192022|NCT03270085|64445775|FG001|Overall Study|Withdrawal by Subject|0|||
23192023|NCT05253807|64445779|FG000|Overall Study|Death|1|||
23476091|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
23476092|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
23476093|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
23476094|NCT01087788|65488001|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
23476095|NCT01087788|65488002|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
23476096|NCT01087788|65488003|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
23476097|NCT01087788|65488001|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
23590126|NCT03959241|65889578|FG001|Overall Study|Screen Failure|0|||
23590127|NCT03959241|65889577|FG000|Overall Study|Disease Relapse|0|||
23590128|NCT03959241|65889578|FG001|Overall Study|Disease Relapse|1|||
23476098|NCT01087788|65488002|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
23476099|NCT01087788|65488003|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
23476100|NCT01087788|65488001|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
23476101|NCT01087788|65488002|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
23476102|NCT01087788|65488003|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
23476103|NCT01087788|65488001|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
23476104|NCT01087788|65488002|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
23476105|NCT01087788|65488003|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
23476106|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
23476107|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
23476108|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
23476109|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
23476110|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
23476111|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
23476112|NCT01087788|65488001|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
23476113|NCT01087788|65488002|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
23476114|NCT01087788|65488003|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
23476115|NCT01087788|65488001|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
23476116|NCT01087788|65488002|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
23476117|NCT01087788|65488003|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
23476118|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
23476119|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
23476120|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
23476121|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
23476122|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
23476123|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
23476124|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
23476125|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
23476126|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
23476127|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
23476128|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
23476129|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
23476130|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
23476131|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
23476132|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
23476133|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
23476134|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
23476135|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
23590129|NCT03959241|65889577|FG000|Overall Study|Off Study|1|||
23590130|NCT03959241|65889578|FG001|Overall Study|Off Study|0|||
23590131|NCT02715258|65889579|FG000|Overall Study|Withdrawal by Subject|6|||
23590132|NCT02715258|65889580|FG001|Overall Study|Withdrawal by Subject|1|||
23590133|NCT02715258|65889579|FG000|Overall Study|Lost to Follow-up|7|||
23590134|NCT02715258|65889580|FG001|Overall Study|Lost to Follow-up|1|||
23253207|NCT03611751|64667957|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
23253208|NCT03611751|64667958|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
23253209|NCT03611751|64667959|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
23253210|NCT03611751|64667957|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
23253211|NCT03611751|64667958|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
23253212|NCT03611751|64667959|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
23253213|NCT03611751|64667957|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
23253214|NCT03611751|64667958|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
23253215|NCT03611751|64667959|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
23590135|NCT02715258|65889579|FG000|Overall Study|Terminated by Sponsor|0|||
23590136|NCT02715258|65889580|FG001|Overall Study|Terminated by Sponsor|1|||
23590137|NCT02715258|65889579|FG000|Overall Study|Death|0|||
23253216|NCT03611751|64667957|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
23253217|NCT03611751|64667958|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
23253218|NCT03611751|64667959|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
23476136|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
23476137|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
23476138|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
23476139|NCT01087788|65488001|FG000|24-weeks Dose-blind Period|Patient moved|0|||
23590138|NCT02715258|65889580|FG001|Overall Study|Death|1|||
23253219|NCT03611751|64667957|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
23590139|NCT02715258|65889579|FG000|Overall Study|Subject non-compliant|1|||
23590140|NCT02715258|65889580|FG001|Overall Study|Subject non-compliant|1|||
23590141|NCT02715258|65889579|FG000|Overall Study|GCP violation|2|||
23590142|NCT02715258|65889580|FG001|Overall Study|GCP violation|1|||
23590143|NCT00688519|65889581|FG000|Overall Study|Adverse Event|2|||
23590144|NCT00688519|65889582|FG001|Overall Study|Adverse Event|3|||
23590145|NCT00688519|65889581|FG000|Overall Study|Lost to Follow-up|3|||
23590146|NCT00688519|65889582|FG001|Overall Study|Lost to Follow-up|3|||
23590147|NCT00688519|65889581|FG000|Overall Study|Lack of Efficacy|3|||
23590148|NCT00688519|65889582|FG001|Overall Study|Lack of Efficacy|1|||
23590149|NCT00688519|65889581|FG000|Overall Study|Withdrawal by Subject|7|||
23590150|NCT00688519|65889582|FG001|Overall Study|Withdrawal by Subject|6|||
23590151|NCT00688519|65889581|FG000|Overall Study|Prohibited medication|1|||
23590152|NCT00688519|65889582|FG001|Overall Study|Prohibited medication|0|||
23192024|NCT05253807|64445780|FG001|Overall Study|Death|4|||
23192025|NCT05253807|64445779|FG000|Overall Study|Withdrawal by Subject|1|||
23590153|NCT00688519|65889581|FG000|Overall Study|Non-compliance|0|||
23590154|NCT00688519|65889582|FG001|Overall Study|Non-compliance|1|||
23590155|NCT00688519|65889581|FG000|Overall Study|Subject moved out of state|1|||
23590156|NCT00688519|65889582|FG001|Overall Study|Subject moved out of state|0|||
23590157|NCT00688519|65889581|FG000|Overall Study|Investigator decision|1|||
23590158|NCT00688519|65889582|FG001|Overall Study|Investigator decision|0|||
23192026|NCT05253807|64445780|FG001|Overall Study|Withdrawal by Subject|0|||
23192027|NCT05253807|64445779|FG000|Overall Study|Study Terminated by Sponsor|1|||
23192028|NCT05253807|64445780|FG001|Overall Study|Study Terminated by Sponsor|1|||
23192029|NCT03598777|64445783|FG000|Overall Study|Study Terminated by Sponsor|3|||
23192030|NCT03598777|64445784|FG001|Overall Study|Study Terminated by Sponsor|0|||
23192031|NCT03598777|64445785|FG002|Overall Study|Study Terminated by Sponsor|0|||
23192032|NCT03598777|64445786|FG003|Overall Study|Study Terminated by Sponsor|0|||
23590159|NCT00688519|65889581|FG000|Overall Study|Subject moved out of area|1|||
23590160|NCT00688519|65889582|FG001|Overall Study|Subject moved out of area|0|||
23590161|NCT00688519|65889581|FG000|Overall Study|Pregnancy|0|||
23590162|NCT00688519|65889582|FG001|Overall Study|Pregnancy|1|||
23590163|NCT00436644|65889583|FG000|Overall Study|Adverse Event|2|||
23590164|NCT00436644|65889583|FG000|Overall Study|Death|1|||
23590165|NCT04340362|65889584|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
23590166|NCT02878330|65889585|FG000|Overall Study|Death|3|||
23590167|NCT02878330|65889586|FG001|Overall Study|Death|2|||
23590168|NCT02878330|65889585|FG000|Overall Study|Lost to Follow-up|11|||
23590169|NCT02878330|65889586|FG001|Overall Study|Lost to Follow-up|26|||
23590170|NCT02878330|65889585|FG000|Overall Study|Withdrawal by Subject|11|||
23590171|NCT02878330|65889586|FG001|Overall Study|Withdrawal by Subject|21|||
23590172|NCT02878330|65889585|FG000|Overall Study|Other|4|||
23590173|NCT02878330|65889586|FG001|Overall Study|Other|7|||
23590174|NCT00319436|65889587|FG000|Overall Study|Withdrawal by Subject|6|||
23590175|NCT00319436|65889588|FG001|Overall Study|Withdrawal by Subject|7|||
23590176|NCT00739102|65889589|FG000|Overall Study|Death|5|||
23590177|NCT00739102|65889589|FG000|Overall Study|Withdrawal by Subject|10|||
23590178|NCT03876457|65889590|FG000|Overall Study|Lost to Follow-up|1|||
23590179|NCT03876457|65889591|FG001|Overall Study|Lost to Follow-up|3|||
23590180|NCT01959412|65889594|FG000|Overall Study|Protocol deviation|1|||
23590181|NCT01959412|65889595|FG001|Overall Study|Protocol deviation|1|||
23590182|NCT01959412|65889596|FG002|Overall Study|Protocol deviation|0|||
23590183|NCT01959412|65889597|FG003|Overall Study|Protocol deviation|1|||
23590184|NCT01959412|65889598|FG004|Overall Study|Protocol deviation|3|||
23590185|NCT01959412|65889599|FG005|Overall Study|Protocol deviation|0|||
23590186|NCT01959412|65889594|FG000|Overall Study|Adverse Event|0|||
23590187|NCT01959412|65889595|FG001|Overall Study|Adverse Event|0|||
23590188|NCT01959412|65889596|FG002|Overall Study|Adverse Event|0|||
23590189|NCT01959412|65889597|FG003|Overall Study|Adverse Event|1|||
23590190|NCT01959412|65889598|FG004|Overall Study|Adverse Event|0|||
23590191|NCT01959412|65889599|FG005|Overall Study|Adverse Event|0|||
23590192|NCT00855465|65889600|FG000|Treatment Period|Adverse Event|4|||
23590193|NCT00855465|65889601|FG001|Treatment Period|Adverse Event|2|||
23590194|NCT00855465|65889600|FG000|Treatment Period|Death|2|||
23590195|NCT00855465|65889601|FG001|Treatment Period|Death|2|||
23590196|NCT00855465|65889600|FG000|Treatment Period|Lack of Efficacy|2|||
23590197|NCT00855465|65889601|FG001|Treatment Period|Lack of Efficacy|1|||
23590198|NCT00855465|65889600|FG000|Treatment Period|Non-compliance|1|||
23590199|NCT00855465|65889601|FG001|Treatment Period|Non-compliance|0|||
23590200|NCT00855465|65889600|FG000|Treatment Period|Protocol Violation|2|||
23590201|NCT00855465|65889601|FG001|Treatment Period|Protocol Violation|0|||
23590202|NCT00855465|65889600|FG000|Treatment Period|Withdrawal by Subject|2|||
23590203|NCT00855465|65889601|FG001|Treatment Period|Withdrawal by Subject|0|||
23590204|NCT00855465|65889600|FG000|Treatment Period|Not treated|1|||
23590205|NCT00855465|65889601|FG001|Treatment Period|Not treated|0|||
23590206|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Adverse Event|0|||
23359377|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
23359378|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
23359379|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
23590207|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Adverse Event|1|||
23590208|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Death|0|||
23590209|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Death|1|||
23590210|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
23590211|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
23590212|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
23590213|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
23590214|NCT00855465|65889600|FG000|Follow-up Period (FUP)|Missing|1|||
23590215|NCT00855465|65889601|FG001|Follow-up Period (FUP)|Missing|0|||
23590216|NCT02031471|65889602|FG000|24 Week Treatment Period|Adverse Event|6|||
23590217|NCT02031471|65889602|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
23590218|NCT02031471|65889602|FG000|24 Week Treatment Period|Protocol Violation|1|||
23590219|NCT02031471|65889602|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
23590220|NCT02031471|65889602|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
23590221|NCT02031471|65889602|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
23359380|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
23590222|NCT02031471|65889602|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
23590223|NCT01091454|65889605|FG000|Overall Study|Ineligible|1|||
23590224|NCT01510912|65889606|FG000|Overall Study|Adverse Event|99|||
23590225|NCT01510912|65889606|FG000|Overall Study|Lack of Efficacy|12|||
23590226|NCT01510912|65889606|FG000|Overall Study|Non-compliance with trial drug|23|||
23590227|NCT01510912|65889606|FG000|Overall Study|Withdrawal by Subject|49|||
23590228|NCT01510912|65889606|FG000|Overall Study|Physician Decision|1|||
23590229|NCT01510912|65889606|FG000|Overall Study|Protocol Violation|27|||
23590230|NCT01510912|65889606|FG000|Overall Study|Lost to Follow-up|26|||
23590231|NCT01510912|65889606|FG000|Overall Study|Other, including joint replacement|5|||
23590232|NCT01585558|65889614|FG000|Overall Study|Withdrawal by Subject|4|||
23590233|NCT01585558|65889615|FG001|Overall Study|Withdrawal by Subject|5|||
23590234|NCT01585558|65889616|FG002|Overall Study|Withdrawal by Subject|8|||
23359381|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
23359382|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
23359383|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
23359384|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
23359385|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
23359386|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
23359387|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
23359388|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
23359389|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
23359390|NCT01042392|65060068|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
23359391|NCT01042392|65060069|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
23359392|NCT01042392|65060070|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
23359393|NCT01042392|65060071|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
23359394|NCT01042392|65060068|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
23359395|NCT01042392|65060069|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
23359396|NCT01042392|65060070|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
23359397|NCT01042392|65060071|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
23359398|NCT01042392|65060068|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
23359399|NCT01042392|65060069|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
23359400|NCT01042392|65060070|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
23359401|NCT01042392|65060071|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
23359402|NCT01042392|65060068|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
23359403|NCT01042392|65060069|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
23359404|NCT01042392|65060070|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
23359405|NCT01042392|65060071|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
23359406|NCT01042392|65060068|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
23359407|NCT01042392|65060069|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
23359408|NCT01042392|65060070|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
23359409|NCT01042392|65060071|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
23359410|NCT01639703|65060077|FG000|Overall Study|Withdrawal by Subject|5|||
23359411|NCT01639703|65060077|FG000|Overall Study|Other reason|7|||
23359412|NCT02081001|65060078|FG000|Overall Study|Adverse Event|0|||
23359413|NCT02081001|65060079|FG001|Overall Study|Adverse Event|0|||
23359414|NCT02081001|65060080|FG002|Overall Study|Adverse Event|0|||
23359415|NCT02081001|65060081|FG003|Overall Study|Adverse Event|0|||
23359416|NCT02081001|65060082|FG004|Overall Study|Adverse Event|1|||
23359417|NCT02081001|65060083|FG005|Overall Study|Adverse Event|0|||
23359418|NCT02081001|65060084|FG006|Overall Study|Adverse Event|0|||
23359419|NCT02081001|65060085|FG007|Overall Study|Adverse Event|0|||
23359420|NCT02081001|65060086|FG008|Overall Study|Adverse Event|0|||
23359421|NCT02081001|65060087|FG009|Overall Study|Adverse Event|0|||
23359422|NCT02081001|65060088|FG010|Overall Study|Adverse Event|0|||
23359423|NCT02081001|65060089|FG011|Overall Study|Adverse Event|0|||
23359424|NCT01093586|65060090|FG000|Overall Study|Failed to engraft|3|||
23359425|NCT02732015|65060091|FG000|Overall Study|Lost to Follow-up|0|||
23359426|NCT02732015|65060092|FG001|Overall Study|Lost to Follow-up|1|||
23359427|NCT04501952|65060097|FG000|Overall Study|Adverse Event|0|||
23359428|NCT04501952|65060098|FG001|Overall Study|Adverse Event|3|||
23359429|NCT04501952|65060097|FG000|Overall Study|Investigator's Discretion|0|||
23359430|NCT04501952|65060098|FG001|Overall Study|Investigator's Discretion|1|||
23359431|NCT04501952|65060097|FG000|Overall Study|Protocol Violation|1|||
23359432|NCT04501952|65060098|FG001|Overall Study|Protocol Violation|1|||
23359433|NCT04501952|65060097|FG000|Overall Study|Withdrew Consent|5|||
23359434|NCT04501952|65060098|FG001|Overall Study|Withdrew Consent|4|||
23359435|NCT04501952|65060097|FG000|Overall Study|Lost to Follow-up|7|||
23359436|NCT04501952|65060098|FG001|Overall Study|Lost to Follow-up|2|||
23359437|NCT04501952|65060097|FG000|Overall Study|Randomized and Never Treated|13|||
23590235|NCT01585558|65889614|FG000|Overall Study|Lost to Follow-up|2|||
23590236|NCT01585558|65889615|FG001|Overall Study|Lost to Follow-up|0|||
23590237|NCT01585558|65889616|FG002|Overall Study|Lost to Follow-up|3|||
23590238|NCT01585558|65889614|FG000|Overall Study|Adverse Event|3|||
23590239|NCT01585558|65889615|FG001|Overall Study|Adverse Event|4|||
23590240|NCT01585558|65889616|FG002|Overall Study|Adverse Event|1|||
23590241|NCT01585558|65889614|FG000|Overall Study|Protocol Violation|4|||
23590242|NCT01585558|65889615|FG001|Overall Study|Protocol Violation|3|||
23590243|NCT01585558|65889616|FG002|Overall Study|Protocol Violation|2|||
23590244|NCT01585558|65889614|FG000|Overall Study|Lack of Efficacy|0|||
23590245|NCT01585558|65889615|FG001|Overall Study|Lack of Efficacy|0|||
23590246|NCT01585558|65889616|FG002|Overall Study|Lack of Efficacy|1|||
23590247|NCT01212991|65889618|FG000|Double-blind|Lost to Follow-up|8|||
23590248|NCT01212991|65889619|FG001|Double-blind|Lost to Follow-up|4|||
23590249|NCT01212991|65889620|FG002|Double-blind|Lost to Follow-up|0|||
23590250|NCT01212991|65889618|FG000|Double-blind|Death|699|||
23590251|NCT01212991|65889619|FG001|Double-blind|Death|550|||
23590252|NCT01212991|65889620|FG002|Double-blind|Death|0|||
23590253|NCT01212991|65889618|FG000|Double-blind|Withdrawal by Subject|16|||
23590254|NCT01212991|65889619|FG001|Double-blind|Withdrawal by Subject|19|||
23590255|NCT01212991|65889620|FG002|Double-blind|Withdrawal by Subject|0|||
23590256|NCT01212991|65889618|FG000|Double-blind|Other|7|||
23590257|NCT01212991|65889619|FG001|Double-blind|Other|0|||
23590258|NCT01212991|65889620|FG002|Double-blind|Other|0|||
23590259|NCT01212991|65889618|FG000|Double-blind|Sponsor decision|142|||
23590260|NCT01212991|65889619|FG001|Double-blind|Sponsor decision|38|||
23590261|NCT01212991|65889620|FG002|Double-blind|Sponsor decision|0|||
23590262|NCT01212991|65889618|FG000|Open-label|Death|0|||
23590263|NCT01212991|65889619|FG001|Open-label|Death|0|||
23590264|NCT01212991|65889620|FG002|Open-label|Death|166|||
23590265|NCT01212991|65889618|FG000|Open-label|Lost to Follow-up|0|||
23590266|NCT01212991|65889619|FG001|Open-label|Lost to Follow-up|0|||
23590267|NCT01212991|65889620|FG002|Open-label|Lost to Follow-up|5|||
23590268|NCT01212991|65889618|FG000|Open-label|Withdrawal by Subject|0|||
23590269|NCT01212991|65889619|FG001|Open-label|Withdrawal by Subject|0|||
23590270|NCT01212991|65889620|FG002|Open-label|Withdrawal by Subject|7|||
23590271|NCT01212991|65889618|FG000|Open-label|Sponsor decision|0|||
23590272|NCT01212991|65889619|FG001|Open-label|Sponsor decision|0|||
23590273|NCT01212991|65889620|FG002|Open-label|Sponsor decision|53|||
23590274|NCT01212991|65889618|FG000|Open-label|Other|0|||
23590275|NCT01212991|65889619|FG001|Open-label|Other|0|||
23590276|NCT01212991|65889620|FG002|Open-label|Other|3|||
23590277|NCT02698241|65889624|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
23590278|NCT02698241|65889624|FG000|Overall Study|Screening not met|7|||
23590279|NCT02698241|65889624|FG000|Overall Study|Withdrawal by Subject|7|||
23590280|NCT02698241|65889624|FG000|Overall Study|Physician Decision|2|||
23590281|NCT02698241|65889624|FG000|Overall Study|Subject underwent system modification|2|||
23590282|NCT02698241|65889624|FG000|Overall Study|Lost to Follow-up|3|||
23590283|NCT02698241|65889624|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
23590284|NCT02698241|65889624|FG000|Overall Study|geographic and licensing issue|1|||
23590285|NCT02698241|65889624|FG000|Overall Study|Death|2|||
23590286|NCT00468910|65889626|FG000|Overall Study|Lost to Follow-up|2|||
23590287|NCT00468910|65889627|FG001|Overall Study|Lost to Follow-up|1|||
23590288|NCT00468910|65889626|FG000|Overall Study|Withdrawal by Subject|2|||
23590289|NCT00468910|65889627|FG001|Overall Study|Withdrawal by Subject|1|||
23590290|NCT00468910|65889626|FG000|Overall Study|Medical Contraindication|0|||
23590291|NCT00468910|65889627|FG001|Overall Study|Medical Contraindication|1|||
23590292|NCT02507752|65889630|FG000|Overall Study|Adverse Event|1|||
23590293|NCT02507752|65889630|FG000|Overall Study|Protocol Violation|6|||
23590294|NCT02507752|65889630|FG000|Overall Study|Lost to Follow-up|7|||
23590295|NCT02507752|65889630|FG000|Overall Study|Infusion reaction at first infusion|1|||
23590296|NCT02507752|65889630|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
23590297|NCT02507752|65889630|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
23590298|NCT00293293|65889631|FG000|Overall Study|Withdrawal by Subject|1|||
23590299|NCT00293293|65889632|FG001|Overall Study|Withdrawal by Subject|1|||
23590300|NCT00293293|65889631|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
23590301|NCT00293293|65889632|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
23590302|NCT00293293|65889631|FG000|Overall Study|Patient discontinued chemotherapy|0|||
23590303|NCT00293293|65889632|FG001|Overall Study|Patient discontinued chemotherapy|1|||
23590304|NCT00726999|65889636|FG000|Overall Study|Physician Decision|0|||
23590305|NCT00726999|65889637|FG001|Overall Study|Physician Decision|1|||
23590306|NCT00726999|65889636|FG000|Overall Study|Withdrawal by Subject|2|||
23590307|NCT00726999|65889637|FG001|Overall Study|Withdrawal by Subject|0|||
23590308|NCT00726999|65889636|FG000|Overall Study|Protocol Violation|1|||
23590309|NCT00726999|65889637|FG001|Overall Study|Protocol Violation|0|||
23590310|NCT01194154|65889643|FG000|Overall Study|Adverse Event|12|||
23590311|NCT01194154|65889644|FG001|Overall Study|Adverse Event|7|||
23590312|NCT01194154|65889643|FG000|Overall Study|Lost to Follow-up|2|||
23590313|NCT01194154|65889644|FG001|Overall Study|Lost to Follow-up|3|||
23590314|NCT01194154|65889643|FG000|Overall Study|Protocol Violation|0|||
23590315|NCT01194154|65889644|FG001|Overall Study|Protocol Violation|1|||
23590316|NCT01194154|65889643|FG000|Overall Study|Withdrawal by Subject|5|||
23590317|NCT01194154|65889644|FG001|Overall Study|Withdrawal by Subject|6|||
23590318|NCT01194154|65889643|FG000|Overall Study|Blood pressure increase|5|||
23590319|NCT01194154|65889644|FG001|Overall Study|Blood pressure increase|3|||
23590320|NCT01194154|65889643|FG000|Overall Study|Hemoglobin decrease|0|||
23590321|NCT01194154|65889644|FG001|Overall Study|Hemoglobin decrease|1|||
23590322|NCT01194154|65889643|FG000|Overall Study|Hemoglobin increase|12|||
23590323|NCT01194154|65889644|FG001|Overall Study|Hemoglobin increase|3|||
23590324|NCT01194154|65889643|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
23590325|NCT01194154|65889644|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
23590326|NCT01194154|65889643|FG000|Overall Study|Treatment with prohibited medication|4|||
23590327|NCT01194154|65889644|FG001|Overall Study|Treatment with prohibited medication|5|||
23590328|NCT01194154|65889643|FG000|Overall Study|Other|4|||
23590329|NCT01194154|65889644|FG001|Overall Study|Other|0|||
23590330|NCT01194154|65889643|FG000|Overall Study|Did not receive study medication|2|||
23590331|NCT01194154|65889644|FG001|Overall Study|Did not receive study medication|4|||
23590332|NCT01943799|65889647|FG000|Overall Study|Lost to Follow-up|0|||
23590333|NCT01943799|65889648|FG001|Overall Study|Lost to Follow-up|1|||
23590334|NCT01943799|65889649|FG002|Overall Study|Lost to Follow-up|1|||
23590335|NCT01943799|65889650|FG003|Overall Study|Lost to Follow-up|0|||
23590336|NCT01943799|65889647|FG000|Overall Study|Protocol Violation|1|||
23590337|NCT01943799|65889648|FG001|Overall Study|Protocol Violation|0|||
23590338|NCT01943799|65889649|FG002|Overall Study|Protocol Violation|0|||
23590339|NCT01943799|65889650|FG003|Overall Study|Protocol Violation|0|||
23590340|NCT01943799|65889647|FG000|Overall Study|Withdrawal by Subject|4|||
23590341|NCT01943799|65889648|FG001|Overall Study|Withdrawal by Subject|2|||
23590342|NCT01943799|65889649|FG002|Overall Study|Withdrawal by Subject|1|||
23590343|NCT01943799|65889650|FG003|Overall Study|Withdrawal by Subject|0|||
23590344|NCT00346151|65889653|FG000|Overall Study|Withdrawal by Subject|3|||
23590345|NCT05308004|65889654|FG000|Overall Study|Not seen by Palliative Care NP|0|||
23590346|NCT05308004|65889655|FG001|Overall Study|Not seen by Palliative Care NP|1|||
23590347|NCT02524288|65889660|FG000|Overall Study|Adverse Event|115|||
23590348|NCT02524288|65889660|FG000|Overall Study|Lost to Follow-up|216|||
23590349|NCT02524288|65889660|FG000|Overall Study|Non-Compliance With Protocol|32|||
23590350|NCT02524288|65889660|FG000|Overall Study|Non-Compliance With Study Drug|14|||
23590351|NCT02524288|65889660|FG000|Overall Study|Pregnancy Wish|6|||
23590352|NCT02524288|65889660|FG000|Overall Study|Protocol Violation|6|||
23590353|NCT02524288|65889660|FG000|Overall Study|Screen Failure|2|||
23590354|NCT02524288|65889660|FG000|Overall Study|Site Discontinued Study Participation|1|||
23590355|NCT02524288|65889660|FG000|Overall Study|Study Terminated By Sponsor|1417|||
23590356|NCT02524288|65889660|FG000|Overall Study|Subject Moved|32|||
23590357|NCT02524288|65889660|FG000|Overall Study|Withdrawal by Subject|76|||
23590358|NCT02524288|65889660|FG000|Overall Study|Pregnancy|22|||
23590359|NCT02524288|65889660|FG000|Overall Study|Physician Decision|2|||
23590360|NCT02888080|65889666|FG000|Overall Study|Subject / Guardian decision|1|||
23590361|NCT02888080|65889667|FG001|Overall Study|Subject / Guardian decision|3|||
23590362|NCT02888080|65889666|FG000|Overall Study|New Therapy for study indication|1|||
23590363|NCT02888080|65889667|FG001|Overall Study|New Therapy for study indication|0|||
23590364|NCT02888080|65889666|FG000|Overall Study|Lack of Efficacy|0|||
23476140|NCT01087788|65488002|FG001|24-weeks Dose-blind Period|Patient moved|0|||
23590365|NCT02888080|65889667|FG001|Overall Study|Lack of Efficacy|1|||
23590366|NCT02888080|65889666|FG000|Overall Study|Adverse Event|0|||
23590367|NCT02888080|65889667|FG001|Overall Study|Adverse Event|1|||
23192033|NCT03598777|64445787|FG004|Overall Study|Study Terminated by Sponsor|15|||
23590368|NCT00794118|65889668|FG000|Overall Study|Lost to Follow-up|16|||
23590369|NCT00794118|65889668|FG000|Overall Study|Withdrawal by Subject|9|||
23590370|NCT00794118|65889668|FG000|Overall Study|Changed hospital center|2|||
23590371|NCT03804918|65889669|FG000|Overall Study|Participant did not use the app|1|||
23590372|NCT02441036|65889672|FG000|Overall Study|No tissue resected|0|||
23590373|NCT02441036|65889673|FG001|Overall Study|No tissue resected|1|||
23590374|NCT02441036|65889674|FG002|Overall Study|No tissue resected|0|||
23590375|NCT02441036|65889675|FG003|Overall Study|No tissue resected|1|||
23590376|NCT02441036|65889676|FG004|Overall Study|No tissue resected|0|||
23590377|NCT00414648|65889677|FG000|Overall Study|Adverse Event|5|||
23590378|NCT00414648|65889678|FG001|Overall Study|Adverse Event|5|||
23590379|NCT00414648|65889677|FG000|Overall Study|Death|0|||
23590380|NCT00414648|65889678|FG001|Overall Study|Death|1|||
23590381|NCT00414648|65889677|FG000|Overall Study|Lack of Efficacy|0|||
23590382|NCT00414648|65889678|FG001|Overall Study|Lack of Efficacy|2|||
23590383|NCT00414648|65889677|FG000|Overall Study|Withdrawal by Subject|0|||
23590384|NCT00414648|65889678|FG001|Overall Study|Withdrawal by Subject|1|||
23590385|NCT04353037|65889681|FG000|Overall Study|Lost to Follow-up|0|||
23590386|NCT04353037|65889682|FG001|Overall Study|Lost to Follow-up|1|||
23590387|NCT04353037|65889683|FG002|Overall Study|Lost to Follow-up|2|||
23192034|NCT03598777|64445783|FG000|Overall Study|Withdrawal by Subject|1|||
23192035|NCT03598777|64445784|FG001|Overall Study|Withdrawal by Subject|1|||
23192036|NCT03598777|64445785|FG002|Overall Study|Withdrawal by Subject|0|||
23192037|NCT03598777|64445786|FG003|Overall Study|Withdrawal by Subject|0|||
23590388|NCT04353037|65889684|FG003|Overall Study|Lost to Follow-up|3|||
23590389|NCT04353037|65889681|FG000|Overall Study|Withdrawal by Subject|0|||
23590390|NCT04353037|65889682|FG001|Overall Study|Withdrawal by Subject|2|||
23590391|NCT04353037|65889683|FG002|Overall Study|Withdrawal by Subject|3|||
23590392|NCT04353037|65889684|FG003|Overall Study|Withdrawal by Subject|5|||
23590393|NCT04353037|65889681|FG000|Overall Study|Adverse Event|0|||
23590394|NCT04353037|65889682|FG001|Overall Study|Adverse Event|0|||
23590395|NCT04353037|65889683|FG002|Overall Study|Adverse Event|2|||
23590396|NCT04353037|65889684|FG003|Overall Study|Adverse Event|0|||
23590397|NCT04353037|65889681|FG000|Overall Study|Exposure Change|0|||
23590398|NCT04353037|65889682|FG001|Overall Study|Exposure Change|0|||
23590399|NCT04353037|65889683|FG002|Overall Study|Exposure Change|0|||
23590400|NCT04353037|65889684|FG003|Overall Study|Exposure Change|2|||
23590401|NCT05190419|65889685|FG000|Overall Study|Lack of Efficacy|8|||
23590402|NCT05190419|65889686|FG001|Overall Study|Lack of Efficacy|0|||
23590403|NCT05190419|65889687|FG002|Overall Study|Lack of Efficacy|1|||
23590404|NCT05190419|65889688|FG003|Overall Study|Lack of Efficacy|0|||
23590405|NCT05190419|65889685|FG000|Overall Study|Withdrawal by Subject|7|||
23590406|NCT05190419|65889686|FG001|Overall Study|Withdrawal by Subject|1|||
23590407|NCT05190419|65889687|FG002|Overall Study|Withdrawal by Subject|2|||
23590408|NCT05190419|65889688|FG003|Overall Study|Withdrawal by Subject|2|||
23590409|NCT05190419|65889685|FG000|Overall Study|Adverse Event|2|||
23590410|NCT05190419|65889686|FG001|Overall Study|Adverse Event|10|||
23590411|NCT05190419|65889687|FG002|Overall Study|Adverse Event|11|||
23590412|NCT05190419|65889688|FG003|Overall Study|Adverse Event|21|||
23590413|NCT05190419|65889685|FG000|Overall Study|Lost to Follow-up|1|||
23590414|NCT05190419|65889686|FG001|Overall Study|Lost to Follow-up|2|||
23590415|NCT05190419|65889687|FG002|Overall Study|Lost to Follow-up|3|||
23590416|NCT05190419|65889688|FG003|Overall Study|Lost to Follow-up|1|||
23590417|NCT05190419|65889685|FG000|Overall Study|Other|1|||
23590418|NCT05190419|65889686|FG001|Overall Study|Other|1|||
23590419|NCT05190419|65889687|FG002|Overall Study|Other|0|||
23590420|NCT05190419|65889688|FG003|Overall Study|Other|3|||
23590421|NCT02041104|65889689|FG000|Overall Study|Lost to Follow-up|1|||
23590422|NCT02041104|65889690|FG001|Overall Study|Lost to Follow-up|4|||
23590423|NCT02041104|65889689|FG000|Overall Study|discomfort during OGTT|0|||
23590424|NCT02041104|65889690|FG001|Overall Study|discomfort during OGTT|3|||
23590425|NCT02969863|65889691|FG000|Overall Study|Physician Decision|1|||
23590426|NCT02969863|65889692|FG001|Overall Study|Physician Decision|0|||
23590427|NCT02969863|65889693|FG002|Overall Study|Physician Decision|0|||
23590428|NCT02969863|65889694|FG003|Overall Study|Physician Decision|0|||
23590429|NCT02969863|65889695|FG004|Overall Study|Physician Decision|0|||
23590430|NCT02969863|65889696|FG005|Overall Study|Physician Decision|0|||
23590431|NCT01281813|65889697|FG000|Overall Study|Adverse Event|0|||
23192038|NCT03598777|64445787|FG004|Overall Study|Withdrawal by Subject|0|||
23590432|NCT01281813|65889698|FG001|Overall Study|Adverse Event|0|||
23590433|NCT01281813|65889699|FG002|Overall Study|Adverse Event|10|||
23590434|NCT01281813|65889697|FG000|Overall Study|Lost to Follow-up|0|||
23590435|NCT01281813|65889698|FG001|Overall Study|Lost to Follow-up|0|||
23590436|NCT01281813|65889699|FG002|Overall Study|Lost to Follow-up|31|||
23590437|NCT01281813|65889697|FG000|Overall Study|Withdrawal by Subject|0|||
23192039|NCT03598777|64445783|FG000|Overall Study|Adverse Event|1|||
23192040|NCT03598777|64445784|FG001|Overall Study|Adverse Event|0|||
23590438|NCT01281813|65889698|FG001|Overall Study|Withdrawal by Subject|0|||
23590439|NCT01281813|65889699|FG002|Overall Study|Withdrawal by Subject|13|||
23590440|NCT01281813|65889697|FG000|Overall Study|Subject Non-Compliant|0|||
23192041|NCT03598777|64445785|FG002|Overall Study|Adverse Event|0|||
23590441|NCT01281813|65889698|FG001|Overall Study|Subject Non-Compliant|0|||
23590442|NCT01281813|65889699|FG002|Overall Study|Subject Non-Compliant|6|||
23192042|NCT03598777|64445786|FG003|Overall Study|Adverse Event|0|||
23590443|NCT01281813|65889697|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
23590444|NCT01281813|65889698|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
23590445|NCT01281813|65889699|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
23590446|NCT01281813|65889697|FG000|Overall Study|Sponsor's Decision|4|||
23590447|NCT01281813|65889698|FG001|Overall Study|Sponsor's Decision|3|||
23590448|NCT01281813|65889699|FG002|Overall Study|Sponsor's Decision|7|||
23590449|NCT01281813|65889697|FG000|Overall Study|Switched to Commercially Available Medication|0|||
23590450|NCT01281813|65889698|FG001|Overall Study|Switched to Commercially Available Medication|0|||
23359438|NCT04501952|65060098|FG001|Overall Study|Randomized and Never Treated|9|||
23359439|NCT02309723|65060099|FG000|Overall Study|Withdrawal by Subject|24|||
23359440|NCT02309723|65060100|FG001|Overall Study|Withdrawal by Subject|23|||
23359441|NCT02309723|65060101|FG002|Overall Study|Withdrawal by Subject|24|||
23359442|NCT02716584|65060102|FG000|Overall Study|Lost to Follow-up|8|||
23359443|NCT02716584|65060103|FG001|Overall Study|Lost to Follow-up|5|||
23359444|NCT03117361|65060108|FG000|Overall Study|Progressive disease|5|||
23359445|NCT03117361|65060108|FG000|Overall Study|Death|1|||
23359446|NCT03117361|65060108|FG000|Overall Study|Physician Decision|2|||
23359447|NCT03117361|65060108|FG000|Overall Study|On study treatment at the end of study|1|||
23590451|NCT01281813|65889699|FG002|Overall Study|Switched to Commercially Available Medication|26|||
23590452|NCT01281813|65889697|FG000|Overall Study|Other|0|||
23253220|NCT03611751|64667958|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
23253221|NCT03611751|64667959|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
23253222|NCT03611751|64667957|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
23253223|NCT03611751|64667958|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
23253224|NCT03611751|64667959|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
23253225|NCT03611751|64667957|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
23253226|NCT03611751|64667958|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
23253227|NCT03611751|64667959|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
23253228|NCT03611751|64667957|FG000|Treatment Week 0 - Week 16|Death|0|||
23253229|NCT03611751|64667958|FG001|Treatment Week 0 - Week 16|Death|0|||
23253230|NCT03611751|64667959|FG002|Treatment Week 0 - Week 16|Death|1|||
23359448|NCT03117361|65060108|FG000|Overall Study|Treatment-related adverse event|1|||
23359449|NCT03334422|65060111|FG000|Overall Study|Adverse Event|1|||
23359450|NCT03334422|65060112|FG001|Overall Study|Adverse Event|3|||
23192043|NCT03598777|64445787|FG004|Overall Study|Adverse Event|0|||
23192044|NCT03598777|64445783|FG000|Overall Study|Lost to Follow-up|1|||
23192045|NCT03598777|64445784|FG001|Overall Study|Lost to Follow-up|0|||
23192046|NCT03598777|64445785|FG002|Overall Study|Lost to Follow-up|0|||
23359451|NCT03334422|65060113|FG002|Overall Study|Adverse Event|2|||
23590453|NCT01281813|65889698|FG001|Overall Study|Other|1|||
23192047|NCT03598777|64445786|FG003|Overall Study|Lost to Follow-up|0|||
23192048|NCT03598777|64445787|FG004|Overall Study|Lost to Follow-up|0|||
23253231|NCT03611751|64667957|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
23253232|NCT03611751|64667958|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
23253233|NCT03611751|64667959|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
23359452|NCT03334422|65060114|FG003|Overall Study|Adverse Event|2|||
23359453|NCT03334422|65060111|FG000|Overall Study|Lack of Efficacy|10|||
23359454|NCT03334422|65060112|FG001|Overall Study|Lack of Efficacy|2|||
23359455|NCT03334422|65060113|FG002|Overall Study|Lack of Efficacy|7|||
23359456|NCT03334422|65060114|FG003|Overall Study|Lack of Efficacy|3|||
23359457|NCT03334422|65060111|FG000|Overall Study|Withdrawal by Subject|8|||
23359458|NCT03334422|65060112|FG001|Overall Study|Withdrawal by Subject|3|||
23359459|NCT03334422|65060113|FG002|Overall Study|Withdrawal by Subject|1|||
23359460|NCT03334422|65060114|FG003|Overall Study|Withdrawal by Subject|0|||
23359461|NCT03334422|65060111|FG000|Overall Study|Lost to Follow-up|0|||
23359462|NCT03334422|65060112|FG001|Overall Study|Lost to Follow-up|0|||
23359463|NCT03334422|65060113|FG002|Overall Study|Lost to Follow-up|0|||
23359464|NCT03334422|65060114|FG003|Overall Study|Lost to Follow-up|1|||
23359465|NCT03334422|65060111|FG000|Overall Study|Inability to obtain laboratory samples|0|||
23359466|NCT03334422|65060112|FG001|Overall Study|Inability to obtain laboratory samples|1|||
23359467|NCT03334422|65060113|FG002|Overall Study|Inability to obtain laboratory samples|0|||
23359468|NCT03334422|65060114|FG003|Overall Study|Inability to obtain laboratory samples|0|||
23359469|NCT03334422|65060111|FG000|Overall Study|Pregnancy|0|||
23359470|NCT03334422|65060112|FG001|Overall Study|Pregnancy|1|||
23359471|NCT03334422|65060113|FG002|Overall Study|Pregnancy|0|||
23359472|NCT03334422|65060114|FG003|Overall Study|Pregnancy|0|||
23359473|NCT03630705|65060115|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
23359474|NCT03630705|65060116|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
23359475|NCT03630705|65060117|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
23359476|NCT03630705|65060118|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23359477|NCT03630705|65060115|FG000|Overall Study|Lost to Follow-up|1|||
23359478|NCT03630705|65060116|FG001|Overall Study|Lost to Follow-up|2|||
23359479|NCT03630705|65060117|FG002|Overall Study|Lost to Follow-up|0|||
23359480|NCT03630705|65060118|FG003|Overall Study|Lost to Follow-up|0|||
23359481|NCT00186485|65060127|FG000|Overall Study|Lost to Follow-up|3|||
23359482|NCT00790556|65060128|FG000|Treatment Period 1|Physician Decision|1|||
23359483|NCT00790556|65060129|FG001|Treatment Period 1|Physician Decision|0|||
23359484|NCT00790556|65060128|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23359485|NCT00790556|65060129|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23359486|NCT02087670|65060130|FG000|Overall Study|Withdrawal by Subject|3|||
23359487|NCT02087670|65060131|FG001|Overall Study|Withdrawal by Subject|2|||
23359488|NCT02308228|65060133|FG000|Overall Study|Adverse Event|3|||
23359489|NCT02308228|65060134|FG001|Overall Study|Adverse Event|4|||
23359490|NCT02308228|65060133|FG000|Overall Study|Withdrawal by Subject|5|||
23359491|NCT02308228|65060134|FG001|Overall Study|Withdrawal by Subject|3|||
23359492|NCT00460239|65060137|FG000|Overall Study|Physician Decision|0|||
23359493|NCT00460239|65060138|FG001|Overall Study|Physician Decision|1|||
23359494|NCT00460239|65060139|FG002|Overall Study|Physician Decision|0|||
23359495|NCT00460239|65060140|FG003|Overall Study|Physician Decision|0|||
23359496|NCT00460239|65060141|FG004|Overall Study|Physician Decision|0|||
23359497|NCT00460239|65060142|FG005|Overall Study|Physician Decision|2|||
23359498|NCT00460239|65060143|FG006|Overall Study|Physician Decision|0|||
23359499|NCT00460239|65060144|FG007|Overall Study|Physician Decision|0|||
23359500|NCT00460239|65060145|FG008|Overall Study|Physician Decision|0|||
23359501|NCT00460239|65060137|FG000|Overall Study|Withdrawal by Subject|0|||
23359502|NCT00460239|65060138|FG001|Overall Study|Withdrawal by Subject|0|||
23359503|NCT00460239|65060139|FG002|Overall Study|Withdrawal by Subject|0|||
23359504|NCT00460239|65060140|FG003|Overall Study|Withdrawal by Subject|0|||
23359505|NCT00460239|65060141|FG004|Overall Study|Withdrawal by Subject|0|||
23359506|NCT00460239|65060142|FG005|Overall Study|Withdrawal by Subject|1|||
23476141|NCT01087788|65488003|FG002|24-weeks Dose-blind Period|Patient moved|1|||
23476142|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
23476143|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
23476144|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
23476145|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
23476146|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
23590454|NCT01281813|65889699|FG002|Overall Study|Other|39|||
23590455|NCT00736853|65889700|FG000|Open-Label Period|Physician Decision|2|||
23359507|NCT00460239|65060143|FG006|Overall Study|Withdrawal by Subject|0|||
23359508|NCT00460239|65060144|FG007|Overall Study|Withdrawal by Subject|0|||
23359509|NCT00460239|65060145|FG008|Overall Study|Withdrawal by Subject|0|||
23359510|NCT02232061|65060147|FG000|Overall Study|Administrative problems|1|||
23359511|NCT02232061|65060147|FG000|Overall Study|Withdrawal by Subject|1|||
23359512|NCT01673984|65060148|FG000|Overall Study|Adverse Event|1|||
23476147|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
23359513|NCT01673984|65060149|FG001|Overall Study|Adverse Event|0|||
23359514|NCT01673984|65060148|FG000|Overall Study|Study termination|9|||
23359515|NCT01673984|65060149|FG001|Overall Study|Study termination|6|||
23253234|NCT03611751|64667957|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
23590456|NCT00736853|65889701|FG001|Open-Label Period|Physician Decision|0|||
23590457|NCT00736853|65889702|FG002|Open-Label Period|Physician Decision|0|||
23590458|NCT00736853|65889700|FG000|Open-Label Period|Adverse Event|31|||
23590459|NCT00736853|65889701|FG001|Open-Label Period|Adverse Event|0|||
23590460|NCT00736853|65889702|FG002|Open-Label Period|Adverse Event|0|||
23590461|NCT00736853|65889700|FG000|Open-Label Period|Withdrawal by Subject|16|||
23253235|NCT03611751|64667958|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
23253236|NCT03611751|64667959|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
23253237|NCT03611751|64667957|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
23253238|NCT03611751|64667958|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
23359516|NCT02497404|65060150|FG000|Overall Study|Adverse Event|1|||
23590462|NCT00736853|65889701|FG001|Open-Label Period|Withdrawal by Subject|0|||
23590463|NCT00736853|65889702|FG002|Open-Label Period|Withdrawal by Subject|0|||
23476148|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
23476149|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
23476150|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
23253239|NCT03611751|64667959|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
23253240|NCT03611751|64667957|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
23253241|NCT03611751|64667958|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
23253242|NCT03611751|64667959|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
23253243|NCT03611751|64667957|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
23253244|NCT03611751|64667958|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
23253245|NCT03611751|64667959|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
23253246|NCT03611751|64667957|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
23253247|NCT03611751|64667958|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
23253248|NCT03611751|64667959|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
23359517|NCT03178851|65060153|FG000|Overall Study|Death|48|||
23359518|NCT03178851|65060154|FG001|Overall Study|Death|2|||
23359519|NCT03178851|65060155|FG002|Overall Study|Death|25|||
23359520|NCT03178851|65060153|FG000|Overall Study|Withdrawal by Subject|8|||
23359521|NCT03178851|65060154|FG001|Overall Study|Withdrawal by Subject|0|||
23359522|NCT03178851|65060155|FG002|Overall Study|Withdrawal by Subject|0|||
23359523|NCT03178851|65060153|FG000|Overall Study|Lost to Follow-up|5|||
23359524|NCT03178851|65060154|FG001|Overall Study|Lost to Follow-up|2|||
23359525|NCT03178851|65060155|FG002|Overall Study|Lost to Follow-up|0|||
23359526|NCT03178851|65060153|FG000|Overall Study|Adverse Event|0|||
23359527|NCT03178851|65060154|FG001|Overall Study|Adverse Event|0|||
23359528|NCT03178851|65060155|FG002|Overall Study|Adverse Event|1|||
23359529|NCT03178851|65060153|FG000|Overall Study|Study Termination by Sponsor|31|||
23359530|NCT03178851|65060154|FG001|Overall Study|Study Termination by Sponsor|7|||
23359531|NCT03178851|65060155|FG002|Overall Study|Study Termination by Sponsor|26|||
23359532|NCT03959527|65060165|FG000|Overall Study|Withdrawal by Subject|8|||
23359533|NCT03959527|65060166|FG001|Overall Study|Withdrawal by Subject|3|||
23359534|NCT03959527|65060165|FG000|Overall Study|Lost to Follow-up|31|||
23359535|NCT03959527|65060166|FG001|Overall Study|Lost to Follow-up|15|||
23359536|NCT03959527|65060165|FG000|Overall Study|Did not meet eligibility criteria|1|||
23359537|NCT03959527|65060166|FG001|Overall Study|Did not meet eligibility criteria|1|||
23359538|NCT03959527|65060165|FG000|Overall Study|Protocol Violation|10|||
23359539|NCT03959527|65060166|FG001|Overall Study|Protocol Violation|5|||
23359540|NCT01409915|65060169|FG000|Overall Study|Adverse Event|0|||
23359541|NCT01409915|65060170|FG001|Overall Study|Adverse Event|2|||
23359542|NCT01409915|65060169|FG000|Overall Study|Withdrawal by Subject|0|||
23359543|NCT01409915|65060170|FG001|Overall Study|Withdrawal by Subject|1|||
23359544|NCT01409915|65060169|FG000|Overall Study|Protocol Violation|1|||
23359545|NCT01409915|65060170|FG001|Overall Study|Protocol Violation|0|||
23359546|NCT03091738|65060171|FG000|Overall Study|Adverse Event|1|||
23359547|NCT03091738|65060171|FG000|Overall Study|Lost to Follow-up|1|||
23359548|NCT01272908|65060174|FG000|Initial Treatment Period|Adverse Event|1|||
23359549|NCT01272908|65060174|FG000|Initial Treatment Period|Lack of Efficacy|5|||
23359550|NCT01272908|65060174|FG000|Initial Treatment Period|Protocol Violation|1|||
23359551|NCT01272908|65060174|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
23359552|NCT01272908|65060174|FG000|Re-Treatment Period|Adverse Event|2|||
23359553|NCT01272908|65060174|FG000|Re-Treatment Period|Lack of Efficacy|3|||
23359554|NCT01272908|65060174|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
23359555|NCT00158262|65060176|FG000|Overall Study|Lost to Follow-up|1|||
23359556|NCT00158262|65060177|FG001|Overall Study|Lost to Follow-up|1|||
23359557|NCT01421147|65060178|FG000|Treatment Period|Adverse Event|2|||
23359558|NCT01421147|65060179|FG001|Treatment Period|Adverse Event|3|||
23359559|NCT01421147|65060178|FG000|Treatment Period|Lost to Follow-up|2|||
23359560|NCT01421147|65060179|FG001|Treatment Period|Lost to Follow-up|1|||
23359561|NCT01421147|65060178|FG000|Treatment Period|Physician Decision|2|||
23359562|NCT01421147|65060179|FG001|Treatment Period|Physician Decision|2|||
23359563|NCT01421147|65060178|FG000|Treatment Period|Withdrawal by Subject|10|||
23253249|NCT03611751|64667957|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
23359564|NCT01421147|65060179|FG001|Treatment Period|Withdrawal by Subject|5|||
23359565|NCT01421147|65060178|FG000|Extension Period|Adverse Event|0|||
23359566|NCT01421147|65060179|FG001|Extension Period|Adverse Event|2|||
23359567|NCT01421147|65060178|FG000|Extension Period|Death|0|||
23359568|NCT01421147|65060179|FG001|Extension Period|Death|1|||
23192049|NCT00377299|64445788|FG000|Overall Study|Lost to Follow-up|14|||
23359569|NCT01421147|65060178|FG000|Extension Period|Lost to Follow-up|2|||
23359570|NCT01421147|65060179|FG001|Extension Period|Lost to Follow-up|5|||
23359571|NCT01421147|65060178|FG000|Extension Period|Physician Decision|1|||
23359572|NCT01421147|65060179|FG001|Extension Period|Physician Decision|0|||
23359573|NCT01421147|65060178|FG000|Extension Period|Withdrawal by Subject|5|||
23359574|NCT01421147|65060179|FG001|Extension Period|Withdrawal by Subject|3|||
23359575|NCT05359952|65060180|FG000|Overall Study|Lost to Follow-up|1|||
23359576|NCT05359952|65060181|FG001|Overall Study|Lost to Follow-up|0|||
23359577|NCT00991289|65060184|FG000|Overall Study|Adverse Event|1|||
23359578|NCT00991289|65060184|FG000|Overall Study|Physician Decision|2|||
23359579|NCT00991289|65060184|FG000|Overall Study|Withdrawal by Subject|3|||
23359580|NCT00991289|65060184|FG000|Overall Study|Lost to Follow-up|4|||
23359581|NCT00991289|65060184|FG000|Overall Study|Protocol Violation|2|||
23359582|NCT00547248|65060188|FG000|Overall Study|Protocol Violation|0|||
23359583|NCT00547248|65060189|FG001|Overall Study|Protocol Violation|0|||
23359584|NCT00547248|65060190|FG002|Overall Study|Protocol Violation|1|||
23359585|NCT00547248|65060191|FG003|Overall Study|Protocol Violation|1|||
23359586|NCT00547248|65060188|FG000|Overall Study|Migrated/moved from study area|0|||
23359587|NCT00547248|65060189|FG001|Overall Study|Migrated/moved from study area|0|||
23359588|NCT00547248|65060190|FG002|Overall Study|Migrated/moved from study area|2|||
23359589|NCT00547248|65060191|FG003|Overall Study|Migrated/moved from study area|0|||
23253250|NCT03611751|64667958|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
23253251|NCT03611751|64667959|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
23253252|NCT03611751|64667957|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
23253253|NCT03611751|64667958|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
23253254|NCT03611751|64667959|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
23253255|NCT03611751|64667957|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
23253256|NCT03611751|64667958|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
23253257|NCT03611751|64667959|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
23253258|NCT03611751|64667957|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
23253259|NCT03611751|64667958|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
23253260|NCT03611751|64667959|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
23253261|NCT03611751|64667957|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
23253262|NCT03611751|64667958|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
23253263|NCT03611751|64667959|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
23253264|NCT03611751|64667957|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
23253265|NCT03611751|64667958|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
23253266|NCT03611751|64667959|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
23253267|NCT03611751|64667957|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
23192050|NCT00377299|64445789|FG001|Overall Study|Lost to Follow-up|19|||
23192051|NCT00377299|64445788|FG000|Overall Study|Adverse Event|0|||
23192052|NCT00377299|64445789|FG001|Overall Study|Adverse Event|1|||
23192053|NCT00377299|64445788|FG000|Overall Study|Withdrawal by Subject|5|||
23192054|NCT00377299|64445789|FG001|Overall Study|Withdrawal by Subject|4|||
23192055|NCT04101422|64445790|FG000|Overall Study|Ineligible|1|||
23253268|NCT03611751|64667958|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
23253269|NCT03611751|64667959|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
23253270|NCT03611751|64667957|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
23253271|NCT03611751|64667958|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
23253272|NCT03611751|64667959|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
23359590|NCT00547248|65060188|FG000|Overall Study|Withdrawal by Subject|0|||
23359591|NCT00547248|65060189|FG001|Overall Study|Withdrawal by Subject|0|||
23359592|NCT00547248|65060190|FG002|Overall Study|Withdrawal by Subject|7|||
23359593|NCT00547248|65060191|FG003|Overall Study|Withdrawal by Subject|1|||
23253273|NCT01787188|64667960|FG000|Overall Study|Adverse Event|2|||
23253274|NCT01787188|64667961|FG001|Overall Study|Adverse Event|4|||
23253275|NCT01787188|64667962|FG002|Overall Study|Adverse Event|6|||
23253276|NCT01787188|64667960|FG000|Overall Study|Lack of Efficacy|7|||
23253277|NCT01787188|64667961|FG001|Overall Study|Lack of Efficacy|3|||
23253278|NCT01787188|64667962|FG002|Overall Study|Lack of Efficacy|5|||
23253279|NCT01787188|64667960|FG000|Overall Study|Non-compliance with Study Drug|0|||
23253280|NCT01787188|64667961|FG001|Overall Study|Non-compliance with Study Drug|1|||
23253281|NCT01787188|64667962|FG002|Overall Study|Non-compliance with Study Drug|0|||
23359594|NCT02600923|65060192|FG000|Overall Study|Death|10|||
23359595|NCT02600923|65060192|FG000|Overall Study|Adverse Event|3|||
23359596|NCT02600923|65060192|FG000|Overall Study|Global deterioration of health status|2|||
23359597|NCT02600923|65060192|FG000|Overall Study|Insufficient clinical response|6|||
23359598|NCT02600923|65060192|FG000|Overall Study|Lost to Follow-up|1|||
23359599|NCT02600923|65060192|FG000|Overall Study|Withdrawal by Subject|5|||
23359600|NCT02600923|65060192|FG000|Overall Study|Objective progression or relapse|50|||
23359601|NCT02600923|65060192|FG000|Overall Study|Study terminated by Sponsor|53|||
23359602|NCT02600923|65060192|FG000|Overall Study|Not treated|1|||
23359603|NCT01467271|65060193|FG000|Overall Study|Death|84|||
23359604|NCT01467271|65060193|FG000|Overall Study|Lost to Follow-up|83|||
23359605|NCT01467271|65060193|FG000|Overall Study|Retraction of patient's consent|21|||
23359606|NCT01467271|65060193|FG000|Overall Study|Other reason|14|||
23359607|NCT03360019|65060194|FG000|Overall Study|Withdrawal by Subject|2|||
23359608|NCT03360019|65060195|FG001|Overall Study|Withdrawal by Subject|0|||
23359609|NCT03360019|65060196|FG002|Overall Study|Withdrawal by Subject|0|||
23359610|NCT03360019|65060194|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
23359611|NCT03360019|65060195|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
23359612|NCT03360019|65060196|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
23359613|NCT00391872|65060197|FG000|Overall Study|Protocol Violation|7|||
23359614|NCT00391872|65060198|FG001|Overall Study|Protocol Violation|2|||
23359615|NCT00391872|65060197|FG000|Overall Study|Withdrawal by Subject|296|||
23359616|NCT00391872|65060198|FG001|Overall Study|Withdrawal by Subject|249|||
23359617|NCT00391872|65060197|FG000|Overall Study|Reason unknown|2|||
23359618|NCT00391872|65060198|FG001|Overall Study|Reason unknown|4|||
23359619|NCT00391872|65060197|FG000|Overall Study|Lost to Follow-up|2|||
23359620|NCT00391872|65060198|FG001|Overall Study|Lost to Follow-up|0|||
23359621|NCT01957579|65060201|FG000|Overall Study|Withdrawal of concent|0|||
23359622|NCT01957579|65060202|FG001|Overall Study|Withdrawal of concent|1|||
23359623|NCT01957579|65060203|FG002|Overall Study|Withdrawal of concent|0|||
23359624|NCT01957579|65060204|FG003|Overall Study|Withdrawal of concent|0|||
23359625|NCT01957579|65060201|FG000|Overall Study|Death|0|||
23359626|NCT01957579|65060202|FG001|Overall Study|Death|0|||
23359627|NCT01957579|65060203|FG002|Overall Study|Death|2|||
23359628|NCT01957579|65060204|FG003|Overall Study|Death|0|||
23359629|NCT01980628|65060205|FG000|Overall Study|Adverse Event|12|||
23359630|NCT01980628|65060205|FG000|Overall Study|Physician Decision|5|||
23359631|NCT01980628|65060205|FG000|Overall Study|Withdrawal by Subject|4|||
23359632|NCT01980628|65060205|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
23359633|NCT01408901|65060207|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
23359634|NCT01408901|65060208|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
23359635|NCT01408901|65060209|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
23359636|NCT01408901|65060210|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
23359637|NCT01408901|65060207|FG000|6-Week Follow-Up|Death|1|||
23359638|NCT01408901|65060208|FG001|6-Week Follow-Up|Death|0|||
23359639|NCT01408901|65060209|FG002|6-Week Follow-Up|Death|0|||
23359640|NCT01408901|65060210|FG003|6-Week Follow-Up|Death|0|||
23359641|NCT01408901|65060207|FG000|6-Week Follow-Up|Cancelled visit|0|||
23359642|NCT01408901|65060208|FG001|6-Week Follow-Up|Cancelled visit|1|||
23359643|NCT01408901|65060209|FG002|6-Week Follow-Up|Cancelled visit|0|||
23359644|NCT01408901|65060210|FG003|6-Week Follow-Up|Cancelled visit|2|||
23359645|NCT01408901|65060207|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
23359646|NCT01408901|65060208|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
23359647|NCT01408901|65060209|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
23359648|NCT01408901|65060210|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
23359649|NCT01408901|65060207|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
23476151|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
23253282|NCT01787188|64667960|FG000|Overall Study|Withdrawal by Subject|4|||
23253283|NCT01787188|64667961|FG001|Overall Study|Withdrawal by Subject|3|||
23253284|NCT01787188|64667962|FG002|Overall Study|Withdrawal by Subject|2|||
23359650|NCT01408901|65060208|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
23359651|NCT01408901|65060209|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
23359652|NCT01408901|65060210|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
23359653|NCT01408901|65060207|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
23359654|NCT01408901|65060208|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
23359655|NCT01408901|65060209|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
23476152|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
23359656|NCT01408901|65060210|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
23359657|NCT01408901|65060207|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
23359658|NCT01408901|65060208|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
23359659|NCT01408901|65060209|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
23359660|NCT01408901|65060210|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
23359661|NCT01408901|65060207|FG000|26-Week Follow-Up|Death|0|||
23359662|NCT01408901|65060208|FG001|26-Week Follow-Up|Death|1|||
23359663|NCT01408901|65060209|FG002|26-Week Follow-Up|Death|0|||
23359664|NCT01408901|65060210|FG003|26-Week Follow-Up|Death|0|||
23359665|NCT00320788|65060211|FG000|Overall Study|Adverse Event|0|||
23359666|NCT00320788|65060212|FG001|Overall Study|Adverse Event|0|||
23359667|NCT00320788|65060213|FG002|Overall Study|Adverse Event|0|||
23359668|NCT00320788|65060214|FG003|Overall Study|Adverse Event|1|||
23359669|NCT00320788|65060215|FG004|Overall Study|Adverse Event|0|||
23359670|NCT00320788|65060211|FG000|Overall Study|Death|0|||
23359671|NCT00320788|65060212|FG001|Overall Study|Death|0|||
23359672|NCT00320788|65060213|FG002|Overall Study|Death|1|||
23359673|NCT00320788|65060214|FG003|Overall Study|Death|0|||
23359674|NCT00320788|65060215|FG004|Overall Study|Death|1|||
23359675|NCT00320788|65060211|FG000|Overall Study|Lost to Follow-up|0|||
23359676|NCT00320788|65060212|FG001|Overall Study|Lost to Follow-up|2|||
23359677|NCT00320788|65060213|FG002|Overall Study|Lost to Follow-up|1|||
23359678|NCT00320788|65060214|FG003|Overall Study|Lost to Follow-up|0|||
23359679|NCT00320788|65060215|FG004|Overall Study|Lost to Follow-up|0|||
23359680|NCT00320788|65060211|FG000|Overall Study|Decision by the Sponsor|1|||
23359681|NCT00320788|65060212|FG001|Overall Study|Decision by the Sponsor|1|||
23359682|NCT00320788|65060213|FG002|Overall Study|Decision by the Sponsor|0|||
23359683|NCT00320788|65060214|FG003|Overall Study|Decision by the Sponsor|0|||
23359684|NCT00320788|65060215|FG004|Overall Study|Decision by the Sponsor|1|||
23359685|NCT00320788|65060211|FG000|Overall Study|Other|1|||
23359686|NCT00320788|65060212|FG001|Overall Study|Other|2|||
23359687|NCT00320788|65060213|FG002|Overall Study|Other|1|||
23359688|NCT00320788|65060214|FG003|Overall Study|Other|1|||
23359689|NCT00320788|65060215|FG004|Overall Study|Other|1|||
23359690|NCT00320788|65060211|FG000|Overall Study|Physician Decision|1|||
23359691|NCT00320788|65060212|FG001|Overall Study|Physician Decision|1|||
23359692|NCT00320788|65060213|FG002|Overall Study|Physician Decision|0|||
23359693|NCT00320788|65060214|FG003|Overall Study|Physician Decision|0|||
23359694|NCT00320788|65060215|FG004|Overall Study|Physician Decision|0|||
23359695|NCT00320788|65060211|FG000|Overall Study|Protocol Violation|0|||
23359696|NCT00320788|65060212|FG001|Overall Study|Protocol Violation|0|||
23359697|NCT00320788|65060213|FG002|Overall Study|Protocol Violation|0|||
23359698|NCT00320788|65060214|FG003|Overall Study|Protocol Violation|0|||
23253285|NCT01787188|64667960|FG000|Overall Study|Protocol Violation|3|||
23253286|NCT01787188|64667961|FG001|Overall Study|Protocol Violation|2|||
23359699|NCT00320788|65060215|FG004|Overall Study|Protocol Violation|1|||
23359700|NCT00320788|65060211|FG000|Overall Study|Withdrawal by Subject|3|||
23253287|NCT01787188|64667962|FG002|Overall Study|Protocol Violation|3|||
23253288|NCT01787188|64667960|FG000|Overall Study|Lost to Follow-up|1|||
23253289|NCT01787188|64667961|FG001|Overall Study|Lost to Follow-up|2|||
23253290|NCT01787188|64667962|FG002|Overall Study|Lost to Follow-up|2|||
23253291|NCT01787188|64667960|FG000|Overall Study|Other, including patient moved|0|||
23253292|NCT01787188|64667961|FG001|Overall Study|Other, including patient moved|3|||
23253293|NCT01787188|64667962|FG002|Overall Study|Other, including patient moved|0|||
23253294|NCT03263819|64667980|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
23253295|NCT03263819|64667981|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
23253296|NCT03001011|64667984|FG000|Overall Study|Adverse Event|9|||
23253297|NCT03001011|64667985|FG001|Overall Study|Adverse Event|3|||
23253298|NCT03001011|64667984|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
23253299|NCT03001011|64667985|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
23253300|NCT03001011|64667984|FG000|Overall Study|Other than specified above|3|||
23253301|NCT03001011|64667985|FG001|Overall Study|Other than specified above|8|||
23253302|NCT02746705|64667990|FG000|Overall Study|Physician Decision|1|||
23253303|NCT02746705|64667991|FG001|Overall Study|Physician Decision|1|||
23253304|NCT02746705|64667990|FG000|Overall Study|Lost to Follow-up|1|||
23359701|NCT00320788|65060212|FG001|Overall Study|Withdrawal by Subject|0|||
23359702|NCT00320788|65060213|FG002|Overall Study|Withdrawal by Subject|0|||
23359703|NCT00320788|65060214|FG003|Overall Study|Withdrawal by Subject|3|||
23359704|NCT00320788|65060215|FG004|Overall Study|Withdrawal by Subject|1|||
23253305|NCT02746705|64667991|FG001|Overall Study|Lost to Follow-up|0|||
23253306|NCT02746705|64667990|FG000|Overall Study|outlier scores deemed not valid|0|||
23253307|NCT02746705|64667991|FG001|Overall Study|outlier scores deemed not valid|1|||
23359705|NCT02903420|65060218|FG000|Overall Study|Death|3|||
23359706|NCT02216214|65060224|FG000|Overall Study|Randomized Never Received Study Drug|1|||
23359707|NCT02216214|65060225|FG001|Overall Study|Randomized Never Received Study Drug|0|||
23359708|NCT02216214|65060224|FG000|Overall Study|Adverse Event|10|||
23359709|NCT02216214|65060225|FG001|Overall Study|Adverse Event|8|||
23359710|NCT02216214|65060224|FG000|Overall Study|Lack of Efficacy|2|||
23359711|NCT02216214|65060225|FG001|Overall Study|Lack of Efficacy|2|||
23359712|NCT02216214|65060224|FG000|Overall Study|Lost to Follow-up|3|||
23359713|NCT02216214|65060225|FG001|Overall Study|Lost to Follow-up|2|||
23359714|NCT02216214|65060224|FG000|Overall Study|Protocol Violation|4|||
23359715|NCT02216214|65060225|FG001|Overall Study|Protocol Violation|2|||
23359716|NCT02216214|65060224|FG000|Overall Study|Withdrawal by Subject|22|||
23359717|NCT02216214|65060225|FG001|Overall Study|Withdrawal by Subject|20|||
23359718|NCT02216214|65060224|FG000|Overall Study|Study Terminated By Sponsor|0|||
23359719|NCT02216214|65060225|FG001|Overall Study|Study Terminated By Sponsor|1|||
23359720|NCT02216214|65060224|FG000|Overall Study|Miscellaneous|1|||
23359721|NCT02216214|65060225|FG001|Overall Study|Miscellaneous|1|||
23359722|NCT02499120|65060226|FG000|Overall Study|Death|52|||
23359723|NCT02499120|65060227|FG001|Overall Study|Death|43|||
23359724|NCT02499120|65060226|FG000|Overall Study|Lost to Follow-up|1|||
23359725|NCT02499120|65060227|FG001|Overall Study|Lost to Follow-up|2|||
23359726|NCT02499120|65060226|FG000|Overall Study|Participant refused further follow-up|1|||
23359727|NCT02499120|65060227|FG001|Overall Study|Participant refused further follow-up|0|||
23359728|NCT02499120|65060226|FG000|Overall Study|Withdrawal by Subject|2|||
23359729|NCT02499120|65060227|FG001|Overall Study|Withdrawal by Subject|5|||
23359730|NCT02499120|65060226|FG000|Overall Study|Other|9|||
23359731|NCT02499120|65060227|FG001|Overall Study|Other|10|||
23359732|NCT03315455|65060228|FG000|Overall Study|Ongoing in the Study|13|||
23359733|NCT03315455|65060229|FG001|Overall Study|Ongoing in the Study|24|||
23359734|NCT03315455|65060230|FG002|Overall Study|Ongoing in the Study|17|||
23359735|NCT03315455|65060231|FG003|Overall Study|Ongoing in the Study|15|||
23359736|NCT03315455|65060228|FG000|Overall Study|Withdrawal by Subject|0|||
23359737|NCT03315455|65060229|FG001|Overall Study|Withdrawal by Subject|1|||
23359738|NCT03315455|65060230|FG002|Overall Study|Withdrawal by Subject|0|||
23359739|NCT03315455|65060231|FG003|Overall Study|Withdrawal by Subject|0|||
23359740|NCT00524771|65062697|FG000|Overall Study|Protocol Violation|220|||
23359741|NCT00524771|65062698|FG001|Overall Study|Protocol Violation|585|||
23359742|NCT03126786|65062699|FG000|Overall Study|Adverse Event|3|||
23359743|NCT03126786|65062700|FG001|Overall Study|Adverse Event|0|||
23359744|NCT03126786|65062699|FG000|Overall Study|Lost to Follow-up|0|||
23359745|NCT03126786|65062700|FG001|Overall Study|Lost to Follow-up|1|||
23359746|NCT03126786|65062699|FG000|Overall Study|Withdrawal by Subject|3|||
23359747|NCT03126786|65062700|FG001|Overall Study|Withdrawal by Subject|1|||
23359748|NCT01223937|65062701|FG000|Overall Study|Withdrawal by Subject|3|||
23476153|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
23476154|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
23590464|NCT00736853|65889700|FG000|Open-Label Period|Started but not treated|42|||
23590465|NCT00736853|65889701|FG001|Open-Label Period|Started but not treated|0|||
23590466|NCT00736853|65889702|FG002|Open-Label Period|Started but not treated|0|||
23590467|NCT00736853|65889700|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
23359749|NCT01223937|65062702|FG001|Overall Study|Withdrawal by Subject|2|||
23590468|NCT00736853|65889701|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
23590469|NCT00736853|65889702|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
23590470|NCT00736853|65889700|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
23590471|NCT00736853|65889701|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
23590472|NCT00736853|65889702|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
23590473|NCT00736853|65889700|FG000|Double-Blind Period|Lack of Efficacy|0|||
23590474|NCT00736853|65889701|FG001|Double-Blind Period|Lack of Efficacy|19|||
23590475|NCT00736853|65889702|FG002|Double-Blind Period|Lack of Efficacy|42|||
23590476|NCT00736853|65889700|FG000|Double-Blind Period|Adverse Event|0|||
23590477|NCT00736853|65889701|FG001|Double-Blind Period|Adverse Event|3|||
23590478|NCT00736853|65889702|FG002|Double-Blind Period|Adverse Event|2|||
23590479|NCT00736853|65889700|FG000|Double-Blind Period|Withdrawal by Subject|0|||
23590480|NCT00736853|65889701|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23590481|NCT00736853|65889702|FG002|Double-Blind Period|Withdrawal by Subject|4|||
23590482|NCT00736853|65889700|FG000|Double-Blind Period|Ineligible to participate the study|0|||
23590483|NCT00736853|65889701|FG001|Double-Blind Period|Ineligible to participate the study|1|||
23590484|NCT00736853|65889702|FG002|Double-Blind Period|Ineligible to participate the study|0|||
23590485|NCT00463788|65889705|FG000|Overall Study|Progressive Disease|86|||
23590486|NCT00463788|65889706|FG001|Overall Study|Progressive Disease|42|||
23590487|NCT00463788|65889705|FG000|Overall Study|Adverse Event|6|||
23590488|NCT00463788|65889706|FG001|Overall Study|Adverse Event|2|||
23192056|NCT04101422|64445791|FG001|Overall Study|Ineligible|0|||
23192057|NCT04101422|64445792|FG002|Overall Study|Ineligible|9|||
23192058|NCT04101422|64445793|FG003|Overall Study|Ineligible|0|||
23192059|NCT04101422|64445790|FG000|Overall Study|Withdrawal by Subject|0|||
23192060|NCT04101422|64445791|FG001|Overall Study|Withdrawal by Subject|0|||
23192061|NCT04101422|64445792|FG002|Overall Study|Withdrawal by Subject|1|||
23192062|NCT04101422|64445793|FG003|Overall Study|Withdrawal by Subject|0|||
23192063|NCT04101422|64445790|FG000|Overall Study|Not attending to the stimuli|0|||
23192064|NCT04101422|64445791|FG001|Overall Study|Not attending to the stimuli|0|||
23192065|NCT04101422|64445792|FG002|Overall Study|Not attending to the stimuli|4|||
23192066|NCT04101422|64445793|FG003|Overall Study|Not attending to the stimuli|0|||
23192067|NCT04101422|64445790|FG000|Overall Study|Did not download app|0|||
23192068|NCT04101422|64445791|FG001|Overall Study|Did not download app|0|||
23192069|NCT04101422|64445792|FG002|Overall Study|Did not download app|0|||
23192070|NCT04101422|64445793|FG003|Overall Study|Did not download app|17|||
23192071|NCT04101422|64445790|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
23192072|NCT04101422|64445791|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
23192073|NCT04101422|64445792|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
23192074|NCT04101422|64445793|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
23192075|NCT04601272|64445794|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
23192076|NCT04601272|64445795|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
23192077|NCT04601272|64445796|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
23192078|NCT00922935|64445798|FG000|Overall Study|Protocol Violation|0|||
23192079|NCT00922935|64445799|FG001|Overall Study|Protocol Violation|3|||
23192080|NCT00922935|64445800|FG002|Overall Study|Protocol Violation|0|||
23192081|NCT00922935|64445798|FG000|Overall Study|Physician Decision|1|||
23192082|NCT00922935|64445799|FG001|Overall Study|Physician Decision|1|||
23192083|NCT00922935|64445800|FG002|Overall Study|Physician Decision|0|||
23192084|NCT00922935|64445798|FG000|Overall Study|Lost to Follow-up|0|||
23192085|NCT00922935|64445799|FG001|Overall Study|Lost to Follow-up|1|||
23192086|NCT00922935|64445800|FG002|Overall Study|Lost to Follow-up|0|||
23192087|NCT00231062|64445811|FG000|Overall Study|Physician Decision|6|||
23192088|NCT00857246|64445812|FG000|Induction Regimen|Adverse Event|1|||
23192089|NCT00857246|64445812|FG000|Induction Regimen|disease-related complications|1|||
23192090|NCT00857246|64445812|FG000|Induction Regimen|Withdrawal by Subject|1|||
23192091|NCT00857246|64445812|FG000|Surgery (Curative)|disease progression|6|||
23192092|NCT00857246|64445812|FG000|ChemoRT|Withdrawal by Subject|1|||
23192093|NCT00857246|64445812|FG000|ChemoRT|Adverse Event|2|||
23192094|NCT00404768|64445813|FG000|Part A and B|Withdrawn due to labor progression|1|||
23192095|NCT00404768|64445814|FG001|Part A and B|Withdrawn due to labor progression|0|||
23192096|NCT00404768|64445815|FG002|Part A and B|Withdrawn due to labor progression|0|||
23192097|NCT00404768|64445816|FG003|Part A and B|Withdrawn due to labor progression|0|||
23192098|NCT00404768|64445813|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
23192099|NCT00404768|64445814|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
23192100|NCT00404768|64445815|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
23192101|NCT00404768|64445816|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
23192102|NCT00404768|64445813|FG000|Part C|Adverse Event|0|||
23192103|NCT00404768|64445814|FG001|Part C|Adverse Event|0|||
23192104|NCT00404768|64445815|FG002|Part C|Adverse Event|0|||
23192105|NCT00404768|64445816|FG003|Part C|Adverse Event|3|||
23192106|NCT00404768|64445813|FG000|Part C|Lost to Follow-up|0|||
23192107|NCT00404768|64445814|FG001|Part C|Lost to Follow-up|0|||
23192108|NCT00404768|64445815|FG002|Part C|Lost to Follow-up|3|||
23192109|NCT00404768|64445816|FG003|Part C|Lost to Follow-up|1|||
23253308|NCT00597207|64667992|FG000|Overall Study|Lost to Follow-up|5|||
23253309|NCT00597207|64667993|FG001|Overall Study|Lost to Follow-up|7|||
23253310|NCT04444752|64667994|FG000|Overall Study|Adverse Event|1|||
23192110|NCT00404768|64445813|FG000|Part C|Withdrawal by Subject|0|||
23192111|NCT00404768|64445814|FG001|Part C|Withdrawal by Subject|0|||
23192112|NCT00404768|64445815|FG002|Part C|Withdrawal by Subject|2|||
23192113|NCT00404768|64445816|FG003|Part C|Withdrawal by Subject|1|||
23192114|NCT00404768|64445813|FG000|Part C|Early withdrawal from study medication|0|||
23192115|NCT00404768|64445814|FG001|Part C|Early withdrawal from study medication|0|||
23192116|NCT00404768|64445815|FG002|Part C|Early withdrawal from study medication|1|||
23192117|NCT00404768|64445816|FG003|Part C|Early withdrawal from study medication|0|||
23192118|NCT00404768|64445813|FG000|Part C|Participant did not respond to therapy|0|||
23192119|NCT00404768|64445814|FG001|Part C|Participant did not respond to therapy|0|||
23192120|NCT00404768|64445815|FG002|Part C|Participant did not respond to therapy|1|||
23192121|NCT00404768|64445816|FG003|Part C|Participant did not respond to therapy|1|||
23192122|NCT00404768|64445813|FG000|Part C|Physician withdrew the study medication|0|||
23192123|NCT00404768|64445814|FG001|Part C|Physician withdrew the study medication|0|||
23192124|NCT00404768|64445815|FG002|Part C|Physician withdrew the study medication|1|||
23192125|NCT00404768|64445816|FG003|Part C|Physician withdrew the study medication|0|||
23192126|NCT00404768|64445813|FG000|Part C|Participant delivered baby|0|||
23192127|NCT00404768|64445814|FG001|Part C|Participant delivered baby|0|||
23192128|NCT00404768|64445815|FG002|Part C|Participant delivered baby|0|||
23192129|NCT00404768|64445816|FG003|Part C|Participant delivered baby|1|||
23192130|NCT00404768|64445813|FG000|Part C|Unsatisfactory uterine response to IP|0|||
23192131|NCT00404768|64445814|FG001|Part C|Unsatisfactory uterine response to IP|0|||
23192132|NCT00404768|64445815|FG002|Part C|Unsatisfactory uterine response to IP|0|||
23253311|NCT04444752|64667995|FG001|Overall Study|Adverse Event|0|||
23253312|NCT04444752|64667996|FG002|Overall Study|Adverse Event|0|||
23253313|NCT04444752|64667997|FG003|Overall Study|Adverse Event|2|||
23253314|NCT04444752|64667994|FG000|Overall Study|Lost to Follow-up|2|||
23253315|NCT04444752|64667995|FG001|Overall Study|Lost to Follow-up|6|||
23253316|NCT04444752|64667996|FG002|Overall Study|Lost to Follow-up|2|||
23253317|NCT04444752|64667997|FG003|Overall Study|Lost to Follow-up|5|||
23253318|NCT04444752|64667994|FG000|Overall Study|Physician Decision|0|||
23253319|NCT04444752|64667995|FG001|Overall Study|Physician Decision|0|||
23253320|NCT04444752|64667996|FG002|Overall Study|Physician Decision|0|||
23253321|NCT04444752|64667997|FG003|Overall Study|Physician Decision|2|||
23253322|NCT04444752|64667994|FG000|Overall Study|Pregnancy|0|||
23253323|NCT04444752|64667995|FG001|Overall Study|Pregnancy|0|||
23253324|NCT04444752|64667996|FG002|Overall Study|Pregnancy|0|||
23253325|NCT04444752|64667997|FG003|Overall Study|Pregnancy|1|||
23253326|NCT04444752|64667994|FG000|Overall Study|Withdrawal by Subject|6|||
23253327|NCT04444752|64667995|FG001|Overall Study|Withdrawal by Subject|5|||
23253328|NCT04444752|64667996|FG002|Overall Study|Withdrawal by Subject|3|||
23253329|NCT04444752|64667997|FG003|Overall Study|Withdrawal by Subject|4|||
23253330|NCT04444752|64667994|FG000|Overall Study|Protocol Violation|1|||
23253331|NCT04444752|64667995|FG001|Overall Study|Protocol Violation|1|||
23253332|NCT04444752|64667996|FG002|Overall Study|Protocol Violation|0|||
23253333|NCT04444752|64667997|FG003|Overall Study|Protocol Violation|0|||
23253334|NCT04444752|64667994|FG000|Overall Study|Patient moving out of town|1|||
23253335|NCT04444752|64667995|FG001|Overall Study|Patient moving out of town|0|||
23253336|NCT04444752|64667996|FG002|Overall Study|Patient moving out of town|0|||
23253337|NCT04444752|64667997|FG003|Overall Study|Patient moving out of town|1|||
23253338|NCT04444752|64667994|FG000|Overall Study|Lack of Efficacy|0|||
23253339|NCT04444752|64667995|FG001|Overall Study|Lack of Efficacy|0|||
23253340|NCT04444752|64667996|FG002|Overall Study|Lack of Efficacy|0|||
23253341|NCT04444752|64667997|FG003|Overall Study|Lack of Efficacy|1|||
23253342|NCT04444752|64667994|FG000|Overall Study|Death|0|||
23253343|NCT04444752|64667995|FG001|Overall Study|Death|0|||
23253344|NCT04444752|64667996|FG002|Overall Study|Death|1|||
23253345|NCT04444752|64667997|FG003|Overall Study|Death|0|||
23192133|NCT00404768|64445816|FG003|Part C|Unsatisfactory uterine response to IP|1|||
23253346|NCT02444182|64668003|FG000|Overall Study|non-compliance|2|||
23192134|NCT00404768|64445813|FG000|Part C|Active labor|0|||
23192135|NCT00404768|64445814|FG001|Part C|Active labor|0|||
23192136|NCT00404768|64445815|FG002|Part C|Active labor|0|||
23253347|NCT02444182|64668004|FG001|Overall Study|non-compliance|1|||
23253348|NCT02444182|64668003|FG000|Overall Study|Lost to Follow-up|0|||
23253349|NCT02444182|64668004|FG001|Overall Study|Lost to Follow-up|4|||
23590489|NCT00463788|65889705|FG000|Overall Study|Withdrawal by Subject|6|||
23590490|NCT00463788|65889706|FG001|Overall Study|Withdrawal by Subject|2|||
23590491|NCT00463788|65889705|FG000|Overall Study|Death|4|||
23590492|NCT00463788|65889706|FG001|Overall Study|Death|3|||
23590493|NCT00463788|65889705|FG000|Overall Study|Symptomatic Deterioration|2|||
23590494|NCT00463788|65889706|FG001|Overall Study|Symptomatic Deterioration|3|||
23590495|NCT00463788|65889705|FG000|Overall Study|Lost to Follow-up|1|||
23590496|NCT00463788|65889706|FG001|Overall Study|Lost to Follow-up|0|||
23590497|NCT00463788|65889705|FG000|Overall Study|Protocol Violation|0|||
23590498|NCT00463788|65889706|FG001|Overall Study|Protocol Violation|1|||
23590499|NCT00463788|65889705|FG000|Overall Study|Other|3|||
23590500|NCT00463788|65889706|FG001|Overall Study|Other|0|||
23590501|NCT00463788|65889705|FG000|Overall Study|Randomized but not treated|1|||
23590502|NCT00463788|65889706|FG001|Overall Study|Randomized but not treated|1|||
23590503|NCT00943735|65889707|FG000|Overall Study|Adverse Event|12|||
23590504|NCT00943735|65889707|FG000|Overall Study|Withdrawal by Subject|8|||
23590505|NCT00943735|65889707|FG000|Overall Study|Death|1|||
23590506|NCT00943735|65889707|FG000|Overall Study|Other|8|||
23192137|NCT00404768|64445816|FG003|Part C|Active labor|1|||
23590507|NCT00943735|65889707|FG000|Overall Study|Other|3|||
23590508|NCT02814643|65889710|FG000|Overall Study|Lost to Follow-up|0|||
23590509|NCT02814643|65889711|FG001|Overall Study|Lost to Follow-up|1|||
23590510|NCT02814643|65889710|FG000|Overall Study|Withdrawal by Subject|1|||
23590511|NCT02814643|65889711|FG001|Overall Study|Withdrawal by Subject|2|||
23590512|NCT01787760|65889716|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
23590513|NCT01787760|65889717|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
23590514|NCT01787760|65889718|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
23590515|NCT01787760|65889716|FG000|Overall Study|Decompensated on left exotropia|0|||
23590516|NCT01787760|65889717|FG001|Overall Study|Decompensated on left exotropia|0|||
23590517|NCT01787760|65889718|FG002|Overall Study|Decompensated on left exotropia|1|||
23590518|NCT01787760|65889716|FG000|Overall Study|Dryness|0|||
23590519|NCT01787760|65889717|FG001|Overall Study|Dryness|1|||
23590520|NCT01787760|65889718|FG002|Overall Study|Dryness|0|||
23590521|NCT01787760|65889716|FG000|Overall Study|Relocation|1|||
23590522|NCT01787760|65889717|FG001|Overall Study|Relocation|1|||
23590523|NCT01787760|65889718|FG002|Overall Study|Relocation|0|||
23590524|NCT01787760|65889716|FG000|Overall Study|Lens discomfort|3|||
23590525|NCT01787760|65889717|FG001|Overall Study|Lens discomfort|0|||
23590526|NCT01787760|65889718|FG002|Overall Study|Lens discomfort|0|||
23590527|NCT01787760|65889716|FG000|Overall Study|Lens handling difficulty|1|||
23590528|NCT01787760|65889717|FG001|Overall Study|Lens handling difficulty|2|||
23590529|NCT01787760|65889718|FG002|Overall Study|Lens handling difficulty|0|||
23590530|NCT01787760|65889716|FG000|Overall Study|Protocol Violation|6|||
23590531|NCT01787760|65889717|FG001|Overall Study|Protocol Violation|0|||
23590532|NCT01787760|65889718|FG002|Overall Study|Protocol Violation|1|||
23590533|NCT01787760|65889716|FG000|Overall Study|Withdrawal by Subject|5|||
23590534|NCT01787760|65889717|FG001|Overall Study|Withdrawal by Subject|1|||
23590535|NCT01787760|65889718|FG002|Overall Study|Withdrawal by Subject|2|||
23590536|NCT01787760|65889716|FG000|Overall Study|Lost to Follow-up|1|||
23590537|NCT01787760|65889717|FG001|Overall Study|Lost to Follow-up|0|||
23590538|NCT01787760|65889718|FG002|Overall Study|Lost to Follow-up|1|||
23590539|NCT01787760|65889716|FG000|Overall Study|Stroke|1|||
23192138|NCT00404768|64445813|FG000|Part C|Lack of Efficacy|0|||
23192139|NCT00404768|64445814|FG001|Part C|Lack of Efficacy|0|||
23192140|NCT00404768|64445815|FG002|Part C|Lack of Efficacy|0|||
23192141|NCT00404768|64445816|FG003|Part C|Lack of Efficacy|2|||
23192142|NCT00404768|64445813|FG000|Part C|Treatment failure|0|||
23359750|NCT01223937|65062701|FG000|Overall Study|Lost to Follow-up|1|||
23359751|NCT01223937|65062702|FG001|Overall Study|Lost to Follow-up|4|||
23359752|NCT01223937|65062701|FG000|Overall Study|Adverse Event|1|||
23359753|NCT01223937|65062702|FG001|Overall Study|Adverse Event|4|||
23359754|NCT01223937|65062701|FG000|Overall Study|Protocol Violation|8|||
23590540|NCT01787760|65889717|FG001|Overall Study|Stroke|0|||
23590541|NCT01787760|65889718|FG002|Overall Study|Stroke|0|||
23192143|NCT00404768|64445814|FG001|Part C|Treatment failure|0|||
23192144|NCT00404768|64445815|FG002|Part C|Treatment failure|0|||
23590542|NCT01787760|65889716|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
23590543|NCT01787760|65889717|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
23192145|NCT00404768|64445816|FG003|Part C|Treatment failure|1|||
23192146|NCT00404768|64445813|FG000|Part C|Investigator discretion|0|||
23359755|NCT01223937|65062702|FG001|Overall Study|Protocol Violation|7|||
23590544|NCT01787760|65889718|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
23590545|NCT01787760|65889716|FG000|Overall Study|Unsatisfactory physiological response|2|||
23590546|NCT01787760|65889717|FG001|Overall Study|Unsatisfactory physiological response|4|||
23359756|NCT01223937|65062701|FG000|Overall Study|Other|4|||
23359757|NCT01223937|65062702|FG001|Overall Study|Other|1|||
23359758|NCT01535443|65062705|FG000|Overall Study|Physician Decision|3|||
23359759|NCT04441788|65062707|FG000|Overall Study|Voluntary Withdrawl|0|||
23359760|NCT04441788|65062708|FG001|Overall Study|Voluntary Withdrawl|1|||
23359761|NCT04441788|65062709|FG002|Overall Study|Voluntary Withdrawl|0|||
23359762|NCT04441788|65062707|FG000|Overall Study|Ineligibility|1|||
23359763|NCT04441788|65062708|FG001|Overall Study|Ineligibility|0|||
23359764|NCT04441788|65062709|FG002|Overall Study|Ineligibility|0|||
23359765|NCT04441788|65062707|FG000|Overall Study|Adverse Event|0|||
23359766|NCT04441788|65062708|FG001|Overall Study|Adverse Event|0|||
23476155|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
23476156|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
23476157|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
23476158|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
23192147|NCT00404768|64445814|FG001|Part C|Investigator discretion|0|||
23192148|NCT00404768|64445815|FG002|Part C|Investigator discretion|0|||
23192149|NCT00404768|64445816|FG003|Part C|Investigator discretion|1|||
23253350|NCT03726437|64668005|FG000|Overall Study|Lost to Follow-up|85|||
23253351|NCT03726437|64668006|FG001|Overall Study|Lost to Follow-up|76|||
23253352|NCT02643966|64668007|FG000|First Screening Round|ineligible|1|||
23253353|NCT02643966|64668007|FG000|First Screening Round|excluded from analysis|2|||
23253354|NCT02643966|64668007|FG000|First Screening Round|Lost to Follow-up|56|||
23253355|NCT02643966|64668007|FG000|First Screening Round|Withdrawal by Subject|28|||
23253356|NCT02643966|64668007|FG000|First Screening Round|Death|1|||
23253357|NCT02643966|64668007|FG000|Between First and Second Screening|Lost to Follow-up|65|||
23192150|NCT00404768|64445813|FG000|Part C|Researcher suspended study medication|0|||
23192151|NCT00404768|64445814|FG001|Part C|Researcher suspended study medication|0|||
23192152|NCT00404768|64445815|FG002|Part C|Researcher suspended study medication|0|||
23253358|NCT02643966|64668007|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
23476159|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
23476160|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
23476161|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
23476162|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
23476163|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
23476164|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
23476165|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
23476166|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
23476167|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
23476168|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
23476169|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
23192153|NCT00404768|64445816|FG003|Part C|Researcher suspended study medication|1|||
23192154|NCT00375934|64445821|FG000|Overall Study|Adverse Event|1|||
23476170|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
23476171|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
23476172|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
23476173|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
23476174|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
23476175|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
23476176|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
23476177|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
23476178|NCT01087788|65488001|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
23476179|NCT01087788|65488002|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
23476180|NCT01087788|65488003|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
23476181|NCT01431638|65488012|FG000|Overall Study|Adverse Event|1|||
23476182|NCT01431638|65488013|FG001|Overall Study|Adverse Event|3|||
23476183|NCT01431638|65488014|FG002|Overall Study|Adverse Event|1|||
23192155|NCT00375934|64445822|FG001|Overall Study|Adverse Event|1|||
23192156|NCT00375934|64445821|FG000|Overall Study|Withdrawal by Subject|2|||
23192157|NCT00375934|64445822|FG001|Overall Study|Withdrawal by Subject|2|||
23192158|NCT00375934|64445821|FG000|Overall Study|Lack of Efficacy|0|||
23192159|NCT00375934|64445822|FG001|Overall Study|Lack of Efficacy|2|||
23192160|NCT00375934|64445821|FG000|Overall Study|Physician Decision|0|||
23253359|NCT02643966|64668007|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
23253360|NCT02643966|64668007|FG000|Second Screening Round|Withdrawal by Subject|20|||
23253361|NCT02643966|64668007|FG000|Second Screening Round|Lost to Follow-up|57|||
23476184|NCT01431638|65488012|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23192161|NCT00375934|64445822|FG001|Overall Study|Physician Decision|1|||
23253362|NCT02643966|64668007|FG000|Second Screening Round|Physician Decision|2|||
23359767|NCT04441788|65062709|FG002|Overall Study|Adverse Event|4|||
23359768|NCT04441788|65062707|FG000|Overall Study|Study Terminated by Sponsor|16|||
23359769|NCT04441788|65062708|FG001|Overall Study|Study Terminated by Sponsor|16|||
23192162|NCT01821677|64445825|FG000|Overall Study|Adverse Event|4|||
23476185|NCT01431638|65488013|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23476186|NCT01431638|65488014|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
23192163|NCT01821677|64445826|FG001|Overall Study|Adverse Event|6|||
23192164|NCT01821677|64445827|FG002|Overall Study|Adverse Event|5|||
23192165|NCT01821677|64445825|FG000|Overall Study|Physician Decision|1|||
23192166|NCT01821677|64445826|FG001|Overall Study|Physician Decision|4|||
23192167|NCT01821677|64445827|FG002|Overall Study|Physician Decision|1|||
23192168|NCT01821677|64445825|FG000|Overall Study|Non-compliance|0|||
23192169|NCT01821677|64445826|FG001|Overall Study|Non-compliance|1|||
23192170|NCT01821677|64445827|FG002|Overall Study|Non-compliance|2|||
23192171|NCT01821677|64445825|FG000|Overall Study|Lost to Follow-up|2|||
23192172|NCT01821677|64445826|FG001|Overall Study|Lost to Follow-up|1|||
23192173|NCT01821677|64445827|FG002|Overall Study|Lost to Follow-up|3|||
23192174|NCT01821677|64445825|FG000|Overall Study|Protocol Violation|0|||
23476187|NCT01431638|65488012|FG000|Overall Study|Participants condition no longer requires study drug|0|||
23476188|NCT01431638|65488013|FG001|Overall Study|Participants condition no longer requires study drug|1|||
23476189|NCT01431638|65488014|FG002|Overall Study|Participants condition no longer requires study drug|0|||
23476190|NCT01431638|65488012|FG000|Overall Study|Participant withdrew consent|14|||
23476191|NCT01431638|65488013|FG001|Overall Study|Participant withdrew consent|5|||
23476192|NCT01431638|65488014|FG002|Overall Study|Participant withdrew consent|8|||
23476193|NCT01431638|65488012|FG000|Overall Study|Lost to Follow-up|7|||
23476194|NCT01431638|65488013|FG001|Overall Study|Lost to Follow-up|9|||
23476195|NCT01431638|65488014|FG002|Overall Study|Lost to Follow-up|7|||
23192175|NCT01821677|64445826|FG001|Overall Study|Protocol Violation|0|||
23192176|NCT01821677|64445827|FG002|Overall Study|Protocol Violation|2|||
23192177|NCT01821677|64445825|FG000|Overall Study|Withdrawal by Subject|7|||
23192178|NCT01821677|64445826|FG001|Overall Study|Withdrawal by Subject|3|||
23192179|NCT01821677|64445827|FG002|Overall Study|Withdrawal by Subject|2|||
23192180|NCT01821677|64445825|FG000|Overall Study|Other|9|||
23192181|NCT01821677|64445826|FG001|Overall Study|Other|0|||
23192182|NCT01821677|64445827|FG002|Overall Study|Other|0|||
23253363|NCT02643966|64668007|FG000|Second Screening Round|Death|4|||
23253364|NCT02643966|64668007|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
23253365|NCT02643966|64668007|FG000|Between Second and Third Screening|Death|1|||
23253366|NCT02643966|64668007|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
23253367|NCT02643966|64668007|FG000|Third Screening Round|PI excluded|2|||
23253368|NCT02643966|64668007|FG000|Third Screening Round|Lost to Follow-up|241|||
23253369|NCT01629693|64668008|FG000|Overall Study|Lost to Follow-up|2|||
23476196|NCT01431638|65488012|FG000|Overall Study|Administrative problems|1|||
23192183|NCT02224846|64445833|FG000|Period 1 (Month 3)|Adverse Event|2|||
23192184|NCT02224846|64445834|FG001|Period 1 (Month 3)|Adverse Event|1|||
23192185|NCT02224846|64445833|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
23192186|NCT02224846|64445834|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
23192187|NCT02224846|64445833|FG000|Period 1 (Month 3)|Protocol Violation|4|||
23253370|NCT01629693|64668009|FG001|Overall Study|Lost to Follow-up|4|||
23476197|NCT01431638|65488013|FG001|Overall Study|Administrative problems|4|||
23476198|NCT01431638|65488014|FG002|Overall Study|Administrative problems|6|||
23476199|NCT01431638|65488012|FG000|Overall Study|Death|1|||
23476200|NCT01431638|65488013|FG001|Overall Study|Death|0|||
23476201|NCT01431638|65488014|FG002|Overall Study|Death|0|||
23590547|NCT01787760|65889718|FG002|Overall Study|Unsatisfactory physiological response|0|||
23590548|NCT01787760|65889716|FG000|Overall Study|Unsatisfactory visual response|1|||
23590549|NCT01787760|65889717|FG001|Overall Study|Unsatisfactory visual response|1|||
23590550|NCT01787760|65889718|FG002|Overall Study|Unsatisfactory visual response|0|||
23590551|NCT01787760|65889716|FG000|Overall Study|Near vision blur|1|||
23590552|NCT01787760|65889717|FG001|Overall Study|Near vision blur|0|||
23590553|NCT01787760|65889718|FG002|Overall Study|Near vision blur|0|||
23590554|NCT03737240|65889719|FG000|Overall Study|Lost to Follow-up|16|||
23590555|NCT03737240|65889720|FG001|Overall Study|Lost to Follow-up|15|||
23590556|NCT01956669|65889721|FG000|Overall Study|Disease Progression|12|||
23590557|NCT01956669|65889722|FG001|Overall Study|Disease Progression|7|||
23590558|NCT01956669|65889723|FG002|Overall Study|Disease Progression|7|||
23590559|NCT01956669|65889724|FG003|Overall Study|Disease Progression|8|||
23590560|NCT01956669|65889725|FG004|Overall Study|Disease Progression|4|||
23590561|NCT01956669|65889726|FG005|Overall Study|Disease Progression|3|||
23192188|NCT02224846|64445834|FG001|Period 1 (Month 3)|Protocol Violation|8|||
23192189|NCT02224846|64445833|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
23192190|NCT02224846|64445834|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
23253371|NCT01629693|64668008|FG000|Overall Study|Withdrawal by Subject|2|||
23253372|NCT01629693|64668009|FG001|Overall Study|Withdrawal by Subject|2|||
23476202|NCT01431638|65488012|FG000|Overall Study|Protocol deviation|1|||
23590562|NCT01956669|65889727|FG006|Overall Study|Disease Progression|5|||
23590563|NCT01956669|65889721|FG000|Overall Study|Adverse Event|0|||
23192191|NCT02224846|64445833|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
23192192|NCT02224846|64445834|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
23192193|NCT02224846|64445833|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
23192194|NCT02224846|64445834|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
23476203|NCT01431638|65488013|FG001|Overall Study|Protocol deviation|1|||
23476204|NCT01431638|65488014|FG002|Overall Study|Protocol deviation|4|||
23359770|NCT04441788|65062709|FG002|Overall Study|Study Terminated by Sponsor|12|||
23359771|NCT02164318|65062716|FG000|Overall Study|Withdrawal by Subject|0|||
23359772|NCT02164318|65062717|FG001|Overall Study|Withdrawal by Subject|1|||
23359773|NCT02164318|65062718|FG002|Overall Study|Withdrawal by Subject|0|||
23359774|NCT02164318|65062719|FG003|Overall Study|Withdrawal by Subject|1|||
23359775|NCT03214679|65062721|FG000|Overall Study|Lost to Follow-up|12|||
23359776|NCT03214679|65062722|FG001|Overall Study|Lost to Follow-up|14|||
23359777|NCT03214679|65062721|FG000|Overall Study|not eligible|2|||
23359778|NCT03214679|65062722|FG001|Overall Study|not eligible|0|||
23359779|NCT01447719|65062723|FG000|Overall Study|Image acquisition failure|2|||
23359780|NCT01447719|65062723|FG000|Overall Study|Invalid image or not imaged|3|||
23359781|NCT01447719|65062723|FG000|Overall Study|Subject still living at end of study|79|||
23359782|NCT01447719|65062723|FG000|Overall Study|Withdrawal by Subject|2|||
23359783|NCT01447719|65062723|FG000|Overall Study|Family withdrew autopsy consent|7|||
23359784|NCT00339833|65062725|FG000|Overall Study|Withdrawal by Subject|1|||
23359785|NCT00339833|65062726|FG001|Overall Study|Withdrawal by Subject|2|||
23359786|NCT00339833|65062725|FG000|Overall Study|toothache|0|||
23192195|NCT02224846|64445833|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
23192196|NCT02224846|64445834|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
23192197|NCT02224846|64445833|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
23192198|NCT02224846|64445834|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
23192199|NCT02224846|64445833|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
23192200|NCT02224846|64445834|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
23192201|NCT02224846|64445833|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
23192202|NCT02224846|64445834|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
23192203|NCT02224846|64445833|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
23192204|NCT02224846|64445834|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
23192205|NCT02224846|64445833|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
23192206|NCT02224846|64445834|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
23192207|NCT02224846|64445833|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
23359787|NCT00339833|65062726|FG001|Overall Study|toothache|1|||
23192208|NCT02224846|64445834|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
23359788|NCT00339833|65062725|FG000|Overall Study|indigestion|0|||
23359789|NCT00339833|65062726|FG001|Overall Study|indigestion|1|||
23359790|NCT00339833|65062725|FG000|Overall Study|Chest pain|0|||
23359791|NCT00339833|65062726|FG001|Overall Study|Chest pain|1|||
23359792|NCT00339833|65062725|FG000|Overall Study|minor infection|0|||
23359793|NCT00339833|65062726|FG001|Overall Study|minor infection|1|||
23359794|NCT00339833|65062725|FG000|Overall Study|Poor venous access|2|||
23359795|NCT00339833|65062726|FG001|Overall Study|Poor venous access|2|||
23359796|NCT00339833|65062725|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
23359797|NCT00339833|65062726|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
23476205|NCT01431638|65488012|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
23476206|NCT01431638|65488013|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
23590564|NCT01956669|65889722|FG001|Overall Study|Adverse Event|2|||
23359798|NCT00339833|65062725|FG000|Overall Study|Error in data records|1|||
23359799|NCT00339833|65062726|FG001|Overall Study|Error in data records|0|||
23359800|NCT03061188|65062727|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
23359801|NCT03061188|65062728|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
23359802|NCT03061188|65062729|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
23359803|NCT03061188|65062730|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
23359804|NCT03061188|65062727|FG000|On Follow-up for 3 Years|Death|0|||
23359805|NCT03061188|65062728|FG001|On Follow-up for 3 Years|Death|3|||
23192209|NCT02224846|64445833|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
23192210|NCT02224846|64445834|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
23192211|NCT02224846|64445833|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
23192212|NCT02224846|64445834|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
23192213|NCT02224846|64445833|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
23192214|NCT02224846|64445834|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
23192215|NCT02224846|64445833|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
23192216|NCT02224846|64445834|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
23192217|NCT04334148|64445837|FG000|Overall Study|positive nasal swab at baseline|0|||
23192218|NCT04334148|64445838|FG001|Overall Study|positive nasal swab at baseline|1|||
23192219|NCT02613572|64445839|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
23192220|NCT02613572|64445840|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
23192221|NCT02613572|64445841|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
23192222|NCT02613572|64445839|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
23192223|NCT02613572|64445840|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
23192224|NCT02613572|64445841|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
23192225|NCT03199911|64445844|FG000|Overall Study|Lost to Follow-up|5|||
23192226|NCT03199911|64445845|FG001|Overall Study|Lost to Follow-up|5|||
23192227|NCT03199911|64445844|FG000|Overall Study|Did not proceed with surgery|2|||
23192228|NCT03199911|64445845|FG001|Overall Study|Did not proceed with surgery|1|||
23192229|NCT01348919|64445855|FG000|Overall Study|Adverse Event|3|||
23192230|NCT01348919|64445856|FG001|Overall Study|Adverse Event|1|||
23192231|NCT01348919|64445857|FG002|Overall Study|Adverse Event|0|||
23192232|NCT01348919|64445855|FG000|Overall Study|Withdrawal by Subject|0|||
23192233|NCT01348919|64445856|FG001|Overall Study|Withdrawal by Subject|1|||
23192234|NCT01348919|64445857|FG002|Overall Study|Withdrawal by Subject|0|||
23192235|NCT01348919|64445855|FG000|Overall Study|Disease progression|0|||
23476207|NCT01431638|65488014|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
23476208|NCT00926029|65488015|FG000|Overall Study|Lost to Follow-up|2|||
23590565|NCT01956669|65889723|FG002|Overall Study|Adverse Event|2|||
23590566|NCT01956669|65889724|FG003|Overall Study|Adverse Event|1|||
23590567|NCT01956669|65889725|FG004|Overall Study|Adverse Event|0|||
23590568|NCT01956669|65889726|FG005|Overall Study|Adverse Event|0|||
23590569|NCT01956669|65889727|FG006|Overall Study|Adverse Event|0|||
23590570|NCT01956669|65889721|FG000|Overall Study|Physician Decision|0|||
23590571|NCT01956669|65889722|FG001|Overall Study|Physician Decision|2|||
23590572|NCT01956669|65889723|FG002|Overall Study|Physician Decision|0|||
23590573|NCT01956669|65889724|FG003|Overall Study|Physician Decision|0|||
23590574|NCT01956669|65889725|FG004|Overall Study|Physician Decision|0|||
23590575|NCT01956669|65889726|FG005|Overall Study|Physician Decision|1|||
23590576|NCT01956669|65889727|FG006|Overall Study|Physician Decision|0|||
23590577|NCT01956669|65889721|FG000|Overall Study|Withdrawal by Subject|0|||
23590578|NCT01956669|65889722|FG001|Overall Study|Withdrawal by Subject|0|||
23590579|NCT01956669|65889723|FG002|Overall Study|Withdrawal by Subject|1|||
23590580|NCT01956669|65889724|FG003|Overall Study|Withdrawal by Subject|1|||
23590581|NCT01956669|65889725|FG004|Overall Study|Withdrawal by Subject|0|||
23590582|NCT01956669|65889726|FG005|Overall Study|Withdrawal by Subject|0|||
23590583|NCT01956669|65889727|FG006|Overall Study|Withdrawal by Subject|1|||
23590584|NCT02412748|65889736|FG000|Overall Study|Lost to Follow-up|38|||
23590585|NCT02412748|65889737|FG001|Overall Study|Lost to Follow-up|39|||
23590586|NCT01111526|65889740|FG000|Overall Study|GVHD Disease Progression|0|||
23590587|NCT01111526|65889741|FG001|Overall Study|GVHD Disease Progression|1|||
23590588|NCT01111526|65889742|FG002|Overall Study|GVHD Disease Progression|2|||
23590589|NCT00079183|65889749|FG000|Overall Study|Withdrawal by Subject|4|||
23590590|NCT00079183|65889749|FG000|Overall Study|Study medication non-compliance|2|||
23590591|NCT00079183|65889749|FG000|Overall Study|Specimen collection non-compliance|1|||
23590592|NCT00746330|65892787|FG000|Period 1|Abnormal test procedure result|0|||
23590593|NCT00746330|65892788|FG001|Period 1|Abnormal test procedure result|0|||
23590594|NCT00746330|65892789|FG002|Period 1|Abnormal test procedure result|1|||
23590595|NCT00746330|65892790|FG003|Period 1|Abnormal test procedure result|0|||
23590596|NCT00102063|65892791|FG000|Overall Study|Lack of Efficacy|5|||
23590597|NCT00102063|65892792|FG001|Overall Study|Lack of Efficacy|1|||
23590598|NCT00102063|65892793|FG002|Overall Study|Lack of Efficacy|1|||
23590599|NCT00102063|65892791|FG000|Overall Study|Adverse Event|7|||
23590600|NCT00102063|65892792|FG001|Overall Study|Adverse Event|4|||
23590601|NCT00102063|65892793|FG002|Overall Study|Adverse Event|2|||
23590602|NCT00102063|65892791|FG000|Overall Study|Withdrawal by Subject|4|||
23192236|NCT01348919|64445856|FG001|Overall Study|Disease progression|1|||
23253373|NCT01629693|64668008|FG000|Overall Study|Adverse Event|1|||
23476209|NCT00926029|65488016|FG001|Overall Study|Lost to Follow-up|1|||
23590603|NCT00102063|65892792|FG001|Overall Study|Withdrawal by Subject|12|||
23192237|NCT01348919|64445857|FG002|Overall Study|Disease progression|1|||
23590604|NCT00102063|65892793|FG002|Overall Study|Withdrawal by Subject|5|||
23590605|NCT00102063|65892791|FG000|Overall Study|Lost to Follow-up|0|||
23590606|NCT00102063|65892792|FG001|Overall Study|Lost to Follow-up|0|||
23590607|NCT00102063|65892793|FG002|Overall Study|Lost to Follow-up|1|||
23590608|NCT00102063|65892791|FG000|Overall Study|Protocol Violation|0|||
23590609|NCT00102063|65892792|FG001|Overall Study|Protocol Violation|1|||
23590610|NCT00102063|65892793|FG002|Overall Study|Protocol Violation|1|||
23590611|NCT03201562|65892794|FG000|Overall Study|Physician Decision|0|||
23590612|NCT03201562|65892795|FG001|Overall Study|Physician Decision|0|||
23192238|NCT01873950|64445860|FG000|Period 5|Withdrawal by Subject|0|||
23192239|NCT01873950|64445861|FG001|Period 5|Withdrawal by Subject|0|||
23590613|NCT03201562|65892796|FG002|Overall Study|Physician Decision|1|||
23590614|NCT03201562|65892794|FG000|Overall Study|Adverse Event|0|||
23590615|NCT03201562|65892795|FG001|Overall Study|Adverse Event|0|||
23590616|NCT03201562|65892796|FG002|Overall Study|Adverse Event|1|||
23590617|NCT03201562|65892794|FG000|Overall Study|Lost to Follow-up|0|||
23192240|NCT01873950|64445862|FG002|Period 5|Withdrawal by Subject|0|||
23192241|NCT01873950|64445863|FG003|Period 5|Withdrawal by Subject|1|||
23192242|NCT01873950|64445864|FG004|Period 5|Withdrawal by Subject|0|||
23192243|NCT02362412|64445865|FG000|Treatment Period III|Lost to Follow-up|0|||
23192244|NCT02362412|64445866|FG001|Treatment Period III|Lost to Follow-up|1|||
23192245|NCT04021862|64445867|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23192246|NCT04021862|64445868|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
23192247|NCT04021862|64445869|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23192248|NCT04021862|64445870|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23192249|NCT04021862|64445871|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23192250|NCT04021862|64445872|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
23192251|NCT04021862|64445867|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
23192252|NCT04021862|64445868|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23192253|NCT04021862|64445869|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23192254|NCT04021862|64445870|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23192255|NCT04021862|64445871|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23192256|NCT04021862|64445872|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
23192257|NCT04021862|64445867|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23192258|NCT04021862|64445868|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23192259|NCT04021862|64445869|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
23192260|NCT04021862|64445870|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23192261|NCT04021862|64445871|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23192262|NCT04021862|64445872|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
23192263|NCT04021862|64445867|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
23192264|NCT04021862|64445868|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
23192265|NCT04021862|64445869|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
23192266|NCT04021862|64445870|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
23192267|NCT04021862|64445871|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
23192268|NCT04021862|64445872|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
23192269|NCT04021862|64445867|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23192270|NCT04021862|64445868|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23192271|NCT04021862|64445869|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23192272|NCT04021862|64445870|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
23192273|NCT04021862|64445871|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23192274|NCT04021862|64445872|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
23192275|NCT00564629|64445873|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
23192276|NCT00564629|64445874|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
23192277|NCT04407507|64445875|FG000|Overall Study|Withdrawal by Subject|0|||
23192278|NCT04407507|64445876|FG001|Overall Study|Withdrawal by Subject|1|||
23192279|NCT00144300|64445878|FG000|Overall Study|Adverse Event|18|||
23192280|NCT00144300|64445879|FG001|Overall Study|Adverse Event|16|||
23192281|NCT00144300|64445878|FG000|Overall Study|Protocol Violation|1|||
23192282|NCT00144300|64445879|FG001|Overall Study|Protocol Violation|3|||
23192283|NCT00144300|64445878|FG000|Overall Study|Lost to Follow-up|3|||
23192284|NCT00144300|64445879|FG001|Overall Study|Lost to Follow-up|0|||
23192285|NCT00144300|64445878|FG000|Overall Study|Withdrawal by Subject|6|||
23192286|NCT00144300|64445879|FG001|Overall Study|Withdrawal by Subject|6|||
23192287|NCT00144300|64445878|FG000|Overall Study|Other reason (not specified)|1|||
23192288|NCT00144300|64445879|FG001|Overall Study|Other reason (not specified)|3|||
23590618|NCT03201562|65892795|FG001|Overall Study|Lost to Follow-up|1|||
23590619|NCT03201562|65892796|FG002|Overall Study|Lost to Follow-up|2|||
23590620|NCT03546907|65892797|FG000|Overall Study|Lack of Efficacy|1|||
23192289|NCT02234622|64445880|FG000|Overall Study|Withdrawal by Subject|16|||
23253374|NCT01629693|64668009|FG001|Overall Study|Adverse Event|0|||
23253375|NCT01629693|64668008|FG000|Overall Study|Investigator decision|0|||
23253376|NCT01629693|64668009|FG001|Overall Study|Investigator decision|1|||
23590621|NCT03546907|65892798|FG001|Overall Study|Lack of Efficacy|1|||
23590622|NCT03546907|65892797|FG000|Overall Study|Withdrawal by Subject|8|||
23590623|NCT03546907|65892798|FG001|Overall Study|Withdrawal by Subject|9|||
23192290|NCT02234622|64445881|FG001|Overall Study|Withdrawal by Subject|22|||
23192291|NCT02234622|64445880|FG000|Overall Study|Lost to Follow-up|27|||
23192292|NCT02234622|64445881|FG001|Overall Study|Lost to Follow-up|14|||
23192293|NCT01787591|64445882|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
23192294|NCT01787591|64445883|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
23192295|NCT01787591|64445884|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
23253377|NCT01629693|64668008|FG000|Overall Study|Poor comfort of study lenses|0|||
23253378|NCT01629693|64668009|FG001|Overall Study|Poor comfort of study lenses|2|||
23253379|NCT01629693|64668008|FG000|Overall Study|Subject decision unrelated to AE|0|||
23253380|NCT01629693|64668009|FG001|Overall Study|Subject decision unrelated to AE|1|||
23253381|NCT03078192|64668010|FG000|Overall Study|Withdrawal by Subject|2|||
23253382|NCT03078192|64668011|FG001|Overall Study|Withdrawal by Subject|1|||
23253383|NCT03078192|64668010|FG000|Overall Study|screen failure|0|||
23192296|NCT01787591|64445885|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
23192297|NCT03114969|64445886|FG000|Overall Study|Lost to Follow-up|0|||
23192298|NCT03114969|64445887|FG001|Overall Study|Lost to Follow-up|0|||
23192299|NCT03114969|64445888|FG002|Overall Study|Lost to Follow-up|3|||
23253384|NCT03078192|64668011|FG001|Overall Study|screen failure|3|||
23253385|NCT00709735|64668014|FG000|Overall Study|Lost to Follow-up|1|||
23253386|NCT00709735|64668015|FG001|Overall Study|Lost to Follow-up|1|||
23253387|NCT00709735|64668014|FG000|Overall Study|Relapse into Opioid Abuse|0|||
23253388|NCT00709735|64668015|FG001|Overall Study|Relapse into Opioid Abuse|1|||
23253389|NCT00709735|64668014|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
23253390|NCT00709735|64668015|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
23253391|NCT03467971|64668016|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23476210|NCT00926029|65488017|FG002|Overall Study|Lost to Follow-up|1|||
23476211|NCT04255394|65488025|FG000|Overall Study|Death|35|||
23476212|NCT04255394|65488026|FG001|Overall Study|Death|25|||
23476213|NCT04255394|65488025|FG000|Overall Study|Device removed|2|||
23476214|NCT04255394|65488026|FG001|Overall Study|Device removed|10|||
23476215|NCT04255394|65488025|FG000|Overall Study|Withdrawal by Subject|9|||
23476216|NCT04255394|65488026|FG001|Overall Study|Withdrawal by Subject|8|||
23476217|NCT04255394|65488025|FG000|Overall Study|Screen Failure/Not treated|12|||
23476218|NCT04255394|65488026|FG001|Overall Study|Screen Failure/Not treated|8|||
23476219|NCT04255394|65488025|FG000|Overall Study|Lost to Follow-up|123|||
23476220|NCT04255394|65488026|FG001|Overall Study|Lost to Follow-up|265|||
23590624|NCT03546907|65892797|FG000|Overall Study|Adverse events (AEs)|7|||
23590625|NCT03546907|65892798|FG001|Overall Study|Adverse events (AEs)|10|||
23590626|NCT03546907|65892797|FG000|Overall Study|Other-unspecified|1|||
23590627|NCT03546907|65892798|FG001|Overall Study|Other-unspecified|1|||
23590628|NCT00588666|65892799|FG000|Overall Study|Adverse Event|4|||
23590629|NCT02274493|65892802|FG000|Overall Study|Withdrawal by Subject|1|||
23590630|NCT01802632|65892803|FG000|Overall Study|Death|28|||
23253392|NCT03467971|64668017|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23590631|NCT01802632|65892804|FG001|Overall Study|Death|1|||
23192300|NCT03114969|64445889|FG003|Overall Study|Lost to Follow-up|2|||
23253393|NCT00758706|64668018|FG000|Overall Study|Adverse Event|4|||
23253394|NCT00758706|64668019|FG001|Overall Study|Adverse Event|4|||
23253395|NCT00972153|64668020|FG000|Overall Study|Equipment malfunction during case|0|||
23253396|NCT00972153|64668021|FG001|Overall Study|Equipment malfunction during case|1|||
23253397|NCT00972153|64668022|FG002|Overall Study|Equipment malfunction during case|0|||
23253398|NCT00568776|64668029|FG000|Overall Study|Adverse Event|8|||
23253399|NCT00568776|64668030|FG001|Overall Study|Adverse Event|8|||
23253400|NCT00568776|64668031|FG002|Overall Study|Adverse Event|10|||
23253401|NCT00568776|64668032|FG003|Overall Study|Adverse Event|8|||
23253402|NCT00568776|64668029|FG000|Overall Study|Death|0|||
23253403|NCT00568776|64668030|FG001|Overall Study|Death|1|||
23253404|NCT00568776|64668031|FG002|Overall Study|Death|4|||
23253405|NCT00568776|64668032|FG003|Overall Study|Death|3|||
23253406|NCT00568776|64668029|FG000|Overall Study|Physician Decision|0|||
23253407|NCT00568776|64668030|FG001|Overall Study|Physician Decision|2|||
23253408|NCT00568776|64668031|FG002|Overall Study|Physician Decision|0|||
23253409|NCT00568776|64668032|FG003|Overall Study|Physician Decision|0|||
23253410|NCT00568776|64668029|FG000|Overall Study|Lack of Efficacy|2|||
23253411|NCT00568776|64668030|FG001|Overall Study|Lack of Efficacy|2|||
23253412|NCT00568776|64668031|FG002|Overall Study|Lack of Efficacy|2|||
23253413|NCT00568776|64668032|FG003|Overall Study|Lack of Efficacy|4|||
23253414|NCT00568776|64668029|FG000|Overall Study|Lost to Follow-up|1|||
23253415|NCT00568776|64668030|FG001|Overall Study|Lost to Follow-up|1|||
23590632|NCT01802632|65892805|FG002|Overall Study|Death|38|||
23192301|NCT03114969|64445890|FG004|Overall Study|Lost to Follow-up|0|||
23192302|NCT03114969|64445891|FG005|Overall Study|Lost to Follow-up|0|||
23192303|NCT03114969|64445892|FG006|Overall Study|Lost to Follow-up|0|||
23192304|NCT03114969|64445893|FG007|Overall Study|Lost to Follow-up|0|||
23253416|NCT00568776|64668031|FG002|Overall Study|Lost to Follow-up|1|||
23476221|NCT04255394|65488025|FG000|Overall Study|Adverse Event|1|||
23476222|NCT04255394|65488026|FG001|Overall Study|Adverse Event|3|||
23476223|NCT00282347|65488028|FG000|Treatment Period|Death|2|||
23476224|NCT00282347|65488029|FG001|Treatment Period|Death|0|||
23253417|NCT00568776|64668032|FG003|Overall Study|Lost to Follow-up|1|||
23253418|NCT00568776|64668029|FG000|Overall Study|Protocol Violation|1|||
23590633|NCT01802632|65892806|FG003|Overall Study|Death|0|||
23590634|NCT01802632|65892807|FG004|Overall Study|Death|2|||
23590635|NCT01802632|65892808|FG005|Overall Study|Death|0|||
23590636|NCT01802632|65892803|FG000|Overall Study|Withdrawal by Subject|4|||
23590637|NCT01802632|65892804|FG001|Overall Study|Withdrawal by Subject|2|||
23590638|NCT01802632|65892805|FG002|Overall Study|Withdrawal by Subject|7|||
23590639|NCT01802632|65892806|FG003|Overall Study|Withdrawal by Subject|3|||
23590640|NCT01802632|65892807|FG004|Overall Study|Withdrawal by Subject|0|||
23590641|NCT01802632|65892808|FG005|Overall Study|Withdrawal by Subject|1|||
23590642|NCT01802632|65892803|FG000|Overall Study|Objective Disease Progression|1|||
23590643|NCT01802632|65892804|FG001|Overall Study|Objective Disease Progression|12|||
23590644|NCT01802632|65892805|FG002|Overall Study|Objective Disease Progression|104|||
23590645|NCT01802632|65892806|FG003|Overall Study|Objective Disease Progression|6|||
23590646|NCT01802632|65892807|FG004|Overall Study|Objective Disease Progression|4|||
23590647|NCT01802632|65892808|FG005|Overall Study|Objective Disease Progression|4|||
23590648|NCT01802632|65892803|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
23590649|NCT01802632|65892804|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
23590650|NCT01802632|65892805|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
23590651|NCT01802632|65892806|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
23590652|NCT01802632|65892807|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
23590653|NCT01802632|65892808|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
23590654|NCT01802632|65892803|FG000|Overall Study|Other (not specified)|0|||
23590655|NCT01802632|65892804|FG001|Overall Study|Other (not specified)|0|||
23590656|NCT01802632|65892805|FG002|Overall Study|Other (not specified)|7|||
23590657|NCT01802632|65892806|FG003|Overall Study|Other (not specified)|1|||
23590658|NCT01802632|65892807|FG004|Overall Study|Other (not specified)|0|||
23590659|NCT01802632|65892808|FG005|Overall Study|Other (not specified)|1|||
23590660|NCT02631148|65892811|FG000|Overall Study|8 were ineligible|8|||
23590661|NCT02631148|65892812|FG001|Overall Study|8 were ineligible|0|||
23590662|NCT02631148|65892811|FG000|Overall Study|Withdrawal by Subject|1|||
23590663|NCT02631148|65892812|FG001|Overall Study|Withdrawal by Subject|0|||
23590664|NCT02631148|65892811|FG000|Overall Study|PAH not available to study participant|1|||
23590665|NCT02631148|65892812|FG001|Overall Study|PAH not available to study participant|0|||
23590666|NCT00028769|65892815|FG000|Overall Study|Adverse Event|2|||
23590667|NCT00028769|65892815|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
23590668|NCT00028769|65892815|FG000|Overall Study|Progression or Death|31|||
23590669|NCT00028769|65892815|FG000|Overall Study|Other - Not Protocol Specified|1|||
23590670|NCT00028769|65892815|FG000|Overall Study|Ineligible|5|||
23590671|NCT00028769|65892815|FG000|Overall Study|Not Analyzable|1|||
23590672|NCT00486330|65892827|FG000|Overall Study|Adverse Event|2|||
23590673|NCT01490086|65892828|FG000|Overall Study|Consent withdrawn|4|||
23590674|NCT01490086|65892829|FG001|Overall Study|Consent withdrawn|4|||
23590675|NCT01490086|65892830|FG002|Overall Study|Consent withdrawn|3|||
23590676|NCT01490086|65892831|FG003|Overall Study|Consent withdrawn|0|||
23590677|NCT01490086|65892832|FG004|Overall Study|Consent withdrawn|1|||
23590678|NCT01490086|65892828|FG000|Overall Study|Non-compliance|0|||
23590679|NCT01490086|65892829|FG001|Overall Study|Non-compliance|1|||
23590680|NCT01490086|65892830|FG002|Overall Study|Non-compliance|0|||
23590681|NCT01490086|65892831|FG003|Overall Study|Non-compliance|0|||
23590682|NCT01490086|65892832|FG004|Overall Study|Non-compliance|0|||
23590683|NCT01490086|65892828|FG000|Overall Study|Abnormal laboratory findings|1|||
23590684|NCT01490086|65892829|FG001|Overall Study|Abnormal laboratory findings|0|||
23590685|NCT01490086|65892830|FG002|Overall Study|Abnormal laboratory findings|0|||
23590686|NCT01490086|65892831|FG003|Overall Study|Abnormal laboratory findings|0|||
23590687|NCT01490086|65892832|FG004|Overall Study|Abnormal laboratory findings|0|||
23590688|NCT01490086|65892828|FG000|Overall Study|Lost to Follow-up|0|||
23253419|NCT00568776|64668030|FG001|Overall Study|Protocol Violation|0|||
23590689|NCT01490086|65892829|FG001|Overall Study|Lost to Follow-up|0|||
23590690|NCT01490086|65892830|FG002|Overall Study|Lost to Follow-up|0|||
23590691|NCT01490086|65892831|FG003|Overall Study|Lost to Follow-up|0|||
23590692|NCT01490086|65892832|FG004|Overall Study|Lost to Follow-up|1|||
23590693|NCT01490086|65892828|FG000|Overall Study|Physician Decision|3|||
23590694|NCT01490086|65892829|FG001|Overall Study|Physician Decision|4|||
23590695|NCT01490086|65892830|FG002|Overall Study|Physician Decision|2|||
23590696|NCT01490086|65892831|FG003|Overall Study|Physician Decision|3|||
23590697|NCT01490086|65892832|FG004|Overall Study|Physician Decision|1|||
23590698|NCT01490086|65892828|FG000|Overall Study|Adverse Event|0|||
23590699|NCT01490086|65892829|FG001|Overall Study|Adverse Event|0|||
23590700|NCT01490086|65892830|FG002|Overall Study|Adverse Event|1|||
23590701|NCT01490086|65892831|FG003|Overall Study|Adverse Event|2|||
23590702|NCT01490086|65892832|FG004|Overall Study|Adverse Event|0|||
23590703|NCT01490086|65892828|FG000|Overall Study|Lack of Efficacy|0|||
23590704|NCT01490086|65892829|FG001|Overall Study|Lack of Efficacy|3|||
23590705|NCT01490086|65892830|FG002|Overall Study|Lack of Efficacy|1|||
23590706|NCT01490086|65892831|FG003|Overall Study|Lack of Efficacy|0|||
23590707|NCT01490086|65892832|FG004|Overall Study|Lack of Efficacy|8|||
23590708|NCT01490086|65892828|FG000|Overall Study|Worsening of symptoms|0|||
23590709|NCT01490086|65892829|FG001|Overall Study|Worsening of symptoms|1|||
23590710|NCT01490086|65892830|FG002|Overall Study|Worsening of symptoms|0|||
23590711|NCT01490086|65892831|FG003|Overall Study|Worsening of symptoms|1|||
23590712|NCT01490086|65892832|FG004|Overall Study|Worsening of symptoms|0|||
23590713|NCT01490086|65892828|FG000|Overall Study|Subject uncontrollable and abusive|0|||
23590714|NCT01490086|65892829|FG001|Overall Study|Subject uncontrollable and abusive|1|||
23590715|NCT01490086|65892830|FG002|Overall Study|Subject uncontrollable and abusive|0|||
23590716|NCT01490086|65892831|FG003|Overall Study|Subject uncontrollable and abusive|0|||
23590717|NCT01490086|65892832|FG004|Overall Study|Subject uncontrollable and abusive|0|||
23590718|NCT01490086|65892828|FG000|Overall Study|Subject left hospital|0|||
23590719|NCT01490086|65892829|FG001|Overall Study|Subject left hospital|1|||
23590720|NCT01490086|65892830|FG002|Overall Study|Subject left hospital|0|||
23590721|NCT01490086|65892831|FG003|Overall Study|Subject left hospital|1|||
23590722|NCT01490086|65892832|FG004|Overall Study|Subject left hospital|0|||
23590723|NCT02202499|65892836|FG000|Overall Study|Cancer diagnosis|0|||
23590724|NCT02202499|65892837|FG001|Overall Study|Cancer diagnosis|0|||
23590725|NCT02202499|65892838|FG002|Overall Study|Cancer diagnosis|1|||
23590726|NCT02202499|65892836|FG000|Overall Study|Moved from area|0|||
23590727|NCT02202499|65892837|FG001|Overall Study|Moved from area|0|||
23590728|NCT02202499|65892838|FG002|Overall Study|Moved from area|1|||
23590729|NCT02202499|65892836|FG000|Overall Study|Declined before randomization|1|||
23590730|NCT02202499|65892837|FG001|Overall Study|Declined before randomization|0|||
23590731|NCT02202499|65892838|FG002|Overall Study|Declined before randomization|0|||
23590732|NCT02202499|65892836|FG000|Overall Study|Auto accident|1|||
23590733|NCT02202499|65892837|FG001|Overall Study|Auto accident|0|||
23590734|NCT02202499|65892838|FG002|Overall Study|Auto accident|0|||
23590735|NCT01157182|65892849|FG000|Washout of 28 Days|Adverse Event|2|||
23590736|NCT01157182|65892850|FG001|Washout of 28 Days|Adverse Event|0|||
23590737|NCT00545077|65892852|FG000|Overall Study|Treatment not received|5|||
23590738|NCT00545077|65892853|FG001|Overall Study|Treatment not received|1|||
23590739|NCT00545077|65892852|FG000|Overall Study|Disease Progression|131|||
23590740|NCT00545077|65892853|FG001|Overall Study|Disease Progression|98|||
23590741|NCT00545077|65892852|FG000|Overall Study|Withdrawal by Subject|3|||
23590742|NCT00545077|65892853|FG001|Overall Study|Withdrawal by Subject|14|||
23590743|NCT00545077|65892852|FG000|Overall Study|Physician Decision|6|||
23590744|NCT00545077|65892853|FG001|Overall Study|Physician Decision|3|||
23590745|NCT00545077|65892852|FG000|Overall Study|Lost to Follow-up|2|||
23590746|NCT00545077|65892853|FG001|Overall Study|Lost to Follow-up|0|||
23590747|NCT00545077|65892852|FG000|Overall Study|Protocol Violation|1|||
23590748|NCT00545077|65892853|FG001|Overall Study|Protocol Violation|0|||
23590749|NCT00545077|65892852|FG000|Overall Study|Adverse Event|0|||
23590750|NCT00545077|65892853|FG001|Overall Study|Adverse Event|31|||
23590751|NCT00545077|65892852|FG000|Overall Study|Death|0|||
23590752|NCT00545077|65892853|FG001|Overall Study|Death|8|||
23590753|NCT02937831|65892854|FG000|Overall Study|Protocol Violation|4|||
23590754|NCT00419094|65892861|FG000|Overall Study|Adverse Event|3|||
23590755|NCT00419094|65892862|FG001|Overall Study|Adverse Event|7|||
23590756|NCT00419094|65892861|FG000|Overall Study|Lack of Efficacy|1|||
23590757|NCT00419094|65892862|FG001|Overall Study|Lack of Efficacy|0|||
23590758|NCT00419094|65892861|FG000|Overall Study|Lost to Follow-up|0|||
23590759|NCT00419094|65892862|FG001|Overall Study|Lost to Follow-up|2|||
23590760|NCT00419094|65892861|FG000|Overall Study|Protocol Violation|1|||
23590761|NCT00419094|65892862|FG001|Overall Study|Protocol Violation|14|||
23590762|NCT00419094|65892861|FG000|Overall Study|Withdrawal of consent|1|||
23590763|NCT00419094|65892862|FG001|Overall Study|Withdrawal of consent|5|||
23590764|NCT00419094|65892861|FG000|Overall Study|Other: Error determining exit criteria|1|||
23590765|NCT00419094|65892862|FG001|Overall Study|Other: Error determining exit criteria|0|||
23590766|NCT00419094|65892861|FG000|Overall Study|Other: Patient non-compliant|0|||
23590767|NCT00419094|65892862|FG001|Overall Study|Other: Patient non-compliant|1|||
23590768|NCT00419094|65892861|FG000|Overall Study|Other: No contact for extended period|0|||
23590769|NCT00419094|65892862|FG001|Overall Study|Other: No contact for extended period|1|||
23590770|NCT00101010|65892863|FG000|Overall Study|Physician Decision|1|||
23590771|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
23590772|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
23590773|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
23590774|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
23590775|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
23590776|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
23590777|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
23590778|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
23590779|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
23590780|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
23590781|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
23590782|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
23590783|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Death|7|||
23590784|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Death|4|||
23590785|NCT00410124|65892873|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
23590786|NCT00410124|65892874|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
23590787|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
23590788|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
23590789|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
23590790|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
23590791|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
23590792|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
23590793|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
23590794|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
23590795|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
23590796|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
23590797|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
23590798|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
23590799|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
23590800|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
23590801|NCT00410124|65892873|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
23590802|NCT00410124|65892874|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
23590803|NCT04480827|65892877|FG000|Overall Study|Adverse Event|0|||
23590804|NCT04480827|65892878|FG001|Overall Study|Adverse Event|0|||
23590805|NCT04480827|65892879|FG002|Overall Study|Adverse Event|0|||
23590806|NCT04480827|65892880|FG003|Overall Study|Adverse Event|0|||
23590807|NCT04480827|65892881|FG004|Overall Study|Adverse Event|0|||
23590808|NCT04480827|65892882|FG005|Overall Study|Adverse Event|1|||
23590809|NCT04480827|65892883|FG006|Overall Study|Adverse Event|0|||
23590810|NCT01883492|65892886|FG000|Overall Study|Lost to Follow-up|3|||
23590811|NCT01883492|65892887|FG001|Overall Study|Lost to Follow-up|4|||
23590812|NCT01883492|65892886|FG000|Overall Study|Surgery on contra-lateral hip|0|||
23590813|NCT01883492|65892887|FG001|Overall Study|Surgery on contra-lateral hip|1|||
23192305|NCT03114969|64445894|FG008|Overall Study|Lost to Follow-up|0|||
23192306|NCT03114969|64445886|FG000|Overall Study|Adverse Event|0|||
23253420|NCT00568776|64668031|FG002|Overall Study|Protocol Violation|1|||
23253421|NCT00568776|64668032|FG003|Overall Study|Protocol Violation|1|||
23253422|NCT00568776|64668029|FG000|Overall Study|Withdrawal by Subject|13|||
23359806|NCT03061188|65062729|FG002|On Follow-up for 3 Years|Death|5|||
23359807|NCT03061188|65062730|FG003|On Follow-up for 3 Years|Death|4|||
23359808|NCT03061188|65062727|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
23359809|NCT03061188|65062728|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
23359810|NCT03061188|65062729|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
23359811|NCT03061188|65062730|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
23359812|NCT01462110|65062751|FG000|Overall Study|Adverse Event|1|||
23359813|NCT01462110|65062752|FG001|Overall Study|Adverse Event|0|||
23359814|NCT02020889|65062753|FG000|Overall Study|Adverse Event|0|||
23359815|NCT02020889|65062754|FG001|Overall Study|Adverse Event|1|||
23359816|NCT02020889|65062753|FG000|Overall Study|Lack of Efficacy|1|||
23359817|NCT02020889|65062754|FG001|Overall Study|Lack of Efficacy|0|||
23359818|NCT02020889|65062753|FG000|Overall Study|Lost to Follow-up|1|||
23359819|NCT02020889|65062754|FG001|Overall Study|Lost to Follow-up|0|||
23359820|NCT02020889|65062753|FG000|Overall Study|Physician Decision|2|||
23359821|NCT02020889|65062754|FG001|Overall Study|Physician Decision|0|||
23359822|NCT02020889|65062753|FG000|Overall Study|Withdrawal by Subject|3|||
23359823|NCT02020889|65062754|FG001|Overall Study|Withdrawal by Subject|2|||
23359824|NCT00520039|65062759|FG000|Overall Study|Exclusion criteria met at first visit|7|||
23590814|NCT01883492|65892886|FG000|Overall Study|Poor X-ray quality|7|||
23590815|NCT01883492|65892887|FG001|Overall Study|Poor X-ray quality|4|||
23590816|NCT01883492|65892886|FG000|Overall Study|Withdrawal by Subject|1|||
23192307|NCT03114969|64445887|FG001|Overall Study|Adverse Event|0|||
23192308|NCT03114969|64445888|FG002|Overall Study|Adverse Event|1|||
23192309|NCT03114969|64445889|FG003|Overall Study|Adverse Event|0|||
23192310|NCT03114969|64445890|FG004|Overall Study|Adverse Event|0|||
23192311|NCT03114969|64445891|FG005|Overall Study|Adverse Event|1|||
23192312|NCT03114969|64445892|FG006|Overall Study|Adverse Event|1|||
23192313|NCT03114969|64445893|FG007|Overall Study|Adverse Event|0|||
23192314|NCT03114969|64445894|FG008|Overall Study|Adverse Event|2|||
23359825|NCT00520039|65062760|FG001|Overall Study|Exclusion criteria met at first visit|5|||
23359826|NCT01404949|65062761|FG000|Overall Study|Not Treated|1|||
23359827|NCT00435461|65062762|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
23192315|NCT00306891|64445900|FG000|Part A|Withdrawal by Subject|1|||
23359828|NCT00435461|65062763|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
23359829|NCT00435461|65062764|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
23359830|NCT00435461|65062762|FG000|Overall Study|Protocol Violation|6|||
23359831|NCT00435461|65062763|FG001|Overall Study|Protocol Violation|9|||
23359832|NCT00435461|65062764|FG002|Overall Study|Protocol Violation|10|||
23359833|NCT00435461|65062762|FG000|Overall Study|Participant randomized(inadequate score)|1|||
23359834|NCT00435461|65062763|FG001|Overall Study|Participant randomized(inadequate score)|0|||
23359835|NCT00435461|65062764|FG002|Overall Study|Participant randomized(inadequate score)|0|||
23359836|NCT00435461|65062762|FG000|Overall Study|Compliance less than 80 percent|1|||
23359837|NCT00435461|65062763|FG001|Overall Study|Compliance less than 80 percent|0|||
23359838|NCT00435461|65062764|FG002|Overall Study|Compliance less than 80 percent|0|||
23359839|NCT00435461|65062762|FG000|Overall Study|In error, two study medications switched|1|||
23359840|NCT00435461|65062763|FG001|Overall Study|In error, two study medications switched|0|||
23359841|NCT00435461|65062764|FG002|Overall Study|In error, two study medications switched|0|||
23359842|NCT00435461|65062762|FG000|Overall Study|Lack of Efficacy|2|||
23359843|NCT00435461|65062763|FG001|Overall Study|Lack of Efficacy|1|||
23253423|NCT00568776|64668030|FG001|Overall Study|Withdrawal by Subject|15|||
23253424|NCT00568776|64668031|FG002|Overall Study|Withdrawal by Subject|13|||
23253425|NCT00568776|64668032|FG003|Overall Study|Withdrawal by Subject|7|||
23253426|NCT00568776|64668029|FG000|Overall Study|Loss of Caregiver|0|||
23253427|NCT00568776|64668030|FG001|Overall Study|Loss of Caregiver|2|||
23253428|NCT00568776|64668031|FG002|Overall Study|Loss of Caregiver|1|||
23253429|NCT00568776|64668032|FG003|Overall Study|Loss of Caregiver|2|||
23253430|NCT00568776|64668029|FG000|Overall Study|Sponsor Decision|2|||
23253431|NCT00568776|64668030|FG001|Overall Study|Sponsor Decision|2|||
23253432|NCT00568776|64668031|FG002|Overall Study|Sponsor Decision|41|||
23253433|NCT00568776|64668032|FG003|Overall Study|Sponsor Decision|42|||
23253434|NCT00568776|64668029|FG000|Overall Study|Miscellaeneous|3|||
23253435|NCT00568776|64668030|FG001|Overall Study|Miscellaeneous|3|||
23253436|NCT00568776|64668031|FG002|Overall Study|Miscellaeneous|1|||
23253437|NCT00568776|64668032|FG003|Overall Study|Miscellaeneous|4|||
23253438|NCT04147611|64668033|FG000|Overall Study|Physician Decision|0|||
23253439|NCT04147611|64668034|FG001|Overall Study|Physician Decision|1|||
23253440|NCT03734679|64668037|FG000|Overall Study|Missed Visit|1|||
23253441|NCT01392170|64670216|FG000|Overall Study|Withdrawal by Subject|1|||
23253442|NCT01392170|64670216|FG000|Overall Study|Ineligible|1|||
23253443|NCT02477696|64670217|FG000|Overall Study|Death|89|||
23253444|NCT02477696|64670218|FG001|Overall Study|Death|106|||
23253445|NCT02477696|64670217|FG000|Overall Study|Lost to Follow-up|7|||
23253446|NCT02477696|64670218|FG001|Overall Study|Lost to Follow-up|5|||
23253447|NCT02477696|64670217|FG000|Overall Study|Withdrawal by Subject|37|||
23253448|NCT02477696|64670218|FG001|Overall Study|Withdrawal by Subject|34|||
23253449|NCT02477696|64670217|FG000|Overall Study|Physician Decision|7|||
23253450|NCT02477696|64670218|FG001|Overall Study|Physician Decision|9|||
23253451|NCT02477696|64670217|FG000|Overall Study|Study terminated by sponsor|103|||
23253452|NCT02477696|64670218|FG001|Overall Study|Study terminated by sponsor|99|||
23253453|NCT02477696|64670217|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
23253454|NCT02477696|64670218|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
23253455|NCT02477696|64670217|FG000|Overall Study|Missing/Unknown|2|||
23253456|NCT02477696|64670218|FG001|Overall Study|Missing/Unknown|0|||
23253457|NCT02923115|64670219|FG000|Overall Study|Lost to Follow-up|0|||
23253458|NCT02923115|64670220|FG001|Overall Study|Lost to Follow-up|0|||
23253459|NCT02923115|64670221|FG002|Overall Study|Lost to Follow-up|0|||
23253460|NCT02923115|64670222|FG003|Overall Study|Lost to Follow-up|1|||
23253461|NCT02923115|64670223|FG004|Overall Study|Lost to Follow-up|0|||
23253462|NCT02923115|64670224|FG005|Overall Study|Lost to Follow-up|0|||
23253463|NCT02923115|64670219|FG000|Overall Study|Withdrawal by Subject|0|||
23253464|NCT02923115|64670220|FG001|Overall Study|Withdrawal by Subject|1|||
23253465|NCT02923115|64670221|FG002|Overall Study|Withdrawal by Subject|0|||
23253466|NCT02923115|64670222|FG003|Overall Study|Withdrawal by Subject|0|||
23253467|NCT02923115|64670223|FG004|Overall Study|Withdrawal by Subject|0|||
23253468|NCT02923115|64670224|FG005|Overall Study|Withdrawal by Subject|0|||
23253469|NCT02923115|64670219|FG000|Overall Study|Randomized, but not dosed|0|||
23253470|NCT02923115|64670220|FG001|Overall Study|Randomized, but not dosed|0|||
23253471|NCT02923115|64670221|FG002|Overall Study|Randomized, but not dosed|3|||
23253472|NCT02923115|64670222|FG003|Overall Study|Randomized, but not dosed|1|||
23253473|NCT02923115|64670223|FG004|Overall Study|Randomized, but not dosed|5|||
23253474|NCT02923115|64670224|FG005|Overall Study|Randomized, but not dosed|0|||
23253475|NCT00971204|64670227|FG000|Overall Study|Did not meet all criteria-not treated|14|||
23253476|NCT00971204|64670227|FG000|Overall Study|Lost to Follow-up|10|||
23253477|NCT02953262|64670228|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
23253478|NCT02953262|64670229|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
23359844|NCT00435461|65062764|FG002|Overall Study|Lack of Efficacy|0|||
23359845|NCT00435461|65062762|FG000|Overall Study|Withdrawal by Subject|1|||
23253479|NCT02953262|64670230|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
23590817|NCT01883492|65892887|FG001|Overall Study|Withdrawal by Subject|0|||
23590818|NCT01883492|65892886|FG000|Overall Study|inappropriate implant used|1|||
23590819|NCT01883492|65892887|FG001|Overall Study|inappropriate implant used|1|||
23590820|NCT01883492|65892886|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
23590821|NCT01883492|65892887|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
23590822|NCT01184508|65892888|FG000|Overall Study|Adverse Event|4|||
23253480|NCT02953262|64670231|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
23253481|NCT00681824|64670236|FG000|Overall Study|withdrawn by investigator|0|||
23253482|NCT00681824|64670237|FG001|Overall Study|withdrawn by investigator|0|||
23253483|NCT00681824|64670238|FG002|Overall Study|withdrawn by investigator|1|||
23253484|NCT00681824|64670236|FG000|Overall Study|scheduling conflict|1|||
23253485|NCT00681824|64670237|FG001|Overall Study|scheduling conflict|0|||
23253486|NCT00681824|64670238|FG002|Overall Study|scheduling conflict|0|||
23253487|NCT00681824|64670236|FG000|Overall Study|Death|0|||
23192316|NCT00306891|64445901|FG001|Part A|Withdrawal by Subject|1|||
23192317|NCT00306891|64445902|FG002|Part A|Withdrawal by Subject|0|||
23253488|NCT00681824|64670237|FG001|Overall Study|Death|1|||
23253489|NCT00681824|64670238|FG002|Overall Study|Death|0|||
23253490|NCT01458119|64670239|FG000|Overall Study|Physician Decision|4|||
23253491|NCT01458119|64670239|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
23253492|NCT01458119|64670239|FG000|Overall Study|Pregnancy|1|||
23253493|NCT01458119|64670239|FG000|Overall Study|Death|2|||
23253494|NCT01458119|64670239|FG000|Overall Study|Adverse Event|1|||
23253495|NCT01458119|64670239|FG000|Overall Study|Consent Withdrawn by Participant|8|||
23253496|NCT01458119|64670239|FG000|Overall Study|Non-compliance With Study Drug|3|||
23253497|NCT02236754|64670240|FG000|Overall Study|Withdrawal by Subject|1|||
23253498|NCT02236754|64670241|FG001|Overall Study|Withdrawal by Subject|0|||
23253499|NCT00051636|64670242|FG000|Period 1 - Core|Adverse Event|2|||
23253500|NCT00051636|64670243|FG001|Period 1 - Core|Adverse Event|2|||
23253501|NCT00051636|64670242|FG000|Period 1 - Core|Protocol Violation|1|||
23253502|NCT00051636|64670243|FG001|Period 1 - Core|Protocol Violation|0|||
23253503|NCT00051636|64670242|FG000|Period 1 - Core|Withdrawal by Subject|1|||
23253504|NCT00051636|64670243|FG001|Period 1 - Core|Withdrawal by Subject|2|||
23359846|NCT00435461|65062763|FG001|Overall Study|Withdrawal by Subject|0|||
23590823|NCT01184508|65892889|FG001|Overall Study|Adverse Event|6|||
23192318|NCT00306891|64445903|FG003|Part A|Withdrawal by Subject|0|||
23192319|NCT00306891|64445900|FG000|Part A|Condition under investigation worsened|2|||
23192320|NCT00306891|64445901|FG001|Part A|Condition under investigation worsened|2|||
23192321|NCT00306891|64445902|FG002|Part A|Condition under investigation worsened|0|||
23192322|NCT00306891|64445903|FG003|Part A|Condition under investigation worsened|0|||
23192323|NCT00306891|64445900|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
23192324|NCT00306891|64445901|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
23192325|NCT00306891|64445902|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
23192326|NCT00306891|64445903|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
23192327|NCT00306891|64445900|FG000|Part A|Partial bowel obstruction|1|||
23192328|NCT00306891|64445901|FG001|Part A|Partial bowel obstruction|0|||
23192329|NCT00306891|64445902|FG002|Part A|Partial bowel obstruction|0|||
23192330|NCT00306891|64445903|FG003|Part A|Partial bowel obstruction|0|||
23192331|NCT00306891|64445900|FG000|Part A|Reaccumul. of ascites following drainage|0|||
23192332|NCT00306891|64445901|FG001|Part A|Reaccumul. of ascites following drainage|1|||
23192333|NCT00306891|64445902|FG002|Part A|Reaccumul. of ascites following drainage|0|||
23192334|NCT00306891|64445903|FG003|Part A|Reaccumul. of ascites following drainage|0|||
23192335|NCT00306891|64445900|FG000|Part A|Suspicion of second malignancy|0|||
23192336|NCT00306891|64445901|FG001|Part A|Suspicion of second malignancy|1|||
23192337|NCT00306891|64445902|FG002|Part A|Suspicion of second malignancy|0|||
23590824|NCT01184508|65892888|FG000|Overall Study|Lack of Efficacy|1|||
23590825|NCT01184508|65892889|FG001|Overall Study|Lack of Efficacy|1|||
23590826|NCT01184508|65892888|FG000|Overall Study|Lost to Follow-up|1|||
23590827|NCT01184508|65892889|FG001|Overall Study|Lost to Follow-up|1|||
23590828|NCT01184508|65892888|FG000|Overall Study|Physician Decision|1|||
23590829|NCT01184508|65892889|FG001|Overall Study|Physician Decision|0|||
23590830|NCT01184508|65892888|FG000|Overall Study|Protocol Violation|3|||
23192338|NCT00306891|64445903|FG003|Part A|Suspicion of second malignancy|0|||
23253505|NCT00051636|64670242|FG000|Period 1 - Core|Lost to Follow-up|0|||
23590831|NCT01184508|65892889|FG001|Overall Study|Protocol Violation|1|||
23590832|NCT01184508|65892888|FG000|Overall Study|Sponsor Decision|5|||
23192339|NCT00306891|64445900|FG000|Part A|QTC interval outwith elig. criteria|1|||
23192340|NCT00306891|64445901|FG001|Part A|QTC interval outwith elig. criteria|0|||
23253506|NCT00051636|64670243|FG001|Period 1 - Core|Lost to Follow-up|2|||
23359847|NCT00435461|65062764|FG002|Overall Study|Withdrawal by Subject|2|||
23253507|NCT00051636|64670242|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
23253508|NCT00051636|64670243|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
23253509|NCT00051636|64670242|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
23253510|NCT00051636|64670243|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
23253511|NCT00051636|64670242|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
23253512|NCT00051636|64670243|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
23253513|NCT00051636|64670242|FG000|Period 2- Extended Observation Period|Death|4|||
23253514|NCT00051636|64670243|FG001|Period 2- Extended Observation Period|Death|5|||
23359848|NCT00435461|65062762|FG000|Overall Study|Randomized in error|1|||
23359849|NCT00435461|65062763|FG001|Overall Study|Randomized in error|0|||
23359850|NCT00435461|65062764|FG002|Overall Study|Randomized in error|0|||
23359851|NCT00435461|65062762|FG000|Overall Study|Participant could not tolerate symptoms|0|||
23253515|NCT00051636|64670242|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
23253516|NCT00051636|64670243|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
23253517|NCT01401478|64670244|FG000|Overall Study|Study drug not available|6|||
23253518|NCT01401478|64670244|FG000|Overall Study|Adverse Event|5|||
23253519|NCT01401478|64670244|FG000|Overall Study|Hyperphosphatemia|5|||
23253520|NCT01401478|64670244|FG000|Overall Study|Lost to Follow-up|5|||
23253521|NCT01401478|64670244|FG000|Overall Study|Kidney transplantation|3|||
23253522|NCT01401478|64670244|FG000|Overall Study|Withdrawal by Subject|3|||
23253523|NCT01401478|64670244|FG000|Overall Study|Blood samples not available|1|||
23253524|NCT01401478|64670244|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
23253525|NCT01401478|64670244|FG000|Overall Study|Low intact parathyroid hormone|1|||
23253526|NCT01401478|64670244|FG000|Overall Study|Serious adverse event|1|||
23253527|NCT01408576|64670245|FG000|Overall Study|Lack of Efficacy|17|||
23253528|NCT01408576|64670246|FG001|Overall Study|Lack of Efficacy|30|||
23253529|NCT01408576|64670247|FG002|Overall Study|Lack of Efficacy|48|||
23253530|NCT01408576|64670245|FG000|Overall Study|Protocol Violation|1|||
23253531|NCT01408576|64670246|FG001|Overall Study|Protocol Violation|2|||
23253532|NCT01408576|64670247|FG002|Overall Study|Protocol Violation|2|||
23253533|NCT01408576|64670245|FG000|Overall Study|Lost to Follow-up|10|||
23253534|NCT01408576|64670246|FG001|Overall Study|Lost to Follow-up|9|||
23253535|NCT01408576|64670247|FG002|Overall Study|Lost to Follow-up|17|||
23359852|NCT00435461|65062763|FG001|Overall Study|Participant could not tolerate symptoms|0|||
23359853|NCT00435461|65062764|FG002|Overall Study|Participant could not tolerate symptoms|1|||
23359854|NCT00435461|65062762|FG000|Overall Study|Participant could not swallow capsule|0|||
23359855|NCT00435461|65062763|FG001|Overall Study|Participant could not swallow capsule|0|||
23359856|NCT00435461|65062764|FG002|Overall Study|Participant could not swallow capsule|1|||
23359857|NCT00435461|65062762|FG000|Overall Study|Pregnancy|2|||
23359858|NCT00435461|65062763|FG001|Overall Study|Pregnancy|0|||
23359859|NCT00435461|65062764|FG002|Overall Study|Pregnancy|0|||
23359860|NCT00435461|65062762|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
23359861|NCT00435461|65062763|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
23359862|NCT00435461|65062764|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
23359863|NCT00435461|65062762|FG000|Overall Study|Participant ended study one day early|1|||
23359864|NCT00435461|65062763|FG001|Overall Study|Participant ended study one day early|0|||
23359865|NCT00435461|65062764|FG002|Overall Study|Participant ended study one day early|0|||
23359866|NCT00435461|65062762|FG000|Overall Study|Noncompliance with study requirements|1|||
23359867|NCT00435461|65062763|FG001|Overall Study|Noncompliance with study requirements|1|||
23359868|NCT00435461|65062764|FG002|Overall Study|Noncompliance with study requirements|1|||
23359869|NCT00435461|65062762|FG000|Overall Study|Adverse Event|1|||
23253536|NCT01408576|64670245|FG000|Overall Study|Withdrawal by Subject|34|||
23253537|NCT01408576|64670246|FG001|Overall Study|Withdrawal by Subject|60|||
23253538|NCT01408576|64670247|FG002|Overall Study|Withdrawal by Subject|66|||
23253539|NCT01408576|64670245|FG000|Overall Study|Sponsor terminated study|89|||
23476225|NCT00282347|65488028|FG000|Treatment Period|Lost to Follow-up|2|||
23476226|NCT00282347|65488029|FG001|Treatment Period|Lost to Follow-up|5|||
23476227|NCT00282347|65488028|FG000|Treatment Period|Withdrawal by Subject|1|||
23476228|NCT00282347|65488029|FG001|Treatment Period|Withdrawal by Subject|3|||
23476229|NCT00282347|65488028|FG000|Treatment Period|Physician Decision|0|||
23476230|NCT00282347|65488029|FG001|Treatment Period|Physician Decision|1|||
23476231|NCT00282347|65488028|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
23476232|NCT00282347|65488029|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
23476233|NCT00282347|65488028|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
23476234|NCT00282347|65488029|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
23476235|NCT00282347|65488028|FG000|Safety Follow-up Period|Physician Decision|1|||
23476236|NCT00282347|65488029|FG001|Safety Follow-up Period|Physician Decision|1|||
23476237|NCT00282347|65488028|FG000|Safety Follow-up Period|Protocol Deviation|0|||
23476238|NCT00282347|65488029|FG001|Safety Follow-up Period|Protocol Deviation|2|||
23476239|NCT00282347|65488028|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
23476240|NCT00282347|65488029|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
23476241|NCT00282347|65488028|FG000|B Cell Follow-up Period|Physician Decision|1|||
23476242|NCT00282347|65488029|FG001|B Cell Follow-up Period|Physician Decision|0|||
23476243|NCT00282347|65488028|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
23476244|NCT00282347|65488029|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
23476245|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476246|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476247|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476248|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476249|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23476250|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
23476251|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
23192341|NCT00306891|64445902|FG002|Part A|QTC interval outwith elig. criteria|0|||
23192342|NCT00306891|64445903|FG003|Part A|QTC interval outwith elig. criteria|0|||
23192343|NCT00306891|64445900|FG000|Part B|Death|0|||
23192344|NCT00306891|64445901|FG001|Part B|Death|0|||
23192345|NCT00306891|64445902|FG002|Part B|Death|1|||
23192346|NCT00306891|64445903|FG003|Part B|Death|2|||
23192347|NCT00306891|64445900|FG000|Part B|Adverse Event|0|||
23192348|NCT00306891|64445901|FG001|Part B|Adverse Event|0|||
23192349|NCT00306891|64445902|FG002|Part B|Adverse Event|5|||
23192350|NCT00306891|64445903|FG003|Part B|Adverse Event|5|||
23192351|NCT00306891|64445900|FG000|Part B|Withdrawal by Subject|0|||
23192352|NCT00306891|64445901|FG001|Part B|Withdrawal by Subject|0|||
23192353|NCT00306891|64445902|FG002|Part B|Withdrawal by Subject|3|||
23192354|NCT00306891|64445903|FG003|Part B|Withdrawal by Subject|1|||
23192355|NCT00306891|64445900|FG000|Part B|Condition under investigation worsened|0|||
23192356|NCT00306891|64445901|FG001|Part B|Condition under investigation worsened|0|||
23192357|NCT00306891|64445902|FG002|Part B|Condition under investigation worsened|2|||
23192358|NCT00306891|64445903|FG003|Part B|Condition under investigation worsened|8|||
23192359|NCT00306891|64445900|FG000|Part B|Development of study specific disc crit.|0|||
23192360|NCT00306891|64445901|FG001|Part B|Development of study specific disc crit.|0|||
23192361|NCT00306891|64445902|FG002|Part B|Development of study specific disc crit.|0|||
23192362|NCT00306891|64445903|FG003|Part B|Development of study specific disc crit.|1|||
23192363|NCT00663858|64445906|FG000|Overall Study|Adverse Event|9|||
23192364|NCT00663858|64445907|FG001|Overall Study|Adverse Event|1|||
23192365|NCT00663858|64445908|FG002|Overall Study|Adverse Event|6|||
23192366|NCT00663858|64445906|FG000|Overall Study|Lack of Efficacy|5|||
23192367|NCT00663858|64445907|FG001|Overall Study|Lack of Efficacy|1|||
23192368|NCT00663858|64445908|FG002|Overall Study|Lack of Efficacy|3|||
23192369|NCT00663858|64445906|FG000|Overall Study|Withdrawal by Subject|7|||
23192370|NCT00663858|64445907|FG001|Overall Study|Withdrawal by Subject|3|||
23192371|NCT00663858|64445908|FG002|Overall Study|Withdrawal by Subject|3|||
23192372|NCT00663858|64445906|FG000|Overall Study|Protocol Violation|5|||
23192373|NCT00663858|64445907|FG001|Overall Study|Protocol Violation|3|||
23192374|NCT00663858|64445908|FG002|Overall Study|Protocol Violation|4|||
23192375|NCT00663858|64445906|FG000|Overall Study|Other|8|||
23476252|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23192376|NCT00663858|64445907|FG001|Overall Study|Other|2|||
23192377|NCT00663858|64445908|FG002|Overall Study|Other|4|||
23192378|NCT02031146|64445917|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
23253540|NCT01408576|64670246|FG001|Overall Study|Sponsor terminated study|333|||
23192379|NCT02031146|64445918|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
23192380|NCT02031146|64445919|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
23192381|NCT02031146|64445920|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
23192382|NCT02031146|64445921|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
23253541|NCT01408576|64670247|FG002|Overall Study|Sponsor terminated study|330|||
23253542|NCT01408576|64670245|FG000|Overall Study|AE, serious fatal|4|||
23253543|NCT01408576|64670246|FG001|Overall Study|AE, serious fatal|4|||
23253544|NCT01408576|64670247|FG002|Overall Study|AE, serious fatal|1|||
23253545|NCT01408576|64670245|FG000|Overall Study|SAE, non-fatal|11|||
23253546|NCT01408576|64670246|FG001|Overall Study|SAE, non-fatal|23|||
23253547|NCT01408576|64670247|FG002|Overall Study|SAE, non-fatal|14|||
23253548|NCT01408576|64670245|FG000|Overall Study|AE, non-serious non-fatal|12|||
23253549|NCT01408576|64670246|FG001|Overall Study|AE, non-serious non-fatal|19|||
23253550|NCT01408576|64670247|FG002|Overall Study|AE, non-serious non-fatal|11|||
23253551|NCT01408576|64670245|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23253552|NCT01408576|64670246|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23253553|NCT01408576|64670247|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23192383|NCT02031146|64445922|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
23192384|NCT02031146|64445923|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
23192385|NCT03000452|64445924|FG000|Treatment Period|Death|1|||
23192386|NCT03000452|64445924|FG000|Treatment Period|Progressive Disease (PD)|14|||
23192387|NCT03000452|64445924|FG000|Treatment Period|Physician Decision|1|||
23192388|NCT03000452|64445924|FG000|Treatment Period|Miscellaneous|2|||
23192389|NCT03000452|64445924|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
23192390|NCT03000452|64445924|FG000|Follow-Up Period|Death|3|||
23192391|NCT03000452|64445924|FG000|Follow-Up Period|Withdrawal by Subject|3|||
23192392|NCT00621023|64445925|FG000|Overall Study|Death|5|||
23192393|NCT00621023|64445925|FG000|Overall Study|Follow up discontinued|1|||
23192394|NCT01663740|64445926|FG000|Overall Study|Lost to Follow-up|1|||
23192395|NCT01663740|64445927|FG001|Overall Study|Lost to Follow-up|4|||
23192396|NCT01663740|64445926|FG000|Overall Study|Other|9|||
23192397|NCT01663740|64445927|FG001|Overall Study|Other|2|||
23192398|NCT01663740|64445926|FG000|Overall Study|Inclusion/Exclusion not met|1|||
23192399|NCT01663740|64445927|FG001|Overall Study|Inclusion/Exclusion not met|0|||
23192400|NCT01663740|64445926|FG000|Overall Study|Death|0|||
23192401|NCT01663740|64445927|FG001|Overall Study|Death|1|||
23192402|NCT01663740|64445926|FG000|Overall Study|Withdrawal by Subject|2|||
23192403|NCT01663740|64445927|FG001|Overall Study|Withdrawal by Subject|1|||
23192404|NCT01663740|64445926|FG000|Overall Study|No end of study status|3|||
23192405|NCT01663740|64445927|FG001|Overall Study|No end of study status|0|||
23192406|NCT03517722|64445928|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
23192407|NCT03517722|64445929|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
23192408|NCT03517722|64445928|FG000|Double Blind Period: Week 0-52|Death|0|||
23192409|NCT03517722|64445929|FG001|Double Blind Period: Week 0-52|Death|4|||
23192410|NCT03517722|64445928|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
23192411|NCT03517722|64445929|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
23192412|NCT03517722|64445928|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
23192413|NCT03517722|64445929|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
23192414|NCT03517722|64445928|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
23192415|NCT03517722|64445929|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
23192416|NCT03517722|64445928|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
23192417|NCT03517722|64445929|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
23192418|NCT03517722|64445928|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
23192419|NCT03517722|64445929|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
23192420|NCT03517722|64445928|FG000|Double Blind Period: Week 0-52|Other|4|||
23192421|NCT03517722|64445929|FG001|Double Blind Period: Week 0-52|Other|3|||
23192422|NCT03517722|64445928|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
23192423|NCT03517722|64445929|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
23192424|NCT03517722|64445928|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
23192425|NCT03517722|64445929|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
23192426|NCT03517722|64445928|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
23192427|NCT03517722|64445929|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
23192428|NCT03517722|64445928|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
23192429|NCT03517722|64445929|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
23192430|NCT03517722|64445928|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
23192431|NCT03517722|64445929|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
23192432|NCT01713348|64445930|FG000|Overall Study|Withdrawal by Subject|3|||
23192433|NCT01713348|64445931|FG001|Overall Study|Withdrawal by Subject|2|||
23192434|NCT01713348|64445932|FG002|Overall Study|Withdrawal by Subject|2|||
23192435|NCT01713348|64445933|FG003|Overall Study|Withdrawal by Subject|0|||
23253554|NCT01408576|64670245|FG000|Overall Study|AE, unknown type|0|||
23253555|NCT01408576|64670246|FG001|Overall Study|AE, unknown type|1|||
23476253|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23253556|NCT01408576|64670247|FG002|Overall Study|AE, unknown type|0|||
23192436|NCT01713348|64445930|FG000|Overall Study|Lost to Follow-up|1|||
23192437|NCT01713348|64445931|FG001|Overall Study|Lost to Follow-up|0|||
23253557|NCT01408576|64670245|FG000|Overall Study|Other|10|||
23192438|NCT01713348|64445932|FG002|Overall Study|Lost to Follow-up|0|||
23192439|NCT01713348|64445933|FG003|Overall Study|Lost to Follow-up|0|||
23192440|NCT04814823|64445934|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
23192441|NCT02614794|64445937|FG000|Overall Study|Death|258|||
23192442|NCT02614794|64445938|FG001|Overall Study|Death|151|||
23253558|NCT01408576|64670246|FG001|Overall Study|Other|16|||
23253559|NCT01408576|64670247|FG002|Overall Study|Other|18|||
23253560|NCT03836729|64670251|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
23253561|NCT01488071|64670252|FG000|Overall Study|Adverse Event|15|||
23253562|NCT01488071|64670253|FG001|Overall Study|Adverse Event|23|||
23253563|NCT01488071|64670252|FG000|Overall Study|Lack of Efficacy|11|||
23253564|NCT01488071|64670253|FG001|Overall Study|Lack of Efficacy|17|||
23359870|NCT00435461|65062763|FG001|Overall Study|Adverse Event|2|||
23359871|NCT00435461|65062764|FG002|Overall Study|Adverse Event|6|||
23359872|NCT00435461|65062762|FG000|Overall Study|Non-Compliance of diary|2|||
23359873|NCT00435461|65062763|FG001|Overall Study|Non-Compliance of diary|0|||
23359874|NCT00435461|65062764|FG002|Overall Study|Non-Compliance of diary|1|||
23359875|NCT00435461|65062762|FG000|Overall Study|Lost to Follow-up|1|||
23359876|NCT00435461|65062763|FG001|Overall Study|Lost to Follow-up|1|||
23359877|NCT00435461|65062764|FG002|Overall Study|Lost to Follow-up|2|||
23359878|NCT03810456|65062766|FG000|Treatment|Urgent Family Matters|3|||
23359879|NCT03810456|65062767|FG001|Treatment|Urgent Family Matters|0|||
23359880|NCT03810456|65062768|FG002|Treatment|Urgent Family Matters|0|||
23359881|NCT03810456|65062766|FG000|Treatment|Scheduling Conflicts|0|||
23359882|NCT03810456|65062767|FG001|Treatment|Scheduling Conflicts|11|||
23359883|NCT03810456|65062768|FG002|Treatment|Scheduling Conflicts|0|||
23359884|NCT03810456|65062766|FG000|Treatment|No Longer Interested|0|||
23359885|NCT03810456|65062767|FG001|Treatment|No Longer Interested|12|||
23359886|NCT03810456|65062768|FG002|Treatment|No Longer Interested|0|||
23359887|NCT03810456|65062766|FG000|Treatment|Transportation Issues|0|||
23359888|NCT03810456|65062767|FG001|Treatment|Transportation Issues|1|||
23359889|NCT03810456|65062768|FG002|Treatment|Transportation Issues|0|||
23359890|NCT03810456|65062766|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
23359891|NCT03810456|65062767|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
23359892|NCT03810456|65062768|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
23359893|NCT03810456|65062766|FG000|1 Month Follow-Up|Relocated to Different State|1|||
23359894|NCT03810456|65062767|FG001|1 Month Follow-Up|Relocated to Different State|0|||
23192443|NCT02614794|64445937|FG000|Overall Study|Study closure by Sponsor|119|||
23192444|NCT02614794|64445938|FG001|Overall Study|Study closure by Sponsor|45|||
23192445|NCT02614794|64445937|FG000|Overall Study|Withdrawal by Subject|24|||
23192446|NCT02614794|64445938|FG001|Overall Study|Withdrawal by Subject|5|||
23192447|NCT02614794|64445937|FG000|Overall Study|Lost to Follow-up|7|||
23192448|NCT02614794|64445938|FG001|Overall Study|Lost to Follow-up|0|||
23192449|NCT02614794|64445937|FG000|Overall Study|Physician Decision|1|||
23192450|NCT02614794|64445938|FG001|Overall Study|Physician Decision|1|||
23192451|NCT02614794|64445937|FG000|Overall Study|Hospital closure|1|||
23192452|NCT02614794|64445938|FG001|Overall Study|Hospital closure|0|||
23192453|NCT00443560|64445939|FG000|Overall Study|No intrathecal dose|58|||
23359895|NCT03810456|65062768|FG002|1 Month Follow-Up|Relocated to Different State|1|||
23359896|NCT03810456|65062766|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
23192454|NCT00443560|64445940|FG001|Overall Study|No intrathecal dose|26|||
23253565|NCT01488071|64670252|FG000|Overall Study|Non-compliance with study drug|2|||
23359897|NCT03810456|65062767|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
23359898|NCT03810456|65062768|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
23359899|NCT03810456|65062766|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
23359900|NCT03810456|65062767|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
23192455|NCT00443560|64445939|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
23192456|NCT00443560|64445940|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
23192457|NCT02388776|64445946|FG000|Overall Study|Death|1|||
23192458|NCT02388776|64445946|FG000|Overall Study|Lost to Follow-up|1|||
23192459|NCT00482001|64445947|FG000|Overall Study|Protocol Violation|1|||
23192460|NCT00482001|64445948|FG001|Overall Study|Protocol Violation|1|||
23192461|NCT01024465|64445956|FG000|Overall Study|Adverse Event|2|||
23192462|NCT01024465|64445956|FG000|Overall Study|Physician Decision|1|||
23192463|NCT01330381|64445959|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
23192464|NCT01330381|64445960|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
23192465|NCT01330381|64445961|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
23192466|NCT01330381|64445959|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
23192467|NCT01330381|64445960|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
23192468|NCT01330381|64445961|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
23192469|NCT01330381|64445959|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
23192470|NCT01330381|64445960|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
23192471|NCT01330381|64445961|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
23253566|NCT01488071|64670253|FG001|Overall Study|Non-compliance with study drug|0|||
23476254|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
23476255|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23476256|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23476257|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23476258|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
23476259|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
23476260|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476261|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476262|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476263|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476264|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23476265|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
23253567|NCT01488071|64670252|FG000|Overall Study|Protocol Violation|5|||
23253568|NCT01488071|64670253|FG001|Overall Study|Protocol Violation|7|||
23253569|NCT01488071|64670252|FG000|Overall Study|Withdrawal of Consent|14|||
23253570|NCT01488071|64670253|FG001|Overall Study|Withdrawal of Consent|12|||
23253571|NCT01488071|64670252|FG000|Overall Study|Lost to Follow-up|1|||
23590833|NCT01184508|65892889|FG001|Overall Study|Sponsor Decision|2|||
23590834|NCT01184508|65892888|FG000|Overall Study|Withdrawal by Subject|1|||
23590835|NCT01184508|65892889|FG001|Overall Study|Withdrawal by Subject|3|||
23590836|NCT01184508|65892888|FG000|Overall Study|Randomized, Not Treated|0|||
23590837|NCT01184508|65892889|FG001|Overall Study|Randomized, Not Treated|1|||
23590838|NCT01063517|65892890|FG000|Overall Study|Consent withdrawal|1|||
23590839|NCT01063517|65892891|FG001|Overall Study|Consent withdrawal|0|||
23590840|NCT01063517|65892890|FG000|Overall Study|Study reached data cut-off|19|||
23590841|NCT01063517|65892891|FG001|Overall Study|Study reached data cut-off|7|||
23590842|NCT01063517|65892890|FG000|Overall Study|Lost to Follow-up|4|||
23590843|NCT01063517|65892891|FG001|Overall Study|Lost to Follow-up|3|||
23590844|NCT01063517|65892890|FG000|Overall Study|Withdrawal by Subject|1|||
23590845|NCT01063517|65892891|FG001|Overall Study|Withdrawal by Subject|2|||
23590846|NCT01063517|65892890|FG000|Overall Study|Death|33|||
23253572|NCT01488071|64670253|FG001|Overall Study|Lost to Follow-up|0|||
23476266|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
23476267|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
23590847|NCT01063517|65892891|FG001|Overall Study|Death|48|||
23590848|NCT05001945|65892892|FG000|Overall Study|Adverse Event|0|||
23590849|NCT05001945|65892893|FG001|Overall Study|Adverse Event|0|||
23590850|NCT05001945|65892894|FG002|Overall Study|Adverse Event|0|||
23253573|NCT01488071|64670252|FG000|Overall Study|Administrative or Other Reason(s)|5|||
23253574|NCT01488071|64670253|FG001|Overall Study|Administrative or Other Reason(s)|4|||
23253575|NCT03740100|64670257|FG000|Overall Study|Adverse Event|1|||
23253576|NCT03740100|64670257|FG000|Overall Study|Death|1|||
23253577|NCT03578276|64670259|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
23253578|NCT03578276|64670260|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
23359901|NCT03810456|65062768|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
23590851|NCT05001945|65892895|FG003|Overall Study|Adverse Event|1|||
23590852|NCT05001945|65892896|FG004|Overall Study|Adverse Event|0|||
23253579|NCT00457665|64670261|FG000|12 Months|Drug allergy|1|||
23253580|NCT00457665|64670262|FG001|12 Months|Drug allergy|1|||
23359902|NCT03810456|65062766|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
23192472|NCT01330381|64445959|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
23253581|NCT00457665|64670261|FG000|12 Months|High HIV viral load|5|||
23359903|NCT03810456|65062767|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
23359904|NCT03810456|65062768|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
23359905|NCT03810456|65062766|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
23359906|NCT03810456|65062767|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
23359907|NCT03810456|65062768|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
23359908|NCT03810456|65062766|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
23359909|NCT03810456|65062767|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
23476268|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
23253582|NCT00457665|64670262|FG001|12 Months|High HIV viral load|1|||
23253583|NCT00457665|64670261|FG000|12 Months|Lipodystrophy|2|||
23253584|NCT00457665|64670262|FG001|12 Months|Lipodystrophy|0|||
23253585|NCT00457665|64670261|FG000|12 Months|Withdrawal by Subject|0|||
23253586|NCT00457665|64670262|FG001|12 Months|Withdrawal by Subject|2|||
23253587|NCT00457665|64670261|FG000|12 Months|Abnormal Liver function tests|0|||
23253588|NCT00457665|64670262|FG001|12 Months|Abnormal Liver function tests|5|||
23253589|NCT00457665|64670261|FG000|24 Months|Withdrawal by Subject|3|||
23253590|NCT00457665|64670262|FG001|24 Months|Withdrawal by Subject|2|||
23253591|NCT00457665|64670261|FG000|24 Months|Lipodystrophy|1|||
23253592|NCT00457665|64670262|FG001|24 Months|Lipodystrophy|1|||
23253593|NCT00457665|64670261|FG000|24 Months|Abnormal liver function tests|1|||
23253594|NCT00457665|64670262|FG001|24 Months|Abnormal liver function tests|5|||
23253595|NCT02868281|64670263|FG000|Overall Study|Adverse Event|2|||
23253596|NCT02868281|64670264|FG001|Overall Study|Adverse Event|2|||
23253597|NCT02868281|64670263|FG000|Overall Study|Protocol Violation|13|||
23253598|NCT02868281|64670264|FG001|Overall Study|Protocol Violation|10|||
23253599|NCT02868281|64670263|FG000|Overall Study|Lost to Follow-up|3|||
23253600|NCT02868281|64670264|FG001|Overall Study|Lost to Follow-up|6|||
23253601|NCT02868281|64670263|FG000|Overall Study|Withdrawal by Subject|11|||
23253602|NCT02868281|64670264|FG001|Overall Study|Withdrawal by Subject|15|||
23253603|NCT02868281|64670263|FG000|Overall Study|Physician Decision|2|||
23253604|NCT02868281|64670264|FG001|Overall Study|Physician Decision|0|||
23253605|NCT02868281|64670263|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
23359910|NCT03810456|65062768|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
23359911|NCT02149264|65062769|FG000|Overall Study|Withdrawal by Subject|9|||
23476269|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
23192473|NCT01330381|64445960|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
23192474|NCT01330381|64445961|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
23192475|NCT01330381|64445959|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
23192476|NCT01330381|64445960|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
23192477|NCT01330381|64445961|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
23192478|NCT01330381|64445959|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
23192479|NCT01330381|64445960|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
23192480|NCT01330381|64445961|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
23192481|NCT01330381|64445959|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
23192482|NCT01330381|64445960|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
23192483|NCT01330381|64445961|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
23192484|NCT01330381|64445959|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
23192485|NCT01330381|64445960|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
23192486|NCT01330381|64445961|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
23192487|NCT01330381|64445959|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
23192488|NCT01330381|64445960|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
23192489|NCT01330381|64445961|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
23192490|NCT01330381|64445959|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
23192491|NCT01330381|64445960|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
23192492|NCT01330381|64445961|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
23192493|NCT03705494|64445964|FG000|Overall Study|Lost to Follow-up|2|||
23192494|NCT03705494|64445965|FG001|Overall Study|Lost to Follow-up|1|||
23192495|NCT03705494|64445964|FG000|Overall Study|Withdrawal by Subject|5|||
23192496|NCT03705494|64445965|FG001|Overall Study|Withdrawal by Subject|2|||
23192497|NCT00893789|64445968|FG000|Overall Study|Withdrawal by Subject|3|||
23192498|NCT00893789|64445969|FG001|Overall Study|Withdrawal by Subject|1|||
23192499|NCT00893789|64445970|FG002|Overall Study|Withdrawal by Subject|3|||
23192500|NCT00893789|64445971|FG003|Overall Study|Withdrawal by Subject|1|||
23192501|NCT00893789|64445968|FG000|Overall Study|Noncompliance With Study Drug|1|||
23192502|NCT00893789|64445969|FG001|Overall Study|Noncompliance With Study Drug|0|||
23192503|NCT00893789|64445970|FG002|Overall Study|Noncompliance With Study Drug|1|||
23192504|NCT00893789|64445971|FG003|Overall Study|Noncompliance With Study Drug|2|||
23192505|NCT00893789|64445968|FG000|Overall Study|Noncompliance With Study Procedures|1|||
23192506|NCT00893789|64445969|FG001|Overall Study|Noncompliance With Study Procedures|0|||
23192507|NCT00893789|64445970|FG002|Overall Study|Noncompliance With Study Procedures|0|||
23192508|NCT00893789|64445971|FG003|Overall Study|Noncompliance With Study Procedures|0|||
23590853|NCT05001945|65892897|FG005|Overall Study|Adverse Event|0|||
23590854|NCT05001945|65892898|FG006|Overall Study|Adverse Event|0|||
23590855|NCT05001945|65892899|FG007|Overall Study|Adverse Event|0|||
23590856|NCT05001945|65892892|FG000|Overall Study|Lost to Follow-up|0|||
23590857|NCT05001945|65892893|FG001|Overall Study|Lost to Follow-up|1|||
23590858|NCT05001945|65892894|FG002|Overall Study|Lost to Follow-up|1|||
23590859|NCT05001945|65892895|FG003|Overall Study|Lost to Follow-up|2|||
23590860|NCT05001945|65892896|FG004|Overall Study|Lost to Follow-up|0|||
23590861|NCT05001945|65892897|FG005|Overall Study|Lost to Follow-up|1|||
23590862|NCT05001945|65892898|FG006|Overall Study|Lost to Follow-up|0|||
23590863|NCT05001945|65892899|FG007|Overall Study|Lost to Follow-up|0|||
23590864|NCT05001945|65892892|FG000|Overall Study|Protocol Violation|1|||
23590865|NCT05001945|65892893|FG001|Overall Study|Protocol Violation|0|||
23590866|NCT05001945|65892894|FG002|Overall Study|Protocol Violation|1|||
23590867|NCT05001945|65892895|FG003|Overall Study|Protocol Violation|1|||
23590868|NCT05001945|65892896|FG004|Overall Study|Protocol Violation|0|||
23590869|NCT05001945|65892897|FG005|Overall Study|Protocol Violation|1|||
23590870|NCT05001945|65892898|FG006|Overall Study|Protocol Violation|0|||
23590871|NCT05001945|65892899|FG007|Overall Study|Protocol Violation|0|||
23359912|NCT02149264|65062769|FG000|Overall Study|Adverse Event|7|||
23359913|NCT02149264|65062769|FG000|Overall Study|Physician Decision|3|||
23359914|NCT02149264|65062769|FG000|Overall Study|Protocol Violation|1|||
23359915|NCT01051557|65062770|FG000|Overall Study|Physician Decision|1|||
23359916|NCT01051557|65062771|FG001|Overall Study|Physician Decision|0|||
23359917|NCT01051557|65062772|FG002|Overall Study|Physician Decision|0|||
23359918|NCT01051557|65062773|FG003|Overall Study|Physician Decision|0|||
23359919|NCT01051557|65062774|FG004|Overall Study|Physician Decision|0|||
23590872|NCT05001945|65892892|FG000|Overall Study|Withdrawal by Subject|0|||
23590873|NCT05001945|65892893|FG001|Overall Study|Withdrawal by Subject|0|||
23590874|NCT05001945|65892894|FG002|Overall Study|Withdrawal by Subject|0|||
23590875|NCT05001945|65892895|FG003|Overall Study|Withdrawal by Subject|1|||
23590876|NCT05001945|65892896|FG004|Overall Study|Withdrawal by Subject|1|||
23590877|NCT05001945|65892897|FG005|Overall Study|Withdrawal by Subject|1|||
23590878|NCT05001945|65892898|FG006|Overall Study|Withdrawal by Subject|0|||
23590879|NCT05001945|65892899|FG007|Overall Study|Withdrawal by Subject|1|||
23590880|NCT05001945|65892892|FG000|Overall Study|Not specified by Investigator|0|||
23590881|NCT05001945|65892893|FG001|Overall Study|Not specified by Investigator|3|||
23590882|NCT05001945|65892894|FG002|Overall Study|Not specified by Investigator|0|||
23590883|NCT05001945|65892895|FG003|Overall Study|Not specified by Investigator|0|||
23590884|NCT05001945|65892896|FG004|Overall Study|Not specified by Investigator|1|||
23590885|NCT05001945|65892897|FG005|Overall Study|Not specified by Investigator|0|||
23590886|NCT05001945|65892898|FG006|Overall Study|Not specified by Investigator|0|||
23590887|NCT05001945|65892899|FG007|Overall Study|Not specified by Investigator|0|||
23590888|NCT02393716|65892900|FG000|Overall Study|Death|29|||
23590889|NCT02393716|65892900|FG000|Overall Study|Withdrawal by Subject|8|||
23590890|NCT02393716|65892900|FG000|Overall Study|Device Explanted|8|||
23590891|NCT02393716|65892900|FG000|Overall Study|Missed visit|16|||
23590892|NCT03923491|65892901|FG000|Overall Study|Lost to Follow-up|5|||
23590893|NCT03923491|65892902|FG001|Overall Study|Lost to Follow-up|8|||
23590894|NCT03923491|65892901|FG000|Overall Study|Withdrawal by Subject|4|||
23590895|NCT03923491|65892902|FG001|Overall Study|Withdrawal by Subject|6|||
23590896|NCT04594759|65892903|FG000|Overall Study|Lost to Follow-up|3|||
23590897|NCT00711958|65892904|FG000|Overall Study|Withdrawal by Subject|6|||
23590898|NCT00711958|65892905|FG001|Overall Study|Withdrawal by Subject|8|||
23192509|NCT00893789|64445968|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
23192510|NCT00893789|64445969|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
23192511|NCT00893789|64445970|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
23192512|NCT00893789|64445971|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
23192513|NCT00893789|64445968|FG000|Overall Study|Adverse Event|0|||
23192514|NCT00893789|64445969|FG001|Overall Study|Adverse Event|2|||
23192515|NCT00893789|64445970|FG002|Overall Study|Adverse Event|1|||
23192516|NCT00893789|64445971|FG003|Overall Study|Adverse Event|5|||
23192517|NCT00893789|64445968|FG000|Overall Study|Protocol Violation|0|||
23192518|NCT00893789|64445969|FG001|Overall Study|Protocol Violation|1|||
23192519|NCT00893789|64445970|FG002|Overall Study|Protocol Violation|1|||
23192520|NCT00893789|64445971|FG003|Overall Study|Protocol Violation|4|||
23192521|NCT00893789|64445968|FG000|Overall Study|Lost to Follow-up|0|||
23192522|NCT00893789|64445969|FG001|Overall Study|Lost to Follow-up|0|||
23192523|NCT00893789|64445970|FG002|Overall Study|Lost to Follow-up|0|||
23192524|NCT00893789|64445971|FG003|Overall Study|Lost to Follow-up|1|||
23192525|NCT01009463|64445973|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
23192526|NCT01009463|64445974|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23192527|NCT01009463|64445975|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23359920|NCT01051557|65062775|FG005|Overall Study|Physician Decision|0|||
23359921|NCT01051557|65062776|FG006|Overall Study|Physician Decision|0|||
23476270|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
23590899|NCT00711958|65892904|FG000|Overall Study|Lack of Efficacy|3|||
23253606|NCT02868281|64670264|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
23253607|NCT02868281|64670263|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
23253608|NCT02868281|64670264|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
23253609|NCT02868281|64670263|FG000|Overall Study|Long journey/moving away|1|||
23253610|NCT02868281|64670264|FG001|Overall Study|Long journey/moving away|1|||
23253611|NCT03724968|64670268|FG000|Overall Study|Insurance issues|0|||
23253612|NCT03724968|64670269|FG001|Overall Study|Insurance issues|1|||
23253613|NCT03724968|64670268|FG000|Overall Study|Study closed|0|||
23253614|NCT03724968|64670269|FG001|Overall Study|Study closed|1|||
23253615|NCT01246973|64670270|FG000|Overall Study|Other|38|||
23253616|NCT01246973|64670271|FG001|Overall Study|Other|25|||
23253617|NCT01246973|64670270|FG000|Overall Study|Adverse Event|16|||
23253618|NCT01246973|64670271|FG001|Overall Study|Adverse Event|9|||
23253619|NCT01246973|64670270|FG000|Overall Study|Withdrawal by Subject|7|||
23253620|NCT01246973|64670271|FG001|Overall Study|Withdrawal by Subject|13|||
23253621|NCT02191579|64670272|FG000|Treatment 1|Multiple Reasons Specified|27|||
23253622|NCT02191579|64670273|FG001|Treatment 1|Multiple Reasons Specified|58|||
23253623|NCT02191579|64670272|FG000|Treatment 2|Multiple Reasons Specified|0|||
23253624|NCT02191579|64670273|FG001|Treatment 2|Multiple Reasons Specified|25|||
23253625|NCT01613131|64670274|FG000|Overall Study|Withdrawal by Subject|3|||
23253626|NCT01613131|64670275|FG001|Overall Study|Withdrawal by Subject|5|||
23253627|NCT02117479|64670280|FG000|Overall Study|Death|13|||
23253628|NCT02117479|64670281|FG001|Overall Study|Death|8|||
23253629|NCT02117479|64670280|FG000|Overall Study|Adverse Event|8|||
23253630|NCT02117479|64670281|FG001|Overall Study|Adverse Event|16|||
23253631|NCT02117479|64670280|FG000|Overall Study|Subject decision|8|||
23253632|NCT02117479|64670281|FG001|Overall Study|Subject decision|9|||
23253633|NCT02117479|64670280|FG000|Overall Study|Disease progression|104|||
23253634|NCT02117479|64670281|FG001|Overall Study|Disease progression|108|||
23253635|NCT02117479|64670280|FG000|Overall Study|Noncompliance with study treatment|1|||
23253636|NCT02117479|64670281|FG001|Overall Study|Noncompliance with study treatment|0|||
23253637|NCT02117479|64670280|FG000|Overall Study|Study terminated by the sponsor|4|||
23253638|NCT02117479|64670281|FG001|Overall Study|Study terminated by the sponsor|6|||
23253639|NCT02117479|64670280|FG000|Overall Study|Physician Decision|7|||
23253640|NCT02117479|64670281|FG001|Overall Study|Physician Decision|2|||
23253641|NCT02117479|64670280|FG000|Overall Study|Other unspecified|11|||
23590900|NCT00711958|65892905|FG001|Overall Study|Lack of Efficacy|1|||
23590901|NCT00711958|65892904|FG000|Overall Study|Clinical deterioration|1|||
23590902|NCT00711958|65892905|FG001|Overall Study|Clinical deterioration|0|||
23590903|NCT00711958|65892904|FG000|Overall Study|Adverse Event|9|||
23590904|NCT00711958|65892905|FG001|Overall Study|Adverse Event|7|||
23590905|NCT00711958|65892904|FG000|Overall Study|Protocol Violation|1|||
23590906|NCT00711958|65892905|FG001|Overall Study|Protocol Violation|0|||
23590907|NCT00711958|65892904|FG000|Overall Study|Lost to Follow-up|2|||
23590908|NCT00711958|65892905|FG001|Overall Study|Lost to Follow-up|2|||
23590909|NCT00711958|65892904|FG000|Overall Study|Death|10|||
23590910|NCT00711958|65892905|FG001|Overall Study|Death|5|||
23192528|NCT01009463|64445976|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23192529|NCT01009463|64445977|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
23192530|NCT01009463|64445973|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
23192531|NCT01009463|64445974|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
23192532|NCT01009463|64445975|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
23192533|NCT01009463|64445976|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
23192534|NCT01009463|64445977|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
23192535|NCT01009463|64445973|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
23192536|NCT01009463|64445974|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23192537|NCT01009463|64445975|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23192538|NCT01009463|64445976|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23192539|NCT01009463|64445977|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
23192540|NCT01009463|64445973|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
23192541|NCT01009463|64445974|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
23192542|NCT01009463|64445975|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
23192543|NCT01009463|64445976|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
23192544|NCT01009463|64445977|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
23192545|NCT01009463|64445973|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
23192546|NCT01009463|64445974|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23192547|NCT01009463|64445975|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23192548|NCT01009463|64445976|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23192549|NCT01009463|64445977|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
23192550|NCT01009463|64445973|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
23192551|NCT01009463|64445974|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
23192552|NCT01009463|64445975|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
23192553|NCT01009463|64445976|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
23590911|NCT00711958|65892904|FG000|Overall Study|Progression of disease|1|||
23590912|NCT00711958|65892905|FG001|Overall Study|Progression of disease|0|||
23590913|NCT00346333|65892906|FG000|Overall Study|Death|1|||
23590914|NCT00346333|65892907|FG001|Overall Study|Death|0|||
23590915|NCT00346333|65892906|FG000|Overall Study|unwilling or unable to continue|4|||
23590916|NCT00346333|65892907|FG001|Overall Study|unwilling or unable to continue|8|||
23590917|NCT03837028|65892908|FG000|Overall Study|Lost to Follow-up|4|||
23590918|NCT03837028|65892909|FG001|Overall Study|Lost to Follow-up|0|||
23359922|NCT01051557|65062770|FG000|Overall Study|disease progression|3|||
23359923|NCT01051557|65062771|FG001|Overall Study|disease progression|3|||
23359924|NCT01051557|65062772|FG002|Overall Study|disease progression|5|||
23359925|NCT01051557|65062773|FG003|Overall Study|disease progression|2|||
23359926|NCT01051557|65062774|FG004|Overall Study|disease progression|4|||
23359927|NCT01051557|65062775|FG005|Overall Study|disease progression|3|||
23359928|NCT01051557|65062776|FG006|Overall Study|disease progression|1|||
23359929|NCT01051557|65062770|FG000|Overall Study|Withdrawal by Subject|0|||
23359930|NCT01051557|65062771|FG001|Overall Study|Withdrawal by Subject|0|||
23359931|NCT01051557|65062772|FG002|Overall Study|Withdrawal by Subject|1|||
23359932|NCT01051557|65062773|FG003|Overall Study|Withdrawal by Subject|0|||
23359933|NCT01051557|65062774|FG004|Overall Study|Withdrawal by Subject|2|||
23359934|NCT01051557|65062775|FG005|Overall Study|Withdrawal by Subject|0|||
23359935|NCT01051557|65062776|FG006|Overall Study|Withdrawal by Subject|1|||
23359936|NCT01051557|65062770|FG000|Overall Study|Adverse Event|0|||
23359937|NCT01051557|65062771|FG001|Overall Study|Adverse Event|0|||
23359938|NCT01051557|65062772|FG002|Overall Study|Adverse Event|0|||
23359939|NCT01051557|65062773|FG003|Overall Study|Adverse Event|1|||
23359940|NCT01051557|65062774|FG004|Overall Study|Adverse Event|1|||
23359941|NCT01051557|65062775|FG005|Overall Study|Adverse Event|3|||
23359942|NCT01051557|65062776|FG006|Overall Study|Adverse Event|4|||
23359943|NCT05176717|65062787|FG000|Overall Study|Sponsor Decision|1|||
23359944|NCT05176717|65062788|FG001|Overall Study|Sponsor Decision|2|||
23359945|NCT05176717|65062789|FG002|Overall Study|Sponsor Decision|2|||
23359946|NCT00171158|65062790|FG000|Core Study|Death|27|||
23359947|NCT00171158|65062790|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
23359948|NCT00171158|65062790|FG000|Core Study|Protocol Violation|4|||
23192554|NCT01009463|64445977|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
23192555|NCT01009463|64445973|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
23192556|NCT01009463|64445974|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
23359949|NCT00171158|65062790|FG000|Core Study|Administrative problems|1|||
23359950|NCT00171158|65062790|FG000|Core Study|Adverse event, non-fatal|21|||
23359951|NCT00171158|65062790|FG000|Core Study|Consent withdrawn by subject|6|||
23359952|NCT00171158|65062790|FG000|Core Study|No longer required drug (BMT)|14|||
23359953|NCT00171158|65062790|FG000|Core Study|Abnormal Laboratory Values|2|||
23359954|NCT00171158|65062790|FG000|Core Study|Lost to Follow-up|1|||
23359955|NCT00171158|65062790|FG000|E2 Extension|Other|7|||
23359956|NCT04668209|65062793|FG000|Overall Study|Withdrawal by Subject|2|||
23359957|NCT04668209|65062794|FG001|Overall Study|Withdrawal by Subject|2|||
23359958|NCT04668209|65062793|FG000|Overall Study|Lost to Follow-up|3|||
23359959|NCT04668209|65062794|FG001|Overall Study|Lost to Follow-up|4|||
23359960|NCT04668209|65062793|FG000|Overall Study|Subject Expired|2|||
23359961|NCT04668209|65062794|FG001|Overall Study|Subject Expired|0|||
23359962|NCT04668209|65062793|FG000|Overall Study|Withdrawn from study|0|||
23359963|NCT04668209|65062794|FG001|Overall Study|Withdrawn from study|1|||
23359964|NCT04668209|65062793|FG000|Overall Study|Adverse Event|0|||
23359965|NCT04668209|65062794|FG001|Overall Study|Adverse Event|1|||
23359966|NCT01509664|65062797|FG000|Overall Study|Lost to Follow-up|15|||
23359967|NCT01509664|65062798|FG001|Overall Study|Lost to Follow-up|21|||
23359968|NCT04162795|65062801|FG000|Overall Study|Other|16|||
23359969|NCT04162795|65062801|FG000|Overall Study|Screen failures|10|||
23359970|NCT01826981|65062802|FG000|Overall Study|Lack of Efficacy|0|||
23359971|NCT01826981|65062803|FG001|Overall Study|Lack of Efficacy|1|||
23359972|NCT01826981|65062804|FG002|Overall Study|Lack of Efficacy|0|||
23359973|NCT01826981|65062805|FG003|Overall Study|Lack of Efficacy|0|||
23359974|NCT01826981|65062806|FG004|Overall Study|Lack of Efficacy|5|||
23590919|NCT03837028|65892910|FG002|Overall Study|Lost to Follow-up|2|||
23192557|NCT01009463|64445975|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
23359975|NCT01826981|65062807|FG005|Overall Study|Lack of Efficacy|0|||
23359976|NCT01826981|65062808|FG006|Overall Study|Lack of Efficacy|0|||
23359977|NCT01826981|65062809|FG007|Overall Study|Lack of Efficacy|8|||
23359978|NCT01826981|65062810|FG008|Overall Study|Lack of Efficacy|7|||
23590920|NCT03837028|65892911|FG003|Overall Study|Lost to Follow-up|0|||
23359979|NCT01826981|65062811|FG009|Overall Study|Lack of Efficacy|0|||
23590921|NCT03837028|65892908|FG000|Overall Study|Withdrawal by Subject|12|||
23359980|NCT01826981|65062812|FG010|Overall Study|Lack of Efficacy|1|||
23359981|NCT01826981|65062813|FG011|Overall Study|Lack of Efficacy|0|||
23359982|NCT01826981|65062814|FG012|Overall Study|Lack of Efficacy|0|||
23359983|NCT01826981|65062815|FG013|Overall Study|Lack of Efficacy|3|||
23359984|NCT01826981|65062816|FG014|Overall Study|Lack of Efficacy|0|||
23253642|NCT02117479|64670281|FG001|Overall Study|Other unspecified|7|||
23253643|NCT00103259|64670282|FG000|Overall Study|Death|3|||
23253644|NCT00103259|64670283|FG001|Overall Study|Death|2|||
23253645|NCT00103259|64670282|FG000|Overall Study|Withdrawal by Subject|2|||
23253646|NCT00103259|64670283|FG001|Overall Study|Withdrawal by Subject|3|||
23253647|NCT00103259|64670282|FG000|Overall Study|alternative therapy|1|||
23253648|NCT00103259|64670283|FG001|Overall Study|alternative therapy|0|||
23253649|NCT00103259|64670282|FG000|Overall Study|other (reasons were not specified)|2|||
23253650|NCT00103259|64670283|FG001|Overall Study|other (reasons were not specified)|1|||
23253651|NCT00103259|64670282|FG000|Overall Study|ineligible/no protocol therapy|4|||
23253652|NCT00103259|64670283|FG001|Overall Study|ineligible/no protocol therapy|6|||
23253653|NCT03670537|64670288|FG000|Overall Study|Protocol Violation|1|||
23253654|NCT00272961|64670289|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
23253655|NCT00272961|64670290|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
23253656|NCT00272961|64670291|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
23253657|NCT00272961|64670292|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
23253658|NCT00272961|64670293|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
23253659|NCT00272961|64670289|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
23253660|NCT00272961|64670290|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
23253661|NCT00272961|64670291|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
23253662|NCT00272961|64670292|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
23253663|NCT00272961|64670293|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
23253664|NCT00272961|64670289|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
23253665|NCT00272961|64670290|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
23253666|NCT00272961|64670291|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
23253667|NCT00272961|64670292|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
23253668|NCT00272961|64670293|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
23253669|NCT00272961|64670289|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
23253670|NCT00272961|64670290|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
23253671|NCT00272961|64670291|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
23253672|NCT00272961|64670292|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
23253673|NCT00272961|64670293|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
23253674|NCT00272961|64670289|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
23253675|NCT00272961|64670290|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
23253676|NCT00272961|64670291|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
23253677|NCT00272961|64670292|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
23253678|NCT00272961|64670293|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
23253679|NCT00272961|64670289|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
23253680|NCT00272961|64670290|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
23253681|NCT00272961|64670291|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
23253682|NCT00272961|64670292|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
23253683|NCT00272961|64670293|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
23253684|NCT00272961|64670289|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
23359985|NCT01826981|65062802|FG000|Overall Study|Lost to Follow-up|0|||
23359986|NCT01826981|65062803|FG001|Overall Study|Lost to Follow-up|0|||
23359987|NCT01826981|65062804|FG002|Overall Study|Lost to Follow-up|0|||
23359988|NCT01826981|65062805|FG003|Overall Study|Lost to Follow-up|0|||
23359989|NCT01826981|65062806|FG004|Overall Study|Lost to Follow-up|1|||
23359990|NCT01826981|65062807|FG005|Overall Study|Lost to Follow-up|1|||
23359991|NCT01826981|65062808|FG006|Overall Study|Lost to Follow-up|0|||
23359992|NCT01826981|65062809|FG007|Overall Study|Lost to Follow-up|1|||
23359993|NCT01826981|65062810|FG008|Overall Study|Lost to Follow-up|0|||
23359994|NCT01826981|65062811|FG009|Overall Study|Lost to Follow-up|1|||
23359995|NCT01826981|65062812|FG010|Overall Study|Lost to Follow-up|1|||
23359996|NCT01826981|65062813|FG011|Overall Study|Lost to Follow-up|1|||
23359997|NCT01826981|65062814|FG012|Overall Study|Lost to Follow-up|1|||
23359998|NCT01826981|65062815|FG013|Overall Study|Lost to Follow-up|0|||
23359999|NCT01826981|65062816|FG014|Overall Study|Lost to Follow-up|0|||
23360000|NCT01826981|65062802|FG000|Overall Study|Withdrew Consent|0|||
23360001|NCT01826981|65062803|FG001|Overall Study|Withdrew Consent|0|||
23360002|NCT01826981|65062804|FG002|Overall Study|Withdrew Consent|0|||
23360003|NCT01826981|65062805|FG003|Overall Study|Withdrew Consent|0|||
23360004|NCT01826981|65062806|FG004|Overall Study|Withdrew Consent|0|||
23360005|NCT01826981|65062807|FG005|Overall Study|Withdrew Consent|0|||
23360006|NCT01826981|65062808|FG006|Overall Study|Withdrew Consent|1|||
23360007|NCT01826981|65062809|FG007|Overall Study|Withdrew Consent|1|||
23360008|NCT01826981|65062810|FG008|Overall Study|Withdrew Consent|0|||
23360009|NCT01826981|65062811|FG009|Overall Study|Withdrew Consent|0|||
23360010|NCT01826981|65062812|FG010|Overall Study|Withdrew Consent|0|||
23360011|NCT01826981|65062813|FG011|Overall Study|Withdrew Consent|1|||
23360012|NCT01826981|65062814|FG012|Overall Study|Withdrew Consent|0|||
23360013|NCT01826981|65062815|FG013|Overall Study|Withdrew Consent|1|||
23360014|NCT01826981|65062816|FG014|Overall Study|Withdrew Consent|0|||
23360015|NCT01826981|65062802|FG000|Overall Study|Adverse Event|0|||
23360016|NCT01826981|65062803|FG001|Overall Study|Adverse Event|0|||
23360017|NCT01826981|65062804|FG002|Overall Study|Adverse Event|0|||
23360018|NCT01826981|65062805|FG003|Overall Study|Adverse Event|0|||
23360019|NCT01826981|65062806|FG004|Overall Study|Adverse Event|1|||
23360020|NCT01826981|65062807|FG005|Overall Study|Adverse Event|0|||
23360021|NCT01826981|65062808|FG006|Overall Study|Adverse Event|0|||
23360022|NCT01826981|65062809|FG007|Overall Study|Adverse Event|0|||
23360023|NCT01826981|65062810|FG008|Overall Study|Adverse Event|0|||
23360024|NCT01826981|65062811|FG009|Overall Study|Adverse Event|0|||
23360025|NCT01826981|65062812|FG010|Overall Study|Adverse Event|0|||
23360026|NCT01826981|65062813|FG011|Overall Study|Adverse Event|0|||
23360027|NCT01826981|65062814|FG012|Overall Study|Adverse Event|0|||
23360028|NCT01826981|65062815|FG013|Overall Study|Adverse Event|0|||
23360029|NCT01826981|65062816|FG014|Overall Study|Adverse Event|0|||
23360030|NCT01826981|65062802|FG000|Overall Study|Upper G-I Haemorrhage|0|||
23360031|NCT01826981|65062803|FG001|Overall Study|Upper G-I Haemorrhage|0|||
23360032|NCT01826981|65062804|FG002|Overall Study|Upper G-I Haemorrhage|0|||
23360033|NCT01826981|65062805|FG003|Overall Study|Upper G-I Haemorrhage|0|||
23360034|NCT01826981|65062806|FG004|Overall Study|Upper G-I Haemorrhage|0|||
23360035|NCT01826981|65062807|FG005|Overall Study|Upper G-I Haemorrhage|0|||
23360036|NCT01826981|65062808|FG006|Overall Study|Upper G-I Haemorrhage|0|||
23360037|NCT01826981|65062809|FG007|Overall Study|Upper G-I Haemorrhage|0|||
23360038|NCT01826981|65062810|FG008|Overall Study|Upper G-I Haemorrhage|0|||
23360039|NCT01826981|65062811|FG009|Overall Study|Upper G-I Haemorrhage|0|||
23360040|NCT01826981|65062812|FG010|Overall Study|Upper G-I Haemorrhage|0|||
23360041|NCT01826981|65062813|FG011|Overall Study|Upper G-I Haemorrhage|0|||
23360042|NCT01826981|65062814|FG012|Overall Study|Upper G-I Haemorrhage|0|||
23360043|NCT01826981|65062815|FG013|Overall Study|Upper G-I Haemorrhage|1|||
23360044|NCT01826981|65062816|FG014|Overall Study|Upper G-I Haemorrhage|0|||
23360045|NCT01826981|65062802|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
23192558|NCT01009463|64445976|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
23360046|NCT01826981|65062803|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360047|NCT01826981|65062804|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360048|NCT01826981|65062805|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360049|NCT01826981|65062806|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360050|NCT01826981|65062807|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360051|NCT01826981|65062808|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360052|NCT01826981|65062809|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
23360053|NCT01826981|65062810|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360054|NCT01826981|65062811|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360055|NCT01826981|65062812|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360056|NCT01826981|65062813|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360057|NCT01826981|65062814|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360058|NCT01826981|65062815|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360059|NCT01826981|65062816|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
23360060|NCT00401193|65062817|FG000|Overall Study|Adverse Event|1|||
23590922|NCT03837028|65892909|FG001|Overall Study|Withdrawal by Subject|11|||
23590923|NCT03837028|65892910|FG002|Overall Study|Withdrawal by Subject|11|||
23590924|NCT03837028|65892911|FG003|Overall Study|Withdrawal by Subject|7|||
23590925|NCT04128319|65892912|FG000|Overall Study|Death|3|||
23590926|NCT05641311|65892913|FG000|Dosing Period 1|Adverse Event|1|||
23590927|NCT05641311|65892914|FG001|Dosing Period 1|Adverse Event|0|||
23590928|NCT02534350|65892917|FG000|Overall Study|Randomized But Not Treated|1|||
23590929|NCT02534350|65892918|FG001|Overall Study|Randomized But Not Treated|0|||
23590930|NCT02534350|65892917|FG000|Overall Study|Protocol Violation|1|||
23590931|NCT02534350|65892918|FG001|Overall Study|Protocol Violation|0|||
23590932|NCT02534350|65892917|FG000|Overall Study|Withdrew Consent|2|||
23590933|NCT02534350|65892918|FG001|Overall Study|Withdrew Consent|0|||
23590934|NCT00753012|65892921|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
23590935|NCT00753012|65892922|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
23590936|NCT00753012|65892921|FG000|Overall Study|Adverse Event|2|||
23590937|NCT00753012|65892922|FG001|Overall Study|Adverse Event|0|||
23590938|NCT00753012|65892921|FG000|Overall Study|Withdrawal by Subject|0|||
23590939|NCT00753012|65892922|FG001|Overall Study|Withdrawal by Subject|1|||
23590940|NCT00753012|65892921|FG000|Overall Study|Lost to Follow-up|4|||
23590941|NCT00753012|65892922|FG001|Overall Study|Lost to Follow-up|0|||
23590942|NCT00753012|65892921|FG000|Overall Study|Confounded endpoint data|1|||
23590943|NCT00753012|65892922|FG001|Overall Study|Confounded endpoint data|0|||
23590944|NCT04493242|65892923|FG000|Overall Study|Death|10|||
23590945|NCT04493242|65892924|FG001|Overall Study|Death|14|||
23590946|NCT04493242|65892925|FG002|Overall Study|Death|16|||
23590947|NCT04493242|65892923|FG000|Overall Study|Lost to Follow-up|1|||
23590948|NCT04493242|65892924|FG001|Overall Study|Lost to Follow-up|1|||
23590949|NCT04493242|65892925|FG002|Overall Study|Lost to Follow-up|0|||
23590950|NCT04493242|65892923|FG000|Overall Study|Withdrawal by Subject|1|||
23590951|NCT04493242|65892924|FG001|Overall Study|Withdrawal by Subject|0|||
23590952|NCT04493242|65892925|FG002|Overall Study|Withdrawal by Subject|0|||
23590953|NCT04493242|65892923|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
23590954|NCT04493242|65892924|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
23590955|NCT04493242|65892925|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
23590956|NCT04493242|65892923|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
23590957|NCT04493242|65892924|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
23590958|NCT04493242|65892925|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
23590959|NCT04504916|65892926|FG000|Overall Study|Study terminated|7|||
23590960|NCT04504916|65892927|FG001|Overall Study|Study terminated|8|||
23590961|NCT04504916|65892926|FG000|Overall Study|Death|54|||
23590962|NCT04504916|65892927|FG001|Overall Study|Death|18|||
23590963|NCT04504916|65892926|FG000|Overall Study|Lost to Follow-up|1|||
23590964|NCT04504916|65892927|FG001|Overall Study|Lost to Follow-up|1|||
23590965|NCT04504916|65892926|FG000|Overall Study|Withdrawal by Subject|8|||
23590966|NCT04504916|65892927|FG001|Overall Study|Withdrawal by Subject|4|||
23590967|NCT04504916|65892926|FG000|Overall Study|Did not agree to follow-up|0|||
23590968|NCT04504916|65892927|FG001|Overall Study|Did not agree to follow-up|1|||
23590969|NCT02754479|65892929|FG000|Overall Study|Lost to Follow-up|1|||
23590970|NCT00546871|65892930|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
23590971|NCT00546871|65892931|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
23476271|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
23476272|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
23590972|NCT00546871|65892930|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
23590973|NCT00546871|65892931|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
23590974|NCT00546871|65892930|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
23590975|NCT00546871|65892931|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
23590976|NCT00546871|65892930|FG000|Study Extension Period|Protocol Violation|1|||
23590977|NCT00546871|65892931|FG001|Study Extension Period|Protocol Violation|0|||
23590978|NCT00546871|65892930|FG000|Study Extension Period|Withdrawal by Subject|0|||
23590979|NCT00546871|65892931|FG001|Study Extension Period|Withdrawal by Subject|1|||
23590980|NCT00665444|65892932|FG000|Overall Study|Physician Decision|1|||
23360061|NCT00401193|65062818|FG001|Overall Study|Adverse Event|3|||
23476273|NCT00065429|65488030|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
23590981|NCT00665444|65892932|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
23590982|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
23590983|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
23590984|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
23590985|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
23590986|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
23590987|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
23590988|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
23590989|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
23476274|NCT00065429|65488031|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
23590990|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
23590991|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
23590992|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
23590993|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
23590994|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
23590995|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
23590996|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
23590997|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
23590998|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
23590999|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
23591000|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
23591001|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
23591002|NCT01087762|65892933|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
23591003|NCT01087762|65892934|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
23591004|NCT01087762|65892935|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
23591005|NCT01087762|65892936|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
23591006|NCT01087762|65892937|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
23591007|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
23591008|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
23591009|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
23591010|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
23591011|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
23591012|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
23591013|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
23591014|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
23591015|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
23591016|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
23591017|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
23591018|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
23591019|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
23591020|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
23591021|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
23591022|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
23591023|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
23360062|NCT00401193|65062819|FG002|Overall Study|Adverse Event|1|||
23360063|NCT00401193|65062817|FG000|Overall Study|Protocol Violation|3|||
23360064|NCT00401193|65062818|FG001|Overall Study|Protocol Violation|1|||
23591024|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
23591025|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
23591026|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
23360065|NCT00401193|65062819|FG002|Overall Study|Protocol Violation|1|||
23360066|NCT00401193|65062817|FG000|Overall Study|Lost to Follow-up|6|||
23360067|NCT00401193|65062818|FG001|Overall Study|Lost to Follow-up|5|||
23360068|NCT00401193|65062819|FG002|Overall Study|Lost to Follow-up|1|||
23360069|NCT00401193|65062817|FG000|Overall Study|Withdrawal by Subject|2|||
23360070|NCT00401193|65062818|FG001|Overall Study|Withdrawal by Subject|0|||
23360071|NCT00401193|65062819|FG002|Overall Study|Withdrawal by Subject|1|||
23360072|NCT00401193|65062817|FG000|Overall Study|Other Event|3|||
23360073|NCT00401193|65062818|FG001|Overall Study|Other Event|2|||
23360074|NCT00401193|65062819|FG002|Overall Study|Other Event|2|||
23476275|NCT00065429|65488032|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
23476276|NCT00065429|65488033|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
23360075|NCT03746405|65062822|FG000|Overall Study|Withdrawal by Subject|3|||
23360076|NCT03746405|65062823|FG001|Overall Study|Withdrawal by Subject|0|||
23476277|NCT00065429|65488034|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
23591027|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
23360077|NCT03746405|65062822|FG000|Overall Study|technical difficulties|0|||
23360078|NCT03746405|65062823|FG001|Overall Study|technical difficulties|2|||
23360079|NCT02489448|65062826|FG000|Overall Study|Death|3|||
23360080|NCT02489448|65062826|FG000|Overall Study|Withdrawal by Subject|2|||
23360081|NCT01720524|65062832|FG000|Part A|Insufficient Clinical Response|2|||
23360082|NCT01720524|65062833|FG001|Part A|Insufficient Clinical Response|4|||
23360083|NCT01720524|65062832|FG000|Part A|Adverse Event|2|||
23360084|NCT01720524|65062833|FG001|Part A|Adverse Event|2|||
23360085|NCT01720524|65062832|FG000|Part A|Death|2|||
23591028|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
23360086|NCT01720524|65062833|FG001|Part A|Death|1|||
23360087|NCT01720524|65062832|FG000|Part A|Lost to Follow-up|0|||
23360088|NCT01720524|65062833|FG001|Part A|Lost to Follow-up|1|||
23360089|NCT01720524|65062832|FG000|Part A|Missed 28 day follow-up visit|1|||
23360090|NCT01720524|65062833|FG001|Part A|Missed 28 day follow-up visit|1|||
23591029|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
23591030|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
23591031|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
23591032|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
23591033|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
23591034|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
23591035|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
23591036|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
23591037|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
23591038|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
23591039|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
23591040|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
23591041|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
23591042|NCT01087762|65892933|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
23591043|NCT01087762|65892934|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
23591044|NCT01087762|65892935|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
23591045|NCT01087762|65892936|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
23591046|NCT01087762|65892937|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
23591047|NCT01290224|65892940|FG000|Overall Study|Adverse Event|1|||
23591048|NCT01290224|65892940|FG000|Overall Study|Refused Further Treatment|4|||
23591049|NCT02808338|65892951|FG000|Screening|Screen Failure|10|||
23591050|NCT02808338|65892951|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
23591051|NCT02808338|65892951|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
23591052|NCT00057837|65892957|FG000|Overall Study|Progression/relapse|12|||
23591053|NCT00057837|65892958|FG001|Overall Study|Progression/relapse|14|||
23591054|NCT00057837|65892957|FG000|Overall Study|Adverse Event|2|||
23591055|NCT00057837|65892958|FG001|Overall Study|Adverse Event|12|||
23591056|NCT00057837|65892957|FG000|Overall Study|Death|5|||
23591057|NCT00057837|65892958|FG001|Overall Study|Death|4|||
23591058|NCT00057837|65892957|FG000|Overall Study|Withdrawal by Subject|5|||
23591059|NCT00057837|65892958|FG001|Overall Study|Withdrawal by Subject|3|||
23591060|NCT00057837|65892957|FG000|Overall Study|Alternative therapy|0|||
23591061|NCT00057837|65892958|FG001|Overall Study|Alternative therapy|1|||
23591062|NCT00057837|65892957|FG000|Overall Study|Other complicating disease|2|||
23591063|NCT00057837|65892958|FG001|Overall Study|Other complicating disease|1|||
23591064|NCT00057837|65892957|FG000|Overall Study|Physician Decision|1|||
23591065|NCT00057837|65892958|FG001|Overall Study|Physician Decision|0|||
23591066|NCT00057837|65892957|FG000|Overall Study|Ineligible|3|||
23591067|NCT00057837|65892958|FG001|Overall Study|Ineligible|3|||
23591068|NCT00057837|65892957|FG000|Overall Study|Never started treatment|1|||
23591069|NCT00057837|65892958|FG001|Overall Study|Never started treatment|1|||
23591070|NCT00367991|65892959|FG000|Overall Study|Withdrawal by Subject|1|||
23591071|NCT00367991|65892960|FG001|Overall Study|Withdrawal by Subject|1|||
23591072|NCT00367991|65892959|FG000|Overall Study|Adverse Event|1|||
23591073|NCT00367991|65892960|FG001|Overall Study|Adverse Event|1|||
23591074|NCT00666276|65892961|FG000|Overall Study|Protocol Violation|34|||
23591075|NCT00940992|65892964|FG000|Overall Study|Adverse Event|2|||
23591076|NCT00940992|65892965|FG001|Overall Study|Adverse Event|0|||
23591077|NCT00940992|65892966|FG002|Overall Study|Adverse Event|1|||
23591078|NCT00940992|65892964|FG000|Overall Study|subject request|2|||
23591079|NCT00940992|65892965|FG001|Overall Study|subject request|1|||
23591080|NCT00940992|65892966|FG002|Overall Study|subject request|0|||
23591081|NCT00940992|65892964|FG000|Overall Study|Lost to Follow-up|0|||
23591082|NCT00940992|65892965|FG001|Overall Study|Lost to Follow-up|1|||
23591083|NCT00940992|65892966|FG002|Overall Study|Lost to Follow-up|1|||
23591084|NCT04580303|65892967|FG000|Overall Study|Adverse Event|0|||
23591085|NCT04580303|65892968|FG001|Overall Study|Adverse Event|1|||
23591086|NCT04580303|65892969|FG002|Overall Study|Adverse Event|0|||
23591087|NCT04580303|65892970|FG003|Overall Study|Adverse Event|0|||
23591088|NCT04580303|65892967|FG000|Overall Study|Withdrawal by Subject|0|||
23591089|NCT04580303|65892968|FG001|Overall Study|Withdrawal by Subject|0|||
23192559|NCT01009463|64445977|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
23192560|NCT01009463|64445973|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
23253685|NCT00272961|64670290|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
23253686|NCT00272961|64670291|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
23591090|NCT04580303|65892969|FG002|Overall Study|Withdrawal by Subject|1|||
23591091|NCT04580303|65892970|FG003|Overall Study|Withdrawal by Subject|0|||
23591092|NCT00834834|65892975|FG000|Overall Study|Withdrawal by Subject|4|||
23591093|NCT00834834|65892976|FG001|Overall Study|Withdrawal by Subject|3|||
23591094|NCT02194933|65892978|FG000|Overall Study|Lost to Follow-up|1|||
23591095|NCT02194933|65892979|FG001|Overall Study|Lost to Follow-up|2|||
23591096|NCT02194933|65892978|FG000|Overall Study|Participant met withdrawal criteria|1|||
23591097|NCT02194933|65892979|FG001|Overall Study|Participant met withdrawal criteria|3|||
23591098|NCT02194933|65892978|FG000|Overall Study|Withdrawal by Subject|0|||
23591099|NCT02194933|65892979|FG001|Overall Study|Withdrawal by Subject|2|||
23591100|NCT02194933|65892978|FG000|Overall Study|Lack of Efficacy|1|||
23591101|NCT02194933|65892979|FG001|Overall Study|Lack of Efficacy|2|||
23192561|NCT01009463|64445974|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
23192562|NCT01009463|64445975|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
23192563|NCT01009463|64445976|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
23192564|NCT01009463|64445977|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
23192565|NCT01009463|64445973|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
23192566|NCT01009463|64445974|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
23192567|NCT01009463|64445975|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
23192568|NCT01009463|64445976|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
23192569|NCT01009463|64445977|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
23192570|NCT01009463|64445973|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
23192571|NCT01009463|64445974|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
23192572|NCT01009463|64445975|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
23192573|NCT01009463|64445976|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
23192574|NCT01009463|64445977|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
23192575|NCT01009463|64445973|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23192576|NCT01009463|64445974|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
23192577|NCT01009463|64445975|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23192578|NCT01009463|64445976|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
23360091|NCT01720524|65062832|FG000|Part A|Withdrawal by Subject|0|||
23476278|NCT00065429|65488035|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
23476279|NCT00065429|65488036|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
23476280|NCT00065429|65488030|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476281|NCT00065429|65488031|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23591102|NCT02553460|65892984|FG000|Overall Study|Death|3|||
23591103|NCT02553460|65892984|FG000|Overall Study|Withdrawal by Subject|1|||
23591104|NCT02553460|65892984|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
23591105|NCT02553460|65892984|FG000|Overall Study|Relapse or Transplant|14|||
23591106|NCT02553460|65892984|FG000|Overall Study|No response to treatment|2|||
23591107|NCT02553460|65892984|FG000|Overall Study|Still on therapy|7|||
23591108|NCT02553460|65892984|FG000|Overall Study|CAR T cells|1|||
23591109|NCT00918957|65892985|FG000|Overall Study|Adverse Event|2|||
23591110|NCT00918957|65892986|FG001|Overall Study|Adverse Event|0|||
23591111|NCT00918957|65892985|FG000|Overall Study|Withdrawal by Subject|1|||
23591112|NCT00918957|65892986|FG001|Overall Study|Withdrawal by Subject|0|||
23591113|NCT02425111|65892987|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
23591114|NCT02425111|65892987|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
23591115|NCT02425111|65892987|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
23591116|NCT02425111|65892987|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
23591117|NCT02425111|65892987|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
23591118|NCT02425111|65892987|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
23591119|NCT02341625|65892991|FG000|Overall Study|Disease Progression|2|||
23591120|NCT02341625|65892992|FG001|Overall Study|Disease Progression|2|||
23591121|NCT02341625|65892993|FG002|Overall Study|Disease Progression|3|||
23591122|NCT02341625|65892994|FG003|Overall Study|Disease Progression|6|||
23591123|NCT02341625|65892995|FG004|Overall Study|Disease Progression|7|||
23591124|NCT02341625|65892996|FG005|Overall Study|Disease Progression|7|||
23591125|NCT02341625|65892997|FG006|Overall Study|Disease Progression|28|||
23591126|NCT02341625|65892998|FG007|Overall Study|Disease Progression|5|||
23591127|NCT02341625|65892999|FG008|Overall Study|Disease Progression|4|||
23591128|NCT02341625|65893000|FG009|Overall Study|Disease Progression|19|||
23591129|NCT02341625|65892991|FG000|Overall Study|Study Drug Toxicity|0|||
23591130|NCT02341625|65892992|FG001|Overall Study|Study Drug Toxicity|0|||
23192579|NCT01009463|64445977|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
23192580|NCT01009463|64445973|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
23192581|NCT01009463|64445974|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
23192582|NCT01009463|64445975|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
23192583|NCT01009463|64445976|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
23192584|NCT01009463|64445977|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
23192585|NCT01009463|64445973|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
23192586|NCT01009463|64445974|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
23192587|NCT01009463|64445975|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
23192588|NCT01009463|64445976|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
23192589|NCT01009463|64445977|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
23192590|NCT02795767|64445979|FG000|Overall Study|Received Commercial Emicizumab|1|||
23192591|NCT02795767|64445980|FG001|Overall Study|Received Commercial Emicizumab|0|||
23192592|NCT02795767|64445981|FG002|Overall Study|Received Commercial Emicizumab|0|||
23192593|NCT04799782|64445988|FG000|Washout|Physician Decision|2|||
23192594|NCT04799782|64445989|FG001|Washout|Physician Decision|0|||
23192595|NCT04799782|64445988|FG000|Washout|Withdrawal by Subject|0|||
23192596|NCT04799782|64445989|FG001|Washout|Withdrawal by Subject|2|||
23192597|NCT04799782|64445988|FG000|Washout|Lost to Follow-up|0|||
23192598|NCT04799782|64445989|FG001|Washout|Lost to Follow-up|1|||
23192599|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Adverse Event|37|||
23192600|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Adverse Event|0|||
23192601|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Adverse Event|0|||
23192602|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Adverse Event|0|||
23192603|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Death|2|||
23192604|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Death|0|||
23192605|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Death|0|||
23192606|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Death|0|||
23192607|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
23192608|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
23192609|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
23192610|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
23192611|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
23192612|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
23192613|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
23192614|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
23192615|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
23192616|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
23192617|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
23192618|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
23192619|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
23192620|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
23192621|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
23192622|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
23192623|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Physician Decision|4|||
23192624|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Physician Decision|0|||
23192625|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Physician Decision|0|||
23192626|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Physician Decision|0|||
23192627|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Pregnancy|1|||
23192628|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Pregnancy|0|||
23253687|NCT00272961|64670292|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
23253688|NCT00272961|64670293|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
23253689|NCT00272961|64670289|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
23253690|NCT00272961|64670290|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
23253691|NCT00272961|64670291|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
23253692|NCT00272961|64670292|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
23253693|NCT00272961|64670293|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
23253694|NCT04363736|64670294|FG000|Overall Study|Withdrawal by Subject|1|||
23253695|NCT04363736|64670295|FG001|Overall Study|Withdrawal by Subject|0|||
23253696|NCT04363736|64670294|FG000|Overall Study|Lost to Follow-up|10|||
23253697|NCT04363736|64670295|FG001|Overall Study|Lost to Follow-up|7|||
23253698|NCT04363736|64670294|FG000|Overall Study|Death|8|||
23253699|NCT04363736|64670295|FG001|Overall Study|Death|6|||
23253700|NCT01375010|64670298|FG000|Overall Study|Lost to Follow-up|8|||
23253701|NCT01375010|64670299|FG001|Overall Study|Lost to Follow-up|2|||
23253702|NCT01375010|64670298|FG000|Overall Study|Withdrawal by Subject|4|||
23253703|NCT01375010|64670299|FG001|Overall Study|Withdrawal by Subject|2|||
23253704|NCT01142466|64670300|FG000|Overall Study|Adverse Event|2|||
23253705|NCT01142466|64670301|FG001|Overall Study|Adverse Event|1|||
23253706|NCT01142466|64670300|FG000|Overall Study|Withdrawal by Subject|1|||
23253707|NCT01142466|64670301|FG001|Overall Study|Withdrawal by Subject|1|||
23253708|NCT02072174|64670302|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
23360092|NCT01720524|65062833|FG001|Part A|Withdrawal by Subject|1|||
23591131|NCT02341625|65892993|FG002|Overall Study|Study Drug Toxicity|0|||
23591132|NCT02341625|65892994|FG003|Overall Study|Study Drug Toxicity|1|||
23591133|NCT02341625|65892995|FG004|Overall Study|Study Drug Toxicity|0|||
23591134|NCT02341625|65892996|FG005|Overall Study|Study Drug Toxicity|3|||
23591135|NCT02341625|65892997|FG006|Overall Study|Study Drug Toxicity|10|||
23591136|NCT02341625|65892998|FG007|Overall Study|Study Drug Toxicity|0|||
23591137|NCT02341625|65892999|FG008|Overall Study|Study Drug Toxicity|0|||
23591138|NCT02341625|65893000|FG009|Overall Study|Study Drug Toxicity|3|||
23591139|NCT02341625|65892991|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591140|NCT02341625|65892992|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591141|NCT02341625|65892993|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591142|NCT02341625|65892994|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591143|NCT02341625|65892995|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591144|NCT02341625|65892996|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591145|NCT02341625|65892997|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23591146|NCT02341625|65892998|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
23591147|NCT02341625|65892999|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23591148|NCT02341625|65893000|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23591149|NCT02341625|65892991|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591150|NCT02341625|65892992|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591151|NCT02341625|65892993|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591152|NCT02341625|65892994|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591153|NCT02341625|65892995|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591154|NCT02341625|65892996|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591155|NCT02341625|65892997|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
23591156|NCT02341625|65892998|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
23591157|NCT02341625|65892999|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591158|NCT02341625|65893000|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
23591159|NCT02341625|65892991|FG000|Overall Study|Participant Withdrew Consent|0|||
23591160|NCT02341625|65892992|FG001|Overall Study|Participant Withdrew Consent|0|||
23591161|NCT02341625|65892993|FG002|Overall Study|Participant Withdrew Consent|0|||
23591162|NCT02341625|65892994|FG003|Overall Study|Participant Withdrew Consent|1|||
23591163|NCT02341625|65892995|FG004|Overall Study|Participant Withdrew Consent|0|||
23591164|NCT02341625|65892996|FG005|Overall Study|Participant Withdrew Consent|0|||
23591165|NCT02341625|65892997|FG006|Overall Study|Participant Withdrew Consent|0|||
23591166|NCT02341625|65892998|FG007|Overall Study|Participant Withdrew Consent|0|||
23591167|NCT02341625|65892999|FG008|Overall Study|Participant Withdrew Consent|0|||
23591168|NCT02341625|65893000|FG009|Overall Study|Participant Withdrew Consent|0|||
23591169|NCT02341625|65892991|FG000|Overall Study|Completed Treatment as per Protocol|0|||
23591170|NCT02341625|65892992|FG001|Overall Study|Completed Treatment as per Protocol|0|||
23591171|NCT02341625|65892993|FG002|Overall Study|Completed Treatment as per Protocol|0|||
23591172|NCT02341625|65892994|FG003|Overall Study|Completed Treatment as per Protocol|0|||
23591173|NCT02341625|65892995|FG004|Overall Study|Completed Treatment as per Protocol|0|||
23591174|NCT02341625|65892996|FG005|Overall Study|Completed Treatment as per Protocol|0|||
23591175|NCT02341625|65892997|FG006|Overall Study|Completed Treatment as per Protocol|0|||
23591176|NCT02341625|65892998|FG007|Overall Study|Completed Treatment as per Protocol|0|||
23591177|NCT02341625|65892999|FG008|Overall Study|Completed Treatment as per Protocol|0|||
23591178|NCT02341625|65893000|FG009|Overall Study|Completed Treatment as per Protocol|1|||
23591179|NCT02341625|65892991|FG000|Overall Study|Other Reasons|0|||
23591180|NCT02341625|65892992|FG001|Overall Study|Other Reasons|0|||
23591181|NCT02341625|65892993|FG002|Overall Study|Other Reasons|0|||
23591182|NCT02341625|65892994|FG003|Overall Study|Other Reasons|0|||
23591183|NCT02341625|65892995|FG004|Overall Study|Other Reasons|1|||
23591184|NCT02341625|65892996|FG005|Overall Study|Other Reasons|0|||
23591185|NCT02341625|65892997|FG006|Overall Study|Other Reasons|5|||
23591186|NCT02341625|65892998|FG007|Overall Study|Other Reasons|0|||
23591187|NCT02341625|65892999|FG008|Overall Study|Other Reasons|0|||
23591188|NCT02341625|65893000|FG009|Overall Study|Other Reasons|2|||
23591189|NCT02341625|65892991|FG000|Overall Study|Not Reported|0|||
23591190|NCT02341625|65892992|FG001|Overall Study|Not Reported|0|||
23591191|NCT02341625|65892993|FG002|Overall Study|Not Reported|0|||
23591192|NCT02341625|65892994|FG003|Overall Study|Not Reported|0|||
23591193|NCT02341625|65892995|FG004|Overall Study|Not Reported|0|||
23591194|NCT02341625|65892996|FG005|Overall Study|Not Reported|0|||
23591195|NCT02341625|65892997|FG006|Overall Study|Not Reported|0|||
23591196|NCT02341625|65892998|FG007|Overall Study|Not Reported|0|||
23591197|NCT02341625|65892999|FG008|Overall Study|Not Reported|0|||
23253709|NCT02072174|64670303|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
23591198|NCT02341625|65893000|FG009|Overall Study|Not Reported|3|||
23591199|NCT00959946|65893001|FG000|Overall Study|Adverse Event|0|||
23591200|NCT00959946|65893002|FG001|Overall Study|Adverse Event|0|||
23253710|NCT02072174|64670302|FG000|Overall Study|Protocol Violation|16|||
23591201|NCT00959946|65893003|FG002|Overall Study|Adverse Event|2|||
23591202|NCT00959946|65893004|FG003|Overall Study|Adverse Event|1|||
23591203|NCT00959946|65893005|FG004|Overall Study|Adverse Event|0|||
23591204|NCT00959946|65893006|FG005|Overall Study|Adverse Event|1|||
23591205|NCT00959946|65893007|FG006|Overall Study|Adverse Event|0|||
23591206|NCT00959946|65893008|FG007|Overall Study|Adverse Event|0|||
23591207|NCT00959946|65893001|FG000|Overall Study|Death|0|||
23591208|NCT00959946|65893002|FG001|Overall Study|Death|0|||
23591209|NCT00959946|65893003|FG002|Overall Study|Death|0|||
23591210|NCT00959946|65893004|FG003|Overall Study|Death|0|||
23591211|NCT00959946|65893005|FG004|Overall Study|Death|0|||
23591212|NCT00959946|65893006|FG005|Overall Study|Death|1|||
23591213|NCT00959946|65893007|FG006|Overall Study|Death|0|||
23591214|NCT00959946|65893008|FG007|Overall Study|Death|0|||
23591215|NCT00959946|65893001|FG000|Overall Study|Disease Progression|2|||
23591216|NCT00959946|65893002|FG001|Overall Study|Disease Progression|4|||
23591217|NCT00959946|65893003|FG002|Overall Study|Disease Progression|2|||
23591218|NCT00959946|65893004|FG003|Overall Study|Disease Progression|4|||
23591219|NCT00959946|65893005|FG004|Overall Study|Disease Progression|4|||
23591220|NCT00959946|65893006|FG005|Overall Study|Disease Progression|6|||
23591221|NCT00959946|65893007|FG006|Overall Study|Disease Progression|2|||
23591222|NCT00959946|65893008|FG007|Overall Study|Disease Progression|2|||
23591223|NCT00959946|65893001|FG000|Overall Study|Withdrawal by Subject|0|||
23591224|NCT00959946|65893002|FG001|Overall Study|Withdrawal by Subject|0|||
23591225|NCT00959946|65893003|FG002|Overall Study|Withdrawal by Subject|0|||
23591226|NCT00959946|65893004|FG003|Overall Study|Withdrawal by Subject|0|||
23591227|NCT00959946|65893005|FG004|Overall Study|Withdrawal by Subject|0|||
23591228|NCT00959946|65893006|FG005|Overall Study|Withdrawal by Subject|1|||
23591229|NCT00959946|65893007|FG006|Overall Study|Withdrawal by Subject|0|||
23591230|NCT00959946|65893008|FG007|Overall Study|Withdrawal by Subject|0|||
23591231|NCT01849055|65893011|FG000|Overall Study|Withdrawal by Subject|0|||
23591232|NCT01849055|65893012|FG001|Overall Study|Withdrawal by Subject|0|||
23591233|NCT01849055|65893013|FG002|Overall Study|Withdrawal by Subject|1|||
23591234|NCT01849055|65893014|FG003|Overall Study|Withdrawal by Subject|0|||
23591235|NCT01849055|65893015|FG004|Overall Study|Withdrawal by Subject|0|||
23591236|NCT01849055|65893016|FG005|Overall Study|Withdrawal by Subject|0|||
23591237|NCT06136897|65893017|FG000|Overall Study|Ineligible|3|||
23591238|NCT06136897|65893017|FG000|Overall Study|Mutation status not confirmed|7|||
23591239|NCT06136897|65893017|FG000|Overall Study|Adverse Event|2|||
23591240|NCT06136897|65893017|FG000|Overall Study|Death|1|||
23591241|NCT06136897|65893017|FG000|Overall Study|Disease progression|18|||
23591242|NCT06136897|65893017|FG000|Overall Study|Other complicating disease|1|||
23591243|NCT06136897|65893017|FG000|Overall Study|Withdrawal by Subject|1|||
23591244|NCT06136897|65893017|FG000|Overall Study|Still on treatment|1|||
23591245|NCT06136897|65893017|FG000|Overall Study|Lost to Follow-up|1|||
23591246|NCT01576484|65893020|FG000|Overall Study|Adverse Event|1|||
23591247|NCT01576484|65893021|FG001|Overall Study|Adverse Event|1|||
23591248|NCT01576484|65893020|FG000|Overall Study|Protocol Violation|0|||
23360093|NCT01720524|65062832|FG000|Part A|Other|0|||
23476282|NCT00065429|65488032|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476283|NCT00065429|65488033|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476284|NCT00065429|65488034|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
23476285|NCT00065429|65488035|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476286|NCT00065429|65488036|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
23476287|NCT00065429|65488030|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476288|NCT00065429|65488031|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476289|NCT00065429|65488032|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476290|NCT00065429|65488033|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476291|NCT00065429|65488034|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
23476292|NCT00065429|65488035|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476293|NCT00065429|65488036|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
23476294|NCT04364984|65488037|FG000|Overall Study|Death|2|||
23476295|NCT04364984|65488038|FG001|Overall Study|Death|2|||
23476296|NCT04364984|65488039|FG002|Overall Study|Death|0|||
23476297|NCT01028300|65488040|FG000|Overall Study|Study Terminated|4|||
23476298|NCT00978757|65488041|FG000|Overall Study|Physician Decision|1|||
23476299|NCT00978757|65488042|FG001|Overall Study|Physician Decision|3|||
23476300|NCT00899353|65488045|FG000|Overall Study|Adverse Event|2|||
23591249|NCT01576484|65893021|FG001|Overall Study|Protocol Violation|2|||
23591250|NCT01576484|65893020|FG000|Overall Study|Sponsor Decision|2|||
23591251|NCT01576484|65893021|FG001|Overall Study|Sponsor Decision|8|||
23591252|NCT01576484|65893020|FG000|Overall Study|Withdrawal by Subject|0|||
23591253|NCT01576484|65893021|FG001|Overall Study|Withdrawal by Subject|3|||
23591254|NCT01576484|65893020|FG000|Overall Study|Other|2|||
23591255|NCT01576484|65893021|FG001|Overall Study|Other|5|||
23476301|NCT00899353|65488045|FG000|Overall Study|Lost to Follow-up|1|||
23476302|NCT00899353|65488045|FG000|Overall Study|Withdrawal by Subject|2|||
23591256|NCT00716144|65893022|FG000|Overall Study|Withdrawal by Subject|4|||
23591257|NCT00716144|65893023|FG001|Overall Study|Withdrawal by Subject|2|||
23591258|NCT00716144|65893024|FG002|Overall Study|Withdrawal by Subject|6|||
23591259|NCT00716144|65893025|FG003|Overall Study|Withdrawal by Subject|6|||
23591260|NCT00716144|65893022|FG000|Overall Study|Lost to Follow-up|2|||
23591261|NCT00716144|65893023|FG001|Overall Study|Lost to Follow-up|2|||
23591262|NCT00716144|65893024|FG002|Overall Study|Lost to Follow-up|1|||
23591263|NCT00716144|65893025|FG003|Overall Study|Lost to Follow-up|2|||
23591264|NCT00716144|65893022|FG000|Overall Study|Adverse Event|0|||
23591265|NCT00716144|65893023|FG001|Overall Study|Adverse Event|0|||
23591266|NCT00716144|65893024|FG002|Overall Study|Adverse Event|0|||
23591267|NCT00716144|65893025|FG003|Overall Study|Adverse Event|2|||
23591268|NCT00716144|65893022|FG000|Overall Study|Non-compliance|1|||
23591269|NCT00716144|65893023|FG001|Overall Study|Non-compliance|0|||
23591270|NCT00716144|65893024|FG002|Overall Study|Non-compliance|0|||
23591271|NCT00716144|65893025|FG003|Overall Study|Non-compliance|0|||
23591272|NCT00716144|65893022|FG000|Overall Study|Protocol Violation|2|||
23591273|NCT00716144|65893023|FG001|Overall Study|Protocol Violation|0|||
23591274|NCT00716144|65893024|FG002|Overall Study|Protocol Violation|1|||
23591275|NCT00716144|65893025|FG003|Overall Study|Protocol Violation|0|||
23591276|NCT00716144|65893022|FG000|Overall Study|Physician Decision|0|||
23591277|NCT00716144|65893023|FG001|Overall Study|Physician Decision|1|||
23591278|NCT00716144|65893024|FG002|Overall Study|Physician Decision|2|||
23591279|NCT00716144|65893025|FG003|Overall Study|Physician Decision|2|||
23591280|NCT00716144|65893022|FG000|Overall Study|Intercurrent illness|0|||
23591281|NCT00716144|65893023|FG001|Overall Study|Intercurrent illness|0|||
23591282|NCT00716144|65893024|FG002|Overall Study|Intercurrent illness|1|||
23591283|NCT00716144|65893025|FG003|Overall Study|Intercurrent illness|0|||
23591284|NCT00716144|65893022|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
23591285|NCT00716144|65893023|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
23591286|NCT00716144|65893024|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
23591287|NCT00716144|65893025|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
23591288|NCT00716144|65893022|FG000|Overall Study|Adverse event: left foot pain|0|||
23591289|NCT00716144|65893023|FG001|Overall Study|Adverse event: left foot pain|1|||
23591290|NCT00716144|65893024|FG002|Overall Study|Adverse event: left foot pain|0|||
23591291|NCT00716144|65893025|FG003|Overall Study|Adverse event: left foot pain|0|||
23591292|NCT00716144|65893022|FG000|Overall Study|Clinical Depression|0|||
23591293|NCT00716144|65893023|FG001|Overall Study|Clinical Depression|1|||
23591294|NCT00716144|65893024|FG002|Overall Study|Clinical Depression|0|||
23591295|NCT00716144|65893025|FG003|Overall Study|Clinical Depression|0|||
23591296|NCT02139046|65893026|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23591297|NCT02139046|65893027|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
23591298|NCT02139046|65893028|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
23591299|NCT02139046|65893029|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
23591300|NCT02139046|65893030|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
23591301|NCT02139046|65893026|FG000|Overall Study|Major Protocol Deviation|9|||
23591302|NCT02139046|65893027|FG001|Overall Study|Major Protocol Deviation|10|||
23591303|NCT02139046|65893028|FG002|Overall Study|Major Protocol Deviation|16|||
23591304|NCT02139046|65893029|FG003|Overall Study|Major Protocol Deviation|12|||
23591305|NCT02139046|65893030|FG004|Overall Study|Major Protocol Deviation|6|||
23591306|NCT02139046|65893026|FG000|Overall Study|Lost to Follow-up|13|||
23591307|NCT02139046|65893027|FG001|Overall Study|Lost to Follow-up|16|||
23591308|NCT02139046|65893028|FG002|Overall Study|Lost to Follow-up|16|||
23591309|NCT02139046|65893029|FG003|Overall Study|Lost to Follow-up|18|||
23591310|NCT02139046|65893030|FG004|Overall Study|Lost to Follow-up|13|||
23591311|NCT02139046|65893026|FG000|Overall Study|Voluntary Withdrawal|20|||
23591312|NCT02139046|65893027|FG001|Overall Study|Voluntary Withdrawal|8|||
23591313|NCT02139046|65893028|FG002|Overall Study|Voluntary Withdrawal|10|||
23591314|NCT02139046|65893029|FG003|Overall Study|Voluntary Withdrawal|15|||
23591315|NCT02139046|65893030|FG004|Overall Study|Voluntary Withdrawal|16|||
23591316|NCT02139046|65893026|FG000|Overall Study|Lack of Efficacy|0|||
23591317|NCT02139046|65893027|FG001|Overall Study|Lack of Efficacy|1|||
23591318|NCT02139046|65893028|FG002|Overall Study|Lack of Efficacy|2|||
23591319|NCT02139046|65893029|FG003|Overall Study|Lack of Efficacy|1|||
23591320|NCT02139046|65893030|FG004|Overall Study|Lack of Efficacy|2|||
23591321|NCT02139046|65893026|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
23591322|NCT02139046|65893027|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
23591323|NCT02139046|65893028|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
23591324|NCT02139046|65893029|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
23591325|NCT02139046|65893030|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
23591326|NCT02139046|65893026|FG000|Overall Study|Other Miscellaneous Reasons|10|||
23591327|NCT02139046|65893027|FG001|Overall Study|Other Miscellaneous Reasons|9|||
23591328|NCT02139046|65893028|FG002|Overall Study|Other Miscellaneous Reasons|4|||
23476303|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
23591329|NCT02139046|65893029|FG003|Overall Study|Other Miscellaneous Reasons|9|||
23591330|NCT02139046|65893030|FG004|Overall Study|Other Miscellaneous Reasons|12|||
23591331|NCT00630786|65893031|FG000|Overall Study|Physician Decision|0|||
23591332|NCT00630786|65893032|FG001|Overall Study|Physician Decision|0|||
23591333|NCT00630786|65893033|FG002|Overall Study|Physician Decision|1|||
23591334|NCT00630786|65893031|FG000|Overall Study|Withdrawal by Subject|0|||
23591335|NCT00630786|65893032|FG001|Overall Study|Withdrawal by Subject|1|||
23591336|NCT00630786|65893033|FG002|Overall Study|Withdrawal by Subject|1|||
23591337|NCT00630786|65893031|FG000|Overall Study|Lost to Follow-up|0|||
23591338|NCT00630786|65893032|FG001|Overall Study|Lost to Follow-up|1|||
23591339|NCT00630786|65893033|FG002|Overall Study|Lost to Follow-up|0|||
23591340|NCT00630786|65893031|FG000|Overall Study|Other|1|||
23591341|NCT00630786|65893032|FG001|Overall Study|Other|0|||
23591342|NCT00630786|65893033|FG002|Overall Study|Other|0|||
23591343|NCT01135511|65893036|FG000|Overall Study|Adverse Event|0|||
23591344|NCT01135511|65893037|FG001|Overall Study|Adverse Event|1|||
23591345|NCT01135511|65893038|FG002|Overall Study|Adverse Event|2|||
23591346|NCT01135511|65893039|FG003|Overall Study|Adverse Event|0|||
23591347|NCT01135511|65893040|FG004|Overall Study|Adverse Event|0|||
23591348|NCT01135511|65893041|FG005|Overall Study|Adverse Event|1|||
23591349|NCT01135511|65893042|FG006|Overall Study|Adverse Event|0|||
23591350|NCT01135511|65893043|FG007|Overall Study|Adverse Event|1|||
23591351|NCT01135511|65893044|FG008|Overall Study|Adverse Event|0|||
23591352|NCT01135511|65893036|FG000|Overall Study|Lack of Efficacy|0|||
23591353|NCT01135511|65893037|FG001|Overall Study|Lack of Efficacy|1|||
23591354|NCT01135511|65893038|FG002|Overall Study|Lack of Efficacy|1|||
23192629|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Pregnancy|0|||
23192630|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Pregnancy|0|||
23192631|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
23192632|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
23192633|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
23192634|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
23192635|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
23192636|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
23192637|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
23192638|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
23192639|NCT01855789|64445990|FG000|1) Baseline up to Week 24|Other|4|||
23192640|NCT01855789|64445991|FG001|1) Baseline up to Week 24|Other|0|||
23192641|NCT01855789|64445992|FG002|1) Baseline up to Week 24|Other|0|||
23192642|NCT01855789|64445993|FG003|1) Baseline up to Week 24|Other|0|||
23192643|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
23192644|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
23192645|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
23192646|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
23192647|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
23192648|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
23192649|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
23476304|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
23476305|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Adverse Event|7|||
23476306|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Adverse Event|6|||
23476307|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
23476308|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
23476309|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Physician Decision|4|||
23476310|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Physician Decision|4|||
23476311|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
23476312|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
23476313|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
23476314|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
23476315|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
23476316|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
23476317|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Non-compliance|1|||
23476318|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Non-compliance|0|||
23476319|NCT00470834|65488050|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
23476320|NCT00470834|65488051|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
23476321|NCT00470834|65488050|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
23476322|NCT00470834|65488051|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
23476323|NCT00470834|65488050|FG000|Extension Period (24 Months)|Adverse Event|3|||
23476324|NCT00470834|65488051|FG001|Extension Period (24 Months)|Adverse Event|4|||
23476325|NCT00470834|65488050|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
23591355|NCT01135511|65893039|FG003|Overall Study|Lack of Efficacy|2|||
23591356|NCT01135511|65893040|FG004|Overall Study|Lack of Efficacy|0|||
23591357|NCT01135511|65893041|FG005|Overall Study|Lack of Efficacy|0|||
23591358|NCT01135511|65893042|FG006|Overall Study|Lack of Efficacy|0|||
23591359|NCT01135511|65893043|FG007|Overall Study|Lack of Efficacy|0|||
23591360|NCT01135511|65893044|FG008|Overall Study|Lack of Efficacy|0|||
23591361|NCT01135511|65893036|FG000|Overall Study|Protocol Violation|0|||
23192650|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
23192651|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
23192652|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
23192653|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
23192654|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
23192655|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
23192656|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
23192657|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
23192658|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
23192659|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
23192660|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
23192661|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
23192662|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
23192663|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
23192664|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
23591362|NCT01135511|65893037|FG001|Overall Study|Protocol Violation|0|||
23591363|NCT01135511|65893038|FG002|Overall Study|Protocol Violation|3|||
23591364|NCT01135511|65893039|FG003|Overall Study|Protocol Violation|0|||
23591365|NCT01135511|65893040|FG004|Overall Study|Protocol Violation|0|||
23591366|NCT01135511|65893041|FG005|Overall Study|Protocol Violation|0|||
23591367|NCT01135511|65893042|FG006|Overall Study|Protocol Violation|0|||
23591368|NCT01135511|65893043|FG007|Overall Study|Protocol Violation|0|||
23591369|NCT01135511|65893044|FG008|Overall Study|Protocol Violation|0|||
23591370|NCT01135511|65893036|FG000|Overall Study|Pregnancy|0|||
23591371|NCT01135511|65893037|FG001|Overall Study|Pregnancy|0|||
23591372|NCT01135511|65893038|FG002|Overall Study|Pregnancy|0|||
23591373|NCT01135511|65893039|FG003|Overall Study|Pregnancy|1|||
23591374|NCT01135511|65893040|FG004|Overall Study|Pregnancy|0|||
23591375|NCT01135511|65893041|FG005|Overall Study|Pregnancy|0|||
23591376|NCT01135511|65893042|FG006|Overall Study|Pregnancy|0|||
23591377|NCT01135511|65893043|FG007|Overall Study|Pregnancy|0|||
23591378|NCT01135511|65893044|FG008|Overall Study|Pregnancy|0|||
23591379|NCT01135511|65893036|FG000|Overall Study|could not visit the clinic|0|||
23591380|NCT01135511|65893037|FG001|Overall Study|could not visit the clinic|1|||
23591381|NCT01135511|65893038|FG002|Overall Study|could not visit the clinic|2|||
23591382|NCT01135511|65893039|FG003|Overall Study|could not visit the clinic|0|||
23591383|NCT01135511|65893040|FG004|Overall Study|could not visit the clinic|0|||
23591384|NCT01135511|65893041|FG005|Overall Study|could not visit the clinic|0|||
23591385|NCT01135511|65893042|FG006|Overall Study|could not visit the clinic|0|||
23591386|NCT01135511|65893043|FG007|Overall Study|could not visit the clinic|0|||
23591387|NCT01135511|65893044|FG008|Overall Study|could not visit the clinic|0|||
23591388|NCT01135511|65893036|FG000|Overall Study|noncompliance with study drug taken|0|||
23591389|NCT01135511|65893037|FG001|Overall Study|noncompliance with study drug taken|0|||
23591390|NCT01135511|65893038|FG002|Overall Study|noncompliance with study drug taken|0|||
23591391|NCT01135511|65893039|FG003|Overall Study|noncompliance with study drug taken|0|||
23591392|NCT01135511|65893040|FG004|Overall Study|noncompliance with study drug taken|1|||
23591393|NCT01135511|65893041|FG005|Overall Study|noncompliance with study drug taken|0|||
23591394|NCT01135511|65893042|FG006|Overall Study|noncompliance with study drug taken|0|||
23591395|NCT01135511|65893043|FG007|Overall Study|noncompliance with study drug taken|0|||
23591396|NCT01135511|65893044|FG008|Overall Study|noncompliance with study drug taken|0|||
23591397|NCT01135511|65893036|FG000|Overall Study|Withdrawal by Subject|0|||
23591398|NCT01135511|65893037|FG001|Overall Study|Withdrawal by Subject|0|||
23591399|NCT01135511|65893038|FG002|Overall Study|Withdrawal by Subject|0|||
23591400|NCT01135511|65893039|FG003|Overall Study|Withdrawal by Subject|0|||
23591401|NCT01135511|65893040|FG004|Overall Study|Withdrawal by Subject|0|||
23591402|NCT01135511|65893041|FG005|Overall Study|Withdrawal by Subject|0|||
23360094|NCT01720524|65062833|FG001|Part A|Other|1|||
23360095|NCT01720524|65062832|FG000|Part A|Lost to Follow-up|0|||
23591403|NCT01135511|65893042|FG006|Overall Study|Withdrawal by Subject|1|||
23591404|NCT01135511|65893043|FG007|Overall Study|Withdrawal by Subject|0|||
23591405|NCT01135511|65893044|FG008|Overall Study|Withdrawal by Subject|1|||
23192665|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
23476326|NCT00470834|65488051|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
23476327|NCT00470834|65488050|FG000|Extension Period (24 Months)|Physician Decision|4|||
23192666|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
23192667|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
23360096|NCT01720524|65062833|FG001|Part A|Lost to Follow-up|1|||
23591406|NCT02613364|65893045|FG000|Overall Study|Other|19|||
23591407|NCT02613364|65893046|FG001|Overall Study|Other|29|||
23591408|NCT02613364|65893047|FG002|Overall Study|Other|17|||
23591409|NCT02613364|65893045|FG000|Overall Study|Too time consuming|21|||
23591410|NCT02613364|65893046|FG001|Overall Study|Too time consuming|26|||
23591411|NCT02613364|65893047|FG002|Overall Study|Too time consuming|26|||
23591412|NCT02613364|65893045|FG000|Overall Study|Withdrawal by Subject|13|||
23591413|NCT02613364|65893046|FG001|Overall Study|Withdrawal by Subject|18|||
23591414|NCT02613364|65893047|FG002|Overall Study|Withdrawal by Subject|17|||
23591415|NCT02613364|65893045|FG000|Overall Study|Medical|12|||
23192668|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
23192669|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
23192670|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
23192671|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
23192672|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
23192673|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
23192674|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
23192675|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
23192676|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
23192677|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
23192678|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
23192679|NCT01855789|64445990|FG000|2) Week 24 up to End of Study|Other|0|||
23192680|NCT01855789|64445991|FG001|2) Week 24 up to End of Study|Other|0|||
23192681|NCT01855789|64445992|FG002|2) Week 24 up to End of Study|Other|0|||
23192682|NCT01855789|64445993|FG003|2) Week 24 up to End of Study|Other|1|||
23192683|NCT00872898|64445994|FG000|Part Two - Double Blind|Adverse Event|4|||
23192684|NCT00872898|64445995|FG001|Part Two - Double Blind|Adverse Event|3|||
23192685|NCT00872898|64445994|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
23192686|NCT00872898|64445995|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
23192687|NCT00872898|64445994|FG000|Part Two - Double Blind|Protocol Violation|1|||
23192688|NCT00872898|64445995|FG001|Part Two - Double Blind|Protocol Violation|0|||
23192689|NCT00872898|64445994|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
23192690|NCT00872898|64445995|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
23192691|NCT00872898|64445994|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
23192692|NCT00872898|64445995|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
23192693|NCT00872898|64445994|FG000|Part Two - Double Blind|Other reasons|2|||
23192694|NCT00872898|64445995|FG001|Part Two - Double Blind|Other reasons|0|||
23192695|NCT02369510|64445998|FG000|Overall Study|Spilled Medication|1|||
23192696|NCT02369510|64445999|FG001|Overall Study|Spilled Medication|2|||
23192697|NCT02369510|64446000|FG002|Overall Study|Spilled Medication|1|||
23192698|NCT02369510|64445998|FG000|Overall Study|Epidural Activation|1|||
23192699|NCT02369510|64445999|FG001|Overall Study|Epidural Activation|1|||
23192700|NCT02369510|64446000|FG002|Overall Study|Epidural Activation|5|||
23192701|NCT03894904|64446004|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
23192702|NCT03894904|64446005|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
23192703|NCT03894904|64446004|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
23192704|NCT03894904|64446005|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
23253711|NCT02072174|64670303|FG001|Overall Study|Protocol Violation|23|||
23253712|NCT02072174|64670302|FG000|Overall Study|Physician Decision|0|||
23253713|NCT02072174|64670303|FG001|Overall Study|Physician Decision|1|||
23253714|NCT02072174|64670302|FG000|Overall Study|Non-compliance with protocol requirement|2|||
23253715|NCT02072174|64670303|FG001|Overall Study|Non-compliance with protocol requirement|0|||
23253716|NCT01600014|64670304|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
23360097|NCT01720524|65062832|FG000|Part B|No longer willing to participate in study|1|||
23360098|NCT01720524|65062833|FG001|Part B|No longer willing to participate in study|4|||
23360099|NCT01720524|65062832|FG000|Part B|Other|2|||
23360100|NCT01720524|65062833|FG001|Part B|Other|0|||
23360101|NCT01720524|65062832|FG000|Part B|Lost to Follow-up|2|||
23360102|NCT01720524|65062833|FG001|Part B|Lost to Follow-up|3|||
23360103|NCT01720524|65062832|FG000|Part B|Death|0|||
23360104|NCT01720524|65062833|FG001|Part B|Death|2|||
23360105|NCT04399889|65062834|FG000|Overall Study|Death|5|||
23360106|NCT04399889|65062835|FG001|Overall Study|Death|1|||
23360107|NCT04399889|65062836|FG002|Overall Study|Death|1|||
23360108|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
23360109|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
23360110|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
23360111|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
23360112|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
23360113|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
23360114|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
23476328|NCT00470834|65488051|FG001|Extension Period (24 Months)|Physician Decision|3|||
23192705|NCT02021812|64446009|FG000|Overall Study|Death|8|||
23192706|NCT02021812|64446009|FG000|Overall Study|Withdrawal by Subject|3|||
23192707|NCT02021812|64446009|FG000|Overall Study|Lost to Follow-up|2|||
23192708|NCT02021812|64446009|FG000|Overall Study|Refuse to return, COVD 19|2|||
23192709|NCT02859415|64446011|FG000|Overall Study|Physician Decision|1|||
23253717|NCT01600014|64670305|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
23253718|NCT01600014|64670304|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
23360115|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
23360116|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
23360117|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
23591416|NCT02613364|65893046|FG001|Overall Study|Medical|13|||
23591417|NCT02613364|65893047|FG002|Overall Study|Medical|9|||
23591418|NCT02613364|65893045|FG000|Overall Study|Disliked Study Procedure|1|||
23591419|NCT02613364|65893046|FG001|Overall Study|Disliked Study Procedure|1|||
23591420|NCT02613364|65893047|FG002|Overall Study|Disliked Study Procedure|4|||
23591421|NCT02613364|65893045|FG000|Overall Study|Disliked Intervention|0|||
23591422|NCT02613364|65893046|FG001|Overall Study|Disliked Intervention|3|||
23591423|NCT02613364|65893047|FG002|Overall Study|Disliked Intervention|3|||
23591424|NCT01350804|65893049|FG000|Core Study|Withdrawal by Subject|11|||
23591425|NCT01350804|65893050|FG001|Core Study|Withdrawal by Subject|17|||
23591426|NCT01350804|65893051|FG002|Core Study|Withdrawal by Subject|16|||
23591427|NCT01350804|65893052|FG003|Core Study|Withdrawal by Subject|7|||
23591428|NCT01350804|65893049|FG000|Core Study|Study terminated by Sponsor|0|||
23591429|NCT01350804|65893050|FG001|Core Study|Study terminated by Sponsor|0|||
23591430|NCT01350804|65893051|FG002|Core Study|Study terminated by Sponsor|0|||
23591431|NCT01350804|65893052|FG003|Core Study|Study terminated by Sponsor|2|||
23591432|NCT01350804|65893049|FG000|Core Study|Protocol deviation|1|||
23591433|NCT01350804|65893050|FG001|Core Study|Protocol deviation|0|||
23591434|NCT01350804|65893051|FG002|Core Study|Protocol deviation|1|||
23591435|NCT01350804|65893052|FG003|Core Study|Protocol deviation|0|||
23591436|NCT01350804|65893049|FG000|Core Study|Physician Decision|1|||
23591437|NCT01350804|65893050|FG001|Core Study|Physician Decision|0|||
23591438|NCT01350804|65893051|FG002|Core Study|Physician Decision|1|||
23591439|NCT01350804|65893052|FG003|Core Study|Physician Decision|3|||
23591440|NCT01350804|65893049|FG000|Core Study|Lost to Follow-up|3|||
23591441|NCT01350804|65893050|FG001|Core Study|Lost to Follow-up|0|||
23591442|NCT01350804|65893051|FG002|Core Study|Lost to Follow-up|2|||
23591443|NCT01350804|65893052|FG003|Core Study|Lost to Follow-up|1|||
23591444|NCT01350804|65893049|FG000|Core Study|Lack of Efficacy|16|||
23591445|NCT01350804|65893050|FG001|Core Study|Lack of Efficacy|19|||
23591446|NCT01350804|65893051|FG002|Core Study|Lack of Efficacy|18|||
23591447|NCT01350804|65893052|FG003|Core Study|Lack of Efficacy|5|||
23591448|NCT01350804|65893049|FG000|Core Study|Death|1|||
23591449|NCT01350804|65893050|FG001|Core Study|Death|1|||
23591450|NCT01350804|65893051|FG002|Core Study|Death|1|||
23591451|NCT01350804|65893052|FG003|Core Study|Death|0|||
23591452|NCT01350804|65893049|FG000|Core Study|Adverse Event|8|||
23591453|NCT01350804|65893050|FG001|Core Study|Adverse Event|10|||
23591454|NCT01350804|65893051|FG002|Core Study|Adverse Event|8|||
23591455|NCT01350804|65893052|FG003|Core Study|Adverse Event|8|||
23591456|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
23591457|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
23591458|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
23591459|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
23591460|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
23591461|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
23591462|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
23591463|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
23591464|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
23591465|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
23591466|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
23591467|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
23591468|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
23591469|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
23591470|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
23591471|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
23591472|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
23591473|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
23591474|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
23591475|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
23591476|NCT01350804|65893049|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
23591477|NCT01350804|65893050|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
23591478|NCT01350804|65893051|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
23591479|NCT01350804|65893052|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
23591480|NCT01321606|65893053|FG000|Overall Study|Lost to Follow-up|0|||
23591481|NCT01321606|65893054|FG001|Overall Study|Lost to Follow-up|0|||
23591482|NCT01321606|65893055|FG002|Overall Study|Lost to Follow-up|0|||
23591483|NCT01321606|65893056|FG003|Overall Study|Lost to Follow-up|1|||
23192710|NCT02859415|64446012|FG001|Overall Study|Physician Decision|0|||
23591484|NCT00558363|65893058|FG000|Overall Study|Physician Decision|18|||
23591485|NCT00558363|65893059|FG001|Overall Study|Physician Decision|4|||
23591486|NCT00558363|65893058|FG000|Overall Study|Withdrawal by Subject|11|||
23591487|NCT00558363|65893059|FG001|Overall Study|Withdrawal by Subject|4|||
23591488|NCT00558363|65893058|FG000|Overall Study|Adverse Event|5|||
23591489|NCT00558363|65893059|FG001|Overall Study|Adverse Event|5|||
23591490|NCT00558363|65893058|FG000|Overall Study|Lack of Efficacy|2|||
23591491|NCT00558363|65893059|FG001|Overall Study|Lack of Efficacy|2|||
23591492|NCT00558363|65893058|FG000|Overall Study|Protocol Violation|2|||
23591493|NCT00558363|65893059|FG001|Overall Study|Protocol Violation|1|||
23591494|NCT00558363|65893058|FG000|Overall Study|Lost to Follow-up|0|||
23591495|NCT00558363|65893059|FG001|Overall Study|Lost to Follow-up|1|||
23591496|NCT00558363|65893058|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
23591497|NCT00558363|65893059|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
23591498|NCT00558363|65893058|FG000|Overall Study|Randomized in Error|1|||
23591499|NCT00558363|65893059|FG001|Overall Study|Randomized in Error|2|||
23591500|NCT00558363|65893058|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
23591501|NCT00558363|65893059|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
23591502|NCT00617201|65893060|FG000|Overall Study|Lost to Follow-up|9|||
23591503|NCT00617201|65893061|FG001|Overall Study|Lost to Follow-up|13|||
23591504|NCT01147341|65893062|FG000|Double Blind Period|Lack of Efficacy|1|||
23591505|NCT01147341|65893063|FG001|Double Blind Period|Lack of Efficacy|1|||
23591506|NCT01147341|65893062|FG000|Double Blind Period|Withdrawal by Subject|0|||
23591507|NCT01147341|65893063|FG001|Double Blind Period|Withdrawal by Subject|1|||
23591508|NCT01147341|65893062|FG000|Open Label Period|Lack of Efficacy|3|||
23591509|NCT01147341|65893063|FG001|Open Label Period|Lack of Efficacy|0|||
23591510|NCT01147341|65893062|FG000|Open Label Period|Subject moved|1|||
23591511|NCT01147341|65893063|FG001|Open Label Period|Subject moved|0|||
23591512|NCT00951379|65893071|FG000|Overall Study|Adverse Event|4|||
23591513|NCT00951379|65893072|FG001|Overall Study|Adverse Event|1|||
23591514|NCT00951379|65893071|FG000|Overall Study|Withdrawal by Subject|1|||
23591515|NCT00951379|65893072|FG001|Overall Study|Withdrawal by Subject|0|||
23591516|NCT00951379|65893071|FG000|Overall Study|Noncompliance|1|||
23591517|NCT00951379|65893072|FG001|Overall Study|Noncompliance|0|||
23591518|NCT00951379|65893071|FG000|Overall Study|Disease Progression|0|||
23591519|NCT00951379|65893072|FG001|Overall Study|Disease Progression|1|||
23591520|NCT03299816|65893084|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
23591521|NCT03299816|65893085|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
23591522|NCT03299816|65893084|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
23591523|NCT03299816|65893085|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
23591524|NCT03299816|65893084|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
23591525|NCT03299816|65893085|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
23591526|NCT00585533|65893086|FG000|Overall Study|objective or symptomatic progression|9|||
23591527|NCT02613871|65895940|FG000|Overall Study|Death|2|||
23591528|NCT02613871|65895940|FG000|Overall Study|Withdrew Consent|1|||
23591529|NCT00638963|65895946|FG000|Overall Study|Withdrawal by Subject|1|||
23591530|NCT00638963|65895947|FG001|Overall Study|Withdrawal by Subject|0|||
23591531|NCT01259102|65895948|FG000|Overall Study|Adverse Event|1|||
23591532|NCT01259102|65895949|FG001|Overall Study|Adverse Event|0|||
23591533|NCT01259102|65895950|FG002|Overall Study|Adverse Event|1|||
23591534|NCT01259102|65895951|FG003|Overall Study|Adverse Event|1|||
23591535|NCT01259102|65895952|FG004|Overall Study|Adverse Event|0|||
23591536|NCT01259102|65895948|FG000|Overall Study|Other|0|||
23591537|NCT01259102|65895949|FG001|Overall Study|Other|0|||
23591538|NCT01259102|65895950|FG002|Overall Study|Other|1|||
23591539|NCT01259102|65895951|FG003|Overall Study|Other|1|||
23591540|NCT01259102|65895952|FG004|Overall Study|Other|1|||
23591541|NCT03720210|65895955|FG000|Overall Study|Lost to Follow-up|1|||
23591542|NCT02694978|65895956|FG000|Overall Study|Adverse Event|10|||
23591543|NCT02694978|65895957|FG001|Overall Study|Adverse Event|9|||
23591544|NCT02694978|65895956|FG000|Overall Study|Withdrawal by Subject|22|||
23591545|NCT02694978|65895957|FG001|Overall Study|Withdrawal by Subject|19|||
23591546|NCT02694978|65895956|FG000|Overall Study|Lost to Follow-up|14|||
23591547|NCT02694978|65895957|FG001|Overall Study|Lost to Follow-up|17|||
23591548|NCT02694978|65895956|FG000|Overall Study|Death|4|||
23591549|NCT02694978|65895957|FG001|Overall Study|Death|1|||
23591550|NCT02694978|65895956|FG000|Overall Study|Other-Decision of Participant|6|||
23591551|NCT02694978|65895957|FG001|Overall Study|Other-Decision of Participant|1|||
23591552|NCT02694978|65895956|FG000|Overall Study|Other-Investigator's decision|1|||
23591553|NCT02694978|65895957|FG001|Overall Study|Other-Investigator's decision|0|||
23591554|NCT02694978|65895956|FG000|Overall Study|Other-Unable to be reached|0|||
23591555|NCT02694978|65895957|FG001|Overall Study|Other-Unable to be reached|1|||
23591556|NCT02694978|65895956|FG000|Overall Study|Other-Protocol noncompliant|2|||
23253719|NCT01600014|64670305|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
23591557|NCT02694978|65895957|FG001|Overall Study|Other-Protocol noncompliant|1|||
23591558|NCT02694978|65895956|FG000|Overall Study|Other-Personal reasons|3|||
23591559|NCT02694978|65895957|FG001|Overall Study|Other-Personal reasons|3|||
23591560|NCT02694978|65895956|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
23591561|NCT02694978|65895957|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
23591562|NCT02594735|65895958|FG000|Overall Study|Adverse Event|1|||
23591563|NCT00178399|65895959|FG000|Overall Study|Physician Decision|4|||
23591564|NCT00178399|65895959|FG000|Overall Study|Withdrawal by Subject|8|||
23591565|NCT00178399|65895959|FG000|Overall Study|Lost to Follow-up|1|||
23591566|NCT02692417|65895960|FG000|Overall Study|Withdrawal by Subject|5|||
23591567|NCT02692417|65895961|FG001|Overall Study|Withdrawal by Subject|1|||
23591568|NCT02692417|65895960|FG000|Overall Study|Adverse Event|1|||
23591569|NCT02692417|65895961|FG001|Overall Study|Adverse Event|0|||
23591570|NCT01161498|65895967|FG000|Overall Study|Disease Progression|0|||
23591571|NCT01161498|65895968|FG001|Overall Study|Disease Progression|1|||
23591572|NCT01692730|65895976|FG000|Overall Study|Lost to Follow-up|225|||
23591573|NCT01692730|65895977|FG001|Overall Study|Lost to Follow-up|227|||
23591574|NCT02027558|65895978|FG000|Overall Study|Death|0|||
23591575|NCT02027558|65895979|FG001|Overall Study|Death|1|||
23591576|NCT02027558|65895978|FG000|Overall Study|Withdrawal by Subject|2|||
23591577|NCT02027558|65895979|FG001|Overall Study|Withdrawal by Subject|0|||
23591578|NCT02027558|65895978|FG000|Overall Study|Lost to Follow-up|4|||
23591579|NCT02027558|65895979|FG001|Overall Study|Lost to Follow-up|1|||
23591580|NCT02027558|65895978|FG000|Overall Study|Refused assessment|3|||
23591581|NCT02027558|65895979|FG001|Overall Study|Refused assessment|0|||
23591582|NCT00361283|65895980|FG000|Overall Study|Lost to Follow-up|27|||
23591583|NCT01458210|65895984|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
23591584|NCT01458210|65895984|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
23591585|NCT01458210|65895984|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
23591586|NCT01458210|65895984|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
23591587|NCT01104415|65895985|FG000|Core Phase|Consent withdrawn by subjects|1|||
23591588|NCT01104415|65895986|FG001|Core Phase|Consent withdrawn by subjects|0|||
23591589|NCT01104415|65895985|FG000|Extension Period|Progressive disease|0|||
23591590|NCT01104415|65895986|FG001|Extension Period|Progressive disease|4|||
23591591|NCT01104415|65895985|FG000|Extension Period|Death|0|||
23591592|NCT01104415|65895986|FG001|Extension Period|Death|1|||
23591593|NCT01104415|65895985|FG000|Extension Period|Physician Decision|0|||
23591594|NCT01104415|65895986|FG001|Extension Period|Physician Decision|1|||
23591595|NCT01104415|65895985|FG000|Extension Period|Transition to Study LX1606.302|0|||
23591596|NCT01104415|65895986|FG001|Extension Period|Transition to Study LX1606.302|4|||
23591597|NCT01104415|65895985|FG000|Extension Period|Heart surgery/feeling miserable|0|||
23591598|NCT01104415|65895986|FG001|Extension Period|Heart surgery/feeling miserable|1|||
23591599|NCT00980330|65895991|FG000|Overall Study|Adverse Event|0|||
23591600|NCT00980330|65895992|FG001|Overall Study|Adverse Event|0|||
23591601|NCT00980330|65895993|FG002|Overall Study|Adverse Event|0|||
23591602|NCT00980330|65895994|FG003|Overall Study|Adverse Event|1|||
23591603|NCT00980330|65895995|FG004|Overall Study|Adverse Event|0|||
23591604|NCT00980330|65895996|FG005|Overall Study|Adverse Event|0|||
23591605|NCT00980330|65895997|FG006|Overall Study|Adverse Event|0|||
23591606|NCT00980330|65895991|FG000|Overall Study|Lost to Follow-up|1|||
23591607|NCT00980330|65895992|FG001|Overall Study|Lost to Follow-up|1|||
23591608|NCT00980330|65895993|FG002|Overall Study|Lost to Follow-up|4|||
23591609|NCT00980330|65895994|FG003|Overall Study|Lost to Follow-up|2|||
23591610|NCT00980330|65895995|FG004|Overall Study|Lost to Follow-up|1|||
23591611|NCT00980330|65895996|FG005|Overall Study|Lost to Follow-up|1|||
23591612|NCT00980330|65895997|FG006|Overall Study|Lost to Follow-up|2|||
23192711|NCT02859415|64446011|FG000|Overall Study|Off treatment due to cardiac event|0|||
23192712|NCT02859415|64446012|FG001|Overall Study|Off treatment due to cardiac event|1|||
23192713|NCT01458340|64446013|FG000|Overall Study|Adverse Event|5|||
23253720|NCT01600014|64670304|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
23253721|NCT01600014|64670305|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
23253722|NCT01600014|64670304|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
23253723|NCT01600014|64670305|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
23253724|NCT01600014|64670304|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
23253725|NCT01600014|64670305|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
23253726|NCT01600014|64670304|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
23253727|NCT01600014|64670305|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
23192714|NCT01458340|64446014|FG001|Overall Study|Adverse Event|4|||
23192715|NCT01458340|64446015|FG002|Overall Study|Adverse Event|2|||
23192716|NCT01458340|64446013|FG000|Overall Study|Lost to Follow-up|3|||
23192717|NCT01458340|64446014|FG001|Overall Study|Lost to Follow-up|3|||
23253728|NCT01600014|64670304|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
23253729|NCT01600014|64670305|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
23591613|NCT00980330|65895991|FG000|Overall Study|Withdrawal by Subject|2|||
23591614|NCT00980330|65895992|FG001|Overall Study|Withdrawal by Subject|4|||
23591615|NCT00980330|65895993|FG002|Overall Study|Withdrawal by Subject|4|||
23591616|NCT00980330|65895994|FG003|Overall Study|Withdrawal by Subject|1|||
23591617|NCT00980330|65895995|FG004|Overall Study|Withdrawal by Subject|3|||
23591618|NCT00980330|65895996|FG005|Overall Study|Withdrawal by Subject|2|||
23591619|NCT00980330|65895997|FG006|Overall Study|Withdrawal by Subject|5|||
23591620|NCT00980330|65895991|FG000|Overall Study|(not specified)|2|||
23591621|NCT00980330|65895992|FG001|Overall Study|(not specified)|0|||
23591622|NCT00980330|65895993|FG002|Overall Study|(not specified)|0|||
23591623|NCT00980330|65895994|FG003|Overall Study|(not specified)|1|||
23591624|NCT00980330|65895995|FG004|Overall Study|(not specified)|1|||
23591625|NCT00980330|65895996|FG005|Overall Study|(not specified)|1|||
23591626|NCT00980330|65895997|FG006|Overall Study|(not specified)|0|||
23591627|NCT02082158|65895998|FG000|Overall Study|Withdrawal by Subject|0|||
23591628|NCT02082158|65895999|FG001|Overall Study|Withdrawal by Subject|0|||
23591629|NCT02082158|65896000|FG002|Overall Study|Withdrawal by Subject|0|||
23591630|NCT02082158|65896001|FG003|Overall Study|Withdrawal by Subject|0|||
23591631|NCT02082158|65896002|FG004|Overall Study|Withdrawal by Subject|1|||
23591632|NCT02082158|65896003|FG005|Overall Study|Withdrawal by Subject|0|||
23591633|NCT02082158|65895998|FG000|Overall Study|Failed Fit-testing|8|||
23591634|NCT02082158|65895999|FG001|Overall Study|Failed Fit-testing|8|||
23591635|NCT02082158|65896000|FG002|Overall Study|Failed Fit-testing|14|||
23591636|NCT02082158|65896001|FG003|Overall Study|Failed Fit-testing|4|||
23591637|NCT02082158|65896002|FG004|Overall Study|Failed Fit-testing|3|||
23591638|NCT02082158|65896003|FG005|Overall Study|Failed Fit-testing|7|||
23591639|NCT01039688|65896005|FG000|Overall Study|Adverse Event|38|||
23591640|NCT01039688|65896006|FG001|Overall Study|Adverse Event|39|||
23591641|NCT01039688|65896007|FG002|Overall Study|Adverse Event|24|||
23591642|NCT01039688|65896005|FG000|Overall Study|Lack of Efficacy|20|||
23591643|NCT01039688|65896006|FG001|Overall Study|Lack of Efficacy|11|||
23591644|NCT01039688|65896007|FG002|Overall Study|Lack of Efficacy|26|||
23591645|NCT01039688|65896005|FG000|Overall Study|Lost to Follow-up|11|||
23591646|NCT01039688|65896006|FG001|Overall Study|Lost to Follow-up|9|||
23591647|NCT01039688|65896007|FG002|Overall Study|Lost to Follow-up|5|||
23591648|NCT01039688|65896005|FG000|Overall Study|Other|13|||
23591649|NCT01039688|65896006|FG001|Overall Study|Other|25|||
23591650|NCT01039688|65896007|FG002|Overall Study|Other|12|||
23591651|NCT01039688|65896005|FG000|Overall Study|Withdrawal by Subject|23|||
23591652|NCT01039688|65896006|FG001|Overall Study|Withdrawal by Subject|27|||
23591653|NCT01039688|65896007|FG002|Overall Study|Withdrawal by Subject|13|||
23591654|NCT01039688|65896005|FG000|Overall Study|Death|2|||
23591655|NCT01039688|65896006|FG001|Overall Study|Death|0|||
23591656|NCT01039688|65896007|FG002|Overall Study|Death|0|||
23591657|NCT02471755|65896027|FG000|Overall Study|Withdrawal by Subject|1|||
23591658|NCT02471755|65896028|FG001|Overall Study|Withdrawal by Subject|0|||
23591659|NCT02471755|65896027|FG000|Overall Study|Lost to Follow-up|0|||
23591660|NCT02471755|65896028|FG001|Overall Study|Lost to Follow-up|1|||
23591661|NCT00658996|65896029|FG000|First Intervention|Positive slit lamp finding|1|||
23591662|NCT00658996|65896030|FG001|First Intervention|Positive slit lamp finding|0|||
23591663|NCT00658996|65896029|FG000|First Intervention|Lack of lenses|0|||
23591664|NCT00658996|65896030|FG001|First Intervention|Lack of lenses|1|||
23591665|NCT00658996|65896029|FG000|Crossover Period|Physician Decision|1|||
23591666|NCT00658996|65896030|FG001|Crossover Period|Physician Decision|0|||
23591667|NCT00658996|65896029|FG000|Crossover Period|Ineligible|1|||
23591668|NCT00658996|65896030|FG001|Crossover Period|Ineligible|1|||
23591669|NCT00658996|65896029|FG000|Second Intervention|Developed a stye on upper lid|1|||
23591670|NCT00658996|65896030|FG001|Second Intervention|Developed a stye on upper lid|0|||
23591671|NCT00658996|65896029|FG000|Second Intervention|Positive slit lamp finding|0|||
23591672|NCT00658996|65896030|FG001|Second Intervention|Positive slit lamp finding|1|||
23591673|NCT00446550|65896031|FG000|Overall Study|Adverse Event|1|||
23591674|NCT00446550|65896032|FG001|Overall Study|Adverse Event|0|||
23591675|NCT02529995|65896033|FG000|Part A|Ongoing Study at Data Cut-off|14|||
23591676|NCT02529995|65896034|FG001|Part A|Ongoing Study at Data Cut-off|16|||
23591677|NCT02529995|65896033|FG000|Part A|Discontinued Study|1|||
23591678|NCT02529995|65896034|FG001|Part A|Discontinued Study|0|||
23591679|NCT02529995|65896033|FG000|Part B|Ongoing Study at Data Cut-off|0|||
23591680|NCT02529995|65896034|FG001|Part B|Ongoing Study at Data Cut-off|7|||
23591681|NCT02529995|65896033|FG000|Part B|Discontinued Study|6|||
23591682|NCT02529995|65896034|FG001|Part B|Discontinued Study|5|||
23591683|NCT01901276|65896038|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
23591684|NCT01901276|65896039|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
23591685|NCT00835770|65896040|FG000|Overall Study|MS Relapse|17|||
23591686|NCT00835770|65896041|FG001|Overall Study|MS Relapse|23|||
23591687|NCT00835770|65896040|FG000|Overall Study|MS Progression|14|||
23253730|NCT01600014|64670304|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
23253731|NCT01600014|64670305|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
23253732|NCT01600014|64670304|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
23253733|NCT01600014|64670305|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
23253734|NCT01600014|64670304|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
23253735|NCT01600014|64670305|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
23253736|NCT01600014|64670304|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
23253737|NCT01600014|64670305|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
23253738|NCT01600014|64670304|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
23360118|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
23591688|NCT00835770|65896041|FG001|Overall Study|MS Progression|9|||
23591689|NCT00835770|65896040|FG000|Overall Study|Adverse Event|113|||
23591690|NCT00835770|65896041|FG001|Overall Study|Adverse Event|124|||
23591691|NCT00835770|65896040|FG000|Overall Study|Lost to Follow-up|22|||
23591692|NCT00835770|65896041|FG001|Overall Study|Lost to Follow-up|19|||
23591693|NCT00835770|65896040|FG000|Overall Study|Consent Withdrawn|144|||
23591694|NCT00835770|65896041|FG001|Overall Study|Consent Withdrawn|156|||
23591695|NCT00835770|65896040|FG000|Overall Study|Investigator Decision|42|||
23591696|NCT00835770|65896041|FG001|Overall Study|Investigator Decision|42|||
23591697|NCT00835770|65896040|FG000|Overall Study|Participant Non-Compliance|11|||
23591698|NCT00835770|65896041|FG001|Overall Study|Participant Non-Compliance|9|||
23591699|NCT00835770|65896040|FG000|Overall Study|Death|4|||
23591700|NCT00835770|65896041|FG001|Overall Study|Death|6|||
23591701|NCT00835770|65896040|FG000|Overall Study|Other|115|||
23591702|NCT00835770|65896041|FG001|Overall Study|Other|104|||
23591703|NCT00835770|65896040|FG000|Overall Study|Other|2|||
23591704|NCT00835770|65896041|FG001|Overall Study|Other|1|||
23360119|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
23360120|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
23360121|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
23360122|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Death|1|||
23360123|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Death|0|||
23360124|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
23360125|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
23360126|NCT00105989|65062843|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
23360127|NCT00105989|65062844|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
23360128|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
23360129|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
23360130|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
23360131|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
23360132|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
23360133|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
23360134|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
23360135|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
23360136|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
23360137|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
23360138|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
23360139|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
23360140|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
23360141|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
23360142|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Death|0|||
23360143|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Death|0|||
23360144|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
23360145|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
23360146|NCT00105989|65062843|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
23360147|NCT00105989|65062844|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
23360148|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
23360149|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
23591705|NCT02547922|65896042|FG000|Overall Study|Withdrawal by Subject|9|||
23591706|NCT02547922|65896043|FG001|Overall Study|Withdrawal by Subject|6|||
23591707|NCT02547922|65896044|FG002|Overall Study|Withdrawal by Subject|10|||
23591708|NCT02547922|65896042|FG000|Overall Study|Adverse Event|3|||
23360150|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
23476329|NCT00470834|65488050|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
23591709|NCT02547922|65896043|FG001|Overall Study|Adverse Event|1|||
23591710|NCT02547922|65896044|FG002|Overall Study|Adverse Event|2|||
23591711|NCT02547922|65896042|FG000|Overall Study|Lost to Follow-up|1|||
23591712|NCT02547922|65896043|FG001|Overall Study|Lost to Follow-up|0|||
23591713|NCT02547922|65896044|FG002|Overall Study|Lost to Follow-up|0|||
23591714|NCT02547922|65896042|FG000|Overall Study|Lack of Efficacy|5|||
23591715|NCT02547922|65896043|FG001|Overall Study|Lack of Efficacy|7|||
23591716|NCT02547922|65896044|FG002|Overall Study|Lack of Efficacy|4|||
23591717|NCT02547922|65896042|FG000|Overall Study|Death|1|||
23591718|NCT02547922|65896043|FG001|Overall Study|Death|0|||
23591719|NCT02547922|65896044|FG002|Overall Study|Death|0|||
23591720|NCT02547922|65896042|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
23591721|NCT02547922|65896043|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
23591722|NCT02547922|65896044|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
23591723|NCT02547922|65896042|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
23591724|NCT02547922|65896043|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
23591725|NCT02547922|65896044|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
23591726|NCT02547922|65896042|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
23591727|NCT02547922|65896043|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
23591728|NCT02547922|65896044|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
23591729|NCT02547922|65896042|FG000|Overall Study|Physician Decision|2|||
23591730|NCT02547922|65896043|FG001|Overall Study|Physician Decision|1|||
23591731|NCT02547922|65896044|FG002|Overall Study|Physician Decision|2|||
23591732|NCT02547922|65896042|FG000|Overall Study|Patients did not receive IP|1|||
23591733|NCT02547922|65896043|FG001|Overall Study|Patients did not receive IP|1|||
23591734|NCT02547922|65896044|FG002|Overall Study|Patients did not receive IP|0|||
23591735|NCT01266265|65896045|FG000|Overall Study|Death|95|||
23591736|NCT01266265|65896046|FG001|Overall Study|Death|73|||
23591737|NCT01266265|65896045|FG000|Overall Study|Lost to Follow-up|23|||
23591738|NCT01266265|65896046|FG001|Overall Study|Lost to Follow-up|28|||
23591739|NCT01266265|65896045|FG000|Overall Study|Withdrawal by Subject|13|||
23591740|NCT01266265|65896046|FG001|Overall Study|Withdrawal by Subject|11|||
23591741|NCT01266265|65896045|FG000|Overall Study|Respiratory-related adverse event|2|||
23591742|NCT01266265|65896046|FG001|Overall Study|Respiratory-related adverse event|1|||
23591743|NCT01266265|65896045|FG000|Overall Study|Transferred care to another provider|22|||
23591744|NCT01266265|65896046|FG001|Overall Study|Transferred care to another provider|28|||
23591745|NCT01266265|65896045|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
23591746|NCT01266265|65896046|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
23591747|NCT01266265|65896045|FG000|Overall Study|Enrolled in another clinical study|15|||
23591748|NCT01266265|65896046|FG001|Overall Study|Enrolled in another clinical study|26|||
23591749|NCT01266265|65896045|FG000|Overall Study|Non-compliance|8|||
23591750|NCT01266265|65896046|FG001|Overall Study|Non-compliance|5|||
23591751|NCT01266265|65896045|FG000|Overall Study|Lung transplant|6|||
23591752|NCT01266265|65896046|FG001|Overall Study|Lung transplant|5|||
23591753|NCT01266265|65896045|FG000|Overall Study|Site closed early|4|||
23591754|NCT01266265|65896046|FG001|Overall Study|Site closed early|3|||
23591755|NCT01266265|65896045|FG000|Overall Study|Clinical worsening|1|||
23591756|NCT01266265|65896046|FG001|Overall Study|Clinical worsening|1|||
23591757|NCT02139943|65896047|FG000|Overall Study|Adverse Event|0|||
23591758|NCT02139943|65896048|FG001|Overall Study|Adverse Event|1|||
23591759|NCT02139943|65896049|FG002|Overall Study|Adverse Event|2|||
23591760|NCT02139943|65896047|FG000|Overall Study|Lost to Follow-up|3|||
23591761|NCT02139943|65896048|FG001|Overall Study|Lost to Follow-up|2|||
23591762|NCT02139943|65896049|FG002|Overall Study|Lost to Follow-up|2|||
23591763|NCT02139943|65896047|FG000|Overall Study|Withdrawal by Subject|4|||
23591764|NCT02139943|65896048|FG001|Overall Study|Withdrawal by Subject|3|||
23591765|NCT02139943|65896049|FG002|Overall Study|Withdrawal by Subject|0|||
23591766|NCT02139943|65896047|FG000|Overall Study|Other|0|||
23591767|NCT02139943|65896048|FG001|Overall Study|Other|0|||
23591768|NCT02139943|65896049|FG002|Overall Study|Other|1|||
23591769|NCT02139943|65896047|FG000|Overall Study|Participant wishes to discontinue|2|||
23591770|NCT02139943|65896048|FG001|Overall Study|Participant wishes to discontinue|0|||
23253739|NCT01600014|64670305|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
23253740|NCT01600014|64670304|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
23253741|NCT01600014|64670305|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
23253742|NCT01600014|64670304|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
23591771|NCT02139943|65896049|FG002|Overall Study|Participant wishes to discontinue|0|||
23591772|NCT02139943|65896047|FG000|Overall Study|Participant in Poor Compliance|1|||
23591773|NCT02139943|65896048|FG001|Overall Study|Participant in Poor Compliance|0|||
23591774|NCT02139943|65896049|FG002|Overall Study|Participant in Poor Compliance|1|||
23591775|NCT02139943|65896047|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
23591776|NCT02139943|65896048|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
23591777|NCT02139943|65896049|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
23360151|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
23591778|NCT00835380|65896050|FG000|Overall Study|Withdrawal by Subject|2|||
23591779|NCT00869258|65896051|FG000|Overall Study|Physician Decision|1|||
23591780|NCT00988637|65896058|FG000|Overall Study|Lost to Follow-up|2|||
23591781|NCT00988637|65896059|FG001|Overall Study|Lost to Follow-up|1|||
23591782|NCT00988637|65896058|FG000|Overall Study|Withdrawal by Subject|1|||
23192718|NCT01458340|64446015|FG002|Overall Study|Lost to Follow-up|10|||
23192719|NCT01458340|64446013|FG000|Overall Study|Miscellaneous|0|||
23192720|NCT01458340|64446014|FG001|Overall Study|Miscellaneous|1|||
23192721|NCT01458340|64446015|FG002|Overall Study|Miscellaneous|0|||
23192722|NCT01458340|64446013|FG000|Overall Study|Physician Decision|1|||
23192723|NCT01458340|64446014|FG001|Overall Study|Physician Decision|1|||
23192724|NCT01458340|64446015|FG002|Overall Study|Physician Decision|2|||
23192725|NCT01458340|64446013|FG000|Overall Study|Protocol Violation|6|||
23192726|NCT01458340|64446014|FG001|Overall Study|Protocol Violation|6|||
23192727|NCT01458340|64446015|FG002|Overall Study|Protocol Violation|5|||
23192728|NCT01458340|64446013|FG000|Overall Study|Withdrawal by Subject|12|||
23192729|NCT01458340|64446014|FG001|Overall Study|Withdrawal by Subject|6|||
23192730|NCT01458340|64446015|FG002|Overall Study|Withdrawal by Subject|4|||
23192731|NCT01171521|64446017|FG000|Overall Study|Lost to Follow-up|5|||
23192732|NCT01171521|64446017|FG000|Overall Study|screen failure|1|||
23192733|NCT00542828|64446019|FG000|Overall Study|Physician Decision|1|||
23192734|NCT00542828|64446019|FG000|Overall Study|Need for Prohibited Treatment|3|||
23192735|NCT00542828|64446019|FG000|Overall Study|Study Prematurely Discontinued|7|||
23192736|NCT00542828|64446019|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
23192737|NCT02144220|64446024|FG000|Overall Study|technology incompatibility|9|||
23192738|NCT02144220|64446024|FG000|Overall Study|Lack of Efficacy|4|||
23192739|NCT02144220|64446024|FG000|Overall Study|Physician Decision|3|||
23192740|NCT02144220|64446024|FG000|Overall Study|Withdrawal by Subject|2|||
23192741|NCT02144220|64446024|FG000|Overall Study|Protocol Violation|1|||
23192742|NCT00933335|64446025|FG000|Overall Study|Lost to Follow-up|1|||
23192743|NCT00933335|64446026|FG001|Overall Study|Lost to Follow-up|3|||
23192744|NCT00933335|64446025|FG000|Overall Study|Withdrawal by Subject|0|||
23192745|NCT00933335|64446026|FG001|Overall Study|Withdrawal by Subject|1|||
23192746|NCT00933335|64446025|FG000|Overall Study|Progressive Disease|0|||
23192747|NCT00933335|64446026|FG001|Overall Study|Progressive Disease|11|||
23192748|NCT00933335|64446025|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
23192749|NCT00933335|64446026|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
23192750|NCT00933335|64446025|FG000|Overall Study|Co-morbid Illness|1|||
23192751|NCT00933335|64446026|FG001|Overall Study|Co-morbid Illness|0|||
23192752|NCT01200511|64446030|FG000|Overall Study|Lost to Follow-up|3|||
23192753|NCT01200511|64446030|FG000|Overall Study|Withdrawal by Subject|1|||
23192754|NCT01200511|64446030|FG000|Overall Study|Adverse Event|1|||
23192755|NCT00875420|64446035|FG000|Overall Study|Adverse Event|0|||
23192756|NCT00875420|64446036|FG001|Overall Study|Adverse Event|1|||
23192757|NCT00875420|64446037|FG002|Overall Study|Adverse Event|1|||
23192758|NCT00875420|64446038|FG003|Overall Study|Adverse Event|0|||
23192759|NCT00875420|64446039|FG004|Overall Study|Adverse Event|0|||
23192760|NCT00875420|64446035|FG000|Overall Study|Inability to complete study procedures|1|||
23192761|NCT00875420|64446036|FG001|Overall Study|Inability to complete study procedures|0|||
23192762|NCT00875420|64446037|FG002|Overall Study|Inability to complete study procedures|1|||
23192763|NCT00875420|64446038|FG003|Overall Study|Inability to complete study procedures|1|||
23192764|NCT00875420|64446039|FG004|Overall Study|Inability to complete study procedures|1|||
23192765|NCT00875420|64446035|FG000|Overall Study|Lost to Follow-up|1|||
23192766|NCT00875420|64446036|FG001|Overall Study|Lost to Follow-up|0|||
23192767|NCT00875420|64446037|FG002|Overall Study|Lost to Follow-up|0|||
23192768|NCT00875420|64446038|FG003|Overall Study|Lost to Follow-up|0|||
23192769|NCT00875420|64446039|FG004|Overall Study|Lost to Follow-up|0|||
23192770|NCT00875420|64446035|FG000|Overall Study|Personal reason|0|||
23192771|NCT00875420|64446036|FG001|Overall Study|Personal reason|0|||
23192772|NCT00875420|64446037|FG002|Overall Study|Personal reason|0|||
23192773|NCT00875420|64446038|FG003|Overall Study|Personal reason|0|||
23192774|NCT00875420|64446039|FG004|Overall Study|Personal reason|1|||
23192775|NCT00875420|64446035|FG000|Overall Study|Prohibited medication|0|||
23192776|NCT00875420|64446036|FG001|Overall Study|Prohibited medication|0|||
23192777|NCT00875420|64446037|FG002|Overall Study|Prohibited medication|0|||
23192778|NCT00875420|64446038|FG003|Overall Study|Prohibited medication|1|||
23192779|NCT00875420|64446039|FG004|Overall Study|Prohibited medication|0|||
23192780|NCT00875420|64446035|FG000|Overall Study|Sponsor decision|0|||
23192781|NCT00875420|64446036|FG001|Overall Study|Sponsor decision|1|||
23192782|NCT00875420|64446037|FG002|Overall Study|Sponsor decision|0|||
23192783|NCT00875420|64446038|FG003|Overall Study|Sponsor decision|0|||
23192784|NCT00875420|64446039|FG004|Overall Study|Sponsor decision|0|||
23192785|NCT00875420|64446035|FG000|Overall Study|Withdrawal by Subject|0|||
23192786|NCT00875420|64446036|FG001|Overall Study|Withdrawal by Subject|0|||
23192787|NCT00875420|64446037|FG002|Overall Study|Withdrawal by Subject|1|||
23192788|NCT00875420|64446038|FG003|Overall Study|Withdrawal by Subject|0|||
23192789|NCT00875420|64446039|FG004|Overall Study|Withdrawal by Subject|0|||
23192790|NCT01903434|64446042|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
23192791|NCT01903434|64446043|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
23192792|NCT01903434|64446042|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
23192793|NCT01903434|64446043|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
23192794|NCT02089737|64446051|FG000|Overall Study|Survey form not completed|5|||
23192795|NCT02089737|64446051|FG000|Overall Study|Not treated|1|||
23192796|NCT01645280|64446055|FG000|Overall Study|Death|0|||
23192797|NCT01645280|64446056|FG001|Overall Study|Death|1|||
23192798|NCT01645280|64446057|FG002|Overall Study|Death|0|||
23192799|NCT01645280|64446058|FG003|Overall Study|Death|0|||
23192800|NCT01645280|64446059|FG004|Overall Study|Death|0|||
23192801|NCT01645280|64446055|FG000|Overall Study|Withdrawal by Subject|4|||
23192802|NCT01645280|64446056|FG001|Overall Study|Withdrawal by Subject|0|||
23192803|NCT01645280|64446057|FG002|Overall Study|Withdrawal by Subject|2|||
23192804|NCT01645280|64446058|FG003|Overall Study|Withdrawal by Subject|4|||
23192805|NCT01645280|64446059|FG004|Overall Study|Withdrawal by Subject|5|||
23192806|NCT01645280|64446055|FG000|Overall Study|Lost to Follow-up|0|||
23192807|NCT01645280|64446056|FG001|Overall Study|Lost to Follow-up|0|||
23192808|NCT01645280|64446057|FG002|Overall Study|Lost to Follow-up|0|||
23192809|NCT01645280|64446058|FG003|Overall Study|Lost to Follow-up|2|||
23192810|NCT01645280|64446059|FG004|Overall Study|Lost to Follow-up|1|||
23192811|NCT01645280|64446055|FG000|Overall Study|Other|1|||
23192812|NCT01645280|64446056|FG001|Overall Study|Other|1|||
23192813|NCT01645280|64446057|FG002|Overall Study|Other|2|||
23192814|NCT01645280|64446058|FG003|Overall Study|Other|0|||
23192815|NCT01645280|64446059|FG004|Overall Study|Other|0|||
23192816|NCT01645280|64446055|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
23192817|NCT01645280|64446056|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
23192818|NCT01645280|64446057|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
23192819|NCT01645280|64446058|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
23253743|NCT01600014|64670305|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
23253744|NCT01600014|64670304|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
23476330|NCT00470834|65488051|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
23476331|NCT00470834|65488050|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
23476332|NCT00470834|65488051|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
23253745|NCT01600014|64670305|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
23253746|NCT01600014|64670304|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
23253747|NCT01600014|64670305|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
23253748|NCT01600014|64670304|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
23253749|NCT01600014|64670305|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
23253750|NCT03840135|64670306|FG000|Overall Study|Protocol Violation|6|||
23253751|NCT03840135|64670307|FG001|Overall Study|Protocol Violation|1|||
23253752|NCT03840135|64670306|FG000|Overall Study|Withdrawal by Subject|1|||
23253753|NCT03840135|64670307|FG001|Overall Study|Withdrawal by Subject|0|||
23253754|NCT00515073|64670309|FG000|Overall Study|Withdrawal by Subject|1|||
23253755|NCT00515073|64670309|FG000|Overall Study|Physician Decision|1|||
23253756|NCT00659581|64670312|FG000|Overall Study|Adverse Event|1006|||
23253757|NCT00659581|64670312|FG000|Overall Study|Lack of Efficacy|1183|||
23253758|NCT00659581|64670312|FG000|Overall Study|Other|6393|||
23476333|NCT00470834|65488050|FG000|Extension Period (24 Months)|Non-compliance|0|||
23192820|NCT01645280|64446059|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
23192821|NCT00552305|64446062|FG000|Overall Study|Adverse Event|43|||
23192822|NCT00552305|64446062|FG000|Overall Study|Lack of Efficacy|120|||
23192823|NCT00552305|64446062|FG000|Overall Study|Lost to Follow-up|4|||
23192824|NCT00552305|64446062|FG000|Overall Study|Protocol Violation|3|||
23192825|NCT00552305|64446062|FG000|Overall Study|Withdrawal by Subject|44|||
23253759|NCT01749033|64670317|FG000|Overall Study|Did not receive allocated intervention|3|||
23476334|NCT00470834|65488051|FG001|Extension Period (24 Months)|Non-compliance|1|||
23476335|NCT00470834|65488050|FG000|Extension Period (24 Months)|Disease Progression|0|||
23476336|NCT00470834|65488051|FG001|Extension Period (24 Months)|Disease Progression|1|||
23476337|NCT02184572|65488052|FG000|Overall Study|Lost to Follow-up|29|||
23476338|NCT02184572|65488053|FG001|Overall Study|Lost to Follow-up|21|||
23476339|NCT02184572|65488052|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
23476340|NCT02184572|65488053|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
23476341|NCT02184572|65488052|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
23476342|NCT02184572|65488053|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
23476343|NCT02184572|65488052|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
23476344|NCT02184572|65488053|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
23476345|NCT02184572|65488052|FG000|Overall Study|Traveling Outside The Country|1|||
23476346|NCT02184572|65488053|FG001|Overall Study|Traveling Outside The Country|0|||
23476347|NCT02184572|65488052|FG000|Overall Study|Withdrawal by Subject|14|||
23476348|NCT02184572|65488053|FG001|Overall Study|Withdrawal by Subject|9|||
23476349|NCT00874939|65488054|FG000|Overall Study|Study terminated|4|||
23476350|NCT01261780|65488055|FG000|Overall Study|Withdrawal by Subject|1|||
23476351|NCT01261780|65488056|FG001|Overall Study|Withdrawal by Subject|0|||
23476352|NCT01261780|65488055|FG000|Overall Study|Event not related to subject|1|||
23476353|NCT01261780|65488056|FG001|Overall Study|Event not related to subject|2|||
23476354|NCT01239732|65488058|FG000|Overall Study|Termination of study per protocol|667|||
23476355|NCT01239732|65488058|FG000|Overall Study|Death|226|||
23476356|NCT01239732|65488058|FG000|Overall Study|Withdrawal by Subject|87|||
23476357|NCT01239732|65488058|FG000|Overall Study|Adverse Event|6|||
23476358|NCT01239732|65488058|FG000|Overall Study|Protocol Violation|3|||
23476359|NCT01239732|65488058|FG000|Overall Study|Participant non compliance|5|||
23476360|NCT01239732|65488058|FG000|Overall Study|Study termination by sponsor|2|||
23476361|NCT01239732|65488058|FG000|Overall Study|Investigator's decision|4|||
23476362|NCT01239732|65488058|FG000|Overall Study|Treatment failure|2|||
23476363|NCT01239732|65488058|FG000|Overall Study|Other|19|||
23476364|NCT02736890|65488063|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
23476365|NCT02736890|65488064|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
23476366|NCT02736890|65488063|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
23476367|NCT02736890|65488064|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
23476368|NCT01771809|65488067|FG000|Overall Study|Adverse Event|4|||
23476369|NCT01771809|65488068|FG001|Overall Study|Adverse Event|12|||
23476370|NCT01771809|65488067|FG000|Overall Study|Protocol Violation|0|||
23476371|NCT01771809|65488068|FG001|Overall Study|Protocol Violation|1|||
23476372|NCT01771809|65488067|FG000|Overall Study|Withdrawal by Subject|34|||
23192826|NCT00552305|64446062|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
23476373|NCT01771809|65488068|FG001|Overall Study|Withdrawal by Subject|42|||
23476374|NCT01771809|65488067|FG000|Overall Study|Lost to Follow-up|1|||
23476375|NCT01771809|65488068|FG001|Overall Study|Lost to Follow-up|3|||
23476376|NCT01771809|65488067|FG000|Overall Study|Other (Insufficient clinical response)|22|||
23476377|NCT01771809|65488068|FG001|Overall Study|Other (Insufficient clinical response)|20|||
23476378|NCT01771809|65488067|FG000|Overall Study|Death|1|||
23476379|NCT01771809|65488068|FG001|Overall Study|Death|0|||
23476380|NCT01771809|65488067|FG000|Overall Study|Other (other)|9|||
23476381|NCT01771809|65488068|FG001|Overall Study|Other (other)|5|||
23476382|NCT02522624|65488069|FG000|Overall Study|Technical failure|1|||
23476383|NCT02522624|65488070|FG001|Overall Study|Technical failure|0|||
23476384|NCT01221285|65488071|FG000|Overall Study|Withdrawal by Subject|1|||
23476385|NCT02694757|65488072|FG000|Overall Study|Lack of Efficacy|3|||
23476386|NCT00913458|65488073|FG000|Phase 1|Non-Responder|54|||
23476387|NCT00913458|65488074|FG001|Phase 1|Non-Responder|0|||
23476388|NCT00913458|65488075|FG002|Phase 1|Non-Responder|0|||
23476389|NCT00913458|65488076|FG003|Phase 1|Non-Responder|0|||
23476390|NCT00913458|65488077|FG004|Phase 1|Non-Responder|0|||
23476391|NCT00913458|65488078|FG005|Phase 1|Non-Responder|0|||
23476392|NCT00913458|65488079|FG006|Phase 1|Non-Responder|0|||
23476393|NCT00913458|65488073|FG000|Phase 1|Subject Request|17|||
23476394|NCT00913458|65488074|FG001|Phase 1|Subject Request|0|||
23476395|NCT00913458|65488075|FG002|Phase 1|Subject Request|0|||
23476396|NCT00913458|65488076|FG003|Phase 1|Subject Request|0|||
23476397|NCT00913458|65488077|FG004|Phase 1|Subject Request|0|||
23192827|NCT00552305|64446062|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
23192828|NCT00552305|64446062|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
23476398|NCT00913458|65488078|FG005|Phase 1|Subject Request|0|||
23476399|NCT00913458|65488079|FG006|Phase 1|Subject Request|0|||
23476400|NCT00913458|65488073|FG000|Phase 1|Adverse Event|20|||
23476401|NCT00913458|65488074|FG001|Phase 1|Adverse Event|0|||
23476402|NCT00913458|65488075|FG002|Phase 1|Adverse Event|0|||
23476403|NCT00913458|65488076|FG003|Phase 1|Adverse Event|0|||
23476404|NCT00913458|65488077|FG004|Phase 1|Adverse Event|0|||
23476405|NCT00913458|65488078|FG005|Phase 1|Adverse Event|0|||
23476406|NCT00913458|65488079|FG006|Phase 1|Adverse Event|0|||
23476407|NCT00913458|65488073|FG000|Phase 1|Lost to Follow-up|2|||
23591783|NCT00988637|65896059|FG001|Overall Study|Withdrawal by Subject|1|||
23591784|NCT00988637|65896058|FG000|Overall Study|non-compliance with study drug|0|||
23591785|NCT00988637|65896059|FG001|Overall Study|non-compliance with study drug|1|||
23591786|NCT01199705|65896062|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
23591787|NCT00004124|65896066|FG000|Overall Study|Received no protocol therapy|12|||
23591788|NCT00004124|65896067|FG001|Overall Study|Received no protocol therapy|20|||
23591789|NCT02705586|65896068|FG000|Overall Study|Health Issues|2|||
23591790|NCT02705586|65896068|FG000|Overall Study|Transportation Difficulties|5|||
23591791|NCT02705586|65896068|FG000|Overall Study|Vacation/Planned Absence|1|||
23591792|NCT04424641|65896071|FG000|Overall Study|Death|1|||
23360152|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
23360153|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
23360154|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
23360155|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
23360156|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
23360157|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
23360158|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
23360159|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
23360160|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
23360161|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
23360162|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
23360163|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
23360164|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
23591793|NCT04424641|65896072|FG001|Overall Study|Death|2|||
23591794|NCT04424641|65896073|FG002|Overall Study|Death|3|||
23591795|NCT04424641|65896074|FG003|Overall Study|Death|0|||
23591796|NCT04424641|65896075|FG004|Overall Study|Death|3|||
23591797|NCT04424641|65896076|FG005|Overall Study|Death|0|||
23591798|NCT04424641|65896077|FG006|Overall Study|Death|1|||
23591799|NCT04424641|65896078|FG007|Overall Study|Death|2|||
23591800|NCT04424641|65896071|FG000|Overall Study|Sponsor decision|0|||
23591801|NCT04424641|65896072|FG001|Overall Study|Sponsor decision|2|||
23591802|NCT04424641|65896073|FG002|Overall Study|Sponsor decision|3|||
23591803|NCT04424641|65896074|FG003|Overall Study|Sponsor decision|7|||
23591804|NCT04424641|65896075|FG004|Overall Study|Sponsor decision|2|||
23591805|NCT04424641|65896076|FG005|Overall Study|Sponsor decision|2|||
23591806|NCT04424641|65896077|FG006|Overall Study|Sponsor decision|3|||
23591807|NCT04424641|65896078|FG007|Overall Study|Sponsor decision|4|||
23591808|NCT04424641|65896071|FG000|Overall Study|Withdrawal by Subject|0|||
23591809|NCT04424641|65896072|FG001|Overall Study|Withdrawal by Subject|0|||
23591810|NCT04424641|65896073|FG002|Overall Study|Withdrawal by Subject|0|||
23591811|NCT04424641|65896074|FG003|Overall Study|Withdrawal by Subject|0|||
23591812|NCT04424641|65896075|FG004|Overall Study|Withdrawal by Subject|1|||
23591813|NCT04424641|65896076|FG005|Overall Study|Withdrawal by Subject|0|||
23591814|NCT04424641|65896077|FG006|Overall Study|Withdrawal by Subject|0|||
23591815|NCT04424641|65896078|FG007|Overall Study|Withdrawal by Subject|0|||
23591816|NCT04424641|65896071|FG000|Overall Study|Other|0|||
23591817|NCT04424641|65896072|FG001|Overall Study|Other|0|||
23591818|NCT04424641|65896073|FG002|Overall Study|Other|1|||
23591819|NCT04424641|65896074|FG003|Overall Study|Other|0|||
23591820|NCT04424641|65896075|FG004|Overall Study|Other|0|||
23591821|NCT04424641|65896076|FG005|Overall Study|Other|0|||
23192829|NCT00552305|64446062|FG000|Overall Study|Unsatisfactory compliance|11|||
23192830|NCT00552305|64446062|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
23192831|NCT00552305|64446062|FG000|Overall Study|AE/Other: prohibited drug required|1|||
23192832|NCT00552305|64446062|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
23192833|NCT00552305|64446062|FG000|Overall Study|Other: Site closed|4|||
23192834|NCT00552305|64446062|FG000|Overall Study|Other: Personal problems|1|||
23192835|NCT00552305|64446062|FG000|Overall Study|Other: Unable to attend visits|1|||
23192836|NCT00552305|64446062|FG000|Overall Study|Other: Subject underwent surgery|4|||
23192837|NCT00552305|64446062|FG000|Overall Study|Other: Subject became pregnant|1|||
23192838|NCT00552305|64446062|FG000|Overall Study|Other: Health problems, not drug related|1|||
23192839|NCT00552305|64446062|FG000|Overall Study|Other: Subject moved from area|2|||
23192840|NCT00552305|64446062|FG000|Overall Study|Other: Subject incarcerated|1|||
23192841|NCT00552305|64446062|FG000|Overall Study|Other: Subject went to rehab|1|||
23192842|NCT03216265|64446067|FG000|Overall Study|Adverse Event|2|||
23192843|NCT03216265|64446068|FG001|Overall Study|Adverse Event|0|||
23192844|NCT03216265|64446069|FG002|Overall Study|Adverse Event|2|||
23192845|NCT03216265|64446067|FG000|Overall Study|Lost to Follow-up|0|||
23192846|NCT03216265|64446068|FG001|Overall Study|Lost to Follow-up|1|||
23591822|NCT04424641|65896077|FG006|Overall Study|Other|0|||
23591823|NCT04424641|65896078|FG007|Overall Study|Other|0|||
23591824|NCT02739035|65896081|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
23591825|NCT02739035|65896082|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
23591826|NCT02739035|65896081|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
23591827|NCT02739035|65896082|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
23591828|NCT02739035|65896081|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
23591829|NCT02739035|65896082|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
23591830|NCT02739035|65896081|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
23591831|NCT02739035|65896082|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
23591832|NCT03380390|65896083|FG000|Overall Study|Adverse Event|3|||
23591833|NCT05790408|65896090|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
23591834|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
23591835|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
23591836|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
23591837|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
23591838|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
23591839|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
23591840|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
23591841|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
23591842|NCT00393484|65896095|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
23591843|NCT00393484|65896096|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
23591844|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
23591845|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
23591846|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
23591847|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
23591848|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
23253760|NCT01749033|64670318|FG001|Overall Study|Did not receive allocated intervention|3|||
23253761|NCT01749033|64670319|FG002|Overall Study|Did not receive allocated intervention|0|||
23253762|NCT01749033|64670317|FG000|Overall Study|Lost to Follow-up|0|||
23253763|NCT01749033|64670318|FG001|Overall Study|Lost to Follow-up|2|||
23253764|NCT01749033|64670319|FG002|Overall Study|Lost to Follow-up|1|||
23253765|NCT00606801|64670320|FG000|Intervention|Protocol Violation|3|||
23253766|NCT00606801|64670321|FG001|Intervention|Protocol Violation|3|||
23476408|NCT00913458|65488074|FG001|Phase 1|Lost to Follow-up|0|||
23476409|NCT00913458|65488075|FG002|Phase 1|Lost to Follow-up|0|||
23476410|NCT00913458|65488076|FG003|Phase 1|Lost to Follow-up|0|||
23476411|NCT00913458|65488077|FG004|Phase 1|Lost to Follow-up|0|||
23476412|NCT00913458|65488078|FG005|Phase 1|Lost to Follow-up|0|||
23476413|NCT00913458|65488079|FG006|Phase 1|Lost to Follow-up|0|||
23476414|NCT00913458|65488073|FG000|Phase 1|Protocol Violation|10|||
23476415|NCT00913458|65488074|FG001|Phase 1|Protocol Violation|0|||
23476416|NCT00913458|65488075|FG002|Phase 1|Protocol Violation|0|||
23476417|NCT00913458|65488076|FG003|Phase 1|Protocol Violation|0|||
23476418|NCT00913458|65488077|FG004|Phase 1|Protocol Violation|0|||
23476419|NCT00913458|65488078|FG005|Phase 1|Protocol Violation|0|||
23476420|NCT00913458|65488079|FG006|Phase 1|Protocol Violation|0|||
23476421|NCT00913458|65488073|FG000|Phase 1|Sponsor|2|||
23476422|NCT00913458|65488074|FG001|Phase 1|Sponsor|0|||
23476423|NCT00913458|65488075|FG002|Phase 1|Sponsor|0|||
23476424|NCT00913458|65488076|FG003|Phase 1|Sponsor|0|||
23476425|NCT00913458|65488077|FG004|Phase 1|Sponsor|0|||
23476426|NCT00913458|65488078|FG005|Phase 1|Sponsor|0|||
23476427|NCT00913458|65488079|FG006|Phase 1|Sponsor|0|||
23476428|NCT00913458|65488073|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
23476429|NCT00913458|65488074|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
23476430|NCT00913458|65488075|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
23476431|NCT00913458|65488076|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
23476432|NCT00913458|65488077|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
23476433|NCT00913458|65488078|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
23476434|NCT00913458|65488079|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
23476435|NCT00913458|65488073|FG000|Phase 2|Non-Responder|0|||
23476436|NCT00913458|65488074|FG001|Phase 2|Non-Responder|5|||
23476437|NCT00913458|65488075|FG002|Phase 2|Non-Responder|7|||
23476438|NCT00913458|65488076|FG003|Phase 2|Non-Responder|12|||
23476439|NCT00913458|65488077|FG004|Phase 2|Non-Responder|0|||
23476440|NCT00913458|65488078|FG005|Phase 2|Non-Responder|0|||
23476441|NCT00913458|65488079|FG006|Phase 2|Non-Responder|0|||
23476442|NCT00913458|65488073|FG000|Phase 2|Subject Request|0|||
23476443|NCT00913458|65488074|FG001|Phase 2|Subject Request|0|||
23476444|NCT00913458|65488075|FG002|Phase 2|Subject Request|1|||
23476445|NCT00913458|65488076|FG003|Phase 2|Subject Request|2|||
23476446|NCT00913458|65488077|FG004|Phase 2|Subject Request|0|||
23476447|NCT00913458|65488078|FG005|Phase 2|Subject Request|0|||
23476448|NCT00913458|65488079|FG006|Phase 2|Subject Request|0|||
23476449|NCT00913458|65488073|FG000|Phase 2|Adverse Event|0|||
23476450|NCT00913458|65488074|FG001|Phase 2|Adverse Event|3|||
23476451|NCT00913458|65488075|FG002|Phase 2|Adverse Event|0|||
23476452|NCT00913458|65488076|FG003|Phase 2|Adverse Event|1|||
23476453|NCT00913458|65488077|FG004|Phase 2|Adverse Event|0|||
23476454|NCT00913458|65488078|FG005|Phase 2|Adverse Event|0|||
23476455|NCT00913458|65488079|FG006|Phase 2|Adverse Event|0|||
23253767|NCT02555618|64670322|FG000|Overall Study|Sponsor's Circumstances|1|||
23253768|NCT02555618|64670323|FG001|Overall Study|Sponsor's Circumstances|0|||
23253769|NCT00936884|64670324|FG000|Double-blind|Withdrawal by Subject|6|||
23253770|NCT00936884|64670325|FG001|Double-blind|Withdrawal by Subject|4|||
23253771|NCT00936884|64670326|FG002|Double-blind|Withdrawal by Subject|0|||
23253772|NCT00936884|64670324|FG000|Double-blind|Death|2|||
23253773|NCT00936884|64670325|FG001|Double-blind|Death|1|||
23253774|NCT00936884|64670326|FG002|Double-blind|Death|0|||
23253775|NCT00936884|64670324|FG000|Double-blind|Lack of Efficacy|1|||
23253776|NCT00936884|64670325|FG001|Double-blind|Lack of Efficacy|1|||
23253777|NCT00936884|64670326|FG002|Double-blind|Lack of Efficacy|0|||
23253778|NCT00936884|64670324|FG000|Double-blind|Adverse Event|1|||
23253779|NCT00936884|64670325|FG001|Double-blind|Adverse Event|0|||
23253780|NCT00936884|64670326|FG002|Double-blind|Adverse Event|0|||
23476456|NCT00913458|65488073|FG000|Phase 2|Lost to Follow-up|0|||
23476457|NCT00913458|65488074|FG001|Phase 2|Lost to Follow-up|0|||
23476458|NCT00913458|65488075|FG002|Phase 2|Lost to Follow-up|0|||
23476459|NCT00913458|65488076|FG003|Phase 2|Lost to Follow-up|1|||
23476460|NCT00913458|65488077|FG004|Phase 2|Lost to Follow-up|0|||
23476461|NCT00913458|65488078|FG005|Phase 2|Lost to Follow-up|0|||
23476462|NCT00913458|65488079|FG006|Phase 2|Lost to Follow-up|0|||
23476463|NCT00913458|65488073|FG000|Phase 2|Protocol Violation|0|||
23476464|NCT00913458|65488074|FG001|Phase 2|Protocol Violation|2|||
23476465|NCT00913458|65488075|FG002|Phase 2|Protocol Violation|0|||
23476466|NCT00913458|65488076|FG003|Phase 2|Protocol Violation|0|||
23476467|NCT00913458|65488077|FG004|Phase 2|Protocol Violation|0|||
23476468|NCT00913458|65488078|FG005|Phase 2|Protocol Violation|0|||
23476469|NCT00913458|65488079|FG006|Phase 2|Protocol Violation|0|||
23476470|NCT00913458|65488073|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
23476471|NCT00913458|65488074|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
23476472|NCT00913458|65488075|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
23476473|NCT00913458|65488076|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
23476474|NCT00913458|65488077|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
23476475|NCT00913458|65488078|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
23476476|NCT00913458|65488079|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
23476477|NCT00913458|65488073|FG000|Phase 3|Adverse Event|0|||
23476478|NCT00913458|65488074|FG001|Phase 3|Adverse Event|0|||
23476479|NCT00913458|65488075|FG002|Phase 3|Adverse Event|0|||
23476480|NCT00913458|65488076|FG003|Phase 3|Adverse Event|0|||
23476481|NCT00913458|65488077|FG004|Phase 3|Adverse Event|5|||
23476482|NCT00913458|65488078|FG005|Phase 3|Adverse Event|4|||
23476483|NCT00913458|65488079|FG006|Phase 3|Adverse Event|1|||
23476484|NCT00913458|65488073|FG000|Phase 3|Lost to Follow-up|0|||
23476485|NCT00913458|65488074|FG001|Phase 3|Lost to Follow-up|0|||
23476486|NCT00913458|65488075|FG002|Phase 3|Lost to Follow-up|0|||
23476487|NCT00913458|65488076|FG003|Phase 3|Lost to Follow-up|0|||
23476488|NCT00913458|65488077|FG004|Phase 3|Lost to Follow-up|2|||
23476489|NCT00913458|65488078|FG005|Phase 3|Lost to Follow-up|0|||
23476490|NCT00913458|65488079|FG006|Phase 3|Lost to Follow-up|0|||
23476491|NCT00913458|65488073|FG000|Phase 3|Non-Responder|0|||
23476492|NCT00913458|65488074|FG001|Phase 3|Non-Responder|0|||
23476493|NCT00913458|65488075|FG002|Phase 3|Non-Responder|0|||
23476494|NCT00913458|65488076|FG003|Phase 3|Non-Responder|0|||
23476495|NCT00913458|65488077|FG004|Phase 3|Non-Responder|0|||
23476496|NCT00913458|65488078|FG005|Phase 3|Non-Responder|1|||
23476497|NCT00913458|65488079|FG006|Phase 3|Non-Responder|3|||
23476498|NCT00913458|65488073|FG000|Phase 3|Withdrawal by Subject|0|||
23476499|NCT00913458|65488074|FG001|Phase 3|Withdrawal by Subject|0|||
23476500|NCT00913458|65488075|FG002|Phase 3|Withdrawal by Subject|0|||
23476501|NCT00913458|65488076|FG003|Phase 3|Withdrawal by Subject|0|||
23476502|NCT00913458|65488077|FG004|Phase 3|Withdrawal by Subject|1|||
23476503|NCT00913458|65488078|FG005|Phase 3|Withdrawal by Subject|2|||
23476504|NCT00913458|65488079|FG006|Phase 3|Withdrawal by Subject|0|||
23476505|NCT00913458|65488073|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
23476506|NCT00913458|65488074|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
23476507|NCT00913458|65488075|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
23476508|NCT00913458|65488076|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
23476509|NCT00913458|65488077|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
23476510|NCT00913458|65488078|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
23253781|NCT00936884|64670324|FG000|Double-blind|Physician Decision|1|||
23253782|NCT00936884|64670325|FG001|Double-blind|Physician Decision|0|||
23253783|NCT00936884|64670326|FG002|Double-blind|Physician Decision|0|||
23253784|NCT00936884|64670324|FG000|Double-blind|No post baseline diary entry|1|||
23476511|NCT00913458|65488079|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
23476512|NCT01853618|65488084|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
23476513|NCT01853618|65488085|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
23476514|NCT01853618|65488086|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
23476515|NCT01853618|65488087|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
23476516|NCT01853618|65488088|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
23476517|NCT01853618|65488084|FG000|Overall Study|Progressive disease|1|||
23591849|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
23591850|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
23591851|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
23591852|NCT00393484|65896095|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
23591853|NCT00393484|65896096|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
23591854|NCT00390299|65896101|FG000|Overall Study|Cancellation|1|||
23591855|NCT00390299|65896102|FG001|Overall Study|Cancellation|0|||
23591856|NCT00390299|65896103|FG002|Overall Study|Cancellation|0|||
23591857|NCT00390299|65896104|FG003|Overall Study|Cancellation|0|||
23591858|NCT00390299|65896105|FG004|Overall Study|Cancellation|0|||
23591859|NCT02506257|65896106|FG000|Overall Study|Adverse Event|0|||
23591860|NCT02506257|65896107|FG001|Overall Study|Adverse Event|2|||
23591861|NCT02506257|65896108|FG002|Overall Study|Adverse Event|3|||
23591862|NCT02506257|65896109|FG003|Overall Study|Adverse Event|0|||
23591863|NCT02506257|65896106|FG000|Overall Study|Protocol Violation|0|||
23591864|NCT02506257|65896107|FG001|Overall Study|Protocol Violation|0|||
23591865|NCT02506257|65896108|FG002|Overall Study|Protocol Violation|1|||
23591866|NCT02506257|65896109|FG003|Overall Study|Protocol Violation|0|||
23591867|NCT00114244|65896111|FG000|Overall Study|Adverse Event|2|||
23591868|NCT00114244|65896112|FG001|Overall Study|Adverse Event|5|||
23591869|NCT00114244|65896111|FG000|Overall Study|Withdrawal by Subject|0|||
23591870|NCT00114244|65896112|FG001|Overall Study|Withdrawal by Subject|2|||
23591871|NCT00159783|65896113|FG000|Overall Study|Adverse Event|5|||
23591872|NCT00159783|65896114|FG001|Overall Study|Adverse Event|7|||
23591873|NCT00159783|65896115|FG002|Overall Study|Adverse Event|9|||
23591874|NCT00159783|65896113|FG000|Overall Study|Lack of Efficacy|1|||
23591875|NCT00159783|65896114|FG001|Overall Study|Lack of Efficacy|2|||
23591876|NCT00159783|65896115|FG002|Overall Study|Lack of Efficacy|3|||
23591877|NCT00159783|65896113|FG000|Overall Study|Withdrawal by Subject|7|||
23591878|NCT00159783|65896114|FG001|Overall Study|Withdrawal by Subject|11|||
23591879|NCT00159783|65896115|FG002|Overall Study|Withdrawal by Subject|12|||
23591880|NCT00159783|65896113|FG000|Overall Study|Lost to Follow-up|6|||
23591881|NCT00159783|65896114|FG001|Overall Study|Lost to Follow-up|5|||
23591882|NCT00159783|65896115|FG002|Overall Study|Lost to Follow-up|11|||
23591883|NCT00159783|65896113|FG000|Overall Study|Other|0|||
23591884|NCT00159783|65896114|FG001|Overall Study|Other|2|||
23591885|NCT00159783|65896115|FG002|Overall Study|Other|4|||
23591886|NCT01202955|65896117|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
23591887|NCT01202955|65896118|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
23591888|NCT04054635|65896119|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
23591889|NCT04054635|65896120|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
23591890|NCT04054635|65896121|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
23591891|NCT04054635|65896119|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
23591892|NCT04054635|65896120|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
23591893|NCT04054635|65896121|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
23591894|NCT02448446|65896122|FG000|Overall Study|Withdrawal by Subject|1|||
23591895|NCT02448446|65896123|FG001|Overall Study|Withdrawal by Subject|0|||
23476518|NCT01853618|65488085|FG001|Overall Study|Progressive disease|1|||
23591896|NCT01692938|65896124|FG000|Overall Study|Protocol Deviation|1|||
23591897|NCT01692938|65896125|FG001|Overall Study|Protocol Deviation|1|||
23591898|NCT01692938|65896124|FG000|Overall Study|Study completed prior to site completion|3|||
23591899|NCT01692938|65896125|FG001|Overall Study|Study completed prior to site completion|3|||
23591900|NCT01803555|65896130|FG000|Overall Study|Adverse Event|3|||
23192847|NCT03216265|64446069|FG002|Overall Study|Lost to Follow-up|0|||
23476519|NCT01853618|65488086|FG002|Overall Study|Progressive disease|1|||
23476520|NCT01853618|65488087|FG003|Overall Study|Progressive disease|1|||
23476521|NCT01853618|65488088|FG004|Overall Study|Progressive disease|2|||
23476522|NCT01853618|65488084|FG000|Overall Study|Physician Decision|0|||
23476523|NCT01853618|65488085|FG001|Overall Study|Physician Decision|1|||
23476524|NCT01853618|65488086|FG002|Overall Study|Physician Decision|1|||
23476525|NCT01853618|65488087|FG003|Overall Study|Physician Decision|0|||
23476526|NCT01853618|65488088|FG004|Overall Study|Physician Decision|0|||
23476527|NCT01853618|65488084|FG000|Overall Study|Refused further treatment|0|||
23476528|NCT01853618|65488085|FG001|Overall Study|Refused further treatment|0|||
23476529|NCT01853618|65488086|FG002|Overall Study|Refused further treatment|0|||
23476530|NCT01853618|65488087|FG003|Overall Study|Refused further treatment|0|||
23476531|NCT01853618|65488088|FG004|Overall Study|Refused further treatment|1|||
23476532|NCT01639729|65488089|FG000|Overall Study|Withdrawal by Subject|1|||
23476533|NCT01639729|65488090|FG001|Overall Study|Withdrawal by Subject|0|||
23476534|NCT01639729|65488091|FG002|Overall Study|Withdrawal by Subject|1|||
23476535|NCT01639729|65488092|FG003|Overall Study|Withdrawal by Subject|1|||
23476536|NCT01639729|65488093|FG004|Overall Study|Withdrawal by Subject|0|||
23476537|NCT01639729|65488094|FG005|Overall Study|Withdrawal by Subject|0|||
23476538|NCT00361634|65488095|FG000|Overall Study|Lost to Follow-up|1|||
23476539|NCT00361634|65488095|FG000|Overall Study|Withdrawal by Subject|1|||
23476540|NCT01368562|65488096|FG000|Overall Study|Adverse Event|1|||
23476541|NCT01368562|65488096|FG000|Overall Study|Disease progression|1|||
23476542|NCT01368562|65488096|FG000|Overall Study|Lost to Follow-up|1|||
23476543|NCT01368562|65488096|FG000|Overall Study|Death|6|||
23476544|NCT01368562|65488096|FG000|Overall Study|Unresponsive to treatment|5|||
23476545|NCT01368562|65488096|FG000|Overall Study|Other|3|||
23476546|NCT01368562|65488096|FG000|Overall Study|Other than specified|2|||
23476547|NCT01317550|65488097|FG000|Overall Study|Withdrawal by Subject|1|||
23476548|NCT01317550|65488098|FG001|Overall Study|Withdrawal by Subject|0|||
23476549|NCT01317550|65488099|FG002|Overall Study|Withdrawal by Subject|0|||
23476550|NCT01317550|65488100|FG003|Overall Study|Withdrawal by Subject|0|||
23476551|NCT01317550|65488097|FG000|Overall Study|Lack of compliance study med|1|||
23476552|NCT01317550|65488098|FG001|Overall Study|Lack of compliance study med|0|||
23476553|NCT01317550|65488099|FG002|Overall Study|Lack of compliance study med|0|||
23476554|NCT01317550|65488100|FG003|Overall Study|Lack of compliance study med|0|||
23476555|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
23476556|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23476557|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23476558|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
23476559|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
23476560|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
23476561|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
23476562|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
23476563|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
23476564|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
23476565|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
23476566|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
23476567|NCT01642615|65488101|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
23476568|NCT01642615|65488102|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
23476569|NCT01642615|65488103|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
23476570|NCT01642615|65488101|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
23476571|NCT01642615|65488102|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
23476572|NCT01642615|65488103|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
23476573|NCT01642615|65488101|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
23476574|NCT01642615|65488102|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
23476575|NCT01642615|65488103|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
23476576|NCT01642615|65488101|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23476577|NCT01642615|65488102|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
23476578|NCT01642615|65488103|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
23476579|NCT01642615|65488101|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
23476580|NCT01642615|65488102|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
23476581|NCT01642615|65488103|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
23591901|NCT01803555|65896131|FG001|Overall Study|Adverse Event|2|||
23591902|NCT01803555|65896130|FG000|Overall Study|Withdrawal by Subject|3|||
23591903|NCT01803555|65896131|FG001|Overall Study|Withdrawal by Subject|3|||
23360165|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
23476582|NCT01149148|65488104|FG000|Overall Study|Lost to Follow-up|1|||
23476583|NCT01149148|65488105|FG001|Overall Study|Lost to Follow-up|2|||
23476584|NCT01149148|65488104|FG000|Overall Study|Death|1|||
23476585|NCT01149148|65488105|FG001|Overall Study|Death|0|||
23591904|NCT01803555|65896130|FG000|Overall Study|Non-compliance|1|||
23591905|NCT01803555|65896131|FG001|Overall Study|Non-compliance|1|||
23591906|NCT01803555|65896130|FG000|Overall Study|Protocol Violation|3|||
23591907|NCT01803555|65896131|FG001|Overall Study|Protocol Violation|5|||
23591908|NCT01803555|65896130|FG000|Overall Study|Lost to Follow-up|0|||
23591909|NCT01803555|65896131|FG001|Overall Study|Lost to Follow-up|2|||
23591910|NCT01803555|65896130|FG000|Overall Study|Other than specified|3|||
23591911|NCT01803555|65896131|FG001|Overall Study|Other than specified|5|||
23591912|NCT02423291|65896132|FG000|Overall Study|Lack of Efficacy|14|||
23591913|NCT02423291|65896132|FG000|Overall Study|Adverse Event|1|||
23591914|NCT02957136|65896133|FG000|Overall Study|Withdrawal by Subject|2|||
23591915|NCT02957136|65896134|FG001|Overall Study|Withdrawal by Subject|1|||
23591916|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
23591917|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
23591918|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
23591919|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
23591920|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
23591921|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
23591922|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
23591923|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
23591924|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
23591925|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
23591926|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
23591927|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
23591928|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
23591929|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
23591930|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
23591931|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
23591932|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
23591933|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
23591934|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
23591935|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
23591936|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
23591937|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
23253785|NCT00936884|64670325|FG001|Double-blind|No post baseline diary entry|0|||
23253786|NCT00936884|64670326|FG002|Double-blind|No post baseline diary entry|0|||
23253787|NCT00936884|64670324|FG000|Double-blind|Did not receive study drug|0|||
23253788|NCT00936884|64670325|FG001|Double-blind|Did not receive study drug|1|||
23253789|NCT00936884|64670326|FG002|Double-blind|Did not receive study drug|0|||
23253790|NCT00344305|64670331|FG000|Overall Study|Lost to Follow-up|2|||
23253791|NCT00344305|64670332|FG001|Overall Study|Lost to Follow-up|0|||
23591938|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
23591939|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
23591940|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
23591941|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
23591942|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
23591943|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
23591944|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
23591945|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
23591946|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
23591947|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
23591948|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
23591949|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591950|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
23591951|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
23591952|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
23591953|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591954|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591955|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591956|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591957|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591958|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23591959|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
23253792|NCT00344305|64670331|FG000|Overall Study|Participant was not contacted in window|0|||
23253793|NCT00344305|64670332|FG001|Overall Study|Participant was not contacted in window|1|||
23253794|NCT00383019|64670333|FG000|Overall Study|Adverse Event|5|||
23253795|NCT00383019|64670334|FG001|Overall Study|Adverse Event|1|||
23591960|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591961|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591962|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591963|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591964|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
23591965|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591966|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591967|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591968|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591969|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23591970|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
23253796|NCT00383019|64670333|FG000|Overall Study|Withdrawal by Subject|0|||
23253797|NCT00383019|64670334|FG001|Overall Study|Withdrawal by Subject|1|||
23253798|NCT00304954|64670337|FG000|Overall Study|Withdrawal by Subject|0|||
23253799|NCT00304954|64670338|FG001|Overall Study|Withdrawal by Subject|0|||
23253800|NCT00304954|64670339|FG002|Overall Study|Withdrawal by Subject|1|||
23253801|NCT00304954|64670340|FG003|Overall Study|Withdrawal by Subject|0|||
23253802|NCT00304954|64670337|FG000|Overall Study|Adverse Event|1|||
23253803|NCT00304954|64670338|FG001|Overall Study|Adverse Event|0|||
23253804|NCT00304954|64670339|FG002|Overall Study|Adverse Event|0|||
23253805|NCT00304954|64670340|FG003|Overall Study|Adverse Event|0|||
23253806|NCT01964105|64670344|FG000|Overall Study|Lost to Follow-up|2|||
23253807|NCT01964105|64670345|FG001|Overall Study|Lost to Follow-up|13|||
23253808|NCT01964105|64670346|FG002|Overall Study|Lost to Follow-up|0|||
23476586|NCT03595618|65488106|FG000|Overall Study|Adverse Event|16|||
23591971|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
23591972|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591973|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591974|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591975|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591976|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591977|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591978|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591979|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591980|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591981|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
23591982|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
23591983|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
23591984|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
23591985|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
23591986|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
23591987|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
23591988|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
23591989|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
23591990|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
23591991|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
23591992|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
23591993|NCT02914522|65896135|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23591994|NCT02914522|65896136|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
23591995|NCT02914522|65896137|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23591996|NCT02914522|65896138|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23591997|NCT02914522|65896139|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
23591998|NCT02914522|65896140|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
23591999|NCT02914522|65896141|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592000|NCT02914522|65896142|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592001|NCT02914522|65896143|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592002|NCT02914522|65896144|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592003|NCT02914522|65896145|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
23592004|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592005|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592006|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592007|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592008|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592009|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
23592010|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
23592011|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
23253809|NCT01355523|64670350|FG000|Overall Study|Withdrawal by Subject|1|||
23253810|NCT01355523|64670351|FG001|Overall Study|Withdrawal by Subject|4|||
23253811|NCT01355523|64670350|FG000|Overall Study|Lost to Follow-up|0|||
23253812|NCT01355523|64670351|FG001|Overall Study|Lost to Follow-up|2|||
23592012|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
23592013|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
23592014|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
23592015|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592016|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592017|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592018|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592019|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592020|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
23592021|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
23592022|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
23592023|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
23592024|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
23592025|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
23592026|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592027|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592028|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592029|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592030|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592031|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592032|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
23592033|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
23592034|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
23592035|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
23592036|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
23592037|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592038|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592039|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592040|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592041|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592042|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
23592043|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
23192848|NCT03216265|64446067|FG000|Overall Study|Withdrawal by Subject|0|||
23192849|NCT03216265|64446068|FG001|Overall Study|Withdrawal by Subject|0|||
23192850|NCT03216265|64446069|FG002|Overall Study|Withdrawal by Subject|1|||
23192851|NCT02675517|64446074|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
23192852|NCT02675517|64446074|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
23192853|NCT02342171|64446076|FG000|Overall Study|Death|4|||
23192854|NCT02342171|64446077|FG001|Overall Study|Death|87|||
23476587|NCT03595618|65488107|FG001|Overall Study|Adverse Event|17|||
23476588|NCT03595618|65488108|FG002|Overall Study|Adverse Event|20|||
23476589|NCT03595618|65488109|FG003|Overall Study|Adverse Event|8|||
23476590|NCT03595618|65488106|FG000|Overall Study|Withdrawal by Subject|12|||
23476591|NCT03595618|65488107|FG001|Overall Study|Withdrawal by Subject|14|||
23476592|NCT03595618|65488108|FG002|Overall Study|Withdrawal by Subject|14|||
23476593|NCT03595618|65488109|FG003|Overall Study|Withdrawal by Subject|10|||
23476594|NCT03595618|65488106|FG000|Overall Study|Lost to Follow-up|6|||
23476595|NCT03595618|65488107|FG001|Overall Study|Lost to Follow-up|4|||
23476596|NCT03595618|65488108|FG002|Overall Study|Lost to Follow-up|5|||
23476597|NCT03595618|65488109|FG003|Overall Study|Lost to Follow-up|6|||
23476598|NCT03595618|65488106|FG000|Overall Study|Protocol Violation|2|||
23476599|NCT03595618|65488107|FG001|Overall Study|Protocol Violation|0|||
23476600|NCT03595618|65488108|FG002|Overall Study|Protocol Violation|6|||
23476601|NCT03595618|65488109|FG003|Overall Study|Protocol Violation|2|||
23476602|NCT03595618|65488106|FG000|Overall Study|Physician Decision|0|||
23592044|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
23192855|NCT02342171|64446076|FG000|Overall Study|Received favipiravir|10|||
23192856|NCT02342171|64446077|FG001|Overall Study|Received favipiravir|0|||
23192857|NCT02342171|64446076|FG000|Overall Study|Missing cycle treshold value|1|||
23192858|NCT02342171|64446077|FG001|Overall Study|Missing cycle treshold value|0|||
23192859|NCT02342171|64446076|FG000|Overall Study|Unknown outcome|0|||
23192860|NCT02342171|64446077|FG001|Overall Study|Unknown outcome|1|||
23192861|NCT02342171|64446076|FG000|Overall Study|Missing age data|0|||
23192862|NCT02342171|64446077|FG001|Overall Study|Missing age data|1|||
23476603|NCT03595618|65488107|FG001|Overall Study|Physician Decision|0|||
23476604|NCT03595618|65488108|FG002|Overall Study|Physician Decision|1|||
23192863|NCT01183858|64446082|FG000|Overall Study|Death not related to Progressive Disease|5|||
23476605|NCT03595618|65488109|FG003|Overall Study|Physician Decision|2|||
23476606|NCT03595618|65488106|FG000|Overall Study|Miscellaneous|7|||
23476607|NCT03595618|65488107|FG001|Overall Study|Miscellaneous|5|||
23253813|NCT01355523|64670350|FG000|Overall Study|Protocol Violation|0|||
23253814|NCT01355523|64670351|FG001|Overall Study|Protocol Violation|2|||
23253815|NCT01355523|64670350|FG000|Overall Study|Adverse Event|0|||
23253816|NCT01355523|64670351|FG001|Overall Study|Adverse Event|2|||
23253817|NCT01463683|64670352|FG000|Overall Study|Adverse Event|2|||
23253818|NCT01463683|64670353|FG001|Overall Study|Adverse Event|0|||
23253819|NCT01463683|64670354|FG002|Overall Study|Adverse Event|0|||
23253820|NCT01463683|64670352|FG000|Overall Study|Lost to Follow-up|10|||
23253821|NCT01463683|64670353|FG001|Overall Study|Lost to Follow-up|9|||
23253822|NCT01463683|64670354|FG002|Overall Study|Lost to Follow-up|7|||
23592045|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
23592046|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
23592047|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
23592048|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
23592049|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
23592050|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
23592051|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
23592052|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
23592053|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
23592054|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
23592055|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
23592056|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
23592057|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
23592058|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
23592059|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592060|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592061|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592062|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592063|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592064|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592065|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592066|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
23592067|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
23592068|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592069|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
23592070|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592071|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592072|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592073|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592074|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592075|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592076|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592077|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592078|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
23253823|NCT01463683|64670352|FG000|Overall Study|Physician Decision|0|||
23253824|NCT01463683|64670353|FG001|Overall Study|Physician Decision|3|||
23592079|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
23592080|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
23592081|NCT02914522|65896135|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592082|NCT02914522|65896136|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592083|NCT02914522|65896137|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592084|NCT02914522|65896138|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592085|NCT02914522|65896139|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592086|NCT02914522|65896140|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592087|NCT02914522|65896141|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592088|NCT02914522|65896142|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592089|NCT02914522|65896143|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592090|NCT02914522|65896144|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
23253825|NCT01463683|64670354|FG002|Overall Study|Physician Decision|1|||
23253826|NCT01463683|64670352|FG000|Overall Study|Pregnancy|2|||
23253827|NCT01463683|64670353|FG001|Overall Study|Pregnancy|2|||
23592091|NCT02914522|65896145|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
23592092|NCT03069313|65896148|FG000|Overall Study|Adverse Event|5|||
23592093|NCT02013830|65896156|FG000|Overall Study|Adverse Event|3|||
23253828|NCT01463683|64670354|FG002|Overall Study|Pregnancy|1|||
23253829|NCT01463683|64670352|FG000|Overall Study|Withdrawal by Subject|5|||
23253830|NCT01463683|64670353|FG001|Overall Study|Withdrawal by Subject|17|||
23253831|NCT01463683|64670354|FG002|Overall Study|Withdrawal by Subject|2|||
23253832|NCT00964223|64670355|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
23592094|NCT02013830|65896156|FG000|Overall Study|Death|1|||
23592095|NCT02013830|65896156|FG000|Overall Study|Insufficient therapeutic response|25|||
23592096|NCT02013830|65896156|FG000|Overall Study|Refused treatment|1|||
23592097|NCT00639002|65896157|FG000|Overall Study|Death|1|||
23592098|NCT00639002|65896157|FG000|Overall Study|Adverse Event|1|||
23592099|NCT00639002|65896157|FG000|Overall Study|Protocol Violation|1|||
23592100|NCT00639002|65896157|FG000|Overall Study|Disease progression|3|||
23592101|NCT00639002|65896157|FG000|Overall Study|Physician Decision|6|||
23592102|NCT00639002|65896157|FG000|Overall Study|Lack of Efficacy|1|||
23592103|NCT00223795|65896158|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
23592104|NCT00223795|65896159|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
23592105|NCT00223795|65896158|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
23592106|NCT00223795|65896159|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
23592107|NCT00756730|65896160|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
23592108|NCT00756730|65896161|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
23592109|NCT00756730|65896160|FG000|Overall Study|persistent low-level viremmia|0|||
23592110|NCT00756730|65896161|FG001|Overall Study|persistent low-level viremmia|1|||
23592111|NCT04464421|65896165|FG000|Overall Study|Lost to Follow-up|2|||
23592112|NCT04464421|65896166|FG001|Overall Study|Lost to Follow-up|2|||
23592113|NCT00891930|65896167|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
23592114|NCT00891930|65896167|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
23592115|NCT00891930|65896167|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
23592116|NCT00891930|65896167|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
23592117|NCT00891930|65896167|FG000|Part 2 Panitumumab + AMG479|Death|30|||
23592118|NCT03830866|65896168|FG000|Overall Study|Death|90|||
23592119|NCT03830866|65896169|FG001|Overall Study|Death|111|||
23592120|NCT03830866|65896168|FG000|Overall Study|Lost to Follow-up|7|||
23592121|NCT03830866|65896169|FG001|Overall Study|Lost to Follow-up|7|||
23592122|NCT03830866|65896168|FG000|Overall Study|Withdrawal by Subject|19|||
23592123|NCT03830866|65896169|FG001|Overall Study|Withdrawal by Subject|16|||
23592124|NCT03830866|65896168|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
23592125|NCT03830866|65896169|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
23592126|NCT03830866|65896168|FG000|Overall Study|Other|1|||
23592127|NCT03830866|65896169|FG001|Overall Study|Other|1|||
23592128|NCT03557008|65896171|FG000|Overall Study|Withdrawal by Subject|2|||
23592129|NCT03557008|65896172|FG001|Overall Study|Withdrawal by Subject|2|||
23592130|NCT03557008|65896171|FG000|Overall Study|Early termination from study|3|||
23592131|NCT03557008|65896172|FG001|Overall Study|Early termination from study|1|||
23592132|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
23592133|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
23592134|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
23592135|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
23592136|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
23592137|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
23592138|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
23592139|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
23592140|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
23592141|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
23592142|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
23592143|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
23592144|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
23592145|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
23592146|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
23253833|NCT01829295|64670358|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
23253834|NCT01829295|64670359|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
23253835|NCT01829295|64670360|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
23253836|NCT01829295|64670361|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
23253837|NCT01829295|64670358|FG000|6-12 Months|Adverse Event|0|||
23253838|NCT01829295|64670359|FG001|6-12 Months|Adverse Event|0|||
23253839|NCT01829295|64670360|FG002|6-12 Months|Adverse Event|3|||
23592147|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
23592148|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
23592149|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
23592150|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
23592151|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
23592152|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
23592153|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
23592154|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
23253840|NCT01829295|64670361|FG003|6-12 Months|Adverse Event|2|||
23253841|NCT01829295|64670358|FG000|6-12 Months|Lost to Follow-up|2|||
23253842|NCT01829295|64670359|FG001|6-12 Months|Lost to Follow-up|0|||
23253843|NCT01829295|64670360|FG002|6-12 Months|Lost to Follow-up|0|||
23253844|NCT01829295|64670361|FG003|6-12 Months|Lost to Follow-up|0|||
23253845|NCT01829295|64670358|FG000|6-12 Months|Withdrawal by Subject|2|||
23253846|NCT01829295|64670359|FG001|6-12 Months|Withdrawal by Subject|2|||
23253847|NCT01829295|64670360|FG002|6-12 Months|Withdrawal by Subject|0|||
23253848|NCT01829295|64670361|FG003|6-12 Months|Withdrawal by Subject|0|||
23253849|NCT03636542|64670363|FG000|Overall Study|Lost to Follow-up|1|||
23592155|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
23592156|NCT00311363|65896178|FG000|24-Week Single-Blind Treatment Period|Death|1|||
23592157|NCT00311363|65896179|FG001|24-Week Single-Blind Treatment Period|Death|0|||
23592158|NCT00311363|65896180|FG002|24-Week Single-Blind Treatment Period|Death|0|||
23592159|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
23592160|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
23592161|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
23592162|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
23592163|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
23592164|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
23592165|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
23592166|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
23592167|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
23592168|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
23592169|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
23592170|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
23592171|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
23592172|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
23592173|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
23592174|NCT00311363|65896178|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
23592175|NCT00311363|65896179|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
23592176|NCT00311363|65896180|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
23192864|NCT01183858|64446083|FG001|Overall Study|Death not related to Progressive Disease|6|||
23192865|NCT01183858|64446082|FG000|Overall Study|Adverse Event|14|||
23192866|NCT01183858|64446083|FG001|Overall Study|Adverse Event|11|||
23192867|NCT01183858|64446082|FG000|Overall Study|Investigator's Decision|0|||
23192868|NCT01183858|64446083|FG001|Overall Study|Investigator's Decision|3|||
23192869|NCT01183858|64446082|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23192870|NCT01183858|64446083|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23192871|NCT01183858|64446082|FG000|Overall Study|Refused Treatment|1|||
23192872|NCT01183858|64446083|FG001|Overall Study|Refused Treatment|4|||
23192873|NCT01183858|64446082|FG000|Overall Study|Withdrew Consent|4|||
23192874|NCT01183858|64446083|FG001|Overall Study|Withdrew Consent|4|||
23192875|NCT01183858|64446082|FG000|Overall Study|Discontinued Smoking|3|||
23192876|NCT01183858|64446083|FG001|Overall Study|Discontinued Smoking|1|||
23192877|NCT01183858|64446082|FG000|Overall Study|Protocol Violation|1|||
23192878|NCT01183858|64446083|FG001|Overall Study|Protocol Violation|0|||
23192879|NCT01183858|64446082|FG000|Overall Study|Administrative/Other|6|||
23192880|NCT01183858|64446083|FG001|Overall Study|Administrative/Other|6|||
23192881|NCT01183858|64446082|FG000|Overall Study|Progressive Disease|112|||
23192882|NCT01183858|64446083|FG001|Overall Study|Progressive Disease|115|||
23192883|NCT01183858|64446082|FG000|Overall Study|Death related to Progressive Disease|4|||
23192884|NCT01183858|64446083|FG001|Overall Study|Death related to Progressive Disease|5|||
23192885|NCT01183858|64446082|FG000|Overall Study|Lost to Follow-up|1|||
23192886|NCT01183858|64446083|FG001|Overall Study|Lost to Follow-up|1|||
23192887|NCT01056107|64446084|FG000|Overall Study|Withdrawal by Subject|0|||
23253850|NCT03636542|64670364|FG001|Overall Study|Lost to Follow-up|1|||
23360166|NCT00105989|65062843|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
23192888|NCT01056107|64446085|FG001|Overall Study|Withdrawal by Subject|1|||
23253851|NCT03636542|64670363|FG000|Overall Study|Physician Decision|0|||
23253852|NCT03636542|64670364|FG001|Overall Study|Physician Decision|1|||
23360167|NCT00105989|65062844|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
23192889|NCT01056107|64446086|FG002|Overall Study|Withdrawal by Subject|3|||
23253853|NCT03636542|64670363|FG000|Overall Study|Withdrawal by Subject|1|||
23592177|NCT02880241|65896181|FG000|Overall Study|Lack of Efficacy|1|||
23253854|NCT03636542|64670364|FG001|Overall Study|Withdrawal by Subject|0|||
23253855|NCT01190098|64670365|FG000|Overall Study|Adverse Event|2|||
23476608|NCT03595618|65488108|FG002|Overall Study|Miscellaneous|10|||
23476609|NCT03595618|65488109|FG003|Overall Study|Miscellaneous|6|||
23476610|NCT01239992|65488110|FG000|Overall Study|Withdrawal by Subject|2|||
23476611|NCT02660138|65488111|FG000|Overall Study|Adverse Event|0|||
23476612|NCT02660138|65488112|FG001|Overall Study|Adverse Event|3|||
23476613|NCT02660138|65488113|FG002|Overall Study|Adverse Event|2|||
23476614|NCT02660138|65488111|FG000|Overall Study|Lack of Efficacy|1|||
23476615|NCT02660138|65488112|FG001|Overall Study|Lack of Efficacy|2|||
23476616|NCT02660138|65488113|FG002|Overall Study|Lack of Efficacy|1|||
23476617|NCT02660138|65488111|FG000|Overall Study|Withdrawal by Subject|7|||
23476618|NCT02660138|65488112|FG001|Overall Study|Withdrawal by Subject|6|||
23476619|NCT02660138|65488113|FG002|Overall Study|Withdrawal by Subject|6|||
23476620|NCT02660138|65488111|FG000|Overall Study|Lost to Follow-up|4|||
23476621|NCT02660138|65488112|FG001|Overall Study|Lost to Follow-up|4|||
23476622|NCT02660138|65488113|FG002|Overall Study|Lost to Follow-up|1|||
23476623|NCT02660138|65488111|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
23476624|NCT02660138|65488112|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
23476625|NCT02660138|65488113|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
23476626|NCT02660138|65488111|FG000|Overall Study|Other|1|||
23476627|NCT02660138|65488112|FG001|Overall Study|Other|1|||
23476628|NCT02660138|65488113|FG002|Overall Study|Other|0|||
23476629|NCT02660138|65488111|FG000|Overall Study|Not treated|0|||
23476630|NCT02660138|65488112|FG001|Overall Study|Not treated|1|||
23476631|NCT02660138|65488113|FG002|Overall Study|Not treated|0|||
23592178|NCT02880241|65896182|FG001|Overall Study|Lack of Efficacy|0|||
23592179|NCT02880241|65896183|FG002|Overall Study|Lack of Efficacy|0|||
23592180|NCT02880241|65896184|FG003|Overall Study|Lack of Efficacy|0|||
23592181|NCT02880241|65896185|FG004|Overall Study|Lack of Efficacy|0|||
23592182|NCT02880241|65896186|FG005|Overall Study|Lack of Efficacy|0|||
23592183|NCT00636207|65896187|FG000|Overall Study|Adverse Event|1|||
23592184|NCT00636207|65896188|FG001|Overall Study|Adverse Event|0|||
23592185|NCT00636207|65896189|FG002|Overall Study|Adverse Event|0|||
23592186|NCT00636207|65896190|FG003|Overall Study|Adverse Event|0|||
23592187|NCT00636207|65896191|FG004|Overall Study|Adverse Event|0|||
23592188|NCT00636207|65896192|FG005|Overall Study|Adverse Event|0|||
23253856|NCT01190098|64670366|FG001|Overall Study|Adverse Event|0|||
23253857|NCT01190098|64670365|FG000|Overall Study|Patient coomorbidity|0|||
23253858|NCT01190098|64670366|FG001|Overall Study|Patient coomorbidity|1|||
23253859|NCT01190098|64670365|FG000|Overall Study|Lack of transportation|1|||
23253860|NCT01190098|64670366|FG001|Overall Study|Lack of transportation|0|||
23253861|NCT01190098|64670365|FG000|Overall Study|Other|0|||
23253862|NCT01190098|64670366|FG001|Overall Study|Other|1|||
23253863|NCT01656967|64670367|FG000|Overall Study|faulty monitor|1|||
23253864|NCT01656967|64670368|FG001|Overall Study|faulty monitor|0|||
23253865|NCT01656967|64670367|FG000|Overall Study|unsuccessful ETT insertion|3|||
23253866|NCT01656967|64670368|FG001|Overall Study|unsuccessful ETT insertion|2|||
23253867|NCT01389024|64670369|FG000|Overall Study|Withdrawal by Subject|0|||
23253868|NCT01389024|64670370|FG001|Overall Study|Withdrawal by Subject|1|||
23253869|NCT01389024|64670369|FG000|Overall Study|Lost to Follow-up|1|||
23253870|NCT01389024|64670370|FG001|Overall Study|Lost to Follow-up|0|||
23253871|NCT03296553|64670371|FG000|Overall Study|Withdrawal by Subject|1|||
23253872|NCT03296553|64670372|FG001|Overall Study|Withdrawal by Subject|1|||
23253873|NCT03296553|64670371|FG000|Overall Study|Death|1|||
23253874|NCT03296553|64670372|FG001|Overall Study|Death|0|||
23253875|NCT00388674|64670373|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
23253876|NCT00388674|64670374|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
23253877|NCT00388674|64670373|FG000|Initial Treatment|Adverse Event|22|||
23253878|NCT00388674|64670374|FG001|Initial Treatment|Adverse Event|87|||
23253879|NCT00388674|64670373|FG000|Initial Treatment|Death|215|||
23253880|NCT00388674|64670374|FG001|Initial Treatment|Death|216|||
23253881|NCT00388674|64670373|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
23253882|NCT00388674|64670374|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
23476632|NCT00734747|65488114|FG000|SRS Procedure|No staples placed|3|||
23476633|NCT00734747|65488114|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
23476634|NCT02338882|65488115|FG000|Overall Study|Death|1|||
23253883|NCT00388674|64670373|FG000|Initial Treatment|HCC|12|||
23476635|NCT02338882|65488116|FG001|Overall Study|Death|0|||
23476636|NCT02338882|65488115|FG000|Overall Study|Lost to Follow-up|6|||
23592189|NCT00636207|65896193|FG006|Overall Study|Adverse Event|0|||
23253884|NCT00388674|64670374|FG001|Initial Treatment|HCC|20|||
23253885|NCT00388674|64670373|FG000|Initial Treatment|Lost to Follow-up|526|||
23253886|NCT00388674|64670374|FG001|Initial Treatment|Lost to Follow-up|624|||
23253887|NCT00388674|64670373|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
23476637|NCT02338882|65488116|FG001|Overall Study|Lost to Follow-up|3|||
23476638|NCT02338232|65488117|FG000|Overall Study|Screen Failure|3|||
23476639|NCT02338232|65488117|FG000|Overall Study|Withdrawal by Subject|6|||
23476640|NCT02338232|65488117|FG000|Overall Study|Adverse Event|2|||
23476641|NCT02364336|65488123|FG000|Overall Study|Adverse Event|0|||
23476642|NCT02364336|65488124|FG001|Overall Study|Adverse Event|1|||
23476643|NCT00483756|65488125|FG000|Overall Study|Death|2|||
23476644|NCT00483756|65488126|FG001|Overall Study|Death|0|||
23476645|NCT00483756|65488127|FG002|Overall Study|Death|1|||
23476646|NCT00483756|65488125|FG000|Overall Study|Adverse Event|19|||
23476647|NCT00483756|65488126|FG001|Overall Study|Adverse Event|38|||
23476648|NCT00483756|65488127|FG002|Overall Study|Adverse Event|40|||
23476649|NCT00483756|65488125|FG000|Overall Study|Lack of Efficacy|1|||
23476650|NCT00483756|65488126|FG001|Overall Study|Lack of Efficacy|0|||
23476651|NCT00483756|65488127|FG002|Overall Study|Lack of Efficacy|0|||
23476652|NCT00483756|65488125|FG000|Overall Study|Lost to Follow-up|3|||
23476653|NCT00483756|65488126|FG001|Overall Study|Lost to Follow-up|1|||
23476654|NCT00483756|65488127|FG002|Overall Study|Lost to Follow-up|0|||
23476655|NCT00483756|65488125|FG000|Overall Study|Withdrawal by Subject|5|||
23476656|NCT00483756|65488126|FG001|Overall Study|Withdrawal by Subject|3|||
23476657|NCT00483756|65488127|FG002|Overall Study|Withdrawal by Subject|4|||
23476658|NCT00483756|65488125|FG000|Overall Study|Other|2|||
23476659|NCT00483756|65488126|FG001|Overall Study|Other|4|||
23476660|NCT00483756|65488127|FG002|Overall Study|Other|3|||
23192890|NCT01056107|64446087|FG003|Overall Study|Withdrawal by Subject|0|||
23192891|NCT03090737|64446088|FG000|Overall Study|Other reasons|1|||
23192892|NCT03090737|64446088|FG000|Overall Study|Completed treatment as per protocol|17|||
23192893|NCT03090737|64446088|FG000|Overall Study|Maximum clinical benefit|2|||
23476661|NCT00483756|65488125|FG000|Overall Study|Randomized, Not Treated|1|||
23476662|NCT00483756|65488126|FG001|Overall Study|Randomized, Not Treated|4|||
23192894|NCT03090737|64446088|FG000|Overall Study|Adverse event unrelated to study drug|7|||
23192895|NCT03090737|64446088|FG000|Overall Study|Study drug toxicity|4|||
23192896|NCT03090737|64446088|FG000|Overall Study|Disease progression|98|||
23192897|NCT00091390|64446092|FG000|Overall Study|Protocol Violation|1|||
23192898|NCT00091390|64446092|FG000|Overall Study|No protocol treatment|3|||
23192899|NCT02385123|64446097|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
23192900|NCT00637728|64446098|FG000|Double-blind Phase|Adverse Event|1|||
23253888|NCT00388674|64670374|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
23253889|NCT00388674|64670373|FG000|Initial Treatment|Never Treated with Study Medication|1|||
23253890|NCT00388674|64670374|FG001|Initial Treatment|Never Treated with Study Medication|7|||
23476663|NCT00483756|65488127|FG002|Overall Study|Randomized, Not Treated|4|||
23476664|NCT04610281|65488131|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
23476665|NCT04610281|65488132|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
23476666|NCT04644315|65488134|FG000|Overall Study|Subject withdrawal of consent|1|||
23476667|NCT01256190|65488137|FG000|Overall Study|Lost to Follow-up|2|||
23476668|NCT01256190|65488138|FG001|Overall Study|Lost to Follow-up|0|||
23476669|NCT01755026|65488145|FG000|Overall Study|Adverse Event|1|||
23476670|NCT01755026|65488146|FG001|Overall Study|Adverse Event|0|||
23476671|NCT01755026|65488145|FG000|Overall Study|Withdrawal by Subject|1|||
23476672|NCT01755026|65488146|FG001|Overall Study|Withdrawal by Subject|1|||
23476673|NCT03860818|65488151|FG000|Overall Study|Death|144|||
23476674|NCT03860818|65488152|FG001|Overall Study|Death|195|||
23476675|NCT03860818|65488151|FG000|Overall Study|Graft Loss|32|||
23476676|NCT03860818|65488152|FG001|Overall Study|Graft Loss|45|||
23476677|NCT00476008|65488155|FG000|Overall Study|Adverse Event|4|||
23476678|NCT00476008|65488156|FG001|Overall Study|Adverse Event|4|||
23476679|NCT00476008|65488155|FG000|Overall Study|Placebo concerns|2|||
23476680|NCT00476008|65488156|FG001|Overall Study|Placebo concerns|2|||
23476681|NCT00476008|65488155|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
23476682|NCT00476008|65488156|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
23476683|NCT00476008|65488155|FG000|Overall Study|Withdrawal by Subject|0|||
23476684|NCT00476008|65488156|FG001|Overall Study|Withdrawal by Subject|1|||
23476685|NCT00476008|65488155|FG000|Overall Study|Death|1|||
23476686|NCT00476008|65488156|FG001|Overall Study|Death|0|||
23192901|NCT00637728|64446099|FG001|Double-blind Phase|Adverse Event|0|||
23192902|NCT00637728|64446100|FG002|Double-blind Phase|Adverse Event|0|||
23253891|NCT00388674|64670373|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
23253892|NCT00388674|64670374|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
23253893|NCT00388674|64670373|FG000|Initial Treatment|Not Defined|125|||
23360168|NCT04739800|65062846|FG000|Overall Study|Adverse Event|2|||
23476687|NCT00934648|65488157|FG000|Overall Study|Failure to return|8|||
23476688|NCT00934648|65488157|FG000|Overall Study|Withdrawal by Subject|1|||
23476689|NCT02929498|65488160|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
23476690|NCT02929498|65488161|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
23476691|NCT02929498|65488162|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
23476692|NCT02929498|65488160|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
23592190|NCT00636207|65896187|FG000|Overall Study|Withdrawal by Subject|0|||
23592191|NCT00636207|65896188|FG001|Overall Study|Withdrawal by Subject|1|||
23592192|NCT00636207|65896189|FG002|Overall Study|Withdrawal by Subject|0|||
23592193|NCT00636207|65896190|FG003|Overall Study|Withdrawal by Subject|0|||
23592194|NCT00636207|65896191|FG004|Overall Study|Withdrawal by Subject|1|||
23592195|NCT00636207|65896192|FG005|Overall Study|Withdrawal by Subject|0|||
23592196|NCT00636207|65896193|FG006|Overall Study|Withdrawal by Subject|0|||
23592197|NCT01561989|65896198|FG000|Overall Study|accural target not met.|5|||
23592198|NCT01561989|65896199|FG001|Overall Study|accural target not met.|6|||
23592199|NCT00813904|65896200|FG000|Overall Study|Death|1|||
23592200|NCT03247543|65896201|FG000|Overall Study|Adverse Event|3|||
23592201|NCT03247543|65896202|FG001|Overall Study|Adverse Event|6|||
23592202|NCT03247543|65896203|FG002|Overall Study|Adverse Event|4|||
23592203|NCT03247543|65896201|FG000|Overall Study|Lost to Follow-up|10|||
23592204|NCT03247543|65896202|FG001|Overall Study|Lost to Follow-up|7|||
23592205|NCT03247543|65896203|FG002|Overall Study|Lost to Follow-up|8|||
23592206|NCT03247543|65896201|FG000|Overall Study|Consent withdrawn by caregiver|2|||
23592207|NCT03247543|65896202|FG001|Overall Study|Consent withdrawn by caregiver|2|||
23592208|NCT03247543|65896203|FG002|Overall Study|Consent withdrawn by caregiver|9|||
23592209|NCT03247543|65896201|FG000|Overall Study|Withdrawal by Subject|0|||
23592210|NCT03247543|65896202|FG001|Overall Study|Withdrawal by Subject|0|||
23253894|NCT00388674|64670374|FG001|Initial Treatment|Not Defined|172|||
23253895|NCT00388674|64670373|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
23253896|NCT00388674|64670374|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
23253897|NCT00388674|64670373|FG000|Initial Treatment|Pregnancy|26|||
23253898|NCT00388674|64670374|FG001|Initial Treatment|Pregnancy|16|||
23253899|NCT00388674|64670373|FG000|Initial Treatment|Study Drug Toxicity|5|||
23253900|NCT00388674|64670374|FG001|Initial Treatment|Study Drug Toxicity|92|||
23592211|NCT03247543|65896203|FG002|Overall Study|Withdrawal by Subject|1|||
23592212|NCT03247543|65896201|FG000|Overall Study|Failure to Follow study procedures|1|||
23592213|NCT03247543|65896202|FG001|Overall Study|Failure to Follow study procedures|3|||
23592214|NCT03247543|65896203|FG002|Overall Study|Failure to Follow study procedures|1|||
23592215|NCT03247543|65896201|FG000|Overall Study|Lack of Efficacy|1|||
23253901|NCT00388674|64670373|FG000|Initial Treatment|Participant Request|501|||
23253902|NCT00388674|64670374|FG001|Initial Treatment|Participant Request|673|||
23476693|NCT02929498|65488161|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
23476694|NCT02929498|65488162|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
23476695|NCT00233454|65488170|FG000|Overall Study|Death|6|||
23476696|NCT02520089|65488171|FG000|Overall Study|Lost to Follow-up|3|||
23592216|NCT03247543|65896202|FG001|Overall Study|Lack of Efficacy|0|||
23592217|NCT03247543|65896203|FG002|Overall Study|Lack of Efficacy|0|||
23592218|NCT03247543|65896201|FG000|Overall Study|Non-compliance with study visits|0|||
23592219|NCT03247543|65896202|FG001|Overall Study|Non-compliance with study visits|1|||
23592220|NCT03247543|65896203|FG002|Overall Study|Non-compliance with study visits|0|||
23592221|NCT01171625|65896207|FG000|Overall Study|On-Protocol|67|||
23592222|NCT01171625|65896207|FG000|Overall Study|Death|38|||
23592223|NCT01171625|65896207|FG000|Overall Study|Withdrawal by Subject|31|||
23592224|NCT01171625|65896207|FG000|Overall Study|Explanted|10|||
23592225|NCT01171625|65896207|FG000|Overall Study|Lost to Follow-up|5|||
23592226|NCT01171625|65896207|FG000|Overall Study|Patient received valve-in-valve|3|||
23476697|NCT02520089|65488172|FG001|Overall Study|Lost to Follow-up|4|||
23476698|NCT01386970|65488173|FG000|Overall Study|Withdrawal by Subject|0|||
23476699|NCT01386970|65488174|FG001|Overall Study|Withdrawal by Subject|1|||
23476700|NCT01386970|65488173|FG000|Overall Study|Adverse Event|4|||
23476701|NCT01386970|65488174|FG001|Overall Study|Adverse Event|1|||
23476702|NCT02730793|65488179|FG000|Overall Study|Physician Decision|0|||
23476703|NCT02730793|65488180|FG001|Overall Study|Physician Decision|1|||
23476704|NCT02730793|65488179|FG000|Overall Study|Withdrawal by Subject|0|||
23476705|NCT02730793|65488180|FG001|Overall Study|Withdrawal by Subject|1|||
23476706|NCT03255629|65488181|FG000|Overall Study|Adverse Event|1|||
23592227|NCT01171625|65896207|FG000|Overall Study|Other|1|||
23592228|NCT01171625|65896207|FG000|Overall Study|Consented but did not receive device|25|||
23592229|NCT00933400|65896208|FG000|Overall Study|Withdrawal by Subject|21|||
23592230|NCT00933400|65896209|FG001|Overall Study|Withdrawal by Subject|1|||
23592231|NCT04833855|65896210|FG000|Overall Study|Decision by sponsor|0|||
23592232|NCT04833855|65896211|FG001|Overall Study|Decision by sponsor|1|||
23592233|NCT04833855|65896212|FG002|Overall Study|Decision by sponsor|0|||
23592234|NCT04833855|65896213|FG003|Overall Study|Decision by sponsor|0|||
23476707|NCT03255629|65488182|FG001|Overall Study|Adverse Event|0|||
23476708|NCT03255629|65488181|FG000|Overall Study|did not experience hypoglycemia|2|||
23592235|NCT04833855|65896210|FG000|Overall Study|Withdrawal by Subject|4|||
23592236|NCT04833855|65896211|FG001|Overall Study|Withdrawal by Subject|1|||
23592237|NCT04833855|65896212|FG002|Overall Study|Withdrawal by Subject|3|||
23592238|NCT04833855|65896213|FG003|Overall Study|Withdrawal by Subject|1|||
23476709|NCT03255629|65488182|FG001|Overall Study|did not experience hypoglycemia|1|||
23476710|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
23592239|NCT04833855|65896210|FG000|Overall Study|Lost to Follow-up|1|||
23592240|NCT04833855|65896211|FG001|Overall Study|Lost to Follow-up|0|||
23592241|NCT04833855|65896212|FG002|Overall Study|Lost to Follow-up|2|||
23592242|NCT04833855|65896213|FG003|Overall Study|Lost to Follow-up|2|||
23592243|NCT04833855|65896210|FG000|Overall Study|Protocol specified criteria|0|||
23592244|NCT04833855|65896211|FG001|Overall Study|Protocol specified criteria|0|||
23592245|NCT04833855|65896212|FG002|Overall Study|Protocol specified criteria|2|||
23592246|NCT04833855|65896213|FG003|Overall Study|Protocol specified criteria|1|||
23592247|NCT02960659|65899472|FG000|Overall Study|Withdrawal by Subject|1|||
23592248|NCT02960659|65899473|FG001|Overall Study|Withdrawal by Subject|0|||
23592249|NCT02960659|65899472|FG000|Overall Study|Poor compliance|0|||
23592250|NCT02960659|65899473|FG001|Overall Study|Poor compliance|1|||
23592251|NCT03648762|65899474|FG000|Overall Study|Lost to Follow-up|1|||
23592252|NCT03648762|65899475|FG001|Overall Study|Lost to Follow-up|2|||
23592253|NCT03648762|65899476|FG002|Overall Study|Lost to Follow-up|0|||
23592254|NCT03648762|65899474|FG000|Overall Study|Withdrawal by Subject|5|||
23592255|NCT03648762|65899475|FG001|Overall Study|Withdrawal by Subject|2|||
23592256|NCT03648762|65899476|FG002|Overall Study|Withdrawal by Subject|1|||
23592257|NCT00414544|65899484|FG000|Overall Study|Lost to Follow-up|14|||
23592258|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
23592259|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
23592260|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
23592261|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
23592262|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
23592263|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
23592264|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
23592265|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
23592266|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
23592267|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
23592268|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
23592269|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
23592270|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
23592271|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
23592272|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
23592273|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
23592274|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
23592275|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
23592276|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
23592277|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
23592278|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
23592279|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
23592280|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
23592281|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
23592282|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
23592283|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
23592284|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
23592285|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
23592286|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
23592287|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
23476711|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
23476712|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
23476713|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
23476714|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
23476715|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
23476716|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23476717|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
23476718|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
23592288|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
23592289|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
23592290|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
23592291|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
23592292|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
23592293|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
23592294|NCT03593213|65899485|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
23592295|NCT03593213|65899486|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
23592296|NCT03593213|65899487|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
23592297|NCT03593213|65899488|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
23592298|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
23592299|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
23592300|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
23592301|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
23592302|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
23592303|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
23592304|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
23592305|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
23592306|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
23592307|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
23592308|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
23592309|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
23592310|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
23592311|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
23592312|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
23592313|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
23592314|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
23592315|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
23592316|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
23592317|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
23592318|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
23592319|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
23592320|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
23592321|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
23592322|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
23592323|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
23592324|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
23253903|NCT00388674|64670373|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
23253904|NCT00388674|64670374|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
23253905|NCT00388674|64670373|FG000|Initial Treatment|Not Reported|10|||
23253906|NCT00388674|64670374|FG001|Initial Treatment|Not Reported|12|||
23253907|NCT00388674|64670373|FG000|End of Study|Administrative Reason By Sponsor|299|||
23253908|NCT00388674|64670374|FG001|End of Study|Administrative Reason By Sponsor|253|||
23253909|NCT00388674|64670373|FG000|End of Study|Death|239|||
23360169|NCT04739800|65062847|FG001|Overall Study|Adverse Event|1|||
23360170|NCT04739800|65062848|FG002|Overall Study|Adverse Event|4|||
23476719|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23476720|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23476721|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23476722|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
23476723|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
23476724|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
23476725|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
23476726|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
23476727|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
23476728|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
23476729|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476730|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476731|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476732|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476733|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
23476734|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
23476735|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
23476736|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
23476737|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
23476738|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
23476739|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
23476740|NCT00600119|65488183|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
23476741|NCT00600119|65488184|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
23476742|NCT00600119|65488185|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
23360171|NCT04739800|65062849|FG003|Overall Study|Adverse Event|5|||
23592325|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
23592326|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
23592327|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
23592328|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
23592329|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
23592330|NCT03593213|65899485|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
23592331|NCT03593213|65899486|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
23592332|NCT03593213|65899487|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
23592333|NCT03593213|65899488|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
23592334|NCT00516386|65899491|FG000|Overall Study|not interested in the study|4|||
23592335|NCT00516386|65899491|FG000|Overall Study|Lost to Follow-up|2|||
23592336|NCT01430611|65899496|FG000|Overall Study|Adverse Event|0|||
23592337|NCT01430611|65899497|FG001|Overall Study|Adverse Event|1|||
23592338|NCT01430611|65899496|FG000|Overall Study|Protocol Violation|1|||
23592339|NCT01430611|65899497|FG001|Overall Study|Protocol Violation|0|||
23592340|NCT01430611|65899496|FG000|Overall Study|Lost to Follow-up|1|||
23592341|NCT01430611|65899497|FG001|Overall Study|Lost to Follow-up|0|||
23592342|NCT01430611|65899496|FG000|Overall Study|Withdrawal by Subject|15|||
23592343|NCT01430611|65899497|FG001|Overall Study|Withdrawal by Subject|14|||
23592344|NCT01415349|65899498|FG000|Treatment Period 1|Adverse Event|0|||
23592345|NCT01415349|65899499|FG001|Treatment Period 1|Adverse Event|1|||
23592346|NCT01415349|65899498|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23592347|NCT01415349|65899499|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23592348|NCT01198275|65899504|FG000|Overall Study|Adverse Event|2|||
23592349|NCT01198275|65899505|FG001|Overall Study|Adverse Event|3|||
23592350|NCT01198275|65899504|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
23592351|NCT01198275|65899505|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
23592352|NCT01546753|65899508|FG000|Overall Study|anxiety|1|||
23592353|NCT01546753|65899509|FG001|Overall Study|anxiety|1|||
23592354|NCT01546753|65899508|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
23592355|NCT01546753|65899509|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
23592356|NCT05132478|65899513|FG000|Overall Study|did not complete survey after consent|1|||
23592357|NCT05132478|65899514|FG001|Overall Study|did not complete survey after consent|1|||
23592358|NCT05132478|65899513|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
23476743|NCT00600119|65488186|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
23476744|NCT00600119|65488187|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
23476745|NCT00600119|65488188|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
23476746|NCT00600119|65488183|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
23476747|NCT00600119|65488184|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
23476748|NCT00600119|65488185|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23476749|NCT00600119|65488186|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
23476750|NCT00600119|65488187|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
23476751|NCT00600119|65488188|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
23476752|NCT00600119|65488183|FG000|Double-blind Treatment Period|Other|0|||
23476753|NCT00600119|65488184|FG001|Double-blind Treatment Period|Other|0|||
23476754|NCT00600119|65488185|FG002|Double-blind Treatment Period|Other|0|||
23476755|NCT00600119|65488186|FG003|Double-blind Treatment Period|Other|0|||
23476756|NCT00600119|65488187|FG004|Double-blind Treatment Period|Other|2|||
23476757|NCT00600119|65488188|FG005|Double-blind Treatment Period|Other|1|||
23476758|NCT00600119|65488183|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
23476759|NCT00600119|65488184|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
23476760|NCT00600119|65488185|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
23476761|NCT00600119|65488186|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
23476762|NCT00600119|65488187|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
23476763|NCT00600119|65488188|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
23476764|NCT00600119|65488183|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23476765|NCT00600119|65488184|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
23476766|NCT00600119|65488185|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23476767|NCT00600119|65488186|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23476768|NCT00600119|65488187|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23476769|NCT00600119|65488188|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
23592359|NCT05132478|65899514|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
23592360|NCT03520413|65899519|FG000|Overall Study|Lost to Follow-up|1|||
23476770|NCT00600119|65488183|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
23592361|NCT03520413|65899520|FG001|Overall Study|Lost to Follow-up|1|||
23592362|NCT03520413|65899519|FG000|Overall Study|Withdrawal by Subject|1|||
23592363|NCT03520413|65899520|FG001|Overall Study|Withdrawal by Subject|2|||
23592364|NCT03520413|65899519|FG000|Overall Study|Death|0|||
23592365|NCT03520413|65899520|FG001|Overall Study|Death|1|||
23592366|NCT03520413|65899519|FG000|Overall Study|Physician Decision|3|||
23592367|NCT03520413|65899520|FG001|Overall Study|Physician Decision|3|||
23592368|NCT03520413|65899519|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
23592369|NCT03520413|65899520|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
23592370|NCT02810080|65899523|FG000|Overall Study|Adverse Event|3|||
23592371|NCT02810080|65899524|FG001|Overall Study|Adverse Event|0|||
23192903|NCT00637728|64446098|FG000|Double-blind Phase|Non-compliance|2|||
23192904|NCT00637728|64446099|FG001|Double-blind Phase|Non-compliance|0|||
23476771|NCT00600119|65488184|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
23476772|NCT00600119|65488185|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
23476773|NCT00600119|65488186|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
23476774|NCT00600119|65488187|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
23476775|NCT00600119|65488188|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
23476776|NCT00600119|65488183|FG000|Double-blind Treatment Period|Physician Decision|2|||
23476777|NCT00600119|65488184|FG001|Double-blind Treatment Period|Physician Decision|0|||
23476778|NCT00600119|65488185|FG002|Double-blind Treatment Period|Physician Decision|0|||
23476779|NCT00600119|65488186|FG003|Double-blind Treatment Period|Physician Decision|0|||
23476780|NCT00600119|65488187|FG004|Double-blind Treatment Period|Physician Decision|0|||
23476781|NCT00600119|65488188|FG005|Double-blind Treatment Period|Physician Decision|0|||
23476782|NCT00600119|65488183|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23476783|NCT00600119|65488184|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
23476784|NCT00600119|65488185|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
23476785|NCT00600119|65488186|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23476786|NCT00600119|65488187|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
23476787|NCT00600119|65488188|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
23476788|NCT00600119|65488183|FG000|Double-blind Treatment Period|Adverse Event|1|||
23476789|NCT00600119|65488184|FG001|Double-blind Treatment Period|Adverse Event|1|||
23476790|NCT00600119|65488185|FG002|Double-blind Treatment Period|Adverse Event|0|||
23476791|NCT00600119|65488186|FG003|Double-blind Treatment Period|Adverse Event|1|||
23476792|NCT00600119|65488187|FG004|Double-blind Treatment Period|Adverse Event|2|||
23476793|NCT00600119|65488188|FG005|Double-blind Treatment Period|Adverse Event|10|||
23476794|NCT00600119|65488183|FG000|Follow-up Period|Adverse Event|0|||
23476795|NCT00600119|65488184|FG001|Follow-up Period|Adverse Event|0|||
23476796|NCT00600119|65488185|FG002|Follow-up Period|Adverse Event|0|||
23476797|NCT00600119|65488186|FG003|Follow-up Period|Adverse Event|0|||
23476798|NCT00600119|65488187|FG004|Follow-up Period|Adverse Event|0|||
23476799|NCT00600119|65488188|FG005|Follow-up Period|Adverse Event|1|||
23476800|NCT00600119|65488183|FG000|Follow-up Period|Other|1|||
23476801|NCT00600119|65488184|FG001|Follow-up Period|Other|0|||
23476802|NCT00600119|65488185|FG002|Follow-up Period|Other|0|||
23192905|NCT00637728|64446100|FG002|Double-blind Phase|Non-compliance|0|||
23192906|NCT00637728|64446098|FG000|Double-blind Phase|Study Discontinued|1|||
23192907|NCT00637728|64446099|FG001|Double-blind Phase|Study Discontinued|1|||
23192908|NCT00637728|64446100|FG002|Double-blind Phase|Study Discontinued|0|||
23253910|NCT00388674|64670374|FG001|End of Study|Death|262|||
23476803|NCT00600119|65488186|FG003|Follow-up Period|Other|0|||
23476804|NCT00600119|65488187|FG004|Follow-up Period|Other|0|||
23476805|NCT00600119|65488188|FG005|Follow-up Period|Other|0|||
23476806|NCT01425463|65488189|FG000|Overall Study|Adverse Event|5|||
23476807|NCT01425463|65488190|FG001|Overall Study|Adverse Event|7|||
23476808|NCT01425463|65488189|FG000|Overall Study|Lack of Efficacy|1|||
23476809|NCT01425463|65488190|FG001|Overall Study|Lack of Efficacy|1|||
23476810|NCT01425463|65488189|FG000|Overall Study|Protocol Violation|2|||
23476811|NCT01425463|65488190|FG001|Overall Study|Protocol Violation|2|||
23476812|NCT01425463|65488189|FG000|Overall Study|Lost to Follow-up|5|||
23476813|NCT01425463|65488190|FG001|Overall Study|Lost to Follow-up|2|||
23476814|NCT01425463|65488189|FG000|Overall Study|Withdrawal by Subject|7|||
23476815|NCT01425463|65488190|FG001|Overall Study|Withdrawal by Subject|5|||
23476816|NCT01425463|65488189|FG000|Overall Study|Unknown Reason|4|||
23592372|NCT02810080|65899523|FG000|Overall Study|Death|0|||
23192909|NCT02239094|64449461|FG000|Overall Study|Withdrawal by Subject|1|||
23192910|NCT02239094|64449461|FG000|Overall Study|Remitted before started|1|||
23253911|NCT00388674|64670373|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
23476817|NCT01425463|65488190|FG001|Overall Study|Unknown Reason|7|||
23476818|NCT03126344|65488191|FG000|Overall Study|Lost to Follow-up|0|||
23476819|NCT03126344|65488192|FG001|Overall Study|Lost to Follow-up|0|||
23476820|NCT03126344|65488193|FG002|Overall Study|Lost to Follow-up|5|||
23476821|NCT00917644|65488194|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
23476822|NCT00917644|65488195|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
23476823|NCT00917644|65488194|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
23476824|NCT00917644|65488195|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
23476825|NCT00917644|65488194|FG000|Period 2: Second Intervention|family emergency|1|||
23476826|NCT00917644|65488195|FG001|Period 2: Second Intervention|family emergency|0|||
23476827|NCT01883453|65488198|FG000|Overall Study|No episode of common cold|25|||
23253912|NCT00388674|64670374|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
23253913|NCT00388674|64670373|FG000|End of Study|HCC|8|||
23253914|NCT00388674|64670374|FG001|End of Study|HCC|7|||
23253915|NCT00388674|64670373|FG000|End of Study|Lost to Follow-up|587|||
23476828|NCT01883453|65488199|FG001|Overall Study|No episode of common cold|23|||
23476829|NCT00097981|65488216|FG000|Overall Study|Adverse Event|31|||
23476830|NCT00097981|65488217|FG001|Overall Study|Adverse Event|44|||
23476831|NCT00097981|65488216|FG000|Overall Study|Withdrawal by Subject|10|||
23476832|NCT00097981|65488217|FG001|Overall Study|Withdrawal by Subject|8|||
23476833|NCT00097981|65488216|FG000|Overall Study|Protocol Violation|1|||
23476834|NCT00097981|65488217|FG001|Overall Study|Protocol Violation|1|||
23476835|NCT00097981|65488216|FG000|Overall Study|Death|2|||
23476836|NCT00097981|65488217|FG001|Overall Study|Death|4|||
23476837|NCT00097981|65488216|FG000|Overall Study|Physician Decision|7|||
23476838|NCT00097981|65488217|FG001|Overall Study|Physician Decision|1|||
23476839|NCT00097981|65488216|FG000|Overall Study|Disease Progression|8|||
23476840|NCT00097981|65488217|FG001|Overall Study|Disease Progression|2|||
23476841|NCT00097981|65488216|FG000|Overall Study|Transplant planned|28|||
23476842|NCT00097981|65488217|FG001|Overall Study|Transplant planned|27|||
23476843|NCT00097981|65488216|FG000|Overall Study|Other|19|||
23476844|NCT00097981|65488217|FG001|Overall Study|Other|13|||
23476845|NCT03316911|65488218|FG000|Overall Study|Lost to Follow-up|33|||
23476846|NCT03316911|65488219|FG001|Overall Study|Lost to Follow-up|29|||
23476847|NCT00870103|65491390|FG000|Overall Study|Physician Decision|2|||
23476848|NCT00870103|65491390|FG000|Overall Study|Lost to Follow-up|2|||
23476849|NCT02142387|65491391|FG000|Overall Study|<19 years old|49|||
23476850|NCT02142387|65491392|FG001|Overall Study|<19 years old|326|||
23476851|NCT02142387|65491391|FG000|Overall Study|non-cardiac etiology|504|||
23476852|NCT02142387|65491392|FG001|Overall Study|non-cardiac etiology|3431|||
23476853|NCT02142387|65491391|FG000|Overall Study|CPR not performed|74|||
23253916|NCT00388674|64670374|FG001|End of Study|Lost to Follow-up|715|||
23476854|NCT02142387|65491392|FG001|Overall Study|CPR not performed|473|||
23253917|NCT00388674|64670373|FG000|End of Study|Malignancy (Non-HCC)|1|||
23253918|NCT00388674|64670374|FG001|End of Study|Malignancy (Non-HCC)|1|||
23253919|NCT00388674|64670373|FG000|End of Study|Non-Study Related Comorbidities|3|||
23476855|NCT02142387|65491391|FG000|Overall Study|witnessed by paramedic|139|||
23476856|NCT02142387|65491392|FG001|Overall Study|witnessed by paramedic|917|||
23476857|NCT02142387|65491391|FG000|Overall Study|incomplete data|1|||
23476858|NCT02142387|65491392|FG001|Overall Study|incomplete data|9|||
23476859|NCT02142387|65491391|FG000|Overall Study|occurred not at home|298|||
23476860|NCT02142387|65491392|FG001|Overall Study|occurred not at home|2474|||
23476861|NCT00167778|65491393|FG000|Overall Study|Withdrawal by Subject|1|||
23476862|NCT02431260|65491396|FG000|Overall Study|Subject Decision|0|||
23476863|NCT02431260|65491397|FG001|Overall Study|Subject Decision|1|||
23476864|NCT02431260|65491398|FG002|Overall Study|Subject Decision|1|||
23476865|NCT02431260|65491399|FG003|Overall Study|Subject Decision|0|||
23476866|NCT02431260|65491400|FG004|Overall Study|Subject Decision|0|||
23476867|NCT02431260|65491401|FG005|Overall Study|Subject Decision|0|||
23192911|NCT00726323|64449467|FG000|Overall Study|Withdrawal by Subject|3|||
23192912|NCT00726323|64449468|FG001|Overall Study|Withdrawal by Subject|1|||
23192913|NCT00726323|64449467|FG000|Overall Study|Physician Decision|1|||
23192914|NCT00726323|64449468|FG001|Overall Study|Physician Decision|0|||
23192915|NCT00726323|64449467|FG000|Overall Study|Progressive disease|23|||
23192916|NCT00726323|64449468|FG001|Overall Study|Progressive disease|16|||
23192917|NCT00726323|64449467|FG000|Overall Study|Clinical progression|0|||
23192918|NCT00726323|64449468|FG001|Overall Study|Clinical progression|3|||
23192919|NCT00726323|64449467|FG000|Overall Study|Adverse Event|9|||
23192920|NCT00726323|64449468|FG001|Overall Study|Adverse Event|9|||
23192921|NCT00726323|64449467|FG000|Overall Study|Death|1|||
23192922|NCT00726323|64449468|FG001|Overall Study|Death|0|||
23192923|NCT00726323|64449467|FG000|Overall Study|Participant wished to discontinue|0|||
23192924|NCT00726323|64449468|FG001|Overall Study|Participant wished to discontinue|1|||
23192925|NCT00726323|64449467|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
23192926|NCT00726323|64449468|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
23192927|NCT01770353|64449469|FG000|Overall Study|Progressive disease|2|||
23192928|NCT01770353|64449470|FG001|Overall Study|Progressive disease|1|||
23192929|NCT01770353|64449469|FG000|Overall Study|Adverse Event|0|||
23192930|NCT01770353|64449470|FG001|Overall Study|Adverse Event|1|||
23192931|NCT01770353|64449469|FG000|Overall Study|Protocol Violation|1|||
23192932|NCT01770353|64449470|FG001|Overall Study|Protocol Violation|0|||
23192933|NCT01770353|64449469|FG000|Overall Study|Physician Decision|0|||
23192934|NCT01770353|64449470|FG001|Overall Study|Physician Decision|3|||
23192935|NCT01770353|64449469|FG000|Overall Study|Clinical deterioration|3|||
23192936|NCT01770353|64449470|FG001|Overall Study|Clinical deterioration|6|||
23253920|NCT00388674|64670374|FG001|End of Study|Non-Study Related Comorbidities|4|||
23253921|NCT00388674|64670373|FG000|End of Study|Not Defined|135|||
23253922|NCT00388674|64670374|FG001|End of Study|Not Defined|214|||
23253923|NCT00388674|64670373|FG000|End of Study|Participant Withdrew Consent|437|||
23253924|NCT00388674|64670374|FG001|End of Study|Participant Withdrew Consent|673|||
23253925|NCT00388674|64670373|FG000|End of Study|No Off-Treatment Status Data|22|||
23253926|NCT00388674|64670374|FG001|End of Study|No Off-Treatment Status Data|30|||
23253927|NCT00388674|64670373|FG000|End of Study|Not Reported|0|||
23253928|NCT00388674|64670374|FG001|End of Study|Not Reported|1|||
23253929|NCT00619619|64670375|FG000|Overall Study|Physician Decision|0|||
23253930|NCT00619619|64670376|FG001|Overall Study|Physician Decision|0|||
23253931|NCT00619619|64670377|FG002|Overall Study|Physician Decision|1|||
23253932|NCT00619619|64670378|FG003|Overall Study|Physician Decision|0|||
23253933|NCT00619619|64670379|FG004|Overall Study|Physician Decision|0|||
23253934|NCT00619619|64670380|FG005|Overall Study|Physician Decision|0|||
23253935|NCT00619619|64670381|FG006|Overall Study|Physician Decision|0|||
23192937|NCT01770353|64449469|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
23192938|NCT01770353|64449470|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
23192939|NCT01302769|64449473|FG000|Overall Study|Lost to Follow-up|1|||
23192940|NCT01302769|64449474|FG001|Overall Study|Lost to Follow-up|1|||
23192941|NCT00945191|64449475|FG000|Overall Study|Did not achieve a complete response|18|||
23192942|NCT00945191|64449475|FG000|Overall Study|Participant relocated to another state|1|||
23192943|NCT00945191|64449475|FG000|Overall Study|Disease progression|3|||
23253936|NCT00619619|64670382|FG007|Overall Study|Physician Decision|0|||
23253937|NCT00619619|64670375|FG000|Overall Study|Protocol Violation|0|||
23253938|NCT00619619|64670376|FG001|Overall Study|Protocol Violation|0|||
23253939|NCT00619619|64670377|FG002|Overall Study|Protocol Violation|0|||
23192944|NCT00945191|64449475|FG000|Overall Study|Serious adverse event or adverse event|1|||
23476868|NCT02431260|65491402|FG006|Overall Study|Subject Decision|0|||
23476869|NCT02431260|65491403|FG007|Overall Study|Subject Decision|0|||
23192945|NCT00945191|64449475|FG000|Overall Study|Investigator's discretion|1|||
23192946|NCT00309777|64449479|FG000|Overall Study|Adverse Event|13|||
23192947|NCT00309777|64449480|FG001|Overall Study|Adverse Event|2|||
23192948|NCT00309777|64449481|FG002|Overall Study|Adverse Event|8|||
23192949|NCT00309777|64449482|FG003|Overall Study|Adverse Event|1|||
23192950|NCT00309777|64449479|FG000|Overall Study|Protocol Violation|4|||
23192951|NCT00309777|64449480|FG001|Overall Study|Protocol Violation|1|||
23192952|NCT00309777|64449481|FG002|Overall Study|Protocol Violation|3|||
23192953|NCT00309777|64449482|FG003|Overall Study|Protocol Violation|1|||
23192954|NCT00309777|64449479|FG000|Overall Study|Withdrawal by Subject|6|||
23192955|NCT00309777|64449480|FG001|Overall Study|Withdrawal by Subject|5|||
23192956|NCT00309777|64449481|FG002|Overall Study|Withdrawal by Subject|7|||
23192957|NCT00309777|64449482|FG003|Overall Study|Withdrawal by Subject|2|||
23192958|NCT00309777|64449479|FG000|Overall Study|Lost to Follow-up|0|||
23192959|NCT00309777|64449480|FG001|Overall Study|Lost to Follow-up|0|||
23192960|NCT00309777|64449481|FG002|Overall Study|Lost to Follow-up|1|||
23192961|NCT00309777|64449482|FG003|Overall Study|Lost to Follow-up|0|||
23192962|NCT00309777|64449479|FG000|Overall Study|Death|0|||
23192963|NCT00309777|64449480|FG001|Overall Study|Death|1|||
23192964|NCT00309777|64449481|FG002|Overall Study|Death|0|||
23192965|NCT00309777|64449482|FG003|Overall Study|Death|0|||
23192966|NCT00882713|64449490|FG000|Overall Study|Adverse Event|2|||
23192967|NCT00882713|64449490|FG000|Overall Study|Death|3|||
23192968|NCT00882713|64449490|FG000|Overall Study|Administrative reasons|4|||
23192969|NCT00882713|64449490|FG000|Overall Study|refused treatment/withdrew consent|4|||
23192970|NCT00882713|64449490|FG000|Overall Study|Blood transfusion|2|||
23192971|NCT00882713|64449490|FG000|Overall Study|Insufficient therapeutic response|3|||
23192972|NCT00882713|64449490|FG000|Overall Study|Failure to return|2|||
23192973|NCT00882713|64449490|FG000|Overall Study|Other - Reasons|2|||
23192974|NCT02732912|64449491|FG000|Overall Study|Discharged before night|2|||
23192975|NCT02732912|64449492|FG001|Overall Study|Discharged before night|6|||
23192976|NCT02732912|64449491|FG000|Overall Study|Incomplete completion of questionnaire|2|||
23192977|NCT02732912|64449492|FG001|Overall Study|Incomplete completion of questionnaire|3|||
23192978|NCT02732912|64449491|FG000|Overall Study|No outcome; discharged or refused|6|||
23192979|NCT02732912|64449492|FG001|Overall Study|No outcome; discharged or refused|9|||
23192980|NCT00593112|64449493|FG000|Overall Study|Scan Anxiety|3|||
23192981|NCT00593112|64449494|FG001|Overall Study|Scan Anxiety|0|||
23192982|NCT00593112|64449493|FG000|Overall Study|Abnormal Scan|1|||
23192983|NCT00593112|64449494|FG001|Overall Study|Abnormal Scan|0|||
23192984|NCT00593112|64449493|FG000|Overall Study|Unreadable Scan|1|||
23192985|NCT00593112|64449494|FG001|Overall Study|Unreadable Scan|0|||
23192986|NCT00593112|64449493|FG000|Overall Study|Withdrawal by Subject|5|||
23192987|NCT00593112|64449494|FG001|Overall Study|Withdrawal by Subject|0|||
23192988|NCT03334214|64449499|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
23192989|NCT03334214|64449500|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
23192990|NCT03334214|64449499|FG000|Overall Study|Withdrawal by Subject|0|||
23192991|NCT03334214|64449500|FG001|Overall Study|Withdrawal by Subject|1|||
23192992|NCT03334214|64449499|FG000|Overall Study|Other|1|||
23192993|NCT03334214|64449500|FG001|Overall Study|Other|0|||
23192994|NCT00734929|64449501|FG000|Overall Study|Lost to Follow-up|1|||
23192995|NCT00734929|64449502|FG001|Overall Study|Lost to Follow-up|2|||
23192996|NCT00734929|64449501|FG000|Overall Study|No intervention/ screen fail|5|||
23192997|NCT00734929|64449502|FG001|Overall Study|No intervention/ screen fail|3|||
23192998|NCT01650779|64449508|FG000|Overall Study|Withdrawal by Subject|1|||
23192999|NCT04238663|64449512|FG000|Overall Study|Lost to Follow-up|0|||
23193000|NCT04238663|64449513|FG001|Overall Study|Lost to Follow-up|1|||
23193001|NCT04238663|64449514|FG002|Overall Study|Lost to Follow-up|0|||
23193002|NCT00312377|64449515|FG000|Overall Study|Death|403|||
23193003|NCT00312377|64449516|FG001|Overall Study|Death|418|||
23193004|NCT00312377|64449515|FG000|Overall Study|Withdrawal by Subject|23|||
23193005|NCT00312377|64449516|FG001|Overall Study|Withdrawal by Subject|30|||
23193006|NCT00312377|64449515|FG000|Overall Study|Lost to Follow-up|9|||
23193007|NCT00312377|64449516|FG001|Overall Study|Lost to Follow-up|12|||
23193008|NCT00312377|64449515|FG000|Overall Study|Non-compliance|0|||
23193009|NCT00312377|64449516|FG001|Overall Study|Non-compliance|2|||
23193010|NCT00312377|64449515|FG000|Overall Study|Randomised but never received treatment|6|||
23193011|NCT00312377|64449516|FG001|Overall Study|Randomised but never received treatment|6|||
23193012|NCT00312377|64449515|FG000|Overall Study|Discontinue treatment survival follow up|202|||
23193013|NCT00312377|64449516|FG001|Overall Study|Discontinue treatment survival follow up|200|||
23592373|NCT02810080|65899524|FG001|Overall Study|Death|2|||
23592374|NCT02810080|65899523|FG000|Overall Study|Physician Decision|4|||
23253940|NCT00619619|64670378|FG003|Overall Study|Protocol Violation|1|||
23253941|NCT00619619|64670379|FG004|Overall Study|Protocol Violation|0|||
23253942|NCT00619619|64670380|FG005|Overall Study|Protocol Violation|0|||
23253943|NCT00619619|64670381|FG006|Overall Study|Protocol Violation|1|||
23253944|NCT00619619|64670382|FG007|Overall Study|Protocol Violation|1|||
23253945|NCT00619619|64670375|FG000|Overall Study|Adverse Event|0|||
23253946|NCT00619619|64670376|FG001|Overall Study|Adverse Event|0|||
23253947|NCT00619619|64670377|FG002|Overall Study|Adverse Event|0|||
23253948|NCT00619619|64670378|FG003|Overall Study|Adverse Event|0|||
23253949|NCT00619619|64670379|FG004|Overall Study|Adverse Event|2|||
23253950|NCT00619619|64670380|FG005|Overall Study|Adverse Event|0|||
23253951|NCT00619619|64670381|FG006|Overall Study|Adverse Event|0|||
23253952|NCT00619619|64670382|FG007|Overall Study|Adverse Event|2|||
23253953|NCT00886782|64670383|FG000|Overall Study|Disease progression|3|||
23253954|NCT00886782|64670384|FG001|Overall Study|Disease progression|3|||
23253955|NCT00886782|64670385|FG002|Overall Study|Disease progression|3|||
23253956|NCT00886782|64670383|FG000|Overall Study|Study drug toxicity|0|||
23253957|NCT00886782|64670384|FG001|Overall Study|Study drug toxicity|0|||
23253958|NCT00886782|64670385|FG002|Overall Study|Study drug toxicity|1|||
23360172|NCT04739800|65062846|FG000|Overall Study|Never Treated|2|||
23360173|NCT04739800|65062847|FG001|Overall Study|Never Treated|0|||
23476870|NCT02431260|65491404|FG008|Overall Study|Subject Decision|1|||
23476871|NCT02431260|65491405|FG009|Overall Study|Subject Decision|1|||
23476872|NCT02431260|65491406|FG010|Overall Study|Subject Decision|0|||
23476873|NCT02431260|65491407|FG011|Overall Study|Subject Decision|1|||
23476874|NCT02431260|65491408|FG012|Overall Study|Subject Decision|0|||
23193014|NCT00312377|64449515|FG000|Overall Study|Site ended participation in study|1|||
23193015|NCT00312377|64449516|FG001|Overall Study|Site ended participation in study|0|||
23193016|NCT04530825|64449517|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
23193017|NCT04530825|64449518|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
23193018|NCT04530825|64449519|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
23193019|NCT04530825|64449520|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
23193020|NCT04530825|64449517|FG000|Overall Study|Did not complete follow-up|3|||
23193021|NCT04530825|64449518|FG001|Overall Study|Did not complete follow-up|0|||
23193022|NCT04530825|64449519|FG002|Overall Study|Did not complete follow-up|0|||
23193023|NCT04530825|64449520|FG003|Overall Study|Did not complete follow-up|0|||
23193024|NCT03472534|64449521|FG000|Overall Study|Withdrawal by Subject|9|||
23193025|NCT03472534|64449521|FG000|Overall Study|Adverse Event|2|||
23193026|NCT00719810|64449522|FG000|Overall Study|Adverse Event|0|||
23193027|NCT00719810|64449523|FG001|Overall Study|Adverse Event|2|||
23193028|NCT00719810|64449524|FG002|Overall Study|Adverse Event|3|||
23193029|NCT00719810|64449522|FG000|Overall Study|Lost to Follow-up|2|||
23193030|NCT00719810|64449523|FG001|Overall Study|Lost to Follow-up|0|||
23193031|NCT00719810|64449524|FG002|Overall Study|Lost to Follow-up|3|||
23193032|NCT00719810|64449522|FG000|Overall Study|Physician Decision|0|||
23193033|NCT00719810|64449523|FG001|Overall Study|Physician Decision|1|||
23193034|NCT00719810|64449524|FG002|Overall Study|Physician Decision|0|||
23193035|NCT00719810|64449522|FG000|Overall Study|Withdrawal by Subject|1|||
23193036|NCT00719810|64449523|FG001|Overall Study|Withdrawal by Subject|1|||
23193037|NCT00719810|64449524|FG002|Overall Study|Withdrawal by Subject|2|||
23193038|NCT01853228|64449529|FG000|Phase 1|Lack of Efficacy|8|||
23193039|NCT01853228|64449530|FG001|Phase 1|Lack of Efficacy|0|||
23193040|NCT01853228|64449529|FG000|Phase 1|Other|1|||
23193041|NCT01853228|64449530|FG001|Phase 1|Other|0|||
23193042|NCT01853228|64449529|FG000|Phase 2|Physician Decision|0|||
23193043|NCT01853228|64449530|FG001|Phase 2|Physician Decision|1|||
23193044|NCT01853228|64449529|FG000|Phase 2|Proceed To Transplant|0|||
23193045|NCT01853228|64449530|FG001|Phase 2|Proceed To Transplant|3|||
23193046|NCT01853228|64449529|FG000|Phase 2|Lack of Efficacy|0|||
23193047|NCT01853228|64449530|FG001|Phase 2|Lack of Efficacy|4|||
23253959|NCT00886782|64670383|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
23253960|NCT00886782|64670384|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
23253961|NCT00886782|64670385|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
23253962|NCT02124746|64670386|FG000|Overall Study|Adverse Event|2|||
23193048|NCT00751881|64449531|FG000|Core Treatment Period|Not treated|1|||
23253963|NCT02124746|64670387|FG001|Overall Study|Adverse Event|1|||
23360174|NCT04739800|65062848|FG002|Overall Study|Never Treated|1|||
23253964|NCT02124746|64670388|FG002|Overall Study|Adverse Event|2|||
23253965|NCT02124746|64670386|FG000|Overall Study|Death|2|||
23253966|NCT02124746|64670387|FG001|Overall Study|Death|1|||
23253967|NCT02124746|64670388|FG002|Overall Study|Death|3|||
23253968|NCT02124746|64670386|FG000|Overall Study|Lack of Efficacy|3|||
23253969|NCT02124746|64670387|FG001|Overall Study|Lack of Efficacy|2|||
23253970|NCT02124746|64670388|FG002|Overall Study|Lack of Efficacy|2|||
23253971|NCT02124746|64670386|FG000|Overall Study|Physician Decision|6|||
23253972|NCT02124746|64670387|FG001|Overall Study|Physician Decision|4|||
23253973|NCT02124746|64670388|FG002|Overall Study|Physician Decision|5|||
23253974|NCT02124746|64670386|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23253975|NCT02124746|64670387|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23253976|NCT02124746|64670388|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23253977|NCT02124746|64670386|FG000|Overall Study|Withdrawal by Subject|3|||
23253978|NCT02124746|64670387|FG001|Overall Study|Withdrawal by Subject|3|||
23253979|NCT02124746|64670388|FG002|Overall Study|Withdrawal by Subject|0|||
23253980|NCT02124746|64670386|FG000|Overall Study|Study Terminated by Sponsor|0|||
23253981|NCT02124746|64670387|FG001|Overall Study|Study Terminated by Sponsor|0|||
23253982|NCT02124746|64670388|FG002|Overall Study|Study Terminated by Sponsor|6|||
23193049|NCT00751881|64449532|FG001|Core Treatment Period|Not treated|1|||
23193050|NCT00751881|64449533|FG002|Core Treatment Period|Not treated|2|||
23193051|NCT00751881|64449531|FG000|Core Treatment Period|Adverse Event|26|||
23193052|NCT00751881|64449532|FG001|Core Treatment Period|Adverse Event|54|||
23193053|NCT00751881|64449533|FG002|Core Treatment Period|Adverse Event|58|||
23193054|NCT00751881|64449531|FG000|Core Treatment Period|Lack of Efficacy|37|||
23193055|NCT00751881|64449532|FG001|Core Treatment Period|Lack of Efficacy|30|||
23193056|NCT00751881|64449533|FG002|Core Treatment Period|Lack of Efficacy|20|||
23253983|NCT02124746|64670386|FG000|Overall Study|Disease Progression|3|||
23253984|NCT02124746|64670387|FG001|Overall Study|Disease Progression|6|||
23253985|NCT02124746|64670388|FG002|Overall Study|Disease Progression|4|||
23253986|NCT01946282|64670389|FG000|Year 1|Did not return FIT kit|4186|||
23253987|NCT01946282|64670390|FG001|Year 1|Did not return FIT kit|608|||
23253988|NCT01946282|64670391|FG002|Year 1|Did not return FIT kit|654|||
23253989|NCT01946282|64670389|FG000|Year 2|Did not return FIT kit|803|||
23253990|NCT01946282|64670390|FG001|Year 2|Did not return FIT kit|131|||
23253991|NCT01946282|64670391|FG002|Year 2|Did not return FIT kit|115|||
23253992|NCT01946282|64670389|FG000|Year 3|Did not return FIT kit|288|||
23253993|NCT01946282|64670390|FG001|Year 3|Did not return FIT kit|43|||
23253994|NCT01946282|64670391|FG002|Year 3|Did not return FIT kit|30|||
23253995|NCT03216954|64670392|FG000|Overall Study|Adverse Event|0|||
23253996|NCT03216954|64670393|FG001|Overall Study|Adverse Event|0|||
23253997|NCT03216954|64670394|FG002|Overall Study|Adverse Event|1|||
23253998|NCT03216954|64670395|FG003|Overall Study|Adverse Event|0|||
23253999|NCT03216954|64670396|FG004|Overall Study|Adverse Event|1|||
23476875|NCT02431260|65491409|FG013|Overall Study|Subject Decision|0|||
23476876|NCT02431260|65491396|FG000|Overall Study|Death|4|||
23476877|NCT02431260|65491397|FG001|Overall Study|Death|4|||
23476878|NCT02431260|65491398|FG002|Overall Study|Death|3|||
23476879|NCT02431260|65491399|FG003|Overall Study|Death|4|||
23476880|NCT02431260|65491400|FG004|Overall Study|Death|2|||
23476881|NCT02431260|65491401|FG005|Overall Study|Death|2|||
23476882|NCT02431260|65491402|FG006|Overall Study|Death|3|||
23193057|NCT00751881|64449531|FG000|Core Treatment Period|Poor compliance to protocol|15|||
23193058|NCT00751881|64449532|FG001|Core Treatment Period|Poor compliance to protocol|3|||
23193059|NCT00751881|64449533|FG002|Core Treatment Period|Poor compliance to protocol|4|||
23254000|NCT03216954|64670392|FG000|Overall Study|Withdrawal by Subject|2|||
23476883|NCT02431260|65491403|FG007|Overall Study|Death|1|||
23476884|NCT02431260|65491404|FG008|Overall Study|Death|6|||
23476885|NCT02431260|65491405|FG009|Overall Study|Death|6|||
23476886|NCT02431260|65491406|FG010|Overall Study|Death|3|||
23592375|NCT02810080|65899524|FG001|Overall Study|Physician Decision|0|||
23592376|NCT02810080|65899523|FG000|Overall Study|Withdrawal by Subject|0|||
23592377|NCT02810080|65899524|FG001|Overall Study|Withdrawal by Subject|2|||
23592378|NCT02238483|65899525|FG000|Overall Study|Withdrawal by Subject|2|||
23592379|NCT02238483|65899526|FG001|Overall Study|Withdrawal by Subject|7|||
23592380|NCT02238483|65899525|FG000|Overall Study|Lost to Follow-up|1|||
23193060|NCT00751881|64449531|FG000|Core Treatment Period|Lost to Follow-up|6|||
23254001|NCT03216954|64670393|FG001|Overall Study|Withdrawal by Subject|0|||
23592381|NCT02238483|65899526|FG001|Overall Study|Lost to Follow-up|1|||
23254002|NCT03216954|64670394|FG002|Overall Study|Withdrawal by Subject|0|||
23254003|NCT03216954|64670395|FG003|Overall Study|Withdrawal by Subject|0|||
23254004|NCT03216954|64670396|FG004|Overall Study|Withdrawal by Subject|0|||
23254005|NCT03216954|64670392|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
23476887|NCT02431260|65491407|FG011|Overall Study|Death|2|||
23254006|NCT03216954|64670393|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
23254007|NCT03216954|64670394|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
23476888|NCT02431260|65491408|FG012|Overall Study|Death|5|||
23592382|NCT02238483|65899525|FG000|Overall Study|Protocol Violation|1|||
23592383|NCT02238483|65899526|FG001|Overall Study|Protocol Violation|2|||
23592384|NCT02238483|65899525|FG000|Overall Study|Death|1|||
23592385|NCT02238483|65899526|FG001|Overall Study|Death|0|||
23592386|NCT02238483|65899525|FG000|Overall Study|Adverse Event|7|||
23592387|NCT02238483|65899526|FG001|Overall Study|Adverse Event|3|||
23592388|NCT02238483|65899525|FG000|Overall Study|Withdrawn due to physician decision|1|||
23592389|NCT02238483|65899526|FG001|Overall Study|Withdrawn due to physician decision|0|||
23592390|NCT02238483|65899525|FG000|Overall Study|Completion status not recorded|1|||
23592391|NCT02238483|65899526|FG001|Overall Study|Completion status not recorded|1|||
23592392|NCT02238483|65899525|FG000|Overall Study|Illness in family member|1|||
23592393|NCT02238483|65899526|FG001|Overall Study|Illness in family member|0|||
23592394|NCT00539292|65899535|FG000|Overall Study|Physician Decision|1|||
23592395|NCT00539292|65899536|FG001|Overall Study|Physician Decision|0|||
23592396|NCT00976937|65899538|FG000|Overall Study|Adverse Event|4|||
23592397|NCT00976937|65899539|FG001|Overall Study|Adverse Event|5|||
23592398|NCT00976937|65899538|FG000|Overall Study|Lost to Follow-up|2|||
23592399|NCT00976937|65899539|FG001|Overall Study|Lost to Follow-up|1|||
23592400|NCT00976937|65899538|FG000|Overall Study|Withdrawal by Subject|5|||
23592401|NCT00976937|65899539|FG001|Overall Study|Withdrawal by Subject|3|||
23592402|NCT00976937|65899538|FG000|Overall Study|Poor compliance to protocol|3|||
23592403|NCT00976937|65899539|FG001|Overall Study|Poor compliance to protocol|0|||
23592404|NCT00976937|65899538|FG000|Overall Study|Personal and Familial Reason|2|||
23592405|NCT00976937|65899539|FG001|Overall Study|Personal and Familial Reason|2|||
23592406|NCT02769858|65899544|FG000|Overall Study|Withdrawal by Subject|2|||
23592407|NCT02544152|65899546|FG000|Overall Study|Adverse Event|0|||
23193061|NCT00751881|64449532|FG001|Core Treatment Period|Lost to Follow-up|4|||
23193062|NCT00751881|64449533|FG002|Core Treatment Period|Lost to Follow-up|3|||
23193063|NCT00751881|64449531|FG000|Core Treatment Period|Other: protocol deviation|3|||
23193064|NCT00751881|64449532|FG001|Core Treatment Period|Other: protocol deviation|3|||
23193065|NCT00751881|64449533|FG002|Core Treatment Period|Other: protocol deviation|7|||
23193066|NCT00751881|64449531|FG000|Core Treatment Period|Other: wish to parent|5|||
23193067|NCT00751881|64449532|FG001|Core Treatment Period|Other: wish to parent|7|||
23193068|NCT00751881|64449533|FG002|Core Treatment Period|Other: wish to parent|4|||
23193069|NCT00751881|64449531|FG000|Core Treatment Period|Other: personal/family constraints|6|||
23193070|NCT00751881|64449532|FG001|Core Treatment Period|Other: personal/family constraints|7|||
23193071|NCT00751881|64449533|FG002|Core Treatment Period|Other: personal/family constraints|10|||
23193072|NCT00751881|64449531|FG000|Core Treatment Period|Other: MS treatment change|6|||
23193073|NCT00751881|64449532|FG001|Core Treatment Period|Other: MS treatment change|4|||
23193074|NCT00751881|64449533|FG002|Core Treatment Period|Other: MS treatment change|4|||
23193075|NCT00751881|64449531|FG000|Core Treatment Period|Other: tolerability complaints|2|||
23193076|NCT00751881|64449532|FG001|Core Treatment Period|Other: tolerability complaints|0|||
23193077|NCT00751881|64449533|FG002|Core Treatment Period|Other: tolerability complaints|0|||
23193078|NCT00751881|64449531|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
23193079|NCT00751881|64449532|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
23193080|NCT00751881|64449533|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
23193081|NCT00751881|64449531|FG000|Extension Study Period|Adverse Event|18|||
23193082|NCT00751881|64449532|FG001|Extension Study Period|Adverse Event|20|||
23193083|NCT00751881|64449533|FG002|Extension Study Period|Adverse Event|21|||
23193084|NCT00751881|64449531|FG000|Extension Study Period|Lack of Efficacy|14|||
23193085|NCT00751881|64449532|FG001|Extension Study Period|Lack of Efficacy|10|||
23193086|NCT00751881|64449533|FG002|Extension Study Period|Lack of Efficacy|20|||
23193087|NCT00751881|64449531|FG000|Extension Study Period|Lost to Follow-up|4|||
23193088|NCT00751881|64449532|FG001|Extension Study Period|Lost to Follow-up|9|||
23193089|NCT00751881|64449533|FG002|Extension Study Period|Lost to Follow-up|6|||
23193090|NCT00751881|64449531|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
23193091|NCT00751881|64449532|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
23193092|NCT00751881|64449533|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
23193093|NCT00751881|64449531|FG000|Extension Study Period|Other than specified above|26|||
23193094|NCT00751881|64449532|FG001|Extension Study Period|Other than specified above|30|||
23193095|NCT00751881|64449533|FG002|Extension Study Period|Other than specified above|18|||
23193096|NCT00265941|64449534|FG000|Overall Study|Protocol Violation|22|||
23193097|NCT00265941|64449535|FG001|Overall Study|Protocol Violation|25|||
23193098|NCT00265941|64449534|FG000|Overall Study|Lost to Follow-up|1|||
23193099|NCT00265941|64449535|FG001|Overall Study|Lost to Follow-up|1|||
23193100|NCT05590403|64449541|FG000|Overall Study|Lost to Follow-up|3|||
23476889|NCT02431260|65491409|FG013|Overall Study|Death|1|||
23592408|NCT02544152|65899547|FG001|Overall Study|Adverse Event|4|||
23193101|NCT05590403|64449542|FG001|Overall Study|Lost to Follow-up|0|||
23592409|NCT02544152|65899546|FG000|Overall Study|Withdrawal by Subject|0|||
23592410|NCT02544152|65899547|FG001|Overall Study|Withdrawal by Subject|3|||
23592411|NCT02544152|65899546|FG000|Overall Study|Other|1|||
23193102|NCT05590403|64449543|FG002|Overall Study|Lost to Follow-up|2|||
23193103|NCT05590403|64449544|FG003|Overall Study|Lost to Follow-up|0|||
23592412|NCT02544152|65899547|FG001|Overall Study|Other|0|||
23592413|NCT01239316|65899549|FG000|Overall Study|Progression/Relapse|11|||
23592414|NCT01239316|65899549|FG000|Overall Study|Adverse Event|1|||
23592415|NCT00396084|65899551|FG000|Overall Study|Adverse Event|0|||
23592416|NCT00396084|65899552|FG001|Overall Study|Adverse Event|0|||
23592417|NCT00396084|65899553|FG002|Overall Study|Adverse Event|0|||
23592418|NCT00396084|65899554|FG003|Overall Study|Adverse Event|0|||
23592419|NCT00396084|65899555|FG004|Overall Study|Adverse Event|1|||
23592420|NCT00396084|65899556|FG005|Overall Study|Adverse Event|2|||
23592421|NCT00396084|65899551|FG000|Overall Study|Withdrawal by Subject|0|||
23592422|NCT00396084|65899552|FG001|Overall Study|Withdrawal by Subject|0|||
23592423|NCT00396084|65899553|FG002|Overall Study|Withdrawal by Subject|0|||
23592424|NCT00396084|65899554|FG003|Overall Study|Withdrawal by Subject|1|||
23592425|NCT00396084|65899555|FG004|Overall Study|Withdrawal by Subject|0|||
23592426|NCT00396084|65899556|FG005|Overall Study|Withdrawal by Subject|0|||
23592427|NCT00668863|65899563|FG000|Overall Study|Objective Progression or Relapse|42|||
23592428|NCT00668863|65899563|FG000|Overall Study|Adverse Event|13|||
23592429|NCT00668863|65899563|FG000|Overall Study|Study Terminated by Sponsor|8|||
23193104|NCT05590403|64449545|FG004|Overall Study|Lost to Follow-up|0|||
23193105|NCT05590403|64449541|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
23193106|NCT05590403|64449542|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
23193107|NCT05590403|64449543|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
23193108|NCT05590403|64449544|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
23193109|NCT05590403|64449545|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
23193110|NCT02749370|64449548|FG000|Overall Study|Withdrawal by Subject|11|||
23193111|NCT02749370|64449548|FG000|Overall Study|Lost to Follow-up|3|||
23193112|NCT03242759|64449549|FG000|Overall Study|Adverse Event|5|||
23193113|NCT03242759|64449550|FG001|Overall Study|Adverse Event|1|||
23193114|NCT03242759|64449549|FG000|Overall Study|Withdrawal by Subject|4|||
23193115|NCT03242759|64449550|FG001|Overall Study|Withdrawal by Subject|3|||
23193116|NCT03242759|64449549|FG000|Overall Study|Lost to Follow-up|3|||
23193117|NCT03242759|64449550|FG001|Overall Study|Lost to Follow-up|1|||
23193118|NCT03242759|64449549|FG000|Overall Study|Administrative problems|1|||
23193119|NCT03242759|64449550|FG001|Overall Study|Administrative problems|1|||
23193120|NCT03242759|64449549|FG000|Overall Study|Death|22|||
23193121|NCT03242759|64449550|FG001|Overall Study|Death|0|||
23193122|NCT03242759|64449549|FG000|Overall Study|Change visit schedule|0|||
23193123|NCT03242759|64449550|FG001|Overall Study|Change visit schedule|1|||
23193124|NCT00537745|64449552|FG000|Overall Study|Did not meet eligibility criteria|2|||
23193125|NCT00537745|64449552|FG000|Overall Study|Withdrawal by Subject|2|||
23193126|NCT00537745|64449552|FG000|Overall Study|Subject unable to provide Interlock info|1|||
23193127|NCT03176966|64449553|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
23193128|NCT03176966|64449554|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
23193129|NCT03176966|64449553|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
23193130|NCT03176966|64449554|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
23193131|NCT03176966|64449553|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
23193132|NCT03176966|64449554|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
23193133|NCT03176966|64449553|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
23193134|NCT03176966|64449554|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
23193135|NCT03176966|64449553|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
23193136|NCT03176966|64449554|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
23193137|NCT03176966|64449553|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
23193138|NCT03176966|64449554|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
23193139|NCT03176966|64449553|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
23193140|NCT03176966|64449554|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
23193141|NCT01050062|64449555|FG000|Overall Study|Adverse Event|75|||
23193142|NCT01050062|64449556|FG001|Overall Study|Adverse Event|22|||
23193143|NCT01050062|64449555|FG000|Overall Study|Lost to Follow-up|83|||
23193144|NCT01050062|64449556|FG001|Overall Study|Lost to Follow-up|35|||
23592430|NCT00668863|65899563|FG000|Overall Study|Global Deterioration of Health Status|4|||
23592431|NCT00668863|65899563|FG000|Overall Study|Withdrawal by Subject|1|||
23592432|NCT00668863|65899563|FG000|Overall Study|Surgery|1|||
23193145|NCT01050062|64449555|FG000|Overall Study|Lack of Efficacy|22|||
23193146|NCT01050062|64449556|FG001|Overall Study|Lack of Efficacy|35|||
23193147|NCT01050062|64449555|FG000|Overall Study|Physician Decision|74|||
23592433|NCT00668863|65899563|FG000|Overall Study|Subject's work scheduling problem|1|||
23193148|NCT01050062|64449556|FG001|Overall Study|Physician Decision|9|||
23193149|NCT01050062|64449555|FG000|Overall Study|Others|17|||
23193150|NCT01050062|64449556|FG001|Overall Study|Others|11|||
23193151|NCT01632878|64449559|FG000|Screening|Physician Decision|268|||
23193152|NCT01632878|64449559|FG000|Treatment|Lost to Follow-up|41|||
23193153|NCT01632878|64449559|FG000|Treatment|Withdrawal by Subject|36|||
23193154|NCT01632878|64449559|FG000|Treatment|Physician Decision|34|||
23193155|NCT01632878|64449559|FG000|Treatment|missing information|4|||
23254008|NCT03216954|64670395|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
23254009|NCT03216954|64670396|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
23254010|NCT01128153|64670397|FG000|Overall Study|Adverse Event|1|||
23254011|NCT01128153|64670398|FG001|Overall Study|Adverse Event|3|||
23254012|NCT01128153|64670397|FG000|Overall Study|Condition under investigation worsened|8|||
23254013|NCT01128153|64670398|FG001|Overall Study|Condition under investigation worsened|7|||
23254014|NCT01128153|64670397|FG000|Overall Study|Withdrawal by Subject|2|||
23254015|NCT01128153|64670398|FG001|Overall Study|Withdrawal by Subject|3|||
23254016|NCT01128153|64670397|FG000|Overall Study|Incorrect enrolment to study|2|||
23254017|NCT01128153|64670398|FG001|Overall Study|Incorrect enrolment to study|1|||
23254018|NCT01128153|64670397|FG000|Overall Study|Protocol Violation|2|||
23254019|NCT01128153|64670398|FG001|Overall Study|Protocol Violation|0|||
23254020|NCT01128153|64670397|FG000|Overall Study|Developed discontinuation criteria|1|||
23254021|NCT01128153|64670398|FG001|Overall Study|Developed discontinuation criteria|1|||
23254022|NCT00579254|64670399|FG000|Overall Study|Lost to Follow-up|39|||
23254023|NCT00579254|64670399|FG000|Overall Study|Discontinued when study terminated|73|||
23254024|NCT04060654|64670406|FG000|Overall Study|Withdrawal by Subject|1|||
23254025|NCT04060654|64670406|FG000|Overall Study|Lost to Follow-up|5|||
23254026|NCT01154127|64670407|FG000|Period 1 (21 Days)|Adverse Event|3|||
23254027|NCT01154127|64670408|FG001|Period 1 (21 Days)|Adverse Event|4|||
23254028|NCT01154127|64670407|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
23254029|NCT01154127|64670408|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
23193156|NCT01632878|64449559|FG000|Treatment|no information on study completion|43|||
23193157|NCT02426086|64449560|FG000|Overall Study|Death|33|||
23193158|NCT02426086|64449561|FG001|Overall Study|Death|36|||
23193159|NCT02426086|64449560|FG000|Overall Study|Lost to Follow-up|2|||
23193160|NCT02426086|64449561|FG001|Overall Study|Lost to Follow-up|0|||
23193161|NCT02426086|64449560|FG000|Overall Study|Study Terminated by Sponsor|5|||
23193162|NCT02426086|64449561|FG001|Overall Study|Study Terminated by Sponsor|14|||
23193163|NCT02426086|64449560|FG000|Overall Study|Withdrawal by Subject|8|||
23193164|NCT02426086|64449561|FG001|Overall Study|Withdrawal by Subject|9|||
23193165|NCT01943539|64449566|FG000|Overall Study|Non-compliance with at-home intervention|4|||
23193166|NCT01943539|64449567|FG001|Overall Study|Non-compliance with at-home intervention|0|||
23193167|NCT02760602|64449568|FG000|Overall Study|Withdrawal by Subject|1|||
23193168|NCT02760602|64449569|FG001|Overall Study|Withdrawal by Subject|0|||
23193169|NCT02760602|64449568|FG000|Overall Study|Terminated by sponsor|12|||
23193170|NCT02760602|64449569|FG001|Overall Study|Terminated by sponsor|13|||
23193171|NCT04542291|64449570|FG000|Overall Study|Adverse Event|1|||
23193172|NCT04542291|64449570|FG000|Overall Study|Physician Decision|2|||
23193173|NCT00784784|64449571|FG000|Overall Study|Withdrawal by Subject|2|||
23193174|NCT00784784|64449572|FG001|Overall Study|Withdrawal by Subject|2|||
23193175|NCT00519623|64449573|FG000|Overall Study|Adverse Event|1|||
23193176|NCT01396525|64449579|FG000|Overall Study|Withdrawal by Subject|8|||
23193177|NCT01396525|64449579|FG000|Overall Study|Death|14|||
23193178|NCT01396525|64449579|FG000|Overall Study|Lost to Follow-up|4|||
23193179|NCT01272180|64449580|FG000|Overall Study|Adverse Event|0|||
23193180|NCT01272180|64449581|FG001|Overall Study|Adverse Event|0|||
23193181|NCT01272180|64449582|FG002|Overall Study|Adverse Event|1|||
23193182|NCT01272180|64449583|FG003|Overall Study|Adverse Event|0|||
23193183|NCT01272180|64449580|FG000|Overall Study|Withdrawal by Subject|2|||
23193184|NCT01272180|64449581|FG001|Overall Study|Withdrawal by Subject|6|||
23193185|NCT01272180|64449582|FG002|Overall Study|Withdrawal by Subject|3|||
23193186|NCT01272180|64449583|FG003|Overall Study|Withdrawal by Subject|2|||
23193187|NCT01272180|64449580|FG000|Overall Study|Lost to Follow-up|15|||
23193188|NCT01272180|64449581|FG001|Overall Study|Lost to Follow-up|14|||
23193189|NCT01272180|64449582|FG002|Overall Study|Lost to Follow-up|8|||
23193190|NCT01272180|64449583|FG003|Overall Study|Lost to Follow-up|10|||
23193191|NCT01272180|64449580|FG000|Overall Study|Inappropriate enrollment|0|||
23193192|NCT01272180|64449581|FG001|Overall Study|Inappropriate enrollment|0|||
23193193|NCT01272180|64449582|FG002|Overall Study|Inappropriate enrollment|1|||
23193194|NCT01272180|64449583|FG003|Overall Study|Inappropriate enrollment|1|||
23193195|NCT01272180|64449580|FG000|Overall Study|Protocol Violation|0|||
23193196|NCT01272180|64449581|FG001|Overall Study|Protocol Violation|1|||
23193197|NCT01272180|64449582|FG002|Overall Study|Protocol Violation|0|||
23193198|NCT01272180|64449583|FG003|Overall Study|Protocol Violation|1|||
23193199|NCT00916721|64449584|FG000|Overall Study|Lost to Follow-up|0|||
23254030|NCT01154127|64670407|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
23592434|NCT00668863|65899563|FG000|Overall Study|Physician Decision|1|||
23592435|NCT00373529|65899564|FG000|Overall Study|Physician Decision|19|||
23193200|NCT00916721|64449585|FG001|Overall Study|Lost to Follow-up|1|||
23193201|NCT00916721|64449584|FG000|Overall Study|Adverse Event|6|||
23193202|NCT00916721|64449585|FG001|Overall Study|Adverse Event|3|||
23193203|NCT00916721|64449584|FG000|Overall Study|Withdrawal by Subject|2|||
23193204|NCT00916721|64449585|FG001|Overall Study|Withdrawal by Subject|2|||
23193205|NCT00916721|64449584|FG000|Overall Study|Protocol Violation|2|||
23193206|NCT00916721|64449585|FG001|Overall Study|Protocol Violation|4|||
23193207|NCT02203838|64449586|FG000|Overall Study|Lack of Efficacy|7|||
23193208|NCT02203838|64449587|FG001|Overall Study|Lack of Efficacy|0|||
23193209|NCT02203838|64449588|FG002|Overall Study|Lack of Efficacy|1|||
23193210|NCT02203838|64449589|FG003|Overall Study|Lack of Efficacy|1|||
23592436|NCT00373529|65899564|FG000|Overall Study|Withdrawal by Subject|7|||
23592437|NCT00373529|65899564|FG000|Overall Study|Adverse Event|7|||
23592438|NCT00373529|65899564|FG000|Overall Study|Treatment failure|36|||
23592439|NCT00373529|65899564|FG000|Overall Study|Disease recurrence|10|||
23592440|NCT00373529|65899564|FG000|Overall Study|Death|16|||
23592441|NCT00373529|65899564|FG000|Overall Study|Need for treatment prohibited by study|1|||
23592442|NCT00373529|65899564|FG000|Overall Study|Other|8|||
23592443|NCT00373529|65899564|FG000|Overall Study|Failed independent confirmation of AML|3|||
23592444|NCT00373529|65899564|FG000|Overall Study|Consent violation|1|||
23592445|NCT04057196|65899565|FG000|Overall Study|Withdrawal by Subject|3|||
23592446|NCT04057196|65899565|FG000|Overall Study|Death|3|||
23592447|NCT00206375|65899566|FG000|Overall Study|Lost to Follow-up|1|||
23592448|NCT00206375|65899567|FG001|Overall Study|Lost to Follow-up|0|||
23592449|NCT00206375|65899568|FG002|Overall Study|Lost to Follow-up|0|||
23592450|NCT00206375|65899566|FG000|Overall Study|Withdrawal by Subject|2|||
23592451|NCT00206375|65899567|FG001|Overall Study|Withdrawal by Subject|1|||
23193211|NCT02203838|64449586|FG000|Overall Study|Adverse Event|46|||
23193212|NCT02203838|64449587|FG001|Overall Study|Adverse Event|6|||
23193213|NCT02203838|64449588|FG002|Overall Study|Adverse Event|3|||
23193214|NCT02203838|64449589|FG003|Overall Study|Adverse Event|2|||
23193215|NCT02203838|64449586|FG000|Overall Study|Lost to Follow-up|39|||
23193216|NCT02203838|64449587|FG001|Overall Study|Lost to Follow-up|3|||
23193217|NCT02203838|64449588|FG002|Overall Study|Lost to Follow-up|2|||
23193218|NCT02203838|64449589|FG003|Overall Study|Lost to Follow-up|1|||
23193219|NCT02203838|64449586|FG000|Overall Study|Protocol Violation|7|||
23193220|NCT02203838|64449587|FG001|Overall Study|Protocol Violation|3|||
23193221|NCT02203838|64449588|FG002|Overall Study|Protocol Violation|0|||
23193222|NCT02203838|64449589|FG003|Overall Study|Protocol Violation|0|||
23193223|NCT02203838|64449586|FG000|Overall Study|Withdrawal by Subject|83|||
23193224|NCT02203838|64449587|FG001|Overall Study|Withdrawal by Subject|10|||
23193225|NCT02203838|64449588|FG002|Overall Study|Withdrawal by Subject|8|||
23193226|NCT02203838|64449589|FG003|Overall Study|Withdrawal by Subject|11|||
23193227|NCT02203838|64449586|FG000|Overall Study|Physician Decision|27|||
23254031|NCT01154127|64670408|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
23254032|NCT01154127|64670407|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
23254033|NCT01154127|64670408|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
23254034|NCT01154127|64670407|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
23254035|NCT01154127|64670408|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
23254036|NCT00895583|64670412|FG000|Overall Study|Adverse Event|28|||
23254037|NCT00895583|64670413|FG001|Overall Study|Adverse Event|4|||
23254038|NCT00895583|64670412|FG000|Overall Study|Death|2|||
23254039|NCT00895583|64670413|FG001|Overall Study|Death|1|||
23193228|NCT02203838|64449587|FG001|Overall Study|Physician Decision|0|||
23193229|NCT02203838|64449588|FG002|Overall Study|Physician Decision|2|||
23193230|NCT02203838|64449589|FG003|Overall Study|Physician Decision|3|||
23193231|NCT02203838|64449586|FG000|Overall Study|Other|1|||
23193232|NCT02203838|64449587|FG001|Overall Study|Other|0|||
23193233|NCT02203838|64449588|FG002|Overall Study|Other|0|||
23476890|NCT02431260|65491396|FG000|Overall Study|Lost to Follow-up|0|||
23592452|NCT00206375|65899568|FG002|Overall Study|Withdrawal by Subject|3|||
23193234|NCT02203838|64449589|FG003|Overall Study|Other|0|||
23193235|NCT01933672|64449590|FG000|Metformin Run-in Period|Adverse Event|1|||
23193236|NCT01933672|64449591|FG001|Metformin Run-in Period|Adverse Event|0|||
23193237|NCT01933672|64449592|FG002|Metformin Run-in Period|Adverse Event|0|||
23193238|NCT01933672|64449593|FG003|Metformin Run-in Period|Adverse Event|0|||
23193239|NCT01933672|64449594|FG004|Metformin Run-in Period|Adverse Event|0|||
23193240|NCT01933672|64449595|FG005|Metformin Run-in Period|Adverse Event|0|||
23193241|NCT01933672|64449596|FG006|Metformin Run-in Period|Adverse Event|0|||
23193242|NCT01933672|64449590|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
23193243|NCT01933672|64449591|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23254040|NCT00895583|64670412|FG000|Overall Study|Physician Decision|3|||
23476891|NCT02431260|65491397|FG001|Overall Study|Lost to Follow-up|0|||
23592453|NCT00206375|65899566|FG000|Overall Study|Study terminated due to lack of funds|0|||
23592454|NCT00206375|65899567|FG001|Overall Study|Study terminated due to lack of funds|1|||
23193244|NCT01933672|64449592|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23193245|NCT01933672|64449593|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23476892|NCT02431260|65491398|FG002|Overall Study|Lost to Follow-up|0|||
23254041|NCT00895583|64670413|FG001|Overall Study|Physician Decision|1|||
23254042|NCT00895583|64670412|FG000|Overall Study|Lost to Follow-up|1|||
23254043|NCT00895583|64670413|FG001|Overall Study|Lost to Follow-up|3|||
23254044|NCT00895583|64670412|FG000|Overall Study|Protocol Violation|1|||
23254045|NCT00895583|64670413|FG001|Overall Study|Protocol Violation|0|||
23254046|NCT00895583|64670412|FG000|Overall Study|Withdrawal by Subject|4|||
23254047|NCT00895583|64670413|FG001|Overall Study|Withdrawal by Subject|2|||
23254048|NCT00895583|64670412|FG000|Overall Study|Lack of Efficacy|5|||
23254049|NCT00895583|64670413|FG001|Overall Study|Lack of Efficacy|0|||
23254050|NCT00895583|64670412|FG000|Overall Study|Other|0|||
23254051|NCT00895583|64670413|FG001|Overall Study|Other|1|||
23254052|NCT02018042|64670414|FG000|Overall Study|Withdrawal by Subject|1|||
23254053|NCT01160198|64670415|FG000|Overall Study|Withdrawal by Subject|2|||
23254054|NCT01160198|64670416|FG001|Overall Study|Withdrawal by Subject|1|||
23592455|NCT00206375|65899568|FG002|Overall Study|Study terminated due to lack of funds|1|||
23592456|NCT00494780|65899569|FG000|Overall Study|Adverse Event|1|||
23592457|NCT00494780|65899570|FG001|Overall Study|Adverse Event|0|||
23592458|NCT00494780|65899569|FG000|Overall Study|Withdrew before Dosed|0|||
23592459|NCT00494780|65899570|FG001|Overall Study|Withdrew before Dosed|1|||
23592460|NCT00494780|65899569|FG000|Overall Study|Progression of Study Disease|7|||
23592461|NCT00494780|65899570|FG001|Overall Study|Progression of Study Disease|8|||
23592462|NCT00494780|65899569|FG000|Overall Study|New Treatment|2|||
23592463|NCT00494780|65899570|FG001|Overall Study|New Treatment|2|||
23592464|NCT00494780|65899569|FG000|Overall Study|Non-compliance|1|||
23592465|NCT00494780|65899570|FG001|Overall Study|Non-compliance|0|||
23592466|NCT00494780|65899569|FG000|Overall Study|Residual Tumour Mass|0|||
23592467|NCT00494780|65899570|FG001|Overall Study|Residual Tumour Mass|1|||
23592468|NCT00494780|65899569|FG000|Overall Study|Insurance Issues|0|||
23592469|NCT00494780|65899570|FG001|Overall Study|Insurance Issues|1|||
23592470|NCT00869323|65899573|FG000|Maintenance Therapy|concurrent illness|1|||
23592471|NCT01580293|65899575|FG000|Part A_Main Trial|Adverse Event|0|||
23592472|NCT01580293|65899576|FG001|Part A_Main Trial|Adverse Event|2|||
23592473|NCT01580293|65899577|FG002|Part A_Main Trial|Adverse Event|0|||
23592474|NCT01580293|65899575|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
23592475|NCT01580293|65899576|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
23592476|NCT01580293|65899577|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
23592477|NCT01580293|65899575|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
23592478|NCT01580293|65899576|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
23592479|NCT01580293|65899577|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
23592480|NCT01580293|65899575|FG000|Part A_Extension|Adverse Event|0|||
23592481|NCT01580293|65899576|FG001|Part A_Extension|Adverse Event|2|||
23592482|NCT01580293|65899577|FG002|Part A_Extension|Adverse Event|0|||
23592483|NCT01580293|65899575|FG000|Part A_Extension|Withdrawal by Subject|0|||
23592484|NCT01580293|65899576|FG001|Part A_Extension|Withdrawal by Subject|3|||
23592485|NCT01580293|65899577|FG002|Part A_Extension|Withdrawal by Subject|0|||
23592486|NCT01580293|65899575|FG000|Part A_Extension|Lost to Follow-up|0|||
23592487|NCT01580293|65899576|FG001|Part A_Extension|Lost to Follow-up|1|||
23592488|NCT01580293|65899577|FG002|Part A_Extension|Lost to Follow-up|0|||
23592489|NCT01580293|65899575|FG000|Part A_Extension|Other Reason|0|||
23592490|NCT01580293|65899576|FG001|Part A_Extension|Other Reason|1|||
23592491|NCT01580293|65899577|FG002|Part A_Extension|Other Reason|0|||
23592492|NCT01580293|65899575|FG000|Part A_Extension|Completed Japan only|0|||
23592493|NCT01580293|65899576|FG001|Part A_Extension|Completed Japan only|5|||
23592494|NCT01580293|65899577|FG002|Part A_Extension|Completed Japan only|0|||
23592495|NCT01580293|65899575|FG000|Part B|Withdrawal by Subject|0|||
23592496|NCT01580293|65899576|FG001|Part B|Withdrawal by Subject|0|||
23592497|NCT01580293|65899577|FG002|Part B|Withdrawal by Subject|1|||
23592498|NCT01580293|65899575|FG000|Part B|Other reason|0|||
23592499|NCT01580293|65899576|FG001|Part B|Other reason|0|||
23592500|NCT01580293|65899577|FG002|Part B|Other reason|1|||
23592501|NCT02731755|65899578|FG000|First Intervention|Withdrawal by Subject|0|||
23193246|NCT01933672|64449594|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23592502|NCT02731755|65899579|FG001|First Intervention|Withdrawal by Subject|2|||
23592503|NCT04009577|65899580|FG000|Core Study|Adverse Event|1|||
23592504|NCT04009577|65899581|FG001|Core Study|Adverse Event|0|||
23592505|NCT04009577|65899582|FG002|Core Study|Adverse Event|2|||
23592506|NCT04009577|65899583|FG003|Core Study|Adverse Event|4|||
23592507|NCT04009577|65899580|FG000|Core Study|Withdrawal by Subject|0|||
23193247|NCT01933672|64449595|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23193248|NCT01933672|64449596|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
23193249|NCT01933672|64449590|FG000|Metformin Run-in Period|Other|5|||
23193250|NCT01933672|64449591|FG001|Metformin Run-in Period|Other|0|||
23254055|NCT01160198|64670417|FG002|Overall Study|Withdrawal by Subject|0|||
23592508|NCT04009577|65899581|FG001|Core Study|Withdrawal by Subject|0|||
23592509|NCT04009577|65899582|FG002|Core Study|Withdrawal by Subject|2|||
23592510|NCT04009577|65899583|FG003|Core Study|Withdrawal by Subject|0|||
23592511|NCT04009577|65899580|FG000|Core Study|Other|0|||
23592512|NCT04009577|65899581|FG001|Core Study|Other|0|||
23592513|NCT04009577|65899582|FG002|Core Study|Other|0|||
23592514|NCT04009577|65899583|FG003|Core Study|Other|1|||
23592515|NCT04009577|65899580|FG000|Extension Phase|Adverse Event|0|||
23592516|NCT04009577|65899581|FG001|Extension Phase|Adverse Event|0|||
23592517|NCT04009577|65899582|FG002|Extension Phase|Adverse Event|0|||
23592518|NCT04009577|65899583|FG003|Extension Phase|Adverse Event|1|||
23592519|NCT04009577|65899580|FG000|Extension Phase|Inadequate therapeutic effect|0|||
23592520|NCT04009577|65899581|FG001|Extension Phase|Inadequate therapeutic effect|0|||
23193251|NCT01933672|64449592|FG002|Metformin Run-in Period|Other|0|||
23193252|NCT01933672|64449593|FG003|Metformin Run-in Period|Other|0|||
23193253|NCT01933672|64449594|FG004|Metformin Run-in Period|Other|0|||
23193254|NCT01933672|64449595|FG005|Metformin Run-in Period|Other|0|||
23193255|NCT01933672|64449596|FG006|Metformin Run-in Period|Other|0|||
23193256|NCT01933672|64449590|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193257|NCT01933672|64449591|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23254056|NCT01160198|64670415|FG000|Overall Study|Adverse Event|0|||
23254057|NCT01160198|64670416|FG001|Overall Study|Adverse Event|1|||
23254058|NCT01160198|64670417|FG002|Overall Study|Adverse Event|0|||
23254059|NCT01160198|64670415|FG000|Overall Study|Lost to Follow-up|0|||
23254060|NCT01160198|64670416|FG001|Overall Study|Lost to Follow-up|1|||
23254061|NCT01160198|64670417|FG002|Overall Study|Lost to Follow-up|0|||
23592521|NCT04009577|65899582|FG002|Extension Phase|Inadequate therapeutic effect|1|||
23592522|NCT04009577|65899583|FG003|Extension Phase|Inadequate therapeutic effect|0|||
23592523|NCT04009577|65899580|FG000|Extension Phase|Withdrawal by Subject|0|||
23592524|NCT04009577|65899581|FG001|Extension Phase|Withdrawal by Subject|0|||
23592525|NCT04009577|65899582|FG002|Extension Phase|Withdrawal by Subject|1|||
23592526|NCT04009577|65899583|FG003|Extension Phase|Withdrawal by Subject|0|||
23592527|NCT04009577|65899580|FG000|Extension Phase|Not Treated|0|||
23592528|NCT04009577|65899581|FG001|Extension Phase|Not Treated|0|||
23592529|NCT04009577|65899582|FG002|Extension Phase|Not Treated|2|||
23592530|NCT04009577|65899583|FG003|Extension Phase|Not Treated|0|||
23592531|NCT03863834|65899584|FG000|Overall Study|Lost to Follow-up|3|||
23592532|NCT03712930|65899591|FG000|Overall Study|Death|7|||
23592533|NCT03712930|65899591|FG000|Overall Study|Physician Decision|1|||
23592534|NCT03712930|65899591|FG000|Overall Study|Study Terminated by Sponsor|3|||
23592535|NCT03712930|65899591|FG000|Overall Study|Progressive Disease|2|||
23592536|NCT00356265|65899594|FG000|Overall Study|Withdrawal by Subject|0|||
23592537|NCT00356265|65899595|FG001|Overall Study|Withdrawal by Subject|0|||
23592538|NCT00356265|65899596|FG002|Overall Study|Withdrawal by Subject|1|||
23592539|NCT01199575|65899597|FG000|Overall Study|Withdrawal by Subject|5|||
23592540|NCT01185782|65899601|FG000|Overall Study|Adverse Event|0|||
23592541|NCT01185782|65899602|FG001|Overall Study|Adverse Event|1|||
23592542|NCT01185782|65899601|FG000|Overall Study|Protocol Violation|1|||
23592543|NCT01185782|65899602|FG001|Overall Study|Protocol Violation|0|||
23592544|NCT01185782|65899601|FG000|Overall Study|Poor Response to Treatment|3|||
23193258|NCT01933672|64449592|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193259|NCT01933672|64449593|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193260|NCT01933672|64449594|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
23193261|NCT01933672|64449595|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193262|NCT01933672|64449596|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193263|NCT01933672|64449590|FG000|First Intervention Period (12-16 Days)|Other|0|||
23193264|NCT01933672|64449591|FG001|First Intervention Period (12-16 Days)|Other|0|||
23193265|NCT01933672|64449592|FG002|First Intervention Period (12-16 Days)|Other|1|||
23592545|NCT01185782|65899602|FG001|Overall Study|Poor Response to Treatment|1|||
23592546|NCT01185782|65899601|FG000|Overall Study|Other|2|||
23592547|NCT01185782|65899602|FG001|Overall Study|Other|5|||
23193266|NCT01933672|64449593|FG003|First Intervention Period (12-16 Days)|Other|0|||
23193267|NCT01933672|64449594|FG004|First Intervention Period (12-16 Days)|Other|0|||
23193268|NCT01933672|64449595|FG005|First Intervention Period (12-16 Days)|Other|1|||
23193269|NCT01933672|64449596|FG006|First Intervention Period (12-16 Days)|Other|0|||
23193270|NCT01933672|64449590|FG000|Second Intervention Period (12-16 Days)|Other|0|||
23193271|NCT01933672|64449591|FG001|Second Intervention Period (12-16 Days)|Other|1|||
23193272|NCT01933672|64449592|FG002|Second Intervention Period (12-16 Days)|Other|1|||
23193273|NCT01933672|64449593|FG003|Second Intervention Period (12-16 Days)|Other|0|||
23193274|NCT01933672|64449594|FG004|Second Intervention Period (12-16 Days)|Other|0|||
23592548|NCT01185782|65899601|FG000|Overall Study|Randomized but not treated|0|||
23592549|NCT01185782|65899602|FG001|Overall Study|Randomized but not treated|4|||
23592550|NCT01068743|65899603|FG000|Period 3|Adverse Event|0|||
23592551|NCT01068743|65899604|FG001|Period 3|Adverse Event|1|||
23592552|NCT01068743|65899605|FG002|Period 3|Adverse Event|0|||
23193275|NCT01933672|64449595|FG005|Second Intervention Period (12-16 Days)|Other|0|||
23193276|NCT01933672|64449596|FG006|Second Intervention Period (12-16 Days)|Other|0|||
23193277|NCT01933672|64449590|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23254062|NCT01160198|64670415|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
23360175|NCT04739800|65062849|FG003|Overall Study|Never Treated|1|||
23592553|NCT01068743|65899606|FG003|Period 3|Adverse Event|0|||
23592554|NCT00703911|65899609|FG000|Overall Study|Death|1|||
23592555|NCT00703911|65899609|FG000|Overall Study|Physician Decision|6|||
23592556|NCT00703911|65899609|FG000|Overall Study|Lost to Follow-up|1|||
23592557|NCT00703911|65899609|FG000|Overall Study|Withdrawal by Subject|2|||
23592558|NCT03020745|65899610|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592559|NCT03020745|65899611|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592560|NCT03020745|65899612|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592561|NCT03020745|65899613|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592562|NCT03020745|65899614|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592563|NCT03020745|65899615|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592564|NCT03020745|65899616|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592565|NCT03020745|65899617|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592566|NCT03020745|65899618|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
23592567|NCT03020745|65899619|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
23592568|NCT03020745|65899610|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592569|NCT03020745|65899611|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592570|NCT03020745|65899612|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592571|NCT03020745|65899613|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592572|NCT03020745|65899614|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592573|NCT03020745|65899615|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592574|NCT03020745|65899616|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592575|NCT03020745|65899617|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
23193278|NCT01933672|64449591|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193279|NCT01933672|64449592|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193280|NCT01933672|64449593|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
23193281|NCT01933672|64449594|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193282|NCT01933672|64449595|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193283|NCT01933672|64449596|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
23193284|NCT01933672|64449590|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23193285|NCT01933672|64449591|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
23193286|NCT01933672|64449592|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23193287|NCT01933672|64449593|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23193288|NCT01933672|64449594|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23193289|NCT01933672|64449595|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23193290|NCT01933672|64449596|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
23193291|NCT02399475|64449597|FG000|Overall Study|Physician Decision|1|||
23193292|NCT02399475|64449598|FG001|Overall Study|Physician Decision|0|||
23193293|NCT02332915|64449599|FG000|Overall Study|Moved out of region|3|||
23193294|NCT02332915|64449600|FG001|Overall Study|Moved out of region|0|||
23193295|NCT02332915|64449599|FG000|Overall Study|Unrelated illness|1|||
23193296|NCT02332915|64449600|FG001|Overall Study|Unrelated illness|1|||
23193297|NCT02332915|64449599|FG000|Overall Study|Travel distance prohibitive|0|||
23193298|NCT02332915|64449600|FG001|Overall Study|Travel distance prohibitive|1|||
23193299|NCT02332915|64449599|FG000|Overall Study|did not meet inclusion criteria|2|||
23193300|NCT02332915|64449600|FG001|Overall Study|did not meet inclusion criteria|4|||
23193301|NCT00196937|64449605|FG000|Overall Study|Serious Adverse Event|1|||
23193302|NCT00196937|64449606|FG001|Overall Study|Serious Adverse Event|0|||
23193303|NCT00196937|64449607|FG002|Overall Study|Serious Adverse Event|0|||
23193304|NCT00196937|64449605|FG000|Overall Study|Non-serious adverse event|1|||
23193305|NCT00196937|64449606|FG001|Overall Study|Non-serious adverse event|1|||
23193306|NCT00196937|64449607|FG002|Overall Study|Non-serious adverse event|1|||
23193307|NCT00196937|64449605|FG000|Overall Study|Withdrawal by Subject|0|||
23193308|NCT00196937|64449606|FG001|Overall Study|Withdrawal by Subject|0|||
23193309|NCT00196937|64449607|FG002|Overall Study|Withdrawal by Subject|2|||
23193310|NCT00196937|64449605|FG000|Overall Study|Lost to Follow-up|4|||
23193311|NCT00196937|64449606|FG001|Overall Study|Lost to Follow-up|3|||
23193312|NCT00196937|64449607|FG002|Overall Study|Lost to Follow-up|3|||
23193313|NCT00196937|64449605|FG000|Overall Study|Other|3|||
23193314|NCT00196937|64449606|FG001|Overall Study|Other|1|||
23193315|NCT00196937|64449607|FG002|Overall Study|Other|1|||
23193316|NCT01952015|64449608|FG000|Induction|Protocol Violation|1|||
23193317|NCT01952015|64449608|FG000|Maintenance|Adverse Event|2|||
23193318|NCT01952015|64449608|FG000|Treatment Period 3|Physician Decision|9|||
23193319|NCT01260181|64449609|FG000|Overall Study|Decision of Investigator|1|||
23193320|NCT01070303|64449610|FG000|Overall Study|Adverse Event|39|||
23193321|NCT01070303|64449610|FG000|Overall Study|Withdrawal by Subject|20|||
23193322|NCT01070303|64449610|FG000|Overall Study|Lost to Follow-up|9|||
23193323|NCT01070303|64449610|FG000|Overall Study|Protocol Violation|0|||
23193324|NCT01070303|64449610|FG000|Overall Study|Lack of Efficacy|2|||
23193325|NCT01070303|64449610|FG000|Overall Study|Administrative Reason|1|||
23193326|NCT01070303|64449610|FG000|Overall Study|Other|18|||
23193327|NCT05165394|64449611|FG000|Overall Study|Withdrawal by Subject|5|||
23592576|NCT03020745|65899618|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23592577|NCT03020745|65899619|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
23193328|NCT05165394|64449612|FG001|Overall Study|Withdrawal by Subject|1|||
23193329|NCT05165394|64449611|FG000|Overall Study|Lost to Follow-up|1|||
23193330|NCT05165394|64449612|FG001|Overall Study|Lost to Follow-up|2|||
23193331|NCT05165394|64449611|FG000|Overall Study|Other Than Specified|0|||
23193332|NCT05165394|64449612|FG001|Overall Study|Other Than Specified|1|||
23193333|NCT03964415|64449614|FG000|Overall Study|Sponsor's decision|1563|||
23193334|NCT03964415|64449615|FG001|Overall Study|Sponsor's decision|1528|||
23193335|NCT03964415|64449614|FG000|Overall Study|Lost to Follow-up|139|||
23193336|NCT03964415|64449615|FG001|Overall Study|Lost to Follow-up|146|||
23193337|NCT03964415|64449614|FG000|Overall Study|Withdrawal by Subject|68|||
23193338|NCT03964415|64449615|FG001|Overall Study|Withdrawal by Subject|72|||
23193339|NCT03964415|64449614|FG000|Overall Study|Physician Decision|34|||
23193340|NCT03964415|64449615|FG001|Overall Study|Physician Decision|48|||
23193341|NCT03964415|64449614|FG000|Overall Study|Adverse Event|3|||
23193342|NCT03964415|64449615|FG001|Overall Study|Adverse Event|0|||
23193343|NCT03964415|64449614|FG000|Overall Study|Death|4|||
23193344|NCT03964415|64449615|FG001|Overall Study|Death|6|||
23193345|NCT03964415|64449614|FG000|Overall Study|Protocol Violation|1|||
23193346|NCT03964415|64449615|FG001|Overall Study|Protocol Violation|4|||
23193347|NCT03964415|64449614|FG000|Overall Study|Other|35|||
23193348|NCT03964415|64449615|FG001|Overall Study|Other|38|||
23193349|NCT03964415|64449614|FG000|Overall Study|Randomized but not treated|6|||
23193350|NCT03964415|64449615|FG001|Overall Study|Randomized but not treated|7|||
23193351|NCT00227877|64449616|FG000|Pre-visit Assessment|Technical difficulties|7|||
23193352|NCT00227877|64449617|FG001|Pre-visit Assessment|Technical difficulties|3|||
23193353|NCT00227877|64449618|FG002|Pre-visit Assessment|Technical difficulties|0|||
23193354|NCT00227877|64449619|FG003|Pre-visit Assessment|Technical difficulties|0|||
23193355|NCT00227877|64449616|FG000|Post-visit Checklist|Lost to Follow-up|24|||
23193356|NCT00227877|64449617|FG001|Post-visit Checklist|Lost to Follow-up|13|||
23193357|NCT00227877|64449618|FG002|Post-visit Checklist|Lost to Follow-up|1|||
23193358|NCT00227877|64449619|FG003|Post-visit Checklist|Lost to Follow-up|0|||
23193359|NCT00227877|64449616|FG000|3-months Follow-up|Completed late|135|||
23254063|NCT01160198|64670416|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
23254064|NCT01160198|64670417|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
23476893|NCT02431260|65491399|FG003|Overall Study|Lost to Follow-up|0|||
23476894|NCT02431260|65491400|FG004|Overall Study|Lost to Follow-up|0|||
23193360|NCT00227877|64449617|FG001|3-months Follow-up|Completed late|128|||
23193361|NCT00227877|64449618|FG002|3-months Follow-up|Completed late|34|||
23476895|NCT02431260|65491401|FG005|Overall Study|Lost to Follow-up|1|||
23476896|NCT02431260|65491402|FG006|Overall Study|Lost to Follow-up|0|||
23476897|NCT02431260|65491403|FG007|Overall Study|Lost to Follow-up|0|||
23476898|NCT02431260|65491404|FG008|Overall Study|Lost to Follow-up|0|||
23476899|NCT02431260|65491405|FG009|Overall Study|Lost to Follow-up|0|||
23476900|NCT02431260|65491406|FG010|Overall Study|Lost to Follow-up|0|||
23476901|NCT02431260|65491407|FG011|Overall Study|Lost to Follow-up|0|||
23476902|NCT02431260|65491408|FG012|Overall Study|Lost to Follow-up|0|||
23476903|NCT02431260|65491409|FG013|Overall Study|Lost to Follow-up|0|||
23476904|NCT02431260|65491396|FG000|Overall Study|Study Terminated by the Sponsor|0|||
23476905|NCT02431260|65491397|FG001|Overall Study|Study Terminated by the Sponsor|0|||
23476906|NCT02431260|65491398|FG002|Overall Study|Study Terminated by the Sponsor|2|||
23476907|NCT02431260|65491399|FG003|Overall Study|Study Terminated by the Sponsor|1|||
23476908|NCT02431260|65491400|FG004|Overall Study|Study Terminated by the Sponsor|1|||
23476909|NCT02431260|65491401|FG005|Overall Study|Study Terminated by the Sponsor|0|||
23476910|NCT02431260|65491402|FG006|Overall Study|Study Terminated by the Sponsor|1|||
23476911|NCT02431260|65491403|FG007|Overall Study|Study Terminated by the Sponsor|2|||
23476912|NCT02431260|65491404|FG008|Overall Study|Study Terminated by the Sponsor|1|||
23476913|NCT02431260|65491405|FG009|Overall Study|Study Terminated by the Sponsor|1|||
23476914|NCT02431260|65491406|FG010|Overall Study|Study Terminated by the Sponsor|1|||
23476915|NCT02431260|65491407|FG011|Overall Study|Study Terminated by the Sponsor|0|||
23476916|NCT02431260|65491408|FG012|Overall Study|Study Terminated by the Sponsor|4|||
23476917|NCT02431260|65491409|FG013|Overall Study|Study Terminated by the Sponsor|0|||
23476918|NCT02431260|65491396|FG000|Overall Study|Physician Decision|0|||
23476919|NCT02431260|65491397|FG001|Overall Study|Physician Decision|0|||
23193362|NCT00227877|64449619|FG003|3-months Follow-up|Completed late|8|||
23193363|NCT00227877|64449616|FG000|3-months Follow-up|Lost to Follow-up|178|||
23193364|NCT00227877|64449617|FG001|3-months Follow-up|Lost to Follow-up|139|||
23193365|NCT00227877|64449618|FG002|3-months Follow-up|Lost to Follow-up|18|||
23193366|NCT00227877|64449619|FG003|3-months Follow-up|Lost to Follow-up|13|||
23193367|NCT00227877|64449616|FG000|12-months Follow-up|Completed late|78|||
23476920|NCT02431260|65491398|FG002|Overall Study|Physician Decision|0|||
23476921|NCT02431260|65491399|FG003|Overall Study|Physician Decision|0|||
23476922|NCT02431260|65491400|FG004|Overall Study|Physician Decision|0|||
23193368|NCT00227877|64449617|FG001|12-months Follow-up|Completed late|74|||
23193369|NCT00227877|64449618|FG002|12-months Follow-up|Completed late|1|||
23476923|NCT02431260|65491401|FG005|Overall Study|Physician Decision|1|||
23476924|NCT02431260|65491402|FG006|Overall Study|Physician Decision|0|||
23592578|NCT03020745|65899610|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592579|NCT03020745|65899611|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592580|NCT03020745|65899612|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592581|NCT03020745|65899613|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592582|NCT03020745|65899614|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592583|NCT03020745|65899615|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
23592584|NCT03020745|65899616|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592585|NCT03020745|65899617|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592586|NCT03020745|65899618|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
23592587|NCT03020745|65899619|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
23592588|NCT03020745|65899610|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592589|NCT03020745|65899611|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592590|NCT03020745|65899612|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592591|NCT03020745|65899613|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592592|NCT03020745|65899614|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592593|NCT03020745|65899615|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592594|NCT03020745|65899616|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592595|NCT03020745|65899617|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592596|NCT03020745|65899618|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
23592597|NCT03020745|65899619|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
23592598|NCT02798835|65899627|FG000|Overall Study|Protocol Violation|0|||
23592599|NCT02798835|65899628|FG001|Overall Study|Protocol Violation|0|||
23592600|NCT02798835|65899629|FG002|Overall Study|Protocol Violation|3|||
23592601|NCT02496702|65899630|FG000|Overall Study|Lost to Follow-up|8|||
23592602|NCT02496702|65899631|FG001|Overall Study|Lost to Follow-up|6|||
23592603|NCT02496702|65899630|FG000|Overall Study|Only partially tested|0|||
23592604|NCT02496702|65899631|FG001|Overall Study|Only partially tested|2|||
23592605|NCT00949975|65899632|FG000|Overall Study|Voluntary discontinuation|6|||
23592606|NCT00949975|65899633|FG001|Overall Study|Voluntary discontinuation|5|||
23592607|NCT00949975|65899634|FG002|Overall Study|Voluntary discontinuation|3|||
23592608|NCT00949975|65899635|FG003|Overall Study|Voluntary discontinuation|6|||
23592609|NCT00949975|65899632|FG000|Overall Study|Adverse Event|11|||
23592610|NCT00949975|65899633|FG001|Overall Study|Adverse Event|11|||
23592611|NCT00949975|65899634|FG002|Overall Study|Adverse Event|10|||
23592612|NCT00949975|65899635|FG003|Overall Study|Adverse Event|10|||
23592613|NCT00949975|65899632|FG000|Overall Study|Safety reason|0|||
23592614|NCT00949975|65899633|FG001|Overall Study|Safety reason|1|||
23592615|NCT00949975|65899634|FG002|Overall Study|Safety reason|0|||
23592616|NCT00949975|65899635|FG003|Overall Study|Safety reason|0|||
23592617|NCT00949975|65899632|FG000|Overall Study|Study-specific criteria|0|||
23592618|NCT00949975|65899633|FG001|Overall Study|Study-specific criteria|1|||
23592619|NCT00949975|65899634|FG002|Overall Study|Study-specific criteria|1|||
23592620|NCT00949975|65899635|FG003|Overall Study|Study-specific criteria|0|||
23592621|NCT00949975|65899632|FG000|Overall Study|Incorrect enrolment|5|||
23592622|NCT00949975|65899633|FG001|Overall Study|Incorrect enrolment|10|||
23592623|NCT00949975|65899634|FG002|Overall Study|Incorrect enrolment|4|||
23592624|NCT00949975|65899635|FG003|Overall Study|Incorrect enrolment|7|||
23592625|NCT00949975|65899632|FG000|Overall Study|Severe non-compliance|3|||
23592626|NCT00949975|65899633|FG001|Overall Study|Severe non-compliance|1|||
23592627|NCT00949975|65899634|FG002|Overall Study|Severe non-compliance|0|||
23592628|NCT00949975|65899635|FG003|Overall Study|Severe non-compliance|2|||
23592629|NCT00949975|65899632|FG000|Overall Study|Lost to Follow-up|1|||
23592630|NCT00949975|65899633|FG001|Overall Study|Lost to Follow-up|0|||
23592631|NCT00949975|65899634|FG002|Overall Study|Lost to Follow-up|1|||
23592632|NCT00949975|65899635|FG003|Overall Study|Lost to Follow-up|3|||
23592633|NCT00949975|65899632|FG000|Overall Study|Other|1|||
23592634|NCT00949975|65899633|FG001|Overall Study|Other|0|||
23592635|NCT00949975|65899634|FG002|Overall Study|Other|0|||
23592636|NCT00949975|65899635|FG003|Overall Study|Other|0|||
23592637|NCT02570711|65899639|FG000|Overall Study|Death|1|||
23592638|NCT02570711|65899640|FG001|Overall Study|Death|0|||
23592639|NCT02570711|65899639|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
23592640|NCT02570711|65899640|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
23592641|NCT00566527|65899642|FG000|Overall Study|Reason not provided|3|||
23592642|NCT00566527|65899643|FG001|Overall Study|Reason not provided|11|||
23592643|NCT00566527|65899644|FG002|Overall Study|Reason not provided|10|||
23592644|NCT00566527|65899642|FG000|Overall Study|Adverse Event|2|||
23193370|NCT00227877|64449619|FG003|12-months Follow-up|Completed late|0|||
23592645|NCT00566527|65899643|FG001|Overall Study|Adverse Event|0|||
23592646|NCT00566527|65899644|FG002|Overall Study|Adverse Event|1|||
23592647|NCT00566527|65899642|FG000|Overall Study|Physician Decision|3|||
23592648|NCT00566527|65899643|FG001|Overall Study|Physician Decision|8|||
23592649|NCT00566527|65899644|FG002|Overall Study|Physician Decision|20|||
23592650|NCT00566527|65899642|FG000|Overall Study|Lost to Follow-up|3|||
23592651|NCT00566527|65899643|FG001|Overall Study|Lost to Follow-up|4|||
23592652|NCT00566527|65899644|FG002|Overall Study|Lost to Follow-up|4|||
23592653|NCT00566527|65899642|FG000|Overall Study|Withdrawal by Subject|6|||
23592654|NCT00566527|65899643|FG001|Overall Study|Withdrawal by Subject|43|||
23592655|NCT00566527|65899644|FG002|Overall Study|Withdrawal by Subject|43|||
23592656|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
23592657|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
23592658|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
23592659|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
23592660|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
23592661|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
23592662|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
23592663|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
23592664|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
23592665|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
23592666|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
23592667|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
23592668|NCT00790790|65899649|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
23592669|NCT00790790|65899650|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
23592670|NCT00790790|65899651|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
23592671|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
23592672|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
23592673|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
23592674|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
23592675|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
23592676|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
23592677|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
23592678|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
23592679|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
23592680|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
23592681|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
23592682|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
23592683|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
23592684|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
23592685|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
23592686|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
23592687|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
23592688|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
23592689|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
23592690|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
23592691|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
23592692|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
23592693|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
23592694|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
23592695|NCT01061151|65899653|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
23592696|NCT01061151|65899654|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
23592697|NCT01061151|65899655|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
23592698|NCT01061151|65899656|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
23592699|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
23592700|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
23592701|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
23592702|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
23592703|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
23592704|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
23592705|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
23592706|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
23592707|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
23592708|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
23592709|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
23592710|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
23592711|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
23592712|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
23592713|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
23592714|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
23592715|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
23592716|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
23592717|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
23592718|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
23592719|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
23476925|NCT02431260|65491403|FG007|Overall Study|Physician Decision|0|||
23476926|NCT02431260|65491404|FG008|Overall Study|Physician Decision|0|||
23476927|NCT02431260|65491405|FG009|Overall Study|Physician Decision|0|||
23476928|NCT02431260|65491406|FG010|Overall Study|Physician Decision|0|||
23476929|NCT02431260|65491407|FG011|Overall Study|Physician Decision|0|||
23476930|NCT02431260|65491408|FG012|Overall Study|Physician Decision|0|||
23476931|NCT02431260|65491409|FG013|Overall Study|Physician Decision|0|||
23476932|NCT02431260|65491396|FG000|Overall Study|Other Unspecified|0|||
23476933|NCT02431260|65491397|FG001|Overall Study|Other Unspecified|0|||
23476934|NCT02431260|65491398|FG002|Overall Study|Other Unspecified|0|||
23476935|NCT02431260|65491399|FG003|Overall Study|Other Unspecified|0|||
23476936|NCT02431260|65491400|FG004|Overall Study|Other Unspecified|0|||
23476937|NCT02431260|65491401|FG005|Overall Study|Other Unspecified|0|||
23476938|NCT02431260|65491402|FG006|Overall Study|Other Unspecified|0|||
23476939|NCT02431260|65491403|FG007|Overall Study|Other Unspecified|0|||
23476940|NCT02431260|65491404|FG008|Overall Study|Other Unspecified|0|||
23476941|NCT02431260|65491405|FG009|Overall Study|Other Unspecified|0|||
23476942|NCT02431260|65491406|FG010|Overall Study|Other Unspecified|0|||
23476943|NCT02431260|65491407|FG011|Overall Study|Other Unspecified|1|||
23476944|NCT02431260|65491408|FG012|Overall Study|Other Unspecified|1|||
23476945|NCT02431260|65491409|FG013|Overall Study|Other Unspecified|0|||
23476946|NCT01105065|65491418|FG000|Overall Study|Adverse Event|5|||
23476947|NCT01105065|65491418|FG000|Overall Study|Technical Problems|1|||
23476948|NCT01129024|65491419|FG000|Overall Study|Physician Decision|5|||
23476949|NCT01129024|65491419|FG000|Overall Study|Study Terminated by Sponsor|8|||
23476950|NCT01129024|65491419|FG000|Overall Study|Withdrawal by Subject|2|||
23476951|NCT01129024|65491419|FG000|Overall Study|Lack of Efficacy|3|||
23476952|NCT01129024|65491419|FG000|Overall Study|Needed a Platelet Transfusion|1|||
23476953|NCT02600819|65491420|FG000|GEN Phase|Adverse Event|2|||
23476954|NCT02600819|65491421|FG001|GEN Phase|Adverse Event|0|||
23476955|NCT02600819|65491420|FG000|GEN Phase|Death|2|||
23476956|NCT02600819|65491421|FG001|GEN Phase|Death|0|||
23476957|NCT02600819|65491420|FG000|GEN Phase|Investigator's Discretion|4|||
23476958|NCT02600819|65491421|FG001|GEN Phase|Investigator's Discretion|0|||
23476959|NCT02600819|65491420|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
23592720|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
23592721|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
23592722|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
23592723|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
23592724|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
23592725|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
23592726|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
23592727|NCT01061151|65899653|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
23592728|NCT01061151|65899654|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
23592729|NCT01061151|65899655|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
23592730|NCT01061151|65899656|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
23592731|NCT03024606|65899657|FG000|Overall Study|Withdrawal by Subject|9|||
23592732|NCT03024606|65899658|FG001|Overall Study|Withdrawal by Subject|10|||
23592733|NCT00712335|65899663|FG000|Overall Study|Withdrawal by Subject|0|||
23592734|NCT00712335|65899664|FG001|Overall Study|Withdrawal by Subject|7|||
23592735|NCT00712335|65899665|FG002|Overall Study|Withdrawal by Subject|2|||
23592736|NCT00712335|65899666|FG003|Overall Study|Withdrawal by Subject|3|||
23592737|NCT00712335|65899667|FG004|Overall Study|Withdrawal by Subject|0|||
23592738|NCT00712335|65899663|FG000|Overall Study|Lost to Follow-up|2|||
23592739|NCT00712335|65899664|FG001|Overall Study|Lost to Follow-up|5|||
23592740|NCT00712335|65899665|FG002|Overall Study|Lost to Follow-up|0|||
23592741|NCT00712335|65899666|FG003|Overall Study|Lost to Follow-up|1|||
23592742|NCT00712335|65899667|FG004|Overall Study|Lost to Follow-up|0|||
23476960|NCT02600819|65491421|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
23592743|NCT00712335|65899663|FG000|Overall Study|Protocol Violation|1|||
23592744|NCT00712335|65899664|FG001|Overall Study|Protocol Violation|2|||
23592745|NCT00712335|65899665|FG002|Overall Study|Protocol Violation|1|||
23476961|NCT02600819|65491420|FG000|GEN Phase|Withdrew Consent|5|||
23476962|NCT02600819|65491421|FG001|GEN Phase|Withdrew Consent|0|||
23476963|NCT02600819|65491420|FG000|GEN Phase|Lost to Follow-up|2|||
23476964|NCT02600819|65491421|FG001|GEN Phase|Lost to Follow-up|0|||
23476965|NCT02788279|65491422|FG000|Overall Study|Death|62|||
23476966|NCT02788279|65491423|FG001|Overall Study|Death|136|||
23476967|NCT02788279|65491424|FG002|Overall Study|Death|72|||
23476968|NCT02788279|65491422|FG000|Overall Study|Withdrawal by Subject|10|||
23476969|NCT02788279|65491423|FG001|Overall Study|Withdrawal by Subject|15|||
23476970|NCT02788279|65491424|FG002|Overall Study|Withdrawal by Subject|5|||
23476971|NCT02788279|65491422|FG000|Overall Study|Lost to Follow-up|0|||
23476972|NCT02788279|65491423|FG001|Overall Study|Lost to Follow-up|3|||
23476973|NCT02788279|65491424|FG002|Overall Study|Lost to Follow-up|2|||
23592746|NCT00712335|65899666|FG003|Overall Study|Protocol Violation|0|||
23592747|NCT00712335|65899667|FG004|Overall Study|Protocol Violation|0|||
23592748|NCT00712335|65899663|FG000|Overall Study|Lack of Efficacy|0|||
23592749|NCT00712335|65899664|FG001|Overall Study|Lack of Efficacy|0|||
23592750|NCT00712335|65899665|FG002|Overall Study|Lack of Efficacy|1|||
23592751|NCT00712335|65899666|FG003|Overall Study|Lack of Efficacy|1|||
23592752|NCT00712335|65899667|FG004|Overall Study|Lack of Efficacy|0|||
23592753|NCT00712335|65899663|FG000|Overall Study|Other Reason|0|||
23592754|NCT00712335|65899664|FG001|Overall Study|Other Reason|3|||
23592755|NCT00712335|65899665|FG002|Overall Study|Other Reason|1|||
23592756|NCT00712335|65899666|FG003|Overall Study|Other Reason|0|||
23592757|NCT00712335|65899667|FG004|Overall Study|Other Reason|0|||
23592758|NCT01066923|65899670|FG000|Overall Study|Withdrawal by Subject|3|||
23592759|NCT01066923|65899671|FG001|Overall Study|Withdrawal by Subject|3|||
23592760|NCT01066923|65899672|FG002|Overall Study|Withdrawal by Subject|8|||
23592761|NCT01066923|65899673|FG003|Overall Study|Withdrawal by Subject|8|||
23592762|NCT02059980|65899674|FG000|Overall Study|Lost to Follow-up|2|||
23592763|NCT02059980|65899675|FG001|Overall Study|Lost to Follow-up|1|||
23592764|NCT00364013|65899680|FG000|Overall Study|Ineligibility determined|4|||
23592765|NCT00364013|65899681|FG001|Overall Study|Ineligibility determined|2|||
23592766|NCT00364013|65899680|FG000|Overall Study|Adverse Event|4|||
23592767|NCT00364013|65899681|FG001|Overall Study|Adverse Event|3|||
23592768|NCT00364013|65899680|FG000|Overall Study|Withdrawal by Subject|13|||
23592769|NCT00364013|65899681|FG001|Overall Study|Withdrawal by Subject|18|||
23592770|NCT00364013|65899680|FG000|Overall Study|Physician Decision|3|||
23592771|NCT00364013|65899681|FG001|Overall Study|Physician Decision|3|||
23592772|NCT00364013|65899680|FG000|Overall Study|Lost to Follow-up|10|||
23592773|NCT00364013|65899681|FG001|Overall Study|Lost to Follow-up|3|||
23592774|NCT00364013|65899680|FG000|Overall Study|Protocol-specified criteria|6|||
23592775|NCT00364013|65899681|FG001|Overall Study|Protocol-specified criteria|6|||
23592776|NCT00364013|65899680|FG000|Overall Study|Other|41|||
23592777|NCT00364013|65899681|FG001|Overall Study|Other|47|||
23592778|NCT00364013|65899680|FG000|Overall Study|Ongoing|20|||
23592779|NCT00364013|65899681|FG001|Overall Study|Ongoing|13|||
23592780|NCT02708108|65899686|FG000|Overall Study|Death|1|||
23592781|NCT02708108|65899687|FG001|Overall Study|Death|2|||
23592782|NCT02708108|65899686|FG000|Overall Study|Regimen change|1|||
23592783|NCT02708108|65899687|FG001|Overall Study|Regimen change|0|||
23592784|NCT02708108|65899686|FG000|Overall Study|No MRD and no imaging available|0|||
23592785|NCT02708108|65899687|FG001|Overall Study|No MRD and no imaging available|1|||
23592786|NCT00716859|65899691|FG000|Overall Study|Adverse Event|4|||
23592787|NCT00716859|65899692|FG001|Overall Study|Adverse Event|1|||
23592788|NCT00716859|65899691|FG000|Overall Study|Lack of Efficacy|3|||
23592789|NCT00716859|65899692|FG001|Overall Study|Lack of Efficacy|0|||
23592790|NCT00716859|65899691|FG000|Overall Study|Withdrawal by Subject|1|||
23592791|NCT00716859|65899692|FG001|Overall Study|Withdrawal by Subject|3|||
23592792|NCT00716859|65899691|FG000|Overall Study|Not treated|1|||
23592793|NCT00716859|65899692|FG001|Overall Study|Not treated|1|||
23592794|NCT01697969|65899693|FG000|Overall Study|Did not meet inc/exc criteria|3|||
23193371|NCT00227877|64449616|FG000|12-months Follow-up|Lost to Follow-up|232|||
23193372|NCT00227877|64449617|FG001|12-months Follow-up|Lost to Follow-up|189|||
23193373|NCT00227877|64449618|FG002|12-months Follow-up|Lost to Follow-up|30|||
23193374|NCT00227877|64449619|FG003|12-months Follow-up|Lost to Follow-up|26|||
23592795|NCT03183518|65899694|FG000|Overall Study|Other (Not specified)|2|||
23592796|NCT03183518|65899694|FG000|Overall Study|Other (Withdrawal of consent)|1|||
23592797|NCT00589667|65899695|FG000|Overall Study|Adverse Event|2|||
23592798|NCT00589667|65899695|FG000|Overall Study|Withdrawal by Subject|1|||
23592799|NCT03997916|65899696|FG000|Overall Study|Protocol Violation|35|||
23592800|NCT01236001|65899698|FG000|Overall Study|Adverse Event|5|||
23592801|NCT01236001|65899699|FG001|Overall Study|Adverse Event|14|||
23592802|NCT01236001|65899698|FG000|Overall Study|Lack of Efficacy|6|||
23592803|NCT01236001|65899699|FG001|Overall Study|Lack of Efficacy|6|||
23592804|NCT01236001|65899698|FG000|Overall Study|Lost to Follow-up|6|||
23592805|NCT01236001|65899699|FG001|Overall Study|Lost to Follow-up|1|||
23592806|NCT01236001|65899698|FG000|Overall Study|Incompliance|1|||
23592807|NCT01236001|65899699|FG001|Overall Study|Incompliance|0|||
23592808|NCT01236001|65899698|FG000|Overall Study|Planned Visit After End of Study|0|||
23592809|NCT01236001|65899699|FG001|Overall Study|Planned Visit After End of Study|1|||
23193375|NCT03103750|64449620|FG000|Overall Study|Adverse Event|1|||
23592810|NCT00391846|65899700|FG000|Overall Study|Adverse Event|4|||
23592811|NCT00391846|65899701|FG001|Overall Study|Adverse Event|1|||
23592812|NCT00391846|65899700|FG000|Overall Study|Did not meet the required elig. crit|2|||
23193376|NCT03103750|64449621|FG001|Overall Study|Adverse Event|0|||
23592813|NCT00391846|65899701|FG001|Overall Study|Did not meet the required elig. crit|2|||
23592814|NCT00391846|65899700|FG000|Overall Study|Withdrawal by Subject|2|||
23592815|NCT00391846|65899701|FG001|Overall Study|Withdrawal by Subject|3|||
23592816|NCT00391846|65899700|FG000|Overall Study|Developed study specific DC criteria|0|||
23592817|NCT00391846|65899701|FG001|Overall Study|Developed study specific DC criteria|1|||
23592818|NCT00089544|65899703|FG000|Overall Study|Ineligible|1|||
23592819|NCT00089544|65899704|FG001|Overall Study|Ineligible|0|||
23592820|NCT02477670|65899705|FG000|Stage 1|Adverse Event|2|||
23592821|NCT02477670|65899706|FG001|Stage 1|Adverse Event|7|||
23592822|NCT02477670|65899707|FG002|Stage 1|Adverse Event|0|||
23592823|NCT02477670|65899708|FG003|Stage 1|Adverse Event|0|||
23592824|NCT02477670|65899709|FG004|Stage 1|Adverse Event|0|||
23592825|NCT02477670|65899710|FG005|Stage 1|Adverse Event|0|||
23592826|NCT02477670|65899711|FG006|Stage 1|Adverse Event|0|||
23592827|NCT02477670|65899705|FG000|Stage 1|Lost to Follow-up|0|||
23592828|NCT02477670|65899706|FG001|Stage 1|Lost to Follow-up|2|||
23592829|NCT02477670|65899707|FG002|Stage 1|Lost to Follow-up|0|||
23592830|NCT02477670|65899708|FG003|Stage 1|Lost to Follow-up|0|||
23592831|NCT02477670|65899709|FG004|Stage 1|Lost to Follow-up|0|||
23592832|NCT02477670|65899710|FG005|Stage 1|Lost to Follow-up|0|||
23592833|NCT02477670|65899711|FG006|Stage 1|Lost to Follow-up|0|||
23592834|NCT02477670|65899705|FG000|Stage 1|Withdrawal by Subject|1|||
23592835|NCT02477670|65899706|FG001|Stage 1|Withdrawal by Subject|2|||
23592836|NCT02477670|65899707|FG002|Stage 1|Withdrawal by Subject|0|||
23592837|NCT02477670|65899708|FG003|Stage 1|Withdrawal by Subject|0|||
23592838|NCT02477670|65899709|FG004|Stage 1|Withdrawal by Subject|0|||
23592839|NCT02477670|65899710|FG005|Stage 1|Withdrawal by Subject|0|||
23592840|NCT02477670|65899711|FG006|Stage 1|Withdrawal by Subject|0|||
23592841|NCT02477670|65899705|FG000|Stage 1|Non-compliance with Study Drug|1|||
23592842|NCT02477670|65899706|FG001|Stage 1|Non-compliance with Study Drug|2|||
23592843|NCT02477670|65899707|FG002|Stage 1|Non-compliance with Study Drug|0|||
23592844|NCT02477670|65899708|FG003|Stage 1|Non-compliance with Study Drug|0|||
23592845|NCT02477670|65899709|FG004|Stage 1|Non-compliance with Study Drug|0|||
23592846|NCT02477670|65899710|FG005|Stage 1|Non-compliance with Study Drug|0|||
23592847|NCT02477670|65899711|FG006|Stage 1|Non-compliance with Study Drug|0|||
23592848|NCT02477670|65899705|FG000|Stage 2|Adverse Event|0|||
23592849|NCT02477670|65899706|FG001|Stage 2|Adverse Event|0|||
23592850|NCT02477670|65899707|FG002|Stage 2|Adverse Event|1|||
23592851|NCT02477670|65899708|FG003|Stage 2|Adverse Event|0|||
23592852|NCT02477670|65899709|FG004|Stage 2|Adverse Event|0|||
23592853|NCT02477670|65899710|FG005|Stage 2|Adverse Event|0|||
23592854|NCT02477670|65899711|FG006|Stage 2|Adverse Event|0|||
23592855|NCT02477670|65899705|FG000|Stage 2|Antipsychotic Medication Changed|0|||
23592856|NCT02477670|65899706|FG001|Stage 2|Antipsychotic Medication Changed|0|||
23592857|NCT02477670|65899707|FG002|Stage 2|Antipsychotic Medication Changed|1|||
23592858|NCT02477670|65899708|FG003|Stage 2|Antipsychotic Medication Changed|0|||
23592859|NCT02477670|65899709|FG004|Stage 2|Antipsychotic Medication Changed|0|||
23592860|NCT02477670|65899710|FG005|Stage 2|Antipsychotic Medication Changed|0|||
23592861|NCT02477670|65899711|FG006|Stage 2|Antipsychotic Medication Changed|0|||
23592862|NCT02477670|65899705|FG000|Stage 2|Withdrawal by Subject|0|||
23592863|NCT02477670|65899706|FG001|Stage 2|Withdrawal by Subject|0|||
23592864|NCT02477670|65899707|FG002|Stage 2|Withdrawal by Subject|0|||
23592865|NCT02477670|65899708|FG003|Stage 2|Withdrawal by Subject|1|||
23592866|NCT02477670|65899709|FG004|Stage 2|Withdrawal by Subject|0|||
23592867|NCT02477670|65899710|FG005|Stage 2|Withdrawal by Subject|0|||
23193377|NCT03103750|64449620|FG000|Overall Study|Lost to Follow-up|1|||
23193378|NCT03103750|64449621|FG001|Overall Study|Lost to Follow-up|0|||
23193379|NCT03103750|64449620|FG000|Overall Study|PET Equipment Related|2|||
23193380|NCT03103750|64449621|FG001|Overall Study|PET Equipment Related|2|||
23193381|NCT00667277|64449622|FG000|Overall Study|Withdrawal by Subject|2|||
23193382|NCT00839098|64449623|FG000|Overall Study|Withdrawal by Subject|2|||
23193383|NCT00839098|64449624|FG001|Overall Study|Withdrawal by Subject|1|||
23193384|NCT00839098|64449625|FG002|Overall Study|Withdrawal by Subject|7|||
23193385|NCT02908477|64449626|FG000|Overall Study|Withdrawal by Subject|8|||
23193386|NCT02908477|64449627|FG001|Overall Study|Withdrawal by Subject|28|||
23193387|NCT01651260|64449628|FG000|Overall Study|unable to apply product|3|||
23193388|NCT04579393|64449639|FG000|Overall Study|Withdrawal by Subject|2|||
23193389|NCT04579393|64449640|FG001|Overall Study|Withdrawal by Subject|2|||
23193390|NCT04579393|64449639|FG000|Overall Study|Death|1|||
23592868|NCT02477670|65899711|FG006|Stage 2|Withdrawal by Subject|0|||
23592869|NCT03102710|65899712|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
23592870|NCT03102710|65899713|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
23592871|NCT03102710|65899714|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
23592872|NCT03102710|65899712|FG000|Overall Study|Technical issues during final MRI scan|0|||
23592873|NCT03102710|65899713|FG001|Overall Study|Technical issues during final MRI scan|1|||
23592874|NCT03102710|65899714|FG002|Overall Study|Technical issues during final MRI scan|0|||
23193391|NCT04579393|64449640|FG001|Overall Study|Death|3|||
23193392|NCT00514449|64449641|FG000|Overall Study|Withdrawal by Subject|1|||
23193393|NCT00514449|64449642|FG001|Overall Study|Withdrawal by Subject|2|||
23193394|NCT00514449|64449641|FG000|Overall Study|Protocol Violation|1|||
23592875|NCT03102710|65899712|FG000|Overall Study|Nausea during MRI scan|0|||
23592876|NCT03102710|65899713|FG001|Overall Study|Nausea during MRI scan|1|||
23592877|NCT03102710|65899714|FG002|Overall Study|Nausea during MRI scan|0|||
23592878|NCT03102710|65899712|FG000|Overall Study|Subject unable to attend final session|0|||
23592879|NCT03102710|65899713|FG001|Overall Study|Subject unable to attend final session|1|||
23592880|NCT03102710|65899714|FG002|Overall Study|Subject unable to attend final session|0|||
23592881|NCT00510887|65899716|FG000|Overall Study|Lost to Follow-up|1|||
23592882|NCT00955825|65899719|FG000|Overall Study|Adverse Event|15|||
23592883|NCT00955825|65899720|FG001|Overall Study|Adverse Event|2|||
23592884|NCT00955825|65899719|FG000|Overall Study|Withdrawal by Subject|4|||
23592885|NCT00955825|65899720|FG001|Overall Study|Withdrawal by Subject|6|||
23592886|NCT00955825|65899719|FG000|Overall Study|Any other reason not above-mentioned|7|||
23592887|NCT00955825|65899720|FG001|Overall Study|Any other reason not above-mentioned|9|||
23592888|NCT00632424|65899721|FG000|Overall Study|Disease Progression|17|||
23592889|NCT00632424|65899721|FG000|Overall Study|Study Drug Toxicity|1|||
23592890|NCT04048135|65899722|FG000|Overall Study|Withdrawal by Subject|1|||
23592891|NCT04048135|65899723|FG001|Overall Study|Withdrawal by Subject|1|||
23592892|NCT04048135|65899724|FG002|Overall Study|Withdrawal by Subject|1|||
23592893|NCT04048135|65899725|FG003|Overall Study|Withdrawal by Subject|2|||
23592894|NCT04048135|65899726|FG004|Overall Study|Withdrawal by Subject|0|||
23592895|NCT04048135|65899727|FG005|Overall Study|Withdrawal by Subject|0|||
23592896|NCT04048135|65899728|FG006|Overall Study|Withdrawal by Subject|1|||
23592897|NCT04048135|65899729|FG007|Overall Study|Withdrawal by Subject|1|||
23592898|NCT04048135|65899722|FG000|Overall Study|Adverse Event|0|||
23592899|NCT04048135|65899723|FG001|Overall Study|Adverse Event|0|||
23592900|NCT04048135|65899724|FG002|Overall Study|Adverse Event|0|||
23592901|NCT04048135|65899725|FG003|Overall Study|Adverse Event|1|||
23592902|NCT04048135|65899726|FG004|Overall Study|Adverse Event|1|||
23592903|NCT04048135|65899727|FG005|Overall Study|Adverse Event|0|||
23592904|NCT04048135|65899728|FG006|Overall Study|Adverse Event|0|||
23592905|NCT04048135|65899729|FG007|Overall Study|Adverse Event|0|||
23592906|NCT04048135|65899722|FG000|Overall Study|Protocol Violation|0|||
23592907|NCT04048135|65899723|FG001|Overall Study|Protocol Violation|0|||
23592908|NCT04048135|65899724|FG002|Overall Study|Protocol Violation|0|||
23592909|NCT04048135|65899725|FG003|Overall Study|Protocol Violation|0|||
23592910|NCT04048135|65899726|FG004|Overall Study|Protocol Violation|0|||
23592911|NCT04048135|65899727|FG005|Overall Study|Protocol Violation|1|||
23592912|NCT04048135|65899728|FG006|Overall Study|Protocol Violation|0|||
23592913|NCT04048135|65899729|FG007|Overall Study|Protocol Violation|0|||
23592914|NCT00457743|65899730|FG000|Overall Study|Adverse Event|0|||
23592915|NCT00457743|65899731|FG001|Overall Study|Adverse Event|4|||
23592916|NCT00457743|65899732|FG002|Overall Study|Adverse Event|0|||
23592917|NCT00457743|65899730|FG000|Overall Study|Lack of Efficacy|3|||
23592918|NCT00457743|65899731|FG001|Overall Study|Lack of Efficacy|23|||
23592919|NCT00457743|65899732|FG002|Overall Study|Lack of Efficacy|3|||
23592920|NCT03844269|65899734|FG000|Overall Study|Withdrawal pre-intervention|1|||
23592921|NCT03844269|65899734|FG000|Overall Study|Did not complete the intervention|2|||
23193395|NCT00514449|64449642|FG001|Overall Study|Protocol Violation|2|||
23193396|NCT00514449|64449641|FG000|Overall Study|Lost to Follow-up|1|||
23193397|NCT00514449|64449642|FG001|Overall Study|Lost to Follow-up|0|||
23193398|NCT01863758|64449645|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
23193399|NCT01863758|64449645|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
23476974|NCT02788279|65491422|FG000|Overall Study|Sponsor decision|18|||
23476975|NCT02788279|65491423|FG001|Overall Study|Sponsor decision|29|||
23476976|NCT02788279|65491424|FG002|Overall Study|Sponsor decision|11|||
23476977|NCT02551991|65491425|FG000|Overall Study|Death|5|||
23476978|NCT02551991|65491426|FG001|Overall Study|Death|7|||
23476979|NCT02551991|65491427|FG002|Overall Study|Death|8|||
23476980|NCT02551991|65491428|FG003|Overall Study|Death|7|||
23476981|NCT02551991|65491429|FG004|Overall Study|Death|17|||
23476982|NCT02551991|65491425|FG000|Overall Study|Withdrawal by Subject|1|||
23476983|NCT02551991|65491426|FG001|Overall Study|Withdrawal by Subject|0|||
23476984|NCT02551991|65491427|FG002|Overall Study|Withdrawal by Subject|0|||
23476985|NCT02551991|65491428|FG003|Overall Study|Withdrawal by Subject|0|||
23476986|NCT02551991|65491429|FG004|Overall Study|Withdrawal by Subject|2|||
23476987|NCT02551991|65491425|FG000|Overall Study|Lost to Follow-up|0|||
23476988|NCT02551991|65491426|FG001|Overall Study|Lost to Follow-up|0|||
23476989|NCT02551991|65491427|FG002|Overall Study|Lost to Follow-up|1|||
23592922|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Adverse Event|5|||
23592923|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Adverse Event|0|||
23592924|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Adverse Event|0|||
23592925|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
23592926|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
23592927|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
23592928|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
23592929|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
23193400|NCT04952389|64449648|FG000|Overall Study|Withdrawal by Subject|8|||
23476990|NCT02551991|65491428|FG003|Overall Study|Lost to Follow-up|0|||
23476991|NCT02551991|65491429|FG004|Overall Study|Lost to Follow-up|0|||
23476992|NCT02551991|65491425|FG000|Overall Study|Sponsor Decision|1|||
23476993|NCT02551991|65491426|FG001|Overall Study|Sponsor Decision|0|||
23193401|NCT04952389|64449649|FG001|Overall Study|Withdrawal by Subject|4|||
23193402|NCT02640612|64449650|FG000|Overall Study|Adverse Event|6|||
23193403|NCT02640612|64449651|FG001|Overall Study|Adverse Event|7|||
23193404|NCT02640612|64449652|FG002|Overall Study|Adverse Event|2|||
23193405|NCT02640612|64449650|FG000|Overall Study|Death|1|||
23193406|NCT02640612|64449651|FG001|Overall Study|Death|0|||
23193407|NCT02640612|64449652|FG002|Overall Study|Death|0|||
23592930|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
23592931|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
23476994|NCT02551991|65491427|FG002|Overall Study|Sponsor Decision|1|||
23476995|NCT02551991|65491428|FG003|Overall Study|Sponsor Decision|0|||
23476996|NCT02551991|65491429|FG004|Overall Study|Sponsor Decision|5|||
23476997|NCT02551991|65491425|FG000|Overall Study|Other|0|||
23476998|NCT02551991|65491426|FG001|Overall Study|Other|0|||
23476999|NCT02551991|65491427|FG002|Overall Study|Other|0|||
23477000|NCT02551991|65491428|FG003|Overall Study|Other|0|||
23477001|NCT02551991|65491429|FG004|Overall Study|Other|1|||
23477002|NCT02081859|65491434|FG000|Overall Study|No fertilization|2|||
23477003|NCT02081859|65491435|FG001|Overall Study|No fertilization|2|||
23477004|NCT02081859|65491434|FG000|Overall Study|No sperm|1|||
23477005|NCT02081859|65491435|FG001|Overall Study|No sperm|0|||
23477006|NCT02081859|65491434|FG000|Overall Study|Unanticipated freeze all cycle|2|||
23477007|NCT02081859|65491435|FG001|Overall Study|Unanticipated freeze all cycle|6|||
23477008|NCT02081859|65491434|FG000|Overall Study|< 4 embryos|27|||
23477009|NCT02081859|65491435|FG001|Overall Study|< 4 embryos|23|||
23477010|NCT02081859|65491434|FG000|Overall Study|Other reasons|2|||
23477011|NCT02081859|65491435|FG001|Overall Study|Other reasons|0|||
23477012|NCT02471612|65491442|FG000|Overall Study|Lost to Follow-up|2|||
23477013|NCT03320824|65491450|FG000|Overall Study|Withdrawal by Subject|8|||
23477014|NCT03320824|65491451|FG001|Overall Study|Withdrawal by Subject|1|||
23477015|NCT03320824|65491450|FG000|Overall Study|Lost to Follow-up|10|||
23477016|NCT03320824|65491451|FG001|Overall Study|Lost to Follow-up|1|||
23477017|NCT03320824|65491450|FG000|Overall Study|moved out of state|0|||
23477018|NCT03320824|65491451|FG001|Overall Study|moved out of state|1|||
23477019|NCT03320824|65491450|FG000|Overall Study|could not complete final visit|0|||
23477020|NCT03320824|65491451|FG001|Overall Study|could not complete final visit|1|||
23477021|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
23477022|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
23477023|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
23477024|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
23477025|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
23477026|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
23193408|NCT02640612|64449650|FG000|Overall Study|Withdrawal by Subject|10|||
23193409|NCT02640612|64449651|FG001|Overall Study|Withdrawal by Subject|3|||
23193410|NCT02640612|64449652|FG002|Overall Study|Withdrawal by Subject|3|||
23193411|NCT02640612|64449650|FG000|Overall Study|Lost to Follow-up|4|||
23193412|NCT02640612|64449651|FG001|Overall Study|Lost to Follow-up|1|||
23193413|NCT02640612|64449652|FG002|Overall Study|Lost to Follow-up|1|||
23193414|NCT02640612|64449650|FG000|Overall Study|Protocol Violation|0|||
23193415|NCT02640612|64449651|FG001|Overall Study|Protocol Violation|2|||
23193416|NCT02640612|64449652|FG002|Overall Study|Protocol Violation|0|||
23193417|NCT02640612|64449650|FG000|Overall Study|Lack of Efficacy|1|||
23193418|NCT02640612|64449651|FG001|Overall Study|Lack of Efficacy|1|||
23193419|NCT02640612|64449652|FG002|Overall Study|Lack of Efficacy|0|||
23193420|NCT00519532|64449653|FG000|Overall Study|Adverse Event|11|||
23193421|NCT00519532|64449653|FG000|Overall Study|Withdrawal by Subject|5|||
23193422|NCT00519532|64449653|FG000|Overall Study|Lost to Follow-up|2|||
23193423|NCT02400346|64449654|FG000|Overall Study|Adverse Event|24|||
23193424|NCT02400346|64449654|FG000|Overall Study|Lack of Efficacy|9|||
23193425|NCT02400346|64449654|FG000|Overall Study|Non-compliance with IMP|1|||
23193426|NCT02400346|64449654|FG000|Overall Study|Withdrawal by Subject|7|||
23193427|NCT02400346|64449654|FG000|Overall Study|Administrative or other reason(s)|2|||
23193428|NCT02400346|64449654|FG000|Overall Study|Lost to Follow-up|1|||
23193429|NCT00537823|64449655|FG000|Overall Study|Adverse Event|2|||
23193430|NCT00537823|64449656|FG001|Overall Study|Adverse Event|0|||
23193431|NCT00611130|64449657|FG000|Overall Study|Lost to Follow-up|25|||
23193432|NCT00611130|64449658|FG001|Overall Study|Lost to Follow-up|29|||
23193433|NCT00611130|64449657|FG000|Overall Study|Protocol noncompliance|7|||
23193434|NCT00611130|64449658|FG001|Overall Study|Protocol noncompliance|6|||
23193435|NCT00611130|64449657|FG000|Overall Study|Withdrawal by Subject|6|||
23477027|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
23477028|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
23477029|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
23477030|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
23477031|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
23477032|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
23477033|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
23477034|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
23592932|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
23592933|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
23592934|NCT01426269|65899742|FG000|Period 1: 12 Weeks|Pregnancy|1|||
23592935|NCT01426269|65899743|FG001|Period 1: 12 Weeks|Pregnancy|0|||
23592936|NCT01426269|65899744|FG002|Period 1: 12 Weeks|Pregnancy|0|||
23592937|NCT01426269|65899742|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
23592938|NCT01426269|65899743|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
23592939|NCT01426269|65899744|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
23592940|NCT01426269|65899742|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
23592941|NCT01426269|65899743|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
23592942|NCT01426269|65899744|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
23592943|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Adverse Event|0|||
23193436|NCT00611130|64449658|FG001|Overall Study|Withdrawal by Subject|5|||
23193437|NCT00611130|64449657|FG000|Overall Study|Other|5|||
23193438|NCT00611130|64449658|FG001|Overall Study|Other|4|||
23193439|NCT00611130|64449657|FG000|Overall Study|Incarceration|3|||
23193440|NCT00611130|64449658|FG001|Overall Study|Incarceration|2|||
23193441|NCT00611130|64449657|FG000|Overall Study|Administrative|1|||
23193442|NCT00611130|64449658|FG001|Overall Study|Administrative|1|||
23193443|NCT00611130|64449657|FG000|Overall Study|Adverse Event|1|||
23193444|NCT00611130|64449658|FG001|Overall Study|Adverse Event|0|||
23193445|NCT00611130|64449657|FG000|Overall Study|Death|1|||
23193446|NCT00611130|64449658|FG001|Overall Study|Death|0|||
23193447|NCT00184054|64449659|FG000|Overall Study|Adverse Event|1|||
23193448|NCT01486238|64449662|FG000|Overall Study|Death|0|||
23193449|NCT01486238|64449663|FG001|Overall Study|Death|2|||
23193450|NCT01486238|64449662|FG000|Overall Study|Withdrawal by Subject|2|||
23193451|NCT01486238|64449663|FG001|Overall Study|Withdrawal by Subject|1|||
23193452|NCT01486238|64449662|FG000|Overall Study|Lost to Follow-up|0|||
23193453|NCT01486238|64449663|FG001|Overall Study|Lost to Follow-up|3|||
23193454|NCT00570739|64449671|FG000|Overall Study|Adverse Event|8|||
23193455|NCT00570739|64449672|FG001|Overall Study|Adverse Event|6|||
23193456|NCT00570739|64449673|FG002|Overall Study|Adverse Event|2|||
23193457|NCT00570739|64449674|FG003|Overall Study|Adverse Event|2|||
23193458|NCT00570739|64449671|FG000|Overall Study|Lost to Follow-up|4|||
23193459|NCT00570739|64449672|FG001|Overall Study|Lost to Follow-up|5|||
23193460|NCT00570739|64449673|FG002|Overall Study|Lost to Follow-up|4|||
23193461|NCT00570739|64449674|FG003|Overall Study|Lost to Follow-up|1|||
23193462|NCT00570739|64449671|FG000|Overall Study|Physician Decision|1|||
23193463|NCT00570739|64449672|FG001|Overall Study|Physician Decision|1|||
23193464|NCT00570739|64449673|FG002|Overall Study|Physician Decision|0|||
23193465|NCT00570739|64449674|FG003|Overall Study|Physician Decision|0|||
23193466|NCT00570739|64449671|FG000|Overall Study|Withdrawal by Subject|7|||
23193467|NCT00570739|64449672|FG001|Overall Study|Withdrawal by Subject|7|||
23193468|NCT00570739|64449673|FG002|Overall Study|Withdrawal by Subject|3|||
23193469|NCT00570739|64449674|FG003|Overall Study|Withdrawal by Subject|5|||
23193470|NCT00570739|64449671|FG000|Overall Study|Required restricted medication|0|||
23193471|NCT00570739|64449672|FG001|Overall Study|Required restricted medication|0|||
23193472|NCT00570739|64449673|FG002|Overall Study|Required restricted medication|1|||
23193473|NCT00570739|64449674|FG003|Overall Study|Required restricted medication|0|||
23592944|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Adverse Event|1|||
23592945|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Adverse Event|2|||
23592946|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
23592947|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
23592948|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
23592949|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
23592950|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
23592951|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
23592952|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
23592953|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
23592954|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
23592955|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Site closed|0|||
23193474|NCT00570739|64449671|FG000|Overall Study|Met discontinuation criteria|1|||
23193475|NCT00570739|64449672|FG001|Overall Study|Met discontinuation criteria|0|||
23193476|NCT00570739|64449673|FG002|Overall Study|Met discontinuation criteria|1|||
23592956|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Site closed|6|||
23592957|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Site closed|5|||
23592958|NCT01426269|65899742|FG000|Period 2: 40 Weeks|Relapsed|0|||
23592959|NCT01426269|65899743|FG001|Period 2: 40 Weeks|Relapsed|9|||
23592960|NCT01426269|65899744|FG002|Period 2: 40 Weeks|Relapsed|18|||
23193477|NCT00570739|64449674|FG003|Overall Study|Met discontinuation criteria|1|||
23193478|NCT00570739|64449671|FG000|Overall Study|Other|0|||
23193479|NCT00570739|64449672|FG001|Overall Study|Other|2|||
23193480|NCT00570739|64449673|FG002|Overall Study|Other|5|||
23193481|NCT00570739|64449674|FG003|Overall Study|Other|3|||
23193482|NCT03988751|64449675|FG000|Overall Study|Withdrawal by Subject|1|||
23193483|NCT03988751|64449676|FG001|Overall Study|Withdrawal by Subject|0|||
23193484|NCT03988751|64449675|FG000|Overall Study|Protocol Violation|0|||
23193485|NCT03988751|64449676|FG001|Overall Study|Protocol Violation|1|||
23193486|NCT02119104|64449677|FG000|Overall Study|Protocol Violation|16|||
23193487|NCT04275310|64449682|FG000|Overall Study|Non-randomized due to running out of funding|4|||
23254069|NCT02046369|64670419|FG000|Overall Study|Adverse Event|3|||
23254070|NCT02046369|64670420|FG001|Overall Study|Adverse Event|3|||
23592961|NCT01081145|65899745|FG000|Open-Label Phase|Lack of Efficacy|56|||
23592962|NCT01081145|65899746|FG001|Open-Label Phase|Lack of Efficacy|0|||
23592963|NCT01081145|65899745|FG000|Open-Label Phase|Response criteria not met|46|||
23592964|NCT01081145|65899746|FG001|Open-Label Phase|Response criteria not met|0|||
23592965|NCT01081145|65899745|FG000|Open-Label Phase|Adverse Event|42|||
23592966|NCT01081145|65899746|FG001|Open-Label Phase|Adverse Event|0|||
23592967|NCT01081145|65899745|FG000|Open-Label Phase|Withdrawal by Subject|41|||
23592968|NCT01081145|65899746|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23592969|NCT01081145|65899745|FG000|Open-Label Phase|Other|12|||
23193488|NCT04275310|64449683|FG001|Overall Study|Non-randomized due to running out of funding|0|||
23193489|NCT02792777|64449686|FG000|Overall Study|Withdrawal by Subject|2|||
23193490|NCT02792777|64449687|FG001|Overall Study|Withdrawal by Subject|0|||
23193491|NCT02792777|64449686|FG000|Overall Study|Recording malfunction|2|||
23193492|NCT02792777|64449687|FG001|Overall Study|Recording malfunction|0|||
23193493|NCT02792777|64449686|FG000|Overall Study|Later determined to be ineligible|2|||
23193494|NCT02792777|64449687|FG001|Overall Study|Later determined to be ineligible|0|||
23193495|NCT02792777|64449686|FG000|Overall Study|Participant interviewed twice|1|||
23193496|NCT02792777|64449687|FG001|Overall Study|Participant interviewed twice|0|||
23193497|NCT00984659|64449693|FG000|2-week Run-in Period|Adverse Event|8|||
23193498|NCT00984659|64449694|FG001|2-week Run-in Period|Adverse Event|0|||
23193499|NCT00984659|64449695|FG002|2-week Run-in Period|Adverse Event|0|||
23193500|NCT00984659|64449696|FG003|2-week Run-in Period|Adverse Event|0|||
23193501|NCT00984659|64449693|FG000|2-week Run-in Period|Protocol Violation|5|||
23193502|NCT00984659|64449694|FG001|2-week Run-in Period|Protocol Violation|0|||
23193503|NCT00984659|64449695|FG002|2-week Run-in Period|Protocol Violation|0|||
23193504|NCT00984659|64449696|FG003|2-week Run-in Period|Protocol Violation|0|||
23592970|NCT01081145|65899746|FG001|Open-Label Phase|Other|0|||
23193505|NCT00984659|64449693|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
23193506|NCT00984659|64449694|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
23193507|NCT00984659|64449695|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
23193508|NCT00984659|64449696|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
23193509|NCT00984659|64449693|FG000|2-week Run-in Period|Lost to Follow-up|3|||
23592971|NCT01081145|65899745|FG000|Open-Label Phase|Lost to Follow-up|11|||
23592972|NCT01081145|65899746|FG001|Open-Label Phase|Lost to Follow-up|0|||
23592973|NCT01081145|65899745|FG000|Open-Label Phase|Protocol Violation|4|||
23592974|NCT01081145|65899746|FG001|Open-Label Phase|Protocol Violation|0|||
23592975|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
23592976|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
23592977|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
23592978|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
23592979|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
23592980|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
23592981|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
23592982|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
23193510|NCT00984659|64449694|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23193511|NCT00984659|64449695|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23254071|NCT02046369|64670419|FG000|Overall Study|Lack of Efficacy|3|||
23254072|NCT02046369|64670420|FG001|Overall Study|Lack of Efficacy|3|||
23254073|NCT02046369|64670419|FG000|Overall Study|Lost to Follow-up|3|||
23254074|NCT02046369|64670420|FG001|Overall Study|Lost to Follow-up|3|||
23254075|NCT02046369|64670419|FG000|Overall Study|Protocol Violation|1|||
23254076|NCT02046369|64670420|FG001|Overall Study|Protocol Violation|2|||
23254077|NCT02046369|64670419|FG000|Overall Study|Withdrawal by Subject|3|||
23254078|NCT02046369|64670420|FG001|Overall Study|Withdrawal by Subject|6|||
23254079|NCT02046369|64670419|FG000|Overall Study|never received study drug|0|||
23254080|NCT02046369|64670420|FG001|Overall Study|never received study drug|1|||
23193512|NCT00984659|64449696|FG003|2-week Run-in Period|Lost to Follow-up|0|||
23193513|NCT00984659|64449693|FG000|2-week Run-in Period|Physician Decision|10|||
23193514|NCT00984659|64449694|FG001|2-week Run-in Period|Physician Decision|0|||
23193515|NCT00984659|64449695|FG002|2-week Run-in Period|Physician Decision|0|||
23193516|NCT00984659|64449696|FG003|2-week Run-in Period|Physician Decision|0|||
23193517|NCT00984659|64449693|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
23193518|NCT00984659|64449694|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23193519|NCT00984659|64449695|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23193520|NCT00984659|64449696|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
23193521|NCT00984659|64449693|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
23193522|NCT00984659|64449694|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23193523|NCT00984659|64449695|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23193524|NCT00984659|64449696|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
23193525|NCT00984659|64449693|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
23193526|NCT00984659|64449694|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
23193527|NCT00984659|64449695|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
23193528|NCT00984659|64449696|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
23254081|NCT02046369|64670419|FG000|Overall Study|non compliance|1|||
23254082|NCT02046369|64670420|FG001|Overall Study|non compliance|0|||
23254083|NCT05003167|64670429|FG000|Overall Study|Withdrawal by Subject|1|||
23592983|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
23193529|NCT00984659|64449693|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
23193530|NCT00984659|64449694|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
23193531|NCT00984659|64449695|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
23477035|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
23477036|NCT00274924|65491452|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
23477037|NCT00274924|65491453|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
23477038|NCT00274924|65491454|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
23477039|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
23477040|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
23477041|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
23477042|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
23477043|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
23477044|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
23477045|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
23477046|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
23477047|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
23193532|NCT00984659|64449696|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
23193533|NCT00984659|64449693|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
23193534|NCT00984659|64449694|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
23193535|NCT00984659|64449695|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
23193536|NCT00984659|64449696|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
23193537|NCT00984659|64449693|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
23193538|NCT00984659|64449694|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
23477048|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
23477049|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
23477050|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
23477051|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
23477052|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
23477053|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
23477054|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
23477055|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
23477056|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
23477057|NCT00274924|65491452|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
23477058|NCT00274924|65491453|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
23477059|NCT00274924|65491454|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
23477060|NCT01589653|65491455|FG000|Overall Study|Protocol Violation|3|||
23477061|NCT01589653|65491456|FG001|Overall Study|Protocol Violation|1|||
23477062|NCT01589653|65491455|FG000|Overall Study|Withdrawal criteria|4|||
23477063|NCT01589653|65491456|FG001|Overall Study|Withdrawal criteria|7|||
23477064|NCT01589653|65491455|FG000|Overall Study|Unclassified|0|||
23477065|NCT01589653|65491456|FG001|Overall Study|Unclassified|3|||
23477066|NCT02745145|65491466|FG000|Overall Study|Adverse Event|1|||
23477067|NCT02745145|65491467|FG001|Overall Study|Adverse Event|0|||
23477068|NCT02745145|65491468|FG002|Overall Study|Adverse Event|0|||
23477069|NCT02745145|65491466|FG000|Overall Study|Death|0|||
23477070|NCT02745145|65491467|FG001|Overall Study|Death|1|||
23477071|NCT02745145|65491468|FG002|Overall Study|Death|0|||
23477072|NCT02745145|65491466|FG000|Overall Study|Progressive disease|0|||
23477073|NCT02745145|65491467|FG001|Overall Study|Progressive disease|0|||
23477074|NCT02745145|65491468|FG002|Overall Study|Progressive disease|1|||
23477075|NCT02745145|65491466|FG000|Overall Study|Withdrew consent|1|||
23477076|NCT02745145|65491467|FG001|Overall Study|Withdrew consent|1|||
23477077|NCT02745145|65491468|FG002|Overall Study|Withdrew consent|1|||
23477078|NCT02745145|65491466|FG000|Overall Study|Study Termination|8|||
23477079|NCT02745145|65491467|FG001|Overall Study|Study Termination|3|||
23477080|NCT02745145|65491468|FG002|Overall Study|Study Termination|7|||
23193539|NCT00984659|64449695|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
23477081|NCT01989208|65491469|FG000|200 mg (7 Days)|Protocol Violation|0|||
23477082|NCT01989208|65491470|FG001|200 mg (7 Days)|Protocol Violation|1|||
23477083|NCT02123251|65491473|FG000|Overall Study|Death|1|||
23477084|NCT02123251|65491474|FG001|Overall Study|Death|1|||
23477085|NCT02123251|65491473|FG000|Overall Study|Withdrawal by Subject|0|||
23477086|NCT02123251|65491474|FG001|Overall Study|Withdrawal by Subject|3|||
23193540|NCT00984659|64449696|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
23254084|NCT01296152|64670434|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
23592984|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
23592985|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
23477087|NCT02123251|65491473|FG000|Overall Study|Lost Medicaid eligibility|29|||
23477088|NCT02123251|65491474|FG001|Overall Study|Lost Medicaid eligibility|22|||
23477089|NCT02123251|65491473|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
23477090|NCT02123251|65491474|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
23477091|NCT02241889|65491475|FG000|Overall Study|device issues|0|||
23477092|NCT02241889|65491476|FG001|Overall Study|device issues|0|||
23477093|NCT02241889|65491477|FG002|Overall Study|device issues|1|||
23254085|NCT00833547|64670435|FG000|Overall Study|Withdrawal by Subject|2|||
23254086|NCT00833547|64670436|FG001|Overall Study|Withdrawal by Subject|2|||
23254087|NCT03707522|64670437|FG000|Overall Study|Lost to Follow-up|24|||
23254088|NCT03707522|64670438|FG001|Overall Study|Lost to Follow-up|27|||
23254089|NCT03707522|64670439|FG002|Overall Study|Lost to Follow-up|41|||
23254090|NCT03707522|64670440|FG003|Overall Study|Lost to Follow-up|36|||
23254091|NCT01766310|64670441|FG000|Overall Study|Lost to Follow-up|1|||
23254092|NCT01766310|64670442|FG001|Overall Study|Lost to Follow-up|3|||
23254093|NCT01585831|64673375|FG000|Overall Study|Physician Decision|0|||
23254094|NCT01585831|64673376|FG001|Overall Study|Physician Decision|1|||
23254095|NCT01585831|64673375|FG000|Overall Study|Withdrawal by Subject|2|||
23254096|NCT01585831|64673376|FG001|Overall Study|Withdrawal by Subject|1|||
23592986|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
23193541|NCT00984659|64449693|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23193542|NCT00984659|64449694|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
23193543|NCT00984659|64449695|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
23193544|NCT00984659|64449696|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
23193545|NCT04770155|64449710|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23193546|NCT04770155|64449711|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23193547|NCT04770155|64449712|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23193548|NCT04770155|64449713|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23193549|NCT04770155|64449714|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23193550|NCT04770155|64449715|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23193551|NCT04770155|64449716|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23193552|NCT04770155|64449717|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
23193553|NCT02413255|64449720|FG000|Overall Study|Voluntary Withdrawal|0|||
23193554|NCT02413255|64449721|FG001|Overall Study|Voluntary Withdrawal|0|||
23193555|NCT02413255|64449722|FG002|Overall Study|Voluntary Withdrawal|0|||
23193556|NCT02413255|64449723|FG003|Overall Study|Voluntary Withdrawal|0|||
23193557|NCT02413255|64449724|FG004|Overall Study|Voluntary Withdrawal|0|||
23193558|NCT02413255|64449725|FG005|Overall Study|Voluntary Withdrawal|0|||
23193559|NCT02413255|64449726|FG006|Overall Study|Voluntary Withdrawal|0|||
23193560|NCT02413255|64449727|FG007|Overall Study|Voluntary Withdrawal|0|||
23193561|NCT02413255|64449728|FG008|Overall Study|Voluntary Withdrawal|0|||
23193562|NCT02413255|64449729|FG009|Overall Study|Voluntary Withdrawal|0|||
23193563|NCT02413255|64449730|FG010|Overall Study|Voluntary Withdrawal|0|||
23193564|NCT02413255|64449731|FG011|Overall Study|Voluntary Withdrawal|0|||
23193565|NCT02413255|64449732|FG012|Overall Study|Voluntary Withdrawal|0|||
23193566|NCT02413255|64449733|FG013|Overall Study|Voluntary Withdrawal|0|||
23193567|NCT02413255|64449734|FG014|Overall Study|Voluntary Withdrawal|1|||
23193568|NCT02413255|64449735|FG015|Overall Study|Voluntary Withdrawal|0|||
23193569|NCT02413255|64449736|FG016|Overall Study|Voluntary Withdrawal|0|||
23193570|NCT00955110|64449741|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
23193571|NCT00955110|64449741|FG000|Treatment Phase|Adverse Event|2|||
23193572|NCT00955110|64449741|FG000|Treatment Phase|Administrative reasons|2|||
23193573|NCT00955110|64449741|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
23193574|NCT00955110|64449741|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
23193575|NCT02441803|64449742|FG000|Overall Study|Physician Decision|0|||
23193576|NCT02441803|64449743|FG001|Overall Study|Physician Decision|2|||
23193577|NCT02441803|64449744|FG002|Overall Study|Physician Decision|2|||
23193578|NCT01364467|64449745|FG000|Overall Study|Lost to Follow-up|1|||
23193579|NCT01364467|64449746|FG001|Overall Study|Lost to Follow-up|2|||
23193580|NCT01001494|64449747|FG000|Overall Study|Adverse Event|8|||
23193581|NCT01001494|64449748|FG001|Overall Study|Adverse Event|4|||
23193582|NCT01001494|64449749|FG002|Overall Study|Adverse Event|6|||
23193583|NCT01001494|64449747|FG000|Overall Study|Protocol Violation|0|||
23193584|NCT01001494|64449748|FG001|Overall Study|Protocol Violation|1|||
23193585|NCT01001494|64449749|FG002|Overall Study|Protocol Violation|1|||
23193586|NCT01001494|64449747|FG000|Overall Study|Lost to Follow-up|2|||
23193587|NCT01001494|64449748|FG001|Overall Study|Lost to Follow-up|0|||
23193588|NCT01001494|64449749|FG002|Overall Study|Lost to Follow-up|1|||
23193589|NCT01001494|64449747|FG000|Overall Study|Withdrawal by Subject|9|||
23193590|NCT01001494|64449748|FG001|Overall Study|Withdrawal by Subject|7|||
23193591|NCT01001494|64449749|FG002|Overall Study|Withdrawal by Subject|17|||
23193592|NCT01001494|64449747|FG000|Overall Study|COPD exacerbation|3|||
23193593|NCT01001494|64449748|FG001|Overall Study|COPD exacerbation|4|||
23193594|NCT01001494|64449749|FG002|Overall Study|COPD exacerbation|5|||
23193595|NCT01001494|64449747|FG000|Overall Study|Lack of Efficacy|2|||
23193596|NCT01001494|64449748|FG001|Overall Study|Lack of Efficacy|0|||
23254097|NCT02623426|64673377|FG000|Overall Study|Lost to Follow-up|0|||
23254098|NCT02623426|64673378|FG001|Overall Study|Lost to Follow-up|0|||
23254099|NCT02623426|64673379|FG002|Overall Study|Lost to Follow-up|1|||
23254100|NCT02623426|64673377|FG000|Overall Study|Withdrawal by Subject|1|||
23254101|NCT02623426|64673378|FG001|Overall Study|Withdrawal by Subject|2|||
23254102|NCT02623426|64673379|FG002|Overall Study|Withdrawal by Subject|2|||
23254103|NCT02766400|64673380|FG000|Overall Study|Death|1|||
23254104|NCT02766400|64673381|FG001|Overall Study|Death|2|||
23254105|NCT02766400|64673380|FG000|Overall Study|Withdrawal by Subject|1|||
23254106|NCT02766400|64673381|FG001|Overall Study|Withdrawal by Subject|0|||
23254107|NCT01169987|64673382|FG000|Overall Study|Withdrawal by Subject|3|||
23254108|NCT01169987|64673382|FG000|Overall Study|Lost to Follow-up|24|||
23254109|NCT01169987|64673382|FG000|Overall Study|Other|4|||
23254110|NCT02576054|64673384|FG000|Overall Study|Withdrawal by Subject|1|||
23254111|NCT00481871|64673385|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
23254112|NCT00481871|64673386|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
23254113|NCT00481871|64673387|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
23254114|NCT00481871|64673388|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
23254115|NCT00481871|64673389|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
23254116|NCT02016755|64673390|FG000|Overall Study|Major amputation of index limb|2|||
23254117|NCT02016755|64673390|FG000|Overall Study|Adverse Event|2|||
23254118|NCT02016755|64673390|FG000|Overall Study|Physician Decision|1|||
23254119|NCT02016755|64673390|FG000|Overall Study|Death|2|||
23254120|NCT00379587|64673391|FG000|Overall Study|Lost to Follow-up|2|||
23254121|NCT03053622|64673392|FG000|Overall Study|Lost to Follow-up|0|||
23254122|NCT03053622|64673393|FG001|Overall Study|Lost to Follow-up|0|||
23254123|NCT03053622|64673394|FG002|Overall Study|Lost to Follow-up|0|||
23254124|NCT03053622|64673395|FG003|Overall Study|Lost to Follow-up|1|||
23254125|NCT01537549|64673396|FG000|Overall Study|Lost to Follow-up|1|||
23254126|NCT01537549|64673396|FG000|Overall Study|Withdrawal by Subject|2|||
23254127|NCT04088734|64673397|FG000|Overall Study|Other, Not Specified|5|||
23254128|NCT00265083|64673398|FG000|Overall Study|Adverse Event|5|||
23254129|NCT00265083|64673399|FG001|Overall Study|Adverse Event|13|||
23254130|NCT00265083|64673400|FG002|Overall Study|Adverse Event|15|||
23254131|NCT00265083|64673398|FG000|Overall Study|Lost to Follow-up|3|||
23254132|NCT00265083|64673399|FG001|Overall Study|Lost to Follow-up|4|||
23254133|NCT00265083|64673400|FG002|Overall Study|Lost to Follow-up|4|||
23254134|NCT00265083|64673398|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
23254135|NCT00265083|64673399|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
23254136|NCT00265083|64673400|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
23254137|NCT00265083|64673398|FG000|Overall Study|Other|1|||
23254138|NCT00265083|64673399|FG001|Overall Study|Other|12|||
23254139|NCT00265083|64673400|FG002|Overall Study|Other|9|||
23254140|NCT00569231|64673401|FG000|Overall Study|Study unrelated surgery|1|||
23254141|NCT00569231|64673401|FG000|Overall Study|Airfare expense|2|||
23254142|NCT00569231|64673401|FG000|Overall Study|Withdrawal by Subject|1|||
23254143|NCT00569231|64673401|FG000|Overall Study|Car accident injury|1|||
23254144|NCT00569231|64673401|FG000|Overall Study|Non-compliance|2|||
23254145|NCT03262233|64673407|FG000|Overall Study|Withdrawal by Subject|12|||
23254146|NCT03262233|64673408|FG001|Overall Study|Withdrawal by Subject|8|||
23254147|NCT03262233|64673409|FG002|Overall Study|Withdrawal by Subject|21|||
23254148|NCT03262233|64673410|FG003|Overall Study|Withdrawal by Subject|13|||
23254149|NCT03262233|64673407|FG000|Overall Study|Declined due to shock|1|||
23254150|NCT03262233|64673408|FG001|Overall Study|Declined due to shock|2|||
23254151|NCT03262233|64673409|FG002|Overall Study|Declined due to shock|2|||
23254152|NCT03262233|64673410|FG003|Overall Study|Declined due to shock|3|||
23254153|NCT03262233|64673407|FG000|Overall Study|Protocol Violation|5|||
23254154|NCT03262233|64673408|FG001|Overall Study|Protocol Violation|10|||
23254155|NCT03262233|64673409|FG002|Overall Study|Protocol Violation|2|||
23254156|NCT03262233|64673410|FG003|Overall Study|Protocol Violation|13|||
23254157|NCT03262233|64673407|FG000|Overall Study|data collection artifact|0|||
23592987|NCT01081145|65899745|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
23592988|NCT01081145|65899746|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
23592989|NCT02965846|65899753|FG000|Overall Study|Lost to Follow-up|1|||
23592990|NCT02965846|65899754|FG001|Overall Study|Lost to Follow-up|0|||
23254158|NCT03262233|64673408|FG001|Overall Study|data collection artifact|1|||
23254159|NCT03262233|64673409|FG002|Overall Study|data collection artifact|0|||
23254160|NCT03262233|64673410|FG003|Overall Study|data collection artifact|0|||
23254161|NCT00729365|64673411|FG000|Overall Study|Physician Decision|33|||
23254162|NCT00729365|64673412|FG001|Overall Study|Physician Decision|6|||
23254163|NCT00729365|64673413|FG002|Overall Study|Physician Decision|7|||
23254164|NCT01796860|64673414|FG000|Overall Study|Withdrawal by Subject|3|||
23254165|NCT03264066|64673421|FG000|Overall Study|Adverse Event|1|||
23254166|NCT03264066|64673422|FG001|Overall Study|Adverse Event|1|||
23254167|NCT03264066|64673423|FG002|Overall Study|Adverse Event|0|||
23254168|NCT03264066|64673424|FG003|Overall Study|Adverse Event|0|||
23254169|NCT03264066|64673425|FG004|Overall Study|Adverse Event|0|||
23254170|NCT03264066|64673426|FG005|Overall Study|Adverse Event|0|||
23254171|NCT03264066|64673421|FG000|Overall Study|Death|12|||
23592991|NCT02965846|65899755|FG002|Overall Study|Lost to Follow-up|0|||
23592992|NCT02965846|65899753|FG000|Overall Study|Withdrawal by Subject|0|||
23592993|NCT02965846|65899754|FG001|Overall Study|Withdrawal by Subject|1|||
23592994|NCT02965846|65899755|FG002|Overall Study|Withdrawal by Subject|0|||
23592995|NCT02965846|65899753|FG000|Overall Study|Study Terminated By Sponsor|4|||
23592996|NCT02965846|65899754|FG001|Overall Study|Study Terminated By Sponsor|4|||
23592997|NCT02965846|65899755|FG002|Overall Study|Study Terminated By Sponsor|0|||
23592998|NCT02965846|65899753|FG000|Overall Study|Participants not randomized|0|||
23592999|NCT02965846|65899754|FG001|Overall Study|Participants not randomized|0|||
23593000|NCT02965846|65899755|FG002|Overall Study|Participants not randomized|33|||
23593001|NCT00177216|65902963|FG000|Overall Study|Withdrawal by Subject|6|||
23593002|NCT00177216|65902964|FG001|Overall Study|Withdrawal by Subject|3|||
23593003|NCT00177216|65902965|FG002|Overall Study|Withdrawal by Subject|1|||
23593004|NCT01400776|65902966|FG000|Overall Study|Adverse Event|7|||
23593005|NCT01400776|65902967|FG001|Overall Study|Adverse Event|2|||
23593006|NCT01400776|65902968|FG002|Overall Study|Adverse Event|9|||
23593007|NCT01400776|65902969|FG003|Overall Study|Adverse Event|2|||
23593008|NCT01400776|65902966|FG000|Overall Study|Lost to Follow-up|1|||
23593009|NCT01400776|65902967|FG001|Overall Study|Lost to Follow-up|0|||
23593010|NCT01400776|65902968|FG002|Overall Study|Lost to Follow-up|4|||
23593011|NCT01400776|65902969|FG003|Overall Study|Lost to Follow-up|1|||
23593012|NCT01400776|65902966|FG000|Overall Study|Withdrew Consent|4|||
23593013|NCT01400776|65902967|FG001|Overall Study|Withdrew Consent|2|||
23593014|NCT01400776|65902968|FG002|Overall Study|Withdrew Consent|6|||
23593015|NCT01400776|65902969|FG003|Overall Study|Withdrew Consent|1|||
23193597|NCT01001494|64449749|FG002|Overall Study|Lack of Efficacy|8|||
23193598|NCT01001494|64449747|FG000|Overall Study|Other|0|||
23193599|NCT01001494|64449748|FG001|Overall Study|Other|1|||
23193600|NCT01001494|64449749|FG002|Overall Study|Other|3|||
23193601|NCT00487279|64449751|FG000|Overall Study|Death|1|||
23193602|NCT00487279|64449752|FG001|Overall Study|Death|0|||
23193603|NCT00487279|64449751|FG000|Overall Study|Withdrawal by Subject|0|||
23477094|NCT02241889|65491478|FG003|Overall Study|device issues|0|||
23477095|NCT02241889|65491479|FG004|Overall Study|device issues|0|||
23477096|NCT02241889|65491480|FG005|Overall Study|device issues|0|||
23477097|NCT02241889|65491475|FG000|Overall Study|Withdrawal by Subject|0|||
23477098|NCT02241889|65491476|FG001|Overall Study|Withdrawal by Subject|0|||
23477099|NCT02241889|65491477|FG002|Overall Study|Withdrawal by Subject|0|||
23477100|NCT02241889|65491478|FG003|Overall Study|Withdrawal by Subject|0|||
23477101|NCT02241889|65491479|FG004|Overall Study|Withdrawal by Subject|0|||
23477102|NCT02241889|65491480|FG005|Overall Study|Withdrawal by Subject|1|||
23477103|NCT02743611|65491484|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
23477104|NCT02743611|65491485|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
23477105|NCT02743611|65491486|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
23477106|NCT02743611|65491487|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
23477107|NCT01699867|65491488|FG000|Overall Study|Screening Failure|3|||
23477108|NCT00402233|65491489|FG000|Overall Study|Adverse Event|1|||
23477109|NCT00402233|65491490|FG001|Overall Study|Adverse Event|7|||
23477110|NCT00402233|65491491|FG002|Overall Study|Adverse Event|9|||
23477111|NCT00402233|65491492|FG003|Overall Study|Adverse Event|9|||
23477112|NCT00402233|65491489|FG000|Overall Study|Protocol Violation|0|||
23477113|NCT00402233|65491490|FG001|Overall Study|Protocol Violation|1|||
23477114|NCT00402233|65491491|FG002|Overall Study|Protocol Violation|0|||
23477115|NCT00402233|65491492|FG003|Overall Study|Protocol Violation|0|||
23477116|NCT00402233|65491489|FG000|Overall Study|Withdrawal by Subject|2|||
23477117|NCT00402233|65491490|FG001|Overall Study|Withdrawal by Subject|1|||
23477118|NCT00402233|65491491|FG002|Overall Study|Withdrawal by Subject|2|||
23477119|NCT00402233|65491492|FG003|Overall Study|Withdrawal by Subject|2|||
23477120|NCT00402233|65491489|FG000|Overall Study|Worsening of disease under study|2|||
23477121|NCT00402233|65491490|FG001|Overall Study|Worsening of disease under study|0|||
23477122|NCT00402233|65491491|FG002|Overall Study|Worsening of disease under study|0|||
23477123|NCT00402233|65491492|FG003|Overall Study|Worsening of disease under study|0|||
23477124|NCT00402233|65491489|FG000|Overall Study|Worsening of other pre-existing disease|0|||
23477125|NCT00402233|65491490|FG001|Overall Study|Worsening of other pre-existing disease|1|||
23593016|NCT01400776|65902966|FG000|Overall Study|Protocol Deviation|6|||
23593017|NCT01400776|65902967|FG001|Overall Study|Protocol Deviation|1|||
23593018|NCT01400776|65902968|FG002|Overall Study|Protocol Deviation|5|||
23593019|NCT01400776|65902969|FG003|Overall Study|Protocol Deviation|2|||
23593020|NCT01400776|65902966|FG000|Overall Study|Reason not Specified|3|||
23593021|NCT01400776|65902967|FG001|Overall Study|Reason not Specified|0|||
23593022|NCT01400776|65902968|FG002|Overall Study|Reason not Specified|4|||
23193604|NCT00487279|64449752|FG001|Overall Study|Withdrawal by Subject|2|||
23477126|NCT00402233|65491491|FG002|Overall Study|Worsening of other pre-existing disease|0|||
23477127|NCT00402233|65491492|FG003|Overall Study|Worsening of other pre-existing disease|0|||
23477128|NCT03254108|65491493|FG000|Overall Study|Adverse Event|0|||
23193605|NCT03141307|64449760|FG000|In-Hospital|Withdrawal by Subject|0|||
23193606|NCT03141307|64449761|FG001|In-Hospital|Withdrawal by Subject|2|||
23193607|NCT03141307|64449760|FG000|In-Hospital|Protocol Violation|4|||
23593023|NCT01400776|65902969|FG003|Overall Study|Reason not Specified|3|||
23593024|NCT00941655|65902970|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
23593025|NCT00941655|65902971|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
23593026|NCT00941655|65902970|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
23593027|NCT00941655|65902971|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
23593028|NCT00941655|65902970|FG000|Overall Study|progressed while on chemo|0|||
23593029|NCT00941655|65902971|FG001|Overall Study|progressed while on chemo|2|||
23593030|NCT00941655|65902970|FG000|Overall Study|refused further treatment|0|||
23593031|NCT00941655|65902971|FG001|Overall Study|refused further treatment|1|||
23593032|NCT00941655|65902970|FG000|Overall Study|withdrew consent|0|||
23593033|NCT00941655|65902971|FG001|Overall Study|withdrew consent|1|||
23593034|NCT00941655|65902970|FG000|Overall Study|non-compliant|0|||
23593035|NCT00941655|65902971|FG001|Overall Study|non-compliant|1|||
23593036|NCT04305405|65902972|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23593037|NCT04305405|65902973|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23193608|NCT03141307|64449761|FG001|In-Hospital|Protocol Violation|0|||
23193609|NCT03141307|64449760|FG000|Follow-Up|Lost to Follow-up|97|||
23193610|NCT03141307|64449761|FG001|Follow-Up|Lost to Follow-up|54|||
23193611|NCT01507545|64449762|FG000|Overall Study|Withdrawal by Subject|6|||
23193612|NCT01507545|64449763|FG001|Overall Study|Withdrawal by Subject|2|||
23193613|NCT01507545|64449762|FG000|Overall Study|Lost to Follow-up|1|||
23193614|NCT01507545|64449763|FG001|Overall Study|Lost to Follow-up|0|||
23593038|NCT00520546|65902974|FG000|Overall Study|Withdrawal by Subject|1|||
23593039|NCT00520546|65902974|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
23593040|NCT03740009|65902975|FG000|Overall Study|Physician Decision|9|||
23593041|NCT03740009|65902975|FG000|Overall Study|Lost to Follow-up|1|||
23593042|NCT02706717|65902976|FG000|Overall Study|Withdrawal by Subject|1|||
23593043|NCT02706717|65902977|FG001|Overall Study|Withdrawal by Subject|8|||
23593044|NCT02706717|65902976|FG000|Overall Study|Lost to Follow-up|0|||
23193615|NCT01507545|64449762|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
23193616|NCT01507545|64449763|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
23193617|NCT01507545|64449762|FG000|Overall Study|Progressive disease|60|||
23193618|NCT01507545|64449763|FG001|Overall Study|Progressive disease|27|||
23193619|NCT01507545|64449762|FG000|Overall Study|Other|6|||
23193620|NCT01507545|64449763|FG001|Overall Study|Other|4|||
23193621|NCT03126227|64452296|FG000|Overall Study|Adverse Event|43|||
23193622|NCT03126227|64452297|FG001|Overall Study|Adverse Event|4|||
23193623|NCT03126227|64452296|FG000|Overall Study|Death|0|||
23193624|NCT03126227|64452297|FG001|Overall Study|Death|1|||
23193625|NCT03126227|64452296|FG000|Overall Study|Lost to Follow-up|0|||
23193626|NCT03126227|64452297|FG001|Overall Study|Lost to Follow-up|1|||
23193627|NCT03126227|64452296|FG000|Overall Study|Physician Decision|2|||
23193628|NCT03126227|64452297|FG001|Overall Study|Physician Decision|0|||
23193629|NCT03126227|64452296|FG000|Overall Study|Protocol Violation|1|||
23593045|NCT02706717|65902977|FG001|Overall Study|Lost to Follow-up|1|||
23593046|NCT02706717|65902976|FG000|Overall Study|Physician Decision|0|||
23593047|NCT02706717|65902977|FG001|Overall Study|Physician Decision|1|||
23593048|NCT02706717|65902976|FG000|Overall Study|Death|0|||
23593049|NCT02706717|65902977|FG001|Overall Study|Death|1|||
23193630|NCT03126227|64452297|FG001|Overall Study|Protocol Violation|0|||
23193631|NCT03126227|64452296|FG000|Overall Study|Withdrawal by Subject|19|||
23254172|NCT03264066|64673422|FG001|Overall Study|Death|12|||
23193632|NCT03126227|64452297|FG001|Overall Study|Withdrawal by Subject|3|||
23193633|NCT03126227|64452296|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
23193634|NCT03126227|64452297|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
23193635|NCT03126227|64452296|FG000|Overall Study|Lack of dosing compliance|2|||
23193636|NCT03126227|64452297|FG001|Overall Study|Lack of dosing compliance|0|||
23193637|NCT03126227|64452296|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
23193638|NCT03126227|64452297|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
23193639|NCT03126227|64452296|FG000|Overall Study|Scheduling conflict|1|||
23593050|NCT00529659|65902978|FG000|Overall Study|Adverse Event|8|||
23593051|NCT00529659|65902979|FG001|Overall Study|Adverse Event|7|||
23593052|NCT00529659|65902978|FG000|Overall Study|Lost to Follow-up|0|||
23593053|NCT00529659|65902979|FG001|Overall Study|Lost to Follow-up|2|||
23593054|NCT00529659|65902978|FG000|Overall Study|Physician Decision|0|||
23593055|NCT00529659|65902979|FG001|Overall Study|Physician Decision|2|||
23593056|NCT00529659|65902978|FG000|Overall Study|Protocol Violation|2|||
23593057|NCT00529659|65902979|FG001|Overall Study|Protocol Violation|6|||
23593058|NCT00529659|65902978|FG000|Overall Study|Withdrawal by Subject|1|||
23593059|NCT00529659|65902979|FG001|Overall Study|Withdrawal by Subject|6|||
23593060|NCT00439569|65902980|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
23593061|NCT00439569|65902980|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
23593062|NCT00439569|65902980|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
23593063|NCT03988023|65902981|FG000|Overall Study|Non-compliance|3|||
23593064|NCT03988023|65902982|FG001|Overall Study|Non-compliance|0|||
23593065|NCT03988023|65902981|FG000|Overall Study|Withdrawal by Subject|39|||
23593066|NCT03988023|65902982|FG001|Overall Study|Withdrawal by Subject|37|||
23593067|NCT03988023|65902981|FG000|Overall Study|Adverse Event|0|||
23593068|NCT03988023|65902982|FG001|Overall Study|Adverse Event|2|||
23593069|NCT03988023|65902981|FG000|Overall Study|Physician Decision|0|||
23593070|NCT03988023|65902982|FG001|Overall Study|Physician Decision|1|||
23593071|NCT03988023|65902981|FG000|Overall Study|Lost to Follow-up|5|||
23593072|NCT03988023|65902982|FG001|Overall Study|Lost to Follow-up|8|||
23593073|NCT03988023|65902981|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
23593074|NCT03988023|65902982|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
23593075|NCT03988023|65902981|FG000|Overall Study|Lack of Efficacy|3|||
23593076|NCT03988023|65902982|FG001|Overall Study|Lack of Efficacy|1|||
23593077|NCT03988023|65902981|FG000|Overall Study|COVID-19 pandemic|225|||
23593078|NCT03988023|65902982|FG001|Overall Study|COVID-19 pandemic|227|||
23593079|NCT00743444|65902985|FG000|First Intervention|Catheter placement problems|0|||
23593080|NCT00743444|65902986|FG001|First Intervention|Catheter placement problems|1|||
23593081|NCT00743444|65902985|FG000|Washout Period|Adverse Event|0|||
23593082|NCT00743444|65902986|FG001|Washout Period|Adverse Event|1|||
23593083|NCT03460756|65902987|FG000|Overall Study|Adverse Event|0|||
23593084|NCT03460756|65902988|FG001|Overall Study|Adverse Event|0|||
23593085|NCT03460756|65902989|FG002|Overall Study|Adverse Event|0|||
23593086|NCT03460756|65902990|FG003|Overall Study|Adverse Event|1|||
23593087|NCT03460756|65902987|FG000|Overall Study|Lack of Efficacy|0|||
23593088|NCT03460756|65902988|FG001|Overall Study|Lack of Efficacy|0|||
23593089|NCT03460756|65902989|FG002|Overall Study|Lack of Efficacy|0|||
23593090|NCT03460756|65902990|FG003|Overall Study|Lack of Efficacy|2|||
23593091|NCT03460756|65902987|FG000|Overall Study|Lost to Follow-up|0|||
23593092|NCT03460756|65902988|FG001|Overall Study|Lost to Follow-up|1|||
23593093|NCT03460756|65902989|FG002|Overall Study|Lost to Follow-up|2|||
23593094|NCT03460756|65902990|FG003|Overall Study|Lost to Follow-up|1|||
23593095|NCT03460756|65902987|FG000|Overall Study|Pregnancy|0|||
23193640|NCT03126227|64452297|FG001|Overall Study|Scheduling conflict|0|||
23193641|NCT01595646|64452300|FG000|Overall Study|Withdrawal by Subject|1|||
23193642|NCT01595646|64452301|FG001|Overall Study|Withdrawal by Subject|0|||
23193643|NCT01595646|64452302|FG002|Overall Study|Withdrawal by Subject|0|||
23593096|NCT03460756|65902988|FG001|Overall Study|Pregnancy|0|||
23593097|NCT03460756|65902989|FG002|Overall Study|Pregnancy|0|||
23593098|NCT03460756|65902990|FG003|Overall Study|Pregnancy|1|||
23593099|NCT03460756|65902987|FG000|Overall Study|Protocol Violation|0|||
23593100|NCT03460756|65902988|FG001|Overall Study|Protocol Violation|0|||
23593101|NCT03460756|65902989|FG002|Overall Study|Protocol Violation|0|||
23593102|NCT03460756|65902990|FG003|Overall Study|Protocol Violation|1|||
23593103|NCT03460756|65902987|FG000|Overall Study|Withdrawal by Subject|0|||
23477129|NCT03254108|65491494|FG001|Overall Study|Adverse Event|2|||
23477130|NCT03254108|65491495|FG002|Overall Study|Adverse Event|0|||
23477131|NCT03254108|65491496|FG003|Overall Study|Adverse Event|1|||
23477132|NCT03254108|65491497|FG004|Overall Study|Adverse Event|1|||
23477133|NCT03254108|65491493|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
23477134|NCT03254108|65491494|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
23477135|NCT03254108|65491495|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
23477136|NCT03254108|65491496|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
23477137|NCT03254108|65491497|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
23477138|NCT00145977|65491498|FG000|Overall Study|Lack of Efficacy|0|||
23477139|NCT00145977|65491499|FG001|Overall Study|Lack of Efficacy|4|||
23254173|NCT03264066|64673423|FG002|Overall Study|Death|8|||
23254174|NCT03264066|64673424|FG003|Overall Study|Death|10|||
23254175|NCT03264066|64673425|FG004|Overall Study|Death|6|||
23254176|NCT03264066|64673426|FG005|Overall Study|Death|1|||
23254177|NCT03264066|64673421|FG000|Overall Study|Lost to Follow-up|1|||
23254178|NCT03264066|64673422|FG001|Overall Study|Lost to Follow-up|0|||
23477140|NCT00145977|65491498|FG000|Overall Study|Lost to Follow-up|1|||
23477141|NCT00145977|65491499|FG001|Overall Study|Lost to Follow-up|0|||
23477142|NCT00145977|65491498|FG000|Overall Study|Withdrawal by Subject|1|||
23477143|NCT00145977|65491499|FG001|Overall Study|Withdrawal by Subject|0|||
23477144|NCT01155167|65491500|FG000|Overall Study|Insufficient ultrasound data|2|||
23477145|NCT01155167|65491501|FG001|Overall Study|Insufficient ultrasound data|0|||
23477146|NCT01155167|65491500|FG000|Overall Study|Access site changed to femoral artery|1|||
23477147|NCT01155167|65491501|FG001|Overall Study|Access site changed to femoral artery|0|||
23193644|NCT02616029|64452303|FG000|Overall Study|Adverse Event|1|||
23193645|NCT02616029|64452304|FG001|Overall Study|Adverse Event|0|||
23193646|NCT02616029|64452303|FG000|Overall Study|Death|0|||
23193647|NCT02616029|64452304|FG001|Overall Study|Death|1|||
23193648|NCT02616029|64452303|FG000|Overall Study|Protocol Violation|1|||
23477148|NCT00459056|65491502|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
23477149|NCT00459056|65491503|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
23477150|NCT02156271|65491504|FG000|Overall Study|Physician Decision|4|||
23477151|NCT02156271|65491505|FG001|Overall Study|Physician Decision|3|||
23477152|NCT00567255|65491506|FG000|Overall Study|Adverse Event|241|||
23477153|NCT00567255|65491507|FG001|Overall Study|Adverse Event|68|||
23477154|NCT00567255|65491506|FG000|Overall Study|Lost to Follow-up|77|||
23477155|NCT00567255|65491507|FG001|Overall Study|Lost to Follow-up|48|||
23477156|NCT00567255|65491506|FG000|Overall Study|Withdrawal by Subject|75|||
23477157|NCT00567255|65491507|FG001|Overall Study|Withdrawal by Subject|56|||
23477158|NCT00567255|65491506|FG000|Overall Study|Lack of Efficacy|19|||
23477159|NCT00567255|65491507|FG001|Overall Study|Lack of Efficacy|33|||
23477160|NCT00567255|65491506|FG000|Overall Study|Protocol Violation|20|||
23477161|NCT00567255|65491507|FG001|Overall Study|Protocol Violation|8|||
23477162|NCT00567255|65491506|FG000|Overall Study|Pregnancy|6|||
23477163|NCT00567255|65491507|FG001|Overall Study|Pregnancy|0|||
23477164|NCT00567255|65491506|FG000|Overall Study|Drug noncompliance,moved,other|25|||
23477165|NCT00567255|65491507|FG001|Overall Study|Drug noncompliance,moved,other|15|||
23477166|NCT01909791|65491508|FG000|Overall Study|Death|9|||
23477167|NCT01909791|65491509|FG001|Overall Study|Death|8|||
23477168|NCT01909791|65491510|FG002|Overall Study|Death|4|||
23477169|NCT01909791|65491508|FG000|Overall Study|Withdrawal by Subject|5|||
23477170|NCT01909791|65491509|FG001|Overall Study|Withdrawal by Subject|9|||
23477171|NCT01909791|65491510|FG002|Overall Study|Withdrawal by Subject|13|||
23477172|NCT01909791|65491508|FG000|Overall Study|Lost to Follow-up|5|||
23477173|NCT01909791|65491509|FG001|Overall Study|Lost to Follow-up|11|||
23477174|NCT01909791|65491510|FG002|Overall Study|Lost to Follow-up|10|||
23477175|NCT01909791|65491508|FG000|Overall Study|Missed Visit|2|||
23193649|NCT02616029|64452304|FG001|Overall Study|Protocol Violation|0|||
23193650|NCT02616029|64452303|FG000|Overall Study|Withdrew Consent|1|||
23193651|NCT02616029|64452304|FG001|Overall Study|Withdrew Consent|0|||
23193652|NCT02616029|64452303|FG000|Overall Study|Enrolled and Never Treated|1|||
23254179|NCT03264066|64673423|FG002|Overall Study|Lost to Follow-up|0|||
23477176|NCT01909791|65491509|FG001|Overall Study|Missed Visit|0|||
23477177|NCT01909791|65491510|FG002|Overall Study|Missed Visit|1|||
23477178|NCT00444678|65491513|FG000|Overall Study|Toxicity|11|||
23477179|NCT00444678|65491513|FG000|Overall Study|Disease Progression|12|||
23477180|NCT00444678|65491513|FG000|Overall Study|Death|3|||
23477181|NCT00444678|65491513|FG000|Overall Study|Physician Decision|3|||
23477182|NCT00444678|65491513|FG000|Overall Study|Withdrawal by Subject|2|||
23477183|NCT00495040|65491514|FG000|Overall Study|Withdrawal by Subject|3|||
23477184|NCT01457352|65491515|FG000|Period 1|Adverse Event|2|||
23254180|NCT03264066|64673424|FG003|Overall Study|Lost to Follow-up|0|||
23193653|NCT02616029|64452304|FG001|Overall Study|Enrolled and Never Treated|1|||
23254181|NCT03264066|64673425|FG004|Overall Study|Lost to Follow-up|0|||
23477185|NCT01457352|65491516|FG001|Period 1|Adverse Event|0|||
23477186|NCT01457352|65491515|FG000|Period 1|Withdrawal by Subject|2|||
23477187|NCT01457352|65491516|FG001|Period 1|Withdrawal by Subject|0|||
23477188|NCT01457352|65491515|FG000|Period 1|Physician Decision|2|||
23477189|NCT01457352|65491516|FG001|Period 1|Physician Decision|0|||
23193654|NCT02532543|64452305|FG000|Overall Study|Lost to Follow-up|0|||
23193655|NCT02532543|64452306|FG001|Overall Study|Lost to Follow-up|0|||
23193656|NCT02532543|64452307|FG002|Overall Study|Lost to Follow-up|1|||
23193657|NCT02532543|64452308|FG003|Overall Study|Lost to Follow-up|0|||
23193658|NCT00425438|64452314|FG000|Overall Study|Termination by Sponsor|25|||
23193659|NCT00425438|64452315|FG001|Overall Study|Termination by Sponsor|27|||
23193660|NCT02805907|64452319|FG000|Overall Study|Lost to Follow-up|3|||
23193661|NCT02805907|64452320|FG001|Overall Study|Lost to Follow-up|3|||
23193662|NCT00739297|64452321|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
23193663|NCT00739297|64452322|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
23193664|NCT00739297|64452323|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
23193665|NCT00739297|64452324|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
23193666|NCT00739297|64452325|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
23193667|NCT00739297|64452326|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
23193668|NCT00739297|64452327|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
23193669|NCT00739297|64452321|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23193670|NCT00739297|64452322|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23193671|NCT00739297|64452323|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23193672|NCT00739297|64452324|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23193673|NCT00739297|64452325|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
23193674|NCT00739297|64452326|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
23193675|NCT00739297|64452327|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
23193676|NCT02747043|64452328|FG000|Overall Study|Other|1|||
23193677|NCT02747043|64452329|FG001|Overall Study|Other|1|||
23193678|NCT02747043|64452328|FG000|Overall Study|Adverse Event|3|||
23193679|NCT02747043|64452329|FG001|Overall Study|Adverse Event|1|||
23193680|NCT02747043|64452328|FG000|Overall Study|Withdrawal by Subject|1|||
23193681|NCT02747043|64452329|FG001|Overall Study|Withdrawal by Subject|1|||
23193682|NCT02747043|64452328|FG000|Overall Study|Physician Decision|1|||
23193683|NCT02747043|64452329|FG001|Overall Study|Physician Decision|1|||
23254182|NCT03264066|64673426|FG005|Overall Study|Lost to Follow-up|0|||
23254183|NCT03264066|64673421|FG000|Overall Study|Progressive Disease|0|||
23477190|NCT01457352|65491515|FG000|Period 1|MS related disease progression|1|||
23477191|NCT01457352|65491516|FG001|Period 1|MS related disease progression|0|||
23254184|NCT03264066|64673422|FG001|Overall Study|Progressive Disease|2|||
23254185|NCT03264066|64673423|FG002|Overall Study|Progressive Disease|1|||
23254186|NCT03264066|64673424|FG003|Overall Study|Progressive Disease|0|||
23254187|NCT03264066|64673425|FG004|Overall Study|Progressive Disease|0|||
23254188|NCT03264066|64673426|FG005|Overall Study|Progressive Disease|0|||
23254189|NCT03264066|64673421|FG000|Overall Study|Study Terminated by Sponsor|5|||
23477192|NCT01457352|65491515|FG000|Period 1|Withdrawn|1|||
23477193|NCT01457352|65491516|FG001|Period 1|Withdrawn|0|||
23477194|NCT01457352|65491515|FG000|Period 1|withdrew per sponsor|1|||
23477195|NCT01457352|65491516|FG001|Period 1|withdrew per sponsor|0|||
23477196|NCT01457352|65491515|FG000|Period 1|Protocol Violation|4|||
23477197|NCT01457352|65491516|FG001|Period 1|Protocol Violation|0|||
23477198|NCT01457352|65491515|FG000|Period 1|Did not meet eligibility criteria|3|||
23477199|NCT01457352|65491516|FG001|Period 1|Did not meet eligibility criteria|0|||
23477200|NCT01457352|65491515|FG000|Period 2|Withdrawal by Subject|23|||
23254190|NCT03264066|64673422|FG001|Overall Study|Study Terminated by Sponsor|5|||
23254191|NCT03264066|64673423|FG002|Overall Study|Study Terminated by Sponsor|8|||
23593104|NCT03460756|65902988|FG001|Overall Study|Withdrawal by Subject|4|||
23193684|NCT02747043|64452328|FG000|Overall Study|Protocol Violation|0|||
23254192|NCT03264066|64673424|FG003|Overall Study|Study Terminated by Sponsor|5|||
23477201|NCT01457352|65491516|FG001|Period 2|Withdrawal by Subject|0|||
23593105|NCT03460756|65902989|FG002|Overall Study|Withdrawal by Subject|7|||
23593106|NCT03460756|65902990|FG003|Overall Study|Withdrawal by Subject|3|||
23193685|NCT02747043|64452329|FG001|Overall Study|Protocol Violation|1|||
23193686|NCT02747043|64452328|FG000|Overall Study|Disease progression|4|||
23193687|NCT02747043|64452329|FG001|Overall Study|Disease progression|0|||
23193688|NCT02601001|64452330|FG000|Dosing Period 2|Adverse Event|0|||
23254193|NCT03264066|64673425|FG004|Overall Study|Study Terminated by Sponsor|1|||
23254194|NCT03264066|64673426|FG005|Overall Study|Study Terminated by Sponsor|2|||
23477202|NCT01457352|65491515|FG000|Period 2|Adverse Event|22|||
23477203|NCT01457352|65491516|FG001|Period 2|Adverse Event|0|||
23477204|NCT01457352|65491515|FG000|Period 2|no analysis|10|||
23593107|NCT00529516|65902991|FG000|Overall Study|Adverse Event|2|||
23593108|NCT00529516|65902992|FG001|Overall Study|Adverse Event|1|||
23593109|NCT00529516|65902993|FG002|Overall Study|Adverse Event|0|||
23593110|NCT00529516|65902991|FG000|Overall Study|Withdrawal by Subject|1|||
23593111|NCT00529516|65902992|FG001|Overall Study|Withdrawal by Subject|1|||
23593112|NCT00529516|65902993|FG002|Overall Study|Withdrawal by Subject|0|||
23593113|NCT00529516|65902991|FG000|Overall Study|Lost to Follow-up|0|||
23593114|NCT00529516|65902992|FG001|Overall Study|Lost to Follow-up|0|||
23593115|NCT00529516|65902993|FG002|Overall Study|Lost to Follow-up|1|||
23593116|NCT00444600|65902994|FG000|Overall Study|Death|7|||
23593117|NCT00444600|65902995|FG001|Overall Study|Death|5|||
23593118|NCT00444600|65902996|FG002|Overall Study|Death|3|||
23593119|NCT00444600|65902997|FG003|Overall Study|Death|2|||
23593120|NCT00444600|65902994|FG000|Overall Study|Dropped|11|||
23593121|NCT00444600|65902995|FG001|Overall Study|Dropped|11|||
23593122|NCT00444600|65902996|FG002|Overall Study|Dropped|7|||
23593123|NCT00444600|65902997|FG003|Overall Study|Dropped|7|||
23593124|NCT00444600|65902994|FG000|Overall Study|Missed visit|1|||
23593125|NCT00444600|65902995|FG001|Overall Study|Missed visit|0|||
23593126|NCT00444600|65902996|FG002|Overall Study|Missed visit|0|||
23593127|NCT00444600|65902997|FG003|Overall Study|Missed visit|1|||
23593128|NCT01968226|65902998|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
23593129|NCT02549170|65903001|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
23593130|NCT02549170|65903002|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
23593131|NCT02549170|65903003|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
23593132|NCT02549170|65903004|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
23593133|NCT02549170|65903005|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
23593134|NCT02549170|65903001|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
23593135|NCT02549170|65903002|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
23593136|NCT02549170|65903003|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
23593137|NCT02549170|65903004|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
23593138|NCT02549170|65903005|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
23593139|NCT02549170|65903001|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
23593140|NCT02549170|65903002|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
23593141|NCT02549170|65903003|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
23593142|NCT02549170|65903004|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
23593143|NCT02549170|65903005|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
23593144|NCT01832480|65903013|FG000|Overall Study|Lost to Follow-up|33|||
23593145|NCT01832480|65903014|FG001|Overall Study|Lost to Follow-up|30|||
23593146|NCT01832480|65903013|FG000|Overall Study|Withdrawal by Subject|0|||
23593147|NCT01832480|65903014|FG001|Overall Study|Withdrawal by Subject|2|||
23593148|NCT01832480|65903013|FG000|Overall Study|post randomization ineligible|8|||
23593149|NCT01832480|65903014|FG001|Overall Study|post randomization ineligible|10|||
23593150|NCT00106080|65903016|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
23593151|NCT00106080|65903017|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
23593152|NCT00150176|65903018|FG000|Overall Study|Adverse Event|16|||
23593153|NCT00150176|65903019|FG001|Overall Study|Adverse Event|53|||
23593154|NCT00150176|65903018|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
23593155|NCT00150176|65903019|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
23593156|NCT00150176|65903018|FG000|Overall Study|Withdrawal by Subject|19|||
23593157|NCT00150176|65903019|FG001|Overall Study|Withdrawal by Subject|12|||
23593158|NCT00150176|65903018|FG000|Overall Study|Lost to Follow-up|3|||
23593159|NCT00150176|65903019|FG001|Overall Study|Lost to Follow-up|3|||
23593160|NCT00150176|65903018|FG000|Overall Study|OTHER|11|||
23593161|NCT00150176|65903019|FG001|Overall Study|OTHER|13|||
23593162|NCT04425629|65903025|FG000|Overall Study|Adverse Event|0|||
23593163|NCT04425629|65903026|FG001|Overall Study|Adverse Event|0|||
23593164|NCT04425629|65903027|FG002|Overall Study|Adverse Event|0|||
23593165|NCT04425629|65903028|FG003|Overall Study|Adverse Event|0|||
23593166|NCT04425629|65903029|FG004|Overall Study|Adverse Event|1|||
23593167|NCT04425629|65903030|FG005|Overall Study|Adverse Event|0|||
23593168|NCT04425629|65903031|FG006|Overall Study|Adverse Event|0|||
23593169|NCT04425629|65903032|FG007|Overall Study|Adverse Event|0|||
23593170|NCT04425629|65903033|FG008|Overall Study|Adverse Event|0|||
23593171|NCT04425629|65903034|FG009|Overall Study|Adverse Event|3|||
23593172|NCT04425629|65903035|FG010|Overall Study|Adverse Event|2|||
23593173|NCT04425629|65903036|FG011|Overall Study|Adverse Event|1|||
23593174|NCT04425629|65903037|FG012|Overall Study|Adverse Event|1|||
23593175|NCT04425629|65903038|FG013|Overall Study|Adverse Event|0|||
23593176|NCT04425629|65903039|FG014|Overall Study|Adverse Event|0|||
23593177|NCT04425629|65903040|FG015|Overall Study|Adverse Event|0|||
23593178|NCT04425629|65903041|FG016|Overall Study|Adverse Event|0|||
23593179|NCT04425629|65903042|FG017|Overall Study|Adverse Event|0|||
23193689|NCT02601001|64452331|FG001|Dosing Period 2|Adverse Event|0|||
23254195|NCT03264066|64673421|FG000|Overall Study|Withdrawal by Subject|1|||
23254196|NCT03264066|64673422|FG001|Overall Study|Withdrawal by Subject|0|||
23254197|NCT03264066|64673423|FG002|Overall Study|Withdrawal by Subject|0|||
23254198|NCT03264066|64673424|FG003|Overall Study|Withdrawal by Subject|5|||
23254199|NCT03264066|64673425|FG004|Overall Study|Withdrawal by Subject|0|||
23254200|NCT03264066|64673426|FG005|Overall Study|Withdrawal by Subject|0|||
23254201|NCT03548207|64673427|FG000|Overall Study|Death|10|||
23254202|NCT03548207|64673428|FG001|Overall Study|Death|23|||
23254203|NCT03548207|64673429|FG002|Overall Study|Death|3|||
23254204|NCT03548207|64673427|FG000|Overall Study|Lost to Follow-up|0|||
23254205|NCT03548207|64673428|FG001|Overall Study|Lost to Follow-up|2|||
23254206|NCT03548207|64673429|FG002|Overall Study|Lost to Follow-up|0|||
23254207|NCT03548207|64673427|FG000|Overall Study|Withdrawal by Subject|0|||
23477205|NCT01457352|65491516|FG001|Period 2|no analysis|0|||
23477206|NCT01457352|65491515|FG000|Period 2|Lack of Efficacy|8|||
23477207|NCT01457352|65491516|FG001|Period 2|Lack of Efficacy|0|||
23193690|NCT02601001|64452332|FG002|Dosing Period 2|Adverse Event|0|||
23193691|NCT02601001|64452333|FG003|Dosing Period 2|Adverse Event|0|||
23193692|NCT02601001|64452334|FG004|Dosing Period 2|Adverse Event|0|||
23193693|NCT02601001|64452335|FG005|Dosing Period 2|Adverse Event|0|||
23193694|NCT02601001|64452336|FG006|Dosing Period 2|Adverse Event|1|||
23193695|NCT01264965|64452340|FG000|Overall Study|Withdrawal by Subject|10|||
23193696|NCT02213198|64452341|FG000|Baseline|No show for intake|7|||
23193697|NCT02213198|64452342|FG001|Baseline|No show for intake|9|||
23193698|NCT02213198|64452341|FG000|Baseline|Withdrawal by Subject|34|||
23193699|NCT02213198|64452342|FG001|Baseline|Withdrawal by Subject|11|||
23193700|NCT02213198|64452341|FG000|Baseline|transferred out of clinic|7|||
23193701|NCT02213198|64452342|FG001|Baseline|transferred out of clinic|9|||
23193702|NCT02213198|64452341|FG000|Baseline|Lost to Follow-up|40|||
23193703|NCT02213198|64452342|FG001|Baseline|Lost to Follow-up|21|||
23193704|NCT02213198|64452341|FG000|Baseline|incarcerated,violent|0|||
23193705|NCT02213198|64452342|FG001|Baseline|incarcerated,violent|1|||
23193706|NCT02213198|64452341|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
23193707|NCT02213198|64452342|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
23193708|NCT02213198|64452341|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
23193709|NCT02213198|64452342|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
23193710|NCT02213198|64452341|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
23193711|NCT02213198|64452342|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
23193712|NCT02213198|64452341|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
23193713|NCT02213198|64452342|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
23193714|NCT02213198|64452341|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
23193715|NCT02213198|64452342|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
23193716|NCT02213198|64452341|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
23193717|NCT02213198|64452342|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
23193718|NCT03704051|64452343|FG000|Overall Study|Withdrawal by Subject|4|||
23193719|NCT03704051|64452344|FG001|Overall Study|Withdrawal by Subject|0|||
23193720|NCT00590681|64452345|FG000|Overall Study|Withdrawal by Subject|7|||
23193721|NCT00590681|64452345|FG000|Overall Study|Adverse Event|8|||
23193722|NCT00590681|64452345|FG000|Overall Study|Death|3|||
23193723|NCT00590681|64452345|FG000|Overall Study|Lost to Follow-up|1|||
23193724|NCT00590681|64452345|FG000|Overall Study|disease progression|1|||
23193725|NCT05372575|64452346|FG000|Overall Study|Protocol Violation|7|||
23193726|NCT05372575|64452347|FG001|Overall Study|Protocol Violation|16|||
23193727|NCT00001259|64452348|FG000|Study 2|Adverse Event|0|||
23193728|NCT00001259|64452349|FG001|Study 2|Adverse Event|0|||
23193729|NCT00001259|64452350|FG002|Study 2|Adverse Event|0|||
23193730|NCT00001259|64452351|FG003|Study 2|Adverse Event|0|||
23193731|NCT00001259|64452352|FG004|Study 2|Adverse Event|2|||
23254208|NCT03548207|64673428|FG001|Overall Study|Withdrawal by Subject|3|||
23254209|NCT03548207|64673429|FG002|Overall Study|Withdrawal by Subject|0|||
23593180|NCT04425629|65903043|FG018|Overall Study|Adverse Event|0|||
23254210|NCT03548207|64673427|FG000|Overall Study|Sponsor decision|19|||
23254211|NCT03548207|64673428|FG001|Overall Study|Sponsor decision|40|||
23593181|NCT04425629|65903025|FG000|Overall Study|Lost to Follow-up|1|||
23193732|NCT00001259|64452353|FG005|Study 2|Adverse Event|0|||
23193733|NCT00001259|64452354|FG006|Study 2|Adverse Event|0|||
23193734|NCT01062399|64452364|FG000|Overall Study|Protocol Violation|0|||
23193735|NCT01062399|64452365|FG001|Overall Study|Protocol Violation|1|||
23193736|NCT01062399|64452366|FG002|Overall Study|Protocol Violation|0|||
23193737|NCT01062399|64452367|FG003|Overall Study|Protocol Violation|6|||
23193738|NCT01062399|64452368|FG004|Overall Study|Protocol Violation|4|||
23254212|NCT03548207|64673429|FG002|Overall Study|Sponsor decision|6|||
23254213|NCT03548207|64673427|FG000|Overall Study|Randomized but not treated|6|||
23254214|NCT03548207|64673428|FG001|Overall Study|Randomized but not treated|10|||
23477208|NCT01457352|65491515|FG000|Period 2|Protocol Violation|4|||
23593182|NCT04425629|65903026|FG001|Overall Study|Lost to Follow-up|3|||
23593183|NCT04425629|65903027|FG002|Overall Study|Lost to Follow-up|1|||
23593184|NCT04425629|65903028|FG003|Overall Study|Lost to Follow-up|7|||
23593185|NCT04425629|65903029|FG004|Overall Study|Lost to Follow-up|1|||
23593186|NCT04425629|65903030|FG005|Overall Study|Lost to Follow-up|2|||
23593187|NCT04425629|65903031|FG006|Overall Study|Lost to Follow-up|1|||
23593188|NCT04425629|65903032|FG007|Overall Study|Lost to Follow-up|0|||
23593189|NCT04425629|65903033|FG008|Overall Study|Lost to Follow-up|1|||
23593190|NCT04425629|65903034|FG009|Overall Study|Lost to Follow-up|64|||
23593191|NCT04425629|65903035|FG010|Overall Study|Lost to Follow-up|70|||
23593192|NCT04425629|65903036|FG011|Overall Study|Lost to Follow-up|98|||
23593193|NCT04425629|65903037|FG012|Overall Study|Lost to Follow-up|30|||
23593194|NCT04425629|65903038|FG013|Overall Study|Lost to Follow-up|0|||
23593195|NCT04425629|65903039|FG014|Overall Study|Lost to Follow-up|5|||
23593196|NCT04425629|65903040|FG015|Overall Study|Lost to Follow-up|4|||
23593197|NCT04425629|65903041|FG016|Overall Study|Lost to Follow-up|0|||
23593198|NCT04425629|65903042|FG017|Overall Study|Lost to Follow-up|3|||
23593199|NCT04425629|65903043|FG018|Overall Study|Lost to Follow-up|1|||
23593200|NCT04425629|65903025|FG000|Overall Study|Subject Decision|0|||
23593201|NCT04425629|65903026|FG001|Overall Study|Subject Decision|2|||
23593202|NCT04425629|65903027|FG002|Overall Study|Subject Decision|1|||
23593203|NCT04425629|65903028|FG003|Overall Study|Subject Decision|3|||
23593204|NCT04425629|65903029|FG004|Overall Study|Subject Decision|6|||
23593205|NCT04425629|65903030|FG005|Overall Study|Subject Decision|6|||
23593206|NCT04425629|65903031|FG006|Overall Study|Subject Decision|3|||
23593207|NCT04425629|65903032|FG007|Overall Study|Subject Decision|3|||
23593208|NCT04425629|65903033|FG008|Overall Study|Subject Decision|1|||
23593209|NCT04425629|65903034|FG009|Overall Study|Subject Decision|70|||
23593210|NCT04425629|65903035|FG010|Overall Study|Subject Decision|95|||
23593211|NCT04425629|65903036|FG011|Overall Study|Subject Decision|124|||
23593212|NCT04425629|65903037|FG012|Overall Study|Subject Decision|25|||
23593213|NCT04425629|65903038|FG013|Overall Study|Subject Decision|0|||
23593214|NCT04425629|65903039|FG014|Overall Study|Subject Decision|1|||
23593215|NCT04425629|65903040|FG015|Overall Study|Subject Decision|4|||
23593216|NCT04425629|65903041|FG016|Overall Study|Subject Decision|1|||
23593217|NCT04425629|65903042|FG017|Overall Study|Subject Decision|0|||
23593218|NCT04425629|65903043|FG018|Overall Study|Subject Decision|2|||
23593219|NCT04425629|65903025|FG000|Overall Study|Death|0|||
23593220|NCT04425629|65903026|FG001|Overall Study|Death|0|||
23593221|NCT04425629|65903027|FG002|Overall Study|Death|0|||
23593222|NCT04425629|65903028|FG003|Overall Study|Death|0|||
23593223|NCT04425629|65903029|FG004|Overall Study|Death|0|||
23593224|NCT04425629|65903030|FG005|Overall Study|Death|0|||
23593225|NCT04425629|65903031|FG006|Overall Study|Death|0|||
23593226|NCT04425629|65903032|FG007|Overall Study|Death|0|||
23593227|NCT04425629|65903033|FG008|Overall Study|Death|0|||
23593228|NCT04425629|65903034|FG009|Overall Study|Death|11|||
23593229|NCT04425629|65903035|FG010|Overall Study|Death|2|||
23593230|NCT04425629|65903036|FG011|Overall Study|Death|4|||
23593231|NCT04425629|65903037|FG012|Overall Study|Death|0|||
23593232|NCT04425629|65903038|FG013|Overall Study|Death|0|||
23593233|NCT04425629|65903039|FG014|Overall Study|Death|0|||
23593234|NCT04425629|65903040|FG015|Overall Study|Death|0|||
23593235|NCT04425629|65903041|FG016|Overall Study|Death|0|||
23593236|NCT04425629|65903042|FG017|Overall Study|Death|0|||
23593237|NCT04425629|65903043|FG018|Overall Study|Death|0|||
23593238|NCT04425629|65903025|FG000|Overall Study|Sponsor Request|0|||
23593239|NCT04425629|65903026|FG001|Overall Study|Sponsor Request|0|||
23593240|NCT04425629|65903027|FG002|Overall Study|Sponsor Request|0|||
23593241|NCT04425629|65903028|FG003|Overall Study|Sponsor Request|2|||
23593242|NCT04425629|65903029|FG004|Overall Study|Sponsor Request|2|||
23593243|NCT04425629|65903030|FG005|Overall Study|Sponsor Request|2|||
23593244|NCT04425629|65903031|FG006|Overall Study|Sponsor Request|1|||
23593245|NCT04425629|65903032|FG007|Overall Study|Sponsor Request|0|||
23593246|NCT04425629|65903033|FG008|Overall Study|Sponsor Request|0|||
23593247|NCT04425629|65903034|FG009|Overall Study|Sponsor Request|9|||
23593248|NCT04425629|65903035|FG010|Overall Study|Sponsor Request|9|||
23593249|NCT04425629|65903036|FG011|Overall Study|Sponsor Request|10|||
23593250|NCT04425629|65903037|FG012|Overall Study|Sponsor Request|8|||
23593251|NCT04425629|65903038|FG013|Overall Study|Sponsor Request|0|||
23593252|NCT04425629|65903039|FG014|Overall Study|Sponsor Request|0|||
23593253|NCT04425629|65903040|FG015|Overall Study|Sponsor Request|1|||
23593254|NCT04425629|65903041|FG016|Overall Study|Sponsor Request|0|||
23593255|NCT04425629|65903042|FG017|Overall Study|Sponsor Request|0|||
23593256|NCT04425629|65903043|FG018|Overall Study|Sponsor Request|0|||
23593257|NCT04425629|65903025|FG000|Overall Study|Physician Decision|0|||
23593258|NCT04425629|65903026|FG001|Overall Study|Physician Decision|0|||
23593259|NCT04425629|65903027|FG002|Overall Study|Physician Decision|0|||
23593260|NCT04425629|65903028|FG003|Overall Study|Physician Decision|0|||
23593261|NCT04425629|65903029|FG004|Overall Study|Physician Decision|0|||
23593262|NCT04425629|65903030|FG005|Overall Study|Physician Decision|0|||
23593263|NCT04425629|65903031|FG006|Overall Study|Physician Decision|0|||
23593264|NCT04425629|65903032|FG007|Overall Study|Physician Decision|0|||
23593265|NCT04425629|65903033|FG008|Overall Study|Physician Decision|0|||
23593266|NCT04425629|65903034|FG009|Overall Study|Physician Decision|4|||
23593267|NCT04425629|65903035|FG010|Overall Study|Physician Decision|3|||
23593268|NCT04425629|65903036|FG011|Overall Study|Physician Decision|5|||
23593269|NCT04425629|65903037|FG012|Overall Study|Physician Decision|1|||
23593270|NCT04425629|65903038|FG013|Overall Study|Physician Decision|0|||
23593271|NCT04425629|65903039|FG014|Overall Study|Physician Decision|0|||
23593272|NCT04425629|65903040|FG015|Overall Study|Physician Decision|1|||
23593273|NCT04425629|65903041|FG016|Overall Study|Physician Decision|0|||
23593274|NCT04425629|65903042|FG017|Overall Study|Physician Decision|0|||
23593275|NCT04425629|65903043|FG018|Overall Study|Physician Decision|0|||
23593276|NCT04425629|65903025|FG000|Overall Study|Lack of Efficacy|0|||
23593277|NCT04425629|65903026|FG001|Overall Study|Lack of Efficacy|0|||
23593278|NCT04425629|65903027|FG002|Overall Study|Lack of Efficacy|0|||
23593279|NCT04425629|65903028|FG003|Overall Study|Lack of Efficacy|0|||
23593280|NCT04425629|65903029|FG004|Overall Study|Lack of Efficacy|0|||
23593281|NCT04425629|65903030|FG005|Overall Study|Lack of Efficacy|0|||
23593282|NCT04425629|65903031|FG006|Overall Study|Lack of Efficacy|0|||
23593283|NCT04425629|65903032|FG007|Overall Study|Lack of Efficacy|0|||
23593284|NCT04425629|65903033|FG008|Overall Study|Lack of Efficacy|0|||
23593285|NCT04425629|65903034|FG009|Overall Study|Lack of Efficacy|0|||
23593286|NCT04425629|65903035|FG010|Overall Study|Lack of Efficacy|1|||
23593287|NCT04425629|65903036|FG011|Overall Study|Lack of Efficacy|0|||
23593288|NCT04425629|65903037|FG012|Overall Study|Lack of Efficacy|0|||
23593289|NCT04425629|65903038|FG013|Overall Study|Lack of Efficacy|0|||
23593290|NCT04425629|65903039|FG014|Overall Study|Lack of Efficacy|0|||
23593291|NCT04425629|65903040|FG015|Overall Study|Lack of Efficacy|0|||
23593292|NCT04425629|65903041|FG016|Overall Study|Lack of Efficacy|0|||
23593293|NCT04425629|65903042|FG017|Overall Study|Lack of Efficacy|0|||
23593294|NCT04425629|65903043|FG018|Overall Study|Lack of Efficacy|0|||
23593295|NCT04530747|65903046|FG000|Overall Study|Withdrawal by Subject|1|||
23593296|NCT04530747|65903047|FG001|Overall Study|Withdrawal by Subject|0|||
23593297|NCT01677936|65903048|FG000|Overall Study|Lost to Follow-up|4|||
23593298|NCT01677936|65903049|FG001|Overall Study|Lost to Follow-up|1|||
23593299|NCT01677936|65903048|FG000|Overall Study|Protocol Violation|3|||
23593300|NCT01677936|65903049|FG001|Overall Study|Protocol Violation|0|||
23254215|NCT03548207|64673429|FG002|Overall Study|Randomized but not treated|4|||
23254216|NCT03012815|64673430|FG000|Overall Study|Lost to Follow-up|1|||
23254217|NCT03012815|64673431|FG001|Overall Study|Lost to Follow-up|0|||
23254218|NCT03012815|64673430|FG000|Overall Study|Physician Decision|3|||
23254219|NCT03012815|64673431|FG001|Overall Study|Physician Decision|2|||
23254220|NCT03012815|64673430|FG000|Overall Study|Adverse Event|1|||
23254221|NCT03012815|64673431|FG001|Overall Study|Adverse Event|0|||
23254222|NCT03118765|64673432|FG000|Overall Study|Withdrawal by Subject|0|||
23254223|NCT03118765|64673433|FG001|Overall Study|Withdrawal by Subject|0|||
23254224|NCT03118765|64673434|FG002|Overall Study|Withdrawal by Subject|1|||
23254225|NCT03118765|64673435|FG003|Overall Study|Withdrawal by Subject|0|||
23254226|NCT03118765|64673436|FG004|Overall Study|Withdrawal by Subject|0|||
23254227|NCT03118765|64673432|FG000|Overall Study|Adverse Event|1|||
23254228|NCT03118765|64673433|FG001|Overall Study|Adverse Event|1|||
23254229|NCT03118765|64673434|FG002|Overall Study|Adverse Event|1|||
23254230|NCT03118765|64673435|FG003|Overall Study|Adverse Event|1|||
23254231|NCT03118765|64673436|FG004|Overall Study|Adverse Event|1|||
23254232|NCT03118765|64673432|FG000|Overall Study|Non compliance with Study Procedures|0|||
23254233|NCT03118765|64673433|FG001|Overall Study|Non compliance with Study Procedures|0|||
23254234|NCT03118765|64673434|FG002|Overall Study|Non compliance with Study Procedures|0|||
23254235|NCT03118765|64673435|FG003|Overall Study|Non compliance with Study Procedures|1|||
23477209|NCT01457352|65491516|FG001|Period 2|Protocol Violation|0|||
23593301|NCT01677936|65903048|FG000|Overall Study|Adverse Event|1|||
23593302|NCT01677936|65903049|FG001|Overall Study|Adverse Event|0|||
23593303|NCT01677936|65903048|FG000|Overall Study|Lost to Follow-up|1|||
23593304|NCT01677936|65903049|FG001|Overall Study|Lost to Follow-up|0|||
23254236|NCT03118765|64673436|FG004|Overall Study|Non compliance with Study Procedures|0|||
23254237|NCT03118765|64673432|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
23360176|NCT04739800|65062846|FG000|Overall Study|On Treatment|5|||
23593305|NCT01677936|65903048|FG000|Overall Study|Protocol Violation|0|||
23593306|NCT01677936|65903049|FG001|Overall Study|Protocol Violation|4|||
23593307|NCT03383146|65903054|FG000|Overall Study|Screen Failure|1|||
23593308|NCT03383146|65903055|FG001|Overall Study|Screen Failure|0|||
23593309|NCT03383146|65903054|FG000|Overall Study|Adverse Event|6|||
23593310|NCT03383146|65903055|FG001|Overall Study|Adverse Event|18|||
23593311|NCT03383146|65903054|FG000|Overall Study|Lack of Efficacy|0|||
23193739|NCT03184701|64452369|FG000|Overall Study|Death|3|||
23193740|NCT03184701|64452369|FG000|Overall Study|Physician Decision|3|||
23193741|NCT03184701|64452369|FG000|Overall Study|Withdrawal by Subject|6|||
23193742|NCT03184701|64452369|FG000|Overall Study|Lost to Follow-up|5|||
23193743|NCT02698423|64452370|FG000|Overall Study|Lost to Follow-up|19|||
23193744|NCT02698423|64452371|FG001|Overall Study|Lost to Follow-up|24|||
23193745|NCT03090191|64452374|FG000|Overall Study|Adverse Event|90|||
23193746|NCT03090191|64452375|FG001|Overall Study|Adverse Event|72|||
23193747|NCT03090191|64452374|FG000|Overall Study|Death|365|||
23193748|NCT03090191|64452375|FG001|Overall Study|Death|358|||
23193749|NCT03090191|64452374|FG000|Overall Study|Lost to Follow-up|382|||
23193750|NCT03090191|64452375|FG001|Overall Study|Lost to Follow-up|394|||
23193751|NCT03090191|64452374|FG000|Overall Study|Physician Decision|77|||
23193752|NCT03090191|64452375|FG001|Overall Study|Physician Decision|66|||
23193753|NCT03090191|64452374|FG000|Overall Study|Protocol Violation|43|||
23193754|NCT03090191|64452375|FG001|Overall Study|Protocol Violation|52|||
23193755|NCT03090191|64452374|FG000|Overall Study|Withdrawal by Subject|2160|||
23193756|NCT03090191|64452375|FG001|Overall Study|Withdrawal by Subject|2133|||
23193757|NCT03090191|64452374|FG000|Overall Study|Site terminated|7|||
23193758|NCT03090191|64452375|FG001|Overall Study|Site terminated|8|||
23193759|NCT03090191|64452374|FG000|Overall Study|Other|66|||
23193760|NCT03090191|64452375|FG001|Overall Study|Other|60|||
23193761|NCT03090191|64452374|FG000|Overall Study|Withdrawn before any study vaccination|43|||
23477210|NCT01457352|65491515|FG000|Period 2|Sponsor's withdrawal|7|||
23477211|NCT01457352|65491516|FG001|Period 2|Sponsor's withdrawal|0|||
23477212|NCT01457352|65491515|FG000|Period 2|Lost to Follow-up|1|||
23193762|NCT03090191|64452375|FG001|Overall Study|Withdrawn before any study vaccination|52|||
23193763|NCT03321929|64452376|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
23193764|NCT02940886|64452377|FG000|Overall Study|Adverse Event|7|||
23193765|NCT02940886|64452378|FG001|Overall Study|Adverse Event|3|||
23477213|NCT01457352|65491516|FG001|Period 2|Lost to Follow-up|0|||
23477214|NCT01457352|65491515|FG000|Period 2|dose change|1|||
23477215|NCT01457352|65491516|FG001|Period 2|dose change|0|||
23477216|NCT01457352|65491515|FG000|Period 2|Physician Decision|1|||
23477217|NCT01457352|65491516|FG001|Period 2|Physician Decision|0|||
23477218|NCT01457352|65491515|FG000|Period 2|Did not meet eligibility criteria|3|||
23477219|NCT01457352|65491516|FG001|Period 2|Did not meet eligibility criteria|0|||
23477220|NCT01457352|65491515|FG000|Period 3|Adverse Event|1|||
23193766|NCT02940886|64452377|FG000|Overall Study|Protocol Violation|0|||
23193767|NCT02940886|64452378|FG001|Overall Study|Protocol Violation|2|||
23193768|NCT02940886|64452377|FG000|Overall Study|Withdrawal by Subject|28|||
23193769|NCT02940886|64452378|FG001|Overall Study|Withdrawal by Subject|20|||
23193770|NCT02940886|64452377|FG000|Overall Study|Death|1|||
23193771|NCT02940886|64452378|FG001|Overall Study|Death|0|||
23193772|NCT02940886|64452377|FG000|Overall Study|Lack of Efficacy|1|||
23193773|NCT02940886|64452378|FG001|Overall Study|Lack of Efficacy|0|||
23477221|NCT01457352|65491516|FG001|Period 3|Adverse Event|1|||
23477222|NCT01457352|65491515|FG000|Period 3|Withdrawal by Subject|0|||
23477223|NCT01457352|65491516|FG001|Period 3|Withdrawal by Subject|2|||
23477224|NCT01457352|65491515|FG000|Period 3|incorrect treatment|0|||
23477225|NCT01457352|65491516|FG001|Period 3|incorrect treatment|1|||
23477226|NCT01457352|65491515|FG000|Period 3|Sponsor's withdrawal|0|||
23477227|NCT01457352|65491516|FG001|Period 3|Sponsor's withdrawal|1|||
23477228|NCT00561977|65491517|FG000|Overall Study|Withdrawal by Subject|0|||
23477229|NCT00561977|65491518|FG001|Overall Study|Withdrawal by Subject|2|||
23477230|NCT00561977|65491519|FG002|Overall Study|Withdrawal by Subject|1|||
23477231|NCT00561977|65491517|FG000|Overall Study|Pregnancy|0|||
23477232|NCT00561977|65491518|FG001|Overall Study|Pregnancy|1|||
23477233|NCT00561977|65491519|FG002|Overall Study|Pregnancy|1|||
23477234|NCT01128621|65491520|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
23477235|NCT01128621|65491521|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
23193774|NCT02940886|64452377|FG000|Overall Study|Lost to Follow-up|49|||
23193775|NCT02940886|64452378|FG001|Overall Study|Lost to Follow-up|21|||
23193776|NCT02940886|64452377|FG000|Overall Study|Physician Decision|9|||
23193777|NCT02940886|64452378|FG001|Overall Study|Physician Decision|4|||
23193778|NCT02940886|64452377|FG000|Overall Study|Sponsor decision|0|||
23193779|NCT02940886|64452378|FG001|Overall Study|Sponsor decision|1|||
23193780|NCT02940886|64452377|FG000|Overall Study|No treatment|7|||
23193781|NCT02940886|64452378|FG001|Overall Study|No treatment|2|||
23477236|NCT00329901|65491526|FG000|Overall Study|Withdrawal by Subject|4|||
23477237|NCT00329901|65491527|FG001|Overall Study|Withdrawal by Subject|3|||
23477238|NCT00329901|65491528|FG002|Overall Study|Withdrawal by Subject|2|||
23193782|NCT02940886|64452377|FG000|Overall Study|Enrolment error|0|||
23193783|NCT02940886|64452378|FG001|Overall Study|Enrolment error|1|||
23193784|NCT01594476|64452380|FG000|Overall Study|Protocol Violation|1|||
23477239|NCT00329901|65491526|FG000|Overall Study|Lost to Follow-up|2|||
23477240|NCT00329901|65491527|FG001|Overall Study|Lost to Follow-up|0|||
23477241|NCT00329901|65491528|FG002|Overall Study|Lost to Follow-up|1|||
23477242|NCT00329901|65491526|FG000|Overall Study|Protocol Violation|1|||
23477243|NCT00329901|65491527|FG001|Overall Study|Protocol Violation|0|||
23593312|NCT03383146|65903055|FG001|Overall Study|Lack of Efficacy|3|||
23593313|NCT03383146|65903054|FG000|Overall Study|Withdrawal by Subject|20|||
23593314|NCT03383146|65903055|FG001|Overall Study|Withdrawal by Subject|36|||
23593315|NCT03383146|65903054|FG000|Overall Study|Lost to Follow-up|5|||
23593316|NCT03383146|65903055|FG001|Overall Study|Lost to Follow-up|15|||
23593317|NCT03383146|65903054|FG000|Overall Study|Death|0|||
23593318|NCT03383146|65903055|FG001|Overall Study|Death|2|||
23593319|NCT03383146|65903054|FG000|Overall Study|Physician Decision|0|||
23593320|NCT03383146|65903055|FG001|Overall Study|Physician Decision|1|||
23593321|NCT03383146|65903054|FG000|Overall Study|Protocol Deviation|1|||
23593322|NCT03383146|65903055|FG001|Overall Study|Protocol Deviation|8|||
23593323|NCT03383146|65903054|FG000|Overall Study|Study Terminated by the Sponsor|48|||
23593324|NCT03383146|65903055|FG001|Overall Study|Study Terminated by the Sponsor|95|||
23593325|NCT03383146|65903054|FG000|Overall Study|Reason not Specified|4|||
23593326|NCT03383146|65903055|FG001|Overall Study|Reason not Specified|6|||
23593327|NCT01376089|65903056|FG000|Overall Study|Patient received no contrast media|3|||
23593328|NCT01376089|65903057|FG001|Overall Study|Patient received no contrast media|4|||
23193785|NCT01594476|64452381|FG001|Overall Study|Protocol Violation|3|||
23193786|NCT02927171|64452382|FG000|Overall Study|Lost to Follow-up|0|||
23193787|NCT02927171|64452383|FG001|Overall Study|Lost to Follow-up|1|||
23193788|NCT01797432|64452384|FG000|Overall Study|Lost to Follow-up|1|||
23193789|NCT01797432|64452384|FG000|Overall Study|Adverse Event|1|||
23193790|NCT01797432|64452384|FG000|Overall Study|Withdrawal by Subject|1|||
23193791|NCT01797432|64452384|FG000|Overall Study|lived too far from study site|1|||
23193792|NCT00098345|64452387|FG000|Overall Study|Adverse Event|7|||
23193793|NCT00098345|64452387|FG000|Overall Study|Withdrawal by Subject|2|||
23193794|NCT00098345|64452387|FG000|Overall Study|progression|4|||
23193795|NCT00537940|64452388|FG000|Overall Study|Adverse Event|20|||
23193796|NCT00537940|64452389|FG001|Overall Study|Adverse Event|19|||
23477244|NCT00329901|65491528|FG002|Overall Study|Protocol Violation|1|||
23477245|NCT00329901|65491526|FG000|Overall Study|Unable to classify|2|||
23477246|NCT00329901|65491527|FG001|Overall Study|Unable to classify|2|||
23477247|NCT00329901|65491528|FG002|Overall Study|Unable to classify|0|||
23477248|NCT01193257|65491531|FG000|Overall Study|Death|202|||
23477249|NCT01193257|65491532|FG001|Overall Study|Death|391|||
23477250|NCT01193257|65491531|FG000|Overall Study|Study termination by sponsor|0|||
23593329|NCT02886286|65903058|FG000|Overall Study|pump motor stall|0|||
23193797|NCT00537940|64452388|FG000|Overall Study|Lack of Efficacy|8|||
23193798|NCT00537940|64452389|FG001|Overall Study|Lack of Efficacy|16|||
23193799|NCT00537940|64452388|FG000|Overall Study|Lost to Follow-up|23|||
23193800|NCT00537940|64452389|FG001|Overall Study|Lost to Follow-up|29|||
23193801|NCT00537940|64452388|FG000|Overall Study|Withdrawal by Subject|113|||
23193802|NCT00537940|64452389|FG001|Overall Study|Withdrawal by Subject|95|||
23193803|NCT00537940|64452388|FG000|Overall Study|Protocol Violation|6|||
23193804|NCT00537940|64452389|FG001|Overall Study|Protocol Violation|4|||
23193805|NCT00537940|64452388|FG000|Overall Study|Pregnancy|1|||
23193806|NCT00537940|64452389|FG001|Overall Study|Pregnancy|1|||
23193807|NCT00537940|64452388|FG000|Overall Study|Study terminated by sponsor|2|||
23477251|NCT01193257|65491532|FG001|Overall Study|Study termination by sponsor|3|||
23477252|NCT01193257|65491531|FG000|Overall Study|Withdrawal by Subject|26|||
23593330|NCT02886286|65903059|FG001|Overall Study|pump motor stall|1|||
23593331|NCT02685488|65903060|FG000|Overall Study|Withdrawal by Subject|0|||
23593332|NCT02685488|65903061|FG001|Overall Study|Withdrawal by Subject|1|||
23593333|NCT01070069|65903064|FG000|Overall Study|Death|1|||
23193808|NCT00537940|64452389|FG001|Overall Study|Study terminated by sponsor|3|||
23593334|NCT01070069|65903065|FG001|Overall Study|Death|0|||
23254238|NCT03118765|64673433|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
23254239|NCT03118765|64673434|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
23254240|NCT03118765|64673435|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
23254241|NCT03118765|64673436|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
23254242|NCT03118765|64673432|FG000|Overall Study|COPD Exacerbation|1|||
23254243|NCT03118765|64673433|FG001|Overall Study|COPD Exacerbation|0|||
23254244|NCT03118765|64673434|FG002|Overall Study|COPD Exacerbation|0|||
23254245|NCT03118765|64673435|FG003|Overall Study|COPD Exacerbation|1|||
23254246|NCT03118765|64673436|FG004|Overall Study|COPD Exacerbation|0|||
23254247|NCT03118765|64673432|FG000|Overall Study|Lost to Follow-up|1|||
23254248|NCT03118765|64673433|FG001|Overall Study|Lost to Follow-up|0|||
23254249|NCT03118765|64673434|FG002|Overall Study|Lost to Follow-up|1|||
23254250|NCT03118765|64673435|FG003|Overall Study|Lost to Follow-up|0|||
23254251|NCT03118765|64673436|FG004|Overall Study|Lost to Follow-up|0|||
23254252|NCT03118765|64673432|FG000|Overall Study|Sponsor Decision|1|||
23254253|NCT03118765|64673433|FG001|Overall Study|Sponsor Decision|0|||
23254254|NCT03118765|64673434|FG002|Overall Study|Sponsor Decision|1|||
23254255|NCT03118765|64673435|FG003|Overall Study|Sponsor Decision|0|||
23254256|NCT03118765|64673436|FG004|Overall Study|Sponsor Decision|1|||
23254257|NCT01542736|64673440|FG000|Overall Study|Death|1|||
23254258|NCT01201356|64673449|FG000|Overall Study|Adverse Event|170|||
23254259|NCT01201356|64673449|FG000|Overall Study|Abnormal laboratory value(s)|51|||
23254260|NCT01201356|64673449|FG000|Overall Study|Abnormal test procedure result(s)|3|||
23254261|NCT01201356|64673449|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
23254262|NCT01201356|64673449|FG000|Overall Study|Condition no longer requires study drug|12|||
23254263|NCT01201356|64673449|FG000|Overall Study|Withdrawal by Subject|144|||
23254264|NCT01201356|64673449|FG000|Overall Study|Lost to Follow-up|50|||
23254265|NCT01201356|64673449|FG000|Overall Study|administrative problems|74|||
23254266|NCT01201356|64673449|FG000|Overall Study|Death|16|||
23254267|NCT01201356|64673449|FG000|Overall Study|Protocol Violation|12|||
23254268|NCT04126733|64673450|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
23254269|NCT04126733|64673450|FG000|Treatment Period|Adverse Event|8|||
23254270|NCT04126733|64673450|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
23254271|NCT04126733|64673450|FG000|Treatment Period|Physician Decision|5|||
23254272|NCT04126733|64673450|FG000|Treatment Period|Death|1|||
23254273|NCT04126733|64673450|FG000|Treatment Period|Other Reasons|2|||
23254274|NCT04126733|64673450|FG000|Active Follow-up Period|Death|13|||
23254275|NCT04126733|64673450|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
23254276|NCT04126733|64673450|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
23254277|NCT04126733|64673450|FG000|Active Follow-up Period|Other Reasons|1|||
23254278|NCT04126733|64673450|FG000|Long-term Follow-up Period|Death|22|||
23254279|NCT04126733|64673450|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
23254280|NCT04126733|64673450|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
23254281|NCT00127192|64673451|FG000|Overall Study|Adverse Event|0|||
23254282|NCT00127192|64673452|FG001|Overall Study|Adverse Event|1|||
23254283|NCT00127192|64673453|FG002|Overall Study|Adverse Event|1|||
23254284|NCT00127192|64673454|FG003|Overall Study|Adverse Event|1|||
23254285|NCT00127192|64673455|FG004|Overall Study|Adverse Event|0|||
23254286|NCT00127192|64673451|FG000|Overall Study|Lack of Efficacy|2|||
23254287|NCT00127192|64673452|FG001|Overall Study|Lack of Efficacy|0|||
23254288|NCT00127192|64673453|FG002|Overall Study|Lack of Efficacy|0|||
23254289|NCT00127192|64673454|FG003|Overall Study|Lack of Efficacy|0|||
23254290|NCT00127192|64673455|FG004|Overall Study|Lack of Efficacy|2|||
23254291|NCT00127192|64673451|FG000|Overall Study|Withdrawal by Subject|0|||
23254292|NCT00127192|64673452|FG001|Overall Study|Withdrawal by Subject|0|||
23254293|NCT00127192|64673453|FG002|Overall Study|Withdrawal by Subject|1|||
23254294|NCT00127192|64673454|FG003|Overall Study|Withdrawal by Subject|0|||
23254295|NCT00127192|64673455|FG004|Overall Study|Withdrawal by Subject|3|||
23254296|NCT00127192|64673451|FG000|Overall Study|Adverse event in pre-treatment period|1|||
23254297|NCT00127192|64673452|FG001|Overall Study|Adverse event in pre-treatment period|0|||
23254298|NCT00127192|64673453|FG002|Overall Study|Adverse event in pre-treatment period|0|||
23254299|NCT00127192|64673454|FG003|Overall Study|Adverse event in pre-treatment period|0|||
23254300|NCT00127192|64673455|FG004|Overall Study|Adverse event in pre-treatment period|0|||
23254301|NCT04556838|64673460|FG000|Overall Study|Withdrawal by Subject|3|||
23254302|NCT04556838|64673461|FG001|Overall Study|Withdrawal by Subject|1|||
23254303|NCT04556838|64673462|FG002|Overall Study|Withdrawal by Subject|2|||
23254304|NCT04556838|64673460|FG000|Overall Study|Adverse Event|0|||
23254305|NCT04556838|64673461|FG001|Overall Study|Adverse Event|1|||
23254306|NCT04556838|64673462|FG002|Overall Study|Adverse Event|1|||
23254307|NCT04556838|64673460|FG000|Overall Study|Lost to Follow-up|0|||
23254308|NCT04556838|64673461|FG001|Overall Study|Lost to Follow-up|0|||
23254309|NCT04556838|64673462|FG002|Overall Study|Lost to Follow-up|2|||
23254310|NCT04556838|64673460|FG000|Overall Study|Subject travel|0|||
23254311|NCT04556838|64673461|FG001|Overall Study|Subject travel|1|||
23254312|NCT04556838|64673462|FG002|Overall Study|Subject travel|0|||
23254313|NCT04556838|64673460|FG000|Overall Study|Physician Decision|1|||
23477253|NCT01193257|65491532|FG001|Overall Study|Withdrawal by Subject|86|||
23477254|NCT01193257|65491531|FG000|Overall Study|Lost to Follow-up|2|||
23477255|NCT01193257|65491532|FG001|Overall Study|Lost to Follow-up|3|||
23477256|NCT01193257|65491531|FG000|Overall Study|Unblinded due to futility|135|||
23254314|NCT04556838|64673461|FG001|Overall Study|Physician Decision|0|||
23254315|NCT04556838|64673462|FG002|Overall Study|Physician Decision|0|||
23477257|NCT01193257|65491532|FG001|Overall Study|Unblinded due to futility|251|||
23477258|NCT01945710|65491533|FG000|Overall Study|Progressive Disease|5|||
23477259|NCT01945710|65491534|FG001|Overall Study|Progressive Disease|4|||
23477260|NCT01945710|65491535|FG002|Overall Study|Progressive Disease|3|||
23477261|NCT01945710|65491536|FG003|Overall Study|Progressive Disease|2|||
23477262|NCT01945710|65491537|FG004|Overall Study|Progressive Disease|7|||
23477263|NCT01945710|65491538|FG005|Overall Study|Progressive Disease|3|||
23477264|NCT01945710|65491539|FG006|Overall Study|Progressive Disease|19|||
23477265|NCT01945710|65491533|FG000|Overall Study|Adverse Event|0|||
23477266|NCT01945710|65491534|FG001|Overall Study|Adverse Event|1|||
23477267|NCT01945710|65491535|FG002|Overall Study|Adverse Event|0|||
23477268|NCT01945710|65491536|FG003|Overall Study|Adverse Event|0|||
23477269|NCT01945710|65491537|FG004|Overall Study|Adverse Event|0|||
23477270|NCT01945710|65491538|FG005|Overall Study|Adverse Event|0|||
23477271|NCT01945710|65491539|FG006|Overall Study|Adverse Event|0|||
23477272|NCT01945710|65491533|FG000|Overall Study|Other|2|||
23477273|NCT01945710|65491534|FG001|Overall Study|Other|0|||
23477274|NCT01945710|65491535|FG002|Overall Study|Other|3|||
23477275|NCT01945710|65491536|FG003|Overall Study|Other|1|||
23477276|NCT01945710|65491537|FG004|Overall Study|Other|1|||
23477277|NCT01945710|65491538|FG005|Overall Study|Other|0|||
23477278|NCT01945710|65491539|FG006|Overall Study|Other|4|||
23477279|NCT01945710|65491533|FG000|Overall Study|Withdrawal by Subject|0|||
23477280|NCT01945710|65491534|FG001|Overall Study|Withdrawal by Subject|1|||
23477281|NCT01945710|65491535|FG002|Overall Study|Withdrawal by Subject|1|||
23477282|NCT01945710|65491536|FG003|Overall Study|Withdrawal by Subject|0|||
23477283|NCT01945710|65491537|FG004|Overall Study|Withdrawal by Subject|1|||
23477284|NCT01945710|65491538|FG005|Overall Study|Withdrawal by Subject|0|||
23477285|NCT01945710|65491539|FG006|Overall Study|Withdrawal by Subject|0|||
23477286|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
23477287|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
23477288|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
23477289|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
23477290|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
23477291|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
23477292|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
23477293|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
23477294|NCT00435045|65491540|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
23477295|NCT00435045|65491541|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
23477296|NCT00435045|65491540|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
23477297|NCT00435045|65491541|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
23477298|NCT00435045|65491540|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
23477299|NCT00435045|65491541|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
23477300|NCT00435045|65491540|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
23477301|NCT00435045|65491541|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
23477302|NCT00435045|65491540|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
23477303|NCT00435045|65491541|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
23477304|NCT00435045|65491540|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
23477305|NCT00435045|65491541|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
23477306|NCT00435045|65491540|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
23477307|NCT00435045|65491541|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
23477308|NCT03387111|65491549|FG000|Overall Study|Progressive Disease|3|||
23477309|NCT03387111|65491549|FG000|Overall Study|Other|1|||
23477310|NCT01700387|65491557|FG000|Overall Study|Withdrawal by Subject|1|||
23254316|NCT01027884|64673463|FG000|Overall Study|Adverse Event|2|||
23477311|NCT01700387|65491558|FG001|Overall Study|Withdrawal by Subject|2|||
23477312|NCT01700387|65491557|FG000|Overall Study|Adverse Event|1|||
23477313|NCT01700387|65491558|FG001|Overall Study|Adverse Event|1|||
23477314|NCT01700387|65491557|FG000|Overall Study|Lost to Follow-up|2|||
23477315|NCT01700387|65491558|FG001|Overall Study|Lost to Follow-up|1|||
23477316|NCT00796445|65491563|FG000|Overall Study|Protocol Violation|5|||
23477317|NCT00796445|65491564|FG001|Overall Study|Protocol Violation|3|||
23477318|NCT00796445|65491563|FG000|Overall Study|Adverse event, serious fatal|10|||
23477319|NCT00796445|65491564|FG001|Overall Study|Adverse event, serious fatal|5|||
23477320|NCT00796445|65491563|FG000|Overall Study|Adverse event, non-fatal|4|||
23477321|NCT00796445|65491564|FG001|Overall Study|Adverse event, non-fatal|0|||
23477322|NCT00796445|65491563|FG000|Overall Study|Disease progression/recurrence|537|||
23254317|NCT01027884|64673464|FG001|Overall Study|Adverse Event|1|||
23254318|NCT01027884|64673463|FG000|Overall Study|Protocol Violation|1|||
23360177|NCT04739800|65062847|FG001|Overall Study|On Treatment|9|||
23193809|NCT00537940|64452388|FG000|Overall Study|Other|10|||
23193810|NCT00537940|64452389|FG001|Overall Study|Other|12|||
23593335|NCT01070069|65903066|FG002|Overall Study|Death|2|||
23593336|NCT01070069|65903067|FG003|Overall Study|Death|0|||
23593337|NCT01070069|65903068|FG004|Overall Study|Death|1|||
23593338|NCT01070069|65903064|FG000|Overall Study|Withdrawal by Subject|1|||
23593339|NCT01070069|65903065|FG001|Overall Study|Withdrawal by Subject|1|||
23593340|NCT01070069|65903066|FG002|Overall Study|Withdrawal by Subject|4|||
23593341|NCT01070069|65903067|FG003|Overall Study|Withdrawal by Subject|0|||
23593342|NCT01070069|65903068|FG004|Overall Study|Withdrawal by Subject|0|||
23593343|NCT01070069|65903064|FG000|Overall Study|Lost to Follow-up|4|||
23593344|NCT01070069|65903065|FG001|Overall Study|Lost to Follow-up|1|||
23593345|NCT01070069|65903066|FG002|Overall Study|Lost to Follow-up|0|||
23593346|NCT01070069|65903067|FG003|Overall Study|Lost to Follow-up|0|||
23593347|NCT01070069|65903068|FG004|Overall Study|Lost to Follow-up|3|||
23593348|NCT02115139|65903069|FG000|Overall Study|Protocol Violation|1|||
23593349|NCT02115139|65903069|FG000|Overall Study|treatment discontinuation|6|||
23593350|NCT00393848|65903070|FG000|Overall Study|Surgical schedule|0|||
23593351|NCT00393848|65903071|FG001|Overall Study|Surgical schedule|0|||
23593352|NCT00393848|65903072|FG002|Overall Study|Surgical schedule|0|||
23593353|NCT00393848|65903073|FG003|Overall Study|Surgical schedule|1|||
23360178|NCT04739800|65062848|FG002|Overall Study|On Treatment|9|||
23360179|NCT04739800|65062849|FG003|Overall Study|On Treatment|9|||
23360180|NCT04739800|65062846|FG000|Overall Study|Symptomatic Deterioration|1|||
23360181|NCT04739800|65062847|FG001|Overall Study|Symptomatic Deterioration|1|||
23360182|NCT04739800|65062848|FG002|Overall Study|Symptomatic Deterioration|3|||
23360183|NCT04739800|65062849|FG003|Overall Study|Symptomatic Deterioration|0|||
23360184|NCT04739800|65062846|FG000|Overall Study|Withdrawal by Subject|1|||
23360185|NCT04739800|65062847|FG001|Overall Study|Withdrawal by Subject|2|||
23360186|NCT04739800|65062848|FG002|Overall Study|Withdrawal by Subject|1|||
23360187|NCT04739800|65062849|FG003|Overall Study|Withdrawal by Subject|3|||
23360188|NCT04739800|65062846|FG000|Overall Study|Other Reason|1|||
23360189|NCT04739800|65062847|FG001|Overall Study|Other Reason|3|||
23360190|NCT04739800|65062848|FG002|Overall Study|Other Reason|5|||
23360191|NCT04739800|65062849|FG003|Overall Study|Other Reason|4|||
23360192|NCT00656175|65062850|FG000|Overall Study|Adverse Event|1|||
23360193|NCT00656175|65062851|FG001|Overall Study|Adverse Event|0|||
23593354|NCT00393848|65903070|FG000|Overall Study|Personal reasons|0|||
23593355|NCT00393848|65903071|FG001|Overall Study|Personal reasons|0|||
23193811|NCT01184989|64452391|FG000|Overall Study|Adverse Event|11|||
23193812|NCT01184989|64452391|FG000|Overall Study|Withdrawal by Subject|1|||
23593356|NCT00393848|65903072|FG002|Overall Study|Personal reasons|2|||
23360194|NCT00656175|65062850|FG000|Overall Study|Transportation issues|0|||
23360195|NCT00656175|65062851|FG001|Overall Study|Transportation issues|1|||
23593357|NCT00393848|65903073|FG003|Overall Study|Personal reasons|0|||
23593358|NCT04218266|65903074|FG000|Overall Study|Death|1|||
23593359|NCT04218266|65903075|FG001|Overall Study|Death|2|||
23193813|NCT00500149|64452392|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
23193814|NCT00500149|64452393|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
23593360|NCT04218266|65903076|FG002|Overall Study|Death|3|||
23477323|NCT00796445|65491564|FG001|Overall Study|Disease progression/recurrence|268|||
23477324|NCT00796445|65491563|FG000|Overall Study|Other|10|||
23477325|NCT00796445|65491564|FG001|Overall Study|Other|7|||
23477326|NCT00796445|65491563|FG000|Overall Study|Withdrawal by Subject|18|||
23477327|NCT00796445|65491564|FG001|Overall Study|Withdrawal by Subject|9|||
23477328|NCT00796445|65491563|FG000|Overall Study|Invalid Informed Consent Form|1|||
23477329|NCT00796445|65491564|FG001|Overall Study|Invalid Informed Consent Form|0|||
23477330|NCT02208063|65491565|FG000|Overall Study|Death|3|||
23477331|NCT02208063|65491566|FG001|Overall Study|Death|5|||
23477332|NCT02208063|65491565|FG000|Overall Study|Not Specified in report|3|||
23477333|NCT02208063|65491566|FG001|Overall Study|Not Specified in report|4|||
23477334|NCT02208063|65491565|FG000|Overall Study|Withdrawal by Subject|5|||
23477335|NCT02208063|65491566|FG001|Overall Study|Withdrawal by Subject|2|||
23477336|NCT02208063|65491565|FG000|Overall Study|Lost to Follow-up|1|||
23477337|NCT02208063|65491566|FG001|Overall Study|Lost to Follow-up|0|||
23477338|NCT00883688|65491570|FG000|Overall Study|Ineligible|2|||
23477339|NCT02122783|65491571|FG000|Overall Study|Adverse Event|0|||
23477340|NCT02122783|65491572|FG001|Overall Study|Adverse Event|1|||
23477341|NCT01022398|65491573|FG000|Overall Study|Study terminated|2|||
23477342|NCT01022398|65491574|FG001|Overall Study|Study terminated|2|||
23477343|NCT01101308|65491577|FG000|Period 1|Adverse Event|2|||
23477344|NCT01101308|65491578|FG001|Period 1|Adverse Event|1|||
23477345|NCT01101308|65491577|FG000|Period 1|Positive for cotinine|1|||
23477346|NCT01101308|65491578|FG001|Period 1|Positive for cotinine|0|||
23477347|NCT01369329|65491580|FG000|Overall Study|Withdrawal by Subject|8|||
23477348|NCT01369329|65491581|FG001|Overall Study|Withdrawal by Subject|6|||
23477349|NCT01369329|65491582|FG002|Overall Study|Withdrawal by Subject|10|||
23477350|NCT01369329|65491580|FG000|Overall Study|Lost to Follow-up|2|||
23477351|NCT01369329|65491581|FG001|Overall Study|Lost to Follow-up|2|||
23477352|NCT01369329|65491582|FG002|Overall Study|Lost to Follow-up|2|||
23477353|NCT01369329|65491580|FG000|Overall Study|Other|2|||
23477354|NCT01369329|65491581|FG001|Overall Study|Other|3|||
23477355|NCT01369329|65491582|FG002|Overall Study|Other|2|||
23477356|NCT00725842|65491583|FG000|Overall Study|Lost to Follow-up|19|||
23477357|NCT00725842|65491583|FG000|Overall Study|Death|1|||
23477358|NCT00725842|65491583|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
23477359|NCT00725842|65491583|FG000|Overall Study|Consent date prior to study start date|5|||
23477360|NCT00725842|65491583|FG000|Overall Study|Inclusion criterion not met|1|||
23477361|NCT00725842|65491583|FG000|Overall Study|No Visit 1 data|1|||
23477362|NCT03032380|65491584|FG000|Overall Study|Adverse Event|0|||
23477363|NCT03032380|65491585|FG001|Overall Study|Adverse Event|1|||
23477364|NCT03032380|65491584|FG000|Overall Study|Lack of Efficacy|1|||
23477365|NCT03032380|65491585|FG001|Overall Study|Lack of Efficacy|0|||
23477366|NCT03032380|65491584|FG000|Overall Study|Withdrawal by Subject|2|||
23477367|NCT03032380|65491585|FG001|Overall Study|Withdrawal by Subject|3|||
23477368|NCT03032380|65491584|FG000|Overall Study|Recovery|0|||
23477369|NCT03032380|65491585|FG001|Overall Study|Recovery|1|||
23477370|NCT03032380|65491584|FG000|Overall Study|Death|39|||
23477371|NCT03032380|65491585|FG001|Overall Study|Death|34|||
23477372|NCT03032380|65491584|FG000|Overall Study|Other - Miscellaneous|0|||
23477373|NCT03032380|65491585|FG001|Overall Study|Other - Miscellaneous|1|||
23477374|NCT00798759|65491586|FG000|Overall Study|Adverse Event|3|||
23477375|NCT00798759|65491587|FG001|Overall Study|Adverse Event|3|||
23477376|NCT00798759|65491586|FG000|Overall Study|Lost to Follow-up|1|||
23477377|NCT00798759|65491587|FG001|Overall Study|Lost to Follow-up|1|||
23477378|NCT00798759|65491586|FG000|Overall Study|Protocol Violation|4|||
23477379|NCT00798759|65491587|FG001|Overall Study|Protocol Violation|8|||
23477380|NCT00798759|65491586|FG000|Overall Study|Other|0|||
23477381|NCT00798759|65491587|FG001|Overall Study|Other|1|||
23477382|NCT01463007|65491588|FG000|Overall Study|Physician Decision|1|||
23477383|NCT00792571|65491589|FG000|Overall Study|Death|1|||
23477384|NCT00792571|65491589|FG000|Overall Study|Adverse Event|4|||
23477385|NCT00792571|65491589|FG000|Overall Study|Withdrawal by Subject|1|||
23477386|NCT00792571|65491589|FG000|Overall Study|Other|4|||
23477387|NCT01870076|65491590|FG000|Overall Study|Withdrawal by Subject|1|||
23477388|NCT01870076|65491591|FG001|Overall Study|Withdrawal by Subject|0|||
23477389|NCT01870076|65491592|FG002|Overall Study|Withdrawal by Subject|1|||
23477390|NCT01870076|65491593|FG003|Overall Study|Withdrawal by Subject|0|||
23477391|NCT00436501|65491594|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
23477392|NCT00436501|65491595|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
23477393|NCT00436501|65491594|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
23593361|NCT04218266|65903074|FG000|Overall Study|Adverse Event|13|||
23593362|NCT04218266|65903075|FG001|Overall Study|Adverse Event|14|||
23477394|NCT00436501|65491595|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
23477395|NCT00606905|65491596|FG000|Overall Study|No Pregnancy|9|||
23477396|NCT00606905|65491597|FG001|Overall Study|No Pregnancy|6|||
23477397|NCT00606905|65491596|FG000|Overall Study|Non-Index Pregnancy|1|||
23477398|NCT00606905|65491597|FG001|Overall Study|Non-Index Pregnancy|4|||
23477399|NCT00606905|65491596|FG000|Overall Study|Withdrew|5|||
23593363|NCT04218266|65903076|FG002|Overall Study|Adverse Event|11|||
23193815|NCT00500149|64452392|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
23193816|NCT00500149|64452393|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
23193817|NCT00500149|64452392|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
23193818|NCT00500149|64452393|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
23193819|NCT00500149|64452392|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
23193820|NCT00500149|64452393|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
23193821|NCT00500149|64452392|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
23193822|NCT00500149|64452393|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
23593364|NCT04218266|65903074|FG000|Overall Study|Other|7|||
23593365|NCT04218266|65903075|FG001|Overall Study|Other|5|||
23593366|NCT04218266|65903076|FG002|Overall Study|Other|14|||
23593367|NCT04218266|65903074|FG000|Overall Study|Physician Decision|1|||
23593368|NCT04218266|65903075|FG001|Overall Study|Physician Decision|3|||
23593369|NCT04218266|65903076|FG002|Overall Study|Physician Decision|2|||
23593370|NCT04218266|65903074|FG000|Overall Study|Non-compliance with study drug|0|||
23593371|NCT04218266|65903075|FG001|Overall Study|Non-compliance with study drug|0|||
23593372|NCT04218266|65903076|FG002|Overall Study|Non-compliance with study drug|1|||
23593373|NCT04218266|65903074|FG000|Overall Study|Withdrawal by Subject|1|||
23193823|NCT00500149|64452392|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
23593374|NCT04218266|65903075|FG001|Overall Study|Withdrawal by Subject|3|||
23593375|NCT04218266|65903076|FG002|Overall Study|Withdrawal by Subject|1|||
23593376|NCT04218266|65903074|FG000|Overall Study|Study drug never administered|2|||
23593377|NCT04218266|65903075|FG001|Overall Study|Study drug never administered|0|||
23593378|NCT04218266|65903076|FG002|Overall Study|Study drug never administered|0|||
23193824|NCT00500149|64452393|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
23477400|NCT00606905|65491597|FG001|Overall Study|Withdrew|5|||
23477401|NCT01049009|65491598|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
23477402|NCT01049009|65491599|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
23477403|NCT01049009|65491598|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23477404|NCT01049009|65491599|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23477405|NCT01049009|65491598|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
23477406|NCT01049009|65491599|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
23477407|NCT01049009|65491598|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
23477408|NCT01049009|65491599|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
23477409|NCT01444092|65491600|FG000|Overall Study|Adverse Event|8|||
23477410|NCT01444092|65491600|FG000|Overall Study|Protocol Violation|1|||
23477411|NCT01444092|65491600|FG000|Overall Study|Withdrawal by Subject|1|||
23477412|NCT01444092|65491600|FG000|Overall Study|Other Eligibility criteria|7|||
23477413|NCT03412565|65491601|FG000|Overall Study|Lost to Follow-up|0|||
23477414|NCT03412565|65491602|FG001|Overall Study|Lost to Follow-up|0|||
23477415|NCT03412565|65491603|FG002|Overall Study|Lost to Follow-up|1|||
23477416|NCT03412565|65491604|FG003|Overall Study|Lost to Follow-up|0|||
23477417|NCT03412565|65491601|FG000|Overall Study|Physician Decision|0|||
23477418|NCT03412565|65491602|FG001|Overall Study|Physician Decision|0|||
23477419|NCT03412565|65491603|FG002|Overall Study|Physician Decision|0|||
23477420|NCT03412565|65491604|FG003|Overall Study|Physician Decision|1|||
23477421|NCT03412565|65491601|FG000|Overall Study|Withdrawal by Subject|0|||
23477422|NCT03412565|65491602|FG001|Overall Study|Withdrawal by Subject|4|||
23477423|NCT03412565|65491603|FG002|Overall Study|Withdrawal by Subject|5|||
23477424|NCT03412565|65491604|FG003|Overall Study|Withdrawal by Subject|5|||
23477425|NCT03412565|65491601|FG000|Overall Study|Death|1|||
23477426|NCT03412565|65491602|FG001|Overall Study|Death|3|||
23477427|NCT03412565|65491603|FG002|Overall Study|Death|4|||
23477428|NCT03412565|65491604|FG003|Overall Study|Death|5|||
23477429|NCT03412565|65491601|FG000|Overall Study|Data collection ended|0|||
23477430|NCT03412565|65491602|FG001|Overall Study|Data collection ended|41|||
23477431|NCT03412565|65491603|FG002|Overall Study|Data collection ended|41|||
23477432|NCT03412565|65491604|FG003|Overall Study|Data collection ended|40|||
23477433|NCT01578850|65491607|FG000|Period 1|Insufficient Clinical Response|1|||
23477434|NCT01578850|65491608|FG001|Period 1|Insufficient Clinical Response|0|||
23477435|NCT01578850|65491609|FG002|Period 1|Insufficient Clinical Response|0|||
23477436|NCT01578850|65491607|FG000|Period 1|Adverse Event|11|||
23477437|NCT01578850|65491608|FG001|Period 1|Adverse Event|0|||
23477438|NCT01578850|65491609|FG002|Period 1|Adverse Event|0|||
23477439|NCT01578850|65491607|FG000|Period 1|Death|1|||
23477440|NCT01578850|65491608|FG001|Period 1|Death|0|||
23477441|NCT01578850|65491609|FG002|Period 1|Death|0|||
23477442|NCT01578850|65491607|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
23477443|NCT01578850|65491608|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
23477444|NCT01578850|65491609|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
23477445|NCT01578850|65491607|FG000|Period 1|Withdrawal by Subject|9|||
23477446|NCT01578850|65491608|FG001|Period 1|Withdrawal by Subject|0|||
23477447|NCT01578850|65491609|FG002|Period 1|Withdrawal by Subject|0|||
23477448|NCT01578850|65491607|FG000|Period 1|Study Terminated by Sponsor|3|||
23477449|NCT01578850|65491608|FG001|Period 1|Study Terminated by Sponsor|0|||
23477450|NCT01578850|65491609|FG002|Period 1|Study Terminated by Sponsor|0|||
23477451|NCT01578850|65491607|FG000|Period 2|Insufficient Clinical Response|0|||
23477452|NCT01578850|65491608|FG001|Period 2|Insufficient Clinical Response|1|||
23477453|NCT01578850|65491609|FG002|Period 2|Insufficient Clinical Response|0|||
23477454|NCT01578850|65491607|FG000|Period 2|Adverse Event|0|||
23477455|NCT01578850|65491608|FG001|Period 2|Adverse Event|3|||
23477456|NCT01578850|65491609|FG002|Period 2|Adverse Event|6|||
23477457|NCT01578850|65491607|FG000|Period 2|Lost to Follow-up|0|||
23193825|NCT00500149|64452392|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
23477458|NCT01578850|65491608|FG001|Period 2|Lost to Follow-up|1|||
23477459|NCT01578850|65491609|FG002|Period 2|Lost to Follow-up|2|||
23477460|NCT01578850|65491607|FG000|Period 2|Withdrawal by Subject|0|||
23477461|NCT01578850|65491608|FG001|Period 2|Withdrawal by Subject|2|||
23477462|NCT01578850|65491609|FG002|Period 2|Withdrawal by Subject|2|||
23477463|NCT01578850|65491607|FG000|Period 2|Study Terminated by Sponsor|0|||
23477464|NCT01578850|65491608|FG001|Period 2|Study Terminated by Sponsor|5|||
23477465|NCT01578850|65491609|FG002|Period 2|Study Terminated by Sponsor|4|||
23477466|NCT01578850|65491607|FG000|Period 2|Unspecified Reasons|0|||
23477467|NCT01578850|65491608|FG001|Period 2|Unspecified Reasons|1|||
23477468|NCT01578850|65491609|FG002|Period 2|Unspecified Reasons|0|||
23477469|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
23477470|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
23477471|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
23477472|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
23477473|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
23477474|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
23477475|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
23593379|NCT02807493|65903082|FG000|Overall Study|Adverse Event|5|||
23593380|NCT02807493|65903083|FG001|Overall Study|Adverse Event|2|||
23593381|NCT02807493|65903082|FG000|Overall Study|Lost to Follow-up|6|||
23593382|NCT02807493|65903083|FG001|Overall Study|Lost to Follow-up|0|||
23593383|NCT02807493|65903082|FG000|Overall Study|Physician Decision|4|||
23593384|NCT02807493|65903083|FG001|Overall Study|Physician Decision|1|||
23593385|NCT02807493|65903082|FG000|Overall Study|Protocol Violation|7|||
23593386|NCT02807493|65903083|FG001|Overall Study|Protocol Violation|0|||
23593387|NCT02807493|65903082|FG000|Overall Study|Withdrawal by Subject|17|||
23593388|NCT02807493|65903083|FG001|Overall Study|Withdrawal by Subject|10|||
23593389|NCT02807493|65903082|FG000|Overall Study|Other withdrawal|17|||
23593390|NCT02807493|65903083|FG001|Overall Study|Other withdrawal|0|||
23593391|NCT02807493|65903082|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
23593392|NCT02807493|65903083|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
23593393|NCT02512965|65903084|FG000|Overall Study|Withdrawal by Subject|0|||
23593394|NCT02512965|65903085|FG001|Overall Study|Withdrawal by Subject|4|||
23593395|NCT01000480|65903086|FG000|Induction Phase|Adverse Event|2|||
23593396|NCT01000480|65903086|FG000|Induction Phase|Lost to Follow-up|1|||
23593397|NCT01000480|65903086|FG000|Induction Phase|Physician Decision|1|||
23593398|NCT01000480|65903086|FG000|Induction Phase|Entry Criteria Not Met|3|||
23593399|NCT01000480|65903086|FG000|Concurrent Therapy Phase|Adverse Event|4|||
23593400|NCT01000480|65903086|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
23593401|NCT01000480|65903086|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
23593402|NCT01000480|65903086|FG000|Concurrent Therapy Phase|Physician Decision|1|||
23593403|NCT00507689|65903087|FG000|Pre-Randomization Period|Adverse Event|1|||
23593404|NCT00507689|65903088|FG001|Pre-Randomization Period|Adverse Event|0|||
23593405|NCT00507689|65903087|FG000|Pre-Randomization Period|Physician Decision|1|||
23593406|NCT00507689|65903088|FG001|Pre-Randomization Period|Physician Decision|0|||
23593407|NCT00507689|65903087|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
23593408|NCT00507689|65903088|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
23593409|NCT00507689|65903087|FG000|Randomized Period|Adverse Event|1|||
23193826|NCT00500149|64452393|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
23193827|NCT00370149|64452394|FG000|Overall Study|Physician Decision|16|||
23193828|NCT00370149|64452395|FG001|Overall Study|Physician Decision|16|||
23193829|NCT00370149|64452394|FG000|Overall Study|Protocol Violation|1|||
23193830|NCT00370149|64452395|FG001|Overall Study|Protocol Violation|0|||
23193831|NCT00370149|64452394|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
23193832|NCT00370149|64452395|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
23193833|NCT00370149|64452394|FG000|Overall Study|Pre-existing infection|0|||
23193834|NCT00370149|64452395|FG001|Overall Study|Pre-existing infection|1|||
23193835|NCT00370149|64452394|FG000|Overall Study|Antibiotic coated dressing placed|0|||
23193836|NCT00370149|64452395|FG001|Overall Study|Antibiotic coated dressing placed|1|||
23193837|NCT01096550|64452396|FG000|Overall Study|discontinued site|10|||
23593410|NCT00507689|65903088|FG001|Randomized Period|Adverse Event|1|||
23593411|NCT00507689|65903087|FG000|Randomized Period|Withdrawal by Subject|0|||
23593412|NCT00507689|65903088|FG001|Randomized Period|Withdrawal by Subject|1|||
23593413|NCT01044303|65903089|FG000|Overall Study|Lost to Follow-up|2|||
23593414|NCT01599104|65903090|FG000|Overall Study|Withdrawal by Subject|1|||
23593415|NCT01599104|65903091|FG001|Overall Study|Withdrawal by Subject|1|||
23193838|NCT01096550|64452397|FG001|Overall Study|discontinued site|11|||
23477476|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
23593416|NCT01599104|65903092|FG002|Overall Study|Withdrawal by Subject|2|||
23593417|NCT01599104|65903090|FG000|Overall Study|Technical Problems|1|||
23593418|NCT01599104|65903091|FG001|Overall Study|Technical Problems|0|||
23593419|NCT01599104|65903092|FG002|Overall Study|Technical Problems|0|||
23593420|NCT01599104|65903090|FG000|Overall Study|Physician Decision|3|||
23593421|NCT01599104|65903091|FG001|Overall Study|Physician Decision|2|||
23593422|NCT01599104|65903092|FG002|Overall Study|Physician Decision|2|||
23593423|NCT01599104|65903090|FG000|Overall Study|Non-compliance with study treatment|0|||
23593424|NCT01599104|65903091|FG001|Overall Study|Non-compliance with study treatment|1|||
23593425|NCT01599104|65903092|FG002|Overall Study|Non-compliance with study treatment|0|||
23593426|NCT01599104|65903090|FG000|Overall Study|Lack of Efficacy|4|||
23593427|NCT01599104|65903091|FG001|Overall Study|Lack of Efficacy|4|||
23593428|NCT01599104|65903092|FG002|Overall Study|Lack of Efficacy|10|||
23593429|NCT01599104|65903090|FG000|Overall Study|Adverse Event|7|||
23593430|NCT01599104|65903091|FG001|Overall Study|Adverse Event|6|||
23593431|NCT01599104|65903092|FG002|Overall Study|Adverse Event|12|||
23593432|NCT03621696|65903095|FG000|Overall Study|Not eligible|0|||
23593433|NCT03621696|65903096|FG001|Overall Study|Not eligible|0|||
23593434|NCT03621696|65903097|FG002|Overall Study|Not eligible|0|||
23593435|NCT03621696|65903098|FG003|Overall Study|Not eligible|5|||
23593436|NCT03621696|65903095|FG000|Overall Study|Withdrawal by Subject|1|||
23593437|NCT03621696|65903096|FG001|Overall Study|Withdrawal by Subject|1|||
23593438|NCT03621696|65903097|FG002|Overall Study|Withdrawal by Subject|1|||
23593439|NCT03621696|65903098|FG003|Overall Study|Withdrawal by Subject|0|||
23593440|NCT03621696|65903095|FG000|Overall Study|Physician Decision|0|||
23593441|NCT03621696|65903096|FG001|Overall Study|Physician Decision|0|||
23593442|NCT03621696|65903097|FG002|Overall Study|Physician Decision|1|||
23593443|NCT03621696|65903098|FG003|Overall Study|Physician Decision|0|||
23254319|NCT01027884|64673464|FG001|Overall Study|Protocol Violation|0|||
23593444|NCT01117480|65903099|FG000|Overall Study|Protocol Violation|8|||
23593445|NCT01117480|65903099|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
23593446|NCT00480077|65903100|FG000|Overall Study|Death|19|||
23593447|NCT00480077|65903101|FG001|Overall Study|Death|15|||
23593448|NCT00480077|65903100|FG000|Overall Study|early exit|12|||
23593449|NCT00480077|65903101|FG001|Overall Study|early exit|11|||
23593450|NCT02192606|65903102|FG000|Overall Study|surgery type was changed|1|||
23593451|NCT02192606|65903103|FG001|Overall Study|surgery type was changed|1|||
23593452|NCT02192606|65903102|FG000|Overall Study|Physician Decision|1|||
23593453|NCT02192606|65903103|FG001|Overall Study|Physician Decision|2|||
23593454|NCT02192606|65903102|FG000|Overall Study|3D equipment rep unable to join|0|||
23593455|NCT02192606|65903103|FG001|Overall Study|3D equipment rep unable to join|1|||
23593456|NCT02577835|65903104|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
23593457|NCT01764464|65903105|FG000|First Intervention|Withdrawal by Subject|1|||
23593458|NCT01764464|65903106|FG001|First Intervention|Withdrawal by Subject|0|||
23593459|NCT01764464|65903105|FG000|First Intervention|Lost to Follow-up|1|||
23593460|NCT01764464|65903106|FG001|First Intervention|Lost to Follow-up|0|||
23593461|NCT01764464|65903105|FG000|First Intervention|Adverse Event|0|||
23593462|NCT01764464|65903106|FG001|First Intervention|Adverse Event|2|||
23593463|NCT01764464|65903105|FG000|First Intervention|did not receive study drug|0|||
23593464|NCT01764464|65903106|FG001|First Intervention|did not receive study drug|1|||
23593465|NCT01764464|65903105|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
23593466|NCT01764464|65903106|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
23593467|NCT00970359|65903107|FG000|Overall Study|Not Treated|4|||
23593468|NCT03452189|65903111|FG000|First Intervention (3 Months)|Adverse Event|1|||
23593469|NCT03452189|65903112|FG001|First Intervention (3 Months)|Adverse Event|0|||
23593470|NCT03452189|65903111|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
23593471|NCT03452189|65903112|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
23593472|NCT04484935|65903113|FG000|Overall Study|Other|0|||
23593473|NCT04484935|65903114|FG001|Overall Study|Other|1|||
23593474|NCT04484935|65903113|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23593475|NCT04484935|65903114|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23593476|NCT04484935|65903113|FG000|Overall Study|Lost to Follow-up|1|||
23593477|NCT04484935|65903114|FG001|Overall Study|Lost to Follow-up|0|||
23593478|NCT04484935|65903113|FG000|Overall Study|Death|2|||
23593479|NCT04484935|65903114|FG001|Overall Study|Death|1|||
23193839|NCT01096550|64452396|FG000|Overall Study|non-regular treatment track at clinic|1|||
23193840|NCT01096550|64452397|FG001|Overall Study|non-regular treatment track at clinic|1|||
23193841|NCT01096550|64452396|FG000|Overall Study|clinic readmission|1|||
23193842|NCT01096550|64452397|FG001|Overall Study|clinic readmission|1|||
23193843|NCT01096550|64452396|FG000|Overall Study|Withdrawal by Subject|0|||
23254320|NCT01027884|64673463|FG000|Overall Study|Non-compliance|1|||
23254321|NCT01027884|64673464|FG001|Overall Study|Non-compliance|1|||
23254322|NCT01027884|64673463|FG000|Overall Study|Withdrawal by Subject|0|||
23254323|NCT01027884|64673464|FG001|Overall Study|Withdrawal by Subject|1|||
23254324|NCT01027884|64673463|FG000|Overall Study|Lost to Follow-up|0|||
23254325|NCT01027884|64673464|FG001|Overall Study|Lost to Follow-up|1|||
23254326|NCT01027884|64673463|FG000|Overall Study|Spinal fixation surgery|0|||
23254327|NCT01027884|64673464|FG001|Overall Study|Spinal fixation surgery|3|||
23254328|NCT02729194|64673468|FG000|Overall Study|Withdrawal by Subject|3|||
23254329|NCT00751998|64673470|FG000|Overall Study|Lost to Follow-up|7|||
23254330|NCT00751998|64673470|FG000|Overall Study|Death|11|||
23254331|NCT00751998|64673470|FG000|Overall Study|Withdrawal by Subject|2|||
23254332|NCT04385199|64673471|FG000|Overall Study|Withdrawal by Subject|1|||
23254333|NCT04385199|64673472|FG001|Overall Study|Withdrawal by Subject|0|||
23254334|NCT02340078|64673473|FG000|Overall Study|Protocol Violation|1|||
23254335|NCT04318535|64673476|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
23254336|NCT04318535|64673477|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
23254337|NCT04318535|64673478|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
23254338|NCT02209454|64673479|FG000|Second Period|Adverse Event|1|||
23254339|NCT02209454|64673480|FG001|Second Period|Adverse Event|0|||
23254340|NCT00283686|64673481|FG000|Overall Study|Death|1|||
23254341|NCT00283686|64673482|FG001|Overall Study|Death|1|||
23254342|NCT00283686|64673483|FG002|Overall Study|Death|1|||
23254343|NCT00283686|64673484|FG003|Overall Study|Death|0|||
23360196|NCT01843803|65062852|FG000|Overall Study|not a Veteran, did not see provider|1|||
23254344|NCT00283686|64673481|FG000|Overall Study|Lost to Follow-up|21|||
23593480|NCT01641198|65903119|FG000|After 12 Months of Function|Lost to Follow-up|3|||
23593481|NCT01641198|65903120|FG001|After 12 Months of Function|Lost to Follow-up|2|||
23254345|NCT00283686|64673482|FG001|Overall Study|Lost to Follow-up|31|||
23254346|NCT00283686|64673483|FG002|Overall Study|Lost to Follow-up|26|||
23254347|NCT00283686|64673484|FG003|Overall Study|Lost to Follow-up|20|||
23254348|NCT00283686|64673481|FG000|Overall Study|Less than full participation|7|||
23254349|NCT00283686|64673482|FG001|Overall Study|Less than full participation|9|||
23254350|NCT00283686|64673483|FG002|Overall Study|Less than full participation|6|||
23254351|NCT00283686|64673484|FG003|Overall Study|Less than full participation|12|||
23254352|NCT04292171|64673485|FG000|Overall Study|Pharmacy error|2|||
23254353|NCT04292171|64673486|FG001|Overall Study|Pharmacy error|0|||
23254354|NCT04292171|64673485|FG000|Overall Study|Delivered prior to procedure|0|||
23254355|NCT04292171|64673486|FG001|Overall Study|Delivered prior to procedure|1|||
23254356|NCT00860574|64673495|FG000|Overall Study|Death|2|||
23254357|NCT00860574|64673495|FG000|Overall Study|Relapse|1|||
23254358|NCT02419469|64673500|FG000|Overall Study|Withdrawal by Subject|1|||
23477477|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
23477478|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
23477479|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
23477480|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
23477481|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
23593482|NCT01641198|65903121|FG002|After 12 Months of Function|Lost to Follow-up|2|||
23593483|NCT01641198|65903119|FG000|After 12 Months of Function|Protocol Violation|1|||
23593484|NCT01641198|65903120|FG001|After 12 Months of Function|Protocol Violation|0|||
23593485|NCT01641198|65903121|FG002|After 12 Months of Function|Protocol Violation|0|||
23593486|NCT01641198|65903119|FG000|After 12 Months of Function|Adverse Event|0|||
23593487|NCT01641198|65903120|FG001|After 12 Months of Function|Adverse Event|1|||
23593488|NCT01641198|65903121|FG002|After 12 Months of Function|Adverse Event|0|||
23593489|NCT01641198|65903119|FG000|After 24 Months of Function|Lost to Follow-up|4|||
23593490|NCT01641198|65903120|FG001|After 24 Months of Function|Lost to Follow-up|9|||
23593491|NCT01641198|65903121|FG002|After 24 Months of Function|Lost to Follow-up|6|||
23593492|NCT01641198|65903119|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
23593493|NCT01641198|65903120|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
23593494|NCT01641198|65903121|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
23593495|NCT01641198|65903119|FG000|At 15-20 Years of Function|Death|1|||
23593496|NCT01641198|65903120|FG001|At 15-20 Years of Function|Death|0|||
23593497|NCT01641198|65903121|FG002|At 15-20 Years of Function|Death|1|||
23593498|NCT01713946|65903123|FG000|Overall Study|Death|0|||
23593499|NCT01713946|65903124|FG001|Overall Study|Death|2|||
23593500|NCT01713946|65903125|FG002|Overall Study|Death|2|||
23593501|NCT01713946|65903123|FG000|Overall Study|Adverse Event|19|||
23593502|NCT01713946|65903124|FG001|Overall Study|Adverse Event|14|||
23593503|NCT01713946|65903125|FG002|Overall Study|Adverse Event|13|||
23593504|NCT01713946|65903123|FG000|Overall Study|Withdrawal by Subject|12|||
23593505|NCT01713946|65903124|FG001|Overall Study|Withdrawal by Subject|12|||
23593506|NCT01713946|65903125|FG002|Overall Study|Withdrawal by Subject|8|||
23593507|NCT01713946|65903123|FG000|Overall Study|Lack of Efficacy|8|||
23593508|NCT01713946|65903124|FG001|Overall Study|Lack of Efficacy|8|||
23593509|NCT01713946|65903125|FG002|Overall Study|Lack of Efficacy|14|||
23593510|NCT01713946|65903123|FG000|Overall Study|Protocol Violation|2|||
23593511|NCT01713946|65903124|FG001|Overall Study|Protocol Violation|4|||
23593512|NCT01713946|65903125|FG002|Overall Study|Protocol Violation|1|||
23593513|NCT01713946|65903123|FG000|Overall Study|Lost to Follow-up|0|||
23593514|NCT01713946|65903124|FG001|Overall Study|Lost to Follow-up|0|||
23593515|NCT01713946|65903125|FG002|Overall Study|Lost to Follow-up|1|||
23593516|NCT01713946|65903123|FG000|Overall Study|Administrative problems|1|||
23593517|NCT01713946|65903124|FG001|Overall Study|Administrative problems|0|||
23593518|NCT01713946|65903125|FG002|Overall Study|Administrative problems|0|||
23593519|NCT01713946|65903123|FG000|Overall Study|Did not continue in Ext|0|||
23593520|NCT01713946|65903124|FG001|Overall Study|Did not continue in Ext|3|||
23593521|NCT01713946|65903125|FG002|Overall Study|Did not continue in Ext|0|||
23593522|NCT01713946|65903123|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
23593523|NCT01713946|65903124|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
23593524|NCT01713946|65903125|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
23593525|NCT01713946|65903123|FG000|Overall Study|Patients never switched to everolimus|0|||
23593526|NCT01713946|65903124|FG001|Overall Study|Patients never switched to everolimus|0|||
23593527|NCT01713946|65903125|FG002|Overall Study|Patients never switched to everolimus|5|||
23593528|NCT01493778|65903126|FG000|Overall Study|Withdrawal by Subject|8|||
23254359|NCT00879970|64673503|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
23254360|NCT00879970|64673504|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
23254361|NCT00879970|64673505|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
23254362|NCT00879970|64673506|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
23254363|NCT00879970|64673507|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
23360197|NCT01843803|65062853|FG001|Overall Study|not a Veteran, did not see provider|3|||
23477482|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
23593529|NCT03194958|65903127|FG000|Overall Study|Death|0|||
23593530|NCT03194958|65903128|FG001|Overall Study|Death|1|||
23593531|NCT03194958|65903129|FG002|Overall Study|Death|1|||
23593532|NCT03194958|65903130|FG003|Overall Study|Death|1|||
23593533|NCT03194958|65903127|FG000|Overall Study|Withdrawal by Subject|24|||
23593534|NCT03194958|65903128|FG001|Overall Study|Withdrawal by Subject|27|||
23593535|NCT03194958|65903129|FG002|Overall Study|Withdrawal by Subject|7|||
23593536|NCT03194958|65903130|FG003|Overall Study|Withdrawal by Subject|22|||
23593537|NCT03194958|65903127|FG000|Overall Study|Lost to Follow-up|168|||
23593538|NCT03194958|65903128|FG001|Overall Study|Lost to Follow-up|196|||
23593539|NCT03194958|65903129|FG002|Overall Study|Lost to Follow-up|174|||
23593540|NCT03194958|65903130|FG003|Overall Study|Lost to Follow-up|186|||
23593541|NCT02528188|65903131|FG000|Overall Study|Adverse Event|23|||
23593542|NCT02528188|65903132|FG001|Overall Study|Adverse Event|22|||
23593543|NCT02528188|65903133|FG002|Overall Study|Adverse Event|8|||
23593544|NCT02528188|65903131|FG000|Overall Study|Protocol Violation|4|||
23593545|NCT02528188|65903132|FG001|Overall Study|Protocol Violation|6|||
23593546|NCT02528188|65903133|FG002|Overall Study|Protocol Violation|4|||
23593547|NCT02528188|65903131|FG000|Overall Study|Lack of Efficacy|19|||
23593548|NCT02528188|65903132|FG001|Overall Study|Lack of Efficacy|21|||
23593549|NCT02528188|65903133|FG002|Overall Study|Lack of Efficacy|22|||
23593550|NCT02528188|65903131|FG000|Overall Study|Withdrawal by Subject|97|||
23593551|NCT02528188|65903132|FG001|Overall Study|Withdrawal by Subject|104|||
23593552|NCT02528188|65903133|FG002|Overall Study|Withdrawal by Subject|100|||
23593553|NCT02528188|65903131|FG000|Overall Study|Lost to Follow-up|25|||
23593554|NCT02528188|65903132|FG001|Overall Study|Lost to Follow-up|21|||
23593555|NCT02528188|65903133|FG002|Overall Study|Lost to Follow-up|31|||
23593556|NCT02528188|65903131|FG000|Overall Study|Death|4|||
23593557|NCT02528188|65903132|FG001|Overall Study|Death|4|||
23593558|NCT02528188|65903133|FG002|Overall Study|Death|0|||
23593559|NCT02528188|65903131|FG000|Overall Study|Other|89|||
23593560|NCT02528188|65903132|FG001|Overall Study|Other|91|||
23593561|NCT02528188|65903133|FG002|Overall Study|Other|74|||
23593562|NCT02528188|65903131|FG000|Overall Study|Randomized but not treated|6|||
23593563|NCT02528188|65903132|FG001|Overall Study|Randomized but not treated|7|||
23593564|NCT02528188|65903133|FG002|Overall Study|Randomized but not treated|12|||
23593565|NCT01595061|65903134|FG000|Overall Study|Never Treated|3|||
23593566|NCT01595061|65903134|FG000|Overall Study|Inadequate Pathology|1|||
23193844|NCT01096550|64452397|FG001|Overall Study|Withdrawal by Subject|1|||
23477483|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
23477484|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
23477485|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
23477486|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
23477487|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
23477488|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
23477489|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
23477490|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
23477491|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
23477492|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
23477493|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
23477494|NCT00095147|65491613|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
23477495|NCT00095147|65491614|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
23477496|NCT00095147|65491615|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
23477497|NCT00095147|65491616|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
23477498|NCT00095147|65491617|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
23477499|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
23477500|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
23477501|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
23477502|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
23477503|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
23477504|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
23477505|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
23477506|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
23477507|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
23477508|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
23477509|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
23593567|NCT02988817|65903135|FG000|Overall Study|Withdrawal by Subject|1|||
23593568|NCT02988817|65903136|FG001|Overall Study|Withdrawal by Subject|0|||
23593569|NCT02988817|65903137|FG002|Overall Study|Withdrawal by Subject|0|||
23593570|NCT02988817|65903138|FG003|Overall Study|Withdrawal by Subject|1|||
23593571|NCT02988817|65903139|FG004|Overall Study|Withdrawal by Subject|3|||
23593572|NCT02988817|65903140|FG005|Overall Study|Withdrawal by Subject|1|||
23593573|NCT02988817|65903141|FG006|Overall Study|Withdrawal by Subject|2|||
23593574|NCT02988817|65903142|FG007|Overall Study|Withdrawal by Subject|1|||
23593575|NCT02988817|65903143|FG008|Overall Study|Withdrawal by Subject|1|||
23593576|NCT02988817|65903144|FG009|Overall Study|Withdrawal by Subject|1|||
23593577|NCT02988817|65903145|FG010|Overall Study|Withdrawal by Subject|1|||
23593578|NCT02988817|65903146|FG011|Overall Study|Withdrawal by Subject|12|||
23593579|NCT02988817|65903147|FG012|Overall Study|Withdrawal by Subject|6|||
23593580|NCT02988817|65903148|FG013|Overall Study|Withdrawal by Subject|6|||
23593581|NCT02988817|65903149|FG014|Overall Study|Withdrawal by Subject|4|||
23593582|NCT02988817|65903150|FG015|Overall Study|Withdrawal by Subject|5|||
23593583|NCT02988817|65903151|FG016|Overall Study|Withdrawal by Subject|4|||
23593584|NCT02988817|65903152|FG017|Overall Study|Withdrawal by Subject|11|||
23593585|NCT02988817|65903153|FG018|Overall Study|Withdrawal by Subject|4|||
23593586|NCT02988817|65903154|FG019|Overall Study|Withdrawal by Subject|2|||
23593587|NCT02988817|65903135|FG000|Overall Study|Death|0|||
23593588|NCT02988817|65903136|FG001|Overall Study|Death|1|||
23593589|NCT02988817|65903137|FG002|Overall Study|Death|3|||
23593590|NCT02988817|65903138|FG003|Overall Study|Death|1|||
23593591|NCT02988817|65903139|FG004|Overall Study|Death|6|||
23593592|NCT02988817|65903140|FG005|Overall Study|Death|10|||
23593593|NCT02988817|65903141|FG006|Overall Study|Death|1|||
23593594|NCT02988817|65903142|FG007|Overall Study|Death|2|||
23593595|NCT02988817|65903143|FG008|Overall Study|Death|1|||
23593596|NCT02988817|65903144|FG009|Overall Study|Death|5|||
23593597|NCT02988817|65903145|FG010|Overall Study|Death|1|||
23593598|NCT02988817|65903146|FG011|Overall Study|Death|8|||
23593599|NCT02988817|65903147|FG012|Overall Study|Death|9|||
23593600|NCT02988817|65903148|FG013|Overall Study|Death|17|||
23593601|NCT02988817|65903149|FG014|Overall Study|Death|18|||
23593602|NCT02988817|65903150|FG015|Overall Study|Death|30|||
23593603|NCT02988817|65903151|FG016|Overall Study|Death|17|||
23593604|NCT02988817|65903152|FG017|Overall Study|Death|38|||
23593605|NCT02988817|65903153|FG018|Overall Study|Death|14|||
23593606|NCT02988817|65903154|FG019|Overall Study|Death|16|||
23593607|NCT02988817|65903135|FG000|Overall Study|Other|0|||
23593608|NCT02988817|65903136|FG001|Overall Study|Other|0|||
23593609|NCT02988817|65903137|FG002|Overall Study|Other|0|||
23593610|NCT02988817|65903138|FG003|Overall Study|Other|1|||
23593611|NCT02988817|65903139|FG004|Overall Study|Other|1|||
23593612|NCT02988817|65903140|FG005|Overall Study|Other|0|||
23593613|NCT02988817|65903141|FG006|Overall Study|Other|0|||
23593614|NCT02988817|65903142|FG007|Overall Study|Other|0|||
23593615|NCT02988817|65903143|FG008|Overall Study|Other|0|||
23593616|NCT02988817|65903144|FG009|Overall Study|Other|0|||
23593617|NCT02988817|65903145|FG010|Overall Study|Other|0|||
23593618|NCT02988817|65903146|FG011|Overall Study|Other|0|||
23593619|NCT02988817|65903147|FG012|Overall Study|Other|0|||
23593620|NCT02988817|65903148|FG013|Overall Study|Other|0|||
23593621|NCT02988817|65903149|FG014|Overall Study|Other|0|||
23593622|NCT02988817|65903150|FG015|Overall Study|Other|1|||
23593623|NCT02988817|65903151|FG016|Overall Study|Other|0|||
23593624|NCT02988817|65903152|FG017|Overall Study|Other|0|||
23593625|NCT02988817|65903153|FG018|Overall Study|Other|0|||
23593626|NCT02988817|65903154|FG019|Overall Study|Other|0|||
23593627|NCT02988817|65903135|FG000|Overall Study|Lost to Follow-up|0|||
23593628|NCT02988817|65903136|FG001|Overall Study|Lost to Follow-up|0|||
23593629|NCT02988817|65903137|FG002|Overall Study|Lost to Follow-up|0|||
23593630|NCT02988817|65903138|FG003|Overall Study|Lost to Follow-up|0|||
23593631|NCT02988817|65903139|FG004|Overall Study|Lost to Follow-up|0|||
23593632|NCT02988817|65903140|FG005|Overall Study|Lost to Follow-up|0|||
23593633|NCT02988817|65903141|FG006|Overall Study|Lost to Follow-up|0|||
23593634|NCT02988817|65903142|FG007|Overall Study|Lost to Follow-up|0|||
23593635|NCT02988817|65903143|FG008|Overall Study|Lost to Follow-up|1|||
23593636|NCT02988817|65903144|FG009|Overall Study|Lost to Follow-up|0|||
23593637|NCT02988817|65903145|FG010|Overall Study|Lost to Follow-up|1|||
23593638|NCT02988817|65903146|FG011|Overall Study|Lost to Follow-up|1|||
23593639|NCT02988817|65903147|FG012|Overall Study|Lost to Follow-up|0|||
23254364|NCT00879970|64673503|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
23593640|NCT02988817|65903148|FG013|Overall Study|Lost to Follow-up|0|||
23593641|NCT02988817|65903149|FG014|Overall Study|Lost to Follow-up|1|||
23593642|NCT02988817|65903150|FG015|Overall Study|Lost to Follow-up|1|||
23593643|NCT02988817|65903151|FG016|Overall Study|Lost to Follow-up|2|||
23593644|NCT02988817|65903152|FG017|Overall Study|Lost to Follow-up|3|||
23593645|NCT02988817|65903153|FG018|Overall Study|Lost to Follow-up|0|||
23593646|NCT02988817|65903154|FG019|Overall Study|Lost to Follow-up|0|||
23593647|NCT02988817|65903135|FG000|Overall Study|Sponsor decision|0|||
23593648|NCT02988817|65903136|FG001|Overall Study|Sponsor decision|0|||
23593649|NCT02988817|65903137|FG002|Overall Study|Sponsor decision|0|||
23593650|NCT02988817|65903138|FG003|Overall Study|Sponsor decision|0|||
23593651|NCT02988817|65903139|FG004|Overall Study|Sponsor decision|0|||
23593652|NCT02988817|65903140|FG005|Overall Study|Sponsor decision|0|||
23593653|NCT02988817|65903141|FG006|Overall Study|Sponsor decision|0|||
23593654|NCT02988817|65903142|FG007|Overall Study|Sponsor decision|0|||
23593655|NCT02988817|65903143|FG008|Overall Study|Sponsor decision|0|||
23593656|NCT02988817|65903144|FG009|Overall Study|Sponsor decision|0|||
23593657|NCT02988817|65903145|FG010|Overall Study|Sponsor decision|0|||
23593658|NCT02988817|65903146|FG011|Overall Study|Sponsor decision|1|||
23593659|NCT02988817|65903147|FG012|Overall Study|Sponsor decision|1|||
23593660|NCT02988817|65903148|FG013|Overall Study|Sponsor decision|2|||
23593661|NCT02988817|65903149|FG014|Overall Study|Sponsor decision|2|||
23593662|NCT02988817|65903150|FG015|Overall Study|Sponsor decision|6|||
23593663|NCT02988817|65903151|FG016|Overall Study|Sponsor decision|2|||
23593664|NCT02988817|65903152|FG017|Overall Study|Sponsor decision|3|||
23593665|NCT02988817|65903153|FG018|Overall Study|Sponsor decision|2|||
23593666|NCT02988817|65903154|FG019|Overall Study|Sponsor decision|7|||
23593667|NCT02988817|65903135|FG000|Overall Study|Physician Decision|0|||
23593668|NCT02988817|65903136|FG001|Overall Study|Physician Decision|0|||
23593669|NCT02988817|65903137|FG002|Overall Study|Physician Decision|0|||
23593670|NCT02988817|65903138|FG003|Overall Study|Physician Decision|0|||
23593671|NCT02988817|65903139|FG004|Overall Study|Physician Decision|0|||
23593672|NCT02988817|65903140|FG005|Overall Study|Physician Decision|0|||
23593673|NCT02988817|65903141|FG006|Overall Study|Physician Decision|0|||
23593674|NCT02988817|65903142|FG007|Overall Study|Physician Decision|0|||
23593675|NCT02988817|65903143|FG008|Overall Study|Physician Decision|0|||
23593676|NCT02988817|65903144|FG009|Overall Study|Physician Decision|0|||
23593677|NCT02988817|65903145|FG010|Overall Study|Physician Decision|0|||
23593678|NCT02988817|65903146|FG011|Overall Study|Physician Decision|0|||
23593679|NCT02988817|65903147|FG012|Overall Study|Physician Decision|0|||
23593680|NCT02988817|65903148|FG013|Overall Study|Physician Decision|0|||
23593681|NCT02988817|65903149|FG014|Overall Study|Physician Decision|0|||
23593682|NCT02988817|65903150|FG015|Overall Study|Physician Decision|1|||
23593683|NCT02988817|65903151|FG016|Overall Study|Physician Decision|0|||
23593684|NCT02988817|65903152|FG017|Overall Study|Physician Decision|0|||
23593685|NCT02988817|65903153|FG018|Overall Study|Physician Decision|1|||
23593686|NCT02988817|65903154|FG019|Overall Study|Physician Decision|1|||
23593687|NCT02568683|65903155|FG000|Overall Study|Death|0|||
23593688|NCT02568683|65903156|FG001|Overall Study|Death|2|||
23593689|NCT02568683|65903155|FG000|Overall Study|Withdrew Consent|1|||
23593690|NCT02568683|65903156|FG001|Overall Study|Withdrew Consent|0|||
23593691|NCT02568683|65903155|FG000|Overall Study|Study Terminated By Sponsor|5|||
23593692|NCT02568683|65903156|FG001|Overall Study|Study Terminated By Sponsor|2|||
23593693|NCT01563354|65903159|FG000|Core Phase|Adverse Event|5|||
23593694|NCT01563354|65903160|FG001|Core Phase|Adverse Event|15|||
23593695|NCT01563354|65903161|FG002|Core Phase|Adverse Event|13|||
23593696|NCT01563354|65903159|FG000|Core Phase|Withdrawal by Subject|1|||
23593697|NCT01563354|65903160|FG001|Core Phase|Withdrawal by Subject|0|||
23593698|NCT01563354|65903161|FG002|Core Phase|Withdrawal by Subject|3|||
23593699|NCT01563354|65903159|FG000|Core Phase|Lost to Follow-up|1|||
23593700|NCT01563354|65903160|FG001|Core Phase|Lost to Follow-up|0|||
23593701|NCT01563354|65903161|FG002|Core Phase|Lost to Follow-up|0|||
23593702|NCT01563354|65903159|FG000|Core Phase|Death|1|||
23593703|NCT01563354|65903160|FG001|Core Phase|Death|5|||
23593704|NCT01563354|65903161|FG002|Core Phase|Death|2|||
23593705|NCT01563354|65903159|FG000|Core Phase|Diseasse progression|18|||
23593706|NCT01563354|65903160|FG001|Core Phase|Diseasse progression|7|||
23593707|NCT01563354|65903161|FG002|Core Phase|Diseasse progression|8|||
23593708|NCT01563354|65903159|FG000|Core Phase|Protocol deviation|2|||
23593709|NCT01563354|65903160|FG001|Core Phase|Protocol deviation|0|||
23593710|NCT01563354|65903161|FG002|Core Phase|Protocol deviation|0|||
23593711|NCT01563354|65903159|FG000|Core Phase|PI decision - did not enter extension|0|||
23593712|NCT01563354|65903160|FG001|Core Phase|PI decision - did not enter extension|1|||
23593713|NCT01563354|65903161|FG002|Core Phase|PI decision - did not enter extension|0|||
23593714|NCT01563354|65903159|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
23593715|NCT01563354|65903160|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
23593716|NCT01563354|65903161|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
23593717|NCT01563354|65903159|FG000|Extension Phase|Adverse Event|0|||
23593718|NCT01563354|65903160|FG001|Extension Phase|Adverse Event|3|||
23593719|NCT01563354|65903161|FG002|Extension Phase|Adverse Event|2|||
23593720|NCT01563354|65903159|FG000|Extension Phase|Withdrawal by Subject|0|||
23593721|NCT01563354|65903160|FG001|Extension Phase|Withdrawal by Subject|1|||
23593722|NCT01563354|65903161|FG002|Extension Phase|Withdrawal by Subject|0|||
23593723|NCT01563354|65903159|FG000|Extension Phase|Administration problems|3|||
23593724|NCT01563354|65903160|FG001|Extension Phase|Administration problems|2|||
23593725|NCT01563354|65903161|FG002|Extension Phase|Administration problems|3|||
23593726|NCT01563354|65903159|FG000|Extension Phase|Disease progression|9|||
23593727|NCT01563354|65903160|FG001|Extension Phase|Disease progression|8|||
23593728|NCT01563354|65903161|FG002|Extension Phase|Disease progression|10|||
23593729|NCT03050814|65903164|FG000|Overall Study|Screen failures|0|||
23593730|NCT03050814|65903165|FG001|Overall Study|Screen failures|0|||
23593731|NCT03050814|65903166|FG002|Overall Study|Screen failures|4|||
23593732|NCT00423098|65903169|FG000|Overall Study|Adverse Event|1|||
23593733|NCT00423098|65903170|FG001|Overall Study|Adverse Event|2|||
23593734|NCT00423098|65903169|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23593735|NCT00423098|65903170|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23593736|NCT00423098|65903169|FG000|Overall Study|Administrative problems|0|||
23593737|NCT00423098|65903170|FG001|Overall Study|Administrative problems|1|||
23593738|NCT00423098|65903169|FG000|Overall Study|Death|2|||
23593739|NCT00423098|65903170|FG001|Overall Study|Death|0|||
23593740|NCT01118377|65903171|FG000|Overall Study|Did Not Receive Study Medication|1|||
23593741|NCT01118377|65903171|FG000|Overall Study|Death|38|||
23593742|NCT01118377|65903171|FG000|Overall Study|Failure to Return|3|||
23593743|NCT00997386|65903172|FG000|Overall Study|Death|7|||
23593744|NCT02815566|65903173|FG000|Overall Study|Adverse Event|1|||
23593745|NCT02815566|65903174|FG001|Overall Study|Adverse Event|1|||
23593746|NCT02815566|65903173|FG000|Overall Study|Withdrawal by Subject|1|||
23593747|NCT02815566|65903174|FG001|Overall Study|Withdrawal by Subject|0|||
23593748|NCT02815566|65903173|FG000|Overall Study|Lost to Follow-up|0|||
23593749|NCT02815566|65903174|FG001|Overall Study|Lost to Follow-up|1|||
23593750|NCT00065260|65903175|FG000|Overall Study|Death|0|||
23593751|NCT00065260|65903176|FG001|Overall Study|Death|1|||
23593752|NCT01538719|65903177|FG000|Overall Study|Lost to Follow-up|2|||
23593753|NCT01538719|65903178|FG001|Overall Study|Lost to Follow-up|0|||
23593754|NCT05082935|65903180|FG000|Overall Study|Lost to Follow-up|549|||
23593755|NCT05082935|65903181|FG001|Overall Study|Lost to Follow-up|631|||
23593756|NCT05082935|65903180|FG000|Overall Study|Withdrawal by Subject|27|||
23593757|NCT05082935|65903181|FG001|Overall Study|Withdrawal by Subject|58|||
23593758|NCT01359592|65903184|FG000|Initial Registration|Adverse Event|1|||
23593759|NCT01359592|65903185|FG001|Initial Registration|Adverse Event|0|||
23593760|NCT01359592|65903186|FG002|Initial Registration|Adverse Event|0|||
23593761|NCT01359592|65903187|FG003|Initial Registration|Adverse Event|0|||
23593762|NCT01359592|65903184|FG000|Initial Registration|Death|1|||
23593763|NCT01359592|65903185|FG001|Initial Registration|Death|0|||
23593764|NCT01359592|65903186|FG002|Initial Registration|Death|0|||
23593765|NCT01359592|65903187|FG003|Initial Registration|Death|0|||
23593766|NCT01359592|65903184|FG000|Initial Registration|Other reason not protocol specified|1|||
23593767|NCT01359592|65903185|FG001|Initial Registration|Other reason not protocol specified|0|||
23593768|NCT01359592|65903186|FG002|Initial Registration|Other reason not protocol specified|0|||
23593769|NCT01359592|65903187|FG003|Initial Registration|Other reason not protocol specified|0|||
23593770|NCT01359592|65903184|FG000|Initial Registration|Ineligible|26|||
23593771|NCT01359592|65903185|FG001|Initial Registration|Ineligible|0|||
23593772|NCT01359592|65903186|FG002|Initial Registration|Ineligible|0|||
23593773|NCT01359592|65903187|FG003|Initial Registration|Ineligible|0|||
23593774|NCT01359592|65903184|FG000|PET-Directed Therapy|Adverse Event|0|||
23593775|NCT01359592|65903185|FG001|PET-Directed Therapy|Adverse Event|0|||
23593776|NCT01359592|65903186|FG002|PET-Directed Therapy|Adverse Event|1|||
23593777|NCT01359592|65903187|FG003|PET-Directed Therapy|Adverse Event|0|||
23593778|NCT01359592|65903184|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
23593779|NCT01359592|65903185|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
23593780|NCT01359592|65903186|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
23593781|NCT01359592|65903187|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
23593782|NCT01359592|65903184|FG000|PET-Directed Therapy|Ineligible|0|||
23593783|NCT01359592|65903185|FG001|PET-Directed Therapy|Ineligible|0|||
23593784|NCT01359592|65903186|FG002|PET-Directed Therapy|Ineligible|24|||
23593785|NCT01359592|65903187|FG003|PET-Directed Therapy|Ineligible|0|||
23593786|NCT04056611|65903189|FG000|Overall Study|Physician Decision|1|||
23593787|NCT04867902|65903190|FG000|Overall Study|Lost to Follow-up|1|||
23593788|NCT04867902|65903190|FG000|Overall Study|Withdrawal by Subject|2|||
23593789|NCT04867902|65903190|FG000|Overall Study|Protocol Violation|1|||
23593790|NCT02372253|65903198|FG000|Overall Study|Non Compliance|2|||
23593791|NCT02372253|65903199|FG001|Overall Study|Non Compliance|0|||
23593792|NCT01064817|65903203|FG000|Study Completion|Physician Decision|1|||
23593793|NCT01064817|65903204|FG001|Study Completion|Physician Decision|0|||
23593794|NCT01064817|65903203|FG000|Study Completion|Withdrawal by Subject|1|||
23593795|NCT01064817|65903204|FG001|Study Completion|Withdrawal by Subject|0|||
23593796|NCT04358549|65903206|FG000|Overall Study|Adverse Event|0|||
23593797|NCT04358549|65903207|FG001|Overall Study|Adverse Event|1|||
23593798|NCT04358549|65903206|FG000|Overall Study|Death|1|||
23593799|NCT04358549|65903207|FG001|Overall Study|Death|0|||
23254365|NCT00879970|64673504|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
23254366|NCT00879970|64673505|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
23360198|NCT00420628|65062854|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
23593800|NCT04358549|65903206|FG000|Overall Study|Lost to Follow-up|2|||
23593801|NCT04358549|65903207|FG001|Overall Study|Lost to Follow-up|1|||
23593802|NCT04358549|65903206|FG000|Overall Study|Withdrawal by Subject|6|||
23593803|NCT04358549|65903207|FG001|Overall Study|Withdrawal by Subject|6|||
23593804|NCT04358549|65903206|FG000|Overall Study|Start remdesivir|1|||
23593805|NCT04358549|65903207|FG001|Overall Study|Start remdesivir|0|||
23593806|NCT00360698|65903209|FG000|Run-In|Physician Decision|0|||
23593807|NCT00360698|65903210|FG001|Run-In|Physician Decision|1|||
23593808|NCT00360698|65903209|FG000|Run-In|Withdrawal by Subject|0|||
23593809|NCT00360698|65903210|FG001|Run-In|Withdrawal by Subject|2|||
23593810|NCT00360698|65903209|FG000|Run-In|Non compliance with treatment procedure|0|||
23593811|NCT00360698|65903210|FG001|Run-In|Non compliance with treatment procedure|1|||
23593812|NCT00360698|65903209|FG000|Run-In|Sponsor request|0|||
23593813|NCT00360698|65903210|FG001|Run-In|Sponsor request|2|||
23593814|NCT00360698|65903209|FG000|Run-In|Patient did not meet inclusion criteria|0|||
23593815|NCT00360698|65903210|FG001|Run-In|Patient did not meet inclusion criteria|1|||
23593816|NCT00360698|65903209|FG000|Run-In|Patient personal reasons|0|||
23593817|NCT00360698|65903210|FG001|Run-In|Patient personal reasons|2|||
23593818|NCT00360698|65903209|FG000|Run-In|Need of insulin with meals|0|||
23593819|NCT00360698|65903210|FG001|Run-In|Need of insulin with meals|1|||
23593820|NCT00360698|65903209|FG000|Treatment Period|Non compliance with treatment procedure|1|||
23593821|NCT00360698|65903210|FG001|Treatment Period|Non compliance with treatment procedure|0|||
23593822|NCT00360698|65903209|FG000|Treatment Period|Early termination by error|0|||
23593823|NCT00360698|65903210|FG001|Treatment Period|Early termination by error|1|||
23593824|NCT00841035|65903211|FG000|Phase 1 Overall Study|Physician Decision|13|||
23593825|NCT01395758|65903212|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
23593826|NCT01395758|65903213|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23593827|NCT01395758|65903214|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
23593828|NCT05283395|65903222|FG000|Overall Study|Adverse Event|4|||
23593829|NCT05283395|65903223|FG001|Overall Study|Adverse Event|4|||
23593830|NCT05283395|65903224|FG002|Overall Study|Adverse Event|0|||
23593831|NCT05283395|65903222|FG000|Overall Study|Patient Lost to Follow-Up|0|||
23593832|NCT05283395|65903223|FG001|Overall Study|Patient Lost to Follow-Up|0|||
23593833|NCT05283395|65903224|FG002|Overall Study|Patient Lost to Follow-Up|1|||
23593834|NCT05283395|65903222|FG000|Overall Study|Patient Withdrawal|2|||
23593835|NCT05283395|65903223|FG001|Overall Study|Patient Withdrawal|4|||
23593836|NCT05283395|65903224|FG002|Overall Study|Patient Withdrawal|2|||
23593837|NCT05283395|65903222|FG000|Overall Study|Investigator Decision|1|||
23593838|NCT05283395|65903223|FG001|Overall Study|Investigator Decision|0|||
23593839|NCT05283395|65903224|FG002|Overall Study|Investigator Decision|1|||
23593840|NCT05283395|65903222|FG000|Overall Study|Enrolled in error|0|||
23593841|NCT05283395|65903223|FG001|Overall Study|Enrolled in error|0|||
23593842|NCT05283395|65903224|FG002|Overall Study|Enrolled in error|1|||
23593843|NCT00661778|65903229|FG000|Overall Study|Disease Progression|23|||
23593844|NCT00661778|65903229|FG000|Overall Study|Adverse Event|18|||
23593845|NCT00661778|65903229|FG000|Overall Study|Reason not Specified|6|||
23593846|NCT00661778|65903229|FG000|Overall Study|Protocol Violation|2|||
23593847|NCT00661778|65903229|FG000|Overall Study|Withdrawal of Consent|1|||
23593848|NCT02320123|65903232|FG000|Overall Study|Lost to Follow-up|4|||
23593849|NCT02320123|65903233|FG001|Overall Study|Lost to Follow-up|6|||
23593850|NCT02320123|65903232|FG000|Overall Study|Death|6|||
23593851|NCT02320123|65903233|FG001|Overall Study|Death|5|||
23593852|NCT02918279|65903236|FG000|Overall Study|Lost to Follow-up|3|||
23593853|NCT02918279|65903237|FG001|Overall Study|Lost to Follow-up|6|||
23593854|NCT02918279|65903236|FG000|Overall Study|Withdrawal by Subject|5|||
23593855|NCT02918279|65903237|FG001|Overall Study|Withdrawal by Subject|15|||
23593856|NCT02918279|65903236|FG000|Overall Study|Withdrawal by parent/guardian|2|||
23593857|NCT02918279|65903237|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23593858|NCT02918279|65903236|FG000|Overall Study|Other|3|||
23593859|NCT02918279|65903237|FG001|Overall Study|Other|1|||
23593860|NCT01041417|65903238|FG000|Overall Study|Adverse Event|5|||
23593861|NCT01041417|65903239|FG001|Overall Study|Adverse Event|2|||
23593862|NCT01041417|65903238|FG000|Overall Study|Lost to Follow-up|1|||
23593863|NCT01041417|65903239|FG001|Overall Study|Lost to Follow-up|1|||
23593864|NCT01041417|65903238|FG000|Overall Study|Death|1|||
23593865|NCT01041417|65903239|FG001|Overall Study|Death|0|||
23593866|NCT03981822|65903240|FG000|Overall Study|Lost to Follow-up|0|||
23593867|NCT03981822|65903241|FG001|Overall Study|Lost to Follow-up|1|||
23593868|NCT03981822|65903242|FG002|Overall Study|Lost to Follow-up|1|||
23593869|NCT03981822|65903243|FG003|Overall Study|Lost to Follow-up|0|||
23593870|NCT03981822|65903244|FG004|Overall Study|Lost to Follow-up|6|||
23593871|NCT03981822|65903245|FG005|Overall Study|Lost to Follow-up|4|||
23593872|NCT03981822|65903246|FG006|Overall Study|Lost to Follow-up|4|||
23593873|NCT03981822|65903247|FG007|Overall Study|Lost to Follow-up|2|||
23593874|NCT03981822|65903240|FG000|Overall Study|Withdrawal by Subject|0|||
23254367|NCT00879970|64673506|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
23593875|NCT03981822|65903241|FG001|Overall Study|Withdrawal by Subject|1|||
23593876|NCT03981822|65903242|FG002|Overall Study|Withdrawal by Subject|0|||
23593877|NCT03981822|65903243|FG003|Overall Study|Withdrawal by Subject|0|||
23193845|NCT01096550|64452396|FG000|Overall Study|non-African American participant|13|||
23254368|NCT00879970|64673507|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
23593878|NCT03981822|65903244|FG004|Overall Study|Withdrawal by Subject|0|||
23593879|NCT03981822|65903245|FG005|Overall Study|Withdrawal by Subject|1|||
23593880|NCT03981822|65903246|FG006|Overall Study|Withdrawal by Subject|0|||
23593881|NCT03981822|65903247|FG007|Overall Study|Withdrawal by Subject|2|||
23593882|NCT03981822|65903240|FG000|Overall Study|COVID-19 Related|0|||
23593883|NCT03981822|65903241|FG001|Overall Study|COVID-19 Related|0|||
23593884|NCT03981822|65903242|FG002|Overall Study|COVID-19 Related|0|||
23593885|NCT03981822|65903243|FG003|Overall Study|COVID-19 Related|0|||
23593886|NCT03981822|65903244|FG004|Overall Study|COVID-19 Related|2|||
23254369|NCT00879970|64673503|FG000|Period 1 TZD Randomization|Death|2|||
23254370|NCT00879970|64673504|FG001|Period 1 TZD Randomization|Death|1|||
23254371|NCT00879970|64673505|FG002|Period 1 TZD Randomization|Death|0|||
23593887|NCT03981822|65903245|FG005|Overall Study|COVID-19 Related|1|||
23593888|NCT03981822|65903246|FG006|Overall Study|COVID-19 Related|2|||
23593889|NCT03981822|65903247|FG007|Overall Study|COVID-19 Related|1|||
23593890|NCT02383472|65906076|FG000|Overall Study|Withdrawal by Subject|1|||
23593891|NCT02383472|65906077|FG001|Overall Study|Withdrawal by Subject|1|||
23593892|NCT02362035|65906078|FG000|Overall Study|Death|67|||
23593893|NCT02362035|65906078|FG000|Overall Study|Lost to Follow-up|3|||
23593894|NCT02362035|65906078|FG000|Overall Study|Adverse Event|1|||
23593895|NCT02362035|65906078|FG000|Overall Study|Physician Decision|1|||
23593896|NCT02362035|65906078|FG000|Overall Study|Subject started another cancer therapy|10|||
23593897|NCT02362035|65906078|FG000|Overall Study|Study terminated by sponsor|45|||
23593898|NCT02362035|65906078|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
23593899|NCT02362035|65906078|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
23593900|NCT02362035|65906078|FG000|Overall Study|Disease progression|11|||
23593901|NCT02362035|65906078|FG000|Overall Study|Withdrawal by Subject|20|||
23593902|NCT02466516|65906079|FG000|Overall Study|Adverse Event|1|||
23254372|NCT00879970|64673506|FG003|Period 1 TZD Randomization|Death|0|||
23593903|NCT02466516|65906080|FG001|Overall Study|Adverse Event|1|||
23593904|NCT02466516|65906081|FG002|Overall Study|Adverse Event|0|||
23593905|NCT02466516|65906082|FG003|Overall Study|Adverse Event|0|||
23593906|NCT02466516|65906083|FG004|Overall Study|Adverse Event|0|||
23593907|NCT02466516|65906079|FG000|Overall Study|Withdrew Consent|1|||
23593908|NCT02466516|65906080|FG001|Overall Study|Withdrew Consent|0|||
23593909|NCT02466516|65906081|FG002|Overall Study|Withdrew Consent|0|||
23593910|NCT02466516|65906082|FG003|Overall Study|Withdrew Consent|0|||
23593911|NCT02466516|65906083|FG004|Overall Study|Withdrew Consent|0|||
23593912|NCT02466516|65906079|FG000|Overall Study|Lost to Follow-up|2|||
23593913|NCT02466516|65906080|FG001|Overall Study|Lost to Follow-up|0|||
23593914|NCT02466516|65906081|FG002|Overall Study|Lost to Follow-up|1|||
23593915|NCT02466516|65906082|FG003|Overall Study|Lost to Follow-up|0|||
23593916|NCT02466516|65906083|FG004|Overall Study|Lost to Follow-up|0|||
23593917|NCT02299375|65906084|FG000|Overall Study|Adverse Event, serious fatal|1|||
23593918|NCT02299375|65906085|FG001|Overall Study|Adverse Event, serious fatal|3|||
23593919|NCT02299375|65906084|FG000|Overall Study|Adverse Event, non-fatal|8|||
23593920|NCT02299375|65906085|FG001|Overall Study|Adverse Event, non-fatal|9|||
23593921|NCT02299375|65906084|FG000|Overall Study|Lack of Efficacy|1|||
23593922|NCT02299375|65906085|FG001|Overall Study|Lack of Efficacy|3|||
23593923|NCT02299375|65906084|FG000|Overall Study|Protocol Violation|1|||
23593924|NCT02299375|65906085|FG001|Overall Study|Protocol Violation|3|||
23593925|NCT02299375|65906084|FG000|Overall Study|Other: Met stopping criteria|1|||
23593926|NCT02299375|65906085|FG001|Overall Study|Other: Met stopping criteria|0|||
23593927|NCT02299375|65906084|FG000|Overall Study|Other: Study closed/terminated|66|||
23593928|NCT02299375|65906085|FG001|Overall Study|Other: Study closed/terminated|55|||
23593929|NCT02299375|65906084|FG000|Overall Study|Lost to Follow-up|0|||
23593930|NCT02299375|65906085|FG001|Overall Study|Lost to Follow-up|2|||
23593931|NCT02299375|65906084|FG000|Overall Study|Physician Decision|1|||
23593932|NCT02299375|65906085|FG001|Overall Study|Physician Decision|1|||
23593933|NCT02299375|65906084|FG000|Overall Study|Withdrawal by Subject|1|||
23593934|NCT02299375|65906085|FG001|Overall Study|Withdrawal by Subject|4|||
23593935|NCT02983617|65906087|FG000|Overall Study|Adverse Event|0|||
23593936|NCT02983617|65906088|FG001|Overall Study|Adverse Event|7|||
23593937|NCT02983617|65906087|FG000|Overall Study|Death|0|||
23593938|NCT02983617|65906088|FG001|Overall Study|Death|1|||
23593939|NCT02983617|65906087|FG000|Overall Study|Investigator's Discretion|0|||
23593940|NCT02983617|65906088|FG001|Overall Study|Investigator's Discretion|1|||
23593941|NCT01925339|65906089|FG000|Overall Study|Adverse Event|2|||
23593942|NCT01925339|65906090|FG001|Overall Study|Adverse Event|0|||
23593943|NCT03544515|65906091|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
23593944|NCT03544515|65906092|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
23593945|NCT03544515|65906091|FG000|Overall Study|Lost to Follow-up|2|||
23593946|NCT03544515|65906092|FG001|Overall Study|Lost to Follow-up|0|||
23593947|NCT03684044|65906094|FG000|Overall Study|Adverse Event|3|||
23593948|NCT03684044|65906095|FG001|Overall Study|Adverse Event|0|||
23593949|NCT03684044|65906094|FG000|Overall Study|Death|4|||
23593950|NCT03684044|65906095|FG001|Overall Study|Death|7|||
23593951|NCT03684044|65906094|FG000|Overall Study|Lost to Follow-up|3|||
23593952|NCT03684044|65906095|FG001|Overall Study|Lost to Follow-up|2|||
23593953|NCT03684044|65906094|FG000|Overall Study|Patient Not Available|0|||
23593954|NCT03684044|65906095|FG001|Overall Study|Patient Not Available|2|||
23593955|NCT03684044|65906094|FG000|Overall Study|Physician Decision|1|||
23593956|NCT03684044|65906095|FG001|Overall Study|Physician Decision|0|||
23593957|NCT03684044|65906094|FG000|Overall Study|Withdrawal by Subject|11|||
23593958|NCT03684044|65906095|FG001|Overall Study|Withdrawal by Subject|9|||
23593959|NCT00001277|65906099|FG000|Overall Study|Adverse Event|0|||
23593960|NCT00001277|65906100|FG001|Overall Study|Adverse Event|0|||
23593961|NCT00001277|65906101|FG002|Overall Study|Adverse Event|1|||
23593962|NCT00001277|65906099|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
23593963|NCT00001277|65906100|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
23593964|NCT00001277|65906101|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
23593965|NCT01227278|65906102|FG000|Overall Study|Withdrawal by Subject|4|||
23593966|NCT01227278|65906103|FG001|Overall Study|Withdrawal by Subject|4|||
23593967|NCT01227278|65906102|FG000|Overall Study|Death|0|||
23593968|NCT01227278|65906103|FG001|Overall Study|Death|2|||
23593969|NCT01227278|65906102|FG000|Overall Study|Other|1|||
23593970|NCT01227278|65906103|FG001|Overall Study|Other|2|||
23593971|NCT02742519|65906104|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
23593972|NCT02742519|65906105|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
23593973|NCT02742519|65906106|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
23593974|NCT02742519|65906104|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
23593975|NCT02742519|65906105|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
23593976|NCT02742519|65906106|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
23593977|NCT02742519|65906104|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
23593978|NCT02742519|65906105|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
23593979|NCT02742519|65906106|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
23593980|NCT00542789|65906111|FG000|Overall Study|Adverse Event|18|||
23593981|NCT00542789|65906112|FG001|Overall Study|Adverse Event|17|||
23593982|NCT00542789|65906111|FG000|Overall Study|Withdrawal by Subject|7|||
23593983|NCT00542789|65906112|FG001|Overall Study|Withdrawal by Subject|3|||
23593984|NCT00542789|65906111|FG000|Overall Study|Protocol Violation|8|||
23593985|NCT00542789|65906112|FG001|Overall Study|Protocol Violation|1|||
23593986|NCT00542789|65906111|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
23593987|NCT00542789|65906112|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
23593988|NCT01278394|65906113|FG000|Overall Study|Lost to Follow-up|1|||
23593989|NCT01759771|65906114|FG000|Overall Study|Withdrawal by Subject|1|||
23593990|NCT01759771|65906115|FG001|Overall Study|Withdrawal by Subject|1|||
23593991|NCT00979992|65906116|FG000|Overall Study|Ineligible - inadequate pathology|1|||
23593992|NCT00979992|65906116|FG000|Overall Study|Ineligible - wrong cell type|2|||
23193846|NCT01096550|64452397|FG001|Overall Study|non-African American participant|6|||
23593993|NCT00979992|65906116|FG000|Overall Study|Refused - Never Treated|2|||
23593994|NCT01662336|65906119|FG000|Overall Study|Adverse Event|1|||
23593995|NCT01662336|65906119|FG000|Overall Study|No longer on LPV/r|30|||
23593996|NCT01662336|65906119|FG000|Overall Study|Other|29|||
23593997|NCT01662336|65906119|FG000|Overall Study|Withdrawal by Subject|6|||
23593998|NCT04252586|65906120|FG000|Overall Study|Withdrawal by parent/guardian|3|||
23593999|NCT04252586|65906120|FG000|Overall Study|Adverse Event|1|||
23594000|NCT04252586|65906120|FG000|Overall Study|Death|2|||
23594001|NCT04252586|65906120|FG000|Overall Study|Study terminated by sponsor|4|||
23594002|NCT04252586|65906120|FG000|Overall Study|Sponsor request|10|||
23594003|NCT04252586|65906120|FG000|Overall Study|Did not complete treatment period|1|||
23594004|NCT01823536|65906121|FG000|Overall Study|Lost to Follow-up|1|||
23594005|NCT01823536|65906122|FG001|Overall Study|Lost to Follow-up|0|||
23594006|NCT01823536|65906123|FG002|Overall Study|Lost to Follow-up|0|||
23594007|NCT01823536|65906124|FG003|Overall Study|Lost to Follow-up|1|||
23594008|NCT01823536|65906125|FG004|Overall Study|Lost to Follow-up|1|||
23594009|NCT01823536|65906126|FG005|Overall Study|Lost to Follow-up|0|||
23594010|NCT01823536|65906121|FG000|Overall Study|Protocol Violation|0|||
23594011|NCT01823536|65906122|FG001|Overall Study|Protocol Violation|1|||
23594012|NCT01823536|65906123|FG002|Overall Study|Protocol Violation|0|||
23594013|NCT01823536|65906124|FG003|Overall Study|Protocol Violation|0|||
23594014|NCT01823536|65906125|FG004|Overall Study|Protocol Violation|0|||
23193847|NCT01096550|64452396|FG000|Overall Study|Lost to Follow-up|12|||
23193848|NCT01096550|64452397|FG001|Overall Study|Lost to Follow-up|9|||
23193849|NCT01781026|64452398|FG000|Overall Study|Lack of Efficacy|2|||
23193850|NCT00474630|64452399|FG000|Overall Study|Adverse Event|98|||
23193851|NCT00474630|64452400|FG001|Overall Study|Adverse Event|26|||
23193852|NCT00474630|64452399|FG000|Overall Study|Lost to Follow-up|22|||
23594015|NCT01823536|65906126|FG005|Overall Study|Protocol Violation|0|||
23193853|NCT00474630|64452400|FG001|Overall Study|Lost to Follow-up|15|||
23193854|NCT00474630|64452399|FG000|Overall Study|Withdrawal by Subject|21|||
23193855|NCT00474630|64452400|FG001|Overall Study|Withdrawal by Subject|15|||
23193856|NCT00474630|64452399|FG000|Overall Study|Protocol Violation|3|||
23193857|NCT00474630|64452400|FG001|Overall Study|Protocol Violation|4|||
23193858|NCT00474630|64452399|FG000|Overall Study|Lack of Efficacy|5|||
23193859|NCT00474630|64452400|FG001|Overall Study|Lack of Efficacy|6|||
23193860|NCT00474630|64452399|FG000|Overall Study|Drug noncompliance, other|11|||
23193861|NCT00474630|64452400|FG001|Overall Study|Drug noncompliance, other|4|||
23193862|NCT01165203|64452409|FG000|Active Phase|Serious Adverse Event|1|||
23193863|NCT01165203|64452410|FG001|Active Phase|Serious Adverse Event|0|||
23477510|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
23477511|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
23477512|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
23477513|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
23477514|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
23477515|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
23594016|NCT01823536|65906121|FG000|Overall Study|Withdrawal by Subject|1|||
23594017|NCT01823536|65906122|FG001|Overall Study|Withdrawal by Subject|1|||
23594018|NCT01823536|65906123|FG002|Overall Study|Withdrawal by Subject|0|||
23594019|NCT01823536|65906124|FG003|Overall Study|Withdrawal by Subject|0|||
23594020|NCT01823536|65906125|FG004|Overall Study|Withdrawal by Subject|0|||
23594021|NCT01823536|65906126|FG005|Overall Study|Withdrawal by Subject|0|||
23594022|NCT01823536|65906121|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594023|NCT01823536|65906122|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594024|NCT01823536|65906123|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
23594025|NCT01823536|65906124|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594026|NCT01823536|65906125|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594027|NCT01823536|65906126|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
23594028|NCT01823536|65906121|FG000|Overall Study|Met exclusion criterion No 6|0|||
23594029|NCT01823536|65906122|FG001|Overall Study|Met exclusion criterion No 6|0|||
23594030|NCT01823536|65906123|FG002|Overall Study|Met exclusion criterion No 6|0|||
23594031|NCT01823536|65906124|FG003|Overall Study|Met exclusion criterion No 6|1|||
23594032|NCT01823536|65906125|FG004|Overall Study|Met exclusion criterion No 6|0|||
23594033|NCT01823536|65906126|FG005|Overall Study|Met exclusion criterion No 6|0|||
23594034|NCT01823536|65906121|FG000|Overall Study|Subject moved out of the state|0|||
23594035|NCT01823536|65906122|FG001|Overall Study|Subject moved out of the state|0|||
23594036|NCT01823536|65906123|FG002|Overall Study|Subject moved out of the state|0|||
23594037|NCT01823536|65906124|FG003|Overall Study|Subject moved out of the state|0|||
23594038|NCT01823536|65906125|FG004|Overall Study|Subject moved out of the state|1|||
23594039|NCT01823536|65906126|FG005|Overall Study|Subject moved out of the state|0|||
23594040|NCT00802464|65906130|FG000|Month 0 - Month 8|Adverse Event|0|||
23594041|NCT00802464|65906131|FG001|Month 0 - Month 8|Adverse Event|1|||
23594042|NCT00802464|65906132|FG002|Month 0 - Month 8|Adverse Event|1|||
23594043|NCT00802464|65906133|FG003|Month 0 - Month 8|Adverse Event|2|||
23594044|NCT00802464|65906130|FG000|Month 0 - Month 8|Protocol Violation|0|||
23594045|NCT00802464|65906131|FG001|Month 0 - Month 8|Protocol Violation|0|||
23594046|NCT00802464|65906132|FG002|Month 0 - Month 8|Protocol Violation|1|||
23594047|NCT00802464|65906133|FG003|Month 0 - Month 8|Protocol Violation|0|||
23594048|NCT00802464|65906130|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
23594049|NCT00802464|65906131|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
23594050|NCT00802464|65906132|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
23594051|NCT00802464|65906133|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
23594052|NCT00802464|65906130|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
23594053|NCT00802464|65906131|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
23594054|NCT00802464|65906132|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
23594055|NCT00802464|65906133|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
23594056|NCT00802464|65906130|FG000|Month 0 - Month 8|Other|0|||
23594057|NCT00802464|65906131|FG001|Month 0 - Month 8|Other|0|||
23594058|NCT00802464|65906132|FG002|Month 0 - Month 8|Other|1|||
23594059|NCT00802464|65906133|FG003|Month 0 - Month 8|Other|0|||
23594060|NCT00802464|65906130|FG000|Month 8 - Month 14|Adverse Event|0|||
23594061|NCT00802464|65906131|FG001|Month 8 - Month 14|Adverse Event|1|||
23594062|NCT00802464|65906132|FG002|Month 8 - Month 14|Adverse Event|0|||
23594063|NCT00802464|65906133|FG003|Month 8 - Month 14|Adverse Event|0|||
23594064|NCT00802464|65906130|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
23594065|NCT00802464|65906131|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
23594066|NCT00802464|65906132|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
23594067|NCT00802464|65906133|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
23594068|NCT00802464|65906130|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
23594069|NCT00802464|65906131|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
23594070|NCT00802464|65906132|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
23594071|NCT00802464|65906133|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
23594072|NCT00549848|65906134|FG000|Overall Study|Death|1|||
23594073|NCT00549848|65906135|FG001|Overall Study|Death|4|||
23594074|NCT00549848|65906136|FG002|Overall Study|Death|13|||
23594075|NCT00549848|65906134|FG000|Overall Study|Physician Decision|0|||
23594076|NCT00549848|65906135|FG001|Overall Study|Physician Decision|0|||
23594077|NCT00549848|65906136|FG002|Overall Study|Physician Decision|4|||
23594078|NCT00549848|65906134|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
23594079|NCT00549848|65906135|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
23594080|NCT00549848|65906136|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
23594081|NCT00549848|65906134|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
23360199|NCT00420628|65062855|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
23594082|NCT00549848|65906135|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
23594083|NCT00549848|65906136|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
23594084|NCT00549848|65906134|FG000|Overall Study|Participant/Family Withdraw|2|||
23594085|NCT00549848|65906135|FG001|Overall Study|Participant/Family Withdraw|3|||
23594086|NCT00549848|65906136|FG002|Overall Study|Participant/Family Withdraw|5|||
23594087|NCT00549848|65906134|FG000|Overall Study|Second Malignancy|1|||
23594088|NCT00549848|65906135|FG001|Overall Study|Second Malignancy|0|||
23594089|NCT00549848|65906136|FG002|Overall Study|Second Malignancy|0|||
23594090|NCT00549848|65906134|FG000|Overall Study|Transplant|3|||
23594091|NCT00549848|65906135|FG001|Overall Study|Transplant|3|||
23594092|NCT00549848|65906136|FG002|Overall Study|Transplant|18|||
23594093|NCT00549848|65906134|FG000|Overall Study|Unacceptable Toxicity|1|||
23254373|NCT00879970|64673507|FG004|Period 1 TZD Randomization|Death|0|||
23254374|NCT00879970|64673503|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
23254375|NCT00879970|64673504|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
23254376|NCT00879970|64673505|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
23254377|NCT00879970|64673506|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
23254378|NCT00879970|64673507|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
23254379|NCT00879970|64673503|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
23360200|NCT00420628|65062854|FG000|Overall Study|Lost to Follow-up|3|||
23477516|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
23477517|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
23477518|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
23477519|NCT00095147|65491613|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
23477520|NCT00095147|65491614|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
23477521|NCT00095147|65491615|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
23477522|NCT00095147|65491616|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
23477523|NCT00095147|65491617|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
23477524|NCT00095147|65491613|FG000|Long-term Extension Period|Death|0|||
23477525|NCT00095147|65491614|FG001|Long-term Extension Period|Death|0|||
23477526|NCT00095147|65491615|FG002|Long-term Extension Period|Death|0|||
23477527|NCT00095147|65491616|FG003|Long-term Extension Period|Death|0|||
23477528|NCT00095147|65491617|FG004|Long-term Extension Period|Death|3|||
23477529|NCT00095147|65491613|FG000|Long-term Extension Period|Adverse Event|0|||
23477530|NCT00095147|65491614|FG001|Long-term Extension Period|Adverse Event|0|||
23477531|NCT00095147|65491615|FG002|Long-term Extension Period|Adverse Event|0|||
23477532|NCT00095147|65491616|FG003|Long-term Extension Period|Adverse Event|0|||
23477533|NCT00095147|65491617|FG004|Long-term Extension Period|Adverse Event|11|||
23477534|NCT00095147|65491613|FG000|Long-term Extension Period|Lack of Efficacy|0|||
23477535|NCT00095147|65491614|FG001|Long-term Extension Period|Lack of Efficacy|0|||
23477536|NCT00095147|65491615|FG002|Long-term Extension Period|Lack of Efficacy|0|||
23477537|NCT00095147|65491616|FG003|Long-term Extension Period|Lack of Efficacy|0|||
23477538|NCT00095147|65491617|FG004|Long-term Extension Period|Lack of Efficacy|9|||
23477539|NCT00095147|65491613|FG000|Long-term Extension Period|Lost to Follow-up|0|||
23477540|NCT00095147|65491614|FG001|Long-term Extension Period|Lost to Follow-up|0|||
23477541|NCT00095147|65491615|FG002|Long-term Extension Period|Lost to Follow-up|0|||
23477542|NCT00095147|65491616|FG003|Long-term Extension Period|Lost to Follow-up|0|||
23477543|NCT00095147|65491617|FG004|Long-term Extension Period|Lost to Follow-up|6|||
23477544|NCT00095147|65491613|FG000|Long-term Extension Period|Withdrawal of consent|0|||
23477545|NCT00095147|65491614|FG001|Long-term Extension Period|Withdrawal of consent|0|||
23477546|NCT00095147|65491615|FG002|Long-term Extension Period|Withdrawal of consent|0|||
23477547|NCT00095147|65491616|FG003|Long-term Extension Period|Withdrawal of consent|0|||
23477548|NCT00095147|65491617|FG004|Long-term Extension Period|Withdrawal of consent|12|||
23477549|NCT00095147|65491613|FG000|Long-term Extension Period|Pregnancy|0|||
23477550|NCT00095147|65491614|FG001|Long-term Extension Period|Pregnancy|0|||
23477551|NCT00095147|65491615|FG002|Long-term Extension Period|Pregnancy|0|||
23477552|NCT00095147|65491616|FG003|Long-term Extension Period|Pregnancy|0|||
23477553|NCT00095147|65491617|FG004|Long-term Extension Period|Pregnancy|1|||
23477554|NCT00095147|65491613|FG000|Long-term Extension Period|No longer meets study criteria|0|||
23477555|NCT00095147|65491614|FG001|Long-term Extension Period|No longer meets study criteria|0|||
23477556|NCT00095147|65491615|FG002|Long-term Extension Period|No longer meets study criteria|0|||
23477557|NCT00095147|65491616|FG003|Long-term Extension Period|No longer meets study criteria|0|||
23477558|NCT00095147|65491617|FG004|Long-term Extension Period|No longer meets study criteria|1|||
23477559|NCT00095147|65491613|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
23477560|NCT00095147|65491614|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
23477561|NCT00095147|65491615|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
23477562|NCT00095147|65491616|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
23477563|NCT00095147|65491617|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
23477564|NCT00095147|65491613|FG000|Long-term Extension Period|Leaving country|0|||
23477565|NCT00095147|65491614|FG001|Long-term Extension Period|Leaving country|0|||
23477566|NCT00095147|65491615|FG002|Long-term Extension Period|Leaving country|0|||
23477567|NCT00095147|65491616|FG003|Long-term Extension Period|Leaving country|0|||
23477568|NCT00095147|65491617|FG004|Long-term Extension Period|Leaving country|1|||
23477569|NCT00727441|65491618|FG000|Overall Study|Disease Progression|11|||
23477570|NCT00727441|65491619|FG001|Overall Study|Disease Progression|14|||
23477571|NCT00727441|65491620|FG002|Overall Study|Disease Progression|17|||
23477572|NCT00727441|65491618|FG000|Overall Study|Eligibility|7|||
23477573|NCT00727441|65491619|FG001|Overall Study|Eligibility|5|||
23477574|NCT00727441|65491620|FG002|Overall Study|Eligibility|7|||
23477575|NCT00727441|65491618|FG000|Overall Study|Death|0|||
23477576|NCT00727441|65491619|FG001|Overall Study|Death|1|||
23477577|NCT00727441|65491620|FG002|Overall Study|Death|1|||
23594094|NCT00549848|65906135|FG001|Overall Study|Unacceptable Toxicity|6|||
23594095|NCT00549848|65906136|FG002|Overall Study|Unacceptable Toxicity|6|||
23594096|NCT01443845|65906140|FG000|Overall Study|Protocol Violation|43|||
23594097|NCT01443845|65906141|FG001|Overall Study|Protocol Violation|45|||
23594098|NCT01443845|65906140|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
23594099|NCT01443845|65906141|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
23594100|NCT01443845|65906140|FG000|Overall Study|Deterioration in pulmonary function|1|||
23594101|NCT01443845|65906141|FG001|Overall Study|Deterioration in pulmonary function|4|||
23594102|NCT01443845|65906140|FG000|Overall Study|Lack of Efficacy|10|||
23594103|NCT01443845|65906141|FG001|Overall Study|Lack of Efficacy|5|||
23594104|NCT01443845|65906140|FG000|Overall Study|Adverse Event|64|||
23594105|NCT01443845|65906141|FG001|Overall Study|Adverse Event|138|||
23594106|NCT01443845|65906140|FG000|Overall Study|Withdrawal by Subject|63|||
23594107|NCT01443845|65906141|FG001|Overall Study|Withdrawal by Subject|67|||
23594108|NCT01443845|65906140|FG000|Overall Study|Military Conflict - Site Terminated|20|||
23594109|NCT01443845|65906141|FG001|Overall Study|Military Conflict - Site Terminated|21|||
23594110|NCT01443845|65906140|FG000|Overall Study|Lost to Follow-up|9|||
23594111|NCT01443845|65906141|FG001|Overall Study|Lost to Follow-up|13|||
23594112|NCT02794480|65906144|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
23594113|NCT02794480|65906145|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
23594114|NCT02794480|65906146|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
23594115|NCT02794480|65906147|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
23594116|NCT02794480|65906144|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
23594117|NCT02794480|65906145|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
23594118|NCT02794480|65906146|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
23594119|NCT02794480|65906147|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
23594120|NCT02794480|65906144|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23594121|NCT02794480|65906145|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23594122|NCT02794480|65906146|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
23594123|NCT02794480|65906147|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
23594124|NCT02794480|65906144|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23594125|NCT02794480|65906145|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
23594126|NCT02794480|65906146|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23594127|NCT02794480|65906147|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23594128|NCT02794480|65906144|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
23594129|NCT02794480|65906145|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23594130|NCT02794480|65906146|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
23594131|NCT02794480|65906147|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
23594132|NCT04732338|65906153|FG000|Overall Study|Lost to Follow-up|3|||
23594133|NCT04732338|65906154|FG001|Overall Study|Lost to Follow-up|3|||
23594134|NCT05382104|65906155|FG000|Period 2 (2 Days)|Adverse Event|0|||
23594135|NCT05382104|65906156|FG001|Period 2 (2 Days)|Adverse Event|1|||
23594136|NCT05382104|65906157|FG002|Period 2 (2 Days)|Adverse Event|0|||
23594137|NCT05382104|65906158|FG003|Period 2 (2 Days)|Adverse Event|0|||
23594138|NCT05382104|65906159|FG004|Period 2 (2 Days)|Adverse Event|0|||
23594139|NCT05382104|65906160|FG005|Period 2 (2 Days)|Adverse Event|0|||
23594140|NCT00857649|65906161|FG000|Overall Study|Adverse Event|15|||
23594141|NCT00857649|65906162|FG001|Overall Study|Adverse Event|10|||
23594142|NCT00857649|65906161|FG000|Overall Study|Non-compliance|1|||
23594143|NCT00857649|65906162|FG001|Overall Study|Non-compliance|1|||
23594144|NCT00857649|65906161|FG000|Overall Study|Protocol Violation|2|||
23594145|NCT00857649|65906162|FG001|Overall Study|Protocol Violation|2|||
23594146|NCT00857649|65906161|FG000|Overall Study|Withdrawal of Consent|10|||
23594147|NCT00857649|65906162|FG001|Overall Study|Withdrawal of Consent|7|||
23594148|NCT00857649|65906161|FG000|Overall Study|Nursing Home Placement|2|||
23594149|NCT00857649|65906162|FG001|Overall Study|Nursing Home Placement|9|||
23594150|NCT00857649|65906161|FG000|Overall Study|Other Reasons|1|||
23594151|NCT00857649|65906162|FG001|Overall Study|Other Reasons|3|||
23594152|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
23254380|NCT00879970|64673504|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
23254381|NCT00879970|64673505|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
23594153|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
23594154|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
23594155|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
23594156|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
23594157|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
23360201|NCT00420628|65062855|FG001|Overall Study|Lost to Follow-up|2|||
23594158|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
23594159|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
23594160|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
23594161|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
23594162|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594163|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23477578|NCT00727441|65491618|FG000|Overall Study|Physician Decision|0|||
23477579|NCT00727441|65491619|FG001|Overall Study|Physician Decision|1|||
23477580|NCT00727441|65491620|FG002|Overall Study|Physician Decision|0|||
23477581|NCT00727441|65491618|FG000|Overall Study|Withdrawal by Subject|0|||
23477582|NCT00727441|65491619|FG001|Overall Study|Withdrawal by Subject|1|||
23477583|NCT00727441|65491620|FG002|Overall Study|Withdrawal by Subject|0|||
23477584|NCT01037088|65491626|FG000|Overall Study|Withdrawal by Subject|3|||
23477585|NCT01236547|65491627|FG000|Overall Study|Protocol Violation|0|||
23477586|NCT01236547|65491628|FG001|Overall Study|Protocol Violation|1|||
23477587|NCT01236547|65491629|FG002|Overall Study|Protocol Violation|1|||
23477588|NCT01236547|65491630|FG003|Overall Study|Protocol Violation|6|||
23477589|NCT01236547|65491631|FG004|Overall Study|Protocol Violation|12|||
23594164|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594165|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594166|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594167|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
23594168|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594169|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
23193864|NCT01165203|64452409|FG000|Active Phase|Withdrawal by Subject|2|||
23193865|NCT01165203|64452410|FG001|Active Phase|Withdrawal by Subject|1|||
23193866|NCT01165203|64452409|FG000|Active Phase|Migrated/moved from study area|0|||
23193867|NCT01165203|64452410|FG001|Active Phase|Migrated/moved from study area|1|||
23193868|NCT01165203|64452409|FG000|Active Phase|Lost to Follow-up|2|||
23193869|NCT01165203|64452410|FG001|Active Phase|Lost to Follow-up|0|||
23193870|NCT01165203|64452409|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
23360202|NCT00420628|65062854|FG000|Overall Study|Adverse Event|1|||
23594170|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594171|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594172|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594173|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594174|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594175|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
23594176|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
23594177|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
23594178|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
23594179|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
23594180|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
23594181|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
23594182|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
23594183|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
23594184|NCT03482011|65906163|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
23594185|NCT03482011|65906164|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
23594186|NCT03482011|65906165|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23594187|NCT03482011|65906166|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23594188|NCT03482011|65906167|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23594189|NCT03482011|65906168|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23477590|NCT01989468|65491632|FG000|Overall Study|Adverse Event|10|||
23477591|NCT01989468|65491633|FG001|Overall Study|Adverse Event|15|||
23477592|NCT01989468|65491634|FG002|Overall Study|Adverse Event|4|||
23594190|NCT03482011|65906169|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23594191|NCT03482011|65906170|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
23477593|NCT01989468|65491635|FG003|Overall Study|Adverse Event|5|||
23477594|NCT01989468|65491636|FG004|Overall Study|Adverse Event|4|||
23594192|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
23193871|NCT01165203|64452410|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
23193872|NCT01165203|64452409|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
23193873|NCT01165203|64452410|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
23193874|NCT01165203|64452409|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
23193875|NCT01165203|64452410|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
23193876|NCT01165203|64452409|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
23193877|NCT01165203|64452410|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
23193878|NCT01165203|64452409|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
23193879|NCT01165203|64452410|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
23193880|NCT00592501|64452414|FG000|Overall Study|Withdrawal by Subject|1|||
23193881|NCT00592501|64452414|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
23193882|NCT05091060|64452415|FG000|Overall Study|Lost to Follow-up|1|||
23193883|NCT00751101|64452416|FG000|Overall Study|Withdrawal by Subject|1|||
23193884|NCT00751101|64452417|FG001|Overall Study|Withdrawal by Subject|0|||
23193885|NCT00751101|64452416|FG000|Overall Study|No HFS / Never Started Patch/|0|||
23193886|NCT00751101|64452417|FG001|Overall Study|No HFS / Never Started Patch/|4|||
23193887|NCT00751101|64452416|FG000|Overall Study|Never began capecitabine|1|||
23193888|NCT00751101|64452417|FG001|Overall Study|Never began capecitabine|0|||
23193889|NCT00751101|64452416|FG000|Overall Study|Physician Decision|0|||
23254382|NCT00879970|64673506|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
23254383|NCT00879970|64673507|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
23254384|NCT00879970|64673503|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
23254385|NCT00879970|64673504|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
23254386|NCT00879970|64673505|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
23254387|NCT00879970|64673506|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
23254388|NCT00879970|64673507|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
23477595|NCT01989468|65491632|FG000|Overall Study|Lack of Efficacy|11|||
23477596|NCT01989468|65491633|FG001|Overall Study|Lack of Efficacy|11|||
23477597|NCT01989468|65491634|FG002|Overall Study|Lack of Efficacy|7|||
23477598|NCT01989468|65491635|FG003|Overall Study|Lack of Efficacy|4|||
23477599|NCT01989468|65491636|FG004|Overall Study|Lack of Efficacy|2|||
23477600|NCT01989468|65491632|FG000|Overall Study|Lost to Follow-up|5|||
23477601|NCT01989468|65491633|FG001|Overall Study|Lost to Follow-up|2|||
23193890|NCT00751101|64452417|FG001|Overall Study|Physician Decision|1|||
23193891|NCT03396471|64452418|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
23193892|NCT03396471|64452418|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
23477602|NCT01989468|65491634|FG002|Overall Study|Lost to Follow-up|0|||
23477603|NCT01989468|65491635|FG003|Overall Study|Lost to Follow-up|1|||
23594193|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
23594194|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
23594195|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
23594196|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
23594197|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
23594198|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
23594199|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
23594200|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
23594201|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
23594202|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
23594203|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
23594204|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
23594205|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
23594206|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
23594207|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
23594208|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594209|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594210|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594211|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594212|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
23594213|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594214|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
23594215|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
23594216|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
23594217|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
23594218|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
23594219|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
23594220|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
23594221|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
23594222|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
23594223|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
23594224|NCT03482011|65906163|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23594225|NCT03482011|65906164|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23594226|NCT03482011|65906165|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
23594227|NCT03482011|65906166|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
23594228|NCT03482011|65906167|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
23594229|NCT03482011|65906168|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
23594230|NCT03482011|65906169|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
23594231|NCT03482011|65906170|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
23594232|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23594233|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23594234|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23254389|NCT00879970|64673503|FG000|Period 2 Vitamin D Randomization|Death|0|||
23254390|NCT00879970|64673504|FG001|Period 2 Vitamin D Randomization|Death|0|||
23594235|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
23594236|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
23594237|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
23594238|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
23594239|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
23594240|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594241|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594242|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594243|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594244|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594245|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
23594246|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
23594247|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
23594248|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594249|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594250|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
23594251|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
23594252|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594253|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594254|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
23594255|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
23594256|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594257|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594258|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594259|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594260|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594261|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594262|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
23594263|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
23594264|NCT03482011|65906163|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594265|NCT03482011|65906164|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594266|NCT03482011|65906165|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594267|NCT03482011|65906166|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594268|NCT03482011|65906167|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594269|NCT03482011|65906168|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594270|NCT03482011|65906169|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
23594271|NCT03482011|65906170|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
23594272|NCT01369498|65906171|FG000|Overall Study|Lack of Efficacy|9|||
23594273|NCT01369498|65906172|FG001|Overall Study|Lack of Efficacy|9|||
23594274|NCT01369498|65906173|FG002|Overall Study|Lack of Efficacy|1|||
23594275|NCT01369498|65906174|FG003|Overall Study|Lack of Efficacy|3|||
23594276|NCT01369498|65906171|FG000|Overall Study|Adverse Event|1|||
23254391|NCT00879970|64673505|FG002|Period 2 Vitamin D Randomization|Death|0|||
23360203|NCT00420628|65062855|FG001|Overall Study|Adverse Event|0|||
23594277|NCT01369498|65906172|FG001|Overall Study|Adverse Event|2|||
23594278|NCT01369498|65906173|FG002|Overall Study|Adverse Event|0|||
23594279|NCT01369498|65906174|FG003|Overall Study|Adverse Event|1|||
23594280|NCT01369498|65906171|FG000|Overall Study|Withdrawal of Consent|0|||
23594281|NCT01369498|65906172|FG001|Overall Study|Withdrawal of Consent|1|||
23594282|NCT01369498|65906173|FG002|Overall Study|Withdrawal of Consent|1|||
23594283|NCT01369498|65906174|FG003|Overall Study|Withdrawal of Consent|1|||
23594284|NCT01369498|65906171|FG000|Overall Study|Death|0|||
23594285|NCT01369498|65906172|FG001|Overall Study|Death|0|||
23594286|NCT01369498|65906173|FG002|Overall Study|Death|1|||
23594287|NCT01369498|65906174|FG003|Overall Study|Death|0|||
23594288|NCT01369498|65906171|FG000|Overall Study|Investigator's Discretion|1|||
23594289|NCT01369498|65906172|FG001|Overall Study|Investigator's Discretion|0|||
23594290|NCT01369498|65906173|FG002|Overall Study|Investigator's Discretion|1|||
23594291|NCT01369498|65906174|FG003|Overall Study|Investigator's Discretion|3|||
23594292|NCT01369498|65906171|FG000|Overall Study|Unknown Reason|1|||
23594293|NCT01369498|65906172|FG001|Overall Study|Unknown Reason|0|||
23594294|NCT01369498|65906173|FG002|Overall Study|Unknown Reason|11|||
23594295|NCT01369498|65906174|FG003|Overall Study|Unknown Reason|6|||
23594296|NCT01369498|65906171|FG000|Overall Study|Disease Progression|0|||
23594297|NCT01369498|65906172|FG001|Overall Study|Disease Progression|0|||
23193893|NCT03396471|64452418|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
23594298|NCT01369498|65906173|FG002|Overall Study|Disease Progression|0|||
23594299|NCT01369498|65906174|FG003|Overall Study|Disease Progression|1|||
23594300|NCT04035668|65906181|FG000|Overall Study|Adverse Event|3|||
23594301|NCT04035668|65906182|FG001|Overall Study|Adverse Event|4|||
23594302|NCT04035668|65906183|FG002|Overall Study|Adverse Event|2|||
23193894|NCT03396471|64452418|FG000|Study Treatment - Up to 22 Months|Death|2|||
23594303|NCT04035668|65906181|FG000|Overall Study|Lost to Follow-up|0|||
23594304|NCT04035668|65906182|FG001|Overall Study|Lost to Follow-up|1|||
23594305|NCT04035668|65906183|FG002|Overall Study|Lost to Follow-up|0|||
23594306|NCT04035668|65906181|FG000|Overall Study|Physician Decision|2|||
23594307|NCT04035668|65906182|FG001|Overall Study|Physician Decision|1|||
23594308|NCT04035668|65906183|FG002|Overall Study|Physician Decision|1|||
23594309|NCT04035668|65906181|FG000|Overall Study|Subject Decision|2|||
23594310|NCT04035668|65906182|FG001|Overall Study|Subject Decision|2|||
23594311|NCT04035668|65906183|FG002|Overall Study|Subject Decision|0|||
23594312|NCT02584829|65906184|FG000|Overall Study|Physician Decision|1|||
23594313|NCT02584829|65906185|FG001|Overall Study|Physician Decision|0|||
23594314|NCT02584829|65906184|FG000|Overall Study|Withdrawal by Subject|0|||
23594315|NCT02584829|65906185|FG001|Overall Study|Withdrawal by Subject|1|||
23193895|NCT03396471|64452418|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
23193896|NCT03396471|64452418|FG000|Follow up - Up to 2 Years|Death|9|||
23594316|NCT02584829|65906184|FG000|Overall Study|Progressive Disease|0|||
23594317|NCT02584829|65906185|FG001|Overall Study|Progressive Disease|3|||
23594318|NCT00761605|65906186|FG000|Overall Study|Adverse Event|26|||
23594319|NCT00761605|65906186|FG000|Overall Study|Death|2|||
23594320|NCT00761605|65906186|FG000|Overall Study|Lack of Efficacy|26|||
23594321|NCT00761605|65906186|FG000|Overall Study|Lost to Follow-up|29|||
23594322|NCT00761605|65906186|FG000|Overall Study|Withdrawal by Subject|37|||
23594323|NCT00761605|65906186|FG000|Overall Study|Other|21|||
23594324|NCT00174382|65906190|FG000|Overall Study|Death|2|||
23594325|NCT00174382|65906190|FG000|Overall Study|Adverse Event|19|||
23594326|NCT00174382|65906190|FG000|Overall Study|Withdrawal by Subject|6|||
23594327|NCT00174382|65906190|FG000|Overall Study|Protocol Violation|3|||
23594328|NCT00174382|65906190|FG000|Overall Study|Arrived early for last visit in error|1|||
23594329|NCT00174382|65906190|FG000|Overall Study|Subject felt pill not effective enough|1|||
23594330|NCT00174382|65906190|FG000|Overall Study|Lost to Follow-up|1|||
23594331|NCT00925899|65906191|FG000|Part 1|Death|1|||
23594332|NCT00925899|65906192|FG001|Part 1|Death|2|||
23594333|NCT00925899|65906191|FG000|Part 1|Withdrawal by Subject|10|||
23594334|NCT00925899|65906192|FG001|Part 1|Withdrawal by Subject|9|||
23594335|NCT02974634|65906193|FG000|Overall Study|Advanced disease|12|||
23594336|NCT02974634|65906194|FG001|Overall Study|Advanced disease|3|||
23594337|NCT02974634|65906193|FG000|Overall Study|Noncompliance|3|||
23594338|NCT02974634|65906194|FG001|Overall Study|Noncompliance|7|||
23594339|NCT02974634|65906193|FG000|Overall Study|intervention technology related issues|5|||
23594340|NCT02974634|65906194|FG001|Overall Study|intervention technology related issues|0|||
23594341|NCT02974634|65906193|FG000|Overall Study|Death|8|||
23594342|NCT02974634|65906194|FG001|Overall Study|Death|11|||
23594343|NCT02477605|65906195|FG000|Overall Study|Discontinued prior to treatment|1|||
23594344|NCT02477605|65906196|FG001|Overall Study|Discontinued prior to treatment|0|||
23594345|NCT02477605|65906195|FG000|Overall Study|Lost to Follow-up|0|||
23594346|NCT02477605|65906196|FG001|Overall Study|Lost to Follow-up|2|||
23594347|NCT02477605|65906195|FG000|Overall Study|Withdrawal by Subject|0|||
23594348|NCT02477605|65906196|FG001|Overall Study|Withdrawal by Subject|1|||
23594349|NCT02477605|65906195|FG000|Overall Study|Administered gas during surgery|0|||
23594350|NCT02477605|65906196|FG001|Overall Study|Administered gas during surgery|1|||
23594351|NCT01198028|65906201|FG000|Overall Study|Adverse Event|5|||
23594352|NCT01198028|65906201|FG000|Overall Study|Death|3|||
23594353|NCT01198028|65906201|FG000|Overall Study|Physician Decision|2|||
23594354|NCT03051165|65906202|FG000|Overall Study|Withdrawal by Subject|1|||
23594355|NCT03051165|65906202|FG000|Overall Study|Early termination of study|12|||
23594356|NCT03074331|65906206|FG000|Overall Study|Enrolled but Not Treated|1|||
23594357|NCT03074331|65906206|FG000|Overall Study|Lost to Follow-up|5|||
23594358|NCT03074331|65906206|FG000|Overall Study|Withdrew Consent|1|||
23594359|NCT01875848|65906213|FG000|Overall Study|Withdrawal by Subject|2|||
23594360|NCT01875848|65906214|FG001|Overall Study|Withdrawal by Subject|0|||
23594361|NCT00807937|65906215|FG000|Overall Study|Adverse Event|12|||
23594362|NCT00807937|65906216|FG001|Overall Study|Adverse Event|12|||
23594363|NCT00807937|65906217|FG002|Overall Study|Adverse Event|5|||
23594364|NCT00807937|65906218|FG003|Overall Study|Adverse Event|4|||
23594365|NCT00807937|65906215|FG000|Overall Study|Protocol Violation|4|||
23594366|NCT00807937|65906216|FG001|Overall Study|Protocol Violation|5|||
23594367|NCT00807937|65906217|FG002|Overall Study|Protocol Violation|3|||
23594368|NCT00807937|65906218|FG003|Overall Study|Protocol Violation|3|||
23594369|NCT00807937|65906215|FG000|Overall Study|Withdrawal by Subject|5|||
23594370|NCT00807937|65906216|FG001|Overall Study|Withdrawal by Subject|4|||
23594371|NCT00807937|65906217|FG002|Overall Study|Withdrawal by Subject|1|||
23594372|NCT00807937|65906218|FG003|Overall Study|Withdrawal by Subject|4|||
23594373|NCT00807937|65906215|FG000|Overall Study|Lost to Follow-up|4|||
23594374|NCT00807937|65906216|FG001|Overall Study|Lost to Follow-up|0|||
23594375|NCT00807937|65906217|FG002|Overall Study|Lost to Follow-up|2|||
23594376|NCT00807937|65906218|FG003|Overall Study|Lost to Follow-up|1|||
23594377|NCT00807937|65906215|FG000|Overall Study|Lack of Efficacy|0|||
23594378|NCT00807937|65906216|FG001|Overall Study|Lack of Efficacy|0|||
23594379|NCT00807937|65906217|FG002|Overall Study|Lack of Efficacy|1|||
23594380|NCT00807937|65906218|FG003|Overall Study|Lack of Efficacy|2|||
23594381|NCT00807937|65906215|FG000|Overall Study|Intake of prohibited medicine|0|||
23594382|NCT00807937|65906216|FG001|Overall Study|Intake of prohibited medicine|0|||
23594383|NCT00807937|65906217|FG002|Overall Study|Intake of prohibited medicine|2|||
23594384|NCT00807937|65906218|FG003|Overall Study|Intake of prohibited medicine|0|||
23594385|NCT00807937|65906215|FG000|Overall Study|All other reasons (not provided)|2|||
23360204|NCT01490840|65062857|FG000|Phase 1|Lost to Follow-up|1|||
23594386|NCT00807937|65906216|FG001|Overall Study|All other reasons (not provided)|4|||
23594387|NCT00807937|65906217|FG002|Overall Study|All other reasons (not provided)|0|||
23594388|NCT00807937|65906218|FG003|Overall Study|All other reasons (not provided)|1|||
23360205|NCT01490840|65062858|FG001|Phase 1|Lost to Follow-up|0|||
23594389|NCT02214160|65906219|FG000|Overall Study|Withdrawal by Subject|1|||
23594390|NCT02214160|65906220|FG001|Overall Study|Withdrawal by Subject|0|||
23594391|NCT02214160|65906221|FG002|Overall Study|Withdrawal by Subject|6|||
23594392|NCT02214160|65906219|FG000|Overall Study|Death|2|||
23594393|NCT02214160|65906220|FG001|Overall Study|Death|2|||
23594394|NCT02214160|65906221|FG002|Overall Study|Death|1|||
23594395|NCT02214160|65906219|FG000|Overall Study|Subject Non-Compliance|0|||
23594396|NCT02214160|65906220|FG001|Overall Study|Subject Non-Compliance|3|||
23594397|NCT02214160|65906221|FG002|Overall Study|Subject Non-Compliance|1|||
23594398|NCT02214160|65906219|FG000|Overall Study|Adverse Event|0|||
23594399|NCT02214160|65906220|FG001|Overall Study|Adverse Event|1|||
23594400|NCT02214160|65906221|FG002|Overall Study|Adverse Event|1|||
23594401|NCT02214160|65906219|FG000|Overall Study|Sponsor Decision|0|||
23594402|NCT02214160|65906220|FG001|Overall Study|Sponsor Decision|2|||
23594403|NCT02214160|65906221|FG002|Overall Study|Sponsor Decision|0|||
23594404|NCT02214160|65906219|FG000|Overall Study|Protocol Violation|1|||
23594405|NCT02214160|65906220|FG001|Overall Study|Protocol Violation|0|||
23594406|NCT02214160|65906221|FG002|Overall Study|Protocol Violation|0|||
23594407|NCT02214160|65906219|FG000|Overall Study|Physician Decision|0|||
23594408|NCT02214160|65906220|FG001|Overall Study|Physician Decision|0|||
23594409|NCT02214160|65906221|FG002|Overall Study|Physician Decision|1|||
23594410|NCT02296424|65906222|FG000|Part 1|New therapy for study indication|0|||
23594411|NCT02296424|65906223|FG001|Part 1|New therapy for study indication|1|||
23594412|NCT02296424|65906224|FG002|Part 1|New therapy for study indication|0|||
23594413|NCT02296424|65906225|FG003|Part 1|New therapy for study indication|0|||
23594414|NCT02296424|65906222|FG000|Part 1|Protocol Violation|0|||
23594415|NCT02296424|65906223|FG001|Part 1|Protocol Violation|1|||
23594416|NCT02296424|65906224|FG002|Part 1|Protocol Violation|0|||
23594417|NCT02296424|65906225|FG003|Part 1|Protocol Violation|0|||
23594418|NCT02296424|65906222|FG000|Part 1|Withdrawal by Subject|0|||
23594419|NCT02296424|65906223|FG001|Part 1|Withdrawal by Subject|2|||
23594420|NCT02296424|65906224|FG002|Part 1|Withdrawal by Subject|0|||
23594421|NCT02296424|65906225|FG003|Part 1|Withdrawal by Subject|0|||
23594422|NCT02296424|65906222|FG000|Part 1|Study terminated by sponsor|0|||
23594423|NCT02296424|65906223|FG001|Part 1|Study terminated by sponsor|1|||
23594424|NCT02296424|65906224|FG002|Part 1|Study terminated by sponsor|0|||
23594425|NCT02296424|65906225|FG003|Part 1|Study terminated by sponsor|0|||
23594426|NCT02296424|65906222|FG000|Part 1|Adverse Event|2|||
23594427|NCT02296424|65906223|FG001|Part 1|Adverse Event|11|||
23594428|NCT02296424|65906224|FG002|Part 1|Adverse Event|0|||
23594429|NCT02296424|65906225|FG003|Part 1|Adverse Event|0|||
23594430|NCT02296424|65906222|FG000|Part 1|Lack of Efficacy|5|||
23594431|NCT02296424|65906223|FG001|Part 1|Lack of Efficacy|17|||
23594432|NCT02296424|65906224|FG002|Part 1|Lack of Efficacy|0|||
23193897|NCT03396471|64452418|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
23193898|NCT03396471|64452418|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
23193899|NCT03396471|64452418|FG000|Follow up - Up to 2 Years|study terminated|1|||
23193900|NCT03396471|64452418|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
23193901|NCT03396471|64452418|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
23193902|NCT01597193|64452421|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
23193903|NCT01597193|64452422|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
23193904|NCT01597193|64452423|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23193905|NCT01597193|64452424|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23594433|NCT02296424|65906225|FG003|Part 1|Lack of Efficacy|0|||
23594434|NCT02296424|65906222|FG000|Part 1|16 directly started part II|16|||
23594435|NCT02296424|65906223|FG001|Part 1|16 directly started part II|0|||
23594436|NCT02296424|65906224|FG002|Part 1|16 directly started part II|0|||
23594437|NCT02296424|65906225|FG003|Part 1|16 directly started part II|0|||
23594438|NCT02296424|65906222|FG000|Part 2|Lack of Efficacy|0|||
23254392|NCT00879970|64673506|FG003|Period 2 Vitamin D Randomization|Death|2|||
23594439|NCT02296424|65906223|FG001|Part 2|Lack of Efficacy|0|||
23594440|NCT02296424|65906224|FG002|Part 2|Lack of Efficacy|1|||
23594441|NCT02296424|65906225|FG003|Part 2|Lack of Efficacy|0|||
23594442|NCT02296424|65906222|FG000|Part 2|Adverse Event|0|||
23594443|NCT02296424|65906223|FG001|Part 2|Adverse Event|0|||
23594444|NCT02296424|65906224|FG002|Part 2|Adverse Event|1|||
23594445|NCT02296424|65906225|FG003|Part 2|Adverse Event|0|||
23594446|NCT02296424|65906222|FG000|Part 2|Lost to Follow-up|0|||
23594447|NCT02296424|65906223|FG001|Part 2|Lost to Follow-up|0|||
23594448|NCT02296424|65906224|FG002|Part 2|Lost to Follow-up|1|||
23594449|NCT02296424|65906225|FG003|Part 2|Lost to Follow-up|0|||
23594450|NCT01771731|65906229|FG000|Overall Study|Physician Decision|1|||
23594451|NCT01771731|65906230|FG001|Overall Study|Physician Decision|0|||
23594452|NCT01771731|65906229|FG000|Overall Study|Protocol Violation|0|||
23594453|NCT01771731|65906230|FG001|Overall Study|Protocol Violation|1|||
23594454|NCT01771731|65906229|FG000|Overall Study|Adverse event: Pain Crisis|1|||
23594455|NCT01771731|65906230|FG001|Overall Study|Adverse event: Pain Crisis|1|||
23594456|NCT00309907|65906237|FG000|Overall Study|Death|4|||
23594457|NCT00309907|65906237|FG000|Overall Study|Physician Decision|1|||
23594458|NCT00309907|65906237|FG000|Overall Study|Ineligible|11|||
23594459|NCT00309907|65906237|FG000|Overall Study|Major infectious event|4|||
23594460|NCT01102231|65906238|FG000|Overall Study|Protocol Violation|3|||
23254393|NCT00879970|64673507|FG004|Period 2 Vitamin D Randomization|Death|0|||
23254394|NCT00328783|64673510|FG000|Overall Study|Could not tolerate ABC|21|||
23254395|NCT00328783|64673510|FG000|Overall Study|No heart in RT field|4|||
23594461|NCT01102231|65906238|FG000|Overall Study|Lack of Efficacy|2|||
23594462|NCT01102231|65906238|FG000|Overall Study|Death|2|||
23594463|NCT01102231|65906238|FG000|Overall Study|Adverse Event|3|||
23594464|NCT01102231|65906238|FG000|Overall Study|Withdrawal by Subject|1|||
23594465|NCT01102231|65906238|FG000|Overall Study|Did not received the treatment|4|||
23594466|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
23594467|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
23254396|NCT00328783|64673510|FG000|Overall Study|Withdrawal by Subject|1|||
23594468|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
23193906|NCT01597193|64452425|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23193907|NCT01597193|64452426|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23193908|NCT01597193|64452427|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
23193909|NCT01597193|64452421|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
23193910|NCT01597193|64452422|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
23193911|NCT01597193|64452423|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
23193912|NCT01597193|64452424|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
23193913|NCT01597193|64452425|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
23193914|NCT01597193|64452426|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
23193915|NCT01597193|64452427|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
23193916|NCT01597193|64452421|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
23477604|NCT01989468|65491636|FG004|Overall Study|Lost to Follow-up|1|||
23477605|NCT01989468|65491632|FG000|Overall Study|Physician Decision|4|||
23477606|NCT01989468|65491633|FG001|Overall Study|Physician Decision|1|||
23477607|NCT01989468|65491634|FG002|Overall Study|Physician Decision|0|||
23477608|NCT01989468|65491635|FG003|Overall Study|Physician Decision|1|||
23477609|NCT01989468|65491636|FG004|Overall Study|Physician Decision|0|||
23477610|NCT01989468|65491632|FG000|Overall Study|Pregnancy|0|||
23477611|NCT01989468|65491633|FG001|Overall Study|Pregnancy|1|||
23477612|NCT01989468|65491634|FG002|Overall Study|Pregnancy|0|||
23477613|NCT01989468|65491635|FG003|Overall Study|Pregnancy|0|||
23193917|NCT01597193|64452422|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
23193918|NCT01597193|64452423|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
23477614|NCT01989468|65491636|FG004|Overall Study|Pregnancy|0|||
23477615|NCT01989468|65491632|FG000|Overall Study|Technical Problems|3|||
23477616|NCT01989468|65491633|FG001|Overall Study|Technical Problems|1|||
23477617|NCT01989468|65491634|FG002|Overall Study|Technical Problems|3|||
23477618|NCT01989468|65491635|FG003|Overall Study|Technical Problems|1|||
23477619|NCT01989468|65491636|FG004|Overall Study|Technical Problems|0|||
23477620|NCT01989468|65491632|FG000|Overall Study|Subject Guardian Decision|11|||
23477621|NCT01989468|65491633|FG001|Overall Study|Subject Guardian Decision|6|||
23477622|NCT01989468|65491634|FG002|Overall Study|Subject Guardian Decision|4|||
23477623|NCT01989468|65491635|FG003|Overall Study|Subject Guardian Decision|4|||
23477624|NCT01989468|65491636|FG004|Overall Study|Subject Guardian Decision|1|||
23477625|NCT01989468|65491632|FG000|Overall Study|Death|3|||
23477626|NCT01989468|65491633|FG001|Overall Study|Death|0|||
23477627|NCT01989468|65491634|FG002|Overall Study|Death|1|||
23477628|NCT01989468|65491635|FG003|Overall Study|Death|0|||
23477629|NCT01989468|65491636|FG004|Overall Study|Death|0|||
23477630|NCT00835731|65491638|FG000|Overall Study|Withdrawal by Subject|1|||
23594469|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
23594470|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
23594471|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
23594472|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
23594473|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
23594474|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
23594475|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
23594476|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
23594477|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
23594478|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
23594479|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
23594480|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
23594481|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
23594482|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
23193919|NCT01597193|64452424|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
23477631|NCT00835731|65491639|FG001|Overall Study|Withdrawal by Subject|0|||
23477632|NCT00835731|65491638|FG000|Overall Study|Physician Decision|1|||
23477633|NCT00835731|65491639|FG001|Overall Study|Physician Decision|1|||
23477634|NCT01888432|65491640|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
23477635|NCT01888432|65491641|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
23594483|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
23594484|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
23594485|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
23594486|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
23594487|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
23594488|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
23594489|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
23594490|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
23594491|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
23594492|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
23594493|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
23594494|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
23594495|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
23594496|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
23594497|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
23594498|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
23594499|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
23594500|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
23594501|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
23594502|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
23594503|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
23594504|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
23594505|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
23594506|NCT02709655|65906247|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
23594507|NCT02709655|65906248|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
23594508|NCT02709655|65906249|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
23594509|NCT02709655|65906250|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
23594510|NCT02709655|65906251|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
23594511|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
23594512|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
23594513|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
23594514|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
23594515|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
23594516|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
23594517|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
23594518|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
23594519|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
23193920|NCT01597193|64452425|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
23193921|NCT01597193|64452426|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
23193922|NCT01597193|64452427|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
23193923|NCT01597193|64452421|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23193924|NCT01597193|64452422|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23193925|NCT01597193|64452423|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23193926|NCT01597193|64452424|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23193927|NCT01597193|64452425|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23193928|NCT01597193|64452426|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
23193929|NCT01597193|64452427|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
23193930|NCT01597193|64452421|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23193931|NCT01597193|64452422|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23193932|NCT01597193|64452423|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23193933|NCT01597193|64452424|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
23193934|NCT01597193|64452425|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23193935|NCT01597193|64452426|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
23193936|NCT01597193|64452427|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
23193937|NCT02760407|64452428|FG000|Overall Study|Death|2|||
23193938|NCT02760407|64452429|FG001|Overall Study|Death|3|||
23193939|NCT02760407|64452430|FG002|Overall Study|Death|1|||
23360206|NCT01490840|65062857|FG000|Phase 1|Adverse Event|2|||
23360207|NCT01490840|65062858|FG001|Phase 1|Adverse Event|1|||
23360208|NCT01490840|65062857|FG000|Phase 1|Withdrawal by Subject|6|||
23360209|NCT01490840|65062858|FG001|Phase 1|Withdrawal by Subject|5|||
23594520|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
23594521|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
23594522|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
23594523|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
23594524|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
23594525|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
23193940|NCT02760407|64452431|FG003|Overall Study|Death|1|||
23193941|NCT02760407|64452428|FG000|Overall Study|Lost to Follow-up|1|||
23193942|NCT02760407|64452429|FG001|Overall Study|Lost to Follow-up|7|||
23193943|NCT02760407|64452430|FG002|Overall Study|Lost to Follow-up|4|||
23193944|NCT02760407|64452431|FG003|Overall Study|Lost to Follow-up|6|||
23193945|NCT02760407|64452428|FG000|Overall Study|Withdrawal by Subject|25|||
23193946|NCT02760407|64452429|FG001|Overall Study|Withdrawal by Subject|31|||
23193947|NCT02760407|64452430|FG002|Overall Study|Withdrawal by Subject|37|||
23193948|NCT02760407|64452431|FG003|Overall Study|Withdrawal by Subject|25|||
23254397|NCT03056352|64673511|FG000|Overall Study|Lost to Follow-up|1|||
23254398|NCT04575038|64673512|FG000|Overall Study|Withdrawal by Subject|1|||
23254399|NCT04575038|64673513|FG001|Overall Study|Withdrawal by Subject|1|||
23254400|NCT01200394|64673515|FG000|Overall Study|Adverse Event|0|||
23254401|NCT01200394|64673516|FG001|Overall Study|Adverse Event|14|||
23594526|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
23594527|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
23594528|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
23594529|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
23594530|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
23594531|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
23594532|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
23594533|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
23594534|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
23594535|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
23594536|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
23594537|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
23594538|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
23594539|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
23594540|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
23594541|NCT02709655|65906247|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
23594542|NCT02709655|65906248|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
23594543|NCT02709655|65906249|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
23594544|NCT02709655|65906250|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
23594545|NCT02709655|65906251|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
23594546|NCT03811574|65906255|FG000|Overall Study|Withdrawal by Subject|2|||
23594547|NCT03811574|65906256|FG001|Overall Study|Withdrawal by Subject|4|||
23594548|NCT03811574|65906257|FG002|Overall Study|Withdrawal by Subject|0|||
23594549|NCT00465816|65906260|FG000|Overall Study|Lost to Follow-up|0|||
23594550|NCT00465816|65906261|FG001|Overall Study|Lost to Follow-up|0|||
23594551|NCT00465816|65906262|FG002|Overall Study|Lost to Follow-up|2|||
23594552|NCT01867216|65906263|FG000|Overall Study|Withdrawal by Subject|2|||
23594553|NCT01867216|65906264|FG001|Overall Study|Withdrawal by Subject|0|||
23594554|NCT01867216|65906265|FG002|Overall Study|Withdrawal by Subject|0|||
23594555|NCT01867216|65906266|FG003|Overall Study|Withdrawal by Subject|0|||
23594556|NCT01867216|65906267|FG004|Overall Study|Withdrawal by Subject|1|||
23594557|NCT01867216|65906268|FG005|Overall Study|Withdrawal by Subject|0|||
23594558|NCT01867216|65906269|FG006|Overall Study|Withdrawal by Subject|1|||
23594559|NCT01867216|65906263|FG000|Overall Study|Physician Decision|1|||
23594560|NCT01867216|65906264|FG001|Overall Study|Physician Decision|0|||
23594561|NCT01867216|65906265|FG002|Overall Study|Physician Decision|0|||
23594562|NCT01867216|65906266|FG003|Overall Study|Physician Decision|0|||
23193949|NCT02760407|64452428|FG000|Overall Study|Violation of Eligibility criteria|0|||
23254402|NCT01200394|64673515|FG000|Overall Study|Death|1|||
23193950|NCT02760407|64452429|FG001|Overall Study|Violation of Eligibility criteria|0|||
23193951|NCT02760407|64452430|FG002|Overall Study|Violation of Eligibility criteria|1|||
23254403|NCT01200394|64673516|FG001|Overall Study|Death|0|||
23193952|NCT02760407|64452431|FG003|Overall Study|Violation of Eligibility criteria|1|||
23193953|NCT02760407|64452428|FG000|Overall Study|Personal reasons|0|||
23193954|NCT02760407|64452429|FG001|Overall Study|Personal reasons|0|||
23193955|NCT02760407|64452430|FG002|Overall Study|Personal reasons|0|||
23193956|NCT02760407|64452431|FG003|Overall Study|Personal reasons|1|||
23193957|NCT02760407|64452428|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
23193958|NCT02760407|64452429|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
23193959|NCT02760407|64452430|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
23193960|NCT02760407|64452431|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
23193961|NCT02760407|64452428|FG000|Overall Study|Use of prohibited Medication|0|||
23193962|NCT02760407|64452429|FG001|Overall Study|Use of prohibited Medication|0|||
23193963|NCT02760407|64452430|FG002|Overall Study|Use of prohibited Medication|1|||
23193964|NCT02760407|64452431|FG003|Overall Study|Use of prohibited Medication|0|||
23193965|NCT02760407|64452428|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
23193966|NCT02760407|64452429|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
23193967|NCT02760407|64452430|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
23254404|NCT01200394|64673515|FG000|Overall Study|Lost to Follow-up|0|||
23254405|NCT01200394|64673516|FG001|Overall Study|Lost to Follow-up|1|||
23254406|NCT01200394|64673515|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23254407|NCT01200394|64673516|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
23254408|NCT01200394|64673515|FG000|Overall Study|Protocol Violation|0|||
23254409|NCT01200394|64673516|FG001|Overall Study|Protocol Violation|3|||
23254410|NCT01200394|64673515|FG000|Overall Study|Withdrawal by Subject|0|||
23254411|NCT01200394|64673516|FG001|Overall Study|Withdrawal by Subject|5|||
23254412|NCT01200394|64673515|FG000|Overall Study|Other|0|||
23254413|NCT01200394|64673516|FG001|Overall Study|Other|1|||
23254414|NCT03255031|64673523|FG000|Overall Study|Adverse Event|5|||
23254415|NCT03255031|64673524|FG001|Overall Study|Adverse Event|3|||
23254416|NCT03255031|64673523|FG000|Overall Study|Physician Decision|2|||
23254417|NCT03255031|64673524|FG001|Overall Study|Physician Decision|1|||
23254418|NCT03255031|64673523|FG000|Overall Study|Withdrawal by Subject|9|||
23254419|NCT03255031|64673524|FG001|Overall Study|Withdrawal by Subject|3|||
23254420|NCT02253654|64673533|FG000|Overall Study|Withdrawal by Subject|12|||
23254421|NCT02253654|64673534|FG001|Overall Study|Withdrawal by Subject|4|||
23254422|NCT02253654|64673533|FG000|Overall Study|Decision by Sponsor|1|||
23254423|NCT02253654|64673534|FG001|Overall Study|Decision by Sponsor|1|||
23254424|NCT02253654|64673533|FG000|Overall Study|Lost to Follow-up|2|||
23254425|NCT02253654|64673534|FG001|Overall Study|Lost to Follow-up|5|||
23254426|NCT02253654|64673533|FG000|Overall Study|Death|4|||
23254427|NCT02253654|64673534|FG001|Overall Study|Death|7|||
23254428|NCT02253654|64673533|FG000|Overall Study|Did Not Receive Study Treatment|4|||
23254429|NCT02253654|64673534|FG001|Overall Study|Did Not Receive Study Treatment|1|||
23254430|NCT02017535|64673538|FG000|Overall Study|Withdrawal by Subject|1|||
23254431|NCT02017535|64673539|FG001|Overall Study|Withdrawal by Subject|0|||
23254432|NCT02017535|64673540|FG002|Overall Study|Withdrawal by Subject|0|||
23254433|NCT02017535|64673541|FG003|Overall Study|Withdrawal by Subject|0|||
23254434|NCT02030834|64673542|FG000|Overall Study|Death|4|||
23254435|NCT02030834|64673543|FG001|Overall Study|Death|0|||
23254436|NCT02030834|64673544|FG002|Overall Study|Death|0|||
23254437|NCT02030834|64673542|FG000|Overall Study|Manufacturing failure|2|||
23254438|NCT02030834|64673543|FG001|Overall Study|Manufacturing failure|0|||
23254439|NCT02030834|64673544|FG002|Overall Study|Manufacturing failure|1|||
23254440|NCT02030834|64673542|FG000|Overall Study|Disease progression|2|||
23254441|NCT02030834|64673543|FG001|Overall Study|Disease progression|0|||
23254442|NCT02030834|64673544|FG002|Overall Study|Disease progression|2|||
23254443|NCT02030834|64673542|FG000|Overall Study|Lost to Follow-up|1|||
23254444|NCT02030834|64673543|FG001|Overall Study|Lost to Follow-up|0|||
23254445|NCT02030834|64673544|FG002|Overall Study|Lost to Follow-up|0|||
23254446|NCT02030834|64673542|FG000|Overall Study|Withdrawal by Subject|1|||
23254447|NCT02030834|64673543|FG001|Overall Study|Withdrawal by Subject|0|||
23254448|NCT02030834|64673544|FG002|Overall Study|Withdrawal by Subject|0|||
23254449|NCT02030834|64673542|FG000|Overall Study|Lack of funding|1|||
23254450|NCT02030834|64673543|FG001|Overall Study|Lack of funding|0|||
23254451|NCT02030834|64673544|FG002|Overall Study|Lack of funding|0|||
23254452|NCT00591253|64673545|FG000|Overall Study|Adverse Event|3|||
23254453|NCT00591253|64673546|FG001|Overall Study|Adverse Event|3|||
23254454|NCT00591253|64673547|FG002|Overall Study|Adverse Event|1|||
23254455|NCT00591253|64673545|FG000|Overall Study|Protocol Violation|2|||
23254456|NCT00591253|64673546|FG001|Overall Study|Protocol Violation|2|||
23254457|NCT00591253|64673547|FG002|Overall Study|Protocol Violation|2|||
23254458|NCT00591253|64673545|FG000|Overall Study|Lost to Follow-up|2|||
23254459|NCT00591253|64673546|FG001|Overall Study|Lost to Follow-up|4|||
23254460|NCT00591253|64673547|FG002|Overall Study|Lost to Follow-up|0|||
23254461|NCT00591253|64673545|FG000|Overall Study|Withdrawal by Subject|1|||
23193968|NCT02760407|64452431|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
23193969|NCT02760407|64452428|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
23193970|NCT02760407|64452429|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
23193971|NCT02760407|64452430|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
23193972|NCT02760407|64452431|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
23193973|NCT02760407|64452428|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
23193974|NCT02760407|64452429|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
23193975|NCT02760407|64452430|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
23193976|NCT02760407|64452431|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
23193977|NCT02760407|64452428|FG000|Overall Study|Inadequately Enrolled|0|||
23193978|NCT02760407|64452429|FG001|Overall Study|Inadequately Enrolled|0|||
23193979|NCT02760407|64452430|FG002|Overall Study|Inadequately Enrolled|0|||
23193980|NCT02760407|64452431|FG003|Overall Study|Inadequately Enrolled|1|||
23594563|NCT01867216|65906267|FG004|Overall Study|Physician Decision|0|||
23594564|NCT01867216|65906268|FG005|Overall Study|Physician Decision|0|||
23594565|NCT01867216|65906269|FG006|Overall Study|Physician Decision|0|||
23594566|NCT01867216|65906263|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
23594567|NCT01867216|65906264|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594568|NCT01867216|65906265|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594569|NCT01867216|65906266|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594570|NCT01867216|65906267|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23193981|NCT02760407|64452428|FG000|Overall Study|Withdrawal By PI's Decision|0|||
23193982|NCT02760407|64452429|FG001|Overall Study|Withdrawal By PI's Decision|1|||
23193983|NCT02760407|64452430|FG002|Overall Study|Withdrawal By PI's Decision|0|||
23193984|NCT02760407|64452431|FG003|Overall Study|Withdrawal By PI's Decision|0|||
23254462|NCT00591253|64673546|FG001|Overall Study|Withdrawal by Subject|7|||
23254463|NCT00591253|64673547|FG002|Overall Study|Withdrawal by Subject|6|||
23254464|NCT00591253|64673545|FG000|Overall Study|Lack of Efficacy|1|||
23254465|NCT00591253|64673546|FG001|Overall Study|Lack of Efficacy|0|||
23193985|NCT02760407|64452428|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
23254466|NCT00591253|64673547|FG002|Overall Study|Lack of Efficacy|3|||
23594571|NCT01867216|65906268|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594572|NCT01867216|65906269|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
23594573|NCT02525796|65906270|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
23594574|NCT02525796|65906271|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
23594575|NCT02525796|65906272|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
23594576|NCT02525796|65906270|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
23594577|NCT02525796|65906271|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
23594578|NCT02525796|65906272|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
23594579|NCT02525796|65906270|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
23594580|NCT02525796|65906271|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
23594581|NCT02525796|65906272|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
23594582|NCT02525796|65906270|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
23594583|NCT02525796|65906271|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
23594584|NCT02525796|65906272|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
23594585|NCT02525796|65906270|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
23594586|NCT02525796|65906271|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
23594587|NCT02525796|65906272|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
23594588|NCT01124734|65906273|FG000|Overall Study|Disease progression|13|||
23594589|NCT01124734|65906273|FG000|Overall Study|Adverse Event|1|||
23594590|NCT01124734|65906273|FG000|Overall Study|Withdrawal by Subject|1|||
23594591|NCT01124734|65906273|FG000|Overall Study|Elected for alternative treatment|2|||
23594592|NCT02539225|65906274|FG000|Part A|Adverse Event|13|||
23594593|NCT02539225|65906275|FG001|Part A|Adverse Event|4|||
23594594|NCT02539225|65906274|FG000|Part A|Withdrawal by Subject|2|||
23594595|NCT02539225|65906275|FG001|Part A|Withdrawal by Subject|4|||
23594596|NCT02539225|65906274|FG000|Part A|Physician Decision|4|||
23594597|NCT02539225|65906275|FG001|Part A|Physician Decision|7|||
23594598|NCT02539225|65906274|FG000|Part A|Did Not Receive study Drug|1|||
23594599|NCT02539225|65906275|FG001|Part A|Did Not Receive study Drug|1|||
23594600|NCT02539225|65906274|FG000|Pre Treatment for Part B|Progressive disease|1|||
23594601|NCT02539225|65906275|FG001|Pre Treatment for Part B|Progressive disease|1|||
23594602|NCT02539225|65906274|FG000|Pre Treatment for Part B|Adverse Event|1|||
23594603|NCT02539225|65906275|FG001|Pre Treatment for Part B|Adverse Event|1|||
23254467|NCT00591253|64673545|FG000|Overall Study|Other|5|||
23254468|NCT00591253|64673546|FG001|Overall Study|Other|5|||
23254469|NCT00591253|64673547|FG002|Overall Study|Other|3|||
23254470|NCT04130919|64673556|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
23254471|NCT04130919|64673557|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
23254472|NCT04130919|64673558|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
23254473|NCT04130919|64673559|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
23254474|NCT04130919|64673560|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
23254475|NCT04130919|64673561|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
23254476|NCT04130919|64673556|FG000|Blinded Treatment Phase|Adverse Event|0|||
23254477|NCT04130919|64673557|FG001|Blinded Treatment Phase|Adverse Event|0|||
23254478|NCT04130919|64673558|FG002|Blinded Treatment Phase|Adverse Event|1|||
23254479|NCT04130919|64673559|FG003|Blinded Treatment Phase|Adverse Event|0|||
23254480|NCT04130919|64673560|FG004|Blinded Treatment Phase|Adverse Event|0|||
23594604|NCT02539225|65906274|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
23594605|NCT02539225|65906275|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
23594606|NCT02539225|65906274|FG000|Pre Treatment for Part B|Physician Decision|2|||
23594607|NCT02539225|65906275|FG001|Pre Treatment for Part B|Physician Decision|0|||
23594608|NCT02539225|65906274|FG000|Part B|Adverse Event|4|||
23594609|NCT02539225|65906275|FG001|Part B|Adverse Event|4|||
23594610|NCT02539225|65906274|FG000|Part B|Withdrawal by Subject|0|||
23594611|NCT02539225|65906275|FG001|Part B|Withdrawal by Subject|3|||
23594612|NCT02539225|65906274|FG000|Part B|Physician Decision|0|||
23254481|NCT04130919|64673561|FG005|Blinded Treatment Phase|Adverse Event|0|||
23254482|NCT04130919|64673556|FG000|Blinded Treatment Phase|Disease worsening|0|||
23254483|NCT04130919|64673557|FG001|Blinded Treatment Phase|Disease worsening|0|||
23254484|NCT04130919|64673558|FG002|Blinded Treatment Phase|Disease worsening|1|||
23254485|NCT04130919|64673559|FG003|Blinded Treatment Phase|Disease worsening|0|||
23254486|NCT04130919|64673560|FG004|Blinded Treatment Phase|Disease worsening|0|||
23477636|NCT01888432|65491640|FG000|12-month Analysis (FAS)|Physician Decision|1|||
23477637|NCT01888432|65491641|FG001|12-month Analysis (FAS)|Physician Decision|1|||
23477638|NCT01888432|65491640|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
23477639|NCT01888432|65491641|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
23477640|NCT01888432|65491640|FG000|12-month Analysis (FAS)|Death|4|||
23477641|NCT01888432|65491641|FG001|12-month Analysis (FAS)|Death|3|||
23477642|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Graft loss|0|||
23477643|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Graft loss|1|||
23477644|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
23477645|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
23477646|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Physician Decision|2|||
23477647|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Physician Decision|4|||
23477648|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
23477649|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
23477650|NCT01888432|65491640|FG000|24-month Analysis (FAS)|Death|8|||
23477651|NCT01888432|65491641|FG001|24-month Analysis (FAS)|Death|4|||
23477652|NCT01888432|65491640|FG000|36-month Analysis (Extension)|Death|1|||
23477653|NCT01888432|65491641|FG001|36-month Analysis (Extension)|Death|0|||
23477654|NCT02785770|65491644|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
23477655|NCT02785770|65491645|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
23477656|NCT02785770|65491646|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
23477657|NCT02785770|65491647|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
23477658|NCT02785770|65491644|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
23477659|NCT02785770|65491645|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
23477660|NCT02785770|65491646|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
23477661|NCT02785770|65491647|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
23477662|NCT02785770|65491644|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
23477663|NCT02785770|65491645|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
23477664|NCT02785770|65491646|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
23477665|NCT02785770|65491647|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
23477666|NCT00653432|65491648|FG000|Overall Study|Adverse Event|4|||
23477667|NCT00653432|65491649|FG001|Overall Study|Adverse Event|1|||
23477668|NCT00653432|65491648|FG000|Overall Study|Withdrawal by Subject|4|||
23477669|NCT00653432|65491649|FG001|Overall Study|Withdrawal by Subject|5|||
23477670|NCT00653432|65491648|FG000|Overall Study|Lost to Follow-up|7|||
23477671|NCT00653432|65491649|FG001|Overall Study|Lost to Follow-up|6|||
23477672|NCT00653432|65491648|FG000|Overall Study|Use/Need of Con Therapy|2|||
23477673|NCT00653432|65491649|FG001|Overall Study|Use/Need of Con Therapy|1|||
23477674|NCT00653432|65491648|FG000|Overall Study|Other - Reason Not Provided|5|||
23477675|NCT00653432|65491649|FG001|Overall Study|Other - Reason Not Provided|3|||
23477676|NCT01395784|65491650|FG000|Overall Study|Lost to Follow-up|7|||
23477677|NCT01395784|65491650|FG000|Overall Study|Withdrawal by Subject|3|||
23477678|NCT01395784|65491650|FG000|Overall Study|Physician Decision|5|||
23477679|NCT00870584|65491651|FG000|Overall Study|Adverse Event|3|||
23477680|NCT00870584|65491652|FG001|Overall Study|Adverse Event|3|||
23477681|NCT00870584|65491651|FG000|Overall Study|Withdrawal by Subject|6|||
23477682|NCT00870584|65491652|FG001|Overall Study|Withdrawal by Subject|7|||
23477683|NCT00870584|65491651|FG000|Overall Study|Lost to Follow-up|5|||
23477684|NCT00870584|65491652|FG001|Overall Study|Lost to Follow-up|1|||
23477685|NCT00870584|65491651|FG000|Overall Study|Protocol Deviation|2|||
23477686|NCT00870584|65491652|FG001|Overall Study|Protocol Deviation|2|||
23477687|NCT02793622|65491655|FG000|Overall Study|Lost to Follow-up|31|||
23477688|NCT02793622|65491656|FG001|Overall Study|Lost to Follow-up|19|||
23477689|NCT02793622|65491655|FG000|Overall Study|Withdrawal by Subject|21|||
23477690|NCT02793622|65491656|FG001|Overall Study|Withdrawal by Subject|17|||
23477691|NCT02793622|65491655|FG000|Overall Study|Adverse Event|0|||
23477692|NCT02793622|65491656|FG001|Overall Study|Adverse Event|1|||
23477693|NCT02793622|65491655|FG000|Overall Study|Protocol Violation|1|||
23477694|NCT02793622|65491656|FG001|Overall Study|Protocol Violation|5|||
23477695|NCT02207946|65491657|FG000|Overall Study|Lost to Follow-up|1|||
23477696|NCT02207946|65491658|FG001|Overall Study|Lost to Follow-up|0|||
23477697|NCT02207946|65491657|FG000|Overall Study|Adverse Event|0|||
23477698|NCT02207946|65491658|FG001|Overall Study|Adverse Event|1|||
23477699|NCT00853970|65491659|FG000|Overall Study|Withdrawal by Subject|2|||
23477700|NCT00853970|65491660|FG001|Overall Study|Withdrawal by Subject|1|||
23477701|NCT00853970|65491659|FG000|Overall Study|Cancelled surgery|4|||
23477702|NCT00853970|65491660|FG001|Overall Study|Cancelled surgery|2|||
23477703|NCT03562767|65491664|FG000|Overall Study|Physician Decision|2|||
23477704|NCT03562767|65491665|FG001|Overall Study|Physician Decision|0|||
23477705|NCT03562767|65491666|FG002|Overall Study|Physician Decision|0|||
23477706|NCT03562767|65491664|FG000|Overall Study|Logistic Reason|1|||
23477707|NCT03562767|65491665|FG001|Overall Study|Logistic Reason|3|||
23477708|NCT03562767|65491666|FG002|Overall Study|Logistic Reason|0|||
23477709|NCT02650921|65491667|FG000|Overall Study|Withdrawal by Subject|4|||
23477710|NCT02650921|65491667|FG000|Overall Study|Lost to Follow-up|2|||
23477711|NCT02650921|65491667|FG000|Overall Study|Adverse Event|1|||
23477712|NCT02650921|65491667|FG000|Overall Study|Due to Medical Condition|1|||
23477713|NCT02848729|65491670|FG000|Overall Study|Withdrawal by Subject|1|||
23477714|NCT02848729|65491671|FG001|Overall Study|Withdrawal by Subject|0|||
23477715|NCT02848729|65491670|FG000|Overall Study|Emesis|15|||
23477716|NCT02848729|65491671|FG001|Overall Study|Emesis|11|||
23477717|NCT01253811|65491674|FG000|Overall Study|Withdrawal criteria|1|||
23477718|NCT05028361|65491676|FG000|Overall Study|Withdrawal by Subject|1|||
23477719|NCT05028361|65491677|FG001|Overall Study|Withdrawal by Subject|0|||
23477720|NCT01853839|65491678|FG000|Overall Study|Violated inclusion criteria|2|||
23477721|NCT01853839|65491678|FG000|Overall Study|Not meet ITT population definition|58|||
23477722|NCT01853839|65491678|FG000|Overall Study|End of treatment visit too early|33|||
23477723|NCT01853839|65491678|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
23477724|NCT03319745|65491679|FG000|Overall Study|Death|1|||
23477725|NCT03319745|65491679|FG000|Overall Study|Toxicity Precluding Surgery|1|||
23477726|NCT03462511|65491680|FG000|Overall Study|Withdrawal by Subject|2|||
23477727|NCT03462511|65491681|FG001|Overall Study|Withdrawal by Subject|3|||
23477728|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
23477729|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
23477730|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
23477731|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
23477732|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
23477733|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23477734|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23477735|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23477736|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23594613|NCT02539225|65906275|FG001|Part B|Physician Decision|9|||
23594614|NCT05368831|65906283|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
23254487|NCT04130919|64673561|FG005|Blinded Treatment Phase|Disease worsening|0|||
23254488|NCT04130919|64673556|FG000|Blinded Treatment Phase|Investigator's decision|0|||
23254489|NCT04130919|64673557|FG001|Blinded Treatment Phase|Investigator's decision|1|||
23254490|NCT04130919|64673558|FG002|Blinded Treatment Phase|Investigator's decision|0|||
23254491|NCT04130919|64673559|FG003|Blinded Treatment Phase|Investigator's decision|0|||
23254492|NCT04130919|64673560|FG004|Blinded Treatment Phase|Investigator's decision|0|||
23254493|NCT04130919|64673561|FG005|Blinded Treatment Phase|Investigator's decision|0|||
23477737|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
23477738|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23254494|NCT04130919|64673556|FG000|Blinded Treatment Phase|Withdrew consent|1|||
23477739|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477740|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477741|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477742|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
23477743|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477744|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23254495|NCT04130919|64673557|FG001|Blinded Treatment Phase|Withdrew consent|0|||
23360210|NCT01490840|65062857|FG000|Phase 1|Visit 6a omitted|1|||
23360211|NCT01490840|65062858|FG001|Phase 1|Visit 6a omitted|0|||
23477745|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477746|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23594615|NCT04218110|65906287|FG000|Overall Study|Withdrawal by Subject|0|||
23594616|NCT04218110|65906288|FG001|Overall Study|Withdrawal by Subject|0|||
23594617|NCT04218110|65906289|FG002|Overall Study|Withdrawal by Subject|0|||
23594618|NCT04218110|65906290|FG003|Overall Study|Withdrawal by Subject|1|||
23594619|NCT03703336|65906303|FG000|Overall Study|Parent withdrew consent|29|||
23594620|NCT03703336|65906304|FG001|Overall Study|Parent withdrew consent|8|||
23594621|NCT03703336|65906303|FG000|Overall Study|Migration|3|||
23594622|NCT03703336|65906304|FG001|Overall Study|Migration|3|||
23594623|NCT03703336|65906303|FG000|Overall Study|Protocol Violation|3|||
23594624|NCT03703336|65906304|FG001|Overall Study|Protocol Violation|1|||
23594625|NCT03703336|65906303|FG000|Overall Study|Physician Decision|2|||
23594626|NCT03703336|65906304|FG001|Overall Study|Physician Decision|0|||
23594627|NCT03703336|65906303|FG000|Overall Study|Adverse Event|0|||
23594628|NCT03703336|65906304|FG001|Overall Study|Adverse Event|2|||
23594629|NCT03703336|65906303|FG000|Overall Study|Lost to Follow-up|1|||
23594630|NCT03703336|65906304|FG001|Overall Study|Lost to Follow-up|0|||
23594631|NCT01144468|65906305|FG000|Overall Study|Lost to Follow-up|4|||
23594632|NCT01144468|65906306|FG001|Overall Study|Lost to Follow-up|7|||
23594633|NCT01144468|65906305|FG000|Overall Study|Adverse Event|3|||
23594634|NCT01144468|65906306|FG001|Overall Study|Adverse Event|2|||
23594635|NCT01144468|65906305|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
23594636|NCT01144468|65906306|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
23594637|NCT02738840|65906307|FG000|Overall Study|MRI Scan not Performed|5|||
23594638|NCT02738840|65906307|FG000|Overall Study|Lost to Follow-up|1|||
23594639|NCT02738840|65906307|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
23594640|NCT02738840|65906307|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
23594641|NCT01736215|65906313|FG000|Overall Study|Early termination of erythropoietin use|1|||
23594642|NCT01736215|65906313|FG000|Overall Study|Adverse Event|4|||
23594643|NCT01736215|65906313|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
23594644|NCT01736215|65906313|FG000|Overall Study|Insufficient data to perform analysis|8|||
23594645|NCT00296036|65906314|FG000|Overall Study|Withdrawal by Subject|1|||
23594646|NCT00296036|65906315|FG001|Overall Study|Withdrawal by Subject|0|||
23254496|NCT04130919|64673558|FG002|Blinded Treatment Phase|Withdrew consent|0|||
23254497|NCT04130919|64673559|FG003|Blinded Treatment Phase|Withdrew consent|0|||
23254498|NCT04130919|64673560|FG004|Blinded Treatment Phase|Withdrew consent|0|||
23254499|NCT04130919|64673561|FG005|Blinded Treatment Phase|Withdrew consent|0|||
23254500|NCT04130919|64673556|FG000|Open-label Treatment Phase|Withdrew consent|0|||
23254501|NCT04130919|64673557|FG001|Open-label Treatment Phase|Withdrew consent|0|||
23254502|NCT04130919|64673558|FG002|Open-label Treatment Phase|Withdrew consent|0|||
23254503|NCT04130919|64673559|FG003|Open-label Treatment Phase|Withdrew consent|1|||
23254504|NCT04130919|64673560|FG004|Open-label Treatment Phase|Withdrew consent|1|||
23254505|NCT04130919|64673561|FG005|Open-label Treatment Phase|Withdrew consent|1|||
23254506|NCT04130919|64673556|FG000|Open-label Treatment Phase|Disease worsening|0|||
23254507|NCT04130919|64673557|FG001|Open-label Treatment Phase|Disease worsening|0|||
23594647|NCT00296036|65906316|FG002|Overall Study|Withdrawal by Subject|2|||
23254508|NCT04130919|64673558|FG002|Open-label Treatment Phase|Disease worsening|0|||
23254509|NCT04130919|64673559|FG003|Open-label Treatment Phase|Disease worsening|1|||
23254510|NCT04130919|64673560|FG004|Open-label Treatment Phase|Disease worsening|0|||
23254511|NCT04130919|64673561|FG005|Open-label Treatment Phase|Disease worsening|1|||
23254512|NCT04130919|64673556|FG000|Open-label Treatment Phase|Investigator's decision|0|||
23254513|NCT04130919|64673557|FG001|Open-label Treatment Phase|Investigator's decision|0|||
23254514|NCT04130919|64673558|FG002|Open-label Treatment Phase|Investigator's decision|0|||
23594648|NCT00296036|65906317|FG003|Overall Study|Withdrawal by Subject|1|||
23254515|NCT04130919|64673559|FG003|Open-label Treatment Phase|Investigator's decision|1|||
23254516|NCT04130919|64673560|FG004|Open-label Treatment Phase|Investigator's decision|0|||
23594649|NCT00296036|65906318|FG004|Overall Study|Withdrawal by Subject|2|||
23594650|NCT00296036|65906319|FG005|Overall Study|Withdrawal by Subject|1|||
23594651|NCT00296036|65906314|FG000|Overall Study|Protocol Violation|0|||
23594652|NCT00296036|65906315|FG001|Overall Study|Protocol Violation|0|||
23594653|NCT00296036|65906316|FG002|Overall Study|Protocol Violation|0|||
23594654|NCT00296036|65906317|FG003|Overall Study|Protocol Violation|0|||
23594655|NCT00296036|65906318|FG004|Overall Study|Protocol Violation|0|||
23594656|NCT00296036|65906319|FG005|Overall Study|Protocol Violation|3|||
23594657|NCT01887600|65906321|FG000|Overall Study|Death|39|||
23594658|NCT01887600|65906322|FG001|Overall Study|Death|16|||
23594659|NCT01887600|65906321|FG000|Overall Study|Lack of Efficacy|3|||
23594660|NCT01887600|65906322|FG001|Overall Study|Lack of Efficacy|26|||
23594661|NCT01887600|65906321|FG000|Overall Study|Lost to Follow-up|5|||
23594662|NCT01887600|65906322|FG001|Overall Study|Lost to Follow-up|1|||
23594663|NCT01887600|65906321|FG000|Overall Study|Physician Decision|7|||
23594664|NCT01887600|65906322|FG001|Overall Study|Physician Decision|8|||
23594665|NCT01887600|65906321|FG000|Overall Study|Protocol Deviation|3|||
23594666|NCT01887600|65906322|FG001|Overall Study|Protocol Deviation|0|||
23594667|NCT01887600|65906321|FG000|Overall Study|Withdrawal by Subject|58|||
23594668|NCT01887600|65906322|FG001|Overall Study|Withdrawal by Subject|52|||
23594669|NCT01887600|65906321|FG000|Overall Study|Adverse Event|21|||
23594670|NCT01887600|65906322|FG001|Overall Study|Adverse Event|9|||
23594671|NCT01887600|65906321|FG000|Overall Study|Non-compliance with study drug|3|||
23594672|NCT01887600|65906322|FG001|Overall Study|Non-compliance with study drug|0|||
23594673|NCT01887600|65906321|FG000|Overall Study|Miscellaneous|6|||
23594674|NCT01887600|65906322|FG001|Overall Study|Miscellaneous|2|||
23594675|NCT01887600|65906321|FG000|Overall Study|Progressive Disease|1|||
23594676|NCT01887600|65906322|FG001|Overall Study|Progressive Disease|0|||
23594677|NCT00704184|65906325|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
23594678|NCT00704184|65906326|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
23594679|NCT00704184|65906327|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
23594680|NCT00704184|65906328|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
23594681|NCT00704184|65906329|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
23594682|NCT00704184|65906325|FG000|Open-Label Treatment|Adverse Event|0|||
23594683|NCT00704184|65906326|FG001|Open-Label Treatment|Adverse Event|0|||
23594684|NCT00704184|65906327|FG002|Open-Label Treatment|Adverse Event|2|||
23594685|NCT00704184|65906328|FG003|Open-Label Treatment|Adverse Event|0|||
23594686|NCT00704184|65906329|FG004|Open-Label Treatment|Adverse Event|1|||
23594687|NCT00704184|65906325|FG000|Open-Label Treatment|Lack of Efficacy|0|||
23594688|NCT00704184|65906326|FG001|Open-Label Treatment|Lack of Efficacy|2|||
23594689|NCT00704184|65906327|FG002|Open-Label Treatment|Lack of Efficacy|2|||
23594690|NCT00704184|65906328|FG003|Open-Label Treatment|Lack of Efficacy|2|||
23594691|NCT00704184|65906329|FG004|Open-Label Treatment|Lack of Efficacy|1|||
23594692|NCT00704184|65906325|FG000|Open-Label Treatment|Physician Decision|0|||
23594693|NCT00704184|65906326|FG001|Open-Label Treatment|Physician Decision|0|||
23594694|NCT00704184|65906327|FG002|Open-Label Treatment|Physician Decision|0|||
23594695|NCT00704184|65906328|FG003|Open-Label Treatment|Physician Decision|0|||
23594696|NCT00704184|65906329|FG004|Open-Label Treatment|Physician Decision|1|||
23594697|NCT00704184|65906325|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
23594698|NCT00704184|65906326|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
23594699|NCT00704184|65906327|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
23594700|NCT00704184|65906328|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
23594701|NCT00704184|65906329|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
23594702|NCT04191096|65906330|FG000|Overall Study|Death|102|||
23594703|NCT04191096|65906331|FG001|Overall Study|Death|89|||
23594704|NCT04191096|65906330|FG000|Overall Study|Lost to Follow-up|1|||
23594705|NCT04191096|65906331|FG001|Overall Study|Lost to Follow-up|1|||
23594706|NCT04191096|65906330|FG000|Overall Study|Withdrawal by Subject|5|||
23594707|NCT04191096|65906331|FG001|Overall Study|Withdrawal by Subject|5|||
23594708|NCT04191096|65906330|FG000|Overall Study|Participants Ongoing|518|||
23594709|NCT04191096|65906331|FG001|Overall Study|Participants Ongoing|530|||
23594710|NCT01061671|65906332|FG000|Overall Study|Withdrawal by Subject|16|||
23594711|NCT01061671|65906333|FG001|Overall Study|Withdrawal by Subject|20|||
23594712|NCT01061671|65906332|FG000|Overall Study|Lost to Follow-up|3|||
23594713|NCT01061671|65906333|FG001|Overall Study|Lost to Follow-up|5|||
23594714|NCT01061671|65906332|FG000|Overall Study|Death|28|||
23594715|NCT01061671|65906333|FG001|Overall Study|Death|30|||
23594716|NCT01444417|65906334|FG000|Overall Study|Ineligibility Determined|0|||
23594717|NCT01444417|65906335|FG001|Overall Study|Ineligibility Determined|1|||
23594718|NCT01444417|65906334|FG000|Overall Study|Withdrawal by Subject|2|||
23594719|NCT01444417|65906335|FG001|Overall Study|Withdrawal by Subject|0|||
23594720|NCT01610297|65906336|FG000|Overall Study|Lost to Follow-up|1|||
23594721|NCT00482729|65906337|FG000|Overall Study|Adverse Event|29|||
23594722|NCT00482729|65906338|FG001|Overall Study|Adverse Event|33|||
23594723|NCT00482729|65906337|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
23594724|NCT00482729|65906338|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
23594725|NCT00482729|65906337|FG000|Overall Study|Hyperglycemia Criteria|7|||
23594726|NCT00482729|65906338|FG001|Overall Study|Hyperglycemia Criteria|5|||
23594727|NCT00482729|65906337|FG000|Overall Study|Lack of Efficacy|4|||
23594728|NCT00482729|65906338|FG001|Overall Study|Lack of Efficacy|16|||
23254517|NCT04130919|64673561|FG005|Open-label Treatment Phase|Investigator's decision|0|||
23254518|NCT04130919|64673556|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
23254519|NCT04130919|64673557|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
23254520|NCT04130919|64673558|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
23254521|NCT04130919|64673559|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
23254522|NCT04130919|64673560|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
23254523|NCT04130919|64673561|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
23254524|NCT04130919|64673556|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23594729|NCT00482729|65906337|FG000|Overall Study|Lost to Follow-up|86|||
23594730|NCT00482729|65906338|FG001|Overall Study|Lost to Follow-up|66|||
23594731|NCT00482729|65906337|FG000|Overall Study|Physician Decision|10|||
23594732|NCT00482729|65906338|FG001|Overall Study|Physician Decision|7|||
23594733|NCT00482729|65906337|FG000|Overall Study|Pregnancy|4|||
23594734|NCT00482729|65906338|FG001|Overall Study|Pregnancy|2|||
23594735|NCT00482729|65906337|FG000|Overall Study|Protocol Violation|10|||
23594736|NCT00482729|65906338|FG001|Overall Study|Protocol Violation|18|||
23594737|NCT00482729|65906337|FG000|Overall Study|Withdrawal by Subject|67|||
23594738|NCT00482729|65906338|FG001|Overall Study|Withdrawal by Subject|69|||
23254525|NCT04130919|64673557|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23254526|NCT04130919|64673558|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23254527|NCT04130919|64673559|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23254528|NCT04130919|64673560|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
23254529|NCT04130919|64673561|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
23254530|NCT01664494|64673567|FG000|Overall Study|Withdrawal by Subject|27|||
23594739|NCT00094575|65906339|FG000|Overall Study|Death|146|||
23594740|NCT00094575|65906340|FG001|Overall Study|Death|146|||
23594741|NCT02271854|65906341|FG000|Overall Study|Withdrawal by Subject|2|||
23594742|NCT02271854|65906341|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
23594743|NCT02271854|65906341|FG000|Overall Study|Lost to Follow-up|1|||
23594744|NCT00610649|65906358|FG000|Overall Study|Adverse Event|1|||
23594745|NCT00610649|65906359|FG001|Overall Study|Adverse Event|0|||
23594746|NCT00610649|65906360|FG002|Overall Study|Adverse Event|0|||
23594747|NCT00610649|65906361|FG003|Overall Study|Adverse Event|0|||
23594748|NCT00610649|65906362|FG004|Overall Study|Adverse Event|0|||
23254531|NCT01664494|64673567|FG000|Overall Study|Death|18|||
23254532|NCT01664494|64673567|FG000|Overall Study|Other|49|||
23594749|NCT00610649|65906363|FG005|Overall Study|Adverse Event|0|||
23594750|NCT00610649|65906364|FG006|Overall Study|Adverse Event|0|||
23594751|NCT00610649|65906365|FG007|Overall Study|Adverse Event|0|||
23594752|NCT00610649|65906366|FG008|Overall Study|Adverse Event|0|||
23594753|NCT00610649|65906367|FG009|Overall Study|Adverse Event|0|||
23594754|NCT00610649|65906368|FG010|Overall Study|Adverse Event|1|||
23594755|NCT00610649|65906358|FG000|Overall Study|Family Emergency|0|||
23594756|NCT00610649|65906359|FG001|Overall Study|Family Emergency|1|||
23594757|NCT00610649|65906360|FG002|Overall Study|Family Emergency|0|||
23594758|NCT00610649|65906361|FG003|Overall Study|Family Emergency|0|||
23594759|NCT00610649|65906362|FG004|Overall Study|Family Emergency|0|||
23594760|NCT00610649|65906363|FG005|Overall Study|Family Emergency|0|||
23594761|NCT00610649|65906364|FG006|Overall Study|Family Emergency|0|||
23594762|NCT00610649|65906365|FG007|Overall Study|Family Emergency|0|||
23594763|NCT00610649|65906366|FG008|Overall Study|Family Emergency|0|||
23594764|NCT00610649|65906367|FG009|Overall Study|Family Emergency|0|||
23594765|NCT00610649|65906368|FG010|Overall Study|Family Emergency|0|||
23594766|NCT00610649|65906358|FG000|Overall Study|Withdrawal by Subject|0|||
23594767|NCT00610649|65906359|FG001|Overall Study|Withdrawal by Subject|0|||
23594768|NCT00610649|65906360|FG002|Overall Study|Withdrawal by Subject|0|||
23594769|NCT00610649|65906361|FG003|Overall Study|Withdrawal by Subject|0|||
23594770|NCT00610649|65906362|FG004|Overall Study|Withdrawal by Subject|0|||
23594771|NCT00610649|65906363|FG005|Overall Study|Withdrawal by Subject|0|||
23594772|NCT00610649|65906364|FG006|Overall Study|Withdrawal by Subject|0|||
23594773|NCT00610649|65906365|FG007|Overall Study|Withdrawal by Subject|0|||
23594774|NCT00610649|65906366|FG008|Overall Study|Withdrawal by Subject|0|||
23594775|NCT00610649|65906367|FG009|Overall Study|Withdrawal by Subject|1|||
23594776|NCT00610649|65906368|FG010|Overall Study|Withdrawal by Subject|0|||
23594777|NCT03990649|65906369|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
23594778|NCT03990649|65906370|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
23594779|NCT03990649|65906371|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
23594780|NCT03990649|65906369|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
23594781|NCT03990649|65906370|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
23594782|NCT03990649|65906371|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
23594783|NCT03990649|65906369|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
23594784|NCT03990649|65906370|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
23594785|NCT03990649|65906371|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
23594786|NCT03990649|65906369|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
23594787|NCT03990649|65906370|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
23594788|NCT03990649|65906371|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
23594789|NCT03990649|65906369|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
23594790|NCT03990649|65906370|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
23594791|NCT03990649|65906371|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
23594792|NCT03990649|65906369|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
23594793|NCT03990649|65906370|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
23594794|NCT03990649|65906371|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
23594795|NCT03990649|65906369|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
23594796|NCT03990649|65906370|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
23594797|NCT03990649|65906371|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
23594798|NCT01875250|65906373|FG000|Overall Study|Adverse Event|2|||
23594799|NCT01875250|65906374|FG001|Overall Study|Adverse Event|0|||
23594800|NCT00818454|65906377|FG000|Treatment Period 1|Adverse Event|0|||
23594801|NCT00818454|65906378|FG001|Treatment Period 1|Adverse Event|1|||
23594802|NCT00818454|65906379|FG002|Treatment Period 1|Adverse Event|0|||
23594803|NCT00818454|65906380|FG003|Treatment Period 1|Adverse Event|0|||
23594804|NCT00818454|65906377|FG000|Treatment Period 1|Other|3|||
23594805|NCT00818454|65906378|FG001|Treatment Period 1|Other|0|||
23594806|NCT00818454|65906379|FG002|Treatment Period 1|Other|0|||
23594807|NCT00818454|65906380|FG003|Treatment Period 1|Other|0|||
23594808|NCT00818454|65906377|FG000|Washout Period of 1 Week|Adverse Event|1|||
23594809|NCT00818454|65906378|FG001|Washout Period of 1 Week|Adverse Event|1|||
23594810|NCT00818454|65906379|FG002|Washout Period of 1 Week|Adverse Event|0|||
23594811|NCT00818454|65906380|FG003|Washout Period of 1 Week|Adverse Event|0|||
23594812|NCT00818454|65906377|FG000|Washout Period of 1 Week|Protocol Violation|2|||
23594813|NCT00818454|65906378|FG001|Washout Period of 1 Week|Protocol Violation|0|||
23594814|NCT00818454|65906379|FG002|Washout Period of 1 Week|Protocol Violation|0|||
23594815|NCT00818454|65906380|FG003|Washout Period of 1 Week|Protocol Violation|0|||
23594816|NCT00818454|65906377|FG000|Washout Period of 1 Week|Other|1|||
23594817|NCT00818454|65906378|FG001|Washout Period of 1 Week|Other|2|||
23594818|NCT00818454|65906379|FG002|Washout Period of 1 Week|Other|0|||
23594819|NCT00818454|65906380|FG003|Washout Period of 1 Week|Other|0|||
23594820|NCT00818454|65906377|FG000|Treatment Period 2|Other|2|||
23594821|NCT00818454|65906378|FG001|Treatment Period 2|Other|1|||
23360212|NCT01490840|65062857|FG000|Phase 2|Withdrawal by Subject|4|||
23360213|NCT01490840|65062858|FG001|Phase 2|Withdrawal by Subject|3|||
23594822|NCT00818454|65906379|FG002|Treatment Period 2|Other|0|||
23594823|NCT00818454|65906380|FG003|Treatment Period 2|Other|0|||
23594824|NCT00818454|65906377|FG000|Treatment Period 3|Adverse Event|0|||
23594825|NCT00818454|65906378|FG001|Treatment Period 3|Adverse Event|0|||
23594826|NCT00818454|65906379|FG002|Treatment Period 3|Adverse Event|0|||
23594827|NCT00818454|65906380|FG003|Treatment Period 3|Adverse Event|1|||
23594828|NCT04723394|65906381|FG000|Overall Study|Adverse Event|0|||
23594829|NCT04723394|65906382|FG001|Overall Study|Adverse Event|3|||
23594830|NCT04723394|65906381|FG000|Overall Study|Death|8|||
23594831|NCT04723394|65906382|FG001|Overall Study|Death|8|||
23594832|NCT04723394|65906381|FG000|Overall Study|Lost to Follow-up|20|||
23594833|NCT04723394|65906382|FG001|Overall Study|Lost to Follow-up|17|||
23594834|NCT04723394|65906381|FG000|Overall Study|Physician Decision|1|||
23594835|NCT04723394|65906382|FG001|Overall Study|Physician Decision|0|||
23594836|NCT04723394|65906381|FG000|Overall Study|Withdrawal by Subject|20|||
23594837|NCT04723394|65906382|FG001|Overall Study|Withdrawal by Subject|34|||
23193986|NCT02760407|64452429|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
23193987|NCT02760407|64452430|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
23193988|NCT02760407|64452431|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
23193989|NCT02760407|64452428|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
23193990|NCT02760407|64452429|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
23193991|NCT02760407|64452430|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
23193992|NCT02760407|64452431|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
23594838|NCT04723394|65906381|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
23594839|NCT04723394|65906382|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
23594840|NCT02759016|65906385|FG000|Overall Study|Not treated with BI 836826|1|||
23594841|NCT02759016|65906386|FG001|Overall Study|Not treated with BI 836826|0|||
23594842|NCT02759016|65906385|FG000|Overall Study|Progressive disease|1|||
23193993|NCT02760407|64452428|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
23193994|NCT02760407|64452429|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
23254533|NCT01664494|64673567|FG000|Overall Study|Lost to Follow-up|99|||
23594843|NCT02759016|65906386|FG001|Overall Study|Progressive disease|0|||
23594844|NCT02759016|65906385|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
23594845|NCT02759016|65906386|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
23594846|NCT02759016|65906385|FG000|Overall Study|Other not defined above|2|||
23594847|NCT02759016|65906386|FG001|Overall Study|Other not defined above|1|||
23594848|NCT02178098|65906387|FG000|Overall Study|Withdrawal by Subject|0|||
23594849|NCT02178098|65906388|FG001|Overall Study|Withdrawal by Subject|6|||
23594850|NCT02178098|65906387|FG000|Overall Study|Adverse Event|1|||
23594851|NCT02178098|65906388|FG001|Overall Study|Adverse Event|2|||
23594852|NCT02178098|65906387|FG000|Overall Study|Protocol Violation|1|||
23594853|NCT02178098|65906388|FG001|Overall Study|Protocol Violation|1|||
23594854|NCT02178098|65906387|FG000|Overall Study|Lost to Follow-up|0|||
23594855|NCT02178098|65906388|FG001|Overall Study|Lost to Follow-up|1|||
23594856|NCT02178098|65906387|FG000|Overall Study|Sponsor Request|1|||
23594857|NCT02178098|65906388|FG001|Overall Study|Sponsor Request|0|||
23594858|NCT02178098|65906387|FG000|Overall Study|Other|2|||
23594859|NCT02178098|65906388|FG001|Overall Study|Other|2|||
23594860|NCT00186186|65909231|FG000|Overall Study|Lack of Efficacy|3|||
23594861|NCT00186186|65909231|FG000|Overall Study|Withdrawal by Subject|3|||
23594862|NCT00186186|65909231|FG000|Overall Study|Not reported as to reason|2|||
23594863|NCT03432858|65909233|FG000|Overall Study|Protocol Violation|2|||
23594864|NCT03432858|65909234|FG001|Overall Study|Protocol Violation|1|||
23594865|NCT03432858|65909235|FG002|Overall Study|Protocol Violation|9|||
23594866|NCT03432858|65909233|FG000|Overall Study|Withdrawal by Subject|0|||
23594867|NCT03432858|65909234|FG001|Overall Study|Withdrawal by Subject|1|||
23594868|NCT03432858|65909235|FG002|Overall Study|Withdrawal by Subject|1|||
23594869|NCT03432858|65909233|FG000|Overall Study|Procedure canceled/rescheduled|0|||
23594870|NCT03432858|65909234|FG001|Overall Study|Procedure canceled/rescheduled|9|||
23594871|NCT03432858|65909235|FG002|Overall Study|Procedure canceled/rescheduled|6|||
23594872|NCT03432858|65909233|FG000|Overall Study|Required postop mobilization with splinting|0|||
23594873|NCT03432858|65909234|FG001|Overall Study|Required postop mobilization with splinting|0|||
23594874|NCT03432858|65909235|FG002|Overall Study|Required postop mobilization with splinting|1|||
23594875|NCT04600752|65909236|FG000|Overall Study|Physician Decision|0|||
23594876|NCT04600752|65909237|FG001|Overall Study|Physician Decision|0|||
23594877|NCT04600752|65909238|FG002|Overall Study|Physician Decision|1|||
23594878|NCT04600752|65909236|FG000|Overall Study|Adverse Event|0|||
23594879|NCT04600752|65909237|FG001|Overall Study|Adverse Event|1|||
23594880|NCT04600752|65909238|FG002|Overall Study|Adverse Event|0|||
23594881|NCT04600752|65909236|FG000|Overall Study|Withdrawal by Subject|2|||
23594882|NCT04600752|65909237|FG001|Overall Study|Withdrawal by Subject|1|||
23594883|NCT04600752|65909238|FG002|Overall Study|Withdrawal by Subject|0|||
23594884|NCT04600752|65909236|FG000|Overall Study|Lack of Efficacy|1|||
23594885|NCT04600752|65909237|FG001|Overall Study|Lack of Efficacy|0|||
23594886|NCT04600752|65909238|FG002|Overall Study|Lack of Efficacy|0|||
23594887|NCT00002842|65909239|FG000|Overall Study|ineligible for surgical resection|27|||
23594888|NCT01499199|65909240|FG000|Overall Study|Adverse Event|1|||
23594889|NCT01499199|65909240|FG000|Overall Study|Lack of Efficacy|1|||
23594890|NCT00686855|65909243|FG000|Overall Study|Lost to Follow-up|1|||
23594891|NCT00686855|65909244|FG001|Overall Study|Lost to Follow-up|0|||
23594892|NCT00686855|65909243|FG000|Overall Study|Progressive GVHD|0|||
23594893|NCT00686855|65909244|FG001|Overall Study|Progressive GVHD|1|||
23594894|NCT01254188|65909245|FG000|Overall Study|Disease Progression|6|||
23594895|NCT01254188|65909245|FG000|Overall Study|Protocol Violation|6|||
23594896|NCT01254188|65909245|FG000|Overall Study|Pregnancy|2|||
23594897|NCT01254188|65909245|FG000|Overall Study|Death|4|||
23594898|NCT01254188|65909245|FG000|Overall Study|Lost to Follow-up|5|||
23594899|NCT01254188|65909245|FG000|Overall Study|Withdrawal by Subject|7|||
23594900|NCT01254188|65909245|FG000|Overall Study|Adverse Event|43|||
23254534|NCT02626182|64673568|FG000|Overall Study|Adverse Event|2|||
23254535|NCT02626182|64673569|FG001|Overall Study|Adverse Event|0|||
23254536|NCT00363129|64673576|FG000|Overall Study|Withdrawal by Subject|11|||
23254537|NCT00363129|64673577|FG001|Overall Study|Withdrawal by Subject|18|||
23254538|NCT00363129|64673576|FG000|Overall Study|Adverse Event|8|||
23254539|NCT00363129|64673577|FG001|Overall Study|Adverse Event|3|||
23254540|NCT00363129|64673576|FG000|Overall Study|Alternate Treatment|2|||
23254541|NCT00363129|64673577|FG001|Overall Study|Alternate Treatment|4|||
23254542|NCT00363129|64673576|FG000|Overall Study|Other Medical Problems|2|||
23254543|NCT00363129|64673577|FG001|Overall Study|Other Medical Problems|4|||
23254544|NCT00363129|64673576|FG000|Overall Study|Death|0|||
23594901|NCT01254188|65909245|FG000|Overall Study|per investigator discretion|20|||
23594902|NCT00411151|65909249|FG000|Overall Study|Death|38|||
23594903|NCT00411151|65909249|FG000|Overall Study|Withdrawal by Subject|2|||
23594904|NCT00411151|65909249|FG000|Overall Study|Lost to Follow-up|2|||
23254545|NCT00363129|64673577|FG001|Overall Study|Death|1|||
23594905|NCT00411151|65909249|FG000|Overall Study|Protocol Violation|1|||
23594906|NCT00411151|65909249|FG000|Overall Study|Trial prematurely closed|4|||
23594907|NCT00726596|65909253|FG000|Overall Study|Adverse Event|2|||
23594908|NCT00726596|65909254|FG001|Overall Study|Adverse Event|1|||
23254546|NCT00363129|64673576|FG000|Overall Study|Other Reasons|6|||
23254547|NCT00363129|64673577|FG001|Overall Study|Other Reasons|3|||
23254548|NCT03125629|64673581|FG000|Overall Study|Withdrawal by Subject|2|||
23254549|NCT03125629|64673581|FG000|Overall Study|Equipment malfunction|1|||
23594909|NCT00726596|65909253|FG000|Overall Study|Withdrawal by Subject|3|||
23594910|NCT00726596|65909254|FG001|Overall Study|Withdrawal by Subject|3|||
23594911|NCT01551355|65909257|FG000|Overall Study|Lost to Follow-up|51|||
23594912|NCT01551355|65909258|FG001|Overall Study|Lost to Follow-up|49|||
23594913|NCT01551355|65909259|FG002|Overall Study|Lost to Follow-up|34|||
23594914|NCT01551355|65909260|FG003|Overall Study|Lost to Follow-up|24|||
23594915|NCT01551355|65909261|FG004|Overall Study|Lost to Follow-up|9|||
23594916|NCT01551355|65909262|FG005|Overall Study|Lost to Follow-up|6|||
23594917|NCT03473340|65909264|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
23594918|NCT03473340|65909265|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
23594919|NCT03473340|65909264|FG000|Overall Study|Withdrawal by Subject|1|||
23594920|NCT03473340|65909265|FG001|Overall Study|Withdrawal by Subject|0|||
23594921|NCT03473340|65909264|FG000|Overall Study|Lost to Follow-up|1|||
23594922|NCT03473340|65909265|FG001|Overall Study|Lost to Follow-up|2|||
23594923|NCT01534494|65909266|FG000|Overall Study|Withdrawal by Subject|1|||
23594924|NCT03101930|65909267|FG000|Overall Study|Withdrawal by Subject|2|||
23594925|NCT03101930|65909268|FG001|Overall Study|Withdrawal by Subject|1|||
23594926|NCT03101930|65909269|FG002|Overall Study|Withdrawal by Subject|2|||
23594927|NCT03262935|65909271|FG000|Overall Study|Withdrawal by Subject|6|||
23254550|NCT00520494|64673584|FG000|Overall Study|Withdrawal by Subject|1|||
23254551|NCT01155284|64673585|FG000|Overall Study|Withdrawal by Subject|4|||
23594928|NCT03262935|65909272|FG001|Overall Study|Withdrawal by Subject|7|||
23594929|NCT03262935|65909271|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
23594930|NCT03262935|65909272|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
23594931|NCT03262935|65909271|FG000|Overall Study|Death|181|||
23594932|NCT03262935|65909272|FG001|Overall Study|Death|94|||
23594933|NCT03262935|65909271|FG000|Overall Study|Lost to Follow-up|9|||
23594934|NCT03262935|65909272|FG001|Overall Study|Lost to Follow-up|4|||
23594935|NCT03262935|65909271|FG000|Overall Study|Other reason|5|||
23594936|NCT03262935|65909272|FG001|Overall Study|Other reason|0|||
23594937|NCT01136876|65909274|FG000|Overall Study|Lost to Follow-up|0|||
23594938|NCT01136876|65909275|FG001|Overall Study|Lost to Follow-up|1|||
23594939|NCT01136876|65909274|FG000|Overall Study|Physician Decision|3|||
23594940|NCT01136876|65909275|FG001|Overall Study|Physician Decision|5|||
23594941|NCT01136876|65909274|FG000|Overall Study|Missing NGAL measurement|2|||
23594942|NCT01136876|65909275|FG001|Overall Study|Missing NGAL measurement|5|||
23594943|NCT02015520|65909277|FG000|Overall Study|Lack of Efficacy|1|||
23594944|NCT02015520|65909278|FG001|Overall Study|Lack of Efficacy|0|||
23594945|NCT02015520|65909279|FG002|Overall Study|Lack of Efficacy|3|||
23594946|NCT02015520|65909280|FG003|Overall Study|Lack of Efficacy|2|||
23594947|NCT02015520|65909277|FG000|Overall Study|Adverse Event|0|||
23594948|NCT02015520|65909278|FG001|Overall Study|Adverse Event|0|||
23594949|NCT02015520|65909279|FG002|Overall Study|Adverse Event|0|||
23594950|NCT02015520|65909280|FG003|Overall Study|Adverse Event|1|||
23594951|NCT02015520|65909277|FG000|Overall Study|Withdrawal by Subject|2|||
23594952|NCT02015520|65909278|FG001|Overall Study|Withdrawal by Subject|2|||
23594953|NCT02015520|65909279|FG002|Overall Study|Withdrawal by Subject|1|||
23594954|NCT02015520|65909280|FG003|Overall Study|Withdrawal by Subject|0|||
23594955|NCT02015520|65909277|FG000|Overall Study|Death|1|||
23594956|NCT02015520|65909278|FG001|Overall Study|Death|0|||
23594957|NCT02015520|65909279|FG002|Overall Study|Death|0|||
23594958|NCT02015520|65909280|FG003|Overall Study|Death|0|||
23594959|NCT02015520|65909277|FG000|Overall Study|Lost to Follow-up|0|||
23254552|NCT01155284|64673586|FG001|Overall Study|Withdrawal by Subject|3|||
23254553|NCT01155284|64673585|FG000|Overall Study|Lost to Follow-up|1|||
23594960|NCT02015520|65909278|FG001|Overall Study|Lost to Follow-up|0|||
23594961|NCT02015520|65909279|FG002|Overall Study|Lost to Follow-up|1|||
23594962|NCT02015520|65909280|FG003|Overall Study|Lost to Follow-up|0|||
23594963|NCT02015520|65909277|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
23594964|NCT02015520|65909278|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
23254554|NCT01155284|64673586|FG001|Overall Study|Lost to Follow-up|2|||
23594965|NCT02015520|65909279|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
23594966|NCT02015520|65909280|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
23594967|NCT02015520|65909277|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
23594968|NCT02015520|65909278|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
23594969|NCT02015520|65909279|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
23594970|NCT02015520|65909280|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
23254555|NCT01155284|64673585|FG000|Overall Study|Physician Decision|1|||
23254556|NCT01155284|64673586|FG001|Overall Study|Physician Decision|0|||
23254557|NCT01155284|64673585|FG000|Overall Study|Adverse Event|1|||
23254558|NCT01155284|64673586|FG001|Overall Study|Adverse Event|0|||
23594971|NCT00433199|65909282|FG000|Double-Blind Period|Adverse Event|0|||
23594972|NCT00433199|65909283|FG001|Double-Blind Period|Adverse Event|25|||
23594973|NCT00433199|65909282|FG000|Double-Blind Period|Lack of Efficacy|0|||
23594974|NCT00433199|65909283|FG001|Double-Blind Period|Lack of Efficacy|2|||
23594975|NCT00433199|65909282|FG000|Double-Blind Period|Lost to Follow-up|2|||
23594976|NCT00433199|65909283|FG001|Double-Blind Period|Lost to Follow-up|5|||
23594977|NCT00433199|65909282|FG000|Double-Blind Period|Withdrawal by Subject|8|||
23594978|NCT00433199|65909283|FG001|Double-Blind Period|Withdrawal by Subject|19|||
23594979|NCT00433199|65909282|FG000|Double-Blind Period|Protocol Violation|1|||
23594980|NCT00433199|65909283|FG001|Double-Blind Period|Protocol Violation|10|||
23594981|NCT00433199|65909282|FG000|Double-Blind Period|Administrative|1|||
23594982|NCT00433199|65909283|FG001|Double-Blind Period|Administrative|5|||
23254559|NCT00080288|64673589|FG000|Overall Study|Adverse Event|7|||
23254560|NCT00080288|64673590|FG001|Overall Study|Adverse Event|4|||
23254561|NCT00080288|64673589|FG000|Overall Study|Lost to Follow-up|3|||
23254562|NCT00080288|64673590|FG001|Overall Study|Lost to Follow-up|5|||
23254563|NCT00080288|64673589|FG000|Overall Study|Physician Decision|6|||
23254564|NCT00080288|64673590|FG001|Overall Study|Physician Decision|2|||
23254565|NCT00080288|64673589|FG000|Overall Study|Withdrawal by Subject|3|||
23254566|NCT00080288|64673590|FG001|Overall Study|Withdrawal by Subject|16|||
23254567|NCT00080288|64673589|FG000|Overall Study|Miscellaneous|11|||
23254568|NCT00080288|64673590|FG001|Overall Study|Miscellaneous|11|||
23254569|NCT01462695|64673593|FG000|Overall Study|Adverse Event|1|||
23254570|NCT01462695|64673594|FG001|Overall Study|Adverse Event|1|||
23254571|NCT01462695|64673593|FG000|Overall Study|Death|2|||
23254572|NCT01462695|64673594|FG001|Overall Study|Death|0|||
23254573|NCT01462695|64673593|FG000|Overall Study|Lack of Efficacy|6|||
23254574|NCT01462695|64673594|FG001|Overall Study|Lack of Efficacy|12|||
23254575|NCT01462695|64673593|FG000|Overall Study|Physician Decision|5|||
23254576|NCT01462695|64673594|FG001|Overall Study|Physician Decision|0|||
23254577|NCT01462695|64673593|FG000|Overall Study|Withdrawal by Subject|2|||
23254578|NCT01462695|64673594|FG001|Overall Study|Withdrawal by Subject|0|||
23594983|NCT00433199|65909282|FG000|Open-Label Period|Adverse Event|0|||
23594984|NCT00433199|65909283|FG001|Open-Label Period|Adverse Event|19|||
23594985|NCT00433199|65909282|FG000|Open-Label Period|Lack of Efficacy|0|||
23594986|NCT00433199|65909283|FG001|Open-Label Period|Lack of Efficacy|2|||
23594987|NCT00433199|65909282|FG000|Open-Label Period|Lost to Follow-up|0|||
23594988|NCT00433199|65909283|FG001|Open-Label Period|Lost to Follow-up|3|||
23594989|NCT00433199|65909282|FG000|Open-Label Period|Withdrawal by Subject|0|||
23594990|NCT00433199|65909283|FG001|Open-Label Period|Withdrawal by Subject|7|||
23594991|NCT00433199|65909282|FG000|Open-Label Period|Protocol Violation|0|||
23594992|NCT00433199|65909283|FG001|Open-Label Period|Protocol Violation|2|||
23594993|NCT00433199|65909282|FG000|Open-Label Period|Administrative|0|||
23594994|NCT00433199|65909283|FG001|Open-Label Period|Administrative|1|||
23594995|NCT03565315|65909289|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
23594996|NCT03565315|65909290|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
23594997|NCT03565315|65909291|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
23594998|NCT03565315|65909292|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
23594999|NCT01989455|65909293|FG000|Overall Study|Adverse Event|0|||
23595000|NCT01989455|65909294|FG001|Overall Study|Adverse Event|1|||
23595001|NCT01989455|65909295|FG002|Overall Study|Adverse Event|0|||
23254579|NCT01462695|64673593|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
23254580|NCT01462695|64673594|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
23254581|NCT05016765|64673596|FG000|Overall Study|Lost to Follow-up|4|||
23254582|NCT02496221|64673597|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
23360214|NCT01490840|65062857|FG000|Phase 2|Permanent interruption of fingolimod|0|||
23595002|NCT01989455|65909296|FG003|Overall Study|Adverse Event|0|||
23254583|NCT02496221|64673598|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
23595003|NCT01989455|65909297|FG004|Overall Study|Adverse Event|0|||
23595004|NCT01989455|65909293|FG000|Overall Study|Withdrawal by Subject|0|||
23595005|NCT01989455|65909294|FG001|Overall Study|Withdrawal by Subject|1|||
23595006|NCT01989455|65909295|FG002|Overall Study|Withdrawal by Subject|0|||
23595007|NCT01989455|65909296|FG003|Overall Study|Withdrawal by Subject|0|||
23595008|NCT01989455|65909297|FG004|Overall Study|Withdrawal by Subject|0|||
23595009|NCT01989455|65909293|FG000|Overall Study|Technical problems with infusion|0|||
23595010|NCT01989455|65909294|FG001|Overall Study|Technical problems with infusion|0|||
23595011|NCT01989455|65909295|FG002|Overall Study|Technical problems with infusion|1|||
23595012|NCT01989455|65909296|FG003|Overall Study|Technical problems with infusion|0|||
23595013|NCT01989455|65909297|FG004|Overall Study|Technical problems with infusion|1|||
23595014|NCT01170962|65909298|FG000|Treatment Period|Lack of Efficacy|96|||
23595015|NCT01170962|65909299|FG001|Treatment Period|Lack of Efficacy|91|||
23595016|NCT01170962|65909300|FG002|Treatment Period|Lack of Efficacy|7|||
23595017|NCT01170962|65909298|FG000|Treatment Period|Adverse Event|11|||
23595018|NCT01170962|65909299|FG001|Treatment Period|Adverse Event|12|||
23595019|NCT01170962|65909300|FG002|Treatment Period|Adverse Event|3|||
23595020|NCT01170962|65909298|FG000|Treatment Period|Withdrawal by Subject|2|||
23595021|NCT01170962|65909299|FG001|Treatment Period|Withdrawal by Subject|1|||
23595022|NCT01170962|65909300|FG002|Treatment Period|Withdrawal by Subject|0|||
23595023|NCT01170962|65909298|FG000|Treatment Period|Lost to Follow-up|1|||
23595024|NCT01170962|65909299|FG001|Treatment Period|Lost to Follow-up|1|||
23595025|NCT01170962|65909300|FG002|Treatment Period|Lost to Follow-up|1|||
23595026|NCT01170962|65909298|FG000|Treatment Period|Participant no longer meets criteria|0|||
23595027|NCT01170962|65909299|FG001|Treatment Period|Participant no longer meets criteria|1|||
23595028|NCT01170962|65909300|FG002|Treatment Period|Participant no longer meets criteria|0|||
23595029|NCT01170962|65909298|FG000|Treatment Period|Request to discontinue treatment|7|||
23595030|NCT01170962|65909299|FG001|Treatment Period|Request to discontinue treatment|3|||
23595031|NCT01170962|65909300|FG002|Treatment Period|Request to discontinue treatment|1|||
23595032|NCT01170962|65909298|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
23595033|NCT01170962|65909299|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
23595034|NCT01170962|65909300|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
23595035|NCT01170962|65909298|FG000|Follow up Period|Withdrawal by Subject|14|||
23595036|NCT01170962|65909299|FG001|Follow up Period|Withdrawal by Subject|10|||
23595037|NCT01170962|65909300|FG002|Follow up Period|Withdrawal by Subject|2|||
23595038|NCT01170962|65909298|FG000|Follow up Period|Lost to Follow-up|13|||
23595039|NCT01170962|65909299|FG001|Follow up Period|Lost to Follow-up|8|||
23595040|NCT01170962|65909300|FG002|Follow up Period|Lost to Follow-up|1|||
23254584|NCT02496221|64673597|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
23254585|NCT02496221|64673598|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
23254586|NCT02496221|64673597|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
23254587|NCT02496221|64673598|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
23254588|NCT02217345|64673599|FG000|Overall Study|Lost to Follow-up|2|||
23254589|NCT02217345|64673600|FG001|Overall Study|Lost to Follow-up|1|||
23254590|NCT02217345|64673599|FG000|Overall Study|Withdrawal by Subject|3|||
23254591|NCT02217345|64673600|FG001|Overall Study|Withdrawal by Subject|2|||
23254592|NCT02217345|64673599|FG000|Overall Study|Adverse Event|2|||
23254593|NCT02217345|64673600|FG001|Overall Study|Adverse Event|1|||
23254594|NCT02217345|64673599|FG000|Overall Study|Physician Decision|0|||
23254595|NCT02217345|64673600|FG001|Overall Study|Physician Decision|1|||
23254596|NCT00660790|64673601|FG000|Baseline to 3 Months|Death|1|||
23254597|NCT00660790|64673601|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
23595041|NCT01170962|65909298|FG000|Follow up Period|Death|2|||
23595042|NCT01170962|65909299|FG001|Follow up Period|Death|2|||
23595043|NCT01170962|65909300|FG002|Follow up Period|Death|0|||
23595044|NCT01170962|65909298|FG000|Follow up Period|Others|10|||
23595045|NCT01170962|65909299|FG001|Follow up Period|Others|7|||
23595046|NCT01170962|65909300|FG002|Follow up Period|Others|3|||
23595047|NCT01308567|65909303|FG000|Overall Study|Lost to Follow-up|2|||
23254598|NCT00660790|64673601|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
23254599|NCT02629965|64673604|FG000|Period 1|Adverse Event|1|||
23254600|NCT02629965|64673605|FG001|Period 1|Adverse Event|0|||
23254601|NCT02629965|64673604|FG000|Period 1|Unexpected worsening of disease|2|||
23254602|NCT02629965|64673605|FG001|Period 1|Unexpected worsening of disease|0|||
23254603|NCT02629965|64673604|FG000|Period 1|Other than listed above|1|||
23254604|NCT02629965|64673605|FG001|Period 1|Other than listed above|2|||
23254605|NCT02629965|64673604|FG000|Period 2|Adverse Event|1|||
23595048|NCT01308567|65909304|FG001|Overall Study|Lost to Follow-up|4|||
23595049|NCT01308567|65909305|FG002|Overall Study|Lost to Follow-up|4|||
23595050|NCT01571596|65909306|FG000|Overall Study|Adverse Event|2|||
23595051|NCT01571596|65909307|FG001|Overall Study|Adverse Event|0|||
23595052|NCT01571596|65909308|FG002|Overall Study|Adverse Event|0|||
23595053|NCT01571596|65909306|FG000|Overall Study|Study Terminated by the Sponsor|0|||
23595054|NCT01571596|65909307|FG001|Overall Study|Study Terminated by the Sponsor|1|||
23595055|NCT01571596|65909308|FG002|Overall Study|Study Terminated by the Sponsor|1|||
23595056|NCT02423798|65909315|FG000|Overall Study|Withdrawal by Subject|3|||
23595057|NCT00968149|65909316|FG000|Overall Study|Adverse Event|5|||
23595058|NCT00968149|65909317|FG001|Overall Study|Adverse Event|1|||
23595059|NCT00968149|65909316|FG000|Overall Study|Lack of Efficacy|0|||
23595060|NCT00968149|65909317|FG001|Overall Study|Lack of Efficacy|4|||
23595061|NCT00968149|65909316|FG000|Overall Study|Lost to Follow-up|0|||
23595062|NCT00968149|65909317|FG001|Overall Study|Lost to Follow-up|1|||
23595063|NCT00968149|65909316|FG000|Overall Study|Protocol Violation|4|||
23595064|NCT00968149|65909317|FG001|Overall Study|Protocol Violation|0|||
23595065|NCT00968149|65909316|FG000|Overall Study|Withdrawal by Subject|2|||
23595066|NCT00968149|65909317|FG001|Overall Study|Withdrawal by Subject|0|||
23595067|NCT00812461|65909320|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
23595068|NCT00812461|65909321|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
23595069|NCT00812461|65909320|FG000|All Treated Patients|Adverse Event|8|||
23595070|NCT00812461|65909321|FG001|All Treated Patients|Adverse Event|15|||
23595071|NCT00812461|65909320|FG000|All Treated Patients|Lack of Efficacy|13|||
23595072|NCT00812461|65909321|FG001|All Treated Patients|Lack of Efficacy|7|||
23595073|NCT00812461|65909320|FG000|All Treated Patients|Non-compliance|6|||
23595074|NCT00812461|65909321|FG001|All Treated Patients|Non-compliance|9|||
23595075|NCT00812461|65909320|FG000|All Treated Patients|Protocol Violation|36|||
23595076|NCT00812461|65909321|FG001|All Treated Patients|Protocol Violation|27|||
23595077|NCT00812461|65909320|FG000|All Treated Patients|Withdrawal by Subject|45|||
23595078|NCT00812461|65909321|FG001|All Treated Patients|Withdrawal by Subject|54|||
23595079|NCT00812461|65909320|FG000|All Treated Patients|Lost to Follow-up|11|||
23595080|NCT00812461|65909321|FG001|All Treated Patients|Lost to Follow-up|14|||
23595081|NCT00812461|65909320|FG000|All Treated Patients|Other Reason|13|||
23595082|NCT00812461|65909321|FG001|All Treated Patients|Other Reason|21|||
23595083|NCT01759264|65909331|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
23595084|NCT01759264|65909331|FG000|Overall Study|Adverse Event|1|||
23595085|NCT01759264|65909331|FG000|Overall Study|Other|2|||
23595086|NCT01759264|65909331|FG000|Overall Study|Lost to Follow-up|2|||
23595087|NCT01759264|65909331|FG000|Overall Study|Withdrawal by Subject|3|||
23595088|NCT01759264|65909331|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
23595089|NCT04452318|65909332|FG000|Overall Study|Physician Decision|1|||
23595090|NCT04452318|65909333|FG001|Overall Study|Physician Decision|2|||
23595091|NCT04452318|65909334|FG002|Overall Study|Physician Decision|0|||
23595092|NCT04452318|65909335|FG003|Overall Study|Physician Decision|2|||
23595093|NCT04452318|65909336|FG004|Overall Study|Physician Decision|0|||
23595094|NCT04452318|65909337|FG005|Overall Study|Physician Decision|2|||
23595095|NCT04452318|65909338|FG006|Overall Study|Physician Decision|5|||
23595096|NCT04452318|65909332|FG000|Overall Study|Death|2|||
23595097|NCT04452318|65909333|FG001|Overall Study|Death|3|||
23595098|NCT04452318|65909334|FG002|Overall Study|Death|0|||
23595099|NCT04452318|65909335|FG003|Overall Study|Death|0|||
23595100|NCT04452318|65909336|FG004|Overall Study|Death|0|||
23595101|NCT04452318|65909337|FG005|Overall Study|Death|0|||
23595102|NCT04452318|65909338|FG006|Overall Study|Death|0|||
23595103|NCT04452318|65909332|FG000|Overall Study|Lost to Follow-up|38|||
23595104|NCT04452318|65909333|FG001|Overall Study|Lost to Follow-up|28|||
23595105|NCT04452318|65909334|FG002|Overall Study|Lost to Follow-up|0|||
23595106|NCT04452318|65909335|FG003|Overall Study|Lost to Follow-up|3|||
23595107|NCT04452318|65909336|FG004|Overall Study|Lost to Follow-up|3|||
23595108|NCT04452318|65909337|FG005|Overall Study|Lost to Follow-up|2|||
23595109|NCT04452318|65909338|FG006|Overall Study|Lost to Follow-up|1|||
23595110|NCT04452318|65909332|FG000|Overall Study|Withdrawal by Subject|46|||
23595111|NCT04452318|65909333|FG001|Overall Study|Withdrawal by Subject|40|||
23254606|NCT02629965|64673605|FG001|Period 2|Adverse Event|0|||
23595112|NCT04452318|65909334|FG002|Overall Study|Withdrawal by Subject|0|||
23595113|NCT04452318|65909335|FG003|Overall Study|Withdrawal by Subject|18|||
23254607|NCT00382291|64673606|FG000|Overall Study|Adverse Event|1|||
23360215|NCT01490840|65062858|FG001|Phase 2|Permanent interruption of fingolimod|1|||
23595114|NCT04452318|65909336|FG004|Overall Study|Withdrawal by Subject|6|||
23595115|NCT04452318|65909337|FG005|Overall Study|Withdrawal by Subject|8|||
23595116|NCT04452318|65909338|FG006|Overall Study|Withdrawal by Subject|6|||
23595117|NCT02928224|65909341|FG000|Overall Study|Lost to Follow-up|1|||
23595118|NCT02928224|65909342|FG001|Overall Study|Lost to Follow-up|1|||
23595119|NCT02928224|65909343|FG002|Overall Study|Lost to Follow-up|3|||
23595120|NCT02928224|65909344|FG003|Overall Study|Lost to Follow-up|0|||
23595121|NCT02928224|65909341|FG000|Overall Study|Death|30|||
23595122|NCT02928224|65909342|FG001|Overall Study|Death|209|||
23595123|NCT02928224|65909343|FG002|Overall Study|Death|193|||
23595124|NCT02928224|65909344|FG003|Overall Study|Death|198|||
23595125|NCT02928224|65909341|FG000|Overall Study|Withdrawal by Subject|0|||
23595126|NCT02928224|65909342|FG001|Overall Study|Withdrawal by Subject|3|||
23595127|NCT02928224|65909343|FG002|Overall Study|Withdrawal by Subject|7|||
23595128|NCT02928224|65909344|FG003|Overall Study|Withdrawal by Subject|20|||
23595129|NCT02928224|65909341|FG000|Overall Study|Study participation terminated by sponsor|3|||
23595130|NCT02928224|65909342|FG001|Overall Study|Study participation terminated by sponsor|8|||
23595131|NCT02928224|65909343|FG002|Overall Study|Study participation terminated by sponsor|12|||
23595132|NCT02928224|65909344|FG003|Overall Study|Study participation terminated by sponsor|3|||
23595133|NCT02928224|65909341|FG000|Overall Study|Other|3|||
23595134|NCT02928224|65909342|FG001|Overall Study|Other|3|||
23595135|NCT02928224|65909343|FG002|Overall Study|Other|5|||
23595136|NCT02928224|65909344|FG003|Overall Study|Other|0|||
23595137|NCT01747486|65909347|FG000|Stage 1|Physician Decision|3|||
23595138|NCT01747486|65909348|FG001|Stage 1|Physician Decision|0|||
23595139|NCT01747486|65909347|FG000|Stage 1|Withdrawal by Subject|4|||
23595140|NCT01747486|65909348|FG001|Stage 1|Withdrawal by Subject|3|||
23595141|NCT01747486|65909347|FG000|Stage 1|Disease progression|4|||
23595142|NCT01747486|65909348|FG001|Stage 1|Disease progression|9|||
23595143|NCT01747486|65909347|FG000|Stage 1|Death|1|||
23595144|NCT01747486|65909348|FG001|Stage 1|Death|1|||
23595145|NCT01747486|65909347|FG000|Stage 2|Physician Decision|2|||
23595146|NCT01747486|65909348|FG001|Stage 2|Physician Decision|0|||
23595147|NCT01747486|65909347|FG000|Stage 2|Withdrawal by Subject|1|||
23595148|NCT01747486|65909348|FG001|Stage 2|Withdrawal by Subject|0|||
23595149|NCT01747486|65909347|FG000|Stage 2|New Cancer Therapy|3|||
23595150|NCT01747486|65909348|FG001|Stage 2|New Cancer Therapy|0|||
23595151|NCT01747486|65909347|FG000|Stage 2|Disease Progression|3|||
23254608|NCT00382291|64673607|FG001|Overall Study|Adverse Event|2|||
23595152|NCT01747486|65909348|FG001|Stage 2|Disease Progression|0|||
23254609|NCT00382291|64673608|FG002|Overall Study|Adverse Event|2|||
23254610|NCT00382291|64673606|FG000|Overall Study|Protocol Violation|1|||
23595153|NCT01318382|65909349|FG000|Overall Study|Physician Decision|2|||
23595154|NCT01318382|65909349|FG000|Overall Study|Device Malfunction|10|||
23595155|NCT01318382|65909349|FG000|Overall Study|Protocol Violation|1|||
23595156|NCT01837966|65909350|FG000|Overall Study|Withdrawal by Subject|2|||
23595157|NCT01837966|65909351|FG001|Overall Study|Withdrawal by Subject|1|||
23595158|NCT02272816|65909352|FG000|Overall Study|Adverse Event|1|||
23595159|NCT00493649|65909353|FG000|Overall Study|Adverse Event|44|||
23254611|NCT00382291|64673607|FG001|Overall Study|Protocol Violation|0|||
23254612|NCT00382291|64673608|FG002|Overall Study|Protocol Violation|0|||
23254613|NCT00382291|64673606|FG000|Overall Study|Temporary study suspension|2|||
23254614|NCT00382291|64673607|FG001|Overall Study|Temporary study suspension|2|||
23254615|NCT00382291|64673608|FG002|Overall Study|Temporary study suspension|5|||
23477747|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
23477748|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
23477749|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477750|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477751|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477752|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
23477753|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477754|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477755|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477756|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477757|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
23477758|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477759|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477760|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
23477761|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477762|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
23477763|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477764|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477765|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477766|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477767|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
23477768|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477769|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477770|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477771|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477772|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
23477773|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23595160|NCT00493649|65909353|FG000|Overall Study|Patient Request|21|||
23595161|NCT00493649|65909353|FG000|Overall Study|Investigator Request|2|||
23595162|NCT00493649|65909353|FG000|Overall Study|Disease Progression|1|||
23595163|NCT00493649|65909353|FG000|Overall Study|Lost to Follow-up|1|||
23595164|NCT00493649|65909353|FG000|Overall Study|Other|13|||
23595165|NCT00761189|65909358|FG000|Overall Study|Adverse Event|42|||
23595166|NCT00761189|65909358|FG000|Overall Study|Lack of Efficacy|45|||
23595167|NCT00761189|65909358|FG000|Overall Study|Lost to Follow-up|36|||
23595168|NCT00761189|65909358|FG000|Overall Study|Withdrawal by Subject|49|||
23595169|NCT00761189|65909358|FG000|Overall Study|Other|13|||
23595170|NCT03036813|65909361|FG000|Overall Study|Adverse Event|6|||
23595171|NCT03036813|65909362|FG001|Overall Study|Adverse Event|11|||
23595172|NCT03036813|65909363|FG002|Overall Study|Adverse Event|6|||
23595173|NCT03036813|65909361|FG000|Overall Study|Withdrawal by Subject|12|||
23595174|NCT03036813|65909362|FG001|Overall Study|Withdrawal by Subject|6|||
23595175|NCT03036813|65909363|FG002|Overall Study|Withdrawal by Subject|10|||
23595176|NCT03036813|65909361|FG000|Overall Study|Lost to Follow-up|1|||
23595177|NCT03036813|65909362|FG001|Overall Study|Lost to Follow-up|1|||
23595178|NCT03036813|65909363|FG002|Overall Study|Lost to Follow-up|0|||
23595179|NCT03036813|65909361|FG000|Overall Study|Physician Decision|2|||
23595180|NCT03036813|65909362|FG001|Overall Study|Physician Decision|1|||
23595181|NCT03036813|65909363|FG002|Overall Study|Physician Decision|1|||
23595182|NCT03036813|65909361|FG000|Overall Study|Non-Compliance|1|||
23595183|NCT03036813|65909362|FG001|Overall Study|Non-Compliance|5|||
23595184|NCT03036813|65909363|FG002|Overall Study|Non-Compliance|3|||
23595185|NCT03036813|65909361|FG000|Overall Study|Pregnancy|0|||
23595186|NCT03036813|65909362|FG001|Overall Study|Pregnancy|0|||
23595187|NCT03036813|65909363|FG002|Overall Study|Pregnancy|1|||
23595188|NCT03036813|65909361|FG000|Overall Study|Other|0|||
23595189|NCT03036813|65909362|FG001|Overall Study|Other|3|||
23595190|NCT03036813|65909363|FG002|Overall Study|Other|5|||
23595191|NCT03086369|65909366|FG000|Overall Study|Lost to Follow-up|1|||
23254616|NCT00382291|64673606|FG000|Overall Study|Withdrawal by Subject|0|||
23477774|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477775|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477776|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23595192|NCT03086369|65909367|FG001|Overall Study|Lost to Follow-up|0|||
23595193|NCT03086369|65909368|FG002|Overall Study|Lost to Follow-up|0|||
23595194|NCT03086369|65909369|FG003|Overall Study|Lost to Follow-up|2|||
23595195|NCT03086369|65909370|FG004|Overall Study|Lost to Follow-up|1|||
23595196|NCT03086369|65909366|FG000|Overall Study|Physician Decision|0|||
23254617|NCT00382291|64673607|FG001|Overall Study|Withdrawal by Subject|2|||
23595197|NCT03086369|65909367|FG001|Overall Study|Physician Decision|0|||
23595198|NCT03086369|65909368|FG002|Overall Study|Physician Decision|0|||
23595199|NCT03086369|65909369|FG003|Overall Study|Physician Decision|1|||
23595200|NCT03086369|65909370|FG004|Overall Study|Physician Decision|2|||
23595201|NCT03086369|65909366|FG000|Overall Study|Withdrawal by Subject|0|||
23595202|NCT03086369|65909367|FG001|Overall Study|Withdrawal by Subject|0|||
23595203|NCT03086369|65909368|FG002|Overall Study|Withdrawal by Subject|0|||
23595204|NCT03086369|65909369|FG003|Overall Study|Withdrawal by Subject|5|||
23595205|NCT03086369|65909370|FG004|Overall Study|Withdrawal by Subject|3|||
23595206|NCT03086369|65909366|FG000|Overall Study|Progressive Disease|0|||
23595207|NCT03086369|65909367|FG001|Overall Study|Progressive Disease|0|||
23254618|NCT00382291|64673608|FG002|Overall Study|Withdrawal by Subject|0|||
23254619|NCT00382291|64673606|FG000|Overall Study|Physician Decision|0|||
23254620|NCT00382291|64673607|FG001|Overall Study|Physician Decision|1|||
23595208|NCT03086369|65909368|FG002|Overall Study|Progressive Disease|0|||
23595209|NCT03086369|65909369|FG003|Overall Study|Progressive Disease|1|||
23595210|NCT03086369|65909370|FG004|Overall Study|Progressive Disease|1|||
23595211|NCT00357097|65909371|FG000|Overall Study|Did not meet inclusion criteria|5|||
23595212|NCT00357097|65909372|FG001|Overall Study|Did not meet inclusion criteria|3|||
23595213|NCT00357097|65909371|FG000|Overall Study|Adverse Event|34|||
23595214|NCT00357097|65909372|FG001|Overall Study|Adverse Event|6|||
23595215|NCT00357097|65909371|FG000|Overall Study|Withdrawal by Subject|8|||
23595216|NCT00357097|65909372|FG001|Overall Study|Withdrawal by Subject|7|||
23595217|NCT00357097|65909371|FG000|Overall Study|Non-compliance|1|||
23595218|NCT00357097|65909372|FG001|Overall Study|Non-compliance|2|||
23595219|NCT00357097|65909371|FG000|Overall Study|Lack of Efficacy|2|||
23595220|NCT00357097|65909372|FG001|Overall Study|Lack of Efficacy|8|||
23595221|NCT00357097|65909371|FG000|Overall Study|Met Exclusion Criteria|3|||
23595222|NCT00357097|65909372|FG001|Overall Study|Met Exclusion Criteria|1|||
23595223|NCT00357097|65909371|FG000|Overall Study|Other|1|||
23595224|NCT00357097|65909372|FG001|Overall Study|Other|1|||
23595225|NCT00357097|65909371|FG000|Overall Study|Increase of RLS Symptoms|0|||
23595226|NCT00357097|65909372|FG001|Overall Study|Increase of RLS Symptoms|1|||
23595227|NCT00539734|65909373|FG000|Overall Study|Protocol Violation|1|||
23595228|NCT02748317|65909374|FG000|Overall Study|Withdrawal by Subject|14|||
23595229|NCT02748317|65909374|FG000|Overall Study|Lost to Follow-up|8|||
23254621|NCT00382291|64673608|FG002|Overall Study|Physician Decision|0|||
23254622|NCT00382291|64673606|FG000|Overall Study|Lack of Efficacy|0|||
23595230|NCT02748317|65909374|FG000|Overall Study|Death|1|||
23595231|NCT03169244|65909375|FG000|Overall Study|Lost to Follow-up|1|||
23595232|NCT03169244|65909376|FG001|Overall Study|Lost to Follow-up|2|||
23595233|NCT03169244|65909375|FG000|Overall Study|Adverse Event|1|||
23595234|NCT03169244|65909376|FG001|Overall Study|Adverse Event|0|||
23595235|NCT03169244|65909375|FG000|Overall Study|Withdrawal by Subject|2|||
23595236|NCT03169244|65909376|FG001|Overall Study|Withdrawal by Subject|2|||
23595237|NCT03169244|65909375|FG000|Overall Study|Physician Decision|1|||
23595238|NCT03169244|65909376|FG001|Overall Study|Physician Decision|0|||
23595239|NCT02200770|65909377|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
23595240|NCT02200770|65909378|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
23595241|NCT02200770|65909377|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
23595242|NCT02200770|65909378|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
23595243|NCT02200770|65909377|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
23254623|NCT00382291|64673607|FG001|Overall Study|Lack of Efficacy|0|||
23254624|NCT00382291|64673608|FG002|Overall Study|Lack of Efficacy|1|||
23254625|NCT00950599|64673609|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23254626|NCT00950599|64673610|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23254627|NCT00950599|64673611|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23254628|NCT00950599|64673612|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
23254629|NCT00950599|64673613|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23254630|NCT00950599|64673614|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23254631|NCT00950599|64673615|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23193995|NCT02760407|64452430|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
23193996|NCT02760407|64452431|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
23193997|NCT02760407|64452428|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
23193998|NCT02760407|64452429|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
23193999|NCT02760407|64452430|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
23194000|NCT02760407|64452431|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
23194001|NCT02760407|64452428|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
23194002|NCT02760407|64452429|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
23194003|NCT02760407|64452430|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
23194004|NCT02760407|64452431|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
23254632|NCT00950599|64673616|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23254633|NCT00950599|64673617|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23254634|NCT00950599|64673618|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
23254635|NCT00950599|64673609|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23254636|NCT00950599|64673610|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23254637|NCT00950599|64673611|FG002|Double-Blind Treatment Period|Adverse Event|1|||
23254638|NCT00950599|64673612|FG003|Double-Blind Treatment Period|Adverse Event|1|||
23254639|NCT00950599|64673613|FG004|Double-Blind Treatment Period|Adverse Event|1|||
23254640|NCT00950599|64673614|FG005|Double-Blind Treatment Period|Adverse Event|1|||
23254641|NCT00950599|64673615|FG006|Double-Blind Treatment Period|Adverse Event|0|||
23254642|NCT00950599|64673616|FG007|Double-Blind Treatment Period|Adverse Event|0|||
23254643|NCT00950599|64673617|FG008|Double-Blind Treatment Period|Adverse Event|0|||
23254644|NCT00950599|64673618|FG009|Double-Blind Treatment Period|Adverse Event|0|||
23254645|NCT00950599|64673609|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
23254646|NCT00950599|64673610|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
23254647|NCT00950599|64673611|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
23254648|NCT00950599|64673612|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
23254649|NCT00950599|64673613|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
23254650|NCT00950599|64673614|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
23254651|NCT00950599|64673615|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
23254652|NCT00950599|64673616|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
23254653|NCT00950599|64673617|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
23254654|NCT00950599|64673618|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
23254655|NCT00950599|64673609|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23254656|NCT00950599|64673610|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
23254657|NCT00950599|64673611|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
23254658|NCT00950599|64673612|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
23254659|NCT00950599|64673613|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
23254660|NCT00950599|64673614|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
23254661|NCT00950599|64673615|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
23254662|NCT00950599|64673616|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
23254663|NCT00950599|64673617|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
23254664|NCT00950599|64673618|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
23254665|NCT00950599|64673609|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
23254666|NCT00950599|64673610|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
23254667|NCT00950599|64673611|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23360216|NCT01490840|65062857|FG000|Phase 2|Lost to Follow-up|1|||
23595244|NCT02200770|65909378|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
23254668|NCT00950599|64673612|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23254669|NCT00950599|64673613|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23254670|NCT00950599|64673614|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23254671|NCT00950599|64673615|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23254672|NCT00950599|64673616|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
23360217|NCT01490840|65062858|FG001|Phase 2|Lost to Follow-up|1|||
23360218|NCT01490840|65062857|FG000|Phase 2|Adverse Event|1|||
23360219|NCT01490840|65062858|FG001|Phase 2|Adverse Event|1|||
23360220|NCT02035553|65062862|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
23360221|NCT02035553|65062863|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
23360222|NCT02035553|65062862|FG000|Overall Study|Adverse Event|10|||
23360223|NCT02035553|65062863|FG001|Overall Study|Adverse Event|6|||
23360224|NCT02035553|65062862|FG000|Overall Study|Physician Decision|3|||
23360225|NCT02035553|65062863|FG001|Overall Study|Physician Decision|2|||
23360226|NCT02035553|65062862|FG000|Overall Study|Lack of Efficacy|1|||
23360227|NCT02035553|65062863|FG001|Overall Study|Lack of Efficacy|1|||
23360228|NCT02035553|65062862|FG000|Overall Study|Withdrawal by Subject|4|||
23194005|NCT02760407|64452428|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
23194006|NCT02760407|64452429|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
23194007|NCT02760407|64452430|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
23194008|NCT02760407|64452431|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
23194009|NCT02760407|64452428|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
23194010|NCT02760407|64452429|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
23194011|NCT02760407|64452430|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
23194012|NCT02760407|64452431|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
23194013|NCT02760407|64452428|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
23194014|NCT02760407|64452429|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
23194015|NCT02760407|64452430|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
23194016|NCT02760407|64452431|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
23194017|NCT02760407|64452428|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
23194018|NCT02760407|64452429|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
23194019|NCT02760407|64452430|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
23194020|NCT02760407|64452431|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
23194021|NCT00779038|64452432|FG000|Overall Study|Study Prematurely Terminated|13|||
23194022|NCT03237845|64452441|FG000|Overall Study|Adverse Event|0|||
23194023|NCT03237845|64452442|FG001|Overall Study|Adverse Event|1|||
23194024|NCT03237845|64452441|FG000|Overall Study|Lost to Follow-up|13|||
23194025|NCT03237845|64452442|FG001|Overall Study|Lost to Follow-up|10|||
23194026|NCT03237845|64452441|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
23194027|NCT03237845|64452442|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
23194028|NCT03237845|64452441|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
23194029|NCT03237845|64452442|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
23194030|NCT03237845|64452441|FG000|Overall Study|Physician Decision|1|||
23194031|NCT03237845|64452442|FG001|Overall Study|Physician Decision|2|||
23194032|NCT03237845|64452441|FG000|Overall Study|Pregnancy|1|||
23194033|NCT03237845|64452442|FG001|Overall Study|Pregnancy|0|||
23194034|NCT03237845|64452441|FG000|Overall Study|Protocol Deviation|0|||
23194035|NCT03237845|64452442|FG001|Overall Study|Protocol Deviation|1|||
23194036|NCT03237845|64452441|FG000|Overall Study|Technical Problems|8|||
23194037|NCT03237845|64452442|FG001|Overall Study|Technical Problems|1|||
23194038|NCT03237845|64452441|FG000|Overall Study|Withdrawal by Subject|3|||
23194039|NCT03237845|64452442|FG001|Overall Study|Withdrawal by Subject|3|||
23194040|NCT03237845|64452441|FG000|Overall Study|Other Reasons|4|||
23194041|NCT03237845|64452442|FG001|Overall Study|Other Reasons|0|||
23194042|NCT02241512|64452449|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
23194043|NCT02241512|64452450|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
23194044|NCT01408537|64452451|FG000|Overall Study|Withdrawal by Subject|2|||
23194045|NCT01408537|64452451|FG000|Overall Study|Protocol Violation|3|||
23194046|NCT01408537|64452451|FG000|Overall Study|Lost to Follow-up|3|||
23194047|NCT01988012|64452453|FG000|Overall Study|Adverse Event|5|||
23194048|NCT01988012|64452453|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23194049|NCT01988012|64452453|FG000|Overall Study|Patient Withdrawal of Consent|4|||
23194050|NCT01988012|64452453|FG000|Overall Study|Lost to Follow-up|1|||
23194051|NCT01988012|64452453|FG000|Overall Study|Physician Decision|1|||
23194052|NCT01988012|64452453|FG000|Overall Study|Protocol Violation|1|||
23194053|NCT01056523|64452454|FG000|Overall Study|Death|1|||
23194054|NCT01056523|64452455|FG001|Overall Study|Death|0|||
23194055|NCT01056523|64452456|FG002|Overall Study|Death|2|||
23360229|NCT02035553|65062863|FG001|Overall Study|Withdrawal by Subject|7|||
23194056|NCT01056523|64452457|FG003|Overall Study|Death|3|||
23194057|NCT01056523|64452458|FG004|Overall Study|Death|0|||
23194058|NCT01056523|64452459|FG005|Overall Study|Death|0|||
23194059|NCT01056523|64452460|FG006|Overall Study|Death|1|||
23360230|NCT02035553|65062862|FG000|Overall Study|Non-compliance with Study Drug|0|||
23360231|NCT02035553|65062863|FG001|Overall Study|Non-compliance with Study Drug|1|||
23360232|NCT02035553|65062862|FG000|Overall Study|Lost to Follow-up|0|||
23360233|NCT02035553|65062863|FG001|Overall Study|Lost to Follow-up|1|||
23360234|NCT02035553|65062862|FG000|Overall Study|Other Reason|0|||
23360235|NCT02035553|65062863|FG001|Overall Study|Other Reason|4|||
23360236|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
23360237|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
23595245|NCT02200770|65909377|FG000|Randomized-controlled Period (RCP)|Other|1|||
23595246|NCT02200770|65909378|FG001|Randomized-controlled Period (RCP)|Other|2|||
23595247|NCT02200770|65909377|FG000|Open-label Period (OLP)|Adverse Event|1|||
23595248|NCT02200770|65909378|FG001|Open-label Period (OLP)|Adverse Event|2|||
23595249|NCT02200770|65909377|FG000|Open-label Period (OLP)|Death|1|||
23360238|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
23360239|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
23360240|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
23360241|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
23360242|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
23360243|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
23360244|NCT00667992|65062864|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
23360245|NCT00667992|65062865|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
23595250|NCT02200770|65909378|FG001|Open-label Period (OLP)|Death|2|||
23595251|NCT02200770|65909377|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
23595252|NCT02200770|65909378|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
23595253|NCT02200770|65909377|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
23194060|NCT04498910|64452461|FG000|Overall Study|Lost to Follow-up|0|||
23595254|NCT02200770|65909378|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
23595255|NCT02200770|65909377|FG000|Open-label Period (OLP)|Other|6|||
23595256|NCT02200770|65909378|FG001|Open-label Period (OLP)|Other|15|||
23595257|NCT03988842|65909379|FG000|Overall Study|Death|1|||
23595258|NCT00508924|65909380|FG000|Overall Study|Protocol Violation|0|||
23194061|NCT04498910|64452462|FG001|Overall Study|Lost to Follow-up|1|||
23360246|NCT00667992|65062864|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
23595259|NCT00508924|65909381|FG001|Overall Study|Protocol Violation|0|||
23595260|NCT00508924|65909382|FG002|Overall Study|Protocol Violation|1|||
23595261|NCT00508924|65909383|FG003|Overall Study|Protocol Violation|1|||
23595262|NCT00088413|65909384|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
23595263|NCT00088413|65909385|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
23595264|NCT00088413|65909386|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
23595265|NCT00088413|65909387|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
23595266|NCT00088413|65909384|FG000|Overall Study|Adverse Events/Side Effects|0|||
23595267|NCT00088413|65909385|FG001|Overall Study|Adverse Events/Side Effects|1|||
23194062|NCT04498910|64452461|FG000|Overall Study|Withdrawal by Subject|2|||
23194063|NCT04498910|64452462|FG001|Overall Study|Withdrawal by Subject|1|||
23194064|NCT04498910|64452461|FG000|Overall Study|Adverse Event|1|||
23194065|NCT04498910|64452462|FG001|Overall Study|Adverse Event|0|||
23194066|NCT01319929|64452465|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
23194067|NCT01319929|64452466|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
23194068|NCT01319929|64452465|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
23194069|NCT01319929|64452466|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
23194070|NCT01319929|64452465|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
23194071|NCT01319929|64452466|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
23194072|NCT01319929|64452465|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
23194073|NCT01319929|64452466|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
23477777|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
23477778|NCT01185353|65491685|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
23477779|NCT01185353|65491686|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477780|NCT01185353|65491687|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477781|NCT01185353|65491688|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477782|NCT01185353|65491689|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
23477783|NCT01185353|65491690|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477784|NCT01185353|65491691|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477785|NCT01185353|65491692|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477786|NCT01185353|65491693|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477787|NCT01185353|65491694|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
23477788|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477789|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477790|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
23477791|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477792|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477793|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
23477794|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477795|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477796|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477797|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
23477798|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477799|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
23477800|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477801|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
23477802|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477803|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477804|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477805|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23595268|NCT00088413|65909386|FG002|Overall Study|Adverse Events/Side Effects|1|||
23595269|NCT00088413|65909387|FG003|Overall Study|Adverse Events/Side Effects|0|||
23595270|NCT00088413|65909384|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
23595271|NCT00088413|65909385|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
23595272|NCT00088413|65909386|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
23194074|NCT01319929|64452465|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
23194075|NCT01319929|64452466|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
23194076|NCT01052012|64452468|FG000|Overall Study|Not treated|2|||
23477806|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477807|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
23477808|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23595273|NCT00088413|65909387|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
23595274|NCT00088413|65909384|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
23254673|NCT00950599|64673617|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23254674|NCT00950599|64673618|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
23254675|NCT00950599|64673609|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23254676|NCT00950599|64673610|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23254677|NCT00950599|64673611|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23254678|NCT00950599|64673612|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23254679|NCT00950599|64673613|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
23254680|NCT00950599|64673614|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
23194077|NCT01052012|64452469|FG001|Overall Study|Not treated|5|||
23194078|NCT01052012|64452470|FG002|Overall Study|Not treated|0|||
23194079|NCT01052012|64452471|FG003|Overall Study|Not treated|0|||
23194080|NCT01052012|64452472|FG004|Overall Study|Not treated|11|||
23194081|NCT01052012|64452473|FG005|Overall Study|Not treated|8|||
23194082|NCT01052012|64452468|FG000|Overall Study|Adverse Event|1|||
23194083|NCT01052012|64452469|FG001|Overall Study|Adverse Event|0|||
23194084|NCT01052012|64452470|FG002|Overall Study|Adverse Event|0|||
23254681|NCT00950599|64673615|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23254682|NCT00950599|64673616|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23254683|NCT00950599|64673617|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23254684|NCT00950599|64673618|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
23254685|NCT00950599|64673609|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
23254686|NCT00950599|64673610|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
23254687|NCT00950599|64673611|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
23254688|NCT00950599|64673612|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
23254689|NCT00950599|64673613|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
23254690|NCT00950599|64673614|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
23254691|NCT00950599|64673615|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
23254692|NCT00950599|64673616|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
23254693|NCT00950599|64673617|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
23254694|NCT00950599|64673618|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
23254695|NCT00950599|64673609|FG000|Follow-Up Period|Adverse Event|0|||
23254696|NCT00950599|64673610|FG001|Follow-Up Period|Adverse Event|0|||
23254697|NCT00950599|64673611|FG002|Follow-Up Period|Adverse Event|0|||
23254698|NCT00950599|64673612|FG003|Follow-Up Period|Adverse Event|0|||
23254699|NCT00950599|64673613|FG004|Follow-Up Period|Adverse Event|0|||
23477809|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23194085|NCT01052012|64452471|FG003|Overall Study|Adverse Event|1|||
23254700|NCT00950599|64673614|FG005|Follow-Up Period|Adverse Event|0|||
23254701|NCT00950599|64673615|FG006|Follow-Up Period|Adverse Event|0|||
23254702|NCT00950599|64673616|FG007|Follow-Up Period|Adverse Event|0|||
23254703|NCT00950599|64673617|FG008|Follow-Up Period|Adverse Event|1|||
23254704|NCT00950599|64673618|FG009|Follow-Up Period|Adverse Event|0|||
23254705|NCT00950599|64673609|FG000|Follow-Up Period|Lack of Efficacy|0|||
23254706|NCT00950599|64673610|FG001|Follow-Up Period|Lack of Efficacy|0|||
23254707|NCT00950599|64673611|FG002|Follow-Up Period|Lack of Efficacy|0|||
23254708|NCT00950599|64673612|FG003|Follow-Up Period|Lack of Efficacy|0|||
23254709|NCT00950599|64673613|FG004|Follow-Up Period|Lack of Efficacy|0|||
23254710|NCT00950599|64673614|FG005|Follow-Up Period|Lack of Efficacy|0|||
23254711|NCT00950599|64673615|FG006|Follow-Up Period|Lack of Efficacy|0|||
23254712|NCT00950599|64673616|FG007|Follow-Up Period|Lack of Efficacy|0|||
23254713|NCT00950599|64673617|FG008|Follow-Up Period|Lack of Efficacy|3|||
23254714|NCT00950599|64673618|FG009|Follow-Up Period|Lack of Efficacy|0|||
23254715|NCT00950599|64673609|FG000|Follow-Up Period|Lost to Follow-up|0|||
23254716|NCT00950599|64673610|FG001|Follow-Up Period|Lost to Follow-up|0|||
23254717|NCT00950599|64673611|FG002|Follow-Up Period|Lost to Follow-up|0|||
23194086|NCT01052012|64452472|FG004|Overall Study|Adverse Event|0|||
23194087|NCT01052012|64452473|FG005|Overall Study|Adverse Event|0|||
23595275|NCT00088413|65909385|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
23595276|NCT00088413|65909386|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
23595277|NCT00088413|65909387|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
23595278|NCT00088413|65909384|FG000|Overall Study|Death|0|||
23595279|NCT00088413|65909385|FG001|Overall Study|Death|1|||
23595280|NCT00088413|65909386|FG002|Overall Study|Death|0|||
23595281|NCT00088413|65909387|FG003|Overall Study|Death|0|||
23595282|NCT00088413|65909384|FG000|Overall Study|Progressive disease|9|||
23595283|NCT00088413|65909385|FG001|Overall Study|Progressive disease|11|||
23595284|NCT00088413|65909386|FG002|Overall Study|Progressive disease|8|||
23194088|NCT01052012|64452468|FG000|Overall Study|Lost to Follow-up|0|||
23194089|NCT01052012|64452469|FG001|Overall Study|Lost to Follow-up|0|||
23194090|NCT01052012|64452470|FG002|Overall Study|Lost to Follow-up|0|||
23360247|NCT00667992|65062865|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
23360248|NCT00667992|65062864|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
23360249|NCT00667992|65062865|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
23194091|NCT01052012|64452471|FG003|Overall Study|Lost to Follow-up|0|||
23194092|NCT01052012|64452472|FG004|Overall Study|Lost to Follow-up|1|||
23194093|NCT01052012|64452473|FG005|Overall Study|Lost to Follow-up|0|||
23194094|NCT01052012|64452468|FG000|Overall Study|Withdrawal by Subject|1|||
23194095|NCT01052012|64452469|FG001|Overall Study|Withdrawal by Subject|1|||
23194096|NCT01052012|64452470|FG002|Overall Study|Withdrawal by Subject|0|||
23194097|NCT01052012|64452471|FG003|Overall Study|Withdrawal by Subject|0|||
23194098|NCT01052012|64452472|FG004|Overall Study|Withdrawal by Subject|3|||
23194099|NCT01052012|64452473|FG005|Overall Study|Withdrawal by Subject|1|||
23194100|NCT01052012|64452468|FG000|Overall Study|Physician Decision|0|||
23194101|NCT01052012|64452469|FG001|Overall Study|Physician Decision|0|||
23194102|NCT01052012|64452470|FG002|Overall Study|Physician Decision|0|||
23194103|NCT01052012|64452471|FG003|Overall Study|Physician Decision|0|||
23360250|NCT00667992|65062864|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
23360251|NCT00667992|65062865|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
23360252|NCT00667992|65062864|FG000|Wash-out|Not within one doubling dilution|4|||
23194104|NCT01052012|64452472|FG004|Overall Study|Physician Decision|0|||
23254718|NCT00950599|64673612|FG003|Follow-Up Period|Lost to Follow-up|0|||
23254719|NCT00950599|64673613|FG004|Follow-Up Period|Lost to Follow-up|0|||
23254720|NCT00950599|64673614|FG005|Follow-Up Period|Lost to Follow-up|0|||
23254721|NCT00950599|64673615|FG006|Follow-Up Period|Lost to Follow-up|0|||
23360253|NCT00667992|65062865|FG001|Wash-out|Not within one doubling dilution|3|||
23360254|NCT00667992|65062864|FG000|Wash-out|Failure to wash-out|2|||
23360255|NCT00667992|65062865|FG001|Wash-out|Failure to wash-out|2|||
23477810|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23595285|NCT00088413|65909387|FG003|Overall Study|Progressive disease|14|||
23595286|NCT00088413|65909384|FG000|Overall Study|Other|0|||
23595287|NCT00088413|65909385|FG001|Overall Study|Other|1|||
23194105|NCT01052012|64452473|FG005|Overall Study|Physician Decision|1|||
23194106|NCT01052012|64452468|FG000|Overall Study|Other|0|||
23194107|NCT01052012|64452469|FG001|Overall Study|Other|0|||
23254722|NCT00950599|64673616|FG007|Follow-Up Period|Lost to Follow-up|0|||
23254723|NCT00950599|64673617|FG008|Follow-Up Period|Lost to Follow-up|5|||
23595288|NCT00088413|65909386|FG002|Overall Study|Other|0|||
23194108|NCT01052012|64452470|FG002|Overall Study|Other|0|||
23194109|NCT01052012|64452471|FG003|Overall Study|Other|0|||
23194110|NCT01052012|64452472|FG004|Overall Study|Other|1|||
23360256|NCT00667992|65062864|FG000|Wash-out|Withdrawal by Subject|1|||
23595289|NCT00088413|65909387|FG003|Overall Study|Other|0|||
23595290|NCT00088413|65909384|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
23595291|NCT00088413|65909385|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
23595292|NCT00088413|65909386|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
23595293|NCT00088413|65909387|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
23595294|NCT00738699|65909389|FG000|Overall Study|Withdrawal by Subject|5|||
23595295|NCT00738699|65909390|FG001|Overall Study|Withdrawal by Subject|0|||
23595296|NCT00738699|65909389|FG000|Overall Study|Lost to Follow-up|1|||
23360257|NCT00667992|65062865|FG001|Wash-out|Withdrawal by Subject|0|||
23360258|NCT00667992|65062864|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
23360259|NCT00667992|65062865|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
23360260|NCT00667992|65062864|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
23360261|NCT00667992|65062865|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
23360262|NCT01949142|65062866|FG000|Overall Study|Withdrawal of consent|1|||
23360263|NCT01949142|65062867|FG001|Overall Study|Withdrawal of consent|0|||
23360264|NCT01949142|65062866|FG000|Overall Study|Lost to Follow-up|1|||
23360265|NCT01949142|65062867|FG001|Overall Study|Lost to Follow-up|1|||
23360266|NCT01949142|65062866|FG000|Overall Study|Parent changed their mind|1|||
23360267|NCT01949142|65062867|FG001|Overall Study|Parent changed their mind|0|||
23360268|NCT00004088|65062871|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
23360269|NCT00004088|65062871|FG000|Overall Study|Withdrawal by Subject|1|||
23360270|NCT00004088|65062871|FG000|Overall Study|Protocol Violation|3|||
23360271|NCT00004088|65062871|FG000|Overall Study|Physician Decision|1|||
23360272|NCT02697916|65062874|FG000|Overall Study|Death|357|||
23360273|NCT02697916|65062875|FG001|Overall Study|Death|315|||
23360274|NCT02697916|65062874|FG000|Overall Study|Withdrawal by Subject|221|||
23360275|NCT02697916|65062875|FG001|Overall Study|Withdrawal by Subject|393|||
23360276|NCT01307891|65062881|FG000|Overall Study|Progressive Disease|3|||
23360277|NCT01307891|65062882|FG001|Overall Study|Progressive Disease|1|||
23360278|NCT01383018|65062883|FG000|Overall Study|Adverse Event|14|||
23360279|NCT01383018|65062883|FG000|Overall Study|Death|10|||
23360280|NCT01383018|65062883|FG000|Overall Study|Lost to Follow-up|5|||
23360281|NCT01383018|65062883|FG000|Overall Study|Physician Decision|5|||
23360282|NCT01383018|65062883|FG000|Overall Study|Withdrawal by Subject|9|||
23360283|NCT01383018|65062883|FG000|Overall Study|Subject not implanted|76|||
23360284|NCT01383018|65062883|FG000|Overall Study|Missed Visit|247|||
23360285|NCT01383018|65062883|FG000|Overall Study|Site closed early-not compliance related|7|||
23360286|NCT01383018|65062883|FG000|Overall Study|Patient moved away from site|1|||
23360287|NCT01383018|65062883|FG000|Overall Study|Subject Incarcerated|1|||
23360288|NCT02091414|65062884|FG000|Overall Study|Withdrawal by Subject|2|||
23360289|NCT02091414|65062884|FG000|Overall Study|Death|2|||
23360290|NCT02465437|65062890|FG000|Overall Study|Physician Decision|0|||
23360291|NCT02465437|65062891|FG001|Overall Study|Physician Decision|0|||
23360292|NCT02465437|65062892|FG002|Overall Study|Physician Decision|1|||
23360293|NCT02465437|65062893|FG003|Overall Study|Physician Decision|0|||
23360294|NCT02465437|65062890|FG000|Overall Study|Withdrawal by Subject|1|||
23360295|NCT02465437|65062891|FG001|Overall Study|Withdrawal by Subject|0|||
23360296|NCT02465437|65062892|FG002|Overall Study|Withdrawal by Subject|0|||
23360297|NCT02465437|65062893|FG003|Overall Study|Withdrawal by Subject|1|||
23360298|NCT02465437|65062890|FG000|Overall Study|Adverse Event|0|||
23360299|NCT02465437|65062891|FG001|Overall Study|Adverse Event|1|||
23360300|NCT02465437|65062892|FG002|Overall Study|Adverse Event|0|||
23360301|NCT02465437|65062893|FG003|Overall Study|Adverse Event|0|||
23360302|NCT01381926|65062896|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
23360303|NCT01381926|65062897|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
23360304|NCT01381926|65062896|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
23360305|NCT01381926|65062897|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
23360306|NCT04978337|65062898|FG000|Overall Study|Withdrawal by Subject|0|||
23360307|NCT04978337|65062899|FG001|Overall Study|Withdrawal by Subject|1|||
23254724|NCT00950599|64673618|FG009|Follow-Up Period|Lost to Follow-up|1|||
23360308|NCT02609386|65062900|FG000|Overall Study|Withdrawal by Subject|6|||
23360309|NCT02609386|65062901|FG001|Overall Study|Withdrawal by Subject|1|||
23360310|NCT02609386|65062900|FG000|Overall Study|Lost to Follow-up|3|||
23360311|NCT02609386|65062901|FG001|Overall Study|Lost to Follow-up|5|||
23360312|NCT02609386|65062900|FG000|Overall Study|Death|19|||
23360313|NCT02609386|65062901|FG001|Overall Study|Death|9|||
23360314|NCT02609386|65062900|FG000|Overall Study|Physician Decision|0|||
23595297|NCT00738699|65909390|FG001|Overall Study|Lost to Follow-up|0|||
23595298|NCT00738699|65909389|FG000|Overall Study|Death|144|||
23595299|NCT00738699|65909390|FG001|Overall Study|Death|68|||
23254725|NCT00950599|64673609|FG000|Follow-Up Period|Physician Decision|0|||
23254726|NCT00950599|64673610|FG001|Follow-Up Period|Physician Decision|0|||
23254727|NCT00950599|64673611|FG002|Follow-Up Period|Physician Decision|0|||
23254728|NCT00950599|64673612|FG003|Follow-Up Period|Physician Decision|0|||
23595300|NCT00738699|65909389|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
23595301|NCT00738699|65909390|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
23595302|NCT00738699|65909389|FG000|Overall Study|Other|2|||
23595303|NCT00738699|65909390|FG001|Overall Study|Other|0|||
23595304|NCT04093752|65909392|FG000|Overall Study|Adverse Event|7|||
23595305|NCT04093752|65909393|FG001|Overall Study|Adverse Event|19|||
23595306|NCT04093752|65909394|FG002|Overall Study|Adverse Event|18|||
23595307|NCT04093752|65909395|FG003|Overall Study|Adverse Event|4|||
23595308|NCT04093752|65909392|FG000|Overall Study|Withdrawal by Subject|6|||
23595309|NCT04093752|65909393|FG001|Overall Study|Withdrawal by Subject|6|||
23595310|NCT04093752|65909394|FG002|Overall Study|Withdrawal by Subject|8|||
23595311|NCT04093752|65909395|FG003|Overall Study|Withdrawal by Subject|20|||
23595312|NCT04093752|65909392|FG000|Overall Study|Lost to Follow-up|2|||
23595313|NCT04093752|65909393|FG001|Overall Study|Lost to Follow-up|1|||
23595314|NCT04093752|65909394|FG002|Overall Study|Lost to Follow-up|1|||
23595315|NCT04093752|65909395|FG003|Overall Study|Lost to Follow-up|1|||
23595316|NCT04093752|65909392|FG000|Overall Study|Death|0|||
23595317|NCT04093752|65909393|FG001|Overall Study|Death|0|||
23595318|NCT04093752|65909394|FG002|Overall Study|Death|1|||
23595319|NCT04093752|65909395|FG003|Overall Study|Death|2|||
23595320|NCT04093752|65909392|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
23595321|NCT04093752|65909393|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
23595322|NCT04093752|65909394|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
23595323|NCT04093752|65909395|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
23595324|NCT04093752|65909392|FG000|Overall Study|Covid 19|0|||
23595325|NCT04093752|65909393|FG001|Overall Study|Covid 19|0|||
23595326|NCT04093752|65909394|FG002|Overall Study|Covid 19|0|||
23595327|NCT04093752|65909395|FG003|Overall Study|Covid 19|1|||
23595328|NCT04093752|65909392|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
23595329|NCT04093752|65909393|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
23595330|NCT04093752|65909394|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
23595331|NCT04093752|65909395|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
23595332|NCT04093752|65909392|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
23595333|NCT04093752|65909393|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
23595334|NCT04093752|65909394|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
23595335|NCT04093752|65909395|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
23595336|NCT04093752|65909392|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
23595337|NCT04093752|65909393|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
23595338|NCT04093752|65909394|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
23595339|NCT04093752|65909395|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
23595340|NCT00332241|65909398|FG000|Overall Study|Lack of Efficacy|6|||
23595341|NCT00332241|65909399|FG001|Overall Study|Lack of Efficacy|1|||
23595342|NCT00332241|65909398|FG000|Overall Study|Adverse Event|3|||
23595343|NCT00332241|65909399|FG001|Overall Study|Adverse Event|5|||
23595344|NCT00332241|65909398|FG000|Overall Study|Withdrawal by Subject|2|||
23595345|NCT00332241|65909399|FG001|Overall Study|Withdrawal by Subject|1|||
23595346|NCT00332241|65909398|FG000|Overall Study|Lost to Follow-up|4|||
23254729|NCT00950599|64673613|FG004|Follow-Up Period|Physician Decision|0|||
23254730|NCT00950599|64673614|FG005|Follow-Up Period|Physician Decision|0|||
23254731|NCT00950599|64673615|FG006|Follow-Up Period|Physician Decision|0|||
23254732|NCT00950599|64673616|FG007|Follow-Up Period|Physician Decision|0|||
23254733|NCT00950599|64673617|FG008|Follow-Up Period|Physician Decision|1|||
23595347|NCT00332241|65909399|FG001|Overall Study|Lost to Follow-up|1|||
23595348|NCT04048382|65909402|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
23595349|NCT04048382|65909403|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
23595350|NCT04048382|65909402|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
23595351|NCT04048382|65909403|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
23595352|NCT04048382|65909402|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
23254734|NCT00950599|64673618|FG009|Follow-Up Period|Physician Decision|0|||
23595353|NCT04048382|65909403|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
23595354|NCT01976312|65909404|FG000|Overall Study|Pregnancy|0|||
23595355|NCT01976312|65909405|FG001|Overall Study|Pregnancy|1|||
23595356|NCT01976312|65909404|FG000|Overall Study|Lost to Follow-up|2|||
23595357|NCT01976312|65909405|FG001|Overall Study|Lost to Follow-up|0|||
23595358|NCT01976312|65909404|FG000|Overall Study|Withdrawal by Subject|7|||
23595359|NCT01976312|65909405|FG001|Overall Study|Withdrawal by Subject|2|||
23595360|NCT01976312|65909404|FG000|Overall Study|Adverse Event|6|||
23595361|NCT01976312|65909405|FG001|Overall Study|Adverse Event|6|||
23595362|NCT01976312|65909404|FG000|Overall Study|Protocol Violation|2|||
23595363|NCT01976312|65909405|FG001|Overall Study|Protocol Violation|0|||
23595364|NCT00529100|65909406|FG000|Overall Study|Adverse Event|0|||
23595365|NCT00529100|65909407|FG001|Overall Study|Adverse Event|5|||
23595366|NCT00529100|65909406|FG000|Overall Study|Protocol Violation|0|||
23595367|NCT00529100|65909407|FG001|Overall Study|Protocol Violation|1|||
23595368|NCT00529100|65909406|FG000|Overall Study|Progressive Disease|0|||
23595369|NCT00529100|65909407|FG001|Overall Study|Progressive Disease|1|||
23595370|NCT00529100|65909406|FG000|Overall Study|Withdrawal by Subject|0|||
23595371|NCT00529100|65909407|FG001|Overall Study|Withdrawal by Subject|1|||
23595372|NCT00529100|65909406|FG000|Overall Study|Participant Ineligibility|0|||
23595373|NCT00529100|65909407|FG001|Overall Study|Participant Ineligibility|1|||
23254735|NCT00950599|64673609|FG000|Follow-Up Period|Poor/Noncompliance|0|||
23254736|NCT00950599|64673610|FG001|Follow-Up Period|Poor/Noncompliance|0|||
23254737|NCT00950599|64673611|FG002|Follow-Up Period|Poor/Noncompliance|0|||
23254738|NCT00950599|64673612|FG003|Follow-Up Period|Poor/Noncompliance|0|||
23254739|NCT00950599|64673613|FG004|Follow-Up Period|Poor/Noncompliance|0|||
23254740|NCT00950599|64673614|FG005|Follow-Up Period|Poor/Noncompliance|0|||
23254741|NCT00950599|64673615|FG006|Follow-Up Period|Poor/Noncompliance|0|||
23254742|NCT00950599|64673616|FG007|Follow-Up Period|Poor/Noncompliance|0|||
23254743|NCT00950599|64673617|FG008|Follow-Up Period|Poor/Noncompliance|1|||
23254744|NCT00950599|64673618|FG009|Follow-Up Period|Poor/Noncompliance|0|||
23254745|NCT00950599|64673609|FG000|Follow-Up Period|Subject withdrew Consent|0|||
23254746|NCT00950599|64673610|FG001|Follow-Up Period|Subject withdrew Consent|0|||
23595374|NCT01179334|65909408|FG000|Treatment Period|Adverse Event|1|||
23595375|NCT01179334|65909409|FG001|Treatment Period|Adverse Event|0|||
23254747|NCT00950599|64673611|FG002|Follow-Up Period|Subject withdrew Consent|0|||
23254748|NCT00950599|64673612|FG003|Follow-Up Period|Subject withdrew Consent|0|||
23254749|NCT00950599|64673613|FG004|Follow-Up Period|Subject withdrew Consent|0|||
23595376|NCT01179334|65909408|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
23595377|NCT01179334|65909409|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
23595378|NCT01179334|65909408|FG000|Long-term Extension (LTE) Period|Death|3|||
23595379|NCT01179334|65909409|FG001|Long-term Extension (LTE) Period|Death|0|||
23595380|NCT01179334|65909408|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
23595381|NCT01179334|65909409|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
23595382|NCT02242487|65909410|FG000|Overall Study|Adverse Event|13|||
23595383|NCT02242487|65909411|FG001|Overall Study|Adverse Event|15|||
23595384|NCT02242487|65909410|FG000|Overall Study|Lack of Efficacy|4|||
23595385|NCT02242487|65909411|FG001|Overall Study|Lack of Efficacy|6|||
23595386|NCT02242487|65909410|FG000|Overall Study|Protocol Violation|2|||
23595387|NCT02242487|65909411|FG001|Overall Study|Protocol Violation|0|||
23595388|NCT02242487|65909410|FG000|Overall Study|Lost to Follow-up|2|||
23254750|NCT00950599|64673614|FG005|Follow-Up Period|Subject withdrew Consent|0|||
23254751|NCT00950599|64673615|FG006|Follow-Up Period|Subject withdrew Consent|0|||
23254752|NCT00950599|64673616|FG007|Follow-Up Period|Subject withdrew Consent|0|||
23254753|NCT00950599|64673617|FG008|Follow-Up Period|Subject withdrew Consent|2|||
23595389|NCT02242487|65909411|FG001|Overall Study|Lost to Follow-up|1|||
23595390|NCT02242487|65909410|FG000|Overall Study|Other - Miscellaneous|4|||
23595391|NCT02242487|65909411|FG001|Overall Study|Other - Miscellaneous|6|||
23595392|NCT02242487|65909410|FG000|Overall Study|Withdrawal by Subject|37|||
23595393|NCT02242487|65909411|FG001|Overall Study|Withdrawal by Subject|19|||
23595394|NCT01307267|65909412|FG000|Overall Study|Death|4|||
23595395|NCT01307267|65909413|FG001|Overall Study|Death|3|||
23595396|NCT01307267|65909414|FG002|Overall Study|Death|5|||
23595397|NCT01307267|65909415|FG003|Overall Study|Death|3|||
23595398|NCT01307267|65909416|FG004|Overall Study|Death|1|||
23595399|NCT01307267|65909417|FG005|Overall Study|Death|26|||
23595400|NCT01307267|65909418|FG006|Overall Study|Death|2|||
23595401|NCT01307267|65909419|FG007|Overall Study|Death|2|||
23360315|NCT02609386|65062901|FG001|Overall Study|Physician Decision|2|||
23477811|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
23477812|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477813|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477814|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
23477815|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477816|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477817|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
23477818|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477819|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477820|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
23477821|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
23477822|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477823|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
23477824|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
23477825|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477826|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477827|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
23477828|NCT01185353|65491685|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477829|NCT01185353|65491686|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477830|NCT01185353|65491687|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477831|NCT01185353|65491688|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477832|NCT01185353|65491689|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477833|NCT01185353|65491690|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477834|NCT01185353|65491691|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
23477835|NCT01185353|65491692|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477836|NCT01185353|65491693|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477837|NCT01185353|65491694|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
23477838|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477839|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477840|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477841|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477842|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477843|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477844|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
23477845|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
23477846|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
23477847|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
23477848|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477849|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477850|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477851|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477852|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477853|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477854|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
23477855|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
23477856|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
23477857|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
23477858|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477859|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477860|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477861|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477862|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477863|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477864|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
23477865|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
23477866|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
23595402|NCT01307267|65909420|FG008|Overall Study|Death|21|||
23595403|NCT01307267|65909421|FG009|Overall Study|Death|2|||
23595404|NCT01307267|65909422|FG010|Overall Study|Death|3|||
23595405|NCT01307267|65909423|FG011|Overall Study|Death|9|||
23360316|NCT02748057|65062902|FG000|Overall Study|Adverse Event|1|||
23595406|NCT01307267|65909424|FG012|Overall Study|Death|0|||
23595407|NCT01307267|65909425|FG013|Overall Study|Death|0|||
23595408|NCT01307267|65909426|FG014|Overall Study|Death|0|||
23595409|NCT01307267|65909427|FG015|Overall Study|Death|0|||
23595410|NCT01307267|65909428|FG016|Overall Study|Death|1|||
23595411|NCT01307267|65909429|FG017|Overall Study|Death|1|||
23595412|NCT01307267|65909430|FG018|Overall Study|Death|2|||
23595413|NCT01307267|65909431|FG019|Overall Study|Death|8|||
23595414|NCT01307267|65909432|FG020|Overall Study|Death|1|||
23595415|NCT01307267|65909433|FG021|Overall Study|Death|2|||
23595416|NCT01307267|65909434|FG022|Overall Study|Death|2|||
23595417|NCT01307267|65909412|FG000|Overall Study|Lost to Follow-up|0|||
23595418|NCT01307267|65909413|FG001|Overall Study|Lost to Follow-up|0|||
23595419|NCT01307267|65909414|FG002|Overall Study|Lost to Follow-up|0|||
23595420|NCT01307267|65909415|FG003|Overall Study|Lost to Follow-up|0|||
23595421|NCT01307267|65909416|FG004|Overall Study|Lost to Follow-up|0|||
23595422|NCT01307267|65909417|FG005|Overall Study|Lost to Follow-up|7|||
23595423|NCT01307267|65909418|FG006|Overall Study|Lost to Follow-up|0|||
23595424|NCT01307267|65909419|FG007|Overall Study|Lost to Follow-up|0|||
23595425|NCT01307267|65909420|FG008|Overall Study|Lost to Follow-up|1|||
23595426|NCT01307267|65909421|FG009|Overall Study|Lost to Follow-up|2|||
23595427|NCT01307267|65909422|FG010|Overall Study|Lost to Follow-up|1|||
23595428|NCT01307267|65909423|FG011|Overall Study|Lost to Follow-up|0|||
23595429|NCT01307267|65909424|FG012|Overall Study|Lost to Follow-up|0|||
23595430|NCT01307267|65909425|FG013|Overall Study|Lost to Follow-up|0|||
23595431|NCT01307267|65909426|FG014|Overall Study|Lost to Follow-up|0|||
23595432|NCT01307267|65909427|FG015|Overall Study|Lost to Follow-up|0|||
23595433|NCT01307267|65909428|FG016|Overall Study|Lost to Follow-up|0|||
23595434|NCT01307267|65909429|FG017|Overall Study|Lost to Follow-up|0|||
23595435|NCT01307267|65909430|FG018|Overall Study|Lost to Follow-up|0|||
23595436|NCT01307267|65909431|FG019|Overall Study|Lost to Follow-up|2|||
23595437|NCT01307267|65909432|FG020|Overall Study|Lost to Follow-up|0|||
23595438|NCT01307267|65909433|FG021|Overall Study|Lost to Follow-up|0|||
23595439|NCT01307267|65909434|FG022|Overall Study|Lost to Follow-up|0|||
23477867|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
23477868|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477869|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477870|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477871|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477872|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477873|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477874|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477875|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477876|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
23477877|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
23477878|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Death|0|||
23477879|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Death|0|||
23477880|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Death|0|||
23477881|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Death|0|||
23477882|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Death|0|||
23477883|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Death|0|||
23477884|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Death|0|||
23477885|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Death|0|||
23477886|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Death|0|||
23477887|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Death|1|||
23477888|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477889|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477890|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477891|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477892|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23595440|NCT01307267|65909412|FG000|Overall Study|Withdrawal by Subject|0|||
23595441|NCT01307267|65909413|FG001|Overall Study|Withdrawal by Subject|0|||
23595442|NCT01307267|65909414|FG002|Overall Study|Withdrawal by Subject|0|||
23595443|NCT01307267|65909415|FG003|Overall Study|Withdrawal by Subject|0|||
23194111|NCT01052012|64452473|FG005|Overall Study|Other|0|||
23595444|NCT01307267|65909416|FG004|Overall Study|Withdrawal by Subject|0|||
23595445|NCT01307267|65909417|FG005|Overall Study|Withdrawal by Subject|1|||
23595446|NCT01307267|65909418|FG006|Overall Study|Withdrawal by Subject|0|||
23595447|NCT01307267|65909419|FG007|Overall Study|Withdrawal by Subject|1|||
23194112|NCT01413178|64452474|FG000|Overall Study|Toxicity|1|||
23194113|NCT01413178|64452475|FG001|Overall Study|Toxicity|0|||
23595448|NCT01307267|65909420|FG008|Overall Study|Withdrawal by Subject|5|||
23595449|NCT01307267|65909421|FG009|Overall Study|Withdrawal by Subject|1|||
23595450|NCT01307267|65909422|FG010|Overall Study|Withdrawal by Subject|1|||
23595451|NCT01307267|65909423|FG011|Overall Study|Withdrawal by Subject|1|||
23477893|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477894|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477895|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23595452|NCT01307267|65909424|FG012|Overall Study|Withdrawal by Subject|0|||
23477896|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
23477897|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
23477898|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477899|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477900|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477901|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477902|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477903|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477904|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477905|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477906|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
23477907|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
23477908|NCT01185353|65491685|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477909|NCT01185353|65491686|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477910|NCT01185353|65491687|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477911|NCT01185353|65491688|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477912|NCT01185353|65491689|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477913|NCT01185353|65491690|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477914|NCT01185353|65491691|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477915|NCT01185353|65491692|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477916|NCT01185353|65491693|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
23477917|NCT01185353|65491694|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
23477918|NCT01185353|65491685|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477919|NCT01185353|65491686|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477920|NCT01185353|65491687|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477921|NCT01185353|65491688|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477922|NCT01185353|65491689|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477923|NCT01185353|65491690|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23595453|NCT01307267|65909425|FG013|Overall Study|Withdrawal by Subject|0|||
23595454|NCT01307267|65909426|FG014|Overall Study|Withdrawal by Subject|0|||
23595455|NCT01307267|65909427|FG015|Overall Study|Withdrawal by Subject|0|||
23595456|NCT01307267|65909428|FG016|Overall Study|Withdrawal by Subject|0|||
23595457|NCT01307267|65909429|FG017|Overall Study|Withdrawal by Subject|0|||
23595458|NCT01307267|65909430|FG018|Overall Study|Withdrawal by Subject|0|||
23595459|NCT01307267|65909431|FG019|Overall Study|Withdrawal by Subject|3|||
23595460|NCT01307267|65909432|FG020|Overall Study|Withdrawal by Subject|0|||
23595461|NCT01307267|65909433|FG021|Overall Study|Withdrawal by Subject|0|||
23595462|NCT01307267|65909434|FG022|Overall Study|Withdrawal by Subject|0|||
23595463|NCT01307267|65909412|FG000|Overall Study|Other|0|||
23595464|NCT01307267|65909413|FG001|Overall Study|Other|0|||
23595465|NCT01307267|65909414|FG002|Overall Study|Other|0|||
23595466|NCT01307267|65909415|FG003|Overall Study|Other|0|||
23595467|NCT01307267|65909416|FG004|Overall Study|Other|0|||
23595468|NCT01307267|65909417|FG005|Overall Study|Other|7|||
23595469|NCT01307267|65909418|FG006|Overall Study|Other|0|||
23595470|NCT01307267|65909419|FG007|Overall Study|Other|1|||
23595471|NCT01307267|65909420|FG008|Overall Study|Other|3|||
23595472|NCT01307267|65909421|FG009|Overall Study|Other|0|||
23595473|NCT01307267|65909422|FG010|Overall Study|Other|1|||
23595474|NCT01307267|65909423|FG011|Overall Study|Other|1|||
23595475|NCT01307267|65909424|FG012|Overall Study|Other|1|||
23595476|NCT01307267|65909425|FG013|Overall Study|Other|0|||
23595477|NCT01307267|65909426|FG014|Overall Study|Other|2|||
23595478|NCT01307267|65909427|FG015|Overall Study|Other|1|||
23254754|NCT00950599|64673618|FG009|Follow-Up Period|Subject withdrew Consent|1|||
23254755|NCT02683187|64673622|FG000|Overall Study|Failed IV access|3|||
23254756|NCT02683187|64673622|FG000|Overall Study|Withdrawal by Subject|5|||
23477924|NCT01185353|65491691|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23595479|NCT01307267|65909428|FG016|Overall Study|Other|0|||
23595480|NCT01307267|65909429|FG017|Overall Study|Other|0|||
23254757|NCT00740480|64673623|FG000|Overall Study|Adverse Event|1|||
23595481|NCT01307267|65909430|FG018|Overall Study|Other|0|||
23595482|NCT01307267|65909431|FG019|Overall Study|Other|19|||
23254758|NCT00740480|64673623|FG000|Overall Study|Physician Decision|1|||
23477925|NCT01185353|65491692|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
23477926|NCT01185353|65491693|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
23595483|NCT01307267|65909432|FG020|Overall Study|Other|2|||
23595484|NCT01307267|65909433|FG021|Overall Study|Other|3|||
23595485|NCT01307267|65909434|FG022|Overall Study|Other|2|||
23254759|NCT03456726|64673624|FG000|Overall Study|Disease Progression|6|||
23254760|NCT03456726|64673625|FG001|Overall Study|Disease Progression|1|||
23254761|NCT03456726|64673624|FG000|Overall Study|Adverse Event|4|||
23254762|NCT03456726|64673625|FG001|Overall Study|Adverse Event|2|||
23254763|NCT03456726|64673624|FG000|Overall Study|Withdrawal by Subject|1|||
23595486|NCT02538107|65909435|FG000|Overall Study|Did not receive any Mircera dose|11|||
23595487|NCT02538107|65909435|FG000|Overall Study|Missing|5|||
23595488|NCT02538107|65909435|FG000|Overall Study|Necessity of dialysis|20|||
23595489|NCT02538107|65909435|FG000|Overall Study|Administration of other ESA|11|||
23595490|NCT02538107|65909435|FG000|Overall Study|No further treatment necessary|18|||
23595491|NCT02538107|65909435|FG000|Overall Study|Withdrawal by Subject|17|||
23595492|NCT02538107|65909435|FG000|Overall Study|Death|4|||
23595493|NCT02538107|65909435|FG000|Overall Study|Administrative reason|5|||
23595494|NCT02538107|65909435|FG000|Overall Study|Adverse Event|4|||
23595495|NCT02538107|65909435|FG000|Overall Study|Surgery|1|||
23595496|NCT02538107|65909435|FG000|Overall Study|Other|7|||
23595497|NCT02538107|65909435|FG000|Overall Study|Not recorded|7|||
23595498|NCT02092116|65909436|FG000|Overall Study|Withdrawal by Subject|0|||
23595499|NCT02092116|65909437|FG001|Overall Study|Withdrawal by Subject|3|||
23595500|NCT02092116|65909436|FG000|Overall Study|Adverse Event|0|||
23595501|NCT02092116|65909437|FG001|Overall Study|Adverse Event|1|||
23595502|NCT01337635|65909441|FG000|Overall Study|Lost to Follow-up|0|||
23595503|NCT01337635|65909442|FG001|Overall Study|Lost to Follow-up|1|||
23595504|NCT02531113|65909443|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
23595505|NCT02531113|65909443|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
23595506|NCT02531113|65909443|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
23595507|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
23254764|NCT03456726|64673625|FG001|Overall Study|Withdrawal by Subject|0|||
23254765|NCT03456726|64673624|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
23194114|NCT01413178|64452474|FG000|Overall Study|Ineligible|0|||
23194115|NCT01413178|64452475|FG001|Overall Study|Ineligible|2|||
23194116|NCT02335450|64452476|FG000|Overall Study|Pregnancy|1|||
23194117|NCT01696877|64452479|FG000|Overall Study|Adverse Event|0|||
23194118|NCT01696877|64452480|FG001|Overall Study|Adverse Event|1|||
23194119|NCT00077623|64452481|FG000|Overall Study|Adverse Event|1|||
23194120|NCT00077623|64452482|FG001|Overall Study|Adverse Event|0|||
23194121|NCT00077623|64452483|FG002|Overall Study|Adverse Event|1|||
23194122|NCT00077623|64452481|FG000|Overall Study|Withdrawal by Subject|2|||
23194123|NCT00077623|64452482|FG001|Overall Study|Withdrawal by Subject|10|||
23194124|NCT00077623|64452483|FG002|Overall Study|Withdrawal by Subject|1|||
23194125|NCT00077623|64452481|FG000|Overall Study|Other-Non safety reason|18|||
23194126|NCT00077623|64452482|FG001|Overall Study|Other-Non safety reason|15|||
23194127|NCT00077623|64452483|FG002|Overall Study|Other-Non safety reason|19|||
23194128|NCT00077623|64452481|FG000|Overall Study|Insufficient therapeutic response|2|||
23194129|NCT00077623|64452482|FG001|Overall Study|Insufficient therapeutic response|0|||
23194130|NCT00077623|64452483|FG002|Overall Study|Insufficient therapeutic response|0|||
23194131|NCT00077623|64452481|FG000|Overall Study|Death|12|||
23194132|NCT00077623|64452482|FG001|Overall Study|Death|18|||
23194133|NCT00077623|64452483|FG002|Overall Study|Death|11|||
23194134|NCT00077623|64452481|FG000|Overall Study|Failure to return|1|||
23194135|NCT00077623|64452482|FG001|Overall Study|Failure to return|0|||
23194136|NCT00077623|64452483|FG002|Overall Study|Failure to return|0|||
23194137|NCT00790296|64452485|FG000|Overall Study|Did not meet study eligibility criteria|1|||
23194138|NCT00790296|64452486|FG001|Overall Study|Did not meet study eligibility criteria|1|||
23194139|NCT00790296|64452485|FG000|Overall Study|Adverse Event|0|||
23194140|NCT00790296|64452486|FG001|Overall Study|Adverse Event|1|||
23194141|NCT01749735|64452487|FG000|Overall Study|Withdrawal by Subject|1|||
23194142|NCT01749735|64452488|FG001|Overall Study|Withdrawal by Subject|0|||
23194143|NCT02117050|64452489|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
23194144|NCT01589094|64452490|FG000|Overall Study|Did not receive treatment|2|||
23194145|NCT01478347|64452495|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
23194146|NCT01478347|64452495|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
23194147|NCT01478347|64452495|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
23194148|NCT00450866|64452501|FG000|Overall Study|Adverse Event|0|||
23194149|NCT00450866|64452502|FG001|Overall Study|Adverse Event|1|||
23194150|NCT00450866|64452501|FG000|Overall Study|Withdrawal by Subject|5|||
23360317|NCT02748057|65062903|FG001|Overall Study|Adverse Event|0|||
23595508|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
23194151|NCT00450866|64452502|FG001|Overall Study|Withdrawal by Subject|2|||
23194152|NCT00450866|64452501|FG000|Overall Study|Death|1|||
23194153|NCT00450866|64452502|FG001|Overall Study|Death|0|||
23194154|NCT00450866|64452501|FG000|Overall Study|Physician Decision|1|||
23194155|NCT00450866|64452502|FG001|Overall Study|Physician Decision|0|||
23194156|NCT01494038|64452503|FG000|Overall Study|Protocol Violation|1|||
23360318|NCT02748057|65062902|FG000|Overall Study|Physician Decision|0|||
23194157|NCT01494038|64452504|FG001|Overall Study|Protocol Violation|1|||
23477927|NCT01185353|65491694|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
23477928|NCT01185353|65491685|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477929|NCT01185353|65491686|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477930|NCT01185353|65491687|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477931|NCT01185353|65491688|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477932|NCT01185353|65491689|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477933|NCT01185353|65491690|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23477934|NCT01185353|65491691|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
23194158|NCT01494038|64452503|FG000|Overall Study|Lost to Follow-up|18|||
23194159|NCT01494038|64452504|FG001|Overall Study|Lost to Follow-up|20|||
23194160|NCT01494038|64452503|FG000|Overall Study|Withdrawal by Subject|44|||
23194161|NCT01494038|64452504|FG001|Overall Study|Withdrawal by Subject|34|||
23194162|NCT01494038|64452503|FG000|Overall Study|Not able to get to clinic|21|||
23194163|NCT01494038|64452504|FG001|Overall Study|Not able to get to clinic|15|||
23194164|NCT01494038|64452503|FG000|Overall Study|Not willing to adhere to reqs|2|||
23194165|NCT01494038|64452504|FG001|Overall Study|Not willing to adhere to reqs|9|||
23194166|NCT01494038|64452503|FG000|Overall Study|Death|2|||
23194167|NCT01494038|64452504|FG001|Overall Study|Death|4|||
23194168|NCT01277289|64452505|FG000|Overall Study|fragile vein|1|||
23194169|NCT01277289|64452506|FG001|Overall Study|fragile vein|0|||
23194170|NCT01277289|64452505|FG000|Overall Study|Physician Decision|1|||
23194171|NCT01277289|64452506|FG001|Overall Study|Physician Decision|0|||
23194172|NCT01277289|64452505|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
23194173|NCT01277289|64452506|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
23194174|NCT01277289|64452505|FG000|Overall Study|Protocol Violation|1|||
23194175|NCT01277289|64452506|FG001|Overall Study|Protocol Violation|1|||
23194176|NCT01277289|64452505|FG000|Overall Study|Adverse Event|2|||
23194177|NCT01277289|64452506|FG001|Overall Study|Adverse Event|1|||
23194178|NCT01277289|64452505|FG000|Overall Study|consent withdrawn|1|||
23194179|NCT01277289|64452506|FG001|Overall Study|consent withdrawn|1|||
23254766|NCT03456726|64673625|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
23254767|NCT00830063|64673628|FG000|Overall Study|Adverse Event|7|||
23254768|NCT00830063|64673629|FG001|Overall Study|Adverse Event|13|||
23254769|NCT00830063|64673630|FG002|Overall Study|Adverse Event|16|||
23254770|NCT00830063|64673631|FG003|Overall Study|Adverse Event|13|||
23254771|NCT00830063|64673628|FG000|Overall Study|Death|1|||
23254772|NCT00830063|64673629|FG001|Overall Study|Death|0|||
23254773|NCT00830063|64673630|FG002|Overall Study|Death|0|||
23254774|NCT00830063|64673631|FG003|Overall Study|Death|0|||
23254775|NCT00830063|64673628|FG000|Overall Study|Lost to Follow-up|0|||
23254776|NCT00830063|64673629|FG001|Overall Study|Lost to Follow-up|0|||
23254777|NCT00830063|64673630|FG002|Overall Study|Lost to Follow-up|3|||
23254778|NCT00830063|64673631|FG003|Overall Study|Lost to Follow-up|1|||
23254779|NCT00830063|64673628|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
23254780|NCT00830063|64673629|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
23254781|NCT00830063|64673630|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
23254782|NCT00830063|64673631|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
23254783|NCT00830063|64673628|FG000|Overall Study|Lack of Efficacy|51|||
23254784|NCT00830063|64673629|FG001|Overall Study|Lack of Efficacy|23|||
23254785|NCT00830063|64673630|FG002|Overall Study|Lack of Efficacy|25|||
23254786|NCT00830063|64673631|FG003|Overall Study|Lack of Efficacy|32|||
23254787|NCT00830063|64673628|FG000|Overall Study|Other|5|||
23254788|NCT00830063|64673629|FG001|Overall Study|Other|5|||
23254789|NCT00830063|64673630|FG002|Overall Study|Other|8|||
23254790|NCT00830063|64673631|FG003|Overall Study|Other|6|||
23254791|NCT00830063|64673628|FG000|Overall Study|Withdrawal by Subject|16|||
23254792|NCT00830063|64673629|FG001|Overall Study|Withdrawal by Subject|10|||
23254793|NCT00830063|64673630|FG002|Overall Study|Withdrawal by Subject|16|||
23254794|NCT00830063|64673631|FG003|Overall Study|Withdrawal by Subject|13|||
23254795|NCT00830063|64673628|FG000|Overall Study|Protocol Violation|1|||
23254796|NCT00830063|64673629|FG001|Overall Study|Protocol Violation|0|||
23254797|NCT00830063|64673630|FG002|Overall Study|Protocol Violation|3|||
23254798|NCT00830063|64673631|FG003|Overall Study|Protocol Violation|2|||
23254799|NCT00830063|64673628|FG000|Overall Study|Randomized But Not Treated|0|||
23254800|NCT00830063|64673629|FG001|Overall Study|Randomized But Not Treated|2|||
23194180|NCT01277289|64452505|FG000|Overall Study|premature closure of the study|4|||
23194181|NCT01277289|64452506|FG001|Overall Study|premature closure of the study|2|||
23194182|NCT01161524|64452510|FG000|Core Study (23 Weeks)|Adverse Event|3|||
23194183|NCT01161524|64452511|FG001|Core Study (23 Weeks)|Adverse Event|0|||
23254801|NCT00830063|64673630|FG002|Overall Study|Randomized But Not Treated|0|||
23254802|NCT00830063|64673631|FG003|Overall Study|Randomized But Not Treated|2|||
23254803|NCT01764854|64673635|FG000|Overall Study|Adverse Event|0|||
23254804|NCT01764854|64673636|FG001|Overall Study|Adverse Event|0|||
23254805|NCT01764854|64673637|FG002|Overall Study|Adverse Event|2|||
23254806|NCT01764854|64673638|FG003|Overall Study|Adverse Event|0|||
23254807|NCT01764854|64673635|FG000|Overall Study|Withdrawal by Subject|0|||
23595509|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
23595510|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
23595511|NCT02531113|65909443|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
23595512|NCT00522951|65909446|FG000|Period 1|body motion|0|||
23595513|NCT00522951|65909447|FG001|Period 1|body motion|1|||
23595514|NCT00522951|65909446|FG000|Washout Period|Adverse Event|0|||
23595515|NCT00522951|65909447|FG001|Washout Period|Adverse Event|1|||
23595516|NCT00522951|65909446|FG000|Washout Period|Death|0|||
23595517|NCT00522951|65909447|FG001|Washout Period|Death|1|||
23595518|NCT00522951|65909446|FG000|Period 2|Withdrawal by Subject|1|||
23595519|NCT00522951|65909447|FG001|Period 2|Withdrawal by Subject|0|||
23595520|NCT00522951|65909446|FG000|Period 2|residual contrast medium|1|||
23595521|NCT00522951|65909447|FG001|Period 2|residual contrast medium|1|||
23595522|NCT01331824|65909448|FG000|Overall Study|Adverse Event|2|||
23595523|NCT01331824|65909448|FG000|Overall Study|Death|1|||
23595524|NCT01331824|65909448|FG000|Overall Study|Disease Progression|9|||
23595525|NCT01331824|65909448|FG000|Overall Study|Withdrawal by Subject|1|||
23595526|NCT04149002|65909449|FG000|Overall Study|Lost to Follow-up|1|||
23595527|NCT04149002|65909450|FG001|Overall Study|Lost to Follow-up|0|||
23595528|NCT04149002|65909449|FG000|Overall Study|Withdrawal by Subject|1|||
23595529|NCT04149002|65909450|FG001|Overall Study|Withdrawal by Subject|0|||
23595530|NCT00807144|65909454|FG000|Overall Study|Lost to Follow-up|0|||
23595531|NCT00807144|65909455|FG001|Overall Study|Lost to Follow-up|1|||
23595532|NCT00785512|65909456|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
23595533|NCT00785512|65909457|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
23595534|NCT00785512|65909456|FG000|Overall Study|Adverse Event|0|||
23595535|NCT00785512|65909457|FG001|Overall Study|Adverse Event|0|||
23595536|NCT00785512|65909456|FG000|Overall Study|Lack of Efficacy|0|||
23595537|NCT00785512|65909457|FG001|Overall Study|Lack of Efficacy|2|||
23595538|NCT00785512|65909456|FG000|Overall Study|Withdrawal by Subject|0|||
23595539|NCT00785512|65909457|FG001|Overall Study|Withdrawal by Subject|1|||
23595540|NCT00785512|65909456|FG000|Overall Study|Lost to Follow-up|3|||
23595541|NCT00785512|65909457|FG001|Overall Study|Lost to Follow-up|0|||
23595542|NCT00785512|65909456|FG000|Overall Study|Precedure Refused|0|||
23595543|NCT00785512|65909457|FG001|Overall Study|Precedure Refused|0|||
23595544|NCT00785512|65909456|FG000|Overall Study|IVRS Programing Error|0|||
23595545|NCT00785512|65909457|FG001|Overall Study|IVRS Programing Error|0|||
23595546|NCT00785512|65909456|FG000|Overall Study|Physician Decision|0|||
23595547|NCT00785512|65909457|FG001|Overall Study|Physician Decision|0|||
23595548|NCT00785512|65909456|FG000|Overall Study|Lack of compliance|0|||
23595549|NCT00785512|65909457|FG001|Overall Study|Lack of compliance|1|||
23595550|NCT02121002|65909458|FG000|Overall Study|Physician Decision|2|||
23595551|NCT02121002|65909459|FG001|Overall Study|Physician Decision|0|||
23595552|NCT02121002|65909460|FG002|Overall Study|Physician Decision|0|||
23595553|NCT02121002|65909458|FG000|Overall Study|Withdrawal by Subject|3|||
23595554|NCT02121002|65909459|FG001|Overall Study|Withdrawal by Subject|1|||
23595555|NCT02121002|65909460|FG002|Overall Study|Withdrawal by Subject|4|||
23595556|NCT02121002|65909458|FG000|Overall Study|Protocol Violation|1|||
23595557|NCT02121002|65909459|FG001|Overall Study|Protocol Violation|2|||
23595558|NCT02121002|65909460|FG002|Overall Study|Protocol Violation|4|||
23595559|NCT02121002|65909458|FG000|Overall Study|Concomitant therapy|0|||
23595560|NCT02121002|65909459|FG001|Overall Study|Concomitant therapy|1|||
23595561|NCT02121002|65909460|FG002|Overall Study|Concomitant therapy|1|||
23595562|NCT02121002|65909458|FG000|Overall Study|Others|1|||
23595563|NCT02121002|65909459|FG001|Overall Study|Others|0|||
23595564|NCT02121002|65909460|FG002|Overall Study|Others|1|||
23595565|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
23595566|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
23595567|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
23595568|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
23595569|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
23595570|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
23595571|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
23595572|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
23595573|NCT01424670|65909461|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
23194184|NCT01161524|64452512|FG002|Core Study (23 Weeks)|Adverse Event|0|||
23194185|NCT01161524|64452510|FG000|Core Study (23 Weeks)|Other|1|||
23194186|NCT01161524|64452511|FG001|Core Study (23 Weeks)|Other|0|||
23194187|NCT01161524|64452512|FG002|Core Study (23 Weeks)|Other|0|||
23595574|NCT01424670|65909462|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
23595575|NCT01424670|65909461|FG000|Continuation Period|Adverse Event|13|||
23595576|NCT01424670|65909462|FG001|Continuation Period|Adverse Event|5|||
23595577|NCT01424670|65909461|FG000|Continuation Period|Lost to Follow-up|2|||
23595578|NCT01424670|65909462|FG001|Continuation Period|Lost to Follow-up|0|||
23360319|NCT02748057|65062903|FG001|Overall Study|Physician Decision|1|||
23595579|NCT01424670|65909461|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
23595580|NCT01424670|65909462|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
23595581|NCT01424670|65909461|FG000|Continuation Period|Physician Decision|5|||
23595582|NCT01424670|65909462|FG001|Continuation Period|Physician Decision|4|||
23595583|NCT01424670|65909461|FG000|Continuation Period|Withdrawal by Subject|13|||
23595584|NCT01424670|65909462|FG001|Continuation Period|Withdrawal by Subject|4|||
23595585|NCT03527160|65909469|FG000|Overall Study|No urine collected|13|||
23595586|NCT03527160|65909469|FG000|Overall Study|No clinical serum creatinine collected|6|||
23595587|NCT03527160|65909469|FG000|Overall Study|Did not meet inclusion|2|||
23595588|NCT03762668|65909470|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
23595589|NCT03762668|65909471|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
23595590|NCT02724592|65909472|FG000|Overall Study|Lost to Follow-up|4|||
23595591|NCT02724592|65909473|FG001|Overall Study|Lost to Follow-up|1|||
23595592|NCT01943916|65912641|FG000|Overall Study|Technically invalid images|10|||
23595593|NCT01943916|65912641|FG000|Overall Study|Enrollment Failure|23|||
23595594|NCT01943916|65912641|FG000|Overall Study|Pilot Phase exclusion|100|||
23595595|NCT01943916|65912641|FG000|Overall Study|Quality Assurance Reader Fail|130|||
23595596|NCT01943916|65912641|FG000|Overall Study|Technical Failure|39|||
23595597|NCT01943916|65912641|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
23595598|NCT01943916|65912641|FG000|Overall Study|No Truth Panel Review|38|||
23595599|NCT01943916|65912641|FG000|Overall Study|Protocol Deviation|1|||
23194188|NCT01161524|64452510|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
23194189|NCT01161524|64452511|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
23194190|NCT01161524|64452512|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
23194191|NCT01161524|64452510|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
23194192|NCT01161524|64452511|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
23194193|NCT01161524|64452512|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
23194194|NCT01161524|64452510|FG000|Core Study (23 Weeks)|Subject Choice|3|||
23194195|NCT01161524|64452511|FG001|Core Study (23 Weeks)|Subject Choice|2|||
23194196|NCT01161524|64452512|FG002|Core Study (23 Weeks)|Subject Choice|0|||
23194197|NCT01161524|64452510|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
23194198|NCT01161524|64452511|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
23194199|NCT01161524|64452512|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
23194200|NCT01161524|64452510|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
23194201|NCT01161524|64452511|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
23194202|NCT01161524|64452512|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
23194203|NCT01161524|64452510|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
23254808|NCT01764854|64673636|FG001|Overall Study|Withdrawal by Subject|0|||
23254809|NCT01764854|64673637|FG002|Overall Study|Withdrawal by Subject|1|||
23254810|NCT01764854|64673638|FG003|Overall Study|Withdrawal by Subject|0|||
23254811|NCT01764854|64673635|FG000|Overall Study|relocation|0|||
23595600|NCT01062126|65912643|FG000|Overall Study|Death|209|||
23595601|NCT01062126|65912643|FG000|Overall Study|All Withdrawals|324|||
23595602|NCT03403413|65912645|FG000|Overall Study|Lack of Efficacy|2|||
23595603|NCT00068601|65912648|FG000|Overall Study|Ineligible|11|||
23595604|NCT00068601|65912649|FG001|Overall Study|Ineligible|13|||
23254812|NCT01764854|64673636|FG001|Overall Study|relocation|0|||
23254813|NCT01764854|64673637|FG002|Overall Study|relocation|2|||
23254814|NCT01764854|64673638|FG003|Overall Study|relocation|0|||
23254815|NCT01764854|64673635|FG000|Overall Study|Protocol Violation|0|||
23254816|NCT01764854|64673636|FG001|Overall Study|Protocol Violation|0|||
23254817|NCT01764854|64673637|FG002|Overall Study|Protocol Violation|1|||
23254818|NCT01764854|64673638|FG003|Overall Study|Protocol Violation|2|||
23254819|NCT01684722|64673639|FG000|Overall Study|Lost to Follow-up|78|||
23254820|NCT01684722|64673640|FG001|Overall Study|Lost to Follow-up|56|||
23254821|NCT01684722|64673641|FG002|Overall Study|Lost to Follow-up|75|||
23595605|NCT00068601|65912648|FG000|Overall Study|Not evaluable: withdrew consent|5|||
23254822|NCT01684722|64673642|FG003|Overall Study|Lost to Follow-up|89|||
23595606|NCT00068601|65912649|FG001|Overall Study|Not evaluable: withdrew consent|4|||
23194204|NCT01161524|64452511|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
23194205|NCT01161524|64452512|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
23254823|NCT01684722|64673639|FG000|Overall Study|Death|19|||
23254824|NCT01684722|64673640|FG001|Overall Study|Death|21|||
23595607|NCT00068601|65912648|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
23595608|NCT00068601|65912649|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
23595609|NCT00068601|65912648|FG000|Overall Study|Death|11|||
23595610|NCT00068601|65912649|FG001|Overall Study|Death|3|||
23595611|NCT00068601|65912648|FG000|Overall Study|Lost to Follow-up|3|||
23595612|NCT00068601|65912649|FG001|Overall Study|Lost to Follow-up|2|||
23595613|NCT00068601|65912648|FG000|Overall Study|Missing primary outcome data|30|||
23595614|NCT00068601|65912649|FG001|Overall Study|Missing primary outcome data|34|||
23595615|NCT02566902|65912650|FG000|Overall Study|Protocol Violation|2|||
23595616|NCT02566902|65912651|FG001|Overall Study|Protocol Violation|1|||
23595617|NCT00111813|65912652|FG000|Overall Study|Adverse Event|1|||
23595618|NCT00111813|65912653|FG001|Overall Study|Adverse Event|2|||
23595619|NCT00111813|65912654|FG002|Overall Study|Adverse Event|4|||
23595620|NCT00111813|65912655|FG003|Overall Study|Adverse Event|2|||
23595621|NCT00111813|65912656|FG004|Overall Study|Adverse Event|2|||
23595622|NCT00111813|65912657|FG005|Overall Study|Adverse Event|2|||
23595623|NCT00111813|65912652|FG000|Overall Study|Progressive disease|2|||
23595624|NCT00111813|65912653|FG001|Overall Study|Progressive disease|1|||
23595625|NCT00111813|65912654|FG002|Overall Study|Progressive disease|5|||
23595626|NCT00111813|65912655|FG003|Overall Study|Progressive disease|3|||
23595627|NCT00111813|65912656|FG004|Overall Study|Progressive disease|4|||
23595628|NCT00111813|65912657|FG005|Overall Study|Progressive disease|3|||
23595629|NCT00111813|65912652|FG000|Overall Study|Lack of Efficacy|0|||
23595630|NCT00111813|65912653|FG001|Overall Study|Lack of Efficacy|0|||
23595631|NCT00111813|65912654|FG002|Overall Study|Lack of Efficacy|0|||
23595632|NCT00111813|65912655|FG003|Overall Study|Lack of Efficacy|0|||
23595633|NCT00111813|65912656|FG004|Overall Study|Lack of Efficacy|0|||
23595634|NCT00111813|65912657|FG005|Overall Study|Lack of Efficacy|1|||
23595635|NCT00111813|65912652|FG000|Overall Study|Other|0|||
23595636|NCT00111813|65912653|FG001|Overall Study|Other|0|||
23595637|NCT00111813|65912654|FG002|Overall Study|Other|1|||
23595638|NCT00111813|65912655|FG003|Overall Study|Other|0|||
23595639|NCT00111813|65912656|FG004|Overall Study|Other|0|||
23595640|NCT00111813|65912657|FG005|Overall Study|Other|0|||
23595641|NCT01565148|65912660|FG000|Overall Study|Withdrawal by Subject|1|||
23595642|NCT01565148|65912661|FG001|Overall Study|Withdrawal by Subject|1|||
23595643|NCT01565148|65912662|FG002|Overall Study|Withdrawal by Subject|1|||
23595644|NCT01565148|65912663|FG003|Overall Study|Withdrawal by Subject|2|||
23595645|NCT01565148|65912660|FG000|Overall Study|Lost to Follow-up|4|||
23595646|NCT01565148|65912661|FG001|Overall Study|Lost to Follow-up|4|||
23595647|NCT01565148|65912662|FG002|Overall Study|Lost to Follow-up|0|||
23595648|NCT01565148|65912663|FG003|Overall Study|Lost to Follow-up|3|||
23595649|NCT01565148|65912660|FG000|Overall Study|Rescue Therapy|8|||
23595650|NCT01565148|65912661|FG001|Overall Study|Rescue Therapy|5|||
23595651|NCT01565148|65912662|FG002|Overall Study|Rescue Therapy|5|||
23595652|NCT01565148|65912663|FG003|Overall Study|Rescue Therapy|8|||
23595653|NCT01565148|65912660|FG000|Overall Study|Death|0|||
23595654|NCT01565148|65912661|FG001|Overall Study|Death|0|||
23595655|NCT01565148|65912662|FG002|Overall Study|Death|1|||
23595656|NCT01565148|65912663|FG003|Overall Study|Death|0|||
23595657|NCT01565148|65912660|FG000|Overall Study|Physician Decision|2|||
23595658|NCT01565148|65912661|FG001|Overall Study|Physician Decision|5|||
23595659|NCT01565148|65912662|FG002|Overall Study|Physician Decision|0|||
23595660|NCT01565148|65912663|FG003|Overall Study|Physician Decision|0|||
23595661|NCT00714714|65912664|FG000|Overall Study|Adverse Event|1|||
23595662|NCT00402246|65912665|FG000|Overall Study|Death|62|||
23595663|NCT00402246|65912666|FG001|Overall Study|Death|58|||
23595664|NCT00402246|65912665|FG000|Overall Study|Lost to Follow-up|20|||
23595665|NCT00402246|65912666|FG001|Overall Study|Lost to Follow-up|28|||
23595666|NCT00402246|65912665|FG000|Overall Study|Withdrawal by Subject|72|||
23595667|NCT00402246|65912666|FG001|Overall Study|Withdrawal by Subject|87|||
23595668|NCT00402246|65912665|FG000|Overall Study|Physician Decision|24|||
23595669|NCT00402246|65912666|FG001|Overall Study|Physician Decision|26|||
23595670|NCT00402246|65912665|FG000|Overall Study|Protocol Violation|25|||
23254825|NCT01684722|64673641|FG002|Overall Study|Death|19|||
23254826|NCT01684722|64673642|FG003|Overall Study|Death|21|||
23254827|NCT03101293|64673644|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
23254828|NCT03101293|64673645|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
23595671|NCT00402246|65912666|FG001|Overall Study|Protocol Violation|24|||
23595672|NCT00402246|65912665|FG000|Overall Study|Missed Final Visit|1|||
23595673|NCT00402246|65912666|FG001|Overall Study|Missed Final Visit|2|||
23595674|NCT00402246|65912665|FG000|Overall Study|Insurance Issues|2|||
23595675|NCT00402246|65912666|FG001|Overall Study|Insurance Issues|1|||
23595676|NCT00402246|65912665|FG000|Overall Study|Heart Transplant|0|||
23595677|NCT00402246|65912666|FG001|Overall Study|Heart Transplant|1|||
23595678|NCT00402246|65912665|FG000|Overall Study|Patient's device explanted|6|||
23595679|NCT00402246|65912666|FG001|Overall Study|Patient's device explanted|2|||
23595680|NCT00402246|65912665|FG000|Overall Study|Center Closure|5|||
23595681|NCT00402246|65912666|FG001|Overall Study|Center Closure|3|||
23595682|NCT00402246|65912665|FG000|Overall Study|Deterioriating Condition|3|||
23595683|NCT00402246|65912666|FG001|Overall Study|Deterioriating Condition|2|||
23595684|NCT01127373|65912671|FG000|Overall Study|Not Treated|3|||
23477935|NCT01185353|65491692|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
23477936|NCT01185353|65491693|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
23477937|NCT01185353|65491694|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
23477938|NCT01185353|65491685|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477939|NCT01185353|65491686|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477940|NCT01185353|65491687|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477941|NCT01185353|65491688|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477942|NCT01185353|65491689|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477943|NCT01185353|65491690|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477944|NCT01185353|65491691|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477945|NCT01185353|65491692|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
23477946|NCT01185353|65491693|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
23477947|NCT01185353|65491694|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
23477948|NCT03459690|65491695|FG000|Overall Study|Lost to Follow-up|0|||
23477949|NCT03459690|65491696|FG001|Overall Study|Lost to Follow-up|1|||
23477950|NCT03459690|65491695|FG000|Overall Study|Withdrawal by Subject|1|||
23477951|NCT03459690|65491696|FG001|Overall Study|Withdrawal by Subject|1|||
23477952|NCT00724711|65491705|FG000|Overall Study|Adverse Event|7|||
23477953|NCT00724711|65491706|FG001|Overall Study|Adverse Event|3|||
23477954|NCT00724711|65491705|FG000|Overall Study|Pregnancy|0|||
23477955|NCT00724711|65491706|FG001|Overall Study|Pregnancy|1|||
23477956|NCT00724711|65491705|FG000|Overall Study|Lack of Efficacy|0|||
23477957|NCT00724711|65491706|FG001|Overall Study|Lack of Efficacy|1|||
23477958|NCT00724711|65491705|FG000|Overall Study|Physician Decision|0|||
23477959|NCT00724711|65491706|FG001|Overall Study|Physician Decision|3|||
23477960|NCT00724711|65491705|FG000|Overall Study|Withdrawal by Subject|5|||
23477961|NCT00724711|65491706|FG001|Overall Study|Withdrawal by Subject|4|||
23477962|NCT00724711|65491705|FG000|Overall Study|Lost to Follow-up|4|||
23477963|NCT00724711|65491706|FG001|Overall Study|Lost to Follow-up|5|||
23477964|NCT00724711|65491705|FG000|Overall Study|Protocol Violation|1|||
23477965|NCT00724711|65491706|FG001|Overall Study|Protocol Violation|0|||
23477966|NCT03565367|65491707|FG000|Overall Study|No scan due to technical issues|4|||
23477967|NCT03565367|65491708|FG001|Overall Study|No scan due to technical issues|0|||
23477968|NCT00275821|65491710|FG000|Overall Study|Adverse Event|4|||
23477969|NCT00275821|65491711|FG001|Overall Study|Adverse Event|12|||
23477970|NCT00275821|65491712|FG002|Overall Study|Adverse Event|5|||
23477971|NCT00275821|65491710|FG000|Overall Study|Administrative problems|3|||
23477972|NCT00275821|65491711|FG001|Overall Study|Administrative problems|4|||
23477973|NCT00275821|65491712|FG002|Overall Study|Administrative problems|4|||
23477974|NCT00275821|65491710|FG000|Overall Study|Withdrawal by Subject|0|||
23477975|NCT00275821|65491711|FG001|Overall Study|Withdrawal by Subject|2|||
23477976|NCT00275821|65491712|FG002|Overall Study|Withdrawal by Subject|1|||
23477977|NCT00275821|65491710|FG000|Overall Study|Lost to Follow-up|0|||
23477978|NCT00275821|65491711|FG001|Overall Study|Lost to Follow-up|1|||
23477979|NCT00275821|65491712|FG002|Overall Study|Lost to Follow-up|1|||
23477980|NCT00275821|65491710|FG000|Overall Study|Death|0|||
23477981|NCT00275821|65491711|FG001|Overall Study|Death|2|||
23477982|NCT00275821|65491712|FG002|Overall Study|Death|1|||
23477983|NCT00275821|65491710|FG000|Overall Study|Lack of Efficacy|2|||
23477984|NCT00275821|65491711|FG001|Overall Study|Lack of Efficacy|1|||
23477985|NCT00275821|65491712|FG002|Overall Study|Lack of Efficacy|0|||
23477986|NCT00275821|65491710|FG000|Overall Study|Protocol Violation|5|||
23477987|NCT00275821|65491711|FG001|Overall Study|Protocol Violation|1|||
23477988|NCT00275821|65491712|FG002|Overall Study|Protocol Violation|0|||
23477989|NCT00635024|65494388|FG000|Overall Study|Adverse Event|1|||
23477990|NCT01547780|65494391|FG000|Baseline PET Scan|Physician Decision|1|||
23477991|NCT01547780|65494392|FG001|Baseline PET Scan|Physician Decision|0|||
23477992|NCT01547780|65494393|FG002|Baseline PET Scan|Physician Decision|1|||
23477993|NCT01547780|65494394|FG003|Baseline PET Scan|Physician Decision|0|||
23477994|NCT01547780|65494391|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
23477995|NCT01547780|65494392|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
23477996|NCT01547780|65494393|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
23477997|NCT01547780|65494394|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
23477998|NCT00608569|65494398|FG000|Overall Study|Death|4|||
23477999|NCT00608569|65494399|FG001|Overall Study|Death|3|||
23478000|NCT00608569|65494398|FG000|Overall Study|Lost to Follow-up|4|||
23478001|NCT00608569|65494399|FG001|Overall Study|Lost to Follow-up|5|||
23478002|NCT00608569|65494398|FG000|Overall Study|Withdrawal by Subject|1|||
23478003|NCT00608569|65494399|FG001|Overall Study|Withdrawal by Subject|0|||
23478004|NCT00608569|65494398|FG000|Overall Study|Adverse Event|1|||
23478005|NCT00608569|65494399|FG001|Overall Study|Adverse Event|0|||
23478006|NCT00608569|65494398|FG000|Overall Study|Unable to adhere with study requirements|0|||
23478007|NCT00608569|65494399|FG001|Overall Study|Unable to adhere with study requirements|1|||
23478008|NCT03041129|65494400|FG000|Overall Study|Withdrawal by Subject|2|||
23478009|NCT03041129|65494401|FG001|Overall Study|Withdrawal by Subject|0|||
23478010|NCT03041129|65494402|FG002|Overall Study|Withdrawal by Subject|0|||
23478011|NCT03041129|65494403|FG003|Overall Study|Withdrawal by Subject|0|||
23595685|NCT01127373|65912671|FG000|Overall Study|Lost to Follow-up|7|||
23595686|NCT01127373|65912671|FG000|Overall Study|Withdrawal by Subject|1|||
23595687|NCT01127373|65912671|FG000|Overall Study|Disease progression|1|||
23595688|NCT04377308|65912672|FG000|Overall Study|Withdrawal by Subject|0|||
23595689|NCT04377308|65912673|FG001|Overall Study|Withdrawal by Subject|1|||
23595690|NCT03482635|65912677|FG000|Overall Study|Lack of Efficacy|0|||
23595691|NCT03482635|65912678|FG001|Overall Study|Lack of Efficacy|0|||
23595692|NCT03482635|65912679|FG002|Overall Study|Lack of Efficacy|1|||
23595693|NCT03482635|65912680|FG003|Overall Study|Lack of Efficacy|3|||
23595694|NCT03482635|65912677|FG000|Overall Study|Adverse Event|2|||
23595695|NCT03482635|65912678|FG001|Overall Study|Adverse Event|2|||
23595696|NCT03482635|65912679|FG002|Overall Study|Adverse Event|0|||
23595697|NCT03482635|65912680|FG003|Overall Study|Adverse Event|3|||
23595698|NCT03482635|65912677|FG000|Overall Study|Withdrawal by Subject|2|||
23595699|NCT03482635|65912678|FG001|Overall Study|Withdrawal by Subject|1|||
23595700|NCT03482635|65912679|FG002|Overall Study|Withdrawal by Subject|0|||
23595701|NCT03482635|65912680|FG003|Overall Study|Withdrawal by Subject|1|||
23595702|NCT03482635|65912677|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
23595703|NCT03482635|65912678|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
23254829|NCT03439293|64676666|FG000|Overall Study|Death|22|||
23254830|NCT03439293|64676666|FG000|Overall Study|Withdrawal by Subject|8|||
23254831|NCT03439293|64676666|FG000|Overall Study|Lost to Follow-up|2|||
23254832|NCT03439293|64676666|FG000|Overall Study|Reason Not Specified|28|||
23254833|NCT03439293|64676666|FG000|Overall Study|Missing|1|||
23254834|NCT04133519|64676667|FG000|Overall Study|Withdrawal by Subject|5|||
23254835|NCT04133519|64676668|FG001|Overall Study|Withdrawal by Subject|4|||
23254836|NCT04133519|64676667|FG000|Overall Study|Protocol Violation|0|||
23254837|NCT04133519|64676668|FG001|Overall Study|Protocol Violation|1|||
23254838|NCT04133519|64676667|FG000|Overall Study|Never started treatment|1|||
23254839|NCT04133519|64676668|FG001|Overall Study|Never started treatment|1|||
23254840|NCT00736099|64676669|FG000|Overall Study|Adverse Event|61|||
23254841|NCT00736099|64676670|FG001|Overall Study|Adverse Event|18|||
23254842|NCT00736099|64676669|FG000|Overall Study|Protocol Violation|10|||
23254843|NCT00736099|64676670|FG001|Overall Study|Protocol Violation|4|||
23254844|NCT00736099|64676669|FG000|Overall Study|Lost to Follow-up|12|||
23254845|NCT00736099|64676670|FG001|Overall Study|Lost to Follow-up|5|||
23254846|NCT00736099|64676669|FG000|Overall Study|Withdrawal by Subject|42|||
23254847|NCT00736099|64676670|FG001|Overall Study|Withdrawal by Subject|13|||
23254848|NCT00736099|64676669|FG000|Overall Study|Lack of Efficacy|15|||
23254849|NCT00736099|64676670|FG001|Overall Study|Lack of Efficacy|8|||
23254850|NCT00736099|64676669|FG000|Overall Study|Other reason|43|||
23254851|NCT00736099|64676670|FG001|Overall Study|Other reason|10|||
23254852|NCT01625845|64676673|FG000|Overall Study|Adverse Event|1|||
23254853|NCT01625845|64676674|FG001|Overall Study|Adverse Event|2|||
23254854|NCT01625845|64676673|FG000|Overall Study|Lost to Follow-up|2|||
23254855|NCT01625845|64676674|FG001|Overall Study|Lost to Follow-up|1|||
23254856|NCT01625845|64676673|FG000|Overall Study|Withdrawal by Subject|2|||
23254857|NCT01625845|64676674|FG001|Overall Study|Withdrawal by Subject|0|||
23254858|NCT03361956|64676675|FG000|Overall Study|Adverse Event|1|||
23254859|NCT03361956|64676676|FG001|Overall Study|Adverse Event|0|||
23254860|NCT03361956|64676677|FG002|Overall Study|Adverse Event|1|||
23595704|NCT03482635|65912679|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
23595705|NCT03482635|65912680|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
23595706|NCT03482635|65912677|FG000|Overall Study|Not treated|0|||
23595707|NCT03482635|65912678|FG001|Overall Study|Not treated|0|||
23595708|NCT03482635|65912679|FG002|Overall Study|Not treated|0|||
23595709|NCT03482635|65912680|FG003|Overall Study|Not treated|1|||
23595710|NCT03887650|65912684|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
23595711|NCT03887650|65912685|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
23595712|NCT03887650|65912684|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
23595713|NCT03887650|65912685|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
23595714|NCT03887650|65912684|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
23595715|NCT03887650|65912685|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
23595716|NCT01303445|65912686|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
23595717|NCT01303445|65912687|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
23254861|NCT03361956|64676678|FG003|Overall Study|Adverse Event|1|||
23254862|NCT03361956|64676679|FG004|Overall Study|Adverse Event|0|||
23254863|NCT03361956|64676675|FG000|Overall Study|Other|0|||
23254864|NCT03361956|64676676|FG001|Overall Study|Other|0|||
23595718|NCT01303445|65912686|FG000|Second Intervention (7 Days)|Adverse Event|0|||
23595719|NCT01303445|65912687|FG001|Second Intervention (7 Days)|Adverse Event|2|||
23595720|NCT01303445|65912686|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
23595721|NCT01303445|65912687|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
23595722|NCT01303445|65912686|FG000|Washout (14 Days)|Protocol Violation|1|||
23254865|NCT03361956|64676677|FG002|Overall Study|Other|0|||
23254866|NCT03361956|64676678|FG003|Overall Study|Other|1|||
23254867|NCT03361956|64676679|FG004|Overall Study|Other|0|||
23595723|NCT01303445|65912687|FG001|Washout (14 Days)|Protocol Violation|0|||
23595724|NCT01303445|65912686|FG000|Washout (14 Days)|Lost to Follow-up|0|||
23595725|NCT01303445|65912687|FG001|Washout (14 Days)|Lost to Follow-up|2|||
23595726|NCT01303445|65912686|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
23595727|NCT01303445|65912687|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
23595728|NCT01303445|65912686|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
23595729|NCT01303445|65912687|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
23595730|NCT01953692|65912688|FG000|Overall Study|Adverse Event|5|||
23595731|NCT01953692|65912689|FG001|Overall Study|Adverse Event|2|||
23595732|NCT01953692|65912690|FG002|Overall Study|Adverse Event|4|||
23595733|NCT01953692|65912691|FG003|Overall Study|Adverse Event|2|||
23595734|NCT01953692|65912692|FG004|Overall Study|Adverse Event|1|||
23595735|NCT01953692|65912693|FG005|Overall Study|Adverse Event|2|||
23595736|NCT01953692|65912694|FG006|Overall Study|Adverse Event|0|||
23595737|NCT01953692|65912695|FG007|Overall Study|Adverse Event|0|||
23595738|NCT01953692|65912696|FG008|Overall Study|Adverse Event|0|||
23595739|NCT01953692|65912688|FG000|Overall Study|Clinical Progression|0|||
23595740|NCT01953692|65912689|FG001|Overall Study|Clinical Progression|15|||
23595741|NCT01953692|65912690|FG002|Overall Study|Clinical Progression|7|||
23595742|NCT01953692|65912691|FG003|Overall Study|Clinical Progression|5|||
23595743|NCT01953692|65912692|FG004|Overall Study|Clinical Progression|0|||
23595744|NCT01953692|65912693|FG005|Overall Study|Clinical Progression|7|||
23595745|NCT01953692|65912694|FG006|Overall Study|Clinical Progression|20|||
23595746|NCT01953692|65912695|FG007|Overall Study|Clinical Progression|3|||
23595747|NCT01953692|65912696|FG008|Overall Study|Clinical Progression|3|||
23595748|NCT01953692|65912688|FG000|Overall Study|Death|5|||
23595749|NCT01953692|65912689|FG001|Overall Study|Death|0|||
23595750|NCT01953692|65912690|FG002|Overall Study|Death|2|||
23595751|NCT01953692|65912691|FG003|Overall Study|Death|2|||
23595752|NCT01953692|65912692|FG004|Overall Study|Death|1|||
23595753|NCT01953692|65912693|FG005|Overall Study|Death|3|||
23595754|NCT01953692|65912694|FG006|Overall Study|Death|6|||
23595755|NCT01953692|65912695|FG007|Overall Study|Death|2|||
23595756|NCT01953692|65912696|FG008|Overall Study|Death|1|||
23595757|NCT01953692|65912688|FG000|Overall Study|Excluded Medication|1|||
23595758|NCT01953692|65912689|FG001|Overall Study|Excluded Medication|0|||
23595759|NCT01953692|65912690|FG002|Overall Study|Excluded Medication|0|||
23595760|NCT01953692|65912691|FG003|Overall Study|Excluded Medication|0|||
23595761|NCT01953692|65912692|FG004|Overall Study|Excluded Medication|0|||
23595762|NCT01953692|65912693|FG005|Overall Study|Excluded Medication|0|||
23595763|NCT01953692|65912694|FG006|Overall Study|Excluded Medication|0|||
23595764|NCT01953692|65912695|FG007|Overall Study|Excluded Medication|0|||
23595765|NCT01953692|65912696|FG008|Overall Study|Excluded Medication|0|||
23595766|NCT01953692|65912688|FG000|Overall Study|Lost to Follow-up|1|||
23595767|NCT01953692|65912689|FG001|Overall Study|Lost to Follow-up|0|||
23595768|NCT01953692|65912690|FG002|Overall Study|Lost to Follow-up|3|||
23595769|NCT01953692|65912691|FG003|Overall Study|Lost to Follow-up|1|||
23595770|NCT01953692|65912692|FG004|Overall Study|Lost to Follow-up|0|||
23595771|NCT01953692|65912693|FG005|Overall Study|Lost to Follow-up|1|||
23194206|NCT01161524|64452510|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
23254868|NCT03361956|64676675|FG000|Overall Study|Withdrawal by Subject|2|||
23254869|NCT03361956|64676676|FG001|Overall Study|Withdrawal by Subject|2|||
23254870|NCT03361956|64676677|FG002|Overall Study|Withdrawal by Subject|2|||
23254871|NCT03361956|64676678|FG003|Overall Study|Withdrawal by Subject|0|||
23254872|NCT03361956|64676679|FG004|Overall Study|Withdrawal by Subject|3|||
23254873|NCT03361956|64676675|FG000|Overall Study|Disease Relapse|0|||
23254874|NCT03361956|64676676|FG001|Overall Study|Disease Relapse|0|||
23254875|NCT03361956|64676677|FG002|Overall Study|Disease Relapse|1|||
23254876|NCT03361956|64676678|FG003|Overall Study|Disease Relapse|0|||
23254877|NCT03361956|64676679|FG004|Overall Study|Disease Relapse|0|||
23254878|NCT03361956|64676675|FG000|Overall Study|Physician Decision|0|||
23254879|NCT03361956|64676676|FG001|Overall Study|Physician Decision|2|||
23254880|NCT03361956|64676677|FG002|Overall Study|Physician Decision|0|||
23254881|NCT03361956|64676678|FG003|Overall Study|Physician Decision|1|||
23254882|NCT03361956|64676679|FG004|Overall Study|Physician Decision|0|||
23254883|NCT03361956|64676675|FG000|Overall Study|Lost to Follow-up|0|||
23595772|NCT01953692|65912694|FG006|Overall Study|Lost to Follow-up|0|||
23595773|NCT01953692|65912695|FG007|Overall Study|Lost to Follow-up|0|||
23595774|NCT01953692|65912696|FG008|Overall Study|Lost to Follow-up|0|||
23595775|NCT01953692|65912688|FG000|Overall Study|Physician Decision|11|||
23595776|NCT01953692|65912689|FG001|Overall Study|Physician Decision|4|||
23595777|NCT01953692|65912690|FG002|Overall Study|Physician Decision|2|||
23595778|NCT01953692|65912691|FG003|Overall Study|Physician Decision|2|||
23595779|NCT01953692|65912692|FG004|Overall Study|Physician Decision|1|||
23595780|NCT01953692|65912693|FG005|Overall Study|Physician Decision|2|||
23595781|NCT01953692|65912694|FG006|Overall Study|Physician Decision|4|||
23595782|NCT01953692|65912695|FG007|Overall Study|Physician Decision|1|||
23595783|NCT01953692|65912696|FG008|Overall Study|Physician Decision|0|||
23194207|NCT01161524|64452511|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
23194208|NCT01161524|64452512|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
23254884|NCT03361956|64676676|FG001|Overall Study|Lost to Follow-up|0|||
23254885|NCT03361956|64676677|FG002|Overall Study|Lost to Follow-up|1|||
23254886|NCT03361956|64676678|FG003|Overall Study|Lost to Follow-up|1|||
23254887|NCT03361956|64676679|FG004|Overall Study|Lost to Follow-up|2|||
23254888|NCT00185211|64676680|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
23254889|NCT00185211|64676681|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
23254890|NCT00185211|64676680|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
23254891|NCT00185211|64676681|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
23254892|NCT00185211|64676680|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
23254893|NCT00185211|64676681|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
23254894|NCT00185211|64676680|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
23254895|NCT00185211|64676681|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
23254896|NCT00185211|64676680|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
23254897|NCT00185211|64676681|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
23254898|NCT00185211|64676680|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
23254899|NCT00185211|64676681|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
23254900|NCT00185211|64676680|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
23254901|NCT00185211|64676681|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
23254902|NCT00185211|64676680|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
23254903|NCT00185211|64676681|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
23254904|NCT00185211|64676680|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
23254905|NCT00185211|64676681|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
23254906|NCT00185211|64676680|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
23254907|NCT00185211|64676681|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
23254908|NCT00185211|64676680|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
23254909|NCT00185211|64676681|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
23254910|NCT00185211|64676680|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
23254911|NCT00185211|64676681|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
23254912|NCT01270841|64676682|FG000|Overall Study|Adverse Event|0|||
23254913|NCT01270841|64676683|FG001|Overall Study|Adverse Event|1|||
23254914|NCT01270841|64676684|FG002|Overall Study|Adverse Event|0|||
23254915|NCT01270841|64676685|FG003|Overall Study|Adverse Event|3|||
23254916|NCT01270841|64676682|FG000|Overall Study|Withdrawal by Subject|3|||
23254917|NCT01270841|64676683|FG001|Overall Study|Withdrawal by Subject|2|||
23254918|NCT01270841|64676684|FG002|Overall Study|Withdrawal by Subject|3|||
23254919|NCT01270841|64676685|FG003|Overall Study|Withdrawal by Subject|3|||
23254920|NCT01270841|64676682|FG000|Overall Study|Lost to Follow-up|3|||
23254921|NCT01270841|64676683|FG001|Overall Study|Lost to Follow-up|1|||
23254922|NCT01270841|64676684|FG002|Overall Study|Lost to Follow-up|4|||
23254923|NCT01270841|64676685|FG003|Overall Study|Lost to Follow-up|2|||
23254924|NCT01270841|64676682|FG000|Overall Study|Physician Decision|0|||
23254925|NCT01270841|64676683|FG001|Overall Study|Physician Decision|1|||
23254926|NCT01270841|64676684|FG002|Overall Study|Physician Decision|0|||
23254927|NCT01270841|64676685|FG003|Overall Study|Physician Decision|0|||
23254928|NCT01270841|64676682|FG000|Overall Study|Did not qualify|6|||
23254929|NCT01270841|64676683|FG001|Overall Study|Did not qualify|3|||
23254930|NCT01270841|64676684|FG002|Overall Study|Did not qualify|4|||
23254931|NCT01270841|64676685|FG003|Overall Study|Did not qualify|5|||
23254932|NCT01270841|64676682|FG000|Overall Study|Protocol Violation|1|||
23254933|NCT01270841|64676683|FG001|Overall Study|Protocol Violation|5|||
23254934|NCT01270841|64676684|FG002|Overall Study|Protocol Violation|0|||
23254935|NCT01270841|64676685|FG003|Overall Study|Protocol Violation|0|||
23254936|NCT01270841|64676682|FG000|Overall Study|Enrolled in error|0|||
23254937|NCT01270841|64676683|FG001|Overall Study|Enrolled in error|1|||
23254938|NCT01270841|64676684|FG002|Overall Study|Enrolled in error|0|||
23254939|NCT01270841|64676685|FG003|Overall Study|Enrolled in error|0|||
23254940|NCT01716754|64676711|FG000|Overall Study|Death|0|||
23254941|NCT01716754|64676712|FG001|Overall Study|Death|0|||
23254942|NCT01716754|64676713|FG002|Overall Study|Death|0|||
23595784|NCT01953692|65912688|FG000|Overall Study|Protocol Violation|0|||
23254943|NCT01716754|64676714|FG003|Overall Study|Death|1|||
23254944|NCT01716754|64676711|FG000|Overall Study|Protocol deviation|0|||
23254945|NCT01716754|64676712|FG001|Overall Study|Protocol deviation|2|||
23254946|NCT01716754|64676713|FG002|Overall Study|Protocol deviation|7|||
23254947|NCT01716754|64676714|FG003|Overall Study|Protocol deviation|2|||
23254948|NCT01716754|64676711|FG000|Overall Study|Non-compliance with study treatment|0|||
23254949|NCT01716754|64676712|FG001|Overall Study|Non-compliance with study treatment|0|||
23254950|NCT01716754|64676713|FG002|Overall Study|Non-compliance with study treatment|1|||
23254951|NCT01716754|64676714|FG003|Overall Study|Non-compliance with study treatment|0|||
23254952|NCT01716754|64676711|FG000|Overall Study|Physician Decision|1|||
23254953|NCT01716754|64676712|FG001|Overall Study|Physician Decision|0|||
23360320|NCT02748057|65062902|FG000|Overall Study|Protocol Violation|2|||
23254954|NCT01716754|64676713|FG002|Overall Study|Physician Decision|0|||
23254955|NCT01716754|64676714|FG003|Overall Study|Physician Decision|0|||
23254956|NCT01716754|64676711|FG000|Overall Study|Lost to Follow-up|1|||
23254957|NCT01716754|64676712|FG001|Overall Study|Lost to Follow-up|0|||
23254958|NCT01716754|64676713|FG002|Overall Study|Lost to Follow-up|0|||
23254959|NCT01716754|64676714|FG003|Overall Study|Lost to Follow-up|1|||
23254960|NCT01716754|64676711|FG000|Overall Study|Adverse Event|4|||
23254961|NCT01716754|64676712|FG001|Overall Study|Adverse Event|2|||
23254962|NCT01716754|64676713|FG002|Overall Study|Adverse Event|2|||
23254963|NCT01716754|64676714|FG003|Overall Study|Adverse Event|1|||
23254964|NCT01716754|64676711|FG000|Overall Study|Withdrawal by Subject|5|||
23254965|NCT01716754|64676712|FG001|Overall Study|Withdrawal by Subject|0|||
23254966|NCT01716754|64676713|FG002|Overall Study|Withdrawal by Subject|4|||
23254967|NCT01716754|64676714|FG003|Overall Study|Withdrawal by Subject|3|||
23254968|NCT00789828|64676715|FG000|Core Period (48 Weeks)|Administrative problems|0|||
23254969|NCT00789828|64676716|FG001|Core Period (48 Weeks)|Administrative problems|1|||
23254970|NCT00789828|64676715|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
23254971|NCT00789828|64676716|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
23254972|NCT00789828|64676715|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
23254973|NCT00789828|64676716|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
23254974|NCT00789828|64676715|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
23254975|NCT00789828|64676716|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
23254976|NCT00789828|64676715|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
23254977|NCT00789828|64676716|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
23254978|NCT00789828|64676715|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
23254979|NCT00789828|64676716|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
23254980|NCT00789828|64676715|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
23254981|NCT00789828|64676716|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
23254982|NCT00789828|64676715|FG000|Open-label Extension Period (4 Years)|Death|1|||
23254983|NCT00789828|64676716|FG001|Open-label Extension Period (4 Years)|Death|0|||
23254984|NCT00789828|64676715|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
23254985|NCT00789828|64676716|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
23254986|NCT00789828|64676715|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
23254987|NCT00789828|64676716|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
23254988|NCT03451331|64676717|FG000|Overall Study|Withdrawal by Subject|1|||
23254989|NCT03451331|64676718|FG001|Overall Study|Withdrawal by Subject|0|||
23254990|NCT03451331|64676717|FG000|Overall Study|Unable to start treatment.|1|||
23254991|NCT03451331|64676718|FG001|Overall Study|Unable to start treatment.|1|||
23254992|NCT00854620|64676720|FG000|Overall Study|Adverse Event|1|||
23254993|NCT01076166|64676721|FG000|Overall Study|Adverse Event|3|||
23254994|NCT01076166|64676721|FG000|Overall Study|Symptoms improved/resolved|6|||
23254995|NCT03586830|64676725|FG000|Overall Study|Site terminated by Sponsor|1|||
23254996|NCT03586830|64676726|FG001|Overall Study|Site terminated by Sponsor|4|||
23254997|NCT03586830|64676727|FG002|Overall Study|Site terminated by Sponsor|3|||
23254998|NCT03586830|64676728|FG003|Overall Study|Site terminated by Sponsor|3|||
23254999|NCT03586830|64676725|FG000|Overall Study|Lost to Follow-up|0|||
23255000|NCT03586830|64676726|FG001|Overall Study|Lost to Follow-up|2|||
23255001|NCT03586830|64676727|FG002|Overall Study|Lost to Follow-up|2|||
23255002|NCT03586830|64676728|FG003|Overall Study|Lost to Follow-up|1|||
23255003|NCT03586830|64676725|FG000|Overall Study|Withdrawal by Subject|1|||
23255004|NCT03586830|64676726|FG001|Overall Study|Withdrawal by Subject|0|||
23255005|NCT03586830|64676727|FG002|Overall Study|Withdrawal by Subject|3|||
23595785|NCT01953692|65912689|FG001|Overall Study|Protocol Violation|2|||
23595786|NCT01953692|65912690|FG002|Overall Study|Protocol Violation|1|||
23595787|NCT01953692|65912691|FG003|Overall Study|Protocol Violation|0|||
23595788|NCT01953692|65912692|FG004|Overall Study|Protocol Violation|0|||
23255006|NCT03586830|64676728|FG003|Overall Study|Withdrawal by Subject|1|||
23255007|NCT03372083|64676729|FG000|Overall Study|Adverse Event|3|||
23255008|NCT03372083|64676729|FG000|Overall Study|Physician Decision|1|||
23255009|NCT03372083|64676729|FG000|Overall Study|Withdrawal by Subject|1|||
23255010|NCT02280356|64676733|FG000|Overall Study|Not Treated|2|||
23595789|NCT01953692|65912693|FG005|Overall Study|Protocol Violation|0|||
23255011|NCT02280356|64676733|FG000|Overall Study|Withdrawal by Subject|1|||
23255012|NCT02280356|64676733|FG000|Overall Study|Not evaluable|2|||
23595790|NCT01953692|65912694|FG006|Overall Study|Protocol Violation|0|||
23595791|NCT01953692|65912695|FG007|Overall Study|Protocol Violation|1|||
23595792|NCT01953692|65912696|FG008|Overall Study|Protocol Violation|0|||
23595793|NCT01953692|65912688|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595794|NCT01953692|65912689|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595795|NCT01953692|65912690|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23255013|NCT00931385|64676734|FG000|Overall Study|Adverse Event|2|||
23255014|NCT00931385|64676735|FG001|Overall Study|Adverse Event|1|||
23255015|NCT00931385|64676736|FG002|Overall Study|Adverse Event|0|||
23255016|NCT00931385|64676737|FG003|Overall Study|Adverse Event|3|||
23360321|NCT02748057|65062903|FG001|Overall Study|Protocol Violation|1|||
23360322|NCT02748057|65062902|FG000|Overall Study|Participant Moved|1|||
23595796|NCT01953692|65912691|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595797|NCT01953692|65912692|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595798|NCT01953692|65912693|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595799|NCT01953692|65912694|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595800|NCT01953692|65912695|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
23595801|NCT01953692|65912696|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
23595802|NCT01953692|65912688|FG000|Overall Study|Withdrawal by Subject|4|||
23595803|NCT01953692|65912689|FG001|Overall Study|Withdrawal by Subject|2|||
23595804|NCT01953692|65912690|FG002|Overall Study|Withdrawal by Subject|1|||
23595805|NCT01953692|65912691|FG003|Overall Study|Withdrawal by Subject|2|||
23595806|NCT01953692|65912692|FG004|Overall Study|Withdrawal by Subject|0|||
23595807|NCT01953692|65912693|FG005|Overall Study|Withdrawal by Subject|3|||
23595808|NCT01953692|65912694|FG006|Overall Study|Withdrawal by Subject|2|||
23595809|NCT01953692|65912695|FG007|Overall Study|Withdrawal by Subject|1|||
23595810|NCT01953692|65912696|FG008|Overall Study|Withdrawal by Subject|1|||
23595811|NCT01109524|65912697|FG000|Overall Study|Disease Progression|29|||
23595812|NCT01109524|65912697|FG000|Overall Study|Study Drug toxicity|6|||
23595813|NCT01109524|65912697|FG000|Overall Study|Adverse Event|4|||
23595814|NCT01109524|65912697|FG000|Overall Study|Withdrawal by Subject|2|||
23595815|NCT01109524|65912697|FG000|Overall Study|Maximum clinical benefit|3|||
23595816|NCT01109524|65912697|FG000|Overall Study|Death|2|||
23595817|NCT01109524|65912697|FG000|Overall Study|No longer meets criteria|2|||
23595818|NCT01109524|65912697|FG000|Overall Study|Participant requested to end treatment|4|||
23595819|NCT01109524|65912697|FG000|Overall Study|Other|5|||
23595820|NCT02755116|65912698|FG000|Overall Study|surgery converted to open, pt admitted|3|||
23595821|NCT02755116|65912699|FG001|Overall Study|surgery converted to open, pt admitted|1|||
23595822|NCT02574455|65912716|FG000|Overall Study|Death|197|||
23595823|NCT02574455|65912717|FG001|Overall Study|Death|210|||
23595824|NCT02574455|65912716|FG000|Overall Study|Withdrawal of Consent|11|||
23595825|NCT02574455|65912717|FG001|Overall Study|Withdrawal of Consent|28|||
23595826|NCT02574455|65912716|FG000|Overall Study|Lost to Follow-up|4|||
23595827|NCT02574455|65912717|FG001|Overall Study|Lost to Follow-up|4|||
23595828|NCT02574455|65912716|FG000|Overall Study|Sponsor's Decision|55|||
23595829|NCT02574455|65912717|FG001|Overall Study|Sponsor's Decision|20|||
23595830|NCT00593489|65912720|FG000|Allocation|did not attend workshop; allocation not|2|||
23595831|NCT00593489|65912721|FG001|Allocation|did not attend workshop; allocation not|1|||
23595832|NCT02101281|65912723|FG000|Overall Study|Adverse Event|0|||
23595833|NCT02101281|65912724|FG001|Overall Study|Adverse Event|1|||
23595834|NCT03175172|65912726|FG000|Overall Study|Death|3|||
23595835|NCT03175172|65912726|FG000|Overall Study|Withdrawal by Subject|3|||
23595836|NCT03175172|65912726|FG000|Overall Study|Lost to Follow-up|1|||
23595837|NCT03175172|65912726|FG000|Overall Study|Study Terminated by Sponsor|3|||
23595838|NCT03345901|65912727|FG000|Overall Study|The study was terminated|18|||
23595839|NCT01460446|65912728|FG000|Overall Study|Non-compliance|2|||
23595840|NCT01460446|65912729|FG001|Overall Study|Non-compliance|9|||
23595841|NCT01460446|65912728|FG000|Overall Study|Consent Withdrawn|0|||
23595842|NCT01460446|65912729|FG001|Overall Study|Consent Withdrawn|4|||
23595843|NCT01460446|65912728|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
23595844|NCT01460446|65912729|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
23595845|NCT01460446|65912728|FG000|Overall Study|Surgery/Illness|1|||
23595846|NCT01460446|65912729|FG001|Overall Study|Surgery/Illness|1|||
23595847|NCT01460446|65912728|FG000|Overall Study|Pregnancy|1|||
23595848|NCT01460446|65912729|FG001|Overall Study|Pregnancy|0|||
23595849|NCT01460446|65912728|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
23595850|NCT01460446|65912729|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
23595851|NCT02015546|65912730|FG000|Overall Study|Withdrawal by Subject|1|||
23595852|NCT02015546|65912731|FG001|Overall Study|Withdrawal by Subject|1|||
23595853|NCT02015546|65912732|FG002|Overall Study|Withdrawal by Subject|1|||
23595854|NCT02015546|65912730|FG000|Overall Study|Screem Failure|2|||
23194209|NCT01161524|64452510|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
23360323|NCT02748057|65062903|FG001|Overall Study|Participant Moved|0|||
23194210|NCT01161524|64452511|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
23360324|NCT02748057|65062902|FG000|Overall Study|Withdrawal by Subject|1|||
23360325|NCT02748057|65062903|FG001|Overall Study|Withdrawal by Subject|0|||
23360326|NCT01601496|65062906|FG000|Overall Study|Physician Decision|1|||
23360327|NCT01601496|65062906|FG000|Overall Study|Withdrawal by Subject|1|||
23595855|NCT02015546|65912731|FG001|Overall Study|Screem Failure|1|||
23595856|NCT02015546|65912732|FG002|Overall Study|Screem Failure|3|||
23595857|NCT01255670|65912737|FG000|Overall Study|Adverse Event|10|||
23595858|NCT01255670|65912738|FG001|Overall Study|Adverse Event|10|||
23595859|NCT01255670|65912737|FG000|Overall Study|Lost to Follow-up|16|||
23595860|NCT01255670|65912738|FG001|Overall Study|Lost to Follow-up|10|||
23595861|NCT00262301|65912742|FG000|Double-blind Phase|Lost to Follow-up|1|||
23595862|NCT00262301|65912743|FG001|Double-blind Phase|Lost to Follow-up|0|||
23595863|NCT00262301|65912744|FG002|Double-blind Phase|Lost to Follow-up|0|||
23478012|NCT02048241|65494404|FG000|Overall Study|Withdrawal by Subject|0|||
23478013|NCT02048241|65494405|FG001|Overall Study|Withdrawal by Subject|1|||
23478014|NCT02184455|65494411|FG000|Overall Study|Lost to Follow-up|1|||
23478015|NCT01954927|65494415|FG000|Overall Study|Withdrawal by Subject|3|||
23478016|NCT01954927|65494416|FG001|Overall Study|Withdrawal by Subject|1|||
23478017|NCT01270802|65494418|FG000|Overall Study|Withdrawal by Subject|1|||
23478018|NCT01270802|65494419|FG001|Overall Study|Withdrawal by Subject|0|||
23478019|NCT01270802|65494418|FG000|Overall Study|Adverse Event|1|||
23478020|NCT01270802|65494419|FG001|Overall Study|Adverse Event|0|||
23478021|NCT01270802|65494418|FG000|Overall Study|Lost to Follow-up|0|||
23478022|NCT01270802|65494419|FG001|Overall Study|Lost to Follow-up|1|||
23478023|NCT00422084|65494420|FG000|Overall Study|Adverse Event|21|||
23478024|NCT00422084|65494421|FG001|Overall Study|Adverse Event|7|||
23478025|NCT00422084|65494420|FG000|Overall Study|Withdrawal by Subject|12|||
23478026|NCT00422084|65494421|FG001|Overall Study|Withdrawal by Subject|9|||
23478027|NCT00422084|65494420|FG000|Overall Study|Lost to Follow-up|14|||
23478028|NCT00422084|65494421|FG001|Overall Study|Lost to Follow-up|9|||
23478029|NCT00422084|65494420|FG000|Overall Study|Protocol Violation|4|||
23478030|NCT00422084|65494421|FG001|Overall Study|Protocol Violation|1|||
23478031|NCT00422084|65494420|FG000|Overall Study|Lack of Efficacy|40|||
23478032|NCT00422084|65494421|FG001|Overall Study|Lack of Efficacy|42|||
23478033|NCT00422084|65494420|FG000|Overall Study|P. vivax infection|3|||
23478034|NCT00422084|65494421|FG001|Overall Study|P. vivax infection|6|||
23478035|NCT00422084|65494420|FG000|Overall Study|Cyesis|1|||
23478036|NCT00422084|65494421|FG001|Overall Study|Cyesis|0|||
23478037|NCT00422084|65494420|FG000|Overall Study|Withdrawn from study accidentally|1|||
23478038|NCT00422084|65494421|FG001|Overall Study|Withdrawn from study accidentally|0|||
23478039|NCT00422084|65494420|FG000|Overall Study|Non-compliance|1|||
23478040|NCT00422084|65494421|FG001|Overall Study|Non-compliance|0|||
23478041|NCT00422084|65494420|FG000|Overall Study|Re-location|0|||
23478042|NCT00422084|65494421|FG001|Overall Study|Re-location|1|||
23478043|NCT00422084|65494420|FG000|Overall Study|Not defined|1|||
23478044|NCT00422084|65494421|FG001|Overall Study|Not defined|1|||
23478045|NCT01836276|65494424|FG000|Overall Study|Lost to Follow-up|28|||
23478046|NCT01836276|65494425|FG001|Overall Study|Lost to Follow-up|51|||
23478047|NCT03579602|65494426|FG000|Overall Study|Subject unable to receive study drug|0|||
23478048|NCT03579602|65494427|FG001|Overall Study|Subject unable to receive study drug|2|||
23478049|NCT03579602|65494426|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
23478050|NCT03579602|65494427|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
23478051|NCT00308581|65494428|FG000|Induction Phase|Adverse Event|0|||
23478052|NCT00308581|65494429|FG001|Induction Phase|Adverse Event|0|||
23478053|NCT00308581|65494430|FG002|Induction Phase|Adverse Event|37|||
23478054|NCT00308581|65494428|FG000|Induction Phase|Lack of Efficacy|0|||
23478055|NCT00308581|65494429|FG001|Induction Phase|Lack of Efficacy|0|||
23478056|NCT00308581|65494430|FG002|Induction Phase|Lack of Efficacy|121|||
23478057|NCT00308581|65494428|FG000|Induction Phase|Withdrawal by Subject|0|||
23478058|NCT00308581|65494429|FG001|Induction Phase|Withdrawal by Subject|0|||
23478059|NCT00308581|65494430|FG002|Induction Phase|Withdrawal by Subject|5|||
23478060|NCT00308581|65494428|FG000|Induction Phase|Unknown reason|0|||
23478061|NCT00308581|65494429|FG001|Induction Phase|Unknown reason|0|||
23478062|NCT00308581|65494430|FG002|Induction Phase|Unknown reason|3|||
23478063|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Adverse Event|10|||
23478064|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Adverse Event|17|||
23478065|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Adverse Event|0|||
23478066|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
23478067|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
23478068|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
23478069|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
23478070|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
23478071|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
23478072|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
23478073|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
23478074|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
23360328|NCT01601496|65062906|FG000|Overall Study|Lost to Follow-up|6|||
23478075|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
23595864|NCT00262301|65912742|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
23478076|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
23478077|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
23478078|NCT00308581|65494428|FG000|Randomized Maintenance Phase|Unknown reason|3|||
23478079|NCT00308581|65494429|FG001|Randomized Maintenance Phase|Unknown reason|0|||
23255017|NCT00931385|64676734|FG000|Overall Study|Protocol Violation|0|||
23478080|NCT00308581|65494430|FG002|Randomized Maintenance Phase|Unknown reason|0|||
23478081|NCT00130247|65494431|FG000|Overall Study|Pregnancy|1|||
23478082|NCT00130247|65494432|FG001|Overall Study|Pregnancy|0|||
23478083|NCT00130247|65494431|FG000|Overall Study|Post-randomization exclusion|1|||
23255018|NCT00931385|64676735|FG001|Overall Study|Protocol Violation|0|||
23255019|NCT00931385|64676736|FG002|Overall Study|Protocol Violation|1|||
23255020|NCT00931385|64676737|FG003|Overall Study|Protocol Violation|0|||
23255021|NCT00931385|64676734|FG000|Overall Study|Withdrawal by Subject|0|||
23255022|NCT00931385|64676735|FG001|Overall Study|Withdrawal by Subject|1|||
23255023|NCT00931385|64676736|FG002|Overall Study|Withdrawal by Subject|0|||
23255024|NCT00931385|64676737|FG003|Overall Study|Withdrawal by Subject|1|||
23255025|NCT00931385|64676734|FG000|Overall Study|Lost to Follow-up|0|||
23255026|NCT00931385|64676735|FG001|Overall Study|Lost to Follow-up|0|||
23255027|NCT00931385|64676736|FG002|Overall Study|Lost to Follow-up|0|||
23255028|NCT00931385|64676737|FG003|Overall Study|Lost to Follow-up|1|||
23595865|NCT00262301|65912743|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
23595866|NCT00262301|65912744|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
23595867|NCT03260140|65912745|FG000|Overall Study|Death|4|||
23595868|NCT03260140|65912746|FG001|Overall Study|Death|1|||
23595869|NCT03260140|65912745|FG000|Overall Study|Withdrawal by Subject|1|||
23595870|NCT03260140|65912746|FG001|Overall Study|Withdrawal by Subject|4|||
23595871|NCT04820686|65912747|FG000|Overall Study|Withdrawal by Subject|5|||
23595872|NCT04820686|65912748|FG001|Overall Study|Withdrawal by Subject|2|||
23595873|NCT04820686|65912749|FG002|Overall Study|Withdrawal by Subject|3|||
23595874|NCT04820686|65912747|FG000|Overall Study|Study Termination|25|||
23595875|NCT04820686|65912748|FG001|Overall Study|Study Termination|13|||
23255029|NCT01690520|64676738|FG000|Overall Study|Death|25|||
23360329|NCT01601496|65062906|FG000|Overall Study|Death|4|||
23478084|NCT00130247|65494432|FG001|Overall Study|Post-randomization exclusion|2|||
23478085|NCT00130247|65494431|FG000|Overall Study|Not compliant with DOT|0|||
23595876|NCT04820686|65912749|FG002|Overall Study|Study Termination|14|||
23595877|NCT04820686|65912747|FG000|Overall Study|Adverse Event|0|||
23595878|NCT04820686|65912748|FG001|Overall Study|Adverse Event|1|||
23595879|NCT04820686|65912749|FG002|Overall Study|Adverse Event|0|||
23595880|NCT01266122|65912750|FG000|Overall Study|Lost to Follow-up|6|||
23595881|NCT01266122|65912751|FG001|Overall Study|Lost to Follow-up|6|||
23595882|NCT01636687|65912752|FG000|Induction Period|Withdrawal by Subject|1|||
23595883|NCT01636687|65912753|FG001|Induction Period|Withdrawal by Subject|0|||
23595884|NCT01636687|65912754|FG002|Induction Period|Withdrawal by Subject|0|||
23595885|NCT01636687|65912755|FG003|Induction Period|Withdrawal by Subject|0|||
23595886|NCT01636687|65912756|FG004|Induction Period|Withdrawal by Subject|0|||
23595887|NCT01636687|65912752|FG000|Induction Period|Adverse Event|1|||
23595888|NCT01636687|65912753|FG001|Induction Period|Adverse Event|0|||
23595889|NCT01636687|65912754|FG002|Induction Period|Adverse Event|0|||
23595890|NCT01636687|65912755|FG003|Induction Period|Adverse Event|0|||
23595891|NCT01636687|65912756|FG004|Induction Period|Adverse Event|1|||
23595892|NCT01636687|65912752|FG000|Induction Period|Lack of Efficacy|0|||
23595893|NCT01636687|65912753|FG001|Induction Period|Lack of Efficacy|0|||
23595894|NCT01636687|65912754|FG002|Induction Period|Lack of Efficacy|0|||
23595895|NCT01636687|65912755|FG003|Induction Period|Lack of Efficacy|0|||
23595896|NCT01636687|65912756|FG004|Induction Period|Lack of Efficacy|1|||
23595897|NCT01636687|65912752|FG000|Induction Period|Physician Decision|1|||
23595898|NCT01636687|65912753|FG001|Induction Period|Physician Decision|0|||
23595899|NCT01636687|65912754|FG002|Induction Period|Physician Decision|0|||
23595900|NCT01636687|65912755|FG003|Induction Period|Physician Decision|0|||
23595901|NCT01636687|65912756|FG004|Induction Period|Physician Decision|0|||
23595902|NCT01636687|65912752|FG000|Maintenance Period|Withdrawal by Subject|2|||
23595903|NCT01636687|65912753|FG001|Maintenance Period|Withdrawal by Subject|0|||
23595904|NCT01636687|65912754|FG002|Maintenance Period|Withdrawal by Subject|2|||
23595905|NCT01636687|65912755|FG003|Maintenance Period|Withdrawal by Subject|0|||
23595906|NCT01636687|65912756|FG004|Maintenance Period|Withdrawal by Subject|0|||
23595907|NCT01636687|65912752|FG000|Maintenance Period|Adverse Event|1|||
23595908|NCT01636687|65912753|FG001|Maintenance Period|Adverse Event|0|||
23595909|NCT01636687|65912754|FG002|Maintenance Period|Adverse Event|0|||
23595910|NCT01636687|65912755|FG003|Maintenance Period|Adverse Event|0|||
23595911|NCT01636687|65912756|FG004|Maintenance Period|Adverse Event|0|||
23595912|NCT01636687|65912752|FG000|Maintenance Period|Lack of Efficacy|4|||
23595913|NCT01636687|65912753|FG001|Maintenance Period|Lack of Efficacy|1|||
23595914|NCT01636687|65912754|FG002|Maintenance Period|Lack of Efficacy|0|||
23595915|NCT01636687|65912755|FG003|Maintenance Period|Lack of Efficacy|0|||
23595916|NCT01636687|65912756|FG004|Maintenance Period|Lack of Efficacy|0|||
23595917|NCT01636687|65912752|FG000|Maintenance Period|Lost to Follow-up|1|||
23595918|NCT01636687|65912753|FG001|Maintenance Period|Lost to Follow-up|1|||
23595919|NCT01636687|65912754|FG002|Maintenance Period|Lost to Follow-up|0|||
23595920|NCT01636687|65912755|FG003|Maintenance Period|Lost to Follow-up|0|||
23595921|NCT01636687|65912756|FG004|Maintenance Period|Lost to Follow-up|1|||
23595922|NCT01636687|65912752|FG000|Maintenance Period|Physician Decision|0|||
23595923|NCT01636687|65912753|FG001|Maintenance Period|Physician Decision|0|||
23595924|NCT01636687|65912754|FG002|Maintenance Period|Physician Decision|0|||
23595925|NCT01636687|65912755|FG003|Maintenance Period|Physician Decision|0|||
23595926|NCT01636687|65912756|FG004|Maintenance Period|Physician Decision|1|||
23595927|NCT01636687|65912752|FG000|Extension Period|technical problems|0|||
23595928|NCT01636687|65912753|FG001|Extension Period|technical problems|1|||
23595929|NCT01636687|65912754|FG002|Extension Period|technical problems|2|||
23595930|NCT01636687|65912755|FG003|Extension Period|technical problems|1|||
23595931|NCT01636687|65912756|FG004|Extension Period|technical problems|0|||
23595932|NCT01636687|65912752|FG000|Extension Period|Adverse Event|4|||
23595933|NCT01636687|65912753|FG001|Extension Period|Adverse Event|3|||
23595934|NCT01636687|65912754|FG002|Extension Period|Adverse Event|2|||
23595935|NCT01636687|65912755|FG003|Extension Period|Adverse Event|1|||
23595936|NCT01636687|65912756|FG004|Extension Period|Adverse Event|0|||
23595937|NCT01636687|65912752|FG000|Extension Period|Lack of Efficacy|7|||
23478086|NCT00130247|65494432|FG001|Overall Study|Not compliant with DOT|2|||
23478087|NCT00043550|65494434|FG000|Overall Study|Withdrawal by Subject|22|||
23478088|NCT00043550|65494435|FG001|Overall Study|Withdrawal by Subject|12|||
23478089|NCT00043550|65494436|FG002|Overall Study|Withdrawal by Subject|20|||
23478090|NCT05615935|65494439|FG000|Overall Study|Lost to Follow-up|1|||
23478091|NCT05615935|65494440|FG001|Overall Study|Lost to Follow-up|1|||
23478092|NCT01328366|65494441|FG000|Overall Study|Death|1|||
23478093|NCT01328366|65494441|FG000|Overall Study|Withdrawal by Subject|2|||
23478094|NCT01328366|65494441|FG000|Overall Study|Lost to Follow-up|7|||
23478095|NCT03751657|65494442|FG000|Overall Study|Physician Decision|0|||
23478096|NCT03751657|65494443|FG001|Overall Study|Physician Decision|1|||
23478097|NCT03751657|65494442|FG000|Overall Study|Withdrawal by Subject|1|||
23478098|NCT03751657|65494443|FG001|Overall Study|Withdrawal by Subject|1|||
23478099|NCT03751657|65494442|FG000|Overall Study|Lost to Follow-up|2|||
23478100|NCT03751657|65494443|FG001|Overall Study|Lost to Follow-up|1|||
23478101|NCT01203852|65494455|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
23478102|NCT01203852|65494455|FG000|Washout 2 Weeks|Physician Decision|46|||
23478103|NCT01357850|65494456|FG000|Overall Study|Lost to Follow-up|1|||
23478104|NCT01357850|65494457|FG001|Overall Study|Lost to Follow-up|0|||
23478105|NCT01357850|65494458|FG002|Overall Study|Lost to Follow-up|0|||
23478106|NCT01357850|65494459|FG003|Overall Study|Lost to Follow-up|0|||
23478107|NCT01903252|65494461|FG000|Double-Blind Induction|Adverse Event|20|||
23478108|NCT01903252|65494462|FG001|Double-Blind Induction|Adverse Event|18|||
23478109|NCT01903252|65494463|FG002|Double-Blind Induction|Adverse Event|0|||
23478110|NCT01903252|65494464|FG003|Double-Blind Induction|Adverse Event|0|||
23478111|NCT01903252|65494465|FG004|Double-Blind Induction|Adverse Event|0|||
23478112|NCT01903252|65494466|FG005|Double-Blind Induction|Adverse Event|0|||
23478113|NCT01903252|65494461|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
23478114|NCT01903252|65494462|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
23478115|NCT01903252|65494463|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
23478116|NCT01903252|65494464|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
23478117|NCT01903252|65494465|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
23478118|NCT01903252|65494466|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
23478119|NCT01903252|65494461|FG000|Double-Blind Induction|Physician Decision|2|||
23478120|NCT01903252|65494462|FG001|Double-Blind Induction|Physician Decision|3|||
23478121|NCT01903252|65494463|FG002|Double-Blind Induction|Physician Decision|0|||
23478122|NCT01903252|65494464|FG003|Double-Blind Induction|Physician Decision|0|||
23478123|NCT01903252|65494465|FG004|Double-Blind Induction|Physician Decision|0|||
23478124|NCT01903252|65494466|FG005|Double-Blind Induction|Physician Decision|0|||
23478125|NCT01903252|65494461|FG000|Double-Blind Induction|non-compliance,|7|||
23478126|NCT01903252|65494462|FG001|Double-Blind Induction|non-compliance,|7|||
23478127|NCT01903252|65494463|FG002|Double-Blind Induction|non-compliance,|0|||
23478128|NCT01903252|65494464|FG003|Double-Blind Induction|non-compliance,|0|||
23478129|NCT01903252|65494465|FG004|Double-Blind Induction|non-compliance,|0|||
23478130|NCT01903252|65494466|FG005|Double-Blind Induction|non-compliance,|0|||
23478131|NCT01903252|65494461|FG000|Extended Induction, Open-Label|Adverse Event|0|||
23478132|NCT01903252|65494462|FG001|Extended Induction, Open-Label|Adverse Event|0|||
23478133|NCT01903252|65494463|FG002|Extended Induction, Open-Label|Adverse Event|17|||
23478134|NCT01903252|65494464|FG003|Extended Induction, Open-Label|Adverse Event|0|||
23478135|NCT01903252|65494465|FG004|Extended Induction, Open-Label|Adverse Event|0|||
23478136|NCT01903252|65494466|FG005|Extended Induction, Open-Label|Adverse Event|0|||
23478137|NCT01903252|65494461|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478138|NCT01903252|65494462|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478139|NCT01903252|65494463|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
23478140|NCT01903252|65494464|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478141|NCT01903252|65494465|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478142|NCT01903252|65494466|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
23478143|NCT01903252|65494461|FG000|Extended Induction, Open-Label|Physician Decision|0|||
23478144|NCT01903252|65494462|FG001|Extended Induction, Open-Label|Physician Decision|0|||
23478145|NCT01903252|65494463|FG002|Extended Induction, Open-Label|Physician Decision|1|||
23478146|NCT01903252|65494464|FG003|Extended Induction, Open-Label|Physician Decision|0|||
23478147|NCT01903252|65494465|FG004|Extended Induction, Open-Label|Physician Decision|0|||
23478148|NCT01903252|65494466|FG005|Extended Induction, Open-Label|Physician Decision|0|||
23478149|NCT01903252|65494461|FG000|Maintenance, Open-Label|Adverse Event|0|||
23478150|NCT01903252|65494462|FG001|Maintenance, Open-Label|Adverse Event|0|||
23478151|NCT01903252|65494463|FG002|Maintenance, Open-Label|Adverse Event|0|||
23478152|NCT01903252|65494464|FG003|Maintenance, Open-Label|Adverse Event|3|||
23595938|NCT01636687|65912753|FG001|Extension Period|Lack of Efficacy|0|||
23478153|NCT01903252|65494465|FG004|Maintenance, Open-Label|Adverse Event|9|||
23478154|NCT01903252|65494466|FG005|Maintenance, Open-Label|Adverse Event|14|||
23478155|NCT01903252|65494461|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
23478156|NCT01903252|65494462|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
23478157|NCT01903252|65494463|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
23595939|NCT01636687|65912754|FG002|Extension Period|Lack of Efficacy|2|||
23595940|NCT01636687|65912755|FG003|Extension Period|Lack of Efficacy|1|||
23595941|NCT01636687|65912756|FG004|Extension Period|Lack of Efficacy|0|||
23595942|NCT01636687|65912752|FG000|Extension Period|Lost to Follow-up|1|||
23595943|NCT01636687|65912753|FG001|Extension Period|Lost to Follow-up|0|||
23595944|NCT01636687|65912754|FG002|Extension Period|Lost to Follow-up|1|||
23255030|NCT01690520|64676739|FG001|Overall Study|Death|21|||
23255031|NCT01690520|64676738|FG000|Overall Study|Lost to Follow-up|2|||
23255032|NCT01690520|64676739|FG001|Overall Study|Lost to Follow-up|3|||
23255033|NCT01690520|64676738|FG000|Overall Study|Withdrawal by Subject|2|||
23255034|NCT01690520|64676739|FG001|Overall Study|Withdrawal by Subject|0|||
23255035|NCT01690520|64676738|FG000|Overall Study|Relapse|0|||
23255036|NCT01690520|64676739|FG001|Overall Study|Relapse|1|||
23255037|NCT01690520|64676738|FG000|Overall Study|Other|0|||
23255038|NCT01690520|64676739|FG001|Overall Study|Other|1|||
23255039|NCT01690520|64676738|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
23255040|NCT01690520|64676739|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
23595945|NCT01636687|65912755|FG003|Extension Period|Lost to Follow-up|0|||
23595946|NCT01636687|65912756|FG004|Extension Period|Lost to Follow-up|0|||
23595947|NCT01636687|65912752|FG000|Extension Period|Physician Decision|1|||
23595948|NCT01636687|65912753|FG001|Extension Period|Physician Decision|0|||
23595949|NCT01636687|65912754|FG002|Extension Period|Physician Decision|0|||
23595950|NCT01636687|65912755|FG003|Extension Period|Physician Decision|1|||
23595951|NCT01636687|65912756|FG004|Extension Period|Physician Decision|0|||
23595952|NCT01636687|65912752|FG000|Extension Period|study terminated by sponsor|33|||
23595953|NCT01636687|65912753|FG001|Extension Period|study terminated by sponsor|50|||
23595954|NCT01636687|65912754|FG002|Extension Period|study terminated by sponsor|17|||
23595955|NCT01636687|65912755|FG003|Extension Period|study terminated by sponsor|23|||
23595956|NCT01636687|65912756|FG004|Extension Period|study terminated by sponsor|0|||
23595957|NCT01636687|65912752|FG000|Extension Period|Withdrawal by Subject|1|||
23595958|NCT01636687|65912753|FG001|Extension Period|Withdrawal by Subject|0|||
23595959|NCT01636687|65912754|FG002|Extension Period|Withdrawal by Subject|1|||
23595960|NCT01636687|65912755|FG003|Extension Period|Withdrawal by Subject|1|||
23595961|NCT01636687|65912756|FG004|Extension Period|Withdrawal by Subject|0|||
23595962|NCT01636687|65912752|FG000|Follow-up Period|Withdrawal by Subject|1|||
23595963|NCT01636687|65912753|FG001|Follow-up Period|Withdrawal by Subject|0|||
23595964|NCT01636687|65912754|FG002|Follow-up Period|Withdrawal by Subject|0|||
23595965|NCT01636687|65912755|FG003|Follow-up Period|Withdrawal by Subject|0|||
23595966|NCT01636687|65912756|FG004|Follow-up Period|Withdrawal by Subject|1|||
23595967|NCT01839331|65912760|FG000|Overall Study|Early Termination|3|||
23595968|NCT01839331|65912761|FG001|Overall Study|Early Termination|0|||
23595969|NCT01839331|65912762|FG002|Overall Study|Early Termination|1|||
23595970|NCT01839331|65912763|FG003|Overall Study|Early Termination|2|||
23595971|NCT01839331|65912760|FG000|Overall Study|Protocol Violation|1|||
23595972|NCT01839331|65912761|FG001|Overall Study|Protocol Violation|6|||
23595973|NCT01839331|65912762|FG002|Overall Study|Protocol Violation|4|||
23595974|NCT01839331|65912763|FG003|Overall Study|Protocol Violation|3|||
23595975|NCT03714815|65912764|FG000|Overall Study|Physician Decision|2|||
23595976|NCT03714815|65912764|FG000|Overall Study|Withdrawal by Subject|2|||
23595977|NCT03714815|65912764|FG000|Overall Study|Death|11|||
23595978|NCT00535145|65912767|FG000|Phase I|Adverse Event|3|||
23595979|NCT00535145|65912767|FG000|Phase I|Lost to Follow-up|7|||
23194211|NCT01161524|64452512|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
23595980|NCT00535145|65912767|FG000|Phase I|Withdrawal by Subject|6|||
23595981|NCT00535145|65912767|FG000|Phase I|(eligibility)|8|||
23595982|NCT00535145|65912767|FG000|Phase I|(protocol violation)|1|||
23595983|NCT00535145|65912767|FG000|Phase I|(PI decision)|1|||
23595984|NCT00535145|65912767|FG000|Phase I|(diagnosis)|3|||
23595985|NCT00535145|65912767|FG000|Phase II|Adverse Event|2|||
23595986|NCT00535145|65912767|FG000|Phase II|Lack of Efficacy|1|||
23595987|NCT00535145|65912767|FG000|Phase II|Lost to Follow-up|5|||
23595988|NCT00535145|65912767|FG000|Phase II|Withdrawal by Subject|5|||
23595989|NCT00535145|65912767|FG000|Phase II|Subject non-compliance|2|||
23595990|NCT00495677|65912768|FG000|Stage 1 (25 Days)|Adverse Event|0|||
23595991|NCT00495677|65912769|FG001|Stage 1 (25 Days)|Adverse Event|0|||
23194212|NCT04222725|64452517|FG000|Overall Study|Adverse Event|0|||
23194213|NCT04222725|64452518|FG001|Overall Study|Adverse Event|1|||
23194214|NCT04222725|64452519|FG002|Overall Study|Adverse Event|0|||
23194215|NCT04222725|64452520|FG003|Overall Study|Adverse Event|0|||
23194216|NCT00390780|64452522|FG000|Overall Study|Not completed|10|||
23595992|NCT00495677|65912770|FG002|Stage 1 (25 Days)|Adverse Event|1|||
23595993|NCT00495677|65912771|FG003|Stage 1 (25 Days)|Adverse Event|0|||
23595994|NCT00495677|65912772|FG004|Stage 1 (25 Days)|Adverse Event|0|||
23595995|NCT00495677|65912773|FG005|Stage 1 (25 Days)|Adverse Event|0|||
23595996|NCT00495677|65912774|FG006|Stage 1 (25 Days)|Adverse Event|0|||
23595997|NCT00031694|65912777|FG000|Overall Study|Adverse Event|12|||
23595998|NCT00031694|65912777|FG000|Overall Study|Death|2|||
23194217|NCT00390780|64452523|FG001|Overall Study|Not completed|4|||
23194218|NCT00390780|64452522|FG000|Overall Study|Protocol Violation|6|||
23194219|NCT00390780|64452523|FG001|Overall Study|Protocol Violation|4|||
23194220|NCT00390780|64452522|FG000|Overall Study|Lost to Follow-up|3|||
23194221|NCT00390780|64452523|FG001|Overall Study|Lost to Follow-up|6|||
23194222|NCT00390780|64452522|FG000|Overall Study|Adverse Event|2|||
23194223|NCT00390780|64452523|FG001|Overall Study|Adverse Event|3|||
23194224|NCT00390780|64452522|FG000|Overall Study|Death|1|||
23194225|NCT00390780|64452523|FG001|Overall Study|Death|3|||
23194226|NCT00390780|64452522|FG000|Overall Study|Withdrawal by Subject|1|||
23194227|NCT00390780|64452523|FG001|Overall Study|Withdrawal by Subject|2|||
23194228|NCT00390780|64452522|FG000|Overall Study|Inclusion criteria not satisfied|0|||
23194229|NCT00390780|64452523|FG001|Overall Study|Inclusion criteria not satisfied|2|||
23194230|NCT00390780|64452522|FG000|Overall Study|Lost to follow up and other reasons|0|||
23194231|NCT00390780|64452523|FG001|Overall Study|Lost to follow up and other reasons|1|||
23194232|NCT00390780|64452522|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
23194233|NCT00390780|64452523|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
23194234|NCT00390780|64452522|FG000|Overall Study|SAE, death|0|||
23194235|NCT00390780|64452523|FG001|Overall Study|SAE, death|1|||
23194236|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
23194237|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
23194238|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
23194239|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
23194240|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
23194241|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
23194242|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
23194243|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
23194244|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
23194245|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
23194246|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
23194247|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
23194248|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
23194249|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
23194250|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
23194251|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
23194252|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
23194253|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
23194254|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Death|0|||
23194255|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Death|1|||
23194256|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Death|0|||
23194257|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
23194258|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
23194259|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
23194260|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
23194261|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
23194262|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
23194263|NCT00430781|64452524|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
23194264|NCT00430781|64452525|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
23194265|NCT00430781|64452526|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
23194266|NCT00430781|64452524|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
23194267|NCT00430781|64452525|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
23194268|NCT00430781|64452526|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
23194269|NCT00430781|64452524|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
23194270|NCT00430781|64452525|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
23194271|NCT00430781|64452526|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
23255041|NCT00923195|64676741|FG000|Overall Study|Death|0|||
23255042|NCT00923195|64676742|FG001|Overall Study|Death|1|||
23255043|NCT00593333|64676748|FG000|Overall Study|Lost to Follow-up|10|||
23255044|NCT00593333|64676749|FG001|Overall Study|Lost to Follow-up|11|||
23255045|NCT00911859|64676750|FG000|Treatment Period|Adverse Event|3|||
23255046|NCT00911859|64676751|FG001|Treatment Period|Adverse Event|3|||
23255047|NCT00911859|64676752|FG002|Treatment Period|Adverse Event|7|||
23255048|NCT00911859|64676750|FG000|Treatment Period|Death|1|||
23194272|NCT00430781|64452524|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
23194273|NCT00430781|64452525|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
23194274|NCT00430781|64452526|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
23255049|NCT00911859|64676751|FG001|Treatment Period|Death|3|||
23194275|NCT00430781|64452524|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
23194276|NCT00430781|64452525|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
23255050|NCT00911859|64676752|FG002|Treatment Period|Death|5|||
23255051|NCT00911859|64676750|FG000|Treatment Period|Lack of Efficacy|1|||
23595999|NCT00031694|65912777|FG000|Overall Study|Withdrawal by Subject|5|||
23596000|NCT01872078|65912780|FG000|Overall Study|Adverse Event|0|||
23596001|NCT01872078|65912781|FG001|Overall Study|Adverse Event|0|||
23596002|NCT01872078|65912782|FG002|Overall Study|Adverse Event|1|||
23596003|NCT01872078|65912783|FG003|Overall Study|Adverse Event|0|||
23596004|NCT01872078|65912780|FG000|Overall Study|Dose administration non-compliance|0|||
23596005|NCT01872078|65912781|FG001|Overall Study|Dose administration non-compliance|0|||
23194277|NCT00430781|64452526|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
23194278|NCT00430781|64452524|FG000|Final Analysis; 31 July 2008|Other|0|||
23194279|NCT00430781|64452525|FG001|Final Analysis; 31 July 2008|Other|1|||
23194280|NCT00430781|64452526|FG002|Final Analysis; 31 July 2008|Other|0|||
23194281|NCT00430781|64452524|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
23194282|NCT00430781|64452525|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
23194283|NCT00430781|64452526|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
23194284|NCT00430781|64452524|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
23194285|NCT00430781|64452525|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
23194286|NCT00430781|64452526|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
23194287|NCT00430781|64452524|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
23194288|NCT00430781|64452525|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
23194289|NCT00430781|64452526|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
23194290|NCT00430781|64452524|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
23194291|NCT00430781|64452525|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
23194292|NCT00430781|64452526|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
23255052|NCT00911859|64676751|FG001|Treatment Period|Lack of Efficacy|7|||
23255053|NCT00911859|64676752|FG002|Treatment Period|Lack of Efficacy|5|||
23596006|NCT01872078|65912782|FG002|Overall Study|Dose administration non-compliance|0|||
23194293|NCT00430781|64452524|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
23194294|NCT00430781|64452525|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
23596007|NCT01872078|65912783|FG003|Overall Study|Dose administration non-compliance|1|||
23596008|NCT01872078|65912780|FG000|Overall Study|Protocol Violation|0|||
23596009|NCT01872078|65912781|FG001|Overall Study|Protocol Violation|0|||
23194295|NCT00430781|64452526|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
23478158|NCT01903252|65494464|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
23478159|NCT01903252|65494465|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
23194296|NCT00430781|64452524|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
23194297|NCT00430781|64452525|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
23194298|NCT00430781|64452526|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
23194299|NCT00430781|64452524|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
23194300|NCT00430781|64452525|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
23194301|NCT00430781|64452526|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
23194302|NCT00942877|64452527|FG000|Overall Study|Refused further treatment|1|||
23194303|NCT00942877|64452528|FG001|Overall Study|Refused further treatment|1|||
23194304|NCT00942877|64452527|FG000|Overall Study|Patient was not treated|1|||
23194305|NCT00942877|64452528|FG001|Overall Study|Patient was not treated|0|||
23194306|NCT00942877|64452527|FG000|Overall Study|Adverse Event|1|||
23194307|NCT00942877|64452528|FG001|Overall Study|Adverse Event|0|||
23194308|NCT00942877|64452527|FG000|Overall Study|Progressive disease|42|||
23194309|NCT00942877|64452528|FG001|Overall Study|Progressive disease|3|||
23194310|NCT01541254|64452531|FG000|Overall Study|Withdrawal by Subject|1|||
23194311|NCT01541254|64452531|FG000|Overall Study|excluded - metal allergy|1|||
23194312|NCT01541254|64452531|FG000|Overall Study|enrolled after study closed|1|||
23194313|NCT01541254|64452531|FG000|Overall Study|GI bleed prior to procedure|1|||
23194314|NCT01541254|64452531|FG000|Overall Study|stent not required|1|||
23194315|NCT01541254|64452531|FG000|Overall Study|alternate stent used|1|||
23194316|NCT03366844|64452532|FG000|Overall Study|Physician Decision|1|||
23194317|NCT03366844|64452532|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
23194318|NCT02746679|64452538|FG000|Overall Study|Lost to Follow-up|4|||
23194319|NCT02746679|64452539|FG001|Overall Study|Lost to Follow-up|6|||
23194320|NCT00909090|64452543|FG000|Overall Study|Lost to Follow-up|17|||
23194321|NCT00909090|64452544|FG001|Overall Study|Lost to Follow-up|17|||
23194322|NCT02504892|64452545|FG000|Overall Study|Adverse event-pneumonitis|2|||
23194323|NCT02606877|64452546|FG000|Overall Study|Adverse Event|3|||
23194324|NCT02606877|64452547|FG001|Overall Study|Adverse Event|0|||
23194325|NCT02606877|64452546|FG000|Overall Study|Non-compliance with protocol|0|||
23194326|NCT02606877|64452547|FG001|Overall Study|Non-compliance with protocol|1|||
23194327|NCT02606877|64452546|FG000|Overall Study|Other than listed above|1|||
23194328|NCT02606877|64452547|FG001|Overall Study|Other than listed above|0|||
23194329|NCT04156646|64452548|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
23194330|NCT04156646|64452549|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
23194331|NCT00399802|64452552|FG000|Overall Study|Adverse Event|0|||
23194332|NCT00399802|64452553|FG001|Overall Study|Adverse Event|2|||
23194333|NCT00399802|64452552|FG000|Overall Study|Participant discontinued by mistake|0|||
23194334|NCT00399802|64452553|FG001|Overall Study|Participant discontinued by mistake|1|||
23194335|NCT03043365|64452555|FG000|Weeks 0 to Week 8|Adverse Event|1|||
23194336|NCT03043365|64452556|FG001|Weeks 0 to Week 8|Adverse Event|3|||
23194337|NCT03043365|64452555|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
23194338|NCT03043365|64452556|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
23194339|NCT03043365|64452555|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
23194340|NCT03043365|64452556|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
23194341|NCT02492711|64452557|FG000|Overall Study|Adverse Event|9|||
23194342|NCT02492711|64452558|FG001|Overall Study|Adverse Event|9|||
23194343|NCT02492711|64452559|FG002|Overall Study|Adverse Event|2|||
23194344|NCT02492711|64452557|FG000|Overall Study|Death|3|||
23194345|NCT02492711|64452558|FG001|Overall Study|Death|3|||
23194346|NCT02492711|64452559|FG002|Overall Study|Death|0|||
23194347|NCT02492711|64452557|FG000|Overall Study|Withdrawal by Subject|10|||
23255054|NCT00911859|64676750|FG000|Treatment Period|Physician Decision|3|||
23360330|NCT01601496|65062906|FG000|Overall Study|Other: patient refusal to continue|3|||
23360331|NCT01429298|65062907|FG000|Overall Study|Protocol Violation|4|||
23360332|NCT01429298|65062908|FG001|Overall Study|Protocol Violation|6|||
23360333|NCT01497067|65062913|FG000|Overall Study|Lost to Follow-up|56|||
23360334|NCT01497067|65062913|FG000|Overall Study|Adverse Event|3|||
23360335|NCT01497067|65062913|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
23360336|NCT01497067|65062913|FG000|Overall Study|Other|13|||
23360337|NCT01939223|65062914|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
23478160|NCT01903252|65494466|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
23478161|NCT01903252|65494461|FG000|Maintenance, Open-Label|Other|0|||
23596010|NCT01872078|65912782|FG002|Overall Study|Protocol Violation|1|||
23596011|NCT01872078|65912783|FG003|Overall Study|Protocol Violation|0|||
23596012|NCT01872078|65912780|FG000|Overall Study|Withdrawal by Subject|0|||
23194348|NCT02492711|64452558|FG001|Overall Study|Withdrawal by Subject|16|||
23194349|NCT02492711|64452559|FG002|Overall Study|Withdrawal by Subject|5|||
23194350|NCT02492711|64452557|FG000|Overall Study|Physician Decision|10|||
23194351|NCT02492711|64452558|FG001|Overall Study|Physician Decision|6|||
23194352|NCT02492711|64452559|FG002|Overall Study|Physician Decision|4|||
23194353|NCT02492711|64452557|FG000|Overall Study|Lost to Follow-up|0|||
23194354|NCT02492711|64452558|FG001|Overall Study|Lost to Follow-up|0|||
23360338|NCT01939223|65062915|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
23194355|NCT02492711|64452559|FG002|Overall Study|Lost to Follow-up|1|||
23194356|NCT02492711|64452557|FG000|Overall Study|study treatment delay|2|||
23194357|NCT02492711|64452558|FG001|Overall Study|study treatment delay|1|||
23255055|NCT00911859|64676751|FG001|Treatment Period|Physician Decision|3|||
23596013|NCT01872078|65912781|FG001|Overall Study|Withdrawal by Subject|0|||
23255056|NCT00911859|64676752|FG002|Treatment Period|Physician Decision|3|||
23255057|NCT00911859|64676750|FG000|Treatment Period|Withdrawal by Subject|0|||
23255058|NCT00911859|64676751|FG001|Treatment Period|Withdrawal by Subject|4|||
23255059|NCT00911859|64676752|FG002|Treatment Period|Withdrawal by Subject|5|||
23255060|NCT00911859|64676750|FG000|Treatment Period|Did not receive study treatment|0|||
23596014|NCT01872078|65912782|FG002|Overall Study|Withdrawal by Subject|1|||
23596015|NCT01872078|65912783|FG003|Overall Study|Withdrawal by Subject|0|||
23596016|NCT01872078|65912780|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
23596017|NCT01872078|65912781|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
23596018|NCT01872078|65912782|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
23596019|NCT01872078|65912783|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
23596020|NCT01188655|65912784|FG000|Overall Study|Lack of Efficacy|1|||
23596021|NCT01188655|65912784|FG000|Overall Study|Lost to Follow-up|1|||
23596022|NCT01188655|65912784|FG000|Overall Study|Other|11|||
23596023|NCT00205179|65912785|FG000|Overall Study|Death|0|||
23596024|NCT00205179|65912786|FG001|Overall Study|Death|2|||
23596025|NCT00205179|65912785|FG000|Overall Study|Physician Decision|1|||
23596026|NCT00205179|65912786|FG001|Overall Study|Physician Decision|1|||
23596027|NCT00205179|65912785|FG000|Overall Study|Adverse Event|1|||
23596028|NCT00205179|65912786|FG001|Overall Study|Adverse Event|1|||
23596029|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Death|186|||
23596030|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Death|222|||
23596031|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Death|0|||
23596032|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
23596033|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
23596034|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
23596035|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
23596036|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
23596037|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
23596038|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
23596039|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
23596040|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
23596041|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Adverse Event|83|||
23596042|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Adverse Event|100|||
23596043|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Adverse Event|0|||
23596044|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Other|70|||
23596045|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Other|75|||
23596046|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Other|0|||
23596047|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
23596048|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
23194358|NCT02492711|64452559|FG002|Overall Study|study treatment delay|0|||
23194359|NCT02492711|64452557|FG000|Overall Study|change in chemotherapy|0|||
23194360|NCT02492711|64452558|FG001|Overall Study|change in chemotherapy|1|||
23194361|NCT02492711|64452559|FG002|Overall Study|change in chemotherapy|0|||
23194362|NCT02492711|64452557|FG000|Overall Study|never treated|2|||
23194363|NCT02492711|64452558|FG001|Overall Study|never treated|4|||
23194364|NCT02492711|64452559|FG002|Overall Study|never treated|0|||
23194365|NCT02492711|64452557|FG000|Overall Study|Other|0|||
23194366|NCT02492711|64452558|FG001|Overall Study|Other|0|||
23255061|NCT00911859|64676751|FG001|Treatment Period|Did not receive study treatment|1|||
23255062|NCT00911859|64676752|FG002|Treatment Period|Did not receive study treatment|0|||
23596049|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
23596050|NCT00232180|65912789|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
23596051|NCT00232180|65912790|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
23596052|NCT00232180|65912791|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
23596053|NCT00232180|65912789|FG000|Open Label Phase|Death|0|||
23596054|NCT00232180|65912790|FG001|Open Label Phase|Death|0|||
23596055|NCT00232180|65912791|FG002|Open Label Phase|Death|48|||
23596056|NCT00232180|65912789|FG000|Open Label Phase|Lost to Follow-up|0|||
23194367|NCT02492711|64452559|FG002|Overall Study|Other|1|||
23596057|NCT00232180|65912790|FG001|Open Label Phase|Lost to Follow-up|0|||
23596058|NCT00232180|65912791|FG002|Open Label Phase|Lost to Follow-up|5|||
23596059|NCT00232180|65912789|FG000|Open Label Phase|Protocol Violation|0|||
23596060|NCT00232180|65912790|FG001|Open Label Phase|Protocol Violation|0|||
23596061|NCT00232180|65912791|FG002|Open Label Phase|Protocol Violation|3|||
23596062|NCT00232180|65912789|FG000|Open Label Phase|Study terminated by sponsor|0|||
23596063|NCT00232180|65912790|FG001|Open Label Phase|Study terminated by sponsor|0|||
23596064|NCT00232180|65912791|FG002|Open Label Phase|Study terminated by sponsor|3|||
23596065|NCT00232180|65912789|FG000|Open Label Phase|Withdrawal by Subject|0|||
23596066|NCT00232180|65912790|FG001|Open Label Phase|Withdrawal by Subject|0|||
23596067|NCT00232180|65912791|FG002|Open Label Phase|Withdrawal by Subject|37|||
23596068|NCT00232180|65912789|FG000|Open Label Phase|Other|0|||
23596069|NCT00232180|65912790|FG001|Open Label Phase|Other|0|||
23596070|NCT00232180|65912791|FG002|Open Label Phase|Other|16|||
23596071|NCT00232180|65912789|FG000|Open Label Phase|Adverse Event|0|||
23596072|NCT00232180|65912790|FG001|Open Label Phase|Adverse Event|0|||
23596073|NCT00232180|65912791|FG002|Open Label Phase|Adverse Event|25|||
23596074|NCT00232180|65912789|FG000|Open Label Phase|Laboratory abnormality|0|||
23596075|NCT00232180|65912790|FG001|Open Label Phase|Laboratory abnormality|0|||
23596076|NCT00232180|65912791|FG002|Open Label Phase|Laboratory abnormality|10|||
23596077|NCT00232180|65912789|FG000|Open Label Phase|Randomized but not treated|0|||
23596078|NCT00232180|65912790|FG001|Open Label Phase|Randomized but not treated|0|||
23596079|NCT00232180|65912791|FG002|Open Label Phase|Randomized but not treated|1|||
23596080|NCT00703820|65912795|FG000|Overall Study|Adverse Event|12|||
23596081|NCT00703820|65912796|FG001|Overall Study|Adverse Event|17|||
23596082|NCT00703820|65912795|FG000|Overall Study|Death|5|||
23596083|NCT00703820|65912796|FG001|Overall Study|Death|0|||
23596084|NCT00703820|65912795|FG000|Overall Study|Lack of Efficacy|11|||
23596085|NCT00703820|65912796|FG001|Overall Study|Lack of Efficacy|11|||
23596086|NCT00703820|65912795|FG000|Overall Study|Received non-protocol therapy|1|||
23596087|NCT00703820|65912796|FG001|Overall Study|Received non-protocol therapy|0|||
23596088|NCT00703820|65912795|FG000|Overall Study|Physician Decision|4|||
23255063|NCT00911859|64676750|FG000|Maintainance Period|Lack of Efficacy|0|||
23255064|NCT00911859|64676751|FG001|Maintainance Period|Lack of Efficacy|0|||
23255065|NCT00911859|64676752|FG002|Maintainance Period|Lack of Efficacy|9|||
23255066|NCT00911859|64676750|FG000|Maintainance Period|Physician Decision|0|||
23255067|NCT00911859|64676751|FG001|Maintainance Period|Physician Decision|0|||
23255068|NCT00911859|64676752|FG002|Maintainance Period|Physician Decision|9|||
23255069|NCT00911859|64676750|FG000|Maintainance Period|Withdrawal by Subject|0|||
23255070|NCT00911859|64676751|FG001|Maintainance Period|Withdrawal by Subject|0|||
23255071|NCT00911859|64676752|FG002|Maintainance Period|Withdrawal by Subject|3|||
23255072|NCT00911859|64676750|FG000|Follow-up Period|Death|5|||
23255073|NCT00911859|64676751|FG001|Follow-up Period|Death|8|||
23255074|NCT00911859|64676752|FG002|Follow-up Period|Death|10|||
23255075|NCT00911859|64676750|FG000|Follow-up Period|Lost to Follow-up|1|||
23255076|NCT00911859|64676751|FG001|Follow-up Period|Lost to Follow-up|1|||
23255077|NCT00911859|64676752|FG002|Follow-up Period|Lost to Follow-up|0|||
23255078|NCT00911859|64676750|FG000|Follow-up Period|Withdrawal by Subject|0|||
23255079|NCT00911859|64676751|FG001|Follow-up Period|Withdrawal by Subject|4|||
23255080|NCT00911859|64676752|FG002|Follow-up Period|Withdrawal by Subject|4|||
23255081|NCT00911859|64676750|FG000|Follow-up Period|Study terminated by sponsor|5|||
23255082|NCT00911859|64676751|FG001|Follow-up Period|Study terminated by sponsor|33|||
23478162|NCT01903252|65494462|FG001|Maintenance, Open-Label|Other|0|||
23596089|NCT00703820|65912796|FG001|Overall Study|Physician Decision|5|||
23596090|NCT00703820|65912795|FG000|Overall Study|Withdrawal by Subject|2|||
23596091|NCT00703820|65912796|FG001|Overall Study|Withdrawal by Subject|1|||
23596092|NCT01414738|65912797|FG000|Overall Study|Death|26|||
23596093|NCT01414738|65912797|FG000|Overall Study|Refused testing|5|||
23596094|NCT01414738|65912797|FG000|Overall Study|Lost to Follow-up|2|||
23596095|NCT01414738|65912797|FG000|Overall Study|Refused, disease progression|8|||
23596096|NCT01414738|65912797|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
23596097|NCT01808339|65912798|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596098|NCT01808339|65912799|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596099|NCT01808339|65912800|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596100|NCT01808339|65912801|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
23596101|NCT01808339|65912802|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
23596102|NCT01808339|65912803|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
23596103|NCT01808339|65912798|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23596104|NCT01808339|65912799|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23596105|NCT01808339|65912800|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23596106|NCT01808339|65912801|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23596107|NCT01808339|65912802|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23255083|NCT00911859|64676752|FG002|Follow-up Period|Study terminated by sponsor|27|||
23478163|NCT01903252|65494463|FG002|Maintenance, Open-Label|Other|0|||
23478164|NCT01903252|65494464|FG003|Maintenance, Open-Label|Other|2|||
23478165|NCT01903252|65494465|FG004|Maintenance, Open-Label|Other|6|||
23478166|NCT01903252|65494466|FG005|Maintenance, Open-Label|Other|2|||
23478167|NCT00729469|65494467|FG000|Overall Study|Adverse Event|14|||
23478168|NCT00729469|65494468|FG001|Overall Study|Adverse Event|25|||
23478169|NCT00729469|65494467|FG000|Overall Study|Lost to Follow-up|9|||
23478170|NCT00729469|65494468|FG001|Overall Study|Lost to Follow-up|9|||
23478171|NCT00729469|65494467|FG000|Overall Study|Protocol Violation|2|||
23478172|NCT00729469|65494468|FG001|Overall Study|Protocol Violation|1|||
23478173|NCT00729469|65494467|FG000|Overall Study|Withdrawal by Subject|19|||
23478174|NCT00729469|65494468|FG001|Overall Study|Withdrawal by Subject|8|||
23478175|NCT00729469|65494467|FG000|Overall Study|Other-Not mentioned|9|||
23478176|NCT00729469|65494468|FG001|Overall Study|Other-Not mentioned|4|||
23478177|NCT04224688|65494469|FG000|Overall Study|Withdrawal by Subject|1|||
23478178|NCT04224688|65494470|FG001|Overall Study|Withdrawal by Subject|3|||
23478179|NCT04224688|65494469|FG000|Overall Study|Lack of Efficacy|1|||
23478180|NCT04224688|65494470|FG001|Overall Study|Lack of Efficacy|1|||
23478181|NCT04224688|65494469|FG000|Overall Study|Adverse event, not fatal|0|||
23478182|NCT04224688|65494470|FG001|Overall Study|Adverse event, not fatal|2|||
23478183|NCT04224688|65494469|FG000|Overall Study|COVID-19|0|||
23478184|NCT04224688|65494470|FG001|Overall Study|COVID-19|1|||
23478185|NCT00321646|65494471|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
23478186|NCT00321646|65494471|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
23478187|NCT00321646|65494471|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
23478188|NCT02536404|65494472|FG000|Overall Study|Adverse Event|5|||
23478189|NCT02536404|65494473|FG001|Overall Study|Adverse Event|0|||
23194368|NCT01118143|64452564|FG000|Overall Study|Withdrawal by Subject|2|||
23194369|NCT01118143|64452565|FG001|Overall Study|Withdrawal by Subject|5|||
23194370|NCT02465034|64452572|FG000|Overall Study|Withdrawal by Subject|1|||
23478190|NCT02536404|65494472|FG000|Overall Study|Withdrawal by Subject|4|||
23478191|NCT02536404|65494473|FG001|Overall Study|Withdrawal by Subject|1|||
23478192|NCT02536404|65494472|FG000|Overall Study|Physician Decision|10|||
23478193|NCT02536404|65494473|FG001|Overall Study|Physician Decision|0|||
23478194|NCT02536404|65494472|FG000|Overall Study|Sponsor decision|1|||
23478195|NCT02536404|65494473|FG001|Overall Study|Sponsor decision|0|||
23478196|NCT02285062|65494474|FG000|Pre-Treatment Period|Protocol Violation|0|||
23478197|NCT02285062|65494475|FG001|Pre-Treatment Period|Protocol Violation|2|||
23478198|NCT02285062|65494474|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
23478199|NCT02285062|65494475|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23478200|NCT00995566|65494482|FG000|Overall Study|Adverse Event|2|||
23478201|NCT00995566|65494482|FG000|Overall Study|Early study termination|52|||
23478202|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
23478203|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Adverse Event|9|||
23478204|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Death|4|||
23478205|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
23596108|NCT01808339|65912803|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
23596109|NCT01808339|65912798|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596110|NCT01808339|65912799|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596111|NCT01808339|65912800|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
23596112|NCT01808339|65912801|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596113|NCT01808339|65912802|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596114|NCT01808339|65912803|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
23596115|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
23596116|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
23596117|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
23596118|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
23596119|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
23596120|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
23596121|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
23596122|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
23596123|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
23596124|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
23360339|NCT01939223|65062914|FG000|Overall Study|Disease recurrence (radiological)|1|||
23360340|NCT01939223|65062915|FG001|Overall Study|Disease recurrence (radiological)|3|||
23360341|NCT01939223|65062914|FG000|Overall Study|Study stopped by Sponsor|5|||
23360342|NCT01939223|65062915|FG001|Overall Study|Study stopped by Sponsor|7|||
23360343|NCT01939223|65062914|FG000|Overall Study|Withdrawal by Subject|6|||
23360344|NCT01939223|65062915|FG001|Overall Study|Withdrawal by Subject|0|||
23360345|NCT04039204|65062916|FG000|Overall Study|Withdrawal by Subject|0|||
23255084|NCT01155063|64676753|FG000|Overall Study|Adverse Event|1|||
23255085|NCT01155063|64676753|FG000|Overall Study|Withdrawal by Subject|1|||
23255086|NCT01155063|64676753|FG000|Overall Study|Study terminated by sponsor|87|||
23255087|NCT01890785|64676754|FG000|Third Intervention|Withdrawal by Subject|0|||
23255088|NCT01890785|64676755|FG001|Third Intervention|Withdrawal by Subject|1|||
23255089|NCT01890785|64676756|FG002|Third Intervention|Withdrawal by Subject|0|||
23255090|NCT01890785|64676757|FG003|Third Intervention|Withdrawal by Subject|0|||
23255091|NCT01890785|64676758|FG004|Third Intervention|Withdrawal by Subject|0|||
23255092|NCT01890785|64676759|FG005|Third Intervention|Withdrawal by Subject|0|||
23255093|NCT00534092|64676760|FG000|Overall Study|Lost to Follow-up|1|||
23255094|NCT00534092|64676761|FG001|Overall Study|Lost to Follow-up|0|||
23478206|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
23478207|NCT00159822|65494491|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
23478208|NCT00159822|65494491|FG000|Post-treatment Follow-up Period|Death|1|||
23478209|NCT00159822|65494491|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
23478210|NCT00159822|65494491|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
23478211|NCT03005873|65494492|FG000|Overall Study|Prohibited medication use post radnomization|1|||
23478212|NCT03005873|65494493|FG001|Overall Study|Prohibited medication use post radnomization|1|||
23478213|NCT03005873|65494494|FG002|Overall Study|Prohibited medication use post radnomization|1|||
23478214|NCT03005873|65494492|FG000|Overall Study|Withdrew consent|0|||
23478215|NCT03005873|65494493|FG001|Overall Study|Withdrew consent|1|||
23478216|NCT03005873|65494494|FG002|Overall Study|Withdrew consent|2|||
23478217|NCT03005873|65494492|FG000|Overall Study|Lost to Follow-up|0|||
23478218|NCT03005873|65494493|FG001|Overall Study|Lost to Follow-up|1|||
23478219|NCT03005873|65494494|FG002|Overall Study|Lost to Follow-up|0|||
23478220|NCT03005873|65494492|FG000|Overall Study|Ineligible post randomization|0|||
23478221|NCT03005873|65494493|FG001|Overall Study|Ineligible post randomization|0|||
23478222|NCT03005873|65494494|FG002|Overall Study|Ineligible post randomization|1|||
23478223|NCT00811642|65494500|FG000|Overall Study|Adverse Event|3|||
23478224|NCT00811642|65494500|FG000|Overall Study|Protocol Violation|1|||
23478225|NCT00811642|65494500|FG000|Overall Study|Death|2|||
23478226|NCT00811642|65494500|FG000|Overall Study|Withdrawal by Subject|7|||
23478227|NCT00811642|65494500|FG000|Overall Study|Cumulative use of antifungal agent|2|||
23478228|NCT02434471|65494501|FG000|Overall Study|Physician Decision|9|||
23360346|NCT04039204|65062917|FG001|Overall Study|Withdrawal by Subject|2|||
23360347|NCT05464420|65062924|FG000|Overall Study|Death|0|||
23360348|NCT05464420|65062925|FG001|Overall Study|Death|0|||
23360349|NCT05464420|65062926|FG002|Overall Study|Death|0|||
23360350|NCT05464420|65062927|FG003|Overall Study|Death|1|||
23194371|NCT02465034|64452573|FG001|Overall Study|Withdrawal by Subject|1|||
23255095|NCT00534092|64676760|FG000|Overall Study|personal reasons/family concerns|1|||
23255096|NCT00534092|64676761|FG001|Overall Study|personal reasons/family concerns|0|||
23478229|NCT03473548|65494504|FG000|Overall Study|Did not attempt HST testing|3|||
23478230|NCT03473548|65494505|FG001|Overall Study|Did not attempt HST testing|0|||
23478231|NCT04250077|65494507|FG000|Overall Study|Withdrawal by Subject|0|||
23360351|NCT05464420|65062924|FG000|Overall Study|Lost to Follow-up|16|||
23360352|NCT05464420|65062925|FG001|Overall Study|Lost to Follow-up|11|||
23360353|NCT05464420|65062926|FG002|Overall Study|Lost to Follow-up|11|||
23360354|NCT05464420|65062927|FG003|Overall Study|Lost to Follow-up|11|||
23360355|NCT05464420|65062924|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
23360356|NCT05464420|65062925|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
23360357|NCT05464420|65062926|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
23360358|NCT05464420|65062927|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
23360359|NCT05464420|65062924|FG000|Overall Study|Withdrawal by Subject|4|||
23360360|NCT05464420|65062925|FG001|Overall Study|Withdrawal by Subject|8|||
23360361|NCT05464420|65062926|FG002|Overall Study|Withdrawal by Subject|3|||
23360362|NCT05464420|65062927|FG003|Overall Study|Withdrawal by Subject|1|||
23360363|NCT05464420|65062924|FG000|Overall Study|Protocol Violation|0|||
23360364|NCT05464420|65062925|FG001|Overall Study|Protocol Violation|0|||
23360365|NCT05464420|65062926|FG002|Overall Study|Protocol Violation|1|||
23255097|NCT01272193|64676762|FG000|Overall Study|Adverse Event|1|||
23255098|NCT01272193|64676763|FG001|Overall Study|Adverse Event|1|||
23255099|NCT01272193|64676762|FG000|Overall Study|Lack of Efficacy|0|||
23255100|NCT01272193|64676763|FG001|Overall Study|Lack of Efficacy|3|||
23255101|NCT01272193|64676762|FG000|Overall Study|Withdrawal Criteria|1|||
23255102|NCT01272193|64676763|FG001|Overall Study|Withdrawal Criteria|1|||
23255103|NCT01272193|64676762|FG000|Overall Study|Unclassified|8|||
23255104|NCT01272193|64676763|FG001|Overall Study|Unclassified|7|||
23255105|NCT00095199|64676764|FG000|Overall Study|Adverse Event|40|||
23255106|NCT00095199|64676765|FG001|Overall Study|Adverse Event|22|||
23255107|NCT00095199|64676766|FG002|Overall Study|Adverse Event|26|||
23255108|NCT00095199|64676767|FG003|Overall Study|Adverse Event|11|||
23255109|NCT00095199|64676764|FG000|Overall Study|Progressive disease|213|||
23255110|NCT00095199|64676765|FG001|Overall Study|Progressive disease|179|||
23255111|NCT00095199|64676766|FG002|Overall Study|Progressive disease|105|||
23255112|NCT00095199|64676767|FG003|Overall Study|Progressive disease|98|||
23255113|NCT00095199|64676764|FG000|Overall Study|Death|10|||
23255114|NCT00095199|64676765|FG001|Overall Study|Death|6|||
23255115|NCT00095199|64676766|FG002|Overall Study|Death|11|||
23255116|NCT00095199|64676767|FG003|Overall Study|Death|9|||
23255117|NCT00095199|64676764|FG000|Overall Study|Withdrawal by Subject|21|||
23255118|NCT00095199|64676765|FG001|Overall Study|Withdrawal by Subject|16|||
23255119|NCT00095199|64676766|FG002|Overall Study|Withdrawal by Subject|13|||
23255120|NCT00095199|64676767|FG003|Overall Study|Withdrawal by Subject|22|||
23360366|NCT05464420|65062927|FG003|Overall Study|Protocol Violation|1|||
23360367|NCT05464420|65062924|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
23360368|NCT05464420|65062925|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
23360369|NCT05464420|65062926|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
23360370|NCT05464420|65062927|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
23360371|NCT03252145|65062928|FG000|Overall Study|Withdrawal by Subject|1|||
23194372|NCT02465034|64452572|FG000|Overall Study|Screen fail|2|||
23194373|NCT02465034|64452573|FG001|Overall Study|Screen fail|0|||
23194374|NCT02465034|64452572|FG000|Overall Study|Could not be scheduled for study visit|0|||
23194375|NCT02465034|64452573|FG001|Overall Study|Could not be scheduled for study visit|5|||
23360372|NCT03252145|65062929|FG001|Overall Study|Withdrawal by Subject|0|||
23194376|NCT02116972|64455922|FG000|Overall Study|Adverse Event|4|||
23194377|NCT02116972|64455923|FG001|Overall Study|Adverse Event|4|||
23360373|NCT03252145|65062928|FG000|Overall Study|Complicating Disease|1|||
23596125|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
23596126|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
23596127|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
23596128|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
23596129|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
23596130|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
23596131|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
23596132|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
23596133|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
23596134|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
23596135|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
23596136|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
23360374|NCT03252145|65062929|FG001|Overall Study|Complicating Disease|2|||
23360375|NCT02466971|65062930|FG000|Overall Study|eligible and never treated|14|||
23360376|NCT02466971|65062931|FG001|Overall Study|eligible and never treated|20|||
23360377|NCT02466971|65062930|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
23360378|NCT02466971|65062931|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
23360379|NCT02466971|65062930|FG000|Overall Study|ineligible and treated|1|||
23360380|NCT02466971|65062931|FG001|Overall Study|ineligible and treated|0|||
23360381|NCT02466971|65062930|FG000|Overall Study|ineligible and never treated|0|||
23360382|NCT02466971|65062931|FG001|Overall Study|ineligible and never treated|1|||
23360383|NCT00215644|65062940|FG000|Overall Study|Disease Progression|28|||
23596137|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
23596138|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
23194378|NCT02116972|64455924|FG002|Overall Study|Adverse Event|1|||
23194379|NCT02116972|64455922|FG000|Overall Study|Withdrawal by Subject|1|||
23194380|NCT02116972|64455923|FG001|Overall Study|Withdrawal by Subject|1|||
23194381|NCT02116972|64455924|FG002|Overall Study|Withdrawal by Subject|5|||
23194382|NCT02116972|64455922|FG000|Overall Study|Protocol Violation|1|||
23194383|NCT02116972|64455923|FG001|Overall Study|Protocol Violation|0|||
23194384|NCT02116972|64455924|FG002|Overall Study|Protocol Violation|1|||
23194385|NCT02116972|64455922|FG000|Overall Study|Lost to Follow-up|4|||
23194386|NCT02116972|64455923|FG001|Overall Study|Lost to Follow-up|3|||
23596139|NCT03338816|65912804|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
23596140|NCT03338816|65912805|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
23596141|NCT03338816|65912806|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
23596142|NCT03338816|65912807|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
23596143|NCT01017146|65912811|FG000|Overall Study|Adverse Event|11|||
23596144|NCT01017146|65912812|FG001|Overall Study|Adverse Event|1|||
23596145|NCT01017146|65912811|FG000|Overall Study|Lost to Follow-up|14|||
23596146|NCT01017146|65912812|FG001|Overall Study|Lost to Follow-up|14|||
23596147|NCT01017146|65912811|FG000|Overall Study|Noncompliance with Study Product|1|||
23596148|NCT01017146|65912812|FG001|Overall Study|Noncompliance with Study Product|1|||
23596149|NCT01017146|65912811|FG000|Overall Study|Withdrawal by Subject|32|||
23596150|NCT01017146|65912812|FG001|Overall Study|Withdrawal by Subject|16|||
23596151|NCT01017146|65912811|FG000|Overall Study|Relocation|0|||
23596152|NCT01017146|65912812|FG001|Overall Study|Relocation|4|||
23596153|NCT01017146|65912811|FG000|Overall Study|Pregnancy|2|||
23596154|NCT01017146|65912812|FG001|Overall Study|Pregnancy|1|||
23596155|NCT01017146|65912811|FG000|Overall Study|Protocol Violation|2|||
23596156|NCT01017146|65912812|FG001|Overall Study|Protocol Violation|0|||
23596157|NCT01017146|65912811|FG000|Overall Study|Took Excluded Medication|2|||
23596158|NCT01017146|65912812|FG001|Overall Study|Took Excluded Medication|0|||
23596159|NCT01017146|65912811|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
23596160|NCT01017146|65912812|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
23596161|NCT01017146|65912811|FG000|Overall Study|Change in Work Situation|1|||
23596162|NCT01017146|65912812|FG001|Overall Study|Change in Work Situation|0|||
23596163|NCT03950622|65912813|FG000|Overall Study|Withdrawal by Subject|1|||
23596164|NCT03950622|65912814|FG001|Overall Study|Withdrawal by Subject|0|||
23596165|NCT03950622|65912813|FG000|Overall Study|Protocol Deviation|0|||
23596166|NCT03950622|65912814|FG001|Overall Study|Protocol Deviation|1|||
23596167|NCT03950622|65912813|FG000|Overall Study|Physician Decision|1|||
23596168|NCT03950622|65912814|FG001|Overall Study|Physician Decision|0|||
23596169|NCT03950622|65912813|FG000|Overall Study|Lost to Follow-up|5|||
23596170|NCT03950622|65912814|FG001|Overall Study|Lost to Follow-up|5|||
23596171|NCT03950622|65912813|FG000|Overall Study|Death|1|||
23596172|NCT03950622|65912814|FG001|Overall Study|Death|1|||
23596173|NCT02079844|65912815|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
23596174|NCT02079844|65912816|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
23596175|NCT02079844|65912817|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
23596176|NCT02079844|65912815|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
23596177|NCT02079844|65912816|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
23596178|NCT02079844|65912817|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
23596179|NCT01264679|65912818|FG000|Overall Study|Participation in Another Clinical Trial|1|||
23596180|NCT01264679|65912818|FG000|Overall Study|Physician Decision|1|||
23596181|NCT01264679|65912818|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
23596182|NCT01264679|65912818|FG000|Overall Study|Withdrawal by Subject|1|||
23596183|NCT02318134|65912819|FG000|Overall Study|Withdrawal by Subject|2|||
23596184|NCT02318134|65912820|FG001|Overall Study|Withdrawal by Subject|1|||
23596185|NCT01049503|65912825|FG000|Overall Study|Lost to Follow-up|11|||
23596186|NCT01049503|65912826|FG001|Overall Study|Lost to Follow-up|12|||
23596187|NCT01049503|65912827|FG002|Overall Study|Lost to Follow-up|24|||
23596188|NCT01049503|65912828|FG003|Overall Study|Lost to Follow-up|26|||
23596189|NCT01049503|65912829|FG004|Overall Study|Lost to Follow-up|27|||
23596190|NCT01049503|65912830|FG005|Overall Study|Lost to Follow-up|8|||
23596191|NCT03840902|65912833|FG000|Overall Study|Randomized but not treated|1|||
23596192|NCT03840902|65912834|FG001|Overall Study|Randomized but not treated|1|||
23596193|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
23596194|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
23596195|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
23596196|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
23596197|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
23596198|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
23596199|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
23596200|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
23596201|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
23596202|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
23596203|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
23255121|NCT00095199|64676764|FG000|Overall Study|Protocol Violation|4|||
23255122|NCT00095199|64676765|FG001|Overall Study|Protocol Violation|4|||
23255123|NCT00095199|64676766|FG002|Overall Study|Protocol Violation|2|||
23255124|NCT00095199|64676767|FG003|Overall Study|Protocol Violation|0|||
23255125|NCT00095199|64676764|FG000|Overall Study|Liver function test results elevated|0|||
23255126|NCT00095199|64676765|FG001|Overall Study|Liver function test results elevated|0|||
23255127|NCT00095199|64676766|FG002|Overall Study|Liver function test results elevated|1|||
23255128|NCT00095199|64676767|FG003|Overall Study|Liver function test results elevated|1|||
23255129|NCT00095199|64676764|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
23255130|NCT00095199|64676765|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
23255131|NCT00095199|64676766|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
23255132|NCT00095199|64676767|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
23255133|NCT00095199|64676764|FG000|Overall Study|Physician Decision|5|||
23255134|NCT00095199|64676765|FG001|Overall Study|Physician Decision|6|||
23255135|NCT00095199|64676766|FG002|Overall Study|Physician Decision|1|||
23255136|NCT00095199|64676767|FG003|Overall Study|Physician Decision|1|||
23255137|NCT00095199|64676764|FG000|Overall Study|Not eligible|1|||
23255138|NCT00095199|64676765|FG001|Overall Study|Not eligible|7|||
23255139|NCT00095199|64676766|FG002|Overall Study|Not eligible|0|||
23255140|NCT00095199|64676767|FG003|Overall Study|Not eligible|1|||
23255141|NCT00095199|64676764|FG000|Overall Study|Started Palliative Radiotherapy|1|||
23255142|NCT00095199|64676765|FG001|Overall Study|Started Palliative Radiotherapy|0|||
23255143|NCT00095199|64676766|FG002|Overall Study|Started Palliative Radiotherapy|0|||
23255144|NCT00095199|64676767|FG003|Overall Study|Started Palliative Radiotherapy|0|||
23255145|NCT00095199|64676764|FG000|Overall Study|Started radiotherapy regimen|0|||
23255146|NCT00095199|64676765|FG001|Overall Study|Started radiotherapy regimen|1|||
23255147|NCT00095199|64676766|FG002|Overall Study|Started radiotherapy regimen|0|||
23255148|NCT00095199|64676767|FG003|Overall Study|Started radiotherapy regimen|0|||
23255149|NCT00095199|64676764|FG000|Overall Study|Primary tumor removed in other surgery|0|||
23255150|NCT00095199|64676765|FG001|Overall Study|Primary tumor removed in other surgery|1|||
23255151|NCT00095199|64676766|FG002|Overall Study|Primary tumor removed in other surgery|0|||
23255152|NCT00095199|64676767|FG003|Overall Study|Primary tumor removed in other surgery|0|||
23255153|NCT00095199|64676764|FG000|Overall Study|Data inadvertently lost by site|1|||
23596204|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
23596205|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
23596206|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
23596207|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
23596208|NCT00516321|65912836|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
23596209|NCT00516321|65912837|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
23596210|NCT00516321|65912838|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
23596211|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
23596212|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
23255154|NCT00095199|64676765|FG001|Overall Study|Data inadvertently lost by site|0|||
23255155|NCT00095199|64676766|FG002|Overall Study|Data inadvertently lost by site|0|||
23596213|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
23596214|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
23596215|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
23596216|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
23596217|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
23596218|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
23596219|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
23596220|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
23596221|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
23596222|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
23596223|NCT00516321|65912836|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
23596224|NCT00516321|65912837|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
23360384|NCT00215644|65062941|FG001|Overall Study|Disease Progression|10|||
23596225|NCT00516321|65912838|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
23596226|NCT01622868|65912841|FG000|Overall Study|Protocol Violation|7|||
23596227|NCT01622868|65912842|FG001|Overall Study|Protocol Violation|0|||
23255156|NCT00095199|64676767|FG003|Overall Study|Data inadvertently lost by site|0|||
23596228|NCT04956575|65912852|FG000|Overall Study|Death|1|||
23596229|NCT04956575|65912853|FG001|Overall Study|Death|0|||
23596230|NCT04956575|65912854|FG002|Overall Study|Death|0|||
23596231|NCT04956575|65912855|FG003|Overall Study|Death|0|||
23596232|NCT04956575|65912856|FG004|Overall Study|Death|0|||
23596233|NCT04956575|65912857|FG005|Overall Study|Death|0|||
23596234|NCT04956575|65912858|FG006|Overall Study|Death|0|||
23596235|NCT04956575|65912859|FG007|Overall Study|Death|1|||
23596236|NCT04956575|65912860|FG008|Overall Study|Death|0|||
23596237|NCT04956575|65912861|FG009|Overall Study|Death|1|||
23596238|NCT04956575|65912862|FG010|Overall Study|Death|0|||
23596239|NCT04956575|65912863|FG011|Overall Study|Death|0|||
23596240|NCT04956575|65912852|FG000|Overall Study|Lost to Follow-up|3|||
23596241|NCT04956575|65912853|FG001|Overall Study|Lost to Follow-up|4|||
23596242|NCT04956575|65912854|FG002|Overall Study|Lost to Follow-up|2|||
23596243|NCT04956575|65912855|FG003|Overall Study|Lost to Follow-up|3|||
23596244|NCT04956575|65912856|FG004|Overall Study|Lost to Follow-up|1|||
23596245|NCT04956575|65912857|FG005|Overall Study|Lost to Follow-up|10|||
23596246|NCT04956575|65912858|FG006|Overall Study|Lost to Follow-up|11|||
23596247|NCT04956575|65912859|FG007|Overall Study|Lost to Follow-up|7|||
23596248|NCT04956575|65912860|FG008|Overall Study|Lost to Follow-up|4|||
23596249|NCT04956575|65912861|FG009|Overall Study|Lost to Follow-up|2|||
23596250|NCT04956575|65912862|FG010|Overall Study|Lost to Follow-up|3|||
23596251|NCT04956575|65912863|FG011|Overall Study|Lost to Follow-up|8|||
23596252|NCT04956575|65912852|FG000|Overall Study|Withdrawal by Subject|1|||
23596253|NCT04956575|65912853|FG001|Overall Study|Withdrawal by Subject|2|||
23596254|NCT04956575|65912854|FG002|Overall Study|Withdrawal by Subject|1|||
23596255|NCT04956575|65912855|FG003|Overall Study|Withdrawal by Subject|4|||
23596256|NCT04956575|65912856|FG004|Overall Study|Withdrawal by Subject|2|||
23596257|NCT04956575|65912857|FG005|Overall Study|Withdrawal by Subject|8|||
23596258|NCT04956575|65912858|FG006|Overall Study|Withdrawal by Subject|5|||
23596259|NCT04956575|65912859|FG007|Overall Study|Withdrawal by Subject|1|||
23596260|NCT04956575|65912860|FG008|Overall Study|Withdrawal by Subject|1|||
23596261|NCT04956575|65912861|FG009|Overall Study|Withdrawal by Subject|0|||
23596262|NCT04956575|65912862|FG010|Overall Study|Withdrawal by Subject|3|||
23596263|NCT04956575|65912863|FG011|Overall Study|Withdrawal by Subject|1|||
23596264|NCT02224924|65912866|FG000|Overall Study|Withdrawal by Subject|7|||
23596265|NCT02224924|65912867|FG001|Overall Study|Withdrawal by Subject|6|||
23596266|NCT02224924|65912866|FG000|Overall Study|Biopsy cancelled|20|||
23596267|NCT02224924|65912867|FG001|Overall Study|Biopsy cancelled|14|||
23596268|NCT02224924|65912866|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
23596269|NCT02224924|65912867|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
23596270|NCT02224924|65912866|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
23596271|NCT02224924|65912867|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
23596272|NCT01613716|65912875|FG000|Overall Study|screen failures|3|||
23596273|NCT01613716|65912875|FG000|Overall Study|Lost to Follow-up|4|||
23596274|NCT03912831|65912878|FG000|Overall Study|Death|1|||
23596275|NCT03912831|65912879|FG001|Overall Study|Death|1|||
23596276|NCT03912831|65912880|FG002|Overall Study|Death|1|||
23596277|NCT03912831|65912881|FG003|Overall Study|Death|1|||
23596278|NCT03912831|65912882|FG004|Overall Study|Death|1|||
23596279|NCT03912831|65912883|FG005|Overall Study|Death|1|||
23596280|NCT03912831|65912878|FG000|Overall Study|Reason not Specified|0|||
23596281|NCT03912831|65912879|FG001|Overall Study|Reason not Specified|0|||
23596282|NCT03912831|65912880|FG002|Overall Study|Reason not Specified|0|||
23596283|NCT03912831|65912881|FG003|Overall Study|Reason not Specified|0|||
23596284|NCT03912831|65912882|FG004|Overall Study|Reason not Specified|1|||
23596285|NCT03912831|65912883|FG005|Overall Study|Reason not Specified|0|||
23596286|NCT03912831|65912878|FG000|Overall Study|Withdrawal by Participant|0|||
23255157|NCT02414854|64676768|FG000|Overall Study|Adverse Event|9|||
23596287|NCT03912831|65912879|FG001|Overall Study|Withdrawal by Participant|0|||
23596288|NCT03912831|65912880|FG002|Overall Study|Withdrawal by Participant|0|||
23596289|NCT03912831|65912881|FG003|Overall Study|Withdrawal by Participant|0|||
23596290|NCT03912831|65912882|FG004|Overall Study|Withdrawal by Participant|1|||
23596291|NCT03912831|65912883|FG005|Overall Study|Withdrawal by Participant|0|||
23596292|NCT02814838|65912884|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
23596293|NCT02814838|65912885|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
23596294|NCT02814838|65912884|FG000|Overall Study|Consent withdrawal|1|||
23255158|NCT02414854|64676769|FG001|Overall Study|Adverse Event|7|||
23596295|NCT02814838|65912885|FG001|Overall Study|Consent withdrawal|1|||
23596296|NCT04766034|65912886|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
23596297|NCT04766034|65912887|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
23255159|NCT02414854|64676770|FG002|Overall Study|Adverse Event|1|||
23255160|NCT02414854|64676771|FG003|Overall Study|Adverse Event|12|||
23255161|NCT02414854|64676768|FG000|Overall Study|Poor compliance to protocol|1|||
23255162|NCT02414854|64676769|FG001|Overall Study|Poor compliance to protocol|1|||
23255163|NCT02414854|64676770|FG002|Overall Study|Poor compliance to protocol|2|||
23255164|NCT02414854|64676771|FG003|Overall Study|Poor compliance to protocol|2|||
23255165|NCT02414854|64676768|FG000|Overall Study|Other than specified above|12|||
23255166|NCT02414854|64676769|FG001|Overall Study|Other than specified above|37|||
23255167|NCT02414854|64676770|FG002|Overall Study|Other than specified above|17|||
23255168|NCT02414854|64676771|FG003|Overall Study|Other than specified above|37|||
23596298|NCT04766034|65912888|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
23596299|NCT04766034|65912889|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
23596300|NCT04766034|65912890|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
23596301|NCT04766034|65912886|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
23596302|NCT04766034|65912887|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
23596303|NCT04766034|65912888|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
23596304|NCT04766034|65912889|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
23596305|NCT04766034|65912890|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
23596306|NCT04766034|65912886|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
23596307|NCT04766034|65912887|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
23596308|NCT04766034|65912888|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
23596309|NCT04766034|65912889|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
23596310|NCT04766034|65912890|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
23596311|NCT04766034|65912886|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
23596312|NCT04766034|65912887|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
23596313|NCT04766034|65912888|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
23255169|NCT04356573|64676772|FG000|Overall Study|Didn't Qualify|1|||
23255170|NCT04356573|64676773|FG001|Overall Study|Didn't Qualify|0|||
23255171|NCT01706770|64676774|FG000|Overall Study|Lost to Follow-up|1|||
23596314|NCT04766034|65912889|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
23596315|NCT04766034|65912890|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
23596316|NCT01095796|65912891|FG000|Overall Study|Randomized but Not Treated|5|||
23596317|NCT01095796|65912892|FG001|Overall Study|Randomized but Not Treated|2|||
23596318|NCT01095796|65912891|FG000|Overall Study|Adverse Event|9|||
23596319|NCT01095796|65912892|FG001|Overall Study|Adverse Event|19|||
23596320|NCT01095796|65912891|FG000|Overall Study|Death|3|||
23596321|NCT01095796|65912892|FG001|Overall Study|Death|2|||
23596322|NCT01095796|65912891|FG000|Overall Study|Pregnancy|2|||
23596323|NCT01095796|65912892|FG001|Overall Study|Pregnancy|0|||
23596324|NCT01095796|65912891|FG000|Overall Study|Lack of Efficacy|5|||
23596325|NCT01095796|65912892|FG001|Overall Study|Lack of Efficacy|3|||
23596326|NCT01095796|65912891|FG000|Overall Study|Investigator's Discretion|7|||
23596327|NCT01095796|65912892|FG001|Overall Study|Investigator's Discretion|2|||
23596328|NCT01095796|65912891|FG000|Overall Study|Withdrew Consent|16|||
23596329|NCT01095796|65912892|FG001|Overall Study|Withdrew Consent|22|||
23596330|NCT01095796|65912891|FG000|Overall Study|Lost to Follow-up|27|||
23596331|NCT01095796|65912892|FG001|Overall Study|Lost to Follow-up|29|||
23596332|NCT01095796|65912891|FG000|Overall Study|Participant Noncompliance|5|||
23596333|NCT01095796|65912892|FG001|Overall Study|Participant Noncompliance|10|||
23194387|NCT02116972|64455924|FG002|Overall Study|Lost to Follow-up|1|||
23255172|NCT01706770|64676775|FG001|Overall Study|Lost to Follow-up|0|||
23255173|NCT01706770|64676774|FG000|Overall Study|Physician Decision|1|||
23255174|NCT01706770|64676775|FG001|Overall Study|Physician Decision|0|||
23255175|NCT02464059|64676776|FG000|Overall Study|Lost to Follow-up|6|||
23255176|NCT02454972|64676777|FG000|Overall Study|Progressive disease|17|||
23255177|NCT02454972|64676778|FG001|Overall Study|Progressive disease|16|||
23255178|NCT02454972|64676779|FG002|Overall Study|Progressive disease|59|||
23255179|NCT02454972|64676780|FG003|Overall Study|Progressive disease|23|||
23255180|NCT02454972|64676781|FG004|Overall Study|Progressive disease|16|||
23255181|NCT02454972|64676782|FG005|Overall Study|Progressive disease|12|||
23255182|NCT02454972|64676783|FG006|Overall Study|Progressive disease|19|||
23478232|NCT04250077|65494508|FG001|Overall Study|Withdrawal by Subject|1|||
23478233|NCT04250077|65494509|FG002|Overall Study|Withdrawal by Subject|0|||
23596334|NCT01095796|65912891|FG000|Overall Study|Protocol Violation|1|||
23596335|NCT01095796|65912892|FG001|Overall Study|Protocol Violation|0|||
23596336|NCT01095796|65912891|FG000|Overall Study|Participant Transferred to Another Study|215|||
23194388|NCT02116972|64455922|FG000|Overall Study|Lack of Efficacy|6|||
23194389|NCT02116972|64455923|FG001|Overall Study|Lack of Efficacy|6|||
23596337|NCT01095796|65912892|FG001|Overall Study|Participant Transferred to Another Study|200|||
23194390|NCT02116972|64455924|FG002|Overall Study|Lack of Efficacy|5|||
23194391|NCT02116972|64455922|FG000|Overall Study|scheduling conflicts and relocation|3|||
23194392|NCT02116972|64455923|FG001|Overall Study|scheduling conflicts and relocation|3|||
23194393|NCT02116972|64455924|FG002|Overall Study|scheduling conflicts and relocation|6|||
23194394|NCT00418886|64455925|FG000|Overall Study|discontinue treatment survival follow up|90|||
23194395|NCT00418886|64455926|FG001|Overall Study|discontinue treatment survival follow up|91|||
23194396|NCT00418886|64455925|FG000|Overall Study|Death|122|||
23194397|NCT00418886|64455926|FG001|Overall Study|Death|147|||
23194398|NCT00418886|64455925|FG000|Overall Study|Withdrawal by Subject|9|||
23194399|NCT00418886|64455926|FG001|Overall Study|Withdrawal by Subject|10|||
23194400|NCT00418886|64455925|FG000|Overall Study|Lost to Follow-up|4|||
23194401|NCT00418886|64455926|FG001|Overall Study|Lost to Follow-up|6|||
23194402|NCT00418886|64455925|FG000|Overall Study|withdrawn due to other reason|1|||
23194403|NCT00418886|64455926|FG001|Overall Study|withdrawn due to other reason|0|||
23194404|NCT00418886|64455925|FG000|Overall Study|randomised but no treatment received|0|||
23194405|NCT00418886|64455926|FG001|Overall Study|randomised but no treatment received|1|||
23194406|NCT02421120|64455927|FG000|Overall Study|Adverse Event|1|||
23194407|NCT00723840|64455928|FG000|Overall Study|Lost to Follow-up|2|||
23478234|NCT04250077|65494507|FG000|Overall Study|Lost to Follow-up|2|||
23194408|NCT00723840|64455928|FG000|Overall Study|Failure to return|18|||
23194409|NCT00723840|64455928|FG000|Overall Study|Withdrawal by Subject|55|||
23255183|NCT02454972|64676784|FG007|Overall Study|Progressive disease|27|||
23478235|NCT04250077|65494508|FG001|Overall Study|Lost to Follow-up|3|||
23478236|NCT04250077|65494509|FG002|Overall Study|Lost to Follow-up|0|||
23596338|NCT02396316|65912895|FG000|Overall Study|Physician Decision|1|||
23596339|NCT02396316|65912896|FG001|Overall Study|Physician Decision|0|||
23596340|NCT02396316|65912895|FG000|Overall Study|Progressive disease|6|||
23596341|NCT02396316|65912896|FG001|Overall Study|Progressive disease|3|||
23596342|NCT02396316|65912895|FG000|Overall Study|Protocol Violation|0|||
23596343|NCT02396316|65912896|FG001|Overall Study|Protocol Violation|1|||
23596344|NCT02396316|65912895|FG000|Overall Study|Treatment unblinded|0|||
23596345|NCT02396316|65912896|FG001|Overall Study|Treatment unblinded|1|||
23596346|NCT00925587|65912902|FG000|Overall Study|Protocol Specified Criteria|6|||
23596347|NCT00925587|65912903|FG001|Overall Study|Protocol Specified Criteria|6|||
23596348|NCT00925587|65912902|FG000|Overall Study|Physician Decision|4|||
23596349|NCT00925587|65912903|FG001|Overall Study|Physician Decision|1|||
23255184|NCT02454972|64676785|FG008|Overall Study|Progressive disease|0|||
23596350|NCT00925587|65912902|FG000|Overall Study|Protocol Violation|6|||
23478237|NCT02446171|65494510|FG000|Overall Study|Withdrawal by Subject|0|||
23478238|NCT02446171|65494511|FG001|Overall Study|Withdrawal by Subject|0|||
23478239|NCT02446171|65494512|FG002|Overall Study|Withdrawal by Subject|2|||
23478240|NCT02446171|65494513|FG003|Overall Study|Withdrawal by Subject|0|||
23478241|NCT02600871|65494514|FG000|Overall Study|Lost to Follow-up|13|||
23478242|NCT02600871|65494515|FG001|Overall Study|Lost to Follow-up|10|||
23478243|NCT00528970|65494516|FG000|Overall Study|Adverse Event|6|||
23478244|NCT00528970|65494517|FG001|Overall Study|Adverse Event|8|||
23478245|NCT00528970|65494518|FG002|Overall Study|Adverse Event|5|||
23478246|NCT00528970|65494516|FG000|Overall Study|Lost to Follow-up|0|||
23478247|NCT00528970|65494517|FG001|Overall Study|Lost to Follow-up|0|||
23478248|NCT00528970|65494518|FG002|Overall Study|Lost to Follow-up|1|||
23478249|NCT00528970|65494516|FG000|Overall Study|Other than specified|2|||
23478250|NCT00528970|65494517|FG001|Overall Study|Other than specified|3|||
23478251|NCT00528970|65494518|FG002|Overall Study|Other than specified|3|||
23478252|NCT00528970|65494516|FG000|Overall Study|Protocol Violation|2|||
23478253|NCT00528970|65494517|FG001|Overall Study|Protocol Violation|1|||
23478254|NCT00528970|65494518|FG002|Overall Study|Protocol Violation|4|||
23478255|NCT00528970|65494516|FG000|Overall Study|Lack of Efficacy|0|||
23478256|NCT00528970|65494517|FG001|Overall Study|Lack of Efficacy|0|||
23478257|NCT00528970|65494518|FG002|Overall Study|Lack of Efficacy|1|||
23478258|NCT00528970|65494516|FG000|Overall Study|Withdrawal by Subject|4|||
23478259|NCT00528970|65494517|FG001|Overall Study|Withdrawal by Subject|3|||
23478260|NCT00528970|65494518|FG002|Overall Study|Withdrawal by Subject|5|||
23478261|NCT00528970|65494516|FG000|Overall Study|Randomized but not treated|0|||
23478262|NCT00528970|65494517|FG001|Overall Study|Randomized but not treated|0|||
23478263|NCT00528970|65494518|FG002|Overall Study|Randomized but not treated|1|||
23478264|NCT04620798|65494519|FG000|Overall Study|Lost to Follow-up|126|||
23478265|NCT04620798|65494520|FG001|Overall Study|Lost to Follow-up|138|||
23478266|NCT01713933|65494521|FG000|Overall Study|Lost to Follow-up|2|||
23478267|NCT01713933|65494521|FG000|Overall Study|Withdrawal by Subject|3|||
23478268|NCT01713933|65494521|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
23478269|NCT02925416|65494523|FG000|Overall Study|Adverse Event|2|||
23478270|NCT02925416|65494524|FG001|Overall Study|Adverse Event|0|||
23478271|NCT00535288|65494525|FG000|Overall Study|Adverse Event|20|||
23478272|NCT00535288|65494526|FG001|Overall Study|Adverse Event|19|||
23478273|NCT00535288|65494527|FG002|Overall Study|Adverse Event|25|||
23478274|NCT00535288|65494528|FG003|Overall Study|Adverse Event|20|||
23478275|NCT00535288|65494529|FG004|Overall Study|Adverse Event|30|||
23478276|NCT00535288|65494525|FG000|Overall Study|Lost to Follow-up|0|||
23478277|NCT00535288|65494526|FG001|Overall Study|Lost to Follow-up|3|||
23478278|NCT00535288|65494527|FG002|Overall Study|Lost to Follow-up|0|||
23478279|NCT00535288|65494528|FG003|Overall Study|Lost to Follow-up|0|||
23478280|NCT00535288|65494529|FG004|Overall Study|Lost to Follow-up|0|||
23478281|NCT00535288|65494525|FG000|Overall Study|Lack of Efficacy|26|||
23478282|NCT00535288|65494526|FG001|Overall Study|Lack of Efficacy|3|||
23478283|NCT00535288|65494527|FG002|Overall Study|Lack of Efficacy|4|||
23478284|NCT00535288|65494528|FG003|Overall Study|Lack of Efficacy|4|||
23478285|NCT00535288|65494529|FG004|Overall Study|Lack of Efficacy|7|||
23478286|NCT00535288|65494525|FG000|Overall Study|Unwilling to cooperate|6|||
23478287|NCT00535288|65494526|FG001|Overall Study|Unwilling to cooperate|6|||
23478288|NCT00535288|65494527|FG002|Overall Study|Unwilling to cooperate|3|||
23478289|NCT00535288|65494528|FG003|Overall Study|Unwilling to cooperate|3|||
23478290|NCT00535288|65494529|FG004|Overall Study|Unwilling to cooperate|4|||
23478291|NCT00535288|65494525|FG000|Overall Study|Other|2|||
23478292|NCT00535288|65494526|FG001|Overall Study|Other|1|||
23478293|NCT00535288|65494527|FG002|Overall Study|Other|1|||
23478294|NCT00535288|65494528|FG003|Overall Study|Other|2|||
23478295|NCT00535288|65494529|FG004|Overall Study|Other|1|||
23478296|NCT00505778|65494530|FG000|Overall Study|Adverse Event|2|||
23478297|NCT00505778|65494531|FG001|Overall Study|Adverse Event|7|||
23478298|NCT00505778|65494530|FG000|Overall Study|Physician Decision|8|||
23478299|NCT00505778|65494531|FG001|Overall Study|Physician Decision|14|||
23478300|NCT00505778|65494530|FG000|Overall Study|Lost to Follow-up|17|||
23478301|NCT00505778|65494531|FG001|Overall Study|Lost to Follow-up|23|||
23478302|NCT00505778|65494530|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
23478303|NCT00505778|65494531|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
23478304|NCT00505778|65494530|FG000|Overall Study|Protocol Violation|7|||
23478305|NCT00505778|65494531|FG001|Overall Study|Protocol Violation|9|||
23478306|NCT00505778|65494530|FG000|Overall Study|Withdrawal by Subject|29|||
23478307|NCT00505778|65494531|FG001|Overall Study|Withdrawal by Subject|14|||
23478308|NCT00505778|65494530|FG000|Overall Study|Relapse|65|||
23478309|NCT00505778|65494531|FG001|Overall Study|Relapse|65|||
23478310|NCT00505778|65494530|FG000|Overall Study|Took No Study Drug|2|||
23478311|NCT00505778|65494531|FG001|Overall Study|Took No Study Drug|2|||
23478312|NCT00910624|65494532|FG000|Treatment Phase|Adverse Event|2|||
23478313|NCT00910624|65494533|FG001|Treatment Phase|Adverse Event|6|||
23596351|NCT00925587|65912903|FG001|Overall Study|Protocol Violation|4|||
23255185|NCT02454972|64676777|FG000|Overall Study|Death|0|||
23255186|NCT02454972|64676778|FG001|Overall Study|Death|0|||
23255187|NCT02454972|64676779|FG002|Overall Study|Death|5|||
23255188|NCT02454972|64676780|FG003|Overall Study|Death|1|||
23255189|NCT02454972|64676781|FG004|Overall Study|Death|0|||
23255190|NCT02454972|64676782|FG005|Overall Study|Death|0|||
23255191|NCT02454972|64676783|FG006|Overall Study|Death|0|||
23596352|NCT00925587|65912902|FG000|Overall Study|Withdrawal by Subject|9|||
23596353|NCT00925587|65912903|FG001|Overall Study|Withdrawal by Subject|6|||
23596354|NCT00925587|65912902|FG000|Overall Study|Death|5|||
23255192|NCT02454972|64676784|FG007|Overall Study|Death|0|||
23255193|NCT02454972|64676785|FG008|Overall Study|Death|95|||
23255194|NCT02454972|64676777|FG000|Overall Study|Physician Decision|0|||
23255195|NCT02454972|64676778|FG001|Overall Study|Physician Decision|1|||
23255196|NCT02454972|64676779|FG002|Overall Study|Physician Decision|2|||
23255197|NCT02454972|64676780|FG003|Overall Study|Physician Decision|1|||
23255198|NCT02454972|64676781|FG004|Overall Study|Physician Decision|2|||
23255199|NCT02454972|64676782|FG005|Overall Study|Physician Decision|0|||
23255200|NCT02454972|64676783|FG006|Overall Study|Physician Decision|0|||
23255201|NCT02454972|64676784|FG007|Overall Study|Physician Decision|1|||
23255202|NCT02454972|64676785|FG008|Overall Study|Physician Decision|0|||
23255203|NCT02454972|64676777|FG000|Overall Study|Non treatment-related adverse event|2|||
23255204|NCT02454972|64676778|FG001|Overall Study|Non treatment-related adverse event|0|||
23255205|NCT02454972|64676779|FG002|Overall Study|Non treatment-related adverse event|1|||
23596355|NCT00925587|65912903|FG001|Overall Study|Death|5|||
23596356|NCT00925587|65912902|FG000|Overall Study|Adverse Event|6|||
23596357|NCT00925587|65912903|FG001|Overall Study|Adverse Event|2|||
23596358|NCT00925587|65912902|FG000|Overall Study|Lost to Follow-up|0|||
23596359|NCT00925587|65912903|FG001|Overall Study|Lost to Follow-up|1|||
23596360|NCT01084707|65912904|FG000|Overall Study|Withdrawal by Subject|6|||
23596361|NCT01765543|65912905|FG000|Overall Study|Death|1|||
23596362|NCT01765543|65912905|FG000|Overall Study|Withdrawal by Subject|2|||
23596363|NCT01198145|65912907|FG000|Overall Study|Withdrawal by Subject|1|||
23596364|NCT01198145|65912908|FG001|Overall Study|Withdrawal by Subject|1|||
23596365|NCT01616459|65912913|FG000|Overall Study|Adverse Event|1|||
23596366|NCT01616459|65912914|FG001|Overall Study|Adverse Event|1|||
23596367|NCT01616459|65912915|FG002|Overall Study|Adverse Event|2|||
23596368|NCT01616459|65912916|FG003|Overall Study|Adverse Event|0|||
23596369|NCT01616459|65912913|FG000|Overall Study|Lost to Follow-up|1|||
23596370|NCT01616459|65912914|FG001|Overall Study|Lost to Follow-up|11|||
23596371|NCT01616459|65912915|FG002|Overall Study|Lost to Follow-up|3|||
23596372|NCT01616459|65912916|FG003|Overall Study|Lost to Follow-up|2|||
23596373|NCT01616459|65912913|FG000|Overall Study|Protocol Violation|0|||
23596374|NCT01616459|65912914|FG001|Overall Study|Protocol Violation|0|||
23596375|NCT01616459|65912915|FG002|Overall Study|Protocol Violation|0|||
23596376|NCT01616459|65912916|FG003|Overall Study|Protocol Violation|2|||
23596377|NCT01616459|65912913|FG000|Overall Study|Withdrawal by Subject|2|||
23596378|NCT01616459|65912914|FG001|Overall Study|Withdrawal by Subject|4|||
23596379|NCT01616459|65912915|FG002|Overall Study|Withdrawal by Subject|4|||
23596380|NCT01616459|65912916|FG003|Overall Study|Withdrawal by Subject|4|||
23596381|NCT01616459|65912913|FG000|Overall Study|Other reason|0|||
23596382|NCT01616459|65912914|FG001|Overall Study|Other reason|1|||
23596383|NCT01616459|65912915|FG002|Overall Study|Other reason|1|||
23596384|NCT01616459|65912916|FG003|Overall Study|Other reason|0|||
23596385|NCT03454529|65912918|FG000|Overall Study|Did not receive treatment|6|||
23596386|NCT03454529|65912918|FG000|Overall Study|Received < 80% doses|1|||
23596387|NCT01149369|65912919|FG000|Overall Study|Adverse Event|6|||
23596388|NCT01149369|65912920|FG001|Overall Study|Adverse Event|3|||
23596389|NCT04056624|65912921|FG000|Overall Study|Withdrawal by Subject|0|||
23255206|NCT02454972|64676780|FG003|Overall Study|Non treatment-related adverse event|0|||
23255207|NCT02454972|64676781|FG004|Overall Study|Non treatment-related adverse event|0|||
23255208|NCT02454972|64676782|FG005|Overall Study|Non treatment-related adverse event|1|||
23255209|NCT02454972|64676783|FG006|Overall Study|Non treatment-related adverse event|0|||
23596390|NCT04056624|65912922|FG001|Overall Study|Withdrawal by Subject|0|||
23596391|NCT04056624|65912923|FG002|Overall Study|Withdrawal by Subject|1|||
23596392|NCT04056624|65912921|FG000|Overall Study|Protocol Violation|1|||
23596393|NCT04056624|65912922|FG001|Overall Study|Protocol Violation|2|||
23596394|NCT04056624|65912923|FG002|Overall Study|Protocol Violation|0|||
23596395|NCT01248936|65912926|FG000|Overall Study|Sponsor Decision|259|||
23255210|NCT02454972|64676784|FG007|Overall Study|Non treatment-related adverse event|1|||
23596396|NCT01248936|65912926|FG000|Overall Study|Progression of Disease|50|||
23596397|NCT01248936|65912926|FG000|Overall Study|Death|26|||
23596398|NCT01248936|65912926|FG000|Overall Study|Withdrawal of Consent|20|||
23255211|NCT02454972|64676785|FG008|Overall Study|Non treatment-related adverse event|0|||
23596399|NCT01248936|65912926|FG000|Overall Study|Adverse Event|8|||
23596400|NCT01248936|65912926|FG000|Overall Study|Lost to Follow-up|7|||
23596401|NCT01248936|65912926|FG000|Overall Study|Refused Treatment|1|||
23596402|NCT01248936|65912926|FG000|Overall Study|Other reason|3|||
23596403|NCT02556138|65912928|FG000|Overall Study|Withdrawal by Subject|1|||
23596404|NCT00632203|65912929|FG000|Overall Study|Did not start study treatment|1|||
23596405|NCT00632203|65912930|FG001|Overall Study|Did not start study treatment|0|||
23596406|NCT04788641|65912932|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
23596407|NCT04788641|65912933|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
23596408|NCT04788641|65912934|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
23596409|NCT04788641|65912935|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
23596410|NCT04788641|65912932|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
23596411|NCT04788641|65912933|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
23596412|NCT04788641|65912934|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
23596413|NCT04788641|65912935|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
23596414|NCT04788641|65912932|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
23596415|NCT04788641|65912933|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
23596416|NCT04788641|65912934|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
23596417|NCT04788641|65912935|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
23596418|NCT00595413|65912939|FG000|Overall Study|Adverse Event|0|||
23596419|NCT00595413|65912940|FG001|Overall Study|Adverse Event|2|||
23596420|NCT00595413|65912941|FG002|Overall Study|Adverse Event|1|||
23596421|NCT00595413|65912942|FG003|Overall Study|Adverse Event|1|||
23596422|NCT00595413|65912939|FG000|Overall Study|Lost to Follow-up|2|||
23596423|NCT00595413|65912940|FG001|Overall Study|Lost to Follow-up|2|||
23596424|NCT00595413|65912941|FG002|Overall Study|Lost to Follow-up|1|||
23596425|NCT00595413|65912942|FG003|Overall Study|Lost to Follow-up|3|||
23596426|NCT00595413|65912939|FG000|Overall Study|Death|0|||
23596427|NCT00595413|65912940|FG001|Overall Study|Death|0|||
23255212|NCT02454972|64676777|FG000|Overall Study|Treatment-related adverse events|0|||
23255213|NCT02454972|64676778|FG001|Overall Study|Treatment-related adverse events|1|||
23255214|NCT02454972|64676779|FG002|Overall Study|Treatment-related adverse events|1|||
23255215|NCT02454972|64676780|FG003|Overall Study|Treatment-related adverse events|0|||
23255216|NCT02454972|64676781|FG004|Overall Study|Treatment-related adverse events|2|||
23255217|NCT02454972|64676782|FG005|Overall Study|Treatment-related adverse events|0|||
23255218|NCT02454972|64676783|FG006|Overall Study|Treatment-related adverse events|0|||
23255219|NCT02454972|64676784|FG007|Overall Study|Treatment-related adverse events|2|||
23255220|NCT02454972|64676785|FG008|Overall Study|Treatment-related adverse events|0|||
23255221|NCT02454972|64676777|FG000|Overall Study|Patient moves to compassionate use|0|||
23255222|NCT02454972|64676778|FG001|Overall Study|Patient moves to compassionate use|0|||
23255223|NCT02454972|64676779|FG002|Overall Study|Patient moves to compassionate use|0|||
23255224|NCT02454972|64676780|FG003|Overall Study|Patient moves to compassionate use|0|||
23255225|NCT02454972|64676781|FG004|Overall Study|Patient moves to compassionate use|0|||
23255226|NCT02454972|64676782|FG005|Overall Study|Patient moves to compassionate use|0|||
23255227|NCT02454972|64676783|FG006|Overall Study|Patient moves to compassionate use|2|||
23255228|NCT02454972|64676784|FG007|Overall Study|Patient moves to compassionate use|0|||
23255229|NCT02454972|64676785|FG008|Overall Study|Patient moves to compassionate use|0|||
23255230|NCT02454972|64676777|FG000|Overall Study|Withdrawal by Subject|0|||
23255231|NCT02454972|64676778|FG001|Overall Study|Withdrawal by Subject|1|||
23255232|NCT02454972|64676779|FG002|Overall Study|Withdrawal by Subject|5|||
23255233|NCT02454972|64676780|FG003|Overall Study|Withdrawal by Subject|2|||
23255234|NCT02454972|64676781|FG004|Overall Study|Withdrawal by Subject|3|||
23255235|NCT02454972|64676782|FG005|Overall Study|Withdrawal by Subject|2|||
23255236|NCT02454972|64676783|FG006|Overall Study|Withdrawal by Subject|0|||
23255237|NCT02454972|64676784|FG007|Overall Study|Withdrawal by Subject|1|||
23255238|NCT02454972|64676785|FG008|Overall Study|Withdrawal by Subject|2|||
23255239|NCT02454972|64676777|FG000|Overall Study|Multiple delay/holds on treatment|0|||
23255240|NCT02454972|64676778|FG001|Overall Study|Multiple delay/holds on treatment|0|||
23255241|NCT02454972|64676779|FG002|Overall Study|Multiple delay/holds on treatment|0|||
23596428|NCT00595413|65912941|FG002|Overall Study|Death|1|||
23596429|NCT00595413|65912942|FG003|Overall Study|Death|0|||
23596430|NCT00595413|65912939|FG000|Overall Study|Other|5|||
23596431|NCT00595413|65912940|FG001|Overall Study|Other|1|||
23596432|NCT00595413|65912941|FG002|Overall Study|Other|5|||
23255242|NCT02454972|64676780|FG003|Overall Study|Multiple delay/holds on treatment|1|||
23255243|NCT02454972|64676781|FG004|Overall Study|Multiple delay/holds on treatment|0|||
23596433|NCT00595413|65912942|FG003|Overall Study|Other|0|||
23596434|NCT00411216|65912950|FG000|Overall Study|Ten participants were entered into the c|0|||
23596435|NCT00411216|65912951|FG001|Overall Study|Ten participants were entered into the c|2|||
23255244|NCT02454972|64676782|FG005|Overall Study|Multiple delay/holds on treatment|0|||
23596436|NCT00683696|65912954|FG000|Overall Study|Withdrawn due to study closure|337|||
23596437|NCT00683696|65912955|FG001|Overall Study|Withdrawn due to study closure|338|||
23596438|NCT00683696|65912954|FG000|Overall Study|Withdrawn prior to study closure|13|||
23596439|NCT00683696|65912955|FG001|Overall Study|Withdrawn prior to study closure|28|||
23596440|NCT00683696|65912954|FG000|Overall Study|Lost to Follow-up|5|||
23596441|NCT00683696|65912955|FG001|Overall Study|Lost to Follow-up|6|||
23596442|NCT00683696|65912954|FG000|Overall Study|Vital status follow-up only|3|||
23596443|NCT00683696|65912955|FG001|Overall Study|Vital status follow-up only|3|||
23596444|NCT00683696|65912954|FG000|Overall Study|Death|46|||
23596445|NCT00683696|65912955|FG001|Overall Study|Death|30|||
23596446|NCT00609336|65912956|FG000|Overall Study|Protocol Violation|3|||
23255245|NCT02454972|64676783|FG006|Overall Study|Multiple delay/holds on treatment|0|||
23255246|NCT02454972|64676784|FG007|Overall Study|Multiple delay/holds on treatment|0|||
23255247|NCT02454972|64676785|FG008|Overall Study|Multiple delay/holds on treatment|0|||
23255248|NCT02454972|64676777|FG000|Overall Study|Never treated|0|||
23255249|NCT02454972|64676778|FG001|Overall Study|Never treated|0|||
23255250|NCT02454972|64676779|FG002|Overall Study|Never treated|3|||
23255251|NCT02454972|64676780|FG003|Overall Study|Never treated|1|||
23478314|NCT00910624|65494534|FG002|Treatment Phase|Adverse Event|6|||
23478315|NCT00910624|65494535|FG003|Treatment Phase|Adverse Event|0|||
23478316|NCT00910624|65494532|FG000|Treatment Phase|Treatment Failure|23|||
23478317|NCT00910624|65494533|FG001|Treatment Phase|Treatment Failure|10|||
23478318|NCT00910624|65494534|FG002|Treatment Phase|Treatment Failure|0|||
23478319|NCT00910624|65494535|FG003|Treatment Phase|Treatment Failure|0|||
23478320|NCT00910624|65494532|FG000|Treatment Phase|Lost to Follow-up|0|||
23478321|NCT00910624|65494533|FG001|Treatment Phase|Lost to Follow-up|0|||
23478322|NCT00910624|65494534|FG002|Treatment Phase|Lost to Follow-up|1|||
23478323|NCT00910624|65494535|FG003|Treatment Phase|Lost to Follow-up|0|||
23478324|NCT00910624|65494532|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
23478325|NCT00910624|65494533|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
23478326|NCT00910624|65494534|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
23478327|NCT00910624|65494535|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
23478328|NCT00910624|65494532|FG000|Treatment Phase|Withdrawal by Subject|2|||
23478329|NCT00910624|65494533|FG001|Treatment Phase|Withdrawal by Subject|1|||
23478330|NCT00910624|65494534|FG002|Treatment Phase|Withdrawal by Subject|0|||
23478331|NCT00910624|65494535|FG003|Treatment Phase|Withdrawal by Subject|0|||
23478332|NCT00910624|65494532|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
23478333|NCT00910624|65494533|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
23478334|NCT00910624|65494534|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
23478335|NCT00910624|65494535|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
23478336|NCT00910624|65494532|FG000|Follow-Up Phase|Adverse Event|0|||
23478337|NCT00910624|65494533|FG001|Follow-Up Phase|Adverse Event|0|||
23478338|NCT00910624|65494534|FG002|Follow-Up Phase|Adverse Event|1|||
23478339|NCT00910624|65494535|FG003|Follow-Up Phase|Adverse Event|0|||
23478340|NCT00910624|65494532|FG000|Follow-Up Phase|Lost to Follow-up|3|||
23478341|NCT00910624|65494533|FG001|Follow-Up Phase|Lost to Follow-up|1|||
23478342|NCT00910624|65494534|FG002|Follow-Up Phase|Lost to Follow-up|2|||
23255252|NCT02454972|64676781|FG004|Overall Study|Never treated|1|||
23360385|NCT00215644|65062940|FG000|Overall Study|Adverse Event|2|||
23478343|NCT00910624|65494535|FG003|Follow-Up Phase|Lost to Follow-up|0|||
23478344|NCT00910624|65494532|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
23478345|NCT00910624|65494533|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
23478346|NCT00910624|65494534|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
23478347|NCT00910624|65494535|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
23478348|NCT00910624|65494532|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
23478349|NCT00910624|65494533|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
23596447|NCT00609336|65912956|FG000|Overall Study|Death|1|||
23255253|NCT02454972|64676782|FG005|Overall Study|Never treated|0|||
23478350|NCT00910624|65494534|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
23596448|NCT00609336|65912956|FG000|Overall Study|LA or Met at Surgery|9|||
23596449|NCT01205048|65915587|FG000|Overall Study|Withdrawal by Subject|14|||
23596450|NCT01205048|65915587|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
23596451|NCT01205048|65915587|FG000|Overall Study|Lost to Follow-up|4|||
23596452|NCT01205048|65915587|FG000|Overall Study|Other|2|||
23596453|NCT03447249|65915588|FG000|Overall Study|Adverse Event|1|||
23596454|NCT03447249|65915589|FG001|Overall Study|Adverse Event|0|||
23596455|NCT03447249|65915588|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
23596456|NCT03447249|65915589|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
23596457|NCT03447249|65915588|FG000|Overall Study|Other|3|||
23596458|NCT03447249|65915589|FG001|Overall Study|Other|0|||
23596459|NCT02422615|65915590|FG000|Treatment Period|Progressive disease|314|||
23596460|NCT02422615|65915591|FG001|Treatment Period|Progressive disease|200|||
23596461|NCT02422615|65915590|FG000|Treatment Period|Adverse Event|51|||
23596462|NCT02422615|65915591|FG001|Treatment Period|Adverse Event|9|||
23596463|NCT02422615|65915590|FG000|Treatment Period|Physician Decision|32|||
23596464|NCT02422615|65915591|FG001|Treatment Period|Physician Decision|8|||
23596465|NCT02422615|65915590|FG000|Treatment Period|Subject/guardian decision|38|||
23596466|NCT02422615|65915591|FG001|Treatment Period|Subject/guardian decision|8|||
23596467|NCT02422615|65915590|FG000|Treatment Period|Death|2|||
23596468|NCT02422615|65915591|FG001|Treatment Period|Death|1|||
23596469|NCT02422615|65915590|FG000|Treatment Period|Technical problems|0|||
23596470|NCT02422615|65915591|FG001|Treatment Period|Technical problems|1|||
23596471|NCT02422615|65915590|FG000|Treatment Period|Protocol deviation|1|||
23596472|NCT02422615|65915591|FG001|Treatment Period|Protocol deviation|1|||
23596473|NCT02422615|65915590|FG000|Treatment Period|Study terminated as per protocol|46|||
23596474|NCT02422615|65915591|FG001|Treatment Period|Study terminated as per protocol|14|||
23596475|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
23596476|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23596477|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Death|2|||
23596478|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Death|1|||
23596479|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23596480|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23596481|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
23596482|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
23596483|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
23596484|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
23596485|NCT02422615|65915590|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
23596486|NCT02422615|65915591|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
23596487|NCT02269475|65915592|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
23596488|NCT02269475|65915593|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
23596489|NCT02269475|65915592|FG000|Overall Study|Withdrawal by Subject|0|||
23596490|NCT02269475|65915593|FG001|Overall Study|Withdrawal by Subject|1|||
23596491|NCT01494922|65915594|FG000|Overall Study|Adverse Event|1|||
23596492|NCT00434304|65915596|FG000|Overall Study|Adverse Event|14|||
23596493|NCT00434304|65915596|FG000|Overall Study|Lack of Efficacy|2|||
23596494|NCT00434304|65915596|FG000|Overall Study|Withdrawal by Subject|4|||
23596495|NCT04512482|65915599|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
23596496|NCT04512482|65915600|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
23596497|NCT01063972|65915603|FG000|Overall Study|Death|12|||
23596498|NCT01063972|65915604|FG001|Overall Study|Death|11|||
23596499|NCT01063972|65915603|FG000|Overall Study|Incarcerated|2|||
23596500|NCT01063972|65915604|FG001|Overall Study|Incarcerated|1|||
23596501|NCT00274469|65915605|FG000|Overall Study|Death|63|||
23596502|NCT00274469|65915606|FG001|Overall Study|Death|74|||
23596503|NCT00274469|65915605|FG000|Overall Study|Did not consent to OS follow-up|16|||
23596504|NCT00274469|65915606|FG001|Overall Study|Did not consent to OS follow-up|19|||
23596505|NCT01421667|65915607|FG000|Overall Study|Withdrawal by Subject|0|||
23596506|NCT01421667|65915608|FG001|Overall Study|Withdrawal by Subject|1|||
23596507|NCT01421667|65915609|FG002|Overall Study|Withdrawal by Subject|2|||
23596508|NCT01421667|65915610|FG003|Overall Study|Withdrawal by Subject|1|||
23596509|NCT01421667|65915607|FG000|Overall Study|Lost to Follow-up|0|||
23596510|NCT01421667|65915608|FG001|Overall Study|Lost to Follow-up|1|||
23596511|NCT01421667|65915609|FG002|Overall Study|Lost to Follow-up|0|||
23596512|NCT01421667|65915610|FG003|Overall Study|Lost to Follow-up|0|||
23596513|NCT01388361|65915611|FG000|Overall Study|Adverse Event|0|||
23596514|NCT01388361|65915612|FG001|Overall Study|Adverse Event|5|||
23596515|NCT01388361|65915613|FG002|Overall Study|Adverse Event|1|||
23596516|NCT01388361|65915611|FG000|Overall Study|Protocol Violation|0|||
23596517|NCT01388361|65915612|FG001|Overall Study|Protocol Violation|0|||
23596518|NCT01388361|65915613|FG002|Overall Study|Protocol Violation|2|||
23596519|NCT01388361|65915611|FG000|Overall Study|Withdrawal criteria|12|||
23596520|NCT01388361|65915612|FG001|Overall Study|Withdrawal criteria|7|||
23596521|NCT01388361|65915613|FG002|Overall Study|Withdrawal criteria|10|||
23596522|NCT01388361|65915611|FG000|Overall Study|Unclassified|0|||
23596523|NCT01388361|65915612|FG001|Overall Study|Unclassified|0|||
23596524|NCT01388361|65915613|FG002|Overall Study|Unclassified|1|||
23596525|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
23596526|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
23596527|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
23596528|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
23596529|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
23596530|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
23596531|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
23596532|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
23596533|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
23596534|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
23596535|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
23596536|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
23596537|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
23596538|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
23596539|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
23596540|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
23596541|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
23596542|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
23596543|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
23596544|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
23596545|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
23596546|NCT00304031|65915616|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
23596547|NCT00304031|65915617|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
23596548|NCT00304031|65915618|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
23596549|NCT00304031|65915616|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
23596550|NCT00304031|65915617|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
23596551|NCT00304031|65915618|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
23596552|NCT03580369|65915626|FG000|Overall Study|No treatment due to mis-randomization|1|||
23596553|NCT03580369|65915627|FG001|Overall Study|No treatment due to mis-randomization|0|||
23596554|NCT03580369|65915628|FG002|Overall Study|No treatment due to mis-randomization|0|||
23596555|NCT03580369|65915629|FG003|Overall Study|No treatment due to mis-randomization|0|||
23596556|NCT03580369|65915630|FG004|Overall Study|No treatment due to mis-randomization|3|||
23596557|NCT03580369|65915631|FG005|Overall Study|No treatment due to mis-randomization|0|||
23596558|NCT03580369|65915632|FG006|Overall Study|No treatment due to mis-randomization|0|||
23596559|NCT03580369|65915633|FG007|Overall Study|No treatment due to mis-randomization|0|||
23596560|NCT03580369|65915626|FG000|Overall Study|Reason unknown|0|||
23596561|NCT03580369|65915627|FG001|Overall Study|Reason unknown|0|||
23596562|NCT03580369|65915628|FG002|Overall Study|Reason unknown|1|||
23596563|NCT03580369|65915629|FG003|Overall Study|Reason unknown|0|||
23596564|NCT03580369|65915630|FG004|Overall Study|Reason unknown|0|||
23596565|NCT03580369|65915631|FG005|Overall Study|Reason unknown|0|||
23596566|NCT03580369|65915632|FG006|Overall Study|Reason unknown|0|||
23596567|NCT03580369|65915633|FG007|Overall Study|Reason unknown|0|||
23596568|NCT03580369|65915626|FG000|Overall Study|Technical problems|0|||
23596569|NCT03580369|65915627|FG001|Overall Study|Technical problems|0|||
23596570|NCT03580369|65915628|FG002|Overall Study|Technical problems|0|||
23596571|NCT03580369|65915629|FG003|Overall Study|Technical problems|0|||
23596572|NCT03580369|65915630|FG004|Overall Study|Technical problems|1|||
23596573|NCT03580369|65915631|FG005|Overall Study|Technical problems|0|||
23596574|NCT03580369|65915632|FG006|Overall Study|Technical problems|2|||
23596575|NCT03580369|65915633|FG007|Overall Study|Technical problems|0|||
23596576|NCT03580369|65915626|FG000|Overall Study|Pregnancy|2|||
23596577|NCT03580369|65915627|FG001|Overall Study|Pregnancy|0|||
23596578|NCT03580369|65915628|FG002|Overall Study|Pregnancy|3|||
23596579|NCT03580369|65915629|FG003|Overall Study|Pregnancy|0|||
23596580|NCT03580369|65915630|FG004|Overall Study|Pregnancy|2|||
23596581|NCT03580369|65915631|FG005|Overall Study|Pregnancy|0|||
23596582|NCT03580369|65915632|FG006|Overall Study|Pregnancy|0|||
23596583|NCT03580369|65915633|FG007|Overall Study|Pregnancy|0|||
23596584|NCT03580369|65915626|FG000|Overall Study|Lost to Follow-up|2|||
23596585|NCT03580369|65915627|FG001|Overall Study|Lost to Follow-up|0|||
23596586|NCT03580369|65915628|FG002|Overall Study|Lost to Follow-up|2|||
23596587|NCT03580369|65915629|FG003|Overall Study|Lost to Follow-up|0|||
23255254|NCT02454972|64676783|FG006|Overall Study|Never treated|0|||
23596588|NCT03580369|65915630|FG004|Overall Study|Lost to Follow-up|3|||
23596589|NCT03580369|65915631|FG005|Overall Study|Lost to Follow-up|0|||
23596590|NCT03580369|65915632|FG006|Overall Study|Lost to Follow-up|1|||
23596591|NCT03580369|65915633|FG007|Overall Study|Lost to Follow-up|0|||
23596592|NCT03580369|65915626|FG000|Overall Study|Physician Decision|4|||
23596593|NCT03580369|65915627|FG001|Overall Study|Physician Decision|0|||
23596594|NCT03580369|65915628|FG002|Overall Study|Physician Decision|4|||
23596595|NCT03580369|65915629|FG003|Overall Study|Physician Decision|1|||
23596596|NCT03580369|65915630|FG004|Overall Study|Physician Decision|1|||
23596597|NCT03580369|65915631|FG005|Overall Study|Physician Decision|0|||
23596598|NCT03580369|65915632|FG006|Overall Study|Physician Decision|0|||
23596599|NCT03580369|65915633|FG007|Overall Study|Physician Decision|0|||
23596600|NCT03580369|65915626|FG000|Overall Study|Lack of Efficacy|3|||
23596601|NCT03580369|65915627|FG001|Overall Study|Lack of Efficacy|0|||
23596602|NCT03580369|65915628|FG002|Overall Study|Lack of Efficacy|7|||
23596603|NCT03580369|65915629|FG003|Overall Study|Lack of Efficacy|0|||
23596604|NCT03580369|65915630|FG004|Overall Study|Lack of Efficacy|2|||
23596605|NCT03580369|65915631|FG005|Overall Study|Lack of Efficacy|0|||
23596606|NCT03580369|65915632|FG006|Overall Study|Lack of Efficacy|3|||
23596607|NCT03580369|65915633|FG007|Overall Study|Lack of Efficacy|0|||
23596608|NCT03580369|65915626|FG000|Overall Study|Protocol Violation|6|||
23596609|NCT03580369|65915627|FG001|Overall Study|Protocol Violation|0|||
23596610|NCT03580369|65915628|FG002|Overall Study|Protocol Violation|6|||
23596611|NCT03580369|65915629|FG003|Overall Study|Protocol Violation|1|||
23596612|NCT03580369|65915630|FG004|Overall Study|Protocol Violation|8|||
23596613|NCT03580369|65915631|FG005|Overall Study|Protocol Violation|2|||
23596614|NCT03580369|65915632|FG006|Overall Study|Protocol Violation|1|||
23596615|NCT03580369|65915633|FG007|Overall Study|Protocol Violation|0|||
23596616|NCT03580369|65915626|FG000|Overall Study|Adverse Event|7|||
23596617|NCT03580369|65915627|FG001|Overall Study|Adverse Event|0|||
23596618|NCT03580369|65915628|FG002|Overall Study|Adverse Event|14|||
23596619|NCT03580369|65915629|FG003|Overall Study|Adverse Event|1|||
23596620|NCT03580369|65915630|FG004|Overall Study|Adverse Event|6|||
23596621|NCT03580369|65915631|FG005|Overall Study|Adverse Event|0|||
23596622|NCT03580369|65915632|FG006|Overall Study|Adverse Event|1|||
23596623|NCT03580369|65915633|FG007|Overall Study|Adverse Event|0|||
23596624|NCT03580369|65915626|FG000|Overall Study|Withdrawal by Subject|19|||
23596625|NCT03580369|65915627|FG001|Overall Study|Withdrawal by Subject|0|||
23596626|NCT03580369|65915628|FG002|Overall Study|Withdrawal by Subject|17|||
23596627|NCT03580369|65915629|FG003|Overall Study|Withdrawal by Subject|0|||
23596628|NCT03580369|65915630|FG004|Overall Study|Withdrawal by Subject|16|||
23596629|NCT03580369|65915631|FG005|Overall Study|Withdrawal by Subject|1|||
23596630|NCT03580369|65915632|FG006|Overall Study|Withdrawal by Subject|7|||
23596631|NCT03580369|65915633|FG007|Overall Study|Withdrawal by Subject|0|||
23596632|NCT00901901|65915634|FG000|Treatment Period|Adverse Event|120|||
23596633|NCT00901901|65915635|FG001|Treatment Period|Adverse Event|128|||
23596634|NCT00901901|65915634|FG000|Treatment Period|Withdrawal by Subject|26|||
23596635|NCT00901901|65915635|FG001|Treatment Period|Withdrawal by Subject|24|||
23596636|NCT00901901|65915634|FG000|Treatment Period|Physician Decision|2|||
23596637|NCT00901901|65915635|FG001|Treatment Period|Physician Decision|2|||
23596638|NCT00901901|65915634|FG000|Treatment Period|Lost to Follow-up|3|||
23596639|NCT00901901|65915635|FG001|Treatment Period|Lost to Follow-up|5|||
23596640|NCT00901901|65915634|FG000|Treatment Period|Noncompliance with study medication|4|||
23596641|NCT00901901|65915635|FG001|Treatment Period|Noncompliance with study medication|1|||
23596642|NCT00901901|65915634|FG000|Treatment Period|Missing|1|||
23596643|NCT00901901|65915635|FG001|Treatment Period|Missing|0|||
23596644|NCT00901901|65915634|FG000|Treatment Period|Never treated|0|||
23596645|NCT00901901|65915635|FG001|Treatment Period|Never treated|3|||
23596646|NCT00901901|65915634|FG000|Treatment Period|Protocol driven decision point|0|||
23596647|NCT00901901|65915635|FG001|Treatment Period|Protocol driven decision point|2|||
23596648|NCT00901901|65915634|FG000|Treatment Period|Study terminated by sponsor|2|||
23596649|NCT00901901|65915635|FG001|Treatment Period|Study terminated by sponsor|0|||
23596650|NCT00901901|65915634|FG000|Treatment Period|Protocol Violation|5|||
23255255|NCT02454972|64676784|FG007|Overall Study|Never treated|0|||
23596651|NCT00901901|65915635|FG001|Treatment Period|Protocol Violation|9|||
23596652|NCT00901901|65915634|FG000|Treatment Period|Switch to commercial drug|1|||
23596653|NCT00901901|65915635|FG001|Treatment Period|Switch to commercial drug|1|||
23596654|NCT00901901|65915634|FG000|Treatment Period|Transfer to treatment continuation study|5|||
23596655|NCT00901901|65915635|FG001|Treatment Period|Transfer to treatment continuation study|2|||
23596656|NCT00901901|65915634|FG000|Follow-up Period|Death|181|||
23596657|NCT00901901|65915635|FG001|Follow-up Period|Death|208|||
23596658|NCT00901901|65915634|FG000|Follow-up Period|Protocol driven decision point|47|||
23596659|NCT00901901|65915635|FG001|Follow-up Period|Protocol driven decision point|36|||
23596660|NCT00901901|65915634|FG000|Follow-up Period|Withdrawal by Subject|6|||
23596661|NCT00901901|65915635|FG001|Follow-up Period|Withdrawal by Subject|9|||
23596662|NCT00901901|65915634|FG000|Follow-up Period|Lost to Follow-up|12|||
23596663|NCT00901901|65915635|FG001|Follow-up Period|Lost to Follow-up|8|||
23596664|NCT00901901|65915634|FG000|Follow-up Period|Missing|94|||
23596665|NCT00901901|65915635|FG001|Follow-up Period|Missing|80|||
23596666|NCT02267824|65915636|FG000|Overall Study|Pregnancy|1|||
23596667|NCT02267824|65915637|FG001|Overall Study|Pregnancy|1|||
23596668|NCT02267824|65915636|FG000|Overall Study|Lost to Follow-up|4|||
23596669|NCT02267824|65915637|FG001|Overall Study|Lost to Follow-up|0|||
23596670|NCT02267824|65915636|FG000|Overall Study|Protocol Violation|3|||
23596671|NCT02267824|65915637|FG001|Overall Study|Protocol Violation|0|||
23596672|NCT02267824|65915636|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
23596673|NCT02267824|65915637|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
23596674|NCT02724956|65915638|FG000|Overall Study|Physician Decision|1|||
23596675|NCT02724956|65915639|FG001|Overall Study|Physician Decision|0|||
23596676|NCT02724956|65915638|FG000|Overall Study|Lack of Efficacy|0|||
23596677|NCT02724956|65915639|FG001|Overall Study|Lack of Efficacy|1|||
23596678|NCT02724956|65915638|FG000|Overall Study|Withdrawal by Subject|0|||
23596679|NCT02724956|65915639|FG001|Overall Study|Withdrawal by Subject|1|||
23596680|NCT03485950|65915641|FG000|Overall Study|Adverse Event|1|||
23596681|NCT03485950|65915642|FG001|Overall Study|Adverse Event|0|||
23596682|NCT03485950|65915641|FG000|Overall Study|Death|3|||
23596683|NCT03485950|65915642|FG001|Overall Study|Death|2|||
23596684|NCT03485950|65915641|FG000|Overall Study|Withdrawal by Subject|3|||
23596685|NCT03485950|65915642|FG001|Overall Study|Withdrawal by Subject|0|||
23596686|NCT02797184|65915643|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
23596687|NCT02797184|65915644|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
23596688|NCT03481816|65915649|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
23596689|NCT03481816|65915650|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
23596690|NCT03481816|65915649|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
23596691|NCT03481816|65915650|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
23596692|NCT03481816|65915649|FG000|Dose Expansion|Withdrawal by Subject|0|||
23596693|NCT03481816|65915650|FG001|Dose Expansion|Withdrawal by Subject|2|||
23596694|NCT03481816|65915649|FG000|Dose Expansion|Physician Decision|0|||
23596695|NCT03481816|65915650|FG001|Dose Expansion|Physician Decision|5|||
23596696|NCT03578536|65915653|FG000|Overall Study|Lost to Follow-up|1|||
23596697|NCT03593876|65915654|FG000|Overall Study|Withdrawal by Subject|1|||
23596698|NCT03593876|65915654|FG000|Overall Study|Discharged home before intervention completion|2|||
23596699|NCT00440011|65915655|FG000|Overall Study|Adverse Event|2|||
23596700|NCT00440011|65915656|FG001|Overall Study|Adverse Event|0|||
23596701|NCT00440011|65915655|FG000|Overall Study|Lost to Follow-up|0|||
23596702|NCT00440011|65915656|FG001|Overall Study|Lost to Follow-up|2|||
23596703|NCT00440011|65915655|FG000|Overall Study|Protocol Violation|1|||
23596704|NCT00440011|65915656|FG001|Overall Study|Protocol Violation|1|||
23596705|NCT00440011|65915655|FG000|Overall Study|Withdrawal by Subject|1|||
23596706|NCT00440011|65915656|FG001|Overall Study|Withdrawal by Subject|0|||
23596707|NCT02374307|65915657|FG000|3-months Follow-up|Lost to Follow-up|1|||
23596708|NCT02374307|65915658|FG001|3-months Follow-up|Lost to Follow-up|2|||
23596709|NCT02374307|65915657|FG000|3-months Follow-up|Withdrawal by Subject|1|||
23596710|NCT02374307|65915658|FG001|3-months Follow-up|Withdrawal by Subject|4|||
23596711|NCT02374307|65915657|FG000|3-months Follow-up|Death|1|||
23596712|NCT02374307|65915658|FG001|3-months Follow-up|Death|2|||
23596713|NCT02374307|65915657|FG000|3-months Follow-up|Missed first follow-up|5|||
23596714|NCT02374307|65915658|FG001|3-months Follow-up|Missed first follow-up|1|||
23596715|NCT02374307|65915657|FG000|6-months Follow-up|Lost to Follow-up|1|||
23596716|NCT02374307|65915658|FG001|6-months Follow-up|Lost to Follow-up|2|||
23596717|NCT02374307|65915657|FG000|6-months Follow-up|Death|2|||
23596718|NCT02374307|65915658|FG001|6-months Follow-up|Death|1|||
23596719|NCT02374307|65915657|FG000|6-months Follow-up|Withdrawal by Subject|0|||
23596720|NCT02374307|65915658|FG001|6-months Follow-up|Withdrawal by Subject|3|||
23596721|NCT01036724|65915659|FG000|Overall Study|Adverse Event|1|||
23596722|NCT01036724|65915660|FG001|Overall Study|Adverse Event|2|||
23596723|NCT01036724|65915659|FG000|Overall Study|Lack of Efficacy|1|||
23596724|NCT01036724|65915660|FG001|Overall Study|Lack of Efficacy|1|||
23596725|NCT01036724|65915659|FG000|Overall Study|Protocol Violation|4|||
23596726|NCT01036724|65915660|FG001|Overall Study|Protocol Violation|5|||
23596727|NCT01185561|65915669|FG000|Overall Study|Lost to Follow-up|0|||
23596728|NCT01185561|65915670|FG001|Overall Study|Lost to Follow-up|4|||
23596729|NCT01185561|65915669|FG000|Overall Study|Withdrawal by Subject|2|||
23596730|NCT01185561|65915670|FG001|Overall Study|Withdrawal by Subject|8|||
23596731|NCT00840177|65915674|FG000|Overall Study|Adverse Event|5|||
23596732|NCT00840177|65915675|FG001|Overall Study|Adverse Event|1|||
23596733|NCT00840177|65915676|FG002|Overall Study|Adverse Event|1|||
23596734|NCT00840177|65915674|FG000|Overall Study|Refusal unrelated to adverse events|1|||
23596735|NCT00840177|65915675|FG001|Overall Study|Refusal unrelated to adverse events|0|||
23596736|NCT00840177|65915676|FG002|Overall Study|Refusal unrelated to adverse events|1|||
23596737|NCT00840177|65915674|FG000|Overall Study|Progression/relapse|2|||
23596738|NCT00840177|65915675|FG001|Overall Study|Progression/relapse|0|||
23596739|NCT00840177|65915676|FG002|Overall Study|Progression/relapse|0|||
23596740|NCT00840177|65915674|FG000|Overall Study|Death|4|||
23596741|NCT00840177|65915675|FG001|Overall Study|Death|5|||
23596742|NCT00840177|65915676|FG002|Overall Study|Death|5|||
23596743|NCT00840177|65915674|FG000|Overall Study|not protocol specified|6|||
23596744|NCT00840177|65915675|FG001|Overall Study|not protocol specified|3|||
23596745|NCT00840177|65915676|FG002|Overall Study|not protocol specified|0|||
23596746|NCT00840177|65915674|FG000|Overall Study|Ineligible|0|||
23255256|NCT02454972|64676785|FG008|Overall Study|Never treated|5|||
23255257|NCT02454972|64676777|FG000|Overall Study|Lost to Follow-up|0|||
23255258|NCT02454972|64676778|FG001|Overall Study|Lost to Follow-up|0|||
23255259|NCT02454972|64676779|FG002|Overall Study|Lost to Follow-up|0|||
23255260|NCT02454972|64676780|FG003|Overall Study|Lost to Follow-up|0|||
23255261|NCT02454972|64676781|FG004|Overall Study|Lost to Follow-up|0|||
23255262|NCT02454972|64676782|FG005|Overall Study|Lost to Follow-up|0|||
23596747|NCT00840177|65915675|FG001|Overall Study|Ineligible|0|||
23596748|NCT00840177|65915676|FG002|Overall Study|Ineligible|3|||
23596749|NCT00840177|65915674|FG000|Overall Study|Did not start treatment|0|||
23596750|NCT00840177|65915675|FG001|Overall Study|Did not start treatment|0|||
23596751|NCT00840177|65915676|FG002|Overall Study|Did not start treatment|1|||
23596752|NCT00978042|65915677|FG000|Initial Treatment Period|Treated in Error|0|||
23596753|NCT00978042|65915678|FG001|Initial Treatment Period|Treated in Error|3|||
23596754|NCT00978042|65915677|FG000|Initial Treatment Period|Ineligibility|1|||
23596755|NCT00978042|65915678|FG001|Initial Treatment Period|Ineligibility|0|||
23596756|NCT00978042|65915677|FG000|Initial Treatment Period|Lost to Follow-up|21|||
23596757|NCT00978042|65915678|FG001|Initial Treatment Period|Lost to Follow-up|3|||
23596758|NCT00978042|65915677|FG000|Initial Treatment Period|Adverse Event|2|||
23596759|NCT00978042|65915678|FG001|Initial Treatment Period|Adverse Event|0|||
23596760|NCT00978042|65915677|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
23596761|NCT00978042|65915678|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
23596762|NCT00978042|65915677|FG000|Initial Treatment Period|Consent withdrawn|22|||
23596763|NCT00978042|65915678|FG001|Initial Treatment Period|Consent withdrawn|9|||
23596764|NCT00978042|65915677|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
23596765|NCT00978042|65915678|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
23596766|NCT01184326|65915679|FG000|Overall Study|Adverse Event|1|||
23596767|NCT01184326|65915680|FG001|Overall Study|Adverse Event|2|||
23596768|NCT01184326|65915681|FG002|Overall Study|Adverse Event|0|||
23596769|NCT01184326|65915679|FG000|Overall Study|Death|0|||
23596770|NCT01184326|65915680|FG001|Overall Study|Death|0|||
23596771|NCT01184326|65915681|FG002|Overall Study|Death|1|||
23596772|NCT01184326|65915679|FG000|Overall Study|Withdrawal by Subject|0|||
23596773|NCT01184326|65915680|FG001|Overall Study|Withdrawal by Subject|0|||
23596774|NCT01184326|65915681|FG002|Overall Study|Withdrawal by Subject|1|||
23596775|NCT01184326|65915679|FG000|Overall Study|Physician Decision|1|||
23596776|NCT01184326|65915680|FG001|Overall Study|Physician Decision|1|||
23596777|NCT01184326|65915681|FG002|Overall Study|Physician Decision|0|||
23596778|NCT01184326|65915679|FG000|Overall Study|Disease Progression|1|||
23596779|NCT01184326|65915680|FG001|Overall Study|Disease Progression|3|||
23596780|NCT01184326|65915681|FG002|Overall Study|Disease Progression|12|||
23596781|NCT03582722|65915686|FG000|Overall Study|Lost to Follow-up|1|||
23596782|NCT03582722|65915687|FG001|Overall Study|Lost to Follow-up|4|||
23596783|NCT03582722|65915686|FG000|Overall Study|Withdrawal by Subject|3|||
23596784|NCT03582722|65915687|FG001|Overall Study|Withdrawal by Subject|3|||
23596785|NCT01424397|65915690|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596786|NCT01424397|65915691|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
23255263|NCT02454972|64676783|FG006|Overall Study|Lost to Follow-up|0|||
23596787|NCT01424397|65915692|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
23596788|NCT01424397|65915693|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596789|NCT01424397|65915694|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596790|NCT01424397|65915695|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596791|NCT01424397|65915696|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596792|NCT01424397|65915697|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596793|NCT01424397|65915698|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596794|NCT01424397|65915699|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
23194410|NCT00723840|64455928|FG000|Overall Study|Serious Adverse Events|3|||
23194411|NCT00723840|64455928|FG000|Overall Study|Other Medical Event|2|||
23194412|NCT00723840|64455928|FG000|Overall Study|Unspecified reason|2|||
23194413|NCT00081289|64455929|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
23194414|NCT00081289|64455930|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
23194415|NCT00081289|64455929|FG000|Overall Study|Ineligible / no protocol treatment|3|||
23360386|NCT00215644|65062941|FG001|Overall Study|Adverse Event|9|||
23360387|NCT00215644|65062940|FG000|Overall Study|Death|1|||
23360388|NCT00215644|65062941|FG001|Overall Study|Death|2|||
23360389|NCT00215644|65062940|FG000|Overall Study|Withdrawal by Subject|1|||
23360390|NCT00215644|65062941|FG001|Overall Study|Withdrawal by Subject|0|||
23360391|NCT00215644|65062940|FG000|Overall Study|Other|3|||
23360392|NCT00215644|65062941|FG001|Overall Study|Other|15|||
23360393|NCT00215644|65062940|FG000|Overall Study|Randomized but Not Treated|1|||
23360394|NCT00215644|65062941|FG001|Overall Study|Randomized but Not Treated|0|||
23360395|NCT03046953|65062942|FG000|Overall Study|Relapse/progressive disease|21|||
23360396|NCT03046953|65062942|FG000|Overall Study|Death|2|||
23360397|NCT03046953|65062942|FG000|Overall Study|Withdrawal by Subject|3|||
23360398|NCT00426764|65062943|FG000|Overall Study|Protocol Violation|1|||
23360399|NCT00426764|65062943|FG000|Overall Study|Withdrawal by Subject|4|||
23360400|NCT00426764|65062943|FG000|Overall Study|Physician Decision|6|||
23360401|NCT00426764|65062943|FG000|Overall Study|Compassionate Use|1|||
23360402|NCT00426764|65062943|FG000|Overall Study|Progressive Disease|83|||
23360403|NCT00426764|65062943|FG000|Overall Study|Adverse Event|24|||
23360404|NCT00426764|65062943|FG000|Overall Study|Other|1|||
23360405|NCT00426764|65062943|FG000|Overall Study|Death|1|||
23360406|NCT00426764|65062943|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
23255264|NCT02454972|64676784|FG007|Overall Study|Lost to Follow-up|0|||
23255265|NCT02454972|64676785|FG008|Overall Study|Lost to Follow-up|2|||
23255266|NCT02454972|64676777|FG000|Overall Study|Study termination|0|||
23360407|NCT02781818|65062944|FG000|Overall Study|Lost to Follow-up|4|||
23360408|NCT02781818|65062945|FG001|Overall Study|Lost to Follow-up|2|||
23360409|NCT02781818|65062946|FG002|Overall Study|Lost to Follow-up|1|||
23360410|NCT02793947|65062947|FG000|Overall Study|Death|1|||
23360411|NCT02793947|65062948|FG001|Overall Study|Death|0|||
23360412|NCT02793947|65062947|FG000|Overall Study|Physician Decision|1|||
23360413|NCT02793947|65062948|FG001|Overall Study|Physician Decision|5|||
23360414|NCT01831427|65062949|FG000|Overall Study|Adverse Event|0|||
23360415|NCT01831427|65062950|FG001|Overall Study|Adverse Event|1|||
23360416|NCT01831427|65062951|FG002|Overall Study|Adverse Event|0|||
23360417|NCT01831427|65062952|FG003|Overall Study|Adverse Event|0|||
23360418|NCT01831427|65062953|FG004|Overall Study|Adverse Event|0|||
23360419|NCT01831427|65062954|FG005|Overall Study|Adverse Event|1|||
23360420|NCT01831427|65062955|FG006|Overall Study|Adverse Event|0|||
23360421|NCT01831427|65062956|FG007|Overall Study|Adverse Event|1|||
23360422|NCT01831427|65062957|FG008|Overall Study|Adverse Event|0|||
23360423|NCT01831427|65062958|FG009|Overall Study|Adverse Event|0|||
23360424|NCT01831427|65062959|FG010|Overall Study|Adverse Event|2|||
23360425|NCT01831427|65062949|FG000|Overall Study|Investigator's Discretion|0|||
23360426|NCT01831427|65062950|FG001|Overall Study|Investigator's Discretion|0|||
23360427|NCT01831427|65062951|FG002|Overall Study|Investigator's Discretion|0|||
23360428|NCT01831427|65062952|FG003|Overall Study|Investigator's Discretion|1|||
23360429|NCT01831427|65062953|FG004|Overall Study|Investigator's Discretion|0|||
23478351|NCT00910624|65494535|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
23194416|NCT00081289|64455930|FG001|Overall Study|Ineligible / no protocol treatment|4|||
23194417|NCT00829166|64455932|FG000|Overall Study|Death|305|||
23255267|NCT02454972|64676778|FG001|Overall Study|Study termination|0|||
23255268|NCT02454972|64676779|FG002|Overall Study|Study termination|0|||
23255269|NCT02454972|64676780|FG003|Overall Study|Study termination|0|||
23360430|NCT01831427|65062954|FG005|Overall Study|Investigator's Discretion|0|||
23360431|NCT01831427|65062955|FG006|Overall Study|Investigator's Discretion|0|||
23360432|NCT01831427|65062956|FG007|Overall Study|Investigator's Discretion|0|||
23360433|NCT01831427|65062957|FG008|Overall Study|Investigator's Discretion|0|||
23360434|NCT01831427|65062958|FG009|Overall Study|Investigator's Discretion|0|||
23478352|NCT00910624|65494532|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
23478353|NCT00910624|65494533|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
23596795|NCT01424397|65915700|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596796|NCT01424397|65915701|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
23596797|NCT02008916|65915702|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
23596798|NCT02008916|65915703|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
23596799|NCT02008916|65915704|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
23596800|NCT02008916|65915702|FG000|Week 16 - 156|Adverse Event|4|||
23596801|NCT02008916|65915703|FG001|Week 16 - 156|Adverse Event|2|||
23596802|NCT02008916|65915704|FG002|Week 16 - 156|Adverse Event|3|||
23596803|NCT02008916|65915702|FG000|Week 16 - 156|Withdrawal by Subject|7|||
23596804|NCT02008916|65915703|FG001|Week 16 - 156|Withdrawal by Subject|3|||
23596805|NCT02008916|65915704|FG002|Week 16 - 156|Withdrawal by Subject|5|||
23596806|NCT02008916|65915702|FG000|Week 16 - 156|No longer requires treatment|0|||
23596807|NCT02008916|65915703|FG001|Week 16 - 156|No longer requires treatment|1|||
23596808|NCT02008916|65915704|FG002|Week 16 - 156|No longer requires treatment|0|||
23596809|NCT02008916|65915702|FG000|Week 16 - 156|Lost to Follow-up|5|||
23596810|NCT02008916|65915703|FG001|Week 16 - 156|Lost to Follow-up|0|||
23596811|NCT02008916|65915704|FG002|Week 16 - 156|Lost to Follow-up|0|||
23596812|NCT02008916|65915702|FG000|Week 16 - 156|Lack of Efficacy|3|||
23596813|NCT02008916|65915703|FG001|Week 16 - 156|Lack of Efficacy|5|||
23596814|NCT02008916|65915704|FG002|Week 16 - 156|Lack of Efficacy|2|||
23596815|NCT02008916|65915702|FG000|Week 16 - 156|Pregnancy|0|||
23596816|NCT02008916|65915703|FG001|Week 16 - 156|Pregnancy|1|||
23596817|NCT02008916|65915704|FG002|Week 16 - 156|Pregnancy|0|||
23596818|NCT02008916|65915702|FG000|Week 16 - 156|Physician Decision|0|||
23596819|NCT02008916|65915703|FG001|Week 16 - 156|Physician Decision|1|||
23596820|NCT02008916|65915704|FG002|Week 16 - 156|Physician Decision|0|||
23596821|NCT01236560|65915707|FG000|Overall Study|Adverse Event|0|||
23596822|NCT01236560|65915708|FG001|Overall Study|Adverse Event|2|||
23596823|NCT01236560|65915709|FG002|Overall Study|Adverse Event|1|||
23596824|NCT01236560|65915710|FG003|Overall Study|Adverse Event|3|||
23596825|NCT01236560|65915711|FG004|Overall Study|Adverse Event|0|||
23596826|NCT01236560|65915712|FG005|Overall Study|Adverse Event|0|||
23596827|NCT01236560|65915707|FG000|Overall Study|Death|0|||
23596828|NCT01236560|65915708|FG001|Overall Study|Death|1|||
23596829|NCT01236560|65915709|FG002|Overall Study|Death|0|||
23596830|NCT01236560|65915710|FG003|Overall Study|Death|1|||
23596831|NCT01236560|65915711|FG004|Overall Study|Death|0|||
23596832|NCT01236560|65915712|FG005|Overall Study|Death|0|||
23596833|NCT01236560|65915707|FG000|Overall Study|Lost to Follow-up|0|||
23596834|NCT01236560|65915708|FG001|Overall Study|Lost to Follow-up|1|||
23596835|NCT01236560|65915709|FG002|Overall Study|Lost to Follow-up|1|||
23596836|NCT01236560|65915710|FG003|Overall Study|Lost to Follow-up|0|||
23596837|NCT01236560|65915711|FG004|Overall Study|Lost to Follow-up|0|||
23596838|NCT01236560|65915712|FG005|Overall Study|Lost to Follow-up|0|||
23596839|NCT01236560|65915707|FG000|Overall Study|Physician Decision|0|||
23596840|NCT01236560|65915708|FG001|Overall Study|Physician Decision|1|||
23596841|NCT01236560|65915709|FG002|Overall Study|Physician Decision|8|||
23596842|NCT01236560|65915710|FG003|Overall Study|Physician Decision|0|||
23596843|NCT01236560|65915711|FG004|Overall Study|Physician Decision|0|||
23596844|NCT01236560|65915712|FG005|Overall Study|Physician Decision|0|||
23596845|NCT01236560|65915707|FG000|Overall Study|Withdrawal by Subject|0|||
23596846|NCT01236560|65915708|FG001|Overall Study|Withdrawal by Subject|0|||
23596847|NCT01236560|65915709|FG002|Overall Study|Withdrawal by Subject|1|||
23596848|NCT01236560|65915710|FG003|Overall Study|Withdrawal by Subject|2|||
23596849|NCT01236560|65915711|FG004|Overall Study|Withdrawal by Subject|0|||
23596850|NCT01236560|65915712|FG005|Overall Study|Withdrawal by Subject|0|||
23596851|NCT01236560|65915707|FG000|Overall Study|Progressive disease|5|||
23596852|NCT01236560|65915708|FG001|Overall Study|Progressive disease|19|||
23596853|NCT01236560|65915709|FG002|Overall Study|Progressive disease|9|||
23596854|NCT01236560|65915710|FG003|Overall Study|Progressive disease|16|||
23596855|NCT01236560|65915711|FG004|Overall Study|Progressive disease|0|||
23596856|NCT01236560|65915712|FG005|Overall Study|Progressive disease|0|||
23596857|NCT02407249|65915713|FG000|Overall Study|Did not complete 12-month follow-up|13|||
23596858|NCT02407249|65915713|FG000|Overall Study|Not treated|13|||
23596859|NCT04210180|65915717|FG000|Overall Study|Withdrawal by Subject|2|||
23596860|NCT00799396|65915718|FG000|Clopidogrel Treatment|Adverse Event|6|||
23596861|NCT00799396|65915718|FG000|Clopidogrel Treatment|Physician Decision|5|||
23596862|NCT00799396|65915718|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
23596863|NCT00799396|65915718|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
23596864|NCT00799396|65915718|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
23596865|NCT01811706|65915719|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
23596866|NCT01811706|65915720|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
23596867|NCT03771352|65915721|FG000|Overall Study|Screen failure|2|||
23596868|NCT03771352|65915721|FG000|Overall Study|Withdrawal by Subject|2|||
23360435|NCT01831427|65062959|FG010|Overall Study|Investigator's Discretion|0|||
23360436|NCT01831427|65062949|FG000|Overall Study|Withdrew Consent|0|||
23360437|NCT01831427|65062950|FG001|Overall Study|Withdrew Consent|0|||
23360438|NCT01831427|65062951|FG002|Overall Study|Withdrew Consent|0|||
23360439|NCT01831427|65062952|FG003|Overall Study|Withdrew Consent|0|||
23255270|NCT02454972|64676781|FG004|Overall Study|Study termination|0|||
23255271|NCT02454972|64676782|FG005|Overall Study|Study termination|0|||
23255272|NCT02454972|64676783|FG006|Overall Study|Study termination|0|||
23255273|NCT02454972|64676784|FG007|Overall Study|Study termination|0|||
23255274|NCT02454972|64676785|FG008|Overall Study|Study termination|6|||
23255275|NCT00124449|64676786|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
23255276|NCT00124449|64676787|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
23255277|NCT00124449|64676786|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
23255278|NCT00124449|64676787|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
23255279|NCT00124449|64676786|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
23255280|NCT00124449|64676787|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
23255281|NCT00124449|64676786|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
23255282|NCT00124449|64676787|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
23255283|NCT00124449|64676786|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
23255284|NCT00124449|64676787|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
23255285|NCT00124449|64676786|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
23255286|NCT00124449|64676787|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
23255287|NCT00124449|64676786|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
23255288|NCT00124449|64676787|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
23255289|NCT00124449|64676786|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
23255290|NCT00124449|64676787|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
23360440|NCT01831427|65062953|FG004|Overall Study|Withdrew Consent|0|||
23360441|NCT01831427|65062954|FG005|Overall Study|Withdrew Consent|0|||
23360442|NCT01831427|65062955|FG006|Overall Study|Withdrew Consent|2|||
23596869|NCT02932579|65915725|FG000|Overall Study|Withdrawal by Subject|4|||
23596870|NCT02932579|65915726|FG001|Overall Study|Withdrawal by Subject|1|||
23596871|NCT00858117|65915731|FG000|Treatment on Study|Adverse Event|2|||
23596872|NCT00858117|65915731|FG000|Follow up for 5 Years|Death|4|||
23596873|NCT00858117|65915731|FG000|Follow up for 5 Years|No further data collected for study|9|||
23596874|NCT02463448|65915747|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
23596875|NCT02463448|65915747|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
23596876|NCT02463448|65915747|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
23596877|NCT02463448|65915747|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
23596878|NCT02275611|65915757|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
23596879|NCT02275611|65915758|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
23596880|NCT02275611|65915759|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
23596881|NCT02275611|65915760|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
23596882|NCT02411084|65915763|FG000|Overall Study|Lack of Efficacy|6|||
23596883|NCT02411084|65915764|FG001|Overall Study|Lack of Efficacy|3|||
23596884|NCT02411084|65915763|FG000|Overall Study|Death|5|||
23596885|NCT02411084|65915764|FG001|Overall Study|Death|4|||
23596886|NCT02411084|65915763|FG000|Overall Study|Adverse Event|2|||
23596887|NCT02411084|65915764|FG001|Overall Study|Adverse Event|1|||
23596888|NCT02411084|65915763|FG000|Overall Study|Other reasons|0|||
23255291|NCT00124449|64676786|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
23360443|NCT01831427|65062956|FG007|Overall Study|Withdrew Consent|0|||
23360444|NCT01831427|65062957|FG008|Overall Study|Withdrew Consent|0|||
23360445|NCT01831427|65062958|FG009|Overall Study|Withdrew Consent|1|||
23596889|NCT02411084|65915764|FG001|Overall Study|Other reasons|5|||
23596890|NCT00308997|65915765|FG000|Overall Study|Subject feigned clinical data|0|||
23596891|NCT00308997|65915766|FG001|Overall Study|Subject feigned clinical data|1|||
23596892|NCT00308997|65915765|FG000|Overall Study|Unable to tolerate intervention|1|||
23596893|NCT00308997|65915766|FG001|Overall Study|Unable to tolerate intervention|0|||
23360446|NCT01831427|65062959|FG010|Overall Study|Withdrew Consent|1|||
23596894|NCT00988858|65915767|FG000|Overall Study|Adverse Event|7|||
23596895|NCT00988858|65915767|FG000|Overall Study|Death|1|||
23596896|NCT00988858|65915767|FG000|Overall Study|Physician Decision|1|||
23596897|NCT00988858|65915767|FG000|Overall Study|Sponsor Decision|1|||
23596898|NCT01007396|65915770|FG000|Overall Study|Lost to Follow-up|47|||
23596899|NCT02554786|65915772|FG000|Overall Study|Subject/guardian decision|29|||
23596900|NCT02554786|65915773|FG001|Overall Study|Subject/guardian decision|17|||
23596901|NCT02554786|65915774|FG002|Overall Study|Subject/guardian decision|18|||
23596902|NCT02554786|65915775|FG003|Overall Study|Subject/guardian decision|30|||
23596903|NCT02554786|65915776|FG004|Overall Study|Subject/guardian decision|20|||
23596904|NCT02554786|65915772|FG000|Overall Study|Lost to Follow-up|4|||
23596905|NCT02554786|65915773|FG001|Overall Study|Lost to Follow-up|3|||
23596906|NCT02554786|65915774|FG002|Overall Study|Lost to Follow-up|4|||
23596907|NCT02554786|65915775|FG003|Overall Study|Lost to Follow-up|2|||
23596908|NCT02554786|65915776|FG004|Overall Study|Lost to Follow-up|2|||
23596909|NCT02554786|65915772|FG000|Overall Study|Protocol deviation|1|||
23596910|NCT02554786|65915773|FG001|Overall Study|Protocol deviation|3|||
23596911|NCT02554786|65915774|FG002|Overall Study|Protocol deviation|3|||
23596912|NCT02554786|65915775|FG003|Overall Study|Protocol deviation|4|||
23596913|NCT02554786|65915776|FG004|Overall Study|Protocol deviation|2|||
23596914|NCT02554786|65915772|FG000|Overall Study|Technical problems|1|||
23596915|NCT02554786|65915773|FG001|Overall Study|Technical problems|1|||
23596916|NCT02554786|65915774|FG002|Overall Study|Technical problems|0|||
23596917|NCT02554786|65915775|FG003|Overall Study|Technical problems|2|||
23596918|NCT02554786|65915776|FG004|Overall Study|Technical problems|1|||
23596919|NCT02554786|65915772|FG000|Overall Study|Adverse Event|0|||
23596920|NCT02554786|65915773|FG001|Overall Study|Adverse Event|0|||
23596921|NCT02554786|65915774|FG002|Overall Study|Adverse Event|0|||
23596922|NCT02554786|65915775|FG003|Overall Study|Adverse Event|0|||
23596923|NCT02554786|65915776|FG004|Overall Study|Adverse Event|2|||
23596924|NCT02554786|65915772|FG000|Overall Study|Death|0|||
23596925|NCT02554786|65915773|FG001|Overall Study|Death|0|||
23596926|NCT02554786|65915774|FG002|Overall Study|Death|0|||
23596927|NCT02554786|65915775|FG003|Overall Study|Death|1|||
23596928|NCT02554786|65915776|FG004|Overall Study|Death|0|||
23596929|NCT02554786|65915772|FG000|Overall Study|Non-compliance with study treatment|0|||
23596930|NCT02554786|65915773|FG001|Overall Study|Non-compliance with study treatment|1|||
23596931|NCT02554786|65915774|FG002|Overall Study|Non-compliance with study treatment|1|||
23596932|NCT02554786|65915775|FG003|Overall Study|Non-compliance with study treatment|0|||
23596933|NCT02554786|65915776|FG004|Overall Study|Non-compliance with study treatment|1|||
23596934|NCT02554786|65915772|FG000|Overall Study|Physician Decision|0|||
23596935|NCT02554786|65915773|FG001|Overall Study|Physician Decision|1|||
23596936|NCT02554786|65915774|FG002|Overall Study|Physician Decision|4|||
23596937|NCT02554786|65915775|FG003|Overall Study|Physician Decision|1|||
23596938|NCT02554786|65915776|FG004|Overall Study|Physician Decision|1|||
23596939|NCT02554786|65915772|FG000|Overall Study|Pregnancy|0|||
23596940|NCT02554786|65915773|FG001|Overall Study|Pregnancy|0|||
23596941|NCT02554786|65915774|FG002|Overall Study|Pregnancy|0|||
23596942|NCT02554786|65915775|FG003|Overall Study|Pregnancy|1|||
23596943|NCT02554786|65915776|FG004|Overall Study|Pregnancy|1|||
23596944|NCT01113931|65915777|FG000|Overall Study|Adverse Event|2|||
23596945|NCT01113931|65915778|FG001|Overall Study|Adverse Event|2|||
23596946|NCT01113931|65915777|FG000|Overall Study|Physician Decision|0|||
23255292|NCT00124449|64676787|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
23360447|NCT04472494|65065715|FG000|Pre-treatment|Other reasons|2|||
23360448|NCT04472494|65065716|FG001|Pre-treatment|Other reasons|0|||
23596947|NCT01113931|65915778|FG001|Overall Study|Physician Decision|2|||
23596948|NCT01113931|65915777|FG000|Overall Study|Lost to Follow-up|12|||
23596949|NCT01113931|65915778|FG001|Overall Study|Lost to Follow-up|9|||
23596950|NCT01113931|65915777|FG000|Overall Study|Various|2|||
23596951|NCT01113931|65915778|FG001|Overall Study|Various|4|||
23596952|NCT01113931|65915777|FG000|Overall Study|Withdrawal by Subject|3|||
23360449|NCT04472494|65065715|FG000|Treatment|Death|5|||
23596953|NCT01113931|65915778|FG001|Overall Study|Withdrawal by Subject|0|||
23596954|NCT01011946|65915779|FG000|Overall Study|Transferred to another hospital|2|||
23596955|NCT01011946|65915779|FG000|Overall Study|No pathological lab value|1|||
23596956|NCT01078116|65915780|FG000|Overall Study|Lost to Follow-up|17|||
23596957|NCT01078116|65915780|FG000|Overall Study|Adverse Event|5|||
23596958|NCT01078116|65915780|FG000|Overall Study|Withdrawal by Subject|8|||
23596959|NCT01078116|65915780|FG000|Overall Study|Lack of effectiveness|15|||
23596960|NCT01078116|65915780|FG000|Overall Study|Case report form not completed|3|||
23596961|NCT02499159|65915781|FG000|Randomization|Protocol Violation|1|||
23596962|NCT02499159|65915782|FG001|Randomization|Protocol Violation|1|||
23255293|NCT00124449|64676786|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
23255294|NCT00124449|64676787|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
23255295|NCT00124449|64676786|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
23255296|NCT00124449|64676787|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
23255297|NCT00124449|64676786|FG000|18-Month Untreated Observation Period|Relocated|1|||
23255298|NCT00124449|64676787|FG001|18-Month Untreated Observation Period|Relocated|0|||
23255299|NCT00736333|64676788|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
23255300|NCT00736333|64676788|FG000|Overall Study|Data Missing|2|||
23255301|NCT00736333|64676788|FG000|Overall Study|Tumor Progression|75|||
23255302|NCT00736333|64676788|FG000|Overall Study|Toxicity|6|||
23255303|NCT00736333|64676788|FG000|Overall Study|Withdrawal by Subject|10|||
23255304|NCT00736333|64676788|FG000|Overall Study|Death|7|||
23255305|NCT00736333|64676788|FG000|Overall Study|Other|4|||
23255306|NCT03877237|64676789|FG000|Overall Study|Adverse Event|1|||
23255307|NCT03877237|64676790|FG001|Overall Study|Adverse Event|2|||
23255308|NCT03877237|64676789|FG000|Overall Study|Death|3|||
23255309|NCT03877237|64676790|FG001|Overall Study|Death|2|||
23255310|NCT03877237|64676789|FG000|Overall Study|Physician Decision|1|||
23255311|NCT03877237|64676790|FG001|Overall Study|Physician Decision|0|||
23255312|NCT03877237|64676789|FG000|Overall Study|Withdrawal by Subject|0|||
23255313|NCT03877237|64676790|FG001|Overall Study|Withdrawal by Subject|2|||
23255314|NCT01252238|64676793|FG000|Overall Study|Sponsor terminated study|4|||
23255315|NCT01252238|64676794|FG001|Overall Study|Sponsor terminated study|4|||
23255316|NCT01252238|64676795|FG002|Overall Study|Sponsor terminated study|4|||
23255317|NCT01901146|64676798|FG000|Neoadjuvant Phase|Death|1|||
23255318|NCT01901146|64676799|FG001|Neoadjuvant Phase|Death|2|||
23255319|NCT01901146|64676800|FG002|Neoadjuvant Phase|Death|0|||
23255320|NCT01901146|64676801|FG003|Neoadjuvant Phase|Death|0|||
23255321|NCT01901146|64676802|FG004|Neoadjuvant Phase|Death|0|||
23255322|NCT01901146|64676798|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
23255323|NCT01901146|64676799|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
23255324|NCT01901146|64676800|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
23255325|NCT01901146|64676801|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
23255326|NCT01901146|64676802|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
23255327|NCT01901146|64676798|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
23478354|NCT00910624|65494534|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
23596963|NCT02499159|65915781|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
23596964|NCT02499159|65915782|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
23596965|NCT02499159|65915781|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
23596966|NCT02499159|65915782|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
23596967|NCT02499159|65915781|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
23596968|NCT02499159|65915782|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
23596969|NCT02499159|65915781|FG000|30-Day Follow-Up Phone Call|Other|1|||
23596970|NCT02499159|65915782|FG001|30-Day Follow-Up Phone Call|Other|0|||
23596971|NCT03531840|65915783|FG000|Overall Study|Death on study|3|||
23596972|NCT03531840|65915784|FG001|Overall Study|Death on study|2|||
23596973|NCT03531840|65915785|FG002|Overall Study|Death on study|1|||
23596974|NCT03531840|65915786|FG003|Overall Study|Death on study|2|||
23596975|NCT03531840|65915783|FG000|Overall Study|Death during follow up|2|||
23596976|NCT03531840|65915784|FG001|Overall Study|Death during follow up|3|||
23596977|NCT03531840|65915785|FG002|Overall Study|Death during follow up|4|||
23596978|NCT03531840|65915786|FG003|Overall Study|Death during follow up|1|||
23596979|NCT02107261|65915796|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
23596980|NCT02107261|65915797|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
23596981|NCT02107261|65915796|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
23596982|NCT02107261|65915797|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
23596983|NCT03756571|65915802|FG000|Overall Study|Lost to Follow-up|1|||
23596984|NCT03756571|65915803|FG001|Overall Study|Lost to Follow-up|1|||
23596985|NCT00709098|65915804|FG000|Double-blind Period|Withdrawal of consent|3|||
23255328|NCT01901146|64676799|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
23255329|NCT01901146|64676800|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
23255330|NCT01901146|64676801|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
23255331|NCT01901146|64676802|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
23255332|NCT01901146|64676798|FG000|Neoadjuvant Phase|Physician Decision|1|||
23255333|NCT01901146|64676799|FG001|Neoadjuvant Phase|Physician Decision|2|||
23596986|NCT00709098|65915805|FG001|Double-blind Period|Withdrawal of consent|3|||
23596987|NCT00709098|65915806|FG002|Double-blind Period|Withdrawal of consent|0|||
23478355|NCT00910624|65494535|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
23478356|NCT00910624|65494532|FG000|Follow-Up Phase|Administrative|0|||
23478357|NCT00910624|65494533|FG001|Follow-Up Phase|Administrative|1|||
23478358|NCT00910624|65494534|FG002|Follow-Up Phase|Administrative|1|||
23478359|NCT00910624|65494535|FG003|Follow-Up Phase|Administrative|0|||
23478360|NCT03472547|65494537|FG000|Overall Study|Withdrawal by Subject|30|||
23478361|NCT00393510|65494538|FG000|Overall Study|Physician Decision|3|||
23478362|NCT00393510|65494539|FG001|Overall Study|Physician Decision|9|||
23478363|NCT00450385|65494541|FG000|Overall Study|Death|3|||
23478364|NCT00450385|65494541|FG000|Overall Study|Protocol Violation|1|||
23478365|NCT00450385|65494541|FG000|Overall Study|Withdrawal by Subject|2|||
23478366|NCT00450385|65494541|FG000|Overall Study|Lack of Efficacy|2|||
23478367|NCT00450385|65494541|FG000|Overall Study|Adverse Event|1|||
23478368|NCT00450385|65494541|FG000|Overall Study|Physician Decision|1|||
23478369|NCT00450385|65494541|FG000|Overall Study|Other|3|||
23478370|NCT00588861|65494542|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
23478371|NCT00588861|65494543|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
23478372|NCT00588861|65494542|FG000|6 Months|Patients did not return for follow-up|98|||
23478373|NCT00588861|65494543|FG001|6 Months|Patients did not return for follow-up|73|||
23478374|NCT00588861|65494542|FG000|1 Year|Patients did not return for follow-up|89|||
23478375|NCT00588861|65494543|FG001|1 Year|Patients did not return for follow-up|82|||
23478376|NCT00588861|65494542|FG000|2 Years|Patients did not return for follow-up|92|||
23478377|NCT00588861|65494543|FG001|2 Years|Patients did not return for follow-up|87|||
23478378|NCT00588861|65494542|FG000|4 Years|Patients did not return for follow-up|91|||
23478379|NCT00588861|65494543|FG001|4 Years|Patients did not return for follow-up|103|||
23478380|NCT00588861|65494542|FG000|6 Years|Patients did not return for follow-up|104|||
23478381|NCT00588861|65494543|FG001|6 Years|Patients did not return for follow-up|109|||
23478382|NCT00588861|65494542|FG000|8 Years|Patients did not return for follow-up|105|||
23478383|NCT00588861|65494543|FG001|8 Years|Patients did not return for follow-up|114|||
23478384|NCT00588861|65494542|FG000|10 Years|Incomplete due to study termination|107|||
23478385|NCT00588861|65494543|FG001|10 Years|Incomplete due to study termination|114|||
23478386|NCT01001299|65494544|FG000|Overall Study|Insufficient Therapeutic Response|20|||
23478387|NCT01001299|65494544|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
23478388|NCT01001299|65494544|FG000|Overall Study|Death|1|||
23478389|NCT01001299|65494544|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
23478390|NCT01001299|65494544|FG000|Overall Study|Withdrew Consent|1|||
23478391|NCT00833417|65494545|FG000|Overall Study|Adverse Event|5|||
23478392|NCT00833417|65494546|FG001|Overall Study|Adverse Event|16|||
23478393|NCT00833417|65494545|FG000|Overall Study|Death|1|||
23478394|NCT00833417|65494546|FG001|Overall Study|Death|3|||
23478395|NCT00833417|65494545|FG000|Overall Study|Lost to Follow-up|1|||
23478396|NCT00833417|65494546|FG001|Overall Study|Lost to Follow-up|2|||
23478397|NCT00833417|65494545|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
23478398|NCT00833417|65494546|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
23478399|NCT00833417|65494545|FG000|Overall Study|Patient Decision to Withdraw|4|||
23478400|NCT00833417|65494546|FG001|Overall Study|Patient Decision to Withdraw|23|||
23478401|NCT00833417|65494545|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
23478402|NCT00833417|65494546|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
23478403|NCT00833417|65494545|FG000|Overall Study|Disease Progression|18|||
23478404|NCT00833417|65494546|FG001|Overall Study|Disease Progression|17|||
23478405|NCT00833417|65494545|FG000|Overall Study|Reason Not Specified|0|||
23478406|NCT00833417|65494546|FG001|Overall Study|Reason Not Specified|1|||
23478407|NCT00409175|65494558|FG000|Overall Study|Adverse Event|4|||
23478408|NCT00409175|65494559|FG001|Overall Study|Adverse Event|3|||
23478409|NCT00409175|65494558|FG000|Overall Study|Withdrawal by Subject|1|||
23478410|NCT00409175|65494559|FG001|Overall Study|Withdrawal by Subject|2|||
23478411|NCT00409175|65494558|FG000|Overall Study|Negative genotype|0|||
23478412|NCT00409175|65494559|FG001|Overall Study|Negative genotype|1|||
23478413|NCT00409175|65494558|FG000|Overall Study|Liver transplantation|13|||
23478414|NCT00409175|65494559|FG001|Overall Study|Liver transplantation|13|||
23596988|NCT00709098|65915804|FG000|Double-blind Period|Administrative reason|1|||
23596989|NCT00709098|65915805|FG001|Double-blind Period|Administrative reason|3|||
23596990|NCT00709098|65915806|FG002|Double-blind Period|Administrative reason|0|||
23596991|NCT00709098|65915804|FG000|Double-blind Period|Death|1|||
23596992|NCT00709098|65915805|FG001|Double-blind Period|Death|1|||
23478415|NCT01092832|65494560|FG000|Overall Study|Other|1|||
23478416|NCT01092832|65494561|FG001|Overall Study|Other|0|||
23478417|NCT04658940|65494562|FG000|Overall Study|Withdrawal by Subject|1|||
23478418|NCT00045942|65494563|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
23478419|NCT00045942|65494564|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23596993|NCT00709098|65915806|FG002|Double-blind Period|Death|0|||
23478420|NCT00045942|65494565|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23478421|NCT00045942|65494566|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23478422|NCT00045942|65494567|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23478423|NCT00045942|65494568|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23478424|NCT00045942|65494569|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23255334|NCT01901146|64676800|FG002|Neoadjuvant Phase|Physician Decision|0|||
23255335|NCT01901146|64676801|FG003|Neoadjuvant Phase|Physician Decision|0|||
23596994|NCT00709098|65915804|FG000|Double-blind Period|Lost to Follow-up|1|||
23596995|NCT00709098|65915805|FG001|Double-blind Period|Lost to Follow-up|1|||
23255336|NCT01901146|64676802|FG004|Neoadjuvant Phase|Physician Decision|0|||
23596996|NCT00709098|65915806|FG002|Double-blind Period|Lost to Follow-up|0|||
23596997|NCT00709098|65915804|FG000|Open-label Period|Withdrawal of consent|0|||
23596998|NCT00709098|65915805|FG001|Open-label Period|Withdrawal of consent|0|||
23596999|NCT00709098|65915806|FG002|Open-label Period|Withdrawal of consent|7|||
23597000|NCT00709098|65915804|FG000|Open-label Period|Administrative reason|0|||
23597001|NCT00709098|65915805|FG001|Open-label Period|Administrative reason|0|||
23597002|NCT00709098|65915806|FG002|Open-label Period|Administrative reason|5|||
23597003|NCT00709098|65915804|FG000|Open-label Period|Death|0|||
23255337|NCT01901146|64676798|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
23255338|NCT01901146|64676799|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
23255339|NCT01901146|64676800|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
23255340|NCT01901146|64676801|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
23255341|NCT01901146|64676802|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
23255342|NCT01901146|64676798|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
23255343|NCT01901146|64676799|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
23255344|NCT01901146|64676800|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
23478425|NCT00045942|65494570|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23597004|NCT00709098|65915805|FG001|Open-label Period|Death|0|||
23194418|NCT00829166|64455933|FG001|Overall Study|Death|333|||
23597005|NCT00709098|65915806|FG002|Open-label Period|Death|1|||
23597006|NCT00709098|65915804|FG000|Open-label Period|Lost to Follow-up|0|||
23194419|NCT00829166|64455932|FG000|Overall Study|Lost to Follow-up|5|||
23194420|NCT00829166|64455933|FG001|Overall Study|Lost to Follow-up|4|||
23194421|NCT00829166|64455932|FG000|Overall Study|Physician's Decision|4|||
23194422|NCT00829166|64455933|FG001|Overall Study|Physician's Decision|3|||
23255345|NCT01901146|64676801|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
23255346|NCT01901146|64676802|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
23255347|NCT01901146|64676798|FG000|Adjuvant Phase|Other|0|||
23255348|NCT01901146|64676799|FG001|Adjuvant Phase|Other|0|||
23255349|NCT01901146|64676800|FG002|Adjuvant Phase|Other|1|||
23255350|NCT01901146|64676801|FG003|Adjuvant Phase|Other|0|||
23255351|NCT01901146|64676802|FG004|Adjuvant Phase|Other|0|||
23597007|NCT00709098|65915805|FG001|Open-label Period|Lost to Follow-up|0|||
23597008|NCT00709098|65915806|FG002|Open-label Period|Lost to Follow-up|1|||
23597009|NCT00585052|65915807|FG000|Overall Study|Withdrawal by Subject|1|||
23597010|NCT03621735|65915809|FG000|Overall Study|Withdrawal by Subject|13|||
23597011|NCT03621735|65915810|FG001|Overall Study|Withdrawal by Subject|13|||
23597012|NCT00424645|65915817|FG000|Overall Study|Death|1|||
23597013|NCT00424645|65915818|FG001|Overall Study|Death|0|||
23597014|NCT00274261|65915819|FG000|Overall Study|Adverse Event|19|||
23597015|NCT00274261|65915820|FG001|Overall Study|Adverse Event|11|||
23597016|NCT00274261|65915819|FG000|Overall Study|Pregnancy|114|||
23597017|NCT00274261|65915820|FG001|Overall Study|Pregnancy|83|||
23597018|NCT00274261|65915819|FG000|Overall Study|Withdrawal by Subject|179|||
23597019|NCT00274261|65915820|FG001|Overall Study|Withdrawal by Subject|126|||
23597020|NCT00274261|65915819|FG000|Overall Study|Protocol Violation|71|||
23597021|NCT00274261|65915820|FG001|Overall Study|Protocol Violation|42|||
23597022|NCT00274261|65915819|FG000|Overall Study|Lost to Follow-up|106|||
23597023|NCT00274261|65915820|FG001|Overall Study|Lost to Follow-up|75|||
23597024|NCT02058108|65915822|FG000|Overall Study|Abnormal Laboratory Values|0|||
23597025|NCT02058108|65915823|FG001|Overall Study|Abnormal Laboratory Values|1|||
23597026|NCT02058108|65915822|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
23597027|NCT02058108|65915823|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23597028|NCT02058108|65915822|FG000|Overall Study|No longer requires study drug|0|||
23597029|NCT02058108|65915823|FG001|Overall Study|No longer requires study drug|1|||
23597030|NCT02058108|65915822|FG000|Overall Study|Withdrawal by Subject|1|||
23255352|NCT01901146|64676798|FG000|Adjuvant Phase|Death|0|||
23255353|NCT01901146|64676799|FG001|Adjuvant Phase|Death|0|||
23255354|NCT01901146|64676800|FG002|Adjuvant Phase|Death|0|||
23255355|NCT01901146|64676801|FG003|Adjuvant Phase|Death|0|||
23597031|NCT02058108|65915823|FG001|Overall Study|Withdrawal by Subject|0|||
23255356|NCT01901146|64676802|FG004|Adjuvant Phase|Death|3|||
23255357|NCT01901146|64676798|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
23360450|NCT04472494|65065716|FG001|Treatment|Death|2|||
23360451|NCT04472494|65065715|FG000|Treatment|Hospital discharge|1|||
23360452|NCT04472494|65065716|FG001|Treatment|Hospital discharge|1|||
23360453|NCT02097823|65065717|FG000|Overall Study|Withdrawal by Subject|1|||
23360454|NCT02097823|65065718|FG001|Overall Study|Withdrawal by Subject|1|||
23360455|NCT03084302|65065719|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
23360456|NCT03084302|65065719|FG000|Overall Study|No valid objective monitor data|6|||
23360457|NCT00217581|65065720|FG000|Overall Study|Withdrawal by Subject|1|||
23360458|NCT01135524|65065725|FG000|Overall Study|Withdrawal by Subject|14|||
23360459|NCT01135524|65065725|FG000|Overall Study|Adverse Event|20|||
23360460|NCT01135524|65065725|FG000|Overall Study|Lost to Follow-up|3|||
23360461|NCT01135524|65065725|FG000|Overall Study|Administrative|151|||
23360462|NCT01135524|65065725|FG000|Overall Study|Lack of Efficacy|8|||
23360463|NCT01540981|65065726|FG000|Overall Study|Withdrawal by Subject|1|||
23360464|NCT01540981|65065727|FG001|Overall Study|Withdrawal by Subject|0|||
23360465|NCT03536663|65065728|FG000|Endexo|Protocol Violation|1|||
23360466|NCT05568797|65065737|FG000|Overall Study|Adverse Event|0|||
23360467|NCT05568797|65065738|FG001|Overall Study|Adverse Event|8|||
23360468|NCT05568797|65065737|FG000|Overall Study|Lost to Follow-up|2|||
23360469|NCT05568797|65065738|FG001|Overall Study|Lost to Follow-up|3|||
23360470|NCT05568797|65065737|FG000|Overall Study|Withdrawal by Subject|1|||
23360471|NCT05568797|65065738|FG001|Overall Study|Withdrawal by Subject|10|||
23194423|NCT00829166|64455932|FG000|Overall Study|Subject's Decision|41|||
23194424|NCT00829166|64455933|FG001|Overall Study|Subject's Decision|55|||
23194425|NCT00829166|64455932|FG000|Overall Study|Sponsor's Decision|137|||
23194426|NCT00829166|64455933|FG001|Overall Study|Sponsor's Decision|98|||
23194427|NCT00829166|64455932|FG000|Overall Study|Reason Not Specified|3|||
23194428|NCT00829166|64455933|FG001|Overall Study|Reason Not Specified|3|||
23194429|NCT01582282|64455942|FG000|Overall Study|Adverse Event|1|||
23194430|NCT01582282|64455943|FG001|Overall Study|Adverse Event|1|||
23194431|NCT01582282|64455944|FG002|Overall Study|Adverse Event|0|||
23194432|NCT01582282|64455942|FG000|Overall Study|Lost to Follow-up|1|||
23194433|NCT01582282|64455943|FG001|Overall Study|Lost to Follow-up|0|||
23194434|NCT01582282|64455944|FG002|Overall Study|Lost to Follow-up|0|||
23194435|NCT01582282|64455942|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
23194436|NCT01582282|64455943|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
23194437|NCT01582282|64455944|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
23194438|NCT01981122|64455945|FG000|Overall Study|Withdrawal by Subject|0|||
23194439|NCT01981122|64455946|FG001|Overall Study|Withdrawal by Subject|2|||
23194440|NCT01981122|64455945|FG000|Overall Study|Protocol Violation|0|||
23360472|NCT05568797|65065737|FG000|Overall Study|Other|2|||
23360473|NCT05568797|65065738|FG001|Overall Study|Other|2|||
23360474|NCT03374488|65065739|FG000|Overall Study|Death|13|||
23360475|NCT03374488|65065740|FG001|Overall Study|Death|13|||
23360476|NCT03374488|65065739|FG000|Overall Study|Withdrawal by Subject|3|||
23360477|NCT03374488|65065740|FG001|Overall Study|Withdrawal by Subject|1|||
23360478|NCT03374488|65065739|FG000|Overall Study|Physician Decision|3|||
23360479|NCT03374488|65065740|FG001|Overall Study|Physician Decision|0|||
23360480|NCT02058589|65065745|FG000|Overall Study|Serious Adverse Event|1|||
23360481|NCT02058589|65065746|FG001|Overall Study|Serious Adverse Event|1|||
23360482|NCT02058589|65065745|FG000|Overall Study|Non-Serious Adverse Event|1|||
23360483|NCT02058589|65065746|FG001|Overall Study|Non-Serious Adverse Event|0|||
23360484|NCT02058589|65065745|FG000|Overall Study|Withdrawal by Subject|0|||
23360485|NCT02058589|65065746|FG001|Overall Study|Withdrawal by Subject|1|||
23360486|NCT00357877|65065747|FG000|Overall Study|Death|2|||
23360487|NCT00357877|65065748|FG001|Overall Study|Death|1|||
23360488|NCT00357877|65065747|FG000|Overall Study|Lost to Follow-up|20|||
23360489|NCT00357877|65065748|FG001|Overall Study|Lost to Follow-up|23|||
23360490|NCT00357877|65065747|FG000|Overall Study|Withdrawal by Subject|3|||
23360491|NCT00357877|65065748|FG001|Overall Study|Withdrawal by Subject|3|||
23360492|NCT00357877|65065747|FG000|Overall Study|Administrative withdrawal|1|||
23360493|NCT00357877|65065748|FG001|Overall Study|Administrative withdrawal|1|||
23360494|NCT00357877|65065747|FG000|Overall Study|Other|0|||
23360495|NCT00357877|65065748|FG001|Overall Study|Other|2|||
23360496|NCT02306850|65065751|FG000|Overall Study|Lack of Efficacy|2|||
23360497|NCT01210482|65065752|FG000|Overall Study|Protocol Violation|1|||
23360498|NCT01210482|65065752|FG000|Overall Study|Case Report Forms were not collected|18|||
23360499|NCT01210482|65065752|FG000|Overall Study|Duplicated|2|||
23360500|NCT01210482|65065752|FG000|Overall Study|No Drug Administration|28|||
23360501|NCT03052920|65065753|FG000|Overall Study|Withdrawal by Subject|1|||
23360502|NCT00792909|65065755|FG000|Overall Study|Withdrawal by Subject|0|||
23194441|NCT01981122|64455946|FG001|Overall Study|Protocol Violation|1|||
23194442|NCT01981122|64455945|FG000|Overall Study|Lost to Follow-up|0|||
23194443|NCT01981122|64455946|FG001|Overall Study|Lost to Follow-up|1|||
23194444|NCT01981122|64455945|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
23194445|NCT01981122|64455946|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
23194446|NCT01981122|64455945|FG000|Overall Study|Death|14|||
23194447|NCT01981122|64455946|FG001|Overall Study|Death|15|||
23360503|NCT00792909|65065756|FG001|Overall Study|Withdrawal by Subject|1|||
23255358|NCT01901146|64676799|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
23255359|NCT01901146|64676800|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
23255360|NCT01901146|64676801|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
23255361|NCT01901146|64676802|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
23255362|NCT01901146|64676798|FG000|Adjuvant Phase|Physician Decision|0|||
23255363|NCT01901146|64676799|FG001|Adjuvant Phase|Physician Decision|0|||
23597032|NCT02058108|65915822|FG000|Overall Study|Administrative problems|3|||
23597033|NCT02058108|65915823|FG001|Overall Study|Administrative problems|3|||
23597034|NCT02058108|65915822|FG000|Overall Study|Protocol Violation|0|||
23597035|NCT02058108|65915823|FG001|Overall Study|Protocol Violation|1|||
23597036|NCT00826280|65915824|FG000|Overall Study|Randomized but drug not received|1|||
23597037|NCT00826280|65915825|FG001|Overall Study|Randomized but drug not received|0|||
23597038|NCT00826280|65915826|FG002|Overall Study|Randomized but drug not received|1|||
23597039|NCT00826280|65915824|FG000|Overall Study|Adverse Event|1|||
23597040|NCT00826280|65915825|FG001|Overall Study|Adverse Event|3|||
23597041|NCT00826280|65915826|FG002|Overall Study|Adverse Event|0|||
23597042|NCT00826280|65915824|FG000|Overall Study|Lost to Follow-up|0|||
23597043|NCT00826280|65915825|FG001|Overall Study|Lost to Follow-up|1|||
23597044|NCT00826280|65915826|FG002|Overall Study|Lost to Follow-up|0|||
23597045|NCT00826280|65915824|FG000|Overall Study|Sponsor discontinued subject or study|1|||
23597046|NCT00826280|65915825|FG001|Overall Study|Sponsor discontinued subject or study|0|||
23597047|NCT00826280|65915826|FG002|Overall Study|Sponsor discontinued subject or study|0|||
23597048|NCT00826280|65915824|FG000|Overall Study|Reversible ischemic defect not present|43|||
23597049|NCT00826280|65915825|FG001|Overall Study|Reversible ischemic defect not present|40|||
23597050|NCT00826280|65915826|FG002|Overall Study|Reversible ischemic defect not present|44|||
23597051|NCT00826280|65915824|FG000|Overall Study|Interpretation Failure|1|||
23255364|NCT01901146|64676800|FG002|Adjuvant Phase|Physician Decision|9|||
23255365|NCT01901146|64676801|FG003|Adjuvant Phase|Physician Decision|2|||
23255366|NCT01901146|64676802|FG004|Adjuvant Phase|Physician Decision|4|||
23255367|NCT01901146|64676798|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
23255368|NCT01901146|64676799|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
23255369|NCT01901146|64676800|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
23597052|NCT00826280|65915825|FG001|Overall Study|Interpretation Failure|0|||
23597053|NCT00826280|65915826|FG002|Overall Study|Interpretation Failure|0|||
23597054|NCT00826280|65915824|FG000|Overall Study|Machine Failure|1|||
23255370|NCT01901146|64676801|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
23255371|NCT01901146|64676802|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
23255372|NCT02402933|64676804|FG000|Overall Study|Withdrawal by Subject|4|||
23597055|NCT00826280|65915825|FG001|Overall Study|Machine Failure|1|||
23597056|NCT00826280|65915826|FG002|Overall Study|Machine Failure|0|||
23597057|NCT00826280|65915824|FG000|Overall Study|One or more non-interpretable scan|0|||
23597058|NCT00826280|65915825|FG001|Overall Study|One or more non-interpretable scan|1|||
23597059|NCT00826280|65915826|FG002|Overall Study|One or more non-interpretable scan|1|||
23597060|NCT01985334|65915827|FG000|Overall Study|Administrative problems|1|||
23597061|NCT01985334|65915828|FG001|Overall Study|Administrative problems|1|||
23597062|NCT01985334|65915829|FG002|Overall Study|Administrative problems|0|||
23597063|NCT01985334|65915830|FG003|Overall Study|Administrative problems|2|||
23597064|NCT01985334|65915831|FG004|Overall Study|Administrative problems|0|||
23597065|NCT01985334|65915832|FG005|Overall Study|Administrative problems|1|||
23597066|NCT01985334|65915833|FG006|Overall Study|Administrative problems|1|||
23597067|NCT01985334|65915834|FG007|Overall Study|Administrative problems|3|||
23597068|NCT01985334|65915827|FG000|Overall Study|Death|1|||
23597069|NCT01985334|65915828|FG001|Overall Study|Death|0|||
23597070|NCT01985334|65915829|FG002|Overall Study|Death|0|||
23597071|NCT01985334|65915830|FG003|Overall Study|Death|3|||
23597072|NCT01985334|65915831|FG004|Overall Study|Death|0|||
23597073|NCT01985334|65915832|FG005|Overall Study|Death|0|||
23360504|NCT00792909|65065757|FG002|Overall Study|Withdrawal by Subject|0|||
23597074|NCT01985334|65915833|FG006|Overall Study|Death|1|||
23597075|NCT01985334|65915834|FG007|Overall Study|Death|2|||
23597076|NCT01985334|65915827|FG000|Overall Study|Worsening of disease|0|||
23597077|NCT01985334|65915828|FG001|Overall Study|Worsening of disease|0|||
23597078|NCT01985334|65915829|FG002|Overall Study|Worsening of disease|0|||
23597079|NCT01985334|65915830|FG003|Overall Study|Worsening of disease|1|||
23597080|NCT01985334|65915831|FG004|Overall Study|Worsening of disease|0|||
23597081|NCT01985334|65915832|FG005|Overall Study|Worsening of disease|3|||
23597082|NCT01985334|65915833|FG006|Overall Study|Worsening of disease|0|||
23597083|NCT01985334|65915834|FG007|Overall Study|Worsening of disease|1|||
23597084|NCT01985334|65915827|FG000|Overall Study|Other|2|||
23597085|NCT01985334|65915828|FG001|Overall Study|Other|9|||
23597086|NCT01985334|65915829|FG002|Overall Study|Other|7|||
23597087|NCT01985334|65915830|FG003|Overall Study|Other|17|||
23597088|NCT01985334|65915831|FG004|Overall Study|Other|4|||
23597089|NCT01985334|65915832|FG005|Overall Study|Other|8|||
23597090|NCT01985334|65915833|FG006|Overall Study|Other|4|||
23194448|NCT01963117|64455947|FG000|Overall Study|Death|1|||
23194449|NCT05301322|64455953|FG000|Overall Study|Adverse Event|7|||
23194450|NCT05301322|64455954|FG001|Overall Study|Adverse Event|3|||
23194451|NCT05301322|64455953|FG000|Overall Study|Death|0|||
23194452|NCT05301322|64455954|FG001|Overall Study|Death|1|||
23194453|NCT05301322|64455953|FG000|Overall Study|Lost to Follow-up|2|||
23194454|NCT05301322|64455954|FG001|Overall Study|Lost to Follow-up|1|||
23194455|NCT05301322|64455953|FG000|Overall Study|Protocol Violation|3|||
23194456|NCT05301322|64455954|FG001|Overall Study|Protocol Violation|1|||
23194457|NCT05301322|64455953|FG000|Overall Study|Withdrawal by Subject|3|||
23194458|NCT05301322|64455954|FG001|Overall Study|Withdrawal by Subject|0|||
23194459|NCT05301322|64455953|FG000|Overall Study|Other|4|||
23194460|NCT05301322|64455954|FG001|Overall Study|Other|0|||
23194461|NCT01518192|64455961|FG000|Overall Study|Lost to Follow-up|29|||
23194462|NCT01518192|64455962|FG001|Overall Study|Lost to Follow-up|26|||
23194463|NCT01518192|64455963|FG002|Overall Study|Lost to Follow-up|35|||
23597091|NCT01985334|65915834|FG007|Overall Study|Other|7|||
23194464|NCT01188798|64455964|FG000|Overall Study|Death|0|||
23194465|NCT01188798|64455965|FG001|Overall Study|Death|1|||
23597092|NCT01985334|65915827|FG000|Overall Study|Protocol deviation|6|||
23597093|NCT01985334|65915828|FG001|Overall Study|Protocol deviation|31|||
23597094|NCT01985334|65915829|FG002|Overall Study|Protocol deviation|25|||
23194466|NCT01188798|64455964|FG000|Overall Study|Required additional transplant|1|||
23194467|NCT01188798|64455965|FG001|Overall Study|Required additional transplant|1|||
23597095|NCT01985334|65915830|FG003|Overall Study|Protocol deviation|84|||
23597096|NCT01985334|65915831|FG004|Overall Study|Protocol deviation|17|||
23194468|NCT01188798|64455964|FG000|Overall Study|Protocol closure|1|||
23597097|NCT01985334|65915832|FG005|Overall Study|Protocol deviation|47|||
23478426|NCT00045942|65494571|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
23194469|NCT01188798|64455965|FG001|Overall Study|Protocol closure|1|||
23194470|NCT01588197|64455966|FG000|Overall Study|Lack of Efficacy|0|||
23255373|NCT02402933|64676804|FG000|Overall Study|Discontinued; Site Termination|10|||
23255374|NCT00845026|64676809|FG000|Study Period III|Adverse Event|23|||
23255375|NCT00845026|64676810|FG001|Study Period III|Adverse Event|19|||
23597098|NCT01985334|65915833|FG006|Overall Study|Protocol deviation|15|||
23597099|NCT01985334|65915834|FG007|Overall Study|Protocol deviation|42|||
23597100|NCT01985334|65915827|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
23597101|NCT01985334|65915828|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
23597102|NCT01985334|65915829|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
23597103|NCT01985334|65915830|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
23597104|NCT01985334|65915831|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
23597105|NCT01985334|65915832|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
23597106|NCT01985334|65915833|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
23597107|NCT01985334|65915834|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
23597108|NCT01985334|65915827|FG000|Overall Study|Subject withdrawal of consent|3|||
23597109|NCT01985334|65915828|FG001|Overall Study|Subject withdrawal of consent|6|||
23597110|NCT01985334|65915829|FG002|Overall Study|Subject withdrawal of consent|2|||
23597111|NCT01985334|65915830|FG003|Overall Study|Subject withdrawal of consent|28|||
23597112|NCT01985334|65915831|FG004|Overall Study|Subject withdrawal of consent|4|||
23597113|NCT01985334|65915832|FG005|Overall Study|Subject withdrawal of consent|19|||
23597114|NCT01985334|65915833|FG006|Overall Study|Subject withdrawal of consent|0|||
23597115|NCT01985334|65915834|FG007|Overall Study|Subject withdrawal of consent|20|||
23597116|NCT01985334|65915827|FG000|Overall Study|Adverse Event|0|||
23597117|NCT01985334|65915828|FG001|Overall Study|Adverse Event|8|||
23597118|NCT01985334|65915829|FG002|Overall Study|Adverse Event|2|||
23597119|NCT01985334|65915830|FG003|Overall Study|Adverse Event|26|||
23597120|NCT01985334|65915831|FG004|Overall Study|Adverse Event|3|||
23597121|NCT01985334|65915832|FG005|Overall Study|Adverse Event|18|||
23597122|NCT01985334|65915833|FG006|Overall Study|Adverse Event|3|||
23597123|NCT01985334|65915834|FG007|Overall Study|Adverse Event|15|||
23597124|NCT01985334|65915827|FG000|Overall Study|Other|4|||
23597125|NCT01985334|65915828|FG001|Overall Study|Other|2|||
23597126|NCT01985334|65915829|FG002|Overall Study|Other|3|||
23597127|NCT01985334|65915830|FG003|Overall Study|Other|10|||
23597128|NCT01985334|65915831|FG004|Overall Study|Other|1|||
23597129|NCT01985334|65915832|FG005|Overall Study|Other|6|||
23597130|NCT01985334|65915833|FG006|Overall Study|Other|2|||
23597131|NCT01985334|65915834|FG007|Overall Study|Other|2|||
23597132|NCT01985334|65915827|FG000|Overall Study|Medication non-compliance|0|||
23255376|NCT00845026|64676809|FG000|Study Period III|Perceived lack of efficacy|27|||
23597133|NCT01985334|65915828|FG001|Overall Study|Medication non-compliance|4|||
23597134|NCT01985334|65915829|FG002|Overall Study|Medication non-compliance|1|||
23597135|NCT01985334|65915830|FG003|Overall Study|Medication non-compliance|6|||
23597136|NCT01985334|65915831|FG004|Overall Study|Medication non-compliance|2|||
23597137|NCT01985334|65915832|FG005|Overall Study|Medication non-compliance|3|||
23597138|NCT01985334|65915833|FG006|Overall Study|Medication non-compliance|1|||
23597139|NCT01985334|65915834|FG007|Overall Study|Medication non-compliance|3|||
23597140|NCT01985334|65915827|FG000|Overall Study|Use of prohibited treatment|1|||
23597141|NCT01985334|65915828|FG001|Overall Study|Use of prohibited treatment|4|||
23597142|NCT01985334|65915829|FG002|Overall Study|Use of prohibited treatment|1|||
23597143|NCT01985334|65915830|FG003|Overall Study|Use of prohibited treatment|2|||
23597144|NCT01985334|65915831|FG004|Overall Study|Use of prohibited treatment|1|||
23597145|NCT01985334|65915832|FG005|Overall Study|Use of prohibited treatment|6|||
23597146|NCT01985334|65915833|FG006|Overall Study|Use of prohibited treatment|2|||
23597147|NCT01985334|65915834|FG007|Overall Study|Use of prohibited treatment|0|||
23597148|NCT01985334|65915827|FG000|Overall Study|Investigator decision|0|||
23597149|NCT01985334|65915828|FG001|Overall Study|Investigator decision|3|||
23597150|NCT01985334|65915829|FG002|Overall Study|Investigator decision|0|||
23597151|NCT01985334|65915830|FG003|Overall Study|Investigator decision|7|||
23597152|NCT01985334|65915831|FG004|Overall Study|Investigator decision|1|||
23597153|NCT01985334|65915832|FG005|Overall Study|Investigator decision|1|||
23597154|NCT01985334|65915833|FG006|Overall Study|Investigator decision|0|||
23597155|NCT01985334|65915834|FG007|Overall Study|Investigator decision|4|||
23597156|NCT01985334|65915827|FG000|Overall Study|Lost to Follow-up|0|||
23597157|NCT01985334|65915828|FG001|Overall Study|Lost to Follow-up|2|||
23194471|NCT01588197|64455967|FG001|Overall Study|Lack of Efficacy|1|||
23194472|NCT01588197|64455966|FG000|Overall Study|No MRI|1|||
23194473|NCT01588197|64455967|FG001|Overall Study|No MRI|0|||
23194474|NCT01753518|64455968|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
23194475|NCT01753518|64455969|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
23194476|NCT01753518|64455968|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
23194477|NCT01753518|64455969|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
23597158|NCT01985334|65915829|FG002|Overall Study|Lost to Follow-up|0|||
23597159|NCT01985334|65915830|FG003|Overall Study|Lost to Follow-up|3|||
23597160|NCT01985334|65915831|FG004|Overall Study|Lost to Follow-up|1|||
23597161|NCT01985334|65915832|FG005|Overall Study|Lost to Follow-up|4|||
23194478|NCT01753518|64455968|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
23597162|NCT01985334|65915833|FG006|Overall Study|Lost to Follow-up|0|||
23597163|NCT01985334|65915834|FG007|Overall Study|Lost to Follow-up|3|||
23255377|NCT00845026|64676810|FG001|Study Period III|Perceived lack of efficacy|15|||
23255378|NCT00845026|64676809|FG000|Study Period III|Withdrawal by Subject|19|||
23255379|NCT00845026|64676810|FG001|Study Period III|Withdrawal by Subject|15|||
23255380|NCT00845026|64676809|FG000|Study Period III|Entry Criteria not met|8|||
23255381|NCT00845026|64676810|FG001|Study Period III|Entry Criteria not met|11|||
23255382|NCT00845026|64676809|FG000|Study Period III|Lost to Follow-up|4|||
23255383|NCT00845026|64676810|FG001|Study Period III|Lost to Follow-up|5|||
23255384|NCT00845026|64676809|FG000|Study Period III|Protocol Violation|8|||
23255385|NCT00845026|64676810|FG001|Study Period III|Protocol Violation|1|||
23255386|NCT00845026|64676809|FG000|Study Period III|Scheduled conflict|3|||
23255387|NCT00845026|64676810|FG001|Study Period III|Scheduled conflict|1|||
23255388|NCT00845026|64676809|FG000|Study Period III|Subject is moving or has moved|2|||
23255389|NCT00845026|64676810|FG001|Study Period III|Subject is moving or has moved|4|||
23255390|NCT00845026|64676809|FG000|Study Period III|Transportation issues|1|||
23255391|NCT00845026|64676810|FG001|Study Period III|Transportation issues|1|||
23255392|NCT00845026|64676809|FG000|Study Period IV|Adverse Event|4|||
23255393|NCT00845026|64676810|FG001|Study Period IV|Adverse Event|0|||
23255394|NCT00845026|64676809|FG000|Study Period IV|Perceived lack of efficacy|2|||
23255395|NCT00845026|64676810|FG001|Study Period IV|Perceived lack of efficacy|1|||
23255396|NCT00845026|64676809|FG000|Study Period IV|Protocol Violation|3|||
23255397|NCT00845026|64676810|FG001|Study Period IV|Protocol Violation|1|||
23255398|NCT00845026|64676809|FG000|Study Period IV|Lost to Follow-up|1|||
23255399|NCT00845026|64676810|FG001|Study Period IV|Lost to Follow-up|0|||
23255400|NCT00845026|64676809|FG000|Study Period IV|Withdrawal by Subject|4|||
23255401|NCT00845026|64676810|FG001|Study Period IV|Withdrawal by Subject|1|||
23255402|NCT00845026|64676809|FG000|Study Period IV|Entry Criteria Not Met|1|||
23255403|NCT00845026|64676810|FG001|Study Period IV|Entry Criteria Not Met|0|||
23255404|NCT00845026|64676809|FG000|Study Period IV|Subject is moving or has moved|0|||
23255405|NCT00845026|64676810|FG001|Study Period IV|Subject is moving or has moved|1|||
23255406|NCT00845026|64676809|FG000|Study Period IV|Scheduling conflict|1|||
23255407|NCT00845026|64676810|FG001|Study Period IV|Scheduling conflict|0|||
23255408|NCT01484028|64676811|FG000|Period 1|Lost to Follow-up|0|||
23255409|NCT01484028|64676812|FG001|Period 1|Lost to Follow-up|1|||
23255410|NCT01484028|64676813|FG002|Period 1|Lost to Follow-up|0|||
23255411|NCT01484028|64676814|FG003|Period 1|Lost to Follow-up|0|||
23255412|NCT01484028|64676811|FG000|Period 1|Non-Compliance to Protocol|0|||
23255413|NCT01484028|64676812|FG001|Period 1|Non-Compliance to Protocol|1|||
23255414|NCT01484028|64676813|FG002|Period 1|Non-Compliance to Protocol|0|||
23255415|NCT01484028|64676814|FG003|Period 1|Non-Compliance to Protocol|1|||
23255416|NCT01484028|64676811|FG000|Period 1|Lens Discomfort|0|||
23255417|NCT01484028|64676812|FG001|Period 1|Lens Discomfort|1|||
23255418|NCT01484028|64676813|FG002|Period 1|Lens Discomfort|0|||
23255419|NCT01484028|64676814|FG003|Period 1|Lens Discomfort|0|||
23255420|NCT00420849|64676822|FG000|Overall Study|Lack of Efficacy|154|||
23255421|NCT00420849|64676822|FG000|Overall Study|Adverse Event|107|||
23360505|NCT04754542|65065758|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
23402809|NCT00560508|65220014|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
23255422|NCT00420849|64676822|FG000|Overall Study|Withdrawal by Subject|28|||
23255423|NCT00420849|64676822|FG000|Overall Study|Death|18|||
23255424|NCT00420849|64676822|FG000|Overall Study|Other|14|||
23255425|NCT00420849|64676822|FG000|Overall Study|Transplant|8|||
23255426|NCT00420849|64676822|FG000|Overall Study|Protocol Violation|1|||
23255427|NCT00420849|64676822|FG000|Overall Study|Lost to Follow-up|1|||
23255428|NCT00558519|64676823|FG000|Overall Study|Ph+|20|||
23194479|NCT01753518|64455969|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
23194480|NCT01753518|64455968|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
23194481|NCT01753518|64455969|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
23194482|NCT04705597|64455970|FG000|Overall Study|Death|16|||
23194483|NCT04705597|64455971|FG001|Overall Study|Death|9|||
23194484|NCT04705597|64455970|FG000|Overall Study|Lost to Follow-up|1|||
23194485|NCT04705597|64455971|FG001|Overall Study|Lost to Follow-up|0|||
23194486|NCT04705597|64455970|FG000|Overall Study|Withdrawal by Subject|1|||
23194487|NCT04705597|64455971|FG001|Overall Study|Withdrawal by Subject|2|||
23194488|NCT02225223|64455972|FG000|Overall Study|Death|10|||
23194489|NCT02225223|64455973|FG001|Overall Study|Death|1|||
23194490|NCT02225223|64455972|FG000|Overall Study|Lost to Follow-up|5|||
23194491|NCT02225223|64455973|FG001|Overall Study|Lost to Follow-up|0|||
23255429|NCT00558519|64676823|FG000|Overall Study|Ineligible|1|||
23194492|NCT02225223|64455972|FG000|Overall Study|Other|1|||
23194493|NCT02225223|64455973|FG001|Overall Study|Other|2|||
23194494|NCT02225223|64455972|FG000|Overall Study|Physician Decision|1|||
23194495|NCT02225223|64455973|FG001|Overall Study|Physician Decision|0|||
23194496|NCT02225223|64455972|FG000|Overall Study|Withdrawal by Subject|2|||
23194497|NCT02225223|64455973|FG001|Overall Study|Withdrawal by Subject|2|||
23194498|NCT01276847|64455974|FG000|Overall Study|Withdrawal by Subject|1|||
23194499|NCT01276847|64455975|FG001|Overall Study|Withdrawal by Subject|0|||
23194500|NCT01276847|64455976|FG002|Overall Study|Withdrawal by Subject|0|||
23194501|NCT02717546|64455977|FG000|Overall Study|Lost to Follow-up|12|||
23194502|NCT04590937|64455983|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
23194503|NCT00970294|64455984|FG000|Overall Study|Physician Decision|4|||
23194504|NCT00970294|64455984|FG000|Overall Study|Withdrawal by Subject|1|||
23194505|NCT00521339|64455985|FG000|Treatment Phase|Adverse Event|2|||
23194506|NCT00521339|64455986|FG001|Treatment Phase|Adverse Event|0|||
23360506|NCT04754542|65065759|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
23360507|NCT00385918|65065760|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
23360508|NCT00385918|65065761|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
23360509|NCT00385918|65065762|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
23360510|NCT00385918|65065760|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
23194507|NCT00521339|64455987|FG002|Treatment Phase|Adverse Event|0|||
23194508|NCT00521339|64455985|FG000|Treatment Phase|Intolerability to study drug|2|||
23194509|NCT00521339|64455986|FG001|Treatment Phase|Intolerability to study drug|0|||
23194510|NCT00521339|64455987|FG002|Treatment Phase|Intolerability to study drug|0|||
23194511|NCT00521339|64455985|FG000|Treatment Phase|Lack of Efficacy|3|||
23194512|NCT00521339|64455986|FG001|Treatment Phase|Lack of Efficacy|0|||
23194513|NCT00521339|64455987|FG002|Treatment Phase|Lack of Efficacy|0|||
23194514|NCT00521339|64455985|FG000|Treatment Phase|Withdrawal by Subject|3|||
23255430|NCT00558519|64676823|FG000|Overall Study|Insufficient data|1|||
23194515|NCT00521339|64455986|FG001|Treatment Phase|Withdrawal by Subject|0|||
23194516|NCT00521339|64455987|FG002|Treatment Phase|Withdrawal by Subject|0|||
23194517|NCT00521339|64455985|FG000|Treatment Phase|Lost to Follow-up|1|||
23194518|NCT00521339|64455986|FG001|Treatment Phase|Lost to Follow-up|0|||
23194519|NCT00521339|64455987|FG002|Treatment Phase|Lost to Follow-up|0|||
23194520|NCT00521339|64455985|FG000|Treatment Phase|Protocol Violation|1|||
23194521|NCT00521339|64455986|FG001|Treatment Phase|Protocol Violation|0|||
23194522|NCT00521339|64455987|FG002|Treatment Phase|Protocol Violation|0|||
23194523|NCT00521339|64455985|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
23360511|NCT00385918|65065761|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
23360512|NCT00385918|65065762|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
23597164|NCT03292913|65915841|FG000|Overall Study|Death|9|||
23597165|NCT03292913|65915842|FG001|Overall Study|Death|3|||
23597166|NCT03292913|65915841|FG000|Overall Study|Lost to Follow-up|49|||
23597167|NCT03292913|65915842|FG001|Overall Study|Lost to Follow-up|49|||
23597168|NCT03292913|65915841|FG000|Overall Study|Withdrawal by Subject|2|||
23597169|NCT03292913|65915842|FG001|Overall Study|Withdrawal by Subject|0|||
23597170|NCT03292913|65915841|FG000|Overall Study|Clinic closed due to COVID|22|||
23597171|NCT03292913|65915842|FG001|Overall Study|Clinic closed due to COVID|36|||
23597172|NCT01391832|65915843|FG000|Overall Study|Withdrawal by Subject|21|||
23597173|NCT01391832|65915844|FG001|Overall Study|Withdrawal by Subject|22|||
23597174|NCT01391832|65915843|FG000|Overall Study|Lost to Follow-up|0|||
23597175|NCT01391832|65915844|FG001|Overall Study|Lost to Follow-up|1|||
23597176|NCT03733119|65915845|FG000|Overall Study|Physician Decision|2|||
23597177|NCT03733119|65915846|FG001|Overall Study|Physician Decision|1|||
23597178|NCT03733119|65915845|FG000|Overall Study|ineligible to treat per protocol|0|||
23597179|NCT03733119|65915846|FG001|Overall Study|ineligible to treat per protocol|1|||
23597180|NCT03451721|65915849|FG000|Overall Study|Death|1|||
23597181|NCT02891915|65915850|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
23597182|NCT02891915|65915851|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
23597183|NCT02891915|65915850|FG000|Overall Study|Withdrawal by Subject|3|||
23597184|NCT02891915|65915851|FG001|Overall Study|Withdrawal by Subject|3|||
23597185|NCT02891915|65915850|FG000|Overall Study|Became Ineligible After Enrollment|2|||
23597186|NCT02891915|65915851|FG001|Overall Study|Became Ineligible After Enrollment|1|||
23597187|NCT02891915|65915850|FG000|Overall Study|Lost to Follow-up|1|||
23597188|NCT02891915|65915851|FG001|Overall Study|Lost to Follow-up|4|||
23597189|NCT02891915|65915850|FG000|Overall Study|Physician Decision|1|||
23597190|NCT02891915|65915851|FG001|Overall Study|Physician Decision|0|||
23597191|NCT01420549|65915852|FG000|Overall Study|Adverse Event|1|||
23597192|NCT01420549|65915853|FG001|Overall Study|Adverse Event|1|||
23597193|NCT01420549|65915852|FG000|Overall Study|Lost to Follow-up|2|||
23597194|NCT01420549|65915853|FG001|Overall Study|Lost to Follow-up|2|||
23597195|NCT01420549|65915852|FG000|Overall Study|Protocol Violation|0|||
23597196|NCT01420549|65915853|FG001|Overall Study|Protocol Violation|1|||
23597197|NCT01420549|65915852|FG000|Overall Study|Non-adherence to medication|4|||
23597198|NCT01420549|65915853|FG001|Overall Study|Non-adherence to medication|1|||
23597199|NCT02426138|65915854|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23597200|NCT02426138|65915855|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23597201|NCT00687219|65915856|FG000|Overall Study|Adverse Event|8|||
23597202|NCT00687219|65915856|FG000|Overall Study|Discontinuance criteria met|7|||
23597203|NCT00687219|65915856|FG000|Overall Study|HCV-RNA positive conversion|34|||
23597204|NCT00687219|65915856|FG000|Overall Study|Withdrawal by Subject|1|||
23597205|NCT00687219|65915856|FG000|Overall Study|Lack of Efficacy|1|||
23597206|NCT01951170|65915857|FG000|Overall Study|Investigator decision|1|||
23597207|NCT02978716|65915859|FG000|Overall Study|Death|25|||
23597208|NCT02978716|65915860|FG001|Overall Study|Death|13|||
23597209|NCT02978716|65915861|FG002|Overall Study|Death|20|||
23597210|NCT02978716|65915859|FG000|Overall Study|Lost to Follow-up|0|||
23597211|NCT02978716|65915860|FG001|Overall Study|Lost to Follow-up|0|||
23597212|NCT02978716|65915861|FG002|Overall Study|Lost to Follow-up|1|||
23597213|NCT02978716|65915859|FG000|Overall Study|Withdrawal by Subject|6|||
23597214|NCT02978716|65915860|FG001|Overall Study|Withdrawal by Subject|4|||
23597215|NCT02978716|65915861|FG002|Overall Study|Withdrawal by Subject|5|||
23597216|NCT02978716|65915859|FG000|Overall Study|Sponsor terminated|2|||
23597217|NCT02978716|65915860|FG001|Overall Study|Sponsor terminated|13|||
23597218|NCT02978716|65915861|FG002|Overall Study|Sponsor terminated|9|||
23597219|NCT02978716|65915859|FG000|Overall Study|Other|1|||
23597220|NCT02978716|65915860|FG001|Overall Study|Other|3|||
23597221|NCT02978716|65915861|FG002|Overall Study|Other|0|||
23597222|NCT02567656|65915862|FG000|Overall Study|Premature discontinuation due to PD|1|||
23597223|NCT02567656|65915863|FG001|Overall Study|Premature discontinuation due to PD|1|||
23597224|NCT02567656|65915864|FG002|Overall Study|Premature discontinuation due to PD|2|||
23597225|NCT02567656|65915865|FG003|Overall Study|Premature discontinuation due to PD|0|||
23597226|NCT02567656|65915866|FG004|Overall Study|Premature discontinuation due to PD|0|||
23597227|NCT02567656|65915867|FG005|Overall Study|Premature discontinuation due to PD|0|||
23597228|NCT01037985|65915868|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
23597229|NCT01037985|65915869|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
23597230|NCT01037985|65915868|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
23597231|NCT01037985|65915869|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
23597232|NCT01037985|65915868|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
23597233|NCT01037985|65915869|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
23597234|NCT01037985|65915868|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
23597235|NCT01037985|65915869|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
23597236|NCT00998881|65915872|FG000|Overall Study|Adverse Event|2|||
23597237|NCT00998881|65915873|FG001|Overall Study|Adverse Event|2|||
23597238|NCT00998881|65915872|FG000|Overall Study|Lack of Efficacy|1|||
23597239|NCT00998881|65915873|FG001|Overall Study|Lack of Efficacy|0|||
23255431|NCT00558519|64676823|FG000|Overall Study|Never received treatment|1|||
23255432|NCT00096486|64676824|FG000|Overall Study|Withdrawal by Subject|0|||
23255433|NCT00096486|64676825|FG001|Overall Study|Withdrawal by Subject|0|||
23255434|NCT00096486|64676826|FG002|Overall Study|Withdrawal by Subject|1|||
23255435|NCT00096486|64676827|FG003|Overall Study|Withdrawal by Subject|1|||
23255436|NCT00096486|64676824|FG000|Overall Study|Not Treated|0|||
23255437|NCT00096486|64676825|FG001|Overall Study|Not Treated|0|||
23255438|NCT00096486|64676826|FG002|Overall Study|Not Treated|1|||
23255439|NCT00096486|64676827|FG003|Overall Study|Not Treated|1|||
23255440|NCT01689974|64676828|FG000|Overall Study|Termination of Study|5|||
23255441|NCT01689974|64676829|FG001|Overall Study|Termination of Study|5|||
23255442|NCT03412019|64676830|FG000|Overall Study|Withdrawal by Subject|1|||
23255443|NCT03412019|64676831|FG001|Overall Study|Withdrawal by Subject|1|||
23255444|NCT04313283|64676832|FG000|Overall Study|did not complete intervention|4|||
23255445|NCT00299728|64676833|FG000|Overall Study|Lost to Follow-up|0|||
23255446|NCT00299728|64676834|FG001|Overall Study|Lost to Follow-up|1|||
23255447|NCT00299728|64676833|FG000|Overall Study|Withdrawal by Subject|0|||
23255448|NCT00299728|64676834|FG001|Overall Study|Withdrawal by Subject|1|||
23255449|NCT00299728|64676833|FG000|Overall Study|Progressive disease|0|||
23255450|NCT00299728|64676834|FG001|Overall Study|Progressive disease|1|||
23255451|NCT01440595|64676835|FG000|Overall Study|Lost to Follow-up|0|||
23255452|NCT01440595|64676836|FG001|Overall Study|Lost to Follow-up|1|||
23255453|NCT01440595|64676837|FG002|Overall Study|Lost to Follow-up|0|||
23255454|NCT01440595|64676835|FG000|Overall Study|Study terminated by sponsor.|1|||
23255455|NCT01440595|64676836|FG001|Overall Study|Study terminated by sponsor.|2|||
23255456|NCT01440595|64676837|FG002|Overall Study|Study terminated by sponsor.|1|||
23255457|NCT01507831|64676845|FG000|Overall Study|Randomized but not treated|0|||
23255458|NCT01507831|64676846|FG001|Overall Study|Randomized but not treated|3|||
23255459|NCT01507831|64676845|FG000|Overall Study|Adverse Event|48|||
23255460|NCT01507831|64676846|FG001|Overall Study|Adverse Event|113|||
23255461|NCT01507831|64676845|FG000|Overall Study|Death|6|||
23255462|NCT01507831|64676846|FG001|Overall Study|Death|2|||
23255463|NCT01507831|64676845|FG000|Overall Study|Poor compliance to protocol|38|||
23255464|NCT01507831|64676846|FG001|Overall Study|Poor compliance to protocol|60|||
23255465|NCT01507831|64676845|FG000|Overall Study|Physician Decision|0|||
23255466|NCT01507831|64676846|FG001|Overall Study|Physician Decision|4|||
23255467|NCT01507831|64676845|FG000|Overall Study|Participant moved|5|||
23255468|NCT01507831|64676846|FG001|Overall Study|Participant moved|19|||
23255469|NCT01507831|64676845|FG000|Overall Study|Consent withdrawn by participant|34|||
23255470|NCT01507831|64676846|FG001|Overall Study|Consent withdrawn by participant|72|||
23255471|NCT01507831|64676845|FG000|Overall Study|Related to study drug administration|5|||
23255472|NCT01507831|64676846|FG001|Overall Study|Related to study drug administration|14|||
23255473|NCT01507831|64676845|FG000|Overall Study|Last visit outside protocol visit window|51|||
23255474|NCT01507831|64676846|FG001|Overall Study|Last visit outside protocol visit window|143|||
23255475|NCT01507831|64676845|FG000|Overall Study|Selection criteria finally not met|0|||
23255476|NCT01507831|64676846|FG001|Overall Study|Selection criteria finally not met|1|||
23255477|NCT01507831|64676845|FG000|Overall Study|Site closure|0|||
23255478|NCT01507831|64676846|FG001|Overall Study|Site closure|3|||
23255479|NCT01507831|64676845|FG000|Overall Study|Potential lost to follow-up|3|||
23255480|NCT01507831|64676846|FG001|Overall Study|Potential lost to follow-up|0|||
23194524|NCT00521339|64455986|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
23194525|NCT00521339|64455987|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
23194526|NCT00521339|64455985|FG000|Treatment Extension Phase|Death|0|||
23194527|NCT00521339|64455986|FG001|Treatment Extension Phase|Death|0|||
23194528|NCT00521339|64455987|FG002|Treatment Extension Phase|Death|1|||
23194529|NCT01544595|64455988|FG000|Status at Week 68|Adverse Event|3|||
23194530|NCT01544595|64455989|FG001|Status at Week 68|Adverse Event|2|||
23194531|NCT01544595|64455990|FG002|Status at Week 68|Adverse Event|1|||
23194532|NCT01544595|64455991|FG003|Status at Week 68|Adverse Event|0|||
23194533|NCT01544595|64455992|FG004|Status at Week 68|Adverse Event|0|||
23194534|NCT01544595|64455993|FG005|Status at Week 68|Adverse Event|0|||
23194535|NCT01544595|64455988|FG000|Status at Week 68|Lack of Efficacy|1|||
23194536|NCT01544595|64455989|FG001|Status at Week 68|Lack of Efficacy|0|||
23194537|NCT01544595|64455990|FG002|Status at Week 68|Lack of Efficacy|0|||
23194538|NCT01544595|64455991|FG003|Status at Week 68|Lack of Efficacy|0|||
23194539|NCT01544595|64455992|FG004|Status at Week 68|Lack of Efficacy|0|||
23194540|NCT01544595|64455993|FG005|Status at Week 68|Lack of Efficacy|0|||
23194541|NCT01544595|64455988|FG000|Status at Week 68|Lost to Follow-up|1|||
23194542|NCT01544595|64455989|FG001|Status at Week 68|Lost to Follow-up|1|||
23194543|NCT01544595|64455990|FG002|Status at Week 68|Lost to Follow-up|0|||
23194544|NCT01544595|64455991|FG003|Status at Week 68|Lost to Follow-up|0|||
23194545|NCT01544595|64455992|FG004|Status at Week 68|Lost to Follow-up|0|||
23194546|NCT01544595|64455993|FG005|Status at Week 68|Lost to Follow-up|0|||
23194547|NCT01544595|64455988|FG000|Status at Week 68|Non-compliance with study treatment|1|||
23194548|NCT01544595|64455989|FG001|Status at Week 68|Non-compliance with study treatment|0|||
23194549|NCT01544595|64455990|FG002|Status at Week 68|Non-compliance with study treatment|0|||
23194550|NCT01544595|64455991|FG003|Status at Week 68|Non-compliance with study treatment|1|||
23255481|NCT01507831|64676845|FG000|Overall Study|Other|3|||
23194551|NCT01544595|64455992|FG004|Status at Week 68|Non-compliance with study treatment|0|||
23194552|NCT01544595|64455993|FG005|Status at Week 68|Non-compliance with study treatment|0|||
23194553|NCT01544595|64455988|FG000|Status at Week 68|Protocol Violation|2|||
23255482|NCT01507831|64676846|FG001|Overall Study|Other|6|||
23255483|NCT01681771|64676847|FG000|Overall Study|Lost to Follow-up|4|||
23255484|NCT01681771|64676848|FG001|Overall Study|Lost to Follow-up|2|||
23255485|NCT03031431|64676849|FG000|Overall Study|Infant removed by maternal request|1|||
23255486|NCT00811070|64676852|FG000|Overall Study|Death|0|||
23255487|NCT00811070|64676853|FG001|Overall Study|Death|0|||
23255488|NCT00811070|64676854|FG002|Overall Study|Death|0|||
23255489|NCT00811070|64676855|FG003|Overall Study|Death|2|||
23255490|NCT00811070|64676856|FG004|Overall Study|Death|5|||
23478427|NCT00045942|65494563|FG000|PKC412A2104 (Core)|Adverse Event|5|||
23478428|NCT00045942|65494564|FG001|PKC412A2104 (Core)|Adverse Event|0|||
23255491|NCT00811070|64676857|FG005|Overall Study|Death|0|||
23255492|NCT00811070|64676852|FG000|Overall Study|Other|1|||
23255493|NCT00811070|64676853|FG001|Overall Study|Other|0|||
23255494|NCT00811070|64676854|FG002|Overall Study|Other|0|||
23255495|NCT00811070|64676855|FG003|Overall Study|Other|0|||
23255496|NCT00811070|64676856|FG004|Overall Study|Other|0|||
23255497|NCT00811070|64676857|FG005|Overall Study|Other|0|||
23255498|NCT00811070|64676852|FG000|Overall Study|Withdrawal by Subject|0|||
23255499|NCT00811070|64676853|FG001|Overall Study|Withdrawal by Subject|1|||
23255500|NCT00811070|64676854|FG002|Overall Study|Withdrawal by Subject|0|||
23255501|NCT00811070|64676855|FG003|Overall Study|Withdrawal by Subject|0|||
23255502|NCT00811070|64676856|FG004|Overall Study|Withdrawal by Subject|0|||
23255503|NCT00811070|64676857|FG005|Overall Study|Withdrawal by Subject|0|||
23255504|NCT00811070|64676852|FG000|Overall Study|Physician Decision|0|||
23255505|NCT00811070|64676853|FG001|Overall Study|Physician Decision|0|||
23255506|NCT00811070|64676854|FG002|Overall Study|Physician Decision|0|||
23255507|NCT00811070|64676855|FG003|Overall Study|Physician Decision|0|||
23255508|NCT00811070|64676856|FG004|Overall Study|Physician Decision|0|||
23255509|NCT00811070|64676857|FG005|Overall Study|Physician Decision|1|||
23255510|NCT00543439|64676858|FG000|Period 1|Adverse Event|0|||
23255511|NCT00543439|64676859|FG001|Period 1|Adverse Event|2|||
23478429|NCT00045942|65494565|FG002|PKC412A2104 (Core)|Adverse Event|0|||
23478430|NCT00045942|65494566|FG003|PKC412A2104 (Core)|Adverse Event|0|||
23478431|NCT00045942|65494567|FG004|PKC412A2104 (Core)|Adverse Event|0|||
23478432|NCT00045942|65494568|FG005|PKC412A2104 (Core)|Adverse Event|0|||
23478433|NCT00045942|65494569|FG006|PKC412A2104 (Core)|Adverse Event|0|||
23478434|NCT00045942|65494570|FG007|PKC412A2104 (Core)|Adverse Event|0|||
23478435|NCT00045942|65494571|FG008|PKC412A2104 (Core)|Adverse Event|0|||
23478436|NCT00045942|65494563|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
23255512|NCT00543439|64676860|FG002|Period 1|Adverse Event|1|||
23255513|NCT00543439|64676858|FG000|Period 1|Withdrawal by Subject|1|||
23255514|NCT00543439|64676859|FG001|Period 1|Withdrawal by Subject|1|||
23255515|NCT00543439|64676860|FG002|Period 1|Withdrawal by Subject|0|||
23255516|NCT00543439|64676858|FG000|Period 1|Physician Decision|0|||
23255517|NCT00543439|64676859|FG001|Period 1|Physician Decision|0|||
23478437|NCT00045942|65494564|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
23255518|NCT00543439|64676860|FG002|Period 1|Physician Decision|1|||
23255519|NCT00543439|64676858|FG000|Period 2|Protocol Violation|1|||
23255520|NCT00543439|64676859|FG001|Period 2|Protocol Violation|0|||
23255521|NCT00543439|64676860|FG002|Period 2|Protocol Violation|1|||
23255522|NCT00543439|64676858|FG000|Period 2|Adverse Event|0|||
23255523|NCT00543439|64676859|FG001|Period 2|Adverse Event|1|||
23255524|NCT00543439|64676860|FG002|Period 2|Adverse Event|1|||
23255525|NCT01697449|64676899|FG000|Overall Study|Disease progression|47|||
23255526|NCT01697449|64676899|FG000|Overall Study|Adverse Event|7|||
23255527|NCT01697449|64676899|FG000|Overall Study|Lost to Follow-up|5|||
23255528|NCT01697449|64676899|FG000|Overall Study|Withdrawal by Subject|2|||
23255529|NCT01697449|64676899|FG000|Overall Study|Physician Decision|1|||
23255530|NCT01697449|64676899|FG000|Overall Study|Death|2|||
23255531|NCT01697449|64676899|FG000|Overall Study|Other|1|||
23255532|NCT01697449|64676899|FG000|Overall Study|Missing|25|||
23255533|NCT03085485|64676900|FG000|Overall Study|Death|1|||
23255534|NCT03085485|64676901|FG001|Overall Study|Death|0|||
23255535|NCT03085485|64676900|FG000|Overall Study|Lost to Follow-up|1|||
23478438|NCT00045942|65494565|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
23255536|NCT03085485|64676901|FG001|Overall Study|Lost to Follow-up|0|||
23478439|NCT00045942|65494566|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
23597240|NCT00998881|65915872|FG000|Overall Study|Physician Decision|3|||
23255537|NCT00084617|64676904|FG000|Overall Study|Withdrawal by Subject|7|||
23255538|NCT00084617|64676904|FG000|Overall Study|Lack of Efficacy|1|||
23255539|NCT00084617|64676904|FG000|Overall Study|Protocol Violation|1|||
23255540|NCT03521999|64676905|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
23255541|NCT03521999|64676906|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
23255542|NCT03521999|64676905|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
23255543|NCT03521999|64676906|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
23255544|NCT03521999|64676905|FG000|Completed 3 Month Follow up|Death|0|||
23255545|NCT03521999|64676906|FG001|Completed 3 Month Follow up|Death|1|||
23255546|NCT03521999|64676905|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
23478440|NCT00045942|65494567|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
23478441|NCT00045942|65494568|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
23255547|NCT03521999|64676906|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
23255548|NCT02544633|64676913|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
23255549|NCT02544633|64676914|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
23255550|NCT02544633|64676915|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
23255551|NCT02544633|64676916|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
23255552|NCT02544633|64676913|FG000|Treatment Period|Adverse Event|7|||
23255553|NCT02544633|64676914|FG001|Treatment Period|Adverse Event|4|||
23255554|NCT02544633|64676915|FG002|Treatment Period|Adverse Event|0|||
23255555|NCT02544633|64676916|FG003|Treatment Period|Adverse Event|5|||
23255556|NCT02544633|64676913|FG000|Treatment Period|Lack of Efficacy|17|||
23255557|NCT02544633|64676914|FG001|Treatment Period|Lack of Efficacy|11|||
23255558|NCT02544633|64676915|FG002|Treatment Period|Lack of Efficacy|5|||
23255559|NCT02544633|64676916|FG003|Treatment Period|Lack of Efficacy|5|||
23255560|NCT02544633|64676913|FG000|Treatment Period|Global Deterioration of Health|3|||
23478442|NCT00045942|65494569|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
23478443|NCT00045942|65494570|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
23194554|NCT01544595|64455989|FG001|Status at Week 68|Protocol Violation|0|||
23194555|NCT01544595|64455990|FG002|Status at Week 68|Protocol Violation|1|||
23194556|NCT01544595|64455991|FG003|Status at Week 68|Protocol Violation|1|||
23194557|NCT01544595|64455992|FG004|Status at Week 68|Protocol Violation|0|||
23194558|NCT01544595|64455993|FG005|Status at Week 68|Protocol Violation|0|||
23194559|NCT01544595|64455988|FG000|Status at Week 68|Technical problems|1|||
23194560|NCT01544595|64455989|FG001|Status at Week 68|Technical problems|0|||
23194561|NCT01544595|64455990|FG002|Status at Week 68|Technical problems|0|||
23194562|NCT01544595|64455991|FG003|Status at Week 68|Technical problems|1|||
23194563|NCT01544595|64455992|FG004|Status at Week 68|Technical problems|0|||
23194564|NCT01544595|64455993|FG005|Status at Week 68|Technical problems|0|||
23255561|NCT02544633|64676914|FG001|Treatment Period|Global Deterioration of Health|3|||
23255562|NCT02544633|64676915|FG002|Treatment Period|Global Deterioration of Health|0|||
23478444|NCT00045942|65494571|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
23478445|NCT00045942|65494563|FG000|PKC412A2104 (Core)|Death|1|||
23478446|NCT00045942|65494564|FG001|PKC412A2104 (Core)|Death|0|||
23478447|NCT00045942|65494565|FG002|PKC412A2104 (Core)|Death|0|||
23478448|NCT00045942|65494566|FG003|PKC412A2104 (Core)|Death|0|||
23478449|NCT00045942|65494567|FG004|PKC412A2104 (Core)|Death|0|||
23478450|NCT00045942|65494568|FG005|PKC412A2104 (Core)|Death|0|||
23597241|NCT00998881|65915873|FG001|Overall Study|Physician Decision|0|||
23597242|NCT00998881|65915872|FG000|Overall Study|Withdrawal by Subject|1|||
23597243|NCT00998881|65915873|FG001|Overall Study|Withdrawal by Subject|0|||
23597244|NCT00998881|65915872|FG000|Overall Study|Personal matter|1|||
23597245|NCT00998881|65915873|FG001|Overall Study|Personal matter|0|||
23597246|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
23597247|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
23597248|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
23597249|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
23597250|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
23597251|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
23597252|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
23597253|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
23597254|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
23597255|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
23597256|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
23597257|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
23597258|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
23597259|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
23597260|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
23597261|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
23597262|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
23597263|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
23597264|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
23597265|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
23597266|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
23597267|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
23597268|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
23597269|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
23597270|NCT01074294|65915875|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
23597271|NCT01074294|65915876|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
23597272|NCT01074294|65915877|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
23597273|NCT01074294|65915878|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
23597274|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
23597275|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
23597276|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
23597277|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
23597278|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
23597279|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
23597280|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
23597281|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
23597282|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
23597283|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
23597284|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
23597285|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
23597286|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
23597287|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
23597288|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
23597289|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
23597290|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
23597291|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
23597292|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
23597293|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
23597294|NCT01074294|65915875|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
23597295|NCT01074294|65915876|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
23597296|NCT01074294|65915877|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
23597297|NCT01074294|65915878|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
23597298|NCT02730871|65919085|FG000|Overall Study|Adverse Event|6|||
23597299|NCT02730871|65919086|FG001|Overall Study|Adverse Event|0|||
23597300|NCT02204982|65919087|FG000|Overall Study|Patient ineligible-medical monitor|1|||
23255563|NCT02544633|64676916|FG003|Treatment Period|Global Deterioration of Health|1|||
23255564|NCT02544633|64676913|FG000|Treatment Period|Withdrawal by Subject|1|||
23255565|NCT02544633|64676914|FG001|Treatment Period|Withdrawal by Subject|0|||
23255566|NCT02544633|64676915|FG002|Treatment Period|Withdrawal by Subject|0|||
23255567|NCT02544633|64676916|FG003|Treatment Period|Withdrawal by Subject|0|||
23255568|NCT02544633|64676913|FG000|Treatment Period|Lost to Follow-up|0|||
23255569|NCT02544633|64676914|FG001|Treatment Period|Lost to Follow-up|1|||
23255570|NCT02544633|64676915|FG002|Treatment Period|Lost to Follow-up|0|||
23255571|NCT02544633|64676916|FG003|Treatment Period|Lost to Follow-up|0|||
23255572|NCT02544633|64676913|FG000|Treatment Period|Death|0|||
23255573|NCT02544633|64676914|FG001|Treatment Period|Death|0|||
23255574|NCT02544633|64676915|FG002|Treatment Period|Death|1|||
23255575|NCT02544633|64676916|FG003|Treatment Period|Death|0|||
23255576|NCT02544633|64676913|FG000|Treatment Period|Non-compliance|0|||
23255577|NCT02544633|64676914|FG001|Treatment Period|Non-compliance|0|||
23255578|NCT02544633|64676915|FG002|Treatment Period|Non-compliance|1|||
23255579|NCT02544633|64676916|FG003|Treatment Period|Non-compliance|0|||
23255580|NCT02544633|64676913|FG000|Treatment Period|Clinical Disease Progression|0|||
23255581|NCT02544633|64676914|FG001|Treatment Period|Clinical Disease Progression|0|||
23255582|NCT02544633|64676915|FG002|Treatment Period|Clinical Disease Progression|0|||
23255583|NCT02544633|64676916|FG003|Treatment Period|Clinical Disease Progression|1|||
23255584|NCT02544633|64676913|FG000|Survival Follow-up Period|Death|12|||
23255585|NCT02544633|64676914|FG001|Survival Follow-up Period|Death|14|||
23255586|NCT02544633|64676915|FG002|Survival Follow-up Period|Death|3|||
23255587|NCT02544633|64676916|FG003|Survival Follow-up Period|Death|9|||
23255588|NCT02544633|64676913|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
23255589|NCT02544633|64676914|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
23360513|NCT00385918|65065760|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
23255590|NCT02544633|64676915|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
23255591|NCT02544633|64676916|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
23360514|NCT00385918|65065761|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
23360515|NCT00385918|65065762|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
23597301|NCT02204982|65919088|FG001|Overall Study|Patient ineligible-medical monitor|0|||
23255592|NCT02544633|64676913|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
23597302|NCT02204982|65919087|FG000|Overall Study|Withdrawal by Subject|1|||
23597303|NCT02204982|65919088|FG001|Overall Study|Withdrawal by Subject|0|||
23597304|NCT02204982|65919087|FG000|Overall Study|Adverse Event|1|||
23597305|NCT02204982|65919088|FG001|Overall Study|Adverse Event|0|||
23597306|NCT02204982|65919087|FG000|Overall Study|Adverse Event and Investigator decision|1|||
23597307|NCT02204982|65919088|FG001|Overall Study|Adverse Event and Investigator decision|0|||
23597308|NCT02204982|65919087|FG000|Overall Study|Physician Decision|0|||
23597309|NCT02204982|65919088|FG001|Overall Study|Physician Decision|2|||
23597310|NCT02204982|65919087|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
23597311|NCT02204982|65919088|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
23597312|NCT02204982|65919087|FG000|Overall Study|Termination of Study bySponsor|0|||
23597313|NCT02204982|65919088|FG001|Overall Study|Termination of Study bySponsor|1|||
23597314|NCT00073749|65919089|FG000|Overall Study|Disease Progression|2|||
23597315|NCT00073749|65919090|FG001|Overall Study|Disease Progression|0|||
23597316|NCT00073749|65919091|FG002|Overall Study|Disease Progression|3|||
23597317|NCT00073749|65919092|FG003|Overall Study|Disease Progression|2|||
23597318|NCT00073749|65919093|FG004|Overall Study|Disease Progression|3|||
23597319|NCT00073749|65919094|FG005|Overall Study|Disease Progression|1|||
23597320|NCT00073749|65919095|FG006|Overall Study|Disease Progression|3|||
23597321|NCT00073749|65919089|FG000|Overall Study|Death|0|||
23597322|NCT00073749|65919090|FG001|Overall Study|Death|1|||
23597323|NCT00073749|65919091|FG002|Overall Study|Death|1|||
23597324|NCT00073749|65919092|FG003|Overall Study|Death|0|||
23597325|NCT00073749|65919093|FG004|Overall Study|Death|0|||
23597326|NCT00073749|65919094|FG005|Overall Study|Death|0|||
23597327|NCT00073749|65919095|FG006|Overall Study|Death|29|||
23597328|NCT00073749|65919089|FG000|Overall Study|Adverse Event|0|||
23597329|NCT00073749|65919090|FG001|Overall Study|Adverse Event|3|||
23597330|NCT00073749|65919091|FG002|Overall Study|Adverse Event|6|||
23597331|NCT00073749|65919092|FG003|Overall Study|Adverse Event|4|||
23597332|NCT00073749|65919093|FG004|Overall Study|Adverse Event|2|||
23360516|NCT00385918|65065760|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
23360517|NCT00385918|65065761|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
23478451|NCT00045942|65494569|FG006|PKC412A2104 (Core)|Death|0|||
23597333|NCT00073749|65919094|FG005|Overall Study|Adverse Event|1|||
23597334|NCT00073749|65919095|FG006|Overall Study|Adverse Event|0|||
23597335|NCT00073749|65919089|FG000|Overall Study|Physician Decision|0|||
23597336|NCT00073749|65919090|FG001|Overall Study|Physician Decision|0|||
23597337|NCT00073749|65919091|FG002|Overall Study|Physician Decision|1|||
23597338|NCT00073749|65919092|FG003|Overall Study|Physician Decision|0|||
23597339|NCT00073749|65919093|FG004|Overall Study|Physician Decision|0|||
23478452|NCT00045942|65494570|FG007|PKC412A2104 (Core)|Death|0|||
23194565|NCT01544595|64455988|FG000|Status at Week 68|Withdrawal by Subject|0|||
23360518|NCT00385918|65065762|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
23597340|NCT00073749|65919094|FG005|Overall Study|Physician Decision|2|||
23597341|NCT00073749|65919095|FG006|Overall Study|Physician Decision|0|||
23597342|NCT00073749|65919089|FG000|Overall Study|Withdrawal by Subject|0|||
23597343|NCT00073749|65919090|FG001|Overall Study|Withdrawal by Subject|1|||
23597344|NCT00073749|65919091|FG002|Overall Study|Withdrawal by Subject|0|||
23597345|NCT00073749|65919092|FG003|Overall Study|Withdrawal by Subject|0|||
23597346|NCT00073749|65919093|FG004|Overall Study|Withdrawal by Subject|1|||
23597347|NCT00073749|65919094|FG005|Overall Study|Withdrawal by Subject|0|||
23597348|NCT00073749|65919095|FG006|Overall Study|Withdrawal by Subject|2|||
23597349|NCT00073749|65919089|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
23597350|NCT00073749|65919090|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
23597351|NCT00073749|65919091|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
23597352|NCT00073749|65919092|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
23597353|NCT00073749|65919093|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
23597354|NCT00073749|65919094|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
23597355|NCT00073749|65919095|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
23597356|NCT00073749|65919089|FG000|Overall Study|Lost to Follow-up|0|||
23597357|NCT00073749|65919090|FG001|Overall Study|Lost to Follow-up|0|||
23597358|NCT00073749|65919091|FG002|Overall Study|Lost to Follow-up|0|||
23597359|NCT00073749|65919092|FG003|Overall Study|Lost to Follow-up|0|||
23597360|NCT00073749|65919093|FG004|Overall Study|Lost to Follow-up|0|||
23597361|NCT00073749|65919094|FG005|Overall Study|Lost to Follow-up|0|||
23597362|NCT00073749|65919095|FG006|Overall Study|Lost to Follow-up|2|||
23597363|NCT00073749|65919089|FG000|Overall Study|Other|0|||
23597364|NCT00073749|65919090|FG001|Overall Study|Other|0|||
23597365|NCT00073749|65919091|FG002|Overall Study|Other|0|||
23597366|NCT00073749|65919092|FG003|Overall Study|Other|0|||
23360519|NCT00385918|65065760|FG000|Intervention Phase After Randomization|Physician Decision|1|||
23597367|NCT00073749|65919093|FG004|Overall Study|Other|0|||
23597368|NCT00073749|65919094|FG005|Overall Study|Other|2|||
23597369|NCT00073749|65919095|FG006|Overall Study|Other|0|||
23597370|NCT03750968|65919096|FG000|Overall Study|Adverse Event|2|||
23597371|NCT03750968|65919097|FG001|Overall Study|Adverse Event|0|||
23597372|NCT03750968|65919096|FG000|Overall Study|Lost to Follow-up|1|||
23597373|NCT03750968|65919097|FG001|Overall Study|Lost to Follow-up|3|||
23597374|NCT02119650|65919098|FG000|Overall Study|Adverse Event|3|||
23597375|NCT02119650|65919099|FG001|Overall Study|Adverse Event|4|||
23597376|NCT02119650|65919098|FG000|Overall Study|Subject decision|2|||
23597377|NCT02119650|65919099|FG001|Overall Study|Subject decision|3|||
23597378|NCT02119650|65919098|FG000|Overall Study|Disease progression|11|||
23597379|NCT02119650|65919099|FG001|Overall Study|Disease progression|14|||
23597380|NCT02119650|65919098|FG000|Overall Study|Death|5|||
23597381|NCT02119650|65919099|FG001|Overall Study|Death|1|||
23478453|NCT00045942|65494571|FG008|PKC412A2104 (Core)|Death|0|||
23478454|NCT00045942|65494563|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
23478455|NCT00045942|65494564|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
23478456|NCT00045942|65494565|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
23478457|NCT00045942|65494566|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
23478458|NCT00045942|65494567|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
23478459|NCT00045942|65494568|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
23478460|NCT00045942|65494569|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
23478461|NCT00045942|65494570|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
23478462|NCT00045942|65494571|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
23478463|NCT00045942|65494563|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
23478464|NCT00045942|65494564|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
23478465|NCT00045942|65494565|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
23478466|NCT00045942|65494566|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
23478467|NCT00045942|65494567|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
23478468|NCT00045942|65494568|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
23478469|NCT00045942|65494569|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
23478470|NCT00045942|65494570|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
23478471|NCT00045942|65494571|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
23478472|NCT00045942|65494563|FG000|PKC412A2104E1|Lack of Efficacy|0|||
23478473|NCT00045942|65494564|FG001|PKC412A2104E1|Lack of Efficacy|11|||
23478474|NCT00045942|65494565|FG002|PKC412A2104E1|Lack of Efficacy|11|||
23478475|NCT00045942|65494566|FG003|PKC412A2104E1|Lack of Efficacy|23|||
23478476|NCT00045942|65494567|FG004|PKC412A2104E1|Lack of Efficacy|17|||
23478477|NCT00045942|65494568|FG005|PKC412A2104E1|Lack of Efficacy|0|||
23478478|NCT00045942|65494569|FG006|PKC412A2104E1|Lack of Efficacy|0|||
23478479|NCT00045942|65494570|FG007|PKC412A2104E1|Lack of Efficacy|0|||
23478480|NCT00045942|65494571|FG008|PKC412A2104E1|Lack of Efficacy|0|||
23478481|NCT00045942|65494563|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
23478482|NCT00045942|65494564|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
23478483|NCT00045942|65494565|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
23478484|NCT00045942|65494566|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
23478485|NCT00045942|65494567|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
23478486|NCT00045942|65494568|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
23478487|NCT00045942|65494569|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
23478488|NCT00045942|65494570|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
23478489|NCT00045942|65494571|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
23478490|NCT00045942|65494563|FG000|PKC412A2104E1|Adverse Event|0|||
23478491|NCT00045942|65494564|FG001|PKC412A2104E1|Adverse Event|1|||
23478492|NCT00045942|65494565|FG002|PKC412A2104E1|Adverse Event|1|||
23478493|NCT00045942|65494566|FG003|PKC412A2104E1|Adverse Event|3|||
23478494|NCT00045942|65494567|FG004|PKC412A2104E1|Adverse Event|6|||
23478495|NCT00045942|65494568|FG005|PKC412A2104E1|Adverse Event|0|||
23478496|NCT00045942|65494569|FG006|PKC412A2104E1|Adverse Event|0|||
23478497|NCT00045942|65494570|FG007|PKC412A2104E1|Adverse Event|0|||
23478498|NCT00045942|65494571|FG008|PKC412A2104E1|Adverse Event|0|||
23478499|NCT00045942|65494563|FG000|PKC412A2104E1|Death|0|||
23478500|NCT00045942|65494564|FG001|PKC412A2104E1|Death|4|||
23478501|NCT00045942|65494565|FG002|PKC412A2104E1|Death|1|||
23478502|NCT00045942|65494566|FG003|PKC412A2104E1|Death|1|||
23478503|NCT00045942|65494567|FG004|PKC412A2104E1|Death|1|||
23478504|NCT00045942|65494568|FG005|PKC412A2104E1|Death|0|||
23478505|NCT00045942|65494569|FG006|PKC412A2104E1|Death|0|||
23478506|NCT00045942|65494570|FG007|PKC412A2104E1|Death|0|||
23478507|NCT00045942|65494571|FG008|PKC412A2104E1|Death|0|||
23478508|NCT00045942|65494563|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478509|NCT00045942|65494564|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478510|NCT00045942|65494565|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
23478511|NCT00045942|65494566|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
23597382|NCT02119650|65919098|FG000|Overall Study|Noncompliance with study treatment|1|||
23597383|NCT02119650|65919099|FG001|Overall Study|Noncompliance with study treatment|1|||
23478512|NCT00045942|65494567|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478513|NCT00045942|65494568|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478514|NCT00045942|65494569|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478515|NCT00045942|65494570|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478516|NCT00045942|65494571|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
23478517|NCT00045942|65494563|FG000|PKC412A2104E2|Lost to Follow-up|0|||
23478518|NCT00045942|65494564|FG001|PKC412A2104E2|Lost to Follow-up|0|||
23478519|NCT00045942|65494565|FG002|PKC412A2104E2|Lost to Follow-up|0|||
23478520|NCT00045942|65494566|FG003|PKC412A2104E2|Lost to Follow-up|0|||
23478521|NCT00045942|65494567|FG004|PKC412A2104E2|Lost to Follow-up|0|||
23478522|NCT00045942|65494568|FG005|PKC412A2104E2|Lost to Follow-up|0|||
23478523|NCT00045942|65494569|FG006|PKC412A2104E2|Lost to Follow-up|0|||
23478524|NCT00045942|65494570|FG007|PKC412A2104E2|Lost to Follow-up|3|||
23597384|NCT02119650|65919098|FG000|Overall Study|Study terminated by the sponsor|1|||
23360520|NCT00385918|65065761|FG001|Intervention Phase After Randomization|Physician Decision|0|||
23360521|NCT00385918|65065762|FG002|Intervention Phase After Randomization|Physician Decision|0|||
23360522|NCT00385918|65065760|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
23360523|NCT00385918|65065761|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
23360524|NCT00385918|65065762|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
23360525|NCT05227118|65065766|FG000|Overall Study|Adverse Event|0|||
23360526|NCT05227118|65065767|FG001|Overall Study|Adverse Event|0|||
23360527|NCT05227118|65065768|FG002|Overall Study|Adverse Event|1|||
23360528|NCT05227118|65065769|FG003|Overall Study|Adverse Event|0|||
23360529|NCT05227118|65065766|FG000|Overall Study|Withdrawal by Subject|0|||
23360530|NCT05227118|65065767|FG001|Overall Study|Withdrawal by Subject|0|||
23360531|NCT05227118|65065768|FG002|Overall Study|Withdrawal by Subject|2|||
23360532|NCT05227118|65065769|FG003|Overall Study|Withdrawal by Subject|0|||
23360533|NCT01266824|65065772|FG000|Overall Study|Study terminated prior to completion|2|||
23360534|NCT01266824|65065773|FG001|Overall Study|Study terminated prior to completion|3|||
23360535|NCT02630563|65065776|FG000|Overall Study|Administrative|1|||
23360536|NCT03512353|65065777|FG000|Overall Study|Sponsor Decision|3|||
23360537|NCT03512353|65065777|FG000|Overall Study|Death|1|||
23360538|NCT00753675|65065780|FG000|Overall Study|other reason|11|||
23360539|NCT00753675|65065781|FG001|Overall Study|other reason|12|||
23360540|NCT00753675|65065782|FG002|Overall Study|other reason|13|||
23360541|NCT00753675|65065780|FG000|Overall Study|Death|1|||
23360542|NCT00753675|65065781|FG001|Overall Study|Death|2|||
23360543|NCT00753675|65065782|FG002|Overall Study|Death|4|||
23360544|NCT00753675|65065780|FG000|Overall Study|Adverse Event|11|||
23360545|NCT00753675|65065781|FG001|Overall Study|Adverse Event|9|||
23360546|NCT00753675|65065782|FG002|Overall Study|Adverse Event|4|||
23360547|NCT00753675|65065780|FG000|Overall Study|Objective progression of disease|35|||
23360548|NCT00753675|65065781|FG001|Overall Study|Objective progression of disease|35|||
23360549|NCT00753675|65065782|FG002|Overall Study|Objective progression of disease|35|||
23360550|NCT00753675|65065780|FG000|Overall Study|Withdrawal by Subject|0|||
23360551|NCT00753675|65065781|FG001|Overall Study|Withdrawal by Subject|1|||
23360552|NCT00753675|65065782|FG002|Overall Study|Withdrawal by Subject|0|||
23360553|NCT00753675|65065780|FG000|Overall Study|Lost to Follow-up|1|||
23360554|NCT00753675|65065781|FG001|Overall Study|Lost to Follow-up|0|||
23360555|NCT00753675|65065782|FG002|Overall Study|Lost to Follow-up|0|||
23360556|NCT05027815|65065787|FG000|Overall Study|Death|2|||
23360557|NCT05027815|65065788|FG001|Overall Study|Death|1|||
23360558|NCT02420119|65065789|FG000|Overall Study|insufficient laboratory data|5|||
23360559|NCT01166750|65065791|FG000|Overall Study|Lost to Follow-up|1|||
23360560|NCT01166750|65065792|FG001|Overall Study|Lost to Follow-up|0|||
23360561|NCT00686335|65065793|FG000|Run-in Period|Adverse Event|1|||
23360562|NCT00686335|65065793|FG000|Run-in Period|asthma exacerbation|1|||
23360563|NCT00686335|65065793|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
23360564|NCT01310127|65065799|FG000|Overall Study|Protocol Violation|1|||
23360565|NCT01310127|65065800|FG001|Overall Study|Protocol Violation|1|||
23360566|NCT01310127|65065799|FG000|Overall Study|advanced psc cataract outlier|1|||
23360567|NCT01310127|65065800|FG001|Overall Study|advanced psc cataract outlier|0|||
23360568|NCT02028507|65065801|FG000|Overall Study|Progressive Disease|122|||
23360569|NCT02028507|65065802|FG001|Overall Study|Progressive Disease|90|||
23360570|NCT02028507|65065803|FG002|Overall Study|Progressive Disease|102|||
23360571|NCT02028507|65065804|FG003|Overall Study|Progressive Disease|89|||
23360572|NCT02028507|65065801|FG000|Overall Study|Adverse Event|8|||
23360573|NCT02028507|65065802|FG001|Overall Study|Adverse Event|25|||
23360574|NCT02028507|65065803|FG002|Overall Study|Adverse Event|3|||
23360575|NCT02028507|65065804|FG003|Overall Study|Adverse Event|16|||
23360576|NCT02028507|65065801|FG000|Overall Study|Withdrawal by Subject|6|||
23360577|NCT02028507|65065802|FG001|Overall Study|Withdrawal by Subject|8|||
23478525|NCT00045942|65494571|FG008|PKC412A2104E2|Lost to Follow-up|0|||
23478526|NCT00045942|65494563|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
23478527|NCT00045942|65494564|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
23478528|NCT00045942|65494565|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
23478529|NCT00045942|65494566|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
23478530|NCT00045942|65494567|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
23360578|NCT02028507|65065803|FG002|Overall Study|Withdrawal by Subject|5|||
23360579|NCT02028507|65065804|FG003|Overall Study|Withdrawal by Subject|9|||
23360580|NCT02028507|65065801|FG000|Overall Study|Protocol Violation|2|||
23360581|NCT02028507|65065802|FG001|Overall Study|Protocol Violation|4|||
23360582|NCT02028507|65065803|FG002|Overall Study|Protocol Violation|1|||
23478531|NCT00045942|65494568|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
23360583|NCT02028507|65065804|FG003|Overall Study|Protocol Violation|3|||
23360584|NCT02028507|65065801|FG000|Overall Study|Physician Decision|0|||
23478532|NCT00045942|65494569|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
23478533|NCT00045942|65494570|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
23478534|NCT00045942|65494571|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
23478535|NCT00045942|65494563|FG000|PKC412A2104E2|Lack of Efficacy|0|||
23597385|NCT02119650|65919099|FG001|Overall Study|Study terminated by the sponsor|0|||
23597386|NCT02119650|65919098|FG000|Overall Study|Physician Decision|0|||
23597387|NCT02119650|65919099|FG001|Overall Study|Physician Decision|2|||
23597388|NCT02119650|65919098|FG000|Overall Study|Multiple reasons for termination|2|||
23597389|NCT02119650|65919099|FG001|Overall Study|Multiple reasons for termination|1|||
23597390|NCT00632749|65919100|FG000|Overall Study|Progressive disease|3|||
23597391|NCT00632749|65919101|FG001|Overall Study|Progressive disease|2|||
23597392|NCT00632749|65919102|FG002|Overall Study|Progressive disease|2|||
23597393|NCT00632749|65919103|FG003|Overall Study|Progressive disease|2|||
23597394|NCT00632749|65919104|FG004|Overall Study|Progressive disease|4|||
23597395|NCT00632749|65919105|FG005|Overall Study|Progressive disease|4|||
23597396|NCT00632749|65919106|FG006|Overall Study|Progressive disease|3|||
23597397|NCT00632749|65919107|FG007|Overall Study|Progressive disease|2|||
23597398|NCT00632749|65919108|FG008|Overall Study|Progressive disease|3|||
23597399|NCT00632749|65919109|FG009|Overall Study|Progressive disease|2|||
23597400|NCT00632749|65919110|FG010|Overall Study|Progressive disease|4|||
23597401|NCT00632749|65919111|FG011|Overall Study|Progressive disease|3|||
23597402|NCT00632749|65919112|FG012|Overall Study|Progressive disease|2|||
23597403|NCT00632749|65919113|FG013|Overall Study|Progressive disease|4|||
23597404|NCT00632749|65919100|FG000|Overall Study|Other Adverse event|1|||
23597405|NCT00632749|65919101|FG001|Overall Study|Other Adverse event|1|||
23597406|NCT00632749|65919102|FG002|Overall Study|Other Adverse event|1|||
23597407|NCT00632749|65919103|FG003|Overall Study|Other Adverse event|1|||
23597408|NCT00632749|65919104|FG004|Overall Study|Other Adverse event|2|||
23597409|NCT00632749|65919105|FG005|Overall Study|Other Adverse event|4|||
23597410|NCT00632749|65919106|FG006|Overall Study|Other Adverse event|1|||
23597411|NCT00632749|65919107|FG007|Overall Study|Other Adverse event|2|||
23597412|NCT00632749|65919108|FG008|Overall Study|Other Adverse event|2|||
23597413|NCT00632749|65919109|FG009|Overall Study|Other Adverse event|0|||
23597414|NCT00632749|65919110|FG010|Overall Study|Other Adverse event|1|||
23597415|NCT00632749|65919111|FG011|Overall Study|Other Adverse event|0|||
23597416|NCT00632749|65919112|FG012|Overall Study|Other Adverse event|1|||
23597417|NCT00632749|65919113|FG013|Overall Study|Other Adverse event|0|||
23597418|NCT00632749|65919100|FG000|Overall Study|Refuse to continue medication|0|||
23597419|NCT00632749|65919101|FG001|Overall Study|Refuse to continue medication|0|||
23597420|NCT00632749|65919102|FG002|Overall Study|Refuse to continue medication|0|||
23597421|NCT00632749|65919103|FG003|Overall Study|Refuse to continue medication|1|||
23597422|NCT00632749|65919104|FG004|Overall Study|Refuse to continue medication|0|||
23597423|NCT00632749|65919105|FG005|Overall Study|Refuse to continue medication|0|||
23597424|NCT00632749|65919106|FG006|Overall Study|Refuse to continue medication|0|||
23597425|NCT00632749|65919107|FG007|Overall Study|Refuse to continue medication|0|||
23597426|NCT00632749|65919108|FG008|Overall Study|Refuse to continue medication|0|||
23597427|NCT00632749|65919109|FG009|Overall Study|Refuse to continue medication|1|||
23597428|NCT00632749|65919110|FG010|Overall Study|Refuse to continue medication|0|||
23597429|NCT00632749|65919111|FG011|Overall Study|Refuse to continue medication|0|||
23597430|NCT00632749|65919112|FG012|Overall Study|Refuse to continue medication|0|||
23597431|NCT00632749|65919113|FG013|Overall Study|Refuse to continue medication|0|||
23597432|NCT00632749|65919100|FG000|Overall Study|Reason other than those specified above|0|||
23597433|NCT00632749|65919101|FG001|Overall Study|Reason other than those specified above|2|||
23597434|NCT00632749|65919102|FG002|Overall Study|Reason other than those specified above|0|||
23597435|NCT00632749|65919103|FG003|Overall Study|Reason other than those specified above|0|||
23597436|NCT00632749|65919104|FG004|Overall Study|Reason other than those specified above|1|||
23597437|NCT00632749|65919105|FG005|Overall Study|Reason other than those specified above|0|||
23597438|NCT00632749|65919106|FG006|Overall Study|Reason other than those specified above|1|||
23597439|NCT00632749|65919107|FG007|Overall Study|Reason other than those specified above|0|||
23597440|NCT00632749|65919108|FG008|Overall Study|Reason other than those specified above|0|||
23597441|NCT00632749|65919109|FG009|Overall Study|Reason other than those specified above|0|||
23597442|NCT00632749|65919110|FG010|Overall Study|Reason other than those specified above|2|||
23194566|NCT01544595|64455989|FG001|Status at Week 68|Withdrawal by Subject|1|||
23597443|NCT00632749|65919111|FG011|Overall Study|Reason other than those specified above|1|||
23597444|NCT00632749|65919112|FG012|Overall Study|Reason other than those specified above|0|||
23597445|NCT00632749|65919113|FG013|Overall Study|Reason other than those specified above|2|||
23597446|NCT03752151|65919114|FG000|Overall Study|Withdrawal by Subject|1|||
23597447|NCT03752151|65919114|FG000|Overall Study|Protocol Violation|1|||
23597448|NCT03287622|65919115|FG000|Overall Study|Withdrawal by Subject|1|||
23597449|NCT03287622|65919116|FG001|Overall Study|Withdrawal by Subject|0|||
23597450|NCT03287622|65919115|FG000|Overall Study|Lost to Follow-up|27|||
23597451|NCT03287622|65919116|FG001|Overall Study|Lost to Follow-up|15|||
23255593|NCT02544633|64676914|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
23360585|NCT02028507|65065802|FG001|Overall Study|Physician Decision|4|||
23478536|NCT00045942|65494564|FG001|PKC412A2104E2|Lack of Efficacy|0|||
23478537|NCT00045942|65494565|FG002|PKC412A2104E2|Lack of Efficacy|0|||
23478538|NCT00045942|65494566|FG003|PKC412A2104E2|Lack of Efficacy|0|||
23478539|NCT00045942|65494567|FG004|PKC412A2104E2|Lack of Efficacy|0|||
23478540|NCT00045942|65494568|FG005|PKC412A2104E2|Lack of Efficacy|3|||
23478541|NCT00045942|65494569|FG006|PKC412A2104E2|Lack of Efficacy|2|||
23478542|NCT00045942|65494570|FG007|PKC412A2104E2|Lack of Efficacy|2|||
23478543|NCT00045942|65494571|FG008|PKC412A2104E2|Lack of Efficacy|6|||
23478544|NCT00045942|65494563|FG000|PKC412A2104E2|Adverse Event|0|||
23478545|NCT00045942|65494564|FG001|PKC412A2104E2|Adverse Event|0|||
23478546|NCT00045942|65494565|FG002|PKC412A2104E2|Adverse Event|0|||
23478547|NCT00045942|65494566|FG003|PKC412A2104E2|Adverse Event|0|||
23478548|NCT00045942|65494567|FG004|PKC412A2104E2|Adverse Event|0|||
23478549|NCT00045942|65494568|FG005|PKC412A2104E2|Adverse Event|4|||
23478550|NCT00045942|65494569|FG006|PKC412A2104E2|Adverse Event|3|||
23478551|NCT00045942|65494570|FG007|PKC412A2104E2|Adverse Event|1|||
23478552|NCT00045942|65494571|FG008|PKC412A2104E2|Adverse Event|0|||
23478553|NCT00045942|65494563|FG000|PKC412A2104E2|Death|0|||
23478554|NCT00045942|65494564|FG001|PKC412A2104E2|Death|0|||
23478555|NCT00045942|65494565|FG002|PKC412A2104E2|Death|0|||
23478556|NCT00045942|65494566|FG003|PKC412A2104E2|Death|0|||
23478557|NCT00045942|65494567|FG004|PKC412A2104E2|Death|0|||
23478558|NCT00045942|65494568|FG005|PKC412A2104E2|Death|1|||
23478559|NCT00045942|65494569|FG006|PKC412A2104E2|Death|2|||
23478560|NCT00045942|65494570|FG007|PKC412A2104E2|Death|0|||
23478561|NCT00045942|65494571|FG008|PKC412A2104E2|Death|0|||
23478562|NCT01892384|65494572|FG000|Overall Study|Withdrawal by Subject|1|||
23478563|NCT01892384|65494573|FG001|Overall Study|Withdrawal by Subject|1|||
23478564|NCT01892384|65494574|FG002|Overall Study|Withdrawal by Subject|0|||
23478565|NCT01892384|65494575|FG003|Overall Study|Withdrawal by Subject|0|||
23478566|NCT03077087|65494576|FG000|Overall Study|Physician Decision|2|||
23478567|NCT00281658|65494577|FG000|Randomized Phase|Adverse Event|0|||
23478568|NCT00281658|65494578|FG001|Randomized Phase|Adverse Event|2|||
23255594|NCT02544633|64676915|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
23255595|NCT02544633|64676916|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
23255596|NCT02544633|64676913|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
23255597|NCT02544633|64676914|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
23255598|NCT02544633|64676915|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
23255599|NCT02544633|64676916|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
23597452|NCT03287622|65919115|FG000|Overall Study|No prescripion after surgery|28|||
23597453|NCT03287622|65919116|FG001|Overall Study|No prescripion after surgery|31|||
23597454|NCT03287622|65919115|FG000|Overall Study|prolonged Length of stay|2|||
23597455|NCT03287622|65919116|FG001|Overall Study|prolonged Length of stay|0|||
23597456|NCT03287622|65919115|FG000|Overall Study|surgery related|0|||
23597457|NCT03287622|65919116|FG001|Overall Study|surgery related|2|||
23597458|NCT01599793|65919117|FG000|Overall Study|Adverse Event|2|||
23597459|NCT02622568|65919118|FG000|Overall Study|Lost to Follow-up|5|||
23597460|NCT02622568|65919119|FG001|Overall Study|Lost to Follow-up|5|||
23597461|NCT03475316|65919121|FG000|6 Month Intervention|Adverse Event|2|||
23597462|NCT03475316|65919122|FG001|6 Month Intervention|Adverse Event|1|||
23597463|NCT03475316|65919121|FG000|6 Month Intervention|Withdrawal by Subject|2|||
23597464|NCT03475316|65919122|FG001|6 Month Intervention|Withdrawal by Subject|0|||
23597465|NCT03475316|65919121|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
23597466|NCT03475316|65919122|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
23597467|NCT03475316|65919121|FG000|9 Months|Study stopped due to COVID pandemic|3|||
23597468|NCT03475316|65919122|FG001|9 Months|Study stopped due to COVID pandemic|4|||
23597469|NCT02006758|65919123|FG000|Overall Study|Protocol Violation|1|||
23597470|NCT02006758|65919123|FG000|Overall Study|Death|1|||
23597471|NCT02006758|65919123|FG000|Overall Study|Lost to Follow-up|4|||
23597472|NCT02006758|65919123|FG000|Overall Study|Withdrawal by Subject|4|||
23597473|NCT02006758|65919123|FG000|Overall Study|Procedurally excluded|1|||
23597474|NCT02006758|65919123|FG000|Overall Study|Other|2|||
23597475|NCT00546754|65919124|FG000|Overall Study|Serious Adverse Event|1|||
23597476|NCT00546754|65919125|FG001|Overall Study|Serious Adverse Event|1|||
23597477|NCT00546754|65919124|FG000|Overall Study|Adverse Event|11|||
23597478|NCT00546754|65919125|FG001|Overall Study|Adverse Event|16|||
23597479|NCT00546754|65919124|FG000|Overall Study|Lack of Efficacy|1|||
23597480|NCT00546754|65919125|FG001|Overall Study|Lack of Efficacy|1|||
23597481|NCT00546754|65919124|FG000|Overall Study|Lost to Follow-up|9|||
23597482|NCT00546754|65919125|FG001|Overall Study|Lost to Follow-up|15|||
23597483|NCT00546754|65919124|FG000|Overall Study|Protocol Violation|3|||
23597484|NCT00546754|65919125|FG001|Overall Study|Protocol Violation|0|||
23597485|NCT00546754|65919124|FG000|Overall Study|Withdrawal by Subject|6|||
23597486|NCT00546754|65919125|FG001|Overall Study|Withdrawal by Subject|7|||
23597487|NCT00546754|65919124|FG000|Overall Study|Dyspnea|1|||
23597488|NCT00546754|65919125|FG001|Overall Study|Dyspnea|0|||
23597489|NCT00546754|65919124|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
23597490|NCT00546754|65919125|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
23597491|NCT00546754|65919124|FG000|Overall Study|Hip Replacement|1|||
23597492|NCT00546754|65919125|FG001|Overall Study|Hip Replacement|0|||
23597493|NCT00546754|65919124|FG000|Overall Study|Suicide|1|||
23597494|NCT00546754|65919125|FG001|Overall Study|Suicide|0|||
23597495|NCT00546754|65919124|FG000|Overall Study|Missing Cooperation|1|||
23597496|NCT00546754|65919125|FG001|Overall Study|Missing Cooperation|0|||
23597497|NCT00546754|65919124|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
23597498|NCT00546754|65919125|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
23597499|NCT00546754|65919124|FG000|Overall Study|Patient's Decision|0|||
23597500|NCT00546754|65919125|FG001|Overall Study|Patient's Decision|1|||
23597501|NCT00546754|65919124|FG000|Overall Study|Missing|14|||
23597502|NCT00546754|65919125|FG001|Overall Study|Missing|7|||
23597503|NCT03246724|65919126|FG000|Overall Study|Withdrawal by Subject|5|||
23597504|NCT03246724|65919127|FG001|Overall Study|Withdrawal by Subject|2|||
23597505|NCT03246724|65919128|FG002|Overall Study|Withdrawal by Subject|4|||
23597506|NCT03246724|65919129|FG003|Overall Study|Withdrawal by Subject|2|||
23597507|NCT03246724|65919126|FG000|Overall Study|Ineligible on day of surgery|7|||
23597508|NCT03246724|65919127|FG001|Overall Study|Ineligible on day of surgery|2|||
23597509|NCT03246724|65919128|FG002|Overall Study|Ineligible on day of surgery|0|||
23597510|NCT03246724|65919129|FG003|Overall Study|Ineligible on day of surgery|3|||
23597511|NCT03246724|65919126|FG000|Overall Study|Study completed before surgical date|2|||
23597512|NCT03246724|65919127|FG001|Overall Study|Study completed before surgical date|1|||
23597513|NCT03246724|65919128|FG002|Overall Study|Study completed before surgical date|8|||
23597514|NCT03246724|65919129|FG003|Overall Study|Study completed before surgical date|1|||
23597515|NCT03246724|65919126|FG000|Overall Study|Transferred to other arm|0|||
23597516|NCT03246724|65919127|FG001|Overall Study|Transferred to other arm|0|||
23597517|NCT03246724|65919128|FG002|Overall Study|Transferred to other arm|1|||
23597518|NCT03246724|65919129|FG003|Overall Study|Transferred to other arm|0|||
23597519|NCT03246724|65919126|FG000|Overall Study|Unable to obtain medication timely|0|||
23597520|NCT03246724|65919127|FG001|Overall Study|Unable to obtain medication timely|2|||
23597521|NCT03246724|65919128|FG002|Overall Study|Unable to obtain medication timely|2|||
23597522|NCT03246724|65919129|FG003|Overall Study|Unable to obtain medication timely|1|||
23597523|NCT03246724|65919126|FG000|Overall Study|Re-consented to participate|0|||
23597524|NCT03246724|65919127|FG001|Overall Study|Re-consented to participate|0|||
23597525|NCT03246724|65919128|FG002|Overall Study|Re-consented to participate|0|||
23597526|NCT03246724|65919129|FG003|Overall Study|Re-consented to participate|1|||
23478569|NCT00281658|65494579|FG002|Randomized Phase|Adverse Event|0|||
23478570|NCT00281658|65494580|FG003|Randomized Phase|Adverse Event|0|||
23478571|NCT00281658|65494577|FG000|Randomized Phase|Lost to Follow-up|34|||
23478572|NCT00281658|65494578|FG001|Randomized Phase|Lost to Follow-up|27|||
23478573|NCT00281658|65494579|FG002|Randomized Phase|Lost to Follow-up|0|||
23478574|NCT00281658|65494580|FG003|Randomized Phase|Lost to Follow-up|0|||
23478575|NCT00281658|65494577|FG000|Randomized Phase|Withdrawal by Subject|8|||
23478576|NCT00281658|65494578|FG001|Randomized Phase|Withdrawal by Subject|7|||
23478577|NCT00281658|65494579|FG002|Randomized Phase|Withdrawal by Subject|0|||
23478578|NCT00281658|65494580|FG003|Randomized Phase|Withdrawal by Subject|0|||
23478579|NCT00281658|65494577|FG000|Randomized Phase|Study closed/terminated|1|||
23478580|NCT00281658|65494578|FG001|Randomized Phase|Study closed/terminated|1|||
23478581|NCT00281658|65494579|FG002|Randomized Phase|Study closed/terminated|0|||
23478582|NCT00281658|65494580|FG003|Randomized Phase|Study closed/terminated|0|||
23478583|NCT00281658|65494577|FG000|Randomized Phase|Disease progression|36|||
23478584|NCT00281658|65494578|FG001|Randomized Phase|Disease progression|27|||
23478585|NCT00281658|65494579|FG002|Randomized Phase|Disease progression|0|||
23478586|NCT00281658|65494580|FG003|Randomized Phase|Disease progression|0|||
23478587|NCT00281658|65494577|FG000|Randomized Phase|Physician Decision|1|||
23478588|NCT00281658|65494578|FG001|Randomized Phase|Physician Decision|1|||
23478589|NCT00281658|65494579|FG002|Randomized Phase|Physician Decision|0|||
23478590|NCT00281658|65494580|FG003|Randomized Phase|Physician Decision|0|||
23478591|NCT00281658|65494577|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
23478592|NCT00281658|65494578|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
23478593|NCT00281658|65494579|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
23478594|NCT00281658|65494580|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
23478595|NCT00281658|65494577|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
23478596|NCT00281658|65494578|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
23478597|NCT00281658|65494579|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
23478598|NCT00281658|65494580|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
23478599|NCT00281658|65494577|FG000|Randomized Phase|Treatment ongoing|1|||
23478600|NCT00281658|65494578|FG001|Randomized Phase|Treatment ongoing|0|||
23255600|NCT00320593|64676917|FG000|Overall Study|Lost to Follow-up|3|||
23360586|NCT02028507|65065803|FG002|Overall Study|Physician Decision|0|||
23478601|NCT00281658|65494579|FG002|Randomized Phase|Treatment ongoing|0|||
23478602|NCT00281658|65494580|FG003|Randomized Phase|Treatment ongoing|0|||
23478603|NCT00281658|65494577|FG000|Open Label Phase|Adverse Event|0|||
23597527|NCT00774852|65919142|FG000|Overall Study|Adverse Event|9|||
23597528|NCT00774852|65919143|FG001|Overall Study|Adverse Event|6|||
23597529|NCT00774852|65919142|FG000|Overall Study|Death|2|||
23597530|NCT00774852|65919143|FG001|Overall Study|Death|1|||
23597531|NCT00774852|65919142|FG000|Overall Study|Lack of Efficacy|3|||
23597532|NCT00774852|65919143|FG001|Overall Study|Lack of Efficacy|7|||
23360587|NCT02028507|65065804|FG003|Overall Study|Physician Decision|0|||
23478604|NCT00281658|65494578|FG001|Open Label Phase|Adverse Event|0|||
23478605|NCT00281658|65494579|FG002|Open Label Phase|Adverse Event|1|||
23478606|NCT00281658|65494580|FG003|Open Label Phase|Adverse Event|0|||
23478607|NCT00281658|65494577|FG000|Open Label Phase|Lost to Follow-up|0|||
23478608|NCT00281658|65494578|FG001|Open Label Phase|Lost to Follow-up|0|||
23255601|NCT00320593|64676918|FG001|Overall Study|Lost to Follow-up|0|||
23255602|NCT00320593|64676917|FG000|Overall Study|Moved to another state|1|||
23255603|NCT00320593|64676918|FG001|Overall Study|Moved to another state|0|||
23478609|NCT00281658|65494579|FG002|Open Label Phase|Lost to Follow-up|16|||
23255604|NCT00320593|64676917|FG000|Overall Study|Withdrawal by Subject|2|||
23255605|NCT00320593|64676918|FG001|Overall Study|Withdrawal by Subject|1|||
23478610|NCT00281658|65494580|FG003|Open Label Phase|Lost to Follow-up|2|||
23478611|NCT00281658|65494577|FG000|Open Label Phase|Withdrawal by Subject|0|||
23478612|NCT00281658|65494578|FG001|Open Label Phase|Withdrawal by Subject|0|||
23478613|NCT00281658|65494579|FG002|Open Label Phase|Withdrawal by Subject|3|||
23478614|NCT00281658|65494580|FG003|Open Label Phase|Withdrawal by Subject|2|||
23255606|NCT00320593|64676917|FG000|Overall Study|Withdrawal by clinical center|1|||
23597533|NCT00774852|65919142|FG000|Overall Study|Lost to Follow-up|9|||
23597534|NCT00774852|65919143|FG001|Overall Study|Lost to Follow-up|5|||
23597535|NCT00774852|65919142|FG000|Overall Study|Physician Decision|2|||
23597536|NCT00774852|65919143|FG001|Overall Study|Physician Decision|6|||
23597537|NCT00774852|65919142|FG000|Overall Study|Pregnancy|1|||
23597538|NCT00774852|65919143|FG001|Overall Study|Pregnancy|2|||
23597539|NCT00774852|65919142|FG000|Overall Study|Withdrawal by Subject|2|||
23597540|NCT00774852|65919143|FG001|Overall Study|Withdrawal by Subject|2|||
23597541|NCT00774852|65919142|FG000|Overall Study|Non-responder|15|||
23597542|NCT00774852|65919143|FG001|Overall Study|Non-responder|11|||
23597543|NCT00774852|65919142|FG000|Overall Study|Subject non-compliance|0|||
23597544|NCT00774852|65919143|FG001|Overall Study|Subject non-compliance|1|||
23597545|NCT00774852|65919142|FG000|Overall Study|Protocol Violation|1|||
23597546|NCT00774852|65919143|FG001|Overall Study|Protocol Violation|0|||
23597547|NCT00774852|65919142|FG000|Overall Study|Subject received prohibited medication|1|||
23597548|NCT00774852|65919143|FG001|Overall Study|Subject received prohibited medication|0|||
23597549|NCT02140645|65919145|FG000|Overall Study|Not linked|5489|||
23597550|NCT02140645|65919146|FG001|Overall Study|Not linked|61654|||
23597551|NCT02140645|65919147|FG002|Overall Study|Not linked|4236|||
23597552|NCT02140645|65919148|FG003|Overall Study|Not linked|13833|||
23597553|NCT02140645|65919149|FG004|Overall Study|Not linked|3286|||
23597554|NCT02140645|65919150|FG005|Overall Study|Not linked|70896|||
23597555|NCT00468052|65919152|FG000|Overall Study|Protocol Violation|7|||
23597556|NCT00468052|65919153|FG001|Overall Study|Protocol Violation|8|||
23597557|NCT00945321|65919155|FG000|Period 1|Adverse Event|0|||
23597558|NCT00945321|65919156|FG001|Period 1|Adverse Event|0|||
23597559|NCT00945321|65919157|FG002|Period 1|Adverse Event|0|||
23597560|NCT00945321|65919158|FG003|Period 1|Adverse Event|0|||
23597561|NCT00945321|65919159|FG004|Period 1|Adverse Event|1|||
23597562|NCT00945321|65919160|FG005|Period 1|Adverse Event|0|||
23597563|NCT00945321|65919155|FG000|Period 4|Lost to Follow-up|0|||
23597564|NCT00945321|65919156|FG001|Period 4|Lost to Follow-up|0|||
23597565|NCT00945321|65919157|FG002|Period 4|Lost to Follow-up|0|||
23597566|NCT00945321|65919158|FG003|Period 4|Lost to Follow-up|0|||
23597567|NCT00945321|65919159|FG004|Period 4|Lost to Follow-up|0|||
23597568|NCT00945321|65919160|FG005|Period 4|Lost to Follow-up|1|||
23597569|NCT03394885|65919161|FG000|Overall Study|Adverse Event|4|||
23597570|NCT03394885|65919161|FG000|Overall Study|Lack of Efficacy|1|||
23597571|NCT03394885|65919161|FG000|Overall Study|Physician Decision|1|||
23597572|NCT03394885|65919161|FG000|Overall Study|Withdrawal by Subject|8|||
23597573|NCT03394885|65919161|FG000|Overall Study|Alternative Therapy|1|||
23597574|NCT04425863|65919162|FG000|Overall Study|Death|0|||
23597575|NCT04425863|65919163|FG001|Overall Study|Death|0|||
23597576|NCT04425863|65919164|FG002|Overall Study|Death|1|||
23597577|NCT00249769|65919167|FG000|Overall Study|Withdrawal by Subject|1|||
23597578|NCT00249769|65919168|FG001|Overall Study|Withdrawal by Subject|10|||
23597579|NCT00249769|65919169|FG002|Overall Study|Withdrawal by Subject|6|||
23597580|NCT00249769|65919167|FG000|Overall Study|Migration from Study Area|1|||
23597581|NCT00249769|65919168|FG001|Overall Study|Migration from Study Area|3|||
23597582|NCT00249769|65919169|FG002|Overall Study|Migration from Study Area|14|||
23597583|NCT00249769|65919167|FG000|Overall Study|Miscellaneous|0|||
23597584|NCT00249769|65919168|FG001|Overall Study|Miscellaneous|2|||
23597585|NCT00249769|65919169|FG002|Overall Study|Miscellaneous|2|||
23597586|NCT00249769|65919167|FG000|Overall Study|Adverse Event|0|||
23597587|NCT00249769|65919168|FG001|Overall Study|Adverse Event|0|||
23597588|NCT00249769|65919169|FG002|Overall Study|Adverse Event|1|||
23597589|NCT00249769|65919167|FG000|Overall Study|Physician Decision|0|||
23597590|NCT00249769|65919168|FG001|Overall Study|Physician Decision|0|||
23597591|NCT00249769|65919169|FG002|Overall Study|Physician Decision|2|||
23597592|NCT00249769|65919167|FG000|Overall Study|Lost to Follow-up|0|||
23597593|NCT00249769|65919168|FG001|Overall Study|Lost to Follow-up|0|||
23597594|NCT00249769|65919169|FG002|Overall Study|Lost to Follow-up|3|||
23597595|NCT01250769|65919170|FG000|Overall Study|Withdrawal by Subject|0|||
23478615|NCT00281658|65494577|FG000|Open Label Phase|Disease progression|0|||
23478616|NCT00281658|65494578|FG001|Open Label Phase|Disease progression|0|||
23255607|NCT00320593|64676918|FG001|Overall Study|Withdrawal by clinical center|0|||
23478617|NCT00281658|65494579|FG002|Open Label Phase|Disease progression|18|||
23478618|NCT00281658|65494580|FG003|Open Label Phase|Disease progression|0|||
23478619|NCT00281658|65494577|FG000|Open Label Phase|Physician Decision|0|||
23478620|NCT00281658|65494578|FG001|Open Label Phase|Physician Decision|0|||
23478621|NCT00281658|65494579|FG002|Open Label Phase|Physician Decision|1|||
23478622|NCT00281658|65494580|FG003|Open Label Phase|Physician Decision|0|||
23597596|NCT01250769|65919171|FG001|Overall Study|Withdrawal by Subject|1|||
23597597|NCT01250769|65919172|FG002|Overall Study|Withdrawal by Subject|1|||
23597598|NCT01250769|65919173|FG003|Overall Study|Withdrawal by Subject|0|||
23597599|NCT01250769|65919170|FG000|Overall Study|Adverse Event|0|||
23597600|NCT01250769|65919171|FG001|Overall Study|Adverse Event|0|||
23597601|NCT01250769|65919172|FG002|Overall Study|Adverse Event|1|||
23597602|NCT01250769|65919173|FG003|Overall Study|Adverse Event|0|||
23597603|NCT00503906|65919174|FG000|Overall Study|Withdrawal by Subject|1|||
23597604|NCT02852824|65919175|FG000|Overall Study|Withdrawal by Subject|1|||
23597605|NCT02852824|65919176|FG001|Overall Study|Withdrawal by Subject|0|||
23597606|NCT02852824|65919177|FG002|Overall Study|Withdrawal by Subject|0|||
23597607|NCT02852824|65919178|FG003|Overall Study|Withdrawal by Subject|0|||
23597608|NCT02852824|65919179|FG004|Overall Study|Withdrawal by Subject|0|||
23597609|NCT02852824|65919180|FG005|Overall Study|Withdrawal by Subject|0|||
23597610|NCT02852824|65919181|FG006|Overall Study|Withdrawal by Subject|0|||
23597611|NCT02852824|65919175|FG000|Overall Study|Adverse Event|0|||
23597612|NCT02852824|65919176|FG001|Overall Study|Adverse Event|0|||
23597613|NCT02852824|65919177|FG002|Overall Study|Adverse Event|0|||
23597614|NCT02852824|65919178|FG003|Overall Study|Adverse Event|0|||
23597615|NCT02852824|65919179|FG004|Overall Study|Adverse Event|2|||
23597616|NCT02852824|65919180|FG005|Overall Study|Adverse Event|0|||
23597617|NCT02852824|65919181|FG006|Overall Study|Adverse Event|0|||
23478623|NCT00281658|65494577|FG000|Open Label Phase|Relocation of patient|0|||
23360588|NCT02028507|65065801|FG000|Overall Study|Death|1|||
23360589|NCT02028507|65065802|FG001|Overall Study|Death|0|||
23360590|NCT02028507|65065803|FG002|Overall Study|Death|1|||
23360591|NCT02028507|65065804|FG003|Overall Study|Death|3|||
23360592|NCT02028507|65065801|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
23360593|NCT02028507|65065802|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
23360594|NCT02028507|65065803|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
23360595|NCT02028507|65065804|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
23360596|NCT02028507|65065801|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
23360597|NCT02028507|65065802|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
23360598|NCT02028507|65065803|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
23360599|NCT02028507|65065804|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
23360600|NCT02028507|65065801|FG000|Overall Study|Randomized But Not Treated|3|||
23360601|NCT02028507|65065802|FG001|Overall Study|Randomized But Not Treated|6|||
23194567|NCT01544595|64455990|FG002|Status at Week 68|Withdrawal by Subject|1|||
23194568|NCT01544595|64455991|FG003|Status at Week 68|Withdrawal by Subject|2|||
23194569|NCT01544595|64455992|FG004|Status at Week 68|Withdrawal by Subject|0|||
23194570|NCT01544595|64455993|FG005|Status at Week 68|Withdrawal by Subject|0|||
23194571|NCT01544595|64455988|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
23255608|NCT03760510|64676919|FG000|Overall Study|Not ventilated for 24 hours|105|||
23194572|NCT01544595|64455989|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
23255609|NCT03760510|64676920|FG001|Overall Study|Not ventilated for 24 hours|97|||
23255610|NCT00525031|64676926|FG000|Overall Study|Disease Progression|1|||
23255611|NCT00525031|64676927|FG001|Overall Study|Disease Progression|1|||
23255612|NCT03070431|64676928|FG000|Overall Study|Withdrawal by Subject|2|||
23255613|NCT03070431|64676928|FG000|Overall Study|Lost to Follow-up|2|||
23255614|NCT01612156|64676929|FG000|Overall Study|Protocol Violation|2|||
23255615|NCT01612156|64676930|FG001|Overall Study|Protocol Violation|0|||
23255616|NCT00409188|64676931|FG000|Overall Study|Ongoing at data cut-off|383|||
23255617|NCT00409188|64676932|FG001|Overall Study|Ongoing at data cut-off|175|||
23255618|NCT01361607|64676933|FG000|Overall Study|Adverse Event|38|||
23255619|NCT01361607|64676934|FG001|Overall Study|Adverse Event|29|||
23478624|NCT00281658|65494578|FG001|Open Label Phase|Relocation of patient|0|||
23478625|NCT00281658|65494579|FG002|Open Label Phase|Relocation of patient|1|||
23478626|NCT00281658|65494580|FG003|Open Label Phase|Relocation of patient|0|||
23478627|NCT00281658|65494577|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
23478628|NCT00281658|65494578|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
23478629|NCT00281658|65494579|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
23478630|NCT00281658|65494580|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
23255620|NCT01361607|64676933|FG000|Overall Study|Withdrawal by Subject|19|||
23255621|NCT01361607|64676934|FG001|Overall Study|Withdrawal by Subject|8|||
23255622|NCT01361607|64676933|FG000|Overall Study|Withdrawal by Investigator|5|||
23255623|NCT01361607|64676934|FG001|Overall Study|Withdrawal by Investigator|3|||
23255624|NCT01361607|64676933|FG000|Overall Study|Lost to Follow-up|1|||
23255625|NCT01361607|64676934|FG001|Overall Study|Lost to Follow-up|0|||
23255626|NCT01361607|64676933|FG000|Overall Study|Met Withdrawal Criteria|1|||
23478631|NCT01306929|65494581|FG000|Overall Study|Withdrawal by Subject|23|||
23255627|NCT01361607|64676934|FG001|Overall Study|Met Withdrawal Criteria|1|||
23255628|NCT02451670|64676944|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
23255629|NCT02451670|64676945|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
23597618|NCT00999167|65919184|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
23597619|NCT00999167|65919185|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
23597620|NCT00999167|65919186|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
23597621|NCT00999167|65919184|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
23597622|NCT00999167|65919185|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
23597623|NCT00999167|65919186|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
23597624|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
23597625|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
23597626|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
23597627|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
23597628|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
23597629|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
23597630|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
23597631|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
23597632|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
23597633|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
23597634|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
23597635|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
23597636|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
23597637|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
23597638|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
23597639|NCT00999167|65919184|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
23597640|NCT00999167|65919185|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
23597641|NCT00999167|65919186|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
23597642|NCT01121991|65919187|FG000|Overall Study|Lack of Ovarian Response|2|||
23597643|NCT01121991|65919187|FG000|Overall Study|No Oocytes Retrieved|3|||
23597644|NCT01121991|65919187|FG000|Overall Study|No Fertilization|1|||
23597645|NCT00792636|65919215|FG000|Overall Study|Protocol Violation|17|||
23597646|NCT00792636|65919216|FG001|Overall Study|Protocol Violation|23|||
23597647|NCT00792636|65919217|FG002|Overall Study|Protocol Violation|20|||
23597648|NCT00792636|65919215|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
23597649|NCT00792636|65919216|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
23597650|NCT00792636|65919217|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
23597651|NCT00792636|65919215|FG000|Overall Study|Lost to Follow-up|13|||
23597652|NCT00792636|65919216|FG001|Overall Study|Lost to Follow-up|19|||
23597653|NCT00792636|65919217|FG002|Overall Study|Lost to Follow-up|14|||
23597654|NCT00792636|65919215|FG000|Overall Study|Withdrew Consent|10|||
23597655|NCT00792636|65919216|FG001|Overall Study|Withdrew Consent|13|||
23597656|NCT00792636|65919217|FG002|Overall Study|Withdrew Consent|9|||
23597657|NCT00792636|65919215|FG000|Overall Study|Lack of Efficacy|3|||
23597658|NCT00792636|65919216|FG001|Overall Study|Lack of Efficacy|4|||
23597659|NCT00792636|65919217|FG002|Overall Study|Lack of Efficacy|13|||
23597660|NCT00792636|65919215|FG000|Overall Study|Adverse Event|4|||
23597661|NCT00792636|65919216|FG001|Overall Study|Adverse Event|2|||
23597662|NCT00792636|65919217|FG002|Overall Study|Adverse Event|3|||
23597663|NCT00792636|65919215|FG000|Overall Study|Investigator Discretion|2|||
23597664|NCT00792636|65919216|FG001|Overall Study|Investigator Discretion|0|||
23597665|NCT00792636|65919217|FG002|Overall Study|Investigator Discretion|2|||
23597666|NCT02251652|65919218|FG000|Overall Study|Withdrawal by Subject|1|||
23597667|NCT00670046|65919219|FG000|Overall Study|Lost to Follow-up|1|||
23597668|NCT00670046|65919220|FG001|Overall Study|Lost to Follow-up|1|||
23597669|NCT00670046|65919219|FG000|Overall Study|Withdrawal by Subject|0|||
23597670|NCT00670046|65919220|FG001|Overall Study|Withdrawal by Subject|1|||
23597671|NCT00145470|65919222|FG000|Overall Study|Adverse Event|19|||
23597672|NCT00145470|65919223|FG001|Overall Study|Adverse Event|25|||
23597673|NCT00145470|65919222|FG000|Overall Study|Lack of Efficacy|27|||
23597674|NCT00145470|65919223|FG001|Overall Study|Lack of Efficacy|13|||
23597675|NCT00145470|65919222|FG000|Overall Study|Withdrawal by Subject|36|||
23597676|NCT00145470|65919223|FG001|Overall Study|Withdrawal by Subject|34|||
23597677|NCT00145470|65919222|FG000|Overall Study|Lost to Follow-up|21|||
23597678|NCT00145470|65919223|FG001|Overall Study|Lost to Follow-up|17|||
23597679|NCT00145470|65919222|FG000|Overall Study|Reason Not Reported|9|||
23597680|NCT00145470|65919223|FG001|Overall Study|Reason Not Reported|9|||
23597681|NCT01083316|65919226|FG000|Overall Study|Adverse Event|2|||
23194573|NCT01544595|64455990|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
23194574|NCT01544595|64455991|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
23194575|NCT01544595|64455992|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
23478632|NCT01306929|65494581|FG000|Overall Study|Adverse Event|21|||
23478633|NCT01306929|65494581|FG000|Overall Study|Physician Decision|13|||
23478634|NCT01306929|65494581|FG000|Overall Study|Death|8|||
23478635|NCT01306929|65494581|FG000|Overall Study|Withdrawal by parent/guardian|5|||
23478636|NCT01306929|65494581|FG000|Overall Study|Protocol Violation|3|||
23478637|NCT01306929|65494581|FG000|Overall Study|Non-compliance with study drug|2|||
23478638|NCT01306929|65494581|FG000|Overall Study|Lost to Follow-up|2|||
23478639|NCT01306929|65494581|FG000|Overall Study|Various|17|||
23478640|NCT02730195|65494582|FG000|Overall Study|Withdrawal by Subject|1|||
23194576|NCT01544595|64455993|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
23194577|NCT01544595|64455988|FG000|Status at Week 156|Withdrawal by Subject|9|||
23194578|NCT01544595|64455989|FG001|Status at Week 156|Withdrawal by Subject|10|||
23194579|NCT01544595|64455990|FG002|Status at Week 156|Withdrawal by Subject|4|||
23194580|NCT01544595|64455991|FG003|Status at Week 156|Withdrawal by Subject|9|||
23194581|NCT01544595|64455992|FG004|Status at Week 156|Withdrawal by Subject|20|||
23194582|NCT01544595|64455993|FG005|Status at Week 156|Withdrawal by Subject|6|||
23194583|NCT01544595|64455988|FG000|Status at Week 156|Adverse Event|9|||
23194584|NCT01544595|64455989|FG001|Status at Week 156|Adverse Event|11|||
23194585|NCT01544595|64455990|FG002|Status at Week 156|Adverse Event|1|||
23194586|NCT01544595|64455991|FG003|Status at Week 156|Adverse Event|3|||
23194587|NCT01544595|64455992|FG004|Status at Week 156|Adverse Event|4|||
23194588|NCT01544595|64455993|FG005|Status at Week 156|Adverse Event|2|||
23194589|NCT01544595|64455988|FG000|Status at Week 156|Lost to Follow-up|4|||
23194590|NCT01544595|64455989|FG001|Status at Week 156|Lost to Follow-up|4|||
23194591|NCT01544595|64455990|FG002|Status at Week 156|Lost to Follow-up|0|||
23478641|NCT01009840|65494583|FG000|Overall Study|Lost to Follow-up|1|||
23194592|NCT01544595|64455991|FG003|Status at Week 156|Lost to Follow-up|1|||
23194593|NCT01544595|64455992|FG004|Status at Week 156|Lost to Follow-up|4|||
23194594|NCT01544595|64455993|FG005|Status at Week 156|Lost to Follow-up|1|||
23194595|NCT01544595|64455988|FG000|Status at Week 156|Non-compliance with study treatement|0|||
23478642|NCT01009840|65494583|FG000|Overall Study|Adverse Event|4|||
23478643|NCT01009840|65494583|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
23478644|NCT01009840|65494583|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
23255630|NCT00871728|64676947|FG000|Overall Study|Adverse Event|1|||
23194596|NCT01544595|64455989|FG001|Status at Week 156|Non-compliance with study treatement|1|||
23194597|NCT01544595|64455990|FG002|Status at Week 156|Non-compliance with study treatement|0|||
23255631|NCT00871728|64676947|FG000|Overall Study|Protocol Violation|7|||
23255632|NCT00871728|64676947|FG000|Overall Study|Lost to Follow-up|2|||
23255633|NCT00871728|64676947|FG000|Overall Study|Failed to Visit Hospital|4|||
23194598|NCT01544595|64455991|FG003|Status at Week 156|Non-compliance with study treatement|1|||
23194599|NCT01544595|64455992|FG004|Status at Week 156|Non-compliance with study treatement|0|||
23194600|NCT01544595|64455993|FG005|Status at Week 156|Non-compliance with study treatement|1|||
23194601|NCT01544595|64455988|FG000|Status at Week 156|Physician Decision|0|||
23194602|NCT01544595|64455989|FG001|Status at Week 156|Physician Decision|3|||
23194603|NCT01544595|64455990|FG002|Status at Week 156|Physician Decision|1|||
23194604|NCT01544595|64455991|FG003|Status at Week 156|Physician Decision|0|||
23194605|NCT01544595|64455992|FG004|Status at Week 156|Physician Decision|0|||
23194606|NCT01544595|64455993|FG005|Status at Week 156|Physician Decision|0|||
23194607|NCT01544595|64455988|FG000|Status at Week 156|Pregnancy|2|||
23194608|NCT01544595|64455989|FG001|Status at Week 156|Pregnancy|3|||
23194609|NCT01544595|64455990|FG002|Status at Week 156|Pregnancy|0|||
23194610|NCT01544595|64455991|FG003|Status at Week 156|Pregnancy|0|||
23194611|NCT01544595|64455992|FG004|Status at Week 156|Pregnancy|0|||
23194612|NCT01544595|64455993|FG005|Status at Week 156|Pregnancy|0|||
23194613|NCT01544595|64455988|FG000|Status at Week 156|Protocol Violation|3|||
23194614|NCT01544595|64455989|FG001|Status at Week 156|Protocol Violation|1|||
23194615|NCT01544595|64455990|FG002|Status at Week 156|Protocol Violation|2|||
23194616|NCT01544595|64455991|FG003|Status at Week 156|Protocol Violation|2|||
23194617|NCT01544595|64455992|FG004|Status at Week 156|Protocol Violation|0|||
23194618|NCT01544595|64455993|FG005|Status at Week 156|Protocol Violation|0|||
23194619|NCT01544595|64455988|FG000|Status at Week 156|Technical problems|3|||
23194620|NCT01544595|64455989|FG001|Status at Week 156|Technical problems|1|||
23194621|NCT01544595|64455990|FG002|Status at Week 156|Technical problems|0|||
23194622|NCT01544595|64455991|FG003|Status at Week 156|Technical problems|1|||
23194623|NCT01544595|64455992|FG004|Status at Week 156|Technical problems|0|||
23194624|NCT01544595|64455993|FG005|Status at Week 156|Technical problems|0|||
23194625|NCT01544595|64455988|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
23194626|NCT01544595|64455989|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
23194627|NCT01544595|64455990|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
23194628|NCT01544595|64455991|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
23194629|NCT01544595|64455992|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
23194630|NCT01544595|64455993|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
23194631|NCT01544595|64455988|FG000|Status at Week 156|Lack of Efficacy|1|||
23194632|NCT01544595|64455989|FG001|Status at Week 156|Lack of Efficacy|0|||
23194633|NCT01544595|64455990|FG002|Status at Week 156|Lack of Efficacy|1|||
23194634|NCT01544595|64455991|FG003|Status at Week 156|Lack of Efficacy|4|||
23194635|NCT01544595|64455992|FG004|Status at Week 156|Lack of Efficacy|10|||
23194636|NCT01544595|64455993|FG005|Status at Week 156|Lack of Efficacy|5|||
23194637|NCT02401256|64455994|FG000|Overall Study|Adverse Event|5|||
23194638|NCT02401256|64455994|FG000|Overall Study|Withdrawal by Subject|12|||
23194639|NCT03408873|64456001|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
23194640|NCT03408873|64456001|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
23194641|NCT03408873|64456001|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
23194642|NCT03408873|64456001|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
23194643|NCT03408873|64456001|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
23194644|NCT03408873|64456001|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
23194645|NCT02375698|64456006|FG000|Overall Study|Withdrawal by Subject|0|||
23194646|NCT02375698|64456007|FG001|Overall Study|Withdrawal by Subject|2|||
23194647|NCT02375698|64456006|FG000|Overall Study|Physician Decision|2|||
23194648|NCT02375698|64456007|FG001|Overall Study|Physician Decision|0|||
23194649|NCT02229864|64456008|FG000|Overall Study|Death|2|||
23194650|NCT02229864|64456008|FG000|Overall Study|Lost to Follow-up|1|||
23194651|NCT01070784|64456009|FG000|Overall Study|Withdrawal by Subject|6|||
23194652|NCT01070784|64456010|FG001|Overall Study|Withdrawal by Subject|9|||
23194653|NCT01070784|64456009|FG000|Overall Study|Adverse Event|14|||
23194654|NCT01070784|64456010|FG001|Overall Study|Adverse Event|9|||
23194655|NCT01022853|64456011|FG000|Overall Study|Progressive disease|2|||
23194656|NCT01022853|64456012|FG001|Overall Study|Progressive disease|3|||
23194657|NCT01022853|64456013|FG002|Overall Study|Progressive disease|11|||
23194658|NCT01022853|64456014|FG003|Overall Study|Progressive disease|7|||
23194659|NCT01022853|64456015|FG004|Overall Study|Progressive disease|1|||
23194660|NCT01022853|64456011|FG000|Overall Study|Dose-limiting toxicity|0|||
23255634|NCT00871728|64676947|FG000|Overall Study|Participant Non-compliance|1|||
23255635|NCT00871728|64676947|FG000|Overall Study|Withdrawal of Informed Consent|5|||
23360602|NCT02028507|65065803|FG002|Overall Study|Randomized But Not Treated|0|||
23360603|NCT02028507|65065804|FG003|Overall Study|Randomized But Not Treated|4|||
23255636|NCT01039584|64676948|FG000|Overall Study|Withdrawal by Subject|4|||
23360604|NCT02028507|65065801|FG000|Overall Study|Enzyme defect|0|||
23360605|NCT02028507|65065802|FG001|Overall Study|Enzyme defect|0|||
23194661|NCT01022853|64456012|FG001|Overall Study|Dose-limiting toxicity|0|||
23194662|NCT01022853|64456013|FG002|Overall Study|Dose-limiting toxicity|0|||
23360606|NCT02028507|65065803|FG002|Overall Study|Enzyme defect|0|||
23478645|NCT01009840|65494583|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
23478646|NCT00362180|65494586|FG000|Treated Period|Withdrawal by Subject|1|||
23478647|NCT00362180|65494587|FG001|Treated Period|Withdrawal by Subject|0|||
23478648|NCT00362180|65494588|FG002|Treated Period|Withdrawal by Subject|0|||
23194663|NCT01022853|64456014|FG003|Overall Study|Dose-limiting toxicity|0|||
23478649|NCT00362180|65494589|FG003|Treated Period|Withdrawal by Subject|0|||
23597682|NCT01083316|65919226|FG000|Overall Study|Withdrawal by Subject|1|||
23597683|NCT01227265|65919227|FG000|Overall Study|Did Not Receive Treatment|1|||
23597684|NCT01227265|65919228|FG001|Overall Study|Did Not Receive Treatment|2|||
23597685|NCT01227265|65919229|FG002|Overall Study|Did Not Receive Treatment|0|||
23597686|NCT01227265|65919227|FG000|Overall Study|Administrative|1|||
23597687|NCT01227265|65919228|FG001|Overall Study|Administrative|0|||
23597688|NCT01227265|65919229|FG002|Overall Study|Administrative|2|||
23597689|NCT01227265|65919227|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
23597690|NCT01227265|65919228|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
23255637|NCT01039584|64676949|FG001|Overall Study|Withdrawal by Subject|2|||
23255638|NCT01039584|64676950|FG002|Overall Study|Withdrawal by Subject|1|||
23597691|NCT01227265|65919229|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
23597692|NCT01227265|65919227|FG000|Overall Study|Protocol Violation|2|||
23597693|NCT01227265|65919228|FG001|Overall Study|Protocol Violation|1|||
23597694|NCT01227265|65919229|FG002|Overall Study|Protocol Violation|0|||
23597695|NCT01227265|65919227|FG000|Overall Study|Withdrawal by Subject|7|||
23597696|NCT01227265|65919228|FG001|Overall Study|Withdrawal by Subject|7|||
23597697|NCT01227265|65919229|FG002|Overall Study|Withdrawal by Subject|3|||
23597698|NCT01227265|65919227|FG000|Overall Study|Lost to Follow-up|2|||
23597699|NCT01227265|65919228|FG001|Overall Study|Lost to Follow-up|0|||
23597700|NCT01227265|65919229|FG002|Overall Study|Lost to Follow-up|3|||
23597701|NCT01227265|65919227|FG000|Overall Study|Adverse Event|6|||
23597702|NCT01227265|65919228|FG001|Overall Study|Adverse Event|10|||
23597703|NCT01227265|65919229|FG002|Overall Study|Adverse Event|5|||
23597704|NCT02754596|65919232|FG000|Overall Study|Withdrawal by Subject|3|||
23597705|NCT02754596|65919233|FG001|Overall Study|Withdrawal by Subject|4|||
23194664|NCT01022853|64456015|FG004|Overall Study|Dose-limiting toxicity|1|||
23194665|NCT01022853|64456011|FG000|Overall Study|Withdrawal by Subject|0|||
23194666|NCT01022853|64456012|FG001|Overall Study|Withdrawal by Subject|1|||
23194667|NCT01022853|64456013|FG002|Overall Study|Withdrawal by Subject|1|||
23194668|NCT01022853|64456014|FG003|Overall Study|Withdrawal by Subject|1|||
23194669|NCT01022853|64456015|FG004|Overall Study|Withdrawal by Subject|0|||
23194670|NCT01022853|64456011|FG000|Overall Study|Other not stated above|1|||
23194671|NCT01022853|64456012|FG001|Overall Study|Other not stated above|0|||
23194672|NCT01022853|64456013|FG002|Overall Study|Other not stated above|1|||
23194673|NCT01022853|64456014|FG003|Overall Study|Other not stated above|0|||
23194674|NCT01022853|64456015|FG004|Overall Study|Other not stated above|0|||
23194675|NCT01937130|64456020|FG000|Overall Study|Withdrawal by Subject|0|||
23194676|NCT01937130|64456021|FG001|Overall Study|Withdrawal by Subject|0|||
23194677|NCT01937130|64456022|FG002|Overall Study|Withdrawal by Subject|0|||
23194678|NCT01937130|64456023|FG003|Overall Study|Withdrawal by Subject|1|||
23194679|NCT01937130|64456020|FG000|Overall Study|Adverse Event|0|||
23194680|NCT01937130|64456021|FG001|Overall Study|Adverse Event|1|||
23194681|NCT01937130|64456022|FG002|Overall Study|Adverse Event|0|||
23194682|NCT01937130|64456023|FG003|Overall Study|Adverse Event|1|||
23194683|NCT01937130|64456020|FG000|Overall Study|Death|1|||
23597706|NCT02754596|65919234|FG002|Overall Study|Withdrawal by Subject|0|||
23597707|NCT02754596|65919232|FG000|Overall Study|Physician Decision|1|||
23597708|NCT02754596|65919233|FG001|Overall Study|Physician Decision|1|||
23597709|NCT02754596|65919234|FG002|Overall Study|Physician Decision|1|||
23597710|NCT02754596|65919232|FG000|Overall Study|Lost to Follow-up|1|||
23597711|NCT02754596|65919233|FG001|Overall Study|Lost to Follow-up|1|||
23597712|NCT02754596|65919234|FG002|Overall Study|Lost to Follow-up|2|||
23597713|NCT02754596|65919232|FG000|Overall Study|Death|0|||
23597714|NCT02754596|65919233|FG001|Overall Study|Death|2|||
23597715|NCT02754596|65919234|FG002|Overall Study|Death|0|||
23597716|NCT02754596|65919232|FG000|Overall Study|Adverse Event|1|||
23597717|NCT02754596|65919233|FG001|Overall Study|Adverse Event|0|||
23597718|NCT02754596|65919234|FG002|Overall Study|Adverse Event|1|||
23597719|NCT02754596|65919232|FG000|Overall Study|Other|1|||
23597720|NCT02754596|65919233|FG001|Overall Study|Other|0|||
23597721|NCT02754596|65919234|FG002|Overall Study|Other|0|||
23597722|NCT00557492|65919236|FG000|Overall Study|Change in health insurance|1|||
23597723|NCT03664960|65919237|FG000|Overall Study|Adverse Event|0|||
23597724|NCT03664960|65919238|FG001|Overall Study|Adverse Event|3|||
23597725|NCT03664960|65919237|FG000|Overall Study|Lost to Follow-up|3|||
23597726|NCT03664960|65919238|FG001|Overall Study|Lost to Follow-up|2|||
23478650|NCT00362180|65494590|FG004|Treated Period|Withdrawal by Subject|0|||
23478651|NCT00362180|65494591|FG005|Treated Period|Withdrawal by Subject|0|||
23478652|NCT00362180|65494592|FG006|Treated Period|Withdrawal by Subject|0|||
23478653|NCT00362180|65494593|FG007|Treated Period|Withdrawal by Subject|0|||
23478654|NCT00362180|65494594|FG008|Treated Period|Withdrawal by Subject|0|||
23478655|NCT00362180|65494586|FG000|Treated Period|Adverse Event|0|||
23478656|NCT00362180|65494587|FG001|Treated Period|Adverse Event|0|||
23478657|NCT00362180|65494588|FG002|Treated Period|Adverse Event|0|||
23478658|NCT00362180|65494589|FG003|Treated Period|Adverse Event|0|||
23478659|NCT00362180|65494590|FG004|Treated Period|Adverse Event|0|||
23478660|NCT00362180|65494591|FG005|Treated Period|Adverse Event|1|||
23478661|NCT00362180|65494592|FG006|Treated Period|Adverse Event|0|||
23478662|NCT00362180|65494593|FG007|Treated Period|Adverse Event|1|||
23478663|NCT00362180|65494594|FG008|Treated Period|Adverse Event|0|||
23478664|NCT00492063|65494595|FG000|Overall Study|Death|0|||
23478665|NCT00492063|65494596|FG001|Overall Study|Death|0|||
23478666|NCT00492063|65494597|FG002|Overall Study|Death|1|||
23478667|NCT00492063|65494598|FG003|Overall Study|Death|2|||
23478668|NCT00492063|65494595|FG000|Overall Study|Withdrawal by Subject|4|||
23478669|NCT00492063|65494596|FG001|Overall Study|Withdrawal by Subject|3|||
23478670|NCT00492063|65494597|FG002|Overall Study|Withdrawal by Subject|5|||
23478671|NCT00492063|65494598|FG003|Overall Study|Withdrawal by Subject|4|||
23478672|NCT00492063|65494595|FG000|Overall Study|Lost to Follow-up|6|||
23478673|NCT00492063|65494596|FG001|Overall Study|Lost to Follow-up|11|||
23478674|NCT00492063|65494597|FG002|Overall Study|Lost to Follow-up|5|||
23478675|NCT00492063|65494598|FG003|Overall Study|Lost to Follow-up|3|||
23478676|NCT00492063|65494595|FG000|Overall Study|Protocol Violation|0|||
23478677|NCT00492063|65494596|FG001|Overall Study|Protocol Violation|0|||
23478678|NCT00492063|65494597|FG002|Overall Study|Protocol Violation|0|||
23478679|NCT00492063|65494598|FG003|Overall Study|Protocol Violation|1|||
23478680|NCT00412373|65494599|FG000|Overall Study|Adverse Event|8|||
23478681|NCT00412373|65494600|FG001|Overall Study|Adverse Event|13|||
23478682|NCT00412373|65494599|FG000|Overall Study|Lack of Efficacy|16|||
23478683|NCT00412373|65494600|FG001|Overall Study|Lack of Efficacy|22|||
23478684|NCT00412373|65494599|FG000|Overall Study|Lost to Follow-up|7|||
23478685|NCT00412373|65494600|FG001|Overall Study|Lost to Follow-up|13|||
23478686|NCT00412373|65494599|FG000|Overall Study|Withdrawal by Subject|8|||
23478687|NCT00412373|65494600|FG001|Overall Study|Withdrawal by Subject|27|||
23478688|NCT00412373|65494599|FG000|Overall Study|Other|2|||
23478689|NCT00412373|65494600|FG001|Overall Study|Other|2|||
23478690|NCT01806662|65494604|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
23478691|NCT01806662|65494605|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
23478692|NCT01806662|65494604|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
23255639|NCT01039584|64676948|FG000|Overall Study|Protocol Violation|10|||
23255640|NCT01039584|64676949|FG001|Overall Study|Protocol Violation|4|||
23255641|NCT01039584|64676950|FG002|Overall Study|Protocol Violation|6|||
23255642|NCT01039584|64676948|FG000|Overall Study|Lost to Follow-up|5|||
23255643|NCT01039584|64676949|FG001|Overall Study|Lost to Follow-up|3|||
23255644|NCT01039584|64676950|FG002|Overall Study|Lost to Follow-up|4|||
23255645|NCT01039584|64676948|FG000|Overall Study|Negative Baseline culture for Candida|59|||
23255646|NCT01039584|64676949|FG001|Overall Study|Negative Baseline culture for Candida|59|||
23255647|NCT01039584|64676950|FG002|Overall Study|Negative Baseline culture for Candida|24|||
23255648|NCT01039584|64676948|FG000|Overall Study|Lack of Efficacy|7|||
23255649|NCT01039584|64676949|FG001|Overall Study|Lack of Efficacy|6|||
23255650|NCT01039584|64676950|FG002|Overall Study|Lack of Efficacy|10|||
23255651|NCT01039584|64676948|FG000|Overall Study|other|1|||
23255652|NCT01039584|64676949|FG001|Overall Study|other|3|||
23255653|NCT01039584|64676950|FG002|Overall Study|other|1|||
23255654|NCT01039584|64676948|FG000|Overall Study|Pap smear with significant pathology|10|||
23255655|NCT01039584|64676949|FG001|Overall Study|Pap smear with significant pathology|10|||
23255656|NCT01039584|64676950|FG002|Overall Study|Pap smear with significant pathology|3|||
23255657|NCT01039584|64676948|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
23255658|NCT01039584|64676949|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
23255659|NCT01039584|64676950|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
23255660|NCT00700310|64676953|FG000|Overall Study|Adverse Event|6|||
23255661|NCT00700310|64676954|FG001|Overall Study|Adverse Event|10|||
23255662|NCT00700310|64676955|FG002|Overall Study|Adverse Event|5|||
23255663|NCT00700310|64676956|FG003|Overall Study|Adverse Event|11|||
23255664|NCT00700310|64676953|FG000|Overall Study|Lost to Follow-up|4|||
23478693|NCT01806662|65494605|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
23478694|NCT01806662|65494604|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
23478695|NCT01806662|65494605|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
23478696|NCT01806662|65494604|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
23478697|NCT01806662|65494605|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
23478698|NCT01129583|65494608|FG000|Overall Study|Death|1|||
23478699|NCT01129583|65494609|FG001|Overall Study|Death|0|||
23478700|NCT01129583|65494608|FG000|Overall Study|Lost to Follow-up|1|||
23478701|NCT01129583|65494609|FG001|Overall Study|Lost to Follow-up|1|||
23255665|NCT00700310|64676954|FG001|Overall Study|Lost to Follow-up|1|||
23255666|NCT00700310|64676955|FG002|Overall Study|Lost to Follow-up|0|||
23255667|NCT00700310|64676956|FG003|Overall Study|Lost to Follow-up|1|||
23255668|NCT00700310|64676953|FG000|Overall Study|Withdrawal by Subject|8|||
23255669|NCT00700310|64676954|FG001|Overall Study|Withdrawal by Subject|9|||
23478702|NCT01129583|65494608|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
23478703|NCT01129583|65494609|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
23478704|NCT00745849|65494612|FG000|First Intervention|Withdrawal by Subject|0|||
23478705|NCT00745849|65494613|FG001|First Intervention|Withdrawal by Subject|1|||
23478706|NCT00745849|65494612|FG000|First Intervention|Lost to Follow-up|1|||
23478707|NCT00745849|65494613|FG001|First Intervention|Lost to Follow-up|1|||
23597727|NCT03664960|65919237|FG000|Overall Study|Physician Decision|1|||
23597728|NCT03664960|65919238|FG001|Overall Study|Physician Decision|0|||
23597729|NCT03664960|65919237|FG000|Overall Study|Withdrawal by Subject|3|||
23597730|NCT03664960|65919238|FG001|Overall Study|Withdrawal by Subject|14|||
23597731|NCT03664960|65919237|FG000|Overall Study|Sponsor Decision|1|||
23597732|NCT03664960|65919238|FG001|Overall Study|Sponsor Decision|1|||
23597733|NCT03664960|65919237|FG000|Overall Study|Other|1|||
23597734|NCT03664960|65919238|FG001|Overall Study|Other|2|||
23597735|NCT03951805|65919239|FG000|Overall Study|Adverse Event|1|||
23597736|NCT03951805|65919240|FG001|Overall Study|Adverse Event|0|||
23597737|NCT03951805|65919241|FG002|Overall Study|Adverse Event|0|||
23597738|NCT03951805|65919242|FG003|Overall Study|Adverse Event|0|||
23597739|NCT02379819|65919244|FG000|Overall Study|Withdrawal by Subject|10|||
23597740|NCT02379819|65919244|FG000|Overall Study|Death|2|||
23597741|NCT02379819|65919244|FG000|Overall Study|Lack of Efficacy|1|||
23597742|NCT02379819|65919244|FG000|Overall Study|Lost to Follow-up|1|||
23597743|NCT00229658|65919245|FG000|Overall Study|Administrative|2|||
23597744|NCT00229658|65919246|FG001|Overall Study|Administrative|1|||
23597745|NCT00229658|65919245|FG000|Overall Study|Investigator decision|13|||
23597746|NCT00229658|65919246|FG001|Overall Study|Investigator decision|10|||
23597747|NCT00229658|65919245|FG000|Overall Study|Other|80|||
23360607|NCT02028507|65065804|FG003|Overall Study|Enzyme defect|1|||
23255670|NCT00700310|64676955|FG002|Overall Study|Withdrawal by Subject|8|||
23255671|NCT00700310|64676956|FG003|Overall Study|Withdrawal by Subject|8|||
23255672|NCT00700310|64676953|FG000|Overall Study|Lack of Efficacy|0|||
23255673|NCT00700310|64676954|FG001|Overall Study|Lack of Efficacy|3|||
23255674|NCT00700310|64676955|FG002|Overall Study|Lack of Efficacy|0|||
23255675|NCT00700310|64676956|FG003|Overall Study|Lack of Efficacy|1|||
23255676|NCT00700310|64676953|FG000|Overall Study|Administrative/Other|1|||
23255677|NCT00700310|64676954|FG001|Overall Study|Administrative/Other|3|||
23478708|NCT00745849|65494612|FG000|Second Intervention|Lost to Follow-up|2|||
23255678|NCT00700310|64676955|FG002|Overall Study|Administrative/Other|1|||
23255679|NCT00700310|64676956|FG003|Overall Study|Administrative/Other|3|||
23255680|NCT00700310|64676953|FG000|Overall Study|Randomized, Not Treated|2|||
23255681|NCT00700310|64676954|FG001|Overall Study|Randomized, Not Treated|0|||
23255682|NCT00700310|64676955|FG002|Overall Study|Randomized, Not Treated|2|||
23255683|NCT00700310|64676956|FG003|Overall Study|Randomized, Not Treated|2|||
23255684|NCT00305110|64676957|FG000|Overall Study|Missing data|29|||
23255685|NCT02196506|64676958|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
23255686|NCT02196506|64676959|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
23255687|NCT02196506|64676960|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
23255688|NCT02196506|64676961|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
23255689|NCT02196506|64676958|FG000|Phase A|Withdrawal by Subject|34|||
23255690|NCT02196506|64676959|FG001|Phase A|Withdrawal by Subject|0|||
23255691|NCT02196506|64676960|FG002|Phase A|Withdrawal by Subject|0|||
23255692|NCT02196506|64676961|FG003|Phase A|Withdrawal by Subject|0|||
23255693|NCT02196506|64676958|FG000|Phase A|Adverse Event|22|||
23255694|NCT02196506|64676959|FG001|Phase A|Adverse Event|0|||
23255695|NCT02196506|64676960|FG002|Phase A|Adverse Event|0|||
23478709|NCT00745849|65494613|FG001|Second Intervention|Lost to Follow-up|1|||
23478710|NCT00779259|65494618|FG000|Quinine Alone|Adverse Event|2|||
23478711|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
23478712|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
23478713|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
23478714|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
23478715|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
23478716|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
23478717|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
23478718|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
23478719|NCT04740905|65494619|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
23478720|NCT04740905|65494620|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
23478721|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
23478722|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
23478723|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
23478724|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
23478725|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
23478726|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
23478727|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
23478728|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
23478729|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
23478730|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
23478731|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
23478732|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
23478733|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
23478734|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
23478735|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
23597748|NCT00229658|65919246|FG001|Overall Study|Other|60|||
23597749|NCT00229658|65919245|FG000|Overall Study|Lost to Follow-up|82|||
23597750|NCT00229658|65919246|FG001|Overall Study|Lost to Follow-up|55|||
23597751|NCT00229658|65919245|FG000|Overall Study|Serious Adverse Event|2|||
23597752|NCT00229658|65919246|FG001|Overall Study|Serious Adverse Event|2|||
23597753|NCT00229658|65919245|FG000|Overall Study|Withdrawal of consent|46|||
23597754|NCT00229658|65919246|FG001|Overall Study|Withdrawal of consent|39|||
23597755|NCT00586313|65919247|FG000|Overall Study|Lack of Efficacy|2|||
23597756|NCT02538341|65919249|FG000|Overall Study|Lost to Follow-up|51|||
23597757|NCT02538341|65919250|FG001|Overall Study|Lost to Follow-up|46|||
23597758|NCT02538341|65919249|FG000|Overall Study|Withdrawal by Subject|3|||
23597759|NCT02538341|65919250|FG001|Overall Study|Withdrawal by Subject|1|||
23597760|NCT02538341|65919249|FG000|Overall Study|Death|2|||
23597761|NCT02538341|65919250|FG001|Overall Study|Death|0|||
23255696|NCT02196506|64676961|FG003|Phase A|Adverse Event|0|||
23478736|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
23478737|NCT04740905|65494619|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
23255697|NCT02196506|64676958|FG000|Phase A|Lost to Follow-up|9|||
23255698|NCT02196506|64676959|FG001|Phase A|Lost to Follow-up|0|||
23255699|NCT02196506|64676960|FG002|Phase A|Lost to Follow-up|0|||
23255700|NCT02196506|64676961|FG003|Phase A|Lost to Follow-up|0|||
23255701|NCT02196506|64676958|FG000|Phase A|Protocol deviation|12|||
23255702|NCT02196506|64676959|FG001|Phase A|Protocol deviation|0|||
23255703|NCT02196506|64676960|FG002|Phase A|Protocol deviation|0|||
23255704|NCT02196506|64676961|FG003|Phase A|Protocol deviation|0|||
23255705|NCT02196506|64676958|FG000|Phase A|Participant withdrawn by investigator|10|||
23255706|NCT02196506|64676959|FG001|Phase A|Participant withdrawn by investigator|0|||
23255707|NCT02196506|64676960|FG002|Phase A|Participant withdrawn by investigator|0|||
23255708|NCT02196506|64676961|FG003|Phase A|Participant withdrawn by investigator|0|||
23255709|NCT02196506|64676958|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
23255710|NCT02196506|64676959|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
23255711|NCT02196506|64676960|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
23255712|NCT02196506|64676961|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
23255713|NCT02196506|64676958|FG000|Phase B|Lack of Efficacy|0|||
23255714|NCT02196506|64676959|FG001|Phase B|Lack of Efficacy|1|||
23255715|NCT02196506|64676960|FG002|Phase B|Lack of Efficacy|2|||
23255716|NCT02196506|64676961|FG003|Phase B|Lack of Efficacy|0|||
23255717|NCT02196506|64676958|FG000|Phase B|Withdrawal by Participant|0|||
23255718|NCT02196506|64676959|FG001|Phase B|Withdrawal by Participant|8|||
23255719|NCT02196506|64676960|FG002|Phase B|Withdrawal by Participant|1|||
23255720|NCT02196506|64676961|FG003|Phase B|Withdrawal by Participant|0|||
23255721|NCT02196506|64676958|FG000|Phase B|Adverse Event|0|||
23255722|NCT02196506|64676959|FG001|Phase B|Adverse Event|4|||
23255723|NCT02196506|64676960|FG002|Phase B|Adverse Event|1|||
23255724|NCT02196506|64676961|FG003|Phase B|Adverse Event|0|||
23478738|NCT04740905|65494620|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
23478739|NCT01120782|65494621|FG000|Overall Study|Test article shipping error|11|||
23478740|NCT00938886|65494623|FG000|Overall Study|Death|0|||
23478741|NCT00938886|65494624|FG001|Overall Study|Death|1|||
23478742|NCT00938886|65494623|FG000|Overall Study|Withdrawal by Subject|4|||
23478743|NCT00938886|65494624|FG001|Overall Study|Withdrawal by Subject|7|||
23478744|NCT00938886|65494623|FG000|Overall Study|Lost to Follow-up|3|||
23255725|NCT02196506|64676958|FG000|Phase B|Lost to Follow-up|0|||
23255726|NCT02196506|64676959|FG001|Phase B|Lost to Follow-up|2|||
23255727|NCT02196506|64676960|FG002|Phase B|Lost to Follow-up|1|||
23255728|NCT02196506|64676961|FG003|Phase B|Lost to Follow-up|0|||
23255729|NCT02196506|64676958|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
23255730|NCT02196506|64676959|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
23478745|NCT00938886|65494624|FG001|Overall Study|Lost to Follow-up|2|||
23478746|NCT00220779|65494625|FG000|Overall Study|Adverse Event|1|||
23478747|NCT00220779|65494626|FG001|Overall Study|Adverse Event|0|||
23478748|NCT00220779|65494627|FG002|Overall Study|Adverse Event|0|||
23478749|NCT00220779|65494625|FG000|Overall Study|Withdrawal by Subject|1|||
23597762|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
23597763|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
23597764|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
23597765|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
23597766|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
23597767|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
23597768|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597769|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597770|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597771|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597772|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
23597773|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
23597774|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597775|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597776|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597777|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597778|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23597779|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
23597780|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
23478750|NCT00220779|65494626|FG001|Overall Study|Withdrawal by Subject|4|||
23478751|NCT00220779|65494627|FG002|Overall Study|Withdrawal by Subject|1|||
23478752|NCT00220779|65494625|FG000|Overall Study|Non-compliance|1|||
23478753|NCT00220779|65494626|FG001|Overall Study|Non-compliance|0|||
23478754|NCT00220779|65494627|FG002|Overall Study|Non-compliance|0|||
23478755|NCT00220779|65494625|FG000|Overall Study|Too time consuming|1|||
23478756|NCT00220779|65494626|FG001|Overall Study|Too time consuming|0|||
23478757|NCT00220779|65494627|FG002|Overall Study|Too time consuming|0|||
23478758|NCT00220779|65494625|FG000|Overall Study|Pregnancy|0|||
23478759|NCT00220779|65494626|FG001|Overall Study|Pregnancy|0|||
23478760|NCT00220779|65494627|FG002|Overall Study|Pregnancy|2|||
23255731|NCT02196506|64676960|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
23478761|NCT00220779|65494625|FG000|Overall Study|Lack of Efficacy|3|||
23478762|NCT00220779|65494626|FG001|Overall Study|Lack of Efficacy|0|||
23478763|NCT00220779|65494627|FG002|Overall Study|Lack of Efficacy|1|||
23194684|NCT01937130|64456021|FG001|Overall Study|Death|1|||
23194685|NCT01937130|64456022|FG002|Overall Study|Death|1|||
23194686|NCT01937130|64456023|FG003|Overall Study|Death|0|||
23255732|NCT02196506|64676961|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
23255733|NCT02196506|64676958|FG000|Phase A+|Withdrawal by Participant|0|||
23194687|NCT01937130|64456020|FG000|Overall Study|Lost to Follow-up|2|||
23478764|NCT00053898|65494628|FG000|Overall Study|No follow-up data from any source|9|||
23478765|NCT00053898|65494629|FG001|Overall Study|No follow-up data from any source|12|||
23478766|NCT00053898|65494628|FG000|Overall Study|Follow-up from telephone contact only|5|||
23478767|NCT00053898|65494629|FG001|Overall Study|Follow-up from telephone contact only|1|||
23478768|NCT00329849|65494630|FG000|Overall Study|Withdrawal by Subject|6|||
23478769|NCT00329849|65494631|FG001|Overall Study|Withdrawal by Subject|4|||
23478770|NCT00662532|65494632|FG000|Overall Study|Adverse Event|0|||
23478771|NCT00662532|65494633|FG001|Overall Study|Adverse Event|1|||
23478772|NCT00662532|65494632|FG000|Overall Study|Lost to Follow-up|0|||
23478773|NCT00662532|65494633|FG001|Overall Study|Lost to Follow-up|1|||
23478774|NCT02395302|65494636|FG000|Overall Study|Screen Failure|3|||
23478775|NCT02395302|65494636|FG000|Overall Study|Run In Failure|7|||
23478776|NCT02395302|65494636|FG000|Overall Study|Withdrawal by Subject|2|||
23478777|NCT02395302|65494636|FG000|Overall Study|Physician Decision|2|||
23478778|NCT03499964|65494637|FG000|Overall Study|Lack of Efficacy|6|||
23478779|NCT03499964|65494638|FG001|Overall Study|Lack of Efficacy|26|||
23478780|NCT03499964|65494637|FG000|Overall Study|Adverse Event|1|||
23478781|NCT03499964|65494638|FG001|Overall Study|Adverse Event|0|||
23478782|NCT03499964|65494637|FG000|Overall Study|Death|1|||
23478783|NCT03499964|65494638|FG001|Overall Study|Death|0|||
23478784|NCT03499964|65494637|FG000|Overall Study|Withdrawal by Subject|2|||
23478785|NCT03499964|65494638|FG001|Overall Study|Withdrawal by Subject|1|||
23478786|NCT03499964|65494637|FG000|Overall Study|Lost to Follow-up|1|||
23478787|NCT03499964|65494638|FG001|Overall Study|Lost to Follow-up|0|||
23478788|NCT00510653|65494650|FG000|Overall Study|Withdrawal by Subject|8|||
23478789|NCT00510653|65494650|FG000|Overall Study|Monetary|3|||
23478790|NCT01139008|65494651|FG000|Overall Study|Withdrawal by Subject|5|||
23478791|NCT01139008|65494651|FG000|Overall Study|Non-compliant, lost product|1|||
23478792|NCT00265148|65494655|FG000|Overall Study|Adverse Event|2|||
23478793|NCT00265148|65494656|FG001|Overall Study|Adverse Event|2|||
23478794|NCT00265148|65494655|FG000|Overall Study|Lack of Efficacy|0|||
23478795|NCT00265148|65494656|FG001|Overall Study|Lack of Efficacy|2|||
23478796|NCT00265148|65494655|FG000|Overall Study|Protocol Violation|3|||
23478797|NCT00265148|65494656|FG001|Overall Study|Protocol Violation|2|||
23478798|NCT00265148|65494655|FG000|Overall Study|Lost to Follow-up|0|||
23478799|NCT00265148|65494656|FG001|Overall Study|Lost to Follow-up|1|||
23478800|NCT00265148|65494655|FG000|Overall Study|Withdrawal by Subject|2|||
23478801|NCT00265148|65494656|FG001|Overall Study|Withdrawal by Subject|1|||
23478802|NCT00265148|65494655|FG000|Overall Study|Physician Decision|1|||
23478803|NCT00265148|65494656|FG001|Overall Study|Physician Decision|0|||
23478804|NCT00265148|65494655|FG000|Overall Study|Increasing frailty|0|||
23478805|NCT00265148|65494656|FG001|Overall Study|Increasing frailty|1|||
23478806|NCT00265148|65494655|FG000|Overall Study|Subject chose to change of the dose|1|||
23478807|NCT00265148|65494656|FG001|Overall Study|Subject chose to change of the dose|0|||
23478808|NCT00958438|65494658|FG000|Overall Study|Protocol Violation|3|||
23478809|NCT00958438|65494659|FG001|Overall Study|Protocol Violation|2|||
23478810|NCT00958438|65494660|FG002|Overall Study|Protocol Violation|2|||
23478811|NCT00958438|65494658|FG000|Overall Study|Withdrawal by Subject|4|||
23478812|NCT00958438|65494659|FG001|Overall Study|Withdrawal by Subject|2|||
23478813|NCT00958438|65494660|FG002|Overall Study|Withdrawal by Subject|1|||
23478814|NCT00958438|65494658|FG000|Overall Study|Adverse Event|0|||
23478815|NCT00958438|65494659|FG001|Overall Study|Adverse Event|3|||
23478816|NCT00958438|65494660|FG002|Overall Study|Adverse Event|0|||
23478817|NCT00958438|65494658|FG000|Overall Study|Physician Decision|1|||
23478818|NCT00958438|65494659|FG001|Overall Study|Physician Decision|0|||
23478819|NCT00958438|65494660|FG002|Overall Study|Physician Decision|1|||
23478820|NCT00958438|65494658|FG000|Overall Study|Other than specified above|2|||
23478821|NCT00958438|65494659|FG001|Overall Study|Other than specified above|3|||
23597781|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
23597782|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
23255734|NCT02196506|64676959|FG001|Phase A+|Withdrawal by Participant|0|||
23255735|NCT02196506|64676960|FG002|Phase A+|Withdrawal by Participant|0|||
23255736|NCT02196506|64676961|FG003|Phase A+|Withdrawal by Participant|5|||
23255737|NCT02196506|64676958|FG000|Phase A+|Adverse Event|0|||
23478822|NCT00958438|65494660|FG002|Overall Study|Other than specified above|2|||
23478823|NCT00864916|65494661|FG000|Overall Study|Lost to Follow-up|4|||
23478824|NCT00864916|65494662|FG001|Overall Study|Lost to Follow-up|4|||
23478825|NCT00864916|65494661|FG000|Overall Study|Protocol Violation|1|||
23478826|NCT00864916|65494662|FG001|Overall Study|Protocol Violation|0|||
23478827|NCT00864916|65494661|FG000|Overall Study|Withdrawal by Subject|1|||
23478828|NCT00864916|65494662|FG001|Overall Study|Withdrawal by Subject|0|||
23478829|NCT01589770|65494663|FG000|Overall Study|EGFR <60ml/min|6|||
23478830|NCT01589770|65494664|FG001|Overall Study|EGFR <60ml/min|4|||
23478831|NCT01589770|65494663|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
23478832|NCT01589770|65494664|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
23478833|NCT04214288|65494665|FG000|Overall Study|Ongoing in the study|41|||
23478834|NCT04214288|65494666|FG001|Overall Study|Ongoing in the study|51|||
23478835|NCT04214288|65494667|FG002|Overall Study|Ongoing in the study|12|||
23255738|NCT02196506|64676959|FG001|Phase A+|Adverse Event|0|||
23255739|NCT02196506|64676960|FG002|Phase A+|Adverse Event|0|||
23255740|NCT02196506|64676961|FG003|Phase A+|Adverse Event|1|||
23597783|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
23597784|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
23597785|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
23597786|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597787|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597788|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597789|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597790|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
23597791|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
23597792|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
23597793|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
23597794|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
23597795|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
23597796|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
23597797|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
23597798|NCT02392234|65919254|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
23597799|NCT02392234|65919255|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
23597800|NCT02392234|65919256|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
23597801|NCT02392234|65919257|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
23597802|NCT02392234|65919258|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
23597803|NCT02392234|65919259|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
23597804|NCT02392234|65919254|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
23597805|NCT02392234|65919255|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597806|NCT02392234|65919256|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597807|NCT02392234|65919257|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597808|NCT02392234|65919258|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597809|NCT02392234|65919259|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
23597810|NCT02616900|65919266|FG000|Overall Study|Lack of Efficacy|7|||
23597811|NCT02616900|65919266|FG000|Overall Study|Lost to Follow-up|2|||
23597812|NCT02616900|65919266|FG000|Overall Study|Protocol Violation|5|||
23597813|NCT02616900|65919266|FG000|Overall Study|Withdrawal by Subject|3|||
23597814|NCT02616900|65919266|FG000|Overall Study|Incomplete data|6|||
23597815|NCT00421889|65919268|FG000|Overall Study|Adverse Event|1|||
23597816|NCT00421889|65919269|FG001|Overall Study|Adverse Event|0|||
23597817|NCT00421889|65919270|FG002|Overall Study|Adverse Event|1|||
23597818|NCT00421889|65919271|FG003|Overall Study|Adverse Event|1|||
23597819|NCT00421889|65919272|FG004|Overall Study|Adverse Event|1|||
23597820|NCT00421889|65919273|FG005|Overall Study|Adverse Event|4|||
23597821|NCT00421889|65919274|FG006|Overall Study|Adverse Event|1|||
23597822|NCT00421889|65919275|FG007|Overall Study|Adverse Event|0|||
23597823|NCT00421889|65919276|FG008|Overall Study|Adverse Event|2|||
23597824|NCT00421889|65919268|FG000|Overall Study|Withdrawal by Subject|1|||
23597825|NCT00421889|65919269|FG001|Overall Study|Withdrawal by Subject|3|||
23597826|NCT00421889|65919270|FG002|Overall Study|Withdrawal by Subject|0|||
23597827|NCT00421889|65919271|FG003|Overall Study|Withdrawal by Subject|0|||
23597828|NCT00421889|65919272|FG004|Overall Study|Withdrawal by Subject|2|||
23597829|NCT00421889|65919273|FG005|Overall Study|Withdrawal by Subject|0|||
23597830|NCT00421889|65919274|FG006|Overall Study|Withdrawal by Subject|0|||
23597831|NCT00421889|65919275|FG007|Overall Study|Withdrawal by Subject|0|||
23597832|NCT00421889|65919276|FG008|Overall Study|Withdrawal by Subject|0|||
23597833|NCT00421889|65919268|FG000|Overall Study|Death|0|||
23597834|NCT00421889|65919269|FG001|Overall Study|Death|0|||
23597835|NCT00421889|65919270|FG002|Overall Study|Death|0|||
23597836|NCT00421889|65919271|FG003|Overall Study|Death|0|||
23597837|NCT00421889|65919272|FG004|Overall Study|Death|1|||
23597838|NCT00421889|65919273|FG005|Overall Study|Death|1|||
23597839|NCT00421889|65919274|FG006|Overall Study|Death|0|||
23597840|NCT00421889|65919275|FG007|Overall Study|Death|0|||
23597841|NCT00421889|65919276|FG008|Overall Study|Death|0|||
23597842|NCT00421889|65919268|FG000|Overall Study|Progressive disease|3|||
23597843|NCT00421889|65919269|FG001|Overall Study|Progressive disease|2|||
23597844|NCT00421889|65919270|FG002|Overall Study|Progressive disease|2|||
23597845|NCT00421889|65919271|FG003|Overall Study|Progressive disease|3|||
23597846|NCT00421889|65919272|FG004|Overall Study|Progressive disease|2|||
23597847|NCT00421889|65919273|FG005|Overall Study|Progressive disease|21|||
23597848|NCT00421889|65919274|FG006|Overall Study|Progressive disease|3|||
23597849|NCT00421889|65919275|FG007|Overall Study|Progressive disease|1|||
23597850|NCT00421889|65919276|FG008|Overall Study|Progressive disease|5|||
23597851|NCT00421889|65919268|FG000|Overall Study|Patient/Investigator request|0|||
23597852|NCT00421889|65919269|FG001|Overall Study|Patient/Investigator request|0|||
23597853|NCT00421889|65919270|FG002|Overall Study|Patient/Investigator request|0|||
23597854|NCT00421889|65919271|FG003|Overall Study|Patient/Investigator request|0|||
23597855|NCT00421889|65919272|FG004|Overall Study|Patient/Investigator request|0|||
23597856|NCT00421889|65919273|FG005|Overall Study|Patient/Investigator request|9|||
23597857|NCT00421889|65919274|FG006|Overall Study|Patient/Investigator request|0|||
23597858|NCT00421889|65919275|FG007|Overall Study|Patient/Investigator request|1|||
23478836|NCT04214288|65494668|FG003|Overall Study|Ongoing in the study|39|||
23478837|NCT04214288|65494665|FG000|Overall Study|Adverse Event|1|||
23478838|NCT04214288|65494666|FG001|Overall Study|Adverse Event|0|||
23478839|NCT04214288|65494667|FG002|Overall Study|Adverse Event|0|||
23478840|NCT04214288|65494668|FG003|Overall Study|Adverse Event|0|||
23478841|NCT04214288|65494665|FG000|Overall Study|Death|22|||
23478842|NCT04214288|65494666|FG001|Overall Study|Death|13|||
23478843|NCT04214288|65494667|FG002|Overall Study|Death|7|||
23478844|NCT04214288|65494668|FG003|Overall Study|Death|19|||
23478845|NCT04214288|65494665|FG000|Overall Study|Lost to Follow-up|1|||
23478846|NCT04214288|65494666|FG001|Overall Study|Lost to Follow-up|2|||
23478847|NCT04214288|65494667|FG002|Overall Study|Lost to Follow-up|1|||
23478848|NCT04214288|65494668|FG003|Overall Study|Lost to Follow-up|0|||
23478849|NCT04214288|65494665|FG000|Overall Study|Other|1|||
23478850|NCT04214288|65494666|FG001|Overall Study|Other|2|||
23478851|NCT04214288|65494667|FG002|Overall Study|Other|0|||
23478852|NCT04214288|65494668|FG003|Overall Study|Other|6|||
23478853|NCT04214288|65494665|FG000|Overall Study|Protocol Violation|0|||
23478854|NCT04214288|65494666|FG001|Overall Study|Protocol Violation|1|||
23478855|NCT04214288|65494667|FG002|Overall Study|Protocol Violation|0|||
23478856|NCT04214288|65494668|FG003|Overall Study|Protocol Violation|0|||
23478857|NCT04214288|65494665|FG000|Overall Study|Withdrawal by Subject|8|||
23478858|NCT04214288|65494666|FG001|Overall Study|Withdrawal by Subject|4|||
23478859|NCT04214288|65494667|FG002|Overall Study|Withdrawal by Subject|0|||
23478860|NCT04214288|65494668|FG003|Overall Study|Withdrawal by Subject|9|||
23478861|NCT00852371|65494669|FG000|Overall Study|Lost to Follow-up|2|||
23478862|NCT00852371|65494670|FG001|Overall Study|Lost to Follow-up|3|||
23478863|NCT00852371|65494671|FG002|Overall Study|Lost to Follow-up|4|||
23478864|NCT00852371|65494672|FG003|Overall Study|Lost to Follow-up|2|||
23478865|NCT00534313|65494673|FG000|Short-term Period|Adverse Event|1|||
23478866|NCT00534313|65494674|FG001|Short-term Period|Adverse Event|2|||
23478867|NCT00534313|65494675|FG002|Short-term Period|Adverse Event|1|||
23478868|NCT00534313|65494676|FG003|Short-term Period|Adverse Event|3|||
23478869|NCT00534313|65494673|FG000|Short-term Period|Lack of Efficacy|3|||
23478870|NCT00534313|65494674|FG001|Short-term Period|Lack of Efficacy|4|||
23478871|NCT00534313|65494675|FG002|Short-term Period|Lack of Efficacy|0|||
23478872|NCT00534313|65494676|FG003|Short-term Period|Lack of Efficacy|3|||
23478873|NCT00534313|65494673|FG000|Short-term Period|Participant not meeting study criteria|0|||
23478874|NCT00534313|65494674|FG001|Short-term Period|Participant not meeting study criteria|0|||
23478875|NCT00534313|65494675|FG002|Short-term Period|Participant not meeting study criteria|0|||
23478876|NCT00534313|65494676|FG003|Short-term Period|Participant not meeting study criteria|1|||
23478877|NCT00534313|65494673|FG000|Short-term Period|Participant withdrew consent|2|||
23478878|NCT00534313|65494674|FG001|Short-term Period|Participant withdrew consent|0|||
23478879|NCT00534313|65494675|FG002|Short-term Period|Participant withdrew consent|0|||
23478880|NCT00534313|65494676|FG003|Short-term Period|Participant withdrew consent|2|||
23478881|NCT00534313|65494673|FG000|Short-term Period|Pregnancy|0|||
23478882|NCT00534313|65494674|FG001|Short-term Period|Pregnancy|0|||
23478883|NCT00534313|65494675|FG002|Short-term Period|Pregnancy|1|||
23478884|NCT00534313|65494676|FG003|Short-term Period|Pregnancy|0|||
23478885|NCT00534313|65494673|FG000|Long-term Period|Adverse Event|2|||
23478886|NCT00534313|65494674|FG001|Long-term Period|Adverse Event|1|||
23478887|NCT00534313|65494675|FG002|Long-term Period|Adverse Event|0|||
23478888|NCT00534313|65494676|FG003|Long-term Period|Adverse Event|1|||
23478889|NCT00534313|65494673|FG000|Long-term Period|Lack of Efficacy|14|||
23478890|NCT00534313|65494674|FG001|Long-term Period|Lack of Efficacy|10|||
23194688|NCT01937130|64456021|FG001|Overall Study|Lost to Follow-up|0|||
23194689|NCT01937130|64456022|FG002|Overall Study|Lost to Follow-up|2|||
23194690|NCT01937130|64456023|FG003|Overall Study|Lost to Follow-up|0|||
23194691|NCT01937130|64456020|FG000|Overall Study|Physician Decision|0|||
23194692|NCT01937130|64456021|FG001|Overall Study|Physician Decision|1|||
23194693|NCT01937130|64456022|FG002|Overall Study|Physician Decision|0|||
23194694|NCT01937130|64456023|FG003|Overall Study|Physician Decision|0|||
23194695|NCT01937130|64456020|FG000|Overall Study|Patients unable to swallow|0|||
23255741|NCT02196506|64676958|FG000|Phase A+|Lost to Follow-up|0|||
23360608|NCT02028507|65065801|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
23478891|NCT00534313|65494675|FG002|Long-term Period|Lack of Efficacy|14|||
23478892|NCT00534313|65494676|FG003|Long-term Period|Lack of Efficacy|12|||
23478893|NCT00534313|65494673|FG000|Long-term Period|Lost to Follow-up|1|||
23478894|NCT00534313|65494674|FG001|Long-term Period|Lost to Follow-up|2|||
23478895|NCT00534313|65494675|FG002|Long-term Period|Lost to Follow-up|0|||
23478896|NCT00534313|65494676|FG003|Long-term Period|Lost to Follow-up|0|||
23478897|NCT00534313|65494673|FG000|Long-term Period|Withdrawal by Subject|2|||
23478898|NCT00534313|65494674|FG001|Long-term Period|Withdrawal by Subject|2|||
23478899|NCT00534313|65494675|FG002|Long-term Period|Withdrawal by Subject|0|||
23194696|NCT01937130|64456021|FG001|Overall Study|Patients unable to swallow|1|||
23478900|NCT00534313|65494676|FG003|Long-term Period|Withdrawal by Subject|0|||
23478901|NCT00534313|65494673|FG000|Long-term Period|No longer meets study criteria|0|||
23478902|NCT00534313|65494674|FG001|Long-term Period|No longer meets study criteria|1|||
23478903|NCT00534313|65494675|FG002|Long-term Period|No longer meets study criteria|0|||
23478904|NCT00534313|65494676|FG003|Long-term Period|No longer meets study criteria|0|||
23478905|NCT00534313|65494673|FG000|Long-term Period|Poor compliance/noncompliance|0|||
23478906|NCT00534313|65494674|FG001|Long-term Period|Poor compliance/noncompliance|1|||
23478907|NCT00534313|65494675|FG002|Long-term Period|Poor compliance/noncompliance|1|||
23478908|NCT00534313|65494676|FG003|Long-term Period|Poor compliance/noncompliance|0|||
23478909|NCT00534313|65494673|FG000|Long-term Period|Administrative reason by sponsor|17|||
23478910|NCT00534313|65494674|FG001|Long-term Period|Administrative reason by sponsor|15|||
23478911|NCT00534313|65494675|FG002|Long-term Period|Administrative reason by sponsor|26|||
23478912|NCT00534313|65494676|FG003|Long-term Period|Administrative reason by sponsor|18|||
23478913|NCT00534313|65494673|FG000|Long-term Period|Other|1|||
23478914|NCT00534313|65494674|FG001|Long-term Period|Other|2|||
23478915|NCT00534313|65494675|FG002|Long-term Period|Other|2|||
23478916|NCT00534313|65494676|FG003|Long-term Period|Other|2|||
23478917|NCT01966432|65494677|FG000|Overall Study|Lost to Follow-up|3|||
23478918|NCT01966432|65494678|FG001|Overall Study|Lost to Follow-up|2|||
23255742|NCT02196506|64676959|FG001|Phase A+|Lost to Follow-up|0|||
23478919|NCT01966432|65494679|FG002|Overall Study|Lost to Follow-up|5|||
23478920|NCT01966432|65494677|FG000|Overall Study|Withdrawal by Subject|1|||
23478921|NCT01966432|65494678|FG001|Overall Study|Withdrawal by Subject|3|||
23478922|NCT01966432|65494679|FG002|Overall Study|Withdrawal by Subject|0|||
23194697|NCT01937130|64456022|FG002|Overall Study|Patients unable to swallow|0|||
23194698|NCT01937130|64456023|FG003|Overall Study|Patients unable to swallow|0|||
23478923|NCT01966432|65494677|FG000|Overall Study|Subject Incarcerated|0|||
23597859|NCT00421889|65919276|FG008|Overall Study|Patient/Investigator request|3|||
23360609|NCT02028507|65065802|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
23360610|NCT02028507|65065803|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
23360611|NCT02028507|65065804|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
23360612|NCT02028507|65065801|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
23360613|NCT02028507|65065802|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
23360614|NCT02028507|65065803|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
23360615|NCT02028507|65065804|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
23360616|NCT04613739|65065805|FG000|Overall Study|Lost to Follow-up|6|||
23478924|NCT01966432|65494678|FG001|Overall Study|Subject Incarcerated|0|||
23255743|NCT02196506|64676960|FG002|Phase A+|Lost to Follow-up|0|||
23255744|NCT02196506|64676961|FG003|Phase A+|Lost to Follow-up|6|||
23255745|NCT02196506|64676958|FG000|Phase A+|Participant withdrawn by investigator|0|||
23255746|NCT02196506|64676959|FG001|Phase A+|Participant withdrawn by investigator|0|||
23478925|NCT01966432|65494679|FG002|Overall Study|Subject Incarcerated|1|||
23194699|NCT01937130|64456020|FG000|Overall Study|Patient lost to FU due to death|2|||
23194700|NCT01937130|64456021|FG001|Overall Study|Patient lost to FU due to death|0|||
23194701|NCT01937130|64456022|FG002|Overall Study|Patient lost to FU due to death|0|||
23194702|NCT01937130|64456023|FG003|Overall Study|Patient lost to FU due to death|0|||
23194703|NCT01743027|64456029|FG000|Overall Study|Adverse Event|2|||
23194704|NCT01743027|64456030|FG001|Overall Study|Adverse Event|0|||
23194705|NCT01743027|64456031|FG002|Overall Study|Adverse Event|0|||
23194706|NCT01743027|64456032|FG003|Overall Study|Adverse Event|0|||
23194707|NCT01743027|64456029|FG000|Overall Study|Lost to Follow-up|0|||
23194708|NCT01743027|64456030|FG001|Overall Study|Lost to Follow-up|0|||
23194709|NCT01743027|64456031|FG002|Overall Study|Lost to Follow-up|2|||
23194710|NCT01743027|64456032|FG003|Overall Study|Lost to Follow-up|0|||
23194711|NCT01743027|64456029|FG000|Overall Study|Progressive Disease|1|||
23194712|NCT01743027|64456030|FG001|Overall Study|Progressive Disease|4|||
23194713|NCT01743027|64456031|FG002|Overall Study|Progressive Disease|3|||
23194714|NCT01743027|64456032|FG003|Overall Study|Progressive Disease|0|||
23194715|NCT01743027|64456029|FG000|Overall Study|Protocol Violation|1|||
23194716|NCT01743027|64456030|FG001|Overall Study|Protocol Violation|1|||
23194717|NCT01743027|64456031|FG002|Overall Study|Protocol Violation|1|||
23194718|NCT01743027|64456032|FG003|Overall Study|Protocol Violation|0|||
23194719|NCT01743027|64456029|FG000|Overall Study|Withdrawal by Subject|1|||
23194720|NCT01743027|64456030|FG001|Overall Study|Withdrawal by Subject|0|||
23194721|NCT01743027|64456031|FG002|Overall Study|Withdrawal by Subject|3|||
23597860|NCT00421889|65919268|FG000|Overall Study|Lost to Follow-up|0|||
23597861|NCT00421889|65919269|FG001|Overall Study|Lost to Follow-up|0|||
23597862|NCT00421889|65919270|FG002|Overall Study|Lost to Follow-up|0|||
23597863|NCT00421889|65919271|FG003|Overall Study|Lost to Follow-up|0|||
23597864|NCT00421889|65919272|FG004|Overall Study|Lost to Follow-up|0|||
23597865|NCT00421889|65919273|FG005|Overall Study|Lost to Follow-up|0|||
23597866|NCT00421889|65919274|FG006|Overall Study|Lost to Follow-up|0|||
23597867|NCT00421889|65919275|FG007|Overall Study|Lost to Follow-up|0|||
23597868|NCT00421889|65919276|FG008|Overall Study|Lost to Follow-up|1|||
23597869|NCT03803475|65919279|FG000|Overall Study|Physician Decision|1|||
23597870|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
23597871|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
23597872|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
23597873|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
23597874|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
23597875|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
23597876|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
23597877|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
23597878|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597879|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597880|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597881|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597882|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
23597883|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
23597884|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597885|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
23597886|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597887|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597888|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597889|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597890|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597891|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
23597892|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
23597893|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
23597894|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597895|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
23597896|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597897|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597898|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597899|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597900|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597901|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
23597902|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597903|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597904|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597905|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
23597906|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
23597907|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597908|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597909|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
23597910|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597911|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597912|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597913|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
23597914|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597915|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597916|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597917|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
23597918|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
23597919|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
23597920|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
23597921|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
23597922|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
23597923|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
23597924|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
23597925|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
23597926|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
23597927|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597928|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597929|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597930|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597931|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
23597932|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597933|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
23597934|NCT03903822|65919282|FG000|Treatment Phase (6 Weeks)|Other|2|||
23597935|NCT03903822|65919283|FG001|Treatment Phase (6 Weeks)|Other|1|||
23597936|NCT03903822|65919284|FG002|Treatment Phase (6 Weeks)|Other|0|||
23597937|NCT03903822|65919285|FG003|Treatment Phase (6 Weeks)|Other|0|||
23597938|NCT03903822|65919286|FG004|Treatment Phase (6 Weeks)|Other|1|||
23597939|NCT03903822|65919287|FG005|Treatment Phase (6 Weeks)|Other|1|||
23597940|NCT03903822|65919288|FG006|Treatment Phase (6 Weeks)|Other|0|||
23597941|NCT03903822|65919289|FG007|Treatment Phase (6 Weeks)|Other|0|||
23597942|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
23597943|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
23597944|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
23597945|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
23597946|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
23597947|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
23597948|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
23597949|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
23597950|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597951|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597952|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597953|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597954|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
23597955|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597956|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597957|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
23597958|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
23597959|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597960|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597961|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597962|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597963|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
23597964|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
23597965|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
23597966|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597967|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597968|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597969|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
23597970|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
23597971|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597972|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597973|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
23597974|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
23597975|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
23597976|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
23597977|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
23597978|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
23597979|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
23597980|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
23597981|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
23597982|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597983|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597984|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597985|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597986|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597987|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
23597988|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597989|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
23597990|NCT03903822|65919282|FG000|Follow up Phase (4 Weeks)|Other|1|||
23597991|NCT03903822|65919283|FG001|Follow up Phase (4 Weeks)|Other|1|||
23597992|NCT03903822|65919284|FG002|Follow up Phase (4 Weeks)|Other|0|||
23597993|NCT03903822|65919285|FG003|Follow up Phase (4 Weeks)|Other|0|||
23597994|NCT03903822|65919286|FG004|Follow up Phase (4 Weeks)|Other|0|||
23194722|NCT01743027|64456032|FG003|Overall Study|Withdrawal by Subject|1|||
23194723|NCT01671085|64456033|FG000|Overall Study|Withdrawal by Subject|1|||
23194724|NCT01671085|64456034|FG001|Overall Study|Withdrawal by Subject|0|||
23194725|NCT02114203|64456036|FG000|Overall Study|Adverse Event|0|||
23194726|NCT02114203|64456037|FG001|Overall Study|Adverse Event|1|||
23597995|NCT03903822|65919287|FG005|Follow up Phase (4 Weeks)|Other|0|||
23597996|NCT03903822|65919288|FG006|Follow up Phase (4 Weeks)|Other|0|||
23597997|NCT03903822|65919289|FG007|Follow up Phase (4 Weeks)|Other|0|||
23597998|NCT00818246|65919290|FG000|Overall Study|Impossible to match pictures|5|||
23597999|NCT02500758|65919291|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
23598000|NCT02500758|65919292|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
23598001|NCT02500758|65919291|FG000|Washout (1 Week)|Lost to Follow-up|2|||
23194727|NCT02114203|64456038|FG002|Overall Study|Adverse Event|0|||
23255747|NCT02196506|64676960|FG002|Phase A+|Participant withdrawn by investigator|0|||
23255748|NCT02196506|64676961|FG003|Phase A+|Participant withdrawn by investigator|1|||
23255749|NCT02323295|64676962|FG000|Overall Study|Adverse Event|0|||
23255750|NCT02323295|64676963|FG001|Overall Study|Adverse Event|1|||
23255751|NCT02323295|64676962|FG000|Overall Study|Withdrawal by Subject|0|||
23255752|NCT02323295|64676963|FG001|Overall Study|Withdrawal by Subject|1|||
23255753|NCT02323295|64676962|FG000|Overall Study|Patient did not have surgery as planned.|0|||
23255754|NCT02323295|64676963|FG001|Overall Study|Patient did not have surgery as planned.|1|||
23255755|NCT00771901|64676965|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
23255756|NCT00771901|64676966|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
23255757|NCT00771901|64676967|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
23255758|NCT01416142|64676968|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
23255759|NCT01416142|64676969|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
23255760|NCT01416142|64676970|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
23255761|NCT02092961|64676977|FG000|Overall Study|Not reported|1|||
23255762|NCT02092961|64676978|FG001|Overall Study|Not reported|0|||
23255763|NCT02092961|64676979|FG002|Overall Study|Not reported|1|||
23255764|NCT02092961|64676977|FG000|Overall Study|Study stopped|13|||
23255765|NCT02092961|64676978|FG001|Overall Study|Study stopped|9|||
23255766|NCT02092961|64676979|FG002|Overall Study|Study stopped|12|||
23255767|NCT02092961|64676977|FG000|Overall Study|Lack of therapeutic response|2|||
23255768|NCT02092961|64676978|FG001|Overall Study|Lack of therapeutic response|1|||
23255769|NCT02092961|64676979|FG002|Overall Study|Lack of therapeutic response|3|||
23255770|NCT02092961|64676977|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
23255771|NCT02092961|64676978|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
23255772|NCT02092961|64676979|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
23255773|NCT02092961|64676977|FG000|Overall Study|Adverse Event|2|||
23255774|NCT02092961|64676978|FG001|Overall Study|Adverse Event|4|||
23478926|NCT01966432|65494677|FG000|Overall Study|SBIRT program ended|1|||
23478927|NCT01966432|65494678|FG001|Overall Study|SBIRT program ended|8|||
23478928|NCT01966432|65494679|FG002|Overall Study|SBIRT program ended|20|||
23478929|NCT00388583|65494680|FG000|Overall Study|Protocol Violation|1|||
23478930|NCT00388583|65494681|FG001|Overall Study|Protocol Violation|0|||
23478931|NCT00388583|65494680|FG000|Overall Study|Withdrawal by Subject|3|||
23478932|NCT00388583|65494681|FG001|Overall Study|Withdrawal by Subject|3|||
23478933|NCT00388583|65494680|FG000|Overall Study|Serious Adverse Event|2|||
23478934|NCT00388583|65494681|FG001|Overall Study|Serious Adverse Event|0|||
23478935|NCT00388583|65494680|FG000|Overall Study|Did not receive vaccine|0|||
23478936|NCT00388583|65494681|FG001|Overall Study|Did not receive vaccine|1|||
23478937|NCT03104816|65498297|FG000|Overall Study|Lack of Efficacy|0|||
23478938|NCT03104816|65498298|FG001|Overall Study|Lack of Efficacy|2|||
23478939|NCT03104816|65498299|FG002|Overall Study|Lack of Efficacy|0|||
23478940|NCT03104816|65498297|FG000|Overall Study|Protocol Violation|2|||
23478941|NCT03104816|65498298|FG001|Overall Study|Protocol Violation|0|||
23478942|NCT03104816|65498299|FG002|Overall Study|Protocol Violation|2|||
23255775|NCT02092961|64676979|FG002|Overall Study|Adverse Event|0|||
23478943|NCT01350544|65498304|FG000|Overall Study|Administrative Withdrawal|0|||
23478944|NCT01350544|65498305|FG001|Overall Study|Administrative Withdrawal|1|||
23478945|NCT01350544|65498304|FG000|Overall Study|Death|1|||
23478946|NCT01350544|65498305|FG001|Overall Study|Death|2|||
23478947|NCT01350544|65498304|FG000|Overall Study|Moved out of LA County|2|||
23255776|NCT00123487|64676980|FG000|Randomized|Death prior to starting treatment|0|||
23255777|NCT00123487|64676981|FG001|Randomized|Death prior to starting treatment|1|||
23255778|NCT00123487|64676980|FG000|Randomized|SAE prior to starting treatment|1|||
23255779|NCT00123487|64676981|FG001|Randomized|SAE prior to starting treatment|0|||
23255780|NCT00123487|64676980|FG000|Treated With Study Drug|Adverse Event|23|||
23255781|NCT00123487|64676981|FG001|Treated With Study Drug|Adverse Event|22|||
23255782|NCT00123487|64676980|FG000|Treated With Study Drug|Disease Progression|141|||
23255783|NCT00123487|64676981|FG001|Treated With Study Drug|Disease Progression|122|||
23255784|NCT00123487|64676980|FG000|Treated With Study Drug|Physician Decision|8|||
23255785|NCT00123487|64676981|FG001|Treated With Study Drug|Physician Decision|9|||
23194728|NCT02114203|64456036|FG000|Overall Study|Withdrawal by Subject|0|||
23194729|NCT02114203|64456037|FG001|Overall Study|Withdrawal by Subject|1|||
23194730|NCT02114203|64456038|FG002|Overall Study|Withdrawal by Subject|0|||
23194731|NCT03290300|64456041|FG000|Overall Study|Lost to Follow-up|3|||
23194732|NCT01070550|64456044|FG000|Overall Study|Adverse Event|43|||
23194733|NCT01070550|64456045|FG001|Overall Study|Adverse Event|1|||
23194734|NCT01070550|64456046|FG002|Overall Study|Adverse Event|3|||
23194735|NCT01070550|64456047|FG003|Overall Study|Adverse Event|0|||
23194736|NCT01070550|64456048|FG004|Overall Study|Adverse Event|0|||
23194737|NCT01070550|64456049|FG005|Overall Study|Adverse Event|0|||
23194738|NCT01070550|64456044|FG000|Overall Study|Death|20|||
23194739|NCT01070550|64456045|FG001|Overall Study|Death|4|||
23194740|NCT01070550|64456046|FG002|Overall Study|Death|3|||
23194741|NCT01070550|64456047|FG003|Overall Study|Death|0|||
23194742|NCT01070550|64456048|FG004|Overall Study|Death|0|||
23194743|NCT01070550|64456049|FG005|Overall Study|Death|0|||
23194744|NCT01070550|64456044|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
23194745|NCT01070550|64456045|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23194746|NCT01070550|64456046|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23194747|NCT01070550|64456047|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23194748|NCT01070550|64456048|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23194749|NCT01070550|64456049|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23194750|NCT01070550|64456044|FG000|Overall Study|Early termination|3|||
23194751|NCT01070550|64456045|FG001|Overall Study|Early termination|0|||
23194752|NCT01070550|64456046|FG002|Overall Study|Early termination|0|||
23194753|NCT01070550|64456047|FG003|Overall Study|Early termination|0|||
23194754|NCT01070550|64456048|FG004|Overall Study|Early termination|0|||
23194755|NCT01070550|64456049|FG005|Overall Study|Early termination|0|||
23194756|NCT01070550|64456044|FG000|Overall Study|Failed to return|450|||
23194757|NCT01070550|64456045|FG001|Overall Study|Failed to return|33|||
23194758|NCT01070550|64456046|FG002|Overall Study|Failed to return|144|||
23194759|NCT01070550|64456047|FG003|Overall Study|Failed to return|40|||
23194760|NCT01070550|64456048|FG004|Overall Study|Failed to return|1|||
23255786|NCT00123487|64676980|FG000|Treated With Study Drug|Other|59|||
23255787|NCT00123487|64676981|FG001|Treated With Study Drug|Other|58|||
23255788|NCT00123487|64676980|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
23255789|NCT00123487|64676981|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
23255790|NCT00123487|64676980|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
23194761|NCT01070550|64456049|FG005|Overall Study|Failed to return|2|||
23194762|NCT01070550|64456044|FG000|Overall Study|Incomplete treatment|2|||
23194763|NCT01070550|64456045|FG001|Overall Study|Incomplete treatment|0|||
23194764|NCT01070550|64456046|FG002|Overall Study|Incomplete treatment|0|||
23598002|NCT02500758|65919292|FG001|Washout (1 Week)|Lost to Follow-up|2|||
23598003|NCT02500758|65919291|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
23598004|NCT02500758|65919292|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
23598005|NCT02500758|65919291|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
23598006|NCT02500758|65919292|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
23598007|NCT02500758|65919291|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
23598008|NCT02500758|65919292|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
23255791|NCT00123487|64676981|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
23255792|NCT00123487|64676980|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
23255793|NCT00123487|64676981|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
23478948|NCT01350544|65498305|FG001|Overall Study|Moved out of LA County|2|||
23598009|NCT00448669|65919297|FG000|Overall Study|Lost to Follow-up|52|||
23194765|NCT01070550|64456047|FG003|Overall Study|Incomplete treatment|0|||
23598010|NCT00448669|65919298|FG001|Overall Study|Lost to Follow-up|63|||
23598011|NCT00448669|65919297|FG000|Overall Study|Withdrawal by Subject|90|||
23598012|NCT00448669|65919298|FG001|Overall Study|Withdrawal by Subject|74|||
23598013|NCT00448669|65919297|FG000|Overall Study|Relocated|49|||
23598014|NCT00448669|65919298|FG001|Overall Study|Relocated|36|||
23598015|NCT00448669|65919297|FG000|Overall Study|Were withdrawn by investigator|10|||
23598016|NCT00448669|65919298|FG001|Overall Study|Were withdrawn by investigator|6|||
23598017|NCT00448669|65919297|FG000|Overall Study|Death|2|||
23598018|NCT00448669|65919298|FG001|Overall Study|Death|4|||
23598019|NCT00448669|65919297|FG000|Overall Study|Had other reasons|5|||
23598020|NCT00448669|65919298|FG001|Overall Study|Had other reasons|6|||
23598021|NCT00448669|65919297|FG000|Overall Study|HIV-infected at enrollment|1|||
23598022|NCT00448669|65919298|FG001|Overall Study|HIV-infected at enrollment|2|||
23598023|NCT00448669|65919297|FG000|Overall Study|Never started drug|9|||
23598024|NCT00448669|65919298|FG001|Overall Study|Never started drug|7|||
23598025|NCT00220740|65919302|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
23598026|NCT00220740|65919303|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
23598027|NCT00220740|65919302|FG000|Efficacy Period|Adverse Event|1|||
23598028|NCT00220740|65919303|FG001|Efficacy Period|Adverse Event|1|||
23598029|NCT00220740|65919302|FG000|Efficacy Period|Withdrawal by Subject|1|||
23598030|NCT00220740|65919303|FG001|Efficacy Period|Withdrawal by Subject|0|||
23598031|NCT00220740|65919302|FG000|Efficacy Period|Protocol Violation|1|||
23598032|NCT00220740|65919303|FG001|Efficacy Period|Protocol Violation|0|||
23598033|NCT00220740|65919302|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
23598034|NCT00220740|65919303|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
23598035|NCT02910713|65919306|FG000|Overall Study|Protocol Violation|2|||
23598036|NCT02910713|65919306|FG000|Overall Study|Subject Choice|4|||
23598037|NCT02910713|65919306|FG000|Overall Study|Received One Application|10|||
23598038|NCT02910713|65919306|FG000|Overall Study|Received Neither Application|18|||
23598039|NCT02910713|65919306|FG000|Overall Study|Enrollment cap|7|||
23598040|NCT02910713|65919306|FG000|Overall Study|Investigator Discretion|1|||
23598041|NCT02374463|65919308|FG000|Overall Study|Withdrawal by Subject|3|||
23598042|NCT02374463|65919309|FG001|Overall Study|Withdrawal by Subject|3|||
23598043|NCT00431834|65919313|FG000|Overall Study|Withdrawal by Subject|7|||
23598044|NCT00431834|65919313|FG000|Overall Study|Death|3|||
23598045|NCT00431834|65919313|FG000|Overall Study|Missed Endpoint Visit|2|||
23598046|NCT00431834|65919313|FG000|Overall Study|Lost to Follow-up|1|||
23598047|NCT00505934|65919314|FG000|Overall Study|Adverse Event|1|||
23598048|NCT00505934|65919314|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
23598049|NCT00505934|65919314|FG000|Overall Study|Other: IV dose needed to be changed|1|||
23598050|NCT04638816|65919317|FG000|Overall Study|Withdrawal by Subject|0|||
23598051|NCT04638816|65919318|FG001|Overall Study|Withdrawal by Subject|1|||
23598052|NCT04638816|65919317|FG000|Overall Study|Lost to Follow-up|0|||
23598053|NCT04638816|65919318|FG001|Overall Study|Lost to Follow-up|1|||
23598054|NCT04436289|65919321|FG000|Overall Study|Death prior to hospital discharge|8|||
23598055|NCT04436289|65919322|FG001|Overall Study|Death prior to hospital discharge|5|||
23598056|NCT04436289|65919323|FG002|Overall Study|Death prior to hospital discharge|0|||
23598057|NCT04436289|65919324|FG003|Overall Study|Death prior to hospital discharge|1|||
23194766|NCT01070550|64456048|FG004|Overall Study|Incomplete treatment|0|||
23598058|NCT04436289|65919321|FG000|Overall Study|Withdrawal by Subject|0|||
23598059|NCT04436289|65919322|FG001|Overall Study|Withdrawal by Subject|1|||
23598060|NCT04436289|65919323|FG002|Overall Study|Withdrawal by Subject|4|||
23598061|NCT04436289|65919324|FG003|Overall Study|Withdrawal by Subject|0|||
23598062|NCT04436289|65919321|FG000|Overall Study|Extended hospital stay|0|||
23598063|NCT04436289|65919322|FG001|Overall Study|Extended hospital stay|1|||
23598064|NCT04436289|65919323|FG002|Overall Study|Extended hospital stay|0|||
23598065|NCT04436289|65919324|FG003|Overall Study|Extended hospital stay|0|||
23598066|NCT04436289|65919321|FG000|Overall Study|Lost to Follow-up|0|||
23598067|NCT04436289|65919322|FG001|Overall Study|Lost to Follow-up|4|||
23598068|NCT04436289|65919323|FG002|Overall Study|Lost to Follow-up|1|||
23478949|NCT01350544|65498304|FG000|Overall Study|Medical Issues|1|||
23478950|NCT01350544|65498305|FG001|Overall Study|Medical Issues|1|||
23478951|NCT01350544|65498304|FG000|Overall Study|Withdrawal by Subject|0|||
23478952|NCT01350544|65498305|FG001|Overall Study|Withdrawal by Subject|1|||
23478953|NCT01350544|65498304|FG000|Overall Study|Incarceration|1|||
23478954|NCT01350544|65498305|FG001|Overall Study|Incarceration|0|||
23478955|NCT01350544|65498304|FG000|Overall Study|Lost to Follow-up|18|||
23478956|NCT01350544|65498305|FG001|Overall Study|Lost to Follow-up|15|||
23478957|NCT02282293|65498306|FG000|Overall Study|Lost to Follow-up|2|||
23478958|NCT02282293|65498307|FG001|Overall Study|Lost to Follow-up|2|||
23478959|NCT02282293|65498306|FG000|Overall Study|Unable to comply with study procedures|1|||
23478960|NCT02282293|65498307|FG001|Overall Study|Unable to comply with study procedures|0|||
23478961|NCT02282293|65498306|FG000|Overall Study|Moved out of study area|0|||
23478962|NCT02282293|65498307|FG001|Overall Study|Moved out of study area|1|||
23478963|NCT02386189|65498312|FG000|Overall Study|Lost to Follow-up|2|||
23478964|NCT02386189|65498313|FG001|Overall Study|Lost to Follow-up|3|||
23478965|NCT02386189|65498312|FG000|Overall Study|Withdrawal by Subject|1|||
23478966|NCT02386189|65498313|FG001|Overall Study|Withdrawal by Subject|0|||
23478967|NCT02386189|65498312|FG000|Overall Study|Death|1|||
23478968|NCT02386189|65498313|FG001|Overall Study|Death|0|||
23478969|NCT01144299|65498314|FG000|Overall Study|Lost to Follow-up|1|||
23478970|NCT01144299|65498315|FG001|Overall Study|Lost to Follow-up|0|||
23478971|NCT01144299|65498314|FG000|Overall Study|Withdrawal by Subject|1|||
23478972|NCT01144299|65498315|FG001|Overall Study|Withdrawal by Subject|0|||
23478973|NCT00952380|65498316|FG000|Overall Study|Other|0|||
23478974|NCT00952380|65498317|FG001|Overall Study|Other|0|||
23478975|NCT00952380|65498318|FG002|Overall Study|Other|0|||
23478976|NCT00952380|65498319|FG003|Overall Study|Other|0|||
23478977|NCT00952380|65498320|FG004|Overall Study|Other|1|||
23478978|NCT00952380|65498316|FG000|Overall Study|Withdrawal by Subject|0|||
23478979|NCT00952380|65498317|FG001|Overall Study|Withdrawal by Subject|0|||
23478980|NCT00952380|65498318|FG002|Overall Study|Withdrawal by Subject|1|||
23478981|NCT00952380|65498319|FG003|Overall Study|Withdrawal by Subject|0|||
23478982|NCT00952380|65498320|FG004|Overall Study|Withdrawal by Subject|2|||
23478983|NCT00952380|65498316|FG000|Overall Study|Adverse Event|0|||
23478984|NCT00952380|65498317|FG001|Overall Study|Adverse Event|1|||
23478985|NCT00952380|65498318|FG002|Overall Study|Adverse Event|0|||
23478986|NCT00952380|65498319|FG003|Overall Study|Adverse Event|0|||
23478987|NCT00952380|65498320|FG004|Overall Study|Adverse Event|3|||
23478988|NCT00952380|65498316|FG000|Overall Study|Physician Decision|0|||
23478989|NCT00952380|65498317|FG001|Overall Study|Physician Decision|0|||
23478990|NCT00952380|65498318|FG002|Overall Study|Physician Decision|1|||
23478991|NCT00952380|65498319|FG003|Overall Study|Physician Decision|2|||
23478992|NCT00952380|65498320|FG004|Overall Study|Physician Decision|0|||
23598069|NCT04436289|65919324|FG003|Overall Study|Lost to Follow-up|3|||
23598070|NCT00975585|65919333|FG000|Overall Study|Adverse Event|0|||
23598071|NCT00975585|65919334|FG001|Overall Study|Adverse Event|4|||
23598072|NCT00975585|65919333|FG000|Overall Study|Lost to Follow-up|3|||
23598073|NCT00975585|65919334|FG001|Overall Study|Lost to Follow-up|5|||
23598074|NCT00975585|65919333|FG000|Overall Study|Withdrawal by Subject|2|||
23598075|NCT00975585|65919334|FG001|Overall Study|Withdrawal by Subject|1|||
23598076|NCT00975585|65919333|FG000|Overall Study|Lens issue|2|||
23598077|NCT00975585|65919334|FG001|Overall Study|Lens issue|2|||
23598078|NCT03764475|65919335|FG000|Overall Study|Adverse Event|11|||
23598079|NCT03764475|65919336|FG001|Overall Study|Adverse Event|2|||
23598080|NCT03764475|65919335|FG000|Overall Study|Lost to Follow-up|24|||
23598081|NCT03764475|65919336|FG001|Overall Study|Lost to Follow-up|10|||
23255794|NCT03705169|64676983|FG000|Overall Study|Lost to Follow-up|0|||
23255795|NCT03705169|64676984|FG001|Overall Study|Lost to Follow-up|0|||
23255796|NCT03705169|64676985|FG002|Overall Study|Lost to Follow-up|0|||
23255797|NCT03705169|64676986|FG003|Overall Study|Lost to Follow-up|2|||
23255798|NCT03705169|64676987|FG004|Overall Study|Lost to Follow-up|0|||
23255799|NCT03705169|64676988|FG005|Overall Study|Lost to Follow-up|2|||
23255800|NCT03705169|64676989|FG006|Overall Study|Lost to Follow-up|1|||
23478993|NCT00952380|65498316|FG000|Overall Study|Non-compliant to protocol|0|||
23478994|NCT00952380|65498317|FG001|Overall Study|Non-compliant to protocol|0|||
23478995|NCT00952380|65498318|FG002|Overall Study|Non-compliant to protocol|0|||
23478996|NCT00952380|65498319|FG003|Overall Study|Non-compliant to protocol|1|||
23255801|NCT03705169|64676990|FG007|Overall Study|Lost to Follow-up|0|||
23478997|NCT00952380|65498320|FG004|Overall Study|Non-compliant to protocol|0|||
23478998|NCT02586506|65498334|FG000|Overall Study|Protocol Violation|6|||
23478999|NCT02586506|65498334|FG000|Overall Study|Lost to Follow-up|1|||
23598082|NCT03764475|65919335|FG000|Overall Study|Withdrawal by Subject|26|||
23598083|NCT03764475|65919336|FG001|Overall Study|Withdrawal by Subject|10|||
23598084|NCT03764475|65919335|FG000|Overall Study|Lack of Efficacy|3|||
23598085|NCT03764475|65919336|FG001|Overall Study|Lack of Efficacy|0|||
23598086|NCT03764475|65919335|FG000|Overall Study|COVID-19 Disruption|2|||
23598087|NCT03764475|65919336|FG001|Overall Study|COVID-19 Disruption|0|||
23598088|NCT02291913|65919337|FG000|Overall Study|Progressive Disease|32|||
23598089|NCT02291913|65919337|FG000|Overall Study|Adverse Event|11|||
23598090|NCT02291913|65919337|FG000|Overall Study|Death|2|||
23598091|NCT02291913|65919337|FG000|Overall Study|Physician Decision|1|||
23598092|NCT02291913|65919337|FG000|Overall Study|Withdrawal by Subject|1|||
23598093|NCT02291913|65919337|FG000|Overall Study|Protocol Violation|1|||
23598094|NCT03283371|65919338|FG000|Placebo-controlled|Adverse Event|1|||
23598095|NCT03283371|65919339|FG001|Placebo-controlled|Adverse Event|1|||
23598096|NCT03283371|65919340|FG002|Placebo-controlled|Adverse Event|0|||
23598097|NCT03283371|65919341|FG003|Placebo-controlled|Adverse Event|0|||
23598098|NCT03283371|65919338|FG000|Placebo-controlled|Lack of Efficacy|1|||
23598099|NCT03283371|65919339|FG001|Placebo-controlled|Lack of Efficacy|0|||
23598100|NCT03283371|65919340|FG002|Placebo-controlled|Lack of Efficacy|0|||
23598101|NCT03283371|65919341|FG003|Placebo-controlled|Lack of Efficacy|0|||
23598102|NCT03283371|65919338|FG000|Placebo-controlled|Withdrawal by Subject|1|||
23598103|NCT03283371|65919339|FG001|Placebo-controlled|Withdrawal by Subject|1|||
23598104|NCT03283371|65919340|FG002|Placebo-controlled|Withdrawal by Subject|0|||
23598105|NCT03283371|65919341|FG003|Placebo-controlled|Withdrawal by Subject|0|||
23598106|NCT03283371|65919338|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
23598107|NCT03283371|65919339|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
23598108|NCT03283371|65919340|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
23598109|NCT03283371|65919341|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
23598110|NCT03283371|65919338|FG000|Open-label Phase|Adverse Event|0|||
23598111|NCT03283371|65919339|FG001|Open-label Phase|Adverse Event|0|||
23598112|NCT03283371|65919340|FG002|Open-label Phase|Adverse Event|2|||
23598113|NCT03283371|65919341|FG003|Open-label Phase|Adverse Event|0|||
23598114|NCT03283371|65919338|FG000|Open-label Phase|Withdrawal by Subject|0|||
23598115|NCT03283371|65919339|FG001|Open-label Phase|Withdrawal by Subject|0|||
23598116|NCT03283371|65919340|FG002|Open-label Phase|Withdrawal by Subject|1|||
23598117|NCT03283371|65919341|FG003|Open-label Phase|Withdrawal by Subject|0|||
23598118|NCT03283371|65919338|FG000|Open-label Phase|Other|0|||
23598119|NCT03283371|65919339|FG001|Open-label Phase|Other|0|||
23598120|NCT03283371|65919340|FG002|Open-label Phase|Other|1|||
23598121|NCT03283371|65919341|FG003|Open-label Phase|Other|1|||
23598122|NCT01737021|65919342|FG000|Overall Study|Lost to Follow-up|5|||
23598123|NCT01737021|65919343|FG001|Overall Study|Lost to Follow-up|3|||
23598124|NCT00931710|65919346|FG000|Overall Study|Adverse Event|16|||
23598125|NCT00931710|65919347|FG001|Overall Study|Adverse Event|10|||
23598126|NCT00931710|65919346|FG000|Overall Study|Abnormal test procedure results|2|||
23598127|NCT00931710|65919347|FG001|Overall Study|Abnormal test procedure results|0|||
23598128|NCT00931710|65919346|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
23598129|NCT00931710|65919347|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
23598130|NCT00931710|65919346|FG000|Overall Study|Patient withdrew consent|4|||
23598131|NCT00931710|65919347|FG001|Overall Study|Patient withdrew consent|9|||
23598132|NCT00931710|65919346|FG000|Overall Study|Lost to Follow-up|6|||
23598133|NCT00931710|65919347|FG001|Overall Study|Lost to Follow-up|5|||
23598134|NCT00931710|65919346|FG000|Overall Study|Protocol deviation|1|||
23598135|NCT00931710|65919347|FG001|Overall Study|Protocol deviation|2|||
23598136|NCT01972724|65919350|FG000|Double-Blind|Rescue Criteria Met|1|||
23598137|NCT01972724|65919351|FG001|Double-Blind|Rescue Criteria Met|0|||
23598138|NCT01972724|65919352|FG002|Double-Blind|Rescue Criteria Met|0|||
23598139|NCT01972724|65919350|FG000|Double-Blind|Adverse Event|1|||
23598140|NCT01972724|65919351|FG001|Double-Blind|Adverse Event|0|||
23598141|NCT01972724|65919352|FG002|Double-Blind|Adverse Event|0|||
23598142|NCT01972724|65919350|FG000|Double-Blind|Withdrawal of Consent|2|||
23598143|NCT01972724|65919351|FG001|Double-Blind|Withdrawal of Consent|1|||
23598144|NCT01972724|65919352|FG002|Double-Blind|Withdrawal of Consent|0|||
23598145|NCT01972724|65919350|FG000|Double-Blind|Significant Protocol Deviation|5|||
23598146|NCT01972724|65919351|FG001|Double-Blind|Significant Protocol Deviation|8|||
23598147|NCT01972724|65919352|FG002|Double-Blind|Significant Protocol Deviation|0|||
23598148|NCT01972724|65919350|FG000|Open-Label|Withdrew Consent|0|||
23598149|NCT01972724|65919351|FG001|Open-Label|Withdrew Consent|0|||
23598150|NCT01972724|65919352|FG002|Open-Label|Withdrew Consent|3|||
23598151|NCT01972724|65919350|FG000|Open-Label|Significant Protocol Deviation|0|||
23598152|NCT01972724|65919351|FG001|Open-Label|Significant Protocol Deviation|0|||
23598153|NCT01972724|65919352|FG002|Open-Label|Significant Protocol Deviation|2|||
23598154|NCT03785405|65919353|FG000|Overall Study|Adverse Event|16|||
23598155|NCT03785405|65919354|FG001|Overall Study|Adverse Event|1|||
23598156|NCT03785405|65919353|FG000|Overall Study|Death|6|||
23598157|NCT03785405|65919354|FG001|Overall Study|Death|4|||
23598158|NCT03785405|65919353|FG000|Overall Study|Guardian decision|4|||
23598159|NCT03785405|65919354|FG001|Overall Study|Guardian decision|1|||
23598160|NCT03785405|65919353|FG000|Overall Study|Lost to Follow-up|1|||
23598161|NCT03785405|65919354|FG001|Overall Study|Lost to Follow-up|0|||
23598162|NCT03785405|65919353|FG000|Overall Study|Physician Decision|8|||
23598163|NCT03785405|65919354|FG001|Overall Study|Physician Decision|5|||
23598164|NCT03785405|65919353|FG000|Overall Study|Participant decision|2|||
23255802|NCT03705169|64676991|FG008|Overall Study|Lost to Follow-up|0|||
23194767|NCT01070550|64456049|FG005|Overall Study|Incomplete treatment|0|||
23194768|NCT01070550|64456044|FG000|Overall Study|Lab test not done|22|||
23194769|NCT01070550|64456045|FG001|Overall Study|Lab test not done|3|||
23255803|NCT03705169|64676992|FG009|Overall Study|Lost to Follow-up|1|||
23255804|NCT03705169|64676983|FG000|Overall Study|Adverse Event|0|||
23255805|NCT03705169|64676984|FG001|Overall Study|Adverse Event|0|||
23255806|NCT03705169|64676985|FG002|Overall Study|Adverse Event|0|||
23255807|NCT03705169|64676986|FG003|Overall Study|Adverse Event|1|||
23255808|NCT03705169|64676987|FG004|Overall Study|Adverse Event|0|||
23255809|NCT03705169|64676988|FG005|Overall Study|Adverse Event|0|||
23255810|NCT03705169|64676989|FG006|Overall Study|Adverse Event|0|||
23255811|NCT03705169|64676990|FG007|Overall Study|Adverse Event|0|||
23255812|NCT03705169|64676991|FG008|Overall Study|Adverse Event|0|||
23255813|NCT03705169|64676992|FG009|Overall Study|Adverse Event|0|||
23255814|NCT03705169|64676983|FG000|Overall Study|Site Closure|0|||
23255815|NCT03705169|64676984|FG001|Overall Study|Site Closure|0|||
23255816|NCT03705169|64676985|FG002|Overall Study|Site Closure|0|||
23255817|NCT03705169|64676986|FG003|Overall Study|Site Closure|1|||
23255818|NCT03705169|64676987|FG004|Overall Study|Site Closure|0|||
23255819|NCT03705169|64676988|FG005|Overall Study|Site Closure|0|||
23255820|NCT03705169|64676989|FG006|Overall Study|Site Closure|0|||
23194770|NCT01070550|64456046|FG002|Overall Study|Lab test not done|4|||
23194771|NCT01070550|64456047|FG003|Overall Study|Lab test not done|1|||
23194772|NCT01070550|64456048|FG004|Overall Study|Lab test not done|0|||
23194773|NCT01070550|64456049|FG005|Overall Study|Lab test not done|1|||
23194774|NCT01070550|64456044|FG000|Overall Study|Lack of Efficacy|65|||
23194775|NCT01070550|64456045|FG001|Overall Study|Lack of Efficacy|1|||
23194776|NCT01070550|64456046|FG002|Overall Study|Lack of Efficacy|5|||
23194777|NCT01070550|64456047|FG003|Overall Study|Lack of Efficacy|5|||
23194778|NCT01070550|64456048|FG004|Overall Study|Lack of Efficacy|0|||
23255821|NCT03705169|64676990|FG007|Overall Study|Site Closure|0|||
23194779|NCT01070550|64456049|FG005|Overall Study|Lack of Efficacy|1|||
23194780|NCT01070550|64456044|FG000|Overall Study|Miscellaneous|12|||
23194781|NCT01070550|64456045|FG001|Overall Study|Miscellaneous|2|||
23194782|NCT01070550|64456046|FG002|Overall Study|Miscellaneous|3|||
23255822|NCT03705169|64676991|FG008|Overall Study|Site Closure|0|||
23255823|NCT03705169|64676992|FG009|Overall Study|Site Closure|0|||
23598165|NCT03785405|65919354|FG001|Overall Study|Participant decision|0|||
23598166|NCT03785405|65919353|FG000|Overall Study|Other|1|||
23598167|NCT03785405|65919354|FG001|Overall Study|Other|0|||
23598168|NCT03785405|65919353|FG000|Overall Study|No treatment was received|0|||
23598169|NCT03785405|65919354|FG001|Overall Study|No treatment was received|1|||
23598170|NCT02034916|65919356|FG000|Overall Study|Death|39|||
23598171|NCT02034916|65919357|FG001|Overall Study|Death|28|||
23598172|NCT02034916|65919356|FG000|Overall Study|Withdrawal by Subject|2|||
23598173|NCT02034916|65919357|FG001|Overall Study|Withdrawal by Subject|1|||
23598174|NCT02034916|65919356|FG000|Overall Study|Lost to Follow-up|4|||
23598175|NCT02034916|65919357|FG001|Overall Study|Lost to Follow-up|1|||
23598176|NCT02034916|65919356|FG000|Overall Study|Study terminated by sponsor|4|||
23598177|NCT02034916|65919357|FG001|Overall Study|Study terminated by sponsor|5|||
23598178|NCT00914589|65919358|FG000|Overall Study|Adverse Event|1|||
23598179|NCT00914589|65919359|FG001|Overall Study|Adverse Event|0|||
23598180|NCT00914589|65919360|FG002|Overall Study|Adverse Event|1|||
23598181|NCT00914589|65919358|FG000|Overall Study|Protocol Violation|8|||
23598182|NCT00914589|65919359|FG001|Overall Study|Protocol Violation|6|||
23598183|NCT00914589|65919360|FG002|Overall Study|Protocol Violation|3|||
23598184|NCT00914589|65919358|FG000|Overall Study|unclassified|16|||
23598185|NCT00914589|65919359|FG001|Overall Study|unclassified|9|||
23598186|NCT00914589|65919360|FG002|Overall Study|unclassified|7|||
23598187|NCT00914589|65919358|FG000|Overall Study|Death|0|||
23598188|NCT00914589|65919359|FG001|Overall Study|Death|1|||
23598189|NCT00914589|65919360|FG002|Overall Study|Death|1|||
23598190|NCT03644849|65919361|FG000|Overall Study|Lost to Follow-up|1|||
23598191|NCT03644849|65919362|FG001|Overall Study|Lost to Follow-up|3|||
23598192|NCT00087139|65919363|FG000|Overall Study|Adverse Event|18|||
23598193|NCT00087139|65919364|FG001|Overall Study|Adverse Event|17|||
23598194|NCT00087139|65919365|FG002|Overall Study|Adverse Event|13|||
23598195|NCT00087139|65919363|FG000|Overall Study|Death|2|||
23598196|NCT00087139|65919364|FG001|Overall Study|Death|1|||
23598197|NCT00087139|65919365|FG002|Overall Study|Death|0|||
23598198|NCT00087139|65919363|FG000|Overall Study|Withdrawal by Subject|3|||
23598199|NCT00087139|65919364|FG001|Overall Study|Withdrawal by Subject|2|||
23598200|NCT00087139|65919365|FG002|Overall Study|Withdrawal by Subject|2|||
23598201|NCT00087139|65919363|FG000|Overall Study|Physician Decision|1|||
23598202|NCT00087139|65919364|FG001|Overall Study|Physician Decision|1|||
23598203|NCT00087139|65919365|FG002|Overall Study|Physician Decision|1|||
23598204|NCT00087139|65919363|FG000|Overall Study|Disease progression|9|||
23598205|NCT00087139|65919364|FG001|Overall Study|Disease progression|19|||
23598206|NCT00087139|65919365|FG002|Overall Study|Disease progression|12|||
23598207|NCT00087139|65919363|FG000|Overall Study|Ineligible|4|||
23598208|NCT00087139|65919364|FG001|Overall Study|Ineligible|7|||
23598209|NCT00087139|65919365|FG002|Overall Study|Ineligible|4|||
23598210|NCT00087139|65919363|FG000|Overall Study|Symptomatic deterioration|1|||
23598211|NCT00087139|65919364|FG001|Overall Study|Symptomatic deterioration|1|||
23598212|NCT00087139|65919365|FG002|Overall Study|Symptomatic deterioration|3|||
23598213|NCT00087139|65919363|FG000|Overall Study|Use of coumadin|1|||
23598214|NCT00087139|65919364|FG001|Overall Study|Use of coumadin|0|||
23598215|NCT00087139|65919365|FG002|Overall Study|Use of coumadin|0|||
23598216|NCT00087139|65919363|FG000|Overall Study|Response achieved|0|||
23598217|NCT00087139|65919364|FG001|Overall Study|Response achieved|1|||
23598218|NCT00087139|65919365|FG002|Overall Study|Response achieved|0|||
23598219|NCT00087139|65919363|FG000|Overall Study|Extradural disease|0|||
23598220|NCT00087139|65919364|FG001|Overall Study|Extradural disease|0|||
23598221|NCT00087139|65919365|FG002|Overall Study|Extradural disease|1|||
23598222|NCT03892564|65919367|FG000|Overall Study|Withdrawal by Subject|2|||
23360617|NCT04613739|65065806|FG001|Overall Study|Lost to Follow-up|9|||
23598223|NCT00203411|65919368|FG000|Follow-up|Progressive Disease|4|||
23598224|NCT02601820|65919369|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
23598225|NCT02601820|65919369|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
23598226|NCT02601820|65919369|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
23598227|NCT02601820|65919369|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
23598228|NCT00150813|65919370|FG000|Overall Study|Adverse Event|1|||
23598229|NCT00150813|65919370|FG000|Overall Study|Lack of Efficacy|1|||
23598230|NCT00150813|65919370|FG000|Overall Study|Lost to Follow-up|5|||
23598231|NCT00150813|65919370|FG000|Overall Study|Withdrawal by Subject|5|||
23598232|NCT00150813|65919370|FG000|Overall Study|Remission|3|||
23598233|NCT00150813|65919370|FG000|Overall Study|Planned pregancy|1|||
23598234|NCT00150813|65919370|FG000|Overall Study|Switch to commercially available LEV|2|||
23598235|NCT01582100|65919371|FG000|Overall Study|Adverse Event|1|||
23598236|NCT01582100|65919371|FG000|Overall Study|Withdrawal by Subject|1|||
23598237|NCT01808534|65919372|FG000|Overall Study|Disease progression|3|||
23598238|NCT01808534|65919372|FG000|Overall Study|Physician Decision|1|||
23598239|NCT00243503|65919373|FG000|Overall Study|Adverse Event|11|||
23598240|NCT00243503|65919373|FG000|Overall Study|Withdrawal by Subject|1|||
23598241|NCT00243503|65919373|FG000|Overall Study|Lack of Efficacy|44|||
23598242|NCT00243503|65919373|FG000|Overall Study|Death|1|||
23598243|NCT00243503|65919373|FG000|Overall Study|Other|1|||
23598244|NCT00823472|65919374|FG000|Overall Study|Physician Decision|24|||
23598245|NCT00823472|65919375|FG001|Overall Study|Physician Decision|28|||
23598246|NCT03655262|65919376|FG000|Overall Study|Withdrawal by Subject|0|||
23598247|NCT03655262|65919377|FG001|Overall Study|Withdrawal by Subject|0|||
23598248|NCT03655262|65919378|FG002|Overall Study|Withdrawal by Subject|1|||
23598249|NCT05262738|65919379|FG000|Overall Study|Withdrawal by Subject|1|||
23598250|NCT05262738|65919380|FG001|Overall Study|Withdrawal by Subject|0|||
23598251|NCT00093496|65919383|FG000|Overall Study|Protocol Violation|1|||
23598252|NCT00093496|65919384|FG001|Overall Study|Protocol Violation|3|||
23598253|NCT02647905|65919385|FG000|Overall Study|Lost to Follow-up|1|||
23598254|NCT02647905|65919385|FG000|Overall Study|Withdrawal by Subject|2|||
23598255|NCT01579916|65919390|FG000|Overall Study|Lost to Follow-up|6|||
23598256|NCT01579916|65919391|FG001|Overall Study|Lost to Follow-up|1|||
23598257|NCT01579916|65919390|FG000|Overall Study|Withdrawal by Subject|1|||
23598258|NCT01579916|65919391|FG001|Overall Study|Withdrawal by Subject|1|||
23598259|NCT01579916|65919390|FG000|Overall Study|Death|1|||
23598260|NCT01579916|65919391|FG001|Overall Study|Death|0|||
23598261|NCT02590432|65919392|FG000|Open-label Treatment Period|Adverse Event|97|||
23598262|NCT02590432|65919393|FG001|Open-label Treatment Period|Adverse Event|79|||
23598263|NCT02590432|65919394|FG002|Open-label Treatment Period|Adverse Event|0|||
23598264|NCT02590432|65919395|FG003|Open-label Treatment Period|Adverse Event|0|||
23598265|NCT02590432|65919396|FG004|Open-label Treatment Period|Adverse Event|0|||
23194783|NCT01070550|64456047|FG003|Overall Study|Miscellaneous|1|||
23598266|NCT02590432|65919397|FG005|Open-label Treatment Period|Adverse Event|0|||
23598267|NCT02590432|65919398|FG006|Open-label Treatment Period|Adverse Event|0|||
23598268|NCT02590432|65919399|FG007|Open-label Treatment Period|Adverse Event|0|||
23598269|NCT02590432|65919400|FG008|Open-label Treatment Period|Adverse Event|0|||
23598270|NCT02590432|65919392|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
23598271|NCT02590432|65919393|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
23598272|NCT02590432|65919394|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
23598273|NCT02590432|65919395|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
23598274|NCT02590432|65919396|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
23598275|NCT02590432|65919397|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
23598276|NCT02590432|65919398|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
23598277|NCT02590432|65919399|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
23598278|NCT02590432|65919400|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
23598279|NCT02590432|65919392|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
23598280|NCT02590432|65919393|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
23598281|NCT02590432|65919394|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
23598282|NCT02590432|65919395|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
23598283|NCT02590432|65919396|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
23598284|NCT02590432|65919397|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
23598285|NCT02590432|65919398|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
23598286|NCT02590432|65919399|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
23598287|NCT02590432|65919400|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
23598288|NCT02590432|65919392|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
23598289|NCT02590432|65919393|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
23598290|NCT02590432|65919394|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
23598291|NCT02590432|65919395|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
23598292|NCT02590432|65919396|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
23598293|NCT02590432|65919397|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
23598294|NCT02590432|65919398|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
23598295|NCT02590432|65919399|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
23598296|NCT02590432|65919400|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
23598297|NCT02590432|65919392|FG000|Open-label Treatment Period|Protocol Violation|10|||
23598298|NCT02590432|65919393|FG001|Open-label Treatment Period|Protocol Violation|4|||
23598299|NCT02590432|65919394|FG002|Open-label Treatment Period|Protocol Violation|0|||
23598300|NCT02590432|65919395|FG003|Open-label Treatment Period|Protocol Violation|0|||
23598301|NCT02590432|65919396|FG004|Open-label Treatment Period|Protocol Violation|0|||
23598302|NCT02590432|65919397|FG005|Open-label Treatment Period|Protocol Violation|0|||
23598303|NCT02590432|65919398|FG006|Open-label Treatment Period|Protocol Violation|0|||
23598304|NCT02590432|65919399|FG007|Open-label Treatment Period|Protocol Violation|0|||
23598305|NCT02590432|65919400|FG008|Open-label Treatment Period|Protocol Violation|0|||
23598306|NCT02590432|65919392|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
23598307|NCT02590432|65919393|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
23598308|NCT02590432|65919394|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598309|NCT02590432|65919395|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598310|NCT02590432|65919396|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598311|NCT02590432|65919397|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598312|NCT02590432|65919398|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598313|NCT02590432|65919399|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598314|NCT02590432|65919400|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
23598315|NCT02590432|65919392|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
23598316|NCT02590432|65919393|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
23194784|NCT01070550|64456048|FG004|Overall Study|Miscellaneous|0|||
23598317|NCT02590432|65919394|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598318|NCT02590432|65919395|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598319|NCT02590432|65919396|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598320|NCT02590432|65919397|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598321|NCT02590432|65919398|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598322|NCT02590432|65919399|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598323|NCT02590432|65919400|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
23598324|NCT02590432|65919392|FG000|Double-blind Treatment Period|Adverse Event|0|||
23598325|NCT02590432|65919393|FG001|Double-blind Treatment Period|Adverse Event|0|||
23598326|NCT02590432|65919394|FG002|Double-blind Treatment Period|Adverse Event|14|||
23598327|NCT02590432|65919395|FG003|Double-blind Treatment Period|Adverse Event|12|||
23598328|NCT02590432|65919396|FG004|Double-blind Treatment Period|Adverse Event|6|||
23598329|NCT02590432|65919397|FG005|Double-blind Treatment Period|Adverse Event|22|||
23598330|NCT02590432|65919398|FG006|Double-blind Treatment Period|Adverse Event|20|||
23598331|NCT02590432|65919399|FG007|Double-blind Treatment Period|Adverse Event|0|||
23598332|NCT02590432|65919400|FG008|Double-blind Treatment Period|Adverse Event|0|||
23598333|NCT02590432|65919392|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23598334|NCT02590432|65919393|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
23598335|NCT02590432|65919394|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
23598336|NCT02590432|65919395|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
23598337|NCT02590432|65919396|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
23598338|NCT02590432|65919397|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
23598339|NCT02590432|65919398|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
23598340|NCT02590432|65919399|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
23598341|NCT02590432|65919400|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
23598342|NCT02590432|65919392|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
23598343|NCT02590432|65919393|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
23598344|NCT02590432|65919394|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
23598345|NCT02590432|65919395|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
23598346|NCT02590432|65919396|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
23598347|NCT02590432|65919397|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
23598348|NCT02590432|65919398|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
23598349|NCT02590432|65919399|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
23598350|NCT02590432|65919400|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
23598351|NCT02590432|65919392|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23598352|NCT02590432|65919393|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23598353|NCT02590432|65919394|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
23598354|NCT02590432|65919395|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
23598355|NCT02590432|65919396|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
23598356|NCT02590432|65919397|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
23598357|NCT02590432|65919398|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
23598358|NCT02590432|65919399|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
23598359|NCT02590432|65919400|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
23598360|NCT02590432|65919392|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598361|NCT02590432|65919393|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598362|NCT02590432|65919394|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598363|NCT02590432|65919395|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598364|NCT02590432|65919396|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598365|NCT02590432|65919397|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
23598366|NCT02590432|65919398|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598367|NCT02590432|65919399|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598368|NCT02590432|65919400|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
23598369|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598370|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598371|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598372|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598373|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598374|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598375|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
23598376|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
23598377|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
23598378|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23194785|NCT01070550|64456049|FG005|Overall Study|Miscellaneous|0|||
23194786|NCT01070550|64456044|FG000|Overall Study|New treatment started|3|||
23255824|NCT03705169|64676983|FG000|Overall Study|Did not receive study treatment|0|||
23255825|NCT03705169|64676984|FG001|Overall Study|Did not receive study treatment|0|||
23194787|NCT01070550|64456045|FG001|Overall Study|New treatment started|1|||
23194788|NCT01070550|64456046|FG002|Overall Study|New treatment started|0|||
23194789|NCT01070550|64456047|FG003|Overall Study|New treatment started|2|||
23194790|NCT01070550|64456048|FG004|Overall Study|New treatment started|0|||
23194791|NCT01070550|64456049|FG005|Overall Study|New treatment started|0|||
23194792|NCT01070550|64456044|FG000|Overall Study|Non-responders|493|||
23194793|NCT01070550|64456045|FG001|Overall Study|Non-responders|4|||
23194794|NCT01070550|64456046|FG002|Overall Study|Non-responders|21|||
23194795|NCT01070550|64456047|FG003|Overall Study|Non-responders|20|||
23194796|NCT01070550|64456048|FG004|Overall Study|Non-responders|0|||
23194797|NCT01070550|64456049|FG005|Overall Study|Non-responders|2|||
23194798|NCT01070550|64456044|FG000|Overall Study|Not categorized|33|||
23194799|NCT01070550|64456045|FG001|Overall Study|Not categorized|2|||
23194800|NCT01070550|64456046|FG002|Overall Study|Not categorized|6|||
23194801|NCT01070550|64456047|FG003|Overall Study|Not categorized|1|||
23194802|NCT01070550|64456048|FG004|Overall Study|Not categorized|0|||
23194803|NCT01070550|64456049|FG005|Overall Study|Not categorized|1|||
23194804|NCT01070550|64456044|FG000|Overall Study|Protocol Violation|15|||
23194805|NCT01070550|64456045|FG001|Overall Study|Protocol Violation|1|||
23194806|NCT01070550|64456046|FG002|Overall Study|Protocol Violation|1|||
23194807|NCT01070550|64456047|FG003|Overall Study|Protocol Violation|1|||
23194808|NCT01070550|64456048|FG004|Overall Study|Protocol Violation|0|||
23194809|NCT01070550|64456049|FG005|Overall Study|Protocol Violation|0|||
23194810|NCT01070550|64456044|FG000|Overall Study|Relapse|44|||
23194811|NCT01070550|64456045|FG001|Overall Study|Relapse|5|||
23194812|NCT01070550|64456046|FG002|Overall Study|Relapse|14|||
23194813|NCT01070550|64456047|FG003|Overall Study|Relapse|4|||
23194814|NCT01070550|64456048|FG004|Overall Study|Relapse|0|||
23194815|NCT01070550|64456049|FG005|Overall Study|Relapse|0|||
23194816|NCT01070550|64456044|FG000|Overall Study|Result not available|3|||
23194817|NCT01070550|64456045|FG001|Overall Study|Result not available|1|||
23194818|NCT01070550|64456046|FG002|Overall Study|Result not available|3|||
23194819|NCT01070550|64456047|FG003|Overall Study|Result not available|0|||
23194820|NCT01070550|64456048|FG004|Overall Study|Result not available|0|||
23194821|NCT01070550|64456049|FG005|Overall Study|Result not available|0|||
23194822|NCT01070550|64456044|FG000|Overall Study|Screen failure|1|||
23194823|NCT01070550|64456045|FG001|Overall Study|Screen failure|0|||
23194824|NCT01070550|64456046|FG002|Overall Study|Screen failure|0|||
23194825|NCT01070550|64456047|FG003|Overall Study|Screen failure|0|||
23194826|NCT01070550|64456048|FG004|Overall Study|Screen failure|0|||
23194827|NCT01070550|64456049|FG005|Overall Study|Screen failure|0|||
23194828|NCT01070550|64456044|FG000|Overall Study|Sponsor decision|1|||
23194829|NCT01070550|64456045|FG001|Overall Study|Sponsor decision|0|||
23194830|NCT01070550|64456046|FG002|Overall Study|Sponsor decision|0|||
23194831|NCT01070550|64456047|FG003|Overall Study|Sponsor decision|0|||
23194832|NCT01070550|64456048|FG004|Overall Study|Sponsor decision|0|||
23194833|NCT01070550|64456049|FG005|Overall Study|Sponsor decision|0|||
23194834|NCT01070550|64456044|FG000|Overall Study|Treatment duration shortened|1|||
23194835|NCT01070550|64456045|FG001|Overall Study|Treatment duration shortened|0|||
23194836|NCT01070550|64456046|FG002|Overall Study|Treatment duration shortened|0|||
23194837|NCT01070550|64456047|FG003|Overall Study|Treatment duration shortened|0|||
23194838|NCT01070550|64456048|FG004|Overall Study|Treatment duration shortened|0|||
23194839|NCT01070550|64456049|FG005|Overall Study|Treatment duration shortened|0|||
23194840|NCT01070550|64456044|FG000|Overall Study|Treatment interrupted|7|||
23194841|NCT01070550|64456045|FG001|Overall Study|Treatment interrupted|0|||
23194842|NCT01070550|64456046|FG002|Overall Study|Treatment interrupted|1|||
23194843|NCT01070550|64456047|FG003|Overall Study|Treatment interrupted|1|||
23194844|NCT01070550|64456048|FG004|Overall Study|Treatment interrupted|0|||
23194845|NCT01070550|64456049|FG005|Overall Study|Treatment interrupted|0|||
23194846|NCT01070550|64456044|FG000|Overall Study|Treatment not started|14|||
23194847|NCT01070550|64456045|FG001|Overall Study|Treatment not started|2|||
23194848|NCT01070550|64456046|FG002|Overall Study|Treatment not started|4|||
23194849|NCT01070550|64456047|FG003|Overall Study|Treatment not started|0|||
23194850|NCT01070550|64456048|FG004|Overall Study|Treatment not started|0|||
23255826|NCT03705169|64676985|FG002|Overall Study|Did not receive study treatment|0|||
23194851|NCT01070550|64456049|FG005|Overall Study|Treatment not started|0|||
23194852|NCT01070550|64456044|FG000|Overall Study|Treatment restarted|0|||
23194853|NCT01070550|64456045|FG001|Overall Study|Treatment restarted|1|||
23194854|NCT01070550|64456046|FG002|Overall Study|Treatment restarted|0|||
23194855|NCT01070550|64456047|FG003|Overall Study|Treatment restarted|0|||
23194856|NCT01070550|64456048|FG004|Overall Study|Treatment restarted|0|||
23194857|NCT01070550|64456049|FG005|Overall Study|Treatment restarted|0|||
23194858|NCT01070550|64456044|FG000|Overall Study|Treatment stopped|3|||
23194859|NCT01070550|64456045|FG001|Overall Study|Treatment stopped|0|||
23194860|NCT01070550|64456046|FG002|Overall Study|Treatment stopped|0|||
23479000|NCT02586506|65498334|FG000|Overall Study|Other Reason|2|||
23598379|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598380|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598381|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598382|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598383|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598384|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598385|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
23598386|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
23598387|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598388|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598389|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598390|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598391|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598392|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598393|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
23598394|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
23598395|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
23598396|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598397|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598398|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598399|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23194861|NCT01070550|64456047|FG003|Overall Study|Treatment stopped|0|||
23598400|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598401|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598402|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598403|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
23598404|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
23598405|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598406|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598407|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598408|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598409|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598410|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598411|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23255827|NCT03705169|64676986|FG003|Overall Study|Did not receive study treatment|1|||
23255828|NCT03705169|64676987|FG004|Overall Study|Did not receive study treatment|0|||
23255829|NCT03705169|64676988|FG005|Overall Study|Did not receive study treatment|0|||
23255830|NCT03705169|64676989|FG006|Overall Study|Did not receive study treatment|0|||
23255831|NCT03705169|64676990|FG007|Overall Study|Did not receive study treatment|0|||
23255832|NCT03705169|64676991|FG008|Overall Study|Did not receive study treatment|0|||
23255833|NCT03705169|64676992|FG009|Overall Study|Did not receive study treatment|0|||
23255834|NCT03705169|64676983|FG000|Overall Study|Concerns about study visit compliance|0|||
23255835|NCT03705169|64676984|FG001|Overall Study|Concerns about study visit compliance|0|||
23255836|NCT03705169|64676985|FG002|Overall Study|Concerns about study visit compliance|0|||
23255837|NCT03705169|64676986|FG003|Overall Study|Concerns about study visit compliance|1|||
23255838|NCT03705169|64676987|FG004|Overall Study|Concerns about study visit compliance|0|||
23255839|NCT03705169|64676988|FG005|Overall Study|Concerns about study visit compliance|0|||
23255840|NCT03705169|64676989|FG006|Overall Study|Concerns about study visit compliance|0|||
23255841|NCT03705169|64676990|FG007|Overall Study|Concerns about study visit compliance|0|||
23255842|NCT03705169|64676991|FG008|Overall Study|Concerns about study visit compliance|0|||
23255843|NCT03705169|64676992|FG009|Overall Study|Concerns about study visit compliance|0|||
23360618|NCT04613739|65065805|FG000|Overall Study|potentially duplicative/fraudulent|1|||
23360619|NCT04613739|65065806|FG001|Overall Study|potentially duplicative/fraudulent|3|||
23360620|NCT02937740|65065807|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
23598412|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
23598413|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
23598414|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598415|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598416|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598417|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598418|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598419|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598420|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598421|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
23360621|NCT02937740|65065808|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
23360622|NCT02937740|65065807|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
23360623|NCT02937740|65065808|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
23360624|NCT02937740|65065807|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
23360625|NCT02937740|65065808|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
23360626|NCT02937740|65065807|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
23360627|NCT02937740|65065808|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
23360628|NCT02937740|65065807|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
23360629|NCT02937740|65065808|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
23360630|NCT02937740|65065807|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
23360631|NCT02937740|65065808|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
23360632|NCT02169505|65065809|FG000|Overall Study|Withdrawal by Subject|1|||
23360633|NCT01733121|65065810|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
23360634|NCT01733121|65065811|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
23360635|NCT01733121|65065810|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
23360636|NCT01733121|65065811|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
23360637|NCT01733121|65065810|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
23360638|NCT01733121|65065811|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
23479001|NCT02810444|65498335|FG000|Overall Study|Screen Failures|14|||
23479002|NCT02810444|65498335|FG000|Overall Study|Withdrawal by Subject|4|||
23479003|NCT02810444|65498335|FG000|Overall Study|Adverse Event|3|||
23479004|NCT00357760|65498336|FG000|Overall Study|Disease progression|44|||
23479005|NCT00357760|65498337|FG001|Overall Study|Disease progression|17|||
23479006|NCT00357760|65498336|FG000|Overall Study|Adverse Event|10|||
23479007|NCT00357760|65498337|FG001|Overall Study|Adverse Event|7|||
23479008|NCT00357760|65498336|FG000|Overall Study|Death|0|||
23479009|NCT00357760|65498337|FG001|Overall Study|Death|3|||
23479010|NCT00357760|65498336|FG000|Overall Study|Alternative therapy|1|||
23479011|NCT00357760|65498337|FG001|Overall Study|Alternative therapy|0|||
23479012|NCT00357760|65498336|FG000|Overall Study|Withdrawal by Subject|0|||
23479013|NCT00357760|65498337|FG001|Overall Study|Withdrawal by Subject|2|||
23479014|NCT00357760|65498336|FG000|Overall Study|Never started treatment|2|||
23479015|NCT00357760|65498337|FG001|Overall Study|Never started treatment|1|||
23479016|NCT00357760|65498336|FG000|Overall Study|Ineligible|0|||
23479017|NCT00357760|65498337|FG001|Overall Study|Ineligible|2|||
23479018|NCT00357760|65498336|FG000|Overall Study|Physician Decision|2|||
23479019|NCT00357760|65498337|FG001|Overall Study|Physician Decision|1|||
23479020|NCT00357760|65498336|FG000|Overall Study|Protocol Violation|0|||
23479021|NCT00357760|65498337|FG001|Overall Study|Protocol Violation|1|||
23479022|NCT00357760|65498336|FG000|Overall Study|To receive hospice care|0|||
23479023|NCT00357760|65498337|FG001|Overall Study|To receive hospice care|1|||
23479024|NCT02518464|65498343|FG000|Overall Study|Adverse Event|2|||
23479025|NCT02527200|65498345|FG000|Overall Study|Withdrawal by Subject|3|||
23479026|NCT02527200|65498346|FG001|Overall Study|Withdrawal by Subject|2|||
23479027|NCT02527200|65498347|FG002|Overall Study|Withdrawal by Subject|1|||
23479028|NCT02527200|65498348|FG003|Overall Study|Withdrawal by Subject|0|||
23479029|NCT02527200|65498345|FG000|Overall Study|Unclassified|0|||
23479030|NCT02527200|65498346|FG001|Overall Study|Unclassified|1|||
23479031|NCT02527200|65498347|FG002|Overall Study|Unclassified|0|||
23479032|NCT02527200|65498348|FG003|Overall Study|Unclassified|0|||
23479033|NCT02527200|65498345|FG000|Overall Study|Lost to Follow-up|0|||
23479034|NCT02527200|65498346|FG001|Overall Study|Lost to Follow-up|0|||
23194862|NCT01070550|64456048|FG004|Overall Study|Treatment stopped|0|||
23194863|NCT01070550|64456049|FG005|Overall Study|Treatment stopped|0|||
23194864|NCT01070550|64456044|FG000|Overall Study|Treatment unavailable|1|||
23194865|NCT01070550|64456045|FG001|Overall Study|Treatment unavailable|0|||
23194866|NCT01070550|64456046|FG002|Overall Study|Treatment unavailable|0|||
23194867|NCT01070550|64456047|FG003|Overall Study|Treatment unavailable|0|||
23194868|NCT01070550|64456048|FG004|Overall Study|Treatment unavailable|0|||
23194869|NCT01070550|64456049|FG005|Overall Study|Treatment unavailable|0|||
23194870|NCT01070550|64456044|FG000|Overall Study|Treatment was stopped early|7|||
23194871|NCT01070550|64456045|FG001|Overall Study|Treatment was stopped early|0|||
23194872|NCT01070550|64456046|FG002|Overall Study|Treatment was stopped early|0|||
23194873|NCT01070550|64456047|FG003|Overall Study|Treatment was stopped early|0|||
23194874|NCT01070550|64456048|FG004|Overall Study|Treatment was stopped early|0|||
23194875|NCT01070550|64456049|FG005|Overall Study|Treatment was stopped early|0|||
23194876|NCT01070550|64456044|FG000|Overall Study|Other|5|||
23194877|NCT01070550|64456045|FG001|Overall Study|Other|0|||
23194878|NCT01070550|64456046|FG002|Overall Study|Other|0|||
23194879|NCT01070550|64456047|FG003|Overall Study|Other|1|||
23194880|NCT01070550|64456048|FG004|Overall Study|Other|0|||
23194881|NCT01070550|64456049|FG005|Overall Study|Other|0|||
23194882|NCT01070550|64456044|FG000|Overall Study|Withdrawal by Subject|35|||
23194883|NCT01070550|64456045|FG001|Overall Study|Withdrawal by Subject|0|||
23479035|NCT02527200|65498347|FG002|Overall Study|Lost to Follow-up|1|||
23194884|NCT01070550|64456046|FG002|Overall Study|Withdrawal by Subject|3|||
23194885|NCT01070550|64456047|FG003|Overall Study|Withdrawal by Subject|0|||
23194886|NCT01070550|64456048|FG004|Overall Study|Withdrawal by Subject|0|||
23194887|NCT01070550|64456049|FG005|Overall Study|Withdrawal by Subject|0|||
23194888|NCT00914628|64456050|FG000|Overall Study|Death|35|||
23194889|NCT00914628|64456051|FG001|Overall Study|Death|17|||
23194890|NCT00914628|64456050|FG000|Overall Study|Medical decision|4|||
23194891|NCT00914628|64456051|FG001|Overall Study|Medical decision|0|||
23194892|NCT00914628|64456050|FG000|Overall Study|Protocol Violation|1|||
23194893|NCT00914628|64456051|FG001|Overall Study|Protocol Violation|0|||
23479036|NCT02527200|65498348|FG003|Overall Study|Lost to Follow-up|0|||
23479037|NCT02168387|65498351|FG000|Overall Study|Planned exubation|6|||
23479038|NCT02168387|65498352|FG001|Overall Study|Planned exubation|3|||
23479039|NCT02168387|65498351|FG000|Overall Study|Death|1|||
23479040|NCT02168387|65498352|FG001|Overall Study|Death|0|||
23479041|NCT03700684|65498353|FG000|Overall Study|COVID-19|0|||
23479042|NCT03700684|65498354|FG001|Overall Study|COVID-19|0|||
23479043|NCT03700684|65498355|FG002|Overall Study|COVID-19|2|||
23479044|NCT01143389|65498359|FG000|Overall Study|Lost to Follow-up|26|||
23194894|NCT00914628|64456050|FG000|Overall Study|Lack of Efficacy|1|||
23598422|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
23598423|NCT02590432|65919392|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598424|NCT02590432|65919393|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598425|NCT02590432|65919394|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598426|NCT02590432|65919395|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598427|NCT02590432|65919396|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598428|NCT02590432|65919397|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598429|NCT02590432|65919398|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598430|NCT02590432|65919399|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
23598431|NCT02590432|65919400|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
23598432|NCT00739908|65919401|FG000|Overall Study|Adverse Event|5|||
23598433|NCT00739908|65919402|FG001|Overall Study|Adverse Event|6|||
23598434|NCT00739908|65919401|FG000|Overall Study|Withdrawal by Subject|4|||
23598435|NCT00739908|65919402|FG001|Overall Study|Withdrawal by Subject|2|||
23598436|NCT00739908|65919401|FG000|Overall Study|Lost to Follow-up|14|||
23598437|NCT00739908|65919402|FG001|Overall Study|Lost to Follow-up|9|||
23598438|NCT00739908|65919401|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
23598439|NCT00739908|65919402|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
23598440|NCT00739908|65919401|FG000|Overall Study|Non-Compliance With Study Medication|0|||
23598441|NCT00739908|65919402|FG001|Overall Study|Non-Compliance With Study Medication|3|||
23598442|NCT00739908|65919401|FG000|Overall Study|Lack of Efficacy|0|||
23598443|NCT00739908|65919402|FG001|Overall Study|Lack of Efficacy|1|||
23598444|NCT00739908|65919401|FG000|Overall Study|Relocation|0|||
23598445|NCT00739908|65919402|FG001|Overall Study|Relocation|1|||
23598446|NCT00409838|65919403|FG000|Short-term Period|Adverse Event|0|||
23598447|NCT00409838|65919404|FG001|Short-term Period|Adverse Event|1|||
23598448|NCT00409838|65919403|FG000|Short-term Period|Lost to Follow-up|0|||
23598449|NCT00409838|65919404|FG001|Short-term Period|Lost to Follow-up|1|||
23598450|NCT00409838|65919403|FG000|Short-term Period|Withdrawal by Subject|2|||
23598451|NCT00409838|65919404|FG001|Short-term Period|Withdrawal by Subject|3|||
23598452|NCT00409838|65919403|FG000|Short-term Period|Never Treated|1|||
23598453|NCT00409838|65919404|FG001|Short-term Period|Never Treated|0|||
23598454|NCT00409838|65919403|FG000|Long-term Extension Period|Adverse Event|10|||
23598455|NCT00409838|65919404|FG001|Long-term Extension Period|Adverse Event|0|||
23598456|NCT00409838|65919403|FG000|Long-term Extension Period|Death|1|||
23598457|NCT00409838|65919404|FG001|Long-term Extension Period|Death|0|||
23598458|NCT00409838|65919403|FG000|Long-term Extension Period|Lack of Efficacy|2|||
23598459|NCT00409838|65919404|FG001|Long-term Extension Period|Lack of Efficacy|0|||
23598460|NCT00409838|65919403|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
23598461|NCT00409838|65919404|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
23598462|NCT00409838|65919403|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
23598463|NCT00409838|65919404|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
23598464|NCT00409838|65919403|FG000|Long-term Extension Period|Pregnancy|1|||
23598465|NCT00409838|65919404|FG001|Long-term Extension Period|Pregnancy|0|||
23598466|NCT00642850|65919405|FG000|Overall Study|Death|7|||
23598467|NCT00642850|65919405|FG000|Overall Study|Adverse Event|2|||
23598468|NCT00642850|65919405|FG000|Overall Study|Lack of Efficacy|1|||
23598469|NCT00642850|65919405|FG000|Overall Study|Protocol Violation|2|||
23598470|NCT00642850|65919405|FG000|Overall Study|Kidney transplantation|8|||
23598471|NCT00642850|65919405|FG000|Overall Study|Blood transfusion|6|||
23598472|NCT00642850|65919405|FG000|Overall Study|Other reasons|7|||
23598473|NCT01376700|65919413|FG000|Overall Study|Sponsor terminated study early|8|||
23598474|NCT01376700|65919413|FG000|Overall Study|Low or high titer inhibitor|8|||
23598475|NCT02376790|65919416|FG000|Overall Study|Withdrawal by Subject|43|||
23598476|NCT02376790|65919417|FG001|Overall Study|Withdrawal by Subject|36|||
23598477|NCT02376790|65919418|FG002|Overall Study|Withdrawal by Subject|37|||
23598478|NCT02376790|65919416|FG000|Overall Study|Decision by Sponsor|2|||
23598479|NCT02376790|65919417|FG001|Overall Study|Decision by Sponsor|1|||
23598480|NCT02376790|65919418|FG002|Overall Study|Decision by Sponsor|4|||
23598481|NCT02376790|65919416|FG000|Overall Study|Lost to Follow-up|15|||
23598482|NCT02376790|65919417|FG001|Overall Study|Lost to Follow-up|10|||
23598483|NCT02376790|65919418|FG002|Overall Study|Lost to Follow-up|12|||
23598484|NCT01510717|65919419|FG000|Overall Study|Adverse Event|1|||
23598485|NCT01510717|65919420|FG001|Overall Study|Adverse Event|2|||
23598486|NCT01510717|65919419|FG000|Overall Study|Death|1|||
23598487|NCT01510717|65919420|FG001|Overall Study|Death|0|||
23598488|NCT01510717|65919419|FG000|Overall Study|Lost to Follow-up|0|||
23598489|NCT01510717|65919420|FG001|Overall Study|Lost to Follow-up|1|||
23598490|NCT01510717|65919419|FG000|Overall Study|Withdrawal by Subject|0|||
23479045|NCT01143389|65498360|FG001|Overall Study|Lost to Follow-up|25|||
23479046|NCT02015221|65498362|FG000|Overall Study|Withdrawal by Subject|8|||
23479047|NCT02015221|65498363|FG001|Overall Study|Withdrawal by Subject|6|||
23479048|NCT02015221|65498362|FG000|Overall Study|Lost to Follow-up|1|||
23479049|NCT02015221|65498363|FG001|Overall Study|Lost to Follow-up|0|||
23479050|NCT04473235|65498364|FG000|Overall Study|Lost to Follow-up|6|||
23479051|NCT04473235|65498365|FG001|Overall Study|Lost to Follow-up|5|||
23479052|NCT04473235|65498364|FG000|Overall Study|Declined continuation|2|||
23479053|NCT04473235|65498365|FG001|Overall Study|Declined continuation|0|||
23479054|NCT04473235|65498364|FG000|Overall Study|Physician Decision|1|||
23479055|NCT04473235|65498365|FG001|Overall Study|Physician Decision|1|||
23479056|NCT04473235|65498364|FG000|Overall Study|Protocol Violation|10|||
23598491|NCT01510717|65919420|FG001|Overall Study|Withdrawal by Subject|2|||
23598492|NCT00003222|65919421|FG000|Overall Study|Physician Decision|0|||
23598493|NCT00003222|65919422|FG001|Overall Study|Physician Decision|1|||
23598494|NCT00529789|65919423|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
23598495|NCT00529789|65919423|FG000|Study Period II/III|Adverse Event|3|||
23598496|NCT00529789|65919423|FG000|Study Period II/III|Lack of Efficacy|2|||
23598497|NCT00529789|65919423|FG000|Study Period II/III|Withdrawal by Subject|1|||
23598498|NCT00529789|65919423|FG000|Study Period II/III|Protocol Violation|3|||
23598499|NCT00529789|65919423|FG000|Study Period II/III|Physician Decision|3|||
23598500|NCT00529789|65919423|FG000|Study Period II/III|Lost to Follow-up|3|||
23598501|NCT00529789|65919423|FG000|Study Period IV|Parent/Caregiver Decision|1|||
23598502|NCT00529789|65919423|FG000|Study Period IV|Adverse Event|1|||
23598503|NCT00529789|65919423|FG000|Study Period IV|Lack of Efficacy|1|||
23598504|NCT00529789|65919423|FG000|Study Period IV|Lost to Follow-up|3|||
23598505|NCT00623194|65922244|FG000|Overall Study|Lack of Efficacy|1|||
23598506|NCT00623194|65922244|FG000|Overall Study|Protocol Violation|3|||
23598507|NCT00623194|65922244|FG000|Overall Study|Unclassified|1|||
23598508|NCT00640159|65922245|FG000|Overall Study|Lost to Follow-up|2|||
23598509|NCT01094184|65922248|FG000|Overall Study|Death|35|||
23598510|NCT01094184|65922249|FG001|Overall Study|Death|11|||
23598511|NCT01532388|65922268|FG000|3-month Follow-up|Lost to Follow-up|68|||
23598512|NCT01532388|65922269|FG001|3-month Follow-up|Lost to Follow-up|68|||
23598513|NCT01532388|65922268|FG000|6-month Follow-up|Lost to Follow-up|74|||
23598514|NCT01532388|65922269|FG001|6-month Follow-up|Lost to Follow-up|66|||
23598515|NCT01532388|65922268|FG000|12-month Follow-up|Lost to Follow-up|69|||
23598516|NCT01532388|65922269|FG001|12-month Follow-up|Lost to Follow-up|67|||
23598517|NCT03101371|65922270|FG000|Overall Study|Physician Decision|0|||
23598518|NCT03101371|65922271|FG001|Overall Study|Physician Decision|1|||
23479057|NCT04473235|65498365|FG001|Overall Study|Protocol Violation|6|||
23479058|NCT00075270|65498366|FG000|Overall Study|Withdrawal by Subject|28|||
23598519|NCT03101371|65922270|FG000|Overall Study|Lost to Follow-up|1|||
23598520|NCT03101371|65922271|FG001|Overall Study|Lost to Follow-up|4|||
23598521|NCT03101371|65922270|FG000|Overall Study|Did not meet eligibility criteria|2|||
23598522|NCT03101371|65922271|FG001|Overall Study|Did not meet eligibility criteria|1|||
23598523|NCT01367236|65922273|FG000|Overall Study|Withdrawal by Subject|3|||
23598524|NCT01367236|65922274|FG001|Overall Study|Withdrawal by Subject|1|||
23255844|NCT02082912|64676997|FG000|Overall Study|Physician Decision|0|||
23479059|NCT00075270|65498367|FG001|Overall Study|Withdrawal by Subject|21|||
23479060|NCT00075270|65498366|FG000|Overall Study|Lost to Follow-up|25|||
23479061|NCT00075270|65498367|FG001|Overall Study|Lost to Follow-up|28|||
23479062|NCT00075270|65498366|FG000|Overall Study|Protocol Violation|0|||
23479063|NCT00075270|65498367|FG001|Overall Study|Protocol Violation|2|||
23479064|NCT00075270|65498366|FG000|Overall Study|Death|198|||
23479065|NCT00075270|65498367|FG001|Overall Study|Death|215|||
23479066|NCT00075270|65498366|FG000|Overall Study|Other/Unknown|9|||
23479067|NCT00075270|65498367|FG001|Overall Study|Other/Unknown|5|||
23479068|NCT00075270|65498366|FG000|Overall Study|Missing|26|||
23479069|NCT00075270|65498367|FG001|Overall Study|Missing|13|||
23479070|NCT00868517|65498370|FG000|Overall Study|Withdrawal by Subject|3|||
23479071|NCT00868517|65498371|FG001|Overall Study|Withdrawal by Subject|3|||
23479072|NCT00868517|65498372|FG002|Overall Study|Withdrawal by Subject|2|||
23479073|NCT00868517|65498370|FG000|Overall Study|Protocol Violation|1|||
23479074|NCT00868517|65498371|FG001|Overall Study|Protocol Violation|1|||
23194895|NCT00914628|64456051|FG001|Overall Study|Lack of Efficacy|0|||
23194896|NCT00914628|64456050|FG000|Overall Study|non-randomized|1|||
23194897|NCT00914628|64456051|FG001|Overall Study|non-randomized|0|||
23194898|NCT00914628|64456050|FG000|Overall Study|Relapse|1|||
23194899|NCT00914628|64456051|FG001|Overall Study|Relapse|2|||
23194900|NCT00914628|64456050|FG000|Overall Study|Study terminated by Sponsor|14|||
23194901|NCT00914628|64456051|FG001|Overall Study|Study terminated by Sponsor|8|||
23194902|NCT00914628|64456050|FG000|Overall Study|Patients who did not receive a single dose|7|||
23255845|NCT02082912|64676998|FG001|Overall Study|Physician Decision|1|||
23255846|NCT00616928|64676999|FG000|Overall Study|Adverse Event|6|||
23255847|NCT00616928|64677000|FG001|Overall Study|Adverse Event|3|||
23255848|NCT00616928|64677001|FG002|Overall Study|Adverse Event|2|||
23479075|NCT00868517|65498372|FG002|Overall Study|Protocol Violation|0|||
23479076|NCT01119937|65498373|FG000|Overall Study|Adverse Event|11|||
23479077|NCT01119937|65498374|FG001|Overall Study|Adverse Event|5|||
23479078|NCT01119937|65498373|FG000|Overall Study|Protocol deviation|3|||
23479079|NCT01119937|65498374|FG001|Overall Study|Protocol deviation|1|||
23479080|NCT01119937|65498373|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23479081|NCT01119937|65498374|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23479082|NCT01119937|65498373|FG000|Overall Study|Withdrawal by Subject|2|||
23479083|NCT01119937|65498374|FG001|Overall Study|Withdrawal by Subject|1|||
23479084|NCT05315908|65498375|FG000|Overall Study|Lost to Follow-up|4477|||
23479085|NCT05315908|65498376|FG001|Overall Study|Lost to Follow-up|4606|||
23479086|NCT04931888|65498377|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
23479087|NCT04931888|65498378|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
23479088|NCT04931888|65498379|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
23479089|NCT04931888|65498380|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
23479090|NCT03996369|65498384|FG000|Overall Study|Protocol deviation|1|||
23479091|NCT03996369|65498385|FG001|Overall Study|Protocol deviation|1|||
23479092|NCT03996369|65498384|FG000|Overall Study|Physician Decision|4|||
23255849|NCT00616928|64677002|FG003|Overall Study|Adverse Event|2|||
23255850|NCT00616928|64676999|FG000|Overall Study|Other|51|||
23255851|NCT00616928|64677000|FG001|Overall Study|Other|8|||
23255852|NCT00616928|64677001|FG002|Overall Study|Other|15|||
23255853|NCT00616928|64677002|FG003|Overall Study|Other|5|||
23255854|NCT00616928|64676999|FG000|Overall Study|Lost to Follow-up|5|||
23255855|NCT00616928|64677000|FG001|Overall Study|Lost to Follow-up|7|||
23255856|NCT00616928|64677001|FG002|Overall Study|Lost to Follow-up|0|||
23255857|NCT00616928|64677002|FG003|Overall Study|Lost to Follow-up|0|||
23255858|NCT01862328|64677005|FG000|Overall Study|Progressive Disease|3|||
23255859|NCT01862328|64677006|FG001|Overall Study|Progressive Disease|11|||
23255860|NCT01862328|64677007|FG002|Overall Study|Progressive Disease|5|||
23255861|NCT01862328|64677008|FG003|Overall Study|Progressive Disease|6|||
23255862|NCT01862328|64677009|FG004|Overall Study|Progressive Disease|7|||
23255863|NCT01862328|64677010|FG005|Overall Study|Progressive Disease|4|||
23479093|NCT03996369|65498385|FG001|Overall Study|Physician Decision|2|||
23479094|NCT03996369|65498384|FG000|Overall Study|Participant decision|0|||
23479095|NCT03996369|65498385|FG001|Overall Study|Participant decision|1|||
23194903|NCT00914628|64456051|FG001|Overall Study|Patients who did not receive a single dose|1|||
23255864|NCT01862328|64677011|FG006|Overall Study|Progressive Disease|3|||
23255865|NCT01862328|64677005|FG000|Overall Study|Adverse Event|0|||
23479096|NCT03996369|65498384|FG000|Overall Study|Lack of Efficacy|4|||
23479097|NCT03996369|65498385|FG001|Overall Study|Lack of Efficacy|0|||
23479098|NCT03996369|65498384|FG000|Overall Study|Adverse Event|9|||
23194904|NCT01996319|64456056|FG000|Overall Study|Protocol Violation|1|||
23255866|NCT01862328|64677006|FG001|Overall Study|Adverse Event|4|||
23255867|NCT01862328|64677007|FG002|Overall Study|Adverse Event|0|||
23255868|NCT01862328|64677008|FG003|Overall Study|Adverse Event|1|||
23479099|NCT03996369|65498385|FG001|Overall Study|Adverse Event|0|||
23255869|NCT01862328|64677009|FG004|Overall Study|Adverse Event|0|||
23479100|NCT03996369|65498384|FG000|Overall Study|Withdrawal by Subject|6|||
23479101|NCT03996369|65498385|FG001|Overall Study|Withdrawal by Subject|8|||
23598525|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
23598526|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
23598527|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
23598528|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
23598529|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
23598530|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
23598531|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
23598532|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
23598533|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
23598534|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
23598535|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
23598536|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
23598537|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
23598538|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
23598539|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
23598540|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
23598541|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
23598542|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
23598543|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
23598544|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
23598545|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
23598546|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
23598547|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
23598548|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
23598549|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
23598550|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
23598551|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
23598552|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
23598553|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
23598554|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
23598555|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
23598556|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
23598557|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
23598558|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
23598559|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
23598560|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
23598561|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
23598562|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
23598563|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
23598564|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
23598565|NCT02409667|65922275|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
23598566|NCT02409667|65922276|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
23598567|NCT02409667|65922277|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
23598568|NCT02409667|65922278|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
23598569|NCT02409667|65922279|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
23598570|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
23598571|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
23598572|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
23598573|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
23598574|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
23598575|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
23598576|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
23598577|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
23598578|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
23598579|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
23598580|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
23598581|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
23598582|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
23598583|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
23598584|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
23598585|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
23598586|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
23598587|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
23598588|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
23598589|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
23598590|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
23598591|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
23194905|NCT01996319|64456057|FG001|Overall Study|Protocol Violation|0|||
23194906|NCT01996319|64456056|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
23194907|NCT01996319|64456057|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
23194908|NCT01996319|64456056|FG000|Overall Study|Adverse Event|2|||
23194909|NCT01996319|64456057|FG001|Overall Study|Adverse Event|2|||
23194910|NCT02749721|64456060|FG000|Screening|Withdrawal by Subject|1|||
23194911|NCT02749721|64456060|FG000|Screening|Lost to Follow-up|2|||
23194912|NCT02749721|64456060|FG000|Screening|Protocol Violation|3|||
23194913|NCT02749721|64456060|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
23194914|NCT02749721|64456060|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
23194915|NCT02702193|64456061|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
23194916|NCT02702193|64456062|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
23194917|NCT02702193|64456061|FG000|4 Month Follow up|Withdrawal by Subject|1|||
23194918|NCT02702193|64456062|FG001|4 Month Follow up|Withdrawal by Subject|0|||
23194919|NCT02702193|64456061|FG000|4 Month Follow up|Lost to Follow-up|17|||
23194920|NCT02702193|64456062|FG001|4 Month Follow up|Lost to Follow-up|18|||
23194921|NCT02702193|64456061|FG000|8 Month Follow up|Withdrawal by Subject|1|||
23194922|NCT02702193|64456062|FG001|8 Month Follow up|Withdrawal by Subject|0|||
23194923|NCT02702193|64456061|FG000|8 Month Follow up|Lost to Follow-up|14|||
23194924|NCT02702193|64456062|FG001|8 Month Follow up|Lost to Follow-up|18|||
23194925|NCT02702193|64456061|FG000|12 Month Follow up|Withdrawal by Subject|1|||
23194926|NCT02702193|64456062|FG001|12 Month Follow up|Withdrawal by Subject|0|||
23194927|NCT02702193|64456061|FG000|12 Month Follow up|Lost to Follow-up|16|||
23598592|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
23598593|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
23598594|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
23598595|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
23598596|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
23598597|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
23598598|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
23598599|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
23598600|NCT02409667|65922275|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
23598601|NCT02409667|65922276|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
23598602|NCT02409667|65922277|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
23598603|NCT02409667|65922278|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
23598604|NCT02409667|65922279|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
23598605|NCT02132949|65922283|FG000|Overall Study|Death|7|||
23598606|NCT02132949|65922284|FG001|Overall Study|Death|13|||
23598607|NCT02132949|65922283|FG000|Overall Study|Lost to Follow-up|14|||
23598608|NCT02132949|65922284|FG001|Overall Study|Lost to Follow-up|4|||
23598609|NCT02132949|65922283|FG000|Overall Study|Withdrawal by Subject|6|||
23598610|NCT02132949|65922284|FG001|Overall Study|Withdrawal by Subject|5|||
23598611|NCT02132949|65922283|FG000|Overall Study|Noncompliance|5|||
23598612|NCT02132949|65922284|FG001|Overall Study|Noncompliance|1|||
23598613|NCT02132949|65922283|FG000|Overall Study|Physician Decision|3|||
23598614|NCT02132949|65922284|FG001|Overall Study|Physician Decision|1|||
23598615|NCT02132949|65922283|FG000|Overall Study|Disease Progression|3|||
23598616|NCT02132949|65922284|FG001|Overall Study|Disease Progression|0|||
23598617|NCT02132949|65922283|FG000|Overall Study|Adverse Event|2|||
23598618|NCT02132949|65922284|FG001|Overall Study|Adverse Event|1|||
23598619|NCT02132949|65922283|FG000|Overall Study|Withdrew Prior to Treatment|1|||
23598620|NCT02132949|65922284|FG001|Overall Study|Withdrew Prior to Treatment|2|||
23598621|NCT02132949|65922283|FG000|Overall Study|Reason Unspecified|0|||
23598622|NCT02132949|65922284|FG001|Overall Study|Reason Unspecified|1|||
23598623|NCT01721291|65922285|FG000|Overall Study|Withdrawal by Subject|1|||
23598624|NCT01721291|65922286|FG001|Overall Study|Withdrawal by Subject|0|||
23598625|NCT01721291|65922285|FG000|Overall Study|did not like the treatment|1|||
23598626|NCT01721291|65922286|FG001|Overall Study|did not like the treatment|0|||
23598627|NCT01400958|65922292|FG000|Overall Study|Physician Decision|0|||
23598628|NCT01400958|65922293|FG001|Overall Study|Physician Decision|1|||
23360639|NCT01733121|65065810|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
23479102|NCT03996369|65498384|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
23479103|NCT03996369|65498385|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
23479104|NCT03996369|65498384|FG000|Overall Study|Lost to Follow-up|0|||
23479105|NCT03996369|65498385|FG001|Overall Study|Lost to Follow-up|1|||
23479106|NCT01917656|65498390|FG000|Overall Study|Adverse Event|11|||
23479107|NCT01917656|65498391|FG001|Overall Study|Adverse Event|0|||
23479108|NCT01917656|65498390|FG000|Overall Study|Withdrawal criteria|8|||
23479109|NCT01917656|65498391|FG001|Overall Study|Withdrawal criteria|14|||
23479110|NCT01917656|65498390|FG000|Overall Study|Unclassified|0|||
23479111|NCT01917656|65498391|FG001|Overall Study|Unclassified|3|||
23479112|NCT01917656|65498390|FG000|Overall Study|Withdrawal by Subject|4|||
23479113|NCT01917656|65498391|FG001|Overall Study|Withdrawal by Subject|3|||
23479114|NCT01917656|65498390|FG000|Overall Study|Lost to Follow-up|3|||
23479115|NCT01917656|65498391|FG001|Overall Study|Lost to Follow-up|4|||
23479116|NCT01343901|65498392|FG000|Overall Study|Death|85|||
23479117|NCT01343901|65498392|FG000|Overall Study|Physician Decision|4|||
23479118|NCT01343901|65498392|FG000|Overall Study|Lost to Follow-up|12|||
23479119|NCT01343901|65498392|FG000|Overall Study|Management by another medical team|11|||
23479120|NCT01343901|65498392|FG000|Overall Study|Participant decision|1|||
23479121|NCT00369629|65498393|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
23479122|NCT00369629|65498394|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
23479123|NCT00369629|65498395|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
23479124|NCT00369629|65498396|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
23479125|NCT00369629|65498393|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
23479126|NCT00369629|65498394|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
23479127|NCT00369629|65498395|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
23479128|NCT00369629|65498396|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
23479129|NCT00369629|65498393|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
23479130|NCT00369629|65498394|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
23479131|NCT00369629|65498395|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
23479132|NCT00369629|65498396|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
23479133|NCT00369629|65498393|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
23479134|NCT00369629|65498394|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
23479135|NCT00369629|65498395|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
23479136|NCT00369629|65498396|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
23479137|NCT00369629|65498393|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
23479138|NCT00369629|65498394|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
23479139|NCT00369629|65498395|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
23479140|NCT00369629|65498396|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
23479141|NCT00369629|65498393|FG000|Completed 4 More Cycles|Progressive disease|2|||
23479142|NCT00369629|65498394|FG001|Completed 4 More Cycles|Progressive disease|1|||
23479143|NCT00369629|65498395|FG002|Completed 4 More Cycles|Progressive disease|2|||
23479144|NCT00369629|65498396|FG003|Completed 4 More Cycles|Progressive disease|0|||
23479145|NCT00369629|65498393|FG000|Follow up for 1 Year|Death|2|||
23479146|NCT00369629|65498394|FG001|Follow up for 1 Year|Death|1|||
23479147|NCT00369629|65498395|FG002|Follow up for 1 Year|Death|1|||
23479148|NCT00369629|65498396|FG003|Follow up for 1 Year|Death|0|||
23479149|NCT00369629|65498393|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
23479150|NCT00369629|65498394|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
23479151|NCT00369629|65498395|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
23479152|NCT00369629|65498396|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
23598629|NCT01400958|65922292|FG000|Overall Study|Withdrawal by Subject|0|||
23598630|NCT01400958|65922293|FG001|Overall Study|Withdrawal by Subject|1|||
23255870|NCT01862328|64677010|FG005|Overall Study|Adverse Event|2|||
23255871|NCT01862328|64677011|FG006|Overall Study|Adverse Event|4|||
23255872|NCT01862328|64677005|FG000|Overall Study|Other|0|||
23255873|NCT01862328|64677006|FG001|Overall Study|Other|2|||
23255874|NCT01862328|64677007|FG002|Overall Study|Other|1|||
23255875|NCT01862328|64677008|FG003|Overall Study|Other|0|||
23255876|NCT01862328|64677009|FG004|Overall Study|Other|4|||
23255877|NCT01862328|64677010|FG005|Overall Study|Other|0|||
23255878|NCT01862328|64677011|FG006|Overall Study|Other|1|||
23255879|NCT01862328|64677005|FG000|Overall Study|Withdrawal by Subject|1|||
23255880|NCT01862328|64677006|FG001|Overall Study|Withdrawal by Subject|1|||
23255881|NCT01862328|64677007|FG002|Overall Study|Withdrawal by Subject|0|||
23255882|NCT01862328|64677008|FG003|Overall Study|Withdrawal by Subject|0|||
23255883|NCT01862328|64677009|FG004|Overall Study|Withdrawal by Subject|1|||
23360640|NCT01733121|65065811|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
23479153|NCT00369629|65498393|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
23255884|NCT01862328|64677010|FG005|Overall Study|Withdrawal by Subject|1|||
23255885|NCT01862328|64677011|FG006|Overall Study|Withdrawal by Subject|1|||
23255886|NCT01862328|64677005|FG000|Overall Study|Symptomatic Deterioration|0|||
23255887|NCT01862328|64677006|FG001|Overall Study|Symptomatic Deterioration|0|||
23255888|NCT01862328|64677007|FG002|Overall Study|Symptomatic Deterioration|0|||
23255889|NCT01862328|64677008|FG003|Overall Study|Symptomatic Deterioration|0|||
23479154|NCT00369629|65498394|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
23194928|NCT02702193|64456062|FG001|12 Month Follow up|Lost to Follow-up|18|||
23598631|NCT01400958|65922292|FG000|Overall Study|Adverse Event|1|||
23598632|NCT01400958|65922293|FG001|Overall Study|Adverse Event|0|||
23598633|NCT00331136|65922294|FG000|Overall Study|Adverse Event|3|||
23598634|NCT00331136|65922295|FG001|Overall Study|Adverse Event|5|||
23598635|NCT00331136|65922296|FG002|Overall Study|Adverse Event|0|||
23598636|NCT00331136|65922297|FG003|Overall Study|Adverse Event|1|||
23598637|NCT00331136|65922294|FG000|Overall Study|Withdrawal by Subject|0|||
23598638|NCT00331136|65922295|FG001|Overall Study|Withdrawal by Subject|1|||
23598639|NCT00331136|65922296|FG002|Overall Study|Withdrawal by Subject|0|||
23598640|NCT00331136|65922297|FG003|Overall Study|Withdrawal by Subject|0|||
23598641|NCT00331136|65922294|FG000|Overall Study|Lost to Follow-up|0|||
23598642|NCT00331136|65922295|FG001|Overall Study|Lost to Follow-up|1|||
23598643|NCT00331136|65922296|FG002|Overall Study|Lost to Follow-up|0|||
23598644|NCT00331136|65922297|FG003|Overall Study|Lost to Follow-up|0|||
23598645|NCT00331136|65922294|FG000|Overall Study|Protocol Violation|1|||
23598646|NCT00331136|65922295|FG001|Overall Study|Protocol Violation|0|||
23598647|NCT00331136|65922296|FG002|Overall Study|Protocol Violation|0|||
23598648|NCT00331136|65922297|FG003|Overall Study|Protocol Violation|0|||
23598649|NCT00331136|65922294|FG000|Overall Study|Not treated|1|||
23598650|NCT00331136|65922295|FG001|Overall Study|Not treated|0|||
23598651|NCT00331136|65922296|FG002|Overall Study|Not treated|0|||
23598652|NCT00331136|65922297|FG003|Overall Study|Not treated|0|||
23598653|NCT00371787|65922298|FG000|Overall Study|Withdrawal by Subject|3|||
23598654|NCT00371787|65922299|FG001|Overall Study|Withdrawal by Subject|1|||
23598655|NCT02555215|65922300|FG000|Overall Study|Other|1|||
23598656|NCT02555215|65922300|FG000|Overall Study|Investigator Decision|2|||
23598657|NCT04121546|65922301|FG000|Overall Study|Lost to Follow-up|1|||
23598658|NCT04121546|65922302|FG001|Overall Study|Lost to Follow-up|3|||
23598659|NCT04860505|65922307|FG000|Overall Study|Lost to Follow-up|2|||
23598660|NCT02147093|65922308|FG000|Period 1|Lost to Follow-up|0|||
23598661|NCT02147093|65922309|FG001|Period 1|Lost to Follow-up|1|||
23598662|NCT02147093|65922308|FG000|Period 2|Protocol Violation|2|||
23598663|NCT02147093|65922309|FG001|Period 2|Protocol Violation|0|||
23194929|NCT03662334|64456063|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
23194930|NCT03662334|64456064|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
23194931|NCT00436215|64456070|FG000|Overall Study|Refused further treatment|3|||
23194932|NCT00436215|64456070|FG000|Overall Study|Small bowel obstruction|1|||
23194933|NCT02046564|64456073|FG000|Overall Study|Adverse Event|6|||
23194934|NCT02046564|64456074|FG001|Overall Study|Adverse Event|3|||
23194935|NCT02046564|64456073|FG000|Overall Study|Physician Decision|0|||
23194936|NCT02046564|64456074|FG001|Overall Study|Physician Decision|1|||
23194937|NCT02046564|64456073|FG000|Overall Study|Protocol Violation|3|||
23194938|NCT02046564|64456074|FG001|Overall Study|Protocol Violation|1|||
23194939|NCT02046564|64456073|FG000|Overall Study|Withdrawal by Subject|4|||
23194940|NCT02046564|64456074|FG001|Overall Study|Withdrawal by Subject|10|||
23194941|NCT02046564|64456073|FG000|Overall Study|Subject met withdrawal criteria|2|||
23194942|NCT02046564|64456074|FG001|Overall Study|Subject met withdrawal criteria|5|||
23194943|NCT02062151|64456075|FG000|Overall Study|screen failure|1|||
23479155|NCT00369629|65498395|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
23479156|NCT00369629|65498396|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
23479157|NCT01470989|65498397|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
23479158|NCT01470989|65498398|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
23479159|NCT01470989|65498397|FG000|Overall Study|Adverse Event|2|||
23479160|NCT01470989|65498398|FG001|Overall Study|Adverse Event|5|||
23479161|NCT01470989|65498397|FG000|Overall Study|Abnormal laboratory value|1|||
23479162|NCT01470989|65498398|FG001|Overall Study|Abnormal laboratory value|1|||
23194944|NCT04283461|64456076|FG000|Overall Study|Enrolled in separate trial|0|||
23194945|NCT04283461|64456077|FG001|Overall Study|Enrolled in separate trial|0|||
23194946|NCT04283461|64456078|FG002|Overall Study|Enrolled in separate trial|8|||
23479163|NCT01470989|65498397|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23479164|NCT01470989|65498398|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
23598664|NCT01079949|65922310|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
23598665|NCT01079949|65922311|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
23598666|NCT01079949|65922310|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
23598667|NCT01079949|65922311|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
23598668|NCT01079949|65922310|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
23598669|NCT01079949|65922311|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
23598670|NCT01079949|65922310|FG000|Overall Study|Randomized but not treated|1|||
23479165|NCT01470989|65498397|FG000|Overall Study|Withdrawal by Subject|19|||
23479166|NCT01470989|65498398|FG001|Overall Study|Withdrawal by Subject|17|||
23479167|NCT01470989|65498397|FG000|Overall Study|Lost to Follow-up|18|||
23255890|NCT01862328|64677009|FG004|Overall Study|Symptomatic Deterioration|0|||
23255891|NCT01862328|64677010|FG005|Overall Study|Symptomatic Deterioration|0|||
23255892|NCT01862328|64677011|FG006|Overall Study|Symptomatic Deterioration|1|||
23255893|NCT03156270|64677020|FG000|Overall Study|Failed pre-treatment screening|1|||
23255894|NCT03156270|64677020|FG000|Overall Study|Lost to Follow-up|1|||
23479168|NCT01470989|65498398|FG001|Overall Study|Lost to Follow-up|13|||
23479169|NCT01470989|65498397|FG000|Overall Study|Administrative problems|2|||
23479170|NCT01470989|65498398|FG001|Overall Study|Administrative problems|4|||
23479171|NCT01470989|65498397|FG000|Overall Study|Death|2|||
23479172|NCT01470989|65498398|FG001|Overall Study|Death|2|||
23479173|NCT01470989|65498397|FG000|Overall Study|Protocol deviation|1|||
23479174|NCT01470989|65498398|FG001|Overall Study|Protocol deviation|2|||
23479175|NCT01561898|65498399|FG000|Overall Study|Withdrawal by Subject|0|||
23479176|NCT01561898|65498400|FG001|Overall Study|Withdrawal by Subject|8|||
23479177|NCT01561898|65498401|FG002|Overall Study|Withdrawal by Subject|12|||
23479178|NCT01561898|65498402|FG003|Overall Study|Withdrawal by Subject|5|||
23479179|NCT01561898|65498399|FG000|Overall Study|Lack of Efficacy|0|||
23479180|NCT01561898|65498400|FG001|Overall Study|Lack of Efficacy|8|||
23479181|NCT01561898|65498401|FG002|Overall Study|Lack of Efficacy|10|||
23479182|NCT01561898|65498402|FG003|Overall Study|Lack of Efficacy|5|||
23479183|NCT01561898|65498399|FG000|Overall Study|Worsening of complications|0|||
23598671|NCT01079949|65922311|FG001|Overall Study|Randomized but not treated|0|||
23598672|NCT03014453|65922312|FG000|Overall Study|Lost to Follow-up|12|||
23598673|NCT03014453|65922312|FG000|Overall Study|Discontinued GER|3|||
23598674|NCT03014453|65922312|FG000|Overall Study|Excluded|19|||
23194947|NCT04283461|64456079|FG003|Overall Study|Enrolled in separate trial|13|||
23360641|NCT00960804|65065819|FG000|Overall Study|Adverse Event|1|||
23479184|NCT01561898|65498400|FG001|Overall Study|Worsening of complications|1|||
23479185|NCT01561898|65498401|FG002|Overall Study|Worsening of complications|0|||
23479186|NCT01561898|65498402|FG003|Overall Study|Worsening of complications|0|||
23479187|NCT01561898|65498399|FG000|Overall Study|Lost to Follow-up|0|||
23479188|NCT01561898|65498400|FG001|Overall Study|Lost to Follow-up|0|||
23479189|NCT01561898|65498401|FG002|Overall Study|Lost to Follow-up|1|||
23479190|NCT01561898|65498402|FG003|Overall Study|Lost to Follow-up|0|||
23479191|NCT01561898|65498399|FG000|Overall Study|Adverse Event|1|||
23479192|NCT01561898|65498400|FG001|Overall Study|Adverse Event|19|||
23479193|NCT01561898|65498401|FG002|Overall Study|Adverse Event|14|||
23479194|NCT01561898|65498402|FG003|Overall Study|Adverse Event|9|||
23479195|NCT01561898|65498399|FG000|Overall Study|Physician Decision|1|||
23479196|NCT01561898|65498400|FG001|Overall Study|Physician Decision|5|||
23479197|NCT01561898|65498401|FG002|Overall Study|Physician Decision|7|||
23479198|NCT01561898|65498402|FG003|Overall Study|Physician Decision|1|||
23479199|NCT01566214|65498403|FG000|Overall Study|Lost to Follow-up|3|||
23479200|NCT01566214|65498404|FG001|Overall Study|Lost to Follow-up|0|||
23479201|NCT00129311|65498407|FG000|Overall Study|Withdrawal by Subject|12|||
23479202|NCT00129311|65498408|FG001|Overall Study|Withdrawal by Subject|19|||
23479203|NCT00890045|65498409|FG000|Overall Study|Death|0|||
23479204|NCT00890045|65498410|FG001|Overall Study|Death|1|||
23479205|NCT00890045|65498409|FG000|Overall Study|Did not receive HeRO Graft|0|||
23479206|NCT00890045|65498410|FG001|Overall Study|Did not receive HeRO Graft|2|||
23479207|NCT00890045|65498409|FG000|Overall Study|Lost to Follow-up|5|||
23479208|NCT00890045|65498410|FG001|Overall Study|Lost to Follow-up|7|||
23479209|NCT03452527|65498415|FG000|Overall Study|Withdrawal by Subject|1|||
23479210|NCT03452527|65498416|FG001|Overall Study|Withdrawal by Subject|1|||
23479211|NCT03452527|65498415|FG000|Overall Study|Study Terminated|2|||
23479212|NCT03452527|65498416|FG001|Overall Study|Study Terminated|3|||
23479213|NCT00879879|65498418|FG000|Overall Study|Death|1|||
23479214|NCT00879879|65498418|FG000|Overall Study|Withdrawal by Subject|1|||
23479215|NCT00879879|65498418|FG000|Overall Study|Physician Decision|1|||
23479216|NCT01106092|65498421|FG000|Overall Study|Withdrawal by Subject|0|||
23479217|NCT01106092|65498422|FG001|Overall Study|Withdrawal by Subject|0|||
23479218|NCT01106092|65498423|FG002|Overall Study|Withdrawal by Subject|0|||
23479219|NCT01106092|65498424|FG003|Overall Study|Withdrawal by Subject|1|||
23479220|NCT01642732|65498433|FG000|Overall Study|Withdrawal by Subject|1|||
23479221|NCT02683746|65498444|FG000|Overall Study|Adverse Event|3|||
23479222|NCT02683746|65498445|FG001|Overall Study|Adverse Event|2|||
23479223|NCT02683746|65498444|FG000|Overall Study|Lost to Follow-up|5|||
23479224|NCT02683746|65498445|FG001|Overall Study|Lost to Follow-up|6|||
23479225|NCT02683746|65498444|FG000|Overall Study|Withdrawal by Subject|6|||
23479226|NCT02683746|65498445|FG001|Overall Study|Withdrawal by Subject|5|||
23479227|NCT02683746|65498444|FG000|Overall Study|Physician Decision|2|||
23479228|NCT02683746|65498445|FG001|Overall Study|Physician Decision|1|||
23479229|NCT01579812|65498447|FG000|Overall Study|Ineligible after treatment start|40|||
23479230|NCT01579812|65498447|FG000|Overall Study|Patient choice|3|||
23479231|NCT01579812|65498447|FG000|Overall Study|Noncompliance|3|||
23479232|NCT01579812|65498447|FG000|Overall Study|Withdrawal by Subject|6|||
23479233|NCT01375075|65498448|FG000|Overall Study|Adverse Event|0|||
23479234|NCT01375075|65498449|FG001|Overall Study|Adverse Event|0|||
23479235|NCT01375075|65498450|FG002|Overall Study|Adverse Event|3|||
23479236|NCT01375075|65498451|FG003|Overall Study|Adverse Event|1|||
23479237|NCT01375075|65498452|FG004|Overall Study|Adverse Event|0|||
23479238|NCT01375075|65498453|FG005|Overall Study|Adverse Event|1|||
23479239|NCT01375075|65498448|FG000|Overall Study|Entry Criterion Not Met|1|||
23479240|NCT01375075|65498449|FG001|Overall Study|Entry Criterion Not Met|0|||
23479241|NCT01375075|65498450|FG002|Overall Study|Entry Criterion Not Met|0|||
23479242|NCT01375075|65498451|FG003|Overall Study|Entry Criterion Not Met|0|||
23479243|NCT01375075|65498452|FG004|Overall Study|Entry Criterion Not Met|0|||
23479244|NCT01375075|65498453|FG005|Overall Study|Entry Criterion Not Met|1|||
23479245|NCT01375075|65498448|FG000|Overall Study|Withdrawal by Subject|0|||
23479246|NCT01375075|65498449|FG001|Overall Study|Withdrawal by Subject|1|||
23598675|NCT03014453|65922312|FG000|Overall Study|Refused to take part in|37|||
23598676|NCT00943917|65922313|FG000|Stage I|Adverse Event|1|||
23479247|NCT01375075|65498450|FG002|Overall Study|Withdrawal by Subject|0|||
23479248|NCT01375075|65498451|FG003|Overall Study|Withdrawal by Subject|0|||
23479249|NCT01375075|65498452|FG004|Overall Study|Withdrawal by Subject|0|||
23479250|NCT01375075|65498453|FG005|Overall Study|Withdrawal by Subject|1|||
23479251|NCT04136444|65498456|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
23479252|NCT04136444|65498457|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
23479253|NCT02923921|65498459|FG000|Overall Study|Sponsor Decision|39|||
23598677|NCT00943917|65922314|FG001|Stage I|Adverse Event|2|||
23598678|NCT00943917|65922315|FG002|Stage I|Adverse Event|2|||
23598679|NCT00943917|65922316|FG003|Stage I|Adverse Event|0|||
23598680|NCT00943917|65922317|FG004|Stage I|Adverse Event|0|||
23598681|NCT00943917|65922318|FG005|Stage I|Adverse Event|0|||
23598682|NCT00943917|65922319|FG006|Stage I|Adverse Event|0|||
23598683|NCT00943917|65922320|FG007|Stage I|Adverse Event|0|||
23598684|NCT00943917|65922321|FG008|Stage I|Adverse Event|0|||
23598685|NCT00943917|65922322|FG009|Stage I|Adverse Event|0|||
23598686|NCT00943917|65922323|FG010|Stage I|Adverse Event|0|||
23598687|NCT00943917|65922324|FG011|Stage I|Adverse Event|0|||
23598688|NCT00943917|65922325|FG012|Stage I|Adverse Event|0|||
23598689|NCT00943917|65922326|FG013|Stage I|Adverse Event|0|||
23598690|NCT00943917|65922327|FG014|Stage I|Adverse Event|0|||
23598691|NCT00943917|65922313|FG000|Stage I|Lost to Follow-up|0|||
23598692|NCT00943917|65922314|FG001|Stage I|Lost to Follow-up|0|||
23598693|NCT00943917|65922315|FG002|Stage I|Lost to Follow-up|1|||
23598694|NCT00943917|65922316|FG003|Stage I|Lost to Follow-up|0|||
23598695|NCT00943917|65922317|FG004|Stage I|Lost to Follow-up|0|||
23598696|NCT00943917|65922318|FG005|Stage I|Lost to Follow-up|0|||
23598697|NCT00943917|65922319|FG006|Stage I|Lost to Follow-up|0|||
23598698|NCT00943917|65922320|FG007|Stage I|Lost to Follow-up|0|||
23598699|NCT00943917|65922321|FG008|Stage I|Lost to Follow-up|0|||
23598700|NCT00943917|65922322|FG009|Stage I|Lost to Follow-up|0|||
23598701|NCT00943917|65922323|FG010|Stage I|Lost to Follow-up|0|||
23598702|NCT00943917|65922324|FG011|Stage I|Lost to Follow-up|0|||
23598703|NCT00943917|65922325|FG012|Stage I|Lost to Follow-up|0|||
23598704|NCT00943917|65922326|FG013|Stage I|Lost to Follow-up|0|||
23598705|NCT00943917|65922327|FG014|Stage I|Lost to Follow-up|0|||
23598706|NCT00943917|65922313|FG000|Stage I|hyperglycemia|0|||
23598707|NCT00943917|65922314|FG001|Stage I|hyperglycemia|0|||
23598708|NCT00943917|65922315|FG002|Stage I|hyperglycemia|1|||
23598709|NCT00943917|65922316|FG003|Stage I|hyperglycemia|0|||
23598710|NCT00943917|65922317|FG004|Stage I|hyperglycemia|0|||
23598711|NCT00943917|65922318|FG005|Stage I|hyperglycemia|0|||
23598712|NCT00943917|65922319|FG006|Stage I|hyperglycemia|0|||
23598713|NCT00943917|65922320|FG007|Stage I|hyperglycemia|0|||
23598714|NCT00943917|65922321|FG008|Stage I|hyperglycemia|0|||
23598715|NCT00943917|65922322|FG009|Stage I|hyperglycemia|0|||
23598716|NCT00943917|65922323|FG010|Stage I|hyperglycemia|0|||
23598717|NCT00943917|65922324|FG011|Stage I|hyperglycemia|0|||
23598718|NCT00943917|65922325|FG012|Stage I|hyperglycemia|0|||
23598719|NCT00943917|65922326|FG013|Stage I|hyperglycemia|0|||
23598720|NCT00943917|65922327|FG014|Stage I|hyperglycemia|0|||
23598721|NCT00943917|65922313|FG000|Stage I|A1C elevation|1|||
23598722|NCT00943917|65922314|FG001|Stage I|A1C elevation|0|||
23598723|NCT00943917|65922315|FG002|Stage I|A1C elevation|0|||
23598724|NCT00943917|65922316|FG003|Stage I|A1C elevation|0|||
23598725|NCT00943917|65922317|FG004|Stage I|A1C elevation|0|||
23598726|NCT00943917|65922318|FG005|Stage I|A1C elevation|0|||
23598727|NCT00943917|65922319|FG006|Stage I|A1C elevation|0|||
23598728|NCT00943917|65922320|FG007|Stage I|A1C elevation|0|||
23598729|NCT00943917|65922321|FG008|Stage I|A1C elevation|0|||
23598730|NCT00943917|65922322|FG009|Stage I|A1C elevation|0|||
23598731|NCT00943917|65922323|FG010|Stage I|A1C elevation|0|||
23598732|NCT00943917|65922324|FG011|Stage I|A1C elevation|0|||
23598733|NCT00943917|65922325|FG012|Stage I|A1C elevation|0|||
23598734|NCT00943917|65922326|FG013|Stage I|A1C elevation|0|||
23598735|NCT00943917|65922327|FG014|Stage I|A1C elevation|0|||
23598736|NCT00943917|65922313|FG000|Stage I|Withdrawal by Subject|2|||
23598737|NCT00943917|65922314|FG001|Stage I|Withdrawal by Subject|1|||
23598738|NCT00943917|65922315|FG002|Stage I|Withdrawal by Subject|2|||
23598739|NCT00943917|65922316|FG003|Stage I|Withdrawal by Subject|0|||
23598740|NCT00943917|65922317|FG004|Stage I|Withdrawal by Subject|0|||
23598741|NCT00943917|65922318|FG005|Stage I|Withdrawal by Subject|0|||
23598742|NCT00943917|65922319|FG006|Stage I|Withdrawal by Subject|0|||
23598743|NCT00943917|65922320|FG007|Stage I|Withdrawal by Subject|0|||
23598744|NCT00943917|65922321|FG008|Stage I|Withdrawal by Subject|0|||
23598745|NCT00943917|65922322|FG009|Stage I|Withdrawal by Subject|0|||
23598746|NCT00943917|65922323|FG010|Stage I|Withdrawal by Subject|0|||
23598747|NCT00943917|65922324|FG011|Stage I|Withdrawal by Subject|0|||
23598748|NCT00943917|65922325|FG012|Stage I|Withdrawal by Subject|0|||
23598749|NCT00943917|65922326|FG013|Stage I|Withdrawal by Subject|0|||
23598750|NCT00943917|65922327|FG014|Stage I|Withdrawal by Subject|0|||
23255895|NCT00065065|64677021|FG000|Overall Study|Adverse Event|3|||
23598751|NCT00943917|65922313|FG000|Stage II|Adverse Event|0|||
23598752|NCT00943917|65922314|FG001|Stage II|Adverse Event|0|||
23598753|NCT00943917|65922315|FG002|Stage II|Adverse Event|0|||
23598754|NCT00943917|65922316|FG003|Stage II|Adverse Event|0|||
23598755|NCT00943917|65922317|FG004|Stage II|Adverse Event|0|||
23598756|NCT00943917|65922318|FG005|Stage II|Adverse Event|1|||
23598757|NCT00943917|65922319|FG006|Stage II|Adverse Event|3|||
23598758|NCT00943917|65922320|FG007|Stage II|Adverse Event|0|||
23598759|NCT00943917|65922321|FG008|Stage II|Adverse Event|1|||
23598760|NCT00943917|65922322|FG009|Stage II|Adverse Event|0|||
23598761|NCT00943917|65922323|FG010|Stage II|Adverse Event|0|||
23598762|NCT00943917|65922324|FG011|Stage II|Adverse Event|0|||
23598763|NCT00943917|65922325|FG012|Stage II|Adverse Event|0|||
23598764|NCT00943917|65922326|FG013|Stage II|Adverse Event|0|||
23598765|NCT00943917|65922327|FG014|Stage II|Adverse Event|0|||
23598766|NCT00943917|65922313|FG000|Stage II|Withdrawal by Subject|0|||
23598767|NCT00943917|65922314|FG001|Stage II|Withdrawal by Subject|0|||
23598768|NCT00943917|65922315|FG002|Stage II|Withdrawal by Subject|0|||
23598769|NCT00943917|65922316|FG003|Stage II|Withdrawal by Subject|0|||
23598770|NCT00943917|65922317|FG004|Stage II|Withdrawal by Subject|0|||
23255896|NCT00065065|64677022|FG001|Overall Study|Adverse Event|2|||
23598771|NCT00943917|65922318|FG005|Stage II|Withdrawal by Subject|1|||
23598772|NCT00943917|65922319|FG006|Stage II|Withdrawal by Subject|0|||
23598773|NCT00943917|65922320|FG007|Stage II|Withdrawal by Subject|0|||
23598774|NCT00943917|65922321|FG008|Stage II|Withdrawal by Subject|0|||
23598775|NCT00943917|65922322|FG009|Stage II|Withdrawal by Subject|0|||
23598776|NCT00943917|65922323|FG010|Stage II|Withdrawal by Subject|0|||
23255897|NCT00065065|64677021|FG000|Overall Study|Withdrawal by Subject|1|||
23255898|NCT00065065|64677022|FG001|Overall Study|Withdrawal by Subject|5|||
23255899|NCT00065065|64677021|FG000|Overall Study|Lack of Efficacy|4|||
23255900|NCT00065065|64677022|FG001|Overall Study|Lack of Efficacy|11|||
23255901|NCT00065065|64677021|FG000|Overall Study|Other|2|||
23598777|NCT00943917|65922324|FG011|Stage II|Withdrawal by Subject|0|||
23598778|NCT00943917|65922325|FG012|Stage II|Withdrawal by Subject|0|||
23598779|NCT00943917|65922326|FG013|Stage II|Withdrawal by Subject|0|||
23598780|NCT00943917|65922327|FG014|Stage II|Withdrawal by Subject|0|||
23598781|NCT00943917|65922313|FG000|Stage II|Pregnancy|0|||
23598782|NCT00943917|65922314|FG001|Stage II|Pregnancy|0|||
23598783|NCT00943917|65922315|FG002|Stage II|Pregnancy|0|||
23598784|NCT00943917|65922316|FG003|Stage II|Pregnancy|0|||
23598785|NCT00943917|65922317|FG004|Stage II|Pregnancy|0|||
23598786|NCT00943917|65922318|FG005|Stage II|Pregnancy|1|||
23598787|NCT00943917|65922319|FG006|Stage II|Pregnancy|0|||
23598788|NCT00943917|65922320|FG007|Stage II|Pregnancy|0|||
23598789|NCT00943917|65922321|FG008|Stage II|Pregnancy|0|||
23598790|NCT00943917|65922322|FG009|Stage II|Pregnancy|0|||
23360642|NCT00960804|65065820|FG001|Overall Study|Adverse Event|0|||
23360643|NCT00960804|65065821|FG002|Overall Study|Adverse Event|0|||
23360644|NCT00960804|65065819|FG000|Overall Study|Withdrawal by Subject|1|||
23360645|NCT00960804|65065820|FG001|Overall Study|Withdrawal by Subject|0|||
23360646|NCT00960804|65065821|FG002|Overall Study|Withdrawal by Subject|0|||
23360647|NCT00960804|65065819|FG000|Overall Study|Study terminated by the sponsor|5|||
23360648|NCT00960804|65065820|FG001|Overall Study|Study terminated by the sponsor|4|||
23598791|NCT00943917|65922323|FG010|Stage II|Pregnancy|0|||
23255902|NCT00065065|64677022|FG001|Overall Study|Other|2|||
23255903|NCT00986154|64679894|FG000|Overall Study|Death|136|||
23598792|NCT00943917|65922324|FG011|Stage II|Pregnancy|0|||
23598793|NCT00943917|65922325|FG012|Stage II|Pregnancy|0|||
23598794|NCT00943917|65922326|FG013|Stage II|Pregnancy|0|||
23255904|NCT00986154|64679895|FG001|Overall Study|Death|127|||
23598795|NCT00943917|65922327|FG014|Stage II|Pregnancy|0|||
23255905|NCT00986154|64679894|FG000|Overall Study|Lost to Follow-up|7|||
23255906|NCT00986154|64679895|FG001|Overall Study|Lost to Follow-up|4|||
23255907|NCT00986154|64679894|FG000|Overall Study|Withdrawal by Subject|32|||
23255908|NCT00986154|64679895|FG001|Overall Study|Withdrawal by Subject|33|||
23255909|NCT00986154|64679894|FG000|Overall Study|investigator/subject decide not continue|6|||
23255910|NCT00986154|64679895|FG001|Overall Study|investigator/subject decide not continue|3|||
23255911|NCT00986154|64679894|FG000|Overall Study|never received study drug|25|||
23255912|NCT00986154|64679895|FG001|Overall Study|never received study drug|27|||
23255913|NCT01759537|64679898|FG000|Overall Study|Death|1|||
23255914|NCT01759537|64679899|FG001|Overall Study|Death|1|||
23255915|NCT01759537|64679898|FG000|Overall Study|Pregnancy|1|||
23255916|NCT01759537|64679899|FG001|Overall Study|Pregnancy|1|||
23255917|NCT01759537|64679898|FG000|Overall Study|Lost to Follow-up|9|||
23360649|NCT00960804|65065821|FG002|Overall Study|Study terminated by the sponsor|10|||
23255918|NCT01759537|64679899|FG001|Overall Study|Lost to Follow-up|9|||
23255919|NCT01759537|64679898|FG000|Overall Study|Accident involving jaw fracture|1|||
23598796|NCT00943917|65922313|FG000|Stage II Continuation|Adverse Event|0|||
23598797|NCT00943917|65922314|FG001|Stage II Continuation|Adverse Event|0|||
23598798|NCT00943917|65922315|FG002|Stage II Continuation|Adverse Event|0|||
23598799|NCT00943917|65922316|FG003|Stage II Continuation|Adverse Event|0|||
23598800|NCT00943917|65922317|FG004|Stage II Continuation|Adverse Event|0|||
23598801|NCT00943917|65922318|FG005|Stage II Continuation|Adverse Event|0|||
23598802|NCT00943917|65922319|FG006|Stage II Continuation|Adverse Event|0|||
23598803|NCT00943917|65922320|FG007|Stage II Continuation|Adverse Event|0|||
23598804|NCT00943917|65922321|FG008|Stage II Continuation|Adverse Event|0|||
23598805|NCT00943917|65922322|FG009|Stage II Continuation|Adverse Event|0|||
23598806|NCT00943917|65922323|FG010|Stage II Continuation|Adverse Event|0|||
23598807|NCT00943917|65922324|FG011|Stage II Continuation|Adverse Event|1|||
23598808|NCT00943917|65922325|FG012|Stage II Continuation|Adverse Event|2|||
23598809|NCT00943917|65922326|FG013|Stage II Continuation|Adverse Event|1|||
23598810|NCT00943917|65922327|FG014|Stage II Continuation|Adverse Event|1|||
23598811|NCT00943917|65922313|FG000|Stage II Continuation|Withdrawal by Subject|0|||
23598812|NCT00943917|65922314|FG001|Stage II Continuation|Withdrawal by Subject|0|||
23598813|NCT00943917|65922315|FG002|Stage II Continuation|Withdrawal by Subject|0|||
23598814|NCT00943917|65922316|FG003|Stage II Continuation|Withdrawal by Subject|0|||
23598815|NCT00943917|65922317|FG004|Stage II Continuation|Withdrawal by Subject|0|||
23598816|NCT00943917|65922318|FG005|Stage II Continuation|Withdrawal by Subject|0|||
23598817|NCT00943917|65922319|FG006|Stage II Continuation|Withdrawal by Subject|0|||
23598818|NCT00943917|65922320|FG007|Stage II Continuation|Withdrawal by Subject|0|||
23598819|NCT00943917|65922321|FG008|Stage II Continuation|Withdrawal by Subject|0|||
23598820|NCT00943917|65922322|FG009|Stage II Continuation|Withdrawal by Subject|0|||
23598821|NCT00943917|65922323|FG010|Stage II Continuation|Withdrawal by Subject|0|||
23598822|NCT00943917|65922324|FG011|Stage II Continuation|Withdrawal by Subject|0|||
23598823|NCT00943917|65922325|FG012|Stage II Continuation|Withdrawal by Subject|0|||
23598824|NCT00943917|65922326|FG013|Stage II Continuation|Withdrawal by Subject|1|||
23598825|NCT00943917|65922327|FG014|Stage II Continuation|Withdrawal by Subject|3|||
23598826|NCT00943917|65922313|FG000|Stage II Continuation|Protocol Violation|0|||
23598827|NCT00943917|65922314|FG001|Stage II Continuation|Protocol Violation|0|||
23598828|NCT00943917|65922315|FG002|Stage II Continuation|Protocol Violation|0|||
23598829|NCT00943917|65922316|FG003|Stage II Continuation|Protocol Violation|0|||
23598830|NCT00943917|65922317|FG004|Stage II Continuation|Protocol Violation|0|||
23598831|NCT00943917|65922318|FG005|Stage II Continuation|Protocol Violation|0|||
23598832|NCT00943917|65922319|FG006|Stage II Continuation|Protocol Violation|0|||
23598833|NCT00943917|65922320|FG007|Stage II Continuation|Protocol Violation|0|||
23598834|NCT00943917|65922321|FG008|Stage II Continuation|Protocol Violation|0|||
23598835|NCT00943917|65922322|FG009|Stage II Continuation|Protocol Violation|1|||
23598836|NCT00943917|65922323|FG010|Stage II Continuation|Protocol Violation|0|||
23598837|NCT00943917|65922324|FG011|Stage II Continuation|Protocol Violation|1|||
23598838|NCT00943917|65922325|FG012|Stage II Continuation|Protocol Violation|0|||
23598839|NCT00943917|65922326|FG013|Stage II Continuation|Protocol Violation|0|||
23598840|NCT00943917|65922327|FG014|Stage II Continuation|Protocol Violation|0|||
23598841|NCT00943917|65922313|FG000|Stage II Continuation|hypoglycemia|0|||
23598842|NCT00943917|65922314|FG001|Stage II Continuation|hypoglycemia|0|||
23598843|NCT00943917|65922315|FG002|Stage II Continuation|hypoglycemia|0|||
23598844|NCT00943917|65922316|FG003|Stage II Continuation|hypoglycemia|0|||
23598845|NCT00943917|65922317|FG004|Stage II Continuation|hypoglycemia|0|||
23598846|NCT00943917|65922318|FG005|Stage II Continuation|hypoglycemia|0|||
23598847|NCT00943917|65922319|FG006|Stage II Continuation|hypoglycemia|0|||
23598848|NCT00943917|65922320|FG007|Stage II Continuation|hypoglycemia|0|||
23598849|NCT00943917|65922321|FG008|Stage II Continuation|hypoglycemia|0|||
23598850|NCT00943917|65922322|FG009|Stage II Continuation|hypoglycemia|0|||
23598851|NCT00943917|65922323|FG010|Stage II Continuation|hypoglycemia|0|||
23598852|NCT00943917|65922324|FG011|Stage II Continuation|hypoglycemia|0|||
23598853|NCT00943917|65922325|FG012|Stage II Continuation|hypoglycemia|1|||
23598854|NCT00943917|65922326|FG013|Stage II Continuation|hypoglycemia|0|||
23598855|NCT00943917|65922327|FG014|Stage II Continuation|hypoglycemia|0|||
23598856|NCT00943917|65922313|FG000|Stage II Continuation|A1C elevation|0|||
23598857|NCT00943917|65922314|FG001|Stage II Continuation|A1C elevation|0|||
23598858|NCT00943917|65922315|FG002|Stage II Continuation|A1C elevation|0|||
23598859|NCT00943917|65922316|FG003|Stage II Continuation|A1C elevation|0|||
23598860|NCT00943917|65922317|FG004|Stage II Continuation|A1C elevation|0|||
23598861|NCT00943917|65922318|FG005|Stage II Continuation|A1C elevation|0|||
23598862|NCT00943917|65922319|FG006|Stage II Continuation|A1C elevation|0|||
23598863|NCT00943917|65922320|FG007|Stage II Continuation|A1C elevation|0|||
23598864|NCT00943917|65922321|FG008|Stage II Continuation|A1C elevation|0|||
23598865|NCT00943917|65922322|FG009|Stage II Continuation|A1C elevation|0|||
23598866|NCT00943917|65922323|FG010|Stage II Continuation|A1C elevation|0|||
23598867|NCT00943917|65922324|FG011|Stage II Continuation|A1C elevation|0|||
23598868|NCT00943917|65922325|FG012|Stage II Continuation|A1C elevation|0|||
23598869|NCT00943917|65922326|FG013|Stage II Continuation|A1C elevation|1|||
23479254|NCT02923921|65498460|FG001|Overall Study|Sponsor Decision|38|||
23598870|NCT00943917|65922327|FG014|Stage II Continuation|A1C elevation|0|||
23598871|NCT03102034|65922328|FG000|Overall Study|Withdrawal by Subject|1|||
23598872|NCT03102034|65922329|FG001|Overall Study|Withdrawal by Subject|0|||
23598873|NCT01939899|65922330|FG000|Lead-in Dose Finding Phase|Death|0|||
23598874|NCT01939899|65922331|FG001|Lead-in Dose Finding Phase|Death|3|||
23598875|NCT01939899|65922332|FG002|Lead-in Dose Finding Phase|Death|1|||
23598876|NCT01939899|65922333|FG003|Lead-in Dose Finding Phase|Death|0|||
23598877|NCT01939899|65922334|FG004|Lead-in Dose Finding Phase|Death|0|||
23598878|NCT01939899|65922330|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
23598879|NCT01939899|65922331|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
23598880|NCT01939899|65922332|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
23598881|NCT01939899|65922333|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
23598882|NCT01939899|65922334|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
23598883|NCT01939899|65922330|FG000|Lead-in Dose Finding Phase|Other|0|||
23598884|NCT01939899|65922331|FG001|Lead-in Dose Finding Phase|Other|0|||
23598885|NCT01939899|65922332|FG002|Lead-in Dose Finding Phase|Other|1|||
23598886|NCT01939899|65922333|FG003|Lead-in Dose Finding Phase|Other|0|||
23598887|NCT01939899|65922334|FG004|Lead-in Dose Finding Phase|Other|0|||
23598888|NCT01939899|65922330|FG000|Phase 2|Withdrawal by Subject|0|||
23598889|NCT01939899|65922331|FG001|Phase 2|Withdrawal by Subject|0|||
23598890|NCT01939899|65922332|FG002|Phase 2|Withdrawal by Subject|0|||
23598891|NCT01939899|65922333|FG003|Phase 2|Withdrawal by Subject|2|||
23598892|NCT01939899|65922334|FG004|Phase 2|Withdrawal by Subject|0|||
23598893|NCT01939899|65922330|FG000|Phase 2|Disease Progression|0|||
23598894|NCT01939899|65922331|FG001|Phase 2|Disease Progression|0|||
23598895|NCT01939899|65922332|FG002|Phase 2|Disease Progression|0|||
23598896|NCT01939899|65922333|FG003|Phase 2|Disease Progression|9|||
23598897|NCT01939899|65922334|FG004|Phase 2|Disease Progression|1|||
23598898|NCT00093015|65922336|FG000|Overall Study|Withdrawal by Subject|194|||
23598899|NCT00093015|65922337|FG001|Overall Study|Withdrawal by Subject|171|||
23598900|NCT00093015|65922336|FG000|Overall Study|Lost to Follow-up|96|||
23598901|NCT00093015|65922337|FG001|Overall Study|Lost to Follow-up|108|||
23598902|NCT00093015|65922336|FG000|Overall Study|Death|375|||
23598903|NCT00093015|65922337|FG001|Overall Study|Death|385|||
23598904|NCT02962284|65922338|FG000|Overall Study|Death|2|||
23598905|NCT02962284|65922339|FG001|Overall Study|Death|0|||
23598906|NCT02962284|65922338|FG000|Overall Study|Progressive disease|2|||
23598907|NCT02962284|65922339|FG001|Overall Study|Progressive disease|3|||
23598908|NCT02962284|65922338|FG000|Overall Study|Withdrawal by Subject|1|||
23598909|NCT02962284|65922339|FG001|Overall Study|Withdrawal by Subject|0|||
23598910|NCT00112359|65922340|FG000|Overall Study|Unrelated adverse event|16|||
23598911|NCT00112359|65922341|FG001|Overall Study|Unrelated adverse event|8|||
23598912|NCT00112359|65922340|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
23598913|NCT00112359|65922341|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
23598914|NCT00112359|65922340|FG000|Overall Study|Related adverse event|5|||
23598915|NCT00112359|65922341|FG001|Overall Study|Related adverse event|3|||
23598916|NCT00112359|65922340|FG000|Overall Study|Lost to Follow-up|0|||
23598917|NCT00112359|65922341|FG001|Overall Study|Lost to Follow-up|1|||
23598918|NCT00112359|65922340|FG000|Overall Study|Personal/administrative|1|||
23598919|NCT00112359|65922341|FG001|Overall Study|Personal/administrative|1|||
23360650|NCT03318003|65065822|FG000|Overall Study|Withdrawal by Subject|1|||
23598920|NCT00112359|65922340|FG000|Overall Study|Other|3|||
23598921|NCT00112359|65922341|FG001|Overall Study|Other|0|||
23598922|NCT01063881|65922342|FG000|Overall Study|Adverse Event|12|||
23598923|NCT01063881|65922343|FG001|Overall Study|Adverse Event|2|||
23598924|NCT01063881|65922344|FG002|Overall Study|Adverse Event|0|||
23598925|NCT01063881|65922342|FG000|Overall Study|Lost to Follow-up|13|||
23598926|NCT01063881|65922343|FG001|Overall Study|Lost to Follow-up|7|||
23598927|NCT01063881|65922344|FG002|Overall Study|Lost to Follow-up|1|||
23598928|NCT01063881|65922342|FG000|Overall Study|Withdrawal by Subject|25|||
23598929|NCT01063881|65922343|FG001|Overall Study|Withdrawal by Subject|1|||
23598930|NCT01063881|65922344|FG002|Overall Study|Withdrawal by Subject|0|||
23598931|NCT01063881|65922342|FG000|Overall Study|Reason for not completed not specified|5|||
23598932|NCT01063881|65922343|FG001|Overall Study|Reason for not completed not specified|1|||
23598933|NCT01063881|65922344|FG002|Overall Study|Reason for not completed not specified|0|||
23598934|NCT00879710|65922353|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
23360651|NCT03318003|65065823|FG001|Overall Study|Withdrawal by Subject|1|||
23598935|NCT00879710|65922354|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
23598936|NCT00879710|65922355|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
23598937|NCT00879710|65922356|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
23194948|NCT04283461|64456080|FG004|Overall Study|Enrolled in separate trial|12|||
23194949|NCT04283461|64456081|FG005|Overall Study|Enrolled in separate trial|0|||
23194950|NCT04283461|64456082|FG006|Overall Study|Enrolled in separate trial|0|||
23194951|NCT04283461|64456083|FG007|Overall Study|Enrolled in separate trial|8|||
23194952|NCT04283461|64456084|FG008|Overall Study|Enrolled in separate trial|0|||
23194953|NCT04283461|64456085|FG009|Overall Study|Enrolled in separate trial|0|||
23194954|NCT04283461|64456086|FG010|Overall Study|Enrolled in separate trial|0|||
23194955|NCT04283461|64456087|FG011|Overall Study|Enrolled in separate trial|7|||
23194956|NCT04283461|64456088|FG012|Overall Study|Enrolled in separate trial|0|||
23194957|NCT02452970|64456089|FG000|Overall Study|Adverse Event|1|||
23194958|NCT04329923|64456090|FG000|Overall Study|Withdrawal by Subject|1|||
23194959|NCT04329923|64456091|FG001|Overall Study|Withdrawal by Subject|4|||
23194960|NCT04329923|64456092|FG002|Overall Study|Withdrawal by Subject|1|||
23194961|NCT04329923|64456093|FG003|Overall Study|Withdrawal by Subject|1|||
23194962|NCT04329923|64456094|FG004|Overall Study|Withdrawal by Subject|1|||
23194963|NCT04329923|64456095|FG005|Overall Study|Withdrawal by Subject|1|||
23194964|NCT04329923|64456090|FG000|Overall Study|early termination of study|0|||
23194965|NCT04329923|64456091|FG001|Overall Study|early termination of study|0|||
23194966|NCT04329923|64456092|FG002|Overall Study|early termination of study|0|||
23194967|NCT04329923|64456093|FG003|Overall Study|early termination of study|0|||
23194968|NCT04329923|64456094|FG004|Overall Study|early termination of study|1|||
23194969|NCT04329923|64456095|FG005|Overall Study|early termination of study|2|||
23194970|NCT04329923|64456090|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23194971|NCT04329923|64456091|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23194972|NCT04329923|64456092|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23194973|NCT04329923|64456093|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23194974|NCT04329923|64456094|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
23194975|NCT04329923|64456095|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
23194976|NCT01334125|64456097|FG000|Overall Study|Lost to Follow-up|3|||
23598938|NCT00879710|65922353|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
23598939|NCT00879710|65922354|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
23194977|NCT01334125|64456098|FG001|Overall Study|Lost to Follow-up|3|||
23194978|NCT01671488|64456104|FG000|Overall Study|Withdrawal by Subject|1|||
23194979|NCT00893113|64456105|FG000|Overall Study|Lost to Follow-up|4|||
23194980|NCT00893113|64456106|FG001|Overall Study|Lost to Follow-up|8|||
23598940|NCT00879710|65922355|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
23598941|NCT00879710|65922356|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
23598942|NCT03781375|65922363|FG000|Double-blind Phase|Adverse Event|0|||
23598943|NCT03781375|65922364|FG001|Double-blind Phase|Adverse Event|1|||
23598944|NCT03781375|65922363|FG000|Double-blind Phase|Lack of Response|6|||
23598945|NCT03781375|65922364|FG001|Double-blind Phase|Lack of Response|2|||
23598946|NCT03781375|65922363|FG000|Double-blind Phase|Other|1|||
23598947|NCT03781375|65922364|FG001|Double-blind Phase|Other|3|||
23598948|NCT03781375|65922363|FG000|Open-label Phase|Protocol Issues|0|||
23598949|NCT03781375|65922364|FG001|Open-label Phase|Protocol Issues|1|||
23598950|NCT03781375|65922363|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
23360652|NCT03318003|65065822|FG000|Overall Study|fetal loss|0|||
23598951|NCT03781375|65922364|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
23598952|NCT03781375|65922363|FG000|Open-label Phase|Other|2|||
23598953|NCT03781375|65922364|FG001|Open-label Phase|Other|2|||
23479255|NCT02923921|65498459|FG000|Overall Study|Lost to Follow-up|1|||
23479256|NCT02923921|65498460|FG001|Overall Study|Lost to Follow-up|0|||
23479257|NCT02923921|65498459|FG000|Overall Study|Withdrawal by Subject|6|||
23479258|NCT02923921|65498460|FG001|Overall Study|Withdrawal by Subject|13|||
23479259|NCT02923921|65498459|FG000|Overall Study|Unknown, Not Collected|7|||
23479260|NCT02923921|65498460|FG001|Overall Study|Unknown, Not Collected|6|||
23479261|NCT04518995|65498464|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
23479262|NCT04518995|65498465|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
23479263|NCT04518995|65498466|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
23479264|NCT04518995|65498464|FG000|Overall Study|Lack of Efficacy|2|||
23479265|NCT04518995|65498465|FG001|Overall Study|Lack of Efficacy|1|||
23479266|NCT04518995|65498466|FG002|Overall Study|Lack of Efficacy|0|||
23479267|NCT04518995|65498464|FG000|Overall Study|Non-compliance With Study Drug|0|||
23479268|NCT04518995|65498465|FG001|Overall Study|Non-compliance With Study Drug|3|||
23479269|NCT04518995|65498466|FG002|Overall Study|Non-compliance With Study Drug|2|||
23479270|NCT04518995|65498464|FG000|Overall Study|Pregnancy|0|||
23479271|NCT04518995|65498465|FG001|Overall Study|Pregnancy|0|||
23479272|NCT04518995|65498466|FG002|Overall Study|Pregnancy|1|||
23479273|NCT04518995|65498464|FG000|Overall Study|Protocol Violation|2|||
23479274|NCT04518995|65498465|FG001|Overall Study|Protocol Violation|0|||
23479275|NCT04518995|65498466|FG002|Overall Study|Protocol Violation|1|||
23479276|NCT04518995|65498464|FG000|Overall Study|Reason not Specified|4|||
23479277|NCT04518995|65498465|FG001|Overall Study|Reason not Specified|11|||
23479278|NCT04518995|65498466|FG002|Overall Study|Reason not Specified|2|||
23479279|NCT04518995|65498464|FG000|Overall Study|Lost to Follow-up|1|||
23479280|NCT04518995|65498465|FG001|Overall Study|Lost to Follow-up|10|||
23479281|NCT04518995|65498466|FG002|Overall Study|Lost to Follow-up|6|||
23479282|NCT01403948|65498467|FG000|Overall Study|Progressive disease|0|||
23479283|NCT01403948|65498468|FG001|Overall Study|Progressive disease|2|||
23479284|NCT01403948|65498469|FG002|Overall Study|Progressive disease|2|||
23479285|NCT01403948|65498470|FG003|Overall Study|Progressive disease|4|||
23479286|NCT01403948|65498471|FG004|Overall Study|Progressive disease|2|||
23479287|NCT01403948|65498472|FG005|Overall Study|Progressive disease|6|||
23479288|NCT01403948|65498473|FG006|Overall Study|Progressive disease|2|||
23479289|NCT01403948|65498474|FG007|Overall Study|Progressive disease|4|||
23479290|NCT01403948|65498475|FG008|Overall Study|Progressive disease|5|||
23479291|NCT01403948|65498476|FG009|Overall Study|Progressive disease|5|||
23479292|NCT01403948|65498467|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479293|NCT01403948|65498468|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479294|NCT01403948|65498469|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479295|NCT01403948|65498470|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479296|NCT01403948|65498471|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
23479297|NCT01403948|65498472|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479298|NCT01403948|65498473|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
23479299|NCT01403948|65498474|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479300|NCT01403948|65498475|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
23479301|NCT01403948|65498476|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
23479302|NCT01403948|65498467|FG000|Overall Study|Lost to Follow-up|0|||
23479303|NCT01403948|65498468|FG001|Overall Study|Lost to Follow-up|0|||
23479304|NCT01403948|65498469|FG002|Overall Study|Lost to Follow-up|0|||
23479305|NCT01403948|65498470|FG003|Overall Study|Lost to Follow-up|0|||
23479306|NCT01403948|65498471|FG004|Overall Study|Lost to Follow-up|0|||
23598954|NCT01609218|65922367|FG000|Period 1|Adverse Event|3|||
23598955|NCT01609218|65922368|FG001|Period 1|Adverse Event|5|||
23598956|NCT01609218|65922367|FG000|Period 1|Sponsor Decision|0|||
23598957|NCT01609218|65922368|FG001|Period 1|Sponsor Decision|1|||
23598958|NCT01609218|65922367|FG000|Period 2|Adverse Event|1|||
23598959|NCT01609218|65922368|FG001|Period 2|Adverse Event|0|||
23479307|NCT01403948|65498472|FG005|Overall Study|Lost to Follow-up|0|||
23479308|NCT01403948|65498473|FG006|Overall Study|Lost to Follow-up|0|||
23479309|NCT01403948|65498474|FG007|Overall Study|Lost to Follow-up|0|||
23479310|NCT01403948|65498475|FG008|Overall Study|Lost to Follow-up|0|||
23479311|NCT01403948|65498476|FG009|Overall Study|Lost to Follow-up|1|||
23479312|NCT01403948|65498467|FG000|Overall Study|Refused cont. medication|0|||
23479313|NCT01403948|65498468|FG001|Overall Study|Refused cont. medication|0|||
23479314|NCT01403948|65498469|FG002|Overall Study|Refused cont. medication|0|||
23479315|NCT01403948|65498470|FG003|Overall Study|Refused cont. medication|0|||
23479316|NCT01403948|65498471|FG004|Overall Study|Refused cont. medication|1|||
23598960|NCT02438137|65922369|FG000|Overall Study|Lost to Follow-up|3|||
23598961|NCT02438137|65922370|FG001|Overall Study|Lost to Follow-up|2|||
23360653|NCT03318003|65065823|FG001|Overall Study|fetal loss|1|||
23360654|NCT02372383|65065824|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
23360655|NCT02372383|65065825|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
23360656|NCT02372383|65065826|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
23360657|NCT00672633|65065846|FG000|Overall Study|Withdrawal by Subject|0|||
23360658|NCT00672633|65065847|FG001|Overall Study|Withdrawal by Subject|1|||
23479317|NCT01403948|65498472|FG005|Overall Study|Refused cont. medication|0|||
23598962|NCT02438137|65922369|FG000|Overall Study|Adverse Event|1|||
23598963|NCT02438137|65922370|FG001|Overall Study|Adverse Event|0|||
23598964|NCT02438137|65922369|FG000|Overall Study|Withdrawal by Subject|4|||
23598965|NCT02438137|65922370|FG001|Overall Study|Withdrawal by Subject|3|||
23598966|NCT02438137|65922369|FG000|Overall Study|Physician Decision|0|||
23598967|NCT02438137|65922370|FG001|Overall Study|Physician Decision|1|||
23598968|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
23598969|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
23598970|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
23598971|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
23598972|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
23598973|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
23598974|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
23598975|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
23598976|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
23598977|NCT03939312|65922378|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
23598978|NCT03939312|65922378|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
23598979|NCT03939312|65922378|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
23598980|NCT02866942|65922379|FG000|Overall Study|Invalid consent|1|||
23598981|NCT01932970|65922382|FG000|Overall Study|Withdrawal by Subject|5|||
23598982|NCT01932970|65922382|FG000|Overall Study|Death|1|||
23598983|NCT01932970|65922382|FG000|Overall Study|Lost to Follow-up|2|||
23598984|NCT01932970|65922382|FG000|Overall Study|Protocol Specified Criteria|10|||
23598985|NCT04110054|65922384|FG000|Overall Study|COVID-19 reason other than AE|0|||
23598986|NCT04110054|65922385|FG001|Overall Study|COVID-19 reason other than AE|0|||
23598987|NCT04110054|65922386|FG002|Overall Study|COVID-19 reason other than AE|2|||
23598988|NCT04110054|65922387|FG003|Overall Study|COVID-19 reason other than AE|0|||
23598989|NCT04110054|65922384|FG000|Overall Study|Withdrawal by Subject|0|||
23598990|NCT04110054|65922385|FG001|Overall Study|Withdrawal by Subject|3|||
23598991|NCT04110054|65922386|FG002|Overall Study|Withdrawal by Subject|2|||
23598992|NCT04110054|65922387|FG003|Overall Study|Withdrawal by Subject|0|||
23598993|NCT04110054|65922384|FG000|Overall Study|Adverse Event|1|||
23598994|NCT04110054|65922385|FG001|Overall Study|Adverse Event|1|||
23598995|NCT04110054|65922386|FG002|Overall Study|Adverse Event|4|||
23598996|NCT04110054|65922387|FG003|Overall Study|Adverse Event|3|||
23598997|NCT02128113|65922393|FG000|Overall Study|Withdrawal by Subject|3|||
23598998|NCT02128113|65922394|FG001|Overall Study|Withdrawal by Subject|1|||
23598999|NCT02128113|65922395|FG002|Overall Study|Withdrawal by Subject|0|||
23599000|NCT02128113|65922393|FG000|Overall Study|Protocol Violation|0|||
23599001|NCT02128113|65922394|FG001|Overall Study|Protocol Violation|1|||
23599002|NCT02128113|65922395|FG002|Overall Study|Protocol Violation|0|||
23599003|NCT02128113|65922393|FG000|Overall Study|Surgery cancelled|0|||
23599004|NCT02128113|65922394|FG001|Overall Study|Surgery cancelled|1|||
23599005|NCT02128113|65922395|FG002|Overall Study|Surgery cancelled|0|||
23360659|NCT00803712|65065855|FG000|Overall Study|Noncompliance|3|||
23360660|NCT00803712|65065856|FG001|Overall Study|Noncompliance|0|||
23360661|NCT00803712|65065855|FG000|Overall Study|Adverse Event|5|||
23360662|NCT00803712|65065856|FG001|Overall Study|Adverse Event|0|||
23599006|NCT02128113|65922393|FG000|Overall Study|Adverse Event|0|||
23599007|NCT02128113|65922394|FG001|Overall Study|Adverse Event|0|||
23599008|NCT02128113|65922395|FG002|Overall Study|Adverse Event|1|||
23599009|NCT00589875|65922400|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
23599010|NCT00589875|65922400|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
23599011|NCT00676091|65922406|FG000|Infant Series|Parent or legal guardian request|10|||
23599012|NCT00676091|65922407|FG001|Infant Series|Parent or legal guardian request|8|||
23599013|NCT00676091|65922406|FG000|Infant Series|Protocol Violation|6|||
23599014|NCT00676091|65922407|FG001|Infant Series|Protocol Violation|3|||
23599015|NCT00676091|65922406|FG000|Infant Series|Adverse Event|2|||
23599016|NCT00676091|65922407|FG001|Infant Series|Adverse Event|3|||
23599017|NCT00676091|65922406|FG000|Infant Series|Failed to return|1|||
23599018|NCT00676091|65922407|FG001|Infant Series|Failed to return|3|||
23599019|NCT00676091|65922406|FG000|Infant Series|Lost to Follow-up|1|||
23599020|NCT00676091|65922407|FG001|Infant Series|Lost to Follow-up|0|||
23599021|NCT00676091|65922406|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
23599022|NCT00676091|65922407|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
23599023|NCT00676091|65922406|FG000|After Infant Series|Adverse Event|0|||
23599024|NCT00676091|65922407|FG001|After Infant Series|Adverse Event|1|||
23599025|NCT00676091|65922406|FG000|After Infant Series|Protocol Violation|0|||
23599026|NCT00676091|65922407|FG001|After Infant Series|Protocol Violation|1|||
23599027|NCT00676091|65922406|FG000|After Infant Series|Failed to return|1|||
23599028|NCT00676091|65922407|FG001|After Infant Series|Failed to return|1|||
23599029|NCT00676091|65922406|FG000|Toddler Dose|Failed to return|2|||
23599030|NCT00676091|65922407|FG001|Toddler Dose|Failed to return|0|||
23599031|NCT00676091|65922406|FG000|Toddler Dose|Parent or legal guardian request|1|||
23599032|NCT00676091|65922407|FG001|Toddler Dose|Parent or legal guardian request|0|||
23599033|NCT00446459|65922408|FG000|8 Months|Protocol Violation|12|||
23599034|NCT00446459|65922408|FG000|12 Months|Protocol Violation|4|||
23599035|NCT00446459|65922408|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
23599036|NCT00976495|65922409|FG000|Overall Study|Withdrawal by Subject|0|||
23599037|NCT00976495|65922410|FG001|Overall Study|Withdrawal by Subject|1|||
23599038|NCT00976495|65922411|FG002|Overall Study|Withdrawal by Subject|0|||
23599039|NCT00611559|65922412|FG000|Overall Study|Lost to Follow-up|0|||
23599040|NCT00611559|65922413|FG001|Overall Study|Lost to Follow-up|1|||
23599041|NCT00611559|65922414|FG002|Overall Study|Lost to Follow-up|0|||
23599042|NCT00611559|65922412|FG000|Overall Study|Protocol Violation|1|||
23599043|NCT00611559|65922413|FG001|Overall Study|Protocol Violation|0|||
23599044|NCT00611559|65922414|FG002|Overall Study|Protocol Violation|1|||
23599045|NCT00277355|65922415|FG000|Overall Study|Withdrawal by Subject|3|||
23599046|NCT00277355|65922416|FG001|Overall Study|Withdrawal by Subject|3|||
23360663|NCT00803712|65065855|FG000|Overall Study|Death|8|||
23360664|NCT00803712|65065856|FG001|Overall Study|Death|7|||
23360665|NCT00803712|65065855|FG000|Overall Study|Lost to Follow-up|3|||
23360666|NCT00803712|65065856|FG001|Overall Study|Lost to Follow-up|1|||
23360667|NCT00803712|65065855|FG000|Overall Study|Withdrawal by Subject|2|||
23360668|NCT00803712|65065856|FG001|Overall Study|Withdrawal by Subject|4|||
23360669|NCT00803712|65065855|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
23360670|NCT00803712|65065856|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
23360671|NCT00803712|65065855|FG000|Overall Study|Protocol criteria (other)|0|||
23360672|NCT00803712|65065856|FG001|Overall Study|Protocol criteria (other)|2|||
23360673|NCT00803712|65065855|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
23360674|NCT00803712|65065856|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
23360675|NCT00803712|65065855|FG000|Overall Study|Administrative decision|2|||
23360676|NCT00803712|65065856|FG001|Overall Study|Administrative decision|3|||
23360677|NCT00803712|65065855|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
23360678|NCT00803712|65065856|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
23360679|NCT00996034|65065857|FG000|Overall Study|Lost to Follow-up|2|||
23360680|NCT00996034|65065857|FG000|Overall Study|withdrawn by PI|1|||
23360681|NCT01845597|65065858|FG000|Overall Study|Death|8|||
23360682|NCT01845597|65065858|FG000|Overall Study|Lost to Follow-up|22|||
23360683|NCT04633226|65065863|FG000|Overall Study|Withdrawal by parent/guardian|4|||
23360684|NCT04633226|65065863|FG000|Overall Study|Randomized by mistake without study treatment|1|||
23360685|NCT00943592|65065864|FG000|Overall Study|Death|3|||
23194981|NCT00893113|64456105|FG000|Overall Study|Early Termination|1|||
23360686|NCT00540644|65065865|FG000|Overall Study|Adverse Event|3|||
23360687|NCT00540644|65065866|FG001|Overall Study|Adverse Event|1|||
23360688|NCT00540644|65065865|FG000|Overall Study|Disease Progression|3|||
23360689|NCT00540644|65065866|FG001|Overall Study|Disease Progression|1|||
23479318|NCT01403948|65498473|FG006|Overall Study|Refused cont. medication|0|||
23479319|NCT01403948|65498474|FG007|Overall Study|Refused cont. medication|0|||
23255920|NCT01759537|64679899|FG001|Overall Study|Accident involving jaw fracture|1|||
23255921|NCT01759537|64679898|FG000|Overall Study|Subcrestal implant too coronal|1|||
23255922|NCT01759537|64679899|FG001|Overall Study|Subcrestal implant too coronal|1|||
23255923|NCT02513459|64679900|FG000|Overall Study|Adverse Event|7|||
23255924|NCT02513459|64679900|FG000|Overall Study|Withdrew consent|5|||
23255925|NCT02513459|64679900|FG000|Overall Study|Loss of efficacy|2|||
23255926|NCT02513459|64679900|FG000|Overall Study|Pregnancy|2|||
23255927|NCT02513459|64679900|FG000|Overall Study|Subject decision|2|||
23194982|NCT00893113|64456106|FG001|Overall Study|Early Termination|1|||
23194983|NCT00893113|64456105|FG000|Overall Study|Withdrew Consent|8|||
23194984|NCT00893113|64456106|FG001|Overall Study|Withdrew Consent|7|||
23479320|NCT01403948|65498475|FG008|Overall Study|Refused cont. medication|0|||
23599047|NCT00277355|65922415|FG000|Overall Study|Lost to Follow-up|2|||
23599048|NCT00277355|65922416|FG001|Overall Study|Lost to Follow-up|2|||
23599049|NCT00277355|65922415|FG000|Overall Study|Adverse Event|5|||
23599050|NCT00277355|65922416|FG001|Overall Study|Adverse Event|0|||
23599051|NCT00277355|65922415|FG000|Overall Study|Death|3|||
23599052|NCT00277355|65922416|FG001|Overall Study|Death|0|||
23599053|NCT00277355|65922415|FG000|Overall Study|Physician Decision|1|||
23599054|NCT00277355|65922416|FG001|Overall Study|Physician Decision|0|||
23599055|NCT02919449|65922420|FG000|Overall Study|Withdrawal by Subject|1|||
23599056|NCT02919449|65922420|FG000|Overall Study|Investigator decision|1|||
23599057|NCT03801148|65922421|FG000|Period 1 (2 Days)|Adverse Event|1|||
23599058|NCT03801148|65922422|FG001|Period 1 (2 Days)|Adverse Event|1|||
23599059|NCT03801148|65922423|FG002|Period 1 (2 Days)|Adverse Event|0|||
23599060|NCT03801148|65922424|FG003|Period 1 (2 Days)|Adverse Event|0|||
23599061|NCT03801148|65922421|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
23599062|NCT03801148|65922422|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
23599063|NCT03801148|65922423|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
23599064|NCT03801148|65922424|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
23599065|NCT03801148|65922421|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23599066|NCT03801148|65922422|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23599067|NCT03801148|65922423|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
23599068|NCT03801148|65922424|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23599069|NCT03801148|65922421|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
23599070|NCT03801148|65922422|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
23599071|NCT03801148|65922423|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
23599072|NCT03801148|65922424|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
23599073|NCT00350792|65922433|FG000|Overall Study|Adverse Event|11|||
23599074|NCT00350792|65922433|FG000|Overall Study|Death from Study Disease|1|||
23599075|NCT00350792|65922433|FG000|Overall Study|Death from Study Drug Toxicity|1|||
23599076|NCT00350792|65922433|FG000|Overall Study|Death Not Study Drug Related|2|||
23599077|NCT00350792|65922433|FG000|Overall Study|Protocol Violation|1|||
23599078|NCT00350792|65922433|FG000|Overall Study|Withdrawal by Subject|4|||
23599079|NCT00350792|65922433|FG000|Overall Study|Physician Decision|2|||
23599080|NCT00350792|65922433|FG000|Overall Study|Lack of Efficacy|11|||
23599081|NCT02928172|65922434|FG000|Overall Study|Device did not record data|1|||
23599082|NCT01040689|65922435|FG000|Overall Study|Adverse Event|0|||
23599083|NCT01040689|65922436|FG001|Overall Study|Adverse Event|0|||
23599084|NCT01040689|65922437|FG002|Overall Study|Adverse Event|2|||
23599085|NCT01040689|65922438|FG003|Overall Study|Adverse Event|4|||
23599086|NCT01040689|65922435|FG000|Overall Study|Lack of Efficacy|0|||
23599087|NCT01040689|65922436|FG001|Overall Study|Lack of Efficacy|0|||
23599088|NCT01040689|65922437|FG002|Overall Study|Lack of Efficacy|1|||
23599089|NCT01040689|65922438|FG003|Overall Study|Lack of Efficacy|0|||
23599090|NCT01040689|65922435|FG000|Overall Study|Lost to Follow-up|1|||
23599091|NCT01040689|65922436|FG001|Overall Study|Lost to Follow-up|0|||
23599092|NCT01040689|65922437|FG002|Overall Study|Lost to Follow-up|0|||
23194985|NCT03635190|64456108|FG000|Overall Study|Lost to Follow-up|4|||
23194986|NCT03635190|64456108|FG000|Overall Study|Death|3|||
23194987|NCT03635190|64456108|FG000|Overall Study|Withdrawal by Subject|1|||
23194988|NCT03635190|64456108|FG000|Overall Study|Patient moved and did not return for follow up|1|||
23194989|NCT02275026|64456109|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
23194990|NCT02275026|64456109|FG000|Overall Study|Withdrawal by Subject|4|||
23194991|NCT02275026|64456109|FG000|Overall Study|Ineligible due to medical history|13|||
23194992|NCT02275026|64456109|FG000|Overall Study|MRI malfunction precluded testing|1|||
23194993|NCT02275026|64456109|FG000|Overall Study|Ineligible after MRI findings|1|||
23194994|NCT02275026|64456109|FG000|Overall Study|Lost to Follow-up|2|||
23194995|NCT02275026|64456109|FG000|Overall Study|Scanner failure|1|||
23194996|NCT01013883|64456110|FG000|Overall Study|Lost to Follow-up|2|||
23194997|NCT01013883|64456111|FG001|Overall Study|Lost to Follow-up|2|||
23599093|NCT01040689|65922438|FG003|Overall Study|Lost to Follow-up|0|||
23599094|NCT01040689|65922435|FG000|Overall Study|Withdrawal by Subject|2|||
23599095|NCT01040689|65922436|FG001|Overall Study|Withdrawal by Subject|1|||
23599096|NCT01040689|65922437|FG002|Overall Study|Withdrawal by Subject|1|||
23599097|NCT01040689|65922438|FG003|Overall Study|Withdrawal by Subject|0|||
23599098|NCT01040689|65922435|FG000|Overall Study|Other reasons not listed above|0|||
23599099|NCT01040689|65922436|FG001|Overall Study|Other reasons not listed above|1|||
23599100|NCT01040689|65922437|FG002|Overall Study|Other reasons not listed above|0|||
23599101|NCT01040689|65922438|FG003|Overall Study|Other reasons not listed above|0|||
23599102|NCT00680771|65922441|FG000|Overall Study|Withdrawal by Subject|1|||
23599103|NCT00680771|65922442|FG001|Overall Study|Withdrawal by Subject|0|||
23599104|NCT00680771|65922441|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
23599105|NCT00680771|65922442|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
23599106|NCT00680771|65922441|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
23599107|NCT00680771|65922442|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
23599108|NCT02252042|65922443|FG000|Overall Study|Adverse Event|9|||
23599109|NCT02252042|65922444|FG001|Overall Study|Adverse Event|6|||
23599110|NCT02252042|65922443|FG000|Overall Study|Death|209|||
23599111|NCT02252042|65922444|FG001|Overall Study|Death|217|||
23479321|NCT01403948|65498476|FG009|Overall Study|Refused cont. medication|1|||
23479322|NCT01403948|65498467|FG000|Overall Study|other than above|1|||
23479323|NCT01403948|65498468|FG001|Overall Study|other than above|2|||
23255928|NCT02513459|64679900|FG000|Overall Study|Lack of response|1|||
23255929|NCT02513459|64679900|FG000|Overall Study|Reproductive plans|1|||
23255930|NCT02513459|64679900|FG000|Overall Study|Surgery planned-- not done|1|||
23255931|NCT00520351|64679901|FG000|First Intervention|Withdrawal by Subject|1|||
23255932|NCT00520351|64679902|FG001|First Intervention|Withdrawal by Subject|1|||
23255933|NCT04071626|64679903|FG000|Overall Study|Withdrawal by Subject|1|||
23255934|NCT04071626|64679904|FG001|Overall Study|Withdrawal by Subject|1|||
23255935|NCT04071626|64679903|FG000|Overall Study|Protocol Violation|0|||
23255936|NCT04071626|64679904|FG001|Overall Study|Protocol Violation|1|||
23255937|NCT01299038|64679906|FG000|Overall Study|Withdrawal by Subject|1|||
23255938|NCT01299038|64679907|FG001|Overall Study|Withdrawal by Subject|0|||
23255939|NCT02437890|64679910|FG000|Overall Study|Non-compliance to study drug|0|||
23255940|NCT02437890|64679911|FG001|Overall Study|Non-compliance to study drug|1|||
23255941|NCT02437890|64679912|FG002|Overall Study|Non-compliance to study drug|0|||
23255942|NCT02437890|64679913|FG003|Overall Study|Non-compliance to study drug|0|||
23255943|NCT02437890|64679914|FG004|Overall Study|Non-compliance to study drug|1|||
23599112|NCT02252042|65922443|FG000|Overall Study|Physician Decision|0|||
23599113|NCT02252042|65922444|FG001|Overall Study|Physician Decision|2|||
23599114|NCT02252042|65922443|FG000|Overall Study|Transferred to Extension Study|7|||
23599115|NCT02252042|65922444|FG001|Overall Study|Transferred to Extension Study|1|||
23599116|NCT02252042|65922443|FG000|Overall Study|Did Not Continue on Extension Study|7|||
23599117|NCT02252042|65922444|FG001|Overall Study|Did Not Continue on Extension Study|2|||
23599118|NCT02252042|65922443|FG000|Overall Study|Withdrawal by Subject|15|||
23599119|NCT02252042|65922444|FG001|Overall Study|Withdrawal by Subject|20|||
23599120|NCT02698475|65922445|FG000|Main Study Period|Lack of Efficacy|1|||
23599121|NCT02698475|65922445|FG000|Main Study Period|Protocol Violation|2|||
23599122|NCT02698475|65922445|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
23255944|NCT02437890|64679910|FG000|Overall Study|Sponsor's decision|1|||
23255945|NCT02437890|64679911|FG001|Overall Study|Sponsor's decision|1|||
23255946|NCT02437890|64679912|FG002|Overall Study|Sponsor's decision|4|||
23255947|NCT02437890|64679913|FG003|Overall Study|Sponsor's decision|0|||
23599123|NCT02698475|65922445|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
23599124|NCT02698475|65922445|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
23599125|NCT02698475|65922445|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
23599126|NCT02698475|65922445|FG000|Long-Term Extension Period|Other|1|||
23599127|NCT01629589|65922456|FG000|Overall Study|Protocol Violation|4|||
23599128|NCT01629589|65922457|FG001|Overall Study|Protocol Violation|2|||
23599129|NCT01629589|65922456|FG000|Overall Study|Lost to Follow-up|2|||
23599130|NCT01629589|65922457|FG001|Overall Study|Lost to Follow-up|1|||
23599131|NCT01629589|65922456|FG000|Overall Study|Withdrawal by Subject|2|||
23255948|NCT02437890|64679914|FG004|Overall Study|Sponsor's decision|2|||
23255949|NCT02437890|64679910|FG000|Overall Study|Physician Decision|0|||
23255950|NCT02437890|64679911|FG001|Overall Study|Physician Decision|0|||
23255951|NCT02437890|64679912|FG002|Overall Study|Physician Decision|0|||
23255952|NCT02437890|64679913|FG003|Overall Study|Physician Decision|1|||
23255953|NCT02437890|64679914|FG004|Overall Study|Physician Decision|0|||
23255954|NCT02437890|64679910|FG000|Overall Study|Unable to attend visit(s)|1|||
23360690|NCT00540644|65065865|FG000|Overall Study|Physician Decision|0|||
23360691|NCT00540644|65065866|FG001|Overall Study|Physician Decision|5|||
23360692|NCT00540644|65065865|FG000|Overall Study|Withdrawal by Subject|2|||
23360693|NCT00540644|65065866|FG001|Overall Study|Withdrawal by Subject|2|||
23360694|NCT00540644|65065865|FG000|Overall Study|Noncomplilance|1|||
23360695|NCT00540644|65065866|FG001|Overall Study|Noncomplilance|0|||
23360696|NCT01004978|65065867|FG000|Overall Study|Disease progression|31|||
23360697|NCT01004978|65065868|FG001|Overall Study|Disease progression|48|||
23360698|NCT01004978|65065867|FG000|Overall Study|Adverse Event|42|||
23360699|NCT01004978|65065868|FG001|Overall Study|Adverse Event|22|||
23360700|NCT01004978|65065867|FG000|Overall Study|Death|3|||
23360701|NCT01004978|65065868|FG001|Overall Study|Death|2|||
23360702|NCT01004978|65065867|FG000|Overall Study|Withdrawal by Subject|16|||
23360703|NCT01004978|65065868|FG001|Overall Study|Withdrawal by Subject|16|||
23360704|NCT01004978|65065867|FG000|Overall Study|Alternative therapy|4|||
23360705|NCT01004978|65065868|FG001|Overall Study|Alternative therapy|8|||
23360706|NCT01004978|65065867|FG000|Overall Study|Physician Decision|6|||
23360707|NCT01004978|65065868|FG001|Overall Study|Physician Decision|3|||
23360708|NCT01004978|65065867|FG000|Overall Study|Other complicating disease|2|||
23360709|NCT01004978|65065868|FG001|Overall Study|Other complicating disease|2|||
23360710|NCT01004978|65065867|FG000|Overall Study|Protocol Violation|2|||
23360711|NCT01004978|65065868|FG001|Overall Study|Protocol Violation|3|||
23360712|NCT01004978|65065867|FG000|Overall Study|Non-compliance|3|||
23360713|NCT01004978|65065868|FG001|Overall Study|Non-compliance|2|||
23360714|NCT01004978|65065867|FG000|Overall Study|Ineligible|1|||
23360715|NCT01004978|65065868|FG001|Overall Study|Ineligible|0|||
23360716|NCT01004978|65065867|FG000|Overall Study|Unblinded|0|||
23360717|NCT01004978|65065868|FG001|Overall Study|Unblinded|1|||
23360718|NCT01004978|65065867|FG000|Overall Study|Performance status worsening|0|||
23360719|NCT01004978|65065868|FG001|Overall Study|Performance status worsening|1|||
23360720|NCT01004978|65065867|FG000|Overall Study|Never started treatment|8|||
23360721|NCT01004978|65065868|FG001|Overall Study|Never started treatment|9|||
23360722|NCT01827592|65065869|FG000|Overall Study|Adverse Event|11|||
23360723|NCT01827592|65065870|FG001|Overall Study|Adverse Event|9|||
23360724|NCT01827592|65065871|FG002|Overall Study|Adverse Event|2|||
23360725|NCT01827592|65065869|FG000|Overall Study|Physician Decision|0|||
23360726|NCT01827592|65065870|FG001|Overall Study|Physician Decision|2|||
23360727|NCT01827592|65065871|FG002|Overall Study|Physician Decision|1|||
23360728|NCT01827592|65065869|FG000|Overall Study|Protocol Violation|2|||
23360729|NCT01827592|65065870|FG001|Overall Study|Protocol Violation|1|||
23360730|NCT01827592|65065871|FG002|Overall Study|Protocol Violation|0|||
23255955|NCT02437890|64679911|FG001|Overall Study|Unable to attend visit(s)|0|||
23255956|NCT02437890|64679912|FG002|Overall Study|Unable to attend visit(s)|0|||
23255957|NCT02437890|64679913|FG003|Overall Study|Unable to attend visit(s)|0|||
23255958|NCT02437890|64679914|FG004|Overall Study|Unable to attend visit(s)|0|||
23255959|NCT02437890|64679910|FG000|Overall Study|Lack of Efficacy|1|||
23255960|NCT02437890|64679911|FG001|Overall Study|Lack of Efficacy|3|||
23255961|NCT02437890|64679912|FG002|Overall Study|Lack of Efficacy|0|||
23255962|NCT02437890|64679913|FG003|Overall Study|Lack of Efficacy|3|||
23255963|NCT02437890|64679914|FG004|Overall Study|Lack of Efficacy|1|||
23255964|NCT02437890|64679910|FG000|Overall Study|Adverse Event|4|||
23360731|NCT01827592|65065869|FG000|Overall Study|Lost to Follow-up|1|||
23360732|NCT01827592|65065870|FG001|Overall Study|Lost to Follow-up|2|||
23360733|NCT01827592|65065871|FG002|Overall Study|Lost to Follow-up|2|||
23599132|NCT01629589|65922457|FG001|Overall Study|Withdrawal by Subject|3|||
23255965|NCT02437890|64679911|FG001|Overall Study|Adverse Event|9|||
23360734|NCT01827592|65065869|FG000|Overall Study|Withdrawal by Subject|12|||
23360735|NCT01827592|65065870|FG001|Overall Study|Withdrawal by Subject|11|||
23360736|NCT01827592|65065871|FG002|Overall Study|Withdrawal by Subject|11|||
23255966|NCT02437890|64679912|FG002|Overall Study|Adverse Event|5|||
23255967|NCT02437890|64679913|FG003|Overall Study|Adverse Event|11|||
23360737|NCT01827592|65065869|FG000|Overall Study|Patient's substantial non-compliance|1|||
23360738|NCT01827592|65065870|FG001|Overall Study|Patient's substantial non-compliance|1|||
23360739|NCT01827592|65065871|FG002|Overall Study|Patient's substantial non-compliance|6|||
23255968|NCT02437890|64679914|FG004|Overall Study|Adverse Event|7|||
23255969|NCT02437890|64679910|FG000|Overall Study|Withdrawal by Subject|1|||
23255970|NCT02437890|64679911|FG001|Overall Study|Withdrawal by Subject|2|||
23255971|NCT02437890|64679912|FG002|Overall Study|Withdrawal by Subject|6|||
23255972|NCT02437890|64679913|FG003|Overall Study|Withdrawal by Subject|5|||
23255973|NCT02437890|64679914|FG004|Overall Study|Withdrawal by Subject|5|||
23255974|NCT02437890|64679910|FG000|Overall Study|Death|0|||
23255975|NCT02437890|64679911|FG001|Overall Study|Death|0|||
23255976|NCT02437890|64679912|FG002|Overall Study|Death|0|||
23255977|NCT02437890|64679913|FG003|Overall Study|Death|2|||
23255978|NCT02437890|64679914|FG004|Overall Study|Death|0|||
23255979|NCT01347879|64679915|FG000|Overall Study|Adverse Event|0|||
23255980|NCT01347879|64679916|FG001|Overall Study|Adverse Event|12|||
23255981|NCT01347879|64679915|FG000|Overall Study|Lost to Follow-up|2|||
23255982|NCT01347879|64679916|FG001|Overall Study|Lost to Follow-up|0|||
23255983|NCT01347879|64679915|FG000|Overall Study|Withdrawal by Subject|3|||
23255984|NCT01347879|64679916|FG001|Overall Study|Withdrawal by Subject|2|||
23255985|NCT01347879|64679915|FG000|Overall Study|Other|2|||
23255986|NCT01347879|64679916|FG001|Overall Study|Other|3|||
23255987|NCT03063632|64679917|FG000|Overall Study|Death|4|||
23255988|NCT03063632|64679918|FG001|Overall Study|Death|6|||
23255989|NCT03063632|64679917|FG000|Overall Study|Lost to Follow-up|0|||
23255990|NCT03063632|64679918|FG001|Overall Study|Lost to Follow-up|1|||
23255991|NCT03063632|64679917|FG000|Overall Study|Withdrawal by Subject|0|||
23255992|NCT03063632|64679918|FG001|Overall Study|Withdrawal by Subject|2|||
23255993|NCT03063632|64679917|FG000|Overall Study|Physician Decision|2|||
23255994|NCT03063632|64679918|FG001|Overall Study|Physician Decision|0|||
23255995|NCT03063632|64679917|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
23255996|NCT03063632|64679918|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
23255997|NCT01504867|64679920|FG000|Overall Study|Inclusion criteria not met|2|||
23255998|NCT01504867|64679921|FG001|Overall Study|Inclusion criteria not met|2|||
23255999|NCT01504867|64679920|FG000|Overall Study|Consent revoked|5|||
23256000|NCT01504867|64679921|FG001|Overall Study|Consent revoked|1|||
23256001|NCT00066807|64679922|FG000|Overall Study|Study was terminated early|14|||
23256002|NCT00066807|64679923|FG001|Overall Study|Study was terminated early|15|||
23256003|NCT00856778|64679927|FG000|Overall Study|Adverse Event|7|||
23256004|NCT00856778|64679927|FG000|Overall Study|Withdrawal by Subject|10|||
23256005|NCT00856778|64679927|FG000|Overall Study|Study deviation|2|||
23256006|NCT00856778|64679927|FG000|Overall Study|Lost to Follow-up|5|||
23256007|NCT00446654|64679928|FG000|Overall Study|Withdrawal by Subject|1|||
23256008|NCT00446654|64679929|FG001|Overall Study|Withdrawal by Subject|0|||
23256009|NCT00446654|64679928|FG000|Overall Study|Adverse Event|1|||
23256010|NCT00446654|64679929|FG001|Overall Study|Adverse Event|0|||
23256011|NCT01872689|64679930|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
23256012|NCT01872689|64679931|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
23256013|NCT01872689|64679932|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
23256014|NCT01872689|64679933|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
23256015|NCT01872689|64679930|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
23256016|NCT01872689|64679931|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
23256017|NCT01872689|64679932|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
23256018|NCT01872689|64679933|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
23256019|NCT01872689|64679930|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
23256020|NCT01872689|64679931|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
23256021|NCT01872689|64679932|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
23256022|NCT01872689|64679933|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
23256023|NCT01872689|64679930|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
23256024|NCT01872689|64679931|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
23256025|NCT01872689|64679932|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
23256026|NCT01872689|64679933|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
23256027|NCT01872689|64679930|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
23256028|NCT01872689|64679931|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
23256029|NCT01872689|64679932|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
23256030|NCT01872689|64679933|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
23256031|NCT01872689|64679930|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
23256032|NCT01872689|64679931|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
23256033|NCT01872689|64679932|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
23256034|NCT01872689|64679933|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
23256035|NCT01872689|64679930|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
23256036|NCT01872689|64679931|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
23256037|NCT01872689|64679932|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
23256038|NCT01872689|64679933|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
23256039|NCT01872689|64679930|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
23256040|NCT01872689|64679931|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
23256041|NCT01872689|64679932|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
23256042|NCT01872689|64679933|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
23256043|NCT01872689|64679930|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
23256044|NCT01872689|64679931|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
23256045|NCT01872689|64679932|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
23194998|NCT02341014|64456112|FG000|Overall Study|Adverse Event|0|||
23194999|NCT02341014|64456113|FG001|Overall Study|Adverse Event|1|||
23195000|NCT02341014|64456114|FG002|Overall Study|Adverse Event|0|||
23195001|NCT02341014|64456115|FG003|Overall Study|Adverse Event|0|||
23195002|NCT02341014|64456116|FG004|Overall Study|Adverse Event|2|||
23195003|NCT01751646|64456117|FG000|Overall Study|Lost to Follow-up|5|||
23195004|NCT01751646|64456118|FG001|Overall Study|Lost to Follow-up|1|||
23195005|NCT01751646|64456117|FG000|Overall Study|Withdrawal by Subject|0|||
23195006|NCT01751646|64456118|FG001|Overall Study|Withdrawal by Subject|4|||
23195007|NCT01751646|64456117|FG000|Overall Study|Starting hormone therapy|1|||
23195008|NCT01751646|64456118|FG001|Overall Study|Starting hormone therapy|0|||
23195009|NCT01751646|64456117|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
23195010|NCT01751646|64456118|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
23195011|NCT01751646|64456117|FG000|Overall Study|Inadvertent enrollment|1|||
23195012|NCT01751646|64456118|FG001|Overall Study|Inadvertent enrollment|1|||
23195013|NCT01751646|64456117|FG000|Overall Study|Moved out of the area|1|||
23195014|NCT01751646|64456118|FG001|Overall Study|Moved out of the area|5|||
23195015|NCT01751646|64456117|FG000|Overall Study|Inability to attend required visits|0|||
23195016|NCT01751646|64456118|FG001|Overall Study|Inability to attend required visits|1|||
23195017|NCT01751646|64456117|FG000|Overall Study|Off study due to multiple obligations|0|||
23195018|NCT01751646|64456118|FG001|Overall Study|Off study due to multiple obligations|1|||
23195019|NCT01751646|64456117|FG000|Overall Study|Fails to comply with study requirements|0|||
23195020|NCT01751646|64456118|FG001|Overall Study|Fails to comply with study requirements|1|||
23195021|NCT01751646|64456117|FG000|Overall Study|Childcare issues|1|||
23195022|NCT01751646|64456118|FG001|Overall Study|Childcare issues|1|||
23195023|NCT00443430|64456119|FG000|Overall Study|Lack of Efficacy|3|||
23195024|NCT00443430|64456120|FG001|Overall Study|Lack of Efficacy|3|||
23195025|NCT00443430|64456119|FG000|Overall Study|Adverse Event|1|||
23195026|NCT00443430|64456120|FG001|Overall Study|Adverse Event|1|||
23256046|NCT01872689|64679933|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
23195027|NCT01095250|64456124|FG000|Overall Study|administrative reasons|8|||
23256047|NCT01872689|64679930|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
23479324|NCT01403948|65498469|FG002|Overall Study|other than above|1|||
23479325|NCT01403948|65498470|FG003|Overall Study|other than above|0|||
23195028|NCT01095250|64456125|FG001|Overall Study|administrative reasons|10|||
23195029|NCT01095250|64456126|FG002|Overall Study|administrative reasons|7|||
23195030|NCT01095250|64456127|FG003|Overall Study|administrative reasons|5|||
23479326|NCT01403948|65498471|FG004|Overall Study|other than above|1|||
23479327|NCT01403948|65498472|FG005|Overall Study|other than above|1|||
23479328|NCT01403948|65498473|FG006|Overall Study|other than above|2|||
23479329|NCT01403948|65498474|FG007|Overall Study|other than above|0|||
23479330|NCT01403948|65498475|FG008|Overall Study|other than above|0|||
23479331|NCT01403948|65498476|FG009|Overall Study|other than above|0|||
23479332|NCT03149848|65498479|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
23479333|NCT03149848|65498479|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
23479334|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
23479335|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
23479336|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
23479337|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
23479338|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
23479339|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
23479340|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
23479341|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
23479342|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
23479343|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
23479344|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
23479345|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
23479346|NCT00322621|65498480|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
23479347|NCT00322621|65498481|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
23479348|NCT00322621|65498482|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
23479349|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
23479350|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
23479351|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
23479352|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
23479353|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
23479354|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
23479355|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
23479356|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
23479357|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
23479358|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
23479359|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
23479360|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
23479361|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
23479362|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
23479363|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
23479364|NCT00322621|65498480|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
23479365|NCT00322621|65498481|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
23479366|NCT00322621|65498482|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
23479367|NCT04987944|65498483|FG000|Overall Study|Adverse Event|0|||
23479368|NCT04987944|65498484|FG001|Overall Study|Adverse Event|1|||
23479369|NCT04987944|65498483|FG000|Overall Study|Withdrawal by Subject|0|||
23479370|NCT04987944|65498484|FG001|Overall Study|Withdrawal by Subject|1|||
23479371|NCT00395343|65498487|FG000|Overall Study|Adverse Event|13|||
23479372|NCT00395343|65498488|FG001|Overall Study|Adverse Event|5|||
23479373|NCT00395343|65498487|FG000|Overall Study|Lack of Efficacy|0|||
23479374|NCT00395343|65498488|FG001|Overall Study|Lack of Efficacy|1|||
23479375|NCT00395343|65498487|FG000|Overall Study|Lost to Follow-up|4|||
23479376|NCT00395343|65498488|FG001|Overall Study|Lost to Follow-up|4|||
23479377|NCT00395343|65498487|FG000|Overall Study|Physician Decision|2|||
23479378|NCT00395343|65498488|FG001|Overall Study|Physician Decision|4|||
23479379|NCT00395343|65498487|FG000|Overall Study|Protocol Violation|6|||
23479380|NCT00395343|65498488|FG001|Overall Study|Protocol Violation|8|||
23479381|NCT00395343|65498487|FG000|Overall Study|Withdrawal by Subject|11|||
23479382|NCT00395343|65498488|FG001|Overall Study|Withdrawal by Subject|12|||
23479383|NCT00395343|65498487|FG000|Overall Study|Other|5|||
23479384|NCT00395343|65498488|FG001|Overall Study|Other|2|||
23256048|NCT01872689|64679931|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
23256049|NCT01872689|64679932|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
23479385|NCT05277337|65498489|FG000|Overall Study|Lost to Follow-up|2|||
23479386|NCT05277337|65498490|FG001|Overall Study|Lost to Follow-up|0|||
23479387|NCT05277337|65498489|FG000|Overall Study|Withdrawal by Subject|1|||
23479388|NCT05277337|65498490|FG001|Overall Study|Withdrawal by Subject|0|||
23479389|NCT01782469|65498491|FG000|Overall Study|Lost to Follow-up|1|||
23479390|NCT01029405|65498492|FG000|Overall Study|Withdrawal by Subject|0|||
23479391|NCT01029405|65498493|FG001|Overall Study|Withdrawal by Subject|1|||
23479392|NCT01029405|65498494|FG002|Overall Study|Withdrawal by Subject|2|||
23479393|NCT01029405|65498495|FG003|Overall Study|Withdrawal by Subject|0|||
23479394|NCT01029405|65498492|FG000|Overall Study|Protocol Violation|0|||
23479395|NCT01029405|65498493|FG001|Overall Study|Protocol Violation|0|||
23256050|NCT01872689|64679933|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
23256051|NCT01872689|64679930|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
23599133|NCT01629589|65922456|FG000|Overall Study|Did not receive study vaccine|0|||
23599134|NCT01629589|65922457|FG001|Overall Study|Did not receive study vaccine|1|||
23599135|NCT01968967|65922458|FG000|Treatment Period|Other|22|||
23599136|NCT01968967|65922459|FG001|Treatment Period|Other|22|||
23599137|NCT01968967|65922460|FG002|Treatment Period|Other|0|||
23599138|NCT01968967|65922461|FG003|Treatment Period|Other|0|||
23599139|NCT01968967|65922462|FG004|Treatment Period|Other|0|||
23599140|NCT01968967|65922458|FG000|Treatment Period|Withdrawal by Subject|71|||
23599141|NCT01968967|65922459|FG001|Treatment Period|Withdrawal by Subject|61|||
23599142|NCT01968967|65922460|FG002|Treatment Period|Withdrawal by Subject|0|||
23599143|NCT01968967|65922461|FG003|Treatment Period|Withdrawal by Subject|0|||
23599144|NCT01968967|65922462|FG004|Treatment Period|Withdrawal by Subject|0|||
23599145|NCT01968967|65922458|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
23599146|NCT01968967|65922459|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
23599147|NCT01968967|65922460|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
23599148|NCT01968967|65922461|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
23599149|NCT01968967|65922462|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
23599150|NCT01968967|65922458|FG000|Treatment Period|Lost to Follow-up|26|||
23599151|NCT01968967|65922459|FG001|Treatment Period|Lost to Follow-up|31|||
23599152|NCT01968967|65922460|FG002|Treatment Period|Lost to Follow-up|0|||
23599153|NCT01968967|65922461|FG003|Treatment Period|Lost to Follow-up|0|||
23599154|NCT01968967|65922462|FG004|Treatment Period|Lost to Follow-up|0|||
23599155|NCT01968967|65922458|FG000|Treatment Period|Protocol Violation|1|||
23599156|NCT01968967|65922459|FG001|Treatment Period|Protocol Violation|2|||
23599157|NCT01968967|65922460|FG002|Treatment Period|Protocol Violation|0|||
23599158|NCT01968967|65922461|FG003|Treatment Period|Protocol Violation|0|||
23599159|NCT01968967|65922462|FG004|Treatment Period|Protocol Violation|0|||
23599160|NCT01968967|65922458|FG000|Treatment Period|Adverse Event|9|||
23599161|NCT01968967|65922459|FG001|Treatment Period|Adverse Event|8|||
23599162|NCT01968967|65922460|FG002|Treatment Period|Adverse Event|0|||
23599163|NCT01968967|65922461|FG003|Treatment Period|Adverse Event|0|||
23599164|NCT01968967|65922462|FG004|Treatment Period|Adverse Event|0|||
23599165|NCT01968967|65922458|FG000|Treatment Period|Death|9|||
23599166|NCT01968967|65922459|FG001|Treatment Period|Death|2|||
23599167|NCT01968967|65922460|FG002|Treatment Period|Death|0|||
23599168|NCT01968967|65922461|FG003|Treatment Period|Death|0|||
23599169|NCT01968967|65922462|FG004|Treatment Period|Death|0|||
23599170|NCT01968967|65922458|FG000|Treatment Period|Randomized Not Treated|6|||
23599171|NCT01968967|65922459|FG001|Treatment Period|Randomized Not Treated|5|||
23256052|NCT01872689|64679931|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
23599172|NCT01968967|65922460|FG002|Treatment Period|Randomized Not Treated|0|||
23599173|NCT01968967|65922461|FG003|Treatment Period|Randomized Not Treated|0|||
23599174|NCT01968967|65922462|FG004|Treatment Period|Randomized Not Treated|0|||
23599175|NCT01968967|65922458|FG000|Extension Period|Withdrew Consent|0|||
23599176|NCT01968967|65922459|FG001|Extension Period|Withdrew Consent|0|||
23599177|NCT01968967|65922460|FG002|Extension Period|Withdrew Consent|2|||
23599178|NCT01968967|65922461|FG003|Extension Period|Withdrew Consent|0|||
23256053|NCT01872689|64679932|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
23256054|NCT01872689|64679933|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
23256055|NCT01872689|64679930|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
23256056|NCT01872689|64679931|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
23256057|NCT01872689|64679932|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
23256058|NCT01872689|64679933|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
23256059|NCT01872689|64679930|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
23256060|NCT01872689|64679931|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
23599179|NCT01968967|65922462|FG004|Extension Period|Withdrew Consent|5|||
23599180|NCT02285270|65922463|FG000|Overall Study|Lost to Follow-up|1|||
23599181|NCT02285270|65922463|FG000|Overall Study|Physician Decision|3|||
23599182|NCT02285270|65922463|FG000|Overall Study|Determined to be ineligible|1|||
23599183|NCT03257410|65922464|FG000|Overall Study|Adverse Event|2|||
23599184|NCT03257410|65922465|FG001|Overall Study|Adverse Event|3|||
23599185|NCT03257410|65922464|FG000|Overall Study|Protocol Violation|1|||
23599186|NCT03257410|65922465|FG001|Overall Study|Protocol Violation|2|||
23599187|NCT03257410|65922464|FG000|Overall Study|Lost to Follow-up|1|||
23599188|NCT03257410|65922465|FG001|Overall Study|Lost to Follow-up|0|||
23599189|NCT03257410|65922464|FG000|Overall Study|Withdrawal by Subject|1|||
23599190|NCT03257410|65922465|FG001|Overall Study|Withdrawal by Subject|2|||
23599191|NCT03257410|65922464|FG000|Overall Study|Physician Decision|1|||
23599192|NCT03257410|65922465|FG001|Overall Study|Physician Decision|1|||
23599193|NCT03257410|65922464|FG000|Overall Study|Renal transplantation|2|||
23599194|NCT03257410|65922465|FG001|Overall Study|Renal transplantation|0|||
23599195|NCT03257410|65922464|FG000|Overall Study|Switch to peritoneal dialysis|1|||
23599196|NCT03257410|65922465|FG001|Overall Study|Switch to peritoneal dialysis|0|||
23599197|NCT03257410|65922464|FG000|Overall Study|Death|3|||
23599198|NCT03257410|65922465|FG001|Overall Study|Death|2|||
23599199|NCT03257410|65922464|FG000|Overall Study|Change to another dialysis center|2|||
23599200|NCT03257410|65922465|FG001|Overall Study|Change to another dialysis center|2|||
23599201|NCT03257410|65922464|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
23599202|NCT03257410|65922465|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
23599203|NCT03257410|65922464|FG000|Overall Study|Miscellaneous|2|||
23599204|NCT03257410|65922465|FG001|Overall Study|Miscellaneous|2|||
23599205|NCT03257410|65922464|FG000|Overall Study|Other|0|||
23599206|NCT03257410|65922465|FG001|Overall Study|Other|1|||
23599207|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
23599208|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
23599209|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
23599210|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23599211|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
23599212|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
23599213|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
23599214|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
23599215|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
23599216|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
23256061|NCT01872689|64679932|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
23256062|NCT01872689|64679933|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
23256063|NCT01872689|64679930|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
23256064|NCT01872689|64679931|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
23256065|NCT01872689|64679932|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
23256066|NCT01872689|64679933|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
23256067|NCT02657356|64679934|FG000|Overall Study|Death|1|||
23256068|NCT02657356|64679935|FG001|Overall Study|Death|0|||
23256069|NCT02657356|64679934|FG000|Overall Study|Withdrawal by Subject|5|||
23256070|NCT02657356|64679935|FG001|Overall Study|Withdrawal by Subject|6|||
23256071|NCT02657356|64679934|FG000|Overall Study|Terminated by Sponsor|8|||
23256072|NCT02657356|64679935|FG001|Overall Study|Terminated by Sponsor|5|||
23256073|NCT02657356|64679934|FG000|Overall Study|Rolled over to EAP study|6|||
23256074|NCT02657356|64679935|FG001|Overall Study|Rolled over to EAP study|4|||
23256075|NCT00626925|64679936|FG000|Overall Study|Lost to Follow-up|1|||
23256076|NCT00626925|64679937|FG001|Overall Study|Lost to Follow-up|2|||
23256077|NCT00626925|64679936|FG000|Overall Study|relapse|1|||
23256078|NCT00626925|64679937|FG001|Overall Study|relapse|0|||
23256079|NCT00626925|64679936|FG000|Overall Study|Adverse effect|6|||
23256080|NCT00626925|64679937|FG001|Overall Study|Adverse effect|2|||
23256081|NCT00626925|64679936|FG000|Overall Study|Lack of Efficacy|1|||
23256082|NCT00626925|64679937|FG001|Overall Study|Lack of Efficacy|4|||
23256083|NCT00626925|64679936|FG000|Overall Study|Time constraints|3|||
23256084|NCT00626925|64679937|FG001|Overall Study|Time constraints|1|||
23256085|NCT01098240|64679938|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
23256086|NCT01098240|64679939|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
23256087|NCT01098240|64679940|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
23256088|NCT01098240|64679938|FG000|Open-Label Phase|Protocol Violation|4|||
23256089|NCT01098240|64679939|FG001|Open-Label Phase|Protocol Violation|0|||
23256090|NCT01098240|64679940|FG002|Open-Label Phase|Protocol Violation|0|||
23256091|NCT01098240|64679938|FG000|Open-Label Phase|Lost to Follow-up|13|||
23256092|NCT01098240|64679939|FG001|Open-Label Phase|Lost to Follow-up|0|||
23256093|NCT01098240|64679940|FG002|Open-Label Phase|Lost to Follow-up|0|||
23256094|NCT01098240|64679938|FG000|Open-Label Phase|Other|19|||
23256095|NCT01098240|64679939|FG001|Open-Label Phase|Other|0|||
23256096|NCT01098240|64679940|FG002|Open-Label Phase|Other|0|||
23256097|NCT01098240|64679938|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
23256098|NCT01098240|64679939|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23256099|NCT01098240|64679940|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
23256100|NCT01098240|64679938|FG000|Open-Label Phase|Pregnancy|1|||
23256101|NCT01098240|64679939|FG001|Open-Label Phase|Pregnancy|0|||
23256102|NCT01098240|64679940|FG002|Open-Label Phase|Pregnancy|0|||
23256103|NCT01098240|64679938|FG000|Open-Label Phase|Withdrawal by Subject|9|||
23256104|NCT01098240|64679939|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23256105|NCT01098240|64679940|FG002|Open-Label Phase|Withdrawal by Subject|0|||
23256106|NCT01098240|64679938|FG000|Open-Label Phase|Adverse Event|12|||
23256107|NCT01098240|64679939|FG001|Open-Label Phase|Adverse Event|0|||
23479396|NCT01029405|65498494|FG002|Overall Study|Protocol Violation|0|||
23479397|NCT01029405|65498495|FG003|Overall Study|Protocol Violation|1|||
23479398|NCT01029405|65498492|FG000|Overall Study|Adverse Event|0|||
23479399|NCT01029405|65498493|FG001|Overall Study|Adverse Event|0|||
23479400|NCT01029405|65498494|FG002|Overall Study|Adverse Event|1|||
23479401|NCT01029405|65498495|FG003|Overall Study|Adverse Event|1|||
23479402|NCT01029405|65498492|FG000|Overall Study|Lost to Follow-up|2|||
23479403|NCT01029405|65498493|FG001|Overall Study|Lost to Follow-up|1|||
23479404|NCT01029405|65498494|FG002|Overall Study|Lost to Follow-up|1|||
23479405|NCT01029405|65498495|FG003|Overall Study|Lost to Follow-up|2|||
23479406|NCT01029405|65498492|FG000|Overall Study|Other|0|||
23479407|NCT01029405|65498493|FG001|Overall Study|Other|1|||
23479408|NCT01029405|65498494|FG002|Overall Study|Other|0|||
23479409|NCT01029405|65498495|FG003|Overall Study|Other|1|||
23479410|NCT02545543|65498496|FG000|Overall Study|Lost to Follow-up|67|||
23479411|NCT02545543|65498497|FG001|Overall Study|Lost to Follow-up|25|||
23256108|NCT01098240|64679940|FG002|Open-Label Phase|Adverse Event|0|||
23256109|NCT01098240|64679938|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
23256110|NCT01098240|64679939|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
23256111|NCT01098240|64679940|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
23256112|NCT01098240|64679938|FG000|Double-Blind Phase|Protocol Violation|0|||
23256113|NCT01098240|64679939|FG001|Double-Blind Phase|Protocol Violation|2|||
23256114|NCT01098240|64679940|FG002|Double-Blind Phase|Protocol Violation|4|||
23479412|NCT02545543|65498496|FG000|Overall Study|Physician Decision|3|||
23479413|NCT02545543|65498497|FG001|Overall Study|Physician Decision|0|||
23479414|NCT02545543|65498496|FG000|Overall Study|Withdrawal by Subject|9|||
23256115|NCT01098240|64679938|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23256116|NCT01098240|64679939|FG001|Double-Blind Phase|Lost to Follow-up|2|||
23256117|NCT01098240|64679940|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23479415|NCT02545543|65498497|FG001|Overall Study|Withdrawal by Subject|8|||
23479416|NCT02545543|65498496|FG000|Overall Study|Noncomplaince|1|||
23256118|NCT01098240|64679938|FG000|Double-Blind Phase|Other|0|||
23256119|NCT01098240|64679939|FG001|Double-Blind Phase|Other|2|||
23479417|NCT02545543|65498497|FG001|Overall Study|Noncomplaince|0|||
23479418|NCT02545543|65498496|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
23479419|NCT02545543|65498497|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
23479420|NCT00509262|65498501|FG000|Overall Study|Adverse Event|16|||
23479421|NCT00509262|65498502|FG001|Overall Study|Adverse Event|18|||
23479422|NCT00509262|65498501|FG000|Overall Study|Other|2|||
23479423|NCT00509262|65498502|FG001|Overall Study|Other|2|||
23479424|NCT00509262|65498501|FG000|Overall Study|Lack of Efficacy|1|||
23479425|NCT00509262|65498502|FG001|Overall Study|Lack of Efficacy|0|||
23479426|NCT00509262|65498501|FG000|Overall Study|Lost to Follow-up|1|||
23479427|NCT00509262|65498502|FG001|Overall Study|Lost to Follow-up|6|||
23479428|NCT00509262|65498501|FG000|Overall Study|Physician Decision|1|||
23479429|NCT00509262|65498502|FG001|Overall Study|Physician Decision|3|||
23479430|NCT00509262|65498501|FG000|Overall Study|Protocol Violation|2|||
23479431|NCT00509262|65498502|FG001|Overall Study|Protocol Violation|2|||
23479432|NCT00509262|65498501|FG000|Overall Study|Withdrawal by Subject|24|||
23479433|NCT00509262|65498502|FG001|Overall Study|Withdrawal by Subject|11|||
23479434|NCT01030666|65498503|FG000|Overall Study|Lost to Follow-up|3|||
23479435|NCT01030666|65498504|FG001|Overall Study|Lost to Follow-up|2|||
23479436|NCT03044574|65498505|FG000|Overall Study|Lost to Follow-up|37|||
23479437|NCT03044574|65498506|FG001|Overall Study|Lost to Follow-up|45|||
23479438|NCT00420641|65498507|FG000|Overall Study|Adverse Event|3|||
23479439|NCT00420641|65498508|FG001|Overall Study|Adverse Event|25|||
23479440|NCT00420641|65498509|FG002|Overall Study|Adverse Event|10|||
23479441|NCT00420641|65498507|FG000|Overall Study|Lost to Follow-up|2|||
23479442|NCT00420641|65498508|FG001|Overall Study|Lost to Follow-up|4|||
23479443|NCT00420641|65498509|FG002|Overall Study|Lost to Follow-up|2|||
23479444|NCT00420641|65498507|FG000|Overall Study|Protocol Violation|8|||
23479445|NCT00420641|65498508|FG001|Overall Study|Protocol Violation|8|||
23256120|NCT01098240|64679940|FG002|Double-Blind Phase|Other|2|||
23479446|NCT00420641|65498509|FG002|Overall Study|Protocol Violation|7|||
23479447|NCT00420641|65498507|FG000|Overall Study|Withdrawal by Subject|15|||
23479448|NCT00420641|65498508|FG001|Overall Study|Withdrawal by Subject|21|||
23479449|NCT00420641|65498509|FG002|Overall Study|Withdrawal by Subject|14|||
23256121|NCT01098240|64679938|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
23256122|NCT01098240|64679939|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
23256123|NCT01098240|64679940|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
23256124|NCT01098240|64679938|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
23256125|NCT01098240|64679939|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
23256126|NCT01098240|64679940|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
23256127|NCT01098240|64679938|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23256128|NCT01098240|64679939|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
23256129|NCT01098240|64679940|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
23256130|NCT01098240|64679938|FG000|Double-Blind Phase|Adverse Event|0|||
23256131|NCT01098240|64679939|FG001|Double-Blind Phase|Adverse Event|3|||
23256132|NCT01098240|64679940|FG002|Double-Blind Phase|Adverse Event|3|||
23479450|NCT00420641|65498507|FG000|Overall Study|Lack of Efficacy|6|||
23256133|NCT04006847|64679941|FG000|Overall Study|Product issue|1|||
23479451|NCT00420641|65498508|FG001|Overall Study|Lack of Efficacy|5|||
23479452|NCT00420641|65498509|FG002|Overall Study|Lack of Efficacy|4|||
23479453|NCT00420641|65498507|FG000|Overall Study|Non-compliance|7|||
23479454|NCT00420641|65498508|FG001|Overall Study|Non-compliance|5|||
23479455|NCT00420641|65498509|FG002|Overall Study|Non-compliance|4|||
23599217|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
23599218|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
23599219|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
23599220|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
23599221|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
23599222|NCT03333109|65922466|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
23599223|NCT03333109|65922467|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
23599224|NCT03333109|65922468|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
23599225|NCT03333109|65922466|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
23599226|NCT03333109|65922467|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
23599227|NCT03333109|65922468|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
23599228|NCT03333109|65922466|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
23599229|NCT03333109|65922467|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
23599230|NCT03333109|65922468|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
23599231|NCT02633215|65922469|FG000|Overall Study|Lost to Follow-up|2|||
23599232|NCT02633215|65922470|FG001|Overall Study|Lost to Follow-up|3|||
23599233|NCT00701701|65922472|FG000|Overall Study|Withdrawal by Subject|0|||
23599234|NCT00701701|65922473|FG001|Overall Study|Withdrawal by Subject|1|||
23599235|NCT00701701|65922472|FG000|Overall Study|Adverse Event|0|||
23599236|NCT00701701|65922473|FG001|Overall Study|Adverse Event|1|||
23599237|NCT01952366|65922474|FG000|Overall Study|Death|22|||
23599238|NCT01952366|65922474|FG000|Overall Study|Withdrawal by Subject|9|||
23599239|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
23599240|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
23599241|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
23599242|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
23599243|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
23599244|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
23599245|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
23599246|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
23195031|NCT01095250|64456124|FG000|Overall Study|Withdrawal by Subject|0|||
23195032|NCT01095250|64456125|FG001|Overall Study|Withdrawal by Subject|0|||
23195033|NCT01095250|64456126|FG002|Overall Study|Withdrawal by Subject|1|||
23195034|NCT01095250|64456127|FG003|Overall Study|Withdrawal by Subject|0|||
23195035|NCT01422304|64456130|FG000|Overall Study|Adverse Event|0|||
23195036|NCT01422304|64456131|FG001|Overall Study|Adverse Event|1|||
23195037|NCT01422304|64456130|FG000|Overall Study|Lost to Follow-up|14|||
23195038|NCT01422304|64456131|FG001|Overall Study|Lost to Follow-up|20|||
23195039|NCT01422304|64456130|FG000|Overall Study|Never Entered Follow-up|2|||
23195040|NCT01422304|64456131|FG001|Overall Study|Never Entered Follow-up|1|||
23195041|NCT01422304|64456130|FG000|Overall Study|Protocol Violation|1|||
23195042|NCT01422304|64456131|FG001|Overall Study|Protocol Violation|0|||
23195043|NCT01422304|64456130|FG000|Overall Study|Withdrawal by Subject|4|||
23195044|NCT01422304|64456131|FG001|Overall Study|Withdrawal by Subject|2|||
23195045|NCT01422304|64456130|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
23195046|NCT01422304|64456131|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
23195047|NCT01422304|64456130|FG000|Overall Study|Not Treated|3|||
23195048|NCT01422304|64456131|FG001|Overall Study|Not Treated|11|||
23195049|NCT01894516|64456132|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
23195050|NCT01894516|64456133|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
23256134|NCT02109133|64679942|FG000|Overall Study|Lost to Follow-up|1|||
23256135|NCT02109133|64679943|FG001|Overall Study|Lost to Follow-up|0|||
23256136|NCT00871169|64679944|FG000|Overall Study|Protocol Violation|1|||
23256137|NCT00871169|64679944|FG000|Overall Study|Patient did not receive study treatment|2|||
23256138|NCT04470622|64679945|FG000|Overall Study|Withdrawal by Subject|0|||
23256139|NCT04470622|64679946|FG001|Overall Study|Withdrawal by Subject|1|||
23599247|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
23599248|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
23599249|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
23599250|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
23195051|NCT01894516|64456134|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
23195052|NCT01894516|64456135|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
23256140|NCT04470622|64679945|FG000|Overall Study|Screen Failure|0|||
23256141|NCT04470622|64679946|FG001|Overall Study|Screen Failure|1|||
23195053|NCT01894516|64456132|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
23195054|NCT01894516|64456133|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23256142|NCT04470622|64679945|FG000|Overall Study|Death|0|||
23479456|NCT00420641|65498507|FG000|Overall Study|Other|4|||
23479457|NCT00420641|65498508|FG001|Overall Study|Other|4|||
23479458|NCT00420641|65498509|FG002|Overall Study|Other|3|||
23479459|NCT00484185|65498510|FG000|Overall Study|Lost to Follow-up|44|||
23479460|NCT00484185|65498510|FG000|Overall Study|Other|20|||
23479461|NCT00484185|65498510|FG000|Overall Study|Randomized but not treated|5|||
23479462|NCT00484185|65498510|FG000|Overall Study|Death|2|||
23479463|NCT03254459|65498511|FG000|Overall Study|Adverse Event|7|||
23479464|NCT03254459|65498512|FG001|Overall Study|Adverse Event|20|||
23479465|NCT03254459|65498511|FG000|Overall Study|Withdrawal by Subject Consent|3|||
23479466|NCT03254459|65498512|FG001|Overall Study|Withdrawal by Subject Consent|1|||
23479467|NCT03254459|65498511|FG000|Overall Study|Lost to Follow-up|0|||
23195055|NCT01894516|64456134|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23195056|NCT01894516|64456135|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
23195057|NCT01894516|64456132|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
23195058|NCT01894516|64456133|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
23195059|NCT01894516|64456134|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
23195060|NCT01894516|64456135|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
23195061|NCT01894516|64456132|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
23195062|NCT01894516|64456133|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
23195063|NCT01894516|64456134|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
23195064|NCT01894516|64456135|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
23195065|NCT01894516|64456132|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
23195066|NCT01894516|64456133|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
23195067|NCT01894516|64456134|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
23195068|NCT01894516|64456135|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
23195069|NCT01894516|64456132|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
23195070|NCT01894516|64456133|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
23195071|NCT01894516|64456134|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
23195072|NCT01894516|64456135|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
23195073|NCT01894516|64456132|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
23195074|NCT01894516|64456133|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
23195075|NCT01894516|64456134|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
23195076|NCT01894516|64456135|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
23195077|NCT01894516|64456132|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23195078|NCT01894516|64456133|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23195079|NCT01894516|64456134|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
23195080|NCT01894516|64456135|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
23195081|NCT00719732|64456138|FG000|Overall Study|Lost to Follow-up|20|||
23195082|NCT00719732|64456138|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
23195083|NCT00719732|64456138|FG000|Overall Study|Illness not associated with device|1|||
23195084|NCT00864227|64456139|FG000|Overall Study|Withdrawal by Subject|1|||
23195085|NCT00864227|64456139|FG000|Overall Study|Disease Relapse/Progression|3|||
23195086|NCT04333433|64456140|FG000|Overall Study|Withdrawal by Subject|6|||
23195087|NCT04333433|64456141|FG001|Overall Study|Withdrawal by Subject|3|||
23195088|NCT04333433|64456140|FG000|Overall Study|Death|3|||
23195089|NCT04333433|64456141|FG001|Overall Study|Death|0|||
23195090|NCT04333433|64456140|FG000|Overall Study|Lost to Follow-up|6|||
23195091|NCT04333433|64456141|FG001|Overall Study|Lost to Follow-up|1|||
23195092|NCT04333433|64456140|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
23195093|NCT04333433|64456141|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
23195094|NCT00573131|64456142|FG000|Overall Study|Withdrawal by Subject|10|||
23195095|NCT00573131|64456143|FG001|Overall Study|Withdrawal by Subject|8|||
23195096|NCT02284906|64456146|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23195097|NCT02284906|64456147|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23256143|NCT04470622|64679946|FG001|Overall Study|Death|1|||
23256144|NCT01991977|64679948|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
23256145|NCT01991977|64679948|FG000|Overall Study|Withdrew after start of treatment|5|||
23479468|NCT03254459|65498512|FG001|Overall Study|Lost to Follow-up|1|||
23479469|NCT03254459|65498511|FG000|Overall Study|Miscellaneous|0|||
23479470|NCT03254459|65498512|FG001|Overall Study|Miscellaneous|1|||
23599251|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
23599252|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
23599253|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
23195098|NCT02284906|64456148|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23195099|NCT02284906|64456146|FG000|Overall Study|Major Protocol Deviation|0|||
23195100|NCT02284906|64456147|FG001|Overall Study|Major Protocol Deviation|1|||
23195101|NCT02284906|64456148|FG002|Overall Study|Major Protocol Deviation|0|||
23256146|NCT01255722|64679956|FG000|Overall Study|Adverse Event|0|||
23479471|NCT03467152|65498516|FG000|Overall Study|Adverse Event|4|||
23599254|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
23256147|NCT01255722|64679957|FG001|Overall Study|Adverse Event|1|||
23256148|NCT01255722|64679958|FG002|Overall Study|Adverse Event|1|||
23256149|NCT01255722|64679956|FG000|Overall Study|asymptomatic patient|1|||
23360740|NCT01827592|65065869|FG000|Overall Study|Trial terminated by Sponsor|47|||
23360741|NCT01827592|65065870|FG001|Overall Study|Trial terminated by Sponsor|53|||
23360742|NCT01827592|65065871|FG002|Overall Study|Trial terminated by Sponsor|51|||
23360743|NCT01827592|65065869|FG000|Overall Study|Others|0|||
23360744|NCT01827592|65065870|FG001|Overall Study|Others|1|||
23479472|NCT03467152|65498517|FG001|Overall Study|Adverse Event|5|||
23479473|NCT03467152|65498518|FG002|Overall Study|Adverse Event|0|||
23479474|NCT03467152|65498516|FG000|Overall Study|Subject Choice|1|||
23479475|NCT03467152|65498517|FG001|Overall Study|Subject Choice|3|||
23479476|NCT03467152|65498518|FG002|Overall Study|Subject Choice|0|||
23479477|NCT03467152|65498516|FG000|Overall Study|Lost to Follow-up|1|||
23479478|NCT03467152|65498517|FG001|Overall Study|Lost to Follow-up|0|||
23479479|NCT03467152|65498518|FG002|Overall Study|Lost to Follow-up|0|||
23479480|NCT03467152|65498516|FG000|Overall Study|Withdrawal by Subject|4|||
23479481|NCT03467152|65498517|FG001|Overall Study|Withdrawal by Subject|2|||
23479482|NCT03467152|65498518|FG002|Overall Study|Withdrawal by Subject|0|||
23479483|NCT03467152|65498516|FG000|Overall Study|Others|3|||
23479484|NCT03467152|65498517|FG001|Overall Study|Others|0|||
23479485|NCT03467152|65498518|FG002|Overall Study|Others|0|||
23479486|NCT03467152|65498516|FG000|Overall Study|Not treated|3|||
23479487|NCT03467152|65498517|FG001|Overall Study|Not treated|1|||
23479488|NCT03467152|65498518|FG002|Overall Study|Not treated|6|||
23479489|NCT02009384|65498519|FG000|Overall Study|Death|2|||
23479490|NCT01268579|65498520|FG000|Overall Study|Adverse Event|1|||
23479491|NCT01268579|65498520|FG000|Overall Study|Withdrawal by Subject|2|||
23479492|NCT02093351|65498521|FG000|Part A|Adverse Event|0|||
23479493|NCT02093351|65498522|FG001|Part A|Adverse Event|1|||
23479494|NCT02093351|65498523|FG002|Part A|Adverse Event|1|||
23479495|NCT02093351|65498524|FG003|Part A|Adverse Event|0|||
23479496|NCT02093351|65498521|FG000|Part A|Condition under investigation worsened|2|||
23479497|NCT02093351|65498522|FG001|Part A|Condition under investigation worsened|0|||
23479498|NCT02093351|65498523|FG002|Part A|Condition under investigation worsened|2|||
23479499|NCT02093351|65498524|FG003|Part A|Condition under investigation worsened|0|||
23479500|NCT02093351|65498521|FG000|Part A|Death|0|||
23479501|NCT02093351|65498522|FG001|Part A|Death|1|||
23479502|NCT02093351|65498523|FG002|Part A|Death|0|||
23479503|NCT02093351|65498524|FG003|Part A|Death|0|||
23479504|NCT02093351|65498521|FG000|Part B|Patient decision|0|||
23479505|NCT02093351|65498522|FG001|Part B|Patient decision|0|||
23479506|NCT02093351|65498523|FG002|Part B|Patient decision|0|||
23479507|NCT02093351|65498524|FG003|Part B|Patient decision|3|||
23479508|NCT02093351|65498521|FG000|Part B|Disease progression|0|||
23479509|NCT02093351|65498522|FG001|Part B|Disease progression|0|||
23479510|NCT02093351|65498523|FG002|Part B|Disease progression|0|||
23479511|NCT02093351|65498524|FG003|Part B|Disease progression|4|||
23479512|NCT02093351|65498521|FG000|Part B|Complete response|0|||
23195102|NCT02284906|64456146|FG000|Overall Study|Voluntary Withdrawal|2|||
23195103|NCT02284906|64456147|FG001|Overall Study|Voluntary Withdrawal|4|||
23195104|NCT02284906|64456148|FG002|Overall Study|Voluntary Withdrawal|5|||
23195105|NCT02284906|64456146|FG000|Overall Study|Study Termination|0|||
23195106|NCT02284906|64456147|FG001|Overall Study|Study Termination|11|||
23195107|NCT02284906|64456148|FG002|Overall Study|Study Termination|14|||
23195108|NCT02284906|64456146|FG000|Overall Study|Reason not Specified|1|||
23195109|NCT02284906|64456147|FG001|Overall Study|Reason not Specified|1|||
23195110|NCT02284906|64456148|FG002|Overall Study|Reason not Specified|0|||
23195111|NCT01469052|64456151|FG000|Overall Study|Adverse Event|2|||
23195112|NCT01469052|64456152|FG001|Overall Study|Adverse Event|3|||
23195113|NCT01469052|64456153|FG002|Overall Study|Adverse Event|0|||
23195114|NCT01469052|64456154|FG003|Overall Study|Adverse Event|2|||
23195115|NCT01469052|64456155|FG004|Overall Study|Adverse Event|0|||
23195116|NCT01469052|64456156|FG005|Overall Study|Adverse Event|1|||
23195117|NCT01469052|64456151|FG000|Overall Study|Progressive disease|3|||
23195118|NCT01469052|64456152|FG001|Overall Study|Progressive disease|0|||
23195119|NCT01469052|64456153|FG002|Overall Study|Progressive disease|5|||
23195120|NCT01469052|64456154|FG003|Overall Study|Progressive disease|3|||
23195121|NCT01469052|64456155|FG004|Overall Study|Progressive disease|7|||
23195122|NCT01469052|64456156|FG005|Overall Study|Progressive disease|2|||
23479513|NCT02093351|65498522|FG001|Part B|Complete response|0|||
23479514|NCT02093351|65498523|FG002|Part B|Complete response|0|||
23195123|NCT01469052|64456151|FG000|Overall Study|Lack of Efficacy|0|||
23195124|NCT01469052|64456152|FG001|Overall Study|Lack of Efficacy|0|||
23479515|NCT02093351|65498524|FG003|Part B|Complete response|1|||
23479516|NCT02093351|65498521|FG000|Part B|Adverse event + disease progression|0|||
23195125|NCT01469052|64456153|FG002|Overall Study|Lack of Efficacy|0|||
23195126|NCT01469052|64456154|FG003|Overall Study|Lack of Efficacy|0|||
23479517|NCT02093351|65498522|FG001|Part B|Adverse event + disease progression|0|||
23479518|NCT02093351|65498523|FG002|Part B|Adverse event + disease progression|0|||
23479519|NCT02093351|65498524|FG003|Part B|Adverse event + disease progression|1|||
23599255|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
23599256|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
23599257|NCT02222493|65922475|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
23360745|NCT01827592|65065871|FG002|Overall Study|Others|3|||
23195127|NCT01469052|64456155|FG004|Overall Study|Lack of Efficacy|0|||
23195128|NCT01469052|64456156|FG005|Overall Study|Lack of Efficacy|2|||
23195129|NCT01469052|64456151|FG000|Overall Study|Moved to rollover protocol|1|||
23479520|NCT02093351|65498521|FG000|Part B|Lack of therapeutic response|0|||
23479521|NCT02093351|65498522|FG001|Part B|Lack of therapeutic response|0|||
23479522|NCT02093351|65498523|FG002|Part B|Lack of therapeutic response|0|||
23195130|NCT01469052|64456152|FG001|Overall Study|Moved to rollover protocol|0|||
23195131|NCT01469052|64456153|FG002|Overall Study|Moved to rollover protocol|1|||
23195132|NCT01469052|64456154|FG003|Overall Study|Moved to rollover protocol|0|||
23195133|NCT01469052|64456155|FG004|Overall Study|Moved to rollover protocol|0|||
23195134|NCT01469052|64456156|FG005|Overall Study|Moved to rollover protocol|1|||
23195135|NCT01469052|64456151|FG000|Overall Study|Other|0|||
23195136|NCT01469052|64456152|FG001|Overall Study|Other|1|||
23195137|NCT01469052|64456153|FG002|Overall Study|Other|0|||
23195138|NCT01469052|64456154|FG003|Overall Study|Other|0|||
23195139|NCT01469052|64456155|FG004|Overall Study|Other|1|||
23195140|NCT01469052|64456156|FG005|Overall Study|Other|0|||
23195141|NCT00273858|64456157|FG000|Overall Study|Not completed 24 month observation time|334|||
23195142|NCT00273858|64456157|FG000|Overall Study|Lost to Follow-up|101|||
23195143|NCT00273858|64456157|FG000|Overall Study|Withdrawal by Subject|21|||
23195144|NCT00273858|64456157|FG000|Overall Study|Adverse Event|81|||
23195145|NCT00455858|64456169|FG000|Overall Study|Lost to Follow-up|2|||
23195146|NCT00455858|64456169|FG000|Overall Study|Protocol Violation|1|||
23195147|NCT00455858|64456169|FG000|Overall Study|Lack of Efficacy|1|||
23195148|NCT00455858|64456169|FG000|Overall Study|Well controlled FPG without insulin|1|||
23195149|NCT00455858|64456169|FG000|Overall Study|Withdrawal|1|||
23195150|NCT01512368|64456170|FG000|Overall Study|Protocol Violation|3|||
23195151|NCT01266148|64456171|FG000|Overall Study|Adverse Event|2|||
23195152|NCT01266148|64456172|FG001|Overall Study|Adverse Event|0|||
23195153|NCT01266148|64456171|FG000|Overall Study|Ongoing rejection|1|||
23195154|NCT01266148|64456172|FG001|Overall Study|Ongoing rejection|0|||
23256150|NCT01255722|64679957|FG001|Overall Study|asymptomatic patient|0|||
23256151|NCT01255722|64679958|FG002|Overall Study|asymptomatic patient|0|||
23256152|NCT01255722|64679956|FG000|Overall Study|beta-blocker contraindicated|2|||
23479523|NCT02093351|65498524|FG003|Part B|Lack of therapeutic response|12|||
23599258|NCT02222493|65922476|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
23195155|NCT01266148|64456171|FG000|Overall Study|2 2R rejections|1|||
23195156|NCT01266148|64456172|FG001|Overall Study|2 2R rejections|0|||
23195157|NCT01266148|64456171|FG000|Overall Study|Death|2|||
23195158|NCT01266148|64456172|FG001|Overall Study|Death|3|||
23360746|NCT00398047|65065874|FG000|Overall Study|all patient progressed before completion|3|||
23360747|NCT02072941|65065875|FG000|Overall Study|Withdrawal by Subject|29|||
23360748|NCT02072941|65065876|FG001|Overall Study|Withdrawal by Subject|21|||
23360749|NCT02072941|65065875|FG000|Overall Study|Lost to Follow-up|4|||
23360750|NCT02072941|65065876|FG001|Overall Study|Lost to Follow-up|4|||
23599259|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
23599260|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
23599261|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
23599262|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
23599263|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
23599264|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
23599265|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
23599266|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
23599267|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
23599268|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
23599269|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
23599270|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
23599271|NCT02222493|65922475|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
23599272|NCT02222493|65922476|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
23599273|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
23599274|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
23599275|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
23599276|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
23599277|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
23599278|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
23599279|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
23599280|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
23256153|NCT01255722|64679957|FG001|Overall Study|beta-blocker contraindicated|0|||
23256154|NCT01255722|64679958|FG002|Overall Study|beta-blocker contraindicated|0|||
23256155|NCT00948025|64679961|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
23256156|NCT00948025|64679962|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
23256157|NCT00948025|64679961|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
23256158|NCT00948025|64679962|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
23256159|NCT00948025|64679961|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
23256160|NCT00948025|64679962|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
23256161|NCT02962882|64679971|FG000|Overall Study|Adverse Event|2|||
23256162|NCT02962882|64679971|FG000|Overall Study|Withdrawal by Subject|2|||
23256163|NCT02962882|64679971|FG000|Overall Study|Transfer from ICU|32|||
23256164|NCT00926289|64679973|FG000|Overall Study|Adverse Event|9|||
23256165|NCT00926289|64679974|FG001|Overall Study|Adverse Event|11|||
23256166|NCT00926289|64679973|FG000|Overall Study|Protocol Violation|8|||
23256167|NCT00926289|64679974|FG001|Overall Study|Protocol Violation|12|||
23360751|NCT02072941|65065875|FG000|Overall Study|Death|3|||
23599281|NCT02222493|65922475|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
23599282|NCT02222493|65922476|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
23599283|NCT01639131|65922477|FG000|Overall Study|Disease Progression|6|||
23599284|NCT00822120|65922478|FG000|Initial Registration|Adverse Event|1|||
23599285|NCT00822120|65922479|FG001|Initial Registration|Adverse Event|0|||
23599286|NCT00822120|65922480|FG002|Initial Registration|Adverse Event|0|||
23599287|NCT00822120|65922481|FG003|Initial Registration|Adverse Event|0|||
23599288|NCT00822120|65922482|FG004|Initial Registration|Adverse Event|0|||
23599289|NCT00822120|65922483|FG005|Initial Registration|Adverse Event|0|||
23599290|NCT00822120|65922478|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
23599291|NCT00822120|65922479|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599292|NCT00822120|65922480|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599293|NCT00822120|65922481|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599294|NCT00822120|65922482|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599295|NCT00822120|65922483|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
23599296|NCT00822120|65922478|FG000|Initial Registration|Reasons not Protocol Specified|2|||
23599297|NCT00822120|65922479|FG001|Initial Registration|Reasons not Protocol Specified|0|||
23599298|NCT00822120|65922480|FG002|Initial Registration|Reasons not Protocol Specified|0|||
23599299|NCT00822120|65922481|FG003|Initial Registration|Reasons not Protocol Specified|0|||
23599300|NCT00822120|65922482|FG004|Initial Registration|Reasons not Protocol Specified|0|||
23599301|NCT00822120|65922483|FG005|Initial Registration|Reasons not Protocol Specified|0|||
23599302|NCT00822120|65922478|FG000|Initial Registration|Ineligible|22|||
23599303|NCT00822120|65922479|FG001|Initial Registration|Ineligible|1|||
23599304|NCT00822120|65922480|FG002|Initial Registration|Ineligible|0|||
23360752|NCT02072941|65065876|FG001|Overall Study|Death|2|||
23360753|NCT02072941|65065875|FG000|Overall Study|Removed by Study Staff|2|||
23256168|NCT00926289|64679973|FG000|Overall Study|Lost to Follow-up|3|||
23256169|NCT00926289|64679974|FG001|Overall Study|Lost to Follow-up|6|||
23256170|NCT00926289|64679973|FG000|Overall Study|Withdrawal by Subject|4|||
23256171|NCT00926289|64679974|FG001|Overall Study|Withdrawal by Subject|4|||
23479524|NCT02093351|65498521|FG000|Part B|Condition under investigation worsened|0|||
23479525|NCT02093351|65498522|FG001|Part B|Condition under investigation worsened|0|||
23479526|NCT02093351|65498523|FG002|Part B|Condition under investigation worsened|0|||
23479527|NCT02093351|65498524|FG003|Part B|Condition under investigation worsened|39|||
23479528|NCT02093351|65498521|FG000|Part B|Adverse Event|0|||
23479529|NCT02093351|65498522|FG001|Part B|Adverse Event|0|||
23479530|NCT02093351|65498523|FG002|Part B|Adverse Event|0|||
23479531|NCT02093351|65498524|FG003|Part B|Adverse Event|2|||
23479532|NCT02093351|65498521|FG000|Part B|Death|0|||
23479533|NCT02093351|65498522|FG001|Part B|Death|0|||
23479534|NCT02093351|65498523|FG002|Part B|Death|0|||
23479535|NCT02093351|65498524|FG003|Part B|Death|1|||
23479536|NCT00843778|65498525|FG000|Overall Study|Adverse Event|15|||
23479537|NCT00843778|65498525|FG000|Overall Study|Lack of Efficacy|14|||
23479538|NCT00843778|65498525|FG000|Overall Study|Loss of efficacy|2|||
23479539|NCT00843778|65498525|FG000|Overall Study|Withdrawal by Subject|4|||
23479540|NCT00722371|65498528|FG000|Overall Study|Adverse Event|6|||
23479541|NCT00722371|65498529|FG001|Overall Study|Adverse Event|13|||
23479542|NCT00722371|65498530|FG002|Overall Study|Adverse Event|9|||
23479543|NCT00722371|65498531|FG003|Overall Study|Adverse Event|10|||
23479544|NCT00722371|65498532|FG004|Overall Study|Adverse Event|6|||
23479545|NCT00722371|65498533|FG005|Overall Study|Adverse Event|8|||
23479546|NCT00722371|65498534|FG006|Overall Study|Adverse Event|4|||
23479547|NCT00722371|65498528|FG000|Overall Study|Contraindication|0|||
23479548|NCT00722371|65498529|FG001|Overall Study|Contraindication|0|||
23479549|NCT00722371|65498530|FG002|Overall Study|Contraindication|1|||
23479550|NCT00722371|65498531|FG003|Overall Study|Contraindication|0|||
23479551|NCT00722371|65498532|FG004|Overall Study|Contraindication|0|||
23479552|NCT00722371|65498533|FG005|Overall Study|Contraindication|0|||
23479553|NCT00722371|65498534|FG006|Overall Study|Contraindication|0|||
23479554|NCT00722371|65498528|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
23479555|NCT00722371|65498529|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
23479556|NCT00722371|65498530|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
23479557|NCT00722371|65498531|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
23479558|NCT00722371|65498532|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
23479559|NCT00722371|65498533|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
23479560|NCT00722371|65498534|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
23479561|NCT00722371|65498528|FG000|Overall Study|Excluded medication|0|||
23479562|NCT00722371|65498529|FG001|Overall Study|Excluded medication|1|||
23479563|NCT00722371|65498530|FG002|Overall Study|Excluded medication|1|||
23479564|NCT00722371|65498531|FG003|Overall Study|Excluded medication|0|||
23479565|NCT00722371|65498532|FG004|Overall Study|Excluded medication|0|||
23479566|NCT00722371|65498533|FG005|Overall Study|Excluded medication|0|||
23479567|NCT00722371|65498534|FG006|Overall Study|Excluded medication|1|||
23479568|NCT00722371|65498528|FG000|Overall Study|Hyperglycemia|2|||
23479569|NCT00722371|65498529|FG001|Overall Study|Hyperglycemia|6|||
23479570|NCT00722371|65498530|FG002|Overall Study|Hyperglycemia|4|||
23599305|NCT00822120|65922481|FG003|Initial Registration|Ineligible|0|||
23599306|NCT00822120|65922482|FG004|Initial Registration|Ineligible|0|||
23599307|NCT00822120|65922483|FG005|Initial Registration|Ineligible|0|||
23599308|NCT00822120|65922478|FG000|PET-directed Therapy|Adverse Event|0|||
23599309|NCT00822120|65922479|FG001|PET-directed Therapy|Adverse Event|0|||
23599310|NCT00822120|65922480|FG002|PET-directed Therapy|Adverse Event|0|||
23599311|NCT00822120|65922481|FG003|PET-directed Therapy|Adverse Event|1|||
23599312|NCT00822120|65922482|FG004|PET-directed Therapy|Adverse Event|0|||
23599313|NCT00822120|65922483|FG005|PET-directed Therapy|Adverse Event|0|||
23599314|NCT00822120|65922478|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599315|NCT00822120|65922479|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599316|NCT00822120|65922480|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599317|NCT00822120|65922481|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
23599318|NCT00822120|65922482|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599319|NCT00822120|65922483|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
23599320|NCT00822120|65922478|FG000|PET-directed Therapy|Death|0|||
23599321|NCT00822120|65922479|FG001|PET-directed Therapy|Death|0|||
23599322|NCT00822120|65922480|FG002|PET-directed Therapy|Death|0|||
23479571|NCT00722371|65498531|FG003|Overall Study|Hyperglycemia|2|||
23479572|NCT00722371|65498532|FG004|Overall Study|Hyperglycemia|5|||
23479573|NCT00722371|65498533|FG005|Overall Study|Hyperglycemia|1|||
23479574|NCT00722371|65498534|FG006|Overall Study|Hyperglycemia|1|||
23599323|NCT00822120|65922481|FG003|PET-directed Therapy|Death|2|||
23479575|NCT00722371|65498528|FG000|Overall Study|Hypoglycemia|1|||
23479576|NCT00722371|65498529|FG001|Overall Study|Hypoglycemia|0|||
23479577|NCT00722371|65498530|FG002|Overall Study|Hypoglycemia|0|||
23599324|NCT00822120|65922482|FG004|PET-directed Therapy|Death|0|||
23479578|NCT00722371|65498531|FG003|Overall Study|Hypoglycemia|0|||
23479579|NCT00722371|65498532|FG004|Overall Study|Hypoglycemia|0|||
23479580|NCT00722371|65498533|FG005|Overall Study|Hypoglycemia|0|||
23479581|NCT00722371|65498534|FG006|Overall Study|Hypoglycemia|0|||
23479582|NCT00722371|65498528|FG000|Overall Study|Lack of Efficacy|4|||
23479583|NCT00722371|65498529|FG001|Overall Study|Lack of Efficacy|6|||
23479584|NCT00722371|65498530|FG002|Overall Study|Lack of Efficacy|6|||
23479585|NCT00722371|65498531|FG003|Overall Study|Lack of Efficacy|6|||
23479586|NCT00722371|65498532|FG004|Overall Study|Lack of Efficacy|2|||
23479587|NCT00722371|65498533|FG005|Overall Study|Lack of Efficacy|3|||
23479588|NCT00722371|65498534|FG006|Overall Study|Lack of Efficacy|0|||
23479589|NCT00722371|65498528|FG000|Overall Study|Lost to Follow-up|11|||
23479590|NCT00722371|65498529|FG001|Overall Study|Lost to Follow-up|14|||
23479591|NCT00722371|65498530|FG002|Overall Study|Lost to Follow-up|21|||
23479592|NCT00722371|65498531|FG003|Overall Study|Lost to Follow-up|13|||
23479593|NCT00722371|65498532|FG004|Overall Study|Lost to Follow-up|8|||
23479594|NCT00722371|65498533|FG005|Overall Study|Lost to Follow-up|16|||
23479595|NCT00722371|65498534|FG006|Overall Study|Lost to Follow-up|13|||
23479596|NCT00722371|65498528|FG000|Overall Study|Physician Decision|5|||
23479597|NCT00722371|65498529|FG001|Overall Study|Physician Decision|2|||
23479598|NCT00722371|65498530|FG002|Overall Study|Physician Decision|2|||
23479599|NCT00722371|65498531|FG003|Overall Study|Physician Decision|5|||
23479600|NCT00722371|65498532|FG004|Overall Study|Physician Decision|2|||
23479601|NCT00722371|65498533|FG005|Overall Study|Physician Decision|3|||
23479602|NCT00722371|65498534|FG006|Overall Study|Physician Decision|4|||
23479603|NCT00722371|65498528|FG000|Overall Study|Pregnancy|1|||
23479604|NCT00722371|65498529|FG001|Overall Study|Pregnancy|1|||
23479605|NCT00722371|65498530|FG002|Overall Study|Pregnancy|0|||
23479606|NCT00722371|65498531|FG003|Overall Study|Pregnancy|0|||
23479607|NCT00722371|65498532|FG004|Overall Study|Pregnancy|0|||
23479608|NCT00722371|65498533|FG005|Overall Study|Pregnancy|1|||
23479609|NCT00722371|65498534|FG006|Overall Study|Pregnancy|0|||
23479610|NCT00722371|65498528|FG000|Overall Study|Protocol Violation|6|||
23479611|NCT00722371|65498529|FG001|Overall Study|Protocol Violation|1|||
23479612|NCT00722371|65498530|FG002|Overall Study|Protocol Violation|0|||
23479613|NCT00722371|65498531|FG003|Overall Study|Protocol Violation|1|||
23195159|NCT01266148|64456171|FG000|Overall Study|missing mGFR value + AE|1|||
23195160|NCT01266148|64456172|FG001|Overall Study|missing mGFR value + AE|0|||
23195161|NCT00053846|64456173|FG000|Overall Study|Changed mind|8|||
23195162|NCT00053846|64456174|FG001|Overall Study|Changed mind|13|||
23195163|NCT00053846|64456173|FG000|Overall Study|Became too ill|8|||
23195164|NCT00053846|64456174|FG001|Overall Study|Became too ill|7|||
23195165|NCT00053846|64456173|FG000|Overall Study|Expired|5|||
23195166|NCT00053846|64456174|FG001|Overall Study|Expired|0|||
23195167|NCT00053846|64456173|FG000|Overall Study|Became ineligible|3|||
23195168|NCT00053846|64456174|FG001|Overall Study|Became ineligible|1|||
23195169|NCT00053846|64456173|FG000|Overall Study|Did not return data|1|||
23195170|NCT00053846|64456174|FG001|Overall Study|Did not return data|2|||
23195171|NCT00053846|64456173|FG000|Overall Study|Quit due to side effects|1|||
23195172|NCT00053846|64456174|FG001|Overall Study|Quit due to side effects|3|||
23195173|NCT00053846|64456173|FG000|Overall Study|Pills too large|0|||
23195174|NCT00053846|64456174|FG001|Overall Study|Pills too large|1|||
23195175|NCT02296840|64456175|FG000|Overall Study|Adverse Event|1|||
23195176|NCT02296840|64456176|FG001|Overall Study|Adverse Event|1|||
23195177|NCT02296840|64456175|FG000|Overall Study|Protocol Violation|2|||
23195178|NCT02296840|64456176|FG001|Overall Study|Protocol Violation|1|||
23195179|NCT02296840|64456175|FG000|Overall Study|Lost to Follow-up|6|||
23195180|NCT02296840|64456176|FG001|Overall Study|Lost to Follow-up|17|||
23195181|NCT01208662|64456178|FG000|Induction and Consolidation|Disease Progression|23|||
23195182|NCT01208662|64456179|FG001|Induction and Consolidation|Disease Progression|13|||
23195183|NCT01208662|64456180|FG002|Induction and Consolidation|Disease Progression|0|||
23195184|NCT01208662|64456178|FG000|Induction and Consolidation|Adverse Event|16|||
23195185|NCT01208662|64456179|FG001|Induction and Consolidation|Adverse Event|18|||
23195186|NCT01208662|64456180|FG002|Induction and Consolidation|Adverse Event|2|||
23195187|NCT01208662|64456178|FG000|Induction and Consolidation|MD or Participant Decision|16|||
23195188|NCT01208662|64456179|FG001|Induction and Consolidation|MD or Participant Decision|34|||
23195189|NCT01208662|64456180|FG002|Induction and Consolidation|MD or Participant Decision|4|||
23479614|NCT00722371|65498532|FG004|Overall Study|Protocol Violation|4|||
23195190|NCT01208662|64456178|FG000|Induction and Consolidation|Death|1|||
23195191|NCT01208662|64456179|FG001|Induction and Consolidation|Death|3|||
23479615|NCT00722371|65498533|FG005|Overall Study|Protocol Violation|2|||
23479616|NCT00722371|65498534|FG006|Overall Study|Protocol Violation|1|||
23479617|NCT00722371|65498528|FG000|Overall Study|Withdrawal by Subject|18|||
23479618|NCT00722371|65498529|FG001|Overall Study|Withdrawal by Subject|27|||
23479619|NCT00722371|65498530|FG002|Overall Study|Withdrawal by Subject|19|||
23479620|NCT00722371|65498531|FG003|Overall Study|Withdrawal by Subject|23|||
23479621|NCT00722371|65498532|FG004|Overall Study|Withdrawal by Subject|19|||
23479622|NCT00722371|65498533|FG005|Overall Study|Withdrawal by Subject|18|||
23479623|NCT00722371|65498534|FG006|Overall Study|Withdrawal by Subject|26|||
23479624|NCT01227629|65498535|FG000|Overall Study|Adverse Event|2|||
23479625|NCT01227629|65498536|FG001|Overall Study|Adverse Event|2|||
23479626|NCT01227629|65498537|FG002|Overall Study|Adverse Event|1|||
23479627|NCT01227629|65498538|FG003|Overall Study|Adverse Event|6|||
23479628|NCT01227629|65498539|FG004|Overall Study|Adverse Event|1|||
23479629|NCT01227629|65498540|FG005|Overall Study|Adverse Event|1|||
23479630|NCT01227629|65498541|FG006|Overall Study|Adverse Event|6|||
23479631|NCT01227629|65498542|FG007|Overall Study|Adverse Event|6|||
23479632|NCT01227629|65498543|FG008|Overall Study|Adverse Event|4|||
23479633|NCT01227629|65498544|FG009|Overall Study|Adverse Event|0|||
23479634|NCT01227629|65498535|FG000|Overall Study|Protocol Violation|0|||
23479635|NCT01227629|65498536|FG001|Overall Study|Protocol Violation|0|||
23479636|NCT01227629|65498537|FG002|Overall Study|Protocol Violation|0|||
23479637|NCT01227629|65498538|FG003|Overall Study|Protocol Violation|1|||
23479638|NCT01227629|65498539|FG004|Overall Study|Protocol Violation|0|||
23479639|NCT01227629|65498540|FG005|Overall Study|Protocol Violation|0|||
23479640|NCT01227629|65498541|FG006|Overall Study|Protocol Violation|0|||
23479641|NCT01227629|65498542|FG007|Overall Study|Protocol Violation|0|||
23479642|NCT01227629|65498543|FG008|Overall Study|Protocol Violation|0|||
23479643|NCT01227629|65498544|FG009|Overall Study|Protocol Violation|0|||
23479644|NCT01227629|65498535|FG000|Overall Study|Lost to Follow-up|0|||
23479645|NCT01227629|65498536|FG001|Overall Study|Lost to Follow-up|0|||
23479646|NCT01227629|65498537|FG002|Overall Study|Lost to Follow-up|0|||
23479647|NCT01227629|65498538|FG003|Overall Study|Lost to Follow-up|0|||
23479648|NCT01227629|65498539|FG004|Overall Study|Lost to Follow-up|1|||
23479649|NCT01227629|65498540|FG005|Overall Study|Lost to Follow-up|0|||
23479650|NCT01227629|65498541|FG006|Overall Study|Lost to Follow-up|0|||
23479651|NCT01227629|65498542|FG007|Overall Study|Lost to Follow-up|0|||
23479652|NCT01227629|65498543|FG008|Overall Study|Lost to Follow-up|0|||
23479653|NCT01227629|65498544|FG009|Overall Study|Lost to Follow-up|0|||
23479654|NCT01227629|65498535|FG000|Overall Study|Withdrawal by Subject|0|||
23479655|NCT01227629|65498536|FG001|Overall Study|Withdrawal by Subject|0|||
23479656|NCT01227629|65498537|FG002|Overall Study|Withdrawal by Subject|0|||
23479657|NCT01227629|65498538|FG003|Overall Study|Withdrawal by Subject|0|||
23479658|NCT01227629|65498539|FG004|Overall Study|Withdrawal by Subject|0|||
23479659|NCT01227629|65498540|FG005|Overall Study|Withdrawal by Subject|0|||
23479660|NCT01227629|65498541|FG006|Overall Study|Withdrawal by Subject|2|||
23195192|NCT01208662|64456180|FG002|Induction and Consolidation|Death|1|||
23195193|NCT01208662|64456178|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
23195194|NCT01208662|64456179|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
23195195|NCT01208662|64456180|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
23195196|NCT01208662|64456178|FG000|Maintenance|Disease Progression|156|||
23195197|NCT01208662|64456179|FG001|Maintenance|Disease Progression|102|||
23195198|NCT01208662|64456180|FG002|Maintenance|Disease Progression|0|||
23195199|NCT01208662|64456178|FG000|Maintenance|Adverse Event|12|||
23195200|NCT01208662|64456179|FG001|Maintenance|Adverse Event|28|||
23195201|NCT01208662|64456180|FG002|Maintenance|Adverse Event|0|||
23195202|NCT01208662|64456178|FG000|Maintenance|MD or Participant Decision|24|||
23195203|NCT01208662|64456179|FG001|Maintenance|MD or Participant Decision|36|||
23195204|NCT01208662|64456180|FG002|Maintenance|MD or Participant Decision|0|||
23195205|NCT01208662|64456178|FG000|Maintenance|Death|0|||
23195206|NCT01208662|64456179|FG001|Maintenance|Death|3|||
23195207|NCT01208662|64456180|FG002|Maintenance|Death|0|||
23195208|NCT01208662|64456178|FG000|Maintenance|Discontinued for other reasons|21|||
23195209|NCT01208662|64456179|FG001|Maintenance|Discontinued for other reasons|31|||
23195210|NCT01208662|64456180|FG002|Maintenance|Discontinued for other reasons|0|||
23195211|NCT01208662|64456178|FG000|Maintenance|Still on Treatment|78|||
23195212|NCT01208662|64456179|FG001|Maintenance|Still on Treatment|89|||
23195213|NCT01208662|64456180|FG002|Maintenance|Still on Treatment|0|||
23195214|NCT01713036|64456181|FG000|Overall Study|Death|1|||
23195215|NCT02345434|64456184|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
23195216|NCT02345434|64456185|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
23195217|NCT00374907|64456186|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
23479661|NCT01227629|65498542|FG007|Overall Study|Withdrawal by Subject|0|||
23195218|NCT00374907|64456187|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
23195219|NCT00374907|64456186|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
23195220|NCT00374907|64456187|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
23256172|NCT00926289|64679973|FG000|Overall Study|Other|1|||
23479662|NCT01227629|65498543|FG008|Overall Study|Withdrawal by Subject|0|||
23479663|NCT01227629|65498544|FG009|Overall Study|Withdrawal by Subject|1|||
23195221|NCT00374907|64456186|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
23256173|NCT00926289|64679974|FG001|Overall Study|Other|3|||
23256174|NCT02270983|64679975|FG000|Overall Study|Adverse Event|3|||
23256175|NCT02270983|64679976|FG001|Overall Study|Adverse Event|2|||
23195222|NCT00374907|64456187|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
23195223|NCT00374907|64456186|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
23195224|NCT00374907|64456187|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
23195225|NCT00374907|64456186|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
23195226|NCT00374907|64456187|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
23479664|NCT01227629|65498535|FG000|Overall Study|Other|0|||
23479665|NCT01227629|65498536|FG001|Overall Study|Other|0|||
23479666|NCT01227629|65498537|FG002|Overall Study|Other|0|||
23479667|NCT01227629|65498538|FG003|Overall Study|Other|1|||
23479668|NCT01227629|65498539|FG004|Overall Study|Other|0|||
23479669|NCT01227629|65498540|FG005|Overall Study|Other|0|||
23479670|NCT01227629|65498541|FG006|Overall Study|Other|0|||
23479671|NCT01227629|65498542|FG007|Overall Study|Other|0|||
23479672|NCT01227629|65498543|FG008|Overall Study|Other|2|||
23479673|NCT01227629|65498544|FG009|Overall Study|Other|1|||
23479674|NCT01700439|65498545|FG000|Overall Study|Lost to Follow-up|47|||
23479675|NCT01700439|65498545|FG000|Overall Study|Withdrawal by Subject|183|||
23479676|NCT01700439|65498545|FG000|Overall Study|Death|186|||
23479677|NCT03051620|65498552|FG000|Overall Study|Lost to Follow-up|6|||
23479678|NCT03051620|65498552|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
23479679|NCT01215916|65498559|FG000|Overall Study|Progressive Disease|0|||
23479680|NCT01215916|65498560|FG001|Overall Study|Progressive Disease|2|||
23479681|NCT01215916|65498561|FG002|Overall Study|Progressive Disease|1|||
23479682|NCT01215916|65498562|FG003|Overall Study|Progressive Disease|2|||
23479683|NCT01215916|65498563|FG004|Overall Study|Progressive Disease|5|||
23479684|NCT01215916|65498564|FG005|Overall Study|Progressive Disease|4|||
23479685|NCT01215916|65498565|FG006|Overall Study|Progressive Disease|5|||
23479686|NCT01215916|65498566|FG007|Overall Study|Progressive Disease|3|||
23479687|NCT01215916|65498567|FG008|Overall Study|Progressive Disease|1|||
23479688|NCT01215916|65498559|FG000|Overall Study|Adverse Event|1|||
23479689|NCT01215916|65498560|FG001|Overall Study|Adverse Event|1|||
23479690|NCT01215916|65498561|FG002|Overall Study|Adverse Event|0|||
23479691|NCT01215916|65498562|FG003|Overall Study|Adverse Event|1|||
23479692|NCT01215916|65498563|FG004|Overall Study|Adverse Event|0|||
23479693|NCT01215916|65498564|FG005|Overall Study|Adverse Event|0|||
23479694|NCT01215916|65498565|FG006|Overall Study|Adverse Event|3|||
23479695|NCT01215916|65498566|FG007|Overall Study|Adverse Event|0|||
23479696|NCT01215916|65498567|FG008|Overall Study|Adverse Event|0|||
23479697|NCT01215916|65498559|FG000|Overall Study|Withdrawal by Subject|0|||
23479698|NCT01215916|65498560|FG001|Overall Study|Withdrawal by Subject|1|||
23479699|NCT01215916|65498561|FG002|Overall Study|Withdrawal by Subject|1|||
23479700|NCT01215916|65498562|FG003|Overall Study|Withdrawal by Subject|2|||
23479701|NCT01215916|65498563|FG004|Overall Study|Withdrawal by Subject|0|||
23479702|NCT01215916|65498564|FG005|Overall Study|Withdrawal by Subject|0|||
23479703|NCT01215916|65498565|FG006|Overall Study|Withdrawal by Subject|1|||
23479704|NCT01215916|65498566|FG007|Overall Study|Withdrawal by Subject|0|||
23479705|NCT01215916|65498567|FG008|Overall Study|Withdrawal by Subject|0|||
23195227|NCT00426751|64456188|FG000|Overall Study|Adverse Event|8|||
23479706|NCT01215916|65498559|FG000|Overall Study|Death|0|||
23479707|NCT01215916|65498560|FG001|Overall Study|Death|1|||
23195228|NCT00426751|64456189|FG001|Overall Study|Adverse Event|1|||
23195229|NCT00426751|64456188|FG000|Overall Study|Lost to Follow-up|7|||
23195230|NCT00426751|64456189|FG001|Overall Study|Lost to Follow-up|6|||
23195231|NCT00426751|64456188|FG000|Overall Study|Consent Withdrawn|0|||
23195232|NCT00426751|64456189|FG001|Overall Study|Consent Withdrawn|1|||
23195233|NCT00426751|64456188|FG000|Overall Study|Other Reasons|7|||
23195234|NCT00426751|64456189|FG001|Overall Study|Other Reasons|12|||
23360754|NCT02072941|65065876|FG001|Overall Study|Removed by Study Staff|2|||
23360755|NCT00587795|65065877|FG000|Overall Study|Withdrawal by Subject|1|||
23479708|NCT01215916|65498561|FG002|Overall Study|Death|0|||
23479709|NCT01215916|65498562|FG003|Overall Study|Death|0|||
23479710|NCT01215916|65498563|FG004|Overall Study|Death|1|||
23479711|NCT01215916|65498564|FG005|Overall Study|Death|0|||
23479712|NCT01215916|65498565|FG006|Overall Study|Death|0|||
23479713|NCT01215916|65498566|FG007|Overall Study|Death|0|||
23479714|NCT01215916|65498567|FG008|Overall Study|Death|1|||
23479715|NCT01215916|65498559|FG000|Overall Study|Physician Decision|0|||
23479716|NCT01215916|65498560|FG001|Overall Study|Physician Decision|0|||
23479717|NCT01215916|65498561|FG002|Overall Study|Physician Decision|1|||
23479718|NCT01215916|65498562|FG003|Overall Study|Physician Decision|1|||
23479719|NCT01215916|65498563|FG004|Overall Study|Physician Decision|0|||
23479720|NCT01215916|65498564|FG005|Overall Study|Physician Decision|0|||
23479721|NCT01215916|65498565|FG006|Overall Study|Physician Decision|0|||
23479722|NCT01215916|65498566|FG007|Overall Study|Physician Decision|0|||
23479723|NCT01215916|65498567|FG008|Overall Study|Physician Decision|0|||
23479724|NCT01038869|65498568|FG000|Overall Study|Withdrawal by Subject|1|||
23479725|NCT01038869|65498568|FG000|Overall Study|Lost to Follow-up|6|||
23195235|NCT03700892|64456190|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
23195236|NCT03700892|64456191|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
23195237|NCT03700892|64456192|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
23195238|NCT00803244|64456193|FG000|Overall Study|Adverse Event|1|||
23195239|NCT00803244|64456194|FG001|Overall Study|Adverse Event|2|||
23195240|NCT00803244|64456193|FG000|Overall Study|Withdrawal by Subject|2|||
23195241|NCT00803244|64456194|FG001|Overall Study|Withdrawal by Subject|3|||
23195242|NCT00803244|64456193|FG000|Overall Study|Any other reason not above-mentioned|4|||
23195243|NCT00803244|64456194|FG001|Overall Study|Any other reason not above-mentioned|10|||
23195244|NCT04220866|64456196|FG000|Overall Study|Death|4|||
23195245|NCT04220866|64456197|FG001|Overall Study|Death|5|||
23195246|NCT04220866|64456196|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
23195247|NCT04220866|64456197|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
23195248|NCT04220866|64456196|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
23195249|NCT04220866|64456197|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
23195250|NCT04220866|64456196|FG000|Overall Study|Withdrawal by Subject|0|||
23195251|NCT04220866|64456197|FG001|Overall Study|Withdrawal by Subject|1|||
23195252|NCT01544114|64459567|FG000|Overall Study|Withdrawal by Subject|0|||
23195253|NCT01544114|64459568|FG001|Overall Study|Withdrawal by Subject|0|||
23195254|NCT01544114|64459569|FG002|Overall Study|Withdrawal by Subject|3|||
23195255|NCT01544114|64459567|FG000|Overall Study|Lost to Follow-up|0|||
23195256|NCT01544114|64459568|FG001|Overall Study|Lost to Follow-up|2|||
23195257|NCT01544114|64459569|FG002|Overall Study|Lost to Follow-up|0|||
23195258|NCT01544114|64459567|FG000|Overall Study|Adverse Event|1|||
23195259|NCT01544114|64459568|FG001|Overall Study|Adverse Event|1|||
23195260|NCT01544114|64459569|FG002|Overall Study|Adverse Event|2|||
23195261|NCT01544114|64459567|FG000|Overall Study|Protocol Violation|0|||
23195262|NCT01544114|64459568|FG001|Overall Study|Protocol Violation|1|||
23479726|NCT00686634|65498569|FG000|Overall Study|Protocol Violation|6|||
23479727|NCT03584373|65498570|FG000|Overall Study|Lost to Follow-up|7|||
23479728|NCT03584373|65498571|FG001|Overall Study|Lost to Follow-up|8|||
23479729|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
23479730|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
23599325|NCT00822120|65922483|FG005|PET-directed Therapy|Death|0|||
23479731|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
23195263|NCT01544114|64459569|FG002|Overall Study|Protocol Violation|0|||
23195264|NCT01345786|64459570|FG000|Overall Study|Adverse Event|0|||
23599326|NCT00822120|65922478|FG000|PET-directed Therapy|Protocol Violation|0|||
23599327|NCT00822120|65922479|FG001|PET-directed Therapy|Protocol Violation|0|||
23599328|NCT00822120|65922480|FG002|PET-directed Therapy|Protocol Violation|0|||
23599329|NCT00822120|65922481|FG003|PET-directed Therapy|Protocol Violation|6|||
23599330|NCT00822120|65922482|FG004|PET-directed Therapy|Protocol Violation|0|||
23599331|NCT00822120|65922483|FG005|PET-directed Therapy|Protocol Violation|0|||
23599332|NCT04019444|65922484|FG000|Overall Study|Withdrawal by Subject|0|||
23599333|NCT04019444|65922485|FG001|Overall Study|Withdrawal by Subject|1|||
23599334|NCT04019444|65922486|FG002|Overall Study|Withdrawal by Subject|0|||
23599335|NCT04019444|65922487|FG003|Overall Study|Withdrawal by Subject|1|||
23599336|NCT04019444|65922484|FG000|Overall Study|Solicited Event|0|||
23599337|NCT04019444|65922485|FG001|Overall Study|Solicited Event|0|||
23599338|NCT04019444|65922486|FG002|Overall Study|Solicited Event|2|||
23599339|NCT04019444|65922487|FG003|Overall Study|Solicited Event|0|||
23599340|NCT02029235|65922499|FG000|Overall Study|Non-compliance with study meds or diary|4|||
23599341|NCT02029235|65922500|FG001|Overall Study|Non-compliance with study meds or diary|1|||
23599342|NCT01303510|65922501|FG000|Overall Study|Lost to Follow-up|1|||
23599343|NCT01303510|65922502|FG001|Overall Study|Lost to Follow-up|0|||
23599344|NCT03861052|65922503|FG000|Overall Study|Adverse Event|1|||
23599345|NCT03861052|65922504|FG001|Overall Study|Adverse Event|1|||
23599346|NCT03861052|65922505|FG002|Overall Study|Adverse Event|2|||
23599347|NCT03861052|65922506|FG003|Overall Study|Adverse Event|4|||
23599348|NCT03861052|65922503|FG000|Overall Study|Lost to Follow-up|0|||
23599349|NCT03861052|65922504|FG001|Overall Study|Lost to Follow-up|0|||
23599350|NCT03861052|65922505|FG002|Overall Study|Lost to Follow-up|0|||
23256176|NCT02270983|64679977|FG002|Overall Study|Adverse Event|6|||
23256177|NCT02270983|64679975|FG000|Overall Study|Lack of Efficacy|2|||
23256178|NCT02270983|64679976|FG001|Overall Study|Lack of Efficacy|1|||
23256179|NCT02270983|64679977|FG002|Overall Study|Lack of Efficacy|1|||
23256180|NCT02270983|64679975|FG000|Overall Study|Withdrawal by Subject|1|||
23256181|NCT02270983|64679976|FG001|Overall Study|Withdrawal by Subject|0|||
23256182|NCT02270983|64679977|FG002|Overall Study|Withdrawal by Subject|2|||
23256183|NCT02270983|64679975|FG000|Overall Study|Lost to Follow-up|1|||
23256184|NCT02270983|64679976|FG001|Overall Study|Lost to Follow-up|1|||
23256185|NCT02270983|64679977|FG002|Overall Study|Lost to Follow-up|2|||
23256186|NCT02270983|64679975|FG000|Overall Study|Protocol Violation|1|||
23256187|NCT02270983|64679976|FG001|Overall Study|Protocol Violation|1|||
23256188|NCT02270983|64679977|FG002|Overall Study|Protocol Violation|1|||
23256189|NCT02270983|64679975|FG000|Overall Study|family emergency|0|||
23256190|NCT02270983|64679976|FG001|Overall Study|family emergency|1|||
23256191|NCT02270983|64679977|FG002|Overall Study|family emergency|0|||
23256192|NCT02270983|64679975|FG000|Overall Study|study procedure non-compliance|1|||
23256193|NCT02270983|64679976|FG001|Overall Study|study procedure non-compliance|0|||
23360756|NCT00587795|65065878|FG001|Overall Study|Withdrawal by Subject|0|||
23360757|NCT02658669|65065879|FG000|Overall Study|Lost to Follow-up|7|||
23360758|NCT02658669|65065880|FG001|Overall Study|Lost to Follow-up|5|||
23360759|NCT00878800|65065881|FG000|Overall Study|Adverse Event|0|||
23360760|NCT00878800|65065882|FG001|Overall Study|Adverse Event|0|||
23360761|NCT00878800|65065883|FG002|Overall Study|Adverse Event|2|||
23360762|NCT00878800|65065884|FG003|Overall Study|Adverse Event|0|||
23360763|NCT00878800|65065885|FG004|Overall Study|Adverse Event|1|||
23360764|NCT00878800|65065881|FG000|Overall Study|Progressive disease|1|||
23360765|NCT00878800|65065882|FG001|Overall Study|Progressive disease|5|||
23360766|NCT00878800|65065883|FG002|Overall Study|Progressive disease|6|||
23360767|NCT00878800|65065884|FG003|Overall Study|Progressive disease|5|||
23360768|NCT00878800|65065885|FG004|Overall Study|Progressive disease|13|||
23360769|NCT00878800|65065881|FG000|Overall Study|Withdrew consent|1|||
23360770|NCT00878800|65065882|FG001|Overall Study|Withdrew consent|1|||
23360771|NCT00878800|65065883|FG002|Overall Study|Withdrew consent|0|||
23360772|NCT00878800|65065884|FG003|Overall Study|Withdrew consent|1|||
23360773|NCT00878800|65065885|FG004|Overall Study|Withdrew consent|1|||
23256194|NCT02270983|64679977|FG002|Overall Study|study procedure non-compliance|0|||
23256195|NCT02270983|64679975|FG000|Overall Study|moved away from study site|0|||
23256196|NCT02270983|64679976|FG001|Overall Study|moved away from study site|1|||
23256197|NCT02270983|64679977|FG002|Overall Study|moved away from study site|0|||
23360774|NCT00878800|65065881|FG000|Overall Study|Death|0|||
23360775|NCT00878800|65065882|FG001|Overall Study|Death|0|||
23360776|NCT00878800|65065883|FG002|Overall Study|Death|1|||
23360777|NCT00878800|65065884|FG003|Overall Study|Death|0|||
23360778|NCT00878800|65065885|FG004|Overall Study|Death|0|||
23256198|NCT01325532|64679978|FG000|Overall Study|Withdrawal by Subject|2|||
23360779|NCT00878800|65065881|FG000|Overall Study|Other|1|||
23360780|NCT00878800|65065882|FG001|Overall Study|Other|1|||
23195265|NCT01345786|64459571|FG001|Overall Study|Adverse Event|1|||
23479732|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
23256199|NCT01325532|64679979|FG001|Overall Study|Withdrawal by Subject|0|||
23256200|NCT01841359|64679988|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
23256201|NCT01841359|64679988|FG000|Overall Study|Concommitant medical issues|2|||
23256202|NCT01841359|64679988|FG000|Overall Study|Adverse Event|3|||
23256203|NCT01841359|64679988|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
23256204|NCT02957682|64679992|FG000|Overall Study|Adverse Event|64|||
23256205|NCT02957682|64679993|FG001|Overall Study|Adverse Event|67|||
23256206|NCT02957682|64679992|FG000|Overall Study|Poor Compliance to Protocol|30|||
23479733|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
23479734|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
23479735|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
23479736|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
23479737|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
23479738|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
23479739|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
23479740|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
23479741|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23479742|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23479743|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23479744|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23479745|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
23479746|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
23479747|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
23479748|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
23479749|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
23479750|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
23479751|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
23479752|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
23479753|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
23479754|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23479755|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23479756|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23479757|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
23479758|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
23479759|NCT01328444|65498583|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23479760|NCT01328444|65498584|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
23479761|NCT01328444|65498585|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23479762|NCT01328444|65498586|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
23479763|NCT01328444|65498587|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
23479764|NCT01328444|65498588|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23479765|NCT01328444|65498583|FG000|Washout Period (14 Days)|Adverse Event|1|||
23479766|NCT01328444|65498584|FG001|Washout Period (14 Days)|Adverse Event|1|||
23479767|NCT01328444|65498585|FG002|Washout Period (14 Days)|Adverse Event|0|||
23479768|NCT01328444|65498586|FG003|Washout Period (14 Days)|Adverse Event|1|||
23479769|NCT01328444|65498587|FG004|Washout Period (14 Days)|Adverse Event|1|||
23479770|NCT01328444|65498588|FG005|Washout Period (14 Days)|Adverse Event|2|||
23479771|NCT01328444|65498583|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
23479772|NCT01328444|65498584|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
23479773|NCT01328444|65498585|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
23479774|NCT01328444|65498586|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
23479775|NCT01328444|65498587|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
23479776|NCT01328444|65498588|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
23479777|NCT01328444|65498583|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
23479778|NCT01328444|65498584|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
23479779|NCT01328444|65498585|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
23479780|NCT01328444|65498586|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
23256207|NCT02957682|64679993|FG001|Overall Study|Poor Compliance to Protocol|26|||
23256208|NCT02957682|64679992|FG000|Overall Study|Physician Decision|4|||
23256209|NCT02957682|64679993|FG001|Overall Study|Physician Decision|4|||
23256210|NCT02957682|64679992|FG000|Overall Study|Study Terminated by Sponsor|4|||
23256211|NCT02957682|64679993|FG001|Overall Study|Study Terminated by Sponsor|3|||
23256212|NCT02957682|64679992|FG000|Overall Study|Subject Moved|10|||
23479781|NCT01328444|65498587|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
23479782|NCT01328444|65498588|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
23479783|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
23479784|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23479785|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23479786|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23479787|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
23479788|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
23360781|NCT00878800|65065883|FG002|Overall Study|Other|0|||
23256213|NCT02957682|64679993|FG001|Overall Study|Subject Moved|16|||
23256214|NCT02957682|64679992|FG000|Overall Study|Withdrawal by Subject|64|||
23256215|NCT02957682|64679993|FG001|Overall Study|Withdrawal by Subject|33|||
23256216|NCT02957682|64679992|FG000|Overall Study|Related to IMP Administration|3|||
23256217|NCT02957682|64679993|FG001|Overall Study|Related to IMP Administration|6|||
23256218|NCT02957682|64679992|FG000|Overall Study|Non-disclosed|16|||
23256219|NCT02957682|64679993|FG001|Overall Study|Non-disclosed|12|||
23256220|NCT02957682|64679992|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
23360782|NCT00878800|65065884|FG003|Overall Study|Other|0|||
23360783|NCT00878800|65065885|FG004|Overall Study|Other|1|||
23479789|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
23479790|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
23479791|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
23479792|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
23479793|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
23479794|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
23360784|NCT01890759|65065892|FG000|Overall Study|Protocol Violation|0|||
23360785|NCT01890759|65065893|FG001|Overall Study|Protocol Violation|2|||
23479795|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
23479796|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
23479797|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
23479798|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
23479799|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
23479800|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
23479801|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
23479802|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
23479803|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
23479804|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
23479805|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
23479806|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
23479807|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23479808|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
23479809|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23479810|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23479811|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
23479812|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
23479813|NCT01328444|65498583|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23479814|NCT01328444|65498584|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23479815|NCT01328444|65498585|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23479816|NCT01328444|65498586|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23479817|NCT01328444|65498587|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23599351|NCT03861052|65922506|FG003|Overall Study|Lost to Follow-up|1|||
23195266|NCT01345786|64459572|FG002|Overall Study|Adverse Event|3|||
23360786|NCT01890759|65065892|FG000|Overall Study|Lost to Follow-up|0|||
23360787|NCT01890759|65065893|FG001|Overall Study|Lost to Follow-up|2|||
23360788|NCT01890759|65065892|FG000|Overall Study|Withdrawal by Subject|2|||
23360789|NCT01890759|65065893|FG001|Overall Study|Withdrawal by Subject|8|||
23360790|NCT01968811|65065897|FG000|Overall Study|Protocol Violation|4|||
23360791|NCT01968811|65065897|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
23360792|NCT04086121|65065899|FG000|Overall Study|Other than listed|8|||
23360793|NCT04086121|65065899|FG000|Overall Study|Withdrawal by Subject|3|||
23360794|NCT04086121|65065899|FG000|Overall Study|Lost to Follow-up|2|||
23360795|NCT04086121|65065899|FG000|Overall Study|Adverse Event|1|||
23360796|NCT04001803|65065902|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
23360797|NCT04001803|65065902|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
23360798|NCT04001803|65065902|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
23360799|NCT04001803|65065902|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
23360800|NCT04001803|65065902|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
23360801|NCT04001803|65065902|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
23360802|NCT04001803|65065902|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
23360803|NCT04001803|65065902|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
23360804|NCT04001803|65065902|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
23360805|NCT04001803|65065902|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
23360806|NCT05285787|65065908|FG000|Overall Study|Withdrawal by Subject|1|||
23360807|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
23360808|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
23360809|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
23360810|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
23360811|NCT00412932|65065911|FG000|Olmesartan (Olm) 20 mg|Other|1|||
23360812|NCT00412932|65065911|FG000|Olmesartan 40 mg|Adverse Event|4|||
23360813|NCT00412932|65065911|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
23360814|NCT00412932|65065911|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
23479818|NCT01328444|65498588|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23479819|NCT01820260|65498598|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479820|NCT01820260|65498599|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479821|NCT01820260|65498600|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479822|NCT01820260|65498601|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479823|NCT01820260|65498602|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23256221|NCT02957682|64679993|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
23256222|NCT04023994|64679994|FG000|Overall Study|Lost to Follow-up|0|||
23256223|NCT04023994|64679995|FG001|Overall Study|Lost to Follow-up|1|||
23256224|NCT04023994|64679996|FG002|Overall Study|Lost to Follow-up|2|||
23256225|NCT04023994|64679997|FG003|Overall Study|Lost to Follow-up|0|||
23256226|NCT04023994|64679998|FG004|Overall Study|Lost to Follow-up|0|||
23256227|NCT04023994|64679999|FG005|Overall Study|Lost to Follow-up|0|||
23256228|NCT04023994|64679994|FG000|Overall Study|Withdrawal by Subject|0|||
23256229|NCT04023994|64679995|FG001|Overall Study|Withdrawal by Subject|0|||
23256230|NCT04023994|64679996|FG002|Overall Study|Withdrawal by Subject|0|||
23256231|NCT04023994|64679997|FG003|Overall Study|Withdrawal by Subject|1|||
23256232|NCT04023994|64679998|FG004|Overall Study|Withdrawal by Subject|0|||
23256233|NCT04023994|64679999|FG005|Overall Study|Withdrawal by Subject|0|||
23256234|NCT04908722|64680002|FG000|Overall Study|Protocol deviation|1|||
23256235|NCT04908722|64680003|FG001|Overall Study|Protocol deviation|0|||
23256236|NCT04908722|64680004|FG002|Overall Study|Protocol deviation|0|||
23256237|NCT04908722|64680005|FG003|Overall Study|Protocol deviation|0|||
23256238|NCT04908722|64680006|FG004|Overall Study|Protocol deviation|0|||
23256239|NCT04908722|64680007|FG005|Overall Study|Protocol deviation|1|||
23256240|NCT04908722|64680002|FG000|Overall Study|Lost to Follow-up|33|||
23256241|NCT04908722|64680003|FG001|Overall Study|Lost to Follow-up|33|||
23256242|NCT04908722|64680004|FG002|Overall Study|Lost to Follow-up|36|||
23256243|NCT04908722|64680005|FG003|Overall Study|Lost to Follow-up|30|||
23256244|NCT04908722|64680006|FG004|Overall Study|Lost to Follow-up|32|||
23256245|NCT04908722|64680007|FG005|Overall Study|Lost to Follow-up|34|||
23256246|NCT04908722|64680002|FG000|Overall Study|Physician Decision|1|||
23256247|NCT04908722|64680003|FG001|Overall Study|Physician Decision|1|||
23256248|NCT04908722|64680004|FG002|Overall Study|Physician Decision|1|||
23256249|NCT04908722|64680005|FG003|Overall Study|Physician Decision|2|||
23256250|NCT04908722|64680006|FG004|Overall Study|Physician Decision|0|||
23256251|NCT04908722|64680007|FG005|Overall Study|Physician Decision|0|||
23256252|NCT04908722|64680002|FG000|Overall Study|Death|1|||
23256253|NCT04908722|64680003|FG001|Overall Study|Death|0|||
23256254|NCT04908722|64680004|FG002|Overall Study|Death|0|||
23256255|NCT04908722|64680005|FG003|Overall Study|Death|0|||
23256256|NCT04908722|64680006|FG004|Overall Study|Death|0|||
23256257|NCT04908722|64680007|FG005|Overall Study|Death|1|||
23256258|NCT04908722|64680002|FG000|Overall Study|Withdrawal by Subject|12|||
23256259|NCT04908722|64680003|FG001|Overall Study|Withdrawal by Subject|8|||
23256260|NCT04908722|64680004|FG002|Overall Study|Withdrawal by Subject|7|||
23256261|NCT04908722|64680005|FG003|Overall Study|Withdrawal by Subject|6|||
23256262|NCT04908722|64680006|FG004|Overall Study|Withdrawal by Subject|12|||
23256263|NCT04908722|64680007|FG005|Overall Study|Withdrawal by Subject|14|||
23256264|NCT04908722|64680002|FG000|Overall Study|Other|3|||
23256265|NCT04908722|64680003|FG001|Overall Study|Other|1|||
23256266|NCT04908722|64680004|FG002|Overall Study|Other|3|||
23256267|NCT04908722|64680005|FG003|Overall Study|Other|2|||
23256268|NCT04908722|64680006|FG004|Overall Study|Other|4|||
23256269|NCT04908722|64680007|FG005|Overall Study|Other|1|||
23256270|NCT04908722|64680002|FG000|Overall Study|Initiated prohibited medication|0|||
23256271|NCT04908722|64680003|FG001|Overall Study|Initiated prohibited medication|0|||
23256272|NCT04908722|64680004|FG002|Overall Study|Initiated prohibited medication|0|||
23256273|NCT04908722|64680005|FG003|Overall Study|Initiated prohibited medication|1|||
23256274|NCT04908722|64680006|FG004|Overall Study|Initiated prohibited medication|0|||
23256275|NCT04908722|64680007|FG005|Overall Study|Initiated prohibited medication|1|||
23256276|NCT04908722|64680002|FG000|Overall Study|Randomized but not vaccinated|3|||
23256277|NCT04908722|64680003|FG001|Overall Study|Randomized but not vaccinated|1|||
23256278|NCT04908722|64680004|FG002|Overall Study|Randomized but not vaccinated|2|||
23256279|NCT04908722|64680005|FG003|Overall Study|Randomized but not vaccinated|2|||
23256280|NCT04908722|64680006|FG004|Overall Study|Randomized but not vaccinated|3|||
23256281|NCT04908722|64680007|FG005|Overall Study|Randomized but not vaccinated|4|||
23360815|NCT00412932|65065911|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
23479824|NCT01820260|65498603|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23599352|NCT03861052|65922503|FG000|Overall Study|Physician Decision|0|||
23256282|NCT00096382|64680008|FG000|Overall Study|Not treated|1|||
23256283|NCT00096382|64680009|FG001|Overall Study|Not treated|0|||
23256284|NCT00096382|64680008|FG000|Overall Study|Death during treatment|1|||
23256285|NCT00096382|64680009|FG001|Overall Study|Death during treatment|0|||
23256286|NCT03066440|64680010|FG000|Overall Study|Physician Decision|1|||
23256287|NCT03066440|64680011|FG001|Overall Study|Physician Decision|1|||
23256288|NCT03066440|64680010|FG000|Overall Study|Protocol Violation|0|||
23256289|NCT03066440|64680011|FG001|Overall Study|Protocol Violation|2|||
23256290|NCT01021137|64680012|FG000|Overall Study|Lost to Follow-up|9|||
23360816|NCT00412932|65065911|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
23256291|NCT01021137|64680013|FG001|Overall Study|Lost to Follow-up|4|||
23256292|NCT01021137|64680014|FG002|Overall Study|Lost to Follow-up|2|||
23360817|NCT00412932|65065911|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
23256293|NCT01021137|64680015|FG003|Overall Study|Lost to Follow-up|6|||
23256294|NCT01021137|64680012|FG000|Overall Study|Withdrawal by Subject|1|||
23256295|NCT01021137|64680013|FG001|Overall Study|Withdrawal by Subject|0|||
23256296|NCT01021137|64680014|FG002|Overall Study|Withdrawal by Subject|0|||
23256297|NCT01021137|64680015|FG003|Overall Study|Withdrawal by Subject|3|||
23256298|NCT01446913|64680020|FG000|Overall Study|Significant illness|1|||
23256299|NCT01446913|64680021|FG001|Overall Study|Significant illness|1|||
23360818|NCT00412932|65065911|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
23479825|NCT01820260|65498604|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
23599353|NCT03861052|65922504|FG001|Overall Study|Physician Decision|1|||
23195267|NCT01345786|64459573|FG003|Overall Study|Adverse Event|1|||
23599354|NCT03861052|65922505|FG002|Overall Study|Physician Decision|0|||
23599355|NCT03861052|65922506|FG003|Overall Study|Physician Decision|0|||
23599356|NCT03861052|65922503|FG000|Overall Study|Withdrawal by Subject|2|||
23599357|NCT03861052|65922504|FG001|Overall Study|Withdrawal by Subject|5|||
23599358|NCT03861052|65922505|FG002|Overall Study|Withdrawal by Subject|3|||
23599359|NCT03861052|65922506|FG003|Overall Study|Withdrawal by Subject|0|||
23599360|NCT03861052|65922503|FG000|Overall Study|Relocation to other city|1|||
23599361|NCT03861052|65922504|FG001|Overall Study|Relocation to other city|0|||
23599362|NCT03861052|65922505|FG002|Overall Study|Relocation to other city|0|||
23599363|NCT03861052|65922506|FG003|Overall Study|Relocation to other city|0|||
23599364|NCT00174252|65922513|FG000|Overall Study|Protocol Violation|2|||
23599365|NCT00566735|65922515|FG000|Overall Study|Withdrawal by Subject|0|||
23599366|NCT00566735|65922516|FG001|Overall Study|Withdrawal by Subject|1|||
23599367|NCT00566735|65922515|FG000|Overall Study|Refused neuropsychological testing|2|||
23599368|NCT00566735|65922516|FG001|Overall Study|Refused neuropsychological testing|5|||
23599369|NCT00566735|65922515|FG000|Overall Study|Switched into a manic episode|0|||
23599370|NCT00566735|65922516|FG001|Overall Study|Switched into a manic episode|1|||
23599371|NCT01324310|65925557|FG000|Overall Study|Adverse Event|1|||
23599372|NCT01324310|65925557|FG000|Overall Study|Disease Progression|1|||
23599373|NCT01854385|65925560|FG000|Pre-Treatment|Withdrawal by Subject|4|||
23599374|NCT01854385|65925560|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
23599375|NCT01854385|65925560|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
23599376|NCT01854385|65925560|FG000|Pre-Treatment|Unable to come for study visits|1|||
23599377|NCT01854385|65925560|FG000|Treatment|Lost to Follow-up|1|||
23599378|NCT01750684|65925561|FG000|Overall Study|Death|1|||
23599379|NCT01750684|65925562|FG001|Overall Study|Death|0|||
23599380|NCT01750684|65925561|FG000|Overall Study|Non-compliance with Study Drug|0|||
23599381|NCT01750684|65925562|FG001|Overall Study|Non-compliance with Study Drug|1|||
23599382|NCT01750684|65925561|FG000|Overall Study|Withdrawn by Sponsor|0|||
23599383|NCT01750684|65925562|FG001|Overall Study|Withdrawn by Sponsor|1|||
23599384|NCT01750684|65925561|FG000|Overall Study|Protocol Violation|1|||
23599385|NCT01750684|65925562|FG001|Overall Study|Protocol Violation|0|||
23599386|NCT01288443|65925565|FG000|Overall Study|Adverse Event|0|||
23599387|NCT01288443|65925566|FG001|Overall Study|Adverse Event|0|||
23599388|NCT01288443|65925567|FG002|Overall Study|Adverse Event|1|||
23599389|NCT01288443|65925568|FG003|Overall Study|Adverse Event|1|||
23599390|NCT01288443|65925569|FG004|Overall Study|Adverse Event|3|||
23599391|NCT01288443|65925570|FG005|Overall Study|Adverse Event|1|||
23599392|NCT01288443|65925565|FG000|Overall Study|Poor compliance to protocol|0|||
23599393|NCT01288443|65925566|FG001|Overall Study|Poor compliance to protocol|0|||
23599394|NCT01288443|65925567|FG002|Overall Study|Poor compliance to protocol|0|||
23599395|NCT01288443|65925568|FG003|Overall Study|Poor compliance to protocol|0|||
23599396|NCT01288443|65925569|FG004|Overall Study|Poor compliance to protocol|0|||
23599397|NCT01288443|65925570|FG005|Overall Study|Poor compliance to protocol|1|||
23599398|NCT01288443|65925565|FG000|Overall Study|Participant Moved|0|||
23599399|NCT01288443|65925566|FG001|Overall Study|Participant Moved|0|||
23599400|NCT01288443|65925567|FG002|Overall Study|Participant Moved|0|||
23599401|NCT01288443|65925568|FG003|Overall Study|Participant Moved|1|||
23599402|NCT01288443|65925569|FG004|Overall Study|Participant Moved|2|||
23360819|NCT03335813|65065912|FG000|Overall Study|Withdrawal by Subject|1|||
23360820|NCT00184002|65065913|FG000|Overall Study|Adverse Event|9|||
23360821|NCT00184002|65065913|FG000|Overall Study|Death|3|||
23360822|NCT00184002|65065913|FG000|Overall Study|Physician Decision|1|||
23360823|NCT00184002|65065913|FG000|Overall Study|Withdrawal by Subject|4|||
23360824|NCT01909804|65065915|FG000|Overall Study|Randomized but Never Treated|0|||
23360825|NCT01909804|65065916|FG001|Overall Study|Randomized but Never Treated|0|||
23360826|NCT01909804|65065917|FG002|Overall Study|Randomized but Never Treated|0|||
23360827|NCT01909804|65065918|FG003|Overall Study|Randomized but Never Treated|0|||
23360828|NCT01909804|65065919|FG004|Overall Study|Randomized but Never Treated|0|||
23360829|NCT01909804|65065920|FG005|Overall Study|Randomized but Never Treated|0|||
23360830|NCT01909804|65065921|FG006|Overall Study|Randomized but Never Treated|1|||
23360831|NCT01909804|65065922|FG007|Overall Study|Randomized but Never Treated|0|||
23360832|NCT01909804|65065923|FG008|Overall Study|Randomized but Never Treated|0|||
23360833|NCT01909804|65065924|FG009|Overall Study|Randomized but Never Treated|0|||
23360834|NCT01909804|65065925|FG010|Overall Study|Randomized but Never Treated|0|||
23360835|NCT01909804|65065926|FG011|Overall Study|Randomized but Never Treated|1|||
23360836|NCT01909804|65065915|FG000|Overall Study|Death|0|||
23360837|NCT01909804|65065916|FG001|Overall Study|Death|0|||
23360838|NCT01909804|65065917|FG002|Overall Study|Death|0|||
23360839|NCT01909804|65065918|FG003|Overall Study|Death|0|||
23360840|NCT01909804|65065919|FG004|Overall Study|Death|0|||
23360841|NCT01909804|65065920|FG005|Overall Study|Death|0|||
23360842|NCT01909804|65065921|FG006|Overall Study|Death|0|||
23360843|NCT01909804|65065922|FG007|Overall Study|Death|0|||
23360844|NCT01909804|65065923|FG008|Overall Study|Death|0|||
23360845|NCT01909804|65065924|FG009|Overall Study|Death|0|||
23360846|NCT01909804|65065925|FG010|Overall Study|Death|1|||
23360847|NCT01909804|65065926|FG011|Overall Study|Death|0|||
23360848|NCT01909804|65065915|FG000|Overall Study|Lack of Efficacy|4|||
23360849|NCT01909804|65065916|FG001|Overall Study|Lack of Efficacy|1|||
23360850|NCT01909804|65065917|FG002|Overall Study|Lack of Efficacy|0|||
23360851|NCT01909804|65065918|FG003|Overall Study|Lack of Efficacy|0|||
23479826|NCT01820260|65498605|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479827|NCT01820260|65498606|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479828|NCT01820260|65498607|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479829|NCT01820260|65498608|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479830|NCT01820260|65498609|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479831|NCT01820260|65498610|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479832|NCT01820260|65498611|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
23479833|NCT01820260|65498598|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479834|NCT01820260|65498599|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479835|NCT01820260|65498600|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479836|NCT01820260|65498601|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479837|NCT01820260|65498602|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479838|NCT01820260|65498603|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479839|NCT01820260|65498604|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479840|NCT01820260|65498605|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479841|NCT01820260|65498606|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479842|NCT01820260|65498607|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
23479843|NCT01820260|65498608|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479844|NCT01820260|65498609|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479845|NCT01820260|65498610|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479846|NCT01820260|65498611|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
23479847|NCT05347147|65498613|FG000|Overall Study|Lost to Follow-up|0|||
23479848|NCT05347147|65498614|FG001|Overall Study|Lost to Follow-up|1|||
23479849|NCT05347147|65498613|FG000|Overall Study|Sponsor request|3|||
23479850|NCT05347147|65498614|FG001|Overall Study|Sponsor request|3|||
23479851|NCT05347147|65498613|FG000|Overall Study|Study termination|2|||
23479852|NCT05347147|65498614|FG001|Overall Study|Study termination|1|||
23479853|NCT04381988|65501814|FG000|Overall Study|The study was terminated|4|||
23479854|NCT04381988|65501815|FG001|Overall Study|The study was terminated|0|||
23479855|NCT03680742|65501822|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
23479856|NCT03821844|65501829|FG000|Overall Study|Death|37|||
23479857|NCT03821844|65501830|FG001|Overall Study|Death|31|||
23479858|NCT03821844|65501829|FG000|Overall Study|Discharged|10|||
23479859|NCT03821844|65501830|FG001|Overall Study|Discharged|14|||
23479860|NCT03821844|65501829|FG000|Overall Study|Not present in facility at followup|2|||
23479861|NCT03821844|65501830|FG001|Overall Study|Not present in facility at followup|3|||
23479862|NCT03007888|65501831|FG000|First Intervention (14 Days)|Adverse Event|1|||
23479863|NCT03007888|65501832|FG001|First Intervention (14 Days)|Adverse Event|0|||
23479864|NCT01993836|65501835|FG000|Overall Study|Surgery Cancelled|3|||
23479865|NCT01993836|65501836|FG001|Overall Study|Surgery Cancelled|0|||
23479866|NCT01993836|65501837|FG002|Overall Study|Surgery Cancelled|0|||
23479867|NCT01993836|65501835|FG000|Overall Study|Physician Decision|2|||
23479868|NCT01993836|65501836|FG001|Overall Study|Physician Decision|1|||
23479869|NCT01993836|65501837|FG002|Overall Study|Physician Decision|0|||
23479870|NCT01993836|65501835|FG000|Overall Study|Death|0|||
23479871|NCT01993836|65501836|FG001|Overall Study|Death|2|||
23479872|NCT01993836|65501837|FG002|Overall Study|Death|0|||
23479873|NCT01993836|65501835|FG000|Overall Study|Withdrawal by Subject|12|||
23479874|NCT01993836|65501836|FG001|Overall Study|Withdrawal by Subject|10|||
23479875|NCT01993836|65501837|FG002|Overall Study|Withdrawal by Subject|5|||
23479876|NCT02656680|65501838|FG000|Overall Study|Lost to Follow-up|0|||
23479877|NCT02656680|65501839|FG001|Overall Study|Lost to Follow-up|1|||
23479878|NCT02656680|65501840|FG002|Overall Study|Lost to Follow-up|7|||
23479879|NCT02296138|65501843|FG000|Overall Study|Adverse Event|348|||
23479880|NCT02296138|65501844|FG001|Overall Study|Adverse Event|259|||
23479881|NCT02296138|65501843|FG000|Overall Study|Lack of Efficacy|59|||
23479882|NCT02296138|65501844|FG001|Overall Study|Lack of Efficacy|37|||
23479883|NCT02296138|65501843|FG000|Overall Study|Protocol Violation|35|||
23479884|NCT02296138|65501844|FG001|Overall Study|Protocol Violation|36|||
23479885|NCT02296138|65501843|FG000|Overall Study|Lost to Follow-up|9|||
23479886|NCT02296138|65501844|FG001|Overall Study|Lost to Follow-up|12|||
23479887|NCT02296138|65501843|FG000|Overall Study|Withdrawal by Subject|184|||
23479888|NCT02296138|65501844|FG001|Overall Study|Withdrawal by Subject|131|||
23479889|NCT02296138|65501843|FG000|Overall Study|Not Treated|1|||
23479890|NCT02296138|65501844|FG001|Overall Study|Not Treated|1|||
23479891|NCT02296138|65501843|FG000|Overall Study|Patients with data irregularities|10|||
23479892|NCT02296138|65501844|FG001|Overall Study|Patients with data irregularities|11|||
23479893|NCT02296138|65501843|FG000|Overall Study|Other than specified|15|||
23479894|NCT02296138|65501844|FG001|Overall Study|Other than specified|13|||
23479895|NCT00348933|65501848|FG000|Overall Study|Withdrawal by Subject|10|||
23479896|NCT00348933|65501848|FG000|Overall Study|Lost to Follow-up|6|||
23479897|NCT00348933|65501848|FG000|Overall Study|Protocol Violation|2|||
23479898|NCT00348933|65501848|FG000|Overall Study|Adverse Event|7|||
23360852|NCT01909804|65065919|FG004|Overall Study|Lack of Efficacy|7|||
23195268|NCT01345786|64459570|FG000|Overall Study|Subject withdrew consent|2|||
23195269|NCT01345786|64459571|FG001|Overall Study|Subject withdrew consent|2|||
23360853|NCT01909804|65065920|FG005|Overall Study|Lack of Efficacy|3|||
23599403|NCT01288443|65925570|FG005|Overall Study|Participant Moved|1|||
23599404|NCT01288443|65925565|FG000|Overall Study|Consent withdrawn by Participant|0|||
23599405|NCT01288443|65925566|FG001|Overall Study|Consent withdrawn by Participant|0|||
23599406|NCT01288443|65925567|FG002|Overall Study|Consent withdrawn by Participant|0|||
23599407|NCT01288443|65925568|FG003|Overall Study|Consent withdrawn by Participant|0|||
23599408|NCT01288443|65925569|FG004|Overall Study|Consent withdrawn by Participant|0|||
23599409|NCT01288443|65925570|FG005|Overall Study|Consent withdrawn by Participant|1|||
23599410|NCT01288443|65925565|FG000|Overall Study|Lost to Follow-up|0|||
23599411|NCT01288443|65925566|FG001|Overall Study|Lost to Follow-up|1|||
23599412|NCT01288443|65925567|FG002|Overall Study|Lost to Follow-up|0|||
23599413|NCT01288443|65925568|FG003|Overall Study|Lost to Follow-up|0|||
23599414|NCT01288443|65925569|FG004|Overall Study|Lost to Follow-up|0|||
23599415|NCT01288443|65925570|FG005|Overall Study|Lost to Follow-up|0|||
23599416|NCT01288443|65925565|FG000|Overall Study|Study drug auto-injector administration|0|||
23599417|NCT01288443|65925566|FG001|Overall Study|Study drug auto-injector administration|0|||
23599418|NCT01288443|65925567|FG002|Overall Study|Study drug auto-injector administration|0|||
23599419|NCT01288443|65925568|FG003|Overall Study|Study drug auto-injector administration|0|||
23599420|NCT01288443|65925569|FG004|Overall Study|Study drug auto-injector administration|1|||
23599421|NCT01288443|65925570|FG005|Overall Study|Study drug auto-injector administration|1|||
23599422|NCT01288443|65925565|FG000|Overall Study|Other than above|0|||
23599423|NCT01288443|65925566|FG001|Overall Study|Other than above|0|||
23599424|NCT01288443|65925567|FG002|Overall Study|Other than above|0|||
23599425|NCT01288443|65925568|FG003|Overall Study|Other than above|2|||
23599426|NCT01288443|65925569|FG004|Overall Study|Other than above|1|||
23599427|NCT01288443|65925570|FG005|Overall Study|Other than above|0|||
23599428|NCT00795184|65925571|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
23599429|NCT00795184|65925572|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
23599430|NCT02844439|65925574|FG000|Overall Study|Withdrawal by Subject|1|||
23599431|NCT02844439|65925574|FG000|Overall Study|Lost to Follow-up|2|||
23599432|NCT02844439|65925574|FG000|Overall Study|Termination by Sponsor|4|||
23599433|NCT02844439|65925574|FG000|Overall Study|Death|28|||
23599434|NCT02844439|65925574|FG000|Overall Study|Other|5|||
23599435|NCT01823224|65925576|FG000|Overall Study|Lost to Follow-up|5|||
23599436|NCT01823224|65925577|FG001|Overall Study|Lost to Follow-up|6|||
23599437|NCT01823224|65925576|FG000|Overall Study|didn't qualify|1|||
23599438|NCT01823224|65925577|FG001|Overall Study|didn't qualify|2|||
23599439|NCT01823224|65925576|FG000|Overall Study|pharmacy error|0|||
23599440|NCT01823224|65925577|FG001|Overall Study|pharmacy error|1|||
23599441|NCT01823224|65925576|FG000|Overall Study|missed med dose|0|||
23599442|NCT01823224|65925577|FG001|Overall Study|missed med dose|1|||
23599443|NCT01823224|65925576|FG000|Overall Study|Withdrawal by Subject|0|||
23599444|NCT01823224|65925577|FG001|Overall Study|Withdrawal by Subject|1|||
23599445|NCT02652442|65925578|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
23599446|NCT01637402|65925586|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
23599447|NCT01637402|65925587|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
23195270|NCT01345786|64459572|FG002|Overall Study|Subject withdrew consent|1|||
23195271|NCT01345786|64459573|FG003|Overall Study|Subject withdrew consent|0|||
23195272|NCT01345786|64459570|FG000|Overall Study|Noncompliance with protocol|1|||
23195273|NCT01345786|64459571|FG001|Overall Study|Noncompliance with protocol|0|||
23360854|NCT01909804|65065921|FG006|Overall Study|Lack of Efficacy|1|||
23195274|NCT01345786|64459572|FG002|Overall Study|Noncompliance with protocol|1|||
23195275|NCT01345786|64459573|FG003|Overall Study|Noncompliance with protocol|0|||
23195276|NCT01345786|64459570|FG000|Overall Study|Administrative|3|||
23195277|NCT01345786|64459571|FG001|Overall Study|Administrative|5|||
23195278|NCT01345786|64459572|FG002|Overall Study|Administrative|0|||
23195279|NCT01345786|64459573|FG003|Overall Study|Administrative|0|||
23195280|NCT01345786|64459570|FG000|Overall Study|Lost to Follow-up|0|||
23195281|NCT01345786|64459571|FG001|Overall Study|Lost to Follow-up|0|||
23195282|NCT01345786|64459572|FG002|Overall Study|Lost to Follow-up|0|||
23195283|NCT01345786|64459573|FG003|Overall Study|Lost to Follow-up|2|||
23195284|NCT00328198|64459574|FG000|Treatment|Adverse Event|21|||
23195285|NCT00328198|64459574|FG000|Treatment|Death|1|||
23195286|NCT00328198|64459574|FG000|Treatment|Physician Decision|5|||
23195287|NCT00328198|64459574|FG000|Treatment|Withdrawal by Subject|5|||
23195288|NCT00328198|64459574|FG000|Treatment|Evidence of disease progression|2|||
23195289|NCT00328198|64459574|FG000|Treatment|Non-compliance|1|||
23256300|NCT01446913|64680022|FG002|Overall Study|Significant illness|1|||
23256301|NCT01446913|64680020|FG000|Overall Study|Withdrawal by Subject|5|||
23256302|NCT01446913|64680021|FG001|Overall Study|Withdrawal by Subject|3|||
23256303|NCT01446913|64680022|FG002|Overall Study|Withdrawal by Subject|5|||
23256304|NCT01446913|64680020|FG000|Overall Study|Physician Decision|0|||
23256305|NCT01446913|64680021|FG001|Overall Study|Physician Decision|0|||
23256306|NCT01446913|64680022|FG002|Overall Study|Physician Decision|2|||
23256307|NCT01446913|64680020|FG000|Overall Study|Lost to Follow-up|3|||
23256308|NCT01446913|64680021|FG001|Overall Study|Lost to Follow-up|5|||
23256309|NCT01446913|64680022|FG002|Overall Study|Lost to Follow-up|3|||
23256310|NCT02063698|64680023|FG000|Overall Study|did not complete booklet for days 2-8|1|||
23256311|NCT02063698|64680024|FG001|Overall Study|did not complete booklet for days 2-8|2|||
23256312|NCT03811249|64680025|FG000|Overall Study|Withdrawal by Subject|44|||
23256313|NCT03811249|64680025|FG000|Overall Study|Missed Visit|24|||
23256314|NCT02230085|64680028|FG000|Overall Study|Physician Decision|1|||
23256315|NCT02230085|64680028|FG000|Overall Study|Withdrawal by Subject|3|||
23256316|NCT01473758|64680029|FG000|Cycle 1|Adverse Event|10|||
23256317|NCT01473758|64680030|FG001|Cycle 1|Adverse Event|2|||
23256318|NCT01473758|64680031|FG002|Cycle 1|Adverse Event|0|||
23256319|NCT01473758|64680032|FG003|Cycle 1|Adverse Event|0|||
23256320|NCT01473758|64680029|FG000|Cycle 1|Withdrawal by Subject|1|||
23256321|NCT01473758|64680030|FG001|Cycle 1|Withdrawal by Subject|1|||
23256322|NCT01473758|64680031|FG002|Cycle 1|Withdrawal by Subject|0|||
23256323|NCT01473758|64680032|FG003|Cycle 1|Withdrawal by Subject|0|||
23256324|NCT01473758|64680029|FG000|Cycle 2|Adverse Event|0|||
23256325|NCT01473758|64680030|FG001|Cycle 2|Adverse Event|0|||
23256326|NCT01473758|64680031|FG002|Cycle 2|Adverse Event|5|||
23256327|NCT01473758|64680032|FG003|Cycle 2|Adverse Event|0|||
23256328|NCT01086215|64680033|FG000|Overall Study|Death|14|||
23256329|NCT01086215|64680034|FG001|Overall Study|Death|8|||
23256330|NCT01086215|64680035|FG002|Overall Study|Death|8|||
23256331|NCT01086215|64680036|FG003|Overall Study|Death|1|||
23256332|NCT01086215|64680033|FG000|Overall Study|Lost to Follow-up|22|||
23256333|NCT01086215|64680034|FG001|Overall Study|Lost to Follow-up|39|||
23256334|NCT01086215|64680035|FG002|Overall Study|Lost to Follow-up|18|||
23256335|NCT01086215|64680036|FG003|Overall Study|Lost to Follow-up|2|||
23256336|NCT01020305|64680042|FG000|Overall Study|Adverse Event|2|||
23256337|NCT02971605|64680043|FG000|Overall Study|Withdrawal by Subject|1|||
23256338|NCT01605461|64680044|FG000|Overall Study|Lost to Follow-up|3|||
23256339|NCT01605461|64680044|FG000|Overall Study|Withdrawal by Subject|1|||
23256340|NCT01377233|64680048|FG000|Open-label|Adverse Event|1|||
23479899|NCT02969408|65501849|FG000|Overall Study|Adverse Event|2|||
23479900|NCT02969408|65501849|FG000|Overall Study|Withdrawal by Subject|8|||
23479901|NCT02969408|65501849|FG000|Overall Study|Lost to Follow-up|4|||
23479902|NCT02969408|65501849|FG000|Overall Study|Protocol Violation|1|||
23479903|NCT02969408|65501849|FG000|Overall Study|Other than specified|1|||
23479904|NCT00945906|65501853|FG000|Overall Study|Withdrawal by Subject|1|||
23479905|NCT00945906|65501853|FG000|Overall Study|Did not want to return for last visit|2|||
23479906|NCT00945906|65501853|FG000|Overall Study|Unable to return for last visit|2|||
23479907|NCT00945906|65501853|FG000|Overall Study|Moved to another country|2|||
23479908|NCT04604132|65501854|FG000|Overall Study|Adverse Event|2|||
23479909|NCT04604132|65501855|FG001|Overall Study|Adverse Event|0|||
23479910|NCT04604132|65501856|FG002|Overall Study|Adverse Event|0|||
23479911|NCT04604132|65501857|FG003|Overall Study|Adverse Event|1|||
23479912|NCT04604132|65501858|FG004|Overall Study|Adverse Event|2|||
23479913|NCT04604132|65501854|FG000|Overall Study|Study terminated by sponsor|0|||
23479914|NCT04604132|65501855|FG001|Overall Study|Study terminated by sponsor|0|||
23479915|NCT04604132|65501856|FG002|Overall Study|Study terminated by sponsor|0|||
23479916|NCT04604132|65501857|FG003|Overall Study|Study terminated by sponsor|0|||
23479917|NCT04604132|65501858|FG004|Overall Study|Study terminated by sponsor|1|||
23479918|NCT04604132|65501854|FG000|Overall Study|Progressive disease: Clinical progression|0|||
23479919|NCT04604132|65501855|FG001|Overall Study|Progressive disease: Clinical progression|0|||
23479920|NCT04604132|65501856|FG002|Overall Study|Progressive disease: Clinical progression|1|||
23479921|NCT04604132|65501857|FG003|Overall Study|Progressive disease: Clinical progression|0|||
23479922|NCT04604132|65501858|FG004|Overall Study|Progressive disease: Clinical progression|0|||
23479923|NCT04604132|65501854|FG000|Overall Study|Progressive disease: Radiological progression|8|||
23479924|NCT04604132|65501855|FG001|Overall Study|Progressive disease: Radiological progression|7|||
23479925|NCT04604132|65501856|FG002|Overall Study|Progressive disease: Radiological progression|10|||
23479926|NCT04604132|65501857|FG003|Overall Study|Progressive disease: Radiological progression|4|||
23479927|NCT04604132|65501858|FG004|Overall Study|Progressive disease: Radiological progression|3|||
23479928|NCT04604132|65501854|FG000|Overall Study|Death|3|||
23479929|NCT04604132|65501855|FG001|Overall Study|Death|1|||
23479930|NCT04604132|65501856|FG002|Overall Study|Death|2|||
23479931|NCT04604132|65501857|FG003|Overall Study|Death|1|||
23479932|NCT04604132|65501858|FG004|Overall Study|Death|0|||
23479933|NCT03859973|65501860|FG000|Overall Study|Other reason than listed|3|||
23479934|NCT03859973|65501861|FG001|Overall Study|Other reason than listed|2|||
23479935|NCT03859973|65501860|FG000|Overall Study|COVID-19 related, not due to AE|3|||
23479936|NCT03859973|65501861|FG001|Overall Study|COVID-19 related, not due to AE|4|||
23479937|NCT03859973|65501860|FG000|Overall Study|Withdrawal by Subject|8|||
23479938|NCT03859973|65501861|FG001|Overall Study|Withdrawal by Subject|9|||
23479939|NCT03859973|65501860|FG000|Overall Study|Lost to Follow-up|2|||
23479940|NCT03859973|65501861|FG001|Overall Study|Lost to Follow-up|3|||
23479941|NCT03859973|65501860|FG000|Overall Study|Protocol Violation|1|||
23479942|NCT03859973|65501861|FG001|Overall Study|Protocol Violation|3|||
23479943|NCT03859973|65501860|FG000|Overall Study|Adverse Event|3|||
23479944|NCT03859973|65501861|FG001|Overall Study|Adverse Event|5|||
23479945|NCT02047318|65501862|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
23479946|NCT02047318|65501862|FG000|Core Study Period|Adverse Event|1|||
23479947|NCT02047318|65501862|FG000|Core Study Period|Withdrawal by caregiver|3|||
23479948|NCT02047318|65501862|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
23479949|NCT00327470|65501867|FG000|Overall Study|Randomized, but not treated|0|||
23479950|NCT00327470|65501868|FG001|Overall Study|Randomized, but not treated|2|||
23479951|NCT00327470|65501867|FG000|Overall Study|Adverse Event|9|||
23479952|NCT00327470|65501868|FG001|Overall Study|Adverse Event|14|||
23479953|NCT00327470|65501867|FG000|Overall Study|Lack of Efficacy|7|||
23479954|NCT00327470|65501868|FG001|Overall Study|Lack of Efficacy|19|||
23479955|NCT00327470|65501867|FG000|Overall Study|Other|5|||
23479956|NCT00327470|65501868|FG001|Overall Study|Other|9|||
23479957|NCT00327470|65501867|FG000|Overall Study|Lost to Follow-up|1|||
23479958|NCT00327470|65501868|FG001|Overall Study|Lost to Follow-up|3|||
23479959|NCT00327470|65501867|FG000|Overall Study|Withdrawal by Subject|6|||
23479960|NCT00327470|65501868|FG001|Overall Study|Withdrawal by Subject|12|||
23479961|NCT00327470|65501867|FG000|Overall Study|Death|1|||
23479962|NCT00327470|65501868|FG001|Overall Study|Death|4|||
23479963|NCT01120067|65501869|FG000|Overall Study|Lost to Follow-up|3|||
23479964|NCT01120067|65501870|FG001|Overall Study|Lost to Follow-up|1|||
23256341|NCT01377233|64680049|FG001|Open-label|Adverse Event|0|||
23256342|NCT01377233|64680050|FG002|Open-label|Adverse Event|0|||
23256343|NCT01377233|64680051|FG003|Open-label|Adverse Event|0|||
23256344|NCT01377233|64680052|FG004|Open-label|Adverse Event|0|||
23256345|NCT01377233|64680048|FG000|Open-label|Withdrawal by Subject|3|||
23479965|NCT01120067|65501869|FG000|Overall Study|fail to engage >3 sessions|2|||
23479966|NCT01120067|65501870|FG001|Overall Study|fail to engage >3 sessions|0|||
23479967|NCT03400956|65501871|FG000|Treatment Period 1|Adverse Event|0|||
23479968|NCT03400956|65501872|FG001|Treatment Period 1|Adverse Event|1|||
23256346|NCT01377233|64680049|FG001|Open-label|Withdrawal by Subject|0|||
23256347|NCT01377233|64680050|FG002|Open-label|Withdrawal by Subject|0|||
23195290|NCT00328198|64459574|FG000|Treatment|Confirmed complete response, MRD -|3|||
23195291|NCT00328198|64459574|FG000|Follow-up|Lost to Follow-up|4|||
23195292|NCT00328198|64459574|FG000|Follow-up|Death|31|||
23256348|NCT01377233|64680051|FG003|Open-label|Withdrawal by Subject|0|||
23195293|NCT01197378|64459578|FG000|Overall Study|Adverse Event|3|||
23599448|NCT01637402|65925586|FG000|Standard Dose Regimen|Adverse Event|1|||
23599449|NCT01637402|65925587|FG001|Standard Dose Regimen|Adverse Event|0|||
23599450|NCT01637402|65925586|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
23599451|NCT01637402|65925587|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
23599452|NCT01637402|65925586|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
23599453|NCT01637402|65925587|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
23599454|NCT01637402|65925586|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
23599455|NCT01637402|65925587|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
23599456|NCT01637402|65925586|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
23599457|NCT01637402|65925587|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
23599458|NCT00879333|65925589|FG000|Overall Study|Adverse Event|94|||
23599459|NCT00879333|65925590|FG001|Overall Study|Adverse Event|34|||
23599460|NCT00879333|65925589|FG000|Overall Study|Abnormal Laboratory Value|1|||
23599461|NCT00879333|65925590|FG001|Overall Study|Abnormal Laboratory Value|0|||
23599462|NCT00879333|65925589|FG000|Overall Study|Withdrawal by Subject|20|||
23599463|NCT00879333|65925590|FG001|Overall Study|Withdrawal by Subject|7|||
23599464|NCT00879333|65925589|FG000|Overall Study|Lost to Follow-up|2|||
23599465|NCT00879333|65925590|FG001|Overall Study|Lost to Follow-up|1|||
23599466|NCT00879333|65925589|FG000|Overall Study|Administrative Problems|2|||
23599467|NCT00879333|65925590|FG001|Overall Study|Administrative Problems|0|||
23599468|NCT00879333|65925589|FG000|Overall Study|Death|16|||
23599469|NCT00879333|65925590|FG001|Overall Study|Death|5|||
23599470|NCT00879333|65925589|FG000|Overall Study|Disease Progression|292|||
23599471|NCT00879333|65925590|FG001|Overall Study|Disease Progression|169|||
23599472|NCT00879333|65925589|FG000|Overall Study|Protocol Violation|1|||
23599473|NCT00879333|65925590|FG001|Overall Study|Protocol Violation|1|||
23599474|NCT00774397|65925594|FG000|Overall Study|Adverse Event|1|||
23599475|NCT00774397|65925595|FG001|Overall Study|Adverse Event|3|||
23599476|NCT00774397|65925596|FG002|Overall Study|Adverse Event|16|||
23599477|NCT00774397|65925597|FG003|Overall Study|Adverse Event|8|||
23599478|NCT00774397|65925598|FG004|Overall Study|Adverse Event|8|||
23599479|NCT00774397|65925599|FG005|Overall Study|Adverse Event|3|||
23599480|NCT00774397|65925600|FG006|Overall Study|Adverse Event|16|||
23599481|NCT00774397|65925594|FG000|Overall Study|Lack of Efficacy|11|||
23599482|NCT00774397|65925595|FG001|Overall Study|Lack of Efficacy|4|||
23599483|NCT00774397|65925596|FG002|Overall Study|Lack of Efficacy|5|||
23599484|NCT00774397|65925597|FG003|Overall Study|Lack of Efficacy|3|||
23599485|NCT00774397|65925598|FG004|Overall Study|Lack of Efficacy|27|||
23599486|NCT00774397|65925599|FG005|Overall Study|Lack of Efficacy|15|||
23599487|NCT00774397|65925600|FG006|Overall Study|Lack of Efficacy|9|||
23599488|NCT00774397|65925594|FG000|Overall Study|Protocol Violation|0|||
23599489|NCT00774397|65925595|FG001|Overall Study|Protocol Violation|1|||
23599490|NCT00774397|65925596|FG002|Overall Study|Protocol Violation|3|||
23599491|NCT00774397|65925597|FG003|Overall Study|Protocol Violation|1|||
23599492|NCT00774397|65925598|FG004|Overall Study|Protocol Violation|2|||
23599493|NCT00774397|65925599|FG005|Overall Study|Protocol Violation|1|||
23599494|NCT00774397|65925600|FG006|Overall Study|Protocol Violation|0|||
23599495|NCT00774397|65925594|FG000|Overall Study|Lost to Follow-up|0|||
23599496|NCT00774397|65925595|FG001|Overall Study|Lost to Follow-up|1|||
23599497|NCT00774397|65925596|FG002|Overall Study|Lost to Follow-up|1|||
23599498|NCT00774397|65925597|FG003|Overall Study|Lost to Follow-up|1|||
23599499|NCT00774397|65925598|FG004|Overall Study|Lost to Follow-up|0|||
23599500|NCT00774397|65925599|FG005|Overall Study|Lost to Follow-up|1|||
23599501|NCT00774397|65925600|FG006|Overall Study|Lost to Follow-up|0|||
23599502|NCT00774397|65925594|FG000|Overall Study|Refused to continue trial medication|1|||
23599503|NCT00774397|65925595|FG001|Overall Study|Refused to continue trial medication|3|||
23599504|NCT00774397|65925596|FG002|Overall Study|Refused to continue trial medication|2|||
23599505|NCT00774397|65925597|FG003|Overall Study|Refused to continue trial medication|2|||
23599506|NCT00774397|65925598|FG004|Overall Study|Refused to continue trial medication|6|||
23256349|NCT01377233|64680052|FG004|Open-label|Withdrawal by Subject|0|||
23599507|NCT00774397|65925599|FG005|Overall Study|Refused to continue trial medication|2|||
23599508|NCT00774397|65925600|FG006|Overall Study|Refused to continue trial medication|3|||
23599509|NCT00774397|65925594|FG000|Overall Study|Not treated|0|||
23599510|NCT00774397|65925595|FG001|Overall Study|Not treated|0|||
23599511|NCT00774397|65925596|FG002|Overall Study|Not treated|0|||
23599512|NCT00774397|65925597|FG003|Overall Study|Not treated|0|||
23599513|NCT00774397|65925598|FG004|Overall Study|Not treated|1|||
23599514|NCT00774397|65925599|FG005|Overall Study|Not treated|0|||
23599515|NCT00774397|65925600|FG006|Overall Study|Not treated|1|||
23599516|NCT00774397|65925594|FG000|Overall Study|Other than those stated above|1|||
23599517|NCT00774397|65925595|FG001|Overall Study|Other than those stated above|1|||
23599518|NCT00774397|65925596|FG002|Overall Study|Other than those stated above|3|||
23599519|NCT00774397|65925597|FG003|Overall Study|Other than those stated above|2|||
23599520|NCT00774397|65925598|FG004|Overall Study|Other than those stated above|2|||
23479969|NCT03400956|65501873|FG002|Treatment Period 1|Adverse Event|0|||
23599521|NCT00774397|65925599|FG005|Overall Study|Other than those stated above|0|||
23599522|NCT00774397|65925600|FG006|Overall Study|Other than those stated above|1|||
23599523|NCT04876417|65925601|FG000|Overall Study|Lost to Follow-up|5|||
23599524|NCT04876417|65925602|FG001|Overall Study|Lost to Follow-up|8|||
23599525|NCT04876417|65925603|FG002|Overall Study|Lost to Follow-up|0|||
23599526|NCT04876417|65925604|FG003|Overall Study|Lost to Follow-up|0|||
23599527|NCT01290341|65925605|FG000|Overall Study|Protocol Violation|7|||
23599528|NCT01290341|65925606|FG001|Overall Study|Protocol Violation|3|||
23599529|NCT01290341|65925605|FG000|Overall Study|Adverse Event|1|||
23599530|NCT01290341|65925606|FG001|Overall Study|Adverse Event|0|||
23599531|NCT01290341|65925605|FG000|Overall Study|Lost to Follow-up|21|||
23599532|NCT01290341|65925606|FG001|Overall Study|Lost to Follow-up|10|||
23599533|NCT01290341|65925605|FG000|Overall Study|Withdrawal by Subject|19|||
23599534|NCT01290341|65925606|FG001|Overall Study|Withdrawal by Subject|5|||
23599535|NCT01290341|65925605|FG000|Overall Study|Negative baseline culture and others|44|||
23599536|NCT01290341|65925606|FG001|Overall Study|Negative baseline culture and others|11|||
23599537|NCT02638337|65925614|FG000|Overall Study|Adverse Event|6|||
23599538|NCT02638337|65925615|FG001|Overall Study|Adverse Event|10|||
23599539|NCT02638337|65925614|FG000|Overall Study|Protocol Violation|3|||
23599540|NCT02638337|65925615|FG001|Overall Study|Protocol Violation|0|||
23599541|NCT02638337|65925614|FG000|Overall Study|Withdrawal by Subject|13|||
23599542|NCT02638337|65925615|FG001|Overall Study|Withdrawal by Subject|16|||
23599543|NCT02638337|65925614|FG000|Overall Study|Lost to Follow-up|7|||
23599544|NCT02638337|65925615|FG001|Overall Study|Lost to Follow-up|7|||
23599545|NCT02638337|65925614|FG000|Overall Study|Other - Miscellaneous|4|||
23599546|NCT02638337|65925615|FG001|Overall Study|Other - Miscellaneous|3|||
23599547|NCT02075554|65925618|FG000|Overall Study|Lost to Follow-up|7|||
23599548|NCT02075554|65925618|FG000|Overall Study|Withdrawal by Subject|5|||
23599549|NCT02075554|65925618|FG000|Overall Study|Physician Decision|3|||
23599550|NCT02462759|65925619|FG000|Part 1: Double Blind|Death|1|||
23599551|NCT02462759|65925620|FG001|Part 1: Double Blind|Death|0|||
23479970|NCT03400956|65501871|FG000|Treatment Period 1|Lost to Follow-up|0|||
23599552|NCT02462759|65925621|FG002|Part 1: Double Blind|Death|0|||
23599553|NCT04337931|65925622|FG000|Overall Study|Death|4|||
23599554|NCT04337931|65925623|FG001|Overall Study|Death|1|||
23599555|NCT04337931|65925624|FG002|Overall Study|Death|7|||
23599556|NCT04337931|65925622|FG000|Overall Study|Withdrawal by Subject|0|||
23599557|NCT04337931|65925623|FG001|Overall Study|Withdrawal by Subject|1|||
23599558|NCT04337931|65925624|FG002|Overall Study|Withdrawal by Subject|0|||
23599559|NCT04337931|65925622|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
23599560|NCT04337931|65925623|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
23479971|NCT03400956|65501872|FG001|Treatment Period 1|Lost to Follow-up|0|||
23256350|NCT01377233|64680048|FG000|Double-blind|Adverse Event|0|||
23256351|NCT01377233|64680049|FG001|Double-blind|Adverse Event|1|||
23256352|NCT01377233|64680050|FG002|Double-blind|Adverse Event|2|||
23360855|NCT01909804|65065922|FG007|Overall Study|Lack of Efficacy|1|||
23360856|NCT01909804|65065923|FG008|Overall Study|Lack of Efficacy|0|||
23360857|NCT01909804|65065924|FG009|Overall Study|Lack of Efficacy|1|||
23360858|NCT01909804|65065925|FG010|Overall Study|Lack of Efficacy|0|||
23360859|NCT01909804|65065926|FG011|Overall Study|Lack of Efficacy|1|||
23360860|NCT01909804|65065915|FG000|Overall Study|Withdrew Consent|0|||
23360861|NCT01909804|65065916|FG001|Overall Study|Withdrew Consent|0|||
23360862|NCT01909804|65065917|FG002|Overall Study|Withdrew Consent|0|||
23360863|NCT01909804|65065918|FG003|Overall Study|Withdrew Consent|0|||
23360864|NCT01909804|65065919|FG004|Overall Study|Withdrew Consent|1|||
23360865|NCT01909804|65065920|FG005|Overall Study|Withdrew Consent|1|||
23360866|NCT01909804|65065921|FG006|Overall Study|Withdrew Consent|0|||
23360867|NCT01909804|65065922|FG007|Overall Study|Withdrew Consent|0|||
23360868|NCT01909804|65065923|FG008|Overall Study|Withdrew Consent|0|||
23360869|NCT01909804|65065924|FG009|Overall Study|Withdrew Consent|0|||
23360870|NCT01909804|65065925|FG010|Overall Study|Withdrew Consent|0|||
23360871|NCT01909804|65065926|FG011|Overall Study|Withdrew Consent|0|||
23360872|NCT01909804|65065915|FG000|Overall Study|Protocol Violation|0|||
23360873|NCT01909804|65065916|FG001|Overall Study|Protocol Violation|0|||
23360874|NCT01909804|65065917|FG002|Overall Study|Protocol Violation|0|||
23360875|NCT01909804|65065918|FG003|Overall Study|Protocol Violation|0|||
23360876|NCT01909804|65065919|FG004|Overall Study|Protocol Violation|0|||
23360877|NCT01909804|65065920|FG005|Overall Study|Protocol Violation|0|||
23360878|NCT01909804|65065921|FG006|Overall Study|Protocol Violation|0|||
23360879|NCT01909804|65065922|FG007|Overall Study|Protocol Violation|0|||
23360880|NCT01909804|65065923|FG008|Overall Study|Protocol Violation|0|||
23360881|NCT01909804|65065924|FG009|Overall Study|Protocol Violation|0|||
23360882|NCT01909804|65065925|FG010|Overall Study|Protocol Violation|0|||
23360883|NCT01909804|65065926|FG011|Overall Study|Protocol Violation|1|||
23360884|NCT02757352|65065930|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
23360885|NCT02757352|65065931|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360886|NCT02757352|65065932|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
23360887|NCT02757352|65065933|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360888|NCT02757352|65065934|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360889|NCT02757352|65065935|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360890|NCT02757352|65065936|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360891|NCT02757352|65065937|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360892|NCT02757352|65065938|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360893|NCT02757352|65065939|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
23360894|NCT02757352|65065930|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360895|NCT02757352|65065931|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360896|NCT02757352|65065932|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
23360897|NCT02757352|65065933|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360898|NCT02757352|65065934|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360899|NCT02757352|65065935|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360900|NCT02757352|65065936|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360901|NCT02757352|65065937|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360902|NCT02757352|65065938|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360903|NCT02757352|65065939|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
23360904|NCT02757352|65065930|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
23360905|NCT02757352|65065931|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
23360906|NCT02757352|65065932|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
23360907|NCT02757352|65065933|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360908|NCT02757352|65065934|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360909|NCT02757352|65065935|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360910|NCT02757352|65065936|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360911|NCT02757352|65065937|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360912|NCT02757352|65065938|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23360913|NCT02757352|65065939|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
23195294|NCT01197378|64459578|FG000|Overall Study|Withdrawal by Subject|1|||
23360914|NCT02757352|65065930|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360915|NCT02757352|65065931|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
23360916|NCT02757352|65065932|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360917|NCT02757352|65065933|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360918|NCT02757352|65065934|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360919|NCT02757352|65065935|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360920|NCT02757352|65065936|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360921|NCT02757352|65065937|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360922|NCT02757352|65065938|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23360923|NCT02757352|65065939|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
23479972|NCT03400956|65501873|FG002|Treatment Period 1|Lost to Follow-up|1|||
23479973|NCT03400956|65501871|FG000|Treatment Period 1|Protocol Violation|0|||
23479974|NCT03400956|65501872|FG001|Treatment Period 1|Protocol Violation|2|||
23479975|NCT03400956|65501873|FG002|Treatment Period 1|Protocol Violation|0|||
23479976|NCT03400956|65501871|FG000|Treatment Period 1|Study terminated by sponsor|3|||
23479977|NCT03400956|65501872|FG001|Treatment Period 1|Study terminated by sponsor|1|||
23479978|NCT03400956|65501873|FG002|Treatment Period 1|Study terminated by sponsor|1|||
23479979|NCT03400956|65501871|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23479980|NCT03400956|65501872|FG001|Treatment Period 1|Withdrawal by Subject|2|||
23479981|NCT03400956|65501873|FG002|Treatment Period 1|Withdrawal by Subject|4|||
23479982|NCT03400956|65501871|FG000|Treatment Period 1|Other|1|||
23479983|NCT03400956|65501872|FG001|Treatment Period 1|Other|2|||
23479984|NCT03400956|65501873|FG002|Treatment Period 1|Other|3|||
23479985|NCT03400956|65501871|FG000|Post-treatment Period 1|Adverse Event|0|||
23479986|NCT03400956|65501872|FG001|Post-treatment Period 1|Adverse Event|0|||
23479987|NCT03400956|65501873|FG002|Post-treatment Period 1|Adverse Event|1|||
23479988|NCT03400956|65501871|FG000|Post-treatment Period 1|Physician Decision|2|||
23479989|NCT03400956|65501872|FG001|Post-treatment Period 1|Physician Decision|3|||
23479990|NCT03400956|65501873|FG002|Post-treatment Period 1|Physician Decision|0|||
23479991|NCT03400956|65501871|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
23479992|NCT03400956|65501872|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
23479993|NCT03400956|65501873|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
23479994|NCT03400956|65501871|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
23479995|NCT03400956|65501872|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
23479996|NCT03400956|65501873|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
23256353|NCT01377233|64680051|FG003|Double-blind|Adverse Event|2|||
23256354|NCT01377233|64680052|FG004|Double-blind|Adverse Event|0|||
23256355|NCT01377233|64680048|FG000|Double-blind|Protocol Violation|0|||
23256356|NCT01377233|64680049|FG001|Double-blind|Protocol Violation|0|||
23479997|NCT03400956|65501871|FG000|Post-treatment Period 1|Other|4|||
23479998|NCT03400956|65501872|FG001|Post-treatment Period 1|Other|3|||
23479999|NCT03400956|65501873|FG002|Post-treatment Period 1|Other|4|||
23480000|NCT03400956|65501871|FG000|Treatment Period 2|Adverse Event|2|||
23480001|NCT03400956|65501872|FG001|Treatment Period 2|Adverse Event|1|||
23480002|NCT03400956|65501873|FG002|Treatment Period 2|Adverse Event|1|||
23480003|NCT03400956|65501871|FG000|Treatment Period 2|Lost to Follow-up|1|||
23195295|NCT01197378|64459578|FG000|Overall Study|Physician Decision|1|||
23195296|NCT01197378|64459578|FG000|Overall Study|Other|2|||
23195297|NCT00783705|64459591|FG000|Overall Study|Adverse Event|2|||
23195298|NCT00783705|64459592|FG001|Overall Study|Adverse Event|0|||
23195299|NCT00783705|64459591|FG000|Overall Study|Withdrawal by Subject|3|||
23195300|NCT00783705|64459592|FG001|Overall Study|Withdrawal by Subject|2|||
23195301|NCT00783705|64459591|FG000|Overall Study|Lost to Follow-up|1|||
23195302|NCT00783705|64459592|FG001|Overall Study|Lost to Follow-up|3|||
23195303|NCT00401973|64459596|FG000|Overall Study|Adverse Event|2|||
23195304|NCT00401973|64459597|FG001|Overall Study|Adverse Event|8|||
23195305|NCT00401973|64459598|FG002|Overall Study|Adverse Event|4|||
23195306|NCT00401973|64459596|FG000|Overall Study|Clinical Relapse|0|||
23195307|NCT00401973|64459597|FG001|Overall Study|Clinical Relapse|1|||
23195308|NCT00401973|64459598|FG002|Overall Study|Clinical Relapse|1|||
23195309|NCT00401973|64459596|FG000|Overall Study|Lack of Efficacy|0|||
23195310|NCT00401973|64459597|FG001|Overall Study|Lack of Efficacy|0|||
23195311|NCT00401973|64459598|FG002|Overall Study|Lack of Efficacy|3|||
23195312|NCT00401973|64459596|FG000|Overall Study|Lost to Follow-up|2|||
23195313|NCT00401973|64459597|FG001|Overall Study|Lost to Follow-up|2|||
23195314|NCT00401973|64459598|FG002|Overall Study|Lost to Follow-up|2|||
23195315|NCT00401973|64459596|FG000|Overall Study|Physician Decision|2|||
23195316|NCT00401973|64459597|FG001|Overall Study|Physician Decision|0|||
23195317|NCT00401973|64459598|FG002|Overall Study|Physician Decision|1|||
23195318|NCT00401973|64459596|FG000|Overall Study|Protocol Violation|1|||
23195319|NCT00401973|64459597|FG001|Overall Study|Protocol Violation|2|||
23195320|NCT00401973|64459598|FG002|Overall Study|Protocol Violation|3|||
23195321|NCT00401973|64459596|FG000|Overall Study|Sponsor Decision|0|||
23195322|NCT00401973|64459597|FG001|Overall Study|Sponsor Decision|1|||
23195323|NCT00401973|64459598|FG002|Overall Study|Sponsor Decision|0|||
23195324|NCT00401973|64459596|FG000|Overall Study|Withdrawal by Subject|4|||
23195325|NCT00401973|64459597|FG001|Overall Study|Withdrawal by Subject|12|||
23195326|NCT00401973|64459598|FG002|Overall Study|Withdrawal by Subject|9|||
23195327|NCT01978912|64459599|FG000|Overall Study|Adverse Event|0|||
23256357|NCT01377233|64680050|FG002|Double-blind|Protocol Violation|0|||
23195328|NCT01978912|64459600|FG001|Overall Study|Adverse Event|1|||
23195329|NCT01978912|64459601|FG002|Overall Study|Adverse Event|0|||
23195330|NCT01978912|64459602|FG003|Overall Study|Adverse Event|0|||
23195331|NCT01978912|64459599|FG000|Overall Study|Lost to Follow-up|1|||
23195332|NCT01978912|64459600|FG001|Overall Study|Lost to Follow-up|1|||
23195333|NCT01978912|64459601|FG002|Overall Study|Lost to Follow-up|0|||
23195334|NCT01978912|64459602|FG003|Overall Study|Lost to Follow-up|1|||
23195335|NCT01978912|64459599|FG000|Overall Study|Withdrawal by Subject|1|||
23195336|NCT01978912|64459600|FG001|Overall Study|Withdrawal by Subject|0|||
23195337|NCT01978912|64459601|FG002|Overall Study|Withdrawal by Subject|2|||
23195338|NCT01978912|64459602|FG003|Overall Study|Withdrawal by Subject|2|||
23599561|NCT04337931|65925624|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
23599562|NCT04337931|65925622|FG000|Overall Study|Study terminated by sponsor|3|||
23599563|NCT04337931|65925623|FG001|Overall Study|Study terminated by sponsor|6|||
23599564|NCT04337931|65925624|FG002|Overall Study|Study terminated by sponsor|2|||
23599565|NCT04337931|65925622|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
23599566|NCT04337931|65925623|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
23599567|NCT04337931|65925624|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
23599568|NCT04337931|65925622|FG000|Overall Study|Colorectal cancer treatment|1|||
23599569|NCT04337931|65925623|FG001|Overall Study|Colorectal cancer treatment|0|||
23599570|NCT04337931|65925624|FG002|Overall Study|Colorectal cancer treatment|0|||
23599571|NCT04337931|65925622|FG000|Overall Study|Participant decision|0|||
23599572|NCT04337931|65925623|FG001|Overall Study|Participant decision|1|||
23599573|NCT04337931|65925624|FG002|Overall Study|Participant decision|0|||
23599574|NCT02964741|65925625|FG000|Overall Study|Protocol Violation|1|||
23599575|NCT02964741|65925626|FG001|Overall Study|Protocol Violation|0|||
23599576|NCT02964741|65925627|FG002|Overall Study|Protocol Violation|0|||
23599577|NCT02964741|65925625|FG000|Overall Study|Withdrawal by Subject|0|||
23599578|NCT02964741|65925626|FG001|Overall Study|Withdrawal by Subject|1|||
23599579|NCT02964741|65925627|FG002|Overall Study|Withdrawal by Subject|0|||
23599580|NCT02964741|65925625|FG000|Overall Study|claustrophobia|1|||
23599581|NCT02964741|65925626|FG001|Overall Study|claustrophobia|0|||
23599582|NCT02964741|65925627|FG002|Overall Study|claustrophobia|0|||
23599583|NCT02157116|65925628|FG000|Overall Study|Withdrawal by Subject|4|||
23599584|NCT02157116|65925628|FG000|Overall Study|Physician Decision|3|||
23599585|NCT02157116|65925628|FG000|Overall Study|Failed Screening|2|||
23599586|NCT00077675|65925630|FG000|Overall Study|Adverse Event|1|||
23599587|NCT00077675|65925631|FG001|Overall Study|Adverse Event|2|||
23599588|NCT00077675|65925630|FG000|Overall Study|Lost to Follow-up|6|||
23599589|NCT00077675|65925631|FG001|Overall Study|Lost to Follow-up|3|||
23599590|NCT00077675|65925630|FG000|Overall Study|Withdrawal by Subject|1|||
23599591|NCT00077675|65925631|FG001|Overall Study|Withdrawal by Subject|0|||
23599592|NCT00077675|65925630|FG000|Overall Study|Other|0|||
23599593|NCT00077675|65925631|FG001|Overall Study|Other|1|||
23599594|NCT00077675|65925630|FG000|Overall Study|Never received study treatment|3|||
23599595|NCT00077675|65925631|FG001|Overall Study|Never received study treatment|3|||
23195339|NCT01978912|64459599|FG000|Overall Study|Lumbar Surgery|1|||
23195340|NCT01978912|64459600|FG001|Overall Study|Lumbar Surgery|0|||
23195341|NCT01978912|64459601|FG002|Overall Study|Lumbar Surgery|1|||
23195342|NCT01978912|64459602|FG003|Overall Study|Lumbar Surgery|0|||
23360924|NCT02757352|65065930|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360925|NCT02757352|65065931|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
23360926|NCT02757352|65065932|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360927|NCT02757352|65065933|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360928|NCT02757352|65065934|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360929|NCT02757352|65065935|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360930|NCT02757352|65065936|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360931|NCT02757352|65065937|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360932|NCT02757352|65065938|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360933|NCT02757352|65065939|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360934|NCT02757352|65065930|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
23360935|NCT02757352|65065931|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
23360936|NCT02757352|65065932|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
23360937|NCT02757352|65065933|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360938|NCT02757352|65065934|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23195343|NCT01978912|64459599|FG000|Overall Study|Intradiscal Steroid Injection|0|||
23195344|NCT01978912|64459600|FG001|Overall Study|Intradiscal Steroid Injection|1|||
23195345|NCT01978912|64459601|FG002|Overall Study|Intradiscal Steroid Injection|0|||
23195346|NCT01978912|64459602|FG003|Overall Study|Intradiscal Steroid Injection|0|||
23195347|NCT00394914|64459607|FG000|Treatment Period|Adverse Event|0|||
23195348|NCT00394914|64459608|FG001|Treatment Period|Adverse Event|3|||
23195349|NCT00394914|64459609|FG002|Treatment Period|Adverse Event|1|||
23195350|NCT00394914|64459607|FG000|Treatment Period|Lost to Follow-up|0|||
23195351|NCT00394914|64459608|FG001|Treatment Period|Lost to Follow-up|1|||
23195352|NCT00394914|64459609|FG002|Treatment Period|Lost to Follow-up|0|||
23195353|NCT00394914|64459607|FG000|Treatment Period|Withdrawal by Subject|0|||
23195354|NCT00394914|64459608|FG001|Treatment Period|Withdrawal by Subject|2|||
23195355|NCT00394914|64459609|FG002|Treatment Period|Withdrawal by Subject|2|||
23195356|NCT00394914|64459607|FG000|Treatment Period|Noncompliance with protocol|0|||
23195357|NCT00394914|64459608|FG001|Treatment Period|Noncompliance with protocol|3|||
23195358|NCT00394914|64459609|FG002|Treatment Period|Noncompliance with protocol|2|||
23256358|NCT01377233|64680051|FG003|Double-blind|Protocol Violation|0|||
23256359|NCT01377233|64680052|FG004|Double-blind|Protocol Violation|1|||
23256360|NCT01377233|64680048|FG000|Double-blind|Withdrawal by Subject|0|||
23256361|NCT01377233|64680049|FG001|Double-blind|Withdrawal by Subject|0|||
23256362|NCT01377233|64680050|FG002|Double-blind|Withdrawal by Subject|0|||
23256363|NCT01377233|64680051|FG003|Double-blind|Withdrawal by Subject|1|||
23256364|NCT01377233|64680052|FG004|Double-blind|Withdrawal by Subject|0|||
23256365|NCT01377233|64680048|FG000|Double-blind|Administrative or other|0|||
23256366|NCT01377233|64680049|FG001|Double-blind|Administrative or other|0|||
23256367|NCT01377233|64680050|FG002|Double-blind|Administrative or other|0|||
23256368|NCT01377233|64680051|FG003|Double-blind|Administrative or other|1|||
23256369|NCT01377233|64680052|FG004|Double-blind|Administrative or other|1|||
23256370|NCT03124381|64680056|FG000|Overall Study|Lost to Follow-up|1|||
23256371|NCT03124381|64680057|FG001|Overall Study|Lost to Follow-up|1|||
23256372|NCT03124381|64680056|FG000|Overall Study|Withdrawal by Subject|6|||
23256373|NCT03124381|64680057|FG001|Overall Study|Withdrawal by Subject|3|||
23195359|NCT00394914|64459607|FG000|Treatment Period|Did not meet protocol eligibility|0|||
23195360|NCT00394914|64459608|FG001|Treatment Period|Did not meet protocol eligibility|1|||
23256374|NCT03124381|64680056|FG000|Overall Study|Protocol Violation|0|||
23195361|NCT00394914|64459609|FG002|Treatment Period|Did not meet protocol eligibility|1|||
23256375|NCT03124381|64680057|FG001|Overall Study|Protocol Violation|1|||
23195362|NCT00886821|64459616|FG000|Stage 2|Adverse Event|0|||
23195363|NCT00886821|64459617|FG001|Stage 2|Adverse Event|0|||
23599596|NCT03220724|65925641|FG000|Overall Study|Lost to Follow-up|2|||
23599597|NCT03220724|65925642|FG001|Overall Study|Lost to Follow-up|2|||
23599598|NCT03220724|65925643|FG002|Overall Study|Lost to Follow-up|0|||
23599599|NCT03220724|65925644|FG003|Overall Study|Lost to Follow-up|3|||
23599600|NCT03220724|65925645|FG004|Overall Study|Lost to Follow-up|1|||
23599601|NCT03220724|65925646|FG005|Overall Study|Lost to Follow-up|0|||
23599602|NCT03220724|65925647|FG006|Overall Study|Lost to Follow-up|2|||
23599603|NCT03220724|65925648|FG007|Overall Study|Lost to Follow-up|1|||
23599604|NCT03220724|65925649|FG008|Overall Study|Lost to Follow-up|0|||
23599605|NCT03220724|65925641|FG000|Overall Study|Withdrawal by Subject|1|||
23599606|NCT03220724|65925642|FG001|Overall Study|Withdrawal by Subject|0|||
23599607|NCT03220724|65925643|FG002|Overall Study|Withdrawal by Subject|1|||
23599608|NCT03220724|65925644|FG003|Overall Study|Withdrawal by Subject|0|||
23599609|NCT03220724|65925645|FG004|Overall Study|Withdrawal by Subject|0|||
23599610|NCT03220724|65925646|FG005|Overall Study|Withdrawal by Subject|0|||
23599611|NCT03220724|65925647|FG006|Overall Study|Withdrawal by Subject|0|||
23599612|NCT03220724|65925648|FG007|Overall Study|Withdrawal by Subject|0|||
23599613|NCT03220724|65925649|FG008|Overall Study|Withdrawal by Subject|0|||
23599614|NCT03113409|65925650|FG000|Overall Study|Withdrawal by Subject|5|||
23599615|NCT03113409|65925651|FG001|Overall Study|Withdrawal by Subject|0|||
23599616|NCT03113409|65925652|FG002|Overall Study|Withdrawal by Subject|0|||
23599617|NCT01260896|65925653|FG000|First Intervention|Withdrawn Due to Emesis|2|||
23599618|NCT01260896|65925654|FG001|First Intervention|Withdrawn Due to Emesis|0|||
23599619|NCT02564744|65925659|FG000|Overall Study|Investigator decision|0|||
23599620|NCT02564744|65925660|FG001|Overall Study|Investigator decision|0|||
23599621|NCT02564744|65925661|FG002|Overall Study|Investigator decision|0|||
23599622|NCT02564744|65925662|FG003|Overall Study|Investigator decision|0|||
23599623|NCT02564744|65925663|FG004|Overall Study|Investigator decision|1|||
23599624|NCT02564744|65925659|FG000|Overall Study|Death|10|||
23599625|NCT02564744|65925660|FG001|Overall Study|Death|5|||
23599626|NCT02564744|65925661|FG002|Overall Study|Death|4|||
23599627|NCT02564744|65925662|FG003|Overall Study|Death|16|||
23599628|NCT02564744|65925663|FG004|Overall Study|Death|16|||
23599629|NCT02564744|65925659|FG000|Overall Study|End of study Page Missing|0|||
23599630|NCT02564744|65925660|FG001|Overall Study|End of study Page Missing|0|||
23599631|NCT02564744|65925661|FG002|Overall Study|End of study Page Missing|3|||
23599632|NCT02564744|65925662|FG003|Overall Study|End of study Page Missing|3|||
23195364|NCT00886821|64459618|FG002|Stage 2|Adverse Event|0|||
23195365|NCT00886821|64459619|FG003|Stage 2|Adverse Event|0|||
23195366|NCT00886821|64459620|FG004|Stage 2|Adverse Event|0|||
23195367|NCT00886821|64459621|FG005|Stage 2|Adverse Event|0|||
23599633|NCT02564744|65925663|FG004|Overall Study|End of study Page Missing|0|||
23599634|NCT02564744|65925659|FG000|Overall Study|Subject Withdrew Consent|1|||
23599635|NCT02564744|65925660|FG001|Overall Study|Subject Withdrew Consent|1|||
23599636|NCT02564744|65925661|FG002|Overall Study|Subject Withdrew Consent|1|||
23599637|NCT02564744|65925662|FG003|Overall Study|Subject Withdrew Consent|0|||
23599638|NCT02564744|65925663|FG004|Overall Study|Subject Withdrew Consent|2|||
23599639|NCT02564744|65925659|FG000|Overall Study|Lost to Follow-up|0|||
23195368|NCT00886821|64459622|FG006|Stage 2|Adverse Event|0|||
23195369|NCT00886821|64459623|FG007|Stage 2|Adverse Event|0|||
23195370|NCT00886821|64459624|FG008|Stage 2|Adverse Event|0|||
23195371|NCT00886821|64459625|FG009|Stage 2|Adverse Event|0|||
23195372|NCT00886821|64459626|FG010|Stage 2|Adverse Event|0|||
23256376|NCT03124381|64680056|FG000|Overall Study|Adverse Event|1|||
23480004|NCT03400956|65501872|FG001|Treatment Period 2|Lost to Follow-up|1|||
23480005|NCT03400956|65501873|FG002|Treatment Period 2|Lost to Follow-up|0|||
23195373|NCT00886821|64459627|FG011|Stage 2|Adverse Event|1|||
23195374|NCT00886821|64459628|FG012|Stage 2|Adverse Event|3|||
23195375|NCT00886821|64459629|FG013|Stage 2|Adverse Event|0|||
23195376|NCT00886821|64459616|FG000|Stage 2|Lost to Follow-up|0|||
23256377|NCT03124381|64680057|FG001|Overall Study|Adverse Event|1|||
23195377|NCT00886821|64459617|FG001|Stage 2|Lost to Follow-up|0|||
23195378|NCT00886821|64459618|FG002|Stage 2|Lost to Follow-up|0|||
23256378|NCT03124381|64680056|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
23360939|NCT02757352|65065935|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360940|NCT02757352|65065936|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360941|NCT02757352|65065937|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360942|NCT02757352|65065938|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360943|NCT02757352|65065939|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360944|NCT02757352|65065930|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
23360945|NCT02757352|65065931|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
23360946|NCT02757352|65065932|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
23360947|NCT02757352|65065933|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360948|NCT02757352|65065934|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360949|NCT02757352|65065935|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360950|NCT02757352|65065936|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360951|NCT02757352|65065937|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360952|NCT02757352|65065938|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360953|NCT02757352|65065939|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
23360954|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360955|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360956|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360957|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
23360958|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360959|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
23360960|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360961|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360962|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360963|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
23360964|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360965|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360966|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360967|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
23360968|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
23360969|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
23360970|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360971|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23195379|NCT00886821|64459619|FG003|Stage 2|Lost to Follow-up|0|||
23195380|NCT00886821|64459620|FG004|Stage 2|Lost to Follow-up|0|||
23195381|NCT00886821|64459621|FG005|Stage 2|Lost to Follow-up|0|||
23256379|NCT03124381|64680057|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
23256380|NCT02624518|64680058|FG000|Overall Study|Physician Decision|1|||
23256381|NCT02378506|64680059|FG000|Overall Study|Lack of Efficacy|3|||
23360972|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360973|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
23360974|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360975|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360976|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360977|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360978|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
23360979|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23256382|NCT02378506|64680059|FG000|Overall Study|Withdrawal by Subject|4|||
23256383|NCT02378506|64680059|FG000|Overall Study|Protocol Violation|2|||
23256384|NCT02378506|64680059|FG000|Overall Study|Death|1|||
23256385|NCT02378506|64680059|FG000|Overall Study|Adverse Event|14|||
23256386|NCT02378506|64680059|FG000|Overall Study|Randomized But Not Treated|1|||
23360980|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360981|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23599640|NCT02564744|65925660|FG001|Overall Study|Lost to Follow-up|1|||
23599641|NCT02564744|65925661|FG002|Overall Study|Lost to Follow-up|0|||
23599642|NCT02564744|65925662|FG003|Overall Study|Lost to Follow-up|0|||
23599643|NCT02564744|65925663|FG004|Overall Study|Lost to Follow-up|1|||
23599644|NCT02564744|65925659|FG000|Overall Study|Reason not specified|1|||
23599645|NCT02564744|65925660|FG001|Overall Study|Reason not specified|0|||
23599646|NCT02564744|65925661|FG002|Overall Study|Reason not specified|0|||
23599647|NCT02564744|65925662|FG003|Overall Study|Reason not specified|0|||
23599648|NCT02564744|65925663|FG004|Overall Study|Reason not specified|0|||
23599649|NCT01211184|65925666|FG000|Overall Study|Withdrawal by Subject|0|||
23599650|NCT01211184|65925667|FG001|Overall Study|Withdrawal by Subject|2|||
23195382|NCT00886821|64459622|FG006|Stage 2|Lost to Follow-up|0|||
23360982|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23195383|NCT00886821|64459623|FG007|Stage 2|Lost to Follow-up|0|||
23480006|NCT03400956|65501871|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23480007|NCT03400956|65501872|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23480008|NCT03400956|65501873|FG002|Treatment Period 2|Withdrawal by Subject|3|||
23480009|NCT03400956|65501871|FG000|Treatment Period 2|Other|1|||
23480010|NCT03400956|65501872|FG001|Treatment Period 2|Other|1|||
23480011|NCT03400956|65501873|FG002|Treatment Period 2|Other|0|||
23480012|NCT03400956|65501871|FG000|Follow-up Period|Withdrawal by Subject|0|||
23480013|NCT03400956|65501872|FG001|Follow-up Period|Withdrawal by Subject|0|||
23480014|NCT03400956|65501873|FG002|Follow-up Period|Withdrawal by Subject|1|||
23480015|NCT03400956|65501871|FG000|Follow-up Period|Other|0|||
23480016|NCT03400956|65501872|FG001|Follow-up Period|Other|0|||
23480017|NCT03400956|65501873|FG002|Follow-up Period|Other|1|||
23480018|NCT03234881|65501874|FG000|Overall Study|Lost to Follow-up|9|||
23480019|NCT03234881|65501875|FG001|Overall Study|Lost to Follow-up|3|||
23480020|NCT01659554|65501878|FG000|Overall Study|Study Termination|4|||
23480021|NCT03206788|65501879|FG000|Overall Study|Withdrawal by Subject|0|||
23480022|NCT03206788|65501880|FG001|Overall Study|Withdrawal by Subject|1|||
23480023|NCT03206788|65501879|FG000|Overall Study|Adverse Event|0|||
23480024|NCT03206788|65501880|FG001|Overall Study|Adverse Event|1|||
23480025|NCT03206788|65501879|FG000|Overall Study|Physician Decision|0|||
23480026|NCT03206788|65501880|FG001|Overall Study|Physician Decision|1|||
23480027|NCT00592774|65501881|FG000|Overall Study|Adverse Event|5|||
23480028|NCT00592774|65501882|FG001|Overall Study|Adverse Event|19|||
23480029|NCT00592774|65501883|FG002|Overall Study|Adverse Event|2|||
23480030|NCT00592774|65501884|FG003|Overall Study|Adverse Event|14|||
23480031|NCT00592774|65501885|FG004|Overall Study|Adverse Event|8|||
23480032|NCT00592774|65501881|FG000|Overall Study|Protocol Violation|0|||
23480033|NCT00592774|65501882|FG001|Overall Study|Protocol Violation|1|||
23480034|NCT00592774|65501883|FG002|Overall Study|Protocol Violation|0|||
23480035|NCT00592774|65501884|FG003|Overall Study|Protocol Violation|0|||
23480036|NCT00592774|65501885|FG004|Overall Study|Protocol Violation|1|||
23480037|NCT00592774|65501881|FG000|Overall Study|Withdrawal by Subject|3|||
23480038|NCT00592774|65501882|FG001|Overall Study|Withdrawal by Subject|7|||
23480039|NCT00592774|65501883|FG002|Overall Study|Withdrawal by Subject|0|||
23195384|NCT00886821|64459624|FG008|Stage 2|Lost to Follow-up|0|||
23195385|NCT00886821|64459625|FG009|Stage 2|Lost to Follow-up|0|||
23195386|NCT00886821|64459626|FG010|Stage 2|Lost to Follow-up|0|||
23195387|NCT00886821|64459627|FG011|Stage 2|Lost to Follow-up|0|||
23195388|NCT00886821|64459628|FG012|Stage 2|Lost to Follow-up|2|||
23195389|NCT00886821|64459629|FG013|Stage 2|Lost to Follow-up|1|||
23195390|NCT02168946|64459630|FG000|Overall Study|Adverse Event|8|||
23195391|NCT02168946|64459631|FG001|Overall Study|Adverse Event|5|||
23195392|NCT02168946|64459630|FG000|Overall Study|Lost to Follow-up|3|||
23195393|NCT02168946|64459631|FG001|Overall Study|Lost to Follow-up|0|||
23195394|NCT02168946|64459630|FG000|Overall Study|Subject unable to come back for visits|1|||
23195395|NCT02168946|64459631|FG001|Overall Study|Subject unable to come back for visits|0|||
23195396|NCT02209597|64459632|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
23195397|NCT02209597|64459632|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
23256387|NCT01244815|64680061|FG000|Overall Study|Not Treated|0|||
23256388|NCT01244815|64680062|FG001|Overall Study|Not Treated|1|||
23256389|NCT01244815|64680063|FG002|Overall Study|Not Treated|0|||
23256390|NCT01244815|64680064|FG003|Overall Study|Not Treated|0|||
23256391|NCT01244815|64680061|FG000|Overall Study|Adverse Event|4|||
23256392|NCT01244815|64680062|FG001|Overall Study|Adverse Event|7|||
23256393|NCT01244815|64680063|FG002|Overall Study|Adverse Event|5|||
23256394|NCT01244815|64680064|FG003|Overall Study|Adverse Event|5|||
23256395|NCT01244815|64680061|FG000|Overall Study|Treatment Failure|0|||
23256396|NCT01244815|64680062|FG001|Overall Study|Treatment Failure|0|||
23256397|NCT01244815|64680063|FG002|Overall Study|Treatment Failure|0|||
23256398|NCT01244815|64680064|FG003|Overall Study|Treatment Failure|1|||
23256399|NCT01244815|64680061|FG000|Overall Study|Lost to Follow-up|3|||
23256400|NCT01244815|64680062|FG001|Overall Study|Lost to Follow-up|2|||
23256401|NCT01244815|64680063|FG002|Overall Study|Lost to Follow-up|3|||
23256402|NCT01244815|64680064|FG003|Overall Study|Lost to Follow-up|2|||
23256403|NCT01244815|64680061|FG000|Overall Study|Withdrawal by Subject|0|||
23256404|NCT01244815|64680062|FG001|Overall Study|Withdrawal by Subject|2|||
23480040|NCT00592774|65501884|FG003|Overall Study|Withdrawal by Subject|0|||
23195398|NCT02209597|64459632|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
23195399|NCT02209597|64459632|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
23195400|NCT03135028|64459633|FG000|Overall Study|Death|6|||
23256405|NCT01244815|64680063|FG002|Overall Study|Withdrawal by Subject|0|||
23256406|NCT01244815|64680064|FG003|Overall Study|Withdrawal by Subject|3|||
23195401|NCT03135028|64459633|FG000|Overall Study|Study Terminated by Sponsor|2|||
23480041|NCT00592774|65501885|FG004|Overall Study|Withdrawal by Subject|0|||
23480042|NCT00592774|65501881|FG000|Overall Study|Lack of Efficacy|3|||
23480043|NCT00592774|65501882|FG001|Overall Study|Lack of Efficacy|3|||
23480044|NCT00592774|65501883|FG002|Overall Study|Lack of Efficacy|0|||
23480045|NCT00592774|65501884|FG003|Overall Study|Lack of Efficacy|0|||
23480046|NCT00592774|65501885|FG004|Overall Study|Lack of Efficacy|2|||
23480047|NCT00592774|65501881|FG000|Overall Study|Physician Decision|0|||
23256407|NCT01244815|64680061|FG000|Overall Study|Protocol Violation|7|||
23256408|NCT01244815|64680062|FG001|Overall Study|Protocol Violation|4|||
23360983|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
23360984|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23480048|NCT00592774|65501882|FG001|Overall Study|Physician Decision|1|||
23195402|NCT03135028|64459633|FG000|Overall Study|Withdrew Consent|1|||
23195403|NCT03196297|64459634|FG000|Main Period|Withdrawal by Subject|4|||
23195404|NCT03196297|64459634|FG000|Extension Period|Withdrawal by Subject|1|||
23360985|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360986|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23195405|NCT03196297|64459634|FG000|Extension Period|Lack of Efficacy|2|||
23480049|NCT00592774|65501883|FG002|Overall Study|Physician Decision|1|||
23480050|NCT00592774|65501884|FG003|Overall Study|Physician Decision|0|||
23480051|NCT00592774|65501885|FG004|Overall Study|Physician Decision|1|||
23480052|NCT00592774|65501881|FG000|Overall Study|Other|0|||
23480053|NCT00592774|65501882|FG001|Overall Study|Other|1|||
23480054|NCT00592774|65501883|FG002|Overall Study|Other|1|||
23480055|NCT00592774|65501884|FG003|Overall Study|Other|0|||
23480056|NCT00592774|65501885|FG004|Overall Study|Other|2|||
23480057|NCT00731042|65501886|FG000|Second Intervention|Did not meet inclusion criteria|0|||
23480058|NCT00731042|65501887|FG001|Second Intervention|Did not meet inclusion criteria|2|||
23480059|NCT04575597|65501888|FG000|Overall Study|Death|0|||
23480060|NCT04575597|65501889|FG001|Overall Study|Death|0|||
23480061|NCT04575597|65501890|FG002|Overall Study|Death|0|||
23480062|NCT04575597|65501891|FG003|Overall Study|Death|1|||
23480063|NCT04575597|65501892|FG004|Overall Study|Death|3|||
23480064|NCT04575597|65501893|FG005|Overall Study|Death|14|||
23480065|NCT04575597|65501888|FG000|Overall Study|Lost to Follow-up|2|||
23480066|NCT04575597|65501889|FG001|Overall Study|Lost to Follow-up|1|||
23480067|NCT04575597|65501890|FG002|Overall Study|Lost to Follow-up|1|||
23480068|NCT04575597|65501891|FG003|Overall Study|Lost to Follow-up|2|||
23480069|NCT04575597|65501892|FG004|Overall Study|Lost to Follow-up|10|||
23480070|NCT04575597|65501893|FG005|Overall Study|Lost to Follow-up|8|||
23480071|NCT04575597|65501888|FG000|Overall Study|Withdrawal by Subject|2|||
23480072|NCT04575597|65501889|FG001|Overall Study|Withdrawal by Subject|2|||
23480073|NCT04575597|65501890|FG002|Overall Study|Withdrawal by Subject|4|||
23480074|NCT04575597|65501891|FG003|Overall Study|Withdrawal by Subject|2|||
23480075|NCT04575597|65501892|FG004|Overall Study|Withdrawal by Subject|25|||
23480076|NCT04575597|65501893|FG005|Overall Study|Withdrawal by Subject|28|||
23480077|NCT04575597|65501888|FG000|Overall Study|Not Recorded|0|||
23480078|NCT04575597|65501889|FG001|Overall Study|Not Recorded|0|||
23480079|NCT04575597|65501890|FG002|Overall Study|Not Recorded|0|||
23480080|NCT04575597|65501891|FG003|Overall Study|Not Recorded|0|||
23480081|NCT04575597|65501892|FG004|Overall Study|Not Recorded|0|||
23480082|NCT04575597|65501893|FG005|Overall Study|Not Recorded|2|||
23480083|NCT04575597|65501888|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23480084|NCT04575597|65501889|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23480085|NCT04575597|65501890|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23480086|NCT04575597|65501891|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23480087|NCT04575597|65501892|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
23480088|NCT04575597|65501893|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
23480089|NCT01715129|65501894|FG000|Overall Study|Adverse Event, fatal|1|||
23480090|NCT01715129|65501894|FG000|Overall Study|Lack of Efficacy|3|||
23480091|NCT01715129|65501894|FG000|Overall Study|Protocol Violation|1|||
23480092|NCT01715129|65501894|FG000|Overall Study|Consent Withdrawn|2|||
23480093|NCT01715129|65501894|FG000|Overall Study|Lost to Follow-up|1|||
23480094|NCT01715129|65501894|FG000|Overall Study|Other|1|||
23480095|NCT02742246|65501895|FG000|Overall Study|Never initiated treatment|5|||
23480096|NCT02742246|65501896|FG001|Overall Study|Never initiated treatment|3|||
23480097|NCT02742246|65501897|FG002|Overall Study|Never initiated treatment|1|||
23256409|NCT01244815|64680063|FG002|Overall Study|Protocol Violation|3|||
23256410|NCT01244815|64680064|FG003|Overall Study|Protocol Violation|1|||
23256411|NCT01244815|64680061|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
23256412|NCT01244815|64680062|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
23256413|NCT01244815|64680063|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
23256414|NCT01244815|64680064|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
23480098|NCT02742246|65501895|FG000|Overall Study|dropped out during treatment|7|||
23480099|NCT02742246|65501896|FG001|Overall Study|dropped out during treatment|13|||
23480100|NCT02742246|65501897|FG002|Overall Study|dropped out during treatment|10|||
23480101|NCT02742246|65501895|FG000|Overall Study|Death|1|||
23480102|NCT02742246|65501896|FG001|Overall Study|Death|0|||
23480103|NCT02742246|65501897|FG002|Overall Study|Death|0|||
23480104|NCT00927940|65501898|FG000|Overall Study|Death|1|||
23480105|NCT00527488|65501899|FG000|Overall Study|Withdrawn prior to dosing|0|||
23480106|NCT00527488|65501900|FG001|Overall Study|Withdrawn prior to dosing|1|||
23480107|NCT00527488|65501901|FG002|Overall Study|Withdrawn prior to dosing|1|||
23480108|NCT00527488|65501902|FG003|Overall Study|Withdrawn prior to dosing|0|||
23480109|NCT01146860|65501903|FG000|Overall Study|Withdrawal by Subject|0|||
23480110|NCT01146860|65501904|FG001|Overall Study|Withdrawal by Subject|1|||
23480111|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
23480112|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
23480113|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
23480114|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
23256415|NCT02278952|64680065|FG000|Overall Study|Insufficient Sample|6|||
23256416|NCT04345471|64680066|FG000|Overall Study|Adverse Event|8|||
23480115|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
23480116|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
23195406|NCT01809262|64459637|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
23195407|NCT01809262|64459638|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
23195408|NCT01809262|64459639|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
23195409|NCT01809262|64459640|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
23195410|NCT01809262|64459641|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
23195411|NCT01809262|64459642|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
23195412|NCT01809262|64459643|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
23195413|NCT01809262|64459644|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
23256417|NCT04345471|64680067|FG001|Overall Study|Adverse Event|5|||
23256418|NCT04345471|64680068|FG002|Overall Study|Adverse Event|6|||
23360987|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360988|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360989|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
23360990|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360991|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23599651|NCT01211184|65925668|FG002|Overall Study|Withdrawal by Subject|1|||
23599652|NCT00419341|65925672|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
23195414|NCT01809262|64459645|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
23195415|NCT01809262|64459646|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
23195416|NCT01809262|64459637|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23256419|NCT04345471|64680066|FG000|Overall Study|Lack of Efficacy|1|||
23256420|NCT04345471|64680067|FG001|Overall Study|Lack of Efficacy|1|||
23256421|NCT04345471|64680068|FG002|Overall Study|Lack of Efficacy|0|||
23256422|NCT04345471|64680066|FG000|Overall Study|Protocol Violation|0|||
23256423|NCT04345471|64680067|FG001|Overall Study|Protocol Violation|1|||
23256424|NCT04345471|64680068|FG002|Overall Study|Protocol Violation|2|||
23256425|NCT04345471|64680066|FG000|Overall Study|Withdrawal by Subject|10|||
23256426|NCT04345471|64680067|FG001|Overall Study|Withdrawal by Subject|5|||
23256427|NCT04345471|64680068|FG002|Overall Study|Withdrawal by Subject|10|||
23256428|NCT02970669|64680069|FG000|Double-blind Period|Adverse Event|4|||
23256429|NCT02970669|64680070|FG001|Double-blind Period|Adverse Event|0|||
23256430|NCT02970669|64680069|FG000|Double-blind Period|Death|1|||
23256431|NCT02970669|64680070|FG001|Double-blind Period|Death|0|||
23256432|NCT02970669|64680069|FG000|Double-blind Period|Study terminated by sponsor|1|||
23256433|NCT02970669|64680070|FG001|Double-blind Period|Study terminated by sponsor|2|||
23256434|NCT02970669|64680069|FG000|Double-blind Period|Physician Decision|0|||
23256435|NCT02970669|64680070|FG001|Double-blind Period|Physician Decision|2|||
23256436|NCT02970669|64680069|FG000|Double-blind Period|Withdrawal by Subject|2|||
23256437|NCT02970669|64680070|FG001|Double-blind Period|Withdrawal by Subject|2|||
23256438|NCT02970669|64680069|FG000|Open-label Period|Withdrawal by Subject|2|||
23256439|NCT02970669|64680070|FG001|Open-label Period|Withdrawal by Subject|2|||
23256440|NCT02970669|64680069|FG000|Open-label Period|Adverse Event|1|||
23256441|NCT02970669|64680070|FG001|Open-label Period|Adverse Event|0|||
23256442|NCT02970669|64680069|FG000|Open-label Period|Physician Decision|1|||
23256443|NCT02970669|64680070|FG001|Open-label Period|Physician Decision|0|||
23256444|NCT02065791|64680071|FG000|Overall Study|Closed Site|1|||
23256445|NCT02065791|64680072|FG001|Overall Study|Closed Site|1|||
23256446|NCT02065791|64680071|FG000|Overall Study|Withdrawal by Subject|11|||
23256447|NCT02065791|64680072|FG001|Overall Study|Withdrawal by Subject|5|||
23256448|NCT02065791|64680071|FG000|Overall Study|Lost to Follow-up|13|||
23256449|NCT02065791|64680072|FG001|Overall Study|Lost to Follow-up|9|||
23256450|NCT03202511|64680073|FG000|Overall Study|Withdrawal by Subject|1|||
23256451|NCT03202511|64680074|FG001|Overall Study|Withdrawal by Subject|0|||
23256452|NCT03989115|64680075|FG000|Overall Study|Withdrawal by Subject|2|||
23256453|NCT03989115|64680076|FG001|Overall Study|Withdrawal by Subject|1|||
23256454|NCT03989115|64680077|FG002|Overall Study|Withdrawal by Subject|3|||
23256455|NCT03989115|64680078|FG003|Overall Study|Withdrawal by Subject|0|||
23256456|NCT03989115|64680079|FG004|Overall Study|Withdrawal by Subject|17|||
23256457|NCT03989115|64680080|FG005|Overall Study|Withdrawal by Subject|1|||
23256458|NCT03989115|64680081|FG006|Overall Study|Withdrawal by Subject|0|||
23256459|NCT03989115|64680082|FG007|Overall Study|Withdrawal by Subject|0|||
23256460|NCT03989115|64680075|FG000|Overall Study|Sponsor decision to terminate the study|1|||
23256461|NCT03989115|64680076|FG001|Overall Study|Sponsor decision to terminate the study|1|||
23256462|NCT03989115|64680077|FG002|Overall Study|Sponsor decision to terminate the study|0|||
23599653|NCT00419341|65925672|FG000|Wash in/Wash Out Period|Adverse Event|2|||
23195417|NCT01809262|64459638|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
23195418|NCT01809262|64459639|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23195419|NCT01809262|64459640|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23256463|NCT03989115|64680078|FG003|Overall Study|Sponsor decision to terminate the study|1|||
23256464|NCT03989115|64680079|FG004|Overall Study|Sponsor decision to terminate the study|11|||
23256465|NCT03989115|64680080|FG005|Overall Study|Sponsor decision to terminate the study|0|||
23599654|NCT00419341|65925672|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
23195420|NCT01809262|64459641|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23256466|NCT03989115|64680081|FG006|Overall Study|Sponsor decision to terminate the study|2|||
23256467|NCT03989115|64680082|FG007|Overall Study|Sponsor decision to terminate the study|1|||
23256468|NCT03989115|64680075|FG000|Overall Study|Lost to Follow-up|2|||
23195421|NCT01809262|64459642|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23195422|NCT01809262|64459643|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23195423|NCT01809262|64459644|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23195424|NCT01809262|64459645|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23195425|NCT01809262|64459646|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
23195426|NCT01400971|64459647|FG000|Overall Study|Death|82|||
23195427|NCT01400971|64459647|FG000|Overall Study|Lost to Follow-up|196|||
23195428|NCT01400971|64459647|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
23195429|NCT01400971|64459647|FG000|Overall Study|Physician Decision|57|||
23195430|NCT01400971|64459647|FG000|Overall Study|Withdrawal by Subject|158|||
23195431|NCT01400971|64459647|FG000|Overall Study|Other|422|||
23195432|NCT01004146|64459650|FG000|Overall Study|Withdrawal by Subject|4|||
23195433|NCT01004146|64459651|FG001|Overall Study|Withdrawal by Subject|5|||
23195434|NCT00863928|64459652|FG000|Overall Study|Protocol Violation|26|||
23195435|NCT00863928|64459653|FG001|Overall Study|Protocol Violation|0|||
23195436|NCT00863928|64459652|FG000|Overall Study|Withdrawal by Subject|3|||
23195437|NCT00863928|64459653|FG001|Overall Study|Withdrawal by Subject|0|||
23195438|NCT00863928|64459652|FG000|Overall Study|surgery cancellation|4|||
23195439|NCT00863928|64459653|FG001|Overall Study|surgery cancellation|0|||
23195440|NCT00863928|64459652|FG000|Overall Study|medication allergy|3|||
23195441|NCT00863928|64459653|FG001|Overall Study|medication allergy|0|||
23195442|NCT01100307|64459654|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
23195443|NCT01100307|64459655|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
23195444|NCT01100307|64459654|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
23195445|NCT01100307|64459655|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
23195446|NCT01100307|64459654|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
23195447|NCT01100307|64459655|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
23195448|NCT01100307|64459654|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
23195449|NCT01100307|64459655|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
23195450|NCT01100307|64459654|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
23195451|NCT01100307|64459655|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
23195452|NCT01100307|64459654|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
23195453|NCT01100307|64459655|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
23195454|NCT01558089|64459656|FG000|Overall Study|Adverse Event|1|||
23195455|NCT01558089|64459656|FG000|Overall Study|Lack of Efficacy|1|||
23195456|NCT01558089|64459656|FG000|Overall Study|Lost to Follow-up|5|||
23195457|NCT01558089|64459656|FG000|Overall Study|Withdrawal by Subject|6|||
23195458|NCT03153111|64459657|FG000|Overall Study|Death|2|||
23195459|NCT03153111|64459658|FG001|Overall Study|Death|5|||
23195460|NCT03153111|64459657|FG000|Overall Study|Lost to Follow-up|1|||
23195461|NCT03153111|64459658|FG001|Overall Study|Lost to Follow-up|0|||
23195462|NCT03153111|64459657|FG000|Overall Study|Physician Decision|5|||
23195463|NCT03153111|64459658|FG001|Overall Study|Physician Decision|1|||
23195464|NCT03153111|64459657|FG000|Overall Study|Withdrawal by Subject|3|||
23195465|NCT03153111|64459658|FG001|Overall Study|Withdrawal by Subject|3|||
23195466|NCT04983940|64459660|FG000|Overall Study|Lost to Follow-up|14|||
23195467|NCT04983940|64459660|FG000|Overall Study|Lack of Efficacy|2|||
23195468|NCT02160977|64459661|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
23195469|NCT02160977|64459662|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
23360992|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360993|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
23360994|NCT02757352|65065930|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360995|NCT02757352|65065931|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360996|NCT02757352|65065932|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23360997|NCT02757352|65065933|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
23360998|NCT02757352|65065934|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
23360999|NCT02757352|65065935|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
23361000|NCT02757352|65065936|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23361001|NCT02757352|65065937|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23599655|NCT00419341|65925672|FG000|Efficacy Period|Withdrawal by Subject|6|||
23599656|NCT00419341|65925672|FG000|Efficacy Period|Protocol Violation|1|||
23599657|NCT00419341|65925672|FG000|Efficacy Period|Lost to Follow-up|1|||
23599658|NCT00419341|65925672|FG000|Efficacy Period|Non-compliance|1|||
23599659|NCT00419341|65925672|FG000|Efficacy Period|Termination of study site|1|||
23599660|NCT02755805|65925673|FG000|Overall Study|Lost to Follow-up|1|||
23195470|NCT02160977|64459661|FG000|Three Months After Surgery|Lost to Follow-up|0|||
23195471|NCT02160977|64459662|FG001|Three Months After Surgery|Lost to Follow-up|2|||
23195472|NCT02160977|64459661|FG000|Six Months After Surgery|Lost to Follow-up|2|||
23195473|NCT02160977|64459662|FG001|Six Months After Surgery|Lost to Follow-up|1|||
23195474|NCT00769704|64459665|FG000|Overall Study|Lost to Follow-up|3|||
23195475|NCT00769704|64459666|FG001|Overall Study|Lost to Follow-up|2|||
23195476|NCT00769704|64459665|FG000|Overall Study|Death|95|||
23195477|NCT00769704|64459666|FG001|Overall Study|Death|190|||
23480117|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
23480118|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
23480119|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
23480120|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
23480121|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
23480122|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
23480123|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
23599661|NCT02755805|65925674|FG001|Overall Study|Lost to Follow-up|2|||
23256469|NCT03989115|64680076|FG001|Overall Study|Lost to Follow-up|0|||
23256470|NCT03989115|64680077|FG002|Overall Study|Lost to Follow-up|0|||
23256471|NCT03989115|64680078|FG003|Overall Study|Lost to Follow-up|0|||
23256472|NCT03989115|64680079|FG004|Overall Study|Lost to Follow-up|1|||
23256473|NCT03989115|64680080|FG005|Overall Study|Lost to Follow-up|0|||
23256474|NCT03989115|64680081|FG006|Overall Study|Lost to Follow-up|0|||
23256475|NCT03989115|64680082|FG007|Overall Study|Lost to Follow-up|0|||
23256476|NCT03989115|64680075|FG000|Overall Study|Death|2|||
23256477|NCT03989115|64680076|FG001|Overall Study|Death|2|||
23256478|NCT03989115|64680077|FG002|Overall Study|Death|9|||
23256479|NCT03989115|64680078|FG003|Overall Study|Death|6|||
23256480|NCT03989115|64680079|FG004|Overall Study|Death|31|||
23256481|NCT03989115|64680080|FG005|Overall Study|Death|6|||
23256482|NCT03989115|64680081|FG006|Overall Study|Death|2|||
23256483|NCT03989115|64680082|FG007|Overall Study|Death|3|||
23256484|NCT03989115|64680075|FG000|Overall Study|Other|1|||
23256485|NCT03989115|64680076|FG001|Overall Study|Other|2|||
23256486|NCT03989115|64680077|FG002|Overall Study|Other|0|||
23256487|NCT03989115|64680078|FG003|Overall Study|Other|0|||
23256488|NCT03989115|64680079|FG004|Overall Study|Other|5|||
23256489|NCT03989115|64680080|FG005|Overall Study|Other|0|||
23256490|NCT03989115|64680081|FG006|Overall Study|Other|0|||
23256491|NCT03989115|64680082|FG007|Overall Study|Other|0|||
23256492|NCT01453374|64680086|FG000|Overall Study|Adverse Event|7|||
23256493|NCT01453374|64680086|FG000|Overall Study|Lack of Efficacy|1|||
23256494|NCT01453374|64680086|FG000|Overall Study|Lost to Follow-up|3|||
23256495|NCT01453374|64680086|FG000|Overall Study|Withdrawal by Subject|5|||
23256496|NCT01453374|64680086|FG000|Overall Study|Incarcerated|2|||
23256497|NCT04409002|64680098|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
23256498|NCT02410837|64680103|FG000|Overall Study|Death|387|||
23256499|NCT02410837|64680103|FG000|Overall Study|Lost to Follow-up|50|||
23256500|NCT02410837|64680103|FG000|Overall Study|Withdrawal by Subject|44|||
23256501|NCT02410837|64680103|FG000|Overall Study|Physician Decision|6|||
23256502|NCT02410837|64680103|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
23256503|NCT03769181|64680104|FG000|Overall Study|Adverse Event|1|||
23256504|NCT03769181|64680105|FG001|Overall Study|Adverse Event|0|||
23256505|NCT03769181|64680106|FG002|Overall Study|Adverse Event|2|||
23256506|NCT03769181|64680107|FG003|Overall Study|Adverse Event|4|||
23256507|NCT03769181|64680104|FG000|Overall Study|Withdrawal by Subject|1|||
23256508|NCT03769181|64680105|FG001|Overall Study|Withdrawal by Subject|0|||
23256509|NCT03769181|64680106|FG002|Overall Study|Withdrawal by Subject|2|||
23256510|NCT03769181|64680107|FG003|Overall Study|Withdrawal by Subject|1|||
23256511|NCT03769181|64680104|FG000|Overall Study|Progressive disease|9|||
23256512|NCT03769181|64680105|FG001|Overall Study|Progressive disease|7|||
23256513|NCT03769181|64680106|FG002|Overall Study|Progressive disease|13|||
23256514|NCT03769181|64680107|FG003|Overall Study|Progressive disease|6|||
23256515|NCT03769181|64680104|FG000|Overall Study|Other - Unspecified|2|||
23256516|NCT03769181|64680105|FG001|Overall Study|Other - Unspecified|1|||
23256517|NCT03769181|64680106|FG002|Overall Study|Other - Unspecified|0|||
23256518|NCT03769181|64680107|FG003|Overall Study|Other - Unspecified|0|||
23256519|NCT03990389|64680112|FG000|Overall Study|Lost to Follow-up|3|||
23256520|NCT03990389|64680113|FG001|Overall Study|Lost to Follow-up|0|||
23256521|NCT00326885|64680115|FG000|Overall Study|Adverse Event|1|||
23361002|NCT02757352|65065938|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23599662|NCT02755805|65925673|FG000|Overall Study|Refused assessments|1|||
23599663|NCT02755805|65925674|FG001|Overall Study|Refused assessments|0|||
23256522|NCT00326885|64680115|FG000|Overall Study|Withdrawal by Subject|3|||
23256523|NCT00326885|64680115|FG000|Overall Study|Physician Decision|1|||
23256524|NCT00326885|64680115|FG000|Overall Study|Hospice withdrew consent|2|||
23256525|NCT00217971|64680116|FG000|Overall Study|Adverse Event|1|||
23256526|NCT00217971|64680117|FG001|Overall Study|Adverse Event|1|||
23256527|NCT00217971|64680116|FG000|Overall Study|Lost to Follow-up|15|||
23256528|NCT00217971|64680117|FG001|Overall Study|Lost to Follow-up|19|||
23256529|NCT00217971|64680116|FG000|Overall Study|Physician Decision|0|||
23256530|NCT00217971|64680117|FG001|Overall Study|Physician Decision|1|||
23256531|NCT00217971|64680116|FG000|Overall Study|Withdrawal by Subject|7|||
23256532|NCT00217971|64680117|FG001|Overall Study|Withdrawal by Subject|12|||
23256533|NCT00217971|64680116|FG000|Overall Study|non compliant|1|||
23256534|NCT00217971|64680117|FG001|Overall Study|non compliant|0|||
23256535|NCT04741503|64680118|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
23256536|NCT04741503|64680119|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
23256537|NCT04741503|64680120|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
23480124|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
23361003|NCT02757352|65065939|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
23361004|NCT02757352|65065930|FG000|Follow-Up Period|Adverse Event|0|||
23361005|NCT02757352|65065931|FG001|Follow-Up Period|Adverse Event|0|||
23361006|NCT02757352|65065932|FG002|Follow-Up Period|Adverse Event|0|||
23361007|NCT02757352|65065933|FG003|Follow-Up Period|Adverse Event|0|||
23361008|NCT02757352|65065934|FG004|Follow-Up Period|Adverse Event|0|||
23361009|NCT02757352|65065935|FG005|Follow-Up Period|Adverse Event|0|||
23361010|NCT02757352|65065936|FG006|Follow-Up Period|Adverse Event|1|||
23361011|NCT02757352|65065937|FG007|Follow-Up Period|Adverse Event|0|||
23361012|NCT02757352|65065938|FG008|Follow-Up Period|Adverse Event|2|||
23361013|NCT02757352|65065939|FG009|Follow-Up Period|Adverse Event|0|||
23361014|NCT02757352|65065930|FG000|Follow-Up Period|Lost to Follow-up|0|||
23361015|NCT02757352|65065931|FG001|Follow-Up Period|Lost to Follow-up|0|||
23361016|NCT02757352|65065932|FG002|Follow-Up Period|Lost to Follow-up|0|||
23361017|NCT02757352|65065933|FG003|Follow-Up Period|Lost to Follow-up|0|||
23195478|NCT00769704|64459665|FG000|Overall Study|Withdrawal by Subject|12|||
23195479|NCT00769704|64459666|FG001|Overall Study|Withdrawal by Subject|5|||
23195480|NCT00769704|64459665|FG000|Overall Study|Other|1|||
23195481|NCT00769704|64459666|FG001|Overall Study|Other|2|||
23195482|NCT01306058|64459668|FG000|Overall Study|Death|1|||
23599664|NCT02755805|65925673|FG000|Overall Study|Withdrawal by Subject|0|||
23599665|NCT02755805|65925674|FG001|Overall Study|Withdrawal by Subject|2|||
23599666|NCT02461628|65925675|FG000|Overall Study|Refused to complete survey|4|||
23599667|NCT02461628|65925676|FG001|Overall Study|Refused to complete survey|7|||
23599668|NCT00439270|65925677|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
23599669|NCT00439270|65925678|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
23599670|NCT00439270|65925679|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
23599671|NCT00439270|65925680|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
23599672|NCT00439270|65925681|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
23599673|NCT00439270|65925677|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
23599674|NCT00439270|65925678|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
23599675|NCT00439270|65925679|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
23599676|NCT00439270|65925680|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
23599677|NCT00439270|65925681|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
23599678|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
23599679|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
23599680|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
23599681|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
23599682|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
23599683|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
23599684|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
23599685|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
23599686|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
23599687|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
23599688|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
23599689|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
23599690|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
23195483|NCT01306058|64459668|FG000|Overall Study|Enrolled but did not get treatment|1|||
23195484|NCT00637273|64459669|FG000|Overall Study|Adverse Event|11|||
23361018|NCT02757352|65065934|FG004|Follow-Up Period|Lost to Follow-up|0|||
23361019|NCT02757352|65065935|FG005|Follow-Up Period|Lost to Follow-up|0|||
23361020|NCT02757352|65065936|FG006|Follow-Up Period|Lost to Follow-up|0|||
23361021|NCT02757352|65065937|FG007|Follow-Up Period|Lost to Follow-up|0|||
23361022|NCT02757352|65065938|FG008|Follow-Up Period|Lost to Follow-up|1|||
23361023|NCT02757352|65065939|FG009|Follow-Up Period|Lost to Follow-up|0|||
23599691|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
23599692|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
23599693|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
23599694|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
23480125|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
23480126|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
23480127|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
23480128|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
23480129|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
23480130|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
23480131|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
23480132|NCT01227824|65501907|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
23480133|NCT01227824|65501908|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
23480134|NCT01227824|65501909|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
23480135|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
23480136|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
23480137|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
23480138|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
23480139|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
23480140|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
23480141|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
23480142|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
23480143|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
23480144|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
23480145|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
23480146|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
23480147|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
23480148|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
23480149|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
23480150|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
23480151|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
23480152|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
23480153|NCT01227824|65501907|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
23480154|NCT01227824|65501908|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
23480155|NCT01227824|65501909|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
23480156|NCT00797966|65501914|FG000|Phase A|Lost to Follow-up|0|||
23480157|NCT00797966|65501915|FG001|Phase A|Lost to Follow-up|0|||
23480158|NCT00797966|65501916|FG002|Phase A|Lost to Follow-up|0|||
23480159|NCT00797966|65501917|FG003|Phase A|Lost to Follow-up|0|||
23480160|NCT00797966|65501918|FG004|Phase A|Lost to Follow-up|33|||
23599695|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
23599696|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
23599697|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
23599698|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
23599699|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
23599700|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
23599701|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
23599702|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
23599703|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
23599704|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
23599705|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
23599706|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
23599707|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
23599708|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
23599709|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
23599710|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
23599711|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
23361024|NCT02757352|65065930|FG000|Follow-Up Period|Lack of Efficacy|0|||
23361025|NCT02757352|65065931|FG001|Follow-Up Period|Lack of Efficacy|0|||
23361026|NCT02757352|65065932|FG002|Follow-Up Period|Lack of Efficacy|0|||
23361027|NCT02757352|65065933|FG003|Follow-Up Period|Lack of Efficacy|0|||
23361028|NCT02757352|65065934|FG004|Follow-Up Period|Lack of Efficacy|0|||
23361029|NCT02757352|65065935|FG005|Follow-Up Period|Lack of Efficacy|0|||
23361030|NCT02757352|65065936|FG006|Follow-Up Period|Lack of Efficacy|0|||
23361031|NCT02757352|65065937|FG007|Follow-Up Period|Lack of Efficacy|0|||
23361032|NCT02757352|65065938|FG008|Follow-Up Period|Lack of Efficacy|1|||
23361033|NCT02757352|65065939|FG009|Follow-Up Period|Lack of Efficacy|1|||
23361034|NCT02757352|65065930|FG000|Follow-Up Period|Withdrawal by Subject|0|||
23361035|NCT02757352|65065931|FG001|Follow-Up Period|Withdrawal by Subject|0|||
23195485|NCT00637273|64459670|FG001|Overall Study|Adverse Event|5|||
23361036|NCT02757352|65065932|FG002|Follow-Up Period|Withdrawal by Subject|0|||
23361037|NCT02757352|65065933|FG003|Follow-Up Period|Withdrawal by Subject|0|||
23256538|NCT04741503|64680118|FG000|Initial Enrollment|Overquotas removed|0|||
23599712|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
23599713|NCT00439270|65925677|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
23599714|NCT00439270|65925678|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
23599715|NCT00439270|65925679|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
23599716|NCT00439270|65925680|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
23599717|NCT00439270|65925681|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
23256539|NCT04741503|64680119|FG001|Initial Enrollment|Overquotas removed|0|||
23256540|NCT04741503|64680120|FG002|Initial Enrollment|Overquotas removed|186|||
23195486|NCT00637273|64459671|FG002|Overall Study|Adverse Event|7|||
23195487|NCT00637273|64459669|FG000|Overall Study|Lost to Follow-up|8|||
23195488|NCT00637273|64459670|FG001|Overall Study|Lost to Follow-up|9|||
23195489|NCT00637273|64459671|FG002|Overall Study|Lost to Follow-up|13|||
23195490|NCT00637273|64459669|FG000|Overall Study|Protocol Violation|2|||
23195491|NCT00637273|64459670|FG001|Overall Study|Protocol Violation|4|||
23195492|NCT00637273|64459671|FG002|Overall Study|Protocol Violation|1|||
23195493|NCT00637273|64459669|FG000|Overall Study|Withdrawal of Consent|18|||
23195494|NCT00637273|64459670|FG001|Overall Study|Withdrawal of Consent|6|||
23195495|NCT00637273|64459671|FG002|Overall Study|Withdrawal of Consent|18|||
23195496|NCT00637273|64459669|FG000|Overall Study|Investigator Decision|1|||
23195497|NCT00637273|64459670|FG001|Overall Study|Investigator Decision|3|||
23195498|NCT00637273|64459671|FG002|Overall Study|Investigator Decision|1|||
23195499|NCT00637273|64459669|FG000|Overall Study|Administrative|2|||
23195500|NCT00637273|64459670|FG001|Overall Study|Administrative|0|||
23195501|NCT00637273|64459671|FG002|Overall Study|Administrative|0|||
23195502|NCT00637273|64459669|FG000|Overall Study|Loss of Glucose Control|1|||
23195503|NCT00637273|64459670|FG001|Overall Study|Loss of Glucose Control|1|||
23195504|NCT00637273|64459671|FG002|Overall Study|Loss of Glucose Control|1|||
23195505|NCT02546856|64459672|FG000|4 Months Evaluation|Death|2|||
23195506|NCT02546856|64459673|FG001|4 Months Evaluation|Death|3|||
23195507|NCT02546856|64459672|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
23195508|NCT02546856|64459673|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
23195509|NCT02546856|64459672|FG000|4 Months Evaluation|Lost to Follow-up|3|||
23195510|NCT02546856|64459673|FG001|4 Months Evaluation|Lost to Follow-up|3|||
23195511|NCT02546856|64459672|FG000|4 Months Evaluation|Physician Decision|3|||
23195512|NCT02546856|64459673|FG001|4 Months Evaluation|Physician Decision|0|||
23195513|NCT02546856|64459672|FG000|4 Months Evaluation|Working or living abroad|5|||
23195514|NCT02546856|64459673|FG001|4 Months Evaluation|Working or living abroad|1|||
23195515|NCT02546856|64459672|FG000|4 Months Evaluation|reasons not due to titration|4|||
23195516|NCT02546856|64459673|FG001|4 Months Evaluation|reasons not due to titration|1|||
23195517|NCT02546856|64459672|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
23195518|NCT02546856|64459673|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
23195519|NCT02546856|64459672|FG000|6 Months Evaluation|Death|1|||
23195520|NCT02546856|64459673|FG001|6 Months Evaluation|Death|1|||
23195521|NCT02546856|64459672|FG000|6 Months Evaluation|Lost to Follow-up|1|||
23195522|NCT02546856|64459673|FG001|6 Months Evaluation|Lost to Follow-up|1|||
23195523|NCT02546856|64459672|FG000|6 Months Evaluation|Working or living abroad|6|||
23195524|NCT02546856|64459673|FG001|6 Months Evaluation|Working or living abroad|4|||
23195525|NCT02546856|64459672|FG000|6 Months Evaluation|reasons not due to titration|0|||
23195526|NCT02546856|64459673|FG001|6 Months Evaluation|reasons not due to titration|1|||
23195527|NCT02807454|64459674|FG000|Overall Study|Adverse Event|1|||
23195528|NCT02807454|64459675|FG001|Overall Study|Adverse Event|0|||
23195529|NCT02807454|64459674|FG000|Overall Study|Withdrawal by Subject|0|||
23195530|NCT02807454|64459675|FG001|Overall Study|Withdrawal by Subject|1|||
23195531|NCT02807454|64459674|FG000|Overall Study|Progressive Disease|30|||
23195532|NCT02807454|64459675|FG001|Overall Study|Progressive Disease|3|||
23195533|NCT02807454|64459674|FG000|Overall Study|Other Reasons|1|||
23195534|NCT02807454|64459675|FG001|Overall Study|Other Reasons|1|||
23195535|NCT02260193|64459676|FG000|Overall Study|Lack of Efficacy|0|||
23195536|NCT02260193|64459677|FG001|Overall Study|Lack of Efficacy|1|||
23195537|NCT02260193|64459678|FG002|Overall Study|Lack of Efficacy|6|||
23195538|NCT02260193|64459676|FG000|Overall Study|Adverse Event|3|||
23195539|NCT02260193|64459677|FG001|Overall Study|Adverse Event|4|||
23195540|NCT02260193|64459678|FG002|Overall Study|Adverse Event|1|||
23195541|NCT02260193|64459676|FG000|Overall Study|Protocol Violation|0|||
23195542|NCT02260193|64459677|FG001|Overall Study|Protocol Violation|4|||
23195543|NCT02260193|64459678|FG002|Overall Study|Protocol Violation|0|||
23195544|NCT02260193|64459676|FG000|Overall Study|Withdrawal by Subject|3|||
23195545|NCT02260193|64459677|FG001|Overall Study|Withdrawal by Subject|0|||
23195546|NCT02260193|64459678|FG002|Overall Study|Withdrawal by Subject|2|||
23195547|NCT02260193|64459676|FG000|Overall Study|Kidney Transplantation|0|||
23361038|NCT02757352|65065934|FG004|Follow-Up Period|Withdrawal by Subject|0|||
23361039|NCT02757352|65065935|FG005|Follow-Up Period|Withdrawal by Subject|0|||
23361040|NCT02757352|65065936|FG006|Follow-Up Period|Withdrawal by Subject|0|||
23361041|NCT02757352|65065937|FG007|Follow-Up Period|Withdrawal by Subject|1|||
23361042|NCT02757352|65065938|FG008|Follow-Up Period|Withdrawal by Subject|6|||
23480161|NCT00797966|65501919|FG005|Phase A|Lost to Follow-up|0|||
23480162|NCT00797966|65501914|FG000|Phase A|Adverse Event|0|||
23195548|NCT02260193|64459677|FG001|Overall Study|Kidney Transplantation|0|||
23195549|NCT02260193|64459678|FG002|Overall Study|Kidney Transplantation|1|||
23195550|NCT00778999|64459683|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
23195551|NCT00778999|64459684|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
23195552|NCT00778999|64459683|FG000|Overall Study|Did not receive recFSH|14|||
23195553|NCT00778999|64459684|FG001|Overall Study|Did not receive recFSH|20|||
23195554|NCT01769404|64459688|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
23195555|NCT01769404|64459689|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
23195556|NCT01769404|64459688|FG000|Treatment Period 1|Withdrawal by Subject|3|||
23480163|NCT00797966|65501915|FG001|Phase A|Adverse Event|0|||
23480164|NCT00797966|65501916|FG002|Phase A|Adverse Event|0|||
23361043|NCT02757352|65065939|FG009|Follow-Up Period|Withdrawal by Subject|2|||
23195557|NCT01769404|64459689|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23195558|NCT01769404|64459688|FG000|Treatment Period 1|Sponsor decision|1|||
23195559|NCT01769404|64459689|FG001|Treatment Period 1|Sponsor decision|0|||
23195560|NCT01769404|64459688|FG000|Treatment Period 2|Sponsor decision|7|||
23195561|NCT01769404|64459689|FG001|Treatment Period 2|Sponsor decision|0|||
23195562|NCT02090114|64459690|FG000|Overall Study|Withdrawal by Subject|3|||
23195563|NCT02090114|64459691|FG001|Overall Study|Withdrawal by Subject|6|||
23195564|NCT02090114|64459692|FG002|Overall Study|Withdrawal by Subject|2|||
23195565|NCT02090114|64459693|FG003|Overall Study|Withdrawal by Subject|1|||
23195566|NCT02090114|64459690|FG000|Overall Study|Physician Decision|5|||
23195567|NCT02090114|64459691|FG001|Overall Study|Physician Decision|0|||
23195568|NCT02090114|64459692|FG002|Overall Study|Physician Decision|1|||
23195569|NCT02090114|64459693|FG003|Overall Study|Physician Decision|1|||
23195570|NCT02090114|64459690|FG000|Overall Study|Adverse Event|1|||
23195571|NCT02090114|64459691|FG001|Overall Study|Adverse Event|2|||
23195572|NCT02090114|64459692|FG002|Overall Study|Adverse Event|2|||
23195573|NCT02090114|64459693|FG003|Overall Study|Adverse Event|0|||
23195574|NCT02090114|64459690|FG000|Overall Study|Progressive Disease|20|||
23195575|NCT02090114|64459691|FG001|Overall Study|Progressive Disease|21|||
23195576|NCT02090114|64459692|FG002|Overall Study|Progressive Disease|23|||
23195577|NCT02090114|64459693|FG003|Overall Study|Progressive Disease|6|||
23195578|NCT02090114|64459690|FG000|Overall Study|Death|1|||
23195579|NCT02090114|64459691|FG001|Overall Study|Death|0|||
23195580|NCT02090114|64459692|FG002|Overall Study|Death|1|||
23195581|NCT02090114|64459693|FG003|Overall Study|Death|0|||
23195582|NCT01214616|64459696|FG000|Overall Study|Progressive disease|2|||
23195583|NCT01214616|64459697|FG001|Overall Study|Progressive disease|2|||
23195584|NCT01214616|64459698|FG002|Overall Study|Progressive disease|2|||
23195585|NCT01214616|64459699|FG003|Overall Study|Progressive disease|4|||
23195586|NCT01214616|64459696|FG000|Overall Study|Dose limiting toxicity|0|||
23195587|NCT01214616|64459697|FG001|Overall Study|Dose limiting toxicity|2|||
23195588|NCT01214616|64459698|FG002|Overall Study|Dose limiting toxicity|0|||
23195589|NCT01214616|64459699|FG003|Overall Study|Dose limiting toxicity|0|||
23195590|NCT01214616|64459696|FG000|Overall Study|Other adverse events|0|||
23195591|NCT01214616|64459697|FG001|Overall Study|Other adverse events|1|||
23195592|NCT01214616|64459698|FG002|Overall Study|Other adverse events|1|||
23195593|NCT01214616|64459699|FG003|Overall Study|Other adverse events|1|||
23195594|NCT01214616|64459696|FG000|Overall Study|Withdrawal by Subject|1|||
23195595|NCT01214616|64459697|FG001|Overall Study|Withdrawal by Subject|0|||
23195596|NCT01214616|64459698|FG002|Overall Study|Withdrawal by Subject|0|||
23195597|NCT01214616|64459699|FG003|Overall Study|Withdrawal by Subject|1|||
23195598|NCT01753115|64459700|FG000|Overall Study|Lost to Follow-up|3|||
23195599|NCT01753115|64459701|FG001|Overall Study|Lost to Follow-up|6|||
23195600|NCT01753115|64459702|FG002|Overall Study|Lost to Follow-up|8|||
23195601|NCT01753115|64459700|FG000|Overall Study|Withdrawal by Subject|6|||
23195602|NCT01753115|64459701|FG001|Overall Study|Withdrawal by Subject|5|||
23195603|NCT01753115|64459702|FG002|Overall Study|Withdrawal by Subject|6|||
23195604|NCT01753115|64459700|FG000|Overall Study|Subject non-compliant|3|||
23195605|NCT01753115|64459701|FG001|Overall Study|Subject non-compliant|3|||
23195606|NCT01753115|64459702|FG002|Overall Study|Subject non-compliant|0|||
23195607|NCT01753115|64459700|FG000|Overall Study|Used excluded drug|0|||
23361044|NCT00110357|65065940|FG000|Overall Study|Deterioration without progression|2|||
23195608|NCT01753115|64459701|FG001|Overall Study|Used excluded drug|1|||
23195609|NCT01753115|64459702|FG002|Overall Study|Used excluded drug|0|||
23195610|NCT00486226|64459703|FG000|Overall Study|Death|3|||
23195611|NCT00486226|64459703|FG000|Overall Study|Adverse Event|1|||
23195612|NCT00486226|64459703|FG000|Overall Study|Withdrawal by Subject|1|||
23195613|NCT00486226|64459703|FG000|Overall Study|Lost to Follow-up|8|||
23195614|NCT03692910|64459704|FG000|Overall Study|Lost to Follow-up|4|||
23195615|NCT03692910|64459705|FG001|Overall Study|Lost to Follow-up|0|||
23195616|NCT03692910|64459706|FG002|Overall Study|Lost to Follow-up|0|||
23195617|NCT03692910|64459704|FG000|Overall Study|Withdrawal by Subject|2|||
23195618|NCT03692910|64459705|FG001|Overall Study|Withdrawal by Subject|0|||
23195619|NCT03692910|64459706|FG002|Overall Study|Withdrawal by Subject|0|||
23195620|NCT02834403|64459717|FG000|Overall Study|Physician Decision|2|||
23195621|NCT02834403|64459718|FG001|Overall Study|Physician Decision|1|||
23195622|NCT02834403|64459719|FG002|Overall Study|Physician Decision|2|||
23195623|NCT02834403|64459720|FG003|Overall Study|Physician Decision|1|||
23195624|NCT02834403|64459721|FG004|Overall Study|Physician Decision|1|||
23195625|NCT02834403|64459722|FG005|Overall Study|Physician Decision|2|||
23195626|NCT02834403|64459723|FG006|Overall Study|Physician Decision|12|||
23195627|NCT02834403|64459717|FG000|Overall Study|Adverse Event|0|||
23195628|NCT02834403|64459718|FG001|Overall Study|Adverse Event|0|||
23195629|NCT02834403|64459719|FG002|Overall Study|Adverse Event|0|||
23195630|NCT02834403|64459720|FG003|Overall Study|Adverse Event|0|||
23195631|NCT02834403|64459721|FG004|Overall Study|Adverse Event|1|||
23195632|NCT02834403|64459722|FG005|Overall Study|Adverse Event|1|||
23195633|NCT02834403|64459723|FG006|Overall Study|Adverse Event|3|||
23195634|NCT02834403|64459717|FG000|Overall Study|Withdrawal by Subject|0|||
23195635|NCT02834403|64459718|FG001|Overall Study|Withdrawal by Subject|1|||
23195636|NCT02834403|64459719|FG002|Overall Study|Withdrawal by Subject|0|||
23195637|NCT02834403|64459720|FG003|Overall Study|Withdrawal by Subject|0|||
23195638|NCT02834403|64459721|FG004|Overall Study|Withdrawal by Subject|1|||
23195639|NCT02834403|64459722|FG005|Overall Study|Withdrawal by Subject|0|||
23195640|NCT02834403|64459723|FG006|Overall Study|Withdrawal by Subject|0|||
23195641|NCT02834403|64459717|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
23195642|NCT02834403|64459718|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
23195643|NCT02834403|64459719|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
23195644|NCT02834403|64459720|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
23195645|NCT02834403|64459721|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
23361045|NCT00110357|65065941|FG001|Overall Study|Deterioration without progression|0|||
23361046|NCT00110357|65065940|FG000|Overall Study|Disease progression/relapse|20|||
23361047|NCT00110357|65065941|FG001|Overall Study|Disease progression/relapse|15|||
23361048|NCT00110357|65065940|FG000|Overall Study|Study Closure|1|||
23361049|NCT00110357|65065941|FG001|Overall Study|Study Closure|0|||
23361050|NCT00110357|65065940|FG000|Overall Study|Study Drug Toxicity|1|||
23361051|NCT00110357|65065941|FG001|Overall Study|Study Drug Toxicity|3|||
23361052|NCT00110357|65065940|FG000|Overall Study|Withdrawal by Subject|3|||
23361053|NCT00110357|65065941|FG001|Overall Study|Withdrawal by Subject|1|||
23361054|NCT05259163|65065942|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
23361055|NCT05259163|65065943|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
23599718|NCT01268306|65925682|FG000|Overall Study|Lost to Follow-up|1|||
23599719|NCT01738438|65925685|FG000|Overall Study|Disease Progression|32|||
23599720|NCT01738438|65925685|FG000|Overall Study|Adverse Event|3|||
23599721|NCT03709706|65925686|FG000|Overall Study|Adverse Event|0|||
23599722|NCT03709706|65925687|FG001|Overall Study|Adverse Event|1|||
23599723|NCT03709706|65925686|FG000|Overall Study|Physician Decision|14|||
23599724|NCT03709706|65925687|FG001|Overall Study|Physician Decision|8|||
23195646|NCT02834403|64459722|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
23195647|NCT02834403|64459723|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
23195648|NCT01712438|64459726|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
23195649|NCT01712438|64459726|FG000|Overall Study|Ongoing ITI treatment|6|||
23195650|NCT01712438|64459726|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
23195651|NCT01712438|64459726|FG000|Overall Study|Prematurely Discontinued|25|||
23195652|NCT01912872|64459727|FG000|Overall Study|Lost to Follow-up|2|||
23195653|NCT01912872|64459728|FG001|Overall Study|Lost to Follow-up|3|||
23195654|NCT01912872|64459729|FG002|Overall Study|Lost to Follow-up|5|||
23195655|NCT01912872|64459730|FG003|Overall Study|Lost to Follow-up|5|||
23195656|NCT01912872|64459727|FG000|Overall Study|Other unspecified|3|||
23195657|NCT01912872|64459728|FG001|Overall Study|Other unspecified|1|||
23195658|NCT01912872|64459729|FG002|Overall Study|Other unspecified|3|||
23195659|NCT01912872|64459730|FG003|Overall Study|Other unspecified|0|||
23195660|NCT01912872|64459727|FG000|Overall Study|Informed consent withdrawn|0|||
23195661|NCT01912872|64459728|FG001|Overall Study|Informed consent withdrawn|0|||
23195662|NCT01912872|64459729|FG002|Overall Study|Informed consent withdrawn|1|||
23195663|NCT01912872|64459730|FG003|Overall Study|Informed consent withdrawn|1|||
23195664|NCT01912872|64459727|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
23195665|NCT01912872|64459728|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
23195666|NCT01912872|64459729|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
23195667|NCT01912872|64459730|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
23195668|NCT01912872|64459727|FG000|Overall Study|Protocol Violation|0|||
23195669|NCT01912872|64459728|FG001|Overall Study|Protocol Violation|0|||
23195670|NCT01912872|64459729|FG002|Overall Study|Protocol Violation|1|||
23195671|NCT01912872|64459730|FG003|Overall Study|Protocol Violation|0|||
23195672|NCT01912872|64459727|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23195673|NCT01912872|64459728|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23195674|NCT01912872|64459729|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
23195675|NCT01912872|64459730|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
23195676|NCT01912872|64459727|FG000|Overall Study|Withdrawal of study medication|0|||
23195677|NCT01912872|64459728|FG001|Overall Study|Withdrawal of study medication|0|||
23195678|NCT01912872|64459729|FG002|Overall Study|Withdrawal of study medication|0|||
23195679|NCT01912872|64459730|FG003|Overall Study|Withdrawal of study medication|2|||
23195680|NCT01912872|64459727|FG000|Overall Study|Missing|0|||
23195681|NCT01912872|64459728|FG001|Overall Study|Missing|0|||
23195682|NCT01912872|64459729|FG002|Overall Study|Missing|0|||
23195683|NCT01912872|64459730|FG003|Overall Study|Missing|1|||
23195684|NCT02691247|64459731|FG000|Overall Study|Withdrawal by Subject|1|||
23195685|NCT02691247|64459732|FG001|Overall Study|Withdrawal by Subject|2|||
23195686|NCT02691247|64459733|FG002|Overall Study|Withdrawal by Subject|2|||
23195687|NCT02691247|64459731|FG000|Overall Study|Lost to Follow-up|2|||
23195688|NCT02691247|64459732|FG001|Overall Study|Lost to Follow-up|0|||
23195689|NCT02691247|64459733|FG002|Overall Study|Lost to Follow-up|1|||
23195690|NCT00450372|64459734|FG000|Overall Study|Physician Decision|1|||
23195691|NCT01733316|64459737|FG000|RP103 Phase|Non-compliance|1|||
23195692|NCT01733316|64459737|FG000|Long Term Extension Phase|Adverse Event|1|||
23195693|NCT01733316|64459737|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
23195694|NCT01733316|64459737|FG000|Long Term Extension Phase|Sponsor Decision|2|||
23195695|NCT00592358|64459738|FG000|Overall Study|Withdrawal by Subject|2|||
23195696|NCT00592358|64459738|FG000|Overall Study|Adverse Event|1|||
23195697|NCT00592358|64459738|FG000|Overall Study|Lack of Efficacy|2|||
23195698|NCT00592358|64459738|FG000|Overall Study|Inability to swallow pills|1|||
23195699|NCT02100657|64459739|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
23195700|NCT02100657|64459740|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
23195701|NCT02100657|64459741|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
23195702|NCT02100657|64459739|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
23195703|NCT02100657|64459740|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
23195704|NCT02100657|64459741|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
23195705|NCT02100657|64459739|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
23195706|NCT02100657|64459740|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
23195707|NCT02100657|64459741|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
23195708|NCT02100657|64459739|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
23195709|NCT02100657|64459740|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
23195710|NCT02100657|64459741|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
23195711|NCT02100657|64459739|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
23256541|NCT04741503|64680118|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
23195712|NCT02100657|64459740|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
23195713|NCT02100657|64459741|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
23195714|NCT02100657|64459739|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
23195715|NCT02100657|64459740|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
23195716|NCT02100657|64459741|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
23195717|NCT02100657|64459739|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
23195718|NCT02100657|64459740|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
23195719|NCT02100657|64459741|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
23195720|NCT02100657|64459739|FG000|Cohort 3: Dose Level 3|Death|0|||
23195721|NCT02100657|64459740|FG001|Cohort 3: Dose Level 3|Death|0|||
23195722|NCT02100657|64459741|FG002|Cohort 3: Dose Level 3|Death|1|||
23195723|NCT02100657|64459739|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
23195724|NCT02100657|64459740|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
23195725|NCT02100657|64459741|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
23195726|NCT02100657|64459739|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
23195727|NCT02100657|64459740|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
23195728|NCT02100657|64459741|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
23195729|NCT02100657|64459739|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
23195730|NCT02100657|64459740|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
23195731|NCT02100657|64459741|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
23195732|NCT02100657|64459739|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
23195733|NCT02100657|64459740|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
23195734|NCT02100657|64459741|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
23256542|NCT04741503|64680119|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
23256543|NCT04741503|64680120|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
23256544|NCT00697112|64680121|FG000|Overall Study|Adverse Event|8|||
23256545|NCT00697112|64680121|FG000|Overall Study|Lost to Follow-up|1|||
23256546|NCT00697112|64680121|FG000|Overall Study|Did not meet inclusion criteria|1|||
23256547|NCT01851590|64680123|FG000|Overall Study|Withdrawal by Subject|0|||
23256548|NCT01851590|64680124|FG001|Overall Study|Withdrawal by Subject|0|||
23599725|NCT03709706|65925686|FG000|Overall Study|Withdrawal by Subject|2|||
23599726|NCT03709706|65925687|FG001|Overall Study|Withdrawal by Subject|1|||
23599727|NCT03709706|65925686|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
23599728|NCT03709706|65925687|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
23599729|NCT00960141|65925688|FG000|Overall Study|Adverse Event|4|||
23599730|NCT00960141|65925689|FG001|Overall Study|Adverse Event|8|||
23599731|NCT00960141|65925690|FG002|Overall Study|Adverse Event|2|||
23599732|NCT00960141|65925688|FG000|Overall Study|Lack of Efficacy|3|||
23599733|NCT00960141|65925689|FG001|Overall Study|Lack of Efficacy|4|||
23599734|NCT00960141|65925690|FG002|Overall Study|Lack of Efficacy|2|||
23599735|NCT00960141|65925688|FG000|Overall Study|Lost to Follow-up|1|||
23599736|NCT00960141|65925689|FG001|Overall Study|Lost to Follow-up|0|||
23599737|NCT00960141|65925690|FG002|Overall Study|Lost to Follow-up|0|||
23599738|NCT00960141|65925688|FG000|Overall Study|Protocol Violation|1|||
23599739|NCT00960141|65925689|FG001|Overall Study|Protocol Violation|3|||
23599740|NCT00960141|65925690|FG002|Overall Study|Protocol Violation|2|||
23599741|NCT00960141|65925688|FG000|Overall Study|Withdrawal by Subject|1|||
23599742|NCT00960141|65925689|FG001|Overall Study|Withdrawal by Subject|2|||
23256549|NCT01851590|64680125|FG002|Overall Study|Withdrawal by Subject|1|||
23256550|NCT01851590|64680123|FG000|Overall Study|Adverse Event|0|||
23256551|NCT01851590|64680124|FG001|Overall Study|Adverse Event|0|||
23256552|NCT01851590|64680125|FG002|Overall Study|Adverse Event|2|||
23256553|NCT01851590|64680123|FG000|Overall Study|Lack of Efficacy|0|||
23256554|NCT01851590|64680124|FG001|Overall Study|Lack of Efficacy|1|||
23256555|NCT01851590|64680125|FG002|Overall Study|Lack of Efficacy|0|||
23256556|NCT02535000|64680128|FG000|Overall Study|Cancellation of surgery.|1|||
23256557|NCT02535000|64680129|FG001|Overall Study|Cancellation of surgery.|2|||
23256558|NCT01619085|64680130|FG000|Overall Study|Adverse Event|231|||
23256559|NCT01619085|64680130|FG000|Overall Study|Protocol Violation|4|||
23256560|NCT01619085|64680130|FG000|Overall Study|Lost to Follow-up|3|||
23256561|NCT01619085|64680130|FG000|Overall Study|Withdrawal by Subject|45|||
23256562|NCT01619085|64680130|FG000|Overall Study|Other than specified|96|||
23256563|NCT01619085|64680130|FG000|Overall Study|Not treated|1|||
23599743|NCT00960141|65925690|FG002|Overall Study|Withdrawal by Subject|1|||
23599744|NCT01700205|65925693|FG000|Overall Study|Withdrawal by Subject|13|||
23599745|NCT01700205|65925694|FG001|Overall Study|Withdrawal by Subject|13|||
23599746|NCT01700205|65925693|FG000|Overall Study|Protocol Violation|2|||
23599747|NCT01700205|65925694|FG001|Overall Study|Protocol Violation|2|||
23599748|NCT01075152|65925697|FG000|Overall Study|Withdrawal by Subject|1|||
23599749|NCT01075152|65925698|FG001|Overall Study|Withdrawal by Subject|0|||
23599750|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
23599751|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
23195735|NCT02100657|64459739|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
23195736|NCT02100657|64459740|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
23256564|NCT01619085|64680130|FG000|Overall Study|Death|145|||
23256565|NCT01512979|64680133|FG000|Overall Study|Adverse Event|2|||
23256566|NCT01512979|64680134|FG001|Overall Study|Adverse Event|2|||
23256567|NCT01512979|64680133|FG000|Overall Study|Protocol Violation|1|||
23256568|NCT01512979|64680134|FG001|Overall Study|Protocol Violation|4|||
23599752|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
23599753|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
23599754|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
23599755|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
23599756|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
23599757|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
23256569|NCT01512979|64680133|FG000|Overall Study|Lost to Follow-up|2|||
23256570|NCT01512979|64680134|FG001|Overall Study|Lost to Follow-up|5|||
23256571|NCT01512979|64680133|FG000|Overall Study|Withdrawal by Subject|1|||
23256572|NCT01512979|64680134|FG001|Overall Study|Withdrawal by Subject|2|||
23256573|NCT01512979|64680133|FG000|Overall Study|Reason other than stated above|13|||
23256574|NCT01512979|64680134|FG001|Overall Study|Reason other than stated above|9|||
23256575|NCT01677910|64680135|FG000|Double-Blind Treatment Period|Adverse Event|6|||
23256576|NCT01677910|64680136|FG001|Double-Blind Treatment Period|Adverse Event|2|||
23256577|NCT01677910|64680137|FG002|Double-Blind Treatment Period|Adverse Event|3|||
23256578|NCT01677910|64680138|FG003|Double-Blind Treatment Period|Adverse Event|0|||
23256579|NCT01677910|64680135|FG000|Double-Blind Treatment Period|Physician Decision|0|||
23256580|NCT01677910|64680136|FG001|Double-Blind Treatment Period|Physician Decision|0|||
23256581|NCT01677910|64680137|FG002|Double-Blind Treatment Period|Physician Decision|1|||
23256582|NCT01677910|64680138|FG003|Double-Blind Treatment Period|Physician Decision|0|||
23256583|NCT01677910|64680135|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
23256584|NCT01677910|64680136|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
23256585|NCT01677910|64680137|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
23256586|NCT01677910|64680138|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
23256587|NCT01677910|64680135|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
23256588|NCT01677910|64680136|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
23256589|NCT01677910|64680137|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
23256590|NCT01677910|64680138|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
23361056|NCT00807885|65065946|FG000|Overall Study|Lost to Follow-up|0|||
23256591|NCT01677910|64680135|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
23256592|NCT01677910|64680136|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
23195737|NCT02100657|64459741|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
23195738|NCT00791128|64459742|FG000|Overall Study|Adverse Event|4|||
23195739|NCT00791128|64459742|FG000|Overall Study|Device migration|2|||
23195740|NCT00791128|64459742|FG000|Overall Study|non-compliance by subject|2|||
23195741|NCT00791128|64459742|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
23195742|NCT00515463|64459743|FG000|Overall Study|Physician Decision|4|||
23195743|NCT00515463|64459744|FG001|Overall Study|Physician Decision|2|||
23195744|NCT00515463|64459743|FG000|Overall Study|Adverse Event|1|||
23195745|NCT00515463|64459744|FG001|Overall Study|Adverse Event|2|||
23195746|NCT00515463|64459743|FG000|Overall Study|Withdrawal by Subject|3|||
23195747|NCT00515463|64459744|FG001|Overall Study|Withdrawal by Subject|4|||
23195748|NCT00515463|64459743|FG000|Overall Study|Lost to Follow-up|6|||
23195749|NCT00515463|64459744|FG001|Overall Study|Lost to Follow-up|5|||
23195750|NCT00515463|64459743|FG000|Overall Study|Other|0|||
23195751|NCT00515463|64459744|FG001|Overall Study|Other|1|||
23195752|NCT02660580|64459747|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
23195753|NCT02660580|64459748|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
23195754|NCT02660580|64459749|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
23195755|NCT02660580|64459750|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
23195756|NCT02660580|64459751|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
23195757|NCT02660580|64459747|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
23195758|NCT02660580|64459748|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
23195759|NCT02660580|64459749|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
23195760|NCT02660580|64459750|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
23195761|NCT02660580|64459751|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
23195762|NCT02660580|64459747|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
23480165|NCT00797966|65501917|FG003|Phase A|Adverse Event|0|||
23480166|NCT00797966|65501918|FG004|Phase A|Adverse Event|46|||
23480167|NCT00797966|65501919|FG005|Phase A|Adverse Event|0|||
23480168|NCT00797966|65501914|FG000|Phase A|Met withdrawal criteria|0|||
23195763|NCT02660580|64459748|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
23195764|NCT02660580|64459749|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
23195765|NCT02660580|64459750|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
23195766|NCT02660580|64459751|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
23195767|NCT02660580|64459747|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
23195768|NCT02660580|64459748|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
23195769|NCT02660580|64459749|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
23195770|NCT02660580|64459750|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
23195771|NCT02660580|64459751|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
23195772|NCT02660580|64459747|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
23195773|NCT02660580|64459748|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
23195774|NCT02660580|64459749|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
23195775|NCT02660580|64459750|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
23195776|NCT02660580|64459751|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
23195777|NCT02660580|64459747|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
23195778|NCT02660580|64459748|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
23195779|NCT02660580|64459749|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
23195780|NCT02660580|64459750|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
23195781|NCT02660580|64459751|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
23195782|NCT02660580|64459747|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
23195783|NCT02660580|64459748|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
23195784|NCT02660580|64459749|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
23195785|NCT02660580|64459750|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
23195786|NCT02660580|64459751|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
23195787|NCT02660580|64459747|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
23195788|NCT02660580|64459748|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
23195789|NCT02660580|64459749|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
23195790|NCT02660580|64459750|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
23195791|NCT02660580|64459751|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
23195792|NCT02660580|64459747|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
23195793|NCT02660580|64459748|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
23195794|NCT02660580|64459749|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
23195795|NCT02660580|64459750|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
23195796|NCT02660580|64459751|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
23480169|NCT00797966|65501915|FG001|Phase A|Met withdrawal criteria|0|||
23195797|NCT02660580|64459747|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
23195798|NCT02660580|64459748|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
23480170|NCT00797966|65501916|FG002|Phase A|Met withdrawal criteria|0|||
23195799|NCT02660580|64459749|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
23195800|NCT02660580|64459750|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
23195801|NCT02660580|64459751|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
23195802|NCT02660580|64459747|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
23195803|NCT02660580|64459748|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
23195804|NCT02660580|64459749|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
23195805|NCT02660580|64459750|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
23195806|NCT02660580|64459751|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
23195807|NCT02660580|64459747|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
23195808|NCT02660580|64459748|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
23195809|NCT02660580|64459749|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
23195810|NCT02660580|64459750|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
23195811|NCT02660580|64459751|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
23195812|NCT02660580|64459747|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
23195813|NCT02660580|64459748|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
23195814|NCT02660580|64459749|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
23195815|NCT02660580|64459750|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
23195816|NCT02660580|64459751|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
23195817|NCT00931892|64459752|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
23195818|NCT00931892|64459753|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
23195819|NCT00469014|64459754|FG000|Initial Phase Randomization|Disease Progression|0|||
23195820|NCT00469014|64459755|FG001|Initial Phase Randomization|Disease Progression|1|||
23195821|NCT00469014|64459756|FG002|Initial Phase Randomization|Disease Progression|1|||
23195822|NCT00469014|64459757|FG003|Initial Phase Randomization|Disease Progression|0|||
23195823|NCT00469014|64459754|FG000|Initial Phase Randomization|No Response|1|||
23195824|NCT00469014|64459755|FG001|Initial Phase Randomization|No Response|0|||
23195825|NCT00469014|64459756|FG002|Initial Phase Randomization|No Response|0|||
23195826|NCT00469014|64459757|FG003|Initial Phase Randomization|No Response|1|||
23195827|NCT00469014|64459754|FG000|Adaptive Randomization|Not Evaluable|1|||
23195828|NCT00469014|64459755|FG001|Adaptive Randomization|Not Evaluable|0|||
23195829|NCT00469014|64459756|FG002|Adaptive Randomization|Not Evaluable|0|||
23195830|NCT00469014|64459757|FG003|Adaptive Randomization|Not Evaluable|1|||
23195831|NCT00469014|64459754|FG000|Adaptive Randomization|No Response|0|||
23195832|NCT00469014|64459755|FG001|Adaptive Randomization|No Response|1|||
23195833|NCT00469014|64459756|FG002|Adaptive Randomization|No Response|0|||
23195834|NCT00469014|64459757|FG003|Adaptive Randomization|No Response|0|||
23195835|NCT00469014|64459754|FG000|Adaptive Randomization|Death|0|||
23195836|NCT00469014|64459755|FG001|Adaptive Randomization|Death|0|||
23195837|NCT00469014|64459756|FG002|Adaptive Randomization|Death|1|||
23195838|NCT00469014|64459757|FG003|Adaptive Randomization|Death|0|||
23195839|NCT00151411|64459762|FG000|Overall Study|Lost to Follow-up|15|||
23195840|NCT00151411|64459763|FG001|Overall Study|Lost to Follow-up|19|||
23195841|NCT00151411|64459762|FG000|Overall Study|Withdrawal by Subject|12|||
23361057|NCT00807885|65065947|FG001|Overall Study|Lost to Follow-up|0|||
23361058|NCT00807885|65065948|FG002|Overall Study|Lost to Follow-up|0|||
23361059|NCT00807885|65065949|FG003|Overall Study|Lost to Follow-up|0|||
23361060|NCT00807885|65065950|FG004|Overall Study|Lost to Follow-up|0|||
23361061|NCT00807885|65065951|FG005|Overall Study|Lost to Follow-up|1|||
23361062|NCT00807885|65065952|FG006|Overall Study|Lost to Follow-up|0|||
23361063|NCT00807885|65065953|FG007|Overall Study|Lost to Follow-up|0|||
23195842|NCT00151411|64459763|FG001|Overall Study|Withdrawal by Subject|20|||
23195843|NCT00151411|64459762|FG000|Overall Study|Adverse Event|6|||
23195844|NCT00151411|64459763|FG001|Overall Study|Adverse Event|0|||
23195845|NCT00151411|64459762|FG000|Overall Study|Pregnancy|0|||
23195846|NCT00151411|64459763|FG001|Overall Study|Pregnancy|4|||
23195847|NCT02815397|64459767|FG000|Overall Study|Physician Decision|2|||
23195848|NCT01356602|64459768|FG000|Overall Study|Protocol Deviation|0|||
23195849|NCT01356602|64459769|FG001|Overall Study|Protocol Deviation|1|||
23195850|NCT01356602|64459770|FG002|Overall Study|Protocol Deviation|1|||
23195851|NCT01356602|64459768|FG000|Overall Study|Administrative Problems|1|||
23361064|NCT00807885|65065954|FG008|Overall Study|Lost to Follow-up|0|||
23361065|NCT03311841|65065957|FG000|14-day Wash-out|Adverse Event|0|||
23361066|NCT03311841|65065958|FG001|14-day Wash-out|Adverse Event|1|||
23361067|NCT03311841|65065959|FG002|14-day Wash-out|Adverse Event|0|||
23361068|NCT03311841|65065960|FG003|14-day Wash-out|Adverse Event|0|||
23599758|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
23195852|NCT01356602|64459769|FG001|Overall Study|Administrative Problems|4|||
23195853|NCT01356602|64459770|FG002|Overall Study|Administrative Problems|5|||
23195854|NCT01356602|64459768|FG000|Overall Study|Lost to Follow-up|4|||
23361069|NCT03311841|65065961|FG004|14-day Wash-out|Adverse Event|0|||
23195855|NCT01356602|64459769|FG001|Overall Study|Lost to Follow-up|5|||
23195856|NCT01356602|64459770|FG002|Overall Study|Lost to Follow-up|6|||
23195857|NCT01356602|64459768|FG000|Overall Study|Withdrawal by Subject|4|||
23195858|NCT01356602|64459769|FG001|Overall Study|Withdrawal by Subject|3|||
23195859|NCT01356602|64459770|FG002|Overall Study|Withdrawal by Subject|7|||
23195860|NCT01356602|64459768|FG000|Overall Study|Lack of Efficacy|0|||
23195861|NCT01356602|64459769|FG001|Overall Study|Lack of Efficacy|1|||
23195862|NCT01356602|64459770|FG002|Overall Study|Lack of Efficacy|4|||
23195863|NCT01356602|64459768|FG000|Overall Study|Adverse Event|0|||
23195864|NCT01356602|64459769|FG001|Overall Study|Adverse Event|1|||
23195865|NCT01356602|64459770|FG002|Overall Study|Adverse Event|1|||
23195866|NCT02028338|64459771|FG000|Overall Study|Withdrawal by Subject|3|||
23195867|NCT02028338|64459772|FG001|Overall Study|Withdrawal by Subject|1|||
23195868|NCT02028338|64459771|FG000|Overall Study|Unable to contact participant|1|||
23195869|NCT02028338|64459772|FG001|Overall Study|Unable to contact participant|0|||
23195870|NCT01312428|64459773|FG000|Overall Study|Study Termination|3|||
23195871|NCT01312428|64459774|FG001|Overall Study|Study Termination|4|||
23195872|NCT00222729|64459779|FG000|Overall Study|Adverse Event|3|||
23195873|NCT01734993|64459780|FG000|Overall Study|Adverse Event|1|||
23195874|NCT01734993|64459780|FG000|Overall Study|Lack of Efficacy|1|||
23195875|NCT01780389|64459783|FG000|Overall Study|Adverse Event|1|||
23195876|NCT00878072|64459784|FG000|Overall Study|Withdrew consent|2|||
23195877|NCT02612077|64459795|FG000|Overall Study|Adverse Event|3|||
23195878|NCT02612077|64459795|FG000|Overall Study|Withdrawal by Subject|9|||
23195879|NCT02612077|64459795|FG000|Overall Study|Protocol Violation|28|||
23195880|NCT02612077|64459795|FG000|Overall Study|Lost to Follow-up|20|||
23195881|NCT02612077|64459795|FG000|Overall Study|Death|377|||
23195882|NCT02612077|64459795|FG000|Overall Study|Moved or Changed Medical Team|23|||
23195883|NCT02612077|64459795|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
23195884|NCT02612077|64459795|FG000|Overall Study|Disease Progression|3|||
23195885|NCT02612077|64459795|FG000|Overall Study|Unknown reason|2|||
23195886|NCT03880227|64459812|FG000|First Visit|Withdrawal by Subject|1|||
23195887|NCT03880227|64459813|FG001|First Visit|Withdrawal by Subject|0|||
23195888|NCT03880227|64459814|FG002|First Visit|Withdrawal by Subject|0|||
23195889|NCT03880227|64459815|FG003|First Visit|Withdrawal by Subject|0|||
23195890|NCT03880227|64459812|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
23195891|NCT03880227|64459813|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
23195892|NCT03880227|64459814|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
23195893|NCT03880227|64459815|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
23195894|NCT03880227|64459812|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
23195895|NCT03880227|64459813|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
23195896|NCT03880227|64459814|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
23195897|NCT03880227|64459815|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
23195898|NCT03880227|64459812|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
23195899|NCT03880227|64459813|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
23195900|NCT03880227|64459814|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
23195901|NCT03880227|64459815|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
23195902|NCT04370028|64459817|FG000|Overall Study|Withdrawal by Subject|695|||
23195903|NCT04370028|64459817|FG000|Overall Study|Protocol Violation|9|||
23195904|NCT04370028|64459817|FG000|Overall Study|Adverse Event|3|||
23195905|NCT00224107|64459818|FG000|Overall Study|Adverse Event|20|||
23195906|NCT00224107|64459819|FG001|Overall Study|Adverse Event|6|||
23195907|NCT00224107|64459818|FG000|Overall Study|Protocol Violation|2|||
23195908|NCT00224107|64459819|FG001|Overall Study|Protocol Violation|3|||
23195909|NCT00224107|64459818|FG000|Overall Study|Withdrawal by Subject|1|||
23195910|NCT00224107|64459819|FG001|Overall Study|Withdrawal by Subject|4|||
23195911|NCT00224107|64459818|FG000|Overall Study|Lack of Efficacy|2|||
23195912|NCT00224107|64459819|FG001|Overall Study|Lack of Efficacy|0|||
23195913|NCT00224107|64459818|FG000|Overall Study|Lost to Follow-up|4|||
23195914|NCT00224107|64459819|FG001|Overall Study|Lost to Follow-up|0|||
23195915|NCT00224107|64459818|FG000|Overall Study|Physician Decision|1|||
23195916|NCT00224107|64459819|FG001|Overall Study|Physician Decision|0|||
23195917|NCT00224107|64459818|FG000|Overall Study|Other|1|||
23195918|NCT00224107|64459819|FG001|Overall Study|Other|1|||
23195919|NCT00576693|64459820|FG000|Overall Study|Lost to Follow-up|7|||
23195920|NCT00576693|64459821|FG001|Overall Study|Lost to Follow-up|11|||
23195921|NCT00576693|64459820|FG000|Overall Study|Withdrawal by Subject|3|||
23195922|NCT00576693|64459821|FG001|Overall Study|Withdrawal by Subject|13|||
23195923|NCT02429427|64459824|FG000|Overall Study|Adverse Event|220|||
23195924|NCT02429427|64459825|FG001|Overall Study|Adverse Event|92|||
23195925|NCT02429427|64459824|FG000|Overall Study|Protocol Violation|10|||
23195926|NCT02429427|64459825|FG001|Overall Study|Protocol Violation|6|||
23195927|NCT02429427|64459824|FG000|Overall Study|Lost to Follow-up|15|||
23195928|NCT02429427|64459825|FG001|Overall Study|Lost to Follow-up|6|||
23195929|NCT02429427|64459824|FG000|Overall Study|Withdrawal by Subject|64|||
23195930|NCT02429427|64459825|FG001|Overall Study|Withdrawal by Subject|34|||
23195931|NCT02429427|64459824|FG000|Overall Study|Other|62|||
23361070|NCT03311841|65065957|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
23195932|NCT02429427|64459825|FG001|Overall Study|Other|41|||
23195933|NCT00149825|64459826|FG000|Overall Study|Intolerance to medication side effects|1|||
23195934|NCT00149825|64459827|FG001|Overall Study|Intolerance to medication side effects|2|||
23195935|NCT00149825|64459826|FG000|Overall Study|Time commitments|2|||
23195936|NCT00149825|64459827|FG001|Overall Study|Time commitments|1|||
23195937|NCT00149825|64459826|FG000|Overall Study|Not liking insomnia therapy|1|||
23195938|NCT00149825|64459827|FG001|Overall Study|Not liking insomnia therapy|0|||
23195939|NCT00149825|64459826|FG000|Overall Study|Other|1|||
23195940|NCT00149825|64459827|FG001|Overall Study|Other|0|||
23195941|NCT02874794|64459836|FG000|Overall Study|Physician Decision|3|||
23195942|NCT02874794|64459837|FG001|Overall Study|Physician Decision|2|||
23195943|NCT02874794|64459836|FG000|Overall Study|Withdrawal by Subject|2|||
23195944|NCT02874794|64459837|FG001|Overall Study|Withdrawal by Subject|8|||
23195945|NCT02874794|64459836|FG000|Overall Study|Death|2|||
23195946|NCT02874794|64459837|FG001|Overall Study|Death|1|||
23195947|NCT00069095|64459838|FG000|Primary Treatment Phase|Ongoing|0|||
23195948|NCT00069095|64459839|FG001|Primary Treatment Phase|Ongoing|0|||
23195949|NCT00069095|64459840|FG002|Primary Treatment Phase|Ongoing|5|||
23195950|NCT00069095|64459841|FG003|Primary Treatment Phase|Ongoing|7|||
23195951|NCT00069095|64459842|FG004|Primary Treatment Phase|Ongoing|7|||
23195952|NCT00069095|64459843|FG005|Primary Treatment Phase|Ongoing|4|||
23195953|NCT00069095|64459838|FG000|Primary Treatment Phase|Admin/Other|29|||
23195954|NCT00069095|64459839|FG001|Primary Treatment Phase|Admin/Other|38|||
23195955|NCT00069095|64459840|FG002|Primary Treatment Phase|Admin/Other|31|||
23195956|NCT00069095|64459841|FG003|Primary Treatment Phase|Admin/Other|45|||
23195957|NCT00069095|64459842|FG004|Primary Treatment Phase|Admin/Other|48|||
23195958|NCT00069095|64459843|FG005|Primary Treatment Phase|Admin/Other|42|||
23195959|NCT00069095|64459838|FG000|Primary Treatment Phase|Adverse Event|99|||
23195960|NCT00069095|64459839|FG001|Primary Treatment Phase|Adverse Event|92|||
23195961|NCT00069095|64459840|FG002|Primary Treatment Phase|Adverse Event|71|||
23195962|NCT00069095|64459841|FG003|Primary Treatment Phase|Adverse Event|72|||
23195963|NCT00069095|64459842|FG004|Primary Treatment Phase|Adverse Event|109|||
23195964|NCT00069095|64459843|FG005|Primary Treatment Phase|Adverse Event|101|||
23195965|NCT00069095|64459838|FG000|Primary Treatment Phase|Death|14|||
23195966|NCT00069095|64459839|FG001|Primary Treatment Phase|Death|8|||
23195967|NCT00069095|64459840|FG002|Primary Treatment Phase|Death|2|||
23195968|NCT00069095|64459841|FG003|Primary Treatment Phase|Death|5|||
23195969|NCT00069095|64459842|FG004|Primary Treatment Phase|Death|8|||
23195970|NCT00069095|64459843|FG005|Primary Treatment Phase|Death|8|||
23195971|NCT00069095|64459838|FG000|Primary Treatment Phase|Failure to return|5|||
23195972|NCT00069095|64459839|FG001|Primary Treatment Phase|Failure to return|5|||
23195973|NCT00069095|64459840|FG002|Primary Treatment Phase|Failure to return|0|||
23195974|NCT00069095|64459841|FG003|Primary Treatment Phase|Failure to return|0|||
23195975|NCT00069095|64459842|FG004|Primary Treatment Phase|Failure to return|0|||
23195976|NCT00069095|64459843|FG005|Primary Treatment Phase|Failure to return|2|||
23195977|NCT00069095|64459838|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
23195978|NCT00069095|64459839|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
23195979|NCT00069095|64459840|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
23195980|NCT00069095|64459841|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
23195981|NCT00069095|64459842|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
23195982|NCT00069095|64459843|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
23195983|NCT00069095|64459838|FG000|Primary Treatment Phase|Refused treatment|15|||
23195984|NCT00069095|64459839|FG001|Primary Treatment Phase|Refused treatment|26|||
23195985|NCT00069095|64459840|FG002|Primary Treatment Phase|Refused treatment|17|||
23195986|NCT00069095|64459841|FG003|Primary Treatment Phase|Refused treatment|31|||
23195987|NCT00069095|64459842|FG004|Primary Treatment Phase|Refused treatment|24|||
23195988|NCT00069095|64459843|FG005|Primary Treatment Phase|Refused treatment|27|||
23195989|NCT00069095|64459838|FG000|Primary Treatment Phase|Withdrew|2|||
23195990|NCT00069095|64459839|FG001|Primary Treatment Phase|Withdrew|3|||
23195991|NCT00069095|64459840|FG002|Primary Treatment Phase|Withdrew|8|||
23195992|NCT00069095|64459841|FG003|Primary Treatment Phase|Withdrew|2|||
23195993|NCT00069095|64459842|FG004|Primary Treatment Phase|Withdrew|4|||
23195994|NCT00069095|64459843|FG005|Primary Treatment Phase|Withdrew|9|||
23195995|NCT00069095|64459838|FG000|Primary Treatment Phase|Other Violation|0|||
23195996|NCT00069095|64459839|FG001|Primary Treatment Phase|Other Violation|1|||
23195997|NCT00069095|64459840|FG002|Primary Treatment Phase|Other Violation|1|||
23195998|NCT00069095|64459841|FG003|Primary Treatment Phase|Other Violation|1|||
23195999|NCT00069095|64459842|FG004|Primary Treatment Phase|Other Violation|0|||
23196000|NCT00069095|64459843|FG005|Primary Treatment Phase|Other Violation|1|||
23196001|NCT00069095|64459838|FG000|Primary Treatment Phase|Violation criteria|0|||
23196002|NCT00069095|64459839|FG001|Primary Treatment Phase|Violation criteria|2|||
23196003|NCT00069095|64459840|FG002|Primary Treatment Phase|Violation criteria|4|||
23196004|NCT00069095|64459841|FG003|Primary Treatment Phase|Violation criteria|3|||
23196005|NCT00069095|64459842|FG004|Primary Treatment Phase|Violation criteria|1|||
23196006|NCT00069095|64459843|FG005|Primary Treatment Phase|Violation criteria|5|||
23196007|NCT00069095|64459838|FG000|Post-study Treatment Phase|Missing reason|1|||
23196008|NCT00069095|64459839|FG001|Post-study Treatment Phase|Missing reason|3|||
23196009|NCT00069095|64459840|FG002|Post-study Treatment Phase|Missing reason|12|||
23196010|NCT00069095|64459841|FG003|Post-study Treatment Phase|Missing reason|8|||
23196011|NCT00069095|64459842|FG004|Post-study Treatment Phase|Missing reason|18|||
23196012|NCT00069095|64459843|FG005|Post-study Treatment Phase|Missing reason|17|||
23196013|NCT00069095|64459838|FG000|Post-study Treatment Phase|Adverse Event|2|||
23196014|NCT00069095|64459839|FG001|Post-study Treatment Phase|Adverse Event|3|||
23196015|NCT00069095|64459840|FG002|Post-study Treatment Phase|Adverse Event|1|||
23196016|NCT00069095|64459841|FG003|Post-study Treatment Phase|Adverse Event|0|||
23196017|NCT00069095|64459842|FG004|Post-study Treatment Phase|Adverse Event|5|||
23196018|NCT00069095|64459843|FG005|Post-study Treatment Phase|Adverse Event|1|||
23196019|NCT00069095|64459838|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
23196020|NCT00069095|64459839|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
23196021|NCT00069095|64459840|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
23196022|NCT00069095|64459841|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
23196023|NCT00069095|64459842|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
23196024|NCT00069095|64459843|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
23196025|NCT00069095|64459838|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
23196026|NCT00069095|64459839|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
23196027|NCT00069095|64459840|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
23196028|NCT00069095|64459841|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
23196029|NCT00069095|64459842|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
23196030|NCT00069095|64459843|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
23196031|NCT00069095|64459838|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
23196032|NCT00069095|64459839|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
23196033|NCT00069095|64459840|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
23196034|NCT00069095|64459841|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
23196035|NCT00069095|64459842|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
23196036|NCT00069095|64459843|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
23196037|NCT00069095|64459838|FG000|Post-study Treatment Phase|Participant had complete response|1|||
23196038|NCT00069095|64459839|FG001|Post-study Treatment Phase|Participant had complete response|1|||
23196039|NCT00069095|64459840|FG002|Post-study Treatment Phase|Participant had complete response|0|||
23196040|NCT00069095|64459841|FG003|Post-study Treatment Phase|Participant had complete response|0|||
23196041|NCT00069095|64459842|FG004|Post-study Treatment Phase|Participant had complete response|0|||
23196042|NCT00069095|64459843|FG005|Post-study Treatment Phase|Participant had complete response|0|||
23196043|NCT00069095|64459838|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23196044|NCT00069095|64459839|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
23196045|NCT00069095|64459840|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23196046|NCT00069095|64459841|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23196047|NCT00069095|64459842|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23196048|NCT00069095|64459843|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
23196049|NCT00069095|64459838|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
23196050|NCT00069095|64459839|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
23196051|NCT00069095|64459840|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
23196052|NCT00069095|64459841|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
23196053|NCT00069095|64459842|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
23196054|NCT00069095|64459843|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
23196055|NCT00069095|64459838|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
23196056|NCT00069095|64459839|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
23196057|NCT00069095|64459840|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
23196058|NCT00069095|64459841|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
23196059|NCT00069095|64459842|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
23196060|NCT00069095|64459843|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
23196061|NCT00069095|64459838|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
23196062|NCT00069095|64459839|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
23196063|NCT00069095|64459840|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
23196064|NCT00069095|64459841|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
23196065|NCT00069095|64459842|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
23196066|NCT00069095|64459843|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
23196067|NCT00069095|64459838|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23196068|NCT00069095|64459839|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23196069|NCT00069095|64459840|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23196070|NCT00069095|64459841|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
23361071|NCT03311841|65065958|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
23196071|NCT00069095|64459842|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23196072|NCT00069095|64459843|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
23196073|NCT00069095|64459838|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
23196074|NCT00069095|64459839|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
23196075|NCT00069095|64459840|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
23196076|NCT00069095|64459841|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
23196077|NCT00069095|64459842|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
23196078|NCT00069095|64459843|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
23196079|NCT00069095|64459838|FG000|Post-study Treatment Phase|Surgery|0|||
23196080|NCT00069095|64459839|FG001|Post-study Treatment Phase|Surgery|0|||
23196081|NCT00069095|64459840|FG002|Post-study Treatment Phase|Surgery|0|||
23196082|NCT00069095|64459841|FG003|Post-study Treatment Phase|Surgery|1|||
23196083|NCT00069095|64459842|FG004|Post-study Treatment Phase|Surgery|1|||
23196084|NCT00069095|64459843|FG005|Post-study Treatment Phase|Surgery|0|||
23196085|NCT00069095|64459838|FG000|Post-study Treatment Phase|Death|0|||
23196086|NCT00069095|64459839|FG001|Post-study Treatment Phase|Death|0|||
23196087|NCT00069095|64459840|FG002|Post-study Treatment Phase|Death|0|||
23196088|NCT00069095|64459841|FG003|Post-study Treatment Phase|Death|0|||
23196089|NCT00069095|64459842|FG004|Post-study Treatment Phase|Death|1|||
23196090|NCT00069095|64459843|FG005|Post-study Treatment Phase|Death|0|||
23196091|NCT00069095|64459838|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
23196092|NCT00069095|64459839|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
23196093|NCT00069095|64459840|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
23196094|NCT00069095|64459841|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
23196095|NCT00069095|64459842|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
23196096|NCT00069095|64459843|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
23196097|NCT00069095|64459838|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23196098|NCT00069095|64459839|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23196099|NCT00069095|64459840|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23196100|NCT00069095|64459841|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23196101|NCT00069095|64459842|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
23196102|NCT00069095|64459843|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
23196103|NCT00069095|64459838|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23196104|NCT00069095|64459839|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23196105|NCT00069095|64459840|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23196106|NCT00069095|64459841|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23196107|NCT00069095|64459842|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
23196108|NCT00069095|64459843|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
23196109|NCT00069095|64459838|FG000|Post-study Treatment Phase|Investigator decision|0|||
23196110|NCT00069095|64459839|FG001|Post-study Treatment Phase|Investigator decision|0|||
23196111|NCT00069095|64459840|FG002|Post-study Treatment Phase|Investigator decision|0|||
23196112|NCT00069095|64459841|FG003|Post-study Treatment Phase|Investigator decision|0|||
23196113|NCT00069095|64459842|FG004|Post-study Treatment Phase|Investigator decision|0|||
23196114|NCT00069095|64459843|FG005|Post-study Treatment Phase|Investigator decision|1|||
23196115|NCT00069095|64459838|FG000|Follow-up Phase|Death|174|||
23196116|NCT00069095|64459839|FG001|Follow-up Phase|Death|206|||
23196117|NCT00069095|64459840|FG002|Follow-up Phase|Death|120|||
23196118|NCT00069095|64459841|FG003|Follow-up Phase|Death|112|||
23196119|NCT00069095|64459842|FG004|Follow-up Phase|Death|92|||
23196120|NCT00069095|64459843|FG005|Follow-up Phase|Death|101|||
23196121|NCT01372878|64459844|FG000|Overall Study|Withdrawal by Subject|63|||
23196122|NCT01372878|64459844|FG000|Overall Study|Protocol Violation|17|||
23256593|NCT01677910|64680137|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
23256594|NCT01677910|64680138|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
23256595|NCT01677910|64680135|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23256596|NCT01677910|64680136|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23256597|NCT01677910|64680137|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23256598|NCT01677910|64680138|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
23256599|NCT01677910|64680135|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23256600|NCT01677910|64680136|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23256601|NCT01677910|64680137|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23256602|NCT01677910|64680138|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
23256603|NCT01677910|64680135|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23196123|NCT01372878|64459844|FG000|Overall Study|incomplete study procedure|104|||
23196124|NCT00546819|64459847|FG000|Overall Study|Adverse Event|2|||
23196125|NCT00546819|64459848|FG001|Overall Study|Adverse Event|3|||
23196126|NCT00546819|64459847|FG000|Overall Study|Lost to Follow-up|2|||
23256604|NCT01677910|64680136|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23480171|NCT00797966|65501917|FG003|Phase A|Met withdrawal criteria|0|||
23256605|NCT01677910|64680137|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23256606|NCT01677910|64680138|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
23256607|NCT01677910|64680135|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
23256608|NCT01677910|64680136|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
23256609|NCT01677910|64680137|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
23256610|NCT01677910|64680138|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
23256611|NCT01677910|64680135|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
23256612|NCT01677910|64680136|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
23480172|NCT00797966|65501918|FG004|Phase A|Met withdrawal criteria|4|||
23196127|NCT00546819|64459848|FG001|Overall Study|Lost to Follow-up|1|||
23196128|NCT00546819|64459847|FG000|Overall Study|Withdrawal by Subject|4|||
23196129|NCT00546819|64459848|FG001|Overall Study|Withdrawal by Subject|2|||
23196130|NCT00406315|64459849|FG000|Overall Study|Death|1|||
23196131|NCT00406315|64459849|FG000|Overall Study|Adverse Event|39|||
23196132|NCT00406315|64459849|FG000|Overall Study|Laboratory Abnormality|4|||
23196133|NCT00406315|64459849|FG000|Overall Study|Lack of Efficacy|13|||
23196134|NCT00406315|64459849|FG000|Overall Study|Other|33|||
23196135|NCT00406315|64459849|FG000|Overall Study|Lost to Follow-up|21|||
23196136|NCT00406315|64459849|FG000|Overall Study|Withdrawal by Subject|30|||
23196137|NCT01757704|64459850|FG000|Overall Study|Protocol Violation|1|||
23196138|NCT01757704|64459851|FG001|Overall Study|Protocol Violation|3|||
23196139|NCT02433210|64459852|FG000|Overall Study|Physician Decision|1|||
23196140|NCT02433210|64459853|FG001|Overall Study|Physician Decision|0|||
23196141|NCT02433210|64459854|FG002|Overall Study|Physician Decision|0|||
23196142|NCT01605071|64459855|FG000|Overall Study|Withdrawal by Subject|3|||
23196143|NCT01605071|64459856|FG001|Overall Study|Withdrawal by Subject|2|||
23196144|NCT02518620|64459859|FG000|Overall Study|Adverse Event|23|||
23196145|NCT02518620|64459860|FG001|Overall Study|Adverse Event|11|||
23196146|NCT02518620|64459859|FG000|Overall Study|Lack of Efficacy|2|||
23196147|NCT02518620|64459860|FG001|Overall Study|Lack of Efficacy|0|||
23196148|NCT02518620|64459859|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23196149|NCT02518620|64459860|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23196150|NCT02518620|64459859|FG000|Overall Study|Physician Decision|1|||
23196151|NCT02518620|64459860|FG001|Overall Study|Physician Decision|1|||
23196152|NCT02518620|64459859|FG000|Overall Study|Sponsor's Decision|0|||
23196153|NCT02518620|64459860|FG001|Overall Study|Sponsor's Decision|3|||
23196154|NCT02518620|64459859|FG000|Overall Study|Lost to Follow-up|1|||
23196155|NCT02518620|64459860|FG001|Overall Study|Lost to Follow-up|1|||
23196156|NCT02518620|64459859|FG000|Overall Study|Withdrawal by Subject|17|||
23196157|NCT02518620|64459860|FG001|Overall Study|Withdrawal by Subject|9|||
23196158|NCT02518620|64459859|FG000|Overall Study|Death|1|||
23196159|NCT02518620|64459860|FG001|Overall Study|Death|0|||
23196160|NCT02518620|64459859|FG000|Overall Study|Pregnancy Wish|3|||
23196161|NCT02518620|64459860|FG001|Overall Study|Pregnancy Wish|0|||
23196162|NCT02518620|64459859|FG000|Overall Study|Pregnancy|1|||
23196163|NCT02518620|64459860|FG001|Overall Study|Pregnancy|0|||
23196164|NCT02518620|64459859|FG000|Overall Study|Relocation|2|||
23196165|NCT02518620|64459860|FG001|Overall Study|Relocation|1|||
23196166|NCT01721369|64459863|FG000|Overall Study|Not initial etiological diagnosis|12|||
23196167|NCT00907478|64459864|FG000|Overall Study|Ineligibility determined|0|||
23196168|NCT00907478|64459865|FG001|Overall Study|Ineligibility determined|0|||
23196169|NCT00907478|64459866|FG002|Overall Study|Ineligibility determined|1|||
23196170|NCT00907478|64459864|FG000|Overall Study|Noncompliance|0|||
23256613|NCT01677910|64680137|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
23196171|NCT00907478|64459865|FG001|Overall Study|Noncompliance|0|||
23196172|NCT00907478|64459866|FG002|Overall Study|Noncompliance|1|||
23196173|NCT00907478|64459864|FG000|Overall Study|Adverse Event|3|||
23196174|NCT00907478|64459865|FG001|Overall Study|Adverse Event|1|||
23196175|NCT00907478|64459866|FG002|Overall Study|Adverse Event|2|||
23196176|NCT00907478|64459864|FG000|Overall Study|Withdrawal by Subject|8|||
23196177|NCT00907478|64459865|FG001|Overall Study|Withdrawal by Subject|9|||
23196178|NCT00907478|64459866|FG002|Overall Study|Withdrawal by Subject|6|||
23256614|NCT01677910|64680138|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
23196179|NCT00907478|64459864|FG000|Overall Study|Requirement for alternative therapy|1|||
23196180|NCT00907478|64459865|FG001|Overall Study|Requirement for alternative therapy|2|||
23196181|NCT00907478|64459866|FG002|Overall Study|Requirement for alternative therapy|3|||
23196182|NCT00907478|64459864|FG000|Overall Study|Physician Decision|2|||
23196183|NCT00907478|64459865|FG001|Overall Study|Physician Decision|0|||
23196184|NCT00907478|64459866|FG002|Overall Study|Physician Decision|3|||
23196185|NCT00907478|64459864|FG000|Overall Study|Death|4|||
23196186|NCT00907478|64459865|FG001|Overall Study|Death|2|||
23196187|NCT00907478|64459866|FG002|Overall Study|Death|1|||
23196188|NCT00907478|64459864|FG000|Overall Study|Protocol-specified criteria|5|||
23196189|NCT00907478|64459865|FG001|Overall Study|Protocol-specified criteria|2|||
23196190|NCT00907478|64459866|FG002|Overall Study|Protocol-specified criteria|3|||
23196191|NCT00907478|64459864|FG000|Overall Study|Pregnancy|0|||
23196192|NCT00907478|64459865|FG001|Overall Study|Pregnancy|1|||
23361072|NCT03311841|65065959|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
23196193|NCT00907478|64459866|FG002|Overall Study|Pregnancy|1|||
23196194|NCT00907478|64459864|FG000|Overall Study|Lost to Follow-up|1|||
23196195|NCT00907478|64459865|FG001|Overall Study|Lost to Follow-up|0|||
23196196|NCT00907478|64459866|FG002|Overall Study|Lost to Follow-up|0|||
23196197|NCT00907478|64459864|FG000|Overall Study|Other|3|||
23196198|NCT00907478|64459865|FG001|Overall Study|Other|0|||
23196199|NCT00907478|64459866|FG002|Overall Study|Other|1|||
23196200|NCT00092547|64459870|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
23196201|NCT00092547|64459871|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
23196202|NCT00092547|64459872|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
23196203|NCT00092547|64459870|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
23196204|NCT00092547|64459871|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
23196205|NCT00092547|64459872|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
23196206|NCT00092547|64459870|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
23196207|NCT00092547|64459871|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
23196208|NCT00092547|64459872|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
23196209|NCT00092547|64459870|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
23196210|NCT00092547|64459871|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
23196211|NCT00092547|64459872|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
23196212|NCT00092547|64459870|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
23196213|NCT00092547|64459871|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
23196214|NCT00092547|64459872|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
23196215|NCT00092547|64459870|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
23196216|NCT00092547|64459871|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
23196217|NCT00092547|64459872|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
23196218|NCT00092547|64459870|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
23196219|NCT00092547|64459871|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
23196220|NCT00092547|64459872|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
23196221|NCT00092547|64459870|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
23196222|NCT00092547|64459871|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
23196223|NCT00092547|64459872|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
23196224|NCT00092547|64459870|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
23599759|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
23599760|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
23599761|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
23599762|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Other|1|||
23599763|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Other|0|||
23599764|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Other|0|||
23599765|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
23599766|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
23599767|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
23599768|NCT00887224|65925699|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
23599769|NCT00887224|65925700|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
23599770|NCT00887224|65925701|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
23599771|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
23196225|NCT00092547|64459871|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
23196226|NCT00092547|64459872|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
23196227|NCT00092547|64459870|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
23361073|NCT03311841|65065960|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
23361074|NCT03311841|65065961|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
23599772|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
23599773|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
23599774|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
23599775|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
23196228|NCT00092547|64459871|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
23196229|NCT00092547|64459872|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
23196230|NCT00092547|64459870|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
23196231|NCT00092547|64459871|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
23196232|NCT00092547|64459872|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
23196233|NCT00092547|64459870|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
23196234|NCT00092547|64459871|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
23196235|NCT00092547|64459872|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
23196236|NCT00092547|64459870|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
23196237|NCT00092547|64459871|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
23196238|NCT00092547|64459872|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
23196239|NCT00092547|64459870|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
23196240|NCT00092547|64459871|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
23196241|NCT00092547|64459872|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
23196242|NCT00092547|64459870|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
23196243|NCT00092547|64459871|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
23196244|NCT00092547|64459872|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
23196245|NCT00092547|64459870|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
23196246|NCT00092547|64459871|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
23196247|NCT00092547|64459872|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
23196248|NCT00092547|64459870|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
23196249|NCT00092547|64459871|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
23196250|NCT00092547|64459872|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
23196251|NCT00092547|64459870|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
23196252|NCT00092547|64459871|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
23196253|NCT00092547|64459872|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
23196254|NCT00092547|64459870|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
23196255|NCT00092547|64459871|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
23196256|NCT00092547|64459872|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
23196257|NCT00092547|64459870|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
23196258|NCT00092547|64459871|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
23196259|NCT00092547|64459872|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
23196260|NCT00092547|64459870|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
23196261|NCT00092547|64459871|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
23196262|NCT00092547|64459872|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
23196263|NCT01152450|64459873|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
23196264|NCT01152450|64459874|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
23196265|NCT01152450|64459875|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
23196266|NCT01152450|64459876|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
23196267|NCT01152450|64459877|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
23196268|NCT01152450|64459878|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
23196269|NCT01152450|64459873|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
23196270|NCT01152450|64459874|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
23196271|NCT01152450|64459875|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
23196272|NCT01152450|64459876|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
23196273|NCT01152450|64459877|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
23196274|NCT01152450|64459878|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
23196275|NCT01152450|64459873|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23196276|NCT01152450|64459874|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
23196277|NCT01152450|64459875|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
23196278|NCT01152450|64459876|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23196279|NCT01152450|64459877|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23196280|NCT01152450|64459878|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
23196281|NCT00258154|64459879|FG000|Overall Study|Adverse Event|1|||
23196282|NCT00258154|64459880|FG001|Overall Study|Adverse Event|0|||
23196283|NCT00258154|64459879|FG000|Overall Study|Lost to Follow-up|0|||
23196284|NCT00258154|64459880|FG001|Overall Study|Lost to Follow-up|1|||
23196285|NCT00258154|64459879|FG000|Overall Study|Protocol Violation|2|||
23196286|NCT00258154|64459880|FG001|Overall Study|Protocol Violation|1|||
23196287|NCT00258154|64459879|FG000|Overall Study|Withdrawal by Subject|3|||
23196288|NCT00258154|64459880|FG001|Overall Study|Withdrawal by Subject|4|||
23196289|NCT00258154|64459879|FG000|Overall Study|Patient Moved|3|||
23196290|NCT00258154|64459880|FG001|Overall Study|Patient Moved|1|||
23196291|NCT00616239|64459881|FG000|Overall Study|Withdrawal by Subject|2|||
23256615|NCT02265952|64680139|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
23256616|NCT02265952|64680140|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
23256617|NCT02265952|64680139|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
23361075|NCT04058028|65065962|FG000|Overall Study|Withdrawal of Consent from Study|12|||
23361076|NCT04058028|65065963|FG001|Overall Study|Withdrawal of Consent from Study|8|||
23361077|NCT04058028|65065964|FG002|Overall Study|Withdrawal of Consent from Study|6|||
23196292|NCT03643432|64462515|FG000|Overall Study|Lost to Follow-up|1|||
23196293|NCT03643432|64462516|FG001|Overall Study|Lost to Follow-up|0|||
23196294|NCT00844428|64462517|FG000|Screening Period|Screen Failure|3|||
23196295|NCT00844428|64462517|FG000|Extension Treatment Period|Death|1|||
23196296|NCT00844428|64462517|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
23196297|NCT01905397|64462520|FG000|Overall Study|Death|0|||
23196298|NCT01905397|64462521|FG001|Overall Study|Death|1|||
23196299|NCT01905397|64462520|FG000|Overall Study|Withdrawal by Subject|2|||
23196300|NCT01905397|64462521|FG001|Overall Study|Withdrawal by Subject|0|||
23196301|NCT01905397|64462520|FG000|Overall Study|Surgery canceled/aborted|9|||
23196302|NCT01905397|64462521|FG001|Overall Study|Surgery canceled/aborted|5|||
23196303|NCT01905397|64462520|FG000|Overall Study|Incision < 7 cm|2|||
23196304|NCT01905397|64462521|FG001|Overall Study|Incision < 7 cm|0|||
23196305|NCT01905397|64462520|FG000|Overall Study|Wrong treatment|1|||
23196306|NCT01905397|64462521|FG001|Overall Study|Wrong treatment|1|||
23196307|NCT01905397|64462520|FG000|Overall Study|Device not applied|3|||
23196308|NCT01905397|64462521|FG001|Overall Study|Device not applied|0|||
23196309|NCT01905397|64462520|FG000|Overall Study|Dressing not applied in operating room|1|||
23196310|NCT01905397|64462521|FG001|Overall Study|Dressing not applied in operating room|0|||
23196311|NCT01905397|64462520|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
23196312|NCT01905397|64462521|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
23196313|NCT03844633|64462522|FG000|1 Week FU|Lost to Follow-up|0|||
23196314|NCT03844633|64462523|FG001|1 Week FU|Lost to Follow-up|1|||
23196315|NCT03844633|64462524|FG002|1 Week FU|Lost to Follow-up|4|||
23196316|NCT03844633|64462522|FG000|12-month Follow-up|Lost to Follow-up|7|||
23196317|NCT03844633|64462523|FG001|12-month Follow-up|Lost to Follow-up|5|||
23196318|NCT03844633|64462524|FG002|12-month Follow-up|Lost to Follow-up|8|||
23196319|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
23196320|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
23196321|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
23196322|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
23196323|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
23196324|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
23196325|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
23196326|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
23196327|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
23196328|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
23196329|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
23196330|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
23196331|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
23196332|NCT02232516|64462525|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
23196333|NCT02232516|64462525|FG000|Survival Follow-up|Death|15|||
23196334|NCT02232516|64462525|FG000|Survival Follow-up|Withdrawal by Subject|3|||
23196335|NCT02232516|64462525|FG000|Survival Follow-up|Lost to Follow-up|1|||
23196336|NCT02232516|64462525|FG000|Survival Follow-up|Still in follow-up|5|||
23196337|NCT05258058|64462528|FG000|Overall Study|Withdrawal by Subject|2|||
23196338|NCT01215734|64462529|FG000|Overall Study|Death|0|||
23196339|NCT01215734|64462530|FG001|Overall Study|Death|1|||
23196340|NCT02399813|64462534|FG000|Overall Study|Progressive Disease-Radiographic|2|||
23196341|NCT02399813|64462534|FG000|Overall Study|Death|20|||
23196342|NCT02399813|64462534|FG000|Overall Study|Withdrawal by Subject|3|||
23196343|NCT02399813|64462534|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
23196344|NCT02399813|64462534|FG000|Overall Study|Lost to Follow-up|2|||
23196345|NCT02399813|64462534|FG000|Overall Study|Other than specified|5|||
23196346|NCT01214434|64462541|FG000|Overall Study|Withdrawal by Subject|1|||
23196347|NCT01214434|64462542|FG001|Overall Study|Withdrawal by Subject|0|||
23196348|NCT01214434|64462541|FG000|Overall Study|Lost to Follow-up|2|||
23196349|NCT01214434|64462542|FG001|Overall Study|Lost to Follow-up|2|||
23196350|NCT01214434|64462541|FG000|Overall Study|Site error|1|||
23196351|NCT01214434|64462542|FG001|Overall Study|Site error|0|||
23196352|NCT01797783|64462543|FG000|Overall Study|Adverse Event|1|||
23196353|NCT01797783|64462544|FG001|Overall Study|Adverse Event|1|||
23196354|NCT01797783|64462543|FG000|Overall Study|Withdrawal by Subject|1|||
23196355|NCT01797783|64462544|FG001|Overall Study|Withdrawal by Subject|0|||
23196356|NCT00849693|64462545|FG000|Acute Treatment Phase|Adverse Event|12|||
23196357|NCT00849693|64462546|FG001|Acute Treatment Phase|Adverse Event|7|||
23196358|NCT00849693|64462547|FG002|Acute Treatment Phase|Adverse Event|6|||
23196359|NCT00849693|64462548|FG003|Acute Treatment Phase|Adverse Event|4|||
23196360|NCT00849693|64462545|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
23196361|NCT00849693|64462546|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
23196362|NCT00849693|64462547|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
23196363|NCT00849693|64462548|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
23196364|NCT00849693|64462545|FG000|Acute Treatment Phase|Protocol Violation|1|||
23196365|NCT00849693|64462546|FG001|Acute Treatment Phase|Protocol Violation|5|||
23196366|NCT00849693|64462547|FG002|Acute Treatment Phase|Protocol Violation|2|||
23196367|NCT00849693|64462548|FG003|Acute Treatment Phase|Protocol Violation|6|||
23196368|NCT00849693|64462545|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
23196369|NCT00849693|64462546|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
23196370|NCT00849693|64462547|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
23196371|NCT00849693|64462548|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
23196372|NCT00849693|64462545|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
23196373|NCT00849693|64462546|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
23196374|NCT00849693|64462547|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
23196375|NCT00849693|64462548|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
23196376|NCT00849693|64462545|FG000|Acute Treatment Phase|Physician Decision|2|||
23196377|NCT00849693|64462546|FG001|Acute Treatment Phase|Physician Decision|1|||
23196378|NCT00849693|64462547|FG002|Acute Treatment Phase|Physician Decision|2|||
23196379|NCT00849693|64462548|FG003|Acute Treatment Phase|Physician Decision|1|||
23196380|NCT00849693|64462545|FG000|Acute Treatment Phase|Sponsor decision|0|||
23196381|NCT00849693|64462546|FG001|Acute Treatment Phase|Sponsor decision|0|||
23196382|NCT00849693|64462547|FG002|Acute Treatment Phase|Sponsor decision|1|||
23196383|NCT00849693|64462548|FG003|Acute Treatment Phase|Sponsor decision|0|||
23196384|NCT00849693|64462545|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
23196385|NCT00849693|64462546|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
23196386|NCT00849693|64462547|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
23196387|NCT00849693|64462548|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
23196388|NCT00849693|64462545|FG000|Extension Phase|Adverse Event|4|||
23196389|NCT00849693|64462546|FG001|Extension Phase|Adverse Event|6|||
23196390|NCT00849693|64462547|FG002|Extension Phase|Adverse Event|3|||
23196391|NCT00849693|64462548|FG003|Extension Phase|Adverse Event|7|||
23196392|NCT00849693|64462545|FG000|Extension Phase|Lost to Follow-up|7|||
23196393|NCT00849693|64462546|FG001|Extension Phase|Lost to Follow-up|5|||
23196394|NCT00849693|64462547|FG002|Extension Phase|Lost to Follow-up|6|||
23196395|NCT00849693|64462548|FG003|Extension Phase|Lost to Follow-up|6|||
23196396|NCT00849693|64462545|FG000|Extension Phase|Protocol Violation|0|||
23196397|NCT00849693|64462546|FG001|Extension Phase|Protocol Violation|3|||
23196398|NCT00849693|64462547|FG002|Extension Phase|Protocol Violation|2|||
23196399|NCT00849693|64462548|FG003|Extension Phase|Protocol Violation|3|||
23196400|NCT00849693|64462545|FG000|Extension Phase|Withdrawal by Subject|6|||
23196401|NCT00849693|64462546|FG001|Extension Phase|Withdrawal by Subject|9|||
23196402|NCT00849693|64462547|FG002|Extension Phase|Withdrawal by Subject|10|||
23196403|NCT00849693|64462548|FG003|Extension Phase|Withdrawal by Subject|15|||
23196404|NCT00849693|64462545|FG000|Extension Phase|Parent or caregiver decision|9|||
23196405|NCT00849693|64462546|FG001|Extension Phase|Parent or caregiver decision|4|||
23196406|NCT00849693|64462547|FG002|Extension Phase|Parent or caregiver decision|10|||
23196407|NCT00849693|64462548|FG003|Extension Phase|Parent or caregiver decision|5|||
23196408|NCT00849693|64462545|FG000|Extension Phase|Physician Decision|1|||
23196409|NCT00849693|64462546|FG001|Extension Phase|Physician Decision|1|||
23196410|NCT00849693|64462547|FG002|Extension Phase|Physician Decision|2|||
23196411|NCT00849693|64462548|FG003|Extension Phase|Physician Decision|0|||
23196412|NCT00849693|64462545|FG000|Extension Phase|Sponsor decision|1|||
23196413|NCT00849693|64462546|FG001|Extension Phase|Sponsor decision|0|||
23196414|NCT00849693|64462547|FG002|Extension Phase|Sponsor decision|0|||
23196415|NCT00849693|64462548|FG003|Extension Phase|Sponsor decision|1|||
23196416|NCT00849693|64462545|FG000|Extension Phase|Lack of Efficacy|2|||
23196417|NCT00849693|64462546|FG001|Extension Phase|Lack of Efficacy|2|||
23196418|NCT00849693|64462547|FG002|Extension Phase|Lack of Efficacy|2|||
23196419|NCT00849693|64462548|FG003|Extension Phase|Lack of Efficacy|1|||
23196420|NCT02538666|64462549|FG000|Pre-Treatment|Disease progression|1|||
23196421|NCT02538666|64462550|FG001|Pre-Treatment|Disease progression|0|||
23196422|NCT02538666|64462551|FG002|Pre-Treatment|Disease progression|0|||
23196423|NCT02538666|64462549|FG000|Pre-Treatment|no longer meets study criteria|1|||
23196424|NCT02538666|64462550|FG001|Pre-Treatment|no longer meets study criteria|0|||
23196425|NCT02538666|64462551|FG002|Pre-Treatment|no longer meets study criteria|0|||
23196426|NCT02538666|64462549|FG000|Pre-Treatment|Withdrew Consent|0|||
23196427|NCT02538666|64462550|FG001|Pre-Treatment|Withdrew Consent|1|||
23196428|NCT02538666|64462551|FG002|Pre-Treatment|Withdrew Consent|1|||
23196429|NCT02538666|64462549|FG000|Treatment|Disease progression|270|||
23196430|NCT02538666|64462550|FG001|Treatment|Disease progression|227|||
23196431|NCT02538666|64462551|FG002|Treatment|Disease progression|165|||
23196432|NCT02538666|64462549|FG000|Treatment|Study drug toxicity|1|||
23196433|NCT02538666|64462550|FG001|Treatment|Study drug toxicity|29|||
23196434|NCT02538666|64462551|FG002|Treatment|Study drug toxicity|92|||
23196435|NCT02538666|64462549|FG000|Treatment|Death|0|||
23196436|NCT02538666|64462550|FG001|Treatment|Death|2|||
23196437|NCT02538666|64462551|FG002|Treatment|Death|3|||
23196438|NCT02538666|64462549|FG000|Treatment|Adverse event unrelated to study drug|8|||
23196439|NCT02538666|64462550|FG001|Treatment|Adverse event unrelated to study drug|10|||
23196440|NCT02538666|64462551|FG002|Treatment|Adverse event unrelated to study drug|15|||
23196441|NCT02538666|64462549|FG000|Treatment|Participant request to discontinue study treatment|3|||
23196442|NCT02538666|64462550|FG001|Treatment|Participant request to discontinue study treatment|6|||
23196443|NCT02538666|64462551|FG002|Treatment|Participant request to discontinue study treatment|11|||
23196444|NCT02538666|64462549|FG000|Treatment|Participant withdrew consent|2|||
23196445|NCT02538666|64462550|FG001|Treatment|Participant withdrew consent|5|||
23196446|NCT02538666|64462551|FG002|Treatment|Participant withdrew consent|3|||
23196447|NCT02538666|64462549|FG000|Treatment|Lost to Follow-up|0|||
23196448|NCT02538666|64462550|FG001|Treatment|Lost to Follow-up|1|||
23196449|NCT02538666|64462551|FG002|Treatment|Lost to Follow-up|1|||
23196450|NCT02538666|64462549|FG000|Treatment|Maximum clinical benefit|4|||
23196451|NCT02538666|64462550|FG001|Treatment|Maximum clinical benefit|3|||
23196452|NCT02538666|64462551|FG002|Treatment|Maximum clinical benefit|4|||
23196453|NCT02538666|64462549|FG000|Treatment|Poor/non-compliance|0|||
23196454|NCT02538666|64462550|FG001|Treatment|Poor/non-compliance|1|||
23196455|NCT02538666|64462551|FG002|Treatment|Poor/non-compliance|0|||
23196456|NCT02538666|64462549|FG000|Treatment|Participant no longer meets study criteria|0|||
23196457|NCT02538666|64462550|FG001|Treatment|Participant no longer meets study criteria|2|||
23196458|NCT02538666|64462551|FG002|Treatment|Participant no longer meets study criteria|0|||
23196459|NCT02538666|64462549|FG000|Treatment|Administrative reason by sponsor|0|||
23196460|NCT02538666|64462550|FG001|Treatment|Administrative reason by sponsor|0|||
23196461|NCT02538666|64462551|FG002|Treatment|Administrative reason by sponsor|1|||
23196462|NCT02538666|64462549|FG000|Treatment|Other reasons|8|||
23196463|NCT02538666|64462550|FG001|Treatment|Other reasons|15|||
23196464|NCT02538666|64462551|FG002|Treatment|Other reasons|5|||
23196465|NCT02538666|64462549|FG000|Treatment|Not reported|2|||
23196466|NCT02538666|64462550|FG001|Treatment|Not reported|2|||
23196467|NCT02538666|64462551|FG002|Treatment|Not reported|2|||
23196468|NCT00858702|64462552|FG000|Overall Study|Lack of Efficacy|1|||
23196469|NCT00858702|64462553|FG001|Overall Study|Lack of Efficacy|0|||
23196470|NCT00858702|64462552|FG000|Overall Study|Protocol Violation|1|||
23256618|NCT02265952|64680140|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
23256619|NCT03077828|64680141|FG000|Treatment Cycles|Death|1|||
23256620|NCT03077828|64680141|FG000|Treatment Cycles|Withdrawal by Subject|1|||
23256621|NCT03077828|64680141|FG000|Treatment Cycles|Screen Fail|2|||
23256622|NCT03077828|64680141|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
23256623|NCT03077828|64680141|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
23256624|NCT03077828|64680141|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
23256625|NCT03077828|64680141|FG000|Follow-up|Patients still in follow-up|15|||
23256626|NCT02521948|64680142|FG000|Overall Study|Adverse Event|2|||
23256627|NCT02521948|64680142|FG000|Overall Study|Death|4|||
23256628|NCT02521948|64680142|FG000|Overall Study|Lost to Follow-up|1|||
23256629|NCT02521948|64680142|FG000|Overall Study|Did not attend one or both follow-ups|6|||
23256630|NCT03862625|64680143|FG000|Overall Study|Lost to Follow-up|0|||
23256631|NCT03862625|64680144|FG001|Overall Study|Lost to Follow-up|1|||
23256632|NCT03083132|64680145|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
23256633|NCT03083132|64680146|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
23256634|NCT03083132|64680145|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
23256635|NCT03083132|64680146|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
23256636|NCT03083132|64680145|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
23256637|NCT03083132|64680146|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
23256638|NCT03740698|64680149|FG000|Overall Study|Physician Decision|0|||
23256639|NCT03740698|64680150|FG001|Overall Study|Physician Decision|1|||
23256640|NCT03740698|64680151|FG002|Overall Study|Physician Decision|1|||
23256641|NCT02995837|64683559|FG000|Overall Study|Lost to Follow-up|9|||
23256642|NCT02995837|64683560|FG001|Overall Study|Lost to Follow-up|8|||
23256643|NCT01904383|64683561|FG000|Overall Study|CRF not collected|117|||
23256644|NCT01904383|64683561|FG000|Overall Study|Reason not listed|147|||
23256645|NCT01904383|64683561|FG000|Overall Study|Lost to Follow-up|674|||
23256646|NCT01904383|64683561|FG000|Overall Study|Lack of Efficacy|370|||
23256647|NCT01904383|64683561|FG000|Overall Study|Improvement|141|||
23256648|NCT01904383|64683561|FG000|Overall Study|Adverse Event|271|||
23256649|NCT01904383|64683561|FG000|Overall Study|No patient visit after entry|54|||
23256650|NCT01254045|64683562|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
23196471|NCT00858702|64462553|FG001|Overall Study|Protocol Violation|1|||
23256651|NCT01254045|64683563|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23256652|NCT01254045|64683564|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23196472|NCT00858702|64462552|FG000|Overall Study|Other|2|||
23196473|NCT00858702|64462553|FG001|Overall Study|Other|1|||
23196474|NCT00858702|64462552|FG000|Overall Study|Withdrawal by Subject|1|||
23196475|NCT00858702|64462553|FG001|Overall Study|Withdrawal by Subject|0|||
23196476|NCT00001262|64462554|FG000|Overall Study|Death|10|||
23196477|NCT00001262|64462555|FG001|Overall Study|Death|11|||
23196478|NCT00001262|64462556|FG002|Overall Study|Death|0|||
23256653|NCT01254045|64683565|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23256654|NCT01254045|64683566|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23196479|NCT00001262|64462554|FG000|Overall Study|Withdrawal by Subject|0|||
23256655|NCT01254045|64683567|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
23196480|NCT00001262|64462555|FG001|Overall Study|Withdrawal by Subject|3|||
23196481|NCT00001262|64462556|FG002|Overall Study|Withdrawal by Subject|0|||
23196482|NCT03229759|64462557|FG000|Overall Study|Screen Failure|30|||
23196483|NCT00798967|64462558|FG000|Overall Study|Adverse Event|2|||
23196484|NCT00798967|64462559|FG001|Overall Study|Adverse Event|3|||
23196485|NCT00798967|64462558|FG000|Overall Study|Withdrawal by Subject|0|||
23196486|NCT00798967|64462559|FG001|Overall Study|Withdrawal by Subject|1|||
23196487|NCT00798967|64462558|FG000|Overall Study|Physician Decision|1|||
23196488|NCT00798967|64462559|FG001|Overall Study|Physician Decision|0|||
23196489|NCT00798967|64462558|FG000|Overall Study|Randomized in error by site|1|||
23196490|NCT00798967|64462559|FG001|Overall Study|Randomized in error by site|0|||
23196491|NCT01678807|64462564|FG000|Overall Study|Adverse Event|4|||
23196492|NCT01678807|64462565|FG001|Overall Study|Adverse Event|4|||
23196493|NCT01678807|64462566|FG002|Overall Study|Adverse Event|0|||
23196494|NCT01678807|64462564|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
23196495|NCT01678807|64462565|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
23196496|NCT01678807|64462566|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
23196497|NCT01097616|64462567|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
23196498|NCT01097616|64462568|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
23196499|NCT01097616|64462569|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
23196500|NCT01097616|64462570|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23196501|NCT01097616|64462571|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23196502|NCT01097616|64462572|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23196503|NCT01097616|64462573|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23196504|NCT01097616|64462574|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
23196505|NCT01097616|64462567|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
23196506|NCT01097616|64462568|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
23196507|NCT01097616|64462569|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
23196508|NCT01097616|64462570|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23196509|NCT01097616|64462571|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23196510|NCT01097616|64462572|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23196511|NCT01097616|64462573|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23196512|NCT01097616|64462574|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
23196513|NCT01097616|64462567|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
23196514|NCT01097616|64462568|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
23196515|NCT01097616|64462569|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
23196516|NCT01097616|64462570|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23196517|NCT01097616|64462571|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23196518|NCT01097616|64462572|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23196519|NCT01097616|64462573|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23196520|NCT01097616|64462574|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
23196521|NCT01097616|64462567|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
23196522|NCT01097616|64462568|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
23196523|NCT01097616|64462569|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23196524|NCT01097616|64462570|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23196525|NCT01097616|64462571|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23196526|NCT01097616|64462572|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23196527|NCT01097616|64462573|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23196528|NCT01097616|64462574|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
23196529|NCT01097616|64462567|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
23196530|NCT01097616|64462568|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
23196531|NCT01097616|64462569|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
23196532|NCT01097616|64462570|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23196533|NCT01097616|64462571|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23196534|NCT01097616|64462572|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23196535|NCT01097616|64462573|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23196536|NCT01097616|64462574|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
23196537|NCT01097616|64462567|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
23196538|NCT01097616|64462568|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
23196539|NCT01097616|64462569|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23196540|NCT01097616|64462570|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23196541|NCT01097616|64462571|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23196542|NCT01097616|64462572|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23196543|NCT01097616|64462573|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23196544|NCT01097616|64462574|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
23196545|NCT01097616|64462567|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
23599776|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
23196546|NCT01097616|64462568|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
23196547|NCT01097616|64462569|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23196548|NCT01097616|64462570|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23196549|NCT01097616|64462571|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23196550|NCT01097616|64462572|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23196551|NCT01097616|64462573|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23196552|NCT01097616|64462574|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
23196553|NCT01097616|64462567|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23196554|NCT01097616|64462568|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23196555|NCT01097616|64462569|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
23196556|NCT01097616|64462570|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23196557|NCT01097616|64462571|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23196558|NCT01097616|64462572|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23196559|NCT01097616|64462573|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23196560|NCT01097616|64462574|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
23196561|NCT01097616|64462567|FG000|Optional DB EXT Phase|Adverse Event|0|||
23196562|NCT01097616|64462568|FG001|Optional DB EXT Phase|Adverse Event|7|||
23196563|NCT01097616|64462569|FG002|Optional DB EXT Phase|Adverse Event|2|||
23196564|NCT01097616|64462570|FG003|Optional DB EXT Phase|Adverse Event|0|||
23196565|NCT01097616|64462571|FG004|Optional DB EXT Phase|Adverse Event|0|||
23196566|NCT01097616|64462572|FG005|Optional DB EXT Phase|Adverse Event|0|||
23196567|NCT01097616|64462573|FG006|Optional DB EXT Phase|Adverse Event|0|||
23196568|NCT01097616|64462574|FG007|Optional DB EXT Phase|Adverse Event|0|||
23196569|NCT01097616|64462567|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
23196570|NCT01097616|64462568|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
23196571|NCT01097616|64462569|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
23196572|NCT01097616|64462570|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
23196573|NCT01097616|64462571|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
23196574|NCT01097616|64462572|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
23196575|NCT01097616|64462573|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
23196576|NCT01097616|64462574|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
23196577|NCT01097616|64462567|FG000|Optional DB EXT Phase|Protocol Violation|0|||
23196578|NCT01097616|64462568|FG001|Optional DB EXT Phase|Protocol Violation|2|||
23196579|NCT01097616|64462569|FG002|Optional DB EXT Phase|Protocol Violation|3|||
23196580|NCT01097616|64462570|FG003|Optional DB EXT Phase|Protocol Violation|0|||
23196581|NCT01097616|64462571|FG004|Optional DB EXT Phase|Protocol Violation|0|||
23196582|NCT01097616|64462572|FG005|Optional DB EXT Phase|Protocol Violation|0|||
23196583|NCT01097616|64462573|FG006|Optional DB EXT Phase|Protocol Violation|0|||
23196584|NCT01097616|64462574|FG007|Optional DB EXT Phase|Protocol Violation|0|||
23196585|NCT01097616|64462567|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
23196586|NCT01097616|64462568|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
23196587|NCT01097616|64462569|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
23196588|NCT01097616|64462570|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
23196589|NCT01097616|64462571|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
23196590|NCT01097616|64462572|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
23196591|NCT01097616|64462573|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
23196592|NCT01097616|64462574|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
23196593|NCT01097616|64462567|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
23196594|NCT01097616|64462568|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
23196595|NCT01097616|64462569|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
23196596|NCT01097616|64462570|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
23196597|NCT01097616|64462571|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
23196598|NCT01097616|64462572|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
23196599|NCT01097616|64462573|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
23196600|NCT01097616|64462574|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
23196601|NCT01097616|64462567|FG000|Optional DB EXT Phase|Physician Decision|1|||
23196602|NCT01097616|64462568|FG001|Optional DB EXT Phase|Physician Decision|0|||
23196603|NCT01097616|64462569|FG002|Optional DB EXT Phase|Physician Decision|0|||
23196604|NCT01097616|64462570|FG003|Optional DB EXT Phase|Physician Decision|0|||
23196605|NCT01097616|64462571|FG004|Optional DB EXT Phase|Physician Decision|0|||
23196606|NCT01097616|64462572|FG005|Optional DB EXT Phase|Physician Decision|0|||
23196607|NCT01097616|64462573|FG006|Optional DB EXT Phase|Physician Decision|0|||
23256656|NCT01084603|64683568|FG000|Baseline|Withdrawal by Subject|2|||
23256657|NCT01084603|64683568|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
23256658|NCT01084603|64683568|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
23256659|NCT01084603|64683568|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
23256660|NCT01084603|64683568|FG000|Washout Period 4|Adverse Event|1|||
23256661|NCT01102777|64683573|FG000|Overall Study|Death|2|||
23256662|NCT01102777|64683574|FG001|Overall Study|Death|6|||
23256663|NCT01102777|64683573|FG000|Overall Study|Lost to Follow-up|7|||
23256664|NCT01102777|64683574|FG001|Overall Study|Lost to Follow-up|10|||
23256665|NCT01859390|64683575|FG000|Overall Study|Insufficient Sputum Collected|1|||
23196608|NCT01097616|64462574|FG007|Optional DB EXT Phase|Physician Decision|0|||
23196609|NCT01097616|64462567|FG000|DB RO Phase|Adverse Event|0|||
23196610|NCT01097616|64462568|FG001|DB RO Phase|Adverse Event|0|||
23196611|NCT01097616|64462569|FG002|DB RO Phase|Adverse Event|0|||
23480173|NCT00797966|65501919|FG005|Phase A|Met withdrawal criteria|0|||
23480174|NCT00797966|65501914|FG000|Phase A|Physician Decision|0|||
23480175|NCT00797966|65501915|FG001|Phase A|Physician Decision|0|||
23480176|NCT00797966|65501916|FG002|Phase A|Physician Decision|0|||
23480177|NCT00797966|65501917|FG003|Phase A|Physician Decision|0|||
23480178|NCT00797966|65501918|FG004|Phase A|Physician Decision|13|||
23480179|NCT00797966|65501919|FG005|Phase A|Physician Decision|0|||
23480180|NCT00797966|65501914|FG000|Phase A|Withdrawal by Subject|0|||
23480181|NCT00797966|65501915|FG001|Phase A|Withdrawal by Subject|0|||
23480182|NCT00797966|65501916|FG002|Phase A|Withdrawal by Subject|0|||
23480183|NCT00797966|65501917|FG003|Phase A|Withdrawal by Subject|0|||
23480184|NCT00797966|65501918|FG004|Phase A|Withdrawal by Subject|33|||
23480185|NCT00797966|65501919|FG005|Phase A|Withdrawal by Subject|0|||
23480186|NCT00797966|65501914|FG000|Phase A|Protocol deviation|0|||
23480187|NCT00797966|65501915|FG001|Phase A|Protocol deviation|0|||
23480188|NCT00797966|65501916|FG002|Phase A|Protocol deviation|0|||
23480189|NCT00797966|65501917|FG003|Phase A|Protocol deviation|0|||
23480190|NCT00797966|65501918|FG004|Phase A|Protocol deviation|56|||
23480191|NCT00797966|65501919|FG005|Phase A|Protocol deviation|0|||
23480192|NCT00797966|65501914|FG000|Phase B|Lost to Follow-up|0|||
23480193|NCT00797966|65501915|FG001|Phase B|Lost to Follow-up|1|||
23480194|NCT00797966|65501916|FG002|Phase B|Lost to Follow-up|3|||
23480195|NCT00797966|65501917|FG003|Phase B|Lost to Follow-up|0|||
23480196|NCT00797966|65501918|FG004|Phase B|Lost to Follow-up|0|||
23480197|NCT00797966|65501919|FG005|Phase B|Lost to Follow-up|0|||
23480198|NCT00797966|65501914|FG000|Phase B|Adverse Event|2|||
23480199|NCT00797966|65501915|FG001|Phase B|Adverse Event|1|||
23480200|NCT00797966|65501916|FG002|Phase B|Adverse Event|3|||
23480201|NCT00797966|65501917|FG003|Phase B|Adverse Event|1|||
23480202|NCT00797966|65501918|FG004|Phase B|Adverse Event|0|||
23480203|NCT00797966|65501919|FG005|Phase B|Adverse Event|0|||
23480204|NCT00797966|65501914|FG000|Phase B|Met Withdrawal Criteria|3|||
23480205|NCT00797966|65501915|FG001|Phase B|Met Withdrawal Criteria|3|||
23480206|NCT00797966|65501916|FG002|Phase B|Met Withdrawal Criteria|6|||
23480207|NCT00797966|65501917|FG003|Phase B|Met Withdrawal Criteria|1|||
23480208|NCT00797966|65501918|FG004|Phase B|Met Withdrawal Criteria|0|||
23480209|NCT00797966|65501919|FG005|Phase B|Met Withdrawal Criteria|0|||
23480210|NCT00797966|65501914|FG000|Phase B|Physician Decision|1|||
23480211|NCT00797966|65501915|FG001|Phase B|Physician Decision|0|||
23480212|NCT00797966|65501916|FG002|Phase B|Physician Decision|3|||
23480213|NCT00797966|65501917|FG003|Phase B|Physician Decision|1|||
23480214|NCT00797966|65501918|FG004|Phase B|Physician Decision|0|||
23480215|NCT00797966|65501919|FG005|Phase B|Physician Decision|0|||
23480216|NCT00797966|65501914|FG000|Phase B|Withdrawal by Subject|1|||
23480217|NCT00797966|65501915|FG001|Phase B|Withdrawal by Subject|4|||
23480218|NCT00797966|65501916|FG002|Phase B|Withdrawal by Subject|3|||
23480219|NCT00797966|65501917|FG003|Phase B|Withdrawal by Subject|3|||
23480220|NCT00797966|65501918|FG004|Phase B|Withdrawal by Subject|0|||
23480221|NCT00797966|65501919|FG005|Phase B|Withdrawal by Subject|0|||
23480222|NCT00797966|65501914|FG000|Phase B|Protocol Deviation|4|||
23480223|NCT00797966|65501915|FG001|Phase B|Protocol Deviation|8|||
23480224|NCT00797966|65501916|FG002|Phase B|Protocol Deviation|2|||
23480225|NCT00797966|65501917|FG003|Phase B|Protocol Deviation|6|||
23196612|NCT01097616|64462570|FG003|DB RO Phase|Adverse Event|0|||
23480226|NCT00797966|65501918|FG004|Phase B|Protocol Deviation|0|||
23480227|NCT00797966|65501919|FG005|Phase B|Protocol Deviation|0|||
23480228|NCT00797966|65501914|FG000|Phase B|Lack of Efficacy|0|||
23480229|NCT00797966|65501915|FG001|Phase B|Lack of Efficacy|1|||
23480230|NCT00797966|65501916|FG002|Phase B|Lack of Efficacy|1|||
23480231|NCT00797966|65501917|FG003|Phase B|Lack of Efficacy|4|||
23480232|NCT00797966|65501918|FG004|Phase B|Lack of Efficacy|0|||
23480233|NCT00797966|65501919|FG005|Phase B|Lack of Efficacy|0|||
23196613|NCT01097616|64462571|FG004|DB RO Phase|Adverse Event|0|||
23196614|NCT01097616|64462572|FG005|DB RO Phase|Adverse Event|0|||
23196615|NCT01097616|64462573|FG006|DB RO Phase|Adverse Event|1|||
23196616|NCT01097616|64462574|FG007|DB RO Phase|Adverse Event|0|||
23196617|NCT01097616|64462567|FG000|DB RO Phase|Withdrawal by Subject|0|||
23196618|NCT01097616|64462568|FG001|DB RO Phase|Withdrawal by Subject|0|||
23196619|NCT01097616|64462569|FG002|DB RO Phase|Withdrawal by Subject|0|||
23196620|NCT01097616|64462570|FG003|DB RO Phase|Withdrawal by Subject|0|||
23196621|NCT01097616|64462571|FG004|DB RO Phase|Withdrawal by Subject|0|||
23196622|NCT01097616|64462572|FG005|DB RO Phase|Withdrawal by Subject|1|||
23196623|NCT01097616|64462573|FG006|DB RO Phase|Withdrawal by Subject|0|||
23196624|NCT01097616|64462574|FG007|DB RO Phase|Withdrawal by Subject|0|||
23196625|NCT01097616|64462567|FG000|DB RO Phase|Lost to Follow-up|0|||
23196626|NCT01097616|64462568|FG001|DB RO Phase|Lost to Follow-up|0|||
23196627|NCT01097616|64462569|FG002|DB RO Phase|Lost to Follow-up|0|||
23196628|NCT01097616|64462570|FG003|DB RO Phase|Lost to Follow-up|1|||
23196629|NCT01097616|64462571|FG004|DB RO Phase|Lost to Follow-up|1|||
23196630|NCT01097616|64462572|FG005|DB RO Phase|Lost to Follow-up|0|||
23196631|NCT01097616|64462573|FG006|DB RO Phase|Lost to Follow-up|0|||
23196632|NCT01097616|64462574|FG007|DB RO Phase|Lost to Follow-up|1|||
23196633|NCT01097616|64462567|FG000|DB RO Phase|Not Treated in RO|0|||
23196634|NCT01097616|64462568|FG001|DB RO Phase|Not Treated in RO|0|||
23196635|NCT01097616|64462569|FG002|DB RO Phase|Not Treated in RO|0|||
23196636|NCT01097616|64462570|FG003|DB RO Phase|Not Treated in RO|0|||
23196637|NCT01097616|64462571|FG004|DB RO Phase|Not Treated in RO|0|||
23196638|NCT01097616|64462572|FG005|DB RO Phase|Not Treated in RO|1|||
23196639|NCT01097616|64462573|FG006|DB RO Phase|Not Treated in RO|0|||
23196640|NCT01097616|64462574|FG007|DB RO Phase|Not Treated in RO|0|||
23196641|NCT01454401|64462575|FG000|Overall Study|Death|1|||
23196642|NCT01454401|64462575|FG000|Overall Study|hospitalised|1|||
23196643|NCT01454401|64462575|FG000|Overall Study|osteomyelitis|2|||
23196644|NCT01454401|64462575|FG000|Overall Study|non-adherence|1|||
23196645|NCT01703819|64462580|FG000|Overall Study|Adverse Event|0|||
23196646|NCT01703819|64462581|FG001|Overall Study|Adverse Event|1|||
23196647|NCT01703819|64462580|FG000|Overall Study|Withdrawal by Subject|0|||
23196648|NCT01703819|64462581|FG001|Overall Study|Withdrawal by Subject|1|||
23196649|NCT02564120|64462584|FG000|Overall Study|Did not return release forms|160|||
23196650|NCT02564120|64462584|FG000|Overall Study|Death|58|||
23196651|NCT02564120|64462584|FG000|Overall Study|Withdrawal by Subject|204|||
23196652|NCT02564120|64462584|FG000|Overall Study|Other medical condition|24|||
23196653|NCT00651118|64462587|FG000|Overall Study|Adverse Event|4|||
23196654|NCT00651118|64462588|FG001|Overall Study|Adverse Event|0|||
23196655|NCT00651118|64462589|FG002|Overall Study|Adverse Event|1|||
23196656|NCT00651118|64462590|FG003|Overall Study|Adverse Event|1|||
23196657|NCT00651118|64462587|FG000|Overall Study|Protocol Violation|2|||
23196658|NCT00651118|64462588|FG001|Overall Study|Protocol Violation|2|||
23196659|NCT00651118|64462589|FG002|Overall Study|Protocol Violation|6|||
23196660|NCT00651118|64462590|FG003|Overall Study|Protocol Violation|2|||
23196661|NCT00651118|64462587|FG000|Overall Study|Lost to Follow-up|2|||
23196662|NCT00651118|64462588|FG001|Overall Study|Lost to Follow-up|0|||
23196663|NCT00651118|64462589|FG002|Overall Study|Lost to Follow-up|1|||
23196664|NCT00651118|64462590|FG003|Overall Study|Lost to Follow-up|2|||
23196665|NCT00651118|64462587|FG000|Overall Study|administrative|1|||
23196666|NCT00651118|64462588|FG001|Overall Study|administrative|4|||
23196667|NCT00651118|64462589|FG002|Overall Study|administrative|2|||
23196668|NCT00651118|64462590|FG003|Overall Study|administrative|1|||
23196669|NCT00651118|64462587|FG000|Overall Study|Withdrawal by Subject|0|||
23196670|NCT00651118|64462588|FG001|Overall Study|Withdrawal by Subject|1|||
23196671|NCT00651118|64462589|FG002|Overall Study|Withdrawal by Subject|1|||
23196672|NCT00651118|64462590|FG003|Overall Study|Withdrawal by Subject|1|||
23196673|NCT02190435|64462594|FG000|Overall Study|First 12 patients were lead-ins|12|||
23196674|NCT02190435|64462595|FG001|Overall Study|First 12 patients were lead-ins|0|||
23196675|NCT02190435|64462594|FG000|Overall Study|3 consented screen fails|3|||
23196676|NCT02190435|64462595|FG001|Overall Study|3 consented screen fails|0|||
23256666|NCT01859390|64683576|FG001|Overall Study|Insufficient Sputum Collected|3|||
23256667|NCT01859390|64683575|FG000|Overall Study|Sample Missing Collection Date|0|||
23196677|NCT00950690|64462597|FG000|Overall Study|Death|4|||
23196678|NCT00950690|64462597|FG000|Overall Study|Adverse Event|15|||
23196679|NCT00950690|64462597|FG000|Overall Study|Lack of Efficacy|22|||
23256668|NCT01859390|64683576|FG001|Overall Study|Sample Missing Collection Date|1|||
23256669|NCT01859390|64683575|FG000|Overall Study|Tube Cracked|0|||
23480234|NCT00797966|65501914|FG000|Phase A+|Lost to Follow-up|0|||
23196680|NCT00950690|64462597|FG000|Overall Study|Lost to Follow-up|40|||
23196681|NCT00950690|64462597|FG000|Overall Study|Other|163|||
23196682|NCT01323673|64462598|FG000|Overall Study|Adverse Event|0|||
23196683|NCT01323673|64462599|FG001|Overall Study|Adverse Event|1|||
23196684|NCT01323673|64462598|FG000|Overall Study|Lost to Follow-up|0|||
23196685|NCT01323673|64462599|FG001|Overall Study|Lost to Follow-up|1|||
23196686|NCT01323673|64462598|FG000|Overall Study|Protocol Violation|1|||
23196687|NCT01323673|64462599|FG001|Overall Study|Protocol Violation|0|||
23256670|NCT01859390|64683576|FG001|Overall Study|Tube Cracked|2|||
23256671|NCT01859390|64683575|FG000|Overall Study|Shipment Error|0|||
23256672|NCT01859390|64683576|FG001|Overall Study|Shipment Error|1|||
23256673|NCT01835132|64683577|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
23256674|NCT00707174|64683578|FG000|Overall Study|Adverse Event|1|||
23256675|NCT00707174|64683579|FG001|Overall Study|Adverse Event|6|||
23256676|NCT00707174|64683578|FG000|Overall Study|Withdrawal by Subject|4|||
23256677|NCT00707174|64683579|FG001|Overall Study|Withdrawal by Subject|1|||
23256678|NCT02354976|64683580|FG000|Overall Study|Other - reason not specified|1|||
23256679|NCT02354976|64683581|FG001|Overall Study|Other - reason not specified|0|||
23256680|NCT02354976|64683582|FG002|Overall Study|Other - reason not specified|1|||
23256681|NCT02354976|64683580|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
23256682|NCT02354976|64683581|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
23256683|NCT02354976|64683582|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
23256684|NCT02354976|64683580|FG000|Overall Study|Adverse Event|1|||
23256685|NCT02354976|64683581|FG001|Overall Study|Adverse Event|0|||
23256686|NCT02354976|64683582|FG002|Overall Study|Adverse Event|2|||
23256687|NCT02675426|64683583|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
23256688|NCT02675426|64683584|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
23256689|NCT02675426|64683585|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
23256690|NCT02675426|64683586|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
23256691|NCT02675426|64683583|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
23256692|NCT02675426|64683584|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
23256693|NCT02675426|64683585|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
23256694|NCT02675426|64683586|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
23256695|NCT02675426|64683583|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
23256696|NCT02675426|64683584|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
23256697|NCT02675426|64683585|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
23480235|NCT00797966|65501915|FG001|Phase A+|Lost to Follow-up|0|||
23196688|NCT01323673|64462598|FG000|Overall Study|Withdrawal by Subject|2|||
23196689|NCT01323673|64462599|FG001|Overall Study|Withdrawal by Subject|3|||
23196690|NCT00718861|64462600|FG000|Overall Study|Withdrawal by Subject|15|||
23196691|NCT00718861|64462601|FG001|Overall Study|Withdrawal by Subject|10|||
23196692|NCT00718861|64462600|FG000|Overall Study|Adverse Event|2|||
23196693|NCT00718861|64462601|FG001|Overall Study|Adverse Event|1|||
23196694|NCT00718861|64462600|FG000|Overall Study|Lost to Follow-up|2|||
23196695|NCT00718861|64462601|FG001|Overall Study|Lost to Follow-up|1|||
23196696|NCT00718861|64462600|FG000|Overall Study|Administrative Problems|1|||
23196697|NCT00718861|64462601|FG001|Overall Study|Administrative Problems|1|||
23196698|NCT00718861|64462600|FG000|Overall Study|Death|1|||
23196699|NCT00718861|64462601|FG001|Overall Study|Death|5|||
23196700|NCT02582749|64462602|FG000|Overall Study|Study terminated by funder|5|||
23196701|NCT02582749|64462603|FG001|Overall Study|Study terminated by funder|10|||
23196702|NCT02582749|64462602|FG000|Overall Study|Withdrawal by Subject|0|||
23196703|NCT02582749|64462603|FG001|Overall Study|Withdrawal by Subject|1|||
23196704|NCT04973228|64462610|FG000|Overall Study|Adverse Event|2|||
23196705|NCT04973228|64462611|FG001|Overall Study|Adverse Event|3|||
23196706|NCT04973228|64462610|FG000|Overall Study|Lack of Efficacy|1|||
23196707|NCT04973228|64462611|FG001|Overall Study|Lack of Efficacy|3|||
23196708|NCT04973228|64462610|FG000|Overall Study|Lost to Follow-up|12|||
23196709|NCT04973228|64462611|FG001|Overall Study|Lost to Follow-up|4|||
23196710|NCT04973228|64462610|FG000|Overall Study|Withdrawal by Subject|11|||
23196711|NCT04973228|64462611|FG001|Overall Study|Withdrawal by Subject|4|||
23196712|NCT04973228|64462610|FG000|Overall Study|Did not tolerate application|1|||
23196713|NCT04973228|64462611|FG001|Overall Study|Did not tolerate application|0|||
23196714|NCT04973228|64462610|FG000|Overall Study|Wanted to early terminate and use own product|0|||
23196715|NCT04973228|64462611|FG001|Overall Study|Wanted to early terminate and use own product|1|||
23196716|NCT04973228|64462610|FG000|Overall Study|Missed visits due to new work schedule|1|||
23196717|NCT04973228|64462611|FG001|Overall Study|Missed visits due to new work schedule|0|||
23196718|NCT04743635|64462617|FG000|Overall Study|Lost to Follow-up|2|||
23196719|NCT04743635|64462618|FG001|Overall Study|Lost to Follow-up|0|||
23196720|NCT01954121|64462619|FG000|Overall Study|Lack of Efficacy|94|||
23196721|NCT01954121|64462620|FG001|Overall Study|Lack of Efficacy|41|||
23196722|NCT01954121|64462619|FG000|Overall Study|Protocol Violation|0|||
23196723|NCT01954121|64462620|FG001|Overall Study|Protocol Violation|2|||
23196724|NCT01954121|64462619|FG000|Overall Study|Lost to Follow-up|5|||
23196725|NCT01954121|64462620|FG001|Overall Study|Lost to Follow-up|6|||
23196726|NCT01954121|64462619|FG000|Overall Study|Withdrawal by Subject|18|||
23256698|NCT02675426|64683586|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
23256699|NCT02675426|64683583|FG000|Period 1: Week 1 to Week 12|Other|2|||
23196727|NCT01954121|64462620|FG001|Overall Study|Withdrawal by Subject|12|||
23196728|NCT01954121|64462619|FG000|Overall Study|Pregnancy|1|||
23256700|NCT02675426|64683584|FG001|Period 1: Week 1 to Week 12|Other|1|||
23361078|NCT04058028|65065965|FG003|Overall Study|Withdrawal of Consent from Study|7|||
23196729|NCT01954121|64462620|FG001|Overall Study|Pregnancy|1|||
23196730|NCT01954121|64462619|FG000|Overall Study|AE, serious fatal|1|||
23196731|NCT01954121|64462620|FG001|Overall Study|AE, serious fatal|0|||
23196732|NCT01954121|64462619|FG000|Overall Study|AE, non-serious non-fatal|5|||
23196733|NCT01954121|64462620|FG001|Overall Study|AE, non-serious non-fatal|22|||
23196734|NCT01954121|64462619|FG000|Overall Study|SAE, non-fatal|1|||
23196735|NCT01954121|64462620|FG001|Overall Study|SAE, non-fatal|4|||
23196736|NCT01954121|64462619|FG000|Overall Study|Non-compliant with study procedures|1|||
23196737|NCT01954121|64462620|FG001|Overall Study|Non-compliant with study procedures|0|||
23196738|NCT01954121|64462619|FG000|Overall Study|Non-compliant patient|1|||
23196739|NCT01954121|64462620|FG001|Overall Study|Non-compliant patient|1|||
23196740|NCT01954121|64462619|FG000|Overall Study|Subject did not follow instructions|0|||
23196741|NCT01954121|64462620|FG001|Overall Study|Subject did not follow instructions|2|||
23196742|NCT03123939|64462621|FG000|Overall Study|Lack of Efficacy|6|||
23196743|NCT03123939|64462621|FG000|Overall Study|Death|5|||
23196744|NCT03123939|64462621|FG000|Overall Study|Physician Decision|2|||
23196745|NCT03123939|64462621|FG000|Overall Study|Subject/guardian decision|2|||
23196746|NCT03123939|64462621|FG000|Overall Study|Lost to Follow-up|1|||
23196747|NCT03123939|64462621|FG000|Overall Study|New therapy for study indication|1|||
23196748|NCT03123939|64462621|FG000|Overall Study|Protocol deviation|1|||
23196749|NCT03123939|64462621|FG000|Overall Study|Progressive disease|18|||
23196750|NCT03123939|64462621|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
23196751|NCT03123939|64462621|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
23196752|NCT00935220|64462624|FG000|Overall Study|Adverse Event|1|||
23196753|NCT00935220|64462624|FG000|Overall Study|Other reason (not specified)|1|||
23196754|NCT00085540|64462625|FG000|Overall Study|Withdrawal by Subject|0|||
23196755|NCT00085540|64462626|FG001|Overall Study|Withdrawal by Subject|1|||
23196756|NCT00085540|64462625|FG000|Overall Study|Protocol Violation|0|||
23196757|NCT00085540|64462626|FG001|Overall Study|Protocol Violation|1|||
23196758|NCT00515008|64462627|FG000|Overall Study|Lost to Follow-up|1|||
23196759|NCT00515008|64462628|FG001|Overall Study|Lost to Follow-up|0|||
23196760|NCT00515008|64462627|FG000|Overall Study|Declined|0|||
23196761|NCT00515008|64462628|FG001|Overall Study|Declined|3|||
23196762|NCT00515008|64462627|FG000|Overall Study|Left the Boston Area|1|||
23196763|NCT00515008|64462628|FG001|Overall Study|Left the Boston Area|1|||
23196764|NCT00515008|64462627|FG000|Overall Study|Scheduling conflict|1|||
23196765|NCT00515008|64462628|FG001|Overall Study|Scheduling conflict|0|||
23196766|NCT01486316|64462632|FG000|Overall Study|Device explanted with/without re-implant|3|||
23196767|NCT01486316|64462633|FG001|Overall Study|Device explanted with/without re-implant|2|||
23196768|NCT01486316|64462634|FG002|Overall Study|Device explanted with/without re-implant|0|||
23196769|NCT01486316|64462635|FG003|Overall Study|Device explanted with/without re-implant|2|||
23196770|NCT01486316|64462632|FG000|Overall Study|Not meeting eligibility criteria|0|||
23196771|NCT01486316|64462633|FG001|Overall Study|Not meeting eligibility criteria|0|||
23196772|NCT01486316|64462634|FG002|Overall Study|Not meeting eligibility criteria|1|||
23196773|NCT01486316|64462635|FG003|Overall Study|Not meeting eligibility criteria|0|||
23196774|NCT01486316|64462632|FG000|Overall Study|Withdrawal by Subject|1|||
23196775|NCT01486316|64462633|FG001|Overall Study|Withdrawal by Subject|0|||
23196776|NCT01486316|64462634|FG002|Overall Study|Withdrawal by Subject|3|||
23196777|NCT01486316|64462635|FG003|Overall Study|Withdrawal by Subject|0|||
23196778|NCT01486316|64462632|FG000|Overall Study|Physician Decision|0|||
23196779|NCT01486316|64462633|FG001|Overall Study|Physician Decision|0|||
23196780|NCT01486316|64462634|FG002|Overall Study|Physician Decision|1|||
23196781|NCT01486316|64462635|FG003|Overall Study|Physician Decision|0|||
23196782|NCT01486316|64462632|FG000|Overall Study|Death|0|||
23196783|NCT01486316|64462633|FG001|Overall Study|Death|1|||
23196784|NCT01486316|64462634|FG002|Overall Study|Death|0|||
23196785|NCT01486316|64462635|FG003|Overall Study|Death|0|||
23196786|NCT02839746|64462636|FG000|Overall Study|Not met selection criteria|12|||
23196787|NCT01520324|64462637|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
23196788|NCT00923091|64462643|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
23196789|NCT00923091|64462644|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
23196790|NCT00923091|64462645|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
23599777|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
23196791|NCT00923091|64462646|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
23599778|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
23196792|NCT00923091|64462647|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
23196793|NCT00923091|64462648|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
23196794|NCT00923091|64462649|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
23196795|NCT00923091|64462650|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
23196796|NCT00923091|64462651|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23196797|NCT00923091|64462652|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23196798|NCT00923091|64462653|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23196799|NCT00923091|64462654|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23196800|NCT00923091|64462655|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
23196801|NCT00923091|64462643|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
23196802|NCT00923091|64462644|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
23196803|NCT00923091|64462645|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
23196804|NCT00923091|64462646|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
23196805|NCT00923091|64462647|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
23196806|NCT00923091|64462648|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
23196807|NCT00923091|64462649|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
23196808|NCT00923091|64462650|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
23196809|NCT00923091|64462651|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23196810|NCT00923091|64462652|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23196811|NCT00923091|64462653|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23196812|NCT00923091|64462654|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23196813|NCT00923091|64462655|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
23196814|NCT00923091|64462643|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
23196815|NCT00923091|64462644|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
23196816|NCT00923091|64462645|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
23196817|NCT00923091|64462646|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
23196818|NCT00923091|64462647|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
23196819|NCT00923091|64462648|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
23196820|NCT00923091|64462649|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
23196821|NCT00923091|64462650|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
23196822|NCT00923091|64462651|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23196823|NCT00923091|64462652|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23196824|NCT00923091|64462653|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23196825|NCT00923091|64462654|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23196826|NCT00923091|64462655|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
23196827|NCT00923091|64462643|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196828|NCT00923091|64462644|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196829|NCT00923091|64462645|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196830|NCT00923091|64462646|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196831|NCT00923091|64462647|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196832|NCT00923091|64462648|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
23196833|NCT00923091|64462649|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196834|NCT00923091|64462650|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196835|NCT00923091|64462651|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196836|NCT00923091|64462652|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196837|NCT00923091|64462653|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196838|NCT00923091|64462654|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196839|NCT00923091|64462655|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
23196840|NCT00923091|64462643|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196841|NCT00923091|64462644|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
23196842|NCT00923091|64462645|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196843|NCT00923091|64462646|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
23196844|NCT00923091|64462647|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196845|NCT00923091|64462648|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
23196846|NCT00923091|64462649|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196847|NCT00923091|64462650|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196848|NCT00923091|64462651|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196849|NCT00923091|64462652|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196850|NCT00923091|64462653|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196851|NCT00923091|64462654|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196852|NCT00923091|64462655|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
23196853|NCT00923091|64462643|FG000|Period III (Single-Blind)|Adverse Event|5|||
23196854|NCT00923091|64462644|FG001|Period III (Single-Blind)|Adverse Event|0|||
23196855|NCT00923091|64462645|FG002|Period III (Single-Blind)|Adverse Event|0|||
23196856|NCT00923091|64462646|FG003|Period III (Single-Blind)|Adverse Event|0|||
23196857|NCT00923091|64462647|FG004|Period III (Single-Blind)|Adverse Event|0|||
23196858|NCT00923091|64462648|FG005|Period III (Single-Blind)|Adverse Event|0|||
23361079|NCT04058028|65065962|FG000|Overall Study|Decision by Sponsor|13|||
23196859|NCT00923091|64462649|FG006|Period III (Single-Blind)|Adverse Event|0|||
23196860|NCT00923091|64462650|FG007|Period III (Single-Blind)|Adverse Event|0|||
23196861|NCT00923091|64462651|FG008|Period III (Single-Blind)|Adverse Event|0|||
23196862|NCT00923091|64462652|FG009|Period III (Single-Blind)|Adverse Event|0|||
23196863|NCT00923091|64462653|FG010|Period III (Single-Blind)|Adverse Event|0|||
23361080|NCT04058028|65065963|FG001|Overall Study|Decision by Sponsor|4|||
23361081|NCT04058028|65065964|FG002|Overall Study|Decision by Sponsor|1|||
23196864|NCT00923091|64462654|FG011|Period III (Single-Blind)|Adverse Event|0|||
23196865|NCT00923091|64462655|FG012|Period III (Single-Blind)|Adverse Event|0|||
23480236|NCT00797966|65501916|FG002|Phase A+|Lost to Follow-up|0|||
23480237|NCT00797966|65501917|FG003|Phase A+|Lost to Follow-up|0|||
23480238|NCT00797966|65501918|FG004|Phase A+|Lost to Follow-up|0|||
23480239|NCT00797966|65501919|FG005|Phase A+|Lost to Follow-up|9|||
23480240|NCT00797966|65501914|FG000|Phase A+|Met withdrawal criteria|0|||
23480241|NCT00797966|65501915|FG001|Phase A+|Met withdrawal criteria|0|||
23480242|NCT00797966|65501916|FG002|Phase A+|Met withdrawal criteria|0|||
23480243|NCT00797966|65501917|FG003|Phase A+|Met withdrawal criteria|0|||
23480244|NCT00797966|65501918|FG004|Phase A+|Met withdrawal criteria|0|||
23480245|NCT00797966|65501919|FG005|Phase A+|Met withdrawal criteria|5|||
23480246|NCT00797966|65501914|FG000|Phase A+|Withdrawal by Subject|0|||
23480247|NCT00797966|65501915|FG001|Phase A+|Withdrawal by Subject|0|||
23480248|NCT00797966|65501916|FG002|Phase A+|Withdrawal by Subject|0|||
23480249|NCT00797966|65501917|FG003|Phase A+|Withdrawal by Subject|0|||
23480250|NCT00797966|65501918|FG004|Phase A+|Withdrawal by Subject|0|||
23480251|NCT00797966|65501919|FG005|Phase A+|Withdrawal by Subject|6|||
23480252|NCT00797966|65501914|FG000|Phase A+|Adverse Event|0|||
23480253|NCT00797966|65501915|FG001|Phase A+|Adverse Event|0|||
23480254|NCT00797966|65501916|FG002|Phase A+|Adverse Event|0|||
23480255|NCT00797966|65501917|FG003|Phase A+|Adverse Event|0|||
23480256|NCT00797966|65501918|FG004|Phase A+|Adverse Event|0|||
23480257|NCT00797966|65501919|FG005|Phase A+|Adverse Event|4|||
23480258|NCT00797966|65501914|FG000|Phase A+|Protocol deviation|0|||
23480259|NCT00797966|65501915|FG001|Phase A+|Protocol deviation|0|||
23480260|NCT00797966|65501916|FG002|Phase A+|Protocol deviation|0|||
23480261|NCT00797966|65501917|FG003|Phase A+|Protocol deviation|0|||
23480262|NCT00797966|65501918|FG004|Phase A+|Protocol deviation|0|||
23480263|NCT00797966|65501919|FG005|Phase A+|Protocol deviation|4|||
23480264|NCT01527357|65501920|FG000|Overall Study|Death|8|||
23480265|NCT01527357|65501921|FG001|Overall Study|Death|2|||
23480266|NCT01527357|65501920|FG000|Overall Study|Lost to Follow-up|6|||
23480267|NCT01527357|65501921|FG001|Overall Study|Lost to Follow-up|4|||
23480268|NCT01527357|65501920|FG000|Overall Study|Withdrew Consent|1|||
23480269|NCT01527357|65501921|FG001|Overall Study|Withdrew Consent|1|||
23480270|NCT01527357|65501920|FG000|Overall Study|Non-compliance|0|||
23480271|NCT01527357|65501921|FG001|Overall Study|Non-compliance|1|||
23480272|NCT01527357|65501920|FG000|Overall Study|No Day 29 Visit|0|||
23480273|NCT01527357|65501921|FG001|Overall Study|No Day 29 Visit|1|||
23480274|NCT01527357|65501920|FG000|Overall Study|Did Not Receive Treatment|2|||
23480275|NCT01527357|65501921|FG001|Overall Study|Did Not Receive Treatment|0|||
23480276|NCT00710762|65501925|FG000|Overall Study|Progressive disease|27|||
23480277|NCT00710762|65501926|FG001|Overall Study|Progressive disease|30|||
23480278|NCT00710762|65501925|FG000|Overall Study|Adverse Event other disease worsening|2|||
23480279|NCT00710762|65501926|FG001|Overall Study|Adverse Event other disease worsening|1|||
23480280|NCT00710762|65501925|FG000|Overall Study|Other Adverse Event|7|||
23480281|NCT00710762|65501926|FG001|Overall Study|Other Adverse Event|7|||
23480282|NCT00710762|65501925|FG000|Overall Study|Lost to Follow-up|1|||
23480283|NCT00710762|65501926|FG001|Overall Study|Lost to Follow-up|0|||
23480284|NCT00710762|65501925|FG000|Overall Study|Reason other than listed above|2|||
23480285|NCT00710762|65501926|FG001|Overall Study|Reason other than listed above|2|||
23480286|NCT00217464|65501929|FG000|Overall Study|Progression|15|||
23480287|NCT00217464|65501929|FG000|Overall Study|Other|2|||
23480288|NCT00266877|65501930|FG000|Overall Study|Death|1|||
23480289|NCT00266877|65501931|FG001|Overall Study|Death|1|||
23480290|NCT00266877|65501932|FG002|Overall Study|Death|1|||
23480291|NCT00266877|65501930|FG000|Overall Study|Adverse Event|6|||
23480292|NCT00266877|65501931|FG001|Overall Study|Adverse Event|4|||
23480293|NCT00266877|65501932|FG002|Overall Study|Adverse Event|1|||
23480294|NCT00266877|65501930|FG000|Overall Study|Physician Decision|2|||
23480295|NCT00266877|65501931|FG001|Overall Study|Physician Decision|1|||
23480296|NCT00266877|65501932|FG002|Overall Study|Physician Decision|1|||
23480297|NCT00266877|65501930|FG000|Overall Study|Withdrawal by Subject|3|||
23480298|NCT00266877|65501931|FG001|Overall Study|Withdrawal by Subject|1|||
23480299|NCT00266877|65501932|FG002|Overall Study|Withdrawal by Subject|1|||
23480300|NCT00266877|65501930|FG000|Overall Study|Disease Progression|72|||
23480301|NCT00266877|65501931|FG001|Overall Study|Disease Progression|37|||
23480302|NCT00266877|65501932|FG002|Overall Study|Disease Progression|23|||
23480303|NCT00266877|65501930|FG000|Overall Study|Symptomatic Deterioration|6|||
23480304|NCT00266877|65501931|FG001|Overall Study|Symptomatic Deterioration|3|||
23480305|NCT00266877|65501932|FG002|Overall Study|Symptomatic Deterioration|1|||
23480306|NCT00266877|65501930|FG000|Overall Study|Hospitalization|1|||
23480307|NCT00266877|65501931|FG001|Overall Study|Hospitalization|0|||
23480308|NCT00266877|65501932|FG002|Overall Study|Hospitalization|0|||
23480309|NCT00266877|65501930|FG000|Overall Study|Concomitant Radiotherapy|0|||
23480310|NCT00266877|65501931|FG001|Overall Study|Concomitant Radiotherapy|1|||
23480311|NCT00266877|65501932|FG002|Overall Study|Concomitant Radiotherapy|0|||
23480312|NCT03338959|65501933|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
23480313|NCT03338959|65501933|FG000|Overall Study|Physician Decision|1|||
23196866|NCT00923091|64462643|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
23196867|NCT00923091|64462644|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196868|NCT00923091|64462645|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196869|NCT00923091|64462646|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196870|NCT00923091|64462647|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196871|NCT00923091|64462648|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196872|NCT00923091|64462649|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196873|NCT00923091|64462650|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196874|NCT00923091|64462651|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196875|NCT00923091|64462652|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196876|NCT00923091|64462653|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196877|NCT00923091|64462654|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196878|NCT00923091|64462655|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
23196879|NCT00923091|64462643|FG000|Period III (Single-Blind)|Protocol Violation|3|||
23196880|NCT00923091|64462644|FG001|Period III (Single-Blind)|Protocol Violation|0|||
23196881|NCT00923091|64462645|FG002|Period III (Single-Blind)|Protocol Violation|0|||
23196882|NCT00923091|64462646|FG003|Period III (Single-Blind)|Protocol Violation|0|||
23196883|NCT00923091|64462647|FG004|Period III (Single-Blind)|Protocol Violation|0|||
23196884|NCT00923091|64462648|FG005|Period III (Single-Blind)|Protocol Violation|0|||
23196885|NCT00923091|64462649|FG006|Period III (Single-Blind)|Protocol Violation|0|||
23196886|NCT00923091|64462650|FG007|Period III (Single-Blind)|Protocol Violation|0|||
23196887|NCT00923091|64462651|FG008|Period III (Single-Blind)|Protocol Violation|0|||
23196888|NCT00923091|64462652|FG009|Period III (Single-Blind)|Protocol Violation|0|||
23196889|NCT00923091|64462653|FG010|Period III (Single-Blind)|Protocol Violation|0|||
23196890|NCT00923091|64462654|FG011|Period III (Single-Blind)|Protocol Violation|0|||
23196891|NCT00923091|64462655|FG012|Period III (Single-Blind)|Protocol Violation|0|||
23196892|NCT00923091|64462643|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
23196893|NCT00923091|64462644|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
23196894|NCT00923091|64462645|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
23196895|NCT00923091|64462646|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
23196896|NCT00923091|64462647|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
23196897|NCT00923091|64462648|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
23196898|NCT00923091|64462649|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
23196899|NCT00923091|64462650|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
23196900|NCT00923091|64462651|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
23196901|NCT00923091|64462652|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
23196902|NCT00923091|64462653|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
23196903|NCT00923091|64462654|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
23196904|NCT00923091|64462655|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
23196905|NCT00923091|64462643|FG000|Period IV (Double-Blind)|Adverse Event|2|||
23196906|NCT00923091|64462644|FG001|Period IV (Double-Blind)|Adverse Event|0|||
23196907|NCT00923091|64462645|FG002|Period IV (Double-Blind)|Adverse Event|0|||
23196908|NCT00923091|64462646|FG003|Period IV (Double-Blind)|Adverse Event|0|||
23196909|NCT00923091|64462647|FG004|Period IV (Double-Blind)|Adverse Event|0|||
23196910|NCT00923091|64462648|FG005|Period IV (Double-Blind)|Adverse Event|0|||
23196911|NCT00923091|64462649|FG006|Period IV (Double-Blind)|Adverse Event|0|||
23196912|NCT00923091|64462650|FG007|Period IV (Double-Blind)|Adverse Event|0|||
23196913|NCT00923091|64462651|FG008|Period IV (Double-Blind)|Adverse Event|0|||
23196914|NCT00923091|64462652|FG009|Period IV (Double-Blind)|Adverse Event|0|||
23196915|NCT00923091|64462653|FG010|Period IV (Double-Blind)|Adverse Event|0|||
23196916|NCT00923091|64462654|FG011|Period IV (Double-Blind)|Adverse Event|0|||
23196917|NCT00923091|64462655|FG012|Period IV (Double-Blind)|Adverse Event|0|||
23196918|NCT00923091|64462643|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196919|NCT00923091|64462644|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
23196920|NCT00923091|64462645|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196921|NCT00923091|64462646|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196922|NCT00923091|64462647|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196923|NCT00923091|64462648|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196924|NCT00923091|64462649|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196925|NCT00923091|64462650|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196926|NCT00923091|64462651|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196927|NCT00923091|64462652|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196928|NCT00923091|64462653|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196929|NCT00923091|64462654|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23480314|NCT00246571|65501934|FG000|Overall Study|Adverse Event|7|||
23480315|NCT00246571|65501935|FG001|Overall Study|Adverse Event|0|||
23196930|NCT00923091|64462655|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
23196931|NCT00923091|64462643|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
23196932|NCT00923091|64462644|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
23256701|NCT02675426|64683585|FG002|Period 1: Week 1 to Week 12|Other|0|||
23256702|NCT02675426|64683586|FG003|Period 1: Week 1 to Week 12|Other|2|||
23196933|NCT00923091|64462645|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
23196934|NCT00923091|64462646|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
23196935|NCT00923091|64462647|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
23196936|NCT00923091|64462648|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
23196937|NCT00923091|64462649|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
23196938|NCT00923091|64462650|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
23196939|NCT00923091|64462651|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
23196940|NCT00923091|64462652|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
23196941|NCT00923091|64462653|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
23196942|NCT00923091|64462654|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
23196943|NCT00923091|64462655|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
23196944|NCT00923091|64462643|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196945|NCT00923091|64462644|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196946|NCT00923091|64462645|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196947|NCT00923091|64462646|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196948|NCT00923091|64462647|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196949|NCT00923091|64462648|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196950|NCT00923091|64462649|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196951|NCT00923091|64462650|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196952|NCT00923091|64462651|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
23196953|NCT00923091|64462652|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196954|NCT00923091|64462653|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196955|NCT00923091|64462654|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
23196956|NCT00923091|64462655|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
23196957|NCT00923091|64462643|FG000|Period V (Double -Blind)|Protocol Violation|0|||
23196958|NCT00923091|64462644|FG001|Period V (Double -Blind)|Protocol Violation|0|||
23196959|NCT00923091|64462645|FG002|Period V (Double -Blind)|Protocol Violation|0|||
23196960|NCT00923091|64462646|FG003|Period V (Double -Blind)|Protocol Violation|0|||
23196961|NCT00923091|64462647|FG004|Period V (Double -Blind)|Protocol Violation|0|||
23196962|NCT00923091|64462648|FG005|Period V (Double -Blind)|Protocol Violation|0|||
23196963|NCT00923091|64462649|FG006|Period V (Double -Blind)|Protocol Violation|0|||
23196964|NCT00923091|64462650|FG007|Period V (Double -Blind)|Protocol Violation|0|||
23196965|NCT00923091|64462651|FG008|Period V (Double -Blind)|Protocol Violation|0|||
23196966|NCT00923091|64462652|FG009|Period V (Double -Blind)|Protocol Violation|0|||
23196967|NCT00923091|64462653|FG010|Period V (Double -Blind)|Protocol Violation|0|||
23196968|NCT00923091|64462654|FG011|Period V (Double -Blind)|Protocol Violation|0|||
23196969|NCT00923091|64462655|FG012|Period V (Double -Blind)|Protocol Violation|1|||
23196970|NCT00923091|64462643|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
23196971|NCT00923091|64462644|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
23196972|NCT00923091|64462645|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
23196973|NCT00923091|64462646|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
23196974|NCT00923091|64462647|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
23196975|NCT00923091|64462648|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
23196976|NCT00923091|64462649|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
23196977|NCT00923091|64462650|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
23196978|NCT00923091|64462651|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
23196979|NCT00923091|64462652|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
23196980|NCT00923091|64462653|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
23196981|NCT00923091|64462654|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
23196982|NCT00923091|64462655|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
23196983|NCT00923091|64462643|FG000|Period VI (Open-Label)|Adverse Event|17|||
23196984|NCT00923091|64462644|FG001|Period VI (Open-Label)|Adverse Event|0|||
23256703|NCT02675426|64683583|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
23256704|NCT02675426|64683584|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
23256705|NCT02675426|64683585|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
23256706|NCT02675426|64683586|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
23256707|NCT02675426|64683583|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
23256708|NCT02675426|64683584|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
23256709|NCT02675426|64683585|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
23256710|NCT02675426|64683586|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
23256711|NCT02675426|64683583|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
23256712|NCT02675426|64683584|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
23256713|NCT02675426|64683585|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
23256714|NCT02675426|64683586|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
23196985|NCT00923091|64462645|FG002|Period VI (Open-Label)|Adverse Event|4|||
23196986|NCT00923091|64462646|FG003|Period VI (Open-Label)|Adverse Event|1|||
23196987|NCT00923091|64462647|FG004|Period VI (Open-Label)|Adverse Event|1|||
23196988|NCT00923091|64462648|FG005|Period VI (Open-Label)|Adverse Event|0|||
23196989|NCT00923091|64462649|FG006|Period VI (Open-Label)|Adverse Event|0|||
23256715|NCT02675426|64683583|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
23256716|NCT02675426|64683584|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
23256717|NCT02675426|64683585|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
23256718|NCT02675426|64683586|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
23256719|NCT02675426|64683583|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
23256720|NCT02675426|64683584|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
23256721|NCT02675426|64683585|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
23256722|NCT02675426|64683586|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
23256723|NCT02675426|64683583|FG000|Period 2: Week 12 to Week 260|Other|8|||
23256724|NCT02675426|64683584|FG001|Period 2: Week 12 to Week 260|Other|12|||
23256725|NCT02675426|64683585|FG002|Period 2: Week 12 to Week 260|Other|23|||
23256726|NCT02675426|64683586|FG003|Period 2: Week 12 to Week 260|Other|15|||
23256727|NCT00686374|64683587|FG000|Overall Study|Lack of Efficacy|10|||
23196990|NCT00923091|64462650|FG007|Period VI (Open-Label)|Adverse Event|0|||
23196991|NCT00923091|64462651|FG008|Period VI (Open-Label)|Adverse Event|0|||
23196992|NCT00923091|64462652|FG009|Period VI (Open-Label)|Adverse Event|0|||
23196993|NCT00923091|64462653|FG010|Period VI (Open-Label)|Adverse Event|0|||
23196994|NCT00923091|64462654|FG011|Period VI (Open-Label)|Adverse Event|0|||
23196995|NCT00923091|64462655|FG012|Period VI (Open-Label)|Adverse Event|0|||
23196996|NCT00923091|64462643|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
23196997|NCT00923091|64462644|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
23196998|NCT00923091|64462645|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
23196999|NCT00923091|64462646|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
23197000|NCT00923091|64462647|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
23197001|NCT00923091|64462648|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
23197002|NCT00923091|64462649|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
23197003|NCT00923091|64462650|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
23197004|NCT00923091|64462651|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
23197005|NCT00923091|64462652|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
23197006|NCT00923091|64462653|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
23197007|NCT00923091|64462654|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
23197008|NCT00923091|64462655|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
23197009|NCT00923091|64462643|FG000|Period VI (Open-Label)|Protocol Violation|6|||
23197010|NCT00923091|64462644|FG001|Period VI (Open-Label)|Protocol Violation|1|||
23197011|NCT00923091|64462645|FG002|Period VI (Open-Label)|Protocol Violation|3|||
23197012|NCT00923091|64462646|FG003|Period VI (Open-Label)|Protocol Violation|1|||
23197013|NCT00923091|64462647|FG004|Period VI (Open-Label)|Protocol Violation|4|||
23197014|NCT00923091|64462648|FG005|Period VI (Open-Label)|Protocol Violation|0|||
23197015|NCT00923091|64462649|FG006|Period VI (Open-Label)|Protocol Violation|0|||
23197016|NCT00923091|64462650|FG007|Period VI (Open-Label)|Protocol Violation|0|||
23197017|NCT00923091|64462651|FG008|Period VI (Open-Label)|Protocol Violation|0|||
23197018|NCT00923091|64462652|FG009|Period VI (Open-Label)|Protocol Violation|0|||
23197019|NCT00923091|64462653|FG010|Period VI (Open-Label)|Protocol Violation|0|||
23197020|NCT00923091|64462654|FG011|Period VI (Open-Label)|Protocol Violation|0|||
23197021|NCT00923091|64462655|FG012|Period VI (Open-Label)|Protocol Violation|0|||
23197022|NCT00923091|64462643|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
23197023|NCT00923091|64462644|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
23197024|NCT00923091|64462645|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
23197025|NCT00923091|64462646|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
23197026|NCT00923091|64462647|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
23197027|NCT00923091|64462648|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
23197028|NCT00923091|64462649|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
23197029|NCT00923091|64462650|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
23197030|NCT00923091|64462651|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
23197031|NCT00923091|64462652|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
23197032|NCT00923091|64462653|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
23197033|NCT00923091|64462654|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
23197034|NCT00923091|64462655|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
23197035|NCT00923091|64462643|FG000|Period VI (Open-Label)|Other Reason|0|||
23197036|NCT00923091|64462644|FG001|Period VI (Open-Label)|Other Reason|0|||
23197037|NCT00923091|64462645|FG002|Period VI (Open-Label)|Other Reason|0|||
23197038|NCT00923091|64462646|FG003|Period VI (Open-Label)|Other Reason|1|||
23197039|NCT00923091|64462647|FG004|Period VI (Open-Label)|Other Reason|1|||
23197040|NCT00923091|64462648|FG005|Period VI (Open-Label)|Other Reason|0|||
23197041|NCT00923091|64462649|FG006|Period VI (Open-Label)|Other Reason|0|||
23197042|NCT00923091|64462650|FG007|Period VI (Open-Label)|Other Reason|0|||
23256728|NCT00686374|64683587|FG000|Overall Study|Adverse Event|8|||
23256729|NCT00686374|64683587|FG000|Overall Study|Withdrew consent|5|||
23256730|NCT00686374|64683587|FG000|Overall Study|Lost to Follow-up|1|||
23256731|NCT00686374|64683587|FG000|Overall Study|Missing reason|33|||
23197043|NCT00923091|64462651|FG008|Period VI (Open-Label)|Other Reason|0|||
23197044|NCT00923091|64462652|FG009|Period VI (Open-Label)|Other Reason|0|||
23197045|NCT00923091|64462653|FG010|Period VI (Open-Label)|Other Reason|0|||
23197046|NCT00923091|64462654|FG011|Period VI (Open-Label)|Other Reason|0|||
23197047|NCT00923091|64462655|FG012|Period VI (Open-Label)|Other Reason|0|||
23197048|NCT00392171|64462656|FG000|Overall Study|Did not meet inclusion criteria|4|||
23197049|NCT00392171|64462656|FG000|Overall Study|Disease progression|101|||
23197050|NCT02951988|64462658|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
23197051|NCT02951988|64462659|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
23197052|NCT02951988|64462660|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
23197053|NCT02951988|64462661|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
23197054|NCT02951988|64462658|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
23197055|NCT02951988|64462659|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
23197056|NCT02951988|64462660|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
23197057|NCT02951988|64462661|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
23197058|NCT02951988|64462658|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
23197059|NCT02951988|64462659|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
23197060|NCT02951988|64462660|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
23197061|NCT02951988|64462661|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
23197062|NCT02951988|64462658|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
23197063|NCT02951988|64462659|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
23197064|NCT02951988|64462660|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
23197065|NCT02951988|64462661|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
23197066|NCT02951988|64462658|FG000|Open-Label Treatment Period|Protocol Violation|22|||
23197067|NCT02951988|64462659|FG001|Open-Label Treatment Period|Protocol Violation|0|||
23197068|NCT02951988|64462660|FG002|Open-Label Treatment Period|Protocol Violation|0|||
23197069|NCT02951988|64462661|FG003|Open-Label Treatment Period|Protocol Violation|0|||
23197070|NCT02951988|64462658|FG000|Open-Label Treatment Period|Pregnancy|2|||
23197071|NCT02951988|64462659|FG001|Open-Label Treatment Period|Pregnancy|0|||
23197072|NCT02951988|64462660|FG002|Open-Label Treatment Period|Pregnancy|0|||
23197073|NCT02951988|64462661|FG003|Open-Label Treatment Period|Pregnancy|0|||
23197074|NCT02951988|64462658|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
23197075|NCT02951988|64462659|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
23197076|NCT02951988|64462660|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
23197077|NCT02951988|64462661|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
23197078|NCT02951988|64462658|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
23197079|NCT02951988|64462659|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
23197080|NCT02951988|64462660|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
23197081|NCT02951988|64462661|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
23197082|NCT02951988|64462658|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
23197083|NCT02951988|64462659|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
23197084|NCT02951988|64462660|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
23197085|NCT02951988|64462661|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
23197086|NCT02951988|64462658|FG000|Open-Label Treatment Period|Adverse Event|45|||
23197087|NCT02951988|64462659|FG001|Open-Label Treatment Period|Adverse Event|0|||
23197088|NCT02951988|64462660|FG002|Open-Label Treatment Period|Adverse Event|0|||
23197089|NCT02951988|64462661|FG003|Open-Label Treatment Period|Adverse Event|0|||
23197090|NCT02951988|64462658|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
23197091|NCT02951988|64462659|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
23197092|NCT02951988|64462660|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
23197093|NCT02951988|64462661|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
23197094|NCT02951988|64462658|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
23197095|NCT02951988|64462659|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
23197096|NCT02951988|64462660|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
23197097|NCT02951988|64462661|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
23197098|NCT02951988|64462658|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
23197099|NCT02951988|64462659|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
23197100|NCT02951988|64462660|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
23197101|NCT02951988|64462661|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
23197102|NCT02951988|64462658|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23197103|NCT02951988|64462659|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
23197104|NCT02951988|64462660|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
23197105|NCT02951988|64462661|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
23197106|NCT02951988|64462658|FG000|Double-Blind Treatment Period|Pregnancy|0|||
23197107|NCT02951988|64462659|FG001|Double-Blind Treatment Period|Pregnancy|1|||
23197108|NCT02951988|64462660|FG002|Double-Blind Treatment Period|Pregnancy|1|||
23197109|NCT02951988|64462661|FG003|Double-Blind Treatment Period|Pregnancy|0|||
23197110|NCT02951988|64462658|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23197111|NCT02951988|64462659|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
23197112|NCT02951988|64462660|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
23197113|NCT02951988|64462661|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
23197114|NCT02951988|64462658|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23197115|NCT02951988|64462659|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
23197116|NCT02951988|64462660|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
23197117|NCT02951988|64462661|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
23197118|NCT02951988|64462658|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23197119|NCT02951988|64462659|FG001|Double-Blind Treatment Period|Adverse Event|8|||
23197120|NCT02951988|64462660|FG002|Double-Blind Treatment Period|Adverse Event|3|||
23197121|NCT02951988|64462661|FG003|Double-Blind Treatment Period|Adverse Event|6|||
23197122|NCT02951988|64462658|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
23197123|NCT02951988|64462659|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
23197124|NCT02951988|64462660|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
23197125|NCT02951988|64462661|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
23197126|NCT00504166|64462663|FG000|Overall Study|Adverse Event|1|||
23197127|NCT00504166|64462664|FG001|Overall Study|Adverse Event|4|||
23197128|NCT00504166|64462663|FG000|Overall Study|Withdrawal by Subject|3|||
23197129|NCT00504166|64462664|FG001|Overall Study|Withdrawal by Subject|6|||
23197130|NCT00504166|64462663|FG000|Overall Study|Physician Decision|1|||
23197131|NCT00504166|64462664|FG001|Overall Study|Physician Decision|1|||
23197132|NCT00504166|64462663|FG000|Overall Study|Lost to Follow-up|1|||
23197133|NCT00504166|64462664|FG001|Overall Study|Lost to Follow-up|3|||
23197134|NCT00958568|64462665|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
23197135|NCT00958568|64462666|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
23197136|NCT00958568|64462667|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
23197137|NCT00958568|64462668|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
23197138|NCT00958568|64462665|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
23197139|NCT00958568|64462666|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
23197140|NCT00958568|64462667|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
23197141|NCT00958568|64462668|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
23197142|NCT00958568|64462665|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
23197143|NCT00958568|64462666|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
23197144|NCT00958568|64462667|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
23197145|NCT00958568|64462668|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
23197146|NCT00958568|64462665|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
23197147|NCT00958568|64462666|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
23197148|NCT00958568|64462667|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
23197149|NCT00958568|64462668|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
23197150|NCT00958568|64462665|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
23197151|NCT00958568|64462666|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
23197152|NCT00958568|64462667|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
23197153|NCT00958568|64462668|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
23197154|NCT00958568|64462665|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
23197155|NCT00958568|64462666|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
23197156|NCT00958568|64462667|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
23197157|NCT00958568|64462668|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
23197158|NCT00958568|64462665|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
23197159|NCT00958568|64462666|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
23197160|NCT00958568|64462667|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
23197161|NCT00958568|64462668|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
23197162|NCT00958568|64462665|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
23197163|NCT00958568|64462666|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
23197164|NCT00958568|64462667|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
23197165|NCT00958568|64462668|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
23197166|NCT00958568|64462665|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
23197167|NCT00958568|64462666|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
23197168|NCT00958568|64462667|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
23197169|NCT00958568|64462668|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
23197170|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
23197171|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
23197172|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
23197173|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
23197174|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
23197175|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
23197176|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
23197177|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
23197178|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
23197179|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
23197180|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
23197181|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
23197182|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
23197183|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
23197184|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
23197185|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
23197186|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
23197187|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
23197188|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
23197189|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
23197190|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
23197191|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
23197192|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
23197193|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
23197194|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
23197195|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
23197196|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
23197197|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
23197198|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
23197199|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
23197200|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
23197201|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
23197202|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
23197203|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
23197204|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
23197205|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
23197206|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
23197207|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
23197208|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
23197209|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
23197210|NCT00958568|64462665|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
23197211|NCT00958568|64462666|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
23197212|NCT00958568|64462667|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
23197213|NCT00958568|64462668|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
23197214|NCT00958568|64462665|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
23197215|NCT00958568|64462666|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
23197216|NCT00958568|64462667|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
23197217|NCT00958568|64462668|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
23197218|NCT00958568|64462665|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
23197219|NCT00958568|64462666|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
23197220|NCT00958568|64462667|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
23197221|NCT00958568|64462668|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
23197222|NCT00958568|64462665|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
23197223|NCT00958568|64462666|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
23197224|NCT00958568|64462667|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
23197225|NCT00958568|64462668|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
23197226|NCT00958568|64462665|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
23197227|NCT00958568|64462666|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
23197228|NCT00958568|64462667|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
23197229|NCT00958568|64462668|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
23197230|NCT00958568|64462665|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
23197231|NCT00958568|64462666|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
23197232|NCT00958568|64462667|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
23197233|NCT00958568|64462668|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
23197234|NCT00958568|64462665|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
23197235|NCT00958568|64462666|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
23197236|NCT00958568|64462667|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
23197237|NCT00958568|64462668|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
23197238|NCT00958568|64462665|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
23197239|NCT00958568|64462666|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
23197240|NCT00958568|64462667|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
23197241|NCT00958568|64462668|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
23197242|NCT00958568|64462665|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
23197243|NCT00958568|64462666|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
23197244|NCT00958568|64462667|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
23197245|NCT00958568|64462668|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
23197246|NCT00958568|64462665|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
23197247|NCT00958568|64462666|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
23197248|NCT00958568|64462667|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
23197249|NCT00958568|64462668|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
23197250|NCT00064662|64462669|FG000|Overall Study|Death|1|||
23197251|NCT00064662|64462670|FG001|Overall Study|Death|1|||
23197252|NCT00064662|64462669|FG000|Overall Study|Lost to Follow-up|57|||
23197253|NCT00064662|64462670|FG001|Overall Study|Lost to Follow-up|44|||
23197254|NCT00064662|64462669|FG000|Overall Study|Withdrawal by Subject|14|||
23197255|NCT00064662|64462670|FG001|Overall Study|Withdrawal by Subject|14|||
23197256|NCT00064662|64462669|FG000|Overall Study|Administratively withdrawn|2|||
23197257|NCT00064662|64462670|FG001|Overall Study|Administratively withdrawn|2|||
23197258|NCT01465178|64462671|FG000|Overall Study|Withdrawal by Subject|1|||
23197259|NCT01465178|64462672|FG001|Overall Study|Withdrawal by Subject|0|||
23197260|NCT03042611|64462676|FG000|Core Phase|Withdrawal by Subject|13|||
23197261|NCT03042611|64462677|FG001|Core Phase|Withdrawal by Subject|4|||
23197262|NCT03042611|64462678|FG002|Core Phase|Withdrawal by Subject|0|||
23197263|NCT03042611|64462679|FG003|Core Phase|Withdrawal by Subject|0|||
23197264|NCT03042611|64462676|FG000|Core Phase|Death|232|||
23197265|NCT03042611|64462677|FG001|Core Phase|Death|110|||
23197266|NCT03042611|64462678|FG002|Core Phase|Death|0|||
23197267|NCT03042611|64462679|FG003|Core Phase|Death|0|||
23197268|NCT03042611|64462676|FG000|Core Phase|Lost to Follow-up|4|||
23197269|NCT03042611|64462677|FG001|Core Phase|Lost to Follow-up|7|||
23197270|NCT03042611|64462678|FG002|Core Phase|Lost to Follow-up|0|||
23197271|NCT03042611|64462679|FG003|Core Phase|Lost to Follow-up|0|||
23197272|NCT03042611|64462676|FG000|Core Phase|Physician Decision|7|||
23197273|NCT03042611|64462677|FG001|Core Phase|Physician Decision|2|||
23197274|NCT03042611|64462678|FG002|Core Phase|Physician Decision|0|||
23197275|NCT03042611|64462679|FG003|Core Phase|Physician Decision|0|||
23197276|NCT03042611|64462676|FG000|Core Phase|Study Closed|0|||
23197277|NCT03042611|64462677|FG001|Core Phase|Study Closed|1|||
23197278|NCT03042611|64462678|FG002|Core Phase|Study Closed|0|||
23197279|NCT03042611|64462679|FG003|Core Phase|Study Closed|0|||
23197280|NCT03042611|64462676|FG000|Extension Phase|Death|0|||
23197281|NCT03042611|64462677|FG001|Extension Phase|Death|0|||
23197282|NCT03042611|64462678|FG002|Extension Phase|Death|34|||
23197283|NCT03042611|64462679|FG003|Extension Phase|Death|16|||
23197284|NCT03042611|64462676|FG000|Extension Phase|Lost to Follow-up|0|||
23197285|NCT03042611|64462677|FG001|Extension Phase|Lost to Follow-up|0|||
23197286|NCT03042611|64462678|FG002|Extension Phase|Lost to Follow-up|1|||
23197287|NCT03042611|64462679|FG003|Extension Phase|Lost to Follow-up|1|||
23197288|NCT03042611|64462676|FG000|Extension Phase|Study Closed|0|||
23197289|NCT03042611|64462677|FG001|Extension Phase|Study Closed|0|||
23197290|NCT03042611|64462678|FG002|Extension Phase|Study Closed|17|||
23197291|NCT03042611|64462679|FG003|Extension Phase|Study Closed|11|||
23197292|NCT01844700|64462680|FG000|Overall Study|Lack of Efficacy|1|||
23197293|NCT01844700|64462681|FG001|Overall Study|Lack of Efficacy|0|||
23197294|NCT01844700|64462680|FG000|Overall Study|refused medication switch|1|||
23197295|NCT01844700|64462681|FG001|Overall Study|refused medication switch|0|||
23197296|NCT01844700|64462680|FG000|Overall Study|Withdrawal by Subject|1|||
23197297|NCT01844700|64462681|FG001|Overall Study|Withdrawal by Subject|0|||
23197298|NCT01844700|64462680|FG000|Overall Study|stopped taking meds|0|||
23197299|NCT01844700|64462681|FG001|Overall Study|stopped taking meds|1|||
23197300|NCT02092389|64462682|FG000|Overall Study|Adverse Event|1|||
23197301|NCT02092389|64462682|FG000|Overall Study|Other|5|||
23256732|NCT00686374|64683587|FG000|Overall Study|Other, not specified|4|||
23256733|NCT00597584|64683588|FG000|Overall Study|Adverse Event|4|||
23256734|NCT00597584|64683589|FG001|Overall Study|Adverse Event|2|||
23256735|NCT00597584|64683588|FG000|Overall Study|Death|53|||
23256736|NCT00597584|64683589|FG001|Overall Study|Death|30|||
23256737|NCT00597584|64683588|FG000|Overall Study|Lack of Efficacy|1|||
23256738|NCT00597584|64683589|FG001|Overall Study|Lack of Efficacy|0|||
23256739|NCT00597584|64683588|FG000|Overall Study|Lost to Follow-up|2|||
23197302|NCT04436822|64462687|FG000|Overall Study|Physician Decision|2|||
23197303|NCT04436822|64462688|FG001|Overall Study|Physician Decision|0|||
23197304|NCT04436822|64462687|FG000|Overall Study|Sponsor request|1|||
23197305|NCT04436822|64462688|FG001|Overall Study|Sponsor request|0|||
23197306|NCT04436822|64462687|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23256740|NCT00597584|64683589|FG001|Overall Study|Lost to Follow-up|4|||
23256741|NCT00597584|64683588|FG000|Overall Study|Physician Decision|3|||
23361082|NCT04058028|65065965|FG003|Overall Study|Decision by Sponsor|35|||
23197307|NCT04436822|64462688|FG001|Overall Study|Withdrawal by parent/guardian|3|||
23256742|NCT00597584|64683589|FG001|Overall Study|Physician Decision|0|||
23197308|NCT04436822|64462687|FG000|Overall Study|Unsuccessful procedure|0|||
23197309|NCT04436822|64462688|FG001|Overall Study|Unsuccessful procedure|1|||
23197310|NCT04436822|64462687|FG000|Overall Study|Withdrawal due to Covid-19|8|||
23197311|NCT04436822|64462688|FG001|Overall Study|Withdrawal due to Covid-19|1|||
23197312|NCT04436822|64462687|FG000|Overall Study|Withdrawal by Subject|1|||
23197313|NCT04436822|64462688|FG001|Overall Study|Withdrawal by Subject|0|||
23197314|NCT04436822|64462687|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
23197315|NCT04436822|64462688|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
23197316|NCT01605396|64462692|FG000|Overall Study|Adverse Event|5|||
23197317|NCT01605396|64462693|FG001|Overall Study|Adverse Event|3|||
23197318|NCT01605396|64462692|FG000|Overall Study|Lost to Follow-up|1|||
23197319|NCT01605396|64462693|FG001|Overall Study|Lost to Follow-up|0|||
23197320|NCT01605396|64462692|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23197321|NCT01605396|64462693|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23197322|NCT01605396|64462692|FG000|Overall Study|Physician Decision|2|||
23197323|NCT01605396|64462693|FG001|Overall Study|Physician Decision|2|||
23197324|NCT01605396|64462692|FG000|Overall Study|Progressive Disease|23|||
23197325|NCT01605396|64462693|FG001|Overall Study|Progressive Disease|27|||
23197326|NCT01605396|64462692|FG000|Overall Study|Withdrawal by Subject|4|||
23197327|NCT01605396|64462693|FG001|Overall Study|Withdrawal by Subject|2|||
23197328|NCT01605396|64462692|FG000|Overall Study|Transfer Off Study|4|||
23197329|NCT01605396|64462693|FG001|Overall Study|Transfer Off Study|5|||
23197330|NCT01721408|64462696|FG000|Overall Study|Adverse Event|6|||
23197331|NCT01721408|64462697|FG001|Overall Study|Adverse Event|1|||
23197332|NCT01721408|64462696|FG000|Overall Study|Death|1|||
23197333|NCT01721408|64462697|FG001|Overall Study|Death|0|||
23197334|NCT01721408|64462696|FG000|Overall Study|Insufficient clinical response|15|||
23197335|NCT01721408|64462697|FG001|Overall Study|Insufficient clinical response|6|||
23197336|NCT01721408|64462696|FG000|Overall Study|No longer willing to participate study|9|||
23197337|NCT01721408|64462697|FG001|Overall Study|No longer willing to participate study|10|||
23197338|NCT01721408|64462696|FG000|Overall Study|Protocol Violation|0|||
23197339|NCT01721408|64462697|FG001|Overall Study|Protocol Violation|2|||
23197340|NCT01721408|64462696|FG000|Overall Study|Other|3|||
23197341|NCT01721408|64462697|FG001|Overall Study|Other|3|||
23197342|NCT01721408|64462696|FG000|Overall Study|Lost to Follow-up|1|||
23197343|NCT01721408|64462697|FG001|Overall Study|Lost to Follow-up|2|||
23197344|NCT01721408|64462696|FG000|Overall Study|Does not meet entrance criteria|1|||
23197345|NCT01721408|64462697|FG001|Overall Study|Does not meet entrance criteria|0|||
23197346|NCT00128206|64462698|FG000|Overall Study|Lost to Follow-up|137|||
23197347|NCT00128206|64462699|FG001|Overall Study|Lost to Follow-up|118|||
23197348|NCT00128206|64462698|FG000|Overall Study|Adverse Event|0|||
23197349|NCT00128206|64462699|FG001|Overall Study|Adverse Event|2|||
23197350|NCT00524745|64462700|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
23197351|NCT00524745|64462701|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
23197352|NCT00524745|64462702|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
23197353|NCT00524745|64462703|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
23197354|NCT02650284|64462704|FG000|Overall Study|Lost to Follow-up|3|||
23197355|NCT02650284|64462705|FG001|Overall Study|Lost to Follow-up|3|||
23197356|NCT02650284|64462704|FG000|Overall Study|Consent incorrectly taken|0|||
23197357|NCT02650284|64462705|FG001|Overall Study|Consent incorrectly taken|1|||
23197358|NCT01936649|64462706|FG000|Overall Study|Withdrawal by Subject|4|||
23197359|NCT01936649|64462706|FG000|Overall Study|Physician Decision|2|||
23197360|NCT01936649|64462706|FG000|Overall Study|Protocol Violation|2|||
23197361|NCT01936649|64462706|FG000|Overall Study|Other than specified above|5|||
23197362|NCT02574312|64462709|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
23197363|NCT02574312|64462710|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
23197364|NCT03288779|64462711|FG000|Overall Study|Withdrawal by Subject|3|||
23197365|NCT01166659|64462715|FG000|Overall Study|Subject Decision|8|||
23197366|NCT01166659|64462715|FG000|Overall Study|Investigator Decision|2|||
23197367|NCT01166659|64462715|FG000|Overall Study|Death|1|||
23197368|NCT01166659|64462715|FG000|Overall Study|Lost to Follow-up|1|||
23197369|NCT01166659|64462715|FG000|Overall Study|Study Closed at Site|1|||
23197370|NCT04598165|64462716|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
23197371|NCT04598165|64462717|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
23197372|NCT04598165|64462716|FG000|Completed 6-week Follow-up|Death|2|||
23197373|NCT04598165|64462717|FG001|Completed 6-week Follow-up|Death|1|||
23197374|NCT04598165|64462716|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
23480316|NCT00246571|65501934|FG000|Overall Study|Protocol Violation|0|||
23480317|NCT00246571|65501935|FG001|Overall Study|Protocol Violation|1|||
23480318|NCT00246571|65501934|FG000|Overall Study|Withdrawal by Subject|2|||
23197375|NCT04598165|64462717|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
23197376|NCT04598165|64462716|FG000|Completed 6-week Follow-up|Ineligible|4|||
23197377|NCT04598165|64462717|FG001|Completed 6-week Follow-up|Ineligible|3|||
23197378|NCT04598165|64462716|FG000|Completed 6-week Follow-up|Partner refusal|0|||
23197379|NCT04598165|64462717|FG001|Completed 6-week Follow-up|Partner refusal|1|||
23197380|NCT04598165|64462716|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
23197381|NCT04598165|64462717|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
23197382|NCT04359823|64462718|FG000|Overall Study|Lost to Follow-up|0|||
23197383|NCT04359823|64462719|FG001|Overall Study|Lost to Follow-up|1|||
23197384|NCT04359823|64462718|FG000|Overall Study|Withdrawal by Subject|0|||
23197385|NCT04359823|64462719|FG001|Overall Study|Withdrawal by Subject|1|||
23256743|NCT00597584|64683588|FG000|Overall Study|Pregnancy|2|||
23197386|NCT03191396|64462720|FG000|Overall Study|Lost to Follow-up|0|||
23197387|NCT03191396|64462721|FG001|Overall Study|Lost to Follow-up|3|||
23197388|NCT03191396|64462720|FG000|Overall Study|Withdrawal by Subject|3|||
23197389|NCT03191396|64462721|FG001|Overall Study|Withdrawal by Subject|2|||
23197390|NCT02778867|64462722|FG000|Phase 1|Withdrawal by Subject|2|||
23197391|NCT02778867|64462723|FG001|Phase 1|Withdrawal by Subject|3|||
23197392|NCT02778867|64462724|FG002|Phase 1|Withdrawal by Subject|0|||
23197393|NCT02778867|64462725|FG003|Phase 1|Withdrawal by Subject|0|||
23197394|NCT02778867|64462722|FG000|Phase 2|Withdrawal by Subject|0|||
23197395|NCT02778867|64462723|FG001|Phase 2|Withdrawal by Subject|0|||
23197396|NCT02778867|64462724|FG002|Phase 2|Withdrawal by Subject|1|||
23197397|NCT02778867|64462725|FG003|Phase 2|Withdrawal by Subject|0|||
23197398|NCT02778867|64462722|FG000|Phase 2|Physician Decision|0|||
23197399|NCT02778867|64462723|FG001|Phase 2|Physician Decision|0|||
23197400|NCT02778867|64462724|FG002|Phase 2|Physician Decision|0|||
23197401|NCT02778867|64462725|FG003|Phase 2|Physician Decision|1|||
23197402|NCT02778867|64462722|FG000|Phase 2|Adverse Event|0|||
23197403|NCT02778867|64462723|FG001|Phase 2|Adverse Event|0|||
23197404|NCT02778867|64462724|FG002|Phase 2|Adverse Event|0|||
23197405|NCT02778867|64462725|FG003|Phase 2|Adverse Event|1|||
23197406|NCT02379923|64462726|FG000|Overall Study|Death|5|||
23197407|NCT03242928|64462727|FG000|Overall Study|Adverse Event|2|||
23197408|NCT03242928|64462728|FG001|Overall Study|Adverse Event|1|||
23197409|NCT03242928|64462727|FG000|Overall Study|Lost to Follow-up|2|||
23197410|NCT03242928|64462728|FG001|Overall Study|Lost to Follow-up|0|||
23197411|NCT03242928|64462727|FG000|Overall Study|Physician Decision|0|||
23197412|NCT03242928|64462728|FG001|Overall Study|Physician Decision|1|||
23197413|NCT03242928|64462727|FG000|Overall Study|Withdrawal by Subject|5|||
23197414|NCT03242928|64462728|FG001|Overall Study|Withdrawal by Subject|3|||
23197415|NCT00365716|64462731|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
23197416|NCT00365716|64462732|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
23197417|NCT00365716|64462733|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23197418|NCT00365716|64462734|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23197419|NCT00365716|64462735|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23197420|NCT00365716|64462736|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23197421|NCT00365716|64462737|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
23197422|NCT00365716|64462731|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23197423|NCT00365716|64462732|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
23197424|NCT00365716|64462733|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23197425|NCT00365716|64462734|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23256744|NCT00597584|64683589|FG001|Overall Study|Pregnancy|0|||
23256745|NCT00597584|64683588|FG000|Overall Study|Withdrawal by Subject|44|||
23256746|NCT00597584|64683589|FG001|Overall Study|Withdrawal by Subject|12|||
23256747|NCT00597584|64683588|FG000|Overall Study|Discontinued Dialysis|0|||
23256748|NCT00597584|64683589|FG001|Overall Study|Discontinued Dialysis|1|||
23256749|NCT00597584|64683588|FG000|Overall Study|Lost ability to consent|1|||
23256750|NCT00597584|64683589|FG001|Overall Study|Lost ability to consent|1|||
23256751|NCT00597584|64683588|FG000|Overall Study|Never dosed|1|||
23256752|NCT00597584|64683589|FG001|Overall Study|Never dosed|0|||
23256753|NCT00597584|64683588|FG000|Overall Study|Relocation|8|||
23256754|NCT00597584|64683589|FG001|Overall Study|Relocation|6|||
23480319|NCT00246571|65501935|FG001|Overall Study|Withdrawal by Subject|3|||
23480320|NCT00246571|65501934|FG000|Overall Study|Lack of Efficacy|84|||
23197426|NCT00365716|64462735|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
23197427|NCT00365716|64462736|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23197428|NCT00365716|64462737|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
23197429|NCT00365716|64462731|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
23197430|NCT00365716|64462732|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
23197431|NCT00365716|64462733|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
23197432|NCT00365716|64462734|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
23197433|NCT00365716|64462735|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
23197434|NCT00365716|64462736|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
23197435|NCT00365716|64462737|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
23197436|NCT00365716|64462731|FG000|Base Study (Day 1 to Month 7)|Other|0|||
23197437|NCT00365716|64462732|FG001|Base Study (Day 1 to Month 7)|Other|1|||
23197438|NCT00365716|64462733|FG002|Base Study (Day 1 to Month 7)|Other|0|||
23197439|NCT00365716|64462734|FG003|Base Study (Day 1 to Month 7)|Other|0|||
23197440|NCT00365716|64462735|FG004|Base Study (Day 1 to Month 7)|Other|0|||
23197441|NCT00365716|64462736|FG005|Base Study (Day 1 to Month 7)|Other|0|||
23197442|NCT00365716|64462737|FG006|Base Study (Day 1 to Month 7)|Other|0|||
23256755|NCT00597584|64683588|FG000|Overall Study|Renal transplant|9|||
23256756|NCT00597584|64683589|FG001|Overall Study|Renal transplant|7|||
23361083|NCT04058028|65065962|FG000|Overall Study|Lost to Follow-up|1|||
23480321|NCT00246571|65501935|FG001|Overall Study|Lack of Efficacy|21|||
23480322|NCT00246571|65501934|FG000|Overall Study|Death|17|||
23480323|NCT00246571|65501935|FG001|Overall Study|Death|3|||
23480324|NCT00246571|65501934|FG000|Overall Study|Sponsor|0|||
23480325|NCT00246571|65501935|FG001|Overall Study|Sponsor|1|||
23480326|NCT00246571|65501934|FG000|Overall Study|Did not meet entrance criteria|2|||
23480327|NCT00246571|65501935|FG001|Overall Study|Did not meet entrance criteria|1|||
23480328|NCT00246571|65501934|FG000|Overall Study|Laboratory abnormalities|1|||
23480329|NCT00246571|65501935|FG001|Overall Study|Laboratory abnormalities|0|||
23480330|NCT00246571|65501934|FG000|Overall Study|Crossover participants|0|||
23480331|NCT00246571|65501935|FG001|Overall Study|Crossover participants|74|||
23480332|NCT03739242|65501938|FG000|Overall Study|Withdrawal by Subject|1|||
23480333|NCT03739242|65501939|FG001|Overall Study|Withdrawal by Subject|1|||
23480334|NCT03739242|65501938|FG000|Overall Study|Protocol Violation|0|||
23480335|NCT03739242|65501939|FG001|Overall Study|Protocol Violation|1|||
23480336|NCT00617669|65501952|FG000|Overall Study|Withdrawal by Subject|71|||
23480337|NCT00617669|65501953|FG001|Overall Study|Withdrawal by Subject|77|||
23480338|NCT00617669|65501952|FG000|Overall Study|Lost to Follow-up|3|||
23480339|NCT00617669|65501953|FG001|Overall Study|Lost to Follow-up|2|||
23480340|NCT00617669|65501952|FG000|Overall Study|Adverse Event|87|||
23480341|NCT00617669|65501953|FG001|Overall Study|Adverse Event|76|||
23480342|NCT00617669|65501952|FG000|Overall Study|Protocol Violation|2|||
23256757|NCT00947011|64683590|FG000|Overall Study|Study was terminated,PI left institution|12|||
23256758|NCT02133352|64683592|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
23256759|NCT02984683|64683595|FG000|Overall Study|Adverse Event|3|||
23256760|NCT02984683|64683596|FG001|Overall Study|Adverse Event|3|||
23256761|NCT02984683|64683595|FG000|Overall Study|Withdrawal by Subject|1|||
23256762|NCT02984683|64683596|FG001|Overall Study|Withdrawal by Subject|0|||
23256763|NCT02984683|64683595|FG000|Overall Study|Disease progression|7|||
23256764|NCT02984683|64683596|FG001|Overall Study|Disease progression|9|||
23256765|NCT01335464|64683597|FG000|Overall Study|Adverse Event|15|||
23256766|NCT01335464|64683598|FG001|Overall Study|Adverse Event|25|||
23256767|NCT01335464|64683597|FG000|Overall Study|Non compliant with protocol|2|||
23256768|NCT01335464|64683598|FG001|Overall Study|Non compliant with protocol|0|||
23256769|NCT01335464|64683597|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
23256770|NCT01335464|64683598|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
23256771|NCT01335464|64683597|FG000|Overall Study|Not treated|2|||
23256772|NCT01335464|64683598|FG001|Overall Study|Not treated|0|||
23256773|NCT01335464|64683597|FG000|Overall Study|Reason other than those stated above|1|||
23256774|NCT01335464|64683598|FG001|Overall Study|Reason other than those stated above|1|||
23256775|NCT03705351|64683599|FG000|Overall Study|Study termination|3|||
23256776|NCT03705351|64683599|FG000|Overall Study|Death|1|||
23256777|NCT03705351|64683599|FG000|Overall Study|Lack of Efficacy|2|||
23256778|NCT03705351|64683599|FG000|Overall Study|Withdrawal by Subject|1|||
23256779|NCT00408876|64683600|FG000|Overall Study|Adverse Event|9|||
23256780|NCT00408876|64683601|FG001|Overall Study|Adverse Event|17|||
23599779|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
23599780|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
23599781|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
23599782|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
23599783|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Other|1|||
23599784|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Other|0|||
23599785|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Other|0|||
23599786|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
23599787|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
23599788|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
23599789|NCT00887224|65925699|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
23599790|NCT00887224|65925700|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
23599791|NCT00887224|65925701|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
23599792|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
23599793|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
23599794|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
23599795|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
23599796|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
23599797|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
23256781|NCT00408876|64683602|FG002|Overall Study|Adverse Event|27|||
23256782|NCT00408876|64683603|FG003|Overall Study|Adverse Event|10|||
23256783|NCT00408876|64683600|FG000|Overall Study|Withdrawal by Subject|3|||
23256784|NCT00408876|64683601|FG001|Overall Study|Withdrawal by Subject|6|||
23256785|NCT00408876|64683602|FG002|Overall Study|Withdrawal by Subject|6|||
23256786|NCT00408876|64683603|FG003|Overall Study|Withdrawal by Subject|14|||
23480343|NCT00617669|65501953|FG001|Overall Study|Protocol Violation|3|||
23480344|NCT00617669|65501952|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
23480345|NCT00617669|65501953|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
23599798|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
23197443|NCT00365716|64462731|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
23197444|NCT00365716|64462732|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
23197445|NCT00365716|64462733|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
23197446|NCT00365716|64462734|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
23197447|NCT00365716|64462735|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
23197448|NCT00365716|64462736|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
23197449|NCT00365716|64462737|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
23197450|NCT00365716|64462731|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
23197451|NCT00365716|64462732|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
23197452|NCT00365716|64462733|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
23197453|NCT00365716|64462734|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
23197454|NCT00365716|64462735|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
23197455|NCT00365716|64462736|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
23197456|NCT00365716|64462737|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
23197457|NCT00365716|64462731|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
23197458|NCT00365716|64462732|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
23197459|NCT00365716|64462733|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
23197460|NCT00365716|64462734|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
23197461|NCT00365716|64462735|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
23197462|NCT00365716|64462736|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
23197463|NCT00365716|64462737|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
23197464|NCT00365716|64462731|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
23197465|NCT00365716|64462732|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
23197466|NCT00365716|64462733|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
23197467|NCT00365716|64462734|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
23197468|NCT00365716|64462735|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
23197469|NCT00365716|64462736|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
23197470|NCT00365716|64462737|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
23197471|NCT00365716|64462731|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
23197472|NCT00365716|64462732|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
23197473|NCT00365716|64462733|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
23197474|NCT00365716|64462734|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
23197475|NCT00365716|64462735|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
23197476|NCT00365716|64462736|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
23197477|NCT00365716|64462737|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
23197478|NCT00365716|64462731|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
23197479|NCT00365716|64462732|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
23197480|NCT00365716|64462733|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
23197481|NCT00365716|64462734|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
23197482|NCT00365716|64462735|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
23197483|NCT00365716|64462736|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
23197484|NCT00365716|64462737|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
23197485|NCT00365716|64462731|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
23197486|NCT00365716|64462732|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23197487|NCT00365716|64462733|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23197488|NCT00365716|64462734|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23197489|NCT00365716|64462735|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
23197490|NCT00365716|64462736|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23197491|NCT00365716|64462737|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
23197492|NCT00365716|64462731|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23197493|NCT00365716|64462732|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
23197494|NCT00365716|64462733|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
23197495|NCT00365716|64462734|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23197496|NCT00365716|64462735|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23197497|NCT00365716|64462736|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23197498|NCT00365716|64462737|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
23197499|NCT00365716|64462731|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
23197500|NCT00365716|64462732|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
23197501|NCT00365716|64462733|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
23197502|NCT00365716|64462734|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
23197503|NCT00365716|64462735|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
23480346|NCT00617669|65501952|FG000|Overall Study|Patients randomized but not treated|2|||
23599799|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
23197504|NCT00365716|64462736|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
23197505|NCT00365716|64462737|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
23197506|NCT00365716|64462731|FG000|Extension 1|Lost to Follow-up|0|||
23197507|NCT00365716|64462732|FG001|Extension 1|Lost to Follow-up|0|||
23256787|NCT00408876|64683600|FG000|Overall Study|Lack of Efficacy|2|||
23256788|NCT00408876|64683601|FG001|Overall Study|Lack of Efficacy|4|||
23480347|NCT00617669|65501953|FG001|Overall Study|Patients randomized but not treated|3|||
23480348|NCT01330017|65501954|FG000|Overall Study|Adverse Event|0|||
23197508|NCT00365716|64462733|FG002|Extension 1|Lost to Follow-up|0|||
23197509|NCT00365716|64462734|FG003|Extension 1|Lost to Follow-up|0|||
23197510|NCT00365716|64462735|FG004|Extension 1|Lost to Follow-up|0|||
23197511|NCT00365716|64462736|FG005|Extension 1|Lost to Follow-up|1|||
23197512|NCT00365716|64462737|FG006|Extension 1|Lost to Follow-up|0|||
23197513|NCT00365716|64462731|FG000|Extension 1|Other|0|||
23197514|NCT00365716|64462732|FG001|Extension 1|Other|0|||
23197515|NCT00365716|64462733|FG002|Extension 1|Other|0|||
23197516|NCT00365716|64462734|FG003|Extension 1|Other|0|||
23197517|NCT00365716|64462735|FG004|Extension 1|Other|0|||
23197518|NCT00365716|64462736|FG005|Extension 1|Other|9|||
23197519|NCT00365716|64462737|FG006|Extension 1|Other|0|||
23197520|NCT00365716|64462731|FG000|Extension 1|Moved|0|||
23197521|NCT00365716|64462732|FG001|Extension 1|Moved|0|||
23197522|NCT00365716|64462733|FG002|Extension 1|Moved|0|||
23197523|NCT00365716|64462734|FG003|Extension 1|Moved|0|||
23197524|NCT00365716|64462735|FG004|Extension 1|Moved|0|||
23197525|NCT00365716|64462736|FG005|Extension 1|Moved|4|||
23197526|NCT00365716|64462737|FG006|Extension 1|Moved|0|||
23197527|NCT00365716|64462731|FG000|Extension 1|Withdrawal by Subject|0|||
23197528|NCT00365716|64462732|FG001|Extension 1|Withdrawal by Subject|0|||
23197529|NCT00365716|64462733|FG002|Extension 1|Withdrawal by Subject|0|||
23197530|NCT00365716|64462734|FG003|Extension 1|Withdrawal by Subject|0|||
23197531|NCT00365716|64462735|FG004|Extension 1|Withdrawal by Subject|0|||
23197532|NCT00365716|64462736|FG005|Extension 1|Withdrawal by Subject|3|||
23197533|NCT00365716|64462737|FG006|Extension 1|Withdrawal by Subject|0|||
23197534|NCT00365716|64462731|FG000|Extension 1|Pregnancy|0|||
23197535|NCT00365716|64462732|FG001|Extension 1|Pregnancy|0|||
23197536|NCT00365716|64462733|FG002|Extension 1|Pregnancy|0|||
23197537|NCT00365716|64462734|FG003|Extension 1|Pregnancy|0|||
23197538|NCT00365716|64462735|FG004|Extension 1|Pregnancy|0|||
23197539|NCT00365716|64462736|FG005|Extension 1|Pregnancy|4|||
23197540|NCT00365716|64462737|FG006|Extension 1|Pregnancy|0|||
23197541|NCT00365716|64462731|FG000|Extension 1|Protocol Violation|0|||
23197542|NCT00365716|64462732|FG001|Extension 1|Protocol Violation|0|||
23197543|NCT00365716|64462733|FG002|Extension 1|Protocol Violation|0|||
23197544|NCT00365716|64462734|FG003|Extension 1|Protocol Violation|0|||
23197545|NCT00365716|64462735|FG004|Extension 1|Protocol Violation|0|||
23197546|NCT00365716|64462736|FG005|Extension 1|Protocol Violation|1|||
23197547|NCT00365716|64462737|FG006|Extension 1|Protocol Violation|0|||
23197548|NCT00365716|64462731|FG000|Extension 2|Lost to Follow-up|0|||
23197549|NCT00365716|64462732|FG001|Extension 2|Lost to Follow-up|0|||
23197550|NCT00365716|64462733|FG002|Extension 2|Lost to Follow-up|0|||
23197551|NCT00365716|64462734|FG003|Extension 2|Lost to Follow-up|0|||
23197552|NCT00365716|64462735|FG004|Extension 2|Lost to Follow-up|0|||
23197553|NCT00365716|64462736|FG005|Extension 2|Lost to Follow-up|0|||
23197554|NCT00365716|64462737|FG006|Extension 2|Lost to Follow-up|2|||
23197555|NCT00365716|64462731|FG000|Extension 2|Other|0|||
23197556|NCT00365716|64462732|FG001|Extension 2|Other|0|||
23197557|NCT00365716|64462733|FG002|Extension 2|Other|0|||
23197558|NCT00365716|64462734|FG003|Extension 2|Other|0|||
23197559|NCT00365716|64462735|FG004|Extension 2|Other|0|||
23197560|NCT00365716|64462736|FG005|Extension 2|Other|0|||
23197561|NCT00365716|64462737|FG006|Extension 2|Other|3|||
23197562|NCT00365716|64462731|FG000|Extension 2|Withdrawal by Subject|0|||
23197563|NCT00365716|64462732|FG001|Extension 2|Withdrawal by Subject|0|||
23197564|NCT00365716|64462733|FG002|Extension 2|Withdrawal by Subject|0|||
23197565|NCT00365716|64462734|FG003|Extension 2|Withdrawal by Subject|0|||
23197566|NCT00365716|64462735|FG004|Extension 2|Withdrawal by Subject|0|||
23197567|NCT00365716|64462736|FG005|Extension 2|Withdrawal by Subject|0|||
23197568|NCT00365716|64462737|FG006|Extension 2|Withdrawal by Subject|5|||
23197569|NCT00589472|64462740|FG000|Overall Study|Adverse Event|1|||
23256789|NCT00408876|64683602|FG002|Overall Study|Lack of Efficacy|5|||
23256790|NCT00408876|64683603|FG003|Overall Study|Lack of Efficacy|6|||
23480349|NCT01330017|65501955|FG001|Overall Study|Adverse Event|1|||
23197570|NCT03648996|64462741|FG000|Overall Study|Withdrawal by Subject|0|||
23197571|NCT03648996|64462742|FG001|Overall Study|Withdrawal by Subject|2|||
23197572|NCT03648996|64462743|FG002|Overall Study|Withdrawal by Subject|2|||
23197573|NCT03648996|64462741|FG000|Overall Study|Physician Decision|2|||
23197574|NCT03648996|64462742|FG001|Overall Study|Physician Decision|0|||
23197575|NCT03648996|64462743|FG002|Overall Study|Physician Decision|0|||
23197576|NCT03283163|64462744|FG000|Overall Study|Lost to Follow-up|1|||
23197577|NCT03283163|64462744|FG000|Overall Study|other life commitments|6|||
23197578|NCT03283163|64462744|FG000|Overall Study|COVID-19 institution wide halting|1|||
23197579|NCT03283163|64462744|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
23197580|NCT03283163|64462744|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
23197581|NCT01327339|64462755|FG000|Overall Study|Protocol Violation|8|||
23197582|NCT01254604|64462763|FG000|Overall Study|Lost to Follow-up|1|||
23197583|NCT01254604|64462764|FG001|Overall Study|Lost to Follow-up|1|||
23197584|NCT01254604|64462763|FG000|Overall Study|Protocol Violation|2|||
23197585|NCT01254604|64462764|FG001|Overall Study|Protocol Violation|2|||
23197586|NCT01254604|64462763|FG000|Overall Study|Withdrawal by Subject|2|||
23197587|NCT01254604|64462764|FG001|Overall Study|Withdrawal by Subject|4|||
23197588|NCT01254604|64462763|FG000|Overall Study|Adverse Event|3|||
23197589|NCT01254604|64462764|FG001|Overall Study|Adverse Event|2|||
23197590|NCT04760314|64462765|FG000|Induction Period|Withdrawal by Subject|0|||
23197591|NCT04760314|64462766|FG001|Induction Period|Withdrawal by Subject|1|||
23197592|NCT04760314|64462767|FG002|Induction Period|Withdrawal by Subject|1|||
23197593|NCT04760314|64462768|FG003|Induction Period|Withdrawal by Subject|0|||
23197594|NCT04760314|64462769|FG004|Induction Period|Withdrawal by Subject|0|||
23197595|NCT04760314|64462770|FG005|Induction Period|Withdrawal by Subject|0|||
23197596|NCT04760314|64462771|FG006|Induction Period|Withdrawal by Subject|0|||
23197597|NCT04760314|64462772|FG007|Induction Period|Withdrawal by Subject|0|||
23197598|NCT04760314|64462773|FG008|Induction Period|Withdrawal by Subject|0|||
23197599|NCT04760314|64462774|FG009|Induction Period|Withdrawal by Subject|0|||
23197600|NCT04760314|64462775|FG010|Induction Period|Withdrawal by Subject|0|||
23197601|NCT04760314|64462765|FG000|Induction Period|Adverse Event|0|||
23197602|NCT04760314|64462766|FG001|Induction Period|Adverse Event|0|||
23197603|NCT04760314|64462767|FG002|Induction Period|Adverse Event|2|||
23197604|NCT04760314|64462768|FG003|Induction Period|Adverse Event|0|||
23197605|NCT04760314|64462769|FG004|Induction Period|Adverse Event|0|||
23197606|NCT04760314|64462770|FG005|Induction Period|Adverse Event|0|||
23197607|NCT04760314|64462771|FG006|Induction Period|Adverse Event|0|||
23197608|NCT04760314|64462772|FG007|Induction Period|Adverse Event|0|||
23197609|NCT04760314|64462773|FG008|Induction Period|Adverse Event|0|||
23197610|NCT04760314|64462774|FG009|Induction Period|Adverse Event|0|||
23197611|NCT04760314|64462775|FG010|Induction Period|Adverse Event|0|||
23197612|NCT04760314|64462765|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
23197613|NCT04760314|64462766|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
23197614|NCT04760314|64462767|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
23197615|NCT04760314|64462768|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
23197616|NCT04760314|64462769|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
23197617|NCT04760314|64462770|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
23197618|NCT04760314|64462771|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
23197619|NCT04760314|64462772|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
23197620|NCT04760314|64462773|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
23197621|NCT04760314|64462774|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
23197622|NCT04760314|64462775|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
23197623|NCT04760314|64462765|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23197624|NCT04760314|64462766|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23197625|NCT04760314|64462767|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23197626|NCT04760314|64462768|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
23197627|NCT04760314|64462769|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23197628|NCT04760314|64462770|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
23197629|NCT04760314|64462771|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
23197630|NCT04760314|64462772|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23197631|NCT04760314|64462773|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23197632|NCT04760314|64462774|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23197633|NCT04760314|64462775|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
23197634|NCT04760314|64462765|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23197635|NCT04760314|64462766|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23197636|NCT04760314|64462767|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23197637|NCT04760314|64462768|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23197638|NCT04760314|64462769|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
23197639|NCT04760314|64462770|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23256791|NCT00408876|64683600|FG000|Overall Study|Lost to Follow-up|1|||
23256792|NCT00408876|64683601|FG001|Overall Study|Lost to Follow-up|6|||
23256793|NCT00408876|64683602|FG002|Overall Study|Lost to Follow-up|5|||
23256794|NCT00408876|64683603|FG003|Overall Study|Lost to Follow-up|2|||
23256795|NCT00408876|64683600|FG000|Overall Study|Protocol Violation|0|||
23256796|NCT00408876|64683601|FG001|Overall Study|Protocol Violation|3|||
23256797|NCT00408876|64683602|FG002|Overall Study|Protocol Violation|4|||
23197640|NCT04760314|64462771|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23256798|NCT00408876|64683603|FG003|Overall Study|Protocol Violation|3|||
23197641|NCT04760314|64462772|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23197642|NCT04760314|64462773|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23197643|NCT04760314|64462774|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23197644|NCT04760314|64462775|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
23256799|NCT00408876|64683600|FG000|Overall Study|Physician Decision|1|||
23256800|NCT00408876|64683601|FG001|Overall Study|Physician Decision|0|||
23256801|NCT00408876|64683602|FG002|Overall Study|Physician Decision|3|||
23361084|NCT04058028|65065963|FG001|Overall Study|Lost to Follow-up|1|||
23256802|NCT00408876|64683603|FG003|Overall Study|Physician Decision|0|||
23256803|NCT03493698|64683604|FG000|Treatment Period C|Adverse Event|1|||
23256804|NCT03493698|64683604|FG000|Treatment Period C|Withdrawal by Subject|1|||
23256805|NCT00881959|64683608|FG000|Overall Study|Lost to Follow-up|2|||
23256806|NCT00881959|64683609|FG001|Overall Study|Lost to Follow-up|4|||
23256807|NCT00490061|64683610|FG000|Overall Study|Physician Decision|1|||
23197645|NCT04760314|64462765|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
23197646|NCT04760314|64462766|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
23197647|NCT04760314|64462767|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
23197648|NCT04760314|64462768|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
23197649|NCT04760314|64462769|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
23197650|NCT04760314|64462770|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
23197651|NCT04760314|64462771|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
23197652|NCT04760314|64462772|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
23197653|NCT04760314|64462773|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
23197654|NCT04760314|64462774|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
23197655|NCT04760314|64462775|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
23197656|NCT04760314|64462765|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23197657|NCT04760314|64462766|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23197658|NCT04760314|64462767|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23197659|NCT04760314|64462768|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23197660|NCT04760314|64462769|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23197661|NCT04760314|64462770|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23197662|NCT04760314|64462771|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23197663|NCT04760314|64462772|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
23197664|NCT04760314|64462773|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23197665|NCT04760314|64462774|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
23197666|NCT04760314|64462775|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
23197667|NCT04760314|64462765|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23197668|NCT04760314|64462766|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23197669|NCT04760314|64462767|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23197670|NCT04760314|64462768|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23197671|NCT04760314|64462769|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23197672|NCT04760314|64462770|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23197673|NCT04760314|64462771|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23197674|NCT04760314|64462772|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
23197675|NCT04760314|64462773|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
23197676|NCT04760314|64462774|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
23197677|NCT04760314|64462775|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23197678|NCT04760314|64462765|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23197679|NCT04760314|64462766|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23197680|NCT04760314|64462767|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23197681|NCT04760314|64462768|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23197682|NCT04760314|64462769|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23197683|NCT04760314|64462770|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23256808|NCT00770315|64683611|FG000|Overall Study|Adverse Event|11|||
23256809|NCT00770315|64683612|FG001|Overall Study|Adverse Event|17|||
23256810|NCT00770315|64683613|FG002|Overall Study|Adverse Event|16|||
23256811|NCT00770315|64683614|FG003|Overall Study|Adverse Event|6|||
23256812|NCT00770315|64683611|FG000|Overall Study|Lost to Follow-up|9|||
23256813|NCT00770315|64683612|FG001|Overall Study|Lost to Follow-up|5|||
23256814|NCT00770315|64683613|FG002|Overall Study|Lost to Follow-up|10|||
23256815|NCT00770315|64683614|FG003|Overall Study|Lost to Follow-up|3|||
23256816|NCT00770315|64683611|FG000|Overall Study|Withdrawal by Subject|13|||
23256817|NCT00770315|64683612|FG001|Overall Study|Withdrawal by Subject|17|||
23256818|NCT00770315|64683613|FG002|Overall Study|Withdrawal by Subject|24|||
23256819|NCT00770315|64683614|FG003|Overall Study|Withdrawal by Subject|20|||
23256820|NCT00770315|64683611|FG000|Overall Study|Noncompliance with Protocol|7|||
23256821|NCT00770315|64683612|FG001|Overall Study|Noncompliance with Protocol|4|||
23256822|NCT00770315|64683613|FG002|Overall Study|Noncompliance with Protocol|7|||
23197684|NCT04760314|64462771|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23256823|NCT00770315|64683614|FG003|Overall Study|Noncompliance with Protocol|9|||
23256824|NCT02499354|64683615|FG000|Overall Study|Withdrawal by Subject|1|||
23256825|NCT02499354|64683616|FG001|Overall Study|Withdrawal by Subject|0|||
23256826|NCT05476679|64683626|FG000|Overall Study|Withdrawal by Subject|0|||
23256827|NCT05476679|64683627|FG001|Overall Study|Withdrawal by Subject|0|||
23256828|NCT05476679|64683628|FG002|Overall Study|Withdrawal by Subject|0|||
23256829|NCT05476679|64683629|FG003|Overall Study|Withdrawal by Subject|1|||
23361085|NCT04058028|65065964|FG002|Overall Study|Lost to Follow-up|1|||
23256830|NCT05476679|64683630|FG004|Overall Study|Withdrawal by Subject|0|||
23256831|NCT05476679|64683626|FG000|Overall Study|Lost to Follow-up|0|||
23256832|NCT05476679|64683627|FG001|Overall Study|Lost to Follow-up|0|||
23256833|NCT05476679|64683628|FG002|Overall Study|Lost to Follow-up|0|||
23256834|NCT05476679|64683629|FG003|Overall Study|Lost to Follow-up|1|||
23256835|NCT05476679|64683630|FG004|Overall Study|Lost to Follow-up|0|||
23256836|NCT02981602|64683631|FG000|Overall Study|Adverse Event|0|||
23256837|NCT02981602|64683632|FG001|Overall Study|Adverse Event|0|||
23256838|NCT02981602|64683633|FG002|Overall Study|Adverse Event|0|||
23256839|NCT02981602|64683634|FG003|Overall Study|Adverse Event|1|||
23256840|NCT02981602|64683635|FG004|Overall Study|Adverse Event|0|||
23256841|NCT04132232|64683636|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
23256842|NCT04132232|64683637|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
23256843|NCT04132232|64683636|FG000|Overall Study|Lost to Follow-up|6|||
23197685|NCT04760314|64462772|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
23197686|NCT04760314|64462773|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23197687|NCT04760314|64462774|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23197688|NCT04760314|64462775|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23197689|NCT04760314|64462765|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
23197690|NCT04760314|64462766|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
23197691|NCT04760314|64462767|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
23197692|NCT04760314|64462768|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
23197693|NCT04760314|64462769|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
23197694|NCT04760314|64462770|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
23197695|NCT04760314|64462771|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
23197696|NCT04760314|64462772|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
23197697|NCT04760314|64462773|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
23197698|NCT04760314|64462774|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
23197699|NCT04760314|64462775|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
23197700|NCT03502707|64462778|FG000|Overall Study|Adverse Event|0|||
23197701|NCT03502707|64462779|FG001|Overall Study|Adverse Event|0|||
23197702|NCT03502707|64462780|FG002|Overall Study|Adverse Event|0|||
23197703|NCT03502707|64462781|FG003|Overall Study|Adverse Event|0|||
23197704|NCT03502707|64462782|FG004|Overall Study|Adverse Event|0|||
23197705|NCT03502707|64462783|FG005|Overall Study|Adverse Event|0|||
23197706|NCT03502707|64462784|FG006|Overall Study|Adverse Event|0|||
23197707|NCT03502707|64462785|FG007|Overall Study|Adverse Event|0|||
23197708|NCT03502707|64462786|FG008|Overall Study|Adverse Event|0|||
23197709|NCT03502707|64462787|FG009|Overall Study|Adverse Event|0|||
23197710|NCT03502707|64462788|FG010|Overall Study|Adverse Event|0|||
23197711|NCT03502707|64462789|FG011|Overall Study|Adverse Event|0|||
23197712|NCT03502707|64462790|FG012|Overall Study|Adverse Event|0|||
23197713|NCT03502707|64462791|FG013|Overall Study|Adverse Event|0|||
23197714|NCT03502707|64462792|FG014|Overall Study|Adverse Event|0|||
23197715|NCT03502707|64462793|FG015|Overall Study|Adverse Event|1|||
23197716|NCT03502707|64462794|FG016|Overall Study|Adverse Event|5|||
23197717|NCT03502707|64462795|FG017|Overall Study|Adverse Event|0|||
23197718|NCT03502707|64462778|FG000|Overall Study|Death|0|||
23197719|NCT03502707|64462779|FG001|Overall Study|Death|0|||
23197720|NCT03502707|64462780|FG002|Overall Study|Death|0|||
23197721|NCT03502707|64462781|FG003|Overall Study|Death|1|||
23197722|NCT03502707|64462782|FG004|Overall Study|Death|0|||
23197723|NCT03502707|64462783|FG005|Overall Study|Death|0|||
23197724|NCT03502707|64462784|FG006|Overall Study|Death|0|||
23197725|NCT03502707|64462785|FG007|Overall Study|Death|0|||
23197726|NCT03502707|64462786|FG008|Overall Study|Death|1|||
23197727|NCT03502707|64462787|FG009|Overall Study|Death|1|||
23197728|NCT03502707|64462788|FG010|Overall Study|Death|0|||
23197729|NCT03502707|64462789|FG011|Overall Study|Death|0|||
23197730|NCT03502707|64462790|FG012|Overall Study|Death|1|||
23197731|NCT03502707|64462791|FG013|Overall Study|Death|0|||
23256844|NCT04132232|64683637|FG001|Overall Study|Lost to Follow-up|7|||
23256845|NCT02741271|64683638|FG000|Overall Study|Lost to Follow-up|2|||
23256846|NCT02741271|64683639|FG001|Overall Study|Lost to Follow-up|0|||
23197732|NCT03502707|64462792|FG014|Overall Study|Death|0|||
23197733|NCT03502707|64462793|FG015|Overall Study|Death|1|||
23256847|NCT02741271|64683638|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23480350|NCT01330017|65501956|FG002|Overall Study|Adverse Event|1|||
23197734|NCT03502707|64462794|FG016|Overall Study|Death|0|||
23197735|NCT03502707|64462795|FG017|Overall Study|Death|0|||
23197736|NCT03502707|64462778|FG000|Overall Study|Lost to Follow-up|0|||
23197737|NCT03502707|64462779|FG001|Overall Study|Lost to Follow-up|0|||
23197738|NCT03502707|64462780|FG002|Overall Study|Lost to Follow-up|0|||
23256848|NCT02741271|64683639|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23197739|NCT03502707|64462781|FG003|Overall Study|Lost to Follow-up|0|||
23256849|NCT01623830|64683640|FG000|Overall Study|Withdrawal by Subject|6|||
23197740|NCT03502707|64462782|FG004|Overall Study|Lost to Follow-up|0|||
23197741|NCT03502707|64462783|FG005|Overall Study|Lost to Follow-up|0|||
23197742|NCT03502707|64462784|FG006|Overall Study|Lost to Follow-up|0|||
23197743|NCT03502707|64462785|FG007|Overall Study|Lost to Follow-up|5|||
23197744|NCT03502707|64462786|FG008|Overall Study|Lost to Follow-up|0|||
23197745|NCT03502707|64462787|FG009|Overall Study|Lost to Follow-up|2|||
23197746|NCT03502707|64462788|FG010|Overall Study|Lost to Follow-up|1|||
23197747|NCT03502707|64462789|FG011|Overall Study|Lost to Follow-up|2|||
23197748|NCT03502707|64462790|FG012|Overall Study|Lost to Follow-up|1|||
23197749|NCT03502707|64462791|FG013|Overall Study|Lost to Follow-up|1|||
23197750|NCT03502707|64462792|FG014|Overall Study|Lost to Follow-up|0|||
23197751|NCT03502707|64462793|FG015|Overall Study|Lost to Follow-up|4|||
23197752|NCT03502707|64462794|FG016|Overall Study|Lost to Follow-up|9|||
23197753|NCT03502707|64462795|FG017|Overall Study|Lost to Follow-up|2|||
23197754|NCT03502707|64462778|FG000|Overall Study|Physician Decision|0|||
23197755|NCT03502707|64462779|FG001|Overall Study|Physician Decision|0|||
23197756|NCT03502707|64462780|FG002|Overall Study|Physician Decision|0|||
23197757|NCT03502707|64462781|FG003|Overall Study|Physician Decision|0|||
23197758|NCT03502707|64462782|FG004|Overall Study|Physician Decision|0|||
23197759|NCT03502707|64462783|FG005|Overall Study|Physician Decision|0|||
23197760|NCT03502707|64462784|FG006|Overall Study|Physician Decision|0|||
23197761|NCT03502707|64462785|FG007|Overall Study|Physician Decision|0|||
23197762|NCT03502707|64462786|FG008|Overall Study|Physician Decision|2|||
23197763|NCT03502707|64462787|FG009|Overall Study|Physician Decision|1|||
23197764|NCT03502707|64462788|FG010|Overall Study|Physician Decision|0|||
23197765|NCT03502707|64462789|FG011|Overall Study|Physician Decision|0|||
23197766|NCT03502707|64462790|FG012|Overall Study|Physician Decision|0|||
23197767|NCT03502707|64462791|FG013|Overall Study|Physician Decision|0|||
23197768|NCT03502707|64462792|FG014|Overall Study|Physician Decision|1|||
23197769|NCT03502707|64462793|FG015|Overall Study|Physician Decision|3|||
23197770|NCT03502707|64462794|FG016|Overall Study|Physician Decision|0|||
23197771|NCT03502707|64462795|FG017|Overall Study|Physician Decision|0|||
23197772|NCT03502707|64462778|FG000|Overall Study|Protocol Violation|0|||
23197773|NCT03502707|64462779|FG001|Overall Study|Protocol Violation|0|||
23197774|NCT03502707|64462780|FG002|Overall Study|Protocol Violation|0|||
23197775|NCT03502707|64462781|FG003|Overall Study|Protocol Violation|0|||
23197776|NCT03502707|64462782|FG004|Overall Study|Protocol Violation|0|||
23197777|NCT03502707|64462783|FG005|Overall Study|Protocol Violation|0|||
23197778|NCT03502707|64462784|FG006|Overall Study|Protocol Violation|0|||
23197779|NCT03502707|64462785|FG007|Overall Study|Protocol Violation|0|||
23197780|NCT03502707|64462786|FG008|Overall Study|Protocol Violation|0|||
23197781|NCT03502707|64462787|FG009|Overall Study|Protocol Violation|0|||
23197782|NCT03502707|64462788|FG010|Overall Study|Protocol Violation|0|||
23197783|NCT03502707|64462789|FG011|Overall Study|Protocol Violation|0|||
23197784|NCT03502707|64462790|FG012|Overall Study|Protocol Violation|0|||
23197785|NCT03502707|64462791|FG013|Overall Study|Protocol Violation|0|||
23197786|NCT03502707|64462792|FG014|Overall Study|Protocol Violation|0|||
23197787|NCT03502707|64462793|FG015|Overall Study|Protocol Violation|1|||
23197788|NCT03502707|64462794|FG016|Overall Study|Protocol Violation|0|||
23197789|NCT03502707|64462795|FG017|Overall Study|Protocol Violation|0|||
23197790|NCT03502707|64462778|FG000|Overall Study|Withdrawal by Subject|1|||
23197791|NCT03502707|64462779|FG001|Overall Study|Withdrawal by Subject|1|||
23197792|NCT03502707|64462780|FG002|Overall Study|Withdrawal by Subject|0|||
23197793|NCT03502707|64462781|FG003|Overall Study|Withdrawal by Subject|0|||
23197794|NCT03502707|64462782|FG004|Overall Study|Withdrawal by Subject|0|||
23197795|NCT03502707|64462783|FG005|Overall Study|Withdrawal by Subject|2|||
23197796|NCT03502707|64462784|FG006|Overall Study|Withdrawal by Subject|0|||
23197797|NCT03502707|64462785|FG007|Overall Study|Withdrawal by Subject|3|||
23197798|NCT03502707|64462786|FG008|Overall Study|Withdrawal by Subject|1|||
23197799|NCT03502707|64462787|FG009|Overall Study|Withdrawal by Subject|2|||
23197800|NCT03502707|64462788|FG010|Overall Study|Withdrawal by Subject|12|||
23197801|NCT03502707|64462789|FG011|Overall Study|Withdrawal by Subject|23|||
23197802|NCT03502707|64462790|FG012|Overall Study|Withdrawal by Subject|5|||
23197803|NCT03502707|64462791|FG013|Overall Study|Withdrawal by Subject|3|||
23197804|NCT03502707|64462792|FG014|Overall Study|Withdrawal by Subject|3|||
23197805|NCT03502707|64462793|FG015|Overall Study|Withdrawal by Subject|43|||
23197806|NCT03502707|64462794|FG016|Overall Study|Withdrawal by Subject|44|||
23197807|NCT03502707|64462795|FG017|Overall Study|Withdrawal by Subject|18|||
23197808|NCT03502707|64462778|FG000|Overall Study|Sponsor's Decision|1|||
23197809|NCT03502707|64462779|FG001|Overall Study|Sponsor's Decision|0|||
23197810|NCT03502707|64462780|FG002|Overall Study|Sponsor's Decision|0|||
23197811|NCT03502707|64462781|FG003|Overall Study|Sponsor's Decision|0|||
23197812|NCT03502707|64462782|FG004|Overall Study|Sponsor's Decision|0|||
23197813|NCT03502707|64462783|FG005|Overall Study|Sponsor's Decision|0|||
23197814|NCT03502707|64462784|FG006|Overall Study|Sponsor's Decision|0|||
23197815|NCT03502707|64462785|FG007|Overall Study|Sponsor's Decision|0|||
23197816|NCT03502707|64462786|FG008|Overall Study|Sponsor's Decision|0|||
23197817|NCT03502707|64462787|FG009|Overall Study|Sponsor's Decision|1|||
23197818|NCT03502707|64462788|FG010|Overall Study|Sponsor's Decision|0|||
23197819|NCT03502707|64462789|FG011|Overall Study|Sponsor's Decision|0|||
23197820|NCT03502707|64462790|FG012|Overall Study|Sponsor's Decision|0|||
23197821|NCT03502707|64462791|FG013|Overall Study|Sponsor's Decision|0|||
23197822|NCT03502707|64462792|FG014|Overall Study|Sponsor's Decision|0|||
23197823|NCT03502707|64462793|FG015|Overall Study|Sponsor's Decision|2|||
23197824|NCT03502707|64462794|FG016|Overall Study|Sponsor's Decision|1|||
23197825|NCT03502707|64462795|FG017|Overall Study|Sponsor's Decision|0|||
23197826|NCT03502707|64462778|FG000|Overall Study|Initiated Prohibited Medication|0|||
23197827|NCT03502707|64462779|FG001|Overall Study|Initiated Prohibited Medication|0|||
23197828|NCT03502707|64462780|FG002|Overall Study|Initiated Prohibited Medication|0|||
23197829|NCT03502707|64462781|FG003|Overall Study|Initiated Prohibited Medication|0|||
23197830|NCT03502707|64462782|FG004|Overall Study|Initiated Prohibited Medication|0|||
23197831|NCT03502707|64462783|FG005|Overall Study|Initiated Prohibited Medication|0|||
23197832|NCT03502707|64462784|FG006|Overall Study|Initiated Prohibited Medication|0|||
23197833|NCT03502707|64462785|FG007|Overall Study|Initiated Prohibited Medication|0|||
23197834|NCT03502707|64462786|FG008|Overall Study|Initiated Prohibited Medication|0|||
23197835|NCT03502707|64462787|FG009|Overall Study|Initiated Prohibited Medication|0|||
23197836|NCT03502707|64462788|FG010|Overall Study|Initiated Prohibited Medication|0|||
23197837|NCT03502707|64462789|FG011|Overall Study|Initiated Prohibited Medication|0|||
23197838|NCT03502707|64462790|FG012|Overall Study|Initiated Prohibited Medication|0|||
23197839|NCT03502707|64462791|FG013|Overall Study|Initiated Prohibited Medication|0|||
23197840|NCT03502707|64462792|FG014|Overall Study|Initiated Prohibited Medication|0|||
23197841|NCT03502707|64462793|FG015|Overall Study|Initiated Prohibited Medication|0|||
23197842|NCT03502707|64462794|FG016|Overall Study|Initiated Prohibited Medication|1|||
23197843|NCT03502707|64462795|FG017|Overall Study|Initiated Prohibited Medication|0|||
23197844|NCT03502707|64462778|FG000|Overall Study|Other|0|||
23197845|NCT03502707|64462779|FG001|Overall Study|Other|0|||
23197846|NCT03502707|64462780|FG002|Overall Study|Other|0|||
23197847|NCT03502707|64462781|FG003|Overall Study|Other|0|||
23197848|NCT03502707|64462782|FG004|Overall Study|Other|0|||
23197849|NCT03502707|64462783|FG005|Overall Study|Other|0|||
23197850|NCT03502707|64462784|FG006|Overall Study|Other|0|||
23197851|NCT03502707|64462785|FG007|Overall Study|Other|0|||
23197852|NCT03502707|64462786|FG008|Overall Study|Other|1|||
23197853|NCT03502707|64462787|FG009|Overall Study|Other|1|||
23197854|NCT03502707|64462788|FG010|Overall Study|Other|2|||
23197855|NCT03502707|64462789|FG011|Overall Study|Other|0|||
23197856|NCT03502707|64462790|FG012|Overall Study|Other|0|||
23197857|NCT03502707|64462791|FG013|Overall Study|Other|0|||
23197858|NCT03502707|64462792|FG014|Overall Study|Other|0|||
23197859|NCT03502707|64462793|FG015|Overall Study|Other|4|||
23197860|NCT03502707|64462794|FG016|Overall Study|Other|1|||
23197861|NCT03502707|64462795|FG017|Overall Study|Other|0|||
23197862|NCT03502707|64462778|FG000|Overall Study|Randomized but not vaccinated|0|||
23197863|NCT03502707|64462779|FG001|Overall Study|Randomized but not vaccinated|0|||
23197864|NCT03502707|64462780|FG002|Overall Study|Randomized but not vaccinated|0|||
23197865|NCT03502707|64462781|FG003|Overall Study|Randomized but not vaccinated|0|||
23197866|NCT03502707|64462782|FG004|Overall Study|Randomized but not vaccinated|0|||
23197867|NCT03502707|64462783|FG005|Overall Study|Randomized but not vaccinated|0|||
23197868|NCT03502707|64462784|FG006|Overall Study|Randomized but not vaccinated|0|||
23197869|NCT03502707|64462785|FG007|Overall Study|Randomized but not vaccinated|0|||
23197870|NCT03502707|64462786|FG008|Overall Study|Randomized but not vaccinated|0|||
23197871|NCT03502707|64462787|FG009|Overall Study|Randomized but not vaccinated|0|||
23197872|NCT03502707|64462788|FG010|Overall Study|Randomized but not vaccinated|0|||
23197873|NCT03502707|64462789|FG011|Overall Study|Randomized but not vaccinated|1|||
23197874|NCT03502707|64462790|FG012|Overall Study|Randomized but not vaccinated|0|||
23197875|NCT03502707|64462791|FG013|Overall Study|Randomized but not vaccinated|0|||
23197876|NCT03502707|64462792|FG014|Overall Study|Randomized but not vaccinated|0|||
23197877|NCT03502707|64462793|FG015|Overall Study|Randomized but not vaccinated|0|||
23197878|NCT03502707|64462794|FG016|Overall Study|Randomized but not vaccinated|0|||
23197879|NCT03502707|64462795|FG017|Overall Study|Randomized but not vaccinated|1|||
23197880|NCT01971476|64462797|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
23197881|NCT01971476|64462798|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
23197882|NCT01971476|64462799|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
23197883|NCT01971476|64462797|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
23197884|NCT01971476|64462798|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
23197885|NCT01971476|64462799|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
23197886|NCT01971476|64462797|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
23197887|NCT01971476|64462798|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
23197888|NCT01971476|64462799|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
23197889|NCT04956692|64462800|FG000|Overall Study|Death|115|||
23197890|NCT04956692|64462801|FG001|Overall Study|Death|47|||
23197891|NCT04956692|64462800|FG000|Overall Study|Lost to Follow-up|0|||
23197892|NCT04956692|64462801|FG001|Overall Study|Lost to Follow-up|1|||
23256850|NCT01623830|64683641|FG001|Overall Study|Withdrawal by Subject|7|||
23197893|NCT04956692|64462800|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23197894|NCT04956692|64462801|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23197895|NCT04956692|64462800|FG000|Overall Study|Withdrawal by Subject|5|||
23197896|NCT04956692|64462801|FG001|Overall Study|Withdrawal by Subject|2|||
23197897|NCT04956692|64462800|FG000|Overall Study|Ongoing in Study|236|||
23197898|NCT04956692|64462801|FG001|Overall Study|Ongoing in Study|123|||
23197899|NCT03282123|64462802|FG000|Overall Study|Withdrawal by Subject|5|||
23197900|NCT00611455|64462803|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
23197901|NCT00611455|64462804|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
23197902|NCT00611455|64462805|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23197903|NCT00611455|64462803|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
23197904|NCT00611455|64462804|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23197905|NCT00611455|64462805|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
23197906|NCT00611455|64462803|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
23197907|NCT00611455|64462804|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
23197908|NCT00611455|64462805|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23197909|NCT00611455|64462803|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
23197910|NCT00611455|64462804|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
23197911|NCT00611455|64462805|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23197912|NCT00611455|64462803|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
23197913|NCT00611455|64462804|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
23197914|NCT00611455|64462805|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
23197915|NCT00611455|64462803|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
23197916|NCT00611455|64462804|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
23197917|NCT00611455|64462805|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
23197918|NCT00611455|64462803|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
23197919|NCT00611455|64462804|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
23197920|NCT00611455|64462805|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
23197921|NCT00611455|64462803|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
23197922|NCT00611455|64462804|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
23197923|NCT00611455|64462805|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
23197924|NCT00611455|64462803|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
23197925|NCT00611455|64462804|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
23197926|NCT00611455|64462805|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
23197927|NCT00611455|64462803|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
23197928|NCT00611455|64462804|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
23197929|NCT00611455|64462805|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
23197930|NCT00611455|64462803|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
23197931|NCT00611455|64462804|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
23197932|NCT00611455|64462805|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
23197933|NCT00611455|64462803|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
23197934|NCT00611455|64462804|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
23197935|NCT00611455|64462805|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
23599800|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
23599801|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
23599802|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
23599803|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
23599804|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Other|30|||
23599805|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Other|0|||
23599806|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Other|0|||
23599807|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
23197936|NCT00611455|64462803|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
23197937|NCT00611455|64462804|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
23197938|NCT00611455|64462805|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
23197939|NCT00611455|64462803|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
23197940|NCT00611455|64462804|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
23197941|NCT00611455|64462805|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
23197942|NCT00611455|64462803|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
23197943|NCT00611455|64462804|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
23197944|NCT00611455|64462805|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
23197945|NCT00611455|64462803|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
23197946|NCT00611455|64462804|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
23197947|NCT00611455|64462805|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
23197948|NCT00611455|64462803|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
23197949|NCT00611455|64462804|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
23197950|NCT00611455|64462805|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
23361086|NCT04058028|65065965|FG003|Overall Study|Lost to Follow-up|0|||
23599808|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
23599809|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
23197951|NCT00611455|64462803|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
23197952|NCT00611455|64462804|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
23197953|NCT00611455|64462805|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
23197954|NCT00611455|64462803|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
23197955|NCT00611455|64462804|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
23197956|NCT00611455|64462805|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
23197957|NCT00611455|64462803|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
23197958|NCT00611455|64462804|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
23197959|NCT00611455|64462805|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
23197960|NCT00611455|64462803|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
23197961|NCT00611455|64462804|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
23197962|NCT00611455|64462805|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
23197963|NCT02416908|64462807|FG000|Dose Escalation Phase|Adverse Event|0|||
23197964|NCT02416908|64462808|FG001|Dose Escalation Phase|Adverse Event|0|||
23197965|NCT02416908|64462809|FG002|Dose Escalation Phase|Adverse Event|3|||
23197966|NCT02416908|64462810|FG003|Dose Escalation Phase|Adverse Event|0|||
23197967|NCT02416908|64462807|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23197968|NCT02416908|64462808|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
23197969|NCT02416908|64462809|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
23197970|NCT02416908|64462810|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23197971|NCT02037919|64462811|FG000|Overall Study|Lost to Follow-up|30|||
23197972|NCT02037919|64462812|FG001|Overall Study|Lost to Follow-up|45|||
23197973|NCT01000064|64462813|FG000|Overall Study|Withdrawal by Subject|1|||
23197974|NCT01000064|64462814|FG001|Overall Study|Withdrawal by Subject|1|||
23197975|NCT03345836|64462815|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
23197976|NCT03345836|64462816|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
23197977|NCT03345836|64462817|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
23197978|NCT03345836|64462818|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
23197979|NCT03345836|64462819|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
23197980|NCT03345836|64462820|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
23197981|NCT03345836|64462815|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
23197982|NCT03345836|64462816|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
23197983|NCT03345836|64462817|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
23197984|NCT03345836|64462818|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
23197985|NCT03345836|64462819|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
23197986|NCT03345836|64462820|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
23197987|NCT03345836|64462815|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23197988|NCT03345836|64462816|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
23197989|NCT03345836|64462817|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23197990|NCT03345836|64462818|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23197991|NCT03345836|64462819|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23197992|NCT03345836|64462820|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
23197993|NCT03345836|64462815|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
23197994|NCT03345836|64462816|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
23197995|NCT03345836|64462817|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
23197996|NCT03345836|64462818|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
23197997|NCT03345836|64462819|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
23197998|NCT03345836|64462820|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
23197999|NCT03345836|64462815|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
23198000|NCT03345836|64462816|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
23198001|NCT03345836|64462817|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
23198002|NCT03345836|64462818|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
23198003|NCT03345836|64462819|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
23198004|NCT03345836|64462820|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
23198005|NCT03345836|64462815|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
23198006|NCT03345836|64462816|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
23198007|NCT03345836|64462817|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
23198008|NCT03345836|64462818|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
23198009|NCT03345836|64462819|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
23198010|NCT03345836|64462820|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
23198011|NCT03345836|64462815|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
23256851|NCT01623830|64683640|FG000|Overall Study|Exclusion from Study|1|||
23256852|NCT01623830|64683641|FG001|Overall Study|Exclusion from Study|2|||
23256853|NCT01637961|64683643|FG000|Overall Study|Ineligible: wrong primary|1|||
23256854|NCT01637961|64683643|FG000|Overall Study|Ineligible: inadequate pathology|1|||
23256855|NCT02418910|64683650|FG000|Overall Study|Lost to Follow-up|3|||
23198012|NCT03345836|64462816|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
23198013|NCT03345836|64462817|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
23198014|NCT03345836|64462818|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
23198015|NCT03345836|64462819|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
23198016|NCT03345836|64462820|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
23198017|NCT03345836|64462815|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23198018|NCT03345836|64462816|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23256856|NCT02418910|64683650|FG000|Overall Study|Withdrawal by Subject|4|||
23256857|NCT03210259|64683651|FG000|12-Week Run-in Period|Adverse Event|1|||
23256858|NCT03210259|64683652|FG001|12-Week Run-in Period|Adverse Event|0|||
23256859|NCT03210259|64683653|FG002|12-Week Run-in Period|Adverse Event|0|||
23256860|NCT03210259|64683651|FG000|12-Week Run-in Period|Death|1|||
23256861|NCT03210259|64683652|FG001|12-Week Run-in Period|Death|0|||
23256862|NCT03210259|64683653|FG002|12-Week Run-in Period|Death|0|||
23256863|NCT03210259|64683651|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
23256864|NCT03210259|64683652|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
23256865|NCT03210259|64683653|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
23256866|NCT03210259|64683651|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
23256867|NCT03210259|64683652|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
23256868|NCT03210259|64683653|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
23256869|NCT03210259|64683651|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
23256870|NCT03210259|64683652|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
23256871|NCT03210259|64683653|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
23256872|NCT03210259|64683651|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
23198019|NCT03345836|64462817|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23256873|NCT03210259|64683652|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
23256874|NCT03210259|64683653|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
23198020|NCT03345836|64462818|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23256875|NCT03210259|64683651|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
23256876|NCT03210259|64683652|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
23256877|NCT03210259|64683653|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
23256878|NCT03210259|64683651|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
23256879|NCT03210259|64683652|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
23256880|NCT03210259|64683653|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
23256881|NCT03210259|64683651|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
23256882|NCT03210259|64683652|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
23256883|NCT03210259|64683653|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
23256884|NCT03210259|64683651|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
23256885|NCT03210259|64683652|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
23256886|NCT03210259|64683653|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
23256887|NCT03210259|64683651|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
23256888|NCT03210259|64683652|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
23198021|NCT03345836|64462819|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
23198022|NCT03345836|64462820|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
23480351|NCT01330017|65501957|FG003|Overall Study|Adverse Event|4|||
23198023|NCT03345836|64462815|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
23198024|NCT03345836|64462816|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
23198025|NCT03345836|64462817|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
23198026|NCT03345836|64462818|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
23198027|NCT03345836|64462819|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
23198028|NCT03345836|64462820|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
23198029|NCT03345836|64462815|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23198030|NCT03345836|64462816|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23198031|NCT03345836|64462817|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23198032|NCT03345836|64462818|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23198033|NCT03345836|64462819|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
23198034|NCT03345836|64462820|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
23198035|NCT03345836|64462815|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
23198036|NCT03345836|64462816|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
23198037|NCT03345836|64462817|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
23198038|NCT03345836|64462818|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
23198039|NCT03345836|64462819|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
23198040|NCT03345836|64462820|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
23198041|NCT00938327|64462821|FG000|Overall Study|Adverse Event|2|||
23198042|NCT00938327|64462821|FG000|Overall Study|Protocol Violation|1|||
23198043|NCT00938327|64462821|FG000|Overall Study|Withdrawal by Subject|4|||
23198044|NCT00938327|64462821|FG000|Overall Study|Lost to Follow-up|37|||
23198045|NCT00938327|64462821|FG000|Overall Study|2nd dose received outside of the study|7|||
23198046|NCT00938327|64462821|FG000|Overall Study|Vaccine not received as out of stock|9|||
23198047|NCT01790438|64462822|FG000|Overall Study|Adverse Event|3|||
23198048|NCT01790438|64462823|FG001|Overall Study|Adverse Event|2|||
23198049|NCT01790438|64462822|FG000|Overall Study|Death|4|||
23198050|NCT01790438|64462823|FG001|Overall Study|Death|0|||
23198051|NCT01790438|64462822|FG000|Overall Study|Lost to Follow-up|5|||
23198052|NCT01790438|64462823|FG001|Overall Study|Lost to Follow-up|2|||
23198053|NCT01790438|64462822|FG000|Overall Study|Withdrawal by Subject|13|||
23198054|NCT01790438|64462823|FG001|Overall Study|Withdrawal by Subject|2|||
23198055|NCT01790438|64462822|FG000|Overall Study|Physician Decision|3|||
23198056|NCT01790438|64462823|FG001|Overall Study|Physician Decision|1|||
23198057|NCT01790438|64462822|FG000|Overall Study|Sponsor Decision|0|||
23198058|NCT01790438|64462823|FG001|Overall Study|Sponsor Decision|3|||
23198059|NCT01790438|64462822|FG000|Overall Study|Protocol Required Discontinuation|7|||
23198060|NCT01790438|64462823|FG001|Overall Study|Protocol Required Discontinuation|1|||
23256889|NCT03210259|64683653|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
23198061|NCT03303339|64462824|FG000|Overall Study|Death|2|||
23198062|NCT03303339|64462825|FG001|Overall Study|Death|2|||
23198063|NCT03303339|64462826|FG002|Overall Study|Death|2|||
23198064|NCT03303339|64462827|FG003|Overall Study|Death|1|||
23198065|NCT03303339|64462828|FG004|Overall Study|Death|4|||
23198066|NCT03303339|64462829|FG005|Overall Study|Death|2|||
23198067|NCT03303339|64462830|FG006|Overall Study|Death|2|||
23198068|NCT03303339|64462831|FG007|Overall Study|Death|2|||
23198069|NCT03303339|64462832|FG008|Overall Study|Death|3|||
23256890|NCT00686920|64683654|FG000|Overall Study|Death|45|||
23256891|NCT00686920|64683655|FG001|Overall Study|Death|14|||
23256892|NCT00686920|64683654|FG000|Overall Study|Liver Transplant|23|||
23256893|NCT00686920|64683655|FG001|Overall Study|Liver Transplant|8|||
23256894|NCT00686920|64683654|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
23256895|NCT00686920|64683655|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
23256896|NCT00686920|64683654|FG000|Overall Study|Withdrawal by Subject|23|||
23256897|NCT00686920|64683655|FG001|Overall Study|Withdrawal by Subject|5|||
23256898|NCT00686920|64683654|FG000|Overall Study|Protocol Violation|2|||
23256899|NCT00686920|64683655|FG001|Overall Study|Protocol Violation|1|||
23256900|NCT00686920|64683654|FG000|Overall Study|Adverse Event|10|||
23256901|NCT00686920|64683655|FG001|Overall Study|Adverse Event|2|||
23256902|NCT00686920|64683654|FG000|Overall Study|Personal Reason|0|||
23256903|NCT00686920|64683655|FG001|Overall Study|Personal Reason|1|||
23256904|NCT00686920|64683654|FG000|Overall Study|Lost to Follow-up|15|||
23256905|NCT00686920|64683655|FG001|Overall Study|Lost to Follow-up|3|||
23256906|NCT00686920|64683654|FG000|Overall Study|Moved to Another State|1|||
23256907|NCT00686920|64683655|FG001|Overall Study|Moved to Another State|0|||
23256908|NCT00686920|64683654|FG000|Overall Study|Transferred to Nursing Home|1|||
23256909|NCT00686920|64683655|FG001|Overall Study|Transferred to Nursing Home|0|||
23256910|NCT00686920|64683654|FG000|Overall Study|Noncompliance|9|||
23256911|NCT00686920|64683655|FG001|Overall Study|Noncompliance|0|||
23256912|NCT00686920|64683654|FG000|Overall Study|Principal Investigator Decision|2|||
23256913|NCT00686920|64683655|FG001|Overall Study|Principal Investigator Decision|0|||
23256914|NCT00571922|64683658|FG000|Overall Study|Completion unknown|36|||
23256915|NCT00571922|64683659|FG001|Overall Study|Completion unknown|36|||
23256916|NCT00461500|64683662|FG000|Overall Study|Adverse Event|1|||
23256917|NCT00461500|64683663|FG001|Overall Study|Adverse Event|0|||
23256918|NCT00461500|64683662|FG000|Overall Study|Lack of Efficacy|0|||
23256919|NCT00461500|64683663|FG001|Overall Study|Lack of Efficacy|1|||
23256920|NCT00461500|64683662|FG000|Overall Study|Expired Drug Treatment|1|||
23256921|NCT00461500|64683663|FG001|Overall Study|Expired Drug Treatment|1|||
23256922|NCT00461500|64683662|FG000|Overall Study|Study Stopped|1|||
23256923|NCT00461500|64683663|FG001|Overall Study|Study Stopped|2|||
23256924|NCT00461500|64683662|FG000|Overall Study|Drug Treatment Misuse|1|||
23256925|NCT00461500|64683663|FG001|Overall Study|Drug Treatment Misuse|0|||
23256926|NCT00461500|64683662|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
23256927|NCT00461500|64683663|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
23256928|NCT00461500|64683662|FG000|Overall Study|Lost to Follow-up|2|||
23256929|NCT00461500|64683663|FG001|Overall Study|Lost to Follow-up|2|||
23256930|NCT02024698|64683664|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
23256931|NCT02024698|64683665|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
23256932|NCT02290028|64683666|FG000|Overall Study|Death|217|||
23256933|NCT02290028|64683666|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
23256934|NCT02290028|64683666|FG000|Overall Study|No longer under care of study physician|76|||
23256935|NCT02290028|64683666|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
23256936|NCT02290028|64683666|FG000|Overall Study|Withdrawal by Subject|52|||
23256937|NCT02290028|64683666|FG000|Overall Study|Study site closure|44|||
23256938|NCT02290028|64683666|FG000|Overall Study|Lost to Follow-up|34|||
23256939|NCT02290028|64683666|FG000|Overall Study|Miscellaneous|10|||
23599810|NCT00887224|65925699|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
23599811|NCT00887224|65925700|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
23599812|NCT00887224|65925701|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
23599813|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Adverse Event|0|||
23599814|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Adverse Event|7|||
23599815|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Adverse Event|2|||
23599816|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Failed to return|0|||
23599817|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Failed to return|2|||
23599818|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Failed to return|2|||
23599819|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
23599820|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
23599821|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
23256940|NCT02290028|64683666|FG000|Overall Study|Transition to EP PASSION|1295|||
23256941|NCT02290028|64683666|FG000|Overall Study|Planned study completion at 12 months|257|||
23256942|NCT02762565|64683680|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
23256943|NCT00475852|64683687|FG000|Overall Study|Death|444|||
23256944|NCT00475852|64683688|FG001|Overall Study|Death|456|||
23256945|NCT00475852|64683687|FG000|Overall Study|Withdrawal by Subject|19|||
23480352|NCT01330017|65501958|FG004|Overall Study|Adverse Event|0|||
23256946|NCT00475852|64683688|FG001|Overall Study|Withdrawal by Subject|24|||
23256947|NCT00475852|64683687|FG000|Overall Study|Lost to Follow-up|54|||
23480353|NCT01330017|65501954|FG000|Overall Study|Withdrawal by Subject|0|||
23599822|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
23599823|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
23599824|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
23599825|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Other|0|||
23256948|NCT00475852|64683688|FG001|Overall Study|Lost to Follow-up|68|||
23256949|NCT02763579|64683690|FG000|Global Period|Death|167|||
23256950|NCT02763579|64683691|FG001|Global Period|Death|151|||
23256951|NCT02763579|64683692|FG002|Global Period|Death|0|||
23256952|NCT02763579|64683693|FG003|Global Period|Death|0|||
23256953|NCT02763579|64683690|FG000|Global Period|Lost to Follow-up|2|||
23256954|NCT02763579|64683691|FG001|Global Period|Lost to Follow-up|4|||
23198070|NCT03303339|64462833|FG009|Overall Study|Death|3|||
23198071|NCT03303339|64462834|FG010|Overall Study|Death|4|||
23198072|NCT03303339|64462835|FG011|Overall Study|Death|24|||
23198073|NCT03303339|64462824|FG000|Overall Study|Study Terminated by Sponsor|0|||
23198074|NCT03303339|64462825|FG001|Overall Study|Study Terminated by Sponsor|0|||
23198075|NCT03303339|64462826|FG002|Overall Study|Study Terminated by Sponsor|0|||
23198076|NCT03303339|64462827|FG003|Overall Study|Study Terminated by Sponsor|0|||
23198077|NCT03303339|64462828|FG004|Overall Study|Study Terminated by Sponsor|0|||
23198078|NCT03303339|64462829|FG005|Overall Study|Study Terminated by Sponsor|0|||
23198079|NCT03303339|64462830|FG006|Overall Study|Study Terminated by Sponsor|0|||
23198080|NCT03303339|64462831|FG007|Overall Study|Study Terminated by Sponsor|0|||
23198081|NCT03303339|64462832|FG008|Overall Study|Study Terminated by Sponsor|1|||
23198082|NCT03303339|64462833|FG009|Overall Study|Study Terminated by Sponsor|0|||
23198083|NCT03303339|64462834|FG010|Overall Study|Study Terminated by Sponsor|1|||
23198084|NCT03303339|64462835|FG011|Overall Study|Study Terminated by Sponsor|1|||
23198085|NCT03303339|64462824|FG000|Overall Study|Withdrawal by Subject|1|||
23198086|NCT03303339|64462825|FG001|Overall Study|Withdrawal by Subject|0|||
23198087|NCT03303339|64462826|FG002|Overall Study|Withdrawal by Subject|0|||
23198088|NCT03303339|64462827|FG003|Overall Study|Withdrawal by Subject|0|||
23198089|NCT03303339|64462828|FG004|Overall Study|Withdrawal by Subject|0|||
23198090|NCT03303339|64462829|FG005|Overall Study|Withdrawal by Subject|1|||
23198091|NCT03303339|64462830|FG006|Overall Study|Withdrawal by Subject|1|||
23198092|NCT03303339|64462831|FG007|Overall Study|Withdrawal by Subject|0|||
23198093|NCT03303339|64462832|FG008|Overall Study|Withdrawal by Subject|0|||
23198094|NCT03303339|64462833|FG009|Overall Study|Withdrawal by Subject|0|||
23198095|NCT03303339|64462834|FG010|Overall Study|Withdrawal by Subject|0|||
23198096|NCT03303339|64462835|FG011|Overall Study|Withdrawal by Subject|2|||
23198097|NCT03303339|64462824|FG000|Overall Study|Physician Decision|0|||
23198098|NCT03303339|64462825|FG001|Overall Study|Physician Decision|0|||
23198099|NCT03303339|64462826|FG002|Overall Study|Physician Decision|0|||
23198100|NCT03303339|64462827|FG003|Overall Study|Physician Decision|0|||
23198101|NCT03303339|64462828|FG004|Overall Study|Physician Decision|1|||
23198102|NCT03303339|64462829|FG005|Overall Study|Physician Decision|0|||
23198103|NCT03303339|64462830|FG006|Overall Study|Physician Decision|0|||
23198104|NCT03303339|64462831|FG007|Overall Study|Physician Decision|0|||
23198105|NCT03303339|64462832|FG008|Overall Study|Physician Decision|0|||
23198106|NCT03303339|64462833|FG009|Overall Study|Physician Decision|0|||
23198107|NCT03303339|64462834|FG010|Overall Study|Physician Decision|0|||
23198108|NCT03303339|64462835|FG011|Overall Study|Physician Decision|0|||
23198109|NCT03303339|64462824|FG000|Overall Study|Safety/Non-compliance|0|||
23198110|NCT03303339|64462825|FG001|Overall Study|Safety/Non-compliance|0|||
23198111|NCT03303339|64462826|FG002|Overall Study|Safety/Non-compliance|0|||
23198112|NCT03303339|64462827|FG003|Overall Study|Safety/Non-compliance|0|||
23198113|NCT03303339|64462828|FG004|Overall Study|Safety/Non-compliance|0|||
23198114|NCT03303339|64462829|FG005|Overall Study|Safety/Non-compliance|0|||
23198115|NCT03303339|64462830|FG006|Overall Study|Safety/Non-compliance|0|||
23198116|NCT03303339|64462831|FG007|Overall Study|Safety/Non-compliance|0|||
23198117|NCT03303339|64462832|FG008|Overall Study|Safety/Non-compliance|0|||
23198118|NCT03303339|64462833|FG009|Overall Study|Safety/Non-compliance|0|||
23198119|NCT03303339|64462834|FG010|Overall Study|Safety/Non-compliance|0|||
23198120|NCT03303339|64462835|FG011|Overall Study|Safety/Non-compliance|1|||
23198121|NCT00496873|64462836|FG000|Overall Study|Ineligible|2|||
23198122|NCT00496873|64462836|FG000|Overall Study|Death|2|||
23198123|NCT00496873|64462836|FG000|Overall Study|Withdrawal by Subject|3|||
23256955|NCT02763579|64683692|FG002|Global Period|Lost to Follow-up|0|||
23256956|NCT02763579|64683693|FG003|Global Period|Lost to Follow-up|0|||
23256957|NCT02763579|64683690|FG000|Global Period|Physician Decision|0|||
23256958|NCT02763579|64683691|FG001|Global Period|Physician Decision|2|||
23256959|NCT02763579|64683692|FG002|Global Period|Physician Decision|0|||
23256960|NCT02763579|64683693|FG003|Global Period|Physician Decision|0|||
23256961|NCT02763579|64683690|FG000|Global Period|Study Terminated By Sponsor|21|||
23256962|NCT02763579|64683691|FG001|Global Period|Study Terminated By Sponsor|26|||
23256963|NCT02763579|64683692|FG002|Global Period|Study Terminated By Sponsor|0|||
23256964|NCT02763579|64683693|FG003|Global Period|Study Terminated By Sponsor|0|||
23256965|NCT02763579|64683690|FG000|Global Period|Withdrawal by Subject|12|||
23361087|NCT04058028|65065962|FG000|Overall Study|Death|0|||
23256966|NCT02763579|64683691|FG001|Global Period|Withdrawal by Subject|18|||
23256967|NCT02763579|64683692|FG002|Global Period|Withdrawal by Subject|0|||
23256968|NCT02763579|64683693|FG003|Global Period|Withdrawal by Subject|0|||
23256969|NCT02763579|64683690|FG000|China Period|Death|0|||
23256970|NCT02763579|64683691|FG001|China Period|Death|0|||
23256971|NCT02763579|64683692|FG002|China Period|Death|46|||
23256972|NCT02763579|64683693|FG003|China Period|Death|48|||
23256973|NCT02763579|64683690|FG000|China Period|Lost to Follow-up|0|||
23256974|NCT02763579|64683691|FG001|China Period|Lost to Follow-up|0|||
23256975|NCT02763579|64683692|FG002|China Period|Lost to Follow-up|1|||
23256976|NCT02763579|64683693|FG003|China Period|Lost to Follow-up|1|||
23256977|NCT02763579|64683690|FG000|China Period|Physician Decision|0|||
23256978|NCT02763579|64683691|FG001|China Period|Physician Decision|0|||
23256979|NCT02763579|64683692|FG002|China Period|Physician Decision|0|||
23256980|NCT02763579|64683693|FG003|China Period|Physician Decision|1|||
23198124|NCT03977727|64465346|FG000|Second Treatment|Lost to Follow-up|0|||
23198125|NCT03977727|64465347|FG001|Second Treatment|Lost to Follow-up|3|||
23198126|NCT00369668|64465348|FG000|Overall Study|Lack of Efficacy|4|||
23198127|NCT00369668|64465349|FG001|Overall Study|Lack of Efficacy|5|||
23198128|NCT00369668|64465350|FG002|Overall Study|Lack of Efficacy|7|||
23198129|NCT00084682|64465351|FG000|Overall Study|Withdrawal by Subject|1|||
23198130|NCT02086565|64465353|FG000|Overall Study|Lost to Follow-up|9|||
23198131|NCT02086565|64465354|FG001|Overall Study|Lost to Follow-up|7|||
23198132|NCT02086565|64465353|FG000|Overall Study|Withdrawal by Subject|2|||
23198133|NCT02086565|64465354|FG001|Overall Study|Withdrawal by Subject|1|||
23198134|NCT02086565|64465353|FG000|Overall Study|Death|3|||
23198135|NCT02086565|64465354|FG001|Overall Study|Death|2|||
23198136|NCT02086565|64465353|FG000|Overall Study|withdrawn by research team|2|||
23198137|NCT02086565|64465354|FG001|Overall Study|withdrawn by research team|2|||
23198138|NCT03268746|64465355|FG000|Overall Study|Withdrawal by Subject|1|||
23198139|NCT01765764|64465356|FG000|Treatment Period|Adverse Event|1|||
23198140|NCT01765764|64465357|FG001|Treatment Period|Adverse Event|2|||
23198141|NCT01765764|64465358|FG002|Treatment Period|Adverse Event|1|||
23198142|NCT01765764|64465356|FG000|Treatment Period|Lost to Follow-up|0|||
23198143|NCT01765764|64465357|FG001|Treatment Period|Lost to Follow-up|3|||
23198144|NCT01765764|64465358|FG002|Treatment Period|Lost to Follow-up|2|||
23198145|NCT01765764|64465356|FG000|Treatment Period|Personal Reasons|1|||
23198146|NCT01765764|64465357|FG001|Treatment Period|Personal Reasons|2|||
23198147|NCT01765764|64465358|FG002|Treatment Period|Personal Reasons|1|||
23198148|NCT01765764|64465356|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
23198149|NCT01765764|64465357|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
23198150|NCT01765764|64465358|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
23198151|NCT02775864|64465366|FG000|Overall Study|Data ended end of 2010|1764|||
23198152|NCT02775864|64465367|FG001|Overall Study|Data ended end of 2010|2880|||
23198153|NCT02775864|64465368|FG002|Overall Study|Data ended end of 2010|1140|||
23198154|NCT02775864|64465369|FG003|Overall Study|Data ended end of 2010|1194|||
23198155|NCT02775864|64465366|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
23198156|NCT02775864|64465367|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
23198157|NCT02775864|64465368|FG002|Overall Study|Medicaid eligibility discontinued|720|||
23198158|NCT02775864|64465369|FG003|Overall Study|Medicaid eligibility discontinued|890|||
23198159|NCT00536978|64465370|FG000|Overall Study|Not eligible for Adback Infusion|22|||
23198160|NCT01614769|64465371|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
23198161|NCT01614769|64465372|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
23198162|NCT01614769|64465373|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
23198163|NCT01614769|64465374|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
23198164|NCT01614769|64465375|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
23198165|NCT01614769|64465376|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
23198166|NCT01614769|64465371|FG000|Period 1|Protocol Violation|0|||
23198167|NCT01614769|64465372|FG001|Period 1|Protocol Violation|0|||
23198168|NCT01614769|64465373|FG002|Period 1|Protocol Violation|0|||
23198169|NCT01614769|64465374|FG003|Period 1|Protocol Violation|1|||
23198170|NCT01614769|64465375|FG004|Period 1|Protocol Violation|0|||
23198171|NCT01614769|64465376|FG005|Period 1|Protocol Violation|0|||
23198172|NCT01614769|64465371|FG000|Period 1|Withdrawal by Subject|1|||
23198173|NCT01614769|64465372|FG001|Period 1|Withdrawal by Subject|0|||
23198174|NCT01614769|64465373|FG002|Period 1|Withdrawal by Subject|0|||
23198175|NCT01614769|64465374|FG003|Period 1|Withdrawal by Subject|0|||
23256981|NCT02763579|64683690|FG000|China Period|Study Terminated By Sponsor|0|||
23256982|NCT02763579|64683691|FG001|China Period|Study Terminated By Sponsor|0|||
23256983|NCT02763579|64683692|FG002|China Period|Study Terminated By Sponsor|3|||
23256984|NCT02763579|64683693|FG003|China Period|Study Terminated By Sponsor|4|||
23198176|NCT01614769|64465375|FG004|Period 1|Withdrawal by Subject|0|||
23198177|NCT01614769|64465376|FG005|Period 1|Withdrawal by Subject|0|||
23198178|NCT01614769|64465371|FG000|Period 3|Withdrawal by Subject|0|||
23198179|NCT01614769|64465372|FG001|Period 3|Withdrawal by Subject|0|||
23198180|NCT01614769|64465373|FG002|Period 3|Withdrawal by Subject|1|||
23256985|NCT02763579|64683690|FG000|China Period|Withdrawal by Subject|0|||
23256986|NCT02763579|64683691|FG001|China Period|Withdrawal by Subject|0|||
23198181|NCT01614769|64465374|FG003|Period 3|Withdrawal by Subject|0|||
23198182|NCT01614769|64465375|FG004|Period 3|Withdrawal by Subject|0|||
23198183|NCT01614769|64465376|FG005|Period 3|Withdrawal by Subject|0|||
23198184|NCT01666444|64465380|FG000|Overall Study|Did not initiate treatment|2|||
23198185|NCT01666444|64465381|FG001|Overall Study|Did not initiate treatment|1|||
23198186|NCT04229446|64465382|FG000|Overall Study|Death|12|||
23198187|NCT04229446|64465383|FG001|Overall Study|Death|10|||
23198188|NCT04229446|64465382|FG000|Overall Study|Lost to Follow-up|5|||
23198189|NCT04229446|64465383|FG001|Overall Study|Lost to Follow-up|8|||
23256987|NCT02763579|64683692|FG002|China Period|Withdrawal by Subject|3|||
23256988|NCT02763579|64683693|FG003|China Period|Withdrawal by Subject|3|||
23256989|NCT01326702|64683694|FG000|Overall Study|Other|1|||
23256990|NCT01326702|64683695|FG001|Overall Study|Other|0|||
23256991|NCT01326702|64683696|FG002|Overall Study|Other|0|||
23256992|NCT01326702|64683697|FG003|Overall Study|Other|0|||
23256993|NCT01326702|64683698|FG004|Overall Study|Other|0|||
23256994|NCT01326702|64683699|FG005|Overall Study|Other|1|||
23256995|NCT01326702|64683700|FG006|Overall Study|Other|0|||
23256996|NCT01326702|64683694|FG000|Overall Study|progressive disease|1|||
23256997|NCT01326702|64683695|FG001|Overall Study|progressive disease|1|||
23256998|NCT01326702|64683696|FG002|Overall Study|progressive disease|3|||
23256999|NCT01326702|64683697|FG003|Overall Study|progressive disease|1|||
23257000|NCT01326702|64683698|FG004|Overall Study|progressive disease|3|||
23257001|NCT01326702|64683699|FG005|Overall Study|progressive disease|2|||
23257002|NCT01326702|64683700|FG006|Overall Study|progressive disease|3|||
23257003|NCT01326702|64683694|FG000|Overall Study|Death|0|||
23257004|NCT01326702|64683695|FG001|Overall Study|Death|1|||
23257005|NCT01326702|64683696|FG002|Overall Study|Death|0|||
23257006|NCT01326702|64683697|FG003|Overall Study|Death|0|||
23257007|NCT01326702|64683698|FG004|Overall Study|Death|0|||
23257008|NCT01326702|64683699|FG005|Overall Study|Death|0|||
23257009|NCT01326702|64683700|FG006|Overall Study|Death|0|||
23257010|NCT01326702|64683694|FG000|Overall Study|Adverse Event|0|||
23257011|NCT01326702|64683695|FG001|Overall Study|Adverse Event|0|||
23257012|NCT01326702|64683696|FG002|Overall Study|Adverse Event|1|||
23257013|NCT01326702|64683697|FG003|Overall Study|Adverse Event|1|||
23257014|NCT01326702|64683698|FG004|Overall Study|Adverse Event|0|||
23257015|NCT01326702|64683699|FG005|Overall Study|Adverse Event|3|||
23257016|NCT01326702|64683700|FG006|Overall Study|Adverse Event|1|||
23257017|NCT01326702|64683694|FG000|Overall Study|Withdrawal by Subject|0|||
23257018|NCT01326702|64683695|FG001|Overall Study|Withdrawal by Subject|0|||
23257019|NCT01326702|64683696|FG002|Overall Study|Withdrawal by Subject|1|||
23257020|NCT01326702|64683697|FG003|Overall Study|Withdrawal by Subject|0|||
23257021|NCT01326702|64683698|FG004|Overall Study|Withdrawal by Subject|1|||
23257022|NCT01326702|64683699|FG005|Overall Study|Withdrawal by Subject|1|||
23257023|NCT01326702|64683700|FG006|Overall Study|Withdrawal by Subject|3|||
23257024|NCT01326702|64683694|FG000|Overall Study|Not Treated|0|||
23257025|NCT01326702|64683695|FG001|Overall Study|Not Treated|0|||
23257026|NCT01326702|64683696|FG002|Overall Study|Not Treated|0|||
23257027|NCT01326702|64683697|FG003|Overall Study|Not Treated|1|||
23257028|NCT01326702|64683698|FG004|Overall Study|Not Treated|0|||
23257029|NCT01326702|64683699|FG005|Overall Study|Not Treated|1|||
23257030|NCT01326702|64683700|FG006|Overall Study|Not Treated|0|||
23257031|NCT03763331|64683713|FG000|Overall Study|Lost to Follow-up|1|||
23257032|NCT03763331|64683714|FG001|Overall Study|Lost to Follow-up|0|||
23257033|NCT03763331|64683713|FG000|Overall Study|Withdrawal by Subject|1|||
23257034|NCT03763331|64683714|FG001|Overall Study|Withdrawal by Subject|0|||
23257035|NCT03763331|64683713|FG000|Overall Study|Non-compliance|0|||
23257036|NCT03763331|64683714|FG001|Overall Study|Non-compliance|3|||
23257037|NCT00289458|64683715|FG000|Overall Study|Death|1|||
23257038|NCT00289458|64683716|FG001|Overall Study|Death|0|||
23257039|NCT00289458|64683717|FG002|Overall Study|Death|0|||
23257040|NCT00289458|64683715|FG000|Overall Study|Physician Decision|3|||
23257041|NCT00289458|64683716|FG001|Overall Study|Physician Decision|4|||
23257042|NCT00289458|64683717|FG002|Overall Study|Physician Decision|2|||
23257043|NCT00289458|64683715|FG000|Overall Study|Withdrawal by Subject|2|||
23257044|NCT00289458|64683716|FG001|Overall Study|Withdrawal by Subject|2|||
23198190|NCT05836818|64465384|FG000|Overall Study|Physician Decision|1|||
23198191|NCT05836818|64465385|FG001|Overall Study|Physician Decision|1|||
23198192|NCT05836818|64465386|FG002|Overall Study|Physician Decision|0|||
23198193|NCT05836818|64465384|FG000|Overall Study|Withdrawal by Subject|0|||
23198194|NCT05836818|64465385|FG001|Overall Study|Withdrawal by Subject|0|||
23198195|NCT05836818|64465386|FG002|Overall Study|Withdrawal by Subject|1|||
23198196|NCT05836818|64465384|FG000|Overall Study|Later found to be previously vaccinated|0|||
23198197|NCT05836818|64465385|FG001|Overall Study|Later found to be previously vaccinated|1|||
23198198|NCT05836818|64465386|FG002|Overall Study|Later found to be previously vaccinated|3|||
23198199|NCT05836818|64465384|FG000|Overall Study|Pregnancy|0|||
23198200|NCT05836818|64465385|FG001|Overall Study|Pregnancy|1|||
23198201|NCT05836818|64465386|FG002|Overall Study|Pregnancy|0|||
23198202|NCT05836818|64465384|FG000|Overall Study|Allergic to vaccines|0|||
23198203|NCT05836818|64465385|FG001|Overall Study|Allergic to vaccines|1|||
23198204|NCT05836818|64465386|FG002|Overall Study|Allergic to vaccines|0|||
23198205|NCT05094154|64465387|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
23198206|NCT05094154|64465388|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
23198207|NCT05094154|64465387|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
23198208|NCT05094154|64465388|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
23198209|NCT02413398|64465390|FG000|Overall Study|Lost to Follow-up|2|||
23198210|NCT02413398|64465391|FG001|Overall Study|Lost to Follow-up|4|||
23198211|NCT02413398|64465390|FG000|Overall Study|Withdrawal by Subject|1|||
23198212|NCT02413398|64465391|FG001|Overall Study|Withdrawal by Subject|1|||
23198213|NCT02413398|64465390|FG000|Overall Study|Other Eligibility criteria|1|||
23198214|NCT02413398|64465391|FG001|Overall Study|Other Eligibility criteria|2|||
23198215|NCT01915849|64465392|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
23198216|NCT01915849|64465393|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
23198217|NCT01915849|64465394|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
23198218|NCT01915849|64465395|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
23198219|NCT01915849|64465392|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
23198220|NCT01915849|64465393|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23198221|NCT01915849|64465394|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23198222|NCT01915849|64465395|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
23198223|NCT04160468|64465400|FG000|Overall Study|Lost to Follow-up|19|||
23198224|NCT04160468|64465401|FG001|Overall Study|Lost to Follow-up|4|||
23198225|NCT04160468|64465400|FG000|Overall Study|Randomized but not dosed|6|||
23198226|NCT04160468|64465401|FG001|Overall Study|Randomized but not dosed|0|||
23198227|NCT04160468|64465400|FG000|Overall Study|Withdrawal by Subject|4|||
23198228|NCT04160468|64465401|FG001|Overall Study|Withdrawal by Subject|1|||
23361088|NCT04058028|65065963|FG001|Overall Study|Death|1|||
23257045|NCT00289458|64683717|FG002|Overall Study|Withdrawal by Subject|4|||
23257046|NCT01663714|64683721|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
23257047|NCT01663714|64683721|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
23257048|NCT01663714|64683721|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
23257049|NCT01663714|64683721|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
23257050|NCT01663714|64683721|FG000|Long-Term Follow-Up|Death|4|||
23257051|NCT01663714|64683721|FG000|Long-Term Follow-Up|Non-compliance|1|||
23257052|NCT00323609|64683722|FG000|Overall Study|Death|16|||
23257053|NCT00323609|64683723|FG001|Overall Study|Death|21|||
23257054|NCT00323609|64683724|FG002|Overall Study|Death|0|||
23257055|NCT00323609|64683725|FG003|Overall Study|Death|0|||
23257056|NCT00323609|64683722|FG000|Overall Study|Lost to Follow-up|9|||
23257057|NCT00323609|64683723|FG001|Overall Study|Lost to Follow-up|10|||
23257058|NCT00323609|64683724|FG002|Overall Study|Lost to Follow-up|0|||
23257059|NCT00323609|64683725|FG003|Overall Study|Lost to Follow-up|0|||
23257060|NCT00323609|64683722|FG000|Overall Study|Physician Decision|2|||
23257061|NCT00323609|64683723|FG001|Overall Study|Physician Decision|0|||
23257062|NCT00323609|64683724|FG002|Overall Study|Physician Decision|0|||
23257063|NCT00323609|64683725|FG003|Overall Study|Physician Decision|1|||
23257064|NCT00323609|64683722|FG000|Overall Study|Withdrawal by Subject|11|||
23198229|NCT04160468|64465400|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
23198230|NCT04160468|64465401|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
23198231|NCT04160468|64465400|FG000|Overall Study|Participant incarcerated|1|||
23198232|NCT04160468|64465401|FG001|Overall Study|Participant incarcerated|0|||
23198233|NCT01318083|64465404|FG000|Overall Study|Adverse Event|4|||
23198234|NCT01318083|64465405|FG001|Overall Study|Adverse Event|1|||
23198235|NCT01318083|64465406|FG002|Overall Study|Adverse Event|2|||
23198236|NCT01318083|64465404|FG000|Overall Study|Withdrawal by Subject|1|||
23198237|NCT01318083|64465405|FG001|Overall Study|Withdrawal by Subject|0|||
23198238|NCT01318083|64465406|FG002|Overall Study|Withdrawal by Subject|2|||
23198239|NCT01318083|64465404|FG000|Overall Study|Lack of Efficacy|0|||
23198240|NCT01318083|64465405|FG001|Overall Study|Lack of Efficacy|0|||
23198241|NCT01318083|64465406|FG002|Overall Study|Lack of Efficacy|1|||
23198242|NCT01318083|64465404|FG000|Overall Study|Treatment Complications|1|||
23198243|NCT01318083|64465405|FG001|Overall Study|Treatment Complications|0|||
23198244|NCT01318083|64465406|FG002|Overall Study|Treatment Complications|0|||
23198245|NCT01318083|64465404|FG000|Overall Study|Lack of Study Medication Compliance|0|||
23198246|NCT01318083|64465405|FG001|Overall Study|Lack of Study Medication Compliance|1|||
23198247|NCT01318083|64465406|FG002|Overall Study|Lack of Study Medication Compliance|0|||
23198248|NCT00234104|64465408|FG000|Overall Study|Adverse Event|4|||
23198249|NCT00234104|64465409|FG001|Overall Study|Adverse Event|0|||
23198250|NCT00234104|64465410|FG002|Overall Study|Adverse Event|3|||
23198251|NCT00234104|64465411|FG003|Overall Study|Adverse Event|5|||
23198252|NCT00234104|64465408|FG000|Overall Study|Protocol Violation|0|||
23198253|NCT00234104|64465409|FG001|Overall Study|Protocol Violation|0|||
23198254|NCT00234104|64465410|FG002|Overall Study|Protocol Violation|0|||
23198255|NCT00234104|64465411|FG003|Overall Study|Protocol Violation|1|||
23198256|NCT00234104|64465408|FG000|Overall Study|Physician Decision|0|||
23198257|NCT00234104|64465409|FG001|Overall Study|Physician Decision|1|||
23198258|NCT00234104|64465410|FG002|Overall Study|Physician Decision|2|||
23198259|NCT00234104|64465411|FG003|Overall Study|Physician Decision|2|||
23198260|NCT00634543|64465412|FG000|Overall Study|Other|1|||
23198261|NCT00634543|64465413|FG001|Overall Study|Other|2|||
23198262|NCT00634543|64465412|FG000|Overall Study|Protocol Violation|3|||
23198263|NCT00634543|64465413|FG001|Overall Study|Protocol Violation|3|||
23198264|NCT00634543|64465412|FG000|Overall Study|Adverse Event|11|||
23198265|NCT00634543|64465413|FG001|Overall Study|Adverse Event|11|||
23198266|NCT00634543|64465412|FG000|Overall Study|Withdrawal by Subject|4|||
23198267|NCT00634543|64465413|FG001|Overall Study|Withdrawal by Subject|4|||
23198268|NCT00634543|64465412|FG000|Overall Study|Lost to Follow-up|0|||
23198269|NCT00634543|64465413|FG001|Overall Study|Lost to Follow-up|1|||
23198270|NCT01555463|64465419|FG000|Treatment|Adverse Event|6|||
23198271|NCT01555463|64465420|FG001|Treatment|Adverse Event|12|||
23257065|NCT00323609|64683723|FG001|Overall Study|Withdrawal by Subject|23|||
23257066|NCT00323609|64683724|FG002|Overall Study|Withdrawal by Subject|4|||
23257067|NCT00323609|64683725|FG003|Overall Study|Withdrawal by Subject|4|||
23257068|NCT00323609|64683722|FG000|Overall Study|Other non-VCF-related medical condition|3|||
23198272|NCT01555463|64465419|FG000|Treatment|Withdrawal by Subject|24|||
23599826|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Other|2|||
23599827|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Other|0|||
23599828|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
23599829|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
23599830|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
23599831|NCT00887224|65925699|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
23599832|NCT00887224|65925700|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
23198273|NCT01555463|64465420|FG001|Treatment|Withdrawal by Subject|36|||
23198274|NCT01555463|64465419|FG000|Treatment|Lost to Follow-up|28|||
23198275|NCT01555463|64465420|FG001|Treatment|Lost to Follow-up|23|||
23198276|NCT01555463|64465419|FG000|Treatment|Protocol Violation|4|||
23198277|NCT01555463|64465420|FG001|Treatment|Protocol Violation|5|||
23198278|NCT01555463|64465419|FG000|Treatment|Other reason|2|||
23198279|NCT01555463|64465420|FG001|Treatment|Other reason|3|||
23198280|NCT01555463|64465419|FG000|Follow up|Adverse Event|2|||
23198281|NCT01555463|64465420|FG001|Follow up|Adverse Event|5|||
23198282|NCT01555463|64465419|FG000|Follow up|Death|0|||
23198283|NCT01555463|64465420|FG001|Follow up|Death|1|||
23198284|NCT01555463|64465419|FG000|Follow up|Withdrawal by Subject|22|||
23198285|NCT01555463|64465420|FG001|Follow up|Withdrawal by Subject|22|||
23198286|NCT01555463|64465419|FG000|Follow up|Lost to Follow-up|9|||
23198287|NCT01555463|64465420|FG001|Follow up|Lost to Follow-up|10|||
23198288|NCT01555463|64465419|FG000|Follow up|Protocol Violation|2|||
23198289|NCT01555463|64465420|FG001|Follow up|Protocol Violation|4|||
23198290|NCT01555463|64465419|FG000|Follow up|Other reason|3|||
23257069|NCT00323609|64683723|FG001|Overall Study|Other non-VCF-related medical condition|2|||
23599833|NCT00887224|65925701|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
23599834|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
23599835|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
23599836|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
23599837|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
23599838|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
23599839|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
23599840|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
23599841|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
23599842|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
23599843|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
23599844|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
23599845|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
23599846|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
23599847|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
23599848|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
23599849|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
23599850|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
23599851|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
23599852|NCT00887224|65925699|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
23599853|NCT00887224|65925700|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
23599854|NCT00887224|65925701|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
23599855|NCT04679675|65925702|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
23599856|NCT04679675|65925703|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
23599857|NCT04679675|65925704|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
23599858|NCT04679675|65925705|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
23599859|NCT04679675|65925702|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
23599860|NCT04679675|65925703|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
23599861|NCT04679675|65925704|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
23198291|NCT01555463|64465420|FG001|Follow up|Other reason|3|||
23198292|NCT03510663|64465421|FG000|Overall Study|Withdrawal by Subject|0|||
23198293|NCT03510663|64465422|FG001|Overall Study|Withdrawal by Subject|1|||
23198294|NCT03510663|64465423|FG002|Overall Study|Withdrawal by Subject|0|||
23198295|NCT03510663|64465424|FG003|Overall Study|Withdrawal by Subject|0|||
23257070|NCT00323609|64683724|FG002|Overall Study|Other non-VCF-related medical condition|0|||
23198296|NCT03510663|64465425|FG004|Overall Study|Withdrawal by Subject|0|||
23198297|NCT03510663|64465426|FG005|Overall Study|Withdrawal by Subject|0|||
23198298|NCT03510663|64465427|FG006|Overall Study|Withdrawal by Subject|0|||
23198299|NCT03510663|64465428|FG007|Overall Study|Withdrawal by Subject|0|||
23198300|NCT00540436|64465435|FG000|First 12-Week Treatment Period|Adverse Event|1|||
23198301|NCT00540436|64465435|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
23198302|NCT00540436|64465435|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
23198303|NCT00540436|64465435|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
23198304|NCT01518699|64465438|FG000|Period 2|Protocol Violation|1|||
23198305|NCT01518699|64465439|FG001|Period 2|Protocol Violation|1|||
23198306|NCT01518699|64465440|FG002|Period 2|Protocol Violation|0|||
23198307|NCT01518699|64465441|FG003|Period 2|Protocol Violation|0|||
23198308|NCT01518699|64465442|FG004|Period 2|Protocol Violation|0|||
23198309|NCT01518699|64465443|FG005|Period 2|Protocol Violation|0|||
23198310|NCT01518699|64465438|FG000|Period 2|Lost to Follow-up|0|||
23198311|NCT01518699|64465439|FG001|Period 2|Lost to Follow-up|1|||
23257071|NCT00323609|64683725|FG003|Overall Study|Other non-VCF-related medical condition|0|||
23257072|NCT00323609|64683722|FG000|Overall Study|Sponsor discontinued trial|29|||
23257073|NCT00323609|64683723|FG001|Overall Study|Sponsor discontinued trial|29|||
23257074|NCT00323609|64683724|FG002|Overall Study|Sponsor discontinued trial|0|||
23257075|NCT00323609|64683725|FG003|Overall Study|Sponsor discontinued trial|0|||
23257076|NCT00323609|64683722|FG000|Overall Study|Unrelenting or severe back pain|1|||
23257077|NCT00323609|64683723|FG001|Overall Study|Unrelenting or severe back pain|1|||
23257078|NCT00323609|64683724|FG002|Overall Study|Unrelenting or severe back pain|0|||
23257079|NCT00323609|64683725|FG003|Overall Study|Unrelenting or severe back pain|0|||
23257080|NCT00323609|64683722|FG000|Overall Study|Logistical withdrawal|9|||
23257081|NCT00323609|64683723|FG001|Overall Study|Logistical withdrawal|5|||
23257082|NCT00323609|64683724|FG002|Overall Study|Logistical withdrawal|0|||
23257083|NCT00323609|64683725|FG003|Overall Study|Logistical withdrawal|1|||
23257084|NCT00323609|64683722|FG000|Overall Study|Other reason|11|||
23257085|NCT00323609|64683723|FG001|Overall Study|Other reason|8|||
23257086|NCT00323609|64683724|FG002|Overall Study|Other reason|4|||
23257087|NCT00323609|64683725|FG003|Overall Study|Other reason|9|||
23257088|NCT02725671|64683726|FG000|Overall Study|Lost to Follow-up|1|||
23257089|NCT00399490|64683727|FG000|Overall Study|Adverse Event|19|||
23198312|NCT01518699|64465440|FG002|Period 2|Lost to Follow-up|0|||
23198313|NCT01518699|64465441|FG003|Period 2|Lost to Follow-up|0|||
23198314|NCT01518699|64465442|FG004|Period 2|Lost to Follow-up|0|||
23198315|NCT01518699|64465443|FG005|Period 2|Lost to Follow-up|0|||
23198316|NCT01518699|64465438|FG000|Period 2|Adverse Event|1|||
23198317|NCT01518699|64465439|FG001|Period 2|Adverse Event|0|||
23257090|NCT00399490|64683727|FG000|Overall Study|Lack of Efficacy|31|||
23257091|NCT00399490|64683727|FG000|Overall Study|Lost to Follow-up|5|||
23257092|NCT00399490|64683727|FG000|Overall Study|Withdrawal by Subject|18|||
23198318|NCT01518699|64465440|FG002|Period 2|Adverse Event|0|||
23198319|NCT01518699|64465441|FG003|Period 2|Adverse Event|0|||
23198320|NCT01518699|64465442|FG004|Period 2|Adverse Event|0|||
23198321|NCT01518699|64465443|FG005|Period 2|Adverse Event|0|||
23198322|NCT01221233|64465444|FG000|Overall Study|Withdrawal by Subject|3|||
23198323|NCT01221233|64465445|FG001|Overall Study|Withdrawal by Subject|1|||
23198324|NCT00992446|64465446|FG000|Overall Study|Disease Progression|1|||
23198325|NCT00992446|64465446|FG000|Overall Study|Withdrawal by Subject|2|||
23198326|NCT00992446|64465446|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
23198327|NCT02761993|64465447|FG000|Overall Study|Adverse Event|0|||
23198328|NCT02761993|64465448|FG001|Overall Study|Adverse Event|2|||
23198329|NCT02761993|64465449|FG002|Overall Study|Adverse Event|0|||
23198330|NCT02761993|64465447|FG000|Overall Study|Lost to Follow-up|1|||
23198331|NCT02761993|64465448|FG001|Overall Study|Lost to Follow-up|3|||
23198332|NCT02761993|64465449|FG002|Overall Study|Lost to Follow-up|2|||
23198333|NCT02761993|64465447|FG000|Overall Study|Withdrawal by Subject|1|||
23198334|NCT02761993|64465448|FG001|Overall Study|Withdrawal by Subject|1|||
23198335|NCT02761993|64465449|FG002|Overall Study|Withdrawal by Subject|2|||
23198336|NCT01879618|64465457|FG000|Overall Study|Does not meet entrance criteria|1|||
23198337|NCT01879618|64465457|FG000|Overall Study|Withdrawal by Subject|1|||
23198338|NCT01879618|64465457|FG000|Overall Study|Surgery;changed schedule; not available|8|||
23198339|NCT01879618|64465457|FG000|Overall Study|Protocol Violation|6|||
23198340|NCT01879618|64465457|FG000|Overall Study|Adverse Event|5|||
23198341|NCT04429503|64465465|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
23599862|NCT04679675|65925705|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
23599863|NCT02161146|65925706|FG000|Overall Study|Adverse Event|1|||
23599864|NCT02161146|65925707|FG001|Overall Study|Adverse Event|1|||
23599865|NCT02161146|65925708|FG002|Overall Study|Adverse Event|0|||
23599866|NCT02161146|65925709|FG003|Overall Study|Adverse Event|1|||
23599867|NCT02161146|65925710|FG004|Overall Study|Adverse Event|0|||
23599868|NCT02161146|65925706|FG000|Overall Study|Lost to Follow-up|0|||
23599869|NCT02161146|65925707|FG001|Overall Study|Lost to Follow-up|1|||
23599870|NCT02161146|65925708|FG002|Overall Study|Lost to Follow-up|0|||
23599871|NCT02161146|65925709|FG003|Overall Study|Lost to Follow-up|0|||
23198342|NCT04429503|64465466|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
23198343|NCT04429503|64465467|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
23198344|NCT04429503|64465465|FG000|Overall Study|Adverse Event|1|||
23198345|NCT04429503|64465466|FG001|Overall Study|Adverse Event|9|||
23198346|NCT04429503|64465467|FG002|Overall Study|Adverse Event|2|||
23198347|NCT04429503|64465465|FG000|Overall Study|Decision by the investigator/sponsor|2|||
23198348|NCT04429503|64465466|FG001|Overall Study|Decision by the investigator/sponsor|9|||
23361089|NCT04058028|65065964|FG002|Overall Study|Death|0|||
23599872|NCT02161146|65925710|FG004|Overall Study|Lost to Follow-up|0|||
23599873|NCT02161146|65925706|FG000|Overall Study|Personal Reasons|0|||
23198349|NCT04429503|64465467|FG002|Overall Study|Decision by the investigator/sponsor|3|||
23257093|NCT00399490|64683727|FG000|Overall Study|Other|25|||
23257094|NCT01489956|64683728|FG000|Overall Study|Lost to Follow-up|1|||
23257095|NCT01489956|64683729|FG001|Overall Study|Lost to Follow-up|0|||
23257096|NCT01489956|64683730|FG002|Overall Study|Lost to Follow-up|0|||
23257097|NCT01489956|64683728|FG000|Overall Study|Withdrawal by Subject|0|||
23257098|NCT01489956|64683729|FG001|Overall Study|Withdrawal by Subject|0|||
23257099|NCT01489956|64683730|FG002|Overall Study|Withdrawal by Subject|1|||
23257100|NCT01225991|64683733|FG000|Overall Study|Withdrawal by Subject|6|||
23257101|NCT04071366|64683734|FG000|Part 1: Open-label (29 Days)|Death|4|||
23257102|NCT04071366|64683735|FG001|Part 1: Open-label (29 Days)|Death|2|||
23257103|NCT04071366|64683736|FG002|Part 1: Open-label (29 Days)|Death|8|||
23257104|NCT04071366|64683737|FG003|Part 1: Open-label (29 Days)|Death|0|||
23257105|NCT04071366|64683738|FG004|Part 1: Open-label (29 Days)|Death|0|||
23257106|NCT04071366|64683734|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
23257107|NCT04071366|64683735|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
23257108|NCT04071366|64683736|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
23257109|NCT04071366|64683737|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
23257110|NCT04071366|64683738|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
23257111|NCT04071366|64683734|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
23257112|NCT04071366|64683735|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
23257113|NCT04071366|64683736|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
23257114|NCT04071366|64683737|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
23257115|NCT04071366|64683738|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
23257116|NCT04071366|64683734|FG000|Part 2: Randomized (29 Days)|Death|0|||
23257117|NCT04071366|64683735|FG001|Part 2: Randomized (29 Days)|Death|0|||
23257118|NCT04071366|64683736|FG002|Part 2: Randomized (29 Days)|Death|0|||
23257119|NCT04071366|64683737|FG003|Part 2: Randomized (29 Days)|Death|2|||
23257120|NCT04071366|64683738|FG004|Part 2: Randomized (29 Days)|Death|2|||
23257121|NCT04071366|64683734|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
23257122|NCT04071366|64683735|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
23257123|NCT04071366|64683736|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
23257124|NCT04071366|64683737|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
23257125|NCT04071366|64683738|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
23257126|NCT04071366|64683734|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
23257127|NCT04071366|64683735|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
23257128|NCT04071366|64683736|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
23599874|NCT02161146|65925707|FG001|Overall Study|Personal Reasons|1|||
23198350|NCT04429503|64465465|FG000|Overall Study|Withdrawal by Subject|9|||
23198351|NCT04429503|64465466|FG001|Overall Study|Withdrawal by Subject|17|||
23198352|NCT04429503|64465467|FG002|Overall Study|Withdrawal by Subject|8|||
23198353|NCT04429503|64465465|FG000|Overall Study|Lost to Follow-up|5|||
23198354|NCT04429503|64465466|FG001|Overall Study|Lost to Follow-up|19|||
23198355|NCT04429503|64465467|FG002|Overall Study|Lost to Follow-up|7|||
23198356|NCT04429503|64465465|FG000|Overall Study|Death|9|||
23198357|NCT04429503|64465466|FG001|Overall Study|Death|18|||
23198358|NCT04429503|64465467|FG002|Overall Study|Death|5|||
23198359|NCT02680847|64465468|FG000|Overall Study|Other|2|||
23198360|NCT02680847|64465469|FG001|Overall Study|Other|0|||
23198361|NCT02680847|64465470|FG002|Overall Study|Other|0|||
23198362|NCT02680847|64465468|FG000|Overall Study|No longer met eligibility criteria|2|||
23198363|NCT02680847|64465469|FG001|Overall Study|No longer met eligibility criteria|2|||
23198364|NCT02680847|64465470|FG002|Overall Study|No longer met eligibility criteria|0|||
23198365|NCT02680847|64465468|FG000|Overall Study|Unwilling to participate in study|1|||
23198366|NCT02680847|64465469|FG001|Overall Study|Unwilling to participate in study|1|||
23198367|NCT02680847|64465470|FG002|Overall Study|Unwilling to participate in study|0|||
23198368|NCT02680847|64465468|FG000|Overall Study|Lack of Efficacy|0|||
23198369|NCT02680847|64465469|FG001|Overall Study|Lack of Efficacy|0|||
23198370|NCT02680847|64465470|FG002|Overall Study|Lack of Efficacy|2|||
23198371|NCT02680847|64465468|FG000|Overall Study|Adverse Event|0|||
23198372|NCT02680847|64465469|FG001|Overall Study|Adverse Event|0|||
23198373|NCT02680847|64465470|FG002|Overall Study|Adverse Event|1|||
23198374|NCT01302041|64465476|FG000|Overall Study|Death|5|||
23198375|NCT01302041|64465476|FG000|Overall Study|Withdrawal by Subject|4|||
23198376|NCT01302041|64465476|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
23198377|NCT01302041|64465476|FG000|Overall Study|Other-Miscellaneous Reason|2|||
23198378|NCT03072719|64465477|FG000|Overall Study|Adverse Event|1|||
23198379|NCT03072719|64465478|FG001|Overall Study|Adverse Event|1|||
23198380|NCT00243230|64465479|FG000|Double-Blind Period|Adverse Event|0|||
23198381|NCT00243230|64465480|FG001|Double-Blind Period|Adverse Event|2|||
23198382|NCT00243230|64465481|FG002|Double-Blind Period|Adverse Event|2|||
23198383|NCT00243230|64465482|FG003|Double-Blind Period|Adverse Event|0|||
23198384|NCT00243230|64465479|FG000|Double-Blind Period|Withdrawal by Subject|1|||
23198385|NCT00243230|64465480|FG001|Double-Blind Period|Withdrawal by Subject|0|||
23198386|NCT00243230|64465481|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23198387|NCT00243230|64465482|FG003|Double-Blind Period|Withdrawal by Subject|0|||
23198388|NCT00243230|64465479|FG000|Double-Blind Period|Protocol Violation|0|||
23198389|NCT00243230|64465480|FG001|Double-Blind Period|Protocol Violation|0|||
23198390|NCT00243230|64465481|FG002|Double-Blind Period|Protocol Violation|1|||
23198391|NCT00243230|64465482|FG003|Double-Blind Period|Protocol Violation|0|||
23198392|NCT00243230|64465479|FG000|Double-Blind Period|Randomized but Not Treated|0|||
23198393|NCT00243230|64465480|FG001|Double-Blind Period|Randomized but Not Treated|0|||
23198394|NCT00243230|64465481|FG002|Double-Blind Period|Randomized but Not Treated|2|||
23198395|NCT00243230|64465482|FG003|Double-Blind Period|Randomized but Not Treated|0|||
23198396|NCT00243230|64465479|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
23198397|NCT00243230|64465480|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
23198398|NCT00243230|64465481|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
23198399|NCT00243230|64465482|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
23198400|NCT00243230|64465479|FG000|Open Label Period|Adverse Event|0|||
23198401|NCT00243230|64465480|FG001|Open Label Period|Adverse Event|0|||
23198402|NCT00243230|64465481|FG002|Open Label Period|Adverse Event|0|||
23198403|NCT00243230|64465482|FG003|Open Label Period|Adverse Event|2|||
23198404|NCT00243230|64465479|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
23198405|NCT00243230|64465480|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
23198406|NCT00243230|64465481|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
23198407|NCT00243230|64465482|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
23198408|NCT00243230|64465479|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
23198409|NCT00243230|64465480|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
23198410|NCT00243230|64465481|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
23198411|NCT00243230|64465482|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
23198412|NCT00243230|64465479|FG000|Open Label Period|Lost to Follow-up|0|||
23198413|NCT00243230|64465480|FG001|Open Label Period|Lost to Follow-up|0|||
23198414|NCT00243230|64465481|FG002|Open Label Period|Lost to Follow-up|0|||
23198415|NCT00243230|64465482|FG003|Open Label Period|Lost to Follow-up|2|||
23198416|NCT00243230|64465479|FG000|Open Label Period|Withdrawal by Subject|0|||
23198417|NCT00243230|64465480|FG001|Open Label Period|Withdrawal by Subject|0|||
23198418|NCT00243230|64465481|FG002|Open Label Period|Withdrawal by Subject|0|||
23198419|NCT00243230|64465482|FG003|Open Label Period|Withdrawal by Subject|2|||
23198420|NCT00243230|64465479|FG000|Open Label Period|Protocol Violation|0|||
23198421|NCT00243230|64465480|FG001|Open Label Period|Protocol Violation|0|||
23198422|NCT00243230|64465481|FG002|Open Label Period|Protocol Violation|0|||
23198423|NCT00243230|64465482|FG003|Open Label Period|Protocol Violation|2|||
23198424|NCT00243230|64465479|FG000|Open Label Period|Administrative Reason|0|||
23198425|NCT00243230|64465480|FG001|Open Label Period|Administrative Reason|0|||
23198426|NCT00243230|64465481|FG002|Open Label Period|Administrative Reason|0|||
23198427|NCT00243230|64465482|FG003|Open Label Period|Administrative Reason|63|||
23198428|NCT02065869|64465484|FG000|Overall Study|Death|7|||
23198429|NCT02065869|64465484|FG000|Overall Study|Disease relapse|16|||
23198430|NCT02065869|64465484|FG000|Overall Study|Lost to Follow-up|4|||
23599875|NCT02161146|65925708|FG002|Overall Study|Personal Reasons|0|||
23599876|NCT02161146|65925709|FG003|Overall Study|Personal Reasons|2|||
23599877|NCT02161146|65925710|FG004|Overall Study|Personal Reasons|1|||
23599878|NCT02161146|65925706|FG000|Overall Study|Other Miscellaneous Reasons|0|||
23198431|NCT02065869|64465484|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
23198432|NCT02065869|64465484|FG000|Overall Study|Withdrawal by Subject|1|||
23198433|NCT01754922|64465485|FG000|Overall Study|Adverse Event|0|||
23198434|NCT01754922|64465486|FG001|Overall Study|Adverse Event|1|||
23198435|NCT00257192|64465488|FG000|Overall Study|Adverse Event|21|||
23198436|NCT00257192|64465489|FG001|Overall Study|Adverse Event|10|||
23198437|NCT00257192|64465488|FG000|Overall Study|Laboratory abnormality|1|||
23198438|NCT00257192|64465489|FG001|Overall Study|Laboratory abnormality|1|||
23198439|NCT00257192|64465488|FG000|Overall Study|Lost to Follow-up|3|||
23198440|NCT00257192|64465489|FG001|Overall Study|Lost to Follow-up|3|||
23198441|NCT00257192|64465488|FG000|Overall Study|Insufficient clinical response|18|||
23198442|NCT00257192|64465489|FG001|Overall Study|Insufficient clinical response|18|||
23198443|NCT00257192|64465488|FG000|Overall Study|Withdrawal by Subject|14|||
23198444|NCT00257192|64465489|FG001|Overall Study|Withdrawal by Subject|2|||
23198445|NCT00257192|64465488|FG000|Overall Study|Randomized but not treated|0|||
23198446|NCT00257192|64465489|FG001|Overall Study|Randomized but not treated|1|||
23198447|NCT00257192|64465488|FG000|Overall Study|Study terminated by sponsor|1|||
23198448|NCT00257192|64465489|FG001|Overall Study|Study terminated by sponsor|0|||
23198449|NCT00257192|64465488|FG000|Overall Study|Miscellaneous|0|||
23198450|NCT00257192|64465489|FG001|Overall Study|Miscellaneous|4|||
23198451|NCT03032068|64465493|FG000|Overall Study|Adverse Event|1|||
23198452|NCT01519427|64465494|FG000|Overall Study|disease progression|2|||
23198453|NCT01993329|64465499|FG000|Period 2|Adverse Event|0|||
23198454|NCT01993329|64465500|FG001|Period 2|Adverse Event|0|||
23198455|NCT01993329|64465501|FG002|Period 2|Adverse Event|0|||
23198456|NCT01993329|64465502|FG003|Period 2|Adverse Event|0|||
23198457|NCT01993329|64465503|FG004|Period 2|Adverse Event|0|||
23198458|NCT01993329|64465504|FG005|Period 2|Adverse Event|1|||
23198459|NCT01993329|64465499|FG000|Wash-out|Personal reasons|0|||
23198460|NCT01993329|64465500|FG001|Wash-out|Personal reasons|1|||
23198461|NCT01993329|64465501|FG002|Wash-out|Personal reasons|0|||
23198462|NCT01993329|64465502|FG003|Wash-out|Personal reasons|0|||
23198463|NCT01993329|64465503|FG004|Wash-out|Personal reasons|0|||
23198464|NCT01993329|64465504|FG005|Wash-out|Personal reasons|0|||
23198465|NCT01629667|64465505|FG000|Overall Study|Lost to Follow-up|0|||
23198466|NCT01629667|64465506|FG001|Overall Study|Lost to Follow-up|1|||
23198467|NCT01629667|64465507|FG002|Overall Study|Lost to Follow-up|1|||
23198468|NCT01629667|64465505|FG000|Overall Study|Withdrawal by Subject|31|||
23198469|NCT01629667|64465506|FG001|Overall Study|Withdrawal by Subject|20|||
23198470|NCT01629667|64465507|FG002|Overall Study|Withdrawal by Subject|28|||
23198471|NCT01629667|64465505|FG000|Overall Study|Death|1|||
23198472|NCT01629667|64465506|FG001|Overall Study|Death|5|||
23198473|NCT01629667|64465507|FG002|Overall Study|Death|3|||
23198474|NCT01629667|64465505|FG000|Overall Study|Randomized, not treated|2|||
23198475|NCT01629667|64465506|FG001|Overall Study|Randomized, not treated|1|||
23198476|NCT01629667|64465507|FG002|Overall Study|Randomized, not treated|0|||
23198477|NCT01629667|64465505|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
23198478|NCT01629667|64465506|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
23198479|NCT01629667|64465507|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
23198480|NCT01629667|64465505|FG000|Overall Study|Requiring lung transplant|2|||
23198481|NCT01629667|64465506|FG001|Overall Study|Requiring lung transplant|1|||
23198482|NCT01629667|64465507|FG002|Overall Study|Requiring lung transplant|3|||
23198483|NCT01629667|64465505|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
23198484|NCT01629667|64465506|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
23198485|NCT01629667|64465507|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
23198486|NCT01629667|64465505|FG000|Overall Study|Started other medicine|1|||
23198487|NCT01629667|64465506|FG001|Overall Study|Started other medicine|0|||
23198488|NCT01629667|64465507|FG002|Overall Study|Started other medicine|1|||
23198489|NCT01629667|64465505|FG000|Overall Study|Site error in safety follow-up|0|||
23198490|NCT01629667|64465506|FG001|Overall Study|Site error in safety follow-up|0|||
23198491|NCT01629667|64465507|FG002|Overall Study|Site error in safety follow-up|1|||
23198492|NCT01629667|64465505|FG000|Overall Study|Enrolled in another clinical study|0|||
23198493|NCT01629667|64465506|FG001|Overall Study|Enrolled in another clinical study|1|||
23198494|NCT01629667|64465507|FG002|Overall Study|Enrolled in another clinical study|0|||
23198495|NCT01629667|64465505|FG000|Overall Study|Code break|1|||
23198496|NCT01629667|64465506|FG001|Overall Study|Code break|0|||
23198497|NCT01629667|64465507|FG002|Overall Study|Code break|0|||
23198498|NCT01259492|64465511|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
23198499|NCT01259492|64465512|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
23198500|NCT01259492|64465513|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
23198501|NCT01259492|64465514|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
23198502|NCT01259492|64465511|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
23198503|NCT01259492|64465512|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
23198504|NCT01259492|64465513|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
23198505|NCT01259492|64465514|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
23198506|NCT01259492|64465511|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
23198507|NCT01259492|64465512|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
23198508|NCT01259492|64465513|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
23198509|NCT01259492|64465514|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
23198510|NCT01259492|64465511|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
23198511|NCT01259492|64465512|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
23198512|NCT01259492|64465513|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
23198513|NCT01259492|64465514|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
23257129|NCT04071366|64683737|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
23257130|NCT04071366|64683738|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
23257131|NCT04071366|64683734|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
23257132|NCT04071366|64683735|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
23257133|NCT04071366|64683736|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
23257134|NCT04071366|64683737|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
23257135|NCT04071366|64683738|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
23257136|NCT04071366|64683734|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
23257137|NCT04071366|64683735|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
23257138|NCT04071366|64683736|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
23257139|NCT04071366|64683737|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
23257140|NCT04071366|64683738|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
23257141|NCT04071366|64683734|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
23257142|NCT04071366|64683735|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
23257143|NCT04071366|64683736|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
23257144|NCT04071366|64683737|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
23257145|NCT04071366|64683738|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
23257146|NCT04071366|64683734|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
23257147|NCT04071366|64683735|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
23257148|NCT04071366|64683736|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
23257149|NCT04071366|64683737|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
23257150|NCT04071366|64683738|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
23257151|NCT02094937|64683739|FG000|8 Weeks in Period 1|Adverse Event|9|||
23257152|NCT02094937|64683740|FG001|8 Weeks in Period 1|Adverse Event|0|||
23257153|NCT02094937|64683741|FG002|8 Weeks in Period 1|Adverse Event|0|||
23257154|NCT02094937|64683742|FG003|8 Weeks in Period 1|Adverse Event|0|||
23257155|NCT02094937|64683739|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
23257156|NCT02094937|64683740|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
23257157|NCT02094937|64683741|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
23257158|NCT02094937|64683742|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
23257159|NCT02094937|64683739|FG000|8 Weeks in Period 1|Protocol Violation|2|||
23257160|NCT02094937|64683740|FG001|8 Weeks in Period 1|Protocol Violation|0|||
23257161|NCT02094937|64683741|FG002|8 Weeks in Period 1|Protocol Violation|0|||
23257162|NCT02094937|64683742|FG003|8 Weeks in Period 1|Protocol Violation|0|||
23257163|NCT02094937|64683739|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
23257164|NCT02094937|64683740|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
23257165|NCT02094937|64683741|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
23257166|NCT02094937|64683742|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
23257167|NCT02094937|64683739|FG000|8 Weeks in Period 1|Physician Decision|1|||
23257168|NCT02094937|64683740|FG001|8 Weeks in Period 1|Physician Decision|0|||
23257169|NCT02094937|64683741|FG002|8 Weeks in Period 1|Physician Decision|0|||
23257170|NCT02094937|64683742|FG003|8 Weeks in Period 1|Physician Decision|0|||
23257171|NCT02094937|64683739|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
23257172|NCT02094937|64683740|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
23257173|NCT02094937|64683741|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
23257174|NCT02094937|64683742|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
23257175|NCT02094937|64683739|FG000|12 Weeks in Period 2|Adverse Event|0|||
23257176|NCT02094937|64683740|FG001|12 Weeks in Period 2|Adverse Event|2|||
23257177|NCT02094937|64683741|FG002|12 Weeks in Period 2|Adverse Event|4|||
23257178|NCT02094937|64683742|FG003|12 Weeks in Period 2|Adverse Event|1|||
23257179|NCT02094937|64683739|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
23257180|NCT02094937|64683740|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
23257181|NCT02094937|64683741|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
23257182|NCT02094937|64683742|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
23257183|NCT02094937|64683739|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
23257184|NCT02094937|64683740|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
23257185|NCT02094937|64683741|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
23257186|NCT02094937|64683742|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
23257187|NCT02094937|64683739|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
23257188|NCT02094937|64683740|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
23257189|NCT02094937|64683741|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
23257190|NCT02094937|64683742|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
23257191|NCT02094937|64683739|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
23257192|NCT02094937|64683740|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
23257193|NCT02094937|64683741|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
23257194|NCT02094937|64683742|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
23257195|NCT04535583|64683747|FG000|Overall Study|Lost to Follow-up|1|||
23257196|NCT04535583|64683747|FG000|Overall Study|Physician Decision|1|||
23257197|NCT04535583|64683747|FG000|Overall Study|Withdrawal by Subject|1|||
23257198|NCT05017493|64683748|FG000|Overall Study|Withdrawal by Subject|26|||
23257199|NCT05017493|64683749|FG001|Overall Study|Withdrawal by Subject|0|||
23257200|NCT05017493|64683748|FG000|Overall Study|Physician Decision|15|||
23257201|NCT05017493|64683749|FG001|Overall Study|Physician Decision|0|||
23257202|NCT05017493|64683748|FG000|Overall Study|Protocol Violation|81|||
23257203|NCT05017493|64683749|FG001|Overall Study|Protocol Violation|0|||
23257204|NCT01456052|64683752|FG000|Overall Study|Adverse Event|1|||
23257205|NCT01456052|64683753|FG001|Overall Study|Adverse Event|1|||
23257206|NCT01456052|64683754|FG002|Overall Study|Adverse Event|2|||
23257207|NCT01456052|64683752|FG000|Overall Study|Consent withdrawn|0|||
23257208|NCT01456052|64683753|FG001|Overall Study|Consent withdrawn|2|||
23257209|NCT01456052|64683754|FG002|Overall Study|Consent withdrawn|1|||
23257210|NCT01456052|64683752|FG000|Overall Study|Protocol Violation|0|||
23257211|NCT01456052|64683753|FG001|Overall Study|Protocol Violation|1|||
23257212|NCT01456052|64683754|FG002|Overall Study|Protocol Violation|0|||
23257213|NCT01456052|64683752|FG000|Overall Study|Physician Decision|1|||
23257214|NCT01456052|64683753|FG001|Overall Study|Physician Decision|0|||
23257215|NCT01456052|64683754|FG002|Overall Study|Physician Decision|1|||
23257216|NCT01456052|64683752|FG000|Overall Study|Treatment Failure|0|||
23257217|NCT01456052|64683753|FG001|Overall Study|Treatment Failure|1|||
23257218|NCT01456052|64683754|FG002|Overall Study|Treatment Failure|1|||
23257219|NCT04274192|64683757|FG000|Overall Study|Protocol Violation|1|||
23257220|NCT04274192|64683758|FG001|Overall Study|Protocol Violation|0|||
23257221|NCT01388647|64683759|FG000|Overall Study|Adverse Event|1|||
23257222|NCT01388647|64683760|FG001|Overall Study|Adverse Event|2|||
23257223|NCT03712228|64683763|FG000|Treatment Period 1|Lack of Efficacy|0|||
23257224|NCT03712228|64683764|FG001|Treatment Period 1|Lack of Efficacy|0|||
23257225|NCT03712228|64683765|FG002|Treatment Period 1|Lack of Efficacy|0|||
23257226|NCT03712228|64683766|FG003|Treatment Period 1|Lack of Efficacy|0|||
23257227|NCT03712228|64683767|FG004|Treatment Period 1|Lack of Efficacy|0|||
23257228|NCT03712228|64683768|FG005|Treatment Period 1|Lack of Efficacy|1|||
23257229|NCT03712228|64683763|FG000|Treatment Period 2|Pregnancy|0|||
23257230|NCT03712228|64683764|FG001|Treatment Period 2|Pregnancy|0|||
23257231|NCT03712228|64683765|FG002|Treatment Period 2|Pregnancy|0|||
23257232|NCT03712228|64683766|FG003|Treatment Period 2|Pregnancy|1|||
23257233|NCT03712228|64683767|FG004|Treatment Period 2|Pregnancy|0|||
23257234|NCT03712228|64683768|FG005|Treatment Period 2|Pregnancy|0|||
23257235|NCT03712228|64683763|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23257236|NCT03712228|64683764|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23257237|NCT03712228|64683765|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23257238|NCT03712228|64683766|FG003|Treatment Period 2|Withdrawal by Subject|1|||
23257239|NCT03712228|64683767|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23257240|NCT03712228|64683768|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23257241|NCT01306253|64683769|FG000|Overall Study|Lost to Follow-up|1|||
23257242|NCT01306253|64683770|FG001|Overall Study|Lost to Follow-up|1|||
23257243|NCT00633152|64683771|FG000|Overall Study|Adverse Event|1|||
23257244|NCT00633152|64683772|FG001|Overall Study|Adverse Event|0|||
23257245|NCT00633152|64683771|FG000|Overall Study|Randomized, did not receive study drug|5|||
23257246|NCT00633152|64683772|FG001|Overall Study|Randomized, did not receive study drug|2|||
23257247|NCT00633152|64683771|FG000|Overall Study|Withdrawal by Subject|1|||
23257248|NCT00633152|64683772|FG001|Overall Study|Withdrawal by Subject|1|||
23599879|NCT02161146|65925707|FG001|Overall Study|Other Miscellaneous Reasons|1|||
23599880|NCT02161146|65925708|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23599881|NCT02161146|65925709|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23599882|NCT02161146|65925710|FG004|Overall Study|Other Miscellaneous Reasons|0|||
23257249|NCT00633152|64683771|FG000|Overall Study|Lost to Follow-up|4|||
23257250|NCT00633152|64683772|FG001|Overall Study|Lost to Follow-up|1|||
23257251|NCT00633152|64683771|FG000|Overall Study|Miscellaneous Other|3|||
23257252|NCT00633152|64683772|FG001|Overall Study|Miscellaneous Other|2|||
23257253|NCT01427803|64683776|FG000|Overall Study|Lost to Follow-up|32|||
23257254|NCT01427803|64683777|FG001|Overall Study|Lost to Follow-up|26|||
23257255|NCT01427803|64683776|FG000|Overall Study|Withdrawal by Subject|20|||
23257256|NCT01427803|64683777|FG001|Overall Study|Withdrawal by Subject|0|||
23257257|NCT01427803|64683776|FG000|Overall Study|Unable to complete full treatment period|6|||
23257258|NCT01427803|64683777|FG001|Overall Study|Unable to complete full treatment period|0|||
23257259|NCT01427803|64683776|FG000|Overall Study|Protocol Violation|1|||
23257260|NCT01427803|64683777|FG001|Overall Study|Protocol Violation|0|||
23257261|NCT01427803|64683776|FG000|Overall Study|Physician Decision|3|||
23257262|NCT01427803|64683777|FG001|Overall Study|Physician Decision|0|||
23257263|NCT01427803|64683776|FG000|Overall Study|did not take product|1|||
23257264|NCT01427803|64683777|FG001|Overall Study|did not take product|0|||
23257265|NCT02390219|64683778|FG000|Overall Study|Death|1|||
23257266|NCT02390219|64683778|FG000|Overall Study|Physician Decision|1|||
23257267|NCT02390219|64683778|FG000|Overall Study|Adverse Event|6|||
23257268|NCT02390219|64683778|FG000|Overall Study|Withdrawal by Subject|1|||
23257269|NCT02390219|64683778|FG000|Overall Study|Lost to Follow-up|2|||
23257270|NCT02390219|64683778|FG000|Overall Study|Other|2|||
23257271|NCT00614055|64683779|FG000|Overall Study|Adverse Event|1|||
23257272|NCT00614055|64683780|FG001|Overall Study|Adverse Event|0|||
23257273|NCT00614055|64683781|FG002|Overall Study|Adverse Event|0|||
23257274|NCT00614055|64683779|FG000|Overall Study|Protocol Violation|2|||
23257275|NCT00614055|64683780|FG001|Overall Study|Protocol Violation|2|||
23257276|NCT00614055|64683781|FG002|Overall Study|Protocol Violation|1|||
23257277|NCT00614055|64683779|FG000|Overall Study|Lack of Efficacy|0|||
23257278|NCT00614055|64683780|FG001|Overall Study|Lack of Efficacy|0|||
23257279|NCT00614055|64683781|FG002|Overall Study|Lack of Efficacy|2|||
23257280|NCT00614055|64683779|FG000|Overall Study|Unclassified|1|||
23257281|NCT00614055|64683780|FG001|Overall Study|Unclassified|4|||
23257282|NCT00614055|64683781|FG002|Overall Study|Unclassified|2|||
23257283|NCT03208933|64683784|FG000|Overall Study|Death|3|||
23257284|NCT03208933|64683784|FG000|Overall Study|Withdrawal by Subject|3|||
23257285|NCT03208933|64683784|FG000|Overall Study|Adverse Event|1|||
23257286|NCT03208933|64683784|FG000|Overall Study|Lost to Follow-up|2|||
23257287|NCT03208933|64683784|FG000|Overall Study|Physician Decision|3|||
23257288|NCT03208933|64683784|FG000|Overall Study|Protocol Violation|1|||
23257289|NCT00006721|64683785|FG000|Overall Study|Adverse Event|0|||
23257290|NCT00006721|64683786|FG001|Overall Study|Adverse Event|4|||
23257291|NCT00006721|64683787|FG002|Overall Study|Adverse Event|4|||
23257292|NCT00006721|64683785|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
23257293|NCT00006721|64683786|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
23257294|NCT00006721|64683787|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
23257295|NCT00006721|64683785|FG000|Overall Study|Progression/Relapse|0|||
23257296|NCT00006721|64683786|FG001|Overall Study|Progression/Relapse|1|||
23257297|NCT00006721|64683787|FG002|Overall Study|Progression/Relapse|2|||
23257298|NCT00006721|64683785|FG000|Overall Study|Death|0|||
23257299|NCT00006721|64683786|FG001|Overall Study|Death|1|||
23257300|NCT00006721|64683787|FG002|Overall Study|Death|2|||
23257301|NCT00006721|64683785|FG000|Overall Study|Other - Not Protocol Specified|0|||
23257302|NCT00006721|64683786|FG001|Overall Study|Other - Not Protocol Specified|7|||
23257303|NCT00006721|64683787|FG002|Overall Study|Other - Not Protocol Specified|7|||
23257304|NCT00006721|64683785|FG000|Overall Study|Ineligible|2|||
23257305|NCT00006721|64683786|FG001|Overall Study|Ineligible|12|||
23257306|NCT00006721|64683787|FG002|Overall Study|Ineligible|10|||
23257307|NCT00006721|64683785|FG000|Overall Study|Eligible but no Treatment Received|1|||
23257308|NCT00006721|64683786|FG001|Overall Study|Eligible but no Treatment Received|0|||
23257309|NCT00006721|64683787|FG002|Overall Study|Eligible but no Treatment Received|0|||
23257310|NCT03812679|64683798|FG000|Overall Study|Adverse Event|2|||
23257311|NCT03812679|64683798|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
23257312|NCT03812679|64683798|FG000|Overall Study|Renal transplant|1|||
23257313|NCT03812679|64683798|FG000|Overall Study|Withdrawal by Subject|1|||
23257314|NCT03812679|64683798|FG000|Overall Study|Termination of study|2|||
23257315|NCT03812679|64683798|FG000|Overall Study|Water device replacement|1|||
23257316|NCT01814137|64683799|FG000|Overall Study|Adverse Event|0|||
23257317|NCT01814137|64683800|FG001|Overall Study|Adverse Event|1|||
23257318|NCT01814137|64683799|FG000|Overall Study|Withdrawal by Subject|2|||
23257319|NCT01814137|64683800|FG001|Overall Study|Withdrawal by Subject|2|||
23257320|NCT01814137|64683799|FG000|Overall Study|Physician Decision|1|||
23257321|NCT01814137|64683800|FG001|Overall Study|Physician Decision|1|||
23257322|NCT01814137|64683799|FG000|Overall Study|Unclassified|2|||
23257323|NCT01814137|64683800|FG001|Overall Study|Unclassified|1|||
23257324|NCT00437281|64683807|FG000|Overall Study|Adverse Event|0|||
23257325|NCT00437281|64683808|FG001|Overall Study|Adverse Event|0|||
23257326|NCT00437281|64683809|FG002|Overall Study|Adverse Event|0|||
23257327|NCT00437281|64683810|FG003|Overall Study|Adverse Event|1|||
23257328|NCT00437281|64683811|FG004|Overall Study|Adverse Event|0|||
23257329|NCT00437281|64683812|FG005|Overall Study|Adverse Event|1|||
23361090|NCT04058028|65065965|FG003|Overall Study|Death|0|||
23361091|NCT00410072|65065968|FG000|Day 1 to Week 48|Adverse Event|1|||
23257330|NCT00437281|64683813|FG006|Overall Study|Adverse Event|0|||
23257331|NCT00437281|64683814|FG007|Overall Study|Adverse Event|0|||
23257332|NCT00437281|64683815|FG008|Overall Study|Adverse Event|0|||
23257333|NCT00437281|64683816|FG009|Overall Study|Adverse Event|1|||
23257334|NCT00437281|64683817|FG010|Overall Study|Adverse Event|0|||
23257335|NCT00437281|64683818|FG011|Overall Study|Adverse Event|0|||
23257336|NCT00437281|64683819|FG012|Overall Study|Adverse Event|0|||
23361092|NCT00410072|65065969|FG001|Day 1 to Week 48|Adverse Event|2|||
23257337|NCT00437281|64683820|FG013|Overall Study|Adverse Event|1|||
23257338|NCT00437281|64683821|FG014|Overall Study|Adverse Event|1|||
23257339|NCT00437281|64683822|FG015|Overall Study|Adverse Event|0|||
23257340|NCT00437281|64683823|FG016|Overall Study|Adverse Event|0|||
23257341|NCT00437281|64683824|FG017|Overall Study|Adverse Event|0|||
23257342|NCT00437281|64683825|FG018|Overall Study|Adverse Event|1|||
23257343|NCT00437281|64683826|FG019|Overall Study|Adverse Event|0|||
23257344|NCT00437281|64683807|FG000|Overall Study|Lost to Follow-up|0|||
23257345|NCT00437281|64683808|FG001|Overall Study|Lost to Follow-up|0|||
23257346|NCT00437281|64683809|FG002|Overall Study|Lost to Follow-up|0|||
23257347|NCT00437281|64683810|FG003|Overall Study|Lost to Follow-up|0|||
23257348|NCT00437281|64683811|FG004|Overall Study|Lost to Follow-up|0|||
23257349|NCT00437281|64683812|FG005|Overall Study|Lost to Follow-up|0|||
23257350|NCT00437281|64683813|FG006|Overall Study|Lost to Follow-up|0|||
23257351|NCT00437281|64683814|FG007|Overall Study|Lost to Follow-up|0|||
23257352|NCT00437281|64683815|FG008|Overall Study|Lost to Follow-up|0|||
23257353|NCT00437281|64683816|FG009|Overall Study|Lost to Follow-up|0|||
23257354|NCT00437281|64683817|FG010|Overall Study|Lost to Follow-up|0|||
23257355|NCT00437281|64683818|FG011|Overall Study|Lost to Follow-up|0|||
23257356|NCT00437281|64683819|FG012|Overall Study|Lost to Follow-up|0|||
23257357|NCT00437281|64683820|FG013|Overall Study|Lost to Follow-up|0|||
23257358|NCT00437281|64683821|FG014|Overall Study|Lost to Follow-up|0|||
23257359|NCT00437281|64683822|FG015|Overall Study|Lost to Follow-up|0|||
23257360|NCT00437281|64683823|FG016|Overall Study|Lost to Follow-up|0|||
23257361|NCT00437281|64683824|FG017|Overall Study|Lost to Follow-up|0|||
23257362|NCT00437281|64683825|FG018|Overall Study|Lost to Follow-up|0|||
23257363|NCT00437281|64683826|FG019|Overall Study|Lost to Follow-up|1|||
23257364|NCT02328547|64683829|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
23257365|NCT02328547|64683830|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
23257366|NCT02328547|64683829|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
23257367|NCT02328547|64683830|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
23257368|NCT00528879|64683831|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
23257369|NCT00528879|64683832|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
23257370|NCT00528879|64683833|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
23257371|NCT00528879|64683834|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
23257372|NCT00528879|64683831|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
23257373|NCT00528879|64683832|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
23257374|NCT00528879|64683833|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
23257375|NCT00528879|64683834|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
23257376|NCT00528879|64683831|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
23257377|NCT00528879|64683832|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
23257378|NCT00528879|64683833|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
23257379|NCT00528879|64683834|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
23257380|NCT00528879|64683831|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
23257381|NCT00528879|64683832|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
23257382|NCT00528879|64683833|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
23257383|NCT00528879|64683834|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
23257384|NCT00528879|64683831|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
23257385|NCT00528879|64683832|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
23257386|NCT00528879|64683833|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
23257387|NCT00528879|64683834|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
23257388|NCT00528879|64683831|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
23257389|NCT00528879|64683832|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
23257390|NCT00528879|64683833|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
23257391|NCT00528879|64683834|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
23257392|NCT00528879|64683831|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
23257393|NCT00528879|64683832|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
23257394|NCT00528879|64683833|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
23599883|NCT03274076|65925712|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
23599884|NCT03274076|65925713|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
23599885|NCT03274076|65925714|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
23599886|NCT03274076|65925715|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
23257395|NCT00528879|64683834|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
23257396|NCT00528879|64683831|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
23257397|NCT00528879|64683832|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
23257398|NCT00528879|64683833|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
23257399|NCT00528879|64683834|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
23257400|NCT00528879|64683831|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
23257401|NCT00528879|64683832|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
23599887|NCT03274076|65925712|FG000|24 Weeks Open Label|Adverse Event|0|||
23257402|NCT00528879|64683833|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
23257403|NCT00528879|64683834|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
23257404|NCT00528879|64683831|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
23257405|NCT00528879|64683832|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
23257406|NCT00528879|64683833|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
23257407|NCT00528879|64683834|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
23257408|NCT00528879|64683831|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
23257409|NCT00528879|64683832|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
23257410|NCT00528879|64683833|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
23257411|NCT00528879|64683834|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
23257412|NCT00528879|64683831|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
23257413|NCT00528879|64683832|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
23257414|NCT00528879|64683833|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
23257415|NCT00528879|64683834|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
23257416|NCT00528879|64683831|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
23257417|NCT00528879|64683832|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
23257418|NCT00528879|64683833|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
23257419|NCT00528879|64683834|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
23257420|NCT00528879|64683831|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
23257421|NCT00528879|64683832|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
23257422|NCT00528879|64683833|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
23257423|NCT00528879|64683834|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
23257424|NCT00528879|64683831|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
23257425|NCT00528879|64683832|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
23257426|NCT00528879|64683833|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
23257427|NCT00528879|64683834|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
23257428|NCT00528879|64683831|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
23257429|NCT00528879|64683832|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
23257430|NCT00528879|64683833|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
23257431|NCT00528879|64683834|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
23257432|NCT00068237|64683846|FG000|Overall Study|Ineligible|3|||
23257433|NCT00068237|64683846|FG000|Overall Study|No protocol treatment received|2|||
23257434|NCT01827371|64683847|FG000|Overall Study|Adverse Event|0|||
23257435|NCT01827371|64683848|FG001|Overall Study|Adverse Event|0|||
23257436|NCT01827371|64683849|FG002|Overall Study|Adverse Event|4|||
23257437|NCT01827371|64683850|FG003|Overall Study|Adverse Event|2|||
23257438|NCT01827371|64683847|FG000|Overall Study|Lost to Follow-up|0|||
23257439|NCT01827371|64683848|FG001|Overall Study|Lost to Follow-up|2|||
23198514|NCT01259492|64465511|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
23198515|NCT01259492|64465512|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
23198516|NCT01259492|64465513|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
23198517|NCT01259492|64465514|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
23198518|NCT01259492|64465511|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
23198519|NCT01259492|64465512|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
23198520|NCT01259492|64465513|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
23198521|NCT01259492|64465514|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
23198522|NCT01259492|64465511|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
23198523|NCT01259492|64465512|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
23198524|NCT01259492|64465513|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
23198525|NCT01259492|64465514|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
23198526|NCT01259492|64465511|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
23198527|NCT01259492|64465512|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
23198528|NCT01259492|64465513|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
23198529|NCT01259492|64465514|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
23198530|NCT01259492|64465511|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
23198531|NCT01259492|64465512|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
23198532|NCT01259492|64465513|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
23198533|NCT01259492|64465514|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
23198534|NCT01259492|64465511|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
23257440|NCT01827371|64683849|FG002|Overall Study|Lost to Follow-up|0|||
23257441|NCT01827371|64683850|FG003|Overall Study|Lost to Follow-up|4|||
23257442|NCT01827371|64683847|FG000|Overall Study|Protocol Violation|1|||
23257443|NCT01827371|64683848|FG001|Overall Study|Protocol Violation|0|||
23257444|NCT01827371|64683849|FG002|Overall Study|Protocol Violation|0|||
23257445|NCT01827371|64683850|FG003|Overall Study|Protocol Violation|0|||
23257446|NCT01827371|64683847|FG000|Overall Study|Withdrawal by Subject|1|||
23257447|NCT01827371|64683848|FG001|Overall Study|Withdrawal by Subject|2|||
23257448|NCT01827371|64683849|FG002|Overall Study|Withdrawal by Subject|2|||
23257449|NCT01827371|64683850|FG003|Overall Study|Withdrawal by Subject|3|||
23257450|NCT01827371|64683847|FG000|Overall Study|Physician Decision|0|||
23257451|NCT01827371|64683848|FG001|Overall Study|Physician Decision|1|||
23198535|NCT01259492|64465512|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
23198536|NCT01259492|64465513|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
23198537|NCT01259492|64465514|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
23198538|NCT01259492|64465511|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
23198539|NCT01259492|64465512|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
23198540|NCT01259492|64465513|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
23198541|NCT01259492|64465514|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
23198542|NCT01259492|64465511|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
23198543|NCT01259492|64465512|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
23198544|NCT01259492|64465513|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
23198545|NCT01259492|64465514|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
23198546|NCT01259492|64465511|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
23198547|NCT01259492|64465512|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
23198548|NCT01259492|64465513|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
23198549|NCT01259492|64465514|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
23198550|NCT01259492|64465511|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
23198551|NCT01259492|64465512|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
23198552|NCT01259492|64465513|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
23198553|NCT01259492|64465514|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
23198554|NCT01259492|64465511|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
23198555|NCT01259492|64465512|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
23198556|NCT01259492|64465513|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
23198557|NCT01259492|64465514|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
23198558|NCT01259492|64465511|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
23198559|NCT01259492|64465512|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
23198560|NCT01259492|64465513|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
23198561|NCT01259492|64465514|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
23198562|NCT01259492|64465511|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
23198563|NCT01259492|64465512|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
23198564|NCT01259492|64465513|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
23198565|NCT01259492|64465514|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
23198566|NCT01259492|64465511|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
23198567|NCT01259492|64465512|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
23198568|NCT01259492|64465513|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
23198569|NCT01259492|64465514|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
23198570|NCT01259492|64465511|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
23198571|NCT01259492|64465512|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
23198572|NCT01259492|64465513|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
23198573|NCT01259492|64465514|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
23198574|NCT01259492|64465511|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
23198575|NCT01259492|64465512|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
23198576|NCT01259492|64465513|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
23198577|NCT01259492|64465514|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
23198578|NCT00830037|64465515|FG000|Overall Study|Withdrawal by Subject|2|||
23198579|NCT00830037|64465516|FG001|Overall Study|Withdrawal by Subject|3|||
23198580|NCT00830037|64465515|FG000|Overall Study|Lost to Follow-up|1|||
23198581|NCT00830037|64465516|FG001|Overall Study|Lost to Follow-up|2|||
23198582|NCT00830037|64465515|FG000|Overall Study|Active when terminated by DSMB|15|||
23198583|NCT00830037|64465516|FG001|Overall Study|Active when terminated by DSMB|14|||
23198584|NCT01158534|64465517|FG000|Overall Study|Withdrawal by Subject|1|||
23198585|NCT01158534|64465517|FG000|Overall Study|Death|1|||
23198586|NCT01158534|64465517|FG000|Overall Study|Other|1|||
23198587|NCT01873742|64465522|FG000|Overall Study|Lost to Follow-up|68|||
23198588|NCT01873742|64465523|FG001|Overall Study|Lost to Follow-up|76|||
23198589|NCT01103349|64465532|FG000|Overall Study|Adverse Event|8|||
23198590|NCT01103349|64465533|FG001|Overall Study|Adverse Event|5|||
23198591|NCT01103349|64465534|FG002|Overall Study|Adverse Event|3|||
23198592|NCT01103349|64465532|FG000|Overall Study|Consent withdrawn|1|||
23198593|NCT01103349|64465533|FG001|Overall Study|Consent withdrawn|0|||
23198594|NCT01103349|64465534|FG002|Overall Study|Consent withdrawn|0|||
23198595|NCT01103349|64465532|FG000|Overall Study|Incorrectly included in the trial|1|||
23198596|NCT01103349|64465533|FG001|Overall Study|Incorrectly included in the trial|0|||
23198597|NCT01103349|64465534|FG002|Overall Study|Incorrectly included in the trial|0|||
23198598|NCT01103349|64465532|FG000|Overall Study|Withdrawal by Subject|1|||
23198599|NCT01103349|64465533|FG001|Overall Study|Withdrawal by Subject|1|||
23198600|NCT01103349|64465534|FG002|Overall Study|Withdrawal by Subject|0|||
23198601|NCT01103349|64465532|FG000|Overall Study|did not want to take trial medication|0|||
23257452|NCT01827371|64683849|FG002|Overall Study|Physician Decision|0|||
23257453|NCT01827371|64683850|FG003|Overall Study|Physician Decision|1|||
23257454|NCT01827371|64683847|FG000|Overall Study|Temporary study halt to vaccinations|11|||
23257455|NCT01827371|64683848|FG001|Overall Study|Temporary study halt to vaccinations|2|||
23257456|NCT01827371|64683849|FG002|Overall Study|Temporary study halt to vaccinations|5|||
23257457|NCT01827371|64683850|FG003|Overall Study|Temporary study halt to vaccinations|13|||
23599888|NCT03274076|65925713|FG001|24 Weeks Open Label|Adverse Event|0|||
23599889|NCT03274076|65925714|FG002|24 Weeks Open Label|Adverse Event|2|||
23257458|NCT00345683|64683851|FG000|Overall Study|Lost to Follow-up|19|||
23599890|NCT03274076|65925715|FG003|24 Weeks Open Label|Adverse Event|0|||
23599891|NCT03274076|65925712|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
23599892|NCT03274076|65925713|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
23599893|NCT03274076|65925714|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
23599894|NCT03274076|65925715|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
23257459|NCT00345683|64683852|FG001|Overall Study|Lost to Follow-up|7|||
23257460|NCT00345683|64683851|FG000|Overall Study|Other|6|||
23257461|NCT00345683|64683852|FG001|Overall Study|Other|2|||
23257462|NCT01155583|64683853|FG000|Phase I|Screen failure - did not start treatment|0|||
23257463|NCT01155583|64683854|FG001|Phase I|Screen failure - did not start treatment|0|||
23257464|NCT01155583|64683855|FG002|Phase I|Screen failure - did not start treatment|0|||
23257465|NCT01155583|64683856|FG003|Phase I|Screen failure - did not start treatment|0|||
23361093|NCT00410072|65065968|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
23361094|NCT00410072|65065969|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
23361095|NCT00410072|65065968|FG000|Day 1 to Week 48|Other|0|||
23257466|NCT01155583|64683857|FG004|Phase I|Screen failure - did not start treatment|1|||
23257467|NCT01155583|64683858|FG005|Phase I|Screen failure - did not start treatment|0|||
23257468|NCT01155583|64683859|FG006|Phase I|Screen failure - did not start treatment|0|||
23257469|NCT01155583|64683860|FG007|Phase I|Screen failure - did not start treatment|2|||
23257470|NCT01155583|64683861|FG008|Phase I|Screen failure - did not start treatment|0|||
23257471|NCT01155583|64683853|FG000|Phase I|Withdrawal by Subject|0|||
23257472|NCT01155583|64683854|FG001|Phase I|Withdrawal by Subject|0|||
23257473|NCT01155583|64683855|FG002|Phase I|Withdrawal by Subject|0|||
23257474|NCT01155583|64683856|FG003|Phase I|Withdrawal by Subject|0|||
23257475|NCT01155583|64683857|FG004|Phase I|Withdrawal by Subject|0|||
23257476|NCT01155583|64683858|FG005|Phase I|Withdrawal by Subject|0|||
23257477|NCT01155583|64683859|FG006|Phase I|Withdrawal by Subject|0|||
23257478|NCT01155583|64683860|FG007|Phase I|Withdrawal by Subject|1|||
23257479|NCT01155583|64683861|FG008|Phase I|Withdrawal by Subject|0|||
23257480|NCT03835975|64683862|FG000|Overall Study|Lost to Follow-up|1|||
23257481|NCT03835975|64683863|FG001|Overall Study|Lost to Follow-up|1|||
23257482|NCT03835975|64683864|FG002|Overall Study|Lost to Follow-up|0|||
23257483|NCT03835975|64683865|FG003|Overall Study|Lost to Follow-up|0|||
23257484|NCT03835975|64683866|FG004|Overall Study|Lost to Follow-up|0|||
23257485|NCT03835975|64683862|FG000|Overall Study|No longer met eligibility criteria|0|||
23257486|NCT03835975|64683863|FG001|Overall Study|No longer met eligibility criteria|1|||
23257487|NCT03835975|64683864|FG002|Overall Study|No longer met eligibility criteria|0|||
23257488|NCT03835975|64683865|FG003|Overall Study|No longer met eligibility criteria|0|||
23257489|NCT03835975|64683866|FG004|Overall Study|No longer met eligibility criteria|0|||
23257490|NCT03835975|64683862|FG000|Overall Study|Protocol Violation|1|||
23257491|NCT03835975|64683863|FG001|Overall Study|Protocol Violation|1|||
23257492|NCT03835975|64683864|FG002|Overall Study|Protocol Violation|2|||
23257493|NCT03835975|64683865|FG003|Overall Study|Protocol Violation|0|||
23257494|NCT03835975|64683866|FG004|Overall Study|Protocol Violation|0|||
23257495|NCT03835975|64683862|FG000|Overall Study|Withdrawal by Subject|1|||
23361096|NCT00410072|65065969|FG001|Day 1 to Week 48|Other|1|||
23599895|NCT04579250|65925720|FG000|Overall Study|Withdrawal by Subject|1|||
23599896|NCT04579250|65925721|FG001|Overall Study|Withdrawal by Subject|1|||
23599897|NCT04579250|65925722|FG002|Overall Study|Withdrawal by Subject|0|||
23599898|NCT04579250|65925720|FG000|Overall Study|Lost to Follow-up|1|||
23599899|NCT04579250|65925721|FG001|Overall Study|Lost to Follow-up|1|||
23599900|NCT04579250|65925722|FG002|Overall Study|Lost to Follow-up|0|||
23599901|NCT04579250|65925720|FG000|Overall Study|Moved from area|0|||
23599902|NCT04579250|65925721|FG001|Overall Study|Moved from area|1|||
23599903|NCT04579250|65925722|FG002|Overall Study|Moved from area|2|||
23599904|NCT00918203|65925730|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
23599905|NCT00918203|65925731|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
23599906|NCT00918203|65925732|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
23599907|NCT00918203|65925730|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
23257496|NCT03835975|64683863|FG001|Overall Study|Withdrawal by Subject|0|||
23257497|NCT03835975|64683864|FG002|Overall Study|Withdrawal by Subject|1|||
23257498|NCT03835975|64683865|FG003|Overall Study|Withdrawal by Subject|1|||
23257499|NCT03835975|64683866|FG004|Overall Study|Withdrawal by Subject|0|||
23257500|NCT04335110|64683867|FG000|Overall Study|Withdrawal by Subject|1|||
23257501|NCT04335110|64683868|FG001|Overall Study|Withdrawal by Subject|1|||
23599908|NCT00918203|65925731|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
23599909|NCT00918203|65925732|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
23599910|NCT00918203|65925730|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
23599911|NCT00918203|65925731|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
23599912|NCT00918203|65925732|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
23599913|NCT00918203|65925730|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
23599914|NCT00918203|65925731|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
23599915|NCT00918203|65925732|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
23599916|NCT01588951|65925733|FG000|Overall Study|Ineligible in retrospect|0|||
23599917|NCT01588951|65925734|FG001|Overall Study|Ineligible in retrospect|0|||
23599918|NCT01588951|65925735|FG002|Overall Study|Ineligible in retrospect|1|||
23599919|NCT01574716|65925736|FG000|Part 1|Death|3|||
23599920|NCT01574716|65925737|FG001|Part 1|Death|1|||
23599921|NCT01574716|65925738|FG002|Part 1|Death|8|||
23599922|NCT01574716|65925739|FG003|Part 1|Death|0|||
23599923|NCT01574716|65925740|FG004|Part 1|Death|0|||
23599924|NCT01574716|65925736|FG000|Part 1|Discontinuation of study by sponsor|0|||
23599925|NCT01574716|65925737|FG001|Part 1|Discontinuation of study by sponsor|0|||
23599926|NCT01574716|65925738|FG002|Part 1|Discontinuation of study by sponsor|1|||
23599927|NCT01574716|65925739|FG003|Part 1|Discontinuation of study by sponsor|0|||
23599928|NCT01574716|65925740|FG004|Part 1|Discontinuation of study by sponsor|0|||
23599929|NCT01574716|65925736|FG000|Part 1|Withdrawal by Subject|0|||
23599930|NCT01574716|65925737|FG001|Part 1|Withdrawal by Subject|2|||
23599931|NCT01574716|65925738|FG002|Part 1|Withdrawal by Subject|0|||
23599932|NCT01574716|65925739|FG003|Part 1|Withdrawal by Subject|0|||
23599933|NCT01574716|65925740|FG004|Part 1|Withdrawal by Subject|0|||
23599934|NCT01574716|65925736|FG000|Part 1|Lost to Follow-up|0|||
23599935|NCT01574716|65925737|FG001|Part 1|Lost to Follow-up|1|||
23599936|NCT01574716|65925738|FG002|Part 1|Lost to Follow-up|0|||
23599937|NCT01574716|65925739|FG003|Part 1|Lost to Follow-up|0|||
23599938|NCT01574716|65925740|FG004|Part 1|Lost to Follow-up|0|||
23599939|NCT01574716|65925736|FG000|Part 2|Progressive disease|0|||
23599940|NCT01574716|65925737|FG001|Part 2|Progressive disease|0|||
23599941|NCT01574716|65925738|FG002|Part 2|Progressive disease|0|||
23599942|NCT01574716|65925739|FG003|Part 2|Progressive disease|1|||
23599943|NCT01574716|65925740|FG004|Part 2|Progressive disease|0|||
23599944|NCT01574716|65925736|FG000|Part 2|Death|0|||
23599945|NCT01574716|65925737|FG001|Part 2|Death|0|||
23599946|NCT01574716|65925738|FG002|Part 2|Death|0|||
23599947|NCT01574716|65925739|FG003|Part 2|Death|76|||
23599948|NCT01574716|65925740|FG004|Part 2|Death|35|||
23599949|NCT01574716|65925736|FG000|Part 2|Discontinuation of study by sponsor|0|||
23599950|NCT01574716|65925737|FG001|Part 2|Discontinuation of study by sponsor|0|||
23599951|NCT01574716|65925738|FG002|Part 2|Discontinuation of study by sponsor|0|||
23599952|NCT01574716|65925739|FG003|Part 2|Discontinuation of study by sponsor|51|||
23599953|NCT01574716|65925740|FG004|Part 2|Discontinuation of study by sponsor|31|||
23599954|NCT01574716|65925736|FG000|Part 2|Withdrawal by Subject|0|||
23599955|NCT01574716|65925737|FG001|Part 2|Withdrawal by Subject|0|||
23599956|NCT01574716|65925738|FG002|Part 2|Withdrawal by Subject|0|||
23599957|NCT01574716|65925739|FG003|Part 2|Withdrawal by Subject|5|||
23599958|NCT01574716|65925740|FG004|Part 2|Withdrawal by Subject|4|||
23599959|NCT01574716|65925736|FG000|Part 2|Brain metastases|0|||
23599960|NCT01574716|65925737|FG001|Part 2|Brain metastases|0|||
23599961|NCT01574716|65925738|FG002|Part 2|Brain metastases|0|||
23599962|NCT01574716|65925739|FG003|Part 2|Brain metastases|1|||
23599963|NCT01574716|65925740|FG004|Part 2|Brain metastases|0|||
23599964|NCT01574716|65925736|FG000|Part 2|Lost to Follow-up|0|||
23599965|NCT01574716|65925737|FG001|Part 2|Lost to Follow-up|0|||
23599966|NCT01574716|65925738|FG002|Part 2|Lost to Follow-up|0|||
23599967|NCT01574716|65925739|FG003|Part 2|Lost to Follow-up|3|||
23599968|NCT01574716|65925740|FG004|Part 2|Lost to Follow-up|0|||
23599969|NCT04048681|65925741|FG000|Overall Study|family emergency|0|||
23599970|NCT04048681|65925742|FG001|Overall Study|family emergency|0|||
23599971|NCT04048681|65925743|FG002|Overall Study|family emergency|0|||
23599972|NCT04048681|65925744|FG003|Overall Study|family emergency|1|||
23599973|NCT04048681|65925745|FG004|Overall Study|family emergency|0|||
23599974|NCT02023866|65925753|FG000|Overall Study|Non-compliance|2|||
23599975|NCT02023866|65925753|FG000|Overall Study|Adverse Event|3|||
23599976|NCT02023866|65925753|FG000|Overall Study|Withdrawal by Subject|1|||
23599977|NCT01964300|65925754|FG000|Overall Study|Ineligible after enrollment|0|||
23599978|NCT01964300|65925755|FG001|Overall Study|Ineligible after enrollment|1|||
23599979|NCT01964300|65925754|FG000|Overall Study|Adverse Event|1|||
23599980|NCT01964300|65925755|FG001|Overall Study|Adverse Event|1|||
23599981|NCT01964300|65925754|FG000|Overall Study|Lack of Efficacy|3|||
23599982|NCT01964300|65925755|FG001|Overall Study|Lack of Efficacy|5|||
23599983|NCT01964300|65925754|FG000|Overall Study|Withdrawal by Subject|0|||
23599984|NCT01964300|65925755|FG001|Overall Study|Withdrawal by Subject|1|||
23599985|NCT01964300|65925754|FG000|Overall Study|To receive alternative therapy|1|||
23198602|NCT01103349|64465533|FG001|Overall Study|did not want to take trial medication|1|||
23198603|NCT01103349|64465534|FG002|Overall Study|did not want to take trial medication|0|||
23198604|NCT01103349|64465532|FG000|Overall Study|forgot to take medication|0|||
23198605|NCT01103349|64465533|FG001|Overall Study|forgot to take medication|0|||
23198606|NCT01103349|64465534|FG002|Overall Study|forgot to take medication|1|||
23198607|NCT01539837|64465535|FG000|Overall Study|reduce neutrophil level|0|||
23198608|NCT01539837|64465536|FG001|Overall Study|reduce neutrophil level|1|||
23198609|NCT01539837|64465537|FG002|Overall Study|reduce neutrophil level|1|||
23198610|NCT01539837|64465535|FG000|Overall Study|bad compliance|0|||
23198611|NCT01539837|64465536|FG001|Overall Study|bad compliance|0|||
23198612|NCT01539837|64465537|FG002|Overall Study|bad compliance|1|||
23198613|NCT00705224|64465538|FG000|Overall Study|Adverse Event|1|||
23198614|NCT00705224|64465538|FG000|Overall Study|Lack of Efficacy|2|||
23198615|NCT00705224|64465538|FG000|Overall Study|Withdrawal by Subject|3|||
23198616|NCT00705224|64465538|FG000|Overall Study|Lost to Follow-up|5|||
23198617|NCT03117049|64465539|FG000|Overall Study|Continued the follow-up period|109|||
23198618|NCT03117049|64465540|FG001|Overall Study|Continued the follow-up period|129|||
23198619|NCT03117049|64465539|FG000|Overall Study|Died|82|||
23198620|NCT03117049|64465540|FG001|Overall Study|Died|93|||
23198621|NCT03117049|64465539|FG000|Overall Study|Consent withdrawal|7|||
23198622|NCT03117049|64465540|FG001|Overall Study|Consent withdrawal|6|||
23198623|NCT03117049|64465539|FG000|Overall Study|Missing contact|3|||
23198624|NCT03117049|64465540|FG001|Overall Study|Missing contact|3|||
23198625|NCT02552355|64465541|FG000|Overall Study|Adverse Event|0|||
23198626|NCT02552355|64465542|FG001|Overall Study|Adverse Event|2|||
23198627|NCT02552355|64465543|FG002|Overall Study|Adverse Event|2|||
23198628|NCT02552355|64465544|FG003|Overall Study|Adverse Event|0|||
23198629|NCT02552355|64465541|FG000|Overall Study|Withdrawal by Subject|0|||
23198630|NCT02552355|64465542|FG001|Overall Study|Withdrawal by Subject|0|||
23198631|NCT02552355|64465543|FG002|Overall Study|Withdrawal by Subject|0|||
23198632|NCT02552355|64465544|FG003|Overall Study|Withdrawal by Subject|1|||
23198633|NCT00320385|64465547|FG000|Overall Study|Lost to Follow-up|7|||
23198634|NCT00320385|64465548|FG001|Overall Study|Lost to Follow-up|10|||
23198635|NCT00320385|64465547|FG000|Overall Study|Withdrawal by Subject|6|||
23198636|NCT00320385|64465548|FG001|Overall Study|Withdrawal by Subject|7|||
23198637|NCT00320385|64465547|FG000|Overall Study|Sponsor Terminated Study|2|||
23198638|NCT00320385|64465548|FG001|Overall Study|Sponsor Terminated Study|1|||
23198639|NCT00320385|64465547|FG000|Overall Study|Investigator Decision|0|||
23198640|NCT00320385|64465548|FG001|Overall Study|Investigator Decision|1|||
23198641|NCT00320385|64465547|FG000|Overall Study|Death|1|||
23198642|NCT00320385|64465548|FG001|Overall Study|Death|2|||
23198643|NCT00320385|64465547|FG000|Overall Study|Serious Adverse Event|1|||
23198644|NCT00320385|64465548|FG001|Overall Study|Serious Adverse Event|0|||
23198645|NCT00320385|64465547|FG000|Overall Study|Withdrew Consent|1|||
23198646|NCT00320385|64465548|FG001|Overall Study|Withdrew Consent|0|||
23198647|NCT00320385|64465547|FG000|Overall Study|Adverse Event|0|||
23198648|NCT00320385|64465548|FG001|Overall Study|Adverse Event|1|||
23198649|NCT01554956|64465549|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
23198650|NCT01554956|64465550|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
23198651|NCT01554956|64465551|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
23198652|NCT01554956|64465549|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
23198653|NCT01554956|64465550|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
23198654|NCT01554956|64465551|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
23198655|NCT01554956|64465549|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
23198656|NCT01554956|64465550|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
23198657|NCT01554956|64465551|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
23198658|NCT02084134|64465555|FG000|Overall Study|Protocol Violation|4|||
23198659|NCT02084134|64465556|FG001|Overall Study|Protocol Violation|2|||
23198660|NCT02084134|64465555|FG000|Overall Study|Death|0|||
23198661|NCT02084134|64465556|FG001|Overall Study|Death|1|||
23198662|NCT01814800|64465557|FG000|Overall Study|Adverse Event|2|||
23198663|NCT01814800|64465557|FG000|Overall Study|Pregnancy|1|||
23198664|NCT01814800|64465557|FG000|Overall Study|Sponsor decision|1|||
23198665|NCT01814800|64465557|FG000|Overall Study|Subject relocation|1|||
23198666|NCT01371838|64465558|FG000|Overall Study|Withdrawal by Subject|27|||
23198667|NCT01371838|64465559|FG001|Overall Study|Withdrawal by Subject|33|||
23198668|NCT01371838|64465558|FG000|Overall Study|Lost to Follow-up|10|||
23198669|NCT01371838|64465559|FG001|Overall Study|Lost to Follow-up|20|||
23198670|NCT01371838|64465558|FG000|Overall Study|Death|3|||
23198671|NCT01371838|64465559|FG001|Overall Study|Death|4|||
23198672|NCT01371838|64465558|FG000|Overall Study|Protocol Violation|3|||
23198673|NCT01371838|64465559|FG001|Overall Study|Protocol Violation|0|||
23198674|NCT01371838|64465558|FG000|Overall Study|Investigator Decision|3|||
23198675|NCT01371838|64465559|FG001|Overall Study|Investigator Decision|8|||
23198676|NCT01371838|64465558|FG000|Overall Study|Last follow-up visit not conducted|2|||
23257502|NCT04335110|64683867|FG000|Overall Study|Death|0|||
23257503|NCT04335110|64683868|FG001|Overall Study|Death|1|||
23257504|NCT02622074|64683869|FG000|Overall Study|Death|4|||
23257505|NCT02622074|64683870|FG001|Overall Study|Death|0|||
23257506|NCT02622074|64683871|FG002|Overall Study|Death|0|||
23257507|NCT02622074|64683872|FG003|Overall Study|Death|1|||
23257508|NCT02622074|64683873|FG004|Overall Study|Death|1|||
23257509|NCT02622074|64683874|FG005|Overall Study|Death|0|||
23257510|NCT02622074|64683869|FG000|Overall Study|Withdrawal by Subject|0|||
23257511|NCT02622074|64683870|FG001|Overall Study|Withdrawal by Subject|1|||
23257512|NCT02622074|64683871|FG002|Overall Study|Withdrawal by Subject|0|||
23257513|NCT02622074|64683872|FG003|Overall Study|Withdrawal by Subject|0|||
23257514|NCT02622074|64683873|FG004|Overall Study|Withdrawal by Subject|0|||
23257515|NCT02622074|64683874|FG005|Overall Study|Withdrawal by Subject|0|||
23257516|NCT00415532|64683875|FG000|Treatment Period|Adverse Event|2|||
23257517|NCT00415532|64683876|FG001|Treatment Period|Adverse Event|3|||
23257518|NCT00415532|64683875|FG000|Treatment Period|Death|2|||
23257519|NCT00415532|64683876|FG001|Treatment Period|Death|1|||
23257520|NCT00415532|64683875|FG000|Treatment Period|Lost to Follow-up|1|||
23257521|NCT00415532|64683876|FG001|Treatment Period|Lost to Follow-up|1|||
23257522|NCT00415532|64683875|FG000|Treatment Period|Protocol Violation|1|||
23257523|NCT00415532|64683876|FG001|Treatment Period|Protocol Violation|0|||
23257524|NCT00415532|64683875|FG000|Treatment Period|Withdrawal by Subject|6|||
23257525|NCT00415532|64683876|FG001|Treatment Period|Withdrawal by Subject|6|||
23257526|NCT00415532|64683875|FG000|Treatment Period|Other|2|||
23257527|NCT00415532|64683876|FG001|Treatment Period|Other|2|||
23257528|NCT00415532|64683875|FG000|Treatment Period|Ineligibility determined|1|||
23257529|NCT00415532|64683876|FG001|Treatment Period|Ineligibility determined|1|||
23257530|NCT00415532|64683875|FG000|Treatment Period|Noncompliance|1|||
23257531|NCT00415532|64683876|FG001|Treatment Period|Noncompliance|1|||
23257532|NCT00415532|64683875|FG000|Treatment Period|Requirement for alternative therapy|1|||
23257533|NCT00415532|64683876|FG001|Treatment Period|Requirement for alternative therapy|0|||
23257534|NCT00415532|64683875|FG000|Safety Follow Up Period|Adverse Event|1|||
23257535|NCT00415532|64683876|FG001|Safety Follow Up Period|Adverse Event|3|||
23257536|NCT00415532|64683875|FG000|Safety Follow Up Period|Death|3|||
23257537|NCT00415532|64683876|FG001|Safety Follow Up Period|Death|0|||
23257538|NCT00415532|64683875|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
23257539|NCT00415532|64683876|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
23257540|NCT00415532|64683875|FG000|Safety Follow Up Period|Other|1|||
23257541|NCT00415532|64683876|FG001|Safety Follow Up Period|Other|4|||
23257542|NCT00415532|64683875|FG000|Safety Follow Up Period|Ineligibility determined|1|||
23257543|NCT00415532|64683876|FG001|Safety Follow Up Period|Ineligibility determined|1|||
23257544|NCT00415532|64683875|FG000|Safety Follow Up Period|Noncompliance|1|||
23257545|NCT00415532|64683876|FG001|Safety Follow Up Period|Noncompliance|0|||
23257546|NCT00415532|64683875|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
23257547|NCT00415532|64683876|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
23257548|NCT02904200|64683877|FG000|Overall Study|Withdrawal by Subject|1|||
23257549|NCT02904200|64683878|FG001|Overall Study|Withdrawal by Subject|0|||
23257550|NCT01792284|64683885|FG000|Lead-in Period|Adverse Event|15|||
23257551|NCT01792284|64683886|FG001|Lead-in Period|Adverse Event|0|||
23257552|NCT01792284|64683887|FG002|Lead-in Period|Adverse Event|0|||
23257553|NCT01792284|64683885|FG000|Lead-in Period|Lost to Follow-up|2|||
23257554|NCT01792284|64683886|FG001|Lead-in Period|Lost to Follow-up|0|||
23198677|NCT01371838|64465559|FG001|Overall Study|Last follow-up visit not conducted|0|||
23257555|NCT01792284|64683887|FG002|Lead-in Period|Lost to Follow-up|0|||
23257556|NCT01792284|64683885|FG000|Lead-in Period|Protocol Violation|1|||
23257557|NCT01792284|64683886|FG001|Lead-in Period|Protocol Violation|0|||
23257558|NCT01792284|64683887|FG002|Lead-in Period|Protocol Violation|0|||
23257559|NCT01792284|64683885|FG000|Lead-in Period|Withdrawal by Subject|10|||
23257560|NCT01792284|64683886|FG001|Lead-in Period|Withdrawal by Subject|0|||
23257561|NCT01792284|64683887|FG002|Lead-in Period|Withdrawal by Subject|0|||
23257562|NCT01792284|64683885|FG000|Lead-in Period|Physician Decision|1|||
23257563|NCT01792284|64683886|FG001|Lead-in Period|Physician Decision|0|||
23361097|NCT00410072|65065968|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
23257564|NCT01792284|64683887|FG002|Lead-in Period|Physician Decision|0|||
23257565|NCT01792284|64683885|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
23257566|NCT01792284|64683886|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
23257567|NCT01792284|64683887|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
23257568|NCT01792284|64683885|FG000|Randomization Period 1|Withdrawal by Subject|0|||
23257569|NCT01792284|64683886|FG001|Randomization Period 1|Withdrawal by Subject|1|||
23257570|NCT01792284|64683887|FG002|Randomization Period 1|Withdrawal by Subject|1|||
23257571|NCT01792284|64683885|FG000|Randomization Period 1|Physician Decision|0|||
23257572|NCT01792284|64683886|FG001|Randomization Period 1|Physician Decision|1|||
23257573|NCT01792284|64683887|FG002|Randomization Period 1|Physician Decision|1|||
23257574|NCT01792284|64683885|FG000|Randomization Period 1|Adverse Event|0|||
23257575|NCT01792284|64683886|FG001|Randomization Period 1|Adverse Event|0|||
23257576|NCT01792284|64683887|FG002|Randomization Period 1|Adverse Event|2|||
23257577|NCT01792284|64683885|FG000|Randomization Period 1|Lost to Follow-up|0|||
23257578|NCT01792284|64683886|FG001|Randomization Period 1|Lost to Follow-up|0|||
23257579|NCT01792284|64683887|FG002|Randomization Period 1|Lost to Follow-up|1|||
23257580|NCT01792284|64683885|FG000|Randomization Period 2|Protocol Violation|0|||
23257581|NCT01792284|64683886|FG001|Randomization Period 2|Protocol Violation|1|||
23257582|NCT01792284|64683887|FG002|Randomization Period 2|Protocol Violation|0|||
23257583|NCT01792284|64683885|FG000|Randomization Period 2|Withdrawal by Subject|0|||
23257584|NCT01792284|64683886|FG001|Randomization Period 2|Withdrawal by Subject|2|||
23257585|NCT01792284|64683887|FG002|Randomization Period 2|Withdrawal by Subject|0|||
23257586|NCT02280421|64683888|FG000|Washout (2 Weeks)|Adverse Event|0|||
23257587|NCT02280421|64683889|FG001|Washout (2 Weeks)|Adverse Event|1|||
23257588|NCT02280421|64683888|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
23257589|NCT02280421|64683889|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
23257590|NCT00409578|64683890|FG000|Overall Study|Adverse Event|27|||
23257591|NCT00409578|64683891|FG001|Overall Study|Adverse Event|37|||
23257592|NCT00409578|64683892|FG002|Overall Study|Adverse Event|25|||
23257593|NCT00409578|64683893|FG003|Overall Study|Adverse Event|33|||
23257594|NCT00409578|64683890|FG000|Overall Study|Abnormal laboratory value(s)|2|||
23257595|NCT00409578|64683891|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23257596|NCT00409578|64683892|FG002|Overall Study|Abnormal laboratory value(s)|2|||
23257597|NCT00409578|64683893|FG003|Overall Study|Abnormal laboratory value(s)|4|||
23257598|NCT00409578|64683890|FG000|Overall Study|Lack of Efficacy|0|||
23257599|NCT00409578|64683891|FG001|Overall Study|Lack of Efficacy|0|||
23257600|NCT00409578|64683892|FG002|Overall Study|Lack of Efficacy|0|||
23257601|NCT00409578|64683893|FG003|Overall Study|Lack of Efficacy|2|||
23257602|NCT00409578|64683890|FG000|Overall Study|Subject no longer requires study drug|0|||
23257603|NCT00409578|64683891|FG001|Overall Study|Subject no longer requires study drug|0|||
23257604|NCT00409578|64683892|FG002|Overall Study|Subject no longer requires study drug|0|||
23257605|NCT00409578|64683893|FG003|Overall Study|Subject no longer requires study drug|1|||
23257606|NCT00409578|64683890|FG000|Overall Study|Withdrawal by Subject|8|||
23257607|NCT00409578|64683891|FG001|Overall Study|Withdrawal by Subject|15|||
23257608|NCT00409578|64683892|FG002|Overall Study|Withdrawal by Subject|16|||
23257609|NCT00409578|64683893|FG003|Overall Study|Withdrawal by Subject|17|||
23257610|NCT00409578|64683890|FG000|Overall Study|Lost to Follow-up|2|||
23257611|NCT00409578|64683891|FG001|Overall Study|Lost to Follow-up|0|||
23257612|NCT00409578|64683892|FG002|Overall Study|Lost to Follow-up|2|||
23257613|NCT00409578|64683893|FG003|Overall Study|Lost to Follow-up|2|||
23257614|NCT00409578|64683890|FG000|Overall Study|Administrative problems|8|||
23257615|NCT00409578|64683891|FG001|Overall Study|Administrative problems|9|||
23257616|NCT00409578|64683892|FG002|Overall Study|Administrative problems|2|||
23257617|NCT00409578|64683893|FG003|Overall Study|Administrative problems|4|||
23257618|NCT00409578|64683890|FG000|Overall Study|Death|2|||
23257619|NCT00409578|64683891|FG001|Overall Study|Death|4|||
23257620|NCT00409578|64683892|FG002|Overall Study|Death|4|||
23257621|NCT00409578|64683893|FG003|Overall Study|Death|2|||
23257622|NCT00409578|64683890|FG000|Overall Study|Protocol Violation|3|||
23257623|NCT00409578|64683891|FG001|Overall Study|Protocol Violation|2|||
23257624|NCT00409578|64683892|FG002|Overall Study|Protocol Violation|3|||
23257625|NCT00409578|64683893|FG003|Overall Study|Protocol Violation|1|||
23257626|NCT00409578|64683890|FG000|Overall Study|Missing|0|||
23257627|NCT00409578|64683891|FG001|Overall Study|Missing|1|||
23257628|NCT00409578|64683892|FG002|Overall Study|Missing|0|||
23257629|NCT00409578|64683893|FG003|Overall Study|Missing|1|||
23257630|NCT01348542|64683894|FG000|Overall Study|Withdrawal by Subject|3|||
23257631|NCT01348542|64683895|FG001|Overall Study|Withdrawal by Subject|0|||
23257632|NCT01967888|64683896|FG000|Overall Study|Lost to Follow-up|6|||
23257633|NCT01967888|64683897|FG001|Overall Study|Lost to Follow-up|4|||
23257634|NCT01967888|64683896|FG000|Overall Study|Withdrawal by Subject|1|||
23257635|NCT01967888|64683897|FG001|Overall Study|Withdrawal by Subject|1|||
23257636|NCT01967888|64683896|FG000|Overall Study|Did Not Have Transplant|1|||
23257637|NCT01967888|64683897|FG001|Overall Study|Did Not Have Transplant|0|||
23257638|NCT01967888|64683896|FG000|Overall Study|Research visit not done, data recorded|1|||
23257639|NCT01967888|64683897|FG001|Overall Study|Research visit not done, data recorded|0|||
23257640|NCT01967888|64683896|FG000|Overall Study|Subject excluded after randomization|1|||
23480354|NCT01330017|65501955|FG001|Overall Study|Withdrawal by Subject|0|||
23480355|NCT01330017|65501956|FG002|Overall Study|Withdrawal by Subject|1|||
23198678|NCT01371838|64465558|FG000|Overall Study|Lack of therapeutic response|0|||
23257641|NCT01967888|64683897|FG001|Overall Study|Subject excluded after randomization|0|||
23257642|NCT01967888|64683896|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
23257643|NCT01967888|64683897|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
23257644|NCT01967888|64683896|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
23257645|NCT01967888|64683897|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
23257646|NCT02711956|64686582|FG000|Overall Study|Adverse Event|0|||
23257647|NCT02711956|64686583|FG001|Overall Study|Adverse Event|0|||
23257648|NCT02711956|64686584|FG002|Overall Study|Adverse Event|0|||
23257649|NCT02711956|64686585|FG003|Overall Study|Adverse Event|1|||
23257650|NCT02711956|64686586|FG004|Overall Study|Adverse Event|2|||
23257651|NCT02711956|64686587|FG005|Overall Study|Adverse Event|0|||
23257652|NCT02711956|64686588|FG006|Overall Study|Adverse Event|0|||
23257653|NCT02711956|64686589|FG007|Overall Study|Adverse Event|1|||
23257654|NCT02711956|64686590|FG008|Overall Study|Adverse Event|1|||
23257655|NCT02711956|64686591|FG009|Overall Study|Adverse Event|1|||
23257656|NCT02711956|64686592|FG010|Overall Study|Adverse Event|1|||
23257657|NCT02711956|64686593|FG011|Overall Study|Adverse Event|0|||
23257658|NCT02711956|64686594|FG012|Overall Study|Adverse Event|0|||
23257659|NCT02711956|64686595|FG013|Overall Study|Adverse Event|0|||
23257660|NCT02711956|64686596|FG014|Overall Study|Adverse Event|2|||
23257661|NCT02711956|64686582|FG000|Overall Study|Physician Decision|0|||
23257662|NCT02711956|64686583|FG001|Overall Study|Physician Decision|0|||
23257663|NCT02711956|64686584|FG002|Overall Study|Physician Decision|0|||
23257664|NCT02711956|64686585|FG003|Overall Study|Physician Decision|2|||
23257665|NCT02711956|64686586|FG004|Overall Study|Physician Decision|0|||
23257666|NCT02711956|64686587|FG005|Overall Study|Physician Decision|0|||
23257667|NCT02711956|64686588|FG006|Overall Study|Physician Decision|0|||
23257668|NCT02711956|64686589|FG007|Overall Study|Physician Decision|0|||
23257669|NCT02711956|64686590|FG008|Overall Study|Physician Decision|0|||
23257670|NCT02711956|64686591|FG009|Overall Study|Physician Decision|0|||
23257671|NCT02711956|64686592|FG010|Overall Study|Physician Decision|0|||
23257672|NCT02711956|64686593|FG011|Overall Study|Physician Decision|0|||
23257673|NCT02711956|64686594|FG012|Overall Study|Physician Decision|0|||
23257674|NCT02711956|64686595|FG013|Overall Study|Physician Decision|0|||
23257675|NCT02711956|64686596|FG014|Overall Study|Physician Decision|0|||
23257676|NCT02711956|64686582|FG000|Overall Study|Withdrawal by Subject|0|||
23257677|NCT02711956|64686583|FG001|Overall Study|Withdrawal by Subject|0|||
23257678|NCT02711956|64686584|FG002|Overall Study|Withdrawal by Subject|0|||
23257679|NCT02711956|64686585|FG003|Overall Study|Withdrawal by Subject|0|||
23257680|NCT02711956|64686586|FG004|Overall Study|Withdrawal by Subject|0|||
23257681|NCT02711956|64686587|FG005|Overall Study|Withdrawal by Subject|0|||
23257682|NCT02711956|64686588|FG006|Overall Study|Withdrawal by Subject|1|||
23257683|NCT02711956|64686589|FG007|Overall Study|Withdrawal by Subject|0|||
23257684|NCT02711956|64686590|FG008|Overall Study|Withdrawal by Subject|0|||
23257685|NCT02711956|64686591|FG009|Overall Study|Withdrawal by Subject|0|||
23257686|NCT02711956|64686592|FG010|Overall Study|Withdrawal by Subject|0|||
23257687|NCT02711956|64686593|FG011|Overall Study|Withdrawal by Subject|1|||
23257688|NCT02711956|64686594|FG012|Overall Study|Withdrawal by Subject|6|||
23257689|NCT02711956|64686595|FG013|Overall Study|Withdrawal by Subject|0|||
23257690|NCT02711956|64686596|FG014|Overall Study|Withdrawal by Subject|1|||
23257691|NCT02711956|64686582|FG000|Overall Study|Clinical progression|1|||
23257692|NCT02711956|64686583|FG001|Overall Study|Clinical progression|0|||
23257693|NCT02711956|64686584|FG002|Overall Study|Clinical progression|0|||
23257694|NCT02711956|64686585|FG003|Overall Study|Clinical progression|0|||
23257695|NCT02711956|64686586|FG004|Overall Study|Clinical progression|0|||
23257696|NCT02711956|64686587|FG005|Overall Study|Clinical progression|0|||
23257697|NCT02711956|64686588|FG006|Overall Study|Clinical progression|1|||
23257698|NCT02711956|64686589|FG007|Overall Study|Clinical progression|0|||
23257699|NCT02711956|64686590|FG008|Overall Study|Clinical progression|1|||
23257700|NCT02711956|64686591|FG009|Overall Study|Clinical progression|0|||
23257701|NCT02711956|64686592|FG010|Overall Study|Clinical progression|0|||
23257702|NCT02711956|64686593|FG011|Overall Study|Clinical progression|2|||
23257703|NCT02711956|64686594|FG012|Overall Study|Clinical progression|4|||
23257704|NCT02711956|64686595|FG013|Overall Study|Clinical progression|1|||
23257705|NCT02711956|64686596|FG014|Overall Study|Clinical progression|1|||
23257706|NCT02711956|64686582|FG000|Overall Study|Radiographic progression|1|||
23257707|NCT02711956|64686583|FG001|Overall Study|Radiographic progression|1|||
23257708|NCT02711956|64686584|FG002|Overall Study|Radiographic progression|2|||
23257709|NCT02711956|64686585|FG003|Overall Study|Radiographic progression|0|||
23257710|NCT02711956|64686586|FG004|Overall Study|Radiographic progression|1|||
23257711|NCT02711956|64686587|FG005|Overall Study|Radiographic progression|0|||
23257712|NCT02711956|64686588|FG006|Overall Study|Radiographic progression|0|||
23257713|NCT02711956|64686589|FG007|Overall Study|Radiographic progression|0|||
23257714|NCT02711956|64686590|FG008|Overall Study|Radiographic progression|2|||
23257715|NCT02711956|64686591|FG009|Overall Study|Radiographic progression|1|||
23257716|NCT02711956|64686592|FG010|Overall Study|Radiographic progression|0|||
23257717|NCT02711956|64686593|FG011|Overall Study|Radiographic progression|5|||
23257718|NCT02711956|64686594|FG012|Overall Study|Radiographic progression|3|||
23257719|NCT02711956|64686595|FG013|Overall Study|Radiographic progression|0|||
23257720|NCT02711956|64686596|FG014|Overall Study|Radiographic progression|1|||
23257721|NCT02711956|64686582|FG000|Overall Study|PSA progression with clinical progression|0|||
23257722|NCT02711956|64686583|FG001|Overall Study|PSA progression with clinical progression|0|||
23257723|NCT02711956|64686584|FG002|Overall Study|PSA progression with clinical progression|0|||
23257724|NCT02711956|64686585|FG003|Overall Study|PSA progression with clinical progression|0|||
23257725|NCT02711956|64686586|FG004|Overall Study|PSA progression with clinical progression|1|||
23257726|NCT02711956|64686587|FG005|Overall Study|PSA progression with clinical progression|0|||
23257727|NCT02711956|64686588|FG006|Overall Study|PSA progression with clinical progression|0|||
23257728|NCT02711956|64686589|FG007|Overall Study|PSA progression with clinical progression|0|||
23257729|NCT02711956|64686590|FG008|Overall Study|PSA progression with clinical progression|0|||
23257730|NCT02711956|64686591|FG009|Overall Study|PSA progression with clinical progression|0|||
23257731|NCT02711956|64686592|FG010|Overall Study|PSA progression with clinical progression|0|||
23257732|NCT02711956|64686593|FG011|Overall Study|PSA progression with clinical progression|0|||
23257733|NCT02711956|64686594|FG012|Overall Study|PSA progression with clinical progression|1|||
23257734|NCT02711956|64686595|FG013|Overall Study|PSA progression with clinical progression|1|||
23257735|NCT02711956|64686596|FG014|Overall Study|PSA progression with clinical progression|0|||
23257736|NCT02711956|64686582|FG000|Overall Study|PSA progression with radiographic progression|0|||
23257737|NCT02711956|64686583|FG001|Overall Study|PSA progression with radiographic progression|1|||
23257738|NCT02711956|64686584|FG002|Overall Study|PSA progression with radiographic progression|0|||
23257739|NCT02711956|64686585|FG003|Overall Study|PSA progression with radiographic progression|0|||
23257740|NCT02711956|64686586|FG004|Overall Study|PSA progression with radiographic progression|0|||
23257741|NCT02711956|64686587|FG005|Overall Study|PSA progression with radiographic progression|2|||
23257742|NCT02711956|64686588|FG006|Overall Study|PSA progression with radiographic progression|2|||
23257743|NCT02711956|64686589|FG007|Overall Study|PSA progression with radiographic progression|1|||
23257744|NCT02711956|64686590|FG008|Overall Study|PSA progression with radiographic progression|0|||
23257745|NCT02711956|64686591|FG009|Overall Study|PSA progression with radiographic progression|1|||
23257746|NCT02711956|64686592|FG010|Overall Study|PSA progression with radiographic progression|0|||
23257747|NCT02711956|64686593|FG011|Overall Study|PSA progression with radiographic progression|1|||
23257748|NCT02711956|64686594|FG012|Overall Study|PSA progression with radiographic progression|2|||
23257749|NCT02711956|64686595|FG013|Overall Study|PSA progression with radiographic progression|3|||
23257750|NCT02711956|64686596|FG014|Overall Study|PSA progression with radiographic progression|3|||
23257751|NCT01722266|64686597|FG000|Overall Study|Withdrawal by Subject|1|||
23257752|NCT01722266|64686598|FG001|Overall Study|Withdrawal by Subject|2|||
23257753|NCT01722266|64686599|FG002|Overall Study|Withdrawal by Subject|0|||
23257754|NCT01722266|64686600|FG003|Overall Study|Withdrawal by Subject|0|||
23257755|NCT01722266|64686597|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
23257756|NCT01722266|64686598|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
23257757|NCT01722266|64686599|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
23257758|NCT01722266|64686600|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
23257759|NCT01722266|64686597|FG000|Overall Study|Dropped out due to Nausea|0|||
23257760|NCT01722266|64686598|FG001|Overall Study|Dropped out due to Nausea|0|||
23257761|NCT01722266|64686599|FG002|Overall Study|Dropped out due to Nausea|2|||
23257762|NCT01722266|64686600|FG003|Overall Study|Dropped out due to Nausea|0|||
23257763|NCT00373685|64686603|FG000|Overall Study|Death|2|||
23257764|NCT00373685|64686604|FG001|Overall Study|Death|1|||
23257765|NCT00373685|64686603|FG000|Overall Study|Adverse Event|278|||
23257766|NCT00373685|64686604|FG001|Overall Study|Adverse Event|253|||
23257767|NCT00373685|64686603|FG000|Overall Study|Insufficient clinical response|169|||
23257768|NCT00373685|64686604|FG001|Overall Study|Insufficient clinical response|119|||
23257769|NCT00373685|64686603|FG000|Overall Study|Did not meet entrance criteria|167|||
23257770|NCT00373685|64686604|FG001|Overall Study|Did not meet entrance criteria|184|||
23257771|NCT00373685|64686603|FG000|Overall Study|Lost to follow up|83|||
23257772|NCT00373685|64686604|FG001|Overall Study|Lost to follow up|103|||
23257773|NCT00373685|64686603|FG000|Overall Study|No longer willing to participate|337|||
23257774|NCT00373685|64686604|FG001|Overall Study|No longer willing to participate|352|||
23257775|NCT00373685|64686603|FG000|Overall Study|Other|149|||
23257776|NCT00373685|64686604|FG001|Overall Study|Other|146|||
23257777|NCT00373685|64686603|FG000|Overall Study|Protocol Violation|191|||
23257778|NCT00373685|64686604|FG001|Overall Study|Protocol Violation|182|||
23257779|NCT00373685|64686603|FG000|Overall Study|Final Status Unknown|12|||
23257780|NCT00373685|64686604|FG001|Overall Study|Final Status Unknown|4|||
23257781|NCT00373685|64686603|FG000|Overall Study|Randomized, not treated|51|||
23257782|NCT00373685|64686604|FG001|Overall Study|Randomized, not treated|77|||
23257783|NCT01121900|64686606|FG000|First Intervention Period|Adverse Event|1|||
23257784|NCT01121900|64686607|FG001|First Intervention Period|Adverse Event|1|||
23257785|NCT01121900|64686606|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23257786|NCT01121900|64686607|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23257787|NCT03558997|64686608|FG000|Overall Study|Adverse Event|0|||
23257788|NCT03558997|64686609|FG001|Overall Study|Adverse Event|2|||
23257789|NCT03558997|64686610|FG002|Overall Study|Adverse Event|5|||
23257790|NCT03558997|64686611|FG003|Overall Study|Adverse Event|1|||
23257791|NCT03558997|64686608|FG000|Overall Study|Physician Decision|0|||
23257792|NCT03558997|64686609|FG001|Overall Study|Physician Decision|0|||
23257793|NCT03558997|64686610|FG002|Overall Study|Physician Decision|1|||
23257794|NCT03558997|64686611|FG003|Overall Study|Physician Decision|0|||
23257795|NCT03558997|64686608|FG000|Overall Study|Withdrawal by Subject|1|||
23257796|NCT03558997|64686609|FG001|Overall Study|Withdrawal by Subject|0|||
23257797|NCT03558997|64686610|FG002|Overall Study|Withdrawal by Subject|1|||
23257798|NCT03558997|64686611|FG003|Overall Study|Withdrawal by Subject|1|||
23257799|NCT03558997|64686608|FG000|Overall Study|Lost to Follow-up|0|||
23257800|NCT03558997|64686609|FG001|Overall Study|Lost to Follow-up|0|||
23257801|NCT03558997|64686610|FG002|Overall Study|Lost to Follow-up|1|||
23257802|NCT03558997|64686611|FG003|Overall Study|Lost to Follow-up|0|||
23257803|NCT01017029|64686612|FG000|Overall Study|Lost to Follow-up|1|||
23257804|NCT01017029|64686613|FG001|Overall Study|Lost to Follow-up|0|||
23257805|NCT01017029|64686612|FG000|Overall Study|Administrative problem|0|||
23257806|NCT01017029|64686613|FG001|Overall Study|Administrative problem|1|||
23257807|NCT01017029|64686612|FG000|Overall Study|Death|3|||
23257808|NCT01017029|64686613|FG001|Overall Study|Death|1|||
23257809|NCT01259401|64686614|FG000|4-month Follow-up|Death|0|||
23257810|NCT01259401|64686615|FG001|4-month Follow-up|Death|1|||
23257811|NCT01259401|64686614|FG000|4-month Follow-up|Lost to Follow-up|0|||
23257812|NCT01259401|64686615|FG001|4-month Follow-up|Lost to Follow-up|1|||
23257813|NCT03111147|64686616|FG000|Overall Study|Lost to Follow-up|2|||
23257814|NCT03111147|64686617|FG001|Overall Study|Lost to Follow-up|5|||
23257815|NCT03111147|64686616|FG000|Overall Study|Withdrawal by Subject|4|||
23257816|NCT03111147|64686617|FG001|Overall Study|Withdrawal by Subject|3|||
23257817|NCT03111147|64686616|FG000|Overall Study|Protocol Violation|2|||
23257818|NCT03111147|64686617|FG001|Overall Study|Protocol Violation|1|||
23257819|NCT03111147|64686616|FG000|Overall Study|Death|1|||
23257820|NCT03111147|64686617|FG001|Overall Study|Death|1|||
23257821|NCT02087046|64686618|FG000|Overall Study|Adverse Event|4|||
23257822|NCT02087046|64686618|FG000|Overall Study|Death|1|||
23257823|NCT02087046|64686618|FG000|Overall Study|Lost to Follow-up|3|||
23257824|NCT02087046|64686618|FG000|Overall Study|Withdrawal by Subject|2|||
23257825|NCT02087046|64686618|FG000|Overall Study|Physician Decision|1|||
23257826|NCT01806597|64686619|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
23257827|NCT01806597|64686620|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
23257828|NCT01806597|64686621|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
23257829|NCT01806597|64686622|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
23257830|NCT01806597|64686623|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
23257831|NCT01806597|64686624|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
23257832|NCT01806597|64686619|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
23257833|NCT01806597|64686620|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
23257834|NCT01806597|64686621|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
23257835|NCT01806597|64686622|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
23361098|NCT00410072|65065969|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
23361099|NCT00410072|65065968|FG000|Day 1 to Week 48|Pregnancy|0|||
23257836|NCT01806597|64686623|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
23257837|NCT01806597|64686624|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
23257838|NCT01806597|64686619|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23257839|NCT01806597|64686620|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
23257840|NCT01806597|64686621|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23257841|NCT01806597|64686622|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23257842|NCT01806597|64686623|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23257843|NCT01806597|64686624|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
23361100|NCT00410072|65065969|FG001|Day 1 to Week 48|Pregnancy|2|||
23361101|NCT00410072|65065968|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
23361102|NCT00410072|65065969|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
23361103|NCT00410072|65065968|FG000|After Week 48 to Week 96|Adverse Event|1|||
23361104|NCT00410072|65065969|FG001|After Week 48 to Week 96|Adverse Event|2|||
23361105|NCT00410072|65065968|FG000|After Week 48 to Week 96|Death|0|||
23257844|NCT01806597|64686619|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
23257845|NCT01806597|64686620|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
23257846|NCT01806597|64686621|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
23257847|NCT01806597|64686622|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
23257848|NCT01806597|64686623|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
23257849|NCT01806597|64686624|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
23257850|NCT01806597|64686619|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23257851|NCT01806597|64686620|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
23257852|NCT01806597|64686621|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23257853|NCT01806597|64686622|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23257854|NCT01806597|64686623|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23257855|NCT01806597|64686624|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
23257856|NCT01806597|64686619|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
23257857|NCT01806597|64686620|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
23257858|NCT01806597|64686621|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
23257859|NCT01806597|64686622|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
23257860|NCT01806597|64686623|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
23198679|NCT01371838|64465559|FG001|Overall Study|Lack of therapeutic response|1|||
23198680|NCT01371838|64465558|FG000|Overall Study|Surgery|1|||
23198681|NCT01371838|64465559|FG001|Overall Study|Surgery|0|||
23198682|NCT05038163|64465565|FG000|Stage 1|Did not complete survey|374|||
23198683|NCT05038163|64465566|FG001|Stage 1|Did not complete survey|0|||
23198684|NCT05038163|64465567|FG002|Stage 1|Did not complete survey|0|||
23198685|NCT05038163|64465568|FG003|Stage 1|Did not complete survey|0|||
23198686|NCT05038163|64465569|FG004|Stage 1|Did not complete survey|0|||
23198687|NCT05038163|64465570|FG005|Stage 1|Did not complete survey|0|||
23198688|NCT05038163|64465565|FG000|Stage 2|Did not complete Stage 2 survey|0|||
23198689|NCT05038163|64465566|FG001|Stage 2|Did not complete Stage 2 survey|29|||
23198690|NCT05038163|64465567|FG002|Stage 2|Did not complete Stage 2 survey|30|||
23198691|NCT05038163|64465568|FG003|Stage 2|Did not complete Stage 2 survey|24|||
23198692|NCT05038163|64465569|FG004|Stage 2|Did not complete Stage 2 survey|21|||
23198693|NCT05038163|64465570|FG005|Stage 2|Did not complete Stage 2 survey|100|||
23198694|NCT03596177|64465573|FG000|Single Blind Period|Withdrawal by Subject|1|||
23198695|NCT03596177|64465574|FG001|Single Blind Period|Withdrawal by Subject|1|||
23198696|NCT03596177|64465573|FG000|Single Blind Period|Other|1|||
23198697|NCT03596177|64465574|FG001|Single Blind Period|Other|0|||
23198698|NCT03596177|64465573|FG000|Double Blind Period|Withdrawal by Subject|0|||
23198699|NCT03596177|64465574|FG001|Double Blind Period|Withdrawal by Subject|1|||
23198700|NCT03596177|64465573|FG000|Double Blind Period|Other|0|||
23198701|NCT03596177|64465574|FG001|Double Blind Period|Other|4|||
23198702|NCT03596177|64465573|FG000|Double Blind Period|Death during safety follow-up|0|||
23198703|NCT03596177|64465574|FG001|Double Blind Period|Death during safety follow-up|1|||
23198704|NCT02426658|64465575|FG000|Overall Study|Withdrawal by Subject|1|||
23198705|NCT02426658|64465575|FG000|Overall Study|Patient expired before treatment|2|||
23198706|NCT00850460|64465578|FG000|Overall Study|Lost to Follow-up|4|||
23198707|NCT00850460|64465579|FG001|Overall Study|Lost to Follow-up|4|||
23198708|NCT01097330|64465581|FG000|Overall Study|Study terminated early|7|||
23198709|NCT01097330|64465582|FG001|Overall Study|Study terminated early|5|||
23198710|NCT03430245|64465583|FG000|Overall Study|Withdrawal by Subject|6|||
23198711|NCT03430245|64465583|FG000|Overall Study|Lost to Follow-up|1|||
23198712|NCT01655823|64465584|FG000|Overall Study|Lost to Follow-up|0|||
23198713|NCT01655823|64465585|FG001|Overall Study|Lost to Follow-up|1|||
23198714|NCT01655823|64465586|FG002|Overall Study|Lost to Follow-up|0|||
23198715|NCT01655823|64465587|FG003|Overall Study|Lost to Follow-up|0|||
23198716|NCT01655823|64465588|FG004|Overall Study|Lost to Follow-up|1|||
23198717|NCT01655823|64465584|FG000|Overall Study|Withdrawal by Subject|0|||
23198718|NCT01655823|64465585|FG001|Overall Study|Withdrawal by Subject|1|||
23198719|NCT01655823|64465586|FG002|Overall Study|Withdrawal by Subject|0|||
23198720|NCT01655823|64465587|FG003|Overall Study|Withdrawal by Subject|1|||
23198721|NCT01655823|64465588|FG004|Overall Study|Withdrawal by Subject|0|||
23198722|NCT04070378|64465590|FG000|Overall Study|Withdrawal by Subject|2|||
23198723|NCT04070378|64465590|FG000|Overall Study|Screen Failure|6|||
23198724|NCT04070378|64465590|FG000|Overall Study|Physician Decision|1|||
23198725|NCT04070378|64465590|FG000|Overall Study|Adverse Event|1|||
23198726|NCT02606045|64465595|FG000|Overall Study|Study closed before treament could begin|1|||
23198727|NCT02606045|64465596|FG001|Overall Study|Study closed before treament could begin|2|||
23198728|NCT01199263|64465597|FG000|Overall Study|Ineligible|0|||
23198729|NCT01199263|64465598|FG001|Overall Study|Ineligible|2|||
23198730|NCT01199263|64465597|FG000|Overall Study|Never Treated|6|||
23198731|NCT01199263|64465598|FG001|Overall Study|Never Treated|0|||
23599986|NCT01964300|65925755|FG001|Overall Study|To receive alternative therapy|2|||
23599987|NCT01964300|65925754|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
23599988|NCT01964300|65925755|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
23599989|NCT01964300|65925754|FG000|Overall Study|Weight criteria not met|0|||
23599990|NCT01964300|65925755|FG001|Overall Study|Weight criteria not met|1|||
23599991|NCT00727909|65925759|FG000|Overall Study|Withdrawal by Subject|5|||
23599992|NCT00727909|65925760|FG001|Overall Study|Withdrawal by Subject|11|||
23599993|NCT00727909|65925761|FG002|Overall Study|Withdrawal by Subject|8|||
23599994|NCT00727909|65925762|FG003|Overall Study|Withdrawal by Subject|5|||
23599995|NCT00727909|65925759|FG000|Overall Study|Death|0|||
23599996|NCT00727909|65925760|FG001|Overall Study|Death|0|||
23599997|NCT00727909|65925761|FG002|Overall Study|Death|1|||
23599998|NCT00727909|65925762|FG003|Overall Study|Death|0|||
23599999|NCT02816398|65925765|FG000|Overall Study|Death|5|||
23600000|NCT02816398|65925765|FG000|Overall Study|Lack of Efficacy|8|||
23600001|NCT02816398|65925765|FG000|Overall Study|Lost to Follow-up|1|||
23600002|NCT03057600|65925770|FG000|Overall Study|Adverse Event|0|||
23600003|NCT03057600|65925771|FG001|Overall Study|Adverse Event|0|||
23600004|NCT03057600|65925772|FG002|Overall Study|Adverse Event|4|||
23600005|NCT03057600|65925773|FG003|Overall Study|Adverse Event|0|||
23600006|NCT03057600|65925770|FG000|Overall Study|Radiologic Disease Progression|8|||
23600007|NCT03057600|65925771|FG001|Overall Study|Radiologic Disease Progression|7|||
23600008|NCT03057600|65925772|FG002|Overall Study|Radiologic Disease Progression|13|||
23600009|NCT03057600|65925773|FG003|Overall Study|Radiologic Disease Progression|10|||
23600010|NCT03057600|65925770|FG000|Overall Study|Symptomatic Deterioration|0|||
23600011|NCT03057600|65925771|FG001|Overall Study|Symptomatic Deterioration|1|||
23600012|NCT03057600|65925772|FG002|Overall Study|Symptomatic Deterioration|1|||
23600013|NCT03057600|65925773|FG003|Overall Study|Symptomatic Deterioration|0|||
23600014|NCT03057600|65925770|FG000|Overall Study|Investigator Decision|0|||
23600015|NCT03057600|65925771|FG001|Overall Study|Investigator Decision|0|||
23600016|NCT03057600|65925772|FG002|Overall Study|Investigator Decision|1|||
23600017|NCT03057600|65925773|FG003|Overall Study|Investigator Decision|0|||
23600018|NCT03057600|65925770|FG000|Overall Study|Study Termination by Sponsor|0|||
23600019|NCT03057600|65925771|FG001|Overall Study|Study Termination by Sponsor|0|||
23600020|NCT03057600|65925772|FG002|Overall Study|Study Termination by Sponsor|0|||
23600021|NCT03057600|65925773|FG003|Overall Study|Study Termination by Sponsor|2|||
23600022|NCT03057600|65925770|FG000|Overall Study|Withdrawal by Subject|0|||
23600023|NCT03057600|65925771|FG001|Overall Study|Withdrawal by Subject|1|||
23600024|NCT03057600|65925772|FG002|Overall Study|Withdrawal by Subject|0|||
23600025|NCT03057600|65925773|FG003|Overall Study|Withdrawal by Subject|0|||
23600026|NCT03057600|65925770|FG000|Overall Study|Other, Not Specified|1|||
23600027|NCT03057600|65925771|FG001|Overall Study|Other, Not Specified|1|||
23600028|NCT03057600|65925772|FG002|Overall Study|Other, Not Specified|1|||
23600029|NCT03057600|65925773|FG003|Overall Study|Other, Not Specified|1|||
23600030|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
23600031|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
23600032|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
23600033|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
23600034|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
23600035|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
23600036|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
23600037|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
23600038|NCT00982644|65925774|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
23600039|NCT00982644|65925775|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
23600040|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
23257861|NCT01806597|64686624|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
23257862|NCT01806597|64686619|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
23257863|NCT01806597|64686620|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
23257864|NCT01806597|64686621|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
23257865|NCT01806597|64686622|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
23257866|NCT01806597|64686623|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
23257867|NCT01806597|64686624|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
23257868|NCT01806597|64686619|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
23257869|NCT01806597|64686620|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23257870|NCT01806597|64686621|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23257871|NCT01806597|64686622|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23257872|NCT01806597|64686623|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23257873|NCT01806597|64686624|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
23257874|NCT01806597|64686619|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
23257875|NCT01806597|64686620|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
23257876|NCT01806597|64686621|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
23257877|NCT01806597|64686622|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
23257878|NCT01806597|64686623|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
23257879|NCT01806597|64686624|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
23257880|NCT01806597|64686619|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
23257881|NCT01806597|64686620|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23257882|NCT01806597|64686621|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23257883|NCT01806597|64686622|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23257884|NCT01806597|64686623|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23257885|NCT01806597|64686624|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
23257886|NCT01806597|64686619|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
23257887|NCT01806597|64686620|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
23257888|NCT01806597|64686621|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
23257889|NCT01806597|64686622|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
23257890|NCT01806597|64686623|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
23257891|NCT01806597|64686624|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
23257892|NCT01806597|64686619|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
23257893|NCT01806597|64686620|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
23257894|NCT01806597|64686621|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
23257895|NCT01806597|64686622|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
23257896|NCT01806597|64686623|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
23257897|NCT01806597|64686624|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
23257898|NCT01806597|64686619|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
23257899|NCT01806597|64686620|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
23257900|NCT01806597|64686621|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
23257901|NCT01806597|64686622|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
23257902|NCT01806597|64686623|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
23257903|NCT01806597|64686624|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
23257904|NCT01806597|64686619|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
23257905|NCT01806597|64686620|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23257906|NCT01806597|64686621|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23257907|NCT01806597|64686622|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23198732|NCT02075255|64465599|FG000|Overall Study|Study specific withdrawal criteria|0|||
23198733|NCT02075255|64465600|FG001|Overall Study|Study specific withdrawal criteria|1|||
23198734|NCT02075255|64465601|FG002|Overall Study|Study specific withdrawal criteria|1|||
23198735|NCT02075255|64465599|FG000|Overall Study|Withdrawal by Subject|4|||
23198736|NCT02075255|64465600|FG001|Overall Study|Withdrawal by Subject|1|||
23198737|NCT02075255|64465601|FG002|Overall Study|Withdrawal by Subject|0|||
23198738|NCT02075255|64465599|FG000|Overall Study|Lost to Follow-up|0|||
23198739|NCT02075255|64465600|FG001|Overall Study|Lost to Follow-up|0|||
23198740|NCT02075255|64465601|FG002|Overall Study|Lost to Follow-up|1|||
23198741|NCT02075255|64465599|FG000|Overall Study|Adverse Event|0|||
23198742|NCT02075255|64465600|FG001|Overall Study|Adverse Event|0|||
23198743|NCT02075255|64465601|FG002|Overall Study|Adverse Event|1|||
23198744|NCT02075255|64465599|FG000|Overall Study|Death|0|||
23198745|NCT02075255|64465600|FG001|Overall Study|Death|2|||
23198746|NCT02075255|64465601|FG002|Overall Study|Death|0|||
23198747|NCT00641043|64465603|FG000|Overall Study|Adverse Event|6|||
23198748|NCT00641043|64465604|FG001|Overall Study|Adverse Event|4|||
23198749|NCT00641043|64465603|FG000|Overall Study|Protocol Violation|2|||
23257908|NCT01806597|64686623|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23257909|NCT01806597|64686624|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
23257910|NCT01806597|64686619|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23257911|NCT01806597|64686620|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23257912|NCT01806597|64686621|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23257913|NCT01806597|64686622|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23257914|NCT01806597|64686623|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
23361106|NCT00410072|65065969|FG001|After Week 48 to Week 96|Death|1|||
23361107|NCT00410072|65065968|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
23361108|NCT00410072|65065969|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
23361109|NCT00410072|65065968|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
23361110|NCT00410072|65065969|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
23361111|NCT00410072|65065968|FG000|After Week 48 to Week 96|Other|2|||
23198750|NCT00641043|64465604|FG001|Overall Study|Protocol Violation|3|||
23198751|NCT00641043|64465603|FG000|Overall Study|Lost to Follow-up|3|||
23198752|NCT00641043|64465604|FG001|Overall Study|Lost to Follow-up|2|||
23198753|NCT00641043|64465603|FG000|Overall Study|Withdrawal by Subject|4|||
23198754|NCT00641043|64465604|FG001|Overall Study|Withdrawal by Subject|4|||
23198755|NCT00641043|64465603|FG000|Overall Study|Other incl. lack of efficacy|4|||
23198756|NCT00641043|64465604|FG001|Overall Study|Other incl. lack of efficacy|2|||
23198757|NCT03011840|64465607|FG000|Overall Study|Not received PIL in post PIL phase|0|||
23198758|NCT03011840|64465608|FG001|Overall Study|Not received PIL in post PIL phase|21|||
23198759|NCT01455428|64465612|FG000|Overall Study|Protocol Violation|2|||
23198760|NCT01455428|64465613|FG001|Overall Study|Protocol Violation|1|||
23198761|NCT01455428|64465612|FG000|Overall Study|Adverse Event|6|||
23198762|NCT01455428|64465613|FG001|Overall Study|Adverse Event|2|||
23198763|NCT01455428|64465612|FG000|Overall Study|Lost to Follow-up|1|||
23198764|NCT01455428|64465613|FG001|Overall Study|Lost to Follow-up|1|||
23198765|NCT01455428|64465612|FG000|Overall Study|Withdrawal by Subject|2|||
23198766|NCT01455428|64465613|FG001|Overall Study|Withdrawal by Subject|5|||
23198767|NCT01455428|64465612|FG000|Overall Study|Did not meet entrance criteria|0|||
23198768|NCT01455428|64465613|FG001|Overall Study|Did not meet entrance criteria|2|||
23198769|NCT01455428|64465612|FG000|Overall Study|Insufficient clinical response|0|||
23198770|NCT01455428|64465613|FG001|Overall Study|Insufficient clinical response|2|||
23198771|NCT01455428|64465612|FG000|Overall Study|Did not receive treatment|1|||
23198772|NCT01455428|64465613|FG001|Overall Study|Did not receive treatment|1|||
23198773|NCT01455428|64465612|FG000|Overall Study|Other|2|||
23198774|NCT01455428|64465613|FG001|Overall Study|Other|4|||
23198775|NCT00875017|64465615|FG000|First Intervention|Withdrawal by Subject|1|||
23198776|NCT00875017|64465616|FG001|First Intervention|Withdrawal by Subject|0|||
23198777|NCT00875017|64465617|FG002|First Intervention|Withdrawal by Subject|1|||
23198778|NCT00875017|64465618|FG003|First Intervention|Withdrawal by Subject|0|||
23198779|NCT00875017|64465619|FG004|First Intervention|Withdrawal by Subject|0|||
23198780|NCT00875017|64465620|FG005|First Intervention|Withdrawal by Subject|0|||
23198781|NCT00875017|64465615|FG000|First Intervention|Adverse Event|0|||
23198782|NCT00875017|64465616|FG001|First Intervention|Adverse Event|0|||
23198783|NCT00875017|64465617|FG002|First Intervention|Adverse Event|0|||
23198784|NCT00875017|64465618|FG003|First Intervention|Adverse Event|1|||
23198785|NCT00875017|64465619|FG004|First Intervention|Adverse Event|0|||
23198786|NCT00875017|64465620|FG005|First Intervention|Adverse Event|0|||
23198787|NCT00875017|64465615|FG000|First Intervention|Problems collecting rectal effluent|1|||
23198788|NCT00875017|64465616|FG001|First Intervention|Problems collecting rectal effluent|0|||
23198789|NCT00875017|64465617|FG002|First Intervention|Problems collecting rectal effluent|0|||
23198790|NCT00875017|64465618|FG003|First Intervention|Problems collecting rectal effluent|0|||
23198791|NCT00875017|64465619|FG004|First Intervention|Problems collecting rectal effluent|0|||
23198792|NCT00875017|64465620|FG005|First Intervention|Problems collecting rectal effluent|0|||
23198793|NCT00875017|64465615|FG000|First Intervention|Intolerance to nasogastric tube|0|||
23198794|NCT00875017|64465616|FG001|First Intervention|Intolerance to nasogastric tube|0|||
23198795|NCT00875017|64465617|FG002|First Intervention|Intolerance to nasogastric tube|0|||
23198796|NCT00875017|64465618|FG003|First Intervention|Intolerance to nasogastric tube|0|||
23198797|NCT00875017|64465619|FG004|First Intervention|Intolerance to nasogastric tube|1|||
23198798|NCT00875017|64465620|FG005|First Intervention|Intolerance to nasogastric tube|0|||
23198799|NCT00875017|64465615|FG000|Washout|Problem collecting rectal effluent|0|||
23198800|NCT00875017|64465616|FG001|Washout|Problem collecting rectal effluent|0|||
23198801|NCT00875017|64465617|FG002|Washout|Problem collecting rectal effluent|1|||
23198802|NCT00875017|64465618|FG003|Washout|Problem collecting rectal effluent|0|||
23198803|NCT00875017|64465619|FG004|Washout|Problem collecting rectal effluent|0|||
23198804|NCT00875017|64465620|FG005|Washout|Problem collecting rectal effluent|0|||
23198805|NCT00875017|64465615|FG000|Second Intervention|Adverse Event|0|||
23198806|NCT00875017|64465616|FG001|Second Intervention|Adverse Event|0|||
23198807|NCT00875017|64465617|FG002|Second Intervention|Adverse Event|0|||
23198808|NCT00875017|64465618|FG003|Second Intervention|Adverse Event|1|||
23198809|NCT00875017|64465619|FG004|Second Intervention|Adverse Event|0|||
23198810|NCT00875017|64465620|FG005|Second Intervention|Adverse Event|0|||
23198811|NCT00875017|64465615|FG000|Washout|Problems collecting rectal effluent|0|||
23198812|NCT00875017|64465616|FG001|Washout|Problems collecting rectal effluent|1|||
23198813|NCT00875017|64465617|FG002|Washout|Problems collecting rectal effluent|0|||
23198814|NCT00875017|64465618|FG003|Washout|Problems collecting rectal effluent|0|||
23198815|NCT00875017|64465619|FG004|Washout|Problems collecting rectal effluent|0|||
23198816|NCT00875017|64465620|FG005|Washout|Problems collecting rectal effluent|0|||
23198817|NCT00875017|64465615|FG000|Third Intervention|Adverse Event|0|||
23198818|NCT00875017|64465616|FG001|Third Intervention|Adverse Event|1|||
23198819|NCT00875017|64465617|FG002|Third Intervention|Adverse Event|1|||
23198820|NCT00875017|64465618|FG003|Third Intervention|Adverse Event|0|||
23198821|NCT00875017|64465619|FG004|Third Intervention|Adverse Event|0|||
23198822|NCT00875017|64465620|FG005|Third Intervention|Adverse Event|0|||
23198823|NCT00875017|64465615|FG000|Washout|Withdrawal by Subject|0|||
23198824|NCT00875017|64465616|FG001|Washout|Withdrawal by Subject|0|||
23198825|NCT00875017|64465617|FG002|Washout|Withdrawal by Subject|0|||
23198826|NCT00875017|64465618|FG003|Washout|Withdrawal by Subject|0|||
23198827|NCT00875017|64465619|FG004|Washout|Withdrawal by Subject|1|||
23198828|NCT00875017|64465620|FG005|Washout|Withdrawal by Subject|0|||
23198829|NCT00875017|64465615|FG000|Fourth Intervention|Inability to comply with fasting|0|||
23198830|NCT00875017|64465616|FG001|Fourth Intervention|Inability to comply with fasting|0|||
23198831|NCT00875017|64465617|FG002|Fourth Intervention|Inability to comply with fasting|0|||
23198832|NCT00875017|64465618|FG003|Fourth Intervention|Inability to comply with fasting|0|||
23198833|NCT00875017|64465619|FG004|Fourth Intervention|Inability to comply with fasting|0|||
23198834|NCT00875017|64465620|FG005|Fourth Intervention|Inability to comply with fasting|1|||
23198835|NCT04346628|64465622|FG000|Overall Study|Lost to Follow-up|4|||
23198836|NCT04346628|64465623|FG001|Overall Study|Lost to Follow-up|4|||
23198837|NCT04346628|64465622|FG000|Overall Study|Withdrew (had personal reasons)|2|||
23198838|NCT04346628|64465623|FG001|Overall Study|Withdrew (had personal reasons)|5|||
23198839|NCT04346628|64465622|FG000|Overall Study|Withdrew (medication intolerant)|0|||
23198840|NCT04346628|64465623|FG001|Overall Study|Withdrew (medication intolerant)|3|||
23198841|NCT04346628|64465622|FG000|Overall Study|Withdrew (declined intervention)|0|||
23198842|NCT04346628|64465623|FG001|Overall Study|Withdrew (declined intervention)|1|||
23198843|NCT00850759|64465624|FG000|Overall Study|Lost to Follow-up|7|||
23198844|NCT00850759|64465625|FG001|Overall Study|Lost to Follow-up|5|||
23198845|NCT00850759|64465626|FG002|Overall Study|Lost to Follow-up|5|||
23198846|NCT00850759|64465627|FG003|Overall Study|Lost to Follow-up|3|||
23198847|NCT03201198|64465631|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
23198848|NCT03201198|64465632|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
23198849|NCT03201198|64465631|FG000|Overall Study|Withdrawal by Subject|2|||
23198850|NCT03201198|64465632|FG001|Overall Study|Withdrawal by Subject|3|||
23198851|NCT02495077|64465633|FG000|Overall Study|Adverse Event|0|||
23198852|NCT02495077|64465634|FG001|Overall Study|Adverse Event|1|||
23198853|NCT02495077|64465635|FG002|Overall Study|Adverse Event|1|||
23198854|NCT02495077|64465636|FG003|Overall Study|Adverse Event|0|||
23198855|NCT02495077|64465633|FG000|Overall Study|Death|3|||
23198856|NCT02495077|64465634|FG001|Overall Study|Death|5|||
23198857|NCT02495077|64465635|FG002|Overall Study|Death|0|||
23198858|NCT02495077|64465636|FG003|Overall Study|Death|0|||
23198859|NCT02495077|64465633|FG000|Overall Study|Lost to Follow-up|6|||
23198860|NCT02495077|64465634|FG001|Overall Study|Lost to Follow-up|4|||
23198861|NCT02495077|64465635|FG002|Overall Study|Lost to Follow-up|0|||
23198862|NCT02495077|64465636|FG003|Overall Study|Lost to Follow-up|0|||
23198863|NCT02495077|64465633|FG000|Overall Study|Physician Decision|2|||
23198864|NCT02495077|64465634|FG001|Overall Study|Physician Decision|1|||
23198865|NCT02495077|64465635|FG002|Overall Study|Physician Decision|4|||
23198866|NCT02495077|64465636|FG003|Overall Study|Physician Decision|0|||
23198867|NCT02495077|64465633|FG000|Overall Study|Protocol Violation|0|||
23198868|NCT02495077|64465634|FG001|Overall Study|Protocol Violation|1|||
23198869|NCT02495077|64465635|FG002|Overall Study|Protocol Violation|0|||
23198870|NCT02495077|64465636|FG003|Overall Study|Protocol Violation|0|||
23198871|NCT02495077|64465633|FG000|Overall Study|Screen Failure|0|||
23198872|NCT02495077|64465634|FG001|Overall Study|Screen Failure|0|||
23198873|NCT02495077|64465635|FG002|Overall Study|Screen Failure|0|||
23198874|NCT02495077|64465636|FG003|Overall Study|Screen Failure|48|||
23198875|NCT02495077|64465633|FG000|Overall Study|Withdrawal by Subject|7|||
23198876|NCT02495077|64465634|FG001|Overall Study|Withdrawal by Subject|7|||
23198877|NCT02495077|64465635|FG002|Overall Study|Withdrawal by Subject|7|||
23257915|NCT01806597|64686624|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
23257916|NCT01806597|64686619|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23257917|NCT01806597|64686620|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23257918|NCT01806597|64686621|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23257919|NCT01806597|64686622|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23257920|NCT01806597|64686623|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
23257921|NCT01806597|64686624|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
23257922|NCT01806597|64686619|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23257923|NCT01806597|64686620|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23257924|NCT01806597|64686621|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23257925|NCT01806597|64686622|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23257926|NCT01806597|64686623|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
23257927|NCT01806597|64686624|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
23257928|NCT01806597|64686619|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23257929|NCT01806597|64686620|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23257930|NCT01806597|64686621|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23257931|NCT01806597|64686622|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23257932|NCT01806597|64686623|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
23257933|NCT01806597|64686624|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
23257934|NCT01806597|64686619|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23257935|NCT01806597|64686620|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23257936|NCT01806597|64686621|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23257937|NCT01806597|64686622|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23257938|NCT01806597|64686623|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
23257939|NCT01806597|64686624|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
23257940|NCT00905489|64686626|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
23257941|NCT00905489|64686626|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
23257942|NCT00905489|64686626|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
23257943|NCT00566098|64686627|FG000|Collection of MILs|Withdrawal by Subject|1|||
23257944|NCT00566098|64686627|FG000|Collection of MILs|Relapsed|1|||
23257945|NCT00566098|64686627|FG000|Generation of MILs Product|Relapsed|1|||
23257946|NCT00566098|64686627|FG000|Administration of ASCT+MILs|Death|10|||
23257947|NCT00566098|64686627|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
23257948|NCT00876733|64686628|FG000|Overall Study|Adverse Event|34|||
23257949|NCT00876733|64686629|FG001|Overall Study|Adverse Event|20|||
23257950|NCT00876733|64686630|FG002|Overall Study|Adverse Event|10|||
23257951|NCT00876733|64686631|FG003|Overall Study|Adverse Event|3|||
23257952|NCT00876733|64686628|FG000|Overall Study|Lack of Efficacy|17|||
23257953|NCT00876733|64686629|FG001|Overall Study|Lack of Efficacy|9|||
23257954|NCT00876733|64686630|FG002|Overall Study|Lack of Efficacy|10|||
23257955|NCT00876733|64686631|FG003|Overall Study|Lack of Efficacy|1|||
23257956|NCT00876733|64686628|FG000|Overall Study|Lost to Follow-up|26|||
23257957|NCT00876733|64686629|FG001|Overall Study|Lost to Follow-up|10|||
23257958|NCT00876733|64686630|FG002|Overall Study|Lost to Follow-up|3|||
23257959|NCT00876733|64686631|FG003|Overall Study|Lost to Follow-up|2|||
23257960|NCT00876733|64686628|FG000|Overall Study|Data not available|14|||
23257961|NCT00876733|64686629|FG001|Overall Study|Data not available|3|||
23257962|NCT00876733|64686630|FG002|Overall Study|Data not available|7|||
23257963|NCT00876733|64686631|FG003|Overall Study|Data not available|1|||
23257964|NCT01186978|64686633|FG000|Overall Study|Withdrawal by Subject|1|||
23257965|NCT02770716|64686634|FG000|Overall Study|Death|101|||
23257966|NCT02770716|64686635|FG001|Overall Study|Death|45|||
23257967|NCT02770716|64686634|FG000|Overall Study|Withdrawal by Subject|4|||
23257968|NCT02770716|64686635|FG001|Overall Study|Withdrawal by Subject|2|||
23257969|NCT02770716|64686634|FG000|Overall Study|Lost to Follow-up|1|||
23257970|NCT02770716|64686635|FG001|Overall Study|Lost to Follow-up|0|||
23257971|NCT02770716|64686634|FG000|Overall Study|Various reasons|6|||
23257972|NCT02770716|64686635|FG001|Overall Study|Various reasons|2|||
23257973|NCT01664052|64686636|FG000|Phase 1|No device placement|6|||
23257974|NCT01664052|64686637|FG001|Phase 1|No device placement|0|||
23257975|NCT01664052|64686636|FG000|Phase 1|No HSG 1 hr post placement|1|||
23257976|NCT01664052|64686637|FG001|Phase 1|No HSG 1 hr post placement|0|||
23257977|NCT01664052|64686636|FG000|Phase 2|No device placement|0|||
23480356|NCT01330017|65501957|FG003|Overall Study|Withdrawal by Subject|0|||
23257978|NCT01664052|64686637|FG001|Phase 2|No device placement|4|||
23257979|NCT00254397|64686642|FG000|Overall Study|Disease Progression|4|||
23257980|NCT00254397|64686643|FG001|Overall Study|Disease Progression|1|||
23257981|NCT00254397|64686644|FG002|Overall Study|Disease Progression|16|||
23257982|NCT00254397|64686645|FG003|Overall Study|Disease Progression|23|||
23257983|NCT00254397|64686642|FG000|Overall Study|Non-Compliant|0|||
23480357|NCT01330017|65501958|FG004|Overall Study|Withdrawal by Subject|1|||
23257984|NCT00254397|64686643|FG001|Overall Study|Non-Compliant|0|||
23257985|NCT00254397|64686644|FG002|Overall Study|Non-Compliant|0|||
23257986|NCT00254397|64686645|FG003|Overall Study|Non-Compliant|1|||
23257987|NCT00254397|64686642|FG000|Overall Study|Adverse Event|2|||
23257988|NCT00254397|64686643|FG001|Overall Study|Adverse Event|0|||
23257989|NCT00254397|64686644|FG002|Overall Study|Adverse Event|3|||
23257990|NCT00254397|64686645|FG003|Overall Study|Adverse Event|1|||
23257991|NCT01084005|64686646|FG000|Overall Study|Adverse Event|1|||
23257992|NCT01084005|64686647|FG001|Overall Study|Adverse Event|8|||
23257993|NCT01084005|64686646|FG000|Overall Study|Protocol Violation|3|||
23257994|NCT01084005|64686647|FG001|Overall Study|Protocol Violation|7|||
23257995|NCT01084005|64686646|FG000|Overall Study|Withdrawal by Subject|1|||
23257996|NCT01084005|64686647|FG001|Overall Study|Withdrawal by Subject|1|||
23257997|NCT03273387|64686648|FG000|Overall Study|Death|2|||
23257998|NCT03273387|64686649|FG001|Overall Study|Death|2|||
23257999|NCT03273387|64686648|FG000|Overall Study|Withdrawal by Subject|1|||
23258000|NCT03273387|64686649|FG001|Overall Study|Withdrawal by Subject|1|||
23258001|NCT02424565|64686650|FG000|Period 1 (D0)|Protocol Violation|0|||
23258002|NCT02424565|64686651|FG001|Period 1 (D0)|Protocol Violation|1|||
23258003|NCT00580983|64686652|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
23258004|NCT00003102|64686653|FG000|Overall Study|Physician Decision|1|||
23258005|NCT00003102|64686654|FG001|Overall Study|Physician Decision|1|||
23198878|NCT02495077|64465636|FG003|Overall Study|Withdrawal by Subject|0|||
23198879|NCT02495077|64465633|FG000|Overall Study|Covid-19 research restrictions|1|||
23198880|NCT02495077|64465634|FG001|Overall Study|Covid-19 research restrictions|0|||
23198881|NCT02495077|64465635|FG002|Overall Study|Covid-19 research restrictions|0|||
23198882|NCT02495077|64465636|FG003|Overall Study|Covid-19 research restrictions|0|||
23198883|NCT02495077|64465633|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
23198884|NCT02495077|64465634|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
23198885|NCT02495077|64465635|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
23198886|NCT02495077|64465636|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
23198887|NCT02495077|64465633|FG000|Overall Study|Incarcerated|0|||
23198888|NCT02495077|64465634|FG001|Overall Study|Incarcerated|1|||
23198889|NCT02495077|64465635|FG002|Overall Study|Incarcerated|0|||
23198890|NCT02495077|64465636|FG003|Overall Study|Incarcerated|0|||
23198891|NCT02495077|64465633|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
23198892|NCT02495077|64465634|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
23198893|NCT02495077|64465635|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
23198894|NCT02495077|64465636|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
23198895|NCT02495077|64465633|FG000|Overall Study|Timing of transplant and randomization|0|||
23198896|NCT02495077|64465634|FG001|Overall Study|Timing of transplant and randomization|0|||
23198897|NCT02495077|64465635|FG002|Overall Study|Timing of transplant and randomization|5|||
23198898|NCT02495077|64465636|FG003|Overall Study|Timing of transplant and randomization|0|||
23198899|NCT00700752|64465637|FG000|First Intervention|Withdrawal by Subject|0|||
23198900|NCT00700752|64465638|FG001|First Intervention|Withdrawal by Subject|2|||
23198901|NCT01108809|64465641|FG000|Overall Study|Adverse Event|3|||
23198902|NCT01108809|64465641|FG000|Overall Study|Lost to Follow-up|1|||
23198903|NCT01283581|64468649|FG000|Overall Study|Lost to Follow-up|8|||
23198904|NCT01283581|64468650|FG001|Overall Study|Lost to Follow-up|6|||
23198905|NCT01283581|64468651|FG002|Overall Study|Lost to Follow-up|8|||
23198906|NCT01283581|64468649|FG000|Overall Study|Withdrawal by Subject|2|||
23198907|NCT01283581|64468650|FG001|Overall Study|Withdrawal by Subject|5|||
23258006|NCT00003102|64686655|FG002|Overall Study|Physician Decision|0|||
23258007|NCT00003102|64686653|FG000|Overall Study|Progressive Disease|0|||
23258008|NCT00003102|64686654|FG001|Overall Study|Progressive Disease|1|||
23258009|NCT00003102|64686655|FG002|Overall Study|Progressive Disease|0|||
23258010|NCT00003102|64686653|FG000|Overall Study|Adverse Event|0|||
23258011|NCT00003102|64686654|FG001|Overall Study|Adverse Event|1|||
23258012|NCT00003102|64686655|FG002|Overall Study|Adverse Event|1|||
23258013|NCT00003102|64686653|FG000|Overall Study|Death|0|||
23198908|NCT01283581|64468651|FG002|Overall Study|Withdrawal by Subject|2|||
23361112|NCT00410072|65065969|FG001|After Week 48 to Week 96|Other|0|||
23198909|NCT01283581|64468649|FG000|Overall Study|Adverse Event|1|||
23198910|NCT01283581|64468650|FG001|Overall Study|Adverse Event|1|||
23198911|NCT01283581|64468651|FG002|Overall Study|Adverse Event|4|||
23198912|NCT01283581|64468649|FG000|Overall Study|Physician Decision|0|||
23198913|NCT01283581|64468650|FG001|Overall Study|Physician Decision|1|||
23198914|NCT01283581|64468651|FG002|Overall Study|Physician Decision|2|||
23198915|NCT01283581|64468649|FG000|Overall Study|Protocol Violation|0|||
23198916|NCT01283581|64468650|FG001|Overall Study|Protocol Violation|1|||
23198917|NCT01283581|64468651|FG002|Overall Study|Protocol Violation|2|||
23198918|NCT01283581|64468649|FG000|Overall Study|Noncompliance|1|||
23198919|NCT01283581|64468650|FG001|Overall Study|Noncompliance|0|||
23198920|NCT01283581|64468651|FG002|Overall Study|Noncompliance|0|||
23198921|NCT01283581|64468649|FG000|Overall Study|Investigator unblinded|0|||
23198922|NCT01283581|64468650|FG001|Overall Study|Investigator unblinded|0|||
23198923|NCT01283581|64468651|FG002|Overall Study|Investigator unblinded|1|||
23198924|NCT01283581|64468649|FG000|Overall Study|"Early termination"|0|||
23198925|NCT01283581|64468650|FG001|Overall Study|"Early termination"|0|||
23198926|NCT01283581|64468651|FG002|Overall Study|"Early termination"|1|||
23198927|NCT01850563|64468652|FG000|Overall Study|Not eligible|3|||
23198928|NCT01850563|64468653|FG001|Overall Study|Not eligible|0|||
23198929|NCT03161678|64468654|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
23258014|NCT00003102|64686654|FG001|Overall Study|Death|0|||
23258015|NCT00003102|64686655|FG002|Overall Study|Death|1|||
23258016|NCT03840811|64686656|FG000|Overall Study|Lost to Follow-up|0|||
23258017|NCT03840811|64686657|FG001|Overall Study|Lost to Follow-up|0|||
23258018|NCT03840811|64686658|FG002|Overall Study|Lost to Follow-up|1|||
23258019|NCT04304950|64686659|FG000|Overall Study|Lost to Follow-up|1|||
23258020|NCT04304950|64686660|FG001|Overall Study|Lost to Follow-up|1|||
23258021|NCT02965820|64686661|FG000|Period 2, Second 30 Days|Adverse Event|1|||
23258022|NCT02965820|64686662|FG001|Period 2, Second 30 Days|Adverse Event|1|||
23258023|NCT00003782|64686664|FG000|Overall Study|No follow up data|30|||
23258024|NCT00003782|64686665|FG001|Overall Study|No follow up data|31|||
23258025|NCT00003782|64686666|FG002|Overall Study|No follow up data|26|||
23258026|NCT00526890|64686669|FG000|Overall Study|Adverse Event|2|||
23258027|NCT02742181|64686672|FG000|Overall Study|Physician Decision|1|||
23258028|NCT02742181|64686673|FG001|Overall Study|Physician Decision|0|||
23258029|NCT01965652|64686674|FG000|Overall Study|Adverse Event|40|||
23258030|NCT01965652|64686675|FG001|Overall Study|Adverse Event|37|||
23258031|NCT01965652|64686674|FG000|Overall Study|Withdrawal by Subject|62|||
23258032|NCT01965652|64686675|FG001|Overall Study|Withdrawal by Subject|69|||
23258033|NCT01965652|64686674|FG000|Overall Study|Lost to Follow-up|53|||
23258034|NCT01965652|64686675|FG001|Overall Study|Lost to Follow-up|40|||
23258035|NCT01965652|64686674|FG000|Overall Study|Protocol Violation|34|||
23258036|NCT01965652|64686675|FG001|Overall Study|Protocol Violation|38|||
23258037|NCT01965652|64686674|FG000|Overall Study|Death|3|||
23258038|NCT01965652|64686675|FG001|Overall Study|Death|4|||
23361113|NCT00410072|65065968|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
23258039|NCT01965652|64686674|FG000|Overall Study|Other - Miscellaneous|18|||
23258040|NCT01965652|64686675|FG001|Overall Study|Other - Miscellaneous|21|||
23258041|NCT01965652|64686674|FG000|Overall Study|Pregnancy|0|||
23258042|NCT01965652|64686675|FG001|Overall Study|Pregnancy|1|||
23361114|NCT00410072|65065969|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
23361115|NCT00410072|65065968|FG000|After Week 48 to Week 96|Pregnancy|0|||
23258043|NCT00671879|64686676|FG000|Overall Study|Withdrawal by Subject|0|||
23258044|NCT00671879|64686677|FG001|Overall Study|Withdrawal by Subject|4|||
23258045|NCT00671879|64686678|FG002|Overall Study|Withdrawal by Subject|6|||
23361116|NCT00410072|65065969|FG001|After Week 48 to Week 96|Pregnancy|2|||
23258046|NCT03568500|64686680|FG000|Overall Study|Lost to Follow-up|1|||
23258047|NCT03568500|64686681|FG001|Overall Study|Lost to Follow-up|1|||
23258048|NCT03568500|64686682|FG002|Overall Study|Lost to Follow-up|2|||
23258049|NCT03568500|64686680|FG000|Overall Study|Adverse Event|1|||
23198930|NCT03161678|64468655|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
23198931|NCT03161678|64468656|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23198932|NCT03161678|64468657|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
23258050|NCT03568500|64686681|FG001|Overall Study|Adverse Event|1|||
23258051|NCT03568500|64686682|FG002|Overall Study|Adverse Event|2|||
23258052|NCT03568500|64686680|FG000|Overall Study|Physician Decision|1|||
23258053|NCT03568500|64686681|FG001|Overall Study|Physician Decision|0|||
23258054|NCT03568500|64686682|FG002|Overall Study|Physician Decision|0|||
23258055|NCT03568500|64686680|FG000|Overall Study|Withdrawal by Subject|4|||
23198933|NCT03161678|64468658|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
23198934|NCT03161678|64468659|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
23258056|NCT03568500|64686681|FG001|Overall Study|Withdrawal by Subject|2|||
23258057|NCT03568500|64686682|FG002|Overall Study|Withdrawal by Subject|0|||
23258058|NCT03568500|64686680|FG000|Overall Study|Technical Problems|2|||
23258059|NCT03568500|64686681|FG001|Overall Study|Technical Problems|1|||
23258060|NCT03568500|64686682|FG002|Overall Study|Technical Problems|0|||
23258061|NCT03568500|64686680|FG000|Overall Study|Participant Noncompliance|1|||
23258062|NCT03568500|64686681|FG001|Overall Study|Participant Noncompliance|1|||
23258063|NCT03568500|64686682|FG002|Overall Study|Participant Noncompliance|0|||
23258064|NCT02268045|64686683|FG000|Overall Study|Death|4|||
23258065|NCT02268045|64686684|FG001|Overall Study|Death|4|||
23258066|NCT02268045|64686683|FG000|Overall Study|Disease Progression|2|||
23258067|NCT02268045|64686684|FG001|Overall Study|Disease Progression|1|||
23258068|NCT02268045|64686683|FG000|Overall Study|Adverse Event|7|||
23258069|NCT02268045|64686684|FG001|Overall Study|Adverse Event|7|||
23258070|NCT02268045|64686683|FG000|Overall Study|Withdrawal by Subject|2|||
23258071|NCT02268045|64686684|FG001|Overall Study|Withdrawal by Subject|6|||
23258072|NCT02268045|64686683|FG000|Overall Study|Physician Decision|0|||
23258073|NCT02268045|64686684|FG001|Overall Study|Physician Decision|1|||
23258074|NCT02268045|64686683|FG000|Overall Study|Protocol Violation|1|||
23258075|NCT02268045|64686684|FG001|Overall Study|Protocol Violation|1|||
23258076|NCT03751020|64686690|FG000|Overall Study|Withdrawal by Subject|2|||
23258077|NCT03751020|64686691|FG001|Overall Study|Withdrawal by Subject|0|||
23258078|NCT03751020|64686692|FG002|Overall Study|Withdrawal by Subject|0|||
23258079|NCT03751020|64686690|FG000|Overall Study|Lost to Follow-up|7|||
23361117|NCT00410072|65065968|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
23361118|NCT00410072|65065969|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
23361119|NCT02105285|65065970|FG000|Overall Study|Adverse Event|1|||
23361120|NCT02105285|65065971|FG001|Overall Study|Adverse Event|1|||
23361121|NCT02105285|65065972|FG002|Overall Study|Adverse Event|0|||
23198935|NCT03161678|64468654|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
23198936|NCT03161678|64468655|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
23198937|NCT03161678|64468656|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
23258080|NCT03751020|64686691|FG001|Overall Study|Lost to Follow-up|4|||
23258081|NCT03751020|64686692|FG002|Overall Study|Lost to Follow-up|10|||
23258082|NCT01159769|64686693|FG000|Overall Study|Adverse Event|1|||
23198938|NCT03161678|64468657|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
23258083|NCT00544557|64686694|FG000|Overall Study|Adverse Event|140|||
23258084|NCT00544557|64686694|FG000|Overall Study|Lack of Efficacy|196|||
23258085|NCT00544557|64686694|FG000|Overall Study|Other|98|||
23258086|NCT02666430|64686700|FG000|Period 1|Lost to Follow-up|1|||
23258087|NCT02666430|64686701|FG001|Period 1|Lost to Follow-up|0|||
23361122|NCT02105285|65065970|FG000|Overall Study|Protocol Violation|0|||
23258088|NCT02666430|64686700|FG000|Period 1|Adverse Event|0|||
23258089|NCT02666430|64686701|FG001|Period 1|Adverse Event|1|||
23258090|NCT02666430|64686700|FG000|Period 2|Withdrawal by Subject|1|||
23258091|NCT02666430|64686701|FG001|Period 2|Withdrawal by Subject|4|||
23258092|NCT02666430|64686700|FG000|Period 3|Lost to Follow-up|1|||
23258093|NCT02666430|64686701|FG001|Period 3|Lost to Follow-up|0|||
23258094|NCT01783496|64686703|FG000|Overall Study|Lost to Follow-up|0|||
23258095|NCT01783496|64686704|FG001|Overall Study|Lost to Follow-up|0|||
23258096|NCT01783496|64686705|FG002|Overall Study|Lost to Follow-up|0|||
23258097|NCT01783496|64686706|FG003|Overall Study|Lost to Follow-up|2|||
23258098|NCT01783496|64686707|FG004|Overall Study|Lost to Follow-up|0|||
23258099|NCT01783496|64686708|FG005|Overall Study|Lost to Follow-up|1|||
23258100|NCT01783496|64686703|FG000|Overall Study|Withdrawal by Subject|1|||
23258101|NCT01783496|64686704|FG001|Overall Study|Withdrawal by Subject|0|||
23258102|NCT01783496|64686705|FG002|Overall Study|Withdrawal by Subject|0|||
23258103|NCT01783496|64686706|FG003|Overall Study|Withdrawal by Subject|0|||
23258104|NCT01783496|64686707|FG004|Overall Study|Withdrawal by Subject|0|||
23258105|NCT01783496|64686708|FG005|Overall Study|Withdrawal by Subject|0|||
23258106|NCT02040428|64686709|FG000|Overall Study|Death|4|||
23258107|NCT02040428|64686710|FG001|Overall Study|Death|3|||
23258108|NCT02040428|64686709|FG000|Overall Study|Withdrawal by Subject|1|||
23258109|NCT02040428|64686710|FG001|Overall Study|Withdrawal by Subject|1|||
23258110|NCT03555890|64686711|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23258111|NCT03555890|64686712|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23258112|NCT03555890|64686713|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23258113|NCT03555890|64686714|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
23258114|NCT04428502|64686727|FG000|Overall Study|Did not meet entrance criteria|14|||
23258115|NCT04242186|64686729|FG000|Overall Study|Death|5|||
23258116|NCT03137082|64686731|FG000|Overall Study|Withdrawal by Subject|1|||
23258117|NCT03137082|64686732|FG001|Overall Study|Withdrawal by Subject|1|||
23258118|NCT03137082|64686731|FG000|Overall Study|Lost to Follow-up|1|||
23258119|NCT03137082|64686732|FG001|Overall Study|Lost to Follow-up|0|||
23258120|NCT03469271|64686733|FG000|Overall Study|Withdrawal by Subject|2|||
23258121|NCT03469271|64686734|FG001|Overall Study|Withdrawal by Subject|0|||
23258122|NCT03469271|64686735|FG002|Overall Study|Withdrawal by Subject|0|||
23258123|NCT03469271|64686736|FG003|Overall Study|Withdrawal by Subject|1|||
23258124|NCT03349333|64686737|FG000|Overall Study|Progression of Disease|36|||
23258125|NCT03349333|64686737|FG000|Overall Study|Adverse Event|11|||
23258126|NCT03349333|64686737|FG000|Overall Study|Other|6|||
23258127|NCT03349333|64686737|FG000|Overall Study|Withdrawal by Subject|5|||
23258128|NCT03349333|64686737|FG000|Overall Study|Conditions interfere with participation|2|||
23258129|NCT03349333|64686737|FG000|Overall Study|Physician Decision|2|||
23258130|NCT03349333|64686737|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
23258131|NCT03349333|64686737|FG000|Overall Study|Patients in treatment less than 24 month|8|||
23258132|NCT00455533|64686738|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
23258133|NCT00455533|64686739|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
23258134|NCT00455533|64686740|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
23258135|NCT00455533|64686738|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
23258136|NCT00455533|64686739|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
23258137|NCT00455533|64686740|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
23258138|NCT00455533|64686738|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
23258139|NCT00455533|64686739|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
23258140|NCT00455533|64686740|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
23258141|NCT00455533|64686738|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
23258142|NCT00455533|64686739|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
23258143|NCT00455533|64686740|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
23258144|NCT00455533|64686738|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
23258145|NCT00455533|64686739|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
23258146|NCT00455533|64686740|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
23258147|NCT00455533|64686738|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
23361123|NCT02105285|65065971|FG001|Overall Study|Protocol Violation|1|||
23361124|NCT02105285|65065972|FG002|Overall Study|Protocol Violation|0|||
23258148|NCT00455533|64686739|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
23258149|NCT00455533|64686740|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
23258150|NCT00455533|64686738|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
23258151|NCT00455533|64686739|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
23258152|NCT00455533|64686740|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
23258153|NCT00455533|64686738|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
23258154|NCT00455533|64686739|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
23258155|NCT00455533|64686740|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
23258156|NCT00455533|64686738|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
23258157|NCT00455533|64686739|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
23258158|NCT00455533|64686740|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
23258159|NCT00455533|64686738|FG000|Period Two: Randomized Period|Death|0|||
23258160|NCT00455533|64686739|FG001|Period Two: Randomized Period|Death|0|||
23258161|NCT00455533|64686740|FG002|Period Two: Randomized Period|Death|3|||
23258162|NCT00455533|64686738|FG000|Period Two: Randomized Period|Disease Progression|0|||
23258163|NCT00455533|64686739|FG001|Period Two: Randomized Period|Disease Progression|1|||
23258164|NCT00455533|64686740|FG002|Period Two: Randomized Period|Disease Progression|1|||
23258165|NCT00455533|64686738|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
23258166|NCT00455533|64686739|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
23258167|NCT00455533|64686740|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
23258168|NCT00455533|64686738|FG000|Period Two: Randomized Period|Other - need reasons|0|||
23258169|NCT00455533|64686739|FG001|Period Two: Randomized Period|Other - need reasons|1|||
23258170|NCT00455533|64686740|FG002|Period Two: Randomized Period|Other - need reasons|0|||
23258171|NCT00455533|64686738|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
23258172|NCT00455533|64686739|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
23258173|NCT00455533|64686740|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
23258174|NCT00455533|64686738|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
23258175|NCT00455533|64686739|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
23258176|NCT00455533|64686740|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
23258177|NCT00575328|64686741|FG000|Overall Study|Adverse Event|1|||
23258178|NCT00575328|64686742|FG001|Overall Study|Adverse Event|1|||
23258179|NCT00575328|64686741|FG000|Overall Study|Lost to Follow-up|2|||
23258180|NCT00575328|64686742|FG001|Overall Study|Lost to Follow-up|1|||
23258181|NCT03549130|64686748|FG000|Overall Study|Adverse Event|0|||
23258182|NCT03549130|64686749|FG001|Overall Study|Adverse Event|1|||
23258183|NCT03549130|64686748|FG000|Overall Study|Lost to Follow-up|0|||
23258184|NCT03549130|64686749|FG001|Overall Study|Lost to Follow-up|1|||
23258185|NCT01113710|64686756|FG000|Overall Study|Adverse Event|64|||
23258186|NCT01113710|64686756|FG000|Overall Study|Lack of Efficacy|41|||
23198939|NCT03161678|64468658|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
23258187|NCT01113710|64686756|FG000|Overall Study|No Information Available|40|||
23258188|NCT01113710|64686756|FG000|Overall Study|Withdrawal by Subject|28|||
23258189|NCT01113710|64686756|FG000|Overall Study|Lost to Follow-up|20|||
23258190|NCT01113710|64686756|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
23198940|NCT03161678|64468659|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
23198941|NCT03161678|64468654|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
23198942|NCT03161678|64468655|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
23198943|NCT03161678|64468656|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
23198944|NCT03161678|64468657|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
23198945|NCT03161678|64468658|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
23198946|NCT03161678|64468659|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
23198947|NCT03161678|64468654|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23198948|NCT03161678|64468655|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23258191|NCT01113710|64686756|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
23258192|NCT01113710|64686756|FG000|Overall Study|Lack of Patient's Compliance|8|||
23258193|NCT01113710|64686756|FG000|Overall Study|Other|7|||
23258194|NCT01113710|64686756|FG000|Overall Study|Adverse Event/Other|5|||
23258195|NCT01113710|64686756|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
23258196|NCT01113710|64686756|FG000|Overall Study|Lack of Efficacy/Other|4|||
23258197|NCT01113710|64686756|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
23258198|NCT01113710|64686756|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
23258199|NCT01113710|64686756|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
23258200|NCT01113710|64686756|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
23258201|NCT01113710|64686756|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
23361125|NCT02105285|65065970|FG000|Overall Study|Withdrawal by Subject|1|||
23480358|NCT01330017|65501954|FG000|Overall Study|Lost to Follow-up|0|||
23198949|NCT03161678|64468656|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23198950|NCT03161678|64468657|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
23198951|NCT03161678|64468658|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23198952|NCT03161678|64468659|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
23198953|NCT01552928|64468660|FG000|Period 3|Adverse Event|0|||
23258202|NCT01113710|64686756|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
23258203|NCT01113710|64686756|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
23361126|NCT02105285|65065971|FG001|Overall Study|Withdrawal by Subject|0|||
23258204|NCT01113710|64686756|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
23258205|NCT01113710|64686756|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
23258206|NCT01113710|64686756|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
23258207|NCT01113710|64686756|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
23258208|NCT01113710|64686756|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
23258209|NCT01113710|64686756|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
23258210|NCT00410410|64686764|FG000|Induction Period (IP)|Death|1|||
23258211|NCT00410410|64686765|FG001|Induction Period (IP)|Death|0|||
23258212|NCT00410410|64686766|FG002|Induction Period (IP)|Death|0|||
23258213|NCT00410410|64686767|FG003|Induction Period (IP)|Death|0|||
23258214|NCT00410410|64686768|FG004|Induction Period (IP)|Death|0|||
23258215|NCT00410410|64686769|FG005|Induction Period (IP)|Death|0|||
23258216|NCT00410410|64686770|FG006|Induction Period (IP)|Death|0|||
23258217|NCT00410410|64686771|FG007|Induction Period (IP)|Death|0|||
23258218|NCT00410410|64686772|FG008|Induction Period (IP)|Death|0|||
23198954|NCT01552928|64468661|FG001|Period 3|Adverse Event|0|||
23198955|NCT01552928|64468662|FG002|Period 3|Adverse Event|1|||
23198956|NCT01552928|64468663|FG003|Period 3|Adverse Event|0|||
23198957|NCT03885726|64468664|FG000|Overall Study|Staffing issues/lost interest|1|||
23198958|NCT03885726|64468664|FG000|Overall Study|Early discharge from hospital|3|||
23198959|NCT01259297|64468665|FG000|Double Blind Randomized Period|Death|1|||
23198960|NCT01259297|64468666|FG001|Double Blind Randomized Period|Death|1|||
23198961|NCT01259297|64468667|FG002|Double Blind Randomized Period|Death|1|||
23198962|NCT01259297|64468668|FG003|Double Blind Randomized Period|Death|2|||
23198963|NCT01259297|64468669|FG004|Double Blind Randomized Period|Death|1|||
23198964|NCT01259297|64468670|FG005|Double Blind Randomized Period|Death|5|||
23198965|NCT01259297|64468671|FG006|Double Blind Randomized Period|Death|2|||
23198966|NCT01259297|64468672|FG007|Double Blind Randomized Period|Death|1|||
23198967|NCT01259297|64468665|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23198968|NCT01259297|64468666|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23198969|NCT01259297|64468667|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
23198970|NCT01259297|64468668|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
23198971|NCT01259297|64468669|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
23198972|NCT01259297|64468670|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23198973|NCT01259297|64468671|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23198974|NCT01259297|64468672|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
23198975|NCT01259297|64468665|FG000|Double Blind Randomized Period|Other reasons|0|||
23198976|NCT01259297|64468666|FG001|Double Blind Randomized Period|Other reasons|1|||
23198977|NCT01259297|64468667|FG002|Double Blind Randomized Period|Other reasons|0|||
23198978|NCT01259297|64468668|FG003|Double Blind Randomized Period|Other reasons|0|||
23198979|NCT01259297|64468669|FG004|Double Blind Randomized Period|Other reasons|1|||
23198980|NCT01259297|64468670|FG005|Double Blind Randomized Period|Other reasons|2|||
23198981|NCT01259297|64468671|FG006|Double Blind Randomized Period|Other reasons|3|||
23198982|NCT01259297|64468672|FG007|Double Blind Randomized Period|Other reasons|1|||
23198983|NCT02435277|64468687|FG000|Overall Study|Adverse Event|1|||
23198984|NCT02435277|64468688|FG001|Overall Study|Adverse Event|1|||
23198985|NCT02435277|64468689|FG002|Overall Study|Adverse Event|0|||
23198986|NCT02435277|64468690|FG003|Overall Study|Adverse Event|0|||
23198987|NCT02435277|64468687|FG000|Overall Study|Withdrawal by Subject|1|||
23198988|NCT02435277|64468688|FG001|Overall Study|Withdrawal by Subject|0|||
23198989|NCT02435277|64468689|FG002|Overall Study|Withdrawal by Subject|0|||
23198990|NCT02435277|64468690|FG003|Overall Study|Withdrawal by Subject|0|||
23198991|NCT00952289|64468695|FG000|All Participants|Death|9|||
23198992|NCT00952289|64468696|FG001|All Participants|Death|9|||
23198993|NCT00952289|64468695|FG000|All Participants|Adverse Event|8|||
23198994|NCT00952289|64468696|FG001|All Participants|Adverse Event|8|||
23198995|NCT00952289|64468695|FG000|All Participants|Disease progression|3|||
23198996|NCT00952289|64468696|FG001|All Participants|Disease progression|12|||
23198997|NCT00952289|64468695|FG000|All Participants|Withdrawal by Subject|1|||
23198998|NCT00952289|64468696|FG001|All Participants|Withdrawal by Subject|10|||
23198999|NCT00952289|64468695|FG000|All Participants|Data lost during site relocation|0|||
23199000|NCT00952289|64468696|FG001|All Participants|Data lost during site relocation|1|||
23199001|NCT00952289|64468695|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
23199002|NCT00952289|64468696|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
23199003|NCT00952289|64468695|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
23199004|NCT00952289|64468696|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
23199005|NCT00952289|64468695|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
23199006|NCT00952289|64468696|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
23258219|NCT00410410|64686764|FG000|Induction Period (IP)|Adverse Event|3|||
23258220|NCT00410410|64686765|FG001|Induction Period (IP)|Adverse Event|4|||
23258221|NCT00410410|64686766|FG002|Induction Period (IP)|Adverse Event|2|||
23258222|NCT00410410|64686767|FG003|Induction Period (IP)|Adverse Event|4|||
23361127|NCT02105285|65065972|FG002|Overall Study|Withdrawal by Subject|0|||
23361128|NCT02532283|65065973|FG000|Overall Study|Adverse Event|0|||
23361129|NCT02532283|65065974|FG001|Overall Study|Adverse Event|1|||
23600041|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
23600042|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
23600043|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
23600044|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
23600045|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
23600046|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
23600047|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
23600048|NCT00982644|65925774|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
23199007|NCT00952289|64468695|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
23199008|NCT00952289|64468696|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
23199009|NCT00952289|64468695|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
23199010|NCT00952289|64468696|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
23199011|NCT02184143|64468700|FG000|Overall Study|Withdrawal by Subject|4|||
23199012|NCT02184143|64468701|FG001|Overall Study|Withdrawal by Subject|4|||
23199013|NCT02184143|64468700|FG000|Overall Study|Lost to Follow-up|5|||
23199014|NCT02184143|64468701|FG001|Overall Study|Lost to Follow-up|3|||
23199015|NCT02184143|64468700|FG000|Overall Study|Death|1|||
23199016|NCT02184143|64468701|FG001|Overall Study|Death|0|||
23199017|NCT03827473|64468702|FG000|Overall Study|Withdrawal by Subject|1|||
23199018|NCT03827473|64468703|FG001|Overall Study|Withdrawal by Subject|0|||
23199019|NCT03213626|64468704|FG000|Overall Study|Adverse Event|1|||
23199020|NCT03213626|64468704|FG000|Overall Study|Progressive Disease|6|||
23199021|NCT03691610|64468707|FG000|Overall Study|Adverse Event|0|||
23199022|NCT03691610|64468708|FG001|Overall Study|Adverse Event|1|||
23199023|NCT03691610|64468709|FG002|Overall Study|Adverse Event|0|||
23199024|NCT03691610|64468710|FG003|Overall Study|Adverse Event|0|||
23199025|NCT03691610|64468707|FG000|Overall Study|Protocol Deviation|15|||
23199026|NCT03691610|64468708|FG001|Overall Study|Protocol Deviation|8|||
23199027|NCT03691610|64468709|FG002|Overall Study|Protocol Deviation|1|||
23199028|NCT03691610|64468710|FG003|Overall Study|Protocol Deviation|2|||
23199029|NCT03691610|64468707|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
23199030|NCT03691610|64468708|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
23199031|NCT03691610|64468709|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
23199032|NCT03691610|64468710|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
23199033|NCT03691610|64468707|FG000|Overall Study|Lost to Follow-up|20|||
23199034|NCT03691610|64468708|FG001|Overall Study|Lost to Follow-up|11|||
23199035|NCT03691610|64468709|FG002|Overall Study|Lost to Follow-up|5|||
23199036|NCT03691610|64468710|FG003|Overall Study|Lost to Follow-up|2|||
23199037|NCT03865407|64468713|FG000|Overall Study|Adverse Event|1|||
23199038|NCT03865407|64468714|FG001|Overall Study|Adverse Event|0|||
23199039|NCT03865407|64468713|FG000|Overall Study|Withdrawal by Subject|1|||
23199040|NCT03865407|64468714|FG001|Overall Study|Withdrawal by Subject|0|||
23199041|NCT03865407|64468713|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
23199042|NCT03865407|64468714|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
23199043|NCT04095286|64468717|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23199044|NCT04095286|64468718|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
23199045|NCT04095286|64468719|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23199046|NCT04095286|64468720|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23199047|NCT04095286|64468721|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23199048|NCT04095286|64468722|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23199049|NCT04095286|64468717|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
23199050|NCT04095286|64468718|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23199051|NCT04095286|64468719|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23199052|NCT04095286|64468720|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23199053|NCT04095286|64468721|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23199054|NCT04095286|64468722|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
23199055|NCT04095286|64468717|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23199056|NCT04095286|64468718|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23199057|NCT04095286|64468719|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
23199058|NCT04095286|64468720|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23199059|NCT04095286|64468721|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23199060|NCT04095286|64468722|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
23199061|NCT04095286|64468717|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23199062|NCT04095286|64468718|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23600049|NCT00982644|65925775|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
23361130|NCT02532283|65065973|FG000|Overall Study|Death|1|||
23361131|NCT02532283|65065974|FG001|Overall Study|Death|0|||
23361132|NCT02532283|65065973|FG000|Overall Study|Lost to Follow-up|0|||
23361133|NCT02532283|65065974|FG001|Overall Study|Lost to Follow-up|1|||
23361134|NCT02532283|65065973|FG000|Overall Study|Withdrawal by Subject|8|||
23361135|NCT02532283|65065974|FG001|Overall Study|Withdrawal by Subject|3|||
23258223|NCT00410410|64686768|FG004|Induction Period (IP)|Adverse Event|1|||
23258224|NCT00410410|64686769|FG005|Induction Period (IP)|Adverse Event|0|||
23258225|NCT00410410|64686770|FG006|Induction Period (IP)|Adverse Event|0|||
23258226|NCT00410410|64686771|FG007|Induction Period (IP)|Adverse Event|0|||
23258227|NCT00410410|64686772|FG008|Induction Period (IP)|Adverse Event|0|||
23258228|NCT00410410|64686764|FG000|Induction Period (IP)|Lack of Efficacy|26|||
23258229|NCT00410410|64686765|FG001|Induction Period (IP)|Lack of Efficacy|24|||
23258230|NCT00410410|64686766|FG002|Induction Period (IP)|Lack of Efficacy|8|||
23258231|NCT00410410|64686767|FG003|Induction Period (IP)|Lack of Efficacy|8|||
23258232|NCT00410410|64686768|FG004|Induction Period (IP)|Lack of Efficacy|7|||
23258233|NCT00410410|64686769|FG005|Induction Period (IP)|Lack of Efficacy|7|||
23258234|NCT00410410|64686770|FG006|Induction Period (IP)|Lack of Efficacy|0|||
23258235|NCT00410410|64686771|FG007|Induction Period (IP)|Lack of Efficacy|0|||
23258236|NCT00410410|64686772|FG008|Induction Period (IP)|Lack of Efficacy|0|||
23258237|NCT00410410|64686764|FG000|Induction Period (IP)|Lost to Follow-up|2|||
23258238|NCT00410410|64686765|FG001|Induction Period (IP)|Lost to Follow-up|2|||
23258239|NCT00410410|64686766|FG002|Induction Period (IP)|Lost to Follow-up|2|||
23258240|NCT00410410|64686767|FG003|Induction Period (IP)|Lost to Follow-up|3|||
23258241|NCT00410410|64686768|FG004|Induction Period (IP)|Lost to Follow-up|0|||
23258242|NCT00410410|64686769|FG005|Induction Period (IP)|Lost to Follow-up|1|||
23258243|NCT00410410|64686770|FG006|Induction Period (IP)|Lost to Follow-up|0|||
23258244|NCT00410410|64686771|FG007|Induction Period (IP)|Lost to Follow-up|0|||
23258245|NCT00410410|64686772|FG008|Induction Period (IP)|Lost to Follow-up|0|||
23258246|NCT00410410|64686764|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
23258247|NCT00410410|64686765|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
23258248|NCT00410410|64686766|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
23258249|NCT00410410|64686767|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
23258250|NCT00410410|64686768|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
23258251|NCT00410410|64686769|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
23258252|NCT00410410|64686770|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
23258253|NCT00410410|64686771|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
23258254|NCT00410410|64686772|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
23258255|NCT00410410|64686764|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23258256|NCT00410410|64686765|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23258257|NCT00410410|64686766|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
23258258|NCT00410410|64686767|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23258259|NCT00410410|64686768|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23258260|NCT00410410|64686769|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23258261|NCT00410410|64686770|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23258262|NCT00410410|64686771|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23258263|NCT00410410|64686772|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
23258264|NCT00410410|64686764|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23258265|NCT00410410|64686765|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23258266|NCT00410410|64686766|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23258267|NCT00410410|64686767|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23258268|NCT00410410|64686768|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
23258269|NCT00410410|64686769|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
23258270|NCT00410410|64686770|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23258271|NCT00410410|64686771|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23258272|NCT00410410|64686772|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
23258273|NCT00410410|64686764|FG000|Induction Period (IP)|Other|0|||
23258274|NCT00410410|64686765|FG001|Induction Period (IP)|Other|0|||
23258275|NCT00410410|64686766|FG002|Induction Period (IP)|Other|1|||
23258276|NCT00410410|64686767|FG003|Induction Period (IP)|Other|0|||
23258277|NCT00410410|64686768|FG004|Induction Period (IP)|Other|0|||
23258278|NCT00410410|64686769|FG005|Induction Period (IP)|Other|0|||
23258279|NCT00410410|64686770|FG006|Induction Period (IP)|Other|0|||
23258280|NCT00410410|64686771|FG007|Induction Period (IP)|Other|0|||
23258281|NCT00410410|64686772|FG008|Induction Period (IP)|Other|0|||
23258282|NCT00410410|64686764|FG000|Maintenance Period (MP)|Death|0|||
23258283|NCT00410410|64686765|FG001|Maintenance Period (MP)|Death|0|||
23258284|NCT00410410|64686766|FG002|Maintenance Period (MP)|Death|0|||
23258285|NCT00410410|64686767|FG003|Maintenance Period (MP)|Death|0|||
23258286|NCT00410410|64686768|FG004|Maintenance Period (MP)|Death|0|||
23361136|NCT02532257|65065975|FG000|Overall Study|Adverse Event|2|||
23361137|NCT02532257|65065975|FG000|Overall Study|Physician Decision|4|||
23258287|NCT00410410|64686769|FG005|Maintenance Period (MP)|Death|0|||
23258288|NCT00410410|64686770|FG006|Maintenance Period (MP)|Death|1|||
23258289|NCT00410410|64686771|FG007|Maintenance Period (MP)|Death|0|||
23258290|NCT00410410|64686772|FG008|Maintenance Period (MP)|Death|0|||
23258291|NCT00410410|64686764|FG000|Maintenance Period (MP)|Adverse Event|0|||
23258292|NCT00410410|64686765|FG001|Maintenance Period (MP)|Adverse Event|0|||
23258293|NCT00410410|64686766|FG002|Maintenance Period (MP)|Adverse Event|0|||
23199063|NCT04095286|64468719|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
23199064|NCT04095286|64468720|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23199065|NCT04095286|64468721|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23199066|NCT04095286|64468722|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
23199067|NCT04095286|64468717|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23199068|NCT04095286|64468718|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23199069|NCT04095286|64468719|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23199070|NCT04095286|64468720|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23199071|NCT04095286|64468721|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
23199072|NCT04095286|64468722|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
23199073|NCT00807846|64468725|FG000|Overall Study|Adverse Event|5|||
23199074|NCT00807846|64468726|FG001|Overall Study|Adverse Event|0|||
23199075|NCT00807846|64468725|FG000|Overall Study|Lack of Efficacy|2|||
23199076|NCT00807846|64468726|FG001|Overall Study|Lack of Efficacy|0|||
23199077|NCT00807846|64468725|FG000|Overall Study|Protocol Violation|2|||
23199078|NCT00807846|64468726|FG001|Overall Study|Protocol Violation|1|||
23199079|NCT00807846|64468725|FG000|Overall Study|Withdrawal by Subject|2|||
23199080|NCT00807846|64468726|FG001|Overall Study|Withdrawal by Subject|1|||
23199081|NCT00807846|64468725|FG000|Overall Study|Other|1|||
23199082|NCT00807846|64468726|FG001|Overall Study|Other|2|||
23199083|NCT01576016|64468727|FG000|Lead Safety|Death|132|||
23199084|NCT01576016|64468728|FG001|Lead Safety|Death|0|||
23199085|NCT01576016|64468727|FG000|Lead Safety|Withdrawal by Subject|81|||
23199086|NCT01576016|64468728|FG001|Lead Safety|Withdrawal by Subject|0|||
23199087|NCT01576016|64468727|FG000|Lead Safety|System Explanted without Replacement|24|||
23199088|NCT01576016|64468728|FG001|Lead Safety|System Explanted without Replacement|0|||
23199089|NCT01576016|64468727|FG000|Lead Safety|Physician Decision|14|||
23199090|NCT01576016|64468728|FG001|Lead Safety|Physician Decision|0|||
23199091|NCT01576016|64468727|FG000|Lead Safety|Lost to Follow-up|13|||
23199092|NCT01576016|64468728|FG001|Lead Safety|Lost to Follow-up|0|||
23199093|NCT01576016|64468727|FG000|Lead Safety|Unsuccessful implant|2|||
23199094|NCT01576016|64468728|FG001|Lead Safety|Unsuccessful implant|0|||
23199095|NCT01576016|64468727|FG000|Lead Safety|Sponsor request|1|||
23199096|NCT01576016|64468728|FG001|Lead Safety|Sponsor request|0|||
23199097|NCT01576016|64468727|FG000|Lead Safety|Device replaced with CRT-D|1|||
23199098|NCT01576016|64468728|FG001|Lead Safety|Device replaced with CRT-D|0|||
23199099|NCT01576016|64468727|FG000|Lead Safety|Patient on Palliative Care|1|||
23199100|NCT01576016|64468728|FG001|Lead Safety|Patient on Palliative Care|0|||
23199101|NCT01576016|64468727|FG000|Lead Safety|Patient noncompliance|1|||
23199102|NCT01576016|64468728|FG001|Lead Safety|Patient noncompliance|0|||
23199103|NCT01576016|64468727|FG000|Lead Safety|Too far from study site|1|||
23199104|NCT01576016|64468728|FG001|Lead Safety|Too far from study site|0|||
23199105|NCT01576016|64468727|FG000|Lead Safety|System deactivated|1|||
23199106|NCT01576016|64468728|FG001|Lead Safety|System deactivated|0|||
23199107|NCT01576016|64468727|FG000|Lead Safety|Patient no longer followed by study PI|1|||
23199108|NCT01576016|64468728|FG001|Lead Safety|Patient no longer followed by study PI|0|||
23199109|NCT01576016|64468727|FG000|MRI Safety|Withdrawal by Subject|0|||
23199110|NCT01576016|64468728|FG001|MRI Safety|Withdrawal by Subject|10|||
23199111|NCT01576016|64468727|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
23199112|NCT01576016|64468728|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
23199113|NCT01576016|64468727|FG000|MRI Safety|Has not yet completed MRI scan|0|||
23199114|NCT01576016|64468728|FG001|MRI Safety|Has not yet completed MRI scan|56|||
23199115|NCT01576016|64468727|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
23199116|NCT01576016|64468728|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
23199117|NCT00303108|64468729|FG000|Overall Study|Adverse Event|5|||
23480359|NCT01330017|65501955|FG001|Overall Study|Lost to Follow-up|0|||
23199118|NCT00303108|64468730|FG001|Overall Study|Adverse Event|6|||
23199119|NCT00303108|64468731|FG002|Overall Study|Adverse Event|7|||
23199120|NCT00303108|64468729|FG000|Overall Study|Patient Request|4|||
23199121|NCT00303108|64468730|FG001|Overall Study|Patient Request|2|||
23199122|NCT00303108|64468731|FG002|Overall Study|Patient Request|8|||
23199123|NCT00303108|64468729|FG000|Overall Study|Failed Entry|1|||
23199124|NCT00303108|64468730|FG001|Overall Study|Failed Entry|0|||
23199125|NCT00303108|64468731|FG002|Overall Study|Failed Entry|1|||
23199126|NCT00303108|64468729|FG000|Overall Study|ineligible|2|||
23199127|NCT00303108|64468730|FG001|Overall Study|ineligible|1|||
23258294|NCT00410410|64686767|FG003|Maintenance Period (MP)|Adverse Event|0|||
23199128|NCT00303108|64468731|FG002|Overall Study|ineligible|0|||
23258295|NCT00410410|64686768|FG004|Maintenance Period (MP)|Adverse Event|0|||
23258296|NCT00410410|64686769|FG005|Maintenance Period (MP)|Adverse Event|0|||
23258297|NCT00410410|64686770|FG006|Maintenance Period (MP)|Adverse Event|1|||
23258298|NCT00410410|64686771|FG007|Maintenance Period (MP)|Adverse Event|3|||
23258299|NCT00410410|64686772|FG008|Maintenance Period (MP)|Adverse Event|0|||
23258300|NCT00410410|64686764|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
23258301|NCT00410410|64686765|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
23258302|NCT00410410|64686766|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
23258303|NCT00410410|64686767|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
23258304|NCT00410410|64686768|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
23258305|NCT00410410|64686769|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
23258306|NCT00410410|64686770|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
23258307|NCT00410410|64686771|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
23258308|NCT00410410|64686772|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
23258309|NCT00410410|64686764|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
23258310|NCT00410410|64686765|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
23258311|NCT00410410|64686766|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
23258312|NCT00410410|64686767|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
23258313|NCT00410410|64686768|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
23258314|NCT00410410|64686769|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
23258315|NCT00410410|64686770|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
23258316|NCT00410410|64686771|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
23258317|NCT00410410|64686772|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
23258318|NCT00410410|64686764|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
23258319|NCT00410410|64686765|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
23258320|NCT00410410|64686766|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
23258321|NCT00410410|64686767|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
23258322|NCT00410410|64686768|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
23258323|NCT00410410|64686769|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
23258324|NCT00410410|64686770|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
23258325|NCT00410410|64686771|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
23258326|NCT00410410|64686772|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
23258327|NCT00410410|64686764|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23258328|NCT00410410|64686765|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23258329|NCT00410410|64686766|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23258330|NCT00410410|64686767|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23258331|NCT00410410|64686768|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23258332|NCT00410410|64686769|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23258333|NCT00410410|64686770|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
23258334|NCT00410410|64686771|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
23258335|NCT00410410|64686772|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
23258336|NCT00410410|64686764|FG000|Open-Label Period (OL)|Death|0|||
23258337|NCT00410410|64686765|FG001|Open-Label Period (OL)|Death|0|||
23258338|NCT00410410|64686766|FG002|Open-Label Period (OL)|Death|0|||
23258339|NCT00410410|64686767|FG003|Open-Label Period (OL)|Death|0|||
23258340|NCT00410410|64686768|FG004|Open-Label Period (OL)|Death|0|||
23258341|NCT00410410|64686769|FG005|Open-Label Period (OL)|Death|0|||
23258342|NCT00410410|64686770|FG006|Open-Label Period (OL)|Death|0|||
23258343|NCT00410410|64686771|FG007|Open-Label Period (OL)|Death|0|||
23258344|NCT00410410|64686772|FG008|Open-Label Period (OL)|Death|1|||
23258345|NCT00410410|64686764|FG000|Open-Label Period (OL)|Adverse Event|0|||
23361138|NCT02532257|65065975|FG000|Overall Study|Withdrawal by Subject|3|||
23361139|NCT02532257|65065975|FG000|Overall Study|Progressive Disease|10|||
23480360|NCT01330017|65501956|FG002|Overall Study|Lost to Follow-up|1|||
23258346|NCT00410410|64686765|FG001|Open-Label Period (OL)|Adverse Event|0|||
23258347|NCT00410410|64686766|FG002|Open-Label Period (OL)|Adverse Event|0|||
23258348|NCT00410410|64686767|FG003|Open-Label Period (OL)|Adverse Event|0|||
23258349|NCT00410410|64686768|FG004|Open-Label Period (OL)|Adverse Event|0|||
23258350|NCT00410410|64686769|FG005|Open-Label Period (OL)|Adverse Event|0|||
23258351|NCT00410410|64686770|FG006|Open-Label Period (OL)|Adverse Event|0|||
23258352|NCT00410410|64686771|FG007|Open-Label Period (OL)|Adverse Event|0|||
23258353|NCT00410410|64686772|FG008|Open-Label Period (OL)|Adverse Event|10|||
23258354|NCT00410410|64686764|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
23258355|NCT00410410|64686765|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
23258356|NCT00410410|64686766|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
23258357|NCT00410410|64686767|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
23258358|NCT00410410|64686768|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
23258359|NCT00410410|64686769|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
23258360|NCT00410410|64686770|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
23258361|NCT00410410|64686771|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
23258362|NCT00410410|64686772|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
23258363|NCT00410410|64686764|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
23258364|NCT00410410|64686765|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
23258365|NCT00410410|64686766|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
23258366|NCT00410410|64686767|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
23258367|NCT00410410|64686768|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
23258368|NCT00410410|64686769|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
23258369|NCT00410410|64686770|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
23258370|NCT00410410|64686771|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
23258371|NCT00410410|64686772|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
23258372|NCT00410410|64686764|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
23258373|NCT00410410|64686765|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
23258374|NCT00410410|64686766|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
23258375|NCT00410410|64686767|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
23258376|NCT00410410|64686768|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
23258377|NCT00410410|64686769|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
23258378|NCT00410410|64686770|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
23258379|NCT00410410|64686771|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
23258380|NCT00410410|64686772|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
23258381|NCT00410410|64686764|FG000|Open-Label Period (OL)|Pregnancy|0|||
23258382|NCT00410410|64686765|FG001|Open-Label Period (OL)|Pregnancy|0|||
23258383|NCT00410410|64686766|FG002|Open-Label Period (OL)|Pregnancy|0|||
23258384|NCT00410410|64686767|FG003|Open-Label Period (OL)|Pregnancy|0|||
23258385|NCT00410410|64686768|FG004|Open-Label Period (OL)|Pregnancy|0|||
23258386|NCT00410410|64686769|FG005|Open-Label Period (OL)|Pregnancy|0|||
23258387|NCT00410410|64686770|FG006|Open-Label Period (OL)|Pregnancy|0|||
23258388|NCT00410410|64686771|FG007|Open-Label Period (OL)|Pregnancy|0|||
23258389|NCT00410410|64686772|FG008|Open-Label Period (OL)|Pregnancy|1|||
23258390|NCT00410410|64686764|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23258391|NCT00410410|64686765|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23258392|NCT00410410|64686766|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23258393|NCT00410410|64686767|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23258394|NCT00410410|64686768|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23258395|NCT00410410|64686769|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23258396|NCT00410410|64686770|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23258397|NCT00410410|64686771|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
23258398|NCT00410410|64686772|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
23258399|NCT00410410|64686764|FG000|Open-Label Period (OL)|Other|0|||
23258400|NCT00410410|64686765|FG001|Open-Label Period (OL)|Other|0|||
23361140|NCT03293394|65065977|FG000|Follow-up (6 Months)|Adverse Event|4|||
23361141|NCT03293394|65065978|FG001|Follow-up (6 Months)|Adverse Event|2|||
23361142|NCT02861664|65065979|FG000|Overall Study|Withdrawal of Consent|0|||
23600050|NCT01499849|65925776|FG000|Overall Study|Adverse Event|28|||
23600051|NCT01499849|65925777|FG001|Overall Study|Adverse Event|32|||
23600052|NCT01499849|65925776|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
23600053|NCT01499849|65925777|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
23600054|NCT01499849|65925776|FG000|Overall Study|Withdrawal by Subject|43|||
23600055|NCT01499849|65925777|FG001|Overall Study|Withdrawal by Subject|43|||
23600056|NCT01499849|65925776|FG000|Overall Study|Death|5|||
23600057|NCT01499849|65925777|FG001|Overall Study|Death|7|||
23600058|NCT01499849|65925776|FG000|Overall Study|Disease Progression|11|||
23600059|NCT01499849|65925777|FG001|Overall Study|Disease Progression|10|||
23600060|NCT01499849|65925776|FG000|Overall Study|Protocol Violation|11|||
23600061|NCT01499849|65925777|FG001|Overall Study|Protocol Violation|11|||
23600062|NCT01499849|65925776|FG000|Overall Study|Physician Decision|20|||
23600063|NCT01499849|65925777|FG001|Overall Study|Physician Decision|19|||
23600064|NCT01499849|65925776|FG000|Overall Study|Lack of Efficacy|3|||
23600065|NCT01499849|65925777|FG001|Overall Study|Lack of Efficacy|4|||
23600066|NCT01499849|65925776|FG000|Overall Study|Lost to Follow-up|6|||
23600067|NCT01499849|65925777|FG001|Overall Study|Lost to Follow-up|3|||
23600068|NCT01499849|65925776|FG000|Overall Study|Other Reasons|27|||
23600069|NCT01499849|65925777|FG001|Overall Study|Other Reasons|30|||
23600070|NCT01701401|65925788|FG000|Overall Study|Randomized But Not Treated|3|||
23600071|NCT01701401|65925789|FG001|Overall Study|Randomized But Not Treated|1|||
23600072|NCT01701401|65925790|FG002|Overall Study|Randomized But Not Treated|0|||
23600073|NCT01701401|65925791|FG003|Overall Study|Randomized But Not Treated|1|||
23600074|NCT01701401|65925788|FG000|Overall Study|Lost to Follow-up|5|||
23600075|NCT01701401|65925789|FG001|Overall Study|Lost to Follow-up|5|||
23600076|NCT01701401|65925790|FG002|Overall Study|Lost to Follow-up|1|||
23600077|NCT01701401|65925791|FG003|Overall Study|Lost to Follow-up|3|||
23199129|NCT01505491|64468733|FG000|Overall Study|Other reason not listed|1|||
23199130|NCT01505491|64468734|FG001|Overall Study|Other reason not listed|0|||
23199131|NCT01505491|64468735|FG002|Overall Study|Other reason not listed|0|||
23199132|NCT01505491|64468733|FG000|Overall Study|Withdrawal by Subject|1|||
23199133|NCT01505491|64468734|FG001|Overall Study|Withdrawal by Subject|1|||
23199134|NCT01505491|64468735|FG002|Overall Study|Withdrawal by Subject|4|||
23199135|NCT01505491|64468733|FG000|Overall Study|Lost to Follow-up|0|||
23199136|NCT01505491|64468734|FG001|Overall Study|Lost to Follow-up|0|||
23199137|NCT01505491|64468735|FG002|Overall Study|Lost to Follow-up|1|||
23199138|NCT04285346|64468736|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
23199139|NCT04285346|64468737|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
23199140|NCT04285346|64468736|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
23199141|NCT04285346|64468737|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23199142|NCT04285346|64468736|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
23199143|NCT04285346|64468737|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
23199144|NCT01931462|64468745|FG000|Overall Study|Withdrawal by Subject|1|||
23199145|NCT03792750|64468748|FG000|Overall Study|Death|3|||
23199146|NCT01987986|64468749|FG000|Overall Study|Lost to Follow-up|1|||
23199147|NCT01987986|64468750|FG001|Overall Study|Lost to Follow-up|0|||
23199148|NCT01987986|64468751|FG002|Overall Study|Lost to Follow-up|0|||
23199149|NCT01987986|64468752|FG003|Overall Study|Lost to Follow-up|0|||
23199150|NCT01987986|64468749|FG000|Overall Study|Adverse Event|1|||
23199151|NCT01987986|64468750|FG001|Overall Study|Adverse Event|0|||
23199152|NCT01987986|64468751|FG002|Overall Study|Adverse Event|2|||
23199153|NCT01987986|64468752|FG003|Overall Study|Adverse Event|0|||
23199154|NCT01728584|64468753|FG000|Overall Study|Adverse Event|1|||
23199155|NCT01728584|64468754|FG001|Overall Study|Adverse Event|0|||
23199156|NCT01728584|64468755|FG002|Overall Study|Adverse Event|0|||
23361143|NCT02861664|65065980|FG001|Overall Study|Withdrawal of Consent|1|||
23361144|NCT02030119|65065981|FG000|Overall Study|Withdrawal by Subject|3|||
23199157|NCT01728584|64468756|FG003|Overall Study|Adverse Event|0|||
23199158|NCT01728584|64468753|FG000|Overall Study|Physician Decision|4|||
23199159|NCT01728584|64468754|FG001|Overall Study|Physician Decision|0|||
23600078|NCT01701401|65925788|FG000|Overall Study|Withdrew Consent|0|||
23600079|NCT01701401|65925789|FG001|Overall Study|Withdrew Consent|3|||
23600080|NCT01701401|65925790|FG002|Overall Study|Withdrew Consent|1|||
23199160|NCT01728584|64468755|FG002|Overall Study|Physician Decision|1|||
23199161|NCT01728584|64468756|FG003|Overall Study|Physician Decision|0|||
23258401|NCT00410410|64686766|FG002|Open-Label Period (OL)|Other|0|||
23600081|NCT01701401|65925791|FG003|Overall Study|Withdrew Consent|2|||
23600082|NCT01701401|65925788|FG000|Overall Study|Lack of Efficacy|1|||
23600083|NCT01701401|65925789|FG001|Overall Study|Lack of Efficacy|0|||
23258402|NCT00410410|64686767|FG003|Open-Label Period (OL)|Other|0|||
23258403|NCT00410410|64686768|FG004|Open-Label Period (OL)|Other|0|||
23258404|NCT00410410|64686769|FG005|Open-Label Period (OL)|Other|0|||
23258405|NCT00410410|64686770|FG006|Open-Label Period (OL)|Other|0|||
23258406|NCT00410410|64686771|FG007|Open-Label Period (OL)|Other|0|||
23258407|NCT00410410|64686772|FG008|Open-Label Period (OL)|Other|7|||
23258408|NCT02557672|64686773|FG000|Overall Study|Withdrawal by Subject|4|||
23258409|NCT02557672|64686774|FG001|Overall Study|Withdrawal by Subject|2|||
23258410|NCT01698320|64686776|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
23258411|NCT01698320|64686777|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
23258412|NCT01698320|64686778|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
23258413|NCT01698320|64686776|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
23258414|NCT01698320|64686777|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
23258415|NCT01698320|64686778|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
23258416|NCT01698320|64686776|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
23258417|NCT01698320|64686777|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
23258418|NCT01698320|64686778|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
23258419|NCT01698320|64686776|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
23258420|NCT01698320|64686777|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
23258421|NCT01698320|64686778|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
23258422|NCT01698320|64686776|FG000|12-Week Double-Blind Period|Adverse Event|0|||
23258423|NCT01698320|64686777|FG001|12-Week Double-Blind Period|Adverse Event|1|||
23258424|NCT01698320|64686778|FG002|12-Week Double-Blind Period|Adverse Event|1|||
23258425|NCT01698320|64686776|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
23258426|NCT01698320|64686777|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
23258427|NCT01698320|64686778|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
23258428|NCT01698320|64686776|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
23258429|NCT01698320|64686777|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
23258430|NCT01698320|64686778|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
23258431|NCT01698320|64686776|FG000|12-Week Double-Blind Period|Pregnancy|0|||
23258432|NCT01698320|64686777|FG001|12-Week Double-Blind Period|Pregnancy|1|||
23258433|NCT01698320|64686778|FG002|12-Week Double-Blind Period|Pregnancy|1|||
23258434|NCT01698320|64686776|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
23258435|NCT01698320|64686777|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
23258436|NCT01698320|64686778|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
23258437|NCT01698320|64686776|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
23258438|NCT01698320|64686777|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
23258439|NCT01698320|64686778|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
23258440|NCT01698320|64686776|FG000|40-Week Open-Label Period|Adverse Event|0|||
23258441|NCT01698320|64686777|FG001|40-Week Open-Label Period|Adverse Event|3|||
23258442|NCT01698320|64686778|FG002|40-Week Open-Label Period|Adverse Event|2|||
23258443|NCT01698320|64686776|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
23480361|NCT01330017|65501957|FG003|Overall Study|Lost to Follow-up|0|||
23199162|NCT01728584|64468753|FG000|Overall Study|Withdrawal by Subject|1|||
23199163|NCT01728584|64468754|FG001|Overall Study|Withdrawal by Subject|0|||
23199164|NCT01728584|64468755|FG002|Overall Study|Withdrawal by Subject|0|||
23199165|NCT01728584|64468756|FG003|Overall Study|Withdrawal by Subject|0|||
23199166|NCT01728584|64468753|FG000|Overall Study|Screen failure|1|||
23199167|NCT01728584|64468754|FG001|Overall Study|Screen failure|0|||
23199168|NCT01728584|64468755|FG002|Overall Study|Screen failure|0|||
23199169|NCT01728584|64468756|FG003|Overall Study|Screen failure|0|||
23199170|NCT01728584|64468753|FG000|Overall Study|Other reason (not specified)|1|||
23199171|NCT01728584|64468754|FG001|Overall Study|Other reason (not specified)|0|||
23199172|NCT01728584|64468755|FG002|Overall Study|Other reason (not specified)|0|||
23199173|NCT01728584|64468756|FG003|Overall Study|Other reason (not specified)|1|||
23199174|NCT03097328|64468757|FG000|Overall Study|Still on Therapy|2|||
23199175|NCT03097328|64468757|FG000|Overall Study|Progressive Disease|29|||
23199176|NCT03097328|64468757|FG000|Overall Study|Adverse Event|4|||
23199177|NCT03097328|64468757|FG000|Overall Study|Withdrawal by Subject|1|||
23199178|NCT03097328|64468757|FG000|Overall Study|Physician Decision|1|||
23199179|NCT03097328|64468757|FG000|Overall Study|Patient Decision|1|||
23199180|NCT03097328|64468757|FG000|Overall Study|Ineligible for Study Drug|1|||
23258444|NCT01698320|64686777|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
23258445|NCT01698320|64686778|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
23258446|NCT01698320|64686776|FG000|40-Week Open-Label Period|Pregnancy|0|||
23258447|NCT01698320|64686777|FG001|40-Week Open-Label Period|Pregnancy|2|||
23258448|NCT01698320|64686778|FG002|40-Week Open-Label Period|Pregnancy|1|||
23258449|NCT01698320|64686776|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
23258450|NCT01698320|64686777|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
23258451|NCT01698320|64686778|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
23258452|NCT01698320|64686776|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
23258453|NCT01698320|64686777|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
23258454|NCT01698320|64686778|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
23258455|NCT02082262|64686779|FG000|Overall Study|Withdrawal by Subject|3|||
23258456|NCT02082262|64686779|FG000|Overall Study|Adverse Event|48|||
23258457|NCT00638157|64686783|FG000|Overall Study|Adverse Event|0|||
23258458|NCT00638157|64686784|FG001|Overall Study|Adverse Event|1|||
23258459|NCT00638157|64686783|FG000|Overall Study|Clinical (symptomatic) failure|1|||
23258460|NCT00638157|64686784|FG001|Overall Study|Clinical (symptomatic) failure|1|||
23258461|NCT00638157|64686783|FG000|Overall Study|Microbiological failure|1|||
23258462|NCT00638157|64686784|FG001|Overall Study|Microbiological failure|0|||
23258463|NCT00638157|64686783|FG000|Overall Study|Lost to Follow-up|1|||
23258464|NCT00638157|64686784|FG001|Overall Study|Lost to Follow-up|0|||
23258465|NCT00638157|64686783|FG000|Overall Study|Physician Decision|1|||
23258466|NCT00638157|64686784|FG001|Overall Study|Physician Decision|0|||
23258467|NCT00638157|64686783|FG000|Overall Study|Other|1|||
23258468|NCT00638157|64686784|FG001|Overall Study|Other|2|||
23258469|NCT00638157|64686783|FG000|Overall Study|Randomized, not treated|2|||
23258470|NCT00638157|64686784|FG001|Overall Study|Randomized, not treated|0|||
23258471|NCT01590433|64686785|FG000|Overall Study|Lost to Follow-up|20|||
23258472|NCT01590433|64686786|FG001|Overall Study|Lost to Follow-up|8|||
23258473|NCT01590433|64686785|FG000|Overall Study|Withdrawal by Subject|21|||
23361145|NCT02030119|65065982|FG001|Overall Study|Withdrawal by Subject|1|||
23361146|NCT02030119|65065983|FG002|Overall Study|Withdrawal by Subject|5|||
23361147|NCT02030119|65065984|FG003|Overall Study|Withdrawal by Subject|3|||
23361148|NCT02030119|65065981|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
23361149|NCT02030119|65065982|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
23361150|NCT02030119|65065983|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
23361151|NCT02030119|65065984|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
23361152|NCT01254656|65065987|FG000|Overall Study|Discontinued due to termination of study|40|||
23361153|NCT01254656|65065988|FG001|Overall Study|Discontinued due to termination of study|39|||
23361154|NCT01254656|65065989|FG002|Overall Study|Discontinued due to termination of study|13|||
23361155|NCT01254656|65065987|FG000|Overall Study|Lack of Efficacy|3|||
23361156|NCT01254656|65065988|FG001|Overall Study|Lack of Efficacy|0|||
23361157|NCT01254656|65065989|FG002|Overall Study|Lack of Efficacy|0|||
23361158|NCT01254656|65065987|FG000|Overall Study|Lost to Follow-up|1|||
23361159|NCT01254656|65065988|FG001|Overall Study|Lost to Follow-up|0|||
23361160|NCT01254656|65065989|FG002|Overall Study|Lost to Follow-up|2|||
23361161|NCT01254656|65065987|FG000|Overall Study|Withdrawal by Subject|2|||
23361162|NCT01254656|65065988|FG001|Overall Study|Withdrawal by Subject|2|||
23361163|NCT01254656|65065989|FG002|Overall Study|Withdrawal by Subject|1|||
23361164|NCT01254656|65065987|FG000|Overall Study|Pregnancy|0|||
23361165|NCT01254656|65065988|FG001|Overall Study|Pregnancy|0|||
23361166|NCT01254656|65065989|FG002|Overall Study|Pregnancy|2|||
23361167|NCT01254656|65065987|FG000|Overall Study|Adverse Event|1|||
23361168|NCT01254656|65065988|FG001|Overall Study|Adverse Event|1|||
23361169|NCT01254656|65065989|FG002|Overall Study|Adverse Event|0|||
23361170|NCT01254656|65065987|FG000|Overall Study|Death|0|||
23361171|NCT01254656|65065988|FG001|Overall Study|Death|1|||
23361172|NCT01254656|65065989|FG002|Overall Study|Death|0|||
23361173|NCT00196105|65065990|FG000|Overall Study|Lost to Follow-up|4|||
23361174|NCT00196105|65065991|FG001|Overall Study|Lost to Follow-up|5|||
23361175|NCT00196105|65065992|FG002|Overall Study|Lost to Follow-up|7|||
23361176|NCT00905567|65065995|FG000|Washout|Withdrawal by Subject|0|||
23361177|NCT00905567|65065996|FG001|Washout|Withdrawal by Subject|1|||
23361178|NCT03300050|65069628|FG000|Overall Study|Lost to Follow-up|2|||
23361179|NCT03300050|65069629|FG001|Overall Study|Lost to Follow-up|1|||
23361180|NCT03300050|65069630|FG002|Overall Study|Lost to Follow-up|0|||
23361181|NCT03300050|65069631|FG003|Overall Study|Lost to Follow-up|0|||
23361182|NCT03300050|65069632|FG004|Overall Study|Lost to Follow-up|1|||
23361183|NCT03300050|65069628|FG000|Overall Study|Withdrawal by Subject|1|||
23361184|NCT03300050|65069629|FG001|Overall Study|Withdrawal by Subject|1|||
23361185|NCT03300050|65069630|FG002|Overall Study|Withdrawal by Subject|1|||
23361186|NCT03300050|65069631|FG003|Overall Study|Withdrawal by Subject|0|||
23361187|NCT03300050|65069632|FG004|Overall Study|Withdrawal by Subject|0|||
23361188|NCT03300050|65069628|FG000|Overall Study|Death|0|||
23361189|NCT03300050|65069629|FG001|Overall Study|Death|0|||
23361190|NCT03300050|65069630|FG002|Overall Study|Death|1|||
23258474|NCT01590433|64686786|FG001|Overall Study|Withdrawal by Subject|11|||
23258475|NCT01590433|64686785|FG000|Overall Study|Adverse Event|11|||
23258476|NCT01590433|64686786|FG001|Overall Study|Adverse Event|3|||
23258477|NCT00863057|64686789|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
23258478|NCT00863057|64686790|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
23258479|NCT00863057|64686791|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
23258480|NCT00863057|64686792|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
23258481|NCT00863057|64686789|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
23258482|NCT00863057|64686790|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
23258483|NCT00863057|64686791|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
23258484|NCT00863057|64686792|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
23258485|NCT00863057|64686789|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
23258486|NCT00863057|64686790|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
23258487|NCT00863057|64686791|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
23258488|NCT00863057|64686792|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
23258489|NCT00863057|64686789|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
23258490|NCT00863057|64686790|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
23258491|NCT00863057|64686791|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
23258492|NCT00863057|64686792|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
23258493|NCT03280537|64686796|FG000|Overall Study|Withdrawal by Subject|2|||
23258494|NCT03280537|64686797|FG001|Overall Study|Withdrawal by Subject|4|||
23258495|NCT03433001|64686798|FG000|Overall Study|Lack of Efficacy|109|||
23258496|NCT03433001|64686798|FG000|Overall Study|Adverse Event|69|||
23258497|NCT03433001|64686798|FG000|Overall Study|Withdrawal by Subject|10|||
23258498|NCT03433001|64686798|FG000|Overall Study|Death|12|||
23258499|NCT03433001|64686798|FG000|Overall Study|Lost to Follow-up|4|||
23258500|NCT03433001|64686798|FG000|Overall Study|Other|25|||
23258501|NCT03008460|64686799|FG000|Overall Study|Protocol deviation|0|||
23258502|NCT03008460|64686800|FG001|Overall Study|Protocol deviation|2|||
23258503|NCT03008460|64686799|FG000|Overall Study|Study drug not dispensed|0|||
23258504|NCT03008460|64686800|FG001|Overall Study|Study drug not dispensed|1|||
23258505|NCT03008460|64686799|FG000|Overall Study|Adverse Event|0|||
23258506|NCT03008460|64686800|FG001|Overall Study|Adverse Event|1|||
23258507|NCT03008460|64686799|FG000|Overall Study|Withdrawal by Subject|5|||
23258508|NCT03008460|64686800|FG001|Overall Study|Withdrawal by Subject|6|||
23258509|NCT03008460|64686799|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
23258510|NCT03008460|64686800|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
23258511|NCT03008460|64686799|FG000|Overall Study|End of study visit outside permitted time window|0|||
23258512|NCT03008460|64686800|FG001|Overall Study|End of study visit outside permitted time window|1|||
23258513|NCT03008460|64686799|FG000|Overall Study|Lost to Follow-up|1|||
23258514|NCT03008460|64686800|FG001|Overall Study|Lost to Follow-up|3|||
23258515|NCT02370784|64686803|FG000|Overall Study|Patient started prohibited medication|0|||
23258516|NCT02370784|64686804|FG001|Overall Study|Patient started prohibited medication|1|||
23258517|NCT01298596|64686812|FG000|Overall Study|Withdrawal by Subject|1|||
23258518|NCT01298596|64686813|FG001|Overall Study|Withdrawal by Subject|1|||
23258519|NCT01298596|64686812|FG000|Overall Study|Death|5|||
23258520|NCT01298596|64686813|FG001|Overall Study|Death|3|||
23258521|NCT01298596|64686812|FG000|Overall Study|Lost to Follow-up|6|||
23258522|NCT01298596|64686813|FG001|Overall Study|Lost to Follow-up|14|||
23258523|NCT01298596|64686812|FG000|Overall Study|Referred for further management|16|||
23258524|NCT01298596|64686813|FG001|Overall Study|Referred for further management|15|||
23258525|NCT01023269|64686814|FG000|Overall Study|early termination of the study|2|||
23258526|NCT01023269|64686815|FG001|Overall Study|early termination of the study|0|||
23258527|NCT01169649|64686816|FG000|Overall Study|Patient Not Treated|3|||
23258528|NCT02791659|64686820|FG000|Overall Study|Protocol Violation|0|||
23258529|NCT02791659|64686821|FG001|Overall Study|Protocol Violation|1|||
23258530|NCT02400905|64686822|FG000|Overall Study|Death|24|||
23258531|NCT02400905|64686822|FG000|Overall Study|Lost to Follow-up|18|||
23258532|NCT02400905|64686822|FG000|Overall Study|Withdrawal by Subject|16|||
23258533|NCT02400905|64686822|FG000|Overall Study|Physician Decision|4|||
23258534|NCT02400905|64686822|FG000|Overall Study|Other|1|||
23258535|NCT01588106|64686823|FG000|Overall Study|Withdrawal by Subject|5|||
23258536|NCT01588106|64686824|FG001|Overall Study|Withdrawal by Subject|4|||
23258537|NCT00787566|64686825|FG000|Overall Study|AE related to chemotherapy|0|||
23258538|NCT00787566|64686826|FG001|Overall Study|AE related to chemotherapy|1|||
23258539|NCT00787566|64686827|FG002|Overall Study|AE related to chemotherapy|0|||
23258540|NCT00686790|64686828|FG000|Overall Study|Adverse Event|2|||
23258541|NCT00686790|64686828|FG000|Overall Study|Withdrawal by Subject|1|||
23258542|NCT00686790|64686828|FG000|Overall Study|Death|1|||
23258543|NCT00686790|64686828|FG000|Overall Study|Lost to Follow-up|12|||
23258544|NCT02415959|64686829|FG000|Overall Study|Adverse Event|0|||
23258545|NCT02415959|64686830|FG001|Overall Study|Adverse Event|1|||
23258546|NCT02415959|64686831|FG002|Overall Study|Adverse Event|0|||
23258547|NCT02415959|64686832|FG003|Overall Study|Adverse Event|0|||
23258548|NCT02415959|64686833|FG004|Overall Study|Adverse Event|0|||
23258549|NCT02415959|64686829|FG000|Overall Study|Protocol Violation|0|||
23258550|NCT02415959|64686830|FG001|Overall Study|Protocol Violation|0|||
23258551|NCT02415959|64686831|FG002|Overall Study|Protocol Violation|0|||
23258552|NCT02415959|64686832|FG003|Overall Study|Protocol Violation|1|||
23258553|NCT02415959|64686833|FG004|Overall Study|Protocol Violation|0|||
23258554|NCT00297479|64686834|FG000|Overall Study|Lost to Follow-up|37|||
23258555|NCT00297479|64686835|FG001|Overall Study|Lost to Follow-up|54|||
23258556|NCT00297479|64686836|FG002|Overall Study|Lost to Follow-up|51|||
23258557|NCT02598193|64686837|FG000|Overall Study|Adverse Event|13|||
23258558|NCT02598193|64686837|FG000|Overall Study|Withdrawal by Subject|1|||
23258559|NCT02598193|64686837|FG000|Overall Study|Listed in active lung transplant list|1|||
23258560|NCT02598193|64686837|FG000|Overall Study|Does not want to take Nintedanib|1|||
23258561|NCT00219557|64686838|FG000|Phase 1|Lack of Efficacy|3|||
23258562|NCT00219557|64686839|FG001|Phase 1|Lack of Efficacy|0|||
23258563|NCT00219557|64686840|FG002|Phase 1|Lack of Efficacy|0|||
23258564|NCT00219557|64686838|FG000|Phase 1|Adverse Event|2|||
23258565|NCT00219557|64686839|FG001|Phase 1|Adverse Event|0|||
23258566|NCT00219557|64686840|FG002|Phase 1|Adverse Event|0|||
23258567|NCT00219557|64686838|FG000|Phase 1|Withdrawal by Subject|1|||
23258568|NCT00219557|64686839|FG001|Phase 1|Withdrawal by Subject|0|||
23258569|NCT00219557|64686840|FG002|Phase 1|Withdrawal by Subject|0|||
23258570|NCT00219557|64686838|FG000|Phase 1|Started chemotherapy at other institute|1|||
23258571|NCT00219557|64686839|FG001|Phase 1|Started chemotherapy at other institute|0|||
23258572|NCT00219557|64686840|FG002|Phase 1|Started chemotherapy at other institute|0|||
23258573|NCT00219557|64686838|FG000|Phase 2|Lack of Efficacy|0|||
23258574|NCT00219557|64686839|FG001|Phase 2|Lack of Efficacy|21|||
23258575|NCT00219557|64686840|FG002|Phase 2|Lack of Efficacy|15|||
23258576|NCT00219557|64686838|FG000|Phase 2|Adverse Event|0|||
23258577|NCT00219557|64686839|FG001|Phase 2|Adverse Event|22|||
23258578|NCT00219557|64686840|FG002|Phase 2|Adverse Event|2|||
23258579|NCT00219557|64686838|FG000|Phase 2|Death|0|||
23258580|NCT00219557|64686839|FG001|Phase 2|Death|8|||
23258581|NCT00219557|64686840|FG002|Phase 2|Death|2|||
23258582|NCT00219557|64686838|FG000|Phase 2|Other|0|||
23258583|NCT00219557|64686839|FG001|Phase 2|Other|8|||
23258584|NCT00219557|64686840|FG002|Phase 2|Other|6|||
23258585|NCT00219557|64686838|FG000|Phase 2|Withdrawal by Subject|0|||
23258586|NCT00219557|64686839|FG001|Phase 2|Withdrawal by Subject|9|||
23258587|NCT00219557|64686840|FG002|Phase 2|Withdrawal by Subject|5|||
23258588|NCT00219557|64686838|FG000|Phase 2|Treatment not received|0|||
23258589|NCT00219557|64686839|FG001|Phase 2|Treatment not received|1|||
23258590|NCT00219557|64686840|FG002|Phase 2|Treatment not received|3|||
23258591|NCT00395083|64686841|FG000|Overall Study|Withdrawal by Subject|6|||
23258592|NCT00395083|64686842|FG001|Overall Study|Withdrawal by Subject|5|||
23258593|NCT00395083|64686841|FG000|Overall Study|Developed another disease|4|||
23258594|NCT00395083|64686842|FG001|Overall Study|Developed another disease|3|||
23258595|NCT00693784|64686843|FG000|Overall Study|Lost to Follow-up|2|||
23258596|NCT00693784|64686843|FG000|Overall Study|Withdrawal by Subject|2|||
23258597|NCT02732561|64689772|FG000|Overall Study|Lost to Follow-up|1|||
23258598|NCT02732561|64689773|FG001|Overall Study|Lost to Follow-up|1|||
23258599|NCT02732561|64689772|FG000|Overall Study|Withdrawal by Subject|1|||
23258600|NCT02732561|64689773|FG001|Overall Study|Withdrawal by Subject|0|||
23258601|NCT01337050|64689774|FG000|Overall Study|Death|0|||
23258602|NCT01337050|64689775|FG001|Overall Study|Death|0|||
23258603|NCT01337050|64689776|FG002|Overall Study|Death|4|||
23258604|NCT01337050|64689774|FG000|Overall Study|Other|4|||
23258605|NCT01337050|64689775|FG001|Overall Study|Other|6|||
23258606|NCT01337050|64689776|FG002|Overall Study|Other|8|||
23258607|NCT01337050|64689774|FG000|Overall Study|Participants refused further follow-up|0|||
23258608|NCT01337050|64689775|FG001|Overall Study|Participants refused further follow-up|7|||
23258609|NCT01337050|64689776|FG002|Overall Study|Participants refused further follow-up|7|||
23258610|NCT02139306|64689777|FG000|Overall Study|Withdrawal by Subject|4|||
23258611|NCT02139306|64689778|FG001|Overall Study|Withdrawal by Subject|6|||
23258612|NCT02139306|64689777|FG000|Overall Study|Adverse Event|3|||
23258613|NCT02139306|64689778|FG001|Overall Study|Adverse Event|4|||
23258614|NCT02139306|64689777|FG000|Overall Study|Physician Decision|0|||
23258615|NCT02139306|64689778|FG001|Overall Study|Physician Decision|1|||
23258616|NCT02139306|64689777|FG000|Overall Study|Other Unspecified|2|||
23258617|NCT02139306|64689778|FG001|Overall Study|Other Unspecified|3|||
23258618|NCT02139306|64689777|FG000|Overall Study|Protocol Violation|4|||
23600084|NCT01701401|65925790|FG002|Overall Study|Lack of Efficacy|2|||
23600085|NCT01701401|65925791|FG003|Overall Study|Lack of Efficacy|0|||
23258619|NCT02139306|64689778|FG001|Overall Study|Protocol Violation|0|||
23258620|NCT03770000|64689784|FG000|Overall Study|Premature discontinuation due to PD|0|||
23258621|NCT03770000|64689785|FG001|Overall Study|Premature discontinuation due to PD|0|||
23258622|NCT03770000|64689786|FG002|Overall Study|Premature discontinuation due to PD|1|||
23258623|NCT03770000|64689787|FG003|Overall Study|Premature discontinuation due to PD|3|||
23258624|NCT03770000|64689788|FG004|Overall Study|Premature discontinuation due to PD|2|||
23258625|NCT02480010|64689789|FG000|Overall Study|Adverse Event|3|||
23258626|NCT02480010|64689790|FG001|Overall Study|Adverse Event|1|||
23258627|NCT02480010|64689789|FG000|Overall Study|Death|1|||
23258628|NCT02480010|64689790|FG001|Overall Study|Death|0|||
23258629|NCT02480010|64689789|FG000|Overall Study|Insufficient therapeutic response|31|||
23258630|NCT02480010|64689790|FG001|Overall Study|Insufficient therapeutic response|29|||
23258631|NCT02480010|64689789|FG000|Overall Study|Refused Treatment|0|||
23258632|NCT02480010|64689790|FG001|Overall Study|Refused Treatment|3|||
23258633|NCT01798485|64689791|FG000|Overall Study|Adverse Event|32|||
23258634|NCT01798485|64689792|FG001|Overall Study|Adverse Event|40|||
23199181|NCT00540449|64468758|FG000|Overall Study|Adverse Event|12|||
23199182|NCT00540449|64468759|FG001|Overall Study|Adverse Event|32|||
23199183|NCT00540449|64468758|FG000|Overall Study|Sponsor's Decision|1|||
23258635|NCT01798485|64689791|FG000|Overall Study|Withdrawal by Subject|27|||
23258636|NCT01798485|64689792|FG001|Overall Study|Withdrawal by Subject|31|||
23258637|NCT01798485|64689791|FG000|Overall Study|Lost to Follow-up|0|||
23258638|NCT01798485|64689792|FG001|Overall Study|Lost to Follow-up|3|||
23258639|NCT01798485|64689791|FG000|Overall Study|Physician Decision|14|||
23258640|NCT01798485|64689792|FG001|Overall Study|Physician Decision|10|||
23258641|NCT01798485|64689791|FG000|Overall Study|Objective Disease Progression|152|||
23258642|NCT01798485|64689792|FG001|Overall Study|Objective Disease Progression|106|||
23258643|NCT01798485|64689791|FG000|Overall Study|Death|25|||
23600086|NCT01701401|65925788|FG000|Overall Study|Adverse Event|1|||
23600087|NCT01701401|65925789|FG001|Overall Study|Adverse Event|0|||
23600088|NCT01701401|65925790|FG002|Overall Study|Adverse Event|0|||
23600089|NCT01701401|65925791|FG003|Overall Study|Adverse Event|0|||
23199184|NCT00540449|64468759|FG001|Overall Study|Sponsor's Decision|1|||
23199185|NCT00540449|64468758|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
23199186|NCT00540449|64468759|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
23199187|NCT00540449|64468758|FG000|Overall Study|Lost to Follow-up|19|||
23199188|NCT00540449|64468759|FG001|Overall Study|Lost to Follow-up|17|||
23199189|NCT00540449|64468758|FG000|Overall Study|Subject Non-Compliant|7|||
23199190|NCT00540449|64468759|FG001|Overall Study|Subject Non-Compliant|5|||
23199191|NCT00540449|64468758|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
23199192|NCT00540449|64468759|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
23199193|NCT00540449|64468758|FG000|Overall Study|Withdrawal by Subject|10|||
23199194|NCT00540449|64468759|FG001|Overall Study|Withdrawal by Subject|10|||
23199195|NCT00540449|64468758|FG000|Overall Study|Other|1|||
23199196|NCT00540449|64468759|FG001|Overall Study|Other|4|||
23199197|NCT01703286|64468764|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
23199198|NCT01703286|64468765|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
23199199|NCT01703286|64468766|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
23199200|NCT01703286|64468767|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
23199201|NCT01703286|64468768|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
23199202|NCT01703286|64468769|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
23199203|NCT01703286|64468764|FG000|Period 2 Including Washout|Adverse Event|0|||
23199204|NCT01703286|64468765|FG001|Period 2 Including Washout|Adverse Event|0|||
23199205|NCT01703286|64468766|FG002|Period 2 Including Washout|Adverse Event|0|||
23199206|NCT01703286|64468767|FG003|Period 2 Including Washout|Adverse Event|1|||
23199207|NCT01703286|64468768|FG004|Period 2 Including Washout|Adverse Event|0|||
23199208|NCT01703286|64468769|FG005|Period 2 Including Washout|Adverse Event|0|||
23199209|NCT02064439|64468770|FG000|Overall Study|Adverse Event|51|||
23199210|NCT02064439|64468771|FG001|Overall Study|Adverse Event|47|||
23199211|NCT02064439|64468772|FG002|Overall Study|Adverse Event|46|||
23199212|NCT02064439|64468770|FG000|Overall Study|Death|0|||
23199213|NCT02064439|64468771|FG001|Overall Study|Death|2|||
23199214|NCT02064439|64468772|FG002|Overall Study|Death|3|||
23199215|NCT02064439|64468770|FG000|Overall Study|Withdrawal by Subject|29|||
23199216|NCT02064439|64468771|FG001|Overall Study|Withdrawal by Subject|18|||
23199217|NCT02064439|64468772|FG002|Overall Study|Withdrawal by Subject|26|||
23199218|NCT02064439|64468770|FG000|Overall Study|Protocol Violation|3|||
23199219|NCT02064439|64468771|FG001|Overall Study|Protocol Violation|5|||
23199220|NCT02064439|64468772|FG002|Overall Study|Protocol Violation|3|||
23199221|NCT02064439|64468770|FG000|Overall Study|Lost to Follow-up|1|||
23199222|NCT02064439|64468771|FG001|Overall Study|Lost to Follow-up|3|||
23199223|NCT02064439|64468772|FG002|Overall Study|Lost to Follow-up|4|||
23199224|NCT02064439|64468770|FG000|Overall Study|Non-compliance with study medication|21|||
23199225|NCT02064439|64468771|FG001|Overall Study|Non-compliance with study medication|19|||
23199226|NCT02064439|64468772|FG002|Overall Study|Non-compliance with study medication|23|||
23258644|NCT01798485|64689792|FG001|Overall Study|Death|22|||
23258645|NCT01798485|64689791|FG000|Overall Study|Sponsor Decision|61|||
23258646|NCT01798485|64689792|FG001|Overall Study|Sponsor Decision|54|||
23258647|NCT01798485|64689791|FG000|Overall Study|Clinical Progression|35|||
23600090|NCT01701401|65925788|FG000|Overall Study|Protocol Violation|0|||
23199227|NCT02064439|64468770|FG000|Overall Study|Physician Decision|0|||
23199228|NCT02064439|64468771|FG001|Overall Study|Physician Decision|1|||
23199229|NCT02064439|64468772|FG002|Overall Study|Physician Decision|1|||
23199230|NCT02064439|64468770|FG000|Overall Study|Logistical difficulties|6|||
23199231|NCT02064439|64468771|FG001|Overall Study|Logistical difficulties|5|||
23199232|NCT02064439|64468772|FG002|Overall Study|Logistical difficulties|2|||
23258648|NCT01798485|64689792|FG001|Overall Study|Clinical Progression|24|||
23258649|NCT00310856|64689800|FG000|Overall Study|Withdrawal by Subject|2|||
23258650|NCT00310856|64689801|FG001|Overall Study|Withdrawal by Subject|2|||
23258651|NCT00310856|64689802|FG002|Overall Study|Withdrawal by Subject|2|||
23258652|NCT00310856|64689800|FG000|Overall Study|Lost to Follow-up|1|||
23258653|NCT00310856|64689801|FG001|Overall Study|Lost to Follow-up|2|||
23258654|NCT00310856|64689802|FG002|Overall Study|Lost to Follow-up|6|||
23258655|NCT00310856|64689800|FG000|Overall Study|Inappropriate enrollment|1|||
23258656|NCT00310856|64689801|FG001|Overall Study|Inappropriate enrollment|1|||
23258657|NCT00310856|64689802|FG002|Overall Study|Inappropriate enrollment|0|||
23258658|NCT00310856|64689800|FG000|Overall Study|Unable to classify|1|||
23258659|NCT00310856|64689801|FG001|Overall Study|Unable to classify|0|||
23258660|NCT00310856|64689802|FG002|Overall Study|Unable to classify|0|||
23258661|NCT01034137|64689804|FG000|Overall Study|Adverse Event|9|||
23258662|NCT01034137|64689805|FG001|Overall Study|Adverse Event|10|||
23258663|NCT01034137|64689806|FG002|Overall Study|Adverse Event|8|||
23258664|NCT01034137|64689804|FG000|Overall Study|Withdrawal by Subject|4|||
23258665|NCT01034137|64689805|FG001|Overall Study|Withdrawal by Subject|3|||
23258666|NCT01034137|64689806|FG002|Overall Study|Withdrawal by Subject|3|||
23258667|NCT01034137|64689804|FG000|Overall Study|Lack of Efficacy|9|||
23258668|NCT01034137|64689805|FG001|Overall Study|Lack of Efficacy|4|||
23258669|NCT01034137|64689806|FG002|Overall Study|Lack of Efficacy|13|||
23258670|NCT01034137|64689804|FG000|Overall Study|Protocol Violation|2|||
23258671|NCT01034137|64689805|FG001|Overall Study|Protocol Violation|2|||
23258672|NCT01034137|64689806|FG002|Overall Study|Protocol Violation|1|||
23258673|NCT01034137|64689804|FG000|Overall Study|Refused treatment or did not cooperate|2|||
23258674|NCT01034137|64689805|FG001|Overall Study|Refused treatment or did not cooperate|0|||
23258675|NCT01034137|64689806|FG002|Overall Study|Refused treatment or did not cooperate|1|||
23258676|NCT01034137|64689804|FG000|Overall Study|Administrative or other|2|||
23258677|NCT01034137|64689805|FG001|Overall Study|Administrative or other|3|||
23258678|NCT01034137|64689806|FG002|Overall Study|Administrative or other|4|||
23258679|NCT02780700|64689807|FG000|Overall Study|Progressive disease|1|||
23258680|NCT03016078|64689810|FG000|Overall Study|Protocol Violation|1|||
23258681|NCT03016078|64689810|FG000|Overall Study|Protocol Violation|1|||
23258682|NCT00775983|64689829|FG000|Overall Study|Protocol Violation|1|||
23258683|NCT00775983|64689830|FG001|Overall Study|Protocol Violation|2|||
23361191|NCT03300050|65069631|FG003|Overall Study|Death|0|||
23361192|NCT03300050|65069632|FG004|Overall Study|Death|0|||
23361193|NCT03300050|65069628|FG000|Overall Study|Not Eligible at Randomization|0|||
23361194|NCT03300050|65069629|FG001|Overall Study|Not Eligible at Randomization|0|||
23361195|NCT03300050|65069630|FG002|Overall Study|Not Eligible at Randomization|1|||
23258684|NCT00836927|64689831|FG000|Overall Study|Progressive disease|2|||
23361196|NCT03300050|65069631|FG003|Overall Study|Not Eligible at Randomization|1|||
23361197|NCT03300050|65069632|FG004|Overall Study|Not Eligible at Randomization|0|||
23361198|NCT00130689|65069633|FG000|Overall Study|Progressive Disease|29|||
23361199|NCT00130689|65069633|FG000|Overall Study|Death|1|||
23361200|NCT00130689|65069633|FG000|Overall Study|Clinical Deterioration|4|||
23361201|NCT00130689|65069633|FG000|Overall Study|Withdrawal by Subject|3|||
23361202|NCT00130689|65069633|FG000|Overall Study|Ineligible|6|||
23361203|NCT02258659|65069637|FG000|Overall Study|Withdrawal by Subject|1|||
23600091|NCT01701401|65925789|FG001|Overall Study|Protocol Violation|0|||
23600092|NCT01701401|65925790|FG002|Overall Study|Protocol Violation|1|||
23361206|NCT01188668|65069640|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
23361207|NCT01188668|65069640|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
23361208|NCT01188668|65069640|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
23361209|NCT00673257|65069641|FG000|Overall Study|Withdrawal by Subject|4|||
23361210|NCT00673257|65069641|FG000|Overall Study|Unable to obtain specimen|1|||
23361211|NCT01098162|65069642|FG000|Overall Study|Adverse Event|37|||
23258685|NCT00836927|64689832|FG001|Overall Study|Progressive disease|0|||
23258686|NCT00836927|64689833|FG002|Overall Study|Progressive disease|0|||
23258687|NCT00836927|64689834|FG003|Overall Study|Progressive disease|1|||
23361212|NCT01098162|65069642|FG000|Overall Study|Lack of Efficacy|4|||
23361213|NCT01098162|65069642|FG000|Overall Study|Wish of Patient|7|||
23361214|NCT01098162|65069642|FG000|Overall Study|Lost to Follow-up|9|||
23361215|NCT01098162|65069642|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
23361216|NCT01098162|65069642|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
23361217|NCT01098162|65069642|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
23258688|NCT00836927|64689835|FG004|Overall Study|Progressive disease|1|||
23258689|NCT00836927|64689831|FG000|Overall Study|Withdrawal by Subject|1|||
23258690|NCT00836927|64689832|FG001|Overall Study|Withdrawal by Subject|0|||
23258691|NCT00836927|64689833|FG002|Overall Study|Withdrawal by Subject|0|||
23258692|NCT00836927|64689834|FG003|Overall Study|Withdrawal by Subject|0|||
23258693|NCT00836927|64689835|FG004|Overall Study|Withdrawal by Subject|0|||
23199233|NCT02064439|64468770|FG000|Overall Study|Efficacy outcome reached|18|||
23199234|NCT02064439|64468771|FG001|Overall Study|Efficacy outcome reached|16|||
23199235|NCT02064439|64468772|FG002|Overall Study|Efficacy outcome reached|57|||
23199236|NCT02064439|64468770|FG000|Overall Study|Safety outcome reached|12|||
23199237|NCT02064439|64468771|FG001|Overall Study|Safety outcome reached|20|||
23199238|NCT02064439|64468772|FG002|Overall Study|Safety outcome reached|10|||
23199239|NCT02064439|64468770|FG000|Overall Study|Other|2|||
23199240|NCT02064439|64468771|FG001|Overall Study|Other|2|||
23199241|NCT02064439|64468772|FG002|Overall Study|Other|7|||
23199242|NCT02137772|64468773|FG000|Overall Study|Adverse Event|6|||
23199243|NCT02137772|64468774|FG001|Overall Study|Adverse Event|3|||
23199244|NCT02137772|64468773|FG000|Overall Study|Death|71|||
23199245|NCT02137772|64468774|FG001|Overall Study|Death|44|||
23199246|NCT02137772|64468773|FG000|Overall Study|Lost to Follow-up|8|||
23199247|NCT02137772|64468774|FG001|Overall Study|Lost to Follow-up|4|||
23199248|NCT02137772|64468773|FG000|Overall Study|Physician Decision|15|||
23199249|NCT02137772|64468774|FG001|Overall Study|Physician Decision|5|||
23199250|NCT02137772|64468773|FG000|Overall Study|Withdrawal by Subject|28|||
23199251|NCT02137772|64468774|FG001|Overall Study|Withdrawal by Subject|17|||
23199252|NCT02137772|64468773|FG000|Overall Study|Non-compliance with study drug|1|||
23199253|NCT02137772|64468774|FG001|Overall Study|Non-compliance with study drug|0|||
23199254|NCT02137772|64468773|FG000|Overall Study|Not treated|3|||
23199255|NCT02137772|64468774|FG001|Overall Study|Not treated|2|||
23199256|NCT01355068|64468775|FG000|First Intervention Period|Adverse Event|0|||
23199257|NCT01355068|64468776|FG001|First Intervention Period|Adverse Event|1|||
23199258|NCT01355068|64468775|FG000|First Intervention Period|Withdrawal by Subject|0|||
23199259|NCT01355068|64468776|FG001|First Intervention Period|Withdrawal by Subject|1|||
23199260|NCT01253421|64468777|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
23199261|NCT01253421|64468778|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
23199262|NCT01253421|64468779|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
23199263|NCT01253421|64468780|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
23199264|NCT01253421|64468781|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
23199265|NCT01253421|64468777|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
23199266|NCT01253421|64468778|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
23199267|NCT01253421|64468779|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
23199268|NCT01253421|64468780|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
23199269|NCT01253421|64468781|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
23199270|NCT01253421|64468777|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
23199271|NCT01253421|64468778|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
23199272|NCT01253421|64468779|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
23199273|NCT01253421|64468780|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
23199274|NCT01253421|64468781|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
23199275|NCT01253421|64468777|FG000|Assessment and Scheduling|Physician Decision|1|||
23258694|NCT04317781|64689840|FG000|Overall Study|Adverse Event|1|||
23361218|NCT01098162|65069642|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
23199276|NCT01253421|64468778|FG001|Assessment and Scheduling|Physician Decision|0|||
23199277|NCT01253421|64468779|FG002|Assessment and Scheduling|Physician Decision|0|||
23258695|NCT04317781|64689840|FG000|Overall Study|Disease relapse|1|||
23258696|NCT04317781|64689840|FG000|Overall Study|Withdrawal by Subject|1|||
23258697|NCT00472446|64689843|FG000|Overall Study|Protocol Violation|0|||
23258698|NCT00472446|64689844|FG001|Overall Study|Protocol Violation|0|||
23258699|NCT00472446|64689845|FG002|Overall Study|Protocol Violation|0|||
23258700|NCT00472446|64689846|FG003|Overall Study|Protocol Violation|1|||
23258701|NCT00472446|64689843|FG000|Overall Study|Reintervention|0|||
23258702|NCT00472446|64689844|FG001|Overall Study|Reintervention|0|||
23258703|NCT00472446|64689845|FG002|Overall Study|Reintervention|1|||
23480362|NCT01330017|65501958|FG004|Overall Study|Lost to Follow-up|0|||
23480363|NCT01330017|65501954|FG000|Overall Study|Protocol Violation|0|||
23258704|NCT00472446|64689846|FG003|Overall Study|Reintervention|1|||
23258705|NCT00472446|64689843|FG000|Overall Study|Questionnaires not returned|5|||
23258706|NCT00472446|64689844|FG001|Overall Study|Questionnaires not returned|6|||
23258707|NCT00472446|64689845|FG002|Overall Study|Questionnaires not returned|6|||
23258708|NCT00472446|64689846|FG003|Overall Study|Questionnaires not returned|4|||
23258709|NCT01162499|64689849|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
23258710|NCT01162499|64689850|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
23258711|NCT01312779|64689851|FG000|Overall Study|Withdrawal by Subject|2|||
23258712|NCT01312779|64689851|FG000|Overall Study|Death|3|||
23258713|NCT01312779|64689851|FG000|Overall Study|Not Implanted with Device|27|||
23258714|NCT02789111|64689852|FG000|Overall Study|Withdrawal by Subject|1|||
23258715|NCT02789111|64689853|FG001|Overall Study|Withdrawal by Subject|4|||
23258716|NCT01154153|64689855|FG000|Overall Study|Poor compliance to protocol|2|||
23258717|NCT01154153|64689856|FG001|Overall Study|Poor compliance to protocol|0|||
23258718|NCT01154153|64689855|FG000|Overall Study|Unable to use labs|2|||
23258719|NCT01154153|64689856|FG001|Overall Study|Unable to use labs|3|||
23258720|NCT01154153|64689855|FG000|Overall Study|Withdrew consent|1|||
23258721|NCT01154153|64689856|FG001|Overall Study|Withdrew consent|0|||
23258722|NCT01381900|64689859|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
23258723|NCT01381900|64689860|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
23258724|NCT01381900|64689861|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
23258725|NCT01381900|64689859|FG000|Overall Study|Adverse Event|4|||
23361219|NCT01098162|65069642|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
23480364|NCT01330017|65501955|FG001|Overall Study|Protocol Violation|0|||
23199278|NCT01253421|64468780|FG003|Assessment and Scheduling|Physician Decision|0|||
23199279|NCT01253421|64468781|FG004|Assessment and Scheduling|Physician Decision|0|||
23199280|NCT01253421|64468777|FG000|Drug+Scanning Visit|Physician Decision|0|||
23199281|NCT01253421|64468778|FG001|Drug+Scanning Visit|Physician Decision|0|||
23199282|NCT01253421|64468779|FG002|Drug+Scanning Visit|Physician Decision|0|||
23199283|NCT01253421|64468780|FG003|Drug+Scanning Visit|Physician Decision|0|||
23199284|NCT01253421|64468781|FG004|Drug+Scanning Visit|Physician Decision|1|||
23199285|NCT00365976|64468782|FG000|Overall Study|Withdrawal by Subject|1|||
23199286|NCT00365976|64468783|FG001|Overall Study|Withdrawal by Subject|5|||
23199287|NCT01035606|64468784|FG000|Overall Study|change in health, job demands,family|3|||
23199288|NCT01035606|64468785|FG001|Overall Study|change in health, job demands,family|3|||
23199289|NCT01035606|64468786|FG002|Overall Study|change in health, job demands,family|4|||
23199290|NCT00051558|64468788|FG000|Overall Study|Adverse Event|30|||
23199291|NCT00051558|64468789|FG001|Overall Study|Adverse Event|18|||
23199292|NCT00051558|64468788|FG000|Overall Study|Withdrawal by Subject|29|||
23199293|NCT00051558|64468789|FG001|Overall Study|Withdrawal by Subject|42|||
23199294|NCT00051558|64468788|FG000|Overall Study|Death|9|||
23199295|NCT00051558|64468789|FG001|Overall Study|Death|15|||
23199296|NCT00051558|64468788|FG000|Overall Study|Lost to Follow-up|4|||
23199297|NCT00051558|64468789|FG001|Overall Study|Lost to Follow-up|13|||
23199298|NCT00051558|64468788|FG000|Overall Study|Protocol Violation|3|||
23199299|NCT00051558|64468789|FG001|Overall Study|Protocol Violation|4|||
23199300|NCT00051558|64468788|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
23199301|NCT00051558|64468789|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
23199302|NCT00051558|64468788|FG000|Overall Study|Sponsor Decision|6|||
23199303|NCT00051558|64468789|FG001|Overall Study|Sponsor Decision|1|||
23199304|NCT00051558|64468788|FG000|Overall Study|Other|2|||
23199305|NCT00051558|64468789|FG001|Overall Study|Other|1|||
23199306|NCT00051558|64468788|FG000|Overall Study|Significant Lab Value|2|||
23199307|NCT00051558|64468789|FG001|Overall Study|Significant Lab Value|0|||
23199308|NCT00051558|64468788|FG000|Overall Study|Physician Decision|5|||
23199309|NCT00051558|64468789|FG001|Overall Study|Physician Decision|0|||
23199310|NCT02508701|64468790|FG000|Overall Study|Lost to Follow-up|9|||
23199311|NCT02508701|64468791|FG001|Overall Study|Lost to Follow-up|5|||
23258726|NCT01381900|64689860|FG001|Overall Study|Adverse Event|6|||
23258727|NCT01381900|64689861|FG002|Overall Study|Adverse Event|7|||
23258728|NCT01381900|64689859|FG000|Overall Study|Noncompliance with study drug|0|||
23258729|NCT01381900|64689860|FG001|Overall Study|Noncompliance with study drug|0|||
23199312|NCT02508701|64468792|FG002|Overall Study|Lost to Follow-up|5|||
23199313|NCT02508701|64468793|FG003|Overall Study|Lost to Follow-up|3|||
23199314|NCT00913978|64468794|FG000|Overall Study|Surgeon choice|1|||
23199315|NCT00913978|64468795|FG001|Overall Study|Surgeon choice|3|||
23199316|NCT05896761|64468796|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
23199317|NCT05896761|64468797|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
23199318|NCT05896761|64468796|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
23199319|NCT05896761|64468797|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
23199320|NCT00101192|64468798|FG000|Overall Study|Ineligible|6|||
23199321|NCT00101192|64468798|FG000|Overall Study|Inevaluable|1|||
23199322|NCT02584634|64468799|FG000|Overall Study|Adverse Event|3|||
23199323|NCT02584634|64468800|FG001|Overall Study|Adverse Event|5|||
23199324|NCT02584634|64468799|FG000|Overall Study|Death|0|||
23199325|NCT02584634|64468800|FG001|Overall Study|Death|1|||
23199326|NCT02584634|64468799|FG000|Overall Study|Lost to Follow-up|0|||
23199327|NCT02584634|64468800|FG001|Overall Study|Lost to Follow-up|1|||
23199328|NCT02584634|64468799|FG000|Overall Study|Physician Decision|1|||
23199329|NCT02584634|64468800|FG001|Overall Study|Physician Decision|2|||
23199330|NCT02584634|64468799|FG000|Overall Study|Progressive disease|7|||
23199331|NCT02584634|64468800|FG001|Overall Study|Progressive disease|15|||
23199332|NCT02584634|64468799|FG000|Overall Study|Withdrawal by Subject|1|||
23199333|NCT02584634|64468800|FG001|Overall Study|Withdrawal by Subject|1|||
23199334|NCT02584634|64468799|FG000|Overall Study|Other|0|||
23199335|NCT02584634|64468800|FG001|Overall Study|Other|6|||
23199336|NCT00833248|64468802|FG000|Overall Study|Adverse Event|3|||
23199337|NCT00833248|64468803|FG001|Overall Study|Adverse Event|0|||
23199338|NCT00833248|64468802|FG000|Overall Study|Protocol Violation|1|||
23199339|NCT00833248|64468803|FG001|Overall Study|Protocol Violation|2|||
23199340|NCT00833248|64468802|FG000|Overall Study|Withdrawal by Subject|0|||
23199341|NCT00833248|64468803|FG001|Overall Study|Withdrawal by Subject|1|||
23199342|NCT01005732|64468805|FG000|Overall Study|Lost to Follow-up|10|||
23199343|NCT01005732|64468805|FG000|Overall Study|Death|1|||
23199344|NCT00430521|64468806|FG000|Overall Study|Adverse Event|0|||
23199345|NCT00430521|64468807|FG001|Overall Study|Adverse Event|0|||
23199346|NCT00430521|64468808|FG002|Overall Study|Adverse Event|0|||
23199347|NCT00430521|64468809|FG003|Overall Study|Adverse Event|0|||
23199348|NCT00430521|64468810|FG004|Overall Study|Adverse Event|0|||
23199349|NCT00430521|64468811|FG005|Overall Study|Adverse Event|2|||
23199350|NCT00430521|64468812|FG006|Overall Study|Adverse Event|1|||
23199351|NCT00430521|64468813|FG007|Overall Study|Adverse Event|0|||
23199352|NCT00430521|64468806|FG000|Overall Study|Lost to Follow-up|7|||
23199353|NCT00430521|64468807|FG001|Overall Study|Lost to Follow-up|8|||
23199354|NCT00430521|64468808|FG002|Overall Study|Lost to Follow-up|3|||
23199355|NCT00430521|64468809|FG003|Overall Study|Lost to Follow-up|5|||
23199356|NCT00430521|64468810|FG004|Overall Study|Lost to Follow-up|5|||
23199357|NCT00430521|64468811|FG005|Overall Study|Lost to Follow-up|2|||
23199358|NCT00430521|64468812|FG006|Overall Study|Lost to Follow-up|8|||
23199359|NCT00430521|64468813|FG007|Overall Study|Lost to Follow-up|10|||
23199360|NCT00430521|64468806|FG000|Overall Study|Pregnancy|0|||
23199361|NCT00430521|64468807|FG001|Overall Study|Pregnancy|0|||
23199362|NCT00430521|64468808|FG002|Overall Study|Pregnancy|0|||
23199363|NCT00430521|64468809|FG003|Overall Study|Pregnancy|0|||
23199364|NCT00430521|64468810|FG004|Overall Study|Pregnancy|0|||
23199365|NCT00430521|64468811|FG005|Overall Study|Pregnancy|0|||
23199366|NCT00430521|64468812|FG006|Overall Study|Pregnancy|1|||
23199367|NCT00430521|64468813|FG007|Overall Study|Pregnancy|0|||
23199368|NCT00430521|64468806|FG000|Overall Study|Vaccine Expired|0|||
23199369|NCT00430521|64468807|FG001|Overall Study|Vaccine Expired|0|||
23199370|NCT00430521|64468808|FG002|Overall Study|Vaccine Expired|0|||
23199371|NCT00430521|64468809|FG003|Overall Study|Vaccine Expired|0|||
23199372|NCT00430521|64468810|FG004|Overall Study|Vaccine Expired|0|||
23199373|NCT00430521|64468811|FG005|Overall Study|Vaccine Expired|1|||
23199374|NCT00430521|64468812|FG006|Overall Study|Vaccine Expired|0|||
23199375|NCT00430521|64468813|FG007|Overall Study|Vaccine Expired|0|||
23199376|NCT00430521|64468806|FG000|Overall Study|Protocol Violation|1|||
23199377|NCT00430521|64468807|FG001|Overall Study|Protocol Violation|0|||
23199378|NCT00430521|64468808|FG002|Overall Study|Protocol Violation|0|||
23199379|NCT00430521|64468809|FG003|Overall Study|Protocol Violation|0|||
23199380|NCT00430521|64468810|FG004|Overall Study|Protocol Violation|0|||
23199381|NCT00430521|64468811|FG005|Overall Study|Protocol Violation|0|||
23199382|NCT00430521|64468812|FG006|Overall Study|Protocol Violation|0|||
23199383|NCT00430521|64468813|FG007|Overall Study|Protocol Violation|0|||
23199384|NCT00430521|64468806|FG000|Overall Study|Withdrawal by Subject|3|||
23480365|NCT01330017|65501956|FG002|Overall Study|Protocol Violation|0|||
23199385|NCT00430521|64468807|FG001|Overall Study|Withdrawal by Subject|1|||
23199386|NCT00430521|64468808|FG002|Overall Study|Withdrawal by Subject|0|||
23199387|NCT00430521|64468809|FG003|Overall Study|Withdrawal by Subject|3|||
23199388|NCT00430521|64468810|FG004|Overall Study|Withdrawal by Subject|0|||
23199389|NCT00430521|64468811|FG005|Overall Study|Withdrawal by Subject|0|||
23199390|NCT00430521|64468812|FG006|Overall Study|Withdrawal by Subject|0|||
23199391|NCT00430521|64468813|FG007|Overall Study|Withdrawal by Subject|2|||
23199392|NCT01930799|64468816|FG000|Overall Study|Withdrawal by Subject|3|||
23199393|NCT01930799|64468816|FG000|Overall Study|Lost to Follow-up|5|||
23600093|NCT01701401|65925791|FG003|Overall Study|Protocol Violation|0|||
23600094|NCT01953224|65925799|FG000|Overall Study|Lost to Follow-up|1|||
23600095|NCT01953224|65925800|FG001|Overall Study|Lost to Follow-up|1|||
23600096|NCT01953224|65925799|FG000|Overall Study|Withdrawal by Subject|1|||
23600097|NCT01953224|65925800|FG001|Overall Study|Withdrawal by Subject|2|||
23600098|NCT02111096|65925801|FG000|Overall Study|Adverse Event|4|||
23199394|NCT01929044|64468819|FG000|Overall Study|Adverse Event|1|||
23199395|NCT01929044|64468820|FG001|Overall Study|Adverse Event|0|||
23199396|NCT01929044|64468819|FG000|Overall Study|Protocol Violation|9|||
23199397|NCT01929044|64468820|FG001|Overall Study|Protocol Violation|14|||
23600099|NCT02111096|65925802|FG001|Overall Study|Adverse Event|1|||
23199398|NCT01929044|64468819|FG000|Overall Study|Not Treated|1|||
23199399|NCT01929044|64468820|FG001|Overall Study|Not Treated|3|||
23199400|NCT03074162|64468821|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23199401|NCT03074162|64468822|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23199402|NCT03074162|64468823|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
23199403|NCT03074162|64468824|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23199404|NCT03074162|64468825|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23199405|NCT03074162|64468826|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
23199406|NCT03074162|64468821|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
23199407|NCT03074162|64468822|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
23199408|NCT03074162|64468823|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
23480366|NCT01330017|65501957|FG003|Overall Study|Protocol Violation|1|||
23600100|NCT02111096|65925803|FG002|Overall Study|Adverse Event|2|||
23199409|NCT03074162|64468824|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
23199410|NCT03074162|64468825|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
23199411|NCT03074162|64468826|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
23361220|NCT01098162|65069642|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
23600101|NCT02111096|65925801|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23600102|NCT02111096|65925802|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23600103|NCT02111096|65925803|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23600104|NCT02111096|65925801|FG000|Overall Study|Lost to Follow Up|1|||
23600105|NCT02111096|65925802|FG001|Overall Study|Lost to Follow Up|1|||
23600106|NCT02111096|65925803|FG002|Overall Study|Lost to Follow Up|1|||
23600107|NCT02111096|65925801|FG000|Overall Study|Physician Decision|0|||
23600108|NCT02111096|65925802|FG001|Overall Study|Physician Decision|1|||
23600109|NCT02111096|65925803|FG002|Overall Study|Physician Decision|0|||
23600110|NCT02111096|65925801|FG000|Overall Study|Protocol Violation|1|||
23600111|NCT02111096|65925802|FG001|Overall Study|Protocol Violation|0|||
23600112|NCT02111096|65925803|FG002|Overall Study|Protocol Violation|1|||
23600113|NCT02111096|65925801|FG000|Overall Study|Terminated by Sponsor|53|||
23600114|NCT02111096|65925802|FG001|Overall Study|Terminated by Sponsor|35|||
23600115|NCT02111096|65925803|FG002|Overall Study|Terminated by Sponsor|54|||
23600116|NCT02111096|65925801|FG000|Overall Study|Withdrawal by Subject|4|||
23600117|NCT02111096|65925802|FG001|Overall Study|Withdrawal by Subject|2|||
23600118|NCT02111096|65925803|FG002|Overall Study|Withdrawal by Subject|8|||
23600119|NCT04334317|65925806|FG000|Overall Study|Adverse Event|1|||
23600120|NCT04334317|65925807|FG001|Overall Study|Adverse Event|2|||
23600121|NCT04334317|65925808|FG002|Overall Study|Adverse Event|0|||
23600122|NCT04334317|65925809|FG003|Overall Study|Adverse Event|0|||
23600123|NCT04334317|65925806|FG000|Overall Study|Protocol Deviation|0|||
23600124|NCT04334317|65925807|FG001|Overall Study|Protocol Deviation|1|||
23600125|NCT04334317|65925808|FG002|Overall Study|Protocol Deviation|0|||
23600126|NCT04334317|65925809|FG003|Overall Study|Protocol Deviation|0|||
23361221|NCT01098162|65069642|FG000|Overall Study|Other Reason|1|||
23600127|NCT04334317|65925806|FG000|Overall Study|Withdrawal by Subject|2|||
23600128|NCT04334317|65925807|FG001|Overall Study|Withdrawal by Subject|2|||
23258730|NCT01381900|64689861|FG002|Overall Study|Noncompliance with study drug|1|||
23258731|NCT01381900|64689859|FG000|Overall Study|Physician Decision|0|||
23258732|NCT01381900|64689860|FG001|Overall Study|Physician Decision|1|||
23258733|NCT01381900|64689861|FG002|Overall Study|Physician Decision|1|||
23258734|NCT01381900|64689859|FG000|Overall Study|Protocol Violation|0|||
23258735|NCT01381900|64689860|FG001|Overall Study|Protocol Violation|1|||
23258736|NCT01381900|64689861|FG002|Overall Study|Protocol Violation|1|||
23258737|NCT01381900|64689859|FG000|Overall Study|Withdrawal by Subject|0|||
23258738|NCT01381900|64689860|FG001|Overall Study|Withdrawal by Subject|0|||
23258739|NCT01381900|64689861|FG002|Overall Study|Withdrawal by Subject|1|||
23258740|NCT01381900|64689859|FG000|Overall Study|Early withdraw|3|||
23258741|NCT01381900|64689860|FG001|Overall Study|Early withdraw|1|||
23258742|NCT01381900|64689861|FG002|Overall Study|Early withdraw|1|||
23258743|NCT00303316|64689862|FG000|Overall Study|Protocol Violation|1|||
23258744|NCT00303316|64689863|FG001|Overall Study|Protocol Violation|0|||
23258745|NCT00303316|64689862|FG000|Overall Study|Lost to Follow-up|0|||
23258746|NCT00303316|64689863|FG001|Overall Study|Lost to Follow-up|1|||
23258747|NCT00303316|64689862|FG000|Overall Study|Withdrawal by Subject|1|||
23258748|NCT00303316|64689863|FG001|Overall Study|Withdrawal by Subject|2|||
23258749|NCT02257632|64689864|FG000|Overall Study|Withdrawal by Subject|0|||
23258750|NCT02257632|64689865|FG001|Overall Study|Withdrawal by Subject|1|||
23258751|NCT02257632|64689864|FG000|Overall Study|Adverse Event|1|||
23258752|NCT02257632|64689865|FG001|Overall Study|Adverse Event|2|||
23258753|NCT01452529|64689868|FG000|Run-in Period|Adverse Event|96|||
23258754|NCT01452529|64689869|FG001|Run-in Period|Adverse Event|0|||
23258755|NCT01452529|64689870|FG002|Run-in Period|Adverse Event|0|||
23258756|NCT01452529|64689868|FG000|Run-in Period|Withdrawal by Subject|49|||
23258757|NCT01452529|64689869|FG001|Run-in Period|Withdrawal by Subject|0|||
23258758|NCT01452529|64689870|FG002|Run-in Period|Withdrawal by Subject|0|||
23258759|NCT01452529|64689868|FG000|Run-in Period|Lost to Follow-up|19|||
23258760|NCT01452529|64689869|FG001|Run-in Period|Lost to Follow-up|0|||
23258761|NCT01452529|64689870|FG002|Run-in Period|Lost to Follow-up|0|||
23258762|NCT01452529|64689868|FG000|Run-in Period|Lack of Efficacy|46|||
23258763|NCT01452529|64689869|FG001|Run-in Period|Lack of Efficacy|0|||
23258764|NCT01452529|64689870|FG002|Run-in Period|Lack of Efficacy|0|||
23258765|NCT01452529|64689868|FG000|Run-in Period|Confirmed or suspected diversion|23|||
23258766|NCT01452529|64689869|FG001|Run-in Period|Confirmed or suspected diversion|0|||
23258767|NCT01452529|64689870|FG002|Run-in Period|Confirmed or suspected diversion|0|||
23258768|NCT01452529|64689868|FG000|Run-in Period|Administrative|21|||
23258769|NCT01452529|64689869|FG001|Run-in Period|Administrative|0|||
23258770|NCT01452529|64689870|FG002|Run-in Period|Administrative|0|||
23258771|NCT01452529|64689868|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
23258772|NCT01452529|64689869|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
23258773|NCT01452529|64689870|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
23258774|NCT01452529|64689868|FG000|Double-blind (DB) Period|Adverse Event|0|||
23258775|NCT01452529|64689869|FG001|Double-blind (DB) Period|Adverse Event|18|||
23258776|NCT01452529|64689870|FG002|Double-blind (DB) Period|Adverse Event|11|||
23258777|NCT01452529|64689868|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
23258778|NCT01452529|64689869|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
23258779|NCT01452529|64689870|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
23258780|NCT01452529|64689868|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
23258781|NCT01452529|64689869|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
23258782|NCT01452529|64689870|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
23258783|NCT01452529|64689868|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
23258784|NCT01452529|64689869|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
23258785|NCT01452529|64689870|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
23258786|NCT01452529|64689868|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
23258787|NCT01452529|64689869|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
23258788|NCT01452529|64689870|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
23258789|NCT01452529|64689868|FG000|Double-blind (DB) Period|Administrative|0|||
23258790|NCT01452529|64689869|FG001|Double-blind (DB) Period|Administrative|11|||
23258791|NCT01452529|64689870|FG002|Double-blind (DB) Period|Administrative|7|||
23258792|NCT02472977|64689871|FG000|Overall Study|Disease progression|4|||
23258793|NCT02472977|64689872|FG001|Overall Study|Disease progression|25|||
23258794|NCT02472977|64689873|FG002|Overall Study|Disease progression|6|||
23258795|NCT02472977|64689871|FG000|Overall Study|Withdrawal by Subject|0|||
23258796|NCT02472977|64689872|FG001|Overall Study|Withdrawal by Subject|1|||
23258797|NCT02472977|64689873|FG002|Overall Study|Withdrawal by Subject|0|||
23258798|NCT02472977|64689871|FG000|Overall Study|Study drug toxicity|2|||
23258799|NCT02472977|64689872|FG001|Overall Study|Study drug toxicity|0|||
23258800|NCT02472977|64689873|FG002|Overall Study|Study drug toxicity|2|||
23258801|NCT02472977|64689871|FG000|Overall Study|Subject request to discontinue treatment|0|||
23258802|NCT02472977|64689872|FG001|Overall Study|Subject request to discontinue treatment|1|||
23258803|NCT02472977|64689873|FG002|Overall Study|Subject request to discontinue treatment|0|||
23258804|NCT00384033|64689874|FG000|Overall Study|Adverse Event|10|||
23258805|NCT00384033|64689875|FG001|Overall Study|Adverse Event|8|||
23258806|NCT00384033|64689876|FG002|Overall Study|Adverse Event|11|||
23258807|NCT00384033|64689877|FG003|Overall Study|Adverse Event|20|||
23258808|NCT00384033|64689874|FG000|Overall Study|Failed to return|1|||
23258809|NCT00384033|64689875|FG001|Overall Study|Failed to return|3|||
23258810|NCT00384033|64689876|FG002|Overall Study|Failed to return|2|||
23258811|NCT00384033|64689877|FG003|Overall Study|Failed to return|2|||
23258812|NCT00384033|64689874|FG000|Overall Study|Physician Decision|1|||
23258813|NCT00384033|64689875|FG001|Overall Study|Physician Decision|0|||
23258814|NCT00384033|64689876|FG002|Overall Study|Physician Decision|0|||
23258815|NCT00384033|64689877|FG003|Overall Study|Physician Decision|0|||
23258816|NCT00384033|64689874|FG000|Overall Study|Lost to Follow-up|6|||
23258817|NCT00384033|64689875|FG001|Overall Study|Lost to Follow-up|12|||
23258818|NCT00384033|64689876|FG002|Overall Study|Lost to Follow-up|7|||
23258819|NCT00384033|64689877|FG003|Overall Study|Lost to Follow-up|7|||
23258820|NCT00384033|64689874|FG000|Overall Study|Other|2|||
23258821|NCT00384033|64689875|FG001|Overall Study|Other|0|||
23258822|NCT00384033|64689876|FG002|Overall Study|Other|0|||
23258823|NCT00384033|64689877|FG003|Overall Study|Other|0|||
23258824|NCT00384033|64689874|FG000|Overall Study|Protocol Violation|5|||
23258825|NCT00384033|64689875|FG001|Overall Study|Protocol Violation|0|||
23258826|NCT00384033|64689876|FG002|Overall Study|Protocol Violation|5|||
23258827|NCT00384033|64689877|FG003|Overall Study|Protocol Violation|6|||
23258828|NCT00384033|64689874|FG000|Overall Study|Withdrawal by Subject|6|||
23258829|NCT00384033|64689875|FG001|Overall Study|Withdrawal by Subject|2|||
23258830|NCT00384033|64689876|FG002|Overall Study|Withdrawal by Subject|5|||
23258831|NCT00384033|64689877|FG003|Overall Study|Withdrawal by Subject|2|||
23258832|NCT00384033|64689874|FG000|Overall Study|Lack of Efficacy|7|||
23258833|NCT00384033|64689875|FG001|Overall Study|Lack of Efficacy|3|||
23258834|NCT00384033|64689876|FG002|Overall Study|Lack of Efficacy|3|||
23258835|NCT00384033|64689877|FG003|Overall Study|Lack of Efficacy|1|||
23258836|NCT00384033|64689874|FG000|Overall Study|Randomized but not treated|3|||
23258837|NCT00384033|64689875|FG001|Overall Study|Randomized but not treated|7|||
23258838|NCT00384033|64689876|FG002|Overall Study|Randomized but not treated|10|||
23258839|NCT00384033|64689877|FG003|Overall Study|Randomized but not treated|2|||
23258840|NCT00450216|64689878|FG000|Overall Study|Adverse Event|38|||
23258841|NCT00450216|64689879|FG001|Overall Study|Adverse Event|23|||
23258842|NCT00450216|64689878|FG000|Overall Study|Withdrawal by Subject|48|||
23258843|NCT00450216|64689879|FG001|Overall Study|Withdrawal by Subject|26|||
23258844|NCT00450216|64689878|FG000|Overall Study|Lost to Follow-up|16|||
23258845|NCT00450216|64689879|FG001|Overall Study|Lost to Follow-up|9|||
23258846|NCT00450216|64689878|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
23258847|NCT00450216|64689879|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
23258848|NCT00450216|64689878|FG000|Overall Study|misc|21|||
23258849|NCT00450216|64689879|FG001|Overall Study|misc|20|||
23258850|NCT02436135|64689880|FG000|Overall Study|Progressive Disease|3|||
23258851|NCT02436135|64689881|FG001|Overall Study|Progressive Disease|1|||
23258852|NCT02436135|64689880|FG000|Overall Study|Investigator Discretion|1|||
23258853|NCT02436135|64689881|FG001|Overall Study|Investigator Discretion|2|||
23258854|NCT02436135|64689880|FG000|Overall Study|Adverse Event|1|||
23258855|NCT02436135|64689881|FG001|Overall Study|Adverse Event|0|||
23258856|NCT02436135|64689880|FG000|Overall Study|Withdrawal by Participant|1|||
23258857|NCT02436135|64689881|FG001|Overall Study|Withdrawal by Participant|0|||
23258858|NCT02436135|64689880|FG000|Overall Study|Study Terminated By Sponsor|0|||
23258859|NCT02436135|64689881|FG001|Overall Study|Study Terminated By Sponsor|1|||
23258860|NCT02260492|64689882|FG000|Overall Study|Adverse Event|6|||
23258861|NCT02260492|64689883|FG001|Overall Study|Adverse Event|1|||
23258862|NCT02260492|64689884|FG002|Overall Study|Adverse Event|2|||
23258863|NCT02260492|64689882|FG000|Overall Study|Death|0|||
23361222|NCT01098162|65069642|FG000|Overall Study|Reason Unknown|26|||
23361223|NCT01073163|65069643|FG000|Overall Study|Adverse Event|1|||
23361224|NCT01073163|65069643|FG000|Overall Study|Disease Progression|1|||
23361225|NCT01073163|65069643|FG000|Overall Study|Early termination|1|||
23361226|NCT01021332|65069646|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
23361227|NCT01021332|65069646|FG000|Overall Study|Adverse Event|43|||
23480367|NCT01330017|65501958|FG004|Overall Study|Protocol Violation|0|||
23480368|NCT01330017|65501954|FG000|Overall Study|Unknown Reason|5|||
23361228|NCT01021332|65069646|FG000|Overall Study|Lack of Efficacy|19|||
23361229|NCT01021332|65069646|FG000|Overall Study|Withdrawal of Consent|23|||
23361230|NCT01021332|65069646|FG000|Overall Study|Lost to Follow-up|4|||
23361231|NCT01021332|65069646|FG000|Overall Study|Protocol Violation|9|||
23258864|NCT02260492|64689883|FG001|Overall Study|Death|1|||
23258865|NCT02260492|64689884|FG002|Overall Study|Death|0|||
23258866|NCT02260492|64689882|FG000|Overall Study|Lost to Follow-up|12|||
23258867|NCT02260492|64689883|FG001|Overall Study|Lost to Follow-up|9|||
23258868|NCT02260492|64689884|FG002|Overall Study|Lost to Follow-up|0|||
23258869|NCT02260492|64689882|FG000|Overall Study|Physician Decision|2|||
23258870|NCT02260492|64689883|FG001|Overall Study|Physician Decision|0|||
23258871|NCT02260492|64689884|FG002|Overall Study|Physician Decision|1|||
23258872|NCT02260492|64689882|FG000|Overall Study|Withdrawal by Subject|3|||
23258873|NCT02260492|64689883|FG001|Overall Study|Withdrawal by Subject|2|||
23258874|NCT02260492|64689884|FG002|Overall Study|Withdrawal by Subject|2|||
23258875|NCT00207714|64689885|FG000|Overall Study|Adverse Event|6|||
23258876|NCT00207714|64689886|FG001|Overall Study|Adverse Event|2|||
23258877|NCT00207714|64689887|FG002|Overall Study|Adverse Event|4|||
23258878|NCT00207714|64689888|FG003|Overall Study|Adverse Event|3|||
23258879|NCT00207714|64689889|FG004|Overall Study|Adverse Event|1|||
23258880|NCT00207714|64689885|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23258881|NCT00207714|64689886|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23480369|NCT01330017|65501955|FG001|Overall Study|Unknown Reason|3|||
23199412|NCT03074162|64468821|FG000|Period 3|Withdrawal by Subject|1|||
23199413|NCT03074162|64468822|FG001|Period 3|Withdrawal by Subject|0|||
23199414|NCT03074162|64468823|FG002|Period 3|Withdrawal by Subject|0|||
23199415|NCT03074162|64468824|FG003|Period 3|Withdrawal by Subject|0|||
23199416|NCT03074162|64468825|FG004|Period 3|Withdrawal by Subject|1|||
23199417|NCT03074162|64468826|FG005|Period 3|Withdrawal by Subject|0|||
23199418|NCT01984346|64468829|FG000|Overall Study|Physician Decision|4|||
23199419|NCT01984346|64468830|FG001|Overall Study|Physician Decision|2|||
23199420|NCT01984346|64468829|FG000|Overall Study|Withdrawal by Subject|2|||
23199421|NCT01984346|64468830|FG001|Overall Study|Withdrawal by Subject|2|||
23199422|NCT01984346|64468829|FG000|Overall Study|Enrollment Closed|8|||
23199423|NCT01984346|64468830|FG001|Overall Study|Enrollment Closed|1|||
23199424|NCT01984346|64468829|FG000|Overall Study|Insurance Coverage|1|||
23199425|NCT01984346|64468830|FG001|Overall Study|Insurance Coverage|0|||
23199426|NCT01984346|64468829|FG000|Overall Study|Intra-operative Exclusion|2|||
23199427|NCT01984346|64468830|FG001|Overall Study|Intra-operative Exclusion|0|||
23199428|NCT00633139|64468831|FG000|Overall Study|Non compliance|0|||
23199429|NCT00633139|64468832|FG001|Overall Study|Non compliance|0|||
23199430|NCT00633139|64468833|FG002|Overall Study|Non compliance|1|||
23199431|NCT00633139|64468831|FG000|Overall Study|Withdrawal by Subject|0|||
23199432|NCT00633139|64468832|FG001|Overall Study|Withdrawal by Subject|1|||
23199433|NCT00633139|64468833|FG002|Overall Study|Withdrawal by Subject|0|||
23199434|NCT01441440|64468834|FG000|Overall Study|Death|1|||
23199435|NCT01441440|64468835|FG001|Overall Study|Death|0|||
23199436|NCT01441440|64468836|FG002|Overall Study|Death|1|||
23199437|NCT01441440|64468834|FG000|Overall Study|Adverse Event|2|||
23199438|NCT01441440|64468835|FG001|Overall Study|Adverse Event|9|||
23199439|NCT01441440|64468836|FG002|Overall Study|Adverse Event|9|||
23199440|NCT01441440|64468834|FG000|Overall Study|Lost to Follow-up|0|||
23199441|NCT01441440|64468835|FG001|Overall Study|Lost to Follow-up|2|||
23199442|NCT01441440|64468836|FG002|Overall Study|Lost to Follow-up|1|||
23199443|NCT01441440|64468834|FG000|Overall Study|Withdrawal by Subject|11|||
23199444|NCT01441440|64468835|FG001|Overall Study|Withdrawal by Subject|9|||
23199445|NCT01441440|64468836|FG002|Overall Study|Withdrawal by Subject|9|||
23199446|NCT01441440|64468834|FG000|Overall Study|Pregnancy|1|||
23199447|NCT01441440|64468835|FG001|Overall Study|Pregnancy|0|||
23199448|NCT01441440|64468836|FG002|Overall Study|Pregnancy|0|||
23199449|NCT01441440|64468834|FG000|Overall Study|Lack of Efficacy|1|||
23199450|NCT01441440|64468835|FG001|Overall Study|Lack of Efficacy|0|||
23199451|NCT01441440|64468836|FG002|Overall Study|Lack of Efficacy|1|||
23199452|NCT01441440|64468834|FG000|Overall Study|Moving|0|||
23199453|NCT01441440|64468835|FG001|Overall Study|Moving|1|||
23199454|NCT01441440|64468836|FG002|Overall Study|Moving|1|||
23199455|NCT01441440|64468834|FG000|Overall Study|Work-related matter|0|||
23199456|NCT01441440|64468835|FG001|Overall Study|Work-related matter|1|||
23199457|NCT01441440|64468836|FG002|Overall Study|Work-related matter|0|||
23199458|NCT01441440|64468834|FG000|Overall Study|Difficllty in keeping the schedule|1|||
23199459|NCT01441440|64468835|FG001|Overall Study|Difficllty in keeping the schedule|1|||
23199460|NCT01441440|64468836|FG002|Overall Study|Difficllty in keeping the schedule|0|||
23199461|NCT01126619|64468837|FG000|Overall Study|Not eligible for the study|2|||
23199462|NCT01126619|64468837|FG000|Overall Study|Investigator decision|4|||
23199463|NCT01126619|64468837|FG000|Overall Study|Serious adverse event|1|||
23199464|NCT01126619|64468837|FG000|Overall Study|Withdrawal by Subject|9|||
23199465|NCT01126619|64468837|FG000|Overall Study|Non-compliance|1|||
23199466|NCT00301067|64468838|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
23199467|NCT00301067|64468839|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
23199468|NCT00301067|64468840|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
23199469|NCT00301067|64468841|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
23258882|NCT00207714|64689887|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
23258883|NCT00207714|64689888|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
23199470|NCT00301067|64468838|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
23199471|NCT00301067|64468839|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
23199472|NCT00301067|64468840|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
23199473|NCT00301067|64468841|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
23361232|NCT01021332|65069646|FG000|Overall Study|Miscellaneous|3|||
23480370|NCT01330017|65501956|FG002|Overall Study|Unknown Reason|5|||
23480371|NCT01330017|65501957|FG003|Overall Study|Unknown Reason|7|||
23361233|NCT01001520|65069647|FG000|Medication Period 1|Withdrawal by Subject|2|||
23480372|NCT01330017|65501958|FG004|Overall Study|Unknown Reason|2|||
23258884|NCT00207714|64689889|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
23258885|NCT00207714|64689885|FG000|Overall Study|Other|3|||
23258886|NCT00207714|64689886|FG001|Overall Study|Other|2|||
23258887|NCT00207714|64689887|FG002|Overall Study|Other|5|||
23258888|NCT00207714|64689888|FG003|Overall Study|Other|1|||
23258889|NCT00207714|64689889|FG004|Overall Study|Other|0|||
23258890|NCT02444533|64689894|FG000|Overall Study|Not able to complete forms|0|||
23258891|NCT02444533|64689895|FG001|Overall Study|Not able to complete forms|2|||
23258892|NCT02444533|64689894|FG000|Overall Study|Only gave post-procedure complications|2|||
23258893|NCT02444533|64689895|FG001|Overall Study|Only gave post-procedure complications|2|||
23258894|NCT02041494|64689896|FG000|Overall Study|Death|1|||
23258895|NCT02041494|64689897|FG001|Overall Study|Death|3|||
23258896|NCT02041494|64689896|FG000|Overall Study|Lost to Follow-up|2|||
23258897|NCT02041494|64689897|FG001|Overall Study|Lost to Follow-up|6|||
23258898|NCT02041494|64689896|FG000|Overall Study|study terminated|16|||
23258899|NCT02041494|64689897|FG001|Overall Study|study terminated|11|||
23258900|NCT03731182|64689898|FG000|Overall Study|Lost to Follow-up|2|||
23258901|NCT03731182|64689899|FG001|Overall Study|Lost to Follow-up|0|||
23258902|NCT03731182|64689898|FG000|Overall Study|Physician Decision|1|||
23258903|NCT03731182|64689899|FG001|Overall Study|Physician Decision|0|||
23258904|NCT03731182|64689898|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
23258905|NCT03731182|64689899|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
23258906|NCT02110706|64689900|FG000|Overall Study|Adverse Event|2|||
23258907|NCT02110706|64689901|FG001|Overall Study|Adverse Event|3|||
23258908|NCT02110706|64689900|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
23258909|NCT02110706|64689901|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
23258910|NCT02295774|64689908|FG000|Overall Study|Physician Decision|1|||
23258911|NCT02295774|64689908|FG000|Overall Study|Withdrawal by Subject|2|||
23258912|NCT00618774|64689909|FG000|Overall Study|Adverse Event|5|||
23258913|NCT00618774|64689910|FG001|Overall Study|Adverse Event|3|||
23258914|NCT00618774|64689909|FG000|Overall Study|Withdrawal by Subject|1|||
23258915|NCT00618774|64689910|FG001|Overall Study|Withdrawal by Subject|0|||
23258916|NCT01785875|64689911|FG000|Overall Study|Withdrawal by Subject|41|||
23258917|NCT01785875|64689912|FG001|Overall Study|Withdrawal by Subject|34|||
23600129|NCT04334317|65925808|FG002|Overall Study|Withdrawal by Subject|0|||
23600130|NCT04334317|65925809|FG003|Overall Study|Withdrawal by Subject|0|||
23600131|NCT02148705|65925810|FG000|Overall Study|Death|2|||
23600132|NCT02148705|65925811|FG001|Overall Study|Death|0|||
23600133|NCT02148705|65925812|FG002|Overall Study|Death|0|||
23600134|NCT02148705|65925810|FG000|Overall Study|Lost to Follow-up|13|||
23600135|NCT02148705|65925811|FG001|Overall Study|Lost to Follow-up|4|||
23199474|NCT00301067|64468838|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
23199475|NCT00301067|64468839|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
23199476|NCT00301067|64468840|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
23199477|NCT00301067|64468841|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
23199478|NCT00301067|64468838|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
23199479|NCT00301067|64468839|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
23199480|NCT00301067|64468840|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
23199481|NCT00301067|64468841|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
23199482|NCT00301067|64468838|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
23199483|NCT00301067|64468839|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
23199484|NCT00301067|64468840|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
23199485|NCT00301067|64468841|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
23199486|NCT00301067|64468838|FG000|Follow up Until Death|Alive at last data cut point|1|||
23199487|NCT00301067|64468839|FG001|Follow up Until Death|Alive at last data cut point|0|||
23199488|NCT00301067|64468840|FG002|Follow up Until Death|Alive at last data cut point|0|||
23199489|NCT00301067|64468841|FG003|Follow up Until Death|Alive at last data cut point|1|||
23199490|NCT01752842|64468842|FG000|Overall Study|Adverse Event|3|||
23199491|NCT01752842|64468843|FG001|Overall Study|Adverse Event|0|||
23199492|NCT01752842|64468842|FG000|Overall Study|Withdrawal by Subject|0|||
23199493|NCT01752842|64468843|FG001|Overall Study|Withdrawal by Subject|2|||
23199494|NCT00321984|64468844|FG000|Overall Study|Adverse Event|9|||
23199495|NCT00321984|64468845|FG001|Overall Study|Adverse Event|6|||
23600136|NCT02148705|65925812|FG002|Overall Study|Lost to Follow-up|10|||
23199496|NCT00321984|64468846|FG002|Overall Study|Adverse Event|8|||
23199497|NCT00321984|64468844|FG000|Overall Study|Protocol Violation|0|||
23199498|NCT00321984|64468845|FG001|Overall Study|Protocol Violation|1|||
23480373|NCT01829243|65501959|FG000|First Intervention|Screen Failure|4|||
23199499|NCT00321984|64468846|FG002|Overall Study|Protocol Violation|1|||
23258918|NCT01785875|64689913|FG002|Overall Study|Withdrawal by Subject|36|||
23258919|NCT01785875|64689911|FG000|Overall Study|Lost to Follow-up|19|||
23258920|NCT01785875|64689912|FG001|Overall Study|Lost to Follow-up|22|||
23258921|NCT01785875|64689913|FG002|Overall Study|Lost to Follow-up|6|||
23258922|NCT01785875|64689911|FG000|Overall Study|Death|27|||
23258923|NCT01785875|64689912|FG001|Overall Study|Death|16|||
23258924|NCT01785875|64689913|FG002|Overall Study|Death|7|||
23258925|NCT01785875|64689911|FG000|Overall Study|Sponsor Decision|0|||
23258926|NCT01785875|64689912|FG001|Overall Study|Sponsor Decision|2|||
23258927|NCT01785875|64689913|FG002|Overall Study|Sponsor Decision|0|||
23258928|NCT01785875|64689911|FG000|Overall Study|Protocol Specified Criteria|207|||
23258929|NCT01785875|64689912|FG001|Overall Study|Protocol Specified Criteria|214|||
23258930|NCT01785875|64689913|FG002|Overall Study|Protocol Specified Criteria|55|||
23258931|NCT01785875|64689911|FG000|Overall Study|Missing|0|||
23258932|NCT01785875|64689912|FG001|Overall Study|Missing|1|||
23258933|NCT01785875|64689913|FG002|Overall Study|Missing|3|||
23258934|NCT02168270|64689914|FG000|Overall Study|Lack of Efficacy|4|||
23258935|NCT01141283|64689915|FG000|Overall Study|Adverse Event|56|||
23258936|NCT01141283|64689915|FG000|Overall Study|Lost to Follow-up|4|||
23258937|NCT01141283|64689915|FG000|Overall Study|Withdrawal by Subject|14|||
23258938|NCT01141283|64689915|FG000|Overall Study|Administrative|4|||
23258939|NCT01141283|64689915|FG000|Overall Study|Lack of Efficacy|10|||
23258940|NCT02884206|64689916|FG000|Valsartan Run-in Period|Death|1|||
23258941|NCT02884206|64689917|FG001|Valsartan Run-in Period|Death|0|||
23258942|NCT02884206|64689918|FG002|Valsartan Run-in Period|Death|0|||
23258943|NCT02884206|64689916|FG000|Valsartan Run-in Period|Adverse Event|31|||
23258944|NCT02884206|64689917|FG001|Valsartan Run-in Period|Adverse Event|0|||
23258945|NCT02884206|64689918|FG002|Valsartan Run-in Period|Adverse Event|0|||
23258946|NCT02884206|64689916|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
23258947|NCT02884206|64689917|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
23258948|NCT02884206|64689918|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
23258949|NCT02884206|64689916|FG000|Valsartan Run-in Period|Protocol deviation|4|||
23258950|NCT02884206|64689917|FG001|Valsartan Run-in Period|Protocol deviation|0|||
23258951|NCT02884206|64689918|FG002|Valsartan Run-in Period|Protocol deviation|0|||
23258952|NCT02884206|64689916|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
23258953|NCT02884206|64689917|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
23258954|NCT02884206|64689918|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
23258955|NCT02884206|64689916|FG000|Valsartan Run-in Period|Physician Decision|1|||
23258956|NCT02884206|64689917|FG001|Valsartan Run-in Period|Physician Decision|0|||
23258957|NCT02884206|64689918|FG002|Valsartan Run-in Period|Physician Decision|0|||
23258958|NCT02884206|64689916|FG000|LCZ696 Run-in Period|Adverse Event|38|||
23258959|NCT02884206|64689917|FG001|LCZ696 Run-in Period|Adverse Event|0|||
23258960|NCT02884206|64689918|FG002|LCZ696 Run-in Period|Adverse Event|0|||
23258961|NCT02884206|64689916|FG000|LCZ696 Run-in Period|Death|2|||
23258962|NCT02884206|64689917|FG001|LCZ696 Run-in Period|Death|0|||
23258963|NCT02884206|64689918|FG002|LCZ696 Run-in Period|Death|0|||
23258964|NCT02884206|64689916|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
23258965|NCT02884206|64689917|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
23258966|NCT02884206|64689918|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
23258967|NCT02884206|64689916|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
23258968|NCT02884206|64689917|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
23258969|NCT02884206|64689918|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
23258970|NCT02884206|64689916|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
23258971|NCT02884206|64689917|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
23258972|NCT02884206|64689918|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
23258973|NCT02884206|64689916|FG000|LCZ696 Run-in Period|Physician Decision|1|||
23258974|NCT02884206|64689917|FG001|LCZ696 Run-in Period|Physician Decision|0|||
23258975|NCT02884206|64689918|FG002|LCZ696 Run-in Period|Physician Decision|0|||
23258976|NCT02884206|64689916|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
23258977|NCT02884206|64689917|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
23258978|NCT02884206|64689918|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
23258979|NCT02884206|64689916|FG000|Double-Blind Period|Death|0|||
23258980|NCT02884206|64689917|FG001|Double-Blind Period|Death|28|||
23258981|NCT02884206|64689918|FG002|Double-Blind Period|Death|39|||
23258982|NCT02884206|64689916|FG000|Double-Blind Period|Patient/guardian decision|0|||
23258983|NCT02884206|64689917|FG001|Double-Blind Period|Patient/guardian decision|10|||
23258984|NCT02884206|64689918|FG002|Double-Blind Period|Patient/guardian decision|13|||
23258985|NCT02884206|64689916|FG000|Double-Blind Period|Lost to Follow-up|0|||
23258986|NCT02884206|64689917|FG001|Double-Blind Period|Lost to Follow-up|4|||
23258987|NCT02884206|64689918|FG002|Double-Blind Period|Lost to Follow-up|4|||
23258988|NCT02884206|64689916|FG000|Double-Blind Period|Physician Decision|0|||
23258989|NCT02884206|64689917|FG001|Double-Blind Period|Physician Decision|2|||
23258990|NCT02884206|64689918|FG002|Double-Blind Period|Physician Decision|0|||
23258991|NCT02884206|64689916|FG000|Double-Blind Period|Adverse Event|0|||
23258992|NCT02884206|64689917|FG001|Double-Blind Period|Adverse Event|0|||
23258993|NCT02884206|64689918|FG002|Double-Blind Period|Adverse Event|3|||
23258994|NCT02884206|64689916|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
23258995|NCT02884206|64689917|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
23258996|NCT02884206|64689918|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
23258997|NCT01626885|64689941|FG000|Overall Study|Adverse Event|8|||
23258998|NCT01626885|64689941|FG000|Overall Study|Withdrawal by Subject|4|||
23258999|NCT00910858|64689942|FG000|Pharmacokinetic Phase|Adverse Event|1|||
23259000|NCT00910858|64689943|FG001|Pharmacokinetic Phase|Adverse Event|0|||
23259001|NCT00910858|64689944|FG002|Pharmacokinetic Phase|Adverse Event|0|||
23259002|NCT00910858|64689942|FG000|Monotherapy Phase|Adverse Event|3|||
23259003|NCT00910858|64689943|FG001|Monotherapy Phase|Adverse Event|2|||
23259004|NCT00910858|64689944|FG002|Monotherapy Phase|Adverse Event|0|||
23259005|NCT00910858|64689942|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
23259006|NCT00910858|64689943|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
23259007|NCT00910858|64689944|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
23259008|NCT00910858|64689942|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
23259009|NCT00910858|64689943|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
23259010|NCT00910858|64689944|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
23259011|NCT00910858|64689942|FG000|Monotherapy Phase|Protocol Violation|1|||
23259012|NCT00910858|64689943|FG001|Monotherapy Phase|Protocol Violation|0|||
23259013|NCT00910858|64689944|FG002|Monotherapy Phase|Protocol Violation|0|||
23259014|NCT00910858|64689942|FG000|Monotherapy Phase|Other|3|||
23259015|NCT00910858|64689943|FG001|Monotherapy Phase|Other|4|||
23259016|NCT00910858|64689944|FG002|Monotherapy Phase|Other|2|||
23259017|NCT00910858|64689942|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
23259018|NCT00910858|64689943|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
23259019|NCT00910858|64689944|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
23259020|NCT00910858|64689942|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
23259021|NCT00910858|64689943|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
23259022|NCT00910858|64689944|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
23259023|NCT00910858|64689942|FG000|Combined Treatment Phase|Protocol Violation|1|||
23259024|NCT00910858|64689943|FG001|Combined Treatment Phase|Protocol Violation|0|||
23259025|NCT00910858|64689944|FG002|Combined Treatment Phase|Protocol Violation|0|||
23259026|NCT00910858|64689942|FG000|Combined Treatment Phase|Other|0|||
23259027|NCT00910858|64689943|FG001|Combined Treatment Phase|Other|2|||
23259028|NCT00910858|64689944|FG002|Combined Treatment Phase|Other|1|||
23259029|NCT01133392|64689945|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
23259030|NCT01133392|64689946|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
23259031|NCT01133392|64689945|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
23259032|NCT01133392|64689946|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
23259033|NCT01507896|64689947|FG000|Overall Study|Withdrawal by Subject|1|||
23259034|NCT01507896|64689947|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
23259035|NCT01313728|64689948|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
23259036|NCT01025193|64689949|FG000|Overall Study|Protocol Violation|1|||
23259037|NCT01025193|64689949|FG000|Overall Study|Adverse Event|3|||
23259038|NCT00706706|64689952|FG000|Overall Study|Death|53|||
23259039|NCT00706706|64689952|FG000|Overall Study|Lost to Follow-up|7|||
23259040|NCT00706706|64689952|FG000|Overall Study|Study endpoint had reached|45|||
23259041|NCT02853929|64689955|FG000|Overall Study|Lost to Follow-up|3|||
23259042|NCT02853929|64689956|FG001|Overall Study|Lost to Follow-up|0|||
23259043|NCT02853929|64689955|FG000|Overall Study|Withdrawal by Subject|1|||
23259044|NCT02853929|64689956|FG001|Overall Study|Withdrawal by Subject|0|||
23259045|NCT02853929|64689955|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
23259046|NCT02853929|64689956|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
23259047|NCT01070394|64689957|FG000|Overall Study|Adverse Event|6|||
23259048|NCT01070394|64689957|FG000|Overall Study|Withdrawal by Subject|1|||
23259049|NCT02308111|64689958|FG000|Overall Study|Adverse Event|31|||
23259050|NCT02308111|64689959|FG001|Overall Study|Adverse Event|19|||
23259051|NCT02308111|64689958|FG000|Overall Study|Death|9|||
23259052|NCT02308111|64689959|FG001|Overall Study|Death|6|||
23259053|NCT02308111|64689958|FG000|Overall Study|Lost to Follow-up|2|||
23259054|NCT02308111|64689959|FG001|Overall Study|Lost to Follow-up|7|||
23259055|NCT02308111|64689958|FG000|Overall Study|Physician Decision|6|||
23259056|NCT02308111|64689959|FG001|Overall Study|Physician Decision|17|||
23259057|NCT02308111|64689958|FG000|Overall Study|Protocol Violation|0|||
23259058|NCT02308111|64689959|FG001|Overall Study|Protocol Violation|1|||
23259059|NCT02308111|64689958|FG000|Overall Study|Withdrawal by Subject|28|||
23259060|NCT02308111|64689959|FG001|Overall Study|Withdrawal by Subject|38|||
23259061|NCT02308111|64689958|FG000|Overall Study|Study Terminated by Sponsor|72|||
23259062|NCT02308111|64689959|FG001|Overall Study|Study Terminated by Sponsor|61|||
23259063|NCT02308111|64689958|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
23259064|NCT02308111|64689959|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
23259065|NCT02308111|64689958|FG000|Overall Study|Site Closure|3|||
23259066|NCT02308111|64689959|FG001|Overall Study|Site Closure|3|||
23259067|NCT02308111|64689958|FG000|Overall Study|Non-compliance with Study Drug|3|||
23259068|NCT02308111|64689959|FG001|Overall Study|Non-compliance with Study Drug|1|||
23259069|NCT02308111|64689958|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
23259070|NCT02308111|64689959|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
23259071|NCT02308111|64689958|FG000|Overall Study|Liver Transplant|3|||
23259072|NCT02308111|64689959|FG001|Overall Study|Liver Transplant|3|||
23259073|NCT02308111|64689958|FG000|Overall Study|Liver Transplant Waitlist|2|||
23259074|NCT02308111|64689959|FG001|Overall Study|Liver Transplant Waitlist|2|||
23259075|NCT02308111|64689958|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
23259076|NCT02308111|64689959|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
23259077|NCT01261325|64689960|FG000|Overall Study|Lack of Efficacy|1|||
23259078|NCT01261325|64689961|FG001|Overall Study|Lack of Efficacy|1|||
23259079|NCT01261325|64689962|FG002|Overall Study|Lack of Efficacy|0|||
23259080|NCT01261325|64689960|FG000|Overall Study|Withdrawal by Subject|2|||
23259081|NCT01261325|64689961|FG001|Overall Study|Withdrawal by Subject|2|||
23259082|NCT01261325|64689962|FG002|Overall Study|Withdrawal by Subject|4|||
23259083|NCT01261325|64689960|FG000|Overall Study|SAE, non-fatal|1|||
23259084|NCT01261325|64689961|FG001|Overall Study|SAE, non-fatal|5|||
23259085|NCT01261325|64689962|FG002|Overall Study|SAE, non-fatal|1|||
23259086|NCT01261325|64689960|FG000|Overall Study|AE, non-serious non-fatal|9|||
23259087|NCT01261325|64689961|FG001|Overall Study|AE, non-serious non-fatal|15|||
23259088|NCT01261325|64689962|FG002|Overall Study|AE, non-serious non-fatal|13|||
23259089|NCT01261325|64689960|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
23259090|NCT01261325|64689961|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23259091|NCT01261325|64689962|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
23259092|NCT01261325|64689960|FG000|Overall Study|Non Compliance|2|||
23259093|NCT01261325|64689961|FG001|Overall Study|Non Compliance|0|||
23259094|NCT01261325|64689962|FG002|Overall Study|Non Compliance|0|||
23259095|NCT01261325|64689960|FG000|Overall Study|Patient Randomized by Mistake|0|||
23259096|NCT01261325|64689961|FG001|Overall Study|Patient Randomized by Mistake|1|||
23259097|NCT01261325|64689962|FG002|Overall Study|Patient Randomized by Mistake|0|||
23199500|NCT00321984|64468844|FG000|Overall Study|Lost to Follow-up|2|||
23199501|NCT00321984|64468845|FG001|Overall Study|Lost to Follow-up|4|||
23259098|NCT01261325|64689960|FG000|Overall Study|Erroneously Randomized|1|||
23259099|NCT01261325|64689961|FG001|Overall Study|Erroneously Randomized|0|||
23259100|NCT01261325|64689962|FG002|Overall Study|Erroneously Randomized|0|||
23259101|NCT01261325|64689960|FG000|Overall Study|Screen Failure|1|||
23259102|NCT01261325|64689961|FG001|Overall Study|Screen Failure|0|||
23259103|NCT01261325|64689962|FG002|Overall Study|Screen Failure|0|||
23259104|NCT01261325|64689960|FG000|Overall Study|Randomized in Error|0|||
23259105|NCT01261325|64689961|FG001|Overall Study|Randomized in Error|0|||
23259106|NCT01261325|64689962|FG002|Overall Study|Randomized in Error|1|||
23259107|NCT01261325|64689960|FG000|Overall Study|Protocol Violation|0|||
23259108|NCT01261325|64689961|FG001|Overall Study|Protocol Violation|3|||
23259109|NCT01261325|64689962|FG002|Overall Study|Protocol Violation|1|||
23259110|NCT01261325|64689960|FG000|Overall Study|Lost to Follow-up|0|||
23259111|NCT01261325|64689961|FG001|Overall Study|Lost to Follow-up|1|||
23259112|NCT01261325|64689962|FG002|Overall Study|Lost to Follow-up|3|||
23259113|NCT01261325|64689960|FG000|Overall Study|AE, serious fatal|0|||
23259114|NCT01261325|64689961|FG001|Overall Study|AE, serious fatal|0|||
23259115|NCT01261325|64689962|FG002|Overall Study|AE, serious fatal|2|||
23259116|NCT01907087|64689963|FG000|Overall Study|Withdrawal by Subject|1|||
23259117|NCT01405950|64689964|FG000|Overall Study|Withdrawal by Subject|1|||
23259118|NCT01405950|64689965|FG001|Overall Study|Withdrawal by Subject|0|||
23361234|NCT01001520|65069648|FG001|Medication Period 1|Withdrawal by Subject|2|||
23600137|NCT02148705|65925810|FG000|Overall Study|Withdrawal by Subject|3|||
23600138|NCT02148705|65925811|FG001|Overall Study|Withdrawal by Subject|0|||
23600139|NCT02148705|65925812|FG002|Overall Study|Withdrawal by Subject|2|||
23600140|NCT02148705|65925810|FG000|Overall Study|Not Treated|0|||
23600141|NCT02148705|65925811|FG001|Overall Study|Not Treated|1|||
23600142|NCT02148705|65925812|FG002|Overall Study|Not Treated|5|||
23600143|NCT01485887|65925814|FG000|Overall Study|Withdrawal by Subject|2|||
23600144|NCT01485887|65925814|FG000|Overall Study|Adverse Event|8|||
23600145|NCT01485887|65925814|FG000|Overall Study|Deterioration of primary disease|1|||
23199502|NCT00321984|64468846|FG002|Overall Study|Lost to Follow-up|2|||
23199503|NCT00321984|64468844|FG000|Overall Study|Withdrawal by Subject|8|||
23199504|NCT00321984|64468845|FG001|Overall Study|Withdrawal by Subject|6|||
23199505|NCT00321984|64468846|FG002|Overall Study|Withdrawal by Subject|5|||
23199506|NCT00321984|64468844|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
23199507|NCT00321984|64468845|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
23199508|NCT00321984|64468846|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
23199509|NCT00321984|64468844|FG000|Overall Study|Lack of Efficacy|3|||
23199510|NCT00321984|64468845|FG001|Overall Study|Lack of Efficacy|1|||
23199511|NCT00321984|64468846|FG002|Overall Study|Lack of Efficacy|3|||
23361235|NCT01001520|65069647|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
23600146|NCT01485887|65925814|FG000|Overall Study|Primary disease markedly improved|1|||
23259119|NCT01405950|64689966|FG002|Overall Study|Withdrawal by Subject|0|||
23259120|NCT01405950|64689967|FG003|Overall Study|Withdrawal by Subject|0|||
23259121|NCT03507439|64689969|FG000|Overall Study|Other|2|||
23259122|NCT03507439|64689970|FG001|Overall Study|Other|1|||
23259123|NCT03507439|64689969|FG000|Overall Study|Withdrawal by Subject|1|||
23259124|NCT03507439|64689970|FG001|Overall Study|Withdrawal by Subject|0|||
23259125|NCT03507439|64689969|FG000|Overall Study|Death|1|||
23259126|NCT03507439|64689970|FG001|Overall Study|Death|1|||
23259127|NCT03567057|64689971|FG000|Overall Study|Adverse Event|56|||
23259128|NCT03567057|64689972|FG001|Overall Study|Adverse Event|53|||
23259129|NCT03567057|64689973|FG002|Overall Study|Adverse Event|28|||
23259130|NCT03567057|64689971|FG000|Overall Study|Withdrawal by Subject|22|||
23259131|NCT03567057|64689972|FG001|Overall Study|Withdrawal by Subject|24|||
23259132|NCT03567057|64689973|FG002|Overall Study|Withdrawal by Subject|13|||
23259133|NCT03567057|64689971|FG000|Overall Study|Lost to Follow-up|3|||
23259134|NCT03567057|64689972|FG001|Overall Study|Lost to Follow-up|5|||
23259135|NCT03567057|64689973|FG002|Overall Study|Lost to Follow-up|2|||
23259136|NCT03567057|64689971|FG000|Overall Study|COVID-19 pandemic|4|||
23259137|NCT03567057|64689972|FG001|Overall Study|COVID-19 pandemic|3|||
23259138|NCT03567057|64689973|FG002|Overall Study|COVID-19 pandemic|0|||
23259139|NCT03567057|64689971|FG000|Overall Study|Non-compliance with study drug|4|||
23259140|NCT03567057|64689972|FG001|Overall Study|Non-compliance with study drug|2|||
23259141|NCT03567057|64689973|FG002|Overall Study|Non-compliance with study drug|0|||
23259142|NCT03567057|64689971|FG000|Overall Study|Lack of Efficacy|3|||
23259143|NCT03567057|64689972|FG001|Overall Study|Lack of Efficacy|0|||
23259144|NCT03567057|64689973|FG002|Overall Study|Lack of Efficacy|1|||
23259145|NCT03567057|64689971|FG000|Overall Study|Death|1|||
23259146|NCT03567057|64689972|FG001|Overall Study|Death|0|||
23259147|NCT03567057|64689973|FG002|Overall Study|Death|0|||
23259148|NCT03567057|64689971|FG000|Overall Study|Physician Decision|1|||
23259149|NCT03567057|64689972|FG001|Overall Study|Physician Decision|0|||
23259150|NCT03567057|64689973|FG002|Overall Study|Physician Decision|0|||
23259151|NCT03567057|64689971|FG000|Overall Study|Unstable medical condition|1|||
23259152|NCT03567057|64689972|FG001|Overall Study|Unstable medical condition|0|||
23259153|NCT03567057|64689973|FG002|Overall Study|Unstable medical condition|0|||
23259154|NCT03567057|64689971|FG000|Overall Study|Medical history event|0|||
23259155|NCT03567057|64689972|FG001|Overall Study|Medical history event|0|||
23259156|NCT03567057|64689973|FG002|Overall Study|Medical history event|1|||
23259157|NCT03567057|64689971|FG000|Overall Study|Other|0|||
23259158|NCT03567057|64689972|FG001|Overall Study|Other|0|||
23259159|NCT03567057|64689973|FG002|Overall Study|Other|1|||
23259160|NCT01208402|64689975|FG000|Overall Study|Withdrawal by Subject|1|||
23259161|NCT01208402|64689976|FG001|Overall Study|Withdrawal by Subject|0|||
23259162|NCT02123459|64689986|FG000|Washout Period (1 Day)|Adverse Event|1|||
23259163|NCT02123459|64689987|FG001|Washout Period (1 Day)|Adverse Event|0|||
23259164|NCT00772577|64689992|FG000|Overall Study|Adverse Event|6|||
23259165|NCT00772577|64689993|FG001|Overall Study|Adverse Event|3|||
23259166|NCT00772577|64689992|FG000|Overall Study|Abnormal laboratory values|0|||
23259167|NCT00772577|64689993|FG001|Overall Study|Abnormal laboratory values|1|||
23259168|NCT00772577|64689992|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23259169|NCT00772577|64689993|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
23259170|NCT00772577|64689992|FG000|Overall Study|Patient withdrew consent|8|||
23259171|NCT00772577|64689993|FG001|Overall Study|Patient withdrew consent|5|||
23259172|NCT00772577|64689992|FG000|Overall Study|Lost to Follow-up|4|||
23259173|NCT00772577|64689993|FG001|Overall Study|Lost to Follow-up|3|||
23259174|NCT00772577|64689992|FG000|Overall Study|Administrative problems|2|||
23259175|NCT00772577|64689993|FG001|Overall Study|Administrative problems|1|||
23259176|NCT00772577|64689992|FG000|Overall Study|Protocol Deviation|3|||
23259177|NCT00772577|64689993|FG001|Overall Study|Protocol Deviation|2|||
23259178|NCT01223196|64689997|FG000|Overall Study|Lost to Follow-up|2|||
23259179|NCT01223196|64689998|FG001|Overall Study|Lost to Follow-up|0|||
23259180|NCT01223196|64689997|FG000|Overall Study|Physician Decision|1|||
23259181|NCT01223196|64689998|FG001|Overall Study|Physician Decision|0|||
23259182|NCT01223196|64689997|FG000|Overall Study|Withdrawal by Subject|1|||
23259183|NCT01223196|64689998|FG001|Overall Study|Withdrawal by Subject|0|||
23259184|NCT03196791|64689999|FG000|Overall Study|Protocol Violation|7|||
23361236|NCT01001520|65069648|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
23199512|NCT00321984|64468844|FG000|Overall Study|Noncompliant|0|||
23259185|NCT03196791|64690000|FG001|Overall Study|Protocol Violation|3|||
23259186|NCT03196791|64689999|FG000|Overall Study|Withdrawal by Subject|3|||
23259187|NCT03196791|64690000|FG001|Overall Study|Withdrawal by Subject|2|||
23259188|NCT02102490|64690001|FG000|Overall Study|Death|6|||
23259189|NCT02102490|64690001|FG000|Overall Study|Lost to Follow-up|1|||
23259190|NCT01789281|64690004|FG000|Overall Study|Disease progression|15|||
23259191|NCT01789281|64690005|FG001|Overall Study|Disease progression|4|||
23259192|NCT01789281|64690004|FG000|Overall Study|Adverse Event|5|||
23199513|NCT00321984|64468845|FG001|Overall Study|Noncompliant|0|||
23199514|NCT00321984|64468846|FG002|Overall Study|Noncompliant|2|||
23199515|NCT00321984|64468844|FG000|Overall Study|Pregnancy|0|||
23199516|NCT00321984|64468845|FG001|Overall Study|Pregnancy|1|||
23199517|NCT00321984|64468846|FG002|Overall Study|Pregnancy|0|||
23199518|NCT00321984|64468844|FG000|Overall Study|Per Subject Request|1|||
23199519|NCT00321984|64468845|FG001|Overall Study|Per Subject Request|0|||
23199520|NCT00321984|64468846|FG002|Overall Study|Per Subject Request|0|||
23199521|NCT00321984|64468844|FG000|Overall Study|Per Investigator Request|1|||
23199522|NCT00321984|64468845|FG001|Overall Study|Per Investigator Request|0|||
23199523|NCT00321984|64468846|FG002|Overall Study|Per Investigator Request|0|||
23199524|NCT00321984|64468844|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
23199525|NCT00321984|64468845|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
23199526|NCT00321984|64468846|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
23199527|NCT03567291|64468847|FG000|Period I|Adverse Event|14|||
23199528|NCT03567291|64468848|FG001|Period I|Adverse Event|0|||
23199529|NCT03567291|64468849|FG002|Period I|Adverse Event|0|||
23199530|NCT03567291|64468850|FG003|Period I|Adverse Event|0|||
23199531|NCT03567291|64468847|FG000|Period I|Protocol Violation|1|||
23199532|NCT03567291|64468848|FG001|Period I|Protocol Violation|0|||
23199533|NCT03567291|64468849|FG002|Period I|Protocol Violation|0|||
23199534|NCT03567291|64468850|FG003|Period I|Protocol Violation|0|||
23199535|NCT03567291|64468847|FG000|Period I|Withdrawal by Subject|23|||
23199536|NCT03567291|64468848|FG001|Period I|Withdrawal by Subject|0|||
23199537|NCT03567291|64468849|FG002|Period I|Withdrawal by Subject|0|||
23199538|NCT03567291|64468850|FG003|Period I|Withdrawal by Subject|0|||
23199539|NCT03567291|64468847|FG000|Period I|Lost to Follow-up|2|||
23199540|NCT03567291|64468848|FG001|Period I|Lost to Follow-up|0|||
23199541|NCT03567291|64468849|FG002|Period I|Lost to Follow-up|0|||
23199542|NCT03567291|64468850|FG003|Period I|Lost to Follow-up|0|||
23199543|NCT03567291|64468847|FG000|Period I|Terminated by sponsor|44|||
23199544|NCT03567291|64468848|FG001|Period I|Terminated by sponsor|0|||
23199545|NCT03567291|64468849|FG002|Period I|Terminated by sponsor|0|||
23199546|NCT03567291|64468850|FG003|Period I|Terminated by sponsor|0|||
23199547|NCT03567291|64468847|FG000|Period I|Missing or unknown|7|||
23199548|NCT03567291|64468848|FG001|Period I|Missing or unknown|0|||
23199549|NCT03567291|64468849|FG002|Period I|Missing or unknown|0|||
23199550|NCT03567291|64468850|FG003|Period I|Missing or unknown|0|||
23199551|NCT03567291|64468847|FG000|Period II|Adverse Event|0|||
23199552|NCT03567291|64468848|FG001|Period II|Adverse Event|1|||
23199553|NCT03567291|64468849|FG002|Period II|Adverse Event|0|||
23199554|NCT03567291|64468850|FG003|Period II|Adverse Event|0|||
23199555|NCT03567291|64468847|FG000|Period II|Missing or unknown|0|||
23259193|NCT01789281|64690005|FG001|Overall Study|Adverse Event|5|||
23259194|NCT01789281|64690004|FG000|Overall Study|Withdrawal by Subject|1|||
23259195|NCT01789281|64690005|FG001|Overall Study|Withdrawal by Subject|0|||
23259196|NCT01789281|64690004|FG000|Overall Study|Lost to Follow-up|1|||
23259197|NCT01789281|64690005|FG001|Overall Study|Lost to Follow-up|0|||
23259198|NCT01789281|64690004|FG000|Overall Study|Administrative problems|0|||
23259199|NCT01789281|64690005|FG001|Overall Study|Administrative problems|1|||
23259200|NCT03237611|64690006|FG000|Overall Study|Withdrawal by Subject|1|||
23259201|NCT03237611|64690006|FG000|Overall Study|Ineligible|1|||
23259202|NCT04049552|64690007|FG000|Overall Study|Lost to Follow-up|1|||
23480374|NCT01829243|65501960|FG001|First Intervention|Screen Failure|2|||
23480375|NCT02342418|65501961|FG000|Overall Study|Adverse Event|0|||
23480376|NCT02342418|65501962|FG001|Overall Study|Adverse Event|1|||
23480377|NCT02195011|65501963|FG000|Overall Study|Adverse Event|4|||
23480378|NCT02195011|65501964|FG001|Overall Study|Adverse Event|0|||
23480379|NCT02195011|65501963|FG000|Overall Study|Progressive Disease|18|||
23480380|NCT02195011|65501964|FG001|Overall Study|Progressive Disease|1|||
23480381|NCT02195011|65501963|FG000|Overall Study|Withdrawal by Subject|3|||
23480382|NCT02195011|65501964|FG001|Overall Study|Withdrawal by Subject|0|||
23480383|NCT00266864|65501965|FG000|Overall Study|Lost to Follow-up|4|||
23480384|NCT00266864|65501966|FG001|Overall Study|Lost to Follow-up|1|||
23480385|NCT00266864|65501965|FG000|Overall Study|Withdrawal by Subject|1|||
23480386|NCT00266864|65501966|FG001|Overall Study|Withdrawal by Subject|1|||
23600147|NCT00692913|65925815|FG000|Overall Study|Adverse Event|8|||
23600148|NCT00692913|65925816|FG001|Overall Study|Adverse Event|4|||
23600149|NCT00692913|65925815|FG000|Overall Study|Lost to Follow-up|3|||
23600150|NCT00692913|65925816|FG001|Overall Study|Lost to Follow-up|5|||
23259218|NCT02629133|64690014|FG000|Overall Study|Lost to Follow-up|3|||
23259219|NCT02629133|64690015|FG001|Overall Study|Lost to Follow-up|1|||
23259220|NCT02629133|64690014|FG000|Overall Study|Withdrawal by Subject|1|||
23600151|NCT00692913|65925815|FG000|Overall Study|Physician Decision|2|||
23600152|NCT00692913|65925816|FG001|Overall Study|Physician Decision|0|||
23600153|NCT00692913|65925815|FG000|Overall Study|Protocol Violation|1|||
23600154|NCT00692913|65925816|FG001|Overall Study|Protocol Violation|1|||
23600155|NCT00692913|65925815|FG000|Overall Study|Withdrawal by Subject|15|||
23600156|NCT00692913|65925816|FG001|Overall Study|Withdrawal by Subject|20|||
23600157|NCT02701296|65925822|FG000|Overall Study|Incomplete Data|0|||
23600158|NCT02701296|65925823|FG001|Overall Study|Incomplete Data|2|||
23600159|NCT02130557|65925829|FG000|Overall Study|Withdrawal by Subject|12|||
23600160|NCT02130557|65925830|FG001|Overall Study|Withdrawal by Subject|12|||
23600161|NCT02130557|65925829|FG000|Overall Study|Investigator Request|0|||
23600162|NCT02130557|65925830|FG001|Overall Study|Investigator Request|2|||
23600163|NCT02130557|65925829|FG000|Overall Study|Deceased|14|||
23600164|NCT02130557|65925830|FG001|Overall Study|Deceased|14|||
23600165|NCT02130557|65925829|FG000|Overall Study|Lost to Follow-up|6|||
23600166|NCT02130557|65925830|FG001|Overall Study|Lost to Follow-up|7|||
23600167|NCT02130557|65925829|FG000|Overall Study|Other|2|||
23600168|NCT02130557|65925830|FG001|Overall Study|Other|1|||
23199556|NCT03567291|64468848|FG001|Period II|Missing or unknown|2|||
23199557|NCT03567291|64468849|FG002|Period II|Missing or unknown|1|||
23199558|NCT03567291|64468850|FG003|Period II|Missing or unknown|0|||
23199559|NCT03567291|64468847|FG000|Period III|Adverse Event|0|||
23199560|NCT03567291|64468848|FG001|Period III|Adverse Event|0|||
23199561|NCT03567291|64468849|FG002|Period III|Adverse Event|0|||
23199562|NCT03567291|64468850|FG003|Period III|Adverse Event|4|||
23199563|NCT03567291|64468847|FG000|Period III|Withdrawal by Subject|0|||
23199564|NCT03567291|64468848|FG001|Period III|Withdrawal by Subject|0|||
23199565|NCT03567291|64468849|FG002|Period III|Withdrawal by Subject|0|||
23199566|NCT03567291|64468850|FG003|Period III|Withdrawal by Subject|4|||
23199567|NCT03567291|64468847|FG000|Period III|Lost to Follow-up|0|||
23199568|NCT03567291|64468848|FG001|Period III|Lost to Follow-up|0|||
23199569|NCT03567291|64468849|FG002|Period III|Lost to Follow-up|0|||
23199570|NCT03567291|64468850|FG003|Period III|Lost to Follow-up|1|||
23199571|NCT03567291|64468847|FG000|Period III|Terminated by sponsor|0|||
23199572|NCT03567291|64468848|FG001|Period III|Terminated by sponsor|0|||
23199573|NCT03567291|64468849|FG002|Period III|Terminated by sponsor|0|||
23199574|NCT03567291|64468850|FG003|Period III|Terminated by sponsor|68|||
23199575|NCT03567291|64468847|FG000|Period III|Missing or unknown|0|||
23199576|NCT03567291|64468848|FG001|Period III|Missing or unknown|0|||
23199577|NCT03567291|64468849|FG002|Period III|Missing or unknown|0|||
23199578|NCT03567291|64468850|FG003|Period III|Missing or unknown|8|||
23199579|NCT00524316|64468861|FG000|Overall Study|Withdrawal by Subject|2|||
23199580|NCT00524316|64468861|FG000|Overall Study|Adverse Event|7|||
23199581|NCT00524316|64468861|FG000|Overall Study|Disease Progression|7|||
23199582|NCT03255291|64468870|FG000|Overall Study|Determined to be ineligible|10|||
23199583|NCT03255291|64468871|FG001|Overall Study|Determined to be ineligible|12|||
23199584|NCT03255291|64468872|FG002|Overall Study|Determined to be ineligible|6|||
23199585|NCT03255291|64468873|FG003|Overall Study|Determined to be ineligible|6|||
23199586|NCT03255291|64468874|FG004|Overall Study|Determined to be ineligible|5|||
23199587|NCT03255291|64468875|FG005|Overall Study|Determined to be ineligible|10|||
23199588|NCT03255291|64468870|FG000|Overall Study|Baseline data collection issues|3|||
23199589|NCT03255291|64468871|FG001|Overall Study|Baseline data collection issues|0|||
23199590|NCT03255291|64468872|FG002|Overall Study|Baseline data collection issues|0|||
23199591|NCT03255291|64468873|FG003|Overall Study|Baseline data collection issues|0|||
23199592|NCT03255291|64468874|FG004|Overall Study|Baseline data collection issues|2|||
23199593|NCT03255291|64468875|FG005|Overall Study|Baseline data collection issues|0|||
23199594|NCT00859898|64468878|FG000|Overall Study|Lack of Efficacy|0|||
23199595|NCT00859898|64468879|FG001|Overall Study|Lack of Efficacy|1|||
23199596|NCT00859898|64468880|FG002|Overall Study|Lack of Efficacy|1|||
23199597|NCT00859898|64468878|FG000|Overall Study|Adverse Event|4|||
23199598|NCT00859898|64468879|FG001|Overall Study|Adverse Event|9|||
23199599|NCT00859898|64468880|FG002|Overall Study|Adverse Event|8|||
23600169|NCT02130557|65925829|FG000|Overall Study|Missing|2|||
23600170|NCT02130557|65925830|FG001|Overall Study|Missing|1|||
23600171|NCT00116649|65925831|FG000|Overall Study|Adverse Event|20|||
23259221|NCT02629133|64690015|FG001|Overall Study|Withdrawal by Subject|1|||
23259222|NCT00673790|64690017|FG000|Overall Study|Adverse Event|23|||
23259223|NCT00673790|64690018|FG001|Overall Study|Adverse Event|14|||
23259224|NCT00673790|64690019|FG002|Overall Study|Adverse Event|2|||
23259225|NCT00673790|64690017|FG000|Overall Study|Lack of Efficacy|2|||
23259226|NCT00673790|64690018|FG001|Overall Study|Lack of Efficacy|2|||
23259227|NCT00673790|64690019|FG002|Overall Study|Lack of Efficacy|2|||
23259228|NCT00673790|64690017|FG000|Overall Study|Protocol Violation|6|||
23259229|NCT00673790|64690018|FG001|Overall Study|Protocol Violation|9|||
23259230|NCT00673790|64690019|FG002|Overall Study|Protocol Violation|1|||
23259231|NCT00673790|64690017|FG000|Overall Study|Withdrawal by Subject|7|||
23259232|NCT00673790|64690018|FG001|Overall Study|Withdrawal by Subject|4|||
23259233|NCT00673790|64690019|FG002|Overall Study|Withdrawal by Subject|1|||
23259234|NCT00673790|64690017|FG000|Overall Study|Lost to Follow-up|6|||
23259235|NCT00673790|64690018|FG001|Overall Study|Lost to Follow-up|6|||
23259236|NCT00673790|64690019|FG002|Overall Study|Lost to Follow-up|5|||
23259237|NCT00673790|64690017|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
23259238|NCT00673790|64690018|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
23259239|NCT00673790|64690019|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
23259240|NCT00673790|64690017|FG000|Overall Study|Poor compliance|1|||
23259241|NCT00673790|64690018|FG001|Overall Study|Poor compliance|0|||
23259242|NCT00673790|64690019|FG002|Overall Study|Poor compliance|0|||
23259243|NCT00673790|64690017|FG000|Overall Study|Participated in two Nebivolol studies|0|||
23259244|NCT00673790|64690018|FG001|Overall Study|Participated in two Nebivolol studies|0|||
23259245|NCT00673790|64690019|FG002|Overall Study|Participated in two Nebivolol studies|1|||
23259246|NCT00673790|64690017|FG000|Overall Study|Unconfirmed pregnancy|0|||
23259247|NCT00673790|64690018|FG001|Overall Study|Unconfirmed pregnancy|1|||
23259248|NCT00673790|64690019|FG002|Overall Study|Unconfirmed pregnancy|0|||
23259249|NCT00673790|64690017|FG000|Overall Study|Randomization criteria not met|0|||
23259250|NCT00673790|64690018|FG001|Overall Study|Randomization criteria not met|1|||
23259251|NCT00673790|64690019|FG002|Overall Study|Randomization criteria not met|0|||
23259252|NCT02482805|64690020|FG000|Overall Study|Lost to Follow-up|4|||
23259253|NCT02482805|64690021|FG001|Overall Study|Lost to Follow-up|4|||
23259254|NCT02482805|64690022|FG002|Overall Study|Lost to Follow-up|0|||
23259255|NCT02151461|64690030|FG000|Overall Study|Adverse Event|5|||
23259256|NCT02151461|64690031|FG001|Overall Study|Adverse Event|1|||
23259257|NCT02151461|64690032|FG002|Overall Study|Adverse Event|0|||
23259258|NCT02151461|64690033|FG003|Overall Study|Adverse Event|2|||
23259259|NCT02151461|64690030|FG000|Overall Study|Lost to Follow-up|0|||
23259260|NCT02151461|64690031|FG001|Overall Study|Lost to Follow-up|0|||
23259261|NCT02151461|64690032|FG002|Overall Study|Lost to Follow-up|1|||
23259262|NCT02151461|64690033|FG003|Overall Study|Lost to Follow-up|1|||
23259263|NCT02151461|64690030|FG000|Overall Study|Withdrawal by Subject|1|||
23259264|NCT02151461|64690031|FG001|Overall Study|Withdrawal by Subject|0|||
23259265|NCT02151461|64690032|FG002|Overall Study|Withdrawal by Subject|1|||
23259266|NCT02151461|64690033|FG003|Overall Study|Withdrawal by Subject|1|||
23259267|NCT02151461|64690030|FG000|Overall Study|Treatment discontinuation|0|||
23259268|NCT02151461|64690031|FG001|Overall Study|Treatment discontinuation|0|||
23259269|NCT02151461|64690032|FG002|Overall Study|Treatment discontinuation|1|||
23600172|NCT00116649|65925831|FG000|Overall Study|Lack of Efficacy|1|||
23600173|NCT00116649|65925831|FG000|Overall Study|Lost to Follow-up|32|||
23600174|NCT00116649|65925831|FG000|Overall Study|Withdrawal by Subject|68|||
23600175|NCT00116649|65925831|FG000|Overall Study|Local Skin Reaction|9|||
23600176|NCT00116649|65925831|FG000|Overall Study|Various Reasons|18|||
23600177|NCT00116649|65925831|FG000|Overall Study|Protocol Specified|7|||
23600178|NCT00146172|65925834|FG000|Overall Study|Adverse Event|0|||
23600179|NCT00146172|65925835|FG001|Overall Study|Adverse Event|0|||
23600180|NCT00146172|65925836|FG002|Overall Study|Adverse Event|1|||
23259270|NCT02151461|64690033|FG003|Overall Study|Treatment discontinuation|0|||
23259271|NCT01688037|64690034|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
23259272|NCT01688037|64690035|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
23259273|NCT01688037|64690036|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
23259274|NCT01688037|64690034|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
23259275|NCT01688037|64690035|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
23259276|NCT01688037|64690036|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
23480387|NCT00727532|65501967|FG000|Overall Study|Adverse Event|1|||
23600181|NCT00146172|65925837|FG003|Overall Study|Adverse Event|1|||
23259277|NCT01688037|64690034|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
23259278|NCT01688037|64690035|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
23259279|NCT01688037|64690036|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
23259280|NCT01688037|64690034|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
23259281|NCT01688037|64690035|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
23259282|NCT01688037|64690036|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
23259283|NCT01688037|64690034|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
23259284|NCT01688037|64690035|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
23259285|NCT01688037|64690036|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
23259286|NCT01688037|64690034|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
23259287|NCT01688037|64690035|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
23259288|NCT01688037|64690036|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
23259289|NCT01688037|64690034|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
23259290|NCT01688037|64690035|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
23259291|NCT01688037|64690036|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
23259292|NCT01688037|64690034|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
23259293|NCT01688037|64690035|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
23259294|NCT01688037|64690036|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
23259295|NCT01688037|64690034|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
23259296|NCT01688037|64690035|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
23259297|NCT01688037|64690036|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
23259298|NCT01688037|64690034|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
23259299|NCT01688037|64690035|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
23259300|NCT01688037|64690036|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
23259301|NCT00936975|64690037|FG000|Overall Study|Withdrawal by Subject|1|||
23600182|NCT00146172|65925838|FG004|Overall Study|Adverse Event|0|||
23600183|NCT00146172|65925839|FG005|Overall Study|Adverse Event|2|||
23600184|NCT00146172|65925840|FG006|Overall Study|Adverse Event|3|||
23600185|NCT00146172|65925841|FG007|Overall Study|Adverse Event|10|||
23600186|NCT00146172|65925834|FG000|Overall Study|Lost to Follow-up|0|||
23600187|NCT00146172|65925835|FG001|Overall Study|Lost to Follow-up|0|||
23600188|NCT00146172|65925836|FG002|Overall Study|Lost to Follow-up|0|||
23600189|NCT00146172|65925837|FG003|Overall Study|Lost to Follow-up|0|||
23600190|NCT00146172|65925838|FG004|Overall Study|Lost to Follow-up|0|||
23600191|NCT00146172|65925839|FG005|Overall Study|Lost to Follow-up|0|||
23600192|NCT00146172|65925840|FG006|Overall Study|Lost to Follow-up|0|||
23600193|NCT00146172|65925841|FG007|Overall Study|Lost to Follow-up|1|||
23600194|NCT00146172|65925834|FG000|Overall Study|Disease Progression|2|||
23600195|NCT00146172|65925835|FG001|Overall Study|Disease Progression|4|||
23600196|NCT00146172|65925836|FG002|Overall Study|Disease Progression|2|||
23600197|NCT00146172|65925837|FG003|Overall Study|Disease Progression|5|||
23600198|NCT00146172|65925838|FG004|Overall Study|Disease Progression|2|||
23600199|NCT00146172|65925839|FG005|Overall Study|Disease Progression|2|||
23600200|NCT00146172|65925840|FG006|Overall Study|Disease Progression|1|||
23600201|NCT00146172|65925841|FG007|Overall Study|Disease Progression|22|||
23600202|NCT00146172|65925834|FG000|Overall Study|Death|0|||
23600203|NCT00146172|65925835|FG001|Overall Study|Death|0|||
23600204|NCT00146172|65925836|FG002|Overall Study|Death|0|||
23600205|NCT00146172|65925837|FG003|Overall Study|Death|0|||
23600206|NCT00146172|65925838|FG004|Overall Study|Death|0|||
23600207|NCT00146172|65925839|FG005|Overall Study|Death|0|||
23600208|NCT00146172|65925840|FG006|Overall Study|Death|1|||
23600209|NCT00146172|65925841|FG007|Overall Study|Death|0|||
23600210|NCT00146172|65925834|FG000|Overall Study|Physician Decision|0|||
23600211|NCT00146172|65925835|FG001|Overall Study|Physician Decision|0|||
23600212|NCT00146172|65925836|FG002|Overall Study|Physician Decision|0|||
23600213|NCT00146172|65925837|FG003|Overall Study|Physician Decision|0|||
23600214|NCT00146172|65925838|FG004|Overall Study|Physician Decision|0|||
23600215|NCT00146172|65925839|FG005|Overall Study|Physician Decision|0|||
23600216|NCT00146172|65925840|FG006|Overall Study|Physician Decision|0|||
23600217|NCT00146172|65925841|FG007|Overall Study|Physician Decision|1|||
23480388|NCT00727532|65501967|FG000|Overall Study|Withdrawal by Subject|1|||
23480389|NCT02216812|65501968|FG000|Overall Study|Lost to Follow-up|10|||
23600218|NCT00146172|65925834|FG000|Overall Study|Withdrawal by Subject|0|||
23600219|NCT00146172|65925835|FG001|Overall Study|Withdrawal by Subject|0|||
23600220|NCT00146172|65925836|FG002|Overall Study|Withdrawal by Subject|0|||
23600221|NCT00146172|65925837|FG003|Overall Study|Withdrawal by Subject|0|||
23600222|NCT00146172|65925838|FG004|Overall Study|Withdrawal by Subject|0|||
23600223|NCT00146172|65925839|FG005|Overall Study|Withdrawal by Subject|1|||
23600224|NCT00146172|65925840|FG006|Overall Study|Withdrawal by Subject|1|||
23600225|NCT00146172|65925841|FG007|Overall Study|Withdrawal by Subject|4|||
23600226|NCT00146172|65925834|FG000|Overall Study|Symptomatic Deterioration|1|||
23600227|NCT00146172|65925835|FG001|Overall Study|Symptomatic Deterioration|0|||
23600228|NCT00146172|65925836|FG002|Overall Study|Symptomatic Deterioration|1|||
23600229|NCT00146172|65925837|FG003|Overall Study|Symptomatic Deterioration|0|||
23259302|NCT00936975|64690037|FG000|Overall Study|Disease progression|3|||
23259303|NCT00936975|64690037|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
23259304|NCT03031899|64690042|FG000|Overall Study|Protocol Violation|1|||
23259305|NCT03031899|64690042|FG000|Overall Study|lesion disappeared after stopping habit|1|||
23259306|NCT01238822|64690043|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
23259307|NCT01314703|64690044|FG000|Overall Study|screen failure and closed enrollment|8|||
23259308|NCT04079842|64690045|FG000|Overall Study|Request of subject|2|||
23259309|NCT04079842|64690045|FG000|Overall Study|Unable to draw Arterial samples|1|||
23259310|NCT00685919|64690046|FG000|Overall Study|Withdrawal by Subject|0|||
23259311|NCT00685919|64690047|FG001|Overall Study|Withdrawal by Subject|0|||
23259312|NCT00685919|64690048|FG002|Overall Study|Withdrawal by Subject|1|||
23259313|NCT00685919|64690049|FG003|Overall Study|Withdrawal by Subject|0|||
23259314|NCT00685919|64690046|FG000|Overall Study|Physician Decision|1|||
23259315|NCT00685919|64690047|FG001|Overall Study|Physician Decision|0|||
23259316|NCT00685919|64690048|FG002|Overall Study|Physician Decision|0|||
23259317|NCT00685919|64690049|FG003|Overall Study|Physician Decision|0|||
23259318|NCT00827827|64690050|FG000|Overall Study|Lost to Follow-up|3|||
23259319|NCT00827827|64690051|FG001|Overall Study|Lost to Follow-up|0|||
23259320|NCT00827827|64690050|FG000|Overall Study|Fall at home- hospitalization|1|||
23259321|NCT00827827|64690051|FG001|Overall Study|Fall at home- hospitalization|0|||
23259322|NCT00827827|64690050|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
23259323|NCT00827827|64690051|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
23259324|NCT00827827|64690050|FG000|Overall Study|Gout|1|||
23259325|NCT00827827|64690051|FG001|Overall Study|Gout|0|||
23259326|NCT00827827|64690050|FG000|Overall Study|Transportation issues|1|||
23259327|NCT00827827|64690051|FG001|Overall Study|Transportation issues|0|||
23259328|NCT00827827|64690050|FG000|Overall Study|Burned with water at home|1|||
23259329|NCT00827827|64690051|FG001|Overall Study|Burned with water at home|0|||
23259330|NCT01193517|64690053|FG000|Overall Study|Early Progression|1|||
23259331|NCT01193517|64690054|FG001|Overall Study|Early Progression|0|||
23259332|NCT01193517|64690055|FG002|Overall Study|Early Progression|0|||
23259333|NCT02004847|64690056|FG000|Overall Study|Protocol Violation|1|||
23259334|NCT02004847|64690057|FG001|Overall Study|Protocol Violation|1|||
23259335|NCT00319449|64690067|FG000|Overall Study|Subject did not wish to continue|1|||
23259336|NCT00319449|64690068|FG001|Overall Study|Subject did not wish to continue|0|||
23259337|NCT00319449|64690067|FG000|Overall Study|Noncompliance with the protocol|1|||
23259338|NCT00319449|64690068|FG001|Overall Study|Noncompliance with the protocol|0|||
23259339|NCT00798889|64690071|FG000|Overall Study|Adverse Event|53|||
23259340|NCT00798889|64690071|FG000|Overall Study|Protocol Violation|2|||
23259341|NCT00798889|64690071|FG000|Overall Study|Withdrawal by Subject|31|||
23259342|NCT00798889|64690071|FG000|Overall Study|Lost to Follow-up|1|||
23361237|NCT01001520|65069647|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
23259343|NCT00798889|64690071|FG000|Overall Study|Lack of Efficacy|213|||
23259344|NCT00798889|64690071|FG000|Overall Study|Decision of Sponsor|11|||
23259345|NCT00798889|64690071|FG000|Overall Study|Enrolled, Not treated|3|||
23259346|NCT00576199|64690072|FG000|Overall Study|Adverse Event|12|||
23259347|NCT00576199|64690072|FG000|Overall Study|Insufficient Therapeutic Response|14|||
23259348|NCT00576199|64690072|FG000|Overall Study|Refused Treatment|2|||
23259349|NCT00576199|64690072|FG000|Overall Study|Reason Unspecified|2|||
23259350|NCT02533999|64690073|FG000|Overall Study|Lost to Follow-up|3|||
23259351|NCT02533999|64690074|FG001|Overall Study|Lost to Follow-up|5|||
23259352|NCT02533999|64690073|FG000|Overall Study|Protocol Violation|3|||
23259353|NCT02533999|64690074|FG001|Overall Study|Protocol Violation|0|||
23259354|NCT02533999|64690073|FG000|Overall Study|Adverse Event|0|||
23259355|NCT02533999|64690074|FG001|Overall Study|Adverse Event|1|||
23259356|NCT02533999|64690073|FG000|Overall Study|Randomized but intervention not received|0|||
23259357|NCT02533999|64690074|FG001|Overall Study|Randomized but intervention not received|1|||
23259358|NCT01620983|64690076|FG000|Overall Study|Lost to Follow-up|8|||
23259359|NCT01620983|64690077|FG001|Overall Study|Lost to Follow-up|4|||
23259360|NCT01620983|64690078|FG002|Overall Study|Lost to Follow-up|9|||
23259361|NCT01620983|64690076|FG000|Overall Study|Withdrawal by Subject|6|||
23259362|NCT01620983|64690077|FG001|Overall Study|Withdrawal by Subject|8|||
23259363|NCT01620983|64690078|FG002|Overall Study|Withdrawal by Subject|1|||
23259364|NCT01620983|64690076|FG000|Overall Study|Death|2|||
23259365|NCT01620983|64690077|FG001|Overall Study|Death|0|||
23259366|NCT01620983|64690078|FG002|Overall Study|Death|0|||
23259367|NCT01620983|64690076|FG000|Overall Study|Physician Decision|3|||
23259368|NCT01620983|64690077|FG001|Overall Study|Physician Decision|10|||
23259369|NCT01620983|64690078|FG002|Overall Study|Physician Decision|5|||
23259370|NCT01859702|64692994|FG000|Overall Study|Protocol deviation|3|||
23259371|NCT01859702|64692994|FG000|Overall Study|Adverse Event|2|||
23259372|NCT01015612|64692997|FG000|Overall Study|Death|113|||
23259373|NCT01015612|64692997|FG000|Overall Study|Withdrawal by Subject|40|||
23259374|NCT00613574|64693012|FG000|Overall Study|Adverse Event|3|||
23259375|NCT00613574|64693012|FG000|Overall Study|Lost to Follow-up|2|||
23259376|NCT00613574|64693012|FG000|Overall Study|Other|1|||
23259377|NCT03372369|64693019|FG000|Qualification Period|Withdrawal by Subject|16|||
23259378|NCT03372369|64693020|FG001|Qualification Period|Withdrawal by Subject|13|||
23259379|NCT03372369|64693019|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
23259380|NCT03372369|64693020|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
23259381|NCT03372369|64693019|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
23259382|NCT03372369|64693020|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
23259383|NCT04378010|64693021|FG000|Overall Study|Adverse Event|8|||
23259384|NCT04378010|64693022|FG001|Overall Study|Adverse Event|14|||
23259385|NCT04378010|64693023|FG002|Overall Study|Adverse Event|4|||
23259386|NCT04378010|64693021|FG000|Overall Study|Withdrawal by Subject|0|||
23259387|NCT04378010|64693022|FG001|Overall Study|Withdrawal by Subject|2|||
23259388|NCT04378010|64693023|FG002|Overall Study|Withdrawal by Subject|1|||
23259389|NCT04378010|64693021|FG000|Overall Study|Protocol Violation|2|||
23199600|NCT00859898|64468878|FG000|Overall Study|Withdrawal by Subject|11|||
23199601|NCT00859898|64468879|FG001|Overall Study|Withdrawal by Subject|8|||
23199602|NCT00859898|64468880|FG002|Overall Study|Withdrawal by Subject|11|||
23199603|NCT00859898|64468878|FG000|Overall Study|Death|0|||
23199604|NCT00859898|64468879|FG001|Overall Study|Death|0|||
23199605|NCT00859898|64468880|FG002|Overall Study|Death|1|||
23199606|NCT00859898|64468878|FG000|Overall Study|Lost to Follow-up|10|||
23199607|NCT00859898|64468879|FG001|Overall Study|Lost to Follow-up|11|||
23199608|NCT00859898|64468880|FG002|Overall Study|Lost to Follow-up|5|||
23199609|NCT00859898|64468878|FG000|Overall Study|poor/non-compliance|2|||
23199610|NCT00859898|64468879|FG001|Overall Study|poor/non-compliance|0|||
23199611|NCT00859898|64468880|FG002|Overall Study|poor/non-compliance|0|||
23199612|NCT00859898|64468878|FG000|Overall Study|No longer meets criteria|0|||
23199613|NCT00859898|64468879|FG001|Overall Study|No longer meets criteria|1|||
23199614|NCT00859898|64468880|FG002|Overall Study|No longer meets criteria|0|||
23199615|NCT00859898|64468878|FG000|Overall Study|non-specified|1|||
23199616|NCT00859898|64468879|FG001|Overall Study|non-specified|1|||
23199617|NCT00859898|64468880|FG002|Overall Study|non-specified|1|||
23199618|NCT02689219|64468881|FG000|Overall Study|Death|1|||
23199619|NCT02689219|64468882|FG001|Overall Study|Death|1|||
23199620|NCT02689219|64468881|FG000|Overall Study|Disease Progression|10|||
23199621|NCT02689219|64468882|FG001|Overall Study|Disease Progression|6|||
23199622|NCT02207530|64468883|FG000|Overall Study|Worsening condition under investigation|78|||
23361238|NCT01001520|65069648|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
23199623|NCT02207530|64468883|FG000|Overall Study|Patient decision to stop study treatment|5|||
23199624|NCT02207530|64468883|FG000|Overall Study|Adverse Event|8|||
23259390|NCT04378010|64693022|FG001|Overall Study|Protocol Violation|1|||
23259391|NCT04378010|64693023|FG002|Overall Study|Protocol Violation|4|||
23259392|NCT04378010|64693021|FG000|Overall Study|Study terminated by Sponsor|22|||
23199625|NCT01402284|64468884|FG000|Overall Study|Withdrawal consent|2|||
23259393|NCT04378010|64693022|FG001|Overall Study|Study terminated by Sponsor|16|||
23259394|NCT04378010|64693023|FG002|Overall Study|Study terminated by Sponsor|22|||
23259395|NCT04378010|64693021|FG000|Overall Study|Subject inability to complete study visit|0|||
23259396|NCT04378010|64693022|FG001|Overall Study|Subject inability to complete study visit|0|||
23259397|NCT04378010|64693023|FG002|Overall Study|Subject inability to complete study visit|1|||
23259398|NCT04378010|64693021|FG000|Overall Study|Subject never dosed|0|||
23259399|NCT04378010|64693022|FG001|Overall Study|Subject never dosed|1|||
23259400|NCT04378010|64693023|FG002|Overall Study|Subject never dosed|0|||
23259401|NCT02668783|64693025|FG000|Overall Study|Pregnancy|0|||
23259402|NCT02668783|64693026|FG001|Overall Study|Pregnancy|1|||
23259403|NCT02668783|64693025|FG000|Overall Study|Protocol Violation|2|||
23259404|NCT02668783|64693026|FG001|Overall Study|Protocol Violation|1|||
23259405|NCT02668783|64693025|FG000|Overall Study|Study terminated by sponsor|9|||
23259406|NCT02668783|64693026|FG001|Overall Study|Study terminated by sponsor|10|||
23259407|NCT02668783|64693025|FG000|Overall Study|Subject moved|1|||
23259408|NCT02668783|64693026|FG001|Overall Study|Subject moved|0|||
23259409|NCT02668783|64693025|FG000|Overall Study|Withdrawal by Subject|1|||
23259410|NCT02668783|64693026|FG001|Overall Study|Withdrawal by Subject|0|||
23259411|NCT03627195|64693027|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
23361239|NCT01001520|65069647|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
23600230|NCT00146172|65925838|FG004|Overall Study|Symptomatic Deterioration|1|||
23600231|NCT00146172|65925839|FG005|Overall Study|Symptomatic Deterioration|2|||
23600232|NCT00146172|65925840|FG006|Overall Study|Symptomatic Deterioration|0|||
23600233|NCT00146172|65925841|FG007|Overall Study|Symptomatic Deterioration|2|||
23600234|NCT00753545|65925844|FG000|Overall Study|Death|98|||
23600235|NCT00753545|65925845|FG001|Overall Study|Death|112|||
23600236|NCT00753545|65925844|FG000|Overall Study|Lost to Follow-up|2|||
23600237|NCT00753545|65925845|FG001|Overall Study|Lost to Follow-up|3|||
23600238|NCT00753545|65925844|FG000|Overall Study|Protocol Violation|1|||
23600239|NCT00753545|65925845|FG001|Overall Study|Protocol Violation|0|||
23600240|NCT00753545|65925844|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
23600241|NCT00753545|65925845|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
23600242|NCT00914966|65925850|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
23600243|NCT00914966|65925850|FG000|Step 1: 1500 Units|Physician Decision|1|||
23600244|NCT00914966|65925850|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
23600245|NCT03624972|65925851|FG000|Overall Study|Lost to Follow-up|2|||
23600246|NCT03624972|65925852|FG001|Overall Study|Lost to Follow-up|0|||
23600247|NCT03624972|65925853|FG002|Overall Study|Lost to Follow-up|0|||
23600248|NCT03624972|65925851|FG000|Overall Study|Withdrawal by Subject|0|||
23600249|NCT03624972|65925852|FG001|Overall Study|Withdrawal by Subject|2|||
23600250|NCT03624972|65925853|FG002|Overall Study|Withdrawal by Subject|0|||
23600251|NCT04075396|65925854|FG000|Overall Study|Death|11|||
23600252|NCT04075396|65925855|FG001|Overall Study|Death|9|||
23600253|NCT04075396|65925854|FG000|Overall Study|Withdrawal by Subject|1|||
23600254|NCT04075396|65925855|FG001|Overall Study|Withdrawal by Subject|2|||
23600255|NCT04075396|65925854|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
23600256|NCT04075396|65925855|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
23600257|NCT04075396|65925854|FG000|Overall Study|Enrolled but not-treated|0|||
23600258|NCT04075396|65925855|FG001|Overall Study|Enrolled but not-treated|1|||
23600259|NCT01000805|65925856|FG000|Overall Study|Adverse Event|21|||
23600260|NCT01000805|65925857|FG001|Overall Study|Adverse Event|9|||
23600261|NCT01000805|65925856|FG000|Overall Study|Lack of Efficacy|5|||
23600262|NCT01000805|65925857|FG001|Overall Study|Lack of Efficacy|16|||
23600263|NCT01000805|65925856|FG000|Overall Study|Lost to Follow-up|16|||
23600264|NCT01000805|65925857|FG001|Overall Study|Lost to Follow-up|21|||
23600265|NCT01000805|65925856|FG000|Overall Study|Physician Decision|0|||
23600266|NCT01000805|65925857|FG001|Overall Study|Physician Decision|1|||
23600267|NCT01000805|65925856|FG000|Overall Study|Protocol Violation|12|||
23600268|NCT01000805|65925857|FG001|Overall Study|Protocol Violation|8|||
23600269|NCT01000805|65925856|FG000|Overall Study|Withdrawal by Subject|16|||
23600270|NCT01000805|65925857|FG001|Overall Study|Withdrawal by Subject|6|||
23600271|NCT01000805|65925856|FG000|Overall Study|Sponsor Decision|0|||
23600272|NCT01000805|65925857|FG001|Overall Study|Sponsor Decision|1|||
23600273|NCT02568215|65925858|FG000|Overall Study|Death|1|||
23259412|NCT03627195|64693028|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23259413|NCT03627195|64693029|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23361240|NCT01001520|65069648|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
23361241|NCT01001520|65069647|FG000|Washout Period|Withdrawal by Subject|2|||
23259414|NCT03627195|64693030|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23259415|NCT03627195|64693031|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23259416|NCT03627195|64693032|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
23259417|NCT02764489|64693035|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
23259418|NCT02764489|64693036|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
23259419|NCT02764489|64693035|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
23259420|NCT02764489|64693036|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
23259421|NCT02764489|64693035|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
23259422|NCT02764489|64693036|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
23259423|NCT02764489|64693035|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
23259424|NCT02764489|64693036|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
23259425|NCT02006147|64693037|FG000|Overall Study|Protocol Violation|1|||
23259426|NCT02006147|64693038|FG001|Overall Study|Protocol Violation|1|||
23480390|NCT02216812|65501969|FG001|Overall Study|Lost to Follow-up|5|||
23480391|NCT01673347|65501975|FG000|Overall Study|failure of allograft|7|||
23480392|NCT02635646|65501976|FG000|Overall Study|Lost to Follow-up|24|||
23480393|NCT02635646|65501977|FG001|Overall Study|Lost to Follow-up|25|||
23480394|NCT02635646|65501976|FG000|Overall Study|Pregnancy|1|||
23259427|NCT02006147|64693039|FG002|Overall Study|Protocol Violation|0|||
23259428|NCT02006147|64693040|FG003|Overall Study|Protocol Violation|0|||
23259429|NCT02006147|64693037|FG000|Overall Study|Withdrawal by Subject|0|||
23259430|NCT02006147|64693038|FG001|Overall Study|Withdrawal by Subject|1|||
23259431|NCT02006147|64693039|FG002|Overall Study|Withdrawal by Subject|0|||
23259432|NCT02006147|64693040|FG003|Overall Study|Withdrawal by Subject|0|||
23259433|NCT02006147|64693037|FG000|Overall Study|Withdrawal by Sponsor|1|||
23600274|NCT02568215|65925859|FG001|Overall Study|Death|2|||
23600275|NCT02568215|65925860|FG002|Overall Study|Death|0|||
23600276|NCT02568215|65925858|FG000|Overall Study|Physician Decision|2|||
23600277|NCT02568215|65925859|FG001|Overall Study|Physician Decision|2|||
23600278|NCT02568215|65925860|FG002|Overall Study|Physician Decision|2|||
23600279|NCT02568215|65925858|FG000|Overall Study|Lost to Follow-up|29|||
23259434|NCT02006147|64693038|FG001|Overall Study|Withdrawal by Sponsor|0|||
23259435|NCT02006147|64693039|FG002|Overall Study|Withdrawal by Sponsor|0|||
23259436|NCT02006147|64693040|FG003|Overall Study|Withdrawal by Sponsor|0|||
23259437|NCT03551730|64693041|FG000|Overall Study|Adverse Event|1|||
23259438|NCT03551730|64693042|FG001|Overall Study|Adverse Event|0|||
23259439|NCT03551730|64693043|FG002|Overall Study|Adverse Event|0|||
23259440|NCT03551730|64693044|FG003|Overall Study|Adverse Event|0|||
23259441|NCT00901628|64693045|FG000|Overall Study|disconnection of catheter|4|||
23259442|NCT00901628|64693046|FG001|Overall Study|disconnection of catheter|8|||
23259443|NCT00901628|64693045|FG000|Overall Study|disconnection of drain|0|||
23259444|NCT00901628|64693046|FG001|Overall Study|disconnection of drain|1|||
23259445|NCT00901628|64693045|FG000|Overall Study|peroneal nerve palsy|0|||
23259446|NCT00901628|64693046|FG001|Overall Study|peroneal nerve palsy|1|||
23259447|NCT01907737|64693047|FG000|Overall Study|Withdrawal by Subject|1|||
23259448|NCT00275028|64693048|FG000|Overall Study|Withdrew consent before treatment began|1|||
23259449|NCT00275028|64693048|FG000|Overall Study|Withdrawal by Subject|5|||
23259450|NCT00275028|64693048|FG000|Overall Study|Adverse Event|9|||
23361242|NCT01001520|65069648|FG001|Washout Period|Withdrawal by Subject|1|||
23480395|NCT02635646|65501977|FG001|Overall Study|Pregnancy|1|||
23480396|NCT01604278|65501982|FG000|Overall Study|Lack of Efficacy|0|||
23600280|NCT02568215|65925859|FG001|Overall Study|Lost to Follow-up|32|||
23600281|NCT02568215|65925860|FG002|Overall Study|Lost to Follow-up|41|||
23600282|NCT02568215|65925858|FG000|Overall Study|Withdrawal by Subject|21|||
23259451|NCT00275028|64693048|FG000|Overall Study|Progressive Disease|30|||
23259452|NCT00275028|64693048|FG000|Overall Study|Physician Decision|2|||
23361243|NCT01001520|65069647|FG000|Medication Period 2|Withdrawal by Subject|0|||
23361244|NCT01001520|65069648|FG001|Medication Period 2|Withdrawal by Subject|3|||
23259453|NCT00210626|64693049|FG000|Overall Study|Adverse Event|1|||
23259454|NCT00210626|64693050|FG001|Overall Study|Adverse Event|2|||
23259455|NCT00210626|64693049|FG000|Overall Study|Protocol Violation|1|||
23259456|NCT00210626|64693050|FG001|Overall Study|Protocol Violation|5|||
23259457|NCT00210626|64693049|FG000|Overall Study|Lost to Follow-up|11|||
23259458|NCT00210626|64693050|FG001|Overall Study|Lost to Follow-up|11|||
23259459|NCT00210626|64693049|FG000|Overall Study|Death|1|||
23259460|NCT00210626|64693050|FG001|Overall Study|Death|0|||
23259461|NCT00210626|64693049|FG000|Overall Study|Withdrawal by Subject|29|||
23259462|NCT00210626|64693050|FG001|Overall Study|Withdrawal by Subject|20|||
23259463|NCT00210626|64693049|FG000|Overall Study|Physician Decision|0|||
23259464|NCT00210626|64693050|FG001|Overall Study|Physician Decision|2|||
23259465|NCT00210626|64693049|FG000|Overall Study|Sponser Request|1|||
23259466|NCT00210626|64693050|FG001|Overall Study|Sponser Request|0|||
23259467|NCT00210626|64693049|FG000|Overall Study|Other|4|||
23259468|NCT00210626|64693050|FG001|Overall Study|Other|5|||
23259469|NCT00759148|64693051|FG000|Overall Study|Adverse Event|1|||
23259470|NCT00759148|64693052|FG001|Overall Study|Adverse Event|6|||
23259471|NCT00759148|64693051|FG000|Overall Study|Withdrawal by Subject|3|||
23259472|NCT00759148|64693052|FG001|Overall Study|Withdrawal by Subject|7|||
23259473|NCT00759148|64693051|FG000|Overall Study|Lost to Follow-up|3|||
23259474|NCT00759148|64693052|FG001|Overall Study|Lost to Follow-up|9|||
23259475|NCT00759148|64693051|FG000|Overall Study|Treatment Failure|6|||
23259476|NCT00759148|64693052|FG001|Overall Study|Treatment Failure|10|||
23259477|NCT00759148|64693051|FG000|Overall Study|Reason not given|1|||
23259478|NCT00759148|64693052|FG001|Overall Study|Reason not given|0|||
23259479|NCT02611752|64693053|FG000|Overall Study|Adverse Event|0|||
23259480|NCT02611752|64693054|FG001|Overall Study|Adverse Event|1|||
23259481|NCT01138150|64693055|FG000|Overall Study|blood unable to be processed|0|||
23259482|NCT01138150|64693056|FG001|Overall Study|blood unable to be processed|1|||
23259483|NCT01138150|64693055|FG000|Overall Study|Physician Decision|1|||
23259484|NCT01138150|64693056|FG001|Overall Study|Physician Decision|0|||
23259485|NCT02750761|64693057|FG000|Overall Study|Lost to Follow-up|0|||
23259486|NCT02750761|64693058|FG001|Overall Study|Lost to Follow-up|0|||
23259487|NCT02750761|64693059|FG002|Overall Study|Lost to Follow-up|1|||
23259488|NCT02750761|64693060|FG003|Overall Study|Lost to Follow-up|0|||
23259489|NCT02750761|64693061|FG004|Overall Study|Lost to Follow-up|0|||
23259490|NCT02750761|64693062|FG005|Overall Study|Lost to Follow-up|0|||
23259491|NCT02708277|64693063|FG000|Overall Study|Lost to Follow-up|7|||
23259492|NCT02708277|64693064|FG001|Overall Study|Lost to Follow-up|4|||
23199626|NCT01402284|64468884|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
23199627|NCT01402284|64468884|FG000|Overall Study|Physician Decision|1|||
23199628|NCT01402284|64468884|FG000|Overall Study|Disease progression on study|10|||
23199629|NCT04964063|64468885|FG000|Overall Study|Adverse Event|4|||
23199630|NCT04964063|64468885|FG000|Overall Study|Lost to Follow-up|47|||
23199631|NCT04964063|64468885|FG000|Overall Study|Withdrawal by Subject|5|||
23199632|NCT04964063|64468885|FG000|Overall Study|Baseline Tasks Expired|41|||
23199633|NCT04964063|64468885|FG000|Overall Study|Participant withdrawn in error|1|||
23199634|NCT00536731|64468886|FG000|Overall Study|Adverse Event|3|||
23199635|NCT00536731|64468887|FG001|Overall Study|Adverse Event|2|||
23199636|NCT00536731|64468888|FG002|Overall Study|Adverse Event|3|||
23199637|NCT00536731|64468886|FG000|Overall Study|Withdrawal by Subject|0|||
23199638|NCT00536731|64468887|FG001|Overall Study|Withdrawal by Subject|2|||
23199639|NCT00536731|64468888|FG002|Overall Study|Withdrawal by Subject|0|||
23199640|NCT00536731|64468886|FG000|Overall Study|Intake of prohibited conc. medication|0|||
23199641|NCT00536731|64468887|FG001|Overall Study|Intake of prohibited conc. medication|0|||
23199642|NCT00536731|64468888|FG002|Overall Study|Intake of prohibited conc. medication|1|||
23199643|NCT00536731|64468886|FG000|Overall Study|Safety reasons|0|||
23199644|NCT00536731|64468887|FG001|Overall Study|Safety reasons|0|||
23199645|NCT00536731|64468888|FG002|Overall Study|Safety reasons|1|||
23199646|NCT00536731|64468886|FG000|Overall Study|Other|1|||
23199647|NCT00536731|64468887|FG001|Overall Study|Other|1|||
23199648|NCT00536731|64468888|FG002|Overall Study|Other|0|||
23199649|NCT01798706|64468889|FG000|Overall Study|Adverse Event|15|||
23199650|NCT01798706|64468890|FG001|Overall Study|Adverse Event|10|||
23199651|NCT01798706|64468889|FG000|Overall Study|Lack of Efficacy|0|||
23199652|NCT01798706|64468890|FG001|Overall Study|Lack of Efficacy|2|||
23199653|NCT01798706|64468889|FG000|Overall Study|Poor compliance to protocol|1|||
23259493|NCT02742090|64693065|FG000|Overall Study|Adverse Event|10|||
23259494|NCT02742090|64693065|FG000|Overall Study|Death|3|||
23259495|NCT02742090|64693065|FG000|Overall Study|Disease Progression|25|||
23259496|NCT02742090|64693065|FG000|Overall Study|Investigator's Decision|1|||
23259497|NCT02742090|64693065|FG000|Overall Study|Lost to Follow-up|1|||
23259498|NCT02742090|64693065|FG000|Overall Study|Non-compliance with Study|1|||
23199654|NCT01798706|64468890|FG001|Overall Study|Poor compliance to protocol|0|||
23199655|NCT01798706|64468889|FG000|Overall Study|Other than specified above|5|||
23199656|NCT01798706|64468890|FG001|Overall Study|Other than specified above|9|||
23259499|NCT02742090|64693065|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
23259500|NCT02742090|64693065|FG000|Overall Study|Withdrawal by Subject|4|||
23259501|NCT02742090|64693065|FG000|Overall Study|Reason Not Specified|1|||
23259502|NCT01199601|64693069|FG000|Overall Study|Lost to Follow-up|47|||
23259503|NCT01199601|64693070|FG001|Overall Study|Lost to Follow-up|66|||
23259504|NCT01199601|64693069|FG000|Overall Study|Withdrawal by Subject|15|||
23259505|NCT01199601|64693070|FG001|Overall Study|Withdrawal by Subject|3|||
23259506|NCT01199601|64693069|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
23259507|NCT01199601|64693070|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
23259508|NCT00608205|64693071|FG000|Overall Study|Adverse Event|3|||
23259509|NCT00608205|64693072|FG001|Overall Study|Adverse Event|2|||
23259510|NCT00608205|64693071|FG000|Overall Study|Patient non-compliant|0|||
23259511|NCT00608205|64693072|FG001|Overall Study|Patient non-compliant|1|||
23600283|NCT02568215|65925859|FG001|Overall Study|Withdrawal by Subject|19|||
23600284|NCT02568215|65925860|FG002|Overall Study|Withdrawal by Subject|22|||
23600285|NCT02568215|65925858|FG000|Overall Study|Protocol Violation|1|||
23600286|NCT02568215|65925859|FG001|Overall Study|Protocol Violation|1|||
23600287|NCT02568215|65925860|FG002|Overall Study|Protocol Violation|0|||
23600288|NCT02568215|65925858|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
23600289|NCT02568215|65925859|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
23600290|NCT02568215|65925860|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
23600291|NCT02568215|65925858|FG000|Overall Study|Other|0|||
23600292|NCT02568215|65925859|FG001|Overall Study|Other|1|||
23600293|NCT02568215|65925860|FG002|Overall Study|Other|4|||
23259512|NCT01783483|64693078|FG000|Overall Study|Death|3|||
23259513|NCT01783483|64693079|FG001|Overall Study|Death|3|||
23259514|NCT01783483|64693078|FG000|Overall Study|Lost to Follow-up|14|||
23259515|NCT01783483|64693079|FG001|Overall Study|Lost to Follow-up|10|||
23259516|NCT01783483|64693078|FG000|Overall Study|Withdrawal by Subject|2|||
23259517|NCT01783483|64693079|FG001|Overall Study|Withdrawal by Subject|1|||
23259518|NCT01783483|64693078|FG000|Overall Study|Physician Decision|1|||
23259519|NCT01783483|64693079|FG001|Overall Study|Physician Decision|1|||
23361245|NCT03839394|65069649|FG000|Overall Study|Lost to Follow-up|6|||
23361246|NCT03839394|65069650|FG001|Overall Study|Lost to Follow-up|8|||
23199657|NCT03569293|64468891|FG000|Overall Study|Adverse Event|4|||
23199658|NCT03569293|64468892|FG001|Overall Study|Adverse Event|1|||
23199659|NCT03569293|64468893|FG002|Overall Study|Adverse Event|5|||
23199660|NCT03569293|64468894|FG003|Overall Study|Adverse Event|1|||
23199661|NCT03569293|64468895|FG004|Overall Study|Adverse Event|0|||
23199662|NCT03569293|64468896|FG005|Overall Study|Adverse Event|0|||
23199663|NCT03569293|64468891|FG000|Overall Study|Withdrawal by Subject|16|||
23199664|NCT03569293|64468892|FG001|Overall Study|Withdrawal by Subject|2|||
23199665|NCT03569293|64468893|FG002|Overall Study|Withdrawal by Subject|4|||
23199666|NCT03569293|64468894|FG003|Overall Study|Withdrawal by Subject|1|||
23199667|NCT03569293|64468895|FG004|Overall Study|Withdrawal by Subject|0|||
23199668|NCT03569293|64468896|FG005|Overall Study|Withdrawal by Subject|0|||
23199669|NCT03569293|64468891|FG000|Overall Study|Lost to Follow-up|1|||
23199670|NCT03569293|64468892|FG001|Overall Study|Lost to Follow-up|3|||
23199671|NCT03569293|64468893|FG002|Overall Study|Lost to Follow-up|1|||
23199672|NCT03569293|64468894|FG003|Overall Study|Lost to Follow-up|1|||
23199673|NCT03569293|64468895|FG004|Overall Study|Lost to Follow-up|0|||
23199674|NCT03569293|64468896|FG005|Overall Study|Lost to Follow-up|0|||
23199675|NCT03569293|64468891|FG000|Overall Study|Other|8|||
23199676|NCT03569293|64468892|FG001|Overall Study|Other|2|||
23199677|NCT03569293|64468893|FG002|Overall Study|Other|1|||
23259520|NCT00717756|64693080|FG000|Overall Study|Withdrawal by Subject|1|||
23259521|NCT00909727|64693081|FG000|Overall Study|Adverse Event|1|||
23361247|NCT03839394|65069649|FG000|Overall Study|Withdrawal by Subject|0|||
23361248|NCT03839394|65069650|FG001|Overall Study|Withdrawal by Subject|2|||
23361249|NCT00760487|65069652|FG000|Overall Study|Unilateral implantation|3|||
23361250|NCT00369343|65069653|FG000|Double-blind Phase|Adverse Event|19|||
23361251|NCT00369343|65069654|FG001|Double-blind Phase|Adverse Event|4|||
23361252|NCT00369343|65069653|FG000|Double-blind Phase|Failed to return|2|||
23361253|NCT00369343|65069654|FG001|Double-blind Phase|Failed to return|0|||
23361254|NCT00369343|65069653|FG000|Double-blind Phase|Lost to Follow-up|9|||
23361255|NCT00369343|65069654|FG001|Double-blind Phase|Lost to Follow-up|2|||
23361256|NCT00369343|65069653|FG000|Double-blind Phase|Protocol Violation|2|||
23600294|NCT03489369|65925861|FG000|Overall Study|Documented Progressive Disease|3|||
23600295|NCT03489369|65925862|FG001|Overall Study|Documented Progressive Disease|2|||
23361257|NCT00369343|65069654|FG001|Double-blind Phase|Protocol Violation|0|||
23361258|NCT00369343|65069653|FG000|Double-blind Phase|Withdrawal by Subject|8|||
23361259|NCT00369343|65069654|FG001|Double-blind Phase|Withdrawal by Subject|6|||
23361260|NCT00369343|65069653|FG000|Double-blind Phase|Lack of Efficacy|0|||
23361261|NCT00369343|65069654|FG001|Double-blind Phase|Lack of Efficacy|4|||
23361262|NCT00369343|65069653|FG000|Double-blind Phase|Protocol deviation|4|||
23600296|NCT03489369|65925863|FG002|Overall Study|Documented Progressive Disease|3|||
23361263|NCT00369343|65069654|FG001|Double-blind Phase|Protocol deviation|0|||
23199678|NCT03569293|64468894|FG003|Overall Study|Other|1|||
23361264|NCT00369343|65069653|FG000|Open-label Phase|Adverse Event|19|||
23199679|NCT03569293|64468895|FG004|Overall Study|Other|0|||
23199680|NCT03569293|64468896|FG005|Overall Study|Other|0|||
23199681|NCT03569293|64468891|FG000|Overall Study|Ongoing at Time of Analysis|8|||
23199682|NCT03569293|64468892|FG001|Overall Study|Ongoing at Time of Analysis|1|||
23259522|NCT00909727|64693082|FG001|Overall Study|Adverse Event|0|||
23259523|NCT00909727|64693081|FG000|Overall Study|Wrong Genotype|1|||
23259524|NCT00909727|64693082|FG001|Overall Study|Wrong Genotype|0|||
23259525|NCT00909727|64693081|FG000|Overall Study|Withdrawal of Consent|1|||
23361265|NCT00369343|65069654|FG001|Open-label Phase|Adverse Event|7|||
23361266|NCT00369343|65069653|FG000|Open-label Phase|Failed to return|4|||
23600297|NCT03489369|65925864|FG003|Overall Study|Documented Progressive Disease|6|||
23259526|NCT00909727|64693082|FG001|Overall Study|Withdrawal of Consent|0|||
23259527|NCT00909727|64693081|FG000|Overall Study|Prohibited Medication|1|||
23259528|NCT00909727|64693082|FG001|Overall Study|Prohibited Medication|0|||
23259529|NCT00429923|64693086|FG000|Overall Study|Adverse Event|0|||
23259530|NCT00429923|64693087|FG001|Overall Study|Adverse Event|2|||
23259531|NCT00429923|64693088|FG002|Overall Study|Adverse Event|3|||
23259532|NCT00429923|64693086|FG000|Overall Study|Lack of Efficacy|4|||
23259533|NCT00429923|64693087|FG001|Overall Study|Lack of Efficacy|1|||
23259534|NCT00429923|64693088|FG002|Overall Study|Lack of Efficacy|33|||
23259535|NCT00429923|64693086|FG000|Overall Study|Lost to Follow-up|0|||
23259536|NCT00429923|64693087|FG001|Overall Study|Lost to Follow-up|0|||
23259537|NCT00429923|64693088|FG002|Overall Study|Lost to Follow-up|2|||
23259538|NCT00429923|64693086|FG000|Overall Study|Withdrew Consent|1|||
23259539|NCT00429923|64693087|FG001|Overall Study|Withdrew Consent|0|||
23259540|NCT00429923|64693088|FG002|Overall Study|Withdrew Consent|1|||
23259541|NCT00429923|64693086|FG000|Overall Study|Early Termination|0|||
23600298|NCT03489369|65925861|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
23600299|NCT03489369|65925862|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
23600300|NCT03489369|65925863|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
23600301|NCT03489369|65925864|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
23600302|NCT03205566|65925865|FG000|Phase 1|Protocol Violation|1|||
23600303|NCT03205566|65925866|FG001|Phase 1|Protocol Violation|1|||
23600304|NCT02408887|65929626|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
23600305|NCT02408887|65929627|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
23600306|NCT02408887|65929626|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
23600307|NCT02408887|65929627|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
23600308|NCT00090519|65929628|FG000|Overall Study|Adverse Event|5|||
23600309|NCT00090519|65929629|FG001|Overall Study|Adverse Event|4|||
23600310|NCT00090519|65929628|FG000|Overall Study|Death|9|||
23600311|NCT00090519|65929629|FG001|Overall Study|Death|9|||
23600312|NCT00090519|65929628|FG000|Overall Study|Lost to Follow-up|26|||
23600313|NCT00090519|65929629|FG001|Overall Study|Lost to Follow-up|29|||
23600314|NCT00090519|65929628|FG000|Overall Study|Withdrawal by Subject|28|||
23600315|NCT00090519|65929629|FG001|Overall Study|Withdrawal by Subject|29|||
23600316|NCT00090519|65929628|FG000|Overall Study|Physician Decision|2|||
23600317|NCT00090519|65929629|FG001|Overall Study|Physician Decision|3|||
23600318|NCT00090519|65929628|FG000|Overall Study|Sponsor Decision|3|||
23600319|NCT00090519|65929629|FG001|Overall Study|Sponsor Decision|1|||
23600320|NCT00293397|65929630|FG000|Overall Study|Death|2|||
23600321|NCT02513667|65929631|FG000|Overall Study|Withdrawal by Subject|0|||
23600322|NCT02513667|65929632|FG001|Overall Study|Withdrawal by Subject|1|||
23600323|NCT03675321|65929637|FG000|Overall Study|Lack of Efficacy|2|||
23600324|NCT03675321|65929638|FG001|Overall Study|Lack of Efficacy|2|||
23600325|NCT03675321|65929637|FG000|Overall Study|Withdrawal by Subject|1|||
23600326|NCT03675321|65929638|FG001|Overall Study|Withdrawal by Subject|3|||
23600327|NCT01084694|65929639|FG000|Overall Study|Withdrawal by Subject|2|||
23600328|NCT01084694|65929640|FG001|Overall Study|Withdrawal by Subject|1|||
23600329|NCT01084694|65929639|FG000|Overall Study|Death|2|||
23600330|NCT01084694|65929640|FG001|Overall Study|Death|12|||
23600331|NCT01084694|65929639|FG000|Overall Study|eligibility not maintained|2|||
23600332|NCT01084694|65929640|FG001|Overall Study|eligibility not maintained|7|||
23600333|NCT00894543|65929642|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
23600334|NCT00894543|65929643|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
23600335|NCT00894543|65929642|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
23600336|NCT00894543|65929643|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
23600337|NCT02765100|65929644|FG000|Overall Study|subject found ineligible after baseline|1|||
23600338|NCT02765100|65929645|FG001|Overall Study|subject found ineligible after baseline|1|||
23259542|NCT00429923|64693087|FG001|Overall Study|Early Termination|1|||
23259543|NCT00429923|64693088|FG002|Overall Study|Early Termination|0|||
23361267|NCT00369343|65069654|FG001|Open-label Phase|Failed to return|0|||
23600339|NCT02765100|65929644|FG000|Overall Study|Lost to Follow-up|0|||
23361268|NCT00369343|65069653|FG000|Open-label Phase|Physician Decision|2|||
23600340|NCT02765100|65929645|FG001|Overall Study|Lost to Follow-up|1|||
23259544|NCT04527471|64693089|FG000|Overall Study|Adverse Event|1|||
23259545|NCT04527471|64693090|FG001|Overall Study|Adverse Event|0|||
23600341|NCT02561195|65929651|FG000|Vaccination 1 to 3|Adverse Event|4|||
23600342|NCT02561195|65929652|FG001|Vaccination 1 to 3|Adverse Event|5|||
23600343|NCT02561195|65929653|FG002|Vaccination 1 to 3|Adverse Event|0|||
23259546|NCT04527471|64693089|FG000|Overall Study|Lost to Follow-up|1|||
23259547|NCT04527471|64693090|FG001|Overall Study|Lost to Follow-up|0|||
23259548|NCT01606137|64693091|FG000|Overall Study|Adverse Event|85|||
23480397|NCT01604278|65501983|FG001|Overall Study|Lack of Efficacy|1|||
23480398|NCT01604278|65501982|FG000|Overall Study|Lost to Follow-up|1|||
23480399|NCT01604278|65501983|FG001|Overall Study|Lost to Follow-up|0|||
23480400|NCT01604278|65501982|FG000|Overall Study|Administrative problems|2|||
23480401|NCT01604278|65501983|FG001|Overall Study|Administrative problems|1|||
23480402|NCT01604278|65501982|FG000|Overall Study|Withdrawal by Subject|3|||
23480403|NCT01604278|65501983|FG001|Overall Study|Withdrawal by Subject|3|||
23480404|NCT01604278|65501982|FG000|Overall Study|Adverse Event|3|||
23480405|NCT01604278|65501983|FG001|Overall Study|Adverse Event|5|||
23480406|NCT01604278|65501982|FG000|Overall Study|Protocol Deviation|5|||
23480407|NCT01604278|65501983|FG001|Overall Study|Protocol Deviation|3|||
23480408|NCT02217527|65501984|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
23480409|NCT02217527|65501985|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
23480410|NCT02217527|65501984|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
23480411|NCT02217527|65501985|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
23480412|NCT00392379|65501989|FG000|Overall Study|Withdrawal by Subject|17|||
23480413|NCT00392379|65501990|FG001|Overall Study|Withdrawal by Subject|28|||
23480414|NCT00392379|65501989|FG000|Overall Study|Lost to Follow-up|4|||
23480415|NCT00392379|65501990|FG001|Overall Study|Lost to Follow-up|9|||
23480416|NCT00392379|65501989|FG000|Overall Study|Adverse Event|1|||
23480417|NCT00392379|65501990|FG001|Overall Study|Adverse Event|1|||
23480418|NCT04585009|65501991|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
23480419|NCT04585009|65501992|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480420|NCT04585009|65501993|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480421|NCT04585009|65501994|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480422|NCT04585009|65501995|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480423|NCT04585009|65501996|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480424|NCT04585009|65501997|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480425|NCT04585009|65501998|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480426|NCT04585009|65501999|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480427|NCT04585009|65502000|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480428|NCT04585009|65502001|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480429|NCT04585009|65502002|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
23480430|NCT04585009|65501991|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
23480431|NCT04585009|65501992|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480432|NCT04585009|65501993|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480433|NCT04585009|65501994|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480434|NCT04585009|65501995|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480435|NCT04585009|65501996|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480436|NCT04585009|65501997|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480437|NCT04585009|65501998|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480438|NCT04585009|65501999|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480439|NCT04585009|65502000|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480440|NCT04585009|65502001|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480441|NCT04585009|65502002|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
23480442|NCT04585009|65501991|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480443|NCT04585009|65501992|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480444|NCT04585009|65501993|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480445|NCT04585009|65501994|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480446|NCT04585009|65501995|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480447|NCT04585009|65501996|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480448|NCT04585009|65501997|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480449|NCT04585009|65501998|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
23480450|NCT04585009|65501999|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480451|NCT04585009|65502000|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480452|NCT04585009|65502001|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480453|NCT04585009|65502002|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
23480454|NCT04585009|65501991|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480455|NCT04585009|65501992|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480456|NCT04585009|65501993|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23199683|NCT03569293|64468893|FG002|Overall Study|Ongoing at Time of Analysis|3|||
23199684|NCT03569293|64468894|FG003|Overall Study|Ongoing at Time of Analysis|0|||
23199685|NCT03569293|64468895|FG004|Overall Study|Ongoing at Time of Analysis|0|||
23480457|NCT04585009|65501994|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480458|NCT04585009|65501995|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
23480459|NCT04585009|65501996|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480460|NCT04585009|65501997|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23259549|NCT01606137|64693091|FG000|Overall Study|Withdrawal by Subject|74|||
23259550|NCT01606137|64693091|FG000|Overall Study|Lack of Efficacy|56|||
23259551|NCT01606137|64693091|FG000|Overall Study|Lost to Follow-up|15|||
23259552|NCT01606137|64693091|FG000|Overall Study|Protocol Violation|1|||
23259553|NCT01606137|64693091|FG000|Overall Study|Patient non-compliance|9|||
23259554|NCT01606137|64693091|FG000|Overall Study|Death|1|||
23259555|NCT01606137|64693091|FG000|Overall Study|Decreased/no pain|4|||
23259556|NCT01606137|64693091|FG000|Overall Study|Issues with driving|4|||
23259557|NCT01606137|64693091|FG000|Overall Study|multiple sclerosis less stable|1|||
23259558|NCT01606137|64693091|FG000|Overall Study|Increased bilirubin|1|||
23259559|NCT01606137|64693091|FG000|Overall Study|Spray causes nausea|1|||
23259560|NCT01606137|64693091|FG000|Overall Study|Not enough improvement|4|||
23259561|NCT01606137|64693091|FG000|Overall Study|Wanted to try another treatment|1|||
23259562|NCT01606137|64693091|FG000|Overall Study|Patient leaving country|1|||
23259563|NCT01606137|64693091|FG000|Overall Study|Personal reasons|1|||
23259564|NCT01606137|64693091|FG000|Overall Study|Unable to tolerate study med. taste|1|||
23259565|NCT01606137|64693091|FG000|Overall Study|Patient moving|1|||
23259566|NCT01606137|64693091|FG000|Overall Study|Unable to collect consistent data|1|||
23259567|NCT01333033|64693092|FG000|Overall Study|Ineligible|0|||
23259568|NCT01333033|64693093|FG001|Overall Study|Ineligible|0|||
23259569|NCT01333033|64693094|FG002|Overall Study|Ineligible|0|||
23259570|NCT01333033|64693095|FG003|Overall Study|Ineligible|0|||
23259571|NCT01333033|64693096|FG004|Overall Study|Ineligible|6|||
23259572|NCT01333033|64693097|FG005|Overall Study|Ineligible|8|||
23259573|NCT01333033|64693092|FG000|Overall Study|Withdrawal by Subject|0|||
23259574|NCT01333033|64693093|FG001|Overall Study|Withdrawal by Subject|0|||
23259575|NCT01333033|64693094|FG002|Overall Study|Withdrawal by Subject|0|||
23259576|NCT01333033|64693095|FG003|Overall Study|Withdrawal by Subject|0|||
23259577|NCT01333033|64693096|FG004|Overall Study|Withdrawal by Subject|4|||
23259578|NCT01333033|64693097|FG005|Overall Study|Withdrawal by Subject|2|||
23259579|NCT01333033|64693092|FG000|Overall Study|PET inevaluable|0|||
23259580|NCT01333033|64693093|FG001|Overall Study|PET inevaluable|0|||
23259581|NCT01333033|64693094|FG002|Overall Study|PET inevaluable|0|||
23259582|NCT01333033|64693095|FG003|Overall Study|PET inevaluable|0|||
23259583|NCT01333033|64693096|FG004|Overall Study|PET inevaluable|2|||
23259584|NCT01333033|64693097|FG005|Overall Study|PET inevaluable|4|||
23259585|NCT01333033|64693092|FG000|Overall Study|Adverse Event|0|||
23259586|NCT01333033|64693093|FG001|Overall Study|Adverse Event|0|||
23259587|NCT01333033|64693094|FG002|Overall Study|Adverse Event|0|||
23259588|NCT01333033|64693095|FG003|Overall Study|Adverse Event|0|||
23259589|NCT01333033|64693096|FG004|Overall Study|Adverse Event|2|||
23259590|NCT01333033|64693097|FG005|Overall Study|Adverse Event|1|||
23259591|NCT01333033|64693092|FG000|Overall Study|Progression|0|||
23259592|NCT01333033|64693093|FG001|Overall Study|Progression|0|||
23259593|NCT01333033|64693094|FG002|Overall Study|Progression|0|||
23259594|NCT01333033|64693095|FG003|Overall Study|Progression|0|||
23259595|NCT01333033|64693096|FG004|Overall Study|Progression|0|||
23259596|NCT01333033|64693097|FG005|Overall Study|Progression|1|||
23259597|NCT01333033|64693092|FG000|Overall Study|MD Decision|0|||
23259598|NCT01333033|64693093|FG001|Overall Study|MD Decision|0|||
23259599|NCT01333033|64693094|FG002|Overall Study|MD Decision|0|||
23259600|NCT01333033|64693095|FG003|Overall Study|MD Decision|0|||
23259601|NCT01333033|64693096|FG004|Overall Study|MD Decision|0|||
23259602|NCT01333033|64693097|FG005|Overall Study|MD Decision|2|||
23259603|NCT00481247|64693105|FG000|Overall Study|Death|0|||
23259604|NCT00481247|64693106|FG001|Overall Study|Death|1|||
23259605|NCT00481247|64693105|FG000|Overall Study|Disease progression|18|||
23259606|NCT00481247|64693106|FG001|Overall Study|Disease progression|22|||
23259607|NCT00481247|64693105|FG000|Overall Study|Intolerance|42|||
23259608|NCT00481247|64693106|FG001|Overall Study|Intolerance|17|||
23259609|NCT00481247|64693105|FG000|Overall Study|Treatment failure|10|||
23259610|NCT00481247|64693106|FG001|Overall Study|Treatment failure|14|||
23259611|NCT00481247|64693105|FG000|Overall Study|AE unrelated to study drug|13|||
23259612|NCT00481247|64693106|FG001|Overall Study|AE unrelated to study drug|4|||
23259613|NCT00481247|64693105|FG000|Overall Study|Withdrawal by Subject|8|||
23259614|NCT00481247|64693106|FG001|Overall Study|Withdrawal by Subject|13|||
23600344|NCT02561195|65929654|FG003|Vaccination 1 to 3|Adverse Event|3|||
23259615|NCT00481247|64693105|FG000|Overall Study|Pregnancy|2|||
23259616|NCT00481247|64693106|FG001|Overall Study|Pregnancy|1|||
23259617|NCT00481247|64693105|FG000|Overall Study|Lost to Follow-up|1|||
23600345|NCT02561195|65929655|FG004|Vaccination 1 to 3|Adverse Event|4|||
23259618|NCT00481247|64693106|FG001|Overall Study|Lost to Follow-up|2|||
23259619|NCT00481247|64693105|FG000|Overall Study|Poor compliance/noncompliance|1|||
23259620|NCT00481247|64693106|FG001|Overall Study|Poor compliance/noncompliance|7|||
23259621|NCT00481247|64693105|FG000|Overall Study|Administrative reason by sponsor|157|||
23259622|NCT00481247|64693106|FG001|Overall Study|Administrative reason by sponsor|162|||
23259623|NCT00481247|64693105|FG000|Overall Study|Varied|6|||
23259624|NCT00481247|64693106|FG001|Overall Study|Varied|15|||
23259625|NCT00481247|64693105|FG000|Overall Study|Did not receive treatment|1|||
23259626|NCT00481247|64693106|FG001|Overall Study|Did not receive treatment|2|||
23259627|NCT00252187|64693107|FG000|Overall Study|Adverse Event|3|||
23259628|NCT00252187|64693108|FG001|Overall Study|Adverse Event|1|||
23259629|NCT00252187|64693107|FG000|Overall Study|Withdrawal by Subject|1|||
23259630|NCT00252187|64693108|FG001|Overall Study|Withdrawal by Subject|0|||
23259631|NCT02753400|64693109|FG000|Overall Study|Adverse Event|3|||
23259632|NCT02753400|64693110|FG001|Overall Study|Adverse Event|0|||
23259633|NCT02753400|64693109|FG000|Overall Study|Withdrawal by Subject|2|||
23259634|NCT02753400|64693110|FG001|Overall Study|Withdrawal by Subject|1|||
23259635|NCT04896385|64693112|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
23259636|NCT04896385|64693113|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
23259637|NCT04896385|64693114|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
23259638|NCT04896385|64693115|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
23259639|NCT04896385|64693112|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
23259640|NCT04896385|64693113|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
23259641|NCT04896385|64693114|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
23259642|NCT04896385|64693115|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
23259643|NCT04896385|64693112|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
23259644|NCT04896385|64693113|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
23259645|NCT04896385|64693114|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
23259646|NCT04896385|64693115|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
23259647|NCT04896385|64693112|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
23259648|NCT04896385|64693113|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
23259649|NCT04896385|64693114|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
23259650|NCT04896385|64693115|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
23259651|NCT04896385|64693112|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
23259652|NCT04896385|64693113|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
23259653|NCT04896385|64693114|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
23259654|NCT04896385|64693115|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
23259655|NCT04896385|64693112|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
23259656|NCT04896385|64693113|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
23259657|NCT04896385|64693114|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
23259658|NCT04896385|64693115|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
23259659|NCT01965535|64693118|FG000|Overall Study|Lack of Efficacy|2|||
23259660|NCT01965535|64693119|FG001|Overall Study|Lack of Efficacy|1|||
23259661|NCT02266706|64693121|FG000|Overall Study|Withdrawal by Subject|0|||
23259662|NCT02266706|64693122|FG001|Overall Study|Withdrawal by Subject|1|||
23259663|NCT02266706|64693123|FG002|Overall Study|Withdrawal by Subject|1|||
23259664|NCT02266706|64693124|FG003|Overall Study|Withdrawal by Subject|0|||
23259665|NCT02266706|64693125|FG004|Overall Study|Withdrawal by Subject|0|||
23259666|NCT02266706|64693126|FG005|Overall Study|Withdrawal by Subject|1|||
23259667|NCT02266706|64693127|FG006|Overall Study|Withdrawal by Subject|0|||
23259668|NCT02266706|64693128|FG007|Overall Study|Withdrawal by Subject|0|||
23259669|NCT02266706|64693129|FG008|Overall Study|Withdrawal by Subject|0|||
23259670|NCT02266706|64693121|FG000|Overall Study|Screen failure|0|||
23259671|NCT02266706|64693122|FG001|Overall Study|Screen failure|0|||
23259672|NCT02266706|64693123|FG002|Overall Study|Screen failure|0|||
23259673|NCT02266706|64693124|FG003|Overall Study|Screen failure|0|||
23259674|NCT02266706|64693125|FG004|Overall Study|Screen failure|0|||
23259675|NCT02266706|64693126|FG005|Overall Study|Screen failure|1|||
23259676|NCT02266706|64693127|FG006|Overall Study|Screen failure|1|||
23259677|NCT02266706|64693128|FG007|Overall Study|Screen failure|0|||
23259678|NCT02266706|64693129|FG008|Overall Study|Screen failure|0|||
23259679|NCT02266706|64693121|FG000|Overall Study|Enrollment in another study|0|||
23259680|NCT02266706|64693122|FG001|Overall Study|Enrollment in another study|0|||
23259681|NCT02266706|64693123|FG002|Overall Study|Enrollment in another study|0|||
23259682|NCT02266706|64693124|FG003|Overall Study|Enrollment in another study|1|||
23259683|NCT02266706|64693125|FG004|Overall Study|Enrollment in another study|0|||
23259684|NCT02266706|64693126|FG005|Overall Study|Enrollment in another study|0|||
23259685|NCT02266706|64693127|FG006|Overall Study|Enrollment in another study|0|||
23259686|NCT02266706|64693128|FG007|Overall Study|Enrollment in another study|0|||
23259687|NCT02266706|64693129|FG008|Overall Study|Enrollment in another study|0|||
23259688|NCT04014959|64693131|FG000|Baseline MRI and Assessments|Physician Decision|2|||
23259689|NCT04014959|64693131|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
23259690|NCT04014959|64693131|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
23259691|NCT02140164|64693132|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
23259692|NCT00752791|64693133|FG000|Overall Study|Adverse Event|7|||
23259693|NCT00752791|64693133|FG000|Overall Study|Withdrawal by Subject|1|||
23259694|NCT00752791|64693133|FG000|Overall Study|Physician Decision|1|||
23259695|NCT00752791|64693133|FG000|Overall Study|Death|1|||
23259696|NCT00752791|64693133|FG000|Overall Study|Renal transplant|3|||
23259697|NCT00752791|64693133|FG000|Overall Study|Switched to hemodialysis|2|||
23259698|NCT00752791|64693133|FG000|Overall Study|Protocol deviation|1|||
23259699|NCT04633837|64693134|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
23600346|NCT02561195|65929656|FG005|Vaccination 1 to 3|Adverse Event|0|||
23259700|NCT04633837|64693135|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
23259701|NCT00368537|64693136|FG000|Randomization|No study drug dosed|13|||
23259702|NCT00368537|64693137|FG001|Randomization|No study drug dosed|6|||
23259703|NCT00368537|64693136|FG000|Baseline Participants|Lost to Follow-up|16|||
23259704|NCT00368537|64693137|FG001|Baseline Participants|Lost to Follow-up|17|||
23259705|NCT00368537|64693136|FG000|Baseline Participants|Withdrawal by Subject|6|||
23259706|NCT00368537|64693137|FG001|Baseline Participants|Withdrawal by Subject|4|||
23259707|NCT00368537|64693136|FG000|Baseline Participants|Death|1|||
23259708|NCT00368537|64693137|FG001|Baseline Participants|Death|2|||
23259709|NCT00368537|64693136|FG000|Baseline Participants|No susceptibility|1|||
23259710|NCT00368537|64693137|FG001|Baseline Participants|No susceptibility|0|||
23259711|NCT00368537|64693136|FG000|Baseline Participants|Patient uncompliant|0|||
23259712|NCT00368537|64693137|FG001|Baseline Participants|Patient uncompliant|1|||
23259713|NCT01625377|64693138|FG000|Overall Study|Death|1|||
23259714|NCT01625377|64693139|FG001|Overall Study|Death|1|||
23259715|NCT01625377|64693138|FG000|Overall Study|Administrative Problem|1|||
23259716|NCT01625377|64693139|FG001|Overall Study|Administrative Problem|1|||
23259717|NCT01625377|64693138|FG000|Overall Study|Protocol Violation|0|||
23259718|NCT01625377|64693139|FG001|Overall Study|Protocol Violation|3|||
23259719|NCT01625377|64693138|FG000|Overall Study|Adverse Event|3|||
23259720|NCT01625377|64693139|FG001|Overall Study|Adverse Event|16|||
23259721|NCT01625377|64693138|FG000|Overall Study|Graft loss|1|||
23259722|NCT01625377|64693139|FG001|Overall Study|Graft loss|0|||
23259723|NCT01625377|64693138|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23259724|NCT01625377|64693139|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23259725|NCT01625377|64693138|FG000|Overall Study|Abnormal laboratory values|1|||
23259726|NCT01625377|64693139|FG001|Overall Study|Abnormal laboratory values|0|||
23259727|NCT00673361|64693140|FG000|Overall Study|Screen Failure|2|||
23259728|NCT02035137|64693141|FG000|Overall Study|Physician Decision|0|||
23259729|NCT02035137|64693142|FG001|Overall Study|Physician Decision|0|||
23259730|NCT02035137|64693143|FG002|Overall Study|Physician Decision|1|||
23259731|NCT02035137|64693141|FG000|Overall Study|Withdrawal by Subject|0|||
23259732|NCT02035137|64693142|FG001|Overall Study|Withdrawal by Subject|1|||
23259733|NCT02035137|64693143|FG002|Overall Study|Withdrawal by Subject|2|||
23259734|NCT02035137|64693141|FG000|Overall Study|Ineligible|0|||
23259735|NCT02035137|64693142|FG001|Overall Study|Ineligible|1|||
23259736|NCT02035137|64693143|FG002|Overall Study|Ineligible|2|||
23259737|NCT02035137|64693141|FG000|Overall Study|Disease progression prior to treatment start|2|||
23259738|NCT02035137|64693142|FG001|Overall Study|Disease progression prior to treatment start|0|||
23259739|NCT02035137|64693143|FG002|Overall Study|Disease progression prior to treatment start|0|||
23259740|NCT04947579|64693144|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23259741|NCT04947579|64693145|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23259742|NCT04947579|64693146|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23259743|NCT04947579|64693147|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
23259744|NCT04947579|64693148|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23259745|NCT04947579|64693149|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
23259746|NCT04947579|64693144|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23259747|NCT04947579|64693145|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23259748|NCT04947579|64693146|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
23259749|NCT04947579|64693147|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23259750|NCT04947579|64693148|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23259751|NCT04947579|64693149|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
23259752|NCT04947579|64693144|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
23259753|NCT04947579|64693145|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
23259754|NCT04947579|64693146|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
23259755|NCT04947579|64693147|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
23259756|NCT04947579|64693148|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
23259757|NCT04947579|64693149|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
23259758|NCT04947579|64693144|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
23259759|NCT04947579|64693145|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
23259760|NCT04947579|64693146|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
23259761|NCT04947579|64693147|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
23259762|NCT04947579|64693148|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
23259763|NCT04947579|64693149|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
23259764|NCT04947579|64693144|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
23259765|NCT04947579|64693145|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23259766|NCT04947579|64693146|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23259767|NCT04947579|64693147|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23259768|NCT04947579|64693148|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23600347|NCT02561195|65929657|FG006|Vaccination 1 to 3|Adverse Event|0|||
23199686|NCT03569293|64468896|FG005|Overall Study|Ongoing at Time of Analysis|0|||
23199687|NCT01457118|64468911|FG000|Overall Study|Adverse Event|1|||
23199688|NCT01457118|64468912|FG001|Overall Study|Adverse Event|0|||
23199689|NCT01457118|64468913|FG002|Overall Study|Adverse Event|0|||
23199690|NCT01457118|64468914|FG003|Overall Study|Adverse Event|1|||
23199691|NCT01457118|64468911|FG000|Overall Study|Clinical Progression|0|||
23199692|NCT01457118|64468912|FG001|Overall Study|Clinical Progression|1|||
23199693|NCT01457118|64468913|FG002|Overall Study|Clinical Progression|0|||
23199694|NCT01457118|64468914|FG003|Overall Study|Clinical Progression|1|||
23199695|NCT01457118|64468911|FG000|Overall Study|Physician Decision|2|||
23199696|NCT01457118|64468912|FG001|Overall Study|Physician Decision|0|||
23199697|NCT01457118|64468913|FG002|Overall Study|Physician Decision|0|||
23199698|NCT01457118|64468914|FG003|Overall Study|Physician Decision|0|||
23199699|NCT01457118|64468911|FG000|Overall Study|Progressive Disease by RECIST|12|||
23199700|NCT01457118|64468912|FG001|Overall Study|Progressive Disease by RECIST|3|||
23199701|NCT01457118|64468913|FG002|Overall Study|Progressive Disease by RECIST|1|||
23199702|NCT01457118|64468914|FG003|Overall Study|Progressive Disease by RECIST|0|||
23199703|NCT01457118|64468911|FG000|Overall Study|Withdrawal by Subject|5|||
23199704|NCT01457118|64468912|FG001|Overall Study|Withdrawal by Subject|0|||
23199705|NCT01457118|64468913|FG002|Overall Study|Withdrawal by Subject|0|||
23199706|NCT01457118|64468914|FG003|Overall Study|Withdrawal by Subject|0|||
23199707|NCT01295905|64468915|FG000|Overall Study|Did not meet inclusion criteria|1|||
23199708|NCT01295905|64468916|FG001|Overall Study|Did not meet inclusion criteria|0|||
23199709|NCT01295905|64468915|FG000|Overall Study|Met exclusion criteria|1|||
23199710|NCT01295905|64468916|FG001|Overall Study|Met exclusion criteria|0|||
23199711|NCT00337467|64468917|FG000|Overall Study|Adverse Event|3|||
23199712|NCT00337467|64468917|FG000|Overall Study|Subject Withdrew Consent|2|||
23199713|NCT00337467|64468917|FG000|Overall Study|Pregnancy|1|||
23199714|NCT00337467|64468917|FG000|Overall Study|Lost to Follow-up|2|||
23199715|NCT00337467|64468917|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
23199716|NCT03488472|64468918|FG000|Overall Study|disease progression additional mets|1|||
23199717|NCT00872170|64468924|FG000|Overall Study|Adverse Event|1|||
23199718|NCT00872170|64468925|FG001|Overall Study|Adverse Event|0|||
23199719|NCT01029002|64468926|FG000|Overall Study|Lost to Follow-up|2|||
23199720|NCT01029002|64468927|FG001|Overall Study|Lost to Follow-up|4|||
23199721|NCT01921270|64468928|FG000|Overall Study|Withdrawal by Subject|1|||
23199722|NCT02531035|64468932|FG000|Overall Study|Death|0|||
23199723|NCT02531035|64468933|FG001|Overall Study|Death|1|||
23199724|NCT02531035|64468932|FG000|Overall Study|Protocol Violation|1|||
23199725|NCT02531035|64468933|FG001|Overall Study|Protocol Violation|1|||
23199726|NCT02531035|64468932|FG000|Overall Study|Noncompliance with study drug|8|||
23199727|NCT02531035|64468933|FG001|Overall Study|Noncompliance with study drug|3|||
23199728|NCT02531035|64468932|FG000|Overall Study|Physician Decision|1|||
23199729|NCT02531035|64468933|FG001|Overall Study|Physician Decision|0|||
23199730|NCT02531035|64468932|FG000|Overall Study|Adverse Event|16|||
23199731|NCT02531035|64468933|FG001|Overall Study|Adverse Event|45|||
23199732|NCT02531035|64468932|FG000|Overall Study|Other|3|||
23199733|NCT02531035|64468933|FG001|Overall Study|Other|2|||
23199734|NCT02531035|64468932|FG000|Overall Study|Withdrawal by Subject|42|||
23199735|NCT02531035|64468933|FG001|Overall Study|Withdrawal by Subject|32|||
23199736|NCT02531035|64468932|FG000|Overall Study|Lost to Follow-up|8|||
23199737|NCT02531035|64468933|FG001|Overall Study|Lost to Follow-up|10|||
23199738|NCT02531035|64468932|FG000|Overall Study|Randomized, not treated|2|||
23199739|NCT02531035|64468933|FG001|Overall Study|Randomized, not treated|1|||
23199740|NCT03738566|64468939|FG000|Initial Study Phase|Withdrawal by Subject|1|||
23199741|NCT03738566|64468940|FG001|Initial Study Phase|Withdrawal by Subject|1|||
23199742|NCT03738566|64468941|FG002|Initial Study Phase|Withdrawal by Subject|2|||
23199743|NCT03738566|64468942|FG003|Initial Study Phase|Withdrawal by Subject|0|||
23199744|NCT03738566|64468939|FG000|Initial Study Phase|Death|0|||
23199745|NCT03738566|64468940|FG001|Initial Study Phase|Death|1|||
23199746|NCT03738566|64468941|FG002|Initial Study Phase|Death|0|||
23199747|NCT03738566|64468942|FG003|Initial Study Phase|Death|0|||
23199748|NCT03738566|64468939|FG000|Initial Study Phase|Treatment failure|5|||
23199749|NCT03738566|64468940|FG001|Initial Study Phase|Treatment failure|0|||
23199750|NCT03738566|64468941|FG002|Initial Study Phase|Treatment failure|0|||
23199751|NCT03738566|64468942|FG003|Initial Study Phase|Treatment failure|0|||
23199752|NCT03738566|64468939|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
23199753|NCT03738566|64468940|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
23199754|NCT03738566|64468941|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
23199755|NCT03738566|64468942|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
23199756|NCT03352414|64468943|FG000|Overall Study|Ineligible by operative criteria|12|||
23199757|NCT03352414|64468944|FG001|Overall Study|Ineligible by operative criteria|10|||
23199758|NCT03041116|64468947|FG000|Double-blind|Death|0|||
23199759|NCT03041116|64468948|FG001|Double-blind|Death|2|||
23199760|NCT03041116|64468947|FG000|Double-blind|Withdrawal by Subject|0|||
23199761|NCT03041116|64468948|FG001|Double-blind|Withdrawal by Subject|4|||
23199762|NCT03041116|64468947|FG000|Open-label|Death|1|||
23259769|NCT04947579|64693149|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
23259770|NCT04947579|64693144|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23259771|NCT04947579|64693145|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23259772|NCT04947579|64693146|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
23259773|NCT04947579|64693147|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23259774|NCT04947579|64693148|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23259775|NCT04947579|64693149|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
23259776|NCT04947579|64693144|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
23259777|NCT04947579|64693145|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
23259778|NCT04947579|64693146|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
23259779|NCT04947579|64693147|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
23259780|NCT04947579|64693148|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
23259781|NCT04947579|64693149|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
23259782|NCT04947579|64693144|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23259783|NCT04947579|64693145|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23259784|NCT04947579|64693146|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
23259785|NCT04947579|64693147|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23259786|NCT04947579|64693148|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23259787|NCT04947579|64693149|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
23259788|NCT04947579|64693144|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
23259789|NCT04947579|64693145|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
23259790|NCT04947579|64693146|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
23259791|NCT04947579|64693147|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
23259792|NCT04947579|64693148|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
23259793|NCT04947579|64693149|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
23259794|NCT04947579|64693144|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
23259795|NCT04947579|64693145|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
23259796|NCT04947579|64693146|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
23259797|NCT04947579|64693147|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
23259798|NCT04947579|64693148|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
23259799|NCT04947579|64693149|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
23259800|NCT04947579|64693144|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
23259801|NCT04947579|64693145|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
23259802|NCT04947579|64693146|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
23259803|NCT04947579|64693147|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
23259804|NCT04947579|64693148|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
23259805|NCT04947579|64693149|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
23259806|NCT01070966|64693151|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
23259807|NCT01070966|64693151|FG000|Participants for Safety Evaluation|Off-label use|9|||
23259808|NCT01070966|64693151|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
23259809|NCT01070966|64693151|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
23259810|NCT01070966|64693151|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
23259811|NCT01070966|64693151|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
23259812|NCT01070966|64693151|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
23259813|NCT01070966|64693151|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
23259814|NCT00979628|64693152|FG000|Overall Study|received regimen < 24 hours|7|||
23259815|NCT00979628|64693153|FG001|Overall Study|received regimen < 24 hours|6|||
23259816|NCT00979628|64693154|FG002|Overall Study|received regimen < 24 hours|5|||
23259817|NCT00979628|64693152|FG000|Overall Study|received steroids|1|||
23259818|NCT00979628|64693153|FG001|Overall Study|received steroids|1|||
23259819|NCT00979628|64693154|FG002|Overall Study|received steroids|0|||
23259820|NCT00979628|64693152|FG000|Overall Study|transferred to ICU|1|||
23259821|NCT00979628|64693153|FG001|Overall Study|transferred to ICU|2|||
23259822|NCT00979628|64693154|FG002|Overall Study|transferred to ICU|1|||
23259823|NCT00444795|64693160|FG000|Overall Study|Not Treated|1|||
23259824|NCT00444795|64693160|FG000|Overall Study|Treated Prior to the Contract Date|2|||
23259825|NCT00753714|64693164|FG000|Overall Study|Lack of Efficacy|21|||
23259826|NCT00753714|64693165|FG001|Overall Study|Lack of Efficacy|34|||
23259827|NCT00753714|64693164|FG000|Overall Study|Adverse Event|26|||
23259828|NCT00753714|64693165|FG001|Overall Study|Adverse Event|18|||
23259829|NCT00753714|64693164|FG000|Overall Study|Protocol Violation|1|||
23259830|NCT00753714|64693165|FG001|Overall Study|Protocol Violation|0|||
23259831|NCT00753714|64693164|FG000|Overall Study|Lost to Follow-up|0|||
23259832|NCT00753714|64693165|FG001|Overall Study|Lost to Follow-up|1|||
23259833|NCT00753714|64693164|FG000|Overall Study|Withdrawal by Subject|2|||
23259834|NCT00753714|64693165|FG001|Overall Study|Withdrawal by Subject|1|||
23259835|NCT00753714|64693164|FG000|Overall Study|Death|3|||
23259836|NCT00753714|64693165|FG001|Overall Study|Death|3|||
23259837|NCT00753714|64693164|FG000|Overall Study|Other|7|||
23259838|NCT00753714|64693165|FG001|Overall Study|Other|5|||
23259839|NCT02143947|64693166|FG000|Overall Study|Lost to Follow-up|4|||
23259840|NCT02143947|64693167|FG001|Overall Study|Lost to Follow-up|2|||
23259841|NCT00463866|64693168|FG000|Overall Study|Adverse Event|70|||
23259842|NCT00463866|64693169|FG001|Overall Study|Adverse Event|93|||
23259843|NCT00463866|64693168|FG000|Overall Study|Withdrawal by Subject|81|||
23259844|NCT00463866|64693169|FG001|Overall Study|Withdrawal by Subject|79|||
23259845|NCT00463866|64693168|FG000|Overall Study|Lost to Follow-up|46|||
23480461|NCT04585009|65501998|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23600348|NCT02561195|65929658|FG007|Vaccination 1 to 3|Adverse Event|0|||
23600349|NCT02561195|65929659|FG008|Vaccination 1 to 3|Adverse Event|0|||
23199763|NCT03041116|64468948|FG001|Open-label|Death|0|||
23199764|NCT03041116|64468947|FG000|Open-label|Termination of the study by Sponsor|39|||
23199765|NCT03041116|64468948|FG001|Open-label|Termination of the study by Sponsor|37|||
23199766|NCT03041116|64468947|FG000|Open-label|Withdrawal by Subject|1|||
23199767|NCT03041116|64468948|FG001|Open-label|Withdrawal by Subject|0|||
23199768|NCT01106534|64468949|FG000|Overall Study|Withdrawal by Subject|18|||
23199769|NCT01106534|64468949|FG000|Overall Study|Lost to Follow-up|2|||
23199770|NCT01106534|64468949|FG000|Overall Study|Death|16|||
23199771|NCT01106534|64468949|FG000|Overall Study|Physician Decision|1|||
23199772|NCT04009096|64468951|FG000|Overall Study|Withdrawal by Subject|0|||
23199773|NCT04009096|64468952|FG001|Overall Study|Withdrawal by Subject|7|||
23199774|NCT04009096|64468953|FG002|Overall Study|Withdrawal by Subject|0|||
23199775|NCT04009096|64468951|FG000|Overall Study|Physician Decision|0|||
23199776|NCT04009096|64468952|FG001|Overall Study|Physician Decision|1|||
23199777|NCT04009096|64468953|FG002|Overall Study|Physician Decision|0|||
23199778|NCT01998581|64468954|FG000|Overall Study|Refused repeat treatment|20|||
23199779|NCT01998581|64468955|FG001|Overall Study|Refused repeat treatment|4|||
23199780|NCT01998581|64468954|FG000|Overall Study|Protocol Violation|1|||
23199781|NCT01998581|64468955|FG001|Overall Study|Protocol Violation|0|||
23199782|NCT01998581|64468954|FG000|Overall Study|Withdrawal by Subject|8|||
23199783|NCT01998581|64468955|FG001|Overall Study|Withdrawal by Subject|1|||
23199784|NCT01998581|64468954|FG000|Overall Study|Lost to Follow-up|12|||
23199785|NCT01998581|64468955|FG001|Overall Study|Lost to Follow-up|4|||
23199786|NCT01998581|64468954|FG000|Overall Study|Adverse Event|1|||
23199787|NCT01998581|64468955|FG001|Overall Study|Adverse Event|1|||
23199788|NCT01998581|64468954|FG000|Overall Study|Other reasons|3|||
23199789|NCT01998581|64468955|FG001|Overall Study|Other reasons|2|||
23199790|NCT01998581|64468954|FG000|Overall Study|Randomized but withdrew before treatment|1|||
23199791|NCT01998581|64468955|FG001|Overall Study|Randomized but withdrew before treatment|0|||
23199792|NCT00520676|64468956|FG000|Overall Study|Death|84|||
23199793|NCT00520676|64468957|FG001|Overall Study|Death|81|||
23199794|NCT00520676|64468956|FG000|Overall Study|Lost to Follow-up|6|||
23199795|NCT00520676|64468957|FG001|Overall Study|Lost to Follow-up|10|||
23199796|NCT00520676|64468956|FG000|Overall Study|Physician Decision|4|||
23199797|NCT00520676|64468957|FG001|Overall Study|Physician Decision|1|||
23199798|NCT00520676|64468956|FG000|Overall Study|Withdrawal by Subject|7|||
23199799|NCT00520676|64468957|FG001|Overall Study|Withdrawal by Subject|11|||
23199800|NCT04328623|64468958|FG000|Overall Study|Protocol Violation|0|||
23199801|NCT04328623|64468959|FG001|Overall Study|Protocol Violation|1|||
23199802|NCT02998554|64468961|FG000|Overall Study|Adverse Event|8|||
23199803|NCT02998554|64468962|FG001|Overall Study|Adverse Event|3|||
23199804|NCT02998554|64468961|FG000|Overall Study|Protocol deviation|1|||
23199805|NCT02998554|64468962|FG001|Overall Study|Protocol deviation|0|||
23199806|NCT02998554|64468961|FG000|Overall Study|Withdrawal by Subject|2|||
23199807|NCT02998554|64468962|FG001|Overall Study|Withdrawal by Subject|6|||
23199808|NCT02998554|64468961|FG000|Overall Study|Lost to Follow-up|0|||
23199809|NCT02998554|64468962|FG001|Overall Study|Lost to Follow-up|1|||
23199810|NCT02998554|64468961|FG000|Overall Study|Lack of Efficacy|0|||
23199811|NCT02998554|64468962|FG001|Overall Study|Lack of Efficacy|1|||
23199812|NCT03259334|64473207|FG000|Overall Study|Adverse Event|3|||
23199813|NCT03259334|64473208|FG001|Overall Study|Adverse Event|8|||
23199814|NCT03259334|64473209|FG002|Overall Study|Adverse Event|5|||
23199815|NCT03259334|64473207|FG000|Overall Study|Withdrawal by Subject|4|||
23199816|NCT03259334|64473208|FG001|Overall Study|Withdrawal by Subject|2|||
23199817|NCT03259334|64473209|FG002|Overall Study|Withdrawal by Subject|4|||
23199818|NCT03259334|64473207|FG000|Overall Study|Physician Decision|1|||
23199819|NCT03259334|64473208|FG001|Overall Study|Physician Decision|0|||
23199820|NCT03259334|64473209|FG002|Overall Study|Physician Decision|0|||
23199821|NCT03259334|64473207|FG000|Overall Study|Lost to Follow-up|0|||
23199822|NCT03259334|64473208|FG001|Overall Study|Lost to Follow-up|2|||
23199823|NCT03259334|64473209|FG002|Overall Study|Lost to Follow-up|1|||
23199824|NCT03259334|64473207|FG000|Overall Study|Protocol Deviation|0|||
23259846|NCT00463866|64693169|FG001|Overall Study|Lost to Follow-up|55|||
23259847|NCT00463866|64693168|FG000|Overall Study|Incorrect Enrolment|64|||
23600350|NCT02561195|65929660|FG009|Vaccination 1 to 3|Adverse Event|0|||
23199825|NCT03259334|64473208|FG001|Overall Study|Protocol Deviation|3|||
23199826|NCT03259334|64473209|FG002|Overall Study|Protocol Deviation|2|||
23199827|NCT03259334|64473207|FG000|Overall Study|Lack of Efficacy|2|||
23199828|NCT03259334|64473208|FG001|Overall Study|Lack of Efficacy|0|||
23199829|NCT03259334|64473209|FG002|Overall Study|Lack of Efficacy|1|||
23199830|NCT03259334|64473207|FG000|Overall Study|Randomized but never treated|0|||
23199831|NCT03259334|64473208|FG001|Overall Study|Randomized but never treated|2|||
23199832|NCT03259334|64473209|FG002|Overall Study|Randomized but never treated|0|||
23199833|NCT02750813|64473212|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
23199834|NCT02750813|64473213|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
23199835|NCT02750813|64473212|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
23199836|NCT02750813|64473213|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
23199837|NCT02750800|64473216|FG000|Overall Study|Adverse Event|18|||
23199838|NCT02750800|64473216|FG000|Overall Study|Lost to Follow-up|12|||
23199839|NCT02750800|64473216|FG000|Overall Study|Investigator decision|53|||
23199840|NCT02750800|64473216|FG000|Overall Study|Patient request|12|||
23199841|NCT02750800|64473216|FG000|Overall Study|Other, not specified|3|||
23361269|NCT00369343|65069654|FG001|Open-label Phase|Physician Decision|0|||
23361270|NCT00369343|65069653|FG000|Open-label Phase|Lost to Follow-up|5|||
23361271|NCT00369343|65069654|FG001|Open-label Phase|Lost to Follow-up|3|||
23361272|NCT00369343|65069653|FG000|Open-label Phase|inadvertently reported study completers|3|||
23361273|NCT00369343|65069654|FG001|Open-label Phase|inadvertently reported study completers|2|||
23361274|NCT00369343|65069653|FG000|Open-label Phase|Protocol Violation|1|||
23361275|NCT00369343|65069654|FG001|Open-label Phase|Protocol Violation|3|||
23361276|NCT00369343|65069653|FG000|Open-label Phase|Withdrawal by Subject|15|||
23361277|NCT00369343|65069654|FG001|Open-label Phase|Withdrawal by Subject|6|||
23361278|NCT00369343|65069653|FG000|Open-label Phase|Lack of Efficacy|4|||
23361279|NCT00369343|65069654|FG001|Open-label Phase|Lack of Efficacy|3|||
23361280|NCT00369343|65069653|FG000|Open-label Phase|Lack of continuance tolerability|3|||
23361281|NCT00369343|65069654|FG001|Open-label Phase|Lack of continuance tolerability|4|||
23361282|NCT00369343|65069653|FG000|Open-label Phase|did not take study drug|1|||
23361283|NCT00369343|65069654|FG001|Open-label Phase|did not take study drug|2|||
23361284|NCT03014206|65069655|FG000|Overall Study|Registration Violation|12|||
23361285|NCT00715299|65069656|FG000|Overall Study|Withdrawal by Subject|1|||
23361286|NCT00715299|65069656|FG000|Overall Study|Adverse Event|3|||
23361287|NCT00715299|65069656|FG000|Overall Study|failed the pre-screen exercise test|2|||
23361288|NCT02989402|65069657|FG000|Overall Study|Adverse event, or serious adverse event|4|||
23361289|NCT02989402|65069657|FG000|Overall Study|Death|2|||
23361290|NCT02989402|65069657|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
23361291|NCT02989402|65069657|FG000|Overall Study|Lost to Follow-up|8|||
23361292|NCT02989402|65069657|FG000|Overall Study|Patient no longer on monotherapy|1|||
23361293|NCT02989402|65069657|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
23361294|NCT02989402|65069657|FG000|Overall Study|Withdrawal by Subject|7|||
23361295|NCT02989402|65069657|FG000|Overall Study|Other|2|||
23361296|NCT00837967|65069658|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
23361297|NCT00837967|65069659|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
23361298|NCT00149396|65069663|FG000|Overall Study|Death|15|||
23361299|NCT00149396|65069663|FG000|Overall Study|Withdrawal by Subject|1|||
23361300|NCT00149396|65069663|FG000|Overall Study|Subject noncompliance|2|||
23361301|NCT00149396|65069663|FG000|Overall Study|other treatment|5|||
23361302|NCT01738919|65069671|FG000|Overall Study|Lost to Follow-up|1|||
23361303|NCT01738919|65069672|FG001|Overall Study|Lost to Follow-up|0|||
23361304|NCT01738919|65069671|FG000|Overall Study|Immigrated|0|||
23361305|NCT01738919|65069672|FG001|Overall Study|Immigrated|1|||
23361306|NCT01738919|65069671|FG000|Overall Study|Withdrawal by Subject|0|||
23361307|NCT01738919|65069672|FG001|Overall Study|Withdrawal by Subject|1|||
23361308|NCT01738919|65069671|FG000|Overall Study|Not treated in accordance to guidelines|0|||
23361309|NCT01738919|65069672|FG001|Overall Study|Not treated in accordance to guidelines|1|||
23361310|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
23361311|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
23361312|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
23361313|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
23361314|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
23361315|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
23361316|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
23199842|NCT01519245|64473217|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
23199843|NCT01519245|64473218|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
23199844|NCT03294681|64473219|FG000|Overall Study|Withdrawal by Subject|1|||
23199845|NCT01793051|64473220|FG000|Overall Study|Withdrawal by Subject|6|||
23361317|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361318|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361319|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361320|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361321|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
23361322|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
23480462|NCT04585009|65501999|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480463|NCT04585009|65502000|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480464|NCT04585009|65502001|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480465|NCT04585009|65502002|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
23480466|NCT04585009|65501991|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480467|NCT04585009|65501992|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480468|NCT04585009|65501993|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480469|NCT04585009|65501994|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480470|NCT04585009|65501995|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23199846|NCT01793051|64473221|FG001|Overall Study|Withdrawal by Subject|4|||
23199847|NCT01793051|64473220|FG000|Overall Study|Adverse Event|0|||
23199848|NCT01793051|64473221|FG001|Overall Study|Adverse Event|2|||
23199849|NCT01793051|64473220|FG000|Overall Study|Too ill to continue|1|||
23199850|NCT01793051|64473221|FG001|Overall Study|Too ill to continue|0|||
23199851|NCT01793051|64473220|FG000|Overall Study|Switched chemo|1|||
23199852|NCT01793051|64473221|FG001|Overall Study|Switched chemo|1|||
23199853|NCT01793051|64473220|FG000|Overall Study|Lack of compliance|1|||
23199854|NCT01793051|64473221|FG001|Overall Study|Lack of compliance|0|||
23199855|NCT01793051|64473220|FG000|Overall Study|Requested to be removed from the study|1|||
23199856|NCT01793051|64473221|FG001|Overall Study|Requested to be removed from the study|1|||
23199857|NCT01989546|64473226|FG000|Overall Study|Clinical Progression|1|||
23199858|NCT01989546|64473226|FG000|Overall Study|Disease progression on study|8|||
23199859|NCT00894413|64473227|FG000|Overall Study|Physician Decision|0|||
23199860|NCT00894413|64473228|FG001|Overall Study|Physician Decision|2|||
23199861|NCT00894413|64473227|FG000|Overall Study|Adverse Event|0|||
23199862|NCT00894413|64473228|FG001|Overall Study|Adverse Event|2|||
23199863|NCT00894413|64473227|FG000|Overall Study|Withdrawal by Subject|0|||
23199864|NCT00894413|64473228|FG001|Overall Study|Withdrawal by Subject|4|||
23600351|NCT02561195|65929661|FG010|Vaccination 1 to 3|Adverse Event|0|||
23600352|NCT02561195|65929662|FG011|Vaccination 1 to 3|Adverse Event|0|||
23600353|NCT02561195|65929663|FG012|Vaccination 1 to 3|Adverse Event|0|||
23600354|NCT02561195|65929664|FG013|Vaccination 1 to 3|Adverse Event|0|||
23600355|NCT02561195|65929651|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
23600356|NCT02561195|65929652|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
23600357|NCT02561195|65929653|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
23600358|NCT02561195|65929654|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
23600359|NCT02561195|65929655|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
23600360|NCT02561195|65929656|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
23600361|NCT02561195|65929657|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
23600362|NCT02561195|65929658|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
23600363|NCT02561195|65929659|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
23600364|NCT02561195|65929660|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
23600365|NCT02561195|65929661|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
23600366|NCT02561195|65929662|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
23600367|NCT02561195|65929663|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
23600368|NCT02561195|65929664|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
23600369|NCT02561195|65929651|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600370|NCT02561195|65929652|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
23600371|NCT02561195|65929653|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600372|NCT02561195|65929654|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
23600373|NCT02561195|65929655|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
23600374|NCT02561195|65929656|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
23600375|NCT02561195|65929657|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600376|NCT02561195|65929658|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600377|NCT02561195|65929659|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600378|NCT02561195|65929660|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600379|NCT02561195|65929661|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600380|NCT02561195|65929662|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600381|NCT02561195|65929663|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600382|NCT02561195|65929664|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
23600383|NCT02561195|65929651|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
23600384|NCT02561195|65929652|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
23600385|NCT02561195|65929653|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
23199865|NCT02050048|64473232|FG000|Overall Study|Lost to Follow-up|0|||
23199866|NCT02050048|64473233|FG001|Overall Study|Lost to Follow-up|1|||
23199867|NCT02050048|64473232|FG000|Overall Study|Death|1|||
23600386|NCT02561195|65929654|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
23600387|NCT02561195|65929655|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
23600388|NCT02561195|65929656|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
23361323|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23199868|NCT02050048|64473233|FG001|Overall Study|Death|0|||
23361324|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23361325|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23361326|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23600389|NCT02561195|65929657|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
23600390|NCT02561195|65929658|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
23600391|NCT02561195|65929659|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
23600392|NCT02561195|65929660|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
23600393|NCT02561195|65929661|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
23600394|NCT02561195|65929662|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
23600395|NCT02561195|65929663|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
23600396|NCT02561195|65929664|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
23600397|NCT02561195|65929651|FG000|Vaccination 1 to 3|Other|7|||
23600398|NCT02561195|65929652|FG001|Vaccination 1 to 3|Other|3|||
23600399|NCT02561195|65929653|FG002|Vaccination 1 to 3|Other|1|||
23600400|NCT02561195|65929654|FG003|Vaccination 1 to 3|Other|7|||
23600401|NCT02561195|65929655|FG004|Vaccination 1 to 3|Other|5|||
23600402|NCT02561195|65929656|FG005|Vaccination 1 to 3|Other|1|||
23600403|NCT02561195|65929657|FG006|Vaccination 1 to 3|Other|0|||
23600404|NCT02561195|65929658|FG007|Vaccination 1 to 3|Other|0|||
23600405|NCT02561195|65929659|FG008|Vaccination 1 to 3|Other|0|||
23600406|NCT02561195|65929660|FG009|Vaccination 1 to 3|Other|0|||
23600407|NCT02561195|65929661|FG010|Vaccination 1 to 3|Other|0|||
23600408|NCT02561195|65929662|FG011|Vaccination 1 to 3|Other|0|||
23199869|NCT02050048|64473232|FG000|Overall Study|Ineligible after ERCP|4|||
23199870|NCT02050048|64473233|FG001|Overall Study|Ineligible after ERCP|1|||
23199871|NCT05013905|64473234|FG000|Overall Study|Adverse Event|1|||
23199872|NCT05013905|64473234|FG000|Overall Study|Lack of Efficacy|1|||
23199873|NCT01514188|64473236|FG000|Overall Study|Adverse Event|3|||
23199874|NCT01514188|64473237|FG001|Overall Study|Adverse Event|5|||
23199875|NCT01514188|64473236|FG000|Overall Study|Withdrawal by Subject|2|||
23199876|NCT01514188|64473237|FG001|Overall Study|Withdrawal by Subject|4|||
23199877|NCT01514188|64473236|FG000|Overall Study|Protocol Violation|2|||
23199878|NCT01514188|64473237|FG001|Overall Study|Protocol Violation|4|||
23199879|NCT01514188|64473236|FG000|Overall Study|Physician Decision|0|||
23199880|NCT01514188|64473237|FG001|Overall Study|Physician Decision|2|||
23199881|NCT01514188|64473236|FG000|Overall Study|Disease Progression|13|||
23199882|NCT01514188|64473237|FG001|Overall Study|Disease Progression|14|||
23199883|NCT01514188|64473236|FG000|Overall Study|Death|1|||
23199884|NCT01514188|64473237|FG001|Overall Study|Death|3|||
23199885|NCT01514188|64473236|FG000|Overall Study|Other|2|||
23199886|NCT01514188|64473237|FG001|Overall Study|Other|1|||
23199887|NCT02632110|64473238|FG000|Overall Study|Withdrawal by Subject|1|||
23199888|NCT02632110|64473239|FG001|Overall Study|Withdrawal by Subject|1|||
23199889|NCT02632110|64473240|FG002|Overall Study|Withdrawal by Subject|0|||
23199890|NCT02632110|64473241|FG003|Overall Study|Withdrawal by Subject|0|||
23199891|NCT02632110|64473242|FG004|Overall Study|Withdrawal by Subject|1|||
23199892|NCT02632110|64473243|FG005|Overall Study|Withdrawal by Subject|1|||
23199893|NCT02632110|64473244|FG006|Overall Study|Withdrawal by Subject|3|||
23199894|NCT02632110|64473245|FG007|Overall Study|Withdrawal by Subject|3|||
23199895|NCT02632110|64473246|FG008|Overall Study|Withdrawal by Subject|1|||
23199896|NCT02632110|64473247|FG009|Overall Study|Withdrawal by Subject|1|||
23199897|NCT01120093|64473248|FG000|Treatment Period 1|Adverse Event|0|||
23361327|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
23361328|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
23361329|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23361330|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23361331|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23361332|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23361333|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
23600409|NCT02561195|65929663|FG012|Vaccination 1 to 3|Other|0|||
23600410|NCT02561195|65929664|FG013|Vaccination 1 to 3|Other|0|||
23600411|NCT02561195|65929651|FG000|Vaccination 1 to 3|Protocol Violation|1|||
23600412|NCT02561195|65929652|FG001|Vaccination 1 to 3|Protocol Violation|0|||
23199898|NCT01120093|64473249|FG001|Treatment Period 1|Adverse Event|0|||
23199899|NCT01120093|64473250|FG002|Treatment Period 1|Adverse Event|1|||
23259848|NCT00463866|64693169|FG001|Overall Study|Incorrect Enrolment|66|||
23259849|NCT00463866|64693168|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
23259850|NCT00463866|64693169|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
23259851|NCT00463866|64693168|FG000|Overall Study|Safety Reason|1|||
23259852|NCT00463866|64693169|FG001|Overall Study|Safety Reason|3|||
23259853|NCT00463866|64693168|FG000|Overall Study|Mis-Randomization of subject|0|||
23259854|NCT00463866|64693169|FG001|Overall Study|Mis-Randomization of subject|1|||
23259855|NCT00463866|64693168|FG000|Overall Study|Other|22|||
23259856|NCT00463866|64693169|FG001|Overall Study|Other|22|||
23259857|NCT00606684|64693170|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
23259858|NCT00606684|64693171|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23259859|NCT00606684|64693172|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23259860|NCT00606684|64693173|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23259861|NCT00606684|64693174|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23259862|NCT00606684|64693175|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23259863|NCT00606684|64693176|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
23259864|NCT00606684|64693170|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
23259865|NCT00606684|64693171|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23361334|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
23361335|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23259866|NCT00606684|64693172|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23259867|NCT00606684|64693173|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23259868|NCT00606684|64693174|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23259869|NCT00606684|64693175|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23259870|NCT00606684|64693176|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
23259871|NCT00606684|64693170|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
23259872|NCT00606684|64693171|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
23259873|NCT00606684|64693172|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
23259874|NCT00606684|64693173|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
23259875|NCT00606684|64693174|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
23259876|NCT00606684|64693175|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
23259877|NCT00606684|64693176|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
23259878|NCT00606684|64693170|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
23259879|NCT00606684|64693171|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23259880|NCT00606684|64693172|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23259881|NCT00606684|64693173|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23259882|NCT00606684|64693174|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23259883|NCT00606684|64693175|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23259884|NCT00606684|64693176|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
23259885|NCT00606684|64693170|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
23259886|NCT00606684|64693171|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23259887|NCT00606684|64693172|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23259888|NCT00606684|64693173|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23259889|NCT00606684|64693174|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23259890|NCT00606684|64693175|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23259891|NCT00606684|64693176|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
23259892|NCT00606684|64693170|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
23259893|NCT00606684|64693171|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
23259894|NCT00606684|64693172|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
23259895|NCT00606684|64693173|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
23259896|NCT00606684|64693174|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
23259897|NCT00606684|64693175|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
23259898|NCT00606684|64693176|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
23259899|NCT00606684|64693170|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
23259900|NCT00606684|64693171|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23259901|NCT00606684|64693172|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23259902|NCT00606684|64693173|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23259903|NCT00606684|64693174|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23259904|NCT00606684|64693175|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23259905|NCT00606684|64693176|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
23259906|NCT00606684|64693170|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23259907|NCT00606684|64693171|FG001|Double-Blind Treatment Period|Adverse Event|3|||
23259908|NCT00606684|64693172|FG002|Double-Blind Treatment Period|Adverse Event|2|||
23259909|NCT00606684|64693173|FG003|Double-Blind Treatment Period|Adverse Event|4|||
23259910|NCT00606684|64693174|FG004|Double-Blind Treatment Period|Adverse Event|2|||
23259911|NCT00606684|64693175|FG005|Double-Blind Treatment Period|Adverse Event|0|||
23259912|NCT00606684|64693176|FG006|Double-Blind Treatment Period|Adverse Event|1|||
23259913|NCT00606684|64693170|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23259914|NCT00606684|64693171|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
23259915|NCT00606684|64693172|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
23259916|NCT00606684|64693173|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
23259917|NCT00606684|64693174|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
23600413|NCT02561195|65929653|FG002|Vaccination 1 to 3|Protocol Violation|1|||
23600414|NCT02561195|65929654|FG003|Vaccination 1 to 3|Protocol Violation|2|||
23600415|NCT02561195|65929655|FG004|Vaccination 1 to 3|Protocol Violation|5|||
23600416|NCT02561195|65929656|FG005|Vaccination 1 to 3|Protocol Violation|2|||
23600417|NCT02561195|65929657|FG006|Vaccination 1 to 3|Protocol Violation|0|||
23600418|NCT02561195|65929658|FG007|Vaccination 1 to 3|Protocol Violation|0|||
23600419|NCT02561195|65929659|FG008|Vaccination 1 to 3|Protocol Violation|0|||
23600420|NCT02561195|65929660|FG009|Vaccination 1 to 3|Protocol Violation|0|||
23600421|NCT02561195|65929661|FG010|Vaccination 1 to 3|Protocol Violation|0|||
23600422|NCT02561195|65929662|FG011|Vaccination 1 to 3|Protocol Violation|0|||
23600423|NCT02561195|65929663|FG012|Vaccination 1 to 3|Protocol Violation|0|||
23259918|NCT00606684|64693175|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
23259919|NCT00606684|64693176|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
23259920|NCT00606684|64693170|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23259921|NCT00606684|64693171|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
23259922|NCT00606684|64693172|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
23259923|NCT00606684|64693173|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
23259924|NCT00606684|64693174|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
23259925|NCT00606684|64693175|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
23259926|NCT00606684|64693176|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
23259927|NCT00606684|64693170|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
23259928|NCT00606684|64693171|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
23259929|NCT00606684|64693172|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
23259930|NCT00606684|64693173|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
23259931|NCT00606684|64693174|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
23259932|NCT00606684|64693175|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
23259933|NCT00606684|64693176|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
23259934|NCT00606684|64693170|FG000|Double-Blind Treatment Period|Physician Decision|0|||
23259935|NCT00606684|64693171|FG001|Double-Blind Treatment Period|Physician Decision|5|||
23259936|NCT00606684|64693172|FG002|Double-Blind Treatment Period|Physician Decision|1|||
23259937|NCT00606684|64693173|FG003|Double-Blind Treatment Period|Physician Decision|0|||
23259938|NCT00606684|64693174|FG004|Double-Blind Treatment Period|Physician Decision|3|||
23259939|NCT00606684|64693175|FG005|Double-Blind Treatment Period|Physician Decision|1|||
23259940|NCT00606684|64693176|FG006|Double-Blind Treatment Period|Physician Decision|2|||
23259941|NCT00606684|64693170|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23259942|NCT00606684|64693171|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23259943|NCT00606684|64693172|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23259944|NCT00606684|64693173|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23259945|NCT00606684|64693174|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23259946|NCT00606684|64693175|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23259947|NCT00606684|64693176|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23259948|NCT01889862|64693177|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
23259949|NCT01889862|64693178|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
23259950|NCT01889862|64693179|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
23259951|NCT01889862|64693180|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
23259952|NCT01889862|64693181|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
23259953|NCT01889862|64693177|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
23259954|NCT01889862|64693178|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
23259955|NCT01889862|64693179|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
23259956|NCT01889862|64693180|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
23259957|NCT01889862|64693181|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
23259958|NCT01889862|64693177|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
23259959|NCT01889862|64693178|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
23259960|NCT01889862|64693179|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
23259961|NCT01889862|64693180|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
23259962|NCT01889862|64693181|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
23259963|NCT01889862|64693177|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
23259964|NCT01889862|64693178|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
23259965|NCT01889862|64693179|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
23259966|NCT01889862|64693180|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
23259967|NCT01889862|64693181|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
23259968|NCT01889862|64693177|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
23259969|NCT01889862|64693178|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
23259970|NCT01889862|64693179|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
23600424|NCT02561195|65929664|FG013|Vaccination 1 to 3|Protocol Violation|0|||
23259971|NCT01889862|64693180|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
23259972|NCT01889862|64693181|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
23259973|NCT01889862|64693177|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
23259974|NCT01889862|64693178|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
23259975|NCT01889862|64693179|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
23259976|NCT01889862|64693180|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
23259977|NCT01889862|64693181|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
23259978|NCT01889862|64693177|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
23259979|NCT01889862|64693178|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
23259980|NCT01889862|64693179|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
23259981|NCT01889862|64693180|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
23259982|NCT01889862|64693181|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
23259983|NCT01889862|64693177|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
23259984|NCT01889862|64693178|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
23259985|NCT01889862|64693179|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
23259986|NCT01889862|64693180|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
23259987|NCT01889862|64693181|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
23259988|NCT01889862|64693177|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
23259989|NCT01889862|64693178|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
23259990|NCT01889862|64693179|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
23259991|NCT01889862|64693180|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
23259992|NCT01889862|64693181|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
23259993|NCT01889862|64693177|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
23259994|NCT01889862|64693178|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
23259995|NCT01889862|64693179|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
23259996|NCT01889862|64693180|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
23259997|NCT01889862|64693181|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
23259998|NCT01751412|64693187|FG000|Overall Study|Disease Progression Before Treatment|1|||
23259999|NCT00814658|64693190|FG000|Overall Study|Lost to Follow-up|0|||
23260000|NCT00814658|64693191|FG001|Overall Study|Lost to Follow-up|1|||
23260001|NCT00814658|64693190|FG000|Overall Study|Physician Decision|1|||
23260002|NCT00814658|64693191|FG001|Overall Study|Physician Decision|0|||
23260003|NCT00814658|64693190|FG000|Overall Study|Adverse Event|3|||
23260004|NCT00814658|64693191|FG001|Overall Study|Adverse Event|3|||
23260005|NCT00832078|64693192|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
23260006|NCT00832078|64693193|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
23260007|NCT00832078|64693192|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
23260008|NCT00832078|64693193|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
23260009|NCT02752776|64693194|FG000|Overall Study|Adverse Event|15|||
23260010|NCT02752776|64693195|FG001|Overall Study|Adverse Event|23|||
23260011|NCT02752776|64693196|FG002|Overall Study|Adverse Event|11|||
23260012|NCT02752776|64693194|FG000|Overall Study|Lack of Efficacy|2|||
23260013|NCT02752776|64693195|FG001|Overall Study|Lack of Efficacy|6|||
23260014|NCT02752776|64693196|FG002|Overall Study|Lack of Efficacy|14|||
23260015|NCT02752776|64693194|FG000|Overall Study|Lost to Follow-up|11|||
23260016|NCT02752776|64693195|FG001|Overall Study|Lost to Follow-up|12|||
23260017|NCT02752776|64693196|FG002|Overall Study|Lost to Follow-up|4|||
23260018|NCT02752776|64693194|FG000|Overall Study|Non-compliance with study treatment|0|||
23260019|NCT02752776|64693195|FG001|Overall Study|Non-compliance with study treatment|0|||
23260020|NCT02752776|64693196|FG002|Overall Study|Non-compliance with study treatment|1|||
23260021|NCT02752776|64693194|FG000|Overall Study|Physician Decision|2|||
23260022|NCT02752776|64693195|FG001|Overall Study|Physician Decision|6|||
23260023|NCT02752776|64693196|FG002|Overall Study|Physician Decision|2|||
23260024|NCT02752776|64693194|FG000|Overall Study|Pregnancy|1|||
23361336|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361337|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361338|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361339|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361340|NCT01435759|65069673|FG000|Antidepressant Lead-in Phase|Other|119|||
23361341|NCT01435759|65069674|FG001|Antidepressant Lead-in Phase|Other|0|||
23361342|NCT01435759|65069675|FG002|Antidepressant Lead-in Phase|Other|0|||
23361343|NCT01435759|65069676|FG003|Antidepressant Lead-in Phase|Other|0|||
23361344|NCT01435759|65069677|FG004|Antidepressant Lead-in Phase|Other|0|||
23361345|NCT01435759|65069678|FG005|Antidepressant Lead-in Phase|Other|0|||
23361346|NCT01435759|65069673|FG000|Double-blind Phase|Adverse Event|7|||
23361347|NCT01435759|65069674|FG001|Double-blind Phase|Adverse Event|0|||
23361348|NCT01435759|65069675|FG002|Double-blind Phase|Adverse Event|1|||
23199900|NCT01120093|64473251|FG003|Treatment Period 1|Adverse Event|0|||
23199901|NCT01120093|64473252|FG004|Treatment Period 1|Adverse Event|1|||
23199902|NCT01120093|64473248|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23199903|NCT01120093|64473249|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23199904|NCT01120093|64473250|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23199905|NCT01120093|64473251|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23199906|NCT01120093|64473252|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23199907|NCT01120093|64473248|FG000|Treatment Period 2|Adverse Event|0|||
23199908|NCT01120093|64473249|FG001|Treatment Period 2|Adverse Event|0|||
23199909|NCT01120093|64473250|FG002|Treatment Period 2|Adverse Event|0|||
23199910|NCT01120093|64473251|FG003|Treatment Period 2|Adverse Event|1|||
23199911|NCT01120093|64473252|FG004|Treatment Period 2|Adverse Event|0|||
23199912|NCT01120093|64473248|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23199913|NCT01120093|64473249|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23199914|NCT01120093|64473250|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23199915|NCT01120093|64473251|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23199916|NCT01120093|64473252|FG004|Treatment Period 2|Withdrawal by Subject|1|||
23199917|NCT01120093|64473248|FG000|Treatment Period 3|Lack of Efficacy|0|||
23199918|NCT01120093|64473249|FG001|Treatment Period 3|Lack of Efficacy|0|||
23199919|NCT01120093|64473250|FG002|Treatment Period 3|Lack of Efficacy|0|||
23199920|NCT01120093|64473251|FG003|Treatment Period 3|Lack of Efficacy|1|||
23199921|NCT01120093|64473252|FG004|Treatment Period 3|Lack of Efficacy|0|||
23199922|NCT01120093|64473248|FG000|Treatment Period 3|Adverse Event|0|||
23199923|NCT01120093|64473249|FG001|Treatment Period 3|Adverse Event|0|||
23199924|NCT01120093|64473250|FG002|Treatment Period 3|Adverse Event|0|||
23199925|NCT01120093|64473251|FG003|Treatment Period 3|Adverse Event|0|||
23199926|NCT01120093|64473252|FG004|Treatment Period 3|Adverse Event|1|||
23199927|NCT01120093|64473248|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23199928|NCT01120093|64473249|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23199929|NCT01120093|64473250|FG002|Treatment Period 3|Withdrawal by Subject|1|||
23199930|NCT01120093|64473251|FG003|Treatment Period 3|Withdrawal by Subject|0|||
23199931|NCT01120093|64473252|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23199932|NCT01120093|64473248|FG000|Treatment Period 4|Adverse Event|1|||
23199933|NCT01120093|64473249|FG001|Treatment Period 4|Adverse Event|0|||
23199934|NCT01120093|64473250|FG002|Treatment Period 4|Adverse Event|0|||
23199935|NCT01120093|64473251|FG003|Treatment Period 4|Adverse Event|0|||
23199936|NCT01120093|64473252|FG004|Treatment Period 4|Adverse Event|0|||
23199937|NCT01120093|64473248|FG000|Treatment Period 5|Adverse Event|0|||
23260025|NCT02752776|64693195|FG001|Overall Study|Pregnancy|6|||
23361349|NCT01435759|65069676|FG003|Double-blind Phase|Adverse Event|1|||
23361350|NCT01435759|65069677|FG004|Double-blind Phase|Adverse Event|1|||
23199938|NCT01120093|64473249|FG001|Treatment Period 5|Adverse Event|1|||
23199939|NCT01120093|64473250|FG002|Treatment Period 5|Adverse Event|0|||
23199940|NCT01120093|64473251|FG003|Treatment Period 5|Adverse Event|1|||
23199941|NCT01120093|64473252|FG004|Treatment Period 5|Adverse Event|0|||
23260026|NCT02752776|64693196|FG002|Overall Study|Pregnancy|3|||
23260027|NCT02752776|64693194|FG000|Overall Study|Protocol Violation|10|||
23260028|NCT02752776|64693195|FG001|Overall Study|Protocol Violation|13|||
23260029|NCT02752776|64693196|FG002|Overall Study|Protocol Violation|6|||
23260030|NCT02752776|64693194|FG000|Overall Study|Subject/guardian decision|8|||
23260031|NCT02752776|64693195|FG001|Overall Study|Subject/guardian decision|6|||
23361351|NCT01435759|65069678|FG005|Double-blind Phase|Adverse Event|3|||
23361352|NCT01435759|65069673|FG000|Double-blind Phase|Protocol Violation|2|||
23260032|NCT02752776|64693196|FG002|Overall Study|Subject/guardian decision|4|||
23260033|NCT02752776|64693194|FG000|Overall Study|Death|0|||
23260034|NCT02752776|64693195|FG001|Overall Study|Death|0|||
23260035|NCT02752776|64693196|FG002|Overall Study|Death|1|||
23260036|NCT02752776|64693194|FG000|Overall Study|Withdrawal by Subject|3|||
23260037|NCT02752776|64693195|FG001|Overall Study|Withdrawal by Subject|4|||
23260038|NCT02752776|64693196|FG002|Overall Study|Withdrawal by Subject|2|||
23260039|NCT00583596|64693198|FG000|Overall Study|Lost to Follow-up|110|||
23260040|NCT00583596|64693198|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
23260041|NCT00583596|64693198|FG000|Overall Study|Death|2|||
23260042|NCT00583596|64693198|FG000|Overall Study|Withdrawal by Subject|6|||
23260043|NCT00583596|64693198|FG000|Overall Study|Lost to Follow-up|94|||
23260044|NCT00583596|64693198|FG000|Overall Study|Data not complete|1|||
23260045|NCT00583596|64693198|FG000|Overall Study|Not consented|15|||
23260046|NCT00583596|64693198|FG000|Overall Study|Outside f-up window|26|||
23260047|NCT00788957|64693199|FG000|Part 1|Death|8|||
23260048|NCT00788957|64693200|FG001|Part 1|Death|0|||
23260049|NCT00788957|64693201|FG002|Part 1|Death|0|||
23260050|NCT00788957|64693202|FG003|Part 1|Death|0|||
23260051|NCT00788957|64693203|FG004|Part 1|Death|0|||
23260052|NCT00788957|64693204|FG005|Part 1|Death|0|||
23260053|NCT00788957|64693199|FG000|Part 1|Lost to Follow-up|1|||
23260054|NCT00788957|64693200|FG001|Part 1|Lost to Follow-up|0|||
23260055|NCT00788957|64693201|FG002|Part 1|Lost to Follow-up|0|||
23260056|NCT00788957|64693202|FG003|Part 1|Lost to Follow-up|0|||
23260057|NCT00788957|64693203|FG004|Part 1|Lost to Follow-up|0|||
23260058|NCT00788957|64693204|FG005|Part 1|Lost to Follow-up|0|||
23260059|NCT00788957|64693199|FG000|Part 2|Withdrawal by Subject|0|||
23260060|NCT00788957|64693200|FG001|Part 2|Withdrawal by Subject|9|||
23260061|NCT00788957|64693201|FG002|Part 2|Withdrawal by Subject|5|||
23260062|NCT00788957|64693202|FG003|Part 2|Withdrawal by Subject|3|||
23260063|NCT00788957|64693203|FG004|Part 2|Withdrawal by Subject|0|||
23260064|NCT00788957|64693204|FG005|Part 2|Withdrawal by Subject|0|||
23260065|NCT00788957|64693199|FG000|Part 2|Death|0|||
23260066|NCT00788957|64693200|FG001|Part 2|Death|32|||
23260067|NCT00788957|64693201|FG002|Part 2|Death|35|||
23260068|NCT00788957|64693202|FG003|Part 2|Death|37|||
23260069|NCT00788957|64693203|FG004|Part 2|Death|0|||
23260070|NCT00788957|64693204|FG005|Part 2|Death|0|||
23260071|NCT00788957|64693199|FG000|Part 2|Lost to Follow-up|0|||
23260072|NCT00788957|64693200|FG001|Part 2|Lost to Follow-up|0|||
23260073|NCT00788957|64693201|FG002|Part 2|Lost to Follow-up|3|||
23260074|NCT00788957|64693202|FG003|Part 2|Lost to Follow-up|0|||
23260075|NCT00788957|64693203|FG004|Part 2|Lost to Follow-up|0|||
23260076|NCT00788957|64693204|FG005|Part 2|Lost to Follow-up|0|||
23260077|NCT00788957|64693199|FG000|Part 2|On-study at time of data cut-off|0|||
23260078|NCT00788957|64693200|FG001|Part 2|On-study at time of data cut-off|1|||
23260079|NCT00788957|64693201|FG002|Part 2|On-study at time of data cut-off|1|||
23260080|NCT00788957|64693202|FG003|Part 2|On-study at time of data cut-off|1|||
23260081|NCT00788957|64693203|FG004|Part 2|On-study at time of data cut-off|0|||
23260082|NCT00788957|64693204|FG005|Part 2|On-study at time of data cut-off|0|||
23260083|NCT00788957|64693199|FG000|Part 3|Withdrawal by Subject|0|||
23260084|NCT00788957|64693200|FG001|Part 3|Withdrawal by Subject|0|||
23260085|NCT00788957|64693201|FG002|Part 3|Withdrawal by Subject|0|||
23260086|NCT00788957|64693202|FG003|Part 3|Withdrawal by Subject|0|||
23260087|NCT00788957|64693203|FG004|Part 3|Withdrawal by Subject|0|||
23260088|NCT00788957|64693204|FG005|Part 3|Withdrawal by Subject|2|||
23260089|NCT00788957|64693199|FG000|Part 3|Death|0|||
23260090|NCT00788957|64693200|FG001|Part 3|Death|0|||
23260091|NCT00788957|64693201|FG002|Part 3|Death|0|||
23260092|NCT00788957|64693202|FG003|Part 3|Death|0|||
23260093|NCT00788957|64693203|FG004|Part 3|Death|8|||
23260094|NCT00788957|64693204|FG005|Part 3|Death|8|||
23260095|NCT00788957|64693199|FG000|Part 3|On-study at time of data cut-off|0|||
23260096|NCT00788957|64693200|FG001|Part 3|On-study at time of data cut-off|0|||
23260097|NCT00788957|64693201|FG002|Part 3|On-study at time of data cut-off|0|||
23260098|NCT00788957|64693202|FG003|Part 3|On-study at time of data cut-off|0|||
23260099|NCT00788957|64693203|FG004|Part 3|On-study at time of data cut-off|1|||
23260100|NCT00788957|64693204|FG005|Part 3|On-study at time of data cut-off|0|||
23260101|NCT01214330|64693205|FG000|Overall Study|Withdrawal by Subject|2|||
23260102|NCT01214330|64693205|FG000|Overall Study|Withdrawal by Subject|2|||
23260103|NCT01580020|64693209|FG000|Overall Study|Lack of Efficacy|0|||
23260104|NCT01580020|64693210|FG001|Overall Study|Lack of Efficacy|5|||
23260105|NCT01580020|64693211|FG002|Overall Study|Lack of Efficacy|0|||
23260106|NCT01580020|64693212|FG003|Overall Study|Lack of Efficacy|1|||
23260107|NCT01580020|64693209|FG000|Overall Study|Withdrawal by Subject|0|||
23260108|NCT01580020|64693210|FG001|Overall Study|Withdrawal by Subject|1|||
23260109|NCT01580020|64693211|FG002|Overall Study|Withdrawal by Subject|1|||
23260110|NCT01580020|64693212|FG003|Overall Study|Withdrawal by Subject|0|||
23260111|NCT01580020|64693209|FG000|Overall Study|Adverse Event|1|||
23260112|NCT01580020|64693210|FG001|Overall Study|Adverse Event|1|||
23260113|NCT01580020|64693211|FG002|Overall Study|Adverse Event|1|||
23260114|NCT01580020|64693212|FG003|Overall Study|Adverse Event|1|||
23260115|NCT01580020|64693209|FG000|Overall Study|Administrative Problems|0|||
23260116|NCT01580020|64693210|FG001|Overall Study|Administrative Problems|0|||
23260117|NCT01580020|64693211|FG002|Overall Study|Administrative Problems|1|||
23260118|NCT01580020|64693212|FG003|Overall Study|Administrative Problems|0|||
23260119|NCT01580020|64693209|FG000|Overall Study|Lost to Follow-up|0|||
23260120|NCT01580020|64693210|FG001|Overall Study|Lost to Follow-up|0|||
23260121|NCT01580020|64693211|FG002|Overall Study|Lost to Follow-up|1|||
23260122|NCT01580020|64693212|FG003|Overall Study|Lost to Follow-up|0|||
23260123|NCT01809314|64693213|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
23260124|NCT01809314|64693213|FG000|Overall Study|Adverse Event|6|||
23260125|NCT01809314|64693213|FG000|Overall Study|Insufficient Therapeutic Response|14|||
23260126|NCT01809314|64693213|FG000|Overall Study|Lost to Follow-up|724|||
23260127|NCT02360397|64693214|FG000|Overall Study|Incomplete screening|3|||
23260128|NCT02360397|64693214|FG000|Overall Study|Adverse Event|1|||
23260129|NCT03652961|64693215|FG000|Overall Study|Lost to Follow-up|3|||
23260130|NCT03652961|64693215|FG000|Overall Study|Screen Failure|1|||
23260131|NCT02497391|64693216|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
23260132|NCT02497391|64693217|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
23260133|NCT02497391|64693218|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
23260134|NCT02497391|64693219|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
23260135|NCT02497391|64693220|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
23260136|NCT02497391|64693221|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
23260137|NCT02497391|64693216|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
23260138|NCT02497391|64693217|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
23260139|NCT02497391|64693218|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
23260140|NCT02497391|64693219|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
23260141|NCT02497391|64693220|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
23260142|NCT02497391|64693221|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
23260143|NCT02497391|64693216|FG000|Period 3 (14 Days)|Adverse Event|0|||
23260144|NCT02497391|64693217|FG001|Period 3 (14 Days)|Adverse Event|1|||
23260145|NCT02497391|64693218|FG002|Period 3 (14 Days)|Adverse Event|0|||
23260146|NCT02497391|64693219|FG003|Period 3 (14 Days)|Adverse Event|0|||
23260147|NCT02497391|64693220|FG004|Period 3 (14 Days)|Adverse Event|0|||
23260148|NCT02497391|64693221|FG005|Period 3 (14 Days)|Adverse Event|0|||
23260149|NCT02497391|64693216|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
23260150|NCT02497391|64693217|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
23260151|NCT02497391|64693218|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
23260152|NCT02497391|64693219|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
23260153|NCT02497391|64693220|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
23260154|NCT02497391|64693221|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
23260155|NCT02497391|64693216|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
23260156|NCT02497391|64693217|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
23260157|NCT02497391|64693218|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
23260158|NCT02497391|64693219|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
23260159|NCT02497391|64693220|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
23260160|NCT02497391|64693221|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
23260161|NCT01896297|64693222|FG000|Overall Study|Died in post treatment phase|1|||
23260162|NCT03355742|64693223|FG000|Overall Study|Lost to Follow-up|4|||
23260163|NCT03355742|64693223|FG000|Overall Study|Withdrawal by Subject|29|||
23260164|NCT03355742|64693223|FG000|Overall Study|Physician Decision|6|||
23260165|NCT03355742|64693223|FG000|Overall Study|Death|55|||
23260166|NCT03355742|64693223|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
23260167|NCT00106028|64693227|FG000|Overall Study|Adverse Event|3|||
23260168|NCT00106028|64693228|FG001|Overall Study|Adverse Event|2|||
23260169|NCT00106028|64693227|FG000|Overall Study|Protocol Violation|1|||
23260170|NCT00106028|64693228|FG001|Overall Study|Protocol Violation|1|||
23260171|NCT00106028|64693227|FG000|Overall Study|Withdrawal by Subject|2|||
23260172|NCT00106028|64693228|FG001|Overall Study|Withdrawal by Subject|8|||
23260173|NCT00106028|64693227|FG000|Overall Study|Lost to Follow-up|0|||
23260174|NCT00106028|64693228|FG001|Overall Study|Lost to Follow-up|1|||
23260175|NCT01294592|64693229|FG000|Overall Study|Adverse Event|28|||
23260176|NCT01294592|64693230|FG001|Overall Study|Adverse Event|13|||
23260177|NCT01294592|64693229|FG000|Overall Study|Lack of Efficacy|7|||
23260178|NCT01294592|64693230|FG001|Overall Study|Lack of Efficacy|5|||
23260179|NCT01294592|64693229|FG000|Overall Study|Protocol Violation|1|||
23260180|NCT01294592|64693230|FG001|Overall Study|Protocol Violation|7|||
23260181|NCT01294592|64693229|FG000|Overall Study|Lost to Follow-up|7|||
23260182|NCT01294592|64693230|FG001|Overall Study|Lost to Follow-up|9|||
23260183|NCT01294592|64693229|FG000|Overall Study|Physician Decision|6|||
23260184|NCT01294592|64693230|FG001|Overall Study|Physician Decision|11|||
23260185|NCT01294592|64693229|FG000|Overall Study|Withdrawal by Subject|28|||
23260186|NCT01294592|64693230|FG001|Overall Study|Withdrawal by Subject|28|||
23260187|NCT01873859|64693233|FG000|Overall Study|Withdrawal by Subject|0|||
23260188|NCT01873859|64693234|FG001|Overall Study|Withdrawal by Subject|4|||
23260189|NCT02049359|64693237|FG000|Overall Study|Lost to Follow-up|26|||
23260190|NCT02049359|64693238|FG001|Overall Study|Lost to Follow-up|19|||
23260191|NCT01960816|64693244|FG000|Overall Study|Lost to Follow-up|1|||
23260192|NCT04104646|64693245|FG000|Overall Study|Withdrawal by Subject|1|||
23260193|NCT04104646|64693246|FG001|Overall Study|Withdrawal by Subject|1|||
23260194|NCT04104646|64693245|FG000|Overall Study|Lost to Follow-up|1|||
23260195|NCT04104646|64693246|FG001|Overall Study|Lost to Follow-up|0|||
23260196|NCT04104646|64693245|FG000|Overall Study|Physician Decision|2|||
23260197|NCT04104646|64693246|FG001|Overall Study|Physician Decision|0|||
23260198|NCT01759381|64693247|FG000|Overall Study|Death|1|||
23260199|NCT01759381|64693248|FG001|Overall Study|Death|0|||
23260200|NCT01165242|64693249|FG000|Overall Study|Unreachable Subjects|1|||
23260201|NCT01165242|64693250|FG001|Overall Study|Unreachable Subjects|0|||
23260202|NCT01165242|64693251|FG002|Overall Study|Unreachable Subjects|0|||
23260203|NCT01165242|64693249|FG000|Overall Study|Incarcerated Subjects|0|||
23260204|NCT01165242|64693250|FG001|Overall Study|Incarcerated Subjects|1|||
23260205|NCT01165242|64693251|FG002|Overall Study|Incarcerated Subjects|0|||
23260206|NCT01165242|64693249|FG000|Overall Study|Visit 2 Declined by Subject|0|||
23260207|NCT01165242|64693250|FG001|Overall Study|Visit 2 Declined by Subject|0|||
23361353|NCT01435759|65069674|FG001|Double-blind Phase|Protocol Violation|0|||
23260208|NCT01165242|64693251|FG002|Overall Study|Visit 2 Declined by Subject|1|||
23260209|NCT01165242|64693249|FG000|Overall Study|Withdrawal by Subject|0|||
23361354|NCT01435759|65069675|FG002|Double-blind Phase|Protocol Violation|1|||
23260210|NCT01165242|64693250|FG001|Overall Study|Withdrawal by Subject|2|||
23260211|NCT01165242|64693251|FG002|Overall Study|Withdrawal by Subject|2|||
23260212|NCT01165242|64693249|FG000|Overall Study|Extended Holiday|0|||
23260213|NCT01165242|64693250|FG001|Overall Study|Extended Holiday|0|||
23260214|NCT01165242|64693251|FG002|Overall Study|Extended Holiday|1|||
23260215|NCT01165242|64693249|FG000|Overall Study|Lost to Follow-up|9|||
23260216|NCT01165242|64693250|FG001|Overall Study|Lost to Follow-up|7|||
23260217|NCT01165242|64693251|FG002|Overall Study|Lost to Follow-up|10|||
23260218|NCT01073020|64693256|FG000|Overall Study|Withdrawal by Subject|6|||
23260219|NCT01073020|64693257|FG001|Overall Study|Withdrawal by Subject|4|||
23260220|NCT01073020|64693258|FG002|Overall Study|Withdrawal by Subject|1|||
23260221|NCT01073020|64693259|FG003|Overall Study|Withdrawal by Subject|2|||
23260222|NCT01073020|64693256|FG000|Overall Study|Physician Decision|1|||
23260223|NCT01073020|64693257|FG001|Overall Study|Physician Decision|0|||
23260224|NCT01073020|64693258|FG002|Overall Study|Physician Decision|2|||
23260225|NCT01073020|64693259|FG003|Overall Study|Physician Decision|0|||
23260226|NCT01073020|64693256|FG000|Overall Study|Death|0|||
23260227|NCT01073020|64693257|FG001|Overall Study|Death|1|||
23260228|NCT01073020|64693258|FG002|Overall Study|Death|0|||
23260229|NCT01073020|64693259|FG003|Overall Study|Death|0|||
23260230|NCT03384745|64693260|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
23260231|NCT03384745|64693261|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
23260232|NCT03384745|64693262|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
23260233|NCT03384745|64693263|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
23260234|NCT03384745|64693264|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
23260235|NCT03384745|64693265|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
23260236|NCT03384745|64693260|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
23260237|NCT03384745|64693261|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
23260238|NCT03384745|64693262|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
23260239|NCT03384745|64693263|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
23260240|NCT03384745|64693264|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
23260241|NCT03384745|64693265|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
23260242|NCT03384745|64693260|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
23260243|NCT03384745|64693261|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
23260244|NCT03384745|64693262|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
23260245|NCT03384745|64693263|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
23260246|NCT03384745|64693264|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
23260247|NCT03384745|64693265|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
23260248|NCT03384745|64693260|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23260249|NCT03384745|64693261|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23260250|NCT03384745|64693262|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
23260251|NCT03384745|64693263|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23260252|NCT03384745|64693264|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23260253|NCT03384745|64693265|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
23260254|NCT03384745|64693260|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
23260255|NCT03384745|64693261|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
23260256|NCT03384745|64693262|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
23199942|NCT01474746|64473253|FG000|Overall Study|Lost to Follow-up|1|||
23600425|NCT02561195|65929651|FG000|Vaccination 1 to 3|Death|2|||
23600426|NCT02561195|65929652|FG001|Vaccination 1 to 3|Death|1|||
23600427|NCT02561195|65929653|FG002|Vaccination 1 to 3|Death|0|||
23600428|NCT02561195|65929654|FG003|Vaccination 1 to 3|Death|2|||
23600429|NCT02561195|65929655|FG004|Vaccination 1 to 3|Death|0|||
23600430|NCT02561195|65929656|FG005|Vaccination 1 to 3|Death|0|||
23600431|NCT02561195|65929657|FG006|Vaccination 1 to 3|Death|0|||
23600432|NCT02561195|65929658|FG007|Vaccination 1 to 3|Death|0|||
23600433|NCT02561195|65929659|FG008|Vaccination 1 to 3|Death|0|||
23600434|NCT02561195|65929660|FG009|Vaccination 1 to 3|Death|0|||
23600435|NCT02561195|65929661|FG010|Vaccination 1 to 3|Death|0|||
23600436|NCT02561195|65929662|FG011|Vaccination 1 to 3|Death|0|||
23600437|NCT02561195|65929663|FG012|Vaccination 1 to 3|Death|0|||
23600438|NCT02561195|65929664|FG013|Vaccination 1 to 3|Death|0|||
23600439|NCT02561195|65929651|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
23600440|NCT02561195|65929652|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
23600441|NCT02561195|65929653|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
23600442|NCT02561195|65929654|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
23199943|NCT01474746|64473254|FG001|Overall Study|Lost to Follow-up|1|||
23199944|NCT01474746|64473253|FG000|Overall Study|Withdrawal by Subject|2|||
23600443|NCT02561195|65929655|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
23600444|NCT02561195|65929656|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600445|NCT02561195|65929657|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600446|NCT02561195|65929658|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600447|NCT02561195|65929659|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600448|NCT02561195|65929660|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600449|NCT02561195|65929661|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600450|NCT02561195|65929662|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600451|NCT02561195|65929663|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600452|NCT02561195|65929664|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
23600453|NCT02561195|65929651|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
23600454|NCT02561195|65929652|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
23600455|NCT02561195|65929653|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
23600456|NCT02561195|65929654|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
23600457|NCT02561195|65929655|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
23600458|NCT02561195|65929656|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
23600459|NCT02561195|65929657|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
23600460|NCT02561195|65929658|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
23600461|NCT02561195|65929659|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
23600462|NCT02561195|65929660|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
23600463|NCT02561195|65929661|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
23600464|NCT02561195|65929662|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
23600465|NCT02561195|65929663|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
23600466|NCT02561195|65929664|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
23600467|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600468|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600469|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23199945|NCT01474746|64473254|FG001|Overall Study|Withdrawal by Subject|1|||
23199946|NCT03382899|64473257|FG000|Overall Study|Ineligibility Determined|0|||
23199947|NCT03382899|64473258|FG001|Overall Study|Ineligibility Determined|1|||
23199948|NCT03382899|64473257|FG000|Overall Study|Lost to Follow-up|0|||
23199949|NCT03382899|64473258|FG001|Overall Study|Lost to Follow-up|1|||
23199950|NCT03382899|64473257|FG000|Overall Study|Sponsor's decision|31|||
23199951|NCT03382899|64473258|FG001|Overall Study|Sponsor's decision|28|||
23199952|NCT03382899|64473257|FG000|Overall Study|Withdrawal by Subject|0|||
23199953|NCT03382899|64473258|FG001|Overall Study|Withdrawal by Subject|5|||
23199954|NCT03007953|64473259|FG000|Overall Study|Withdrawal by Subject|5|||
23199955|NCT03007953|64473260|FG001|Overall Study|Withdrawal by Subject|2|||
23199956|NCT03007953|64473259|FG000|Overall Study|Death|5|||
23199957|NCT03007953|64473260|FG001|Overall Study|Death|7|||
23199958|NCT03007953|64473259|FG000|Overall Study|Lost to Follow-up|3|||
23199959|NCT03007953|64473260|FG001|Overall Study|Lost to Follow-up|2|||
23199960|NCT03007953|64473259|FG000|Overall Study|Enrolled in Hospice|3|||
23260257|NCT03384745|64693263|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
23199961|NCT03007953|64473260|FG001|Overall Study|Enrolled in Hospice|2|||
23199962|NCT02411201|64473261|FG000|Overall Study|Adverse Event|2|||
23199963|NCT02411201|64473261|FG000|Overall Study|Withdrawal by Subject|2|||
23260258|NCT03384745|64693264|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
23600470|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600471|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600472|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600473|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600474|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600475|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
23600476|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
23361355|NCT01435759|65069676|FG003|Double-blind Phase|Protocol Violation|2|||
23361356|NCT01435759|65069677|FG004|Double-blind Phase|Protocol Violation|0|||
23361357|NCT01435759|65069678|FG005|Double-blind Phase|Protocol Violation|1|||
23361358|NCT01435759|65069673|FG000|Double-blind Phase|Withdrawal by Subject|17|||
23361359|NCT01435759|65069674|FG001|Double-blind Phase|Withdrawal by Subject|4|||
23361360|NCT01435759|65069675|FG002|Double-blind Phase|Withdrawal by Subject|3|||
23361361|NCT01435759|65069676|FG003|Double-blind Phase|Withdrawal by Subject|4|||
23361362|NCT01435759|65069677|FG004|Double-blind Phase|Withdrawal by Subject|2|||
23600477|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
23600478|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
23600479|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
23600480|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
23600481|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600482|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600483|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600484|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600485|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600486|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600487|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600488|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600489|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600490|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600491|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600492|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600493|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
23600494|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
23600495|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Death|0|||
23600496|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Death|0|||
23600497|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Death|0|||
23600498|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Death|0|||
23600499|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Death|0|||
23600500|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Death|0|||
23600501|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Death|0|||
23600502|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Death|0|||
23600503|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Death|0|||
23600504|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Death|1|||
23600505|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Death|0|||
23600506|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Death|0|||
23600507|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Death|0|||
23600508|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Death|0|||
23600509|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600510|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600511|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600512|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600513|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600514|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600515|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
23600516|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
23600517|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23600518|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
23361363|NCT01435759|65069678|FG005|Double-blind Phase|Withdrawal by Subject|2|||
23361364|NCT01435759|65069673|FG000|Double-blind Phase|Lost to Follow-up|31|||
23361365|NCT01435759|65069674|FG001|Double-blind Phase|Lost to Follow-up|1|||
23600519|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
23600520|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
23600521|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
23600522|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
23600523|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600524|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600525|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600526|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600527|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23199964|NCT02411201|64473261|FG000|Overall Study|Age group completed|2|||
23199965|NCT02402218|64473262|FG000|Overall Study|Did not pickup study medication|12|||
23199966|NCT02402218|64473263|FG001|Overall Study|Did not pickup study medication|9|||
23199967|NCT02402218|64473264|FG002|Overall Study|Did not pickup study medication|13|||
23199968|NCT02402218|64473262|FG000|Overall Study|Lack of Efficacy|0|||
23199969|NCT02402218|64473263|FG001|Overall Study|Lack of Efficacy|1|||
23199970|NCT02402218|64473264|FG002|Overall Study|Lack of Efficacy|1|||
23199971|NCT02402218|64473262|FG000|Overall Study|Death|1|||
23199972|NCT02402218|64473263|FG001|Overall Study|Death|0|||
23199973|NCT02402218|64473264|FG002|Overall Study|Death|0|||
23199974|NCT02402218|64473262|FG000|Overall Study|Reinfection|0|||
23199975|NCT02402218|64473263|FG001|Overall Study|Reinfection|0|||
23199976|NCT02402218|64473264|FG002|Overall Study|Reinfection|1|||
23361366|NCT01435759|65069675|FG002|Double-blind Phase|Lost to Follow-up|2|||
23361367|NCT01435759|65069676|FG003|Double-blind Phase|Lost to Follow-up|0|||
23600528|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600529|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600530|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600531|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600532|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600533|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
23600534|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
23600535|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
23600536|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
23600537|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Other|0|||
23199977|NCT02402218|64473262|FG000|Overall Study|Adverse Event|0|||
23199978|NCT02402218|64473263|FG001|Overall Study|Adverse Event|2|||
23199979|NCT02402218|64473264|FG002|Overall Study|Adverse Event|1|||
23199980|NCT02402218|64473262|FG000|Overall Study|Withdrawal by Subject|1|||
23199981|NCT02402218|64473263|FG001|Overall Study|Withdrawal by Subject|1|||
23199982|NCT02402218|64473264|FG002|Overall Study|Withdrawal by Subject|1|||
23199983|NCT01808118|64473265|FG000|Period 1|Adverse Event|15|||
23199984|NCT01808118|64473266|FG001|Period 1|Adverse Event|0|||
23199985|NCT01808118|64473267|FG002|Period 1|Adverse Event|0|||
23199986|NCT01808118|64473265|FG000|Period 1|Withdrew consent|24|||
23199987|NCT01808118|64473266|FG001|Period 1|Withdrew consent|0|||
23199988|NCT01808118|64473267|FG002|Period 1|Withdrew consent|0|||
23199989|NCT01808118|64473265|FG000|Period 1|Lost to Follow-up|9|||
23199990|NCT01808118|64473266|FG001|Period 1|Lost to Follow-up|0|||
23199991|NCT01808118|64473267|FG002|Period 1|Lost to Follow-up|0|||
23199992|NCT01808118|64473265|FG000|Period 1|Did not meet criteria for remission|303|||
23199993|NCT01808118|64473266|FG001|Period 1|Did not meet criteria for remission|0|||
23600538|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Other|0|||
23600539|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Other|0|||
23600540|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Other|0|||
23600541|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Other|0|||
23600542|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Other|0|||
23199994|NCT01808118|64473267|FG002|Period 1|Did not meet criteria for remission|0|||
23199995|NCT01808118|64473265|FG000|Period 1|Enrolled in error|7|||
23199996|NCT01808118|64473266|FG001|Period 1|Enrolled in error|0|||
23600543|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Other|0|||
23199997|NCT01808118|64473267|FG002|Period 1|Enrolled in error|0|||
23199998|NCT01808118|64473265|FG000|Period 1|Did not meet inclusion criteria|3|||
23199999|NCT01808118|64473266|FG001|Period 1|Did not meet inclusion criteria|0|||
23200000|NCT01808118|64473267|FG002|Period 1|Did not meet inclusion criteria|0|||
23200001|NCT01808118|64473265|FG000|Period 1|Non-conformance with inclusion criteria|3|||
23260259|NCT03384745|64693265|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
23361368|NCT01435759|65069677|FG004|Double-blind Phase|Lost to Follow-up|3|||
23600544|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Other|0|||
23260260|NCT03384745|64693260|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23260261|NCT03384745|64693261|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23260262|NCT03384745|64693262|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23260263|NCT03384745|64693263|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23260264|NCT03384745|64693264|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
23260265|NCT03384745|64693265|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
23260266|NCT03384745|64693260|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
23260267|NCT03384745|64693261|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
23260268|NCT03384745|64693262|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
23260269|NCT03384745|64693263|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
23260270|NCT03384745|64693264|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
23260271|NCT03384745|64693265|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
23260272|NCT03384745|64693260|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
23260273|NCT03384745|64693261|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
23260274|NCT03384745|64693262|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
23260275|NCT03384745|64693263|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
23260276|NCT03384745|64693264|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
23260277|NCT03384745|64693265|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
23260278|NCT03384745|64693260|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
23260279|NCT03384745|64693261|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
23260280|NCT03384745|64693262|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
23260281|NCT03384745|64693263|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
23260282|NCT03384745|64693264|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
23260283|NCT03384745|64693265|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
23260284|NCT03384745|64693260|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23260285|NCT03384745|64693261|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23260286|NCT03384745|64693262|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23260287|NCT03384745|64693263|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
23260288|NCT03384745|64693264|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23260289|NCT03384745|64693265|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
23260290|NCT03384745|64693260|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
23260291|NCT03384745|64693261|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
23260292|NCT03384745|64693262|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
23260293|NCT03384745|64693263|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
23260294|NCT03384745|64693264|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
23260295|NCT03384745|64693265|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
23260296|NCT01738581|64693271|FG000|Overall Study|Lost to Follow-up|1|||
23260297|NCT01738581|64693272|FG001|Overall Study|Lost to Follow-up|0|||
23260298|NCT02585258|64693273|FG000|Overall Study|Adverse Event|28|||
23260299|NCT02585258|64693274|FG001|Overall Study|Adverse Event|29|||
23260300|NCT02585258|64693273|FG000|Overall Study|Death|3|||
23260301|NCT02585258|64693274|FG001|Overall Study|Death|2|||
23260302|NCT02585258|64693273|FG000|Overall Study|Lack of Efficacy|7|||
23260303|NCT02585258|64693274|FG001|Overall Study|Lack of Efficacy|9|||
23260304|NCT02585258|64693273|FG000|Overall Study|includes covid-related access problems|42|||
23260305|NCT02585258|64693274|FG001|Overall Study|includes covid-related access problems|46|||
23260306|NCT02585258|64693273|FG000|Overall Study|Lost to Follow-up|5|||
23260307|NCT02585258|64693274|FG001|Overall Study|Lost to Follow-up|2|||
23260308|NCT01165684|64693276|FG000|Overall Study|Adverse Event|1|||
23260309|NCT01165684|64693277|FG001|Overall Study|Adverse Event|1|||
23260310|NCT01165684|64693276|FG000|Overall Study|Lack of Efficacy|2|||
23260311|NCT01165684|64693277|FG001|Overall Study|Lack of Efficacy|1|||
23260312|NCT01165684|64693276|FG000|Overall Study|Protocol Violation|7|||
23260313|NCT01165684|64693277|FG001|Overall Study|Protocol Violation|15|||
23260314|NCT01165684|64693276|FG000|Overall Study|Withdrawal Criteria|2|||
23260315|NCT01165684|64693277|FG001|Overall Study|Withdrawal Criteria|13|||
23260316|NCT01165684|64693276|FG000|Overall Study|Unclassified|16|||
23260317|NCT01165684|64693277|FG001|Overall Study|Unclassified|22|||
23260318|NCT03459846|64693278|FG000|Overall Study|Death|52|||
23260319|NCT03459846|64693279|FG001|Overall Study|Death|46|||
23260320|NCT03459846|64693278|FG000|Overall Study|Study terminated by sponsor|24|||
23260321|NCT03459846|64693279|FG001|Overall Study|Study terminated by sponsor|28|||
23260322|NCT03459846|64693278|FG000|Overall Study|Withdrawal by Subject|2|||
23200002|NCT01808118|64473266|FG001|Period 1|Non-conformance with inclusion criteria|0|||
23200003|NCT01808118|64473267|FG002|Period 1|Non-conformance with inclusion criteria|0|||
23200004|NCT01808118|64473265|FG000|Period 1|Investigator decision: site closure|2|||
23200005|NCT01808118|64473266|FG001|Period 1|Investigator decision: site closure|0|||
23200006|NCT01808118|64473267|FG002|Period 1|Investigator decision: site closure|0|||
23200007|NCT01808118|64473265|FG000|Period 1|Non-compliance per sponsor|1|||
23200008|NCT01808118|64473266|FG001|Period 1|Non-compliance per sponsor|0|||
23200009|NCT01808118|64473267|FG002|Period 1|Non-compliance per sponsor|0|||
23200010|NCT01808118|64473265|FG000|Period 1|Lack of Efficacy|1|||
23200011|NCT01808118|64473266|FG001|Period 1|Lack of Efficacy|0|||
23200012|NCT01808118|64473267|FG002|Period 1|Lack of Efficacy|0|||
23200013|NCT01808118|64473265|FG000|Period 2|Adverse Event|0|||
23200014|NCT01808118|64473266|FG001|Period 2|Adverse Event|4|||
23200015|NCT01808118|64473267|FG002|Period 2|Adverse Event|0|||
23200016|NCT01808118|64473265|FG000|Period 2|Withdrew consent|0|||
23200017|NCT01808118|64473266|FG001|Period 2|Withdrew consent|7|||
23200018|NCT01808118|64473267|FG002|Period 2|Withdrew consent|6|||
23200019|NCT01808118|64473265|FG000|Period 2|Lost to Follow-up|0|||
23200020|NCT01808118|64473266|FG001|Period 2|Lost to Follow-up|0|||
23200021|NCT01808118|64473267|FG002|Period 2|Lost to Follow-up|2|||
23200022|NCT01808118|64473265|FG000|Period 2|Investigator no longer conducting trials|0|||
23200023|NCT01808118|64473266|FG001|Period 2|Investigator no longer conducting trials|1|||
23200024|NCT01808118|64473267|FG002|Period 2|Investigator no longer conducting trials|0|||
23200025|NCT01808118|64473265|FG000|Period 2|Switched to other therapy|0|||
23200026|NCT01808118|64473266|FG001|Period 2|Switched to other therapy|1|||
23200027|NCT01808118|64473267|FG002|Period 2|Switched to other therapy|0|||
23200028|NCT02720016|64473268|FG000|Overall Study|Separation of couple|6|||
23200029|NCT02720016|64473269|FG001|Overall Study|Separation of couple|8|||
23200030|NCT02720016|64473270|FG002|Overall Study|Separation of couple|2|||
23200031|NCT02720016|64473268|FG000|Overall Study|Withdrawal by Subject|6|||
23200032|NCT02720016|64473269|FG001|Overall Study|Withdrawal by Subject|6|||
23200033|NCT02720016|64473270|FG002|Overall Study|Withdrawal by Subject|4|||
23200034|NCT02720016|64473268|FG000|Overall Study|Scheduling issues|2|||
23200035|NCT02720016|64473269|FG001|Overall Study|Scheduling issues|4|||
23200036|NCT02720016|64473270|FG002|Overall Study|Scheduling issues|7|||
23200037|NCT02720016|64473268|FG000|Overall Study|Childcare|2|||
23200038|NCT02720016|64473269|FG001|Overall Study|Childcare|0|||
23200039|NCT02720016|64473270|FG002|Overall Study|Childcare|2|||
23200040|NCT02720016|64473268|FG000|Overall Study|Withdrawal by PI|2|||
23200041|NCT02720016|64473269|FG001|Overall Study|Withdrawal by PI|2|||
23200042|NCT02720016|64473270|FG002|Overall Study|Withdrawal by PI|0|||
23200043|NCT02720016|64473268|FG000|Overall Study|Moved away|2|||
23200044|NCT02720016|64473269|FG001|Overall Study|Moved away|0|||
23200045|NCT02720016|64473270|FG002|Overall Study|Moved away|0|||
23200046|NCT02720016|64473268|FG000|Overall Study|Not Primary Health Concern|0|||
23200047|NCT02720016|64473269|FG001|Overall Study|Not Primary Health Concern|0|||
23200048|NCT02720016|64473270|FG002|Overall Study|Not Primary Health Concern|2|||
23200049|NCT02720016|64473268|FG000|Overall Study|Transportation issues|0|||
23200050|NCT02720016|64473269|FG001|Overall Study|Transportation issues|0|||
23200051|NCT02720016|64473270|FG002|Overall Study|Transportation issues|1|||
23200052|NCT02720016|64473268|FG000|Overall Study|Other|0|||
23200053|NCT02720016|64473269|FG001|Overall Study|Other|0|||
23200054|NCT02720016|64473270|FG002|Overall Study|Other|2|||
23200055|NCT04544709|64473271|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
23200056|NCT02196038|64473272|FG000|Overall Study|Death|16|||
23200057|NCT02196038|64473273|FG001|Overall Study|Death|21|||
23200058|NCT02196038|64473272|FG000|Overall Study|Withdrawal by Subject|0|||
23200059|NCT02196038|64473273|FG001|Overall Study|Withdrawal by Subject|1|||
23200060|NCT02196038|64473272|FG000|Overall Study|Lost to Follow-up|1|||
23200061|NCT02196038|64473273|FG001|Overall Study|Lost to Follow-up|0|||
23200062|NCT05131451|64473276|FG000|Overall Study|Protocol Violation|1|||
23260323|NCT03459846|64693279|FG001|Overall Study|Withdrawal by Subject|2|||
23260324|NCT00458302|64693280|FG000|Overall Study|Adverse Event|4|||
23260325|NCT00458302|64693281|FG001|Overall Study|Adverse Event|14|||
23260326|NCT00458302|64693280|FG000|Overall Study|Pregnancy|2|||
23260327|NCT00458302|64693281|FG001|Overall Study|Pregnancy|1|||
23260328|NCT00458302|64693280|FG000|Overall Study|Protocol Violation|0|||
23260329|NCT00458302|64693281|FG001|Overall Study|Protocol Violation|2|||
23260330|NCT00458302|64693280|FG000|Overall Study|Withdrawal by Subject|6|||
23260331|NCT00458302|64693281|FG001|Overall Study|Withdrawal by Subject|4|||
23260332|NCT00458302|64693280|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
23260333|NCT00458302|64693281|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
23260334|NCT00458302|64693280|FG000|Overall Study|Study Termination By Sponsor|1|||
23260335|NCT00458302|64693281|FG001|Overall Study|Study Termination By Sponsor|0|||
23260336|NCT00458302|64693280|FG000|Overall Study|Lost to Follow-up|2|||
23260337|NCT00458302|64693281|FG001|Overall Study|Lost to Follow-up|0|||
23260338|NCT00458302|64693280|FG000|Overall Study|Other|4|||
23260339|NCT00458302|64693281|FG001|Overall Study|Other|2|||
23260340|NCT00767325|64693282|FG000|Overall Study|Lack of Efficacy|2|||
23260341|NCT00767325|64693282|FG000|Overall Study|Adverse Event|7|||
23260342|NCT00767325|64693282|FG000|Overall Study|Lost to Follow-up|3|||
23260343|NCT00767325|64693282|FG000|Overall Study|No longer met study criteria|2|||
23260344|NCT00767325|64693282|FG000|Overall Study|Missed visit due to family reasons|1|||
23260345|NCT00112489|64693283|FG000|Overall Study|Refused further treatment|8|||
23260346|NCT00112489|64693283|FG000|Overall Study|Adverse Event|12|||
23260347|NCT00112489|64693283|FG000|Overall Study|Death|2|||
23260348|NCT00112489|64693283|FG000|Overall Study|Other, Not Specified|9|||
23260349|NCT00112489|64693283|FG000|Overall Study|Patient never treated|2|||
23260350|NCT00112489|64693283|FG000|Overall Study|Ineligible|7|||
23260351|NCT00290745|64693284|FG000|Overall Study|Withdrawal by Subject|4|||
23260352|NCT00290745|64693284|FG000|Overall Study|Physician Decision|2|||
23260353|NCT00290745|64693284|FG000|Overall Study|Surgery after 3 months for progression|3|||
23260354|NCT00290745|64693284|FG000|Overall Study|Baseline MRI not available|3|||
23260355|NCT02576990|64693287|FG000|Overall Study|Death|29|||
23260356|NCT02576990|64693288|FG001|Overall Study|Death|18|||
23260357|NCT02576990|64693287|FG000|Overall Study|Physician Decision|1|||
23260358|NCT02576990|64693288|FG001|Overall Study|Physician Decision|0|||
23260359|NCT02576990|64693287|FG000|Overall Study|Screen failure|2|||
23260360|NCT02576990|64693288|FG001|Overall Study|Screen failure|0|||
23260361|NCT02576990|64693287|FG000|Overall Study|Sponsor's decision|24|||
23260362|NCT02576990|64693288|FG001|Overall Study|Sponsor's decision|4|||
23260363|NCT02576990|64693287|FG000|Overall Study|Withdrawal by Subject|0|||
23260364|NCT02576990|64693288|FG001|Overall Study|Withdrawal by Subject|2|||
23260365|NCT03682536|64693289|FG000|Randomization|Withdrawal by Subject|0|||
23260366|NCT03682536|64693290|FG001|Randomization|Withdrawal by Subject|2|||
23260367|NCT03682536|64693289|FG000|Treatment|Other Reasons|8|||
23260368|NCT03682536|64693290|FG001|Treatment|Other Reasons|7|||
23260369|NCT03682536|64693289|FG000|Treatment|Physician Decision|5|||
23260370|NCT03682536|64693290|FG001|Treatment|Physician Decision|5|||
23260371|NCT03682536|64693289|FG000|Treatment|Protocol Violation|1|||
23260372|NCT03682536|64693290|FG001|Treatment|Protocol Violation|0|||
23260373|NCT03682536|64693289|FG000|Treatment|Study Terminated by Sponsor|1|||
23260374|NCT03682536|64693290|FG001|Treatment|Study Terminated by Sponsor|2|||
23260375|NCT03682536|64693289|FG000|Treatment|Lost to Follow-up|0|||
23260376|NCT03682536|64693290|FG001|Treatment|Lost to Follow-up|1|||
23260377|NCT03682536|64693289|FG000|Treatment|Withdrawal by Subject|16|||
23260378|NCT03682536|64693290|FG001|Treatment|Withdrawal by Subject|18|||
23260379|NCT03682536|64693289|FG000|Treatment|Lack of Efficacy|41|||
23260380|NCT03682536|64693290|FG001|Treatment|Lack of Efficacy|68|||
23260381|NCT03682536|64693289|FG000|Treatment|Disease Progression|9|||
23260382|NCT03682536|64693290|FG001|Treatment|Disease Progression|7|||
23260383|NCT03682536|64693289|FG000|Treatment|Adverse Event|9|||
23260384|NCT03682536|64693290|FG001|Treatment|Adverse Event|5|||
23260385|NCT03682536|64693289|FG000|Treatment|Death|14|||
23260386|NCT03682536|64693290|FG001|Treatment|Death|13|||
23260387|NCT02100956|64693298|FG000|At Least One Week Between Injections|Adverse Event|0|||
23260388|NCT02100956|64693299|FG001|At Least One Week Between Injections|Adverse Event|1|||
23260389|NCT00752856|64693300|FG000|Overall Study|randomized but did not do viral kinetics|0|||
23260390|NCT00752856|64693301|FG001|Overall Study|randomized but did not do viral kinetics|1|||
23260391|NCT01875445|64693302|FG000|Overall Study|Lost to Follow-up|5|||
23260392|NCT01875445|64693303|FG001|Overall Study|Lost to Follow-up|0|||
23260393|NCT01875445|64693302|FG000|Overall Study|Withdrawal by Subject|2|||
23361369|NCT01435759|65069678|FG005|Double-blind Phase|Lost to Follow-up|3|||
23361370|NCT01435759|65069673|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
23260394|NCT01875445|64693303|FG001|Overall Study|Withdrawal by Subject|0|||
23260395|NCT02891200|64693306|FG000|Overall Study|Lost to Follow-up|31|||
23260396|NCT02891200|64693307|FG001|Overall Study|Lost to Follow-up|36|||
23260397|NCT02891200|64693306|FG000|Overall Study|Death|10|||
23260398|NCT02891200|64693307|FG001|Overall Study|Death|9|||
23260399|NCT02891200|64693306|FG000|Overall Study|Withdrawal by Subject|1|||
23260400|NCT02891200|64693307|FG001|Overall Study|Withdrawal by Subject|4|||
23260401|NCT03522948|64696685|FG000|Overall Study|Lost to Follow-up|1|||
23260402|NCT01706198|64696687|FG000|Overall Study|Adverse Event|12|||
23260403|NCT01706198|64696688|FG001|Overall Study|Adverse Event|15|||
23260404|NCT01706198|64696687|FG000|Overall Study|Protocol Violation|7|||
23260405|NCT01706198|64696688|FG001|Overall Study|Protocol Violation|5|||
23260406|NCT01706198|64696687|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
23260407|NCT01706198|64696688|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
23260408|NCT01706198|64696687|FG000|Overall Study|Lost to Follow-up|97|||
23260409|NCT01706198|64696688|FG001|Overall Study|Lost to Follow-up|93|||
23260410|NCT01706198|64696687|FG000|Overall Study|Physician Decision|23|||
23260411|NCT01706198|64696688|FG001|Overall Study|Physician Decision|37|||
23260412|NCT01706198|64696687|FG000|Overall Study|Withdrawal by Subject|23|||
23260413|NCT01706198|64696688|FG001|Overall Study|Withdrawal by Subject|31|||
23260414|NCT01001169|64696691|FG000|Overall Study|Withdrawal by Subject|2|||
23260415|NCT01001169|64696692|FG001|Overall Study|Withdrawal by Subject|1|||
23260416|NCT01736553|64696693|FG000|Overall Study|Death|12|||
23260417|NCT01736553|64696694|FG001|Overall Study|Death|0|||
23200063|NCT05131451|64473277|FG001|Overall Study|Protocol Violation|0|||
23200064|NCT02566525|64473278|FG000|Overall Study|Protocol Violation|3|||
23200065|NCT02566525|64473279|FG001|Overall Study|Protocol Violation|5|||
23200066|NCT02371759|64473280|FG000|Overall Study|Protocol Violation|3|||
23200067|NCT02371759|64473281|FG001|Overall Study|Protocol Violation|1|||
23200068|NCT02371759|64473282|FG002|Overall Study|Protocol Violation|1|||
23200069|NCT02371759|64473283|FG003|Overall Study|Protocol Violation|0|||
23200070|NCT02371759|64473284|FG004|Overall Study|Protocol Violation|3|||
23200071|NCT02371759|64473285|FG005|Overall Study|Protocol Violation|1|||
23200072|NCT02371759|64473286|FG006|Overall Study|Protocol Violation|0|||
23200073|NCT02371759|64473287|FG007|Overall Study|Protocol Violation|3|||
23200074|NCT02371759|64473280|FG000|Overall Study|Withdrawal by Subject|0|||
23200075|NCT02371759|64473281|FG001|Overall Study|Withdrawal by Subject|0|||
23200076|NCT02371759|64473282|FG002|Overall Study|Withdrawal by Subject|0|||
23200077|NCT02371759|64473283|FG003|Overall Study|Withdrawal by Subject|0|||
23200078|NCT02371759|64473284|FG004|Overall Study|Withdrawal by Subject|0|||
23200079|NCT02371759|64473285|FG005|Overall Study|Withdrawal by Subject|0|||
23200080|NCT02371759|64473286|FG006|Overall Study|Withdrawal by Subject|0|||
23200081|NCT02371759|64473287|FG007|Overall Study|Withdrawal by Subject|1|||
23200082|NCT00940342|64473288|FG000|Overall Study|Adverse Event|0|||
23200083|NCT00940342|64473289|FG001|Overall Study|Adverse Event|2|||
23200084|NCT00940342|64473290|FG002|Overall Study|Adverse Event|1|||
23260418|NCT01736553|64696693|FG000|Overall Study|Withdrawal by Subject|5|||
23260419|NCT01736553|64696694|FG001|Overall Study|Withdrawal by Subject|2|||
23200085|NCT01617681|64473294|FG000|Period 1 Double Blind|Adverse Event|2|||
23200086|NCT01617681|64473295|FG001|Period 1 Double Blind|Adverse Event|0|||
23200087|NCT01617681|64473296|FG002|Period 1 Double Blind|Adverse Event|0|||
23260420|NCT01736553|64696693|FG000|Overall Study|Lost to Follow-up|2|||
23200088|NCT01617681|64473297|FG003|Period 1 Double Blind|Adverse Event|2|||
23260421|NCT01736553|64696694|FG001|Overall Study|Lost to Follow-up|2|||
23260422|NCT00770991|64696697|FG000|Overall Study|Physician Decision|2|||
23260423|NCT00770991|64696698|FG001|Overall Study|Physician Decision|0|||
23260424|NCT00770991|64696697|FG000|Overall Study|Withdrawal by Subject|1|||
23260425|NCT00770991|64696698|FG001|Overall Study|Withdrawal by Subject|0|||
23260426|NCT00770991|64696697|FG000|Overall Study|Adverse Event|1|||
23200089|NCT01617681|64473298|FG004|Period 1 Double Blind|Adverse Event|0|||
23200090|NCT01617681|64473294|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
23200091|NCT01617681|64473295|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
23200092|NCT01617681|64473296|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
23200093|NCT01617681|64473297|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
23200094|NCT01617681|64473298|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
23200095|NCT01617681|64473294|FG000|Period 2 Open Label|Adverse Event|0|||
23200096|NCT01617681|64473295|FG001|Period 2 Open Label|Adverse Event|0|||
23200097|NCT01617681|64473296|FG002|Period 2 Open Label|Adverse Event|0|||
23200098|NCT01617681|64473297|FG003|Period 2 Open Label|Adverse Event|0|||
23200099|NCT01617681|64473298|FG004|Period 2 Open Label|Adverse Event|3|||
23200100|NCT01617681|64473294|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
23200101|NCT01617681|64473295|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
23200102|NCT01617681|64473296|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
23200103|NCT01617681|64473297|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
23200104|NCT01617681|64473298|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
23200105|NCT00421343|64473299|FG000|Overall Study|Death|1|||
23200106|NCT00421343|64473299|FG000|Overall Study|Withdrawal by Subject|2|||
23200107|NCT00421343|64473299|FG000|Overall Study|Lost to Follow-up|3|||
23200108|NCT03375112|64473301|FG000|Overall Study|Withdrawal by Subject|3|||
23200109|NCT03375112|64473302|FG001|Overall Study|Withdrawal by Subject|0|||
23200110|NCT01193348|64473303|FG000|Screening Period|Screen Failure|5|||
23200111|NCT01193348|64473303|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
23200112|NCT01193348|64473303|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
23200113|NCT01193348|64473303|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
23200114|NCT01193348|64473303|FG000|Extension Treatment Period|Physician Decision|1|||
23200115|NCT01193348|64473303|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
23200116|NCT03471767|64473304|FG000|Overall Study|Withdrawal by Subject|3|||
23200117|NCT03471767|64473305|FG001|Overall Study|Withdrawal by Subject|1|||
23200118|NCT03471767|64473304|FG000|Overall Study|Adverse Event|1|||
23200119|NCT03471767|64473305|FG001|Overall Study|Adverse Event|0|||
23200120|NCT03471767|64473304|FG000|Overall Study|Lost to Follow-up|1|||
23200121|NCT03471767|64473305|FG001|Overall Study|Lost to Follow-up|0|||
23200122|NCT03471767|64473304|FG000|Overall Study|PI Withdrawal|1|||
23260427|NCT00770991|64696698|FG001|Overall Study|Adverse Event|5|||
23260428|NCT00770991|64696697|FG000|Overall Study|Pregnancy|1|||
23260429|NCT00770991|64696698|FG001|Overall Study|Pregnancy|0|||
23361371|NCT01435759|65069674|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
23200123|NCT03471767|64473305|FG001|Overall Study|PI Withdrawal|3|||
23200124|NCT00915005|64473308|FG000|Overall Study|Withdrawal by Subject|4|||
23200125|NCT00915005|64473309|FG001|Overall Study|Withdrawal by Subject|4|||
23200126|NCT00915005|64473308|FG000|Overall Study|Patient preferred protons therapy|6|||
23200127|NCT00915005|64473309|FG001|Overall Study|Patient preferred protons therapy|0|||
23200128|NCT00915005|64473308|FG000|Overall Study|Insurance denial|3|||
23200129|NCT00915005|64473309|FG001|Overall Study|Insurance denial|15|||
23200130|NCT02361762|64473312|FG000|Overall Study|Withdrawal by Subject|0|||
23200131|NCT02361762|64473313|FG001|Overall Study|Withdrawal by Subject|1|||
23200132|NCT02361762|64473312|FG000|Overall Study|Lost to Follow-up|0|||
23200133|NCT02361762|64473313|FG001|Overall Study|Lost to Follow-up|1|||
23200134|NCT00907881|64473314|FG000|Overall Study|Lost to Follow-up|59|||
23200135|NCT00907881|64473314|FG000|Overall Study|Noncompliance|5|||
23200136|NCT00907881|64473314|FG000|Overall Study|Withdrawal by Subject|5|||
23200137|NCT00907881|64473314|FG000|Overall Study|Protocol Violation|1|||
23200138|NCT00907881|64473314|FG000|Overall Study|Missing discontinuation information|15|||
23200139|NCT02928406|64473315|FG000|Overall Study|Death|780|||
23200140|NCT02928406|64473315|FG000|Overall Study|Progressive disease|3|||
23200141|NCT02928406|64473315|FG000|Overall Study|Lost to Follow-up|49|||
23200142|NCT02928406|64473315|FG000|Overall Study|Non-compliance|2|||
23200143|NCT02928406|64473315|FG000|Overall Study|Withdrawal by Subject|40|||
23200144|NCT02928406|64473315|FG000|Overall Study|Study terminated by sponsor|57|||
23200145|NCT02928406|64473315|FG000|Overall Study|Physician Decision|1|||
23200146|NCT02928406|64473315|FG000|Overall Study|Various reasons|72|||
23200147|NCT00109733|64473319|FG000|Overall Study|Protocol Violation|0|||
23200148|NCT00109733|64473320|FG001|Overall Study|Protocol Violation|1|||
23200149|NCT00109733|64473319|FG000|Overall Study|Stopped taking study drug|1|||
23200150|NCT00109733|64473320|FG001|Overall Study|Stopped taking study drug|1|||
23200151|NCT00109733|64473319|FG000|Overall Study|Non-compliant|0|||
23200152|NCT00109733|64473320|FG001|Overall Study|Non-compliant|1|||
23200153|NCT00109733|64473319|FG000|Overall Study|Could not commit time for study|1|||
23200154|NCT00109733|64473320|FG001|Overall Study|Could not commit time for study|1|||
23200155|NCT00748540|64473321|FG000|Overall Study|Physician Decision|1|||
23200156|NCT00553059|64473322|FG000|Overall Study|Deemed ineligible|1|||
23200157|NCT00553059|64473323|FG001|Overall Study|Deemed ineligible|1|||
23200158|NCT00553059|64473322|FG000|Overall Study|Drug supply not available|0|||
23200159|NCT00553059|64473323|FG001|Overall Study|Drug supply not available|1|||
23200160|NCT00988559|64473324|FG000|Overall Study|Withdrawal by Subject|1|||
23200161|NCT00988559|64473325|FG001|Overall Study|Withdrawal by Subject|1|||
23200162|NCT00988559|64473326|FG002|Overall Study|Withdrawal by Subject|0|||
23200163|NCT00988559|64473327|FG003|Overall Study|Withdrawal by Subject|1|||
23200164|NCT00988559|64473324|FG000|Overall Study|Pregnancy|0|||
23200165|NCT00988559|64473325|FG001|Overall Study|Pregnancy|1|||
23200166|NCT00988559|64473326|FG002|Overall Study|Pregnancy|1|||
23200167|NCT00988559|64473327|FG003|Overall Study|Pregnancy|0|||
23200168|NCT00988559|64473324|FG000|Overall Study|Lost to Follow-up|0|||
23200169|NCT00988559|64473325|FG001|Overall Study|Lost to Follow-up|0|||
23200170|NCT00988559|64473326|FG002|Overall Study|Lost to Follow-up|1|||
23200171|NCT00988559|64473327|FG003|Overall Study|Lost to Follow-up|0|||
23200172|NCT00417976|64473328|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
23200173|NCT00417976|64473328|FG000|Overall Study|Treatment -related toxicity|2|||
23200174|NCT03260205|64473329|FG000|Overall Study|Adverse Event|2|||
23200175|NCT03260205|64473330|FG001|Overall Study|Adverse Event|0|||
23200176|NCT03260205|64473331|FG002|Overall Study|Adverse Event|2|||
23200177|NCT03260205|64473332|FG003|Overall Study|Adverse Event|2|||
23200178|NCT03260205|64473333|FG004|Overall Study|Adverse Event|4|||
23200179|NCT03260205|64473329|FG000|Overall Study|Lost to Follow-up|2|||
23200180|NCT03260205|64473330|FG001|Overall Study|Lost to Follow-up|2|||
23200181|NCT03260205|64473331|FG002|Overall Study|Lost to Follow-up|1|||
23200182|NCT03260205|64473332|FG003|Overall Study|Lost to Follow-up|1|||
23200183|NCT03260205|64473333|FG004|Overall Study|Lost to Follow-up|5|||
23200184|NCT03260205|64473329|FG000|Overall Study|Protocol Violation|0|||
23200185|NCT03260205|64473330|FG001|Overall Study|Protocol Violation|0|||
23200186|NCT03260205|64473331|FG002|Overall Study|Protocol Violation|2|||
23200187|NCT03260205|64473332|FG003|Overall Study|Protocol Violation|0|||
23200188|NCT03260205|64473333|FG004|Overall Study|Protocol Violation|1|||
23200189|NCT03260205|64473329|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
23200190|NCT03260205|64473330|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
23200191|NCT03260205|64473331|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
23200192|NCT03260205|64473332|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
23200193|NCT03260205|64473333|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
23200194|NCT03260205|64473329|FG000|Overall Study|Other: Unspecified|0|||
23200195|NCT03260205|64473330|FG001|Overall Study|Other: Unspecified|0|||
23200196|NCT03260205|64473331|FG002|Overall Study|Other: Unspecified|3|||
23200197|NCT03260205|64473332|FG003|Overall Study|Other: Unspecified|1|||
23200198|NCT03260205|64473333|FG004|Overall Study|Other: Unspecified|1|||
23200199|NCT03260205|64473329|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
23200200|NCT03260205|64473330|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
23200201|NCT03260205|64473331|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
23200202|NCT03260205|64473332|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
23200203|NCT03260205|64473333|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
23260430|NCT02175966|64696699|FG000|Follow-up Period|Lack of Efficacy|10|||
23260431|NCT02175966|64696700|FG001|Follow-up Period|Lack of Efficacy|6|||
23260432|NCT01814761|64696701|FG000|Overall Study|Other Reasons|1|||
23260433|NCT01814761|64696702|FG001|Overall Study|Other Reasons|10|||
23260434|NCT01814761|64696701|FG000|Overall Study|Ocular Adverse Event|6|||
23260435|NCT01814761|64696702|FG001|Overall Study|Ocular Adverse Event|15|||
23260436|NCT01814761|64696701|FG000|Overall Study|Lost to Follow-up|1|||
23260437|NCT01814761|64696702|FG001|Overall Study|Lost to Follow-up|5|||
23260438|NCT00623623|64696703|FG000|Overall Study|Previous enrolment into this study|1|||
23260439|NCT00623623|64696704|FG001|Overall Study|Previous enrolment into this study|1|||
23260440|NCT00385541|64696705|FG000|Overall Study|severe pain, clinician requested unblind|0|||
23260441|NCT00385541|64696706|FG001|Overall Study|severe pain, clinician requested unblind|1|||
23260442|NCT00969332|64696723|FG000|Overall Study|Physician Decision|8|||
23260443|NCT00969332|64696723|FG000|Overall Study|Withdrawal by Subject|3|||
23260444|NCT01620489|64696724|FG000|Overall Study|Adverse Event|17|||
23260445|NCT01620489|64696725|FG001|Overall Study|Adverse Event|4|||
23260446|NCT01620489|64696724|FG000|Overall Study|Protocol Violation|0|||
23260447|NCT01620489|64696725|FG001|Overall Study|Protocol Violation|3|||
23260448|NCT01620489|64696724|FG000|Overall Study|Withdrawal Criteria|17|||
23260449|NCT01620489|64696725|FG001|Overall Study|Withdrawal Criteria|25|||
23260450|NCT01620489|64696724|FG000|Overall Study|Unclassified|1|||
23260451|NCT01620489|64696725|FG001|Overall Study|Unclassified|2|||
23260452|NCT00947427|64696726|FG000|Overall Study|Withdrawal by Subject|1|||
23260453|NCT00947427|64696727|FG001|Overall Study|Withdrawal by Subject|3|||
23260454|NCT00947427|64696726|FG000|Overall Study|Protocol Violation|0|||
23260455|NCT00947427|64696727|FG001|Overall Study|Protocol Violation|1|||
23260456|NCT00130520|64696734|FG000|Overall Study|Adverse Event|11|||
23260457|NCT00130520|64696734|FG000|Overall Study|Death|1|||
23260458|NCT00130520|64696734|FG000|Overall Study|Physician Decision|1|||
23260459|NCT00130520|64696734|FG000|Overall Study|Withdrawal by Subject|1|||
23260460|NCT00130520|64696734|FG000|Overall Study|Disease Progression|23|||
23260461|NCT00130520|64696734|FG000|Overall Study|Protocol non-compliance|1|||
23260462|NCT00130520|64696734|FG000|Overall Study|Did not meet re-treatment criteria|1|||
23260463|NCT00679783|64696735|FG000|Overall Study|Adverse Event|0|||
23260464|NCT00679783|64696736|FG001|Overall Study|Adverse Event|0|||
23260465|NCT00679783|64696737|FG002|Overall Study|Adverse Event|0|||
23260466|NCT00679783|64696738|FG003|Overall Study|Adverse Event|3|||
23260467|NCT00679783|64696739|FG004|Overall Study|Adverse Event|0|||
23260468|NCT00679783|64696740|FG005|Overall Study|Adverse Event|0|||
23260469|NCT00679783|64696741|FG006|Overall Study|Adverse Event|1|||
23260470|NCT00679783|64696735|FG000|Overall Study|Lack of Efficacy|0|||
23260471|NCT00679783|64696736|FG001|Overall Study|Lack of Efficacy|1|||
23260472|NCT00679783|64696737|FG002|Overall Study|Lack of Efficacy|0|||
23260473|NCT00679783|64696738|FG003|Overall Study|Lack of Efficacy|2|||
23260474|NCT00679783|64696739|FG004|Overall Study|Lack of Efficacy|0|||
23260475|NCT00679783|64696740|FG005|Overall Study|Lack of Efficacy|0|||
23260476|NCT00679783|64696741|FG006|Overall Study|Lack of Efficacy|0|||
23260477|NCT00679783|64696735|FG000|Overall Study|Withdrawal by Subject|0|||
23260478|NCT00679783|64696736|FG001|Overall Study|Withdrawal by Subject|0|||
23260479|NCT00679783|64696737|FG002|Overall Study|Withdrawal by Subject|1|||
23260480|NCT00679783|64696738|FG003|Overall Study|Withdrawal by Subject|1|||
23200204|NCT02577406|64473334|FG000|Randomized Period|Death|1|||
23200205|NCT02577406|64473335|FG001|Randomized Period|Death|0|||
23200206|NCT02577406|64473334|FG000|Randomized Period|Other reasons|0|||
23200207|NCT02577406|64473335|FG001|Randomized Period|Other reasons|20|||
23200208|NCT02577406|64473334|FG000|Treatment Period|Transition to commercially available treatment|1|||
23200209|NCT02577406|64473335|FG001|Treatment Period|Transition to commercially available treatment|0|||
23200210|NCT02577406|64473334|FG000|Treatment Period|Progressive disease|47|||
23200211|NCT02577406|64473335|FG001|Treatment Period|Progressive disease|36|||
23200212|NCT02577406|64473334|FG000|Treatment Period|Death|36|||
23200213|NCT02577406|64473335|FG001|Treatment Period|Death|23|||
23200214|NCT02577406|64473334|FG000|Treatment Period|Other reasons|3|||
23260481|NCT00679783|64696739|FG004|Overall Study|Withdrawal by Subject|0|||
23260482|NCT00679783|64696740|FG005|Overall Study|Withdrawal by Subject|0|||
23260483|NCT00679783|64696741|FG006|Overall Study|Withdrawal by Subject|0|||
23260484|NCT00679783|64696735|FG000|Overall Study|Not Captured|0|||
23260485|NCT00679783|64696736|FG001|Overall Study|Not Captured|0|||
23260486|NCT00679783|64696737|FG002|Overall Study|Not Captured|0|||
23260487|NCT00679783|64696738|FG003|Overall Study|Not Captured|5|||
23260488|NCT00679783|64696739|FG004|Overall Study|Not Captured|0|||
23260489|NCT00679783|64696740|FG005|Overall Study|Not Captured|0|||
23200215|NCT02577406|64473335|FG001|Treatment Period|Other reasons|37|||
23200216|NCT02577406|64473334|FG000|Treatment Period|Withdrawal by Subject|10|||
23200217|NCT02577406|64473335|FG001|Treatment Period|Withdrawal by Subject|24|||
23260490|NCT00679783|64696741|FG006|Overall Study|Not Captured|0|||
23260491|NCT00679783|64696735|FG000|Overall Study|Ongoing at data cut-off|2|||
23260492|NCT00679783|64696736|FG001|Overall Study|Ongoing at data cut-off|2|||
23260493|NCT00679783|64696737|FG002|Overall Study|Ongoing at data cut-off|0|||
23260494|NCT00679783|64696738|FG003|Overall Study|Ongoing at data cut-off|9|||
23260495|NCT00679783|64696739|FG004|Overall Study|Ongoing at data cut-off|1|||
23260496|NCT00679783|64696740|FG005|Overall Study|Ongoing at data cut-off|0|||
23260497|NCT00679783|64696741|FG006|Overall Study|Ongoing at data cut-off|0|||
23260498|NCT05751629|64696743|FG000|Overall Study|Withdrawal by Subject|6|||
23260499|NCT05751629|64696743|FG000|Overall Study|Death|25|||
23260500|NCT05751629|64696743|FG000|Overall Study|Study Site Closed|9|||
23260501|NCT05751629|64696743|FG000|Overall Study|Physician Decision|1|||
23260502|NCT02008721|64696751|FG000|Overall Study|Withdrawal by Subject|5|||
23260503|NCT02008721|64696752|FG001|Overall Study|Withdrawal by Subject|1|||
23260504|NCT02008721|64696751|FG000|Overall Study|Death|4|||
23260505|NCT02008721|64696752|FG001|Overall Study|Death|2|||
23260506|NCT02008721|64696751|FG000|Overall Study|Adverse Event|3|||
23260507|NCT02008721|64696752|FG001|Overall Study|Adverse Event|5|||
23260508|NCT02008721|64696751|FG000|Overall Study|Protocol Violation|3|||
23260509|NCT02008721|64696752|FG001|Overall Study|Protocol Violation|2|||
23260510|NCT01533428|64696760|FG000|Overall Study|Adverse Event|0|||
23260511|NCT01533428|64696761|FG001|Overall Study|Adverse Event|1|||
23260512|NCT01533428|64696760|FG000|Overall Study|Lost to Follow-up|2|||
23260513|NCT01533428|64696761|FG001|Overall Study|Lost to Follow-up|1|||
23260514|NCT01533428|64696760|FG000|Overall Study|Withdrawal by Subject|7|||
23260515|NCT01533428|64696761|FG001|Overall Study|Withdrawal by Subject|6|||
23260516|NCT03404206|64696762|FG000|Overall Study|Withdrawal by Subject|1|||
23260517|NCT03404206|64696763|FG001|Overall Study|Withdrawal by Subject|1|||
23260518|NCT03404206|64696764|FG002|Overall Study|Withdrawal by Subject|0|||
23260519|NCT03404206|64696762|FG000|Overall Study|Lost to Follow-up|3|||
23361372|NCT01435759|65069675|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361373|NCT01435759|65069676|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
23260520|NCT03404206|64696763|FG001|Overall Study|Lost to Follow-up|1|||
23260521|NCT03404206|64696764|FG002|Overall Study|Lost to Follow-up|0|||
23260522|NCT01007916|64696765|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
23260523|NCT01007916|64696766|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
23260524|NCT01007916|64696765|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
23260525|NCT01007916|64696766|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
23260526|NCT01797120|64696770|FG000|Overall Study|Disesae progression|37|||
23260527|NCT01797120|64696771|FG001|Overall Study|Disesae progression|49|||
23260528|NCT01797120|64696770|FG000|Overall Study|Adverse Event|13|||
23260529|NCT01797120|64696771|FG001|Overall Study|Adverse Event|5|||
23260530|NCT01797120|64696770|FG000|Overall Study|Withdrawal by Subject|6|||
23260531|NCT01797120|64696771|FG001|Overall Study|Withdrawal by Subject|6|||
23260532|NCT01797120|64696770|FG000|Overall Study|Symptomatic progression|2|||
23260533|NCT01797120|64696771|FG001|Overall Study|Symptomatic progression|1|||
23260534|NCT01797120|64696770|FG000|Overall Study|Non-compliance|1|||
23260535|NCT01797120|64696771|FG001|Overall Study|Non-compliance|0|||
23260536|NCT01797120|64696770|FG000|Overall Study|Physician Decision|3|||
23260537|NCT01797120|64696771|FG001|Overall Study|Physician Decision|0|||
23260538|NCT01797120|64696770|FG000|Overall Study|still on treatment|2|||
23260539|NCT01797120|64696771|FG001|Overall Study|still on treatment|4|||
23260540|NCT01797120|64696770|FG000|Overall Study|never start protocol therapy|2|||
23260541|NCT01797120|64696771|FG001|Overall Study|never start protocol therapy|0|||
23260542|NCT00319956|64696778|FG000|Overall Study|Death|20|||
23260543|NCT00319956|64696779|FG001|Overall Study|Death|24|||
23260544|NCT03377556|64696780|FG000|Overall Study|Adverse Event|5|||
23260545|NCT03377556|64696780|FG000|Overall Study|Refusal unrelated to adverse events|1|||
23260546|NCT03377556|64696780|FG000|Overall Study|Progression/relapse|38|||
23260547|NCT03377556|64696780|FG000|Overall Study|Death|3|||
23260548|NCT01844583|64696782|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
23260549|NCT01844583|64696783|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
23260550|NCT00467818|64696784|FG000|Overall Study|Adverse Event|1|||
23260551|NCT00467818|64696785|FG001|Overall Study|Adverse Event|0|||
23260552|NCT00467818|64696784|FG000|Overall Study|Lost to Follow-up|2|||
23260553|NCT00467818|64696785|FG001|Overall Study|Lost to Follow-up|2|||
23260554|NCT02739984|64696786|FG000|Overall Study|Sponsor Decision|1|||
23260555|NCT02739984|64696787|FG001|Overall Study|Sponsor Decision|0|||
23260556|NCT02739984|64696786|FG000|Overall Study|Withdrawal by Subject|1|||
23260557|NCT02739984|64696787|FG001|Overall Study|Withdrawal by Subject|1|||
23260558|NCT02739984|64696786|FG000|Overall Study|Death|0|||
23260559|NCT02739984|64696787|FG001|Overall Study|Death|1|||
23260560|NCT02739984|64696786|FG000|Overall Study|Lost to Follow-up|3|||
23260561|NCT02739984|64696787|FG001|Overall Study|Lost to Follow-up|0|||
23260562|NCT01886300|64696788|FG000|Overall Study|Trial terminated by sponsor|16|||
23260563|NCT01709383|64696789|FG000|Overall Study|Lost to Follow-up|1|||
23260564|NCT01709383|64696790|FG001|Overall Study|Lost to Follow-up|0|||
23260565|NCT00634179|64696791|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
23260566|NCT03487796|64696792|FG000|Overall Study|Lost to Follow-up|18|||
23260567|NCT03487796|64696793|FG001|Overall Study|Lost to Follow-up|6|||
23260568|NCT01890707|64696801|FG000|Overall Study|Lost to Follow-up|1|||
23260569|NCT01890707|64696802|FG001|Overall Study|Lost to Follow-up|1|||
23260570|NCT02545998|64696805|FG000|Overall Study|Lost to Follow-up|12|||
23260571|NCT02545998|64696806|FG001|Overall Study|Lost to Follow-up|3|||
23260572|NCT02545998|64696805|FG000|Overall Study|Withdrawal by Subject|3|||
23260573|NCT02545998|64696806|FG001|Overall Study|Withdrawal by Subject|2|||
23260574|NCT00417027|64696808|FG000|Overall Study|Protocol Violation|0|||
23260575|NCT00417027|64696809|FG001|Overall Study|Protocol Violation|5|||
23260576|NCT00417027|64696810|FG002|Overall Study|Protocol Violation|5|||
23260577|NCT02577354|64696812|FG000|Overall Study|Lack of Efficacy|4|||
23260578|NCT02577354|64696813|FG001|Overall Study|Lack of Efficacy|4|||
23260579|NCT02577354|64696812|FG000|Overall Study|Lost to Follow-up|3|||
23260580|NCT02577354|64696813|FG001|Overall Study|Lost to Follow-up|1|||
23260581|NCT02577354|64696812|FG000|Overall Study|Missed Visit|4|||
23600545|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Other|0|||
23600546|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Other|0|||
23600547|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Other|2|||
23600548|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Other|2|||
23600549|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Other|1|||
23600550|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Other|0|||
23260582|NCT02577354|64696813|FG001|Overall Study|Missed Visit|3|||
23260583|NCT02577354|64696812|FG000|Overall Study|Adverse Event|4|||
23600551|NCT02561195|65929651|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23260584|NCT02577354|64696813|FG001|Overall Study|Adverse Event|5|||
23260585|NCT01772368|64696814|FG000|Overall Study|Adverse Event|1|||
23260586|NCT01772368|64696814|FG000|Overall Study|Withdrawal by Subject|3|||
23260587|NCT01772368|64696814|FG000|Overall Study|Protocol Violation|2|||
23260588|NCT01772368|64696814|FG000|Overall Study|Other|1|||
23260589|NCT01214603|64696818|FG000|Overall Study|Adverse Event|0|||
23260590|NCT01214603|64696819|FG001|Overall Study|Adverse Event|0|||
23260591|NCT01214603|64696820|FG002|Overall Study|Adverse Event|1|||
23600552|NCT02561195|65929652|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23260592|NCT01214603|64696818|FG000|Overall Study|Death|1|||
23260593|NCT01214603|64696819|FG001|Overall Study|Death|0|||
23260594|NCT01214603|64696820|FG002|Overall Study|Death|0|||
23260595|NCT01214603|64696818|FG000|Overall Study|Progressive Disease|4|||
23260596|NCT01214603|64696819|FG001|Overall Study|Progressive Disease|1|||
23260597|NCT01214603|64696820|FG002|Overall Study|Progressive Disease|3|||
23260598|NCT03118739|64696821|FG000|Overall Study|Physician Decision|0|||
23260599|NCT03118739|64696822|FG001|Overall Study|Physician Decision|1|||
23260600|NCT03118739|64696821|FG000|Overall Study|Withdrawal by Subject|5|||
23260601|NCT03118739|64696822|FG001|Overall Study|Withdrawal by Subject|3|||
23260602|NCT03118739|64696821|FG000|Overall Study|Lost to Follow-up|2|||
23260603|NCT03118739|64696822|FG001|Overall Study|Lost to Follow-up|0|||
23260604|NCT05266456|64696824|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
23260605|NCT05266456|64696825|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
23260606|NCT05266456|64696826|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
23260607|NCT05266456|64696827|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
23260608|NCT05266456|64696824|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
23260609|NCT05266456|64696825|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
23260610|NCT05266456|64696826|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
23260611|NCT05266456|64696827|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
23260612|NCT05266456|64696824|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
23260613|NCT05266456|64696825|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
23260614|NCT05266456|64696826|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
23260615|NCT05266456|64696827|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
23260616|NCT05266456|64696824|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
23260617|NCT05266456|64696825|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
23260618|NCT05266456|64696826|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
23260619|NCT05266456|64696827|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
23260620|NCT05266456|64696824|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
23260621|NCT05266456|64696825|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
23260622|NCT05266456|64696826|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
23260623|NCT05266456|64696827|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
23260624|NCT01766778|64696830|FG000|Overall Study|Adverse Event|4|||
23260625|NCT01766778|64696831|FG001|Overall Study|Adverse Event|4|||
23260626|NCT01766778|64696830|FG000|Overall Study|Withdrawal by Subject|1|||
23260627|NCT01766778|64696831|FG001|Overall Study|Withdrawal by Subject|0|||
23260628|NCT03035227|64696833|FG000|Overall Study|study stopped due to PI leaving institut|1|||
23260629|NCT03035227|64696834|FG001|Overall Study|study stopped due to PI leaving institut|1|||
23260630|NCT00712010|64696835|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
23260631|NCT01830920|64696850|FG000|Overall Study|Adverse Event|1|||
23260632|NCT01830920|64696851|FG001|Overall Study|Adverse Event|0|||
23260633|NCT01830920|64696852|FG002|Overall Study|Adverse Event|1|||
23260634|NCT01830920|64696853|FG003|Overall Study|Adverse Event|0|||
23260635|NCT01830920|64696854|FG004|Overall Study|Adverse Event|0|||
23260636|NCT01830920|64696850|FG000|Overall Study|Withdrawal by Subject|2|||
23260637|NCT01830920|64696851|FG001|Overall Study|Withdrawal by Subject|2|||
23260638|NCT01830920|64696852|FG002|Overall Study|Withdrawal by Subject|1|||
23260639|NCT01830920|64696853|FG003|Overall Study|Withdrawal by Subject|7|||
23260640|NCT01830920|64696854|FG004|Overall Study|Withdrawal by Subject|1|||
23260641|NCT01830920|64696850|FG000|Overall Study|Death|3|||
23260642|NCT01830920|64696851|FG001|Overall Study|Death|3|||
23260643|NCT01830920|64696852|FG002|Overall Study|Death|5|||
23260644|NCT01830920|64696853|FG003|Overall Study|Death|4|||
23260645|NCT01830920|64696854|FG004|Overall Study|Death|4|||
23260646|NCT01830920|64696850|FG000|Overall Study|Other|15|||
23260647|NCT01830920|64696851|FG001|Overall Study|Other|1|||
23260648|NCT01830920|64696852|FG002|Overall Study|Other|1|||
23260649|NCT01830920|64696853|FG003|Overall Study|Other|5|||
23260650|NCT01830920|64696854|FG004|Overall Study|Other|3|||
23260651|NCT03538756|64696855|FG000|Long-Term Follow-up|Adverse Event|0|||
23260652|NCT03538756|64696856|FG001|Long-Term Follow-up|Adverse Event|0|||
23260653|NCT03538756|64696857|FG002|Long-Term Follow-up|Adverse Event|6|||
23260654|NCT03538756|64696855|FG000|Long-Term Follow-up|Death|0|||
23260655|NCT03538756|64696856|FG001|Long-Term Follow-up|Death|0|||
23260656|NCT03538756|64696857|FG002|Long-Term Follow-up|Death|1|||
23260657|NCT03538756|64696855|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
23260658|NCT03538756|64696856|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
23260659|NCT03538756|64696857|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
23260660|NCT03538756|64696855|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
23260661|NCT03538756|64696856|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
23260662|NCT03538756|64696857|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
23260663|NCT03538756|64696855|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
23260664|NCT03538756|64696856|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
23260665|NCT03538756|64696857|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
23260666|NCT04828161|64696858|FG000|Overall Study|Withdrawal by Subject|0|||
23260667|NCT04828161|64696859|FG001|Overall Study|Withdrawal by Subject|3|||
23260668|NCT04828161|64696860|FG002|Overall Study|Withdrawal by Subject|3|||
23260669|NCT04828161|64696861|FG003|Overall Study|Withdrawal by Subject|4|||
23260670|NCT04828161|64696858|FG000|Overall Study|Lost to Follow-up|1|||
23260671|NCT04828161|64696859|FG001|Overall Study|Lost to Follow-up|4|||
23361374|NCT01435759|65069677|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
23200218|NCT02577406|64473334|FG000|Treatment Period|Adverse Event|17|||
23200219|NCT02577406|64473335|FG001|Treatment Period|Adverse Event|12|||
23200220|NCT02577406|64473334|FG000|Treatment Period|Disease relapse|27|||
23200221|NCT02577406|64473335|FG001|Treatment Period|Disease relapse|1|||
23200222|NCT02577406|64473334|FG000|Treatment Period|HSCT|6|||
23200223|NCT02577406|64473335|FG001|Treatment Period|HSCT|2|||
23200224|NCT02577406|64473334|FG000|Treatment Period|Lost to Follow-up|0|||
23200225|NCT02577406|64473335|FG001|Treatment Period|Lost to Follow-up|1|||
23200226|NCT02577406|64473334|FG000|Treatment Period|Protocol Violation|0|||
23200227|NCT02577406|64473335|FG001|Treatment Period|Protocol Violation|1|||
23200228|NCT01958671|64473337|FG000|Overall Study|Adverse Event|1|||
23200229|NCT01958671|64473338|FG001|Overall Study|Adverse Event|1|||
23200230|NCT01958671|64473339|FG002|Overall Study|Adverse Event|5|||
23200231|NCT01958671|64473337|FG000|Overall Study|Death|1|||
23200232|NCT01958671|64473338|FG001|Overall Study|Death|0|||
23200233|NCT01958671|64473339|FG002|Overall Study|Death|0|||
23200234|NCT01958671|64473337|FG000|Overall Study|Excluded medication|0|||
23200235|NCT01958671|64473338|FG001|Overall Study|Excluded medication|0|||
23200236|NCT01958671|64473339|FG002|Overall Study|Excluded medication|1|||
23200237|NCT01958671|64473337|FG000|Overall Study|Hyperglycemia|0|||
23200238|NCT01958671|64473338|FG001|Overall Study|Hyperglycemia|0|||
23200239|NCT01958671|64473339|FG002|Overall Study|Hyperglycemia|2|||
23200240|NCT01958671|64473337|FG000|Overall Study|Lost to Follow-up|7|||
23200241|NCT01958671|64473338|FG001|Overall Study|Lost to Follow-up|11|||
23200242|NCT01958671|64473339|FG002|Overall Study|Lost to Follow-up|7|||
23200243|NCT01958671|64473337|FG000|Overall Study|Non-compliance with study drug|1|||
23200244|NCT01958671|64473338|FG001|Overall Study|Non-compliance with study drug|1|||
23200245|NCT01958671|64473339|FG002|Overall Study|Non-compliance with study drug|1|||
23200246|NCT01958671|64473337|FG000|Overall Study|Pregnancy|0|||
23200247|NCT01958671|64473338|FG001|Overall Study|Pregnancy|0|||
23200248|NCT01958671|64473339|FG002|Overall Study|Pregnancy|1|||
23200249|NCT01958671|64473337|FG000|Overall Study|Protocol Violation|0|||
23200250|NCT01958671|64473338|FG001|Overall Study|Protocol Violation|1|||
23200251|NCT01958671|64473339|FG002|Overall Study|Protocol Violation|0|||
23200252|NCT01958671|64473337|FG000|Overall Study|Study site terminated by sponsor|1|||
23200253|NCT01958671|64473338|FG001|Overall Study|Study site terminated by sponsor|0|||
23200254|NCT01958671|64473339|FG002|Overall Study|Study site terminated by sponsor|1|||
23200255|NCT01958671|64473337|FG000|Overall Study|Participant moved|0|||
23200256|NCT01958671|64473338|FG001|Overall Study|Participant moved|0|||
23200257|NCT01958671|64473339|FG002|Overall Study|Participant moved|1|||
23200258|NCT01958671|64473337|FG000|Overall Study|Withdrawal by Subject|8|||
23200259|NCT01958671|64473338|FG001|Overall Study|Withdrawal by Subject|10|||
23200260|NCT01958671|64473339|FG002|Overall Study|Withdrawal by Subject|13|||
23200261|NCT00406640|64473351|FG000|Acute Phase|Adverse Event|18|||
23200262|NCT00406640|64473352|FG001|Acute Phase|Adverse Event|13|||
23200263|NCT00406640|64473351|FG000|Acute Phase|Failed to Return|5|||
23200264|NCT00406640|64473352|FG001|Acute Phase|Failed to Return|1|||
23200265|NCT00406640|64473351|FG000|Acute Phase|Physician Decision|0|||
23200266|NCT00406640|64473352|FG001|Acute Phase|Physician Decision|1|||
23200267|NCT00406640|64473351|FG000|Acute Phase|Lost to Follow-up|7|||
23200268|NCT00406640|64473352|FG001|Acute Phase|Lost to Follow-up|4|||
23200269|NCT00406640|64473351|FG000|Acute Phase|Protocol deviation|4|||
23200270|NCT00406640|64473352|FG001|Acute Phase|Protocol deviation|10|||
23200271|NCT00406640|64473351|FG000|Acute Phase|Protocol Violation|3|||
23200272|NCT00406640|64473352|FG001|Acute Phase|Protocol Violation|2|||
23200273|NCT00406640|64473351|FG000|Acute Phase|Withdrawal by Subject|11|||
23200274|NCT00406640|64473352|FG001|Acute Phase|Withdrawal by Subject|9|||
23200275|NCT00406640|64473351|FG000|Acute Phase|Lack of Efficacy|3|||
23200276|NCT00406640|64473352|FG001|Acute Phase|Lack of Efficacy|3|||
23200277|NCT00406640|64473351|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
23200278|NCT00406640|64473352|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
23200279|NCT00406640|64473351|FG000|DB Continuation Phase for Responders|Death|1|||
23200280|NCT00406640|64473352|FG001|DB Continuation Phase for Responders|Death|0|||
23200281|NCT00406640|64473351|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
23200282|NCT00406640|64473352|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
23200283|NCT00406640|64473351|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
23200284|NCT00406640|64473352|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
23200285|NCT00406640|64473351|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
23200286|NCT00406640|64473352|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
23200287|NCT00406640|64473351|FG000|DB Continuation Phase for Responders|non-compliance|7|||
23200288|NCT00406640|64473352|FG001|DB Continuation Phase for Responders|non-compliance|5|||
23200289|NCT00406640|64473351|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
23200290|NCT00406640|64473352|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
23200291|NCT00406640|64473351|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
23200292|NCT00406640|64473352|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
23200293|NCT00406640|64473351|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
23200294|NCT00406640|64473352|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
23200295|NCT00406640|64473351|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
23200296|NCT00406640|64473352|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
23200297|NCT00406640|64473351|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
23200298|NCT00406640|64473352|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
23200299|NCT00406640|64473351|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
23200300|NCT00406640|64473352|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
23200301|NCT00406640|64473351|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
23200302|NCT00406640|64473352|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
23200303|NCT00406640|64473351|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
23200304|NCT00406640|64473352|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
23200305|NCT00406640|64473351|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
23200306|NCT00406640|64473352|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
23200307|NCT00406640|64473351|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
23200308|NCT00406640|64473352|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
23200309|NCT00698516|64473362|FG000|Overall Study|Study Termination|2|||
23200310|NCT00698516|64473362|FG000|Overall Study|Withdrawal by Subject|3|||
23200311|NCT00256867|64473363|FG000|Overall Study|Adverse Event|0|||
23200312|NCT00256867|64473364|FG001|Overall Study|Adverse Event|1|||
23200313|NCT00256867|64473365|FG002|Overall Study|Adverse Event|1|||
23200314|NCT00256867|64473366|FG003|Overall Study|Adverse Event|1|||
23480471|NCT04585009|65501996|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23480472|NCT04585009|65501997|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23200315|NCT00256867|64473367|FG004|Overall Study|Adverse Event|2|||
23200316|NCT00256867|64473368|FG005|Overall Study|Adverse Event|2|||
23200317|NCT00256867|64473369|FG006|Overall Study|Adverse Event|1|||
23200318|NCT00256867|64473370|FG007|Overall Study|Adverse Event|4|||
23200319|NCT00256867|64473363|FG000|Overall Study|Lost to Follow-up|2|||
23200320|NCT00256867|64473364|FG001|Overall Study|Lost to Follow-up|2|||
23200321|NCT00256867|64473365|FG002|Overall Study|Lost to Follow-up|2|||
23200322|NCT00256867|64473366|FG003|Overall Study|Lost to Follow-up|3|||
23200323|NCT00256867|64473367|FG004|Overall Study|Lost to Follow-up|2|||
23200324|NCT00256867|64473368|FG005|Overall Study|Lost to Follow-up|0|||
23200325|NCT00256867|64473369|FG006|Overall Study|Lost to Follow-up|1|||
23200326|NCT00256867|64473370|FG007|Overall Study|Lost to Follow-up|2|||
23200327|NCT00256867|64473363|FG000|Overall Study|Protocol Violation|0|||
23200328|NCT00256867|64473364|FG001|Overall Study|Protocol Violation|0|||
23200329|NCT00256867|64473365|FG002|Overall Study|Protocol Violation|0|||
23200330|NCT00256867|64473366|FG003|Overall Study|Protocol Violation|1|||
23200331|NCT00256867|64473367|FG004|Overall Study|Protocol Violation|0|||
23200332|NCT00256867|64473368|FG005|Overall Study|Protocol Violation|1|||
23200333|NCT00256867|64473369|FG006|Overall Study|Protocol Violation|0|||
23200334|NCT00256867|64473370|FG007|Overall Study|Protocol Violation|1|||
23200335|NCT00256867|64473363|FG000|Overall Study|Withdrawal by Subject|0|||
23200336|NCT00256867|64473364|FG001|Overall Study|Withdrawal by Subject|0|||
23600553|NCT02561195|65929653|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600554|NCT02561195|65929654|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600555|NCT02561195|65929655|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600556|NCT02561195|65929656|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600557|NCT02561195|65929657|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
23600558|NCT02561195|65929658|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600559|NCT02561195|65929659|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600560|NCT02561195|65929660|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600561|NCT02561195|65929661|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
23600562|NCT02561195|65929662|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
23600563|NCT02561195|65929663|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
23600564|NCT02561195|65929664|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
23600565|NCT02022657|65929666|FG000|Overall Study|Withdrawal by Subject|2|||
23600566|NCT02022657|65929667|FG001|Overall Study|Withdrawal by Subject|0|||
23600567|NCT02022657|65929668|FG002|Overall Study|Withdrawal by Subject|1|||
23600568|NCT02022657|65929669|FG003|Overall Study|Withdrawal by Subject|0|||
23600569|NCT02022657|65929670|FG004|Overall Study|Withdrawal by Subject|0|||
23600570|NCT02022657|65929671|FG005|Overall Study|Withdrawal by Subject|0|||
23600571|NCT02022657|65929666|FG000|Overall Study|Physician Decision|0|||
23600572|NCT02022657|65929667|FG001|Overall Study|Physician Decision|0|||
23600573|NCT02022657|65929668|FG002|Overall Study|Physician Decision|0|||
23600574|NCT02022657|65929669|FG003|Overall Study|Physician Decision|0|||
23600575|NCT02022657|65929670|FG004|Overall Study|Physician Decision|0|||
23600576|NCT02022657|65929671|FG005|Overall Study|Physician Decision|1|||
23600577|NCT02675244|65929672|FG000|Overall Study|Death|9|||
23200337|NCT00256867|64473365|FG002|Overall Study|Withdrawal by Subject|1|||
23200338|NCT00256867|64473366|FG003|Overall Study|Withdrawal by Subject|1|||
23200339|NCT00256867|64473367|FG004|Overall Study|Withdrawal by Subject|2|||
23200340|NCT00256867|64473368|FG005|Overall Study|Withdrawal by Subject|2|||
23600578|NCT02675244|65929673|FG001|Overall Study|Death|6|||
23600579|NCT02675244|65929672|FG000|Overall Study|Withdrawal by Subject|3|||
23600580|NCT02675244|65929673|FG001|Overall Study|Withdrawal by Subject|6|||
23200341|NCT00256867|64473369|FG006|Overall Study|Withdrawal by Subject|3|||
23200342|NCT00256867|64473370|FG007|Overall Study|Withdrawal by Subject|2|||
23200343|NCT00256867|64473363|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23200344|NCT00256867|64473364|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
23200345|NCT00256867|64473365|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23200346|NCT00256867|64473366|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23200347|NCT00256867|64473367|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23200348|NCT00256867|64473368|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23200349|NCT00256867|64473369|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23200350|NCT00256867|64473370|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
23200351|NCT00256867|64473363|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23200352|NCT00256867|64473364|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23200353|NCT00256867|64473365|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23200354|NCT00256867|64473366|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23200355|NCT00256867|64473367|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23200356|NCT00256867|64473368|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23200357|NCT00256867|64473369|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
23200358|NCT00256867|64473370|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
23200359|NCT00256867|64473363|FG000|Overall Study|Investigator's Decision|0|||
23200360|NCT00256867|64473364|FG001|Overall Study|Investigator's Decision|0|||
23200361|NCT00256867|64473365|FG002|Overall Study|Investigator's Decision|0|||
23200362|NCT00256867|64473366|FG003|Overall Study|Investigator's Decision|0|||
23200363|NCT00256867|64473367|FG004|Overall Study|Investigator's Decision|1|||
23200364|NCT00256867|64473368|FG005|Overall Study|Investigator's Decision|0|||
23200365|NCT00256867|64473369|FG006|Overall Study|Investigator's Decision|0|||
23200366|NCT00256867|64473370|FG007|Overall Study|Investigator's Decision|0|||
23200367|NCT00256867|64473363|FG000|Overall Study|Non-compliance with study medication|0|||
23200368|NCT00256867|64473364|FG001|Overall Study|Non-compliance with study medication|0|||
23200369|NCT00256867|64473365|FG002|Overall Study|Non-compliance with study medication|0|||
23200370|NCT00256867|64473366|FG003|Overall Study|Non-compliance with study medication|0|||
23200371|NCT00256867|64473367|FG004|Overall Study|Non-compliance with study medication|0|||
23200372|NCT00256867|64473368|FG005|Overall Study|Non-compliance with study medication|0|||
23200373|NCT00256867|64473369|FG006|Overall Study|Non-compliance with study medication|0|||
23200374|NCT00256867|64473370|FG007|Overall Study|Non-compliance with study medication|1|||
23200375|NCT00256867|64473363|FG000|Overall Study|Participant travelled Overseas|0|||
23200376|NCT00256867|64473364|FG001|Overall Study|Participant travelled Overseas|1|||
23200377|NCT00256867|64473365|FG002|Overall Study|Participant travelled Overseas|0|||
23200378|NCT00256867|64473366|FG003|Overall Study|Participant travelled Overseas|0|||
23200379|NCT00256867|64473367|FG004|Overall Study|Participant travelled Overseas|0|||
23200380|NCT00256867|64473368|FG005|Overall Study|Participant travelled Overseas|0|||
23200381|NCT00256867|64473369|FG006|Overall Study|Participant travelled Overseas|0|||
23200382|NCT00256867|64473370|FG007|Overall Study|Participant travelled Overseas|0|||
23200383|NCT00256867|64473363|FG000|Overall Study|Participant out of assessment window|0|||
23200384|NCT00256867|64473364|FG001|Overall Study|Participant out of assessment window|0|||
23200385|NCT00256867|64473365|FG002|Overall Study|Participant out of assessment window|1|||
23200386|NCT00256867|64473366|FG003|Overall Study|Participant out of assessment window|0|||
23200387|NCT00256867|64473367|FG004|Overall Study|Participant out of assessment window|0|||
23200388|NCT00256867|64473368|FG005|Overall Study|Participant out of assessment window|0|||
23200389|NCT00256867|64473369|FG006|Overall Study|Participant out of assessment window|0|||
23200390|NCT00256867|64473370|FG007|Overall Study|Participant out of assessment window|0|||
23200391|NCT00256867|64473363|FG000|Overall Study|Withdrawal by participant|0|||
23200392|NCT00256867|64473364|FG001|Overall Study|Withdrawal by participant|0|||
23200393|NCT00256867|64473365|FG002|Overall Study|Withdrawal by participant|0|||
23200394|NCT00256867|64473366|FG003|Overall Study|Withdrawal by participant|0|||
23200395|NCT00256867|64473367|FG004|Overall Study|Withdrawal by participant|0|||
23200396|NCT00256867|64473368|FG005|Overall Study|Withdrawal by participant|1|||
23200397|NCT00256867|64473369|FG006|Overall Study|Withdrawal by participant|0|||
23200398|NCT00256867|64473370|FG007|Overall Study|Withdrawal by participant|0|||
23600581|NCT02675244|65929672|FG000|Overall Study|Lost to Follow-up|1|||
23600582|NCT02675244|65929673|FG001|Overall Study|Lost to Follow-up|1|||
23600583|NCT02675244|65929672|FG000|Overall Study|Ongoing at 2 Years|190|||
23600584|NCT02675244|65929673|FG001|Overall Study|Ongoing at 2 Years|185|||
23600585|NCT03653364|65929677|FG000|Overall Study|Withdrawal by Subject|1|||
23600586|NCT03653364|65929677|FG000|Overall Study|Enrolled in Error|1|||
23600587|NCT03653364|65929677|FG000|Overall Study|Death|1|||
23600588|NCT03478969|65929681|FG000|Overall Study|Withdrawal by Subject|4|||
23260672|NCT04828161|64696860|FG002|Overall Study|Lost to Follow-up|2|||
23260673|NCT04828161|64696861|FG003|Overall Study|Lost to Follow-up|2|||
23260674|NCT04828161|64696858|FG000|Overall Study|Other|2|||
23260675|NCT04828161|64696859|FG001|Overall Study|Other|0|||
23260676|NCT04828161|64696860|FG002|Overall Study|Other|2|||
23260677|NCT04828161|64696861|FG003|Overall Study|Other|0|||
23260678|NCT04828161|64696858|FG000|Overall Study|Death|0|||
23260679|NCT04828161|64696859|FG001|Overall Study|Death|0|||
23260680|NCT04828161|64696860|FG002|Overall Study|Death|0|||
23260681|NCT04828161|64696861|FG003|Overall Study|Death|2|||
23260682|NCT01754259|64696865|FG000|Overall Study|Withdrawal by Subject|2|||
23260683|NCT01754259|64696866|FG001|Overall Study|Withdrawal by Subject|4|||
23260684|NCT01754259|64696865|FG000|Overall Study|Adverse Event|3|||
23260685|NCT01754259|64696866|FG001|Overall Study|Adverse Event|1|||
23260686|NCT01754259|64696865|FG000|Overall Study|Lost to Follow-up|0|||
23260687|NCT01754259|64696866|FG001|Overall Study|Lost to Follow-up|1|||
23260688|NCT01132118|64696867|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
23260689|NCT01132118|64696868|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
23260690|NCT01132118|64696867|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
23260691|NCT01132118|64696868|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
23260692|NCT01132118|64696867|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
23260693|NCT01132118|64696868|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
23260694|NCT03828461|64696874|FG000|Overall Study|Lost to Follow-up|1|||
23260695|NCT03828461|64696874|FG000|Overall Study|Withdrawal by Subject|3|||
23260696|NCT04820842|64696875|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23260697|NCT04820842|64696876|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
23260698|NCT04820842|64696877|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
23260699|NCT04820842|64696878|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23260700|NCT04820842|64696879|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23260701|NCT04820842|64696880|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23260702|NCT04820842|64696881|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
23260703|NCT04820842|64696875|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
23260704|NCT04820842|64696876|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
23260705|NCT04820842|64696877|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
23260706|NCT04820842|64696878|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23260707|NCT04820842|64696879|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23260708|NCT04820842|64696880|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23260709|NCT04820842|64696881|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23260710|NCT04820842|64696875|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23260711|NCT04820842|64696876|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
23260712|NCT04820842|64696877|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23260713|NCT04820842|64696878|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23260714|NCT04820842|64696879|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23260715|NCT04820842|64696880|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23260716|NCT04820842|64696881|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
23260717|NCT04820842|64696875|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23260718|NCT04820842|64696876|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23260719|NCT04820842|64696877|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23260720|NCT04820842|64696878|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
23260721|NCT04820842|64696879|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23260722|NCT04820842|64696880|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
23260723|NCT04820842|64696881|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
23361375|NCT01435759|65069678|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
23361376|NCT01435759|65069673|FG000|Double-blind Phase|Other|8|||
23361377|NCT01435759|65069674|FG001|Double-blind Phase|Other|2|||
23361378|NCT01435759|65069675|FG002|Double-blind Phase|Other|0|||
23361379|NCT01435759|65069676|FG003|Double-blind Phase|Other|2|||
23600589|NCT03478969|65929682|FG001|Overall Study|Withdrawal by Subject|7|||
23600590|NCT03478969|65929683|FG002|Overall Study|Withdrawal by Subject|6|||
23600591|NCT03478969|65929681|FG000|Overall Study|Adverse Event|2|||
23600592|NCT03478969|65929682|FG001|Overall Study|Adverse Event|0|||
23600593|NCT03478969|65929683|FG002|Overall Study|Adverse Event|1|||
23260724|NCT00720122|64696885|FG000|Overall Study|Lost to Follow-up|1|||
23260725|NCT00720122|64696885|FG000|Overall Study|Physician Decision|1|||
23260726|NCT00720122|64696885|FG000|Overall Study|Withdrawal by Subject|7|||
23260727|NCT01042977|64696889|FG000|Overall Study|Adverse Event|4|||
23260728|NCT01042977|64696890|FG001|Overall Study|Adverse Event|12|||
23260729|NCT01042977|64696889|FG000|Overall Study|Death|2|||
23260730|NCT01042977|64696890|FG001|Overall Study|Death|1|||
23260731|NCT01042977|64696889|FG000|Overall Study|Withdrawal by Subject|8|||
23260732|NCT01042977|64696890|FG001|Overall Study|Withdrawal by Subject|16|||
23260733|NCT01042977|64696889|FG000|Overall Study|Lost to Follow-up|0|||
23260734|NCT01042977|64696890|FG001|Overall Study|Lost to Follow-up|2|||
23260735|NCT01042977|64696889|FG000|Overall Study|Poor/non-compliance|3|||
23260736|NCT01042977|64696890|FG001|Overall Study|Poor/non-compliance|4|||
23260737|NCT01042977|64696889|FG000|Overall Study|Subject no longer meets study criteria|15|||
23260738|NCT01042977|64696890|FG001|Overall Study|Subject no longer meets study criteria|13|||
23200399|NCT01419665|64473371|FG000|Combination Treatment|Adverse Event|7|||
23200400|NCT01419665|64473372|FG001|Combination Treatment|Adverse Event|10|||
23200401|NCT01419665|64473371|FG000|Combination Treatment|Physician Decision|5|||
23200402|NCT01419665|64473372|FG001|Combination Treatment|Physician Decision|8|||
23200403|NCT01419665|64473371|FG000|Combination Treatment|Protocol Violation|6|||
23200404|NCT01419665|64473372|FG001|Combination Treatment|Protocol Violation|2|||
23200405|NCT01419665|64473371|FG000|Combination Treatment|disease progression|10|||
23200406|NCT01419665|64473372|FG001|Combination Treatment|disease progression|9|||
23200407|NCT01419665|64473371|FG000|Combination Treatment|Death|5|||
23200408|NCT01419665|64473372|FG001|Combination Treatment|Death|7|||
23200409|NCT01419665|64473371|FG000|Combination Treatment|administrative problems|0|||
23200410|NCT01419665|64473372|FG001|Combination Treatment|administrative problems|1|||
23200411|NCT01419665|64473371|FG000|Combination Treatment|Withdrawal by Subject|5|||
23200412|NCT01419665|64473372|FG001|Combination Treatment|Withdrawal by Subject|4|||
23200413|NCT01419665|64473371|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
23200414|NCT01419665|64473372|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
23200415|NCT01419665|64473371|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
23200416|NCT01419665|64473372|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
23200417|NCT01419665|64473371|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
23200418|NCT01419665|64473372|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
23200419|NCT01419665|64473371|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
23200420|NCT01419665|64473372|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
23200421|NCT01419665|64473371|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
23200422|NCT01419665|64473372|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
23200423|NCT01419665|64473371|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
23200424|NCT01419665|64473372|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
23200425|NCT01419665|64473371|FG000|Maintenance Treatment and/or Follow up|Death|1|||
23200426|NCT01419665|64473372|FG001|Maintenance Treatment and/or Follow up|Death|2|||
23200427|NCT01419665|64473371|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
23200428|NCT01419665|64473372|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
23200429|NCT01419665|64473371|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
23200430|NCT01419665|64473372|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
23200431|NCT01419665|64473371|FG000|Open Label Phase|Death|1|||
23200432|NCT01419665|64473372|FG001|Open Label Phase|Death|0|||
23200433|NCT01419665|64473371|FG000|Open Label Phase|disease progression|0|||
23200434|NCT01419665|64473372|FG001|Open Label Phase|disease progression|1|||
23200435|NCT02739594|64473373|FG000|Overall Study|Undesired Event|3|||
23200436|NCT02739594|64473374|FG001|Overall Study|Undesired Event|4|||
23200437|NCT02739594|64473373|FG000|Overall Study|Violation of Eligibility Criteria|1|||
23200438|NCT02739594|64473374|FG001|Overall Study|Violation of Eligibility Criteria|2|||
23200439|NCT02739594|64473373|FG000|Overall Study|Protocol Violation|5|||
23200440|NCT02739594|64473374|FG001|Overall Study|Protocol Violation|6|||
23200441|NCT02739594|64473373|FG000|Overall Study|Death|4|||
23200442|NCT02739594|64473374|FG001|Overall Study|Death|2|||
23200443|NCT02739594|64473373|FG000|Overall Study|Renal Insufficiency|4|||
23200444|NCT02739594|64473374|FG001|Overall Study|Renal Insufficiency|6|||
23200445|NCT02739594|64473373|FG000|Overall Study|Administrative Reasons|1|||
23200446|NCT02739594|64473374|FG001|Overall Study|Administrative Reasons|3|||
23200447|NCT02739594|64473373|FG000|Overall Study|Withdrawal by Subject|1|||
23200448|NCT02739594|64473374|FG001|Overall Study|Withdrawal by Subject|1|||
23200449|NCT02739594|64473373|FG000|Overall Study|Lost to Follow-up|0|||
23200450|NCT02739594|64473374|FG001|Overall Study|Lost to Follow-up|1|||
23200451|NCT02739594|64473373|FG000|Overall Study|Elevated Serum Creatinine|0|||
23260739|NCT01042977|64696889|FG000|Overall Study|Incorrect enrollment|6|||
23260740|NCT01042977|64696890|FG001|Overall Study|Incorrect enrollment|4|||
23260741|NCT01042977|64696889|FG000|Overall Study|Safety|0|||
23260742|NCT01042977|64696890|FG001|Overall Study|Safety|2|||
23600594|NCT03478969|65929681|FG000|Overall Study|Pregnancy|1|||
23260743|NCT01042977|64696889|FG000|Overall Study|Administrative reason by sponsor|0|||
23260744|NCT01042977|64696890|FG001|Overall Study|Administrative reason by sponsor|1|||
23260745|NCT01042977|64696889|FG000|Overall Study|Various|3|||
23260746|NCT01042977|64696890|FG001|Overall Study|Various|0|||
23260747|NCT02468557|64696891|FG000|Overall Study|Adverse Event|1|||
23260748|NCT02468557|64696891|FG000|Overall Study|Death|1|||
23260749|NCT02468557|64696891|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
23260750|NCT02468557|64696891|FG000|Overall Study|All Enrolled but Never Dosed|4|||
23260751|NCT01868009|64696894|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
23260752|NCT01868009|64696895|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
23260753|NCT01868009|64696894|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
23260754|NCT01868009|64696895|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
23260755|NCT01868009|64696894|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
23260756|NCT01868009|64696895|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
23260757|NCT00906347|64696896|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
23260758|NCT00906347|64696897|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
23260759|NCT00906347|64696896|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
23260760|NCT00906347|64696897|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
23260761|NCT00906347|64696896|FG000|Received Study Drug|Refused study drug|1|||
23260762|NCT00906347|64696897|FG001|Received Study Drug|Refused study drug|0|||
23260763|NCT00906347|64696896|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
23260764|NCT00906347|64696897|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
23260765|NCT01618305|64696898|FG000|Overall Study|Death|0|||
23260766|NCT01618305|64696899|FG001|Overall Study|Death|1|||
23260767|NCT01618305|64696898|FG000|Overall Study|Lost to Follow-up|11|||
23260768|NCT01618305|64696899|FG001|Overall Study|Lost to Follow-up|7|||
23260769|NCT01618305|64696898|FG000|Overall Study|Protocol Violation|1|||
23260770|NCT01618305|64696899|FG001|Overall Study|Protocol Violation|0|||
23260771|NCT01618305|64696898|FG000|Overall Study|Withdrawal by Subject|3|||
23260772|NCT01618305|64696899|FG001|Overall Study|Withdrawal by Subject|2|||
23260773|NCT03896490|64696900|FG000|Overall Study|Withdrawal by Subject|1|||
23260774|NCT03896490|64696901|FG001|Overall Study|Withdrawal by Subject|1|||
23260775|NCT01211769|64696902|FG000|Overall Study|Lost to Follow-up|7|||
23260776|NCT01211769|64696903|FG001|Overall Study|Lost to Follow-up|9|||
23260777|NCT01211769|64696904|FG002|Overall Study|Lost to Follow-up|5|||
23260778|NCT01211769|64696905|FG003|Overall Study|Lost to Follow-up|9|||
23361380|NCT01435759|65069677|FG004|Double-blind Phase|Other|0|||
23361381|NCT01435759|65069678|FG005|Double-blind Phase|Other|0|||
23361382|NCT00463801|65069679|FG000|Overall Study|Protocol Violation|1|||
23361383|NCT00463801|65069679|FG000|Overall Study|Lack of Efficacy|2|||
23361384|NCT00463801|65069679|FG000|Overall Study|Adverse Event|4|||
23361385|NCT00463801|65069679|FG000|Overall Study|Lost to Follow-up|5|||
23361386|NCT00463801|65069679|FG000|Overall Study|No longer require therapy|1|||
23361387|NCT03243305|65069680|FG000|Overall Study|Lost to Follow-up|250|||
23361388|NCT03243305|65069680|FG000|Overall Study|Withdrawal by Subject|170|||
23361389|NCT03243305|65069680|FG000|Overall Study|Pregnancy|104|||
23361390|NCT03243305|65069680|FG000|Overall Study|Non-Compliance with Study Drug|38|||
23361391|NCT03243305|65069680|FG000|Overall Study|Adverse Event|23|||
23361392|NCT03243305|65069680|FG000|Overall Study|No sexually active|26|||
23361393|NCT03243305|65069680|FG000|Overall Study|Physician Decision|22|||
23361394|NCT03243305|65069680|FG000|Overall Study|Protocol Violation|22|||
23361395|NCT03243305|65069680|FG000|Overall Study|Study method no longer primary method|12|||
23361396|NCT03243305|65069680|FG000|Overall Study|Study Terminated by Sponsor|1|||
23361397|NCT03243305|65069680|FG000|Overall Study|Early terminations|267|||
23361398|NCT00810069|65069684|FG000|Lead-in Period I|Adverse Event|43|||
23361399|NCT00810069|65069685|FG001|Lead-in Period I|Adverse Event|0|||
23361400|NCT00810069|65069686|FG002|Lead-in Period I|Adverse Event|0|||
23361401|NCT00810069|65069684|FG000|Lead-in Period I|Lack of Efficacy|1|||
23361402|NCT00810069|65069685|FG001|Lead-in Period I|Lack of Efficacy|0|||
23361403|NCT00810069|65069686|FG002|Lead-in Period I|Lack of Efficacy|0|||
23361404|NCT00810069|65069684|FG000|Lead-in Period I|Lost to Follow-up|19|||
23361405|NCT00810069|65069685|FG001|Lead-in Period I|Lost to Follow-up|0|||
23361406|NCT00810069|65069686|FG002|Lead-in Period I|Lost to Follow-up|0|||
23361407|NCT00810069|65069684|FG000|Lead-in Period I|Physician Decision|1|||
23361408|NCT00810069|65069685|FG001|Lead-in Period I|Physician Decision|0|||
23361409|NCT00810069|65069686|FG002|Lead-in Period I|Physician Decision|0|||
23361410|NCT00810069|65069684|FG000|Lead-in Period I|Protocol Violation|1|||
23361411|NCT00810069|65069685|FG001|Lead-in Period I|Protocol Violation|0|||
23600595|NCT03478969|65929682|FG001|Overall Study|Pregnancy|0|||
23361412|NCT00810069|65069686|FG002|Lead-in Period I|Protocol Violation|0|||
23260779|NCT01211769|64696902|FG000|Overall Study|Physician Decision|2|||
23260780|NCT01211769|64696903|FG001|Overall Study|Physician Decision|0|||
23260781|NCT01211769|64696904|FG002|Overall Study|Physician Decision|2|||
23260782|NCT01211769|64696905|FG003|Overall Study|Physician Decision|1|||
23260783|NCT01211769|64696902|FG000|Overall Study|Adverse Event|0|||
23361413|NCT00810069|65069684|FG000|Lead-in Period I|Withdrawal by Subject|46|||
23361414|NCT00810069|65069685|FG001|Lead-in Period I|Withdrawal by Subject|0|||
23600596|NCT03478969|65929683|FG002|Overall Study|Pregnancy|0|||
23260784|NCT01211769|64696903|FG001|Overall Study|Adverse Event|1|||
23260785|NCT01211769|64696904|FG002|Overall Study|Adverse Event|1|||
23260786|NCT01211769|64696905|FG003|Overall Study|Adverse Event|1|||
23260787|NCT01464827|64696906|FG000|Overall Study|Adverse Event|0|||
23260788|NCT01464827|64696907|FG001|Overall Study|Adverse Event|0|||
23260789|NCT01464827|64696908|FG002|Overall Study|Adverse Event|0|||
23260790|NCT01464827|64696909|FG003|Overall Study|Adverse Event|0|||
23260791|NCT01464827|64696910|FG004|Overall Study|Adverse Event|0|||
23260792|NCT01464827|64696911|FG005|Overall Study|Adverse Event|0|||
23260793|NCT01464827|64696912|FG006|Overall Study|Adverse Event|0|||
23260794|NCT01464827|64696913|FG007|Overall Study|Adverse Event|0|||
23260795|NCT01464827|64696914|FG008|Overall Study|Adverse Event|0|||
23260796|NCT01464827|64696915|FG009|Overall Study|Adverse Event|0|||
23260797|NCT01464827|64696916|FG010|Overall Study|Adverse Event|0|||
23260798|NCT01464827|64696917|FG011|Overall Study|Adverse Event|0|||
23260799|NCT01464827|64696918|FG012|Overall Study|Adverse Event|1|||
23260800|NCT01464827|64696919|FG013|Overall Study|Adverse Event|0|||
23260801|NCT01464827|64696906|FG000|Overall Study|Withdrawal by Subject|1|||
23260802|NCT01464827|64696907|FG001|Overall Study|Withdrawal by Subject|0|||
23260803|NCT01464827|64696908|FG002|Overall Study|Withdrawal by Subject|0|||
23260804|NCT01464827|64696909|FG003|Overall Study|Withdrawal by Subject|0|||
23260805|NCT01464827|64696910|FG004|Overall Study|Withdrawal by Subject|1|||
23260806|NCT01464827|64696911|FG005|Overall Study|Withdrawal by Subject|0|||
23260807|NCT01464827|64696912|FG006|Overall Study|Withdrawal by Subject|0|||
23260808|NCT01464827|64696913|FG007|Overall Study|Withdrawal by Subject|1|||
23260809|NCT01464827|64696914|FG008|Overall Study|Withdrawal by Subject|0|||
23260810|NCT01464827|64696915|FG009|Overall Study|Withdrawal by Subject|0|||
23260811|NCT01464827|64696916|FG010|Overall Study|Withdrawal by Subject|0|||
23260812|NCT01464827|64696917|FG011|Overall Study|Withdrawal by Subject|0|||
23260813|NCT01464827|64696918|FG012|Overall Study|Withdrawal by Subject|0|||
23260814|NCT01464827|64696919|FG013|Overall Study|Withdrawal by Subject|0|||
23260815|NCT01464827|64696906|FG000|Overall Study|Lost to Follow-up|0|||
23260816|NCT01464827|64696907|FG001|Overall Study|Lost to Follow-up|2|||
23260817|NCT01464827|64696908|FG002|Overall Study|Lost to Follow-up|0|||
23260818|NCT01464827|64696909|FG003|Overall Study|Lost to Follow-up|2|||
23260819|NCT01464827|64696910|FG004|Overall Study|Lost to Follow-up|3|||
23260820|NCT01464827|64696911|FG005|Overall Study|Lost to Follow-up|1|||
23260821|NCT01464827|64696912|FG006|Overall Study|Lost to Follow-up|2|||
23260822|NCT01464827|64696913|FG007|Overall Study|Lost to Follow-up|2|||
23260823|NCT01464827|64696914|FG008|Overall Study|Lost to Follow-up|0|||
23260824|NCT01464827|64696915|FG009|Overall Study|Lost to Follow-up|0|||
23260825|NCT01464827|64696916|FG010|Overall Study|Lost to Follow-up|0|||
23260826|NCT01464827|64696917|FG011|Overall Study|Lost to Follow-up|1|||
23260827|NCT01464827|64696918|FG012|Overall Study|Lost to Follow-up|0|||
23260828|NCT01464827|64696919|FG013|Overall Study|Lost to Follow-up|1|||
23260829|NCT01464827|64696906|FG000|Overall Study|Other|2|||
23260830|NCT01464827|64696907|FG001|Overall Study|Other|3|||
23260831|NCT01464827|64696908|FG002|Overall Study|Other|0|||
23260832|NCT01464827|64696909|FG003|Overall Study|Other|2|||
23260833|NCT01464827|64696910|FG004|Overall Study|Other|3|||
23260834|NCT01464827|64696911|FG005|Overall Study|Other|0|||
23260835|NCT01464827|64696912|FG006|Overall Study|Other|1|||
23361415|NCT00810069|65069686|FG002|Lead-in Period I|Withdrawal by Subject|0|||
23260836|NCT01464827|64696913|FG007|Overall Study|Other|0|||
23260837|NCT01464827|64696914|FG008|Overall Study|Other|3|||
23260838|NCT01464827|64696915|FG009|Overall Study|Other|1|||
23260839|NCT01464827|64696916|FG010|Overall Study|Other|2|||
23260840|NCT01464827|64696917|FG011|Overall Study|Other|0|||
23260841|NCT01464827|64696918|FG012|Overall Study|Other|1|||
23480473|NCT04585009|65501998|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23260842|NCT01464827|64696919|FG013|Overall Study|Other|0|||
23260843|NCT01464827|64696906|FG000|Overall Study|Not Treated|0|||
23260844|NCT01464827|64696907|FG001|Overall Study|Not Treated|2|||
23260845|NCT01464827|64696908|FG002|Overall Study|Not Treated|0|||
23260846|NCT01464827|64696909|FG003|Overall Study|Not Treated|0|||
23260847|NCT01464827|64696910|FG004|Overall Study|Not Treated|1|||
23260848|NCT01464827|64696911|FG005|Overall Study|Not Treated|0|||
23260849|NCT01464827|64696912|FG006|Overall Study|Not Treated|1|||
23260850|NCT01464827|64696913|FG007|Overall Study|Not Treated|0|||
23260851|NCT01464827|64696914|FG008|Overall Study|Not Treated|0|||
23260852|NCT01464827|64696915|FG009|Overall Study|Not Treated|2|||
23260853|NCT01464827|64696916|FG010|Overall Study|Not Treated|0|||
23260854|NCT01464827|64696917|FG011|Overall Study|Not Treated|1|||
23260855|NCT01464827|64696918|FG012|Overall Study|Not Treated|0|||
23260856|NCT01464827|64696919|FG013|Overall Study|Not Treated|2|||
23260857|NCT02322879|64696920|FG000|First Intervention|Physician Decision|1|||
23260858|NCT02322879|64696921|FG001|First Intervention|Physician Decision|0|||
23260859|NCT03305055|64696923|FG000|Overall Study|Withdrawal by Subject|0|||
23260860|NCT03305055|64696924|FG001|Overall Study|Withdrawal by Subject|1|||
23260861|NCT03305055|64696923|FG000|Overall Study|Adverse Event|1|||
23260862|NCT03305055|64696924|FG001|Overall Study|Adverse Event|1|||
23260863|NCT04147715|64696925|FG000|Overall Study|Adverse Event|0|||
23260864|NCT04147715|64696926|FG001|Overall Study|Adverse Event|0|||
23260865|NCT04147715|64696927|FG002|Overall Study|Adverse Event|0|||
23260866|NCT04147715|64696928|FG003|Overall Study|Adverse Event|0|||
23260867|NCT04147715|64696929|FG004|Overall Study|Adverse Event|0|||
23260868|NCT04147715|64696930|FG005|Overall Study|Adverse Event|0|||
23260869|NCT04147715|64696931|FG006|Overall Study|Adverse Event|0|||
23260870|NCT04147715|64696932|FG007|Overall Study|Adverse Event|2|||
23260871|NCT04147715|64696933|FG008|Overall Study|Adverse Event|1|||
23260872|NCT04147715|64696934|FG009|Overall Study|Adverse Event|0|||
23260873|NCT04147715|64696935|FG010|Overall Study|Adverse Event|0|||
23260874|NCT04147715|64696936|FG011|Overall Study|Adverse Event|0|||
23260875|NCT00331630|64696940|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
23361416|NCT00810069|65069684|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
23260876|NCT00331630|64696940|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
23260877|NCT00331630|64696940|FG000|Follow up for 5 Years|Death|5|||
23260878|NCT00331630|64696940|FG000|Follow up for 5 Years|Data collection was stopped|24|||
23260879|NCT04228302|64696945|FG000|Overall Study|Adverse Event|0|||
23260880|NCT04228302|64696946|FG001|Overall Study|Adverse Event|0|||
23361417|NCT00810069|65069685|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
23260881|NCT04228302|64696947|FG002|Overall Study|Adverse Event|0|||
23260882|NCT04228302|64696948|FG003|Overall Study|Adverse Event|0|||
23260883|NCT04228302|64696949|FG004|Overall Study|Adverse Event|1|||
23260884|NCT04228302|64696950|FG005|Overall Study|Adverse Event|0|||
23260885|NCT00891774|64696952|FG000|Overall Study|Lost to Follow-up|5|||
23260886|NCT00891774|64696952|FG000|Overall Study|Illness (Self/Mother)|3|||
23260887|NCT00891774|64696952|FG000|Overall Study|Withdrawal by Subject|2|||
23361418|NCT00810069|65069686|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
23361419|NCT00810069|65069684|FG000|Lead-in Period I|Randomization criteria not met|158|||
23361420|NCT00810069|65069685|FG001|Lead-in Period I|Randomization criteria not met|0|||
23361421|NCT00810069|65069686|FG002|Lead-in Period I|Randomization criteria not met|0|||
23361422|NCT00810069|65069684|FG000|Double-Blind Period II|Adverse Event|0|||
23361423|NCT00810069|65069685|FG001|Double-Blind Period II|Adverse Event|9|||
23361424|NCT00810069|65069686|FG002|Double-Blind Period II|Adverse Event|8|||
23361425|NCT00810069|65069684|FG000|Double-Blind Period II|Lack of Efficacy|0|||
23361426|NCT00810069|65069685|FG001|Double-Blind Period II|Lack of Efficacy|7|||
23361427|NCT00810069|65069686|FG002|Double-Blind Period II|Lack of Efficacy|12|||
23361428|NCT00810069|65069684|FG000|Double-Blind Period II|Lost to Follow-up|0|||
23361429|NCT00810069|65069685|FG001|Double-Blind Period II|Lost to Follow-up|9|||
23361430|NCT00810069|65069686|FG002|Double-Blind Period II|Lost to Follow-up|9|||
23361431|NCT00810069|65069684|FG000|Double-Blind Period II|Physician Decision|0|||
23361432|NCT00810069|65069685|FG001|Double-Blind Period II|Physician Decision|0|||
23361433|NCT00810069|65069686|FG002|Double-Blind Period II|Physician Decision|1|||
23361434|NCT00810069|65069684|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
23361435|NCT00810069|65069685|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
23361436|NCT00810069|65069686|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
23260888|NCT00891774|64696952|FG000|Overall Study|Protocol Violation|4|||
23260889|NCT01280981|64696957|FG000|Overall Study|Withdrawal by Subject|11|||
23361437|NCT00810069|65069684|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
23361438|NCT00810069|65069685|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
23361439|NCT00810069|65069686|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
23361440|NCT00810069|65069684|FG000|Double-Blind Period II|Clinical relapse|0|||
23361441|NCT00810069|65069685|FG001|Double-Blind Period II|Clinical relapse|3|||
23361442|NCT00810069|65069686|FG002|Double-Blind Period II|Clinical relapse|0|||
23361443|NCT00810069|65069684|FG000|Double-Blind Period II|Protocol Violation|0|||
23361444|NCT00810069|65069685|FG001|Double-Blind Period II|Protocol Violation|7|||
23361445|NCT00810069|65069686|FG002|Double-Blind Period II|Protocol Violation|6|||
23361446|NCT03012841|65069687|FG000|Overall Study|Protocol Violation|0|||
23361447|NCT03012841|65069688|FG001|Overall Study|Protocol Violation|10|||
23361448|NCT03012841|65069687|FG000|Overall Study|Lost to Follow-up|6|||
23361449|NCT03012841|65069688|FG001|Overall Study|Lost to Follow-up|1|||
23361450|NCT03012841|65069687|FG000|Overall Study|Withdrawal by Subject|6|||
23361451|NCT03012841|65069688|FG001|Overall Study|Withdrawal by Subject|0|||
23361452|NCT03012841|65069687|FG000|Overall Study|Unable to complete 12 month visit|6|||
23361453|NCT03012841|65069688|FG001|Overall Study|Unable to complete 12 month visit|0|||
23361454|NCT03012841|65069687|FG000|Overall Study|Subject relocation|1|||
23361455|NCT03012841|65069688|FG001|Overall Study|Subject relocation|0|||
23361456|NCT03012841|65069687|FG000|Overall Study|Seasonal winter travel|1|||
23361457|NCT03012841|65069688|FG001|Overall Study|Seasonal winter travel|0|||
23361458|NCT03012841|65069687|FG000|Overall Study|Physician Decision|0|||
23361459|NCT03012841|65069688|FG001|Overall Study|Physician Decision|2|||
23361460|NCT03012841|65069687|FG000|Overall Study|No ablation performed|0|||
23361461|NCT03012841|65069688|FG001|Overall Study|No ablation performed|2|||
23361462|NCT03012841|65069687|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
23361463|NCT03012841|65069688|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
23361464|NCT03012841|65069687|FG000|Overall Study|Insurance change|0|||
23361465|NCT03012841|65069688|FG001|Overall Study|Insurance change|1|||
23361466|NCT04826484|65069689|FG000|Overall Study|Lost to Follow-up|2|||
23361467|NCT04826484|65069690|FG001|Overall Study|Lost to Follow-up|0|||
23361468|NCT00943397|65069693|FG000|Overall Study|Adverse Event|0|||
23361469|NCT00943397|65069694|FG001|Overall Study|Adverse Event|6|||
23361470|NCT00943397|65069693|FG000|Overall Study|Lost to Follow-up|0|||
23361471|NCT00943397|65069694|FG001|Overall Study|Lost to Follow-up|4|||
23361472|NCT00943397|65069693|FG000|Overall Study|Protocol Violation|2|||
23361473|NCT00943397|65069694|FG001|Overall Study|Protocol Violation|5|||
23361474|NCT00943397|65069693|FG000|Overall Study|Withdrawal by Subject|1|||
23361475|NCT00943397|65069694|FG001|Overall Study|Withdrawal by Subject|1|||
23361476|NCT00943397|65069693|FG000|Overall Study|Site terminated and other|12|||
23361477|NCT00943397|65069694|FG001|Overall Study|Site terminated and other|56|||
23361478|NCT00536510|65069695|FG000|Overall Study|Adverse Event|27|||
23260890|NCT01280981|64696957|FG000|Overall Study|Protocol Violation|2|||
23260891|NCT01280981|64696957|FG000|Overall Study|Lack of Efficacy|13|||
23260892|NCT01280981|64696957|FG000|Overall Study|Lost to Follow-up|3|||
23260893|NCT01280981|64696957|FG000|Overall Study|Adverse Event|6|||
23260894|NCT01280981|64696957|FG000|Overall Study|Irregular or discontinued menses|3|||
23260895|NCT01280981|64696957|FG000|Overall Study|Failed to return|45|||
23260896|NCT01280981|64696957|FG000|Overall Study|Non-compliance with protocol|3|||
23260897|NCT01280981|64696957|FG000|Overall Study|Withdrawal of consent|3|||
23260898|NCT01280981|64696957|FG000|Overall Study|Elective surgery|2|||
23260899|NCT01280981|64696957|FG000|Overall Study|Study site closure|1|||
23260900|NCT00549198|64696958|FG000|Overall Study|Adverse Event|28|||
23260901|NCT00549198|64696959|FG001|Overall Study|Adverse Event|26|||
23260902|NCT00549198|64696958|FG000|Overall Study|Insufficient Viral Load Response|4|||
23260903|NCT00549198|64696959|FG001|Overall Study|Insufficient Viral Load Response|2|||
23260904|NCT00549198|64696958|FG000|Overall Study|Protocol-defined Virological Failure|7|||
23260905|NCT00549198|64696959|FG001|Overall Study|Protocol-defined Virological Failure|0|||
23260906|NCT00549198|64696958|FG000|Overall Study|Non-compliance|2|||
23260907|NCT00549198|64696959|FG001|Overall Study|Non-compliance|4|||
23260908|NCT00549198|64696958|FG000|Overall Study|Lost to Follow-up|7|||
23260909|NCT00549198|64696959|FG001|Overall Study|Lost to Follow-up|8|||
23260910|NCT00549198|64696958|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
23260911|NCT00549198|64696959|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
23260912|NCT00549198|64696958|FG000|Overall Study|Protocol Violation|7|||
23260913|NCT00549198|64696959|FG001|Overall Study|Protocol Violation|2|||
23260914|NCT00549198|64696958|FG000|Overall Study|Investigator Decision|4|||
23260915|NCT00549198|64696959|FG001|Overall Study|Investigator Decision|3|||
23260916|NCT00549198|64696958|FG000|Overall Study|Withdrawal by Subject|7|||
23260917|NCT00549198|64696959|FG001|Overall Study|Withdrawal by Subject|7|||
23260918|NCT00549198|64696958|FG000|Overall Study|Disease Progression|1|||
23260919|NCT00549198|64696959|FG001|Overall Study|Disease Progression|0|||
23260920|NCT00549198|64696958|FG000|Overall Study|Participant Moved|2|||
23260921|NCT00549198|64696959|FG001|Overall Study|Participant Moved|0|||
23260922|NCT00549198|64696958|FG000|Overall Study|Participant not able to perform Week 96|1|||
23260923|NCT00549198|64696959|FG001|Overall Study|Participant not able to perform Week 96|0|||
23260924|NCT00549198|64696958|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
23260925|NCT00549198|64696959|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
23260926|NCT00549198|64696958|FG000|Overall Study|Prohibited Medication|1|||
23260927|NCT00549198|64696959|FG001|Overall Study|Prohibited Medication|2|||
23260928|NCT00549198|64696958|FG000|Overall Study|Participant planning pregnancy|1|||
23260929|NCT00549198|64696959|FG001|Overall Study|Participant planning pregnancy|0|||
23600597|NCT03478969|65929681|FG000|Overall Study|Personal Reasons|1|||
23260930|NCT00549198|64696958|FG000|Overall Study|Participant overweight, no scan possible|1|||
23260931|NCT00549198|64696959|FG001|Overall Study|Participant overweight, no scan possible|0|||
23260932|NCT00549198|64696958|FG000|Overall Study|No scan facilities|0|||
23260933|NCT00549198|64696959|FG001|Overall Study|No scan facilities|2|||
23260934|NCT00549198|64696958|FG000|Overall Study|Pregnancy|0|||
23260935|NCT00549198|64696959|FG001|Overall Study|Pregnancy|3|||
23260936|NCT00549198|64696958|FG000|Overall Study|Not Exposed to Study Drug|3|||
23361479|NCT00536510|65069696|FG001|Overall Study|Adverse Event|4|||
23361480|NCT00536510|65069695|FG000|Overall Study|Lost to Follow-up|11|||
23361481|NCT00536510|65069696|FG001|Overall Study|Lost to Follow-up|8|||
23361482|NCT00536510|65069695|FG000|Overall Study|Protocol Violation|4|||
23600598|NCT03478969|65929682|FG001|Overall Study|Personal Reasons|0|||
23260937|NCT00549198|64696959|FG001|Overall Study|Not Exposed to Study Drug|4|||
23260938|NCT01847313|64696962|FG000|Overall Study|Death|0|||
23260939|NCT01847313|64696963|FG001|Overall Study|Death|1|||
23260940|NCT01847313|64696962|FG000|Overall Study|Withdrawal by Subject|0|||
23260941|NCT01847313|64696963|FG001|Overall Study|Withdrawal by Subject|1|||
23260942|NCT02097121|64696964|FG000|Overall Study|Other, not specified|4|||
23260943|NCT02097121|64696965|FG001|Overall Study|Other, not specified|2|||
23260944|NCT02097121|64696966|FG002|Overall Study|Other, not specified|3|||
23260945|NCT02097121|64696964|FG000|Overall Study|Lack of Efficacy|2|||
23260946|NCT02097121|64696965|FG001|Overall Study|Lack of Efficacy|1|||
23260947|NCT02097121|64696966|FG002|Overall Study|Lack of Efficacy|3|||
23260948|NCT02097121|64696964|FG000|Overall Study|Withdrawal by Subject|0|||
23260949|NCT02097121|64696965|FG001|Overall Study|Withdrawal by Subject|1|||
23260950|NCT02097121|64696966|FG002|Overall Study|Withdrawal by Subject|2|||
23260951|NCT02097121|64696964|FG000|Overall Study|Adverse Event|0|||
23260952|NCT02097121|64696965|FG001|Overall Study|Adverse Event|1|||
23260953|NCT02097121|64696966|FG002|Overall Study|Adverse Event|0|||
23260954|NCT02097121|64696964|FG000|Overall Study|Lost to Follow-up|1|||
23260955|NCT02097121|64696965|FG001|Overall Study|Lost to Follow-up|1|||
23260956|NCT02097121|64696966|FG002|Overall Study|Lost to Follow-up|2|||
23260957|NCT00306384|64696970|FG000|Overall Study|Adverse Event|103|||
23260958|NCT00306384|64696971|FG001|Overall Study|Adverse Event|87|||
23260959|NCT00306384|64696972|FG002|Overall Study|Adverse Event|40|||
23260960|NCT00306384|64696970|FG000|Overall Study|Major protocol deviation|43|||
23260961|NCT00306384|64696971|FG001|Overall Study|Major protocol deviation|51|||
23260962|NCT00306384|64696972|FG002|Overall Study|Major protocol deviation|18|||
23260963|NCT00306384|64696970|FG000|Overall Study|Lost to Follow-up|57|||
23260964|NCT00306384|64696971|FG001|Overall Study|Lost to Follow-up|41|||
23260965|NCT00306384|64696972|FG002|Overall Study|Lost to Follow-up|35|||
23260966|NCT00306384|64696970|FG000|Overall Study|Voluntary withdrawal|199|||
23260967|NCT00306384|64696971|FG001|Overall Study|Voluntary withdrawal|187|||
23260968|NCT00306384|64696972|FG002|Overall Study|Voluntary withdrawal|91|||
23260969|NCT00306384|64696970|FG000|Overall Study|Study termination|1|||
23260970|NCT00306384|64696971|FG001|Overall Study|Study termination|0|||
23260971|NCT00306384|64696972|FG002|Overall Study|Study termination|1|||
23600599|NCT03478969|65929683|FG002|Overall Study|Personal Reasons|1|||
23600600|NCT03478969|65929681|FG000|Overall Study|Covid-19|1|||
23600601|NCT03478969|65929682|FG001|Overall Study|Covid-19|4|||
23600602|NCT03478969|65929683|FG002|Overall Study|Covid-19|3|||
23600603|NCT03478969|65929681|FG000|Overall Study|Multiple Reasons|0|||
23600604|NCT03478969|65929682|FG001|Overall Study|Multiple Reasons|1|||
23200452|NCT02739594|64473374|FG001|Overall Study|Elevated Serum Creatinine|1|||
23200453|NCT02739594|64473373|FG000|Overall Study|Other|6|||
23200454|NCT02739594|64473374|FG001|Overall Study|Other|2|||
23200455|NCT00237796|64473375|FG000|Overall Study|Baseline and one other ILSS required|10|||
23200456|NCT00237796|64473376|FG001|Overall Study|Baseline and one other ILSS required|5|||
23200457|NCT03484923|64473377|FG000|Overall Study|Adverse Event|3|||
23200458|NCT03484923|64473378|FG001|Overall Study|Adverse Event|3|||
23200459|NCT03484923|64473379|FG002|Overall Study|Adverse Event|5|||
23200460|NCT03484923|64473380|FG003|Overall Study|Adverse Event|11|||
23200461|NCT03484923|64473381|FG004|Overall Study|Adverse Event|1|||
23200462|NCT03484923|64473377|FG000|Overall Study|Death|2|||
23200463|NCT03484923|64473378|FG001|Overall Study|Death|2|||
23200464|NCT03484923|64473379|FG002|Overall Study|Death|3|||
23200465|NCT03484923|64473380|FG003|Overall Study|Death|0|||
23200466|NCT03484923|64473381|FG004|Overall Study|Death|1|||
23200467|NCT03484923|64473377|FG000|Overall Study|Physician Decision|6|||
23260972|NCT00306384|64696970|FG000|Overall Study|Pregnancy|3|||
23260973|NCT00306384|64696971|FG001|Overall Study|Pregnancy|1|||
23260974|NCT00306384|64696972|FG002|Overall Study|Pregnancy|1|||
23260975|NCT00306384|64696970|FG000|Overall Study|Lack of Efficacy|26|||
23260976|NCT00306384|64696971|FG001|Overall Study|Lack of Efficacy|40|||
23260977|NCT00306384|64696972|FG002|Overall Study|Lack of Efficacy|38|||
23260978|NCT00306384|64696970|FG000|Overall Study|Investigator discretion|28|||
23260979|NCT00306384|64696971|FG001|Overall Study|Investigator discretion|31|||
23600605|NCT03478969|65929683|FG002|Overall Study|Multiple Reasons|1|||
23600606|NCT03478969|65929681|FG000|Overall Study|Eligibility Criteria|0|||
23600607|NCT03478969|65929682|FG001|Overall Study|Eligibility Criteria|0|||
23200468|NCT03484923|64473378|FG001|Overall Study|Physician Decision|7|||
23200469|NCT03484923|64473379|FG002|Overall Study|Physician Decision|6|||
23200470|NCT03484923|64473380|FG003|Overall Study|Physician Decision|3|||
23200471|NCT03484923|64473381|FG004|Overall Study|Physician Decision|2|||
23200472|NCT03484923|64473377|FG000|Overall Study|Progressive disease|33|||
23200473|NCT03484923|64473378|FG001|Overall Study|Progressive disease|28|||
23200474|NCT03484923|64473379|FG002|Overall Study|Progressive disease|26|||
23200475|NCT03484923|64473380|FG003|Overall Study|Progressive disease|30|||
23200476|NCT03484923|64473381|FG004|Overall Study|Progressive disease|16|||
23200477|NCT03484923|64473377|FG000|Overall Study|Subject Decision|1|||
23200478|NCT03484923|64473378|FG001|Overall Study|Subject Decision|3|||
23200479|NCT03484923|64473379|FG002|Overall Study|Subject Decision|3|||
23200480|NCT03484923|64473380|FG003|Overall Study|Subject Decision|0|||
23200481|NCT03484923|64473381|FG004|Overall Study|Subject Decision|1|||
23200482|NCT01428063|64473382|FG000|Overall Study|Lack of Efficacy|8|||
23200483|NCT01428063|64473383|FG001|Overall Study|Lack of Efficacy|4|||
23361483|NCT00536510|65069696|FG001|Overall Study|Protocol Violation|5|||
23200484|NCT01428063|64473384|FG002|Overall Study|Lack of Efficacy|1|||
23200485|NCT01428063|64473382|FG000|Overall Study|Adverse Event|2|||
23200486|NCT01428063|64473383|FG001|Overall Study|Adverse Event|3|||
23200487|NCT01428063|64473384|FG002|Overall Study|Adverse Event|0|||
23200488|NCT01428063|64473382|FG000|Overall Study|Lost to Follow-up|0|||
23200489|NCT01428063|64473383|FG001|Overall Study|Lost to Follow-up|2|||
23200490|NCT01428063|64473384|FG002|Overall Study|Lost to Follow-up|0|||
23200491|NCT01428063|64473382|FG000|Overall Study|No longer meets study criteria|0|||
23200492|NCT01428063|64473383|FG001|Overall Study|No longer meets study criteria|1|||
23200493|NCT01428063|64473384|FG002|Overall Study|No longer meets study criteria|0|||
23200494|NCT01423617|64473389|FG000|Overall Study|Lost to Follow-up|0|||
23200495|NCT01423617|64473390|FG001|Overall Study|Lost to Follow-up|1|||
23200496|NCT03126539|64473391|FG000|Overall Study|Lost to Follow-up|1|||
23200497|NCT03126539|64473392|FG001|Overall Study|Lost to Follow-up|1|||
23200498|NCT03126539|64473393|FG002|Overall Study|Lost to Follow-up|1|||
23200499|NCT03126539|64473394|FG003|Overall Study|Lost to Follow-up|0|||
23200500|NCT03126539|64473395|FG004|Overall Study|Lost to Follow-up|0|||
23200501|NCT02588248|64473400|FG000|Overall Study|Physician Decision|4|||
23200502|NCT02588248|64473401|FG001|Overall Study|Physician Decision|3|||
23200503|NCT02948777|64473402|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
23200504|NCT02042404|64473405|FG000|Overall Study|Death|1|||
23200505|NCT02042404|64473406|FG001|Overall Study|Death|0|||
23200506|NCT02042404|64473405|FG000|Overall Study|Unrelated Adverse Event|3|||
23200507|NCT02042404|64473406|FG001|Overall Study|Unrelated Adverse Event|0|||
23200508|NCT02042404|64473405|FG000|Overall Study|Inability to meet time requirements|1|||
23200509|NCT02042404|64473406|FG001|Overall Study|Inability to meet time requirements|0|||
23200510|NCT00532883|64473407|FG000|Overall Study|Adverse Event|1|||
23200511|NCT00532883|64473408|FG001|Overall Study|Adverse Event|0|||
23200512|NCT00532883|64473409|FG002|Overall Study|Adverse Event|0|||
23200513|NCT00532883|64473410|FG003|Overall Study|Adverse Event|1|||
23200514|NCT00532883|64473407|FG000|Overall Study|Lost to Follow-up|1|||
23200515|NCT00532883|64473408|FG001|Overall Study|Lost to Follow-up|1|||
23200516|NCT00532883|64473409|FG002|Overall Study|Lost to Follow-up|1|||
23200517|NCT00532883|64473410|FG003|Overall Study|Lost to Follow-up|0|||
23200518|NCT00532883|64473407|FG000|Overall Study|Withdrawal by Subject|0|||
23200519|NCT00532883|64473408|FG001|Overall Study|Withdrawal by Subject|1|||
23200520|NCT00532883|64473409|FG002|Overall Study|Withdrawal by Subject|1|||
23200521|NCT00532883|64473410|FG003|Overall Study|Withdrawal by Subject|0|||
23200522|NCT00532883|64473407|FG000|Overall Study|Subject was Nonadherent|0|||
23200523|NCT00532883|64473408|FG001|Overall Study|Subject was Nonadherent|1|||
23200524|NCT00532883|64473409|FG002|Overall Study|Subject was Nonadherent|1|||
23200525|NCT00532883|64473410|FG003|Overall Study|Subject was Nonadherent|0|||
23200526|NCT00532883|64473407|FG000|Overall Study|Early Study Termination|4|||
23200527|NCT00532883|64473408|FG001|Overall Study|Early Study Termination|4|||
23200528|NCT00532883|64473409|FG002|Overall Study|Early Study Termination|1|||
23200529|NCT00532883|64473410|FG003|Overall Study|Early Study Termination|4|||
23200530|NCT02052960|64473411|FG000|Overall Study|Adverse Event|19|||
23200531|NCT02052960|64473412|FG001|Overall Study|Adverse Event|17|||
23200532|NCT02052960|64473411|FG000|Overall Study|Protocol Violation|4|||
23200533|NCT02052960|64473412|FG001|Overall Study|Protocol Violation|3|||
23200534|NCT02052960|64473411|FG000|Overall Study|Withdrawal by Subject|6|||
23200535|NCT02052960|64473412|FG001|Overall Study|Withdrawal by Subject|11|||
23200536|NCT02052960|64473411|FG000|Overall Study|Other|25|||
23200537|NCT02052960|64473412|FG001|Overall Study|Other|15|||
23200538|NCT02869867|64473413|FG000|Overall Study|Protocol Violation|1|||
23200539|NCT02869867|64473414|FG001|Overall Study|Protocol Violation|0|||
23200540|NCT02869867|64473413|FG000|Overall Study|Lost to Follow-up|5|||
23200541|NCT02869867|64473414|FG001|Overall Study|Lost to Follow-up|5|||
23200542|NCT00118482|64473415|FG000|Overall Study|Lost to Follow-up|7|||
23200543|NCT00118482|64473416|FG001|Overall Study|Lost to Follow-up|7|||
23200544|NCT00118482|64473415|FG000|Overall Study|Withdrawal by Subject|23|||
23200545|NCT00118482|64473416|FG001|Overall Study|Withdrawal by Subject|22|||
23200546|NCT01331239|64473417|FG000|Part II: Core Study|Adverse Event|0|||
23200547|NCT01331239|64473418|FG001|Part II: Core Study|Adverse Event|3|||
23200548|NCT01331239|64473419|FG002|Part II: Core Study|Adverse Event|0|||
23200549|NCT01331239|64473417|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
23200550|NCT01331239|64473418|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
23200551|NCT01331239|64473419|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
23200552|NCT01331239|64473417|FG000|Part II: Core Study|Withdrawal by Subject|0|||
23200553|NCT01331239|64473418|FG001|Part II: Core Study|Withdrawal by Subject|2|||
23200554|NCT01331239|64473419|FG002|Part II: Core Study|Withdrawal by Subject|0|||
23200555|NCT01331239|64473417|FG000|Part II: Core Study|Administrative problems|0|||
23200556|NCT01331239|64473418|FG001|Part II: Core Study|Administrative problems|1|||
23200557|NCT01331239|64473419|FG002|Part II: Core Study|Administrative problems|0|||
23200558|NCT01341652|64473424|FG000|Overall Study|Incorrect Random Assignment|0|||
23200559|NCT01341652|64473425|FG001|Overall Study|Incorrect Random Assignment|1|||
23260980|NCT00306384|64696972|FG002|Overall Study|Investigator discretion|21|||
23260981|NCT00306384|64696970|FG000|Overall Study|Other|80|||
23260982|NCT00306384|64696971|FG001|Overall Study|Other|70|||
23260983|NCT00306384|64696972|FG002|Overall Study|Other|32|||
23260984|NCT00306384|64696970|FG000|Overall Study|Site closure|2|||
23260985|NCT00306384|64696971|FG001|Overall Study|Site closure|0|||
23260986|NCT00306384|64696972|FG002|Overall Study|Site closure|0|||
23260987|NCT00891293|64696975|FG000|Overall Study|Adverse Event|2|||
23260988|NCT00891293|64696975|FG000|Overall Study|Protocol Violation|2|||
23260989|NCT00891293|64696975|FG000|Overall Study|Laboratory abnormality|4|||
23260990|NCT00891293|64696975|FG000|Overall Study|Lost to Follow-up|7|||
23260991|NCT00891293|64696975|FG000|Overall Study|Subject withdrew consent|7|||
23260992|NCT00891293|64696975|FG000|Overall Study|Sponsor termination|62|||
23260993|NCT01952574|64696996|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
23260994|NCT01952574|64696997|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
23260995|NCT01952574|64696998|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
23260996|NCT01952574|64696999|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
23260997|NCT01952574|64697000|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23260998|NCT01952574|64697001|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23260999|NCT01952574|64697002|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23261000|NCT01952574|64696996|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
23261001|NCT01952574|64696997|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
23261002|NCT01952574|64696998|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
23261003|NCT01952574|64696999|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
23261004|NCT01952574|64697000|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
23261005|NCT01952574|64697001|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
23261006|NCT01952574|64697002|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
23261007|NCT01952574|64696996|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
23261008|NCT01952574|64696997|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
23261009|NCT01952574|64696998|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
23261010|NCT01952574|64696999|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
23261011|NCT01952574|64697000|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
23261012|NCT01952574|64697001|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
23261013|NCT01952574|64697002|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
23261014|NCT01952574|64696996|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
23261015|NCT01952574|64696997|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
23261016|NCT01952574|64696998|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
23261017|NCT01952574|64696999|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
23261018|NCT01952574|64697000|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
23261019|NCT01952574|64697001|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
23261020|NCT01952574|64697002|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
23261021|NCT01952574|64696996|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
23361484|NCT00536510|65069695|FG000|Overall Study|Withdrawal by Subject|16|||
23361485|NCT00536510|65069696|FG001|Overall Study|Withdrawal by Subject|9|||
23361486|NCT00536510|65069695|FG000|Overall Study|Flushing with Product|20|||
23600608|NCT03478969|65929683|FG002|Overall Study|Eligibility Criteria|5|||
23600609|NCT03478969|65929681|FG000|Overall Study|Lost to Follow-up|0|||
23600610|NCT03478969|65929682|FG001|Overall Study|Lost to Follow-up|0|||
23600611|NCT03478969|65929683|FG002|Overall Study|Lost to Follow-up|1|||
23600612|NCT01212744|65929684|FG000|Overall Study|Withdrawal by Subject|1|||
23600613|NCT01596972|65929685|FG000|Overall Study|Physician Decision|1|||
23600614|NCT01596972|65929686|FG001|Overall Study|Physician Decision|9|||
23600615|NCT01596972|65929685|FG000|Overall Study|Lost to Follow-up|0|||
23600616|NCT01596972|65929686|FG001|Overall Study|Lost to Follow-up|4|||
23600617|NCT01596972|65929685|FG000|Overall Study|Withdrawal by Subject|0|||
23600618|NCT01596972|65929686|FG001|Overall Study|Withdrawal by Subject|1|||
23600619|NCT01555138|65929687|FG000|Overall Study|Death|0|||
23600620|NCT01555138|65929688|FG001|Overall Study|Death|1|||
23600621|NCT01555138|65929687|FG000|Overall Study|Lost to Follow-up|1|||
23600622|NCT01555138|65929688|FG001|Overall Study|Lost to Follow-up|0|||
23600623|NCT01555138|65929687|FG000|Overall Study|Abnormal Lab reults|1|||
23600624|NCT01555138|65929688|FG001|Overall Study|Abnormal Lab reults|3|||
23600625|NCT01555138|65929687|FG000|Overall Study|Lack of Efficacy|2|||
23600626|NCT01555138|65929688|FG001|Overall Study|Lack of Efficacy|2|||
23261022|NCT01952574|64696997|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
23261023|NCT01952574|64696998|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
23261024|NCT01952574|64696999|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
23261025|NCT01952574|64697000|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
23261026|NCT01952574|64697001|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
23600627|NCT01555138|65929687|FG000|Overall Study|Protocol Violation|5|||
23600628|NCT01555138|65929688|FG001|Overall Study|Protocol Violation|3|||
23600629|NCT01555138|65929687|FG000|Overall Study|Administrative problems|8|||
23600630|NCT01555138|65929688|FG001|Overall Study|Administrative problems|0|||
23600631|NCT01555138|65929687|FG000|Overall Study|Withdrawal by Subject|16|||
23600632|NCT01555138|65929688|FG001|Overall Study|Withdrawal by Subject|15|||
23600633|NCT01555138|65929687|FG000|Overall Study|Adverse Event|14|||
23261027|NCT01952574|64697002|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
23261028|NCT01952574|64696996|FG000|Open-label Treatment Phase|Missing|0|||
23261029|NCT01952574|64696997|FG001|Open-label Treatment Phase|Missing|0|||
23261030|NCT01952574|64696998|FG002|Open-label Treatment Phase|Missing|0|||
23261031|NCT01952574|64696999|FG003|Open-label Treatment Phase|Missing|0|||
23261032|NCT01952574|64697000|FG004|Open-label Treatment Phase|Missing|4|||
23261033|NCT01952574|64697001|FG005|Open-label Treatment Phase|Missing|0|||
23261034|NCT01952574|64697002|FG006|Open-label Treatment Phase|Missing|0|||
23261035|NCT01952574|64696996|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
23261036|NCT01952574|64696997|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
23261037|NCT01952574|64696998|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
23261038|NCT01952574|64696999|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
23261039|NCT01952574|64697000|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
23261040|NCT01952574|64697001|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
23261041|NCT01952574|64697002|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
23261042|NCT01952574|64696996|FG000|Open-label Treatment Phase|Death|0|||
23261043|NCT01952574|64696997|FG001|Open-label Treatment Phase|Death|0|||
23261044|NCT01952574|64696998|FG002|Open-label Treatment Phase|Death|0|||
23261045|NCT01952574|64696999|FG003|Open-label Treatment Phase|Death|0|||
23261046|NCT01952574|64697000|FG004|Open-label Treatment Phase|Death|1|||
23261047|NCT01952574|64697001|FG005|Open-label Treatment Phase|Death|0|||
23261048|NCT01952574|64697002|FG006|Open-label Treatment Phase|Death|0|||
23261049|NCT01952574|64696996|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23261050|NCT01952574|64696997|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23261051|NCT01952574|64696998|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23261052|NCT01952574|64696999|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23261053|NCT01952574|64697000|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23261054|NCT01952574|64697001|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
23261055|NCT01952574|64697002|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
23261056|NCT01952574|64696996|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
23261057|NCT01952574|64696997|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
23261058|NCT01952574|64696998|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
23261059|NCT01952574|64696999|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
23261060|NCT01952574|64697000|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
23261061|NCT01952574|64697001|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
23261062|NCT01952574|64697002|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
23261063|NCT01347710|64697003|FG000|Overall Study|Withdrawal by Subject|2|||
23261064|NCT01347710|64697003|FG000|Overall Study|Adverse Event|4|||
23261065|NCT01347710|64697003|FG000|Overall Study|Angio or SPECT not completed|18|||
23261066|NCT01347710|64697003|FG000|Overall Study|issue with vitals prior to dosing|1|||
23261067|NCT01347710|64697003|FG000|Overall Study|Lost to Follow-up|1|||
23261068|NCT01347710|64697003|FG000|Overall Study|Physician Decision|2|||
23261069|NCT01347710|64697003|FG000|Overall Study|Other|3|||
23261070|NCT00681863|64697004|FG000|Overall Study|Adverse Event|1|||
23261071|NCT00681863|64697004|FG000|Overall Study|Lost to Follow-up|2|||
23261072|NCT00681863|64697004|FG000|Overall Study|Lack of Efficacy|2|||
23261073|NCT00681863|64697004|FG000|Overall Study|Other|18|||
23261074|NCT02232074|64697016|FG000|Overall Study|Withdrawal by Subject|5|||
23261075|NCT02232074|64697017|FG001|Overall Study|Withdrawal by Subject|3|||
23261076|NCT02232074|64697016|FG000|Overall Study|No legal concerns at baseline|36|||
23261077|NCT02232074|64697017|FG001|Overall Study|No legal concerns at baseline|41|||
23261078|NCT02232074|64697016|FG000|Overall Study|deemed ineligible|0|||
23261079|NCT02232074|64697017|FG001|Overall Study|deemed ineligible|1|||
23261080|NCT00441584|64697018|FG000|Overall Study|Lack of Efficacy|79|||
23261081|NCT00441584|64697018|FG000|Overall Study|Withdrawal by Subject|8|||
23261082|NCT00441584|64697018|FG000|Overall Study|Adverse Event|6|||
23261083|NCT00441584|64697018|FG000|Overall Study|Protocol Violation|5|||
23261084|NCT00441584|64697018|FG000|Overall Study|Lost to Follow-up|4|||
23261085|NCT00441584|64697018|FG000|Overall Study|Failure to meet eligibility criteria|3|||
23261086|NCT01618266|64700283|FG000|Overall Study|Lost to Follow-up|9|||
23261087|NCT01618266|64700283|FG000|Overall Study|Treatment satisfaction|10|||
23261088|NCT01618266|64700283|FG000|Overall Study|Other reasons|11|||
23261089|NCT01618266|64700283|FG000|Overall Study|Lack of Efficacy|23|||
23261090|NCT01618266|64700283|FG000|Overall Study|Protocol Violation|43|||
23261091|NCT03907280|64700284|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
23261092|NCT03907280|64700285|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
23261093|NCT03907280|64700286|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
23261094|NCT00264810|64700287|FG000|Baseline|Withdrawal by Subject|10|||
23261095|NCT00264810|64700288|FG001|Baseline|Withdrawal by Subject|10|||
23261096|NCT00264810|64700287|FG000|Baseline|Physician Decision|7|||
23261097|NCT00264810|64700288|FG001|Baseline|Physician Decision|8|||
23261098|NCT00264810|64700287|FG000|Baseline|Subject Compliance Failure|3|||
23261099|NCT00264810|64700288|FG001|Baseline|Subject Compliance Failure|3|||
23261100|NCT00264810|64700287|FG000|Baseline|Insufficient Seizure Frequency|2|||
23261101|NCT00264810|64700288|FG001|Baseline|Insufficient Seizure Frequency|2|||
23261102|NCT00264810|64700287|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
23261103|NCT00264810|64700288|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
23261104|NCT00264810|64700287|FG000|Baseline|Other|0|||
23261105|NCT00264810|64700288|FG001|Baseline|Other|1|||
23261106|NCT00264810|64700287|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
23261107|NCT00264810|64700288|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
23261108|NCT00264810|64700287|FG000|Stimulation Optimization Period|Death|0|||
23261109|NCT00264810|64700288|FG001|Stimulation Optimization Period|Death|1|||
23261110|NCT00264810|64700287|FG000|Blinded Evaluation Period|Explant due to infection|1|||
23261111|NCT00264810|64700288|FG001|Blinded Evaluation Period|Explant due to infection|1|||
23261112|NCT00264810|64700287|FG000|Open Label Evaluation Period|Explant due to infection|1|||
23261113|NCT00264810|64700288|FG001|Open Label Evaluation Period|Explant due to infection|1|||
23261114|NCT00264810|64700287|FG000|Open Label Evaluation Period|Death|3|||
23261115|NCT00264810|64700288|FG001|Open Label Evaluation Period|Death|2|||
23261116|NCT00264810|64700287|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
23261117|NCT00264810|64700288|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
23261118|NCT05216978|64700291|FG000|Overall Study|Withdrawal by Subject|3|||
23261119|NCT05216978|64700291|FG000|Overall Study|Lost to Follow-up|5|||
23261120|NCT00601484|64700292|FG000|Overall Study|Adverse Event|0|||
23261121|NCT00601484|64700293|FG001|Overall Study|Adverse Event|1|||
23261122|NCT00601484|64700292|FG000|Overall Study|Lost to Follow-up|4|||
23261123|NCT00601484|64700293|FG001|Overall Study|Lost to Follow-up|3|||
23261124|NCT00601484|64700292|FG000|Overall Study|Lack of Efficacy|0|||
23261125|NCT00601484|64700293|FG001|Overall Study|Lack of Efficacy|2|||
23261126|NCT00601484|64700292|FG000|Overall Study|Withdrawal by Subject|1|||
23261127|NCT00601484|64700293|FG001|Overall Study|Withdrawal by Subject|1|||
23261128|NCT00601484|64700292|FG000|Overall Study|Randomized, but not treated|0|||
23261129|NCT00601484|64700293|FG001|Overall Study|Randomized, but not treated|1|||
23261130|NCT01339910|64700294|FG000|Overall Study|Withdrawal by Subject|1|||
23261131|NCT01339910|64700295|FG001|Overall Study|Withdrawal by Subject|0|||
23261132|NCT01339910|64700294|FG000|Overall Study|Physician Decision|1|||
23261133|NCT01339910|64700295|FG001|Overall Study|Physician Decision|0|||
23261134|NCT01339910|64700294|FG000|Overall Study|Disease relapse|1|||
23261135|NCT01339910|64700295|FG001|Overall Study|Disease relapse|4|||
23261136|NCT03982433|64700296|FG000|Overall Study|Lost to Follow-up|1|||
23261137|NCT00927810|64700297|FG000|Overall Study|Withdrawal by Subject|0|||
23261138|NCT00927810|64700298|FG001|Overall Study|Withdrawal by Subject|3|||
23261139|NCT00927810|64700299|FG002|Overall Study|Withdrawal by Subject|0|||
23261140|NCT00927810|64700300|FG003|Overall Study|Withdrawal by Subject|1|||
23261141|NCT00927810|64700297|FG000|Overall Study|Lost to Follow-up|0|||
23261142|NCT00927810|64700298|FG001|Overall Study|Lost to Follow-up|2|||
23261143|NCT00927810|64700299|FG002|Overall Study|Lost to Follow-up|1|||
23261144|NCT00927810|64700300|FG003|Overall Study|Lost to Follow-up|1|||
23261145|NCT00927810|64700297|FG000|Overall Study|Death|0|||
23261146|NCT00927810|64700298|FG001|Overall Study|Death|2|||
23261147|NCT00927810|64700299|FG002|Overall Study|Death|0|||
23261148|NCT00927810|64700300|FG003|Overall Study|Death|0|||
23261149|NCT00927810|64700297|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23261150|NCT00927810|64700298|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23261151|NCT00927810|64700299|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23261152|NCT00927810|64700300|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23261153|NCT02736227|64700301|FG000|Overall Study|Withdrawal by Subject|0|||
23261154|NCT02736227|64700302|FG001|Overall Study|Withdrawal by Subject|0|||
23261155|NCT02736227|64700303|FG002|Overall Study|Withdrawal by Subject|1|||
23261156|NCT02736227|64700301|FG000|Overall Study|Physician Decision|0|||
23261157|NCT02736227|64700302|FG001|Overall Study|Physician Decision|0|||
23261158|NCT02736227|64700303|FG002|Overall Study|Physician Decision|5|||
23261159|NCT02736227|64700301|FG000|Overall Study|Non Compliant|0|||
23261160|NCT02736227|64700302|FG001|Overall Study|Non Compliant|0|||
23261161|NCT02736227|64700303|FG002|Overall Study|Non Compliant|2|||
23261162|NCT01078623|64700304|FG000|Treatment Period 1|Adverse Event|1|||
23261163|NCT01078623|64700305|FG001|Treatment Period 1|Adverse Event|1|||
23261164|NCT01078623|64700306|FG002|Treatment Period 1|Adverse Event|1|||
23261165|NCT01078623|64700307|FG003|Treatment Period 1|Adverse Event|0|||
23261166|NCT01078623|64700308|FG004|Treatment Period 1|Adverse Event|0|||
23261167|NCT01078623|64700309|FG005|Treatment Period 1|Adverse Event|0|||
23261168|NCT01078623|64700310|FG006|Treatment Period 1|Adverse Event|1|||
23261169|NCT01078623|64700311|FG007|Treatment Period 1|Adverse Event|0|||
23261170|NCT01078623|64700312|FG008|Treatment Period 1|Adverse Event|1|||
23261171|NCT01078623|64700313|FG009|Treatment Period 1|Adverse Event|1|||
23261172|NCT01078623|64700314|FG010|Treatment Period 1|Adverse Event|0|||
23261173|NCT01078623|64700315|FG011|Treatment Period 1|Adverse Event|0|||
23261174|NCT01078623|64700316|FG012|Treatment Period 1|Adverse Event|0|||
23261175|NCT01078623|64700317|FG013|Treatment Period 1|Adverse Event|0|||
23361487|NCT00536510|65069696|FG001|Overall Study|Flushing with Product|0|||
23361488|NCT00536510|65069695|FG000|Overall Study|Laboratory Adverse Event|2|||
23361489|NCT00536510|65069696|FG001|Overall Study|Laboratory Adverse Event|1|||
23361490|NCT00536510|65069695|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
23261176|NCT01078623|64700318|FG014|Treatment Period 1|Adverse Event|0|||
23261177|NCT01078623|64700319|FG015|Treatment Period 1|Adverse Event|0|||
23261178|NCT01078623|64700320|FG016|Treatment Period 1|Adverse Event|0|||
23261179|NCT01078623|64700321|FG017|Treatment Period 1|Adverse Event|0|||
23261180|NCT01078623|64700322|FG018|Treatment Period 1|Adverse Event|0|||
23261181|NCT01078623|64700323|FG019|Treatment Period 1|Adverse Event|0|||
23261182|NCT01078623|64700304|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23261183|NCT01078623|64700305|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23261184|NCT01078623|64700306|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23261185|NCT01078623|64700307|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23261186|NCT01078623|64700308|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23261187|NCT01078623|64700309|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23261188|NCT01078623|64700310|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23261189|NCT01078623|64700311|FG007|Treatment Period 1|Withdrawal by Subject|1|||
23261190|NCT01078623|64700312|FG008|Treatment Period 1|Withdrawal by Subject|0|||
23261191|NCT01078623|64700313|FG009|Treatment Period 1|Withdrawal by Subject|0|||
23261192|NCT01078623|64700314|FG010|Treatment Period 1|Withdrawal by Subject|1|||
23261193|NCT01078623|64700315|FG011|Treatment Period 1|Withdrawal by Subject|0|||
23261194|NCT01078623|64700316|FG012|Treatment Period 1|Withdrawal by Subject|0|||
23261195|NCT01078623|64700317|FG013|Treatment Period 1|Withdrawal by Subject|0|||
23261196|NCT01078623|64700318|FG014|Treatment Period 1|Withdrawal by Subject|0|||
23261197|NCT01078623|64700319|FG015|Treatment Period 1|Withdrawal by Subject|0|||
23261198|NCT01078623|64700320|FG016|Treatment Period 1|Withdrawal by Subject|0|||
23261199|NCT01078623|64700321|FG017|Treatment Period 1|Withdrawal by Subject|0|||
23261200|NCT01078623|64700322|FG018|Treatment Period 1|Withdrawal by Subject|0|||
23261201|NCT01078623|64700323|FG019|Treatment Period 1|Withdrawal by Subject|0|||
23261202|NCT01078623|64700304|FG000|Treatment Period 1|Protocol Violation|0|||
23261203|NCT01078623|64700305|FG001|Treatment Period 1|Protocol Violation|0|||
23261204|NCT01078623|64700306|FG002|Treatment Period 1|Protocol Violation|0|||
23261205|NCT01078623|64700307|FG003|Treatment Period 1|Protocol Violation|0|||
23261206|NCT01078623|64700308|FG004|Treatment Period 1|Protocol Violation|0|||
23261207|NCT01078623|64700309|FG005|Treatment Period 1|Protocol Violation|1|||
23261208|NCT01078623|64700310|FG006|Treatment Period 1|Protocol Violation|0|||
23261209|NCT01078623|64700311|FG007|Treatment Period 1|Protocol Violation|0|||
23261210|NCT01078623|64700312|FG008|Treatment Period 1|Protocol Violation|0|||
23261211|NCT01078623|64700313|FG009|Treatment Period 1|Protocol Violation|0|||
23261212|NCT01078623|64700314|FG010|Treatment Period 1|Protocol Violation|0|||
23261213|NCT01078623|64700315|FG011|Treatment Period 1|Protocol Violation|0|||
23261214|NCT01078623|64700316|FG012|Treatment Period 1|Protocol Violation|0|||
23261215|NCT01078623|64700317|FG013|Treatment Period 1|Protocol Violation|0|||
23261216|NCT01078623|64700318|FG014|Treatment Period 1|Protocol Violation|0|||
23261217|NCT01078623|64700319|FG015|Treatment Period 1|Protocol Violation|0|||
23261218|NCT01078623|64700320|FG016|Treatment Period 1|Protocol Violation|0|||
23261219|NCT01078623|64700321|FG017|Treatment Period 1|Protocol Violation|0|||
23261220|NCT01078623|64700322|FG018|Treatment Period 1|Protocol Violation|0|||
23261221|NCT01078623|64700323|FG019|Treatment Period 1|Protocol Violation|0|||
23261222|NCT01078623|64700304|FG000|Treatment Period 2|Adverse Event|0|||
23261223|NCT01078623|64700305|FG001|Treatment Period 2|Adverse Event|0|||
23261224|NCT01078623|64700306|FG002|Treatment Period 2|Adverse Event|0|||
23261225|NCT01078623|64700307|FG003|Treatment Period 2|Adverse Event|0|||
23261226|NCT01078623|64700308|FG004|Treatment Period 2|Adverse Event|0|||
23261227|NCT01078623|64700309|FG005|Treatment Period 2|Adverse Event|0|||
23261228|NCT01078623|64700310|FG006|Treatment Period 2|Adverse Event|1|||
23261229|NCT01078623|64700311|FG007|Treatment Period 2|Adverse Event|0|||
23261230|NCT01078623|64700312|FG008|Treatment Period 2|Adverse Event|0|||
23261231|NCT01078623|64700313|FG009|Treatment Period 2|Adverse Event|0|||
23261232|NCT01078623|64700314|FG010|Treatment Period 2|Adverse Event|0|||
23261233|NCT01078623|64700315|FG011|Treatment Period 2|Adverse Event|0|||
23261234|NCT01078623|64700316|FG012|Treatment Period 2|Adverse Event|0|||
23261235|NCT01078623|64700317|FG013|Treatment Period 2|Adverse Event|0|||
23261236|NCT01078623|64700318|FG014|Treatment Period 2|Adverse Event|0|||
23261237|NCT01078623|64700319|FG015|Treatment Period 2|Adverse Event|0|||
23261238|NCT01078623|64700320|FG016|Treatment Period 2|Adverse Event|0|||
23361491|NCT00536510|65069696|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
23261239|NCT01078623|64700321|FG017|Treatment Period 2|Adverse Event|0|||
23261240|NCT01078623|64700322|FG018|Treatment Period 2|Adverse Event|1|||
23261241|NCT01078623|64700323|FG019|Treatment Period 2|Adverse Event|0|||
23261242|NCT01078623|64700304|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23261243|NCT01078623|64700305|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23261244|NCT01078623|64700306|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23261245|NCT01078623|64700307|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23261246|NCT01078623|64700308|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23261247|NCT01078623|64700309|FG005|Treatment Period 2|Withdrawal by Subject|1|||
23261248|NCT01078623|64700310|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23261249|NCT01078623|64700311|FG007|Treatment Period 2|Withdrawal by Subject|0|||
23261250|NCT01078623|64700312|FG008|Treatment Period 2|Withdrawal by Subject|0|||
23261251|NCT01078623|64700313|FG009|Treatment Period 2|Withdrawal by Subject|0|||
23261252|NCT01078623|64700314|FG010|Treatment Period 2|Withdrawal by Subject|0|||
23261253|NCT01078623|64700315|FG011|Treatment Period 2|Withdrawal by Subject|0|||
23261254|NCT01078623|64700316|FG012|Treatment Period 2|Withdrawal by Subject|0|||
23261255|NCT01078623|64700317|FG013|Treatment Period 2|Withdrawal by Subject|0|||
23261256|NCT01078623|64700318|FG014|Treatment Period 2|Withdrawal by Subject|0|||
23261257|NCT01078623|64700319|FG015|Treatment Period 2|Withdrawal by Subject|0|||
23261258|NCT01078623|64700320|FG016|Treatment Period 2|Withdrawal by Subject|0|||
23261259|NCT01078623|64700321|FG017|Treatment Period 2|Withdrawal by Subject|0|||
23261260|NCT01078623|64700322|FG018|Treatment Period 2|Withdrawal by Subject|0|||
23261261|NCT01078623|64700323|FG019|Treatment Period 2|Withdrawal by Subject|0|||
23261262|NCT01078623|64700304|FG000|Treatment Period 3|Adverse Event|0|||
23261263|NCT01078623|64700305|FG001|Treatment Period 3|Adverse Event|0|||
23261264|NCT01078623|64700306|FG002|Treatment Period 3|Adverse Event|0|||
23261265|NCT01078623|64700307|FG003|Treatment Period 3|Adverse Event|0|||
23261266|NCT01078623|64700308|FG004|Treatment Period 3|Adverse Event|1|||
23261267|NCT01078623|64700309|FG005|Treatment Period 3|Adverse Event|0|||
23261268|NCT01078623|64700310|FG006|Treatment Period 3|Adverse Event|0|||
23261269|NCT01078623|64700311|FG007|Treatment Period 3|Adverse Event|0|||
23261270|NCT01078623|64700312|FG008|Treatment Period 3|Adverse Event|0|||
23261271|NCT01078623|64700313|FG009|Treatment Period 3|Adverse Event|0|||
23261272|NCT01078623|64700314|FG010|Treatment Period 3|Adverse Event|0|||
23261273|NCT01078623|64700315|FG011|Treatment Period 3|Adverse Event|0|||
23261274|NCT01078623|64700316|FG012|Treatment Period 3|Adverse Event|0|||
23261275|NCT01078623|64700317|FG013|Treatment Period 3|Adverse Event|1|||
23261276|NCT01078623|64700318|FG014|Treatment Period 3|Adverse Event|0|||
23261277|NCT01078623|64700319|FG015|Treatment Period 3|Adverse Event|0|||
23261278|NCT01078623|64700320|FG016|Treatment Period 3|Adverse Event|0|||
23261279|NCT01078623|64700321|FG017|Treatment Period 3|Adverse Event|0|||
23261280|NCT01078623|64700322|FG018|Treatment Period 3|Adverse Event|0|||
23261281|NCT01078623|64700323|FG019|Treatment Period 3|Adverse Event|0|||
23261282|NCT01078623|64700304|FG000|Treatment Period 4|Adverse Event|0|||
23261283|NCT01078623|64700305|FG001|Treatment Period 4|Adverse Event|0|||
23261284|NCT01078623|64700306|FG002|Treatment Period 4|Adverse Event|1|||
23261285|NCT01078623|64700307|FG003|Treatment Period 4|Adverse Event|0|||
23261286|NCT01078623|64700308|FG004|Treatment Period 4|Adverse Event|0|||
23261287|NCT01078623|64700309|FG005|Treatment Period 4|Adverse Event|0|||
23261288|NCT01078623|64700310|FG006|Treatment Period 4|Adverse Event|0|||
23261289|NCT01078623|64700311|FG007|Treatment Period 4|Adverse Event|0|||
23261290|NCT01078623|64700312|FG008|Treatment Period 4|Adverse Event|0|||
23261291|NCT01078623|64700313|FG009|Treatment Period 4|Adverse Event|0|||
23261292|NCT01078623|64700314|FG010|Treatment Period 4|Adverse Event|0|||
23261293|NCT01078623|64700315|FG011|Treatment Period 4|Adverse Event|0|||
23261294|NCT01078623|64700316|FG012|Treatment Period 4|Adverse Event|0|||
23261295|NCT01078623|64700317|FG013|Treatment Period 4|Adverse Event|0|||
23261296|NCT01078623|64700318|FG014|Treatment Period 4|Adverse Event|0|||
23261297|NCT01078623|64700319|FG015|Treatment Period 4|Adverse Event|0|||
23261298|NCT01078623|64700320|FG016|Treatment Period 4|Adverse Event|0|||
23261299|NCT01078623|64700321|FG017|Treatment Period 4|Adverse Event|0|||
23261300|NCT01078623|64700322|FG018|Treatment Period 4|Adverse Event|0|||
23261301|NCT01078623|64700323|FG019|Treatment Period 4|Adverse Event|0|||
23261302|NCT01078623|64700304|FG000|Treatment Period 4|Withdrawal by Subject|0|||
23261303|NCT01078623|64700305|FG001|Treatment Period 4|Withdrawal by Subject|0|||
23261304|NCT01078623|64700306|FG002|Treatment Period 4|Withdrawal by Subject|0|||
23261305|NCT01078623|64700307|FG003|Treatment Period 4|Withdrawal by Subject|0|||
23261306|NCT01078623|64700308|FG004|Treatment Period 4|Withdrawal by Subject|0|||
23261307|NCT01078623|64700309|FG005|Treatment Period 4|Withdrawal by Subject|0|||
23261308|NCT01078623|64700310|FG006|Treatment Period 4|Withdrawal by Subject|0|||
23261309|NCT01078623|64700311|FG007|Treatment Period 4|Withdrawal by Subject|0|||
23261310|NCT01078623|64700312|FG008|Treatment Period 4|Withdrawal by Subject|0|||
23261311|NCT01078623|64700313|FG009|Treatment Period 4|Withdrawal by Subject|0|||
23261312|NCT01078623|64700314|FG010|Treatment Period 4|Withdrawal by Subject|0|||
23261313|NCT01078623|64700315|FG011|Treatment Period 4|Withdrawal by Subject|0|||
23261314|NCT01078623|64700316|FG012|Treatment Period 4|Withdrawal by Subject|0|||
23261315|NCT01078623|64700317|FG013|Treatment Period 4|Withdrawal by Subject|0|||
23261316|NCT01078623|64700318|FG014|Treatment Period 4|Withdrawal by Subject|0|||
23261317|NCT01078623|64700319|FG015|Treatment Period 4|Withdrawal by Subject|1|||
23261318|NCT01078623|64700320|FG016|Treatment Period 4|Withdrawal by Subject|0|||
23261319|NCT01078623|64700321|FG017|Treatment Period 4|Withdrawal by Subject|0|||
23261320|NCT01078623|64700322|FG018|Treatment Period 4|Withdrawal by Subject|0|||
23261321|NCT01078623|64700323|FG019|Treatment Period 4|Withdrawal by Subject|0|||
23200560|NCT01341652|64473424|FG000|Overall Study|ineligible; presence metastatic disease|0|||
23261322|NCT00952484|64700327|FG000|Overall Study|Withdrawal by Subject|0|||
23261323|NCT00952484|64700328|FG001|Overall Study|Withdrawal by Subject|1|||
23261324|NCT00952484|64700329|FG002|Overall Study|Withdrawal by Subject|0|||
23261325|NCT02614703|64700330|FG000|Overall Study|Withdrawal by Subject|7|||
23261326|NCT02614703|64700331|FG001|Overall Study|Withdrawal by Subject|1|||
23261327|NCT02473510|64700337|FG000|Overall Study|Lost to Follow-up|1|||
23261328|NCT02473510|64700338|FG001|Overall Study|Lost to Follow-up|2|||
23261329|NCT00829413|64700339|FG000|Overall Study|No study drug admimnistered|13|||
23261330|NCT00829413|64700339|FG000|Overall Study|Training Patients|67|||
23261331|NCT00829413|64700339|FG000|Overall Study|No truth standard procedure available|9|||
23261332|NCT00829413|64700339|FG000|Overall Study|Technically inadequate truth standard|2|||
23261333|NCT00829413|64700339|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
23261334|NCT01579474|64700343|FG000|Overall Study|Adverse Event|1|||
23261335|NCT01579474|64700344|FG001|Overall Study|Adverse Event|13|||
23261336|NCT01579474|64700345|FG002|Overall Study|Adverse Event|2|||
23261337|NCT01579474|64700346|FG003|Overall Study|Adverse Event|0|||
23261338|NCT01579474|64700347|FG004|Overall Study|Adverse Event|0|||
23261339|NCT01579474|64700348|FG005|Overall Study|Adverse Event|1|||
23261340|NCT01579474|64700343|FG000|Overall Study|Lack of Efficacy|1|||
23261341|NCT01579474|64700344|FG001|Overall Study|Lack of Efficacy|0|||
23261342|NCT01579474|64700345|FG002|Overall Study|Lack of Efficacy|0|||
23261343|NCT01579474|64700346|FG003|Overall Study|Lack of Efficacy|0|||
23261344|NCT01579474|64700347|FG004|Overall Study|Lack of Efficacy|1|||
23361492|NCT02998151|65069697|FG000|Overall Study|Withdrawal by Subject|3|||
23361493|NCT02998151|65069697|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
23361494|NCT02998151|65069697|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
23361495|NCT04878055|65069703|FG000|Overall Study|Patient transferred in another department|0|||
23361496|NCT04878055|65069704|FG001|Overall Study|Patient transferred in another department|2|||
23361497|NCT04878055|65069703|FG000|Overall Study|Physician Decision|1|||
23361498|NCT04878055|65069704|FG001|Overall Study|Physician Decision|1|||
23361499|NCT04878055|65069703|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
23361500|NCT04878055|65069704|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
23361501|NCT04878055|65069703|FG000|Overall Study|Adverse Event|12|||
23361502|NCT04878055|65069704|FG001|Overall Study|Adverse Event|7|||
23361503|NCT04878055|65069703|FG000|Overall Study|Other|5|||
23361504|NCT04878055|65069704|FG001|Overall Study|Other|0|||
23361505|NCT04878055|65069703|FG000|Overall Study|Withdrawal by Subject|7|||
23361506|NCT04878055|65069704|FG001|Overall Study|Withdrawal by Subject|3|||
23361507|NCT04878055|65069703|FG000|Overall Study|Lost to Follow-up|10|||
23361508|NCT04878055|65069704|FG001|Overall Study|Lost to Follow-up|1|||
23361509|NCT02207400|65069705|FG000|Overall Study|Adverse Event|1|||
23200561|NCT01341652|64473425|FG001|Overall Study|ineligible; presence metastatic disease|1|||
23200562|NCT01856595|64473426|FG000|Overall Study|Withdrawal by Subject|0|||
23200563|NCT01856595|64473427|FG001|Overall Study|Withdrawal by Subject|1|||
23200564|NCT01856595|64473428|FG002|Overall Study|Withdrawal by Subject|0|||
23200565|NCT01856595|64473429|FG003|Overall Study|Withdrawal by Subject|0|||
23200566|NCT01856595|64473430|FG004|Overall Study|Withdrawal by Subject|0|||
23200567|NCT01856595|64473431|FG005|Overall Study|Withdrawal by Subject|0|||
23200568|NCT01856595|64473432|FG006|Overall Study|Withdrawal by Subject|1|||
23200569|NCT01856595|64473433|FG007|Overall Study|Withdrawal by Subject|0|||
23200570|NCT01856595|64473434|FG008|Overall Study|Withdrawal by Subject|0|||
23200571|NCT03744676|64473435|FG000|Pre-Treatment Phase|Death|7|||
23200572|NCT03744676|64473435|FG000|Pre-Treatment Phase|Disease related complications|2|||
23200573|NCT03744676|64473435|FG000|Pre-Treatment Phase|No longer meets eligibility criteria for other reasons|4|||
23200574|NCT03744676|64473435|FG000|Pre-Treatment Phase|Other reasons|8|||
23200575|NCT03744676|64473435|FG000|Treatment Phase|Ongoing in study|18|||
23200576|NCT03744676|64473435|FG000|Treatment Phase|Death|31|||
23200577|NCT03744676|64473435|FG000|Treatment Phase|Withdrawal of consent|8|||
23200578|NCT03744676|64473435|FG000|Treatment Phase|Other reasons|6|||
23200579|NCT05373706|64473436|FG000|Overall Study|Lost to Follow-up|2|||
23200580|NCT05373706|64473437|FG001|Overall Study|Lost to Follow-up|2|||
23200581|NCT03807739|64473438|FG000|Overall Study|Adverse Event|1|||
23200582|NCT03807739|64473439|FG001|Overall Study|Adverse Event|0|||
23261345|NCT01579474|64700348|FG005|Overall Study|Lack of Efficacy|0|||
23361510|NCT02207400|65069706|FG001|Overall Study|Adverse Event|1|||
23361511|NCT02207400|65069705|FG000|Overall Study|Lost to Follow-up|6|||
23361512|NCT02207400|65069706|FG001|Overall Study|Lost to Follow-up|7|||
23361513|NCT02207400|65069705|FG000|Overall Study|Protocol Violation|1|||
23200583|NCT03807739|64473440|FG002|Overall Study|Adverse Event|0|||
23200584|NCT03807739|64473441|FG003|Overall Study|Adverse Event|0|||
23200585|NCT03807739|64473438|FG000|Overall Study|Withdrawal by Subject|1|||
23200586|NCT03807739|64473439|FG001|Overall Study|Withdrawal by Subject|0|||
23200587|NCT03807739|64473440|FG002|Overall Study|Withdrawal by Subject|0|||
23261346|NCT01579474|64700343|FG000|Overall Study|Withdrawal by Subject|1|||
23261347|NCT01579474|64700344|FG001|Overall Study|Withdrawal by Subject|0|||
23261348|NCT01579474|64700345|FG002|Overall Study|Withdrawal by Subject|0|||
23261349|NCT01579474|64700346|FG003|Overall Study|Withdrawal by Subject|0|||
23261350|NCT01579474|64700347|FG004|Overall Study|Withdrawal by Subject|0|||
23261351|NCT01579474|64700348|FG005|Overall Study|Withdrawal by Subject|0|||
23261352|NCT01336894|64700352|FG000|Follow-up|Study terminated prematurely|2|||
23261353|NCT01336894|64700353|FG001|Follow-up|Study terminated prematurely|7|||
23261354|NCT02688400|64700354|FG000|Overall Study|Protocol Violation|2|||
23261355|NCT02688400|64700355|FG001|Overall Study|Protocol Violation|5|||
23261356|NCT02688400|64700354|FG000|Overall Study|Lack of Efficacy|7|||
23261357|NCT02688400|64700355|FG001|Overall Study|Lack of Efficacy|7|||
23261358|NCT02688400|64700354|FG000|Overall Study|Adverse Event|21|||
23261359|NCT02688400|64700355|FG001|Overall Study|Adverse Event|12|||
23261360|NCT02688400|64700354|FG000|Overall Study|Withdrawal by Subject|15|||
23261361|NCT02688400|64700355|FG001|Overall Study|Withdrawal by Subject|13|||
23261362|NCT02688400|64700354|FG000|Overall Study|No study medication intake|1|||
23261363|NCT02688400|64700355|FG001|Overall Study|No study medication intake|4|||
23261364|NCT02688400|64700354|FG000|Overall Study|Lost to Follow-up|0|||
23261365|NCT02688400|64700355|FG001|Overall Study|Lost to Follow-up|3|||
23261366|NCT01415921|64700363|FG000|Overall Study|Adverse Event|0|||
23261367|NCT01415921|64700364|FG001|Overall Study|Adverse Event|1|||
23261368|NCT01415921|64700363|FG000|Overall Study|Physician Decision|1|||
23261369|NCT01415921|64700364|FG001|Overall Study|Physician Decision|1|||
23261370|NCT01415921|64700363|FG000|Overall Study|Withdrawal by Subject|0|||
23261371|NCT01415921|64700364|FG001|Overall Study|Withdrawal by Subject|1|||
23261372|NCT01415921|64700363|FG000|Overall Study|Other|2|||
23261373|NCT01415921|64700364|FG001|Overall Study|Other|0|||
23261374|NCT02784106|64700365|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
23261375|NCT02784106|64700366|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
23261376|NCT02784106|64700367|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
23261377|NCT02784106|64700368|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
23261378|NCT02784106|64700365|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
23261379|NCT02784106|64700366|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
23261380|NCT02784106|64700367|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23261381|NCT02784106|64700368|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23261382|NCT02784106|64700365|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
23261383|NCT02784106|64700366|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
23261384|NCT02784106|64700367|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
23261385|NCT02784106|64700368|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
23261386|NCT02784106|64700365|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
23261387|NCT02784106|64700366|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23261388|NCT02784106|64700367|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23261389|NCT02784106|64700368|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23261390|NCT02784106|64700365|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
23261391|NCT02784106|64700366|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
23261392|NCT02784106|64700367|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
23261393|NCT02784106|64700368|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
23261394|NCT02784106|64700365|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
23261395|NCT02784106|64700366|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
23261396|NCT02784106|64700367|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
23261397|NCT02784106|64700368|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
23261398|NCT02672553|64700369|FG000|Overall Study|Death|3|||
23361514|NCT02207400|65069706|FG001|Overall Study|Protocol Violation|1|||
23261399|NCT02672553|64700370|FG001|Overall Study|Death|5|||
23600634|NCT01555138|65929688|FG001|Overall Study|Adverse Event|14|||
23200588|NCT03807739|64473441|FG003|Overall Study|Withdrawal by Subject|0|||
23261400|NCT02672553|64700369|FG000|Overall Study|Valve Explant|1|||
23261401|NCT02672553|64700370|FG001|Overall Study|Valve Explant|0|||
23261402|NCT02672553|64700369|FG000|Overall Study|Conversion to Commercial Valve|3|||
23261403|NCT02672553|64700370|FG001|Overall Study|Conversion to Commercial Valve|0|||
23261404|NCT02672553|64700369|FG000|Overall Study|Withdrawal by Subject|3|||
23261405|NCT02672553|64700370|FG001|Overall Study|Withdrawal by Subject|3|||
23261406|NCT02672553|64700369|FG000|Overall Study|Intraoperative screen failure|2|||
23261407|NCT02672553|64700370|FG001|Overall Study|Intraoperative screen failure|0|||
23261408|NCT01508936|64700371|FG000|Overall Study|Adverse Event|11|||
23261409|NCT01508936|64700372|FG001|Overall Study|Adverse Event|32|||
23261410|NCT01508936|64700371|FG000|Overall Study|Lack of Efficacy|0|||
23261411|NCT01508936|64700372|FG001|Overall Study|Lack of Efficacy|1|||
23261412|NCT01508936|64700371|FG000|Overall Study|Withdrawal by Subject|4|||
23261413|NCT01508936|64700372|FG001|Overall Study|Withdrawal by Subject|18|||
23261414|NCT01508936|64700371|FG000|Overall Study|Protocol Violation|2|||
23261415|NCT01508936|64700372|FG001|Overall Study|Protocol Violation|3|||
23261416|NCT01508936|64700371|FG000|Overall Study|Lost to Follow-up|2|||
23261417|NCT01508936|64700372|FG001|Overall Study|Lost to Follow-up|9|||
23261418|NCT01508936|64700371|FG000|Overall Study|Other|0|||
23261419|NCT01508936|64700372|FG001|Overall Study|Other|5|||
23261420|NCT01508936|64700371|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
23261421|NCT01508936|64700372|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
23261422|NCT01725113|64700373|FG000|Overall Study|Kidney Transplant|1|||
23261423|NCT01725113|64700374|FG001|Overall Study|Kidney Transplant|1|||
23261424|NCT01725113|64700373|FG000|Overall Study|Withdrawal by Subject|0|||
23261425|NCT01725113|64700374|FG001|Overall Study|Withdrawal by Subject|1|||
23261426|NCT01894984|64700375|FG000|Overall Study|Other|314|||
23261427|NCT01894984|64700376|FG001|Overall Study|Other|175|||
23261428|NCT02660242|64700382|FG000|Glucose Tabs|Lost to Follow-up|1|||
23261429|NCT02660242|64700382|FG000|Glucagon Injection|Lost to Follow-up|1|||
23361515|NCT02207400|65069705|FG000|Overall Study|Withdrawal by Subject|8|||
23361516|NCT02207400|65069706|FG001|Overall Study|Withdrawal by Subject|4|||
23361517|NCT02207400|65069705|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
23261430|NCT01047345|64700383|FG000|Base Study|Adverse Event|3|||
23261431|NCT01047345|64700384|FG001|Base Study|Adverse Event|0|||
23261432|NCT01047345|64700385|FG002|Base Study|Adverse Event|0|||
23261433|NCT01047345|64700383|FG000|Base Study|Lost to Follow-up|4|||
23361518|NCT02207400|65069706|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
23261434|NCT01047345|64700384|FG001|Base Study|Lost to Follow-up|1|||
23261435|NCT01047345|64700385|FG002|Base Study|Lost to Follow-up|0|||
23261436|NCT01047345|64700383|FG000|Base Study|Protocol Violation|3|||
23261437|NCT01047345|64700384|FG001|Base Study|Protocol Violation|1|||
23261438|NCT01047345|64700385|FG002|Base Study|Protocol Violation|0|||
23261439|NCT01047345|64700383|FG000|Base Study|Withdrawal by Subject|12|||
23261440|NCT01047345|64700384|FG001|Base Study|Withdrawal by Subject|4|||
23261441|NCT01047345|64700385|FG002|Base Study|Withdrawal by Subject|0|||
23261442|NCT01047345|64700383|FG000|Extension|Withdrawal by Subject|0|||
23261443|NCT01047345|64700384|FG001|Extension|Withdrawal by Subject|0|||
23261444|NCT01047345|64700385|FG002|Extension|Withdrawal by Subject|1|||
23261445|NCT01047345|64700383|FG000|Extension|Lost to Follow-up|0|||
23261446|NCT01047345|64700384|FG001|Extension|Lost to Follow-up|0|||
23261447|NCT01047345|64700385|FG002|Extension|Lost to Follow-up|5|||
23261448|NCT04120194|64700386|FG000|Overall Study|Lost to Follow-up|11|||
23261449|NCT04120194|64700387|FG001|Overall Study|Lost to Follow-up|8|||
23261450|NCT04120194|64700386|FG000|Overall Study|Adverse Event|4|||
23261451|NCT04120194|64700387|FG001|Overall Study|Adverse Event|5|||
23261452|NCT04120194|64700386|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
23261453|NCT04120194|64700387|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
23261454|NCT04120194|64700386|FG000|Overall Study|Miscellaneous|4|||
23261455|NCT04120194|64700387|FG001|Overall Study|Miscellaneous|5|||
23261456|NCT02637557|64700395|FG000|Overall Study|Adverse Event|3|||
23261457|NCT02637557|64700396|FG001|Overall Study|Adverse Event|1|||
23261458|NCT02637557|64700397|FG002|Overall Study|Adverse Event|3|||
23261459|NCT02637557|64700398|FG003|Overall Study|Adverse Event|3|||
23261460|NCT02637557|64700395|FG000|Overall Study|Lost to Follow-up|1|||
23261461|NCT02637557|64700396|FG001|Overall Study|Lost to Follow-up|1|||
23261462|NCT02637557|64700397|FG002|Overall Study|Lost to Follow-up|0|||
23261463|NCT02637557|64700398|FG003|Overall Study|Lost to Follow-up|1|||
23261464|NCT02637557|64700395|FG000|Overall Study|Physician Decision|1|||
23261465|NCT02637557|64700396|FG001|Overall Study|Physician Decision|0|||
23600635|NCT02740231|65929689|FG000|Overall Study|Withdrawal by Subject|1|||
23600636|NCT02740231|65929690|FG001|Overall Study|Withdrawal by Subject|1|||
23600637|NCT02740231|65929691|FG002|Overall Study|Withdrawal by Subject|1|||
23600638|NCT02740231|65929692|FG003|Overall Study|Withdrawal by Subject|0|||
23600639|NCT02740231|65929689|FG000|Overall Study|Lack of Efficacy|0|||
23600640|NCT02740231|65929690|FG001|Overall Study|Lack of Efficacy|1|||
23600641|NCT02740231|65929691|FG002|Overall Study|Lack of Efficacy|0|||
23600642|NCT02740231|65929692|FG003|Overall Study|Lack of Efficacy|4|||
23600643|NCT02740231|65929689|FG000|Overall Study|Lost to Follow-up|1|||
23600644|NCT02740231|65929690|FG001|Overall Study|Lost to Follow-up|3|||
23600645|NCT02740231|65929691|FG002|Overall Study|Lost to Follow-up|0|||
23600646|NCT02740231|65929692|FG003|Overall Study|Lost to Follow-up|3|||
23600647|NCT02740231|65929689|FG000|Overall Study|Adverse Event|0|||
23600648|NCT02740231|65929690|FG001|Overall Study|Adverse Event|1|||
23600649|NCT02740231|65929691|FG002|Overall Study|Adverse Event|0|||
23600650|NCT02740231|65929692|FG003|Overall Study|Adverse Event|1|||
23600651|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
23600652|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
23600653|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
23600654|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
23600655|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
23600656|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
23600657|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
23261466|NCT02637557|64700397|FG002|Overall Study|Physician Decision|0|||
23261467|NCT02637557|64700398|FG003|Overall Study|Physician Decision|0|||
23261468|NCT02637557|64700395|FG000|Overall Study|Protocol Violation|2|||
23261469|NCT02637557|64700396|FG001|Overall Study|Protocol Violation|0|||
23261470|NCT02637557|64700397|FG002|Overall Study|Protocol Violation|2|||
23261471|NCT02637557|64700398|FG003|Overall Study|Protocol Violation|1|||
23261472|NCT02637557|64700395|FG000|Overall Study|Withdrawal by Subject|1|||
23261473|NCT02637557|64700396|FG001|Overall Study|Withdrawal by Subject|3|||
23600658|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
23600659|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
23261474|NCT02637557|64700397|FG002|Overall Study|Withdrawal by Subject|4|||
23261475|NCT02637557|64700398|FG003|Overall Study|Withdrawal by Subject|2|||
23261476|NCT01059071|64700399|FG000|Overall Study|Lack of Efficacy|1|||
23261477|NCT01059071|64700400|FG001|Overall Study|Lack of Efficacy|4|||
23261478|NCT01059071|64700401|FG002|Overall Study|Lack of Efficacy|2|||
23261479|NCT01059071|64700402|FG003|Overall Study|Lack of Efficacy|3|||
23261480|NCT01059071|64700399|FG000|Overall Study|Withdrawal by Subject|1|||
23261481|NCT01059071|64700400|FG001|Overall Study|Withdrawal by Subject|0|||
23261482|NCT01059071|64700401|FG002|Overall Study|Withdrawal by Subject|0|||
23261483|NCT01059071|64700402|FG003|Overall Study|Withdrawal by Subject|2|||
23261484|NCT01059071|64700399|FG000|Overall Study|Physician Decision|0|||
23261485|NCT01059071|64700400|FG001|Overall Study|Physician Decision|0|||
23261486|NCT01059071|64700401|FG002|Overall Study|Physician Decision|0|||
23261487|NCT01059071|64700402|FG003|Overall Study|Physician Decision|1|||
23261488|NCT01565083|64700407|FG000|Overall Study|Withdrawal by Subject|6|||
23261489|NCT01565083|64700408|FG001|Overall Study|Withdrawal by Subject|4|||
23261490|NCT01565083|64700407|FG000|Overall Study|Lost to Follow-up|2|||
23261491|NCT01565083|64700408|FG001|Overall Study|Lost to Follow-up|7|||
23261492|NCT01565083|64700407|FG000|Overall Study|Death|22|||
23261493|NCT01565083|64700408|FG001|Overall Study|Death|23|||
23261494|NCT01565083|64700407|FG000|Overall Study|Other|3|||
23261495|NCT01565083|64700408|FG001|Overall Study|Other|5|||
23261496|NCT00988169|64700409|FG000|Overall Study|Withdrawal by Subject|1|||
23261497|NCT02178709|64700410|FG000|Overall Study|Adverse Event|5|||
23261498|NCT02178709|64700410|FG000|Overall Study|Death|2|||
23261499|NCT02178709|64700410|FG000|Overall Study|Withdrawal by Subject|2|||
23261500|NCT02178709|64700410|FG000|Overall Study|Physician Decision|2|||
23261501|NCT02178709|64700410|FG000|Overall Study|Disease Progression|5|||
23261502|NCT01427920|64700412|FG000|Overall Study|Adverse Event|1|||
23261503|NCT01427920|64700413|FG001|Overall Study|Adverse Event|2|||
23261504|NCT01427920|64700412|FG000|Overall Study|Lack of Efficacy|1|||
23261505|NCT01427920|64700413|FG001|Overall Study|Lack of Efficacy|0|||
23261506|NCT01427920|64700412|FG000|Overall Study|Protocol Violation|1|||
23261507|NCT01427920|64700413|FG001|Overall Study|Protocol Violation|3|||
23261508|NCT01427920|64700412|FG000|Overall Study|Withdrawal Criteria|4|||
23261509|NCT01427920|64700413|FG001|Overall Study|Withdrawal Criteria|4|||
23261510|NCT01427920|64700412|FG000|Overall Study|Unclassified|2|||
23261511|NCT01427920|64700413|FG001|Overall Study|Unclassified|8|||
23261512|NCT00321711|64700414|FG000|Part A|Adverse Event|3|||
23261513|NCT00321711|64700415|FG001|Part A|Adverse Event|3|||
23261514|NCT00321711|64700416|FG002|Part A|Adverse Event|2|||
23261515|NCT00321711|64700417|FG003|Part A|Adverse Event|0|||
23261516|NCT00321711|64700418|FG004|Part A|Adverse Event|0|||
23261517|NCT00321711|64700414|FG000|Part A|Withdrawal by Subject|1|||
23261518|NCT00321711|64700415|FG001|Part A|Withdrawal by Subject|1|||
23261519|NCT00321711|64700416|FG002|Part A|Withdrawal by Subject|1|||
23261520|NCT00321711|64700417|FG003|Part A|Withdrawal by Subject|0|||
23261521|NCT00321711|64700418|FG004|Part A|Withdrawal by Subject|0|||
23261522|NCT00321711|64700414|FG000|Part A|Disease progression|0|||
23261523|NCT00321711|64700415|FG001|Part A|Disease progression|1|||
23261524|NCT00321711|64700416|FG002|Part A|Disease progression|0|||
23261525|NCT00321711|64700417|FG003|Part A|Disease progression|0|||
23261526|NCT00321711|64700418|FG004|Part A|Disease progression|0|||
23261527|NCT00321711|64700414|FG000|Part A|Requirement for alternative therapy|0|||
23261528|NCT00321711|64700415|FG001|Part A|Requirement for alternative therapy|2|||
23261529|NCT00321711|64700416|FG002|Part A|Requirement for alternative therapy|1|||
23261530|NCT00321711|64700417|FG003|Part A|Requirement for alternative therapy|0|||
23261531|NCT00321711|64700418|FG004|Part A|Requirement for alternative therapy|0|||
23261532|NCT00321711|64700414|FG000|Part A|Physician Decision|0|||
23261533|NCT00321711|64700415|FG001|Part A|Physician Decision|1|||
23261534|NCT00321711|64700416|FG002|Part A|Physician Decision|3|||
23480474|NCT04585009|65501999|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23600660|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
23261535|NCT00321711|64700417|FG003|Part A|Physician Decision|0|||
23261536|NCT00321711|64700418|FG004|Part A|Physician Decision|0|||
23261537|NCT00321711|64700414|FG000|Part A|Other|1|||
23261538|NCT00321711|64700415|FG001|Part A|Other|2|||
23261539|NCT00321711|64700416|FG002|Part A|Other|3|||
23261540|NCT00321711|64700417|FG003|Part A|Other|0|||
23261541|NCT00321711|64700418|FG004|Part A|Other|0|||
23261542|NCT00321711|64700414|FG000|Part A|Protocol deviation|0|||
23261543|NCT00321711|64700415|FG001|Part A|Protocol deviation|0|||
23261544|NCT00321711|64700416|FG002|Part A|Protocol deviation|1|||
23261545|NCT00321711|64700417|FG003|Part A|Protocol deviation|0|||
23480475|NCT04585009|65502000|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
23261546|NCT00321711|64700418|FG004|Part A|Protocol deviation|0|||
23261547|NCT00321711|64700414|FG000|Part B|Noncompliance|0|||
23261548|NCT00321711|64700415|FG001|Part B|Noncompliance|0|||
23261549|NCT00321711|64700416|FG002|Part B|Noncompliance|0|||
23261550|NCT00321711|64700417|FG003|Part B|Noncompliance|0|||
23261551|NCT00321711|64700418|FG004|Part B|Noncompliance|1|||
23261552|NCT00321711|64700414|FG000|Part B|Adverse Event|0|||
23261553|NCT00321711|64700415|FG001|Part B|Adverse Event|0|||
23261554|NCT00321711|64700416|FG002|Part B|Adverse Event|0|||
23261555|NCT00321711|64700417|FG003|Part B|Adverse Event|2|||
23361519|NCT00873730|65069707|FG000|Overall Study|Protocol Deviation|5|||
23361520|NCT00873730|65069708|FG001|Overall Study|Protocol Deviation|2|||
23361521|NCT00873730|65069707|FG000|Overall Study|Adverse Event|0|||
23361522|NCT00873730|65069708|FG001|Overall Study|Adverse Event|2|||
23361523|NCT00873730|65069707|FG000|Overall Study|Withdrawal by Subject|0|||
23361524|NCT00873730|65069708|FG001|Overall Study|Withdrawal by Subject|1|||
23361525|NCT00873730|65069707|FG000|Overall Study|Sponsor decision|1|||
23361526|NCT00873730|65069708|FG001|Overall Study|Sponsor decision|0|||
23361527|NCT01768559|65069709|FG000|Overall Study|Randomized but not treated|0|||
23361528|NCT01768559|65069710|FG001|Overall Study|Randomized but not treated|0|||
23361529|NCT01768559|65069711|FG002|Overall Study|Randomized but not treated|1|||
23361530|NCT01768559|65069709|FG000|Overall Study|Adverse Event|15|||
23361531|NCT01768559|65069710|FG001|Overall Study|Adverse Event|2|||
23361532|NCT01768559|65069711|FG002|Overall Study|Adverse Event|5|||
23361533|NCT01768559|65069709|FG000|Overall Study|Lack of Efficacy|6|||
23361534|NCT01768559|65069710|FG001|Overall Study|Lack of Efficacy|4|||
23361535|NCT01768559|65069711|FG002|Overall Study|Lack of Efficacy|0|||
23361536|NCT01768559|65069709|FG000|Overall Study|Poor compliance to protocol|0|||
23361537|NCT01768559|65069710|FG001|Overall Study|Poor compliance to protocol|3|||
23361538|NCT01768559|65069711|FG002|Overall Study|Poor compliance to protocol|2|||
23361539|NCT01768559|65069709|FG000|Overall Study|Other than specified|9|||
23361540|NCT01768559|65069710|FG001|Overall Study|Other than specified|8|||
23361541|NCT01768559|65069711|FG002|Overall Study|Other than specified|5|||
23361542|NCT00846053|65069712|FG000|Overall Study|Physician Decision|3|||
23361543|NCT00846053|65069713|FG001|Overall Study|Physician Decision|0|||
23361544|NCT02281955|65069719|FG000|Overall Study|Death|1|||
23361545|NCT03193047|65069720|FG000|Overall Study|Physician Decision|1|||
23361546|NCT03193047|65069721|FG001|Overall Study|Physician Decision|0|||
23361547|NCT03193047|65069720|FG000|Overall Study|Participant Left State|1|||
23361548|NCT03193047|65069721|FG001|Overall Study|Participant Left State|0|||
23361549|NCT00618826|65069730|FG000|Overall Study|Adverse Event|1|||
23361550|NCT01395810|65069739|FG000|Overall Study|Adverse Event|0|||
23361551|NCT01395810|65069740|FG001|Overall Study|Adverse Event|1|||
23361552|NCT01395810|65069741|FG002|Overall Study|Adverse Event|0|||
23361553|NCT01395810|65069742|FG003|Overall Study|Adverse Event|0|||
23261556|NCT00321711|64700418|FG004|Part B|Adverse Event|1|||
23261557|NCT00321711|64700414|FG000|Part B|Disease progression|0|||
23261558|NCT00321711|64700415|FG001|Part B|Disease progression|0|||
23261559|NCT00321711|64700416|FG002|Part B|Disease progression|0|||
23261560|NCT00321711|64700417|FG003|Part B|Disease progression|1|||
23261561|NCT00321711|64700418|FG004|Part B|Disease progression|0|||
23261562|NCT00321711|64700414|FG000|Part B|Physician Decision|0|||
23261563|NCT00321711|64700415|FG001|Part B|Physician Decision|0|||
23261564|NCT00321711|64700416|FG002|Part B|Physician Decision|0|||
23261565|NCT00321711|64700417|FG003|Part B|Physician Decision|1|||
23261566|NCT00321711|64700418|FG004|Part B|Physician Decision|2|||
23261567|NCT00321711|64700414|FG000|Part B|Death|0|||
23261568|NCT00321711|64700415|FG001|Part B|Death|0|||
23261569|NCT00321711|64700416|FG002|Part B|Death|0|||
23261570|NCT00321711|64700417|FG003|Part B|Death|2|||
23261571|NCT00321711|64700418|FG004|Part B|Death|1|||
23261572|NCT00814320|64700426|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
23261573|NCT00814320|64700427|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
23261574|NCT00814320|64700426|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
23261575|NCT00814320|64700427|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
23261576|NCT00814320|64700426|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
23261577|NCT00814320|64700427|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
23261578|NCT00814320|64700426|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
23261579|NCT00814320|64700427|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
23261580|NCT00814320|64700426|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
23261581|NCT00814320|64700427|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
23261582|NCT00814320|64700426|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
23261583|NCT00814320|64700427|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
23261584|NCT00814320|64700426|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
23361554|NCT01395810|65069739|FG000|Overall Study|Lack of Efficacy|0|||
23361555|NCT01395810|65069740|FG001|Overall Study|Lack of Efficacy|1|||
23361556|NCT01395810|65069741|FG002|Overall Study|Lack of Efficacy|0|||
23361557|NCT01395810|65069742|FG003|Overall Study|Lack of Efficacy|0|||
23261585|NCT00814320|64700427|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
23261586|NCT00814320|64700426|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
23261587|NCT00814320|64700427|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
23361558|NCT01395810|65069739|FG000|Overall Study|Withdrawal criteria|0|||
23361559|NCT01395810|65069740|FG001|Overall Study|Withdrawal criteria|2|||
23361560|NCT01395810|65069741|FG002|Overall Study|Withdrawal criteria|0|||
23261588|NCT00814320|64700426|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
23261589|NCT00814320|64700427|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
23261590|NCT00814320|64700426|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
23261591|NCT00814320|64700427|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
23261592|NCT03083483|64700428|FG000|Overall Study|Adverse Event|1|||
23261593|NCT03083483|64700429|FG001|Overall Study|Adverse Event|1|||
23261594|NCT03083483|64700430|FG002|Overall Study|Adverse Event|1|||
23261595|NCT03083483|64700428|FG000|Overall Study|Lost to Follow-up|2|||
23261596|NCT03083483|64700429|FG001|Overall Study|Lost to Follow-up|1|||
23261597|NCT03083483|64700430|FG002|Overall Study|Lost to Follow-up|1|||
23261598|NCT03083483|64700428|FG000|Overall Study|technological issues|1|||
23261599|NCT03083483|64700429|FG001|Overall Study|technological issues|0|||
23261600|NCT03083483|64700430|FG002|Overall Study|technological issues|1|||
23261601|NCT00745251|64700432|FG000|Overall Study|Adverse Event|1|||
23261602|NCT00745251|64700433|FG001|Overall Study|Adverse Event|2|||
23261603|NCT00745251|64700432|FG000|Overall Study|Withdrawal by Subject|1|||
23261604|NCT00745251|64700433|FG001|Overall Study|Withdrawal by Subject|1|||
23261605|NCT03072459|64700434|FG000|Overall Study|Device revised/removed|1|||
23261606|NCT03072459|64700434|FG000|Overall Study|Subject not able to return|1|||
23261607|NCT02058628|64700435|FG000|Overall Study|Adverse Event|1|||
23261608|NCT02058628|64700436|FG001|Overall Study|Adverse Event|0|||
23261609|NCT02058628|64700435|FG000|Overall Study|Withdrawal by Subject|2|||
23261610|NCT02058628|64700436|FG001|Overall Study|Withdrawal by Subject|2|||
23261611|NCT02058628|64700435|FG000|Overall Study|Lost to Follow-up|2|||
23261612|NCT02058628|64700436|FG001|Overall Study|Lost to Follow-up|4|||
23261613|NCT02058628|64700435|FG000|Overall Study|Not in time schedule|0|||
23261614|NCT02058628|64700436|FG001|Overall Study|Not in time schedule|1|||
23361561|NCT01395810|65069742|FG003|Overall Study|Withdrawal criteria|0|||
23480476|NCT04585009|65502001|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23261615|NCT02058628|64700435|FG000|Overall Study|The visit date was not in timeline|0|||
23261616|NCT02058628|64700436|FG001|Overall Study|The visit date was not in timeline|1|||
23261617|NCT02058628|64700435|FG000|Overall Study|A lot of time for study for participant|1|||
23480477|NCT04585009|65502002|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
23261618|NCT02058628|64700436|FG001|Overall Study|A lot of time for study for participant|0|||
23261619|NCT02058628|64700435|FG000|Overall Study|Non compliance|1|||
23261620|NCT02058628|64700436|FG001|Overall Study|Non compliance|0|||
23261621|NCT00669955|64700440|FG000|Overall Study|Adverse Event|3|||
23261622|NCT00669955|64700441|FG001|Overall Study|Adverse Event|5|||
23261623|NCT00669955|64700440|FG000|Overall Study|Death|0|||
23261624|NCT00669955|64700441|FG001|Overall Study|Death|1|||
23261625|NCT00669955|64700440|FG000|Overall Study|Withdrawal by Subject|2|||
23261626|NCT00669955|64700441|FG001|Overall Study|Withdrawal by Subject|3|||
23261627|NCT00669955|64700440|FG000|Overall Study|Lost to Follow-up|5|||
23261628|NCT00669955|64700441|FG001|Overall Study|Lost to Follow-up|7|||
23261629|NCT00669955|64700440|FG000|Overall Study|Protocol Violation|2|||
23261630|NCT00669955|64700441|FG001|Overall Study|Protocol Violation|7|||
23261631|NCT00669955|64700440|FG000|Overall Study|Investigator Sponsor Judgement|0|||
23261632|NCT00669955|64700441|FG001|Overall Study|Investigator Sponsor Judgement|1|||
23261633|NCT00669955|64700440|FG000|Overall Study|not compliant with study drug/visit|2|||
23261634|NCT00669955|64700441|FG001|Overall Study|not compliant with study drug/visit|3|||
23261635|NCT03465891|64700446|FG000|Overall Study|Withdrawal by Subject|0|||
23261636|NCT03465891|64700447|FG001|Overall Study|Withdrawal by Subject|1|||
23261637|NCT03465891|64700446|FG000|Overall Study|Disease progression|1|||
23261638|NCT03465891|64700447|FG001|Overall Study|Disease progression|0|||
23261639|NCT00982410|64700449|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
23261640|NCT00982410|64700450|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
23261641|NCT00982410|64700449|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
23261642|NCT00982410|64700450|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
23261643|NCT00982410|64700449|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
23261644|NCT00982410|64700450|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
23261645|NCT00982410|64700449|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
23261646|NCT00982410|64700450|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
23261647|NCT00982410|64700449|FG000|6-month Follow-up Assessment|participant no transportation|1|||
23261648|NCT00982410|64700450|FG001|6-month Follow-up Assessment|participant no transportation|0|||
23261649|NCT00982410|64700449|FG000|6-month Follow-up Assessment|incarceration|0|||
23261650|NCT00982410|64700450|FG001|6-month Follow-up Assessment|incarceration|2|||
23261651|NCT00982410|64700449|FG000|6-month Follow-up Assessment|patent surgery|0|||
23261652|NCT00982410|64700450|FG001|6-month Follow-up Assessment|patent surgery|1|||
23261653|NCT00982410|64700449|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
23261654|NCT00982410|64700450|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
23261655|NCT00982410|64700449|FG000|12-month Follow-up Assessment|Death|0|||
23261656|NCT00982410|64700450|FG001|12-month Follow-up Assessment|Death|2|||
23261657|NCT00982410|64700449|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
23261658|NCT00982410|64700450|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
23261659|NCT00982410|64700449|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
23261660|NCT00982410|64700450|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
23261661|NCT00982410|64700449|FG000|12-month Follow-up Assessment|incarceration|2|||
23261662|NCT00982410|64700450|FG001|12-month Follow-up Assessment|incarceration|1|||
23261663|NCT00982410|64700449|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
23261664|NCT00982410|64700450|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
23261665|NCT02207621|64700451|FG000|Overall Study|Adverse Event|71|||
23261666|NCT02207621|64700452|FG001|Overall Study|Adverse Event|15|||
23261667|NCT02207621|64700453|FG002|Overall Study|Adverse Event|132|||
23261668|NCT02207621|64700451|FG000|Overall Study|Withdrawal by Subject|9|||
23261669|NCT02207621|64700452|FG001|Overall Study|Withdrawal by Subject|9|||
23261670|NCT02207621|64700453|FG002|Overall Study|Withdrawal by Subject|13|||
23261671|NCT02207621|64700451|FG000|Overall Study|Non-Compliant|3|||
23261672|NCT02207621|64700452|FG001|Overall Study|Non-Compliant|3|||
23261673|NCT02207621|64700453|FG002|Overall Study|Non-Compliant|1|||
23261674|NCT02207621|64700451|FG000|Overall Study|Lost to Follow-up|1|||
23261675|NCT02207621|64700452|FG001|Overall Study|Lost to Follow-up|0|||
23261676|NCT02207621|64700453|FG002|Overall Study|Lost to Follow-up|3|||
23261677|NCT02207621|64700451|FG000|Overall Study|Lack of Efficacy|10|||
23261678|NCT02207621|64700452|FG001|Overall Study|Lack of Efficacy|2|||
23261679|NCT02207621|64700453|FG002|Overall Study|Lack of Efficacy|4|||
23261680|NCT02207621|64700451|FG000|Overall Study|Disallowed Concurrent Medication|2|||
23600661|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
23261681|NCT02207621|64700452|FG001|Overall Study|Disallowed Concurrent Medication|5|||
23261682|NCT02207621|64700453|FG002|Overall Study|Disallowed Concurrent Medication|2|||
23261683|NCT02207621|64700451|FG000|Overall Study|Physician Decision|1|||
23261684|NCT02207621|64700452|FG001|Overall Study|Physician Decision|2|||
23261685|NCT02207621|64700453|FG002|Overall Study|Physician Decision|2|||
23261686|NCT02207621|64700451|FG000|Overall Study|Protocol Violation|4|||
23600662|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
23261687|NCT02207621|64700452|FG001|Overall Study|Protocol Violation|10|||
23261688|NCT02207621|64700453|FG002|Overall Study|Protocol Violation|6|||
23261689|NCT02207621|64700451|FG000|Overall Study|Death|2|||
23261690|NCT02207621|64700452|FG001|Overall Study|Death|0|||
23261691|NCT02207621|64700453|FG002|Overall Study|Death|0|||
23261692|NCT02207621|64700451|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
23261693|NCT02207621|64700452|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
23261694|NCT02207621|64700453|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
23261695|NCT00661505|64700462|FG000|Overall Study|Adverse Event|3|||
23261696|NCT00661505|64700462|FG000|Overall Study|Protocol Violation|14|||
23261697|NCT00661505|64700462|FG000|Overall Study|Withdrawal by Subject|8|||
23261698|NCT00661505|64700462|FG000|Overall Study|Lost to Follow-up|3|||
23261699|NCT00661505|64700462|FG000|Overall Study|Other|2|||
23261700|NCT01066052|64700465|FG000|Overall Study|Enrolled But Not Treated|3|||
23261701|NCT01066052|64700466|FG001|Overall Study|Enrolled But Not Treated|0|||
23261702|NCT02224391|64700467|FG000|Overall Study|Lost to Follow-up|26|||
23261703|NCT02224391|64700468|FG001|Overall Study|Lost to Follow-up|19|||
23261704|NCT02224391|64700467|FG000|Overall Study|Withdrawal by Subject|6|||
23261705|NCT02224391|64700468|FG001|Overall Study|Withdrawal by Subject|5|||
23261706|NCT03342898|64700469|FG000|Overall Study|Adverse Event|3|||
23261707|NCT03342898|64700470|FG001|Overall Study|Adverse Event|1|||
23261708|NCT03342898|64700471|FG002|Overall Study|Adverse Event|0|||
23261709|NCT03342898|64700469|FG000|Overall Study|Lost to Follow-up|44|||
23261710|NCT03342898|64700470|FG001|Overall Study|Lost to Follow-up|40|||
23261711|NCT03342898|64700471|FG002|Overall Study|Lost to Follow-up|42|||
23361562|NCT01395810|65069739|FG000|Overall Study|Unclassified|2|||
23261712|NCT03342898|64700469|FG000|Overall Study|Withdrawal of Consent|5|||
23261713|NCT03342898|64700470|FG001|Overall Study|Withdrawal of Consent|9|||
23261714|NCT03342898|64700471|FG002|Overall Study|Withdrawal of Consent|11|||
23261715|NCT03342898|64700469|FG000|Overall Study|Death|0|||
23261716|NCT03342898|64700470|FG001|Overall Study|Death|1|||
23600663|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
23600664|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
23600665|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
23600666|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
23600667|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
23600668|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
23600669|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
23600670|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
23261717|NCT03342898|64700471|FG002|Overall Study|Death|1|||
23261718|NCT03342898|64700469|FG000|Overall Study|Reason not Specified|2|||
23261719|NCT03342898|64700470|FG001|Overall Study|Reason not Specified|2|||
23361563|NCT01395810|65069740|FG001|Overall Study|Unclassified|0|||
23200589|NCT02427477|64473442|FG000|Period 1|Adverse Event|1|||
23200590|NCT02427477|64473443|FG001|Period 1|Adverse Event|0|||
23200591|NCT00114972|64473445|FG000|Overall Study|Withdrawal by Subject|40|||
23200592|NCT00114972|64473446|FG001|Overall Study|Withdrawal by Subject|7|||
23200593|NCT00114972|64473445|FG000|Overall Study|Lost to Follow-up|8|||
23200594|NCT00114972|64473446|FG001|Overall Study|Lost to Follow-up|5|||
23200595|NCT02926573|64473447|FG000|Overall Study|Nausea|1|||
23200596|NCT02926573|64473448|FG001|Overall Study|Nausea|0|||
23200597|NCT02926573|64473447|FG000|Overall Study|Remain intubated|2|||
23200598|NCT02926573|64473448|FG001|Overall Study|Remain intubated|2|||
23200599|NCT02926573|64473447|FG000|Overall Study|Change in surgery plan|3|||
23200600|NCT02926573|64473448|FG001|Overall Study|Change in surgery plan|1|||
23200601|NCT02926573|64473447|FG000|Overall Study|Change to outpatient status|5|||
23200602|NCT02926573|64473448|FG001|Overall Study|Change to outpatient status|1|||
23200603|NCT02926573|64473447|FG000|Overall Study|Withdrawal by Subject|0|||
23200604|NCT02926573|64473448|FG001|Overall Study|Withdrawal by Subject|2|||
23200605|NCT02926573|64473447|FG000|Overall Study|Return to operating room|0|||
23200606|NCT02926573|64473448|FG001|Overall Study|Return to operating room|2|||
23200607|NCT02926573|64473447|FG000|Overall Study|Delirium|0|||
23200608|NCT02926573|64473448|FG001|Overall Study|Delirium|1|||
23200609|NCT01617434|64473451|FG000|Overall Study|Adverse Event|12|||
23200610|NCT01617434|64473452|FG001|Overall Study|Adverse Event|3|||
23200611|NCT01617434|64473451|FG000|Overall Study|Protocol Violation|8|||
23200612|NCT01617434|64473452|FG001|Overall Study|Protocol Violation|7|||
23200613|NCT01617434|64473451|FG000|Overall Study|Withdrawal Criteria|12|||
23200614|NCT01617434|64473452|FG001|Overall Study|Withdrawal Criteria|37|||
23200615|NCT01617434|64473451|FG000|Overall Study|Unclassified|3|||
23200616|NCT01617434|64473452|FG001|Overall Study|Unclassified|4|||
23200617|NCT01379534|64473455|FG000|Treatment Phase|Withdrawal by Subject|2|||
23200618|NCT01379534|64473456|FG001|Treatment Phase|Withdrawal by Subject|2|||
23200619|NCT01379534|64473455|FG000|Treatment Phase|Progressive disease|13|||
23200620|NCT01379534|64473456|FG001|Treatment Phase|Progressive disease|22|||
23200621|NCT01379534|64473455|FG000|Treatment Phase|Adverse Event|7|||
23600671|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
23200622|NCT01379534|64473456|FG001|Treatment Phase|Adverse Event|7|||
23600672|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
23600673|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
23600674|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
23600675|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
23600676|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
23600677|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
23600678|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
23600679|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
23600680|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
23600681|NCT04759833|65929693|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
23600682|NCT04759833|65929694|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
23200623|NCT01379534|64473455|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
23200624|NCT01379534|64473456|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
23200625|NCT01379534|64473455|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
23200626|NCT01379534|64473456|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
23200627|NCT01379534|64473455|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
23200628|NCT01379534|64473456|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
23200629|NCT01379534|64473455|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
23200630|NCT01379534|64473456|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
23200631|NCT01234402|64473457|FG000|Overall Study|Lost to Follow-up|0|||
23200632|NCT01234402|64473458|FG001|Overall Study|Lost to Follow-up|1|||
23200633|NCT01234402|64473459|FG002|Overall Study|Lost to Follow-up|3|||
23200634|NCT01234402|64473457|FG000|Overall Study|Withdrawal by Subject|1|||
23200635|NCT01234402|64473458|FG001|Overall Study|Withdrawal by Subject|3|||
23200636|NCT01234402|64473459|FG002|Overall Study|Withdrawal by Subject|4|||
23200637|NCT01234402|64473457|FG000|Overall Study|Never treated: Death|0|||
23200638|NCT01234402|64473458|FG001|Overall Study|Never treated: Death|0|||
23200639|NCT01234402|64473459|FG002|Overall Study|Never treated: Death|1|||
23200640|NCT01234402|64473457|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
23200641|NCT01234402|64473458|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
23200642|NCT01234402|64473459|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
23200643|NCT01234402|64473457|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
23200644|NCT01234402|64473458|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
23200645|NCT01234402|64473459|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
23200646|NCT00883558|64473460|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
23200647|NCT00883558|64473461|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
23361564|NCT01395810|65069741|FG002|Overall Study|Unclassified|0|||
23361565|NCT01395810|65069742|FG003|Overall Study|Unclassified|0|||
23261720|NCT03342898|64700471|FG002|Overall Study|Reason not Specified|0|||
23261721|NCT00928252|64700472|FG000|Overall Study|Physician Decision|3|||
23261722|NCT02019979|64700475|FG000|Overall Study|study terminated|14|||
23261723|NCT01498484|64700476|FG000|Overall Study|Death|6|||
23261724|NCT01498484|64700477|FG001|Overall Study|Death|3|||
23261725|NCT01498484|64700478|FG002|Overall Study|Death|1|||
23261726|NCT01498484|64700479|FG003|Overall Study|Death|1|||
23261727|NCT01498484|64700480|FG004|Overall Study|Death|0|||
23261728|NCT01498484|64700481|FG005|Overall Study|Death|0|||
23261729|NCT01498484|64700482|FG006|Overall Study|Death|10|||
23261730|NCT01498484|64700483|FG007|Overall Study|Death|1|||
23261731|NCT01498484|64700484|FG008|Overall Study|Death|0|||
23261732|NCT01498484|64700476|FG000|Overall Study|Physician Decision|3|||
23261733|NCT01498484|64700477|FG001|Overall Study|Physician Decision|2|||
23261734|NCT01498484|64700478|FG002|Overall Study|Physician Decision|1|||
23261735|NCT01498484|64700479|FG003|Overall Study|Physician Decision|1|||
23261736|NCT01498484|64700480|FG004|Overall Study|Physician Decision|0|||
23261737|NCT01498484|64700481|FG005|Overall Study|Physician Decision|0|||
23261738|NCT01498484|64700482|FG006|Overall Study|Physician Decision|8|||
23261739|NCT01498484|64700483|FG007|Overall Study|Physician Decision|13|||
23261740|NCT01498484|64700484|FG008|Overall Study|Physician Decision|1|||
23261741|NCT01498484|64700476|FG000|Overall Study|Adverse Event|0|||
23261742|NCT01498484|64700477|FG001|Overall Study|Adverse Event|0|||
23261743|NCT01498484|64700478|FG002|Overall Study|Adverse Event|0|||
23261744|NCT01498484|64700479|FG003|Overall Study|Adverse Event|0|||
23261745|NCT01498484|64700480|FG004|Overall Study|Adverse Event|0|||
23261746|NCT01498484|64700481|FG005|Overall Study|Adverse Event|1|||
23261747|NCT01498484|64700482|FG006|Overall Study|Adverse Event|0|||
23261748|NCT01498484|64700483|FG007|Overall Study|Adverse Event|0|||
23261749|NCT01498484|64700484|FG008|Overall Study|Adverse Event|0|||
23261750|NCT01498484|64700476|FG000|Overall Study|Withdrawal by Subject|0|||
23261751|NCT01498484|64700477|FG001|Overall Study|Withdrawal by Subject|0|||
23261752|NCT01498484|64700478|FG002|Overall Study|Withdrawal by Subject|0|||
23261753|NCT01498484|64700479|FG003|Overall Study|Withdrawal by Subject|1|||
23261754|NCT01498484|64700480|FG004|Overall Study|Withdrawal by Subject|0|||
23361566|NCT04530838|65069743|FG000|Overall Study|Other|2|||
23361567|NCT04530838|65069744|FG001|Overall Study|Other|1|||
23361568|NCT04530838|65069745|FG002|Overall Study|Other|0|||
23200648|NCT00883558|64473462|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
23200649|NCT00883558|64473460|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
23200650|NCT00883558|64473461|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
23200651|NCT00883558|64473462|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
23200652|NCT00883558|64473460|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
23200653|NCT00883558|64473461|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
23200654|NCT00883558|64473462|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
23261755|NCT01498484|64700481|FG005|Overall Study|Withdrawal by Subject|0|||
23261756|NCT01498484|64700482|FG006|Overall Study|Withdrawal by Subject|1|||
23261757|NCT01498484|64700483|FG007|Overall Study|Withdrawal by Subject|0|||
23261758|NCT01498484|64700484|FG008|Overall Study|Withdrawal by Subject|0|||
23261759|NCT01498484|64700476|FG000|Overall Study|Other|5|||
23261760|NCT01498484|64700477|FG001|Overall Study|Other|2|||
23261761|NCT01498484|64700478|FG002|Overall Study|Other|0|||
23261762|NCT01498484|64700479|FG003|Overall Study|Other|0|||
23261763|NCT01498484|64700480|FG004|Overall Study|Other|1|||
23261764|NCT01498484|64700481|FG005|Overall Study|Other|0|||
23261765|NCT01498484|64700482|FG006|Overall Study|Other|3|||
23361569|NCT04530838|65069743|FG000|Overall Study|Physician Decision|0|||
23361570|NCT04530838|65069744|FG001|Overall Study|Physician Decision|0|||
23361571|NCT04530838|65069745|FG002|Overall Study|Physician Decision|1|||
23480478|NCT04585009|65501991|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480479|NCT04585009|65501992|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480480|NCT04585009|65501993|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480481|NCT04585009|65501994|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480482|NCT04585009|65501995|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480483|NCT04585009|65501996|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480484|NCT04585009|65501997|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480485|NCT04585009|65501998|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23200655|NCT00883558|64473460|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
23200656|NCT00883558|64473461|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
23200657|NCT00883558|64473462|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
23200658|NCT00883558|64473460|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
23200659|NCT00883558|64473461|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
23200660|NCT00883558|64473462|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
23200661|NCT02819310|64473463|FG000|Overall Study|Withdrawal by Subject|37|||
23200662|NCT02819310|64473463|FG000|Overall Study|Lost to Follow-up|16|||
23200663|NCT02819310|64473463|FG000|Overall Study|Adverse Event|13|||
23200664|NCT02819310|64473463|FG000|Overall Study|Lack of Efficacy|5|||
23200665|NCT02819310|64473463|FG000|Overall Study|Physician Decision|8|||
23200666|NCT02819310|64473463|FG000|Overall Study|Protocol Violation|30|||
23200667|NCT03010423|64473471|FG000|Overall Study|Study termination|8|||
23200668|NCT03987620|64473472|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
23200669|NCT03987620|64473473|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
23200670|NCT03987620|64473472|FG000|Overall Study|Adverse Event|3|||
23200671|NCT03987620|64473473|FG001|Overall Study|Adverse Event|0|||
23200672|NCT03987620|64473472|FG000|Overall Study|Lost to Follow-up|1|||
23200673|NCT03987620|64473473|FG001|Overall Study|Lost to Follow-up|2|||
23200674|NCT03987620|64473472|FG000|Overall Study|Physician Decision|0|||
23200675|NCT03987620|64473473|FG001|Overall Study|Physician Decision|1|||
23200676|NCT03987620|64473472|FG000|Overall Study|Pregnancy|1|||
23200677|NCT03987620|64473473|FG001|Overall Study|Pregnancy|0|||
23200678|NCT03987620|64473472|FG000|Overall Study|Withdrawal by Subject|7|||
23200679|NCT03987620|64473473|FG001|Overall Study|Withdrawal by Subject|1|||
23200680|NCT03987620|64473472|FG000|Overall Study|Other|2|||
23200681|NCT03987620|64473473|FG001|Overall Study|Other|5|||
23200682|NCT00130208|64473474|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
23200683|NCT00130208|64473475|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
23200684|NCT00130208|64473474|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
23200685|NCT00130208|64473475|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
23200686|NCT00130208|64473474|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
23200687|NCT00130208|64473475|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
23200688|NCT00130208|64473474|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
23200689|NCT00130208|64473475|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
23200690|NCT00130208|64473474|FG000|Maintenance Period (26 Weeks)|Other|1|||
23200691|NCT00130208|64473475|FG001|Maintenance Period (26 Weeks)|Other|1|||
23200692|NCT00130208|64473474|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
23200693|NCT00130208|64473475|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
23200694|NCT00130208|64473474|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
23200695|NCT00130208|64473475|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
23200696|NCT00130208|64473474|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
23200697|NCT00130208|64473475|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
23200698|NCT00130208|64473474|FG000|Washout Period (8 Weeks)|Other|1|||
23200699|NCT00130208|64473475|FG001|Washout Period (8 Weeks)|Other|1|||
23600683|NCT04759833|65929695|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
23600684|NCT04759833|65929696|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
23200700|NCT04799405|64473480|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
23200701|NCT04230486|64473481|FG000|Overall Study|Screen Failure|1|||
23200702|NCT05118386|64473482|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23261766|NCT01498484|64700483|FG007|Overall Study|Other|0|||
23261767|NCT01498484|64700484|FG008|Overall Study|Other|1|||
23261768|NCT03271528|64700487|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
23261769|NCT03271528|64700488|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
23261770|NCT03271528|64700487|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
23261771|NCT03271528|64700488|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
23261772|NCT03271528|64700487|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
23261773|NCT03271528|64700488|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
23261774|NCT03271528|64700487|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
23261775|NCT03271528|64700488|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
23261776|NCT03271528|64700487|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
23261777|NCT03271528|64700488|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
23261778|NCT03271528|64700487|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
23261779|NCT03271528|64700488|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
23261780|NCT03271528|64700487|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
23261781|NCT03271528|64700488|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
23261782|NCT01346410|64700489|FG000|Overall Study|Death|1|||
23261783|NCT00447603|64700491|FG000|Screening|Withdrawal by Subject|1|||
23261784|NCT00447603|64700492|FG001|Screening|Withdrawal by Subject|0|||
23261785|NCT00447603|64700493|FG002|Screening|Withdrawal by Subject|0|||
23261786|NCT00447603|64700491|FG000|Screening|Protocol Violation|1|||
23261787|NCT00447603|64700492|FG001|Screening|Protocol Violation|0|||
23261788|NCT00447603|64700493|FG002|Screening|Protocol Violation|0|||
23261789|NCT00447603|64700491|FG000|Screening|Screen Failure|4|||
23261790|NCT00447603|64700492|FG001|Screening|Screen Failure|0|||
23261791|NCT00447603|64700493|FG002|Screening|Screen Failure|0|||
23261792|NCT00447603|64700491|FG000|Screening|Study Terminated by Sponsor|15|||
23261793|NCT00447603|64700492|FG001|Screening|Study Terminated by Sponsor|0|||
23261794|NCT00447603|64700493|FG002|Screening|Study Terminated by Sponsor|0|||
23261795|NCT00447603|64700491|FG000|Filter Period|Adverse Event|0|||
23261796|NCT00447603|64700492|FG001|Filter Period|Adverse Event|0|||
23261797|NCT00447603|64700493|FG002|Filter Period|Adverse Event|1|||
23261798|NCT00447603|64700491|FG000|Filter Period|Screen Failure|0|||
23261799|NCT00447603|64700492|FG001|Filter Period|Screen Failure|3|||
23261800|NCT00447603|64700493|FG002|Filter Period|Screen Failure|4|||
23261801|NCT00447603|64700491|FG000|Filter Period|Study terminated by Sponsor|0|||
23261802|NCT00447603|64700492|FG001|Filter Period|Study terminated by Sponsor|1|||
23261803|NCT00447603|64700493|FG002|Filter Period|Study terminated by Sponsor|10|||
23261804|NCT00760383|64700494|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
23261805|NCT00760383|64700495|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
23261806|NCT03572933|64700496|FG000|Overall Study|Adverse Event|4|||
23261807|NCT03572933|64700497|FG001|Overall Study|Adverse Event|1|||
23261808|NCT03572933|64700496|FG000|Overall Study|Withdrawal by Subject|0|||
23261809|NCT03572933|64700497|FG001|Overall Study|Withdrawal by Subject|1|||
23261810|NCT02826603|64700500|FG000|Overall Study|Adverse Event|17|||
23261811|NCT02826603|64700501|FG001|Overall Study|Adverse Event|9|||
23261812|NCT02826603|64700500|FG000|Overall Study|Lack of Efficacy|4|||
23261813|NCT02826603|64700501|FG001|Overall Study|Lack of Efficacy|9|||
23261814|NCT02826603|64700500|FG000|Overall Study|Lost to Follow-up|13|||
23261815|NCT02826603|64700501|FG001|Overall Study|Lost to Follow-up|12|||
23261816|NCT02826603|64700500|FG000|Overall Study|Noncompliance with treatment|0|||
23261817|NCT02826603|64700501|FG001|Overall Study|Noncompliance with treatment|2|||
23261818|NCT02826603|64700500|FG000|Overall Study|Physician Decision|1|||
23261819|NCT02826603|64700501|FG001|Overall Study|Physician Decision|7|||
23261820|NCT02826603|64700500|FG000|Overall Study|Pregnancy|1|||
23261821|NCT02826603|64700501|FG001|Overall Study|Pregnancy|2|||
23261822|NCT02826603|64700500|FG000|Overall Study|Protocol Violation|3|||
23261823|NCT02826603|64700501|FG001|Overall Study|Protocol Violation|3|||
23261824|NCT02826603|64700500|FG000|Overall Study|Withdrawal by Subject|20|||
23261825|NCT02826603|64700501|FG001|Overall Study|Withdrawal by Subject|19|||
23261826|NCT02826603|64700500|FG000|Overall Study|Death|2|||
23361572|NCT04530838|65069743|FG000|Overall Study|Death|0|||
23261827|NCT02826603|64700501|FG001|Overall Study|Death|0|||
23261828|NCT02826603|64700500|FG000|Overall Study|New therapy for study indication|0|||
23261829|NCT02826603|64700501|FG001|Overall Study|New therapy for study indication|1|||
23261830|NCT01829477|64700506|FG000|Overall Study|Study Terminated by Sponsor|15|||
23261831|NCT01829477|64700507|FG001|Overall Study|Study Terminated by Sponsor|15|||
23261832|NCT01829477|64700506|FG000|Overall Study|Withdrawal by Subject|1|||
23261833|NCT01829477|64700507|FG001|Overall Study|Withdrawal by Subject|0|||
23261834|NCT01717456|64700508|FG000|End of Treatment|Physician Decision|0|||
23261835|NCT01717456|64700509|FG001|End of Treatment|Physician Decision|1|||
23261836|NCT01717456|64700508|FG000|End of Treatment|Lost to Follow-up|0|||
23261837|NCT01717456|64700509|FG001|End of Treatment|Lost to Follow-up|1|||
23480486|NCT04585009|65501999|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23261838|NCT01717456|64700508|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
23261839|NCT01717456|64700509|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
23261840|NCT01612000|64700510|FG000|Overall Study|Lost to Follow-up|6|||
23261841|NCT01612000|64700511|FG001|Overall Study|Lost to Follow-up|4|||
23261842|NCT01612000|64700512|FG002|Overall Study|Lost to Follow-up|4|||
23261843|NCT01612000|64700513|FG003|Overall Study|Lost to Follow-up|8|||
23261844|NCT01612000|64700510|FG000|Overall Study|Physician Decision|0|||
23261845|NCT01612000|64700511|FG001|Overall Study|Physician Decision|0|||
23261846|NCT01612000|64700512|FG002|Overall Study|Physician Decision|1|||
23261847|NCT01612000|64700513|FG003|Overall Study|Physician Decision|0|||
23261848|NCT01612000|64700510|FG000|Overall Study|Withdrawal by Subject|3|||
23261849|NCT01612000|64700511|FG001|Overall Study|Withdrawal by Subject|1|||
23261850|NCT01612000|64700512|FG002|Overall Study|Withdrawal by Subject|2|||
23261851|NCT01612000|64700513|FG003|Overall Study|Withdrawal by Subject|2|||
23261852|NCT03387059|64700517|FG000|Overall Study|Study termination|5|||
23261853|NCT03387059|64700518|FG001|Overall Study|Study termination|4|||
23261854|NCT01966042|64700532|FG000|Overall Study|Death|2|||
23261855|NCT00903383|64700537|FG000|Overall Study|Adverse Event|1|||
23261856|NCT00903383|64700538|FG001|Overall Study|Adverse Event|2|||
23261857|NCT00903383|64700539|FG002|Overall Study|Adverse Event|3|||
23261858|NCT00903383|64700540|FG003|Overall Study|Adverse Event|1|||
23261859|NCT00903383|64700537|FG000|Overall Study|Physician Decision|1|||
23261860|NCT00903383|64700538|FG001|Overall Study|Physician Decision|2|||
23261861|NCT00903383|64700539|FG002|Overall Study|Physician Decision|0|||
23261862|NCT00903383|64700540|FG003|Overall Study|Physician Decision|0|||
23261863|NCT00903383|64700537|FG000|Overall Study|Lost to Follow-up|0|||
23261864|NCT00903383|64700538|FG001|Overall Study|Lost to Follow-up|0|||
23261865|NCT00903383|64700539|FG002|Overall Study|Lost to Follow-up|0|||
23261866|NCT00903383|64700540|FG003|Overall Study|Lost to Follow-up|1|||
23261867|NCT00903383|64700537|FG000|Overall Study|Decision of Sponsor|1|||
23261868|NCT00903383|64700538|FG001|Overall Study|Decision of Sponsor|0|||
23261869|NCT00903383|64700539|FG002|Overall Study|Decision of Sponsor|0|||
23261870|NCT00903383|64700540|FG003|Overall Study|Decision of Sponsor|0|||
23261871|NCT00903383|64700537|FG000|Overall Study|Withdrawal by Subject|4|||
23261872|NCT00903383|64700538|FG001|Overall Study|Withdrawal by Subject|1|||
23261873|NCT00903383|64700539|FG002|Overall Study|Withdrawal by Subject|0|||
23261874|NCT00903383|64700540|FG003|Overall Study|Withdrawal by Subject|2|||
23261875|NCT00903383|64700537|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
23261876|NCT00903383|64700538|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
23261877|NCT00903383|64700539|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
23261878|NCT00903383|64700540|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
23261879|NCT00903383|64700537|FG000|Overall Study|Patient Decision|0|||
23261880|NCT00903383|64700538|FG001|Overall Study|Patient Decision|0|||
23261881|NCT00903383|64700539|FG002|Overall Study|Patient Decision|0|||
23261882|NCT00903383|64700540|FG003|Overall Study|Patient Decision|1|||
23261883|NCT00124020|64700541|FG000|Overall Study|Death|67|||
23261884|NCT00124020|64700542|FG001|Overall Study|Death|71|||
23261885|NCT00124020|64700541|FG000|Overall Study|Withdrawal by Subject|13|||
23261886|NCT00124020|64700542|FG001|Overall Study|Withdrawal by Subject|11|||
23261887|NCT00124020|64700541|FG000|Overall Study|Lost to Follow-up|5|||
23261888|NCT00124020|64700542|FG001|Overall Study|Lost to Follow-up|8|||
23261889|NCT00124020|64700541|FG000|Overall Study|Other|1|||
23261890|NCT00124020|64700542|FG001|Overall Study|Other|1|||
23261891|NCT00124020|64700541|FG000|Overall Study|Transfer to another hospital|2|||
23261892|NCT00124020|64700542|FG001|Overall Study|Transfer to another hospital|0|||
23261893|NCT01104662|64700543|FG000|Overall Study|Adverse Event|2|||
23261894|NCT01104662|64700544|FG001|Overall Study|Adverse Event|2|||
23261895|NCT01104662|64700545|FG002|Overall Study|Adverse Event|0|||
23261896|NCT01104662|64700546|FG003|Overall Study|Adverse Event|1|||
23261897|NCT01104662|64700547|FG004|Overall Study|Adverse Event|1|||
23261898|NCT01104662|64700548|FG005|Overall Study|Adverse Event|1|||
23261899|NCT01104662|64700549|FG006|Overall Study|Adverse Event|0|||
23600685|NCT04759833|65929697|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
23600686|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
23600687|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
23600688|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
23261900|NCT01104662|64700550|FG007|Overall Study|Adverse Event|0|||
23261901|NCT01104662|64700543|FG000|Overall Study|Clinical Failure|1|||
23261902|NCT01104662|64700544|FG001|Overall Study|Clinical Failure|0|||
23261903|NCT01104662|64700545|FG002|Overall Study|Clinical Failure|0|||
23261904|NCT01104662|64700546|FG003|Overall Study|Clinical Failure|0|||
23261905|NCT01104662|64700547|FG004|Overall Study|Clinical Failure|0|||
23261906|NCT01104662|64700548|FG005|Overall Study|Clinical Failure|1|||
23261907|NCT01104662|64700549|FG006|Overall Study|Clinical Failure|0|||
23261908|NCT01104662|64700550|FG007|Overall Study|Clinical Failure|0|||
23261909|NCT01104662|64700543|FG000|Overall Study|Participant left investigator's care|1|||
23261910|NCT01104662|64700544|FG001|Overall Study|Participant left investigator's care|1|||
23261911|NCT01104662|64700545|FG002|Overall Study|Participant left investigator's care|0|||
23261912|NCT01104662|64700546|FG003|Overall Study|Participant left investigator's care|0|||
23261913|NCT01104662|64700547|FG004|Overall Study|Participant left investigator's care|0|||
23261914|NCT01104662|64700548|FG005|Overall Study|Participant left investigator's care|0|||
23261915|NCT01104662|64700549|FG006|Overall Study|Participant left investigator's care|0|||
23261916|NCT01104662|64700550|FG007|Overall Study|Participant left investigator's care|0|||
23261917|NCT01104662|64700543|FG000|Overall Study|Reason not specified|3|||
23261918|NCT01104662|64700544|FG001|Overall Study|Reason not specified|3|||
23261919|NCT01104662|64700545|FG002|Overall Study|Reason not specified|0|||
23261920|NCT01104662|64700546|FG003|Overall Study|Reason not specified|0|||
23261921|NCT01104662|64700547|FG004|Overall Study|Reason not specified|0|||
23261922|NCT01104662|64700548|FG005|Overall Study|Reason not specified|1|||
23261923|NCT01104662|64700549|FG006|Overall Study|Reason not specified|0|||
23261924|NCT01104662|64700550|FG007|Overall Study|Reason not specified|0|||
23261925|NCT01104662|64700543|FG000|Overall Study|Randomized but not treated|3|||
23261926|NCT01104662|64700544|FG001|Overall Study|Randomized but not treated|4|||
23261927|NCT01104662|64700545|FG002|Overall Study|Randomized but not treated|1|||
23261928|NCT01104662|64700546|FG003|Overall Study|Randomized but not treated|0|||
23261929|NCT01104662|64700547|FG004|Overall Study|Randomized but not treated|0|||
23261930|NCT01104662|64700548|FG005|Overall Study|Randomized but not treated|1|||
23261931|NCT01104662|64700549|FG006|Overall Study|Randomized but not treated|0|||
23261932|NCT01104662|64700550|FG007|Overall Study|Randomized but not treated|0|||
23261933|NCT03692676|64700551|FG000|Overall Study|exclude patients with prior use|4424|||
23261934|NCT03692676|64700552|FG001|Overall Study|exclude patients with prior use|24726|||
23261935|NCT03692676|64700553|FG002|Overall Study|exclude patients with prior use|0|||
23261936|NCT03692676|64700554|FG003|Overall Study|exclude patients with prior use|0|||
23261937|NCT03692676|64700551|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
23261938|NCT03692676|64700552|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
23261939|NCT03692676|64700553|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
23261940|NCT03692676|64700554|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
23261941|NCT03692676|64700551|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
23261942|NCT03692676|64700552|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
23261943|NCT03692676|64700553|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
23261944|NCT03692676|64700554|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
23261945|NCT03692676|64700551|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
23261946|NCT03692676|64700552|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
23261947|NCT03692676|64700553|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
23261948|NCT03692676|64700554|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
23261949|NCT03692676|64700551|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
23261950|NCT03692676|64700552|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
23261951|NCT03692676|64700553|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
23261952|NCT03692676|64700554|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
23261953|NCT03692676|64700551|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
23261954|NCT03692676|64700552|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
23261955|NCT03692676|64700553|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
23261956|NCT03692676|64700554|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
23261957|NCT03692676|64700551|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
23261958|NCT03692676|64700552|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
23261959|NCT03692676|64700553|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
23261960|NCT03692676|64700554|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
23261961|NCT03692676|64700551|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
23261962|NCT03692676|64700552|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
23261963|NCT03692676|64700553|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
23261964|NCT03692676|64700554|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
23261965|NCT03692676|64700551|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
23261966|NCT03692676|64700552|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
23261967|NCT03692676|64700553|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
23261968|NCT03692676|64700554|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
23261969|NCT03692676|64700551|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
23261970|NCT03692676|64700552|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
23261971|NCT03692676|64700553|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
23361573|NCT04530838|65069744|FG001|Overall Study|Death|0|||
23361574|NCT04530838|65069745|FG002|Overall Study|Death|1|||
23261972|NCT03692676|64700554|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
23261973|NCT03692676|64700551|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
23261974|NCT03692676|64700552|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
23261975|NCT03692676|64700553|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
23261976|NCT03692676|64700554|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
23261977|NCT03692676|64700551|FG000|Overall Study|Other|0|||
23261978|NCT03692676|64700552|FG001|Overall Study|Other|805|||
23261979|NCT03692676|64700553|FG002|Overall Study|Other|758|||
23261980|NCT03692676|64700554|FG003|Overall Study|Other|277|||
23361575|NCT04530838|65069743|FG000|Overall Study|Adverse Event|0|||
23361576|NCT04530838|65069744|FG001|Overall Study|Adverse Event|1|||
23361577|NCT04530838|65069745|FG002|Overall Study|Adverse Event|0|||
23361578|NCT04530838|65069743|FG000|Overall Study|No longer meets eligibility criteria|1|||
23361579|NCT04530838|65069744|FG001|Overall Study|No longer meets eligibility criteria|0|||
23361580|NCT04530838|65069745|FG002|Overall Study|No longer meets eligibility criteria|2|||
23361581|NCT04530838|65069743|FG000|Overall Study|Withdrawal by parent/guardian|5|||
23361582|NCT04530838|65069744|FG001|Overall Study|Withdrawal by parent/guardian|2|||
23361583|NCT04530838|65069745|FG002|Overall Study|Withdrawal by parent/guardian|2|||
23361584|NCT04235504|65069748|FG000|Study Phase|Withdrawal by Subject|5|||
23361585|NCT04235504|65069749|FG001|Study Phase|Withdrawal by Subject|2|||
23361586|NCT04235504|65069750|FG002|Study Phase|Withdrawal by Subject|0|||
23361587|NCT04235504|65069751|FG003|Study Phase|Withdrawal by Subject|0|||
23361588|NCT04235504|65069748|FG000|Continuation Phase|Withdrawal by Subject|0|||
23361589|NCT04235504|65069749|FG001|Continuation Phase|Withdrawal by Subject|4|||
23361590|NCT04235504|65069750|FG002|Continuation Phase|Withdrawal by Subject|0|||
23361591|NCT04235504|65069751|FG003|Continuation Phase|Withdrawal by Subject|0|||
23361592|NCT04235504|65069748|FG000|Continuation Phase|Adverse Event|0|||
23361593|NCT04235504|65069749|FG001|Continuation Phase|Adverse Event|1|||
23361594|NCT04235504|65069750|FG002|Continuation Phase|Adverse Event|0|||
23361595|NCT04235504|65069751|FG003|Continuation Phase|Adverse Event|0|||
23361596|NCT04235504|65069748|FG000|Continuation Phase|Physician Decision|1|||
23361597|NCT04235504|65069749|FG001|Continuation Phase|Physician Decision|2|||
23361598|NCT04235504|65069750|FG002|Continuation Phase|Physician Decision|1|||
23361599|NCT04235504|65069751|FG003|Continuation Phase|Physician Decision|0|||
23361600|NCT02421419|65069752|FG000|Overall Study|Physician Decision|0|||
23361601|NCT02421419|65069753|FG001|Overall Study|Physician Decision|0|||
23361602|NCT02421419|65069754|FG002|Overall Study|Physician Decision|1|||
23361603|NCT00497146|65069755|FG000|Treatment Period|Adverse Event|6|||
23361604|NCT00497146|65069756|FG001|Treatment Period|Adverse Event|2|||
23361605|NCT00497146|65069755|FG000|Treatment Period|Withdrawal by Subject|5|||
23361606|NCT00497146|65069756|FG001|Treatment Period|Withdrawal by Subject|9|||
23361607|NCT00497146|65069755|FG000|Treatment Period|Lost to Follow-up|1|||
23361608|NCT00497146|65069756|FG001|Treatment Period|Lost to Follow-up|3|||
23361609|NCT00497146|65069755|FG000|Treatment Period|Required dialysis|4|||
23361610|NCT00497146|65069756|FG001|Treatment Period|Required dialysis|1|||
23361611|NCT00497146|65069755|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
23361612|NCT00497146|65069756|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
23361613|NCT00497146|65069755|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
23361614|NCT00497146|65069756|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
23361615|NCT00497146|65069755|FG000|Treatment Period|Other Reason|2|||
23361616|NCT00497146|65069756|FG001|Treatment Period|Other Reason|3|||
23361617|NCT00497146|65069755|FG000|Long-term Follow-up Period|Adverse Event|2|||
23361618|NCT00497146|65069756|FG001|Long-term Follow-up Period|Adverse Event|2|||
23361619|NCT00497146|65069755|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
23361620|NCT00497146|65069756|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
23361621|NCT00497146|65069755|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
23361622|NCT00497146|65069756|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
23361623|NCT00497146|65069755|FG000|Long-term Follow-up Period|Other|0|||
23361624|NCT00497146|65069756|FG001|Long-term Follow-up Period|Other|1|||
23361625|NCT02384538|65069760|FG000|Overall Study|Adverse Event|1|||
23361626|NCT02384538|65069761|FG001|Overall Study|Adverse Event|4|||
23200703|NCT05118386|64473483|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23200704|NCT05118386|64473484|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23200705|NCT05118386|64473485|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
23200706|NCT05118386|64473486|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23200707|NCT05118386|64473487|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
23200708|NCT05118386|64473482|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23200709|NCT05118386|64473483|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23200710|NCT05118386|64473484|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23200711|NCT05118386|64473485|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23361627|NCT02384538|65069760|FG000|Overall Study|Lack of Efficacy|4|||
23261981|NCT03692676|64700551|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
23261982|NCT03692676|64700552|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
23261983|NCT03692676|64700553|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
23261984|NCT03692676|64700554|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
23261985|NCT01393990|64700555|FG000|Overall Study|Adverse Event|0|||
23261986|NCT01393990|64700556|FG001|Overall Study|Adverse Event|0|||
23261987|NCT01393990|64700557|FG002|Overall Study|Adverse Event|0|||
23261988|NCT01393990|64700558|FG003|Overall Study|Adverse Event|0|||
23261989|NCT01393990|64700559|FG004|Overall Study|Adverse Event|0|||
23261990|NCT01393990|64700560|FG005|Overall Study|Adverse Event|0|||
23261991|NCT01393990|64700561|FG006|Overall Study|Adverse Event|0|||
23261992|NCT01393990|64700562|FG007|Overall Study|Adverse Event|0|||
23261993|NCT01393990|64700563|FG008|Overall Study|Adverse Event|0|||
23261994|NCT01393990|64700564|FG009|Overall Study|Adverse Event|0|||
23261995|NCT01393990|64700565|FG010|Overall Study|Adverse Event|0|||
23261996|NCT01393990|64700566|FG011|Overall Study|Adverse Event|0|||
23261997|NCT01393990|64700567|FG012|Overall Study|Adverse Event|0|||
23261998|NCT01393990|64700568|FG013|Overall Study|Adverse Event|0|||
23261999|NCT01393990|64700569|FG014|Overall Study|Adverse Event|1|||
23262000|NCT01393990|64700570|FG015|Overall Study|Adverse Event|1|||
23262001|NCT01393990|64700571|FG016|Overall Study|Adverse Event|0|||
23262002|NCT01393990|64700572|FG017|Overall Study|Adverse Event|0|||
23262003|NCT01393990|64700555|FG000|Overall Study|Progressive Disease|1|||
23262004|NCT01393990|64700556|FG001|Overall Study|Progressive Disease|0|||
23262005|NCT01393990|64700557|FG002|Overall Study|Progressive Disease|0|||
23262006|NCT01393990|64700558|FG003|Overall Study|Progressive Disease|1|||
23361628|NCT02384538|65069761|FG001|Overall Study|Lack of Efficacy|4|||
23361629|NCT02384538|65069760|FG000|Overall Study|Withdrew Consent|0|||
23361630|NCT02384538|65069761|FG001|Overall Study|Withdrew Consent|4|||
23361631|NCT02384538|65069760|FG000|Overall Study|Other|1|||
23361632|NCT02384538|65069761|FG001|Overall Study|Other|3|||
23361633|NCT03479008|65069762|FG000|Overall Study|Withdrawal by Subject|3|||
23361634|NCT03560869|65069764|FG000|Overall Study|Withdrawal by Subject|3|||
23361635|NCT03560869|65069765|FG001|Overall Study|Withdrawal by Subject|4|||
23361636|NCT03560869|65069764|FG000|Overall Study|Screening failure|4|||
23361637|NCT03560869|65069765|FG001|Overall Study|Screening failure|4|||
23361638|NCT03560869|65069764|FG000|Overall Study|Withdrawal by PI|0|||
23361639|NCT03560869|65069765|FG001|Overall Study|Withdrawal by PI|1|||
23361640|NCT01938846|65069769|FG000|Overall Study|Progressive disease|26|||
23361641|NCT01938846|65069770|FG001|Overall Study|Progressive disease|18|||
23361642|NCT01938846|65069771|FG002|Overall Study|Progressive disease|16|||
23361643|NCT01938846|65069769|FG000|Overall Study|Adverse Event|8|||
23361644|NCT01938846|65069770|FG001|Overall Study|Adverse Event|4|||
23361645|NCT01938846|65069771|FG002|Overall Study|Adverse Event|3|||
23361646|NCT01938846|65069769|FG000|Overall Study|Withdrawal by Subject|2|||
23361647|NCT01938846|65069770|FG001|Overall Study|Withdrawal by Subject|2|||
23361648|NCT01938846|65069771|FG002|Overall Study|Withdrawal by Subject|1|||
23361649|NCT01938846|65069769|FG000|Overall Study|Other than listed|5|||
23361650|NCT01938846|65069770|FG001|Overall Study|Other than listed|1|||
23361651|NCT01938846|65069771|FG002|Overall Study|Other than listed|4|||
23361652|NCT02360280|65069772|FG000|Overall Study|Withdrawal by Subject|2|||
23361653|NCT02360280|65069773|FG001|Overall Study|Withdrawal by Subject|0|||
23361654|NCT02360280|65069772|FG000|Overall Study|Adverse Event|0|||
23361655|NCT02360280|65069773|FG001|Overall Study|Adverse Event|1|||
23361656|NCT02360280|65069772|FG000|Overall Study|Lost to Follow-up|1|||
23361657|NCT02360280|65069773|FG001|Overall Study|Lost to Follow-up|0|||
23361658|NCT00436826|65069778|FG000|Double Blind Period (DBP)|Adverse Event|2|||
23361659|NCT00436826|65069779|FG001|Double Blind Period (DBP)|Adverse Event|0|||
23361660|NCT00436826|65069780|FG002|Double Blind Period (DBP)|Adverse Event|0|||
23361661|NCT00436826|65069781|FG003|Double Blind Period (DBP)|Adverse Event|0|||
23361662|NCT00436826|65069782|FG004|Double Blind Period (DBP)|Adverse Event|0|||
23361663|NCT00436826|65069783|FG005|Double Blind Period (DBP)|Adverse Event|0|||
23361664|NCT00436826|65069778|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
23361665|NCT00436826|65069779|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
23361666|NCT00436826|65069780|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
23361667|NCT00436826|65069781|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
23361668|NCT00436826|65069782|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
23361669|NCT00436826|65069783|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
23262007|NCT01393990|64700559|FG004|Overall Study|Progressive Disease|1|||
23361670|NCT00436826|65069778|FG000|Double Blind Period (DBP)|Other|10|||
23361671|NCT00436826|65069779|FG001|Double Blind Period (DBP)|Other|11|||
23361672|NCT00436826|65069780|FG002|Double Blind Period (DBP)|Other|0|||
23361673|NCT00436826|65069781|FG003|Double Blind Period (DBP)|Other|0|||
23361674|NCT00436826|65069782|FG004|Double Blind Period (DBP)|Other|0|||
23361675|NCT00436826|65069783|FG005|Double Blind Period (DBP)|Other|0|||
23361676|NCT00436826|65069778|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23262008|NCT01393990|64700560|FG005|Overall Study|Progressive Disease|1|||
23262009|NCT01393990|64700561|FG006|Overall Study|Progressive Disease|1|||
23262010|NCT01393990|64700562|FG007|Overall Study|Progressive Disease|1|||
23262011|NCT01393990|64700563|FG008|Overall Study|Progressive Disease|3|||
23262012|NCT01393990|64700564|FG009|Overall Study|Progressive Disease|1|||
23262013|NCT01393990|64700565|FG010|Overall Study|Progressive Disease|0|||
23361677|NCT00436826|65069779|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23361678|NCT00436826|65069780|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23361679|NCT00436826|65069781|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
23600689|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
23600690|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
23600691|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
23600692|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
23600693|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
23600694|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
23600695|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
23600696|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
23600697|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
23600698|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
23600699|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
23600700|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
23600701|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
23600702|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
23600703|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
23600704|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
23600705|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
23600706|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
23600707|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
23600708|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
23600709|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
23600710|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
23600711|NCT04759833|65929693|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
23600712|NCT04759833|65929694|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
23600713|NCT04759833|65929695|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
23600714|NCT04759833|65929696|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
23600715|NCT04759833|65929697|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
23600716|NCT02079649|65929698|FG000|Overall Study|Lost to Follow-up|0|||
23600717|NCT02079649|65929699|FG001|Overall Study|Lost to Follow-up|0|||
23600718|NCT02079649|65929700|FG002|Overall Study|Lost to Follow-up|0|||
23600719|NCT02079649|65929701|FG003|Overall Study|Lost to Follow-up|1|||
23600720|NCT02079649|65929698|FG000|Overall Study|Withdrawal by Subject|0|||
23600721|NCT02079649|65929699|FG001|Overall Study|Withdrawal by Subject|0|||
23600722|NCT02079649|65929700|FG002|Overall Study|Withdrawal by Subject|0|||
23600723|NCT02079649|65929701|FG003|Overall Study|Withdrawal by Subject|1|||
23600724|NCT02079649|65929698|FG000|Overall Study|Randomization error (prior to treatment)|1|||
23600725|NCT02079649|65929699|FG001|Overall Study|Randomization error (prior to treatment)|0|||
23600726|NCT02079649|65929700|FG002|Overall Study|Randomization error (prior to treatment)|1|||
23200712|NCT05118386|64473486|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
23200713|NCT05118386|64473487|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
23200714|NCT01187901|64473490|FG000|Overall Study|Protocol Violation|1|||
23200715|NCT01187901|64473491|FG001|Overall Study|Protocol Violation|0|||
23200716|NCT01187901|64473490|FG000|Overall Study|Lost to Follow-up|1|||
23200717|NCT01187901|64473491|FG001|Overall Study|Lost to Follow-up|2|||
23200718|NCT01187901|64473490|FG000|Overall Study|Unrelated Health Reasons|1|||
23200719|NCT01187901|64473491|FG001|Overall Study|Unrelated Health Reasons|2|||
23200720|NCT01187901|64473490|FG000|Overall Study|Suspected Allergic Reaction|1|||
23200721|NCT01187901|64473491|FG001|Overall Study|Suspected Allergic Reaction|1|||
23200722|NCT01187901|64473490|FG000|Overall Study|Adverse Event|3|||
23200723|NCT01187901|64473491|FG001|Overall Study|Adverse Event|0|||
23200724|NCT01187901|64473490|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
23200725|NCT01187901|64473491|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
23200726|NCT01187901|64473490|FG000|Overall Study|Pregnancy|0|||
23200727|NCT01187901|64473491|FG001|Overall Study|Pregnancy|2|||
23200728|NCT00972244|64473495|FG000|Overall Study|Incorrect Enrolment|1|||
23262014|NCT01393990|64700566|FG011|Overall Study|Progressive Disease|0|||
23200729|NCT00972244|64473496|FG001|Overall Study|Incorrect Enrolment|0|||
23200730|NCT00972244|64473497|FG002|Overall Study|Incorrect Enrolment|0|||
23200731|NCT00972244|64473498|FG003|Overall Study|Incorrect Enrolment|0|||
23361680|NCT00436826|65069782|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23361681|NCT00436826|65069783|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
23262015|NCT01393990|64700567|FG012|Overall Study|Progressive Disease|0|||
23262016|NCT01393990|64700568|FG013|Overall Study|Progressive Disease|1|||
23262017|NCT01393990|64700569|FG014|Overall Study|Progressive Disease|6|||
23262018|NCT01393990|64700570|FG015|Overall Study|Progressive Disease|1|||
23262019|NCT01393990|64700571|FG016|Overall Study|Progressive Disease|0|||
23262020|NCT01393990|64700572|FG017|Overall Study|Progressive Disease|0|||
23262021|NCT01393990|64700555|FG000|Overall Study|Death|0|||
23262022|NCT01393990|64700556|FG001|Overall Study|Death|0|||
23262023|NCT01393990|64700557|FG002|Overall Study|Death|0|||
23262024|NCT01393990|64700558|FG003|Overall Study|Death|0|||
23361682|NCT00436826|65069778|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
23361683|NCT00436826|65069779|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
23361684|NCT00436826|65069780|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
23361685|NCT00436826|65069781|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
23361686|NCT00436826|65069782|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
23361687|NCT00436826|65069783|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
23361688|NCT00436826|65069778|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
23361689|NCT00436826|65069779|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
23361690|NCT00436826|65069780|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
23361691|NCT00436826|65069781|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
23361692|NCT00436826|65069782|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
23361693|NCT00436826|65069783|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
23361694|NCT03518086|65069784|FG000|Overall Study|Adverse Event|23|||
23361695|NCT03518086|65069785|FG001|Overall Study|Adverse Event|15|||
23361696|NCT03518086|65069786|FG002|Overall Study|Adverse Event|0|||
23361697|NCT03518086|65069787|FG003|Overall Study|Adverse Event|0|||
23361698|NCT03518086|65069784|FG000|Overall Study|Withdrawal by Subject|8|||
23361699|NCT03518086|65069785|FG001|Overall Study|Withdrawal by Subject|5|||
23361700|NCT03518086|65069786|FG002|Overall Study|Withdrawal by Subject|0|||
23361701|NCT03518086|65069787|FG003|Overall Study|Withdrawal by Subject|0|||
23361702|NCT03518086|65069784|FG000|Overall Study|Lack of Efficacy|5|||
23361703|NCT03518086|65069785|FG001|Overall Study|Lack of Efficacy|5|||
23361704|NCT03518086|65069786|FG002|Overall Study|Lack of Efficacy|0|||
23361705|NCT03518086|65069787|FG003|Overall Study|Lack of Efficacy|0|||
23361706|NCT03518086|65069784|FG000|Overall Study|Protocol Violation|1|||
23361707|NCT03518086|65069785|FG001|Overall Study|Protocol Violation|5|||
23361708|NCT03518086|65069786|FG002|Overall Study|Protocol Violation|0|||
23361709|NCT03518086|65069787|FG003|Overall Study|Protocol Violation|0|||
23361710|NCT03518086|65069784|FG000|Overall Study|Lost to Follow-up|0|||
23361711|NCT03518086|65069785|FG001|Overall Study|Lost to Follow-up|3|||
23361712|NCT03518086|65069786|FG002|Overall Study|Lost to Follow-up|0|||
23361713|NCT03518086|65069787|FG003|Overall Study|Lost to Follow-up|0|||
23361714|NCT03518086|65069784|FG000|Overall Study|Insufficient Diary Data|0|||
23600727|NCT02079649|65929701|FG003|Overall Study|Randomization error (prior to treatment)|0|||
23600728|NCT01532648|65929702|FG000|Overall Study|Lost to Follow-up|3|||
23600729|NCT01532648|65929703|FG001|Overall Study|Lost to Follow-up|4|||
23600730|NCT01532648|65929702|FG000|Overall Study|Lack of Efficacy|4|||
23600731|NCT01532648|65929703|FG001|Overall Study|Lack of Efficacy|1|||
23600732|NCT01532648|65929702|FG000|Overall Study|Protocol Violation|1|||
23600733|NCT01532648|65929703|FG001|Overall Study|Protocol Violation|1|||
23600734|NCT01532648|65929702|FG000|Overall Study|Adverse Event|12|||
23600735|NCT01532648|65929703|FG001|Overall Study|Adverse Event|9|||
23600736|NCT01532648|65929702|FG000|Overall Study|Withdrawal by Subject|16|||
23600737|NCT01532648|65929703|FG001|Overall Study|Withdrawal by Subject|2|||
23262025|NCT01393990|64700559|FG004|Overall Study|Death|1|||
23262026|NCT01393990|64700560|FG005|Overall Study|Death|0|||
23361715|NCT03518086|65069785|FG001|Overall Study|Insufficient Diary Data|2|||
23361716|NCT03518086|65069786|FG002|Overall Study|Insufficient Diary Data|0|||
23361717|NCT03518086|65069787|FG003|Overall Study|Insufficient Diary Data|0|||
23361718|NCT03518086|65069784|FG000|Overall Study|Non- compliance to Protocol|0|||
23361719|NCT03518086|65069785|FG001|Overall Study|Non- compliance to Protocol|1|||
23361720|NCT03518086|65069786|FG002|Overall Study|Non- compliance to Protocol|0|||
23361721|NCT03518086|65069787|FG003|Overall Study|Non- compliance to Protocol|0|||
23600738|NCT04220775|65929705|FG000|Overall Study|Adverse Event|1|||
23600739|NCT04220775|65929706|FG001|Overall Study|Adverse Event|0|||
23600740|NCT04220775|65929705|FG000|Overall Study|Disease Progression|1|||
23262027|NCT01393990|64700561|FG006|Overall Study|Death|0|||
23262028|NCT01393990|64700562|FG007|Overall Study|Death|0|||
23262029|NCT01393990|64700563|FG008|Overall Study|Death|0|||
23262030|NCT01393990|64700564|FG009|Overall Study|Death|0|||
23262031|NCT01393990|64700565|FG010|Overall Study|Death|0|||
23262032|NCT01393990|64700566|FG011|Overall Study|Death|0|||
23262033|NCT01393990|64700567|FG012|Overall Study|Death|0|||
23262034|NCT01393990|64700568|FG013|Overall Study|Death|1|||
23262035|NCT01393990|64700569|FG014|Overall Study|Death|1|||
23262036|NCT01393990|64700570|FG015|Overall Study|Death|0|||
23262037|NCT01393990|64700571|FG016|Overall Study|Death|0|||
23262038|NCT01393990|64700572|FG017|Overall Study|Death|0|||
23262039|NCT01393990|64700555|FG000|Overall Study|Withdrawal by Subject|0|||
23262040|NCT01393990|64700556|FG001|Overall Study|Withdrawal by Subject|0|||
23262041|NCT01393990|64700557|FG002|Overall Study|Withdrawal by Subject|0|||
23262042|NCT01393990|64700558|FG003|Overall Study|Withdrawal by Subject|0|||
23262043|NCT01393990|64700559|FG004|Overall Study|Withdrawal by Subject|0|||
23262044|NCT01393990|64700560|FG005|Overall Study|Withdrawal by Subject|0|||
23262045|NCT01393990|64700561|FG006|Overall Study|Withdrawal by Subject|0|||
23262046|NCT01393990|64700562|FG007|Overall Study|Withdrawal by Subject|0|||
23262047|NCT01393990|64700563|FG008|Overall Study|Withdrawal by Subject|0|||
23262048|NCT01393990|64700564|FG009|Overall Study|Withdrawal by Subject|0|||
23262049|NCT01393990|64700565|FG010|Overall Study|Withdrawal by Subject|0|||
23361722|NCT03518086|65069784|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
23361723|NCT03518086|65069785|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
23480487|NCT04585009|65502000|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480488|NCT04585009|65502001|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
23480489|NCT04585009|65502002|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
23480490|NCT04839562|65502006|FG000|Overall Study|Withdrawal by Subject|0|||
23361724|NCT03518086|65069786|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
23361725|NCT03518086|65069787|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
23361726|NCT03518086|65069784|FG000|Overall Study|Site Terminated by Sponsor|0|||
23361727|NCT03518086|65069785|FG001|Overall Study|Site Terminated by Sponsor|1|||
23361728|NCT03518086|65069786|FG002|Overall Study|Site Terminated by Sponsor|0|||
23361729|NCT03518086|65069787|FG003|Overall Study|Site Terminated by Sponsor|0|||
23361730|NCT00621257|65069788|FG000|Overall Study|Lost to Follow-up|4|||
23361731|NCT00621257|65069789|FG001|Overall Study|Lost to Follow-up|0|||
23361732|NCT00621257|65069790|FG002|Overall Study|Lost to Follow-up|2|||
23361733|NCT00621257|65069791|FG003|Overall Study|Lost to Follow-up|4|||
23361734|NCT00621257|65069792|FG004|Overall Study|Lost to Follow-up|7|||
23480491|NCT04839562|65502007|FG001|Overall Study|Withdrawal by Subject|1|||
23480492|NCT04839562|65502006|FG000|Overall Study|Physician Decision|0|||
23480493|NCT04839562|65502007|FG001|Overall Study|Physician Decision|1|||
23480494|NCT00775203|65502008|FG000|Overall Study|Adverse Event|25|||
23480495|NCT00775203|65502009|FG001|Overall Study|Adverse Event|6|||
23480496|NCT00775203|65502008|FG000|Overall Study|Lack of Efficacy|8|||
23480497|NCT00775203|65502009|FG001|Overall Study|Lack of Efficacy|9|||
23361735|NCT00621257|65069788|FG000|Overall Study|Adverse Event|0|||
23480498|NCT00775203|65502008|FG000|Overall Study|Withdrawal by Subject|11|||
23480499|NCT00775203|65502009|FG001|Overall Study|Withdrawal by Subject|9|||
23262050|NCT01393990|64700566|FG011|Overall Study|Withdrawal by Subject|0|||
23262051|NCT01393990|64700567|FG012|Overall Study|Withdrawal by Subject|0|||
23262052|NCT01393990|64700568|FG013|Overall Study|Withdrawal by Subject|0|||
23262053|NCT01393990|64700569|FG014|Overall Study|Withdrawal by Subject|1|||
23262054|NCT01393990|64700570|FG015|Overall Study|Withdrawal by Subject|1|||
23262055|NCT01393990|64700571|FG016|Overall Study|Withdrawal by Subject|0|||
23361736|NCT00621257|65069789|FG001|Overall Study|Adverse Event|1|||
23262056|NCT01393990|64700572|FG017|Overall Study|Withdrawal by Subject|0|||
23262057|NCT01118728|64700575|FG000|Overall Study|Adverse Event|17|||
23262058|NCT01118728|64700575|FG000|Overall Study|Lack of Efficacy|27|||
23262059|NCT01118728|64700575|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
23262060|NCT01118728|64700575|FG000|Overall Study|Withdrawal by Subject|3|||
23262061|NCT01118728|64700575|FG000|Overall Study|Lost to Follow-up|4|||
23262062|NCT01488578|64700576|FG000|Overall Study|Protocol Violation|1836|||
23262063|NCT01497938|64700577|FG000|Overall Study|Adverse Event|0|||
23262064|NCT01497938|64700578|FG001|Overall Study|Adverse Event|1|||
23262065|NCT01497938|64700577|FG000|Overall Study|Physician Decision|0|||
23262066|NCT01497938|64700578|FG001|Overall Study|Physician Decision|1|||
23262067|NCT01497938|64700577|FG000|Overall Study|Withdrawal by Subject|4|||
23262068|NCT01497938|64700578|FG001|Overall Study|Withdrawal by Subject|0|||
23262069|NCT01497938|64700577|FG000|Overall Study|Device Violation|1|||
23262070|NCT01497938|64700578|FG001|Overall Study|Device Violation|0|||
23262071|NCT02919475|64700582|FG000|Overall Study|Adverse Event|3|||
23262072|NCT02919475|64700583|FG001|Overall Study|Adverse Event|3|||
23262073|NCT02919475|64700584|FG002|Overall Study|Adverse Event|3|||
23262074|NCT02919475|64700585|FG003|Overall Study|Adverse Event|9|||
23262075|NCT02919475|64700586|FG004|Overall Study|Adverse Event|2|||
23262076|NCT02919475|64700582|FG000|Overall Study|Death|0|||
23262077|NCT02919475|64700583|FG001|Overall Study|Death|1|||
23262078|NCT02919475|64700584|FG002|Overall Study|Death|0|||
23262079|NCT02919475|64700585|FG003|Overall Study|Death|0|||
23262080|NCT02919475|64700586|FG004|Overall Study|Death|0|||
23262081|NCT02919475|64700582|FG000|Overall Study|Lost to Follow-up|0|||
23262082|NCT02919475|64700583|FG001|Overall Study|Lost to Follow-up|0|||
23262083|NCT02919475|64700584|FG002|Overall Study|Lost to Follow-up|0|||
23262084|NCT02919475|64700585|FG003|Overall Study|Lost to Follow-up|1|||
23262085|NCT02919475|64700586|FG004|Overall Study|Lost to Follow-up|0|||
23262086|NCT02919475|64700582|FG000|Overall Study|Withdrawal by Subject|2|||
23262087|NCT02919475|64700583|FG001|Overall Study|Withdrawal by Subject|3|||
23262088|NCT02919475|64700584|FG002|Overall Study|Withdrawal by Subject|1|||
23262089|NCT02919475|64700585|FG003|Overall Study|Withdrawal by Subject|2|||
23361737|NCT00621257|65069790|FG002|Overall Study|Adverse Event|1|||
23361738|NCT00621257|65069791|FG003|Overall Study|Adverse Event|0|||
23361739|NCT00621257|65069792|FG004|Overall Study|Adverse Event|0|||
23361740|NCT00621257|65069788|FG000|Overall Study|Physician Decision|0|||
23361741|NCT00621257|65069789|FG001|Overall Study|Physician Decision|2|||
23361742|NCT00621257|65069790|FG002|Overall Study|Physician Decision|0|||
23361743|NCT00621257|65069791|FG003|Overall Study|Physician Decision|1|||
23361744|NCT00621257|65069792|FG004|Overall Study|Physician Decision|1|||
23361745|NCT00621257|65069788|FG000|Overall Study|Withdrawal by Subject|0|||
23361746|NCT00621257|65069789|FG001|Overall Study|Withdrawal by Subject|0|||
23200732|NCT00972244|64473499|FG004|Overall Study|Incorrect Enrolment|0|||
23200733|NCT00972244|64473495|FG000|Overall Study|Adverse Event|0|||
23200734|NCT00972244|64473496|FG001|Overall Study|Adverse Event|1|||
23200735|NCT00972244|64473497|FG002|Overall Study|Adverse Event|1|||
23200736|NCT00972244|64473498|FG003|Overall Study|Adverse Event|0|||
23200737|NCT00972244|64473499|FG004|Overall Study|Adverse Event|0|||
23200738|NCT00972244|64473495|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
23200739|NCT00972244|64473496|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
23200740|NCT00972244|64473497|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
23200741|NCT00972244|64473498|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
23200742|NCT00972244|64473499|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
23200743|NCT00972244|64473495|FG000|Overall Study|Withdrawal by Subject|1|||
23200744|NCT00972244|64473496|FG001|Overall Study|Withdrawal by Subject|2|||
23200745|NCT00972244|64473497|FG002|Overall Study|Withdrawal by Subject|1|||
23200746|NCT00972244|64473498|FG003|Overall Study|Withdrawal by Subject|0|||
23200747|NCT00972244|64473499|FG004|Overall Study|Withdrawal by Subject|1|||
23200748|NCT00972244|64473495|FG000|Overall Study|Safety|0|||
23200749|NCT00972244|64473496|FG001|Overall Study|Safety|0|||
23262090|NCT02919475|64700586|FG004|Overall Study|Withdrawal by Subject|2|||
23262091|NCT02919475|64700582|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23262092|NCT02919475|64700583|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23262093|NCT02919475|64700584|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23262094|NCT02919475|64700585|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
23361747|NCT00621257|65069790|FG002|Overall Study|Withdrawal by Subject|0|||
23361748|NCT00621257|65069791|FG003|Overall Study|Withdrawal by Subject|1|||
23361749|NCT00621257|65069792|FG004|Overall Study|Withdrawal by Subject|1|||
23200750|NCT00972244|64473497|FG002|Overall Study|Safety|0|||
23200751|NCT00972244|64473498|FG003|Overall Study|Safety|0|||
23262095|NCT02919475|64700586|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
23361750|NCT00397189|65069800|FG000|3 Weeks Period|Lost to Follow-up|5|||
23361751|NCT00397189|65069801|FG001|3 Weeks Period|Lost to Follow-up|4|||
23200752|NCT00972244|64473499|FG004|Overall Study|Safety|1|||
23200753|NCT00972244|64473495|FG000|Overall Study|Death|1|||
23262096|NCT01165996|64700587|FG000|Overall Study|Death|1|||
23361752|NCT00397189|65069800|FG000|3 Weeks Period|Adverse Event|3|||
23600741|NCT04220775|65929706|FG001|Overall Study|Disease Progression|0|||
23200754|NCT00972244|64473496|FG001|Overall Study|Death|0|||
23200755|NCT00972244|64473497|FG002|Overall Study|Death|0|||
23200756|NCT00972244|64473498|FG003|Overall Study|Death|0|||
23200757|NCT00972244|64473499|FG004|Overall Study|Death|0|||
23200758|NCT00972244|64473495|FG000|Overall Study|Various|0|||
23200759|NCT00972244|64473496|FG001|Overall Study|Various|0|||
23200760|NCT00972244|64473497|FG002|Overall Study|Various|0|||
23200761|NCT00972244|64473498|FG003|Overall Study|Various|0|||
23262097|NCT01165996|64700587|FG000|Overall Study|Physician Decision|1|||
23262098|NCT00419926|64700592|FG000|Overall Study|Withdrawal by Subject|7|||
23262099|NCT00419926|64700593|FG001|Overall Study|Withdrawal by Subject|3|||
23262100|NCT00419926|64700592|FG000|Overall Study|Administrative Problem|4|||
23262101|NCT00419926|64700593|FG001|Overall Study|Administrative Problem|4|||
23262102|NCT00419926|64700592|FG000|Overall Study|Lost to Follow-up|1|||
23262103|NCT00419926|64700593|FG001|Overall Study|Lost to Follow-up|2|||
23262104|NCT00419926|64700592|FG000|Overall Study|Death|2|||
23262105|NCT00419926|64700593|FG001|Overall Study|Death|1|||
23262106|NCT01227668|64700596|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
23262107|NCT01227668|64700597|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
23262108|NCT01227668|64700596|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
23262109|NCT01227668|64700597|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
23262110|NCT01227668|64700596|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
23262111|NCT01227668|64700597|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
23262112|NCT01227668|64700596|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
23262113|NCT01227668|64700597|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
23262114|NCT01227668|64700596|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
23262115|NCT01227668|64700597|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
23262116|NCT01227668|64700596|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
23262117|NCT01227668|64700597|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
23262118|NCT01227668|64700596|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
23262119|NCT01227668|64700597|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
23262120|NCT01227668|64700596|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
23262121|NCT01227668|64700597|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
23262122|NCT01227668|64700596|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
23262123|NCT01227668|64700597|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
23262124|NCT01227668|64700596|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
23262125|NCT01227668|64700597|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
23262126|NCT01227668|64700596|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
23262127|NCT01227668|64700597|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
23262128|NCT01227668|64700596|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
23262129|NCT01227668|64700597|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
23262130|NCT01564758|64700598|FG000|Overall Study|Death|8|||
23262131|NCT01564758|64700598|FG000|Overall Study|Adverse Event|3|||
23262132|NCT01564758|64700598|FG000|Overall Study|Other|3|||
23262133|NCT03937466|64700599|FG000|Overall Study|not eligbile after the 2-week diary|9|||
23262134|NCT03937466|64700599|FG000|Overall Study|never returned their diary|6|||
23262135|NCT03937466|64700599|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
23262136|NCT03937466|64700599|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
23200762|NCT00972244|64473499|FG004|Overall Study|Various|2|||
23262137|NCT02231710|64700600|FG000|Overall Study|Physician Decision|1|||
23262138|NCT01628120|64700601|FG000|Overall Study|Withdrawal by Subject|7|||
23262139|NCT01628120|64700601|FG000|Overall Study|Adverse Event|12|||
23200763|NCT00620321|64473500|FG000|Overall Study|Adverse Event|1|||
23200764|NCT00620321|64473501|FG001|Overall Study|Adverse Event|1|||
23200765|NCT00620321|64473500|FG000|Overall Study|Death|1|||
23262140|NCT01628120|64700601|FG000|Overall Study|Lost to Follow-up|1|||
23262141|NCT01628120|64700601|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
23262142|NCT01628120|64700601|FG000|Overall Study|Non-compliant with Study Procedures|1|||
23262143|NCT01628120|64700601|FG000|Overall Study|Not Treated|3|||
23262144|NCT01628120|64700601|FG000|Overall Study|Sponsor Decision|5|||
23262145|NCT01628120|64700601|FG000|Overall Study|Switched Dialysis Method|2|||
23262146|NCT01628120|64700601|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
23262147|NCT01628120|64700601|FG000|Overall Study|Moved or Relocated|5|||
23262148|NCT01628120|64700601|FG000|Overall Study|Kidney Transplant|2|||
23262149|NCT01628120|64700601|FG000|Overall Study|Use of Standard of Care|1|||
23262150|NCT02497781|64700602|FG000|Overall Study|Withdrawal by Subject|2|||
23262151|NCT02497781|64700603|FG001|Overall Study|Withdrawal by Subject|0|||
23262152|NCT02497781|64700602|FG000|Overall Study|Lack of Efficacy|0|||
23262153|NCT02497781|64700603|FG001|Overall Study|Lack of Efficacy|1|||
23262154|NCT02497781|64700602|FG000|Overall Study|Randomised but not treated|1|||
23262155|NCT02497781|64700603|FG001|Overall Study|Randomised but not treated|1|||
23262156|NCT02497781|64700602|FG000|Overall Study|Lost to Follow-up|1|||
23262157|NCT02497781|64700603|FG001|Overall Study|Lost to Follow-up|1|||
23262158|NCT01090765|64700606|FG000|Overall Study|Patient withdrew consent|0|||
23262159|NCT01090765|64700607|FG001|Overall Study|Patient withdrew consent|0|||
23262160|NCT01090765|64700608|FG002|Overall Study|Patient withdrew consent|0|||
23361753|NCT00397189|65069801|FG001|3 Weeks Period|Adverse Event|2|||
23361754|NCT00397189|65069800|FG000|3 Weeks Period|Withdrawal by Subject|13|||
23361755|NCT00397189|65069801|FG001|3 Weeks Period|Withdrawal by Subject|9|||
23361756|NCT00397189|65069800|FG000|3 Weeks Period|Physician Decision|0|||
23361757|NCT00397189|65069801|FG001|3 Weeks Period|Physician Decision|2|||
23361758|NCT00397189|65069800|FG000|3 Weeks Period|Protocol Violation|0|||
23361759|NCT00397189|65069801|FG001|3 Weeks Period|Protocol Violation|3|||
23361760|NCT00397189|65069800|FG000|3 Weeks Period|Other|0|||
23262161|NCT01090765|64700609|FG003|Overall Study|Patient withdrew consent|0|||
23262162|NCT01090765|64700610|FG004|Overall Study|Patient withdrew consent|1|||
23262163|NCT01090765|64700611|FG005|Overall Study|Patient withdrew consent|1|||
23262164|NCT01090765|64700606|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
23262165|NCT01090765|64700607|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
23262166|NCT01090765|64700608|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
23262167|NCT01090765|64700609|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
23262168|NCT01090765|64700610|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
23262169|NCT01090765|64700611|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
23262170|NCT01090765|64700606|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
23262171|NCT01090765|64700607|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
23262172|NCT01090765|64700608|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
23262173|NCT01090765|64700609|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
23262174|NCT01090765|64700610|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
23262175|NCT01090765|64700611|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
23262176|NCT02038634|64700612|FG000|Overall Study|Lost to Follow-up|0|||
23262177|NCT02038634|64700613|FG001|Overall Study|Lost to Follow-up|1|||
23262178|NCT01048333|64700614|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23262179|NCT01048333|64700615|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
23262180|NCT01048333|64700616|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23262181|NCT01048333|64700617|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23262182|NCT01048333|64700618|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23262183|NCT01048333|64700619|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
23262184|NCT05188521|64700624|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
23262185|NCT05188521|64700625|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
23262186|NCT03850509|64700627|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
23262187|NCT03850509|64700628|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
23262188|NCT00278200|64700630|FG000|Overall Study|Death|1|||
23262189|NCT00278200|64700631|FG001|Overall Study|Death|3|||
23262190|NCT00278200|64700630|FG000|Overall Study|Physician Decision|0|||
23262191|NCT00278200|64700631|FG001|Overall Study|Physician Decision|1|||
23262192|NCT00704418|64700632|FG000|Overall Study|Withdrawal by Subject|2|||
23262193|NCT00704418|64700633|FG001|Overall Study|Withdrawal by Subject|0|||
23262194|NCT00704418|64700632|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
23262195|NCT00704418|64700633|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
23262196|NCT03734237|64700634|FG000|Overall Study|Lost to Follow-up|1|||
23262197|NCT03734237|64700635|FG001|Overall Study|Lost to Follow-up|3|||
23262198|NCT03734237|64700636|FG002|Overall Study|Lost to Follow-up|0|||
23262199|NCT03734237|64700634|FG000|Overall Study|Withdrawal by Subject|7|||
23262200|NCT03734237|64700635|FG001|Overall Study|Withdrawal by Subject|9|||
23262201|NCT03734237|64700636|FG002|Overall Study|Withdrawal by Subject|10|||
23262202|NCT02087059|64700641|FG000|Overall Study|Disease Progression|1|||
23262203|NCT02087059|64700641|FG000|Overall Study|Adverse Event|5|||
23262204|NCT02087059|64700641|FG000|Overall Study|Lost to Follow-up|1|||
23262205|NCT01752920|64700642|FG000|Overall Study|Adverse Event|1|||
23262206|NCT01752920|64700643|FG001|Overall Study|Adverse Event|0|||
23262207|NCT01752920|64700644|FG002|Overall Study|Adverse Event|5|||
23262208|NCT01752920|64700645|FG003|Overall Study|Adverse Event|10|||
23262209|NCT01752920|64700642|FG000|Overall Study|Clinical Disease Progression|6|||
23262210|NCT01752920|64700643|FG001|Overall Study|Clinical Disease Progression|4|||
23361761|NCT00397189|65069801|FG001|3 Weeks Period|Other|2|||
23361762|NCT05401565|65069808|FG000|Overall Study|Lost to Follow-up|1|||
23262211|NCT01752920|64700644|FG002|Overall Study|Clinical Disease Progression|1|||
23262212|NCT01752920|64700645|FG003|Overall Study|Clinical Disease Progression|13|||
23262213|NCT01752920|64700642|FG000|Overall Study|Physician Decision|1|||
23262214|NCT01752920|64700643|FG001|Overall Study|Physician Decision|0|||
23262215|NCT01752920|64700644|FG002|Overall Study|Physician Decision|0|||
23262216|NCT01752920|64700645|FG003|Overall Study|Physician Decision|3|||
23262217|NCT01752920|64700642|FG000|Overall Study|Radiographic Disease Progression|20|||
23262218|NCT01752920|64700643|FG001|Overall Study|Radiographic Disease Progression|7|||
23262219|NCT01752920|64700644|FG002|Overall Study|Radiographic Disease Progression|12|||
23262220|NCT01752920|64700645|FG003|Overall Study|Radiographic Disease Progression|29|||
23262221|NCT01752920|64700642|FG000|Overall Study|Study Terminated by Sponsor|0|||
23262222|NCT01752920|64700643|FG001|Overall Study|Study Terminated by Sponsor|0|||
23262223|NCT01752920|64700644|FG002|Overall Study|Study Terminated by Sponsor|0|||
23262224|NCT01752920|64700645|FG003|Overall Study|Study Terminated by Sponsor|1|||
23262225|NCT01752920|64700642|FG000|Overall Study|Withdrawal by Subject|0|||
23262226|NCT01752920|64700643|FG001|Overall Study|Withdrawal by Subject|1|||
23262227|NCT01752920|64700644|FG002|Overall Study|Withdrawal by Subject|0|||
23262228|NCT01752920|64700645|FG003|Overall Study|Withdrawal by Subject|1|||
23262229|NCT01752920|64700642|FG000|Overall Study|Lack of clinical benefit|1|||
23262230|NCT01752920|64700643|FG001|Overall Study|Lack of clinical benefit|1|||
23262231|NCT01752920|64700644|FG002|Overall Study|Lack of clinical benefit|1|||
23262232|NCT01752920|64700645|FG003|Overall Study|Lack of clinical benefit|1|||
23262233|NCT00423800|64700646|FG000|Overall Study|Protocol Violation|0|||
23262234|NCT00423800|64700647|FG001|Overall Study|Protocol Violation|1|||
23262235|NCT02180061|64700648|FG000|Overall Study|Adverse Event|4|||
23262236|NCT02180061|64700649|FG001|Overall Study|Adverse Event|2|||
23262237|NCT02180061|64700648|FG000|Overall Study|Clinical Progression|5|||
23262238|NCT02180061|64700649|FG001|Overall Study|Clinical Progression|1|||
23262239|NCT02180061|64700648|FG000|Overall Study|Progressive Disease|15|||
23262240|NCT02180061|64700649|FG001|Overall Study|Progressive Disease|5|||
23262241|NCT02180061|64700648|FG000|Overall Study|Physician Decision|1|||
23262242|NCT02180061|64700649|FG001|Overall Study|Physician Decision|0|||
23262243|NCT01368276|64700650|FG000|Overall Study|Death|1|||
23262244|NCT01368276|64700651|FG001|Overall Study|Death|10|||
23262245|NCT03650400|64700652|FG000|Overall Study|Study terminated by sponsor|0|||
23262246|NCT03650400|64700653|FG001|Overall Study|Study terminated by sponsor|5|||
23262247|NCT00947856|64700654|FG000|Treatment Period|Progressive Disease|33|||
23262248|NCT00947856|64700655|FG001|Treatment Period|Progressive Disease|12|||
23262249|NCT00947856|64700654|FG000|Treatment Period|Adverse Event|15|||
23262250|NCT00947856|64700655|FG001|Treatment Period|Adverse Event|9|||
23262251|NCT00947856|64700654|FG000|Treatment Period|Physician Decision|14|||
23262252|NCT00947856|64700655|FG001|Treatment Period|Physician Decision|6|||
23262253|NCT00947856|64700654|FG000|Treatment Period|Study Stopped by Sponsor|4|||
23262254|NCT00947856|64700655|FG001|Treatment Period|Study Stopped by Sponsor|4|||
23262255|NCT00947856|64700654|FG000|Treatment Period|Withdrawal by Subject|12|||
23262256|NCT00947856|64700655|FG001|Treatment Period|Withdrawal by Subject|1|||
23262257|NCT00947856|64700654|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
23262258|NCT00947856|64700655|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
23361763|NCT05401565|65069809|FG001|Overall Study|Lost to Follow-up|0|||
23200766|NCT00620321|64473501|FG001|Overall Study|Death|1|||
23200767|NCT00620321|64473500|FG000|Overall Study|Physician Decision|0|||
23200768|NCT00620321|64473501|FG001|Overall Study|Physician Decision|7|||
23200769|NCT00620321|64473500|FG000|Overall Study|Progressive Disease|5|||
23200770|NCT00620321|64473501|FG001|Overall Study|Progressive Disease|5|||
23200771|NCT00620321|64473500|FG000|Overall Study|Sponsor Decision|0|||
23200772|NCT00620321|64473501|FG001|Overall Study|Sponsor Decision|1|||
23200773|NCT00620321|64473500|FG000|Overall Study|Withdrawal by Subject|1|||
23200774|NCT00620321|64473501|FG001|Overall Study|Withdrawal by Subject|1|||
23200775|NCT00960440|64473513|FG000|Overall Study|Death|0|||
23200776|NCT00960440|64473514|FG001|Overall Study|Death|0|||
23200777|NCT00960440|64473515|FG002|Overall Study|Death|0|||
23200778|NCT00960440|64473516|FG003|Overall Study|Death|1|||
23200779|NCT00960440|64473513|FG000|Overall Study|Adverse Event|12|||
23200780|NCT00960440|64473514|FG001|Overall Study|Adverse Event|12|||
23200781|NCT00960440|64473515|FG002|Overall Study|Adverse Event|4|||
23200782|NCT00960440|64473516|FG003|Overall Study|Adverse Event|4|||
23200783|NCT00960440|64473513|FG000|Overall Study|Lack of Efficacy|2|||
23200784|NCT00960440|64473514|FG001|Overall Study|Lack of Efficacy|5|||
23200785|NCT00960440|64473515|FG002|Overall Study|Lack of Efficacy|3|||
23200786|NCT00960440|64473516|FG003|Overall Study|Lack of Efficacy|8|||
23200787|NCT00960440|64473513|FG000|Overall Study|Protocol Violation|2|||
23200788|NCT00960440|64473514|FG001|Overall Study|Protocol Violation|8|||
23200789|NCT00960440|64473515|FG002|Overall Study|Protocol Violation|3|||
23200790|NCT00960440|64473516|FG003|Overall Study|Protocol Violation|4|||
23200791|NCT00960440|64473513|FG000|Overall Study|Withdrawal by Subject|9|||
23200792|NCT00960440|64473514|FG001|Overall Study|Withdrawal by Subject|5|||
23200793|NCT00960440|64473515|FG002|Overall Study|Withdrawal by Subject|2|||
23200794|NCT00960440|64473516|FG003|Overall Study|Withdrawal by Subject|1|||
23200795|NCT00960440|64473513|FG000|Overall Study|Other|1|||
23200796|NCT00960440|64473514|FG001|Overall Study|Other|1|||
23200797|NCT00960440|64473515|FG002|Overall Study|Other|1|||
23200798|NCT00960440|64473516|FG003|Overall Study|Other|0|||
23200799|NCT00601523|64473517|FG000|Overall Study|Adverse Event|42|||
23200800|NCT00601523|64473518|FG001|Overall Study|Adverse Event|14|||
23200801|NCT00601523|64473517|FG000|Overall Study|Lack of Efficacy|3|||
23200802|NCT00601523|64473518|FG001|Overall Study|Lack of Efficacy|0|||
23200803|NCT00601523|64473517|FG000|Overall Study|Protocol Violation|5|||
23200804|NCT00601523|64473518|FG001|Overall Study|Protocol Violation|1|||
23200805|NCT00601523|64473517|FG000|Overall Study|Lost to Follow-up|0|||
23200806|NCT00601523|64473518|FG001|Overall Study|Lost to Follow-up|1|||
23200807|NCT00601523|64473517|FG000|Overall Study|Withdrawal by Subject|18|||
23200808|NCT00601523|64473518|FG001|Overall Study|Withdrawal by Subject|9|||
23200809|NCT00601523|64473517|FG000|Overall Study|Other|9|||
23200810|NCT00601523|64473518|FG001|Overall Study|Other|1|||
23200811|NCT01842620|64473521|FG000|Period 1|Withdrawal by Subject|1|||
23200812|NCT01842620|64473522|FG001|Period 1|Withdrawal by Subject|0|||
23200813|NCT01849250|64473523|FG000|Overall Study|Withdrawal by Subject|1|||
23200814|NCT01849250|64473524|FG001|Overall Study|Withdrawal by Subject|0|||
23200815|NCT01849250|64473523|FG000|Overall Study|Not Evaluable|5|||
23200816|NCT01849250|64473524|FG001|Overall Study|Not Evaluable|3|||
23200817|NCT01849250|64473523|FG000|Overall Study|Screen Failure|1|||
23200818|NCT01849250|64473524|FG001|Overall Study|Screen Failure|0|||
23200819|NCT05523362|64473526|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
23200820|NCT05523362|64473526|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
23262259|NCT00947856|64700654|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
23262260|NCT00947856|64700655|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
23262261|NCT00947856|64700654|FG000|Follow-up Period|Lost to Follow-up|7|||
23262262|NCT00947856|64700655|FG001|Follow-up Period|Lost to Follow-up|0|||
23262263|NCT00947856|64700654|FG000|Follow-up Period|Patient unavailable for site visits|1|||
23262264|NCT00947856|64700655|FG001|Follow-up Period|Patient unavailable for site visits|0|||
23262265|NCT00947856|64700654|FG000|Follow-up Period|Withdrawal by Subject|1|||
23262266|NCT00947856|64700655|FG001|Follow-up Period|Withdrawal by Subject|0|||
23262267|NCT01078090|64700656|FG000|Overall Study|Lost to Follow-up|2363|||
23262268|NCT01078090|64700656|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
23262269|NCT01078090|64700656|FG000|Overall Study|Lack of Efficacy|1193|||
23262270|NCT01078090|64700656|FG000|Overall Study|ADR and lack of efficacy|61|||
23262271|NCT01078090|64700656|FG000|Overall Study|Other|523|||
23262272|NCT00993616|64700657|FG000|Overall Study|No tumor at entry|1|||
23262273|NCT00993616|64700657|FG000|Overall Study|Never treated|1|||
23262274|NCT01724359|64700664|FG000|Overall Study|Adverse Event|10|||
23262275|NCT01724359|64700664|FG000|Overall Study|Death|1|||
23262276|NCT01724359|64700664|FG000|Overall Study|Other|20|||
23262277|NCT01958281|64700665|FG000|Overall Study|Lack of Efficacy|5|||
23262278|NCT01958281|64700666|FG001|Overall Study|Lack of Efficacy|2|||
23262279|NCT01958281|64700667|FG002|Overall Study|Lack of Efficacy|0|||
23262280|NCT01958281|64700665|FG000|Overall Study|Adverse Event|0|||
23262281|NCT01958281|64700666|FG001|Overall Study|Adverse Event|2|||
23262282|NCT01958281|64700667|FG002|Overall Study|Adverse Event|0|||
23262283|NCT01958281|64700665|FG000|Overall Study|Withdrew Consent|1|||
23262284|NCT01958281|64700666|FG001|Overall Study|Withdrew Consent|0|||
23262285|NCT01958281|64700667|FG002|Overall Study|Withdrew Consent|0|||
23262286|NCT01341639|64700673|FG000|Infant Series|Protocol Violation|1|||
23262287|NCT01341639|64700674|FG001|Infant Series|Protocol Violation|0|||
23262288|NCT01341639|64700673|FG000|Infant Series|Not Vaccinated|0|||
23262289|NCT01341639|64700674|FG001|Infant Series|Not Vaccinated|1|||
23262290|NCT01341639|64700673|FG000|Infant Series|Adverse Event|0|||
23262291|NCT01341639|64700674|FG001|Infant Series|Adverse Event|5|||
23262292|NCT01341639|64700673|FG000|Infant Series|Withdrawal by Subject|11|||
23262293|NCT01341639|64700674|FG001|Infant Series|Withdrawal by Subject|8|||
23262294|NCT01341639|64700673|FG000|Infant Series|Lost to Follow-up|0|||
23262295|NCT01341639|64700674|FG001|Infant Series|Lost to Follow-up|2|||
23262296|NCT01341639|64700673|FG000|Infant Series|Site 0048 Participants|17|||
23262297|NCT01341639|64700674|FG001|Infant Series|Site 0048 Participants|16|||
23262298|NCT01341639|64700673|FG000|Interim Period|Withdrawal by Subject|6|||
23262299|NCT01341639|64700674|FG001|Interim Period|Withdrawal by Subject|7|||
23262300|NCT01341639|64700673|FG000|Interim Period|Lost to Follow-up|2|||
23262301|NCT01341639|64700674|FG001|Interim Period|Lost to Follow-up|0|||
23262302|NCT01341639|64700673|FG000|Interim Period|Physician Decision|0|||
23262303|NCT01341639|64700674|FG001|Interim Period|Physician Decision|1|||
23262304|NCT01341639|64700673|FG000|Interim Period|Protocol Violation|0|||
23262305|NCT01341639|64700674|FG001|Interim Period|Protocol Violation|1|||
23262306|NCT01341639|64700673|FG000|Post-Treatment|Withdrawal by Subject|0|||
23262307|NCT01341639|64700674|FG001|Post-Treatment|Withdrawal by Subject|1|||
23262308|NCT01341639|64700673|FG000|Post-Treatment|Adverse Event|0|||
23262309|NCT01341639|64700674|FG001|Post-Treatment|Adverse Event|2|||
23262310|NCT02843074|64703039|FG000|Overall Study|Withdrawal by Subject|5|||
23262311|NCT02843074|64703039|FG000|Overall Study|Progressive disease|1|||
23262312|NCT02843074|64703039|FG000|Overall Study|Physician Decision|1|||
23262313|NCT02843074|64703039|FG000|Overall Study|Lost to Follow-up|1|||
23262314|NCT02843074|64703039|FG000|Overall Study|Death|9|||
23262315|NCT01767597|64703044|FG000|Overall Study|Incomplete intervention|3|||
23262316|NCT01767597|64703045|FG001|Overall Study|Incomplete intervention|1|||
23262317|NCT01767597|64703044|FG000|Overall Study|Withdrawal by Subject|1|||
23262318|NCT01767597|64703045|FG001|Overall Study|Withdrawal by Subject|0|||
23262319|NCT00506753|64703048|FG000|Overall Study|Lost to Follow-up|21|||
23262320|NCT00506753|64703049|FG001|Overall Study|Lost to Follow-up|15|||
23361764|NCT05401565|65069808|FG000|Overall Study|Adverse Event|2|||
23262321|NCT03141177|64703051|FG000|Overall Study|Death|62|||
23262322|NCT03141177|64703052|FG001|Overall Study|Death|13|||
23262323|NCT03141177|64703053|FG002|Overall Study|Death|84|||
23262324|NCT03141177|64703051|FG000|Overall Study|Participant withdrew consent|9|||
23262325|NCT03141177|64703052|FG001|Overall Study|Participant withdrew consent|2|||
23262326|NCT03141177|64703053|FG002|Overall Study|Participant withdrew consent|13|||
23262327|NCT03141177|64703051|FG000|Overall Study|Not reported|1|||
23262328|NCT03141177|64703052|FG001|Overall Study|Not reported|0|||
23262329|NCT03141177|64703053|FG002|Overall Study|Not reported|1|||
23262330|NCT03141177|64703051|FG000|Overall Study|Lost to Follow-up|2|||
23262331|NCT03141177|64703052|FG001|Overall Study|Lost to Follow-up|1|||
23262332|NCT03141177|64703053|FG002|Overall Study|Lost to Follow-up|1|||
23262333|NCT03141177|64703051|FG000|Overall Study|Other reasons|4|||
23262334|NCT03141177|64703052|FG001|Overall Study|Other reasons|0|||
23262335|NCT03141177|64703053|FG002|Overall Study|Other reasons|11|||
23262336|NCT03141177|64703051|FG000|Overall Study|Participants did not start treatment period|3|||
23262337|NCT03141177|64703052|FG001|Overall Study|Participants did not start treatment period|0|||
23262338|NCT03141177|64703053|FG002|Overall Study|Participants did not start treatment period|8|||
23262339|NCT00449072|64703054|FG000|Overall Study|Adverse Event|3|||
23262340|NCT00449072|64703055|FG001|Overall Study|Adverse Event|1|||
23262341|NCT00449072|64703054|FG000|Overall Study|Protocol Violation|14|||
23262342|NCT00449072|64703055|FG001|Overall Study|Protocol Violation|12|||
23262343|NCT00449072|64703054|FG000|Overall Study|Lost to Follow-up|5|||
23262344|NCT00449072|64703055|FG001|Overall Study|Lost to Follow-up|7|||
23262345|NCT00449072|64703054|FG000|Overall Study|Withdrawal by Subject|11|||
23262346|NCT00449072|64703055|FG001|Overall Study|Withdrawal by Subject|8|||
23262347|NCT00449072|64703054|FG000|Overall Study|Lack of Efficacy|1|||
23262348|NCT00449072|64703055|FG001|Overall Study|Lack of Efficacy|1|||
23262349|NCT00449072|64703054|FG000|Overall Study|Physician Decision|1|||
23262350|NCT00449072|64703055|FG001|Overall Study|Physician Decision|0|||
23262351|NCT00449072|64703054|FG000|Overall Study|Not treated|0|||
23262352|NCT00449072|64703055|FG001|Overall Study|Not treated|1|||
23262353|NCT00449072|64703054|FG000|Overall Study|Excluded medication|0|||
23262354|NCT00449072|64703055|FG001|Overall Study|Excluded medication|2|||
23262355|NCT00449072|64703054|FG000|Overall Study|Non-compliance|2|||
23262356|NCT00449072|64703055|FG001|Overall Study|Non-compliance|5|||
23262357|NCT00449072|64703054|FG000|Overall Study|Sponsor decision|1|||
23262358|NCT00449072|64703055|FG001|Overall Study|Sponsor decision|3|||
23262359|NCT00449072|64703054|FG000|Overall Study|Relocation|3|||
23262360|NCT00449072|64703055|FG001|Overall Study|Relocation|2|||
23262361|NCT02315898|64703060|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
23262362|NCT02315898|64703061|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
23262363|NCT02315898|64703062|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
23262364|NCT02315898|64703063|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
23262365|NCT00783796|64703064|FG000|Overall Study|Did not receive any stent|4|||
23262366|NCT00783796|64703064|FG000|Overall Study|Received non-XIENCE V stent|1|||
23262367|NCT00783796|64703064|FG000|Overall Study|Received commercial XIENCE V stent|1|||
23262368|NCT02115256|64703065|FG000|Overall Study|Withdrawal by Subject|0|||
23262369|NCT02115256|64703066|FG001|Overall Study|Withdrawal by Subject|1|||
23262370|NCT00434161|64703067|FG000|Overall Study|Adverse Event|5|||
23262371|NCT00434161|64703068|FG001|Overall Study|Adverse Event|1|||
23262372|NCT00434161|64703069|FG002|Overall Study|Adverse Event|4|||
23262373|NCT00434161|64703067|FG000|Overall Study|Lost to Follow-up|0|||
23262374|NCT00434161|64703068|FG001|Overall Study|Lost to Follow-up|1|||
23262375|NCT00434161|64703069|FG002|Overall Study|Lost to Follow-up|0|||
23262376|NCT00434161|64703067|FG000|Overall Study|Death|1|||
23262377|NCT00434161|64703068|FG001|Overall Study|Death|0|||
23262378|NCT00434161|64703069|FG002|Overall Study|Death|1|||
23262379|NCT00434161|64703067|FG000|Overall Study|Non-Compliance|1|||
23262380|NCT00434161|64703068|FG001|Overall Study|Non-Compliance|1|||
23262381|NCT00434161|64703069|FG002|Overall Study|Non-Compliance|0|||
23262382|NCT00434161|64703067|FG000|Overall Study|Withdrawal by Subject|2|||
23262383|NCT00434161|64703068|FG001|Overall Study|Withdrawal by Subject|0|||
23262384|NCT00434161|64703069|FG002|Overall Study|Withdrawal by Subject|3|||
23262385|NCT00434161|64703067|FG000|Overall Study|Logistical error study assessments|1|||
23262386|NCT00434161|64703068|FG001|Overall Study|Logistical error study assessments|0|||
23262387|NCT00434161|64703069|FG002|Overall Study|Logistical error study assessments|3|||
23262388|NCT02396381|64703070|FG000|Overall Study|Adverse Event|3|||
23262389|NCT02396381|64703071|FG001|Overall Study|Adverse Event|2|||
23262390|NCT02396381|64703070|FG000|Overall Study|Withdrawal by Subject|33|||
23262391|NCT02396381|64703071|FG001|Overall Study|Withdrawal by Subject|24|||
23262392|NCT02396381|64703070|FG000|Overall Study|Lost to Follow-up|49|||
23262393|NCT02396381|64703071|FG001|Overall Study|Lost to Follow-up|31|||
23262394|NCT02396381|64703070|FG000|Overall Study|Protocol Violation|1|||
23262395|NCT02396381|64703071|FG001|Overall Study|Protocol Violation|0|||
23262396|NCT02396381|64703070|FG000|Overall Study|Site terminated by sponsor|7|||
23262397|NCT02396381|64703071|FG001|Overall Study|Site terminated by sponsor|8|||
23262398|NCT02396381|64703070|FG000|Overall Study|Physician Decision|5|||
23361765|NCT05401565|65069809|FG001|Overall Study|Adverse Event|0|||
23361766|NCT05404711|65069811|FG000|Completed Study Visit|Withdrawal by Subject|1|||
23361767|NCT05404711|65069811|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
23600742|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
23262399|NCT02396381|64703071|FG001|Overall Study|Physician Decision|5|||
23262400|NCT02396381|64703070|FG000|Overall Study|Pregnancy|2|||
23262401|NCT02396381|64703071|FG001|Overall Study|Pregnancy|0|||
23262402|NCT02396381|64703070|FG000|Overall Study|Non-compliance with study procedures|1|||
23262403|NCT02396381|64703071|FG001|Overall Study|Non-compliance with study procedures|0|||
23262404|NCT02396381|64703070|FG000|Overall Study|Moved out of town/state|1|||
23262405|NCT02396381|64703071|FG001|Overall Study|Moved out of town/state|3|||
23262406|NCT02396381|64703070|FG000|Overall Study|Could not complete visit|1|||
23262407|NCT02396381|64703071|FG001|Overall Study|Could not complete visit|0|||
23262408|NCT02396381|64703070|FG000|Overall Study|Possible conflict of interest|1|||
23262409|NCT02396381|64703071|FG001|Overall Study|Possible conflict of interest|0|||
23262410|NCT02396381|64703070|FG000|Overall Study|Randomization/Screening Error|3|||
23262411|NCT02396381|64703071|FG001|Overall Study|Randomization/Screening Error|1|||
23262412|NCT01466686|64703072|FG000|Overall Study|Withdrawal by Subject|1|||
23262413|NCT03341273|64703075|FG000|Overall Study|Lost to Follow-up|7|||
23262414|NCT03341273|64703076|FG001|Overall Study|Lost to Follow-up|7|||
23262415|NCT03341273|64703075|FG000|Overall Study|Withdrawal by Subject|4|||
23262416|NCT03341273|64703076|FG001|Overall Study|Withdrawal by Subject|2|||
23262417|NCT03341273|64703075|FG000|Overall Study|Physician Decision|1|||
23262418|NCT03341273|64703076|FG001|Overall Study|Physician Decision|0|||
23262419|NCT03341273|64703075|FG000|Overall Study|Protocol Violation|0|||
23262420|NCT03341273|64703076|FG001|Overall Study|Protocol Violation|1|||
23262421|NCT03341273|64703075|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
23262422|NCT03341273|64703076|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
23262423|NCT03341273|64703075|FG000|Overall Study|Became ineligible after enrollment|1|||
23262424|NCT03341273|64703076|FG001|Overall Study|Became ineligible after enrollment|0|||
23262425|NCT03341273|64703075|FG000|Overall Study|Not Eligible at Enrollment|0|||
23262426|NCT03341273|64703076|FG001|Overall Study|Not Eligible at Enrollment|1|||
23262427|NCT03341273|64703075|FG000|Overall Study|Participant incarcerated|1|||
23262428|NCT03341273|64703076|FG001|Overall Study|Participant incarcerated|0|||
23262429|NCT00672620|64703077|FG000|Overall Study|Adverse Event|7|||
23262430|NCT00672620|64703078|FG001|Overall Study|Adverse Event|7|||
23262431|NCT00672620|64703079|FG002|Overall Study|Adverse Event|12|||
23262432|NCT00672620|64703080|FG003|Overall Study|Adverse Event|17|||
23262433|NCT00672620|64703077|FG000|Overall Study|Lack of Efficacy|1|||
23262434|NCT00672620|64703078|FG001|Overall Study|Lack of Efficacy|2|||
23262435|NCT00672620|64703079|FG002|Overall Study|Lack of Efficacy|2|||
23262436|NCT00672620|64703080|FG003|Overall Study|Lack of Efficacy|0|||
23262437|NCT00672620|64703077|FG000|Overall Study|Noncompliance with Study Drug|3|||
23262438|NCT00672620|64703078|FG001|Overall Study|Noncompliance with Study Drug|4|||
23262439|NCT00672620|64703079|FG002|Overall Study|Noncompliance with Study Drug|0|||
23262440|NCT00672620|64703080|FG003|Overall Study|Noncompliance with Study Drug|2|||
23262441|NCT00672620|64703077|FG000|Overall Study|Protocol Deviations|5|||
23262442|NCT00672620|64703078|FG001|Overall Study|Protocol Deviations|7|||
23262443|NCT00672620|64703079|FG002|Overall Study|Protocol Deviations|2|||
23262444|NCT00672620|64703080|FG003|Overall Study|Protocol Deviations|5|||
23262445|NCT00672620|64703077|FG000|Overall Study|Withdrawal of Consent|6|||
23262446|NCT00672620|64703078|FG001|Overall Study|Withdrawal of Consent|12|||
23262447|NCT00672620|64703079|FG002|Overall Study|Withdrawal of Consent|5|||
23262448|NCT00672620|64703080|FG003|Overall Study|Withdrawal of Consent|6|||
23262449|NCT00672620|64703077|FG000|Overall Study|Lost to Follow-up|8|||
23262450|NCT00672620|64703078|FG001|Overall Study|Lost to Follow-up|19|||
23262451|NCT00672620|64703079|FG002|Overall Study|Lost to Follow-up|8|||
23262452|NCT00672620|64703080|FG003|Overall Study|Lost to Follow-up|11|||
23262453|NCT00672620|64703077|FG000|Overall Study|Reason not Specified|3|||
23262454|NCT00672620|64703078|FG001|Overall Study|Reason not Specified|3|||
23262455|NCT00672620|64703079|FG002|Overall Study|Reason not Specified|2|||
23262456|NCT00672620|64703080|FG003|Overall Study|Reason not Specified|1|||
23262457|NCT04272775|64703081|FG000|Overall Study|Study Terminated by Sponsor|1|||
23262458|NCT04272775|64703082|FG001|Overall Study|Study Terminated by Sponsor|0|||
23262459|NCT04272775|64703081|FG000|Overall Study|Protocol Violation|0|||
23262460|NCT04272775|64703082|FG001|Overall Study|Protocol Violation|1|||
23262461|NCT04272775|64703081|FG000|Overall Study|Symptomatic Deterioration|1|||
23262462|NCT04272775|64703082|FG001|Overall Study|Symptomatic Deterioration|1|||
23262463|NCT04272775|64703081|FG000|Overall Study|Withdrawal by Subject|1|||
23262464|NCT04272775|64703082|FG001|Overall Study|Withdrawal by Subject|2|||
23262465|NCT04272775|64703081|FG000|Overall Study|Adverse Event|1|||
23262466|NCT04272775|64703082|FG001|Overall Study|Adverse Event|2|||
23262467|NCT04272775|64703081|FG000|Overall Study|Progressive Disease|3|||
23262468|NCT04272775|64703082|FG001|Overall Study|Progressive Disease|1|||
23262469|NCT02101853|64703085|FG000|Block 1 Induction|Adverse Event|11|||
23262470|NCT02101853|64703086|FG001|Block 1 Induction|Adverse Event|0|||
23262471|NCT02101853|64703087|FG002|Block 1 Induction|Adverse Event|0|||
23262472|NCT02101853|64703088|FG003|Block 1 Induction|Adverse Event|0|||
23262473|NCT02101853|64703089|FG004|Block 1 Induction|Adverse Event|0|||
23262474|NCT02101853|64703090|FG005|Block 1 Induction|Adverse Event|0|||
23262475|NCT02101853|64703085|FG000|Block 1 Induction|Death|20|||
23262476|NCT02101853|64703086|FG001|Block 1 Induction|Death|0|||
23262477|NCT02101853|64703087|FG002|Block 1 Induction|Death|0|||
23262478|NCT02101853|64703088|FG003|Block 1 Induction|Death|0|||
23262479|NCT02101853|64703089|FG004|Block 1 Induction|Death|0|||
23262480|NCT02101853|64703090|FG005|Block 1 Induction|Death|0|||
23262481|NCT02101853|64703085|FG000|Block 1 Induction|Lack of Efficacy|6|||
23262482|NCT02101853|64703086|FG001|Block 1 Induction|Lack of Efficacy|0|||
23262483|NCT02101853|64703087|FG002|Block 1 Induction|Lack of Efficacy|0|||
23262484|NCT02101853|64703088|FG003|Block 1 Induction|Lack of Efficacy|0|||
23262485|NCT02101853|64703089|FG004|Block 1 Induction|Lack of Efficacy|0|||
23262486|NCT02101853|64703090|FG005|Block 1 Induction|Lack of Efficacy|0|||
23262487|NCT02101853|64703085|FG000|Block 1 Induction|Physician Decision|61|||
23262488|NCT02101853|64703086|FG001|Block 1 Induction|Physician Decision|0|||
23262489|NCT02101853|64703087|FG002|Block 1 Induction|Physician Decision|0|||
23262490|NCT02101853|64703088|FG003|Block 1 Induction|Physician Decision|0|||
23262491|NCT02101853|64703089|FG004|Block 1 Induction|Physician Decision|0|||
23262492|NCT02101853|64703090|FG005|Block 1 Induction|Physician Decision|0|||
23262493|NCT02101853|64703085|FG000|Block 1 Induction|Protocol Violation|2|||
23262494|NCT02101853|64703086|FG001|Block 1 Induction|Protocol Violation|0|||
23262495|NCT02101853|64703087|FG002|Block 1 Induction|Protocol Violation|0|||
23262496|NCT02101853|64703088|FG003|Block 1 Induction|Protocol Violation|0|||
23262497|NCT02101853|64703089|FG004|Block 1 Induction|Protocol Violation|0|||
23262498|NCT02101853|64703090|FG005|Block 1 Induction|Protocol Violation|0|||
23262499|NCT02101853|64703085|FG000|Block 1 Induction|Withdrawal by Subject|65|||
23262500|NCT02101853|64703086|FG001|Block 1 Induction|Withdrawal by Subject|0|||
23262501|NCT02101853|64703087|FG002|Block 1 Induction|Withdrawal by Subject|0|||
23262502|NCT02101853|64703088|FG003|Block 1 Induction|Withdrawal by Subject|0|||
23262503|NCT02101853|64703089|FG004|Block 1 Induction|Withdrawal by Subject|0|||
23262504|NCT02101853|64703090|FG005|Block 1 Induction|Withdrawal by Subject|0|||
23262505|NCT02101853|64703085|FG000|Block 1 Induction|Ineligible|8|||
23262506|NCT02101853|64703086|FG001|Block 1 Induction|Ineligible|0|||
23262507|NCT02101853|64703087|FG002|Block 1 Induction|Ineligible|0|||
23262508|NCT02101853|64703088|FG003|Block 1 Induction|Ineligible|0|||
23262509|NCT02101853|64703089|FG004|Block 1 Induction|Ineligible|0|||
23262510|NCT02101853|64703090|FG005|Block 1 Induction|Ineligible|0|||
23262511|NCT02101853|64703085|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
23262512|NCT02101853|64703086|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23262513|NCT02101853|64703087|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23262514|NCT02101853|64703088|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23262515|NCT02101853|64703089|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23262516|NCT02101853|64703090|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
23262517|NCT02101853|64703085|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
23262518|NCT02101853|64703086|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262519|NCT02101853|64703087|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262520|NCT02101853|64703088|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262521|NCT02101853|64703089|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262522|NCT02101853|64703090|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262523|NCT02101853|64703085|FG000|Post Induction Randomization|Adverse Event|0|||
23262524|NCT02101853|64703086|FG001|Post Induction Randomization|Adverse Event|3|||
23262525|NCT02101853|64703087|FG002|Post Induction Randomization|Adverse Event|8|||
23262526|NCT02101853|64703088|FG003|Post Induction Randomization|Adverse Event|4|||
23262527|NCT02101853|64703089|FG004|Post Induction Randomization|Adverse Event|4|||
23262528|NCT02101853|64703090|FG005|Post Induction Randomization|Adverse Event|0|||
23262529|NCT02101853|64703085|FG000|Post Induction Randomization|Death|0|||
23262530|NCT02101853|64703086|FG001|Post Induction Randomization|Death|9|||
23262531|NCT02101853|64703087|FG002|Post Induction Randomization|Death|2|||
23262532|NCT02101853|64703088|FG003|Post Induction Randomization|Death|2|||
23262533|NCT02101853|64703089|FG004|Post Induction Randomization|Death|0|||
23262534|NCT02101853|64703090|FG005|Post Induction Randomization|Death|0|||
23262535|NCT02101853|64703085|FG000|Post Induction Randomization|Lack of Efficacy|0|||
23262536|NCT02101853|64703086|FG001|Post Induction Randomization|Lack of Efficacy|14|||
23262537|NCT02101853|64703087|FG002|Post Induction Randomization|Lack of Efficacy|23|||
23262538|NCT02101853|64703088|FG003|Post Induction Randomization|Lack of Efficacy|18|||
23262539|NCT02101853|64703089|FG004|Post Induction Randomization|Lack of Efficacy|21|||
23262540|NCT02101853|64703090|FG005|Post Induction Randomization|Lack of Efficacy|0|||
23262541|NCT02101853|64703085|FG000|Post Induction Randomization|Physician Decision|0|||
23600743|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
23600744|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
23600745|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
23200821|NCT05523362|64473526|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
23200822|NCT05523362|64473526|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
23200823|NCT00488033|64473527|FG000|Overall Study|Withdrawal by Subject|1|||
23200824|NCT00488033|64473528|FG001|Overall Study|Withdrawal by Subject|0|||
23200825|NCT01081873|64473529|FG000|Overall Study|Death|86|||
23200826|NCT01081873|64473529|FG000|Overall Study|Withdrawal by Subject|10|||
23200827|NCT01081873|64473529|FG000|Overall Study|Lost to Follow-up|142|||
23200828|NCT01081873|64473529|FG000|Overall Study|Progression of prostate cancer|13|||
23200829|NCT01081873|64473529|FG000|Overall Study|Other|47|||
23200830|NCT01798134|64473530|FG000|Overall Study|Lost to Follow-up|1|||
23200831|NCT01798134|64473530|FG000|Overall Study|Withdrawal by Subject|3|||
23200832|NCT01798134|64473530|FG000|Overall Study|Death|2|||
23200833|NCT01798134|64473530|FG000|Overall Study|Adverse Event|3|||
23200834|NCT01798134|64473530|FG000|Overall Study|Physician Decision|3|||
23200835|NCT01798134|64473530|FG000|Overall Study|Liver transplant/surgery|4|||
23200836|NCT01087528|64473532|FG000|Overall Study|Withdrawal by Subject|1|||
23200837|NCT01087528|64473532|FG000|Overall Study|Incomplete CE procedure|6|||
23200838|NCT04360187|64473535|FG000|Double-Blind Treatment|Adverse Event|9|||
23200839|NCT04360187|64473536|FG001|Double-Blind Treatment|Adverse Event|11|||
23200840|NCT04360187|64473535|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
23200841|NCT04360187|64473536|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
23200842|NCT04360187|64473535|FG000|Double-Blind Treatment|Physician Decision|1|||
23200843|NCT04360187|64473536|FG001|Double-Blind Treatment|Physician Decision|0|||
23200844|NCT04360187|64473535|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
23200845|NCT04360187|64473536|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
23200846|NCT04360187|64473535|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
23200847|NCT04360187|64473536|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
23200848|NCT04360187|64473535|FG000|Follow-Up|Lost to Follow-up|1|||
23200849|NCT04360187|64473536|FG001|Follow-Up|Lost to Follow-up|0|||
23200850|NCT03342469|64473538|FG000|Overall Study|Withdrawal by Subject|0|||
23200851|NCT03342469|64473539|FG001|Overall Study|Withdrawal by Subject|1|||
23200852|NCT03342469|64473540|FG002|Overall Study|Withdrawal by Subject|0|||
23200853|NCT03342469|64473541|FG003|Overall Study|Withdrawal by Subject|0|||
23200854|NCT01876732|64473542|FG000|Overall Study|MMA was not over 800mg/dL|75|||
23200855|NCT02116660|64473543|FG000|Overall Study|Deteriorating renal function|0|||
23200856|NCT02116660|64473544|FG001|Overall Study|Deteriorating renal function|1|||
23200857|NCT02116660|64473543|FG000|Overall Study|Adverse Event|1|||
23200858|NCT02116660|64473544|FG001|Overall Study|Adverse Event|1|||
23200859|NCT02116660|64473543|FG000|Overall Study|Withdrawal by Subject|0|||
23200860|NCT02116660|64473544|FG001|Overall Study|Withdrawal by Subject|2|||
23200861|NCT02116660|64473543|FG000|Overall Study|Organization reason|1|||
23200862|NCT02116660|64473544|FG001|Overall Study|Organization reason|0|||
23200863|NCT05058664|64473545|FG000|Overall Study|No follow-up data provided|4|||
23200864|NCT05058664|64473546|FG001|Overall Study|No follow-up data provided|0|||
23200865|NCT05058664|64473547|FG002|Overall Study|No follow-up data provided|2|||
23200866|NCT05058664|64473545|FG000|Overall Study|Withdrawal by Subject|0|||
23200867|NCT05058664|64473546|FG001|Overall Study|Withdrawal by Subject|0|||
23200868|NCT05058664|64473547|FG002|Overall Study|Withdrawal by Subject|1|||
23200869|NCT04594239|64473553|FG000|Overall Study|Withdrawal by Subject|3|||
23200870|NCT04594239|64473554|FG001|Overall Study|Withdrawal by Subject|4|||
23200871|NCT04594239|64473555|FG002|Overall Study|Withdrawal by Subject|2|||
23200872|NCT04594239|64473556|FG003|Overall Study|Withdrawal by Subject|4|||
23200873|NCT04594239|64473553|FG000|Overall Study|Lost to Follow-up|8|||
23200874|NCT04594239|64473554|FG001|Overall Study|Lost to Follow-up|5|||
23200875|NCT04594239|64473555|FG002|Overall Study|Lost to Follow-up|4|||
23200876|NCT04594239|64473556|FG003|Overall Study|Lost to Follow-up|6|||
23200877|NCT04594239|64473553|FG000|Overall Study|Subject relocated|0|||
23200878|NCT04594239|64473554|FG001|Overall Study|Subject relocated|0|||
23200879|NCT04594239|64473555|FG002|Overall Study|Subject relocated|0|||
23200880|NCT04594239|64473556|FG003|Overall Study|Subject relocated|1|||
23200881|NCT00632463|64473557|FG000|Overall Study|Adverse Event|0|||
23600746|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
23200882|NCT00632463|64473558|FG001|Overall Study|Adverse Event|1|||
23200883|NCT00632463|64473559|FG002|Overall Study|Adverse Event|0|||
23200884|NCT04072146|64476486|FG000|Overall Study|Adverse Event|0|||
23262542|NCT02101853|64703086|FG001|Post Induction Randomization|Physician Decision|43|||
23262543|NCT02101853|64703087|FG002|Post Induction Randomization|Physician Decision|23|||
23262544|NCT02101853|64703088|FG003|Post Induction Randomization|Physician Decision|14|||
23262545|NCT02101853|64703089|FG004|Post Induction Randomization|Physician Decision|14|||
23262546|NCT02101853|64703090|FG005|Post Induction Randomization|Physician Decision|0|||
23262547|NCT02101853|64703085|FG000|Post Induction Randomization|Protocol Violation|0|||
23262548|NCT02101853|64703086|FG001|Post Induction Randomization|Protocol Violation|3|||
23262549|NCT02101853|64703087|FG002|Post Induction Randomization|Protocol Violation|0|||
23262550|NCT02101853|64703088|FG003|Post Induction Randomization|Protocol Violation|0|||
23262551|NCT02101853|64703089|FG004|Post Induction Randomization|Protocol Violation|0|||
23262552|NCT02101853|64703090|FG005|Post Induction Randomization|Protocol Violation|0|||
23262553|NCT02101853|64703085|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
23262554|NCT02101853|64703086|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
23200885|NCT04072146|64476487|FG001|Overall Study|Adverse Event|1|||
23200886|NCT02635737|64476491|FG000|Overall Study|Protocol Violation|1|||
23200887|NCT01260467|64476495|FG000|Overall Study|Withdrawal by Subject|2|||
23200888|NCT05142332|64476496|FG000|Overall Study|Withdrawal by Subject|0|||
23200889|NCT05142332|64476497|FG001|Overall Study|Withdrawal by Subject|1|||
23200890|NCT05142332|64476498|FG002|Overall Study|Withdrawal by Subject|2|||
23200891|NCT05142332|64476499|FG003|Overall Study|Withdrawal by Subject|0|||
23200892|NCT05142332|64476500|FG004|Overall Study|Withdrawal by Subject|0|||
23200893|NCT05142332|64476501|FG005|Overall Study|Withdrawal by Subject|2|||
23200894|NCT05142332|64476502|FG006|Overall Study|Withdrawal by Subject|6|||
23200895|NCT05142332|64476496|FG000|Overall Study|Left ED|3|||
23200896|NCT05142332|64476497|FG001|Overall Study|Left ED|0|||
23200897|NCT05142332|64476498|FG002|Overall Study|Left ED|4|||
23200898|NCT05142332|64476499|FG003|Overall Study|Left ED|6|||
23200899|NCT05142332|64476500|FG004|Overall Study|Left ED|1|||
23200900|NCT05142332|64476501|FG005|Overall Study|Left ED|2|||
23200901|NCT05142332|64476502|FG006|Overall Study|Left ED|6|||
23200902|NCT05142332|64476496|FG000|Overall Study|Physician Decision|0|||
23200903|NCT05142332|64476497|FG001|Overall Study|Physician Decision|0|||
23200904|NCT05142332|64476498|FG002|Overall Study|Physician Decision|2|||
23200905|NCT05142332|64476499|FG003|Overall Study|Physician Decision|1|||
23200906|NCT05142332|64476500|FG004|Overall Study|Physician Decision|0|||
23200907|NCT05142332|64476501|FG005|Overall Study|Physician Decision|0|||
23200908|NCT05142332|64476502|FG006|Overall Study|Physician Decision|3|||
23200909|NCT05142332|64476496|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
23200910|NCT05142332|64476497|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
23200911|NCT05142332|64476498|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
23200912|NCT05142332|64476499|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
23200913|NCT05142332|64476500|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
23200914|NCT05142332|64476501|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
23200915|NCT05142332|64476502|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
23200916|NCT03276936|64476503|FG000|Overall Study|Adverse Event|4|||
23200917|NCT03276936|64476504|FG001|Overall Study|Adverse Event|2|||
23200918|NCT03276936|64476503|FG000|Overall Study|Lost to Follow-up|16|||
23200919|NCT03276936|64476504|FG001|Overall Study|Lost to Follow-up|13|||
23200920|NCT03276936|64476503|FG000|Overall Study|Withdrawal by Subject|30|||
23200921|NCT03276936|64476504|FG001|Overall Study|Withdrawal by Subject|20|||
23200922|NCT03276936|64476503|FG000|Overall Study|Not mentioned|6|||
23200923|NCT03276936|64476504|FG001|Overall Study|Not mentioned|3|||
23200924|NCT03176277|64476505|FG000|Part A Dose Escalation Study|Adverse Event|1|||
23200925|NCT03176277|64476506|FG001|Part A Dose Escalation Study|Adverse Event|0|||
23200926|NCT03176277|64476507|FG002|Part A Dose Escalation Study|Adverse Event|1|||
23200927|NCT03176277|64476508|FG003|Part A Dose Escalation Study|Adverse Event|0|||
23200928|NCT03176277|64476505|FG000|Part A Dose Escalation Study|Physician Decision|1|||
23200929|NCT03176277|64476506|FG001|Part A Dose Escalation Study|Physician Decision|1|||
23200930|NCT03176277|64476507|FG002|Part A Dose Escalation Study|Physician Decision|2|||
23200931|NCT03176277|64476508|FG003|Part A Dose Escalation Study|Physician Decision|0|||
23200932|NCT03176277|64476505|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
23200933|NCT03176277|64476506|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
23200934|NCT03176277|64476507|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
23200935|NCT03176277|64476508|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
23200936|NCT03176277|64476505|FG000|Part A Dose Escalation Study|Progressive disease|3|||
23262555|NCT02101853|64703087|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
23262556|NCT02101853|64703088|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
23262557|NCT02101853|64703089|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
23200937|NCT03176277|64476506|FG001|Part A Dose Escalation Study|Progressive disease|1|||
23200938|NCT03176277|64476507|FG002|Part A Dose Escalation Study|Progressive disease|3|||
23262558|NCT02101853|64703090|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
23361768|NCT05404711|65069811|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
23262559|NCT02101853|64703085|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262560|NCT02101853|64703086|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262561|NCT02101853|64703087|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262562|NCT02101853|64703088|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
23262563|NCT02101853|64703089|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262564|NCT02101853|64703090|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
23262565|NCT02101853|64703085|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
23262566|NCT02101853|64703086|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
23262567|NCT02101853|64703087|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
23262568|NCT02101853|64703088|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
23262569|NCT02101853|64703089|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
23262570|NCT02101853|64703090|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
23262571|NCT02101853|64703085|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23262572|NCT02101853|64703086|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
23262573|NCT02101853|64703087|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23262574|NCT02101853|64703088|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23262575|NCT02101853|64703089|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23262576|NCT02101853|64703090|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
23262577|NCT02101853|64703085|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
23262578|NCT02101853|64703086|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
23262579|NCT02101853|64703087|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
23262580|NCT02101853|64703088|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
23262581|NCT02101853|64703089|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
23262582|NCT02101853|64703090|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
23262583|NCT02101853|64703085|FG000|Blinatumomab Salvage Therapy|Death|0|||
23262584|NCT02101853|64703086|FG001|Blinatumomab Salvage Therapy|Death|0|||
23262585|NCT02101853|64703087|FG002|Blinatumomab Salvage Therapy|Death|0|||
23262586|NCT02101853|64703088|FG003|Blinatumomab Salvage Therapy|Death|0|||
23262587|NCT02101853|64703089|FG004|Blinatumomab Salvage Therapy|Death|0|||
23262588|NCT02101853|64703090|FG005|Blinatumomab Salvage Therapy|Death|2|||
23262589|NCT02101853|64703085|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23262590|NCT02101853|64703086|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23262591|NCT02101853|64703087|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23262592|NCT02101853|64703088|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23262593|NCT02101853|64703089|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
23262594|NCT02101853|64703090|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
23262595|NCT02101853|64703085|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
23262596|NCT02101853|64703086|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
23262597|NCT02101853|64703087|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
23262598|NCT02101853|64703088|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
23262599|NCT02101853|64703089|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
23262600|NCT02101853|64703090|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
23262601|NCT02101853|64703085|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23262602|NCT02101853|64703086|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23262603|NCT02101853|64703087|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23262604|NCT02101853|64703088|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23262605|NCT02101853|64703089|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
23262606|NCT02101853|64703090|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
23262607|NCT00686036|64703092|FG000|Overall Study|Adverse Event|3|||
23262608|NCT00686036|64703093|FG001|Overall Study|Adverse Event|0|||
23262609|NCT00686036|64703092|FG000|Overall Study|Withdrawal by Subject|3|||
23262610|NCT00686036|64703093|FG001|Overall Study|Withdrawal by Subject|1|||
23262611|NCT00686036|64703092|FG000|Overall Study|Study terminated by AstraZeneca|2|||
23262612|NCT00686036|64703093|FG001|Overall Study|Study terminated by AstraZeneca|1|||
23262613|NCT00686036|64703092|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
23262614|NCT00686036|64703093|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
23262615|NCT00686036|64703092|FG000|Overall Study|Other reasons not identified|0|||
23262616|NCT00686036|64703093|FG001|Overall Study|Other reasons not identified|4|||
23262617|NCT00696709|64703094|FG000|Overall Study|Withdrawal by Subject|1|||
23262618|NCT00696709|64703095|FG001|Overall Study|Withdrawal by Subject|2|||
23262619|NCT00696709|64703096|FG002|Overall Study|Withdrawal by Subject|1|||
23262620|NCT00696709|64703097|FG003|Overall Study|Withdrawal by Subject|4|||
23600747|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
23600748|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
23262621|NCT00696709|64703098|FG004|Overall Study|Withdrawal by Subject|3|||
23262622|NCT00696709|64703094|FG000|Overall Study|Protocol Violation|1|||
23262623|NCT00696709|64703095|FG001|Overall Study|Protocol Violation|0|||
23262624|NCT00696709|64703096|FG002|Overall Study|Protocol Violation|0|||
23262625|NCT00696709|64703097|FG003|Overall Study|Protocol Violation|0|||
23262626|NCT00696709|64703098|FG004|Overall Study|Protocol Violation|0|||
23262627|NCT00696709|64703094|FG000|Overall Study|Lost to Follow-up|1|||
23262628|NCT00696709|64703095|FG001|Overall Study|Lost to Follow-up|1|||
23262629|NCT00696709|64703096|FG002|Overall Study|Lost to Follow-up|0|||
23262630|NCT00696709|64703097|FG003|Overall Study|Lost to Follow-up|0|||
23262631|NCT00696709|64703098|FG004|Overall Study|Lost to Follow-up|0|||
23262632|NCT00696709|64703094|FG000|Overall Study|Adverse Event|0|||
23262633|NCT00696709|64703095|FG001|Overall Study|Adverse Event|0|||
23262634|NCT00696709|64703096|FG002|Overall Study|Adverse Event|0|||
23262635|NCT00696709|64703097|FG003|Overall Study|Adverse Event|1|||
23262636|NCT00696709|64703098|FG004|Overall Study|Adverse Event|0|||
23262637|NCT00295854|64703099|FG000|Overall Study|Adverse Event|7|||
23262638|NCT00295854|64703100|FG001|Overall Study|Adverse Event|7|||
23262639|NCT00295854|64703101|FG002|Overall Study|Adverse Event|6|||
23262640|NCT00295854|64703099|FG000|Overall Study|Protocol Violation|1|||
23262641|NCT00295854|64703100|FG001|Overall Study|Protocol Violation|1|||
23262642|NCT00295854|64703101|FG002|Overall Study|Protocol Violation|1|||
23262643|NCT00295854|64703099|FG000|Overall Study|Lost to Follow-up|2|||
23262644|NCT00295854|64703100|FG001|Overall Study|Lost to Follow-up|0|||
23262645|NCT00295854|64703101|FG002|Overall Study|Lost to Follow-up|1|||
23262646|NCT00295854|64703099|FG000|Overall Study|Withdrawal by Subject|3|||
23262647|NCT00295854|64703100|FG001|Overall Study|Withdrawal by Subject|7|||
23262648|NCT00295854|64703101|FG002|Overall Study|Withdrawal by Subject|4|||
23262649|NCT00295854|64703099|FG000|Overall Study|did not continue to meet criteria|1|||
23262650|NCT00295854|64703100|FG001|Overall Study|did not continue to meet criteria|1|||
23262651|NCT00295854|64703101|FG002|Overall Study|did not continue to meet criteria|2|||
23262652|NCT00295854|64703099|FG000|Overall Study|required a prohibited medication|1|||
23262653|NCT00295854|64703100|FG001|Overall Study|required a prohibited medication|0|||
23262654|NCT00295854|64703101|FG002|Overall Study|required a prohibited medication|0|||
23262655|NCT00295854|64703099|FG000|Overall Study|Other|3|||
23262656|NCT00295854|64703100|FG001|Overall Study|Other|5|||
23262657|NCT00295854|64703101|FG002|Overall Study|Other|1|||
23262658|NCT02006706|64703102|FG000|Overall Study|Lost to Follow-up|1|||
23262659|NCT04534283|64703111|FG000|Overall Study|Physician Decision|2|||
23262660|NCT04534283|64703111|FG000|Overall Study|Withdrawal by Subject|1|||
23262661|NCT04534283|64703111|FG000|Overall Study|Disease Progression|12|||
23262662|NCT04534283|64703111|FG000|Overall Study|Adverse Event|1|||
23262663|NCT02570165|64703113|FG000|Overall Study|Adverse Event|1|||
23262664|NCT02570165|64703114|FG001|Overall Study|Adverse Event|0|||
23262665|NCT02570165|64703115|FG002|Overall Study|Adverse Event|2|||
23262666|NCT02570165|64703116|FG003|Overall Study|Adverse Event|0|||
23262667|NCT02570165|64703117|FG004|Overall Study|Adverse Event|0|||
23262668|NCT02570165|64703118|FG005|Overall Study|Adverse Event|0|||
23262669|NCT02570165|64703119|FG006|Overall Study|Adverse Event|0|||
23262670|NCT02570165|64703113|FG000|Overall Study|Lack of Efficacy|0|||
23262671|NCT02570165|64703114|FG001|Overall Study|Lack of Efficacy|1|||
23262672|NCT02570165|64703115|FG002|Overall Study|Lack of Efficacy|0|||
23262673|NCT02570165|64703116|FG003|Overall Study|Lack of Efficacy|0|||
23262674|NCT02570165|64703117|FG004|Overall Study|Lack of Efficacy|4|||
23262675|NCT02570165|64703118|FG005|Overall Study|Lack of Efficacy|0|||
23262676|NCT02570165|64703119|FG006|Overall Study|Lack of Efficacy|0|||
23262677|NCT02570165|64703113|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
23262678|NCT02570165|64703114|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
23262679|NCT02570165|64703115|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
23262680|NCT02570165|64703116|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
23262681|NCT02570165|64703117|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
23262682|NCT02570165|64703118|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
23262683|NCT02570165|64703119|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
23361769|NCT05404711|65069811|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
23361770|NCT05404711|65069811|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
23361771|NCT05404711|65069811|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
23361772|NCT01979523|65069816|FG000|Overall Study|Withdrawal by Subject|1|||
23361773|NCT01979523|65069817|FG001|Overall Study|Withdrawal by Subject|0|||
23262684|NCT02570165|64703113|FG000|Overall Study|Lost to Follow-up|0|||
23262685|NCT02570165|64703114|FG001|Overall Study|Lost to Follow-up|0|||
23361774|NCT03915626|65069818|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
23262686|NCT02570165|64703115|FG002|Overall Study|Lost to Follow-up|1|||
23262687|NCT02570165|64703116|FG003|Overall Study|Lost to Follow-up|1|||
23262688|NCT02570165|64703117|FG004|Overall Study|Lost to Follow-up|0|||
23262689|NCT02570165|64703118|FG005|Overall Study|Lost to Follow-up|0|||
23262690|NCT02570165|64703119|FG006|Overall Study|Lost to Follow-up|0|||
23262691|NCT02570165|64703113|FG000|Overall Study|Physician Decision|0|||
23262692|NCT02570165|64703114|FG001|Overall Study|Physician Decision|1|||
23262693|NCT02570165|64703115|FG002|Overall Study|Physician Decision|0|||
23262694|NCT02570165|64703116|FG003|Overall Study|Physician Decision|0|||
23262695|NCT02570165|64703117|FG004|Overall Study|Physician Decision|0|||
23262696|NCT02570165|64703118|FG005|Overall Study|Physician Decision|0|||
23262697|NCT02570165|64703119|FG006|Overall Study|Physician Decision|0|||
23262698|NCT02570165|64703113|FG000|Overall Study|Withdrawal by Subject|0|||
23262699|NCT02570165|64703114|FG001|Overall Study|Withdrawal by Subject|0|||
23262700|NCT02570165|64703115|FG002|Overall Study|Withdrawal by Subject|0|||
23262701|NCT02570165|64703116|FG003|Overall Study|Withdrawal by Subject|2|||
23262702|NCT02570165|64703117|FG004|Overall Study|Withdrawal by Subject|1|||
23262703|NCT02570165|64703118|FG005|Overall Study|Withdrawal by Subject|0|||
23262704|NCT02570165|64703119|FG006|Overall Study|Withdrawal by Subject|0|||
23262705|NCT02570165|64703113|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
23262706|NCT02570165|64703114|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
23262707|NCT02570165|64703115|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
23262708|NCT02570165|64703116|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
23262709|NCT02570165|64703117|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
23262710|NCT02570165|64703118|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
23262711|NCT02570165|64703119|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
23262712|NCT02570165|64703113|FG000|Overall Study|Withdrawal Request by GSK|0|||
23262713|NCT02570165|64703114|FG001|Overall Study|Withdrawal Request by GSK|0|||
23262714|NCT02570165|64703115|FG002|Overall Study|Withdrawal Request by GSK|2|||
23262715|NCT02570165|64703116|FG003|Overall Study|Withdrawal Request by GSK|0|||
23262716|NCT02570165|64703117|FG004|Overall Study|Withdrawal Request by GSK|0|||
23262717|NCT02570165|64703118|FG005|Overall Study|Withdrawal Request by GSK|0|||
23262718|NCT02570165|64703119|FG006|Overall Study|Withdrawal Request by GSK|0|||
23262719|NCT03093454|64703120|FG000|Overall Study|Withdrawal by Subject|1|||
23262720|NCT03093454|64703121|FG001|Overall Study|Withdrawal by Subject|1|||
23262721|NCT03093454|64703120|FG000|Overall Study|Scheduling conflict|3|||
23262722|NCT03093454|64703121|FG001|Overall Study|Scheduling conflict|1|||
23262723|NCT03093454|64703120|FG000|Overall Study|Physician Decision|2|||
23262724|NCT03093454|64703121|FG001|Overall Study|Physician Decision|1|||
23262725|NCT02224456|64703128|FG000|Overall Study|Lack of Efficacy|1|||
23262726|NCT02224456|64703128|FG000|Overall Study|Lost to Follow-up|15|||
23262727|NCT02224456|64703128|FG000|Overall Study|Withdrawal by Subject|9|||
23262728|NCT02224456|64703128|FG000|Overall Study|Physician Decision|3|||
23262729|NCT02224456|64703128|FG000|Overall Study|Death|2|||
23262730|NCT02224456|64703128|FG000|Overall Study|Pregnancy|4|||
23262731|NCT02224456|64703128|FG000|Overall Study|Protocol Violation|1|||
23262732|NCT02224456|64703128|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
23262733|NCT02410252|64703129|FG000|Overall Study|Withdrawal by Subject|4|||
23262734|NCT02410252|64703129|FG000|Overall Study|Physician Decision|2|||
23262735|NCT00113490|64703130|FG000|Overall Study|Withdrawal by Subject|1|||
23262736|NCT00113490|64703131|FG001|Overall Study|Withdrawal by Subject|3|||
23262737|NCT00113490|64703130|FG000|Overall Study|Lost to Follow-up|1|||
23262738|NCT00113490|64703131|FG001|Overall Study|Lost to Follow-up|0|||
23262739|NCT02974114|64703133|FG000|Overall Study|Other (Not specified)|0|||
23262740|NCT02974114|64703134|FG001|Overall Study|Other (Not specified)|1|||
23262741|NCT02974114|64703135|FG002|Overall Study|Other (Not specified)|2|||
23262742|NCT02114931|64703136|FG000|Overall Study|Withdrawal by Subject|15|||
23262743|NCT02114931|64703137|FG001|Overall Study|Withdrawal by Subject|18|||
23262744|NCT02114931|64703136|FG000|Overall Study|Adverse Event|4|||
23262745|NCT02114931|64703137|FG001|Overall Study|Adverse Event|6|||
23262746|NCT02114931|64703136|FG000|Overall Study|Lost to Follow-up|3|||
23262747|NCT02114931|64703137|FG001|Overall Study|Lost to Follow-up|3|||
23262748|NCT02114931|64703136|FG000|Overall Study|Physician Decision|1|||
23262749|NCT02114931|64703137|FG001|Overall Study|Physician Decision|2|||
23262750|NCT02114931|64703136|FG000|Overall Study|Other|2|||
23262751|NCT02114931|64703137|FG001|Overall Study|Other|1|||
23262752|NCT03443869|64703138|FG000|Overall Study|Death|3|||
23262753|NCT03443869|64703139|FG001|Overall Study|Death|3|||
23361775|NCT02768792|65069819|FG000|Overall Study|Adverse Event|1|||
23361776|NCT01081626|65069820|FG000|Overall Study|Dosing error|1|||
23361777|NCT01081626|65069821|FG001|Overall Study|Dosing error|1|||
23262754|NCT03443869|64703138|FG000|Overall Study|Withdrawal by Subject|34|||
23262755|NCT03443869|64703139|FG001|Overall Study|Withdrawal by Subject|22|||
23262756|NCT03443869|64703138|FG000|Overall Study|Lost to Follow-up|1|||
23262757|NCT03443869|64703139|FG001|Overall Study|Lost to Follow-up|2|||
23262758|NCT03443869|64703138|FG000|Overall Study|Physician Decision|3|||
23262759|NCT03443869|64703139|FG001|Overall Study|Physician Decision|3|||
23262760|NCT03443869|64703138|FG000|Overall Study|Other|4|||
23262761|NCT03443869|64703139|FG001|Overall Study|Other|4|||
23262762|NCT02795104|64703140|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
23262763|NCT02795104|64703141|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
23262764|NCT02795104|64703142|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
23262765|NCT02795104|64703140|FG000|Overall Study|Withdrawal by Subject|0|||
23262766|NCT02795104|64703141|FG001|Overall Study|Withdrawal by Subject|2|||
23262767|NCT02795104|64703142|FG002|Overall Study|Withdrawal by Subject|0|||
23262768|NCT02795104|64703140|FG000|Overall Study|Lost to Follow-up|0|||
23262769|NCT02795104|64703141|FG001|Overall Study|Lost to Follow-up|0|||
23262770|NCT02795104|64703142|FG002|Overall Study|Lost to Follow-up|1|||
23262771|NCT00192296|64703143|FG000|Overall Study|Withdrawal by Subject|0|||
23262772|NCT00192296|64703144|FG001|Overall Study|Withdrawal by Subject|1|||
23262773|NCT00192296|64703145|FG002|Overall Study|Withdrawal by Subject|0|||
23262774|NCT00192296|64703146|FG003|Overall Study|Withdrawal by Subject|0|||
23262775|NCT01399723|64703147|FG000|Overall Study|Lost to Follow-up|0|||
23262776|NCT01399723|64703148|FG001|Overall Study|Lost to Follow-up|1|||
23262777|NCT01656889|64703149|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
23262778|NCT01656889|64703150|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
23262779|NCT01656889|64703149|FG000|Treatment Period, 12 Weeks|Death|0|||
23262780|NCT01656889|64703150|FG001|Treatment Period, 12 Weeks|Death|1|||
23262781|NCT01656889|64703149|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
23262782|NCT01656889|64703150|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
23262783|NCT01656889|64703149|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
23262784|NCT01656889|64703150|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
23262785|NCT01656889|64703149|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
23262786|NCT01656889|64703150|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
23262787|NCT01656889|64703149|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
23262788|NCT01656889|64703150|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
23262789|NCT01656889|64703149|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
23262790|NCT01656889|64703150|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
23262791|NCT01656889|64703149|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
23262792|NCT01656889|64703150|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
23262793|NCT01656889|64703149|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
23262794|NCT01656889|64703150|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
23262795|NCT01656889|64703149|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
23262796|NCT01656889|64703150|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
23262797|NCT02688608|64703151|FG000|Overall Study|Lost to Follow-up|1|||
23262798|NCT00524459|64703152|FG000|Overall Study|Withdrawal by Subject|1|||
23262799|NCT00524459|64703152|FG000|Overall Study|Other|1|||
23262800|NCT00125359|64703157|FG000|Overall Study|Death|4|||
23262801|NCT00125359|64703157|FG000|Overall Study|Adverse Event|5|||
23262802|NCT00125359|64703157|FG000|Overall Study|Physician Decision|14|||
23262803|NCT02637076|64703159|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
23262804|NCT02637076|64703160|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
23262805|NCT02637076|64703159|FG000|Overall Study|Withdrawal by Subject|0|||
23262806|NCT02637076|64703160|FG001|Overall Study|Withdrawal by Subject|4|||
23262807|NCT02710071|64703161|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
23262808|NCT02710071|64703162|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
23262809|NCT02710071|64703161|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
23262810|NCT02710071|64703162|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
23262811|NCT01691859|64703168|FG000|Overall Study|Adverse Event|19|||
23262812|NCT01691859|64703168|FG000|Overall Study|Lack of Efficacy|11|||
23262813|NCT01691859|64703168|FG000|Overall Study|Protocol Violation|4|||
23262814|NCT01691859|64703168|FG000|Overall Study|Product commercially available|221|||
23262815|NCT01691859|64703168|FG000|Overall Study|Study closed/terminated|50|||
23262816|NCT01691859|64703168|FG000|Overall Study|Lost to Follow-up|5|||
23262817|NCT01691859|64703168|FG000|Overall Study|Physician Decision|6|||
23262818|NCT01691859|64703168|FG000|Overall Study|Withdrawal by Subject|31|||
23262819|NCT00329602|64703169|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
23262820|NCT00329602|64703170|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
23262821|NCT00329602|64703171|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
23262822|NCT00329602|64703169|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
23262823|NCT00329602|64703170|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
23262824|NCT00329602|64703171|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
23262825|NCT00329602|64703169|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
23262826|NCT00329602|64703170|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
23262827|NCT00329602|64703171|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
23262828|NCT00329602|64703169|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
23262829|NCT00329602|64703170|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
23262830|NCT00329602|64703171|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
23262831|NCT00329602|64703169|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
23262832|NCT00329602|64703170|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
23361778|NCT01081626|65069820|FG000|Overall Study|Missing Estradiol|25|||
23262833|NCT00329602|64703171|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
23262834|NCT00329602|64703169|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
23361779|NCT01081626|65069821|FG001|Overall Study|Missing Estradiol|28|||
23361780|NCT01081626|65069820|FG000|Overall Study|Low antral follicle count|1|||
23361781|NCT01081626|65069821|FG001|Overall Study|Low antral follicle count|0|||
23361782|NCT01081626|65069820|FG000|Overall Study|Overstimulation|0|||
23361783|NCT01081626|65069821|FG001|Overall Study|Overstimulation|1|||
23361784|NCT01081626|65069820|FG000|Overall Study|Lost to Follow-up|0|||
23361785|NCT01081626|65069821|FG001|Overall Study|Lost to Follow-up|1|||
23262835|NCT00329602|64703170|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
23262836|NCT00329602|64703171|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
23262837|NCT03267264|64703172|FG000|Overall Study|Withdrawal by Subject|1|||
23262838|NCT03267264|64703173|FG001|Overall Study|Withdrawal by Subject|0|||
23262839|NCT03267264|64703174|FG002|Overall Study|Withdrawal by Subject|2|||
23262840|NCT03267264|64703175|FG003|Overall Study|Withdrawal by Subject|4|||
23262841|NCT04467697|64703176|FG000|Overall Study|Adverse Event|2|||
23262842|NCT04467697|64703176|FG000|Overall Study|Lost to Follow-up|6|||
23262843|NCT04467697|64703176|FG000|Overall Study|Withdrawal by Subject|9|||
23262844|NCT04467697|64703176|FG000|Overall Study|Protocol Violation|3|||
23262845|NCT00598559|64703177|FG000|Overall Study|Adverse Event|11|||
23262846|NCT00598559|64703178|FG001|Overall Study|Adverse Event|7|||
23262847|NCT00598559|64703179|FG002|Overall Study|Adverse Event|0|||
23262848|NCT00598559|64703177|FG000|Overall Study|Withdrawal by Subject|2|||
23262849|NCT00598559|64703178|FG001|Overall Study|Withdrawal by Subject|2|||
23262850|NCT00598559|64703179|FG002|Overall Study|Withdrawal by Subject|0|||
23262851|NCT00598559|64703177|FG000|Overall Study|Protocol Non-compliance|1|||
23262852|NCT00598559|64703178|FG001|Overall Study|Protocol Non-compliance|0|||
23262853|NCT00598559|64703179|FG002|Overall Study|Protocol Non-compliance|0|||
23262854|NCT00598559|64703177|FG000|Overall Study|Early discharge from hospital|9|||
23262855|NCT00598559|64703178|FG001|Overall Study|Early discharge from hospital|12|||
23262856|NCT00598559|64703179|FG002|Overall Study|Early discharge from hospital|3|||
23262857|NCT00598559|64703177|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
23262858|NCT00598559|64703178|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
23262859|NCT00598559|64703179|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
23262860|NCT01992107|64703182|FG000|Overall Study|Administrative reasons|2|||
23262861|NCT01992107|64703183|FG001|Overall Study|Administrative reasons|0|||
23262862|NCT01992107|64703184|FG002|Overall Study|Administrative reasons|0|||
23262863|NCT01992107|64703182|FG000|Overall Study|Adverse Event|0|||
23262864|NCT01992107|64703183|FG001|Overall Study|Adverse Event|1|||
23262865|NCT01992107|64703184|FG002|Overall Study|Adverse Event|0|||
23262866|NCT01992107|64703182|FG000|Overall Study|Lost to Follow-up|46|||
23262867|NCT01992107|64703183|FG001|Overall Study|Lost to Follow-up|22|||
23262868|NCT01992107|64703184|FG002|Overall Study|Lost to Follow-up|26|||
23262869|NCT01992107|64703182|FG000|Overall Study|noncompliance and were unavailable|7|||
23262870|NCT01992107|64703183|FG001|Overall Study|noncompliance and were unavailable|3|||
23262871|NCT01992107|64703184|FG002|Overall Study|noncompliance and were unavailable|2|||
23262872|NCT01992107|64703182|FG000|Overall Study|Withdrawal by Subject|13|||
23262873|NCT01992107|64703183|FG001|Overall Study|Withdrawal by Subject|7|||
23262874|NCT01992107|64703184|FG002|Overall Study|Withdrawal by Subject|8|||
23262875|NCT01405820|64703185|FG000|Randomized Treatment Period|Adverse Event|3|||
23262876|NCT01405820|64703186|FG001|Randomized Treatment Period|Adverse Event|3|||
23262877|NCT01405820|64703187|FG002|Randomized Treatment Period|Adverse Event|3|||
23262878|NCT01405820|64703188|FG003|Randomized Treatment Period|Adverse Event|0|||
23262879|NCT01405820|64703189|FG004|Randomized Treatment Period|Adverse Event|2|||
23262880|NCT01405820|64703190|FG005|Randomized Treatment Period|Adverse Event|1|||
23262881|NCT01405820|64703185|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
23262882|NCT01405820|64703186|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
23262883|NCT01405820|64703187|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
23262884|NCT01405820|64703188|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
23262885|NCT01405820|64703189|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
23262886|NCT01405820|64703190|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
23262887|NCT01405820|64703185|FG000|Randomized Treatment Period|Other|2|||
23262888|NCT01405820|64703186|FG001|Randomized Treatment Period|Other|2|||
23262889|NCT01405820|64703187|FG002|Randomized Treatment Period|Other|1|||
23262890|NCT01405820|64703188|FG003|Randomized Treatment Period|Other|1|||
23262891|NCT01405820|64703189|FG004|Randomized Treatment Period|Other|0|||
23262892|NCT01405820|64703190|FG005|Randomized Treatment Period|Other|0|||
23262893|NCT01405820|64703185|FG000|Randomized Treatment Period|Physician Decision|0|||
23262894|NCT01405820|64703186|FG001|Randomized Treatment Period|Physician Decision|2|||
23262895|NCT01405820|64703187|FG002|Randomized Treatment Period|Physician Decision|1|||
23262896|NCT01405820|64703188|FG003|Randomized Treatment Period|Physician Decision|0|||
23262897|NCT01405820|64703189|FG004|Randomized Treatment Period|Physician Decision|0|||
23361786|NCT01081626|65069820|FG000|Overall Study|Other|33|||
23361787|NCT01081626|65069821|FG001|Overall Study|Other|30|||
23200939|NCT03176277|64476508|FG003|Part A Dose Escalation Study|Progressive disease|0|||
23200940|NCT02488759|64476509|FG000|Overall Study|Disease progression|73|||
23200941|NCT02488759|64476510|FG001|Overall Study|Disease progression|111|||
23200942|NCT02488759|64476511|FG002|Overall Study|Disease progression|62|||
23200943|NCT02488759|64476512|FG003|Overall Study|Disease progression|7|||
23200944|NCT02488759|64476513|FG004|Overall Study|Disease progression|4|||
23200945|NCT02488759|64476514|FG005|Overall Study|Disease progression|2|||
23200946|NCT02488759|64476509|FG000|Overall Study|Study drug toxicity|11|||
23200947|NCT02488759|64476510|FG001|Overall Study|Study drug toxicity|33|||
23361788|NCT00613366|65069822|FG000|Overall Study|Withdrawal by Subject|3|||
23200948|NCT02488759|64476511|FG002|Overall Study|Study drug toxicity|31|||
23361789|NCT00613366|65069823|FG001|Overall Study|Withdrawal by Subject|2|||
23361790|NCT01211145|65069825|FG000|Overall Study|Reason not specified|3|||
23600749|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
23600750|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
23600751|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
23600752|NCT01767467|65929707|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
23600753|NCT01767467|65929708|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
23600754|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
23600755|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
23600756|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
23600757|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
23600758|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
23600759|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
23600760|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
23600761|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
23600762|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
23600763|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
23600764|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
23600765|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
23600766|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
23600767|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
23600768|NCT01767467|65929707|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
23600769|NCT01767467|65929708|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
23600770|NCT01988402|65929709|FG000|Overall Study|Adverse Event|1|||
23600771|NCT01988402|65929710|FG001|Overall Study|Adverse Event|2|||
23600772|NCT01988402|65929709|FG000|Overall Study|Withdrawal by Subject|1|||
23600773|NCT01988402|65929710|FG001|Overall Study|Withdrawal by Subject|0|||
23600774|NCT02767765|65929713|FG000|Overall Study|Adverse Event|4|||
23600775|NCT02767765|65929713|FG000|Overall Study|Death|1|||
23600776|NCT02767765|65929713|FG000|Overall Study|Insufficient response|1|||
23600777|NCT02767765|65929713|FG000|Overall Study|Lost to Follow-up|2|||
23600778|NCT02767765|65929713|FG000|Overall Study|Investigator decision|1|||
23600779|NCT02767765|65929713|FG000|Overall Study|Non-Compliance|1|||
23600780|NCT02767765|65929713|FG000|Overall Study|Withdrawal by Subject|1|||
23600781|NCT01827839|65929714|FG000|Overall Study|Adverse Event|1|||
23600782|NCT01827839|65929714|FG000|Overall Study|Consent Withdrawal|2|||
23600783|NCT02189759|65929715|FG000|Overall Study|Lost to Follow-up|0|||
23600784|NCT02189759|65929716|FG001|Overall Study|Lost to Follow-up|0|||
23600785|NCT02189759|65929717|FG002|Overall Study|Lost to Follow-up|2|||
23600786|NCT02189759|65929718|FG003|Overall Study|Lost to Follow-up|5|||
23600787|NCT01057433|65929719|FG000|Overall Study|Adverse Event|1|||
23600788|NCT01426412|65929724|FG000|Overall Study|Withdrawal by Subject|1|||
23600789|NCT01426412|65929725|FG001|Overall Study|Withdrawal by Subject|0|||
23600790|NCT01426412|65929726|FG002|Overall Study|Withdrawal by Subject|0|||
23600791|NCT01426412|65929727|FG003|Overall Study|Withdrawal by Subject|0|||
23600792|NCT01426412|65929728|FG004|Overall Study|Withdrawal by Subject|1|||
23600793|NCT01426412|65929729|FG005|Overall Study|Withdrawal by Subject|0|||
23600794|NCT01426412|65929730|FG006|Overall Study|Withdrawal by Subject|0|||
23600795|NCT01426412|65929731|FG007|Overall Study|Withdrawal by Subject|3|||
23600796|NCT01426412|65929732|FG008|Overall Study|Withdrawal by Subject|1|||
23600797|NCT02189252|65929745|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
23600798|NCT02189252|65929746|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
23600799|NCT02189252|65929747|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
23600800|NCT02189252|65929748|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
23600801|NCT02189252|65929745|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
23600802|NCT02189252|65929746|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
23600803|NCT02189252|65929747|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
23600804|NCT02189252|65929748|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
23600805|NCT03539952|65929751|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
23600806|NCT03539952|65929752|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
23600807|NCT03539952|65929751|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
23600808|NCT03539952|65929752|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
23600809|NCT03539952|65929751|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
23600810|NCT03539952|65929752|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
23600811|NCT03539952|65929751|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
23600812|NCT03539952|65929752|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
23600813|NCT03539952|65929751|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
23600814|NCT03539952|65929752|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
23361791|NCT01211145|65069826|FG001|Overall Study|Reason not specified|2|||
23361792|NCT01211145|65069827|FG002|Overall Study|Reason not specified|2|||
23200949|NCT02488759|64476512|FG003|Overall Study|Study drug toxicity|0|||
23200950|NCT02488759|64476513|FG004|Overall Study|Study drug toxicity|0|||
23200951|NCT02488759|64476514|FG005|Overall Study|Study drug toxicity|2|||
23200952|NCT02488759|64476509|FG000|Overall Study|Adverse event unrelated to study drug|9|||
23200953|NCT02488759|64476510|FG001|Overall Study|Adverse event unrelated to study drug|11|||
23200954|NCT02488759|64476511|FG002|Overall Study|Adverse event unrelated to study drug|7|||
23200955|NCT02488759|64476512|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23200956|NCT02488759|64476513|FG004|Overall Study|Adverse event unrelated to study drug|1|||
23200957|NCT02488759|64476514|FG005|Overall Study|Adverse event unrelated to study drug|0|||
23200958|NCT02488759|64476509|FG000|Overall Study|Participant request to discontinue study treatment|6|||
23200959|NCT02488759|64476510|FG001|Overall Study|Participant request to discontinue study treatment|8|||
23200960|NCT02488759|64476511|FG002|Overall Study|Participant request to discontinue study treatment|4|||
23200961|NCT02488759|64476512|FG003|Overall Study|Participant request to discontinue study treatment|0|||
23200962|NCT02488759|64476513|FG004|Overall Study|Participant request to discontinue study treatment|0|||
23200963|NCT02488759|64476514|FG005|Overall Study|Participant request to discontinue study treatment|0|||
23200964|NCT02488759|64476509|FG000|Overall Study|Withdrawal by Subject|4|||
23262898|NCT01405820|64703190|FG005|Randomized Treatment Period|Physician Decision|0|||
23262899|NCT01405820|64703185|FG000|Randomized Treatment Period|Rescue|0|||
23262900|NCT01405820|64703186|FG001|Randomized Treatment Period|Rescue|1|||
23262901|NCT01405820|64703187|FG002|Randomized Treatment Period|Rescue|13|||
23262902|NCT01405820|64703188|FG003|Randomized Treatment Period|Rescue|10|||
23262903|NCT01405820|64703189|FG004|Randomized Treatment Period|Rescue|8|||
23262904|NCT01405820|64703190|FG005|Randomized Treatment Period|Rescue|8|||
23200965|NCT02488759|64476510|FG001|Overall Study|Withdrawal by Subject|0|||
23200966|NCT02488759|64476511|FG002|Overall Study|Withdrawal by Subject|3|||
23200967|NCT02488759|64476512|FG003|Overall Study|Withdrawal by Subject|0|||
23200968|NCT02488759|64476513|FG004|Overall Study|Withdrawal by Subject|0|||
23200969|NCT02488759|64476514|FG005|Overall Study|Withdrawal by Subject|2|||
23200970|NCT02488759|64476509|FG000|Overall Study|Lost to Follow-up|0|||
23200971|NCT02488759|64476510|FG001|Overall Study|Lost to Follow-up|0|||
23200972|NCT02488759|64476511|FG002|Overall Study|Lost to Follow-up|2|||
23200973|NCT02488759|64476512|FG003|Overall Study|Lost to Follow-up|0|||
23200974|NCT02488759|64476513|FG004|Overall Study|Lost to Follow-up|0|||
23200975|NCT02488759|64476514|FG005|Overall Study|Lost to Follow-up|0|||
23200976|NCT02488759|64476509|FG000|Overall Study|Maximum clinical benefit|3|||
23200977|NCT02488759|64476510|FG001|Overall Study|Maximum clinical benefit|0|||
23200978|NCT02488759|64476511|FG002|Overall Study|Maximum clinical benefit|1|||
23200979|NCT02488759|64476512|FG003|Overall Study|Maximum clinical benefit|0|||
23200980|NCT02488759|64476513|FG004|Overall Study|Maximum clinical benefit|0|||
23200981|NCT02488759|64476514|FG005|Overall Study|Maximum clinical benefit|0|||
23200982|NCT02488759|64476509|FG000|Overall Study|Other reasons|7|||
23200983|NCT02488759|64476510|FG001|Overall Study|Other reasons|32|||
23200984|NCT02488759|64476511|FG002|Overall Study|Other reasons|23|||
23361793|NCT01211145|65069828|FG003|Overall Study|Reason not specified|1|||
23361794|NCT01211145|65069825|FG000|Overall Study|Lost to Follow-up|3|||
23361795|NCT01211145|65069826|FG001|Overall Study|Lost to Follow-up|2|||
23600815|NCT03539952|65929751|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
23600816|NCT03539952|65929752|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
23600817|NCT03539952|65929751|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
23600818|NCT03539952|65929752|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
23600819|NCT00210106|65929753|FG000|Overall Study|Death|1|||
23600820|NCT00210106|65929753|FG000|Overall Study|Protocol Violation|13|||
23600821|NCT02941549|65929754|FG000|Overall Study|Adverse Event|1|||
23600822|NCT02941549|65929755|FG001|Overall Study|Adverse Event|0|||
23600823|NCT02941549|65929756|FG002|Overall Study|Adverse Event|0|||
23600824|NCT02941549|65929754|FG000|Overall Study|Withdrawal by Subject|2|||
23600825|NCT02941549|65929755|FG001|Overall Study|Withdrawal by Subject|1|||
23600826|NCT02941549|65929756|FG002|Overall Study|Withdrawal by Subject|2|||
23600827|NCT01340066|65929757|FG000|Placebo Run in Period|Screen Failures|27|||
23600828|NCT01340066|65929758|FG001|Placebo Run in Period|Screen Failures|0|||
23600829|NCT01340066|65929759|FG002|Placebo Run in Period|Screen Failures|0|||
23200985|NCT02488759|64476512|FG003|Overall Study|Other reasons|1|||
23200986|NCT02488759|64476513|FG004|Overall Study|Other reasons|1|||
23200987|NCT02488759|64476514|FG005|Overall Study|Other reasons|1|||
23200988|NCT02493426|64476515|FG000|Overall Study|Withdrawal by Subject|0|||
23200989|NCT02493426|64476516|FG001|Overall Study|Withdrawal by Subject|1|||
23200990|NCT01689207|64476526|FG000|Overall Study|Adverse Event|0|||
23200991|NCT01689207|64476527|FG001|Overall Study|Adverse Event|1|||
23200992|NCT01689207|64476528|FG002|Overall Study|Adverse Event|0|||
23200993|NCT01689207|64476529|FG003|Overall Study|Adverse Event|0|||
23200994|NCT01689207|64476530|FG004|Overall Study|Adverse Event|2|||
23200995|NCT01689207|64476531|FG005|Overall Study|Adverse Event|1|||
23262905|NCT01405820|64703185|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
23361796|NCT01211145|65069827|FG002|Overall Study|Lost to Follow-up|1|||
23262906|NCT01405820|64703186|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
23262907|NCT01405820|64703187|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
23262908|NCT01405820|64703188|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
23262909|NCT01405820|64703189|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
23262910|NCT01405820|64703190|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
23262911|NCT01405820|64703185|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
23262912|NCT01405820|64703186|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
23262913|NCT01405820|64703187|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
23262914|NCT01405820|64703188|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
23262915|NCT01405820|64703189|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
23262916|NCT01405820|64703190|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
23262917|NCT01405820|64703185|FG000|Randomized Treatment Period|Death|0|||
23262918|NCT01405820|64703186|FG001|Randomized Treatment Period|Death|0|||
23262919|NCT01405820|64703187|FG002|Randomized Treatment Period|Death|0|||
23262920|NCT01405820|64703188|FG003|Randomized Treatment Period|Death|1|||
23262921|NCT01405820|64703189|FG004|Randomized Treatment Period|Death|0|||
23262922|NCT01405820|64703190|FG005|Randomized Treatment Period|Death|0|||
23262923|NCT01405820|64703185|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23262924|NCT01405820|64703186|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23262925|NCT01405820|64703187|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23262926|NCT01405820|64703188|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
23262927|NCT01405820|64703189|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23262928|NCT01405820|64703190|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
23262929|NCT01405820|64703185|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
23262930|NCT01405820|64703186|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
23262931|NCT01405820|64703187|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
23361797|NCT01211145|65069828|FG003|Overall Study|Lost to Follow-up|2|||
23361798|NCT01211145|65069825|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23361799|NCT01211145|65069826|FG001|Overall Study|Study-specific withdrawal criteria|0|||
23361800|NCT01211145|65069827|FG002|Overall Study|Study-specific withdrawal criteria|0|||
23361801|NCT01211145|65069828|FG003|Overall Study|Study-specific withdrawal criteria|0|||
23361802|NCT01211145|65069825|FG000|Overall Study|Severe noncompliance to protocol|1|||
23361803|NCT01211145|65069826|FG001|Overall Study|Severe noncompliance to protocol|0|||
23361804|NCT01211145|65069827|FG002|Overall Study|Severe noncompliance to protocol|0|||
23361805|NCT01211145|65069828|FG003|Overall Study|Severe noncompliance to protocol|0|||
23361806|NCT01211145|65069825|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
23361807|NCT01211145|65069826|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
23361808|NCT01211145|65069827|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
23361809|NCT01211145|65069828|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
23361810|NCT01211145|65069825|FG000|Overall Study|Patient decision|2|||
23361811|NCT01211145|65069826|FG001|Overall Study|Patient decision|1|||
23361812|NCT01211145|65069827|FG002|Overall Study|Patient decision|0|||
23361813|NCT01211145|65069828|FG003|Overall Study|Patient decision|2|||
23361814|NCT02735980|65069829|FG000|Overall Study|Adverse Event|0|||
23361815|NCT02735980|65069830|FG001|Overall Study|Adverse Event|4|||
23361816|NCT02735980|65069831|FG002|Overall Study|Adverse Event|1|||
23361817|NCT02735980|65069829|FG000|Overall Study|Death|5|||
23361818|NCT02735980|65069830|FG001|Overall Study|Death|4|||
23361819|NCT02735980|65069831|FG002|Overall Study|Death|0|||
23262932|NCT01405820|64703188|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
23361820|NCT02735980|65069829|FG000|Overall Study|Physician Decision|3|||
23361821|NCT02735980|65069830|FG001|Overall Study|Physician Decision|1|||
23361822|NCT02735980|65069831|FG002|Overall Study|Physician Decision|0|||
23361823|NCT02735980|65069829|FG000|Overall Study|Screen failure|1|||
23361824|NCT02735980|65069830|FG001|Overall Study|Screen failure|0|||
23361825|NCT02735980|65069831|FG002|Overall Study|Screen failure|0|||
23361826|NCT02735980|65069829|FG000|Overall Study|Withdrawal by Subject|1|||
23361827|NCT02735980|65069830|FG001|Overall Study|Withdrawal by Subject|2|||
23361828|NCT02735980|65069831|FG002|Overall Study|Withdrawal by Subject|0|||
23361829|NCT00758498|65069832|FG000|Overall Study|Adverse Event|2|||
23361830|NCT00758498|65069833|FG001|Overall Study|Adverse Event|2|||
23361831|NCT00758498|65069834|FG002|Overall Study|Adverse Event|3|||
23361832|NCT00758498|65069832|FG000|Overall Study|Subject legally detained out of state|1|||
23361833|NCT00758498|65069833|FG001|Overall Study|Subject legally detained out of state|0|||
23361834|NCT00758498|65069834|FG002|Overall Study|Subject legally detained out of state|0|||
23361835|NCT00758498|65069832|FG000|Overall Study|Withdrawal by Subject|0|||
23361836|NCT00758498|65069833|FG001|Overall Study|Withdrawal by Subject|0|||
23361837|NCT00758498|65069834|FG002|Overall Study|Withdrawal by Subject|1|||
23361838|NCT00758498|65069832|FG000|Overall Study|Noncompliance to study procedures|0|||
23361839|NCT00758498|65069833|FG001|Overall Study|Noncompliance to study procedures|0|||
23361840|NCT00758498|65069834|FG002|Overall Study|Noncompliance to study procedures|1|||
23361841|NCT02227784|65069842|FG000|Double-Blind Phase|Adverse Event|3|||
23361842|NCT02227784|65069843|FG001|Double-Blind Phase|Adverse Event|2|||
23262933|NCT01405820|64703189|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
23262934|NCT01405820|64703190|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
23262935|NCT01405820|64703185|FG000|Open-Label Treatment Period|Other|1|||
23262936|NCT01405820|64703186|FG001|Open-Label Treatment Period|Other|1|||
23262937|NCT01405820|64703187|FG002|Open-Label Treatment Period|Other|1|||
23262938|NCT01405820|64703188|FG003|Open-Label Treatment Period|Other|1|||
23200996|NCT01689207|64476532|FG006|Overall Study|Adverse Event|0|||
23200997|NCT01689207|64476533|FG007|Overall Study|Adverse Event|0|||
23262939|NCT01405820|64703189|FG004|Open-Label Treatment Period|Other|1|||
23262940|NCT01405820|64703190|FG005|Open-Label Treatment Period|Other|1|||
23262941|NCT01405820|64703185|FG000|Open-Label Treatment Period|Physician Decision|0|||
23262942|NCT01405820|64703186|FG001|Open-Label Treatment Period|Physician Decision|0|||
23262943|NCT01405820|64703187|FG002|Open-Label Treatment Period|Physician Decision|1|||
23262944|NCT01405820|64703188|FG003|Open-Label Treatment Period|Physician Decision|2|||
23262945|NCT01405820|64703189|FG004|Open-Label Treatment Period|Physician Decision|1|||
23262946|NCT01405820|64703190|FG005|Open-Label Treatment Period|Physician Decision|0|||
23262947|NCT01405820|64703185|FG000|Open-Label Treatment Period|Adverse Event|0|||
23262948|NCT01405820|64703186|FG001|Open-Label Treatment Period|Adverse Event|0|||
23262949|NCT01405820|64703187|FG002|Open-Label Treatment Period|Adverse Event|0|||
23262950|NCT01405820|64703188|FG003|Open-Label Treatment Period|Adverse Event|1|||
23262951|NCT01405820|64703189|FG004|Open-Label Treatment Period|Adverse Event|0|||
23262952|NCT01405820|64703190|FG005|Open-Label Treatment Period|Adverse Event|0|||
23262953|NCT01953783|64703193|FG000|Overall Study|Progressive disease|2|||
23262954|NCT05085964|64703194|FG000|Overall Study|Premature termination of study|21|||
23262955|NCT05085964|64703195|FG001|Overall Study|Premature termination of study|0|||
23262956|NCT04081337|64703196|FG000|Overall Study|Adverse Event|0|||
23262957|NCT04081337|64703197|FG001|Overall Study|Adverse Event|1|||
23262958|NCT04081337|64703196|FG000|Overall Study|Withdrawal by Subject|2|||
23200998|NCT01689207|64476534|FG008|Overall Study|Adverse Event|1|||
23200999|NCT01689207|64476535|FG009|Overall Study|Adverse Event|0|||
23201000|NCT01689207|64476536|FG010|Overall Study|Adverse Event|0|||
23201001|NCT02164513|64476540|FG000|Overall Study|Adverse Event|162|||
23201002|NCT02164513|64476541|FG001|Overall Study|Adverse Event|180|||
23201003|NCT02164513|64476542|FG002|Overall Study|Adverse Event|111|||
23262959|NCT04081337|64703197|FG001|Overall Study|Withdrawal by Subject|0|||
23262960|NCT04081337|64703196|FG000|Overall Study|Physician Decision|1|||
23201004|NCT02164513|64476540|FG000|Overall Study|Other: Study Closed or terminated|5|||
23201005|NCT02164513|64476541|FG001|Overall Study|Other: Study Closed or terminated|2|||
23201006|NCT02164513|64476542|FG002|Overall Study|Other: Study Closed or terminated|4|||
23201007|NCT02164513|64476540|FG000|Overall Study|Lost to Follow-up|30|||
23262961|NCT04081337|64703197|FG001|Overall Study|Physician Decision|2|||
23262962|NCT04081337|64703196|FG000|Overall Study|Lost to Follow-up|1|||
23262963|NCT04081337|64703197|FG001|Overall Study|Lost to Follow-up|0|||
23201008|NCT02164513|64476541|FG001|Overall Study|Lost to Follow-up|36|||
23201009|NCT02164513|64476542|FG002|Overall Study|Lost to Follow-up|22|||
23201010|NCT02164513|64476540|FG000|Overall Study|Physician Decision|47|||
23201011|NCT02164513|64476541|FG001|Overall Study|Physician Decision|57|||
23201012|NCT02164513|64476542|FG002|Overall Study|Physician Decision|28|||
23201013|NCT02164513|64476540|FG000|Overall Study|Withdrawal by Subject|192|||
23201014|NCT02164513|64476541|FG001|Overall Study|Withdrawal by Subject|261|||
23262964|NCT00322556|64703198|FG000|Overall Study|Adverse Event|1|||
23262965|NCT00322556|64703198|FG000|Overall Study|Withdrawal by Subject|1|||
23262966|NCT00322556|64703198|FG000|Overall Study|Lost to Follow-up|3|||
23262967|NCT00322556|64703198|FG000|Overall Study|Other Reason|7|||
23262968|NCT00859469|64703204|FG000|Overall Study|Adverse Event|2|||
23262969|NCT00859469|64703204|FG000|Overall Study|Lack of Efficacy|9|||
23262970|NCT00859469|64703204|FG000|Overall Study|Withdrawal by Subject|1|||
23201015|NCT02164513|64476542|FG002|Overall Study|Withdrawal by Subject|130|||
23201016|NCT02164513|64476540|FG000|Overall Study|Other: Reason not provided by site|1|||
23201017|NCT02164513|64476541|FG001|Overall Study|Other: Reason not provided by site|0|||
23201018|NCT02164513|64476542|FG002|Overall Study|Other: Reason not provided by site|0|||
23201019|NCT00975195|64476554|FG000|Overall Study|Adverse Event|108|||
23262971|NCT00859469|64703204|FG000|Overall Study|Death|16|||
23262972|NCT01411995|64703210|FG000|Overall Study|Failed IUD insertion|0|||
23262973|NCT01411995|64703211|FG001|Overall Study|Failed IUD insertion|1|||
23262974|NCT00182091|64703212|FG000|Overall Study|Withdrawal by Subject|1|||
23262975|NCT00182091|64703213|FG001|Overall Study|Withdrawal by Subject|0|||
23262976|NCT00182091|64703214|FG002|Overall Study|Withdrawal by Subject|0|||
23262977|NCT00182091|64703215|FG003|Overall Study|Withdrawal by Subject|0|||
23262978|NCT03922477|64703216|FG000|Overall Study|Death|9|||
23262979|NCT03922477|64703216|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
23262980|NCT03922477|64703216|FG000|Overall Study|Physician Decision|1|||
23262981|NCT03922477|64703216|FG000|Overall Study|Withdrawal by Subject|2|||
23262982|NCT02043366|64703217|FG000|Overall Study|Lost to Follow-up|2|||
23361843|NCT02227784|65069844|FG002|Double-Blind Phase|Adverse Event|1|||
23361844|NCT02227784|65069845|FG003|Double-Blind Phase|Adverse Event|3|||
23361845|NCT02227784|65069846|FG004|Double-Blind Phase|Adverse Event|0|||
23361846|NCT02227784|65069842|FG000|Double-Blind Phase|Physician Decision|1|||
23361847|NCT02227784|65069843|FG001|Double-Blind Phase|Physician Decision|0|||
23361848|NCT02227784|65069844|FG002|Double-Blind Phase|Physician Decision|0|||
23361849|NCT02227784|65069845|FG003|Double-Blind Phase|Physician Decision|1|||
23361850|NCT02227784|65069846|FG004|Double-Blind Phase|Physician Decision|0|||
23361851|NCT02227784|65069842|FG000|Double-Blind Phase|Protocol Violation|0|||
23361852|NCT02227784|65069843|FG001|Double-Blind Phase|Protocol Violation|0|||
23361853|NCT02227784|65069844|FG002|Double-Blind Phase|Protocol Violation|1|||
23361854|NCT02227784|65069845|FG003|Double-Blind Phase|Protocol Violation|1|||
23361855|NCT02227784|65069846|FG004|Double-Blind Phase|Protocol Violation|0|||
23361856|NCT02227784|65069842|FG000|Double-Blind Phase|Sponsor Decision|34|||
23361857|NCT02227784|65069843|FG001|Double-Blind Phase|Sponsor Decision|15|||
23361858|NCT02227784|65069844|FG002|Double-Blind Phase|Sponsor Decision|14|||
23361859|NCT02227784|65069845|FG003|Double-Blind Phase|Sponsor Decision|32|||
23361860|NCT02227784|65069846|FG004|Double-Blind Phase|Sponsor Decision|0|||
23361861|NCT02227784|65069842|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
23361862|NCT02227784|65069843|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
23361863|NCT02227784|65069844|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
23361864|NCT02227784|65069845|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
23361865|NCT02227784|65069846|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23361866|NCT02227784|65069842|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
23361867|NCT02227784|65069843|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
23361868|NCT02227784|65069844|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
23361869|NCT02227784|65069845|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
23480500|NCT00775203|65502008|FG000|Overall Study|Lost to Follow-up|11|||
23480501|NCT00775203|65502009|FG001|Overall Study|Lost to Follow-up|15|||
23480502|NCT00775203|65502008|FG000|Overall Study|Administrative reason|2|||
23480503|NCT00775203|65502009|FG001|Overall Study|Administrative reason|0|||
23480504|NCT00775203|65502008|FG000|Overall Study|Noncompliance|4|||
23480505|NCT00775203|65502009|FG001|Overall Study|Noncompliance|2|||
23480506|NCT00775203|65502008|FG000|Overall Study|Protocol Violation|0|||
23480507|NCT00775203|65502009|FG001|Overall Study|Protocol Violation|1|||
23480508|NCT00775203|65502008|FG000|Overall Study|Entered other study|1|||
23480509|NCT00775203|65502009|FG001|Overall Study|Entered other study|0|||
23480510|NCT00775203|65502008|FG000|Overall Study|Physician Decision|0|||
23480511|NCT00775203|65502009|FG001|Overall Study|Physician Decision|1|||
23480512|NCT02186301|65502012|FG000|Overall Study|Progressive Disease|7|||
23480513|NCT02186301|65502013|FG001|Overall Study|Progressive Disease|22|||
23480514|NCT02186301|65502014|FG002|Overall Study|Progressive Disease|27|||
23480515|NCT02186301|65502012|FG000|Overall Study|Adverse Event|5|||
23480516|NCT02186301|65502013|FG001|Overall Study|Adverse Event|5|||
23480517|NCT02186301|65502014|FG002|Overall Study|Adverse Event|5|||
23480518|NCT02186301|65502012|FG000|Overall Study|Death|1|||
23480519|NCT02186301|65502013|FG001|Overall Study|Death|0|||
23480520|NCT02186301|65502014|FG002|Overall Study|Death|0|||
23201020|NCT00975195|64476555|FG001|Overall Study|Adverse Event|101|||
23201021|NCT00975195|64476554|FG000|Overall Study|Lack of Efficacy|6|||
23201022|NCT00975195|64476555|FG001|Overall Study|Lack of Efficacy|6|||
23201023|NCT00975195|64476554|FG000|Overall Study|Protocol Violation|27|||
23201024|NCT00975195|64476555|FG001|Overall Study|Protocol Violation|23|||
23600830|NCT01340066|65929757|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
23600831|NCT01340066|65929758|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
23201025|NCT00975195|64476554|FG000|Overall Study|Lost to Follow-up|9|||
23262983|NCT02043366|64703218|FG001|Overall Study|Lost to Follow-up|2|||
23262984|NCT02043366|64703219|FG002|Overall Study|Lost to Follow-up|2|||
23361870|NCT02227784|65069846|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
23361871|NCT02227784|65069842|FG000|Open-Label Extension Phase (OLE)|Death|0|||
23361872|NCT02227784|65069843|FG001|Open-Label Extension Phase (OLE)|Death|0|||
23361873|NCT02227784|65069844|FG002|Open-Label Extension Phase (OLE)|Death|0|||
23480521|NCT02186301|65502012|FG000|Overall Study|Withdrawal by Subject|5|||
23480522|NCT02186301|65502013|FG001|Overall Study|Withdrawal by Subject|1|||
23480523|NCT02186301|65502014|FG002|Overall Study|Withdrawal by Subject|3|||
23201026|NCT00975195|64476555|FG001|Overall Study|Lost to Follow-up|7|||
23480524|NCT02186301|65502012|FG000|Overall Study|Physician Decision|1|||
23262985|NCT02043366|64703220|FG003|Overall Study|Lost to Follow-up|2|||
23262986|NCT02043366|64703221|FG004|Overall Study|Lost to Follow-up|2|||
23262987|NCT02043366|64703222|FG005|Overall Study|Lost to Follow-up|2|||
23262988|NCT01855126|64703223|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
23262989|NCT01855126|64703224|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
23262990|NCT01855126|64703223|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
23262991|NCT01855126|64703224|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
23361874|NCT02227784|65069845|FG003|Open-Label Extension Phase (OLE)|Death|0|||
23361875|NCT02227784|65069846|FG004|Open-Label Extension Phase (OLE)|Death|1|||
23201027|NCT00975195|64476554|FG000|Overall Study|Withdrawal by Subject|48|||
23201028|NCT00975195|64476555|FG001|Overall Study|Withdrawal by Subject|61|||
23201029|NCT00975195|64476554|FG000|Overall Study|Other reason not defined above|29|||
23201030|NCT00975195|64476555|FG001|Overall Study|Other reason not defined above|33|||
23201031|NCT00975195|64476554|FG000|Overall Study|Not treated|1|||
23201032|NCT00975195|64476555|FG001|Overall Study|Not treated|2|||
23201033|NCT01701583|64476560|FG000|Overall Study|Withdrawal by Subject|2|||
23201034|NCT01701583|64476561|FG001|Overall Study|Withdrawal by Subject|0|||
23201035|NCT01766336|64476562|FG000|Overall Study|Adverse Event|11|||
23201036|NCT01766336|64476563|FG001|Overall Study|Adverse Event|8|||
23201037|NCT01766336|64476562|FG000|Overall Study|Death|4|||
23201038|NCT01766336|64476563|FG001|Overall Study|Death|3|||
23201039|NCT01766336|64476562|FG000|Overall Study|Lost to Follow-up|1|||
23201040|NCT01766336|64476563|FG001|Overall Study|Lost to Follow-up|3|||
23201041|NCT01766336|64476562|FG000|Overall Study|Physician Decision|4|||
23201042|NCT01766336|64476563|FG001|Overall Study|Physician Decision|2|||
23201043|NCT01766336|64476562|FG000|Overall Study|Protocol Violation|0|||
23201044|NCT01766336|64476563|FG001|Overall Study|Protocol Violation|1|||
23201045|NCT01766336|64476562|FG000|Overall Study|Sponsor Decision|52|||
23201046|NCT01766336|64476563|FG001|Overall Study|Sponsor Decision|43|||
23201047|NCT01766336|64476562|FG000|Overall Study|Withdrawal by Subject|18|||
23201048|NCT01766336|64476563|FG001|Overall Study|Withdrawal by Subject|15|||
23201049|NCT03552549|64476568|FG000|Overall Study|Disease progression|25|||
23201050|NCT03552549|64476569|FG001|Overall Study|Disease progression|17|||
23201051|NCT03552549|64476568|FG000|Overall Study|Adverse event in first 12 months|12|||
23201052|NCT03552549|64476569|FG001|Overall Study|Adverse event in first 12 months|8|||
23201053|NCT03552549|64476568|FG000|Overall Study|Withdrawal by Subject|7|||
23201054|NCT03552549|64476569|FG001|Overall Study|Withdrawal by Subject|7|||
23201055|NCT03552549|64476568|FG000|Overall Study|Unknown (no reason provided)|4|||
23201056|NCT03552549|64476569|FG001|Overall Study|Unknown (no reason provided)|2|||
23201057|NCT03552549|64476568|FG000|Overall Study|Not in participant's best interest|2|||
23201058|NCT03552549|64476569|FG001|Overall Study|Not in participant's best interest|1|||
23201059|NCT03552549|64476568|FG000|Overall Study|Did not complete study treatment|2|||
23201060|NCT03552549|64476569|FG001|Overall Study|Did not complete study treatment|3|||
23201061|NCT03552549|64476568|FG000|Overall Study|Did not meet eligibility criteria|1|||
23201062|NCT03552549|64476569|FG001|Overall Study|Did not meet eligibility criteria|0|||
23201063|NCT03552549|64476568|FG000|Overall Study|Administrative|0|||
23201064|NCT03552549|64476569|FG001|Overall Study|Administrative|14|||
23201065|NCT03350750|64476574|FG000|Overall Study|Death|1|||
23201066|NCT03350750|64476575|FG001|Overall Study|Death|1|||
23201067|NCT01912729|64476576|FG000|Overall Study|Withdrawal by Subject|0|||
23201068|NCT01912729|64476577|FG001|Overall Study|Withdrawal by Subject|1|||
23201069|NCT00804193|64476578|FG000|Overall Study|Lack of baseline fungus|32|||
23201070|NCT00804193|64476579|FG001|Overall Study|Lack of baseline fungus|31|||
23201071|NCT00804193|64476580|FG002|Overall Study|Lack of baseline fungus|19|||
23201072|NCT00804193|64476578|FG000|Overall Study|Adverse Event|0|||
23201073|NCT00804193|64476579|FG001|Overall Study|Adverse Event|0|||
23201074|NCT00804193|64476580|FG002|Overall Study|Adverse Event|2|||
23201075|NCT00804193|64476578|FG000|Overall Study|Lack of Efficacy|1|||
23201076|NCT00804193|64476579|FG001|Overall Study|Lack of Efficacy|1|||
23201077|NCT00804193|64476580|FG002|Overall Study|Lack of Efficacy|3|||
23201078|NCT00804193|64476578|FG000|Overall Study|Protocol Violation|0|||
23262992|NCT01842958|64703225|FG000|Overall Study|Lost to Follow-up|1|||
23262993|NCT01842958|64703226|FG001|Overall Study|Lost to Follow-up|1|||
23201079|NCT00804193|64476579|FG001|Overall Study|Protocol Violation|8|||
23201080|NCT00804193|64476580|FG002|Overall Study|Protocol Violation|2|||
23201081|NCT00804193|64476578|FG000|Overall Study|Lost to Follow-up|3|||
23201082|NCT00804193|64476579|FG001|Overall Study|Lost to Follow-up|3|||
23201083|NCT00804193|64476580|FG002|Overall Study|Lost to Follow-up|4|||
23201084|NCT00804193|64476578|FG000|Overall Study|Withdrawal by Subject|3|||
23201085|NCT00804193|64476579|FG001|Overall Study|Withdrawal by Subject|1|||
23201086|NCT00804193|64476580|FG002|Overall Study|Withdrawal by Subject|2|||
23201087|NCT03491553|64476581|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
23201088|NCT03491553|64476582|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
23361876|NCT02227784|65069842|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23201089|NCT03491553|64476583|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
23201090|NCT03491553|64476584|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
23201091|NCT03491553|64476585|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
23262994|NCT00720798|64703229|FG000|Overall Study|Adverse Event|304|||
23262995|NCT00720798|64703229|FG000|Overall Study|Death|39|||
23262996|NCT00720798|64703229|FG000|Overall Study|Insufficient Therapeutic Response|129|||
23262997|NCT00720798|64703229|FG000|Overall Study|Protocol Violation|4|||
23262998|NCT00720798|64703229|FG000|Overall Study|Refused Treatment|151|||
23361877|NCT02227784|65069843|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23361878|NCT02227784|65069844|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23361879|NCT02227784|65069845|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
23361880|NCT02227784|65069846|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
23361881|NCT02227784|65069842|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
23361882|NCT02227784|65069843|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
23361883|NCT02227784|65069844|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
23361884|NCT02227784|65069845|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
23361885|NCT02227784|65069846|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
23361886|NCT03280056|65069851|FG000|Overall Study|Withdrawal by Subject|12|||
23361887|NCT03280056|65069852|FG001|Overall Study|Withdrawal by Subject|14|||
23361888|NCT03280056|65069851|FG000|Overall Study|Death|9|||
23361889|NCT03280056|65069852|FG001|Overall Study|Death|2|||
23361890|NCT03280056|65069851|FG000|Overall Study|Adverse Event|1|||
23361891|NCT03280056|65069852|FG001|Overall Study|Adverse Event|3|||
23262999|NCT00720798|64703229|FG000|Overall Study|Failure to Return|46|||
23263000|NCT00720798|64703229|FG000|Overall Study|Reason not Specified|83|||
23263001|NCT02649231|64703231|FG000|Overall Study|Adverse Event|0|||
23263002|NCT02649231|64703232|FG001|Overall Study|Adverse Event|0|||
23263003|NCT02649231|64703233|FG002|Overall Study|Adverse Event|0|||
23263004|NCT02649231|64703234|FG003|Overall Study|Adverse Event|1|||
23263005|NCT02649231|64703231|FG000|Overall Study|Lost to Follow-up|2|||
23263006|NCT02649231|64703232|FG001|Overall Study|Lost to Follow-up|1|||
23263007|NCT02649231|64703233|FG002|Overall Study|Lost to Follow-up|1|||
23263008|NCT02649231|64703234|FG003|Overall Study|Lost to Follow-up|0|||
23263009|NCT02649231|64703231|FG000|Overall Study|Withdrawal by Subject|0|||
23263010|NCT02649231|64703232|FG001|Overall Study|Withdrawal by Subject|1|||
23263011|NCT02649231|64703233|FG002|Overall Study|Withdrawal by Subject|0|||
23263012|NCT02649231|64703234|FG003|Overall Study|Withdrawal by Subject|1|||
23263013|NCT02649231|64703231|FG000|Overall Study|Protocol Violation|2|||
23263014|NCT02649231|64703232|FG001|Overall Study|Protocol Violation|1|||
23263015|NCT02649231|64703233|FG002|Overall Study|Protocol Violation|1|||
23263016|NCT02649231|64703234|FG003|Overall Study|Protocol Violation|0|||
23263017|NCT01326026|64703235|FG000|Overall Study|Adverse Event|4|||
23263018|NCT01326026|64703236|FG001|Overall Study|Adverse Event|3|||
23263019|NCT01326026|64703235|FG000|Overall Study|Withdrawal Criteria|5|||
23263020|NCT01326026|64703236|FG001|Overall Study|Withdrawal Criteria|7|||
23263021|NCT01326026|64703235|FG000|Overall Study|Other|3|||
23263022|NCT01326026|64703236|FG001|Overall Study|Other|3|||
23263023|NCT00619385|64703238|FG000|Overall Study|Adverse Event|0|||
23263024|NCT00619385|64703239|FG001|Overall Study|Adverse Event|0|||
23263025|NCT00619385|64703240|FG002|Overall Study|Adverse Event|3|||
23263026|NCT00619385|64703238|FG000|Overall Study|Other|1|||
23361892|NCT03280056|65069851|FG000|Overall Study|Lost to Follow-up|1|||
23361893|NCT03280056|65069852|FG001|Overall Study|Lost to Follow-up|1|||
23361894|NCT03280056|65069851|FG000|Overall Study|Physician Decision|0|||
23361895|NCT03280056|65069852|FG001|Overall Study|Physician Decision|1|||
23361896|NCT03280056|65069851|FG000|Overall Study|Early Discontinuation|1|||
23361897|NCT03280056|65069852|FG001|Overall Study|Early Discontinuation|0|||
23361898|NCT00905632|65069853|FG000|Overall Study|Adverse Event|0|||
23361899|NCT00905632|65069854|FG001|Overall Study|Adverse Event|0|||
23361900|NCT00905632|65069855|FG002|Overall Study|Adverse Event|0|||
23361901|NCT00905632|65069856|FG003|Overall Study|Adverse Event|0|||
23361902|NCT00905632|65069857|FG004|Overall Study|Adverse Event|0|||
23361903|NCT00905632|65069858|FG005|Overall Study|Adverse Event|1|||
23361904|NCT00905632|65069859|FG006|Overall Study|Adverse Event|4|||
23361905|NCT05279131|65069860|FG000|Overall Study|Lost to Follow-up|1|||
23361906|NCT05279131|65069860|FG000|Overall Study|Death|1|||
23361907|NCT05279131|65069860|FG000|Overall Study|Physician Decision|1|||
23263027|NCT00619385|64703239|FG001|Overall Study|Other|2|||
23263028|NCT00619385|64703240|FG002|Overall Study|Other|1|||
23361908|NCT04265261|65069861|FG000|Overall Study|Adverse Event|2|||
23263029|NCT01400113|64703242|FG000|Overall Study|Withdrawal by Subject|1|||
23263030|NCT01400113|64703243|FG001|Overall Study|Withdrawal by Subject|1|||
23263031|NCT05487456|64703256|FG000|Overall Study|Withdrawal by Subject|0|||
23263032|NCT05487456|64703257|FG001|Overall Study|Withdrawal by Subject|0|||
23263033|NCT05487456|64703258|FG002|Overall Study|Withdrawal by Subject|1|||
23263034|NCT05487456|64703259|FG003|Overall Study|Withdrawal by Subject|0|||
23361909|NCT04265261|65069862|FG001|Overall Study|Adverse Event|0|||
23263035|NCT00368277|64703260|FG000|Overall Study|Adverse Event|33|||
23263036|NCT00368277|64703261|FG001|Overall Study|Adverse Event|49|||
23361910|NCT04265261|65069863|FG002|Overall Study|Adverse Event|0|||
23361911|NCT04265261|65069861|FG000|Overall Study|Death|1|||
23361912|NCT04265261|65069862|FG001|Overall Study|Death|0|||
23201092|NCT03491553|64476586|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
23201093|NCT03491553|64476581|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
23201094|NCT03491553|64476582|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
23201095|NCT03491553|64476583|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
23201096|NCT03491553|64476584|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
23201097|NCT03491553|64476585|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
23201098|NCT03491553|64476586|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
23201099|NCT01585961|64476587|FG000|Overall Study|Death|6|||
23201100|NCT01585961|64476587|FG000|Overall Study|Physician Decision|1|||
23201101|NCT01585961|64476587|FG000|Overall Study|Decision to use non-study catheter|1|||
23201102|NCT01585961|64476587|FG000|Overall Study|Withdrawal by Subject|1|||
23201103|NCT01585961|64476587|FG000|Overall Study|Lost to Follow-up|23|||
23201104|NCT01585961|64476587|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
23201105|NCT01165021|64476588|FG000|Overall Study|Death|1|||
23201106|NCT03599141|64476589|FG000|Overall Study|Lost to Follow-up|3|||
23201107|NCT03599141|64476590|FG001|Overall Study|Lost to Follow-up|1|||
23201108|NCT01361009|64476591|FG000|Overall Study|Protocol Violation|116|||
23201109|NCT01839188|64476597|FG000|Overall Study|Withdrawal by Subject|1|||
23201110|NCT01551758|64476601|FG000|Overall Study|Adverse Event|29|||
23201111|NCT01551758|64476602|FG001|Overall Study|Adverse Event|43|||
23201112|NCT01551758|64476601|FG000|Overall Study|Lack of Efficacy|0|||
23201113|NCT01551758|64476602|FG001|Overall Study|Lack of Efficacy|1|||
23201114|NCT01551758|64476601|FG000|Overall Study|Protocol Violation|5|||
23201115|NCT01551758|64476602|FG001|Overall Study|Protocol Violation|6|||
23201116|NCT01551758|64476601|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
23201117|NCT01551758|64476602|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
23201118|NCT01551758|64476601|FG000|Overall Study|Lost to Follow-up|29|||
23201119|NCT01551758|64476602|FG001|Overall Study|Lost to Follow-up|25|||
23263037|NCT00368277|64703260|FG000|Overall Study|Death|2|||
23263038|NCT00368277|64703261|FG001|Overall Study|Death|1|||
23263039|NCT00368277|64703260|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
23263040|NCT00368277|64703261|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
23263041|NCT00368277|64703260|FG000|Overall Study|Protocol deviation|7|||
23263042|NCT00368277|64703261|FG001|Overall Study|Protocol deviation|0|||
23263043|NCT00368277|64703260|FG000|Overall Study|Patient withdrew consent|32|||
23263044|NCT00368277|64703261|FG001|Overall Study|Patient withdrew consent|28|||
23263045|NCT00368277|64703260|FG000|Overall Study|Lost to Follow-up|8|||
23263046|NCT00368277|64703261|FG001|Overall Study|Lost to Follow-up|6|||
23263047|NCT02354586|64703262|FG000|Overall Study|Death|230|||
23263048|NCT02354586|64703262|FG000|Overall Study|Withdrawal by Subject|59|||
23263049|NCT02354586|64703262|FG000|Overall Study|Lost to Follow-up|11|||
23263050|NCT02354586|64703262|FG000|Overall Study|Sponsor decision|51|||
23263051|NCT02354586|64703262|FG000|Overall Study|Site closure|2|||
23263052|NCT02354586|64703262|FG000|Overall Study|Intercurrent illness|1|||
23263053|NCT02354586|64703262|FG000|Overall Study|Protocol Violation|3|||
23263054|NCT02354586|64703262|FG000|Overall Study|Physician Decision|13|||
23263055|NCT02354586|64703262|FG000|Overall Study|Lack of Efficacy|86|||
23263056|NCT02354586|64703262|FG000|Overall Study|Adverse Event|7|||
23263057|NCT00582036|64703267|FG000|Overall Study|Withdrawal by Subject|0|||
23263058|NCT00582036|64703268|FG001|Overall Study|Withdrawal by Subject|1|||
23263059|NCT02040766|64703269|FG000|Overall Study|Adverse Event|1|||
23263060|NCT02040766|64703270|FG001|Overall Study|Adverse Event|1|||
23263061|NCT02040766|64703271|FG002|Overall Study|Adverse Event|1|||
23263062|NCT02040766|64703272|FG003|Overall Study|Adverse Event|0|||
23263063|NCT02040766|64703273|FG004|Overall Study|Adverse Event|2|||
23263064|NCT02040766|64703269|FG000|Overall Study|Withdrawal by Subject|4|||
23263065|NCT02040766|64703270|FG001|Overall Study|Withdrawal by Subject|3|||
23263066|NCT02040766|64703271|FG002|Overall Study|Withdrawal by Subject|2|||
23263067|NCT02040766|64703272|FG003|Overall Study|Withdrawal by Subject|3|||
23263068|NCT02040766|64703273|FG004|Overall Study|Withdrawal by Subject|2|||
23263069|NCT02040766|64703269|FG000|Overall Study|Non-compliance|0|||
23263070|NCT02040766|64703270|FG001|Overall Study|Non-compliance|1|||
23263071|NCT02040766|64703271|FG002|Overall Study|Non-compliance|0|||
23263072|NCT02040766|64703272|FG003|Overall Study|Non-compliance|0|||
23263073|NCT02040766|64703273|FG004|Overall Study|Non-compliance|0|||
23263074|NCT02040766|64703269|FG000|Overall Study|Protocol Violation|2|||
23263075|NCT02040766|64703270|FG001|Overall Study|Protocol Violation|1|||
23263076|NCT02040766|64703271|FG002|Overall Study|Protocol Violation|2|||
23263077|NCT02040766|64703272|FG003|Overall Study|Protocol Violation|3|||
23263078|NCT02040766|64703273|FG004|Overall Study|Protocol Violation|0|||
23263079|NCT02040766|64703269|FG000|Overall Study|Lost to Follow-up|4|||
23263080|NCT02040766|64703270|FG001|Overall Study|Lost to Follow-up|1|||
23263081|NCT02040766|64703271|FG002|Overall Study|Lost to Follow-up|3|||
23263082|NCT02040766|64703272|FG003|Overall Study|Lost to Follow-up|1|||
23263083|NCT02040766|64703273|FG004|Overall Study|Lost to Follow-up|4|||
23263084|NCT02040766|64703269|FG000|Overall Study|Not reported|1|||
23263085|NCT02040766|64703270|FG001|Overall Study|Not reported|0|||
23263086|NCT02040766|64703271|FG002|Overall Study|Not reported|0|||
23361913|NCT04265261|65069863|FG002|Overall Study|Death|0|||
23361914|NCT04265261|65069861|FG000|Overall Study|Lost to Follow-up|4|||
23361915|NCT04265261|65069862|FG001|Overall Study|Lost to Follow-up|1|||
23361916|NCT04265261|65069863|FG002|Overall Study|Lost to Follow-up|3|||
23361917|NCT04265261|65069861|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23361918|NCT04265261|65069862|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23361919|NCT04265261|65069863|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23361920|NCT04265261|65069861|FG000|Overall Study|Physician Decision|0|||
23361921|NCT04265261|65069862|FG001|Overall Study|Physician Decision|0|||
23361922|NCT04265261|65069863|FG002|Overall Study|Physician Decision|1|||
23263087|NCT02040766|64703272|FG003|Overall Study|Not reported|0|||
23263088|NCT02040766|64703273|FG004|Overall Study|Not reported|0|||
23263089|NCT02040766|64703269|FG000|Overall Study|Lack of Efficacy|6|||
23263090|NCT02040766|64703270|FG001|Overall Study|Lack of Efficacy|3|||
23263091|NCT02040766|64703271|FG002|Overall Study|Lack of Efficacy|4|||
23263092|NCT02040766|64703272|FG003|Overall Study|Lack of Efficacy|6|||
23263093|NCT02040766|64703273|FG004|Overall Study|Lack of Efficacy|5|||
23263094|NCT03870997|64703274|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
23263095|NCT03870997|64703275|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
23263096|NCT03870997|64703276|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
23263097|NCT03870997|64703277|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
23263098|NCT03870997|64703278|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
23263099|NCT03870997|64703279|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
23263100|NCT00278512|64703280|FG000|Overall Study|Death|1|||
23263101|NCT00278512|64703281|FG001|Overall Study|Death|0|||
23263102|NCT01298323|64703289|FG000|Overall Study|Adverse Event|2|||
23263103|NCT01298323|64703290|FG001|Overall Study|Adverse Event|4|||
23263104|NCT01298323|64703289|FG000|Overall Study|Death|11|||
23263105|NCT01298323|64703290|FG001|Overall Study|Death|16|||
23263106|NCT01298323|64703289|FG000|Overall Study|Lost to Follow-up|1|||
23263107|NCT01298323|64703290|FG001|Overall Study|Lost to Follow-up|0|||
23263108|NCT01298323|64703289|FG000|Overall Study|Withdrawal by Subject|6|||
23263109|NCT01298323|64703290|FG001|Overall Study|Withdrawal by Subject|3|||
23263110|NCT01298323|64703289|FG000|Overall Study|Protocol Violation|1|||
23263111|NCT01298323|64703290|FG001|Overall Study|Protocol Violation|0|||
23263112|NCT01298323|64703289|FG000|Overall Study|Other|10|||
23263113|NCT01298323|64703290|FG001|Overall Study|Other|9|||
23263114|NCT01298323|64703289|FG000|Overall Study|Ongoing|55|||
23263115|NCT01298323|64703290|FG001|Overall Study|Ongoing|55|||
23263116|NCT01298323|64703289|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23263117|NCT01298323|64703290|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23263118|NCT00622908|64703291|FG000|Overall Study|Protocol Violation|1|||
23263119|NCT00622908|64703292|FG001|Overall Study|Protocol Violation|0|||
23263120|NCT00622908|64703291|FG000|Overall Study|Adverse Event|0|||
23361923|NCT04265261|65069861|FG000|Overall Study|Protocol Deviation|0|||
23361924|NCT04265261|65069862|FG001|Overall Study|Protocol Deviation|2|||
23361925|NCT04265261|65069863|FG002|Overall Study|Protocol Deviation|0|||
23263121|NCT00622908|64703292|FG001|Overall Study|Adverse Event|1|||
23263122|NCT00622908|64703291|FG000|Overall Study|Lack of Efficacy|1|||
23361926|NCT04265261|65069861|FG000|Overall Study|Withdrawal by Subject|2|||
23263123|NCT00622908|64703292|FG001|Overall Study|Lack of Efficacy|7|||
23263124|NCT00622908|64703291|FG000|Overall Study|Lost to Follow-up|1|||
23263125|NCT00622908|64703292|FG001|Overall Study|Lost to Follow-up|0|||
23263126|NCT00622908|64703291|FG000|Overall Study|Refusal|0|||
23263127|NCT00622908|64703292|FG001|Overall Study|Refusal|1|||
23263128|NCT00622908|64703291|FG000|Overall Study|Termination by study sponser|0|||
23480525|NCT02186301|65502013|FG001|Overall Study|Physician Decision|0|||
23263129|NCT00622908|64703292|FG001|Overall Study|Termination by study sponser|1|||
23263130|NCT00146770|64703296|FG000|Overall Study|Adverse Event|2|||
23263131|NCT00146770|64703297|FG001|Overall Study|Adverse Event|0|||
23263132|NCT00146770|64703296|FG000|Overall Study|Pregnancy|1|||
23263133|NCT00146770|64703297|FG001|Overall Study|Pregnancy|0|||
23263134|NCT00146770|64703296|FG000|Overall Study|Withdrawal by Subject|2|||
23263135|NCT00146770|64703297|FG001|Overall Study|Withdrawal by Subject|0|||
23263136|NCT00553540|64703298|FG000|Overall Study|discharged after first visit|2|||
23263137|NCT00553540|64703299|FG001|Overall Study|discharged after first visit|5|||
23263138|NCT00698685|64703300|FG000|Overall Study|Sister withdrew as donor|1|||
23263139|NCT00698685|64703300|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
23263140|NCT01748890|64703301|FG000|Overall Study|Insufficient recruitment for analysis|4|||
23263141|NCT02507375|64703302|FG000|Overall Study|Progressive Disease|4|||
23263142|NCT02507375|64703303|FG001|Overall Study|Progressive Disease|5|||
23263143|NCT02507375|64703302|FG000|Overall Study|Death|0|||
23263144|NCT02507375|64703303|FG001|Overall Study|Death|1|||
23263145|NCT02507375|64703302|FG000|Overall Study|Refused treatment|0|||
23263146|NCT02507375|64703303|FG001|Overall Study|Refused treatment|1|||
23263147|NCT02507375|64703302|FG000|Overall Study|Adverse Event|0|||
23263148|NCT02507375|64703303|FG001|Overall Study|Adverse Event|1|||
23263149|NCT00522457|64703304|FG000|Overall Study|Due to disease progression|16|||
23263150|NCT00522457|64703304|FG000|Overall Study|Adverse Event|2|||
23263151|NCT00582309|64703306|FG000|Overall Study|Protocol Violation|0|||
23263152|NCT00582309|64703307|FG001|Overall Study|Protocol Violation|0|||
23263153|NCT00582309|64703308|FG002|Overall Study|Protocol Violation|2|||
23263154|NCT02866175|64703309|FG000|Overall Study|Adverse Event|56|||
23263155|NCT02866175|64703310|FG001|Overall Study|Adverse Event|54|||
23263156|NCT02866175|64703309|FG000|Overall Study|Withdrawal by Subject|31|||
23201120|NCT01551758|64476601|FG000|Overall Study|Physician Decision|9|||
23263157|NCT02866175|64703310|FG001|Overall Study|Withdrawal by Subject|52|||
23263158|NCT02866175|64703309|FG000|Overall Study|Death|30|||
23263159|NCT02866175|64703310|FG001|Overall Study|Death|23|||
23263160|NCT02866175|64703309|FG000|Overall Study|Other|7|||
23263161|NCT02866175|64703310|FG001|Overall Study|Other|14|||
23263162|NCT02866175|64703309|FG000|Overall Study|Progressive disease|1|||
23263163|NCT02866175|64703310|FG001|Overall Study|Progressive disease|1|||
23263164|NCT02866175|64703309|FG000|Overall Study|Lost to Follow-up|2|||
23263165|NCT02866175|64703310|FG001|Overall Study|Lost to Follow-up|0|||
23263166|NCT02866175|64703309|FG000|Overall Study|Lack of Efficacy|0|||
23263167|NCT02866175|64703310|FG001|Overall Study|Lack of Efficacy|1|||
23263168|NCT02866175|64703309|FG000|Overall Study|Physician Decision|3|||
23263169|NCT02866175|64703310|FG001|Overall Study|Physician Decision|15|||
23263170|NCT02866175|64703309|FG000|Overall Study|Did not receive treatment|5|||
23263171|NCT02866175|64703310|FG001|Overall Study|Did not receive treatment|15|||
23263172|NCT01901055|64703312|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
23263173|NCT01901055|64703313|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
23263174|NCT01901055|64703312|FG000|Randomization But Not Titrated|Physician Decision|0|||
23263175|NCT01901055|64703313|FG001|Randomization But Not Titrated|Physician Decision|1|||
23263176|NCT01901055|64703312|FG000|Started Protocol to Week 6|Physician Decision|2|||
23263177|NCT01901055|64703313|FG001|Started Protocol to Week 6|Physician Decision|1|||
23263178|NCT01901055|64703312|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
23263179|NCT01901055|64703313|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
23263180|NCT01901055|64703312|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
23263181|NCT01901055|64703313|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
23263182|NCT01901055|64703312|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
23263183|NCT01901055|64703313|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
23263184|NCT01901055|64703312|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
23263185|NCT01901055|64703313|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
23263186|NCT01901055|64703312|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
23263187|NCT01901055|64703313|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
23263188|NCT01901055|64703312|FG000|Week 24|Withdrawal by Subject|13|||
23263189|NCT01901055|64703313|FG001|Week 24|Withdrawal by Subject|19|||
23263190|NCT01901055|64703312|FG000|Week 24|Physician Decision|1|||
23263191|NCT01901055|64703313|FG001|Week 24|Physician Decision|0|||
23263192|NCT01901055|64703312|FG000|Week 36|Withdrawal by Subject|0|||
23263193|NCT01901055|64703313|FG001|Week 36|Withdrawal by Subject|5|||
23263194|NCT03066999|64706920|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
23263195|NCT03066999|64706921|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
23263196|NCT00738673|64706925|FG000|Overall Study|Adverse Event|1|||
23263197|NCT00738673|64706926|FG001|Overall Study|Adverse Event|0|||
23263198|NCT00738673|64706925|FG000|Overall Study|Lack of Efficacy|19|||
23263199|NCT00738673|64706926|FG001|Overall Study|Lack of Efficacy|8|||
23201121|NCT01551758|64476602|FG001|Overall Study|Physician Decision|3|||
23201122|NCT01551758|64476601|FG000|Overall Study|Withdrawal by Subject|14|||
23201123|NCT01551758|64476602|FG001|Overall Study|Withdrawal by Subject|17|||
23201124|NCT02626819|64476603|FG000|Overall Study|Lost to Follow-up|3|||
23201125|NCT02626819|64476604|FG001|Overall Study|Lost to Follow-up|2|||
23201126|NCT02626819|64476603|FG000|Overall Study|Withdrawal by Subject|1|||
23201127|NCT02626819|64476604|FG001|Overall Study|Withdrawal by Subject|0|||
23201128|NCT02626819|64476603|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
23201129|NCT02626819|64476604|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
23201130|NCT00740779|64476605|FG000|Overall Study|Adverse Event|4|||
23201131|NCT00740779|64476606|FG001|Overall Study|Adverse Event|6|||
23201132|NCT00740779|64476607|FG002|Overall Study|Adverse Event|3|||
23201133|NCT00740779|64476605|FG000|Overall Study|Protocol Violation|1|||
23263200|NCT00738673|64706925|FG000|Overall Study|Protocol Violation|1|||
23263201|NCT00738673|64706926|FG001|Overall Study|Protocol Violation|2|||
23263202|NCT00738673|64706925|FG000|Overall Study|Withdrawal by Subject|3|||
23263203|NCT00738673|64706926|FG001|Overall Study|Withdrawal by Subject|1|||
23263204|NCT03131999|64706927|FG000|Overall Study|Withdrawal by Subject|0|||
23263205|NCT03131999|64706928|FG001|Overall Study|Withdrawal by Subject|1|||
23201134|NCT00740779|64476606|FG001|Overall Study|Protocol Violation|1|||
23263206|NCT02220907|64706932|FG000|Overall Study|Adverse Event|7|||
23263207|NCT02220907|64706932|FG000|Overall Study|Physician Decision|1|||
23263208|NCT02220907|64706932|FG000|Overall Study|Withdrawal by Subject|2|||
23263209|NCT02220907|64706932|FG000|Overall Study|Conflict with the stopping criteria|1|||
23263210|NCT03347695|64706933|FG000|Overall Study|Death|0|||
23263211|NCT03347695|64706934|FG001|Overall Study|Death|4|||
23263212|NCT03347695|64706933|FG000|Overall Study|Lost to Follow-up|0|||
23263213|NCT03347695|64706934|FG001|Overall Study|Lost to Follow-up|1|||
23263214|NCT04634409|64706939|FG000|Overall Study|Death|0|||
23263215|NCT04634409|64706940|FG001|Overall Study|Death|0|||
23263216|NCT04634409|64706941|FG002|Overall Study|Death|0|||
23263217|NCT04634409|64706942|FG003|Overall Study|Death|0|||
23263218|NCT04634409|64706943|FG004|Overall Study|Death|0|||
23263219|NCT04634409|64706944|FG005|Overall Study|Death|0|||
23263220|NCT04634409|64706945|FG006|Overall Study|Death|0|||
23263221|NCT04634409|64706946|FG007|Overall Study|Death|0|||
23263222|NCT04634409|64706947|FG008|Overall Study|Death|0|||
23263223|NCT04634409|64706948|FG009|Overall Study|Death|0|||
23263224|NCT04634409|64706949|FG010|Overall Study|Death|1|||
23263225|NCT04634409|64706950|FG011|Overall Study|Death|0|||
23263226|NCT04634409|64706951|FG012|Overall Study|Death|1|||
23263227|NCT04634409|64706952|FG013|Overall Study|Death|0|||
23263228|NCT04634409|64706953|FG014|Overall Study|Death|0|||
23263229|NCT04634409|64706954|FG015|Overall Study|Death|0|||
23263230|NCT04634409|64706955|FG016|Overall Study|Death|0|||
23263231|NCT04634409|64706956|FG017|Overall Study|Death|0|||
23263232|NCT04634409|64706957|FG018|Overall Study|Death|0|||
23263233|NCT04634409|64706958|FG019|Overall Study|Death|0|||
23263234|NCT04634409|64706959|FG020|Overall Study|Death|0|||
23263235|NCT04634409|64706960|FG021|Overall Study|Death|0|||
23263236|NCT04634409|64706961|FG022|Overall Study|Death|0|||
23263237|NCT04634409|64706962|FG023|Overall Study|Death|0|||
23263238|NCT04634409|64706963|FG024|Overall Study|Death|0|||
23263239|NCT04634409|64706964|FG025|Overall Study|Death|0|||
23263240|NCT04634409|64706965|FG026|Overall Study|Death|0|||
23263241|NCT04634409|64706939|FG000|Overall Study|Adverse Event|0|||
23263242|NCT04634409|64706940|FG001|Overall Study|Adverse Event|0|||
23263243|NCT04634409|64706941|FG002|Overall Study|Adverse Event|1|||
23263244|NCT04634409|64706942|FG003|Overall Study|Adverse Event|0|||
23263245|NCT04634409|64706943|FG004|Overall Study|Adverse Event|0|||
23263246|NCT04634409|64706944|FG005|Overall Study|Adverse Event|1|||
23263247|NCT04634409|64706945|FG006|Overall Study|Adverse Event|0|||
23263248|NCT04634409|64706946|FG007|Overall Study|Adverse Event|0|||
23263249|NCT04634409|64706947|FG008|Overall Study|Adverse Event|0|||
23263250|NCT04634409|64706948|FG009|Overall Study|Adverse Event|0|||
23263251|NCT04634409|64706949|FG010|Overall Study|Adverse Event|0|||
23263252|NCT04634409|64706950|FG011|Overall Study|Adverse Event|0|||
23263253|NCT04634409|64706951|FG012|Overall Study|Adverse Event|0|||
23263254|NCT04634409|64706952|FG013|Overall Study|Adverse Event|0|||
23263255|NCT04634409|64706953|FG014|Overall Study|Adverse Event|0|||
23263256|NCT04634409|64706954|FG015|Overall Study|Adverse Event|0|||
23263257|NCT04634409|64706955|FG016|Overall Study|Adverse Event|0|||
23263258|NCT04634409|64706956|FG017|Overall Study|Adverse Event|0|||
23263259|NCT04634409|64706957|FG018|Overall Study|Adverse Event|0|||
23263260|NCT04634409|64706958|FG019|Overall Study|Adverse Event|0|||
23263261|NCT04634409|64706959|FG020|Overall Study|Adverse Event|0|||
23263262|NCT04634409|64706960|FG021|Overall Study|Adverse Event|0|||
23263263|NCT04634409|64706961|FG022|Overall Study|Adverse Event|0|||
23263264|NCT04634409|64706962|FG023|Overall Study|Adverse Event|0|||
23263265|NCT04634409|64706963|FG024|Overall Study|Adverse Event|0|||
23263266|NCT04634409|64706964|FG025|Overall Study|Adverse Event|0|||
23263267|NCT04634409|64706965|FG026|Overall Study|Adverse Event|0|||
23263268|NCT04634409|64706939|FG000|Overall Study|Lost to Follow-up|3|||
23263269|NCT04634409|64706940|FG001|Overall Study|Lost to Follow-up|1|||
23263270|NCT04634409|64706941|FG002|Overall Study|Lost to Follow-up|1|||
23263271|NCT04634409|64706942|FG003|Overall Study|Lost to Follow-up|3|||
23263272|NCT04634409|64706943|FG004|Overall Study|Lost to Follow-up|1|||
23263273|NCT04634409|64706944|FG005|Overall Study|Lost to Follow-up|1|||
23263274|NCT04634409|64706945|FG006|Overall Study|Lost to Follow-up|1|||
23263275|NCT04634409|64706946|FG007|Overall Study|Lost to Follow-up|3|||
23263276|NCT04634409|64706947|FG008|Overall Study|Lost to Follow-up|3|||
23263277|NCT04634409|64706948|FG009|Overall Study|Lost to Follow-up|11|||
23263278|NCT04634409|64706949|FG010|Overall Study|Lost to Follow-up|8|||
23263279|NCT04634409|64706950|FG011|Overall Study|Lost to Follow-up|15|||
23263280|NCT04634409|64706951|FG012|Overall Study|Lost to Follow-up|3|||
23263281|NCT04634409|64706952|FG013|Overall Study|Lost to Follow-up|2|||
23263282|NCT04634409|64706953|FG014|Overall Study|Lost to Follow-up|7|||
23263283|NCT04634409|64706954|FG015|Overall Study|Lost to Follow-up|0|||
23263284|NCT04634409|64706955|FG016|Overall Study|Lost to Follow-up|0|||
23263285|NCT04634409|64706956|FG017|Overall Study|Lost to Follow-up|0|||
23263286|NCT04634409|64706957|FG018|Overall Study|Lost to Follow-up|0|||
23263287|NCT04634409|64706958|FG019|Overall Study|Lost to Follow-up|0|||
23263288|NCT04634409|64706959|FG020|Overall Study|Lost to Follow-up|0|||
23263289|NCT04634409|64706960|FG021|Overall Study|Lost to Follow-up|0|||
23201135|NCT00740779|64476607|FG002|Overall Study|Protocol Violation|1|||
23263290|NCT04634409|64706961|FG022|Overall Study|Lost to Follow-up|0|||
23263291|NCT04634409|64706962|FG023|Overall Study|Lost to Follow-up|0|||
23263292|NCT04634409|64706963|FG024|Overall Study|Lost to Follow-up|0|||
23263293|NCT04634409|64706964|FG025|Overall Study|Lost to Follow-up|0|||
23263294|NCT04634409|64706965|FG026|Overall Study|Lost to Follow-up|0|||
23263295|NCT04634409|64706939|FG000|Overall Study|Withdrawal by Subject|3|||
23263296|NCT04634409|64706940|FG001|Overall Study|Withdrawal by Subject|1|||
23263297|NCT04634409|64706941|FG002|Overall Study|Withdrawal by Subject|6|||
23263298|NCT04634409|64706942|FG003|Overall Study|Withdrawal by Subject|4|||
23263299|NCT04634409|64706943|FG004|Overall Study|Withdrawal by Subject|2|||
23263300|NCT04634409|64706944|FG005|Overall Study|Withdrawal by Subject|0|||
23263301|NCT04634409|64706945|FG006|Overall Study|Withdrawal by Subject|0|||
23263302|NCT04634409|64706946|FG007|Overall Study|Withdrawal by Subject|2|||
23263303|NCT04634409|64706947|FG008|Overall Study|Withdrawal by Subject|3|||
23263304|NCT04634409|64706948|FG009|Overall Study|Withdrawal by Subject|2|||
23263305|NCT04634409|64706949|FG010|Overall Study|Withdrawal by Subject|3|||
23263306|NCT04634409|64706950|FG011|Overall Study|Withdrawal by Subject|2|||
23263307|NCT04634409|64706951|FG012|Overall Study|Withdrawal by Subject|2|||
23263308|NCT04634409|64706952|FG013|Overall Study|Withdrawal by Subject|1|||
23263309|NCT04634409|64706953|FG014|Overall Study|Withdrawal by Subject|5|||
23263310|NCT04634409|64706954|FG015|Overall Study|Withdrawal by Subject|0|||
23263311|NCT04634409|64706955|FG016|Overall Study|Withdrawal by Subject|0|||
23263312|NCT04634409|64706956|FG017|Overall Study|Withdrawal by Subject|1|||
23263313|NCT04634409|64706957|FG018|Overall Study|Withdrawal by Subject|0|||
23263314|NCT04634409|64706958|FG019|Overall Study|Withdrawal by Subject|0|||
23263315|NCT04634409|64706959|FG020|Overall Study|Withdrawal by Subject|0|||
23263316|NCT04634409|64706960|FG021|Overall Study|Withdrawal by Subject|0|||
23263317|NCT04634409|64706961|FG022|Overall Study|Withdrawal by Subject|0|||
23263318|NCT04634409|64706962|FG023|Overall Study|Withdrawal by Subject|1|||
23263319|NCT04634409|64706963|FG024|Overall Study|Withdrawal by Subject|0|||
23263320|NCT04634409|64706964|FG025|Overall Study|Withdrawal by Subject|0|||
23263321|NCT04634409|64706965|FG026|Overall Study|Withdrawal by Subject|0|||
23263322|NCT04634409|64706939|FG000|Overall Study|Other - As reported by Investigator|1|||
23263323|NCT04634409|64706940|FG001|Overall Study|Other - As reported by Investigator|0|||
23263324|NCT04634409|64706941|FG002|Overall Study|Other - As reported by Investigator|0|||
23263325|NCT04634409|64706942|FG003|Overall Study|Other - As reported by Investigator|0|||
23263326|NCT04634409|64706943|FG004|Overall Study|Other - As reported by Investigator|0|||
23263327|NCT04634409|64706944|FG005|Overall Study|Other - As reported by Investigator|0|||
23263328|NCT04634409|64706945|FG006|Overall Study|Other - As reported by Investigator|0|||
23263329|NCT04634409|64706946|FG007|Overall Study|Other - As reported by Investigator|6|||
23263330|NCT04634409|64706947|FG008|Overall Study|Other - As reported by Investigator|4|||
23263331|NCT04634409|64706948|FG009|Overall Study|Other - As reported by Investigator|0|||
23263332|NCT04634409|64706949|FG010|Overall Study|Other - As reported by Investigator|1|||
23263333|NCT04634409|64706950|FG011|Overall Study|Other - As reported by Investigator|2|||
23263334|NCT04634409|64706951|FG012|Overall Study|Other - As reported by Investigator|2|||
23263335|NCT04634409|64706952|FG013|Overall Study|Other - As reported by Investigator|1|||
23263336|NCT04634409|64706953|FG014|Overall Study|Other - As reported by Investigator|0|||
23263337|NCT04634409|64706954|FG015|Overall Study|Other - As reported by Investigator|0|||
23263338|NCT04634409|64706955|FG016|Overall Study|Other - As reported by Investigator|0|||
23263339|NCT04634409|64706956|FG017|Overall Study|Other - As reported by Investigator|0|||
23263340|NCT04634409|64706957|FG018|Overall Study|Other - As reported by Investigator|0|||
23263341|NCT04634409|64706958|FG019|Overall Study|Other - As reported by Investigator|0|||
23263342|NCT04634409|64706959|FG020|Overall Study|Other - As reported by Investigator|0|||
23263343|NCT04634409|64706960|FG021|Overall Study|Other - As reported by Investigator|0|||
23263344|NCT04634409|64706961|FG022|Overall Study|Other - As reported by Investigator|0|||
23263345|NCT04634409|64706962|FG023|Overall Study|Other - As reported by Investigator|0|||
23263346|NCT04634409|64706963|FG024|Overall Study|Other - As reported by Investigator|0|||
23263347|NCT04634409|64706964|FG025|Overall Study|Other - As reported by Investigator|0|||
23263348|NCT04634409|64706965|FG026|Overall Study|Other - As reported by Investigator|0|||
23263349|NCT00475020|64706970|FG000|Overall Study|Physician Decision|3|||
23263350|NCT00475020|64706970|FG000|Overall Study|Insurance Denial|1|||
23263351|NCT00475020|64706970|FG000|Overall Study|Donor not able to donate the last minute|1|||
23263352|NCT02456909|64706973|FG000|Overall Study|Did not receive allocated intervention|24|||
23263353|NCT02456909|64706974|FG001|Overall Study|Did not receive allocated intervention|26|||
23263354|NCT02456909|64706973|FG000|Overall Study|Did not complete the primary outcome|0|||
23263355|NCT02456909|64706974|FG001|Overall Study|Did not complete the primary outcome|1|||
23263356|NCT01703741|64706975|FG000|Overall Study|Withdrawal by Subject|6|||
23263357|NCT01703741|64706975|FG000|Overall Study|Adverse Event|2|||
23263358|NCT01703741|64706975|FG000|Overall Study|Physician Decision|2|||
23263359|NCT01703741|64706975|FG000|Overall Study|Protocol Violation|1|||
23263360|NCT01703741|64706975|FG000|Overall Study|Lost to Follow-up|3|||
23263361|NCT01703741|64706975|FG000|Overall Study|Subject did not want to continue|2|||
23263362|NCT01703741|64706975|FG000|Overall Study|Subject cannot comply with study visits|1|||
23263363|NCT01703741|64706975|FG000|Overall Study|Subject started testosterone injections|1|||
23263364|NCT01567306|64706976|FG000|Overall Study|Protocol Violation|2|||
23263365|NCT01567306|64706977|FG001|Overall Study|Protocol Violation|2|||
23263366|NCT01567306|64706978|FG002|Overall Study|Protocol Violation|0|||
23263367|NCT01567306|64706979|FG003|Overall Study|Protocol Violation|3|||
23263368|NCT01567306|64706980|FG004|Overall Study|Protocol Violation|1|||
23263369|NCT01567306|64706981|FG005|Overall Study|Protocol Violation|1|||
23263370|NCT01567306|64706976|FG000|Overall Study|Change site living|1|||
23263371|NCT01567306|64706977|FG001|Overall Study|Change site living|0|||
23263372|NCT01567306|64706978|FG002|Overall Study|Change site living|0|||
23263373|NCT01567306|64706979|FG003|Overall Study|Change site living|0|||
23263374|NCT01567306|64706980|FG004|Overall Study|Change site living|0|||
23263375|NCT01567306|64706981|FG005|Overall Study|Change site living|0|||
23263376|NCT01567306|64706976|FG000|Overall Study|Adverse Event|0|||
23263377|NCT01567306|64706977|FG001|Overall Study|Adverse Event|0|||
23263378|NCT01567306|64706978|FG002|Overall Study|Adverse Event|0|||
23263379|NCT01567306|64706979|FG003|Overall Study|Adverse Event|2|||
23263380|NCT01567306|64706980|FG004|Overall Study|Adverse Event|4|||
23263381|NCT01567306|64706981|FG005|Overall Study|Adverse Event|1|||
23263382|NCT01567306|64706976|FG000|Overall Study|Lost to Follow-up|0|||
23263383|NCT01567306|64706977|FG001|Overall Study|Lost to Follow-up|0|||
23263384|NCT01567306|64706978|FG002|Overall Study|Lost to Follow-up|0|||
23263385|NCT01567306|64706979|FG003|Overall Study|Lost to Follow-up|0|||
23263386|NCT01567306|64706980|FG004|Overall Study|Lost to Follow-up|2|||
23263387|NCT01567306|64706981|FG005|Overall Study|Lost to Follow-up|0|||
23263388|NCT01567306|64706976|FG000|Overall Study|Withdrawal by Subject|0|||
23263389|NCT01567306|64706977|FG001|Overall Study|Withdrawal by Subject|0|||
23263390|NCT01567306|64706978|FG002|Overall Study|Withdrawal by Subject|0|||
23263391|NCT01567306|64706979|FG003|Overall Study|Withdrawal by Subject|0|||
23263392|NCT01567306|64706980|FG004|Overall Study|Withdrawal by Subject|0|||
23263393|NCT01567306|64706981|FG005|Overall Study|Withdrawal by Subject|1|||
23263394|NCT02427607|64706982|FG000|Overall Study|Withdrawal by Subject|1|||
23263395|NCT00433381|64706983|FG000|Overall Study|Ineligible / no protocol treatment|3|||
23263396|NCT00433381|64706984|FG001|Overall Study|Ineligible / no protocol treatment|3|||
23263397|NCT03276975|64706985|FG000|Overall Study|Withdrawal by Subject|1|||
23263398|NCT03276975|64706986|FG001|Overall Study|Withdrawal by Subject|0|||
23263399|NCT03519256|64706987|FG000|Overall Study|Disease recurrence|4|||
23263400|NCT03519256|64706988|FG001|Overall Study|Disease recurrence|4|||
23263401|NCT03519256|64706989|FG002|Overall Study|Disease recurrence|5|||
23263402|NCT03519256|64706990|FG003|Overall Study|Disease recurrence|2|||
23263403|NCT03519256|64706987|FG000|Overall Study|Study drug toxicity|0|||
23263404|NCT03519256|64706988|FG001|Overall Study|Study drug toxicity|2|||
23263405|NCT03519256|64706989|FG002|Overall Study|Study drug toxicity|5|||
23263406|NCT03519256|64706990|FG003|Overall Study|Study drug toxicity|2|||
23263407|NCT03519256|64706987|FG000|Overall Study|Adverse event unrelated to study drug|0|||
23263408|NCT03519256|64706988|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23263409|NCT03519256|64706989|FG002|Overall Study|Adverse event unrelated to study drug|1|||
23263410|NCT03519256|64706990|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23263411|NCT03519256|64706987|FG000|Overall Study|Participant request to discontinue study treatment|0|||
23263412|NCT03519256|64706988|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23263413|NCT03519256|64706989|FG002|Overall Study|Participant request to discontinue study treatment|0|||
23263414|NCT03519256|64706990|FG003|Overall Study|Participant request to discontinue study treatment|2|||
23263415|NCT03519256|64706987|FG000|Overall Study|Other reasons|0|||
23263416|NCT03519256|64706988|FG001|Overall Study|Other reasons|0|||
23263417|NCT03519256|64706989|FG002|Overall Study|Other reasons|2|||
23263418|NCT03519256|64706990|FG003|Overall Study|Other reasons|0|||
23600832|NCT01340066|65929759|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
23600833|NCT01340066|65929757|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
23600834|NCT01340066|65929758|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
23600835|NCT01340066|65929759|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
23600836|NCT01340066|65929757|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
23600837|NCT01340066|65929758|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
23600838|NCT01340066|65929759|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
23263419|NCT03519256|64706987|FG000|Overall Study|Disease progression|6|||
23263420|NCT03519256|64706988|FG001|Overall Study|Disease progression|3|||
23263421|NCT03519256|64706989|FG002|Overall Study|Disease progression|2|||
23263422|NCT03519256|64706990|FG003|Overall Study|Disease progression|1|||
23263423|NCT03519256|64706987|FG000|Overall Study|Lost to Follow-up|0|||
23263424|NCT03519256|64706988|FG001|Overall Study|Lost to Follow-up|1|||
23263425|NCT03519256|64706989|FG002|Overall Study|Lost to Follow-up|0|||
23263426|NCT03519256|64706990|FG003|Overall Study|Lost to Follow-up|0|||
23263427|NCT02352337|64706993|FG000|Overall Study|Patients never treated|4|||
23263428|NCT02352337|64706994|FG001|Overall Study|Patients never treated|1|||
23263429|NCT02352337|64706995|FG002|Overall Study|Patients never treated|2|||
23263430|NCT03175120|64706996|FG000|Overall Study|Adverse Event|2|||
23263431|NCT03175120|64706997|FG001|Overall Study|Adverse Event|2|||
23263432|NCT03175120|64706996|FG000|Overall Study|Protocol Violation|5|||
23263433|NCT03175120|64706997|FG001|Overall Study|Protocol Violation|2|||
23263434|NCT03175120|64706996|FG000|Overall Study|Lost to Follow-up|1|||
23263435|NCT03175120|64706997|FG001|Overall Study|Lost to Follow-up|0|||
23263436|NCT03175120|64706996|FG000|Overall Study|Withdrawal by Subject|2|||
23263437|NCT03175120|64706997|FG001|Overall Study|Withdrawal by Subject|5|||
23263438|NCT03175120|64706996|FG000|Overall Study|Other|2|||
23263439|NCT03175120|64706997|FG001|Overall Study|Other|3|||
23263440|NCT01927757|64706998|FG000|Overall Study|Withdrawal by Subject|14|||
23263441|NCT01927757|64706998|FG000|Overall Study|Lost to Follow-up|2|||
23263442|NCT01927757|64706998|FG000|Overall Study|Decision by Sponsor|2|||
23263443|NCT01927757|64706998|FG000|Overall Study|Other|1|||
23263444|NCT01927757|64706998|FG000|Overall Study|Ethical Reasons|4|||
23263445|NCT00745095|64706999|FG000|Overall Study|Declined to participate|1|||
23263446|NCT00745095|64707000|FG001|Overall Study|Declined to participate|0|||
23263447|NCT00745095|64707001|FG002|Overall Study|Declined to participate|0|||
23263448|NCT00745095|64707002|FG003|Overall Study|Declined to participate|0|||
23263449|NCT00745095|64707003|FG004|Overall Study|Declined to participate|92|||
23263450|NCT00745095|64707004|FG005|Overall Study|Declined to participate|95|||
23263451|NCT00745095|64706999|FG000|Overall Study|Ineligible due to GFR criteria|0|||
23263452|NCT00745095|64707000|FG001|Overall Study|Ineligible due to GFR criteria|2|||
23263453|NCT00745095|64707001|FG002|Overall Study|Ineligible due to GFR criteria|3|||
23263454|NCT00745095|64707002|FG003|Overall Study|Ineligible due to GFR criteria|3|||
23263455|NCT00745095|64707003|FG004|Overall Study|Ineligible due to GFR criteria|30|||
23263456|NCT00745095|64707004|FG005|Overall Study|Ineligible due to GFR criteria|28|||
23263457|NCT01387282|64707007|FG000|Overall Study|Death|47|||
23263458|NCT01387282|64707008|FG001|Overall Study|Death|16|||
23263459|NCT01387282|64707007|FG000|Overall Study|Other|5|||
23263460|NCT01387282|64707008|FG001|Overall Study|Other|1|||
23263461|NCT01387282|64707007|FG000|Overall Study|Unrelated AE|6|||
23263462|NCT01387282|64707008|FG001|Overall Study|Unrelated AE|4|||
23263463|NCT01387282|64707007|FG000|Overall Study|Withdrawal by patient|33|||
23263464|NCT01387282|64707008|FG001|Overall Study|Withdrawal by patient|23|||
23263465|NCT01387282|64707007|FG000|Overall Study|Study drug-related AE|2|||
23263466|NCT01387282|64707008|FG001|Overall Study|Study drug-related AE|2|||
23263467|NCT01387282|64707007|FG000|Overall Study|Lost to Follow-up|4|||
23263468|NCT01387282|64707008|FG001|Overall Study|Lost to Follow-up|1|||
23263469|NCT05200858|64707011|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
23263470|NCT05200858|64707012|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
23263471|NCT05200858|64707013|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
23263472|NCT05200858|64707014|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
23263473|NCT00566709|64707015|FG000|Overall Study|Protocol Violation|5|||
23263474|NCT00566709|64707016|FG001|Overall Study|Protocol Violation|0|||
23263475|NCT00376220|64707017|FG000|Overall Study|Lost to Follow-up|7|||
23263476|NCT00376220|64707018|FG001|Overall Study|Lost to Follow-up|10|||
23263477|NCT00376220|64707017|FG000|Overall Study|Withdrawal by Subject|3|||
23263478|NCT00376220|64707018|FG001|Overall Study|Withdrawal by Subject|2|||
23263479|NCT01432171|64707019|FG000|Overall Study|Death|1|||
23263480|NCT01432171|64707020|FG001|Overall Study|Death|2|||
23263481|NCT01432171|64707019|FG000|Overall Study|Lost to Follow-up|6|||
23263482|NCT01432171|64707020|FG001|Overall Study|Lost to Follow-up|5|||
23263483|NCT01432171|64707019|FG000|Overall Study|Withdrawal by Subject|3|||
23263484|NCT01432171|64707020|FG001|Overall Study|Withdrawal by Subject|1|||
23263485|NCT01432171|64707019|FG000|Overall Study|Noncompliance|2|||
23263486|NCT01432171|64707020|FG001|Overall Study|Noncompliance|3|||
23263487|NCT01432171|64707019|FG000|Overall Study|Insurance denial trial coverage|1|||
23263488|NCT01432171|64707020|FG001|Overall Study|Insurance denial trial coverage|0|||
23263489|NCT01432171|64707019|FG000|Overall Study|Patient moved to palliative care|1|||
23263490|NCT01432171|64707020|FG001|Overall Study|Patient moved to palliative care|0|||
23263491|NCT00729859|64707023|FG000|Overall Study|Adverse Event|0|||
23263492|NCT00729859|64707024|FG001|Overall Study|Adverse Event|1|||
23263493|NCT00729859|64707025|FG002|Overall Study|Adverse Event|0|||
23263494|NCT00729859|64707023|FG000|Overall Study|Withdrawal by Subject|0|||
23263495|NCT00729859|64707024|FG001|Overall Study|Withdrawal by Subject|1|||
23263496|NCT00729859|64707025|FG002|Overall Study|Withdrawal by Subject|0|||
23263497|NCT03702621|64707026|FG000|Overall Study|Physician Decision|6|||
23263498|NCT03702621|64707027|FG001|Overall Study|Physician Decision|6|||
23263499|NCT00806156|64707028|FG000|Overall Study|Death|35|||
23263500|NCT00806156|64707029|FG001|Overall Study|Death|95|||
23263501|NCT00806156|64707028|FG000|Overall Study|Did not meet eligibility criteria|1|||
23263502|NCT00806156|64707029|FG001|Overall Study|Did not meet eligibility criteria|0|||
23263503|NCT00806156|64707028|FG000|Overall Study|Study terminated by Sponsor|2|||
23263504|NCT00806156|64707029|FG001|Overall Study|Study terminated by Sponsor|40|||
23263505|NCT00806156|64707028|FG000|Overall Study|Consent withdrawn by subject|1|||
23263506|NCT00806156|64707029|FG001|Overall Study|Consent withdrawn by subject|3|||
23263507|NCT00806156|64707028|FG000|Overall Study|Lost to Follow-up|0|||
23263508|NCT00806156|64707029|FG001|Overall Study|Lost to Follow-up|1|||
23263509|NCT00319111|64707030|FG000|Overall Study|Adverse Event|20|||
23263510|NCT00319111|64707030|FG000|Overall Study|Withdrawal of consent|11|||
23263511|NCT00319111|64707030|FG000|Overall Study|Death|9|||
23263512|NCT00319111|64707030|FG000|Overall Study|Lack of clinical improvement|4|||
23263513|NCT00319111|64707030|FG000|Overall Study|Administrative|2|||
23263514|NCT00319111|64707030|FG000|Overall Study|Treatment failure|1|||
23263515|NCT02540356|64707031|FG000|Overall Study|Terminated due to disease progression|1|||
23263516|NCT02540356|64707032|FG001|Overall Study|Terminated due to disease progression|0|||
23263517|NCT00708422|64707034|FG000|Overall Study|Adverse Event|3|||
23263518|NCT00708422|64707035|FG001|Overall Study|Adverse Event|1|||
23263519|NCT00708422|64707034|FG000|Overall Study|Withdrawal by Subject|1|||
23263520|NCT00708422|64707035|FG001|Overall Study|Withdrawal by Subject|0|||
23263521|NCT02419313|64707038|FG000|First Intervention|Lost to Follow-up|2|||
23263522|NCT02419313|64707039|FG001|First Intervention|Lost to Follow-up|0|||
23263523|NCT02419313|64707038|FG000|Second Intervention|Lost to Follow-up|1|||
23263524|NCT02419313|64707039|FG001|Second Intervention|Lost to Follow-up|0|||
23263525|NCT02518113|64707046|FG000|Overall Study|Adverse Event|1|||
23263526|NCT02518113|64707047|FG001|Overall Study|Adverse Event|0|||
23263527|NCT02518113|64707048|FG002|Overall Study|Adverse Event|1|||
23263528|NCT02518113|64707049|FG003|Overall Study|Adverse Event|0|||
23263529|NCT02518113|64707046|FG000|Overall Study|Death|1|||
23263530|NCT02518113|64707047|FG001|Overall Study|Death|2|||
23263531|NCT02518113|64707048|FG002|Overall Study|Death|0|||
23263532|NCT02518113|64707049|FG003|Overall Study|Death|0|||
23263533|NCT02518113|64707046|FG000|Overall Study|Physician Decision|0|||
23263534|NCT02518113|64707047|FG001|Overall Study|Physician Decision|1|||
23263535|NCT02518113|64707048|FG002|Overall Study|Physician Decision|0|||
23263536|NCT02518113|64707049|FG003|Overall Study|Physician Decision|0|||
23263537|NCT02518113|64707046|FG000|Overall Study|Progressive Disease|1|||
23263538|NCT02518113|64707047|FG001|Overall Study|Progressive Disease|2|||
23263539|NCT02518113|64707048|FG002|Overall Study|Progressive Disease|3|||
23263540|NCT02518113|64707049|FG003|Overall Study|Progressive Disease|0|||
23263541|NCT00467584|64707050|FG000|Overall Study|Withdrawal by Subject|4|||
23263542|NCT00467584|64707051|FG001|Overall Study|Withdrawal by Subject|5|||
23263543|NCT00467584|64707052|FG002|Overall Study|Withdrawal by Subject|1|||
23263544|NCT02737306|64707055|FG000|Overall Study|Adverse Event|3|||
23263545|NCT02737306|64707056|FG001|Overall Study|Adverse Event|0|||
23263546|NCT02737306|64707055|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
23263547|NCT02737306|64707056|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
23263548|NCT00970281|64707057|FG000|Overall Study|Lack of Efficacy|1|||
23263549|NCT00970281|64707058|FG001|Overall Study|Lack of Efficacy|14|||
23263550|NCT00970281|64707057|FG000|Overall Study|Withdrawal by Subject|0|||
23263551|NCT00970281|64707058|FG001|Overall Study|Withdrawal by Subject|1|||
23263552|NCT00970281|64707057|FG000|Overall Study|Physician Decision|1|||
23263553|NCT00970281|64707058|FG001|Overall Study|Physician Decision|1|||
23361927|NCT04265261|65069862|FG001|Overall Study|Withdrawal by Subject|1|||
23600839|NCT02972359|65929762|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
23263554|NCT01909466|64707059|FG000|Overall Study|Lost to Follow-up|5|||
23263555|NCT01909466|64707060|FG001|Overall Study|Lost to Follow-up|7|||
23263556|NCT01909466|64707059|FG000|Overall Study|Adverse Event|3|||
23263557|NCT01909466|64707060|FG001|Overall Study|Adverse Event|4|||
23263558|NCT01909466|64707059|FG000|Overall Study|Met Withdrawal Criteria|0|||
23263559|NCT01909466|64707060|FG001|Overall Study|Met Withdrawal Criteria|3|||
23263560|NCT01909466|64707059|FG000|Overall Study|Physician Decision|2|||
23263561|NCT01909466|64707060|FG001|Overall Study|Physician Decision|0|||
23263562|NCT01909466|64707059|FG000|Overall Study|Withdrawal by Subject|11|||
23263563|NCT01909466|64707060|FG001|Overall Study|Withdrawal by Subject|9|||
23263564|NCT01909466|64707059|FG000|Overall Study|Lack of Efficacy|1|||
23263565|NCT01909466|64707060|FG001|Overall Study|Lack of Efficacy|0|||
23263566|NCT02153736|64707067|FG000|Overall Study|Lost to Follow-up|1|||
23263567|NCT02153736|64707068|FG001|Overall Study|Lost to Follow-up|0|||
23263568|NCT02153736|64707067|FG000|Overall Study|Medical status change made ineligible|1|||
23263569|NCT02153736|64707068|FG001|Overall Study|Medical status change made ineligible|0|||
23263570|NCT02153736|64707067|FG000|Overall Study|Death|0|||
23263571|NCT02153736|64707068|FG001|Overall Study|Death|1|||
23263572|NCT02153736|64707067|FG000|Overall Study|Withdrawal by Subject|0|||
23263573|NCT02153736|64707068|FG001|Overall Study|Withdrawal by Subject|1|||
23263574|NCT03687125|64707073|FG000|Overall Study|Progressive Disease|2|||
23263575|NCT03687125|64707074|FG001|Overall Study|Progressive Disease|1|||
23263576|NCT03687125|64707073|FG000|Overall Study|Protocol Violation|1|||
23263577|NCT03687125|64707074|FG001|Overall Study|Protocol Violation|0|||
23263578|NCT02001558|64707075|FG000|Overall Study|Lost to Follow-up|8|||
23263579|NCT02001558|64707076|FG001|Overall Study|Lost to Follow-up|14|||
23263580|NCT01107535|64707078|FG000|Overall Study|Death|5|||
23263581|NCT02668302|64707081|FG000|Overall Study|Withdrawal by Subject|1|||
23263582|NCT02668302|64707082|FG001|Overall Study|Withdrawal by Subject|0|||
23263583|NCT02607800|64707083|FG000|Overall Study|Lost to Follow-up|7|||
23263584|NCT02607800|64707084|FG001|Overall Study|Lost to Follow-up|10|||
23263585|NCT02607800|64707083|FG000|Overall Study|Withdrew Consent|2|||
23263586|NCT02607800|64707084|FG001|Overall Study|Withdrew Consent|0|||
23263587|NCT02607800|64707083|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
23263588|NCT02607800|64707084|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
23263589|NCT00545233|64707085|FG000|Overall Study|Adverse Event|10|||
23263590|NCT00545233|64707086|FG001|Overall Study|Adverse Event|5|||
23263591|NCT00545233|64707085|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
23263592|NCT00545233|64707086|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23263593|NCT00545233|64707085|FG000|Overall Study|Protocol Violation|2|||
23263594|NCT00545233|64707086|FG001|Overall Study|Protocol Violation|0|||
23263595|NCT00545233|64707085|FG000|Overall Study|Refused Treatment|9|||
23263596|NCT00545233|64707086|FG001|Overall Study|Refused Treatment|7|||
23263597|NCT00545233|64707085|FG000|Overall Study|Failure to Return|4|||
23263598|NCT00545233|64707086|FG001|Overall Study|Failure to Return|6|||
23263599|NCT00545233|64707085|FG000|Overall Study|Insufficient response|14|||
23263600|NCT00545233|64707086|FG001|Overall Study|Insufficient response|15|||
23263601|NCT00545233|64707085|FG000|Overall Study|Physician Decision|2|||
23263602|NCT00545233|64707086|FG001|Overall Study|Physician Decision|1|||
23263603|NCT01003886|64707089|FG000|Overall Study|Lack of Efficacy|5|||
23263604|NCT01003886|64707089|FG000|Overall Study|Lost to Follow-up|169|||
23263605|NCT01003886|64707089|FG000|Overall Study|Withdrawal by Subject|39|||
23263606|NCT01003886|64707089|FG000|Overall Study|Other|14|||
23263607|NCT01003886|64707089|FG000|Overall Study|Adverse Event|3|||
23263608|NCT01031537|64707092|FG000|Overall Study|medical reasons not related to study|3|||
23263609|NCT01031537|64707092|FG000|Overall Study|Lack of Efficacy|1|||
23263610|NCT01031537|64707092|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
23263611|NCT01031537|64707092|FG000|Overall Study|moved, met exclusion criteria|10|||
23263612|NCT01031537|64707092|FG000|Overall Study|Withdrawal by Subject|5|||
23263613|NCT01031537|64707092|FG000|Overall Study|PI removal, no longer met eligibility|12|||
23263614|NCT02669264|64707095|FG000|Overall Study|Death|5|||
23263615|NCT02669264|64707096|FG001|Overall Study|Death|5|||
23263616|NCT02669264|64707097|FG002|Overall Study|Death|3|||
23263617|NCT02669264|64707098|FG003|Overall Study|Death|3|||
23263618|NCT02669264|64707099|FG004|Overall Study|Death|3|||
23263619|NCT02669264|64707100|FG005|Overall Study|Death|6|||
23263620|NCT02669264|64707101|FG006|Overall Study|Death|3|||
23263621|NCT02669264|64707095|FG000|Overall Study|Withdrawal by Subject|0|||
23263622|NCT02669264|64707096|FG001|Overall Study|Withdrawal by Subject|1|||
23263623|NCT02669264|64707097|FG002|Overall Study|Withdrawal by Subject|0|||
23263624|NCT02669264|64707098|FG003|Overall Study|Withdrawal by Subject|0|||
23263625|NCT02669264|64707099|FG004|Overall Study|Withdrawal by Subject|1|||
23263626|NCT02669264|64707100|FG005|Overall Study|Withdrawal by Subject|0|||
23263627|NCT02669264|64707101|FG006|Overall Study|Withdrawal by Subject|0|||
23263628|NCT02669264|64707095|FG000|Overall Study|Lost to Follow-up|0|||
23263629|NCT02669264|64707096|FG001|Overall Study|Lost to Follow-up|0|||
23263630|NCT02669264|64707097|FG002|Overall Study|Lost to Follow-up|0|||
23263631|NCT02669264|64707098|FG003|Overall Study|Lost to Follow-up|0|||
23263632|NCT02669264|64707099|FG004|Overall Study|Lost to Follow-up|1|||
23263633|NCT02669264|64707100|FG005|Overall Study|Lost to Follow-up|0|||
23263634|NCT02669264|64707101|FG006|Overall Study|Lost to Follow-up|0|||
23263635|NCT02669264|64707095|FG000|Overall Study|Miscellaneous|0|||
23263636|NCT02669264|64707096|FG001|Overall Study|Miscellaneous|0|||
23263637|NCT02669264|64707097|FG002|Overall Study|Miscellaneous|0|||
23263638|NCT02669264|64707098|FG003|Overall Study|Miscellaneous|0|||
23263639|NCT02669264|64707099|FG004|Overall Study|Miscellaneous|0|||
23263640|NCT02669264|64707100|FG005|Overall Study|Miscellaneous|0|||
23263641|NCT02669264|64707101|FG006|Overall Study|Miscellaneous|2|||
23263642|NCT00265759|64707102|FG000|Overall Study|Withdrawal by Subject|0|||
23263643|NCT00265759|64707103|FG001|Overall Study|Withdrawal by Subject|1|||
23263644|NCT00265759|64707104|FG002|Overall Study|Withdrawal by Subject|2|||
23263645|NCT00265759|64707105|FG003|Overall Study|Withdrawal by Subject|2|||
23263646|NCT00265759|64707102|FG000|Overall Study|Cancel|0|||
23263647|NCT00265759|64707103|FG001|Overall Study|Cancel|0|||
23263648|NCT00265759|64707104|FG002|Overall Study|Cancel|0|||
23263649|NCT00265759|64707105|FG003|Overall Study|Cancel|3|||
23263650|NCT00265759|64707102|FG000|Overall Study|Ineligible|0|||
23263651|NCT00265759|64707103|FG001|Overall Study|Ineligible|0|||
23263652|NCT00265759|64707104|FG002|Overall Study|Ineligible|0|||
23263653|NCT00265759|64707105|FG003|Overall Study|Ineligible|1|||
23263654|NCT00265759|64707102|FG000|Overall Study|Bilateral disease|0|||
23263655|NCT00265759|64707103|FG001|Overall Study|Bilateral disease|0|||
23263656|NCT00265759|64707104|FG002|Overall Study|Bilateral disease|0|||
23263657|NCT00265759|64707105|FG003|Overall Study|Bilateral disease|2|||
23263658|NCT00265759|64707102|FG000|Overall Study|Discontinued due to intolerability|0|||
23263659|NCT00265759|64707103|FG001|Overall Study|Discontinued due to intolerability|0|||
23263660|NCT00265759|64707104|FG002|Overall Study|Discontinued due to intolerability|0|||
23263661|NCT00265759|64707105|FG003|Overall Study|Discontinued due to intolerability|1|||
23263662|NCT01621490|64707106|FG000|Overall Study|Subject no longer meets study criteria|0|||
23263663|NCT01621490|64707107|FG001|Overall Study|Subject no longer meets study criteria|0|||
23263664|NCT01621490|64707108|FG002|Overall Study|Subject no longer meets study criteria|0|||
23263665|NCT01621490|64707109|FG003|Overall Study|Subject no longer meets study criteria|0|||
23263666|NCT01621490|64707110|FG004|Overall Study|Subject no longer meets study criteria|1|||
23263667|NCT01621490|64707111|FG005|Overall Study|Subject no longer meets study criteria|0|||
23263668|NCT01621490|64707112|FG006|Overall Study|Subject no longer meets study criteria|0|||
23263669|NCT01621490|64707113|FG007|Overall Study|Subject no longer meets study criteria|0|||
23263670|NCT01621490|64707114|FG008|Overall Study|Subject no longer meets study criteria|0|||
23263671|NCT01621490|64707115|FG009|Overall Study|Subject no longer meets study criteria|0|||
23263672|NCT01621490|64707116|FG010|Overall Study|Subject no longer meets study criteria|0|||
23263673|NCT01621490|64707106|FG000|Overall Study|Maximum clinical benefit|3|||
23263674|NCT01621490|64707107|FG001|Overall Study|Maximum clinical benefit|2|||
23263675|NCT01621490|64707108|FG002|Overall Study|Maximum clinical benefit|0|||
23263676|NCT01621490|64707109|FG003|Overall Study|Maximum clinical benefit|0|||
23263677|NCT01621490|64707110|FG004|Overall Study|Maximum clinical benefit|0|||
23263678|NCT01621490|64707111|FG005|Overall Study|Maximum clinical benefit|0|||
23263679|NCT01621490|64707112|FG006|Overall Study|Maximum clinical benefit|1|||
23263680|NCT01621490|64707113|FG007|Overall Study|Maximum clinical benefit|2|||
23263681|NCT01621490|64707114|FG008|Overall Study|Maximum clinical benefit|2|||
23263682|NCT01621490|64707115|FG009|Overall Study|Maximum clinical benefit|0|||
23263683|NCT01621490|64707116|FG010|Overall Study|Maximum clinical benefit|0|||
23263684|NCT01621490|64707106|FG000|Overall Study|Withdrawal by Subject|1|||
23263685|NCT01621490|64707107|FG001|Overall Study|Withdrawal by Subject|0|||
23263686|NCT01621490|64707108|FG002|Overall Study|Withdrawal by Subject|0|||
23263687|NCT01621490|64707109|FG003|Overall Study|Withdrawal by Subject|0|||
23263688|NCT01621490|64707110|FG004|Overall Study|Withdrawal by Subject|0|||
23263689|NCT01621490|64707111|FG005|Overall Study|Withdrawal by Subject|1|||
23263690|NCT01621490|64707112|FG006|Overall Study|Withdrawal by Subject|0|||
23263691|NCT01621490|64707113|FG007|Overall Study|Withdrawal by Subject|0|||
23263692|NCT01621490|64707114|FG008|Overall Study|Withdrawal by Subject|0|||
23263693|NCT01621490|64707115|FG009|Overall Study|Withdrawal by Subject|0|||
23263694|NCT01621490|64707116|FG010|Overall Study|Withdrawal by Subject|0|||
23263695|NCT01621490|64707106|FG000|Overall Study|Subject request to discontinue study|1|||
23263696|NCT01621490|64707107|FG001|Overall Study|Subject request to discontinue study|3|||
23263697|NCT01621490|64707108|FG002|Overall Study|Subject request to discontinue study|1|||
23263698|NCT01621490|64707109|FG003|Overall Study|Subject request to discontinue study|1|||
23263699|NCT01621490|64707110|FG004|Overall Study|Subject request to discontinue study|0|||
23263700|NCT01621490|64707111|FG005|Overall Study|Subject request to discontinue study|2|||
23263701|NCT01621490|64707112|FG006|Overall Study|Subject request to discontinue study|1|||
23263702|NCT01621490|64707113|FG007|Overall Study|Subject request to discontinue study|0|||
23263703|NCT01621490|64707114|FG008|Overall Study|Subject request to discontinue study|1|||
23263704|NCT01621490|64707115|FG009|Overall Study|Subject request to discontinue study|0|||
23263705|NCT01621490|64707116|FG010|Overall Study|Subject request to discontinue study|0|||
23263706|NCT01621490|64707106|FG000|Overall Study|Adverse event unrelated to study drug|1|||
23263707|NCT01621490|64707107|FG001|Overall Study|Adverse event unrelated to study drug|1|||
23263708|NCT01621490|64707108|FG002|Overall Study|Adverse event unrelated to study drug|0|||
23263709|NCT01621490|64707109|FG003|Overall Study|Adverse event unrelated to study drug|0|||
23263710|NCT01621490|64707110|FG004|Overall Study|Adverse event unrelated to study drug|0|||
23263711|NCT01621490|64707111|FG005|Overall Study|Adverse event unrelated to study drug|0|||
23263712|NCT01621490|64707112|FG006|Overall Study|Adverse event unrelated to study drug|0|||
23263713|NCT01621490|64707113|FG007|Overall Study|Adverse event unrelated to study drug|2|||
23263714|NCT01621490|64707114|FG008|Overall Study|Adverse event unrelated to study drug|0|||
23263715|NCT01621490|64707115|FG009|Overall Study|Adverse event unrelated to study drug|0|||
23263716|NCT01621490|64707116|FG010|Overall Study|Adverse event unrelated to study drug|0|||
23263717|NCT01621490|64707106|FG000|Overall Study|Disease progression|27|||
23263718|NCT01621490|64707107|FG001|Overall Study|Disease progression|28|||
23263719|NCT01621490|64707108|FG002|Overall Study|Disease progression|1|||
23263720|NCT01621490|64707109|FG003|Overall Study|Disease progression|5|||
23263721|NCT01621490|64707110|FG004|Overall Study|Disease progression|3|||
23263722|NCT01621490|64707111|FG005|Overall Study|Disease progression|8|||
23263723|NCT01621490|64707112|FG006|Overall Study|Disease progression|7|||
23263724|NCT01621490|64707113|FG007|Overall Study|Disease progression|1|||
23263725|NCT01621490|64707114|FG008|Overall Study|Disease progression|4|||
23263726|NCT01621490|64707115|FG009|Overall Study|Disease progression|1|||
23263727|NCT01621490|64707116|FG010|Overall Study|Disease progression|1|||
23263728|NCT01621490|64707106|FG000|Overall Study|Study drug toxicity|1|||
23263729|NCT01621490|64707107|FG001|Overall Study|Study drug toxicity|4|||
23263730|NCT01621490|64707108|FG002|Overall Study|Study drug toxicity|5|||
23263731|NCT01621490|64707109|FG003|Overall Study|Study drug toxicity|3|||
23263732|NCT01621490|64707110|FG004|Overall Study|Study drug toxicity|1|||
23263733|NCT01621490|64707111|FG005|Overall Study|Study drug toxicity|10|||
23263734|NCT01621490|64707112|FG006|Overall Study|Study drug toxicity|1|||
23263735|NCT01621490|64707113|FG007|Overall Study|Study drug toxicity|4|||
23263736|NCT01621490|64707114|FG008|Overall Study|Study drug toxicity|1|||
23263737|NCT01621490|64707115|FG009|Overall Study|Study drug toxicity|0|||
23263738|NCT01621490|64707116|FG010|Overall Study|Study drug toxicity|0|||
23263739|NCT01621490|64707106|FG000|Overall Study|Death|0|||
23263740|NCT01621490|64707107|FG001|Overall Study|Death|0|||
23263741|NCT01621490|64707108|FG002|Overall Study|Death|0|||
23263742|NCT01621490|64707109|FG003|Overall Study|Death|0|||
23263743|NCT01621490|64707110|FG004|Overall Study|Death|0|||
23263744|NCT01621490|64707111|FG005|Overall Study|Death|0|||
23263745|NCT01621490|64707112|FG006|Overall Study|Death|0|||
23263746|NCT01621490|64707113|FG007|Overall Study|Death|0|||
23263747|NCT01621490|64707114|FG008|Overall Study|Death|1|||
23361928|NCT04265261|65069863|FG002|Overall Study|Withdrawal by Subject|4|||
23201136|NCT00740779|64476605|FG000|Overall Study|Lack of Efficacy|0|||
23201137|NCT00740779|64476606|FG001|Overall Study|Lack of Efficacy|0|||
23201138|NCT00740779|64476607|FG002|Overall Study|Lack of Efficacy|2|||
23201139|NCT00740779|64476605|FG000|Overall Study|Withdrawal by Subject|2|||
23201140|NCT00740779|64476606|FG001|Overall Study|Withdrawal by Subject|4|||
23201141|NCT00740779|64476607|FG002|Overall Study|Withdrawal by Subject|2|||
23201142|NCT00740779|64476605|FG000|Overall Study|Lost to Follow-up|2|||
23201143|NCT00740779|64476606|FG001|Overall Study|Lost to Follow-up|3|||
23201144|NCT00740779|64476607|FG002|Overall Study|Lost to Follow-up|5|||
23201145|NCT01912768|64476610|FG000|Overall Study|Adverse Event|2|||
23201146|NCT01912768|64476611|FG001|Overall Study|Adverse Event|0|||
23201147|NCT01912768|64476610|FG000|Overall Study|Lost to Follow-up|2|||
23201148|NCT01912768|64476611|FG001|Overall Study|Lost to Follow-up|1|||
23201149|NCT01912768|64476610|FG000|Overall Study|Withdrawal by Subject|5|||
23201150|NCT01912768|64476611|FG001|Overall Study|Withdrawal by Subject|3|||
23201151|NCT01912768|64476610|FG000|Overall Study|Randomized in error|1|||
23263748|NCT01621490|64707115|FG009|Overall Study|Death|0|||
23263749|NCT01621490|64707116|FG010|Overall Study|Death|0|||
23263750|NCT01621490|64707106|FG000|Overall Study|Other reasons|7|||
23263751|NCT01621490|64707107|FG001|Overall Study|Other reasons|6|||
23263752|NCT01621490|64707108|FG002|Overall Study|Other reasons|4|||
23263753|NCT01621490|64707109|FG003|Overall Study|Other reasons|1|||
23201152|NCT01912768|64476611|FG001|Overall Study|Randomized in error|0|||
23201153|NCT02596711|64476612|FG000|Overall Study|Lost to Follow-up|1|||
23201154|NCT02596711|64476613|FG001|Overall Study|Lost to Follow-up|2|||
23201155|NCT02596711|64476614|FG002|Overall Study|Lost to Follow-up|3|||
23201156|NCT03165721|64476615|FG000|Overall Study|Refused further treatment|3|||
23201157|NCT03165721|64476616|FG001|Overall Study|Refused further treatment|0|||
23201158|NCT03165721|64476617|FG002|Overall Study|Refused further treatment|0|||
23201159|NCT03165721|64476615|FG000|Overall Study|Physician Decision|1|||
23201160|NCT03165721|64476616|FG001|Overall Study|Physician Decision|0|||
23201161|NCT03165721|64476617|FG002|Overall Study|Physician Decision|0|||
23201162|NCT01204658|64476618|FG000|Primary Phase|Adverse Event|0|||
23201163|NCT01204658|64476619|FG001|Primary Phase|Adverse Event|0|||
23201164|NCT01204658|64476620|FG002|Primary Phase|Adverse Event|1|||
23201165|NCT01204658|64476621|FG003|Primary Phase|Adverse Event|0|||
23201166|NCT01863849|64476628|FG000|Overall Study|Lost to Follow-up|1|||
23201167|NCT01863849|64476629|FG001|Overall Study|Lost to Follow-up|0|||
23201168|NCT02324842|64476632|FG000|Overall Study|Lost to Follow-up|1|||
23201169|NCT02324842|64476633|FG001|Overall Study|Lost to Follow-up|1|||
23201170|NCT02324842|64476634|FG002|Overall Study|Lost to Follow-up|2|||
23201171|NCT01115569|64476636|FG000|Conversion/Titration Phase|Adverse Event|59|||
23201172|NCT01115569|64476637|FG001|Conversion/Titration Phase|Adverse Event|0|||
23263754|NCT01621490|64707110|FG004|Overall Study|Other reasons|1|||
23263755|NCT01621490|64707111|FG005|Overall Study|Other reasons|3|||
23263756|NCT01621490|64707112|FG006|Overall Study|Other reasons|1|||
23263757|NCT01621490|64707113|FG007|Overall Study|Other reasons|1|||
23263758|NCT01621490|64707114|FG008|Overall Study|Other reasons|1|||
23263759|NCT01621490|64707115|FG009|Overall Study|Other reasons|0|||
23263760|NCT01621490|64707116|FG010|Overall Study|Other reasons|0|||
23263761|NCT00922779|64707118|FG000|Overall Study|Adverse Event|67|||
23263762|NCT00922779|64707118|FG000|Overall Study|Pregnancy|7|||
23263763|NCT00922779|64707118|FG000|Overall Study|Withdrawal by Subject|308|||
23263764|NCT00922779|64707118|FG000|Overall Study|Lost to Follow-up|44|||
23263765|NCT00922779|64707118|FG000|Overall Study|Other|27|||
23263766|NCT00922779|64707118|FG000|Overall Study|Missing|1874|||
23263767|NCT01309919|64707119|FG000|Overall Study|Did not receive a postpartum IUD|17|||
23263768|NCT01309919|64707120|FG001|Overall Study|Did not receive a postpartum IUD|48|||
23263769|NCT02192905|64707124|FG000|Overall Study|Lost to Follow-up|1|||
23263770|NCT01974895|64707127|FG000|Overall Study|Protocol Violation|1|||
23263771|NCT01974895|64707128|FG001|Overall Study|Protocol Violation|0|||
23263772|NCT01974895|64707127|FG000|Overall Study|Lost to Follow-up|4|||
23263773|NCT01974895|64707128|FG001|Overall Study|Lost to Follow-up|6|||
23263774|NCT01974895|64707127|FG000|Overall Study|Withdrawal by Subject|0|||
23263775|NCT01974895|64707128|FG001|Overall Study|Withdrawal by Subject|1|||
23263776|NCT01974895|64707127|FG000|Overall Study|Other (Missed Visit)|1|||
23263777|NCT01974895|64707128|FG001|Overall Study|Other (Missed Visit)|0|||
23263778|NCT01974895|64707127|FG000|Overall Study|Other (Reason unknown)|9|||
23263779|NCT01974895|64707128|FG001|Overall Study|Other (Reason unknown)|8|||
23263780|NCT00617461|64707131|FG000|First Treatment Intervention Period|Adverse Event|2|||
23263781|NCT00617461|64707132|FG001|First Treatment Intervention Period|Adverse Event|0|||
23263782|NCT00617461|64707131|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
23263783|NCT00617461|64707132|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
23263784|NCT00617461|64707131|FG000|First Treatment Intervention Period|Protocol Violation|2|||
23263785|NCT00617461|64707132|FG001|First Treatment Intervention Period|Protocol Violation|1|||
23263786|NCT00617461|64707131|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
23263787|NCT00617461|64707132|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
23263788|NCT00617461|64707131|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
23263789|NCT00617461|64707132|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
23263790|NCT00617461|64707131|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
23263791|NCT00617461|64707132|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
23263792|NCT00617461|64707131|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
23263793|NCT00617461|64707132|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
23263794|NCT00617461|64707131|FG000|Second Treatment Intervention Period|Adverse Event|0|||
23263795|NCT00617461|64707132|FG001|Second Treatment Intervention Period|Adverse Event|1|||
23263796|NCT00617461|64707131|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
23263797|NCT00617461|64707132|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
23263798|NCT00617461|64707131|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
23263799|NCT00617461|64707132|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
23263800|NCT00617461|64707131|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
23263801|NCT00617461|64707132|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
23263802|NCT00635778|64707139|FG000|Overall Study|Adverse Event|1|||
23263803|NCT00635778|64707140|FG001|Overall Study|Adverse Event|0|||
23263804|NCT00635778|64707141|FG002|Overall Study|Adverse Event|0|||
23263805|NCT00635778|64707142|FG003|Overall Study|Adverse Event|3|||
23263806|NCT00635778|64707143|FG004|Overall Study|Adverse Event|3|||
23263807|NCT00635778|64707144|FG005|Overall Study|Adverse Event|6|||
23263808|NCT00635778|64707145|FG006|Overall Study|Adverse Event|1|||
23263809|NCT00635778|64707139|FG000|Overall Study|Withdrawal by Subject|0|||
23263810|NCT00635778|64707140|FG001|Overall Study|Withdrawal by Subject|0|||
23263811|NCT00635778|64707141|FG002|Overall Study|Withdrawal by Subject|0|||
23263812|NCT00635778|64707142|FG003|Overall Study|Withdrawal by Subject|1|||
23263813|NCT00635778|64707143|FG004|Overall Study|Withdrawal by Subject|0|||
23263814|NCT00635778|64707144|FG005|Overall Study|Withdrawal by Subject|1|||
23263815|NCT00635778|64707145|FG006|Overall Study|Withdrawal by Subject|1|||
23600840|NCT02972359|65929762|FG000|Overall Study|Lack of Efficacy|1|||
23600841|NCT02972359|65929762|FG000|Overall Study|Adverse Event|4|||
23600842|NCT02972359|65929762|FG000|Overall Study|Death|1|||
23600843|NCT02972359|65929762|FG000|Overall Study|Withdrawal by Subject|30|||
23263816|NCT00635778|64707139|FG000|Overall Study|Progressive disease|0|||
23263817|NCT00635778|64707140|FG001|Overall Study|Progressive disease|3|||
23263818|NCT00635778|64707141|FG002|Overall Study|Progressive disease|3|||
23263819|NCT00635778|64707142|FG003|Overall Study|Progressive disease|4|||
23263820|NCT00635778|64707143|FG004|Overall Study|Progressive disease|5|||
23263821|NCT00635778|64707144|FG005|Overall Study|Progressive disease|14|||
23263822|NCT00635778|64707145|FG006|Overall Study|Progressive disease|4|||
23263823|NCT01659567|64707146|FG000|Overall Study|Lack of Efficacy|22|||
23600844|NCT02972359|65929762|FG000|Overall Study|Protocol Violation|1|||
23263824|NCT01659567|64707146|FG000|Overall Study|Switched to Pegferon|6|||
23263825|NCT01659567|64707146|FG000|Overall Study|Adverse Event|12|||
23263826|NCT01659567|64707146|FG000|Overall Study|Good result at early stage of treatment|5|||
23263827|NCT01659567|64707146|FG000|Overall Study|Withdrawal by Subject|64|||
23263828|NCT01659567|64707146|FG000|Overall Study|Progression of the main disease|1|||
23263829|NCT01659567|64707146|FG000|Overall Study|Other|13|||
23263830|NCT01025037|64707147|FG000|Overall Study|Adverse Event|3|||
23263831|NCT01025037|64707147|FG000|Overall Study|Lost to Follow-up|7|||
23263832|NCT01025037|64707147|FG000|Overall Study|Withdrawal by Subject|1|||
23263833|NCT01939197|64707153|FG000|Overall Study|Withdrawal by Subject|1|||
23263834|NCT01939197|64707154|FG001|Overall Study|Withdrawal by Subject|0|||
23263835|NCT01939197|64707155|FG002|Overall Study|Withdrawal by Subject|0|||
23263836|NCT01939197|64707156|FG003|Overall Study|Withdrawal by Subject|0|||
23263837|NCT01939197|64707157|FG004|Overall Study|Withdrawal by Subject|1|||
23263838|NCT01939197|64707158|FG005|Overall Study|Withdrawal by Subject|0|||
23263839|NCT01939197|64707159|FG006|Overall Study|Withdrawal by Subject|0|||
23263840|NCT01939197|64707153|FG000|Overall Study|Lost to Follow-up|0|||
23263841|NCT01939197|64707154|FG001|Overall Study|Lost to Follow-up|1|||
23263842|NCT01939197|64707155|FG002|Overall Study|Lost to Follow-up|0|||
23263843|NCT01939197|64707156|FG003|Overall Study|Lost to Follow-up|1|||
23263844|NCT01939197|64707157|FG004|Overall Study|Lost to Follow-up|3|||
23263845|NCT01939197|64707158|FG005|Overall Study|Lost to Follow-up|1|||
23263846|NCT01939197|64707159|FG006|Overall Study|Lost to Follow-up|2|||
23263847|NCT01185288|64707160|FG000|Overall Study|Adverse Event|7|||
23263848|NCT01185288|64707161|FG001|Overall Study|Adverse Event|6|||
23263849|NCT01185288|64707160|FG000|Overall Study|Withdrawal by Subject|6|||
23263850|NCT01185288|64707161|FG001|Overall Study|Withdrawal by Subject|4|||
23263851|NCT01185288|64707160|FG000|Overall Study|Lost to Follow-up|2|||
23263852|NCT01185288|64707161|FG001|Overall Study|Lost to Follow-up|5|||
23263853|NCT01185288|64707160|FG000|Overall Study|Lack of Efficacy|2|||
23263854|NCT01185288|64707161|FG001|Overall Study|Lack of Efficacy|0|||
23263855|NCT01185288|64707160|FG000|Overall Study|Investigator discretion|1|||
23263856|NCT01185288|64707161|FG001|Overall Study|Investigator discretion|0|||
23263857|NCT01185288|64707160|FG000|Overall Study|Did not meet inclusion criteria|1|||
23263858|NCT01185288|64707161|FG001|Overall Study|Did not meet inclusion criteria|0|||
23263859|NCT01185288|64707160|FG000|Overall Study|Noncompliance|0|||
23263860|NCT01185288|64707161|FG001|Overall Study|Noncompliance|1|||
23263861|NCT01996033|64707162|FG000|Overall Study|Death|1|||
23263862|NCT01996033|64707162|FG000|Overall Study|Physician Decision|1|||
23263863|NCT01996033|64707162|FG000|Overall Study|Withdrawal by Subject|4|||
23263864|NCT01996033|64707162|FG000|Overall Study|Lost to Follow-up|3|||
23263865|NCT02322047|64707163|FG000|Overall Study|Physician Decision|1|||
23263866|NCT02322047|64707164|FG001|Overall Study|Physician Decision|0|||
23263867|NCT02322047|64707165|FG002|Overall Study|Physician Decision|0|||
23263868|NCT02322047|64707166|FG003|Overall Study|Physician Decision|0|||
23263869|NCT02322047|64707163|FG000|Overall Study|Withdrawal by Subject|1|||
23263870|NCT02322047|64707164|FG001|Overall Study|Withdrawal by Subject|0|||
23263871|NCT02322047|64707165|FG002|Overall Study|Withdrawal by Subject|0|||
23263872|NCT02322047|64707166|FG003|Overall Study|Withdrawal by Subject|1|||
23263873|NCT02322047|64707163|FG000|Overall Study|Adverse Event|0|||
23263874|NCT02322047|64707164|FG001|Overall Study|Adverse Event|1|||
23263875|NCT02322047|64707165|FG002|Overall Study|Adverse Event|0|||
23263876|NCT02322047|64707166|FG003|Overall Study|Adverse Event|0|||
23263877|NCT02322047|64707163|FG000|Overall Study|Lost to Follow-up|0|||
23263878|NCT02322047|64707164|FG001|Overall Study|Lost to Follow-up|0|||
23263879|NCT02322047|64707165|FG002|Overall Study|Lost to Follow-up|1|||
23263880|NCT02322047|64707166|FG003|Overall Study|Lost to Follow-up|1|||
23263881|NCT01058421|64707167|FG000|1 Month Outcomes|Death|10|||
23263882|NCT01058421|64707168|FG001|1 Month Outcomes|Death|6|||
23263883|NCT01058421|64707167|FG000|1 Month Outcomes|Lost to Follow-up|8|||
23263884|NCT01058421|64707168|FG001|1 Month Outcomes|Lost to Follow-up|7|||
23263885|NCT01058421|64707167|FG000|1 Month Outcomes|Remained in Hospital|5|||
23263886|NCT01058421|64707168|FG001|1 Month Outcomes|Remained in Hospital|12|||
23263887|NCT01058421|64707167|FG000|1 Month Outcomes|Remained in Other Facility|16|||
23263888|NCT01058421|64707168|FG001|1 Month Outcomes|Remained in Other Facility|17|||
23263889|NCT01058421|64707167|FG000|3 Month Outcomes|Death|3|||
23263890|NCT01058421|64707168|FG001|3 Month Outcomes|Death|5|||
23263891|NCT01058421|64707167|FG000|3 Month Outcomes|Lost to Follow-up|12|||
23263892|NCT01058421|64707168|FG001|3 Month Outcomes|Lost to Follow-up|11|||
23263893|NCT01058421|64707167|FG000|3 Month Outcomes|Remained in Hospital|0|||
23263894|NCT01058421|64707168|FG001|3 Month Outcomes|Remained in Hospital|2|||
23263895|NCT01058421|64707167|FG000|3 Month Outcomes|Remained in Other Facility|5|||
23263896|NCT01058421|64707168|FG001|3 Month Outcomes|Remained in Other Facility|8|||
23263897|NCT01058421|64707167|FG000|6 Month Outcomes|Death|2|||
23263898|NCT01058421|64707168|FG001|6 Month Outcomes|Death|2|||
23263899|NCT01058421|64707167|FG000|6 Month Outcomes|Lost to Follow-up|16|||
23263900|NCT01058421|64707168|FG001|6 Month Outcomes|Lost to Follow-up|21|||
23263901|NCT01058421|64707167|FG000|6 Month Outcomes|Remained in Other Facility|1|||
23263902|NCT01058421|64707168|FG001|6 Month Outcomes|Remained in Other Facility|3|||
23263903|NCT00886483|64707169|FG000|Overall Study|Lost to Follow-up|0|||
23263904|NCT00886483|64707170|FG001|Overall Study|Lost to Follow-up|1|||
23263905|NCT00886483|64707169|FG000|Overall Study|Pursue medications|1|||
23263906|NCT00886483|64707170|FG001|Overall Study|Pursue medications|2|||
23263907|NCT00886483|64707169|FG000|Overall Study|Distance to center, poor grades|1|||
23263908|NCT00886483|64707170|FG001|Overall Study|Distance to center, poor grades|0|||
23263909|NCT01298570|64707171|FG000|Overall Study|Disease progression, relapse during acti|64|||
23263910|NCT01298570|64707172|FG001|Overall Study|Disease progression, relapse during acti|40|||
23263911|NCT01298570|64707171|FG000|Overall Study|Adverse Event|20|||
23263912|NCT01298570|64707172|FG001|Overall Study|Adverse Event|2|||
23263913|NCT01298570|64707171|FG000|Overall Study|Withdrawal by Subject|21|||
23263914|NCT01298570|64707172|FG001|Overall Study|Withdrawal by Subject|6|||
23263915|NCT01298570|64707171|FG000|Overall Study|Treatment delay > 4 weeks|4|||
23263916|NCT01298570|64707172|FG001|Overall Study|Treatment delay > 4 weeks|5|||
23263917|NCT01298570|64707171|FG000|Overall Study|Physician Decision|4|||
23263918|NCT01298570|64707172|FG001|Overall Study|Physician Decision|2|||
23263919|NCT01298570|64707171|FG000|Overall Study|Other complicating disease|2|||
23263920|NCT01298570|64707172|FG001|Overall Study|Other complicating disease|1|||
23263921|NCT01298570|64707171|FG000|Overall Study|Surgery|2|||
23263922|NCT01298570|64707172|FG001|Overall Study|Surgery|1|||
23263923|NCT01298570|64707171|FG000|Overall Study|Symptomatic progression/deterioration|3|||
23263924|NCT01298570|64707172|FG001|Overall Study|Symptomatic progression/deterioration|2|||
23263925|NCT01298570|64707171|FG000|Overall Study|Death|0|||
23263926|NCT01298570|64707172|FG001|Overall Study|Death|1|||
23263927|NCT01298570|64707171|FG000|Overall Study|Ineligibility|0|||
23263928|NCT01298570|64707172|FG001|Overall Study|Ineligibility|1|||
23263929|NCT02918162|64707175|FG000|Overall Study|Withdrawal by Subject|1|||
23263930|NCT02918162|64707175|FG000|Overall Study|Omental Disease|1|||
23263931|NCT02034799|64707178|FG000|Overall Study|Withdrawal by Subject|0|||
23263932|NCT02034799|64707179|FG001|Overall Study|Withdrawal by Subject|2|||
23263933|NCT02034799|64707178|FG000|Overall Study|Lost to Follow-up|0|||
23263934|NCT02034799|64707179|FG001|Overall Study|Lost to Follow-up|1|||
23263935|NCT02034799|64707178|FG000|Overall Study|Death|2|||
23263936|NCT02034799|64707179|FG001|Overall Study|Death|1|||
23263937|NCT02093689|64707180|FG000|Overall Study|Physician Decision|4|||
23263938|NCT02093689|64707181|FG001|Overall Study|Physician Decision|0|||
23263939|NCT02093689|64707182|FG002|Overall Study|Physician Decision|0|||
23263940|NCT01793610|64707183|FG000|Overall Study|Withdrawal by Subject|1|||
23263941|NCT01793610|64707184|FG001|Overall Study|Withdrawal by Subject|0|||
23263942|NCT01793610|64707185|FG002|Overall Study|Withdrawal by Subject|1|||
23263943|NCT04543136|64707193|FG000|Overall Study|Withdrawal by Subject|0|||
23263944|NCT04543136|64707194|FG001|Overall Study|Withdrawal by Subject|1|||
23263945|NCT04543136|64707195|FG002|Overall Study|Withdrawal by Subject|0|||
23263946|NCT04543136|64707196|FG003|Overall Study|Withdrawal by Subject|1|||
23263947|NCT04543136|64707197|FG004|Overall Study|Withdrawal by Subject|0|||
23263948|NCT04543136|64707198|FG005|Overall Study|Withdrawal by Subject|0|||
23263949|NCT05431153|64707199|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23263950|NCT05431153|64707200|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23263951|NCT05431153|64707201|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23263952|NCT05431153|64707202|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23263953|NCT05431153|64707203|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
23263954|NCT05431153|64707204|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
23263955|NCT02961920|64707208|FG000|Overall Study|did not achive stydy protocol schedule|1|||
23263956|NCT02961920|64707209|FG001|Overall Study|did not achive stydy protocol schedule|1|||
23263957|NCT01144663|64707210|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
23263958|NCT01144663|64707211|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
23263959|NCT01144663|64707212|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
23263960|NCT01144663|64707213|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
23263961|NCT01144663|64707210|FG000|Primary Vaccination Phase|Adverse Event|1|||
23263962|NCT01144663|64707211|FG001|Primary Vaccination Phase|Adverse Event|0|||
23263963|NCT01144663|64707212|FG002|Primary Vaccination Phase|Adverse Event|0|||
23263964|NCT01144663|64707213|FG003|Primary Vaccination Phase|Adverse Event|1|||
23263965|NCT01144663|64707210|FG000|Primary Vaccination Phase|Protocol Violation|2|||
23263966|NCT01144663|64707211|FG001|Primary Vaccination Phase|Protocol Violation|0|||
23263967|NCT01144663|64707212|FG002|Primary Vaccination Phase|Protocol Violation|1|||
23263968|NCT01144663|64707213|FG003|Primary Vaccination Phase|Protocol Violation|0|||
23263969|NCT01144663|64707210|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
23263970|NCT01144663|64707211|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
23263971|NCT01144663|64707212|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
23263972|NCT01144663|64707213|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
23263973|NCT01144663|64707210|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
23263974|NCT01144663|64707211|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
23263975|NCT01144663|64707212|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
23263976|NCT01144663|64707213|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
23263977|NCT01144663|64707210|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
23263978|NCT01144663|64707211|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
23263979|NCT01144663|64707212|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
23263980|NCT01144663|64707213|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
23263981|NCT01144663|64707210|FG000|Primary Vaccination Phase|Other|0|||
23263982|NCT01144663|64707211|FG001|Primary Vaccination Phase|Other|1|||
23263983|NCT01144663|64707212|FG002|Primary Vaccination Phase|Other|0|||
23263984|NCT01144663|64707213|FG003|Primary Vaccination Phase|Other|2|||
23263985|NCT01144663|64707210|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
23263986|NCT01144663|64707211|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
23263987|NCT01144663|64707212|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
23263988|NCT01144663|64707213|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
23263989|NCT01144663|64707210|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
23263990|NCT01144663|64707211|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
23263991|NCT01144663|64707212|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
23263992|NCT01144663|64707213|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
23263993|NCT01144663|64707210|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
23263994|NCT01144663|64707211|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
23263995|NCT01144663|64707212|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
23263996|NCT01144663|64707213|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
23263997|NCT01144663|64707210|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
23263998|NCT01144663|64707211|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
23263999|NCT01144663|64707212|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
23264000|NCT01144663|64707213|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
23264001|NCT01144663|64707210|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
23264002|NCT01144663|64707211|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
23264003|NCT01144663|64707212|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
23264004|NCT01144663|64707213|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
23264005|NCT01144663|64707210|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
23264006|NCT01144663|64707211|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
23264007|NCT01144663|64707212|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
23264008|NCT01144663|64707213|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
23264009|NCT03402893|64707214|FG000|Overall Study|Withdrawal by Subject|1|||
23264010|NCT00268346|64707215|FG000|Overall Study|Adverse Event|0|||
23361929|NCT02335346|65069864|FG000|Overall Study|Adverse Event|11|||
23361930|NCT02335346|65069864|FG000|Overall Study|Withdrawal by Subject|1|||
23361931|NCT02155309|65069865|FG000|Overall Study|Protocol Violation|0|||
23361932|NCT02155309|65069866|FG001|Overall Study|Protocol Violation|0|||
23361933|NCT02155309|65069867|FG002|Overall Study|Protocol Violation|1|||
23361934|NCT01091246|65069868|FG000|Overall Study|Lost to Follow-up|23|||
23361935|NCT01091246|65069869|FG001|Overall Study|Lost to Follow-up|11|||
23361936|NCT01091246|65069870|FG002|Overall Study|Lost to Follow-up|7|||
23361937|NCT01091246|65069868|FG000|Overall Study|Adverse Event|1|||
23361938|NCT01091246|65069869|FG001|Overall Study|Adverse Event|0|||
23361939|NCT01091246|65069870|FG002|Overall Study|Adverse Event|1|||
23361940|NCT01091246|65069868|FG000|Overall Study|Withdrawal by Subject|9|||
23361941|NCT01091246|65069869|FG001|Overall Study|Withdrawal by Subject|5|||
23361942|NCT01091246|65069870|FG002|Overall Study|Withdrawal by Subject|4|||
23361943|NCT01091246|65069868|FG000|Overall Study|Subject not dosed|2|||
23361944|NCT01091246|65069869|FG001|Overall Study|Subject not dosed|0|||
23264011|NCT00268346|64707216|FG001|Overall Study|Adverse Event|1|||
23264012|NCT00268346|64707215|FG000|Overall Study|Death|0|||
23264013|NCT00268346|64707216|FG001|Overall Study|Death|1|||
23264014|NCT00268346|64707215|FG000|Overall Study|Withdrawal by Subject|0|||
23264015|NCT00268346|64707216|FG001|Overall Study|Withdrawal by Subject|1|||
23264016|NCT03532009|64707217|FG000|Overall Study|Other|1|||
23361945|NCT01091246|65069870|FG002|Overall Study|Subject not dosed|1|||
23361946|NCT03339713|65069871|FG000|Overall Study|Lost to Follow-up|2|||
23264017|NCT03532009|64707218|FG001|Overall Study|Other|1|||
23264018|NCT03532009|64707217|FG000|Overall Study|Death|1|||
23264019|NCT03532009|64707218|FG001|Overall Study|Death|1|||
23264020|NCT03532009|64707217|FG000|Overall Study|Withdrawal by Patient|0|||
23264021|NCT03532009|64707218|FG001|Overall Study|Withdrawal by Patient|2|||
23264022|NCT04128007|64707219|FG000|Overall Study|Withdrawal by Subject|9|||
23264023|NCT04128007|64707220|FG001|Overall Study|Withdrawal by Subject|6|||
23264024|NCT04128007|64707219|FG000|Overall Study|Protocol Violation|1|||
23264025|NCT04128007|64707220|FG001|Overall Study|Protocol Violation|0|||
23264026|NCT04128007|64707219|FG000|Overall Study|Lost to Follow-up|8|||
23264027|NCT04128007|64707220|FG001|Overall Study|Lost to Follow-up|7|||
23264028|NCT04128007|64707219|FG000|Overall Study|Adverse Event|5|||
23264029|NCT04128007|64707220|FG001|Overall Study|Adverse Event|2|||
23264030|NCT04128007|64707219|FG000|Overall Study|Not reported|0|||
23264031|NCT04128007|64707220|FG001|Overall Study|Not reported|2|||
23264032|NCT02768298|64707221|FG000|Overall Study|Adverse Event|1|||
23264033|NCT02768298|64707222|FG001|Overall Study|Adverse Event|4|||
23264034|NCT02768298|64707221|FG000|Overall Study|Death|2|||
23264035|NCT02768298|64707222|FG001|Overall Study|Death|1|||
23264036|NCT02768298|64707221|FG000|Overall Study|Non-compliance with study treatment|0|||
23264037|NCT02768298|64707222|FG001|Overall Study|Non-compliance with study treatment|1|||
23264038|NCT02768298|64707221|FG000|Overall Study|Subject/guardian decision|1|||
23264039|NCT02768298|64707222|FG001|Overall Study|Subject/guardian decision|0|||
23264040|NCT02768298|64707221|FG000|Overall Study|Withdrawal of informed consent|0|||
23264041|NCT02768298|64707222|FG001|Overall Study|Withdrawal of informed consent|1|||
23264042|NCT00282256|64707223|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
23264043|NCT00282256|64707223|FG000|Extension Treatment Period|Adverse Event|2|||
23264044|NCT00294723|64707224|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
23264045|NCT00294723|64707225|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
23264046|NCT00294723|64707226|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
23264047|NCT00294723|64707224|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
23264048|NCT00294723|64707225|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
23264049|NCT00294723|64707226|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
23264050|NCT00294723|64707224|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
23264051|NCT00294723|64707225|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
23264052|NCT00294723|64707226|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
23264053|NCT00294723|64707224|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
23264054|NCT00294723|64707225|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
23264055|NCT00294723|64707226|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
23264056|NCT00294723|64707224|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
23264057|NCT00294723|64707225|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
23264058|NCT00294723|64707226|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
23264059|NCT00294723|64707224|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
23264060|NCT00294723|64707225|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
23264061|NCT00294723|64707226|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
23264062|NCT00294723|64707224|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
23264063|NCT00294723|64707225|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
23264064|NCT00294723|64707226|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
23264065|NCT00294723|64707224|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
23264066|NCT00294723|64707225|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
23264067|NCT00294723|64707226|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
23264068|NCT00294723|64707224|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
23264069|NCT00294723|64707225|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
23264070|NCT00294723|64707226|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
23264071|NCT00294723|64707224|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
23264072|NCT00294723|64707225|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
23264073|NCT00294723|64707226|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
23264074|NCT00294723|64707224|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
23264075|NCT00294723|64707225|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
23264076|NCT00294723|64707226|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
23264077|NCT00294723|64707224|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
23264078|NCT00294723|64707225|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
23264079|NCT00294723|64707226|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
23264080|NCT02448771|64707227|FG000|Overall Study|Disease Progression|30|||
23264081|NCT02448771|64707227|FG000|Overall Study|Unacceptable Toxicity|1|||
23264082|NCT02448771|64707227|FG000|Overall Study|Physician Decision|3|||
23264083|NCT02448771|64707227|FG000|Overall Study|Started new therapy|2|||
23264084|NCT02130466|64707228|FG000|Overall Study|Death|4|||
23264085|NCT02130466|64707229|FG001|Overall Study|Death|1|||
23264086|NCT02130466|64707230|FG002|Overall Study|Death|1|||
23264087|NCT02130466|64707231|FG003|Overall Study|Death|3|||
23264088|NCT02130466|64707232|FG004|Overall Study|Death|2|||
23361947|NCT03339713|65069872|FG001|Overall Study|Lost to Follow-up|1|||
23264089|NCT02130466|64707233|FG005|Overall Study|Death|30|||
23264090|NCT02130466|64707234|FG006|Overall Study|Death|45|||
23264091|NCT02130466|64707235|FG007|Overall Study|Death|2|||
23264092|NCT02130466|64707236|FG008|Overall Study|Death|3|||
23264093|NCT02130466|64707237|FG009|Overall Study|Death|4|||
23264094|NCT02130466|64707238|FG010|Overall Study|Death|5|||
23264095|NCT02130466|64707239|FG011|Overall Study|Death|3|||
23264096|NCT02130466|64707240|FG012|Overall Study|Death|11|||
23264097|NCT02130466|64707241|FG013|Overall Study|Death|7|||
23264098|NCT02130466|64707228|FG000|Overall Study|Lost to Follow-up|1|||
23264099|NCT02130466|64707229|FG001|Overall Study|Lost to Follow-up|0|||
23264100|NCT02130466|64707230|FG002|Overall Study|Lost to Follow-up|0|||
23264101|NCT02130466|64707231|FG003|Overall Study|Lost to Follow-up|0|||
23264102|NCT02130466|64707232|FG004|Overall Study|Lost to Follow-up|0|||
23264103|NCT02130466|64707233|FG005|Overall Study|Lost to Follow-up|1|||
23264104|NCT02130466|64707234|FG006|Overall Study|Lost to Follow-up|0|||
23264105|NCT02130466|64707235|FG007|Overall Study|Lost to Follow-up|0|||
23264106|NCT02130466|64707236|FG008|Overall Study|Lost to Follow-up|0|||
23264107|NCT02130466|64707237|FG009|Overall Study|Lost to Follow-up|0|||
23264108|NCT02130466|64707238|FG010|Overall Study|Lost to Follow-up|0|||
23264109|NCT02130466|64707239|FG011|Overall Study|Lost to Follow-up|0|||
23264110|NCT02130466|64707240|FG012|Overall Study|Lost to Follow-up|1|||
23264111|NCT02130466|64707241|FG013|Overall Study|Lost to Follow-up|0|||
23264112|NCT02130466|64707228|FG000|Overall Study|Physician Decision|0|||
23264113|NCT02130466|64707229|FG001|Overall Study|Physician Decision|0|||
23264114|NCT02130466|64707230|FG002|Overall Study|Physician Decision|0|||
23264115|NCT02130466|64707231|FG003|Overall Study|Physician Decision|0|||
23264116|NCT02130466|64707232|FG004|Overall Study|Physician Decision|0|||
23264117|NCT02130466|64707233|FG005|Overall Study|Physician Decision|1|||
23264118|NCT02130466|64707234|FG006|Overall Study|Physician Decision|1|||
23264119|NCT02130466|64707235|FG007|Overall Study|Physician Decision|0|||
23264120|NCT02130466|64707236|FG008|Overall Study|Physician Decision|0|||
23264121|NCT02130466|64707237|FG009|Overall Study|Physician Decision|0|||
23264122|NCT02130466|64707238|FG010|Overall Study|Physician Decision|0|||
23264123|NCT02130466|64707239|FG011|Overall Study|Physician Decision|0|||
23264124|NCT02130466|64707240|FG012|Overall Study|Physician Decision|0|||
23264125|NCT02130466|64707241|FG013|Overall Study|Physician Decision|0|||
23264126|NCT02130466|64707228|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23264127|NCT02130466|64707229|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
23264128|NCT02130466|64707230|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23264129|NCT02130466|64707231|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
23264130|NCT02130466|64707232|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
23264131|NCT02130466|64707233|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
23264132|NCT02130466|64707234|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
23264133|NCT02130466|64707235|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23264134|NCT02130466|64707236|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
23264135|NCT02130466|64707237|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23264136|NCT02130466|64707238|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
23264137|NCT02130466|64707239|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
23264138|NCT02130466|64707240|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
23264139|NCT02130466|64707241|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
23264140|NCT02130466|64707228|FG000|Overall Study|Withdrawal by Subject|1|||
23264141|NCT02130466|64707229|FG001|Overall Study|Withdrawal by Subject|0|||
23264142|NCT02130466|64707230|FG002|Overall Study|Withdrawal by Subject|0|||
23264143|NCT02130466|64707231|FG003|Overall Study|Withdrawal by Subject|0|||
23264144|NCT02130466|64707232|FG004|Overall Study|Withdrawal by Subject|0|||
23264145|NCT02130466|64707233|FG005|Overall Study|Withdrawal by Subject|1|||
23264146|NCT02130466|64707234|FG006|Overall Study|Withdrawal by Subject|0|||
23264147|NCT02130466|64707235|FG007|Overall Study|Withdrawal by Subject|0|||
23361948|NCT03339713|65069871|FG000|Overall Study|Protocol Violation|1|||
23361949|NCT03339713|65069872|FG001|Overall Study|Protocol Violation|0|||
23264148|NCT02130466|64707236|FG008|Overall Study|Withdrawal by Subject|1|||
23264149|NCT02130466|64707237|FG009|Overall Study|Withdrawal by Subject|0|||
23264150|NCT02130466|64707238|FG010|Overall Study|Withdrawal by Subject|0|||
23264151|NCT02130466|64707239|FG011|Overall Study|Withdrawal by Subject|0|||
23264152|NCT02130466|64707240|FG012|Overall Study|Withdrawal by Subject|0|||
23264153|NCT02130466|64707241|FG013|Overall Study|Withdrawal by Subject|0|||
23361950|NCT03339713|65069871|FG000|Overall Study|Withdrawal by Subject|1|||
23264154|NCT04583579|64707244|FG000|Overall Study|Lost to Follow-up|4|||
23264155|NCT01799590|64707245|FG000|Overall Study|Adverse Event|13|||
23264156|NCT01799590|64707246|FG001|Overall Study|Adverse Event|7|||
23264157|NCT01799590|64707247|FG002|Overall Study|Adverse Event|5|||
23264158|NCT01799590|64707245|FG000|Overall Study|Pregnancy|2|||
23264159|NCT01799590|64707246|FG001|Overall Study|Pregnancy|0|||
23264160|NCT01799590|64707247|FG002|Overall Study|Pregnancy|0|||
23264161|NCT01799590|64707245|FG000|Overall Study|Lack of Efficacy|3|||
23264162|NCT01799590|64707246|FG001|Overall Study|Lack of Efficacy|1|||
23264163|NCT01799590|64707247|FG002|Overall Study|Lack of Efficacy|3|||
23264164|NCT01799590|64707245|FG000|Overall Study|Participants convenience|4|||
23264165|NCT01799590|64707246|FG001|Overall Study|Participants convenience|4|||
23264166|NCT01799590|64707247|FG002|Overall Study|Participants convenience|2|||
23264167|NCT01799590|64707245|FG000|Overall Study|Aggravation of complications|0|||
23264168|NCT01799590|64707246|FG001|Overall Study|Aggravation of complications|1|||
23264169|NCT01799590|64707247|FG002|Overall Study|Aggravation of complications|1|||
23264170|NCT01799590|64707245|FG000|Overall Study|Using drugs with restricted days of use|0|||
23264171|NCT01799590|64707246|FG001|Overall Study|Using drugs with restricted days of use|3|||
23264172|NCT01799590|64707247|FG002|Overall Study|Using drugs with restricted days of use|2|||
23264173|NCT01799590|64707245|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
23264174|NCT01799590|64707246|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
23264175|NCT01799590|64707247|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
23264176|NCT01799590|64707245|FG000|Overall Study|Other|3|||
23264177|NCT01799590|64707246|FG001|Overall Study|Other|0|||
23264178|NCT01799590|64707247|FG002|Overall Study|Other|1|||
23264179|NCT01941095|64707248|FG000|Overall Study|Insufficient therapeutic response|13|||
23264180|NCT01941095|64707248|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
23264181|NCT01941095|64707248|FG000|Overall Study|Adverse Event|11|||
23264182|NCT01941095|64707248|FG000|Overall Study|Physician Decision|3|||
23264183|NCT01941095|64707248|FG000|Overall Study|Withdrawal by Subject|17|||
23264184|NCT01941095|64707248|FG000|Overall Study|Lost to Follow-up|10|||
23264185|NCT02848599|64707249|FG000|Overall Study|Protocol Violation|7|||
23264186|NCT02848599|64707250|FG001|Overall Study|Protocol Violation|9|||
23264187|NCT01937364|64707251|FG000|Overall Study|Adverse Event|2|||
23264188|NCT01937364|64707252|FG001|Overall Study|Adverse Event|1|||
23264189|NCT02985151|64707253|FG000|Original Randomization|Withdrawal by Subject|0|||
23264190|NCT02985151|64707254|FG001|Original Randomization|Withdrawal by Subject|1|||
23264191|NCT02564263|64707255|FG000|Overall Study|Adverse Event|31|||
23264192|NCT02564263|64707256|FG001|Overall Study|Adverse Event|29|||
23264193|NCT02564263|64707255|FG000|Overall Study|Death|270|||
23264194|NCT02564263|64707256|FG001|Overall Study|Death|262|||
23264195|NCT02564263|64707255|FG000|Overall Study|Withdrawal by Subject|4|||
23264196|NCT02564263|64707256|FG001|Overall Study|Withdrawal by Subject|19|||
23264197|NCT02564263|64707255|FG000|Overall Study|Sponsor's decision|9|||
23264198|NCT02564263|64707256|FG001|Overall Study|Sponsor's decision|4|||
23264199|NCT02518685|64707257|FG000|Overall Study|Adverse Event|29|||
23264200|NCT02518685|64707258|FG001|Overall Study|Adverse Event|1|||
23264201|NCT02518685|64707257|FG000|Overall Study|Withdrawal by Subject|10|||
23264202|NCT02518685|64707258|FG001|Overall Study|Withdrawal by Subject|3|||
23264203|NCT02518685|64707257|FG000|Overall Study|relocation, study fatigue|7|||
23264204|NCT02518685|64707258|FG001|Overall Study|relocation, study fatigue|2|||
23264205|NCT02518685|64707257|FG000|Overall Study|Pregnancy|1|||
23264206|NCT02518685|64707258|FG001|Overall Study|Pregnancy|0|||
23264207|NCT02518685|64707257|FG000|Overall Study|Physician Decision|1|||
23264208|NCT02518685|64707258|FG001|Overall Study|Physician Decision|0|||
23264209|NCT02518685|64707257|FG000|Overall Study|Lost to Follow-up|1|||
23264210|NCT02518685|64707258|FG001|Overall Study|Lost to Follow-up|4|||
23264211|NCT02896361|64710418|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
23264212|NCT02896361|64710419|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
23264213|NCT02896361|64710420|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
23264214|NCT02896361|64710418|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
23264215|NCT02896361|64710419|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
23264216|NCT02896361|64710420|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
23264217|NCT01247922|64710421|FG000|Overall Study|Disease progression|4|||
23264218|NCT01977092|64710426|FG000|Overall Study|Death|3|||
23264219|NCT01977092|64710427|FG001|Overall Study|Death|4|||
23264220|NCT01977092|64710426|FG000|Overall Study|Lost to Follow-up|23|||
23264221|NCT01977092|64710427|FG001|Overall Study|Lost to Follow-up|14|||
23264222|NCT01977092|64710426|FG000|Overall Study|Withdrawal by Subject|2|||
23264223|NCT01977092|64710427|FG001|Overall Study|Withdrawal by Subject|1|||
23264224|NCT01977092|64710426|FG000|Overall Study|In prison|3|||
23264225|NCT01977092|64710427|FG001|Overall Study|In prison|11|||
23264226|NCT02204371|64710438|FG000|Overall Study|Adverse Event|1|||
23264227|NCT02674334|64710444|FG000|Overall Study|Lost to Follow-up|5|||
23264228|NCT02674334|64710445|FG001|Overall Study|Lost to Follow-up|3|||
23264229|NCT02674334|64710444|FG000|Overall Study|participant difficulty breathing|1|||
23264230|NCT02674334|64710445|FG001|Overall Study|participant difficulty breathing|0|||
23264231|NCT02674334|64710444|FG000|Overall Study|NIRS not recording|1|||
23264232|NCT02674334|64710445|FG001|Overall Study|NIRS not recording|0|||
23264233|NCT01691248|64710451|FG000|Overall Study|Protocol Violation|43|||
23264234|NCT01691248|64710452|FG001|Overall Study|Protocol Violation|27|||
23264235|NCT01691248|64710451|FG000|Overall Study|Adverse Event|24|||
23264236|NCT01691248|64710452|FG001|Overall Study|Adverse Event|22|||
23264237|NCT01691248|64710451|FG000|Overall Study|Withdrawal by Subject|20|||
23264238|NCT01691248|64710452|FG001|Overall Study|Withdrawal by Subject|18|||
23264239|NCT01691248|64710451|FG000|Overall Study|Confirmed CDAD|14|||
23264240|NCT01691248|64710452|FG001|Overall Study|Confirmed CDAD|31|||
23264241|NCT01691248|64710451|FG000|Overall Study|Lost to Follow-up|2|||
23361951|NCT03339713|65069872|FG001|Overall Study|Withdrawal by Subject|1|||
23264242|NCT01691248|64710452|FG001|Overall Study|Lost to Follow-up|5|||
23361952|NCT00547157|65069875|FG000|Overall Study|Other|1|||
23264243|NCT01691248|64710451|FG000|Overall Study|Reason not provided|4|||
23361953|NCT00547157|65069876|FG001|Overall Study|Other|0|||
23361954|NCT00547157|65069875|FG000|Overall Study|Death|38|||
23264244|NCT01691248|64710452|FG001|Overall Study|Reason not provided|4|||
23361955|NCT00547157|65069876|FG001|Overall Study|Death|18|||
23264245|NCT01691248|64710451|FG000|Overall Study|Not Treated|4|||
23264246|NCT01691248|64710452|FG001|Overall Study|Not Treated|7|||
23264247|NCT01400425|64710453|FG000|Overall Study|Withdrawal by Subject|10|||
23264248|NCT02015793|64710455|FG000|Overall Study|Adverse Event|3|||
23264249|NCT02015793|64710456|FG001|Overall Study|Adverse Event|3|||
23264250|NCT02015793|64710455|FG000|Overall Study|Withdrawal by Subject|1|||
23264251|NCT02015793|64710456|FG001|Overall Study|Withdrawal by Subject|1|||
23264252|NCT01315249|64710459|FG000|Overall Study|Adverse Event|22|||
23264253|NCT01315249|64710460|FG001|Overall Study|Adverse Event|26|||
23264254|NCT01315249|64710459|FG000|Overall Study|Withdrawal by Subject|11|||
23264255|NCT01315249|64710460|FG001|Overall Study|Withdrawal by Subject|10|||
23264256|NCT01315249|64710459|FG000|Overall Study|Protocol Violation|8|||
23264257|NCT01315249|64710460|FG001|Overall Study|Protocol Violation|5|||
23264258|NCT01315249|64710459|FG000|Overall Study|Abnormal test results|1|||
23264259|NCT01315249|64710460|FG001|Overall Study|Abnormal test results|2|||
23264260|NCT01315249|64710459|FG000|Overall Study|Administrative problems|1|||
23264261|NCT01315249|64710460|FG001|Overall Study|Administrative problems|0|||
23264262|NCT01315249|64710459|FG000|Overall Study|inability to use device|1|||
23264263|NCT01315249|64710460|FG001|Overall Study|inability to use device|0|||
23264264|NCT01315249|64710459|FG000|Overall Study|Lack of Efficacy|0|||
23264265|NCT01315249|64710460|FG001|Overall Study|Lack of Efficacy|1|||
23264266|NCT01315249|64710459|FG000|Overall Study|Lost to Follow-up|0|||
23264267|NCT01315249|64710460|FG001|Overall Study|Lost to Follow-up|2|||
23264268|NCT01315249|64710459|FG000|Overall Study|Death|0|||
23264269|NCT01315249|64710460|FG001|Overall Study|Death|1|||
23264270|NCT02346201|64710465|FG000|Overall Study|Adverse Event|3|||
23264271|NCT02346201|64710466|FG001|Overall Study|Adverse Event|2|||
23264272|NCT02346201|64710465|FG000|Overall Study|Lost to Follow-up|1|||
23264273|NCT02346201|64710466|FG001|Overall Study|Lost to Follow-up|0|||
23264274|NCT02346201|64710465|FG000|Overall Study|Withdrawal by Subject|6|||
23264275|NCT02346201|64710466|FG001|Overall Study|Withdrawal by Subject|3|||
23264276|NCT02346201|64710465|FG000|Overall Study|Unavailable for future follow-up|0|||
23264277|NCT02346201|64710466|FG001|Overall Study|Unavailable for future follow-up|1|||
23264278|NCT02346201|64710465|FG000|Overall Study|Physician Decision|0|||
23264279|NCT02346201|64710466|FG001|Overall Study|Physician Decision|1|||
23264280|NCT02346201|64710465|FG000|Overall Study|Missed final visit|0|||
23264281|NCT02346201|64710466|FG001|Overall Study|Missed final visit|2|||
23264282|NCT00635154|64710467|FG000|Overall Study|Alternative Treatment|8|||
23264283|NCT00635154|64710467|FG000|Overall Study|Other|4|||
23600845|NCT02972359|65929762|FG000|Overall Study|Lost to Follow-up|26|||
23600846|NCT02972359|65929762|FG000|Overall Study|Other reasons|5|||
23600847|NCT02972359|65929762|FG000|Overall Study|Missing|1|||
23600848|NCT03905642|65929763|FG000|Overall Study|Withdrawal by Subject|3|||
23600849|NCT03905642|65929763|FG000|Overall Study|Pregnancy|1|||
23600850|NCT03905642|65929763|FG000|Overall Study|Adverse Event|1|||
23600851|NCT03905642|65929763|FG000|Overall Study|Lack of Efficacy|1|||
23600852|NCT03905642|65929763|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
23600853|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
23264284|NCT00635154|64710467|FG000|Overall Study|Still on treatment|21|||
23264285|NCT03341507|64710468|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
23264286|NCT00678392|64710469|FG000|Overall Study|Adverse Event|0|||
23264287|NCT00678392|64710470|FG001|Overall Study|Adverse Event|6|||
23600854|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
23201173|NCT01115569|64476636|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
23264288|NCT00678392|64710469|FG000|Overall Study|Death|280|||
23264289|NCT00678392|64710470|FG001|Overall Study|Death|269|||
23264290|NCT00678392|64710469|FG000|Overall Study|Lost to Follow-up|15|||
23264291|NCT00678392|64710470|FG001|Overall Study|Lost to Follow-up|13|||
23264292|NCT00678392|64710469|FG000|Overall Study|Objective Progression or Relapse|3|||
23264293|NCT00678392|64710470|FG001|Overall Study|Objective Progression or Relapse|8|||
23264294|NCT00678392|64710469|FG000|Overall Study|Sponsor's Decision|1|||
23264295|NCT00678392|64710470|FG001|Overall Study|Sponsor's Decision|2|||
23264296|NCT00678392|64710469|FG000|Overall Study|Withdrawal by Subject|4|||
23264297|NCT00678392|64710470|FG001|Overall Study|Withdrawal by Subject|4|||
23264298|NCT00678392|64710469|FG000|Overall Study|Randomized But Not Treated|2|||
23264299|NCT00678392|64710470|FG001|Overall Study|Randomized But Not Treated|7|||
23264300|NCT00678392|64710469|FG000|Overall Study|Other|56|||
23264301|NCT00678392|64710470|FG001|Overall Study|Other|53|||
23264302|NCT04471935|64710471|FG000|Overall Study|Withdrawal by Subject|1|||
23264303|NCT04471935|64710471|FG000|Overall Study|Deemed ineligible to participate|1|||
23264304|NCT01296932|64710472|FG000|Overall Study|Dose limiting toxicity|0|||
23264305|NCT01296932|64710473|FG001|Overall Study|Dose limiting toxicity|0|||
23264306|NCT01296932|64710474|FG002|Overall Study|Dose limiting toxicity|0|||
23264307|NCT01296932|64710475|FG003|Overall Study|Dose limiting toxicity|0|||
23264308|NCT01296932|64710476|FG004|Overall Study|Dose limiting toxicity|0|||
23264309|NCT01296932|64710477|FG005|Overall Study|Dose limiting toxicity|0|||
23264310|NCT01296932|64710478|FG006|Overall Study|Dose limiting toxicity|1|||
23264311|NCT01296932|64710479|FG007|Overall Study|Dose limiting toxicity|0|||
23264312|NCT01296932|64710480|FG008|Overall Study|Dose limiting toxicity|1|||
23264313|NCT01296932|64710472|FG000|Overall Study|Progressive disease|2|||
23264314|NCT01296932|64710473|FG001|Overall Study|Progressive disease|0|||
23264315|NCT01296932|64710474|FG002|Overall Study|Progressive disease|1|||
23600855|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
23600856|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
23600857|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
23600858|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
23600859|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
23600860|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600861|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
23600862|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600863|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600864|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600865|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600866|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
23600867|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Death|1|||
23600868|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Death|2|||
23600869|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Death|0|||
23600870|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Death|1|||
23600871|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Death|0|||
23600872|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Death|0|||
23600873|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Death|0|||
23600874|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
23600875|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
23600876|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
23600877|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
23600878|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
23264316|NCT01296932|64710475|FG003|Overall Study|Progressive disease|1|||
23264317|NCT01296932|64710476|FG004|Overall Study|Progressive disease|2|||
23264318|NCT01296932|64710477|FG005|Overall Study|Progressive disease|3|||
23264319|NCT01296932|64710478|FG006|Overall Study|Progressive disease|1|||
23264320|NCT01296932|64710479|FG007|Overall Study|Progressive disease|0|||
23264321|NCT01296932|64710480|FG008|Overall Study|Progressive disease|0|||
23264322|NCT01296932|64710472|FG000|Overall Study|Withdrawal by Subject|0|||
23264323|NCT01296932|64710473|FG001|Overall Study|Withdrawal by Subject|0|||
23264324|NCT01296932|64710474|FG002|Overall Study|Withdrawal by Subject|1|||
23264325|NCT01296932|64710475|FG003|Overall Study|Withdrawal by Subject|1|||
23264326|NCT01296932|64710476|FG004|Overall Study|Withdrawal by Subject|0|||
23264327|NCT01296932|64710477|FG005|Overall Study|Withdrawal by Subject|0|||
23264328|NCT01296932|64710478|FG006|Overall Study|Withdrawal by Subject|3|||
23264329|NCT01296932|64710479|FG007|Overall Study|Withdrawal by Subject|0|||
23264330|NCT01296932|64710480|FG008|Overall Study|Withdrawal by Subject|0|||
23264331|NCT01296932|64710472|FG000|Overall Study|Adverse Event|1|||
23264332|NCT01296932|64710473|FG001|Overall Study|Adverse Event|1|||
23264333|NCT01296932|64710474|FG002|Overall Study|Adverse Event|1|||
23264334|NCT01296932|64710475|FG003|Overall Study|Adverse Event|2|||
23600879|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
23480526|NCT02186301|65502014|FG002|Overall Study|Physician Decision|1|||
23264335|NCT01296932|64710476|FG004|Overall Study|Adverse Event|1|||
23600880|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
23600881|NCT02234141|65929767|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23264336|NCT01296932|64710477|FG005|Overall Study|Adverse Event|0|||
23264337|NCT01296932|64710478|FG006|Overall Study|Adverse Event|0|||
23264338|NCT01296932|64710479|FG007|Overall Study|Adverse Event|0|||
23264339|NCT01296932|64710480|FG008|Overall Study|Adverse Event|1|||
23264340|NCT01296932|64710472|FG000|Overall Study|Investigator decision|0|||
23600882|NCT02234141|65929768|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
23600883|NCT02234141|65929769|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23264341|NCT01296932|64710473|FG001|Overall Study|Investigator decision|1|||
23264342|NCT01296932|64710474|FG002|Overall Study|Investigator decision|0|||
23264343|NCT01296932|64710475|FG003|Overall Study|Investigator decision|1|||
23264344|NCT01296932|64710476|FG004|Overall Study|Investigator decision|0|||
23264345|NCT01296932|64710477|FG005|Overall Study|Investigator decision|0|||
23264346|NCT01296932|64710478|FG006|Overall Study|Investigator decision|1|||
23264347|NCT01296932|64710479|FG007|Overall Study|Investigator decision|0|||
23264348|NCT01296932|64710480|FG008|Overall Study|Investigator decision|1|||
23264349|NCT01296932|64710472|FG000|Overall Study|No clinical benefit anymore|0|||
23264350|NCT01296932|64710473|FG001|Overall Study|No clinical benefit anymore|1|||
23264351|NCT01296932|64710474|FG002|Overall Study|No clinical benefit anymore|0|||
23264352|NCT01296932|64710475|FG003|Overall Study|No clinical benefit anymore|0|||
23264353|NCT01296932|64710476|FG004|Overall Study|No clinical benefit anymore|0|||
23264354|NCT01296932|64710477|FG005|Overall Study|No clinical benefit anymore|0|||
23264355|NCT01296932|64710478|FG006|Overall Study|No clinical benefit anymore|0|||
23264356|NCT01296932|64710479|FG007|Overall Study|No clinical benefit anymore|0|||
23264357|NCT01296932|64710480|FG008|Overall Study|No clinical benefit anymore|0|||
23264358|NCT01296932|64710472|FG000|Overall Study|Physician Decision|0|||
23264359|NCT01296932|64710473|FG001|Overall Study|Physician Decision|0|||
23264360|NCT01296932|64710474|FG002|Overall Study|Physician Decision|1|||
23264361|NCT01296932|64710475|FG003|Overall Study|Physician Decision|0|||
23264362|NCT01296932|64710476|FG004|Overall Study|Physician Decision|0|||
23264363|NCT01296932|64710477|FG005|Overall Study|Physician Decision|0|||
23264364|NCT01296932|64710478|FG006|Overall Study|Physician Decision|0|||
23264365|NCT01296932|64710479|FG007|Overall Study|Physician Decision|0|||
23264366|NCT01296932|64710480|FG008|Overall Study|Physician Decision|0|||
23264367|NCT01296932|64710472|FG000|Overall Study|IV problems, administration not possible|0|||
23264368|NCT01296932|64710473|FG001|Overall Study|IV problems, administration not possible|0|||
23264369|NCT01296932|64710474|FG002|Overall Study|IV problems, administration not possible|1|||
23264370|NCT01296932|64710475|FG003|Overall Study|IV problems, administration not possible|0|||
23264371|NCT01296932|64710476|FG004|Overall Study|IV problems, administration not possible|0|||
23264372|NCT01296932|64710477|FG005|Overall Study|IV problems, administration not possible|0|||
23264373|NCT01296932|64710478|FG006|Overall Study|IV problems, administration not possible|0|||
23264374|NCT01296932|64710479|FG007|Overall Study|IV problems, administration not possible|0|||
23264375|NCT01296932|64710480|FG008|Overall Study|IV problems, administration not possible|0|||
23264376|NCT01296932|64710472|FG000|Overall Study|per protocol|0|||
23264377|NCT01296932|64710473|FG001|Overall Study|per protocol|0|||
23264378|NCT01296932|64710474|FG002|Overall Study|per protocol|1|||
23264379|NCT01296932|64710475|FG003|Overall Study|per protocol|1|||
23264380|NCT01296932|64710476|FG004|Overall Study|per protocol|0|||
23264381|NCT01296932|64710477|FG005|Overall Study|per protocol|0|||
23264382|NCT01296932|64710478|FG006|Overall Study|per protocol|0|||
23264383|NCT01296932|64710479|FG007|Overall Study|per protocol|0|||
23264384|NCT01296932|64710480|FG008|Overall Study|per protocol|0|||
23264385|NCT01296932|64710472|FG000|Overall Study|Low benefit and too many side effects|0|||
23264386|NCT01296932|64710473|FG001|Overall Study|Low benefit and too many side effects|0|||
23264387|NCT01296932|64710474|FG002|Overall Study|Low benefit and too many side effects|0|||
23264388|NCT01296932|64710475|FG003|Overall Study|Low benefit and too many side effects|0|||
23264389|NCT01296932|64710476|FG004|Overall Study|Low benefit and too many side effects|0|||
23264390|NCT01296932|64710477|FG005|Overall Study|Low benefit and too many side effects|0|||
23264391|NCT01296932|64710478|FG006|Overall Study|Low benefit and too many side effects|0|||
23264392|NCT01296932|64710479|FG007|Overall Study|Low benefit and too many side effects|1|||
23264393|NCT01296932|64710480|FG008|Overall Study|Low benefit and too many side effects|0|||
23264394|NCT01296932|64710472|FG000|Overall Study|No adequate treatment response|0|||
23264395|NCT01296932|64710473|FG001|Overall Study|No adequate treatment response|0|||
23264396|NCT01296932|64710474|FG002|Overall Study|No adequate treatment response|0|||
23264397|NCT01296932|64710475|FG003|Overall Study|No adequate treatment response|0|||
23264398|NCT01296932|64710476|FG004|Overall Study|No adequate treatment response|0|||
23264399|NCT01296932|64710477|FG005|Overall Study|No adequate treatment response|0|||
23264400|NCT01296932|64710478|FG006|Overall Study|No adequate treatment response|0|||
23264401|NCT01296932|64710479|FG007|Overall Study|No adequate treatment response|1|||
23361956|NCT00547157|65069875|FG000|Overall Study|Withdrawal by Subject|3|||
23361957|NCT00547157|65069876|FG001|Overall Study|Withdrawal by Subject|1|||
23361958|NCT00547157|65069875|FG000|Overall Study|Administrative decision|3|||
23361959|NCT00547157|65069876|FG001|Overall Study|Administrative decision|2|||
23264402|NCT01296932|64710480|FG008|Overall Study|No adequate treatment response|0|||
23264403|NCT01296932|64710472|FG000|Overall Study|Dosage already reduced, AE still present|0|||
23361960|NCT00547157|65069875|FG000|Overall Study|Lost to Follow-up|4|||
23361961|NCT00547157|65069876|FG001|Overall Study|Lost to Follow-up|2|||
23480527|NCT02186301|65502012|FG000|Overall Study|Study Terminated by Sponsor|1|||
23480528|NCT02186301|65502013|FG001|Overall Study|Study Terminated by Sponsor|0|||
23264404|NCT01296932|64710473|FG001|Overall Study|Dosage already reduced, AE still present|0|||
23361962|NCT01556997|65069880|FG000|Overall Study|Adverse Event|10|||
23264405|NCT01296932|64710474|FG002|Overall Study|Dosage already reduced, AE still present|0|||
23264406|NCT01296932|64710475|FG003|Overall Study|Dosage already reduced, AE still present|0|||
23264407|NCT01296932|64710476|FG004|Overall Study|Dosage already reduced, AE still present|0|||
23264408|NCT01296932|64710477|FG005|Overall Study|Dosage already reduced, AE still present|0|||
23264409|NCT01296932|64710478|FG006|Overall Study|Dosage already reduced, AE still present|0|||
23264410|NCT01296932|64710479|FG007|Overall Study|Dosage already reduced, AE still present|0|||
23264411|NCT01296932|64710480|FG008|Overall Study|Dosage already reduced, AE still present|1|||
23264412|NCT01202747|64710487|FG000|Overall Study|Withdrawal by Subject|1|||
23264413|NCT00601354|64710488|FG000|Overall Study|Lost to Follow-up|4|||
23264414|NCT00601354|64710489|FG001|Overall Study|Lost to Follow-up|5|||
23264415|NCT02158936|64710492|FG000|Overall Study|Study closed/ terminated|57|||
23264416|NCT02158936|64710493|FG001|Overall Study|Study closed/ terminated|77|||
23264417|NCT02158936|64710492|FG000|Overall Study|Azacitidine tx discontinued|53|||
23264418|NCT02158936|64710493|FG001|Overall Study|Azacitidine tx discontinued|46|||
23264419|NCT02158936|64710492|FG000|Overall Study|Adverse Event|39|||
23264420|NCT02158936|64710493|FG001|Overall Study|Adverse Event|24|||
23264421|NCT02158936|64710492|FG000|Overall Study|Withdrawal by Subject|15|||
23264422|NCT02158936|64710493|FG001|Overall Study|Withdrawal by Subject|16|||
23264423|NCT02158936|64710492|FG000|Overall Study|Physician Decision|15|||
23264424|NCT02158936|64710493|FG001|Overall Study|Physician Decision|13|||
23264425|NCT02158936|64710492|FG000|Overall Study|Lost to Follow-up|0|||
23264426|NCT02158936|64710493|FG001|Overall Study|Lost to Follow-up|1|||
23264427|NCT00944697|64710494|FG000|Overall Study|Withdrawal by Subject|1|||
23264428|NCT00944697|64710495|FG001|Overall Study|Withdrawal by Subject|1|||
23264429|NCT00944697|64710494|FG000|Overall Study|Adverse Event|0|||
23264430|NCT00944697|64710495|FG001|Overall Study|Adverse Event|3|||
23264431|NCT00944697|64710494|FG000|Overall Study|Administrative|1|||
23264432|NCT00944697|64710495|FG001|Overall Study|Administrative|1|||
23264433|NCT04588259|64710499|FG000|Run-in Period|Run-in failure|0|||
23264434|NCT04588259|64710500|FG001|Run-in Period|Run-in failure|23|||
23264435|NCT04588259|64710499|FG000|Run-in Period|Withdrawn before randomisation|0|||
23264436|NCT04588259|64710500|FG001|Run-in Period|Withdrawn before randomisation|8|||
23264437|NCT04588259|64710499|FG000|Treatment Period|Withdrawal by Subject|6|||
23264438|NCT04588259|64710500|FG001|Treatment Period|Withdrawal by Subject|6|||
23264439|NCT03882047|64710507|FG000|Overall Study|Adverse Event|0|||
23264440|NCT03882047|64710508|FG001|Overall Study|Adverse Event|2|||
23264441|NCT03882047|64710509|FG002|Overall Study|Adverse Event|2|||
23264442|NCT03882047|64710507|FG000|Overall Study|Treatment Failure|3|||
23264443|NCT03882047|64710508|FG001|Overall Study|Treatment Failure|3|||
23264444|NCT03882047|64710509|FG002|Overall Study|Treatment Failure|12|||
23264445|NCT03882047|64710507|FG000|Overall Study|Lost to Follow-up|0|||
23264446|NCT03882047|64710508|FG001|Overall Study|Lost to Follow-up|1|||
23264447|NCT03882047|64710509|FG002|Overall Study|Lost to Follow-up|0|||
23264448|NCT03882047|64710507|FG000|Overall Study|Did Not Wish to Continue|1|||
23264449|NCT03882047|64710508|FG001|Overall Study|Did Not Wish to Continue|4|||
23264450|NCT03882047|64710509|FG002|Overall Study|Did Not Wish to Continue|1|||
23264451|NCT03882047|64710507|FG000|Overall Study|Noncompliance With Protocol|2|||
23264452|NCT03882047|64710508|FG001|Overall Study|Noncompliance With Protocol|0|||
23264453|NCT03882047|64710509|FG002|Overall Study|Noncompliance With Protocol|0|||
23264454|NCT03882047|64710507|FG000|Overall Study|Did Not Meet Eligibility|0|||
23264455|NCT03882047|64710508|FG001|Overall Study|Did Not Meet Eligibility|0|||
23264456|NCT03882047|64710509|FG002|Overall Study|Did Not Meet Eligibility|1|||
23264457|NCT01215942|64710511|FG000|Treatment Period|Adverse Event|15|||
23264458|NCT01215942|64710512|FG001|Treatment Period|Adverse Event|26|||
23264459|NCT01215942|64710511|FG000|Treatment Period|Death|2|||
23264460|NCT01215942|64710512|FG001|Treatment Period|Death|4|||
23264461|NCT01215942|64710511|FG000|Treatment Period|Lack of Efficacy|23|||
23264462|NCT01215942|64710512|FG001|Treatment Period|Lack of Efficacy|62|||
23264463|NCT01215942|64710511|FG000|Treatment Period|Lost to Follow-up|3|||
23264464|NCT01215942|64710512|FG001|Treatment Period|Lost to Follow-up|4|||
23264465|NCT01215942|64710511|FG000|Treatment Period|Withdrawal by Subject|17|||
23264466|NCT01215942|64710512|FG001|Treatment Period|Withdrawal by Subject|40|||
23361963|NCT01556997|65069881|FG001|Overall Study|Adverse Event|12|||
23600884|NCT02234141|65929770|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23264467|NCT01215942|64710511|FG000|Treatment Period|Physician Decision|5|||
23264468|NCT01215942|64710512|FG001|Treatment Period|Physician Decision|5|||
23264469|NCT01215942|64710511|FG000|Treatment Period|Protocol Violation|0|||
23264470|NCT01215942|64710512|FG001|Treatment Period|Protocol Violation|1|||
23264471|NCT01215942|64710511|FG000|Treatment Period|Sponsor Decision|349|||
23264472|NCT01215942|64710512|FG001|Treatment Period|Sponsor Decision|530|||
23264473|NCT01215942|64710511|FG000|Post-Treatment Follow-Up Period|Death|0|||
23264474|NCT01215942|64710512|FG001|Post-Treatment Follow-Up Period|Death|1|||
23264475|NCT01215942|64710511|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
23264476|NCT01215942|64710512|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
23264477|NCT01215942|64710511|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
23264478|NCT01215942|64710512|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
23264479|NCT01215942|64710511|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
23264480|NCT01215942|64710512|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
23264481|NCT01215942|64710511|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
23264482|NCT01215942|64710512|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
23264483|NCT03206203|64710515|FG000|Treatment|Death|38|||
23264484|NCT03206203|64710516|FG001|Treatment|Death|26|||
23264485|NCT03206203|64710517|FG002|Treatment|Death|0|||
23264486|NCT03206203|64710515|FG000|Treatment|Withdrawal by Subject|1|||
23264487|NCT03206203|64710516|FG001|Treatment|Withdrawal by Subject|0|||
23264488|NCT03206203|64710517|FG002|Treatment|Withdrawal by Subject|0|||
23264489|NCT03206203|64710515|FG000|Treatment|Lost to Follow-up|4|||
23264490|NCT03206203|64710516|FG001|Treatment|Lost to Follow-up|0|||
23264491|NCT03206203|64710517|FG002|Treatment|Lost to Follow-up|0|||
23264492|NCT03206203|64710515|FG000|Treatment|N/A in Follow-Up|8|||
23264493|NCT03206203|64710516|FG001|Treatment|N/A in Follow-Up|1|||
23264494|NCT03206203|64710517|FG002|Treatment|N/A in Follow-Up|0|||
23264495|NCT03206203|64710515|FG000|Treatment|Disease progression|0|||
23264496|NCT03206203|64710516|FG001|Treatment|Disease progression|1|||
23264497|NCT03206203|64710517|FG002|Treatment|Disease progression|0|||
23264498|NCT03206203|64710515|FG000|Treatment|Refused follow-up|0|||
23264499|NCT03206203|64710516|FG001|Treatment|Refused follow-up|1|||
23264500|NCT03206203|64710517|FG002|Treatment|Refused follow-up|0|||
23264501|NCT03206203|64710515|FG000|Treatment|Cross over to Arm 1|0|||
23264502|NCT03206203|64710516|FG001|Treatment|Cross over to Arm 1|19|||
23264503|NCT03206203|64710517|FG002|Treatment|Cross over to Arm 1|0|||
23264504|NCT03206203|64710515|FG000|Optional Cross-Over|Death|0|||
23264505|NCT03206203|64710516|FG001|Optional Cross-Over|Death|0|||
23264506|NCT03206203|64710517|FG002|Optional Cross-Over|Death|14|||
23264507|NCT03206203|64710515|FG000|Optional Cross-Over|Refused follow-up|0|||
23264508|NCT03206203|64710516|FG001|Optional Cross-Over|Refused follow-up|0|||
23264509|NCT03206203|64710517|FG002|Optional Cross-Over|Refused follow-up|2|||
23264510|NCT03565211|64710523|FG000|Overall Study|Withdrawal by Subject|2|||
23264511|NCT03565211|64710523|FG000|Overall Study|Lost to Follow-up|1|||
23264512|NCT03565211|64710523|FG000|Overall Study|Adverse Event|44|||
23264513|NCT03565211|64710523|FG000|Overall Study|Personal issues|1|||
23264514|NCT01478620|64710524|FG000|Overall Study|Lost to Follow-up|6|||
23264515|NCT01595009|64710531|FG000|Core|Patients completed per protocol|85|||
23264516|NCT01595009|64710532|FG001|Core|Patients completed per protocol|44|||
23264517|NCT01595009|64710533|FG002|Core|Patients completed per protocol|0|||
23264518|NCT01595009|64710534|FG003|Core|Patients completed per protocol|0|||
23264519|NCT01595009|64710531|FG000|Core|Adverse Event|19|||
23264520|NCT01595009|64710532|FG001|Core|Adverse Event|23|||
23264521|NCT01595009|64710533|FG002|Core|Adverse Event|0|||
23264522|NCT01595009|64710534|FG003|Core|Adverse Event|0|||
23264523|NCT01595009|64710531|FG000|Core|Disease progression|14|||
23264524|NCT01595009|64710532|FG001|Core|Disease progression|26|||
23264525|NCT01595009|64710533|FG002|Core|Disease progression|0|||
23264526|NCT01595009|64710534|FG003|Core|Disease progression|0|||
23264527|NCT01595009|64710531|FG000|Core|Withdrawal by Subject|4|||
23264528|NCT01595009|64710532|FG001|Core|Withdrawal by Subject|17|||
23264529|NCT01595009|64710533|FG002|Core|Withdrawal by Subject|0|||
23264530|NCT01595009|64710534|FG003|Core|Withdrawal by Subject|0|||
23264531|NCT01595009|64710531|FG000|Core|Death|3|||
23264532|NCT01595009|64710532|FG001|Core|Death|6|||
23264533|NCT01595009|64710533|FG002|Core|Death|0|||
23264534|NCT01595009|64710534|FG003|Core|Death|0|||
23264535|NCT01595009|64710531|FG000|Core|Lost to Follow-up|1|||
23264536|NCT01595009|64710532|FG001|Core|Lost to Follow-up|2|||
23264537|NCT01595009|64710533|FG002|Core|Lost to Follow-up|0|||
23264538|NCT01595009|64710534|FG003|Core|Lost to Follow-up|0|||
23264539|NCT01595009|64710531|FG000|Core|Protocol deviation|0|||
23264540|NCT01595009|64710532|FG001|Core|Protocol deviation|1|||
23264541|NCT01595009|64710533|FG002|Core|Protocol deviation|0|||
23264542|NCT01595009|64710534|FG003|Core|Protocol deviation|0|||
23264543|NCT01595009|64710531|FG000|Core|Administrative problems|0|||
23264544|NCT01595009|64710532|FG001|Core|Administrative problems|1|||
23480529|NCT02186301|65502014|FG002|Overall Study|Study Terminated by Sponsor|11|||
23264545|NCT01595009|64710533|FG002|Core|Administrative problems|0|||
23264546|NCT01595009|64710534|FG003|Core|Administrative problems|0|||
23264547|NCT01595009|64710531|FG000|Extension|Administrative problems|0|||
23264548|NCT01595009|64710532|FG001|Extension|Administrative problems|0|||
23264549|NCT01595009|64710533|FG002|Extension|Administrative problems|0|||
23264550|NCT01595009|64710534|FG003|Extension|Administrative problems|1|||
23264551|NCT01595009|64710531|FG000|Extension|Patients completed per protocol|0|||
23264552|NCT01595009|64710532|FG001|Extension|Patients completed per protocol|0|||
23264553|NCT01595009|64710533|FG002|Extension|Patients completed per protocol|0|||
23264554|NCT01595009|64710534|FG003|Extension|Patients completed per protocol|2|||
23264555|NCT01595009|64710531|FG000|Extension|Disease progression|0|||
23264556|NCT01595009|64710532|FG001|Extension|Disease progression|0|||
23264557|NCT01595009|64710533|FG002|Extension|Disease progression|4|||
23264558|NCT01595009|64710534|FG003|Extension|Disease progression|7|||
23264559|NCT01595009|64710531|FG000|Extension|Adverse Event|0|||
23361964|NCT01556997|65069882|FG002|Overall Study|Adverse Event|12|||
23361965|NCT01556997|65069880|FG000|Overall Study|Lost to Follow-up|6|||
23361966|NCT01556997|65069881|FG001|Overall Study|Lost to Follow-up|6|||
23361967|NCT01556997|65069882|FG002|Overall Study|Lost to Follow-up|4|||
23361968|NCT01556997|65069880|FG000|Overall Study|Physician Decision|1|||
23361969|NCT01556997|65069881|FG001|Overall Study|Physician Decision|1|||
23361970|NCT01556997|65069882|FG002|Overall Study|Physician Decision|1|||
23361971|NCT01556997|65069880|FG000|Overall Study|Withdrawal by Subject|7|||
23361972|NCT01556997|65069881|FG001|Overall Study|Withdrawal by Subject|6|||
23361973|NCT01556997|65069882|FG002|Overall Study|Withdrawal by Subject|8|||
23361974|NCT01556997|65069880|FG000|Overall Study|Other|2|||
23361975|NCT01556997|65069881|FG001|Overall Study|Other|3|||
23361976|NCT01556997|65069882|FG002|Overall Study|Other|7|||
23361977|NCT00571662|65069883|FG000|Overall Study|Withdrawal by Subject|2|||
23480530|NCT02186301|65502012|FG000|Overall Study|Protocol Deviation|0|||
23480531|NCT02186301|65502013|FG001|Overall Study|Protocol Deviation|2|||
23480532|NCT02186301|65502014|FG002|Overall Study|Protocol Deviation|0|||
23480533|NCT02186301|65502012|FG000|Overall Study|Missing|0|||
23480534|NCT02186301|65502013|FG001|Overall Study|Missing|0|||
23480535|NCT02186301|65502014|FG002|Overall Study|Missing|2|||
23480536|NCT02186301|65502012|FG000|Overall Study|Other|0|||
23480537|NCT02186301|65502013|FG001|Overall Study|Other|0|||
23480538|NCT02186301|65502014|FG002|Overall Study|Other|1|||
23480539|NCT00770146|65502015|FG000|Treatment Period|Withdrawal by Subject|6|||
23480540|NCT00770146|65502016|FG001|Treatment Period|Withdrawal by Subject|13|||
23480541|NCT00770146|65502015|FG000|Treatment Period|Adverse Event|2|||
23480542|NCT00770146|65502016|FG001|Treatment Period|Adverse Event|26|||
23480543|NCT00770146|65502015|FG000|Treatment Period|Other|1|||
23480544|NCT00770146|65502016|FG001|Treatment Period|Other|5|||
23480545|NCT00770146|65502015|FG000|Treatment Period|Protocol non-compliance|0|||
23480546|NCT00770146|65502016|FG001|Treatment Period|Protocol non-compliance|1|||
23480547|NCT00770146|65502015|FG000|Follow-up Period|Withdrawal by Subject|7|||
23480548|NCT00770146|65502016|FG001|Follow-up Period|Withdrawal by Subject|13|||
23480549|NCT00770146|65502015|FG000|Follow-up Period|Adverse Event|0|||
23480550|NCT00770146|65502016|FG001|Follow-up Period|Adverse Event|2|||
23480551|NCT00770146|65502015|FG000|Follow-up Period|Other|4|||
23480552|NCT00770146|65502016|FG001|Follow-up Period|Other|5|||
23480553|NCT03874429|65502017|FG000|Overall Study|Adverse Event|2|||
23480554|NCT03874429|65502018|FG001|Overall Study|Adverse Event|2|||
23480555|NCT03874429|65502017|FG000|Overall Study|Lack of Efficacy|0|||
23480556|NCT03874429|65502018|FG001|Overall Study|Lack of Efficacy|1|||
23600885|NCT02234141|65929771|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23264560|NCT01595009|64710532|FG001|Extension|Adverse Event|0|||
23264561|NCT01595009|64710533|FG002|Extension|Adverse Event|0|||
23264562|NCT01595009|64710534|FG003|Extension|Adverse Event|1|||
23264563|NCT01077713|64710535|FG000|Overall Study|Withdrawal by Subject|1|||
23264564|NCT01077713|64710536|FG001|Overall Study|Withdrawal by Subject|2|||
23264565|NCT01077713|64710535|FG000|Overall Study|Progressive Disease (PD)|0|||
23264566|NCT01077713|64710536|FG001|Overall Study|Progressive Disease (PD)|1|||
23264567|NCT01077713|64710535|FG000|Overall Study|Death|28|||
23264568|NCT01077713|64710536|FG001|Overall Study|Death|29|||
23264569|NCT01077713|64710535|FG000|Overall Study|Lost to Follow-up|1|||
23264570|NCT01077713|64710536|FG001|Overall Study|Lost to Follow-up|1|||
23264571|NCT01077713|64710535|FG000|Overall Study|Adverse Event|2|||
23264572|NCT01077713|64710536|FG001|Overall Study|Adverse Event|1|||
23264573|NCT01077713|64710535|FG000|Overall Study|Other|4|||
23264574|NCT01077713|64710536|FG001|Overall Study|Other|2|||
23264575|NCT02236130|64710537|FG000|Overall Study|Lost to Follow-up|7|||
23264576|NCT02236130|64710538|FG001|Overall Study|Lost to Follow-up|12|||
23264577|NCT01787825|64710539|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
23264578|NCT01787825|64710540|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
23264579|NCT01787825|64710539|FG000|Overall Study|Data Not Analyzable|5|||
23264580|NCT01787825|64710540|FG001|Overall Study|Data Not Analyzable|1|||
23264581|NCT01029353|64710541|FG000|Overall Study|Lost to Follow-up|4|||
23264582|NCT01029353|64710542|FG001|Overall Study|Lost to Follow-up|5|||
23264583|NCT01029353|64710543|FG002|Overall Study|Lost to Follow-up|5|||
23264584|NCT01029353|64710544|FG003|Overall Study|Lost to Follow-up|4|||
23264585|NCT01029353|64710541|FG000|Overall Study|Consent Withdrawn|2|||
23361978|NCT00571662|65069883|FG000|Overall Study|psychiatric instability|1|||
23361979|NCT00571662|65069883|FG000|Overall Study|Adverse Event|5|||
23480557|NCT03874429|65502017|FG000|Overall Study|Covid-19 pandemic|4|||
23480558|NCT03874429|65502018|FG001|Overall Study|Covid-19 pandemic|2|||
23264586|NCT01029353|64710542|FG001|Overall Study|Consent Withdrawn|0|||
23264587|NCT01029353|64710543|FG002|Overall Study|Consent Withdrawn|0|||
23361980|NCT03365934|65069884|FG000|Overall Study|Adverse Event|1|||
23361981|NCT03365934|65069884|FG000|Overall Study|Withdrawal by Subject|1|||
23480559|NCT02248675|65502020|FG000|Overall Study|Lost to Follow-up|3|||
23480560|NCT02248675|65502021|FG001|Overall Study|Lost to Follow-up|1|||
23480561|NCT00998764|65502022|FG000|Overall Study|Lack of Efficacy|3|||
23480562|NCT00998764|65502023|FG001|Overall Study|Lack of Efficacy|6|||
23480563|NCT00998764|65502022|FG000|Overall Study|Adverse Event|17|||
23361982|NCT02493517|65069885|FG000|Overall Study|Protocol Violation|1|||
23361983|NCT02493517|65069886|FG001|Overall Study|Protocol Violation|2|||
23361984|NCT02493517|65069885|FG000|Overall Study|Withdrawal by Subject|1|||
23361985|NCT02493517|65069886|FG001|Overall Study|Withdrawal by Subject|2|||
23361986|NCT02493517|65069885|FG000|Overall Study|Adverse Event|0|||
23361987|NCT02493517|65069886|FG001|Overall Study|Adverse Event|2|||
23361988|NCT02493517|65069885|FG000|Overall Study|Missed study visit|0|||
23361989|NCT02493517|65069886|FG001|Overall Study|Missed study visit|1|||
23361990|NCT02329327|65069888|FG000|Overall Study|Death|78|||
23361991|NCT02329327|65069889|FG001|Overall Study|Death|0|||
23361992|NCT02329327|65069888|FG000|Overall Study|Withdrawal by Subject|3|||
23361993|NCT02329327|65069889|FG001|Overall Study|Withdrawal by Subject|0|||
23361994|NCT02329327|65069888|FG000|Overall Study|Lost to Follow-up|4|||
23361995|NCT02329327|65069889|FG001|Overall Study|Lost to Follow-up|0|||
23361996|NCT05225389|65069891|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
23361997|NCT01854697|65069892|FG000|Overall Study|Adverse Event|1|||
23361998|NCT01854697|65069893|FG001|Overall Study|Adverse Event|0|||
23361999|NCT01854697|65069894|FG002|Overall Study|Adverse Event|0|||
23362000|NCT01854697|65069895|FG003|Overall Study|Adverse Event|0|||
23362001|NCT01854697|65069896|FG004|Overall Study|Adverse Event|1|||
23362002|NCT01854697|65069892|FG000|Overall Study|Lost to Follow-up|4|||
23362003|NCT01854697|65069893|FG001|Overall Study|Lost to Follow-up|1|||
23362004|NCT01854697|65069894|FG002|Overall Study|Lost to Follow-up|1|||
23362005|NCT01854697|65069895|FG003|Overall Study|Lost to Follow-up|2|||
23362006|NCT01854697|65069896|FG004|Overall Study|Lost to Follow-up|0|||
23362007|NCT01854697|65069892|FG000|Overall Study|To enter another AbbVie study|1|||
23362008|NCT01854697|65069893|FG001|Overall Study|To enter another AbbVie study|0|||
23362009|NCT01854697|65069894|FG002|Overall Study|To enter another AbbVie study|0|||
23362010|NCT01854697|65069895|FG003|Overall Study|To enter another AbbVie study|0|||
23362011|NCT01854697|65069896|FG004|Overall Study|To enter another AbbVie study|1|||
23362012|NCT01854697|65069892|FG000|Overall Study|Withdrew Consent|0|||
23362013|NCT01854697|65069893|FG001|Overall Study|Withdrew Consent|1|||
23362014|NCT01854697|65069894|FG002|Overall Study|Withdrew Consent|0|||
23362015|NCT01854697|65069895|FG003|Overall Study|Withdrew Consent|1|||
23362016|NCT01854697|65069896|FG004|Overall Study|Withdrew Consent|0|||
23362017|NCT01854697|65069892|FG000|Overall Study|Other|0|||
23362018|NCT01854697|65069893|FG001|Overall Study|Other|1|||
23362019|NCT01854697|65069894|FG002|Overall Study|Other|1|||
23362020|NCT01854697|65069895|FG003|Overall Study|Other|0|||
23362021|NCT01854697|65069896|FG004|Overall Study|Other|0|||
23362022|NCT01922258|65069897|FG000|Overall Study|Lost to Follow-up|1|||
23362023|NCT01922258|65069898|FG001|Overall Study|Lost to Follow-up|1|||
23362024|NCT01922258|65069897|FG000|Overall Study|Adverse Event|9|||
23362025|NCT01922258|65069898|FG001|Overall Study|Adverse Event|2|||
23264588|NCT01029353|64710544|FG003|Overall Study|Consent Withdrawn|0|||
23264589|NCT01029353|64710541|FG000|Overall Study|Primary Outcome Indeterminate|1|||
23264590|NCT01029353|64710542|FG001|Overall Study|Primary Outcome Indeterminate|3|||
23264591|NCT01029353|64710543|FG002|Overall Study|Primary Outcome Indeterminate|2|||
23264592|NCT01029353|64710544|FG003|Overall Study|Primary Outcome Indeterminate|0|||
23264593|NCT02292238|64710545|FG000|Overall Study|Protocol Violation|1|||
23264594|NCT02292238|64710546|FG001|Overall Study|Protocol Violation|2|||
23264595|NCT02292238|64710545|FG000|Overall Study|Withdrawal by Subject|2|||
23264596|NCT02292238|64710546|FG001|Overall Study|Withdrawal by Subject|1|||
23264597|NCT02292238|64710545|FG000|Overall Study|Lost to Follow-up|1|||
23264598|NCT02292238|64710546|FG001|Overall Study|Lost to Follow-up|0|||
23264599|NCT02292238|64710545|FG000|Overall Study|Physician Decision|0|||
23264600|NCT02292238|64710546|FG001|Overall Study|Physician Decision|1|||
23264601|NCT04582266|64710547|FG000|Overall Study|Lost to Follow-up|7|||
23264602|NCT04582266|64710548|FG001|Overall Study|Lost to Follow-up|5|||
23362026|NCT01922258|65069897|FG000|Overall Study|Met Withdrawal Criteria|0|||
23362027|NCT01922258|65069898|FG001|Overall Study|Met Withdrawal Criteria|4|||
23362028|NCT01922258|65069897|FG000|Overall Study|Withdrawn by the Investigator|1|||
23362029|NCT01922258|65069898|FG001|Overall Study|Withdrawn by the Investigator|4|||
23264603|NCT04582266|64710547|FG000|Overall Study|Withdrawal by Subject|1|||
23264604|NCT04582266|64710548|FG001|Overall Study|Withdrawal by Subject|0|||
23264605|NCT04582266|64710547|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
23362030|NCT01922258|65069897|FG000|Overall Study|Withdrawal by participant|5|||
23362031|NCT01922258|65069898|FG001|Overall Study|Withdrawal by participant|5|||
23362032|NCT03283930|65069899|FG000|Overall Study|Scheduling conflict|8|||
23264606|NCT04582266|64710548|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
23362033|NCT03283930|65069900|FG001|Overall Study|Scheduling conflict|10|||
23362034|NCT03283930|65069899|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
23362035|NCT03283930|65069900|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
23362036|NCT03283930|65069899|FG000|Overall Study|Technical software issue|2|||
23362037|NCT03283930|65069900|FG001|Overall Study|Technical software issue|2|||
23362038|NCT01411319|65069901|FG000|Overall Study|Lost to Follow-up|1|||
23264607|NCT01606306|64710551|FG000|Overall Study|Lack of Efficacy|2|||
23264608|NCT01606306|64710552|FG001|Overall Study|Lack of Efficacy|1|||
23264609|NCT01606306|64710553|FG002|Overall Study|Lack of Efficacy|4|||
23264610|NCT01606306|64710554|FG003|Overall Study|Lack of Efficacy|4|||
23264611|NCT01606306|64710555|FG004|Overall Study|Lack of Efficacy|1|||
23264612|NCT01606306|64710556|FG005|Overall Study|Lack of Efficacy|2|||
23264613|NCT01606306|64710551|FG000|Overall Study|Adverse Event|1|||
23264614|NCT01606306|64710552|FG001|Overall Study|Adverse Event|0|||
23264615|NCT01606306|64710553|FG002|Overall Study|Adverse Event|1|||
23264616|NCT01606306|64710554|FG003|Overall Study|Adverse Event|1|||
23264617|NCT01606306|64710555|FG004|Overall Study|Adverse Event|2|||
23264618|NCT01606306|64710556|FG005|Overall Study|Adverse Event|0|||
23264619|NCT01606306|64710551|FG000|Overall Study|Lost to Follow-up|7|||
23264620|NCT01606306|64710552|FG001|Overall Study|Lost to Follow-up|4|||
23264621|NCT01606306|64710553|FG002|Overall Study|Lost to Follow-up|5|||
23264622|NCT01606306|64710554|FG003|Overall Study|Lost to Follow-up|4|||
23264623|NCT01606306|64710555|FG004|Overall Study|Lost to Follow-up|3|||
23264624|NCT01606306|64710556|FG005|Overall Study|Lost to Follow-up|5|||
23264625|NCT01606306|64710551|FG000|Overall Study|Withdrawal by Subject|4|||
23264626|NCT01606306|64710552|FG001|Overall Study|Withdrawal by Subject|3|||
23264627|NCT01606306|64710553|FG002|Overall Study|Withdrawal by Subject|4|||
23264628|NCT01606306|64710554|FG003|Overall Study|Withdrawal by Subject|4|||
23264629|NCT01606306|64710555|FG004|Overall Study|Withdrawal by Subject|5|||
23264630|NCT01606306|64710556|FG005|Overall Study|Withdrawal by Subject|4|||
23264631|NCT01606306|64710551|FG000|Overall Study|Physician Decision|1|||
23264632|NCT01606306|64710552|FG001|Overall Study|Physician Decision|2|||
23264633|NCT01606306|64710553|FG002|Overall Study|Physician Decision|0|||
23264634|NCT01606306|64710554|FG003|Overall Study|Physician Decision|0|||
23264635|NCT01606306|64710555|FG004|Overall Study|Physician Decision|0|||
23264636|NCT01606306|64710556|FG005|Overall Study|Physician Decision|0|||
23264637|NCT00989261|64710557|FG000|Overall Study|Still in follow up|12|||
23264638|NCT00989261|64710558|FG001|Overall Study|Still in follow up|21|||
23264639|NCT00989261|64710557|FG000|Overall Study|Withdrawal by Subject|0|||
23264640|NCT00989261|64710558|FG001|Overall Study|Withdrawal by Subject|1|||
23264641|NCT00989261|64710557|FG000|Overall Study|Lost to Follow-up|3|||
23264642|NCT00989261|64710558|FG001|Overall Study|Lost to Follow-up|0|||
23264643|NCT03495869|64710559|FG000|Overall Study|Lost to Follow-up|4|||
23264644|NCT03495869|64710560|FG001|Overall Study|Lost to Follow-up|17|||
23264645|NCT03495869|64710561|FG002|Overall Study|Lost to Follow-up|8|||
23264646|NCT03495869|64710562|FG003|Overall Study|Lost to Follow-up|14|||
23264647|NCT03495869|64710559|FG000|Overall Study|Withdrawal by Subject|0|||
23264648|NCT03495869|64710560|FG001|Overall Study|Withdrawal by Subject|3|||
23264649|NCT03495869|64710561|FG002|Overall Study|Withdrawal by Subject|0|||
23264650|NCT03495869|64710562|FG003|Overall Study|Withdrawal by Subject|3|||
23264651|NCT03495869|64710559|FG000|Overall Study|Dropped from study|0|||
23264652|NCT03495869|64710560|FG001|Overall Study|Dropped from study|7|||
23264653|NCT03495869|64710561|FG002|Overall Study|Dropped from study|2|||
23264654|NCT03495869|64710562|FG003|Overall Study|Dropped from study|4|||
23264655|NCT02492958|64710563|FG000|Overall Study|Withdrawal by Subject|0|||
23264656|NCT02492958|64710564|FG001|Overall Study|Withdrawal by Subject|0|||
23264657|NCT02492958|64710565|FG002|Overall Study|Withdrawal by Subject|1|||
23264658|NCT02492958|64710566|FG003|Overall Study|Withdrawal by Subject|0|||
23264659|NCT02492958|64710563|FG000|Overall Study|Adverse Event|1|||
23264660|NCT02492958|64710564|FG001|Overall Study|Adverse Event|0|||
23264661|NCT02492958|64710565|FG002|Overall Study|Adverse Event|1|||
23264662|NCT02492958|64710566|FG003|Overall Study|Adverse Event|0|||
23264663|NCT00249821|64710570|FG000|Overall Study|Technical problem|0|||
23264664|NCT00249821|64710571|FG001|Overall Study|Technical problem|1|||
23362039|NCT00762034|65069903|FG000|Induction Period|Protocol Violation|1|||
23480564|NCT00998764|65502023|FG001|Overall Study|Adverse Event|12|||
23264665|NCT03361423|64710573|FG000|Overall Study|Withdrawal by Subject|4|||
23264666|NCT03361423|64710574|FG001|Overall Study|Withdrawal by Subject|3|||
23264667|NCT03361423|64710573|FG000|Overall Study|Did not treat|19|||
23264668|NCT03361423|64710574|FG001|Overall Study|Did not treat|18|||
23264669|NCT03361423|64710573|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
23264670|NCT03361423|64710574|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
23264671|NCT03361423|64710573|FG000|Overall Study|Missing data|4|||
23264672|NCT03361423|64710574|FG001|Overall Study|Missing data|1|||
23264673|NCT01249664|64710575|FG000|Overall Study|Withdrawal by Subject|5|||
23264674|NCT01249664|64710576|FG001|Overall Study|Withdrawal by Subject|0|||
23264675|NCT01249664|64710575|FG000|Overall Study|Adverse Event|1|||
23264676|NCT01249664|64710576|FG001|Overall Study|Adverse Event|0|||
23264677|NCT02806232|64710581|FG000|Overall Study|Lost to Follow-up|1|||
23264678|NCT02806232|64710582|FG001|Overall Study|Lost to Follow-up|2|||
23264679|NCT02806232|64710583|FG002|Overall Study|Lost to Follow-up|1|||
23362040|NCT00762034|65069904|FG001|Induction Period|Protocol Violation|2|||
23264680|NCT02806232|64710584|FG003|Overall Study|Lost to Follow-up|0|||
23264681|NCT02806232|64710585|FG004|Overall Study|Lost to Follow-up|0|||
23264682|NCT02806232|64710586|FG005|Overall Study|Lost to Follow-up|1|||
23264683|NCT02806232|64710587|FG006|Overall Study|Lost to Follow-up|0|||
23264684|NCT02806232|64710588|FG007|Overall Study|Lost to Follow-up|0|||
23264685|NCT02806232|64710589|FG008|Overall Study|Lost to Follow-up|0|||
23264686|NCT02806232|64710581|FG000|Overall Study|Withdrawal by Subject|0|||
23264687|NCT02806232|64710582|FG001|Overall Study|Withdrawal by Subject|2|||
23264688|NCT02806232|64710583|FG002|Overall Study|Withdrawal by Subject|0|||
23264689|NCT02806232|64710584|FG003|Overall Study|Withdrawal by Subject|0|||
23264690|NCT02806232|64710585|FG004|Overall Study|Withdrawal by Subject|2|||
23362041|NCT00762034|65069903|FG000|Induction Period|Entry Criterion Not Met|12|||
23264691|NCT02806232|64710586|FG005|Overall Study|Withdrawal by Subject|1|||
23264692|NCT02806232|64710587|FG006|Overall Study|Withdrawal by Subject|0|||
23264693|NCT02806232|64710588|FG007|Overall Study|Withdrawal by Subject|0|||
23264694|NCT02806232|64710589|FG008|Overall Study|Withdrawal by Subject|0|||
23264695|NCT01521559|64710590|FG000|Overall Study|Adverse Event|0|||
23264696|NCT01521559|64710591|FG001|Overall Study|Adverse Event|4|||
23264697|NCT01521559|64710590|FG000|Overall Study|Death|1|||
23264698|NCT01521559|64710591|FG001|Overall Study|Death|0|||
23264699|NCT01521559|64710590|FG000|Overall Study|Withdrawal by Subject|9|||
23264700|NCT01521559|64710591|FG001|Overall Study|Withdrawal by Subject|11|||
23264701|NCT01521559|64710590|FG000|Overall Study|Lost to Follow-up|3|||
23264702|NCT01521559|64710591|FG001|Overall Study|Lost to Follow-up|1|||
23264703|NCT01521559|64710590|FG000|Overall Study|Protocol Violation|1|||
23264704|NCT01521559|64710591|FG001|Overall Study|Protocol Violation|0|||
23264705|NCT01521559|64710590|FG000|Overall Study|Other|1|||
23264706|NCT01521559|64710591|FG001|Overall Study|Other|2|||
23264707|NCT02524379|64710592|FG000|Overall Study|Death|1|||
23264708|NCT04161144|64710593|FG000|Overall Study|Withdrawal by Subject|0|||
23264709|NCT04161144|64710594|FG001|Overall Study|Withdrawal by Subject|1|||
23264710|NCT04161144|64710593|FG000|Overall Study|Protocol Violation|1|||
23264711|NCT04161144|64710594|FG001|Overall Study|Protocol Violation|0|||
23264712|NCT04538170|64710595|FG000|Overall Study|Withdrawal by Subject|104|||
23264713|NCT04538170|64710596|FG001|Overall Study|Withdrawal by Subject|210|||
23264714|NCT03144687|64710597|FG000|Overall Study|Death|0|||
23264715|NCT03144687|64710598|FG001|Overall Study|Death|2|||
23264716|NCT03144687|64710597|FG000|Overall Study|Lost to Follow-up|0|||
23264717|NCT03144687|64710598|FG001|Overall Study|Lost to Follow-up|1|||
23264718|NCT03144687|64710597|FG000|Overall Study|Physician Decision|0|||
23264719|NCT03144687|64710598|FG001|Overall Study|Physician Decision|1|||
23264720|NCT03144687|64710597|FG000|Overall Study|Withdrawal by Subject|1|||
23264721|NCT03144687|64710598|FG001|Overall Study|Withdrawal by Subject|3|||
23264722|NCT03144687|64710597|FG000|Overall Study|Not Reported|2|||
23264723|NCT03144687|64710598|FG001|Overall Study|Not Reported|0|||
23264724|NCT02658084|64710599|FG000|Overall Study|Withdrawal by Subject|1|||
23264725|NCT02658084|64710600|FG001|Overall Study|Withdrawal by Subject|0|||
23264726|NCT02658084|64710599|FG000|Overall Study|Study Termination|1|||
23264727|NCT02658084|64710600|FG001|Overall Study|Study Termination|0|||
23264728|NCT04471207|64710601|FG000|Overall Study|Lost to Follow-up|4|||
23264729|NCT04471207|64710602|FG001|Overall Study|Lost to Follow-up|1|||
23264730|NCT04471207|64710601|FG000|Overall Study|Medication Contraindication|0|||
23264731|NCT04471207|64710602|FG001|Overall Study|Medication Contraindication|1|||
23264732|NCT04471207|64710601|FG000|Overall Study|Loss of Interest|2|||
23264733|NCT04471207|64710602|FG001|Overall Study|Loss of Interest|1|||
23264734|NCT04471207|64710601|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
23264735|NCT04471207|64710602|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
23264736|NCT04471207|64710601|FG000|Overall Study|Scheduling Conflicts|3|||
23264737|NCT04471207|64710602|FG001|Overall Study|Scheduling Conflicts|1|||
23264738|NCT04471207|64710601|FG000|Overall Study|Physician Decision|1|||
23264739|NCT04471207|64710602|FG001|Overall Study|Physician Decision|0|||
23264740|NCT04471207|64710601|FG000|Overall Study|Unwilling to Use System|0|||
23264741|NCT04471207|64710602|FG001|Overall Study|Unwilling to Use System|1|||
23264742|NCT01133821|64710603|FG000|Overall Study|Lost to Follow-up|8|||
23264743|NCT01133821|64710604|FG001|Overall Study|Lost to Follow-up|11|||
23264744|NCT01133821|64710603|FG000|Overall Study|Withdrawal by Subject|8|||
23264745|NCT01133821|64710604|FG001|Overall Study|Withdrawal by Subject|3|||
23264746|NCT01133821|64710603|FG000|Overall Study|preferred other treatment|1|||
23264747|NCT01133821|64710604|FG001|Overall Study|preferred other treatment|1|||
23264748|NCT01133821|64710603|FG000|Overall Study|Protocol Violation|0|||
23264749|NCT01133821|64710604|FG001|Overall Study|Protocol Violation|1|||
23264750|NCT01133821|64710603|FG000|Overall Study|Refused participation|1|||
23264751|NCT01133821|64710604|FG001|Overall Study|Refused participation|3|||
23362042|NCT00762034|65069904|FG001|Induction Period|Entry Criterion Not Met|11|||
23362043|NCT00762034|65069903|FG000|Induction Period|Adverse Event|27|||
23362044|NCT00762034|65069904|FG001|Induction Period|Adverse Event|38|||
23362045|NCT00762034|65069903|FG000|Induction Period|Lost to Follow-up|1|||
23362046|NCT00762034|65069904|FG001|Induction Period|Lost to Follow-up|1|||
23264752|NCT01957488|64710605|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
23264753|NCT01957488|64710606|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
23264754|NCT01957488|64710607|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
23264755|NCT01957488|64710608|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
23264756|NCT01957488|64710609|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
23264757|NCT01957488|64710610|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
23264758|NCT01957488|64710605|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
23362047|NCT00762034|65069903|FG000|Induction Period|Progressive Disease|73|||
23362048|NCT00762034|65069904|FG001|Induction Period|Progressive Disease|55|||
23201174|NCT01115569|64476637|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
23201175|NCT01115569|64476636|FG000|Conversion/Titration Phase|Physician Decision|5|||
23201176|NCT01115569|64476637|FG001|Conversion/Titration Phase|Physician Decision|0|||
23201177|NCT01115569|64476636|FG000|Conversion/Titration Phase|Protocol Violation|68|||
23201178|NCT01115569|64476637|FG001|Conversion/Titration Phase|Protocol Violation|0|||
23201179|NCT01115569|64476636|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
23201180|NCT01115569|64476637|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
23201181|NCT01115569|64476636|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
23201182|NCT01115569|64476637|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
23201183|NCT01115569|64476636|FG000|Maintenance Phase|Adverse Event|0|||
23201184|NCT01115569|64476637|FG001|Maintenance Phase|Adverse Event|43|||
23201185|NCT01115569|64476636|FG000|Maintenance Phase|Lost to Follow-up|0|||
23201186|NCT01115569|64476637|FG001|Maintenance Phase|Lost to Follow-up|8|||
23201187|NCT01115569|64476636|FG000|Maintenance Phase|Physician Decision|0|||
23201188|NCT01115569|64476637|FG001|Maintenance Phase|Physician Decision|3|||
23201189|NCT01115569|64476636|FG000|Maintenance Phase|Protocol Violation|0|||
23201190|NCT01115569|64476637|FG001|Maintenance Phase|Protocol Violation|9|||
23201191|NCT01115569|64476636|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23201192|NCT01115569|64476637|FG001|Maintenance Phase|Withdrawal by Subject|27|||
23201193|NCT01115569|64476636|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
23201194|NCT01115569|64476637|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
23201195|NCT01115569|64476636|FG000|Maintenance Phase|Administrative|0|||
23264759|NCT01957488|64710606|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
23264760|NCT01957488|64710607|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
23264761|NCT01957488|64710608|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
23264762|NCT01957488|64710609|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
23264763|NCT01957488|64710610|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
23264764|NCT01957488|64710605|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
23264765|NCT01957488|64710606|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
23264766|NCT01957488|64710607|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
23264767|NCT01957488|64710608|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
23264768|NCT01957488|64710609|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
23264769|NCT01957488|64710610|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
23264770|NCT01957488|64710605|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23264771|NCT01957488|64710606|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23264772|NCT01957488|64710607|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
23264773|NCT01957488|64710608|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
23264774|NCT01957488|64710609|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
23264775|NCT01957488|64710610|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
23264776|NCT01957488|64710605|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23264777|NCT01957488|64710606|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23264778|NCT01957488|64710607|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23264779|NCT01957488|64710608|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23264780|NCT01957488|64710609|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
23264781|NCT01957488|64710610|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
23264782|NCT01957488|64710605|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
23264783|NCT01957488|64710606|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
23264784|NCT01957488|64710607|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
23264785|NCT01957488|64710608|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
23264786|NCT01957488|64710609|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
23264787|NCT01957488|64710610|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
23264788|NCT01957488|64710605|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
23264789|NCT01957488|64710606|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
23264790|NCT01957488|64710607|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
23264791|NCT01957488|64710608|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
23264792|NCT01957488|64710609|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
23264793|NCT01957488|64710610|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
23264794|NCT01957488|64710605|FG000|Test Period 2 (2 Weeks)|Other|1|||
23264795|NCT01957488|64710606|FG001|Test Period 2 (2 Weeks)|Other|0|||
23264796|NCT01957488|64710607|FG002|Test Period 2 (2 Weeks)|Other|0|||
23264797|NCT01957488|64710608|FG003|Test Period 2 (2 Weeks)|Other|0|||
23264798|NCT01957488|64710609|FG004|Test Period 2 (2 Weeks)|Other|0|||
23264799|NCT01957488|64710610|FG005|Test Period 2 (2 Weeks)|Other|0|||
23264800|NCT01957488|64710605|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23264801|NCT01957488|64710606|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
23264802|NCT01957488|64710607|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23264803|NCT01957488|64710608|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23264804|NCT01957488|64710609|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23264805|NCT01957488|64710610|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
23264806|NCT01957488|64710605|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
23264807|NCT01957488|64710606|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
23264808|NCT01957488|64710607|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
23264809|NCT01957488|64710608|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
23264810|NCT01957488|64710609|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
23264811|NCT01957488|64710610|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
23264812|NCT01957488|64710605|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23264813|NCT01957488|64710606|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23264814|NCT01957488|64710607|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23264815|NCT01957488|64710608|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23264816|NCT01957488|64710609|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
23264817|NCT01957488|64710610|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
23264818|NCT01957488|64710605|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
23264819|NCT01957488|64710606|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23264820|NCT01957488|64710607|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23264821|NCT01957488|64710608|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23264822|NCT01957488|64710609|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23264823|NCT01957488|64710610|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
23264824|NCT01957488|64710605|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23264825|NCT01957488|64710606|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
23264826|NCT01957488|64710607|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23264827|NCT01957488|64710608|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23264828|NCT01957488|64710609|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23264829|NCT01957488|64710610|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
23264830|NCT00358826|64710611|FG000|Core Study|Adverse Event|1|||
23264831|NCT00358826|64710612|FG001|Core Study|Adverse Event|3|||
23264832|NCT00358826|64710613|FG002|Core Study|Adverse Event|1|||
23264833|NCT00358826|64710614|FG003|Core Study|Adverse Event|1|||
23264834|NCT00358826|64710615|FG004|Core Study|Adverse Event|0|||
23264835|NCT00358826|64710616|FG005|Core Study|Adverse Event|0|||
23264836|NCT00358826|64710617|FG006|Core Study|Adverse Event|0|||
23264837|NCT00358826|64710618|FG007|Core Study|Adverse Event|0|||
23264838|NCT00358826|64710611|FG000|Core Study|Withdrawal by Subject|2|||
23264839|NCT00358826|64710612|FG001|Core Study|Withdrawal by Subject|2|||
23264840|NCT00358826|64710613|FG002|Core Study|Withdrawal by Subject|0|||
23264841|NCT00358826|64710614|FG003|Core Study|Withdrawal by Subject|0|||
23264842|NCT00358826|64710615|FG004|Core Study|Withdrawal by Subject|0|||
23264843|NCT00358826|64710616|FG005|Core Study|Withdrawal by Subject|0|||
23264844|NCT00358826|64710617|FG006|Core Study|Withdrawal by Subject|0|||
23264845|NCT00358826|64710618|FG007|Core Study|Withdrawal by Subject|0|||
23264846|NCT00358826|64710611|FG000|Core Study|Lost to Follow-up|0|||
23264847|NCT00358826|64710612|FG001|Core Study|Lost to Follow-up|0|||
23264848|NCT00358826|64710613|FG002|Core Study|Lost to Follow-up|0|||
23264849|NCT00358826|64710614|FG003|Core Study|Lost to Follow-up|1|||
23264850|NCT00358826|64710615|FG004|Core Study|Lost to Follow-up|0|||
23264851|NCT00358826|64710616|FG005|Core Study|Lost to Follow-up|0|||
23264852|NCT00358826|64710617|FG006|Core Study|Lost to Follow-up|0|||
23264853|NCT00358826|64710618|FG007|Core Study|Lost to Follow-up|0|||
23264854|NCT00358826|64710611|FG000|Core Study|Physician Decision|0|||
23264855|NCT00358826|64710612|FG001|Core Study|Physician Decision|0|||
23264856|NCT00358826|64710613|FG002|Core Study|Physician Decision|1|||
23264857|NCT00358826|64710614|FG003|Core Study|Physician Decision|0|||
23264858|NCT00358826|64710615|FG004|Core Study|Physician Decision|0|||
23264859|NCT00358826|64710616|FG005|Core Study|Physician Decision|0|||
23264860|NCT00358826|64710617|FG006|Core Study|Physician Decision|0|||
23264861|NCT00358826|64710618|FG007|Core Study|Physician Decision|0|||
23264862|NCT00358826|64710611|FG000|MDCT Substudy|Adverse Event|0|||
23264863|NCT00358826|64710612|FG001|MDCT Substudy|Adverse Event|0|||
23264864|NCT00358826|64710613|FG002|MDCT Substudy|Adverse Event|0|||
23264865|NCT00358826|64710614|FG003|MDCT Substudy|Adverse Event|0|||
23264866|NCT00358826|64710615|FG004|MDCT Substudy|Adverse Event|1|||
23264867|NCT00358826|64710616|FG005|MDCT Substudy|Adverse Event|0|||
23264868|NCT00358826|64710617|FG006|MDCT Substudy|Adverse Event|0|||
23264869|NCT00358826|64710618|FG007|MDCT Substudy|Adverse Event|0|||
23264870|NCT00358826|64710611|FG000|MDCT Substudy|Lost to Follow-up|0|||
23264871|NCT00358826|64710612|FG001|MDCT Substudy|Lost to Follow-up|0|||
23264872|NCT00358826|64710613|FG002|MDCT Substudy|Lost to Follow-up|0|||
23264873|NCT00358826|64710614|FG003|MDCT Substudy|Lost to Follow-up|0|||
23264874|NCT00358826|64710615|FG004|MDCT Substudy|Lost to Follow-up|0|||
23264875|NCT00358826|64710616|FG005|MDCT Substudy|Lost to Follow-up|1|||
23264876|NCT00358826|64710617|FG006|MDCT Substudy|Lost to Follow-up|0|||
23264877|NCT00358826|64710618|FG007|MDCT Substudy|Lost to Follow-up|0|||
23264878|NCT00358826|64710611|FG000|MDCT Substudy|Withdrawal by Subject|0|||
23264879|NCT00358826|64710612|FG001|MDCT Substudy|Withdrawal by Subject|0|||
23264880|NCT00358826|64710613|FG002|MDCT Substudy|Withdrawal by Subject|0|||
23264881|NCT00358826|64710614|FG003|MDCT Substudy|Withdrawal by Subject|0|||
23362049|NCT00762034|65069903|FG000|Induction Period|Physician Decision|21|||
23362050|NCT00762034|65069904|FG001|Induction Period|Physician Decision|20|||
23600886|NCT02234141|65929772|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23600887|NCT02234141|65929773|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
23600888|NCT02234141|65929767|FG000|Long-Term Treatment Period|Death|0|||
23600889|NCT02234141|65929768|FG001|Long-Term Treatment Period|Death|0|||
23600890|NCT02234141|65929769|FG002|Long-Term Treatment Period|Death|0|||
23600891|NCT02234141|65929770|FG003|Long-Term Treatment Period|Death|0|||
23600892|NCT02234141|65929771|FG004|Long-Term Treatment Period|Death|0|||
23600893|NCT02234141|65929772|FG005|Long-Term Treatment Period|Death|1|||
23600894|NCT02234141|65929773|FG006|Long-Term Treatment Period|Death|0|||
23600895|NCT02234141|65929767|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
23600896|NCT02234141|65929768|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
23600897|NCT02234141|65929769|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
23600898|NCT02234141|65929770|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
23600899|NCT02234141|65929771|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
23600900|NCT02234141|65929772|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
23600901|NCT02234141|65929773|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
23264882|NCT00358826|64710615|FG004|MDCT Substudy|Withdrawal by Subject|0|||
23264883|NCT00358826|64710616|FG005|MDCT Substudy|Withdrawal by Subject|1|||
23264884|NCT00358826|64710617|FG006|MDCT Substudy|Withdrawal by Subject|0|||
23264885|NCT00358826|64710618|FG007|MDCT Substudy|Withdrawal by Subject|0|||
23264886|NCT00299156|64710619|FG000|Period 2 (Randomized)|Screen Failure|0|||
23264887|NCT00299156|64710620|FG001|Period 2 (Randomized)|Screen Failure|1|||
23264888|NCT00299156|64710621|FG002|Period 2 (Randomized)|Screen Failure|0|||
23264889|NCT00819247|64710622|FG000|Overall Study|Adverse Event|0|||
23362051|NCT00762034|65069903|FG000|Induction Period|Withdrawal by Subject|15|||
23362052|NCT00762034|65069904|FG001|Induction Period|Withdrawal by Subject|19|||
23362053|NCT00762034|65069903|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
23362054|NCT00762034|65069904|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
23362055|NCT00762034|65069903|FG000|Induction Period|Deaths Due to Study Disease|9|||
23362056|NCT00762034|65069904|FG001|Induction Period|Deaths Due to Study Disease|9|||
23362057|NCT00762034|65069903|FG000|Maintenance Period|Protocol Violation|1|||
23362058|NCT00762034|65069904|FG001|Maintenance Period|Protocol Violation|3|||
23362059|NCT00762034|65069903|FG000|Maintenance Period|Entry Criterion Not Met|0|||
23362060|NCT00762034|65069904|FG001|Maintenance Period|Entry Criterion Not Met|2|||
23362061|NCT00762034|65069903|FG000|Maintenance Period|Adverse Event|42|||
23362062|NCT00762034|65069904|FG001|Maintenance Period|Adverse Event|26|||
23362063|NCT00762034|65069903|FG000|Maintenance Period|Progressive Disease|186|||
23362064|NCT00762034|65069904|FG001|Maintenance Period|Progressive Disease|224|||
23362065|NCT00762034|65069903|FG000|Maintenance Period|Physician Decision|25|||
23362066|NCT00762034|65069904|FG001|Maintenance Period|Physician Decision|20|||
23362067|NCT00762034|65069903|FG000|Maintenance Period|Withdrawal by Subject|34|||
23362068|NCT00762034|65069904|FG001|Maintenance Period|Withdrawal by Subject|14|||
23362069|NCT00762034|65069903|FG000|Maintenance Period|Death not due to study disease|2|||
23362070|NCT00762034|65069904|FG001|Maintenance Period|Death not due to study disease|5|||
23362071|NCT00762034|65069903|FG000|Maintenance Period|Death due to study disease|3|||
23362072|NCT00762034|65069904|FG001|Maintenance Period|Death due to study disease|3|||
23362073|NCT00762034|65069903|FG000|Maintenance Period|Other|1|||
23362074|NCT00762034|65069904|FG001|Maintenance Period|Other|1|||
23362075|NCT00707980|65069906|FG000|Overall Study|Adverse Event|49|||
23362076|NCT00707980|65069906|FG000|Overall Study|Lack of Efficacy|35|||
23362077|NCT00707980|65069906|FG000|Overall Study|Non-Compliance with Study Drug|28|||
23362078|NCT00707980|65069906|FG000|Overall Study|Protocol Deviations|19|||
23362079|NCT00707980|65069906|FG000|Overall Study|Withdrawal of Consent|81|||
23362080|NCT00707980|65069906|FG000|Overall Study|Lost to Follow-up|59|||
23264890|NCT00819247|64710623|FG001|Overall Study|Adverse Event|5|||
23264891|NCT00819247|64710624|FG002|Overall Study|Adverse Event|3|||
23264892|NCT00819247|64710622|FG000|Overall Study|Insufficient testosterone response|5|||
23264893|NCT00819247|64710623|FG001|Overall Study|Insufficient testosterone response|8|||
23264894|NCT00819247|64710624|FG002|Overall Study|Insufficient testosterone response|10|||
23264895|NCT00819247|64710622|FG000|Overall Study|Withdrawal by Subject|1|||
23264896|NCT00819247|64710623|FG001|Overall Study|Withdrawal by Subject|0|||
23264897|NCT00819247|64710624|FG002|Overall Study|Withdrawal by Subject|0|||
23264898|NCT00819247|64710622|FG000|Overall Study|Protocol Violation|1|||
23264899|NCT00819247|64710623|FG001|Overall Study|Protocol Violation|0|||
23264900|NCT00819247|64710624|FG002|Overall Study|Protocol Violation|1|||
23264901|NCT00819247|64710622|FG000|Overall Study|Mistakenly withdrawn|0|||
23264902|NCT00819247|64710623|FG001|Overall Study|Mistakenly withdrawn|1|||
23264903|NCT00819247|64710624|FG002|Overall Study|Mistakenly withdrawn|0|||
23264904|NCT00819247|64710622|FG000|Overall Study|Bad prostate-specific antigen response|3|||
23264905|NCT00819247|64710623|FG001|Overall Study|Bad prostate-specific antigen response|2|||
23264906|NCT00819247|64710624|FG002|Overall Study|Bad prostate-specific antigen response|0|||
23264907|NCT00819247|64710622|FG000|Overall Study|Other|1|||
23264908|NCT00819247|64710623|FG001|Overall Study|Other|0|||
23264909|NCT00819247|64710624|FG002|Overall Study|Other|0|||
23362081|NCT00707980|65069906|FG000|Overall Study|Other|39|||
23362082|NCT00549549|65069907|FG000|Overall Study|Adverse Event|5|||
23362083|NCT00549549|65069908|FG001|Overall Study|Adverse Event|3|||
23362084|NCT00549549|65069909|FG002|Overall Study|Adverse Event|1|||
23362085|NCT00549549|65069910|FG003|Overall Study|Adverse Event|9|||
23362086|NCT00549549|65069907|FG000|Overall Study|Lack of Efficacy|9|||
23264910|NCT04480463|64710627|FG000|Overall Study|Death|0|||
23264911|NCT04480463|64710628|FG001|Overall Study|Death|1|||
23264912|NCT04480463|64710627|FG000|Overall Study|Adverse Event|6|||
23264913|NCT04480463|64710628|FG001|Overall Study|Adverse Event|8|||
23264914|NCT04480463|64710627|FG000|Overall Study|Lost to Follow-up|3|||
23264915|NCT04480463|64710628|FG001|Overall Study|Lost to Follow-up|2|||
23264916|NCT04480463|64710627|FG000|Overall Study|Physician Decision|2|||
23264917|NCT04480463|64710628|FG001|Overall Study|Physician Decision|5|||
23264918|NCT04480463|64710627|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
23264919|NCT04480463|64710628|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
23264920|NCT04480463|64710627|FG000|Overall Study|Protocol Violation|2|||
23264921|NCT04480463|64710628|FG001|Overall Study|Protocol Violation|1|||
23264922|NCT04480463|64710627|FG000|Overall Study|Withdrawal by Subject|6|||
23264923|NCT04480463|64710628|FG001|Overall Study|Withdrawal by Subject|7|||
23264924|NCT04480463|64710627|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
23264925|NCT04480463|64710628|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
23264926|NCT04480463|64710627|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
23362087|NCT00549549|65069908|FG001|Overall Study|Lack of Efficacy|6|||
23362088|NCT00549549|65069909|FG002|Overall Study|Lack of Efficacy|4|||
23362089|NCT00549549|65069910|FG003|Overall Study|Lack of Efficacy|2|||
23362090|NCT00549549|65069907|FG000|Overall Study|Lost to Follow-up|1|||
23362091|NCT00549549|65069908|FG001|Overall Study|Lost to Follow-up|0|||
23362092|NCT00549549|65069909|FG002|Overall Study|Lost to Follow-up|1|||
23264927|NCT04480463|64710628|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
23264928|NCT04480463|64710627|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
23264929|NCT04480463|64710628|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
23264930|NCT04480463|64710627|FG000|Overall Study|Other|6|||
23264931|NCT04480463|64710628|FG001|Overall Study|Other|4|||
23264932|NCT02153398|64710629|FG000|Overall Study|Withdrawal by Subject|1|||
23362093|NCT00549549|65069910|FG003|Overall Study|Lost to Follow-up|2|||
23362094|NCT00549549|65069907|FG000|Overall Study|Withdrawal by Subject|0|||
23362095|NCT00549549|65069908|FG001|Overall Study|Withdrawal by Subject|4|||
23362096|NCT00549549|65069909|FG002|Overall Study|Withdrawal by Subject|1|||
23362097|NCT00549549|65069910|FG003|Overall Study|Withdrawal by Subject|0|||
23362098|NCT00549549|65069907|FG000|Overall Study|Other|9|||
23362099|NCT00549549|65069908|FG001|Overall Study|Other|9|||
23362100|NCT00549549|65069909|FG002|Overall Study|Other|9|||
23362101|NCT00549549|65069910|FG003|Overall Study|Other|11|||
23362102|NCT00549549|65069907|FG000|Overall Study|Randomized but not treated|0|||
23362103|NCT00549549|65069908|FG001|Overall Study|Randomized but not treated|0|||
23362104|NCT00549549|65069909|FG002|Overall Study|Randomized but not treated|1|||
23362105|NCT00549549|65069910|FG003|Overall Study|Randomized but not treated|1|||
23362106|NCT00807612|65069913|FG000|Overall Study|Death|8|||
23362107|NCT00807612|65069913|FG000|Overall Study|Study early termination|5|||
23362108|NCT00807612|65069913|FG000|Overall Study|Withdrawal by Subject|1|||
23362109|NCT02019550|65069915|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23362110|NCT02019550|65069916|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
23362111|NCT01473940|65069917|FG000|Induction Therapy|Death|0|||
23362112|NCT01473940|65069918|FG001|Induction Therapy|Death|0|||
23362113|NCT01473940|65069919|FG002|Induction Therapy|Death|1|||
23362114|NCT01473940|65069920|FG003|Induction Therapy|Death|1|||
23362115|NCT01473940|65069917|FG000|Induction Therapy|Progressive Disease|0|||
23362116|NCT01473940|65069918|FG001|Induction Therapy|Progressive Disease|1|||
23362117|NCT01473940|65069919|FG002|Induction Therapy|Progressive Disease|1|||
23362118|NCT01473940|65069920|FG003|Induction Therapy|Progressive Disease|0|||
23362119|NCT01473940|65069917|FG000|Maintenance Therapy|Progressive Disease|1|||
23362120|NCT01473940|65069918|FG001|Maintenance Therapy|Progressive Disease|2|||
23362121|NCT01473940|65069919|FG002|Maintenance Therapy|Progressive Disease|1|||
23362122|NCT01473940|65069920|FG003|Maintenance Therapy|Progressive Disease|4|||
23362123|NCT02256839|65072726|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
23362124|NCT02256839|65072727|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
23362125|NCT01951417|65072728|FG000|Overall Study|Withdrawal by Subject|1|||
23362126|NCT01951417|65072728|FG000|Overall Study|Protocol Violation|2|||
23362127|NCT01951417|65072728|FG000|Overall Study|Lost to Follow-up|6|||
23362128|NCT02143024|65072733|FG000|Overall Study|Lost to Follow-up|1|||
23362129|NCT02143024|65072734|FG001|Overall Study|Lost to Follow-up|1|||
23362130|NCT02143024|65072733|FG000|Overall Study|Withdrawal by Subject|1|||
23362131|NCT02143024|65072734|FG001|Overall Study|Withdrawal by Subject|0|||
23362132|NCT02317991|65072736|FG000|Overall Study|Adverse Event|12|||
23362133|NCT02317991|65072736|FG000|Overall Study|Death|4|||
23362134|NCT02317991|65072736|FG000|Overall Study|Withdrawal by Subject|8|||
23362135|NCT02317991|65072736|FG000|Overall Study|Progressive Disease|41|||
23362136|NCT00482170|65072737|FG000|Overall Study|Adverse Event|5|||
23362137|NCT00482170|65072738|FG001|Overall Study|Adverse Event|14|||
23362138|NCT00482170|65072737|FG000|Overall Study|Withdrawal by Subject|6|||
23362139|NCT00482170|65072738|FG001|Overall Study|Withdrawal by Subject|1|||
23362140|NCT00482170|65072737|FG000|Overall Study|Protocol Violation|2|||
23362141|NCT00482170|65072738|FG001|Overall Study|Protocol Violation|3|||
23362142|NCT00482170|65072737|FG000|Overall Study|Lost to Follow-up|2|||
23362143|NCT00482170|65072738|FG001|Overall Study|Lost to Follow-up|0|||
23362144|NCT00482170|65072737|FG000|Overall Study|Unspecified reason|0|||
23362145|NCT00482170|65072738|FG001|Overall Study|Unspecified reason|2|||
23362146|NCT01051817|65072739|FG000|Overall Study|Adverse Event|0|||
23362147|NCT01051817|65072740|FG001|Overall Study|Adverse Event|2|||
23362148|NCT01051817|65072739|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
23362149|NCT01051817|65072740|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
23362150|NCT01051817|65072739|FG000|Overall Study|Withdrawal by Subject|3|||
23362151|NCT01051817|65072740|FG001|Overall Study|Withdrawal by Subject|5|||
23362152|NCT01051817|65072739|FG000|Overall Study|Protocol Violation|0|||
23362153|NCT01051817|65072740|FG001|Overall Study|Protocol Violation|1|||
23362154|NCT00227539|65072742|FG000|Overall Study|Protocol Violation|1|||
23362155|NCT03421379|65072743|FG000|Period 1|Withdrawal by Subject|0|||
23362156|NCT03421379|65072744|FG001|Period 1|Withdrawal by Subject|1|||
23362157|NCT03421379|65072743|FG000|Period 1|Physician Decision|1|||
23362158|NCT03421379|65072744|FG001|Period 1|Physician Decision|1|||
23264933|NCT02153398|64710630|FG001|Overall Study|Withdrawal by Subject|0|||
23264934|NCT02153398|64710631|FG002|Overall Study|Withdrawal by Subject|0|||
23264935|NCT02153398|64710632|FG003|Overall Study|Withdrawal by Subject|0|||
23264936|NCT02153398|64710633|FG004|Overall Study|Withdrawal by Subject|0|||
23264937|NCT02153398|64710629|FG000|Overall Study|Adverse Event|0|||
23264938|NCT02153398|64710630|FG001|Overall Study|Adverse Event|0|||
23264939|NCT02153398|64710631|FG002|Overall Study|Adverse Event|1|||
23264940|NCT02153398|64710632|FG003|Overall Study|Adverse Event|1|||
23264941|NCT02153398|64710633|FG004|Overall Study|Adverse Event|0|||
23264942|NCT02187042|64710634|FG000|Overall Study|Death|1|||
23264943|NCT02187042|64710635|FG001|Overall Study|Death|1|||
23264944|NCT02187042|64710634|FG000|Overall Study|Toxicity|6|||
23264945|NCT02187042|64710635|FG001|Overall Study|Toxicity|5|||
23264946|NCT02187042|64710634|FG000|Overall Study|Participant choice|1|||
23264947|NCT02187042|64710635|FG001|Overall Study|Participant choice|0|||
23264948|NCT02187042|64710634|FG000|Overall Study|Doctor choice|1|||
23264949|NCT02187042|64710635|FG001|Overall Study|Doctor choice|0|||
23264950|NCT02187042|64710634|FG000|Overall Study|Progressive disease|4|||
23264951|NCT02187042|64710635|FG001|Overall Study|Progressive disease|8|||
23264952|NCT01046253|64710636|FG000|Second Intervention|Adverse Event|0|||
23264953|NCT01046253|64710637|FG001|Second Intervention|Adverse Event|1|||
23264954|NCT01046253|64710636|FG000|Second Intervention|Protocol Violation|0|||
23264955|NCT01046253|64710637|FG001|Second Intervention|Protocol Violation|1|||
23264956|NCT03504852|64710644|FG000|Overall Study|Withdrawal of informed consent|2|||
23264957|NCT03504852|64710645|FG001|Overall Study|Withdrawal of informed consent|1|||
23264958|NCT03504852|64710646|FG002|Overall Study|Withdrawal of informed consent|0|||
23264959|NCT03504852|64710644|FG000|Overall Study|Withdrawal by Subject|5|||
23264960|NCT03504852|64710645|FG001|Overall Study|Withdrawal by Subject|5|||
23264961|NCT03504852|64710646|FG002|Overall Study|Withdrawal by Subject|1|||
23264962|NCT03504852|64710644|FG000|Overall Study|Lost to Follow-up|4|||
23264963|NCT03504852|64710645|FG001|Overall Study|Lost to Follow-up|1|||
23264964|NCT03504852|64710646|FG002|Overall Study|Lost to Follow-up|0|||
23264965|NCT03504852|64710644|FG000|Overall Study|New therapy for study indication|1|||
23264966|NCT03504852|64710645|FG001|Overall Study|New therapy for study indication|0|||
23264967|NCT03504852|64710646|FG002|Overall Study|New therapy for study indication|0|||
23264968|NCT03504852|64710644|FG000|Overall Study|Lack of Efficacy|1|||
23264969|NCT03504852|64710645|FG001|Overall Study|Lack of Efficacy|2|||
23264970|NCT03504852|64710646|FG002|Overall Study|Lack of Efficacy|0|||
23264971|NCT03504852|64710644|FG000|Overall Study|Death|0|||
23264972|NCT03504852|64710645|FG001|Overall Study|Death|1|||
23264973|NCT03504852|64710646|FG002|Overall Study|Death|0|||
23264974|NCT03504852|64710644|FG000|Overall Study|Adverse Event|4|||
23264975|NCT03504852|64710645|FG001|Overall Study|Adverse Event|8|||
23362159|NCT03421379|65072743|FG000|Period 1|Did not receive treatment|1|||
23362160|NCT03421379|65072744|FG001|Period 1|Did not receive treatment|2|||
23362161|NCT01302418|65072749|FG000|Overall Study|Protocol Violation|9|||
23362162|NCT01302418|65072749|FG000|Overall Study|Non-evaluable|9|||
23362163|NCT01419535|65072755|FG000|Overall Study|could not maintain iv line|1|||
23362164|NCT01419535|65072756|FG001|Overall Study|could not maintain iv line|1|||
23362165|NCT01419535|65072755|FG000|Overall Study|Withdrawal by Subject|0|||
23201196|NCT01115569|64476637|FG001|Maintenance Phase|Administrative|1|||
23264976|NCT03504852|64710646|FG002|Overall Study|Adverse Event|2|||
23264977|NCT01485536|64710647|FG000|Overall Study|Withdrawal by Subject|3|||
23264978|NCT01485536|64710647|FG000|Overall Study|Adverse Event|1|||
23264979|NCT00680121|64710648|FG000|Overall Study|Lost to Follow-up|27|||
23264980|NCT00680121|64710649|FG001|Overall Study|Lost to Follow-up|23|||
23264981|NCT01808209|64710650|FG000|Overall Study|Lost to Follow-up|0|||
23264982|NCT01808209|64710651|FG001|Overall Study|Lost to Follow-up|1|||
23264983|NCT00536575|64710652|FG000|Overall Study|Withdrawal by Subject|1|||
23362166|NCT01419535|65072756|FG001|Overall Study|Withdrawal by Subject|1|||
23362167|NCT00766597|65072759|FG000|Overall Study|Unexpected closure of study|4|||
23264984|NCT00536575|64710652|FG000|Overall Study|Death|1|||
23264985|NCT00586521|64710655|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
23264986|NCT00929708|64710658|FG000|Overall Study|Protocol Violation|2|||
23264987|NCT00929708|64710659|FG001|Overall Study|Protocol Violation|1|||
23362168|NCT00766597|65072759|FG000|Overall Study|Without CCR5-tropic virus|5|||
23362169|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
23362170|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
23362171|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
23362172|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Adverse Event|2|||
23362173|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Adverse Event|0|||
23362174|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Adverse Event|1|||
23362175|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
23362176|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
23362177|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
23362178|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
23362179|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
23362180|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
23362181|NCT04613518|65072764|FG000|Double-Blind Treatment Period|Other Reasons|2|||
23362182|NCT04613518|65072765|FG001|Double-Blind Treatment Period|Other Reasons|0|||
23362183|NCT04613518|65072766|FG002|Double-Blind Treatment Period|Other Reasons|0|||
23362184|NCT04613518|65072764|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
23362185|NCT04613518|65072765|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
23362186|NCT04613518|65072766|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
23362187|NCT04613518|65072764|FG000|Open-Label Treatment Period|Adverse Event|1|||
23362188|NCT04613518|65072765|FG001|Open-Label Treatment Period|Adverse Event|0|||
23362189|NCT04613518|65072766|FG002|Open-Label Treatment Period|Adverse Event|3|||
23362190|NCT04613518|65072764|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
23362191|NCT04613518|65072765|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
23362192|NCT04613518|65072766|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
23362193|NCT04613518|65072764|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
23362194|NCT04613518|65072765|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
23362195|NCT04613518|65072766|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
23362196|NCT04613518|65072764|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
23362197|NCT04613518|65072765|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
23362198|NCT04613518|65072766|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
23362199|NCT04613518|65072764|FG000|Open-Label Treatment Period|Other reasons|1|||
23362200|NCT04613518|65072765|FG001|Open-Label Treatment Period|Other reasons|0|||
23362201|NCT04613518|65072766|FG002|Open-Label Treatment Period|Other reasons|0|||
23362202|NCT00588146|65072767|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
23362203|NCT00588146|65072768|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
23362204|NCT01212094|65072769|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
23362205|NCT01212094|65072770|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
23362206|NCT01212094|65072771|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
23362207|NCT01212094|65072769|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
23362208|NCT01212094|65072770|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
23362209|NCT01212094|65072771|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
23362210|NCT01212094|65072769|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
23362211|NCT01212094|65072770|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
23362212|NCT01212094|65072771|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
23600902|NCT02234141|65929767|FG000|Long-Term Treatment Period|Adverse Event|4|||
23600903|NCT02234141|65929768|FG001|Long-Term Treatment Period|Adverse Event|0|||
23600904|NCT02234141|65929769|FG002|Long-Term Treatment Period|Adverse Event|5|||
23600905|NCT02234141|65929770|FG003|Long-Term Treatment Period|Adverse Event|0|||
23600906|NCT02234141|65929771|FG004|Long-Term Treatment Period|Adverse Event|1|||
23600907|NCT02234141|65929772|FG005|Long-Term Treatment Period|Adverse Event|1|||
23600908|NCT02234141|65929773|FG006|Long-Term Treatment Period|Adverse Event|1|||
23600909|NCT02234141|65929767|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
23264988|NCT00929708|64710660|FG002|Overall Study|Protocol Violation|1|||
23264989|NCT00929708|64710661|FG003|Overall Study|Protocol Violation|1|||
23264990|NCT00929708|64710662|FG004|Overall Study|Protocol Violation|1|||
23264991|NCT00929708|64710658|FG000|Overall Study|Withdrawal by Subject|2|||
23264992|NCT00929708|64710659|FG001|Overall Study|Withdrawal by Subject|0|||
23600910|NCT02234141|65929768|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
23600911|NCT02234141|65929769|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
23600912|NCT02234141|65929770|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
23600913|NCT02234141|65929771|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
23600914|NCT02234141|65929772|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
23600915|NCT02234141|65929773|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
23600916|NCT02234141|65929767|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
23600917|NCT02234141|65929768|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
23264993|NCT00929708|64710660|FG002|Overall Study|Withdrawal by Subject|0|||
23480565|NCT00998764|65502022|FG000|Overall Study|Withdrawal by Subject|19|||
23600918|NCT02234141|65929769|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
23600919|NCT02234141|65929770|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
23264994|NCT00929708|64710661|FG003|Overall Study|Withdrawal by Subject|2|||
23362213|NCT01212094|65072769|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
23362214|NCT01212094|65072770|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
23362215|NCT01212094|65072771|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
23362216|NCT01212094|65072769|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
23362217|NCT01212094|65072770|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
23362218|NCT01212094|65072771|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
23362219|NCT01212094|65072769|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
23362220|NCT01212094|65072770|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
23264995|NCT00929708|64710662|FG004|Overall Study|Withdrawal by Subject|1|||
23264996|NCT00929708|64710658|FG000|Overall Study|Adverse Event|0|||
23264997|NCT00929708|64710659|FG001|Overall Study|Adverse Event|0|||
23264998|NCT00929708|64710660|FG002|Overall Study|Adverse Event|0|||
23264999|NCT00929708|64710661|FG003|Overall Study|Adverse Event|0|||
23265000|NCT00929708|64710662|FG004|Overall Study|Adverse Event|3|||
23265001|NCT00929708|64710658|FG000|Overall Study|Physician Decision|0|||
23265002|NCT00929708|64710659|FG001|Overall Study|Physician Decision|2|||
23265003|NCT00929708|64710660|FG002|Overall Study|Physician Decision|2|||
23265004|NCT00929708|64710661|FG003|Overall Study|Physician Decision|2|||
23265005|NCT00929708|64710662|FG004|Overall Study|Physician Decision|1|||
23265006|NCT00929708|64710658|FG000|Overall Study|Lost to Follow-up|0|||
23362221|NCT01212094|65072771|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
23362222|NCT01971567|65072779|FG000|Overall Study|Withdrawal by Subject|3|||
23362223|NCT01971567|65072780|FG001|Overall Study|Withdrawal by Subject|2|||
23362224|NCT01971567|65072779|FG000|Overall Study|Lost to Follow-up|1|||
23362225|NCT01971567|65072780|FG001|Overall Study|Lost to Follow-up|0|||
23362226|NCT02710084|65072781|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
23362227|NCT02710084|65072782|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
23362228|NCT00485069|65072784|FG000|Overall Study|Adverse Event|10|||
23362229|NCT00485069|65072785|FG001|Overall Study|Adverse Event|4|||
23362230|NCT00485069|65072784|FG000|Overall Study|Lack of Efficacy|2|||
23362231|NCT00485069|65072785|FG001|Overall Study|Lack of Efficacy|1|||
23362232|NCT00485069|65072784|FG000|Overall Study|Protocol Violation|0|||
23362233|NCT00485069|65072785|FG001|Overall Study|Protocol Violation|1|||
23362234|NCT00485069|65072784|FG000|Overall Study|Withdrawal by Subject|6|||
23362235|NCT00485069|65072785|FG001|Overall Study|Withdrawal by Subject|6|||
23362236|NCT00169104|65072786|FG000|Overall Study|Withdrawal by Subject|2|||
23362237|NCT00169104|65072787|FG001|Overall Study|Withdrawal by Subject|0|||
23362238|NCT00169104|65072786|FG000|Overall Study|Protocol Violation|0|||
23362239|NCT00169104|65072787|FG001|Overall Study|Protocol Violation|1|||
23362240|NCT00169104|65072786|FG000|Overall Study|Physician Decision|0|||
23362241|NCT00169104|65072787|FG001|Overall Study|Physician Decision|1|||
23362242|NCT02250300|65072788|FG000|Expansion Phase|Death|6|||
23362243|NCT02250300|65072789|FG001|Expansion Phase|Death|7|||
23362244|NCT02250300|65072790|FG002|Expansion Phase|Death|0|||
23362245|NCT02250300|65072791|FG003|Expansion Phase|Death|0|||
23362246|NCT02959918|65072792|FG000|Overall Study|Adverse Event|1|||
23362247|NCT02959918|65072793|FG001|Overall Study|Adverse Event|1|||
23362248|NCT02959918|65072794|FG002|Overall Study|Adverse Event|2|||
23362249|NCT02959918|65072795|FG003|Overall Study|Adverse Event|0|||
23362250|NCT02959918|65072796|FG004|Overall Study|Adverse Event|0|||
23362251|NCT02959918|65072797|FG005|Overall Study|Adverse Event|2|||
23362252|NCT02959918|65072798|FG006|Overall Study|Adverse Event|2|||
23362253|NCT02959918|65072799|FG007|Overall Study|Adverse Event|1|||
23362254|NCT02959918|65072800|FG008|Overall Study|Adverse Event|2|||
23362255|NCT02959918|65072801|FG009|Overall Study|Adverse Event|1|||
23362256|NCT02959918|65072802|FG010|Overall Study|Adverse Event|1|||
23362257|NCT02959918|65072803|FG011|Overall Study|Adverse Event|3|||
23362258|NCT02959918|65072804|FG012|Overall Study|Adverse Event|2|||
23362259|NCT02959918|65072805|FG013|Overall Study|Adverse Event|4|||
23600920|NCT02234141|65929771|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
23600921|NCT02234141|65929772|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
23600922|NCT02234141|65929773|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
23600923|NCT00463229|65929774|FG000|Overall Study|Lost to Follow-up|5|||
23600924|NCT00463229|65929775|FG001|Overall Study|Lost to Follow-up|7|||
23600925|NCT00463229|65929774|FG000|Overall Study|Death|4|||
23600926|NCT00463229|65929775|FG001|Overall Study|Death|3|||
23600927|NCT00109031|65929776|FG000|Overall Study|Adverse Event|0|||
23265007|NCT00929708|64710659|FG001|Overall Study|Lost to Follow-up|0|||
23600928|NCT00109031|65929777|FG001|Overall Study|Adverse Event|0|||
23362260|NCT02959918|65072792|FG000|Overall Study|Lost to Follow-up|0|||
23600929|NCT00109031|65929778|FG002|Overall Study|Adverse Event|1|||
23600930|NCT00109031|65929779|FG003|Overall Study|Adverse Event|0|||
23600931|NCT00109031|65929776|FG000|Overall Study|Withdrawal by Subject|0|||
23265008|NCT00929708|64710660|FG002|Overall Study|Lost to Follow-up|0|||
23265009|NCT00929708|64710661|FG003|Overall Study|Lost to Follow-up|1|||
23265010|NCT00929708|64710662|FG004|Overall Study|Lost to Follow-up|0|||
23362261|NCT02959918|65072793|FG001|Overall Study|Lost to Follow-up|0|||
23265011|NCT00721409|64710665|FG000|Overall Study|Global deterioration of health status|2|||
23265012|NCT00721409|64710666|FG001|Overall Study|Global deterioration of health status|6|||
23600932|NCT00109031|65929777|FG001|Overall Study|Withdrawal by Subject|1|||
23600933|NCT00109031|65929778|FG002|Overall Study|Withdrawal by Subject|0|||
23600934|NCT00109031|65929779|FG003|Overall Study|Withdrawal by Subject|0|||
23600935|NCT00109031|65929776|FG000|Overall Study|Physician Decision|0|||
23265013|NCT00721409|64710667|FG002|Overall Study|Global deterioration of health status|3|||
23265014|NCT00721409|64710665|FG000|Overall Study|Death|0|||
23265015|NCT00721409|64710666|FG001|Overall Study|Death|1|||
23265016|NCT00721409|64710667|FG002|Overall Study|Death|0|||
23265017|NCT00721409|64710665|FG000|Overall Study|Randomized not Treated|0|||
23265018|NCT00721409|64710666|FG001|Overall Study|Randomized not Treated|1|||
23265019|NCT00721409|64710667|FG002|Overall Study|Randomized not Treated|4|||
23265020|NCT00721409|64710665|FG000|Overall Study|Reason not specified|1|||
23265021|NCT00721409|64710666|FG001|Overall Study|Reason not specified|0|||
23265022|NCT00721409|64710667|FG002|Overall Study|Reason not specified|2|||
23265023|NCT00721409|64710665|FG000|Overall Study|Adverse Event|0|||
23265024|NCT00721409|64710666|FG001|Overall Study|Adverse Event|13|||
23265025|NCT00721409|64710667|FG002|Overall Study|Adverse Event|2|||
23265026|NCT00721409|64710665|FG000|Overall Study|Lost to Follow-up|0|||
23265027|NCT00721409|64710666|FG001|Overall Study|Lost to Follow-up|0|||
23265028|NCT00721409|64710667|FG002|Overall Study|Lost to Follow-up|1|||
23265029|NCT00721409|64710665|FG000|Overall Study|Withdrawal by Subject|1|||
23265030|NCT00721409|64710666|FG001|Overall Study|Withdrawal by Subject|6|||
23265031|NCT00721409|64710667|FG002|Overall Study|Withdrawal by Subject|5|||
23265032|NCT00721409|64710665|FG000|Overall Study|Objective progression or relapse|8|||
23265033|NCT00721409|64710666|FG001|Overall Study|Objective progression or relapse|55|||
23265034|NCT00721409|64710667|FG002|Overall Study|Objective progression or relapse|62|||
23265035|NCT02729896|64710668|FG000|Overall Study|Death|0|||
23265036|NCT02729896|64710669|FG001|Overall Study|Death|2|||
23265037|NCT02729896|64710670|FG002|Overall Study|Death|13|||
23265038|NCT02729896|64710668|FG000|Overall Study|Lost to Follow-up|0|||
23265039|NCT02729896|64710669|FG001|Overall Study|Lost to Follow-up|2|||
23265040|NCT02729896|64710670|FG002|Overall Study|Lost to Follow-up|3|||
23265041|NCT02729896|64710668|FG000|Overall Study|Other|0|||
23265042|NCT02729896|64710669|FG001|Overall Study|Other|2|||
23265043|NCT02729896|64710670|FG002|Overall Study|Other|0|||
23265044|NCT02729896|64710668|FG000|Overall Study|Physician Decision|1|||
23265045|NCT02729896|64710669|FG001|Overall Study|Physician Decision|2|||
23265046|NCT02729896|64710670|FG002|Overall Study|Physician Decision|3|||
23265047|NCT02729896|64710668|FG000|Overall Study|Progressive Disease|0|||
23265048|NCT02729896|64710669|FG001|Overall Study|Progressive Disease|1|||
23265049|NCT02729896|64710670|FG002|Overall Study|Progressive Disease|0|||
23265050|NCT02729896|64710668|FG000|Overall Study|Withdrawal by Subject|1|||
23265051|NCT02729896|64710669|FG001|Overall Study|Withdrawal by Subject|0|||
23265052|NCT02729896|64710670|FG002|Overall Study|Withdrawal by Subject|3|||
23265053|NCT01644890|64710682|FG000|Overall Study|Adverse Event|7|||
23265054|NCT01644890|64710683|FG001|Overall Study|Adverse Event|20|||
23362262|NCT02959918|65072794|FG002|Overall Study|Lost to Follow-up|0|||
23600936|NCT00109031|65929777|FG001|Overall Study|Physician Decision|1|||
23600937|NCT00109031|65929778|FG002|Overall Study|Physician Decision|0|||
23600938|NCT00109031|65929779|FG003|Overall Study|Physician Decision|0|||
23600939|NCT00109031|65929776|FG000|Overall Study|Protocol Violation|0|||
23600940|NCT00109031|65929777|FG001|Overall Study|Protocol Violation|0|||
23600941|NCT00109031|65929778|FG002|Overall Study|Protocol Violation|1|||
23600942|NCT00109031|65929779|FG003|Overall Study|Protocol Violation|0|||
23600943|NCT03547167|65929780|FG000|Overall Study|Withdrawal by Subject|34|||
23600944|NCT03547167|65929781|FG001|Overall Study|Withdrawal by Subject|12|||
23600945|NCT03547167|65929780|FG000|Overall Study|Screen Failure|0|||
23600946|NCT03547167|65929781|FG001|Overall Study|Screen Failure|1|||
23600947|NCT03547167|65929780|FG000|Overall Study|Lost to Follow-up|59|||
23600948|NCT03547167|65929781|FG001|Overall Study|Lost to Follow-up|15|||
23600949|NCT03547167|65929780|FG000|Overall Study|Death|4|||
23600950|NCT03547167|65929781|FG001|Overall Study|Death|2|||
23600951|NCT01673594|65929790|FG000|Overall Study|Adverse Event|3|||
23600952|NCT01673594|65929791|FG001|Overall Study|Adverse Event|1|||
23362263|NCT02959918|65072795|FG003|Overall Study|Lost to Follow-up|0|||
23600953|NCT01673594|65929790|FG000|Overall Study|Lost to Follow-up|1|||
23600954|NCT01673594|65929791|FG001|Overall Study|Lost to Follow-up|0|||
23600955|NCT01673594|65929790|FG000|Overall Study|Physician Decision|2|||
23265055|NCT01644890|64710682|FG000|Overall Study|Death|1|||
23265056|NCT01644890|64710683|FG001|Overall Study|Death|3|||
23265057|NCT01644890|64710682|FG000|Overall Study|Physician Decision|3|||
23265058|NCT01644890|64710683|FG001|Overall Study|Physician Decision|9|||
23362264|NCT02959918|65072796|FG004|Overall Study|Lost to Follow-up|0|||
23265059|NCT01644890|64710682|FG000|Overall Study|Protocol Violation|6|||
23265060|NCT01644890|64710683|FG001|Overall Study|Protocol Violation|7|||
23265061|NCT01644890|64710682|FG000|Overall Study|Withdrawal by Subject|19|||
23265062|NCT01644890|64710683|FG001|Overall Study|Withdrawal by Subject|27|||
23362265|NCT02959918|65072797|FG005|Overall Study|Lost to Follow-up|0|||
23362266|NCT02959918|65072798|FG006|Overall Study|Lost to Follow-up|0|||
23362267|NCT02959918|65072799|FG007|Overall Study|Lost to Follow-up|0|||
23362268|NCT02959918|65072800|FG008|Overall Study|Lost to Follow-up|0|||
23362269|NCT02959918|65072801|FG009|Overall Study|Lost to Follow-up|1|||
23362270|NCT02959918|65072802|FG010|Overall Study|Lost to Follow-up|0|||
23362271|NCT02959918|65072803|FG011|Overall Study|Lost to Follow-up|0|||
23362272|NCT02959918|65072804|FG012|Overall Study|Lost to Follow-up|1|||
23362273|NCT02959918|65072805|FG013|Overall Study|Lost to Follow-up|0|||
23362274|NCT02959918|65072792|FG000|Overall Study|Withdrawal by Subject|0|||
23362275|NCT02959918|65072793|FG001|Overall Study|Withdrawal by Subject|0|||
23362276|NCT02959918|65072794|FG002|Overall Study|Withdrawal by Subject|1|||
23362277|NCT02959918|65072795|FG003|Overall Study|Withdrawal by Subject|2|||
23362278|NCT02959918|65072796|FG004|Overall Study|Withdrawal by Subject|0|||
23362279|NCT02959918|65072797|FG005|Overall Study|Withdrawal by Subject|0|||
23362280|NCT02959918|65072798|FG006|Overall Study|Withdrawal by Subject|1|||
23265063|NCT01644890|64710682|FG000|Overall Study|Progression Disease|160|||
23362281|NCT02959918|65072799|FG007|Overall Study|Withdrawal by Subject|0|||
23362282|NCT02959918|65072800|FG008|Overall Study|Withdrawal by Subject|1|||
23362283|NCT02959918|65072801|FG009|Overall Study|Withdrawal by Subject|1|||
23362284|NCT02959918|65072802|FG010|Overall Study|Withdrawal by Subject|2|||
23362285|NCT02959918|65072803|FG011|Overall Study|Withdrawal by Subject|3|||
23362286|NCT02959918|65072804|FG012|Overall Study|Withdrawal by Subject|1|||
23362287|NCT02959918|65072805|FG013|Overall Study|Withdrawal by Subject|1|||
23362288|NCT02959918|65072792|FG000|Overall Study|Protocol Violation|0|||
23362289|NCT02959918|65072793|FG001|Overall Study|Protocol Violation|0|||
23362290|NCT02959918|65072794|FG002|Overall Study|Protocol Violation|1|||
23362291|NCT02959918|65072795|FG003|Overall Study|Protocol Violation|0|||
23362292|NCT02959918|65072796|FG004|Overall Study|Protocol Violation|0|||
23362293|NCT02959918|65072797|FG005|Overall Study|Protocol Violation|1|||
23362294|NCT02959918|65072798|FG006|Overall Study|Protocol Violation|0|||
23362295|NCT02959918|65072799|FG007|Overall Study|Protocol Violation|0|||
23362296|NCT02959918|65072800|FG008|Overall Study|Protocol Violation|2|||
23362297|NCT02959918|65072801|FG009|Overall Study|Protocol Violation|1|||
23362298|NCT02959918|65072802|FG010|Overall Study|Protocol Violation|0|||
23265064|NCT01644890|64710683|FG001|Overall Study|Progression Disease|131|||
23265065|NCT01644890|64710682|FG000|Overall Study|Clinical Progression|6|||
23265066|NCT01644890|64710683|FG001|Overall Study|Clinical Progression|6|||
23265067|NCT01644890|64710682|FG000|Overall Study|> 28 days since last dose of study drug|6|||
23265068|NCT01644890|64710683|FG001|Overall Study|> 28 days since last dose of study drug|3|||
23265069|NCT01644890|64710682|FG000|Overall Study|Other|8|||
23265070|NCT01644890|64710683|FG001|Overall Study|Other|9|||
23265071|NCT02330081|64710685|FG000|Overall Study|Adverse Event|1|||
23265072|NCT02330081|64710685|FG000|Overall Study|Donation did not meet criteria|1|||
23265073|NCT02330081|64710685|FG000|Overall Study|Protocol Violation|6|||
23265074|NCT01922349|64710687|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
23265075|NCT01922349|64710688|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
23265076|NCT01922349|64710689|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
23265077|NCT01922349|64710690|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
23265078|NCT03980483|64714269|FG000|Overall Study|Adverse Event|13|||
23265079|NCT03980483|64714270|FG001|Overall Study|Adverse Event|29|||
23265080|NCT03980483|64714271|FG002|Overall Study|Adverse Event|11|||
23265081|NCT03980483|64714272|FG003|Overall Study|Adverse Event|2|||
23265082|NCT03980483|64714273|FG004|Overall Study|Adverse Event|2|||
23265083|NCT03980483|64714274|FG005|Overall Study|Adverse Event|2|||
23265084|NCT03980483|64714269|FG000|Overall Study|Lack of Efficacy|7|||
23265085|NCT03980483|64714270|FG001|Overall Study|Lack of Efficacy|6|||
23265086|NCT03980483|64714271|FG002|Overall Study|Lack of Efficacy|0|||
23265087|NCT03980483|64714272|FG003|Overall Study|Lack of Efficacy|3|||
23265088|NCT03980483|64714273|FG004|Overall Study|Lack of Efficacy|1|||
23265089|NCT03980483|64714274|FG005|Overall Study|Lack of Efficacy|1|||
23265090|NCT03980483|64714269|FG000|Overall Study|Lost to Follow-up|2|||
23265091|NCT03980483|64714270|FG001|Overall Study|Lost to Follow-up|4|||
23265092|NCT03980483|64714271|FG002|Overall Study|Lost to Follow-up|2|||
23265093|NCT03980483|64714272|FG003|Overall Study|Lost to Follow-up|1|||
23265094|NCT03980483|64714273|FG004|Overall Study|Lost to Follow-up|2|||
23362299|NCT02959918|65072803|FG011|Overall Study|Protocol Violation|1|||
23265095|NCT03980483|64714274|FG005|Overall Study|Lost to Follow-up|0|||
23265096|NCT03980483|64714269|FG000|Overall Study|Protocol Violation|4|||
23265097|NCT03980483|64714270|FG001|Overall Study|Protocol Violation|2|||
23265098|NCT03980483|64714271|FG002|Overall Study|Protocol Violation|1|||
23265099|NCT03980483|64714272|FG003|Overall Study|Protocol Violation|1|||
23265100|NCT03980483|64714273|FG004|Overall Study|Protocol Violation|0|||
23362300|NCT02959918|65072804|FG012|Overall Study|Protocol Violation|1|||
23362301|NCT02959918|65072805|FG013|Overall Study|Protocol Violation|0|||
23362302|NCT02959918|65072792|FG000|Overall Study|Stopping Rule Met|1|||
23362303|NCT02959918|65072793|FG001|Overall Study|Stopping Rule Met|0|||
23362304|NCT02959918|65072794|FG002|Overall Study|Stopping Rule Met|3|||
23362305|NCT02959918|65072795|FG003|Overall Study|Stopping Rule Met|4|||
23362306|NCT02959918|65072796|FG004|Overall Study|Stopping Rule Met|5|||
23362307|NCT02959918|65072797|FG005|Overall Study|Stopping Rule Met|3|||
23362308|NCT02959918|65072798|FG006|Overall Study|Stopping Rule Met|2|||
23362309|NCT02959918|65072799|FG007|Overall Study|Stopping Rule Met|4|||
23362310|NCT02959918|65072800|FG008|Overall Study|Stopping Rule Met|1|||
23362311|NCT02959918|65072801|FG009|Overall Study|Stopping Rule Met|1|||
23362312|NCT02959918|65072802|FG010|Overall Study|Stopping Rule Met|3|||
23362313|NCT02959918|65072803|FG011|Overall Study|Stopping Rule Met|5|||
23362314|NCT02959918|65072804|FG012|Overall Study|Stopping Rule Met|2|||
23362315|NCT02959918|65072805|FG013|Overall Study|Stopping Rule Met|1|||
23362316|NCT02959918|65072792|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
23362317|NCT02959918|65072793|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
23362318|NCT02959918|65072794|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
23362319|NCT02959918|65072795|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
23362320|NCT02959918|65072796|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362321|NCT02959918|65072797|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362322|NCT02959918|65072798|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362323|NCT02959918|65072799|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362324|NCT02959918|65072800|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23480566|NCT00998764|65502023|FG001|Overall Study|Withdrawal by Subject|25|||
23480567|NCT00998764|65502022|FG000|Overall Study|Physician Decision|3|||
23480568|NCT00998764|65502023|FG001|Overall Study|Physician Decision|3|||
23480569|NCT00998764|65502022|FG000|Overall Study|Death|3|||
23265101|NCT03980483|64714274|FG005|Overall Study|Protocol Violation|0|||
23265102|NCT03980483|64714269|FG000|Overall Study|Physician Decision|14|||
23265103|NCT03980483|64714270|FG001|Overall Study|Physician Decision|10|||
23265104|NCT03980483|64714271|FG002|Overall Study|Physician Decision|7|||
23265105|NCT03980483|64714272|FG003|Overall Study|Physician Decision|4|||
23265106|NCT03980483|64714273|FG004|Overall Study|Physician Decision|4|||
23265107|NCT03980483|64714274|FG005|Overall Study|Physician Decision|2|||
23265108|NCT03980483|64714269|FG000|Overall Study|Withdrawal by Subject|38|||
23265109|NCT03980483|64714270|FG001|Overall Study|Withdrawal by Subject|21|||
23265110|NCT03980483|64714271|FG002|Overall Study|Withdrawal by Subject|15|||
23265111|NCT03980483|64714272|FG003|Overall Study|Withdrawal by Subject|5|||
23265112|NCT03980483|64714273|FG004|Overall Study|Withdrawal by Subject|3|||
23265113|NCT03980483|64714274|FG005|Overall Study|Withdrawal by Subject|4|||
23265114|NCT03980483|64714269|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
23265115|NCT03980483|64714270|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23265116|NCT03980483|64714271|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23265117|NCT03980483|64714272|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
23265118|NCT03980483|64714273|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23265119|NCT03980483|64714274|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
23265120|NCT03980483|64714269|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23265121|NCT03980483|64714270|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
23265122|NCT03980483|64714271|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23265123|NCT03980483|64714272|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23265124|NCT03980483|64714273|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23265125|NCT03980483|64714274|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
23265126|NCT03980483|64714269|FG000|Overall Study|Other|0|||
23265127|NCT03980483|64714270|FG001|Overall Study|Other|1|||
23265128|NCT03980483|64714271|FG002|Overall Study|Other|0|||
23265129|NCT03980483|64714272|FG003|Overall Study|Other|0|||
23265130|NCT03980483|64714273|FG004|Overall Study|Other|0|||
23265131|NCT03980483|64714274|FG005|Overall Study|Other|0|||
23265132|NCT02305758|64714275|FG000|Overall Study|Death|27|||
23265133|NCT02305758|64714276|FG001|Overall Study|Death|27|||
23265134|NCT02305758|64714275|FG000|Overall Study|Withdrew consent|9|||
23265135|NCT02305758|64714276|FG001|Overall Study|Withdrew consent|2|||
23265136|NCT02305758|64714275|FG000|Overall Study|Lost to Follow-up|6|||
23265137|NCT02305758|64714276|FG001|Overall Study|Lost to Follow-up|1|||
23265138|NCT02305758|64714275|FG000|Overall Study|Study Terminated by Sponsor|21|||
23265139|NCT02305758|64714276|FG001|Overall Study|Study Terminated by Sponsor|34|||
23265140|NCT02305758|64714275|FG000|Overall Study|Other, not specified|2|||
23265141|NCT02305758|64714276|FG001|Overall Study|Other, not specified|1|||
23362325|NCT02959918|65072801|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362326|NCT02959918|65072802|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362327|NCT02959918|65072803|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23265142|NCT00718159|64714279|FG000|Overall Study|Progressive Disease|3|||
23265143|NCT00718159|64714280|FG001|Overall Study|Progressive Disease|3|||
23265144|NCT00718159|64714281|FG002|Overall Study|Progressive Disease|2|||
23362328|NCT02959918|65072804|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23480570|NCT00998764|65502023|FG001|Overall Study|Death|1|||
23265145|NCT00718159|64714282|FG003|Overall Study|Progressive Disease|0|||
23265146|NCT00718159|64714283|FG004|Overall Study|Progressive Disease|6|||
23265147|NCT00718159|64714284|FG005|Overall Study|Progressive Disease|0|||
23265148|NCT00718159|64714285|FG006|Overall Study|Progressive Disease|0|||
23265149|NCT00718159|64714279|FG000|Overall Study|Death due to Adverse Event|0|||
23265150|NCT00718159|64714280|FG001|Overall Study|Death due to Adverse Event|0|||
23265151|NCT00718159|64714281|FG002|Overall Study|Death due to Adverse Event|0|||
23265152|NCT00718159|64714282|FG003|Overall Study|Death due to Adverse Event|2|||
23265153|NCT00718159|64714283|FG004|Overall Study|Death due to Adverse Event|2|||
23265154|NCT00718159|64714284|FG005|Overall Study|Death due to Adverse Event|0|||
23265155|NCT00718159|64714285|FG006|Overall Study|Death due to Adverse Event|0|||
23265156|NCT00718159|64714279|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
23265157|NCT00718159|64714280|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
23265158|NCT00718159|64714281|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
23265159|NCT00718159|64714282|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
23265160|NCT00718159|64714283|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
23265161|NCT00718159|64714284|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
23265162|NCT00718159|64714285|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
23265163|NCT00718159|64714279|FG000|Overall Study|Investigator Decision|0|||
23265164|NCT00718159|64714280|FG001|Overall Study|Investigator Decision|0|||
23265165|NCT00718159|64714281|FG002|Overall Study|Investigator Decision|0|||
23265166|NCT00718159|64714282|FG003|Overall Study|Investigator Decision|0|||
23265167|NCT00718159|64714283|FG004|Overall Study|Investigator Decision|0|||
23265168|NCT00718159|64714284|FG005|Overall Study|Investigator Decision|1|||
23265169|NCT00718159|64714285|FG006|Overall Study|Investigator Decision|1|||
23265170|NCT01631864|64714286|FG000|Overall Study|Withdrawal by Subject|0|||
23265171|NCT01631864|64714287|FG001|Overall Study|Withdrawal by Subject|1|||
23265172|NCT01631864|64714286|FG000|Overall Study|Adverse Event|2|||
23265173|NCT01631864|64714287|FG001|Overall Study|Adverse Event|3|||
23265174|NCT01802879|64714288|FG000|Overall Study|Administrative problems|2|||
23265175|NCT01802879|64714288|FG000|Overall Study|Disease progression|6|||
23265176|NCT02576509|64714291|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
23265177|NCT02576509|64714292|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
23265178|NCT02576509|64714291|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
23265179|NCT02576509|64714292|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
23265180|NCT02576509|64714291|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
23265181|NCT02576509|64714292|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
23265182|NCT02576509|64714291|FG000|Treatment Period|Disease progression|245|||
23265183|NCT02576509|64714292|FG001|Treatment Period|Disease progression|240|||
23265184|NCT02576509|64714291|FG000|Treatment Period|Study drug toxicity|32|||
23265185|NCT02576509|64714292|FG001|Treatment Period|Study drug toxicity|41|||
23265186|NCT02576509|64714291|FG000|Treatment Period|Death|1|||
23265187|NCT02576509|64714292|FG001|Treatment Period|Death|1|||
23265188|NCT02576509|64714291|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
23265189|NCT02576509|64714292|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
23265190|NCT02576509|64714291|FG000|Treatment Period|Participant request to stop treatment|8|||
23265191|NCT02576509|64714292|FG001|Treatment Period|Participant request to stop treatment|17|||
23265192|NCT02576509|64714291|FG000|Treatment Period|Participant withdrew consent|2|||
23265193|NCT02576509|64714292|FG001|Treatment Period|Participant withdrew consent|7|||
23265194|NCT02576509|64714291|FG000|Treatment Period|Lost to Follow-up|0|||
23265195|NCT02576509|64714292|FG001|Treatment Period|Lost to Follow-up|1|||
23265196|NCT02576509|64714291|FG000|Treatment Period|Maximum clinical benefit|1|||
23265197|NCT02576509|64714292|FG001|Treatment Period|Maximum clinical benefit|0|||
23265198|NCT02576509|64714291|FG000|Treatment Period|Poor/non-compliance|0|||
23265199|NCT02576509|64714292|FG001|Treatment Period|Poor/non-compliance|1|||
23265200|NCT02576509|64714291|FG000|Treatment Period|Participant no longer meets criteria|1|||
23265201|NCT02576509|64714292|FG001|Treatment Period|Participant no longer meets criteria|0|||
23265202|NCT02576509|64714291|FG000|Treatment Period|Other reason|2|||
23265203|NCT02576509|64714292|FG001|Treatment Period|Other reason|7|||
23265204|NCT02576509|64714291|FG000|Follow-up Period|Death|41|||
23265205|NCT02576509|64714292|FG001|Follow-up Period|Death|35|||
23265206|NCT02576509|64714291|FG000|Follow-up Period|Participant withdrew consent|7|||
23265207|NCT02576509|64714292|FG001|Follow-up Period|Participant withdrew consent|14|||
23265208|NCT02576509|64714291|FG000|Follow-up Period|Lost to Follow-up|0|||
23265209|NCT02576509|64714292|FG001|Follow-up Period|Lost to Follow-up|1|||
23265210|NCT02576509|64714291|FG000|Follow-up Period|Other reason|1|||
23265211|NCT02576509|64714292|FG001|Follow-up Period|Other reason|2|||
23265212|NCT01626859|64714293|FG000|Overall Study|Adverse Event|1|||
23265213|NCT01626859|64714294|FG001|Overall Study|Adverse Event|3|||
23265214|NCT01626859|64714295|FG002|Overall Study|Adverse Event|2|||
23265215|NCT01626859|64714293|FG000|Overall Study|Physician Decision|0|||
23265216|NCT01626859|64714294|FG001|Overall Study|Physician Decision|1|||
23265217|NCT01626859|64714295|FG002|Overall Study|Physician Decision|0|||
23265218|NCT01626859|64714293|FG000|Overall Study|Withdrawal by Subject|1|||
23265219|NCT01626859|64714294|FG001|Overall Study|Withdrawal by Subject|4|||
23265220|NCT01626859|64714295|FG002|Overall Study|Withdrawal by Subject|2|||
23265221|NCT00502775|64714301|FG000|Overall Study|Adverse Event|1|||
23265222|NCT00502775|64714302|FG001|Overall Study|Adverse Event|2|||
23265223|NCT00502775|64714303|FG002|Overall Study|Adverse Event|1|||
23265224|NCT00502775|64714301|FG000|Overall Study|Protocol Violation|1|||
23265225|NCT00502775|64714302|FG001|Overall Study|Protocol Violation|5|||
23265226|NCT00502775|64714303|FG002|Overall Study|Protocol Violation|2|||
23265227|NCT00502775|64714301|FG000|Overall Study|Withdrawal by Subject|1|||
23265228|NCT00502775|64714302|FG001|Overall Study|Withdrawal by Subject|1|||
23265229|NCT00502775|64714303|FG002|Overall Study|Withdrawal by Subject|2|||
23265230|NCT00502775|64714301|FG000|Overall Study|Sponsor Terminated Study|1|||
23265231|NCT00502775|64714302|FG001|Overall Study|Sponsor Terminated Study|0|||
23265232|NCT00502775|64714303|FG002|Overall Study|Sponsor Terminated Study|1|||
23265233|NCT00502775|64714301|FG000|Overall Study|Non-compliance with eDiary|4|||
23265234|NCT00502775|64714302|FG001|Overall Study|Non-compliance with eDiary|1|||
23265235|NCT00502775|64714303|FG002|Overall Study|Non-compliance with eDiary|1|||
23265236|NCT00502775|64714301|FG000|Overall Study|Subject unable to swallow capsule|1|||
23265237|NCT00502775|64714302|FG001|Overall Study|Subject unable to swallow capsule|0|||
23265238|NCT00502775|64714303|FG002|Overall Study|Subject unable to swallow capsule|1|||
23265239|NCT00502775|64714301|FG000|Overall Study|Logpad compliance <80%|1|||
23265240|NCT00502775|64714302|FG001|Overall Study|Logpad compliance <80%|0|||
23265241|NCT00502775|64714303|FG002|Overall Study|Logpad compliance <80%|0|||
23265242|NCT00502775|64714301|FG000|Overall Study|Randomized in error|0|||
23265243|NCT00502775|64714302|FG001|Overall Study|Randomized in error|1|||
23265244|NCT00502775|64714303|FG002|Overall Study|Randomized in error|1|||
23265245|NCT00502775|64714301|FG000|Overall Study|Non-compliance|0|||
23265246|NCT00502775|64714302|FG001|Overall Study|Non-compliance|2|||
23265247|NCT00502775|64714303|FG002|Overall Study|Non-compliance|2|||
23265248|NCT00502775|64714301|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
23265249|NCT00502775|64714302|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
23265250|NCT00502775|64714303|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
23265251|NCT00502775|64714301|FG000|Overall Study|Declining pollen counts|0|||
23265252|NCT00502775|64714302|FG001|Overall Study|Declining pollen counts|1|||
23265253|NCT00502775|64714303|FG002|Overall Study|Declining pollen counts|1|||
23265254|NCT00502775|64714301|FG000|Overall Study|Subject in jail|0|||
23265255|NCT00502775|64714302|FG001|Overall Study|Subject in jail|1|||
23265256|NCT00502775|64714303|FG002|Overall Study|Subject in jail|0|||
23265257|NCT00502775|64714301|FG000|Overall Study|Subject took disallowed drug|0|||
23265258|NCT00502775|64714302|FG001|Overall Study|Subject took disallowed drug|0|||
23265259|NCT00502775|64714303|FG002|Overall Study|Subject took disallowed drug|1|||
23265260|NCT04000009|64714304|FG000|Overall Study|Adverse Event|13|||
23265261|NCT04000009|64714304|FG000|Overall Study|Lack of Efficacy|7|||
23265262|NCT04000009|64714304|FG000|Overall Study|Lost to Follow-up|8|||
23265263|NCT04000009|64714304|FG000|Overall Study|Noncompliance with study drug|4|||
23265264|NCT04000009|64714304|FG000|Overall Study|Physician Decision|1|||
23265265|NCT04000009|64714304|FG000|Overall Study|Use of prohibited medication|3|||
23265266|NCT04000009|64714304|FG000|Overall Study|Pregnancy|1|||
23265267|NCT04000009|64714304|FG000|Overall Study|Withdrawal by Subject|22|||
23265268|NCT04000009|64714304|FG000|Overall Study|Study terminated by sponsor|98|||
23265269|NCT04000009|64714304|FG000|Overall Study|Not further specified|8|||
23265270|NCT00585351|64714306|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
23265271|NCT00585351|64714307|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
23265272|NCT00585351|64714308|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
23265273|NCT00585351|64714309|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
23265274|NCT00585351|64714310|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
23265275|NCT00585351|64714311|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
23265276|NCT00585351|64714312|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
23265277|NCT00585351|64714313|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
23265278|NCT00585351|64714306|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
23265279|NCT00585351|64714307|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
23265280|NCT00585351|64714308|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
23265281|NCT00585351|64714309|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
23265282|NCT00585351|64714310|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
23265283|NCT00585351|64714311|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
23265284|NCT00585351|64714312|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
23265285|NCT00585351|64714313|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
23265286|NCT00585351|64714306|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
23265287|NCT00585351|64714307|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
23265288|NCT00585351|64714308|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
23362329|NCT02959918|65072805|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
23362330|NCT02959918|65072792|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362331|NCT02959918|65072793|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23265289|NCT00585351|64714309|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
23265290|NCT00585351|64714310|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
23265291|NCT00585351|64714311|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
23265292|NCT00585351|64714312|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
23265293|NCT00585351|64714313|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
23265294|NCT00585351|64714306|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
23265295|NCT00585351|64714307|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
23265296|NCT00585351|64714308|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23265297|NCT00585351|64714309|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23265298|NCT00585351|64714310|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23265299|NCT00585351|64714311|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23265300|NCT00585351|64714312|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23265301|NCT00585351|64714313|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
23265302|NCT00585351|64714306|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23265303|NCT00585351|64714307|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23265304|NCT00585351|64714308|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23265305|NCT00585351|64714309|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23265306|NCT00585351|64714310|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23265307|NCT00585351|64714311|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
23265308|NCT00585351|64714312|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
23362332|NCT02959918|65072794|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362333|NCT02959918|65072795|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362334|NCT02959918|65072796|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362335|NCT02959918|65072797|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362336|NCT02959918|65072798|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362337|NCT02959918|65072799|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
23362338|NCT02959918|65072800|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362339|NCT02959918|65072801|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362340|NCT02959918|65072802|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362341|NCT02959918|65072803|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362342|NCT02959918|65072804|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362343|NCT02959918|65072805|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
23362344|NCT02959918|65072792|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362345|NCT02959918|65072793|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362346|NCT02959918|65072794|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362347|NCT02959918|65072795|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362348|NCT02959918|65072796|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362349|NCT02959918|65072797|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362350|NCT02959918|65072798|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362351|NCT02959918|65072799|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362352|NCT02959918|65072800|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
23362353|NCT02959918|65072801|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362354|NCT02959918|65072802|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362355|NCT02959918|65072803|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362356|NCT02959918|65072804|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362357|NCT02959918|65072805|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
23362358|NCT02959918|65072792|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362359|NCT02959918|65072793|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362360|NCT02959918|65072794|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362361|NCT02959918|65072795|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362362|NCT02959918|65072796|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362363|NCT02959918|65072797|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362364|NCT02959918|65072798|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362365|NCT02959918|65072799|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362366|NCT02959918|65072800|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362367|NCT02959918|65072801|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
23362368|NCT02959918|65072802|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362369|NCT02959918|65072803|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362370|NCT02959918|65072804|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362371|NCT02959918|65072805|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
23362372|NCT02689804|65072806|FG000|Overall Study|Withdrawal by Subject|2|||
23265309|NCT00585351|64714313|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
23265310|NCT00585351|64714306|FG000|Enrollment Period (Intervention)|Death|0|||
23265311|NCT00585351|64714307|FG001|Enrollment Period (Intervention)|Death|0|||
23265312|NCT00585351|64714308|FG002|Enrollment Period (Intervention)|Death|0|||
23265313|NCT00585351|64714309|FG003|Enrollment Period (Intervention)|Death|0|||
23265314|NCT00585351|64714310|FG004|Enrollment Period (Intervention)|Death|1|||
23265315|NCT00585351|64714311|FG005|Enrollment Period (Intervention)|Death|0|||
23265316|NCT00585351|64714312|FG006|Enrollment Period (Intervention)|Death|1|||
23265317|NCT00585351|64714313|FG007|Enrollment Period (Intervention)|Death|0|||
23265318|NCT00585351|64714306|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23265319|NCT00585351|64714307|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23265320|NCT00585351|64714308|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23265321|NCT00585351|64714309|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23265322|NCT00585351|64714310|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
23265323|NCT00585351|64714311|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
23265324|NCT00585351|64714312|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23265325|NCT00585351|64714313|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
23265326|NCT04604184|64714318|FG000|Overall Study|Adverse Event|5|||
23265327|NCT04604184|64714319|FG001|Overall Study|Adverse Event|5|||
23265328|NCT04604184|64714318|FG000|Overall Study|Death|2|||
23265329|NCT04604184|64714319|FG001|Overall Study|Death|1|||
23265330|NCT04604184|64714318|FG000|Overall Study|Withdrawal by Subject|1|||
23265331|NCT04604184|64714319|FG001|Overall Study|Withdrawal by Subject|3|||
23265332|NCT04604184|64714318|FG000|Overall Study|Not treated|2|||
23265333|NCT04604184|64714319|FG001|Overall Study|Not treated|2|||
23265334|NCT04604184|64714318|FG000|Overall Study|Due to sponsor decision|9|||
23265335|NCT04604184|64714319|FG001|Overall Study|Due to sponsor decision|7|||
23265336|NCT04604184|64714318|FG000|Overall Study|Physician Decision|0|||
23265337|NCT04604184|64714319|FG001|Overall Study|Physician Decision|1|||
23265338|NCT04604184|64714318|FG000|Overall Study|Transfer to healthcare|1|||
23265339|NCT04604184|64714319|FG001|Overall Study|Transfer to healthcare|0|||
23265340|NCT03775681|64714320|FG000|Overall Study|Physician Decision|3|||
23265341|NCT02132247|64714321|FG000|Overall Study|Protocol Violation|1|||
23265342|NCT02132247|64714322|FG001|Overall Study|Protocol Violation|0|||
23265343|NCT03222141|64714323|FG000|Overall Study|Death|15|||
23265344|NCT03222141|64714323|FG000|Overall Study|Lost to Follow-up|3|||
23265345|NCT01006707|64714324|FG000|Study Session 1|Lost to Follow-up|2|||
23265346|NCT01006707|64714325|FG001|Study Session 1|Lost to Follow-up|0|||
23265347|NCT01006707|64714326|FG002|Study Session 1|Lost to Follow-up|0|||
23265348|NCT01006707|64714324|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
23265349|NCT01006707|64714325|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
23265350|NCT01006707|64714326|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
23265351|NCT03294538|64714327|FG000|Overall Study|Adverse Event|0|||
23265352|NCT03294538|64714328|FG001|Overall Study|Adverse Event|1|||
23265353|NCT03294538|64714329|FG002|Overall Study|Adverse Event|1|||
23265354|NCT03294538|64714327|FG000|Overall Study|Lost to Follow-up|1|||
23265355|NCT03294538|64714328|FG001|Overall Study|Lost to Follow-up|0|||
23265356|NCT03294538|64714329|FG002|Overall Study|Lost to Follow-up|0|||
23265357|NCT03294538|64714327|FG000|Overall Study|Outside of Visit Window|4|||
23265358|NCT03294538|64714328|FG001|Overall Study|Outside of Visit Window|4|||
23265359|NCT03294538|64714329|FG002|Overall Study|Outside of Visit Window|1|||
23265360|NCT02343120|64714330|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
23265361|NCT02343120|64714331|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
23265362|NCT02343120|64714332|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
23265363|NCT02343120|64714333|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
23265364|NCT02343120|64714334|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
23265365|NCT02343120|64714330|FG000|Part 1: Dose Escalation|Death|1|||
23265366|NCT02343120|64714331|FG001|Part 1: Dose Escalation|Death|2|||
23265367|NCT02343120|64714332|FG002|Part 1: Dose Escalation|Death|2|||
23265368|NCT02343120|64714333|FG003|Part 1: Dose Escalation|Death|2|||
23265369|NCT02343120|64714334|FG004|Part 1: Dose Escalation|Death|1|||
23265370|NCT02343120|64714330|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
23265371|NCT02343120|64714331|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
23265372|NCT02343120|64714332|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
23265373|NCT02343120|64714333|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
23265374|NCT02343120|64714334|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
23265375|NCT02343120|64714330|FG000|Part 2: Expansion|Sponsor decision|0|||
23265376|NCT02343120|64714331|FG001|Part 2: Expansion|Sponsor decision|0|||
23600956|NCT01673594|65929791|FG001|Overall Study|Physician Decision|4|||
23600957|NCT01673594|65929790|FG000|Overall Study|Withdrawal by Subject|0|||
23600958|NCT01673594|65929791|FG001|Overall Study|Withdrawal by Subject|1|||
23265377|NCT02343120|64714332|FG002|Part 2: Expansion|Sponsor decision|0|||
23265378|NCT02343120|64714333|FG003|Part 2: Expansion|Sponsor decision|165|||
23265379|NCT02343120|64714334|FG004|Part 2: Expansion|Sponsor decision|67|||
23265380|NCT02343120|64714330|FG000|Part 2: Expansion|Death|0|||
23265381|NCT02343120|64714331|FG001|Part 2: Expansion|Death|0|||
23265382|NCT02343120|64714332|FG002|Part 2: Expansion|Death|0|||
23362373|NCT02689804|65072807|FG001|Overall Study|Withdrawal by Subject|0|||
23362374|NCT02964338|65072809|FG000|Overall Study|Sponsor terminated study for futility|12|||
23362375|NCT02964338|65072810|FG001|Overall Study|Sponsor terminated study for futility|15|||
23362376|NCT02964338|65072811|FG002|Overall Study|Sponsor terminated study for futility|14|||
23362377|NCT02964338|65072809|FG000|Overall Study|Lack of Efficacy|0|||
23362378|NCT02964338|65072810|FG001|Overall Study|Lack of Efficacy|3|||
23362379|NCT02964338|65072811|FG002|Overall Study|Lack of Efficacy|0|||
23362380|NCT02964338|65072809|FG000|Overall Study|Lost to Follow-up|1|||
23362381|NCT02964338|65072810|FG001|Overall Study|Lost to Follow-up|0|||
23362382|NCT02964338|65072811|FG002|Overall Study|Lost to Follow-up|3|||
23362383|NCT02964338|65072809|FG000|Overall Study|Protocol Violation|0|||
23362384|NCT02964338|65072810|FG001|Overall Study|Protocol Violation|1|||
23362385|NCT02964338|65072811|FG002|Overall Study|Protocol Violation|0|||
23362386|NCT02964338|65072809|FG000|Overall Study|Withdrawal by Subject|1|||
23265383|NCT02343120|64714333|FG003|Part 2: Expansion|Death|74|||
23265384|NCT02343120|64714334|FG004|Part 2: Expansion|Death|17|||
23265385|NCT02343120|64714330|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
23265386|NCT02343120|64714331|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
23265387|NCT02343120|64714332|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
23265388|NCT02343120|64714333|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
23265389|NCT02343120|64714334|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
23265390|NCT02343120|64714330|FG000|Part 2: Expansion|Lost to Follow-up|0|||
23265391|NCT02343120|64714331|FG001|Part 2: Expansion|Lost to Follow-up|0|||
23265392|NCT02343120|64714332|FG002|Part 2: Expansion|Lost to Follow-up|0|||
23265393|NCT02343120|64714333|FG003|Part 2: Expansion|Lost to Follow-up|5|||
23265394|NCT02343120|64714334|FG004|Part 2: Expansion|Lost to Follow-up|2|||
23265395|NCT02343120|64714330|FG000|Part 2: Expansion|Other|0|||
23265396|NCT02343120|64714331|FG001|Part 2: Expansion|Other|0|||
23265397|NCT02343120|64714332|FG002|Part 2: Expansion|Other|0|||
23265398|NCT02343120|64714333|FG003|Part 2: Expansion|Other|1|||
23265399|NCT02343120|64714334|FG004|Part 2: Expansion|Other|5|||
23265400|NCT02343120|64714330|FG000|Part 2: Expansion|Adverse Event|0|||
23265401|NCT02343120|64714331|FG001|Part 2: Expansion|Adverse Event|0|||
23265402|NCT02343120|64714332|FG002|Part 2: Expansion|Adverse Event|0|||
23265403|NCT02343120|64714333|FG003|Part 2: Expansion|Adverse Event|1|||
23265404|NCT02343120|64714334|FG004|Part 2: Expansion|Adverse Event|1|||
23265405|NCT03992196|64714340|FG000|Enrollment|lost to follow-up prior dosing|1|||
23265406|NCT03992196|64714341|FG001|Enrollment|lost to follow-up prior dosing|0|||
23265407|NCT03992196|64714342|FG002|Enrollment|lost to follow-up prior dosing|0|||
23265408|NCT03992196|64714340|FG000|Treatment|Protocol Violation|0|||
23265409|NCT03992196|64714341|FG001|Treatment|Protocol Violation|0|||
23265410|NCT03992196|64714342|FG002|Treatment|Protocol Violation|1|||
23265411|NCT03992196|64714340|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
23265412|NCT03992196|64714341|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
23265413|NCT03992196|64714342|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
23265414|NCT03992196|64714340|FG000|Treatment|Withdrawal due to non-compliance|0|||
23265415|NCT03992196|64714341|FG001|Treatment|Withdrawal due to non-compliance|0|||
23265416|NCT03992196|64714342|FG002|Treatment|Withdrawal due to non-compliance|1|||
23265417|NCT03992196|64714340|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
23265418|NCT03992196|64714341|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
23265419|NCT03992196|64714342|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
23265420|NCT03992196|64714340|FG000|Treatment|Withdrawal by parent/guardian|0|||
23265421|NCT03992196|64714341|FG001|Treatment|Withdrawal by parent/guardian|0|||
23362387|NCT02964338|65072810|FG001|Overall Study|Withdrawal by Subject|3|||
23265422|NCT03992196|64714342|FG002|Treatment|Withdrawal by parent/guardian|2|||
23265423|NCT01890915|64714345|FG000|Overall Study|Adverse Event|1|||
23362388|NCT02964338|65072811|FG002|Overall Study|Withdrawal by Subject|1|||
23265424|NCT01890915|64714346|FG001|Overall Study|Adverse Event|0|||
23265425|NCT01890915|64714345|FG000|Overall Study|Protocol Violation|2|||
23265426|NCT01890915|64714346|FG001|Overall Study|Protocol Violation|0|||
23362389|NCT02964338|65072809|FG000|Overall Study|Adverse Event|2|||
23362390|NCT02964338|65072810|FG001|Overall Study|Adverse Event|1|||
23362391|NCT02964338|65072811|FG002|Overall Study|Adverse Event|1|||
23362392|NCT02964338|65072809|FG000|Overall Study|Non-compliant with e-diary|0|||
23362393|NCT02964338|65072810|FG001|Overall Study|Non-compliant with e-diary|1|||
23362394|NCT02964338|65072811|FG002|Overall Study|Non-compliant with e-diary|0|||
23362395|NCT02964338|65072809|FG000|Overall Study|Did not meet criteria|1|||
23362396|NCT02964338|65072810|FG001|Overall Study|Did not meet criteria|0|||
23362397|NCT02964338|65072811|FG002|Overall Study|Did not meet criteria|0|||
23362398|NCT01465230|65072812|FG000|Overall Study|Withdrawal by Subject|2|||
23362399|NCT01676012|65072813|FG000|Overall Study|Adverse Event|2|||
23362400|NCT01676012|65072813|FG000|Overall Study|incomplete set of videos|1|||
23362401|NCT03146741|65072814|FG000|Overall Study|Txp with non-HCV+ heart|4|||
23362402|NCT03146741|65072814|FG000|Overall Study|Listeted for MOT|2|||
23362403|NCT03146741|65072814|FG000|Overall Study|Physician Decision|2|||
23362404|NCT03146741|65072814|FG000|Overall Study|Awaiting txp|2|||
23362405|NCT02346877|65072815|FG000|Overall Study|Adverse Event|1|||
23362406|NCT02346877|65072816|FG001|Overall Study|Adverse Event|0|||
23362407|NCT02346877|65072815|FG000|Overall Study|Administrative Decision|1|||
23362408|NCT02346877|65072816|FG001|Overall Study|Administrative Decision|0|||
23362409|NCT02346877|65072815|FG000|Overall Study|Sponsor Decision|12|||
23362410|NCT02346877|65072816|FG001|Overall Study|Sponsor Decision|0|||
23362411|NCT02346877|65072815|FG000|Overall Study|Missing|5|||
23362412|NCT02346877|65072816|FG001|Overall Study|Missing|0|||
23362413|NCT02542397|65072824|FG000|Overall Study|Death|2|||
23362414|NCT02542397|65072824|FG000|Overall Study|Physician Decision|6|||
23362415|NCT02542397|65072824|FG000|Overall Study|Withdrawal by Subject|6|||
23265427|NCT01890915|64714345|FG000|Overall Study|Equipment Malfunction|0|||
23265428|NCT01890915|64714346|FG001|Overall Study|Equipment Malfunction|1|||
23265429|NCT04529109|64714347|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
23265430|NCT04529109|64714348|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
23265431|NCT01893138|64714351|FG000|Double-Blind Period|Withdrawal by Subject|1|||
23265432|NCT01893138|64714352|FG001|Double-Blind Period|Withdrawal by Subject|1|||
23265433|NCT01893138|64714351|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
23265434|NCT01893138|64714352|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
23265435|NCT01893138|64714351|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
23265436|NCT01893138|64714352|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
23265437|NCT01893138|64714351|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
23265438|NCT01893138|64714352|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
23265439|NCT01893138|64714351|FG000|Open Label - Unblinded Period|Adverse Event|1|||
23265440|NCT01893138|64714352|FG001|Open Label - Unblinded Period|Adverse Event|0|||
23265441|NCT02568384|64714353|FG000|Overall Study|Mobile devices incompatible with App|2|||
23265442|NCT02275364|64714357|FG000|Period 1|Withdrawal by Subject|1|||
23265443|NCT02275364|64714358|FG001|Period 1|Withdrawal by Subject|0|||
23265444|NCT02275364|64714357|FG000|Period 1|Other reason|1|||
23265445|NCT02275364|64714358|FG001|Period 1|Other reason|0|||
23265446|NCT03481309|64714361|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
23265447|NCT03481309|64714362|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23265448|NCT03481309|64714363|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23265449|NCT03481309|64714364|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23265450|NCT03481309|64714365|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23265451|NCT03481309|64714366|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
23265452|NCT00720096|64714369|FG000|Overall Study|Withdrawal by Subject|0|||
23265453|NCT00720096|64714370|FG001|Overall Study|Withdrawal by Subject|2|||
23265454|NCT02761980|64714371|FG000|Overall Study|Adverse Event|4|||
23362416|NCT02542397|65072824|FG000|Overall Study|Lost to Follow-up|2|||
23362417|NCT01025284|65072825|FG000|Overall Study|Investigator Decision|0|||
23362418|NCT01025284|65072826|FG001|Overall Study|Investigator Decision|1|||
23362419|NCT01025284|65072827|FG002|Overall Study|Investigator Decision|0|||
23362420|NCT01025284|65072825|FG000|Overall Study|Withdrawal by Subject|0|||
23265455|NCT02761980|64714372|FG001|Overall Study|Adverse Event|6|||
23265456|NCT02761980|64714373|FG002|Overall Study|Adverse Event|5|||
23265457|NCT02761980|64714374|FG003|Overall Study|Adverse Event|6|||
23265458|NCT02761980|64714371|FG000|Overall Study|Withdrawal by Subject|0|||
23265459|NCT02761980|64714372|FG001|Overall Study|Withdrawal by Subject|1|||
23265460|NCT02761980|64714373|FG002|Overall Study|Withdrawal by Subject|0|||
23265461|NCT02761980|64714374|FG003|Overall Study|Withdrawal by Subject|0|||
23265462|NCT02761980|64714371|FG000|Overall Study|Other|0|||
23265463|NCT02761980|64714372|FG001|Overall Study|Other|0|||
23265464|NCT02761980|64714373|FG002|Overall Study|Other|1|||
23362421|NCT01025284|65072826|FG001|Overall Study|Withdrawal by Subject|1|||
23362422|NCT01025284|65072827|FG002|Overall Study|Withdrawal by Subject|0|||
23362423|NCT04158219|65072828|FG000|Overall Study|Lost to Follow-up|1|||
23362424|NCT02948829|65072841|FG000|Overall Study|Lost to Follow-up|2|||
23600959|NCT03905512|65929792|FG000|Overall Study|Withdrawal by Subject|9|||
23600960|NCT03905512|65929793|FG001|Overall Study|Withdrawal by Subject|8|||
23600961|NCT03905512|65929792|FG000|Overall Study|Adverse Event|1|||
23600962|NCT03905512|65929793|FG001|Overall Study|Adverse Event|2|||
23600963|NCT03905512|65929792|FG000|Overall Study|Lost to Follow-up|4|||
23600964|NCT03905512|65929793|FG001|Overall Study|Lost to Follow-up|3|||
23600965|NCT03905512|65929792|FG000|Overall Study|Other than Specified|7|||
23600966|NCT03905512|65929793|FG001|Overall Study|Other than Specified|4|||
23600967|NCT02593149|65929796|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
23600968|NCT02593149|65929797|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
23600969|NCT02593149|65929796|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
23600970|NCT02593149|65929797|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
23600971|NCT02823574|65929798|FG000|Randomization|Disease Progression|0|||
23265465|NCT02761980|64714374|FG003|Overall Study|Other|0|||
23265466|NCT03444038|64714375|FG000|Overall Study|Adverse Event|12|||
23265467|NCT03444038|64714375|FG000|Overall Study|Withdrawal by Subject|7|||
23265468|NCT03444038|64714375|FG000|Overall Study|Lost to Follow-up|1|||
23265469|NCT03444038|64714375|FG000|Overall Study|Physician Decision|2|||
23265470|NCT03444038|64714375|FG000|Overall Study|Lack of Efficacy|7|||
23265471|NCT00992407|64714376|FG000|Overall Study|Protocol Violation|2|||
23265472|NCT00992407|64714377|FG001|Overall Study|Protocol Violation|1|||
23265473|NCT00992407|64714376|FG000|Overall Study|Lost to Follow-up|3|||
23265474|NCT00992407|64714377|FG001|Overall Study|Lost to Follow-up|3|||
23265475|NCT00992407|64714376|FG000|Overall Study|Adverse Event|3|||
23265476|NCT00992407|64714377|FG001|Overall Study|Adverse Event|2|||
23265477|NCT00992407|64714376|FG000|Overall Study|protocol Violation & Adverse events|2|||
23265478|NCT00992407|64714377|FG001|Overall Study|protocol Violation & Adverse events|4|||
23265479|NCT00992407|64714376|FG000|Overall Study|Other|2|||
23265480|NCT00992407|64714377|FG001|Overall Study|Other|0|||
23265481|NCT00992407|64714376|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
23265482|NCT00992407|64714377|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
23265483|NCT00992407|64714376|FG000|Overall Study|Study medication not administered|17|||
23265484|NCT00992407|64714377|FG001|Overall Study|Study medication not administered|13|||
23265485|NCT04025879|64714378|FG000|Randomization|Participant withdrew consent|0|||
23265486|NCT04025879|64714379|FG001|Randomization|Participant withdrew consent|1|||
23265487|NCT04025879|64714378|FG000|Randomization|Participant no longer met study criteria|1|||
23265488|NCT04025879|64714379|FG001|Randomization|Participant no longer met study criteria|1|||
23265489|NCT04025879|64714378|FG000|Treatment|Ongoing treatment|10|||
23265490|NCT04025879|64714379|FG001|Treatment|Ongoing treatment|8|||
23265491|NCT04025879|64714378|FG000|Treatment|Disease progression/recurrence|36|||
23362425|NCT02948829|65072841|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
23362426|NCT02948829|65072841|FG000|Overall Study|Pregnancy|1|||
23480571|NCT00998764|65502022|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
23265492|NCT04025879|64714379|FG001|Treatment|Disease progression/recurrence|72|||
23265493|NCT04025879|64714378|FG000|Treatment|Study drug toxicity|36|||
23265494|NCT04025879|64714379|FG001|Treatment|Study drug toxicity|13|||
23265495|NCT04025879|64714378|FG000|Treatment|Death|2|||
23265496|NCT04025879|64714379|FG001|Treatment|Death|0|||
23265497|NCT04025879|64714378|FG000|Treatment|Adverse event unrelated to study drug|21|||
23362427|NCT02948829|65072841|FG000|Overall Study|Other: Reason not Specified|8|||
23600972|NCT02823574|65929799|FG001|Randomization|Disease Progression|0|||
23362428|NCT00181883|65072842|FG000|Overall Study|Lack of Efficacy|2|||
23362429|NCT00181883|65072842|FG000|Overall Study|Treatment Limiting AEs|3|||
23362430|NCT00181883|65072842|FG000|Overall Study|Withdrawal by Subject|4|||
23362431|NCT00181883|65072842|FG000|Overall Study|Lost to Follow-up|1|||
23362432|NCT00613821|65072843|FG000|Overall Study|Withdrawal by Subject|1|||
23362433|NCT00613821|65072844|FG001|Overall Study|Withdrawal by Subject|0|||
23362434|NCT00613821|65072843|FG000|Overall Study|Physician Decision|1|||
23362435|NCT00613821|65072844|FG001|Overall Study|Physician Decision|1|||
23362436|NCT01247350|65072847|FG000|Overall Study|Adverse Event|0|||
23362437|NCT01247350|65072848|FG001|Overall Study|Adverse Event|0|||
23362438|NCT01247350|65072849|FG002|Overall Study|Adverse Event|1|||
23362439|NCT01247350|65072850|FG003|Overall Study|Adverse Event|0|||
23362440|NCT01247350|65072851|FG004|Overall Study|Adverse Event|0|||
23362441|NCT01247350|65072847|FG000|Overall Study|Withdrawal by Subject|0|||
23362442|NCT01247350|65072848|FG001|Overall Study|Withdrawal by Subject|0|||
23362443|NCT01247350|65072849|FG002|Overall Study|Withdrawal by Subject|0|||
23362444|NCT01247350|65072850|FG003|Overall Study|Withdrawal by Subject|1|||
23362445|NCT01247350|65072851|FG004|Overall Study|Withdrawal by Subject|0|||
23362446|NCT01247350|65072847|FG000|Overall Study|Entry criteria not met|0|||
23362447|NCT01247350|65072848|FG001|Overall Study|Entry criteria not met|0|||
23362448|NCT01247350|65072849|FG002|Overall Study|Entry criteria not met|0|||
23362449|NCT01247350|65072850|FG003|Overall Study|Entry criteria not met|0|||
23362450|NCT01247350|65072851|FG004|Overall Study|Entry criteria not met|1|||
23362451|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Other than specified|2|||
23362452|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Other than specified|4|||
23362453|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
23362454|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
23362455|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Pregnancy|0|||
23362456|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Pregnancy|2|||
23362457|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Physician Decision|1|||
23362458|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Physician Decision|1|||
23362459|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
23362460|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
23362461|NCT02003144|65072852|FG000|Open Label Maintenance Phase|Adverse Event|2|||
23362462|NCT02003144|65072853|FG001|Open Label Maintenance Phase|Adverse Event|1|||
23362463|NCT04110314|65072854|FG000|Overall Study|Did not meet inclusion criteria|35255|||
23362464|NCT04110314|65072855|FG001|Overall Study|Did not meet inclusion criteria|35104|||
23362465|NCT04110314|65072856|FG002|Overall Study|Did not meet inclusion criteria|35636|||
23362466|NCT04110314|65072857|FG003|Overall Study|Did not meet inclusion criteria|35135|||
23362467|NCT04110314|65072858|FG004|Overall Study|Did not meet inclusion criteria|35247|||
23362468|NCT04110314|65072859|FG005|Overall Study|Did not meet inclusion criteria|35727|||
23362469|NCT03284853|65072860|FG000|Overall Study|Adverse Event|40|||
23362470|NCT03284853|65072861|FG001|Overall Study|Adverse Event|4|||
23362471|NCT03284853|65072860|FG000|Overall Study|Withdrawal by Subject|5|||
23362472|NCT03284853|65072861|FG001|Overall Study|Withdrawal by Subject|1|||
23362473|NCT03284853|65072860|FG000|Overall Study|Lost to Follow-up|1|||
23362474|NCT03284853|65072861|FG001|Overall Study|Lost to Follow-up|0|||
23362475|NCT03284853|65072860|FG000|Overall Study|Lack of Efficacy|1|||
23362476|NCT03284853|65072861|FG001|Overall Study|Lack of Efficacy|0|||
23362477|NCT03284853|65072860|FG000|Overall Study|Disallowed Concurrent Medication|1|||
23362478|NCT03284853|65072861|FG001|Overall Study|Disallowed Concurrent Medication|1|||
23362479|NCT03284853|65072860|FG000|Overall Study|Protocol Violation|3|||
23362480|NCT03284853|65072861|FG001|Overall Study|Protocol Violation|3|||
23362481|NCT03284853|65072860|FG000|Overall Study|Death|0|||
23362482|NCT03284853|65072861|FG001|Overall Study|Death|1|||
23362483|NCT03284853|65072860|FG000|Overall Study|Other - Reason not reported in CSR|4|||
23362484|NCT03284853|65072861|FG001|Overall Study|Other - Reason not reported in CSR|3|||
23362485|NCT02302846|65072864|FG000|Overall Study|Withdrawal by Subject|1|||
23362486|NCT00490919|65072866|FG000|Open-label Run-in Period|Adverse Event|239|||
23362487|NCT00490919|65072867|FG001|Open-label Run-in Period|Adverse Event|0|||
23362488|NCT00490919|65072868|FG002|Open-label Run-in Period|Adverse Event|0|||
23362489|NCT00490919|65072866|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
23362490|NCT00490919|65072867|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
23362491|NCT00490919|65072868|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
23362492|NCT00490919|65072866|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
23362493|NCT00490919|65072867|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
23362494|NCT00490919|65072868|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
23362495|NCT00490919|65072866|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
23362496|NCT00490919|65072867|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
23362497|NCT00490919|65072868|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
23362498|NCT00490919|65072866|FG000|Open-label Run-in Period|Administrative|40|||
23362499|NCT00490919|65072867|FG001|Open-label Run-in Period|Administrative|0|||
23362500|NCT00490919|65072868|FG002|Open-label Run-in Period|Administrative|0|||
23362501|NCT00490919|65072866|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
23600973|NCT02823574|65929800|FG002|Randomization|Disease Progression|1|||
23362502|NCT00490919|65072867|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
23362503|NCT00490919|65072868|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
23362504|NCT00490919|65072866|FG000|Double-blind Phase|Adverse Event|0|||
23362505|NCT00490919|65072867|FG001|Double-blind Phase|Adverse Event|40|||
23362506|NCT00490919|65072868|FG002|Double-blind Phase|Adverse Event|20|||
23362507|NCT00490919|65072866|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23362508|NCT00490919|65072867|FG001|Double-blind Phase|Withdrawal by Subject|10|||
23362509|NCT00490919|65072868|FG002|Double-blind Phase|Withdrawal by Subject|11|||
23362510|NCT00490919|65072866|FG000|Double-blind Phase|Lost to Follow-up|0|||
23362511|NCT00490919|65072867|FG001|Double-blind Phase|Lost to Follow-up|8|||
23362512|NCT00490919|65072868|FG002|Double-blind Phase|Lost to Follow-up|11|||
23362513|NCT00490919|65072866|FG000|Double-blind Phase|Lack of Efficacy|0|||
23362514|NCT00490919|65072867|FG001|Double-blind Phase|Lack of Efficacy|22|||
23362515|NCT00490919|65072868|FG002|Double-blind Phase|Lack of Efficacy|36|||
23362516|NCT00490919|65072866|FG000|Double-blind Phase|Administrative|0|||
23362517|NCT00490919|65072867|FG001|Double-blind Phase|Administrative|6|||
23362518|NCT00490919|65072868|FG002|Double-blind Phase|Administrative|6|||
23362519|NCT04529538|65072869|FG000|Overall Study|Lost to Follow-up|3|||
23362520|NCT04529538|65072870|FG001|Overall Study|Lost to Follow-up|2|||
23362521|NCT04529538|65072871|FG002|Overall Study|Lost to Follow-up|1|||
23362522|NCT04529538|65072872|FG003|Overall Study|Lost to Follow-up|0|||
23362523|NCT04529538|65072873|FG004|Overall Study|Lost to Follow-up|1|||
23362524|NCT04529538|65072874|FG005|Overall Study|Lost to Follow-up|1|||
23362525|NCT04529538|65072875|FG006|Overall Study|Lost to Follow-up|2|||
23362526|NCT04529538|65072876|FG007|Overall Study|Lost to Follow-up|0|||
23362527|NCT04529538|65072869|FG000|Overall Study|Not eligible at enrollment|0|||
23362528|NCT04529538|65072870|FG001|Overall Study|Not eligible at enrollment|1|||
23362529|NCT04529538|65072871|FG002|Overall Study|Not eligible at enrollment|2|||
23362530|NCT04529538|65072872|FG003|Overall Study|Not eligible at enrollment|1|||
23362531|NCT04529538|65072873|FG004|Overall Study|Not eligible at enrollment|0|||
23362532|NCT04529538|65072874|FG005|Overall Study|Not eligible at enrollment|0|||
23362533|NCT04529538|65072875|FG006|Overall Study|Not eligible at enrollment|0|||
23362534|NCT04529538|65072876|FG007|Overall Study|Not eligible at enrollment|1|||
23362535|NCT04529538|65072869|FG000|Overall Study|Withdrawal by Subject|0|||
23362536|NCT04529538|65072870|FG001|Overall Study|Withdrawal by Subject|1|||
23362537|NCT04529538|65072871|FG002|Overall Study|Withdrawal by Subject|1|||
23362538|NCT04529538|65072872|FG003|Overall Study|Withdrawal by Subject|2|||
23362539|NCT04529538|65072873|FG004|Overall Study|Withdrawal by Subject|0|||
23362540|NCT04529538|65072874|FG005|Overall Study|Withdrawal by Subject|2|||
23362541|NCT04529538|65072875|FG006|Overall Study|Withdrawal by Subject|3|||
23362542|NCT04529538|65072876|FG007|Overall Study|Withdrawal by Subject|0|||
23362543|NCT04529538|65072869|FG000|Overall Study|Other|0|||
23362544|NCT04529538|65072870|FG001|Overall Study|Other|1|||
23362545|NCT04529538|65072871|FG002|Overall Study|Other|0|||
23362546|NCT04529538|65072872|FG003|Overall Study|Other|0|||
23362547|NCT04529538|65072873|FG004|Overall Study|Other|0|||
23362548|NCT04529538|65072874|FG005|Overall Study|Other|0|||
23362549|NCT04529538|65072875|FG006|Overall Study|Other|0|||
23362550|NCT04529538|65072876|FG007|Overall Study|Other|0|||
23362551|NCT04529538|65072869|FG000|Overall Study|Adverse Event|0|||
23362552|NCT04529538|65072870|FG001|Overall Study|Adverse Event|0|||
23362553|NCT04529538|65072871|FG002|Overall Study|Adverse Event|0|||
23362554|NCT04529538|65072872|FG003|Overall Study|Adverse Event|1|||
23362555|NCT04529538|65072873|FG004|Overall Study|Adverse Event|0|||
23362556|NCT04529538|65072874|FG005|Overall Study|Adverse Event|0|||
23362557|NCT04529538|65072875|FG006|Overall Study|Adverse Event|0|||
23362558|NCT04529538|65072876|FG007|Overall Study|Adverse Event|0|||
23362559|NCT04529538|65072869|FG000|Overall Study|Protocol Deviation|0|||
23362560|NCT04529538|65072870|FG001|Overall Study|Protocol Deviation|0|||
23362561|NCT04529538|65072871|FG002|Overall Study|Protocol Deviation|0|||
23362562|NCT04529538|65072872|FG003|Overall Study|Protocol Deviation|1|||
23362563|NCT04529538|65072873|FG004|Overall Study|Protocol Deviation|0|||
23362564|NCT04529538|65072874|FG005|Overall Study|Protocol Deviation|0|||
23362565|NCT04529538|65072875|FG006|Overall Study|Protocol Deviation|0|||
23362566|NCT04529538|65072876|FG007|Overall Study|Protocol Deviation|0|||
23362567|NCT04529538|65072869|FG000|Overall Study|Physician Decision|0|||
23362568|NCT04529538|65072870|FG001|Overall Study|Physician Decision|0|||
23600974|NCT02823574|65929801|FG003|Randomization|Disease Progression|0|||
23600975|NCT02823574|65929798|FG000|Randomization|AE unrelated to Study Drug|1|||
23362569|NCT04529538|65072871|FG002|Overall Study|Physician Decision|0|||
23600976|NCT02823574|65929799|FG001|Randomization|AE unrelated to Study Drug|0|||
23362570|NCT04529538|65072872|FG003|Overall Study|Physician Decision|0|||
23362571|NCT04529538|65072873|FG004|Overall Study|Physician Decision|0|||
23600977|NCT02823574|65929800|FG002|Randomization|AE unrelated to Study Drug|0|||
23362572|NCT04529538|65072874|FG005|Overall Study|Physician Decision|1|||
23362573|NCT04529538|65072875|FG006|Overall Study|Physician Decision|0|||
23362574|NCT04529538|65072876|FG007|Overall Study|Physician Decision|1|||
23362575|NCT02688933|65072877|FG000|Overall Study|Adverse Event|3|||
23265498|NCT04025879|64714379|FG001|Treatment|Adverse event unrelated to study drug|14|||
23265499|NCT04025879|64714378|FG000|Treatment|Participant request to discontinue study treatment|16|||
23265500|NCT04025879|64714379|FG001|Treatment|Participant request to discontinue study treatment|8|||
23265501|NCT04025879|64714378|FG000|Treatment|Participant withdrew consent|1|||
23265502|NCT04025879|64714379|FG001|Treatment|Participant withdrew consent|3|||
23265503|NCT04025879|64714378|FG000|Treatment|Participant no longer meets study criteria|3|||
23265504|NCT04025879|64714379|FG001|Treatment|Participant no longer meets study criteria|2|||
23265505|NCT04025879|64714378|FG000|Treatment|Lost to Follow-up|1|||
23265506|NCT04025879|64714379|FG001|Treatment|Lost to Follow-up|0|||
23265507|NCT04025879|64714378|FG000|Treatment|Other reasons|15|||
23265508|NCT04025879|64714379|FG001|Treatment|Other reasons|17|||
23265509|NCT04025879|64714378|FG000|Treatment|Administrative reason by sponsor|0|||
23265510|NCT04025879|64714379|FG001|Treatment|Administrative reason by sponsor|1|||
23265511|NCT04025879|64714378|FG000|Treatment|Not reported|2|||
23265512|NCT04025879|64714379|FG001|Treatment|Not reported|0|||
23265513|NCT02003183|64714380|FG000|Overall Study|Lost to Follow-up|0|||
23265514|NCT02003183|64714381|FG001|Overall Study|Lost to Follow-up|2|||
23265515|NCT02374918|64714383|FG000|Overall Study|Protocol Violation|2|||
23265516|NCT02374918|64714384|FG001|Overall Study|Protocol Violation|0|||
23265517|NCT02374918|64714385|FG002|Overall Study|Protocol Violation|2|||
23265518|NCT02374918|64714386|FG003|Overall Study|Protocol Violation|1|||
23265519|NCT02374918|64714383|FG000|Overall Study|Withdrawal by Subject|1|||
23265520|NCT02374918|64714384|FG001|Overall Study|Withdrawal by Subject|1|||
23265521|NCT02374918|64714385|FG002|Overall Study|Withdrawal by Subject|1|||
23265522|NCT02374918|64714386|FG003|Overall Study|Withdrawal by Subject|0|||
23265523|NCT02374918|64714383|FG000|Overall Study|Lack of Efficacy|0|||
23265524|NCT02374918|64714384|FG001|Overall Study|Lack of Efficacy|0|||
23265525|NCT02374918|64714385|FG002|Overall Study|Lack of Efficacy|1|||
23265526|NCT02374918|64714386|FG003|Overall Study|Lack of Efficacy|1|||
23265527|NCT01937390|64714390|FG000|Overall Study|Death|2|||
23265528|NCT01937390|64714390|FG000|Overall Study|Lost to Follow-up|7|||
23265529|NCT01937390|64714390|FG000|Overall Study|Withdrawal by Subject|5|||
23265530|NCT01937390|64714390|FG000|Overall Study|Fail to return|21|||
23265531|NCT00387712|64714391|FG000|Overall Study|Physician Decision|6|||
23265532|NCT00387712|64714392|FG001|Overall Study|Physician Decision|4|||
23265533|NCT00387712|64714391|FG000|Overall Study|Lost to Follow-up|17|||
23265534|NCT00387712|64714392|FG001|Overall Study|Lost to Follow-up|20|||
23265535|NCT00387712|64714391|FG000|Overall Study|Withdrawal by Subject|6|||
23265536|NCT00387712|64714392|FG001|Overall Study|Withdrawal by Subject|12|||
23265537|NCT00337077|64714393|FG000|Overall Study|Progressive disease|25|||
23265538|NCT00337077|64714394|FG001|Overall Study|Progressive disease|37|||
23265539|NCT00337077|64714395|FG002|Overall Study|Progressive disease|19|||
23265540|NCT00337077|64714393|FG000|Overall Study|Adverse Event|7|||
23265541|NCT00337077|64714394|FG001|Overall Study|Adverse Event|7|||
23265542|NCT00337077|64714395|FG002|Overall Study|Adverse Event|1|||
23265543|NCT00337077|64714393|FG000|Overall Study|Death|0|||
23265544|NCT00337077|64714394|FG001|Overall Study|Death|1|||
23265545|NCT00337077|64714395|FG002|Overall Study|Death|0|||
23265546|NCT00337077|64714393|FG000|Overall Study|Withdrawal by Subject|7|||
23265547|NCT00337077|64714394|FG001|Overall Study|Withdrawal by Subject|2|||
23265548|NCT00337077|64714395|FG002|Overall Study|Withdrawal by Subject|2|||
23265549|NCT00337077|64714393|FG000|Overall Study|Alternative therapy|1|||
23265550|NCT00337077|64714394|FG001|Overall Study|Alternative therapy|0|||
23265551|NCT00337077|64714395|FG002|Overall Study|Alternative therapy|0|||
23265552|NCT00337077|64714393|FG000|Overall Study|Physician Decision|1|||
23362576|NCT02688933|65072878|FG001|Overall Study|Adverse Event|1|||
23362577|NCT02688933|65072877|FG000|Overall Study|Lack of Efficacy|2|||
23362578|NCT02688933|65072878|FG001|Overall Study|Lack of Efficacy|2|||
23362579|NCT02688933|65072877|FG000|Overall Study|Poor compliance to protocol|7|||
23362580|NCT02688933|65072878|FG001|Overall Study|Poor compliance to protocol|4|||
23362581|NCT02688933|65072877|FG000|Overall Study|Hypoglycemia|2|||
23362582|NCT02688933|65072878|FG001|Overall Study|Hypoglycemia|0|||
23362583|NCT02688933|65072877|FG000|Overall Study|Other than Specified|14|||
23362584|NCT02688933|65072878|FG001|Overall Study|Other than Specified|25|||
23362585|NCT02688933|65072877|FG000|Overall Study|Lost to Follow-up|1|||
23265553|NCT00337077|64714394|FG001|Overall Study|Physician Decision|4|||
23265554|NCT00337077|64714395|FG002|Overall Study|Physician Decision|2|||
23265555|NCT00337077|64714393|FG000|Overall Study|Never started treatment|1|||
23265556|NCT00337077|64714394|FG001|Overall Study|Never started treatment|1|||
23265557|NCT00337077|64714395|FG002|Overall Study|Never started treatment|0|||
23265558|NCT00337077|64714393|FG000|Overall Study|Ineligible|1|||
23265559|NCT00337077|64714394|FG001|Overall Study|Ineligible|1|||
23265560|NCT00337077|64714395|FG002|Overall Study|Ineligible|1|||
23265561|NCT00576381|64714396|FG000|Overall Study|Reoperation|3|||
23265562|NCT00576381|64714396|FG000|Overall Study|Adverse Event|4|||
23265563|NCT00881621|64714399|FG000|Overall Study|Physician Decision|34|||
23265564|NCT01469546|64714400|FG000|Received 5 mg Dose|Adverse Event|13|||
23265565|NCT01469546|64714400|FG000|Received 5 mg Dose|Death|2|||
23265566|NCT01469546|64714400|FG000|Received 5 mg Dose|Protocol Violation|2|||
23265567|NCT01469546|64714400|FG000|Received 5 mg Dose|Progressive Disease|3|||
23265568|NCT01469546|64714400|FG000|Received 5 mg Dose|Physician Decision|3|||
23265569|NCT00925769|64714401|FG000|Overall Study|Major toxicity|1|||
23265570|NCT00925769|64714402|FG001|Overall Study|Major toxicity|0|||
23362586|NCT02688933|65072878|FG001|Overall Study|Lost to Follow-up|5|||
23362587|NCT02291029|65072882|FG000|Overall Study|Withdrawal by Subject|0|||
23362588|NCT02291029|65072883|FG001|Overall Study|Withdrawal by Subject|0|||
23362589|NCT02291029|65072884|FG002|Overall Study|Withdrawal by Subject|1|||
23362590|NCT02291029|65072885|FG003|Overall Study|Withdrawal by Subject|0|||
23362591|NCT02291029|65072886|FG004|Overall Study|Withdrawal by Subject|0|||
23362592|NCT02291029|65072887|FG005|Overall Study|Withdrawal by Subject|0|||
23362593|NCT02291029|65072882|FG000|Overall Study|Adverse Event|0|||
23362594|NCT02291029|65072883|FG001|Overall Study|Adverse Event|1|||
23362595|NCT02291029|65072884|FG002|Overall Study|Adverse Event|0|||
23362596|NCT02291029|65072885|FG003|Overall Study|Adverse Event|0|||
23362597|NCT02291029|65072886|FG004|Overall Study|Adverse Event|0|||
23362598|NCT02291029|65072887|FG005|Overall Study|Adverse Event|0|||
23362599|NCT02322749|65072890|FG000|Period 2|Adverse Event|0|||
23362600|NCT02322749|65072891|FG001|Period 2|Adverse Event|0|||
23362601|NCT02322749|65072892|FG002|Period 2|Adverse Event|0|||
23362602|NCT02322749|65072893|FG003|Period 2|Adverse Event|1|||
23362603|NCT02322749|65072894|FG004|Period 2|Adverse Event|0|||
23362604|NCT02322749|65072895|FG005|Period 2|Adverse Event|0|||
23362605|NCT02322749|65072890|FG000|Period 2|Withdrawal by Subject|0|||
23362606|NCT02322749|65072891|FG001|Period 2|Withdrawal by Subject|0|||
23362607|NCT02322749|65072892|FG002|Period 2|Withdrawal by Subject|0|||
23362608|NCT02322749|65072893|FG003|Period 2|Withdrawal by Subject|1|||
23362609|NCT02322749|65072894|FG004|Period 2|Withdrawal by Subject|0|||
23362610|NCT02322749|65072895|FG005|Period 2|Withdrawal by Subject|0|||
23362611|NCT02322749|65072890|FG000|Period 3|Withdrawal by Subject|0|||
23362612|NCT02322749|65072891|FG001|Period 3|Withdrawal by Subject|0|||
23362613|NCT02322749|65072892|FG002|Period 3|Withdrawal by Subject|1|||
23362614|NCT02322749|65072893|FG003|Period 3|Withdrawal by Subject|0|||
23362615|NCT02322749|65072894|FG004|Period 3|Withdrawal by Subject|0|||
23362616|NCT02322749|65072895|FG005|Period 3|Withdrawal by Subject|0|||
23362617|NCT05502302|65072897|FG000|Overall Study|Lost to Follow-up|6|||
23362618|NCT05502302|65072897|FG000|Overall Study|Death|2|||
23362619|NCT01675492|65072898|FG000|Overall Study|study completed early - product approval|42|||
23362620|NCT02090283|65072899|FG000|Overall Study|Withdrawal by Subject|6|||
23265571|NCT00925769|64714403|FG002|Overall Study|Major toxicity|1|||
23265572|NCT00925769|64714404|FG003|Overall Study|Major toxicity|1|||
23362621|NCT02090283|65072900|FG001|Overall Study|Withdrawal by Subject|6|||
23265573|NCT00925769|64714405|FG004|Overall Study|Major toxicity|0|||
23265574|NCT00925769|64714406|FG005|Overall Study|Major toxicity|0|||
23265575|NCT00925769|64714401|FG000|Overall Study|Disease progression|4|||
23362622|NCT02090283|65072901|FG002|Overall Study|Withdrawal by Subject|6|||
23362623|NCT02090283|65072899|FG000|Overall Study|Sponsor Terminated Study|6|||
23362624|NCT02090283|65072900|FG001|Overall Study|Sponsor Terminated Study|6|||
23362625|NCT02090283|65072901|FG002|Overall Study|Sponsor Terminated Study|1|||
23362626|NCT02090283|65072899|FG000|Overall Study|Lost to Follow-up|2|||
23362627|NCT02090283|65072900|FG001|Overall Study|Lost to Follow-up|2|||
23362628|NCT02090283|65072901|FG002|Overall Study|Lost to Follow-up|3|||
23362629|NCT02090283|65072899|FG000|Overall Study|Adverse Event|1|||
23362630|NCT02090283|65072900|FG001|Overall Study|Adverse Event|1|||
23362631|NCT02090283|65072901|FG002|Overall Study|Adverse Event|0|||
23362632|NCT02090283|65072899|FG000|Overall Study|Protocol Violation|2|||
23362633|NCT02090283|65072900|FG001|Overall Study|Protocol Violation|0|||
23362634|NCT02090283|65072901|FG002|Overall Study|Protocol Violation|0|||
23362635|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
23362636|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
23362637|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
23362638|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
23362639|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
23362640|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
23362641|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
23362642|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
23362643|NCT00972283|65072902|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
23362644|NCT00972283|65072903|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
23362645|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
23362646|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
23362647|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
23362648|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
23362649|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
23362650|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
23362651|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
23362652|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
23362653|NCT00972283|65072902|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
23362654|NCT00972283|65072903|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
23362655|NCT00534248|65072904|FG000|Overall Study|Adverse Event|19|||
23362656|NCT00534248|65072905|FG001|Overall Study|Adverse Event|29|||
23362657|NCT00534248|65072904|FG000|Overall Study|Lost to Follow-up|353|||
23362658|NCT00534248|65072905|FG001|Overall Study|Lost to Follow-up|375|||
23362659|NCT00534248|65072904|FG000|Overall Study|Other protocol specified criteria|13|||
23362660|NCT00534248|65072905|FG001|Overall Study|Other protocol specified criteria|3|||
23362661|NCT00534248|65072904|FG000|Overall Study|Physician Decision|10|||
23362662|NCT00534248|65072905|FG001|Overall Study|Physician Decision|7|||
23362663|NCT00534248|65072904|FG000|Overall Study|Protocol Violation|3|||
23362664|NCT00534248|65072905|FG001|Overall Study|Protocol Violation|4|||
23362665|NCT00534248|65072904|FG000|Overall Study|Withdrawal by Subject|263|||
23362666|NCT00534248|65072905|FG001|Overall Study|Withdrawal by Subject|255|||
23362667|NCT04877990|65072906|FG000|Treatment|Other reasons|3|||
23362668|NCT04877990|65072907|FG001|Treatment|Other reasons|1|||
23362669|NCT04877990|65072906|FG000|Treatment|Administrative reasons by sponsor|17|||
23362670|NCT04877990|65072907|FG001|Treatment|Administrative reasons by sponsor|33|||
23362671|NCT04877990|65072906|FG000|Treatment|Withdrawal by Subject|2|||
23362672|NCT04877990|65072907|FG001|Treatment|Withdrawal by Subject|6|||
23362673|NCT04877990|65072906|FG000|Treatment|Adverse Event|2|||
23362674|NCT04877990|65072907|FG001|Treatment|Adverse Event|1|||
23362675|NCT01450813|65072908|FG000|Overall Study|Physician Decision|1|||
23362676|NCT01450813|65072909|FG001|Overall Study|Physician Decision|1|||
23362677|NCT01450813|65072910|FG002|Overall Study|Physician Decision|0|||
23362678|NCT01450813|65072911|FG003|Overall Study|Physician Decision|3|||
23362679|NCT01853748|65072912|FG000|Allocation|Withdrawal by Subject|1|||
23362680|NCT01853748|65072913|FG001|Allocation|Withdrawal by Subject|13|||
23362681|NCT01853748|65072912|FG000|Allocation|not sufficient to receive intervention|0|||
23265576|NCT00925769|64714402|FG001|Overall Study|Disease progression|5|||
23265577|NCT00925769|64714403|FG002|Overall Study|Disease progression|3|||
23265578|NCT00925769|64714404|FG003|Overall Study|Disease progression|4|||
23265579|NCT00925769|64714405|FG004|Overall Study|Disease progression|2|||
23265580|NCT00925769|64714406|FG005|Overall Study|Disease progression|3|||
23265581|NCT00925769|64714401|FG000|Overall Study|Death|0|||
23265582|NCT00925769|64714402|FG001|Overall Study|Death|0|||
23265583|NCT00925769|64714403|FG002|Overall Study|Death|1|||
23265584|NCT00925769|64714404|FG003|Overall Study|Death|0|||
23265585|NCT00925769|64714405|FG004|Overall Study|Death|0|||
23265586|NCT00925769|64714406|FG005|Overall Study|Death|0|||
23265587|NCT00925769|64714401|FG000|Overall Study|Physician Decision|1|||
23265588|NCT00925769|64714402|FG001|Overall Study|Physician Decision|0|||
23265589|NCT00925769|64714403|FG002|Overall Study|Physician Decision|0|||
23265590|NCT00925769|64714404|FG003|Overall Study|Physician Decision|0|||
23265591|NCT00925769|64714405|FG004|Overall Study|Physician Decision|0|||
23265592|NCT00925769|64714406|FG005|Overall Study|Physician Decision|0|||
23362682|NCT01853748|65072913|FG001|Allocation|not sufficient to receive intervention|1|||
23362683|NCT01853748|65072912|FG000|Follow-Up|Withdrawal by Subject|7|||
23362684|NCT01853748|65072913|FG001|Follow-Up|Withdrawal by Subject|6|||
23480572|NCT00998764|65502023|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
23600978|NCT02823574|65929801|FG003|Randomization|AE unrelated to Study Drug|0|||
23265593|NCT00925769|64714401|FG000|Overall Study|Missing documentation|0|||
23265594|NCT00925769|64714402|FG001|Overall Study|Missing documentation|1|||
23265595|NCT00925769|64714403|FG002|Overall Study|Missing documentation|0|||
23265596|NCT00925769|64714404|FG003|Overall Study|Missing documentation|0|||
23265597|NCT00925769|64714405|FG004|Overall Study|Missing documentation|0|||
23265598|NCT00925769|64714406|FG005|Overall Study|Missing documentation|0|||
23265599|NCT00925769|64714401|FG000|Overall Study|End of study visit not done|0|||
23265600|NCT00925769|64714402|FG001|Overall Study|End of study visit not done|0|||
23265601|NCT00925769|64714403|FG002|Overall Study|End of study visit not done|1|||
23265602|NCT00925769|64714404|FG003|Overall Study|End of study visit not done|0|||
23265603|NCT00925769|64714405|FG004|Overall Study|End of study visit not done|0|||
23265604|NCT00925769|64714406|FG005|Overall Study|End of study visit not done|0|||
23265605|NCT00925769|64714401|FG000|Overall Study|Participant is unable to swallow drug|0|||
23265606|NCT00925769|64714402|FG001|Overall Study|Participant is unable to swallow drug|0|||
23265607|NCT00925769|64714403|FG002|Overall Study|Participant is unable to swallow drug|0|||
23265608|NCT00925769|64714404|FG003|Overall Study|Participant is unable to swallow drug|1|||
23265609|NCT00925769|64714405|FG004|Overall Study|Participant is unable to swallow drug|0|||
23265610|NCT00925769|64714406|FG005|Overall Study|Participant is unable to swallow drug|0|||
23265611|NCT00925769|64714401|FG000|Overall Study|Adverse Event|0|||
23265612|NCT00925769|64714402|FG001|Overall Study|Adverse Event|0|||
23265613|NCT00925769|64714403|FG002|Overall Study|Adverse Event|0|||
23265614|NCT00925769|64714404|FG003|Overall Study|Adverse Event|0|||
23600979|NCT02823574|65929798|FG000|Treatment Period|Poor/Non Compliance|1|||
23600980|NCT02823574|65929799|FG001|Treatment Period|Poor/Non Compliance|0|||
23600981|NCT02823574|65929800|FG002|Treatment Period|Poor/Non Compliance|0|||
23600982|NCT02823574|65929801|FG003|Treatment Period|Poor/Non Compliance|1|||
23600983|NCT02823574|65929798|FG000|Treatment Period|Maximum Clinical Benefit|8|||
23600984|NCT02823574|65929799|FG001|Treatment Period|Maximum Clinical Benefit|4|||
23600985|NCT02823574|65929800|FG002|Treatment Period|Maximum Clinical Benefit|7|||
23600986|NCT02823574|65929801|FG003|Treatment Period|Maximum Clinical Benefit|1|||
23600987|NCT02823574|65929798|FG000|Treatment Period|Lost to Follow-up|1|||
23600988|NCT02823574|65929799|FG001|Treatment Period|Lost to Follow-up|1|||
23600989|NCT02823574|65929800|FG002|Treatment Period|Lost to Follow-up|0|||
23600990|NCT02823574|65929801|FG003|Treatment Period|Lost to Follow-up|0|||
23600991|NCT02823574|65929798|FG000|Treatment Period|Participant withdrew consent|4|||
23600992|NCT02823574|65929799|FG001|Treatment Period|Participant withdrew consent|0|||
23600993|NCT02823574|65929800|FG002|Treatment Period|Participant withdrew consent|0|||
23600994|NCT02823574|65929801|FG003|Treatment Period|Participant withdrew consent|1|||
23600995|NCT02823574|65929798|FG000|Treatment Period|Participant request to discontinue|5|||
23600996|NCT02823574|65929799|FG001|Treatment Period|Participant request to discontinue|0|||
23600997|NCT02823574|65929800|FG002|Treatment Period|Participant request to discontinue|3|||
23600998|NCT02823574|65929801|FG003|Treatment Period|Participant request to discontinue|2|||
23265615|NCT00925769|64714405|FG004|Overall Study|Adverse Event|1|||
23265616|NCT00925769|64714406|FG005|Overall Study|Adverse Event|0|||
23265617|NCT02514174|64714407|FG000|Overall Study|Patient refused to continue medication|1|||
23265618|NCT02514174|64714407|FG000|Overall Study|Adverse Event|2|||
23265619|NCT02514174|64714407|FG000|Overall Study|Study closed by sponsor|9|||
23265620|NCT02514174|64714407|FG000|Overall Study|Progressive disease|11|||
23265621|NCT02514174|64714407|FG000|Overall Study|Treatment change|1|||
23265622|NCT02514174|64714407|FG000|Overall Study|Treated off study with Afatinib.|1|||
23362685|NCT01853748|65072912|FG000|Follow-Up|Adverse Event|67|||
23362686|NCT01853748|65072913|FG001|Follow-Up|Adverse Event|7|||
23362687|NCT01853748|65072912|FG000|Follow-Up|not available for data collection|16|||
23362688|NCT01853748|65072913|FG001|Follow-Up|not available for data collection|4|||
23362689|NCT02324361|65072915|FG000|Overall Study|Lost to Follow-up|5|||
23362690|NCT02324361|65072916|FG001|Overall Study|Lost to Follow-up|2|||
23362691|NCT00807365|65072917|FG000|Overall Study|Study Terminated|5|||
23362692|NCT03654729|65072918|FG000|Overall Study|Death|9|||
23362693|NCT03654729|65072919|FG001|Overall Study|Death|9|||
23362694|NCT03654729|65072920|FG002|Overall Study|Death|16|||
23362695|NCT03654729|65072918|FG000|Overall Study|Withdrawal by Subject|8|||
23362696|NCT03654729|65072919|FG001|Overall Study|Withdrawal by Subject|6|||
23362697|NCT03654729|65072920|FG002|Overall Study|Withdrawal by Subject|4|||
23362698|NCT03654729|65072918|FG000|Overall Study|Study terminated by Sponsor|3|||
23362699|NCT03654729|65072919|FG001|Overall Study|Study terminated by Sponsor|5|||
23362700|NCT03654729|65072920|FG002|Overall Study|Study terminated by Sponsor|4|||
23362701|NCT03654729|65072918|FG000|Overall Study|Not reported|2|||
23362702|NCT03654729|65072919|FG001|Overall Study|Not reported|4|||
23362703|NCT03654729|65072920|FG002|Overall Study|Not reported|5|||
23362704|NCT03654729|65072918|FG000|Overall Study|Progressive disease|3|||
23362705|NCT03654729|65072919|FG001|Overall Study|Progressive disease|0|||
23362706|NCT03654729|65072920|FG002|Overall Study|Progressive disease|0|||
23362707|NCT03654729|65072918|FG000|Overall Study|Lost to Follow-up|2|||
23362708|NCT03654729|65072919|FG001|Overall Study|Lost to Follow-up|0|||
23362709|NCT03654729|65072920|FG002|Overall Study|Lost to Follow-up|0|||
23362710|NCT03654729|65072918|FG000|Overall Study|Physician Decision|2|||
23362711|NCT03654729|65072919|FG001|Overall Study|Physician Decision|0|||
23362712|NCT03654729|65072920|FG002|Overall Study|Physician Decision|0|||
23362713|NCT03654729|65072918|FG000|Overall Study|Protocol Violation|1|||
23362714|NCT03654729|65072919|FG001|Overall Study|Protocol Violation|1|||
23362715|NCT03654729|65072920|FG002|Overall Study|Protocol Violation|0|||
23265623|NCT00743197|64714411|FG000|Overall Study|Study terminated due to departure of PI.|1|||
23265624|NCT00743197|64714412|FG001|Overall Study|Study terminated due to departure of PI.|2|||
23265625|NCT02863575|64714413|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
23265626|NCT02863575|64714414|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
23265627|NCT02863575|64714415|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
23265628|NCT02863575|64714413|FG000|Overall Study|Withdrawal by Subject|0|||
23265629|NCT02863575|64714414|FG001|Overall Study|Withdrawal by Subject|1|||
23265630|NCT02863575|64714415|FG002|Overall Study|Withdrawal by Subject|1|||
23265631|NCT02863575|64714413|FG000|Overall Study|Adverse Event|0|||
23265632|NCT02863575|64714414|FG001|Overall Study|Adverse Event|1|||
23265633|NCT02863575|64714415|FG002|Overall Study|Adverse Event|0|||
23265634|NCT01725451|64714416|FG000|Period 1|Withdrawal by Subject|1|||
23265635|NCT01725451|64714417|FG001|Period 1|Withdrawal by Subject|0|||
23265636|NCT01725451|64714418|FG002|Period 1|Withdrawal by Subject|0|||
23265637|NCT01725451|64714419|FG003|Period 1|Withdrawal by Subject|0|||
23265638|NCT01725451|64714416|FG000|Washout From Period 3|Protocol Violation|0|||
23265639|NCT01725451|64714417|FG001|Washout From Period 3|Protocol Violation|0|||
23265640|NCT01725451|64714418|FG002|Washout From Period 3|Protocol Violation|1|||
23265641|NCT01725451|64714419|FG003|Washout From Period 3|Protocol Violation|0|||
23265642|NCT01725451|64714416|FG000|Washout From Period 3|Adverse Event|0|||
23265643|NCT01725451|64714417|FG001|Washout From Period 3|Adverse Event|1|||
23265644|NCT01725451|64714418|FG002|Washout From Period 3|Adverse Event|0|||
23265645|NCT01725451|64714419|FG003|Washout From Period 3|Adverse Event|0|||
23265646|NCT01725451|64714416|FG000|Period 4|Adverse Event|0|||
23265647|NCT01725451|64714417|FG001|Period 4|Adverse Event|0|||
23265648|NCT01725451|64714418|FG002|Period 4|Adverse Event|1|||
23265649|NCT01725451|64714419|FG003|Period 4|Adverse Event|0|||
23265650|NCT01821625|64714420|FG000|Overall Study|Withdrawal by Subject|2|||
23265651|NCT01821625|64714420|FG000|Overall Study|Lack of Efficacy|2|||
23265652|NCT01821625|64714420|FG000|Overall Study|Adverse Event|1|||
23265653|NCT01821625|64714420|FG000|Overall Study|Medical contraindication|1|||
23265654|NCT00497796|64714421|FG000|Overall Study|Adverse event (not related)|9|||
23265655|NCT00497796|64714422|FG001|Overall Study|Adverse event (not related)|9|||
23362716|NCT03654729|65072918|FG000|Overall Study|Non-compliance with study drug|0|||
23362717|NCT03654729|65072919|FG001|Overall Study|Non-compliance with study drug|1|||
23362718|NCT03654729|65072920|FG002|Overall Study|Non-compliance with study drug|0|||
23362719|NCT03654729|65072918|FG000|Overall Study|Site terminated by Sponsor|1|||
23265656|NCT00497796|64714421|FG000|Overall Study|Adverse event (related)|5|||
23265657|NCT00497796|64714422|FG001|Overall Study|Adverse event (related)|4|||
23362720|NCT03654729|65072919|FG001|Overall Study|Site terminated by Sponsor|0|||
23362721|NCT03654729|65072920|FG002|Overall Study|Site terminated by Sponsor|0|||
23265658|NCT00497796|64714421|FG000|Overall Study|CMV infection or disease treatment|30|||
23362722|NCT01421641|65072931|FG000|Overall Study|Protocol Violation|2|||
23362723|NCT01421641|65072932|FG001|Overall Study|Protocol Violation|2|||
23265659|NCT00497796|64714422|FG001|Overall Study|CMV infection or disease treatment|4|||
23362724|NCT02221648|65072933|FG000|Overall Study|Withdrawal by Subject|3|||
23362725|NCT02221648|65072934|FG001|Overall Study|Withdrawal by Subject|3|||
23362726|NCT00527826|65072937|FG000|Overall Study|Adverse Event|10|||
23362727|NCT00527826|65072938|FG001|Overall Study|Adverse Event|10|||
23600999|NCT02823574|65929798|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
23601000|NCT02823574|65929799|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
23601001|NCT02823574|65929800|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
23601002|NCT02823574|65929801|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
23601003|NCT02823574|65929798|FG000|Treatment Period|Study Drug Toxicity|11|||
23601004|NCT02823574|65929799|FG001|Treatment Period|Study Drug Toxicity|2|||
23601005|NCT02823574|65929800|FG002|Treatment Period|Study Drug Toxicity|14|||
23601006|NCT02823574|65929801|FG003|Treatment Period|Study Drug Toxicity|4|||
23601007|NCT02823574|65929798|FG000|Treatment Period|Disease Progression|113|||
23601008|NCT02823574|65929799|FG001|Treatment Period|Disease Progression|64|||
23601009|NCT02823574|65929800|FG002|Treatment Period|Disease Progression|82|||
23601010|NCT02823574|65929801|FG003|Treatment Period|Disease Progression|43|||
23601011|NCT02823574|65929798|FG000|Treatment Period|Other reasons|5|||
23601012|NCT02823574|65929799|FG001|Treatment Period|Other reasons|9|||
23265660|NCT00497796|64714421|FG000|Overall Study|Consent withdrawn|10|||
23265661|NCT00497796|64714422|FG001|Overall Study|Consent withdrawn|3|||
23265662|NCT00497796|64714421|FG000|Overall Study|Investigator/sponsor discretion|31|||
23265663|NCT00497796|64714422|FG001|Overall Study|Investigator/sponsor discretion|34|||
23265664|NCT00497796|64714421|FG000|Overall Study|Lost to Follow-up|0|||
23265665|NCT00497796|64714422|FG001|Overall Study|Lost to Follow-up|1|||
23265666|NCT00497796|64714421|FG000|Overall Study|Not applicable (randomized not treated)|0|||
23265667|NCT00497796|64714422|FG001|Overall Study|Not applicable (randomized not treated)|4|||
23265668|NCT03036579|64714423|FG000|2 Years|Lost to Follow-up|1|||
23265669|NCT03036579|64714424|FG001|2 Years|Lost to Follow-up|0|||
23265670|NCT03036579|64714423|FG000|3 Years|Lost to Follow-up|0|||
23265671|NCT03036579|64714424|FG001|3 Years|Lost to Follow-up|1|||
23265672|NCT02324465|64714425|FG000|Overall Study|device failure|0|||
23265673|NCT02324465|64714426|FG001|Overall Study|device failure|1|||
23265674|NCT01054599|64714428|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
23265675|NCT01054599|64714429|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
23265676|NCT01054599|64714428|FG000|Overall Study|Protocol Violation|1|||
23265677|NCT01054599|64714429|FG001|Overall Study|Protocol Violation|0|||
23265678|NCT01054599|64714428|FG000|Overall Study|Spells/seizure-like episodes|1|||
23265679|NCT01054599|64714429|FG001|Overall Study|Spells/seizure-like episodes|1|||
23265680|NCT01054599|64714428|FG000|Overall Study|Timing/scheduling difficulties|1|||
23265681|NCT01054599|64714429|FG001|Overall Study|Timing/scheduling difficulties|1|||
23265682|NCT01054599|64714428|FG000|Overall Study|Visual impairment, WTAR <80|0|||
23265683|NCT01054599|64714429|FG001|Overall Study|Visual impairment, WTAR <80|1|||
23265684|NCT01054599|64714428|FG000|Overall Study|Lost to Follow-up|0|||
23265685|NCT01054599|64714429|FG001|Overall Study|Lost to Follow-up|2|||
23265686|NCT01054599|64714428|FG000|Overall Study|Adverse Event|0|||
23265687|NCT01054599|64714429|FG001|Overall Study|Adverse Event|1|||
23265688|NCT01054599|64714428|FG000|Overall Study|Withdrawal by Subject|0|||
23265689|NCT01054599|64714429|FG001|Overall Study|Withdrawal by Subject|1|||
23265690|NCT02199509|64714430|FG000|Overall Study|Suicidal Ideation|0|||
23265691|NCT02199509|64714431|FG001|Overall Study|Suicidal Ideation|1|||
23265692|NCT02199509|64714430|FG000|Overall Study|Misunderstood titration schedule|1|||
23265693|NCT02199509|64714431|FG001|Overall Study|Misunderstood titration schedule|0|||
23265694|NCT02623829|64714433|FG000|Overall Study|Lost to Follow-up|1|||
23265695|NCT02623829|64714434|FG001|Overall Study|Lost to Follow-up|1|||
23265696|NCT02563522|64714435|FG000|Overall Study|Adverse Event|2|||
23265697|NCT02563522|64714436|FG001|Overall Study|Adverse Event|3|||
23265698|NCT02563522|64714435|FG000|Overall Study|Lost to Follow-up|1|||
23265699|NCT02563522|64714436|FG001|Overall Study|Lost to Follow-up|0|||
23362728|NCT00527826|65072937|FG000|Overall Study|Lost to Follow-up|3|||
23362729|NCT00527826|65072938|FG001|Overall Study|Lost to Follow-up|2|||
23362730|NCT00527826|65072937|FG000|Overall Study|Withdrawal by Subject|5|||
23362731|NCT00527826|65072938|FG001|Overall Study|Withdrawal by Subject|8|||
23362732|NCT00527826|65072937|FG000|Overall Study|Inclusion Criteria Not Met|3|||
23362733|NCT00527826|65072938|FG001|Overall Study|Inclusion Criteria Not Met|3|||
23362734|NCT00527826|65072937|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
23362735|NCT00527826|65072938|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
23362736|NCT00527826|65072937|FG000|Overall Study|Additional Intake of Viani forte|0|||
23362737|NCT00527826|65072938|FG001|Overall Study|Additional Intake of Viani forte|1|||
23362738|NCT00527826|65072937|FG000|Overall Study|Participant moved away|0|||
23362739|NCT00527826|65072938|FG001|Overall Study|Participant moved away|1|||
23362740|NCT02714036|65072945|FG000|Overall Study|Adverse Event|9|||
23362741|NCT02714036|65072946|FG001|Overall Study|Adverse Event|2|||
23362742|NCT02714036|65072945|FG000|Overall Study|Withdrawal by Subject|3|||
23362743|NCT02714036|65072946|FG001|Overall Study|Withdrawal by Subject|2|||
23362744|NCT00096538|65072947|FG000|Overall Study|Withdrawal by Subject|1|||
23362745|NCT00751140|65072948|FG000|Overall Study|benign angioma excluded from analysis|1|||
23362746|NCT01711983|65072949|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
23362747|NCT01711983|65072949|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
23362748|NCT01711983|65072949|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
23362749|NCT01711983|65072949|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
23362750|NCT02472886|65072950|FG000|Overall Study|Lack of Efficacy|0|||
23362751|NCT02472886|65072951|FG001|Overall Study|Lack of Efficacy|2|||
23362752|NCT02472886|65072952|FG002|Overall Study|Lack of Efficacy|1|||
23362753|NCT00905424|65072955|FG000|Overall Study|Lost to Follow-up|3|||
23362754|NCT00905424|65072956|FG001|Overall Study|Lost to Follow-up|3|||
23362755|NCT00905424|65072955|FG000|Overall Study|Withdrawal by Subject|1|||
23362756|NCT00905424|65072956|FG001|Overall Study|Withdrawal by Subject|2|||
23362757|NCT00905424|65072955|FG000|Overall Study|Adverse Event|4|||
23362758|NCT00905424|65072956|FG001|Overall Study|Adverse Event|2|||
23362759|NCT00905424|65072955|FG000|Overall Study|Non-compliance with study medication|2|||
23362760|NCT00905424|65072956|FG001|Overall Study|Non-compliance with study medication|0|||
23265700|NCT02563522|64714435|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
23265701|NCT02563522|64714436|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
23265702|NCT03103100|64714437|FG000|Overall Study|Adverse Event|1|||
23265703|NCT03103100|64714438|FG001|Overall Study|Adverse Event|0|||
23265704|NCT03103100|64714439|FG002|Overall Study|Adverse Event|0|||
23265705|NCT03103100|64714437|FG000|Overall Study|Physician Decision|1|||
23265706|NCT03103100|64714438|FG001|Overall Study|Physician Decision|0|||
23265707|NCT03103100|64714439|FG002|Overall Study|Physician Decision|2|||
23265708|NCT03500484|64714443|FG000|Overall Study|Adverse Event|2|||
23265709|NCT03500484|64714444|FG001|Overall Study|Adverse Event|0|||
23265710|NCT03500484|64714443|FG000|Overall Study|Physician Decision|1|||
23265711|NCT03500484|64714444|FG001|Overall Study|Physician Decision|0|||
23265712|NCT03500484|64714443|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
23265713|NCT03500484|64714444|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
23265714|NCT01364870|64714452|FG000|Overall Study|Withdrawal by Subject|13|||
23265715|NCT01364870|64714453|FG001|Overall Study|Withdrawal by Subject|24|||
23265716|NCT01364870|64714454|FG002|Overall Study|Withdrawal by Subject|10|||
23265717|NCT01364870|64714452|FG000|Overall Study|Adverse Event|8|||
23265718|NCT01364870|64714453|FG001|Overall Study|Adverse Event|6|||
23265719|NCT01364870|64714454|FG002|Overall Study|Adverse Event|4|||
23265720|NCT01364870|64714452|FG000|Overall Study|Protocol Violation|1|||
23265721|NCT01364870|64714453|FG001|Overall Study|Protocol Violation|0|||
23265722|NCT01364870|64714454|FG002|Overall Study|Protocol Violation|0|||
23265723|NCT00996736|64714456|FG000|Overall Study|Death|1|||
23265724|NCT00996736|64714457|FG001|Overall Study|Death|1|||
23265725|NCT00996736|64714456|FG000|Overall Study|Lost to Follow-up|15|||
23265726|NCT00996736|64714457|FG001|Overall Study|Lost to Follow-up|14|||
23265727|NCT00996736|64714456|FG000|Overall Study|Visit not within 3-month window|5|||
23265728|NCT00996736|64714457|FG001|Overall Study|Visit not within 3-month window|3|||
23265729|NCT03283709|64714458|FG000|Overall Study|trial terminated|0|||
23265730|NCT03283709|64714459|FG001|Overall Study|trial terminated|1|||
23362761|NCT00905424|65072955|FG000|Overall Study|Sponsor decision|1|||
23362762|NCT00905424|65072956|FG001|Overall Study|Sponsor decision|0|||
23362763|NCT00905424|65072955|FG000|Overall Study|Positive urine drug screen|0|||
23362764|NCT00905424|65072956|FG001|Overall Study|Positive urine drug screen|1|||
23362765|NCT00905424|65072955|FG000|Overall Study|Non-adherence to visit schedule|0|||
23362766|NCT00905424|65072956|FG001|Overall Study|Non-adherence to visit schedule|1|||
23362767|NCT02155985|65072959|FG000|Overall Study|Withdrawal by Subject|0|||
23362768|NCT02155985|65072960|FG001|Overall Study|Withdrawal by Subject|0|||
23362769|NCT02155985|65072961|FG002|Overall Study|Withdrawal by Subject|1|||
23362770|NCT02155985|65072959|FG000|Overall Study|Lost to Follow-up|1|||
23362771|NCT02155985|65072960|FG001|Overall Study|Lost to Follow-up|0|||
23265731|NCT02398188|64714460|FG000|Overall Study|Adverse Event|2|||
23265732|NCT02398188|64714461|FG001|Overall Study|Adverse Event|3|||
23265733|NCT02398188|64714460|FG000|Overall Study|Lost to Follow-up|5|||
23362772|NCT02155985|65072961|FG002|Overall Study|Lost to Follow-up|0|||
23362773|NCT00697593|65072962|FG000|Overall Study|Adverse Event|3|||
23362774|NCT00697593|65072962|FG000|Overall Study|Protocol Violation|1|||
23265734|NCT02398188|64714461|FG001|Overall Study|Lost to Follow-up|0|||
23265735|NCT02398188|64714460|FG000|Overall Study|Non-compliance|4|||
23265736|NCT02398188|64714461|FG001|Overall Study|Non-compliance|4|||
23265737|NCT02398188|64714460|FG000|Overall Study|Protocol Violation|6|||
23265738|NCT02398188|64714461|FG001|Overall Study|Protocol Violation|10|||
23265739|NCT02398188|64714460|FG000|Overall Study|Sponsor Decision|2|||
23265740|NCT02398188|64714461|FG001|Overall Study|Sponsor Decision|1|||
23265741|NCT02398188|64714460|FG000|Overall Study|Pregnancy|1|||
23265742|NCT02398188|64714461|FG001|Overall Study|Pregnancy|0|||
23265743|NCT02398188|64714460|FG000|Overall Study|Withdrawal by Subject|7|||
23265744|NCT02398188|64714461|FG001|Overall Study|Withdrawal by Subject|16|||
23265745|NCT02162758|64714464|FG000|Overall Study|Study termination|0|||
23265746|NCT02162758|64714465|FG001|Overall Study|Study termination|1|||
23265747|NCT00625807|64714466|FG000|Overall Study|schedule conflict|2|||
23265748|NCT00625807|64714467|FG001|Overall Study|schedule conflict|8|||
23265749|NCT01075763|64714474|FG000|Overall Study|Lost to Follow-up|2|||
23265750|NCT01075763|64714475|FG001|Overall Study|Lost to Follow-up|1|||
23265751|NCT01075763|64714474|FG000|Overall Study|Lack of Efficacy|0|||
23265752|NCT01075763|64714475|FG001|Overall Study|Lack of Efficacy|1|||
23265753|NCT01075763|64714474|FG000|Overall Study|Withdrawal by Subject|2|||
23265754|NCT01075763|64714475|FG001|Overall Study|Withdrawal by Subject|2|||
23265755|NCT00424489|64714476|FG000|Overall Study|Death|3|||
23265756|NCT00198029|64714477|FG000|Overall Study|Withdrawal by Subject|4|||
23265757|NCT01658943|64714478|FG000|Overall Study|Adverse Event|6|||
23265758|NCT01658943|64714479|FG001|Overall Study|Adverse Event|13|||
23265759|NCT01658943|64714478|FG000|Overall Study|Withdrawal by Subject|9|||
23265760|NCT01658943|64714479|FG001|Overall Study|Withdrawal by Subject|2|||
23265761|NCT01658943|64714478|FG000|Overall Study|Progression/Relapse|39|||
23265762|NCT01658943|64714479|FG001|Overall Study|Progression/Relapse|40|||
23265763|NCT01658943|64714478|FG000|Overall Study|Death|4|||
23265764|NCT01658943|64714479|FG001|Overall Study|Death|2|||
23265765|NCT01658943|64714478|FG000|Overall Study|not protocol specified|4|||
23265766|NCT01658943|64714479|FG001|Overall Study|not protocol specified|1|||
23265767|NCT01658943|64714478|FG000|Overall Study|Not eligible|7|||
23265768|NCT01658943|64714479|FG001|Overall Study|Not eligible|9|||
23265769|NCT01658943|64714478|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
23265770|NCT01658943|64714479|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
23265771|NCT03019965|64714484|FG000|Overall Study|Withdrawal by Subject|1|||
23265772|NCT03019965|64714485|FG001|Overall Study|Withdrawal by Subject|0|||
23265773|NCT03019965|64714484|FG000|Overall Study|Protocol Violation|1|||
23265774|NCT03019965|64714485|FG001|Overall Study|Protocol Violation|3|||
23265775|NCT03019965|64714484|FG000|Overall Study|viral or fungal infection|3|||
23265776|NCT03019965|64714485|FG001|Overall Study|viral or fungal infection|4|||
23265777|NCT03019965|64714484|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
23265778|NCT03019965|64714485|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
23265779|NCT03019965|64714484|FG000|Overall Study|Physician Decision|1|||
23265780|NCT03019965|64714485|FG001|Overall Study|Physician Decision|1|||
23265781|NCT00135707|64714495|FG000|Overall Study|Lost to Follow-up|94|||
23265782|NCT00135707|64714496|FG001|Overall Study|Lost to Follow-up|89|||
23265783|NCT00135707|64714495|FG000|Overall Study|Withdrawal by Subject|0|||
23265784|NCT00135707|64714496|FG001|Overall Study|Withdrawal by Subject|1|||
23265785|NCT00135707|64714495|FG000|Overall Study|Institutional review board request|1|||
23265786|NCT00135707|64714496|FG001|Overall Study|Institutional review board request|0|||
23265787|NCT00266409|64714501|FG000|Overall Study|Lack of Efficacy|2|||
23265788|NCT00266409|64714502|FG001|Overall Study|Lack of Efficacy|6|||
23265789|NCT00266409|64714503|FG002|Overall Study|Lack of Efficacy|1|||
23265790|NCT00266409|64714504|FG003|Overall Study|Lack of Efficacy|2|||
23265791|NCT00266409|64714501|FG000|Overall Study|Adverse Event|7|||
23265792|NCT00266409|64714502|FG001|Overall Study|Adverse Event|2|||
23265793|NCT00266409|64714503|FG002|Overall Study|Adverse Event|1|||
23265794|NCT00266409|64714504|FG003|Overall Study|Adverse Event|1|||
23265795|NCT00266409|64714501|FG000|Overall Study|Lost to Follow-up|18|||
23265796|NCT00266409|64714502|FG001|Overall Study|Lost to Follow-up|21|||
23265797|NCT00266409|64714503|FG002|Overall Study|Lost to Follow-up|6|||
23265798|NCT00266409|64714504|FG003|Overall Study|Lost to Follow-up|8|||
23265799|NCT00266409|64714501|FG000|Overall Study|Withdrawal by Subject|6|||
23265800|NCT00266409|64714502|FG001|Overall Study|Withdrawal by Subject|10|||
23265801|NCT00266409|64714503|FG002|Overall Study|Withdrawal by Subject|3|||
23265802|NCT00266409|64714504|FG003|Overall Study|Withdrawal by Subject|9|||
23265803|NCT00266409|64714501|FG000|Overall Study|Protocol Violation|5|||
23362775|NCT00697593|65072962|FG000|Overall Study|Lack of Efficacy|3|||
23362776|NCT00697593|65072962|FG000|Overall Study|Suspension of the study by sponsor|12|||
23362777|NCT01964989|65072967|FG000|Overall Study|Protocol Violation|3|||
23362778|NCT01964989|65072968|FG001|Overall Study|Protocol Violation|4|||
23601013|NCT02823574|65929800|FG002|Treatment Period|Other reasons|3|||
23601014|NCT02823574|65929801|FG003|Treatment Period|Other reasons|6|||
23601015|NCT02823574|65929798|FG000|Treatment Period|Participant no longer meets study criteria|0|||
23601016|NCT02823574|65929799|FG001|Treatment Period|Participant no longer meets study criteria|0|||
23601017|NCT02823574|65929800|FG002|Treatment Period|Participant no longer meets study criteria|1|||
23601018|NCT02823574|65929801|FG003|Treatment Period|Participant no longer meets study criteria|0|||
23601019|NCT02823574|65929798|FG000|Treatment Period|Death|0|||
23601020|NCT02823574|65929799|FG001|Treatment Period|Death|0|||
23601021|NCT02823574|65929800|FG002|Treatment Period|Death|3|||
23265804|NCT00266409|64714502|FG001|Overall Study|Protocol Violation|3|||
23265805|NCT00266409|64714503|FG002|Overall Study|Protocol Violation|4|||
23265806|NCT00266409|64714504|FG003|Overall Study|Protocol Violation|2|||
23265807|NCT00266409|64714501|FG000|Overall Study|Other|7|||
23265808|NCT00266409|64714502|FG001|Overall Study|Other|4|||
23265809|NCT00266409|64714503|FG002|Overall Study|Other|2|||
23265810|NCT00266409|64714504|FG003|Overall Study|Other|0|||
23265811|NCT03331042|64714508|FG000|Overall Study|Protocol Violation|1|||
23265812|NCT03331042|64714509|FG001|Overall Study|Protocol Violation|0|||
23265813|NCT03331042|64714510|FG002|Overall Study|Protocol Violation|0|||
23265814|NCT03331042|64714511|FG003|Overall Study|Protocol Violation|0|||
23265815|NCT03331042|64714508|FG000|Overall Study|Physician Decision|0|||
23265816|NCT03331042|64714509|FG001|Overall Study|Physician Decision|0|||
23265817|NCT03331042|64714510|FG002|Overall Study|Physician Decision|1|||
23265818|NCT03331042|64714511|FG003|Overall Study|Physician Decision|0|||
23265819|NCT03331042|64714508|FG000|Overall Study|Lost to Follow-up|0|||
23265820|NCT03331042|64714509|FG001|Overall Study|Lost to Follow-up|0|||
23265821|NCT03331042|64714510|FG002|Overall Study|Lost to Follow-up|0|||
23265822|NCT03331042|64714511|FG003|Overall Study|Lost to Follow-up|1|||
23265823|NCT00865709|64714516|FG000|Treatment|Adverse Event|9|||
23265824|NCT00865709|64714517|FG001|Treatment|Adverse Event|6|||
23265825|NCT00865709|64714516|FG000|Treatment|Withdrawal by Subject|10|||
23265826|NCT00865709|64714517|FG001|Treatment|Withdrawal by Subject|7|||
23265827|NCT00865709|64714516|FG000|Treatment|Physician Decision|3|||
23265828|NCT00865709|64714517|FG001|Treatment|Physician Decision|2|||
23265829|NCT00865709|64714516|FG000|Treatment|Surgery|8|||
23265830|NCT00865709|64714517|FG001|Treatment|Surgery|3|||
23265831|NCT00958256|64714518|FG000|Overall Study|Adverse Event|3|||
23265832|NCT02532764|64714519|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23265833|NCT02532764|64714520|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23265834|NCT02532764|64714521|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23265835|NCT02532764|64714522|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23265836|NCT02532764|64714523|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23265837|NCT02532764|64714524|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23265838|NCT02532764|64714525|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
23265839|NCT02532764|64714526|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
23265840|NCT02532764|64714527|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
23265841|NCT02532764|64714528|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
23265842|NCT00368966|64714529|FG000|Infant Series|Withdrawal by Subject|11|||
23362779|NCT01964989|65072967|FG000|Overall Study|Administrative Reason|103|||
23362780|NCT01964989|65072968|FG001|Overall Study|Administrative Reason|95|||
23601022|NCT02823574|65929801|FG003|Treatment Period|Death|1|||
23265843|NCT00368966|64714530|FG001|Infant Series|Withdrawal by Subject|6|||
23265844|NCT00368966|64714529|FG000|Infant Series|Protocol Violation|2|||
23265845|NCT00368966|64714530|FG001|Infant Series|Protocol Violation|1|||
23265846|NCT00368966|64714529|FG000|Infant Series|Lost to Follow-up|2|||
23265847|NCT00368966|64714530|FG001|Infant Series|Lost to Follow-up|0|||
23265848|NCT00368966|64714529|FG000|Infant Series|Randomization error|0|||
23265849|NCT00368966|64714530|FG001|Infant Series|Randomization error|1|||
23265850|NCT00368966|64714529|FG000|Infant Series|Failed to meet eligibility criteria|0|||
23265851|NCT00368966|64714530|FG001|Infant Series|Failed to meet eligibility criteria|1|||
23265852|NCT00368966|64714529|FG000|Infant Series|Adverse Event|0|||
23265853|NCT00368966|64714530|FG001|Infant Series|Adverse Event|1|||
23265854|NCT00368966|64714529|FG000|Infant Series|Failed to return|1|||
23265855|NCT00368966|64714530|FG001|Infant Series|Failed to return|0|||
23265856|NCT00368966|64714529|FG000|After Infant|Failed to return|3|||
23265857|NCT00368966|64714530|FG001|After Infant|Failed to return|1|||
23265858|NCT00368966|64714529|FG000|After Infant|Adverse Event|1|||
23265859|NCT00368966|64714530|FG001|After Infant|Adverse Event|2|||
23265860|NCT00368966|64714529|FG000|After Infant|Withdrawal by Subject|1|||
23265861|NCT00368966|64714530|FG001|After Infant|Withdrawal by Subject|1|||
23265862|NCT00368966|64714529|FG000|After Infant|Death|1|||
23265863|NCT00368966|64714530|FG001|After Infant|Death|0|||
23265864|NCT00368966|64714529|FG000|After Infant|Lost to Follow-up|0|||
23362781|NCT01964989|65072967|FG000|Overall Study|Adverse Event|0|||
23601023|NCT02613403|65929802|FG000|Overall Study|Lost to Follow-up|0|||
23362782|NCT01964989|65072968|FG001|Overall Study|Adverse Event|1|||
23362783|NCT01964989|65072967|FG000|Overall Study|Death|1|||
23362784|NCT01964989|65072968|FG001|Overall Study|Death|3|||
23362785|NCT01964989|65072967|FG000|Overall Study|Withdrawal by Subject|156|||
23362786|NCT01964989|65072968|FG001|Overall Study|Withdrawal by Subject|160|||
23362787|NCT01964989|65072967|FG000|Overall Study|Lost to Follow-up|254|||
23362788|NCT01964989|65072968|FG001|Overall Study|Lost to Follow-up|232|||
23362789|NCT01964989|65072967|FG000|Overall Study|Other|267|||
23362790|NCT01964989|65072968|FG001|Overall Study|Other|252|||
23362791|NCT01249417|65072969|FG000|Randomised Population|Study treatment not received|0|||
23362792|NCT01249417|65072970|FG001|Randomised Population|Study treatment not received|0|||
23362793|NCT01249417|65072971|FG002|Randomised Population|Study treatment not received|2|||
23362794|NCT01249417|65072969|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
23362795|NCT01249417|65072970|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
23362796|NCT01249417|65072971|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
23362797|NCT01249417|65072969|FG000|Treatment Phase - ITT Population|Other|0|||
23362798|NCT01249417|65072970|FG001|Treatment Phase - ITT Population|Other|0|||
23362799|NCT01249417|65072971|FG002|Treatment Phase - ITT Population|Other|1|||
23362800|NCT01249417|65072969|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
23362801|NCT01249417|65072970|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
23362802|NCT01249417|65072971|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
23362803|NCT01249417|65072969|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
23362804|NCT01249417|65072970|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
23362805|NCT01249417|65072971|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
23362806|NCT01249417|65072969|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
23362807|NCT01249417|65072970|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
23362808|NCT01249417|65072971|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
23362809|NCT01585246|65072974|FG000|Overall Study|Lost to Follow-up|0|||
23362810|NCT01585246|65072975|FG001|Overall Study|Lost to Follow-up|0|||
23362811|NCT01585246|65072976|FG002|Overall Study|Lost to Follow-up|2|||
23362812|NCT01585246|65072977|FG003|Overall Study|Lost to Follow-up|1|||
23362813|NCT01585246|65072978|FG004|Overall Study|Lost to Follow-up|0|||
23362814|NCT01585246|65072974|FG000|Overall Study|Protocol Violation|0|||
23362815|NCT01585246|65072975|FG001|Overall Study|Protocol Violation|0|||
23362816|NCT01585246|65072976|FG002|Overall Study|Protocol Violation|0|||
23362817|NCT01585246|65072977|FG003|Overall Study|Protocol Violation|0|||
23362818|NCT01585246|65072978|FG004|Overall Study|Protocol Violation|1|||
23362819|NCT01585246|65072974|FG000|Overall Study|Withdrawal by Subject|0|||
23362820|NCT01585246|65072975|FG001|Overall Study|Withdrawal by Subject|0|||
23362821|NCT01585246|65072976|FG002|Overall Study|Withdrawal by Subject|1|||
23362822|NCT01585246|65072977|FG003|Overall Study|Withdrawal by Subject|2|||
23362823|NCT01585246|65072978|FG004|Overall Study|Withdrawal by Subject|1|||
23362824|NCT01585246|65072974|FG000|Overall Study|Other|0|||
23362825|NCT01585246|65072975|FG001|Overall Study|Other|1|||
23362826|NCT01585246|65072976|FG002|Overall Study|Other|1|||
23362827|NCT01585246|65072977|FG003|Overall Study|Other|1|||
23362828|NCT01585246|65072978|FG004|Overall Study|Other|0|||
23265865|NCT00368966|64714530|FG001|After Infant|Lost to Follow-up|1|||
23265866|NCT00368966|64714529|FG000|Toddler Dose|Withdrawal by Subject|1|||
23265867|NCT00368966|64714530|FG001|Toddler Dose|Withdrawal by Subject|1|||
23265868|NCT00368966|64714529|FG000|Toddler Dose|Lost to Follow-up|0|||
23265869|NCT00368966|64714530|FG001|Toddler Dose|Lost to Follow-up|2|||
23265870|NCT00442936|64714534|FG000|Overall Study|Protocol Violation|1|||
23265871|NCT00442936|64714535|FG001|Overall Study|Protocol Violation|0|||
23265872|NCT00442936|64714536|FG002|Overall Study|Protocol Violation|1|||
23265873|NCT00442936|64714537|FG003|Overall Study|Protocol Violation|1|||
23265874|NCT01475474|64714540|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
23265875|NCT01475474|64714540|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
23362829|NCT00424593|65072983|FG000|Acute Double-Blind Period|Adverse Event|16|||
23362830|NCT00424593|65072984|FG001|Acute Double-Blind Period|Adverse Event|7|||
23362831|NCT00424593|65072983|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
23362832|NCT00424593|65072984|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
23362833|NCT00424593|65072983|FG000|Acute Double-Blind Period|Protocol Violation|2|||
23362834|NCT00424593|65072984|FG001|Acute Double-Blind Period|Protocol Violation|2|||
23362835|NCT00424593|65072983|FG000|Acute Double-Blind Period|Physician Decision|1|||
23362836|NCT00424593|65072984|FG001|Acute Double-Blind Period|Physician Decision|2|||
23362837|NCT00424593|65072983|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
23362838|NCT00424593|65072984|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
23362839|NCT00424593|65072983|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
23362840|NCT00424593|65072984|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
23265876|NCT04956666|64714544|FG000|Overall Study|Adverse Event|18|||
23362841|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
23265877|NCT04956666|64714544|FG000|Overall Study|Physician Decision|5|||
23362842|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
23362843|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Adverse Event|18|||
23362844|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Adverse Event|0|||
23362845|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
23362846|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
23362847|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
23362848|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
23362849|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
23362850|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
23362851|NCT00424593|65072983|FG000|Dose-Blind Extension Period|Physician Decision|3|||
23362852|NCT00424593|65072984|FG001|Dose-Blind Extension Period|Physician Decision|0|||
23362853|NCT02420262|65072985|FG000|Overall Study|Adverse Event|1|||
23362854|NCT02420262|65072986|FG001|Overall Study|Adverse Event|0|||
23362855|NCT02420262|65072985|FG000|Overall Study|Withdrawal by Subject|1|||
23362856|NCT02420262|65072986|FG001|Overall Study|Withdrawal by Subject|4|||
23362857|NCT02420262|65072985|FG000|Overall Study|Unclassified|0|||
23362858|NCT02420262|65072986|FG001|Overall Study|Unclassified|1|||
23362859|NCT02213380|65073004|FG000|Underwent Randomization|Withdrawal by Subject|2|||
23265878|NCT02022007|64714550|FG000|Overall Study|Withdrawal by Subject|1|||
23265879|NCT02022007|64714551|FG001|Overall Study|Withdrawal by Subject|1|||
23265880|NCT02022007|64714552|FG002|Overall Study|Withdrawal by Subject|1|||
23265881|NCT02022007|64714550|FG000|Overall Study|Noncompliant|0|||
23265882|NCT02022007|64714551|FG001|Overall Study|Noncompliant|0|||
23265883|NCT02022007|64714552|FG002|Overall Study|Noncompliant|1|||
23265884|NCT03529955|64714557|FG000|Overall Study|Adverse Event|1|||
23265885|NCT03529955|64714557|FG000|Overall Study|Lack of Efficacy|1|||
23265886|NCT01153984|64714560|FG000|Overall Study|Withdrawal by Subject|1|||
23265887|NCT01153984|64714560|FG000|Overall Study|Adverse Event|1|||
23265888|NCT00421174|64714561|FG000|Overall Study|Withdrawal by Subject|0|||
23265889|NCT00421174|64714562|FG001|Overall Study|Withdrawal by Subject|1|||
23265890|NCT00421174|64714561|FG000|Overall Study|Ineligible due to infection|2|||
23265891|NCT00421174|64714562|FG001|Overall Study|Ineligible due to infection|0|||
23265892|NCT01929109|64714567|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
23265893|NCT01929109|64714568|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
23265894|NCT01929109|64714569|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
23265895|NCT01929109|64714570|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
23265896|NCT01929109|64714571|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
23265897|NCT02486796|64714575|FG000|Overall Study|Withdrawal by Subject|1|||
23265898|NCT02486796|64714576|FG001|Overall Study|Withdrawal by Subject|1|||
23265899|NCT02486796|64714575|FG000|Overall Study|Physician Decision|1|||
23265900|NCT02486796|64714576|FG001|Overall Study|Physician Decision|0|||
23265901|NCT00193609|64714581|FG000|Overall Study|Lack of Efficacy|2|||
23265902|NCT00193609|64714581|FG000|Overall Study|Adverse Event|2|||
23265903|NCT00658320|64714582|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
23265904|NCT00658320|64714583|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
23265905|NCT00658320|64714582|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
23265906|NCT00658320|64714583|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
23265907|NCT00658320|64714582|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
23265908|NCT00658320|64714583|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
23265909|NCT00658320|64714582|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
23265910|NCT00658320|64714583|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
23265911|NCT02603952|64714584|FG000|Overall Study|Withdrawal by Subject|1|||
23265912|NCT02603952|64714585|FG001|Overall Study|Withdrawal by Subject|0|||
23265913|NCT02603952|64714586|FG002|Overall Study|Withdrawal by Subject|0|||
23265914|NCT02603952|64714587|FG003|Overall Study|Withdrawal by Subject|0|||
23265915|NCT02603952|64714584|FG000|Overall Study|Received oseltamivir by error|0|||
23265916|NCT02603952|64714585|FG001|Overall Study|Received oseltamivir by error|0|||
23265917|NCT02603952|64714586|FG002|Overall Study|Received oseltamivir by error|0|||
23265918|NCT02603952|64714587|FG003|Overall Study|Received oseltamivir by error|1|||
23265919|NCT01654380|64714590|FG000|Part B, Period 1|Physician Decision|0|||
23265920|NCT01654380|64714591|FG001|Part B, Period 1|Physician Decision|0|||
23265921|NCT01654380|64714592|FG002|Part B, Period 1|Physician Decision|1|||
23265922|NCT01654380|64714593|FG003|Part B, Period 1|Physician Decision|0|||
23265923|NCT01325207|64714594|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23265924|NCT01325207|64714595|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23265925|NCT01325207|64714596|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23265926|NCT01325207|64714597|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23362860|NCT02213380|65073005|FG001|Underwent Randomization|Withdrawal by Subject|0|||
23362861|NCT02213380|65073004|FG000|Underwent Randomization|Not treated|3|||
23265927|NCT01325207|64714598|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
23265928|NCT01325207|64714599|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
23362862|NCT02213380|65073005|FG001|Underwent Randomization|Not treated|3|||
23362863|NCT02213380|65073004|FG000|Per-protocol Analysis|Protocol Violation|32|||
23362864|NCT02213380|65073005|FG001|Per-protocol Analysis|Protocol Violation|36|||
23362865|NCT02111174|65073006|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
23362866|NCT02111174|65073007|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
23362867|NCT02111174|65073006|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
23362868|NCT02111174|65073007|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
23362869|NCT02111174|65073006|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
23362870|NCT02111174|65073007|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
23362871|NCT02111174|65073006|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
23362872|NCT02111174|65073007|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
23362873|NCT02824627|65073010|FG000|Overall Study|Adverse Event|1|||
23362874|NCT02824627|65073011|FG001|Overall Study|Adverse Event|2|||
23362875|NCT02824627|65073010|FG000|Overall Study|Lost to Follow-up|2|||
23362876|NCT02824627|65073011|FG001|Overall Study|Lost to Follow-up|1|||
23362877|NCT03113968|65073012|FG000|Overall Study|Withdrawal by Subject|31|||
23362878|NCT03113968|65073013|FG001|Overall Study|Withdrawal by Subject|4|||
23362879|NCT00327717|65073014|FG000|Overall Study|Adverse Event|6|||
23362880|NCT00327717|65073015|FG001|Overall Study|Adverse Event|6|||
23362881|NCT00327717|65073014|FG000|Overall Study|Lack of Efficacy|0|||
23362882|NCT00327717|65073015|FG001|Overall Study|Lack of Efficacy|1|||
23265929|NCT01325207|64714594|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
23265930|NCT01325207|64714595|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
23265931|NCT01325207|64714596|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
23265932|NCT01325207|64714597|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
23265933|NCT01325207|64714598|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
23265934|NCT01325207|64714599|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
23265935|NCT01325207|64714594|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
23265936|NCT01325207|64714595|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
23265937|NCT01325207|64714596|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
23265938|NCT01325207|64714597|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
23265939|NCT01325207|64714598|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
23265940|NCT01325207|64714599|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
23265941|NCT01325207|64714594|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23265942|NCT01325207|64714595|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
23265943|NCT01325207|64714596|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23265944|NCT01325207|64714597|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23265945|NCT01325207|64714598|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23265946|NCT01325207|64714599|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
23265947|NCT01325207|64714594|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23265948|NCT01325207|64714595|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23265949|NCT01325207|64714596|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23265950|NCT01325207|64714597|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23265951|NCT01325207|64714598|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
23265952|NCT01325207|64714599|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
23265953|NCT01325207|64714594|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23265954|NCT01325207|64714595|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23265955|NCT01325207|64714596|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23265956|NCT01325207|64714597|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23265957|NCT01325207|64714598|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
23265958|NCT01325207|64714599|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
23265959|NCT01325207|64714594|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23265960|NCT01325207|64714595|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23265961|NCT01325207|64714596|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23265962|NCT01325207|64714597|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23265963|NCT01325207|64714598|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
23265964|NCT01325207|64714599|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
23265965|NCT01254409|64714601|FG000|Overall Study|Adverse Event|0|||
23265966|NCT01254409|64714602|FG001|Overall Study|Adverse Event|1|||
23265967|NCT01254409|64714603|FG002|Overall Study|Adverse Event|0|||
23265968|NCT01254409|64714604|FG003|Overall Study|Adverse Event|0|||
23265969|NCT01673009|64714607|FG000|Overall Study|Physician Decision|5|||
23265970|NCT01673009|64714607|FG000|Overall Study|Withdrawal by Subject|8|||
23362883|NCT00327717|65073014|FG000|Overall Study|Withdrawal by Subject|3|||
23362884|NCT00327717|65073015|FG001|Overall Study|Withdrawal by Subject|7|||
23362885|NCT01005901|65073017|FG000|Overall Study|Withdrawal by Subject|38|||
23601024|NCT02613403|65929803|FG001|Overall Study|Lost to Follow-up|1|||
23362886|NCT01005901|65073018|FG001|Overall Study|Withdrawal by Subject|14|||
23362887|NCT01005901|65073017|FG000|Overall Study|Adverse Event|30|||
23362888|NCT01005901|65073018|FG001|Overall Study|Adverse Event|16|||
23362889|NCT01005901|65073017|FG000|Overall Study|Administrative problems|21|||
23362890|NCT01005901|65073018|FG001|Overall Study|Administrative problems|13|||
23362891|NCT01005901|65073017|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
23362892|NCT01005901|65073018|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
23362893|NCT01005901|65073017|FG000|Overall Study|Protocol Violation|4|||
23362894|NCT01005901|65073018|FG001|Overall Study|Protocol Violation|3|||
23362895|NCT01005901|65073017|FG000|Overall Study|Death|2|||
23362896|NCT01005901|65073018|FG001|Overall Study|Death|3|||
23362897|NCT01005901|65073017|FG000|Overall Study|Lost to Follow-up|1|||
23362898|NCT01005901|65073018|FG001|Overall Study|Lost to Follow-up|2|||
23362899|NCT01005901|65073017|FG000|Overall Study|Patient's inability to use the device|1|||
23362900|NCT01005901|65073018|FG001|Overall Study|Patient's inability to use the device|1|||
23362901|NCT01005901|65073017|FG000|Overall Study|No longer requires study drug|0|||
23265971|NCT03211156|64714609|FG000|Overall Study|Withdrawal by Subject|0|||
23265972|NCT03211156|64714610|FG001|Overall Study|Withdrawal by Subject|2|||
23265973|NCT03211156|64714609|FG000|Overall Study|Lost to Follow-up|1|||
23265974|NCT03211156|64714610|FG001|Overall Study|Lost to Follow-up|1|||
23265975|NCT03211156|64714609|FG000|Overall Study|Adverse Event|1|||
23265976|NCT03211156|64714610|FG001|Overall Study|Adverse Event|0|||
23265977|NCT03583333|64714611|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
23265978|NCT03583333|64714612|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
23265979|NCT03583333|64714611|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
23265980|NCT03583333|64714612|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
23265981|NCT03583333|64714611|FG000|Overall Study|Withdrawal by Subject|9|||
23265982|NCT03583333|64714612|FG001|Overall Study|Withdrawal by Subject|5|||
23265983|NCT03583333|64714611|FG000|Overall Study|Physician Decision|3|||
23265984|NCT03583333|64714612|FG001|Overall Study|Physician Decision|2|||
23265985|NCT03583333|64714611|FG000|Overall Study|Death|12|||
23265986|NCT03583333|64714612|FG001|Overall Study|Death|7|||
23265987|NCT02750306|64714613|FG000|Overall Study|Withdrawal by Subject|5|||
23265988|NCT02750306|64714614|FG001|Overall Study|Withdrawal by Subject|2|||
23265989|NCT02750306|64714613|FG000|Overall Study|Protocol Violation|1|||
23265990|NCT02750306|64714614|FG001|Overall Study|Protocol Violation|0|||
23265991|NCT00662129|64714615|FG000|Overall Study|Protocol Violation|1|||
23265992|NCT00662129|64714615|FG000|Overall Study|Cancel prior to beginning treatment|1|||
23265993|NCT00662129|64714615|FG000|Overall Study|Ineligible|1|||
23265994|NCT01835145|64714616|FG000|Overall Study|Ineligible prior to treatment|1|||
23265995|NCT01835145|64714617|FG001|Overall Study|Ineligible prior to treatment|0|||
23265996|NCT03381248|64714618|FG000|0-6 Months|Withdrawal by Subject|4|||
23265997|NCT03381248|64714619|FG001|0-6 Months|Withdrawal by Subject|1|||
23265998|NCT03381248|64714618|FG000|0-6 Months|Lost to Follow-up|3|||
23265999|NCT03381248|64714619|FG001|0-6 Months|Lost to Follow-up|2|||
23266000|NCT03381248|64714618|FG000|0-6 Months|Lack of Efficacy|1|||
23266001|NCT03381248|64714619|FG001|0-6 Months|Lack of Efficacy|0|||
23266002|NCT03381248|64714618|FG000|0-6 Months|Adverse Event|1|||
23362902|NCT01005901|65073018|FG001|Overall Study|No longer requires study drug|1|||
23362903|NCT02620787|65073024|FG000|Overall Study|Adverse Event|1|||
23362904|NCT02620787|65073025|FG001|Overall Study|Adverse Event|0|||
23362905|NCT02620787|65073024|FG000|Overall Study|Eligibility Criteria Not Met|1|||
23362906|NCT02620787|65073025|FG001|Overall Study|Eligibility Criteria Not Met|0|||
23362907|NCT00770913|65073026|FG000|Overall Study|Adverse Event|1|||
23362908|NCT00770913|65073027|FG001|Overall Study|Adverse Event|3|||
23362909|NCT00770913|65073028|FG002|Overall Study|Adverse Event|6|||
23362910|NCT00770913|65073026|FG000|Overall Study|Refusal to continue participation|6|||
23362911|NCT00770913|65073027|FG001|Overall Study|Refusal to continue participation|4|||
23362912|NCT00770913|65073028|FG002|Overall Study|Refusal to continue participation|5|||
23362913|NCT00770913|65073026|FG000|Overall Study|Physician Decision|0|||
23362914|NCT00770913|65073027|FG001|Overall Study|Physician Decision|1|||
23362915|NCT00770913|65073028|FG002|Overall Study|Physician Decision|1|||
23266003|NCT03381248|64714619|FG001|0-6 Months|Adverse Event|0|||
23266004|NCT03381248|64714618|FG000|0-6 Months|Protocol Violation|2|||
23266005|NCT03381248|64714619|FG001|0-6 Months|Protocol Violation|1|||
23266006|NCT03381248|64714618|FG000|0-6 Months|Physician Decision|1|||
23266007|NCT03381248|64714619|FG001|0-6 Months|Physician Decision|0|||
23266008|NCT03381248|64714618|FG000|0-6 Months|Planning another procedure|1|||
23266009|NCT03381248|64714619|FG001|0-6 Months|Planning another procedure|2|||
23266010|NCT03381248|64714618|FG000|6-12 Months|Withdrawal by Subject|1|||
23362916|NCT00770913|65073026|FG000|Overall Study|Protocol Violation|3|||
23266011|NCT03381248|64714619|FG001|6-12 Months|Withdrawal by Subject|3|||
23266012|NCT03381248|64714618|FG000|6-12 Months|Lost to Follow-up|0|||
23266013|NCT03381248|64714619|FG001|6-12 Months|Lost to Follow-up|2|||
23362917|NCT00770913|65073027|FG001|Overall Study|Protocol Violation|0|||
23362918|NCT00770913|65073028|FG002|Overall Study|Protocol Violation|1|||
23266014|NCT03381248|64714618|FG000|6-12 Months|Protocol Violation|3|||
23266015|NCT03381248|64714619|FG001|6-12 Months|Protocol Violation|2|||
23266016|NCT03381248|64714618|FG000|6-12 Months|Planning another procedure|6|||
23266017|NCT03381248|64714619|FG001|6-12 Months|Planning another procedure|2|||
23266018|NCT03381248|64714618|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
23266019|NCT03381248|64714619|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
23266020|NCT03381248|64714618|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
23266021|NCT03381248|64714619|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
23266022|NCT03381248|64714618|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
23266023|NCT03381248|64714619|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
23266024|NCT01611090|64717868|FG000|Randomized Period|Lost to Follow-up|8|||
23266025|NCT01611090|64717869|FG001|Randomized Period|Lost to Follow-up|3|||
23266026|NCT01611090|64717870|FG002|Randomized Period|Lost to Follow-up|0|||
23266027|NCT01611090|64717868|FG000|Randomized Period|Withdrawal by Subject|22|||
23266028|NCT01611090|64717869|FG001|Randomized Period|Withdrawal by Subject|26|||
23266029|NCT01611090|64717870|FG002|Randomized Period|Withdrawal by Subject|0|||
23266030|NCT01611090|64717868|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
23266031|NCT01611090|64717869|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
23266032|NCT01611090|64717870|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
23266033|NCT01611090|64717868|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
23266034|NCT01611090|64717869|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
23266035|NCT01611090|64717870|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
23266036|NCT01439165|64717874|FG000|Overall Study|Protocol Violation|3|||
23266037|NCT01439165|64717875|FG001|Overall Study|Protocol Violation|0|||
23266038|NCT01439165|64717874|FG000|Overall Study|Lost to Follow-up|11|||
23266039|NCT01439165|64717875|FG001|Overall Study|Lost to Follow-up|1|||
23266040|NCT01439165|64717874|FG000|Overall Study|Withdrawal by Subject|7|||
23266041|NCT01439165|64717875|FG001|Overall Study|Withdrawal by Subject|1|||
23266042|NCT01789320|64717876|FG000|Overall Study|Re-enrolled into study|1|||
23266043|NCT01789320|64717876|FG000|Overall Study|Lost to Follow-up|1|||
23266044|NCT00669864|64717877|FG000|Overall Study|Lost to Follow-up|2|||
23266045|NCT00669864|64717877|FG000|Overall Study|Protocol Violation|2|||
23266046|NCT00669864|64717877|FG000|Overall Study|Withdrawal by Subject|3|||
23266047|NCT00669864|64717877|FG000|Overall Study|Other|2|||
23266048|NCT01867242|64717878|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
23266049|NCT01867242|64717879|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
23266050|NCT01867242|64717880|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
23266051|NCT03594123|64717881|FG000|Overall Study|Lost to Follow-up|0|||
23266052|NCT03594123|64717882|FG001|Overall Study|Lost to Follow-up|1|||
23266053|NCT03594123|64717881|FG000|Overall Study|Adverse Event|8|||
23266054|NCT03594123|64717882|FG001|Overall Study|Adverse Event|5|||
23266055|NCT03594123|64717881|FG000|Overall Study|Site Terminated by Sponsor|4|||
23266056|NCT03594123|64717882|FG001|Overall Study|Site Terminated by Sponsor|1|||
23266057|NCT03594123|64717881|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
23266058|NCT03594123|64717882|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
23266059|NCT03594123|64717881|FG000|Overall Study|Lack of Efficacy|1|||
23266060|NCT03594123|64717882|FG001|Overall Study|Lack of Efficacy|0|||
23266061|NCT03594123|64717881|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
23266062|NCT03594123|64717882|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
23266063|NCT00623103|64717883|FG000|Overall Study|Adverse Event|70|||
23266064|NCT00623103|64717884|FG001|Overall Study|Adverse Event|60|||
23266065|NCT00623103|64717883|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
23266066|NCT00623103|64717884|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
23266067|NCT00623103|64717883|FG000|Overall Study|Withdrawal by Subject|18|||
23266068|NCT00623103|64717884|FG001|Overall Study|Withdrawal by Subject|24|||
23266069|NCT00623103|64717883|FG000|Overall Study|Lost to Follow-up|4|||
23266070|NCT00623103|64717884|FG001|Overall Study|Lost to Follow-up|1|||
23266071|NCT00623103|64717883|FG000|Overall Study|Administrative problems|2|||
23266072|NCT00623103|64717884|FG001|Overall Study|Administrative problems|4|||
23266073|NCT00623103|64717883|FG000|Overall Study|Death|11|||
23266074|NCT00623103|64717884|FG001|Overall Study|Death|11|||
23266075|NCT00623103|64717883|FG000|Overall Study|Protocol deviation|2|||
23266076|NCT00623103|64717884|FG001|Overall Study|Protocol deviation|1|||
23266077|NCT02460159|64717885|FG000|Overall Study|Adverse Event|4|||
23266078|NCT02460159|64717886|FG001|Overall Study|Adverse Event|1|||
23266079|NCT02460159|64717885|FG000|Overall Study|Withdrawal by Subject|2|||
23266080|NCT02460159|64717886|FG001|Overall Study|Withdrawal by Subject|0|||
23266081|NCT02207231|64717887|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
23266082|NCT02207231|64717888|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
23266083|NCT02207231|64717889|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
23266084|NCT02207231|64717890|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
23266085|NCT02207231|64717887|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
23266086|NCT02207231|64717888|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
23362919|NCT00770913|65073026|FG000|Overall Study|Incorrect drug was allocated|1|||
23362920|NCT00770913|65073027|FG001|Overall Study|Incorrect drug was allocated|0|||
23266087|NCT02207231|64717889|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
23266088|NCT02207231|64717890|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
23266089|NCT02207231|64717887|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
23266090|NCT02207231|64717888|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
23266091|NCT02207231|64717889|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
23266092|NCT02207231|64717890|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
23266093|NCT02207231|64717887|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
23266094|NCT02207231|64717888|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
23266095|NCT02207231|64717889|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
23266096|NCT02207231|64717890|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
23266097|NCT02207231|64717887|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
23266098|NCT02207231|64717888|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
23362921|NCT00770913|65073028|FG002|Overall Study|Incorrect drug was allocated|0|||
23266099|NCT02207231|64717889|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
23266100|NCT02207231|64717890|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
23362922|NCT00509899|65073034|FG000|Overall Study|Progressive disease|1|||
23362923|NCT00509899|65073035|FG001|Overall Study|Progressive disease|3|||
23362924|NCT00509899|65073036|FG002|Overall Study|Progressive disease|5|||
23362925|NCT00509899|65073037|FG003|Overall Study|Progressive disease|1|||
23266101|NCT02207231|64717887|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
23266102|NCT02207231|64717888|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
23266103|NCT02207231|64717889|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
23266104|NCT02207231|64717890|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
23266105|NCT02207231|64717887|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
23266106|NCT02207231|64717888|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
23266107|NCT02207231|64717889|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
23266108|NCT02207231|64717890|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
23266109|NCT02207231|64717887|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
23266110|NCT02207231|64717888|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
23266111|NCT02207231|64717889|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
23266112|NCT02207231|64717890|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
23266113|NCT02207231|64717887|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
23266114|NCT02207231|64717888|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
23266115|NCT02207231|64717889|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
23266116|NCT02207231|64717890|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
23266117|NCT02207231|64717887|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
23266118|NCT02207231|64717888|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
23266119|NCT02207231|64717889|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
23266120|NCT02207231|64717890|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
23266121|NCT02207231|64717887|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
23266122|NCT02207231|64717888|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
23266123|NCT02207231|64717889|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
23266124|NCT02207231|64717890|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
23266125|NCT02207231|64717887|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
23266126|NCT02207231|64717888|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
23266127|NCT02207231|64717889|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
23266128|NCT02207231|64717890|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
23266129|NCT02207231|64717887|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
23266130|NCT02207231|64717888|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
23266131|NCT02207231|64717889|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
23266132|NCT02207231|64717890|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
23266133|NCT02207231|64717887|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
23266134|NCT02207231|64717888|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
23266135|NCT02207231|64717889|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
23266136|NCT02207231|64717890|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
23266137|NCT02207231|64717887|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
23266138|NCT02207231|64717888|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
23266139|NCT02207231|64717889|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
23266140|NCT02207231|64717890|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
23266141|NCT02207231|64717887|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
23266142|NCT02207231|64717888|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
23266143|NCT02207231|64717889|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
23266144|NCT02207231|64717890|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
23266145|NCT02207231|64717887|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
23266146|NCT02207231|64717888|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
23266147|NCT02207231|64717889|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
23266148|NCT02207231|64717890|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
23266149|NCT02207231|64717887|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
23266150|NCT02207231|64717888|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
23266151|NCT02207231|64717889|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
23266152|NCT02207231|64717890|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
23362926|NCT00509899|65073038|FG004|Overall Study|Progressive disease|0|||
23362927|NCT00509899|65073039|FG005|Overall Study|Progressive disease|1|||
23362928|NCT00509899|65073040|FG006|Overall Study|Progressive disease|0|||
23362929|NCT00509899|65073041|FG007|Overall Study|Progressive disease|0|||
23362930|NCT00509899|65073034|FG000|Overall Study|Unacceptable Toxicity|1|||
23362931|NCT00509899|65073035|FG001|Overall Study|Unacceptable Toxicity|0|||
23266153|NCT02207231|64717887|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
23266154|NCT02207231|64717888|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
23362932|NCT00509899|65073036|FG002|Overall Study|Unacceptable Toxicity|0|||
23362933|NCT00509899|65073037|FG003|Overall Study|Unacceptable Toxicity|2|||
23362934|NCT00509899|65073038|FG004|Overall Study|Unacceptable Toxicity|0|||
23266155|NCT02207231|64717889|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
23266156|NCT02207231|64717890|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
23266157|NCT02207231|64717887|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
23266158|NCT02207231|64717888|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
23266159|NCT02207231|64717889|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
23266160|NCT02207231|64717890|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
23266161|NCT02207231|64717887|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
23266162|NCT02207231|64717888|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
23266163|NCT02207231|64717889|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
23266164|NCT02207231|64717890|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
23266165|NCT02359890|64717891|FG000|Overall Study|Not meeting eligibility|4|||
23266166|NCT02359890|64717891|FG000|Overall Study|Never treated with study catheter|6|||
23266167|NCT01759290|64717904|FG000|Overall Study|Subjects withdrawn consent|5|||
23266168|NCT01759290|64717904|FG000|Overall Study|Physician Decision|2|||
23266169|NCT01759290|64717904|FG000|Overall Study|Death|17|||
23266170|NCT01759290|64717904|FG000|Overall Study|Lost to Follow-up|53|||
23266171|NCT01759290|64717904|FG000|Overall Study|Unknown reason|4|||
23362935|NCT00509899|65073039|FG005|Overall Study|Unacceptable Toxicity|0|||
23362936|NCT00509899|65073040|FG006|Overall Study|Unacceptable Toxicity|0|||
23266172|NCT00108732|64717906|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
23266173|NCT00108732|64717906|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
23266174|NCT00108732|64717906|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
23266175|NCT00108732|64717906|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
23266176|NCT00108732|64717906|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
23266177|NCT00108732|64717906|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
23362937|NCT00509899|65073041|FG007|Overall Study|Unacceptable Toxicity|0|||
23362938|NCT00509899|65073034|FG000|Overall Study|Withdrawal by Subject|6|||
23362939|NCT00509899|65073035|FG001|Overall Study|Withdrawal by Subject|2|||
23362940|NCT00509899|65073036|FG002|Overall Study|Withdrawal by Subject|3|||
23362941|NCT00509899|65073037|FG003|Overall Study|Withdrawal by Subject|0|||
23362942|NCT00509899|65073038|FG004|Overall Study|Withdrawal by Subject|3|||
23362943|NCT00509899|65073039|FG005|Overall Study|Withdrawal by Subject|2|||
23362944|NCT00509899|65073040|FG006|Overall Study|Withdrawal by Subject|0|||
23362945|NCT00509899|65073041|FG007|Overall Study|Withdrawal by Subject|0|||
23362946|NCT00509899|65073034|FG000|Overall Study|Physician Decision|4|||
23362947|NCT00509899|65073035|FG001|Overall Study|Physician Decision|2|||
23362948|NCT00509899|65073036|FG002|Overall Study|Physician Decision|7|||
23362949|NCT00509899|65073037|FG003|Overall Study|Physician Decision|0|||
23362950|NCT00509899|65073038|FG004|Overall Study|Physician Decision|1|||
23362951|NCT00509899|65073039|FG005|Overall Study|Physician Decision|4|||
23362952|NCT00509899|65073040|FG006|Overall Study|Physician Decision|0|||
23362953|NCT00509899|65073041|FG007|Overall Study|Physician Decision|0|||
23362954|NCT00509899|65073034|FG000|Overall Study|Intercurrent Illness|1|||
23362955|NCT00509899|65073035|FG001|Overall Study|Intercurrent Illness|0|||
23362956|NCT00509899|65073036|FG002|Overall Study|Intercurrent Illness|0|||
23362957|NCT00509899|65073037|FG003|Overall Study|Intercurrent Illness|1|||
23362958|NCT00509899|65073038|FG004|Overall Study|Intercurrent Illness|0|||
23362959|NCT00509899|65073039|FG005|Overall Study|Intercurrent Illness|1|||
23601025|NCT02613403|65929804|FG002|Overall Study|Lost to Follow-up|0|||
23601026|NCT02613403|65929805|FG003|Overall Study|Lost to Follow-up|0|||
23601027|NCT02613403|65929806|FG004|Overall Study|Lost to Follow-up|0|||
23601028|NCT02613403|65929802|FG000|Overall Study|Withdrawal by Subject|2|||
23601029|NCT02613403|65929803|FG001|Overall Study|Withdrawal by Subject|0|||
23601030|NCT02613403|65929804|FG002|Overall Study|Withdrawal by Subject|0|||
23601031|NCT02613403|65929805|FG003|Overall Study|Withdrawal by Subject|0|||
23601032|NCT02613403|65929806|FG004|Overall Study|Withdrawal by Subject|0|||
23601033|NCT01170208|65929807|FG000|Overall Study|Withdrawal by Subject|5|||
23601034|NCT01170208|65929808|FG001|Overall Study|Withdrawal by Subject|0|||
23601035|NCT01170208|65929809|FG002|Overall Study|Withdrawal by Subject|1|||
23601036|NCT01170208|65929807|FG000|Overall Study|Protocol Violation|1|||
23601037|NCT01170208|65929808|FG001|Overall Study|Protocol Violation|0|||
23601038|NCT01170208|65929809|FG002|Overall Study|Protocol Violation|1|||
23601039|NCT00246805|65929810|FG000|Phase 1|Lost to Follow-up|1|||
23601040|NCT00246805|65929811|FG001|Phase 1|Lost to Follow-up|0|||
23601041|NCT03577106|65929812|FG000|Overall Study|Withdrawal by Subject|3|||
23601042|NCT02284113|65929823|FG000|Overall Study|Adverse Event|1|||
23601043|NCT02284113|65929824|FG001|Overall Study|Adverse Event|0|||
23601044|NCT02284113|65929823|FG000|Overall Study|non-compliance|0|||
23601045|NCT02284113|65929824|FG001|Overall Study|non-compliance|1|||
23601046|NCT02284113|65929823|FG000|Overall Study|Withdrawal by Subject|0|||
23601047|NCT02284113|65929824|FG001|Overall Study|Withdrawal by Subject|1|||
23601048|NCT02284113|65929823|FG000|Overall Study|not provided|0|||
23601049|NCT02284113|65929824|FG001|Overall Study|not provided|1|||
23601050|NCT02284113|65929823|FG000|Overall Study|surgery cancelled|2|||
23601051|NCT02284113|65929824|FG001|Overall Study|surgery cancelled|0|||
23601052|NCT01627561|65929825|FG000|Overall Study|Lost to Follow-up|1|||
23601053|NCT01627561|65929826|FG001|Overall Study|Lost to Follow-up|0|||
23601054|NCT01627561|65929825|FG000|Overall Study|Withdrawal by Subject|0|||
23601055|NCT01627561|65929826|FG001|Overall Study|Withdrawal by Subject|1|||
23601056|NCT01627561|65929825|FG000|Overall Study|Migrated/moved from study area|0|||
23601057|NCT01627561|65929826|FG001|Overall Study|Migrated/moved from study area|2|||
23601058|NCT01437319|65929839|FG000|Phase I|Lost to Follow-up|2|||
23601059|NCT01437319|65929840|FG001|Phase I|Lost to Follow-up|0|||
23601060|NCT01437319|65929841|FG002|Phase I|Lost to Follow-up|0|||
23601061|NCT01437319|65929839|FG000|Phase I|Protocol Violation|1|||
23601062|NCT01437319|65929840|FG001|Phase I|Protocol Violation|0|||
23601063|NCT01437319|65929841|FG002|Phase I|Protocol Violation|0|||
23601064|NCT01437319|65929839|FG000|Phase I|Study related symptoms/complaints|27|||
23601065|NCT01437319|65929840|FG001|Phase I|Study related symptoms/complaints|0|||
23601066|NCT01437319|65929841|FG002|Phase I|Study related symptoms/complaints|0|||
23601067|NCT01437319|65929839|FG000|Phase I|Withdrawal by Subject|25|||
23601068|NCT01437319|65929840|FG001|Phase I|Withdrawal by Subject|0|||
23362960|NCT00509899|65073040|FG006|Overall Study|Intercurrent Illness|0|||
23362961|NCT00509899|65073041|FG007|Overall Study|Intercurrent Illness|0|||
23362962|NCT00509899|65073034|FG000|Overall Study|Death|2|||
23362963|NCT00509899|65073035|FG001|Overall Study|Death|2|||
23362964|NCT00509899|65073036|FG002|Overall Study|Death|3|||
23362965|NCT00509899|65073037|FG003|Overall Study|Death|0|||
23362966|NCT00509899|65073038|FG004|Overall Study|Death|1|||
23362967|NCT00509899|65073039|FG005|Overall Study|Death|1|||
23362968|NCT00509899|65073040|FG006|Overall Study|Death|1|||
23362969|NCT00509899|65073041|FG007|Overall Study|Death|1|||
23362970|NCT00509899|65073034|FG000|Overall Study|Lack of Efficacy|1|||
23362971|NCT00509899|65073035|FG001|Overall Study|Lack of Efficacy|0|||
23362972|NCT00509899|65073036|FG002|Overall Study|Lack of Efficacy|2|||
23362973|NCT00509899|65073037|FG003|Overall Study|Lack of Efficacy|0|||
23362974|NCT00509899|65073038|FG004|Overall Study|Lack of Efficacy|0|||
23362975|NCT00509899|65073039|FG005|Overall Study|Lack of Efficacy|1|||
23362976|NCT00509899|65073040|FG006|Overall Study|Lack of Efficacy|0|||
23362977|NCT00509899|65073041|FG007|Overall Study|Lack of Efficacy|0|||
23362978|NCT02750332|65073042|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23362979|NCT02750332|65073043|FG001|Treatment Period 1|Withdrawal by Subject|1|||
23362980|NCT00402727|65073044|FG000|Overall Study|Adverse Event|10|||
23362981|NCT00402727|65073045|FG001|Overall Study|Adverse Event|6|||
23362982|NCT00402727|65073044|FG000|Overall Study|Death|1|||
23362983|NCT00402727|65073045|FG001|Overall Study|Death|0|||
23362984|NCT00402727|65073044|FG000|Overall Study|Lack of Efficacy|1|||
23362985|NCT00402727|65073045|FG001|Overall Study|Lack of Efficacy|3|||
23362986|NCT00402727|65073044|FG000|Overall Study|Lost to Follow-up|24|||
23362987|NCT00402727|65073045|FG001|Overall Study|Lost to Follow-up|11|||
23362988|NCT00402727|65073044|FG000|Overall Study|Physician Decision|1|||
23362989|NCT00402727|65073045|FG001|Overall Study|Physician Decision|1|||
23362990|NCT00402727|65073044|FG000|Overall Study|Protocol Violation|0|||
23362991|NCT00402727|65073045|FG001|Overall Study|Protocol Violation|4|||
23362992|NCT00402727|65073044|FG000|Overall Study|Withdrawal by Subject|3|||
23362993|NCT00402727|65073045|FG001|Overall Study|Withdrawal by Subject|7|||
23362994|NCT00402727|65073044|FG000|Overall Study|supply problems|2|||
23362995|NCT00402727|65073045|FG001|Overall Study|supply problems|1|||
23362996|NCT00402727|65073044|FG000|Overall Study|non-compliance|0|||
23362997|NCT00402727|65073045|FG001|Overall Study|non-compliance|1|||
23362998|NCT00735943|65073046|FG000|Overall Study|Lost to Follow-up|1|||
23362999|NCT00735943|65073046|FG000|Overall Study|Adverse Event|1|||
23363000|NCT04004260|65073047|FG000|Overall Study|Withdrawal by Subject|7|||
23363001|NCT04004260|65073048|FG001|Overall Study|Withdrawal by Subject|3|||
23363002|NCT04004260|65073047|FG000|Overall Study|Lost to Follow-up|22|||
23363003|NCT04004260|65073048|FG001|Overall Study|Lost to Follow-up|12|||
23363004|NCT04004260|65073047|FG000|Overall Study|Did not engage in intervention|13|||
23363005|NCT04004260|65073048|FG001|Overall Study|Did not engage in intervention|17|||
23363006|NCT04577794|65073052|FG000|Overall Study|Adverse Event|1|||
23363007|NCT04577794|65073053|FG001|Overall Study|Adverse Event|1|||
23363008|NCT01000974|65076914|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
23363009|NCT01000974|65076915|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
23363010|NCT01000974|65076916|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
23363011|NCT01000974|65076914|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
23363012|NCT01000974|65076915|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
23363013|NCT01000974|65076916|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
23363014|NCT01000974|65076914|FG000|Primary Vaccination Phase|Protocol Violation|40|||
23363015|NCT01000974|65076915|FG001|Primary Vaccination Phase|Protocol Violation|3|||
23363016|NCT01000974|65076916|FG002|Primary Vaccination Phase|Protocol Violation|2|||
23363017|NCT01000974|65076914|FG000|Primary Vaccination Phase|Adverse Event|14|||
23363018|NCT01000974|65076915|FG001|Primary Vaccination Phase|Adverse Event|2|||
23363019|NCT01000974|65076916|FG002|Primary Vaccination Phase|Adverse Event|2|||
23363020|NCT01000974|65076914|FG000|Primary Vaccination Phase|Other|4|||
23363021|NCT01000974|65076915|FG001|Primary Vaccination Phase|Other|9|||
23363022|NCT01000974|65076916|FG002|Primary Vaccination Phase|Other|12|||
23363023|NCT01000974|65076914|FG000|Booster Vaccination Phase|Protocol Violation|0|||
23363024|NCT01000974|65076915|FG001|Booster Vaccination Phase|Protocol Violation|0|||
23363025|NCT01000974|65076916|FG002|Booster Vaccination Phase|Protocol Violation|2|||
23363026|NCT01000974|65076914|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
23363027|NCT01000974|65076915|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
23363028|NCT01000974|65076916|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
23363029|NCT01000974|65076914|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
23363030|NCT01000974|65076915|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
23363031|NCT01000974|65076916|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
23363032|NCT01000974|65076914|FG000|Booster Vaccination Phase|Other|24|||
23363033|NCT01000974|65076915|FG001|Booster Vaccination Phase|Other|6|||
23363034|NCT01000974|65076916|FG002|Booster Vaccination Phase|Other|4|||
23363035|NCT01128400|65076917|FG000|Overall Study|Lost to Follow-up|1|||
23363036|NCT01128400|65076918|FG001|Overall Study|Lost to Follow-up|0|||
23363037|NCT01128400|65076919|FG002|Overall Study|Lost to Follow-up|1|||
23363038|NCT01128400|65076917|FG000|Overall Study|Screening failure|1|||
23363039|NCT01128400|65076918|FG001|Overall Study|Screening failure|0|||
23363040|NCT01128400|65076919|FG002|Overall Study|Screening failure|0|||
23363041|NCT01128400|65076917|FG000|Overall Study|were not invited to participate on taste|0|||
23363042|NCT01128400|65076918|FG001|Overall Study|were not invited to participate on taste|0|||
23363043|NCT01128400|65076919|FG002|Overall Study|were not invited to participate on taste|15|||
23363044|NCT01128400|65076917|FG000|Overall Study|Excluded due to sinus problems|0|||
23363045|NCT01128400|65076918|FG001|Overall Study|Excluded due to sinus problems|1|||
23363046|NCT01128400|65076919|FG002|Overall Study|Excluded due to sinus problems|0|||
23363047|NCT02849080|65076920|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
23363048|NCT02849080|65076921|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
23363049|NCT02849080|65076922|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
23363050|NCT02849080|65076923|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
23363051|NCT02849080|65076920|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
23363052|NCT02849080|65076921|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
23363053|NCT02849080|65076922|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
23363054|NCT02849080|65076923|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
23363055|NCT02849080|65076920|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
23363056|NCT02849080|65076921|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
23363057|NCT02849080|65076922|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
23363058|NCT02849080|65076923|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
23363059|NCT02849080|65076920|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
23363060|NCT02849080|65076921|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
23363061|NCT02849080|65076922|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
23363062|NCT02849080|65076923|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
23363063|NCT02849080|65076920|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
23363064|NCT02849080|65076921|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
23363065|NCT02849080|65076922|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
23363066|NCT02849080|65076923|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
23363067|NCT02849080|65076920|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
23363068|NCT02849080|65076921|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
23363069|NCT02849080|65076922|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
23363070|NCT02849080|65076923|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
23363071|NCT01801111|65076924|FG000|Overall Study|Adverse Event|12|||
23363072|NCT01801111|65076924|FG000|Overall Study|Death|8|||
23363073|NCT01801111|65076924|FG000|Overall Study|Physician Decision|5|||
23363074|NCT01801111|65076924|FG000|Overall Study|Other|1|||
23363075|NCT01801111|65076924|FG000|Overall Study|Withdrawal by Subject|4|||
23363076|NCT01801111|65076924|FG000|Overall Study|Study Terminated by Sponsor|27|||
23363077|NCT01801111|65076924|FG000|Overall Study|Progressive Disease|81|||
23363078|NCT02895295|65076927|FG000|Overall Study|Survey Non-response|71|||
23363079|NCT02895295|65076928|FG001|Overall Study|Survey Non-response|94|||
23363080|NCT02895295|65076929|FG002|Overall Study|Survey Non-response|92|||
23363081|NCT04131712|65076932|FG000|Overall Study|COVID related|0|||
23363082|NCT04131712|65076933|FG001|Overall Study|COVID related|0|||
23363083|NCT04131712|65076934|FG002|Overall Study|COVID related|2|||
23363084|NCT04131712|65076935|FG003|Overall Study|COVID related|0|||
23363085|NCT04131712|65076932|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
23363086|NCT04131712|65076933|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
23363087|NCT04131712|65076934|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
23480573|NCT00998764|65502022|FG000|Overall Study|Protocol Violation|0|||
23363088|NCT04131712|65076935|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
23363089|NCT04194489|65076943|FG000|Overall Study|Withdrawal by Subject|5|||
23363090|NCT04194489|65076943|FG000|Overall Study|Lost to Follow-up|48|||
23363091|NCT02557399|65076944|FG000|Overall Study|Adverse Event|6|||
23363092|NCT02557399|65076945|FG001|Overall Study|Adverse Event|5|||
23363093|NCT02557399|65076944|FG000|Overall Study|Protocol Violation|0|||
23363094|NCT02557399|65076945|FG001|Overall Study|Protocol Violation|1|||
23363095|NCT02557399|65076944|FG000|Overall Study|Protocol-defined stopping criteria|0|||
23363096|NCT02557399|65076945|FG001|Overall Study|Protocol-defined stopping criteria|1|||
23363097|NCT02557399|65076944|FG000|Overall Study|Withdrawal by Subject|1|||
23363098|NCT02557399|65076945|FG001|Overall Study|Withdrawal by Subject|1|||
23363099|NCT00715559|65076947|FG000|Overall Study|medication not tolerated - nausea|1|||
23363100|NCT01639144|65076950|FG000|Overall Study|Withdrawal by Subject|4|||
23363101|NCT01639144|65076951|FG001|Overall Study|Withdrawal by Subject|2|||
23363102|NCT01639144|65076950|FG000|Overall Study|Physician Decision|2|||
23363103|NCT01639144|65076951|FG001|Overall Study|Physician Decision|0|||
23363104|NCT01639144|65076950|FG000|Overall Study|Met postoperative exclusion criteria|4|||
23363105|NCT01639144|65076951|FG001|Overall Study|Met postoperative exclusion criteria|3|||
23363106|NCT02504320|65076953|FG000|Treatment Period 1|Positive Drug Screen|0|||
23363107|NCT02504320|65076954|FG001|Treatment Period 1|Positive Drug Screen|0|||
23363108|NCT02504320|65076955|FG002|Treatment Period 1|Positive Drug Screen|1|||
23363109|NCT02504320|65076956|FG003|Treatment Period 1|Positive Drug Screen|0|||
23363110|NCT02504320|65076953|FG000|Treatment Period 2|Positive Drug Screen|0|||
23363111|NCT02504320|65076954|FG001|Treatment Period 2|Positive Drug Screen|1|||
23363112|NCT02504320|65076955|FG002|Treatment Period 2|Positive Drug Screen|0|||
23363113|NCT02504320|65076956|FG003|Treatment Period 2|Positive Drug Screen|0|||
23363114|NCT02504320|65076953|FG000|Treatment Period 3|Positive Drug Screen|0|||
23363115|NCT02504320|65076954|FG001|Treatment Period 3|Positive Drug Screen|0|||
23363116|NCT02504320|65076955|FG002|Treatment Period 3|Positive Drug Screen|0|||
23363117|NCT02504320|65076956|FG003|Treatment Period 3|Positive Drug Screen|1|||
23363118|NCT02504320|65076953|FG000|Treatment Period 3|Adverse Event|0|||
23363119|NCT02504320|65076954|FG001|Treatment Period 3|Adverse Event|0|||
23363120|NCT02504320|65076955|FG002|Treatment Period 3|Adverse Event|1|||
23363121|NCT02504320|65076956|FG003|Treatment Period 3|Adverse Event|0|||
23363122|NCT00685360|65076957|FG000|Overall Study|Lost to Follow-up|0|||
23363123|NCT00685360|65076958|FG001|Overall Study|Lost to Follow-up|1|||
23363124|NCT00685360|65076959|FG002|Overall Study|Lost to Follow-up|2|||
23363125|NCT00685360|65076957|FG000|Overall Study|Adverse Event|4|||
23363126|NCT00685360|65076958|FG001|Overall Study|Adverse Event|6|||
23363127|NCT00685360|65076959|FG002|Overall Study|Adverse Event|4|||
23363128|NCT00685360|65076957|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
23363129|NCT00685360|65076958|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
23363130|NCT00685360|65076959|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
23363131|NCT00685360|65076957|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
23363132|NCT00685360|65076958|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
23363133|NCT00685360|65076959|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
23363134|NCT00685360|65076957|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
23363135|NCT00685360|65076958|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
23363136|NCT00685360|65076959|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
23363137|NCT00685360|65076957|FG000|Overall Study|Protocol Deviation|0|||
23363138|NCT00685360|65076958|FG001|Overall Study|Protocol Deviation|1|||
23363139|NCT00685360|65076959|FG002|Overall Study|Protocol Deviation|1|||
23363140|NCT02718911|65076960|FG000|Overall Study|Adverse Event|0|||
23363141|NCT02718911|65076961|FG001|Overall Study|Adverse Event|0|||
23363142|NCT02718911|65076962|FG002|Overall Study|Adverse Event|0|||
23363143|NCT02718911|65076963|FG003|Overall Study|Adverse Event|0|||
23363144|NCT02718911|65076964|FG004|Overall Study|Adverse Event|0|||
23363145|NCT02718911|65076965|FG005|Overall Study|Adverse Event|0|||
23363146|NCT02718911|65076966|FG006|Overall Study|Adverse Event|0|||
23363147|NCT02718911|65076967|FG007|Overall Study|Adverse Event|0|||
23363148|NCT02718911|65076968|FG008|Overall Study|Adverse Event|0|||
23363149|NCT02718911|65076969|FG009|Overall Study|Adverse Event|2|||
23363150|NCT02718911|65076960|FG000|Overall Study|Death|2|||
23363151|NCT02718911|65076961|FG001|Overall Study|Death|3|||
23363152|NCT02718911|65076962|FG002|Overall Study|Death|1|||
23363153|NCT02718911|65076963|FG003|Overall Study|Death|0|||
23363154|NCT02718911|65076964|FG004|Overall Study|Death|1|||
23363155|NCT02718911|65076965|FG005|Overall Study|Death|3|||
23363156|NCT02718911|65076966|FG006|Overall Study|Death|1|||
23363157|NCT02718911|65076967|FG007|Overall Study|Death|1|||
23363158|NCT02718911|65076968|FG008|Overall Study|Death|4|||
23363159|NCT02718911|65076969|FG009|Overall Study|Death|3|||
23363160|NCT02718911|65076960|FG000|Overall Study|Lost to Follow-up|0|||
23363161|NCT02718911|65076961|FG001|Overall Study|Lost to Follow-up|0|||
23363162|NCT02718911|65076962|FG002|Overall Study|Lost to Follow-up|0|||
23363163|NCT02718911|65076963|FG003|Overall Study|Lost to Follow-up|0|||
23363164|NCT02718911|65076964|FG004|Overall Study|Lost to Follow-up|0|||
23363165|NCT02718911|65076965|FG005|Overall Study|Lost to Follow-up|0|||
23363166|NCT02718911|65076966|FG006|Overall Study|Lost to Follow-up|0|||
23363167|NCT02718911|65076967|FG007|Overall Study|Lost to Follow-up|0|||
23363168|NCT02718911|65076968|FG008|Overall Study|Lost to Follow-up|1|||
23363169|NCT02718911|65076969|FG009|Overall Study|Lost to Follow-up|0|||
23363170|NCT02718911|65076960|FG000|Overall Study|Physician Decision|2|||
23363171|NCT02718911|65076961|FG001|Overall Study|Physician Decision|0|||
23363172|NCT02718911|65076962|FG002|Overall Study|Physician Decision|1|||
23363173|NCT02718911|65076963|FG003|Overall Study|Physician Decision|1|||
23363174|NCT02718911|65076964|FG004|Overall Study|Physician Decision|0|||
23363175|NCT02718911|65076965|FG005|Overall Study|Physician Decision|0|||
23363176|NCT02718911|65076966|FG006|Overall Study|Physician Decision|0|||
23363177|NCT02718911|65076967|FG007|Overall Study|Physician Decision|1|||
23363178|NCT02718911|65076968|FG008|Overall Study|Physician Decision|2|||
23363179|NCT02718911|65076969|FG009|Overall Study|Physician Decision|1|||
23363180|NCT02718911|65076960|FG000|Overall Study|Withdrawal by Subject|0|||
23363181|NCT02718911|65076961|FG001|Overall Study|Withdrawal by Subject|0|||
23363182|NCT02718911|65076962|FG002|Overall Study|Withdrawal by Subject|0|||
23363183|NCT02718911|65076963|FG003|Overall Study|Withdrawal by Subject|0|||
23363184|NCT02718911|65076964|FG004|Overall Study|Withdrawal by Subject|1|||
23363185|NCT02718911|65076965|FG005|Overall Study|Withdrawal by Subject|0|||
23363186|NCT02718911|65076966|FG006|Overall Study|Withdrawal by Subject|0|||
23363187|NCT02718911|65076967|FG007|Overall Study|Withdrawal by Subject|0|||
23363188|NCT02718911|65076968|FG008|Overall Study|Withdrawal by Subject|1|||
23363189|NCT02718911|65076969|FG009|Overall Study|Withdrawal by Subject|4|||
23363190|NCT02718911|65076960|FG000|Overall Study|Reason Not Collected|0|||
23363191|NCT02718911|65076961|FG001|Overall Study|Reason Not Collected|0|||
23363192|NCT02718911|65076962|FG002|Overall Study|Reason Not Collected|1|||
23363193|NCT02718911|65076963|FG003|Overall Study|Reason Not Collected|0|||
23363194|NCT02718911|65076964|FG004|Overall Study|Reason Not Collected|0|||
23363195|NCT02718911|65076965|FG005|Overall Study|Reason Not Collected|0|||
23363196|NCT02718911|65076966|FG006|Overall Study|Reason Not Collected|2|||
23363197|NCT02718911|65076967|FG007|Overall Study|Reason Not Collected|1|||
23363198|NCT02718911|65076968|FG008|Overall Study|Reason Not Collected|4|||
23363199|NCT02718911|65076969|FG009|Overall Study|Reason Not Collected|9|||
23363200|NCT05137717|65076970|FG000|Overall Study|Death|2|||
23363201|NCT05137717|65076970|FG000|Overall Study|Withdrawal by Subject|6|||
23363202|NCT00369915|65076972|FG000|Overall Study|expected side effects|2|||
23363203|NCT00369915|65076973|FG001|Overall Study|expected side effects|1|||
23363204|NCT00369915|65076972|FG000|Overall Study|Withdrawal by Subject|4|||
23363205|NCT00369915|65076973|FG001|Overall Study|Withdrawal by Subject|1|||
23363206|NCT00369915|65076972|FG000|Overall Study|W/drawl by investigators|0|||
23363207|NCT00369915|65076973|FG001|Overall Study|W/drawl by investigators|1|||
23363208|NCT03669549|65076976|FG000|Overall Study|Adverse Event|4|||
23363209|NCT03669549|65076976|FG000|Overall Study|Withdrawal by Subject|1|||
23363210|NCT03669549|65076976|FG000|Overall Study|Study terminated by the Sponsor|1|||
23363211|NCT04249427|65076977|FG000|Overall Study|Adverse Event|3|||
23363212|NCT04249427|65076978|FG001|Overall Study|Adverse Event|1|||
23363213|NCT04249427|65076977|FG000|Overall Study|Lack of Efficacy|0|||
23363214|NCT04249427|65076978|FG001|Overall Study|Lack of Efficacy|1|||
23363215|NCT04249427|65076977|FG000|Overall Study|Withdrawal by Subject|1|||
23363216|NCT04249427|65076978|FG001|Overall Study|Withdrawal by Subject|2|||
23363217|NCT03066830|65076979|FG000|Overall Study|At the Participant's own Request|16|||
23363218|NCT03066830|65076980|FG001|Overall Study|At the Participant's own Request|17|||
23363219|NCT03066830|65076979|FG000|Overall Study|Other|3|||
23363220|NCT03066830|65076980|FG001|Overall Study|Other|0|||
23363221|NCT03066830|65076979|FG000|Overall Study|Poor Compliance to Protocol|1|||
23363222|NCT03066830|65076980|FG001|Overall Study|Poor Compliance to Protocol|0|||
23363223|NCT03066830|65076979|FG000|Overall Study|Adverse Event|2|||
23363224|NCT03066830|65076980|FG001|Overall Study|Adverse Event|2|||
23363225|NCT03066830|65076979|FG000|Overall Study|Lost to Follow-up|11|||
23363226|NCT03066830|65076980|FG001|Overall Study|Lost to Follow-up|3|||
23363227|NCT02061813|65076982|FG000|Overall Study|Withdrawal by Subject|1|||
23363228|NCT02061813|65076982|FG000|Overall Study|Protocol Violation|2|||
23363229|NCT04378569|65076983|FG000|Overall Study|Adverse Event|0|||
23363230|NCT04378569|65076984|FG001|Overall Study|Adverse Event|0|||
23363231|NCT04378569|65076985|FG002|Overall Study|Adverse Event|2|||
23363232|NCT04378569|65076986|FG003|Overall Study|Adverse Event|0|||
23363233|NCT04378569|65076987|FG004|Overall Study|Adverse Event|3|||
23363234|NCT04378569|65076988|FG005|Overall Study|Adverse Event|3|||
23363235|NCT04378569|65076983|FG000|Overall Study|Lost to Follow-up|0|||
23363236|NCT04378569|65076984|FG001|Overall Study|Lost to Follow-up|3|||
23363237|NCT04378569|65076985|FG002|Overall Study|Lost to Follow-up|1|||
23363238|NCT04378569|65076986|FG003|Overall Study|Lost to Follow-up|0|||
23363239|NCT04378569|65076987|FG004|Overall Study|Lost to Follow-up|1|||
23363240|NCT04378569|65076988|FG005|Overall Study|Lost to Follow-up|1|||
23363241|NCT04378569|65076983|FG000|Overall Study|Protocol Violation|0|||
23480574|NCT00998764|65502023|FG001|Overall Study|Protocol Violation|1|||
23480575|NCT00998764|65502022|FG000|Overall Study|Failed to Return|1|||
23480576|NCT00998764|65502023|FG001|Overall Study|Failed to Return|1|||
23480577|NCT00998764|65502022|FG000|Overall Study|Lost to Follow-up|1|||
23480578|NCT00998764|65502023|FG001|Overall Study|Lost to Follow-up|1|||
23480579|NCT00998764|65502022|FG000|Overall Study|Loss of Caregiver|0|||
23480580|NCT00998764|65502023|FG001|Overall Study|Loss of Caregiver|3|||
23480581|NCT00998764|65502022|FG000|Overall Study|Other|4|||
23480582|NCT00998764|65502023|FG001|Overall Study|Other|4|||
23480583|NCT00998764|65502022|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
23480584|NCT00998764|65502023|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
23480585|NCT03339297|65502024|FG000|Overall Study|Relapse of Hematologic Disease|1|||
23480586|NCT03339297|65502025|FG001|Overall Study|Relapse of Hematologic Disease|0|||
23480587|NCT03339297|65502024|FG000|Overall Study|Death|10|||
23480588|NCT03339297|65502025|FG001|Overall Study|Death|7|||
23480589|NCT03339297|65502024|FG000|Overall Study|Hepatic Candidosis|1|||
23480590|NCT03339297|65502025|FG001|Overall Study|Hepatic Candidosis|0|||
23480591|NCT03339297|65502024|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
23480592|NCT03339297|65502025|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
23480593|NCT03339297|65502024|FG000|Overall Study|Consent Withdrawn by Participant|3|||
23480594|NCT03339297|65502025|FG001|Overall Study|Consent Withdrawn by Participant|3|||
23480595|NCT03339297|65502024|FG000|Overall Study|Disease Relapse|2|||
23480596|NCT03339297|65502025|FG001|Overall Study|Disease Relapse|0|||
23480597|NCT03339297|65502024|FG000|Overall Study|Physician Decision|1|||
23480598|NCT03339297|65502025|FG001|Overall Study|Physician Decision|1|||
23480599|NCT03339297|65502024|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
23480600|NCT03339297|65502025|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
23480601|NCT03339297|65502024|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
23480602|NCT03339297|65502025|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
23480603|NCT03339297|65502024|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
23480604|NCT03339297|65502025|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
23480605|NCT03339297|65502024|FG000|Overall Study|Adverse Event, Non-fatal|1|||
23363242|NCT04378569|65076984|FG001|Overall Study|Protocol Violation|0|||
23363243|NCT04378569|65076985|FG002|Overall Study|Protocol Violation|0|||
23363244|NCT04378569|65076986|FG003|Overall Study|Protocol Violation|0|||
23363245|NCT04378569|65076987|FG004|Overall Study|Protocol Violation|0|||
23363246|NCT04378569|65076988|FG005|Overall Study|Protocol Violation|1|||
23363247|NCT04378569|65076983|FG000|Overall Study|Withdrawal by Subject|0|||
23363248|NCT04378569|65076984|FG001|Overall Study|Withdrawal by Subject|6|||
23363249|NCT04378569|65076985|FG002|Overall Study|Withdrawal by Subject|7|||
23363250|NCT04378569|65076986|FG003|Overall Study|Withdrawal by Subject|4|||
23363251|NCT04378569|65076987|FG004|Overall Study|Withdrawal by Subject|5|||
23363252|NCT04378569|65076988|FG005|Overall Study|Withdrawal by Subject|4|||
23363253|NCT04378569|65076983|FG000|Overall Study|Lack of response|0|||
23363254|NCT04378569|65076984|FG001|Overall Study|Lack of response|0|||
23363255|NCT04378569|65076985|FG002|Overall Study|Lack of response|1|||
23363256|NCT04378569|65076986|FG003|Overall Study|Lack of response|0|||
23363257|NCT04378569|65076987|FG004|Overall Study|Lack of response|1|||
23363258|NCT04378569|65076988|FG005|Overall Study|Lack of response|1|||
23363259|NCT02922153|65076989|FG000|Overall Study|Death|8|||
23363260|NCT02922153|65076990|FG001|Overall Study|Death|1|||
23363261|NCT02922153|65076989|FG000|Overall Study|Lost to Follow-up|1|||
23363262|NCT02922153|65076990|FG001|Overall Study|Lost to Follow-up|0|||
23363263|NCT02922153|65076989|FG000|Overall Study|Physician Decision|1|||
23363264|NCT02922153|65076990|FG001|Overall Study|Physician Decision|1|||
23363265|NCT02526160|65076991|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
23363266|NCT02526160|65076992|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
23480606|NCT03339297|65502025|FG001|Overall Study|Adverse Event, Non-fatal|0|||
23480607|NCT03339297|65502024|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
23480608|NCT03339297|65502025|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
23480609|NCT03339297|65502024|FG000|Overall Study|Patient Was Not Eligible|1|||
23480610|NCT03339297|65502025|FG001|Overall Study|Patient Was Not Eligible|0|||
23480611|NCT01743001|65502027|FG000|Overall Study|Physician Decision|1|||
23480612|NCT01743001|65502028|FG001|Overall Study|Physician Decision|0|||
23363267|NCT02526160|65076991|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
23363268|NCT02526160|65076992|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
23363269|NCT02526160|65076991|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
23480613|NCT01743001|65502027|FG000|Overall Study|Pregnancy|1|||
23480614|NCT01743001|65502028|FG001|Overall Study|Pregnancy|0|||
23480615|NCT01743001|65502027|FG000|Overall Study|Death|1|||
23480616|NCT01743001|65502028|FG001|Overall Study|Death|0|||
23480617|NCT02984943|65502029|FG000|Overall Study|Withdrawal by Subject|3|||
23480618|NCT02984943|65502029|FG000|Overall Study|Physician Decision|1|||
23363270|NCT02526160|65076992|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
23363271|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period I|Death|0|||
23363272|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period I|Death|1|||
23363273|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
23363274|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
23363275|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
23363276|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
23363277|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
23363278|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
23363279|NCT02526160|65076991|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
23363280|NCT02526160|65076992|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
23363281|NCT00723229|65076993|FG000|First Intervention|Lost to Follow-up|7|||
23363282|NCT00723229|65076994|FG001|First Intervention|Lost to Follow-up|3|||
23363283|NCT01921517|65076997|FG000|Overall Study|Lost to Follow-up|5|||
23363284|NCT01921517|65076998|FG001|Overall Study|Lost to Follow-up|0|||
23363285|NCT01921517|65076997|FG000|Overall Study|Newly diagnosed health concern|2|||
23363286|NCT01921517|65076998|FG001|Overall Study|Newly diagnosed health concern|0|||
23363287|NCT01921517|65076997|FG000|Overall Study|Physician Decision|0|||
23363288|NCT01921517|65076998|FG001|Overall Study|Physician Decision|2|||
23363289|NCT01921517|65076997|FG000|Overall Study|Withdrawal by Subject|7|||
23363290|NCT01921517|65076998|FG001|Overall Study|Withdrawal by Subject|3|||
23363291|NCT01921517|65076997|FG000|Overall Study|Subject missed final imaging|1|||
23363292|NCT01921517|65076998|FG001|Overall Study|Subject missed final imaging|4|||
23363293|NCT00458003|65076999|FG000|Overall Study|Non protocol spinal anesthesia|1|||
23363294|NCT00458003|65077000|FG001|Overall Study|Non protocol spinal anesthesia|1|||
23363295|NCT01367249|65077001|FG000|Overall Study|Withdrawal by Subject|6|||
23480619|NCT01904773|65502030|FG000|Screen|Screen failure|3|||
23480620|NCT01904773|65502031|FG001|Screen|Screen failure|0|||
23480621|NCT01904773|65502032|FG002|Screen|Screen failure|0|||
23480622|NCT01904773|65502033|FG003|Screen|Screen failure|0|||
23480623|NCT01904773|65502034|FG004|Screen|Screen failure|0|||
23480624|NCT01904773|65502035|FG005|Screen|Screen failure|0|||
23363296|NCT01367249|65077002|FG001|Overall Study|Withdrawal by Subject|6|||
23363297|NCT01367249|65077001|FG000|Overall Study|Other|3|||
23363298|NCT01367249|65077002|FG001|Overall Study|Other|10|||
23363299|NCT02219685|65077003|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
23363300|NCT02219685|65077004|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
23363301|NCT02219685|65077003|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
23363302|NCT02219685|65077004|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
23363303|NCT01038687|65077005|FG000|Overall Study|Adverse Event|0|||
23363304|NCT01038687|65077006|FG001|Overall Study|Adverse Event|2|||
23363305|NCT01038687|65077007|FG002|Overall Study|Adverse Event|1|||
23363306|NCT02131064|65077008|FG000|Overall Study|Death|5|||
23480625|NCT01904773|65502036|FG006|Screen|Screen failure|0|||
23480626|NCT01904773|65502037|FG007|Screen|Screen failure|0|||
23480627|NCT01904773|65502038|FG008|Screen|Screen failure|0|||
23480628|NCT01904773|65502030|FG000|Screen|Withdrawal by Subject|1|||
23480629|NCT01904773|65502031|FG001|Screen|Withdrawal by Subject|0|||
23480630|NCT01904773|65502032|FG002|Screen|Withdrawal by Subject|0|||
23480631|NCT01904773|65502033|FG003|Screen|Withdrawal by Subject|0|||
23480632|NCT01904773|65502034|FG004|Screen|Withdrawal by Subject|0|||
23480633|NCT01904773|65502035|FG005|Screen|Withdrawal by Subject|0|||
23480634|NCT01904773|65502036|FG006|Screen|Withdrawal by Subject|0|||
23363307|NCT02131064|65077009|FG001|Overall Study|Death|6|||
23363308|NCT02131064|65077008|FG000|Overall Study|Lost to Follow-up|4|||
23363309|NCT02131064|65077009|FG001|Overall Study|Lost to Follow-up|8|||
23363310|NCT02131064|65077008|FG000|Overall Study|Withdrawal by Subject|14|||
23363311|NCT02131064|65077009|FG001|Overall Study|Withdrawal by Subject|18|||
23363312|NCT02131064|65077008|FG000|Overall Study|Other|2|||
23480635|NCT01904773|65502037|FG007|Screen|Withdrawal by Subject|0|||
23480636|NCT01904773|65502038|FG008|Screen|Withdrawal by Subject|0|||
23363313|NCT02131064|65077009|FG001|Overall Study|Other|2|||
23363314|NCT00954122|65077010|FG000|Overall Study|Withdrawal by Subject|5|||
23363315|NCT00954122|65077010|FG000|Overall Study|Adverse Event|1|||
23363316|NCT00954122|65077010|FG000|Overall Study|Safety Reason|1|||
23363317|NCT02485483|65077011|FG000|Overall Study|Depression at baseline|15|||
23363318|NCT02485483|65077012|FG001|Overall Study|Depression at baseline|0|||
23363319|NCT02485483|65077011|FG000|Overall Study|Discontinued after baseline|39|||
23363320|NCT02485483|65077012|FG001|Overall Study|Discontinued after baseline|0|||
23480637|NCT01904773|65502030|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
23480638|NCT01904773|65502031|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480639|NCT01904773|65502032|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480640|NCT01904773|65502033|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480641|NCT01904773|65502034|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480642|NCT01904773|65502035|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480643|NCT01904773|65502036|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23601069|NCT01437319|65929841|FG002|Phase I|Withdrawal by Subject|0|||
23480644|NCT01904773|65502037|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480645|NCT01904773|65502038|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
23480646|NCT01904773|65502030|FG000|First Intervention|Adverse Event|0|||
23480647|NCT01904773|65502031|FG001|First Intervention|Adverse Event|0|||
23480648|NCT01904773|65502032|FG002|First Intervention|Adverse Event|0|||
23480649|NCT01904773|65502033|FG003|First Intervention|Adverse Event|0|||
23480650|NCT01904773|65502034|FG004|First Intervention|Adverse Event|0|||
23480651|NCT01904773|65502035|FG005|First Intervention|Adverse Event|0|||
23480652|NCT01904773|65502036|FG006|First Intervention|Adverse Event|1|||
23480653|NCT01904773|65502037|FG007|First Intervention|Adverse Event|0|||
23480654|NCT01904773|65502038|FG008|First Intervention|Adverse Event|0|||
23480655|NCT01904773|65502030|FG000|Placebo Washout First Intervention|Condition worsened|0|||
23480656|NCT01904773|65502031|FG001|Placebo Washout First Intervention|Condition worsened|1|||
23480657|NCT01904773|65502032|FG002|Placebo Washout First Intervention|Condition worsened|0|||
23480658|NCT01904773|65502033|FG003|Placebo Washout First Intervention|Condition worsened|0|||
23480659|NCT01904773|65502034|FG004|Placebo Washout First Intervention|Condition worsened|0|||
23480660|NCT01904773|65502035|FG005|Placebo Washout First Intervention|Condition worsened|0|||
23480661|NCT01904773|65502036|FG006|Placebo Washout First Intervention|Condition worsened|0|||
23480662|NCT01904773|65502037|FG007|Placebo Washout First Intervention|Condition worsened|0|||
23480663|NCT01904773|65502038|FG008|Placebo Washout First Intervention|Condition worsened|0|||
23480664|NCT01904773|65502030|FG000|Fifth Intervention|Adverse Event|0|||
23480665|NCT01904773|65502031|FG001|Fifth Intervention|Adverse Event|0|||
23480666|NCT01904773|65502032|FG002|Fifth Intervention|Adverse Event|0|||
23480667|NCT01904773|65502033|FG003|Fifth Intervention|Adverse Event|0|||
23480668|NCT01904773|65502034|FG004|Fifth Intervention|Adverse Event|0|||
23480669|NCT01904773|65502035|FG005|Fifth Intervention|Adverse Event|0|||
23480670|NCT01904773|65502036|FG006|Fifth Intervention|Adverse Event|0|||
23480671|NCT01904773|65502037|FG007|Fifth Intervention|Adverse Event|1|||
23480672|NCT01904773|65502038|FG008|Fifth Intervention|Adverse Event|0|||
23480673|NCT01904773|65502030|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480674|NCT01904773|65502031|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
23480675|NCT01904773|65502032|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480676|NCT01904773|65502033|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480677|NCT01904773|65502034|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480678|NCT01904773|65502035|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480679|NCT01904773|65502036|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480680|NCT01904773|65502037|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480681|NCT01904773|65502038|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
23480682|NCT00984620|65502039|FG000|Overall Study|Adverse Event|5|||
23480683|NCT00984620|65502040|FG001|Overall Study|Adverse Event|5|||
23480684|NCT00984620|65502039|FG000|Overall Study|Lost to Follow-up|1|||
23480685|NCT00984620|65502040|FG001|Overall Study|Lost to Follow-up|1|||
23480686|NCT00984620|65502039|FG000|Overall Study|Withdrawal by Subject|0|||
23480687|NCT00984620|65502040|FG001|Overall Study|Withdrawal by Subject|2|||
23480688|NCT00984620|65502039|FG000|Overall Study|reason other than listed above|0|||
23480689|NCT00984620|65502040|FG001|Overall Study|reason other than listed above|4|||
23480690|NCT01122264|65502041|FG000|Overall Study|Adverse Event|6|||
23480691|NCT01122264|65502042|FG001|Overall Study|Adverse Event|5|||
23480692|NCT01122264|65502043|FG002|Overall Study|Adverse Event|7|||
23480693|NCT01122264|65502041|FG000|Overall Study|Death|1|||
23480694|NCT01122264|65502042|FG001|Overall Study|Death|0|||
23480695|NCT01122264|65502043|FG002|Overall Study|Death|0|||
23480696|NCT01122264|65502041|FG000|Overall Study|Lost to Follow-up|5|||
23480697|NCT01122264|65502042|FG001|Overall Study|Lost to Follow-up|9|||
23480698|NCT01122264|65502043|FG002|Overall Study|Lost to Follow-up|13|||
23480699|NCT01122264|65502041|FG000|Overall Study|Entry Criteria Not Met|1|||
23480700|NCT01122264|65502042|FG001|Overall Study|Entry Criteria Not Met|0|||
23480701|NCT01122264|65502043|FG002|Overall Study|Entry Criteria Not Met|0|||
23480702|NCT01122264|65502041|FG000|Overall Study|Protocol Violation|7|||
23480703|NCT01122264|65502042|FG001|Overall Study|Protocol Violation|7|||
23480704|NCT01122264|65502043|FG002|Overall Study|Protocol Violation|9|||
23480705|NCT01122264|65502041|FG000|Overall Study|Withdrawal by Subject|6|||
23480706|NCT01122264|65502042|FG001|Overall Study|Withdrawal by Subject|6|||
23480707|NCT01122264|65502043|FG002|Overall Study|Withdrawal by Subject|16|||
23480708|NCT01122264|65502041|FG000|Overall Study|Physician Decision|3|||
23480709|NCT01122264|65502042|FG001|Overall Study|Physician Decision|1|||
23480710|NCT01122264|65502043|FG002|Overall Study|Physician Decision|1|||
23480711|NCT01122264|65502041|FG000|Overall Study|Lack of Efficacy|3|||
23480712|NCT01122264|65502042|FG001|Overall Study|Lack of Efficacy|1|||
23480713|NCT01122264|65502043|FG002|Overall Study|Lack of Efficacy|1|||
23480714|NCT00718237|65502044|FG000|Overall Study|Adverse Event|1|||
23480715|NCT00718237|65502045|FG001|Overall Study|Adverse Event|3|||
23480716|NCT00718237|65502044|FG000|Overall Study|Lost to Follow-up|2|||
23480717|NCT00718237|65502045|FG001|Overall Study|Lost to Follow-up|2|||
23480718|NCT00718237|65502044|FG000|Overall Study|Physician Decision|1|||
23480719|NCT00718237|65502045|FG001|Overall Study|Physician Decision|0|||
23480720|NCT00718237|65502044|FG000|Overall Study|Withdrawal by Subject|9|||
23480721|NCT00718237|65502045|FG001|Overall Study|Withdrawal by Subject|10|||
23480722|NCT03985878|65502047|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
23480723|NCT03985878|65502047|FG000|Overall Study|Study Terminated by Sponsor|12|||
23480724|NCT03985878|65502047|FG000|Overall Study|Withdrawal by Subject|1|||
23480725|NCT01534182|65502048|FG000|Overall Study|Administrative problems|1|||
23480726|NCT01534182|65502049|FG001|Overall Study|Administrative problems|0|||
23266178|NCT00108732|64717906|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
23480727|NCT01534182|65502048|FG000|Overall Study|Withdrawal by Subject|4|||
23266179|NCT01345019|64717914|FG000|Blinded Treatment Phase|Death|147|||
23266180|NCT01345019|64717915|FG001|Blinded Treatment Phase|Death|137|||
23266181|NCT01345019|64717914|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
23266182|NCT01345019|64717915|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
23266183|NCT01345019|64717914|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
23266184|NCT01345019|64717915|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
23266185|NCT01345019|64717914|FG000|Blinded Treatment Phase|Disease Progression|12|||
23266186|NCT01345019|64717915|FG001|Blinded Treatment Phase|Disease Progression|10|||
23266187|NCT01345019|64717914|FG000|Blinded Treatment Phase|Adverse Event|6|||
23266188|NCT01345019|64717915|FG001|Blinded Treatment Phase|Adverse Event|13|||
23266189|NCT01345019|64717914|FG000|Blinded Treatment Phase|Administrative Decision|10|||
23266190|NCT01345019|64717915|FG001|Blinded Treatment Phase|Administrative Decision|8|||
23266191|NCT01345019|64717914|FG000|Blinded Treatment Phase|Noncompliance|5|||
23266192|NCT01345019|64717915|FG001|Blinded Treatment Phase|Noncompliance|3|||
23266193|NCT01345019|64717914|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
23266194|NCT01345019|64717915|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
23266195|NCT01345019|64717914|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
23266196|NCT01345019|64717915|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
23266197|NCT01345019|64717914|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
23266198|NCT01345019|64717915|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
23266199|NCT01345019|64717914|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
23266200|NCT01345019|64717915|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
23266201|NCT01345019|64717914|FG000|Open Label Treatment Phase|Death|49|||
23266202|NCT01345019|64717915|FG001|Open Label Treatment Phase|Death|48|||
23266203|NCT01345019|64717914|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
23266204|NCT01345019|64717915|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
23266205|NCT01345019|64717914|FG000|Open Label Treatment Phase|Adverse Event|30|||
23266206|NCT01345019|64717915|FG001|Open Label Treatment Phase|Adverse Event|51|||
23266207|NCT01345019|64717914|FG000|Open Label Treatment Phase|Administrative Decision|30|||
23266208|NCT01345019|64717915|FG001|Open Label Treatment Phase|Administrative Decision|15|||
23266209|NCT01345019|64717914|FG000|Open Label Treatment Phase|Disease Progression|17|||
23266210|NCT01345019|64717915|FG001|Open Label Treatment Phase|Disease Progression|18|||
23266211|NCT01345019|64717914|FG000|Open Label Treatment Phase|Noncompliance|5|||
23266212|NCT01345019|64717915|FG001|Open Label Treatment Phase|Noncompliance|4|||
23266213|NCT01345019|64717914|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
23266214|NCT01345019|64717915|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
23266215|NCT01345019|64717914|FG000|Open Label Treatment Phase|Pregnancy|1|||
23266216|NCT01345019|64717915|FG001|Open Label Treatment Phase|Pregnancy|0|||
23266217|NCT01345019|64717914|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
23266218|NCT01345019|64717915|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
23266219|NCT01345019|64717914|FG000|Open Label Treatment Phase|Protocol Violation|0|||
23266220|NCT01345019|64717915|FG001|Open Label Treatment Phase|Protocol Violation|1|||
23266221|NCT00356200|64717916|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
23266222|NCT00356200|64717917|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
23266223|NCT00356200|64717916|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
23266224|NCT00356200|64717917|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
23266225|NCT01338636|64717918|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
23266226|NCT03038113|64717921|FG000|Overall Study|Withdrawal by Subject|0|||
23266227|NCT03038113|64717922|FG001|Overall Study|Withdrawal by Subject|0|||
23601070|NCT01437319|65929839|FG000|Phase II|Withdrawal by Subject|0|||
23601071|NCT01437319|65929840|FG001|Phase II|Withdrawal by Subject|8|||
23601072|NCT01437319|65929841|FG002|Phase II|Withdrawal by Subject|16|||
23601073|NCT01437319|65929839|FG000|Phase II|Lost to Follow-up|0|||
23601074|NCT01437319|65929840|FG001|Phase II|Lost to Follow-up|7|||
23601075|NCT01437319|65929841|FG002|Phase II|Lost to Follow-up|2|||
23601076|NCT01437319|65929839|FG000|Phase II|Study related symptoms/complaints|0|||
23601077|NCT01437319|65929840|FG001|Phase II|Study related symptoms/complaints|28|||
23601078|NCT01437319|65929841|FG002|Phase II|Study related symptoms/complaints|19|||
23266228|NCT03038113|64717923|FG002|Overall Study|Withdrawal by Subject|1|||
23480728|NCT01534182|65502049|FG001|Overall Study|Withdrawal by Subject|7|||
23480729|NCT01534182|65502048|FG000|Overall Study|Adverse Event|7|||
23601079|NCT01437319|65929839|FG000|Phase II|Protocol Violation|0|||
23266229|NCT03038113|64717924|FG003|Overall Study|Withdrawal by Subject|0|||
23266230|NCT03038113|64717925|FG004|Overall Study|Withdrawal by Subject|0|||
23266231|NCT03038113|64717926|FG005|Overall Study|Withdrawal by Subject|0|||
23266232|NCT03038113|64717927|FG006|Overall Study|Withdrawal by Subject|0|||
23266233|NCT03038113|64717928|FG007|Overall Study|Withdrawal by Subject|0|||
23266234|NCT03038113|64717929|FG008|Overall Study|Withdrawal by Subject|0|||
23266235|NCT03038113|64717930|FG009|Overall Study|Withdrawal by Subject|0|||
23266236|NCT03038113|64717931|FG010|Overall Study|Withdrawal by Subject|0|||
23266237|NCT03038113|64717932|FG011|Overall Study|Withdrawal by Subject|0|||
23266238|NCT03038113|64717933|FG012|Overall Study|Withdrawal by Subject|0|||
23266239|NCT03038113|64717934|FG013|Overall Study|Withdrawal by Subject|1|||
23266240|NCT03038113|64717921|FG000|Overall Study|Lost to Follow-up|0|||
23266241|NCT03038113|64717922|FG001|Overall Study|Lost to Follow-up|0|||
23266242|NCT03038113|64717923|FG002|Overall Study|Lost to Follow-up|0|||
23266243|NCT03038113|64717924|FG003|Overall Study|Lost to Follow-up|0|||
23266244|NCT03038113|64717925|FG004|Overall Study|Lost to Follow-up|0|||
23266245|NCT03038113|64717926|FG005|Overall Study|Lost to Follow-up|0|||
23266246|NCT03038113|64717927|FG006|Overall Study|Lost to Follow-up|1|||
23266247|NCT03038113|64717928|FG007|Overall Study|Lost to Follow-up|0|||
23266248|NCT03038113|64717929|FG008|Overall Study|Lost to Follow-up|0|||
23266249|NCT03038113|64717930|FG009|Overall Study|Lost to Follow-up|0|||
23266250|NCT03038113|64717931|FG010|Overall Study|Lost to Follow-up|0|||
23266251|NCT03038113|64717932|FG011|Overall Study|Lost to Follow-up|0|||
23266252|NCT03038113|64717933|FG012|Overall Study|Lost to Follow-up|0|||
23266253|NCT03038113|64717934|FG013|Overall Study|Lost to Follow-up|0|||
23266254|NCT01829464|64717941|FG000|Overall Study|Adverse Event|1|||
23480730|NCT01534182|65502049|FG001|Overall Study|Adverse Event|3|||
23480731|NCT04022733|65502059|FG000|Overall Study|conversion to open surgery|3|||
23480732|NCT04022733|65502060|FG001|Overall Study|conversion to open surgery|2|||
23480733|NCT04022733|65502059|FG000|Overall Study|bradycardia|0|||
23480734|NCT04022733|65502060|FG001|Overall Study|bradycardia|1|||
23480735|NCT03011892|65502061|FG000|Double Blind (DB) Period|Adverse Event|0|||
23480736|NCT03011892|65502062|FG001|Double Blind (DB) Period|Adverse Event|1|||
23480737|NCT03011892|65502063|FG002|Double Blind (DB) Period|Adverse Event|1|||
23480738|NCT03011892|65502064|FG003|Double Blind (DB) Period|Adverse Event|0|||
23480739|NCT03011892|65502065|FG004|Double Blind (DB) Period|Adverse Event|0|||
23480740|NCT03011892|65502066|FG005|Double Blind (DB) Period|Adverse Event|0|||
23480741|NCT03011892|65502067|FG006|Double Blind (DB) Period|Adverse Event|0|||
23480742|NCT03011892|65502068|FG007|Double Blind (DB) Period|Adverse Event|0|||
23480743|NCT03011892|65502069|FG008|Double Blind (DB) Period|Adverse Event|0|||
23480744|NCT03011892|65502070|FG009|Double Blind (DB) Period|Adverse Event|0|||
23480745|NCT03011892|65502071|FG010|Double Blind (DB) Period|Adverse Event|0|||
23480746|NCT03011892|65502072|FG011|Double Blind (DB) Period|Adverse Event|0|||
23480747|NCT03011892|65502061|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
23480748|NCT03011892|65502062|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
23480749|NCT03011892|65502063|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
23480750|NCT03011892|65502064|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
23480751|NCT03011892|65502065|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
23480752|NCT03011892|65502066|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
23480753|NCT03011892|65502067|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
23266255|NCT01829464|64717942|FG001|Overall Study|Adverse Event|0|||
23266256|NCT01829464|64717943|FG002|Overall Study|Adverse Event|0|||
23266257|NCT01829464|64717941|FG000|Overall Study|Lost to Follow-up|0|||
23266258|NCT01829464|64717942|FG001|Overall Study|Lost to Follow-up|0|||
23266259|NCT01829464|64717943|FG002|Overall Study|Lost to Follow-up|1|||
23266260|NCT01829464|64717941|FG000|Overall Study|Withdrawal by Subject|2|||
23266261|NCT01829464|64717942|FG001|Overall Study|Withdrawal by Subject|0|||
23266262|NCT01829464|64717943|FG002|Overall Study|Withdrawal by Subject|0|||
23266263|NCT01829464|64717941|FG000|Overall Study|Study terminated by sponsor|25|||
23266264|NCT01829464|64717942|FG001|Overall Study|Study terminated by sponsor|28|||
23266265|NCT01829464|64717943|FG002|Overall Study|Study terminated by sponsor|25|||
23266266|NCT01829464|64717941|FG000|Overall Study|Lack of Efficacy|0|||
23266267|NCT01829464|64717942|FG001|Overall Study|Lack of Efficacy|1|||
23266268|NCT01829464|64717943|FG002|Overall Study|Lack of Efficacy|0|||
23266269|NCT01569152|64717944|FG000|Phase IIa, Period 1|Early Escape|5|||
23266270|NCT01569152|64717945|FG001|Phase IIa, Period 1|Early Escape|22|||
23266271|NCT01569152|64717946|FG002|Phase IIa, Period 1|Early Escape|0|||
23480754|NCT03011892|65502068|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
23480755|NCT03011892|65502069|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
23480756|NCT03011892|65502070|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
23480757|NCT03011892|65502071|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
23266272|NCT01569152|64717944|FG000|Phase IIa, Period 1|Adverse Event|4|||
23363321|NCT02053493|65077016|FG000|Overall Study|Withdrawal by Subject|1|||
23363322|NCT02053493|65077017|FG001|Overall Study|Withdrawal by Subject|1|||
23363323|NCT02283658|65077025|FG000|Overall Study|Withdrawal by Subject|1|||
23363324|NCT02753816|65077028|FG000|Overall Study|Protocol Violation|0|||
23363325|NCT02753816|65077029|FG001|Overall Study|Protocol Violation|1|||
23363326|NCT02753816|65077030|FG002|Overall Study|Protocol Violation|0|||
23363327|NCT00931632|65077031|FG000|Overall Study|Withdrawal by Subject|2|||
23363328|NCT00931632|65077032|FG001|Overall Study|Withdrawal by Subject|3|||
23363329|NCT00931632|65077031|FG000|Overall Study|Adverse Event|19|||
23363330|NCT00931632|65077032|FG001|Overall Study|Adverse Event|15|||
23363331|NCT02492165|65077033|FG000|Overall Study|Withdrawal by Subject|0|||
23363332|NCT02492165|65077034|FG001|Overall Study|Withdrawal by Subject|1|||
23363333|NCT02492165|65077035|FG002|Overall Study|Withdrawal by Subject|0|||
23363334|NCT02492165|65077036|FG003|Overall Study|Withdrawal by Subject|0|||
23363335|NCT00707057|65077039|FG000|Overall Study|Withdrawal by Subject|8|||
23363336|NCT00707057|65077040|FG001|Overall Study|Withdrawal by Subject|3|||
23363337|NCT00707057|65077039|FG000|Overall Study|Dosed incorrectly|0|||
23363338|NCT00707057|65077040|FG001|Overall Study|Dosed incorrectly|1|||
23363339|NCT00447902|65077041|FG000|Overall Study|Adverse Event|0|||
23480758|NCT03011892|65502072|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
23480759|NCT03011892|65502061|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
23480760|NCT03011892|65502062|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
23480761|NCT03011892|65502063|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
23480762|NCT03011892|65502064|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
23480763|NCT03011892|65502065|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
23480764|NCT03011892|65502066|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
23480765|NCT03011892|65502067|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
23480766|NCT03011892|65502068|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
23480767|NCT03011892|65502069|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
23480768|NCT03011892|65502070|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
23480769|NCT03011892|65502071|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
23480770|NCT03011892|65502072|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
23480771|NCT03011892|65502061|FG000|Double Blind (DB) Period|Other|1|||
23480772|NCT03011892|65502062|FG001|Double Blind (DB) Period|Other|1|||
23363340|NCT00447902|65077042|FG001|Overall Study|Adverse Event|3|||
23363341|NCT00447902|65077041|FG000|Overall Study|Protocol Violation|1|||
23480773|NCT03011892|65502063|FG002|Double Blind (DB) Period|Other|1|||
23480774|NCT03011892|65502064|FG003|Double Blind (DB) Period|Other|0|||
23480775|NCT03011892|65502065|FG004|Double Blind (DB) Period|Other|1|||
23480776|NCT03011892|65502066|FG005|Double Blind (DB) Period|Other|0|||
23480777|NCT03011892|65502067|FG006|Double Blind (DB) Period|Other|0|||
23480778|NCT03011892|65502068|FG007|Double Blind (DB) Period|Other|0|||
23480779|NCT03011892|65502069|FG008|Double Blind (DB) Period|Other|0|||
23363342|NCT00447902|65077042|FG001|Overall Study|Protocol Violation|0|||
23363343|NCT00447902|65077041|FG000|Overall Study|Withdrawal by Subject|0|||
23480780|NCT03011892|65502070|FG009|Double Blind (DB) Period|Other|0|||
23480781|NCT03011892|65502071|FG010|Double Blind (DB) Period|Other|0|||
23480782|NCT03011892|65502072|FG011|Double Blind (DB) Period|Other|0|||
23480783|NCT03011892|65502061|FG000|Double Blind (DB) Period|Physician Decision|1|||
23363344|NCT00447902|65077042|FG001|Overall Study|Withdrawal by Subject|1|||
23363345|NCT00447902|65077041|FG000|Overall Study|included patients who discontinued|1|||
23363346|NCT00447902|65077042|FG001|Overall Study|included patients who discontinued|1|||
23363347|NCT00447902|65077041|FG000|Overall Study|Lack of Efficacy|2|||
23363348|NCT00447902|65077042|FG001|Overall Study|Lack of Efficacy|1|||
23363349|NCT02581488|65077043|FG000|Overall Study|Adverse Event|6|||
23363350|NCT02581488|65077044|FG001|Overall Study|Adverse Event|7|||
23363351|NCT02581488|65077043|FG000|Overall Study|Lost to Follow-up|1|||
23363352|NCT02581488|65077044|FG001|Overall Study|Lost to Follow-up|0|||
23363353|NCT02581488|65077043|FG000|Overall Study|Withdrawal by Subject|1|||
23363354|NCT02581488|65077044|FG001|Overall Study|Withdrawal by Subject|0|||
23363355|NCT02581488|65077043|FG000|Overall Study|Non-Compliance|1|||
23363356|NCT02581488|65077044|FG001|Overall Study|Non-Compliance|0|||
23363357|NCT02581488|65077043|FG000|Overall Study|Protocol Violation|0|||
23363358|NCT02581488|65077044|FG001|Overall Study|Protocol Violation|4|||
23363359|NCT00379899|65077045|FG000|Overall Study|Adverse Event|7|||
23363360|NCT00379899|65077046|FG001|Overall Study|Adverse Event|3|||
23363361|NCT00379899|65077045|FG000|Overall Study|Death|10|||
23363362|NCT00379899|65077046|FG001|Overall Study|Death|10|||
23363363|NCT00379899|65077045|FG000|Overall Study|Lost to Follow-up|2|||
23363364|NCT00379899|65077046|FG001|Overall Study|Lost to Follow-up|4|||
23363365|NCT00379899|65077045|FG000|Overall Study|Physician Decision|3|||
23363366|NCT00379899|65077046|FG001|Overall Study|Physician Decision|4|||
23363367|NCT00379899|65077045|FG000|Overall Study|Withdrawal by Subject|5|||
23363368|NCT00379899|65077046|FG001|Overall Study|Withdrawal by Subject|5|||
23363369|NCT00379899|65077045|FG000|Overall Study|Ineligibility determined|0|||
23363370|NCT00379899|65077046|FG001|Overall Study|Ineligibility determined|1|||
23363371|NCT00379899|65077045|FG000|Overall Study|Noncompliance|1|||
23363372|NCT00379899|65077046|FG001|Overall Study|Noncompliance|1|||
23363373|NCT00379899|65077045|FG000|Overall Study|Parathyroidectomy|0|||
23363374|NCT00379899|65077046|FG001|Overall Study|Parathyroidectomy|2|||
23363375|NCT00379899|65077045|FG000|Overall Study|Renal transplantation|5|||
23363376|NCT00379899|65077046|FG001|Overall Study|Renal transplantation|4|||
23363377|NCT00379899|65077045|FG000|Overall Study|Coronary artery bypass graft|1|||
23363378|NCT00379899|65077046|FG001|Overall Study|Coronary artery bypass graft|1|||
23363379|NCT00379899|65077045|FG000|Overall Study|Other protocol-specified criteria|3|||
23363380|NCT00379899|65077046|FG001|Overall Study|Other protocol-specified criteria|4|||
23363381|NCT00379899|65077045|FG000|Overall Study|Other|3|||
23363382|NCT00379899|65077046|FG001|Overall Study|Other|1|||
23266273|NCT01569152|64717945|FG001|Phase IIa, Period 1|Adverse Event|0|||
23266274|NCT01569152|64717946|FG002|Phase IIa, Period 1|Adverse Event|0|||
23266275|NCT01569152|64717944|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
23266276|NCT01569152|64717945|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
23266277|NCT01569152|64717946|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
23266278|NCT01569152|64717944|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
23266279|NCT01569152|64717945|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
23266280|NCT01569152|64717946|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
23266281|NCT01569152|64717944|FG000|Phase IIa, Period 1|Protocol Violation|0|||
23266282|NCT01569152|64717945|FG001|Phase IIa, Period 1|Protocol Violation|1|||
23266283|NCT01569152|64717946|FG002|Phase IIa, Period 1|Protocol Violation|0|||
23266284|NCT01569152|64717944|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
23266285|NCT01569152|64717945|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
23266286|NCT01569152|64717946|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
23266287|NCT01569152|64717944|FG000|Safety Extension, Period 3|Adverse Event|0|||
23266288|NCT01569152|64717945|FG001|Safety Extension, Period 3|Adverse Event|0|||
23363383|NCT01158261|65077048|FG000|Overall Study|Lost to Follow-up|9|||
23363384|NCT01158261|65077048|FG000|Overall Study|Death|7|||
23363385|NCT01158261|65077048|FG000|Overall Study|Withdrawal by Subject|1|||
23266289|NCT01569152|64717946|FG002|Safety Extension, Period 3|Adverse Event|4|||
23363386|NCT02576977|65077049|FG000|Overall Study|Adverse Event|13|||
23363387|NCT02576977|65077050|FG001|Overall Study|Adverse Event|2|||
23363388|NCT02576977|65077049|FG000|Overall Study|Death|73|||
23363389|NCT02576977|65077050|FG001|Overall Study|Death|60|||
23363390|NCT02576977|65077049|FG000|Overall Study|Screen failure|1|||
23363391|NCT02576977|65077050|FG001|Overall Study|Screen failure|0|||
23480784|NCT03011892|65502062|FG001|Double Blind (DB) Period|Physician Decision|0|||
23480785|NCT03011892|65502063|FG002|Double Blind (DB) Period|Physician Decision|1|||
23480786|NCT03011892|65502064|FG003|Double Blind (DB) Period|Physician Decision|0|||
23480787|NCT03011892|65502065|FG004|Double Blind (DB) Period|Physician Decision|0|||
23480788|NCT03011892|65502066|FG005|Double Blind (DB) Period|Physician Decision|0|||
23480789|NCT03011892|65502067|FG006|Double Blind (DB) Period|Physician Decision|0|||
23480790|NCT03011892|65502068|FG007|Double Blind (DB) Period|Physician Decision|0|||
23480791|NCT03011892|65502069|FG008|Double Blind (DB) Period|Physician Decision|0|||
23480792|NCT03011892|65502070|FG009|Double Blind (DB) Period|Physician Decision|0|||
23480793|NCT03011892|65502071|FG010|Double Blind (DB) Period|Physician Decision|0|||
23480794|NCT03011892|65502072|FG011|Double Blind (DB) Period|Physician Decision|0|||
23480795|NCT03011892|65502061|FG000|Double Blind (DB) Period|Pregnancy|0|||
23480796|NCT03011892|65502062|FG001|Double Blind (DB) Period|Pregnancy|0|||
23480797|NCT03011892|65502063|FG002|Double Blind (DB) Period|Pregnancy|0|||
23480798|NCT03011892|65502064|FG003|Double Blind (DB) Period|Pregnancy|0|||
23480799|NCT03011892|65502065|FG004|Double Blind (DB) Period|Pregnancy|1|||
23480800|NCT03011892|65502066|FG005|Double Blind (DB) Period|Pregnancy|0|||
23480801|NCT03011892|65502067|FG006|Double Blind (DB) Period|Pregnancy|0|||
23480802|NCT03011892|65502068|FG007|Double Blind (DB) Period|Pregnancy|0|||
23480803|NCT03011892|65502069|FG008|Double Blind (DB) Period|Pregnancy|0|||
23480804|NCT03011892|65502070|FG009|Double Blind (DB) Period|Pregnancy|0|||
23363392|NCT02576977|65077049|FG000|Overall Study|Study Terminated at Selected Sites|27|||
23363393|NCT02576977|65077050|FG001|Overall Study|Study Terminated at Selected Sites|50|||
23363394|NCT02576977|65077049|FG000|Overall Study|Withdrawal by Subject|11|||
23363395|NCT02576977|65077050|FG001|Overall Study|Withdrawal by Subject|11|||
23363396|NCT02576977|65077049|FG000|Overall Study|Final Disposition Unknown|0|||
23363397|NCT02576977|65077050|FG001|Overall Study|Final Disposition Unknown|1|||
23363398|NCT02576977|65077049|FG000|Overall Study|Lost to Follow-up|1|||
23480805|NCT03011892|65502071|FG010|Double Blind (DB) Period|Pregnancy|0|||
23480806|NCT03011892|65502072|FG011|Double Blind (DB) Period|Pregnancy|0|||
23480807|NCT03011892|65502061|FG000|Double Blind (DB) Period|Protocol Violation|1|||
23266290|NCT01569152|64717944|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
23266291|NCT01569152|64717945|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
23266292|NCT01569152|64717946|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
23266293|NCT01569152|64717944|FG000|Safety Extension, Period 3|Physician Decision|0|||
23480808|NCT03011892|65502062|FG001|Double Blind (DB) Period|Protocol Violation|0|||
23480809|NCT03011892|65502063|FG002|Double Blind (DB) Period|Protocol Violation|0|||
23480810|NCT03011892|65502064|FG003|Double Blind (DB) Period|Protocol Violation|0|||
23480811|NCT03011892|65502065|FG004|Double Blind (DB) Period|Protocol Violation|0|||
23480812|NCT03011892|65502066|FG005|Double Blind (DB) Period|Protocol Violation|0|||
23480813|NCT03011892|65502067|FG006|Double Blind (DB) Period|Protocol Violation|0|||
23480814|NCT03011892|65502068|FG007|Double Blind (DB) Period|Protocol Violation|0|||
23480815|NCT03011892|65502069|FG008|Double Blind (DB) Period|Protocol Violation|0|||
23480816|NCT03011892|65502070|FG009|Double Blind (DB) Period|Protocol Violation|0|||
23480817|NCT03011892|65502071|FG010|Double Blind (DB) Period|Protocol Violation|0|||
23480818|NCT03011892|65502072|FG011|Double Blind (DB) Period|Protocol Violation|0|||
23480819|NCT03011892|65502061|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
23266294|NCT01569152|64717945|FG001|Safety Extension, Period 3|Physician Decision|0|||
23266295|NCT01569152|64717946|FG002|Safety Extension, Period 3|Physician Decision|2|||
23266296|NCT01569152|64717944|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
23266297|NCT01569152|64717945|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
23266298|NCT01569152|64717946|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
23266299|NCT02247479|64717947|FG000|Overall Study|Adverse Event|8|||
23266300|NCT02247479|64717948|FG001|Overall Study|Adverse Event|9|||
23266301|NCT02247479|64717949|FG002|Overall Study|Adverse Event|8|||
23266302|NCT02247479|64717947|FG000|Overall Study|Death|5|||
23266303|NCT02247479|64717948|FG001|Overall Study|Death|4|||
23266304|NCT02247479|64717949|FG002|Overall Study|Death|6|||
23266305|NCT02247479|64717947|FG000|Overall Study|Lost to Follow-up|3|||
23266306|NCT02247479|64717948|FG001|Overall Study|Lost to Follow-up|3|||
23266307|NCT02247479|64717949|FG002|Overall Study|Lost to Follow-up|1|||
23266308|NCT02247479|64717947|FG000|Overall Study|Non-compliance|0|||
23266309|NCT02247479|64717948|FG001|Overall Study|Non-compliance|0|||
23266310|NCT02247479|64717949|FG002|Overall Study|Non-compliance|1|||
23266311|NCT02247479|64717947|FG000|Overall Study|Withdrawal by Subject|25|||
23266312|NCT02247479|64717948|FG001|Overall Study|Withdrawal by Subject|29|||
23266313|NCT02247479|64717949|FG002|Overall Study|Withdrawal by Subject|24|||
23266314|NCT02247479|64717947|FG000|Overall Study|Study Terminated by Sponsor|98|||
23266315|NCT02247479|64717948|FG001|Overall Study|Study Terminated by Sponsor|88|||
23266316|NCT02247479|64717949|FG002|Overall Study|Study Terminated by Sponsor|94|||
23266317|NCT02247479|64717947|FG000|Overall Study|Physician Decision|1|||
23266318|NCT02247479|64717948|FG001|Overall Study|Physician Decision|0|||
23266319|NCT02247479|64717949|FG002|Overall Study|Physician Decision|2|||
23266320|NCT02247479|64717947|FG000|Overall Study|Unspecified Reason|2|||
23266321|NCT02247479|64717948|FG001|Overall Study|Unspecified Reason|5|||
23266322|NCT02247479|64717949|FG002|Overall Study|Unspecified Reason|2|||
23266323|NCT00973700|64717950|FG000|Overall Study|Withdrawal by Subject|2|||
23266324|NCT00973700|64717951|FG001|Overall Study|Withdrawal by Subject|2|||
23266325|NCT00973700|64717952|FG002|Overall Study|Withdrawal by Subject|8|||
23266326|NCT00973700|64717953|FG003|Overall Study|Withdrawal by Subject|4|||
23266327|NCT00973700|64717954|FG004|Overall Study|Withdrawal by Subject|4|||
23266328|NCT00973700|64717950|FG000|Overall Study|Lost to Follow-up|5|||
23266329|NCT00973700|64717951|FG001|Overall Study|Lost to Follow-up|0|||
23266330|NCT00973700|64717952|FG002|Overall Study|Lost to Follow-up|1|||
23363399|NCT02576977|65077050|FG001|Overall Study|Lost to Follow-up|0|||
23480820|NCT03011892|65502062|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
23480821|NCT03011892|65502063|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
23480822|NCT03011892|65502064|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
23363400|NCT02576977|65077049|FG000|Overall Study|Progressive Disease|0|||
23363401|NCT02576977|65077050|FG001|Overall Study|Progressive Disease|1|||
23363402|NCT03771963|65077051|FG000|Overall Study|Lost to Follow-up|22|||
23363403|NCT03771963|65077051|FG000|Overall Study|Withdrawal of Consent|10|||
23363404|NCT02277028|65077052|FG000|Overall Study|Lost to Follow-up|1|||
23363405|NCT02277028|65077053|FG001|Overall Study|Lost to Follow-up|0|||
23363406|NCT02277028|65077052|FG000|Overall Study|Withdrawal by Subject|0|||
23363407|NCT02277028|65077053|FG001|Overall Study|Withdrawal by Subject|1|||
23363408|NCT04069715|65077054|FG000|Overall Study|Lost to Follow-up|1|||
23363409|NCT04069715|65077055|FG001|Overall Study|Lost to Follow-up|1|||
23363410|NCT04069715|65077054|FG000|Overall Study|Physician Decision|1|||
23363411|NCT04069715|65077055|FG001|Overall Study|Physician Decision|1|||
23363412|NCT04069715|65077054|FG000|Overall Study|Withdrawal by Subject|3|||
23363413|NCT04069715|65077055|FG001|Overall Study|Withdrawal by Subject|3|||
23363414|NCT03160716|65077061|FG000|Overall Study|Lost to Follow-up|1|||
23266331|NCT00973700|64717953|FG003|Overall Study|Lost to Follow-up|8|||
23266332|NCT00973700|64717954|FG004|Overall Study|Lost to Follow-up|5|||
23266333|NCT00973700|64717950|FG000|Overall Study|Inappropriate enrolment|0|||
23266334|NCT00973700|64717951|FG001|Overall Study|Inappropriate enrolment|0|||
23266335|NCT00973700|64717952|FG002|Overall Study|Inappropriate enrolment|0|||
23266336|NCT00973700|64717953|FG003|Overall Study|Inappropriate enrolment|4|||
23266337|NCT00973700|64717954|FG004|Overall Study|Inappropriate enrolment|0|||
23266338|NCT00973700|64717950|FG000|Overall Study|Unable to Classify|0|||
23266339|NCT00973700|64717951|FG001|Overall Study|Unable to Classify|0|||
23266340|NCT00973700|64717952|FG002|Overall Study|Unable to Classify|1|||
23266341|NCT00973700|64717953|FG003|Overall Study|Unable to Classify|2|||
23266342|NCT00973700|64717954|FG004|Overall Study|Unable to Classify|1|||
23266343|NCT03322462|64717955|FG000|Overall Study|Technical difficulties|2|||
23266344|NCT03322462|64717955|FG000|Overall Study|Other|1|||
23266345|NCT00287118|64717956|FG000|Overall Study|Adverse Event|30|||
23266346|NCT00287118|64717956|FG000|Overall Study|Death|1|||
23266347|NCT00287118|64717956|FG000|Overall Study|Lack of Efficacy|11|||
23266348|NCT00287118|64717956|FG000|Overall Study|Lost to Follow-up|1|||
23266349|NCT00287118|64717956|FG000|Overall Study|Protocol Violation|2|||
23363415|NCT03755518|65077063|FG000|Overall Study|Adverse Event|6|||
23363416|NCT03755518|65077063|FG000|Overall Study|Lack of Efficacy|6|||
23363417|NCT03755518|65077063|FG000|Overall Study|Bone Marrow Transplant|4|||
23363418|NCT03755518|65077063|FG000|Overall Study|Withdrawal by participant|4|||
23363419|NCT03755518|65077063|FG000|Overall Study|Progressive Disease|2|||
23363420|NCT03755518|65077063|FG000|Overall Study|Death|1|||
23266350|NCT00287118|64717956|FG000|Overall Study|Other|7|||
23266351|NCT03335371|64717957|FG000|Overall Study|Lost to Follow-up|0|||
23266352|NCT03335371|64717958|FG001|Overall Study|Lost to Follow-up|0|||
23266353|NCT03335371|64717959|FG002|Overall Study|Lost to Follow-up|0|||
23266354|NCT03335371|64717960|FG003|Overall Study|Lost to Follow-up|0|||
23266355|NCT03335371|64717961|FG004|Overall Study|Lost to Follow-up|1|||
23266356|NCT03335371|64717957|FG000|Overall Study|Withdrawal by Subject|0|||
23266357|NCT03335371|64717958|FG001|Overall Study|Withdrawal by Subject|0|||
23266358|NCT03335371|64717959|FG002|Overall Study|Withdrawal by Subject|0|||
23266359|NCT03335371|64717960|FG003|Overall Study|Withdrawal by Subject|0|||
23266360|NCT03335371|64717961|FG004|Overall Study|Withdrawal by Subject|1|||
23266361|NCT03335371|64717957|FG000|Overall Study|Randomization Error|0|||
23266362|NCT03335371|64717958|FG001|Overall Study|Randomization Error|0|||
23266363|NCT03335371|64717959|FG002|Overall Study|Randomization Error|1|||
23266364|NCT03335371|64717960|FG003|Overall Study|Randomization Error|0|||
23266365|NCT03335371|64717961|FG004|Overall Study|Randomization Error|0|||
23266366|NCT02192099|64717962|FG000|Overall Study|Adverse Event|1|||
23266367|NCT02192099|64717962|FG000|Overall Study|Lost to Follow-up|2|||
23266368|NCT02192099|64717962|FG000|Overall Study|Physician Decision|1|||
23266369|NCT02192099|64717962|FG000|Overall Study|Pregnancy|1|||
23266370|NCT02192099|64717962|FG000|Overall Study|Protocol Violation|8|||
23266371|NCT02192099|64717962|FG000|Overall Study|Study Terminated by Sponsor|32|||
23266372|NCT02192099|64717962|FG000|Overall Study|Withdrawal by Subject|11|||
23266373|NCT02192099|64717962|FG000|Overall Study|Miscellaneous Reasons|5|||
23266374|NCT03267277|64717966|FG000|Overall Study|Withdrawal by Subject|1|||
23266375|NCT00084084|64717967|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
23266376|NCT00084084|64717967|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
23266377|NCT01241461|64717973|FG000|Overall Study|Progressive Disease|3|||
23266378|NCT01241461|64717974|FG001|Overall Study|Progressive Disease|6|||
23266379|NCT01617668|64717975|FG000|Overall Study|Adverse Event|7|||
23266380|NCT01617668|64717976|FG001|Overall Study|Adverse Event|0|||
23266381|NCT01617668|64717977|FG002|Overall Study|Adverse Event|12|||
23266382|NCT01617668|64717978|FG003|Overall Study|Adverse Event|5|||
23266383|NCT01617668|64717975|FG000|Overall Study|Physician Decision|1|||
23266384|NCT01617668|64717976|FG001|Overall Study|Physician Decision|2|||
23266385|NCT01617668|64717977|FG002|Overall Study|Physician Decision|3|||
23266386|NCT01617668|64717978|FG003|Overall Study|Physician Decision|0|||
23266387|NCT01617668|64717975|FG000|Overall Study|Progressive Disease|4|||
23266388|NCT01617668|64717976|FG001|Overall Study|Progressive Disease|4|||
23266389|NCT01617668|64717977|FG002|Overall Study|Progressive Disease|6|||
23266390|NCT01617668|64717978|FG003|Overall Study|Progressive Disease|9|||
23266391|NCT01617668|64717975|FG000|Overall Study|Subject/guardian decision|1|||
23266392|NCT01617668|64717976|FG001|Overall Study|Subject/guardian decision|3|||
23266393|NCT01617668|64717977|FG002|Overall Study|Subject/guardian decision|2|||
23266394|NCT01617668|64717978|FG003|Overall Study|Subject/guardian decision|1|||
23266395|NCT01694485|64717991|FG000|Overall Study|Withdrawal by Subject|20|||
23266396|NCT01694485|64717992|FG001|Overall Study|Withdrawal by Subject|6|||
23266397|NCT01694485|64717993|FG002|Overall Study|Withdrawal by Subject|7|||
23266398|NCT01694485|64717994|FG003|Overall Study|Withdrawal by Subject|25|||
23266399|NCT01694485|64717995|FG004|Overall Study|Withdrawal by Subject|18|||
23266400|NCT01694485|64717991|FG000|Overall Study|Sponsor Decision|3|||
23363421|NCT03755518|65077063|FG000|Overall Study|Physician Decision|1|||
23363422|NCT03755518|65077063|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
23363423|NCT01683604|65077092|FG000|Overall Study|Adverse Event|2|||
23363424|NCT01683604|65077092|FG000|Overall Study|Lack of Efficacy|1|||
23363425|NCT01683604|65077092|FG000|Overall Study|Other|2|||
23363426|NCT02573259|65077093|FG000|Overall Study|Death|1|||
23363427|NCT02573259|65077094|FG001|Overall Study|Death|6|||
23363428|NCT02573259|65077095|FG002|Overall Study|Death|5|||
23363429|NCT02573259|65077096|FG003|Overall Study|Death|6|||
23363430|NCT02573259|65077097|FG004|Overall Study|Death|9|||
23363431|NCT02573259|65077098|FG005|Overall Study|Death|32|||
23363432|NCT02573259|65077099|FG006|Overall Study|Death|21|||
23363433|NCT02573259|65077093|FG000|Overall Study|Lost to Follow-up|0|||
23363434|NCT02573259|65077094|FG001|Overall Study|Lost to Follow-up|0|||
23363435|NCT02573259|65077095|FG002|Overall Study|Lost to Follow-up|0|||
23363436|NCT02573259|65077096|FG003|Overall Study|Lost to Follow-up|0|||
23363437|NCT02573259|65077097|FG004|Overall Study|Lost to Follow-up|0|||
23363438|NCT02573259|65077098|FG005|Overall Study|Lost to Follow-up|2|||
23363439|NCT02573259|65077099|FG006|Overall Study|Lost to Follow-up|1|||
23363440|NCT02573259|65077093|FG000|Overall Study|Participant refused further follow-up|0|||
23363441|NCT02573259|65077094|FG001|Overall Study|Participant refused further follow-up|2|||
23363442|NCT02573259|65077095|FG002|Overall Study|Participant refused further follow-up|1|||
23363443|NCT02573259|65077096|FG003|Overall Study|Participant refused further follow-up|0|||
23363444|NCT02573259|65077097|FG004|Overall Study|Participant refused further follow-up|3|||
23363445|NCT02573259|65077098|FG005|Overall Study|Participant refused further follow-up|20|||
23363446|NCT02573259|65077099|FG006|Overall Study|Participant refused further follow-up|7|||
23363447|NCT02573259|65077093|FG000|Overall Study|Other|0|||
23363448|NCT02573259|65077094|FG001|Overall Study|Other|0|||
23363449|NCT02573259|65077095|FG002|Overall Study|Other|0|||
23363450|NCT02573259|65077096|FG003|Overall Study|Other|0|||
23363451|NCT02573259|65077097|FG004|Overall Study|Other|1|||
23363452|NCT02573259|65077098|FG005|Overall Study|Other|4|||
23363453|NCT02573259|65077099|FG006|Overall Study|Other|5|||
23266401|NCT01694485|64717992|FG001|Overall Study|Sponsor Decision|0|||
23266402|NCT01694485|64717993|FG002|Overall Study|Sponsor Decision|0|||
23266403|NCT01694485|64717994|FG003|Overall Study|Sponsor Decision|2|||
23266404|NCT01694485|64717995|FG004|Overall Study|Sponsor Decision|0|||
23266405|NCT01694485|64717991|FG000|Overall Study|Lost to Follow-up|9|||
23266406|NCT01694485|64717992|FG001|Overall Study|Lost to Follow-up|1|||
23266407|NCT01694485|64717993|FG002|Overall Study|Lost to Follow-up|6|||
23266408|NCT01694485|64717994|FG003|Overall Study|Lost to Follow-up|10|||
23266409|NCT01694485|64717995|FG004|Overall Study|Lost to Follow-up|7|||
23266410|NCT01694485|64717991|FG000|Overall Study|Death|1|||
23266411|NCT01694485|64717992|FG001|Overall Study|Death|0|||
23266412|NCT01694485|64717993|FG002|Overall Study|Death|0|||
23266413|NCT01694485|64717994|FG003|Overall Study|Death|1|||
23266414|NCT01694485|64717995|FG004|Overall Study|Death|0|||
23363454|NCT00248651|65077103|FG000|Overall Study|Withdrawal by Subject|28|||
23363455|NCT00248651|65077104|FG001|Overall Study|Withdrawal by Subject|40|||
23363456|NCT00248651|65077105|FG002|Overall Study|Withdrawal by Subject|32|||
23363457|NCT00101868|65077106|FG000|Overall Study|Death|10|||
23363458|NCT00101868|65077107|FG001|Overall Study|Death|10|||
23363459|NCT00101868|65077106|FG000|Overall Study|Withdrawal by Subject|8|||
23363460|NCT00101868|65077107|FG001|Overall Study|Withdrawal by Subject|9|||
23363461|NCT00101868|65077106|FG000|Overall Study|Protocol Violation|3|||
23363462|NCT00101868|65077107|FG001|Overall Study|Protocol Violation|0|||
23363463|NCT00101868|65077106|FG000|Overall Study|Lost to Follow-up|8|||
23363464|NCT00101868|65077107|FG001|Overall Study|Lost to Follow-up|13|||
23363465|NCT00003471|65077108|FG000|Overall Study|Not evaluable|4|||
23363466|NCT02039778|65077109|FG000|Overall Study|Death|2|||
23363467|NCT02039778|65077109|FG000|Overall Study|Withdrawal by Subject|1|||
23363468|NCT02039778|65077109|FG000|Overall Study|Never started the protocol treatment|1|||
23363469|NCT02106351|65077110|FG000|Treatment Cycle 1|Adverse Event|2|||
23363470|NCT02106351|65077111|FG001|Treatment Cycle 1|Adverse Event|0|||
23363471|NCT02106351|65077112|FG002|Treatment Cycle 1|Adverse Event|0|||
23266415|NCT01755858|64718001|FG000|Overall Study|Adverse Event|1|||
23266416|NCT01755858|64718002|FG001|Overall Study|Adverse Event|1|||
23266417|NCT00418184|64718005|FG000|Double-blind Phase|Withdrawal by Subject|22|||
23266418|NCT00418184|64718006|FG001|Double-blind Phase|Withdrawal by Subject|9|||
23363472|NCT02106351|65077110|FG000|Treatment Cycle 1|Consent withdrawn|1|||
23363473|NCT02106351|65077111|FG001|Treatment Cycle 1|Consent withdrawn|0|||
23363474|NCT02106351|65077112|FG002|Treatment Cycle 1|Consent withdrawn|2|||
23363475|NCT02106351|65077110|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
23266419|NCT00418184|64718005|FG000|Double-blind Phase|Adverse Event|2|||
23266420|NCT00418184|64718006|FG001|Double-blind Phase|Adverse Event|1|||
23363476|NCT02106351|65077111|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
23266421|NCT00418184|64718005|FG000|Double-blind Phase|Poor compliance|3|||
23363477|NCT02106351|65077112|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
23363478|NCT02106351|65077110|FG000|Treatment Cycle 1|Other|0|||
23363479|NCT02106351|65077111|FG001|Treatment Cycle 1|Other|3|||
23480823|NCT03011892|65502065|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
23480824|NCT03011892|65502066|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
23363480|NCT02106351|65077112|FG002|Treatment Cycle 1|Other|1|||
23363481|NCT02106351|65077110|FG000|Treatment Cycle 1|Randomised but not treated|1|||
23363482|NCT02106351|65077111|FG001|Treatment Cycle 1|Randomised but not treated|0|||
23363483|NCT02106351|65077112|FG002|Treatment Cycle 1|Randomised but not treated|1|||
23363484|NCT02106351|65077110|FG000|Treatment Cycle 2|Adverse Event|0|||
23480825|NCT03011892|65502067|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480826|NCT03011892|65502068|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480827|NCT03011892|65502069|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
23266422|NCT00418184|64718006|FG001|Double-blind Phase|Poor compliance|1|||
23480828|NCT03011892|65502070|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480829|NCT03011892|65502071|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480830|NCT03011892|65502072|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
23480831|NCT03011892|65502061|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
23480832|NCT03011892|65502062|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
23480833|NCT03011892|65502063|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
23480834|NCT03011892|65502064|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
23480835|NCT03011892|65502065|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
23480836|NCT03011892|65502066|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
23480837|NCT03011892|65502067|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
23480838|NCT03011892|65502068|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
23480839|NCT03011892|65502069|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
23480840|NCT03011892|65502070|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
23480841|NCT03011892|65502071|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
23480842|NCT03011892|65502072|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
23480843|NCT03011892|65502061|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
23480844|NCT03011892|65502062|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
23480845|NCT03011892|65502063|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
23480846|NCT03011892|65502064|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
23480847|NCT03011892|65502065|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
23480848|NCT03011892|65502066|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
23480849|NCT03011892|65502067|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
23480850|NCT03011892|65502068|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
23480851|NCT03011892|65502069|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
23480852|NCT03011892|65502070|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
23480853|NCT03011892|65502071|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
23480854|NCT03011892|65502072|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
23480855|NCT03011892|65502061|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
23480856|NCT03011892|65502062|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
23480857|NCT03011892|65502063|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
23480858|NCT03011892|65502064|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
23480859|NCT03011892|65502065|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
23480860|NCT03011892|65502066|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
23480861|NCT03011892|65502067|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
23480862|NCT03011892|65502068|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
23480863|NCT03011892|65502069|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
23480864|NCT03011892|65502070|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
23480865|NCT03011892|65502071|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
23480866|NCT03011892|65502072|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
23480867|NCT03011892|65502061|FG000|Open Label (OL) Period|Reason not specified|0|||
23480868|NCT03011892|65502062|FG001|Open Label (OL) Period|Reason not specified|0|||
23480869|NCT03011892|65502063|FG002|Open Label (OL) Period|Reason not specified|0|||
23480870|NCT03011892|65502064|FG003|Open Label (OL) Period|Reason not specified|0|||
23480871|NCT03011892|65502065|FG004|Open Label (OL) Period|Reason not specified|0|||
23480872|NCT03011892|65502066|FG005|Open Label (OL) Period|Reason not specified|0|||
23480873|NCT03011892|65502067|FG006|Open Label (OL) Period|Reason not specified|0|||
23480874|NCT03011892|65502068|FG007|Open Label (OL) Period|Reason not specified|1|||
23480875|NCT03011892|65502069|FG008|Open Label (OL) Period|Reason not specified|0|||
23480876|NCT03011892|65502070|FG009|Open Label (OL) Period|Reason not specified|0|||
23363485|NCT02106351|65077111|FG001|Treatment Cycle 2|Adverse Event|2|||
23363486|NCT02106351|65077112|FG002|Treatment Cycle 2|Adverse Event|0|||
23363487|NCT02106351|65077110|FG000|Treatment Cycle 2|Consent withdrawn|0|||
23363488|NCT02106351|65077111|FG001|Treatment Cycle 2|Consent withdrawn|1|||
23363489|NCT02106351|65077112|FG002|Treatment Cycle 2|Consent withdrawn|1|||
23480877|NCT03011892|65502071|FG010|Open Label (OL) Period|Reason not specified|0|||
23480878|NCT03011892|65502072|FG011|Open Label (OL) Period|Reason not specified|0|||
23480879|NCT00523367|65502073|FG000|Overall Study|19 screen failures|19|||
23480880|NCT00523367|65502073|FG000|Overall Study|4 Withdrawn by PI|4|||
23480881|NCT01107379|65502076|FG000|Overall Study|Withdrawal by Subject|18|||
23480882|NCT01107379|65502076|FG000|Overall Study|Lost to Follow-up|3|||
23480883|NCT00713310|65502080|FG000|Overall Study|Adverse Event|5|||
23480884|NCT00713310|65502081|FG001|Overall Study|Adverse Event|2|||
23480885|NCT00713310|65502080|FG000|Overall Study|Lack of Efficacy|0|||
23480886|NCT00713310|65502081|FG001|Overall Study|Lack of Efficacy|2|||
23480887|NCT00713310|65502080|FG000|Overall Study|Withdrawal by Subject|0|||
23480888|NCT00713310|65502081|FG001|Overall Study|Withdrawal by Subject|2|||
23480889|NCT01974765|65502082|FG000|Overall Study|Withdrawal by Subject|1|||
23480890|NCT01974765|65502082|FG000|Overall Study|Death|1|||
23480891|NCT01974765|65502082|FG000|Overall Study|Adverse Event|2|||
23480892|NCT02412488|65502089|FG000|Overall Study|Lost to Follow-up|10|||
23480893|NCT02412488|65502089|FG000|Overall Study|Withdrawal by Subject|5|||
23480894|NCT02412488|65502089|FG000|Overall Study|Physician Decision|1|||
23480895|NCT02412488|65502089|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
23480896|NCT02412488|65502089|FG000|Overall Study|Reveal LINQ explant|1|||
23480897|NCT01104376|65502090|FG000|Overall Study|Withdrawal by Subject|15|||
23480898|NCT01104376|65502090|FG000|Overall Study|Consented but excluded after labs|13|||
23480899|NCT02095132|65502091|FG000|Overall Study|Adverse Event|0|||
23363490|NCT02106351|65077110|FG000|Treatment Cycle 2|Other|0|||
23363491|NCT02106351|65077111|FG001|Treatment Cycle 2|Other|2|||
23363492|NCT02106351|65077112|FG002|Treatment Cycle 2|Other|2|||
23363493|NCT02106351|65077110|FG000|Treatment Cycle 3|Adverse Event|0|||
23363494|NCT02106351|65077111|FG001|Treatment Cycle 3|Adverse Event|1|||
23480900|NCT02095132|65502092|FG001|Overall Study|Adverse Event|0|||
23480901|NCT02095132|65502093|FG002|Overall Study|Adverse Event|0|||
23480902|NCT02095132|65502094|FG003|Overall Study|Adverse Event|0|||
23480903|NCT02095132|65502095|FG004|Overall Study|Adverse Event|1|||
23480904|NCT02095132|65502096|FG005|Overall Study|Adverse Event|0|||
23480905|NCT02095132|65502097|FG006|Overall Study|Adverse Event|1|||
23480906|NCT02095132|65502098|FG007|Overall Study|Adverse Event|0|||
23480907|NCT02095132|65502099|FG008|Overall Study|Adverse Event|0|||
23480908|NCT02095132|65502091|FG000|Overall Study|Death|0|||
23480909|NCT02095132|65502092|FG001|Overall Study|Death|0|||
23480910|NCT02095132|65502093|FG002|Overall Study|Death|0|||
23480911|NCT02095132|65502094|FG003|Overall Study|Death|0|||
23480912|NCT02095132|65502095|FG004|Overall Study|Death|0|||
23480913|NCT02095132|65502096|FG005|Overall Study|Death|0|||
23480914|NCT02095132|65502097|FG006|Overall Study|Death|1|||
23480915|NCT02095132|65502098|FG007|Overall Study|Death|0|||
23480916|NCT02095132|65502099|FG008|Overall Study|Death|0|||
23480917|NCT02095132|65502091|FG000|Overall Study|Lack of Efficacy|3|||
23480918|NCT02095132|65502092|FG001|Overall Study|Lack of Efficacy|5|||
23480919|NCT02095132|65502093|FG002|Overall Study|Lack of Efficacy|2|||
23480920|NCT02095132|65502094|FG003|Overall Study|Lack of Efficacy|8|||
23480921|NCT02095132|65502095|FG004|Overall Study|Lack of Efficacy|3|||
23480922|NCT02095132|65502096|FG005|Overall Study|Lack of Efficacy|6|||
23480923|NCT02095132|65502097|FG006|Overall Study|Lack of Efficacy|10|||
23480924|NCT02095132|65502098|FG007|Overall Study|Lack of Efficacy|9|||
23480925|NCT02095132|65502099|FG008|Overall Study|Lack of Efficacy|8|||
23480926|NCT02095132|65502091|FG000|Overall Study|Physician Decision|1|||
23480927|NCT02095132|65502092|FG001|Overall Study|Physician Decision|0|||
23480928|NCT02095132|65502093|FG002|Overall Study|Physician Decision|0|||
23480929|NCT02095132|65502094|FG003|Overall Study|Physician Decision|0|||
23480930|NCT02095132|65502095|FG004|Overall Study|Physician Decision|0|||
23480931|NCT02095132|65502096|FG005|Overall Study|Physician Decision|0|||
23480932|NCT02095132|65502097|FG006|Overall Study|Physician Decision|1|||
23480933|NCT02095132|65502098|FG007|Overall Study|Physician Decision|0|||
23480934|NCT02095132|65502099|FG008|Overall Study|Physician Decision|2|||
23363495|NCT02106351|65077112|FG002|Treatment Cycle 3|Adverse Event|0|||
23480935|NCT02095132|65502091|FG000|Overall Study|Withdrawal by Subject|0|||
23480936|NCT02095132|65502092|FG001|Overall Study|Withdrawal by Subject|0|||
23480937|NCT02095132|65502093|FG002|Overall Study|Withdrawal by Subject|2|||
23480938|NCT02095132|65502094|FG003|Overall Study|Withdrawal by Subject|2|||
23480939|NCT02095132|65502095|FG004|Overall Study|Withdrawal by Subject|3|||
23480940|NCT02095132|65502096|FG005|Overall Study|Withdrawal by Subject|0|||
23480941|NCT02095132|65502097|FG006|Overall Study|Withdrawal by Subject|5|||
23480942|NCT02095132|65502098|FG007|Overall Study|Withdrawal by Subject|0|||
23480943|NCT02095132|65502099|FG008|Overall Study|Withdrawal by Subject|0|||
23480944|NCT03761797|65502100|FG000|Overall Study|Changing hospital|11|||
23480945|NCT03761797|65502100|FG000|Overall Study|Improvement/remission|6|||
23480946|NCT03761797|65502100|FG000|Overall Study|Withdrawal by Subject|19|||
23480947|NCT03761797|65502100|FG000|Overall Study|Lost to Follow-up|33|||
23363496|NCT02106351|65077110|FG000|Treatment Cycle 3|Consent withdrawn|0|||
23363497|NCT02106351|65077111|FG001|Treatment Cycle 3|Consent withdrawn|0|||
23363498|NCT02106351|65077112|FG002|Treatment Cycle 3|Consent withdrawn|2|||
23363499|NCT02106351|65077110|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
23363500|NCT02106351|65077111|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
23363501|NCT02106351|65077112|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
23363502|NCT02106351|65077110|FG000|Treatment Cycle 3|Other|0|||
23363503|NCT02106351|65077111|FG001|Treatment Cycle 3|Other|2|||
23363504|NCT02106351|65077112|FG002|Treatment Cycle 3|Other|3|||
23363505|NCT02106351|65077110|FG000|Treatment Cycle 4|Consent withdrawn|0|||
23363506|NCT02106351|65077111|FG001|Treatment Cycle 4|Consent withdrawn|0|||
23363507|NCT02106351|65077112|FG002|Treatment Cycle 4|Consent withdrawn|2|||
23363508|NCT02106351|65077110|FG000|Treatment Cycle 4|Other|0|||
23363509|NCT02106351|65077111|FG001|Treatment Cycle 4|Other|1|||
23363510|NCT02106351|65077112|FG002|Treatment Cycle 4|Other|0|||
23363511|NCT00922116|65077113|FG000|Overall Study|Adverse Event|4|||
23363512|NCT00922116|65077113|FG000|Overall Study|Death|1|||
23363513|NCT00922116|65077113|FG000|Overall Study|Lost to Follow-up|1|||
23363514|NCT00922116|65077113|FG000|Overall Study|Withdrawal by Subject|4|||
23363515|NCT00922116|65077113|FG000|Overall Study|Other|5|||
23363516|NCT03225170|65077114|FG000|Overall Study|Lost to Follow-up|4|||
23363517|NCT03225170|65077115|FG001|Overall Study|Lost to Follow-up|4|||
23363518|NCT03225170|65077116|FG002|Overall Study|Lost to Follow-up|0|||
23363519|NCT03225170|65077114|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
23363520|NCT03225170|65077115|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
23363521|NCT03225170|65077116|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
23363522|NCT01932697|65077117|FG000|Overall Study|Received a different amount of tx|1|||
23363523|NCT01932697|65077118|FG001|Overall Study|Received a different amount of tx|0|||
23363524|NCT01932697|65077117|FG000|Overall Study|Ineligible|1|||
23363525|NCT01932697|65077118|FG001|Overall Study|Ineligible|0|||
23363526|NCT02686164|65077125|FG000|Overall Study|Adverse Event|1|||
23363527|NCT02686164|65077125|FG000|Overall Study|Withdrawal of consent|1|||
23363528|NCT02686164|65077125|FG000|Overall Study|Clinical progression|1|||
23363529|NCT04202497|65077126|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
23363530|NCT04202497|65077127|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
23363531|NCT04202497|65077128|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
23363532|NCT04202497|65077129|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
23363533|NCT00810199|65077132|FG000|Overall Study|Adverse Event|24|||
23363534|NCT00810199|65077133|FG001|Overall Study|Adverse Event|26|||
23363535|NCT00810199|65077132|FG000|Overall Study|Death|4|||
23363536|NCT00810199|65077133|FG001|Overall Study|Death|6|||
23363537|NCT00810199|65077132|FG000|Overall Study|Withdrew consent|9|||
23363538|NCT00810199|65077133|FG001|Overall Study|Withdrew consent|12|||
23363539|NCT00810199|65077132|FG000|Overall Study|Insufficient therapeutic response|5|||
23363540|NCT00810199|65077133|FG001|Overall Study|Insufficient therapeutic response|14|||
23363541|NCT00810199|65077132|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
23363542|NCT00810199|65077133|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
23363543|NCT00810199|65077132|FG000|Overall Study|Administrative/Other|5|||
23363544|NCT00810199|65077133|FG001|Overall Study|Administrative/Other|6|||
23363545|NCT00810199|65077132|FG000|Overall Study|Protocol Violation|2|||
23363546|NCT00810199|65077133|FG001|Overall Study|Protocol Violation|6|||
23363547|NCT00810199|65077132|FG000|Overall Study|Failure to return|1|||
23363548|NCT00810199|65077133|FG001|Overall Study|Failure to return|4|||
23363549|NCT00810199|65077132|FG000|Overall Study|Did not receive study drug|2|||
23363550|NCT00810199|65077133|FG001|Overall Study|Did not receive study drug|1|||
23363551|NCT02907463|65077134|FG000|Overall Study|Lost to Follow-up|17|||
23363552|NCT02907463|65077134|FG000|Overall Study|Death|10|||
23363553|NCT02907463|65077134|FG000|Overall Study|Withdrawal by Subject|4|||
23363554|NCT02907463|65077134|FG000|Overall Study|MIS Approach was not used|2|||
23363555|NCT02907463|65077134|FG000|Overall Study|Not Implanted with Study Device|2|||
23363556|NCT02907463|65077134|FG000|Overall Study|Device Explanted|1|||
23363557|NCT02907463|65077134|FG000|Overall Study|Missing Exit Form|1|||
23363558|NCT01724177|65077135|FG000|Overall Study|Adverse Event|8|||
23363559|NCT01724177|65077135|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
23363560|NCT01724177|65077135|FG000|Overall Study|Nervous participant|1|||
23363561|NCT01724177|65077135|FG000|Overall Study|Serious Adverse Event Related|1|||
23480948|NCT03761797|65502100|FG000|Overall Study|Adverse Event|37|||
23363562|NCT04157088|65077136|FG000|Overall Study|Study terminated by sponsor|23|||
23363563|NCT04157088|65077136|FG000|Overall Study|Withdrawal by Subject|4|||
23363564|NCT04157088|65077136|FG000|Overall Study|Lost to Follow-up|2|||
23363565|NCT04157088|65077136|FG000|Overall Study|Death|1|||
23363566|NCT02895347|65077137|FG000|Overall Study|Withdrawal by Subject|3|||
23363567|NCT02895347|65077138|FG001|Overall Study|Withdrawal by Subject|1|||
23363568|NCT03786380|65077139|FG000|Overall Study|Adverse Event|1|||
23363569|NCT03786380|65077140|FG001|Overall Study|Adverse Event|0|||
23363570|NCT03786380|65077141|FG002|Overall Study|Adverse Event|0|||
23363571|NCT03786380|65077142|FG003|Overall Study|Adverse Event|3|||
23363572|NCT03786380|65077143|FG004|Overall Study|Adverse Event|1|||
23363573|NCT03786380|65077139|FG000|Overall Study|Lack of Efficacy|0|||
23363574|NCT03786380|65077140|FG001|Overall Study|Lack of Efficacy|0|||
23363575|NCT03786380|65077141|FG002|Overall Study|Lack of Efficacy|0|||
23363576|NCT03786380|65077142|FG003|Overall Study|Lack of Efficacy|0|||
23363577|NCT03786380|65077143|FG004|Overall Study|Lack of Efficacy|1|||
23363578|NCT03786380|65077139|FG000|Overall Study|Withdrawal by Subject|1|||
23363579|NCT03786380|65077140|FG001|Overall Study|Withdrawal by Subject|2|||
23363580|NCT03786380|65077141|FG002|Overall Study|Withdrawal by Subject|2|||
23363581|NCT03786380|65077142|FG003|Overall Study|Withdrawal by Subject|1|||
23363582|NCT03786380|65077143|FG004|Overall Study|Withdrawal by Subject|2|||
23363583|NCT03786380|65077139|FG000|Overall Study|Lost to Follow-up|3|||
23363584|NCT03786380|65077140|FG001|Overall Study|Lost to Follow-up|0|||
23363585|NCT03786380|65077141|FG002|Overall Study|Lost to Follow-up|1|||
23363586|NCT03786380|65077142|FG003|Overall Study|Lost to Follow-up|2|||
23363587|NCT03786380|65077143|FG004|Overall Study|Lost to Follow-up|0|||
23363588|NCT03786380|65077139|FG000|Overall Study|Physician Decision|0|||
23363589|NCT03786380|65077140|FG001|Overall Study|Physician Decision|0|||
23363590|NCT03786380|65077141|FG002|Overall Study|Physician Decision|1|||
23363591|NCT03786380|65077142|FG003|Overall Study|Physician Decision|0|||
23363592|NCT03786380|65077143|FG004|Overall Study|Physician Decision|0|||
23363593|NCT03786380|65077139|FG000|Overall Study|Study Terminated by the Sponsor|30|||
23363594|NCT03786380|65077140|FG001|Overall Study|Study Terminated by the Sponsor|20|||
23363595|NCT03786380|65077141|FG002|Overall Study|Study Terminated by the Sponsor|50|||
23480949|NCT03761797|65502100|FG000|Overall Study|Case report form (CRF) not collected|5|||
23480950|NCT03761797|65502100|FG000|Overall Study|No patient visit after entry|13|||
23480951|NCT03761797|65502100|FG000|Overall Study|Switch to other diabetes medication|10|||
23363596|NCT03786380|65077142|FG003|Overall Study|Study Terminated by the Sponsor|57|||
23363597|NCT03786380|65077143|FG004|Overall Study|Study Terminated by the Sponsor|23|||
23363598|NCT03786380|65077139|FG000|Overall Study|Reason Not Specified|0|||
23363599|NCT03786380|65077140|FG001|Overall Study|Reason Not Specified|0|||
23363600|NCT03786380|65077141|FG002|Overall Study|Reason Not Specified|0|||
23363601|NCT03786380|65077142|FG003|Overall Study|Reason Not Specified|0|||
23363602|NCT03786380|65077143|FG004|Overall Study|Reason Not Specified|1|||
23480952|NCT03761797|65502100|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
23480953|NCT03761797|65502100|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
23480954|NCT03761797|65502100|FG000|Overall Study|Insufficient effectives|2|||
23363603|NCT02007720|65077144|FG000|Overall Study|Withdrawal by Subject|9|||
23363604|NCT02007720|65077145|FG001|Overall Study|Withdrawal by Subject|11|||
23363605|NCT02007720|65077144|FG000|Overall Study|study terminated by sponsor|58|||
23363606|NCT02007720|65077145|FG001|Overall Study|study terminated by sponsor|54|||
23363607|NCT02007720|65077144|FG000|Overall Study|technical problem|4|||
23363608|NCT02007720|65077145|FG001|Overall Study|technical problem|2|||
23363609|NCT02007720|65077144|FG000|Overall Study|patient followd less than 165 days|11|||
23266423|NCT00531206|64718007|FG000|Overall Study|Adverse Event related|5|||
23266424|NCT00531206|64718007|FG000|Overall Study|Lack of Efficacy|2|||
23266425|NCT00531206|64718007|FG000|Overall Study|Lost to Follow-up|5|||
23266426|NCT00531206|64718007|FG000|Overall Study|including non-related adverse events|8|||
23266427|NCT04849988|64718008|FG000|Overall Study|Lack of Efficacy|3|||
23266428|NCT04849988|64718009|FG001|Overall Study|Lack of Efficacy|4|||
23266429|NCT04849988|64718010|FG002|Overall Study|Lack of Efficacy|1|||
23266430|NCT04849988|64718011|FG003|Overall Study|Lack of Efficacy|4|||
23266431|NCT04849988|64718008|FG000|Overall Study|Other reasons|1|||
23266432|NCT04849988|64718009|FG001|Overall Study|Other reasons|2|||
23266433|NCT04849988|64718010|FG002|Overall Study|Other reasons|2|||
23266434|NCT04849988|64718011|FG003|Overall Study|Other reasons|1|||
23266435|NCT00782509|64718017|FG000|Overall Study|Adverse Event|20|||
23266436|NCT00782509|64718018|FG001|Overall Study|Adverse Event|10|||
23266437|NCT00782509|64718019|FG002|Overall Study|Adverse Event|20|||
23266438|NCT00782509|64718017|FG000|Overall Study|Lost to Follow-up|1|||
23266439|NCT00782509|64718018|FG001|Overall Study|Lost to Follow-up|2|||
23266440|NCT00782509|64718019|FG002|Overall Study|Lost to Follow-up|3|||
23363610|NCT02007720|65077145|FG001|Overall Study|patient followd less than 165 days|5|||
23363611|NCT00048035|65077151|FG000|Core Period|Early Withdrawals|4|||
23266441|NCT00782509|64718017|FG000|Overall Study|Withdrawal by Subject|3|||
23266442|NCT00782509|64718018|FG001|Overall Study|Withdrawal by Subject|5|||
23266443|NCT00782509|64718019|FG002|Overall Study|Withdrawal by Subject|8|||
23266444|NCT00782509|64718017|FG000|Overall Study|Non compliance with protocol|2|||
23266445|NCT00782509|64718018|FG001|Overall Study|Non compliance with protocol|0|||
23266446|NCT00782509|64718019|FG002|Overall Study|Non compliance with protocol|0|||
23266447|NCT00782509|64718017|FG000|Overall Study|Other reasons not stated above|5|||
23601080|NCT01437319|65929840|FG001|Phase II|Protocol Violation|1|||
23601081|NCT01437319|65929841|FG002|Phase II|Protocol Violation|0|||
23601082|NCT01471691|65929845|FG000|Overall Study|Lack of Efficacy|0|||
23601083|NCT01471691|65929846|FG001|Overall Study|Lack of Efficacy|1|||
23266448|NCT00782509|64718018|FG001|Overall Study|Other reasons not stated above|2|||
23266449|NCT00782509|64718019|FG002|Overall Study|Other reasons not stated above|3|||
23266450|NCT00782509|64718017|FG000|Overall Study|Lack of Efficacy|10|||
23266451|NCT00782509|64718018|FG001|Overall Study|Lack of Efficacy|5|||
23363612|NCT00048035|65077152|FG001|Core Period|Early Withdrawals|2|||
23363613|NCT00048035|65077153|FG002|Core Period|Early Withdrawals|1|||
23363614|NCT00048035|65077154|FG003|Core Period|Early Withdrawals|1|||
23363615|NCT00048035|65077155|FG004|Core Period|Early Withdrawals|1|||
23363616|NCT00048035|65077156|FG005|Core Period|Early Withdrawals|1|||
23363617|NCT00048035|65077157|FG006|Core Period|Early Withdrawals|0|||
23363618|NCT00048035|65077158|FG007|Core Period|Early Withdrawals|0|||
23363619|NCT00048035|65077151|FG000|Extension Year 1|Early Withdrawals|0|||
23363620|NCT00048035|65077152|FG001|Extension Year 1|Early Withdrawals|0|||
23363621|NCT00048035|65077153|FG002|Extension Year 1|Early Withdrawals|0|||
23363622|NCT00048035|65077154|FG003|Extension Year 1|Early Withdrawals|0|||
23363623|NCT00048035|65077155|FG004|Extension Year 1|Early Withdrawals|0|||
23363624|NCT00048035|65077156|FG005|Extension Year 1|Early Withdrawals|0|||
23363625|NCT00048035|65077157|FG006|Extension Year 1|Early Withdrawals|11|||
23363626|NCT00048035|65077158|FG007|Extension Year 1|Early Withdrawals|11|||
23363627|NCT00048035|65077151|FG000|Extension Year 2|Early Withdrawals|0|||
23363628|NCT00048035|65077152|FG001|Extension Year 2|Early Withdrawals|0|||
23363629|NCT00048035|65077153|FG002|Extension Year 2|Early Withdrawals|0|||
23363630|NCT00048035|65077154|FG003|Extension Year 2|Early Withdrawals|0|||
23363631|NCT00048035|65077155|FG004|Extension Year 2|Early Withdrawals|0|||
23363632|NCT00048035|65077156|FG005|Extension Year 2|Early Withdrawals|0|||
23363633|NCT00048035|65077157|FG006|Extension Year 2|Early Withdrawals|3|||
23363634|NCT00048035|65077158|FG007|Extension Year 2|Early Withdrawals|3|||
23363635|NCT05415462|65077159|FG000|Overall Study|Death|18|||
23363636|NCT05415462|65077160|FG001|Overall Study|Death|10|||
23601084|NCT02404441|65929851|FG000|Phase 1 Part|Adverse Event|1|||
23266452|NCT00782509|64718019|FG002|Overall Study|Lack of Efficacy|2|||
23266453|NCT02534493|64718020|FG000|Overall Study|Lost to Follow-up|1|||
23266454|NCT02534493|64718020|FG000|Overall Study|Withdrawal by Subject|1|||
23266455|NCT01361126|64718021|FG000|Overall Study|Sponsor decision|0|||
23266456|NCT01361126|64718022|FG001|Overall Study|Sponsor decision|2|||
23266457|NCT00922974|64718023|FG000|Phase II Component|Protocol Violation|2|||
23266458|NCT00922974|64718024|FG001|Phase II Component|Protocol Violation|0|||
23266459|NCT00922974|64718023|FG000|Phase II Component|Not evaluable for treatment review|5|||
23266460|NCT00922974|64718024|FG001|Phase II Component|Not evaluable for treatment review|0|||
23266461|NCT00922974|64718023|FG000|Phase III Component|Protocol Violation|8|||
23266462|NCT00922974|64718024|FG001|Phase III Component|Protocol Violation|6|||
23266463|NCT02339909|64718025|FG000|Overall Study|Became ineligible after randomisation|89|||
23266464|NCT02339909|64718026|FG001|Overall Study|Became ineligible after randomisation|63|||
23266465|NCT02339909|64718027|FG002|Overall Study|Became ineligible after randomisation|71|||
23266466|NCT01367275|64718028|FG000|Overall Study|Ineligible|1|||
23266467|NCT01367275|64718028|FG000|Overall Study|Disease Progression|2|||
23266468|NCT03655106|64718029|FG000|Overall Study|Withdrawal by Subject|3|||
23266469|NCT03655106|64718030|FG001|Overall Study|Withdrawal by Subject|2|||
23266470|NCT03655106|64718029|FG000|Overall Study|Lost to Follow-up|2|||
23266471|NCT03655106|64718030|FG001|Overall Study|Lost to Follow-up|1|||
23266472|NCT03655106|64718029|FG000|Overall Study|Duplicate Enrollment|1|||
23266473|NCT03655106|64718030|FG001|Overall Study|Duplicate Enrollment|1|||
23266474|NCT03655106|64718029|FG000|Overall Study|Protocol Violation|3|||
23601085|NCT02404441|65929852|FG001|Phase 1 Part|Adverse Event|0|||
23601086|NCT02404441|65929853|FG002|Phase 1 Part|Adverse Event|0|||
23601087|NCT02404441|65929854|FG003|Phase 1 Part|Adverse Event|0|||
23601088|NCT02404441|65929855|FG004|Phase 1 Part|Adverse Event|0|||
23266475|NCT03655106|64718030|FG001|Overall Study|Protocol Violation|0|||
23266476|NCT01290263|64718036|FG000|Overall Study|Adverse Event|0|||
23266477|NCT01290263|64718037|FG001|Overall Study|Adverse Event|0|||
23266478|NCT01290263|64718038|FG002|Overall Study|Adverse Event|0|||
23266479|NCT01290263|64718039|FG003|Overall Study|Adverse Event|1|||
23363637|NCT05415462|65077159|FG000|Overall Study|Lost to Follow-up|72|||
23363638|NCT05415462|65077160|FG001|Overall Study|Lost to Follow-up|64|||
23363639|NCT05415462|65077159|FG000|Overall Study|Physician Decision|5|||
23363640|NCT05415462|65077160|FG001|Overall Study|Physician Decision|5|||
23363641|NCT05415462|65077159|FG000|Overall Study|Protocol Deviation|1|||
23363642|NCT05415462|65077160|FG001|Overall Study|Protocol Deviation|0|||
23266480|NCT01290263|64718040|FG004|Overall Study|Adverse Event|1|||
23266481|NCT01290263|64718036|FG000|Overall Study|Lack of Efficacy|8|||
23266482|NCT01290263|64718037|FG001|Overall Study|Lack of Efficacy|2|||
23266483|NCT01290263|64718038|FG002|Overall Study|Lack of Efficacy|7|||
23266484|NCT01290263|64718039|FG003|Overall Study|Lack of Efficacy|24|||
23266485|NCT01290263|64718040|FG004|Overall Study|Lack of Efficacy|33|||
23266486|NCT01290263|64718036|FG000|Overall Study|Withdrawal by Subject|3|||
23266487|NCT01290263|64718037|FG001|Overall Study|Withdrawal by Subject|1|||
23266488|NCT01290263|64718038|FG002|Overall Study|Withdrawal by Subject|0|||
23266489|NCT01290263|64718039|FG003|Overall Study|Withdrawal by Subject|1|||
23266490|NCT01290263|64718040|FG004|Overall Study|Withdrawal by Subject|2|||
23266491|NCT01290263|64718036|FG000|Overall Study|Participant Non-Compliance|0|||
23266492|NCT01290263|64718037|FG001|Overall Study|Participant Non-Compliance|0|||
23266493|NCT01290263|64718038|FG002|Overall Study|Participant Non-Compliance|0|||
23266494|NCT01290263|64718039|FG003|Overall Study|Participant Non-Compliance|1|||
23266495|NCT01290263|64718040|FG004|Overall Study|Participant Non-Compliance|1|||
23266496|NCT02309099|64718041|FG000|Overall Study|Adverse Event|2|||
23266497|NCT02309099|64718042|FG001|Overall Study|Adverse Event|0|||
23363643|NCT05415462|65077159|FG000|Overall Study|Withdrawal by Subject|129|||
23363644|NCT05415462|65077160|FG001|Overall Study|Withdrawal by Subject|101|||
23363645|NCT05415462|65077159|FG000|Overall Study|Other Than Specified|8|||
23363646|NCT05415462|65077160|FG001|Overall Study|Other Than Specified|8|||
23363647|NCT01419314|65077161|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
23363648|NCT01419314|65077162|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
23363649|NCT01419314|65077161|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
23480955|NCT03761797|65502100|FG000|Overall Study|Excessive alcohol intake|1|||
23480956|NCT02609503|65502101|FG000|Overall Study|Adverse Event|1|||
23480957|NCT02609503|65502101|FG000|Overall Study|Death|1|||
23480958|NCT02609503|65502101|FG000|Overall Study|Withdrawal by Subject|1|||
23480959|NCT02609503|65502101|FG000|Overall Study|Disease progression|1|||
23480960|NCT00813943|65502103|FG000|Overall Study|Ongoing at cut-off date|5|||
23480961|NCT00813943|65502104|FG001|Overall Study|Ongoing at cut-off date|5|||
23480962|NCT00813943|65502105|FG002|Overall Study|Ongoing at cut-off date|3|||
23480963|NCT04322539|65502106|FG000|Overall Study|Withdrawal of consent|14|||
23480964|NCT04322539|65502107|FG001|Overall Study|Withdrawal of consent|8|||
23480965|NCT04322539|65502106|FG000|Overall Study|Death|317|||
23480966|NCT04322539|65502107|FG001|Overall Study|Death|173|||
23480967|NCT04322539|65502106|FG000|Overall Study|Adverse Event|1|||
23480968|NCT04322539|65502107|FG001|Overall Study|Adverse Event|0|||
23480969|NCT04322539|65502106|FG000|Overall Study|Lost to Follow-up|3|||
23480970|NCT04322539|65502107|FG001|Overall Study|Lost to Follow-up|0|||
23480971|NCT04322539|65502106|FG000|Overall Study|Other|2|||
23480972|NCT04322539|65502107|FG001|Overall Study|Other|3|||
23480973|NCT04322539|65502106|FG000|Overall Study|Ongoing|124|||
23480974|NCT04322539|65502107|FG001|Overall Study|Ongoing|46|||
23480975|NCT02694718|65502108|FG000|Overall Study|Death|1|||
23480976|NCT02694718|65502108|FG000|Overall Study|Withdrawal by Subject|1|||
23480977|NCT00711516|65502109|FG000|Overall Study|Adverse Event|1|||
23601089|NCT02404441|65929856|FG005|Phase 1 Part|Adverse Event|0|||
23601090|NCT02404441|65929857|FG006|Phase 1 Part|Adverse Event|0|||
23601091|NCT02404441|65929858|FG007|Phase 1 Part|Adverse Event|0|||
23601092|NCT02404441|65929859|FG008|Phase 1 Part|Adverse Event|0|||
23601093|NCT02404441|65929860|FG009|Phase 1 Part|Adverse Event|0|||
23601094|NCT02404441|65929851|FG000|Phase 1 Part|Physician Decision|0|||
23601095|NCT02404441|65929852|FG001|Phase 1 Part|Physician Decision|1|||
23601096|NCT02404441|65929853|FG002|Phase 1 Part|Physician Decision|0|||
23601097|NCT02404441|65929854|FG003|Phase 1 Part|Physician Decision|0|||
23266498|NCT02483975|64718043|FG000|Overall Study|Adverse Event|0|||
23266499|NCT02483975|64718044|FG001|Overall Study|Adverse Event|1|||
23266500|NCT02483975|64718043|FG000|Overall Study|Lost to Follow-up|0|||
23266501|NCT02483975|64718044|FG001|Overall Study|Lost to Follow-up|1|||
23266502|NCT02483975|64718043|FG000|Overall Study|Physician Decision|2|||
23266503|NCT02483975|64718044|FG001|Overall Study|Physician Decision|0|||
23266504|NCT02888171|64718045|FG000|Overall Study|Lost to Follow-up|2|||
23266505|NCT02888171|64718046|FG001|Overall Study|Lost to Follow-up|1|||
23266506|NCT02888171|64718045|FG000|Overall Study|Withdrawal by Subject|3|||
23266507|NCT02888171|64718046|FG001|Overall Study|Withdrawal by Subject|2|||
23266508|NCT02888171|64718045|FG000|Overall Study|Adverse Event|0|||
23266509|NCT02888171|64718046|FG001|Overall Study|Adverse Event|1|||
23363650|NCT01419314|65077162|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
23480978|NCT00711516|65502110|FG001|Overall Study|Adverse Event|1|||
23480979|NCT00711516|65502109|FG000|Overall Study|Withdrawal by Subject|0|||
23601098|NCT02404441|65929855|FG004|Phase 1 Part|Physician Decision|0|||
23266510|NCT02841709|64718050|FG000|5th Intervention|Adverse Event|2|||
23480980|NCT00711516|65502110|FG001|Overall Study|Withdrawal by Subject|1|||
23480981|NCT00711516|65502109|FG000|Overall Study|Protocol Violation|0|||
23480982|NCT00711516|65502110|FG001|Overall Study|Protocol Violation|1|||
23480983|NCT01075191|65502113|FG000|Overall Study|Death|1|||
23480984|NCT01075191|65502113|FG000|Overall Study|Intensification|3|||
23480985|NCT01075191|65502113|FG000|Overall Study|Co-morbidities|1|||
23480986|NCT01075191|65502113|FG000|Overall Study|Adverse Event|4|||
23480987|NCT01075191|65502113|FG000|Overall Study|Noncompliance|3|||
23480988|NCT01075191|65502113|FG000|Overall Study|Therapy Break|3|||
23480989|NCT01075191|65502113|FG000|Overall Study|Patient's Wish|2|||
23480990|NCT01075191|65502113|FG000|Overall Study|Unknown Reasons|1|||
23480991|NCT02674854|65502114|FG000|Overall Study|Adverse Event|17|||
23480992|NCT02674854|65502115|FG001|Overall Study|Adverse Event|15|||
23266511|NCT02841709|64718051|FG001|5th Intervention|Adverse Event|0|||
23266512|NCT02841709|64718052|FG002|5th Intervention|Adverse Event|0|||
23266513|NCT02841709|64718053|FG003|5th Intervention|Adverse Event|0|||
23266514|NCT02841709|64718054|FG004|5th Intervention|Adverse Event|2|||
23266515|NCT01030965|64718059|FG000|Overall Study|Lack of Efficacy|3|||
23266516|NCT01030965|64718060|FG001|Overall Study|Lack of Efficacy|2|||
23266517|NCT01030965|64718061|FG002|Overall Study|Lack of Efficacy|0|||
23266518|NCT01030965|64718062|FG003|Overall Study|Lack of Efficacy|3|||
23266519|NCT01030965|64718059|FG000|Overall Study|Protocol Violation|1|||
23266520|NCT01030965|64718060|FG001|Overall Study|Protocol Violation|1|||
23266521|NCT01030965|64718061|FG002|Overall Study|Protocol Violation|1|||
23266522|NCT01030965|64718062|FG003|Overall Study|Protocol Violation|1|||
23266523|NCT01030965|64718059|FG000|Overall Study|Adverse Event|0|||
23266524|NCT01030965|64718060|FG001|Overall Study|Adverse Event|1|||
23266525|NCT01030965|64718061|FG002|Overall Study|Adverse Event|2|||
23266526|NCT01030965|64718062|FG003|Overall Study|Adverse Event|1|||
23266527|NCT01030965|64718059|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
23266528|NCT01030965|64718060|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
23266529|NCT01030965|64718061|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
23266530|NCT01030965|64718062|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
23266531|NCT01030965|64718059|FG000|Overall Study|Withdrawal by Subject|0|||
23266532|NCT01030965|64718060|FG001|Overall Study|Withdrawal by Subject|1|||
23266533|NCT01030965|64718061|FG002|Overall Study|Withdrawal by Subject|0|||
23266534|NCT01030965|64718062|FG003|Overall Study|Withdrawal by Subject|2|||
23363651|NCT01419314|65077161|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
23363652|NCT01419314|65077162|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
23363653|NCT01265394|65077165|FG000|Overall Study|Subjects withdrawn|37|||
23363654|NCT04249362|65077166|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|34|||
23363655|NCT04249362|65077167|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|25|||
23363656|NCT02699996|65077168|FG000|Overall Study|Withdrawal by Subject|5|||
23363657|NCT02699996|65077169|FG001|Overall Study|Withdrawal by Subject|2|||
23363658|NCT03382418|65077170|FG000|Overall Study|Withdrawal by Subject|1|||
23363659|NCT03382418|65077171|FG001|Overall Study|Withdrawal by Subject|0|||
23363660|NCT03382418|65077172|FG002|Overall Study|Withdrawal by Subject|0|||
23363661|NCT03382418|65077170|FG000|Overall Study|Lost to Follow-up|2|||
23363662|NCT03382418|65077171|FG001|Overall Study|Lost to Follow-up|3|||
23363663|NCT03382418|65077172|FG002|Overall Study|Lost to Follow-up|0|||
23363664|NCT03872843|65077173|FG000|Overall Study|Lost to Follow-up|5|||
23363665|NCT03872843|65077174|FG001|Overall Study|Lost to Follow-up|7|||
23363666|NCT00752089|65077175|FG000|Overall Study|Adverse Event|1|||
23363667|NCT00752089|65077175|FG000|Overall Study|Protocol Deviation|2|||
23363668|NCT00752089|65077175|FG000|Overall Study|Could not attend visit 9|1|||
23363669|NCT00752089|65077175|FG000|Overall Study|Not capable of wearing partial denture|1|||
23363670|NCT00752089|65077175|FG000|Overall Study|Cannot continue the study|1|||
23363671|NCT01076543|65077178|FG000|Overall Study|Withdrawal by Subject|2|||
23363672|NCT01076543|65077179|FG001|Overall Study|Withdrawal by Subject|0|||
23363673|NCT01076543|65077180|FG002|Overall Study|Withdrawal by Subject|0|||
23363674|NCT01076543|65077181|FG003|Overall Study|Withdrawal by Subject|0|||
23363675|NCT01076543|65077182|FG004|Overall Study|Withdrawal by Subject|0|||
23363676|NCT01076543|65077183|FG005|Overall Study|Withdrawal by Subject|0|||
23363677|NCT00490971|65077196|FG000|Acute/Continuation|Adverse Event|62|||
23363678|NCT00490971|65077197|FG001|Acute/Continuation|Adverse Event|13|||
23363679|NCT00490971|65077198|FG002|Acute/Continuation|Adverse Event|0|||
23363680|NCT00490971|65077199|FG003|Acute/Continuation|Adverse Event|0|||
23363681|NCT00490971|65077200|FG004|Acute/Continuation|Adverse Event|0|||
23363682|NCT00490971|65077196|FG000|Acute/Continuation|Death|2|||
23363683|NCT00490971|65077197|FG001|Acute/Continuation|Death|0|||
23363684|NCT00490971|65077198|FG002|Acute/Continuation|Death|0|||
23363685|NCT00490971|65077199|FG003|Acute/Continuation|Death|0|||
23363686|NCT00490971|65077200|FG004|Acute/Continuation|Death|0|||
23363687|NCT00490971|65077196|FG000|Acute/Continuation|Lack of Efficacy|106|||
23363688|NCT00490971|65077197|FG001|Acute/Continuation|Lack of Efficacy|12|||
23480993|NCT02674854|65502116|FG002|Overall Study|Adverse Event|5|||
23480994|NCT02674854|65502114|FG000|Overall Study|Withdrawal by Subject|1|||
23480995|NCT02674854|65502115|FG001|Overall Study|Withdrawal by Subject|5|||
23266535|NCT03039023|64718063|FG000|Overall Study|Withdrawal by Subject|1|||
23363689|NCT00490971|65077198|FG002|Acute/Continuation|Lack of Efficacy|0|||
23480996|NCT02674854|65502116|FG002|Overall Study|Withdrawal by Subject|4|||
23266536|NCT03039023|64718064|FG001|Overall Study|Withdrawal by Subject|0|||
23266537|NCT03039023|64718065|FG002|Overall Study|Withdrawal by Subject|1|||
23266538|NCT03039023|64718066|FG003|Overall Study|Withdrawal by Subject|1|||
23266539|NCT03039023|64718067|FG004|Overall Study|Withdrawal by Subject|0|||
23266540|NCT03039023|64718063|FG000|Overall Study|Physician Decision|0|||
23266541|NCT03039023|64718064|FG001|Overall Study|Physician Decision|0|||
23266542|NCT03039023|64718065|FG002|Overall Study|Physician Decision|0|||
23266543|NCT03039023|64718066|FG003|Overall Study|Physician Decision|1|||
23266544|NCT03039023|64718067|FG004|Overall Study|Physician Decision|0|||
23266545|NCT04041570|64718068|FG000|Overall Study|Moved from Area|0|||
23266546|NCT04041570|64718069|FG001|Overall Study|Moved from Area|2|||
23266547|NCT03309956|64718073|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
23266548|NCT03247556|64718074|FG000|Overall Study|Adverse Event|1|||
23266549|NCT03247556|64718075|FG001|Overall Study|Adverse Event|4|||
23266550|NCT03247556|64718076|FG002|Overall Study|Adverse Event|5|||
23266551|NCT03247556|64718074|FG000|Overall Study|Lost to Follow-up|5|||
23266552|NCT03247556|64718075|FG001|Overall Study|Lost to Follow-up|5|||
23266553|NCT03247556|64718076|FG002|Overall Study|Lost to Follow-up|4|||
23266554|NCT03247556|64718074|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
23266555|NCT03247556|64718075|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
23266556|NCT03247556|64718076|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
23601099|NCT02404441|65929856|FG005|Phase 1 Part|Physician Decision|0|||
23601100|NCT02404441|65929857|FG006|Phase 1 Part|Physician Decision|0|||
23601101|NCT02404441|65929858|FG007|Phase 1 Part|Physician Decision|0|||
23601102|NCT02404441|65929859|FG008|Phase 1 Part|Physician Decision|0|||
23601103|NCT02404441|65929860|FG009|Phase 1 Part|Physician Decision|0|||
23601104|NCT02404441|65929851|FG000|Phase 1 Part|Progressive Disease|14|||
23601105|NCT02404441|65929852|FG001|Phase 1 Part|Progressive Disease|11|||
23266557|NCT03247556|64718074|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
23266558|NCT03247556|64718075|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
23266559|NCT03247556|64718076|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
23266560|NCT03247556|64718074|FG000|Overall Study|Protocol Violation|2|||
23266561|NCT03247556|64718075|FG001|Overall Study|Protocol Violation|0|||
23266562|NCT03247556|64718076|FG002|Overall Study|Protocol Violation|1|||
23266563|NCT03247556|64718074|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
23266564|NCT03247556|64718075|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
23266565|NCT03247556|64718076|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
23266566|NCT02041702|64718083|FG000|Overall Study|Lost to Follow-up|1|||
23266567|NCT02041702|64718084|FG001|Overall Study|Lost to Follow-up|6|||
23266568|NCT02041702|64718083|FG000|Overall Study|Death|4|||
23266569|NCT02041702|64718084|FG001|Overall Study|Death|0|||
23266570|NCT02041702|64718083|FG000|Overall Study|Withdrawal by Subject|4|||
23266571|NCT02041702|64718084|FG001|Overall Study|Withdrawal by Subject|3|||
23266572|NCT02041702|64718083|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
23266573|NCT02041702|64718084|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
23266574|NCT02041702|64718083|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
23266575|NCT02041702|64718084|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
23266576|NCT01769378|64718086|FG000|Overall Study|Adverse Event|10|||
23266577|NCT01769378|64718087|FG001|Overall Study|Adverse Event|0|||
23266578|NCT01769378|64718086|FG000|Overall Study|Entry criteria not met|1|||
23266579|NCT01769378|64718087|FG001|Overall Study|Entry criteria not met|0|||
23266580|NCT01769378|64718086|FG000|Overall Study|Protocol Violation|1|||
23266581|NCT01769378|64718087|FG001|Overall Study|Protocol Violation|1|||
23266582|NCT01769378|64718086|FG000|Overall Study|Withdrawal by Subject|10|||
23266583|NCT01769378|64718087|FG001|Overall Study|Withdrawal by Subject|3|||
23266584|NCT01769378|64718086|FG000|Overall Study|Sponsor Decision|1|||
23266585|NCT01769378|64718087|FG001|Overall Study|Sponsor Decision|0|||
23266586|NCT01769378|64718086|FG000|Overall Study|Lost to Follow-up|2|||
23266587|NCT01769378|64718087|FG001|Overall Study|Lost to Follow-up|0|||
23266588|NCT02994056|64718089|FG000|Overall Study|Death|8|||
23266589|NCT02994056|64718089|FG000|Overall Study|Withdrew Consent|1|||
23266590|NCT01170364|64718090|FG000|Overall Study|Protocol Violation|4|||
23266591|NCT01170364|64718091|FG001|Overall Study|Protocol Violation|1|||
23266592|NCT03387098|64718099|FG000|Overall Study|progressive disease|1|||
23266593|NCT03387098|64718099|FG000|Overall Study|Withdrawal by Subject|2|||
23266594|NCT03387098|64718099|FG000|Overall Study|study terminated by sponsor|1|||
23266595|NCT04099888|64718100|FG000|Overall Study|Study terminated by sponsor|9|||
23266596|NCT04099888|64718101|FG001|Overall Study|Study terminated by sponsor|11|||
23266597|NCT04099888|64718100|FG000|Overall Study|Lost to Follow-up|1|||
23266598|NCT04099888|64718101|FG001|Overall Study|Lost to Follow-up|1|||
23266599|NCT04099888|64718100|FG000|Overall Study|Withdrawal by Subject|5|||
23266600|NCT04099888|64718101|FG001|Overall Study|Withdrawal by Subject|6|||
23480997|NCT02674854|65502114|FG000|Overall Study|No-compliant subject|1|||
23601106|NCT02404441|65929853|FG002|Phase 1 Part|Progressive Disease|7|||
23601107|NCT02404441|65929854|FG003|Phase 1 Part|Progressive Disease|6|||
23266601|NCT04099888|64718100|FG000|Overall Study|Death|5|||
23601108|NCT02404441|65929855|FG004|Phase 1 Part|Progressive Disease|9|||
23363690|NCT00490971|65077199|FG003|Acute/Continuation|Lack of Efficacy|0|||
23363691|NCT00490971|65077200|FG004|Acute/Continuation|Lack of Efficacy|0|||
23363692|NCT00490971|65077196|FG000|Acute/Continuation|Lost to Follow-up|23|||
23363693|NCT00490971|65077197|FG001|Acute/Continuation|Lost to Follow-up|7|||
23363694|NCT00490971|65077198|FG002|Acute/Continuation|Lost to Follow-up|0|||
23363695|NCT00490971|65077199|FG003|Acute/Continuation|Lost to Follow-up|0|||
23363696|NCT00490971|65077200|FG004|Acute/Continuation|Lost to Follow-up|0|||
23480998|NCT02674854|65502115|FG001|Overall Study|No-compliant subject|0|||
23480999|NCT02674854|65502116|FG002|Overall Study|No-compliant subject|1|||
23481000|NCT02674854|65502114|FG000|Overall Study|Lost to Follow-up|1|||
23481001|NCT02674854|65502115|FG001|Overall Study|Lost to Follow-up|0|||
23481002|NCT02674854|65502116|FG002|Overall Study|Lost to Follow-up|2|||
23481003|NCT02674854|65502114|FG000|Overall Study|Lack of Efficacy|0|||
23481004|NCT02674854|65502115|FG001|Overall Study|Lack of Efficacy|3|||
23481005|NCT02674854|65502116|FG002|Overall Study|Lack of Efficacy|0|||
23481006|NCT02674854|65502114|FG000|Overall Study|Disallowed Concurrent Medication|2|||
23481007|NCT02674854|65502115|FG001|Overall Study|Disallowed Concurrent Medication|2|||
23481008|NCT02674854|65502116|FG002|Overall Study|Disallowed Concurrent Medication|0|||
23481009|NCT02674854|65502114|FG000|Overall Study|Protocol Violation|1|||
23481010|NCT02674854|65502115|FG001|Overall Study|Protocol Violation|1|||
23481011|NCT02674854|65502116|FG002|Overall Study|Protocol Violation|2|||
23481012|NCT02674854|65502114|FG000|Overall Study|Death|0|||
23481013|NCT02674854|65502115|FG001|Overall Study|Death|1|||
23481014|NCT02674854|65502116|FG002|Overall Study|Death|0|||
23481015|NCT02674854|65502114|FG000|Overall Study|Subject missed V6.2|1|||
23481016|NCT02674854|65502115|FG001|Overall Study|Subject missed V6.2|0|||
23481017|NCT02674854|65502116|FG002|Overall Study|Subject missed V6.2|0|||
23481018|NCT01262352|65502119|FG000|Period 1|Illness after randomization|1|||
23481019|NCT01262352|65502120|FG001|Period 1|Illness after randomization|0|||
23481020|NCT01262352|65502119|FG000|Washout|Adverse Event|1|||
23481021|NCT01262352|65502120|FG001|Washout|Adverse Event|1|||
23481022|NCT01262352|65502119|FG000|Washout|Extended Washout|0|||
23481023|NCT01262352|65502120|FG001|Washout|Extended Washout|1|||
23481024|NCT00934843|65502121|FG000|Overall Study|Protocol Violation|0|||
23481025|NCT00934843|65502122|FG001|Overall Study|Protocol Violation|1|||
23481026|NCT02279407|65502123|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
23481027|NCT02279407|65502124|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
23481028|NCT02279407|65502125|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
23481029|NCT02279407|65502126|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
23481030|NCT02279407|65502123|FG000|Overall Study|Withdrawal by Subject|1|||
23481031|NCT02279407|65502124|FG001|Overall Study|Withdrawal by Subject|0|||
23481032|NCT02279407|65502125|FG002|Overall Study|Withdrawal by Subject|1|||
23481033|NCT02279407|65502126|FG003|Overall Study|Withdrawal by Subject|1|||
23601109|NCT02404441|65929856|FG005|Phase 1 Part|Progressive Disease|0|||
23601110|NCT02404441|65929857|FG006|Phase 1 Part|Progressive Disease|0|||
23601111|NCT02404441|65929858|FG007|Phase 1 Part|Progressive Disease|0|||
23601112|NCT02404441|65929859|FG008|Phase 1 Part|Progressive Disease|0|||
23601113|NCT02404441|65929860|FG009|Phase 1 Part|Progressive Disease|0|||
23601114|NCT02404441|65929851|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
23601115|NCT02404441|65929852|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
23601116|NCT02404441|65929853|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
23601117|NCT02404441|65929854|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
23601118|NCT02404441|65929855|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
23601119|NCT02404441|65929856|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
23601120|NCT02404441|65929857|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
23601121|NCT02404441|65929858|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
23601122|NCT02404441|65929859|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
23601123|NCT02404441|65929860|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
23601124|NCT02404441|65929851|FG000|Phase 1 Part|Death|1|||
23601125|NCT02404441|65929852|FG001|Phase 1 Part|Death|1|||
23601126|NCT02404441|65929853|FG002|Phase 1 Part|Death|1|||
23601127|NCT02404441|65929854|FG003|Phase 1 Part|Death|0|||
23363697|NCT00490971|65077196|FG000|Acute/Continuation|Protocol Violation|10|||
23363698|NCT00490971|65077197|FG001|Acute/Continuation|Protocol Violation|2|||
23601128|NCT02404441|65929855|FG004|Phase 1 Part|Death|1|||
23601129|NCT02404441|65929856|FG005|Phase 1 Part|Death|0|||
23266602|NCT04099888|64718101|FG001|Overall Study|Death|2|||
23363699|NCT00490971|65077198|FG002|Acute/Continuation|Protocol Violation|0|||
23481034|NCT02279407|65502123|FG000|Overall Study|Adverse Event|1|||
23481035|NCT02279407|65502124|FG001|Overall Study|Adverse Event|1|||
23481036|NCT02279407|65502125|FG002|Overall Study|Adverse Event|2|||
23481037|NCT02279407|65502126|FG003|Overall Study|Adverse Event|0|||
23481038|NCT02151773|65502127|FG000|Overall Study|Protocol Deviation|64|||
23481039|NCT04905498|65502128|FG000|Overall Study|Lost to Follow-up|0|||
23481040|NCT04905498|65502129|FG001|Overall Study|Lost to Follow-up|2|||
23481041|NCT04905498|65502128|FG000|Overall Study|COVID lockdown|1|||
23481042|NCT04905498|65502129|FG001|Overall Study|COVID lockdown|0|||
23266603|NCT04099888|64718100|FG000|Overall Study|Other|1|||
23266604|NCT04099888|64718101|FG001|Overall Study|Other|0|||
23601130|NCT02404441|65929857|FG006|Phase 1 Part|Death|0|||
23601131|NCT02404441|65929858|FG007|Phase 1 Part|Death|0|||
23601132|NCT02404441|65929859|FG008|Phase 1 Part|Death|0|||
23601133|NCT02404441|65929860|FG009|Phase 1 Part|Death|0|||
23601134|NCT02404441|65929851|FG000|Phase 2 Part|Adverse Event|0|||
23601135|NCT02404441|65929852|FG001|Phase 2 Part|Adverse Event|0|||
23601136|NCT02404441|65929853|FG002|Phase 2 Part|Adverse Event|0|||
23601137|NCT02404441|65929854|FG003|Phase 2 Part|Adverse Event|0|||
23601138|NCT02404441|65929855|FG004|Phase 2 Part|Adverse Event|0|||
23601139|NCT02404441|65929856|FG005|Phase 2 Part|Adverse Event|2|||
23601140|NCT02404441|65929857|FG006|Phase 2 Part|Adverse Event|3|||
23601141|NCT02404441|65929858|FG007|Phase 2 Part|Adverse Event|3|||
23601142|NCT02404441|65929859|FG008|Phase 2 Part|Adverse Event|6|||
23601143|NCT02404441|65929860|FG009|Phase 2 Part|Adverse Event|1|||
23601144|NCT02404441|65929851|FG000|Phase 2 Part|Physician Decision|0|||
23601145|NCT02404441|65929852|FG001|Phase 2 Part|Physician Decision|0|||
23601146|NCT02404441|65929853|FG002|Phase 2 Part|Physician Decision|0|||
23601147|NCT02404441|65929854|FG003|Phase 2 Part|Physician Decision|0|||
23601148|NCT02404441|65929855|FG004|Phase 2 Part|Physician Decision|0|||
23601149|NCT02404441|65929856|FG005|Phase 2 Part|Physician Decision|7|||
23601150|NCT02404441|65929857|FG006|Phase 2 Part|Physician Decision|9|||
23601151|NCT02404441|65929858|FG007|Phase 2 Part|Physician Decision|2|||
23601152|NCT02404441|65929859|FG008|Phase 2 Part|Physician Decision|1|||
23601153|NCT02404441|65929860|FG009|Phase 2 Part|Physician Decision|3|||
23601154|NCT02404441|65929851|FG000|Phase 2 Part|Progressive disease|0|||
23601155|NCT02404441|65929852|FG001|Phase 2 Part|Progressive disease|0|||
23601156|NCT02404441|65929853|FG002|Phase 2 Part|Progressive disease|0|||
23601157|NCT02404441|65929854|FG003|Phase 2 Part|Progressive disease|0|||
23601158|NCT02404441|65929855|FG004|Phase 2 Part|Progressive disease|0|||
23601159|NCT02404441|65929856|FG005|Phase 2 Part|Progressive disease|43|||
23601160|NCT02404441|65929857|FG006|Phase 2 Part|Progressive disease|32|||
23363700|NCT00490971|65077199|FG003|Acute/Continuation|Protocol Violation|0|||
23363701|NCT00490971|65077200|FG004|Acute/Continuation|Protocol Violation|0|||
23363702|NCT00490971|65077196|FG000|Acute/Continuation|Withdrawal by Subject|92|||
23363703|NCT00490971|65077197|FG001|Acute/Continuation|Withdrawal by Subject|24|||
23363704|NCT00490971|65077198|FG002|Acute/Continuation|Withdrawal by Subject|0|||
23363705|NCT00490971|65077199|FG003|Acute/Continuation|Withdrawal by Subject|0|||
23601161|NCT02404441|65929858|FG007|Phase 2 Part|Progressive disease|31|||
23601162|NCT02404441|65929859|FG008|Phase 2 Part|Progressive disease|39|||
23601163|NCT02404441|65929860|FG009|Phase 2 Part|Progressive disease|27|||
23601164|NCT02404441|65929851|FG000|Phase 2 Part|Subject/guardian decision|0|||
23601165|NCT02404441|65929852|FG001|Phase 2 Part|Subject/guardian decision|0|||
23601166|NCT02404441|65929853|FG002|Phase 2 Part|Subject/guardian decision|0|||
23601167|NCT02404441|65929854|FG003|Phase 2 Part|Subject/guardian decision|0|||
23601168|NCT02404441|65929855|FG004|Phase 2 Part|Subject/guardian decision|0|||
23601169|NCT02404441|65929856|FG005|Phase 2 Part|Subject/guardian decision|3|||
23601170|NCT02404441|65929857|FG006|Phase 2 Part|Subject/guardian decision|9|||
23601171|NCT02404441|65929858|FG007|Phase 2 Part|Subject/guardian decision|0|||
23601172|NCT02404441|65929859|FG008|Phase 2 Part|Subject/guardian decision|3|||
23601173|NCT02404441|65929860|FG009|Phase 2 Part|Subject/guardian decision|2|||
23601174|NCT02404441|65929851|FG000|Phase 2 Part|Death|0|||
23601175|NCT02404441|65929852|FG001|Phase 2 Part|Death|0|||
23601176|NCT02404441|65929853|FG002|Phase 2 Part|Death|0|||
23601177|NCT02404441|65929854|FG003|Phase 2 Part|Death|0|||
23601178|NCT02404441|65929855|FG004|Phase 2 Part|Death|0|||
23601179|NCT02404441|65929856|FG005|Phase 2 Part|Death|4|||
23601180|NCT02404441|65929857|FG006|Phase 2 Part|Death|8|||
23363706|NCT00490971|65077200|FG004|Acute/Continuation|Withdrawal by Subject|0|||
23601181|NCT02404441|65929858|FG007|Phase 2 Part|Death|4|||
23601182|NCT02404441|65929859|FG008|Phase 2 Part|Death|10|||
23601183|NCT02404441|65929860|FG009|Phase 2 Part|Death|9|||
23601184|NCT00603954|65929867|FG000|Overall Study|Protocol Violation|1|||
23363707|NCT00490971|65077196|FG000|Acute/Continuation|Other|11|||
23601185|NCT00603954|65929868|FG001|Overall Study|Protocol Violation|2|||
23601186|NCT04492475|65929869|FG000|Overall Study|Enrolled but not treated|8|||
23601187|NCT04492475|65929870|FG001|Overall Study|Enrolled but not treated|8|||
23601188|NCT04492475|65929869|FG000|Overall Study|Withdrawal by Subject|4|||
23601189|NCT04492475|65929870|FG001|Overall Study|Withdrawal by Subject|0|||
23601190|NCT04492475|65929869|FG000|Overall Study|Became ineligible after enrollment|2|||
23601191|NCT04492475|65929870|FG001|Overall Study|Became ineligible after enrollment|0|||
23601192|NCT00391898|65929876|FG000|Overall Study|Adverse Event|3|||
23601193|NCT00391898|65929877|FG001|Overall Study|Adverse Event|0|||
23601194|NCT00391898|65929876|FG000|Overall Study|Other|8|||
23363708|NCT00490971|65077197|FG001|Acute/Continuation|Other|4|||
23363709|NCT00490971|65077198|FG002|Acute/Continuation|Other|0|||
23601195|NCT00391898|65929877|FG001|Overall Study|Other|10|||
23601196|NCT00939510|65929878|FG000|Overall Study|Withdrawal by Subject|1|||
23601197|NCT03689946|65929879|FG000|Overall Study|Withdrawal by Subject|3|||
23601198|NCT03689946|65929879|FG000|Overall Study|Lost to Follow-up|3|||
23601199|NCT03689946|65929879|FG000|Overall Study|Data corruption|2|||
23601200|NCT00336505|65929880|FG000|Overall Study|Adverse Event|10|||
23363710|NCT00490971|65077199|FG003|Acute/Continuation|Other|0|||
23363711|NCT00490971|65077200|FG004|Acute/Continuation|Other|0|||
23363712|NCT00490971|65077196|FG000|Maintenance|Adverse Event|0|||
23363713|NCT00490971|65077197|FG001|Maintenance|Adverse Event|0|||
23363714|NCT00490971|65077198|FG002|Maintenance|Adverse Event|4|||
23363715|NCT00490971|65077199|FG003|Maintenance|Adverse Event|5|||
23363716|NCT00490971|65077200|FG004|Maintenance|Adverse Event|7|||
23363717|NCT00490971|65077196|FG000|Maintenance|Death|0|||
23363718|NCT00490971|65077197|FG001|Maintenance|Death|0|||
23363719|NCT00490971|65077198|FG002|Maintenance|Death|0|||
23363720|NCT00490971|65077199|FG003|Maintenance|Death|2|||
23363721|NCT00490971|65077200|FG004|Maintenance|Death|0|||
23363722|NCT00490971|65077196|FG000|Maintenance|Lost to Follow-up|0|||
23363723|NCT00490971|65077197|FG001|Maintenance|Lost to Follow-up|0|||
23363724|NCT00490971|65077198|FG002|Maintenance|Lost to Follow-up|5|||
23363725|NCT00490971|65077199|FG003|Maintenance|Lost to Follow-up|8|||
23363726|NCT00490971|65077200|FG004|Maintenance|Lost to Follow-up|10|||
23363727|NCT00490971|65077196|FG000|Maintenance|Pregnancy|0|||
23363728|NCT00490971|65077197|FG001|Maintenance|Pregnancy|0|||
23363729|NCT00490971|65077198|FG002|Maintenance|Pregnancy|1|||
23363730|NCT00490971|65077199|FG003|Maintenance|Pregnancy|0|||
23363731|NCT00490971|65077200|FG004|Maintenance|Pregnancy|0|||
23363732|NCT00490971|65077196|FG000|Maintenance|Protocol Violation|0|||
23363733|NCT00490971|65077197|FG001|Maintenance|Protocol Violation|0|||
23363734|NCT00490971|65077198|FG002|Maintenance|Protocol Violation|4|||
23363735|NCT00490971|65077199|FG003|Maintenance|Protocol Violation|1|||
23363736|NCT00490971|65077200|FG004|Maintenance|Protocol Violation|1|||
23363737|NCT00490971|65077196|FG000|Maintenance|Withdrawal by Subject|0|||
23363738|NCT00490971|65077197|FG001|Maintenance|Withdrawal by Subject|0|||
23363739|NCT00490971|65077198|FG002|Maintenance|Withdrawal by Subject|26|||
23363740|NCT00490971|65077199|FG003|Maintenance|Withdrawal by Subject|28|||
23363741|NCT00490971|65077200|FG004|Maintenance|Withdrawal by Subject|18|||
23363742|NCT00490971|65077196|FG000|Maintenance|Other|0|||
23363743|NCT00490971|65077197|FG001|Maintenance|Other|0|||
23363744|NCT00490971|65077198|FG002|Maintenance|Other|11|||
23363745|NCT00490971|65077199|FG003|Maintenance|Other|9|||
23363746|NCT00490971|65077200|FG004|Maintenance|Other|3|||
23363747|NCT02171429|65077207|FG000|Overall Study|Other|0|||
23363748|NCT02171429|65077208|FG001|Overall Study|Other|1|||
23363749|NCT02171429|65077209|FG002|Overall Study|Other|1|||
23363750|NCT02171429|65077207|FG000|Overall Study|Non-Compliance|0|||
23363751|NCT02171429|65077208|FG001|Overall Study|Non-Compliance|0|||
23363752|NCT02171429|65077209|FG002|Overall Study|Non-Compliance|1|||
23363753|NCT02171429|65077207|FG000|Overall Study|Physician Decision|0|||
23363754|NCT02171429|65077208|FG001|Overall Study|Physician Decision|0|||
23363755|NCT02171429|65077209|FG002|Overall Study|Physician Decision|1|||
23363756|NCT02171429|65077207|FG000|Overall Study|Withdrawal by Subject|1|||
23363757|NCT02171429|65077208|FG001|Overall Study|Withdrawal by Subject|1|||
23363758|NCT02171429|65077209|FG002|Overall Study|Withdrawal by Subject|1|||
23363759|NCT02171429|65077207|FG000|Overall Study|Lost to Follow-up|0|||
23363760|NCT02171429|65077208|FG001|Overall Study|Lost to Follow-up|1|||
23363761|NCT02171429|65077209|FG002|Overall Study|Lost to Follow-up|0|||
23363762|NCT02171429|65077207|FG000|Overall Study|Death|0|||
23363763|NCT02171429|65077208|FG001|Overall Study|Death|0|||
23363764|NCT02171429|65077209|FG002|Overall Study|Death|1|||
23363765|NCT03143101|65077210|FG000|Overall Study|Withdrawal by Subject|0|||
23363766|NCT03143101|65077211|FG001|Overall Study|Withdrawal by Subject|1|||
23363767|NCT03143101|65077212|FG002|Overall Study|Withdrawal by Subject|0|||
23363768|NCT03143101|65077210|FG000|Overall Study|Lost to Follow-up|2|||
23363769|NCT03143101|65077211|FG001|Overall Study|Lost to Follow-up|2|||
23363770|NCT03143101|65077212|FG002|Overall Study|Lost to Follow-up|0|||
23363771|NCT00872521|65077213|FG000|Completed PAD Induction|Patient choice|0|||
23363772|NCT00872521|65077214|FG001|Completed PAD Induction|Patient choice|1|||
23363773|NCT00872521|65077215|FG002|Completed PAD Induction|Patient choice|0|||
23363774|NCT00872521|65077213|FG000|Completed PAD Induction|Disease progression|0|||
23363775|NCT00872521|65077214|FG001|Completed PAD Induction|Disease progression|2|||
23363776|NCT00872521|65077215|FG002|Completed PAD Induction|Disease progression|0|||
23363777|NCT00872521|65077213|FG000|Completed PAD Induction|Adverse Event|4|||
23363778|NCT00872521|65077214|FG001|Completed PAD Induction|Adverse Event|0|||
23363779|NCT00872521|65077215|FG002|Completed PAD Induction|Adverse Event|0|||
23363780|NCT00872521|65077213|FG000|Completed PAD Induction|Death|1|||
23363781|NCT00872521|65077214|FG001|Completed PAD Induction|Death|1|||
23363782|NCT00872521|65077215|FG002|Completed PAD Induction|Death|0|||
23363783|NCT00872521|65077213|FG000|Primary Endpoint Analysis|Other|1|||
23363784|NCT00872521|65077214|FG001|Primary Endpoint Analysis|Other|2|||
23363785|NCT00872521|65077215|FG002|Primary Endpoint Analysis|Other|0|||
23363786|NCT00872521|65077213|FG000|Primary Endpoint Analysis|Patient choice|0|||
23363787|NCT00872521|65077214|FG001|Primary Endpoint Analysis|Patient choice|1|||
23363788|NCT00872521|65077215|FG002|Primary Endpoint Analysis|Patient choice|0|||
23363789|NCT00872521|65077213|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
23363790|NCT00872521|65077214|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
23363791|NCT00872521|65077215|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
23363792|NCT00872521|65077213|FG000|Primary Endpoint Analysis|Patient response missing|0|||
23363793|NCT00872521|65077214|FG001|Primary Endpoint Analysis|Patient response missing|0|||
23363794|NCT00872521|65077215|FG002|Primary Endpoint Analysis|Patient response missing|1|||
23363795|NCT00872521|65077213|FG000|Completed 3-month Follow up|Other|0|||
23363796|NCT00872521|65077214|FG001|Completed 3-month Follow up|Other|2|||
23363797|NCT00872521|65077215|FG002|Completed 3-month Follow up|Other|0|||
23363798|NCT00872521|65077213|FG000|Completed 3-month Follow up|Physician Decision|0|||
23363799|NCT00872521|65077214|FG001|Completed 3-month Follow up|Physician Decision|1|||
23363800|NCT00872521|65077215|FG002|Completed 3-month Follow up|Physician Decision|0|||
23363801|NCT00872521|65077213|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
23363802|NCT00872521|65077214|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
23363803|NCT00872521|65077215|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
23363804|NCT02370511|65077216|FG000|Overall Study|Death|10|||
23363805|NCT02370511|65077217|FG001|Overall Study|Death|7|||
23363806|NCT02370511|65077218|FG002|Overall Study|Death|1|||
23363807|NCT02370511|65077216|FG000|Overall Study|Withdrawal by Subject|2|||
23363808|NCT02370511|65077217|FG001|Overall Study|Withdrawal by Subject|0|||
23363809|NCT02370511|65077218|FG002|Overall Study|Withdrawal by Subject|0|||
23363810|NCT02370511|65077216|FG000|Overall Study|Lost to Follow-up|0|||
23363811|NCT02370511|65077217|FG001|Overall Study|Lost to Follow-up|4|||
23363812|NCT02370511|65077218|FG002|Overall Study|Lost to Follow-up|0|||
23363813|NCT00206427|65077221|FG000|Overall Study|Adverse Event|2|||
23363814|NCT02144701|65077222|FG000|Overall Study|development of relapse, GVHD or death|9|||
23363815|NCT02144701|65077223|FG001|Overall Study|development of relapse, GVHD or death|3|||
23363816|NCT04147247|65077224|FG000|Overall Study|Progressive disease|3|||
23363817|NCT04147247|65077225|FG001|Overall Study|Progressive disease|3|||
23363818|NCT04147247|65077226|FG002|Overall Study|Progressive disease|4|||
23363819|NCT04147247|65077227|FG003|Overall Study|Progressive disease|4|||
23363820|NCT04147247|65077228|FG004|Overall Study|Progressive disease|3|||
23363821|NCT04147247|65077224|FG000|Overall Study|Physician Decision|0|||
23363822|NCT04147247|65077225|FG001|Overall Study|Physician Decision|1|||
23363823|NCT04147247|65077226|FG002|Overall Study|Physician Decision|0|||
23363824|NCT04147247|65077227|FG003|Overall Study|Physician Decision|0|||
23363825|NCT04147247|65077228|FG004|Overall Study|Physician Decision|0|||
23363826|NCT04147247|65077224|FG000|Overall Study|Clinical Disease Progression|0|||
23363827|NCT04147247|65077225|FG001|Overall Study|Clinical Disease Progression|0|||
23363828|NCT04147247|65077226|FG002|Overall Study|Clinical Disease Progression|0|||
23363829|NCT04147247|65077227|FG003|Overall Study|Clinical Disease Progression|0|||
23363830|NCT04147247|65077228|FG004|Overall Study|Clinical Disease Progression|1|||
23363831|NCT04147247|65077224|FG000|Overall Study|Adverse Event|0|||
23363832|NCT04147247|65077225|FG001|Overall Study|Adverse Event|0|||
23363833|NCT04147247|65077226|FG002|Overall Study|Adverse Event|1|||
23363834|NCT04147247|65077227|FG003|Overall Study|Adverse Event|0|||
23363835|NCT04147247|65077228|FG004|Overall Study|Adverse Event|1|||
23363836|NCT00115778|65077236|FG000|Overall Study|Withdrawal by Subject|0|||
23363837|NCT00115778|65077237|FG001|Overall Study|Withdrawal by Subject|1|||
23363838|NCT01935089|65077260|FG000|Overall Study|Adverse Event|2|||
23363839|NCT01935089|65077260|FG000|Overall Study|Withdrawal by Subject|1|||
23363840|NCT02864407|65077261|FG000|Overall Study|Protocol Violation|3|||
23363841|NCT02864407|65077261|FG000|Overall Study|Lost to Follow-up|115|||
23363842|NCT02864407|65077261|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
23363843|NCT02864407|65077261|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
23363844|NCT02864407|65077261|FG000|Overall Study|Consent prior to the contract date|1|||
23363845|NCT01152996|65077262|FG000|Overall Study|Withdrawal by Subject|142|||
23363846|NCT01152996|65077262|FG000|Overall Study|Adverse Event|115|||
23363847|NCT01152996|65077262|FG000|Overall Study|Lost to Follow-up|112|||
23363848|NCT01152996|65077262|FG000|Overall Study|Lack of Efficacy|68|||
23363849|NCT01152996|65077262|FG000|Overall Study|Noncompliance|41|||
23363850|NCT01152996|65077262|FG000|Overall Study|Other|36|||
23363851|NCT01152996|65077262|FG000|Overall Study|Protocol Violation|22|||
23363852|NCT01152996|65077262|FG000|Overall Study|Elevated liver enzymes|1|||
23363853|NCT02849743|65077263|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
23363854|NCT02849743|65077264|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
23363855|NCT02849743|65077263|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
23363856|NCT02849743|65077264|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
23363857|NCT02824224|65077265|FG000|Overall Study|Discontinued, IUS expulsion|0|||
23363858|NCT02824224|65077266|FG001|Overall Study|Discontinued, IUS expulsion|1|||
23363859|NCT02824224|65077265|FG000|Overall Study|Did not show up for allocation visit|2|||
23363860|NCT02824224|65077266|FG001|Overall Study|Did not show up for allocation visit|0|||
23363861|NCT00128661|65081027|FG000|Overall Study|Adverse Event|14|||
23363862|NCT00128661|65081028|FG001|Overall Study|Adverse Event|11|||
23363863|NCT00128661|65081027|FG000|Overall Study|Lost to Follow-up|10|||
23363864|NCT00128661|65081028|FG001|Overall Study|Lost to Follow-up|7|||
23363865|NCT00128661|65081027|FG000|Overall Study|Withdrawal by Subject|243|||
23363866|NCT00128661|65081028|FG001|Overall Study|Withdrawal by Subject|232|||
23363867|NCT00128661|65081027|FG000|Overall Study|Other|7|||
23363868|NCT00128661|65081028|FG001|Overall Study|Other|8|||
23363869|NCT02104895|65081031|FG000|Overall Study|Withdrawal by Subject|0|||
23363870|NCT02104895|65081032|FG001|Overall Study|Withdrawal by Subject|14|||
23363871|NCT02239640|65081036|FG000|Overall Study|Withdrawal by Subject|3|||
23363872|NCT02239640|65081036|FG000|Overall Study|Lost to Follow-up|72|||
23363873|NCT02239640|65081036|FG000|Overall Study|Death|142|||
23363874|NCT01059773|65081041|FG000|Overall Study|Adverse Event|2|||
23363875|NCT01059773|65081042|FG001|Overall Study|Adverse Event|2|||
23363876|NCT01059773|65081041|FG000|Overall Study|Withdrawal by Subject|1|||
23363877|NCT01059773|65081042|FG001|Overall Study|Withdrawal by Subject|5|||
23363878|NCT01059773|65081041|FG000|Overall Study|Lost to Follow-up|1|||
23363879|NCT01059773|65081042|FG001|Overall Study|Lost to Follow-up|1|||
23363880|NCT01059773|65081041|FG000|Overall Study|Pregnancy|1|||
23363881|NCT01059773|65081042|FG001|Overall Study|Pregnancy|1|||
23363882|NCT01059773|65081041|FG000|Overall Study|Protocol Violation|6|||
23363883|NCT01059773|65081042|FG001|Overall Study|Protocol Violation|2|||
23363884|NCT01059773|65081041|FG000|Overall Study|Physician Decision|5|||
23363885|NCT01059773|65081042|FG001|Overall Study|Physician Decision|4|||
23363886|NCT01059773|65081041|FG000|Overall Study|Lack of Efficacy|3|||
23363887|NCT01059773|65081042|FG001|Overall Study|Lack of Efficacy|3|||
23363888|NCT01059773|65081041|FG000|Overall Study|Death|0|||
23363889|NCT01059773|65081042|FG001|Overall Study|Death|1|||
23363890|NCT01059773|65081041|FG000|Overall Study|Malignancy including squamous cell skin|0|||
23363891|NCT01059773|65081042|FG001|Overall Study|Malignancy including squamous cell skin|1|||
23363892|NCT01059773|65081041|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
23363893|NCT01059773|65081042|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
23363894|NCT01059773|65081041|FG000|Overall Study|Other|1|||
23363895|NCT01059773|65081042|FG001|Overall Study|Other|3|||
23363896|NCT00784719|65081045|FG000|Overall Study|Adverse Event|0|||
23363897|NCT00784719|65081046|FG001|Overall Study|Adverse Event|2|||
23363898|NCT00784719|65081047|FG002|Overall Study|Adverse Event|0|||
23363899|NCT00784719|65081048|FG003|Overall Study|Adverse Event|0|||
23363900|NCT00784719|65081049|FG004|Overall Study|Adverse Event|1|||
23363901|NCT00784719|65081050|FG005|Overall Study|Adverse Event|1|||
23363902|NCT00784719|65081051|FG006|Overall Study|Adverse Event|1|||
23363903|NCT00784719|65081045|FG000|Overall Study|Lost to Follow-up|0|||
23363904|NCT00784719|65081046|FG001|Overall Study|Lost to Follow-up|0|||
23363905|NCT00784719|65081047|FG002|Overall Study|Lost to Follow-up|0|||
23363906|NCT00784719|65081048|FG003|Overall Study|Lost to Follow-up|0|||
23363907|NCT00784719|65081049|FG004|Overall Study|Lost to Follow-up|1|||
23363908|NCT00784719|65081050|FG005|Overall Study|Lost to Follow-up|1|||
23363909|NCT00784719|65081051|FG006|Overall Study|Lost to Follow-up|0|||
23363910|NCT00784719|65081045|FG000|Overall Study|Other|2|||
23363911|NCT00784719|65081046|FG001|Overall Study|Other|1|||
23363912|NCT00784719|65081047|FG002|Overall Study|Other|1|||
23363913|NCT00784719|65081048|FG003|Overall Study|Other|0|||
23363914|NCT00784719|65081049|FG004|Overall Study|Other|2|||
23363915|NCT00784719|65081050|FG005|Overall Study|Other|1|||
23481043|NCT03915860|65502130|FG000|Overall Study|Adverse Event|3|||
23266605|NCT01193608|64718102|FG000|Overall Study|Other|0|||
23266606|NCT01193608|64718103|FG001|Overall Study|Other|1|||
23266607|NCT01193608|64718104|FG002|Overall Study|Other|0|||
23266608|NCT01193608|64718105|FG003|Overall Study|Other|0|||
23266609|NCT01193608|64718106|FG004|Overall Study|Other|0|||
23266610|NCT01193608|64718107|FG005|Overall Study|Other|0|||
23266611|NCT01193608|64718102|FG000|Overall Study|Withdrawal by Subject|0|||
23266612|NCT01193608|64718103|FG001|Overall Study|Withdrawal by Subject|1|||
23266613|NCT01193608|64718104|FG002|Overall Study|Withdrawal by Subject|2|||
23266614|NCT01193608|64718105|FG003|Overall Study|Withdrawal by Subject|3|||
23266615|NCT01193608|64718106|FG004|Overall Study|Withdrawal by Subject|3|||
23266616|NCT01193608|64718107|FG005|Overall Study|Withdrawal by Subject|0|||
23266617|NCT01193608|64718102|FG000|Overall Study|Lost to Follow-up|0|||
23266618|NCT01193608|64718103|FG001|Overall Study|Lost to Follow-up|0|||
23363916|NCT00784719|65081051|FG006|Overall Study|Other|3|||
23363917|NCT00784719|65081045|FG000|Overall Study|Withdrawal by Subject|1|||
23363918|NCT00784719|65081046|FG001|Overall Study|Withdrawal by Subject|0|||
23363919|NCT00784719|65081047|FG002|Overall Study|Withdrawal by Subject|0|||
23363920|NCT00784719|65081048|FG003|Overall Study|Withdrawal by Subject|0|||
23363921|NCT00784719|65081049|FG004|Overall Study|Withdrawal by Subject|2|||
23363922|NCT00784719|65081050|FG005|Overall Study|Withdrawal by Subject|0|||
23363923|NCT00784719|65081051|FG006|Overall Study|Withdrawal by Subject|1|||
23363924|NCT01691378|65081052|FG000|Overall Study|Withdrawal by Subject|2|||
23363925|NCT01691378|65081053|FG001|Overall Study|Withdrawal by Subject|0|||
23363926|NCT01691378|65081052|FG000|Overall Study|Lost to Follow-up|5|||
23363927|NCT01691378|65081053|FG001|Overall Study|Lost to Follow-up|2|||
23363928|NCT01178125|65081059|FG000|Overall Study|Lost to Follow-up|397|||
23363929|NCT01178125|65081059|FG000|Overall Study|Adverse Event|244|||
23363930|NCT01178125|65081059|FG000|Overall Study|Withdrawal by Subject|209|||
23363931|NCT01178125|65081059|FG000|Overall Study|Noncompliance|184|||
23601201|NCT00336505|65929881|FG001|Overall Study|Adverse Event|9|||
23601202|NCT00336505|65929880|FG000|Overall Study|Lack of Efficacy|8|||
23601203|NCT00336505|65929881|FG001|Overall Study|Lack of Efficacy|4|||
23601204|NCT00336505|65929880|FG000|Overall Study|Lost to Follow-up|7|||
23601205|NCT00336505|65929881|FG001|Overall Study|Lost to Follow-up|4|||
23601206|NCT00336505|65929880|FG000|Overall Study|Withdrawal by Subject|5|||
23601207|NCT00336505|65929881|FG001|Overall Study|Withdrawal by Subject|3|||
23601208|NCT00336505|65929880|FG000|Overall Study|Other|7|||
23601209|NCT00336505|65929881|FG001|Overall Study|Other|7|||
23601210|NCT01736475|65929882|FG000|Overall Study|Adverse Event|4|||
23601211|NCT01736475|65929883|FG001|Overall Study|Adverse Event|0|||
23601212|NCT01736475|65929882|FG000|Overall Study|Withdrawal by Subject|2|||
23601213|NCT01736475|65929883|FG001|Overall Study|Withdrawal by Subject|0|||
23601214|NCT01736475|65929882|FG000|Overall Study|Protocol Violation|4|||
23601215|NCT01736475|65929883|FG001|Overall Study|Protocol Violation|0|||
23363932|NCT01178125|65081059|FG000|Overall Study|Pregnancy|55|||
23481044|NCT03915860|65502130|FG000|Overall Study|Withdrawal by Subject|6|||
23481045|NCT03915860|65502130|FG000|Overall Study|Lost to Follow-up|2|||
23481046|NCT03915860|65502130|FG000|Overall Study|Other than specified|3|||
23481047|NCT00393042|65505057|FG000|First Intervention|Withdrawal by Subject|1|||
23481048|NCT00393042|65505058|FG001|First Intervention|Withdrawal by Subject|2|||
23481049|NCT00393042|65505057|FG000|First Intervention|Lost to Follow-up|3|||
23481050|NCT00393042|65505058|FG001|First Intervention|Lost to Follow-up|3|||
23481051|NCT00393042|65505057|FG000|First Intervention|Protocol Violation|1|||
23481052|NCT00393042|65505058|FG001|First Intervention|Protocol Violation|0|||
23481053|NCT00393042|65505057|FG000|First Intervention|Adverse Event|0|||
23481054|NCT00393042|65505058|FG001|First Intervention|Adverse Event|1|||
23481055|NCT00393042|65505057|FG000|Second Intervetion|Adverse Event|0|||
23481056|NCT00393042|65505058|FG001|Second Intervetion|Adverse Event|3|||
23481057|NCT00393042|65505057|FG000|Second Intervetion|Withdrawal by Subject|0|||
23481058|NCT00393042|65505058|FG001|Second Intervetion|Withdrawal by Subject|2|||
23363933|NCT01178125|65081059|FG000|Overall Study|Other Reason|39|||
23363934|NCT01178125|65081059|FG000|Overall Study|Sponsor Decision|28|||
23481059|NCT00393042|65505057|FG000|Second Intervetion|Lack of Efficacy|1|||
23481060|NCT00393042|65505058|FG001|Second Intervetion|Lack of Efficacy|0|||
23481061|NCT00393042|65505057|FG000|Second Intervetion|Lost to Follow-up|0|||
23481062|NCT00393042|65505058|FG001|Second Intervetion|Lost to Follow-up|2|||
23481063|NCT00393042|65505057|FG000|Second Intervetion|Protocol Violation|1|||
23481064|NCT00393042|65505058|FG001|Second Intervetion|Protocol Violation|1|||
23481065|NCT00538785|65505059|FG000|Overall Study|Death|9|||
23363935|NCT01178125|65081059|FG000|Overall Study|Protocol Violation|17|||
23363936|NCT01178125|65081059|FG000|Overall Study|Investigator Decision|5|||
23363937|NCT02848664|65081062|FG000|Overall Study|Withdrawal by Subject|2|||
23363938|NCT02848664|65081062|FG000|Overall Study|Adverse Event|1|||
23363939|NCT02848664|65081062|FG000|Overall Study|no assistance for device training|1|||
23363940|NCT04552132|65081063|FG000|Overall Study|Lost to Follow-up|4|||
23363941|NCT04552132|65081064|FG001|Overall Study|Lost to Follow-up|3|||
23363942|NCT04552132|65081063|FG000|Overall Study|Protocol Violation|1|||
23363943|NCT04552132|65081064|FG001|Overall Study|Protocol Violation|0|||
23363944|NCT01223404|65081065|FG000|First Intervention (1 Day)|Adverse Event|0|||
23363945|NCT01223404|65081066|FG001|First Intervention (1 Day)|Adverse Event|0|||
23363946|NCT01223404|65081067|FG002|First Intervention (1 Day)|Adverse Event|0|||
23481066|NCT00538785|65505060|FG001|Overall Study|Death|10|||
23481067|NCT00538785|65505059|FG000|Overall Study|Withdrawal of consent|9|||
23481068|NCT00538785|65505060|FG001|Overall Study|Withdrawal of consent|7|||
23601216|NCT01736475|65929882|FG000|Overall Study|Other - Screen failure|1|||
23363947|NCT01223404|65081068|FG003|First Intervention (1 Day)|Adverse Event|1|||
23363948|NCT01223404|65081069|FG004|First Intervention (1 Day)|Adverse Event|0|||
23363949|NCT01223404|65081070|FG005|First Intervention (1 Day)|Adverse Event|0|||
23481069|NCT00538785|65505059|FG000|Overall Study|Lost to Follow-up|1|||
23481070|NCT00538785|65505060|FG001|Overall Study|Lost to Follow-up|0|||
23481071|NCT00621621|65505061|FG000|Overall Study|Subjects were exited at EP study|30|||
23481072|NCT00621621|65505062|FG001|Overall Study|Subjects were exited at EP study|0|||
23481073|NCT00584740|65505063|FG000|Overall Study|Adverse Event|1|||
23601217|NCT01736475|65929883|FG001|Overall Study|Other - Screen failure|0|||
23363950|NCT01223404|65081065|FG000|Second Intervention (1 Day)|Adverse Event|1|||
23363951|NCT01223404|65081066|FG001|Second Intervention (1 Day)|Adverse Event|0|||
23363952|NCT01223404|65081067|FG002|Second Intervention (1 Day)|Adverse Event|0|||
23363953|NCT01223404|65081068|FG003|Second Intervention (1 Day)|Adverse Event|0|||
23363954|NCT01223404|65081069|FG004|Second Intervention (1 Day)|Adverse Event|0|||
23363955|NCT01223404|65081070|FG005|Second Intervention (1 Day)|Adverse Event|0|||
23363956|NCT01223404|65081065|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363957|NCT01223404|65081066|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363958|NCT01223404|65081067|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363959|NCT01223404|65081068|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
23363960|NCT01223404|65081069|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363961|NCT01223404|65081070|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
23363962|NCT00666211|65081071|FG000|Overall Study|Withdrawal by Subject|10|||
23363963|NCT00666211|65081072|FG001|Overall Study|Withdrawal by Subject|13|||
23363964|NCT00666211|65081071|FG000|Overall Study|went off medication, no more pain|1|||
23363965|NCT00666211|65081072|FG001|Overall Study|went off medication, no more pain|0|||
23363966|NCT00666211|65081071|FG000|Overall Study|patient non-compliant|6|||
23363967|NCT00666211|65081072|FG001|Overall Study|patient non-compliant|6|||
23363968|NCT00666211|65081071|FG000|Overall Study|disease progression|1|||
23363969|NCT00666211|65081072|FG001|Overall Study|disease progression|8|||
23363970|NCT00666211|65081071|FG000|Overall Study|Lost to Follow-up|2|||
23363971|NCT00666211|65081072|FG001|Overall Study|Lost to Follow-up|0|||
23363972|NCT00666211|65081071|FG000|Overall Study|toxicity|0|||
23363973|NCT00666211|65081072|FG001|Overall Study|toxicity|2|||
23363974|NCT00666211|65081071|FG000|Overall Study|hospital admission|0|||
23363975|NCT00666211|65081072|FG001|Overall Study|hospital admission|5|||
23363976|NCT00666211|65081071|FG000|Overall Study|Death|0|||
23363977|NCT00666211|65081072|FG001|Overall Study|Death|2|||
23363978|NCT00666211|65081071|FG000|Overall Study|off tx for other complicating disease|0|||
23363979|NCT00666211|65081072|FG001|Overall Study|off tx for other complicating disease|1|||
23363980|NCT00666211|65081071|FG000|Overall Study|Physician Decision|0|||
23363981|NCT00666211|65081072|FG001|Overall Study|Physician Decision|1|||
23363982|NCT02521792|65081073|FG000|Overall Study|Study Terminated|6|||
23363983|NCT03586050|65081077|FG000|Overall Study|Death|3|||
23363984|NCT03586050|65081077|FG000|Overall Study|Withdrawal by Subject|2|||
23363985|NCT02616783|65081078|FG000|Overall Study|Randomized but Not Treated|1|||
23363986|NCT02616783|65081079|FG001|Overall Study|Randomized but Not Treated|0|||
23363987|NCT02616783|65081078|FG000|Overall Study|Adverse Event|1|||
23601218|NCT01736475|65929882|FG000|Overall Study|Other - Surgical procedure|1|||
23601219|NCT01736475|65929883|FG001|Overall Study|Other - Surgical procedure|0|||
23266619|NCT01193608|64718104|FG002|Overall Study|Lost to Follow-up|0|||
23266620|NCT01193608|64718105|FG003|Overall Study|Lost to Follow-up|0|||
23266621|NCT01193608|64718106|FG004|Overall Study|Lost to Follow-up|1|||
23266622|NCT01193608|64718107|FG005|Overall Study|Lost to Follow-up|2|||
23266623|NCT01193608|64718102|FG000|Overall Study|Adverse Event|0|||
23266624|NCT01193608|64718103|FG001|Overall Study|Adverse Event|0|||
23266625|NCT01193608|64718104|FG002|Overall Study|Adverse Event|0|||
23266626|NCT01193608|64718105|FG003|Overall Study|Adverse Event|0|||
23266627|NCT01193608|64718106|FG004|Overall Study|Adverse Event|1|||
23266628|NCT01193608|64718107|FG005|Overall Study|Adverse Event|0|||
23266629|NCT01506947|64718108|FG000|Overall Study|Lost to Follow-up|7|||
23266630|NCT01506947|64718108|FG000|Overall Study|Adverse Event|5|||
23266631|NCT01506947|64718108|FG000|Overall Study|Death|1|||
23266632|NCT01506947|64718108|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
23266633|NCT01545076|64718110|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
23266634|NCT01545076|64718111|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
23266635|NCT01545076|64718112|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
23266636|NCT01545076|64718113|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
23266637|NCT01545076|64718114|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
23266638|NCT01545076|64718110|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
23266639|NCT01545076|64718111|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
23266640|NCT01545076|64718112|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
23266641|NCT01545076|64718113|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
23266642|NCT01545076|64718114|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
23266643|NCT01545076|64718110|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
23266644|NCT01545076|64718111|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
23363988|NCT02616783|65081079|FG001|Overall Study|Adverse Event|0|||
23363989|NCT02616783|65081078|FG000|Overall Study|Death|1|||
23363990|NCT02616783|65081079|FG001|Overall Study|Death|0|||
23363991|NCT02616783|65081078|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23363992|NCT02616783|65081079|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23363993|NCT02616783|65081078|FG000|Overall Study|Protocol Violation|1|||
23363994|NCT02616783|65081079|FG001|Overall Study|Protocol Violation|1|||
23363995|NCT02616783|65081078|FG000|Overall Study|Withdrew Consent|1|||
23363996|NCT02616783|65081079|FG001|Overall Study|Withdrew Consent|1|||
23363997|NCT00522548|65081080|FG000|Overall Study|Adverse Event|2|||
23601220|NCT02432274|65929884|FG000|Overall Study|Death|2|||
23363998|NCT00522548|65081081|FG001|Overall Study|Adverse Event|2|||
23363999|NCT00522548|65081080|FG000|Overall Study|Withdrawal by Subject|0|||
23364000|NCT00522548|65081081|FG001|Overall Study|Withdrawal by Subject|2|||
23364001|NCT01275144|65081082|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
23364002|NCT01275144|65081083|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
23364003|NCT01673178|65081086|FG000|Overall Study|Lost to Follow-up|0|||
23364004|NCT01673178|65081087|FG001|Overall Study|Lost to Follow-up|1|||
23481074|NCT00584740|65505064|FG001|Overall Study|Adverse Event|1|||
23481075|NCT00584740|65505063|FG000|Overall Study|Lack of Efficacy|8|||
23481076|NCT00584740|65505064|FG001|Overall Study|Lack of Efficacy|2|||
23481077|NCT00584740|65505063|FG000|Overall Study|Withdrawal by Subject|3|||
23481078|NCT00584740|65505064|FG001|Overall Study|Withdrawal by Subject|2|||
23481079|NCT00584740|65505063|FG000|Overall Study|Lost to Follow-up|0|||
23481080|NCT00584740|65505064|FG001|Overall Study|Lost to Follow-up|1|||
23266645|NCT01545076|64718112|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
23266646|NCT01545076|64718113|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
23364005|NCT01673178|65081088|FG002|Overall Study|Lost to Follow-up|0|||
23364006|NCT01673178|65081089|FG003|Overall Study|Lost to Follow-up|0|||
23364007|NCT01673178|65081090|FG004|Overall Study|Lost to Follow-up|0|||
23364008|NCT01673178|65081086|FG000|Overall Study|Withdrawal by Subject|0|||
23364009|NCT01673178|65081087|FG001|Overall Study|Withdrawal by Subject|0|||
23364010|NCT01673178|65081088|FG002|Overall Study|Withdrawal by Subject|1|||
23364011|NCT01673178|65081089|FG003|Overall Study|Withdrawal by Subject|4|||
23364012|NCT01673178|65081090|FG004|Overall Study|Withdrawal by Subject|2|||
23364013|NCT01673178|65081086|FG000|Overall Study|Protocol Violation|1|||
23364014|NCT01673178|65081087|FG001|Overall Study|Protocol Violation|1|||
23364015|NCT01673178|65081088|FG002|Overall Study|Protocol Violation|0|||
23364016|NCT01673178|65081089|FG003|Overall Study|Protocol Violation|1|||
23364017|NCT01673178|65081090|FG004|Overall Study|Protocol Violation|0|||
23364018|NCT01673178|65081086|FG000|Overall Study|Adverse Event|1|||
23364019|NCT01673178|65081087|FG001|Overall Study|Adverse Event|0|||
23364020|NCT01673178|65081088|FG002|Overall Study|Adverse Event|0|||
23364021|NCT01673178|65081089|FG003|Overall Study|Adverse Event|2|||
23364022|NCT01673178|65081090|FG004|Overall Study|Adverse Event|0|||
23364023|NCT01673178|65081086|FG000|Overall Study|Other|1|||
23364024|NCT01673178|65081087|FG001|Overall Study|Other|0|||
23364025|NCT01673178|65081088|FG002|Overall Study|Other|2|||
23364026|NCT01673178|65081089|FG003|Overall Study|Other|1|||
23364027|NCT01673178|65081090|FG004|Overall Study|Other|0|||
23364028|NCT01441973|65081091|FG000|Overall Study|Disease progression|8|||
23364029|NCT01441973|65081092|FG001|Overall Study|Disease progression|6|||
23364030|NCT01441973|65081091|FG000|Overall Study|Adverse event unrelated to study drug|3|||
23364031|NCT01441973|65081092|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23364032|NCT01441973|65081091|FG000|Overall Study|Participant request to discontinue|1|||
23266647|NCT01545076|64718114|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
23266648|NCT01545076|64718110|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
23364033|NCT01441973|65081092|FG001|Overall Study|Participant request to discontinue|1|||
23364034|NCT01441973|65081091|FG000|Overall Study|Poor compliance/noncompliance|0|||
23364035|NCT01441973|65081092|FG001|Overall Study|Poor compliance/noncompliance|1|||
23364036|NCT01441973|65081091|FG000|Overall Study|Administrative reason by sponsor|3|||
23364037|NCT01441973|65081092|FG001|Overall Study|Administrative reason by sponsor|5|||
23364038|NCT01441973|65081091|FG000|Overall Study|Participant withdrew consent|0|||
23364039|NCT01441973|65081092|FG001|Overall Study|Participant withdrew consent|1|||
23266649|NCT01545076|64718111|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
23266650|NCT01545076|64718112|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
23364040|NCT01657162|65081093|FG000|Overall Study|Adverse Event|26|||
23364041|NCT01657162|65081094|FG001|Overall Study|Adverse Event|36|||
23364042|NCT01657162|65081093|FG000|Overall Study|Withdrawal by Subject|13|||
23481081|NCT00830869|65505069|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
23481082|NCT00830869|65505070|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
23266651|NCT01545076|64718113|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
23266652|NCT01545076|64718114|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
23266653|NCT01545076|64718110|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
23266654|NCT01545076|64718111|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
23364043|NCT01657162|65081094|FG001|Overall Study|Withdrawal by Subject|13|||
23364044|NCT01657162|65081093|FG000|Overall Study|Continuing Significant Deterioration|9|||
23364045|NCT01657162|65081094|FG001|Overall Study|Continuing Significant Deterioration|3|||
23364046|NCT01657162|65081093|FG000|Overall Study|Refusal of Treatment|4|||
23364047|NCT01657162|65081094|FG001|Overall Study|Refusal of Treatment|6|||
23364048|NCT01657162|65081093|FG000|Overall Study|Lost to Follow-up|3|||
23201197|NCT02145156|64476638|FG000|Overall Study|No match to vaccination records|60|||
23364049|NCT01657162|65081094|FG001|Overall Study|Lost to Follow-up|4|||
23364050|NCT01657162|65081093|FG000|Overall Study|Death|2|||
23481083|NCT00830869|65505071|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
23481084|NCT00830869|65505072|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
23481085|NCT00830869|65505073|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
23481086|NCT00830869|65505074|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
23481087|NCT00830869|65505075|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
23481088|NCT00830869|65505076|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
23481089|NCT00830869|65505077|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
23481090|NCT00830869|65505078|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
23481091|NCT00830869|65505079|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
23481092|NCT00830869|65505080|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
23481093|NCT00830869|65505069|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
23481094|NCT00830869|65505070|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
23481095|NCT00830869|65505071|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
23481096|NCT00830869|65505072|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
23481097|NCT00830869|65505073|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
23481098|NCT00830869|65505074|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
23481099|NCT00830869|65505075|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
23481100|NCT00830869|65505076|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
23481101|NCT00830869|65505077|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
23481102|NCT00830869|65505078|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
23481103|NCT00830869|65505079|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
23481104|NCT00830869|65505080|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
23481105|NCT00830869|65505069|FG000|Period 1: Part 1|Adverse Event|0|||
23481106|NCT00830869|65505070|FG001|Period 1: Part 1|Adverse Event|0|||
23481107|NCT00830869|65505071|FG002|Period 1: Part 1|Adverse Event|0|||
23481108|NCT00830869|65505072|FG003|Period 1: Part 1|Adverse Event|0|||
23481109|NCT00830869|65505073|FG004|Period 1: Part 1|Adverse Event|0|||
23481110|NCT00830869|65505074|FG005|Period 1: Part 1|Adverse Event|1|||
23481111|NCT00830869|65505075|FG006|Period 1: Part 1|Adverse Event|1|||
23481112|NCT00830869|65505076|FG007|Period 1: Part 1|Adverse Event|0|||
23481113|NCT00830869|65505077|FG008|Period 1: Part 1|Adverse Event|0|||
23481114|NCT00830869|65505078|FG009|Period 1: Part 1|Adverse Event|0|||
23481115|NCT00830869|65505079|FG010|Period 1: Part 1|Adverse Event|0|||
23481116|NCT00830869|65505080|FG011|Period 1: Part 1|Adverse Event|0|||
23481117|NCT00830869|65505069|FG000|Period 1: Part 1|Progressive disease|1|||
23481118|NCT00830869|65505070|FG001|Period 1: Part 1|Progressive disease|0|||
23481119|NCT00830869|65505071|FG002|Period 1: Part 1|Progressive disease|1|||
23481120|NCT00830869|65505072|FG003|Period 1: Part 1|Progressive disease|6|||
23481121|NCT00830869|65505073|FG004|Period 1: Part 1|Progressive disease|4|||
23601221|NCT02432274|65929885|FG001|Overall Study|Death|6|||
23601222|NCT02432274|65929886|FG002|Overall Study|Death|7|||
23481122|NCT00830869|65505074|FG005|Period 1: Part 1|Progressive disease|4|||
23481123|NCT00830869|65505075|FG006|Period 1: Part 1|Progressive disease|1|||
23481124|NCT00830869|65505076|FG007|Period 1: Part 1|Progressive disease|0|||
23481125|NCT00830869|65505077|FG008|Period 1: Part 1|Progressive disease|0|||
23481126|NCT00830869|65505078|FG009|Period 1: Part 1|Progressive disease|0|||
23481127|NCT00830869|65505079|FG010|Period 1: Part 1|Progressive disease|0|||
23481128|NCT00830869|65505080|FG011|Period 1: Part 1|Progressive disease|0|||
23481129|NCT00830869|65505069|FG000|Period 2: Part 2|Protocol Violation|0|||
23481130|NCT00830869|65505070|FG001|Period 2: Part 2|Protocol Violation|0|||
23601223|NCT02432274|65929887|FG003|Overall Study|Death|0|||
23601224|NCT02432274|65929888|FG004|Overall Study|Death|27|||
23601225|NCT02432274|65929889|FG005|Overall Study|Death|7|||
23601226|NCT02432274|65929890|FG006|Overall Study|Death|9|||
23601227|NCT02432274|65929891|FG007|Overall Study|Death|14|||
23601228|NCT02432274|65929884|FG000|Overall Study|Withdrawal of Consent|0|||
23601229|NCT02432274|65929885|FG001|Overall Study|Withdrawal of Consent|0|||
23601230|NCT02432274|65929886|FG002|Overall Study|Withdrawal of Consent|0|||
23601231|NCT02432274|65929887|FG003|Overall Study|Withdrawal of Consent|0|||
23601232|NCT02432274|65929888|FG004|Overall Study|Withdrawal of Consent|2|||
23601233|NCT02432274|65929889|FG005|Overall Study|Withdrawal of Consent|0|||
23601234|NCT02432274|65929890|FG006|Overall Study|Withdrawal of Consent|1|||
23601235|NCT02432274|65929891|FG007|Overall Study|Withdrawal of Consent|2|||
23601236|NCT02185794|65929894|FG000|Overall Study|Enrolled but Never Dosed|1|||
23601237|NCT02185794|65929895|FG001|Overall Study|Enrolled but Never Dosed|6|||
23601238|NCT02185794|65929896|FG002|Overall Study|Enrolled but Never Dosed|3|||
23601239|NCT02185794|65929897|FG003|Overall Study|Enrolled but Never Dosed|1|||
23601240|NCT02185794|65929898|FG004|Overall Study|Enrolled but Never Dosed|1|||
23601241|NCT02185794|65929899|FG005|Overall Study|Enrolled but Never Dosed|0|||
23601242|NCT02185794|65929894|FG000|Overall Study|Investigator's Discretion|1|||
23601243|NCT02185794|65929895|FG001|Overall Study|Investigator's Discretion|0|||
23601244|NCT02185794|65929896|FG002|Overall Study|Investigator's Discretion|1|||
23601245|NCT02185794|65929897|FG003|Overall Study|Investigator's Discretion|2|||
23601246|NCT02185794|65929898|FG004|Overall Study|Investigator's Discretion|2|||
23601247|NCT02185794|65929899|FG005|Overall Study|Investigator's Discretion|15|||
23601248|NCT02185794|65929894|FG000|Overall Study|Withdrew Consent|2|||
23601249|NCT02185794|65929895|FG001|Overall Study|Withdrew Consent|5|||
23601250|NCT02185794|65929896|FG002|Overall Study|Withdrew Consent|10|||
23601251|NCT02185794|65929897|FG003|Overall Study|Withdrew Consent|2|||
23601252|NCT02185794|65929898|FG004|Overall Study|Withdrew Consent|0|||
23601253|NCT02185794|65929899|FG005|Overall Study|Withdrew Consent|0|||
23601254|NCT02185794|65929894|FG000|Overall Study|Lost to Follow-up|1|||
23601255|NCT02185794|65929895|FG001|Overall Study|Lost to Follow-up|2|||
23601256|NCT02185794|65929896|FG002|Overall Study|Lost to Follow-up|2|||
23481131|NCT00830869|65505071|FG002|Period 2: Part 2|Protocol Violation|0|||
23481132|NCT00830869|65505072|FG003|Period 2: Part 2|Protocol Violation|0|||
23481133|NCT00830869|65505073|FG004|Period 2: Part 2|Protocol Violation|0|||
23481134|NCT00830869|65505074|FG005|Period 2: Part 2|Protocol Violation|0|||
23481135|NCT00830869|65505075|FG006|Period 2: Part 2|Protocol Violation|0|||
23481136|NCT00830869|65505076|FG007|Period 2: Part 2|Protocol Violation|1|||
23481137|NCT00830869|65505077|FG008|Period 2: Part 2|Protocol Violation|0|||
23481138|NCT00830869|65505078|FG009|Period 2: Part 2|Protocol Violation|1|||
23481139|NCT00830869|65505079|FG010|Period 2: Part 2|Protocol Violation|0|||
23481140|NCT00830869|65505080|FG011|Period 2: Part 2|Protocol Violation|0|||
23481141|NCT00830869|65505069|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
23481142|NCT00830869|65505070|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
23481143|NCT00830869|65505071|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
23481144|NCT00830869|65505072|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
23481145|NCT00830869|65505073|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
23481146|NCT00830869|65505074|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
23481147|NCT00830869|65505075|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
23481148|NCT00830869|65505076|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
23481149|NCT00830869|65505077|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
23481150|NCT00830869|65505078|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
23481151|NCT00830869|65505079|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
23481152|NCT00830869|65505080|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
23481153|NCT00830869|65505069|FG000|Period 2: Part 2|Adverse Event|0|||
23481154|NCT00830869|65505070|FG001|Period 2: Part 2|Adverse Event|0|||
23481155|NCT00830869|65505071|FG002|Period 2: Part 2|Adverse Event|0|||
23481156|NCT00830869|65505072|FG003|Period 2: Part 2|Adverse Event|0|||
23481157|NCT00830869|65505073|FG004|Period 2: Part 2|Adverse Event|0|||
23481158|NCT00830869|65505074|FG005|Period 2: Part 2|Adverse Event|0|||
23481159|NCT00830869|65505075|FG006|Period 2: Part 2|Adverse Event|0|||
23481160|NCT00830869|65505076|FG007|Period 2: Part 2|Adverse Event|4|||
23481161|NCT00830869|65505077|FG008|Period 2: Part 2|Adverse Event|3|||
23481162|NCT00830869|65505078|FG009|Period 2: Part 2|Adverse Event|2|||
23481163|NCT00830869|65505079|FG010|Period 2: Part 2|Adverse Event|2|||
23481164|NCT00830869|65505080|FG011|Period 2: Part 2|Adverse Event|0|||
23481165|NCT00830869|65505069|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
23481166|NCT00830869|65505070|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
23481167|NCT00830869|65505071|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
23481168|NCT00830869|65505072|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
23481169|NCT00830869|65505073|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
23481170|NCT00830869|65505074|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
23481171|NCT00830869|65505075|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
23481172|NCT00830869|65505076|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
23481173|NCT00830869|65505077|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
23481174|NCT00830869|65505078|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
23481175|NCT00830869|65505079|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
23481176|NCT00830869|65505080|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
23481177|NCT00830869|65505069|FG000|Period 2: Part 2|Progressive disease|0|||
23481178|NCT00830869|65505070|FG001|Period 2: Part 2|Progressive disease|0|||
23481179|NCT00830869|65505071|FG002|Period 2: Part 2|Progressive disease|0|||
23481180|NCT00830869|65505072|FG003|Period 2: Part 2|Progressive disease|0|||
23481181|NCT00830869|65505073|FG004|Period 2: Part 2|Progressive disease|0|||
23481182|NCT00830869|65505074|FG005|Period 2: Part 2|Progressive disease|0|||
23481183|NCT00830869|65505075|FG006|Period 2: Part 2|Progressive disease|0|||
23481184|NCT00830869|65505076|FG007|Period 2: Part 2|Progressive disease|14|||
23481185|NCT00830869|65505077|FG008|Period 2: Part 2|Progressive disease|11|||
23481186|NCT00830869|65505078|FG009|Period 2: Part 2|Progressive disease|12|||
23481187|NCT00830869|65505079|FG010|Period 2: Part 2|Progressive disease|8|||
23481188|NCT00830869|65505080|FG011|Period 2: Part 2|Progressive disease|15|||
23481189|NCT00830869|65505069|FG000|Period 2: Part 2|Other|0|||
23481190|NCT00830869|65505070|FG001|Period 2: Part 2|Other|0|||
23364051|NCT01657162|65081094|FG001|Overall Study|Death|3|||
23364052|NCT01657162|65081093|FG000|Overall Study|Inability to Complete Study Procedures|1|||
23481191|NCT00830869|65505071|FG002|Period 2: Part 2|Other|0|||
23481192|NCT00830869|65505072|FG003|Period 2: Part 2|Other|0|||
23481193|NCT00830869|65505073|FG004|Period 2: Part 2|Other|0|||
23481194|NCT00830869|65505074|FG005|Period 2: Part 2|Other|0|||
23481195|NCT00830869|65505075|FG006|Period 2: Part 2|Other|0|||
23481196|NCT00830869|65505076|FG007|Period 2: Part 2|Other|0|||
23481197|NCT00830869|65505077|FG008|Period 2: Part 2|Other|0|||
23481198|NCT00830869|65505078|FG009|Period 2: Part 2|Other|1|||
23481199|NCT00830869|65505079|FG010|Period 2: Part 2|Other|0|||
23481200|NCT00830869|65505080|FG011|Period 2: Part 2|Other|0|||
23481201|NCT03774823|65505087|FG000|Overall Study|Withdrawal by Subject|1|||
23481202|NCT03774823|65505088|FG001|Overall Study|Withdrawal by Subject|1|||
23481203|NCT00137839|65505089|FG000|Overall Study|Adverse Event|7|||
23481204|NCT00137839|65505089|FG000|Overall Study|Physician Decision|7|||
23266655|NCT01545076|64718112|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
23266656|NCT01545076|64718113|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
23266657|NCT01545076|64718114|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
23266658|NCT01545076|64718110|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
23481205|NCT00137839|65505089|FG000|Overall Study|Death|8|||
23481206|NCT00137839|65505089|FG000|Overall Study|Disease Progression|60|||
23481207|NCT00137839|65505089|FG000|Overall Study|Not Start Treatment|1|||
23481208|NCT00137839|65505089|FG000|Overall Study|Prolonged Treatment Delay|1|||
23481209|NCT02604017|65505090|FG000|Overall Study|Withdrew Consent|0|||
23481210|NCT02604017|65505091|FG001|Overall Study|Withdrew Consent|2|||
23481211|NCT02604017|65505090|FG000|Overall Study|Lost to Follow-up|5|||
23481212|NCT02604017|65505091|FG001|Overall Study|Lost to Follow-up|6|||
23481213|NCT02604017|65505090|FG000|Overall Study|Other|1|||
23481214|NCT02604017|65505091|FG001|Overall Study|Other|0|||
23481215|NCT00913692|65505096|FG000|Screening (4 Months)|Physician Decision|3|||
23481216|NCT00913692|65505096|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
23481217|NCT00913692|65505096|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
23481218|NCT00991952|65505098|FG000|Overall Study|Adverse Event|0|||
23481219|NCT00991952|65505099|FG001|Overall Study|Adverse Event|1|||
23481220|NCT04140227|65505100|FG000|Overall Study|Withdrawal by Subject|26|||
23481221|NCT04140227|65505100|FG000|Overall Study|Lost to Follow-up|8|||
23481222|NCT04140227|65505100|FG000|Overall Study|Adverse Event|8|||
23481223|NCT04140227|65505100|FG000|Overall Study|Death|1|||
23481224|NCT04140227|65505100|FG000|Overall Study|Other|3|||
23481225|NCT04140227|65505100|FG000|Overall Study|Protocol Violation|2|||
23481226|NCT02522871|65505101|FG000|Overall Study|Protocol Violation|1|||
23266659|NCT01545076|64718111|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
23266660|NCT01545076|64718112|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
23266661|NCT01545076|64718113|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
23266662|NCT01545076|64718114|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
23266663|NCT01545076|64718110|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
23266664|NCT01545076|64718111|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
23266665|NCT01545076|64718112|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
23266666|NCT01545076|64718113|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
23266667|NCT01545076|64718114|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
23266668|NCT01545076|64718110|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
23266669|NCT01545076|64718111|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
23266670|NCT01545076|64718112|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
23266671|NCT01545076|64718113|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
23266672|NCT01545076|64718114|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
23266673|NCT01545076|64718110|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
23266674|NCT01545076|64718111|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
23266675|NCT01545076|64718112|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
23266676|NCT01545076|64718113|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
23364053|NCT01657162|65081094|FG001|Overall Study|Inability to Complete Study Procedures|7|||
23364054|NCT01657162|65081093|FG000|Overall Study|Protocol Violation|1|||
23364055|NCT01657162|65081094|FG001|Overall Study|Protocol Violation|0|||
23481227|NCT02522871|65505102|FG001|Overall Study|Protocol Violation|4|||
23481228|NCT02522871|65505101|FG000|Overall Study|Treated without randomization|1|||
23481229|NCT02522871|65505102|FG001|Overall Study|Treated without randomization|0|||
23481230|NCT02522871|65505101|FG000|Overall Study|Death|9|||
23481231|NCT02522871|65505102|FG001|Overall Study|Death|9|||
23364056|NCT01657162|65081093|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
23481232|NCT02522871|65505101|FG000|Overall Study|Died in operating room prior to transplant|0|||
23481233|NCT02522871|65505102|FG001|Overall Study|Died in operating room prior to transplant|1|||
23481234|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
23481235|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
23481236|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
23481237|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
23481238|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
23481239|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
23481240|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
23481241|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
23481242|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
23481243|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
23481244|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
23481245|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
23481246|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
23481247|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23481248|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
23481249|NCT01436162|65505103|FG000|Single-blind Lead-in Phase|Other|107|||
23481250|NCT01436162|65505104|FG001|Single-blind Lead-in Phase|Other|0|||
23481251|NCT01436162|65505105|FG002|Single-blind Lead-in Phase|Other|0|||
23481252|NCT01436162|65505103|FG000|Randomized Phase|Adverse Event|1|||
23481253|NCT01436162|65505104|FG001|Randomized Phase|Adverse Event|5|||
23481254|NCT01436162|65505105|FG002|Randomized Phase|Adverse Event|6|||
23481255|NCT01436162|65505103|FG000|Randomized Phase|Protocol Violation|4|||
23481256|NCT01436162|65505104|FG001|Randomized Phase|Protocol Violation|4|||
23481257|NCT01436162|65505105|FG002|Randomized Phase|Protocol Violation|2|||
23481258|NCT01436162|65505103|FG000|Randomized Phase|Withdrawal by Subject|16|||
23481259|NCT01436162|65505104|FG001|Randomized Phase|Withdrawal by Subject|9|||
23481260|NCT01436162|65505105|FG002|Randomized Phase|Withdrawal by Subject|8|||
23481261|NCT01436162|65505103|FG000|Randomized Phase|Lost to Follow-up|17|||
23481262|NCT01436162|65505104|FG001|Randomized Phase|Lost to Follow-up|5|||
23481263|NCT01436162|65505105|FG002|Randomized Phase|Lost to Follow-up|4|||
23481264|NCT01436162|65505103|FG000|Randomized Phase|Lack of Efficacy|0|||
23481265|NCT01436162|65505104|FG001|Randomized Phase|Lack of Efficacy|1|||
23481266|NCT01436162|65505105|FG002|Randomized Phase|Lack of Efficacy|1|||
23481267|NCT01436162|65505103|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
23481268|NCT01436162|65505104|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
23481269|NCT01436162|65505105|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
23481270|NCT01436162|65505103|FG000|Randomized Phase|Other|2|||
23481271|NCT01436162|65505104|FG001|Randomized Phase|Other|5|||
23481272|NCT01436162|65505105|FG002|Randomized Phase|Other|4|||
23481273|NCT02617485|65505106|FG000|Treatment and Observation Period|Adverse Event|9|||
23601257|NCT02185794|65929897|FG003|Overall Study|Lost to Follow-up|3|||
23601258|NCT02185794|65929898|FG004|Overall Study|Lost to Follow-up|0|||
23601259|NCT02185794|65929899|FG005|Overall Study|Lost to Follow-up|1|||
23601260|NCT00811941|65929900|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
23601261|NCT00811941|65929901|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
23601262|NCT00811941|65929900|FG000|All Treated Patients|Adverse Event|2|||
23601263|NCT00811941|65929901|FG001|All Treated Patients|Adverse Event|43|||
23601264|NCT00811941|65929900|FG000|All Treated Patients|Lack of Efficacy|2|||
23266677|NCT01545076|64718114|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
23266678|NCT01265784|64718115|FG000|Overall Study|Lost to Follow-up|5|||
23266679|NCT01265784|64718116|FG001|Overall Study|Lost to Follow-up|3|||
23266680|NCT01265784|64718117|FG002|Overall Study|Lost to Follow-up|2|||
23601265|NCT00811941|65929901|FG001|All Treated Patients|Lack of Efficacy|3|||
23601266|NCT00811941|65929900|FG000|All Treated Patients|Non-compliance|1|||
23601267|NCT00811941|65929901|FG001|All Treated Patients|Non-compliance|8|||
23601268|NCT00811941|65929900|FG000|All Treated Patients|Protocol Violation|5|||
23601269|NCT00811941|65929901|FG001|All Treated Patients|Protocol Violation|17|||
23266681|NCT01265784|64718115|FG000|Overall Study|Withdrawal by Subject|0|||
23266682|NCT01265784|64718116|FG001|Overall Study|Withdrawal by Subject|5|||
23266683|NCT01265784|64718117|FG002|Overall Study|Withdrawal by Subject|0|||
23266684|NCT01265784|64718115|FG000|Overall Study|Physician Decision|1|||
23266685|NCT01265784|64718116|FG001|Overall Study|Physician Decision|0|||
23266686|NCT01265784|64718117|FG002|Overall Study|Physician Decision|1|||
23266687|NCT01265784|64718115|FG000|Overall Study|Adverse Event|1|||
23266688|NCT01265784|64718116|FG001|Overall Study|Adverse Event|0|||
23266689|NCT01265784|64718117|FG002|Overall Study|Adverse Event|0|||
23266690|NCT01265784|64718115|FG000|Overall Study|Death|3|||
23266691|NCT01265784|64718116|FG001|Overall Study|Death|0|||
23266692|NCT01265784|64718117|FG002|Overall Study|Death|0|||
23266693|NCT01265784|64718115|FG000|Overall Study|Protocol Violation|2|||
23266694|NCT01265784|64718116|FG001|Overall Study|Protocol Violation|0|||
23266695|NCT01265784|64718117|FG002|Overall Study|Protocol Violation|0|||
23266696|NCT01265784|64718115|FG000|Overall Study|Incorrectly Randomized|0|||
23266697|NCT01265784|64718116|FG001|Overall Study|Incorrectly Randomized|0|||
23266698|NCT01265784|64718117|FG002|Overall Study|Incorrectly Randomized|1|||
23266699|NCT00810368|64718127|FG000|Overall Study|Lost to Follow-up|4|||
23266700|NCT00810368|64718128|FG001|Overall Study|Lost to Follow-up|2|||
23266701|NCT00810368|64718127|FG000|Overall Study|Lack of Efficacy|2|||
23266702|NCT00810368|64718128|FG001|Overall Study|Lack of Efficacy|0|||
23266703|NCT00878995|64718129|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
23266704|NCT00878995|64718130|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
23266705|NCT01884025|64718131|FG000|Overall Study|Lost to Follow-up|3|||
23364057|NCT01657162|65081094|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
23481274|NCT02617485|65505107|FG001|Treatment and Observation Period|Adverse Event|1|||
23481275|NCT02617485|65505106|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
23481276|NCT02617485|65505107|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
23481277|NCT02617485|65505106|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
23481278|NCT02617485|65505107|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
23481279|NCT02617485|65505106|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
23481280|NCT02617485|65505107|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
23481281|NCT02617485|65505106|FG000|Treatment and Observation Period|Physician Decision|0|||
23481282|NCT02617485|65505107|FG001|Treatment and Observation Period|Physician Decision|1|||
23481283|NCT02617485|65505106|FG000|Follow-up Period|Adverse Event|1|||
23481284|NCT02617485|65505107|FG001|Follow-up Period|Adverse Event|0|||
23481285|NCT02617485|65505106|FG000|Follow-up Period|Withdrawal by Subject|1|||
23364058|NCT01657162|65081093|FG000|Overall Study|Other than Specified|0|||
23266706|NCT01884025|64718132|FG001|Overall Study|Lost to Follow-up|4|||
23266707|NCT04524364|64718133|FG000|Overall Study|Physician Decision|3|||
23266708|NCT04524364|64718134|FG001|Overall Study|Physician Decision|6|||
23266709|NCT04524364|64718133|FG000|Overall Study|Adverse Event|0|||
23266710|NCT04524364|64718134|FG001|Overall Study|Adverse Event|1|||
23266711|NCT04524364|64718133|FG000|Overall Study|Investigational device deficiency|0|||
23266712|NCT04524364|64718134|FG001|Overall Study|Investigational device deficiency|1|||
23266713|NCT04524364|64718133|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
23266714|NCT04524364|64718134|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
23266715|NCT04524364|64718133|FG000|Overall Study|Device unavailability|0|||
23266716|NCT04524364|64718134|FG001|Overall Study|Device unavailability|2|||
23266717|NCT04524364|64718133|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
23266718|NCT04524364|64718134|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
23266719|NCT04524364|64718133|FG000|Overall Study|Low International normalized ratio (INR)|1|||
23266720|NCT04524364|64718134|FG001|Overall Study|Low International normalized ratio (INR)|0|||
23266721|NCT04700449|64718138|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
23266722|NCT04700449|64718139|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
23266723|NCT04700449|64718140|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
23266724|NCT04700449|64718141|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
23266725|NCT04700449|64718138|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
23266726|NCT04700449|64718139|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
23266727|NCT04700449|64718140|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
23266728|NCT04700449|64718141|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
23266729|NCT04700449|64718138|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
23266730|NCT04700449|64718139|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
23266731|NCT04700449|64718140|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
23266732|NCT04700449|64718141|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
23266733|NCT04700449|64718138|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
23266734|NCT04700449|64718139|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
23266735|NCT04700449|64718140|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
23266736|NCT04700449|64718141|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
23266737|NCT04700449|64718138|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
23266738|NCT04700449|64718139|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
23266739|NCT04700449|64718140|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
23266740|NCT04700449|64718141|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
23266741|NCT04700449|64718138|FG000|Stage 1: Double-Blind Period|Other|0|||
23266742|NCT04700449|64718139|FG001|Stage 1: Double-Blind Period|Other|0|||
23266743|NCT04700449|64718140|FG002|Stage 1: Double-Blind Period|Other|1|||
23266744|NCT04700449|64718141|FG003|Stage 1: Double-Blind Period|Other|0|||
23266745|NCT04700449|64718138|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
23266746|NCT04700449|64718139|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
23266747|NCT04700449|64718140|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
23266748|NCT04700449|64718141|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
23266749|NCT04700449|64718138|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
23266750|NCT04700449|64718139|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
23266751|NCT04700449|64718140|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
23266752|NCT04700449|64718141|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
23266753|NCT04700449|64718138|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
23266754|NCT04700449|64718139|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
23266755|NCT04700449|64718140|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
23266756|NCT04700449|64718141|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
23266757|NCT04700449|64718138|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
23266758|NCT04700449|64718139|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
23266759|NCT04700449|64718140|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
23266760|NCT04700449|64718141|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
23266761|NCT04700449|64718138|FG000|Stage 2 Sub-study 1|Other|1|||
23266762|NCT04700449|64718139|FG001|Stage 2 Sub-study 1|Other|2|||
23266763|NCT04700449|64718140|FG002|Stage 2 Sub-study 1|Other|0|||
23266764|NCT04700449|64718141|FG003|Stage 2 Sub-study 1|Other|0|||
23266765|NCT04700449|64718138|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
23266766|NCT04700449|64718139|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
23266767|NCT04700449|64718140|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
23266768|NCT04700449|64718141|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
23266769|NCT04700449|64718138|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
23266770|NCT04700449|64718139|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
23266771|NCT04700449|64718140|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
23266772|NCT04700449|64718141|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
23266773|NCT04700449|64718138|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
23266774|NCT04700449|64718139|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
23266775|NCT04700449|64718140|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
23266776|NCT04700449|64718141|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
23266777|NCT04700449|64718138|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
23266778|NCT04700449|64718139|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
23266779|NCT04700449|64718140|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
23266780|NCT04700449|64718141|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
23266781|NCT04700449|64718138|FG000|Stage 2 Sub-study 2|Other|0|||
23266782|NCT04700449|64718139|FG001|Stage 2 Sub-study 2|Other|0|||
23266783|NCT04700449|64718140|FG002|Stage 2 Sub-study 2|Other|0|||
23266784|NCT04700449|64718141|FG003|Stage 2 Sub-study 2|Other|5|||
23266785|NCT03738332|64718143|FG000|Overall Study|Withdrawal by Subject|1|||
23266786|NCT01513551|64718144|FG000|Overall Study|Death|0|||
23266787|NCT01513551|64718145|FG001|Overall Study|Death|1|||
23266788|NCT01513551|64718146|FG002|Overall Study|Death|0|||
23266789|NCT01513551|64718144|FG000|Overall Study|Lost to Follow-up|3|||
23266790|NCT01513551|64718145|FG001|Overall Study|Lost to Follow-up|5|||
23266791|NCT01513551|64718146|FG002|Overall Study|Lost to Follow-up|2|||
23266792|NCT01513551|64718144|FG000|Overall Study|Withdrawal by Subject|1|||
23266793|NCT01513551|64718145|FG001|Overall Study|Withdrawal by Subject|0|||
23266794|NCT01513551|64718146|FG002|Overall Study|Withdrawal by Subject|2|||
23266795|NCT01513551|64718144|FG000|Overall Study|Randomized but not vaccinated|0|||
23266796|NCT01513551|64718145|FG001|Overall Study|Randomized but not vaccinated|0|||
23266797|NCT01513551|64718146|FG002|Overall Study|Randomized but not vaccinated|1|||
23266798|NCT00275002|64718147|FG000|Overall Study|Death|1|||
23266799|NCT00275002|64718148|FG001|Overall Study|Death|0|||
23266800|NCT00275002|64718147|FG000|Overall Study|Disease progression|21|||
23266801|NCT00275002|64718148|FG001|Overall Study|Disease progression|15|||
23266802|NCT00275002|64718147|FG000|Overall Study|Adverse Event|0|||
23266803|NCT00275002|64718148|FG001|Overall Study|Adverse Event|1|||
23266804|NCT03810495|64718149|FG000|Overall Study|Lost to Follow-up|2|||
23266805|NCT03810495|64718149|FG000|Overall Study|Withdrawal by Subject|1|||
23266806|NCT02636907|64718150|FG000|Autoinjector Assessment Period|Adverse Event|2|||
23266807|NCT02636907|64718150|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
23266808|NCT02636907|64718150|FG000|Extension Phase|Adverse Event|2|||
23266809|NCT02636907|64718150|FG000|Extension Phase|Withdrawal by Subject|4|||
23266810|NCT02636907|64718150|FG000|Extension Phase|Physician Decision|1|||
23266811|NCT02636907|64718150|FG000|Extension Phase|Lost to Follow-up|2|||
23266812|NCT02636907|64718150|FG000|Extension Phase|Lack of Efficacy|1|||
23266813|NCT01620177|64718151|FG000|Overall Study|Failure at Screening Visit|43|||
23364059|NCT01657162|65081094|FG001|Overall Study|Other than Specified|2|||
23364060|NCT02829047|65081095|FG000|Overall Study|Withdrawal by Subject|1|||
23364061|NCT02259400|65081096|FG000|Overall Study|Death|0|||
23364062|NCT02259400|65081097|FG001|Overall Study|Death|2|||
23364063|NCT00325819|65081103|FG000|Overall Study|Study product lost in mail|2|||
23364064|NCT00325819|65081104|FG001|Overall Study|Study product lost in mail|1|||
23364065|NCT00325819|65081103|FG000|Overall Study|Did not take a dose of study product|4|||
23364066|NCT00325819|65081104|FG001|Overall Study|Did not take a dose of study product|9|||
23364067|NCT00325819|65081103|FG000|Overall Study|Lost to Follow-up|3|||
23364068|NCT00325819|65081104|FG001|Overall Study|Lost to Follow-up|3|||
23364069|NCT05417412|65081112|FG000|Overall Study|Lost to Follow-up|2|||
23364070|NCT04980014|65081113|FG000|Overall Study|Participants who are Duplicated|1|||
23364071|NCT04980014|65081113|FG000|Overall Study|Follow-up Failure|13|||
23364072|NCT04980014|65081113|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
23364073|NCT04980014|65081113|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
23364074|NCT04980014|65081113|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
23364075|NCT02915159|65081114|FG000|Overall Study|Participant no longer meets criteria|2|||
23266814|NCT01620177|64718151|FG000|Overall Study|Withdrawal by Subject|26|||
23266815|NCT01620177|64718151|FG000|Overall Study|Lost to Follow-up|7|||
23266816|NCT01620177|64718151|FG000|Overall Study|Physician Decision|2|||
23266817|NCT01620177|64718151|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
23266818|NCT00634907|64718154|FG000|Overall Study|Withdrawal by Subject|3|||
23266819|NCT00634907|64718155|FG001|Overall Study|Withdrawal by Subject|0|||
23266820|NCT00634907|64718154|FG000|Overall Study|Physician Decision|3|||
23266821|NCT00634907|64718155|FG001|Overall Study|Physician Decision|9|||
23266822|NCT00634907|64718154|FG000|Overall Study|Withdrawal by Subject|11|||
23266823|NCT00634907|64718155|FG001|Overall Study|Withdrawal by Subject|8|||
23266824|NCT00777829|64718160|FG000|Overall Study|Withdrawal by Subject|0|||
23266825|NCT00777829|64718161|FG001|Overall Study|Withdrawal by Subject|2|||
23266826|NCT02201251|64718163|FG000|Overall Study|Adverse Event|1|||
23266827|NCT02201251|64718164|FG001|Overall Study|Adverse Event|1|||
23266828|NCT02201251|64718163|FG000|Overall Study|Protocol Violation|1|||
23266829|NCT02201251|64718164|FG001|Overall Study|Protocol Violation|0|||
23266830|NCT02201251|64718163|FG000|Overall Study|Noncompliance with Study Drug|0|||
23266831|NCT02201251|64718164|FG001|Overall Study|Noncompliance with Study Drug|1|||
23266832|NCT02201251|64718163|FG000|Overall Study|Withdrawal by Subject|2|||
23266833|NCT02201251|64718164|FG001|Overall Study|Withdrawal by Subject|1|||
23266834|NCT01506323|64718168|FG000|Overall Study|Lost to Follow-up|5|||
23266835|NCT01506323|64718169|FG001|Overall Study|Lost to Follow-up|4|||
23266836|NCT01506323|64718168|FG000|Overall Study|Withdrawal by Subject|4|||
23266837|NCT01506323|64718169|FG001|Overall Study|Withdrawal by Subject|4|||
23266838|NCT01506323|64718168|FG000|Overall Study|Lack of Efficacy|1|||
23266839|NCT01506323|64718169|FG001|Overall Study|Lack of Efficacy|3|||
23266840|NCT01506323|64718168|FG000|Overall Study|Moved out of area|5|||
23266841|NCT01506323|64718169|FG001|Overall Study|Moved out of area|2|||
23266842|NCT01506323|64718168|FG000|Overall Study|Schedule or Transportation conflict|8|||
23266843|NCT01506323|64718169|FG001|Overall Study|Schedule or Transportation conflict|0|||
23266844|NCT01506323|64718168|FG000|Overall Study|Started another treatment|1|||
23266845|NCT01506323|64718169|FG001|Overall Study|Started another treatment|0|||
23266846|NCT01531205|64718170|FG000|Overall Study|Did not proceed to surgery|1|||
23266847|NCT01060670|64721597|FG000|Run In|screen failure|0|||
23266848|NCT01060670|64721598|FG001|Run In|screen failure|238|||
23266849|NCT03209570|64721600|FG000|Overall Study|Death|1|||
23266850|NCT03209570|64721601|FG001|Overall Study|Death|0|||
23266851|NCT03209570|64721600|FG000|Overall Study|Incomplete Data|8|||
23266852|NCT03209570|64721601|FG001|Overall Study|Incomplete Data|10|||
23266853|NCT03209570|64721600|FG000|Overall Study|Protocol Violation|1|||
23266854|NCT03209570|64721601|FG001|Overall Study|Protocol Violation|0|||
23266855|NCT03209570|64721600|FG000|Overall Study|Withdrawal by Subject|0|||
23266856|NCT03209570|64721601|FG001|Overall Study|Withdrawal by Subject|3|||
23266857|NCT01717976|64721602|FG000|Overall Study|Protocol Violation|0|||
23266858|NCT01717976|64721603|FG001|Overall Study|Protocol Violation|1|||
23266859|NCT02655237|64721604|FG000|Overall Study|Adverse Event|10|||
23266860|NCT02655237|64721605|FG001|Overall Study|Adverse Event|7|||
23266861|NCT02655237|64721604|FG000|Overall Study|Protocol Deviation|2|||
23266862|NCT02655237|64721605|FG001|Overall Study|Protocol Deviation|0|||
23266863|NCT02655237|64721604|FG000|Overall Study|Withdrawal by Participant|1|||
23266864|NCT02655237|64721605|FG001|Overall Study|Withdrawal by Participant|2|||
23266865|NCT02655237|64721604|FG000|Overall Study|Lack of Efficacy|0|||
23266866|NCT02655237|64721605|FG001|Overall Study|Lack of Efficacy|1|||
23266867|NCT02655237|64721604|FG000|Overall Study|Recovery Leading to Surgery|2|||
23266868|NCT02655237|64721605|FG001|Overall Study|Recovery Leading to Surgery|1|||
23364076|NCT02915159|65081115|FG001|Overall Study|Participant no longer meets criteria|0|||
23364077|NCT02915159|65081114|FG000|Overall Study|poor/non-compliance|1|||
23364078|NCT02915159|65081115|FG001|Overall Study|poor/non-compliance|0|||
23364079|NCT02915159|65081114|FG000|Overall Study|Participant withdrew consent|5|||
23364080|NCT02915159|65081115|FG001|Overall Study|Participant withdrew consent|1|||
23364081|NCT02915159|65081114|FG000|Overall Study|Request to discontinue treatment|1|||
23364082|NCT02915159|65081115|FG001|Overall Study|Request to discontinue treatment|2|||
23364083|NCT02915159|65081114|FG000|Overall Study|Adverse Event|2|||
23364084|NCT02915159|65081115|FG001|Overall Study|Adverse Event|2|||
23364085|NCT02915159|65081114|FG000|Overall Study|Lack of Efficacy|0|||
23364086|NCT02915159|65081115|FG001|Overall Study|Lack of Efficacy|3|||
23364087|NCT04030598|65081116|FG000|Overall Study|Voluntary Withdrawal|0|||
23364088|NCT04030598|65081117|FG001|Overall Study|Voluntary Withdrawal|1|||
23364089|NCT04030598|65081118|FG002|Overall Study|Voluntary Withdrawal|0|||
23364090|NCT02175121|65081119|FG000|Overall Study|Lack of Efficacy|1|||
23364091|NCT02175121|65081120|FG001|Overall Study|Lack of Efficacy|0|||
23364092|NCT02175121|65081121|FG002|Overall Study|Lack of Efficacy|0|||
23364093|NCT02175121|65081122|FG003|Overall Study|Lack of Efficacy|0|||
23364094|NCT02175121|65081123|FG004|Overall Study|Lack of Efficacy|0|||
23364095|NCT02175121|65081119|FG000|Overall Study|Lost to Follow-up|0|||
23364096|NCT02175121|65081120|FG001|Overall Study|Lost to Follow-up|1|||
23364097|NCT02175121|65081121|FG002|Overall Study|Lost to Follow-up|0|||
23364098|NCT02175121|65081122|FG003|Overall Study|Lost to Follow-up|1|||
23364099|NCT02175121|65081123|FG004|Overall Study|Lost to Follow-up|0|||
23364100|NCT02175121|65081119|FG000|Overall Study|Personal emergency|0|||
23364101|NCT02175121|65081120|FG001|Overall Study|Personal emergency|0|||
23364102|NCT02175121|65081121|FG002|Overall Study|Personal emergency|0|||
23364103|NCT02175121|65081122|FG003|Overall Study|Personal emergency|0|||
23364104|NCT02175121|65081123|FG004|Overall Study|Personal emergency|1|||
23364105|NCT02175121|65081119|FG000|Overall Study|Schedule conflict|0|||
23364106|NCT02175121|65081120|FG001|Overall Study|Schedule conflict|0|||
23364107|NCT02175121|65081121|FG002|Overall Study|Schedule conflict|1|||
23364108|NCT02175121|65081122|FG003|Overall Study|Schedule conflict|0|||
23364109|NCT02175121|65081123|FG004|Overall Study|Schedule conflict|0|||
23364110|NCT02175121|65081119|FG000|Overall Study|Time issues|0|||
23364111|NCT02175121|65081120|FG001|Overall Study|Time issues|0|||
23364112|NCT02175121|65081121|FG002|Overall Study|Time issues|1|||
23364113|NCT02175121|65081122|FG003|Overall Study|Time issues|0|||
23364114|NCT02175121|65081123|FG004|Overall Study|Time issues|0|||
23364115|NCT01869777|65081128|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
23364116|NCT01324947|65081130|FG000|Overall Study|Adverse Event|7|||
23364117|NCT01324947|65081130|FG000|Overall Study|Death|10|||
23364118|NCT01324947|65081130|FG000|Overall Study|Other|3|||
23364119|NCT01324947|65081130|FG000|Overall Study|Progressive Disease|50|||
23364120|NCT01324947|65081130|FG000|Overall Study|Withdrawal by Subject|3|||
23364121|NCT01324947|65081130|FG000|Overall Study|1 discontinued before starting drug|1|||
23364122|NCT02157519|65081136|FG000|Overall Study|Death|3|||
23364123|NCT02157519|65081137|FG001|Overall Study|Death|1|||
23364124|NCT02157519|65081136|FG000|Overall Study|Withdrawal by Subject|7|||
23364125|NCT02157519|65081137|FG001|Overall Study|Withdrawal by Subject|0|||
23364126|NCT02157519|65081136|FG000|Overall Study|Lost to Follow-up|1|||
23364127|NCT02157519|65081137|FG001|Overall Study|Lost to Follow-up|0|||
23364128|NCT00165503|65081138|FG000|Overall Study|Death|1|||
23364129|NCT00165503|65081138|FG000|Overall Study|Lost to Follow-up|12|||
23364130|NCT00165503|65081138|FG000|Overall Study|Unresectable|3|||
23364131|NCT01619878|65081143|FG000|6 Week Follow-up Phase|Adverse Event|1|||
23364132|NCT01619878|65081143|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
23364133|NCT01619878|65081143|FG000|Follow-up at 12 Months of Age|Death|2|||
23364134|NCT01628848|65081144|FG000|Overall Study|Adverse Event|9|||
23364135|NCT01628848|65081145|FG001|Overall Study|Adverse Event|7|||
23364136|NCT01628848|65081144|FG000|Overall Study|Lack of Efficacy|0|||
23364137|NCT01628848|65081145|FG001|Overall Study|Lack of Efficacy|4|||
23364138|NCT01628848|65081144|FG000|Overall Study|Withdrawal by Subject|0|||
23364139|NCT01628848|65081145|FG001|Overall Study|Withdrawal by Subject|2|||
23364140|NCT01628848|65081144|FG000|Overall Study|Physician Decision|3|||
23364141|NCT01628848|65081145|FG001|Overall Study|Physician Decision|1|||
23364142|NCT01697800|65081147|FG000|Overall Study|Death|0|||
23364143|NCT01697800|65081148|FG001|Overall Study|Death|1|||
23364144|NCT00268983|65081152|FG000|Overall Study|Death|3|||
23364145|NCT00268983|65081153|FG001|Overall Study|Death|0|||
23364146|NCT00493012|65081156|FG000|Overall Study|Lost to Follow-up|18|||
23364147|NCT00493012|65081157|FG001|Overall Study|Lost to Follow-up|17|||
23364148|NCT00249873|65081158|FG000|Overall Study|Not treated|7|||
23364149|NCT00249873|65081159|FG001|Overall Study|Not treated|8|||
23364150|NCT00249873|65081158|FG000|Overall Study|Significant thrombocytopenia|9|||
23364151|NCT00249873|65081159|FG001|Overall Study|Significant thrombocytopenia|8|||
23364152|NCT00249873|65081158|FG000|Overall Study|Severe allergic reaction|8|||
23364153|NCT00249873|65081159|FG001|Overall Study|Severe allergic reaction|1|||
23364154|NCT00249873|65081158|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
23481286|NCT02617485|65505107|FG001|Follow-up Period|Withdrawal by Subject|0|||
23481287|NCT02617485|65505106|FG000|Follow-up Period|Disease progression|2|||
23481288|NCT02617485|65505107|FG001|Follow-up Period|Disease progression|1|||
23266869|NCT02655237|64721604|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
23266870|NCT02655237|64721605|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
23266871|NCT02655237|64721604|FG000|Overall Study|Randomized but Not Treated|1|||
23266872|NCT02655237|64721605|FG001|Overall Study|Randomized but Not Treated|0|||
23266873|NCT00543309|64721607|FG000|Overall Study|Physician Decision|0|||
23266874|NCT00543309|64721608|FG001|Overall Study|Physician Decision|1|||
23266875|NCT00543309|64721609|FG002|Overall Study|Physician Decision|0|||
23266876|NCT00832377|64721610|FG000|Overall Study|Protocol Violation|1|||
23266877|NCT01238848|64721611|FG000|Overall Study|Physician Decision|13|||
23266878|NCT01238848|64721612|FG001|Overall Study|Physician Decision|5|||
23266879|NCT04117607|64721615|FG000|Overall Study|Early Termination|0|||
23266880|NCT04117607|64721616|FG001|Overall Study|Early Termination|1|||
23266881|NCT04117607|64721617|FG002|Overall Study|Early Termination|0|||
23266882|NCT04117607|64721618|FG003|Overall Study|Early Termination|0|||
23266883|NCT04117607|64721619|FG004|Overall Study|Early Termination|0|||
23266884|NCT04117607|64721620|FG005|Overall Study|Early Termination|0|||
23266885|NCT04117607|64721621|FG006|Overall Study|Early Termination|1|||
23266886|NCT04117607|64721622|FG007|Overall Study|Early Termination|0|||
23266887|NCT04117607|64721623|FG008|Overall Study|Early Termination|0|||
23266888|NCT04117607|64721624|FG009|Overall Study|Early Termination|0|||
23266889|NCT04117607|64721625|FG010|Overall Study|Early Termination|0|||
23266890|NCT04117607|64721626|FG011|Overall Study|Early Termination|0|||
23266891|NCT04117607|64721627|FG012|Overall Study|Early Termination|0|||
23266892|NCT04117607|64721628|FG013|Overall Study|Early Termination|0|||
23266893|NCT01004172|64721633|FG000|Overall Study|Progressive Disease in CNS Only|16|||
23481289|NCT02617485|65505106|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
23481290|NCT02617485|65505107|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
23481291|NCT02617485|65505106|FG000|Follow-up Period|Patient needed radiotherapy|9|||
23481292|NCT02617485|65505107|FG001|Follow-up Period|Patient needed radiotherapy|5|||
23481293|NCT02617485|65505106|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
23481294|NCT02617485|65505107|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
23481295|NCT02815280|65505110|FG000|Double-Blind Phase|Adverse Event|1|||
23481296|NCT02815280|65505111|FG001|Double-Blind Phase|Adverse Event|1|||
23481297|NCT02815280|65505110|FG000|Double-Blind Phase|Lost to Follow-up|10|||
23481298|NCT02815280|65505111|FG001|Double-Blind Phase|Lost to Follow-up|9|||
23481299|NCT02815280|65505110|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
23601270|NCT00811941|65929900|FG000|All Treated Patients|Withdrawal by Subject|35|||
23601271|NCT00811941|65929901|FG001|All Treated Patients|Withdrawal by Subject|94|||
23601272|NCT00811941|65929900|FG000|All Treated Patients|Lost to Follow-up|3|||
23601273|NCT00811941|65929901|FG001|All Treated Patients|Lost to Follow-up|12|||
23266894|NCT01004172|64721633|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
23266895|NCT01004172|64721633|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
23266896|NCT01004172|64721633|FG000|Overall Study|Adverse Event|1|||
23266897|NCT01004172|64721633|FG000|Overall Study|Physician Decision|1|||
23266898|NCT01004172|64721633|FG000|Overall Study|Symptomatic Deterioration|2|||
23266899|NCT01666730|64721634|FG000|Overall Study|Adverse Event|16|||
23601274|NCT00811941|65929900|FG000|All Treated Patients|Other Reason|4|||
23601275|NCT00811941|65929901|FG001|All Treated Patients|Other Reason|14|||
23601276|NCT00650104|65929902|FG000|Overall Study|Adverse Event|17|||
23601277|NCT00650104|65929902|FG000|Overall Study|Death|2|||
23601278|NCT00650104|65929902|FG000|Overall Study|Withdrawal by Subject|11|||
23601279|NCT00650104|65929902|FG000|Overall Study|Physician Decision|7|||
23601280|NCT00650104|65929902|FG000|Overall Study|Lost to Follow-up|1|||
23266900|NCT01666730|64721634|FG000|Overall Study|Death|2|||
23266901|NCT01666730|64721634|FG000|Overall Study|Physician Decision|5|||
23481300|NCT02815280|65505111|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
23601281|NCT00650104|65929902|FG000|Overall Study|Non-compliance|2|||
23601282|NCT00650104|65929902|FG000|Overall Study|Sponsor Terminated Dosing|1|||
23601283|NCT03611075|65929903|FG000|Overall Study|Physician Decision|0|||
23364155|NCT00249873|65081159|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
23364156|NCT00249873|65081158|FG000|Overall Study|Other Serious Adverse Event|86|||
23364157|NCT00249873|65081159|FG001|Overall Study|Other Serious Adverse Event|97|||
23364158|NCT00249873|65081158|FG000|Overall Study|Qualifying condition not present|20|||
23364159|NCT00249873|65081159|FG001|Overall Study|Qualifying condition not present|23|||
23364160|NCT00249873|65081158|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
23364161|NCT00249873|65081159|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
23364162|NCT00249873|65081158|FG000|Overall Study|Withdrawal by Subject|504|||
23364163|NCT00249873|65081159|FG001|Overall Study|Withdrawal by Subject|466|||
23364164|NCT00249873|65081158|FG000|Overall Study|Lost to Follow-up|4|||
23364165|NCT00249873|65081159|FG001|Overall Study|Lost to Follow-up|7|||
23364166|NCT00249873|65081158|FG000|Overall Study|Minor bleeding|99|||
23364167|NCT00249873|65081159|FG001|Overall Study|Minor bleeding|37|||
23364168|NCT00249873|65081158|FG000|Overall Study|Non-compliance|41|||
23364169|NCT00249873|65081159|FG001|Overall Study|Non-compliance|46|||
23364170|NCT00249873|65081158|FG000|Overall Study|Other non serious Adverse Event|112|||
23481301|NCT02815280|65505110|FG000|Double-Blind Phase|Protocol Violation|2|||
23481302|NCT02815280|65505111|FG001|Double-Blind Phase|Protocol Violation|2|||
23601284|NCT03611075|65929904|FG001|Overall Study|Physician Decision|1|||
23601285|NCT03611075|65929905|FG002|Overall Study|Physician Decision|1|||
23601286|NCT03611075|65929906|FG003|Overall Study|Physician Decision|0|||
23601287|NCT03611075|65929907|FG004|Overall Study|Physician Decision|0|||
23601288|NCT03611075|65929908|FG005|Overall Study|Physician Decision|0|||
23266902|NCT01666730|64721634|FG000|Overall Study|Withdrawal by Subject|9|||
23266903|NCT01666730|64721634|FG000|Overall Study|Disease progression/relapse|18|||
23266904|NCT01682083|64721635|FG000|Overall Study|Lost to Follow-up|11|||
23266905|NCT01682083|64721636|FG001|Overall Study|Lost to Follow-up|18|||
23266906|NCT01682083|64721635|FG000|Overall Study|Withdrawal by Subject|31|||
23266907|NCT01682083|64721636|FG001|Overall Study|Withdrawal by Subject|40|||
23266908|NCT01682083|64721635|FG000|Overall Study|Death|60|||
23266909|NCT01682083|64721636|FG001|Overall Study|Death|93|||
23266910|NCT01682083|64721635|FG000|Overall Study|Physician Decision|5|||
23266911|NCT01682083|64721636|FG001|Overall Study|Physician Decision|4|||
23266912|NCT01574248|64721637|FG000|Overall Study|Withdrawal by Subject|2|||
23266913|NCT01574248|64721638|FG001|Overall Study|Withdrawal by Subject|0|||
23266914|NCT01574248|64721637|FG000|Overall Study|Missing primary endpoint data|1|||
23266915|NCT01574248|64721638|FG001|Overall Study|Missing primary endpoint data|0|||
23266916|NCT02785913|64721639|FG000|Overall Study|Adverse Event|5|||
23266917|NCT02785913|64721639|FG000|Overall Study|Death|2|||
23266918|NCT02785913|64721639|FG000|Overall Study|Progression|18|||
23266919|NCT02785913|64721639|FG000|Overall Study|Not protocol specified|1|||
23266920|NCT05034731|64721640|FG000|Overall Study|Screen fail|1|||
23266921|NCT05034731|64721641|FG001|Overall Study|Screen fail|1|||
23266922|NCT00860028|64721642|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
23266923|NCT00860028|64721643|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
23266924|NCT00379340|64721644|FG000|Overall Study|Death|0|||
23266925|NCT00379340|64721645|FG001|Overall Study|Death|0|||
23266926|NCT00379340|64721646|FG002|Overall Study|Death|0|||
23266927|NCT00379340|64721647|FG003|Overall Study|Death|2|||
23266928|NCT00379340|64721648|FG004|Overall Study|Death|0|||
23266929|NCT00379340|64721644|FG000|Overall Study|Lack of Efficacy|6|||
23266930|NCT00379340|64721645|FG001|Overall Study|Lack of Efficacy|1|||
23266931|NCT00379340|64721646|FG002|Overall Study|Lack of Efficacy|0|||
23266932|NCT00379340|64721647|FG003|Overall Study|Lack of Efficacy|4|||
23266933|NCT00379340|64721648|FG004|Overall Study|Lack of Efficacy|3|||
23266934|NCT00379340|64721644|FG000|Overall Study|Physician Decision|6|||
23266935|NCT00379340|64721645|FG001|Overall Study|Physician Decision|2|||
23364171|NCT00249873|65081159|FG001|Overall Study|Other non serious Adverse Event|108|||
23601289|NCT03611075|65929909|FG006|Overall Study|Physician Decision|0|||
23601290|NCT03611075|65929910|FG007|Overall Study|Physician Decision|0|||
23601291|NCT03611075|65929911|FG008|Overall Study|Physician Decision|0|||
23601292|NCT03611075|65929903|FG000|Overall Study|Lost to Follow-up|1|||
23601293|NCT03611075|65929904|FG001|Overall Study|Lost to Follow-up|0|||
23601294|NCT03611075|65929905|FG002|Overall Study|Lost to Follow-up|0|||
23601295|NCT03611075|65929906|FG003|Overall Study|Lost to Follow-up|2|||
23601296|NCT03611075|65929907|FG004|Overall Study|Lost to Follow-up|0|||
23364172|NCT00249873|65081158|FG000|Overall Study|Other contraindicated medication|1|||
23364173|NCT00249873|65081159|FG001|Overall Study|Other contraindicated medication|0|||
23266936|NCT00379340|64721646|FG002|Overall Study|Physician Decision|1|||
23266937|NCT00379340|64721647|FG003|Overall Study|Physician Decision|2|||
23364174|NCT00249873|65081158|FG000|Overall Study|Patient not wish to continue after May08|3|||
23601297|NCT03611075|65929908|FG005|Overall Study|Lost to Follow-up|0|||
23266938|NCT00379340|64721648|FG004|Overall Study|Physician Decision|3|||
23266939|NCT00379340|64721644|FG000|Overall Study|Withdrawal by Subject|0|||
23266940|NCT00379340|64721645|FG001|Overall Study|Withdrawal by Subject|0|||
23601298|NCT03611075|65929909|FG006|Overall Study|Lost to Follow-up|0|||
23601299|NCT03611075|65929910|FG007|Overall Study|Lost to Follow-up|0|||
23364175|NCT00249873|65081159|FG001|Overall Study|Patient not wish to continue after May08|4|||
23364176|NCT00249873|65081158|FG000|Overall Study|Physician withdrew consent|59|||
23364177|NCT00249873|65081159|FG001|Overall Study|Physician withdrew consent|60|||
23364178|NCT00249873|65081158|FG000|Overall Study|Open label clopidogrel required|31|||
23364179|NCT00249873|65081159|FG001|Overall Study|Open label clopidogrel required|42|||
23364180|NCT00249873|65081158|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
23364181|NCT00249873|65081159|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
23364182|NCT00249873|65081158|FG000|Overall Study|Oral anticoagulant required|159|||
23266941|NCT00379340|64721646|FG002|Overall Study|Withdrawal by Subject|0|||
23364183|NCT00249873|65081159|FG001|Overall Study|Oral anticoagulant required|157|||
23364184|NCT00249873|65081158|FG000|Overall Study|Study drug intolerance|5|||
23364185|NCT00249873|65081159|FG001|Overall Study|Study drug intolerance|0|||
23266942|NCT00379340|64721647|FG003|Overall Study|Withdrawal by Subject|1|||
23266943|NCT00379340|64721648|FG004|Overall Study|Withdrawal by Subject|0|||
23266944|NCT00379340|64721644|FG000|Overall Study|Refusal of further protocol therapy|1|||
23266945|NCT00379340|64721645|FG001|Overall Study|Refusal of further protocol therapy|0|||
23266946|NCT00379340|64721646|FG002|Overall Study|Refusal of further protocol therapy|1|||
23481303|NCT02815280|65505110|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
23481304|NCT02815280|65505111|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
23481305|NCT02815280|65505110|FG000|Open-Label Phase|Adverse Event|2|||
23481306|NCT02815280|65505111|FG001|Open-Label Phase|Adverse Event|3|||
23481307|NCT02815280|65505110|FG000|Open-Label Phase|Lost to Follow-up|18|||
23481308|NCT02815280|65505111|FG001|Open-Label Phase|Lost to Follow-up|9|||
23481309|NCT02815280|65505110|FG000|Open-Label Phase|Withdrawal by Subject|33|||
23481310|NCT02815280|65505111|FG001|Open-Label Phase|Withdrawal by Subject|18|||
23481311|NCT02815280|65505110|FG000|Open-Label Phase|Protocol Violation|3|||
23266947|NCT00379340|64721647|FG003|Overall Study|Refusal of further protocol therapy|1|||
23266948|NCT00379340|64721648|FG004|Overall Study|Refusal of further protocol therapy|7|||
23364186|NCT00249873|65081158|FG000|Overall Study|Surgery/ procedure|9|||
23364187|NCT00249873|65081159|FG001|Overall Study|Surgery/ procedure|9|||
23364188|NCT00249873|65081158|FG000|Overall Study|Event related to cardiac condition|12|||
23364189|NCT00249873|65081159|FG001|Overall Study|Event related to cardiac condition|21|||
23364190|NCT00249873|65081158|FG000|Overall Study|Thromboembolic/outcome event|82|||
23364191|NCT00249873|65081159|FG001|Overall Study|Thromboembolic/outcome event|122|||
23364192|NCT00103285|65081160|FG000|Induction|Adverse Event|14|||
23364193|NCT00103285|65081161|FG001|Induction|Adverse Event|0|||
23364194|NCT00103285|65081162|FG002|Induction|Adverse Event|0|||
23364195|NCT00103285|65081163|FG003|Induction|Adverse Event|0|||
23364196|NCT00103285|65081164|FG004|Induction|Adverse Event|0|||
23364197|NCT00103285|65081165|FG005|Induction|Adverse Event|0|||
23364198|NCT00103285|65081166|FG006|Induction|Adverse Event|0|||
23364199|NCT00103285|65081167|FG007|Induction|Adverse Event|0|||
23364200|NCT00103285|65081160|FG000|Induction|Death|24|||
23364201|NCT00103285|65081161|FG001|Induction|Death|0|||
23364202|NCT00103285|65081162|FG002|Induction|Death|0|||
23266949|NCT00379340|64721644|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
23364203|NCT00103285|65081163|FG003|Induction|Death|0|||
23364204|NCT00103285|65081164|FG004|Induction|Death|0|||
23364205|NCT00103285|65081165|FG005|Induction|Death|0|||
23364206|NCT00103285|65081166|FG006|Induction|Death|0|||
23481312|NCT02815280|65505111|FG001|Open-Label Phase|Protocol Violation|0|||
23364207|NCT00103285|65081167|FG007|Induction|Death|0|||
23364208|NCT00103285|65081160|FG000|Induction|Physician Decision|103|||
23364209|NCT00103285|65081161|FG001|Induction|Physician Decision|0|||
23364210|NCT00103285|65081162|FG002|Induction|Physician Decision|0|||
23364211|NCT00103285|65081163|FG003|Induction|Physician Decision|0|||
23266950|NCT00379340|64721645|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
23266951|NCT00379340|64721646|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
23266952|NCT00379340|64721647|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
23266953|NCT00379340|64721648|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
23266954|NCT00379340|64721644|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
23266955|NCT00379340|64721645|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
23266956|NCT00379340|64721646|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
23266957|NCT00379340|64721647|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
23266958|NCT00379340|64721648|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
23266959|NCT01179919|64721653|FG000|Overall Study|Protocol Violation|1|||
23266960|NCT01179919|64721653|FG000|Overall Study|Adverse Event|1|||
23266961|NCT03125200|64721654|FG000|Overall Study|Study Termination|0|||
23266962|NCT03125200|64721655|FG001|Overall Study|Study Termination|0|||
23266963|NCT03125200|64721656|FG002|Overall Study|Study Termination|0|||
23266964|NCT03125200|64721657|FG003|Overall Study|Study Termination|1|||
23266965|NCT03125200|64721658|FG004|Overall Study|Study Termination|1|||
23266966|NCT03125200|64721659|FG005|Overall Study|Study Termination|2|||
23266967|NCT03125200|64721660|FG006|Overall Study|Study Termination|1|||
23266968|NCT03125200|64721654|FG000|Overall Study|Clinical Progression|0|||
23266969|NCT03125200|64721655|FG001|Overall Study|Clinical Progression|0|||
23266970|NCT03125200|64721656|FG002|Overall Study|Clinical Progression|0|||
23266971|NCT03125200|64721657|FG003|Overall Study|Clinical Progression|1|||
23266972|NCT03125200|64721658|FG004|Overall Study|Clinical Progression|0|||
23266973|NCT03125200|64721659|FG005|Overall Study|Clinical Progression|1|||
23266974|NCT03125200|64721660|FG006|Overall Study|Clinical Progression|0|||
23266975|NCT03125200|64721654|FG000|Overall Study|Progressive Disease|2|||
23266976|NCT03125200|64721655|FG001|Overall Study|Progressive Disease|1|||
23266977|NCT03125200|64721656|FG002|Overall Study|Progressive Disease|2|||
23266978|NCT03125200|64721657|FG003|Overall Study|Progressive Disease|1|||
23266979|NCT03125200|64721658|FG004|Overall Study|Progressive Disease|2|||
23266980|NCT03125200|64721659|FG005|Overall Study|Progressive Disease|0|||
23266981|NCT03125200|64721660|FG006|Overall Study|Progressive Disease|1|||
23266982|NCT03125200|64721654|FG000|Overall Study|Lack of Efficacy|0|||
23266983|NCT03125200|64721655|FG001|Overall Study|Lack of Efficacy|0|||
23266984|NCT03125200|64721656|FG002|Overall Study|Lack of Efficacy|0|||
23266985|NCT03125200|64721657|FG003|Overall Study|Lack of Efficacy|1|||
23266986|NCT03125200|64721658|FG004|Overall Study|Lack of Efficacy|0|||
23266987|NCT03125200|64721659|FG005|Overall Study|Lack of Efficacy|0|||
23266988|NCT03125200|64721660|FG006|Overall Study|Lack of Efficacy|0|||
23266989|NCT03125200|64721654|FG000|Overall Study|Toxicity|0|||
23266990|NCT03125200|64721655|FG001|Overall Study|Toxicity|0|||
23266991|NCT03125200|64721656|FG002|Overall Study|Toxicity|0|||
23364212|NCT00103285|65081164|FG004|Induction|Physician Decision|0|||
23201198|NCT02145156|64476639|FG001|Overall Study|No match to vaccination records|52|||
23266992|NCT03125200|64721657|FG003|Overall Study|Toxicity|1|||
23266993|NCT03125200|64721658|FG004|Overall Study|Toxicity|0|||
23266994|NCT03125200|64721659|FG005|Overall Study|Toxicity|0|||
23266995|NCT03125200|64721660|FG006|Overall Study|Toxicity|0|||
23266996|NCT03125200|64721654|FG000|Overall Study|Consent Withdrawn by Subject|0|||
23266997|NCT03125200|64721655|FG001|Overall Study|Consent Withdrawn by Subject|1|||
23266998|NCT03125200|64721656|FG002|Overall Study|Consent Withdrawn by Subject|0|||
23266999|NCT03125200|64721657|FG003|Overall Study|Consent Withdrawn by Subject|0|||
23267000|NCT03125200|64721658|FG004|Overall Study|Consent Withdrawn by Subject|1|||
23267001|NCT03125200|64721659|FG005|Overall Study|Consent Withdrawn by Subject|0|||
23267002|NCT03125200|64721660|FG006|Overall Study|Consent Withdrawn by Subject|1|||
23267003|NCT01915732|64721662|FG000|Overall Study|Withdrawal by Subject|18|||
23267004|NCT01915732|64721663|FG001|Overall Study|Withdrawal by Subject|18|||
23267005|NCT01915732|64721662|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
23267006|NCT01915732|64721663|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
23267007|NCT01915732|64721662|FG000|Overall Study|Adverse Event|12|||
23267008|NCT01915732|64721663|FG001|Overall Study|Adverse Event|4|||
23481313|NCT02815280|65505110|FG000|Open-Label Phase|Administrative|26|||
23481314|NCT02815280|65505111|FG001|Open-Label Phase|Administrative|12|||
23267009|NCT01915732|64721662|FG000|Overall Study|Protocol Violation|5|||
23267010|NCT01915732|64721663|FG001|Overall Study|Protocol Violation|5|||
23267011|NCT01915732|64721662|FG000|Overall Study|Lack of Efficacy|6|||
23267012|NCT01915732|64721663|FG001|Overall Study|Lack of Efficacy|11|||
23267013|NCT01915732|64721662|FG000|Overall Study|Lost to Follow-up|22|||
23267014|NCT01915732|64721663|FG001|Overall Study|Lost to Follow-up|26|||
23267015|NCT01915732|64721662|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
23267016|NCT01915732|64721663|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
23267017|NCT01915732|64721662|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
23267018|NCT01915732|64721663|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
23267019|NCT01915732|64721662|FG000|Overall Study|Drug Release Error|1|||
23267020|NCT01915732|64721663|FG001|Overall Study|Drug Release Error|0|||
23267021|NCT01915732|64721662|FG000|Overall Study|Recovered|1|||
23267022|NCT01915732|64721663|FG001|Overall Study|Recovered|0|||
23267023|NCT01915732|64721662|FG000|Overall Study|Pregnancy|1|||
23267024|NCT01915732|64721663|FG001|Overall Study|Pregnancy|0|||
23267025|NCT01915732|64721662|FG000|Overall Study|Poor Perceived Efficacy|1|||
23267026|NCT01915732|64721663|FG001|Overall Study|Poor Perceived Efficacy|0|||
23267027|NCT01915732|64721662|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
23267028|NCT01915732|64721663|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
23267029|NCT01915732|64721662|FG000|Overall Study|Got Well|0|||
23267030|NCT01915732|64721663|FG001|Overall Study|Got Well|1|||
23267031|NCT01915732|64721662|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
23267032|NCT01915732|64721663|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
23267033|NCT01915732|64721662|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
23267034|NCT01915732|64721663|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
23267035|NCT01915732|64721662|FG000|Overall Study|Job Transfer|0|||
23267036|NCT01915732|64721663|FG001|Overall Study|Job Transfer|1|||
23267037|NCT01915732|64721662|FG000|Overall Study|Improper Facial Procedure|0|||
23267038|NCT01915732|64721663|FG001|Overall Study|Improper Facial Procedure|1|||
23267039|NCT01915732|64721662|FG000|Overall Study|Poor Conscious Effect|0|||
23267040|NCT01915732|64721663|FG001|Overall Study|Poor Conscious Effect|1|||
23267041|NCT00677365|64721664|FG000|Overall Study|Adverse Event|2|||
23267042|NCT00677365|64721665|FG001|Overall Study|Adverse Event|1|||
23267043|NCT00677365|64721666|FG002|Overall Study|Adverse Event|1|||
23267044|NCT00677365|64721667|FG003|Overall Study|Adverse Event|2|||
23267045|NCT00677365|64721664|FG000|Overall Study|Withdrawal by Subject|0|||
23267046|NCT00677365|64721665|FG001|Overall Study|Withdrawal by Subject|0|||
23267047|NCT00677365|64721666|FG002|Overall Study|Withdrawal by Subject|1|||
23267048|NCT00677365|64721667|FG003|Overall Study|Withdrawal by Subject|0|||
23267049|NCT00677365|64721664|FG000|Overall Study|Other reason|0|||
23267050|NCT00677365|64721665|FG001|Overall Study|Other reason|0|||
23267051|NCT00677365|64721666|FG002|Overall Study|Other reason|0|||
23267052|NCT00677365|64721667|FG003|Overall Study|Other reason|1|||
23267053|NCT00723554|64721668|FG000|Overall Study|Adverse Event|12|||
23267054|NCT00723554|64721668|FG000|Overall Study|Investigator's judgement|5|||
23267055|NCT00723554|64721668|FG000|Overall Study|Inhaled medication other than iloprost|4|||
23267056|NCT00723554|64721668|FG000|Overall Study|Withdrawal of consent|3|||
23267057|NCT00723554|64721668|FG000|Overall Study|Other|3|||
23267058|NCT00723554|64721668|FG000|Overall Study|Lost to Follow-up|1|||
23364213|NCT00103285|65081165|FG005|Induction|Physician Decision|0|||
23267059|NCT00723554|64721668|FG000|Overall Study|Non-compliance|1|||
23267060|NCT02927847|64721671|FG000|Overall Study|Lost to Follow-up|1|||
23267061|NCT02927847|64721672|FG001|Overall Study|Lost to Follow-up|0|||
23267062|NCT02927847|64721671|FG000|Overall Study|Withdrawal by Subject|4|||
23481315|NCT02815280|65505110|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
23601300|NCT03611075|65929911|FG008|Overall Study|Lost to Follow-up|0|||
23267063|NCT02927847|64721672|FG001|Overall Study|Withdrawal by Subject|2|||
23267064|NCT02927847|64721671|FG000|Overall Study|PI withdrawn due to missed visits|1|||
23364214|NCT00103285|65081166|FG006|Induction|Physician Decision|0|||
23267065|NCT02927847|64721672|FG001|Overall Study|PI withdrawn due to missed visits|1|||
23267066|NCT00262600|64721673|FG000|Overall Study|Lost to Follow-up|17|||
23267067|NCT00262600|64721674|FG001|Overall Study|Lost to Follow-up|31|||
23267068|NCT00262600|64721675|FG002|Overall Study|Lost to Follow-up|41|||
23267069|NCT00262600|64721673|FG000|Overall Study|Withdrawal by Subject|128|||
23267070|NCT00262600|64721674|FG001|Overall Study|Withdrawal by Subject|145|||
23267071|NCT00262600|64721675|FG002|Overall Study|Withdrawal by Subject|139|||
23267072|NCT00262600|64721673|FG000|Overall Study|Not Treated|32|||
23267073|NCT00262600|64721674|FG001|Overall Study|Not Treated|17|||
23267074|NCT00262600|64721675|FG002|Overall Study|Not Treated|24|||
23267075|NCT00262600|64721673|FG000|Overall Study|Other|58|||
23267076|NCT00262600|64721674|FG001|Overall Study|Other|59|||
23267077|NCT00262600|64721675|FG002|Overall Study|Other|62|||
23267078|NCT02173704|64721676|FG000|Overall Study|Adverse Event|1|||
23267079|NCT02173704|64721677|FG001|Overall Study|Adverse Event|0|||
23267080|NCT02173704|64721676|FG000|Overall Study|Lost to Follow-up|1|||
23267081|NCT02173704|64721677|FG001|Overall Study|Lost to Follow-up|0|||
23267082|NCT02173704|64721676|FG000|Overall Study|Other|1|||
23267083|NCT02173704|64721677|FG001|Overall Study|Other|0|||
23267084|NCT02173704|64721676|FG000|Overall Study|Protocol Violation|1|||
23267085|NCT02173704|64721677|FG001|Overall Study|Protocol Violation|0|||
23267086|NCT02173704|64721676|FG000|Overall Study|Withdrawal by Subject|9|||
23267087|NCT02173704|64721677|FG001|Overall Study|Withdrawal by Subject|4|||
23267088|NCT01379781|64721678|FG000|Overall Study|Lost to Follow-up|11|||
23267089|NCT01379781|64721679|FG001|Overall Study|Lost to Follow-up|8|||
23267090|NCT01492361|64721683|FG000|Overall Study|Withdrawal by Subject|281|||
23267091|NCT01492361|64721684|FG001|Overall Study|Withdrawal by Subject|297|||
23267092|NCT01492361|64721683|FG000|Overall Study|Physician Decision|12|||
23267093|NCT01492361|64721684|FG001|Overall Study|Physician Decision|12|||
23267094|NCT01492361|64721683|FG000|Overall Study|Lost to Follow-up|6|||
23267095|NCT01492361|64721684|FG001|Overall Study|Lost to Follow-up|13|||
23267096|NCT01492361|64721683|FG000|Overall Study|Other than specified above|106|||
23267097|NCT01492361|64721684|FG001|Overall Study|Other than specified above|138|||
23267098|NCT03687736|64721685|FG000|Overall Study|Lost to Follow-up|7|||
23267099|NCT03687736|64721685|FG000|Overall Study|Withdrawal by Subject|3|||
23267100|NCT03977584|64721687|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
23267101|NCT03977584|64721688|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
23267102|NCT03977584|64721689|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
23481316|NCT02815280|65505111|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
23481317|NCT01565343|65505117|FG000|Overall Study|Administrative decision/technical issues|1|||
23601301|NCT03611075|65929903|FG000|Overall Study|Withdrawal by Subject|0|||
23601302|NCT03611075|65929904|FG001|Overall Study|Withdrawal by Subject|1|||
23601303|NCT03611075|65929905|FG002|Overall Study|Withdrawal by Subject|1|||
23601304|NCT03611075|65929906|FG003|Overall Study|Withdrawal by Subject|1|||
23601305|NCT03611075|65929907|FG004|Overall Study|Withdrawal by Subject|0|||
23601306|NCT03611075|65929908|FG005|Overall Study|Withdrawal by Subject|0|||
23601307|NCT03611075|65929909|FG006|Overall Study|Withdrawal by Subject|1|||
23601308|NCT03611075|65929910|FG007|Overall Study|Withdrawal by Subject|0|||
23601309|NCT03611075|65929911|FG008|Overall Study|Withdrawal by Subject|0|||
23267103|NCT02849652|64721694|FG000|Overall Study|Lost to Follow-up|104|||
23267104|NCT02849652|64721695|FG001|Overall Study|Lost to Follow-up|35|||
23267105|NCT02849652|64721696|FG002|Overall Study|Lost to Follow-up|116|||
23267106|NCT02849652|64721697|FG003|Overall Study|Lost to Follow-up|22|||
23267107|NCT02849652|64721694|FG000|Overall Study|Withdrawal by Subject|10|||
23267108|NCT02849652|64721695|FG001|Overall Study|Withdrawal by Subject|2|||
23267109|NCT02849652|64721696|FG002|Overall Study|Withdrawal by Subject|8|||
23267110|NCT02849652|64721697|FG003|Overall Study|Withdrawal by Subject|4|||
23601310|NCT03611075|65929903|FG000|Overall Study|Reason unknown|0|||
23481318|NCT01565343|65505118|FG001|Overall Study|Administrative decision/technical issues|0|||
23481319|NCT01565343|65505119|FG002|Overall Study|Administrative decision/technical issues|0|||
23481320|NCT00555425|65505120|FG000|Overall Study|Missed Medication > 1 wk|34|||
23267111|NCT01513148|64721698|FG000|Overall Study|Protocol Violation|2|||
23267112|NCT01513148|64721699|FG001|Overall Study|Protocol Violation|2|||
23267113|NCT00449150|64721700|FG000|Overall Study|Adverse Event|11|||
23481321|NCT00555425|65505121|FG001|Overall Study|Missed Medication > 1 wk|15|||
23201199|NCT02145156|64476640|FG002|Overall Study|No match to vaccination records|41|||
23481322|NCT00555425|65505120|FG000|Overall Study|Missed 3 physician management visits|1|||
23481323|NCT00555425|65505121|FG001|Overall Study|Missed 3 physician management visits|0|||
23481324|NCT00555425|65505120|FG000|Overall Study|Met criteria for protective transfer|16|||
23481325|NCT00555425|65505121|FG001|Overall Study|Met criteria for protective transfer|3|||
23481326|NCT00555425|65505120|FG000|Overall Study|Became pregnant and transferred care|0|||
23481327|NCT00555425|65505121|FG001|Overall Study|Became pregnant and transferred care|1|||
23481328|NCT02158364|65505122|FG000|Overall Study|Case report forms uncollected|10|||
23481329|NCT02158364|65505122|FG000|Overall Study|Protocol Deviation|50|||
23481330|NCT02068768|65505123|FG000|Overall Study|Lost to Follow-up|5|||
23481331|NCT02068768|65505123|FG000|Overall Study|Early Termination by Sponsor|2|||
23481332|NCT01653132|65505126|FG000|First Intervention|Protocol Violation|1|||
23481333|NCT01653132|65505127|FG001|First Intervention|Protocol Violation|0|||
23481334|NCT02361580|65505128|FG000|Overall Study|Lost to Follow-up|6|||
23481335|NCT02361580|65505129|FG001|Overall Study|Lost to Follow-up|3|||
23481336|NCT01074047|65505130|FG000|Treatment Phase|Adverse Event|89|||
23601311|NCT03611075|65929904|FG001|Overall Study|Reason unknown|0|||
23601312|NCT03611075|65929905|FG002|Overall Study|Reason unknown|0|||
23601313|NCT03611075|65929906|FG003|Overall Study|Reason unknown|1|||
23601314|NCT03611075|65929907|FG004|Overall Study|Reason unknown|0|||
23601315|NCT03611075|65929908|FG005|Overall Study|Reason unknown|0|||
23601316|NCT03611075|65929909|FG006|Overall Study|Reason unknown|1|||
23601317|NCT03611075|65929910|FG007|Overall Study|Reason unknown|0|||
23601318|NCT03611075|65929911|FG008|Overall Study|Reason unknown|0|||
23601319|NCT03875313|65929912|FG000|Overall Study|Withdrawal by Subject|1|||
23601320|NCT03875313|65929913|FG001|Overall Study|Withdrawal by Subject|3|||
23601321|NCT03875313|65929914|FG002|Overall Study|Withdrawal by Subject|0|||
23601322|NCT03875313|65929915|FG003|Overall Study|Withdrawal by Subject|0|||
23601323|NCT03875313|65929916|FG004|Overall Study|Withdrawal by Subject|0|||
23601324|NCT03875313|65929912|FG000|Overall Study|Death|0|||
23601325|NCT03875313|65929913|FG001|Overall Study|Death|0|||
23601326|NCT03875313|65929914|FG002|Overall Study|Death|0|||
23601327|NCT03875313|65929915|FG003|Overall Study|Death|0|||
23601328|NCT03875313|65929916|FG004|Overall Study|Death|1|||
23601329|NCT03875313|65929912|FG000|Overall Study|Lost to Follow-up|0|||
23601330|NCT03875313|65929913|FG001|Overall Study|Lost to Follow-up|0|||
23601331|NCT03875313|65929914|FG002|Overall Study|Lost to Follow-up|0|||
23601332|NCT03875313|65929915|FG003|Overall Study|Lost to Follow-up|0|||
23601333|NCT03875313|65929916|FG004|Overall Study|Lost to Follow-up|1|||
23601334|NCT03875313|65929912|FG000|Overall Study|Study Termination by Sponsor|0|||
23601335|NCT03875313|65929913|FG001|Overall Study|Study Termination by Sponsor|1|||
23601336|NCT03875313|65929914|FG002|Overall Study|Study Termination by Sponsor|1|||
23601337|NCT03875313|65929915|FG003|Overall Study|Study Termination by Sponsor|0|||
23601338|NCT03875313|65929916|FG004|Overall Study|Study Termination by Sponsor|1|||
23601339|NCT03875313|65929912|FG000|Overall Study|New Anticancer Treatment|0|||
23601340|NCT03875313|65929913|FG001|Overall Study|New Anticancer Treatment|1|||
23601341|NCT03875313|65929914|FG002|Overall Study|New Anticancer Treatment|2|||
23601342|NCT03875313|65929915|FG003|Overall Study|New Anticancer Treatment|1|||
23601343|NCT03875313|65929916|FG004|Overall Study|New Anticancer Treatment|0|||
23601344|NCT03875313|65929912|FG000|Overall Study|Other, Not Specified|2|||
23601345|NCT03875313|65929913|FG001|Overall Study|Other, Not Specified|11|||
23601346|NCT03875313|65929914|FG002|Overall Study|Other, Not Specified|3|||
23601347|NCT03875313|65929915|FG003|Overall Study|Other, Not Specified|3|||
23601348|NCT03875313|65929916|FG004|Overall Study|Other, Not Specified|1|||
23601349|NCT01695954|65929918|FG000|Overall Study|Withdrawal by Subject|4|||
23601350|NCT01695954|65929919|FG001|Overall Study|Withdrawal by Subject|0|||
23601351|NCT01695954|65929918|FG000|Overall Study|Adverse Event|0|||
23601352|NCT01695954|65929919|FG001|Overall Study|Adverse Event|2|||
23601353|NCT00836498|65929920|FG000|Overall Study|Adverse Event|1|||
23481337|NCT01074047|65505131|FG001|Treatment Phase|Adverse Event|66|||
23481338|NCT01074047|65505130|FG000|Treatment Phase|Disease Progression|16|||
23481339|NCT01074047|65505131|FG001|Treatment Phase|Disease Progression|21|||
23481340|NCT01074047|65505130|FG000|Treatment Phase|Withdrawal by Subject|27|||
23481341|NCT01074047|65505131|FG001|Treatment Phase|Withdrawal by Subject|48|||
23601354|NCT00836498|65929921|FG001|Overall Study|Adverse Event|0|||
23601355|NCT00836498|65929920|FG000|Overall Study|Lost to Follow-up|1|||
23481342|NCT01074047|65505130|FG000|Treatment Phase|Death|53|||
23481343|NCT01074047|65505131|FG001|Treatment Phase|Death|58|||
23481344|NCT01074047|65505130|FG000|Treatment Phase|Lost to Follow-up|0|||
23481345|NCT01074047|65505131|FG001|Treatment Phase|Lost to Follow-up|1|||
23481346|NCT01074047|65505130|FG000|Treatment Phase|Protocol Violation|0|||
23481347|NCT01074047|65505131|FG001|Treatment Phase|Protocol Violation|1|||
23481348|NCT01074047|65505130|FG000|Treatment Phase|Miscellaneous|32|||
23481349|NCT01074047|65505131|FG001|Treatment Phase|Miscellaneous|39|||
23481350|NCT01074047|65505130|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
23481351|NCT01074047|65505131|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
23481352|NCT01074047|65505130|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
23481353|NCT01074047|65505131|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
23481354|NCT01074047|65505130|FG000|Survival Follow-Up Phase|Death|116|||
23481355|NCT01074047|65505131|FG001|Survival Follow-Up Phase|Death|124|||
23481356|NCT01074047|65505130|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
23481357|NCT01074047|65505131|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
23481358|NCT01074047|65505130|FG000|Extension Phase|Physician Decision|1|||
23481359|NCT01074047|65505131|FG001|Extension Phase|Physician Decision|0|||
23481360|NCT01074047|65505130|FG000|Extension Phase|Adverse Event|5|||
23481361|NCT01074047|65505131|FG001|Extension Phase|Adverse Event|0|||
23481362|NCT01074047|65505130|FG000|Extension Phase|Disease Progression|9|||
23481363|NCT01074047|65505131|FG001|Extension Phase|Disease Progression|0|||
23481364|NCT01074047|65505130|FG000|Extension Phase|Withdrawal by Subject|2|||
23481365|NCT01074047|65505131|FG001|Extension Phase|Withdrawal by Subject|0|||
23481366|NCT01074047|65505130|FG000|Extension Phase|Death|5|||
23481367|NCT01074047|65505131|FG001|Extension Phase|Death|0|||
23481368|NCT02692651|65505132|FG000|Study Treatment|Death|7|||
23481369|NCT02692651|65505133|FG001|Study Treatment|Death|3|||
23481370|NCT02692651|65505132|FG000|Study Treatment|comfort care|1|||
23481371|NCT02692651|65505133|FG001|Study Treatment|comfort care|1|||
23481372|NCT02692651|65505132|FG000|Study Treatment|Protocol violation per treating team preference|8|||
23481373|NCT02692651|65505133|FG001|Study Treatment|Protocol violation per treating team preference|6|||
23481374|NCT02692651|65505132|FG000|Post Study Treatment Follow-up|Death|4|||
23481375|NCT02692651|65505133|FG001|Post Study Treatment Follow-up|Death|4|||
23481376|NCT03603509|65505136|FG000|Overall Study|Lost to Follow-up|3|||
23481377|NCT03603509|65505137|FG001|Overall Study|Lost to Follow-up|4|||
23481378|NCT00706849|65505138|FG000|Treatment Period|Adverse Event|0|||
23481379|NCT00706849|65505139|FG001|Treatment Period|Adverse Event|9|||
23481380|NCT00706849|65505138|FG000|Treatment Period|Other|0|||
23481381|NCT00706849|65505139|FG001|Treatment Period|Other|1|||
23481382|NCT00706849|65505138|FG000|Follow-up Period|Withdrawal by Subject|0|||
23481383|NCT00706849|65505139|FG001|Follow-up Period|Withdrawal by Subject|2|||
23481384|NCT00706849|65505138|FG000|Follow-up Period|Protocol non-compliance|0|||
23481385|NCT00706849|65505139|FG001|Follow-up Period|Protocol non-compliance|1|||
23481386|NCT03330002|65505140|FG000|Overall Study|Lost to Follow-up|15|||
23481387|NCT03330002|65505140|FG000|Overall Study|Death|7|||
23481388|NCT01998984|65505147|FG000|Overall Study|Adverse Event|0|||
23481389|NCT01998984|65505148|FG001|Overall Study|Adverse Event|0|||
23481390|NCT01998984|65505149|FG002|Overall Study|Adverse Event|0|||
23601356|NCT00836498|65929921|FG001|Overall Study|Lost to Follow-up|0|||
23601357|NCT00836498|65929920|FG000|Overall Study|Withdrawal by Subject|2|||
23601358|NCT00836498|65929921|FG001|Overall Study|Withdrawal by Subject|1|||
23201200|NCT01242020|64476645|FG000|Overall Study|Withdrawal by Subject|2|||
23364215|NCT00103285|65081167|FG007|Induction|Physician Decision|0|||
23364216|NCT00103285|65081160|FG000|Induction|Withdrawal by Subject|1|||
23364217|NCT00103285|65081161|FG001|Induction|Withdrawal by Subject|0|||
23481391|NCT01998984|65505150|FG003|Overall Study|Adverse Event|1|||
23481392|NCT01998984|65505147|FG000|Overall Study|Lost to Follow-up|0|||
23481393|NCT01998984|65505148|FG001|Overall Study|Lost to Follow-up|1|||
23481394|NCT01998984|65505149|FG002|Overall Study|Lost to Follow-up|0|||
23364218|NCT00103285|65081162|FG002|Induction|Withdrawal by Subject|0|||
23481395|NCT01998984|65505150|FG003|Overall Study|Lost to Follow-up|1|||
23481396|NCT01998984|65505147|FG000|Overall Study|Withdrawal by Subject|0|||
23481397|NCT01998984|65505148|FG001|Overall Study|Withdrawal by Subject|0|||
23481398|NCT01998984|65505149|FG002|Overall Study|Withdrawal by Subject|1|||
23481399|NCT01998984|65505150|FG003|Overall Study|Withdrawal by Subject|0|||
23481400|NCT01998984|65505147|FG000|Overall Study|Other|0|||
23481401|NCT01998984|65505148|FG001|Overall Study|Other|0|||
23481402|NCT01998984|65505149|FG002|Overall Study|Other|0|||
23481403|NCT01998984|65505150|FG003|Overall Study|Other|1|||
23481404|NCT01073462|65505151|FG000|Overall Study|Death|14|||
23601359|NCT00683800|65929922|FG000|Overall Study|Adverse Event|195|||
23267114|NCT00449150|64721701|FG001|Overall Study|Adverse Event|18|||
23267115|NCT00449150|64721702|FG002|Overall Study|Adverse Event|9|||
23364219|NCT00103285|65081163|FG003|Induction|Withdrawal by Subject|0|||
23364220|NCT00103285|65081164|FG004|Induction|Withdrawal by Subject|0|||
23364221|NCT00103285|65081165|FG005|Induction|Withdrawal by Subject|0|||
23364222|NCT00103285|65081166|FG006|Induction|Withdrawal by Subject|0|||
23481405|NCT01073462|65505151|FG000|Overall Study|Kidney transplant|10|||
23481406|NCT01073462|65505151|FG000|Overall Study|Low parathyroid hormone levels|8|||
23481407|NCT01073462|65505151|FG000|Overall Study|Serious adverse event|2|||
23481408|NCT01073462|65505151|FG000|Overall Study|Lost to Follow-up|7|||
23481409|NCT01238588|65505158|FG000|Overall Study|Withdrawal by Subject|1|||
23481410|NCT01238588|65505158|FG000|Overall Study|Physician Decision|2|||
23481411|NCT03699475|65505159|FG000|Overall Study|Death|1|||
23481412|NCT01077375|65505160|FG000|Overall Study|Adverse Event|2|||
23481413|NCT01077375|65505161|FG001|Overall Study|Adverse Event|15|||
23601360|NCT00683800|65929923|FG001|Overall Study|Adverse Event|102|||
23601361|NCT00683800|65929922|FG000|Overall Study|Death|0|||
23601362|NCT00683800|65929923|FG001|Overall Study|Death|1|||
23601363|NCT00683800|65929922|FG000|Overall Study|Lost to Follow-up|57|||
23601364|NCT00683800|65929923|FG001|Overall Study|Lost to Follow-up|44|||
23601365|NCT00683800|65929922|FG000|Overall Study|Other|5|||
23267116|NCT00449150|64721700|FG000|Overall Study|Lack of Efficacy|1|||
23267117|NCT00449150|64721701|FG001|Overall Study|Lack of Efficacy|2|||
23267118|NCT00449150|64721702|FG002|Overall Study|Lack of Efficacy|2|||
23267119|NCT00449150|64721700|FG000|Overall Study|Other|16|||
23267120|NCT00449150|64721701|FG001|Overall Study|Other|13|||
23364223|NCT00103285|65081167|FG007|Induction|Withdrawal by Subject|0|||
23601366|NCT00683800|65929923|FG001|Overall Study|Other|2|||
23601367|NCT00683800|65929922|FG000|Overall Study|Protocol Violation|13|||
23601368|NCT00683800|65929923|FG001|Overall Study|Protocol Violation|16|||
23601369|NCT00683800|65929922|FG000|Overall Study|Withdrawal by Subject|66|||
23601370|NCT00683800|65929923|FG001|Overall Study|Withdrawal by Subject|64|||
23601371|NCT00683800|65929922|FG000|Overall Study|Lack of Efficacy|61|||
23601372|NCT00683800|65929923|FG001|Overall Study|Lack of Efficacy|104|||
23601373|NCT00683800|65929922|FG000|Overall Study|Randomized, not treated|35|||
23601374|NCT00683800|65929923|FG001|Overall Study|Randomized, not treated|33|||
23267121|NCT00449150|64721702|FG002|Overall Study|Other|14|||
23364224|NCT00103285|65081160|FG000|Induction|Ineligible|43|||
23601375|NCT02789020|65929926|FG000|Overall Study|Withdrawal by Subject|6|||
23601376|NCT02789020|65929927|FG001|Overall Study|Withdrawal by Subject|5|||
23601377|NCT03347396|65929930|FG000|Part A (26 Weeks)|Adverse Event|1|||
23601378|NCT03347396|65929931|FG001|Part A (26 Weeks)|Adverse Event|0|||
23267122|NCT00449150|64721700|FG000|Overall Study|Withdrawal by Subject|17|||
23267123|NCT00449150|64721701|FG001|Overall Study|Withdrawal by Subject|18|||
23364225|NCT00103285|65081161|FG001|Induction|Ineligible|0|||
23267124|NCT00449150|64721702|FG002|Overall Study|Withdrawal by Subject|21|||
23267125|NCT00449150|64721700|FG000|Overall Study|Protocol Violation|1|||
23267126|NCT00449150|64721701|FG001|Overall Study|Protocol Violation|2|||
23267127|NCT00449150|64721702|FG002|Overall Study|Protocol Violation|1|||
23267128|NCT02385526|64721703|FG000|Overall Study|Withdrawal by Subject|0|||
23267129|NCT02385526|64721704|FG001|Overall Study|Withdrawal by Subject|2|||
23364226|NCT00103285|65081162|FG002|Induction|Ineligible|0|||
23267130|NCT02385526|64721705|FG002|Overall Study|Withdrawal by Subject|0|||
23267131|NCT02385526|64721703|FG000|Overall Study|Lost to Follow-up|0|||
23267132|NCT02385526|64721704|FG001|Overall Study|Lost to Follow-up|1|||
23267133|NCT02385526|64721705|FG002|Overall Study|Lost to Follow-up|0|||
23267134|NCT02385526|64721703|FG000|Overall Study|Physician Decision|1|||
23267135|NCT02385526|64721704|FG001|Overall Study|Physician Decision|0|||
23267136|NCT02385526|64721705|FG002|Overall Study|Physician Decision|0|||
23267137|NCT02385526|64721703|FG000|Overall Study|Protocol Violation|1|||
23267138|NCT02385526|64721704|FG001|Overall Study|Protocol Violation|0|||
23267139|NCT02385526|64721705|FG002|Overall Study|Protocol Violation|0|||
23267140|NCT01575054|64721706|FG000|Overall Study|Other Reasons|5|||
23267141|NCT01575054|64721707|FG001|Overall Study|Other Reasons|3|||
23267142|NCT01575054|64721706|FG000|Overall Study|Protocol Violation|2|||
23267143|NCT01575054|64721707|FG001|Overall Study|Protocol Violation|1|||
23267144|NCT01575054|64721706|FG000|Overall Study|Personal Reasons|10|||
23267145|NCT01575054|64721707|FG001|Overall Study|Personal Reasons|11|||
23267146|NCT01575054|64721706|FG000|Overall Study|Lost to Follow-up|3|||
23267147|NCT01575054|64721707|FG001|Overall Study|Lost to Follow-up|3|||
23267148|NCT01575054|64721706|FG000|Overall Study|Adverse Event|9|||
23267149|NCT01575054|64721707|FG001|Overall Study|Adverse Event|8|||
23267150|NCT00243932|64721711|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
23267151|NCT00243932|64721712|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
23364227|NCT00103285|65081163|FG003|Induction|Ineligible|0|||
23364228|NCT00103285|65081164|FG004|Induction|Ineligible|0|||
23364229|NCT00103285|65081165|FG005|Induction|Ineligible|0|||
23364230|NCT00103285|65081166|FG006|Induction|Ineligible|0|||
23601379|NCT03347396|65929930|FG000|Part A (26 Weeks)|Death|0|||
23601380|NCT03347396|65929931|FG001|Part A (26 Weeks)|Death|1|||
23601381|NCT03347396|65929930|FG000|Part B (149 Weeks)|Adverse Event|1|||
23601382|NCT03347396|65929931|FG001|Part B (149 Weeks)|Adverse Event|1|||
23601383|NCT03347396|65929930|FG000|Part B (149 Weeks)|Death|1|||
23601384|NCT03347396|65929931|FG001|Part B (149 Weeks)|Death|0|||
23601385|NCT01759862|65929932|FG000|Overall Study|Physician Decision|3|||
23601386|NCT01759862|65929933|FG001|Overall Study|Physician Decision|1|||
23601387|NCT01759862|65929932|FG000|Overall Study|Adverse Event|0|||
23601388|NCT01759862|65929933|FG001|Overall Study|Adverse Event|1|||
23601389|NCT01323790|65929936|FG000|Overall Study|Other|3|||
23601390|NCT01323790|65929937|FG001|Overall Study|Other|2|||
23601391|NCT01323790|65929938|FG002|Overall Study|Other|1|||
23364231|NCT00103285|65081167|FG007|Induction|Ineligible|0|||
23364232|NCT00103285|65081160|FG000|Induction|Refusal|906|||
23364233|NCT00103285|65081161|FG001|Induction|Refusal|0|||
23364234|NCT00103285|65081162|FG002|Induction|Refusal|0|||
23364235|NCT00103285|65081163|FG003|Induction|Refusal|0|||
23364236|NCT00103285|65081164|FG004|Induction|Refusal|0|||
23364237|NCT00103285|65081165|FG005|Induction|Refusal|0|||
23364238|NCT00103285|65081166|FG006|Induction|Refusal|0|||
23364239|NCT00103285|65081167|FG007|Induction|Refusal|0|||
23364240|NCT00103285|65081160|FG000|Induction|Other|258|||
23364241|NCT00103285|65081161|FG001|Induction|Other|0|||
23364242|NCT00103285|65081162|FG002|Induction|Other|0|||
23364243|NCT00103285|65081163|FG003|Induction|Other|0|||
23364244|NCT00103285|65081164|FG004|Induction|Other|0|||
23364245|NCT00103285|65081165|FG005|Induction|Other|0|||
23364246|NCT00103285|65081166|FG006|Induction|Other|0|||
23364247|NCT00103285|65081167|FG007|Induction|Other|0|||
23364248|NCT00103285|65081160|FG000|Response Assignment|Adverse Event|0|||
23364249|NCT00103285|65081161|FG001|Response Assignment|Adverse Event|8|||
23364250|NCT00103285|65081162|FG002|Response Assignment|Adverse Event|3|||
23364251|NCT00103285|65081163|FG003|Response Assignment|Adverse Event|2|||
23601392|NCT01323790|65929936|FG000|Overall Study|Lost to Follow-up|11|||
23601393|NCT01323790|65929937|FG001|Overall Study|Lost to Follow-up|9|||
23601394|NCT01323790|65929938|FG002|Overall Study|Lost to Follow-up|9|||
23267152|NCT00243932|64721713|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
23267153|NCT00094302|64721714|FG000|Overall Study|Lost to Follow-up|43|||
23267154|NCT00094302|64721715|FG001|Overall Study|Lost to Follow-up|41|||
23267155|NCT00094302|64721714|FG000|Overall Study|Physician Decision|5|||
23267156|NCT00094302|64721715|FG001|Overall Study|Physician Decision|8|||
23267157|NCT00094302|64721714|FG000|Overall Study|Withdrawal by Subject|103|||
23267158|NCT00094302|64721715|FG001|Overall Study|Withdrawal by Subject|111|||
23267159|NCT00094302|64721714|FG000|Overall Study|Death|266|||
23267160|NCT00094302|64721715|FG001|Overall Study|Death|246|||
23267161|NCT02579096|64721716|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
23267162|NCT02579096|64721717|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
23267163|NCT02579096|64721716|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
23267164|NCT02579096|64721717|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
23267165|NCT02579096|64721716|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
23267166|NCT02579096|64721717|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
23267167|NCT02579096|64721716|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
23364252|NCT00103285|65081164|FG004|Response Assignment|Adverse Event|3|||
23364253|NCT00103285|65081165|FG005|Response Assignment|Adverse Event|1|||
23364254|NCT00103285|65081166|FG006|Response Assignment|Adverse Event|1|||
23364255|NCT00103285|65081167|FG007|Response Assignment|Adverse Event|2|||
23364256|NCT00103285|65081160|FG000|Response Assignment|Death|0|||
23364257|NCT00103285|65081161|FG001|Response Assignment|Death|5|||
23601395|NCT01323790|65929936|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
23601396|NCT01323790|65929937|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
23601397|NCT01323790|65929938|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
23364258|NCT00103285|65081162|FG002|Response Assignment|Death|2|||
23364259|NCT00103285|65081163|FG003|Response Assignment|Death|2|||
23364260|NCT00103285|65081164|FG004|Response Assignment|Death|3|||
23364261|NCT00103285|65081165|FG005|Response Assignment|Death|1|||
23364262|NCT00103285|65081166|FG006|Response Assignment|Death|0|||
23364263|NCT00103285|65081167|FG007|Response Assignment|Death|8|||
23364264|NCT00103285|65081160|FG000|Response Assignment|Lost to Follow-up|0|||
23364265|NCT00103285|65081161|FG001|Response Assignment|Lost to Follow-up|9|||
23364266|NCT00103285|65081162|FG002|Response Assignment|Lost to Follow-up|5|||
23364267|NCT00103285|65081163|FG003|Response Assignment|Lost to Follow-up|5|||
23364268|NCT00103285|65081164|FG004|Response Assignment|Lost to Follow-up|1|||
23364269|NCT00103285|65081165|FG005|Response Assignment|Lost to Follow-up|2|||
23364270|NCT00103285|65081166|FG006|Response Assignment|Lost to Follow-up|2|||
23364271|NCT00103285|65081167|FG007|Response Assignment|Lost to Follow-up|5|||
23364272|NCT00103285|65081160|FG000|Response Assignment|Physician Decision|0|||
23364273|NCT00103285|65081161|FG001|Response Assignment|Physician Decision|13|||
23364274|NCT00103285|65081162|FG002|Response Assignment|Physician Decision|14|||
23364275|NCT00103285|65081163|FG003|Response Assignment|Physician Decision|9|||
23364276|NCT00103285|65081164|FG004|Response Assignment|Physician Decision|13|||
23364277|NCT00103285|65081165|FG005|Response Assignment|Physician Decision|7|||
23601398|NCT01323790|65929936|FG000|Overall Study|Lack of Efficacy|3|||
23601399|NCT01323790|65929937|FG001|Overall Study|Lack of Efficacy|0|||
23601400|NCT01323790|65929938|FG002|Overall Study|Lack of Efficacy|3|||
23601401|NCT01323790|65929936|FG000|Overall Study|Adverse Event|11|||
23601402|NCT01323790|65929937|FG001|Overall Study|Adverse Event|24|||
23601403|NCT01323790|65929938|FG002|Overall Study|Adverse Event|12|||
23601404|NCT01323790|65929936|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23601405|NCT01323790|65929937|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
23364278|NCT00103285|65081166|FG006|Response Assignment|Physician Decision|4|||
23364279|NCT00103285|65081167|FG007|Response Assignment|Physician Decision|35|||
23364280|NCT00103285|65081160|FG000|Response Assignment|Protocol Violation|0|||
23364281|NCT00103285|65081161|FG001|Response Assignment|Protocol Violation|2|||
23364282|NCT00103285|65081162|FG002|Response Assignment|Protocol Violation|0|||
23364283|NCT00103285|65081163|FG003|Response Assignment|Protocol Violation|0|||
23364284|NCT00103285|65081164|FG004|Response Assignment|Protocol Violation|0|||
23364285|NCT00103285|65081165|FG005|Response Assignment|Protocol Violation|0|||
23364286|NCT00103285|65081166|FG006|Response Assignment|Protocol Violation|0|||
23364287|NCT00103285|65081167|FG007|Response Assignment|Protocol Violation|0|||
23364288|NCT00103285|65081160|FG000|Response Assignment|Withdrawal by Subject|0|||
23364289|NCT00103285|65081161|FG001|Response Assignment|Withdrawal by Subject|4|||
23364290|NCT00103285|65081162|FG002|Response Assignment|Withdrawal by Subject|1|||
23364291|NCT00103285|65081163|FG003|Response Assignment|Withdrawal by Subject|1|||
23364292|NCT00103285|65081164|FG004|Response Assignment|Withdrawal by Subject|2|||
23364293|NCT00103285|65081165|FG005|Response Assignment|Withdrawal by Subject|2|||
23364294|NCT00103285|65081166|FG006|Response Assignment|Withdrawal by Subject|0|||
23364295|NCT00103285|65081167|FG007|Response Assignment|Withdrawal by Subject|2|||
23601406|NCT01323790|65929938|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
23601407|NCT01323790|65929936|FG000|Overall Study|Withdrawal by Subject|23|||
23601408|NCT01323790|65929937|FG001|Overall Study|Withdrawal by Subject|20|||
23601409|NCT01323790|65929938|FG002|Overall Study|Withdrawal by Subject|13|||
23267168|NCT02579096|64721717|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
23267169|NCT02579096|64721716|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
23267170|NCT02579096|64721717|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
23267171|NCT02579096|64721716|FG000|Phase 2, Weeks 25 - 48|Death|2|||
23267172|NCT02579096|64721717|FG001|Phase 2, Weeks 25 - 48|Death|4|||
23267173|NCT02579096|64721716|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
23267174|NCT02579096|64721717|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
23267175|NCT02579096|64721716|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
23267176|NCT02579096|64721717|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
23267177|NCT02579096|64721716|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
23267178|NCT02579096|64721717|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
23267179|NCT02579096|64721716|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
23267180|NCT02579096|64721717|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
23267181|NCT02579096|64721716|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
23364296|NCT00103285|65081160|FG000|Response Assignment|Ineligible|0|||
23364297|NCT00103285|65081161|FG001|Response Assignment|Ineligible|8|||
23364298|NCT00103285|65081162|FG002|Response Assignment|Ineligible|6|||
23364299|NCT00103285|65081163|FG003|Response Assignment|Ineligible|2|||
23601410|NCT01323790|65929936|FG000|Overall Study|Did Not Receive Treatment|2|||
23601411|NCT01323790|65929937|FG001|Overall Study|Did Not Receive Treatment|0|||
23267182|NCT02579096|64721717|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
23267183|NCT02579096|64721716|FG000|Phase 3, Weeks 49 - 72|Death|3|||
23364300|NCT00103285|65081164|FG004|Response Assignment|Ineligible|0|||
23364301|NCT00103285|65081165|FG005|Response Assignment|Ineligible|3|||
23364302|NCT00103285|65081166|FG006|Response Assignment|Ineligible|1|||
23364303|NCT00103285|65081167|FG007|Response Assignment|Ineligible|5|||
23481414|NCT01077375|65505160|FG000|Overall Study|Lack of Efficacy|6|||
23481415|NCT01077375|65505161|FG001|Overall Study|Lack of Efficacy|8|||
23481416|NCT01077375|65505160|FG000|Overall Study|Withdrawal by Subject|0|||
23481417|NCT01077375|65505161|FG001|Overall Study|Withdrawal by Subject|6|||
23481418|NCT01077375|65505160|FG000|Overall Study|Lost to Follow-up|2|||
23481419|NCT01077375|65505161|FG001|Overall Study|Lost to Follow-up|5|||
23481420|NCT01077375|65505160|FG000|Overall Study|Other Reason|0|||
23481421|NCT01077375|65505161|FG001|Overall Study|Other Reason|1|||
23481422|NCT02325791|65505170|FG000|Overall Study|Adverse Event|0|||
23481423|NCT02325791|65505171|FG001|Overall Study|Adverse Event|1|||
23481424|NCT02325791|65505172|FG002|Overall Study|Adverse Event|1|||
23481425|NCT02325791|65505173|FG003|Overall Study|Adverse Event|0|||
23481426|NCT02325791|65505170|FG000|Overall Study|Death|0|||
23481427|NCT02325791|65505171|FG001|Overall Study|Death|3|||
23481428|NCT02325791|65505172|FG002|Overall Study|Death|0|||
23481429|NCT02325791|65505173|FG003|Overall Study|Death|1|||
23481430|NCT02325791|65505170|FG000|Overall Study|Lost to Follow-up|0|||
23481431|NCT02325791|65505171|FG001|Overall Study|Lost to Follow-up|15|||
23481432|NCT02325791|65505172|FG002|Overall Study|Lost to Follow-up|14|||
23481433|NCT02325791|65505173|FG003|Overall Study|Lost to Follow-up|9|||
23481434|NCT02325791|65505170|FG000|Overall Study|Physician Decision|0|||
23481435|NCT02325791|65505171|FG001|Overall Study|Physician Decision|1|||
23267184|NCT02579096|64721717|FG001|Phase 3, Weeks 49 - 72|Death|2|||
23267185|NCT02579096|64721716|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
23267186|NCT02579096|64721717|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
23267187|NCT02579096|64721716|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
23267188|NCT02579096|64721717|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
23267189|NCT02579096|64721716|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
23267190|NCT02579096|64721717|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
23267191|NCT02579096|64721716|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
23267192|NCT02579096|64721717|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
23267193|NCT02579096|64721716|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
23267194|NCT02579096|64721717|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
23267195|NCT02579096|64721716|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
23267196|NCT02579096|64721717|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
23267197|NCT02536378|64721718|FG000|Overall Study|Physician Decision|0|||
23267198|NCT02536378|64721719|FG001|Overall Study|Physician Decision|2|||
23267199|NCT02536378|64721718|FG000|Overall Study|Withdrawal by Subject|0|||
23267200|NCT02536378|64721719|FG001|Overall Study|Withdrawal by Subject|1|||
23267201|NCT02536378|64721718|FG000|Overall Study|Death|1|||
23267202|NCT02536378|64721719|FG001|Overall Study|Death|2|||
23267203|NCT02536378|64721718|FG000|Overall Study|Patient refused further follow up|6|||
23267204|NCT02536378|64721719|FG001|Overall Study|Patient refused further follow up|2|||
23267205|NCT00818883|64721720|FG000|Overall Study|Adverse Event|28|||
23267206|NCT00818883|64721721|FG001|Overall Study|Adverse Event|19|||
23267207|NCT00818883|64721720|FG000|Overall Study|Protocol Violation|2|||
23267208|NCT00818883|64721721|FG001|Overall Study|Protocol Violation|2|||
23267209|NCT00818883|64721720|FG000|Overall Study|Lost to Follow-up|3|||
23267210|NCT00818883|64721721|FG001|Overall Study|Lost to Follow-up|2|||
23267211|NCT00818883|64721720|FG000|Overall Study|Withdrawal by Subject|16|||
23267212|NCT00818883|64721721|FG001|Overall Study|Withdrawal by Subject|14|||
23267213|NCT00818883|64721720|FG000|Overall Study|Lack of Efficacy|0|||
23267214|NCT00818883|64721721|FG001|Overall Study|Lack of Efficacy|2|||
23267215|NCT00818883|64721720|FG000|Overall Study|Other|2|||
23267216|NCT00818883|64721721|FG001|Overall Study|Other|7|||
23267217|NCT02623959|64721726|FG000|Overall Study|Progression|0|||
23267218|NCT02623959|64721727|FG001|Overall Study|Progression|1|||
23267219|NCT02097290|64721728|FG000|Overall Study|Death|6|||
23267220|NCT02097290|64721728|FG000|Overall Study|Total Withdrawals|3|||
23267221|NCT02097290|64721728|FG000|Overall Study|Attempt|8|||
23481436|NCT02325791|65505172|FG002|Overall Study|Physician Decision|1|||
23481437|NCT02325791|65505173|FG003|Overall Study|Physician Decision|0|||
23481438|NCT02325791|65505170|FG000|Overall Study|Protocol Violation|0|||
23481439|NCT02325791|65505171|FG001|Overall Study|Protocol Violation|0|||
23267222|NCT01126736|64721729|FG000|Overall Study|Death|2|||
23267223|NCT01126736|64721730|FG001|Overall Study|Death|2|||
23267224|NCT01126736|64721731|FG002|Overall Study|Death|1|||
23267225|NCT01126736|64721732|FG003|Overall Study|Death|19|||
23267226|NCT01126736|64721733|FG004|Overall Study|Death|19|||
23267227|NCT01126736|64721729|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
23267228|NCT01126736|64721730|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
23267229|NCT01126736|64721731|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
23267230|NCT01126736|64721732|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
23601412|NCT01323790|65929938|FG002|Overall Study|Did Not Receive Treatment|1|||
23364304|NCT00103285|65081160|FG000|Response Assignment|Refusal|0|||
23481440|NCT02325791|65505172|FG002|Overall Study|Protocol Violation|1|||
23481441|NCT02325791|65505173|FG003|Overall Study|Protocol Violation|0|||
23481442|NCT02325791|65505170|FG000|Overall Study|Withdrawal by Subject|0|||
23267231|NCT01126736|64721733|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
23267232|NCT01126736|64721729|FG000|Overall Study|Lost to Follow-up|0|||
23267233|NCT01126736|64721730|FG001|Overall Study|Lost to Follow-up|0|||
23481443|NCT02325791|65505171|FG001|Overall Study|Withdrawal by Subject|5|||
23481444|NCT02325791|65505172|FG002|Overall Study|Withdrawal by Subject|8|||
23481445|NCT02325791|65505173|FG003|Overall Study|Withdrawal by Subject|16|||
23481446|NCT01185834|65505178|FG000|Overall Study|Lost to Follow-up|2|||
23481447|NCT01185834|65505178|FG000|Overall Study|Discomfort|4|||
23481448|NCT01185834|65505178|FG000|Overall Study|Biomicroscopy|4|||
23481449|NCT01185834|65505178|FG000|Overall Study|Time/Job Conflict|2|||
23481450|NCT01185834|65505178|FG000|Overall Study|Early exit - Site error|2|||
23481451|NCT01289782|65505181|FG000|Overall Study|Lost to Follow-up|14|||
23481452|NCT01289782|65505182|FG001|Overall Study|Lost to Follow-up|7|||
23481453|NCT01289782|65505181|FG000|Overall Study|Protocol Violation|1|||
23481454|NCT01289782|65505182|FG001|Overall Study|Protocol Violation|1|||
23481455|NCT01289782|65505181|FG000|Overall Study|Withdrawal by Subject|8|||
23481456|NCT01289782|65505182|FG001|Overall Study|Withdrawal by Subject|2|||
23481457|NCT01289782|65505181|FG000|Overall Study|Sponsor's Decision|1|||
23481458|NCT01289782|65505182|FG001|Overall Study|Sponsor's Decision|0|||
23481459|NCT01289782|65505181|FG000|Overall Study|Reason not specified|1|||
23481460|NCT01289782|65505182|FG001|Overall Study|Reason not specified|2|||
23481461|NCT00870233|65505183|FG000|Overall Study|Withdrawal by Subject|18|||
23481462|NCT00870233|65505183|FG000|Overall Study|Did not undergo laparotomy|3|||
23481463|NCT00870233|65505183|FG000|Overall Study|Incompatible internet browser|2|||
23481464|NCT00870233|65505183|FG000|Overall Study|Death|1|||
23481465|NCT04966910|65505188|FG000|Baseline|Participant did not complete measure|0|||
23481466|NCT04966910|65505189|FG001|Baseline|Participant did not complete measure|0|||
23481467|NCT04966910|65505190|FG002|Baseline|Participant did not complete measure|1|||
23481468|NCT04966910|65505191|FG003|Baseline|Participant did not complete measure|0|||
23481469|NCT04966910|65505188|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
23481470|NCT04966910|65505189|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
23481471|NCT04966910|65505190|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
23481472|NCT04966910|65505191|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
23481473|NCT04966910|65505188|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
23481474|NCT04966910|65505189|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
23481475|NCT04966910|65505190|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
23481476|NCT04966910|65505191|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
23481477|NCT04966910|65505188|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
23481478|NCT04966910|65505189|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
23481479|NCT04966910|65505190|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
23481480|NCT04966910|65505191|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
23481481|NCT01185301|65505192|FG000|Overall Study|Adverse Event|3|||
23601413|NCT01323790|65929936|FG000|Overall Study|Severe non-compliance with protocol|2|||
23601414|NCT01323790|65929937|FG001|Overall Study|Severe non-compliance with protocol|2|||
23601415|NCT01323790|65929938|FG002|Overall Study|Severe non-compliance with protocol|2|||
23601416|NCT01046136|65929939|FG000|Overall Study|Withdrawal by Subject|0|||
23601417|NCT01046136|65929940|FG001|Overall Study|Withdrawal by Subject|4|||
23601418|NCT01046136|65929939|FG000|Overall Study|Physician Decision|1|||
23601419|NCT01046136|65929940|FG001|Overall Study|Physician Decision|1|||
23601420|NCT01046136|65929939|FG000|Overall Study|Lost to Follow-up|3|||
23601421|NCT01046136|65929940|FG001|Overall Study|Lost to Follow-up|3|||
23601422|NCT00777049|65929941|FG000|Overall Study|Withdrawal by Subject|1|||
23601423|NCT00777049|65929942|FG001|Overall Study|Withdrawal by Subject|0|||
23601424|NCT00777049|65929941|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
23601425|NCT00777049|65929942|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
23601426|NCT02236611|65929943|FG000|Overall Study|Adverse Event|10|||
23601427|NCT02236611|65929944|FG001|Overall Study|Adverse Event|16|||
23601428|NCT02236611|65929943|FG000|Overall Study|Lack of Efficacy|4|||
23601429|NCT02236611|65929944|FG001|Overall Study|Lack of Efficacy|7|||
23267234|NCT01126736|64721731|FG002|Overall Study|Lost to Follow-up|0|||
23267235|NCT01126736|64721732|FG003|Overall Study|Lost to Follow-up|1|||
23267236|NCT01126736|64721733|FG004|Overall Study|Lost to Follow-up|1|||
23267237|NCT01126736|64721729|FG000|Overall Study|Administrative reasons|0|||
23267238|NCT01126736|64721730|FG001|Overall Study|Administrative reasons|0|||
23481482|NCT01185301|65505193|FG001|Overall Study|Adverse Event|0|||
23481483|NCT01185301|65505194|FG002|Overall Study|Adverse Event|2|||
23267239|NCT01126736|64721731|FG002|Overall Study|Administrative reasons|0|||
23481484|NCT01185301|65505195|FG003|Overall Study|Adverse Event|3|||
23481485|NCT01185301|65505192|FG000|Overall Study|Withdrawal by Subject|7|||
23601430|NCT02236611|65929943|FG000|Overall Study|Lost to Follow-up|0|||
23601431|NCT02236611|65929944|FG001|Overall Study|Lost to Follow-up|2|||
23601432|NCT02236611|65929943|FG000|Overall Study|Protocol deviation|3|||
23481486|NCT01185301|65505193|FG001|Overall Study|Withdrawal by Subject|5|||
23481487|NCT01185301|65505194|FG002|Overall Study|Withdrawal by Subject|2|||
23481488|NCT01185301|65505195|FG003|Overall Study|Withdrawal by Subject|3|||
23481489|NCT01185301|65505192|FG000|Overall Study|Lost to Follow-up|2|||
23481490|NCT01185301|65505193|FG001|Overall Study|Lost to Follow-up|0|||
23481491|NCT01185301|65505194|FG002|Overall Study|Lost to Follow-up|0|||
23481492|NCT01185301|65505195|FG003|Overall Study|Lost to Follow-up|1|||
23481493|NCT01185301|65505192|FG000|Overall Study|Other Reason|3|||
23481494|NCT01185301|65505193|FG001|Overall Study|Other Reason|2|||
23481495|NCT01185301|65505194|FG002|Overall Study|Other Reason|2|||
23481496|NCT01185301|65505195|FG003|Overall Study|Other Reason|2|||
23481497|NCT00089674|65505198|FG000|Overall Study|Physician Decision|4|||
23481498|NCT00089674|65505199|FG001|Overall Study|Physician Decision|2|||
23481499|NCT00089674|65505198|FG000|Overall Study|Adverse Event|23|||
23481500|NCT00089674|65505199|FG001|Overall Study|Adverse Event|29|||
23481501|NCT00089674|65505198|FG000|Overall Study|Withdrawal by Subject|143|||
23481502|NCT00089674|65505199|FG001|Overall Study|Withdrawal by Subject|127|||
23481503|NCT00089674|65505198|FG000|Overall Study|Death|43|||
23481504|NCT00089674|65505199|FG001|Overall Study|Death|43|||
23481505|NCT00089674|65505198|FG000|Overall Study|Disease progression|21|||
23481506|NCT00089674|65505199|FG001|Overall Study|Disease progression|23|||
23481507|NCT00089674|65505198|FG000|Overall Study|Ineligibility determined|8|||
23481508|NCT00089674|65505199|FG001|Overall Study|Ineligibility determined|10|||
23481509|NCT00089674|65505198|FG000|Overall Study|Lost to Follow-up|21|||
23481510|NCT00089674|65505199|FG001|Overall Study|Lost to Follow-up|17|||
23481511|NCT00089674|65505198|FG000|Overall Study|Noncompliance|7|||
23481512|NCT00089674|65505199|FG001|Overall Study|Noncompliance|3|||
23481513|NCT00089674|65505198|FG000|Overall Study|Other|5|||
23481514|NCT00089674|65505199|FG001|Overall Study|Other|9|||
23481515|NCT00089674|65505198|FG000|Overall Study|Requirement for alternative therapy|14|||
23481516|NCT00089674|65505199|FG001|Overall Study|Requirement for alternative therapy|4|||
23481517|NCT01658813|65505204|FG000|Overall Study|Disease progression|3|||
23481518|NCT02213133|65505205|FG000|Overall Study|Participant discontinued study therapy|2|||
23481519|NCT02213133|65505206|FG001|Overall Study|Participant discontinued study therapy|0|||
23481520|NCT02213133|65505207|FG002|Overall Study|Participant discontinued study therapy|0|||
23481521|NCT02213133|65505205|FG000|Overall Study|Participant withdrew informed consent|2|||
23481522|NCT02213133|65505206|FG001|Overall Study|Participant withdrew informed consent|1|||
23481523|NCT02213133|65505207|FG002|Overall Study|Participant withdrew informed consent|2|||
23481524|NCT02213133|65505205|FG000|Overall Study|Disease progression|11|||
23481525|NCT02213133|65505206|FG001|Overall Study|Disease progression|2|||
23601433|NCT02236611|65929944|FG001|Overall Study|Protocol deviation|5|||
23267240|NCT01126736|64721732|FG003|Overall Study|Administrative reasons|0|||
23267241|NCT01126736|64721733|FG004|Overall Study|Administrative reasons|1|||
23267242|NCT01126736|64721729|FG000|Overall Study|Progressive disease|0|||
23267243|NCT01126736|64721730|FG001|Overall Study|Progressive disease|0|||
23267244|NCT01126736|64721731|FG002|Overall Study|Progressive disease|0|||
23267245|NCT01126736|64721732|FG003|Overall Study|Progressive disease|2|||
23267246|NCT01126736|64721733|FG004|Overall Study|Progressive disease|1|||
23267247|NCT01126736|64721729|FG000|Overall Study|Withdrawal by Subject|0|||
23267248|NCT01126736|64721730|FG001|Overall Study|Withdrawal by Subject|0|||
23267249|NCT01126736|64721731|FG002|Overall Study|Withdrawal by Subject|0|||
23267250|NCT01126736|64721732|FG003|Overall Study|Withdrawal by Subject|1|||
23267251|NCT01126736|64721733|FG004|Overall Study|Withdrawal by Subject|1|||
23267252|NCT01126736|64721729|FG000|Overall Study|Other|2|||
23267253|NCT01126736|64721730|FG001|Overall Study|Other|4|||
23267254|NCT01126736|64721731|FG002|Overall Study|Other|4|||
23364305|NCT00103285|65081161|FG001|Response Assignment|Refusal|53|||
23267255|NCT01126736|64721732|FG003|Overall Study|Other|16|||
23267256|NCT01126736|64721733|FG004|Overall Study|Other|15|||
23267257|NCT00525590|64721735|FG000|Overall Study|Adverse Event|3|||
23267258|NCT00525590|64721735|FG000|Overall Study|Physician Decision|3|||
23481526|NCT02213133|65505207|FG002|Overall Study|Disease progression|0|||
23481527|NCT02213133|65505205|FG000|Overall Study|Adverse Event (AE)|1|||
23481528|NCT02213133|65505206|FG001|Overall Study|Adverse Event (AE)|0|||
23481529|NCT02213133|65505207|FG002|Overall Study|Adverse Event (AE)|0|||
23481530|NCT02213133|65505205|FG000|Overall Study|Death|16|||
23481531|NCT02213133|65505206|FG001|Overall Study|Death|2|||
23601434|NCT02236611|65929943|FG000|Overall Study|Withdrew consent|9|||
23267259|NCT00525590|64721735|FG000|Overall Study|Withdrawal by Subject|16|||
23267260|NCT00525590|64721735|FG000|Overall Study|Lost to Follow-up|1|||
23267261|NCT00525590|64721735|FG000|Overall Study|Death|9|||
23267262|NCT00525590|64721735|FG000|Overall Study|Other|13|||
23481532|NCT02213133|65505207|FG002|Overall Study|Death|1|||
23481533|NCT02213133|65505205|FG000|Overall Study|Other|5|||
23481534|NCT02213133|65505206|FG001|Overall Study|Other|0|||
23481535|NCT02213133|65505207|FG002|Overall Study|Other|0|||
23267263|NCT01946165|64721736|FG000|Overall Study|Physician Decision|2|||
23601435|NCT02236611|65929944|FG001|Overall Study|Withdrew consent|4|||
23481536|NCT01027273|65505208|FG000|Overall Study|Lost to Follow-up|57|||
23481537|NCT01027273|65505209|FG001|Overall Study|Lost to Follow-up|31|||
23481538|NCT01027273|65505208|FG000|Overall Study|Death|2|||
23481539|NCT01027273|65505209|FG001|Overall Study|Death|2|||
23481540|NCT02273739|65505210|FG000|Overall Study|Progression of Disease|3|||
23481541|NCT02273739|65505211|FG001|Overall Study|Progression of Disease|4|||
23481542|NCT02273739|65505212|FG002|Overall Study|Progression of Disease|5|||
23481543|NCT02273739|65505213|FG003|Overall Study|Progression of Disease|2|||
23481544|NCT02273739|65505210|FG000|Overall Study|Death|0|||
23481545|NCT02273739|65505211|FG001|Overall Study|Death|0|||
23481546|NCT02273739|65505212|FG002|Overall Study|Death|0|||
23481547|NCT02273739|65505213|FG003|Overall Study|Death|2|||
23481548|NCT02273739|65505210|FG000|Overall Study|Adverse Event|0|||
23481549|NCT02273739|65505211|FG001|Overall Study|Adverse Event|0|||
23481550|NCT02273739|65505212|FG002|Overall Study|Adverse Event|0|||
23481551|NCT02273739|65505213|FG003|Overall Study|Adverse Event|1|||
23481552|NCT02273739|65505210|FG000|Overall Study|Withdrawal by Subject|0|||
23481553|NCT02273739|65505211|FG001|Overall Study|Withdrawal by Subject|0|||
23481554|NCT02273739|65505212|FG002|Overall Study|Withdrawal by Subject|2|||
23481555|NCT02273739|65505213|FG003|Overall Study|Withdrawal by Subject|1|||
23481556|NCT02273739|65505210|FG000|Overall Study|Physician Decision|0|||
23481557|NCT02273739|65505211|FG001|Overall Study|Physician Decision|0|||
23481558|NCT02273739|65505212|FG002|Overall Study|Physician Decision|0|||
23481559|NCT02273739|65505213|FG003|Overall Study|Physician Decision|1|||
23481560|NCT02282345|65505214|FG000|Overall Study|Progression|0|||
23481561|NCT02282345|65505215|FG001|Overall Study|Progression|1|||
23481562|NCT01343823|65505218|FG000|Overall Study|Study Terminated|1|||
23481563|NCT01343823|65505219|FG001|Overall Study|Study Terminated|0|||
23481564|NCT01343823|65505220|FG002|Overall Study|Study Terminated|0|||
23481565|NCT01343823|65505221|FG003|Overall Study|Study Terminated|1|||
23481566|NCT01343823|65505218|FG000|Overall Study|Withdrawal by Subject|1|||
23481567|NCT01343823|65505219|FG001|Overall Study|Withdrawal by Subject|0|||
23481568|NCT01343823|65505220|FG002|Overall Study|Withdrawal by Subject|0|||
23481569|NCT01343823|65505221|FG003|Overall Study|Withdrawal by Subject|0|||
23481570|NCT00545129|65505225|FG000|Overall Study|Lack of Efficacy|2|||
23481571|NCT00545129|65505226|FG001|Overall Study|Lack of Efficacy|5|||
23481572|NCT00545129|65505225|FG000|Overall Study|Death|2|||
23481573|NCT00545129|65505226|FG001|Overall Study|Death|1|||
23481574|NCT00545129|65505225|FG000|Overall Study|Adverse Event|1|||
23481575|NCT00545129|65505226|FG001|Overall Study|Adverse Event|1|||
23481576|NCT00545129|65505225|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
23481577|NCT00545129|65505226|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
23481578|NCT00545129|65505225|FG000|Overall Study|Other|3|||
23481579|NCT00545129|65505226|FG001|Overall Study|Other|3|||
23481580|NCT03309046|65505235|FG000|Overall Study|Withdrawal by Subject|4|||
23481581|NCT03309046|65505236|FG001|Overall Study|Withdrawal by Subject|17|||
23481582|NCT00859638|65505237|FG000|Overall Study|Lost to Follow-up|6|||
23481583|NCT00859638|65505238|FG001|Overall Study|Lost to Follow-up|1|||
23481584|NCT00859638|65505237|FG000|Overall Study|Withdrawal by Subject|3|||
23481585|NCT00859638|65505238|FG001|Overall Study|Withdrawal by Subject|2|||
23481586|NCT00859638|65505237|FG000|Overall Study|Ill health|1|||
23481587|NCT00859638|65505238|FG001|Overall Study|Ill health|1|||
23481588|NCT03390101|65505243|FG000|Weeks 0-12|Withdrawal by Subject|0|||
23481589|NCT03390101|65505244|FG001|Weeks 0-12|Withdrawal by Subject|1|||
23481590|NCT03390101|65505245|FG002|Weeks 0-12|Withdrawal by Subject|1|||
23481591|NCT03390101|65505243|FG000|Weeks 0-12|Lost to Follow-up|0|||
23481592|NCT03390101|65505244|FG001|Weeks 0-12|Lost to Follow-up|1|||
23481593|NCT03390101|65505245|FG002|Weeks 0-12|Lost to Follow-up|0|||
23481594|NCT03390101|65505243|FG000|Weeks 12-54|Withdrawal by Subject|0|||
23481595|NCT03390101|65505244|FG001|Weeks 12-54|Withdrawal by Subject|3|||
23481596|NCT03390101|65505245|FG002|Weeks 12-54|Withdrawal by Subject|1|||
23481597|NCT03390101|65505243|FG000|Weeks 12-54|Pregnancy|1|||
23481598|NCT03390101|65505244|FG001|Weeks 12-54|Pregnancy|0|||
23481599|NCT03390101|65505245|FG002|Weeks 12-54|Pregnancy|0|||
23481600|NCT03390101|65505243|FG000|Weeks 12-54|Adverse Event|2|||
23481601|NCT03390101|65505244|FG001|Weeks 12-54|Adverse Event|1|||
23601436|NCT01634165|65929947|FG000|Period 2|Adverse Event|0|||
23481602|NCT03390101|65505245|FG002|Weeks 12-54|Adverse Event|1|||
23481603|NCT01099709|65505246|FG000|Period 1|Withdrawal by Subject|0|||
23481604|NCT01099709|65505247|FG001|Period 1|Withdrawal by Subject|1|||
23481605|NCT01099709|65505246|FG000|Period 1|Positive cotinine test|0|||
23481606|NCT01099709|65505247|FG001|Period 1|Positive cotinine test|1|||
23481607|NCT01099709|65505246|FG000|Period 1|Adverse Event|1|||
23481608|NCT01099709|65505247|FG001|Period 1|Adverse Event|0|||
23481609|NCT00130442|65505248|FG000|Overall Study|Withdrawal by Subject|0|||
23481610|NCT00130442|65505249|FG001|Overall Study|Withdrawal by Subject|1|||
23481611|NCT00130442|65505248|FG000|Overall Study|did not meet criteria|1|||
23364306|NCT00103285|65081162|FG002|Response Assignment|Refusal|5|||
23364307|NCT00103285|65081163|FG003|Response Assignment|Refusal|3|||
23364308|NCT00103285|65081164|FG004|Response Assignment|Refusal|25|||
23364309|NCT00103285|65081165|FG005|Response Assignment|Refusal|15|||
23364310|NCT00103285|65081166|FG006|Response Assignment|Refusal|30|||
23364311|NCT00103285|65081167|FG007|Response Assignment|Refusal|10|||
23364312|NCT00103285|65081160|FG000|Response Assignment|Other|0|||
23364313|NCT00103285|65081161|FG001|Response Assignment|Other|30|||
23481612|NCT00130442|65505249|FG001|Overall Study|did not meet criteria|1|||
23481613|NCT00400153|65505251|FG000|Overall Study|AE due to study disease worsening|14|||
23481614|NCT00400153|65505252|FG001|Overall Study|AE due to study disease worsening|19|||
23481615|NCT00400153|65505253|FG002|Overall Study|AE due to study disease worsening|20|||
23481616|NCT00400153|65505251|FG000|Overall Study|AE due to other disease worsening|2|||
23481617|NCT00400153|65505252|FG001|Overall Study|AE due to other disease worsening|1|||
23481618|NCT00400153|65505253|FG002|Overall Study|AE due to other disease worsening|0|||
23481619|NCT00400153|65505251|FG000|Overall Study|AE due to other condition|3|||
23481620|NCT00400153|65505252|FG001|Overall Study|AE due to other condition|14|||
23481621|NCT00400153|65505253|FG002|Overall Study|AE due to other condition|15|||
23481622|NCT00400153|65505251|FG000|Overall Study|Protocol Violation|7|||
23481623|NCT00400153|65505252|FG001|Overall Study|Protocol Violation|4|||
23481624|NCT00400153|65505253|FG002|Overall Study|Protocol Violation|9|||
23481625|NCT00400153|65505251|FG000|Overall Study|Lost to Follow-up|2|||
23481626|NCT00400153|65505252|FG001|Overall Study|Lost to Follow-up|1|||
23481627|NCT00400153|65505253|FG002|Overall Study|Lost to Follow-up|4|||
23481628|NCT00400153|65505251|FG000|Overall Study|Withdrawal by Subject|12|||
23481629|NCT00400153|65505252|FG001|Overall Study|Withdrawal by Subject|11|||
23364314|NCT00103285|65081162|FG002|Response Assignment|Other|48|||
23481630|NCT00400153|65505253|FG002|Overall Study|Withdrawal by Subject|10|||
23481631|NCT00400153|65505251|FG000|Overall Study|Other reasons - not mentioned above|8|||
23481632|NCT00400153|65505252|FG001|Overall Study|Other reasons - not mentioned above|5|||
23481633|NCT00400153|65505253|FG002|Overall Study|Other reasons - not mentioned above|3|||
23481634|NCT01235598|65505255|FG000|Overall Study|Adverse Event|0|||
23481635|NCT01235598|65505256|FG001|Overall Study|Adverse Event|3|||
23481636|NCT01235598|65505255|FG000|Overall Study|Lack of Efficacy|0|||
23481637|NCT01235598|65505256|FG001|Overall Study|Lack of Efficacy|1|||
23481638|NCT01235598|65505255|FG000|Overall Study|Withdrawal by Subject|1|||
23481639|NCT01235598|65505256|FG001|Overall Study|Withdrawal by Subject|0|||
23481640|NCT02239120|65505257|FG000|Overall Study|Death|56|||
23481641|NCT02239120|65505258|FG001|Overall Study|Death|58|||
23481642|NCT02239120|65505257|FG000|Overall Study|Lost to Follow-up|19|||
23481643|NCT02239120|65505258|FG001|Overall Study|Lost to Follow-up|14|||
23481644|NCT01958827|65505259|FG000|Overall Study|Adverse Event|3|||
23481645|NCT01958827|65505259|FG000|Overall Study|Lack of Efficacy|6|||
23481646|NCT01958827|65505259|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
23481647|NCT02106923|65505260|FG000|Overall Study|Protocol Violation|0|||
23481648|NCT02106923|65505261|FG001|Overall Study|Protocol Violation|0|||
23481649|NCT02106923|65505262|FG002|Overall Study|Protocol Violation|0|||
23481650|NCT02106923|65505263|FG003|Overall Study|Protocol Violation|0|||
23481651|NCT02106923|65505264|FG004|Overall Study|Protocol Violation|0|||
23481652|NCT02106923|65505265|FG005|Overall Study|Protocol Violation|1|||
23481653|NCT01142089|65505266|FG000|Overall Study|Physician Decision|1|||
23481654|NCT01142089|65505267|FG001|Overall Study|Physician Decision|0|||
23481655|NCT01142089|65505266|FG000|Overall Study|Withdrawal by Subject|1|||
23481656|NCT01142089|65505267|FG001|Overall Study|Withdrawal by Subject|2|||
23481657|NCT01142089|65505266|FG000|Overall Study|Use of prohibited medications|0|||
23481658|NCT01142089|65505267|FG001|Overall Study|Use of prohibited medications|1|||
23481659|NCT01142089|65505266|FG000|Overall Study|Noncompliance with study procedures|2|||
23481660|NCT01142089|65505267|FG001|Overall Study|Noncompliance with study procedures|1|||
23481661|NCT01142089|65505266|FG000|Overall Study|Patient required rescue medication|8|||
23481662|NCT01142089|65505267|FG001|Overall Study|Patient required rescue medication|17|||
23481663|NCT02276027|65505268|FG000|Overall Study|Death|1|||
23481664|NCT02276027|65505269|FG001|Overall Study|Death|0|||
23481665|NCT02276027|65505270|FG002|Overall Study|Death|0|||
23481666|NCT02276027|65505271|FG003|Overall Study|Death|2|||
23481667|NCT02276027|65505268|FG000|Overall Study|Physician Decision|0|||
23481668|NCT02276027|65505269|FG001|Overall Study|Physician Decision|0|||
23601437|NCT01634165|65929948|FG001|Period 2|Adverse Event|1|||
23601438|NCT01634165|65929949|FG002|Period 2|Adverse Event|0|||
23601439|NCT01634165|65929950|FG003|Period 2|Adverse Event|0|||
23601440|NCT04250636|65929953|FG000|Overall Study|Lost to Follow-up|2|||
23601441|NCT01532999|65929954|FG000|Overall Study|Lost to Follow-up|14|||
23601442|NCT01532999|65929955|FG001|Overall Study|Lost to Follow-up|8|||
23601443|NCT01532999|65929954|FG000|Overall Study|Physician Decision|1|||
23601444|NCT01532999|65929955|FG001|Overall Study|Physician Decision|2|||
23601445|NCT01532999|65929954|FG000|Overall Study|Withdrawal by Subject|5|||
23601446|NCT01532999|65929955|FG001|Overall Study|Withdrawal by Subject|0|||
23601447|NCT01532999|65929954|FG000|Overall Study|Relocated|2|||
23601448|NCT01532999|65929955|FG001|Overall Study|Relocated|0|||
23601449|NCT01532999|65929954|FG000|Overall Study|should not have been randomized|1|||
23601450|NCT01532999|65929955|FG001|Overall Study|should not have been randomized|0|||
23601451|NCT01532999|65929954|FG000|Overall Study|substantial noncompliance|2|||
23601452|NCT01532999|65929955|FG001|Overall Study|substantial noncompliance|0|||
23601453|NCT01532999|65929954|FG000|Overall Study|no show for week 9 assessments|6|||
23601454|NCT01532999|65929955|FG001|Overall Study|no show for week 9 assessments|4|||
23601455|NCT01532999|65929954|FG000|Overall Study|Adverse Event|0|||
23601456|NCT01532999|65929955|FG001|Overall Study|Adverse Event|1|||
23601457|NCT01532999|65929954|FG000|Overall Study|incarcerated|0|||
23601458|NCT01532999|65929955|FG001|Overall Study|incarcerated|1|||
23601459|NCT01532999|65929954|FG000|Overall Study|New job|0|||
23601460|NCT01532999|65929955|FG001|Overall Study|New job|2|||
23601461|NCT00853580|65929958|FG000|Overall Study|Lost to Follow-up|3|||
23601462|NCT00853580|65929959|FG001|Overall Study|Lost to Follow-up|5|||
23601463|NCT00853580|65929958|FG000|Overall Study|Protocol Violation|2|||
23481669|NCT02276027|65505270|FG002|Overall Study|Physician Decision|0|||
23601464|NCT00853580|65929959|FG001|Overall Study|Protocol Violation|1|||
23601465|NCT00853580|65929958|FG000|Overall Study|Withdrawal by Subject|2|||
23601466|NCT00853580|65929959|FG001|Overall Study|Withdrawal by Subject|8|||
23267264|NCT01946165|64721737|FG001|Overall Study|Physician Decision|0|||
23481670|NCT02276027|65505271|FG003|Overall Study|Physician Decision|1|||
23481671|NCT02276027|65505268|FG000|Overall Study|Progressive disease|1|||
23481672|NCT02276027|65505269|FG001|Overall Study|Progressive disease|13|||
23481673|NCT02276027|65505270|FG002|Overall Study|Progressive disease|12|||
23481674|NCT02276027|65505271|FG003|Overall Study|Progressive disease|14|||
23481675|NCT02276027|65505268|FG000|Overall Study|Subject/guardian decision|0|||
23601467|NCT00853580|65929958|FG000|Overall Study|Commenced contraindicated therapy|0|||
23601468|NCT00853580|65929959|FG001|Overall Study|Commenced contraindicated therapy|2|||
23601469|NCT03739866|65929960|FG000|Overall Study|Lost to Follow-up|0|||
23601470|NCT03739866|65929961|FG001|Overall Study|Lost to Follow-up|0|||
23481676|NCT02276027|65505269|FG001|Overall Study|Subject/guardian decision|1|||
23481677|NCT02276027|65505270|FG002|Overall Study|Subject/guardian decision|0|||
23481678|NCT02276027|65505271|FG003|Overall Study|Subject/guardian decision|3|||
23481679|NCT02276027|65505268|FG000|Overall Study|Adverse Event|0|||
23481680|NCT02276027|65505269|FG001|Overall Study|Adverse Event|2|||
23481681|NCT02276027|65505270|FG002|Overall Study|Adverse Event|8|||
23481682|NCT02276027|65505271|FG003|Overall Study|Adverse Event|2|||
23481683|NCT00783302|65505273|FG000|Overall Study|Lost to Follow-up|17|||
23481684|NCT00783302|65505273|FG000|Overall Study|Technical Problems|11|||
23481685|NCT00783302|65505273|FG000|Overall Study|Protocol Violation|3|||
23481686|NCT00783302|65505273|FG000|Overall Study|Physician Decision|1|||
23481687|NCT00783302|65505273|FG000|Overall Study|Withdrawal by Subject|3|||
23481688|NCT00906971|65505274|FG000|Overall Study|Withdrawal by Subject|8|||
23481689|NCT00906971|65505275|FG001|Overall Study|Withdrawal by Subject|2|||
23481690|NCT00906971|65505274|FG000|Overall Study|Lost to Follow-up|0|||
23481691|NCT00906971|65505275|FG001|Overall Study|Lost to Follow-up|1|||
23481692|NCT03614975|65505276|FG000|Overall Study|Physician Decision|7|||
23481693|NCT03614975|65505277|FG001|Overall Study|Physician Decision|5|||
23481694|NCT03614975|65505276|FG000|Overall Study|Withdrawal by Subject|2|||
23481695|NCT03614975|65505277|FG001|Overall Study|Withdrawal by Subject|2|||
23481696|NCT03614975|65505276|FG000|Overall Study|Specimens not in lab batch shipment|1|||
23481697|NCT03614975|65505277|FG001|Overall Study|Specimens not in lab batch shipment|1|||
23481698|NCT02290431|65505278|FG000|Overall Study|Adverse Event|20|||
23481699|NCT02290431|65505278|FG000|Overall Study|Progressive disease|4|||
23481700|NCT02290431|65505278|FG000|Overall Study|Study terminated by Sponsor|1|||
23481701|NCT02290431|65505278|FG000|Overall Study|Physician Decision|2|||
23481702|NCT02108262|65505279|FG000|Overall Study|Non-compliance|0|||
23481703|NCT02108262|65505280|FG001|Overall Study|Non-compliance|2|||
23267265|NCT01946165|64721736|FG000|Overall Study|Withdrawal by Subject|0|||
23267266|NCT01946165|64721737|FG001|Overall Study|Withdrawal by Subject|2|||
23267267|NCT02428699|64721738|FG000|Washout Period 1|Screen Failure|1|||
23267268|NCT02428699|64721739|FG001|Washout Period 1|Screen Failure|2|||
23267269|NCT02114697|64721740|FG000|Overall Study|Study terminated|5|||
23267270|NCT02114697|64721741|FG001|Overall Study|Study terminated|4|||
23267271|NCT02277769|64721742|FG000|Overall Study|Protocol Violation|3|||
23267272|NCT02277769|64721743|FG001|Overall Study|Protocol Violation|3|||
23267273|NCT02277769|64721744|FG002|Overall Study|Protocol Violation|5|||
23267274|NCT02277769|64721742|FG000|Overall Study|Lack of Efficacy|17|||
23267275|NCT02277769|64721743|FG001|Overall Study|Lack of Efficacy|0|||
23267276|NCT02277769|64721744|FG002|Overall Study|Lack of Efficacy|4|||
23267277|NCT02277769|64721742|FG000|Overall Study|Adverse Event|14|||
23267278|NCT02277769|64721743|FG001|Overall Study|Adverse Event|2|||
23267279|NCT02277769|64721744|FG002|Overall Study|Adverse Event|4|||
23364315|NCT00103285|65081163|FG003|Response Assignment|Other|38|||
23364316|NCT00103285|65081164|FG004|Response Assignment|Other|37|||
23481704|NCT02108262|65505281|FG002|Overall Study|Non-compliance|1|||
23481705|NCT02108262|65505282|FG003|Overall Study|Non-compliance|1|||
23481706|NCT02108262|65505279|FG000|Overall Study|Randomized by error/screen failure|0|||
23481707|NCT02108262|65505280|FG001|Overall Study|Randomized by error/screen failure|0|||
23481708|NCT02108262|65505281|FG002|Overall Study|Randomized by error/screen failure|1|||
23481709|NCT02108262|65505282|FG003|Overall Study|Randomized by error/screen failure|0|||
23481710|NCT02108262|65505279|FG000|Overall Study|Distance to center|0|||
23481711|NCT02108262|65505280|FG001|Overall Study|Distance to center|1|||
23481712|NCT02108262|65505281|FG002|Overall Study|Distance to center|1|||
23481713|NCT02108262|65505282|FG003|Overall Study|Distance to center|0|||
23481714|NCT02108262|65505279|FG000|Overall Study|Adverse Event|0|||
23481715|NCT02108262|65505280|FG001|Overall Study|Adverse Event|11|||
23481716|NCT02108262|65505281|FG002|Overall Study|Adverse Event|6|||
23481717|NCT02108262|65505282|FG003|Overall Study|Adverse Event|12|||
23481718|NCT02108262|65505279|FG000|Overall Study|Death|0|||
23481719|NCT02108262|65505280|FG001|Overall Study|Death|2|||
23481720|NCT02108262|65505281|FG002|Overall Study|Death|2|||
23481721|NCT02108262|65505282|FG003|Overall Study|Death|1|||
23481722|NCT02108262|65505279|FG000|Overall Study|Lost to Follow-up|0|||
23481723|NCT02108262|65505280|FG001|Overall Study|Lost to Follow-up|0|||
23267280|NCT02277769|64721742|FG000|Overall Study|Other than specified above|12|||
23267281|NCT02277769|64721743|FG001|Overall Study|Other than specified above|8|||
23267282|NCT02277769|64721744|FG002|Overall Study|Other than specified above|5|||
23481724|NCT02108262|65505281|FG002|Overall Study|Lost to Follow-up|1|||
23481725|NCT02108262|65505282|FG003|Overall Study|Lost to Follow-up|0|||
23481726|NCT02108262|65505279|FG000|Overall Study|Physician Decision|0|||
23481727|NCT02108262|65505280|FG001|Overall Study|Physician Decision|0|||
23481728|NCT02108262|65505281|FG002|Overall Study|Physician Decision|2|||
23481729|NCT02108262|65505282|FG003|Overall Study|Physician Decision|0|||
23481730|NCT02108262|65505279|FG000|Overall Study|Withdrawal by Subject|0|||
23267283|NCT00090857|64721745|FG000|Overall Study|Lost to Follow-up|0|||
23481731|NCT02108262|65505280|FG001|Overall Study|Withdrawal by Subject|7|||
23481732|NCT02108262|65505281|FG002|Overall Study|Withdrawal by Subject|3|||
23481733|NCT02108262|65505282|FG003|Overall Study|Withdrawal by Subject|4|||
23481734|NCT02108262|65505279|FG000|Overall Study|Due to key hepatic values|0|||
23481735|NCT02108262|65505280|FG001|Overall Study|Due to key hepatic values|1|||
23481736|NCT02108262|65505281|FG002|Overall Study|Due to key hepatic values|0|||
23481737|NCT02108262|65505282|FG003|Overall Study|Due to key hepatic values|0|||
23481738|NCT02108262|65505279|FG000|Overall Study|Unable to contact patient|0|||
23481739|NCT02108262|65505280|FG001|Overall Study|Unable to contact patient|3|||
23267284|NCT00090857|64721746|FG001|Overall Study|Lost to Follow-up|1|||
23267285|NCT00090857|64721745|FG000|Overall Study|Withdrawal by Subject|2|||
23267286|NCT00090857|64721746|FG001|Overall Study|Withdrawal by Subject|0|||
23267287|NCT00090857|64721745|FG000|Overall Study|Adverse Event|2|||
23267288|NCT00090857|64721746|FG001|Overall Study|Adverse Event|2|||
23267289|NCT00462982|64721749|FG000|Overall Study|Adverse Event|1|||
23267290|NCT00462982|64721749|FG000|Overall Study|Patient Not Treated|2|||
23267291|NCT00491504|64721750|FG000|Overall Study|Adverse Event|0|||
23267292|NCT00491504|64721751|FG001|Overall Study|Adverse Event|1|||
23267293|NCT00491504|64721752|FG002|Overall Study|Adverse Event|0|||
23267294|NCT00491504|64721753|FG003|Overall Study|Adverse Event|0|||
23364317|NCT00103285|65081165|FG005|Response Assignment|Other|17|||
23364318|NCT00103285|65081166|FG006|Response Assignment|Other|11|||
23364319|NCT00103285|65081167|FG007|Response Assignment|Other|53|||
23364320|NCT01945944|65081170|FG000|Overall Study|Adverse Event|0|||
23481740|NCT02108262|65505281|FG002|Overall Study|Unable to contact patient|1|||
23481741|NCT02108262|65505282|FG003|Overall Study|Unable to contact patient|2|||
23481742|NCT02108262|65505279|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
23481743|NCT02108262|65505280|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
23481744|NCT02108262|65505281|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
23481745|NCT02108262|65505282|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
23481746|NCT02108262|65505279|FG000|Overall Study|Patient did not want another infusion|0|||
23481747|NCT02108262|65505280|FG001|Overall Study|Patient did not want another infusion|3|||
23481748|NCT02108262|65505281|FG002|Overall Study|Patient did not want another infusion|3|||
23481749|NCT02108262|65505282|FG003|Overall Study|Patient did not want another infusion|2|||
23481750|NCT02108262|65505279|FG000|Overall Study|Vacation|0|||
23481751|NCT02108262|65505280|FG001|Overall Study|Vacation|1|||
23481752|NCT02108262|65505281|FG002|Overall Study|Vacation|0|||
23481753|NCT02108262|65505282|FG003|Overall Study|Vacation|0|||
23481754|NCT02108262|65505279|FG000|Overall Study|Patient decision|0|||
23481755|NCT02108262|65505280|FG001|Overall Study|Patient decision|7|||
23481756|NCT02108262|65505281|FG002|Overall Study|Patient decision|9|||
23481757|NCT02108262|65505282|FG003|Overall Study|Patient decision|14|||
23481758|NCT02108262|65505279|FG000|Overall Study|Missed IV due to pharmacy error|0|||
23481759|NCT02108262|65505280|FG001|Overall Study|Missed IV due to pharmacy error|0|||
23481760|NCT02108262|65505281|FG002|Overall Study|Missed IV due to pharmacy error|1|||
23481761|NCT02108262|65505282|FG003|Overall Study|Missed IV due to pharmacy error|0|||
23481762|NCT02220998|65505285|FG000|Overall Study|Randomized but Never Treated|1|||
23481763|NCT02220998|65505286|FG001|Overall Study|Randomized but Never Treated|2|||
23481764|NCT02220998|65505285|FG000|Overall Study|Death|2|||
23481765|NCT02220998|65505286|FG001|Overall Study|Death|0|||
23481766|NCT02220998|65505285|FG000|Overall Study|Lack of Efficacy|0|||
23481767|NCT02220998|65505286|FG001|Overall Study|Lack of Efficacy|5|||
23481768|NCT02220998|65505285|FG000|Overall Study|Lost to Follow-up|4|||
23481769|NCT02220998|65505286|FG001|Overall Study|Lost to Follow-up|4|||
23481770|NCT01461057|65505294|FG000|Overall Study|Death|10|||
23481771|NCT01461057|65505295|FG001|Overall Study|Death|9|||
23481772|NCT01461057|65505294|FG000|Overall Study|Withdrawal by Subject|2|||
23481773|NCT01461057|65505295|FG001|Overall Study|Withdrawal by Subject|3|||
23481774|NCT01461057|65505294|FG000|Overall Study|Physician Decision|0|||
23481775|NCT01461057|65505295|FG001|Overall Study|Physician Decision|2|||
23481776|NCT01461057|65505294|FG000|Overall Study|Adverse Event|0|||
23481777|NCT01461057|65505295|FG001|Overall Study|Adverse Event|1|||
23481778|NCT01461057|65505294|FG000|Overall Study|Progression of Disease|1|||
23481779|NCT01461057|65505295|FG001|Overall Study|Progression of Disease|0|||
23481780|NCT01461057|65505294|FG000|Overall Study|Study Terminated by Sponsor|2|||
23481781|NCT01461057|65505295|FG001|Overall Study|Study Terminated by Sponsor|0|||
23481782|NCT02483533|65505300|FG000|Overall Study|Lack of Efficacy|50|||
23601471|NCT03739866|65929962|FG002|Overall Study|Lost to Follow-up|0|||
23267295|NCT00491504|64721750|FG000|Overall Study|Withdrawal by Subject|0|||
23267296|NCT00491504|64721751|FG001|Overall Study|Withdrawal by Subject|0|||
23481783|NCT02483533|65505301|FG001|Overall Study|Lack of Efficacy|50|||
23481784|NCT00869778|65505302|FG000|Overall Study|Adverse Event|2|||
23481785|NCT00869778|65505303|FG001|Overall Study|Adverse Event|0|||
23481786|NCT00869778|65505304|FG002|Overall Study|Adverse Event|0|||
23481787|NCT00869778|65505302|FG000|Overall Study|Withdrawal by Subject|3|||
23481788|NCT00869778|65505303|FG001|Overall Study|Withdrawal by Subject|4|||
23481789|NCT00869778|65505304|FG002|Overall Study|Withdrawal by Subject|5|||
23481790|NCT00869778|65505302|FG000|Overall Study|Pregnancy|1|||
23481791|NCT00869778|65505303|FG001|Overall Study|Pregnancy|0|||
23481792|NCT00869778|65505304|FG002|Overall Study|Pregnancy|0|||
23481793|NCT00869778|65505302|FG000|Overall Study|Protocol Violation|5|||
23481794|NCT00869778|65505303|FG001|Overall Study|Protocol Violation|3|||
23481795|NCT00869778|65505304|FG002|Overall Study|Protocol Violation|5|||
23481796|NCT00869778|65505302|FG000|Overall Study|Unblinding|1|||
23481797|NCT00869778|65505303|FG001|Overall Study|Unblinding|0|||
23481798|NCT00869778|65505304|FG002|Overall Study|Unblinding|0|||
23481799|NCT00570232|65505305|FG000|Overall Study|Adverse Event|10|||
23481800|NCT00570232|65505305|FG000|Overall Study|discontinued due to medical condition|3|||
23481801|NCT00570232|65505305|FG000|Overall Study|discontinued due to recurrence|8|||
23481802|NCT00570232|65505305|FG000|Overall Study|discontinued due to noncompliance|2|||
23481803|NCT03709576|65505310|FG000|Overall Study|progression prior to enrollment|1|||
23481804|NCT00816023|65505320|FG000|Overall Study|Lost to Follow-up|1|||
23481805|NCT00816023|65505321|FG001|Overall Study|Lost to Follow-up|1|||
23481806|NCT00816023|65505322|FG002|Overall Study|Lost to Follow-up|0|||
23481807|NCT00816023|65505323|FG003|Overall Study|Lost to Follow-up|0|||
23481808|NCT00816023|65505320|FG000|Overall Study|Withdrawal by Subject|1|||
23481809|NCT00816023|65505321|FG001|Overall Study|Withdrawal by Subject|0|||
23481810|NCT00816023|65505322|FG002|Overall Study|Withdrawal by Subject|0|||
23481811|NCT00816023|65505323|FG003|Overall Study|Withdrawal by Subject|0|||
23481812|NCT00816023|65505320|FG000|Overall Study|Physician Decision|0|||
23481813|NCT00816023|65505321|FG001|Overall Study|Physician Decision|0|||
23481814|NCT00816023|65505322|FG002|Overall Study|Physician Decision|1|||
23481815|NCT00816023|65505323|FG003|Overall Study|Physician Decision|0|||
23481816|NCT00816023|65505320|FG000|Overall Study|assessments complete prior to window|1|||
23481817|NCT00816023|65505321|FG001|Overall Study|assessments complete prior to window|1|||
23481818|NCT00816023|65505322|FG002|Overall Study|assessments complete prior to window|2|||
23267297|NCT00491504|64721752|FG002|Overall Study|Withdrawal by Subject|1|||
23267298|NCT00491504|64721753|FG003|Overall Study|Withdrawal by Subject|2|||
23267299|NCT00491504|64721750|FG000|Overall Study|Protocol Violation|0|||
23267300|NCT00491504|64721751|FG001|Overall Study|Protocol Violation|0|||
23267301|NCT00491504|64721752|FG002|Overall Study|Protocol Violation|3|||
23267302|NCT00491504|64721753|FG003|Overall Study|Protocol Violation|2|||
23267303|NCT00472290|64721755|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
23267304|NCT00472290|64721755|FG000|Overall Study|Protocol Specified Criteria|7|||
23267305|NCT00472290|64721755|FG000|Overall Study|Administrative Decision|37|||
23481819|NCT00816023|65505323|FG003|Overall Study|assessments complete prior to window|1|||
23267306|NCT00472290|64721755|FG000|Overall Study|Death|3|||
23267307|NCT00472290|64721755|FG000|Overall Study|Lost to Follow-up|1|||
23267308|NCT00472290|64721755|FG000|Overall Study|Lack of Efficacy|1|||
23267309|NCT00472290|64721755|FG000|Overall Study|Disease Progression|4|||
23267310|NCT00472290|64721755|FG000|Overall Study|Withdrawal by Subject|5|||
23267311|NCT00472290|64721755|FG000|Overall Study|Adverse Event|6|||
23267312|NCT00472290|64721755|FG000|Overall Study|Requirement for alternative therapy|7|||
23267313|NCT03708211|64721756|FG000|Overall Study|Progressive Disease|10|||
23267314|NCT03708211|64721757|FG001|Overall Study|Progressive Disease|7|||
23267315|NCT03708211|64721756|FG000|Overall Study|Withdrawal by Subject|0|||
23267316|NCT03708211|64721757|FG001|Overall Study|Withdrawal by Subject|1|||
23267317|NCT03708211|64721756|FG000|Overall Study|Other|2|||
23267318|NCT03708211|64721757|FG001|Overall Study|Other|0|||
23267319|NCT02070744|64721759|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
23267320|NCT02070744|64721760|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
23267321|NCT02070744|64721761|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
23267322|NCT02070744|64721762|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
23267323|NCT02070744|64721763|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
23267324|NCT02070744|64721759|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
23481820|NCT00816023|65505320|FG000|Overall Study|Randomized Not Treated|6|||
23601472|NCT03739866|65929963|FG003|Overall Study|Lost to Follow-up|1|||
23267325|NCT02070744|64721760|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
23267326|NCT02070744|64721761|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
23267327|NCT02070744|64721762|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
23267328|NCT02070744|64721763|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
23267329|NCT02070744|64721759|FG000|OLE Phase (48 Weeks)|Other|0|||
23267330|NCT02070744|64721760|FG001|OLE Phase (48 Weeks)|Other|0|||
23267331|NCT02070744|64721761|FG002|OLE Phase (48 Weeks)|Other|0|||
23267332|NCT02070744|64721762|FG003|OLE Phase (48 Weeks)|Other|0|||
23267333|NCT02070744|64721763|FG004|OLE Phase (48 Weeks)|Other|1|||
23481821|NCT00816023|65505321|FG001|Overall Study|Randomized Not Treated|4|||
23481822|NCT00816023|65505322|FG002|Overall Study|Randomized Not Treated|6|||
23481823|NCT00816023|65505323|FG003|Overall Study|Randomized Not Treated|11|||
23481824|NCT04590248|65505324|FG000|Overall Study|Lost to Follow-up|1|||
23481825|NCT04590248|65505324|FG000|Overall Study|Withdrawal by Subject|16|||
23481826|NCT04590248|65505324|FG000|Overall Study|Other|2|||
23267334|NCT00812253|64721764|FG000|Overall Study|Withdrawal by Subject|3|||
23267335|NCT00812253|64721765|FG001|Overall Study|Withdrawal by Subject|2|||
23267336|NCT00812253|64721764|FG000|Overall Study|Protocol Violation|1|||
23267337|NCT00812253|64721765|FG001|Overall Study|Protocol Violation|1|||
23267338|NCT00812253|64721764|FG000|Overall Study|Lost to Follow-up|2|||
23267339|NCT00812253|64721765|FG001|Overall Study|Lost to Follow-up|0|||
23267340|NCT00429364|64721766|FG000|Overall Study|Withdrawal by Subject|11|||
23267341|NCT00429364|64721767|FG001|Overall Study|Withdrawal by Subject|5|||
23267342|NCT00429364|64721766|FG000|Overall Study|Physician Decision|4|||
23267343|NCT00429364|64721767|FG001|Overall Study|Physician Decision|2|||
23267344|NCT00429364|64721766|FG000|Overall Study|Lost to Follow-up|7|||
23267345|NCT00429364|64721767|FG001|Overall Study|Lost to Follow-up|6|||
23267346|NCT00429364|64721766|FG000|Overall Study|Death|0|||
23267347|NCT00429364|64721767|FG001|Overall Study|Death|1|||
23267348|NCT00429364|64721766|FG000|Overall Study|Underwent aortic root surgery|10|||
23267349|NCT00429364|64721767|FG001|Overall Study|Underwent aortic root surgery|18|||
23267350|NCT00429364|64721766|FG000|Overall Study|Pregnancy|0|||
23267351|NCT00429364|64721767|FG001|Overall Study|Pregnancy|1|||
23267352|NCT03295721|64721768|FG000|Overall Study|Adverse Event|1|||
23267353|NCT03295721|64721769|FG001|Overall Study|Adverse Event|0|||
23267354|NCT03295721|64721770|FG002|Overall Study|Adverse Event|0|||
23267355|NCT03295721|64721768|FG000|Overall Study|Lost to Follow-up|1|||
23267356|NCT03295721|64721769|FG001|Overall Study|Lost to Follow-up|1|||
23267357|NCT03295721|64721770|FG002|Overall Study|Lost to Follow-up|1|||
23267358|NCT03295721|64721768|FG000|Overall Study|Withdrawal by Subject|1|||
23267359|NCT03295721|64721769|FG001|Overall Study|Withdrawal by Subject|0|||
23267360|NCT03295721|64721770|FG002|Overall Study|Withdrawal by Subject|1|||
23267361|NCT03295721|64721768|FG000|Overall Study|Death|0|||
23267362|NCT03295721|64721769|FG001|Overall Study|Death|0|||
23267363|NCT03295721|64721770|FG002|Overall Study|Death|1|||
23267364|NCT01440283|64721778|FG000|Overall Study|Death|3|||
23267365|NCT01440283|64721778|FG000|Overall Study|Withdrawal by Subject|4|||
23267366|NCT01440283|64721778|FG000|Overall Study|Physician Decision|3|||
23267367|NCT00948675|64721779|FG000|Overall Study|Lost to Follow-up|1|||
23267368|NCT00948675|64721780|FG001|Overall Study|Lost to Follow-up|0|||
23267369|NCT02152566|64721781|FG000|Overall Study|Lost to Follow-up|1|||
23267370|NCT02152566|64721781|FG000|Overall Study|Withdrawal by Subject|2|||
23267371|NCT01644500|64721786|FG000|Overall Study|Adverse Event|6|||
23267372|NCT01644500|64721787|FG001|Overall Study|Adverse Event|1|||
23267373|NCT01644500|64721788|FG002|Overall Study|Adverse Event|2|||
23267374|NCT01644500|64721786|FG000|Overall Study|Death|0|||
23267375|NCT01644500|64721787|FG001|Overall Study|Death|1|||
23267376|NCT01644500|64721788|FG002|Overall Study|Death|0|||
23267377|NCT01644500|64721786|FG000|Overall Study|Lost to Follow-up|3|||
23267378|NCT01644500|64721787|FG001|Overall Study|Lost to Follow-up|8|||
23267379|NCT01644500|64721788|FG002|Overall Study|Lost to Follow-up|0|||
23267380|NCT01644500|64721786|FG000|Overall Study|Protocol Violation|1|||
23267381|NCT01644500|64721787|FG001|Overall Study|Protocol Violation|1|||
23267382|NCT01644500|64721788|FG002|Overall Study|Protocol Violation|0|||
23267383|NCT01644500|64721786|FG000|Overall Study|Withdrawal by Subject|11|||
23267384|NCT01644500|64721787|FG001|Overall Study|Withdrawal by Subject|12|||
23267385|NCT01644500|64721788|FG002|Overall Study|Withdrawal by Subject|12|||
23267386|NCT01644500|64721786|FG000|Overall Study|Physician Decision|1|||
23267387|NCT01644500|64721787|FG001|Overall Study|Physician Decision|1|||
23267388|NCT01644500|64721788|FG002|Overall Study|Physician Decision|1|||
23267389|NCT00841100|64721789|FG000|Phase 1 (28 Days)|Adverse Event|1|||
23267390|NCT00841100|64721789|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
23267391|NCT03679741|64721790|FG000|Period 1|No longer meet eligibility criteria|1|||
23267392|NCT03679741|64721791|FG001|Period 1|No longer meet eligibility criteria|0|||
23267393|NCT03679741|64721790|FG000|Period 1|Lost to Follow-up|0|||
23267394|NCT03679741|64721791|FG001|Period 1|Lost to Follow-up|1|||
23267395|NCT03679741|64721790|FG000|Period 1|Adverse Event|1|||
23267396|NCT03679741|64721791|FG001|Period 1|Adverse Event|1|||
23267397|NCT03679741|64721790|FG000|Period 1|Withdrawal by Subject|0|||
23267398|NCT03679741|64721791|FG001|Period 1|Withdrawal by Subject|1|||
23267399|NCT03679741|64721790|FG000|Period 2|Adverse Event|2|||
23267400|NCT03679741|64721791|FG001|Period 2|Adverse Event|1|||
23267401|NCT03679741|64721790|FG000|Period 2|Withdrawal by Subject|1|||
23267402|NCT03679741|64721791|FG001|Period 2|Withdrawal by Subject|1|||
23267403|NCT00048048|64721792|FG000|Core Treatment|Withdrawal by Subject|0|||
23267404|NCT00048048|64721793|FG001|Core Treatment|Withdrawal by Subject|0|||
23267405|NCT00048048|64721794|FG002|Core Treatment|Withdrawal by Subject|1|||
23267406|NCT00048048|64721795|FG003|Core Treatment|Withdrawal by Subject|0|||
23267407|NCT00048048|64721796|FG004|Core Treatment|Withdrawal by Subject|0|||
23267408|NCT00048048|64721797|FG005|Core Treatment|Withdrawal by Subject|0|||
23267409|NCT00048048|64721798|FG006|Core Treatment|Withdrawal by Subject|0|||
23267410|NCT00048048|64721799|FG007|Core Treatment|Withdrawal by Subject|0|||
23267411|NCT00048048|64721800|FG008|Core Treatment|Withdrawal by Subject|0|||
23267412|NCT00048048|64721801|FG009|Core Treatment|Withdrawal by Subject|0|||
23267413|NCT00048048|64721802|FG010|Core Treatment|Withdrawal by Subject|0|||
23481827|NCT00424255|65505327|FG000|Overall Study|Death|115|||
23481828|NCT00424255|65505328|FG001|Overall Study|Death|111|||
23481829|NCT00424255|65505327|FG000|Overall Study|Lost to Follow-up|26|||
23481830|NCT00424255|65505328|FG001|Overall Study|Lost to Follow-up|20|||
23481831|NCT00424255|65505327|FG000|Overall Study|Protocol Violation|0|||
23481832|NCT00424255|65505328|FG001|Overall Study|Protocol Violation|1|||
23481833|NCT00424255|65505327|FG000|Overall Study|Withdrawal by Subject|34|||
23481834|NCT00424255|65505328|FG001|Overall Study|Withdrawal by Subject|38|||
23481835|NCT00424255|65505327|FG000|Overall Study|Physician Decision|3|||
23481836|NCT00424255|65505328|FG001|Overall Study|Physician Decision|7|||
23481837|NCT00424255|65505327|FG000|Overall Study|Cognitive Disturbance|1|||
23481838|NCT00424255|65505328|FG001|Overall Study|Cognitive Disturbance|0|||
23481839|NCT00424255|65505327|FG000|Overall Study|Non-compliance by Participants|1|||
23481840|NCT00424255|65505328|FG001|Overall Study|Non-compliance by Participants|0|||
23481841|NCT00424255|65505327|FG000|Overall Study|Fatigue|1|||
23481842|NCT00424255|65505328|FG001|Overall Study|Fatigue|0|||
23481843|NCT00424255|65505327|FG000|Overall Study|Disease Progression|0|||
23481844|NCT00424255|65505328|FG001|Overall Study|Disease Progression|2|||
23481845|NCT00424255|65505327|FG000|Overall Study|Sponsor Terminated Study|161|||
23481846|NCT00424255|65505328|FG001|Overall Study|Sponsor Terminated Study|167|||
23481847|NCT01576159|65505329|FG000|Overall Study|Withdrawal by Subject|0|||
23481848|NCT01576159|65505330|FG001|Overall Study|Withdrawal by Subject|1|||
23481849|NCT01576159|65505331|FG002|Overall Study|Withdrawal by Subject|0|||
23481850|NCT01576159|65505332|FG003|Overall Study|Withdrawal by Subject|0|||
23481851|NCT01576159|65505329|FG000|Overall Study|Physician Decision|0|||
23481852|NCT01576159|65505330|FG001|Overall Study|Physician Decision|0|||
23481853|NCT01576159|65505331|FG002|Overall Study|Physician Decision|1|||
23481854|NCT01576159|65505332|FG003|Overall Study|Physician Decision|0|||
23481855|NCT01576159|65505329|FG000|Overall Study|Lost to Follow-up|0|||
23481856|NCT01576159|65505330|FG001|Overall Study|Lost to Follow-up|0|||
23481857|NCT01576159|65505331|FG002|Overall Study|Lost to Follow-up|0|||
23481858|NCT01576159|65505332|FG003|Overall Study|Lost to Follow-up|1|||
23481859|NCT01576159|65505329|FG000|Overall Study|Protocol Violation|1|||
23267414|NCT00048048|64721803|FG011|Core Treatment|Withdrawal by Subject|0|||
23267415|NCT00048048|64721792|FG000|Core Treatment|Adverse Event|0|||
23481860|NCT01576159|65505330|FG001|Overall Study|Protocol Violation|0|||
23481861|NCT01576159|65505331|FG002|Overall Study|Protocol Violation|0|||
23481862|NCT01576159|65505332|FG003|Overall Study|Protocol Violation|0|||
23481863|NCT04559529|65505337|FG000|First Intervention (1 Day)|Adverse Event|0|||
23481864|NCT04559529|65505338|FG001|First Intervention (1 Day)|Adverse Event|0|||
23481865|NCT04559529|65505339|FG002|First Intervention (1 Day)|Adverse Event|0|||
23481866|NCT04559529|65505340|FG003|First Intervention (1 Day)|Adverse Event|1|||
23481867|NCT04559529|65505337|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
23481868|NCT04559529|65505338|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
23481869|NCT04559529|65505339|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
23481870|NCT04559529|65505340|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
23481871|NCT04559529|65505337|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
23481872|NCT04559529|65505338|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
23481873|NCT04559529|65505339|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
23481874|NCT04559529|65505340|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
23481875|NCT01244490|65505341|FG000|Overall Study|Lack of Efficacy|14|||
23481876|NCT01244490|65505342|FG001|Overall Study|Lack of Efficacy|5|||
23481877|NCT01244490|65505343|FG002|Overall Study|Lack of Efficacy|5|||
23481878|NCT01244490|65505341|FG000|Overall Study|Withdrawal by Subject|4|||
23481879|NCT01244490|65505342|FG001|Overall Study|Withdrawal by Subject|4|||
23481880|NCT01244490|65505343|FG002|Overall Study|Withdrawal by Subject|9|||
23481881|NCT01244490|65505341|FG000|Overall Study|Adverse Event|1|||
23481882|NCT01244490|65505342|FG001|Overall Study|Adverse Event|9|||
23481883|NCT01244490|65505343|FG002|Overall Study|Adverse Event|5|||
23481884|NCT01244490|65505341|FG000|Overall Study|Lost to Follow-up|0|||
23481885|NCT01244490|65505342|FG001|Overall Study|Lost to Follow-up|6|||
23481886|NCT01244490|65505343|FG002|Overall Study|Lost to Follow-up|3|||
23481887|NCT01244490|65505341|FG000|Overall Study|Other|0|||
23481888|NCT01244490|65505342|FG001|Overall Study|Other|0|||
23481889|NCT01244490|65505343|FG002|Overall Study|Other|1|||
23481890|NCT01487577|65505344|FG000|Overall Study|Became ineligible after signing consent|1|||
23481891|NCT02380690|65505345|FG000|Overall Study|Lost to Follow-up|14|||
23481892|NCT02380690|65505346|FG001|Overall Study|Lost to Follow-up|4|||
23481893|NCT02380690|65505345|FG000|Overall Study|Withdrawal by Subject|20|||
23267416|NCT00048048|64721793|FG001|Core Treatment|Adverse Event|0|||
23481894|NCT02380690|65505346|FG001|Overall Study|Withdrawal by Subject|8|||
23481895|NCT05463198|65505350|FG000|Overall Study|Withdrawal by Subject|19|||
23481896|NCT05463198|65505350|FG000|Overall Study|Procedure Notes Missing|18|||
23481897|NCT01133990|65509312|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
23481898|NCT01133990|65509313|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23481899|NCT01133990|65509314|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23481900|NCT01133990|65509315|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23267417|NCT00048048|64721794|FG002|Core Treatment|Adverse Event|0|||
23267418|NCT00048048|64721795|FG003|Core Treatment|Adverse Event|0|||
23267419|NCT00048048|64721796|FG004|Core Treatment|Adverse Event|0|||
23267420|NCT00048048|64721797|FG005|Core Treatment|Adverse Event|0|||
23267421|NCT00048048|64721798|FG006|Core Treatment|Adverse Event|0|||
23267422|NCT00048048|64721799|FG007|Core Treatment|Adverse Event|1|||
23267423|NCT00048048|64721800|FG008|Core Treatment|Adverse Event|0|||
23267424|NCT00048048|64721801|FG009|Core Treatment|Adverse Event|0|||
23267425|NCT00048048|64721802|FG010|Core Treatment|Adverse Event|0|||
23267426|NCT00048048|64721803|FG011|Core Treatment|Adverse Event|0|||
23267427|NCT00048048|64721792|FG000|Extension Year 1|Early withdrawals|0|||
23267428|NCT00048048|64721793|FG001|Extension Year 1|Early withdrawals|0|||
23267429|NCT00048048|64721794|FG002|Extension Year 1|Early withdrawals|0|||
23267430|NCT00048048|64721795|FG003|Extension Year 1|Early withdrawals|0|||
23267431|NCT00048048|64721796|FG004|Extension Year 1|Early withdrawals|0|||
23267432|NCT00048048|64721797|FG005|Extension Year 1|Early withdrawals|0|||
23267433|NCT00048048|64721798|FG006|Extension Year 1|Early withdrawals|0|||
23267434|NCT00048048|64721799|FG007|Extension Year 1|Early withdrawals|0|||
23267435|NCT00048048|64721800|FG008|Extension Year 1|Early withdrawals|0|||
23267436|NCT00048048|64721801|FG009|Extension Year 1|Early withdrawals|2|||
23267437|NCT00048048|64721802|FG010|Extension Year 1|Early withdrawals|2|||
23267438|NCT00048048|64721803|FG011|Extension Year 1|Early withdrawals|4|||
23267439|NCT00048048|64721792|FG000|Extension Year 2|Early withdrawals|0|||
23267440|NCT00048048|64721793|FG001|Extension Year 2|Early withdrawals|0|||
23267441|NCT00048048|64721794|FG002|Extension Year 2|Early withdrawals|0|||
23267442|NCT00048048|64721795|FG003|Extension Year 2|Early withdrawals|0|||
23267443|NCT00048048|64721796|FG004|Extension Year 2|Early withdrawals|0|||
23267444|NCT00048048|64721797|FG005|Extension Year 2|Early withdrawals|0|||
23267445|NCT00048048|64721798|FG006|Extension Year 2|Early withdrawals|0|||
23267446|NCT00048048|64721799|FG007|Extension Year 2|Early withdrawals|0|||
23267447|NCT00048048|64721800|FG008|Extension Year 2|Early withdrawals|0|||
23267448|NCT00048048|64721801|FG009|Extension Year 2|Early withdrawals|0|||
23267449|NCT00048048|64721802|FG010|Extension Year 2|Early withdrawals|4|||
23267450|NCT00048048|64721803|FG011|Extension Year 2|Early withdrawals|2|||
23267451|NCT00048568|64721804|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
23267452|NCT00048568|64721805|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
23267453|NCT00048568|64721806|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
23267454|NCT00048568|64721804|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
23267455|NCT00048568|64721805|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
23267456|NCT00048568|64721806|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
23267457|NCT00048568|64721804|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
23267458|NCT00048568|64721805|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
23267459|NCT00048568|64721806|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
23267460|NCT00048568|64721804|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
23267461|NCT00048568|64721805|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
23267462|NCT00048568|64721806|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
23267463|NCT00048568|64721804|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
23267464|NCT00048568|64721805|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
23267465|NCT00048568|64721806|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
23267466|NCT00048568|64721804|FG000|Double-Blind Period Days 170 to 365|Death|1|||
23267467|NCT00048568|64721805|FG001|Double-Blind Period Days 170 to 365|Death|1|||
23267468|NCT00048568|64721806|FG002|Double-Blind Period Days 170 to 365|Death|0|||
23267469|NCT00048568|64721804|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
23267470|NCT00048568|64721805|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
23267471|NCT00048568|64721806|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
23267472|NCT00048568|64721804|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
23267473|NCT00048568|64721805|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
23267474|NCT00048568|64721806|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
23267475|NCT00048568|64721804|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
23267476|NCT00048568|64721805|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
23267477|NCT00048568|64721806|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
23267478|NCT00048568|64721804|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
23267479|NCT00048568|64721805|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
23267480|NCT00048568|64721806|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
23267481|NCT00048568|64721804|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
23267482|NCT00048568|64721805|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
23267483|NCT00048568|64721806|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
23364321|NCT01945944|65081171|FG001|Overall Study|Adverse Event|2|||
23267484|NCT00048568|64721804|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
23267485|NCT00048568|64721805|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
23267486|NCT00048568|64721806|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
23267487|NCT00048568|64721804|FG000|Open-Label Period|Death|0|||
23267488|NCT00048568|64721805|FG001|Open-Label Period|Death|0|||
23267489|NCT00048568|64721806|FG002|Open-Label Period|Death|13|||
23267490|NCT00048568|64721804|FG000|Open-Label Period|Adverse Event|0|||
23267491|NCT00048568|64721805|FG001|Open-Label Period|Adverse Event|0|||
23267492|NCT00048568|64721806|FG002|Open-Label Period|Adverse Event|49|||
23267493|NCT00048568|64721804|FG000|Open-Label Period|Lack of Efficacy|0|||
23267494|NCT00048568|64721805|FG001|Open-Label Period|Lack of Efficacy|0|||
23267495|NCT00048568|64721806|FG002|Open-Label Period|Lack of Efficacy|32|||
23267496|NCT00048568|64721804|FG000|Open-Label Period|Withdrawal by Subject|0|||
23267497|NCT00048568|64721805|FG001|Open-Label Period|Withdrawal by Subject|0|||
23267498|NCT00048568|64721806|FG002|Open-Label Period|Withdrawal by Subject|26|||
23267499|NCT00048568|64721804|FG000|Open-Label Period|Pregnancy|0|||
23481901|NCT01133990|65509316|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23481902|NCT01133990|65509317|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
23481903|NCT01133990|65509312|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
23481904|NCT01133990|65509313|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481905|NCT01133990|65509314|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481906|NCT01133990|65509315|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481907|NCT01133990|65509316|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481908|NCT01133990|65509317|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
23481909|NCT01133990|65509312|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
23481910|NCT01133990|65509313|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481911|NCT01133990|65509314|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481912|NCT01133990|65509315|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481913|NCT01133990|65509316|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481914|NCT01133990|65509317|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
23481915|NCT01133990|65509312|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
23481916|NCT01133990|65509313|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481917|NCT01133990|65509314|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481918|NCT01133990|65509315|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481919|NCT01133990|65509316|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481920|NCT01133990|65509317|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
23481921|NCT02946931|65509318|FG000|Overall Study|Did not require collection of CRFs|588|||
23481922|NCT02946931|65509318|FG000|Overall Study|Other than listed|37|||
23481923|NCT02946931|65509318|FG000|Overall Study|Discharge from hospital|118|||
23481924|NCT02946931|65509318|FG000|Overall Study|Adverse Event|81|||
23481925|NCT02946931|65509318|FG000|Overall Study|CRFs not valid|1|||
23481926|NCT02946931|65509318|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
23481927|NCT02915874|65509319|FG000|Overall Study|Lost to Follow-up|5|||
23481928|NCT02915874|65509320|FG001|Overall Study|Lost to Follow-up|4|||
23481929|NCT02915874|65509319|FG000|Overall Study|Withdrawal by Subject|1|||
23481930|NCT02915874|65509320|FG001|Overall Study|Withdrawal by Subject|1|||
23481931|NCT02915874|65509319|FG000|Overall Study|Started New Anxiety Medication|0|||
23481932|NCT02915874|65509320|FG001|Overall Study|Started New Anxiety Medication|1|||
23481939|NCT00251004|65509324|FG000|Overall Study|Withdrawal by Subject|23|||
23481940|NCT00251004|65509325|FG001|Overall Study|Withdrawal by Subject|16|||
23481941|NCT00251004|65509326|FG002|Overall Study|Withdrawal by Subject|14|||
23481942|NCT00251004|65509324|FG000|Overall Study|Death|9|||
23481943|NCT00251004|65509325|FG001|Overall Study|Death|10|||
23481944|NCT00251004|65509326|FG002|Overall Study|Death|8|||
23481945|NCT00251004|65509324|FG000|Overall Study|Lost to Follow-up|1|||
23481946|NCT00251004|65509325|FG001|Overall Study|Lost to Follow-up|2|||
23481947|NCT00251004|65509326|FG002|Overall Study|Lost to Follow-up|1|||
23481948|NCT00251004|65509324|FG000|Overall Study|Graft Loss|12|||
23481949|NCT00251004|65509325|FG001|Overall Study|Graft Loss|13|||
23481950|NCT00251004|65509326|FG002|Overall Study|Graft Loss|8|||
23481951|NCT00924781|65509327|FG000|Overall Study|Study terminated by sponsor|12|||
23481952|NCT00924781|65509328|FG001|Overall Study|Study terminated by sponsor|10|||
23267500|NCT00048568|64721805|FG001|Open-Label Period|Pregnancy|0|||
23267501|NCT00048568|64721806|FG002|Open-Label Period|Pregnancy|5|||
23267502|NCT00048568|64721804|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
23267503|NCT00048568|64721805|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
23364322|NCT01945944|65081170|FG000|Overall Study|Physician Decision|1|||
23267504|NCT00048568|64721806|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
23267505|NCT00048568|64721804|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
23267506|NCT00048568|64721805|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
23267507|NCT00048568|64721806|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
23267508|NCT00048568|64721804|FG000|Open-Label Period|Unknown Reasons|0|||
23267509|NCT00048568|64721805|FG001|Open-Label Period|Unknown Reasons|0|||
23267510|NCT00048568|64721806|FG002|Open-Label Period|Unknown Reasons|25|||
23267511|NCT00048568|64721804|FG000|Open-Label Period|Lost to Follow-up|0|||
23267512|NCT00048568|64721805|FG001|Open-Label Period|Lost to Follow-up|0|||
23267513|NCT00048568|64721806|FG002|Open-Label Period|Lost to Follow-up|7|||
23267514|NCT00454636|64721807|FG000|Overall Study|Adverse Event|10|||
23267515|NCT00454636|64721808|FG001|Overall Study|Adverse Event|6|||
23267516|NCT00454636|64721809|FG002|Overall Study|Adverse Event|9|||
23267517|NCT00454636|64721810|FG003|Overall Study|Adverse Event|15|||
23267518|NCT00454636|64721807|FG000|Overall Study|Disease Progression|11|||
23267519|NCT00454636|64721808|FG001|Overall Study|Disease Progression|12|||
23267520|NCT00454636|64721809|FG002|Overall Study|Disease Progression|4|||
23267521|NCT00454636|64721810|FG003|Overall Study|Disease Progression|11|||
23267522|NCT00454636|64721807|FG000|Overall Study|Protocol Violation|3|||
23267523|NCT00454636|64721808|FG001|Overall Study|Protocol Violation|2|||
23267524|NCT00454636|64721809|FG002|Overall Study|Protocol Violation|3|||
23267525|NCT00454636|64721810|FG003|Overall Study|Protocol Violation|3|||
23267526|NCT00454636|64721807|FG000|Overall Study|Death|6|||
23267527|NCT00454636|64721808|FG001|Overall Study|Death|1|||
23267528|NCT00454636|64721809|FG002|Overall Study|Death|1|||
23267529|NCT00454636|64721810|FG003|Overall Study|Death|1|||
23267530|NCT00454636|64721807|FG000|Overall Study|Patient refusal|1|||
23267531|NCT00454636|64721808|FG001|Overall Study|Patient refusal|1|||
23267532|NCT00454636|64721809|FG002|Overall Study|Patient refusal|3|||
23267533|NCT00454636|64721810|FG003|Overall Study|Patient refusal|2|||
23267534|NCT00454636|64721807|FG000|Overall Study|Lost to Follow-up|0|||
23267535|NCT00454636|64721808|FG001|Overall Study|Lost to Follow-up|1|||
23267536|NCT00454636|64721809|FG002|Overall Study|Lost to Follow-up|0|||
23267537|NCT00454636|64721810|FG003|Overall Study|Lost to Follow-up|0|||
23267538|NCT03552757|64721813|FG000|Overall Study|Withdrawal by Subject|10|||
23267539|NCT03552757|64721814|FG001|Overall Study|Withdrawal by Subject|5|||
23267540|NCT03552757|64721815|FG002|Overall Study|Withdrawal by Subject|12|||
23267541|NCT03552757|64721813|FG000|Overall Study|Lost to Follow-up|2|||
23267542|NCT03552757|64721814|FG001|Overall Study|Lost to Follow-up|7|||
23267543|NCT03552757|64721815|FG002|Overall Study|Lost to Follow-up|7|||
23267544|NCT03552757|64721813|FG000|Overall Study|Death|1|||
23267545|NCT03552757|64721814|FG001|Overall Study|Death|1|||
23267546|NCT03552757|64721815|FG002|Overall Study|Death|1|||
23267547|NCT02928848|64721818|FG000|Arm 2|Withdrawal by Subject|1|||
23267548|NCT02928848|64721819|FG001|Arm 2|Withdrawal by Subject|0|||
23267549|NCT02388763|64721823|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
23267550|NCT02388763|64721824|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
23267551|NCT02388763|64721823|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
23267552|NCT02388763|64721824|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
23267553|NCT01856309|64721825|FG000|Overall Study|Death|4|||
23267554|NCT01856309|64721826|FG001|Overall Study|Death|6|||
23267555|NCT01856309|64721827|FG002|Overall Study|Death|11|||
23267556|NCT01856309|64721828|FG003|Overall Study|Death|6|||
23267557|NCT01856309|64721825|FG000|Overall Study|Lost to Follow-up|6|||
23267558|NCT01856309|64721826|FG001|Overall Study|Lost to Follow-up|2|||
23267559|NCT01856309|64721827|FG002|Overall Study|Lost to Follow-up|4|||
23267560|NCT01856309|64721828|FG003|Overall Study|Lost to Follow-up|8|||
23267561|NCT01856309|64721825|FG000|Overall Study|Withdrawal by Subject|11|||
23267562|NCT01856309|64721826|FG001|Overall Study|Withdrawal by Subject|13|||
23267563|NCT01856309|64721827|FG002|Overall Study|Withdrawal by Subject|28|||
23267564|NCT01856309|64721828|FG003|Overall Study|Withdrawal by Subject|26|||
23267565|NCT01856309|64721825|FG000|Overall Study|Other|227|||
23267566|NCT01856309|64721826|FG001|Overall Study|Other|225|||
23267567|NCT01856309|64721827|FG002|Overall Study|Other|447|||
23267568|NCT01856309|64721828|FG003|Overall Study|Other|469|||
23267569|NCT01856309|64721825|FG000|Overall Study|Lack of Efficacy|14|||
23267570|NCT01856309|64721826|FG001|Overall Study|Lack of Efficacy|9|||
23267571|NCT01856309|64721827|FG002|Overall Study|Lack of Efficacy|40|||
23267572|NCT01856309|64721828|FG003|Overall Study|Lack of Efficacy|25|||
23267573|NCT01856309|64721825|FG000|Overall Study|Adverse Event|31|||
23267574|NCT01856309|64721826|FG001|Overall Study|Adverse Event|31|||
23267575|NCT01856309|64721827|FG002|Overall Study|Adverse Event|55|||
23267576|NCT01856309|64721828|FG003|Overall Study|Adverse Event|65|||
23267577|NCT01856309|64721825|FG000|Overall Study|Pregnancy|0|||
23267578|NCT01856309|64721826|FG001|Overall Study|Pregnancy|0|||
23267579|NCT01856309|64721827|FG002|Overall Study|Pregnancy|0|||
23267580|NCT01856309|64721828|FG003|Overall Study|Pregnancy|1|||
23267581|NCT01856309|64721825|FG000|Overall Study|Physician Decision|6|||
23267582|NCT01856309|64721826|FG001|Overall Study|Physician Decision|1|||
23267583|NCT01856309|64721827|FG002|Overall Study|Physician Decision|6|||
23267584|NCT01856309|64721828|FG003|Overall Study|Physician Decision|8|||
23267585|NCT01856309|64721825|FG000|Overall Study|Noncompliance With Study Drug|0|||
23364323|NCT01945944|65081171|FG001|Overall Study|Physician Decision|0|||
23364324|NCT01945944|65081170|FG000|Overall Study|Withdrawal by Subject|0|||
23364325|NCT01945944|65081171|FG001|Overall Study|Withdrawal by Subject|1|||
23364326|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364327|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
23364328|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
23364329|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364330|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364331|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364332|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364333|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364334|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364335|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364336|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364337|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364338|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364339|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364340|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
23364341|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
23364342|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
23364343|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364344|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364345|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364346|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364347|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364348|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364349|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364350|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364351|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364352|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364353|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364354|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364355|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
23364356|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
23364357|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
23364358|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
23364359|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364360|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364361|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364362|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364363|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364364|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364365|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364366|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364367|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364368|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364369|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364370|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
23364371|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364372|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364373|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
23364374|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364375|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364376|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364377|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23267586|NCT01856309|64721826|FG001|Overall Study|Noncompliance With Study Drug|1|||
23267587|NCT01856309|64721827|FG002|Overall Study|Noncompliance With Study Drug|4|||
23267588|NCT01856309|64721828|FG003|Overall Study|Noncompliance With Study Drug|1|||
23267589|NCT03717064|64721835|FG000|Period 2|Adverse Event|1|||
23267590|NCT00555009|64721836|FG000|Overall Study|Withdrawal by Subject|0|||
23267591|NCT00555009|64721837|FG001|Overall Study|Withdrawal by Subject|1|||
23267592|NCT00555009|64721836|FG000|Overall Study|Terminated by Sponsor|2|||
23267593|NCT00555009|64721837|FG001|Overall Study|Terminated by Sponsor|5|||
23364378|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23267594|NCT01087970|64721838|FG000|Overall Study|Protocol Violation|2|||
23267595|NCT01278862|64721842|FG000|Overall Study|Lost to Follow-up|1|||
23364379|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364380|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364381|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364382|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364383|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364384|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364385|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
23364386|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364387|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364388|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
23364389|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364390|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364391|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364392|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364393|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364394|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364395|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364396|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364397|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364398|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364399|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364400|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
23364401|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364402|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364403|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
23364404|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364405|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364406|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364407|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364408|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364409|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364410|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364411|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23402810|NCT00560508|65220013|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
23481953|NCT00674154|65509333|FG000|Overall Study|Withdrawal by Subject|3|||
23601473|NCT03739866|65929964|FG004|Overall Study|Lost to Follow-up|0|||
23601474|NCT03739866|65929965|FG005|Overall Study|Lost to Follow-up|0|||
23601475|NCT03739866|65929966|FG006|Overall Study|Lost to Follow-up|0|||
23601476|NCT03739866|65929967|FG007|Overall Study|Lost to Follow-up|0|||
23267596|NCT01278862|64721843|FG001|Overall Study|Lost to Follow-up|1|||
23267597|NCT03997448|64721844|FG000|Study Treatment|Disease Progression|1|||
23267598|NCT03997448|64721844|FG000|Study Treatment|Symptomatic Deterioration|1|||
23267599|NCT03997448|64721844|FG000|Follow up|Death|2|||
23267600|NCT03997448|64721844|FG000|Follow up|study terminated|1|||
23267601|NCT04094870|64721845|FG000|Overall Study|Lost to Follow-up|1|||
23267602|NCT04094870|64721846|FG001|Overall Study|Lost to Follow-up|1|||
23267603|NCT01706926|64721852|FG000|Overall Study|Lost to Follow-up|0|||
23267604|NCT01706926|64721853|FG001|Overall Study|Lost to Follow-up|0|||
23267605|NCT01706926|64721854|FG002|Overall Study|Lost to Follow-up|1|||
23267606|NCT01706926|64721855|FG003|Overall Study|Lost to Follow-up|0|||
23267607|NCT01706926|64721852|FG000|Overall Study|Withdrawal by Subject|2|||
23267608|NCT01706926|64721853|FG001|Overall Study|Withdrawal by Subject|0|||
23267609|NCT01706926|64721854|FG002|Overall Study|Withdrawal by Subject|1|||
23267610|NCT01706926|64721855|FG003|Overall Study|Withdrawal by Subject|2|||
23267611|NCT01706926|64721852|FG000|Overall Study|Other|4|||
23267612|NCT01706926|64721853|FG001|Overall Study|Other|4|||
23267613|NCT01706926|64721854|FG002|Overall Study|Other|4|||
23267614|NCT01706926|64721855|FG003|Overall Study|Other|3|||
23267615|NCT01267266|64721862|FG000|Enrollment Phase|Withdrawal by Subject|2|||
23267616|NCT01267266|64721863|FG001|Enrollment Phase|Withdrawal by Subject|0|||
23364412|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364413|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364414|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23267617|NCT01267266|64721862|FG000|Lead-in Phase|Lack of Efficacy|20|||
23267618|NCT01267266|64721863|FG001|Lead-in Phase|Lack of Efficacy|0|||
23267619|NCT01267266|64721862|FG000|Lead-in Phase|Adverse Event|2|||
23267620|NCT01267266|64721863|FG001|Lead-in Phase|Adverse Event|0|||
23267621|NCT01267266|64721862|FG000|Lead-in Phase|Withdrawal by Subject|1|||
23267622|NCT01267266|64721863|FG001|Lead-in Phase|Withdrawal by Subject|0|||
23267623|NCT00602030|64721864|FG000|Lead-in Phase|Disease Progression|2|||
23267624|NCT00602030|64721865|FG001|Lead-in Phase|Disease Progression|3|||
23267625|NCT00602030|64721866|FG002|Lead-in Phase|Disease Progression|0|||
23267626|NCT00602030|64721867|FG003|Lead-in Phase|Disease Progression|0|||
23267627|NCT00602030|64721868|FG004|Lead-in Phase|Disease Progression|0|||
23267628|NCT00602030|64721864|FG000|Lead-in Phase|Adverse Event|0|||
23267629|NCT00602030|64721865|FG001|Lead-in Phase|Adverse Event|2|||
23267630|NCT00602030|64721866|FG002|Lead-in Phase|Adverse Event|0|||
23267631|NCT00602030|64721867|FG003|Lead-in Phase|Adverse Event|0|||
23267632|NCT00602030|64721868|FG004|Lead-in Phase|Adverse Event|0|||
23267633|NCT00602030|64721864|FG000|Double-blind Phase|Disease progression|0|||
23267634|NCT00602030|64721865|FG001|Double-blind Phase|Disease progression|0|||
23267635|NCT00602030|64721866|FG002|Double-blind Phase|Disease progression|33|||
23267636|NCT00602030|64721867|FG003|Double-blind Phase|Disease progression|30|||
23267637|NCT00602030|64721868|FG004|Double-blind Phase|Disease progression|0|||
23267638|NCT00602030|64721864|FG000|Double-blind Phase|Adverse Event|0|||
23267639|NCT00602030|64721865|FG001|Double-blind Phase|Adverse Event|0|||
23267640|NCT00602030|64721866|FG002|Double-blind Phase|Adverse Event|9|||
23267641|NCT00602030|64721867|FG003|Double-blind Phase|Adverse Event|18|||
23267642|NCT00602030|64721868|FG004|Double-blind Phase|Adverse Event|0|||
23267643|NCT00602030|64721864|FG000|Double-blind Phase|Consent withdrawal|0|||
23267644|NCT00602030|64721865|FG001|Double-blind Phase|Consent withdrawal|0|||
23267645|NCT00602030|64721866|FG002|Double-blind Phase|Consent withdrawal|4|||
23267646|NCT00602030|64721867|FG003|Double-blind Phase|Consent withdrawal|3|||
23267647|NCT00602030|64721868|FG004|Double-blind Phase|Consent withdrawal|0|||
23267648|NCT00602030|64721864|FG000|Double-blind Phase|Death|0|||
23267649|NCT00602030|64721865|FG001|Double-blind Phase|Death|0|||
23267650|NCT00602030|64721866|FG002|Double-blind Phase|Death|3|||
23267651|NCT00602030|64721867|FG003|Double-blind Phase|Death|3|||
23267652|NCT00602030|64721868|FG004|Double-blind Phase|Death|0|||
23267653|NCT00602030|64721864|FG000|Double-blind Phase|Administrative decision|0|||
23267654|NCT00602030|64721865|FG001|Double-blind Phase|Administrative decision|0|||
23267655|NCT00602030|64721866|FG002|Double-blind Phase|Administrative decision|0|||
23267656|NCT00602030|64721867|FG003|Double-blind Phase|Administrative decision|2|||
23267657|NCT00602030|64721868|FG004|Double-blind Phase|Administrative decision|0|||
23267658|NCT00602030|64721864|FG000|Double-blind Phase|Ineligibility|0|||
23267659|NCT00602030|64721865|FG001|Double-blind Phase|Ineligibility|0|||
23267660|NCT00602030|64721866|FG002|Double-blind Phase|Ineligibility|0|||
23267661|NCT00602030|64721867|FG003|Double-blind Phase|Ineligibility|1|||
23267662|NCT00602030|64721868|FG004|Double-blind Phase|Ineligibility|0|||
23267663|NCT00602030|64721864|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
23267664|NCT00602030|64721865|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
23267665|NCT00602030|64721866|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
23267666|NCT00602030|64721867|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
23267667|NCT00602030|64721868|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
23267668|NCT00602030|64721864|FG000|Double-blind Phase|Reason not specified|0|||
23267669|NCT00602030|64721865|FG001|Double-blind Phase|Reason not specified|0|||
23267670|NCT00602030|64721866|FG002|Double-blind Phase|Reason not specified|4|||
23267671|NCT00602030|64721867|FG003|Double-blind Phase|Reason not specified|2|||
23267672|NCT00602030|64721868|FG004|Double-blind Phase|Reason not specified|0|||
23267673|NCT00602030|64721864|FG000|Crossover Phase|Disease Progression|0|||
23267674|NCT00602030|64721865|FG001|Crossover Phase|Disease Progression|0|||
23267675|NCT00602030|64721866|FG002|Crossover Phase|Disease Progression|0|||
23267676|NCT00602030|64721867|FG003|Crossover Phase|Disease Progression|0|||
23267677|NCT00602030|64721868|FG004|Crossover Phase|Disease Progression|11|||
23267678|NCT00602030|64721864|FG000|Crossover Phase|Adverse Event|0|||
23267679|NCT00602030|64721865|FG001|Crossover Phase|Adverse Event|0|||
23267680|NCT00602030|64721866|FG002|Crossover Phase|Adverse Event|0|||
23267681|NCT00602030|64721867|FG003|Crossover Phase|Adverse Event|0|||
23267682|NCT00602030|64721868|FG004|Crossover Phase|Adverse Event|3|||
23267683|NCT00602030|64721864|FG000|Crossover Phase|Consent withdrawal|0|||
23364415|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
23364416|NCT02326272|65081172|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364417|NCT02326272|65081173|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364418|NCT02326272|65081174|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
23364419|NCT02326272|65081175|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364420|NCT02326272|65081176|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364421|NCT02326272|65081177|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364422|NCT02326272|65081178|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364423|NCT02326272|65081179|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364424|NCT02326272|65081180|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364425|NCT02326272|65081181|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364426|NCT02326272|65081182|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364427|NCT02326272|65081183|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364428|NCT02326272|65081184|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364429|NCT02326272|65081185|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364430|NCT02326272|65081186|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
23364431|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364432|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364433|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364434|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364435|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
23364436|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
23364437|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
23364438|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
23364439|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
23364440|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364441|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364442|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364443|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364444|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364445|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
23364446|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364447|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364448|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364449|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364450|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364451|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
23364452|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
23364453|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364454|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
23364455|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
23364456|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364457|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364458|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364459|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364460|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
23364461|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364462|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364463|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364464|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364465|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364466|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
23364467|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364468|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
23364469|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364470|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364471|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364472|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364473|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364474|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23364475|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
23267684|NCT00602030|64721865|FG001|Crossover Phase|Consent withdrawal|0|||
23267685|NCT00602030|64721866|FG002|Crossover Phase|Consent withdrawal|0|||
23267686|NCT00602030|64721867|FG003|Crossover Phase|Consent withdrawal|0|||
23267687|NCT00602030|64721868|FG004|Crossover Phase|Consent withdrawal|2|||
23267688|NCT02978326|64721869|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
23267689|NCT02978326|64721870|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
23267690|NCT02978326|64721871|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
23267691|NCT02978326|64721869|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
23267692|NCT02978326|64721870|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
23267693|NCT02978326|64721871|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
23267694|NCT02978326|64721869|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
23267695|NCT02978326|64721870|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
23267696|NCT02978326|64721871|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
23267697|NCT02978326|64721869|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
23267698|NCT02978326|64721870|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
23267699|NCT02978326|64721871|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
23267700|NCT05894577|64721872|FG000|Overall Study|No receipt of study drug|14|||
23267701|NCT05894577|64721873|FG001|Overall Study|No receipt of study drug|13|||
23267702|NCT05894577|64721872|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
23267703|NCT05894577|64721873|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
23267704|NCT05894577|64721872|FG000|Overall Study|Screen Fail|2|||
23267705|NCT05894577|64721873|FG001|Overall Study|Screen Fail|0|||
23267706|NCT05894577|64721872|FG000|Overall Study|Study drug recall|86|||
23267707|NCT05894577|64721873|FG001|Overall Study|Study drug recall|63|||
23267708|NCT02154529|64721874|FG000|Overall Study|Death|1|||
23267709|NCT02154529|64721875|FG001|Overall Study|Death|1|||
23267710|NCT02154529|64721876|FG002|Overall Study|Death|5|||
23267711|NCT02154529|64721877|FG003|Overall Study|Death|1|||
23267712|NCT02154529|64721874|FG000|Overall Study|Termination of study by sponsor|2|||
23267713|NCT02154529|64721875|FG001|Overall Study|Termination of study by sponsor|2|||
23267714|NCT02154529|64721876|FG002|Overall Study|Termination of study by sponsor|3|||
23267715|NCT02154529|64721877|FG003|Overall Study|Termination of study by sponsor|1|||
23267716|NCT02154529|64721874|FG000|Overall Study|Lost to Follow-up|1|||
23267717|NCT02154529|64721875|FG001|Overall Study|Lost to Follow-up|0|||
23267718|NCT02154529|64721876|FG002|Overall Study|Lost to Follow-up|0|||
23267719|NCT02154529|64721877|FG003|Overall Study|Lost to Follow-up|0|||
23267720|NCT03464136|64721887|FG000|Overall Study|Lost to Follow-up|5|||
23267721|NCT03464136|64721888|FG001|Overall Study|Lost to Follow-up|8|||
23267722|NCT03464136|64721887|FG000|Overall Study|Withdrawal by Subject|16|||
23267723|NCT03464136|64721888|FG001|Overall Study|Withdrawal by Subject|13|||
23267724|NCT03464136|64721887|FG000|Overall Study|Death|1|||
23267725|NCT03464136|64721888|FG001|Overall Study|Death|0|||
23267726|NCT03464136|64721887|FG000|Overall Study|Other|8|||
23267727|NCT03464136|64721888|FG001|Overall Study|Other|4|||
23267728|NCT01720264|64721889|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
23267729|NCT01720264|64721889|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
23267730|NCT01720264|64721889|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
23267731|NCT00203307|64721890|FG000|First Intervention|Adverse Event|2|||
23267732|NCT00203307|64721891|FG001|First Intervention|Adverse Event|0|||
23267733|NCT02228382|64721895|FG000|Overall Study|Death|5|||
23267734|NCT02228382|64721896|FG001|Overall Study|Death|7|||
23267735|NCT02228382|64721897|FG002|Overall Study|Death|5|||
23267736|NCT02228382|64721898|FG003|Overall Study|Death|0|||
23267737|NCT02228382|64721899|FG004|Overall Study|Death|2|||
23267738|NCT02228382|64721895|FG000|Overall Study|Participant refused further follow-up|0|||
23267739|NCT02228382|64721896|FG001|Overall Study|Participant refused further follow-up|0|||
23267740|NCT02228382|64721897|FG002|Overall Study|Participant refused further follow-up|1|||
23267741|NCT02228382|64721898|FG003|Overall Study|Participant refused further follow-up|0|||
23267742|NCT02228382|64721899|FG004|Overall Study|Participant refused further follow-up|0|||
23267743|NCT02228382|64721895|FG000|Overall Study|Study terminated by sponsor|3|||
23267744|NCT02228382|64721896|FG001|Overall Study|Study terminated by sponsor|5|||
23267745|NCT02228382|64721897|FG002|Overall Study|Study terminated by sponsor|7|||
23267746|NCT02228382|64721898|FG003|Overall Study|Study terminated by sponsor|0|||
23267747|NCT02228382|64721899|FG004|Overall Study|Study terminated by sponsor|0|||
23267748|NCT02228382|64721895|FG000|Overall Study|Lost to Follow-up|0|||
23267749|NCT02228382|64721896|FG001|Overall Study|Lost to Follow-up|0|||
23267750|NCT02228382|64721897|FG002|Overall Study|Lost to Follow-up|3|||
23364476|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364477|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364478|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364479|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23364480|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364481|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
23364482|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23364483|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23364484|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364485|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
23364486|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364487|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364488|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364489|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364490|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
23364491|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364492|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364493|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364494|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364495|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364496|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364497|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364498|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
23364499|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364500|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364501|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364502|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364503|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364504|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364505|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
23364506|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364507|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364508|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364509|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364510|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364511|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364512|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
23364513|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23481954|NCT00674154|65509334|FG001|Overall Study|Withdrawal by Subject|1|||
23481955|NCT00674154|65509333|FG000|Overall Study|Did not want parathyroidectomy|0|||
23481956|NCT00674154|65509334|FG001|Overall Study|Did not want parathyroidectomy|2|||
23481957|NCT03745820|65509335|FG000|Overall Study|Adverse Event|0|||
23481958|NCT03745820|65509336|FG001|Overall Study|Adverse Event|3|||
23267751|NCT02228382|64721898|FG003|Overall Study|Lost to Follow-up|1|||
23481959|NCT03745820|65509337|FG002|Overall Study|Adverse Event|2|||
23481960|NCT03745820|65509335|FG000|Overall Study|Non-Compliance with Study Drug|4|||
23481961|NCT03745820|65509336|FG001|Overall Study|Non-Compliance with Study Drug|3|||
23481962|NCT03745820|65509337|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23481963|NCT03745820|65509335|FG000|Overall Study|Withdrawal by Subject|4|||
23481964|NCT03745820|65509336|FG001|Overall Study|Withdrawal by Subject|4|||
23481965|NCT03745820|65509337|FG002|Overall Study|Withdrawal by Subject|4|||
23267752|NCT02228382|64721899|FG004|Overall Study|Lost to Follow-up|0|||
23267753|NCT02228382|64721895|FG000|Overall Study|Withdrawal by Subject|0|||
23267754|NCT02228382|64721896|FG001|Overall Study|Withdrawal by Subject|3|||
23267755|NCT02228382|64721897|FG002|Overall Study|Withdrawal by Subject|2|||
23267756|NCT02228382|64721898|FG003|Overall Study|Withdrawal by Subject|1|||
23267757|NCT02228382|64721899|FG004|Overall Study|Withdrawal by Subject|0|||
23267758|NCT02228382|64721895|FG000|Overall Study|Other|2|||
23267759|NCT02228382|64721896|FG001|Overall Study|Other|3|||
23267760|NCT02228382|64721897|FG002|Overall Study|Other|3|||
23267761|NCT02228382|64721898|FG003|Overall Study|Other|0|||
23267762|NCT02228382|64721899|FG004|Overall Study|Other|0|||
23267763|NCT01816477|64721900|FG000|Overall Study|Withdrawal by Subject|13|||
23267764|NCT01816477|64721901|FG001|Overall Study|Withdrawal by Subject|1|||
23267765|NCT01816477|64721900|FG000|Overall Study|Unable to tolerate catheter placement|3|||
23267766|NCT01816477|64721901|FG001|Overall Study|Unable to tolerate catheter placement|0|||
23267767|NCT01424722|64721903|FG000|Overall Study|Sponsor terminated investigation|2258|||
23481966|NCT03745820|65509335|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
23481967|NCT03745820|65509336|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
23481968|NCT03745820|65509337|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
23481969|NCT03745820|65509335|FG000|Overall Study|Lost to Follow-up|2|||
23481970|NCT03745820|65509336|FG001|Overall Study|Lost to Follow-up|0|||
23481971|NCT03745820|65509337|FG002|Overall Study|Lost to Follow-up|3|||
23481972|NCT03745820|65509335|FG000|Overall Study|Reason not Specified|2|||
23481973|NCT03745820|65509336|FG001|Overall Study|Reason not Specified|4|||
23481974|NCT03745820|65509337|FG002|Overall Study|Reason not Specified|1|||
23267768|NCT00561730|64721904|FG000|Overall Study|Adverse Event|2|||
23364514|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364515|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364516|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364517|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23267769|NCT00561730|64721904|FG000|Overall Study|Handling of the drug|1|||
23267770|NCT00561730|64721904|FG000|Overall Study|Lost to Follow-up|5|||
23267771|NCT00561730|64721904|FG000|Overall Study|Not specified reasons|1|||
23267772|NCT05546411|64721905|FG000|Overall Study|Progressive Disease|1|||
23267773|NCT05546411|64721906|FG001|Overall Study|Progressive Disease|0|||
23267774|NCT05546411|64721905|FG000|Overall Study|Adverse Event|0|||
23267775|NCT05546411|64721906|FG001|Overall Study|Adverse Event|1|||
23267776|NCT05546411|64721905|FG000|Overall Study|Metastatic disease|1|||
23267777|NCT05546411|64721906|FG001|Overall Study|Metastatic disease|0|||
23267778|NCT04591626|64721907|FG000|Overall Study|Adverse Event|4|||
23267779|NCT04591626|64721908|FG001|Overall Study|Adverse Event|0|||
23267780|NCT04591626|64721907|FG000|Overall Study|Withdrawal by Subject|5|||
23267781|NCT04591626|64721908|FG001|Overall Study|Withdrawal by Subject|3|||
23267782|NCT04591626|64721907|FG000|Overall Study|Physician Decision|0|||
23267783|NCT04591626|64721908|FG001|Overall Study|Physician Decision|1|||
23267784|NCT04591626|64721907|FG000|Overall Study|Death|0|||
23267785|NCT04591626|64721908|FG001|Overall Study|Death|1|||
23267786|NCT04591626|64721907|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23267787|NCT04591626|64721908|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23267788|NCT03312530|64725113|FG000|Overall Study|Death|5|||
23267789|NCT03312530|64725114|FG001|Overall Study|Death|5|||
23267790|NCT03312530|64725115|FG002|Overall Study|Death|4|||
23267791|NCT03312530|64725116|FG003|Overall Study|Death|10|||
23364518|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364519|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364520|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
23364521|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364522|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364523|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364524|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364525|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364526|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364527|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364528|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364529|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
23364530|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364531|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23481975|NCT02101112|65509342|FG000|Overall Study|Adverse Event|0|||
23481976|NCT02101112|65509343|FG001|Overall Study|Adverse Event|0|||
23364532|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23267792|NCT03312530|64725117|FG004|Overall Study|Death|8|||
23267793|NCT03312530|64725113|FG000|Overall Study|Lost to Follow-up|0|||
23267794|NCT03312530|64725114|FG001|Overall Study|Lost to Follow-up|0|||
23267795|NCT03312530|64725115|FG002|Overall Study|Lost to Follow-up|0|||
23267796|NCT03312530|64725116|FG003|Overall Study|Lost to Follow-up|1|||
23481977|NCT02101112|65509344|FG002|Overall Study|Adverse Event|1|||
23481978|NCT02101112|65509345|FG003|Overall Study|Adverse Event|0|||
23481979|NCT02101112|65509346|FG004|Overall Study|Adverse Event|0|||
23481980|NCT02101112|65509347|FG005|Overall Study|Adverse Event|0|||
23481981|NCT02101112|65509342|FG000|Overall Study|Withdrawal by Subject|0|||
23481982|NCT02101112|65509343|FG001|Overall Study|Withdrawal by Subject|0|||
23481983|NCT02101112|65509344|FG002|Overall Study|Withdrawal by Subject|0|||
23481984|NCT02101112|65509345|FG003|Overall Study|Withdrawal by Subject|0|||
23481985|NCT02101112|65509346|FG004|Overall Study|Withdrawal by Subject|1|||
23481986|NCT02101112|65509347|FG005|Overall Study|Withdrawal by Subject|0|||
23481987|NCT03361176|65509348|FG000|Overall Study|Lost to Follow-up|1|||
23481988|NCT03361176|65509349|FG001|Overall Study|Lost to Follow-up|2|||
23481989|NCT03361176|65509348|FG000|Overall Study|Adverse Event|0|||
23481990|NCT03361176|65509349|FG001|Overall Study|Adverse Event|2|||
23481991|NCT03361176|65509348|FG000|Overall Study|Withdrawal by Subject|0|||
23481992|NCT03361176|65509349|FG001|Overall Study|Withdrawal by Subject|1|||
23481993|NCT03780400|65509350|FG000|Overall Study|Lost to Follow-up|5|||
23481994|NCT03780400|65509350|FG000|Overall Study|Withdrawal by Subject|2|||
23481995|NCT02677324|65509359|FG000|Overall Study|Disease Progression|6|||
23481996|NCT02677324|65509359|FG000|Overall Study|Inability to Swallow pills|1|||
23481997|NCT02677324|65509359|FG000|Overall Study|Non-compliance|1|||
23481998|NCT02677324|65509359|FG000|Overall Study|Lack of Efficacy|1|||
23481999|NCT02677324|65509359|FG000|Overall Study|Medical insurance coverage|1|||
23482000|NCT02677324|65509359|FG000|Overall Study|Adverse Event|1|||
23482001|NCT02677324|65509359|FG000|Overall Study|IgM Myeloma diagnosis|1|||
23482002|NCT01275339|65509360|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
23482003|NCT01275339|65509361|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
23482004|NCT01275339|65509362|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
23482005|NCT01275339|65509363|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
23482006|NCT01275339|65509360|FG000|Overall Study|Withdrawal by Subject|0|||
23482007|NCT01275339|65509361|FG001|Overall Study|Withdrawal by Subject|0|||
23482008|NCT01275339|65509362|FG002|Overall Study|Withdrawal by Subject|1|||
23482009|NCT01275339|65509363|FG003|Overall Study|Withdrawal by Subject|0|||
23482010|NCT02925793|65509364|FG000|Overall Study|Adverse Event|3|||
23482011|NCT02925793|65509365|FG001|Overall Study|Adverse Event|3|||
23482012|NCT02925793|65509366|FG002|Overall Study|Adverse Event|6|||
23482013|NCT02925793|65509364|FG000|Overall Study|Withdrawal by Subject|16|||
23482014|NCT02925793|65509365|FG001|Overall Study|Withdrawal by Subject|15|||
23482015|NCT02925793|65509366|FG002|Overall Study|Withdrawal by Subject|13|||
23482016|NCT02925793|65509364|FG000|Overall Study|Investigator Discretion|0|||
23482017|NCT02925793|65509365|FG001|Overall Study|Investigator Discretion|1|||
23482018|NCT02925793|65509366|FG002|Overall Study|Investigator Discretion|1|||
23482019|NCT02925793|65509364|FG000|Overall Study|Lost to Follow-up|2|||
23482020|NCT02925793|65509365|FG001|Overall Study|Lost to Follow-up|3|||
23482021|NCT02925793|65509366|FG002|Overall Study|Lost to Follow-up|1|||
23482022|NCT02925793|65509364|FG000|Overall Study|Lack of Efficacy|2|||
23482023|NCT02925793|65509365|FG001|Overall Study|Lack of Efficacy|6|||
23482024|NCT02925793|65509366|FG002|Overall Study|Lack of Efficacy|4|||
23482025|NCT02925793|65509364|FG000|Overall Study|Other:|2|||
23482026|NCT02925793|65509365|FG001|Overall Study|Other:|1|||
23482027|NCT02925793|65509366|FG002|Overall Study|Other:|3|||
23482028|NCT04010539|65509367|FG000|Overall Study|Withdrawal by Subject|4|||
23482029|NCT04010539|65509368|FG001|Overall Study|Withdrawal by Subject|1|||
23482030|NCT04010539|65509367|FG000|Overall Study|Physician Decision|0|||
23482031|NCT04010539|65509368|FG001|Overall Study|Physician Decision|2|||
23482032|NCT04010539|65509367|FG000|Overall Study|Lost to Follow-up|10|||
23482033|NCT04010539|65509368|FG001|Overall Study|Lost to Follow-up|14|||
23482034|NCT04010539|65509367|FG000|Overall Study|Adverse Event|3|||
23482035|NCT04010539|65509368|FG001|Overall Study|Adverse Event|0|||
23482036|NCT04010539|65509367|FG000|Overall Study|Participant Did Not Receive IP|0|||
23482037|NCT04010539|65509368|FG001|Overall Study|Participant Did Not Receive IP|1|||
23482038|NCT04010539|65509367|FG000|Overall Study|Protocol Deviation|0|||
23482039|NCT04010539|65509368|FG001|Overall Study|Protocol Deviation|1|||
23482040|NCT04010539|65509367|FG000|Overall Study|Randomized in Error/ Mistake|2|||
23482041|NCT04010539|65509368|FG001|Overall Study|Randomized in Error/ Mistake|0|||
23482042|NCT04010539|65509367|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
23482043|NCT04010539|65509368|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
23482044|NCT03188042|65509374|FG000|Overall Study|Withdrawal by Subject|1|||
23482045|NCT03188042|65509375|FG001|Overall Study|Withdrawal by Subject|1|||
23482046|NCT03729362|65509376|FG000|Overall Study|Withdrawal by Subject|2|||
23482047|NCT03729362|65509377|FG001|Overall Study|Withdrawal by Subject|0|||
23482048|NCT03729362|65509376|FG000|Overall Study|Physician Decision|1|||
23482049|NCT03729362|65509377|FG001|Overall Study|Physician Decision|0|||
23482050|NCT03729362|65509376|FG000|Overall Study|COVID-19 Pandemic|1|||
23482051|NCT03729362|65509377|FG001|Overall Study|COVID-19 Pandemic|0|||
23482052|NCT03729362|65509376|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
23267797|NCT03312530|64725117|FG004|Overall Study|Lost to Follow-up|0|||
23267798|NCT03312530|64725113|FG000|Overall Study|Participant in another sponsor study.|0|||
23267799|NCT03312530|64725114|FG001|Overall Study|Participant in another sponsor study.|0|||
23267800|NCT03312530|64725115|FG002|Overall Study|Participant in another sponsor study.|0|||
23267801|NCT03312530|64725116|FG003|Overall Study|Participant in another sponsor study.|1|||
23267802|NCT03312530|64725117|FG004|Overall Study|Participant in another sponsor study.|0|||
23267803|NCT03312530|64725113|FG000|Overall Study|Study terminated by sponsor|1|||
23267804|NCT03312530|64725114|FG001|Overall Study|Study terminated by sponsor|0|||
23267805|NCT03312530|64725115|FG002|Overall Study|Study terminated by sponsor|2|||
23267806|NCT03312530|64725116|FG003|Overall Study|Study terminated by sponsor|3|||
23267807|NCT03312530|64725117|FG004|Overall Study|Study terminated by sponsor|7|||
23267808|NCT03312530|64725113|FG000|Overall Study|Withdrawal by Subject|0|||
23267809|NCT03312530|64725114|FG001|Overall Study|Withdrawal by Subject|1|||
23267810|NCT03312530|64725115|FG002|Overall Study|Withdrawal by Subject|0|||
23267811|NCT03312530|64725116|FG003|Overall Study|Withdrawal by Subject|0|||
23267812|NCT03312530|64725117|FG004|Overall Study|Withdrawal by Subject|0|||
23267813|NCT03312530|64725113|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
23267814|NCT03312530|64725114|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
23267815|NCT03312530|64725115|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
23267816|NCT03312530|64725116|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
23267817|NCT03312530|64725117|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
23267818|NCT03049488|64725120|FG000|Overall Study|Lost to Follow-up|1|||
23267819|NCT03049488|64725121|FG001|Overall Study|Lost to Follow-up|1|||
23267820|NCT03049488|64725122|FG002|Overall Study|Lost to Follow-up|0|||
23267821|NCT03049488|64725123|FG003|Overall Study|Lost to Follow-up|0|||
23267822|NCT03049488|64725124|FG004|Overall Study|Lost to Follow-up|0|||
23267823|NCT03049488|64725125|FG005|Overall Study|Lost to Follow-up|0|||
23267824|NCT03049488|64725120|FG000|Overall Study|Moved from Area|1|||
23267825|NCT03049488|64725121|FG001|Overall Study|Moved from Area|0|||
23267826|NCT03049488|64725122|FG002|Overall Study|Moved from Area|0|||
23267827|NCT03049488|64725123|FG003|Overall Study|Moved from Area|1|||
23267828|NCT03049488|64725124|FG004|Overall Study|Moved from Area|1|||
23267829|NCT03049488|64725125|FG005|Overall Study|Moved from Area|0|||
23267830|NCT03049488|64725120|FG000|Overall Study|Physician Decision|0|||
23267831|NCT03049488|64725121|FG001|Overall Study|Physician Decision|1|||
23267832|NCT03049488|64725122|FG002|Overall Study|Physician Decision|0|||
23267833|NCT03049488|64725123|FG003|Overall Study|Physician Decision|0|||
23267834|NCT03049488|64725124|FG004|Overall Study|Physician Decision|0|||
23267835|NCT03049488|64725125|FG005|Overall Study|Physician Decision|0|||
23267836|NCT03049488|64725120|FG000|Overall Study|Withdrawal by Subject|0|||
23267837|NCT03049488|64725121|FG001|Overall Study|Withdrawal by Subject|0|||
23267838|NCT03049488|64725122|FG002|Overall Study|Withdrawal by Subject|0|||
23267839|NCT03049488|64725123|FG003|Overall Study|Withdrawal by Subject|1|||
23267840|NCT03049488|64725124|FG004|Overall Study|Withdrawal by Subject|1|||
23267841|NCT03049488|64725125|FG005|Overall Study|Withdrawal by Subject|0|||
23267842|NCT03194464|64725126|FG000|Overall Study|data not usable|2|||
23267843|NCT00662025|64725127|FG000|Overall Study|Objective progression or relapse|51|||
23267844|NCT00662025|64725127|FG000|Overall Study|Adverse Event|7|||
23267845|NCT00662025|64725127|FG000|Overall Study|Withdrawal by Subject|1|||
23267846|NCT00662025|64725127|FG000|Overall Study|Results of other clinical study|2|||
23267847|NCT00662025|64725127|FG000|Overall Study|Target lesion cannot be evaluated|1|||
23267848|NCT00662025|64725127|FG000|Overall Study|Domestic circumstances|1|||
23267849|NCT04015232|64725131|FG000|Overall Study|Withdrawal by Subject|7|||
23267850|NCT04015232|64725132|FG001|Overall Study|Withdrawal by Subject|4|||
23267851|NCT04015232|64725131|FG000|Overall Study|Protocol Violation|1|||
23267852|NCT04015232|64725132|FG001|Overall Study|Protocol Violation|0|||
23267853|NCT04015232|64725131|FG000|Overall Study|Medical Grounds|3|||
23267854|NCT04015232|64725132|FG001|Overall Study|Medical Grounds|3|||
23267855|NCT00365352|64725133|FG000|Overall Study|Adverse Event|6|||
23267856|NCT00365352|64725134|FG001|Overall Study|Adverse Event|7|||
23267857|NCT00365352|64725135|FG002|Overall Study|Adverse Event|8|||
23267858|NCT00365352|64725133|FG000|Overall Study|Participant Withdrew Consent|8|||
23267859|NCT00365352|64725134|FG001|Overall Study|Participant Withdrew Consent|3|||
23267860|NCT00365352|64725135|FG002|Overall Study|Participant Withdrew Consent|4|||
23267861|NCT00365352|64725133|FG000|Overall Study|Lack of Efficacy|3|||
23267862|NCT00365352|64725134|FG001|Overall Study|Lack of Efficacy|0|||
23267863|NCT00365352|64725135|FG002|Overall Study|Lack of Efficacy|0|||
23267864|NCT00365352|64725133|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
23267865|NCT00365352|64725134|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
23267866|NCT00365352|64725135|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
23267867|NCT00365352|64725133|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
23267868|NCT00365352|64725134|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
23267869|NCT00365352|64725135|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
23267870|NCT00365352|64725133|FG000|Overall Study|Lost to Follow-up|1|||
23267871|NCT00365352|64725134|FG001|Overall Study|Lost to Follow-up|1|||
23267872|NCT00365352|64725135|FG002|Overall Study|Lost to Follow-up|0|||
23267873|NCT00365352|64725133|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
23267874|NCT00365352|64725134|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
23267875|NCT00365352|64725135|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
23267876|NCT00440557|64725145|FG000|Overall Study|Withdrawal by Subject|10|||
23267877|NCT00440557|64725146|FG001|Overall Study|Withdrawal by Subject|5|||
23267878|NCT00440557|64725147|FG002|Overall Study|Withdrawal by Subject|11|||
23267879|NCT00440557|64725145|FG000|Overall Study|Lost to Follow-up|1|||
23267880|NCT00440557|64725146|FG001|Overall Study|Lost to Follow-up|2|||
23267881|NCT00440557|64725147|FG002|Overall Study|Lost to Follow-up|6|||
23267882|NCT00440557|64725145|FG000|Overall Study|Adverse Event|3|||
23267883|NCT00440557|64725146|FG001|Overall Study|Adverse Event|3|||
23267884|NCT00440557|64725147|FG002|Overall Study|Adverse Event|5|||
23267885|NCT00440557|64725145|FG000|Overall Study|Death|2|||
23267886|NCT00440557|64725146|FG001|Overall Study|Death|6|||
23267887|NCT00440557|64725147|FG002|Overall Study|Death|3|||
23267888|NCT00440557|64725145|FG000|Overall Study|Began Dialysis|4|||
23267889|NCT00440557|64725146|FG001|Overall Study|Began Dialysis|1|||
23267890|NCT00440557|64725147|FG002|Overall Study|Began Dialysis|4|||
23267891|NCT00440557|64725145|FG000|Overall Study|Principal Investigator decision|0|||
23267892|NCT00440557|64725146|FG001|Overall Study|Principal Investigator decision|3|||
23267893|NCT00440557|64725147|FG002|Overall Study|Principal Investigator decision|1|||
23267894|NCT00440557|64725145|FG000|Overall Study|Patient moved|1|||
23267895|NCT00440557|64725146|FG001|Overall Study|Patient moved|2|||
23267896|NCT00440557|64725147|FG002|Overall Study|Patient moved|1|||
23267897|NCT00440557|64725145|FG000|Overall Study|Principal Investigator's office closed|3|||
23267898|NCT00440557|64725146|FG001|Overall Study|Principal Investigator's office closed|6|||
23267899|NCT00440557|64725147|FG002|Overall Study|Principal Investigator's office closed|4|||
23267900|NCT00440557|64725145|FG000|Overall Study|Patient transferred to nursing home|0|||
23267901|NCT00440557|64725146|FG001|Overall Study|Patient transferred to nursing home|1|||
23267902|NCT00440557|64725147|FG002|Overall Study|Patient transferred to nursing home|0|||
23267903|NCT00440557|64725145|FG000|Overall Study|Patient had surgery|1|||
23267904|NCT00440557|64725146|FG001|Overall Study|Patient had surgery|0|||
23267905|NCT00440557|64725147|FG002|Overall Study|Patient had surgery|0|||
23267906|NCT00770510|64725148|FG000|Overall Study|Lost to Follow-up|2|||
23267907|NCT00770510|64725148|FG000|Overall Study|Pregnancy|1|||
23267908|NCT00770510|64725148|FG000|Overall Study|Withdrawal by Subject|2|||
23267909|NCT00626548|64725149|FG000|Overall Study|Adverse Event|164|||
23267910|NCT00626548|64725150|FG001|Overall Study|Adverse Event|44|||
23267911|NCT00626548|64725149|FG000|Overall Study|Withdrawal by Subject|42|||
23267912|NCT00626548|64725150|FG001|Overall Study|Withdrawal by Subject|46|||
23267913|NCT00626548|64725149|FG000|Overall Study|Protocol Violation|4|||
23267914|NCT00626548|64725150|FG001|Overall Study|Protocol Violation|11|||
23267915|NCT00626548|64725149|FG000|Overall Study|Lost to Follow-up|2|||
23267916|NCT00626548|64725150|FG001|Overall Study|Lost to Follow-up|2|||
23267917|NCT00626548|64725149|FG000|Overall Study|Other termination reason|493|||
23267918|NCT00626548|64725150|FG001|Overall Study|Other termination reason|613|||
23267919|NCT03823300|64725151|FG000|Overall Study|Withdrawal by Subject|16|||
23267920|NCT03823300|64725152|FG001|Overall Study|Withdrawal by Subject|22|||
23267921|NCT03823300|64725151|FG000|Overall Study|Death|10|||
23267922|NCT03823300|64725152|FG001|Overall Study|Death|14|||
23267923|NCT03823300|64725151|FG000|Overall Study|Adverse Event|3|||
23267924|NCT03823300|64725152|FG001|Overall Study|Adverse Event|5|||
23267925|NCT03823300|64725151|FG000|Overall Study|Physician Decision|1|||
23267926|NCT03823300|64725152|FG001|Overall Study|Physician Decision|7|||
23267927|NCT03823300|64725151|FG000|Overall Study|Lost to Follow-up|1|||
23267928|NCT03823300|64725152|FG001|Overall Study|Lost to Follow-up|3|||
23267929|NCT03823300|64725151|FG000|Overall Study|Protocol Violation|1|||
23267930|NCT03823300|64725152|FG001|Overall Study|Protocol Violation|1|||
23267931|NCT03823300|64725151|FG000|Overall Study|Lack of Efficacy|1|||
23267932|NCT03823300|64725152|FG001|Overall Study|Lack of Efficacy|1|||
23267933|NCT03823300|64725151|FG000|Overall Study|Not Eligible|0|||
23267934|NCT03823300|64725152|FG001|Overall Study|Not Eligible|1|||
23267935|NCT03823300|64725151|FG000|Overall Study|Other|1|||
23267936|NCT03823300|64725152|FG001|Overall Study|Other|0|||
23267937|NCT00818623|64725155|FG000|Overall Study|Adverse Event|1|||
23267938|NCT00818623|64725156|FG001|Overall Study|Adverse Event|0|||
23267939|NCT00818623|64725157|FG002|Overall Study|Adverse Event|1|||
23267940|NCT00818623|64725158|FG003|Overall Study|Adverse Event|0|||
23267941|NCT00818623|64725159|FG004|Overall Study|Adverse Event|0|||
23267942|NCT00818623|64725160|FG005|Overall Study|Adverse Event|1|||
23267943|NCT00818623|64725161|FG006|Overall Study|Adverse Event|0|||
23267944|NCT00818623|64725162|FG007|Overall Study|Adverse Event|0|||
23267945|NCT00818623|64725155|FG000|Overall Study|Bad prostate specific antigen response|0|||
23267946|NCT00818623|64725156|FG001|Overall Study|Bad prostate specific antigen response|3|||
23267947|NCT00818623|64725157|FG002|Overall Study|Bad prostate specific antigen response|2|||
23267948|NCT00818623|64725158|FG003|Overall Study|Bad prostate specific antigen response|5|||
23267949|NCT00818623|64725159|FG004|Overall Study|Bad prostate specific antigen response|0|||
23267950|NCT00818623|64725160|FG005|Overall Study|Bad prostate specific antigen response|1|||
23267951|NCT00818623|64725161|FG006|Overall Study|Bad prostate specific antigen response|0|||
23267952|NCT00818623|64725162|FG007|Overall Study|Bad prostate specific antigen response|0|||
23267953|NCT00818623|64725155|FG000|Overall Study|Withdrawal by Subject|0|||
23267954|NCT00818623|64725156|FG001|Overall Study|Withdrawal by Subject|1|||
23267955|NCT00818623|64725157|FG002|Overall Study|Withdrawal by Subject|1|||
23267956|NCT00818623|64725158|FG003|Overall Study|Withdrawal by Subject|0|||
23267957|NCT00818623|64725159|FG004|Overall Study|Withdrawal by Subject|0|||
23267958|NCT00818623|64725160|FG005|Overall Study|Withdrawal by Subject|1|||
23267959|NCT00818623|64725161|FG006|Overall Study|Withdrawal by Subject|1|||
23267960|NCT00818623|64725162|FG007|Overall Study|Withdrawal by Subject|1|||
23267961|NCT00818623|64725155|FG000|Overall Study|Protocol Violation|1|||
23267962|NCT00818623|64725156|FG001|Overall Study|Protocol Violation|0|||
23267963|NCT00818623|64725157|FG002|Overall Study|Protocol Violation|0|||
23267964|NCT00818623|64725158|FG003|Overall Study|Protocol Violation|0|||
23267965|NCT00818623|64725159|FG004|Overall Study|Protocol Violation|1|||
23267966|NCT00818623|64725160|FG005|Overall Study|Protocol Violation|0|||
23267967|NCT00818623|64725161|FG006|Overall Study|Protocol Violation|1|||
23267968|NCT00818623|64725162|FG007|Overall Study|Protocol Violation|0|||
23267969|NCT00818623|64725155|FG000|Overall Study|Need of additional treatment|0|||
23267970|NCT00818623|64725156|FG001|Overall Study|Need of additional treatment|0|||
23267971|NCT00818623|64725157|FG002|Overall Study|Need of additional treatment|0|||
23267972|NCT00818623|64725158|FG003|Overall Study|Need of additional treatment|0|||
23267973|NCT00818623|64725159|FG004|Overall Study|Need of additional treatment|1|||
23267974|NCT00818623|64725160|FG005|Overall Study|Need of additional treatment|0|||
23267975|NCT00818623|64725161|FG006|Overall Study|Need of additional treatment|0|||
23267976|NCT00818623|64725162|FG007|Overall Study|Need of additional treatment|0|||
23267977|NCT00818623|64725155|FG000|Overall Study|Lack of trial drug at site|0|||
23267978|NCT00818623|64725156|FG001|Overall Study|Lack of trial drug at site|0|||
23267979|NCT00818623|64725157|FG002|Overall Study|Lack of trial drug at site|0|||
23267980|NCT00818623|64725158|FG003|Overall Study|Lack of trial drug at site|0|||
23267981|NCT00818623|64725159|FG004|Overall Study|Lack of trial drug at site|2|||
23267982|NCT00818623|64725160|FG005|Overall Study|Lack of trial drug at site|0|||
23267983|NCT00818623|64725161|FG006|Overall Study|Lack of trial drug at site|1|||
23267984|NCT00818623|64725162|FG007|Overall Study|Lack of trial drug at site|0|||
23267985|NCT00818623|64725155|FG000|Overall Study|Disease progression|0|||
23267986|NCT00818623|64725156|FG001|Overall Study|Disease progression|0|||
23267987|NCT00818623|64725157|FG002|Overall Study|Disease progression|0|||
23267988|NCT00818623|64725158|FG003|Overall Study|Disease progression|0|||
23267989|NCT00818623|64725159|FG004|Overall Study|Disease progression|0|||
23267990|NCT00818623|64725160|FG005|Overall Study|Disease progression|0|||
23267991|NCT00818623|64725161|FG006|Overall Study|Disease progression|1|||
23267992|NCT00818623|64725162|FG007|Overall Study|Disease progression|0|||
23267993|NCT04060680|64725165|FG000|Overall Study|Unsuccessful implant|17|||
23267994|NCT04060680|64725165|FG000|Overall Study|Adverse Event|3|||
23267995|NCT04060680|64725165|FG000|Overall Study|Death|2|||
23267996|NCT04060680|64725165|FG000|Overall Study|Study product no longer in use|1|||
23267997|NCT04060680|64725165|FG000|Overall Study|Withdrawal by Subject|1|||
23267998|NCT01226797|64725166|FG000|Overall Study|Adverse Event|1|||
23364533|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364534|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23267999|NCT01226797|64725167|FG001|Overall Study|Adverse Event|0|||
23268000|NCT01226797|64725166|FG000|Overall Study|No longer willing to participate|1|||
23268001|NCT01226797|64725167|FG001|Overall Study|No longer willing to participate|0|||
23268002|NCT01226797|64725166|FG000|Overall Study|Protocol Violation|0|||
23268003|NCT01226797|64725167|FG001|Overall Study|Protocol Violation|1|||
23268004|NCT02979353|64725168|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
23268005|NCT02979353|64725169|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
23268006|NCT02979353|64725168|FG000|Overall Study|Withdrawal by Subject|16|||
23268007|NCT02979353|64725169|FG001|Overall Study|Withdrawal by Subject|12|||
23268008|NCT02979353|64725168|FG000|Overall Study|Death|10|||
23268009|NCT02979353|64725169|FG001|Overall Study|Death|11|||
23268010|NCT02979353|64725168|FG000|Overall Study|Transfer to Hospice Care|19|||
23268011|NCT02979353|64725169|FG001|Overall Study|Transfer to Hospice Care|14|||
23268012|NCT02979353|64725168|FG000|Overall Study|Lost to Follow-up|1|||
23268013|NCT02979353|64725169|FG001|Overall Study|Lost to Follow-up|5|||
23268014|NCT00661999|64725170|FG000|Overall Study|Adverse Event|11|||
23268015|NCT00661999|64725171|FG001|Overall Study|Adverse Event|5|||
23268016|NCT00661999|64725172|FG002|Overall Study|Adverse Event|8|||
23268017|NCT00661999|64725170|FG000|Overall Study|Death|8|||
23268018|NCT00661999|64725171|FG001|Overall Study|Death|6|||
23268019|NCT00661999|64725172|FG002|Overall Study|Death|3|||
23268020|NCT00661999|64725170|FG000|Overall Study|Other Reasons|5|||
23268021|NCT00661999|64725171|FG001|Overall Study|Other Reasons|12|||
23268022|NCT00661999|64725172|FG002|Overall Study|Other Reasons|23|||
23268023|NCT00661999|64725170|FG000|Overall Study|Withdrawal by Subject|30|||
23268024|NCT00661999|64725171|FG001|Overall Study|Withdrawal by Subject|23|||
23268025|NCT00661999|64725172|FG002|Overall Study|Withdrawal by Subject|14|||
23268026|NCT00661999|64725170|FG000|Overall Study|Alternative Treatment|1|||
23268027|NCT00661999|64725171|FG001|Overall Study|Alternative Treatment|0|||
23268028|NCT00661999|64725172|FG002|Overall Study|Alternative Treatment|0|||
23268029|NCT00661999|64725170|FG000|Overall Study|Other Medical Problems|4|||
23268030|NCT00661999|64725171|FG001|Overall Study|Other Medical Problems|4|||
23268031|NCT00661999|64725172|FG002|Overall Study|Other Medical Problems|9|||
23268032|NCT00824265|64725185|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
23268033|NCT00824265|64725186|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
23268034|NCT00824265|64725185|FG000|Treatment Phase|Protocol Violation|1|||
23268035|NCT00824265|64725186|FG001|Treatment Phase|Protocol Violation|0|||
23268036|NCT00824265|64725185|FG000|Treatment Phase|Lost to Follow-up|1|||
23268037|NCT00824265|64725186|FG001|Treatment Phase|Lost to Follow-up|1|||
23268038|NCT00824265|64725185|FG000|Treatment Phase|Physician Decision|6|||
23268039|NCT00824265|64725186|FG001|Treatment Phase|Physician Decision|12|||
23268040|NCT00824265|64725185|FG000|Treatment Phase|Withdrawal by Subject|6|||
23268041|NCT00824265|64725186|FG001|Treatment Phase|Withdrawal by Subject|15|||
23268042|NCT00824265|64725185|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
23268043|NCT00824265|64725186|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
23268044|NCT00824265|64725185|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
23268045|NCT00824265|64725186|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
23268046|NCT01256684|64725187|FG000|Overall Study|Adverse Event|1|||
23268047|NCT01256684|64725188|FG001|Overall Study|Adverse Event|4|||
23268048|NCT01256684|64725189|FG002|Overall Study|Adverse Event|2|||
23268049|NCT01256684|64725187|FG000|Overall Study|Withdrawal by Subject|4|||
23268050|NCT01256684|64725188|FG001|Overall Study|Withdrawal by Subject|0|||
23268051|NCT01256684|64725189|FG002|Overall Study|Withdrawal by Subject|2|||
23268052|NCT01256684|64725187|FG000|Overall Study|Physician Decision|0|||
23268053|NCT01256684|64725188|FG001|Overall Study|Physician Decision|1|||
23268054|NCT01256684|64725189|FG002|Overall Study|Physician Decision|0|||
23268055|NCT01256684|64725187|FG000|Overall Study|Lack of Efficacy|0|||
23268056|NCT01256684|64725188|FG001|Overall Study|Lack of Efficacy|1|||
23364535|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
23364536|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364537|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23268057|NCT01256684|64725189|FG002|Overall Study|Lack of Efficacy|1|||
23268058|NCT01256684|64725187|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
23364538|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364539|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23268059|NCT01256684|64725188|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
23268060|NCT01256684|64725189|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
23268061|NCT02016300|64725190|FG000|Overall Study|Lost to Follow-up|0|||
23268062|NCT02016300|64725191|FG001|Overall Study|Lost to Follow-up|3|||
23268063|NCT01180244|64725194|FG000|Overall Study|Lack of Efficacy|0|||
23268064|NCT01180244|64725195|FG001|Overall Study|Lack of Efficacy|7|||
23268065|NCT01180244|64725194|FG000|Overall Study|Physician Decision|3|||
23268066|NCT01180244|64725195|FG001|Overall Study|Physician Decision|0|||
23268067|NCT01180244|64725194|FG000|Overall Study|Adverse Event|1|||
23268068|NCT01180244|64725195|FG001|Overall Study|Adverse Event|0|||
23364540|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364541|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
23364542|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
23364543|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
23364544|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
23364545|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364546|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364547|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364548|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364549|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364550|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
23364551|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364552|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364553|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364554|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364555|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364556|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
23364557|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364558|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364559|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364560|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364561|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364562|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364563|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364564|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364565|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
23364566|NCT02326272|65081172|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364567|NCT02326272|65081173|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364568|NCT02326272|65081174|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364569|NCT02326272|65081175|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364570|NCT02326272|65081176|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364571|NCT02326272|65081177|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364572|NCT02326272|65081178|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
23364573|NCT02326272|65081179|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364574|NCT02326272|65081180|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364575|NCT02326272|65081181|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364576|NCT02326272|65081182|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364577|NCT02326272|65081183|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364578|NCT02326272|65081184|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364579|NCT02326272|65081185|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364580|NCT02326272|65081186|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
23364581|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
23364582|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
23364583|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
23364584|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
23364585|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
23364586|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
23364587|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
23364588|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
23364589|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
23364590|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
23364591|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
23364592|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
23268069|NCT01180244|64725194|FG000|Overall Study|Withdrawal by Subject|0|||
23268070|NCT01180244|64725195|FG001|Overall Study|Withdrawal by Subject|1|||
23268071|NCT01180244|64725194|FG000|Overall Study|Protocol Violation|1|||
23268072|NCT01180244|64725195|FG001|Overall Study|Protocol Violation|0|||
23268073|NCT01180244|64725194|FG000|Overall Study|Lost to Follow-up|1|||
23268074|NCT01180244|64725195|FG001|Overall Study|Lost to Follow-up|0|||
23268075|NCT01475838|64725198|FG000|Randomized Phase|Randomized but Not Treated|0|||
23268076|NCT01475838|64725199|FG001|Randomized Phase|Randomized but Not Treated|5|||
23268077|NCT01475838|64725198|FG000|Randomized Phase|Adverse Event|6|||
23268078|NCT01475838|64725199|FG001|Randomized Phase|Adverse Event|1|||
23268079|NCT01475838|64725198|FG000|Randomized Phase|Pregnancy|0|||
23268080|NCT01475838|64725199|FG001|Randomized Phase|Pregnancy|1|||
23268081|NCT01475838|64725198|FG000|Randomized Phase|Investigators Discretion|1|||
23268082|NCT01475838|64725199|FG001|Randomized Phase|Investigators Discretion|2|||
23268083|NCT01475838|64725198|FG000|Randomized Phase|Withdrew Consent|10|||
23268084|NCT01475838|64725199|FG001|Randomized Phase|Withdrew Consent|14|||
23268085|NCT01475838|64725198|FG000|Randomized Phase|Lost to Follow-up|3|||
23268086|NCT01475838|64725199|FG001|Randomized Phase|Lost to Follow-up|4|||
23268087|NCT01475838|64725198|FG000|Randomized Phase|Participant Noncompliance|1|||
23268088|NCT01475838|64725199|FG001|Randomized Phase|Participant Noncompliance|5|||
23268089|NCT01475838|64725198|FG000|Randomized Phase|Protocol Violation|9|||
23268090|NCT01475838|64725199|FG001|Randomized Phase|Protocol Violation|4|||
23268091|NCT01475838|64725198|FG000|Extension Phase|Participant Noncompliance|1|||
23268092|NCT01475838|64725199|FG001|Extension Phase|Participant Noncompliance|0|||
23268093|NCT00510510|64725200|FG000|Overall Study|Adverse Event|4|||
23268094|NCT00510510|64725201|FG001|Overall Study|Adverse Event|3|||
23268095|NCT00510510|64725202|FG002|Overall Study|Adverse Event|6|||
23268096|NCT00510510|64725200|FG000|Overall Study|Lack of Efficacy|0|||
23268097|NCT00510510|64725201|FG001|Overall Study|Lack of Efficacy|1|||
23268098|NCT00510510|64725202|FG002|Overall Study|Lack of Efficacy|1|||
23268099|NCT00510510|64725200|FG000|Overall Study|Subjects no longer requires study drug|0|||
23268100|NCT00510510|64725201|FG001|Overall Study|Subjects no longer requires study drug|0|||
23268101|NCT00510510|64725202|FG002|Overall Study|Subjects no longer requires study drug|2|||
23268102|NCT00510510|64725200|FG000|Overall Study|Withdrawal by Subject|1|||
23268103|NCT00510510|64725201|FG001|Overall Study|Withdrawal by Subject|2|||
23268104|NCT00510510|64725202|FG002|Overall Study|Withdrawal by Subject|3|||
23268105|NCT00510510|64725200|FG000|Overall Study|Lost to Follow-up|0|||
23268106|NCT00510510|64725201|FG001|Overall Study|Lost to Follow-up|0|||
23268107|NCT00510510|64725202|FG002|Overall Study|Lost to Follow-up|1|||
23268108|NCT00510510|64725200|FG000|Overall Study|Protocol Violation|0|||
23268109|NCT00510510|64725201|FG001|Overall Study|Protocol Violation|3|||
23268110|NCT00510510|64725202|FG002|Overall Study|Protocol Violation|4|||
23268111|NCT02799602|64725203|FG000|Overall Study|Protocol Violation|1|||
23268112|NCT02799602|64725204|FG001|Overall Study|Protocol Violation|0|||
23268113|NCT02799602|64725203|FG000|Overall Study|Physician Decision|5|||
23268114|NCT02799602|64725204|FG001|Overall Study|Physician Decision|6|||
23268115|NCT02799602|64725203|FG000|Overall Study|Lost to Follow-up|4|||
23268116|NCT02799602|64725204|FG001|Overall Study|Lost to Follow-up|2|||
23268117|NCT02799602|64725203|FG000|Overall Study|Additional primary malignancy|11|||
23268118|NCT02799602|64725204|FG001|Overall Study|Additional primary malignancy|6|||
23268119|NCT02799602|64725203|FG000|Overall Study|Non-compliance with study drug|14|||
23268120|NCT02799602|64725204|FG001|Overall Study|Non-compliance with study drug|12|||
23268121|NCT02799602|64725203|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
23268122|NCT02799602|64725204|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
23268123|NCT02799602|64725203|FG000|Overall Study|Withdrawal by Subject|26|||
23268124|NCT02799602|64725204|FG001|Overall Study|Withdrawal by Subject|40|||
23268125|NCT02799602|64725203|FG000|Overall Study|Progressive disease - clinical progression|131|||
23268126|NCT02799602|64725204|FG001|Overall Study|Progressive disease - clinical progression|276|||
23268127|NCT02799602|64725203|FG000|Overall Study|Progressive disease - radiological progression|90|||
23268128|NCT02799602|64725204|FG001|Overall Study|Progressive disease - radiological progression|133|||
23268129|NCT02799602|64725203|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
23268130|NCT02799602|64725204|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
23268131|NCT02799602|64725203|FG000|Overall Study|Death|9|||
23268132|NCT02799602|64725204|FG001|Overall Study|Death|5|||
23268133|NCT02799602|64725203|FG000|Overall Study|Other|287|||
23268134|NCT02799602|64725204|FG001|Overall Study|Other|118|||
23268135|NCT02799602|64725203|FG000|Overall Study|Study drug never administered|0|||
23268136|NCT02799602|64725204|FG001|Overall Study|Study drug never administered|3|||
23268137|NCT00728949|64725207|FG000|Overall Study|Adverse Event|8|||
23268138|NCT00728949|64725208|FG001|Overall Study|Adverse Event|0|||
23364593|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
23268139|NCT00728949|64725207|FG000|Overall Study|Withdrawal by Subject|2|||
23268140|NCT00728949|64725208|FG001|Overall Study|Withdrawal by Subject|2|||
23268141|NCT00728949|64725207|FG000|Overall Study|Abnormal Lab Results|0|||
23268142|NCT00728949|64725208|FG001|Overall Study|Abnormal Lab Results|2|||
23268143|NCT00728949|64725207|FG000|Overall Study|On treatment at cutoff date|1|||
23268144|NCT00728949|64725208|FG001|Overall Study|On treatment at cutoff date|0|||
23268145|NCT00788125|64725209|FG000|Overall Study|Death|6|||
23268146|NCT00560235|64725210|FG000|Phase 1|Discontinued|8|||
23268147|NCT00560235|64725211|FG001|Phase 1|Discontinued|0|||
23268148|NCT00560235|64725212|FG002|Phase 1|Discontinued|0|||
23268149|NCT00560235|64725210|FG000|Phase 1B|Discontinued|0|||
23268150|NCT00560235|64725211|FG001|Phase 1B|Discontinued|19|||
23364594|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
23364595|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
23364596|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23268151|NCT00560235|64725212|FG002|Phase 1B|Discontinued|0|||
23268152|NCT00560235|64725210|FG000|Phase 2|Discontinued|0|||
23364597|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364598|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364599|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364600|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23482053|NCT03729362|65509377|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
23482054|NCT03729362|65509376|FG000|Overall Study|Adverse Event|0|||
23482055|NCT03729362|65509377|FG001|Overall Study|Adverse Event|1|||
23482056|NCT03729362|65509376|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
23482057|NCT03729362|65509377|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
23482058|NCT01115803|65509378|FG000|Overall Study|Withdrawal by Subject|0|||
23482059|NCT01115803|65509379|FG001|Overall Study|Withdrawal by Subject|0|||
23482060|NCT01115803|65509380|FG002|Overall Study|Withdrawal by Subject|0|||
23482061|NCT01115803|65509381|FG003|Overall Study|Withdrawal by Subject|0|||
23482062|NCT01115803|65509382|FG004|Overall Study|Withdrawal by Subject|0|||
23482063|NCT01115803|65509383|FG005|Overall Study|Withdrawal by Subject|0|||
23482064|NCT01115803|65509384|FG006|Overall Study|Withdrawal by Subject|1|||
23482065|NCT01115803|65509378|FG000|Overall Study|Lost to Follow-up|0|||
23482066|NCT01115803|65509379|FG001|Overall Study|Lost to Follow-up|0|||
23482067|NCT01115803|65509380|FG002|Overall Study|Lost to Follow-up|1|||
23268153|NCT00560235|64725211|FG001|Phase 2|Discontinued|0|||
23482068|NCT01115803|65509381|FG003|Overall Study|Lost to Follow-up|0|||
23601477|NCT03739866|65929960|FG000|Overall Study|Enrolled but not treated|0|||
23601478|NCT03739866|65929961|FG001|Overall Study|Enrolled but not treated|0|||
23482069|NCT01115803|65509382|FG004|Overall Study|Lost to Follow-up|0|||
23482070|NCT01115803|65509383|FG005|Overall Study|Lost to Follow-up|0|||
23482071|NCT01115803|65509384|FG006|Overall Study|Lost to Follow-up|0|||
23482072|NCT01115803|65509378|FG000|Overall Study|Progressive Disease during Cycle1|0|||
23482073|NCT01115803|65509379|FG001|Overall Study|Progressive Disease during Cycle1|0|||
23482074|NCT01115803|65509380|FG002|Overall Study|Progressive Disease during Cycle1|0|||
23482075|NCT01115803|65509381|FG003|Overall Study|Progressive Disease during Cycle1|0|||
23482076|NCT01115803|65509382|FG004|Overall Study|Progressive Disease during Cycle1|0|||
23482077|NCT01115803|65509383|FG005|Overall Study|Progressive Disease during Cycle1|0|||
23482078|NCT01115803|65509384|FG006|Overall Study|Progressive Disease during Cycle1|1|||
23482079|NCT01569464|65509385|FG000|Overall Study|Adverse Event|4|||
23482080|NCT01569464|65509386|FG001|Overall Study|Adverse Event|0|||
23482081|NCT01569464|65509385|FG000|Overall Study|Lack of Efficacy|1|||
23482082|NCT01569464|65509386|FG001|Overall Study|Lack of Efficacy|0|||
23482083|NCT01569464|65509385|FG000|Overall Study|Protocol Violation|1|||
23482084|NCT01569464|65509386|FG001|Overall Study|Protocol Violation|0|||
23482085|NCT01569464|65509385|FG000|Overall Study|Lost to Follow-up|2|||
23482086|NCT01569464|65509386|FG001|Overall Study|Lost to Follow-up|3|||
23482087|NCT01569464|65509385|FG000|Overall Study|Withdrawal by Subject|1|||
23482088|NCT01569464|65509386|FG001|Overall Study|Withdrawal by Subject|1|||
23601479|NCT03739866|65929962|FG002|Overall Study|Enrolled but not treated|1|||
23601480|NCT03739866|65929963|FG003|Overall Study|Enrolled but not treated|0|||
23601481|NCT03739866|65929964|FG004|Overall Study|Enrolled but not treated|1|||
23601482|NCT03739866|65929965|FG005|Overall Study|Enrolled but not treated|0|||
23601483|NCT03739866|65929966|FG006|Overall Study|Enrolled but not treated|0|||
23601484|NCT03739866|65929967|FG007|Overall Study|Enrolled but not treated|0|||
23268154|NCT00560235|64725212|FG002|Phase 2|Discontinued|96|||
23268155|NCT00560235|64725210|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
23268156|NCT00560235|64725211|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
23268157|NCT00560235|64725212|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
23268158|NCT02372409|64725213|FG000|Overall Study|Lost to Follow-up|1|||
23268159|NCT02372409|64725214|FG001|Overall Study|Lost to Follow-up|0|||
23268160|NCT02372409|64725213|FG000|Overall Study|Disease progression|1|||
23268161|NCT02372409|64725214|FG001|Overall Study|Disease progression|1|||
23268162|NCT00620763|64725215|FG000|Period: First Intervention|Withdrawal by Subject|0|||
23268163|NCT00620763|64725216|FG001|Period: First Intervention|Withdrawal by Subject|2|||
23268164|NCT00620763|64725215|FG000|Period: First Intervention|Protocol Violation|0|||
23268165|NCT00620763|64725216|FG001|Period: First Intervention|Protocol Violation|3|||
23268166|NCT00620763|64725215|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
23268167|NCT00620763|64725216|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
23268168|NCT04625114|64725217|FG000|Overall Study|Adverse Event|3|||
23268169|NCT04625114|64725218|FG001|Overall Study|Adverse Event|1|||
23268170|NCT04625114|64725217|FG000|Overall Study|Withdrawal by Subject|2|||
23268171|NCT04625114|64725218|FG001|Overall Study|Withdrawal by Subject|0|||
23268172|NCT01203878|64725219|FG000|Overall Study|Withdrawal by Subject|0|||
23268173|NCT01203878|64725220|FG001|Overall Study|Withdrawal by Subject|0|||
23268174|NCT01203878|64725221|FG002|Overall Study|Withdrawal by Subject|1|||
23268175|NCT01203878|64725219|FG000|Overall Study|Adverse Event|0|||
23268176|NCT01203878|64725220|FG001|Overall Study|Adverse Event|0|||
23364601|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364602|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364603|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364604|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364605|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364606|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
23364607|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
23364608|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
23364609|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
23364610|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
23364611|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364612|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364613|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364614|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364615|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364616|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23268177|NCT01203878|64725221|FG002|Overall Study|Adverse Event|2|||
23268178|NCT03465904|64725222|FG000|Overall Study|Withdrawal by Subject|9|||
23268179|NCT03465904|64725223|FG001|Overall Study|Withdrawal by Subject|5|||
23268180|NCT03465904|64725222|FG000|Overall Study|Lost to Follow-up|10|||
23268181|NCT03465904|64725223|FG001|Overall Study|Lost to Follow-up|9|||
23268182|NCT03465904|64725222|FG000|Overall Study|Protocol Violation|8|||
23268183|NCT03465904|64725223|FG001|Overall Study|Protocol Violation|5|||
23268184|NCT03465904|64725222|FG000|Overall Study|Ineligible for mITT analysis|62|||
23268185|NCT03465904|64725223|FG001|Overall Study|Ineligible for mITT analysis|47|||
23268186|NCT00883090|64725226|FG000|Overall Study|Sponsor's decision|1|||
23268187|NCT00883090|64725226|FG000|Overall Study|Withdrawal by Subject|1|||
23268188|NCT00683293|64725233|FG000|Overall Study|Withdrawal by Subject|2|||
23268189|NCT00683293|64725234|FG001|Overall Study|Withdrawal by Subject|3|||
23268190|NCT03401112|64725235|FG000|Overall Study|Adverse Event|1|||
23364617|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364618|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364619|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23268191|NCT03401112|64725236|FG001|Overall Study|Adverse Event|2|||
23268192|NCT03401112|64725237|FG002|Overall Study|Adverse Event|3|||
23268193|NCT03401112|64725238|FG003|Overall Study|Adverse Event|2|||
23268194|NCT03401112|64725239|FG004|Overall Study|Adverse Event|0|||
23268195|NCT03401112|64725235|FG000|Overall Study|Lost to Follow-up|1|||
23268196|NCT03401112|64725236|FG001|Overall Study|Lost to Follow-up|0|||
23268197|NCT03401112|64725237|FG002|Overall Study|Lost to Follow-up|0|||
23268198|NCT03401112|64725238|FG003|Overall Study|Lost to Follow-up|0|||
23268199|NCT03401112|64725239|FG004|Overall Study|Lost to Follow-up|0|||
23268200|NCT03401112|64725235|FG000|Overall Study|Noncompliance|1|||
23268201|NCT03401112|64725236|FG001|Overall Study|Noncompliance|2|||
23268202|NCT03401112|64725237|FG002|Overall Study|Noncompliance|3|||
23268203|NCT03401112|64725238|FG003|Overall Study|Noncompliance|0|||
23268204|NCT03401112|64725239|FG004|Overall Study|Noncompliance|0|||
23268205|NCT03401112|64725235|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
23364620|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364621|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23364622|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23364623|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
23268206|NCT03401112|64725236|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
23268207|NCT03401112|64725237|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
23268208|NCT03401112|64725238|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
23268209|NCT03401112|64725239|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
23268210|NCT03401112|64725235|FG000|Overall Study|Withdrawal by Subject|0|||
23268211|NCT03401112|64725236|FG001|Overall Study|Withdrawal by Subject|3|||
23364624|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23482089|NCT01569464|65509385|FG000|Overall Study|Other|1|||
23268212|NCT03401112|64725237|FG002|Overall Study|Withdrawal by Subject|2|||
23268213|NCT03401112|64725238|FG003|Overall Study|Withdrawal by Subject|1|||
23482090|NCT01569464|65509386|FG001|Overall Study|Other|1|||
23482091|NCT00397943|65509387|FG000|Overall Study|Unspecified reasons|12|||
23482092|NCT00397943|65509388|FG001|Overall Study|Unspecified reasons|9|||
23482093|NCT00397943|65509389|FG002|Overall Study|Unspecified reasons|0|||
23482094|NCT00397943|65509390|FG003|Overall Study|Unspecified reasons|0|||
23482095|NCT00397943|65509391|FG004|Overall Study|Unspecified reasons|0|||
23482096|NCT03269552|65509394|FG000|Overall Study|Adverse Event|2|||
23482097|NCT02456103|65509395|FG000|Overall Study|Study Closure|207|||
23482098|NCT02456103|65509395|FG000|Overall Study|Physician Decision|1|||
23482099|NCT02456103|65509395|FG000|Overall Study|Required prohibited medications|5|||
23482100|NCT02456103|65509395|FG000|Overall Study|Protocol Violation|1|||
23482101|NCT02456103|65509395|FG000|Overall Study|Adverse Event|5|||
23482102|NCT02456103|65509395|FG000|Overall Study|Abnormal Laboratory Value|2|||
23482103|NCT02456103|65509395|FG000|Overall Study|Lost to Follow-up|1|||
23482104|NCT02456103|65509395|FG000|Overall Study|Withdrawal by Subject|24|||
23482105|NCT01511055|65509396|FG000|Overall Study|Withdrawal by Subject|6|||
23482106|NCT01006603|65509399|FG000|Overall Study|Withdrawal by Subject|17|||
23482107|NCT01006603|65509400|FG001|Overall Study|Withdrawal by Subject|19|||
23482108|NCT01006603|65509399|FG000|Overall Study|Lost to Follow-up|0|||
23482109|NCT01006603|65509400|FG001|Overall Study|Lost to Follow-up|1|||
23482110|NCT01006603|65509399|FG000|Overall Study|Safety reason|1|||
23482111|NCT01006603|65509400|FG001|Overall Study|Safety reason|1|||
23482112|NCT01006603|65509399|FG000|Overall Study|Protocol Violation|1|||
23482113|NCT01006603|65509400|FG001|Overall Study|Protocol Violation|3|||
23482114|NCT01006603|65509399|FG000|Overall Study|Incorrect enrolment|0|||
23482115|NCT01006603|65509400|FG001|Overall Study|Incorrect enrolment|2|||
23482116|NCT01006603|65509399|FG000|Overall Study|Adverse Event|15|||
23482117|NCT01006603|65509400|FG001|Overall Study|Adverse Event|7|||
23482118|NCT01006603|65509399|FG000|Overall Study|Death|1|||
23482119|NCT01006603|65509400|FG001|Overall Study|Death|1|||
23482120|NCT01006603|65509399|FG000|Overall Study|Study specific discontinuation criteria|33|||
23482121|NCT01006603|65509400|FG001|Overall Study|Study specific discontinuation criteria|34|||
23482122|NCT01006603|65509399|FG000|Overall Study|Other|3|||
23482123|NCT01006603|65509400|FG001|Overall Study|Other|7|||
23482124|NCT05672667|65509401|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
23482125|NCT01095094|65509402|FG000|Overall Study|Withdrawal by Subject|1|||
23482126|NCT01095094|65509402|FG000|Overall Study|Death|1|||
23482127|NCT01095094|65509402|FG000|Overall Study|Physician Decision|1|||
23482128|NCT03490981|65509407|FG000|Overall Study|Lost to Follow-up|1|||
23482129|NCT03490981|65509408|FG001|Overall Study|Lost to Follow-up|2|||
23482130|NCT01445548|65509409|FG000|Overall Study|Adverse Event|1|||
23482131|NCT00669409|65509410|FG000|Part 2|Withdrawal by Subject|0|||
23482132|NCT00669409|65509411|FG001|Part 2|Withdrawal by Subject|0|||
23482133|NCT00669409|65509412|FG002|Part 2|Withdrawal by Subject|0|||
23482134|NCT00669409|65509413|FG003|Part 2|Withdrawal by Subject|0|||
23482135|NCT00669409|65509414|FG004|Part 2|Withdrawal by Subject|0|||
23482136|NCT00669409|65509415|FG005|Part 2|Withdrawal by Subject|0|||
23482137|NCT00669409|65509416|FG006|Part 2|Withdrawal by Subject|0|||
23482138|NCT00669409|65509417|FG007|Part 2|Withdrawal by Subject|0|||
23482139|NCT00669409|65509418|FG008|Part 2|Withdrawal by Subject|0|||
23482140|NCT00669409|65509419|FG009|Part 2|Withdrawal by Subject|1|||
23482141|NCT00669409|65509420|FG010|Part 2|Withdrawal by Subject|0|||
23482142|NCT04439253|65509425|FG000|Overall Study|Adverse Event|1|||
23482143|NCT04439253|65509425|FG000|Overall Study|Disease progression|2|||
23482144|NCT04439253|65509425|FG000|Overall Study|Complicating disease|1|||
23482145|NCT02616601|65509426|FG000|Overall Study|Withdrawal by Subject|4|||
23482146|NCT02616601|65509427|FG001|Overall Study|Withdrawal by Subject|4|||
23482147|NCT02616601|65509428|FG002|Overall Study|Withdrawal by Subject|3|||
23482148|NCT02616601|65509426|FG000|Overall Study|Adverse Event|2|||
23482149|NCT02616601|65509427|FG001|Overall Study|Adverse Event|0|||
23482150|NCT02616601|65509428|FG002|Overall Study|Adverse Event|2|||
23482151|NCT02616601|65509426|FG000|Overall Study|Death|1|||
23482152|NCT02616601|65509427|FG001|Overall Study|Death|0|||
23601485|NCT02260154|65929968|FG000|Overall Study|Screening failure|2|||
23601486|NCT02931396|65929969|FG000|Overall Study|Lost to Follow-up|3|||
23482153|NCT02616601|65509428|FG002|Overall Study|Death|0|||
23482154|NCT02616601|65509426|FG000|Overall Study|Lost to Follow-up|1|||
23482155|NCT02616601|65509427|FG001|Overall Study|Lost to Follow-up|0|||
23482156|NCT02616601|65509428|FG002|Overall Study|Lost to Follow-up|1|||
23482157|NCT02616601|65509426|FG000|Overall Study|Non-Compliance with Test Article|1|||
23482158|NCT02616601|65509427|FG001|Overall Study|Non-Compliance with Test Article|0|||
23601487|NCT02931396|65929970|FG001|Overall Study|Lost to Follow-up|0|||
23482159|NCT02616601|65509428|FG002|Overall Study|Non-Compliance with Test Article|1|||
23482160|NCT00331552|65509430|FG000|Period 3: Phase II|Neurological Symptoms|1|||
23482161|NCT00331552|65509431|FG001|Period 3: Phase II|Neurological Symptoms|0|||
23482162|NCT00331552|65509430|FG000|Period 3: Phase II|Severe Nausea|1|||
23482163|NCT00331552|65509431|FG001|Period 3: Phase II|Severe Nausea|0|||
23482164|NCT01465191|65509434|FG000|Overall Study|Protocol Violation|6|||
23601488|NCT02931396|65929969|FG000|Overall Study|Withdrawal by Subject|2|||
23482165|NCT01465191|65509435|FG001|Overall Study|Protocol Violation|3|||
23482166|NCT01465191|65509436|FG002|Overall Study|Protocol Violation|3|||
23482167|NCT01465191|65509434|FG000|Overall Study|Lost to Follow-up|3|||
23482168|NCT01465191|65509435|FG001|Overall Study|Lost to Follow-up|6|||
23482169|NCT01465191|65509436|FG002|Overall Study|Lost to Follow-up|4|||
23482170|NCT02661178|65509437|FG000|Part 1|Protocol Violation|1|||
23482171|NCT02661178|65509438|FG001|Part 1|Protocol Violation|0|||
23482172|NCT02661178|65509439|FG002|Part 1|Protocol Violation|0|||
23482173|NCT02661178|65509440|FG003|Part 1|Protocol Violation|0|||
23482174|NCT02661178|65509441|FG004|Part 1|Protocol Violation|0|||
23482175|NCT02661178|65509442|FG005|Part 1|Protocol Violation|0|||
23482176|NCT02661178|65509443|FG006|Part 1|Protocol Violation|0|||
23482177|NCT02661178|65509444|FG007|Part 1|Protocol Violation|0|||
23482178|NCT02661178|65509445|FG008|Part 1|Protocol Violation|0|||
23482179|NCT02661178|65509446|FG009|Part 1|Protocol Violation|0|||
23482180|NCT02661178|65509447|FG010|Part 1|Protocol Violation|0|||
23482181|NCT02661178|65509448|FG011|Part 1|Protocol Violation|0|||
23482182|NCT02661178|65509449|FG012|Part 1|Protocol Violation|0|||
23482183|NCT02661178|65509450|FG013|Part 1|Protocol Violation|0|||
23482184|NCT02661178|65509451|FG014|Part 1|Protocol Violation|0|||
23482185|NCT00323869|65509453|FG000|Overall Study|Death|1|||
23482186|NCT02093026|65509454|FG000|Overall Study|Adverse Event|26|||
23482187|NCT02093026|65509454|FG000|Overall Study|Death|10|||
23482188|NCT02093026|65509454|FG000|Overall Study|Other|157|||
23482189|NCT02232880|65509455|FG000|Overall Study|study stopped prior to randomization|1|||
23482190|NCT01625260|65509456|FG000|Overall Study|Adverse Event|3|||
23482191|NCT01625260|65509457|FG001|Overall Study|Adverse Event|0|||
23482192|NCT01625260|65509456|FG000|Overall Study|Study Terminated by Investigator|2|||
23482193|NCT01625260|65509457|FG001|Overall Study|Study Terminated by Investigator|0|||
23482194|NCT01625260|65509456|FG000|Overall Study|Disease Progression|2|||
23482195|NCT01625260|65509457|FG001|Overall Study|Disease Progression|0|||
23482196|NCT01625260|65509456|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
23482197|NCT01625260|65509457|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
23482198|NCT00586664|65509459|FG000|Overall Study|Withdrawal by Subject|3|||
23482199|NCT00586664|65509460|FG001|Overall Study|Withdrawal by Subject|7|||
23482200|NCT00586664|65509461|FG002|Overall Study|Withdrawal by Subject|1|||
23482201|NCT00586664|65509459|FG000|Overall Study|Exclusion criteria met|2|||
23482202|NCT00586664|65509460|FG001|Overall Study|Exclusion criteria met|0|||
23482203|NCT00586664|65509461|FG002|Overall Study|Exclusion criteria met|0|||
23482204|NCT00923364|65509462|FG000|Overall Study|Death|3|||
23482205|NCT00923364|65509463|FG001|Overall Study|Death|0|||
23482206|NCT00923364|65509462|FG000|Overall Study|Did not go to transplant|1|||
23482207|NCT00923364|65509463|FG001|Overall Study|Did not go to transplant|0|||
23482208|NCT01879579|65509464|FG000|Overall Study|Phone incompatible with texting platform|3|||
23482209|NCT01879579|65509465|FG001|Overall Study|Phone incompatible with texting platform|0|||
23482210|NCT01879579|65509464|FG000|Overall Study|Did not enroll in texting platform|1|||
23482211|NCT01879579|65509465|FG001|Overall Study|Did not enroll in texting platform|0|||
23482212|NCT01879579|65509464|FG000|Overall Study|Did not initiate insulin treatment|1|||
23482213|NCT01879579|65509465|FG001|Overall Study|Did not initiate insulin treatment|0|||
23482214|NCT01879579|65509464|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
23482215|NCT01879579|65509465|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
23482216|NCT01879579|65509464|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
23482217|NCT01879579|65509465|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
23482218|NCT00645788|65509468|FG000|Overall Study|Did not receive study drug|1|||
23482219|NCT00645788|65509469|FG001|Overall Study|Did not receive study drug|1|||
23482220|NCT00645788|65509470|FG002|Overall Study|Did not receive study drug|0|||
23482221|NCT00645788|65509471|FG003|Overall Study|Did not receive study drug|0|||
23601489|NCT02931396|65929970|FG001|Overall Study|Withdrawal by Subject|0|||
23601490|NCT01530334|65929972|FG000|Overall Study|Adverse Event|3|||
23601491|NCT01530334|65929972|FG000|Overall Study|unknown reason|1|||
23268214|NCT03401112|64725239|FG004|Overall Study|Withdrawal by Subject|0|||
23364625|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
23482222|NCT00645788|65509468|FG000|Overall Study|Adverse Event|4|||
23482223|NCT00645788|65509469|FG001|Overall Study|Adverse Event|9|||
23482224|NCT00645788|65509470|FG002|Overall Study|Adverse Event|5|||
23482225|NCT00645788|65509471|FG003|Overall Study|Adverse Event|3|||
23482226|NCT00645788|65509468|FG000|Overall Study|Lost to Follow-up|1|||
23482227|NCT00645788|65509469|FG001|Overall Study|Lost to Follow-up|0|||
23482228|NCT00645788|65509470|FG002|Overall Study|Lost to Follow-up|0|||
23482229|NCT00645788|65509471|FG003|Overall Study|Lost to Follow-up|0|||
23482230|NCT00645788|65509468|FG000|Overall Study|Protocol Violation|1|||
23482231|NCT00645788|65509469|FG001|Overall Study|Protocol Violation|0|||
23482232|NCT00645788|65509470|FG002|Overall Study|Protocol Violation|2|||
23482233|NCT00645788|65509471|FG003|Overall Study|Protocol Violation|0|||
23482234|NCT00645788|65509468|FG000|Overall Study|Withdrawal by Subject|0|||
23482235|NCT00645788|65509469|FG001|Overall Study|Withdrawal by Subject|1|||
23482236|NCT00645788|65509470|FG002|Overall Study|Withdrawal by Subject|0|||
23482237|NCT00645788|65509471|FG003|Overall Study|Withdrawal by Subject|2|||
23268215|NCT03401112|64725235|FG000|Overall Study|Physician Decision|0|||
23268216|NCT03401112|64725236|FG001|Overall Study|Physician Decision|0|||
23268217|NCT03401112|64725237|FG002|Overall Study|Physician Decision|0|||
23268218|NCT03401112|64725238|FG003|Overall Study|Physician Decision|2|||
23268219|NCT03401112|64725239|FG004|Overall Study|Physician Decision|0|||
23268220|NCT03401112|64725235|FG000|Overall Study|Study was Terminated by Sponsor|0|||
23268221|NCT03401112|64725236|FG001|Overall Study|Study was Terminated by Sponsor|0|||
23268222|NCT03401112|64725237|FG002|Overall Study|Study was Terminated by Sponsor|0|||
23268223|NCT03401112|64725238|FG003|Overall Study|Study was Terminated by Sponsor|1|||
23268224|NCT03401112|64725239|FG004|Overall Study|Study was Terminated by Sponsor|0|||
23268225|NCT03401112|64725235|FG000|Overall Study|Day 1 Assessment not Done|1|||
23268226|NCT03401112|64725236|FG001|Overall Study|Day 1 Assessment not Done|0|||
23268227|NCT03401112|64725237|FG002|Overall Study|Day 1 Assessment not Done|0|||
23268228|NCT03401112|64725238|FG003|Overall Study|Day 1 Assessment not Done|0|||
23268229|NCT03401112|64725239|FG004|Overall Study|Day 1 Assessment not Done|0|||
23268230|NCT03401112|64725235|FG000|Overall Study|Not Dosed|0|||
23268231|NCT03401112|64725236|FG001|Overall Study|Not Dosed|0|||
23268232|NCT03401112|64725237|FG002|Overall Study|Not Dosed|1|||
23268233|NCT03401112|64725238|FG003|Overall Study|Not Dosed|0|||
23268234|NCT03401112|64725239|FG004|Overall Study|Not Dosed|0|||
23268235|NCT03401112|64725235|FG000|Overall Study|Missed Clinical Visit|0|||
23268236|NCT03401112|64725236|FG001|Overall Study|Missed Clinical Visit|0|||
23268237|NCT03401112|64725237|FG002|Overall Study|Missed Clinical Visit|1|||
23268238|NCT03401112|64725238|FG003|Overall Study|Missed Clinical Visit|0|||
23364626|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364627|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364628|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364629|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364630|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364631|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364632|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364633|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364634|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364635|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364636|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364637|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
23364638|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364639|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364640|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
23364641|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364642|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364643|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364644|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364645|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364646|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364647|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364648|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364649|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364650|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364651|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
23364652|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364653|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
23364654|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
23364655|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
23364656|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364657|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364658|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364659|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364660|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364661|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364662|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23601492|NCT01530334|65929972|FG000|Overall Study|Progressive disease|47|||
23268239|NCT03401112|64725239|FG004|Overall Study|Missed Clinical Visit|0|||
23268240|NCT03401112|64725235|FG000|Overall Study|Missed Doses|0|||
23268241|NCT03401112|64725236|FG001|Overall Study|Missed Doses|0|||
23268242|NCT03401112|64725237|FG002|Overall Study|Missed Doses|1|||
23268243|NCT03401112|64725238|FG003|Overall Study|Missed Doses|0|||
23268244|NCT03401112|64725239|FG004|Overall Study|Missed Doses|0|||
23268245|NCT01374919|64725240|FG000|Overall Study|Withdrawal by Subject|2|||
23268246|NCT00623779|64725241|FG000|Overall Study|Adverse Event|1|||
23268247|NCT00623779|64725242|FG001|Overall Study|Adverse Event|3|||
23268248|NCT00623779|64725243|FG002|Overall Study|Adverse Event|0|||
23268249|NCT00623779|64725241|FG000|Overall Study|Criteria from CSR|2|||
23268250|NCT00623779|64725242|FG001|Overall Study|Criteria from CSR|0|||
23268251|NCT00623779|64725243|FG002|Overall Study|Criteria from CSR|1|||
23268252|NCT02801877|64725246|FG000|Overall Study|Lost to Follow-up|1|||
23268253|NCT02801877|64725247|FG001|Overall Study|Lost to Follow-up|1|||
23268254|NCT02801877|64725248|FG002|Overall Study|Lost to Follow-up|2|||
23268255|NCT02801877|64725249|FG003|Overall Study|Lost to Follow-up|0|||
23268256|NCT02801877|64725246|FG000|Overall Study|Never Started Treatment|2|||
23268257|NCT02801877|64725247|FG001|Overall Study|Never Started Treatment|0|||
23268258|NCT02801877|64725248|FG002|Overall Study|Never Started Treatment|4|||
23268259|NCT02801877|64725249|FG003|Overall Study|Never Started Treatment|0|||
23268260|NCT00667095|64725250|FG000|Overall Study|Withdrawal by Subject|0|||
23268261|NCT00667095|64725251|FG001|Overall Study|Withdrawal by Subject|1|||
23268262|NCT00101582|64725252|FG000|Overall Study|Ineligibility determined|0|||
23268263|NCT00101582|64725253|FG001|Overall Study|Ineligibility determined|1|||
23268264|NCT00101582|64725252|FG000|Overall Study|Adverse Event|1|||
23268265|NCT00101582|64725253|FG001|Overall Study|Adverse Event|4|||
23268266|NCT00101582|64725252|FG000|Overall Study|Withdrawal by Subject|6|||
23268267|NCT00101582|64725253|FG001|Overall Study|Withdrawal by Subject|4|||
23268268|NCT00101582|64725252|FG000|Overall Study|Physician Decision|1|||
23268269|NCT00101582|64725253|FG001|Overall Study|Physician Decision|0|||
23268270|NCT00101582|64725252|FG000|Overall Study|Death|3|||
23268271|NCT00101582|64725253|FG001|Overall Study|Death|5|||
23268272|NCT00101582|64725252|FG000|Overall Study|Other|0|||
23268273|NCT00101582|64725253|FG001|Overall Study|Other|1|||
23268274|NCT04149964|64725257|FG000|Overall Study|Lost to Follow-up|19|||
23268275|NCT04149964|64725258|FG001|Overall Study|Lost to Follow-up|18|||
23268276|NCT03553823|64725265|FG000|Overall Study|Physician Decision|0|||
23268277|NCT03553823|64725266|FG001|Overall Study|Physician Decision|1|||
23268278|NCT02336737|64725273|FG000|Overall Study|Withdrawal by Subject|5|||
23268279|NCT02336737|64725273|FG000|Overall Study|Physician Decision|8|||
23268280|NCT05150964|64725280|FG000|Overall Study|Lost to Follow-up|2|||
23268281|NCT00984295|64725281|FG000|Overall Study|Lost to Follow-up|31|||
23268282|NCT00984295|64725282|FG001|Overall Study|Lost to Follow-up|12|||
23268283|NCT00984295|64725283|FG002|Overall Study|Lost to Follow-up|13|||
23268284|NCT00984295|64725281|FG000|Overall Study|Protocol Violation|2|||
23268285|NCT00984295|64725282|FG001|Overall Study|Protocol Violation|1|||
23268286|NCT00984295|64725283|FG002|Overall Study|Protocol Violation|4|||
23268287|NCT00984295|64725281|FG000|Overall Study|Withdrawal by Subject|18|||
23268288|NCT00984295|64725282|FG001|Overall Study|Withdrawal by Subject|9|||
23268289|NCT00984295|64725283|FG002|Overall Study|Withdrawal by Subject|12|||
23268290|NCT00984295|64725281|FG000|Overall Study|CAE - discontinued test vaccine|0|||
23268291|NCT00984295|64725282|FG001|Overall Study|CAE - discontinued test vaccine|1|||
23268292|NCT00984295|64725283|FG002|Overall Study|CAE - discontinued test vaccine|3|||
23268293|NCT00984295|64725281|FG000|Overall Study|Missed one or more blood samplings|3|||
23268294|NCT00984295|64725282|FG001|Overall Study|Missed one or more blood samplings|7|||
23268295|NCT00984295|64725283|FG002|Overall Study|Missed one or more blood samplings|2|||
23268296|NCT00984295|64725281|FG000|Overall Study|Incomplete safety follow-up|11|||
23268297|NCT00984295|64725282|FG001|Overall Study|Incomplete safety follow-up|2|||
23268298|NCT00984295|64725283|FG002|Overall Study|Incomplete safety follow-up|3|||
23268299|NCT02433678|64725286|FG000|Overall Study|Lost to Follow-up|1|||
23268300|NCT02433678|64725287|FG001|Overall Study|Lost to Follow-up|2|||
23268301|NCT00322491|64725288|FG000|Overall Study|Adverse Event|1|||
23268302|NCT00322491|64725289|FG001|Overall Study|Adverse Event|0|||
23268303|NCT00322491|64725288|FG000|Overall Study|Death|1|||
23268304|NCT00322491|64725289|FG001|Overall Study|Death|2|||
23268305|NCT02720510|64725296|FG000|Overall Study|Study Terminated by the sponsor|2|||
23268306|NCT02720510|64725297|FG001|Overall Study|Study Terminated by the sponsor|0|||
23268307|NCT02720510|64725296|FG000|Overall Study|Adverse Event|0|||
23268308|NCT02720510|64725297|FG001|Overall Study|Adverse Event|1|||
23268309|NCT02720510|64725296|FG000|Overall Study|Physician Decision|1|||
23268310|NCT02720510|64725297|FG001|Overall Study|Physician Decision|2|||
23268311|NCT00870870|64725298|FG000|Overall Study|Withdrawal by Subject|0|||
23268312|NCT00870870|64725299|FG001|Overall Study|Withdrawal by Subject|1|||
23268313|NCT00870870|64725300|FG002|Overall Study|Withdrawal by Subject|1|||
23268314|NCT00870870|64725301|FG003|Overall Study|Withdrawal by Subject|3|||
23268315|NCT00870870|64725298|FG000|Overall Study|Adverse Event|0|||
23268316|NCT00870870|64725299|FG001|Overall Study|Adverse Event|0|||
23268317|NCT00870870|64725300|FG002|Overall Study|Adverse Event|2|||
23268318|NCT00870870|64725301|FG003|Overall Study|Adverse Event|2|||
23268319|NCT01739790|64725313|FG000|Overall Study|Early Trial Termination|2|||
23268320|NCT01739790|64725314|FG001|Overall Study|Early Trial Termination|4|||
23364663|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364664|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364665|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364666|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364667|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
23364668|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364669|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
23364670|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
23364671|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364672|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364673|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364674|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364675|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364676|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364677|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364678|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364679|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364680|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364681|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364682|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
23364683|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
23364684|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
23364685|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
23364686|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364687|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364688|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364689|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364690|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364691|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364692|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364693|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364694|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364695|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364696|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364697|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
23364698|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364699|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364700|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
23364701|NCT02326272|65081172|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364702|NCT02326272|65081173|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364703|NCT02326272|65081174|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364704|NCT02326272|65081175|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23601493|NCT01185600|65929973|FG000|Overall Study|Adverse Event|1|||
23601494|NCT01185600|65929974|FG001|Overall Study|Adverse Event|1|||
23601495|NCT01185600|65929973|FG000|Overall Study|Death|0|||
23601496|NCT01185600|65929974|FG001|Overall Study|Death|1|||
23601497|NCT01185600|65929973|FG000|Overall Study|Lost to Follow-up|0|||
23601498|NCT01185600|65929974|FG001|Overall Study|Lost to Follow-up|5|||
23601499|NCT01185600|65929973|FG000|Overall Study|Physician Decision|29|||
23601500|NCT01185600|65929974|FG001|Overall Study|Physician Decision|35|||
23601501|NCT01185600|65929973|FG000|Overall Study|Withdrawal by Subject|1|||
23601502|NCT01185600|65929974|FG001|Overall Study|Withdrawal by Subject|1|||
23601503|NCT01185600|65929973|FG000|Overall Study|Hold by DSMB|1|||
23601504|NCT01185600|65929974|FG001|Overall Study|Hold by DSMB|2|||
23364705|NCT02326272|65081176|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364706|NCT02326272|65081177|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364707|NCT02326272|65081178|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23601505|NCT02538900|65929975|FG000|Overall Study|Death|2|||
23601506|NCT02538900|65929976|FG001|Overall Study|Death|2|||
23601507|NCT02538900|65929977|FG002|Overall Study|Death|2|||
23364708|NCT02326272|65081179|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364709|NCT02326272|65081180|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364710|NCT02326272|65081181|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364711|NCT02326272|65081182|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364712|NCT02326272|65081183|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364713|NCT02326272|65081184|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
23364714|NCT02326272|65081185|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364715|NCT02326272|65081186|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
23364716|NCT00917124|65081200|FG000|Overall Study|Protocol Violation|4|||
23364717|NCT00917124|65081201|FG001|Overall Study|Protocol Violation|6|||
23364718|NCT03101150|65081202|FG000|Overall Study|Lost to Follow-up|2|||
23364719|NCT03101150|65081203|FG001|Overall Study|Lost to Follow-up|4|||
23364720|NCT03101150|65081202|FG000|Overall Study|Miscarriage|3|||
23364721|NCT03101150|65081203|FG001|Overall Study|Miscarriage|6|||
23364722|NCT03589807|65081210|FG000|Overall Study|Lost to Follow-up|0|||
23364723|NCT03589807|65081211|FG001|Overall Study|Lost to Follow-up|2|||
23364724|NCT03589807|65081212|FG002|Overall Study|Lost to Follow-up|2|||
23364725|NCT03589807|65081213|FG003|Overall Study|Lost to Follow-up|3|||
23601508|NCT02538900|65929975|FG000|Overall Study|Withdrawal by Subject|18|||
23364726|NCT03589807|65081214|FG004|Overall Study|Lost to Follow-up|1|||
23364727|NCT03589807|65081215|FG005|Overall Study|Lost to Follow-up|1|||
23364728|NCT03589807|65081210|FG000|Overall Study|Withdrawal by Subject|0|||
23364729|NCT03589807|65081211|FG001|Overall Study|Withdrawal by Subject|5|||
23364730|NCT03589807|65081212|FG002|Overall Study|Withdrawal by Subject|0|||
23364731|NCT03589807|65081213|FG003|Overall Study|Withdrawal by Subject|0|||
23364732|NCT03589807|65081214|FG004|Overall Study|Withdrawal by Subject|0|||
23364733|NCT03589807|65081215|FG005|Overall Study|Withdrawal by Subject|0|||
23364734|NCT03589807|65081210|FG000|Overall Study|Protocol Violation|0|||
23364735|NCT03589807|65081211|FG001|Overall Study|Protocol Violation|0|||
23364736|NCT03589807|65081212|FG002|Overall Study|Protocol Violation|0|||
23364737|NCT03589807|65081213|FG003|Overall Study|Protocol Violation|1|||
23364738|NCT03589807|65081214|FG004|Overall Study|Protocol Violation|0|||
23364739|NCT03589807|65081215|FG005|Overall Study|Protocol Violation|0|||
23364740|NCT03589807|65081210|FG000|Overall Study|Enrolled but treatment not administered|0|||
23364741|NCT03589807|65081211|FG001|Overall Study|Enrolled but treatment not administered|0|||
23364742|NCT03589807|65081212|FG002|Overall Study|Enrolled but treatment not administered|0|||
23601509|NCT02538900|65929976|FG001|Overall Study|Withdrawal by Subject|16|||
23601510|NCT02538900|65929977|FG002|Overall Study|Withdrawal by Subject|15|||
23601511|NCT00380250|65933777|FG000|Overall Study|Withdrawal by Subject|39|||
23601512|NCT00380250|65933778|FG001|Overall Study|Withdrawal by Subject|28|||
23601513|NCT00380250|65933777|FG000|Overall Study|Adverse Event|20|||
23601514|NCT00380250|65933778|FG001|Overall Study|Adverse Event|9|||
23268321|NCT01919190|64725319|FG000|Overall Study|Intra-op findings, etc.|3|||
23268322|NCT01919190|64725320|FG001|Overall Study|Intra-op findings, etc.|0|||
23268323|NCT01273181|64725321|FG000|Phase I, Dose 1|Study termination|1|||
23268324|NCT01273181|64725322|FG001|Phase I, Dose 1|Study termination|0|||
23268325|NCT01273181|64725323|FG002|Phase I, Dose 1|Study termination|0|||
23268326|NCT01273181|64725324|FG003|Phase I, Dose 1|Study termination|0|||
23601515|NCT00380250|65933777|FG000|Overall Study|Lack of Efficacy|10|||
23601516|NCT00380250|65933778|FG001|Overall Study|Lack of Efficacy|8|||
23601517|NCT00380250|65933777|FG000|Overall Study|Protocol Violation|15|||
23268327|NCT01273181|64725321|FG000|Phase I, Dose 2|Death during treatment|0|||
23268328|NCT01273181|64725322|FG001|Phase I, Dose 2|Death during treatment|1|||
23268329|NCT01273181|64725323|FG002|Phase I, Dose 2|Death during treatment|0|||
23268330|NCT01273181|64725324|FG003|Phase I, Dose 2|Death during treatment|0|||
23268331|NCT01273181|64725321|FG000|Phase 2, Dose 1|Study termination|0|||
23268332|NCT01273181|64725322|FG001|Phase 2, Dose 1|Study termination|0|||
23364743|NCT03589807|65081213|FG003|Overall Study|Enrolled but treatment not administered|0|||
23601518|NCT00380250|65933778|FG001|Overall Study|Protocol Violation|5|||
23601519|NCT00380250|65933777|FG000|Overall Study|Lost to Follow-up|14|||
23268333|NCT01273181|64725323|FG002|Phase 2, Dose 1|Study termination|1|||
23268334|NCT01273181|64725324|FG003|Phase 2, Dose 1|Study termination|0|||
23268335|NCT01273181|64725321|FG000|Phase 2, Dose 2|Death during treatment|0|||
23268336|NCT01273181|64725322|FG001|Phase 2, Dose 2|Death during treatment|0|||
23268337|NCT01273181|64725323|FG002|Phase 2, Dose 2|Death during treatment|0|||
23268338|NCT01273181|64725324|FG003|Phase 2, Dose 2|Death during treatment|1|||
23268339|NCT00977106|64725327|FG000|Overall Study|Adverse Event|5|||
23364744|NCT03589807|65081214|FG004|Overall Study|Enrolled but treatment not administered|1|||
23364745|NCT03589807|65081215|FG005|Overall Study|Enrolled but treatment not administered|0|||
23364746|NCT00627497|65081217|FG000|Overall Study|Lost to Follow-up|1|||
23364747|NCT00627497|65081218|FG001|Overall Study|Lost to Follow-up|1|||
23364748|NCT00627497|65081219|FG002|Overall Study|Lost to Follow-up|0|||
23364749|NCT00627497|65081220|FG003|Overall Study|Lost to Follow-up|0|||
23364750|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
23364751|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
23364752|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
23364753|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
23364754|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
23364755|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
23364756|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
23364757|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
23364758|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
23364759|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
23268340|NCT00977106|64725328|FG001|Overall Study|Adverse Event|6|||
23268341|NCT00977106|64725327|FG000|Overall Study|Withdrawal by Subject|2|||
23268342|NCT00977106|64725328|FG001|Overall Study|Withdrawal by Subject|2|||
23268343|NCT00977106|64725327|FG000|Overall Study|Lack of Efficacy|2|||
23268344|NCT00977106|64725328|FG001|Overall Study|Lack of Efficacy|2|||
23268345|NCT00977106|64725327|FG000|Overall Study|Protocol Violation|0|||
23268346|NCT00977106|64725328|FG001|Overall Study|Protocol Violation|1|||
23268347|NCT00977106|64725327|FG000|Overall Study|Other|1|||
23268348|NCT00977106|64725328|FG001|Overall Study|Other|0|||
23268349|NCT01494506|64725329|FG000|Overall Study|Lack of Efficacy|77|||
23268350|NCT01494506|64725330|FG001|Overall Study|Lack of Efficacy|83|||
23268351|NCT01494506|64725331|FG002|Overall Study|Lack of Efficacy|57|||
23268352|NCT01494506|64725329|FG000|Overall Study|Adverse Event|17|||
23268353|NCT01494506|64725330|FG001|Overall Study|Adverse Event|10|||
23268354|NCT01494506|64725331|FG002|Overall Study|Adverse Event|11|||
23268355|NCT01494506|64725329|FG000|Overall Study|Death|9|||
23268356|NCT01494506|64725330|FG001|Overall Study|Death|5|||
23268357|NCT01494506|64725331|FG002|Overall Study|Death|2|||
23268358|NCT01494506|64725329|FG000|Overall Study|Physician Decision|7|||
23268359|NCT01494506|64725330|FG001|Overall Study|Physician Decision|5|||
23268360|NCT01494506|64725331|FG002|Overall Study|Physician Decision|4|||
23268361|NCT01494506|64725329|FG000|Overall Study|Withdrawal by Subject|17|||
23268362|NCT01494506|64725330|FG001|Overall Study|Withdrawal by Subject|20|||
23268363|NCT01494506|64725331|FG002|Overall Study|Withdrawal by Subject|14|||
23268364|NCT01494506|64725329|FG000|Overall Study|Clinical Deterioration|21|||
23268365|NCT01494506|64725330|FG001|Overall Study|Clinical Deterioration|17|||
23268366|NCT01494506|64725331|FG002|Overall Study|Clinical Deterioration|13|||
23268367|NCT01494506|64725329|FG000|Overall Study|Sponsor Decision|0|||
23268368|NCT01494506|64725330|FG001|Overall Study|Sponsor Decision|0|||
23268369|NCT01494506|64725331|FG002|Overall Study|Sponsor Decision|1|||
23268370|NCT01494506|64725329|FG000|Overall Study|Other|0|||
23268371|NCT01494506|64725330|FG001|Overall Study|Other|3|||
23268372|NCT01494506|64725331|FG002|Overall Study|Other|1|||
23268373|NCT03213210|64725332|FG000|Overall Study|Lost to Follow-up|2|||
23268374|NCT03213210|64725332|FG000|Overall Study|Study termination|3|||
23268375|NCT00436007|64725333|FG000|Overall Study|Withdrawal by Subject|5|||
23268376|NCT00436007|64725334|FG001|Overall Study|Withdrawal by Subject|3|||
23268377|NCT00436007|64725335|FG002|Overall Study|Withdrawal by Subject|4|||
23268378|NCT00436007|64725333|FG000|Overall Study|Lost to Follow-up|14|||
23364760|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
23364761|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
23364762|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
23364763|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
23364764|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
23364765|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
23268379|NCT00436007|64725334|FG001|Overall Study|Lost to Follow-up|10|||
23601520|NCT00380250|65933778|FG001|Overall Study|Lost to Follow-up|5|||
23364766|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
23268380|NCT00436007|64725335|FG002|Overall Study|Lost to Follow-up|13|||
23268381|NCT00436007|64725333|FG000|Overall Study|Physician Decision|0|||
23268382|NCT00436007|64725334|FG001|Overall Study|Physician Decision|0|||
23268383|NCT00436007|64725335|FG002|Overall Study|Physician Decision|2|||
23268384|NCT00436007|64725333|FG000|Overall Study|Death|0|||
23268385|NCT00436007|64725334|FG001|Overall Study|Death|1|||
23364767|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
23364768|NCT03569098|65081221|FG000|Double-Blind Treatment Cycle 1|Other|1|||
23268386|NCT00436007|64725335|FG002|Overall Study|Death|3|||
23268387|NCT00436007|64725333|FG000|Overall Study|Other|0|||
23268388|NCT00436007|64725334|FG001|Overall Study|Other|0|||
23268389|NCT00436007|64725335|FG002|Overall Study|Other|1|||
23268390|NCT00162123|64725336|FG000|Overall Study|Disease progression|27|||
23268391|NCT00162123|64725337|FG001|Overall Study|Disease progression|19|||
23268392|NCT00162123|64725338|FG002|Overall Study|Disease progression|10|||
23268393|NCT00162123|64725339|FG003|Overall Study|Disease progression|4|||
23268394|NCT00162123|64725340|FG004|Overall Study|Disease progression|8|||
23268395|NCT00162123|64725341|FG005|Overall Study|Disease progression|3|||
23268396|NCT00162123|64725342|FG006|Overall Study|Disease progression|1|||
23268397|NCT00162123|64725343|FG007|Overall Study|Disease progression|0|||
23268398|NCT00162123|64725336|FG000|Overall Study|Study drug toxicity|6|||
23268399|NCT00162123|64725337|FG001|Overall Study|Study drug toxicity|1|||
23268400|NCT00162123|64725338|FG002|Overall Study|Study drug toxicity|5|||
23268401|NCT00162123|64725339|FG003|Overall Study|Study drug toxicity|0|||
23268402|NCT00162123|64725340|FG004|Overall Study|Study drug toxicity|4|||
23268403|NCT00162123|64725341|FG005|Overall Study|Study drug toxicity|1|||
23268404|NCT00162123|64725342|FG006|Overall Study|Study drug toxicity|1|||
23268405|NCT00162123|64725343|FG007|Overall Study|Study drug toxicity|0|||
23268406|NCT00162123|64725336|FG000|Overall Study|Death|3|||
23268407|NCT00162123|64725337|FG001|Overall Study|Death|3|||
23268408|NCT00162123|64725338|FG002|Overall Study|Death|1|||
23268409|NCT00162123|64725339|FG003|Overall Study|Death|1|||
23268410|NCT00162123|64725340|FG004|Overall Study|Death|1|||
23268411|NCT00162123|64725341|FG005|Overall Study|Death|1|||
23268412|NCT00162123|64725342|FG006|Overall Study|Death|0|||
23364769|NCT03569098|65081222|FG001|Double-Blind Treatment Cycle 1|Other|0|||
23364770|NCT03569098|65081223|FG002|Double-Blind Treatment Cycle 1|Other|1|||
23364771|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
23364772|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
23364773|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
23364774|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
23268413|NCT00162123|64725343|FG007|Overall Study|Death|0|||
23268414|NCT00162123|64725336|FG000|Overall Study|Withdrawal by Subject|2|||
23268415|NCT00162123|64725337|FG001|Overall Study|Withdrawal by Subject|0|||
23268416|NCT00162123|64725338|FG002|Overall Study|Withdrawal by Subject|2|||
23364775|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
23364776|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
23364777|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
23364778|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
23364779|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
23364780|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
23364781|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
23268417|NCT00162123|64725339|FG003|Overall Study|Withdrawal by Subject|1|||
23268418|NCT00162123|64725340|FG004|Overall Study|Withdrawal by Subject|1|||
23268419|NCT00162123|64725341|FG005|Overall Study|Withdrawal by Subject|2|||
23268420|NCT00162123|64725342|FG006|Overall Study|Withdrawal by Subject|1|||
23268421|NCT00162123|64725343|FG007|Overall Study|Withdrawal by Subject|0|||
23268422|NCT00162123|64725336|FG000|Overall Study|Deterioration without progression|2|||
23268423|NCT00162123|64725337|FG001|Overall Study|Deterioration without progression|2|||
23268424|NCT00162123|64725338|FG002|Overall Study|Deterioration without progression|3|||
23268425|NCT00162123|64725339|FG003|Overall Study|Deterioration without progression|0|||
23268426|NCT00162123|64725340|FG004|Overall Study|Deterioration without progression|1|||
23268427|NCT00162123|64725341|FG005|Overall Study|Deterioration without progression|0|||
23268428|NCT00162123|64725342|FG006|Overall Study|Deterioration without progression|0|||
23268429|NCT00162123|64725343|FG007|Overall Study|Deterioration without progression|0|||
23268430|NCT00162123|64725336|FG000|Overall Study|Adverse Event|1|||
23364782|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
23364783|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
23601521|NCT00380250|65933777|FG000|Overall Study|Physician Decision|1|||
23268431|NCT00162123|64725337|FG001|Overall Study|Adverse Event|2|||
23268432|NCT00162123|64725338|FG002|Overall Study|Adverse Event|0|||
23268433|NCT00162123|64725339|FG003|Overall Study|Adverse Event|2|||
23268434|NCT00162123|64725340|FG004|Overall Study|Adverse Event|1|||
23268435|NCT00162123|64725341|FG005|Overall Study|Adverse Event|0|||
23268436|NCT00162123|64725342|FG006|Overall Study|Adverse Event|0|||
23268437|NCT00162123|64725343|FG007|Overall Study|Adverse Event|0|||
23268438|NCT00162123|64725336|FG000|Overall Study|Not specified (before treatment)|2|||
23268439|NCT00162123|64725337|FG001|Overall Study|Not specified (before treatment)|0|||
23268440|NCT00162123|64725338|FG002|Overall Study|Not specified (before treatment)|0|||
23364784|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
23268441|NCT00162123|64725339|FG003|Overall Study|Not specified (before treatment)|0|||
23268442|NCT00162123|64725340|FG004|Overall Study|Not specified (before treatment)|12|||
23364785|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
23364786|NCT03569098|65081221|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
23364787|NCT03569098|65081222|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
23364788|NCT03569098|65081223|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
23364789|NCT04396626|65081224|FG000|Overall Study|Premature termination of study|975|||
23364790|NCT00689338|65081230|FG000|Overall Study|Death|65|||
23364791|NCT00689338|65081230|FG000|Overall Study|Adverse Event|13|||
23364792|NCT00689338|65081230|FG000|Overall Study|Insufficient Clinical Response|1|||
23364793|NCT00689338|65081230|FG000|Overall Study|Lack of Efficacy|6|||
23364794|NCT00689338|65081230|FG000|Overall Study|Other|8|||
23364795|NCT00689338|65081230|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
23364796|NCT00689338|65081230|FG000|Overall Study|Lost to Follow-up|5|||
23364797|NCT00689338|65081230|FG000|Overall Study|Withdrawal by Subject|3|||
23364798|NCT00689338|65081230|FG000|Overall Study|Protocol Violation|15|||
23364799|NCT03177148|65081231|FG000|Overall Study|Lost to Follow-up|50|||
23364800|NCT03177148|65081232|FG001|Overall Study|Lost to Follow-up|1|||
23364801|NCT03177148|65081231|FG000|Overall Study|Death|1|||
23364802|NCT03177148|65081232|FG001|Overall Study|Death|0|||
23364803|NCT05133323|65081233|FG000|Overall Study|Lack of Efficacy|0|||
23364804|NCT05133323|65081234|FG001|Overall Study|Lack of Efficacy|0|||
23364805|NCT05133323|65081235|FG002|Overall Study|Lack of Efficacy|1|||
23364806|NCT05133323|65081233|FG000|Overall Study|Withdrawal by Subject|2|||
23364807|NCT05133323|65081234|FG001|Overall Study|Withdrawal by Subject|1|||
23364808|NCT05133323|65081235|FG002|Overall Study|Withdrawal by Subject|0|||
23364809|NCT01519817|65081237|FG000|Overall Study|Withdrawal by Subject|1|||
23364810|NCT01519817|65081238|FG001|Overall Study|Withdrawal by Subject|0|||
23364811|NCT01519817|65081239|FG002|Overall Study|Withdrawal by Subject|0|||
23364812|NCT01519817|65081240|FG003|Overall Study|Withdrawal by Subject|0|||
23364813|NCT01519817|65081237|FG000|Overall Study|Off study due to infection|0|||
23364814|NCT01519817|65081238|FG001|Overall Study|Off study due to infection|0|||
23364815|NCT01519817|65081239|FG002|Overall Study|Off study due to infection|0|||
23364816|NCT01519817|65081240|FG003|Overall Study|Off study due to infection|1|||
23364817|NCT00237692|65081241|FG000|Overall Study|Lost to Follow-up|9|||
23364818|NCT00237692|65081242|FG001|Overall Study|Lost to Follow-up|3|||
23364819|NCT00237692|65081243|FG002|Overall Study|Lost to Follow-up|5|||
23364820|NCT00237692|65081244|FG003|Overall Study|Lost to Follow-up|3|||
23364821|NCT00237692|65081241|FG000|Overall Study|Death|1|||
23364822|NCT00237692|65081242|FG001|Overall Study|Death|2|||
23364823|NCT00237692|65081243|FG002|Overall Study|Death|2|||
23364824|NCT00237692|65081244|FG003|Overall Study|Death|3|||
23364825|NCT00237692|65081241|FG000|Overall Study|Excluded - did not meet criteria|4|||
23364826|NCT00237692|65081242|FG001|Overall Study|Excluded - did not meet criteria|3|||
23364827|NCT00237692|65081243|FG002|Overall Study|Excluded - did not meet criteria|5|||
23364828|NCT00237692|65081244|FG003|Overall Study|Excluded - did not meet criteria|9|||
23364829|NCT00237692|65081241|FG000|Overall Study|Withdrawal by Subject|4|||
23364830|NCT00237692|65081242|FG001|Overall Study|Withdrawal by Subject|6|||
23364831|NCT00237692|65081243|FG002|Overall Study|Withdrawal by Subject|10|||
23364832|NCT00237692|65081244|FG003|Overall Study|Withdrawal by Subject|4|||
23364833|NCT02417753|65081250|FG000|Overall Study|Death|1|||
23364834|NCT01819727|65081253|FG000|Overall Study|Adverse Event|8|||
23364835|NCT01819727|65081254|FG001|Overall Study|Adverse Event|9|||
23364836|NCT01819727|65081253|FG000|Overall Study|Death|1|||
23364837|NCT01819727|65081254|FG001|Overall Study|Death|0|||
23364838|NCT01819727|65081253|FG000|Overall Study|Lost to Follow-up|1|||
23364839|NCT01819727|65081254|FG001|Overall Study|Lost to Follow-up|1|||
23364840|NCT01819727|65081253|FG000|Overall Study|Physician Decision|3|||
23364841|NCT01819727|65081254|FG001|Overall Study|Physician Decision|2|||
23364842|NCT01819727|65081253|FG000|Overall Study|Pregnancy|1|||
23364843|NCT01819727|65081254|FG001|Overall Study|Pregnancy|0|||
23364844|NCT01819727|65081253|FG000|Overall Study|Protocol Violation|0|||
23364845|NCT01819727|65081254|FG001|Overall Study|Protocol Violation|2|||
23364846|NCT01819727|65081253|FG000|Overall Study|Study Terminated by Sponsor|0|||
23364847|NCT01819727|65081254|FG001|Overall Study|Study Terminated by Sponsor|1|||
23364848|NCT01819727|65081253|FG000|Overall Study|Withdrawal by Subject|6|||
23482238|NCT00645788|65509468|FG000|Overall Study|Pulmonary exacerbation|13|||
23364849|NCT01819727|65081254|FG001|Overall Study|Withdrawal by Subject|11|||
23482239|NCT00645788|65509469|FG001|Overall Study|Pulmonary exacerbation|16|||
23482240|NCT00645788|65509470|FG002|Overall Study|Pulmonary exacerbation|11|||
23364850|NCT01819727|65081253|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
23364851|NCT01819727|65081254|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
23364852|NCT01819727|65081253|FG000|Overall Study|Quit due to lack of health benifits|0|||
23364853|NCT01819727|65081254|FG001|Overall Study|Quit due to lack of health benifits|1|||
23364854|NCT02782741|65081255|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
23364855|NCT02782741|65081256|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
23364856|NCT02782741|65081257|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
23364857|NCT02782741|65081255|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
23364858|NCT02782741|65081256|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
23364859|NCT02782741|65081257|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
23364860|NCT02782741|65081255|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
23364861|NCT02782741|65081256|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
23364862|NCT02782741|65081257|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
23364863|NCT02782741|65081255|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
23364864|NCT02782741|65081256|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
23364865|NCT02782741|65081257|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
23364866|NCT02782741|65081255|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
23364867|NCT02782741|65081256|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
23268443|NCT00162123|64725341|FG005|Overall Study|Not specified (before treatment)|1|||
23268444|NCT00162123|64725342|FG006|Overall Study|Not specified (before treatment)|0|||
23268445|NCT00162123|64725343|FG007|Overall Study|Not specified (before treatment)|0|||
23364868|NCT02782741|65081257|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
23364869|NCT00970489|65081258|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
23364870|NCT00970489|65081259|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
23482241|NCT00645788|65509471|FG003|Overall Study|Pulmonary exacerbation|9|||
23268446|NCT00162123|64725336|FG000|Overall Study|Not specified (after start of treatment)|0|||
23268447|NCT00162123|64725337|FG001|Overall Study|Not specified (after start of treatment)|0|||
23268448|NCT00162123|64725338|FG002|Overall Study|Not specified (after start of treatment)|0|||
23268449|NCT00162123|64725339|FG003|Overall Study|Not specified (after start of treatment)|0|||
23268450|NCT00162123|64725340|FG004|Overall Study|Not specified (after start of treatment)|3|||
23268451|NCT00162123|64725341|FG005|Overall Study|Not specified (after start of treatment)|0|||
23268452|NCT00162123|64725342|FG006|Overall Study|Not specified (after start of treatment)|0|||
23268453|NCT00162123|64725343|FG007|Overall Study|Not specified (after start of treatment)|0|||
23268454|NCT00162123|64725336|FG000|Overall Study|Physician Decision|1|||
23268455|NCT00162123|64725337|FG001|Overall Study|Physician Decision|2|||
23268456|NCT00162123|64725338|FG002|Overall Study|Physician Decision|0|||
23268457|NCT00162123|64725339|FG003|Overall Study|Physician Decision|0|||
23268458|NCT00162123|64725340|FG004|Overall Study|Physician Decision|0|||
23268459|NCT00162123|64725341|FG005|Overall Study|Physician Decision|1|||
23268460|NCT00162123|64725342|FG006|Overall Study|Physician Decision|1|||
23482242|NCT04054947|65509472|FG000|Overall Study|Withdrawal by Subject|1|||
23482243|NCT04054947|65509473|FG001|Overall Study|Withdrawal by Subject|0|||
23482244|NCT04054947|65509472|FG000|Overall Study|Lost to Follow-up|2|||
23482245|NCT04054947|65509473|FG001|Overall Study|Lost to Follow-up|5|||
23482246|NCT04761627|65509474|FG000|Run-in Period|Death|1|||
23482247|NCT04761627|65509475|FG001|Run-in Period|Death|0|||
23482248|NCT04761627|65509476|FG002|Run-in Period|Death|0|||
23482249|NCT04761627|65509474|FG000|Run-in Period|Required alternative therapy|2|||
23482250|NCT04761627|65509475|FG001|Run-in Period|Required alternative therapy|0|||
23482251|NCT04761627|65509476|FG002|Run-in Period|Required alternative therapy|0|||
23482252|NCT04761627|65509474|FG000|Run-in Period|Lost to Follow-up|2|||
23482253|NCT04761627|65509475|FG001|Run-in Period|Lost to Follow-up|0|||
23482254|NCT04761627|65509476|FG002|Run-in Period|Lost to Follow-up|0|||
23482255|NCT04761627|65509474|FG000|Run-in Period|Protocol Violation|3|||
23482256|NCT04761627|65509475|FG001|Run-in Period|Protocol Violation|0|||
23482257|NCT04761627|65509476|FG002|Run-in Period|Protocol Violation|0|||
23482258|NCT04761627|65509474|FG000|Run-in Period|Abnormal liver function|1|||
23482259|NCT04761627|65509475|FG001|Run-in Period|Abnormal liver function|0|||
23482260|NCT04761627|65509476|FG002|Run-in Period|Abnormal liver function|0|||
23482261|NCT04761627|65509474|FG000|Run-in Period|Adverse Event|6|||
23482262|NCT04761627|65509475|FG001|Run-in Period|Adverse Event|0|||
23482263|NCT04761627|65509476|FG002|Run-in Period|Adverse Event|0|||
23482264|NCT04761627|65509474|FG000|Run-in Period|Withdrawal by Subject|7|||
23482265|NCT04761627|65509475|FG001|Run-in Period|Withdrawal by Subject|0|||
23482266|NCT04761627|65509476|FG002|Run-in Period|Withdrawal by Subject|0|||
23268461|NCT00162123|64725343|FG007|Overall Study|Physician Decision|0|||
23268462|NCT00162123|64725336|FG000|Overall Study|Tumor assessment only (not treated)|0|||
23268463|NCT00162123|64725337|FG001|Overall Study|Tumor assessment only (not treated)|0|||
23268464|NCT00162123|64725338|FG002|Overall Study|Tumor assessment only (not treated)|0|||
23268465|NCT00162123|64725339|FG003|Overall Study|Tumor assessment only (not treated)|0|||
23268466|NCT00162123|64725340|FG004|Overall Study|Tumor assessment only (not treated)|0|||
23268467|NCT00162123|64725341|FG005|Overall Study|Tumor assessment only (not treated)|0|||
23268468|NCT00162123|64725342|FG006|Overall Study|Tumor assessment only (not treated)|0|||
23268469|NCT00162123|64725343|FG007|Overall Study|Tumor assessment only (not treated)|1|||
23364871|NCT00398216|65081260|FG000|Overall Study|Adverse Event|4|||
23482267|NCT04761627|65509474|FG000|Run-in Period|Did not meet PASI 50|15|||
23482268|NCT04761627|65509475|FG001|Run-in Period|Did not meet PASI 50|0|||
23482269|NCT04761627|65509476|FG002|Run-in Period|Did not meet PASI 50|0|||
23482270|NCT04761627|65509474|FG000|Run-in Period|Study site closure|2|||
23482271|NCT04761627|65509475|FG001|Run-in Period|Study site closure|0|||
23482272|NCT04761627|65509476|FG002|Run-in Period|Study site closure|0|||
23482273|NCT04761627|65509474|FG000|Run-in Period|Pregnancy|2|||
23268470|NCT00162123|64725336|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
23268471|NCT00162123|64725337|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
23268472|NCT00162123|64725338|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
23268473|NCT00162123|64725339|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
23268474|NCT00162123|64725340|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
23268475|NCT00162123|64725341|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
23268476|NCT00162123|64725342|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
23268477|NCT00162123|64725343|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
23268478|NCT03311646|64725345|FG000|Overall Study|Physician Decision|1|||
23268479|NCT03311646|64725345|FG000|Overall Study|Withdrawal by Subject|5|||
23268480|NCT03311646|64725345|FG000|Overall Study|Lost to Follow-up|5|||
23268481|NCT03311646|64725345|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
23268482|NCT00576901|64725346|FG000|Overall Study|Withdrawal by Subject|1|||
23268483|NCT00576901|64725346|FG000|Overall Study|Disease course|1|||
23268484|NCT00576901|64725346|FG000|Overall Study|Protocol Violation|1|||
23268485|NCT00337571|64725347|FG000|Overall Study|Lack of Efficacy|3|||
23268486|NCT00337571|64725348|FG001|Overall Study|Lack of Efficacy|0|||
23268487|NCT00337571|64725349|FG002|Overall Study|Lack of Efficacy|0|||
23268488|NCT00337571|64725350|FG003|Overall Study|Lack of Efficacy|0|||
23268489|NCT00337571|64725347|FG000|Overall Study|Adverse Event|4|||
23268490|NCT00337571|64725348|FG001|Overall Study|Adverse Event|5|||
23268491|NCT00337571|64725349|FG002|Overall Study|Adverse Event|8|||
23268492|NCT00337571|64725350|FG003|Overall Study|Adverse Event|4|||
23268493|NCT00337571|64725347|FG000|Overall Study|Withdrawal by Subject|2|||
23268494|NCT00337571|64725348|FG001|Overall Study|Withdrawal by Subject|2|||
23268495|NCT00337571|64725349|FG002|Overall Study|Withdrawal by Subject|1|||
23268496|NCT00337571|64725350|FG003|Overall Study|Withdrawal by Subject|0|||
23268497|NCT00337571|64725347|FG000|Overall Study|Lost to Follow-up|3|||
23268498|NCT00337571|64725348|FG001|Overall Study|Lost to Follow-up|1|||
23268499|NCT00337571|64725349|FG002|Overall Study|Lost to Follow-up|0|||
23268500|NCT00337571|64725350|FG003|Overall Study|Lost to Follow-up|1|||
23268501|NCT00337571|64725347|FG000|Overall Study|Poor/noncompliance|1|||
23268502|NCT00337571|64725348|FG001|Overall Study|Poor/noncompliance|1|||
23268503|NCT00337571|64725349|FG002|Overall Study|Poor/noncompliance|1|||
23268504|NCT00337571|64725350|FG003|Overall Study|Poor/noncompliance|1|||
23268505|NCT00337571|64725347|FG000|Overall Study|No longer met study criteria|1|||
23268506|NCT00337571|64725348|FG001|Overall Study|No longer met study criteria|0|||
23268507|NCT00337571|64725349|FG002|Overall Study|No longer met study criteria|0|||
23268508|NCT00337571|64725350|FG003|Overall Study|No longer met study criteria|0|||
23268509|NCT00337571|64725347|FG000|Overall Study|High Potassium level|0|||
23268510|NCT00337571|64725348|FG001|Overall Study|High Potassium level|0|||
23268511|NCT00337571|64725349|FG002|Overall Study|High Potassium level|0|||
23268512|NCT00337571|64725350|FG003|Overall Study|High Potassium level|1|||
23268513|NCT02073643|64725356|FG000|Overall Study|Lost to Follow-up|24|||
23268514|NCT02270736|64725357|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
23268515|NCT02270736|64725358|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
23268516|NCT02270736|64725359|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
23268517|NCT02270736|64725360|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
23268518|NCT02270736|64725361|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
23268519|NCT02270736|64725357|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
23268520|NCT02270736|64725358|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
23268521|NCT02270736|64725359|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
23268522|NCT02270736|64725360|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
23268523|NCT02270736|64725361|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
23268524|NCT02270736|64725357|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
23268525|NCT02270736|64725358|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
23268526|NCT02270736|64725359|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
23268527|NCT02270736|64725360|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
23268528|NCT02270736|64725361|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
23268529|NCT02270736|64725357|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
23268530|NCT02270736|64725358|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
23268531|NCT02270736|64725359|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
23601522|NCT00380250|65933778|FG001|Overall Study|Physician Decision|0|||
23268532|NCT02270736|64725360|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
23268533|NCT02270736|64725361|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
23268534|NCT02270736|64725357|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
23268535|NCT02270736|64725358|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
23268536|NCT02270736|64725359|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
23268537|NCT02270736|64725360|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
23268538|NCT02270736|64725361|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
23268539|NCT02270736|64725357|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
23268540|NCT02270736|64725358|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
23268541|NCT02270736|64725359|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
23268542|NCT02270736|64725360|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
23268543|NCT02270736|64725361|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
23268544|NCT02270736|64725357|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
23268545|NCT02270736|64725358|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
23268546|NCT02270736|64725359|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
23268547|NCT02270736|64725360|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
23268548|NCT02270736|64725361|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
23268549|NCT02270736|64725357|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
23268550|NCT02270736|64725358|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
23268551|NCT02270736|64725359|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
23268552|NCT02270736|64725360|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
23268553|NCT02270736|64725361|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
23268554|NCT02270736|64725357|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
23268555|NCT02270736|64725358|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
23268556|NCT02270736|64725359|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
23268557|NCT02270736|64725360|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
23268558|NCT02270736|64725361|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
23268559|NCT00577460|64725362|FG000|Overall Study|Adverse Event|11|||
23268560|NCT00577460|64725363|FG001|Overall Study|Adverse Event|7|||
23268561|NCT00577460|64725364|FG002|Overall Study|Adverse Event|14|||
23268562|NCT00577460|64725362|FG000|Overall Study|Protocol Violation|0|||
23268563|NCT00577460|64725363|FG001|Overall Study|Protocol Violation|1|||
23268564|NCT00577460|64725364|FG002|Overall Study|Protocol Violation|1|||
23268565|NCT00577460|64725362|FG000|Overall Study|Lost to Follow-up|0|||
23268566|NCT00577460|64725363|FG001|Overall Study|Lost to Follow-up|3|||
23268567|NCT00577460|64725364|FG002|Overall Study|Lost to Follow-up|4|||
23268568|NCT00577460|64725362|FG000|Overall Study|Withdrawal by Subject|5|||
23268569|NCT00577460|64725363|FG001|Overall Study|Withdrawal by Subject|5|||
23268570|NCT00577460|64725364|FG002|Overall Study|Withdrawal by Subject|6|||
23268571|NCT00577460|64725362|FG000|Overall Study|Other|0|||
23268572|NCT00577460|64725363|FG001|Overall Study|Other|3|||
23268573|NCT00577460|64725364|FG002|Overall Study|Other|2|||
23268574|NCT01479439|64725365|FG000|Overall Study|Adverse Event|1|||
23268575|NCT01479439|64725366|FG001|Overall Study|Adverse Event|0|||
23268576|NCT01479439|64725367|FG002|Overall Study|Adverse Event|0|||
23268577|NCT01479439|64725365|FG000|Overall Study|Lost to Follow-up|0|||
23268578|NCT01479439|64725366|FG001|Overall Study|Lost to Follow-up|1|||
23268579|NCT01479439|64725367|FG002|Overall Study|Lost to Follow-up|0|||
23268580|NCT01479439|64725365|FG000|Overall Study|Protocol Violation|0|||
23268581|NCT01479439|64725366|FG001|Overall Study|Protocol Violation|0|||
23268582|NCT01479439|64725367|FG002|Overall Study|Protocol Violation|2|||
23268583|NCT00918567|64725368|FG000|Overall Study|Lack of Efficacy|3|||
23268584|NCT00918567|64725369|FG001|Overall Study|Lack of Efficacy|1|||
23268585|NCT00918567|64725368|FG000|Overall Study|Withdrawal by Subject|1|||
23268586|NCT00918567|64725369|FG001|Overall Study|Withdrawal by Subject|1|||
23268587|NCT00918567|64725368|FG000|Overall Study|Adverse Event|1|||
23268588|NCT00918567|64725369|FG001|Overall Study|Adverse Event|0|||
23268589|NCT01893905|64725370|FG000|Overall Study|Withdrawal by Subject|1|||
23268590|NCT01893905|64725371|FG001|Overall Study|Withdrawal by Subject|0|||
23268591|NCT01893905|64725370|FG000|Overall Study|Adverse Event|9|||
23268592|NCT01893905|64725371|FG001|Overall Study|Adverse Event|3|||
23268593|NCT01893905|64725370|FG000|Overall Study|Lack of Efficacy|5|||
23268594|NCT01893905|64725371|FG001|Overall Study|Lack of Efficacy|7|||
23268595|NCT01893905|64725370|FG000|Overall Study|Lost to Follow-up|1|||
23268596|NCT01893905|64725371|FG001|Overall Study|Lost to Follow-up|0|||
23268597|NCT01893905|64725370|FG000|Overall Study|Protocol Violation|6|||
23268598|NCT01893905|64725371|FG001|Overall Study|Protocol Violation|1|||
23268599|NCT01893905|64725370|FG000|Overall Study|Lack of adherence to treatment|2|||
23268600|NCT01893905|64725371|FG001|Overall Study|Lack of adherence to treatment|0|||
23268601|NCT01893905|64725370|FG000|Overall Study|Other reason|1|||
23268602|NCT01893905|64725371|FG001|Overall Study|Other reason|3|||
23268603|NCT01196052|64725372|FG000|Overall Study|Adverse Event|9|||
23268604|NCT01196052|64725372|FG000|Overall Study|Lost to Follow-up|1|||
23268605|NCT01196052|64725372|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
23268606|NCT01196052|64725372|FG000|Overall Study|Reason not Specified|5|||
23268607|NCT01196052|64725372|FG000|Overall Study|Withdrawal by Subject|6|||
23268608|NCT01766921|64725373|FG000|Overall Study|Administrative Reason|5|||
23268609|NCT01766921|64725374|FG001|Overall Study|Administrative Reason|5|||
23268610|NCT01766921|64725373|FG000|Overall Study|Death|1|||
23268611|NCT01766921|64725374|FG001|Overall Study|Death|1|||
23268612|NCT01766921|64725373|FG000|Overall Study|Lost to Follow-up|1|||
23268613|NCT01766921|64725374|FG001|Overall Study|Lost to Follow-up|3|||
23268614|NCT01766921|64725373|FG000|Overall Study|Unclassified|2|||
23268615|NCT01766921|64725374|FG001|Overall Study|Unclassified|2|||
23268616|NCT01766921|64725373|FG000|Overall Study|Protocol Violation|1|||
23268617|NCT01766921|64725374|FG001|Overall Study|Protocol Violation|1|||
23268618|NCT01766921|64725373|FG000|Overall Study|Withdrawal by Subject|14|||
23268619|NCT01766921|64725374|FG001|Overall Study|Withdrawal by Subject|5|||
23268620|NCT03805438|64725375|FG000|Overall Study|Lack of Efficacy|1|||
23268621|NCT03805438|64725375|FG000|Overall Study|Protocol Violation|1|||
23268622|NCT03093324|64725376|FG000|Overall Study|Adverse Event|4|||
23268623|NCT03093324|64725377|FG001|Overall Study|Adverse Event|15|||
23268624|NCT03093324|64725376|FG000|Overall Study|Lost to Follow-up|1|||
23268625|NCT03093324|64725377|FG001|Overall Study|Lost to Follow-up|0|||
23268626|NCT03093324|64725376|FG000|Overall Study|Protocol Deviation|2|||
23268627|NCT03093324|64725377|FG001|Overall Study|Protocol Deviation|2|||
23268628|NCT03093324|64725376|FG000|Overall Study|Withdrawal by Subject|2|||
23268629|NCT03093324|64725377|FG001|Overall Study|Withdrawal by Subject|2|||
23268630|NCT00760266|64725382|FG000|Overall Study|Adverse Event|13|||
23268631|NCT00760266|64725383|FG001|Overall Study|Adverse Event|7|||
23268632|NCT00760266|64725382|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23268633|NCT00760266|64725383|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23268634|NCT00760266|64725382|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23268635|NCT00760266|64725383|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23268636|NCT00760266|64725382|FG000|Overall Study|Lack of Efficacy|2|||
23268637|NCT00760266|64725383|FG001|Overall Study|Lack of Efficacy|2|||
23268638|NCT00760266|64725382|FG000|Overall Study|Protocol deviation|2|||
23268639|NCT00760266|64725383|FG001|Overall Study|Protocol deviation|4|||
23268640|NCT00760266|64725382|FG000|Overall Study|Patient withdrew consent|3|||
23268641|NCT00760266|64725383|FG001|Overall Study|Patient withdrew consent|3|||
23268642|NCT00760266|64725382|FG000|Overall Study|Lost to Follow-up|2|||
23268643|NCT00760266|64725383|FG001|Overall Study|Lost to Follow-up|1|||
23364872|NCT00398216|65081261|FG001|Overall Study|Adverse Event|2|||
23364873|NCT00398216|65081262|FG002|Overall Study|Adverse Event|5|||
23364874|NCT00398216|65081263|FG003|Overall Study|Adverse Event|7|||
23364875|NCT00398216|65081264|FG004|Overall Study|Adverse Event|2|||
23364876|NCT00398216|65081260|FG000|Overall Study|Protocol Violation|2|||
23364877|NCT00398216|65081261|FG001|Overall Study|Protocol Violation|4|||
23364878|NCT00398216|65081262|FG002|Overall Study|Protocol Violation|5|||
23364879|NCT00398216|65081263|FG003|Overall Study|Protocol Violation|7|||
23364880|NCT00398216|65081264|FG004|Overall Study|Protocol Violation|5|||
23364881|NCT00398216|65081260|FG000|Overall Study|Lost to Follow-up|1|||
23482274|NCT04761627|65509475|FG001|Run-in Period|Pregnancy|0|||
23268644|NCT00760266|64725382|FG000|Overall Study|Administrative Problems|0|||
23268645|NCT00760266|64725383|FG001|Overall Study|Administrative Problems|1|||
23268646|NCT03340727|64725384|FG000|Overall Study|Death|1|||
23268647|NCT03340727|64725385|FG001|Overall Study|Death|0|||
23268648|NCT03340727|64725384|FG000|Overall Study|Lost to Follow-up|31|||
23268649|NCT03340727|64725385|FG001|Overall Study|Lost to Follow-up|35|||
23268650|NCT03340727|64725384|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
23268651|NCT03340727|64725385|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
23268652|NCT03340727|64725384|FG000|Overall Study|Transferred to another facility|10|||
23268653|NCT03340727|64725385|FG001|Overall Study|Transferred to another facility|7|||
23268654|NCT03340727|64725384|FG000|Overall Study|Withdrawal by Subject|28|||
23268655|NCT03340727|64725385|FG001|Overall Study|Withdrawal by Subject|17|||
23268656|NCT00520741|64725390|FG000|Overall Study|Adverse Event|16|||
23268657|NCT00520741|64725391|FG001|Overall Study|Adverse Event|56|||
23268658|NCT00520741|64725390|FG000|Overall Study|Lack of Efficacy|11|||
23268659|NCT00520741|64725391|FG001|Overall Study|Lack of Efficacy|30|||
23268660|NCT00520741|64725390|FG000|Overall Study|Withdrawal by Subject|0|||
23268661|NCT00520741|64725391|FG001|Overall Study|Withdrawal by Subject|11|||
23268662|NCT00520741|64725390|FG000|Overall Study|Protocol Violation|2|||
23268663|NCT00520741|64725391|FG001|Overall Study|Protocol Violation|15|||
23268664|NCT00520741|64725390|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
23268665|NCT00520741|64725391|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
23268666|NCT00520741|64725390|FG000|Overall Study|Lost to Follow-up|4|||
23268667|NCT00520741|64725391|FG001|Overall Study|Lost to Follow-up|4|||
23268668|NCT00520741|64725390|FG000|Overall Study|Other reasons for premature termination|0|||
23268669|NCT00520741|64725391|FG001|Overall Study|Other reasons for premature termination|6|||
23268670|NCT03544138|64725394|FG000|Overall Study|Lost to Follow-up|29|||
23364882|NCT00398216|65081261|FG001|Overall Study|Lost to Follow-up|6|||
23482275|NCT04761627|65509476|FG002|Run-in Period|Pregnancy|0|||
23482276|NCT04761627|65509474|FG000|Post-randomization Period|Military service|0|||
23268671|NCT01074554|64725395|FG000|Overall Study|Adverse Event|3|||
23268672|NCT01074554|64725396|FG001|Overall Study|Adverse Event|3|||
23268673|NCT01074554|64725395|FG000|Overall Study|Lost to Follow-up|0|||
23268674|NCT01074554|64725396|FG001|Overall Study|Lost to Follow-up|1|||
23268675|NCT01411332|64725397|FG000|Enrollment|Protocol Violation|0|||
23268676|NCT01411332|64725398|FG001|Enrollment|Protocol Violation|1|||
23268677|NCT01411332|64725397|FG000|Enrollment|Withdrawal by Subject|0|||
23268678|NCT01411332|64725398|FG001|Enrollment|Withdrawal by Subject|1|||
23364883|NCT00398216|65081262|FG002|Overall Study|Lost to Follow-up|4|||
23364884|NCT00398216|65081263|FG003|Overall Study|Lost to Follow-up|4|||
23482277|NCT04761627|65509475|FG001|Post-randomization Period|Military service|1|||
23364885|NCT00398216|65081264|FG004|Overall Study|Lost to Follow-up|1|||
23364886|NCT00398216|65081260|FG000|Overall Study|Death|0|||
23364887|NCT00398216|65081261|FG001|Overall Study|Death|3|||
23364888|NCT00398216|65081262|FG002|Overall Study|Death|0|||
23364889|NCT00398216|65081263|FG003|Overall Study|Death|0|||
23268679|NCT01411332|64725397|FG000|Treatment|Lost to Follow-up|1|||
23268680|NCT01411332|64725398|FG001|Treatment|Lost to Follow-up|0|||
23268681|NCT00797108|64725399|FG000|Overall Study|Adverse Event|1|||
23268682|NCT00797108|64725400|FG001|Overall Study|Adverse Event|0|||
23268683|NCT00797108|64725401|FG002|Overall Study|Adverse Event|3|||
23268684|NCT00797108|64725399|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
23268685|NCT00797108|64725400|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
23268686|NCT00797108|64725401|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
23268687|NCT00797108|64725399|FG000|Overall Study|Global Deterioration of Health Status|0|||
23268688|NCT00797108|64725400|FG001|Overall Study|Global Deterioration of Health Status|1|||
23268689|NCT00797108|64725401|FG002|Overall Study|Global Deterioration of Health Status|0|||
23268690|NCT00797108|64725399|FG000|Overall Study|Lack of Efficacy|1|||
23268691|NCT00797108|64725400|FG001|Overall Study|Lack of Efficacy|0|||
23268692|NCT00797108|64725401|FG002|Overall Study|Lack of Efficacy|1|||
23268693|NCT00797108|64725399|FG000|Overall Study|Other|0|||
23268694|NCT00797108|64725400|FG001|Overall Study|Other|0|||
23268695|NCT00797108|64725401|FG002|Overall Study|Other|2|||
23268696|NCT00797108|64725399|FG000|Overall Study|Randomized but not Treated|2|||
23268697|NCT00797108|64725400|FG001|Overall Study|Randomized but not Treated|0|||
23268698|NCT00797108|64725401|FG002|Overall Study|Randomized but not Treated|0|||
23268699|NCT05346055|64725403|FG000|Overall Study|Withdrawal by Subject|1|||
23268700|NCT05346055|64725403|FG000|Overall Study|Protocol Violation|1|||
23268701|NCT05346055|64725403|FG000|Overall Study|Therapist decision|1|||
23268702|NCT04652453|64725404|FG000|Overall Study|Death|8|||
23268703|NCT04652453|64725405|FG001|Overall Study|Death|2|||
23268704|NCT04652453|64725406|FG002|Overall Study|Death|0|||
23268705|NCT04652453|64725404|FG000|Overall Study|Hospice|5|||
23268706|NCT04652453|64725405|FG001|Overall Study|Hospice|5|||
23364890|NCT00398216|65081264|FG004|Overall Study|Death|0|||
23268707|NCT04652453|64725406|FG002|Overall Study|Hospice|0|||
23268708|NCT04652453|64725404|FG000|Overall Study|Withdrawal by Subject|2|||
23268709|NCT04652453|64725405|FG001|Overall Study|Withdrawal by Subject|0|||
23268710|NCT04652453|64725406|FG002|Overall Study|Withdrawal by Subject|0|||
23364891|NCT00398216|65081260|FG000|Overall Study|Withdrawal by Subject|1|||
23268711|NCT00408902|64725407|FG000|Overall Study|Lack of Efficacy|7|||
23268712|NCT00408902|64725407|FG000|Overall Study|Adverse Event|3|||
23268713|NCT00553280|64728543|FG000|Overall Study|Adverse Event|19|||
23268714|NCT00553280|64728543|FG000|Overall Study|Lack of Efficacy|3|||
23268715|NCT00553280|64728543|FG000|Overall Study|Withdrawal by Subject|3|||
23268716|NCT00553280|64728543|FG000|Overall Study|Physician Decision|1|||
23268717|NCT01089647|64728544|FG000|Overall Study|Lost to Follow-up|2|||
23268718|NCT01089647|64728545|FG001|Overall Study|Lost to Follow-up|2|||
23268719|NCT01089647|64728544|FG000|Overall Study|Withdrawal by Subject|2|||
23268720|NCT01089647|64728545|FG001|Overall Study|Withdrawal by Subject|1|||
23268721|NCT01089647|64728544|FG000|Overall Study|Adverse Event|0|||
23268722|NCT01089647|64728545|FG001|Overall Study|Adverse Event|1|||
23268723|NCT01210001|64728546|FG000|Overall Study|Not treated|1|||
23268724|NCT01210001|64728547|FG001|Overall Study|Not treated|0|||
23268725|NCT01210001|64728548|FG002|Overall Study|Not treated|0|||
23268726|NCT01210001|64728546|FG000|Overall Study|Adverse Event|4|||
23268727|NCT01210001|64728547|FG001|Overall Study|Adverse Event|2|||
23268728|NCT01210001|64728548|FG002|Overall Study|Adverse Event|5|||
23268729|NCT01210001|64728546|FG000|Overall Study|Non compliant with protocol|2|||
23268730|NCT01210001|64728547|FG001|Overall Study|Non compliant with protocol|2|||
23268731|NCT01210001|64728548|FG002|Overall Study|Non compliant with protocol|3|||
23268732|NCT01210001|64728546|FG000|Overall Study|Lost to Follow-up|4|||
23268733|NCT01210001|64728547|FG001|Overall Study|Lost to Follow-up|3|||
23268734|NCT01210001|64728548|FG002|Overall Study|Lost to Follow-up|2|||
23268735|NCT01210001|64728546|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
23268736|NCT01210001|64728547|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
23268737|NCT01210001|64728548|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
23268738|NCT01210001|64728546|FG000|Overall Study|Other reason not defined above|2|||
23268739|NCT01210001|64728547|FG001|Overall Study|Other reason not defined above|2|||
23268740|NCT01210001|64728548|FG002|Overall Study|Other reason not defined above|1|||
23268741|NCT01000337|64728549|FG000|Overall Study|Lost to Follow-up|4|||
23364892|NCT00398216|65081261|FG001|Overall Study|Withdrawal by Subject|0|||
23364893|NCT00398216|65081262|FG002|Overall Study|Withdrawal by Subject|3|||
23364894|NCT00398216|65081263|FG003|Overall Study|Withdrawal by Subject|1|||
23364895|NCT00398216|65081264|FG004|Overall Study|Withdrawal by Subject|2|||
23364896|NCT00398216|65081260|FG000|Overall Study|administrative reasons|3|||
23364897|NCT00398216|65081261|FG001|Overall Study|administrative reasons|4|||
23364898|NCT00398216|65081262|FG002|Overall Study|administrative reasons|4|||
23364899|NCT00398216|65081263|FG003|Overall Study|administrative reasons|3|||
23364900|NCT00398216|65081264|FG004|Overall Study|administrative reasons|3|||
23364901|NCT00398216|65081260|FG000|Overall Study|entrance criteria|0|||
23364902|NCT00398216|65081261|FG001|Overall Study|entrance criteria|0|||
23364903|NCT00398216|65081262|FG002|Overall Study|entrance criteria|0|||
23364904|NCT00398216|65081263|FG003|Overall Study|entrance criteria|0|||
23364905|NCT00398216|65081264|FG004|Overall Study|entrance criteria|2|||
23364906|NCT00929994|65081274|FG000|Overall Study|Withdrawal by Subject|1|||
23364907|NCT00929994|65081274|FG000|Overall Study|medical issue unrelated to intervention|4|||
23364908|NCT00929994|65081274|FG000|Overall Study|employment|1|||
23364909|NCT02896569|65081275|FG000|Overall Study|Lost to Follow-up|2|||
23364910|NCT02896569|65081276|FG001|Overall Study|Lost to Follow-up|1|||
23364911|NCT02896569|65081275|FG000|Overall Study|Physician Decision|1|||
23364912|NCT02896569|65081276|FG001|Overall Study|Physician Decision|3|||
23364913|NCT02896569|65081275|FG000|Overall Study|Adverse Event|0|||
23364914|NCT02896569|65081276|FG001|Overall Study|Adverse Event|1|||
23364915|NCT02896569|65081275|FG000|Overall Study|Withdrawal by Subject|1|||
23364916|NCT02896569|65081276|FG001|Overall Study|Withdrawal by Subject|0|||
23364917|NCT00289276|65081279|FG000|Second Part of FAST Study (Expansion)|Death|0|||
23364918|NCT00289276|65081280|FG001|Second Part of FAST Study (Expansion)|Death|2|||
23364919|NCT00289276|65081279|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
23364920|NCT00289276|65081280|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
23364921|NCT00698815|65081283|FG000|Overall Study|Death|1|||
23364922|NCT00698815|65081284|FG001|Overall Study|Death|2|||
23364923|NCT00698815|65081285|FG002|Overall Study|Death|4|||
23364924|NCT00698815|65081283|FG000|Overall Study|Withdrawal by Subject|6|||
23364925|NCT00698815|65081284|FG001|Overall Study|Withdrawal by Subject|3|||
23364926|NCT00698815|65081285|FG002|Overall Study|Withdrawal by Subject|2|||
23364927|NCT00698815|65081283|FG000|Overall Study|MD discretion|2|||
23364928|NCT00698815|65081284|FG001|Overall Study|MD discretion|7|||
23364929|NCT00698815|65081285|FG002|Overall Study|MD discretion|2|||
23364930|NCT00698815|65081283|FG000|Overall Study|Did not receive protocol treatment|1|||
23268742|NCT01000337|64728550|FG001|Overall Study|Lost to Follow-up|3|||
23364931|NCT00698815|65081284|FG001|Overall Study|Did not receive protocol treatment|2|||
23364932|NCT00698815|65081285|FG002|Overall Study|Did not receive protocol treatment|2|||
23364933|NCT03478371|65081288|FG000|Overall Study|non-compliance|1|||
23268743|NCT01402947|64728551|FG000|First Intervention|Adverse Event|0|||
23268744|NCT01402947|64728552|FG001|First Intervention|Adverse Event|1|||
23268745|NCT00950807|64728555|FG000|Treatment Period 1|Lack of Efficacy|1|||
23364934|NCT03478371|65081288|FG000|Overall Study|Lost to Follow-up|4|||
23364935|NCT02419807|65081289|FG000|Overall Study|Withdrawal by Subject|4|||
23364936|NCT02419807|65081289|FG000|Overall Study|Physician Decision|1|||
23364937|NCT02419807|65081289|FG000|Overall Study|Protocol Violation|5|||
23364938|NCT01251952|65081290|FG000|Overall Study|Adverse Event|1|||
23364939|NCT00941304|65081291|FG000|Overall Study|Lost to Follow-up|1|||
23364940|NCT00941304|65081292|FG001|Overall Study|Lost to Follow-up|0|||
23364941|NCT00941304|65081293|FG002|Overall Study|Lost to Follow-up|0|||
23364942|NCT00941304|65081294|FG003|Overall Study|Lost to Follow-up|0|||
23364943|NCT00941304|65081295|FG004|Overall Study|Lost to Follow-up|0|||
23364944|NCT01704755|65081296|FG000|Overall Study|Adverse Event|4|||
23364945|NCT01704755|65081297|FG001|Overall Study|Adverse Event|1|||
23364946|NCT01704755|65081296|FG000|Overall Study|Lost to Follow-up|3|||
23364947|NCT01704755|65081297|FG001|Overall Study|Lost to Follow-up|4|||
23364948|NCT01704755|65081296|FG000|Overall Study|Withdrew consent|1|||
23364949|NCT01704755|65081297|FG001|Overall Study|Withdrew consent|1|||
23364950|NCT01704755|65081296|FG000|Overall Study|Other (not specified)|3|||
23364951|NCT01704755|65081297|FG001|Overall Study|Other (not specified)|1|||
23364952|NCT01704755|65081296|FG000|Overall Study|Withdrew consent and personal issues|1|||
23364953|NCT01704755|65081297|FG001|Overall Study|Withdrew consent and personal issues|0|||
23364954|NCT02155699|65081298|FG000|Overall Study|Withdrawal by Subject|0|||
23364955|NCT02155699|65081299|FG001|Overall Study|Withdrawal by Subject|3|||
23364956|NCT02155699|65081300|FG002|Overall Study|Withdrawal by Subject|6|||
23268746|NCT00950807|64728556|FG001|Treatment Period 1|Lack of Efficacy|0|||
23268747|NCT00950807|64728557|FG002|Treatment Period 1|Lack of Efficacy|0|||
23268748|NCT00950807|64728558|FG003|Treatment Period 1|Lack of Efficacy|0|||
23268749|NCT00950807|64728559|FG004|Treatment Period 1|Lack of Efficacy|0|||
23268750|NCT00950807|64728560|FG005|Treatment Period 1|Lack of Efficacy|1|||
23268751|NCT00950807|64728561|FG006|Treatment Period 1|Lack of Efficacy|0|||
23268752|NCT00950807|64728562|FG007|Treatment Period 1|Lack of Efficacy|0|||
23268753|NCT00950807|64728563|FG008|Treatment Period 1|Lack of Efficacy|0|||
23268754|NCT00950807|64728564|FG009|Treatment Period 1|Lack of Efficacy|0|||
23268755|NCT00950807|64728555|FG000|Treatment Period 1|Protocol Violation|1|||
23268756|NCT00950807|64728556|FG001|Treatment Period 1|Protocol Violation|0|||
23268757|NCT00950807|64728557|FG002|Treatment Period 1|Protocol Violation|0|||
23268758|NCT00950807|64728558|FG003|Treatment Period 1|Protocol Violation|0|||
23268759|NCT00950807|64728559|FG004|Treatment Period 1|Protocol Violation|0|||
23268760|NCT00950807|64728560|FG005|Treatment Period 1|Protocol Violation|0|||
23268761|NCT00950807|64728561|FG006|Treatment Period 1|Protocol Violation|0|||
23268762|NCT00950807|64728562|FG007|Treatment Period 1|Protocol Violation|0|||
23268763|NCT00950807|64728563|FG008|Treatment Period 1|Protocol Violation|0|||
23268764|NCT00950807|64728564|FG009|Treatment Period 1|Protocol Violation|0|||
23268765|NCT00950807|64728555|FG000|Treatment Period 1|Lost to Follow-up|0|||
23268766|NCT00950807|64728556|FG001|Treatment Period 1|Lost to Follow-up|0|||
23268767|NCT00950807|64728557|FG002|Treatment Period 1|Lost to Follow-up|1|||
23268768|NCT00950807|64728558|FG003|Treatment Period 1|Lost to Follow-up|0|||
23268769|NCT00950807|64728559|FG004|Treatment Period 1|Lost to Follow-up|0|||
23268770|NCT00950807|64728560|FG005|Treatment Period 1|Lost to Follow-up|0|||
23268771|NCT00950807|64728561|FG006|Treatment Period 1|Lost to Follow-up|0|||
23268772|NCT00950807|64728562|FG007|Treatment Period 1|Lost to Follow-up|0|||
23268773|NCT00950807|64728563|FG008|Treatment Period 1|Lost to Follow-up|0|||
23268774|NCT00950807|64728564|FG009|Treatment Period 1|Lost to Follow-up|0|||
23268775|NCT00950807|64728555|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23268776|NCT00950807|64728556|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23268777|NCT00950807|64728557|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23268778|NCT00950807|64728558|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23268779|NCT00950807|64728559|FG004|Treatment Period 1|Withdrawal by Subject|1|||
23268780|NCT00950807|64728560|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23268781|NCT00950807|64728561|FG006|Treatment Period 1|Withdrawal by Subject|0|||
23268782|NCT00950807|64728562|FG007|Treatment Period 1|Withdrawal by Subject|0|||
23268783|NCT00950807|64728563|FG008|Treatment Period 1|Withdrawal by Subject|1|||
23268784|NCT00950807|64728564|FG009|Treatment Period 1|Withdrawal by Subject|0|||
23268785|NCT00950807|64728555|FG000|Treatment Period 1|Adverse Event|0|||
23364957|NCT02155699|65081301|FG003|Overall Study|Withdrawal by Subject|1|||
23364958|NCT02155699|65081298|FG000|Overall Study|Lost to Follow-up|0|||
23364959|NCT02155699|65081299|FG001|Overall Study|Lost to Follow-up|0|||
23364960|NCT02155699|65081300|FG002|Overall Study|Lost to Follow-up|0|||
23364961|NCT02155699|65081301|FG003|Overall Study|Lost to Follow-up|3|||
23268786|NCT00950807|64728556|FG001|Treatment Period 1|Adverse Event|0|||
23268787|NCT00950807|64728557|FG002|Treatment Period 1|Adverse Event|0|||
23268788|NCT00950807|64728558|FG003|Treatment Period 1|Adverse Event|0|||
23268789|NCT00950807|64728559|FG004|Treatment Period 1|Adverse Event|0|||
23268790|NCT00950807|64728560|FG005|Treatment Period 1|Adverse Event|1|||
23268791|NCT00950807|64728561|FG006|Treatment Period 1|Adverse Event|0|||
23268792|NCT00950807|64728562|FG007|Treatment Period 1|Adverse Event|0|||
23364962|NCT02155699|65081298|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
23364963|NCT02155699|65081299|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
23364964|NCT02155699|65081300|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
23364965|NCT02155699|65081301|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
23364966|NCT01839916|65081302|FG000|Overall Study|Death|9|||
23364967|NCT01839916|65081302|FG000|Overall Study|Physician Decision|17|||
23364968|NCT01839916|65081302|FG000|Overall Study|Relapse|12|||
23364969|NCT01839916|65081302|FG000|Overall Study|GVHD|2|||
23364970|NCT01839916|65081302|FG000|Overall Study|Graft Failure|1|||
23364971|NCT00667563|65081303|FG000|Overall Study|Protocol Violation|24|||
23364972|NCT02810418|65081304|FG000|Arm A Dose Escalation|Adverse Event|2|||
23364973|NCT02810418|65081305|FG001|Arm A Dose Escalation|Adverse Event|1|||
23364974|NCT02810418|65081306|FG002|Arm A Dose Escalation|Adverse Event|0|||
23364975|NCT02810418|65081307|FG003|Arm A Dose Escalation|Adverse Event|0|||
23364976|NCT02810418|65081308|FG004|Arm A Dose Escalation|Adverse Event|0|||
23364977|NCT02810418|65081309|FG005|Arm A Dose Escalation|Adverse Event|0|||
23364978|NCT02810418|65081310|FG006|Arm A Dose Escalation|Adverse Event|0|||
23364979|NCT02810418|65081304|FG000|Dose Expansion|Adverse Event|0|||
23364980|NCT02810418|65081305|FG001|Dose Expansion|Adverse Event|1|||
23364981|NCT02810418|65081306|FG002|Dose Expansion|Adverse Event|1|||
23364982|NCT02810418|65081307|FG003|Dose Expansion|Adverse Event|0|||
23364983|NCT02810418|65081308|FG004|Dose Expansion|Adverse Event|0|||
23364984|NCT02810418|65081309|FG005|Dose Expansion|Adverse Event|0|||
23364985|NCT02810418|65081310|FG006|Dose Expansion|Adverse Event|0|||
23364986|NCT02810418|65081304|FG000|Dose Expansion|Physician Decision|0|||
23364987|NCT02810418|65081305|FG001|Dose Expansion|Physician Decision|0|||
23364988|NCT02810418|65081306|FG002|Dose Expansion|Physician Decision|2|||
23364989|NCT02810418|65081307|FG003|Dose Expansion|Physician Decision|0|||
23364990|NCT02810418|65081308|FG004|Dose Expansion|Physician Decision|0|||
23364991|NCT02810418|65081309|FG005|Dose Expansion|Physician Decision|0|||
23364992|NCT02810418|65081310|FG006|Dose Expansion|Physician Decision|0|||
23364993|NCT02810418|65081304|FG000|Arm B Dose Escalation|Adverse Event|0|||
23364994|NCT02810418|65081305|FG001|Arm B Dose Escalation|Adverse Event|0|||
23364995|NCT02810418|65081306|FG002|Arm B Dose Escalation|Adverse Event|0|||
23364996|NCT02810418|65081307|FG003|Arm B Dose Escalation|Adverse Event|0|||
23364997|NCT02810418|65081308|FG004|Arm B Dose Escalation|Adverse Event|1|||
23364998|NCT02810418|65081309|FG005|Arm B Dose Escalation|Adverse Event|2|||
23364999|NCT02810418|65081310|FG006|Arm B Dose Escalation|Adverse Event|0|||
23365000|NCT00919633|65081311|FG000|Overall Study|Adverse Event|1|||
23365001|NCT00919633|65081312|FG001|Overall Study|Adverse Event|9|||
23365002|NCT00919633|65081313|FG002|Overall Study|Adverse Event|12|||
23365003|NCT00919633|65081314|FG003|Overall Study|Adverse Event|10|||
23365004|NCT00919633|65081311|FG000|Overall Study|Death|0|||
23365005|NCT00919633|65081312|FG001|Overall Study|Death|0|||
23365006|NCT00919633|65081313|FG002|Overall Study|Death|2|||
23365007|NCT00919633|65081314|FG003|Overall Study|Death|0|||
23365008|NCT00919633|65081311|FG000|Overall Study|Lack of Efficacy|17|||
23365009|NCT00919633|65081312|FG001|Overall Study|Lack of Efficacy|3|||
23365010|NCT00919633|65081313|FG002|Overall Study|Lack of Efficacy|2|||
23365011|NCT00919633|65081314|FG003|Overall Study|Lack of Efficacy|3|||
23365012|NCT00919633|65081311|FG000|Overall Study|Withdrawal by Subject|1|||
23365013|NCT00919633|65081312|FG001|Overall Study|Withdrawal by Subject|2|||
23365014|NCT00919633|65081313|FG002|Overall Study|Withdrawal by Subject|4|||
23365015|NCT00919633|65081314|FG003|Overall Study|Withdrawal by Subject|3|||
23365016|NCT00919633|65081311|FG000|Overall Study|Lost to Follow-up|3|||
23365017|NCT00919633|65081312|FG001|Overall Study|Lost to Follow-up|1|||
23365018|NCT00919633|65081313|FG002|Overall Study|Lost to Follow-up|0|||
23365019|NCT00919633|65081314|FG003|Overall Study|Lost to Follow-up|2|||
23365020|NCT00919633|65081311|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
23365021|NCT00919633|65081312|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
23365022|NCT00919633|65081313|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
23365023|NCT00919633|65081314|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
23365024|NCT00919633|65081311|FG000|Overall Study|Protocol Violation|0|||
23365025|NCT00919633|65081312|FG001|Overall Study|Protocol Violation|0|||
23365026|NCT00919633|65081313|FG002|Overall Study|Protocol Violation|0|||
23365027|NCT00919633|65081314|FG003|Overall Study|Protocol Violation|1|||
23365028|NCT00919633|65081311|FG000|Overall Study|Physician Decision|0|||
23365029|NCT00919633|65081312|FG001|Overall Study|Physician Decision|0|||
23365030|NCT00919633|65081313|FG002|Overall Study|Physician Decision|0|||
23365031|NCT00919633|65081314|FG003|Overall Study|Physician Decision|1|||
23365032|NCT00919633|65081311|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
23365033|NCT00919633|65081312|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
23365034|NCT00919633|65081313|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
23365035|NCT00919633|65081314|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
23365036|NCT00919633|65081311|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
23365037|NCT00919633|65081312|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
23365038|NCT00919633|65081313|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
23268793|NCT00950807|64728563|FG008|Treatment Period 1|Adverse Event|0|||
23268794|NCT00950807|64728564|FG009|Treatment Period 1|Adverse Event|0|||
23268795|NCT00950807|64728555|FG000|Washout Period 1|Lack of Efficacy|0|||
23268796|NCT00950807|64728556|FG001|Washout Period 1|Lack of Efficacy|0|||
23268797|NCT00950807|64728557|FG002|Washout Period 1|Lack of Efficacy|0|||
23268798|NCT00950807|64728558|FG003|Washout Period 1|Lack of Efficacy|0|||
23268799|NCT00950807|64728559|FG004|Washout Period 1|Lack of Efficacy|0|||
23268800|NCT00950807|64728560|FG005|Washout Period 1|Lack of Efficacy|0|||
23268801|NCT00950807|64728561|FG006|Washout Period 1|Lack of Efficacy|1|||
23268802|NCT00950807|64728562|FG007|Washout Period 1|Lack of Efficacy|0|||
23268803|NCT00950807|64728563|FG008|Washout Period 1|Lack of Efficacy|0|||
23268804|NCT00950807|64728564|FG009|Washout Period 1|Lack of Efficacy|0|||
23268805|NCT00950807|64728555|FG000|Washout Period 1|Withdrawal by Subject|0|||
23268806|NCT00950807|64728556|FG001|Washout Period 1|Withdrawal by Subject|0|||
23268807|NCT00950807|64728557|FG002|Washout Period 1|Withdrawal by Subject|0|||
23268808|NCT00950807|64728558|FG003|Washout Period 1|Withdrawal by Subject|0|||
23268809|NCT00950807|64728559|FG004|Washout Period 1|Withdrawal by Subject|0|||
23268810|NCT00950807|64728560|FG005|Washout Period 1|Withdrawal by Subject|0|||
23268811|NCT00950807|64728561|FG006|Washout Period 1|Withdrawal by Subject|0|||
23268812|NCT00950807|64728562|FG007|Washout Period 1|Withdrawal by Subject|0|||
23268813|NCT00950807|64728563|FG008|Washout Period 1|Withdrawal by Subject|1|||
23268814|NCT00950807|64728564|FG009|Washout Period 1|Withdrawal by Subject|0|||
23268815|NCT00950807|64728555|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
23268816|NCT00950807|64728556|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23268817|NCT00950807|64728557|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23268818|NCT00950807|64728558|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23268819|NCT00950807|64728559|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23268820|NCT00950807|64728560|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23268821|NCT00950807|64728561|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
23268822|NCT00950807|64728562|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
23268823|NCT00950807|64728563|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23268824|NCT00950807|64728564|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
23268825|NCT00950807|64728555|FG000|Washout Period 1|Adverse Event|2|||
23268826|NCT00950807|64728556|FG001|Washout Period 1|Adverse Event|0|||
23268827|NCT00950807|64728557|FG002|Washout Period 1|Adverse Event|0|||
23268828|NCT00950807|64728558|FG003|Washout Period 1|Adverse Event|1|||
23268829|NCT00950807|64728559|FG004|Washout Period 1|Adverse Event|1|||
23268830|NCT00950807|64728560|FG005|Washout Period 1|Adverse Event|0|||
23268831|NCT00950807|64728561|FG006|Washout Period 1|Adverse Event|0|||
23268832|NCT00950807|64728562|FG007|Washout Period 1|Adverse Event|0|||
23268833|NCT00950807|64728563|FG008|Washout Period 1|Adverse Event|0|||
23268834|NCT00950807|64728564|FG009|Washout Period 1|Adverse Event|0|||
23268835|NCT00950807|64728555|FG000|Treatment Period 2|Lack of Efficacy|1|||
23268836|NCT00950807|64728556|FG001|Treatment Period 2|Lack of Efficacy|0|||
23268837|NCT00950807|64728557|FG002|Treatment Period 2|Lack of Efficacy|0|||
23268838|NCT00950807|64728558|FG003|Treatment Period 2|Lack of Efficacy|0|||
23268839|NCT00950807|64728559|FG004|Treatment Period 2|Lack of Efficacy|0|||
23268840|NCT00950807|64728560|FG005|Treatment Period 2|Lack of Efficacy|0|||
23268841|NCT00950807|64728561|FG006|Treatment Period 2|Lack of Efficacy|0|||
23268842|NCT00950807|64728562|FG007|Treatment Period 2|Lack of Efficacy|0|||
23268843|NCT00950807|64728563|FG008|Treatment Period 2|Lack of Efficacy|0|||
23268844|NCT00950807|64728564|FG009|Treatment Period 2|Lack of Efficacy|0|||
23268845|NCT00950807|64728555|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23268846|NCT00950807|64728556|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23268847|NCT00950807|64728557|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23268848|NCT00950807|64728558|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23268849|NCT00950807|64728559|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23268850|NCT00950807|64728560|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23268851|NCT00950807|64728561|FG006|Treatment Period 2|Withdrawal by Subject|1|||
23268852|NCT00950807|64728562|FG007|Treatment Period 2|Withdrawal by Subject|2|||
23268853|NCT00950807|64728563|FG008|Treatment Period 2|Withdrawal by Subject|0|||
23268854|NCT00950807|64728564|FG009|Treatment Period 2|Withdrawal by Subject|0|||
23268855|NCT00950807|64728555|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
23268856|NCT00950807|64728556|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23268857|NCT00950807|64728557|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23268858|NCT00950807|64728558|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23268859|NCT00950807|64728559|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23268860|NCT00950807|64728560|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23268861|NCT00950807|64728561|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23268862|NCT00950807|64728562|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23268863|NCT00950807|64728563|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23268864|NCT00950807|64728564|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
23268865|NCT00950807|64728555|FG000|Treatment Period 2|Adverse Event|0|||
23268866|NCT00950807|64728556|FG001|Treatment Period 2|Adverse Event|1|||
23268867|NCT00950807|64728557|FG002|Treatment Period 2|Adverse Event|0|||
23268868|NCT00950807|64728558|FG003|Treatment Period 2|Adverse Event|1|||
23268869|NCT00950807|64728559|FG004|Treatment Period 2|Adverse Event|0|||
23268870|NCT00950807|64728560|FG005|Treatment Period 2|Adverse Event|1|||
23268871|NCT00950807|64728561|FG006|Treatment Period 2|Adverse Event|0|||
23268872|NCT00950807|64728562|FG007|Treatment Period 2|Adverse Event|1|||
23268873|NCT00950807|64728563|FG008|Treatment Period 2|Adverse Event|0|||
23268874|NCT00950807|64728564|FG009|Treatment Period 2|Adverse Event|0|||
23268875|NCT00950807|64728555|FG000|Washout Period 2|Lack of Efficacy|1|||
23268876|NCT00950807|64728556|FG001|Washout Period 2|Lack of Efficacy|0|||
23268877|NCT00950807|64728557|FG002|Washout Period 2|Lack of Efficacy|0|||
23268878|NCT00950807|64728558|FG003|Washout Period 2|Lack of Efficacy|0|||
23268879|NCT00950807|64728559|FG004|Washout Period 2|Lack of Efficacy|0|||
23268880|NCT00950807|64728560|FG005|Washout Period 2|Lack of Efficacy|0|||
23268881|NCT00950807|64728561|FG006|Washout Period 2|Lack of Efficacy|0|||
23268882|NCT00950807|64728562|FG007|Washout Period 2|Lack of Efficacy|0|||
23268883|NCT00950807|64728563|FG008|Washout Period 2|Lack of Efficacy|0|||
23268884|NCT00950807|64728564|FG009|Washout Period 2|Lack of Efficacy|0|||
23268885|NCT00950807|64728555|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23268886|NCT00950807|64728556|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
23268887|NCT00950807|64728557|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23268888|NCT00950807|64728558|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23268889|NCT00950807|64728559|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
23268890|NCT00950807|64728560|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23268891|NCT00950807|64728561|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
23268892|NCT00950807|64728562|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
23268893|NCT00950807|64728563|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23268894|NCT00950807|64728564|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
23268895|NCT00950807|64728555|FG000|Washout Period 2|Adverse Event|3|||
23268896|NCT00950807|64728556|FG001|Washout Period 2|Adverse Event|0|||
23268897|NCT00950807|64728557|FG002|Washout Period 2|Adverse Event|0|||
23268898|NCT00950807|64728558|FG003|Washout Period 2|Adverse Event|1|||
23268899|NCT00950807|64728559|FG004|Washout Period 2|Adverse Event|0|||
23268900|NCT00950807|64728560|FG005|Washout Period 2|Adverse Event|0|||
23268901|NCT00950807|64728561|FG006|Washout Period 2|Adverse Event|0|||
23268902|NCT00950807|64728562|FG007|Washout Period 2|Adverse Event|0|||
23268903|NCT00950807|64728563|FG008|Washout Period 2|Adverse Event|0|||
23268904|NCT00950807|64728564|FG009|Washout Period 2|Adverse Event|0|||
23268905|NCT00950807|64728555|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23268906|NCT00950807|64728556|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23268907|NCT00950807|64728557|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23268908|NCT00950807|64728558|FG003|Treatment Period 3|Withdrawal by Subject|0|||
23268909|NCT00950807|64728559|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23268910|NCT00950807|64728560|FG005|Treatment Period 3|Withdrawal by Subject|0|||
23268911|NCT00950807|64728561|FG006|Treatment Period 3|Withdrawal by Subject|0|||
23268912|NCT00950807|64728562|FG007|Treatment Period 3|Withdrawal by Subject|0|||
23268913|NCT00950807|64728563|FG008|Treatment Period 3|Withdrawal by Subject|0|||
23268914|NCT00950807|64728564|FG009|Treatment Period 3|Withdrawal by Subject|1|||
23268915|NCT00950807|64728555|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
23268916|NCT00950807|64728556|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23268917|NCT00950807|64728557|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23268918|NCT00950807|64728558|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23268919|NCT00950807|64728559|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23268920|NCT00950807|64728560|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23268921|NCT00950807|64728561|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23268922|NCT00950807|64728562|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
23268923|NCT00950807|64728563|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23268924|NCT00950807|64728564|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
23268925|NCT00950807|64728555|FG000|Treatment Period 3|Adverse Event|0|||
23268926|NCT00950807|64728556|FG001|Treatment Period 3|Adverse Event|0|||
23268927|NCT00950807|64728557|FG002|Treatment Period 3|Adverse Event|0|||
23268928|NCT00950807|64728558|FG003|Treatment Period 3|Adverse Event|0|||
23268929|NCT00950807|64728559|FG004|Treatment Period 3|Adverse Event|0|||
23268930|NCT00950807|64728560|FG005|Treatment Period 3|Adverse Event|0|||
23365039|NCT00919633|65081314|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
23365040|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365041|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
23365042|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365043|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
23365044|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365045|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
23365046|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|Refused|0|||
23365047|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|Refused|0|||
23365048|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|Refused|0|||
23365049|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|Refused|0|||
23365050|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|Refused|1|||
23482278|NCT04761627|65509476|FG002|Post-randomization Period|Military service|0|||
23482279|NCT04761627|65509474|FG000|Post-randomization Period|Adverse Event|0|||
23268931|NCT00950807|64728561|FG006|Treatment Period 3|Adverse Event|1|||
23268932|NCT00950807|64728562|FG007|Treatment Period 3|Adverse Event|0|||
23268933|NCT00950807|64728563|FG008|Treatment Period 3|Adverse Event|0|||
23268934|NCT00950807|64728564|FG009|Treatment Period 3|Adverse Event|0|||
23268935|NCT02999178|64728569|FG000|Overall Study|Adverse Event|85|||
23268936|NCT02999178|64728570|FG001|Overall Study|Adverse Event|62|||
23268937|NCT02999178|64728569|FG000|Overall Study|Protocol Violation|1|||
23268938|NCT02999178|64728570|FG001|Overall Study|Protocol Violation|2|||
23268939|NCT02999178|64728569|FG000|Overall Study|Lost to Follow-up|0|||
23268940|NCT02999178|64728570|FG001|Overall Study|Lost to Follow-up|2|||
23268941|NCT02999178|64728569|FG000|Overall Study|Withdrawal by Subject|21|||
23268942|NCT02999178|64728570|FG001|Overall Study|Withdrawal by Subject|21|||
23482280|NCT04761627|65509475|FG001|Post-randomization Period|Adverse Event|4|||
23268943|NCT02999178|64728569|FG000|Overall Study|Other reason not defined above|7|||
23268944|NCT02999178|64728570|FG001|Overall Study|Other reason not defined above|13|||
23268945|NCT00920140|64728573|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
23268946|NCT00920140|64728574|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
23268947|NCT00920140|64728575|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
23268948|NCT00920140|64728576|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
23482281|NCT04761627|65509476|FG002|Post-randomization Period|Adverse Event|2|||
23482282|NCT04761627|65509474|FG000|Post-randomization Period|Lost to Follow-up|0|||
23268949|NCT00920140|64728577|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
23268950|NCT00920140|64728573|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
23268951|NCT00920140|64728574|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
23268952|NCT00920140|64728575|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
23268953|NCT00920140|64728576|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
23268954|NCT00920140|64728577|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
23365051|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|Refused|0|||
23365052|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365053|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
23365054|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365055|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365056|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365057|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
23365058|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|Death|0|||
23365059|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|Death|0|||
23365060|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|Death|0|||
23365061|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|Death|0|||
23365062|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|Death|1|||
23365063|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|Death|0|||
23365064|NCT03327324|65081315|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365065|NCT03327324|65081316|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365066|NCT03327324|65081317|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365067|NCT03327324|65081318|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365068|NCT03327324|65081319|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365069|NCT03327324|65081320|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
23365070|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365071|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365072|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
23365073|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365074|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365075|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365076|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
23365077|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
23365078|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
23365079|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
23365080|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
23365081|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
23365082|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
23365083|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365084|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365085|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365086|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365087|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
23365088|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|Death|1|||
23365089|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|Death|0|||
23365090|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|Death|1|||
23365091|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|Death|1|||
23365092|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|Death|1|||
23365093|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|Death|0|||
23365094|NCT03327324|65081315|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365095|NCT03327324|65081316|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365096|NCT03327324|65081317|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365097|NCT03327324|65081318|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365098|NCT03327324|65081319|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365099|NCT03327324|65081320|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
23365100|NCT03327324|65081315|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
23365101|NCT03327324|65081316|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365102|NCT03327324|65081317|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365103|NCT03327324|65081318|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23601523|NCT02455557|65933779|FG000|Overall Study|Withdrawal by Subject|2|||
23601524|NCT01394276|65933780|FG000|Overall Study|Related Adverse event (AEs)|15|||
23601525|NCT01394276|65933780|FG000|Overall Study|Not related AEs|9|||
23601526|NCT01394276|65933780|FG000|Overall Study|Remission of disease|2|||
23365104|NCT03327324|65081319|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365105|NCT03327324|65081320|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
23365106|NCT03327324|65081315|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
23365107|NCT03327324|65081316|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
23365108|NCT03327324|65081317|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
23365109|NCT03327324|65081318|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
23365110|NCT03327324|65081319|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
23365111|NCT03327324|65081320|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
23365112|NCT03327324|65081315|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
23365113|NCT03327324|65081316|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
23365114|NCT03327324|65081317|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
23365115|NCT03327324|65081318|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
23365116|NCT03327324|65081319|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
23365117|NCT03327324|65081320|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
23365118|NCT03327324|65081315|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365119|NCT03327324|65081316|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23268955|NCT00920140|64728573|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
23268956|NCT00920140|64728574|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
23268957|NCT00920140|64728575|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
23268958|NCT00920140|64728576|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
23365120|NCT03327324|65081317|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365121|NCT03327324|65081318|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
23365122|NCT03327324|65081319|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
23365123|NCT03327324|65081320|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
23365124|NCT03327324|65081315|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
23365125|NCT03327324|65081316|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23365126|NCT03327324|65081317|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23482283|NCT04761627|65509475|FG001|Post-randomization Period|Lost to Follow-up|6|||
23482284|NCT04761627|65509476|FG002|Post-randomization Period|Lost to Follow-up|6|||
23268959|NCT00920140|64728577|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
23268960|NCT00920140|64728573|FG000|Phase 2|Adverse Event|0|||
23268961|NCT00920140|64728574|FG001|Phase 2|Adverse Event|0|||
23268962|NCT00920140|64728575|FG002|Phase 2|Adverse Event|14|||
23268963|NCT00920140|64728576|FG003|Phase 2|Adverse Event|2|||
23268964|NCT00920140|64728577|FG004|Phase 2|Adverse Event|3|||
23268965|NCT00920140|64728573|FG000|Phase 2|Lack of Efficacy|0|||
23268966|NCT00920140|64728574|FG001|Phase 2|Lack of Efficacy|0|||
23268967|NCT00920140|64728575|FG002|Phase 2|Lack of Efficacy|29|||
23268968|NCT00920140|64728576|FG003|Phase 2|Lack of Efficacy|14|||
23268969|NCT00920140|64728577|FG004|Phase 2|Lack of Efficacy|5|||
23268970|NCT00920140|64728573|FG000|Phase 2|Lost to Follow-up|0|||
23268971|NCT00920140|64728574|FG001|Phase 2|Lost to Follow-up|0|||
23268972|NCT00920140|64728575|FG002|Phase 2|Lost to Follow-up|0|||
23268973|NCT00920140|64728576|FG003|Phase 2|Lost to Follow-up|1|||
23268974|NCT00920140|64728577|FG004|Phase 2|Lost to Follow-up|0|||
23268975|NCT00920140|64728573|FG000|Phase 2|Physician Decision|0|||
23268976|NCT00920140|64728574|FG001|Phase 2|Physician Decision|0|||
23268977|NCT00920140|64728575|FG002|Phase 2|Physician Decision|3|||
23268978|NCT00920140|64728576|FG003|Phase 2|Physician Decision|3|||
23268979|NCT00920140|64728577|FG004|Phase 2|Physician Decision|2|||
23268980|NCT00920140|64728573|FG000|Phase 2|Withdrawal by Subject|0|||
23268981|NCT00920140|64728574|FG001|Phase 2|Withdrawal by Subject|0|||
23268982|NCT00920140|64728575|FG002|Phase 2|Withdrawal by Subject|4|||
23268983|NCT00920140|64728576|FG003|Phase 2|Withdrawal by Subject|2|||
23268984|NCT00920140|64728577|FG004|Phase 2|Withdrawal by Subject|1|||
23268985|NCT01166568|64728581|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
23268986|NCT01166568|64728582|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
23268987|NCT01166568|64728583|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
23268988|NCT01166568|64728581|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
23268989|NCT01166568|64728582|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
23268990|NCT01166568|64728583|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
23268991|NCT01166568|64728581|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
23268992|NCT01166568|64728582|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
23268993|NCT01166568|64728583|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
23268994|NCT02907203|64728584|FG000|Overall Study|Death|1|||
23268995|NCT02907203|64728584|FG000|Overall Study|Lost to Follow-up|3|||
23268996|NCT02907203|64728584|FG000|Overall Study|Withdrawal by Subject|3|||
23268997|NCT02907203|64728584|FG000|Overall Study|Surgical bypass|1|||
23268998|NCT01062256|64728585|FG000|Overall Study|Adverse Event|1|||
23268999|NCT01062256|64728586|FG001|Overall Study|Adverse Event|0|||
23269000|NCT01062256|64728587|FG002|Overall Study|Adverse Event|0|||
23269001|NCT01062256|64728585|FG000|Overall Study|Withdrawal by Subject|1|||
23365127|NCT03327324|65081318|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23365128|NCT03327324|65081319|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23365129|NCT03327324|65081320|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
23365130|NCT03327324|65081315|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
23365131|NCT03327324|65081316|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365132|NCT03327324|65081317|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365133|NCT03327324|65081318|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365134|NCT03327324|65081319|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365135|NCT03327324|65081320|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
23365136|NCT04794751|65081321|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
23365137|NCT04794751|65081322|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
23365138|NCT04794751|65081321|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
23365139|NCT04794751|65081322|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
23365140|NCT04794751|65081321|FG000|Period 1|Protocol Violation|0|||
23365141|NCT04794751|65081322|FG001|Period 1|Protocol Violation|2|||
23365142|NCT04794751|65081321|FG000|Period 1|Withdrawal by Subject|0|||
23365143|NCT04794751|65081322|FG001|Period 1|Withdrawal by Subject|1|||
23365144|NCT04794751|65081321|FG000|Period 2|Withdrawal by Subject|0|||
23365145|NCT04794751|65081322|FG001|Period 2|Withdrawal by Subject|1|||
23365146|NCT04794751|65081321|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
23365147|NCT04794751|65081322|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
23365148|NCT04794751|65081321|FG000|Period 2|Protocol Violation|1|||
23365149|NCT04794751|65081322|FG001|Period 2|Protocol Violation|0|||
23365150|NCT00956839|65081324|FG000|Overall Study|Lost to Follow-up|3|||
23365151|NCT00956839|65081325|FG001|Overall Study|Lost to Follow-up|0|||
23269002|NCT01062256|64728586|FG001|Overall Study|Withdrawal by Subject|1|||
23269003|NCT01062256|64728587|FG002|Overall Study|Withdrawal by Subject|1|||
23269004|NCT01062256|64728585|FG000|Overall Study|Ineligible|1|||
23269005|NCT01062256|64728586|FG001|Overall Study|Ineligible|4|||
23269006|NCT01062256|64728587|FG002|Overall Study|Ineligible|3|||
23365152|NCT00956839|65081326|FG002|Overall Study|Lost to Follow-up|3|||
23365153|NCT00823134|65081327|FG000|Overall Study|Invalid measurement|1|||
23365154|NCT03139552|65081332|FG000|Overall Study|unable to attend tasting due to schedule|3|||
23365155|NCT01222104|65081333|FG000|Overall Study|Lost to Follow-up|37|||
23365156|NCT01222104|65081333|FG000|Overall Study|Death|10|||
23365157|NCT01747499|65084863|FG000|Overall Study|Steroid refractory aGvHD|1|||
23365158|NCT01747499|65084864|FG001|Overall Study|Steroid refractory aGvHD|0|||
23365159|NCT01747499|65084865|FG002|Overall Study|Steroid refractory aGvHD|0|||
23365160|NCT01747499|65084866|FG003|Overall Study|Steroid refractory aGvHD|1|||
23365161|NCT01747499|65084867|FG004|Overall Study|Steroid refractory aGvHD|4|||
23365162|NCT01747499|65084863|FG000|Overall Study|Physician Decision|0|||
23365163|NCT01747499|65084864|FG001|Overall Study|Physician Decision|1|||
23365164|NCT01747499|65084865|FG002|Overall Study|Physician Decision|0|||
23365165|NCT01747499|65084866|FG003|Overall Study|Physician Decision|0|||
23365166|NCT01747499|65084867|FG004|Overall Study|Physician Decision|2|||
23365167|NCT01747499|65084863|FG000|Overall Study|Death|0|||
23365168|NCT01747499|65084864|FG001|Overall Study|Death|0|||
23365169|NCT01747499|65084865|FG002|Overall Study|Death|0|||
23365170|NCT01747499|65084866|FG003|Overall Study|Death|1|||
23365171|NCT01747499|65084867|FG004|Overall Study|Death|1|||
23365172|NCT01747499|65084863|FG000|Overall Study|Withdrawal by Subject|0|||
23365173|NCT01747499|65084864|FG001|Overall Study|Withdrawal by Subject|0|||
23365174|NCT01747499|65084865|FG002|Overall Study|Withdrawal by Subject|0|||
23365175|NCT01747499|65084866|FG003|Overall Study|Withdrawal by Subject|0|||
23365176|NCT01747499|65084867|FG004|Overall Study|Withdrawal by Subject|6|||
23365177|NCT01747499|65084863|FG000|Overall Study|Developed AML and death|0|||
23365178|NCT01747499|65084864|FG001|Overall Study|Developed AML and death|0|||
23365179|NCT01747499|65084865|FG002|Overall Study|Developed AML and death|0|||
23269007|NCT01062256|64728585|FG000|Overall Study|Administrative|0|||
23269008|NCT01062256|64728586|FG001|Overall Study|Administrative|2|||
23365180|NCT01747499|65084866|FG003|Overall Study|Developed AML and death|0|||
23365181|NCT01747499|65084867|FG004|Overall Study|Developed AML and death|1|||
23365182|NCT01747499|65084863|FG000|Overall Study|Determined not to be eligible|0|||
23365183|NCT01747499|65084864|FG001|Overall Study|Determined not to be eligible|0|||
23365184|NCT01747499|65084865|FG002|Overall Study|Determined not to be eligible|0|||
23269009|NCT01062256|64728587|FG002|Overall Study|Administrative|0|||
23269010|NCT04638153|64728588|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23269011|NCT04638153|64728589|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23269012|NCT04638153|64728590|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23269013|NCT04638153|64728588|FG000|Overall Study|Study terminated by sponsor|4|||
23365185|NCT01747499|65084866|FG003|Overall Study|Determined not to be eligible|0|||
23365186|NCT01747499|65084867|FG004|Overall Study|Determined not to be eligible|1|||
23365187|NCT00669318|65084873|FG000|Overall Study|Withdrawal by Subject|2|||
23365188|NCT00828113|65084874|FG000|Overall Study|Withdrawal by Subject|27|||
23365189|NCT00828113|65084875|FG001|Overall Study|Withdrawal by Subject|26|||
23365190|NCT00828113|65084874|FG000|Overall Study|Lost to Follow-up|3|||
23365191|NCT00828113|65084875|FG001|Overall Study|Lost to Follow-up|5|||
23269014|NCT04638153|64728589|FG001|Overall Study|Study terminated by sponsor|2|||
23269015|NCT04638153|64728590|FG002|Overall Study|Study terminated by sponsor|14|||
23269016|NCT00262223|64728591|FG000|Treatment Phase|Withdrawal by Subject|3|||
23269017|NCT00262223|64728592|FG001|Treatment Phase|Withdrawal by Subject|6|||
23269018|NCT00262223|64728591|FG000|Treatment Phase|Adverse Event|1|||
23269019|NCT00262223|64728592|FG001|Treatment Phase|Adverse Event|2|||
23269020|NCT00262223|64728591|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
23269021|NCT00262223|64728592|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
23269022|NCT00262223|64728591|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
23269023|NCT00262223|64728592|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
23269024|NCT00262223|64728591|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
23269025|NCT00262223|64728592|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
23269026|NCT01335477|64728593|FG000|Overall Study|Adverse Event|30|||
23269027|NCT01335477|64728594|FG001|Overall Study|Adverse Event|42|||
23269028|NCT01335477|64728593|FG000|Overall Study|Non compliant with protocol|0|||
23269029|NCT01335477|64728594|FG001|Overall Study|Non compliant with protocol|2|||
23269030|NCT01335477|64728593|FG000|Overall Study|Lost to Follow-up|1|||
23269031|NCT01335477|64728594|FG001|Overall Study|Lost to Follow-up|2|||
23269032|NCT01335477|64728593|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
23269033|NCT01335477|64728594|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
23269034|NCT01335477|64728593|FG000|Overall Study|Not treated|1|||
23269035|NCT01335477|64728594|FG001|Overall Study|Not treated|2|||
23269036|NCT01335477|64728593|FG000|Overall Study|Reason other than those stated above|2|||
23269037|NCT01335477|64728594|FG001|Overall Study|Reason other than those stated above|2|||
23269038|NCT01572948|64728608|FG000|Overall Study|Lost to Follow-up|1|||
23269039|NCT01572948|64728609|FG001|Overall Study|Lost to Follow-up|0|||
23269040|NCT01572948|64728608|FG000|Overall Study|unable to contact|0|||
23269041|NCT01572948|64728609|FG001|Overall Study|unable to contact|1|||
23269042|NCT02227862|64728612|FG000|Overall Study|Protocol Violation|7|||
23269043|NCT02227862|64728613|FG001|Overall Study|Protocol Violation|9|||
23269044|NCT02227862|64728612|FG000|Overall Study|Other|0|||
23269045|NCT02227862|64728613|FG001|Overall Study|Other|2|||
23269046|NCT02227862|64728612|FG000|Overall Study|Adverse Event|4|||
23269047|NCT02227862|64728613|FG001|Overall Study|Adverse Event|3|||
23269048|NCT02227862|64728612|FG000|Overall Study|Withdrawal by Subject|7|||
23365192|NCT01214668|65084882|FG000|Overall Study|Adverse Event|0|||
23269049|NCT02227862|64728613|FG001|Overall Study|Withdrawal by Subject|6|||
23269050|NCT02227862|64728612|FG000|Overall Study|Lost to Follow-up|1|||
23365193|NCT01214668|65084883|FG001|Overall Study|Adverse Event|1|||
23365194|NCT01214668|65084884|FG002|Overall Study|Adverse Event|0|||
23365195|NCT01214668|65084885|FG003|Overall Study|Adverse Event|2|||
23365196|NCT01214668|65084886|FG004|Overall Study|Adverse Event|1|||
23365197|NCT01214668|65084887|FG005|Overall Study|Adverse Event|1|||
23365198|NCT01214668|65084882|FG000|Overall Study|Death|0|||
23365199|NCT01214668|65084883|FG001|Overall Study|Death|0|||
23365200|NCT01214668|65084884|FG002|Overall Study|Death|1|||
23365201|NCT01214668|65084885|FG003|Overall Study|Death|0|||
23365202|NCT01214668|65084886|FG004|Overall Study|Death|0|||
23365203|NCT01214668|65084887|FG005|Overall Study|Death|0|||
23365204|NCT01214668|65084882|FG000|Overall Study|Progressive Disease|4|||
23365205|NCT01214668|65084883|FG001|Overall Study|Progressive Disease|2|||
23365206|NCT01214668|65084884|FG002|Overall Study|Progressive Disease|5|||
23365207|NCT01214668|65084885|FG003|Overall Study|Progressive Disease|4|||
23365208|NCT01214668|65084886|FG004|Overall Study|Progressive Disease|4|||
23365209|NCT01214668|65084887|FG005|Overall Study|Progressive Disease|5|||
23365210|NCT01214668|65084882|FG000|Overall Study|Withdrawal by Subject|0|||
23365211|NCT01214668|65084883|FG001|Overall Study|Withdrawal by Subject|0|||
23365212|NCT01214668|65084884|FG002|Overall Study|Withdrawal by Subject|0|||
23365213|NCT01214668|65084885|FG003|Overall Study|Withdrawal by Subject|0|||
23365214|NCT01214668|65084886|FG004|Overall Study|Withdrawal by Subject|1|||
23365215|NCT01214668|65084887|FG005|Overall Study|Withdrawal by Subject|0|||
23365216|NCT00377637|65084888|FG000|Induction Phase|Adverse Event|12|||
23365217|NCT00377637|65084889|FG001|Induction Phase|Adverse Event|21|||
23365218|NCT00377637|65084890|FG002|Induction Phase|Adverse Event|0|||
23269051|NCT02227862|64728613|FG001|Overall Study|Lost to Follow-up|2|||
23269052|NCT00796822|64728614|FG000|Overall Study|Lost to Follow-up|2|||
23269053|NCT00796822|64728615|FG001|Overall Study|Lost to Follow-up|0|||
23269054|NCT00796822|64728614|FG000|Overall Study|Adverse Event|1|||
23269055|NCT00796822|64728615|FG001|Overall Study|Adverse Event|0|||
23269056|NCT02906709|64728616|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
23269057|NCT02906709|64728617|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
23269058|NCT02906709|64728616|FG000|Phase A (Week 0 to Week 16)|Death|0|||
23269059|NCT02906709|64728617|FG001|Phase A (Week 0 to Week 16)|Death|1|||
23269060|NCT02906709|64728616|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
23269061|NCT02906709|64728617|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
23269062|NCT02906709|64728616|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
23269063|NCT02906709|64728617|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
23269064|NCT00688064|64728619|FG000|Overall Study|Protocol Violation|0|||
23269065|NCT00688064|64728620|FG001|Overall Study|Protocol Violation|1|||
23269066|NCT00688064|64728619|FG000|Overall Study|Adverse Event|2|||
23269067|NCT00688064|64728620|FG001|Overall Study|Adverse Event|4|||
23269068|NCT00688064|64728619|FG000|Overall Study|Withdrawal by Subject|7|||
23269069|NCT00688064|64728620|FG001|Overall Study|Withdrawal by Subject|7|||
23269070|NCT00688064|64728619|FG000|Overall Study|Lost to Follow-up|10|||
23269071|NCT00688064|64728620|FG001|Overall Study|Lost to Follow-up|10|||
23269072|NCT00688064|64728619|FG000|Overall Study|Lack of Efficacy|0|||
23269073|NCT00688064|64728620|FG001|Overall Study|Lack of Efficacy|1|||
23269074|NCT00688064|64728619|FG000|Overall Study|Pregnancy|1|||
23269075|NCT00688064|64728620|FG001|Overall Study|Pregnancy|0|||
23269076|NCT00688064|64728619|FG000|Overall Study|Any other reasons|1|||
23269077|NCT00688064|64728620|FG001|Overall Study|Any other reasons|3|||
23269078|NCT00051025|64728621|FG000|Overall Study|Progressive Disease|1|||
23269079|NCT00051025|64728622|FG001|Overall Study|Progressive Disease|1|||
23269080|NCT00051025|64728621|FG000|Overall Study|Adverse Event|1|||
23269081|NCT00051025|64728622|FG001|Overall Study|Adverse Event|1|||
23269082|NCT00051025|64728621|FG000|Overall Study|Withdrawal by Subject|0|||
23269083|NCT00051025|64728622|FG001|Overall Study|Withdrawal by Subject|1|||
23269084|NCT00051025|64728621|FG000|Overall Study|Death|0|||
23269085|NCT00051025|64728622|FG001|Overall Study|Death|1|||
23269086|NCT02016170|64728623|FG000|Overall Study|Adverse Event|1|||
23269087|NCT02016170|64728624|FG001|Overall Study|Adverse Event|1|||
23269088|NCT02016170|64728625|FG002|Overall Study|Adverse Event|0|||
23365219|NCT00377637|65084891|FG003|Induction Phase|Adverse Event|0|||
23269089|NCT02016170|64728623|FG000|Overall Study|Protocol Violation|1|||
23269090|NCT02016170|64728624|FG001|Overall Study|Protocol Violation|0|||
23269091|NCT02016170|64728625|FG002|Overall Study|Protocol Violation|0|||
23269092|NCT04799158|64728628|FG000|Run-In Period|Adverse Event|6|||
23269093|NCT04799158|64728629|FG001|Run-In Period|Adverse Event|0|||
23269094|NCT04799158|64728630|FG002|Run-In Period|Adverse Event|0|||
23365220|NCT00377637|65084888|FG000|Induction Phase|Deterioration/serum creatinine|2|||
23365221|NCT00377637|65084889|FG001|Induction Phase|Deterioration/serum creatinine|0|||
23365222|NCT00377637|65084890|FG002|Induction Phase|Deterioration/serum creatinine|0|||
23482285|NCT04761627|65509474|FG000|Post-randomization Period|Withdrawal by Subject|0|||
23482286|NCT04761627|65509475|FG001|Post-randomization Period|Withdrawal by Subject|7|||
23482287|NCT04761627|65509476|FG002|Post-randomization Period|Withdrawal by Subject|6|||
23482288|NCT04761627|65509474|FG000|Post-randomization Period|Pregnancy|0|||
23482289|NCT04761627|65509475|FG001|Post-randomization Period|Pregnancy|0|||
23482290|NCT04761627|65509476|FG002|Post-randomization Period|Pregnancy|1|||
23482291|NCT04761627|65509474|FG000|Post-randomization Period|Study site closure|0|||
23482292|NCT04761627|65509475|FG001|Post-randomization Period|Study site closure|0|||
23482293|NCT04761627|65509476|FG002|Post-randomization Period|Study site closure|1|||
23482294|NCT04761627|65509474|FG000|Post-randomization Period|Family planning|0|||
23482295|NCT04761627|65509475|FG001|Post-randomization Period|Family planning|1|||
23482296|NCT04761627|65509476|FG002|Post-randomization Period|Family planning|0|||
23482297|NCT03963401|65509477|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
23482298|NCT03963401|65509478|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
23482299|NCT03963401|65509479|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
23365223|NCT00377637|65084891|FG003|Induction Phase|Deterioration/serum creatinine|0|||
23365224|NCT00377637|65084888|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
23365225|NCT00377637|65084889|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
23365226|NCT00377637|65084890|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
23365227|NCT00377637|65084891|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
23365228|NCT00377637|65084888|FG000|Induction Phase|Lost to Follow-up|2|||
23365229|NCT00377637|65084889|FG001|Induction Phase|Lost to Follow-up|1|||
23365230|NCT00377637|65084890|FG002|Induction Phase|Lost to Follow-up|0|||
23365231|NCT00377637|65084891|FG003|Induction Phase|Lost to Follow-up|0|||
23365232|NCT00377637|65084888|FG000|Induction Phase|Death|1|||
23269095|NCT04799158|64728631|FG003|Run-In Period|Adverse Event|0|||
23269096|NCT04799158|64728632|FG004|Run-In Period|Adverse Event|0|||
23269097|NCT04799158|64728628|FG000|Run-In Period|Lost to Follow-up|4|||
23269098|NCT04799158|64728629|FG001|Run-In Period|Lost to Follow-up|0|||
23269099|NCT04799158|64728630|FG002|Run-In Period|Lost to Follow-up|0|||
23269100|NCT04799158|64728631|FG003|Run-In Period|Lost to Follow-up|0|||
23269101|NCT04799158|64728632|FG004|Run-In Period|Lost to Follow-up|0|||
23269102|NCT04799158|64728628|FG000|Run-In Period|Significant Protocol Deviation|1|||
23269103|NCT04799158|64728629|FG001|Run-In Period|Significant Protocol Deviation|0|||
23269104|NCT04799158|64728630|FG002|Run-In Period|Significant Protocol Deviation|0|||
23269105|NCT04799158|64728631|FG003|Run-In Period|Significant Protocol Deviation|0|||
23269106|NCT04799158|64728632|FG004|Run-In Period|Significant Protocol Deviation|0|||
23269107|NCT04799158|64728628|FG000|Run-In Period|Withdrawal by Subject|11|||
23269108|NCT04799158|64728629|FG001|Run-In Period|Withdrawal by Subject|0|||
23269109|NCT04799158|64728630|FG002|Run-In Period|Withdrawal by Subject|0|||
23365233|NCT00377637|65084889|FG001|Induction Phase|Death|3|||
23365234|NCT00377637|65084890|FG002|Induction Phase|Death|0|||
23365235|NCT00377637|65084891|FG003|Induction Phase|Death|0|||
23365236|NCT00377637|65084888|FG000|Induction Phase|Withdrawal by Subject|5|||
23365237|NCT00377637|65084889|FG001|Induction Phase|Withdrawal by Subject|6|||
23482300|NCT03963401|65509480|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
23482301|NCT03963401|65509481|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
23482302|NCT03963401|65509482|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
23482303|NCT03963401|65509477|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
23482304|NCT03963401|65509478|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
23482305|NCT03963401|65509479|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
23269110|NCT04799158|64728631|FG003|Run-In Period|Withdrawal by Subject|0|||
23269111|NCT04799158|64728632|FG004|Run-In Period|Withdrawal by Subject|0|||
23269112|NCT04799158|64728628|FG000|Run-In Period|Miscellaneous|3|||
23269113|NCT04799158|64728629|FG001|Run-In Period|Miscellaneous|0|||
23269114|NCT04799158|64728630|FG002|Run-In Period|Miscellaneous|0|||
23269115|NCT04799158|64728631|FG003|Run-In Period|Miscellaneous|0|||
23269116|NCT04799158|64728632|FG004|Run-In Period|Miscellaneous|0|||
23269117|NCT04799158|64728628|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
23269118|NCT04799158|64728629|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
23269119|NCT04799158|64728630|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
23269120|NCT04799158|64728631|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
23269121|NCT04799158|64728632|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
23269122|NCT04799158|64728628|FG000|On-Demand Treatment Period|Adverse Event|0|||
23269123|NCT04799158|64728629|FG001|On-Demand Treatment Period|Adverse Event|1|||
23269124|NCT04799158|64728630|FG002|On-Demand Treatment Period|Adverse Event|0|||
23269125|NCT04799158|64728631|FG003|On-Demand Treatment Period|Adverse Event|0|||
23269126|NCT04799158|64728632|FG004|On-Demand Treatment Period|Adverse Event|1|||
23269127|NCT04799158|64728628|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
23269128|NCT04799158|64728629|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
23269129|NCT04799158|64728630|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
23269130|NCT04799158|64728631|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
23269131|NCT04799158|64728632|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
23269132|NCT04799158|64728628|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
23269133|NCT04799158|64728629|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
23269134|NCT04799158|64728630|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
23269135|NCT04799158|64728631|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
23269136|NCT04799158|64728632|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
23269137|NCT04799158|64728628|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
23269138|NCT04799158|64728629|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
23269139|NCT04799158|64728630|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
23269140|NCT04799158|64728631|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
23269141|NCT04799158|64728632|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
23269142|NCT04799158|64728628|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
23269143|NCT04799158|64728629|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
23269144|NCT04799158|64728630|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
23269145|NCT04799158|64728631|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
23269146|NCT04799158|64728632|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
23269147|NCT04799158|64728628|FG000|On-Demand Treatment Period|Miscellaneous|0|||
23269148|NCT04799158|64728629|FG001|On-Demand Treatment Period|Miscellaneous|0|||
23269149|NCT04799158|64728630|FG002|On-Demand Treatment Period|Miscellaneous|0|||
23269150|NCT04799158|64728631|FG003|On-Demand Treatment Period|Miscellaneous|0|||
23269151|NCT04799158|64728632|FG004|On-Demand Treatment Period|Miscellaneous|1|||
23269152|NCT01422538|64728633|FG000|Overall Study|Lost to Follow-up|0|||
23269153|NCT01422538|64728634|FG001|Overall Study|Lost to Follow-up|1|||
23269154|NCT01422538|64728635|FG002|Overall Study|Lost to Follow-up|1|||
23269155|NCT01422538|64728633|FG000|Overall Study|Missed visit|0|||
23269156|NCT01422538|64728634|FG001|Overall Study|Missed visit|1|||
23269157|NCT01422538|64728635|FG002|Overall Study|Missed visit|1|||
23269158|NCT02202850|64728637|FG000|Overall Study|Other|2|||
23269159|NCT02202850|64728638|FG001|Overall Study|Other|2|||
23269160|NCT02202850|64728637|FG000|Overall Study|Enbrel treatment discontinued|15|||
23269161|NCT02202850|64728638|FG001|Overall Study|Enbrel treatment discontinued|3|||
23269162|NCT02202850|64728637|FG000|Overall Study|Lost to Follow-up|7|||
23269163|NCT02202850|64728638|FG001|Overall Study|Lost to Follow-up|1|||
23482306|NCT03963401|65509480|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
23269164|NCT02480764|64728641|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
23269165|NCT02480764|64728642|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
23269166|NCT02480764|64728643|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
23269167|NCT02480764|64728641|FG000|Overall Study|Major Protocol Deviation|1|||
23269168|NCT02480764|64728642|FG001|Overall Study|Major Protocol Deviation|4|||
23269169|NCT02480764|64728643|FG002|Overall Study|Major Protocol Deviation|3|||
23269170|NCT02480764|64728641|FG000|Overall Study|Lost to Follow-up|0|||
23269171|NCT02480764|64728642|FG001|Overall Study|Lost to Follow-up|1|||
23269172|NCT02480764|64728643|FG002|Overall Study|Lost to Follow-up|2|||
23269173|NCT02480764|64728641|FG000|Overall Study|Voluntary Withdrawal|6|||
23269174|NCT02480764|64728642|FG001|Overall Study|Voluntary Withdrawal|5|||
23269175|NCT02480764|64728643|FG002|Overall Study|Voluntary Withdrawal|10|||
23269176|NCT02480764|64728641|FG000|Overall Study|Lack of Efficacy|0|||
23269177|NCT02480764|64728642|FG001|Overall Study|Lack of Efficacy|3|||
23269178|NCT02480764|64728643|FG002|Overall Study|Lack of Efficacy|3|||
23269179|NCT02480764|64728641|FG000|Overall Study|Reason not Specified|0|||
23269180|NCT02480764|64728642|FG001|Overall Study|Reason not Specified|1|||
23269181|NCT02480764|64728643|FG002|Overall Study|Reason not Specified|0|||
23269182|NCT01469364|64728644|FG000|Overall Study|Adverse Event|1|||
23269183|NCT01469364|64728644|FG000|Overall Study|Withdrawal by Subject|1|||
23269184|NCT01370408|64728645|FG000|Overall Study|treatment failure|9|||
23269185|NCT03831048|64728646|FG000|Overall Study|Protocol Violation|9|||
23269186|NCT03831048|64728647|FG001|Overall Study|Protocol Violation|3|||
23269187|NCT03831048|64728646|FG000|Overall Study|Death|4|||
23269188|NCT03831048|64728647|FG001|Overall Study|Death|9|||
23269189|NCT03831048|64728646|FG000|Overall Study|Re-transplant|0|||
23269190|NCT03831048|64728647|FG001|Overall Study|Re-transplant|2|||
23269191|NCT03831048|64728646|FG000|Overall Study|Protocol violation and death|1|||
23269192|NCT03831048|64728647|FG001|Overall Study|Protocol violation and death|1|||
23269193|NCT03184441|64728656|FG000|Overall Study|Withdrawal by Subject|1|||
23269194|NCT02242201|64728663|FG000|Overall Study|preoperative identified neuropathy|2|||
23269195|NCT02242201|64728664|FG001|Overall Study|preoperative identified neuropathy|0|||
23269196|NCT02242201|64728665|FG002|Overall Study|preoperative identified neuropathy|0|||
23269197|NCT02242201|64728663|FG000|Overall Study|planned post-op anticoagulation|1|||
23269198|NCT02242201|64728664|FG001|Overall Study|planned post-op anticoagulation|0|||
23269199|NCT02242201|64728665|FG002|Overall Study|planned post-op anticoagulation|0|||
23269200|NCT02242201|64728663|FG000|Overall Study|changed surgical procedure|1|||
23269201|NCT02242201|64728664|FG001|Overall Study|changed surgical procedure|0|||
23269202|NCT02242201|64728665|FG002|Overall Study|changed surgical procedure|0|||
23269203|NCT02242201|64728663|FG000|Overall Study|postponed surgery|0|||
23269204|NCT02242201|64728664|FG001|Overall Study|postponed surgery|0|||
23269205|NCT02242201|64728665|FG002|Overall Study|postponed surgery|1|||
23269206|NCT02242201|64728663|FG000|Overall Study|preoperative opioid consumption|0|||
23269207|NCT02242201|64728664|FG001|Overall Study|preoperative opioid consumption|1|||
23269208|NCT02242201|64728665|FG002|Overall Study|preoperative opioid consumption|0|||
23269209|NCT03500692|64728670|FG000|Overall Study|Death|163|||
23269210|NCT03500692|64728670|FG000|Overall Study|Lost to Follow-up|75|||
23269211|NCT03500692|64728670|FG000|Overall Study|Termination Reasons|3|||
23269212|NCT02193880|64728672|FG000|Overall Study|patients did not collect enough HPC|3|||
23269213|NCT00365300|64728673|FG000|Open-label Phase|Adverse Event|4|||
23269214|NCT00365300|64728674|FG001|Open-label Phase|Adverse Event|0|||
23269215|NCT00365300|64728673|FG000|Open-label Phase|Failed to Return|1|||
23269216|NCT00365300|64728674|FG001|Open-label Phase|Failed to Return|0|||
23269217|NCT00365300|64728673|FG000|Open-label Phase|Physician Decision|1|||
23269218|NCT00365300|64728674|FG001|Open-label Phase|Physician Decision|0|||
23269219|NCT00365300|64728673|FG000|Open-label Phase|Noncompliance|9|||
23269220|NCT00365300|64728674|FG001|Open-label Phase|Noncompliance|0|||
23269221|NCT00365300|64728673|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
23269222|NCT00365300|64728674|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
23269223|NCT00365300|64728673|FG000|Open-label Phase|Protocol Violation|1|||
23269224|NCT00365300|64728674|FG001|Open-label Phase|Protocol Violation|0|||
23269225|NCT00365300|64728673|FG000|Open-label Phase|Lack of Efficacy|1|||
23269226|NCT00365300|64728674|FG001|Open-label Phase|Lack of Efficacy|0|||
23269227|NCT00365300|64728673|FG000|Open-label Phase|Patient skipped open label phase|1|||
23269228|NCT00365300|64728674|FG001|Open-label Phase|Patient skipped open label phase|0|||
23482307|NCT03963401|65509481|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
23269229|NCT00365300|64728673|FG000|Double-blind Phase|Failed to return|1|||
23269230|NCT00365300|64728674|FG001|Double-blind Phase|Failed to return|0|||
23269231|NCT00365300|64728673|FG000|Double-blind Phase|Noncompliance|1|||
23269232|NCT00365300|64728674|FG001|Double-blind Phase|Noncompliance|1|||
23269233|NCT00365300|64728673|FG000|Double-blind Phase|Withdrawal by Subject|0|||
23269234|NCT00365300|64728674|FG001|Double-blind Phase|Withdrawal by Subject|1|||
23269235|NCT00365300|64728673|FG000|Double-blind Phase|Protocol Violation|3|||
23269236|NCT00365300|64728674|FG001|Double-blind Phase|Protocol Violation|1|||
23365238|NCT00377637|65084890|FG002|Induction Phase|Withdrawal by Subject|0|||
23365239|NCT00377637|65084891|FG003|Induction Phase|Withdrawal by Subject|0|||
23365240|NCT00377637|65084888|FG000|Induction Phase|Physician Decision|3|||
23365241|NCT00377637|65084889|FG001|Induction Phase|Physician Decision|1|||
23365242|NCT00377637|65084890|FG002|Induction Phase|Physician Decision|0|||
23365243|NCT00377637|65084891|FG003|Induction Phase|Physician Decision|0|||
23365244|NCT00377637|65084888|FG000|Induction Phase|Sponsor decision|1|||
23365245|NCT00377637|65084889|FG001|Induction Phase|Sponsor decision|2|||
23365246|NCT00377637|65084890|FG002|Induction Phase|Sponsor decision|0|||
23365247|NCT00377637|65084891|FG003|Induction Phase|Sponsor decision|0|||
23365248|NCT00377637|65084888|FG000|Induction Phase|Non-Compliance|1|||
23365249|NCT00377637|65084889|FG001|Induction Phase|Non-Compliance|0|||
23365250|NCT00377637|65084890|FG002|Induction Phase|Non-Compliance|0|||
23365251|NCT00377637|65084891|FG003|Induction Phase|Non-Compliance|0|||
23365252|NCT00377637|65084888|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
23365253|NCT00377637|65084889|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
23365254|NCT00377637|65084890|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
23365255|NCT00377637|65084891|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
23365256|NCT00377637|65084888|FG000|Maintenance Phase|Adverse Event|0|||
23365257|NCT00377637|65084889|FG001|Maintenance Phase|Adverse Event|0|||
23365258|NCT00377637|65084890|FG002|Maintenance Phase|Adverse Event|29|||
23365259|NCT00377637|65084891|FG003|Maintenance Phase|Adverse Event|43|||
23365260|NCT00377637|65084888|FG000|Maintenance Phase|Physician Decision|0|||
23365261|NCT00377637|65084889|FG001|Maintenance Phase|Physician Decision|0|||
23365262|NCT00377637|65084890|FG002|Maintenance Phase|Physician Decision|5|||
23365263|NCT00377637|65084891|FG003|Maintenance Phase|Physician Decision|4|||
23365264|NCT00377637|65084888|FG000|Maintenance Phase|Lost to Follow-up|0|||
23365265|NCT00377637|65084889|FG001|Maintenance Phase|Lost to Follow-up|0|||
23365266|NCT00377637|65084890|FG002|Maintenance Phase|Lost to Follow-up|3|||
23365267|NCT00377637|65084891|FG003|Maintenance Phase|Lost to Follow-up|1|||
23365268|NCT00377637|65084888|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23365269|NCT00377637|65084889|FG001|Maintenance Phase|Withdrawal by Subject|0|||
23365270|NCT00377637|65084890|FG002|Maintenance Phase|Withdrawal by Subject|3|||
23365271|NCT00377637|65084891|FG003|Maintenance Phase|Withdrawal by Subject|3|||
23365272|NCT00377637|65084888|FG000|Maintenance Phase|Sponsor decision|0|||
23365273|NCT00377637|65084889|FG001|Maintenance Phase|Sponsor decision|0|||
23365274|NCT00377637|65084890|FG002|Maintenance Phase|Sponsor decision|2|||
23365275|NCT00377637|65084891|FG003|Maintenance Phase|Sponsor decision|3|||
23365276|NCT00377637|65084888|FG000|Maintenance Phase|Non-compliance|0|||
23365277|NCT00377637|65084889|FG001|Maintenance Phase|Non-compliance|0|||
23365278|NCT00377637|65084890|FG002|Maintenance Phase|Non-compliance|1|||
23365279|NCT00377637|65084891|FG003|Maintenance Phase|Non-compliance|1|||
23365280|NCT00377637|65084888|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
23365281|NCT00377637|65084889|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
23365282|NCT00377637|65084890|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
23365283|NCT00377637|65084891|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
23482308|NCT03963401|65509482|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
23482309|NCT03963401|65509477|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
23482310|NCT03963401|65509478|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
23482311|NCT03963401|65509479|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
23482312|NCT03963401|65509480|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
23482313|NCT03963401|65509481|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
23482314|NCT03963401|65509482|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
23601527|NCT01394276|65933780|FG000|Overall Study|Insufficient therapeutic effect|17|||
23601528|NCT01394276|65933780|FG000|Overall Study|Insufficient compliance|9|||
23601529|NCT01394276|65933780|FG000|Overall Study|Lost to Follow-up|5|||
23601530|NCT01394276|65933780|FG000|Overall Study|Participant moved to another site|1|||
23601531|NCT01394276|65933780|FG000|Overall Study|Pregnancy|1|||
23601532|NCT01394276|65933780|FG000|Overall Study|unavailability of drug at the Hospital|2|||
23601533|NCT01394276|65933780|FG000|Overall Study|Symptoms of concurrent diseases|1|||
23365284|NCT00377637|65084888|FG000|Maintenance Phase|Death|0|||
23365285|NCT00377637|65084889|FG001|Maintenance Phase|Death|0|||
23482315|NCT03963401|65509477|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23601534|NCT02807857|65933781|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
23365286|NCT00377637|65084890|FG002|Maintenance Phase|Death|0|||
23365287|NCT00377637|65084891|FG003|Maintenance Phase|Death|1|||
23365288|NCT02667301|65084894|FG000|Overall Study|Adverse Event|1|||
23365289|NCT02667301|65084894|FG000|Overall Study|Lack of Efficacy|1|||
23365290|NCT00846586|65084895|FG000|Overall Study|Adverse Event|20|||
23365291|NCT00846586|65084896|FG001|Overall Study|Adverse Event|10|||
23365292|NCT00846586|65084895|FG000|Overall Study|Subject withdrew consent|8|||
23365293|NCT00846586|65084896|FG001|Overall Study|Subject withdrew consent|10|||
23365294|NCT00846586|65084895|FG000|Overall Study|Administrative problems|5|||
23365295|NCT00846586|65084896|FG001|Overall Study|Administrative problems|4|||
23365296|NCT00846586|65084895|FG000|Overall Study|Death|2|||
23365297|NCT00846586|65084896|FG001|Overall Study|Death|0|||
23365298|NCT00846586|65084895|FG000|Overall Study|Protocol deviation|2|||
23365299|NCT00846586|65084896|FG001|Overall Study|Protocol deviation|6|||
23365300|NCT00846586|65084895|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23365301|NCT00846586|65084896|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23365302|NCT00846586|65084895|FG000|Overall Study|Lost to Follow-up|1|||
23365303|NCT00846586|65084896|FG001|Overall Study|Lost to Follow-up|4|||
23365304|NCT00846586|65084895|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23365305|NCT00846586|65084896|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23365306|NCT01663402|65084897|FG000|Overall Study|Randomized but not treated|19|||
23365307|NCT01663402|65084898|FG001|Overall Study|Randomized but not treated|11|||
23365308|NCT01663402|65084897|FG000|Overall Study|Adverse Event|347|||
23365309|NCT01663402|65084898|FG001|Overall Study|Adverse Event|362|||
23365310|NCT01663402|65084897|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
23365311|NCT01663402|65084898|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
23365312|NCT01663402|65084897|FG000|Overall Study|Poor compliance to protocol|529|||
23365313|NCT01663402|65084898|FG001|Overall Study|Poor compliance to protocol|454|||
23365314|NCT01663402|65084897|FG000|Overall Study|Physician Decision|77|||
23365315|NCT01663402|65084898|FG001|Overall Study|Physician Decision|62|||
23365316|NCT01663402|65084897|FG000|Overall Study|Site terminated by sponsor|1|||
23365317|NCT01663402|65084898|FG001|Overall Study|Site terminated by sponsor|3|||
23365318|NCT01663402|65084897|FG000|Overall Study|Participant moved|139|||
23365319|NCT01663402|65084898|FG001|Overall Study|Participant moved|104|||
23365320|NCT01663402|65084897|FG000|Overall Study|Withdrawal by Subject|118|||
23365321|NCT01663402|65084898|FG001|Overall Study|Withdrawal by Subject|91|||
23365322|NCT01663402|65084897|FG000|Overall Study|Related to study drug administration|96|||
23365323|NCT01663402|65084898|FG001|Overall Study|Related to study drug administration|105|||
23365324|NCT01663402|65084897|FG000|Overall Study|Lost to Follow-up|17|||
23365325|NCT01663402|65084898|FG001|Overall Study|Lost to Follow-up|15|||
23365326|NCT01663402|65084897|FG000|Overall Study|Other than specified above|172|||
23365327|NCT01663402|65084898|FG001|Overall Study|Other than specified above|147|||
23365328|NCT01316575|65084899|FG000|Overall Study|Withdrawal by Subject|2|||
23365329|NCT01316575|65084900|FG001|Overall Study|Withdrawal by Subject|0|||
23365330|NCT01316575|65084899|FG000|Overall Study|Required alternate treatment|0|||
23365331|NCT01316575|65084900|FG001|Overall Study|Required alternate treatment|1|||
23365332|NCT02619617|65084904|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
23365333|NCT02619617|65084905|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
23365334|NCT02619617|65084904|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
23365335|NCT02619617|65084905|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
23365336|NCT00126594|65084906|FG000|Overall Study|Ineligible|2|||
23365337|NCT00126594|65084907|FG001|Overall Study|Ineligible|0|||
23365338|NCT00126594|65084906|FG000|Overall Study|Withdrawal by Subject|0|||
23365339|NCT00126594|65084907|FG001|Overall Study|Withdrawal by Subject|4|||
23365340|NCT00126594|65084906|FG000|Overall Study|Physician Decision|1|||
23365341|NCT00126594|65084907|FG001|Overall Study|Physician Decision|3|||
23365342|NCT00126594|65084906|FG000|Overall Study|Adverse Event|7|||
23365343|NCT00126594|65084907|FG001|Overall Study|Adverse Event|5|||
23365344|NCT00126594|65084906|FG000|Overall Study|Non-compliance|0|||
23365345|NCT00126594|65084907|FG001|Overall Study|Non-compliance|1|||
23365346|NCT00126594|65084906|FG000|Overall Study|Disease Progression|29|||
23365347|NCT00126594|65084907|FG001|Overall Study|Disease Progression|24|||
23365348|NCT01484951|65084912|FG000|Overall Study|Adverse Event|3|||
23365349|NCT01484951|65084912|FG000|Overall Study|Personal Reasons|1|||
23365350|NCT01484951|65084912|FG000|Overall Study|Non-Compliance|1|||
23365351|NCT04534517|65084918|FG000|Overall Study|Adverse Event|1|||
23365352|NCT04534517|65084918|FG000|Overall Study|Withdrawal by Subject|1|||
23365353|NCT04534517|65084918|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
23365354|NCT04534517|65084918|FG000|Overall Study|COVID-19 Related|1|||
23365355|NCT01095835|65084919|FG000|Overall Study|Adverse Event|8|||
23365356|NCT01095835|65084920|FG001|Overall Study|Adverse Event|6|||
23365357|NCT01095835|65084921|FG002|Overall Study|Adverse Event|6|||
23365358|NCT01095835|65084919|FG000|Overall Study|Lack of Efficacy|0|||
23601535|NCT02807857|65933781|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
23601536|NCT02807857|65933781|FG000|Follow-Up Set|Withdrawal by Subject|8|||
23601537|NCT02807857|65933781|FG000|Follow-Up Set|Lost to Follow-up|7|||
23601538|NCT02807857|65933781|FG000|Follow-Up Set|Physician Decision|6|||
23601539|NCT02807857|65933781|FG000|Follow-Up Set|Adverse Event|3|||
23365359|NCT01095835|65084920|FG001|Overall Study|Lack of Efficacy|1|||
23365360|NCT01095835|65084921|FG002|Overall Study|Lack of Efficacy|0|||
23365361|NCT01095835|65084919|FG000|Overall Study|Physician Decision|0|||
23365362|NCT01095835|65084920|FG001|Overall Study|Physician Decision|0|||
23365363|NCT01095835|65084921|FG002|Overall Study|Physician Decision|1|||
23365364|NCT01095835|65084919|FG000|Overall Study|Withdrawal by Subject|1|||
23365365|NCT01095835|65084920|FG001|Overall Study|Withdrawal by Subject|3|||
23365366|NCT01095835|65084921|FG002|Overall Study|Withdrawal by Subject|0|||
23365367|NCT01095835|65084919|FG000|Overall Study|Non study compliance|0|||
23365368|NCT01095835|65084920|FG001|Overall Study|Non study compliance|0|||
23365369|NCT01095835|65084921|FG002|Overall Study|Non study compliance|1|||
23365370|NCT01095835|65084919|FG000|Overall Study|Protocol Violation|1|||
23365371|NCT01095835|65084920|FG001|Overall Study|Protocol Violation|2|||
23365372|NCT01095835|65084921|FG002|Overall Study|Protocol Violation|0|||
23365373|NCT01607593|65084922|FG000|Overall Study|Adverse Event|15|||
23365374|NCT01607593|65084922|FG000|Overall Study|Lack of Efficacy|16|||
23365375|NCT01607593|65084922|FG000|Overall Study|Lost to Follow-up|25|||
23365376|NCT01607593|65084922|FG000|Overall Study|Continuation|33|||
23365377|NCT01607593|65084922|FG000|Overall Study|Other|4|||
23365378|NCT02346708|65084935|FG000|Overall Study|Adverse Event|2|||
23365379|NCT02346708|65084936|FG001|Overall Study|Adverse Event|0|||
23365380|NCT02346708|65084935|FG000|Overall Study|Protocol Violation|0|||
23365381|NCT02346708|65084936|FG001|Overall Study|Protocol Violation|1|||
23365382|NCT01630135|65084937|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
23365383|NCT01630135|65084938|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
23365384|NCT00072410|65084939|FG000|Overall Study|Progressive disease|0|||
23365385|NCT00072410|65084940|FG001|Overall Study|Progressive disease|3|||
23365386|NCT01261390|65084943|FG000|Overall Study|Significant Concurrent Illness|1|||
23365387|NCT01261390|65084944|FG001|Overall Study|Significant Concurrent Illness|0|||
23365388|NCT01261390|65084945|FG002|Overall Study|Significant Concurrent Illness|1|||
23365389|NCT01261390|65084946|FG003|Overall Study|Significant Concurrent Illness|0|||
23365390|NCT01261390|65084943|FG000|Overall Study|Dissatisfaction with Treatment|2|||
23365391|NCT01261390|65084944|FG001|Overall Study|Dissatisfaction with Treatment|1|||
23365392|NCT01261390|65084945|FG002|Overall Study|Dissatisfaction with Treatment|1|||
23365393|NCT01261390|65084946|FG003|Overall Study|Dissatisfaction with Treatment|2|||
23365394|NCT01261390|65084943|FG000|Overall Study|Relocation|0|||
23365395|NCT01261390|65084944|FG001|Overall Study|Relocation|1|||
23365396|NCT01261390|65084945|FG002|Overall Study|Relocation|0|||
23365397|NCT01261390|65084946|FG003|Overall Study|Relocation|0|||
23365398|NCT01261390|65084943|FG000|Overall Study|Loss of Interest in the Study|3|||
23365399|NCT01261390|65084944|FG001|Overall Study|Loss of Interest in the Study|1|||
23365400|NCT01261390|65084945|FG002|Overall Study|Loss of Interest in the Study|0|||
23365401|NCT01261390|65084946|FG003|Overall Study|Loss of Interest in the Study|0|||
23365402|NCT01261390|65084943|FG000|Overall Study|Lost to Follow-up|1|||
23365403|NCT01261390|65084944|FG001|Overall Study|Lost to Follow-up|6|||
23365404|NCT01261390|65084945|FG002|Overall Study|Lost to Follow-up|5|||
23365405|NCT01261390|65084946|FG003|Overall Study|Lost to Follow-up|6|||
23365406|NCT04817332|65084947|FG000|Overall Study|Lost to Follow-up|3|||
23365407|NCT04817332|65084948|FG001|Overall Study|Lost to Follow-up|3|||
23365408|NCT04817332|65084947|FG000|Overall Study|Protocol Violation|2|||
23365409|NCT04817332|65084948|FG001|Overall Study|Protocol Violation|0|||
23365410|NCT00902577|65084953|FG000|Overall Study|Withdrawal by Subject|6|||
23365411|NCT00902577|65084953|FG000|Overall Study|FMISO production failure|2|||
23365412|NCT03492437|65084954|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23365413|NCT03492437|65084955|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23365414|NCT00791999|65084956|FG000|Overall Study|Protocol planed withdrawal|14|||
23365415|NCT00791999|65084957|FG001|Overall Study|Protocol planed withdrawal|11|||
23365416|NCT00791999|65084958|FG002|Overall Study|Protocol planed withdrawal|11|||
23365417|NCT00791999|65084959|FG003|Overall Study|Protocol planed withdrawal|45|||
23365418|NCT00791999|65084956|FG000|Overall Study|Withdrawal by Subject|0|||
23365419|NCT00791999|65084957|FG001|Overall Study|Withdrawal by Subject|1|||
23365420|NCT00791999|65084958|FG002|Overall Study|Withdrawal by Subject|0|||
23365421|NCT00791999|65084959|FG003|Overall Study|Withdrawal by Subject|2|||
23365422|NCT00791999|65084956|FG000|Overall Study|Protocol Violation|3|||
23365423|NCT00791999|65084957|FG001|Overall Study|Protocol Violation|0|||
23365424|NCT00791999|65084958|FG002|Overall Study|Protocol Violation|1|||
23365425|NCT00791999|65084959|FG003|Overall Study|Protocol Violation|0|||
23365426|NCT00791999|65084956|FG000|Overall Study|Adverse Event|3|||
23365427|NCT00791999|65084957|FG001|Overall Study|Adverse Event|3|||
23365428|NCT00791999|65084958|FG002|Overall Study|Adverse Event|7|||
23365429|NCT00791999|65084959|FG003|Overall Study|Adverse Event|3|||
23365430|NCT00791999|65084956|FG000|Overall Study|Lack of Efficacy|0|||
23365431|NCT00791999|65084957|FG001|Overall Study|Lack of Efficacy|1|||
23482316|NCT03963401|65509478|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
23365432|NCT00791999|65084958|FG002|Overall Study|Lack of Efficacy|0|||
23482317|NCT03963401|65509479|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23601540|NCT02807857|65933781|FG000|Follow-Up Set|Death|27|||
23365433|NCT00791999|65084959|FG003|Overall Study|Lack of Efficacy|2|||
23365434|NCT00791999|65084956|FG000|Overall Study|Reason other than those above|1|||
23365435|NCT00791999|65084957|FG001|Overall Study|Reason other than those above|0|||
23365436|NCT00791999|65084958|FG002|Overall Study|Reason other than those above|1|||
23365437|NCT00791999|65084959|FG003|Overall Study|Reason other than those above|0|||
23365438|NCT00411450|65084960|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
23365439|NCT01274351|65084961|FG000|Overall Study|Lost to Follow-up|1|||
23365440|NCT01274351|65084961|FG000|Overall Study|patient not compliant with the protocol|1|||
23365441|NCT01274351|65084961|FG000|Overall Study|Pregnancy|1|||
23365442|NCT01274351|65084961|FG000|Overall Study|Death|2|||
23365443|NCT01274351|65084961|FG000|Overall Study|Withdrawal by Subject|3|||
23365444|NCT01274351|65084961|FG000|Overall Study|Adverse Event|8|||
23365445|NCT01274351|65084961|FG000|Overall Study|progression of disease|3|||
23365446|NCT01274351|65084961|FG000|Overall Study|hospitalization|1|||
23365447|NCT03188055|65084962|FG000|Overall Study|Unavailable for training|0|||
23365448|NCT03188055|65084963|FG001|Overall Study|Unavailable for training|0|||
23365449|NCT03188055|65084964|FG002|Overall Study|Unavailable for training|19|||
23365450|NCT03188055|65084965|FG003|Overall Study|Unavailable for training|0|||
23365451|NCT03188055|65084966|FG004|Overall Study|Unavailable for training|0|||
23365452|NCT03188055|65084967|FG005|Overall Study|Unavailable for training|0|||
23365453|NCT03188055|65084962|FG000|Overall Study|Lost to Follow-up|0|||
23365454|NCT03188055|65084963|FG001|Overall Study|Lost to Follow-up|18|||
23365455|NCT03188055|65084964|FG002|Overall Study|Lost to Follow-up|0|||
23365456|NCT03188055|65084965|FG003|Overall Study|Lost to Follow-up|11|||
23365457|NCT03188055|65084966|FG004|Overall Study|Lost to Follow-up|0|||
23365458|NCT03188055|65084967|FG005|Overall Study|Lost to Follow-up|0|||
23365459|NCT03188055|65084962|FG000|Overall Study|Withdrawal by Subject|0|||
23365460|NCT03188055|65084963|FG001|Overall Study|Withdrawal by Subject|1|||
23365461|NCT03188055|65084964|FG002|Overall Study|Withdrawal by Subject|0|||
23365462|NCT03188055|65084965|FG003|Overall Study|Withdrawal by Subject|1|||
23365463|NCT03188055|65084966|FG004|Overall Study|Withdrawal by Subject|0|||
23365464|NCT03188055|65084967|FG005|Overall Study|Withdrawal by Subject|0|||
23365465|NCT02595502|65084968|FG000|Period 1|Adverse Event|0|||
23365466|NCT02595502|65084969|FG001|Period 1|Adverse Event|1|||
23365467|NCT02595502|65084968|FG000|Period 1|Withdrawal by Subject|1|||
23365468|NCT02595502|65084969|FG001|Period 1|Withdrawal by Subject|0|||
23365469|NCT02595502|65084968|FG000|Period 1|Lost to Follow-up|0|||
23365470|NCT02595502|65084969|FG001|Period 1|Lost to Follow-up|1|||
23365471|NCT02595502|65084968|FG000|Period 2|Adverse Event|1|||
23365472|NCT02595502|65084969|FG001|Period 2|Adverse Event|1|||
23365473|NCT02595502|65084968|FG000|Period 2|Received incorrect lens at Period 1|0|||
23365474|NCT02595502|65084969|FG001|Period 2|Received incorrect lens at Period 1|1|||
23365475|NCT02595502|65084968|FG000|Period 3|Protocol Violation|0|||
23365476|NCT02595502|65084969|FG001|Period 3|Protocol Violation|1|||
23365477|NCT02595502|65084968|FG000|Period 3|Lost to Follow-up|1|||
23365478|NCT02595502|65084969|FG001|Period 3|Lost to Follow-up|0|||
23365479|NCT02595502|65084968|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
23365480|NCT02595502|65084969|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
23365481|NCT00577317|65084973|FG000|Overall Study|Study Terminated|0|||
23365482|NCT00577317|65084974|FG001|Overall Study|Study Terminated|2|||
23365483|NCT03498313|65084980|FG000|Experimental Period 1|Adverse Event|1|||
23365484|NCT03498313|65084981|FG001|Experimental Period 1|Adverse Event|0|||
23365485|NCT03498313|65084982|FG002|Experimental Period 1|Adverse Event|0|||
23365486|NCT03498313|65084983|FG003|Experimental Period 1|Adverse Event|1|||
23365487|NCT03498313|65084984|FG004|Experimental Period 1|Adverse Event|0|||
23365488|NCT03498313|65084985|FG005|Experimental Period 1|Adverse Event|0|||
23601541|NCT02807857|65933781|FG000|Follow-Up Set|Relocation|2|||
23365489|NCT03498313|65084980|FG000|Experimental Period 1|Withdrawal by Subject|0|||
23365490|NCT03498313|65084981|FG001|Experimental Period 1|Withdrawal by Subject|1|||
23365491|NCT03498313|65084982|FG002|Experimental Period 1|Withdrawal by Subject|0|||
23365492|NCT03498313|65084983|FG003|Experimental Period 1|Withdrawal by Subject|0|||
23365493|NCT03498313|65084984|FG004|Experimental Period 1|Withdrawal by Subject|0|||
23365494|NCT03498313|65084985|FG005|Experimental Period 1|Withdrawal by Subject|0|||
23601542|NCT00442104|65933782|FG000|Overall Study|Adverse Event|5|||
23601543|NCT00442104|65933782|FG000|Overall Study|Death|2|||
23601544|NCT00442104|65933782|FG000|Overall Study|Lost to Follow-up|3|||
23601545|NCT00442104|65933782|FG000|Overall Study|Withdrawal by Subject|5|||
23365495|NCT03498313|65084980|FG000|Washout Period 1|Anovulation|1|||
23365496|NCT03498313|65084981|FG001|Washout Period 1|Anovulation|0|||
23365497|NCT03498313|65084982|FG002|Washout Period 1|Anovulation|0|||
23365498|NCT03498313|65084983|FG003|Washout Period 1|Anovulation|0|||
23365499|NCT03498313|65084984|FG004|Washout Period 1|Anovulation|0|||
23365500|NCT03498313|65084985|FG005|Washout Period 1|Anovulation|0|||
23601546|NCT00442104|65933782|FG000|Overall Study|Insufficient Clinical Response|10|||
23269237|NCT00365300|64728673|FG000|Double-blind Phase|Lack of Efficacy|6|||
23269238|NCT00365300|64728674|FG001|Double-blind Phase|Lack of Efficacy|6|||
23269239|NCT01984242|64728676|FG000|Overall Study|Death|52|||
23269240|NCT01984242|64728677|FG001|Overall Study|Death|50|||
23269241|NCT01984242|64728678|FG002|Overall Study|Death|52|||
23269242|NCT01984242|64728676|FG000|Overall Study|Withdrawal by Subject|5|||
23269243|NCT01984242|64728677|FG001|Overall Study|Withdrawal by Subject|3|||
23269244|NCT01984242|64728678|FG002|Overall Study|Withdrawal by Subject|10|||
23269245|NCT01984242|64728676|FG000|Overall Study|Physician Decision|0|||
23269246|NCT01984242|64728677|FG001|Overall Study|Physician Decision|0|||
23269247|NCT01984242|64728678|FG002|Overall Study|Physician Decision|1|||
23269248|NCT01984242|64728676|FG000|Overall Study|Lost to Follow-up|4|||
23269249|NCT01984242|64728677|FG001|Overall Study|Lost to Follow-up|0|||
23269250|NCT01984242|64728678|FG002|Overall Study|Lost to Follow-up|3|||
23269251|NCT01984242|64728676|FG000|Overall Study|Sponsor Decision|1|||
23269252|NCT01984242|64728677|FG001|Overall Study|Sponsor Decision|0|||
23269253|NCT01984242|64728678|FG002|Overall Study|Sponsor Decision|0|||
23269254|NCT01984242|64728676|FG000|Overall Study|Non-Compliance|1|||
23269255|NCT01984242|64728677|FG001|Overall Study|Non-Compliance|0|||
23269256|NCT01984242|64728678|FG002|Overall Study|Non-Compliance|0|||
23269257|NCT01984242|64728676|FG000|Overall Study|Study terminated by Sponsor|38|||
23269258|NCT01984242|64728677|FG001|Overall Study|Study terminated by Sponsor|50|||
23269259|NCT01984242|64728678|FG002|Overall Study|Study terminated by Sponsor|34|||
23269260|NCT01984242|64728676|FG000|Overall Study|Disease Progression|0|||
23269261|NCT01984242|64728677|FG001|Overall Study|Disease Progression|0|||
23269262|NCT01984242|64728678|FG002|Overall Study|Disease Progression|1|||
23269263|NCT02974153|64728680|FG000|Overall Study|Adverse Event|6|||
23269264|NCT02974153|64728681|FG001|Overall Study|Adverse Event|0|||
23269265|NCT02974153|64728682|FG002|Overall Study|Adverse Event|1|||
23269266|NCT02974153|64728680|FG000|Overall Study|Lack of Efficacy|6|||
23269267|NCT02974153|64728681|FG001|Overall Study|Lack of Efficacy|5|||
23269268|NCT02974153|64728682|FG002|Overall Study|Lack of Efficacy|10|||
23269269|NCT02974153|64728680|FG000|Overall Study|Lost to Follow-up|9|||
23269270|NCT02974153|64728681|FG001|Overall Study|Lost to Follow-up|10|||
23269271|NCT02974153|64728682|FG002|Overall Study|Lost to Follow-up|17|||
23269272|NCT02974153|64728680|FG000|Overall Study|Physician Decision|0|||
23269273|NCT02974153|64728681|FG001|Overall Study|Physician Decision|2|||
23269274|NCT02974153|64728682|FG002|Overall Study|Physician Decision|1|||
23269275|NCT02974153|64728680|FG000|Overall Study|Withdrawal by Subject|9|||
23269276|NCT02974153|64728681|FG001|Overall Study|Withdrawal by Subject|16|||
23269277|NCT02974153|64728682|FG002|Overall Study|Withdrawal by Subject|11|||
23269278|NCT02974153|64728680|FG000|Overall Study|Study Burden|8|||
23269279|NCT02974153|64728681|FG001|Overall Study|Study Burden|7|||
23269280|NCT02974153|64728682|FG002|Overall Study|Study Burden|3|||
23269281|NCT02974153|64728680|FG000|Overall Study|Other|14|||
23269282|NCT02974153|64728681|FG001|Overall Study|Other|8|||
23269283|NCT02974153|64728682|FG002|Overall Study|Other|7|||
23269284|NCT00727571|64728686|FG000|Overall Study|Ineligibility determined|1|||
23269285|NCT00727571|64728687|FG001|Overall Study|Ineligibility determined|1|||
23269286|NCT00727571|64728688|FG002|Overall Study|Ineligibility determined|1|||
23269287|NCT00727571|64728689|FG003|Overall Study|Ineligibility determined|0|||
23269288|NCT00727571|64728686|FG000|Overall Study|Death|0|||
23269289|NCT00727571|64728687|FG001|Overall Study|Death|19|||
23269290|NCT00727571|64728688|FG002|Overall Study|Death|5|||
23269291|NCT00727571|64728689|FG003|Overall Study|Death|1|||
23269292|NCT00727571|64728686|FG000|Overall Study|Physician Decision|0|||
23269293|NCT00727571|64728687|FG001|Overall Study|Physician Decision|5|||
23269294|NCT00727571|64728688|FG002|Overall Study|Physician Decision|0|||
23269295|NCT00727571|64728689|FG003|Overall Study|Physician Decision|0|||
23269296|NCT00727571|64728686|FG000|Overall Study|Withdrawal by Subject|0|||
23269297|NCT00727571|64728687|FG001|Overall Study|Withdrawal by Subject|10|||
23269298|NCT00727571|64728688|FG002|Overall Study|Withdrawal by Subject|11|||
23269299|NCT00727571|64728689|FG003|Overall Study|Withdrawal by Subject|0|||
23269300|NCT00727571|64728686|FG000|Overall Study|Subject Non Compliance|0|||
23269301|NCT00727571|64728687|FG001|Overall Study|Subject Non Compliance|6|||
23482318|NCT03963401|65509480|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23482319|NCT03963401|65509481|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23482320|NCT03963401|65509482|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
23482321|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
23482322|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
23482323|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
23482324|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
23482325|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
23482326|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
23482327|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
23482328|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
23601547|NCT00442104|65933782|FG000|Overall Study|Other|21|||
23601548|NCT00442104|65933782|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
23601549|NCT00526994|65933783|FG000|Overall Study|Lost to Follow-up|98|||
23601550|NCT00526994|65933784|FG001|Overall Study|Lost to Follow-up|108|||
23601551|NCT00526994|65933785|FG002|Overall Study|Lost to Follow-up|96|||
23601552|NCT00526994|65933783|FG000|Overall Study|Death|4|||
23601553|NCT00526994|65933784|FG001|Overall Study|Death|3|||
23601554|NCT00526994|65933785|FG002|Overall Study|Death|3|||
23601555|NCT00526994|65933783|FG000|Overall Study|Withdrawal by Subject|2|||
23601556|NCT00526994|65933784|FG001|Overall Study|Withdrawal by Subject|7|||
23601557|NCT00526994|65933785|FG002|Overall Study|Withdrawal by Subject|5|||
23601558|NCT00526994|65933783|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
23601559|NCT00526994|65933784|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
23601560|NCT00526994|65933785|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
23601561|NCT00491894|65933788|FG000|Overall Study|Adverse Event|14|||
23601562|NCT00491894|65933788|FG000|Overall Study|Withdrawal by Subject|5|||
23601563|NCT00491894|65933788|FG000|Overall Study|Death|3|||
23601564|NCT00491894|65933788|FG000|Overall Study|Lost to Follow-up|3|||
23601565|NCT00491894|65933788|FG000|Overall Study|Lack of Efficacy|2|||
23601566|NCT00491894|65933788|FG000|Overall Study|Other-Failed to meet any criteria|2|||
23601567|NCT00491894|65933788|FG000|Overall Study|Physician Decision|2|||
23601568|NCT00491894|65933788|FG000|Overall Study|Protocol Violation|2|||
23601569|NCT00491894|65933788|FG000|Overall Study|Other-Intake of prohibited medication|1|||
23601570|NCT00371345|65933789|FG000|Overall Study|Disease Progression|21|||
23601571|NCT00371345|65933790|FG001|Overall Study|Disease Progression|35|||
23601572|NCT00371345|65933789|FG000|Overall Study|Study Drug Toxicity|1|||
23601573|NCT00371345|65933790|FG001|Overall Study|Study Drug Toxicity|7|||
23601574|NCT00371345|65933789|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
23601575|NCT00371345|65933790|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
23601576|NCT00371345|65933789|FG000|Overall Study|Participant Request|1|||
23601577|NCT00371345|65933790|FG001|Overall Study|Participant Request|1|||
23601578|NCT00371345|65933789|FG000|Overall Study|Participant Withdrew Consent|0|||
23601579|NCT00371345|65933790|FG001|Overall Study|Participant Withdrew Consent|1|||
23601580|NCT01619410|65933791|FG000|Overall Study|Lost to Follow-up|7|||
23601581|NCT01619410|65933792|FG001|Overall Study|Lost to Follow-up|4|||
23601582|NCT02399449|65933793|FG000|Overall Study|Withdrawal by Subject|3|||
23601583|NCT02399449|65933794|FG001|Overall Study|Withdrawal by Subject|9|||
23601584|NCT02399449|65933793|FG000|Overall Study|Physician Decision|0|||
23601585|NCT02399449|65933794|FG001|Overall Study|Physician Decision|1|||
23601586|NCT02325466|65933797|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
23601587|NCT02325466|65933798|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
23601588|NCT02325466|65933799|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
23601589|NCT02325466|65933797|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
23601590|NCT02325466|65933798|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
23601591|NCT02325466|65933799|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
23601592|NCT02325466|65933797|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
23601593|NCT02325466|65933798|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
23601594|NCT02325466|65933799|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
23601595|NCT02325466|65933797|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
23601596|NCT02325466|65933798|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
23601597|NCT02325466|65933799|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
23482329|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
23601598|NCT02325466|65933797|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
23482330|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
23601599|NCT02325466|65933798|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
23601600|NCT02325466|65933799|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
23601601|NCT02325466|65933797|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
23601602|NCT02325466|65933798|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
23365501|NCT03498313|65084980|FG000|Washout Period 1|Withdrawal by Subject|0|||
23365502|NCT03498313|65084981|FG001|Washout Period 1|Withdrawal by Subject|3|||
23365503|NCT03498313|65084982|FG002|Washout Period 1|Withdrawal by Subject|0|||
23365504|NCT03498313|65084983|FG003|Washout Period 1|Withdrawal by Subject|1|||
23365505|NCT03498313|65084984|FG004|Washout Period 1|Withdrawal by Subject|0|||
23365506|NCT03498313|65084985|FG005|Washout Period 1|Withdrawal by Subject|1|||
23365507|NCT03498313|65084980|FG000|Experimental Period 2|Adverse Event|0|||
23365508|NCT03498313|65084981|FG001|Experimental Period 2|Adverse Event|0|||
23269302|NCT00727571|64728688|FG002|Overall Study|Subject Non Compliance|0|||
23269303|NCT00727571|64728689|FG003|Overall Study|Subject Non Compliance|4|||
23269304|NCT00727571|64728686|FG000|Overall Study|Dismissed from nursing home|0|||
23269305|NCT00727571|64728687|FG001|Overall Study|Dismissed from nursing home|9|||
23269306|NCT00727571|64728688|FG002|Overall Study|Dismissed from nursing home|5|||
23269307|NCT00727571|64728689|FG003|Overall Study|Dismissed from nursing home|0|||
23269308|NCT00727571|64728686|FG000|Overall Study|Hospitalization|0|||
23269309|NCT00727571|64728687|FG001|Overall Study|Hospitalization|1|||
23269310|NCT00727571|64728688|FG002|Overall Study|Hospitalization|0|||
23269311|NCT00727571|64728689|FG003|Overall Study|Hospitalization|1|||
23269312|NCT00727571|64728686|FG000|Overall Study|AE not leading to hospitalization|0|||
23269313|NCT00727571|64728687|FG001|Overall Study|AE not leading to hospitalization|0|||
23269314|NCT00727571|64728688|FG002|Overall Study|AE not leading to hospitalization|2|||
23269315|NCT00727571|64728689|FG003|Overall Study|AE not leading to hospitalization|0|||
23269316|NCT00727571|64728686|FG000|Overall Study|Other|0|||
23269317|NCT00727571|64728687|FG001|Overall Study|Other|4|||
23269318|NCT00727571|64728688|FG002|Overall Study|Other|6|||
23269319|NCT00727571|64728689|FG003|Overall Study|Other|0|||
23269320|NCT01124149|64728696|FG000|Acute Phase|Withdrawal by Subject|22|||
23269321|NCT01124149|64728696|FG000|Acute Phase|Adverse Event|21|||
23269322|NCT01124149|64728696|FG000|Acute Phase|Lack of Efficacy|17|||
23269323|NCT01124149|64728696|FG000|Acute Phase|Protocol Violation|14|||
23269324|NCT01124149|64728696|FG000|Acute Phase|Lost to Follow-up|2|||
23269325|NCT01124149|64728696|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
23269326|NCT01124149|64728696|FG000|Acute Phase|Sponsor request|1|||
23269327|NCT01124149|64728696|FG000|Acute Phase|UC symptoms not ameliorated|1|||
23269328|NCT01124149|64728696|FG000|Acute Phase|Non-compliance|1|||
23269329|NCT01124149|64728696|FG000|Acute Phase|Low hemoglobin|1|||
23269330|NCT01124149|64728696|FG000|Acute Phase|Travelling to another country|1|||
23269331|NCT01124149|64728696|FG000|Acute Phase|Sponsor decision|1|||
23269332|NCT01124149|64728696|FG000|Maintenance Phase|Lack of Efficacy|40|||
23269333|NCT01124149|64728696|FG000|Maintenance Phase|Adverse Event|24|||
23269334|NCT01124149|64728696|FG000|Maintenance Phase|Lost to Follow-up|15|||
23269335|NCT01124149|64728696|FG000|Maintenance Phase|Withdrawal by Subject|10|||
23269336|NCT01124149|64728696|FG000|Maintenance Phase|Protocol Violation|5|||
23269337|NCT01124149|64728696|FG000|Maintenance Phase|Coordinator error|1|||
23269338|NCT01124149|64728696|FG000|Maintenance Phase|Non-compliance|1|||
23365509|NCT03498313|65084982|FG002|Experimental Period 2|Adverse Event|0|||
23269339|NCT02143102|64728697|FG000|Overall Study|Lost to Follow-up|11|||
23269340|NCT02143102|64728698|FG001|Overall Study|Lost to Follow-up|0|||
23269341|NCT04276883|64728699|FG000|Overall Study|Withdrawal by Subject|2|||
23269342|NCT04276883|64728700|FG001|Overall Study|Withdrawal by Subject|3|||
23269343|NCT04276883|64728701|FG002|Overall Study|Withdrawal by Subject|6|||
23269344|NCT04276883|64728699|FG000|Overall Study|Lost to Follow-up|1|||
23269345|NCT04276883|64728700|FG001|Overall Study|Lost to Follow-up|3|||
23269346|NCT04276883|64728701|FG002|Overall Study|Lost to Follow-up|0|||
23365510|NCT03498313|65084983|FG003|Experimental Period 2|Adverse Event|0|||
23365511|NCT03498313|65084984|FG004|Experimental Period 2|Adverse Event|1|||
23365512|NCT03498313|65084985|FG005|Experimental Period 2|Adverse Event|2|||
23365513|NCT03498313|65084980|FG000|Washout Period 2|Physician Decision|1|||
23365514|NCT03498313|65084981|FG001|Washout Period 2|Physician Decision|0|||
23365515|NCT03498313|65084982|FG002|Washout Period 2|Physician Decision|0|||
23365516|NCT03498313|65084983|FG003|Washout Period 2|Physician Decision|1|||
23365517|NCT03498313|65084984|FG004|Washout Period 2|Physician Decision|0|||
23365518|NCT03498313|65084985|FG005|Washout Period 2|Physician Decision|1|||
23365519|NCT03498313|65084980|FG000|Washout Period 2|Withdrawal by Subject|3|||
23365520|NCT03498313|65084981|FG001|Washout Period 2|Withdrawal by Subject|2|||
23365521|NCT03498313|65084982|FG002|Washout Period 2|Withdrawal by Subject|0|||
23365522|NCT03498313|65084983|FG003|Washout Period 2|Withdrawal by Subject|0|||
23365523|NCT03498313|65084984|FG004|Washout Period 2|Withdrawal by Subject|2|||
23365524|NCT03498313|65084985|FG005|Washout Period 2|Withdrawal by Subject|0|||
23365525|NCT03498313|65084980|FG000|Washout Period 2|Anovulation|0|||
23365526|NCT03498313|65084981|FG001|Washout Period 2|Anovulation|0|||
23365527|NCT03498313|65084982|FG002|Washout Period 2|Anovulation|0|||
23365528|NCT03498313|65084983|FG003|Washout Period 2|Anovulation|0|||
23365529|NCT03498313|65084984|FG004|Washout Period 2|Anovulation|0|||
23365530|NCT03498313|65084985|FG005|Washout Period 2|Anovulation|1|||
23365531|NCT01239394|65084986|FG000|Overall Study|Adverse Event|1|||
23365532|NCT01298700|65084987|FG000|Overall Study|Adverse Event|50|||
23365533|NCT01298700|65084988|FG001|Overall Study|Adverse Event|51|||
23365534|NCT01298700|65084987|FG000|Overall Study|Lack of Efficacy|9|||
23365535|NCT01298700|65084988|FG001|Overall Study|Lack of Efficacy|14|||
23365536|NCT01298700|65084987|FG000|Overall Study|Lost to Follow-up|5|||
23269347|NCT04276883|64728699|FG000|Overall Study|Adverse Event|0|||
23269348|NCT04276883|64728700|FG001|Overall Study|Adverse Event|1|||
23269349|NCT04276883|64728701|FG002|Overall Study|Adverse Event|0|||
23269350|NCT04276883|64728699|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
23269351|NCT04276883|64728700|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
23269352|NCT04276883|64728701|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
23269353|NCT02430870|64728702|FG000|Part 2|Voluntary Withdrawal|0|||
23269354|NCT02430870|64728703|FG001|Part 2|Voluntary Withdrawal|0|||
23269355|NCT02430870|64728704|FG002|Part 2|Voluntary Withdrawal|0|||
23269356|NCT02430870|64728705|FG003|Part 2|Voluntary Withdrawal|0|||
23269357|NCT02430870|64728706|FG004|Part 2|Voluntary Withdrawal|0|||
23269358|NCT02430870|64728707|FG005|Part 2|Voluntary Withdrawal|0|||
23269359|NCT02430870|64728708|FG006|Part 2|Voluntary Withdrawal|1|||
23269360|NCT02430870|64728709|FG007|Part 2|Voluntary Withdrawal|0|||
23269361|NCT02430870|64728702|FG000|Part 2|Other Reason Not Specified|0|||
23269362|NCT02430870|64728703|FG001|Part 2|Other Reason Not Specified|0|||
23269363|NCT02430870|64728704|FG002|Part 2|Other Reason Not Specified|0|||
23269364|NCT02430870|64728705|FG003|Part 2|Other Reason Not Specified|0|||
23269365|NCT02430870|64728706|FG004|Part 2|Other Reason Not Specified|0|||
23269366|NCT02430870|64728707|FG005|Part 2|Other Reason Not Specified|0|||
23269367|NCT02430870|64728708|FG006|Part 2|Other Reason Not Specified|0|||
23269368|NCT02430870|64728709|FG007|Part 2|Other Reason Not Specified|1|||
23269369|NCT00796510|64728710|FG000|Overall Study|Death|1|||
23269370|NCT00796510|64728711|FG001|Overall Study|Death|0|||
23269371|NCT00796510|64728710|FG000|Overall Study|Study Terminated|2|||
23269372|NCT00796510|64728711|FG001|Overall Study|Study Terminated|0|||
23269373|NCT00667862|64728712|FG000|Overall Study|Adverse Event|9|||
23269374|NCT00667862|64728712|FG000|Overall Study|Death|1|||
23269375|NCT00667862|64728712|FG000|Overall Study|Disease Progression|22|||
23269376|NCT00667862|64728712|FG000|Overall Study|Withdrawal by Subject|3|||
23269377|NCT02146430|64728713|FG000|Overall Study|Protocol Violation|5|||
23269378|NCT02146430|64728714|FG001|Overall Study|Protocol Violation|4|||
23269379|NCT02146430|64728715|FG002|Overall Study|Protocol Violation|8|||
23269380|NCT02146430|64728716|FG003|Overall Study|Protocol Violation|6|||
23269381|NCT02146430|64728713|FG000|Overall Study|Lack of Efficacy|13|||
23269382|NCT02146430|64728714|FG001|Overall Study|Lack of Efficacy|11|||
23269383|NCT02146430|64728715|FG002|Overall Study|Lack of Efficacy|8|||
23269384|NCT02146430|64728716|FG003|Overall Study|Lack of Efficacy|5|||
23269385|NCT02146430|64728713|FG000|Overall Study|Adverse Event|20|||
23269386|NCT02146430|64728714|FG001|Overall Study|Adverse Event|40|||
23269387|NCT02146430|64728715|FG002|Overall Study|Adverse Event|32|||
23269388|NCT02146430|64728716|FG003|Overall Study|Adverse Event|49|||
23269389|NCT02146430|64728713|FG000|Overall Study|Reason missing or not reported|2|||
23269390|NCT02146430|64728714|FG001|Overall Study|Reason missing or not reported|3|||
23269391|NCT02146430|64728715|FG002|Overall Study|Reason missing or not reported|4|||
23365537|NCT01298700|65084988|FG001|Overall Study|Lost to Follow-up|2|||
23365538|NCT01298700|65084987|FG000|Overall Study|Withdrawal by Subject|12|||
23269392|NCT02146430|64728716|FG003|Overall Study|Reason missing or not reported|5|||
23269393|NCT02146430|64728713|FG000|Overall Study|Withdrawal by Subject|27|||
23365539|NCT01298700|65084988|FG001|Overall Study|Withdrawal by Subject|9|||
23269394|NCT02146430|64728714|FG001|Overall Study|Withdrawal by Subject|29|||
23269395|NCT02146430|64728715|FG002|Overall Study|Withdrawal by Subject|30|||
23269396|NCT02146430|64728716|FG003|Overall Study|Withdrawal by Subject|34|||
23269397|NCT02402166|64728717|FG000|Overall Study|Adverse Event|2|||
23269398|NCT02402166|64728717|FG000|Overall Study|Withdrawal by Subject|2|||
23269399|NCT02402166|64728717|FG000|Overall Study|Lost to Follow-up|1|||
23269400|NCT01505530|64728718|FG000|Overall Study|Progressive Disease|19|||
23269401|NCT01505530|64728719|FG001|Overall Study|Progressive Disease|17|||
23269402|NCT01505530|64728720|FG002|Overall Study|Progressive Disease|18|||
23269403|NCT01505530|64728718|FG000|Overall Study|Adverse Event|1|||
23269404|NCT01505530|64728719|FG001|Overall Study|Adverse Event|1|||
23269405|NCT01505530|64728720|FG002|Overall Study|Adverse Event|0|||
23269406|NCT01505530|64728718|FG000|Overall Study|Withdrawal by Subject|7|||
23269407|NCT01505530|64728719|FG001|Overall Study|Withdrawal by Subject|8|||
23269408|NCT01505530|64728720|FG002|Overall Study|Withdrawal by Subject|6|||
23269409|NCT01505530|64728718|FG000|Overall Study|Physician Decision|6|||
23269410|NCT01505530|64728719|FG001|Overall Study|Physician Decision|2|||
23269411|NCT01505530|64728720|FG002|Overall Study|Physician Decision|5|||
23269412|NCT01505530|64728718|FG000|Overall Study|Sponsor Decision|1|||
23269413|NCT01505530|64728719|FG001|Overall Study|Sponsor Decision|8|||
23269414|NCT01505530|64728720|FG002|Overall Study|Sponsor Decision|7|||
23269415|NCT01505530|64728718|FG000|Overall Study|Death|7|||
23269416|NCT01505530|64728719|FG001|Overall Study|Death|6|||
23269417|NCT01505530|64728720|FG002|Overall Study|Death|5|||
23269418|NCT01505530|64728718|FG000|Overall Study|entry criteria not met|0|||
23269419|NCT01505530|64728719|FG001|Overall Study|entry criteria not met|1|||
23269420|NCT01505530|64728720|FG002|Overall Study|entry criteria not met|0|||
23269421|NCT03527745|64728721|FG000|Overall Study|Lost to Follow-up|3|||
23269422|NCT03527745|64728722|FG001|Overall Study|Lost to Follow-up|6|||
23269423|NCT03527745|64728723|FG002|Overall Study|Lost to Follow-up|7|||
23269424|NCT03527745|64728724|FG003|Overall Study|Lost to Follow-up|9|||
23269425|NCT03527745|64728725|FG004|Overall Study|Lost to Follow-up|0|||
23269426|NCT03527745|64728726|FG005|Overall Study|Lost to Follow-up|2|||
23269427|NCT03527745|64728727|FG006|Overall Study|Lost to Follow-up|3|||
23269428|NCT03527745|64728728|FG007|Overall Study|Lost to Follow-up|2|||
23269429|NCT03527745|64728729|FG008|Overall Study|Lost to Follow-up|3|||
23269430|NCT03527745|64728730|FG009|Overall Study|Lost to Follow-up|2|||
23269431|NCT03527745|64728731|FG010|Overall Study|Lost to Follow-up|1|||
23269432|NCT03527745|64728732|FG011|Overall Study|Lost to Follow-up|1|||
23269433|NCT03527745|64728733|FG012|Overall Study|Lost to Follow-up|0|||
23269434|NCT03527745|64728734|FG013|Overall Study|Lost to Follow-up|0|||
23269435|NCT03527745|64728735|FG014|Overall Study|Lost to Follow-up|0|||
23269436|NCT03527745|64728736|FG015|Overall Study|Lost to Follow-up|0|||
23269437|NCT03527745|64728737|FG016|Overall Study|Lost to Follow-up|1|||
23269438|NCT03527745|64728738|FG017|Overall Study|Lost to Follow-up|0|||
23269439|NCT03527745|64728739|FG018|Overall Study|Lost to Follow-up|0|||
23269440|NCT03527745|64728740|FG019|Overall Study|Lost to Follow-up|1|||
23269441|NCT03527745|64728741|FG020|Overall Study|Lost to Follow-up|1|||
23269442|NCT03527745|64728742|FG021|Overall Study|Lost to Follow-up|5|||
23269443|NCT03527745|64728743|FG022|Overall Study|Lost to Follow-up|6|||
23269444|NCT03527745|64728744|FG023|Overall Study|Lost to Follow-up|8|||
23269445|NCT03527745|64728745|FG024|Overall Study|Lost to Follow-up|1|||
23269446|NCT03527745|64728746|FG025|Overall Study|Lost to Follow-up|3|||
23482331|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
23482332|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
23601603|NCT02325466|65933799|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
23601604|NCT02325466|65933797|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
23601605|NCT02325466|65933798|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
23601606|NCT02325466|65933799|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
23601607|NCT02325466|65933797|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
23601608|NCT02325466|65933798|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
23601609|NCT02325466|65933799|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
23601610|NCT02325466|65933797|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
23601611|NCT02325466|65933798|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
23601612|NCT02325466|65933799|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
23269447|NCT01225146|64728749|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
23269448|NCT01225146|64728750|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
23269449|NCT01402908|64728753|FG000|Overall Study|Withdrawal by Subject|30|||
23269450|NCT01402908|64728754|FG001|Overall Study|Withdrawal by Subject|17|||
23269451|NCT01402908|64728753|FG000|Overall Study|Lost to Follow-up|3|||
23269452|NCT01402908|64728754|FG001|Overall Study|Lost to Follow-up|1|||
23482333|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23269453|NCT01402908|64728753|FG000|Overall Study|Physician Decision|1|||
23269454|NCT01402908|64728754|FG001|Overall Study|Physician Decision|0|||
23482334|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23482335|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
23482336|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23482337|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23482338|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
23482339|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
23482340|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23482341|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23269455|NCT01287013|64728755|FG000|Overall Study|Non-evaluable|3|||
23269456|NCT01287013|64728756|FG001|Overall Study|Non-evaluable|5|||
23269457|NCT01287013|64728757|FG002|Overall Study|Non-evaluable|21|||
23269458|NCT01536405|64728761|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
23269459|NCT01536405|64728762|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
23269460|NCT01536405|64728761|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
23269461|NCT01536405|64728762|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
23269462|NCT01536405|64728761|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
23269463|NCT01536405|64728762|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
23269464|NCT01536405|64728761|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
23269465|NCT01536405|64728762|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
23269466|NCT01536405|64728761|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
23269467|NCT01536405|64728762|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
23269468|NCT01536405|64728761|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
23269469|NCT01536405|64728762|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
23269470|NCT01536405|64728761|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
23269471|NCT01536405|64728762|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
23482342|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23482343|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23482344|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
23482345|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
23482346|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
23482347|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
23482348|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
23482349|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
23482350|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
23482351|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
23482352|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482353|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482354|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482355|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482356|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
23482357|NCT03963401|65509477|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
23482358|NCT03963401|65509478|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
23482359|NCT03963401|65509479|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
23601613|NCT03041233|65933807|FG000|Overall Study|Death|5|||
23601614|NCT03041233|65933807|FG000|Overall Study|Physician Decision|1|||
23601615|NCT03041233|65933807|FG000|Overall Study|Lost to Follow-up|16|||
23601616|NCT03041233|65933807|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
23269472|NCT01536405|64728761|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
23601617|NCT03041233|65933807|FG000|Overall Study|Sponsor Request|1|||
23269473|NCT01536405|64728762|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
23269474|NCT01536405|64728761|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
23601618|NCT03041233|65933807|FG000|Overall Study|Duplicate subject|1|||
23601619|NCT03041233|65933807|FG000|Overall Study|Re-ablation|1|||
23269475|NCT01536405|64728762|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
23482360|NCT03963401|65509480|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
23482361|NCT03963401|65509481|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
23482362|NCT03963401|65509482|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
23482363|NCT03123185|65509483|FG000|Overall Study|Withdrawal by Subject|0|||
23482364|NCT03123185|65509484|FG001|Overall Study|Withdrawal by Subject|0|||
23482365|NCT03123185|65509485|FG002|Overall Study|Withdrawal by Subject|0|||
23482366|NCT03123185|65509486|FG003|Overall Study|Withdrawal by Subject|0|||
23482367|NCT03123185|65509487|FG004|Overall Study|Withdrawal by Subject|0|||
23482368|NCT03123185|65509488|FG005|Overall Study|Withdrawal by Subject|0|||
23482369|NCT03123185|65509489|FG006|Overall Study|Withdrawal by Subject|0|||
23482370|NCT03123185|65509490|FG007|Overall Study|Withdrawal by Subject|0|||
23482371|NCT03123185|65509491|FG008|Overall Study|Withdrawal by Subject|0|||
23482372|NCT03123185|65509492|FG009|Overall Study|Withdrawal by Subject|0|||
23482373|NCT03123185|65509493|FG010|Overall Study|Withdrawal by Subject|0|||
23482374|NCT03123185|65509494|FG011|Overall Study|Withdrawal by Subject|0|||
23482375|NCT03123185|65509495|FG012|Overall Study|Withdrawal by Subject|1|||
23601620|NCT00609869|65933814|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
23601621|NCT00609869|65933814|FG000|Overall Study|Severe hematologic toxicity|1|||
23601622|NCT00609869|65933814|FG000|Overall Study|Withdrawal by Subject|1|||
23601623|NCT00609869|65933814|FG000|Overall Study|Seizures|1|||
23601624|NCT00609869|65933814|FG000|Overall Study|Severe tumor flare reaction|1|||
23269476|NCT01536405|64728761|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
23482376|NCT03123185|65509496|FG013|Overall Study|Withdrawal by Subject|0|||
23482377|NCT00409331|65509500|FG000|Overall Study|Physician Decision|1|||
23482378|NCT00791076|65509501|FG000|Overall Study|Study was terminated,PI left institution|8|||
23601625|NCT00609869|65933814|FG000|Overall Study|Hepatitis B infection|1|||
23601626|NCT00609869|65933814|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
23601627|NCT00609869|65933814|FG000|Overall Study|Mantle cell: not evaluable|4|||
23601628|NCT00345046|65933822|FG000|Overall Study|Protocol Violation|1|||
23601629|NCT00345046|65933823|FG001|Overall Study|Protocol Violation|1|||
23601630|NCT00345046|65933824|FG002|Overall Study|Protocol Violation|2|||
23601631|NCT03041090|65933825|FG000|Overall Study|technical error|0|||
23601632|NCT03041090|65933826|FG001|Overall Study|technical error|3|||
23601633|NCT01833455|65933827|FG000|Overall Study|Withdrawal by Subject|1|||
23601634|NCT01833455|65933828|FG001|Overall Study|Withdrawal by Subject|0|||
23601635|NCT03520036|65933832|FG000|Overall Study|Adverse Event|1|||
23601636|NCT03520036|65933833|FG001|Overall Study|Adverse Event|2|||
23601637|NCT03520036|65933834|FG002|Overall Study|Adverse Event|0|||
23601638|NCT03520036|65933832|FG000|Overall Study|Protocol Violation|1|||
23601639|NCT03520036|65933833|FG001|Overall Study|Protocol Violation|0|||
23601640|NCT03520036|65933834|FG002|Overall Study|Protocol Violation|0|||
23601641|NCT03520036|65933832|FG000|Overall Study|Withdrawal by Subject|0|||
23601642|NCT03520036|65933833|FG001|Overall Study|Withdrawal by Subject|1|||
23601643|NCT03520036|65933834|FG002|Overall Study|Withdrawal by Subject|4|||
23601644|NCT03520036|65933832|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
23601645|NCT03520036|65933833|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
23601646|NCT03520036|65933834|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
23601647|NCT01957163|65933835|FG000|Overall Study|Adverse Event|5|||
23601648|NCT01957163|65933836|FG001|Overall Study|Adverse Event|2|||
23601649|NCT01957163|65933837|FG002|Overall Study|Adverse Event|4|||
23601650|NCT01957163|65933835|FG000|Overall Study|Lack of Efficacy|5|||
23601651|NCT01957163|65933836|FG001|Overall Study|Lack of Efficacy|4|||
23601652|NCT01957163|65933837|FG002|Overall Study|Lack of Efficacy|9|||
23601653|NCT01957163|65933835|FG000|Overall Study|Protocol Violation|1|||
23601654|NCT01957163|65933836|FG001|Overall Study|Protocol Violation|2|||
23601655|NCT01957163|65933837|FG002|Overall Study|Protocol Violation|0|||
23601656|NCT01957163|65933835|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
23601657|NCT01957163|65933836|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
23601658|NCT01957163|65933837|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
23601659|NCT01957163|65933835|FG000|Overall Study|Lost to Follow-up|0|||
23601660|NCT01957163|65933836|FG001|Overall Study|Lost to Follow-up|1|||
23601661|NCT01957163|65933837|FG002|Overall Study|Lost to Follow-up|0|||
23601662|NCT01957163|65933835|FG000|Overall Study|Withdrawal by Subject|4|||
23601663|NCT01957163|65933836|FG001|Overall Study|Withdrawal by Subject|2|||
23601664|NCT01957163|65933837|FG002|Overall Study|Withdrawal by Subject|4|||
23482379|NCT00877773|65509504|FG000|Overall Study|Disease Progression|44|||
23482380|NCT04473482|65509505|FG000|Overall Study|Death|0|||
23601665|NCT02235298|65933838|FG000|Overall Study|Lost to Follow-up|6|||
23601666|NCT02235298|65933839|FG001|Overall Study|Lost to Follow-up|5|||
23601667|NCT02235298|65933838|FG000|Overall Study|Adverse Event|2|||
23482381|NCT04473482|65509506|FG001|Overall Study|Death|3|||
23482382|NCT04473482|65509505|FG000|Overall Study|Lost to Follow-up|9|||
23482383|NCT04473482|65509506|FG001|Overall Study|Lost to Follow-up|7|||
23482384|NCT04473482|65509505|FG000|Overall Study|Withdrawal by Subject|2|||
23269477|NCT01536405|64728762|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
23482385|NCT04473482|65509506|FG001|Overall Study|Withdrawal by Subject|1|||
23482386|NCT03328182|65509509|FG000|Overall Study|Withdrawal by Subject|1|||
23482387|NCT03328182|65509509|FG000|Overall Study|Protocol Violation|2|||
23482388|NCT03328182|65509509|FG000|Overall Study|No Product Evaluated|1|||
23482389|NCT02052414|65509510|FG000|Overall Study|Adverse Event|12|||
23482390|NCT02052414|65509510|FG000|Overall Study|Lack of Efficacy|2|||
23482391|NCT02052414|65509510|FG000|Overall Study|Withdrawal by Subject|3|||
23482392|NCT05498701|65509515|FG000|Period 3|Adverse Event|1|||
23482393|NCT05498701|65509516|FG001|Period 3|Adverse Event|0|||
23482394|NCT01224782|65509517|FG000|Overall Study|Lost to Follow-up|177|||
23482395|NCT01224782|65509517|FG000|Overall Study|Withdrawal by Subject|16|||
23482396|NCT01224782|65509517|FG000|Overall Study|Death|14|||
23482397|NCT01224782|65509517|FG000|Overall Study|Improvement|13|||
23482398|NCT01224782|65509517|FG000|Overall Study|Adverse Event|12|||
23482399|NCT01224782|65509517|FG000|Overall Study|Adverse Reaction|11|||
23482400|NCT01224782|65509517|FG000|Overall Study|Noncompliance|10|||
23482401|NCT01224782|65509517|FG000|Overall Study|Other|4|||
23482402|NCT01224782|65509517|FG000|Overall Study|Start of Dialysis|3|||
23482403|NCT01224782|65509517|FG000|Overall Study|Change of Treatment|1|||
23482404|NCT01224782|65509517|FG000|Overall Study|Financial Reasons|1|||
23482405|NCT01224782|65509517|FG000|Overall Study|Deterioration|1|||
23482406|NCT01224782|65509517|FG000|Overall Study|Transplantation|1|||
23482407|NCT00282464|65509522|FG000|Overall Study|Adverse Event|26|||
23482408|NCT00282464|65509523|FG001|Overall Study|Adverse Event|20|||
23482409|NCT00282464|65509522|FG000|Overall Study|Lack of Efficacy|8|||
23482410|NCT00282464|65509523|FG001|Overall Study|Lack of Efficacy|8|||
23482411|NCT00282464|65509522|FG000|Overall Study|Lost to Follow-up|10|||
23482412|NCT00282464|65509523|FG001|Overall Study|Lost to Follow-up|10|||
23482413|NCT00282464|65509522|FG000|Overall Study|Withdrawal by Subject|24|||
23482414|NCT00282464|65509523|FG001|Overall Study|Withdrawal by Subject|10|||
23482415|NCT00282464|65509522|FG000|Overall Study|laboratory abnormality|1|||
23482416|NCT00282464|65509523|FG001|Overall Study|laboratory abnormality|2|||
23482417|NCT00282464|65509522|FG000|Overall Study|Protocol Violation|0|||
23482418|NCT00282464|65509523|FG001|Overall Study|Protocol Violation|7|||
23482419|NCT00282464|65509522|FG000|Overall Study|Patient moved|1|||
23482420|NCT00282464|65509523|FG001|Overall Study|Patient moved|0|||
23482421|NCT00282464|65509522|FG000|Overall Study|patient non-compliant|3|||
23482422|NCT00282464|65509523|FG001|Overall Study|patient non-compliant|0|||
23482423|NCT00282464|65509522|FG000|Overall Study|patient no show|0|||
23482424|NCT00282464|65509523|FG001|Overall Study|patient no show|1|||
23482425|NCT00282464|65509522|FG000|Overall Study|patient incarcerated|0|||
23482426|NCT00282464|65509523|FG001|Overall Study|patient incarcerated|1|||
23482427|NCT00282464|65509522|FG000|Overall Study|family crisis|0|||
23482428|NCT00282464|65509523|FG001|Overall Study|family crisis|1|||
23482429|NCT00282464|65509522|FG000|Overall Study|dispensed wrong kit|0|||
23482430|NCT00282464|65509523|FG001|Overall Study|dispensed wrong kit|1|||
23482431|NCT00282464|65509522|FG000|Overall Study|dropped due to missed visits|0|||
23482432|NCT00282464|65509523|FG001|Overall Study|dropped due to missed visits|1|||
23482433|NCT02652767|65509525|FG000|Overall Study|Death|2|||
23601668|NCT02235298|65933839|FG001|Overall Study|Adverse Event|2|||
23601669|NCT02235298|65933838|FG000|Overall Study|Withdrawal by Subject|0|||
23601670|NCT02235298|65933839|FG001|Overall Study|Withdrawal by Subject|1|||
23601671|NCT00667017|65933844|FG000|Overall Study|Withdrawal by Subject|1|||
23601672|NCT01779050|65933845|FG000|Overall Study|Withdrawal by Subject|1|||
23601673|NCT01779050|65933846|FG001|Overall Study|Withdrawal by Subject|0|||
23601674|NCT01218009|65933847|FG000|Overall Study|Protocol Violation|2|||
23601675|NCT01218009|65933848|FG001|Overall Study|Protocol Violation|1|||
23601676|NCT01218009|65933847|FG000|Overall Study|Withdrawal by Subject|3|||
23601677|NCT01218009|65933848|FG001|Overall Study|Withdrawal by Subject|1|||
23601678|NCT01218009|65933847|FG000|Overall Study|Sponsor terminated study|161|||
23601679|NCT01218009|65933848|FG001|Overall Study|Sponsor terminated study|163|||
23601680|NCT01856569|65933849|FG000|Overall Study|Other|1|||
23601681|NCT01856569|65933849|FG000|Overall Study|Changed Site/Structure|1|||
23482434|NCT02652767|65509525|FG000|Overall Study|Lost to Follow-up|1|||
23482435|NCT02652767|65509525|FG000|Overall Study|Withdrawal by Subject|1|||
23482436|NCT00814879|65509526|FG000|By Week 24|Cancer Diagnosis|1|||
23482437|NCT00814879|65509527|FG001|By Week 24|Cancer Diagnosis|0|||
23482438|NCT00814879|65509526|FG000|By Week 24|Incarceration|0|||
23482439|NCT00814879|65509527|FG001|By Week 24|Incarceration|1|||
23482440|NCT00814879|65509526|FG000|By Week 48|Lost to Follow-up|2|||
23482441|NCT00814879|65509527|FG001|By Week 48|Lost to Follow-up|2|||
23482442|NCT00814879|65509526|FG000|By Week 48|Death|0|||
23482443|NCT00814879|65509527|FG001|By Week 48|Death|1|||
23482444|NCT00604214|65509528|FG000|Baseline to Day 28|Death|223|||
23601682|NCT01856569|65933849|FG000|Overall Study|Lost to Follow-up|3|||
23482445|NCT00604214|65509529|FG001|Baseline to Day 28|Death|202|||
23482446|NCT00604214|65509528|FG000|Baseline to Day 28|Lost to Follow-up|2|||
23482447|NCT00604214|65509529|FG001|Baseline to Day 28|Lost to Follow-up|4|||
23482448|NCT00604214|65509528|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
23482449|NCT00604214|65509529|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
23482450|NCT00604214|65509528|FG000|Day 29 to Day 90|Death|64|||
23482451|NCT00604214|65509529|FG001|Day 29 to Day 90|Death|67|||
23482452|NCT00604214|65509528|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
23482453|NCT00604214|65509529|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
23482454|NCT00604214|65509528|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
23482455|NCT00604214|65509529|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
23482456|NCT00604214|65509528|FG000|Day 91 to Day 180|Death|19|||
23482457|NCT00604214|65509529|FG001|Day 91 to Day 180|Death|23|||
23482458|NCT00604214|65509528|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
23482459|NCT00604214|65509529|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
23482460|NCT00604214|65509528|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
23482461|NCT00604214|65509529|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
23482462|NCT01752036|65509531|FG000|Overall Study|Death|2|||
23482463|NCT00064298|65509532|FG000|Overall Study|Withdrawal by Subject|2|||
23482464|NCT00064298|65509533|FG001|Overall Study|Withdrawal by Subject|1|||
23482465|NCT00064298|65509532|FG000|Overall Study|Lost to Follow-up|2|||
23482466|NCT00064298|65509533|FG001|Overall Study|Lost to Follow-up|2|||
23482467|NCT00064298|65509532|FG000|Overall Study|Death|0|||
23482468|NCT00064298|65509533|FG001|Overall Study|Death|1|||
23482469|NCT00064298|65509532|FG000|Overall Study|Disease Progression|2|||
23482470|NCT00064298|65509533|FG001|Overall Study|Disease Progression|1|||
23482471|NCT04738318|65509534|FG000|Overall Study|Protocol Violation|1|||
23482472|NCT04738318|65509535|FG001|Overall Study|Protocol Violation|0|||
23482473|NCT02764190|65509536|FG000|Overall Study|Lost to Follow-up|17|||
23482474|NCT02764190|65509537|FG001|Overall Study|Lost to Follow-up|13|||
23482475|NCT00290407|65509539|FG000|Overall Study|Physician Decision|2|||
23482476|NCT03433339|65509541|FG000|Overall Study|Lost to Follow-up|2|||
23482477|NCT03433339|65509542|FG001|Overall Study|Lost to Follow-up|0|||
23482478|NCT03433339|65509541|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
23482479|NCT03433339|65509542|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
23482480|NCT03433339|65509541|FG000|Overall Study|Withdrawal by Subject|0|||
23482481|NCT03433339|65509542|FG001|Overall Study|Withdrawal by Subject|2|||
23482482|NCT01246466|65509544|FG000|Overall Study|Death|1|||
23482483|NCT01246466|65509544|FG000|Overall Study|Withdrawal by Subject|1|||
23482484|NCT01585584|65509547|FG000|Overall Study|Lack of Efficacy|1|||
23482485|NCT01585584|65509547|FG000|Overall Study|Withdrawal by Subject|1|||
23482486|NCT01585584|65509547|FG000|Overall Study|Physician Decision|2|||
23482487|NCT00475423|65509551|FG000|Overall Study|Protocol Violation|5|||
23482488|NCT00475423|65509551|FG000|Overall Study|Adverse Event|4|||
23482489|NCT00475423|65509551|FG000|Overall Study|Withdrawal by Subject|6|||
23482490|NCT00475423|65509551|FG000|Overall Study|Lack of Efficacy|8|||
23482491|NCT00475423|65509551|FG000|Overall Study|Death|1|||
23482492|NCT00475423|65509551|FG000|Overall Study|Reason not specified|1|||
23482493|NCT00475423|65509551|FG000|Overall Study|Lost to Follow-up|7|||
23601683|NCT01856569|65933849|FG000|Overall Study|Did not met inclusion criteria|8|||
23601684|NCT03697603|65933852|FG000|Overall Study|Adverse Event|3|||
23601685|NCT03697603|65933853|FG001|Overall Study|Adverse Event|18|||
23601686|NCT03697603|65933854|FG002|Overall Study|Adverse Event|3|||
23482494|NCT01551420|65509552|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
23482495|NCT01551420|65509553|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
23482496|NCT01551420|65509552|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
23482497|NCT01551420|65509553|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
23482498|NCT01551420|65509552|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
23482499|NCT01551420|65509553|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
23482500|NCT01551420|65509552|FG000|Screened for Part B Eligibility|Declined participation|8|||
23482501|NCT01551420|65509553|FG001|Screened for Part B Eligibility|Declined participation|1|||
23482502|NCT01551420|65509552|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
23482503|NCT01551420|65509553|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
23482504|NCT01551420|65509552|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
23482505|NCT01551420|65509553|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
23482506|NCT01551420|65509552|FG000|Home Use (Part B)|Withdrawal by staff|0|||
23482507|NCT01551420|65509553|FG001|Home Use (Part B)|Withdrawal by staff|1|||
23482508|NCT03860935|65509556|FG000|Overall Study|Withdrawal of Consent|15|||
23482509|NCT03860935|65509557|FG001|Overall Study|Withdrawal of Consent|6|||
23482510|NCT03860935|65509556|FG000|Overall Study|Death|75|||
23482511|NCT03860935|65509557|FG001|Overall Study|Death|51|||
23482512|NCT03025789|65509558|FG000|Overall Study|Lack of Efficacy|6|||
23482513|NCT03025789|65509559|FG001|Overall Study|Lack of Efficacy|1|||
23482514|NCT03025789|65509558|FG000|Overall Study|Death|1|||
23482515|NCT03025789|65509559|FG001|Overall Study|Death|0|||
23482516|NCT03025789|65509558|FG000|Overall Study|Withdrawal by Subject|0|||
23482517|NCT03025789|65509559|FG001|Overall Study|Withdrawal by Subject|2|||
23269478|NCT01536405|64728761|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
23269479|NCT01536405|64728762|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
23269480|NCT01536405|64728761|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
23269481|NCT01536405|64728762|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
23269482|NCT01536405|64728761|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
23269483|NCT01536405|64728762|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
23269484|NCT02353169|64728765|FG000|Overall Study|QTc > 450 msec|1|||
23269485|NCT02353169|64728766|FG001|Overall Study|QTc > 450 msec|1|||
23269486|NCT02353169|64728767|FG002|Overall Study|QTc > 450 msec|1|||
23269487|NCT02353169|64728768|FG003|Overall Study|QTc > 450 msec|1|||
23269488|NCT02353169|64728765|FG000|Overall Study|OR team declined|2|||
23269489|NCT02353169|64728766|FG001|Overall Study|OR team declined|0|||
23269490|NCT02353169|64728767|FG002|Overall Study|OR team declined|0|||
23269491|NCT02353169|64728768|FG003|Overall Study|OR team declined|0|||
23269492|NCT02353169|64728765|FG000|Overall Study|Inhalational induction|0|||
23269493|NCT02353169|64728766|FG001|Overall Study|Inhalational induction|2|||
23269494|NCT02353169|64728767|FG002|Overall Study|Inhalational induction|0|||
23269495|NCT02353169|64728768|FG003|Overall Study|Inhalational induction|0|||
23269496|NCT02353169|64728765|FG000|Overall Study|ECG data error|0|||
23269497|NCT02353169|64728766|FG001|Overall Study|ECG data error|3|||
23269498|NCT02353169|64728767|FG002|Overall Study|ECG data error|2|||
23269499|NCT02353169|64728768|FG003|Overall Study|ECG data error|2|||
23269500|NCT02353169|64728765|FG000|Overall Study|Pre-op medication|0|||
23269501|NCT02353169|64728766|FG001|Overall Study|Pre-op medication|0|||
23269502|NCT02353169|64728767|FG002|Overall Study|Pre-op medication|1|||
23269503|NCT02353169|64728768|FG003|Overall Study|Pre-op medication|0|||
23269504|NCT00264797|64728770|FG000|Overall Study|Withdrawal by Subject|11|||
23269505|NCT00264797|64728771|FG001|Overall Study|Withdrawal by Subject|11|||
23269506|NCT00264797|64728770|FG000|Overall Study|Lost to Follow-up|9|||
23269507|NCT00264797|64728771|FG001|Overall Study|Lost to Follow-up|17|||
23269508|NCT00264797|64728770|FG000|Overall Study|Moved from area|3|||
23269509|NCT00264797|64728771|FG001|Overall Study|Moved from area|1|||
23269510|NCT00264797|64728770|FG000|Overall Study|Practical Problems|2|||
23269511|NCT00264797|64728771|FG001|Overall Study|Practical Problems|3|||
23269512|NCT00264797|64728770|FG000|Overall Study|Incarceration|4|||
23269513|NCT00264797|64728771|FG001|Overall Study|Incarceration|5|||
23269514|NCT00264797|64728770|FG000|Overall Study|Pressure/advice from Outsiders|1|||
23269515|NCT00264797|64728771|FG001|Overall Study|Pressure/advice from Outsiders|1|||
23269516|NCT00264797|64728770|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
23269517|NCT00264797|64728771|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
23269518|NCT00264797|64728770|FG000|Overall Study|Other|3|||
23269519|NCT00264797|64728771|FG001|Overall Study|Other|4|||
23269520|NCT00663871|64728777|FG000|Overall Study|Lost to Follow-up|5|||
23269521|NCT00663871|64728778|FG001|Overall Study|Lost to Follow-up|5|||
23269522|NCT00663871|64728777|FG000|Overall Study|Withdrawal by Subject|5|||
23269523|NCT00663871|64728778|FG001|Overall Study|Withdrawal by Subject|2|||
23269524|NCT02796664|64728788|FG000|Overall Study|Withdrawal by Subject|0|||
23269525|NCT02796664|64728789|FG001|Overall Study|Withdrawal by Subject|3|||
23269526|NCT02796664|64728788|FG000|Overall Study|Noncompliance|1|||
23269527|NCT02796664|64728789|FG001|Overall Study|Noncompliance|1|||
23269528|NCT02796664|64728788|FG000|Overall Study|Death|0|||
23269529|NCT02796664|64728789|FG001|Overall Study|Death|1|||
23269530|NCT00684671|64728790|FG000|Overall Study|Adverse Event|1|||
23269531|NCT00684671|64728791|FG001|Overall Study|Adverse Event|0|||
23269532|NCT00684671|64728792|FG002|Overall Study|Adverse Event|0|||
23269533|NCT00684671|64728790|FG000|Overall Study|Lost to Follow-up|1|||
23269534|NCT00684671|64728791|FG001|Overall Study|Lost to Follow-up|0|||
23269535|NCT00684671|64728792|FG002|Overall Study|Lost to Follow-up|0|||
23269536|NCT00684671|64728790|FG000|Overall Study|Alcoholic dependance|1|||
23269537|NCT00684671|64728791|FG001|Overall Study|Alcoholic dependance|0|||
23269538|NCT00684671|64728792|FG002|Overall Study|Alcoholic dependance|0|||
23269539|NCT01936948|64728815|FG000|Overall Study|no 30-day follow-up data|0|||
23269540|NCT01936948|64728816|FG001|Overall Study|no 30-day follow-up data|3|||
23269541|NCT01936948|64728817|FG002|Overall Study|no 30-day follow-up data|3|||
23269542|NCT01936948|64728818|FG003|Overall Study|no 30-day follow-up data|3|||
23269543|NCT05612724|64728824|FG000|Overall Study|Lost to Follow-up|4|||
23269544|NCT00552669|64728827|FG000|Overall Study|Death|3|||
23269545|NCT00552669|64728828|FG001|Overall Study|Death|7|||
23269546|NCT00854308|64728829|FG000|Overall Study|Disease progression|42|||
23269547|NCT00854308|64728830|FG001|Overall Study|Disease progression|50|||
23269548|NCT00854308|64728829|FG000|Overall Study|Adverse Event|8|||
23269549|NCT00854308|64728830|FG001|Overall Study|Adverse Event|3|||
23269550|NCT00854308|64728829|FG000|Overall Study|Death|2|||
23269551|NCT00854308|64728830|FG001|Overall Study|Death|5|||
23269552|NCT00854308|64728829|FG000|Overall Study|Physician Decision|6|||
23269553|NCT00854308|64728830|FG001|Overall Study|Physician Decision|6|||
23269554|NCT00854308|64728829|FG000|Overall Study|Withdrawal by Subject|4|||
23269555|NCT00854308|64728830|FG001|Overall Study|Withdrawal by Subject|2|||
23269556|NCT00854308|64728829|FG000|Overall Study|Sponsor's decision to terminate study|0|||
23269557|NCT00854308|64728830|FG001|Overall Study|Sponsor's decision to terminate study|1|||
23269558|NCT00686959|64728831|FG000|Overall Study|Participants censored (no death events)|124|||
23269559|NCT00686959|64728832|FG001|Overall Study|Participants censored (no death events)|117|||
23269560|NCT00385684|64728836|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
23269561|NCT00385684|64728837|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
23269562|NCT00385684|64728836|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
23269563|NCT00385684|64728837|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
23269564|NCT00385684|64728836|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
23269565|NCT00385684|64728837|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
23269566|NCT01735630|64728841|FG000|Overall Study|Adverse Event|8|||
23269567|NCT01735630|64728842|FG001|Overall Study|Adverse Event|7|||
23269568|NCT01735630|64728841|FG000|Overall Study|Lost to Follow-up|1|||
23269569|NCT01735630|64728842|FG001|Overall Study|Lost to Follow-up|0|||
23269570|NCT01735630|64728841|FG000|Overall Study|Physician Decision|0|||
23269571|NCT01735630|64728842|FG001|Overall Study|Physician Decision|1|||
23269572|NCT01735630|64728841|FG000|Overall Study|Sponsor Decision|2|||
23269573|NCT01735630|64728842|FG001|Overall Study|Sponsor Decision|1|||
23269574|NCT01735630|64728841|FG000|Overall Study|Withdrawal by Subject|7|||
23269575|NCT01735630|64728842|FG001|Overall Study|Withdrawal by Subject|9|||
23269576|NCT00220337|64728855|FG000|Overall Study|Adverse Event|70|||
23269577|NCT00220337|64728855|FG000|Overall Study|Lack of Efficacy|17|||
23269578|NCT00220337|64728855|FG000|Overall Study|Withdrawal by Subject|68|||
23269579|NCT00220337|64728855|FG000|Overall Study|Protocol Violation|2|||
23269580|NCT00220337|64728855|FG000|Overall Study|Lost to Follow-up|5|||
23269581|NCT00220337|64728855|FG000|Overall Study|Other|12|||
23269582|NCT00220337|64728855|FG000|Overall Study|Unsatisfactory compliance|5|||
23269583|NCT03583606|64728856|FG000|Overall Study|Lost to Follow-up|0|||
23269584|NCT03583606|64728857|FG001|Overall Study|Lost to Follow-up|1|||
23269585|NCT03583606|64728858|FG002|Overall Study|Lost to Follow-up|0|||
23269586|NCT03583606|64728856|FG000|Overall Study|Ineligible at baseline|1|||
23269587|NCT03583606|64728857|FG001|Overall Study|Ineligible at baseline|0|||
23269588|NCT03583606|64728858|FG002|Overall Study|Ineligible at baseline|0|||
23269589|NCT02626949|64731745|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
23269590|NCT02626949|64731746|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
23269591|NCT02626949|64731745|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
23269592|NCT02626949|64731746|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
23269593|NCT02626949|64731745|FG000|Enrolled|Lost to Follow-up|7|||
23269594|NCT02626949|64731746|FG001|Enrolled|Lost to Follow-up|6|||
23269595|NCT02626949|64731745|FG000|Enrolled|Withdrawal by Subject|3|||
23269596|NCT02626949|64731746|FG001|Enrolled|Withdrawal by Subject|2|||
23269597|NCT00679367|64731752|FG000|Overall Study|Adverse Event|7|||
23269598|NCT00679367|64731752|FG000|Overall Study|inability to swallow oral drugs|1|||
23269599|NCT00679367|64731752|FG000|Overall Study|Lack of Efficacy|3|||
23269600|NCT00679367|64731752|FG000|Overall Study|Withdrawal by Subject|1|||
23269601|NCT00659607|64731753|FG000|Overall Study|No blood pressure recorded|147|||
23269602|NCT00659607|64731753|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
23269603|NCT00659607|64731753|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
23269604|NCT00659607|64731753|FG000|Overall Study|No recorded efficacy data|15|||
23269605|NCT00659607|64731753|FG000|Overall Study|Inconsistent BP measuring date|2|||
23269606|NCT02920996|64731754|FG000|Overall Study|Adverse Event|8|||
23269607|NCT02920996|64731755|FG001|Overall Study|Adverse Event|0|||
23269608|NCT02920996|64731754|FG000|Overall Study|Physician Decision|1|||
23269609|NCT02920996|64731755|FG001|Overall Study|Physician Decision|0|||
23269610|NCT02920996|64731754|FG000|Overall Study|Death|1|||
23269611|NCT02920996|64731755|FG001|Overall Study|Death|0|||
23269612|NCT02920996|64731754|FG000|Overall Study|Missing|1|||
23269613|NCT02920996|64731755|FG001|Overall Study|Missing|0|||
23269614|NCT02920996|64731754|FG000|Overall Study|Subject Non-Compliance|1|||
23269615|NCT02920996|64731755|FG001|Overall Study|Subject Non-Compliance|0|||
23365540|NCT01298700|65084987|FG000|Overall Study|Protocol Violation|6|||
23269616|NCT02899338|64731756|FG000|Overall Study|Adverse Event|1|||
23269617|NCT02899338|64731757|FG001|Overall Study|Adverse Event|2|||
23269618|NCT02899338|64731756|FG000|Overall Study|Withdrawal by Subject|2|||
23269619|NCT02899338|64731757|FG001|Overall Study|Withdrawal by Subject|0|||
23269620|NCT03830164|64731758|FG000|Overall Study|Adverse Event|0|||
23269621|NCT03830164|64731759|FG001|Overall Study|Adverse Event|2|||
23269622|NCT03830164|64731760|FG002|Overall Study|Adverse Event|0|||
23269623|NCT03830164|64731758|FG000|Overall Study|Lack of Efficacy|1|||
23269624|NCT03830164|64731759|FG001|Overall Study|Lack of Efficacy|5|||
23269625|NCT03830164|64731760|FG002|Overall Study|Lack of Efficacy|0|||
23269626|NCT03830164|64731758|FG000|Overall Study|Lost to Follow-up|0|||
23269627|NCT03830164|64731759|FG001|Overall Study|Lost to Follow-up|1|||
23269628|NCT03830164|64731760|FG002|Overall Study|Lost to Follow-up|0|||
23601687|NCT03697603|65933852|FG000|Overall Study|Physician Decision|1|||
23601688|NCT03697603|65933853|FG001|Overall Study|Physician Decision|0|||
23601689|NCT03697603|65933854|FG002|Overall Study|Physician Decision|2|||
23601690|NCT03697603|65933852|FG000|Overall Study|Protocol Violation|3|||
23601691|NCT03697603|65933853|FG001|Overall Study|Protocol Violation|8|||
23601692|NCT03697603|65933854|FG002|Overall Study|Protocol Violation|5|||
23601693|NCT03697603|65933852|FG000|Overall Study|Withdrawal by Subject|5|||
23601694|NCT03697603|65933853|FG001|Overall Study|Withdrawal by Subject|1|||
23601695|NCT03697603|65933854|FG002|Overall Study|Withdrawal by Subject|1|||
23601696|NCT03697603|65933852|FG000|Overall Study|Protocol Violation|0|||
23601697|NCT03697603|65933853|FG001|Overall Study|Protocol Violation|0|||
23601698|NCT03697603|65933854|FG002|Overall Study|Protocol Violation|1|||
23601699|NCT03170882|65933855|FG000|Overall Study|Death|17|||
23601700|NCT03170882|65933856|FG001|Overall Study|Death|29|||
23601701|NCT03170882|65933855|FG000|Overall Study|Lost to Follow-up|0|||
23601702|NCT03170882|65933856|FG001|Overall Study|Lost to Follow-up|1|||
23601703|NCT03170882|65933855|FG000|Overall Study|Withdrawal by Subject|4|||
23601704|NCT03170882|65933856|FG001|Overall Study|Withdrawal by Subject|7|||
23601705|NCT03170882|65933855|FG000|Overall Study|Reason not Specified|28|||
23601706|NCT03170882|65933856|FG001|Overall Study|Reason not Specified|36|||
23601707|NCT00467272|65933857|FG000|Overall Study|Pneumonia|2|||
23601708|NCT00467272|65933857|FG000|Overall Study|Thrombophlebitis|1|||
23601709|NCT02334215|65933870|FG000|Overall Study|Death|1|||
23601710|NCT02334215|65933871|FG001|Overall Study|Death|1|||
23601711|NCT02334215|65933872|FG002|Overall Study|Death|0|||
23601712|NCT02334215|65933870|FG000|Overall Study|Lost to Follow-up|1|||
23601713|NCT02334215|65933871|FG001|Overall Study|Lost to Follow-up|0|||
23601714|NCT02334215|65933872|FG002|Overall Study|Lost to Follow-up|4|||
23601715|NCT02334215|65933870|FG000|Overall Study|Withdrawal by Subject|2|||
23601716|NCT02334215|65933871|FG001|Overall Study|Withdrawal by Subject|2|||
23601717|NCT02334215|65933872|FG002|Overall Study|Withdrawal by Subject|1|||
23601718|NCT02334215|65933870|FG000|Overall Study|Not released from incarceration on time|3|||
23601719|NCT02334215|65933871|FG001|Overall Study|Not released from incarceration on time|3|||
23601720|NCT02334215|65933872|FG002|Overall Study|Not released from incarceration on time|3|||
23601721|NCT02334215|65933870|FG000|Overall Study|Incarcerated|0|||
23601722|NCT02334215|65933871|FG001|Overall Study|Incarcerated|0|||
23601723|NCT02334215|65933872|FG002|Overall Study|Incarcerated|7|||
23601724|NCT02575365|65933878|FG000|Overall Study|Lost to Follow-up|4|||
23601725|NCT02646618|65933881|FG000|Overall Study|Lost to Follow-up|10|||
23601726|NCT02646618|65933882|FG001|Overall Study|Lost to Follow-up|14|||
23269629|NCT03830164|64731758|FG000|Overall Study|Withdrawal by Subject|1|||
23269630|NCT03830164|64731759|FG001|Overall Study|Withdrawal by Subject|0|||
23269631|NCT03830164|64731760|FG002|Overall Study|Withdrawal by Subject|0|||
23269632|NCT00117949|64731763|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
23365541|NCT01298700|65084988|FG001|Overall Study|Protocol Violation|4|||
23482518|NCT01924429|65509560|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
23365542|NCT01298700|65084987|FG000|Overall Study|Other Miscellaneous Reasons|16|||
23365543|NCT01298700|65084988|FG001|Overall Study|Other Miscellaneous Reasons|15|||
23365544|NCT01298700|65084987|FG000|Overall Study|Did not Receive Study Drug|3|||
23365545|NCT01298700|65084988|FG001|Overall Study|Did not Receive Study Drug|5|||
23365546|NCT04346199|65084991|FG000|Overall Study|Death|8|||
23365547|NCT04346199|65084992|FG001|Overall Study|Death|9|||
23365548|NCT04346199|65084991|FG000|Overall Study|Lost to Follow-up|0|||
23365549|NCT04346199|65084992|FG001|Overall Study|Lost to Follow-up|1|||
23365550|NCT04346199|65084991|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
23365551|NCT04346199|65084992|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
23365552|NCT04346199|65084991|FG000|Overall Study|Withdrawal by Subject|5|||
23365553|NCT04346199|65084992|FG001|Overall Study|Withdrawal by Subject|1|||
23365554|NCT01405898|65084993|FG000|Overall Study|Withdrawal by Subject|2|||
23365555|NCT01405898|65084994|FG001|Overall Study|Withdrawal by Subject|2|||
23365556|NCT03028142|65084995|FG000|Overall Study|Adverse Event|1|||
23365557|NCT03028142|65084996|FG001|Overall Study|Adverse Event|1|||
23365558|NCT03028142|65084997|FG002|Overall Study|Adverse Event|0|||
23365559|NCT03028142|65084998|FG003|Overall Study|Adverse Event|0|||
23365560|NCT03028142|65084999|FG004|Overall Study|Adverse Event|0|||
23365561|NCT03028142|65085000|FG005|Overall Study|Adverse Event|1|||
23365562|NCT03028142|65084995|FG000|Overall Study|Withdrawal by Subject|0|||
23365563|NCT03028142|65084996|FG001|Overall Study|Withdrawal by Subject|0|||
23365564|NCT03028142|65084997|FG002|Overall Study|Withdrawal by Subject|0|||
23365565|NCT03028142|65084998|FG003|Overall Study|Withdrawal by Subject|0|||
23365566|NCT03028142|65084999|FG004|Overall Study|Withdrawal by Subject|1|||
23365567|NCT03028142|65085000|FG005|Overall Study|Withdrawal by Subject|0|||
23365568|NCT01026948|65085001|FG000|Overall Study|Physician Decision|8|||
23365569|NCT03092752|65085005|FG000|Overall Study|Aged <40 years|14209|||
23365570|NCT03092752|65085005|FG000|Overall Study|At least one claim with T2DM|61299|||
23365571|NCT03092752|65085005|FG000|Overall Study|Having no claim of study drugs|29282|||
23365572|NCT03092752|65085005|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
23365573|NCT03092752|65085005|FG000|Overall Study|<6 month history|245900|||
23365574|NCT00606307|65085015|FG000|Overall Study|Adverse Event|2|||
23365575|NCT00606307|65085015|FG000|Overall Study|Withdrawal by Subject|2|||
23365576|NCT00606307|65085015|FG000|Overall Study|Disease progression|6|||
23365577|NCT00606307|65085015|FG000|Overall Study|QTc prolongation|1|||
23365578|NCT01151345|65085016|FG000|First Intervention Period|Protocol Violation|0|||
23365579|NCT01151345|65085017|FG001|First Intervention Period|Protocol Violation|1|||
23365580|NCT00338741|65085022|FG000|Overall Study|Lost to Follow-up|2|||
23365581|NCT00338741|65085023|FG001|Overall Study|Lost to Follow-up|0|||
23365582|NCT03200548|65085026|FG000|Overall Study|Withdrawal by Subject|5|||
23365583|NCT03200548|65085027|FG001|Overall Study|Withdrawal by Subject|11|||
23365584|NCT03200548|65085028|FG002|Overall Study|Withdrawal by Subject|7|||
23365585|NCT03200548|65085029|FG003|Overall Study|Withdrawal by Subject|6|||
23365586|NCT03677869|65085031|FG000|Overall Study|Withdrawal by Subject|1|||
23365587|NCT01051921|65085032|FG000|Overall Study|Physician Decision|9|||
23365588|NCT01051921|65085032|FG000|Overall Study|Adverse Event|8|||
23365589|NCT01051921|65085032|FG000|Overall Study|Withdrawal by Subject|7|||
23365590|NCT01051921|65085032|FG000|Overall Study|Lost to Follow-up|4|||
23365591|NCT01051921|65085032|FG000|Overall Study|virological failure|1|||
23365592|NCT01051921|65085032|FG000|Overall Study|patient moved|1|||
23365593|NCT03489343|65085033|FG000|Overall Study|Documented progressive disease|1|||
23365594|NCT03489343|65085034|FG001|Overall Study|Documented progressive disease|0|||
23365595|NCT03489343|65085035|FG002|Overall Study|Documented progressive disease|3|||
23365596|NCT03489343|65085036|FG003|Overall Study|Documented progressive disease|1|||
23365597|NCT03489343|65085037|FG004|Overall Study|Documented progressive disease|3|||
23365598|NCT03489343|65085038|FG005|Overall Study|Documented progressive disease|5|||
23365599|NCT03489343|65085039|FG006|Overall Study|Documented progressive disease|4|||
23365600|NCT03489343|65085033|FG000|Overall Study|Adverse Event|0|||
23365601|NCT03489343|65085034|FG001|Overall Study|Adverse Event|1|||
23365602|NCT03489343|65085035|FG002|Overall Study|Adverse Event|0|||
23482519|NCT01924429|65509561|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
23482520|NCT01401959|65509562|FG000|Enrolled|Withdrawal by Subject|1|||
23601727|NCT00822900|65933883|FG000|Overall Study|Withdrawal by Subject|14|||
23365603|NCT03489343|65085036|FG003|Overall Study|Adverse Event|0|||
23601728|NCT00822900|65933884|FG001|Overall Study|Withdrawal by Subject|14|||
23601729|NCT00822900|65933883|FG000|Overall Study|Lost to Follow-up|9|||
23601730|NCT00822900|65933884|FG001|Overall Study|Lost to Follow-up|9|||
23601731|NCT00822900|65933883|FG000|Overall Study|Death|83|||
23601732|NCT00822900|65933884|FG001|Overall Study|Death|69|||
23601733|NCT00822900|65933883|FG000|Overall Study|Became a ward of the state|2|||
23601734|NCT00822900|65933884|FG001|Overall Study|Became a ward of the state|1|||
23601735|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
23269633|NCT00117949|64731764|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
23269634|NCT00117949|64731765|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
23269635|NCT00117949|64731766|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
23269636|NCT00117949|64731763|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
23269637|NCT00117949|64731764|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
23269638|NCT00117949|64731765|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
23269639|NCT00117949|64731766|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
23269640|NCT00117949|64731763|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
23269641|NCT00117949|64731764|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
23269642|NCT00117949|64731765|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
23269643|NCT00117949|64731766|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
23269644|NCT00117949|64731763|FG000|Overall Study|PSA increase >=10ng/mL|0|||
23269645|NCT00117949|64731764|FG001|Overall Study|PSA increase >=10ng/mL|1|||
23269646|NCT00117949|64731765|FG002|Overall Study|PSA increase >=10ng/mL|1|||
23269647|NCT00117949|64731766|FG003|Overall Study|PSA increase >=10ng/mL|0|||
23269648|NCT00117949|64731763|FG000|Overall Study|PSA reduction <=50%|0|||
23269649|NCT00117949|64731764|FG001|Overall Study|PSA reduction <=50%|2|||
23269650|NCT00117949|64731765|FG002|Overall Study|PSA reduction <=50%|2|||
23269651|NCT00117949|64731766|FG003|Overall Study|PSA reduction <=50%|4|||
23269652|NCT00117949|64731763|FG000|Overall Study|Hepatic abnormalities|0|||
23269653|NCT00117949|64731764|FG001|Overall Study|Hepatic abnormalities|1|||
23269654|NCT00117949|64731765|FG002|Overall Study|Hepatic abnormalities|0|||
23269655|NCT00117949|64731766|FG003|Overall Study|Hepatic abnormalities|1|||
23269656|NCT02032888|64731767|FG000|Treatment Period|Poor compliance/noncompliance|1|||
23269657|NCT02032888|64731768|FG001|Treatment Period|Poor compliance/noncompliance|1|||
23269658|NCT02032888|64731769|FG002|Treatment Period|Poor compliance/noncompliance|0|||
23269659|NCT02032888|64731767|FG000|Treatment Period|Other|1|||
23269660|NCT02032888|64731768|FG001|Treatment Period|Other|1|||
23269661|NCT02032888|64731769|FG002|Treatment Period|Other|0|||
23269662|NCT02032888|64731767|FG000|Follow-up Period|Lost to Follow-up|1|||
23269663|NCT02032888|64731768|FG001|Follow-up Period|Lost to Follow-up|1|||
23269664|NCT02032888|64731769|FG002|Follow-up Period|Lost to Follow-up|0|||
23269665|NCT02032888|64731767|FG000|Follow-up Period|Death|1|||
23269666|NCT02032888|64731768|FG001|Follow-up Period|Death|1|||
23269667|NCT02032888|64731769|FG002|Follow-up Period|Death|0|||
23269668|NCT02032888|64731767|FG000|Follow-up Period|Other|1|||
23269669|NCT02032888|64731768|FG001|Follow-up Period|Other|0|||
23269670|NCT02032888|64731769|FG002|Follow-up Period|Other|0|||
23269671|NCT00389064|64731770|FG000|Overall Study|Adverse Event|11|||
23269672|NCT00389064|64731771|FG001|Overall Study|Adverse Event|3|||
23269673|NCT00389064|64731770|FG000|Overall Study|Lack of Efficacy|3|||
23269674|NCT00389064|64731771|FG001|Overall Study|Lack of Efficacy|14|||
23269675|NCT00389064|64731770|FG000|Overall Study|Withdrawal by Subject|17|||
23269676|NCT00389064|64731771|FG001|Overall Study|Withdrawal by Subject|27|||
23269677|NCT00389064|64731770|FG000|Overall Study|Physician Decision|2|||
23269678|NCT00389064|64731771|FG001|Overall Study|Physician Decision|2|||
23269679|NCT00389064|64731770|FG000|Overall Study|Lost to Follow-up|1|||
23269680|NCT00389064|64731771|FG001|Overall Study|Lost to Follow-up|2|||
23269681|NCT00389064|64731770|FG000|Overall Study|Protocol Violation|2|||
23269682|NCT00389064|64731771|FG001|Overall Study|Protocol Violation|0|||
23269683|NCT00389064|64731770|FG000|Overall Study|Multiple Reasons|9|||
23269684|NCT00389064|64731771|FG001|Overall Study|Multiple Reasons|11|||
23269685|NCT03601637|64731772|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
23269686|NCT03601637|64731773|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
23269687|NCT03601637|64731772|FG000|Overall Study|Adverse Event|1|||
23269688|NCT03601637|64731773|FG001|Overall Study|Adverse Event|1|||
23269689|NCT03601637|64731772|FG000|Overall Study|Other|0|||
23269690|NCT03601637|64731773|FG001|Overall Study|Other|1|||
23269691|NCT01449630|64731775|FG000|Period 1|Physician Decision|1|||
23269692|NCT01449630|64731776|FG001|Period 1|Physician Decision|0|||
23269693|NCT01449630|64731777|FG002|Period 1|Physician Decision|0|||
23269694|NCT01449630|64731778|FG003|Period 1|Physician Decision|1|||
23269695|NCT01449630|64731779|FG004|Period 1|Physician Decision|0|||
23269696|NCT01449630|64731780|FG005|Period 1|Physician Decision|0|||
23269697|NCT01449630|64731781|FG006|Period 1|Physician Decision|0|||
23269698|NCT01449630|64731782|FG007|Period 1|Physician Decision|0|||
23269699|NCT01449630|64731783|FG008|Period 1|Physician Decision|0|||
23269700|NCT01449630|64731775|FG000|Period 1|Sponsor Decision|0|||
23269701|NCT01449630|64731776|FG001|Period 1|Sponsor Decision|0|||
23269702|NCT01449630|64731777|FG002|Period 1|Sponsor Decision|0|||
23365604|NCT03489343|65085037|FG004|Overall Study|Adverse Event|0|||
23269703|NCT01449630|64731778|FG003|Period 1|Sponsor Decision|0|||
23269704|NCT01449630|64731779|FG004|Period 1|Sponsor Decision|0|||
23365605|NCT03489343|65085038|FG005|Overall Study|Adverse Event|1|||
23269705|NCT01449630|64731780|FG005|Period 1|Sponsor Decision|1|||
23269706|NCT01449630|64731781|FG006|Period 1|Sponsor Decision|0|||
23269707|NCT01449630|64731782|FG007|Period 1|Sponsor Decision|0|||
23269708|NCT01449630|64731783|FG008|Period 1|Sponsor Decision|0|||
23269709|NCT01449630|64731775|FG000|Period 2|Sponsor Decision|0|||
23269710|NCT01449630|64731776|FG001|Period 2|Sponsor Decision|0|||
23269711|NCT01449630|64731777|FG002|Period 2|Sponsor Decision|0|||
23269712|NCT01449630|64731778|FG003|Period 2|Sponsor Decision|0|||
23269713|NCT01449630|64731779|FG004|Period 2|Sponsor Decision|0|||
23269714|NCT01449630|64731780|FG005|Period 2|Sponsor Decision|0|||
23269715|NCT01449630|64731781|FG006|Period 2|Sponsor Decision|1|||
23269716|NCT01449630|64731782|FG007|Period 2|Sponsor Decision|0|||
23269717|NCT01449630|64731783|FG008|Period 2|Sponsor Decision|0|||
23269718|NCT01045096|64731784|FG000|Overall Study|Withdrawal by Subject|2|||
23269719|NCT01045096|64731785|FG001|Overall Study|Withdrawal by Subject|0|||
23269720|NCT01045096|64731786|FG002|Overall Study|Withdrawal by Subject|0|||
23269721|NCT01045096|64731784|FG000|Overall Study|Other|1|||
23269722|NCT01045096|64731785|FG001|Overall Study|Other|0|||
23269723|NCT01045096|64731786|FG002|Overall Study|Other|0|||
23269724|NCT00064753|64731791|FG000|Overall Study|Death|251|||
23269725|NCT00064753|64731792|FG001|Overall Study|Death|242|||
23269726|NCT00064753|64731791|FG000|Overall Study|Withdrawal by Subject|198|||
23269727|NCT00064753|64731792|FG001|Overall Study|Withdrawal by Subject|171|||
23269728|NCT00064753|64731791|FG000|Overall Study|Lost to Follow-up|225|||
23269729|NCT00064753|64731792|FG001|Overall Study|Lost to Follow-up|235|||
23269730|NCT00313703|64731793|FG000|Overall Study|Lost to Follow-up|11|||
23269731|NCT00313703|64731794|FG001|Overall Study|Lost to Follow-up|2|||
23269732|NCT00313703|64731795|FG002|Overall Study|Lost to Follow-up|5|||
23269733|NCT00313703|64731796|FG003|Overall Study|Lost to Follow-up|12|||
23269734|NCT00304083|64731802|FG000|Overall Study|Withdrawal by Subject|4|||
23269735|NCT00304083|64731803|FG001|Overall Study|Withdrawal by Subject|2|||
23269736|NCT00304083|64731802|FG000|Overall Study|Physician Decision|8|||
23269737|NCT00304083|64731803|FG001|Overall Study|Physician Decision|3|||
23269738|NCT00304083|64731802|FG000|Overall Study|Disease Progression|5|||
23269739|NCT00304083|64731803|FG001|Overall Study|Disease Progression|1|||
23269740|NCT00304083|64731802|FG000|Overall Study|Other|5|||
23269741|NCT00304083|64731803|FG001|Overall Study|Other|2|||
23269742|NCT02170688|64731810|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
23269743|NCT02170688|64731811|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
23269744|NCT02170688|64731812|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
23269745|NCT02170688|64731813|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
23269746|NCT02170688|64731814|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
23269747|NCT02170688|64731810|FG000|Overall Study|Full dose not received|0|||
23269748|NCT02170688|64731811|FG001|Overall Study|Full dose not received|1|||
23269749|NCT02170688|64731812|FG002|Overall Study|Full dose not received|0|||
23269750|NCT02170688|64731813|FG003|Overall Study|Full dose not received|0|||
23269751|NCT02170688|64731814|FG004|Overall Study|Full dose not received|0|||
23269752|NCT02170688|64731810|FG000|Overall Study|Physician Decision|0|||
23269753|NCT02170688|64731811|FG001|Overall Study|Physician Decision|0|||
23269754|NCT02170688|64731812|FG002|Overall Study|Physician Decision|1|||
23269755|NCT02170688|64731813|FG003|Overall Study|Physician Decision|0|||
23269756|NCT02170688|64731814|FG004|Overall Study|Physician Decision|0|||
23269757|NCT05593965|64731817|FG000|1st Intervention (1 Day)|Technical error|1|||
23269758|NCT05593965|64731818|FG001|1st Intervention (1 Day)|Technical error|0|||
23269759|NCT00958243|64731820|FG000|Overall Study|Withdrawal by Subject|0|||
23269760|NCT00958243|64731821|FG001|Overall Study|Withdrawal by Subject|1|||
23269761|NCT00958243|64731822|FG002|Overall Study|Withdrawal by Subject|3|||
23269762|NCT00958243|64731823|FG003|Overall Study|Withdrawal by Subject|1|||
23269763|NCT00958243|64731824|FG004|Overall Study|Withdrawal by Subject|1|||
23269764|NCT00958243|64731825|FG005|Overall Study|Withdrawal by Subject|5|||
23269765|NCT00958243|64731820|FG000|Overall Study|Lost to Follow-up|2|||
23269766|NCT00958243|64731821|FG001|Overall Study|Lost to Follow-up|5|||
23269767|NCT00958243|64731822|FG002|Overall Study|Lost to Follow-up|11|||
23365606|NCT03489343|65085039|FG006|Overall Study|Adverse Event|0|||
23365607|NCT03489343|65085033|FG000|Overall Study|Withdrawal by Subject|0|||
23269768|NCT00958243|64731823|FG003|Overall Study|Lost to Follow-up|2|||
23269769|NCT00958243|64731824|FG004|Overall Study|Lost to Follow-up|8|||
23269770|NCT00958243|64731825|FG005|Overall Study|Lost to Follow-up|5|||
23269771|NCT00444145|64731831|FG000|Overall Study|Withdrawal by Subject|2|||
23269772|NCT00444145|64731831|FG000|Overall Study|Lost to Follow-up|1|||
23269773|NCT00444145|64731831|FG000|Overall Study|non-compliant|11|||
23269774|NCT00444145|64731831|FG000|Overall Study|Screen Failures|5|||
23269775|NCT01471093|64731834|FG000|Overall Study|Adverse Event|1|||
23269776|NCT01471093|64731835|FG001|Overall Study|Adverse Event|0|||
23269777|NCT01471093|64731836|FG002|Overall Study|Adverse Event|0|||
23269778|NCT01471093|64731837|FG003|Overall Study|Adverse Event|0|||
23269779|NCT00846495|64731840|FG000|Overall Study|Lost to Follow-up|1|||
23269780|NCT00846495|64731841|FG001|Overall Study|Lost to Follow-up|0|||
23269781|NCT00846495|64731840|FG000|Overall Study|Adverse Event|5|||
23269782|NCT00846495|64731841|FG001|Overall Study|Adverse Event|1|||
23269783|NCT00846495|64731840|FG000|Overall Study|Lack of Efficacy|1|||
23269784|NCT00846495|64731841|FG001|Overall Study|Lack of Efficacy|2|||
23269785|NCT00846495|64731840|FG000|Overall Study|Physician Decision|1|||
23269786|NCT00846495|64731841|FG001|Overall Study|Physician Decision|0|||
23269787|NCT02066922|64731842|FG000|Overall Study|Adverse Event|1|||
23482521|NCT01401959|65509563|FG001|Enrolled|Withdrawal by Subject|0|||
23482522|NCT01401959|65509564|FG002|Enrolled|Withdrawal by Subject|0|||
23482523|NCT01401959|65509562|FG000|Treated|Disease Progression|2|||
23482524|NCT01401959|65509563|FG001|Treated|Disease Progression|2|||
23482525|NCT01401959|65509564|FG002|Treated|Disease Progression|1|||
23482526|NCT01401959|65509562|FG000|Treated|Adverse Event|4|||
23482527|NCT01401959|65509563|FG001|Treated|Adverse Event|3|||
23482528|NCT01401959|65509564|FG002|Treated|Adverse Event|2|||
23482529|NCT01401959|65509562|FG000|Treated|Withdrawal by Subject|1|||
23482530|NCT01401959|65509563|FG001|Treated|Withdrawal by Subject|2|||
23482531|NCT01401959|65509564|FG002|Treated|Withdrawal by Subject|2|||
23482532|NCT01401959|65509562|FG000|Treated|Protocol Violation|0|||
23482533|NCT01401959|65509563|FG001|Treated|Protocol Violation|1|||
23482534|NCT01401959|65509564|FG002|Treated|Protocol Violation|0|||
23482535|NCT00636987|65509567|FG000|Overall Study|Death|44|||
23482536|NCT00636987|65509567|FG000|Overall Study|Explanted|13|||
23482537|NCT00636987|65509567|FG000|Overall Study|Lost to Follow-up|63|||
23482538|NCT00636987|65509567|FG000|Overall Study|5 year visit window not complete|69|||
23482539|NCT02478398|65509568|FG000|Overall Study|Adverse Event|20|||
23482540|NCT02478398|65509569|FG001|Overall Study|Adverse Event|5|||
23482541|NCT02478398|65509568|FG000|Overall Study|Lost to Follow-up|5|||
23482542|NCT02478398|65509569|FG001|Overall Study|Lost to Follow-up|4|||
23482543|NCT02478398|65509568|FG000|Overall Study|Non-Compliance With Study Drug|5|||
23482544|NCT02478398|65509569|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23482545|NCT02478398|65509568|FG000|Overall Study|Protocol Violation|3|||
23482546|NCT02478398|65509569|FG001|Overall Study|Protocol Violation|1|||
23482547|NCT02478398|65509568|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
23482548|NCT02478398|65509569|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
23482549|NCT02478398|65509568|FG000|Overall Study|Withdrawal By Participant|10|||
23482550|NCT02478398|65509569|FG001|Overall Study|Withdrawal By Participant|4|||
23482551|NCT00219544|65509570|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
23482552|NCT00219544|65509571|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
23482553|NCT00219544|65509570|FG000|Single Blind Treatment Period|Adverse Event|9|||
23482554|NCT00219544|65509571|FG001|Single Blind Treatment Period|Adverse Event|0|||
23482555|NCT00219544|65509570|FG000|Single Blind Treatment Period|Protocol Violation|4|||
23482556|NCT00219544|65509571|FG001|Single Blind Treatment Period|Protocol Violation|0|||
23482557|NCT00219544|65509570|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
23482558|NCT00219544|65509571|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
23482559|NCT00219544|65509570|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
23482560|NCT00219544|65509571|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
23482561|NCT00219544|65509570|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
23482562|NCT00219544|65509571|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
23269788|NCT03897088|64731843|FG000|Overall Study|Withdrawal by Subject|12|||
23269789|NCT03897088|64731844|FG001|Overall Study|Withdrawal by Subject|12|||
23269790|NCT03897088|64731843|FG000|Overall Study|Lost to Follow-up|7|||
23269791|NCT03897088|64731844|FG001|Overall Study|Lost to Follow-up|15|||
23269792|NCT03897088|64731843|FG000|Overall Study|Sponsor Decision|1|||
23269793|NCT03897088|64731844|FG001|Overall Study|Sponsor Decision|2|||
23269794|NCT03897088|64731843|FG000|Overall Study|COVID-19|2|||
23269795|NCT03897088|64731844|FG001|Overall Study|COVID-19|0|||
23269796|NCT03897088|64731843|FG000|Overall Study|Other|3|||
23269797|NCT03897088|64731844|FG001|Overall Study|Other|0|||
23482563|NCT02882152|65509572|FG000|Overall Study|Lost to Follow-up|1|||
23269798|NCT03897088|64731843|FG000|Overall Study|Non-compliance with Study Drug|1|||
23269799|NCT03897088|64731844|FG001|Overall Study|Non-compliance with Study Drug|1|||
23269800|NCT03897088|64731843|FG000|Overall Study|Pregnancy|0|||
23482564|NCT02882152|65509573|FG001|Overall Study|Lost to Follow-up|0|||
23482565|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
23482566|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
23482567|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
23482568|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
23482569|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
23482570|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
23482571|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
23482572|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
23365608|NCT03489343|65085034|FG001|Overall Study|Withdrawal by Subject|0|||
23365609|NCT03489343|65085035|FG002|Overall Study|Withdrawal by Subject|0|||
23365610|NCT03489343|65085036|FG003|Overall Study|Withdrawal by Subject|1|||
23365611|NCT03489343|65085037|FG004|Overall Study|Withdrawal by Subject|0|||
23365612|NCT03489343|65085038|FG005|Overall Study|Withdrawal by Subject|1|||
23482573|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
23482574|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
23482575|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
23482576|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
23482577|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
23482578|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
23482579|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
23482580|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
23482581|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
23482582|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
23482583|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
23482584|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
23482585|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
23482586|NCT02431247|65509574|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
23482587|NCT02431247|65509575|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
23482588|NCT02431247|65509576|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
23482589|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
23482590|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
23482591|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
23482592|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
23482593|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
23482594|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
23482595|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
23482596|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
23482597|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
23482598|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
23482599|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
23482600|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
23482601|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
23482602|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
23482603|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
23482604|NCT02431247|65509574|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
23482605|NCT02431247|65509575|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
23482606|NCT02431247|65509576|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
23482607|NCT00887744|65509577|FG000|Overall Study|Adverse Event|3|||
23482608|NCT00887744|65509577|FG000|Overall Study|Death|1|||
23482609|NCT00887744|65509577|FG000|Overall Study|Lost to Follow-up|3|||
23482610|NCT00887744|65509577|FG000|Overall Study|Withdrawal by Subject|18|||
23482611|NCT00887744|65509577|FG000|Overall Study|Various reasons|9|||
23482612|NCT02160002|65509580|FG000|Overall Study|Withdrawal by Subject|2|||
23482613|NCT02160002|65509581|FG001|Overall Study|Withdrawal by Subject|1|||
23601736|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
23365613|NCT03489343|65085039|FG006|Overall Study|Withdrawal by Subject|1|||
23365614|NCT03489343|65085033|FG000|Overall Study|Clinical progression|0|||
23365615|NCT03489343|65085034|FG001|Overall Study|Clinical progression|0|||
23365616|NCT03489343|65085035|FG002|Overall Study|Clinical progression|0|||
23482614|NCT03726996|65509582|FG000|Overall Study|Parent's decision|2|||
23482615|NCT03726996|65509582|FG000|Overall Study|Study early termination|2|||
23482616|NCT00829283|65509583|FG000|Overall Study|Lost to Follow-up|7|||
23482617|NCT00829283|65509584|FG001|Overall Study|Lost to Follow-up|25|||
23482618|NCT02536833|65509585|FG000|Overall Study|Discontinued Before Treatment|0|||
23482619|NCT02536833|65509586|FG001|Overall Study|Discontinued Before Treatment|0|||
23482620|NCT02536833|65509587|FG002|Overall Study|Discontinued Before Treatment|1|||
23482621|NCT02536833|65509588|FG003|Overall Study|Discontinued Before Treatment|2|||
23482622|NCT02536833|65509585|FG000|Overall Study|Adverse Event|1|||
23482623|NCT02536833|65509586|FG001|Overall Study|Adverse Event|3|||
23482624|NCT02536833|65509587|FG002|Overall Study|Adverse Event|4|||
23482625|NCT02536833|65509588|FG003|Overall Study|Adverse Event|1|||
23482626|NCT02536833|65509585|FG000|Overall Study|Lost to Follow-up|2|||
23482627|NCT02536833|65509586|FG001|Overall Study|Lost to Follow-up|1|||
23482628|NCT02536833|65509587|FG002|Overall Study|Lost to Follow-up|2|||
23482629|NCT02536833|65509588|FG003|Overall Study|Lost to Follow-up|2|||
23482630|NCT02536833|65509585|FG000|Overall Study|Physician Decision|0|||
23482631|NCT02536833|65509586|FG001|Overall Study|Physician Decision|0|||
23482632|NCT02536833|65509587|FG002|Overall Study|Physician Decision|0|||
23482633|NCT02536833|65509588|FG003|Overall Study|Physician Decision|1|||
23482634|NCT02536833|65509585|FG000|Overall Study|Site Terminated by Sponsor|2|||
23482635|NCT02536833|65509586|FG001|Overall Study|Site Terminated by Sponsor|2|||
23482636|NCT02536833|65509587|FG002|Overall Study|Site Terminated by Sponsor|2|||
23482637|NCT02536833|65509588|FG003|Overall Study|Site Terminated by Sponsor|2|||
23482638|NCT02536833|65509585|FG000|Overall Study|Subject Non-Compliance|0|||
23365617|NCT03489343|65085036|FG003|Overall Study|Clinical progression|1|||
23365618|NCT03489343|65085037|FG004|Overall Study|Clinical progression|0|||
23365619|NCT03489343|65085038|FG005|Overall Study|Clinical progression|0|||
23365620|NCT03489343|65085039|FG006|Overall Study|Clinical progression|1|||
23365621|NCT04435808|65085053|FG000|Overall Study|Study stopped by DSMB|0|||
23365622|NCT04435808|65085054|FG001|Overall Study|Study stopped by DSMB|1|||
23365623|NCT01705080|65085055|FG000|Overall Study|Missed visit|10|||
23482639|NCT02536833|65509586|FG001|Overall Study|Subject Non-Compliance|1|||
23482640|NCT02536833|65509587|FG002|Overall Study|Subject Non-Compliance|1|||
23269801|NCT03897088|64731844|FG001|Overall Study|Pregnancy|1|||
23269802|NCT01860976|64731845|FG000|Blinded Treatment|Adverse Event|1|||
23482641|NCT02536833|65509588|FG003|Overall Study|Subject Non-Compliance|0|||
23482642|NCT02536833|65509585|FG000|Overall Study|Withdrawal by Subject|4|||
23482643|NCT02536833|65509586|FG001|Overall Study|Withdrawal by Subject|3|||
23482644|NCT02536833|65509587|FG002|Overall Study|Withdrawal by Subject|5|||
23482645|NCT02536833|65509588|FG003|Overall Study|Withdrawal by Subject|11|||
23482646|NCT00829933|65509590|FG000|Overall Study|Adverse Event|2|||
23482647|NCT00829933|65509591|FG001|Overall Study|Adverse Event|3|||
23482648|NCT00829933|65509592|FG002|Overall Study|Adverse Event|2|||
23482649|NCT00829933|65509593|FG003|Overall Study|Adverse Event|1|||
23482650|NCT00829933|65509590|FG000|Overall Study|Death|0|||
23482651|NCT00829933|65509591|FG001|Overall Study|Death|0|||
23482652|NCT00829933|65509592|FG002|Overall Study|Death|1|||
23482653|NCT00829933|65509593|FG003|Overall Study|Death|1|||
23482654|NCT00829933|65509590|FG000|Overall Study|Lack of Efficacy|0|||
23482655|NCT00829933|65509591|FG001|Overall Study|Lack of Efficacy|1|||
23482656|NCT00829933|65509592|FG002|Overall Study|Lack of Efficacy|0|||
23482657|NCT00829933|65509593|FG003|Overall Study|Lack of Efficacy|0|||
23482658|NCT00829933|65509590|FG000|Overall Study|Physician Decision|5|||
23482659|NCT00829933|65509591|FG001|Overall Study|Physician Decision|7|||
23482660|NCT00829933|65509592|FG002|Overall Study|Physician Decision|8|||
23482661|NCT00829933|65509593|FG003|Overall Study|Physician Decision|1|||
23482662|NCT00829933|65509590|FG000|Overall Study|Pregnancy|0|||
23482663|NCT00829933|65509591|FG001|Overall Study|Pregnancy|0|||
23482664|NCT00829933|65509592|FG002|Overall Study|Pregnancy|0|||
23482665|NCT00829933|65509593|FG003|Overall Study|Pregnancy|2|||
23482666|NCT00829933|65509590|FG000|Overall Study|Protocol Violation|2|||
23482667|NCT00829933|65509591|FG001|Overall Study|Protocol Violation|1|||
23482668|NCT00829933|65509592|FG002|Overall Study|Protocol Violation|0|||
23482669|NCT00829933|65509593|FG003|Overall Study|Protocol Violation|0|||
23482670|NCT00829933|65509590|FG000|Overall Study|withdrew before treatment started|5|||
23482671|NCT00829933|65509591|FG001|Overall Study|withdrew before treatment started|1|||
23601737|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
23269803|NCT01860976|64731846|FG001|Blinded Treatment|Adverse Event|3|||
23269804|NCT01860976|64731845|FG000|Blinded Treatment|Lack of Efficacy|5|||
23482672|NCT00829933|65509592|FG002|Overall Study|withdrew before treatment started|2|||
23482673|NCT00829933|65509593|FG003|Overall Study|withdrew before treatment started|9|||
23482674|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
23482675|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
23482676|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
23482677|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
23482678|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
23482679|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
23482680|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
23482681|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
23482682|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
23482683|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
23482684|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
23482685|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
23482686|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
23482687|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
23482688|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
23482689|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
23482690|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
23482691|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
23482692|NCT00591578|65509594|FG000|Double-Blind Treatment Phase|Other|4|||
23482693|NCT00591578|65509595|FG001|Double-Blind Treatment Phase|Other|9|||
23482694|NCT00591578|65509596|FG002|Double-Blind Treatment Phase|Other|4|||
23482695|NCT00591578|65509594|FG000|Open-Label Extension Phase|Adverse Event|3|||
23482696|NCT00591578|65509595|FG001|Open-Label Extension Phase|Adverse Event|5|||
23482697|NCT00591578|65509596|FG002|Open-Label Extension Phase|Adverse Event|0|||
23482698|NCT00591578|65509594|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
23482699|NCT00591578|65509595|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
23482700|NCT00591578|65509596|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23482701|NCT00591578|65509594|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
23482702|NCT00591578|65509595|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
23482703|NCT00591578|65509596|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
23482704|NCT00591578|65509594|FG000|Open-Label Extension Phase|Other|1|||
23482705|NCT00591578|65509595|FG001|Open-Label Extension Phase|Other|0|||
23482706|NCT00591578|65509596|FG002|Open-Label Extension Phase|Other|0|||
23482707|NCT03678870|65509599|FG000|Overall Study|prescribed non- protocol medications|10|||
23482708|NCT03678870|65509600|FG001|Overall Study|prescribed non- protocol medications|6|||
23482709|NCT03678870|65509599|FG000|Overall Study|Lost to Follow-up|3|||
23482710|NCT03678870|65509600|FG001|Overall Study|Lost to Follow-up|2|||
23482711|NCT01423604|65509601|FG000|Safety Run-In|Adverse Event|3|||
23482712|NCT01423604|65509602|FG001|Safety Run-In|Adverse Event|0|||
23482713|NCT01423604|65509601|FG000|Safety Run-In|Death|1|||
23482714|NCT01423604|65509602|FG001|Safety Run-In|Death|0|||
23482715|NCT01423604|65509601|FG000|Safety Run-In|Physician Decision|1|||
23482716|NCT01423604|65509602|FG001|Safety Run-In|Physician Decision|0|||
23482717|NCT01423604|65509601|FG000|Safety Run-In|Disease progression|3|||
23482718|NCT01423604|65509602|FG001|Safety Run-In|Disease progression|0|||
23482719|NCT01423604|65509601|FG000|Safety Run-In|Patient decision|1|||
23482720|NCT01423604|65509602|FG001|Safety Run-In|Patient decision|0|||
23482721|NCT01423604|65509601|FG000|Randomized|Adverse Event|4|||
23482722|NCT01423604|65509602|FG001|Randomized|Adverse Event|10|||
23482723|NCT01423604|65509601|FG000|Randomized|Death|1|||
23269805|NCT01860976|64731846|FG001|Blinded Treatment|Lack of Efficacy|12|||
23269806|NCT01860976|64731845|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
23269807|NCT01860976|64731846|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
23269808|NCT01860976|64731845|FG000|Blinded Treatment|Withdrawal by Subject|3|||
23269809|NCT01860976|64731846|FG001|Blinded Treatment|Withdrawal by Subject|5|||
23269810|NCT01860976|64731845|FG000|Blinded Treatment|Subject no longer met criteria|1|||
23269811|NCT01860976|64731846|FG001|Blinded Treatment|Subject no longer met criteria|0|||
23269812|NCT01860976|64731845|FG000|Blinded Treatment|Entered Open-Label in error|0|||
23269813|NCT01860976|64731846|FG001|Blinded Treatment|Entered Open-Label in error|1|||
23269814|NCT01860976|64731845|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
23269815|NCT01860976|64731846|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
23269816|NCT01860976|64731845|FG000|Open-Label|Adverse Event|2|||
23269817|NCT01860976|64731846|FG001|Open-Label|Adverse Event|4|||
23269818|NCT01860976|64731845|FG000|Open-Label|Lack of Efficacy|16|||
23269819|NCT01860976|64731846|FG001|Open-Label|Lack of Efficacy|8|||
23269820|NCT01860976|64731845|FG000|Open-Label|Lost to Follow-up|1|||
23269821|NCT01860976|64731846|FG001|Open-Label|Lost to Follow-up|2|||
23269822|NCT01860976|64731845|FG000|Open-Label|Subject request discontinue treatment|4|||
23269823|NCT01860976|64731846|FG001|Open-Label|Subject request discontinue treatment|3|||
23269824|NCT01860976|64731845|FG000|Open-Label|Withdrawal by Subject|4|||
23269825|NCT01860976|64731846|FG001|Open-Label|Withdrawal by Subject|1|||
23269826|NCT01860976|64731845|FG000|Open-Label|Other Reasons|1|||
23482724|NCT01423604|65509602|FG001|Randomized|Death|0|||
23482725|NCT01423604|65509601|FG000|Randomized|Physician Decision|16|||
23482726|NCT01423604|65509602|FG001|Randomized|Physician Decision|13|||
23269827|NCT01860976|64731846|FG001|Open-Label|Other Reasons|1|||
23269828|NCT01860976|64731845|FG000|Long Term Extension|Adverse Event|4|||
23269829|NCT01860976|64731846|FG001|Long Term Extension|Adverse Event|0|||
23482727|NCT01423604|65509601|FG000|Randomized|Other - unspecified|37|||
23482728|NCT01423604|65509602|FG001|Randomized|Other - unspecified|31|||
23482729|NCT01423604|65509601|FG000|Randomized|Patient decision|5|||
23482730|NCT01423604|65509602|FG001|Randomized|Patient decision|9|||
23482731|NCT02554279|65509603|FG000|Overall Study|Adverse Event|2|||
23269830|NCT01860976|64731845|FG000|Long Term Extension|Lack of Efficacy|2|||
23269831|NCT01860976|64731846|FG001|Long Term Extension|Lack of Efficacy|0|||
23365624|NCT01705080|65085056|FG001|Overall Study|Missed visit|4|||
23482732|NCT02554279|65509604|FG001|Overall Study|Adverse Event|5|||
23482733|NCT02554279|65509603|FG000|Overall Study|Lost to Follow-up|3|||
23269832|NCT01860976|64731845|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
23269833|NCT01860976|64731846|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
23365625|NCT01705080|65085057|FG002|Overall Study|Missed visit|1|||
23365626|NCT01705080|65085055|FG000|Overall Study|Death|4|||
23365627|NCT01705080|65085056|FG001|Overall Study|Death|4|||
23365628|NCT01705080|65085057|FG002|Overall Study|Death|6|||
23365629|NCT01705080|65085055|FG000|Overall Study|Withdrawal by Subject|61|||
23365630|NCT01705080|65085056|FG001|Overall Study|Withdrawal by Subject|44|||
23365631|NCT01705080|65085057|FG002|Overall Study|Withdrawal by Subject|9|||
23365632|NCT02982863|65085058|FG000|Overall Study|Not eligible patients|809|||
23365633|NCT02982863|65085059|FG001|Overall Study|Not eligible patients|4261|||
23365634|NCT02982863|65085060|FG002|Overall Study|Not eligible patients|1852|||
23365635|NCT02982863|65085061|FG003|Overall Study|Not eligible patients|1400|||
23365636|NCT02982863|65085062|FG004|Overall Study|Not eligible patients|492|||
23365637|NCT00780975|65085063|FG000|Overall Study|Progressive disease|3|||
23365638|NCT00780975|65085063|FG000|Overall Study|Toxicity|5|||
23365639|NCT01587885|65085065|FG000|Treatment Period 1|Failure to Return|0|||
23365640|NCT01587885|65085066|FG001|Treatment Period 1|Failure to Return|1|||
23365641|NCT01587885|65085065|FG000|Treatment Period 1|Protocol Violation|0|||
23365642|NCT01587885|65085066|FG001|Treatment Period 1|Protocol Violation|2|||
23365643|NCT01157845|65085067|FG000|Overall Study|Lost to Follow-up|5|||
23365644|NCT01157845|65085067|FG000|Overall Study|Withdrawal by Subject|12|||
23365645|NCT01157845|65085067|FG000|Overall Study|Physician Decision|3|||
23365646|NCT01157845|65085067|FG000|Overall Study|Protocol Violation|13|||
23365647|NCT01157845|65085067|FG000|Overall Study|Study was ended|1|||
23365648|NCT01157845|65085067|FG000|Overall Study|Device malfunction|1|||
23365649|NCT03506438|65085068|FG000|Overall Study|Lost to Follow-up|8|||
23365650|NCT03506438|65085069|FG001|Overall Study|Lost to Follow-up|7|||
23365651|NCT03506438|65085070|FG002|Overall Study|Lost to Follow-up|8|||
23365652|NCT03506438|65085071|FG003|Overall Study|Lost to Follow-up|7|||
23365653|NCT03506438|65085072|FG004|Overall Study|Lost to Follow-up|0|||
23365654|NCT03506438|65085073|FG005|Overall Study|Lost to Follow-up|0|||
23365655|NCT04010461|65085074|FG000|Overall Study|COVID based withdrawal|5|||
23365656|NCT04010461|65085074|FG000|Overall Study|Withdrawal by Subject|5|||
23365657|NCT04010461|65085074|FG000|Overall Study|Adverse Event|1|||
23365658|NCT04010461|65085074|FG000|Overall Study|No Motor Threshold obtainable|1|||
23365659|NCT04010461|65085074|FG000|Overall Study|Physician Decision|1|||
23365660|NCT00823264|65085076|FG000|Overall Study|Protocol Violation|2|||
23365661|NCT00823264|65085077|FG001|Overall Study|Protocol Violation|0|||
23365662|NCT02168491|65085078|FG000|Overall Study|Withdrawal by Subject|1|||
23365663|NCT02185417|65085079|FG000|Overall Study|Death|448|||
23365664|NCT02185417|65085080|FG001|Overall Study|Death|446|||
23365665|NCT02185417|65085081|FG002|Overall Study|Death|0|||
23365666|NCT02185417|65085079|FG000|Overall Study|Withdrawal by Subject|7|||
23365667|NCT02185417|65085080|FG001|Overall Study|Withdrawal by Subject|12|||
23365668|NCT02185417|65085081|FG002|Overall Study|Withdrawal by Subject|0|||
23365669|NCT03075267|65085082|FG000|Overall Study|Protocol Violation|1|||
23365670|NCT03075267|65085083|FG001|Overall Study|Protocol Violation|0|||
23365671|NCT03075267|65085084|FG002|Overall Study|Protocol Violation|0|||
23365672|NCT01789047|65085089|FG000|Overall Study|Adverse Event|3|||
23365673|NCT01789047|65085090|FG001|Overall Study|Adverse Event|2|||
23365674|NCT01789047|65085089|FG000|Overall Study|Withdrawal by Subject|1|||
23365675|NCT01789047|65085090|FG001|Overall Study|Withdrawal by Subject|2|||
23365676|NCT01687218|65085096|FG000|Overall Study|Withdrawal by Subject|2|||
23365677|NCT01687218|65085097|FG001|Overall Study|Withdrawal by Subject|3|||
23365678|NCT01687218|65085098|FG002|Overall Study|Withdrawal by Subject|0|||
23365679|NCT01687218|65085099|FG003|Overall Study|Withdrawal by Subject|1|||
23365680|NCT01687218|65085100|FG004|Overall Study|Withdrawal by Subject|1|||
23365681|NCT01687218|65085101|FG005|Overall Study|Withdrawal by Subject|0|||
23365682|NCT01687218|65085096|FG000|Overall Study|Relocated, no follow-up planned|1|||
23365683|NCT01687218|65085097|FG001|Overall Study|Relocated, no follow-up planned|0|||
23365684|NCT01687218|65085098|FG002|Overall Study|Relocated, no follow-up planned|1|||
23365685|NCT01687218|65085099|FG003|Overall Study|Relocated, no follow-up planned|1|||
23365686|NCT01687218|65085100|FG004|Overall Study|Relocated, no follow-up planned|0|||
23365687|NCT01687218|65085101|FG005|Overall Study|Relocated, no follow-up planned|0|||
23365688|NCT01061606|65085102|FG000|Overall Study|Adverse Event|1|||
23365689|NCT01061606|65085102|FG000|Overall Study|Death|1|||
23365690|NCT01061606|65085102|FG000|Overall Study|Disease Progression|4|||
23365691|NCT01061606|65085102|FG000|Overall Study|alternative therapy|2|||
23365692|NCT01598610|65085103|FG000|Overall Study|Adverse Event|1|||
23269834|NCT01860976|64731845|FG000|Long Term Extension|Lost to Follow-up|2|||
23269835|NCT01860976|64731846|FG001|Long Term Extension|Lost to Follow-up|0|||
23269836|NCT01860976|64731845|FG000|Long Term Extension|subject withdrew consent|7|||
23269837|NCT01860976|64731846|FG001|Long Term Extension|subject withdrew consent|0|||
23269838|NCT00076102|64731848|FG000|Overall Study|Clinical progression|1|||
23269839|NCT00076102|64731848|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
23269840|NCT00076102|64731848|FG000|Overall Study|plexiform neurofibroma surgery|1|||
23269841|NCT00076102|64731848|FG000|Overall Study|refusal of further therapy|2|||
23269842|NCT00854100|64731858|FG000|Overall Study|Inability to complete the study visits|0|||
23269843|NCT00854100|64731859|FG001|Overall Study|Inability to complete the study visits|0|||
23269844|NCT00854100|64731860|FG002|Overall Study|Inability to complete the study visits|1|||
23269845|NCT00854100|64731858|FG000|Overall Study|Lost to Follow-up|2|||
23269846|NCT00854100|64731859|FG001|Overall Study|Lost to Follow-up|0|||
23269847|NCT00854100|64731860|FG002|Overall Study|Lost to Follow-up|3|||
23269848|NCT00854100|64731858|FG000|Overall Study|Withdrawal by Subject|3|||
23482734|NCT02554279|65509604|FG001|Overall Study|Lost to Follow-up|2|||
23269849|NCT00854100|64731859|FG001|Overall Study|Withdrawal by Subject|1|||
23482735|NCT02554279|65509603|FG000|Overall Study|Withdrawal by Subject|6|||
23269850|NCT00854100|64731860|FG002|Overall Study|Withdrawal by Subject|2|||
23269851|NCT00854100|64731858|FG000|Overall Study|Protocol Violation|2|||
23269852|NCT00854100|64731859|FG001|Overall Study|Protocol Violation|4|||
23269853|NCT00854100|64731860|FG002|Overall Study|Protocol Violation|3|||
23365693|NCT00610168|65085104|FG000|Overall Study|Withdrawal by Subject|2|||
23365694|NCT00610168|65085105|FG001|Overall Study|Withdrawal by Subject|0|||
23365695|NCT00281697|65085106|FG000|Overall Study|> 60 days since last dose of study drug|4|||
23365696|NCT00281697|65085107|FG001|Overall Study|> 60 days since last dose of study drug|4|||
23365697|NCT00281697|65085106|FG000|Overall Study|Adverse Event|54|||
23365698|NCT00281697|65085107|FG001|Overall Study|Adverse Event|15|||
23365699|NCT00281697|65085106|FG000|Overall Study|Death|8|||
23365700|NCT00281697|65085107|FG001|Overall Study|Death|3|||
23365701|NCT00281697|65085106|FG000|Overall Study|Disease progression|279|||
23365702|NCT00281697|65085107|FG001|Overall Study|Disease progression|149|||
23365703|NCT00281697|65085106|FG000|Overall Study|Other|5|||
23365704|NCT00281697|65085107|FG001|Overall Study|Other|6|||
23365705|NCT00281697|65085106|FG000|Overall Study|Physician's decision to withdraw|15|||
23482736|NCT02554279|65509604|FG001|Overall Study|Withdrawal by Subject|4|||
23482737|NCT02554279|65509603|FG000|Overall Study|Protocol Violation|2|||
23269854|NCT00854100|64731858|FG000|Overall Study|Adverse Event|2|||
23269855|NCT00854100|64731859|FG001|Overall Study|Adverse Event|1|||
23269856|NCT00854100|64731860|FG002|Overall Study|Adverse Event|2|||
23269857|NCT00813293|64731862|FG000|Overall Study|Intercurrent illness|1|||
23269858|NCT00813293|64731863|FG001|Overall Study|Intercurrent illness|0|||
23269859|NCT00813293|64731862|FG000|Overall Study|Adverse Event|0|||
23269860|NCT00813293|64731863|FG001|Overall Study|Adverse Event|1|||
23269861|NCT00880568|64731864|FG000|Overall Study|Disease progression|3|||
23269862|NCT00880568|64731865|FG001|Overall Study|Disease progression|3|||
23269863|NCT00880568|64731866|FG002|Overall Study|Disease progression|3|||
23269864|NCT00880568|64731867|FG003|Overall Study|Disease progression|1|||
23269865|NCT00880568|64731868|FG004|Overall Study|Disease progression|3|||
23269866|NCT00880568|64731869|FG005|Overall Study|Disease progression|3|||
23269867|NCT00880568|64731870|FG006|Overall Study|Disease progression|5|||
23269868|NCT00880568|64731871|FG007|Overall Study|Disease progression|0|||
23269869|NCT00880568|64731872|FG008|Overall Study|Disease progression|3|||
23269870|NCT00880568|64731864|FG000|Overall Study|Adverse Event|0|||
23269871|NCT00880568|64731865|FG001|Overall Study|Adverse Event|0|||
23269872|NCT00880568|64731866|FG002|Overall Study|Adverse Event|0|||
23269873|NCT00880568|64731867|FG003|Overall Study|Adverse Event|0|||
23269874|NCT00880568|64731868|FG004|Overall Study|Adverse Event|0|||
23269875|NCT00880568|64731869|FG005|Overall Study|Adverse Event|0|||
23269876|NCT00880568|64731870|FG006|Overall Study|Adverse Event|1|||
23269877|NCT00880568|64731871|FG007|Overall Study|Adverse Event|1|||
23269878|NCT00880568|64731872|FG008|Overall Study|Adverse Event|0|||
23269879|NCT00880568|64731864|FG000|Overall Study|Withdrawal by Subject|0|||
23269880|NCT00880568|64731865|FG001|Overall Study|Withdrawal by Subject|0|||
23269881|NCT00880568|64731866|FG002|Overall Study|Withdrawal by Subject|0|||
23365706|NCT00281697|65085107|FG001|Overall Study|Physician's decision to withdraw|12|||
23365707|NCT00281697|65085106|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
23365708|NCT00281697|65085107|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
23365709|NCT00281697|65085106|FG000|Overall Study|Did not receive study drug|3|||
23365710|NCT00281697|65085107|FG001|Overall Study|Did not receive study drug|2|||
23365711|NCT00732069|65085108|FG000|Washout After First Study Drug|Adverse Event|1|||
23365712|NCT00732069|65085109|FG001|Washout After First Study Drug|Adverse Event|0|||
23365713|NCT00732069|65085110|FG002|Washout After First Study Drug|Adverse Event|0|||
23365714|NCT00732069|65085111|FG003|Washout After First Study Drug|Adverse Event|0|||
23365715|NCT00732069|65085112|FG004|Washout After First Study Drug|Adverse Event|0|||
23365716|NCT00732069|65085113|FG005|Washout After First Study Drug|Adverse Event|0|||
23365717|NCT01534273|65085114|FG000|Period 1|Physician Decision|0|||
23365718|NCT01534273|65085115|FG001|Period 1|Physician Decision|0|||
23365719|NCT01534273|65085116|FG002|Period 1|Physician Decision|0|||
23365720|NCT01534273|65085117|FG003|Period 1|Physician Decision|1|||
23365721|NCT01534273|65085118|FG004|Period 1|Physician Decision|0|||
23365722|NCT01534273|65085119|FG005|Period 1|Physician Decision|0|||
23365723|NCT01534273|65085120|FG006|Period 1|Physician Decision|0|||
23365724|NCT02974868|65085121|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
23365725|NCT02974868|65085122|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
23365726|NCT02974868|65085123|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
23365727|NCT02974868|65085124|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
23365728|NCT02974868|65085121|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
23365729|NCT02974868|65085122|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
23365730|NCT02974868|65085123|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
23365731|NCT02974868|65085124|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
23365732|NCT02974868|65085121|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
23365733|NCT02974868|65085122|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
23365734|NCT02974868|65085123|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
23365735|NCT02974868|65085124|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
23365736|NCT02974868|65085121|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
23365737|NCT02974868|65085122|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
23365738|NCT02974868|65085123|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
23365739|NCT02974868|65085124|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
23365740|NCT03225287|65085125|FG000|Overall Study|Adverse Event|0|||
23365741|NCT03225287|65085126|FG001|Overall Study|Adverse Event|0|||
23365742|NCT03225287|65085127|FG002|Overall Study|Adverse Event|1|||
23365743|NCT03225287|65085125|FG000|Overall Study|Protocol non-compliance|0|||
23365744|NCT03225287|65085126|FG001|Overall Study|Protocol non-compliance|0|||
23365745|NCT03225287|65085127|FG002|Overall Study|Protocol non-compliance|1|||
23365746|NCT03225287|65085125|FG000|Overall Study|Subject withdraws consent|3|||
23365747|NCT03225287|65085126|FG001|Overall Study|Subject withdraws consent|0|||
23365748|NCT03225287|65085127|FG002|Overall Study|Subject withdraws consent|0|||
23365749|NCT03225287|65085125|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
23365750|NCT03225287|65085126|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
23365751|NCT03225287|65085127|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
23365752|NCT03225287|65085125|FG000|Overall Study|Trial drug not effective|0|||
23365753|NCT03225287|65085126|FG001|Overall Study|Trial drug not effective|1|||
23365754|NCT03225287|65085127|FG002|Overall Study|Trial drug not effective|0|||
23365755|NCT03225287|65085125|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
23365756|NCT03225287|65085126|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
23365757|NCT03225287|65085127|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
23365758|NCT03225287|65085125|FG000|Overall Study|Stem cell transplantation|0|||
23365759|NCT03225287|65085126|FG001|Overall Study|Stem cell transplantation|1|||
23365760|NCT03225287|65085127|FG002|Overall Study|Stem cell transplantation|0|||
23365761|NCT02486692|65085128|FG000|Overall Study|did not login for randomization|4|||
23365762|NCT02486692|65085129|FG001|Overall Study|did not login for randomization|7|||
23365763|NCT02329847|65085131|FG000|Overall Study|Death|4|||
23365764|NCT02329847|65085132|FG001|Overall Study|Death|4|||
23365765|NCT02329847|65085133|FG002|Overall Study|Death|22|||
23482738|NCT02554279|65509604|FG001|Overall Study|Protocol Violation|1|||
23482739|NCT02554279|65509603|FG000|Overall Study|Other reason|19|||
23482740|NCT02554279|65509604|FG001|Overall Study|Other reason|6|||
23482741|NCT00169442|65509607|FG000|Overall Study|Withdrawal by Subject|0|||
23482742|NCT00169442|65509608|FG001|Overall Study|Withdrawal by Subject|0|||
23482743|NCT00169442|65509609|FG002|Overall Study|Withdrawal by Subject|1|||
23365766|NCT02329847|65085134|FG003|Overall Study|Death|12|||
23365767|NCT02329847|65085135|FG004|Overall Study|Death|20|||
23365768|NCT02329847|65085136|FG005|Overall Study|Death|13|||
23365769|NCT02329847|65085131|FG000|Overall Study|Lost to Follow-up|0|||
23365770|NCT02329847|65085132|FG001|Overall Study|Lost to Follow-up|0|||
23365771|NCT02329847|65085133|FG002|Overall Study|Lost to Follow-up|2|||
23365772|NCT02329847|65085134|FG003|Overall Study|Lost to Follow-up|3|||
23365773|NCT02329847|65085135|FG004|Overall Study|Lost to Follow-up|0|||
23365774|NCT02329847|65085136|FG005|Overall Study|Lost to Follow-up|1|||
23482744|NCT00169442|65509610|FG003|Overall Study|Withdrawal by Subject|0|||
23482745|NCT00169442|65509611|FG004|Overall Study|Withdrawal by Subject|0|||
23482746|NCT00169442|65509612|FG005|Overall Study|Withdrawal by Subject|0|||
23482747|NCT00169442|65509607|FG000|Overall Study|Migrated/moved from study area|0|||
23482748|NCT00169442|65509608|FG001|Overall Study|Migrated/moved from study area|0|||
23482749|NCT00169442|65509609|FG002|Overall Study|Migrated/moved from study area|0|||
23482750|NCT00169442|65509610|FG003|Overall Study|Migrated/moved from study area|0|||
23482751|NCT00169442|65509611|FG004|Overall Study|Migrated/moved from study area|0|||
23482752|NCT00169442|65509612|FG005|Overall Study|Migrated/moved from study area|2|||
23482753|NCT00169442|65509607|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482754|NCT00169442|65509608|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482755|NCT00169442|65509609|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482756|NCT00169442|65509610|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482757|NCT00169442|65509611|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
23482758|NCT00169442|65509612|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
23482759|NCT00169442|65509607|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482760|NCT00169442|65509608|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
23482761|NCT00169442|65509609|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482762|NCT00169442|65509610|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482763|NCT00169442|65509611|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482764|NCT00169442|65509612|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
23482765|NCT03324581|65509613|FG000|Overall Study|Adverse Event|18|||
23482766|NCT03324581|65509614|FG001|Overall Study|Adverse Event|11|||
23482767|NCT03324581|65509615|FG002|Overall Study|Adverse Event|7|||
23482768|NCT03324581|65509613|FG000|Overall Study|Lack of Efficacy|0|||
23482769|NCT03324581|65509614|FG001|Overall Study|Lack of Efficacy|1|||
23482770|NCT03324581|65509615|FG002|Overall Study|Lack of Efficacy|0|||
23482771|NCT03324581|65509613|FG000|Overall Study|Lost to Follow-up|5|||
23482772|NCT03324581|65509614|FG001|Overall Study|Lost to Follow-up|3|||
23482773|NCT03324581|65509615|FG002|Overall Study|Lost to Follow-up|6|||
23482774|NCT03324581|65509613|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
23482775|NCT03324581|65509614|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
23482776|NCT03324581|65509615|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
23482777|NCT03324581|65509613|FG000|Overall Study|Physician Decision|0|||
23482778|NCT03324581|65509614|FG001|Overall Study|Physician Decision|1|||
23482779|NCT03324581|65509615|FG002|Overall Study|Physician Decision|2|||
23482780|NCT03324581|65509613|FG000|Overall Study|Protocol Deviation|8|||
23482781|NCT03324581|65509614|FG001|Overall Study|Protocol Deviation|9|||
23482782|NCT03324581|65509615|FG002|Overall Study|Protocol Deviation|4|||
23482783|NCT03324581|65509613|FG000|Overall Study|Withdrawal by Subject|6|||
23482784|NCT03324581|65509614|FG001|Overall Study|Withdrawal by Subject|8|||
23482785|NCT03324581|65509615|FG002|Overall Study|Withdrawal by Subject|6|||
23482786|NCT03324581|65509613|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
23482787|NCT03324581|65509614|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
23482788|NCT03324581|65509615|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
23482789|NCT00807573|65509616|FG000|Overall Study|Withdrawal by Subject|1|||
23482790|NCT00807573|65509616|FG000|Overall Study|Adverse Event|1|||
23482791|NCT02045303|65509619|FG000|Overall Study|Protocol Violation|2|||
23482792|NCT02045303|65509620|FG001|Overall Study|Protocol Violation|1|||
23482793|NCT02045303|65509621|FG002|Overall Study|Protocol Violation|0|||
23482794|NCT02045303|65509619|FG000|Overall Study|Withdrawal by Subject|0|||
23482795|NCT02045303|65509620|FG001|Overall Study|Withdrawal by Subject|2|||
23482796|NCT02045303|65509621|FG002|Overall Study|Withdrawal by Subject|0|||
23482797|NCT02292784|65509624|FG000|Overall Study|Lost to Follow-up|1|||
23482798|NCT02292784|65509625|FG001|Overall Study|Lost to Follow-up|17|||
23482799|NCT02292784|65509626|FG002|Overall Study|Lost to Follow-up|18|||
23482800|NCT02292784|65509624|FG000|Overall Study|Withdrawal by Subject|0|||
23482801|NCT02292784|65509625|FG001|Overall Study|Withdrawal by Subject|3|||
23482802|NCT02292784|65509626|FG002|Overall Study|Withdrawal by Subject|3|||
23482803|NCT01975831|65509627|FG000|Overall Study|Adverse Event|1|||
23482804|NCT01975831|65509628|FG001|Overall Study|Adverse Event|2|||
23482805|NCT01975831|65509629|FG002|Overall Study|Adverse Event|2|||
23482806|NCT01975831|65509630|FG003|Overall Study|Adverse Event|0|||
23482807|NCT01975831|65509631|FG004|Overall Study|Adverse Event|1|||
23482808|NCT01975831|65509632|FG005|Overall Study|Adverse Event|1|||
23482809|NCT01975831|65509633|FG006|Overall Study|Adverse Event|3|||
23482810|NCT01975831|65509634|FG007|Overall Study|Adverse Event|4|||
23482811|NCT01975831|65509635|FG008|Overall Study|Adverse Event|1|||
23482812|NCT01975831|65509627|FG000|Overall Study|Death|1|||
23482813|NCT01975831|65509628|FG001|Overall Study|Death|1|||
23482814|NCT01975831|65509629|FG002|Overall Study|Death|0|||
23482815|NCT01975831|65509630|FG003|Overall Study|Death|0|||
23482816|NCT01975831|65509631|FG004|Overall Study|Death|1|||
23482817|NCT01975831|65509632|FG005|Overall Study|Death|0|||
23482818|NCT01975831|65509633|FG006|Overall Study|Death|1|||
23482819|NCT01975831|65509634|FG007|Overall Study|Death|0|||
23482820|NCT01975831|65509635|FG008|Overall Study|Death|0|||
23482821|NCT01975831|65509627|FG000|Overall Study|Progressive Disease|1|||
23482822|NCT01975831|65509628|FG001|Overall Study|Progressive Disease|3|||
23482823|NCT01975831|65509629|FG002|Overall Study|Progressive Disease|2|||
23482824|NCT01975831|65509630|FG003|Overall Study|Progressive Disease|4|||
23482825|NCT01975831|65509631|FG004|Overall Study|Progressive Disease|13|||
23482826|NCT01975831|65509632|FG005|Overall Study|Progressive Disease|9|||
23482827|NCT01975831|65509633|FG006|Overall Study|Progressive Disease|10|||
23482828|NCT01975831|65509634|FG007|Overall Study|Progressive Disease|8|||
23482829|NCT01975831|65509635|FG008|Overall Study|Progressive Disease|10|||
23482830|NCT01975831|65509627|FG000|Overall Study|Withdrawal by Subject|0|||
23482831|NCT01975831|65509628|FG001|Overall Study|Withdrawal by Subject|3|||
23482832|NCT01975831|65509629|FG002|Overall Study|Withdrawal by Subject|0|||
23482833|NCT01975831|65509630|FG003|Overall Study|Withdrawal by Subject|0|||
23482834|NCT01975831|65509631|FG004|Overall Study|Withdrawal by Subject|3|||
23482835|NCT01975831|65509632|FG005|Overall Study|Withdrawal by Subject|1|||
23269882|NCT00880568|64731867|FG003|Overall Study|Withdrawal by Subject|0|||
23269883|NCT00880568|64731868|FG004|Overall Study|Withdrawal by Subject|0|||
23269884|NCT00880568|64731869|FG005|Overall Study|Withdrawal by Subject|0|||
23269885|NCT00880568|64731870|FG006|Overall Study|Withdrawal by Subject|0|||
23269886|NCT00880568|64731871|FG007|Overall Study|Withdrawal by Subject|1|||
23269887|NCT00880568|64731872|FG008|Overall Study|Withdrawal by Subject|0|||
23269888|NCT01790568|64731873|FG000|Overall Study|Progression prior to transplant|0|||
23269889|NCT01790568|64731874|FG001|Overall Study|Progression prior to transplant|1|||
23269890|NCT02216071|64731877|FG000|Overall Study|Withdrawal by Subject|7|||
23269891|NCT02216071|64731878|FG001|Overall Study|Withdrawal by Subject|2|||
23269892|NCT02216071|64731877|FG000|Overall Study|Lost to Follow-up|3|||
23269893|NCT02216071|64731878|FG001|Overall Study|Lost to Follow-up|3|||
23269894|NCT02216071|64731877|FG000|Overall Study|Protocol Violation|3|||
23269895|NCT02216071|64731878|FG001|Overall Study|Protocol Violation|5|||
23269896|NCT02216071|64731877|FG000|Overall Study|Other|2|||
23269897|NCT02216071|64731878|FG001|Overall Study|Other|2|||
23269898|NCT01239121|64731881|FG000|Overall Study|Withdrawal by Subject|2|||
23269899|NCT01239121|64731882|FG001|Overall Study|Withdrawal by Subject|4|||
23269900|NCT01239121|64731883|FG002|Overall Study|Withdrawal by Subject|0|||
23269901|NCT01619800|64731889|FG000|Overall Study|study terminated|2|||
23269902|NCT01619800|64731890|FG001|Overall Study|study terminated|0|||
23269903|NCT04646109|64731891|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
23269904|NCT04646109|64731892|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
23269905|NCT04188106|64731893|FG000|Overall Study|Lost to Follow-up|5|||
23269906|NCT04188106|64731893|FG000|Overall Study|Non-Compliance|1|||
23269907|NCT03127137|64731895|FG000|Overall Study|Requested sedation after consent|1|||
23269908|NCT03127137|64731896|FG001|Overall Study|Requested sedation after consent|0|||
23269909|NCT03127137|64731895|FG000|Overall Study|Malfunction in electronic data collection|1|||
23269910|NCT03127137|64731896|FG001|Overall Study|Malfunction in electronic data collection|0|||
23269911|NCT03127137|64731895|FG000|Overall Study|Post procedure testing could not be obtained|0|||
23269912|NCT03127137|64731896|FG001|Overall Study|Post procedure testing could not be obtained|1|||
23269913|NCT02194998|64731897|FG000|On-HCV Treatment|Did not pick up study medication|0|||
23482836|NCT01975831|65509633|FG006|Overall Study|Withdrawal by Subject|1|||
23482837|NCT01975831|65509634|FG007|Overall Study|Withdrawal by Subject|0|||
23482838|NCT01975831|65509635|FG008|Overall Study|Withdrawal by Subject|0|||
23482839|NCT01975831|65509627|FG000|Overall Study|Physician Decision|0|||
23482840|NCT01975831|65509628|FG001|Overall Study|Physician Decision|0|||
23482841|NCT01975831|65509629|FG002|Overall Study|Physician Decision|0|||
23482842|NCT01975831|65509630|FG003|Overall Study|Physician Decision|0|||
23482843|NCT01975831|65509631|FG004|Overall Study|Physician Decision|0|||
23482844|NCT01975831|65509632|FG005|Overall Study|Physician Decision|1|||
23482845|NCT01975831|65509633|FG006|Overall Study|Physician Decision|0|||
23482846|NCT01975831|65509634|FG007|Overall Study|Physician Decision|1|||
23482847|NCT01975831|65509635|FG008|Overall Study|Physician Decision|0|||
23482848|NCT01975831|65509627|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
23482849|NCT01975831|65509628|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
23482850|NCT01975831|65509629|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
23482851|NCT01975831|65509630|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
23482852|NCT01975831|65509631|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
23482853|NCT01975831|65509632|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
23482854|NCT01975831|65509633|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
23482855|NCT01975831|65509634|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
23482856|NCT01975831|65509635|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
23482857|NCT01975831|65509627|FG000|Overall Study|Entered Hospice|0|||
23482858|NCT01975831|65509628|FG001|Overall Study|Entered Hospice|0|||
23482859|NCT01975831|65509629|FG002|Overall Study|Entered Hospice|0|||
23269914|NCT02194998|64731898|FG001|On-HCV Treatment|Did not pick up study medication|1|||
23269915|NCT02194998|64731899|FG002|On-HCV Treatment|Did not pick up study medication|0|||
23269916|NCT02194998|64731900|FG003|On-HCV Treatment|Did not pick up study medication|0|||
23269917|NCT02194998|64731897|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
23482860|NCT01975831|65509630|FG003|Overall Study|Entered Hospice|0|||
23482861|NCT01975831|65509631|FG004|Overall Study|Entered Hospice|0|||
23482862|NCT01975831|65509632|FG005|Overall Study|Entered Hospice|1|||
23482863|NCT01975831|65509633|FG006|Overall Study|Entered Hospice|0|||
23482864|NCT01975831|65509634|FG007|Overall Study|Entered Hospice|0|||
23482865|NCT01975831|65509635|FG008|Overall Study|Entered Hospice|0|||
23482866|NCT01975831|65509627|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482867|NCT01975831|65509628|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482868|NCT01975831|65509629|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482869|NCT01975831|65509630|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482870|NCT01975831|65509631|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482871|NCT01975831|65509632|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482872|NCT01975831|65509633|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
23482873|NCT01975831|65509634|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
23482874|NCT01975831|65509635|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
23482875|NCT00588952|65509637|FG000|Overall Study|Adverse Event|0|||
23482876|NCT00588952|65509638|FG001|Overall Study|Adverse Event|2|||
23482877|NCT00588952|65509637|FG000|Overall Study|Withdrawal by Subject|3|||
23482878|NCT00588952|65509638|FG001|Overall Study|Withdrawal by Subject|5|||
23482879|NCT01226121|65509642|FG000|Overall Study|Lost to Follow-up|2|||
23482880|NCT01226121|65509643|FG001|Overall Study|Lost to Follow-up|0|||
23482881|NCT01226121|65509644|FG002|Overall Study|Lost to Follow-up|1|||
23482882|NCT00973349|65509647|FG000|Overall Study|Adverse Event|0|||
23482883|NCT00973349|65509648|FG001|Overall Study|Adverse Event|0|||
23482884|NCT00973349|65509649|FG002|Overall Study|Adverse Event|0|||
23482885|NCT00973349|65509650|FG003|Overall Study|Adverse Event|0|||
23482886|NCT00973349|65509651|FG004|Overall Study|Adverse Event|1|||
23482887|NCT00973349|65509652|FG005|Overall Study|Adverse Event|0|||
23482888|NCT00973349|65509653|FG006|Overall Study|Adverse Event|0|||
23482889|NCT00973349|65509654|FG007|Overall Study|Adverse Event|0|||
23482890|NCT00973349|65509655|FG008|Overall Study|Adverse Event|1|||
23482891|NCT00973349|65509656|FG009|Overall Study|Adverse Event|0|||
23482892|NCT00973349|65509657|FG010|Overall Study|Adverse Event|0|||
23482893|NCT00973349|65509658|FG011|Overall Study|Adverse Event|0|||
23482894|NCT00973349|65509659|FG012|Overall Study|Adverse Event|0|||
23482895|NCT00973349|65509660|FG013|Overall Study|Adverse Event|0|||
23482896|NCT00973349|65509661|FG014|Overall Study|Adverse Event|1|||
23482897|NCT00973349|65509662|FG015|Overall Study|Adverse Event|0|||
23482898|NCT00973349|65509647|FG000|Overall Study|Withdrawal by Subject|1|||
23482899|NCT00973349|65509648|FG001|Overall Study|Withdrawal by Subject|2|||
23482900|NCT00973349|65509649|FG002|Overall Study|Withdrawal by Subject|2|||
23482901|NCT00973349|65509650|FG003|Overall Study|Withdrawal by Subject|3|||
23482902|NCT00973349|65509651|FG004|Overall Study|Withdrawal by Subject|2|||
23482903|NCT00973349|65509652|FG005|Overall Study|Withdrawal by Subject|0|||
23482904|NCT00973349|65509653|FG006|Overall Study|Withdrawal by Subject|2|||
23482905|NCT00973349|65509654|FG007|Overall Study|Withdrawal by Subject|2|||
23482906|NCT00973349|65509655|FG008|Overall Study|Withdrawal by Subject|0|||
23482907|NCT00973349|65509656|FG009|Overall Study|Withdrawal by Subject|2|||
23482908|NCT00973349|65509657|FG010|Overall Study|Withdrawal by Subject|0|||
23482909|NCT00973349|65509658|FG011|Overall Study|Withdrawal by Subject|1|||
23482910|NCT00973349|65509659|FG012|Overall Study|Withdrawal by Subject|0|||
23482911|NCT00973349|65509660|FG013|Overall Study|Withdrawal by Subject|0|||
23482912|NCT00973349|65509661|FG014|Overall Study|Withdrawal by Subject|0|||
23482913|NCT00973349|65509662|FG015|Overall Study|Withdrawal by Subject|0|||
23482914|NCT00973349|65509647|FG000|Overall Study|Lost to Follow-up|3|||
23482915|NCT00973349|65509648|FG001|Overall Study|Lost to Follow-up|1|||
23482916|NCT00973349|65509649|FG002|Overall Study|Lost to Follow-up|2|||
23482917|NCT00973349|65509650|FG003|Overall Study|Lost to Follow-up|2|||
23482918|NCT00973349|65509651|FG004|Overall Study|Lost to Follow-up|1|||
23482919|NCT00973349|65509652|FG005|Overall Study|Lost to Follow-up|3|||
23482920|NCT00973349|65509653|FG006|Overall Study|Lost to Follow-up|0|||
23482921|NCT00973349|65509654|FG007|Overall Study|Lost to Follow-up|1|||
23482922|NCT00973349|65509655|FG008|Overall Study|Lost to Follow-up|2|||
23482923|NCT00973349|65509656|FG009|Overall Study|Lost to Follow-up|1|||
23601738|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
23601739|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
23482924|NCT00973349|65509657|FG010|Overall Study|Lost to Follow-up|0|||
23482925|NCT00973349|65509658|FG011|Overall Study|Lost to Follow-up|1|||
23482926|NCT00973349|65509659|FG012|Overall Study|Lost to Follow-up|0|||
23482927|NCT00973349|65509660|FG013|Overall Study|Lost to Follow-up|0|||
23482928|NCT00973349|65509661|FG014|Overall Study|Lost to Follow-up|0|||
23482929|NCT00973349|65509662|FG015|Overall Study|Lost to Follow-up|1|||
23482930|NCT00973349|65509647|FG000|Overall Study|Inappropriate enrolment|0|||
23482931|NCT00973349|65509648|FG001|Overall Study|Inappropriate enrolment|0|||
23482932|NCT00973349|65509649|FG002|Overall Study|Inappropriate enrolment|1|||
23482933|NCT00973349|65509650|FG003|Overall Study|Inappropriate enrolment|0|||
23482934|NCT00973349|65509651|FG004|Overall Study|Inappropriate enrolment|0|||
23482935|NCT00973349|65509652|FG005|Overall Study|Inappropriate enrolment|0|||
23482936|NCT00973349|65509653|FG006|Overall Study|Inappropriate enrolment|0|||
23482937|NCT00973349|65509654|FG007|Overall Study|Inappropriate enrolment|0|||
23482938|NCT00973349|65509655|FG008|Overall Study|Inappropriate enrolment|0|||
23482939|NCT00973349|65509656|FG009|Overall Study|Inappropriate enrolment|2|||
23482940|NCT00973349|65509657|FG010|Overall Study|Inappropriate enrolment|0|||
23482941|NCT00973349|65509658|FG011|Overall Study|Inappropriate enrolment|0|||
23482942|NCT00973349|65509659|FG012|Overall Study|Inappropriate enrolment|1|||
23482943|NCT00973349|65509660|FG013|Overall Study|Inappropriate enrolment|0|||
23482944|NCT00973349|65509661|FG014|Overall Study|Inappropriate enrolment|1|||
23482945|NCT00973349|65509662|FG015|Overall Study|Inappropriate enrolment|1|||
23482946|NCT00973349|65509647|FG000|Overall Study|Protocol Violation|0|||
23482947|NCT00973349|65509648|FG001|Overall Study|Protocol Violation|0|||
23482948|NCT00973349|65509649|FG002|Overall Study|Protocol Violation|0|||
23482949|NCT00973349|65509650|FG003|Overall Study|Protocol Violation|0|||
23482950|NCT00973349|65509651|FG004|Overall Study|Protocol Violation|0|||
23482951|NCT00973349|65509652|FG005|Overall Study|Protocol Violation|0|||
23482952|NCT00973349|65509653|FG006|Overall Study|Protocol Violation|0|||
23482953|NCT00973349|65509654|FG007|Overall Study|Protocol Violation|0|||
23482954|NCT00973349|65509655|FG008|Overall Study|Protocol Violation|1|||
23482955|NCT00973349|65509656|FG009|Overall Study|Protocol Violation|0|||
23482956|NCT00973349|65509657|FG010|Overall Study|Protocol Violation|0|||
23482957|NCT00973349|65509658|FG011|Overall Study|Protocol Violation|0|||
23482958|NCT00973349|65509659|FG012|Overall Study|Protocol Violation|0|||
23482959|NCT00973349|65509660|FG013|Overall Study|Protocol Violation|0|||
23482960|NCT00973349|65509661|FG014|Overall Study|Protocol Violation|0|||
23482961|NCT00973349|65509662|FG015|Overall Study|Protocol Violation|0|||
23482962|NCT00973349|65509647|FG000|Overall Study|Unable to classify|0|||
23482963|NCT00973349|65509648|FG001|Overall Study|Unable to classify|0|||
23482964|NCT00973349|65509649|FG002|Overall Study|Unable to classify|0|||
23482965|NCT00973349|65509650|FG003|Overall Study|Unable to classify|0|||
23482966|NCT00973349|65509651|FG004|Overall Study|Unable to classify|1|||
23482967|NCT00973349|65509652|FG005|Overall Study|Unable to classify|1|||
23482968|NCT00973349|65509653|FG006|Overall Study|Unable to classify|0|||
23482969|NCT00973349|65509654|FG007|Overall Study|Unable to classify|0|||
23482970|NCT00973349|65509655|FG008|Overall Study|Unable to classify|0|||
23482971|NCT00973349|65509656|FG009|Overall Study|Unable to classify|1|||
23482972|NCT00973349|65509657|FG010|Overall Study|Unable to classify|0|||
23482973|NCT00973349|65509658|FG011|Overall Study|Unable to classify|0|||
23482974|NCT00973349|65509659|FG012|Overall Study|Unable to classify|0|||
23482975|NCT00973349|65509660|FG013|Overall Study|Unable to classify|0|||
23482976|NCT00973349|65509661|FG014|Overall Study|Unable to classify|0|||
23482977|NCT00973349|65509662|FG015|Overall Study|Unable to classify|0|||
23482978|NCT00821509|65509663|FG000|Overall Study|Withdrawal by Subject|12|||
23482979|NCT00821509|65509664|FG001|Overall Study|Withdrawal by Subject|11|||
23482980|NCT00821509|65509665|FG002|Overall Study|Withdrawal by Subject|34|||
23482981|NCT00769483|65509666|FG000|Overall Study|Withdrawal by Subject|0|||
23482982|NCT00769483|65509667|FG001|Overall Study|Withdrawal by Subject|1|||
23482983|NCT00769483|65509668|FG002|Overall Study|Withdrawal by Subject|0|||
23482984|NCT00769483|65509669|FG003|Overall Study|Withdrawal by Subject|0|||
23482985|NCT00769483|65509670|FG004|Overall Study|Withdrawal by Subject|1|||
23482986|NCT00769483|65509671|FG005|Overall Study|Withdrawal by Subject|0|||
23482987|NCT03828370|65512864|FG000|3 Month Follow-up|Lost to Follow-up|4|||
23482988|NCT03828370|65512865|FG001|3 Month Follow-up|Lost to Follow-up|12|||
23482989|NCT03828370|65512864|FG000|9 Month Follow up|Lost to Follow-up|12|||
23482990|NCT03828370|65512865|FG001|9 Month Follow up|Lost to Follow-up|20|||
23482991|NCT01565499|65512869|FG000|Overall Study|Physician Decision|1|||
23482992|NCT01565499|65512869|FG000|Overall Study|Adverse Event|5|||
23482993|NCT01565499|65512869|FG000|Overall Study|Withdrawal by Subject|2|||
23482994|NCT01150474|65512874|FG000|Overall Study|Withdrawal by Subject|5|||
23482995|NCT01150474|65512875|FG001|Overall Study|Withdrawal by Subject|2|||
23482996|NCT01150474|65512874|FG000|Overall Study|Cancer found|1|||
23482997|NCT01150474|65512875|FG001|Overall Study|Cancer found|0|||
23482998|NCT01150474|65512874|FG000|Overall Study|Multiple Studies|0|||
23482999|NCT01150474|65512875|FG001|Overall Study|Multiple Studies|1|||
23601740|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
23483000|NCT01150474|65512874|FG000|Overall Study|Rectotomy|1|||
23483001|NCT01150474|65512875|FG001|Overall Study|Rectotomy|0|||
23483002|NCT01150474|65512874|FG000|Overall Study|Drug did not arrive in time|1|||
23483003|NCT01150474|65512875|FG001|Overall Study|Drug did not arrive in time|0|||
23483004|NCT01150474|65512874|FG000|Overall Study|Drug not administered|1|||
23483005|NCT01150474|65512875|FG001|Overall Study|Drug not administered|0|||
23483006|NCT01150474|65512874|FG000|Overall Study|Surgery Changed|1|||
23601741|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
23483007|NCT01150474|65512875|FG001|Overall Study|Surgery Changed|0|||
23483008|NCT01214174|65512876|FG000|Overall Study|Withdrawal by Subject|0|||
23483009|NCT01214174|65512877|FG001|Overall Study|Withdrawal by Subject|0|||
23483010|NCT01214174|65512878|FG002|Overall Study|Withdrawal by Subject|1|||
23601742|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
23483011|NCT02927067|65512881|FG000|Overall Study|Withdrawn Consent|20|||
23483012|NCT02927067|65512882|FG001|Overall Study|Withdrawn Consent|12|||
23483013|NCT02927067|65512881|FG000|Overall Study|Death|18|||
23483014|NCT02927067|65512882|FG001|Overall Study|Death|31|||
23483015|NCT02927067|65512881|FG000|Overall Study|Adverse Event|13|||
23483016|NCT02927067|65512882|FG001|Overall Study|Adverse Event|10|||
23483017|NCT02927067|65512881|FG000|Overall Study|Noncompliance|5|||
23483018|NCT02927067|65512882|FG001|Overall Study|Noncompliance|2|||
23483019|NCT02927067|65512881|FG000|Overall Study|Reason not Specified|4|||
23483020|NCT02927067|65512882|FG001|Overall Study|Reason not Specified|6|||
23483021|NCT01101191|65512883|FG000|Period 1|Withdrawal by Subject|1|||
23483022|NCT01101191|65512884|FG001|Period 1|Withdrawal by Subject|0|||
23483023|NCT01101191|65512883|FG000|Period 1|Adverse Event|1|||
23483024|NCT01101191|65512884|FG001|Period 1|Adverse Event|2|||
23483025|NCT02195687|65512885|FG000|Overall Study|Personal Reasons|1|||
23483026|NCT02195687|65512886|FG001|Overall Study|Personal Reasons|1|||
23483027|NCT02195687|65512885|FG000|Overall Study|Lost to Follow-up|4|||
23483028|NCT02195687|65512886|FG001|Overall Study|Lost to Follow-up|1|||
23483029|NCT00136604|65512887|FG000|Overall Study|Lost to Follow-up|1|||
23483030|NCT00136604|65512888|FG001|Overall Study|Lost to Follow-up|0|||
23483031|NCT00136604|65512889|FG002|Overall Study|Lost to Follow-up|0|||
23483032|NCT00136604|65512890|FG003|Overall Study|Lost to Follow-up|0|||
23483033|NCT00136604|65512891|FG004|Overall Study|Lost to Follow-up|1|||
23483034|NCT00136604|65512887|FG000|Overall Study|Migrated/moved from study area|0|||
23483035|NCT00136604|65512888|FG001|Overall Study|Migrated/moved from study area|1|||
23483036|NCT00136604|65512889|FG002|Overall Study|Migrated/moved from study area|0|||
23483037|NCT00136604|65512890|FG003|Overall Study|Migrated/moved from study area|0|||
23483038|NCT00136604|65512891|FG004|Overall Study|Migrated/moved from study area|0|||
23483039|NCT01751802|65512896|FG000|Overall Study|Adverse Event|4|||
23483040|NCT01751802|65512897|FG001|Overall Study|Adverse Event|2|||
23483041|NCT01850602|65512898|FG000|Overall Study|Adverse Event|7|||
23483042|NCT01850602|65512899|FG001|Overall Study|Adverse Event|10|||
23483043|NCT01850602|65512898|FG000|Overall Study|Physician Decision|2|||
23483044|NCT01850602|65512899|FG001|Overall Study|Physician Decision|1|||
23483045|NCT01850602|65512898|FG000|Overall Study|Withdrawal by Subject|2|||
23483046|NCT01850602|65512899|FG001|Overall Study|Withdrawal by Subject|4|||
23483047|NCT01850602|65512898|FG000|Overall Study|Decrease in serum calcium|2|||
23483048|NCT01850602|65512899|FG001|Overall Study|Decrease in serum calcium|3|||
23483049|NCT01850602|65512898|FG000|Overall Study|Increase in serum ferritin|1|||
23483050|NCT01850602|65512899|FG001|Overall Study|Increase in serum ferritin|0|||
23483051|NCT02021656|65512900|FG000|Overall Study|Adverse Event|1|||
23483052|NCT02021656|65512900|FG000|Overall Study|Lack of Efficacy|2|||
23483053|NCT02021656|65512900|FG000|Overall Study|Lost to Follow-up|1|||
23483054|NCT02021656|65512900|FG000|Overall Study|Withdrew Consent|2|||
23483055|NCT00719264|65512901|FG000|Overall Study|Adverse Event|41|||
23483056|NCT00719264|65512902|FG001|Overall Study|Adverse Event|49|||
23483057|NCT00719264|65512901|FG000|Overall Study|Death|13|||
23483058|NCT00719264|65512902|FG001|Overall Study|Death|10|||
23483059|NCT00719264|65512901|FG000|Overall Study|Administrative Problems|6|||
23483060|NCT00719264|65512902|FG001|Overall Study|Administrative Problems|4|||
23483061|NCT00719264|65512901|FG000|Overall Study|Lost to Follow-up|1|||
23483062|NCT00719264|65512902|FG001|Overall Study|Lost to Follow-up|1|||
23483063|NCT00719264|65512901|FG000|Overall Study|Withdrawal by Subject|12|||
23483064|NCT00719264|65512902|FG001|Overall Study|Withdrawal by Subject|7|||
23269918|NCT02194998|64731898|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
23269919|NCT02194998|64731899|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
23269920|NCT02194998|64731900|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
23269921|NCT04657770|64731901|FG000|Overall Study|Withdrawal by Subject|3|||
23269922|NCT04657770|64731901|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
23269923|NCT02924038|64731906|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
23269924|NCT02924038|64731907|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
23269925|NCT00762086|64731908|FG000|Overall Study|Adverse Event|2|||
23269926|NCT00762086|64731909|FG001|Overall Study|Adverse Event|0|||
23269927|NCT00762086|64731908|FG000|Overall Study|Lost to Follow-up|0|||
23269928|NCT00762086|64731909|FG001|Overall Study|Lost to Follow-up|2|||
23483065|NCT00719264|65512901|FG000|Overall Study|Protocol Deviation|1|||
23483066|NCT00719264|65512902|FG001|Overall Study|Protocol Deviation|3|||
23483067|NCT00719264|65512901|FG000|Overall Study|New Cancer Therapy|4|||
23483068|NCT00719264|65512902|FG001|Overall Study|New Cancer Therapy|2|||
23483069|NCT00719264|65512901|FG000|Overall Study|Disease Progression|104|||
23269929|NCT00762086|64731908|FG000|Overall Study|Non compliance|1|||
23483070|NCT00719264|65512902|FG001|Overall Study|Disease Progression|107|||
23483071|NCT01894568|65512903|FG000|Overall Study|Adverse Event|2|||
23483072|NCT01894568|65512904|FG001|Overall Study|Adverse Event|3|||
23483073|NCT01894568|65512903|FG000|Overall Study|Protocol required discontinuation|2|||
23483074|NCT01894568|65512904|FG001|Overall Study|Protocol required discontinuation|1|||
23483075|NCT01894568|65512903|FG000|Overall Study|Withdrawal by Subject|5|||
23483076|NCT01894568|65512904|FG001|Overall Study|Withdrawal by Subject|5|||
23483077|NCT01894568|65512903|FG000|Overall Study|Physician Decision|1|||
23483078|NCT01894568|65512904|FG001|Overall Study|Physician Decision|0|||
23483079|NCT01894568|65512903|FG000|Overall Study|Lost to Follow-up|0|||
23483080|NCT01894568|65512904|FG001|Overall Study|Lost to Follow-up|1|||
23483081|NCT01923168|65512906|FG000|Overall Study|Protocol Violation|1|||
23483082|NCT01923168|65512907|FG001|Overall Study|Protocol Violation|1|||
23483083|NCT01923168|65512908|FG002|Overall Study|Protocol Violation|0|||
23483084|NCT01923168|65512906|FG000|Overall Study|Subject/guardian decision|14|||
23483085|NCT01923168|65512907|FG001|Overall Study|Subject/guardian decision|14|||
23483086|NCT01923168|65512908|FG002|Overall Study|Subject/guardian decision|4|||
23483087|NCT01923168|65512906|FG000|Overall Study|Adverse Event|12|||
23483088|NCT01923168|65512907|FG001|Overall Study|Adverse Event|12|||
23483089|NCT01923168|65512908|FG002|Overall Study|Adverse Event|0|||
23483090|NCT01923168|65512906|FG000|Overall Study|Physician Decision|6|||
23483091|NCT01923168|65512907|FG001|Overall Study|Physician Decision|9|||
23483092|NCT01923168|65512908|FG002|Overall Study|Physician Decision|5|||
23483093|NCT01923168|65512906|FG000|Overall Study|Progressive disease|4|||
23483094|NCT01923168|65512907|FG001|Overall Study|Progressive disease|3|||
23483095|NCT01923168|65512908|FG002|Overall Study|Progressive disease|7|||
23483096|NCT01923168|65512906|FG000|Overall Study|Death|0|||
23483097|NCT01923168|65512907|FG001|Overall Study|Death|0|||
23483098|NCT01923168|65512908|FG002|Overall Study|Death|1|||
23483099|NCT01854944|65512909|FG000|Overall Study|Withdrawal by Subject|0|||
23483100|NCT01854944|65512910|FG001|Overall Study|Withdrawal by Subject|0|||
23269930|NCT00762086|64731909|FG001|Overall Study|Non compliance|0|||
23269931|NCT00762086|64731908|FG000|Overall Study|Withdrawal by Subject|2|||
23269932|NCT00762086|64731909|FG001|Overall Study|Withdrawal by Subject|2|||
23269933|NCT00762086|64731908|FG000|Overall Study|Ineligible to participate in the study|1|||
23269934|NCT00762086|64731909|FG001|Overall Study|Ineligible to participate in the study|0|||
23269935|NCT04786184|64731910|FG000|Overall Study|Adverse Event|4|||
23269936|NCT04786184|64731911|FG001|Overall Study|Adverse Event|0|||
23269937|NCT04786184|64731910|FG000|Overall Study|Withdrawal by Subject|3|||
23269938|NCT04786184|64731911|FG001|Overall Study|Withdrawal by Subject|1|||
23269939|NCT04786184|64731910|FG000|Overall Study|Lost to Follow-up|4|||
23269940|NCT04786184|64731911|FG001|Overall Study|Lost to Follow-up|2|||
23269941|NCT00755196|64731913|FG000|Overall Study|Lost to Follow-up|1|||
23483101|NCT01854944|65512911|FG002|Overall Study|Withdrawal by Subject|1|||
23483102|NCT05070546|65512912|FG000|Overall Study|Death|0|||
23483103|NCT05070546|65512913|FG001|Overall Study|Death|0|||
23483104|NCT05070546|65512914|FG002|Overall Study|Death|0|||
23483105|NCT05070546|65512915|FG003|Overall Study|Death|0|||
23483106|NCT05070546|65512916|FG004|Overall Study|Death|0|||
23483107|NCT05070546|65512917|FG005|Overall Study|Death|1|||
23483108|NCT05070546|65512912|FG000|Overall Study|Lost to Follow-up|8|||
23483109|NCT05070546|65512913|FG001|Overall Study|Lost to Follow-up|2|||
23483110|NCT05070546|65512914|FG002|Overall Study|Lost to Follow-up|7|||
23483111|NCT05070546|65512915|FG003|Overall Study|Lost to Follow-up|1|||
23483112|NCT05070546|65512916|FG004|Overall Study|Lost to Follow-up|2|||
23483113|NCT05070546|65512917|FG005|Overall Study|Lost to Follow-up|0|||
23483114|NCT05070546|65512912|FG000|Overall Study|Withdrawal by Subject|1|||
23483115|NCT05070546|65512913|FG001|Overall Study|Withdrawal by Subject|1|||
23269942|NCT00755196|64731913|FG000|Overall Study|Lack of Efficiency|1|||
23269943|NCT03730103|64731916|FG000|Overall Study|Did not meet inclusion criteria|0|||
23269944|NCT03730103|64731917|FG001|Overall Study|Did not meet inclusion criteria|5|||
23269945|NCT03338972|64731918|FG000|Overall Study|Death|1|||
23269946|NCT03338972|64731919|FG001|Overall Study|Death|1|||
23269947|NCT03338972|64731920|FG002|Overall Study|Death|0|||
23269948|NCT03338972|64731921|FG003|Overall Study|Death|0|||
23483116|NCT05070546|65512914|FG002|Overall Study|Withdrawal by Subject|3|||
23483117|NCT05070546|65512915|FG003|Overall Study|Withdrawal by Subject|0|||
23483118|NCT05070546|65512916|FG004|Overall Study|Withdrawal by Subject|0|||
23601743|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
23601744|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
23601745|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
23601746|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
23601747|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
23601748|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
23601749|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
23601750|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
23601751|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
23601752|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
23269949|NCT03338972|64731918|FG000|Overall Study|Withdrawal by Subject|1|||
23269950|NCT03338972|64731919|FG001|Overall Study|Withdrawal by Subject|0|||
23269951|NCT03338972|64731920|FG002|Overall Study|Withdrawal by Subject|0|||
23483119|NCT05070546|65512917|FG005|Overall Study|Withdrawal by Subject|0|||
23483120|NCT05070546|65512912|FG000|Overall Study|Other|0|||
23483121|NCT05070546|65512913|FG001|Overall Study|Other|0|||
23483122|NCT05070546|65512914|FG002|Overall Study|Other|0|||
23483123|NCT05070546|65512915|FG003|Overall Study|Other|0|||
23483124|NCT05070546|65512916|FG004|Overall Study|Other|3|||
23483125|NCT05070546|65512917|FG005|Overall Study|Other|0|||
23483126|NCT05070546|65512912|FG000|Overall Study|Randomized but not vaccinated|1|||
23483127|NCT05070546|65512913|FG001|Overall Study|Randomized but not vaccinated|0|||
23483128|NCT05070546|65512914|FG002|Overall Study|Randomized but not vaccinated|1|||
23269952|NCT03338972|64731921|FG003|Overall Study|Withdrawal by Subject|0|||
23269953|NCT02495857|64731922|FG000|Overall Study|Adverse Event|5|||
23269954|NCT02495857|64731923|FG001|Overall Study|Adverse Event|0|||
23365775|NCT02329847|65085131|FG000|Overall Study|Physician Decision|0|||
23365776|NCT02329847|65085132|FG001|Overall Study|Physician Decision|0|||
23365777|NCT02329847|65085133|FG002|Overall Study|Physician Decision|0|||
23365778|NCT02329847|65085134|FG003|Overall Study|Physician Decision|0|||
23365779|NCT02329847|65085135|FG004|Overall Study|Physician Decision|1|||
23365780|NCT02329847|65085136|FG005|Overall Study|Physician Decision|0|||
23365781|NCT02329847|65085131|FG000|Overall Study|Withdrawal by Subject|2|||
23365782|NCT02329847|65085132|FG001|Overall Study|Withdrawal by Subject|1|||
23365783|NCT02329847|65085133|FG002|Overall Study|Withdrawal by Subject|5|||
23365784|NCT02329847|65085134|FG003|Overall Study|Withdrawal by Subject|7|||
23365785|NCT02329847|65085135|FG004|Overall Study|Withdrawal by Subject|8|||
23365786|NCT02329847|65085136|FG005|Overall Study|Withdrawal by Subject|3|||
23365787|NCT02329847|65085131|FG000|Overall Study|Other|1|||
23365788|NCT02329847|65085132|FG001|Overall Study|Other|2|||
23365789|NCT02329847|65085133|FG002|Overall Study|Other|6|||
23269955|NCT02495857|64731924|FG002|Overall Study|Adverse Event|1|||
23269956|NCT02495857|64731922|FG000|Overall Study|Withdrawal by Subject|9|||
23269957|NCT02495857|64731923|FG001|Overall Study|Withdrawal by Subject|6|||
23269958|NCT02495857|64731924|FG002|Overall Study|Withdrawal by Subject|10|||
23269959|NCT02495857|64731922|FG000|Overall Study|Physician Decision|0|||
23269960|NCT02495857|64731923|FG001|Overall Study|Physician Decision|1|||
23269961|NCT02495857|64731924|FG002|Overall Study|Physician Decision|0|||
23269962|NCT02495857|64731922|FG000|Overall Study|Protocol Violation|1|||
23269963|NCT02495857|64731923|FG001|Overall Study|Protocol Violation|1|||
23269964|NCT02495857|64731924|FG002|Overall Study|Protocol Violation|2|||
23269965|NCT02495857|64731922|FG000|Overall Study|Lost to Follow-up|4|||
23269966|NCT02495857|64731923|FG001|Overall Study|Lost to Follow-up|5|||
23269967|NCT02495857|64731924|FG002|Overall Study|Lost to Follow-up|3|||
23269968|NCT02495857|64731922|FG000|Overall Study|Other|3|||
23269969|NCT02495857|64731923|FG001|Overall Study|Other|3|||
23269970|NCT02495857|64731924|FG002|Overall Study|Other|2|||
23269971|NCT00406848|64731927|FG000|Overall Study|Withdrawal by Subject|27|||
23269972|NCT00406848|64731928|FG001|Overall Study|Withdrawal by Subject|22|||
23269973|NCT00406848|64731927|FG000|Overall Study|Adverse Event|38|||
23269974|NCT00406848|64731928|FG001|Overall Study|Adverse Event|7|||
23269975|NCT00406848|64731927|FG000|Overall Study|Lack of Efficacy|9|||
23269976|NCT00406848|64731928|FG001|Overall Study|Lack of Efficacy|14|||
23269977|NCT00406848|64731927|FG000|Overall Study|Protocol Violation|10|||
23269978|NCT00406848|64731928|FG001|Overall Study|Protocol Violation|6|||
23269979|NCT00406848|64731927|FG000|Overall Study|Lost to Follow-up|6|||
23269980|NCT00406848|64731928|FG001|Overall Study|Lost to Follow-up|2|||
23269981|NCT00406848|64731927|FG000|Overall Study|Physician Decision|2|||
23269982|NCT00406848|64731928|FG001|Overall Study|Physician Decision|2|||
23269983|NCT00406848|64731927|FG000|Overall Study|Sponsor Decision|1|||
23269984|NCT00406848|64731928|FG001|Overall Study|Sponsor Decision|1|||
23483129|NCT05070546|65512915|FG003|Overall Study|Randomized but not vaccinated|1|||
23269985|NCT00154102|64731929|FG000|Overall Study|investigational study phase ongoing|7|||
23483130|NCT05070546|65512916|FG004|Overall Study|Randomized but not vaccinated|3|||
23483131|NCT05070546|65512917|FG005|Overall Study|Randomized but not vaccinated|0|||
23483132|NCT01307020|65512920|FG000|Overall Study|Lost to Follow-up|0|||
23483133|NCT01307020|65512921|FG001|Overall Study|Lost to Follow-up|0|||
23269986|NCT00154102|64731930|FG001|Overall Study|investigational study phase ongoing|2|||
23269987|NCT02365207|64731931|FG000|Overall Study|Withdrawal by Subject|1|||
23269988|NCT02365207|64731931|FG000|Overall Study|Physician Decision|1|||
23269989|NCT02684578|64731932|FG000|Overall Study|Withdrawal by Subject|10|||
23365790|NCT02329847|65085134|FG003|Overall Study|Other|13|||
23365791|NCT02329847|65085135|FG004|Overall Study|Other|10|||
23365792|NCT02329847|65085136|FG005|Overall Study|Other|3|||
23365793|NCT04155463|65085137|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
23365794|NCT04155463|65085138|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
23365795|NCT01716663|65085143|FG000|Overall Study|Withdrawn prior to procedure|4|||
23365796|NCT01716663|65085143|FG000|Overall Study|Treated with non-study catheter|2|||
23365797|NCT01973218|65085148|FG000|Overall Study|Adverse Event|1|||
23365798|NCT01973218|65085149|FG001|Overall Study|Adverse Event|0|||
23365799|NCT01973218|65085148|FG000|Overall Study|Withdrawal by Subject|1|||
23365800|NCT01973218|65085149|FG001|Overall Study|Withdrawal by Subject|0|||
23365801|NCT00715403|65085150|FG000|Overall Study|Progressive disease|0|||
23365802|NCT00715403|65085151|FG001|Overall Study|Progressive disease|1|||
23365803|NCT00715403|65085152|FG002|Overall Study|Progressive disease|3|||
23365804|NCT00715403|65085153|FG003|Overall Study|Progressive disease|9|||
23365805|NCT00715403|65085154|FG004|Overall Study|Progressive disease|5|||
23365806|NCT00715403|65085155|FG005|Overall Study|Progressive disease|14|||
23365807|NCT00715403|65085156|FG006|Overall Study|Progressive disease|1|||
23365808|NCT00715403|65085150|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365809|NCT00715403|65085151|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365810|NCT00715403|65085152|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365811|NCT00715403|65085153|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365812|NCT00715403|65085154|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365813|NCT00715403|65085155|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
23365814|NCT00715403|65085156|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
23365815|NCT00715403|65085150|FG000|Overall Study|Other Adverse Event than DLT|1|||
23365816|NCT00715403|65085151|FG001|Overall Study|Other Adverse Event than DLT|0|||
23365817|NCT00715403|65085152|FG002|Overall Study|Other Adverse Event than DLT|0|||
23365818|NCT00715403|65085153|FG003|Overall Study|Other Adverse Event than DLT|0|||
23365819|NCT00715403|65085154|FG004|Overall Study|Other Adverse Event than DLT|0|||
23365820|NCT00715403|65085155|FG005|Overall Study|Other Adverse Event than DLT|2|||
23365821|NCT00715403|65085156|FG006|Overall Study|Other Adverse Event than DLT|0|||
23365822|NCT00715403|65085150|FG000|Overall Study|Protocol Violation|0|||
23365823|NCT00715403|65085151|FG001|Overall Study|Protocol Violation|0|||
23365824|NCT00715403|65085152|FG002|Overall Study|Protocol Violation|0|||
23365825|NCT00715403|65085153|FG003|Overall Study|Protocol Violation|0|||
23365826|NCT00715403|65085154|FG004|Overall Study|Protocol Violation|0|||
23365827|NCT00715403|65085155|FG005|Overall Study|Protocol Violation|1|||
23269990|NCT02684578|64731933|FG001|Overall Study|Withdrawal by Subject|7|||
23269991|NCT02684578|64731932|FG000|Overall Study|Lost to Follow-up|0|||
23269992|NCT02684578|64731933|FG001|Overall Study|Lost to Follow-up|3|||
23269993|NCT02684578|64731932|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
23269994|NCT02684578|64731933|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
23269995|NCT02684578|64731932|FG000|Overall Study|Missing follow-up data|0|||
23269996|NCT02684578|64731933|FG001|Overall Study|Missing follow-up data|1|||
23269997|NCT02116803|64731937|FG000|Overall Study|Adverse Event|2|||
23269998|NCT02116803|64731938|FG001|Overall Study|Adverse Event|1|||
23269999|NCT02116803|64731937|FG000|Overall Study|Physician Decision|1|||
23270000|NCT02116803|64731938|FG001|Overall Study|Physician Decision|0|||
23365828|NCT00715403|65085156|FG006|Overall Study|Protocol Violation|0|||
23365829|NCT00715403|65085150|FG000|Overall Study|Other reason not defined above|0|||
23270001|NCT02116803|64731937|FG000|Overall Study|Progressive disease|4|||
23270002|NCT02116803|64731938|FG001|Overall Study|Progressive disease|0|||
23270003|NCT02116803|64731937|FG000|Overall Study|Study terminated by sponsor|2|||
23270004|NCT02116803|64731938|FG001|Overall Study|Study terminated by sponsor|1|||
23270005|NCT02116803|64731937|FG000|Overall Study|Death|1|||
23270006|NCT02116803|64731938|FG001|Overall Study|Death|0|||
23270007|NCT00352690|64731940|FG000|Overall Study|Determined to be ineligible|2|||
23270008|NCT00352690|64731941|FG001|Overall Study|Determined to be ineligible|0|||
23270009|NCT03450070|64731942|FG000|Overall Study|Withdrawal by Subject|8|||
23270010|NCT00755326|64731949|FG000|Overall Study|Lost to Follow-up|2|||
23270011|NCT00755326|64731950|FG001|Overall Study|Lost to Follow-up|3|||
23270012|NCT01781637|64731951|FG000|Overall Study|Adverse Event|1|||
23270013|NCT01781637|64731952|FG001|Overall Study|Adverse Event|0|||
23270014|NCT01781637|64731951|FG000|Overall Study|Lack of Efficacy|2|||
23270015|NCT01781637|64731952|FG001|Overall Study|Lack of Efficacy|6|||
23270016|NCT01781637|64731951|FG000|Overall Study|Withdrawal by Subject|1|||
23270017|NCT01781637|64731952|FG001|Overall Study|Withdrawal by Subject|0|||
23270018|NCT00397488|64731953|FG000|Overall Study|Withdrawal by Subject|3|||
23270019|NCT00397488|64731953|FG000|Overall Study|Adverse Event|3|||
23270020|NCT00397488|64731953|FG000|Overall Study|Death|1|||
23270021|NCT04091971|64731954|FG000|Overall Study|Withdrawal by Subject|1|||
23270022|NCT04091971|64731954|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
23270023|NCT04091971|64731954|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
23270024|NCT02848326|64731958|FG000|Treatment Period|Adverse Event|5|||
23270025|NCT02848326|64731959|FG001|Treatment Period|Adverse Event|4|||
23270026|NCT02848326|64731960|FG002|Treatment Period|Adverse Event|11|||
23270027|NCT02848326|64731961|FG003|Treatment Period|Adverse Event|6|||
23270028|NCT02848326|64731962|FG004|Treatment Period|Adverse Event|5|||
23270029|NCT02848326|64731963|FG005|Treatment Period|Adverse Event|7|||
23270030|NCT02848326|64731958|FG000|Treatment Period|Withdrawal of Consent|20|||
23270031|NCT02848326|64731959|FG001|Treatment Period|Withdrawal of Consent|6|||
23270032|NCT02848326|64731960|FG002|Treatment Period|Withdrawal of Consent|9|||
23270033|NCT02848326|64731961|FG003|Treatment Period|Withdrawal of Consent|6|||
23270034|NCT02848326|64731962|FG004|Treatment Period|Withdrawal of Consent|9|||
23270035|NCT02848326|64731963|FG005|Treatment Period|Withdrawal of Consent|6|||
23270036|NCT02848326|64731958|FG000|Treatment Period|Lost to Follow-up|5|||
23365830|NCT00715403|65085151|FG001|Overall Study|Other reason not defined above|0|||
23365831|NCT00715403|65085152|FG002|Overall Study|Other reason not defined above|1|||
23365832|NCT00715403|65085153|FG003|Overall Study|Other reason not defined above|0|||
23365833|NCT00715403|65085154|FG004|Overall Study|Other reason not defined above|1|||
23365834|NCT00715403|65085155|FG005|Overall Study|Other reason not defined above|1|||
23365835|NCT00715403|65085156|FG006|Overall Study|Other reason not defined above|0|||
23365836|NCT03082729|65085157|FG000|Overall Study|Lost to Follow-up|7|||
23365837|NCT03082729|65085157|FG000|Overall Study|Physician Decision|2|||
23365838|NCT03082729|65085157|FG000|Overall Study|Withdrawal by Subject|1|||
23365839|NCT03082729|65085157|FG000|Overall Study|Lack of Efficacy|9|||
23365840|NCT03082729|65085157|FG000|Overall Study|Adverse Event|4|||
23365841|NCT03082729|65085157|FG000|Overall Study|Protocol Violation|6|||
23365842|NCT03082729|65085157|FG000|Overall Study|Fear of study procedure|1|||
23365843|NCT03082729|65085157|FG000|Overall Study|Scheduling conflict|1|||
23365844|NCT00809445|65085163|FG000|1 Month Follow-up|Lost contact|1|||
23365845|NCT00809445|65085164|FG001|1 Month Follow-up|Lost contact|2|||
23365846|NCT00809445|65085165|FG002|1 Month Follow-up|Lost contact|1|||
23365847|NCT00809445|65085163|FG000|1 Month Follow-up|Withdrew consent|1|||
23365848|NCT00809445|65085164|FG001|1 Month Follow-up|Withdrew consent|1|||
23365849|NCT00809445|65085165|FG002|1 Month Follow-up|Withdrew consent|1|||
23365850|NCT00809445|65085163|FG000|1 Month Follow-up|Death|0|||
23365851|NCT00809445|65085164|FG001|1 Month Follow-up|Death|1|||
23365852|NCT00809445|65085165|FG002|1 Month Follow-up|Death|1|||
23365853|NCT00809445|65085163|FG000|1 Month Follow-up|Incarcerated|0|||
23365854|NCT00809445|65085164|FG001|1 Month Follow-up|Incarcerated|0|||
23365855|NCT00809445|65085165|FG002|1 Month Follow-up|Incarcerated|1|||
23365856|NCT00809445|65085163|FG000|6 Month Follow-up|Lost contact|16|||
23483134|NCT01307020|65512922|FG002|Overall Study|Lost to Follow-up|1|||
23483135|NCT01307020|65512923|FG003|Overall Study|Lost to Follow-up|1|||
23483136|NCT01307020|65512924|FG004|Overall Study|Lost to Follow-up|0|||
23365857|NCT00809445|65085164|FG001|6 Month Follow-up|Lost contact|14|||
23365858|NCT00809445|65085165|FG002|6 Month Follow-up|Lost contact|14|||
23365859|NCT00809445|65085163|FG000|6 Month Follow-up|Death|2|||
23365860|NCT00809445|65085164|FG001|6 Month Follow-up|Death|1|||
23483137|NCT01307020|65512925|FG005|Overall Study|Lost to Follow-up|0|||
23483138|NCT01307020|65512926|FG006|Overall Study|Lost to Follow-up|1|||
23270037|NCT02848326|64731959|FG001|Treatment Period|Lost to Follow-up|1|||
23270038|NCT02848326|64731960|FG002|Treatment Period|Lost to Follow-up|11|||
23270039|NCT02848326|64731961|FG003|Treatment Period|Lost to Follow-up|7|||
23270040|NCT02848326|64731962|FG004|Treatment Period|Lost to Follow-up|2|||
23270041|NCT02848326|64731963|FG005|Treatment Period|Lost to Follow-up|3|||
23270042|NCT02848326|64731958|FG000|Treatment Period|Pregnancy|0|||
23270043|NCT02848326|64731959|FG001|Treatment Period|Pregnancy|0|||
23270044|NCT02848326|64731960|FG002|Treatment Period|Pregnancy|1|||
23365861|NCT00809445|65085165|FG002|6 Month Follow-up|Death|1|||
23365862|NCT00809445|65085163|FG000|6 Month Follow-up|Incarcerated|6|||
23365863|NCT00809445|65085164|FG001|6 Month Follow-up|Incarcerated|8|||
23365864|NCT00809445|65085165|FG002|6 Month Follow-up|Incarcerated|8|||
23365865|NCT00809445|65085163|FG000|6 Month Follow-up|Withdrew consent|0|||
23365866|NCT00809445|65085164|FG001|6 Month Follow-up|Withdrew consent|0|||
23365867|NCT00809445|65085165|FG002|6 Month Follow-up|Withdrew consent|1|||
23365868|NCT02791269|65085166|FG000|Overall Study|Lost to Follow-up|0|||
23365869|NCT02791269|65085167|FG001|Overall Study|Lost to Follow-up|1|||
23365870|NCT00971867|65085168|FG000|Overall Study|Adverse Event|4|||
23365871|NCT00971867|65085168|FG000|Overall Study|Participant Withdrew Consent|1|||
23365872|NCT00971867|65085168|FG000|Overall Study|Disease Progression|6|||
23365873|NCT03410992|65085169|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365874|NCT03410992|65085170|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
23365875|NCT03410992|65085171|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365876|NCT03410992|65085172|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365877|NCT03410992|65085173|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365878|NCT03410992|65085174|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365879|NCT03410992|65085175|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365880|NCT03410992|65085176|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365881|NCT03410992|65085177|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365882|NCT03410992|65085178|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365883|NCT03410992|65085179|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
23365884|NCT03410992|65085169|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
23365885|NCT03410992|65085170|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
23365886|NCT03410992|65085171|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365887|NCT03410992|65085172|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365888|NCT03410992|65085173|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365889|NCT03410992|65085174|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365890|NCT03410992|65085175|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365891|NCT03410992|65085176|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365892|NCT03410992|65085177|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365893|NCT03410992|65085178|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365894|NCT03410992|65085179|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
23365895|NCT03410992|65085169|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
23365896|NCT03410992|65085170|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
23365897|NCT03410992|65085171|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365898|NCT03410992|65085172|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365899|NCT03410992|65085173|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365900|NCT03410992|65085174|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365901|NCT03410992|65085175|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365902|NCT03410992|65085176|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365903|NCT03410992|65085177|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365904|NCT03410992|65085178|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365905|NCT03410992|65085179|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
23365906|NCT03410992|65085169|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
23365907|NCT03410992|65085170|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365908|NCT03410992|65085171|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365909|NCT03410992|65085172|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365910|NCT03410992|65085173|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365911|NCT03410992|65085174|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365912|NCT03410992|65085175|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365913|NCT03410992|65085176|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365914|NCT03410992|65085177|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365915|NCT03410992|65085178|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365916|NCT03410992|65085179|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
23365917|NCT03410992|65085169|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
23365918|NCT03410992|65085170|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
23365919|NCT03410992|65085171|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365920|NCT03410992|65085172|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365921|NCT03410992|65085173|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365922|NCT03410992|65085174|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365923|NCT03410992|65085175|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365924|NCT03410992|65085176|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365925|NCT03410992|65085177|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365926|NCT03410992|65085178|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365927|NCT03410992|65085179|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
23365928|NCT03410992|65085169|FG000|Week 16 Assessment|Incorrect escapers|0|||
23365929|NCT03410992|65085170|FG001|Week 16 Assessment|Incorrect escapers|6|||
23365930|NCT03410992|65085171|FG002|Week 16 Assessment|Incorrect escapers|0|||
23365931|NCT03410992|65085172|FG003|Week 16 Assessment|Incorrect escapers|0|||
23365932|NCT03410992|65085173|FG004|Week 16 Assessment|Incorrect escapers|0|||
23365933|NCT03410992|65085174|FG005|Week 16 Assessment|Incorrect escapers|0|||
23365934|NCT03410992|65085175|FG006|Week 16 Assessment|Incorrect escapers|0|||
23365935|NCT03410992|65085176|FG007|Week 16 Assessment|Incorrect escapers|0|||
23365936|NCT03410992|65085177|FG008|Week 16 Assessment|Incorrect escapers|0|||
23365937|NCT03410992|65085178|FG009|Week 16 Assessment|Incorrect escapers|0|||
23365938|NCT03410992|65085179|FG010|Week 16 Assessment|Incorrect escapers|0|||
23365939|NCT03410992|65085169|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365940|NCT03410992|65085170|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365941|NCT03410992|65085171|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365942|NCT03410992|65085172|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
23365943|NCT03410992|65085173|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
23365944|NCT03410992|65085174|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365945|NCT03410992|65085175|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365946|NCT03410992|65085176|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23270045|NCT02848326|64731961|FG003|Treatment Period|Pregnancy|1|||
23270046|NCT02848326|64731962|FG004|Treatment Period|Pregnancy|0|||
23270047|NCT02848326|64731963|FG005|Treatment Period|Pregnancy|1|||
23270048|NCT02848326|64731958|FG000|Treatment Period|Protocol Violation|4|||
23270049|NCT02848326|64731959|FG001|Treatment Period|Protocol Violation|3|||
23270050|NCT02848326|64731960|FG002|Treatment Period|Protocol Violation|4|||
23270051|NCT02848326|64731961|FG003|Treatment Period|Protocol Violation|2|||
23270052|NCT02848326|64731962|FG004|Treatment Period|Protocol Violation|3|||
23270053|NCT02848326|64731963|FG005|Treatment Period|Protocol Violation|3|||
23270054|NCT02848326|64731958|FG000|Treatment Period|Non-compliance with Study Drug|4|||
23270055|NCT02848326|64731959|FG001|Treatment Period|Non-compliance with Study Drug|0|||
23270056|NCT02848326|64731960|FG002|Treatment Period|Non-compliance with Study Drug|0|||
23270057|NCT02848326|64731961|FG003|Treatment Period|Non-compliance with Study Drug|1|||
23270058|NCT02848326|64731962|FG004|Treatment Period|Non-compliance with Study Drug|0|||
23270059|NCT02848326|64731963|FG005|Treatment Period|Non-compliance with Study Drug|0|||
23270060|NCT02848326|64731958|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
23270061|NCT02848326|64731959|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
23270062|NCT02848326|64731960|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
23270063|NCT02848326|64731961|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
23270064|NCT02848326|64731962|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
23270065|NCT02848326|64731963|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
23270066|NCT02848326|64731958|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
23270067|NCT02848326|64731959|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
23270068|NCT02848326|64731960|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
23270069|NCT02848326|64731961|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
23270070|NCT02848326|64731962|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
23270071|NCT02848326|64731963|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
23270072|NCT02246920|64731966|FG000|Overall Study|Adverse Event|3|||
23270073|NCT02246920|64731967|FG001|Overall Study|Adverse Event|1|||
23270074|NCT02246920|64731968|FG002|Overall Study|Adverse Event|1|||
23270075|NCT02246920|64731966|FG000|Overall Study|Lost to Follow-up|2|||
23270076|NCT02246920|64731967|FG001|Overall Study|Lost to Follow-up|1|||
23270077|NCT02246920|64731968|FG002|Overall Study|Lost to Follow-up|0|||
23270078|NCT02246920|64731966|FG000|Overall Study|Protocol Violation|2|||
23270079|NCT02246920|64731967|FG001|Overall Study|Protocol Violation|5|||
23270080|NCT02246920|64731968|FG002|Overall Study|Protocol Violation|1|||
23270081|NCT02246920|64731966|FG000|Overall Study|Withdrawal by Subject|0|||
23270082|NCT02246920|64731967|FG001|Overall Study|Withdrawal by Subject|0|||
23270083|NCT02246920|64731968|FG002|Overall Study|Withdrawal by Subject|1|||
23270084|NCT00048581|64731970|FG000|Double-Blind Period|Adverse Event|9|||
23270085|NCT00048581|64731971|FG001|Double-Blind Period|Adverse Event|5|||
23270086|NCT00048581|64731972|FG002|Double-Blind Period|Adverse Event|0|||
23270087|NCT00048581|64731970|FG000|Double-Blind Period|Lack of Efficacy|14|||
23270088|NCT00048581|64731971|FG001|Double-Blind Period|Lack of Efficacy|27|||
23270089|NCT00048581|64731972|FG002|Double-Blind Period|Lack of Efficacy|0|||
23270090|NCT00048581|64731970|FG000|Double-Blind Period|Lost to Follow-up|5|||
23270091|NCT00048581|64731971|FG001|Double-Blind Period|Lost to Follow-up|0|||
23270092|NCT00048581|64731972|FG002|Double-Blind Period|Lost to Follow-up|0|||
23365947|NCT03410992|65085177|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23270093|NCT00048581|64731970|FG000|Double-Blind Period|Withdrawal by Subject|5|||
23270094|NCT00048581|64731971|FG001|Double-Blind Period|Withdrawal by Subject|2|||
23270095|NCT00048581|64731972|FG002|Double-Blind Period|Withdrawal by Subject|0|||
23270096|NCT00048581|64731970|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
23270097|NCT00048581|64731971|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
23270098|NCT00048581|64731972|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
23365948|NCT03410992|65085178|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365949|NCT03410992|65085179|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
23365950|NCT03410992|65085169|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365951|NCT03410992|65085170|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365952|NCT03410992|65085171|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365953|NCT03410992|65085172|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
23365954|NCT03410992|65085173|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
23365955|NCT03410992|65085174|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
23365956|NCT03410992|65085175|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365957|NCT03410992|65085176|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365958|NCT03410992|65085177|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365959|NCT03410992|65085178|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365960|NCT03410992|65085179|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
23365961|NCT03410992|65085169|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365962|NCT03410992|65085170|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365963|NCT03410992|65085171|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365964|NCT03410992|65085172|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365965|NCT03410992|65085173|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365966|NCT03410992|65085174|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
23365967|NCT03410992|65085175|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365968|NCT03410992|65085176|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365969|NCT03410992|65085177|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365970|NCT03410992|65085178|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365971|NCT03410992|65085179|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
23365972|NCT03410992|65085169|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365973|NCT03410992|65085170|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365974|NCT03410992|65085171|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365975|NCT03410992|65085172|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
23365976|NCT03410992|65085173|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
23365977|NCT03410992|65085174|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
23365978|NCT03410992|65085175|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365979|NCT03410992|65085176|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365980|NCT03410992|65085177|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365981|NCT03410992|65085178|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365982|NCT03410992|65085179|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
23365983|NCT03410992|65085169|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365984|NCT03410992|65085170|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365985|NCT03410992|65085171|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365986|NCT03410992|65085172|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365987|NCT03410992|65085173|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365988|NCT03410992|65085174|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365989|NCT03410992|65085175|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365990|NCT03410992|65085176|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
23365991|NCT03410992|65085177|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365992|NCT03410992|65085178|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365993|NCT03410992|65085179|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
23365994|NCT03410992|65085169|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365995|NCT03410992|65085170|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365996|NCT03410992|65085171|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365997|NCT03410992|65085172|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365998|NCT03410992|65085173|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23365999|NCT03410992|65085174|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366000|NCT03410992|65085175|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366001|NCT03410992|65085176|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366002|NCT03410992|65085177|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
23366003|NCT03410992|65085178|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366004|NCT03410992|65085179|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
23366005|NCT01468454|65085180|FG000|Overall Study|Did not have surgery after PET|9|||
23366006|NCT00274742|65085188|FG000|Overall Study|Adverse Event|0|||
23366007|NCT00274742|65085189|FG001|Overall Study|Adverse Event|4|||
23366008|NCT00274742|65085190|FG002|Overall Study|Adverse Event|1|||
23366009|NCT00274742|65085191|FG003|Overall Study|Adverse Event|4|||
23366010|NCT00274742|65085192|FG004|Overall Study|Adverse Event|12|||
23366011|NCT00274742|65085193|FG005|Overall Study|Adverse Event|3|||
23366012|NCT00274742|65085188|FG000|Overall Study|Lost to Follow-up|0|||
23366013|NCT00274742|65085189|FG001|Overall Study|Lost to Follow-up|0|||
23366014|NCT00274742|65085190|FG002|Overall Study|Lost to Follow-up|0|||
23366015|NCT00274742|65085191|FG003|Overall Study|Lost to Follow-up|0|||
23366016|NCT00274742|65085192|FG004|Overall Study|Lost to Follow-up|1|||
23366017|NCT00274742|65085193|FG005|Overall Study|Lost to Follow-up|0|||
23366018|NCT00274742|65085188|FG000|Overall Study|End of Study|0|||
23366019|NCT00274742|65085189|FG001|Overall Study|End of Study|0|||
23366020|NCT00274742|65085190|FG002|Overall Study|End of Study|0|||
23366021|NCT00274742|65085191|FG003|Overall Study|End of Study|1|||
23270099|NCT00048581|64731970|FG000|Double-Blind Period|Investigator Decision|1|||
23270100|NCT00048581|64731971|FG001|Double-Blind Period|Investigator Decision|0|||
23270101|NCT00048581|64731972|FG002|Double-Blind Period|Investigator Decision|0|||
23270102|NCT00048581|64731970|FG000|Open-Label Period|Death|0|||
23270103|NCT00048581|64731971|FG001|Open-Label Period|Death|0|||
23270104|NCT00048581|64731972|FG002|Open-Label Period|Death|4|||
23270105|NCT00048581|64731970|FG000|Open-Label Period|Adverse Event|0|||
23270106|NCT00048581|64731971|FG001|Open-Label Period|Adverse Event|0|||
23270107|NCT00048581|64731972|FG002|Open-Label Period|Adverse Event|37|||
23270108|NCT00048581|64731970|FG000|Open-Label Period|Lack of Efficacy|0|||
23270109|NCT00048581|64731971|FG001|Open-Label Period|Lack of Efficacy|0|||
23270110|NCT00048581|64731972|FG002|Open-Label Period|Lack of Efficacy|69|||
23270111|NCT00048581|64731970|FG000|Open-Label Period|Lost to Follow-up|0|||
23270112|NCT00048581|64731971|FG001|Open-Label Period|Lost to Follow-up|0|||
23270113|NCT00048581|64731972|FG002|Open-Label Period|Lost to Follow-up|14|||
23270114|NCT00048581|64731970|FG000|Open-Label Period|Withdrawal by Subject|0|||
23270115|NCT00048581|64731971|FG001|Open-Label Period|Withdrawal by Subject|0|||
23270116|NCT00048581|64731972|FG002|Open-Label Period|Withdrawal by Subject|20|||
23270117|NCT00048581|64731970|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
23270118|NCT00048581|64731971|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
23270119|NCT00048581|64731972|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
23270120|NCT00048581|64731970|FG000|Open-Label Period|Poor/Non-compliance|0|||
23270121|NCT00048581|64731971|FG001|Open-Label Period|Poor/Non-compliance|0|||
23270122|NCT00048581|64731972|FG002|Open-Label Period|Poor/Non-compliance|5|||
23270123|NCT00048581|64731970|FG000|Open-Label Period|Pregnancy|0|||
23270124|NCT00048581|64731971|FG001|Open-Label Period|Pregnancy|0|||
23270125|NCT00048581|64731972|FG002|Open-Label Period|Pregnancy|7|||
23270126|NCT00048581|64731970|FG000|Open-Label Period|Study Site Closure|0|||
23270127|NCT00048581|64731971|FG001|Open-Label Period|Study Site Closure|0|||
23270128|NCT00048581|64731972|FG002|Open-Label Period|Study Site Closure|2|||
23270129|NCT00048581|64731970|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
23270130|NCT00048581|64731971|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
23270131|NCT00048581|64731972|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
23270132|NCT00048581|64731970|FG000|Open-Label Period|Problem With Transportation To Site|0|||
23270133|NCT00048581|64731971|FG001|Open-Label Period|Problem With Transportation To Site|0|||
23270134|NCT00048581|64731972|FG002|Open-Label Period|Problem With Transportation To Site|1|||
23270135|NCT00048581|64731970|FG000|Open-Label Period|Primary Investigator Retired|0|||
23270136|NCT00048581|64731971|FG001|Open-Label Period|Primary Investigator Retired|0|||
23270137|NCT00048581|64731972|FG002|Open-Label Period|Primary Investigator Retired|2|||
23270138|NCT00048581|64731970|FG000|Open-Label Period|Study Ended By Sponsor|0|||
23270139|NCT00048581|64731971|FG001|Open-Label Period|Study Ended By Sponsor|0|||
23270140|NCT00048581|64731972|FG002|Open-Label Period|Study Ended By Sponsor|1|||
23270141|NCT03883906|64731973|FG000|Overall Study|Withdrawal by Subject|2|||
23270142|NCT03883906|64731973|FG000|Overall Study|Physician Decision|5|||
23270143|NCT00436553|64731975|FG000|Overall Study|Adverse Event|4|||
23270144|NCT00436553|64731976|FG001|Overall Study|Adverse Event|3|||
23270145|NCT00436553|64731977|FG002|Overall Study|Adverse Event|4|||
23270146|NCT00436553|64731975|FG000|Overall Study|Death|3|||
23270147|NCT00436553|64731976|FG001|Overall Study|Death|1|||
23270148|NCT00436553|64731977|FG002|Overall Study|Death|3|||
23270149|NCT00436553|64731975|FG000|Overall Study|Lost to Follow-up|0|||
23270150|NCT00436553|64731976|FG001|Overall Study|Lost to Follow-up|2|||
23270151|NCT00436553|64731977|FG002|Overall Study|Lost to Follow-up|0|||
23270152|NCT00436553|64731975|FG000|Overall Study|Protocol Violation|1|||
23366022|NCT00274742|65085192|FG004|Overall Study|End of Study|0|||
23366023|NCT00274742|65085193|FG005|Overall Study|End of Study|0|||
23366024|NCT00274742|65085188|FG000|Overall Study|Disease Progression|0|||
23366025|NCT00274742|65085189|FG001|Overall Study|Disease Progression|1|||
23366026|NCT00274742|65085190|FG002|Overall Study|Disease Progression|1|||
23366027|NCT00274742|65085191|FG003|Overall Study|Disease Progression|0|||
23270153|NCT00436553|64731976|FG001|Overall Study|Protocol Violation|0|||
23270154|NCT00436553|64731977|FG002|Overall Study|Protocol Violation|0|||
23366028|NCT00274742|65085192|FG004|Overall Study|Disease Progression|1|||
23366029|NCT00274742|65085193|FG005|Overall Study|Disease Progression|0|||
23366030|NCT00274742|65085188|FG000|Overall Study|Other|0|||
23270155|NCT00436553|64731975|FG000|Overall Study|Withdrawal by Subject|5|||
23270156|NCT00436553|64731976|FG001|Overall Study|Withdrawal by Subject|6|||
23270157|NCT00436553|64731977|FG002|Overall Study|Withdrawal by Subject|3|||
23270158|NCT00175019|64731993|FG000|Overall Study|Adverse Event|54|||
23270159|NCT00175019|64731994|FG001|Overall Study|Adverse Event|22|||
23270160|NCT00175019|64731995|FG002|Overall Study|Adverse Event|2|||
23270161|NCT00175019|64731993|FG000|Overall Study|Protocol Violation|6|||
23270162|NCT00175019|64731994|FG001|Overall Study|Protocol Violation|3|||
23270163|NCT00175019|64731995|FG002|Overall Study|Protocol Violation|3|||
23270164|NCT00175019|64731993|FG000|Overall Study|Lost to Follow-up|42|||
23270165|NCT00175019|64731994|FG001|Overall Study|Lost to Follow-up|39|||
23270166|NCT00175019|64731995|FG002|Overall Study|Lost to Follow-up|9|||
23270167|NCT00175019|64731993|FG000|Overall Study|Did not continue under Amendment 4|1|||
23270168|NCT00175019|64731994|FG001|Overall Study|Did not continue under Amendment 4|1|||
23270169|NCT00175019|64731995|FG002|Overall Study|Did not continue under Amendment 4|2|||
23270170|NCT00175019|64731993|FG000|Overall Study|Personal Reason(s)|39|||
23270171|NCT00175019|64731994|FG001|Overall Study|Personal Reason(s)|31|||
23270172|NCT00175019|64731995|FG002|Overall Study|Personal Reason(s)|8|||
23270173|NCT00175019|64731993|FG000|Overall Study|Therapeutic Failure|10|||
23270174|NCT00175019|64731994|FG001|Overall Study|Therapeutic Failure|38|||
23270175|NCT00175019|64731995|FG002|Overall Study|Therapeutic Failure|22|||
23483139|NCT01307020|65512927|FG007|Overall Study|Lost to Follow-up|0|||
23483140|NCT01307020|65512928|FG008|Overall Study|Lost to Follow-up|0|||
23483141|NCT01307020|65512929|FG009|Overall Study|Lost to Follow-up|0|||
23270176|NCT00175019|64731993|FG000|Overall Study|Gout Flare|2|||
23270177|NCT00175019|64731994|FG001|Overall Study|Gout Flare|3|||
23483142|NCT01307020|65512920|FG000|Overall Study|Electronic data capture failure|0|||
23270178|NCT00175019|64731995|FG002|Overall Study|Gout Flare|0|||
23270179|NCT00175019|64731993|FG000|Overall Study|Reason Not Specified|40|||
23270180|NCT00175019|64731994|FG001|Overall Study|Reason Not Specified|34|||
23483143|NCT01307020|65512921|FG001|Overall Study|Electronic data capture failure|1|||
23366031|NCT00274742|65085189|FG001|Overall Study|Other|3|||
23366032|NCT00274742|65085190|FG002|Overall Study|Other|0|||
23366033|NCT00274742|65085191|FG003|Overall Study|Other|0|||
23366034|NCT00274742|65085192|FG004|Overall Study|Other|2|||
23601753|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
23270181|NCT00175019|64731995|FG002|Overall Study|Reason Not Specified|11|||
23270182|NCT00376623|64731998|FG000|Overall Study|Progressive disease|35|||
23270183|NCT00376623|64731999|FG001|Overall Study|Progressive disease|22|||
23270184|NCT00376623|64732000|FG002|Overall Study|Progressive disease|17|||
23270185|NCT00376623|64731998|FG000|Overall Study|Lost to Follow-up|0|||
23270186|NCT00376623|64731999|FG001|Overall Study|Lost to Follow-up|1|||
23270187|NCT00376623|64732000|FG002|Overall Study|Lost to Follow-up|0|||
23270188|NCT00376623|64731998|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
23270189|NCT00376623|64731999|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
23270190|NCT00376623|64732000|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
23270191|NCT00376623|64731998|FG000|Overall Study|Not treated with BI 2536|1|||
23270192|NCT00376623|64731999|FG001|Overall Study|Not treated with BI 2536|0|||
23270193|NCT00376623|64732000|FG002|Overall Study|Not treated with BI 2536|0|||
23270194|NCT00376623|64731998|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
23270195|NCT00376623|64731999|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
23270196|NCT00376623|64732000|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
23270197|NCT00376623|64731998|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
23270198|NCT00376623|64731999|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
23270199|NCT00376623|64732000|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
23366035|NCT00274742|65085193|FG005|Overall Study|Other|0|||
23366036|NCT01096160|65085194|FG000|Overall Study|Adverse Event|0|||
23601754|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
23601755|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
23601756|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
23601757|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
23601758|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
23601759|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
23366037|NCT01096160|65085195|FG001|Overall Study|Adverse Event|0|||
23366038|NCT01096160|65085196|FG002|Overall Study|Adverse Event|1|||
23366039|NCT01096160|65085197|FG003|Overall Study|Adverse Event|0|||
23366040|NCT01096160|65085198|FG004|Overall Study|Adverse Event|0|||
23366041|NCT01096160|65085199|FG005|Overall Study|Adverse Event|0|||
23601760|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Other|1|||
23601761|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Other|0|||
23601762|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Other|0|||
23601763|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Other|0|||
23601764|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Other|0|||
23601765|NCT02386098|65933890|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
23601766|NCT02386098|65933891|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
23601767|NCT02386098|65933892|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
23601768|NCT02386098|65933893|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
23601769|NCT02386098|65933894|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
23601770|NCT01372085|65933896|FG000|Washout Period 2|Physician Decision|0|||
23601771|NCT01372085|65933897|FG001|Washout Period 2|Physician Decision|0|||
23601772|NCT01372085|65933898|FG002|Washout Period 2|Physician Decision|0|||
23601773|NCT01372085|65933899|FG003|Washout Period 2|Physician Decision|0|||
23601774|NCT01372085|65933900|FG004|Washout Period 2|Physician Decision|1|||
23601775|NCT01372085|65933901|FG005|Washout Period 2|Physician Decision|0|||
23601776|NCT01372085|65933902|FG006|Washout Period 2|Physician Decision|0|||
23601777|NCT01372085|65933903|FG007|Washout Period 2|Physician Decision|0|||
23601778|NCT01372085|65933904|FG008|Washout Period 2|Physician Decision|0|||
23601779|NCT01372085|65933905|FG009|Washout Period 2|Physician Decision|0|||
23601780|NCT01372085|65933896|FG000|Washout Period 3|Withdrawal by Subject|0|||
23601781|NCT01372085|65933897|FG001|Washout Period 3|Withdrawal by Subject|0|||
23601782|NCT01372085|65933898|FG002|Washout Period 3|Withdrawal by Subject|0|||
23601783|NCT01372085|65933899|FG003|Washout Period 3|Withdrawal by Subject|0|||
23601784|NCT01372085|65933900|FG004|Washout Period 3|Withdrawal by Subject|0|||
23601785|NCT01372085|65933901|FG005|Washout Period 3|Withdrawal by Subject|2|||
23601786|NCT01372085|65933902|FG006|Washout Period 3|Withdrawal by Subject|0|||
23601787|NCT01372085|65933903|FG007|Washout Period 3|Withdrawal by Subject|0|||
23270200|NCT00376623|64731998|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
23270201|NCT00376623|64731999|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
23270202|NCT00376623|64732000|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
23270203|NCT00376623|64731998|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
23270204|NCT00376623|64731999|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
23270205|NCT00376623|64732000|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
23270206|NCT00376623|64731998|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
23270207|NCT00376623|64731999|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
23270208|NCT00376623|64732000|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
23270209|NCT00376623|64731998|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
23270210|NCT00376623|64731999|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
23270211|NCT00376623|64732000|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
23270212|NCT00376623|64731998|FG000|Overall Study|Increase of tumour markers|0|||
23270213|NCT00376623|64731999|FG001|Overall Study|Increase of tumour markers|1|||
23270214|NCT00376623|64732000|FG002|Overall Study|Increase of tumour markers|0|||
23270215|NCT00376623|64731998|FG000|Overall Study|Bone metastasis|1|||
23270216|NCT00376623|64731999|FG001|Overall Study|Bone metastasis|0|||
23270217|NCT00376623|64732000|FG002|Overall Study|Bone metastasis|0|||
23270218|NCT02581345|64732022|FG000|Part 1: up to Week 16|Adverse Event|3|||
23270219|NCT02581345|64732023|FG001|Part 1: up to Week 16|Adverse Event|8|||
23270220|NCT02581345|64732024|FG002|Part 1: up to Week 16|Adverse Event|0|||
23270221|NCT02581345|64732025|FG003|Part 1: up to Week 16|Adverse Event|0|||
23270222|NCT02581345|64732022|FG000|Part 1: up to Week 16|Physician Decision|2|||
23270223|NCT02581345|64732023|FG001|Part 1: up to Week 16|Physician Decision|4|||
23270224|NCT02581345|64732024|FG002|Part 1: up to Week 16|Physician Decision|0|||
23366042|NCT01096160|65085200|FG006|Overall Study|Adverse Event|0|||
23366043|NCT01096160|65085201|FG007|Overall Study|Adverse Event|0|||
23366044|NCT01096160|65085202|FG008|Overall Study|Adverse Event|0|||
23366045|NCT01096160|65085203|FG009|Overall Study|Adverse Event|1|||
23601788|NCT01372085|65933904|FG008|Washout Period 3|Withdrawal by Subject|0|||
23601789|NCT01372085|65933905|FG009|Washout Period 3|Withdrawal by Subject|0|||
23601790|NCT00366249|65933906|FG000|Overall Study|Adverse Event|53|||
23601791|NCT00366249|65933907|FG001|Overall Study|Adverse Event|28|||
23270225|NCT02581345|64732025|FG003|Part 1: up to Week 16|Physician Decision|0|||
23270226|NCT02581345|64732022|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
23270227|NCT02581345|64732023|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
23270228|NCT02581345|64732024|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
23366046|NCT01096160|65085194|FG000|Overall Study|Met stopping criteria per protocol|0|||
23366047|NCT01096160|65085195|FG001|Overall Study|Met stopping criteria per protocol|0|||
23366048|NCT01096160|65085196|FG002|Overall Study|Met stopping criteria per protocol|0|||
23366049|NCT01096160|65085197|FG003|Overall Study|Met stopping criteria per protocol|0|||
23270229|NCT02581345|64732025|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
23270230|NCT02581345|64732022|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
23366050|NCT01096160|65085198|FG004|Overall Study|Met stopping criteria per protocol|1|||
23366051|NCT01096160|65085199|FG005|Overall Study|Met stopping criteria per protocol|0|||
23366052|NCT01096160|65085200|FG006|Overall Study|Met stopping criteria per protocol|2|||
23366053|NCT01096160|65085201|FG007|Overall Study|Met stopping criteria per protocol|0|||
23366054|NCT01096160|65085202|FG008|Overall Study|Met stopping criteria per protocol|2|||
23366055|NCT01096160|65085203|FG009|Overall Study|Met stopping criteria per protocol|0|||
23366056|NCT02783170|65088820|FG000|Overall Study|Randomized but not Vaccinated|1|||
23366057|NCT02783170|65088821|FG001|Overall Study|Randomized but not Vaccinated|0|||
23366058|NCT00447772|65088822|FG000|Overall Study|Lack of Efficacy|3|||
23366059|NCT00447772|65088822|FG000|Overall Study|Insufficient compliance|6|||
23366060|NCT00447772|65088822|FG000|Overall Study|Discontinuation of drug therapy|1|||
23366061|NCT00447772|65088822|FG000|Overall Study|Lost to Follow-up|9|||
23366062|NCT00447772|65088822|FG000|Overall Study|Withdrawal by Subject|1|||
23366063|NCT00447772|65088822|FG000|Overall Study|Unable to attend all study visits|2|||
23366064|NCT00447772|65088822|FG000|Overall Study|Adverse Event|1|||
23366065|NCT00447772|65088822|FG000|Overall Study|Patient relocated|1|||
23270231|NCT02581345|64732023|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
23270232|NCT02581345|64732024|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
23366066|NCT00447772|65088822|FG000|Overall Study|Incomplete documentation at visit 1|1|||
23366067|NCT00447772|65088822|FG000|Overall Study|Chemotherapy for lung cancer|1|||
23366068|NCT00447772|65088822|FG000|Overall Study|Premature re-injection required|1|||
23366069|NCT01781962|65088826|FG000|Overall Study|Other Miscellaneous Reasons|5|||
23366070|NCT03205150|65088827|FG000|Overall Study|Protocol deviation|1|||
23483144|NCT01307020|65512922|FG002|Overall Study|Electronic data capture failure|0|||
23601792|NCT00366249|65933906|FG000|Overall Study|Death|0|||
23601793|NCT00366249|65933907|FG001|Overall Study|Death|1|||
23601794|NCT00366249|65933906|FG000|Overall Study|Physician Decision|5|||
23601795|NCT00366249|65933907|FG001|Overall Study|Physician Decision|2|||
23601796|NCT00366249|65933906|FG000|Overall Study|Lost to Follow-up|2|||
23601797|NCT00366249|65933907|FG001|Overall Study|Lost to Follow-up|0|||
23601798|NCT00366249|65933906|FG000|Overall Study|Protocol Violation|1|||
23601799|NCT00366249|65933907|FG001|Overall Study|Protocol Violation|2|||
23601800|NCT00366249|65933906|FG000|Overall Study|Withdrawal by Subject|18|||
23601801|NCT00366249|65933907|FG001|Overall Study|Withdrawal by Subject|4|||
23601802|NCT00366249|65933906|FG000|Overall Study|Lack of Efficacy|21|||
23601803|NCT00366249|65933907|FG001|Overall Study|Lack of Efficacy|21|||
23601804|NCT00366249|65933906|FG000|Overall Study|Most due to osteomylitis status|31|||
23270233|NCT02581345|64732025|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
23270234|NCT02581345|64732022|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
23270235|NCT02581345|64732023|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
23270236|NCT02581345|64732024|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
23270237|NCT02581345|64732025|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
23366071|NCT03205150|65088828|FG001|Overall Study|Protocol deviation|3|||
23366072|NCT03205150|65088829|FG002|Overall Study|Protocol deviation|0|||
23366073|NCT03205150|65088827|FG000|Overall Study|Patient/guardian decision|0|||
23366074|NCT03205150|65088828|FG001|Overall Study|Patient/guardian decision|3|||
23483145|NCT01307020|65512923|FG003|Overall Study|Electronic data capture failure|0|||
23601805|NCT00366249|65933907|FG001|Overall Study|Most due to osteomylitis status|20|||
23601806|NCT02605174|65933915|FG000|Overall Study|Adverse Event|0|||
23483146|NCT01307020|65512924|FG004|Overall Study|Electronic data capture failure|0|||
23601807|NCT02605174|65933916|FG001|Overall Study|Adverse Event|0|||
23601808|NCT02605174|65933917|FG002|Overall Study|Adverse Event|1|||
23270238|NCT02581345|64732022|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
23366075|NCT03205150|65088829|FG002|Overall Study|Patient/guardian decision|0|||
23366076|NCT03205150|65088827|FG000|Overall Study|Adverse Event|1|||
23366077|NCT03205150|65088828|FG001|Overall Study|Adverse Event|1|||
23366078|NCT03205150|65088829|FG002|Overall Study|Adverse Event|1|||
23483147|NCT01307020|65512925|FG005|Overall Study|Electronic data capture failure|0|||
23270239|NCT02581345|64732023|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
23270240|NCT02581345|64732024|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
23270241|NCT02581345|64732025|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
23270242|NCT02581345|64732022|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
23270243|NCT02581345|64732023|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
23270244|NCT02581345|64732024|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
23270245|NCT02581345|64732025|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
23270246|NCT02581345|64732022|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
23270247|NCT02581345|64732023|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
23270248|NCT02581345|64732024|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
23366079|NCT03205150|65088827|FG000|Overall Study|Lost to Follow-up|0|||
23366080|NCT03205150|65088828|FG001|Overall Study|Lost to Follow-up|0|||
23366081|NCT03205150|65088829|FG002|Overall Study|Lost to Follow-up|1|||
23366082|NCT03110354|65088830|FG000|Overall Study|Death|1|||
23366083|NCT03110354|65088831|FG001|Overall Study|Death|0|||
23366084|NCT03110354|65088832|FG002|Overall Study|Death|0|||
23366085|NCT03110354|65088833|FG003|Overall Study|Death|1|||
23366086|NCT03110354|65088834|FG004|Overall Study|Death|0|||
23366087|NCT03110354|65088830|FG000|Overall Study|Start of new therapy|0|||
23366088|NCT03110354|65088831|FG001|Overall Study|Start of new therapy|0|||
23483148|NCT01307020|65512926|FG006|Overall Study|Electronic data capture failure|0|||
23483149|NCT01307020|65512927|FG007|Overall Study|Electronic data capture failure|0|||
23483150|NCT01307020|65512928|FG008|Overall Study|Electronic data capture failure|0|||
23483151|NCT01307020|65512929|FG009|Overall Study|Electronic data capture failure|0|||
23270249|NCT02581345|64732025|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
23270250|NCT02581345|64732022|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
23270251|NCT02581345|64732023|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
23270252|NCT02581345|64732024|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
23270253|NCT02581345|64732025|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
23270254|NCT02581345|64732022|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
23270255|NCT02581345|64732023|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
23270256|NCT02581345|64732024|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
23270257|NCT02581345|64732025|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
23270258|NCT02581345|64732022|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
23270259|NCT02581345|64732023|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
23270260|NCT02581345|64732024|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
23270261|NCT02581345|64732025|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
23270262|NCT02581345|64732022|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
23270263|NCT02581345|64732023|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
23270264|NCT02581345|64732024|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
23270265|NCT02581345|64732025|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
23270266|NCT02946385|64732030|FG000|Overall Study|Lost to Follow-up|0|||
23270267|NCT02946385|64732031|FG001|Overall Study|Lost to Follow-up|0|||
23270268|NCT02946385|64732032|FG002|Overall Study|Lost to Follow-up|3|||
23270269|NCT02946385|64732033|FG003|Overall Study|Lost to Follow-up|0|||
23270270|NCT02946385|64732034|FG004|Overall Study|Lost to Follow-up|2|||
23270271|NCT02946385|64732035|FG005|Overall Study|Lost to Follow-up|1|||
23270272|NCT02166697|64732036|FG000|Overall Study|Protocol Violation|347|||
23270273|NCT00463606|64732037|FG000|Overall Study|Adverse Event|21|||
23270274|NCT00463606|64732038|FG001|Overall Study|Adverse Event|18|||
23270275|NCT00463606|64732039|FG002|Overall Study|Adverse Event|11|||
23270276|NCT00463606|64732037|FG000|Overall Study|Withdrawal by Subject|11|||
23270277|NCT00463606|64732038|FG001|Overall Study|Withdrawal by Subject|11|||
23366089|NCT03110354|65088832|FG002|Overall Study|Start of new therapy|0|||
23366090|NCT03110354|65088833|FG003|Overall Study|Start of new therapy|0|||
23483152|NCT01002820|65512930|FG000|Overall Study|Adverse Event|1|||
23483153|NCT01002820|65512930|FG000|Overall Study|Withdrawal by Subject|2|||
23483154|NCT01002820|65512930|FG000|Overall Study|Lack of Efficacy|1|||
23483155|NCT01209832|65512936|FG000|Period 1|Sponsor Decision and was not dosed|1|||
23483156|NCT01209832|65512936|FG000|Period 2|Sponsor Decision|1|||
23483157|NCT01634178|65512937|FG000|Treatment Period 1|Adverse Event|0|||
23483158|NCT01634178|65512938|FG001|Treatment Period 1|Adverse Event|1|||
23483159|NCT01634178|65512937|FG000|Treatment Period 2|Adverse Event|1|||
23483160|NCT01634178|65512938|FG001|Treatment Period 2|Adverse Event|0|||
23483161|NCT01489111|65512941|FG000|Overall Study|Withdrawal criterion|1|||
23483162|NCT00739596|65512942|FG000|Overall Study|Adverse Event|12|||
23483163|NCT00739596|65512943|FG001|Overall Study|Adverse Event|6|||
23483164|NCT00739596|65512942|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
23483165|NCT00739596|65512943|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
23483166|NCT00739596|65512942|FG000|Overall Study|Patient Withdrew Consent|8|||
23483167|NCT00739596|65512943|FG001|Overall Study|Patient Withdrew Consent|8|||
23483168|NCT00739596|65512942|FG000|Overall Study|Lost to Follow-up|0|||
23483169|NCT00739596|65512943|FG001|Overall Study|Lost to Follow-up|2|||
23483170|NCT00739596|65512942|FG000|Overall Study|Protocol Deviation|1|||
23483171|NCT00739596|65512943|FG001|Overall Study|Protocol Deviation|1|||
23483172|NCT03021564|65512944|FG000|Overall Study|Death|84|||
23483173|NCT03021564|65512945|FG001|Overall Study|Death|466|||
23483174|NCT03021564|65512944|FG000|Overall Study|Lost to Follow-up|0|||
23270278|NCT00463606|64732039|FG002|Overall Study|Withdrawal by Subject|5|||
23483175|NCT03021564|65512945|FG001|Overall Study|Lost to Follow-up|2|||
23483176|NCT00206076|65512946|FG000|Overall Study|Physician Decision|2|||
23483177|NCT00206076|65512947|FG001|Overall Study|Physician Decision|0|||
23270279|NCT00463606|64732037|FG000|Overall Study|Lost to Follow-up|2|||
23270280|NCT00463606|64732038|FG001|Overall Study|Lost to Follow-up|2|||
23483178|NCT00206076|65512946|FG000|Overall Study|Withdrawal by Subject|1|||
23366091|NCT03110354|65088834|FG004|Overall Study|Start of new therapy|1|||
23366092|NCT03110354|65088830|FG000|Overall Study|Failure to achieve response|2|||
23483179|NCT00206076|65512947|FG001|Overall Study|Withdrawal by Subject|1|||
23270281|NCT00463606|64732039|FG002|Overall Study|Lost to Follow-up|3|||
23270282|NCT00463606|64732037|FG000|Overall Study|Subject noncompliance|1|||
23270283|NCT00463606|64732038|FG001|Overall Study|Subject noncompliance|1|||
23270284|NCT00463606|64732039|FG002|Overall Study|Subject noncompliance|0|||
23270285|NCT00463606|64732037|FG000|Overall Study|Subject moved out of town|1|||
23270286|NCT00463606|64732038|FG001|Overall Study|Subject moved out of town|0|||
23270287|NCT00463606|64732039|FG002|Overall Study|Subject moved out of town|0|||
23270288|NCT00463606|64732037|FG000|Overall Study|Physician Decision|0|||
23270289|NCT00463606|64732038|FG001|Overall Study|Physician Decision|1|||
23270290|NCT00463606|64732039|FG002|Overall Study|Physician Decision|0|||
23270291|NCT00463606|64732037|FG000|Overall Study|Sponsor request|0|||
23270292|NCT00463606|64732038|FG001|Overall Study|Sponsor request|1|||
23270293|NCT00463606|64732039|FG002|Overall Study|Sponsor request|0|||
23270294|NCT00463606|64732037|FG000|Overall Study|Exclusion criteria violation|2|||
23270295|NCT00463606|64732038|FG001|Overall Study|Exclusion criteria violation|0|||
23270296|NCT00463606|64732039|FG002|Overall Study|Exclusion criteria violation|0|||
23270297|NCT00463606|64732037|FG000|Overall Study|Coordinator error|1|||
23270298|NCT00463606|64732038|FG001|Overall Study|Coordinator error|0|||
23270299|NCT00463606|64732039|FG002|Overall Study|Coordinator error|0|||
23270300|NCT00463606|64732037|FG000|Overall Study|Patient randomized in error|1|||
23270301|NCT00463606|64732038|FG001|Overall Study|Patient randomized in error|0|||
23483180|NCT00708201|65512952|FG000|Overall Study|Adverse Event|4|||
23483181|NCT00708201|65512953|FG001|Overall Study|Adverse Event|4|||
23483182|NCT00708201|65512952|FG000|Overall Study|Withdrawal by Subject|1|||
23483183|NCT00708201|65512953|FG001|Overall Study|Withdrawal by Subject|1|||
23483184|NCT00708201|65512952|FG000|Overall Study|Lost to Follow-up|2|||
23483185|NCT00708201|65512953|FG001|Overall Study|Lost to Follow-up|0|||
23483186|NCT00708201|65512952|FG000|Overall Study|Protocol Violation|0|||
23483187|NCT00708201|65512953|FG001|Overall Study|Protocol Violation|1|||
23483188|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
23483189|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
23483190|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
23483191|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
23483192|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
23483193|NCT00586326|65512956|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
23483194|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
23483195|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
23483196|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
23483197|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
23483198|NCT00586326|65512956|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
23483199|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
23483200|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
23483201|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
23483202|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
23483203|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
23483204|NCT00586326|65512956|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
23483205|NCT02519855|65512957|FG000|Overall Study|Adverse Event|0|||
23483206|NCT02519855|65512958|FG001|Overall Study|Adverse Event|1|||
23483207|NCT02519855|65512957|FG000|Overall Study|Lost to Follow-up|3|||
23483208|NCT02519855|65512958|FG001|Overall Study|Lost to Follow-up|3|||
23483209|NCT00760084|65512964|FG000|Overall Study|Physician Decision|5|||
23270302|NCT00463606|64732039|FG002|Overall Study|Patient randomized in error|0|||
23270303|NCT00463606|64732037|FG000|Overall Study|Participation in another ABT-335 trial|1|||
23270304|NCT00463606|64732038|FG001|Overall Study|Participation in another ABT-335 trial|0|||
23483210|NCT00760084|65512964|FG000|Overall Study|Withdrawal by Subject|2|||
23483211|NCT00760084|65512964|FG000|Overall Study|Progressive Disease|3|||
23366093|NCT03110354|65088831|FG001|Overall Study|Failure to achieve response|3|||
23366094|NCT03110354|65088832|FG002|Overall Study|Failure to achieve response|0|||
23366095|NCT03110354|65088833|FG003|Overall Study|Failure to achieve response|2|||
23366096|NCT03110354|65088834|FG004|Overall Study|Failure to achieve response|1|||
23366097|NCT03110354|65088830|FG000|Overall Study|Progressive disease|1|||
23366098|NCT03110354|65088831|FG001|Overall Study|Progressive disease|1|||
23366099|NCT03110354|65088832|FG002|Overall Study|Progressive disease|3|||
23366100|NCT03110354|65088833|FG003|Overall Study|Progressive disease|4|||
23366101|NCT03110354|65088834|FG004|Overall Study|Progressive disease|2|||
23366102|NCT03110354|65088830|FG000|Overall Study|Adverse Event|0|||
23366103|NCT03110354|65088831|FG001|Overall Study|Adverse Event|0|||
23366104|NCT03110354|65088832|FG002|Overall Study|Adverse Event|0|||
23366105|NCT03110354|65088833|FG003|Overall Study|Adverse Event|2|||
23366106|NCT03110354|65088834|FG004|Overall Study|Adverse Event|2|||
23601809|NCT02605174|65933918|FG003|Overall Study|Adverse Event|0|||
23601810|NCT02605174|65933919|FG004|Overall Study|Adverse Event|4|||
23601811|NCT02605174|65933920|FG005|Overall Study|Adverse Event|0|||
23601812|NCT02605174|65933921|FG006|Overall Study|Adverse Event|0|||
23601813|NCT02605174|65933915|FG000|Overall Study|Lost to Follow-up|20|||
23601814|NCT02605174|65933916|FG001|Overall Study|Lost to Follow-up|7|||
23601815|NCT02605174|65933917|FG002|Overall Study|Lost to Follow-up|27|||
23366107|NCT03110354|65088830|FG000|Overall Study|Other|0|||
23601816|NCT02605174|65933918|FG003|Overall Study|Lost to Follow-up|10|||
23601817|NCT02605174|65933919|FG004|Overall Study|Lost to Follow-up|20|||
23601818|NCT02605174|65933920|FG005|Overall Study|Lost to Follow-up|10|||
23366108|NCT03110354|65088831|FG001|Overall Study|Other|0|||
23366109|NCT03110354|65088832|FG002|Overall Study|Other|0|||
23366110|NCT03110354|65088833|FG003|Overall Study|Other|1|||
23366111|NCT03110354|65088834|FG004|Overall Study|Other|1|||
23366112|NCT00419757|65088835|FG000|Overall Study|Adverse Event|1|||
23366113|NCT00419757|65088836|FG001|Overall Study|Adverse Event|4|||
23366114|NCT00419757|65088835|FG000|Overall Study|Lost to Follow-up|1|||
23366115|NCT00419757|65088836|FG001|Overall Study|Lost to Follow-up|4|||
23366116|NCT00419757|65088835|FG000|Overall Study|Withdrawal by Subject|7|||
23366117|NCT00419757|65088836|FG001|Overall Study|Withdrawal by Subject|1|||
23366118|NCT00419757|65088835|FG000|Overall Study|Protocol Violation|2|||
23366119|NCT00419757|65088836|FG001|Overall Study|Protocol Violation|3|||
23366120|NCT00419757|65088835|FG000|Overall Study|Study specific discontinuation criteria|4|||
23366121|NCT00419757|65088836|FG001|Overall Study|Study specific discontinuation criteria|8|||
23366122|NCT00419757|65088835|FG000|Overall Study|Multiple reasons|3|||
23366123|NCT00419757|65088836|FG001|Overall Study|Multiple reasons|1|||
23366124|NCT01048541|65088841|FG000|Overall Study|Withdrawal by Subject|1|||
23366125|NCT01048541|65088842|FG001|Overall Study|Withdrawal by Subject|0|||
23366126|NCT01316224|65088845|FG000|Overall Study|Protocol Violation|3|||
23366127|NCT01316224|65088845|FG000|Overall Study|Adverse Event|3|||
23366128|NCT01316224|65088845|FG000|Overall Study|Lack of Efficacy|1|||
23366129|NCT01316224|65088845|FG000|Overall Study|Withdrawal by Subject|1|||
23366130|NCT01316224|65088845|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
23366131|NCT01316224|65088845|FG000|Overall Study|Other|1|||
23366132|NCT02427841|65088849|FG000|Overall Study|Lack of Efficacy|5|||
23366133|NCT02427841|65088849|FG000|Overall Study|Physician Decision|2|||
23366134|NCT02427841|65088849|FG000|Overall Study|Withdrawal by Subject|1|||
23366135|NCT00614874|65088851|FG000|Overall Study|Protocol Violation|1|||
23366136|NCT00614874|65088851|FG000|Overall Study|Withdrawal by Subject|1|||
23366137|NCT04386902|65088852|FG000|Overall Study|Withdrawal by Subject|5|||
23366138|NCT04386902|65088852|FG000|Overall Study|Technical problems in the recording|5|||
23366139|NCT03286218|65088853|FG000|Qualification Phase Period 1|Adverse Event|1|||
23366140|NCT03286218|65088854|FG001|Qualification Phase Period 1|Adverse Event|0|||
23366141|NCT03286218|65088855|FG002|Qualification Phase Period 1|Adverse Event|0|||
23366142|NCT03286218|65088856|FG003|Qualification Phase Period 1|Adverse Event|0|||
23366143|NCT03286218|65088857|FG004|Qualification Phase Period 1|Adverse Event|0|||
23366144|NCT03286218|65088858|FG005|Qualification Phase Period 1|Adverse Event|0|||
23366145|NCT03286218|65088859|FG006|Qualification Phase Period 1|Adverse Event|0|||
23366146|NCT03286218|65088860|FG007|Qualification Phase Period 1|Adverse Event|0|||
23366147|NCT03286218|65088861|FG008|Qualification Phase Period 1|Adverse Event|0|||
23366148|NCT03286218|65088862|FG009|Qualification Phase Period 1|Adverse Event|0|||
23366149|NCT03286218|65088863|FG010|Qualification Phase Period 1|Adverse Event|0|||
23366150|NCT03286218|65088864|FG011|Qualification Phase Period 1|Adverse Event|0|||
23366151|NCT03286218|65088853|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366152|NCT03286218|65088854|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
23366153|NCT03286218|65088855|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366154|NCT03286218|65088856|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366155|NCT03286218|65088857|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366156|NCT03286218|65088858|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366157|NCT03286218|65088859|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366158|NCT03286218|65088860|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366159|NCT03286218|65088861|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366160|NCT03286218|65088862|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366161|NCT03286218|65088863|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366162|NCT03286218|65088864|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
23366163|NCT03286218|65088853|FG000|Qualification Phase Period 2|Adverse Event|0|||
23366164|NCT03286218|65088854|FG001|Qualification Phase Period 2|Adverse Event|1|||
23366165|NCT03286218|65088855|FG002|Qualification Phase Period 2|Adverse Event|0|||
23366166|NCT03286218|65088856|FG003|Qualification Phase Period 2|Adverse Event|0|||
23366167|NCT03286218|65088857|FG004|Qualification Phase Period 2|Adverse Event|0|||
23366168|NCT03286218|65088858|FG005|Qualification Phase Period 2|Adverse Event|0|||
23366169|NCT03286218|65088859|FG006|Qualification Phase Period 2|Adverse Event|0|||
23366170|NCT03286218|65088860|FG007|Qualification Phase Period 2|Adverse Event|0|||
23366171|NCT03286218|65088861|FG008|Qualification Phase Period 2|Adverse Event|0|||
23366172|NCT03286218|65088862|FG009|Qualification Phase Period 2|Adverse Event|0|||
23366173|NCT03286218|65088863|FG010|Qualification Phase Period 2|Adverse Event|0|||
23366174|NCT03286218|65088864|FG011|Qualification Phase Period 2|Adverse Event|0|||
23483212|NCT00976508|65512970|FG000|Overall Study|Death|7|||
23366175|NCT03286218|65088853|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
23366176|NCT03286218|65088854|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
23366177|NCT03286218|65088855|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366178|NCT03286218|65088856|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366179|NCT03286218|65088857|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23483213|NCT00976508|65512971|FG001|Overall Study|Death|1|||
23366180|NCT03286218|65088858|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366181|NCT03286218|65088859|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366182|NCT03286218|65088860|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366183|NCT03286218|65088861|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366184|NCT03286218|65088862|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366185|NCT03286218|65088863|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366186|NCT03286218|65088864|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
23366187|NCT03286218|65088853|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
23366188|NCT03286218|65088854|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
23366189|NCT03286218|65088855|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
23366190|NCT03286218|65088856|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
23366191|NCT03286218|65088857|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
23366192|NCT03286218|65088858|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
23366193|NCT03286218|65088859|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
23366194|NCT03286218|65088860|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
23366195|NCT03286218|65088861|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
23366196|NCT03286218|65088862|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
23366197|NCT03286218|65088863|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
23366198|NCT03286218|65088864|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
23366199|NCT03286218|65088853|FG000|Qualification Phase Period 2|Protocol Violation|2|||
23366200|NCT03286218|65088854|FG001|Qualification Phase Period 2|Protocol Violation|0|||
23366201|NCT03286218|65088855|FG002|Qualification Phase Period 2|Protocol Violation|0|||
23366202|NCT03286218|65088856|FG003|Qualification Phase Period 2|Protocol Violation|0|||
23366203|NCT03286218|65088857|FG004|Qualification Phase Period 2|Protocol Violation|0|||
23366204|NCT03286218|65088858|FG005|Qualification Phase Period 2|Protocol Violation|0|||
23366205|NCT03286218|65088859|FG006|Qualification Phase Period 2|Protocol Violation|0|||
23366206|NCT03286218|65088860|FG007|Qualification Phase Period 2|Protocol Violation|0|||
23366207|NCT03286218|65088861|FG008|Qualification Phase Period 2|Protocol Violation|0|||
23366208|NCT03286218|65088862|FG009|Qualification Phase Period 2|Protocol Violation|0|||
23366209|NCT03286218|65088863|FG010|Qualification Phase Period 2|Protocol Violation|0|||
23366210|NCT03286218|65088864|FG011|Qualification Phase Period 2|Protocol Violation|0|||
23366211|NCT03286218|65088853|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
23366212|NCT03286218|65088854|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
23366213|NCT03286218|65088855|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366214|NCT03286218|65088856|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366215|NCT03286218|65088857|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366216|NCT03286218|65088858|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366217|NCT03286218|65088859|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366218|NCT03286218|65088860|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366219|NCT03286218|65088861|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366220|NCT03286218|65088862|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366221|NCT03286218|65088863|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366222|NCT03286218|65088864|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
23366223|NCT03286218|65088853|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366224|NCT03286218|65088854|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366225|NCT03286218|65088855|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
23366226|NCT03286218|65088856|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
23366227|NCT03286218|65088857|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366228|NCT03286218|65088858|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
23366229|NCT03286218|65088859|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366230|NCT03286218|65088860|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366231|NCT03286218|65088861|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366232|NCT03286218|65088862|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366233|NCT03286218|65088863|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
23366234|NCT03286218|65088864|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
23366235|NCT03286218|65088853|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366236|NCT03286218|65088854|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366237|NCT03286218|65088855|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366238|NCT03286218|65088856|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366239|NCT03286218|65088857|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366240|NCT03286218|65088858|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366241|NCT03286218|65088859|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366242|NCT03286218|65088860|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366243|NCT03286218|65088861|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366244|NCT03286218|65088862|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366245|NCT03286218|65088863|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
23366246|NCT03286218|65088864|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
23366247|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Death|20|||
23601819|NCT02605174|65933921|FG006|Overall Study|Lost to Follow-up|29|||
23601820|NCT02605174|65933915|FG000|Overall Study|Protocol Violation|10|||
23601821|NCT02605174|65933916|FG001|Overall Study|Protocol Violation|4|||
23601822|NCT02605174|65933917|FG002|Overall Study|Protocol Violation|14|||
23366248|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Death|26|||
23601823|NCT02605174|65933918|FG003|Overall Study|Protocol Violation|6|||
23601824|NCT02605174|65933919|FG004|Overall Study|Protocol Violation|7|||
23601825|NCT02605174|65933920|FG005|Overall Study|Protocol Violation|7|||
23601826|NCT02605174|65933921|FG006|Overall Study|Protocol Violation|12|||
23270305|NCT00463606|64732039|FG002|Overall Study|Participation in another ABT-335 trial|0|||
23270306|NCT00463606|64732037|FG000|Overall Study|Protocol Violation|0|||
23270307|NCT00463606|64732038|FG001|Overall Study|Protocol Violation|0|||
23270308|NCT00463606|64732039|FG002|Overall Study|Protocol Violation|1|||
23270309|NCT02017964|64732040|FG000|Overall Study|Patient deemed ineligible|1|||
23270310|NCT03361228|64732041|FG000|Overall Study|Other|1|||
23270311|NCT03361228|64732042|FG001|Overall Study|Other|1|||
23270312|NCT03361228|64732041|FG000|Overall Study|Death|3|||
23270313|NCT03361228|64732042|FG001|Overall Study|Death|0|||
23366249|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
23366250|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
23366251|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
23366252|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
23366253|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
23366254|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
23366255|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
23366256|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
23366257|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
23366258|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
23366259|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
23366260|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
23366261|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
23366262|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
23366263|NCT00643201|65088865|FG000|Randomized, Completed 6 Months of Study|Other|107|||
23366264|NCT00643201|65088866|FG001|Randomized, Completed 6 Months of Study|Other|107|||
23366265|NCT00643201|65088865|FG000|Completed Study Follow Up|Death|28|||
23366266|NCT00643201|65088866|FG001|Completed Study Follow Up|Death|34|||
23366267|NCT00643201|65088865|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
23366268|NCT00643201|65088866|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
23366269|NCT00643201|65088865|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
23366270|NCT00643201|65088866|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
23366271|NCT00643201|65088865|FG000|Completed Study Follow Up|non-specified|1|||
23366272|NCT00643201|65088866|FG001|Completed Study Follow Up|non-specified|0|||
23366273|NCT03372798|65088869|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
23366274|NCT03372798|65088870|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
23366275|NCT03372798|65088869|FG000|Overall Study|Failure of imaging probe|0|||
23366276|NCT03372798|65088870|FG001|Overall Study|Failure of imaging probe|1|||
23366277|NCT02781324|65088871|FG000|Overall Study|Withdrawal by Subject|1|||
23366278|NCT02781324|65088872|FG001|Overall Study|Withdrawal by Subject|0|||
23483214|NCT00976508|65512970|FG000|Overall Study|Lost to Follow-up|1|||
23601827|NCT02605174|65933915|FG000|Overall Study|Pregnancy|1|||
23270314|NCT00440297|64732043|FG000|Overall Study|Adverse Event|8|||
23270315|NCT00440297|64732044|FG001|Overall Study|Adverse Event|5|||
23270316|NCT00440297|64732043|FG000|Overall Study|Lost to Follow-up|1|||
23366279|NCT02781324|65088871|FG000|Overall Study|Physician Decision|1|||
23366280|NCT02781324|65088872|FG001|Overall Study|Physician Decision|2|||
23366281|NCT02254772|65088873|FG000|Overall Study|Ineligible|1|||
23366282|NCT02254772|65088873|FG000|Overall Study|Withdrawal by Subject|1|||
23366283|NCT01610037|65088880|FG000|All Patients|Adverse Event|27|||
23366284|NCT01610037|65088881|FG001|All Patients|Adverse Event|22|||
23366285|NCT01610037|65088882|FG002|All Patients|Adverse Event|26|||
23601828|NCT02605174|65933916|FG001|Overall Study|Pregnancy|0|||
23601829|NCT02605174|65933917|FG002|Overall Study|Pregnancy|0|||
23270317|NCT00440297|64732044|FG001|Overall Study|Lost to Follow-up|0|||
23601830|NCT02605174|65933918|FG003|Overall Study|Pregnancy|2|||
23601831|NCT02605174|65933919|FG004|Overall Study|Pregnancy|0|||
23366286|NCT01610037|65088880|FG000|All Patients|Withdrawal by Subject|12|||
23366287|NCT01610037|65088881|FG001|All Patients|Withdrawal by Subject|10|||
23366288|NCT01610037|65088882|FG002|All Patients|Withdrawal by Subject|20|||
23366289|NCT01610037|65088880|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
23366290|NCT01610037|65088881|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
23366291|NCT01610037|65088882|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
23366292|NCT01610037|65088880|FG000|All Patients|Death|4|||
23366293|NCT01610037|65088881|FG001|All Patients|Death|2|||
23366294|NCT01610037|65088882|FG002|All Patients|Death|1|||
23366295|NCT01610037|65088880|FG000|All Patients|Protocol deviation|4|||
23366296|NCT01610037|65088881|FG001|All Patients|Protocol deviation|3|||
23366297|NCT01610037|65088882|FG002|All Patients|Protocol deviation|3|||
23366298|NCT01610037|65088880|FG000|All Patients|Abnormal laboratory value|1|||
23366299|NCT01610037|65088881|FG001|All Patients|Abnormal laboratory value|1|||
23366300|NCT01610037|65088882|FG002|All Patients|Abnormal laboratory value|0|||
23366301|NCT01610037|65088880|FG000|All Patients|Administrative problems|1|||
23366302|NCT01610037|65088881|FG001|All Patients|Administrative problems|4|||
23366303|NCT01610037|65088882|FG002|All Patients|Administrative problems|4|||
23366304|NCT01610037|65088880|FG000|All Patients|Lost to Follow-up|1|||
23366305|NCT01610037|65088881|FG001|All Patients|Lost to Follow-up|0|||
23366306|NCT01610037|65088882|FG002|All Patients|Lost to Follow-up|0|||
23366307|NCT01610037|65088880|FG000|All Patients|Abnormal test procedure result(s)|0|||
23366308|NCT01610037|65088881|FG001|All Patients|Abnormal test procedure result(s)|1|||
23366309|NCT01610037|65088882|FG002|All Patients|Abnormal test procedure result(s)|3|||
23366310|NCT01610037|65088880|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
23601832|NCT02605174|65933920|FG005|Overall Study|Pregnancy|0|||
23601833|NCT02605174|65933921|FG006|Overall Study|Pregnancy|0|||
23601834|NCT02605174|65933915|FG000|Overall Study|Withdrawal by Subject|9|||
23601835|NCT02605174|65933916|FG001|Overall Study|Withdrawal by Subject|6|||
23601836|NCT02605174|65933917|FG002|Overall Study|Withdrawal by Subject|14|||
23366311|NCT01610037|65088881|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
23366312|NCT01610037|65088882|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
23366313|NCT01610037|65088880|FG000|Treatment and Follow up Period|Death|10|||
23366314|NCT01610037|65088881|FG001|Treatment and Follow up Period|Death|5|||
23366315|NCT01610037|65088882|FG002|Treatment and Follow up Period|Death|4|||
23366316|NCT01610037|65088880|FG000|Treatment and Follow up Period|Administrative problems|1|||
23270318|NCT00440297|64732043|FG000|Overall Study|Physician Decision|1|||
23366317|NCT01610037|65088881|FG001|Treatment and Follow up Period|Administrative problems|3|||
23366318|NCT01610037|65088882|FG002|Treatment and Follow up Period|Administrative problems|2|||
23366319|NCT01610037|65088880|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
23366320|NCT01610037|65088881|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
23366321|NCT01610037|65088882|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
23366322|NCT02762084|65088885|FG000|Overall Study|Withdrawal by Subject|1|||
23366323|NCT02762084|65088886|FG001|Overall Study|Withdrawal by Subject|0|||
23366324|NCT02762084|65088887|FG002|Overall Study|Withdrawal by Subject|0|||
23601837|NCT02605174|65933918|FG003|Overall Study|Withdrawal by Subject|11|||
23601838|NCT02605174|65933919|FG004|Overall Study|Withdrawal by Subject|6|||
23601839|NCT02605174|65933920|FG005|Overall Study|Withdrawal by Subject|4|||
23270319|NCT00440297|64732044|FG001|Overall Study|Physician Decision|0|||
23270320|NCT00440297|64732043|FG000|Overall Study|Protocol Violation|11|||
23270321|NCT00440297|64732044|FG001|Overall Study|Protocol Violation|7|||
23270322|NCT00440297|64732043|FG000|Overall Study|Withdrawal by Subject|1|||
23270323|NCT00440297|64732044|FG001|Overall Study|Withdrawal by Subject|6|||
23270324|NCT00440297|64732043|FG000|Overall Study|Randomized by mistake|1|||
23270325|NCT00440297|64732044|FG001|Overall Study|Randomized by mistake|0|||
23366325|NCT02762084|65088885|FG000|Overall Study|Adverse Event|0|||
23366326|NCT02762084|65088886|FG001|Overall Study|Adverse Event|0|||
23366327|NCT02762084|65088887|FG002|Overall Study|Adverse Event|1|||
23366328|NCT02446691|65088890|FG000|Overall Study|Withdrawal by Subject|2|||
23366329|NCT02446691|65088890|FG000|Overall Study|Lost to Follow-up|8|||
23366330|NCT02446691|65088890|FG000|Overall Study|Protocol Violation|1|||
23366331|NCT02592447|65088891|FG000|Overall Study|Lost to Follow-up|1|||
23601840|NCT02605174|65933921|FG006|Overall Study|Withdrawal by Subject|15|||
23366332|NCT02592447|65088892|FG001|Overall Study|Lost to Follow-up|0|||
23601841|NCT02605174|65933915|FG000|Overall Study|Physician Decision|2|||
23270326|NCT03048500|64732045|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
23270327|NCT03048500|64732045|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
23366333|NCT02592447|65088891|FG000|Overall Study|Ineligible after randomization|1|||
23366334|NCT02592447|65088892|FG001|Overall Study|Ineligible after randomization|0|||
23366335|NCT02592447|65088891|FG000|Overall Study|Withdrawal by Subject|0|||
23366336|NCT02592447|65088892|FG001|Overall Study|Withdrawal by Subject|1|||
23366337|NCT00901342|65088893|FG000|Overall Study|Adverse Event|1|||
23366338|NCT00901342|65088893|FG000|Overall Study|Death|4|||
23366339|NCT00901342|65088893|FG000|Overall Study|Disease progression|1|||
23366340|NCT00901342|65088893|FG000|Overall Study|Withdrawal by Subject|9|||
23366341|NCT02021292|65088900|FG000|Overall Study|Physician Decision|0|||
23366342|NCT02021292|65088901|FG001|Overall Study|Physician Decision|1|||
23366343|NCT02021292|65088900|FG000|Overall Study|Lost to Follow-up|0|||
23366344|NCT02021292|65088901|FG001|Overall Study|Lost to Follow-up|1|||
23366345|NCT02021292|65088900|FG000|Overall Study|Death|0|||
23366346|NCT02021292|65088901|FG001|Overall Study|Death|1|||
23366347|NCT02949947|65088902|FG000|Overall Study|Non Compliance|0|||
23366348|NCT02949947|65088903|FG001|Overall Study|Non Compliance|1|||
23366349|NCT02949947|65088902|FG000|Overall Study|Insurance change|1|||
23366350|NCT02949947|65088903|FG001|Overall Study|Insurance change|0|||
23366351|NCT00737100|65088904|FG000|Overall Study|Adverse Event|6|||
23366352|NCT00737100|65088905|FG001|Overall Study|Adverse Event|5|||
23366353|NCT00737100|65088906|FG002|Overall Study|Adverse Event|3|||
23366354|NCT00737100|65088904|FG000|Overall Study|Lost to Follow-up|0|||
23366355|NCT00737100|65088905|FG001|Overall Study|Lost to Follow-up|1|||
23366356|NCT00737100|65088906|FG002|Overall Study|Lost to Follow-up|0|||
23366357|NCT00737100|65088904|FG000|Overall Study|Withdrawal by Subject|0|||
23366358|NCT00737100|65088905|FG001|Overall Study|Withdrawal by Subject|0|||
23366359|NCT00737100|65088906|FG002|Overall Study|Withdrawal by Subject|3|||
23366360|NCT00737100|65088904|FG000|Overall Study|Reason discontinued not explained above|1|||
23366361|NCT00737100|65088905|FG001|Overall Study|Reason discontinued not explained above|1|||
23366362|NCT00737100|65088906|FG002|Overall Study|Reason discontinued not explained above|1|||
23366363|NCT00471497|65088907|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
23270328|NCT03048500|64732045|FG000|Reached 1st Response/Continued Treatment|Death|1|||
23270329|NCT03048500|64732045|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
23270330|NCT03048500|64732045|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
23270331|NCT03048500|64732045|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
23270332|NCT03048500|64732045|FG000|Follow up for 3 Years|Death|12|||
23270333|NCT00385593|64732046|FG000|Overall Study|Adverse Event|3|||
23366364|NCT00471497|65088908|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
23366365|NCT00471497|65088909|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
23366366|NCT00471497|65088907|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
23366367|NCT00471497|65088908|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
23366368|NCT00471497|65088909|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
23366369|NCT00471497|65088907|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
23366370|NCT00471497|65088908|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
23366371|NCT00471497|65088909|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
23366372|NCT00471497|65088907|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
23366373|NCT00471497|65088908|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
23483215|NCT00976508|65512971|FG001|Overall Study|Lost to Follow-up|0|||
23483216|NCT00976508|65512970|FG000|Overall Study|Withdrawal by Subject|1|||
23483217|NCT00976508|65512971|FG001|Overall Study|Withdrawal by Subject|0|||
23483218|NCT00976508|65512970|FG000|Overall Study|Disease Progression|4|||
23483219|NCT00976508|65512971|FG001|Overall Study|Disease Progression|4|||
23483220|NCT00976508|65512970|FG000|Overall Study|Subject Enrolled in Hospice|1|||
23483221|NCT00976508|65512971|FG001|Overall Study|Subject Enrolled in Hospice|0|||
23483222|NCT00976508|65512970|FG000|Overall Study|Terminated by the Sponsor|0|||
23483223|NCT00976508|65512971|FG001|Overall Study|Terminated by the Sponsor|1|||
23601842|NCT02605174|65933916|FG001|Overall Study|Physician Decision|0|||
23601843|NCT02605174|65933917|FG002|Overall Study|Physician Decision|0|||
23601844|NCT02605174|65933918|FG003|Overall Study|Physician Decision|0|||
23601845|NCT02605174|65933919|FG004|Overall Study|Physician Decision|0|||
23601846|NCT02605174|65933920|FG005|Overall Study|Physician Decision|0|||
23601847|NCT02605174|65933921|FG006|Overall Study|Physician Decision|3|||
23601848|NCT02605174|65933915|FG000|Overall Study|Randomization Failure|22|||
23270334|NCT00385593|64732047|FG001|Overall Study|Adverse Event|2|||
23366374|NCT00471497|65088909|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
23366375|NCT00471497|65088907|FG000|Core Treatment Phase|Lost to Follow-up|6|||
23483224|NCT02320903|65512972|FG000|Overall Study|Withdrawal by Subject|0|||
23601849|NCT02605174|65933916|FG001|Overall Study|Randomization Failure|6|||
23601850|NCT02605174|65933917|FG002|Overall Study|Randomization Failure|20|||
23601851|NCT02605174|65933918|FG003|Overall Study|Randomization Failure|7|||
23366376|NCT00471497|65088908|FG001|Core Treatment Phase|Lost to Follow-up|6|||
23366377|NCT00471497|65088909|FG002|Core Treatment Phase|Lost to Follow-up|3|||
23366378|NCT00471497|65088907|FG000|Core Treatment Phase|Death|3|||
23366379|NCT00471497|65088908|FG001|Core Treatment Phase|Death|9|||
23366380|NCT00471497|65088909|FG002|Core Treatment Phase|Death|3|||
23483225|NCT02320903|65512973|FG001|Overall Study|Withdrawal by Subject|9|||
23483226|NCT02320903|65512974|FG002|Overall Study|Withdrawal by Subject|9|||
23483227|NCT02320903|65512972|FG000|Overall Study|Exited therapy; no longer eligible|8|||
23483228|NCT02320903|65512973|FG001|Overall Study|Exited therapy; no longer eligible|2|||
23483229|NCT02320903|65512974|FG002|Overall Study|Exited therapy; no longer eligible|2|||
23483230|NCT02320903|65512972|FG000|Overall Study|Lost to Follow-up|0|||
23483231|NCT02320903|65512973|FG001|Overall Study|Lost to Follow-up|5|||
23483232|NCT02320903|65512974|FG002|Overall Study|Lost to Follow-up|5|||
23483233|NCT01369485|65512975|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
23483234|NCT01369485|65512976|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
23483235|NCT01369485|65512975|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
23483236|NCT01369485|65512976|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
23483237|NCT01369485|65512975|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
23483238|NCT01369485|65512976|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
23483239|NCT01369485|65512975|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
23483240|NCT01369485|65512976|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
23483241|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
23483242|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
23483243|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
23483244|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
23483245|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
23270335|NCT00385593|64732046|FG000|Overall Study|Withdrawal by Subject|17|||
23483246|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
23483247|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
23483248|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
23483249|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
23483250|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
23483251|NCT01369485|65512975|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
23483252|NCT01369485|65512976|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
23483253|NCT03312751|65512977|FG000|Overall Study|Death|7|||
23483254|NCT03312751|65512978|FG001|Overall Study|Death|9|||
23483255|NCT03312751|65512977|FG000|Overall Study|Study discontinuation due to other reason|0|||
23483256|NCT03312751|65512978|FG001|Overall Study|Study discontinuation due to other reason|1|||
23483257|NCT03891667|65512979|FG000|Overall Study|Physician Decision|1|||
23483258|NCT03891667|65512980|FG001|Overall Study|Physician Decision|0|||
23483259|NCT03891667|65512979|FG000|Overall Study|COVID related pause|1|||
23483260|NCT03891667|65512980|FG001|Overall Study|COVID related pause|1|||
23483261|NCT03891667|65512979|FG000|Overall Study|Withdrawal by Subject|0|||
23601852|NCT02605174|65933919|FG004|Overall Study|Randomization Failure|16|||
23601853|NCT02605174|65933920|FG005|Overall Study|Randomization Failure|11|||
23601854|NCT02605174|65933921|FG006|Overall Study|Randomization Failure|30|||
23601855|NCT01105975|65933924|FG000|Overall Study|Adverse Event|2|||
23601856|NCT01105975|65933925|FG001|Overall Study|Adverse Event|1|||
23601857|NCT01105975|65933926|FG002|Overall Study|Adverse Event|5|||
23601858|NCT01105975|65933927|FG003|Overall Study|Adverse Event|1|||
23601859|NCT01105975|65933928|FG004|Overall Study|Adverse Event|0|||
23601860|NCT01105975|65933929|FG005|Overall Study|Adverse Event|1|||
23601861|NCT01105975|65933930|FG006|Overall Study|Adverse Event|2|||
23601862|NCT01105975|65933931|FG007|Overall Study|Adverse Event|4|||
23601863|NCT01105975|65933932|FG008|Overall Study|Adverse Event|1|||
23601864|NCT01105975|65933933|FG009|Overall Study|Adverse Event|4|||
23601865|NCT01105975|65933924|FG000|Overall Study|Withdrawal by Subject|2|||
23601866|NCT01105975|65933925|FG001|Overall Study|Withdrawal by Subject|2|||
23601867|NCT01105975|65933926|FG002|Overall Study|Withdrawal by Subject|2|||
23601868|NCT01105975|65933927|FG003|Overall Study|Withdrawal by Subject|0|||
23601869|NCT01105975|65933928|FG004|Overall Study|Withdrawal by Subject|4|||
23601870|NCT01105975|65933929|FG005|Overall Study|Withdrawal by Subject|1|||
23601871|NCT01105975|65933930|FG006|Overall Study|Withdrawal by Subject|2|||
23601872|NCT01105975|65933931|FG007|Overall Study|Withdrawal by Subject|1|||
23601873|NCT01105975|65933932|FG008|Overall Study|Withdrawal by Subject|0|||
23601874|NCT01105975|65933933|FG009|Overall Study|Withdrawal by Subject|3|||
23601875|NCT01105975|65933924|FG000|Overall Study|Lost to Follow-up|1|||
23601876|NCT01105975|65933925|FG001|Overall Study|Lost to Follow-up|0|||
23601877|NCT01105975|65933926|FG002|Overall Study|Lost to Follow-up|0|||
23270336|NCT00385593|64732047|FG001|Overall Study|Withdrawal by Subject|7|||
23601878|NCT01105975|65933927|FG003|Overall Study|Lost to Follow-up|1|||
23601879|NCT01105975|65933928|FG004|Overall Study|Lost to Follow-up|1|||
23601880|NCT01105975|65933929|FG005|Overall Study|Lost to Follow-up|0|||
23601881|NCT01105975|65933930|FG006|Overall Study|Lost to Follow-up|0|||
23601882|NCT01105975|65933931|FG007|Overall Study|Lost to Follow-up|0|||
23601883|NCT01105975|65933932|FG008|Overall Study|Lost to Follow-up|1|||
23270337|NCT00385593|64732046|FG000|Overall Study|Lost to Follow-up|12|||
23601884|NCT01105975|65933933|FG009|Overall Study|Lost to Follow-up|0|||
23601885|NCT01105975|65933924|FG000|Overall Study|Physician Decision|0|||
23483262|NCT03891667|65512980|FG001|Overall Study|Withdrawal by Subject|1|||
23483263|NCT03891667|65512979|FG000|Overall Study|Adverse Event|0|||
23483264|NCT03891667|65512980|FG001|Overall Study|Adverse Event|1|||
23483265|NCT03189381|65512983|FG000|Overall Study|Death|1|||
23483266|NCT03189381|65512984|FG001|Overall Study|Death|0|||
23483267|NCT03222492|65512985|FG000|Overall Study|Withdrawal by Subject|0|||
23483268|NCT03222492|65512986|FG001|Overall Study|Withdrawal by Subject|0|||
23483269|NCT03222492|65512987|FG002|Overall Study|Withdrawal by Subject|1|||
23483270|NCT03222492|65512988|FG003|Overall Study|Withdrawal by Subject|0|||
23483271|NCT03222492|65512985|FG000|Overall Study|COVID-19 related|0|||
23483272|NCT03222492|65512986|FG001|Overall Study|COVID-19 related|0|||
23483273|NCT03222492|65512987|FG002|Overall Study|COVID-19 related|1|||
23483274|NCT03222492|65512988|FG003|Overall Study|COVID-19 related|0|||
23483275|NCT03170232|65512992|FG000|Overall Study|Adverse Event|0|||
23270338|NCT00385593|64732047|FG001|Overall Study|Lost to Follow-up|8|||
23270339|NCT00385593|64732046|FG000|Overall Study|Protocol Violation|7|||
23270340|NCT00385593|64732047|FG001|Overall Study|Protocol Violation|4|||
23483276|NCT03170232|65512993|FG001|Overall Study|Adverse Event|1|||
23483277|NCT03170232|65512992|FG000|Overall Study|Protocol Violation|0|||
23483278|NCT03170232|65512993|FG001|Overall Study|Protocol Violation|1|||
23483279|NCT03170232|65512992|FG000|Overall Study|Lack of Efficacy|0|||
23483280|NCT03170232|65512993|FG001|Overall Study|Lack of Efficacy|1|||
23483281|NCT03170232|65512992|FG000|Overall Study|Study closed/terminated|26|||
23483282|NCT03170232|65512993|FG001|Overall Study|Study closed/terminated|23|||
23483283|NCT03170232|65512992|FG000|Overall Study|Lost to Follow-up|1|||
23483284|NCT03170232|65512993|FG001|Overall Study|Lost to Follow-up|0|||
23483285|NCT03170232|65512992|FG000|Overall Study|Withdrawal by Subject|0|||
23483286|NCT03170232|65512993|FG001|Overall Study|Withdrawal by Subject|1|||
23483287|NCT00278915|65512996|FG000|Overall Study|Disease progression|1|||
23483288|NCT00910247|65512997|FG000|Overall Study|Adverse Event|15|||
23483289|NCT00910247|65512997|FG000|Overall Study|Death|2|||
23483290|NCT00910247|65512997|FG000|Overall Study|Lost to Follow-up|10|||
23483291|NCT00910247|65512997|FG000|Overall Study|Physician Decision|3|||
23483292|NCT00910247|65512997|FG000|Overall Study|Protocol Violation|10|||
23483293|NCT00910247|65512997|FG000|Overall Study|Withdrawal by Subject|25|||
23483294|NCT00910247|65512997|FG000|Overall Study|Not collected|4|||
23483295|NCT02125604|65512998|FG000|Overall Study|Other|4|||
23483296|NCT02125604|65512998|FG000|Overall Study|Investigator Decision|1|||
23483297|NCT02125604|65512998|FG000|Overall Study|Lost to Follow-up|2|||
23483298|NCT02125604|65512998|FG000|Overall Study|Consent Withdrawn|4|||
23483299|NCT02125604|65512998|FG000|Overall Study|Adverse Event|20|||
23483300|NCT03059446|65512999|FG000|Overall Study|Adverse Event|11|||
23483301|NCT03059446|65512999|FG000|Overall Study|Withdrawal of Consent|16|||
23483302|NCT03059446|65512999|FG000|Overall Study|Lost to Follow-up|3|||
23483303|NCT03059446|65512999|FG000|Overall Study|Protocol Violation|1|||
23483304|NCT03059446|65512999|FG000|Overall Study|Study Terminated by Sponsor|131|||
23483305|NCT03059446|65512999|FG000|Overall Study|Reason not Specified|5|||
23483306|NCT01609478|65513002|FG000|Overall Study|Adverse Event|3|||
23483307|NCT01609478|65513003|FG001|Overall Study|Adverse Event|1|||
23483308|NCT01609478|65513004|FG002|Overall Study|Adverse Event|5|||
23270341|NCT00385593|64732046|FG000|Overall Study|Several reasons|17|||
23270342|NCT00385593|64732047|FG001|Overall Study|Several reasons|15|||
23270343|NCT00385593|64732046|FG000|Overall Study|Incorrect inclusion|2|||
23270344|NCT00385593|64732047|FG001|Overall Study|Incorrect inclusion|0|||
23270345|NCT00385593|64732046|FG000|Overall Study|Incorrect randomization|0|||
23270346|NCT00385593|64732047|FG001|Overall Study|Incorrect randomization|1|||
23270347|NCT01318499|64732048|FG000|Overall Study|Adverse Event|16|||
23270348|NCT01318499|64732049|FG001|Overall Study|Adverse Event|11|||
23270349|NCT01318499|64732050|FG002|Overall Study|Adverse Event|6|||
23270350|NCT01318499|64732048|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
23270351|NCT01318499|64732049|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
23270352|NCT01318499|64732050|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
23270353|NCT01318499|64732048|FG000|Overall Study|Noncompliance|2|||
23483309|NCT01609478|65513002|FG000|Overall Study|Protocol Deviation|0|||
23483310|NCT01609478|65513003|FG001|Overall Study|Protocol Deviation|1|||
23483311|NCT01609478|65513004|FG002|Overall Study|Protocol Deviation|1|||
23483312|NCT01609478|65513002|FG000|Overall Study|Non-Compliance with study treatment|1|||
23483313|NCT01609478|65513003|FG001|Overall Study|Non-Compliance with study treatment|0|||
23483314|NCT01609478|65513004|FG002|Overall Study|Non-Compliance with study treatment|0|||
23483315|NCT01609478|65513002|FG000|Overall Study|Physician Decision|1|||
23483316|NCT01609478|65513003|FG001|Overall Study|Physician Decision|0|||
23270354|NCT01318499|64732049|FG001|Overall Study|Noncompliance|3|||
23483317|NCT01609478|65513004|FG002|Overall Study|Physician Decision|1|||
23483318|NCT01609478|65513002|FG000|Overall Study|Withdrawal by Subject|2|||
23270355|NCT01318499|64732050|FG002|Overall Study|Noncompliance|0|||
23270356|NCT01318499|64732048|FG000|Overall Study|Treatment Failure|19|||
23483319|NCT01609478|65513003|FG001|Overall Study|Withdrawal by Subject|0|||
23483320|NCT01609478|65513004|FG002|Overall Study|Withdrawal by Subject|2|||
23483321|NCT01288976|65513005|FG000|Overall Study|Withdrawal by Subject|58|||
23483322|NCT01288976|65513006|FG001|Overall Study|Withdrawal by Subject|12|||
23483323|NCT01288976|65513007|FG002|Overall Study|Withdrawal by Subject|9|||
23483324|NCT01288976|65513005|FG000|Overall Study|Death|98|||
23483325|NCT01288976|65513006|FG001|Overall Study|Death|6|||
23483326|NCT01288976|65513007|FG002|Overall Study|Death|4|||
23483327|NCT01288976|65513005|FG000|Overall Study|Data unavailable|22|||
23483328|NCT01288976|65513006|FG001|Overall Study|Data unavailable|9|||
23483329|NCT01288976|65513007|FG002|Overall Study|Data unavailable|7|||
23483330|NCT00609362|65513008|FG000|Overall Study|Withdrawal by Subject|2|||
23483331|NCT00609362|65513009|FG001|Overall Study|Withdrawal by Subject|1|||
23483332|NCT00609362|65513008|FG000|Overall Study|Adverse Event|1|||
23483333|NCT00609362|65513009|FG001|Overall Study|Adverse Event|0|||
23483334|NCT02230527|65513014|FG000|Overall Study|Withdrawal by Subject|1|||
23483335|NCT02230527|65513015|FG001|Overall Study|Withdrawal by Subject|1|||
23483336|NCT02230527|65513014|FG000|Overall Study|Death|1|||
23270357|NCT01318499|64732049|FG001|Overall Study|Treatment Failure|19|||
23270358|NCT01318499|64732050|FG002|Overall Study|Treatment Failure|101|||
23270359|NCT01318499|64732048|FG000|Overall Study|Protocol Violation|2|||
23270360|NCT01318499|64732049|FG001|Overall Study|Protocol Violation|4|||
23270361|NCT01318499|64732050|FG002|Overall Study|Protocol Violation|2|||
23270362|NCT01318499|64732048|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
23270363|NCT01318499|64732049|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
23270364|NCT01318499|64732050|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
23270365|NCT01318499|64732048|FG000|Overall Study|Other|7|||
23270366|NCT01318499|64732049|FG001|Overall Study|Other|10|||
23270367|NCT01318499|64732050|FG002|Overall Study|Other|22|||
23270368|NCT01406795|64732054|FG000|Overall Study|Withdrawal by Subject|1|||
23270369|NCT01139164|64732057|FG000|Overall Study|Withdrawn prior to study start|0|||
23270370|NCT01139164|64732058|FG001|Overall Study|Withdrawn prior to study start|2|||
23270371|NCT01139164|64732059|FG002|Overall Study|Withdrawn prior to study start|0|||
23270372|NCT02246478|64732060|FG000|Multiple-dose Phase|Protocol Violation|1|||
23270373|NCT02246478|64732061|FG001|Multiple-dose Phase|Protocol Violation|0|||
23270374|NCT02246478|64732062|FG002|Multiple-dose Phase|Protocol Violation|0|||
23270375|NCT02246478|64732063|FG003|Multiple-dose Phase|Protocol Violation|1|||
23270376|NCT00950872|64732069|FG000|Overall Study|Withdrawal by Subject|1|||
23270377|NCT00950872|64732069|FG000|Overall Study|Did not have surgery|2|||
23270378|NCT01734772|64732074|FG000|Overall Study|Adverse Event|1|||
23366381|NCT00471497|65088907|FG000|Core Treatment Phase|Disease Progression|10|||
23366382|NCT00471497|65088908|FG001|Core Treatment Phase|Disease Progression|2|||
23366383|NCT00471497|65088909|FG002|Core Treatment Phase|Disease Progression|4|||
23270379|NCT01734772|64732075|FG001|Overall Study|Adverse Event|2|||
23483337|NCT02230527|65513015|FG001|Overall Study|Death|0|||
23483338|NCT02230527|65513014|FG000|Overall Study|Lost to Follow-up|2|||
23483339|NCT02230527|65513015|FG001|Overall Study|Lost to Follow-up|1|||
23270380|NCT01734772|64732074|FG000|Overall Study|Withdrawal by Subject|0|||
23270381|NCT01734772|64732075|FG001|Overall Study|Withdrawal by Subject|1|||
23270382|NCT00220701|64732076|FG000|Overall Study|Lost to Follow-up|5|||
23270383|NCT00220701|64732077|FG001|Overall Study|Lost to Follow-up|4|||
23270384|NCT03262012|64735225|FG000|Overall Study|Withdrawal by Subject|15|||
23270385|NCT03262012|64735226|FG001|Overall Study|Withdrawal by Subject|13|||
23270386|NCT03262012|64735227|FG002|Overall Study|Withdrawal by Subject|8|||
23270387|NCT03262012|64735228|FG003|Overall Study|Withdrawal by Subject|7|||
23270388|NCT03262012|64735225|FG000|Overall Study|Adverse Event|10|||
23270389|NCT03262012|64735226|FG001|Overall Study|Adverse Event|12|||
23270390|NCT03262012|64735227|FG002|Overall Study|Adverse Event|4|||
23270391|NCT03262012|64735228|FG003|Overall Study|Adverse Event|6|||
23270392|NCT03262012|64735225|FG000|Overall Study|Physician Decision|2|||
23270393|NCT03262012|64735226|FG001|Overall Study|Physician Decision|5|||
23270394|NCT03262012|64735227|FG002|Overall Study|Physician Decision|1|||
23270395|NCT03262012|64735228|FG003|Overall Study|Physician Decision|0|||
23270396|NCT03262012|64735225|FG000|Overall Study|Lack of Efficacy|0|||
23270397|NCT03262012|64735226|FG001|Overall Study|Lack of Efficacy|5|||
23270398|NCT03262012|64735227|FG002|Overall Study|Lack of Efficacy|1|||
23270399|NCT03262012|64735228|FG003|Overall Study|Lack of Efficacy|2|||
23270400|NCT03262012|64735225|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
23483340|NCT02230527|65513014|FG000|Overall Study|Other|1|||
23270401|NCT03262012|64735226|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
23270402|NCT03262012|64735227|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
23270403|NCT03262012|64735228|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
23270404|NCT00527423|64735229|FG000|Overall Study|Protocol Violation|1|||
23270405|NCT00527423|64735229|FG000|Overall Study|Adverse Event|5|||
23270406|NCT00527423|64735229|FG000|Overall Study|Physician Decision|4|||
23270407|NCT00527423|64735229|FG000|Overall Study|Withdrawal by Subject|10|||
23270408|NCT00527423|64735229|FG000|Overall Study|Lost to Follow-up|4|||
23270409|NCT00527423|64735229|FG000|Overall Study|OTHER|4|||
23270410|NCT00527423|64735229|FG000|Overall Study|Death|9|||
23270411|NCT04213326|64735230|FG000|Overall Study|Consent withdrawn|51|||
23270412|NCT04213326|64735231|FG001|Overall Study|Consent withdrawn|241|||
23270413|NCT04213326|64735230|FG000|Overall Study|Lost to Follow-up|50|||
23270414|NCT04213326|64735231|FG001|Overall Study|Lost to Follow-up|902|||
23270415|NCT04213326|64735230|FG000|Overall Study|Protocol Violation|3|||
23270416|NCT04213326|64735231|FG001|Overall Study|Protocol Violation|25|||
23270417|NCT04213326|64735230|FG000|Overall Study|Participant eligibility changed|106|||
23270418|NCT04213326|64735231|FG001|Overall Study|Participant eligibility changed|19|||
23270419|NCT04213326|64735230|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
23270420|NCT04213326|64735231|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
23270421|NCT04213326|64735230|FG000|Overall Study|Incomplete study visit|0|||
23270422|NCT04213326|64735231|FG001|Overall Study|Incomplete study visit|367|||
23270423|NCT03629249|64735232|FG000|Overall Study|Study terminated by sponsor|197|||
23270424|NCT03629249|64735233|FG001|Overall Study|Study terminated by sponsor|197|||
23270425|NCT03629249|64735234|FG002|Overall Study|Study terminated by sponsor|194|||
23270426|NCT03629249|64735232|FG000|Overall Study|Protocol deviation|0|||
23270427|NCT03629249|64735233|FG001|Overall Study|Protocol deviation|2|||
23270428|NCT03629249|64735234|FG002|Overall Study|Protocol deviation|5|||
23270429|NCT03629249|64735232|FG000|Overall Study|Subject decision|1|||
23270430|NCT03629249|64735233|FG001|Overall Study|Subject decision|1|||
23270431|NCT03629249|64735234|FG002|Overall Study|Subject decision|3|||
23270432|NCT03629249|64735232|FG000|Overall Study|Adverse Event|1|||
23270433|NCT03629249|64735233|FG001|Overall Study|Adverse Event|1|||
23270434|NCT03629249|64735234|FG002|Overall Study|Adverse Event|0|||
23270435|NCT03629249|64735232|FG000|Overall Study|Death|1|||
23270436|NCT03629249|64735233|FG001|Overall Study|Death|0|||
23270437|NCT03629249|64735234|FG002|Overall Study|Death|0|||
23270438|NCT03629249|64735232|FG000|Overall Study|Physician Decision|1|||
23270439|NCT03629249|64735233|FG001|Overall Study|Physician Decision|0|||
23270440|NCT03629249|64735234|FG002|Overall Study|Physician Decision|0|||
23601886|NCT01105975|65933925|FG001|Overall Study|Physician Decision|0|||
23270441|NCT00533273|64735240|FG000|Double-blind|Withdrew consent|0|||
23270442|NCT00533273|64735241|FG001|Double-blind|Withdrew consent|2|||
23270443|NCT00533273|64735240|FG000|Open-label|Withdrawal by Subject|6|||
23270444|NCT00533273|64735241|FG001|Open-label|Withdrawal by Subject|0|||
23270445|NCT01044732|64735244|FG000|Overall Study|Lost to Follow-up|2|||
23366384|NCT00471497|65088907|FG000|Core Treatment Phase|Protocol Violation|6|||
23366385|NCT00471497|65088908|FG001|Core Treatment Phase|Protocol Violation|15|||
23366386|NCT00471497|65088909|FG002|Core Treatment Phase|Protocol Violation|11|||
23366387|NCT00471497|65088907|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
23366388|NCT00471497|65088908|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
23366389|NCT00471497|65088909|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
23366390|NCT00471497|65088907|FG000|Core Treatment Phase|Administrative problems|14|||
23366391|NCT00471497|65088908|FG001|Core Treatment Phase|Administrative problems|14|||
23483341|NCT02230527|65513015|FG001|Overall Study|Other|0|||
23483342|NCT03091777|65513020|FG000|Overall Study|Pregnancy|2|||
23483343|NCT03091777|65513021|FG001|Overall Study|Pregnancy|1|||
23483344|NCT03091777|65513022|FG002|Overall Study|Pregnancy|0|||
23483345|NCT03091777|65513020|FG000|Overall Study|Adverse Event|2|||
23366392|NCT00471497|65088909|FG002|Core Treatment Phase|Administrative problems|12|||
23366393|NCT00471497|65088907|FG000|Core Treatment Phase|Adverse Event|43|||
23366394|NCT00471497|65088908|FG001|Core Treatment Phase|Adverse Event|53|||
23366395|NCT00471497|65088909|FG002|Core Treatment Phase|Adverse Event|89|||
23483346|NCT03091777|65513021|FG001|Overall Study|Adverse Event|1|||
23483347|NCT03091777|65513022|FG002|Overall Study|Adverse Event|4|||
23483348|NCT03091777|65513020|FG000|Overall Study|Withdrawal by Subject|4|||
23483349|NCT03091777|65513021|FG001|Overall Study|Withdrawal by Subject|2|||
23483350|NCT03091777|65513022|FG002|Overall Study|Withdrawal by Subject|6|||
23483351|NCT03091777|65513020|FG000|Overall Study|Protocol Violation|2|||
23483352|NCT03091777|65513021|FG001|Overall Study|Protocol Violation|1|||
23483353|NCT03091777|65513022|FG002|Overall Study|Protocol Violation|1|||
23483354|NCT03091777|65513020|FG000|Overall Study|Lost to Follow-up|12|||
23483355|NCT03091777|65513021|FG001|Overall Study|Lost to Follow-up|14|||
23483356|NCT03091777|65513022|FG002|Overall Study|Lost to Follow-up|7|||
23483357|NCT03091777|65513020|FG000|Overall Study|Lack of Efficacy|0|||
23483358|NCT03091777|65513021|FG001|Overall Study|Lack of Efficacy|0|||
23483359|NCT03091777|65513022|FG002|Overall Study|Lack of Efficacy|5|||
23483360|NCT03091777|65513020|FG000|Overall Study|Noncompliance with study drug|2|||
23483361|NCT03091777|65513021|FG001|Overall Study|Noncompliance with study drug|3|||
23483362|NCT03091777|65513022|FG002|Overall Study|Noncompliance with study drug|1|||
23483363|NCT03091777|65513020|FG000|Overall Study|Physician Decision|1|||
23483364|NCT03091777|65513021|FG001|Overall Study|Physician Decision|0|||
23483365|NCT03091777|65513022|FG002|Overall Study|Physician Decision|1|||
23483366|NCT03091777|65513020|FG000|Overall Study|Abnormal Laboratory Value|7|||
23483367|NCT03091777|65513021|FG001|Overall Study|Abnormal Laboratory Value|11|||
23483368|NCT03091777|65513022|FG002|Overall Study|Abnormal Laboratory Value|12|||
23483369|NCT01895361|65513023|FG000|Overall Study|Adverse Event|1|||
23483370|NCT01895361|65513024|FG001|Overall Study|Adverse Event|1|||
23483371|NCT01895361|65513025|FG002|Overall Study|Adverse Event|3|||
23366396|NCT00471497|65088907|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
23366397|NCT00471497|65088908|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
23366398|NCT00471497|65088909|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
23366399|NCT00471497|65088907|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
23366400|NCT00471497|65088908|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
23366401|NCT00471497|65088909|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
23366402|NCT00471497|65088907|FG000|Extension Phase|Adverse Event|9|||
23366403|NCT00471497|65088908|FG001|Extension Phase|Adverse Event|5|||
23483372|NCT01895361|65513023|FG000|Overall Study|Death|2|||
23483373|NCT01895361|65513024|FG001|Overall Study|Death|1|||
23483374|NCT01895361|65513025|FG002|Overall Study|Death|2|||
23483375|NCT01895361|65513023|FG000|Overall Study|Lost to Follow-up|4|||
23483376|NCT01895361|65513024|FG001|Overall Study|Lost to Follow-up|4|||
23483377|NCT01895361|65513025|FG002|Overall Study|Lost to Follow-up|6|||
23483378|NCT01895361|65513023|FG000|Overall Study|Non-compliance with study|1|||
23483379|NCT01895361|65513024|FG001|Overall Study|Non-compliance with study|3|||
23483380|NCT01895361|65513025|FG002|Overall Study|Non-compliance with study|1|||
23483381|NCT01895361|65513023|FG000|Overall Study|Physician Decision|2|||
23483382|NCT01895361|65513024|FG001|Overall Study|Physician Decision|2|||
23483383|NCT01895361|65513025|FG002|Overall Study|Physician Decision|2|||
23601887|NCT01105975|65933926|FG002|Overall Study|Physician Decision|0|||
23601888|NCT01105975|65933927|FG003|Overall Study|Physician Decision|0|||
23270446|NCT01044732|64735245|FG001|Overall Study|Lost to Follow-up|1|||
23270447|NCT01044732|64735244|FG000|Overall Study|Physician Decision|5|||
23483384|NCT01895361|65513023|FG000|Overall Study|Withdrawal by Subject|7|||
23483385|NCT01895361|65513024|FG001|Overall Study|Withdrawal by Subject|6|||
23483386|NCT01895361|65513025|FG002|Overall Study|Withdrawal by Subject|6|||
23483387|NCT01895361|65513023|FG000|Overall Study|Lack of Efficacy|0|||
23483388|NCT01895361|65513024|FG001|Overall Study|Lack of Efficacy|1|||
23270448|NCT01044732|64735245|FG001|Overall Study|Physician Decision|3|||
23270449|NCT01044732|64735244|FG000|Overall Study|Protocol Violation|11|||
23270450|NCT01044732|64735245|FG001|Overall Study|Protocol Violation|12|||
23270451|NCT01044732|64735244|FG000|Overall Study|Withdrawal by Subject|0|||
23483389|NCT01895361|65513025|FG002|Overall Study|Lack of Efficacy|0|||
23483390|NCT01895361|65513023|FG000|Overall Study|Reasons different from categories above|7|||
23483391|NCT01895361|65513024|FG001|Overall Study|Reasons different from categories above|3|||
23270452|NCT01044732|64735245|FG001|Overall Study|Withdrawal by Subject|1|||
23270453|NCT01044732|64735244|FG000|Overall Study|Inadequate bowel preparation|11|||
23270454|NCT01044732|64735245|FG001|Overall Study|Inadequate bowel preparation|17|||
23270455|NCT01044732|64735244|FG000|Overall Study|Inability to reach cecum|5|||
23270456|NCT01044732|64735245|FG001|Overall Study|Inability to reach cecum|2|||
23270457|NCT01044732|64735244|FG000|Overall Study|Technical error or malfunction|15|||
23270458|NCT01044732|64735245|FG001|Overall Study|Technical error or malfunction|14|||
23270459|NCT02374853|64735246|FG000|Overall Study|Surgery Cancelled|5|||
23483392|NCT01895361|65513025|FG002|Overall Study|Reasons different from categories above|4|||
23483393|NCT03631355|65513026|FG000|Overall Study|Lost to Follow-up|1|||
23483394|NCT03631355|65513027|FG001|Overall Study|Lost to Follow-up|2|||
23483395|NCT00134784|65513030|FG000|Overall Study|Withdrawal by Subject|2|||
23483396|NCT00134784|65513031|FG001|Overall Study|Withdrawal by Subject|2|||
23483397|NCT00134784|65513032|FG002|Overall Study|Withdrawal by Subject|2|||
23483398|NCT00134784|65513033|FG003|Overall Study|Withdrawal by Subject|1|||
23483399|NCT01142128|65513034|FG000|Overall Study|Physician Decision|1|||
23483400|NCT01142128|65513034|FG000|Overall Study|Lost to Follow-up|1|||
23483401|NCT01142128|65513034|FG000|Overall Study|Withdrawal by Subject|2|||
23483402|NCT01653782|65513035|FG000|Overall Study|Withdrawal by Subject|9|||
23483403|NCT01653782|65513036|FG001|Overall Study|Withdrawal by Subject|15|||
23483404|NCT01653782|65513037|FG002|Overall Study|Withdrawal by Subject|4|||
23483405|NCT01653782|65513035|FG000|Overall Study|Lost to Follow-up|7|||
23483406|NCT01653782|65513036|FG001|Overall Study|Lost to Follow-up|3|||
23483407|NCT01653782|65513037|FG002|Overall Study|Lost to Follow-up|2|||
23483408|NCT02937584|65513040|FG000|Period 1|Adverse Event|1|||
23483409|NCT02937584|65513041|FG001|Period 1|Adverse Event|2|||
23483410|NCT02937584|65513040|FG000|Washout|Adverse Event|0|||
23483411|NCT02937584|65513041|FG001|Washout|Adverse Event|1|||
23483412|NCT04369924|65513042|FG000|Overall Study|Lost to Follow-up|302|||
23483413|NCT04369924|65513043|FG001|Overall Study|Lost to Follow-up|339|||
23483414|NCT02312687|65513050|FG000|Overall Study|Other, Not Specified|1|||
23483415|NCT03687970|65513051|FG000|Overall Study|visit scheduling conflicts|2|||
23483416|NCT03687970|65513052|FG001|Overall Study|visit scheduling conflicts|0|||
23483417|NCT00827931|65513053|FG000|Overall Study|Death|3|||
23483418|NCT00827931|65513054|FG001|Overall Study|Death|5|||
23483419|NCT00827931|65513053|FG000|Overall Study|Adverse Event|1|||
23483420|NCT00827931|65513054|FG001|Overall Study|Adverse Event|0|||
23483421|NCT00827931|65513053|FG000|Overall Study|Lost to Follow-up|1|||
23483422|NCT00827931|65513054|FG001|Overall Study|Lost to Follow-up|0|||
23483423|NCT00827931|65513053|FG000|Overall Study|Withdrawal by Subject|0|||
23483424|NCT00827931|65513054|FG001|Overall Study|Withdrawal by Subject|1|||
23483425|NCT00827931|65513053|FG000|Overall Study|Other|1|||
23483426|NCT00827931|65513054|FG001|Overall Study|Other|0|||
23483427|NCT00999921|65513056|FG000|Overall Study|Lost to Follow-up|10|||
23483428|NCT00999921|65513057|FG001|Overall Study|Lost to Follow-up|19|||
23483429|NCT02446743|65513059|FG000|Overall Study|Withdrawal by Subject|1|||
23270460|NCT02374853|64735247|FG001|Overall Study|Surgery Cancelled|11|||
23270461|NCT00723528|64735248|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
23270462|NCT00723528|64735249|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
23270463|NCT00723528|64735250|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
23270464|NCT00723528|64735251|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
23270465|NCT00723528|64735252|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
23270466|NCT00723528|64735253|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
23270467|NCT00723528|64735254|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
23270468|NCT00723528|64735248|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
23270469|NCT00723528|64735249|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23270470|NCT00723528|64735250|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23270471|NCT00723528|64735251|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23270472|NCT00723528|64735252|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23270473|NCT00723528|64735253|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23270474|NCT00723528|64735254|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
23483430|NCT02446743|65513060|FG001|Overall Study|Withdrawal by Subject|1|||
23483431|NCT02446743|65513059|FG000|Overall Study|Lost to Follow-up|1|||
23270475|NCT00723528|64735248|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
23483432|NCT02446743|65513060|FG001|Overall Study|Lost to Follow-up|0|||
23483433|NCT02446743|65513059|FG000|Overall Study|Adverse Event|1|||
23483434|NCT02446743|65513060|FG001|Overall Study|Adverse Event|1|||
23483435|NCT02446743|65513059|FG000|Overall Study|Other|2|||
23483436|NCT02446743|65513060|FG001|Overall Study|Other|3|||
23483437|NCT01390220|65513061|FG000|Test Dose Phase|Adverse Event|17|||
23483438|NCT01390220|65513062|FG001|Test Dose Phase|Adverse Event|0|||
23483439|NCT01390220|65513063|FG002|Test Dose Phase|Adverse Event|0|||
23483440|NCT01390220|65513061|FG000|Test Dose Phase|Withdrawal by Subject|8|||
23270476|NCT00723528|64735249|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
23366404|NCT00471497|65088909|FG002|Extension Phase|Adverse Event|1|||
23270477|NCT00723528|64735250|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
23270478|NCT00723528|64735251|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
23270479|NCT00723528|64735252|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
23270480|NCT00723528|64735253|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
23270481|NCT00723528|64735254|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
23270482|NCT00723528|64735248|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23270483|NCT00723528|64735249|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23270484|NCT00723528|64735250|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
23270485|NCT00723528|64735251|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23270486|NCT00723528|64735252|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23270487|NCT00723528|64735253|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23270488|NCT00723528|64735254|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
23270489|NCT00723528|64735248|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
23270490|NCT00723528|64735249|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23270491|NCT00723528|64735250|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
23270492|NCT00723528|64735251|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23270493|NCT00723528|64735252|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23270494|NCT00723528|64735253|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23270495|NCT00723528|64735254|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
23270496|NCT00723528|64735248|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
23270497|NCT00723528|64735249|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
23270498|NCT00723528|64735250|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
23270499|NCT00723528|64735251|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
23270500|NCT00723528|64735252|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
23270501|NCT00723528|64735253|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
23270502|NCT00723528|64735254|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
23270503|NCT00723528|64735248|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23270504|NCT00723528|64735249|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23270505|NCT00723528|64735250|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23270506|NCT00723528|64735251|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23270507|NCT00723528|64735252|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23270508|NCT00723528|64735253|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
23270509|NCT00723528|64735254|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
23270510|NCT00723528|64735248|FG000|Period 2: After Controlled Period|Other|0|||
23270511|NCT00723528|64735249|FG001|Period 2: After Controlled Period|Other|0|||
23270512|NCT00723528|64735250|FG002|Period 2: After Controlled Period|Other|0|||
23270513|NCT00723528|64735251|FG003|Period 2: After Controlled Period|Other|0|||
23270514|NCT00723528|64735252|FG004|Period 2: After Controlled Period|Other|1|||
23270515|NCT00723528|64735253|FG005|Period 2: After Controlled Period|Other|4|||
23270516|NCT00723528|64735254|FG006|Period 2: After Controlled Period|Other|0|||
23270517|NCT00723528|64735248|FG000|Period 2: After Controlled Period|Adverse Event|0|||
23270518|NCT00723528|64735249|FG001|Period 2: After Controlled Period|Adverse Event|0|||
23270519|NCT00723528|64735250|FG002|Period 2: After Controlled Period|Adverse Event|0|||
23270520|NCT00723528|64735251|FG003|Period 2: After Controlled Period|Adverse Event|0|||
23270521|NCT00723528|64735252|FG004|Period 2: After Controlled Period|Adverse Event|1|||
23270522|NCT00723528|64735253|FG005|Period 2: After Controlled Period|Adverse Event|0|||
23270523|NCT00723528|64735254|FG006|Period 2: After Controlled Period|Adverse Event|1|||
23270524|NCT00723528|64735248|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23270525|NCT00723528|64735249|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23366405|NCT00471497|65088907|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
23366406|NCT00471497|65088908|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
23366407|NCT00471497|65088909|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
23366408|NCT00471497|65088907|FG000|Extension Phase|Withdrawal by Subject|3|||
23366409|NCT00471497|65088908|FG001|Extension Phase|Withdrawal by Subject|1|||
23366410|NCT00471497|65088909|FG002|Extension Phase|Withdrawal by Subject|0|||
23366411|NCT00471497|65088907|FG000|Extension Phase|Lost to Follow-up|2|||
23366412|NCT00471497|65088908|FG001|Extension Phase|Lost to Follow-up|0|||
23366413|NCT00471497|65088909|FG002|Extension Phase|Lost to Follow-up|0|||
23366414|NCT00471497|65088907|FG000|Extension Phase|Death|1|||
23366415|NCT00471497|65088908|FG001|Extension Phase|Death|0|||
23366416|NCT00471497|65088909|FG002|Extension Phase|Death|0|||
23366417|NCT00471497|65088907|FG000|Extension Phase|Disease progression|2|||
23366418|NCT00471497|65088908|FG001|Extension Phase|Disease progression|0|||
23366419|NCT00471497|65088909|FG002|Extension Phase|Disease progression|0|||
23366420|NCT00471497|65088907|FG000|Extension Phase|Protocol Violation|2|||
23366421|NCT00471497|65088908|FG001|Extension Phase|Protocol Violation|2|||
23366422|NCT00471497|65088909|FG002|Extension Phase|Protocol Violation|0|||
23483441|NCT01390220|65513062|FG001|Test Dose Phase|Withdrawal by Subject|0|||
23270526|NCT00723528|64735250|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23270527|NCT00723528|64735251|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23270528|NCT00723528|64735252|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23270529|NCT00723528|64735253|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
23270530|NCT00723528|64735254|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
23270531|NCT00723528|64735248|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23270532|NCT00723528|64735249|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23270533|NCT00723528|64735250|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23270534|NCT00723528|64735251|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23270535|NCT00723528|64735252|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23270536|NCT00723528|64735253|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
23270537|NCT00723528|64735254|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
23270538|NCT00366899|64735255|FG000|Infant Series|Withdrawal by Subject|4|||
23270539|NCT00366899|64735256|FG001|Infant Series|Withdrawal by Subject|7|||
23270540|NCT00366899|64735255|FG000|Infant Series|Protocol Violation|2|||
23270541|NCT00366899|64735256|FG001|Infant Series|Protocol Violation|1|||
23270542|NCT00366899|64735255|FG000|Infant Series|Failed to return|1|||
23270543|NCT00366899|64735256|FG001|Infant Series|Failed to return|1|||
23270544|NCT00366899|64735255|FG000|Infant Series|Lost to Follow-up|0|||
23270545|NCT00366899|64735256|FG001|Infant Series|Lost to Follow-up|2|||
23270546|NCT00366899|64735255|FG000|Infant Series|Adverse Event|0|||
23270547|NCT00366899|64735256|FG001|Infant Series|Adverse Event|1|||
23270548|NCT00366899|64735255|FG000|Infant Series|Physician Decision|1|||
23270549|NCT00366899|64735256|FG001|Infant Series|Physician Decision|0|||
23270550|NCT00366899|64735255|FG000|Infant Series|Randomized but not consented|1|||
23270551|NCT00366899|64735256|FG001|Infant Series|Randomized but not consented|0|||
23270552|NCT00366899|64735255|FG000|After Infant Series|Lost to Follow-up|4|||
23270553|NCT00366899|64735256|FG001|After Infant Series|Lost to Follow-up|3|||
23270554|NCT00366899|64735255|FG000|After Infant Series|Withdrawal by Subject|1|||
23270555|NCT00366899|64735256|FG001|After Infant Series|Withdrawal by Subject|4|||
23270556|NCT00366899|64735255|FG000|After Infant Series|Adverse Event|1|||
23270557|NCT00366899|64735256|FG001|After Infant Series|Adverse Event|2|||
23270558|NCT00366899|64735255|FG000|After Infant Series|Protocol Violation|1|||
23270559|NCT00366899|64735256|FG001|After Infant Series|Protocol Violation|0|||
23270560|NCT00366899|64735255|FG000|Toddler Dose|Withdrawal by Subject|1|||
23270561|NCT00366899|64735256|FG001|Toddler Dose|Withdrawal by Subject|1|||
23270562|NCT00366899|64735255|FG000|Toddler Dose|Protocol Violation|1|||
23270563|NCT00366899|64735256|FG001|Toddler Dose|Protocol Violation|0|||
23270564|NCT02015390|64735262|FG000|Overall Study|Lost to Follow-up|1|||
23270565|NCT02015390|64735263|FG001|Overall Study|Lost to Follow-up|0|||
23270566|NCT02015390|64735262|FG000|Overall Study|Adverse Event|0|||
23270567|NCT02015390|64735263|FG001|Overall Study|Adverse Event|3|||
23270568|NCT02015390|64735262|FG000|Overall Study|Physician Decision|0|||
23270569|NCT02015390|64735263|FG001|Overall Study|Physician Decision|1|||
23270570|NCT01700621|64735264|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
23270571|NCT01700621|64735265|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
23270572|NCT01700621|64735264|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
23270573|NCT01700621|64735265|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
23366423|NCT00465517|65088915|FG000|Overall Study|Adverse Event|7|||
23483442|NCT01390220|65513063|FG002|Test Dose Phase|Withdrawal by Subject|0|||
23483443|NCT01390220|65513061|FG000|Test Dose Phase|Lost to Follow-up|2|||
23483444|NCT01390220|65513062|FG001|Test Dose Phase|Lost to Follow-up|0|||
23483445|NCT01390220|65513063|FG002|Test Dose Phase|Lost to Follow-up|0|||
23483446|NCT01390220|65513061|FG000|Test Dose Phase|Protocol Violation|8|||
23483447|NCT01390220|65513062|FG001|Test Dose Phase|Protocol Violation|0|||
23483448|NCT01390220|65513063|FG002|Test Dose Phase|Protocol Violation|0|||
23483449|NCT01390220|65513061|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
23483450|NCT01390220|65513062|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
23483451|NCT01390220|65513063|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
23483452|NCT01390220|65513061|FG000|Test Dose Phase|Study/Site closure|6|||
23270574|NCT01700621|64735264|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
23366424|NCT00465517|65088916|FG001|Overall Study|Adverse Event|3|||
23366425|NCT00465517|65088915|FG000|Overall Study|Lost to Follow-up|1|||
23483453|NCT01390220|65513062|FG001|Test Dose Phase|Study/Site closure|0|||
23483454|NCT01390220|65513063|FG002|Test Dose Phase|Study/Site closure|0|||
23270575|NCT01700621|64735265|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
23270576|NCT01993030|64735266|FG000|Overall Study|Adverse Event|0|||
23270577|NCT01993030|64735267|FG001|Overall Study|Adverse Event|4|||
23483455|NCT01390220|65513061|FG000|Test Dose Phase|Caregiver no longer available|5|||
23270578|NCT01389102|64735268|FG000|Overall Study|Adverse Event|1|||
23270579|NCT01389102|64735269|FG001|Overall Study|Adverse Event|3|||
23270580|NCT01389102|64735270|FG002|Overall Study|Adverse Event|2|||
23270581|NCT01389102|64735271|FG003|Overall Study|Adverse Event|2|||
23270582|NCT01389102|64735272|FG004|Overall Study|Adverse Event|2|||
23270583|NCT01389102|64735273|FG005|Overall Study|Adverse Event|2|||
23270584|NCT01389102|64735268|FG000|Overall Study|Hurricane Katrina|4|||
23270585|NCT01389102|64735269|FG001|Overall Study|Hurricane Katrina|2|||
23270586|NCT01389102|64735270|FG002|Overall Study|Hurricane Katrina|3|||
23270587|NCT01389102|64735271|FG003|Overall Study|Hurricane Katrina|0|||
23270588|NCT01389102|64735272|FG004|Overall Study|Hurricane Katrina|3|||
23270589|NCT01389102|64735273|FG005|Overall Study|Hurricane Katrina|1|||
23270590|NCT01389102|64735268|FG000|Overall Study|Lost to Follow-up|4|||
23270591|NCT01389102|64735269|FG001|Overall Study|Lost to Follow-up|1|||
23270592|NCT01389102|64735270|FG002|Overall Study|Lost to Follow-up|1|||
23270593|NCT01389102|64735271|FG003|Overall Study|Lost to Follow-up|2|||
23270594|NCT01389102|64735272|FG004|Overall Study|Lost to Follow-up|4|||
23270595|NCT01389102|64735273|FG005|Overall Study|Lost to Follow-up|1|||
23270596|NCT01389102|64735268|FG000|Overall Study|Protocol Violation|0|||
23270597|NCT01389102|64735269|FG001|Overall Study|Protocol Violation|0|||
23270598|NCT01389102|64735270|FG002|Overall Study|Protocol Violation|3|||
23270599|NCT01389102|64735271|FG003|Overall Study|Protocol Violation|0|||
23270600|NCT01389102|64735272|FG004|Overall Study|Protocol Violation|1|||
23270601|NCT01389102|64735273|FG005|Overall Study|Protocol Violation|1|||
23270602|NCT01389102|64735268|FG000|Overall Study|Withdrawal by Subject|7|||
23270603|NCT01389102|64735269|FG001|Overall Study|Withdrawal by Subject|4|||
23270604|NCT01389102|64735270|FG002|Overall Study|Withdrawal by Subject|9|||
23270605|NCT01389102|64735271|FG003|Overall Study|Withdrawal by Subject|2|||
23270606|NCT01389102|64735272|FG004|Overall Study|Withdrawal by Subject|3|||
23270607|NCT01389102|64735273|FG005|Overall Study|Withdrawal by Subject|3|||
23270608|NCT01389102|64735268|FG000|Overall Study|Subject Traveling Out of Country|0|||
23270609|NCT01389102|64735269|FG001|Overall Study|Subject Traveling Out of Country|0|||
23270610|NCT01389102|64735270|FG002|Overall Study|Subject Traveling Out of Country|0|||
23270611|NCT01389102|64735271|FG003|Overall Study|Subject Traveling Out of Country|1|||
23270612|NCT01389102|64735272|FG004|Overall Study|Subject Traveling Out of Country|0|||
23270613|NCT01389102|64735273|FG005|Overall Study|Subject Traveling Out of Country|0|||
23270614|NCT01389102|64735268|FG000|Overall Study|Subject Moved|2|||
23270615|NCT01389102|64735269|FG001|Overall Study|Subject Moved|0|||
23270616|NCT01389102|64735270|FG002|Overall Study|Subject Moved|1|||
23270617|NCT01389102|64735271|FG003|Overall Study|Subject Moved|0|||
23270618|NCT01389102|64735272|FG004|Overall Study|Subject Moved|0|||
23270619|NCT01389102|64735273|FG005|Overall Study|Subject Moved|0|||
23270620|NCT01389102|64735268|FG000|Overall Study|Unavailable due to husband's illness|0|||
23270621|NCT01389102|64735269|FG001|Overall Study|Unavailable due to husband's illness|1|||
23270622|NCT01389102|64735270|FG002|Overall Study|Unavailable due to husband's illness|0|||
23270623|NCT01389102|64735271|FG003|Overall Study|Unavailable due to husband's illness|0|||
23270624|NCT01389102|64735272|FG004|Overall Study|Unavailable due to husband's illness|0|||
23270625|NCT01389102|64735273|FG005|Overall Study|Unavailable due to husband's illness|0|||
23270626|NCT01389102|64735268|FG000|Overall Study|Investigator Judgement|0|||
23270627|NCT01389102|64735269|FG001|Overall Study|Investigator Judgement|1|||
23270628|NCT01389102|64735270|FG002|Overall Study|Investigator Judgement|0|||
23270629|NCT01389102|64735271|FG003|Overall Study|Investigator Judgement|0|||
23270630|NCT01389102|64735272|FG004|Overall Study|Investigator Judgement|0|||
23270631|NCT01389102|64735273|FG005|Overall Study|Investigator Judgement|0|||
23270632|NCT00486837|64735274|FG000|Overall Study|Withdrawal by Subject|1|||
23270633|NCT00486837|64735275|FG001|Overall Study|Withdrawal by Subject|0|||
23366426|NCT00465517|65088916|FG001|Overall Study|Lost to Follow-up|0|||
23366427|NCT00465517|65088915|FG000|Overall Study|Withdrawal by Subject|4|||
23366428|NCT00465517|65088916|FG001|Overall Study|Withdrawal by Subject|1|||
23366429|NCT02230891|65088917|FG000|Baseline|Did not meet inclusion|0|||
23366430|NCT02230891|65088918|FG001|Baseline|Did not meet inclusion|1|||
23366431|NCT02230891|65088919|FG002|Baseline|Did not meet inclusion|1|||
23366432|NCT02230891|65088917|FG000|2 Week|Withdrawal by Subject|2|||
23366433|NCT02230891|65088918|FG001|2 Week|Withdrawal by Subject|2|||
23366434|NCT02230891|65088919|FG002|2 Week|Withdrawal by Subject|0|||
23366435|NCT02230891|65088917|FG000|2 Week|Consent withdrawn|1|||
23366436|NCT02230891|65088918|FG001|2 Week|Consent withdrawn|0|||
23366437|NCT02230891|65088919|FG002|2 Week|Consent withdrawn|0|||
23366438|NCT02230891|65088917|FG000|6 Month|Withdrawal by Subject|1|||
23366439|NCT02230891|65088918|FG001|6 Month|Withdrawal by Subject|1|||
23366440|NCT02230891|65088919|FG002|6 Month|Withdrawal by Subject|1|||
23270634|NCT00486837|64735274|FG000|Overall Study|Adverse Event|1|||
23270635|NCT00486837|64735275|FG001|Overall Study|Adverse Event|1|||
23270636|NCT00486837|64735274|FG000|Overall Study|Protocol Violation|4|||
23270637|NCT00486837|64735275|FG001|Overall Study|Protocol Violation|2|||
23270638|NCT00486837|64735274|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
23366441|NCT02230891|65088917|FG000|6 Month|Physician Decision|0|||
23366442|NCT02230891|65088918|FG001|6 Month|Physician Decision|2|||
23270639|NCT00486837|64735275|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
23270640|NCT00995553|64735276|FG000|Overall Study|Withdrawal by Subject|2|||
23270641|NCT00995553|64735277|FG001|Overall Study|Withdrawal by Subject|6|||
23270642|NCT02008565|64735279|FG000|Overall Study|Protocol Violation|1|||
23270643|NCT02008565|64735280|FG001|Overall Study|Protocol Violation|1|||
23270644|NCT02008565|64735281|FG002|Overall Study|Protocol Violation|2|||
23270645|NCT02008565|64735282|FG003|Overall Study|Protocol Violation|0|||
23270646|NCT03561883|64735287|FG000|Overall Study|Adverse Event|10|||
23270647|NCT03561883|64735288|FG001|Overall Study|Adverse Event|13|||
23270648|NCT03561883|64735287|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23270649|NCT03561883|64735288|FG001|Overall Study|Non-Compliance With Study Drug|2|||
23270650|NCT03561883|64735287|FG000|Overall Study|Protocol Violation|2|||
23270651|NCT03561883|64735288|FG001|Overall Study|Protocol Violation|3|||
23270652|NCT03561883|64735287|FG000|Overall Study|Withdrawal by Subject|14|||
23270653|NCT03561883|64735288|FG001|Overall Study|Withdrawal by Subject|6|||
23270654|NCT03561883|64735287|FG000|Overall Study|Lost to Follow-up|2|||
23270655|NCT03561883|64735288|FG001|Overall Study|Lost to Follow-up|6|||
23270656|NCT03561883|64735287|FG000|Overall Study|Study Terminated by Sponsor|12|||
23270657|NCT03561883|64735288|FG001|Overall Study|Study Terminated by Sponsor|11|||
23270658|NCT03561883|64735287|FG000|Overall Study|Physician Decision|1|||
23270659|NCT03561883|64735288|FG001|Overall Study|Physician Decision|0|||
23270660|NCT03561883|64735287|FG000|Overall Study|Randomized by Mistake|1|||
23270661|NCT03561883|64735288|FG001|Overall Study|Randomized by Mistake|0|||
23270662|NCT03561883|64735287|FG000|Overall Study|Other, Not Specified|3|||
23270663|NCT03561883|64735288|FG001|Overall Study|Other, Not Specified|2|||
23270664|NCT00569374|64735289|FG000|Overall Study|Withdrawal by Subject|4|||
23270665|NCT02731157|64735296|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
23270666|NCT00395226|64735297|FG000|Overall Study|Adverse Event|4|||
23270667|NCT00395226|64735298|FG001|Overall Study|Adverse Event|3|||
23270668|NCT00395226|64735297|FG000|Overall Study|Withdrawal by Subject|0|||
23270669|NCT00395226|64735298|FG001|Overall Study|Withdrawal by Subject|1|||
23270670|NCT00395226|64735297|FG000|Overall Study|Lost to Follow-up|0|||
23270671|NCT00395226|64735298|FG001|Overall Study|Lost to Follow-up|1|||
23270672|NCT02319148|64735299|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
23270673|NCT02319148|64735300|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
23270674|NCT02319148|64735301|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
23270675|NCT02319148|64735302|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
23270676|NCT02319148|64735299|FG000|Second Intervention Period|No longer willing to participate|0|||
23270677|NCT02319148|64735300|FG001|Second Intervention Period|No longer willing to participate|1|||
23270678|NCT02319148|64735301|FG002|Second Intervention Period|No longer willing to participate|0|||
23270679|NCT02319148|64735302|FG003|Second Intervention Period|No longer willing to participate|0|||
23270680|NCT02319148|64735299|FG000|Second Intervention Period|Other|0|||
23270681|NCT02319148|64735300|FG001|Second Intervention Period|Other|0|||
23270682|NCT02319148|64735301|FG002|Second Intervention Period|Other|0|||
23270683|NCT02319148|64735302|FG003|Second Intervention Period|Other|1|||
23270684|NCT03568461|64735314|FG000|Overall Study|Death|7|||
23270685|NCT03568461|64735314|FG000|Overall Study|Physician Decision|5|||
23270686|NCT03568461|64735314|FG000|Overall Study|Subject decision|5|||
23270687|NCT03568461|64735314|FG000|Overall Study|Lost to Follow-up|1|||
23270688|NCT02076022|64735315|FG000|Overall Study|Withdrawal by Subject|2|||
23270689|NCT02076022|64735316|FG001|Overall Study|Withdrawal by Subject|0|||
23270690|NCT01703832|64735317|FG000|Overall Study|Withdrawal by Subject|1|||
23270691|NCT01703832|64735318|FG001|Overall Study|Withdrawal by Subject|0|||
23270692|NCT01399736|64735319|FG000|Overall Study|Withdrawal by Subject|4|||
23270693|NCT01399736|64735320|FG001|Overall Study|Withdrawal by Subject|2|||
23270694|NCT01399736|64735319|FG000|Overall Study|Lost to Follow-up|0|||
23270695|NCT01399736|64735320|FG001|Overall Study|Lost to Follow-up|2|||
23270696|NCT01492400|64735321|FG000|Overall Study|Miscellaneous Reasons|2|||
23270697|NCT01492400|64735322|FG001|Overall Study|Miscellaneous Reasons|3|||
23270698|NCT01492400|64735321|FG000|Overall Study|Personal Reasons|0|||
23270699|NCT01492400|64735322|FG001|Overall Study|Personal Reasons|5|||
23270700|NCT01492400|64735321|FG000|Overall Study|Lost to Follow-up|3|||
23270701|NCT01492400|64735322|FG001|Overall Study|Lost to Follow-up|1|||
23366443|NCT02230891|65088919|FG002|6 Month|Physician Decision|0|||
23366444|NCT02230891|65088917|FG000|12 Month|Death|1|||
23270702|NCT01492400|64735321|FG000|Overall Study|Pregnancy|0|||
23270703|NCT01492400|64735322|FG001|Overall Study|Pregnancy|1|||
23270704|NCT01492400|64735321|FG000|Overall Study|Lack of Efficacy|1|||
23270705|NCT01492400|64735322|FG001|Overall Study|Lack of Efficacy|1|||
23270706|NCT01492400|64735321|FG000|Overall Study|Adverse Event|10|||
23270707|NCT01492400|64735322|FG001|Overall Study|Adverse Event|5|||
23270708|NCT02661295|64735324|FG000|Overall Study|Death|1|||
23270709|NCT02661295|64735324|FG000|Overall Study|Transferred Out|1|||
23270710|NCT02661295|64735324|FG000|Overall Study|Kidney Transplant|1|||
23270711|NCT02661295|64735324|FG000|Overall Study|Withdrawn due to side effects|8|||
23270712|NCT02661295|64735324|FG000|Overall Study|Withdrawn due to access type|1|||
23366445|NCT02230891|65088918|FG001|12 Month|Death|0|||
23366446|NCT02230891|65088919|FG002|12 Month|Death|0|||
23366447|NCT02230891|65088917|FG000|12 Month|Lost to Follow-up|0|||
23366448|NCT02230891|65088918|FG001|12 Month|Lost to Follow-up|1|||
23366449|NCT02230891|65088919|FG002|12 Month|Lost to Follow-up|0|||
23366450|NCT02230891|65088917|FG000|12 Month|Withdrawal by Subject|0|||
23366451|NCT02230891|65088918|FG001|12 Month|Withdrawal by Subject|2|||
23366452|NCT02230891|65088919|FG002|12 Month|Withdrawal by Subject|0|||
23366453|NCT02230891|65088917|FG000|18 Month End of Study|Death|0|||
23366454|NCT02230891|65088918|FG001|18 Month End of Study|Death|0|||
23366455|NCT02230891|65088919|FG002|18 Month End of Study|Death|1|||
23366456|NCT02230891|65088917|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
23366457|NCT02230891|65088918|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
23366458|NCT02230891|65088919|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
23366459|NCT01029262|65088927|FG000|Overall Study|Adverse Event|9|||
23366460|NCT01029262|65088928|FG001|Overall Study|Adverse Event|52|||
23366461|NCT01029262|65088927|FG000|Overall Study|Lack of therapeutic effect|57|||
23366462|NCT01029262|65088928|FG001|Overall Study|Lack of therapeutic effect|76|||
23366463|NCT01029262|65088927|FG000|Overall Study|Withdrawal by Subject|10|||
23366464|NCT01029262|65088928|FG001|Overall Study|Withdrawal by Subject|17|||
23366465|NCT01029262|65088927|FG000|Overall Study|Protocol Violation|2|||
23366466|NCT01029262|65088928|FG001|Overall Study|Protocol Violation|3|||
23270713|NCT02661295|64735324|FG000|Overall Study|Withdrawn due to allergies|1|||
23270714|NCT02661295|64735324|FG000|Overall Study|Withdrawn due to non-compliance|1|||
23270715|NCT02661295|64735324|FG000|Overall Study|Withdrawal by Subject|3|||
23270716|NCT02661295|64735324|FG000|Overall Study|Failed screening|2|||
23270717|NCT01648166|64735325|FG000|Overall Study|inadequate toenail samples|53|||
23270718|NCT01648166|64735326|FG001|Overall Study|inadequate toenail samples|100|||
23270719|NCT01434693|64735327|FG000|Overall Study|Adverse Event|1|||
23270720|NCT01434693|64735328|FG001|Overall Study|Adverse Event|0|||
23270721|NCT01434693|64735329|FG002|Overall Study|Adverse Event|0|||
23270722|NCT01434693|64735330|FG003|Overall Study|Adverse Event|0|||
23270723|NCT01434693|64735327|FG000|Overall Study|Withdrawal by Subject|1|||
23270724|NCT01434693|64735328|FG001|Overall Study|Withdrawal by Subject|0|||
23270725|NCT01434693|64735329|FG002|Overall Study|Withdrawal by Subject|1|||
23270726|NCT01434693|64735330|FG003|Overall Study|Withdrawal by Subject|1|||
23270727|NCT01434693|64735327|FG000|Overall Study|Lost to Follow-up|1|||
23270728|NCT01434693|64735328|FG001|Overall Study|Lost to Follow-up|0|||
23270729|NCT01434693|64735329|FG002|Overall Study|Lost to Follow-up|0|||
23270730|NCT01434693|64735330|FG003|Overall Study|Lost to Follow-up|0|||
23270731|NCT00856388|64735331|FG000|Overall Study|Other|1|||
23270732|NCT02262377|64735335|FG000|Overall Study|Lost to Follow-up|5|||
23270733|NCT02262377|64735336|FG001|Overall Study|Lost to Follow-up|6|||
23270734|NCT02262377|64735335|FG000|Overall Study|Found ineligible after enrollment|3|||
23270735|NCT02262377|64735336|FG001|Overall Study|Found ineligible after enrollment|0|||
23270736|NCT02262377|64735335|FG000|Overall Study|Withdrawal by Subject|4|||
23270737|NCT02262377|64735336|FG001|Overall Study|Withdrawal by Subject|0|||
23270738|NCT03785548|64735337|FG000|Overall Study|age > 80|1|||
23270739|NCT03785548|64735338|FG001|Overall Study|age > 80|0|||
23270740|NCT03785548|64735337|FG000|Overall Study|no Postop queries|1|||
23270741|NCT03785548|64735338|FG001|Overall Study|no Postop queries|0|||
23270742|NCT01991470|64735339|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
23270743|NCT01991470|64735339|FG000|Enlite 1 Period|Adverse Event|1|||
23270744|NCT01991470|64735339|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
23270745|NCT01991470|64735339|FG000|Enlite 3 Period|Lost to Follow-up|1|||
23270746|NCT01991470|64735339|FG000|Enlite 3 Period|Physician Decision|2|||
23270747|NCT01991470|64735339|FG000|Enlite 3 Period|Physician Decision|8|||
23270748|NCT01991470|64735339|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
23270749|NCT01223365|64735344|FG000|Open-label Titration Period|Enrolled but not treated|1|||
23270750|NCT01223365|64735344|FG000|Open-label Titration Period|Adverse Event|23|||
23270751|NCT01223365|64735344|FG000|Open-label Titration Period|Lack of Efficacy|3|||
23270752|NCT01223365|64735344|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
23366467|NCT01029262|65088927|FG000|Overall Study|Miscellaneous|1|||
23366468|NCT01029262|65088928|FG001|Overall Study|Miscellaneous|9|||
23366469|NCT01029262|65088927|FG000|Overall Study|Death|0|||
23270753|NCT01223365|64735344|FG000|Open-label Titration Period|Protocol Violation|1|||
23270754|NCT01223365|64735344|FG000|Open-label Titration Period|Lost to Follow-up|2|||
23270755|NCT01223365|64735344|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
23270756|NCT01223365|64735344|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
23270757|NCT01223365|64735344|FG000|Open-label Titration Period|Starting physical therapy|1|||
23366470|NCT01029262|65088928|FG001|Overall Study|Death|3|||
23366471|NCT02869789|65088929|FG000|Overall Study|Disease progression|184|||
23366472|NCT02869789|65088930|FG001|Overall Study|Disease progression|109|||
23366473|NCT02869789|65088931|FG002|Overall Study|Disease progression|260|||
23366474|NCT02869789|65088932|FG003|Overall Study|Disease progression|19|||
23366475|NCT02869789|65088929|FG000|Overall Study|Study drug toxicity|90|||
23366476|NCT02869789|65088930|FG001|Overall Study|Study drug toxicity|32|||
23366477|NCT02869789|65088931|FG002|Overall Study|Study drug toxicity|55|||
23366478|NCT02869789|65088932|FG003|Overall Study|Study drug toxicity|14|||
23366479|NCT02869789|65088929|FG000|Overall Study|Death|7|||
23366480|NCT02869789|65088930|FG001|Overall Study|Death|3|||
23366481|NCT02869789|65088931|FG002|Overall Study|Death|5|||
23366482|NCT02869789|65088932|FG003|Overall Study|Death|1|||
23366483|NCT02869789|65088929|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
23366484|NCT02869789|65088930|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
23366485|NCT02869789|65088931|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
23366486|NCT02869789|65088932|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
23366487|NCT02869789|65088929|FG000|Overall Study|Participant request to discontinue study treatment|10|||
23366488|NCT02869789|65088930|FG001|Overall Study|Participant request to discontinue study treatment|5|||
23366489|NCT02869789|65088931|FG002|Overall Study|Participant request to discontinue study treatment|5|||
23366490|NCT02869789|65088932|FG003|Overall Study|Participant request to discontinue study treatment|3|||
23366491|NCT02869789|65088929|FG000|Overall Study|Withdrawal by Subject|5|||
23366492|NCT02869789|65088930|FG001|Overall Study|Withdrawal by Subject|2|||
23366493|NCT02869789|65088931|FG002|Overall Study|Withdrawal by Subject|7|||
23366494|NCT02869789|65088932|FG003|Overall Study|Withdrawal by Subject|2|||
23270758|NCT01223365|64735344|FG000|Open-label Treatment Period|Adverse Event|39|||
23270759|NCT01223365|64735344|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
23270760|NCT01223365|64735344|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
23270761|NCT01223365|64735344|FG000|Open-label Treatment Period|Protocol Violation|15|||
23270762|NCT01223365|64735344|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
23270763|NCT01223365|64735344|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
23270764|NCT01223365|64735344|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
23270765|NCT01223365|64735344|FG000|Open-label Treatment Period|Moved out of area|2|||
23270766|NCT01223365|64735344|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
23270767|NCT01223365|64735344|FG000|Open-label Treatment Period|"Out of window"|1|||
23270768|NCT01223365|64735344|FG000|Open-label Treatment Period|Starting physical therapy|1|||
23270769|NCT01223365|64735344|FG000|Open-label Treatment Period|Physician Decision|2|||
23270770|NCT02079532|64735345|FG000|Overall Study|Adverse Event|7|||
23270771|NCT02079532|64735345|FG000|Overall Study|Additional or changed therapy|2|||
23270772|NCT02079532|64735345|FG000|Overall Study|Lack of Efficacy|9|||
23270773|NCT02079532|64735345|FG000|Overall Study|Protocol Violation|3|||
23270774|NCT02079532|64735345|FG000|Overall Study|Withdrawal by Subject|1|||
23270775|NCT02079532|64735345|FG000|Overall Study|Administrative problems|1|||
23270776|NCT02079532|64735345|FG000|Overall Study|Inclusion into ReFIRST|3|||
23270777|NCT02079532|64735345|FG000|Overall Study|Other|3|||
23270778|NCT05419908|64735348|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
23270779|NCT05419908|64735349|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
23270780|NCT05419908|64735348|FG000|Overall Study|Serious Adverse Event|0|||
23270781|NCT05419908|64735349|FG001|Overall Study|Serious Adverse Event|2|||
23270782|NCT05419908|64735348|FG000|Overall Study|Withdrawal by Subject|2|||
23270783|NCT05419908|64735349|FG001|Overall Study|Withdrawal by Subject|0|||
23270784|NCT05419908|64735348|FG000|Overall Study|Miscellaneous|1|||
23270785|NCT05419908|64735349|FG001|Overall Study|Miscellaneous|1|||
23270786|NCT05097326|64735350|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
23270787|NCT05097326|64735351|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
23270788|NCT03661528|64735353|FG000|Overall Study|Death|1|||
23270789|NCT03661528|64735354|FG001|Overall Study|Death|0|||
23270790|NCT03661528|64735353|FG000|Overall Study|Physician Decision|3|||
23270791|NCT03661528|64735354|FG001|Overall Study|Physician Decision|1|||
23270792|NCT03661528|64735353|FG000|Overall Study|Other than Specified|5|||
23270793|NCT03661528|64735354|FG001|Overall Study|Other than Specified|2|||
23270794|NCT03661528|64735353|FG000|Overall Study|Withdrawal by Subject|5|||
23366495|NCT02869789|65088929|FG000|Overall Study|Lost to Follow-up|0|||
23366496|NCT02869789|65088930|FG001|Overall Study|Lost to Follow-up|0|||
23366497|NCT02869789|65088931|FG002|Overall Study|Lost to Follow-up|2|||
23270795|NCT03661528|64735354|FG001|Overall Study|Withdrawal by Subject|3|||
23270796|NCT03661528|64735353|FG000|Overall Study|Disease Progression|8|||
23270797|NCT03661528|64735354|FG001|Overall Study|Disease Progression|13|||
23270798|NCT03661528|64735353|FG000|Overall Study|Adverse Event|61|||
23270799|NCT03661528|64735354|FG001|Overall Study|Adverse Event|55|||
23270800|NCT03123471|64735355|FG000|Placebo-controlled Phase|Adverse Event|3|||
23270801|NCT03123471|64735356|FG001|Placebo-controlled Phase|Adverse Event|8|||
23270802|NCT03123471|64735355|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
23270803|NCT03123471|64735356|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
23270804|NCT03123471|64735355|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
23270805|NCT03123471|64735356|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
23270806|NCT03123471|64735355|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
23270807|NCT03123471|64735356|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
23270808|NCT03123471|64735355|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
23270809|NCT03123471|64735356|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
23270810|NCT03123471|64735355|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
23270811|NCT03123471|64735356|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
23270812|NCT03123471|64735355|FG000|Placebo-controlled Phase|Miscellaneous|0|||
23270813|NCT03123471|64735356|FG001|Placebo-controlled Phase|Miscellaneous|1|||
23270814|NCT03123471|64735355|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
23270815|NCT03123471|64735356|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
23270816|NCT03123471|64735355|FG000|Apremilast Extension Phase|Adverse Event|1|||
23270817|NCT03123471|64735356|FG001|Apremilast Extension Phase|Adverse Event|5|||
23270818|NCT03123471|64735355|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
23270819|NCT03123471|64735356|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
23270820|NCT03123471|64735355|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
23270821|NCT03123471|64735356|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
23270822|NCT00860405|64735357|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
23270823|NCT00860405|64735358|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
23270824|NCT02473640|64735359|FG000|Treatment Period 1|Adverse Event|1|||
23270825|NCT01941030|64735362|FG000|Overall Study|Death|3|||
23270826|NCT01941030|64735363|FG001|Overall Study|Death|2|||
23270827|NCT01941030|64735362|FG000|Overall Study|Lost to Follow-up|6|||
23270828|NCT01941030|64735363|FG001|Overall Study|Lost to Follow-up|5|||
23270829|NCT01941030|64735362|FG000|Overall Study|Withdrawal by Subject|4|||
23270830|NCT01941030|64735363|FG001|Overall Study|Withdrawal by Subject|6|||
23270831|NCT00119379|64735366|FG000|Overall Study|Adverse Event|4|||
23270832|NCT00119379|64735367|FG001|Overall Study|Adverse Event|1|||
23270833|NCT00414765|64735371|FG000|Overall Study|Adverse Event|5|||
23270834|NCT00414765|64735372|FG001|Overall Study|Adverse Event|9|||
23270835|NCT00414765|64735371|FG000|Overall Study|Withdrawal by Subject|1|||
23270836|NCT00414765|64735372|FG001|Overall Study|Withdrawal by Subject|1|||
23270837|NCT00414765|64735371|FG000|Overall Study|Disease Progression|0|||
23270838|NCT00414765|64735372|FG001|Overall Study|Disease Progression|1|||
23270839|NCT02678286|64735373|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
23270840|NCT02678286|64735374|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
23270841|NCT02678286|64735373|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
23270842|NCT02678286|64735374|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
23270843|NCT02678286|64735373|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
23270844|NCT02678286|64735374|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
23270845|NCT02678286|64735373|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
23270846|NCT02678286|64735374|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
23270847|NCT02678286|64735373|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
23483456|NCT01390220|65513062|FG001|Test Dose Phase|Caregiver no longer available|0|||
23270848|NCT02678286|64735374|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
23270849|NCT01259869|64735375|FG000|Overall Study|Duplicated registration|1|||
23366498|NCT02869789|65088932|FG003|Overall Study|Lost to Follow-up|0|||
23366499|NCT02869789|65088929|FG000|Overall Study|Maximum clinical benefit|5|||
23366500|NCT02869789|65088930|FG001|Overall Study|Maximum clinical benefit|2|||
23366501|NCT02869789|65088931|FG002|Overall Study|Maximum clinical benefit|1|||
23366502|NCT02869789|65088932|FG003|Overall Study|Maximum clinical benefit|0|||
23366503|NCT02869789|65088929|FG000|Overall Study|Poor/Non-compliance|0|||
23366504|NCT02869789|65088930|FG001|Overall Study|Poor/Non-compliance|2|||
23366505|NCT02869789|65088931|FG002|Overall Study|Poor/Non-compliance|1|||
23366506|NCT02869789|65088932|FG003|Overall Study|Poor/Non-compliance|0|||
23366507|NCT02869789|65088929|FG000|Overall Study|Participant no longer meets study criteria|0|||
23366508|NCT02869789|65088930|FG001|Overall Study|Participant no longer meets study criteria|1|||
23366509|NCT02869789|65088931|FG002|Overall Study|Participant no longer meets study criteria|1|||
23366510|NCT02869789|65088932|FG003|Overall Study|Participant no longer meets study criteria|0|||
23366511|NCT02869789|65088929|FG000|Overall Study|Administrative reason by sponsor|0|||
23366512|NCT02869789|65088930|FG001|Overall Study|Administrative reason by sponsor|0|||
23366513|NCT02869789|65088931|FG002|Overall Study|Administrative reason by sponsor|1|||
23366514|NCT02869789|65088932|FG003|Overall Study|Administrative reason by sponsor|0|||
23366515|NCT02869789|65088929|FG000|Overall Study|Other reasons|4|||
23366516|NCT02869789|65088930|FG001|Overall Study|Other reasons|8|||
23366517|NCT02869789|65088931|FG002|Overall Study|Other reasons|6|||
23366518|NCT02869789|65088932|FG003|Overall Study|Other reasons|0|||
23366519|NCT02340000|65088933|FG000|Time Period 1|Withdrawal by Subject|6|||
23366520|NCT02340000|65088934|FG001|Time Period 1|Withdrawal by Subject|8|||
23366521|NCT02340000|65088933|FG000|Time Period 1|Lost to Follow-up|6|||
23366522|NCT02340000|65088934|FG001|Time Period 1|Lost to Follow-up|7|||
23366523|NCT02340000|65088933|FG000|Time Period 2|Withdrawal by Subject|9|||
23366524|NCT02340000|65088934|FG001|Time Period 2|Withdrawal by Subject|7|||
23366525|NCT02340000|65088933|FG000|Time Period 2|Lost to Follow-up|10|||
23366526|NCT02340000|65088934|FG001|Time Period 2|Lost to Follow-up|8|||
23366527|NCT01348139|65088935|FG000|Period 1|Adverse Event|1|||
23366528|NCT01348139|65088936|FG001|Period 1|Adverse Event|0|||
23366529|NCT01348139|65088937|FG002|Period 1|Adverse Event|0|||
23366530|NCT01348139|65088938|FG003|Period 1|Adverse Event|0|||
23366531|NCT01348139|65088939|FG004|Period 1|Adverse Event|0|||
23366532|NCT01348139|65088940|FG005|Period 1|Adverse Event|0|||
23366533|NCT00928434|65088946|FG000|Overall Study|Adverse Event|14|||
23366534|NCT00928434|65088947|FG001|Overall Study|Adverse Event|5|||
23366535|NCT00928434|65088948|FG002|Overall Study|Adverse Event|18|||
23366536|NCT00928434|65088946|FG000|Overall Study|Protocol Violation|5|||
23366537|NCT00928434|65088947|FG001|Overall Study|Protocol Violation|0|||
23270850|NCT03627091|64735378|FG000|Overall Study|Adverse Event|0|||
23270851|NCT03627091|64735379|FG001|Overall Study|Adverse Event|0|||
23270852|NCT03627091|64735380|FG002|Overall Study|Adverse Event|2|||
23270853|NCT03627091|64735378|FG000|Overall Study|Withdrawal by Subject|2|||
23270854|NCT03627091|64735379|FG001|Overall Study|Withdrawal by Subject|0|||
23270855|NCT03627091|64735380|FG002|Overall Study|Withdrawal by Subject|2|||
23270856|NCT03627091|64735378|FG000|Overall Study|Physician Decision|2|||
23270857|NCT03627091|64735379|FG001|Overall Study|Physician Decision|0|||
23270858|NCT03627091|64735380|FG002|Overall Study|Physician Decision|0|||
23270859|NCT03627091|64735378|FG000|Overall Study|Site terminated by sponsor|0|||
23270860|NCT03627091|64735379|FG001|Overall Study|Site terminated by sponsor|1|||
23270861|NCT03627091|64735380|FG002|Overall Study|Site terminated by sponsor|0|||
23270862|NCT03627091|64735378|FG000|Overall Study|Disease relapse|7|||
23270863|NCT03627091|64735379|FG001|Overall Study|Disease relapse|5|||
23270864|NCT03627091|64735380|FG002|Overall Study|Disease relapse|1|||
23270865|NCT03627091|64735378|FG000|Overall Study|Other|1|||
23270866|NCT03627091|64735379|FG001|Overall Study|Other|0|||
23366538|NCT00928434|65088948|FG002|Overall Study|Protocol Violation|8|||
23366539|NCT00928434|65088946|FG000|Overall Study|Physician Decision|2|||
23366540|NCT00928434|65088947|FG001|Overall Study|Physician Decision|0|||
23366541|NCT00928434|65088948|FG002|Overall Study|Physician Decision|3|||
23366542|NCT00928434|65088946|FG000|Overall Study|Lost to Follow-up|1|||
23366543|NCT00928434|65088947|FG001|Overall Study|Lost to Follow-up|0|||
23366544|NCT00928434|65088948|FG002|Overall Study|Lost to Follow-up|3|||
23270867|NCT03627091|64735380|FG002|Overall Study|Other|0|||
23270868|NCT03787680|64735381|FG000|Overall Study|Physician Decision|2|||
23270869|NCT03787680|64735382|FG001|Overall Study|Physician Decision|3|||
23366545|NCT00928434|65088946|FG000|Overall Study|Withdrawal by Subject|5|||
23366546|NCT00928434|65088947|FG001|Overall Study|Withdrawal by Subject|3|||
23366547|NCT00928434|65088948|FG002|Overall Study|Withdrawal by Subject|2|||
23366548|NCT00928434|65088946|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
23270870|NCT03787680|64735381|FG000|Overall Study|Adverse Event|7|||
23270871|NCT03787680|64735382|FG001|Overall Study|Adverse Event|3|||
23270872|NCT03787680|64735381|FG000|Overall Study|Withdrawal by Subject|2|||
23270873|NCT03787680|64735382|FG001|Overall Study|Withdrawal by Subject|1|||
23270874|NCT02684344|64735383|FG000|Overall Study|Withdrawal by Subject|0|||
23270875|NCT02684344|64735384|FG001|Overall Study|Withdrawal by Subject|1|||
23270876|NCT03639311|64735385|FG000|Maintenance Phase|Lost to Follow-up|1|||
23270877|NCT03639311|64735386|FG001|Maintenance Phase|Lost to Follow-up|0|||
23270878|NCT03639311|64735387|FG002|Maintenance Phase|Lost to Follow-up|0|||
23270879|NCT03639311|64735385|FG000|Maintenance Phase|Adverse Event|1|||
23270880|NCT03639311|64735386|FG001|Maintenance Phase|Adverse Event|0|||
23270881|NCT03639311|64735387|FG002|Maintenance Phase|Adverse Event|0|||
23270882|NCT03639311|64735385|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
23270883|NCT03639311|64735386|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
23270884|NCT03639311|64735387|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
23270885|NCT03639311|64735385|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
23270886|NCT03639311|64735386|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
23270887|NCT03639311|64735387|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
23270888|NCT03639311|64735385|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
23270889|NCT03639311|64735386|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
23270890|NCT03639311|64735387|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
23270891|NCT03639311|64735385|FG000|Maintenance Phase|Lack of Efficacy|1|||
23270892|NCT03639311|64735386|FG001|Maintenance Phase|Lack of Efficacy|0|||
23270893|NCT03639311|64735387|FG002|Maintenance Phase|Lack of Efficacy|0|||
23270894|NCT02465567|64735388|FG000|Overall Study|Adverse Event|118|||
23270895|NCT02465567|64735389|FG001|Overall Study|Adverse Event|113|||
23270896|NCT02465567|64735390|FG002|Overall Study|Adverse Event|147|||
23270897|NCT02465567|64735391|FG003|Overall Study|Adverse Event|138|||
23270898|NCT02465567|64735388|FG000|Overall Study|Lack of Efficacy|103|||
23270899|NCT02465567|64735389|FG001|Overall Study|Lack of Efficacy|102|||
23270900|NCT02465567|64735390|FG002|Overall Study|Lack of Efficacy|171|||
23270901|NCT02465567|64735391|FG003|Overall Study|Lack of Efficacy|135|||
23270902|NCT02465567|64735388|FG000|Overall Study|Withdrawal by Subject|104|||
23270903|NCT02465567|64735389|FG001|Overall Study|Withdrawal by Subject|94|||
23270904|NCT02465567|64735390|FG002|Overall Study|Withdrawal by Subject|123|||
23270905|NCT02465567|64735391|FG003|Overall Study|Withdrawal by Subject|130|||
23270906|NCT02465567|64735388|FG000|Overall Study|Physician Decision|23|||
23270907|NCT02465567|64735389|FG001|Overall Study|Physician Decision|33|||
23270908|NCT02465567|64735390|FG002|Overall Study|Physician Decision|38|||
23270909|NCT02465567|64735391|FG003|Overall Study|Physician Decision|28|||
23270910|NCT02465567|64735388|FG000|Overall Study|Major Protocol Deviation|24|||
23270911|NCT02465567|64735389|FG001|Overall Study|Major Protocol Deviation|26|||
23270912|NCT02465567|64735390|FG002|Overall Study|Major Protocol Deviation|22|||
23270913|NCT02465567|64735391|FG003|Overall Study|Major Protocol Deviation|25|||
23270914|NCT02465567|64735388|FG000|Overall Study|Lost to Follow-up|25|||
23270915|NCT02465567|64735389|FG001|Overall Study|Lost to Follow-up|21|||
23270916|NCT02465567|64735390|FG002|Overall Study|Lost to Follow-up|19|||
23270917|NCT02465567|64735391|FG003|Overall Study|Lost to Follow-up|15|||
23270918|NCT02465567|64735388|FG000|Overall Study|Protocol Specified Criteria|20|||
23270919|NCT02465567|64735389|FG001|Overall Study|Protocol Specified Criteria|10|||
23270920|NCT02465567|64735390|FG002|Overall Study|Protocol Specified Criteria|9|||
23270921|NCT02465567|64735391|FG003|Overall Study|Protocol Specified Criteria|12|||
23270922|NCT02465567|64735388|FG000|Overall Study|Administrative Reasons|12|||
23270923|NCT02465567|64735389|FG001|Overall Study|Administrative Reasons|9|||
23270924|NCT02465567|64735390|FG002|Overall Study|Administrative Reasons|11|||
23270925|NCT02465567|64735391|FG003|Overall Study|Administrative Reasons|5|||
23270926|NCT02465567|64735388|FG000|Overall Study|Randomized but not treated|1|||
23270927|NCT02465567|64735389|FG001|Overall Study|Randomized but not treated|5|||
23270928|NCT02465567|64735390|FG002|Overall Study|Randomized but not treated|4|||
23270929|NCT02465567|64735391|FG003|Overall Study|Randomized but not treated|5|||
23270930|NCT02465567|64735388|FG000|Overall Study|enrolled in >1 studies|18|||
23270931|NCT02465567|64735389|FG001|Overall Study|enrolled in >1 studies|11|||
23366549|NCT00928434|65088947|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
23366550|NCT00928434|65088948|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
23366551|NCT00928434|65088946|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
23366552|NCT00928434|65088947|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
23366553|NCT00928434|65088948|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
23366554|NCT00928434|65088946|FG000|Overall Study|Other (not meeting above criteria)|5|||
23366555|NCT00928434|65088947|FG001|Overall Study|Other (not meeting above criteria)|1|||
23366556|NCT00928434|65088948|FG002|Overall Study|Other (not meeting above criteria)|2|||
23366557|NCT03299101|65088949|FG000|Overall Study|Lost to Follow-up|1|||
23366558|NCT03299101|65088949|FG000|Overall Study|Withdrawal by Subject|5|||
23366559|NCT03299101|65088949|FG000|Overall Study|Surgery was changed|3|||
23366560|NCT03299101|65088949|FG000|Overall Study|Not enough time to complete prehab|1|||
23366561|NCT01896193|65088950|FG000|Overall Study|Lack of Efficacy|20|||
23366562|NCT01896193|65088951|FG001|Overall Study|Lack of Efficacy|11|||
23366563|NCT01896193|65088950|FG000|Overall Study|Protocol Violation|0|||
23366564|NCT01896193|65088951|FG001|Overall Study|Protocol Violation|1|||
23366565|NCT01896193|65088950|FG000|Overall Study|Withdrew Consent|1|||
23366566|NCT01896193|65088951|FG001|Overall Study|Withdrew Consent|0|||
23366567|NCT00643760|65088952|FG000|Overall Study|Adverse Event|11|||
23366568|NCT00643760|65088953|FG001|Overall Study|Adverse Event|5|||
23366569|NCT00643760|65088954|FG002|Overall Study|Adverse Event|12|||
23366570|NCT00643760|65088955|FG003|Overall Study|Adverse Event|21|||
23366571|NCT00643760|65088956|FG004|Overall Study|Adverse Event|6|||
23366572|NCT00643760|65088952|FG000|Overall Study|Lack of Efficacy|3|||
23366573|NCT00643760|65088953|FG001|Overall Study|Lack of Efficacy|1|||
23366574|NCT00643760|65088954|FG002|Overall Study|Lack of Efficacy|0|||
23366575|NCT00643760|65088955|FG003|Overall Study|Lack of Efficacy|4|||
23366576|NCT00643760|65088956|FG004|Overall Study|Lack of Efficacy|3|||
23366577|NCT00643760|65088952|FG000|Overall Study|Protocol Violation|7|||
23366578|NCT00643760|65088953|FG001|Overall Study|Protocol Violation|6|||
23366579|NCT00643760|65088954|FG002|Overall Study|Protocol Violation|4|||
23366580|NCT00643760|65088955|FG003|Overall Study|Protocol Violation|4|||
23366581|NCT00643760|65088956|FG004|Overall Study|Protocol Violation|6|||
23366582|NCT00643760|65088952|FG000|Overall Study|Lost to Follow-up|6|||
23270932|NCT02465567|64735390|FG002|Overall Study|enrolled in >1 studies|19|||
23270933|NCT02465567|64735391|FG003|Overall Study|enrolled in >1 studies|15|||
23270934|NCT02465567|64735388|FG000|Overall Study|missing PI Signature|1|||
23270935|NCT02465567|64735389|FG001|Overall Study|missing PI Signature|0|||
23270936|NCT02465567|64735390|FG002|Overall Study|missing PI Signature|0|||
23366583|NCT00643760|65088953|FG001|Overall Study|Lost to Follow-up|2|||
23366584|NCT00643760|65088954|FG002|Overall Study|Lost to Follow-up|1|||
23270937|NCT02465567|64735391|FG003|Overall Study|missing PI Signature|0|||
23270938|NCT00095212|64735395|FG000|Overall Study|Withdrawal by Subject|1|||
23366585|NCT00643760|65088955|FG003|Overall Study|Lost to Follow-up|3|||
23366586|NCT00643760|65088956|FG004|Overall Study|Lost to Follow-up|3|||
23366587|NCT00643760|65088952|FG000|Overall Study|Investigator Discretion|0|||
23366588|NCT00643760|65088953|FG001|Overall Study|Investigator Discretion|0|||
23366589|NCT00643760|65088954|FG002|Overall Study|Investigator Discretion|0|||
23366590|NCT00643760|65088955|FG003|Overall Study|Investigator Discretion|2|||
23366591|NCT00643760|65088956|FG004|Overall Study|Investigator Discretion|0|||
23366592|NCT00643760|65088952|FG000|Overall Study|Withdrawal by Subject|3|||
23270939|NCT00095212|64735396|FG001|Overall Study|Withdrawal by Subject|3|||
23270940|NCT03227445|64735397|FG000|Period 1 (28 Days)|Adverse Event|1|||
23366593|NCT00643760|65088953|FG001|Overall Study|Withdrawal by Subject|1|||
23270941|NCT03227445|64735398|FG001|Period 1 (28 Days)|Adverse Event|2|||
23270942|NCT03227445|64735399|FG002|Period 1 (28 Days)|Adverse Event|0|||
23270943|NCT03227445|64735400|FG003|Period 1 (28 Days)|Adverse Event|1|||
23270944|NCT03227445|64735397|FG000|Period 1 (28 Days)|Protocol Violation|1|||
23270945|NCT03227445|64735398|FG001|Period 1 (28 Days)|Protocol Violation|0|||
23270946|NCT03227445|64735399|FG002|Period 1 (28 Days)|Protocol Violation|0|||
23270947|NCT03227445|64735400|FG003|Period 1 (28 Days)|Protocol Violation|0|||
23270948|NCT03227445|64735397|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
23270949|NCT03227445|64735398|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
23270950|NCT03227445|64735399|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
23270951|NCT03227445|64735400|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
23270952|NCT03227445|64735397|FG000|Period 2 (28 Days)|Adverse Event|1|||
23270953|NCT03227445|64735398|FG001|Period 2 (28 Days)|Adverse Event|0|||
23270954|NCT03227445|64735399|FG002|Period 2 (28 Days)|Adverse Event|2|||
23270955|NCT03227445|64735400|FG003|Period 2 (28 Days)|Adverse Event|1|||
23270956|NCT03227445|64735397|FG000|Period 2 (28 Days)|Protocol Violation|0|||
23270957|NCT03227445|64735398|FG001|Period 2 (28 Days)|Protocol Violation|0|||
23270958|NCT03227445|64735399|FG002|Period 2 (28 Days)|Protocol Violation|0|||
23270959|NCT03227445|64735400|FG003|Period 2 (28 Days)|Protocol Violation|1|||
23270960|NCT03227445|64735397|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
23270961|NCT03227445|64735398|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
23270962|NCT03227445|64735399|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
23270963|NCT03227445|64735400|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
23270964|NCT01451762|64735401|FG000|Overall Study|Lost to Follow-up|3|||
23270965|NCT01451762|64735402|FG001|Overall Study|Lost to Follow-up|6|||
23270966|NCT01451762|64735403|FG002|Overall Study|Lost to Follow-up|6|||
23270967|NCT00001849|64735404|FG000|Overall Study|Death|4|||
23270968|NCT00001849|64735404|FG000|Overall Study|Lost to Follow-up|2|||
23270969|NCT00001849|64735404|FG000|Overall Study|Withdrawal by Subject|2|||
23270970|NCT00001849|64735404|FG000|Overall Study|tumor remained occult|6|||
23270971|NCT00591630|64735405|FG000|Overall Study|Death|0|||
23270972|NCT00591630|64735406|FG001|Overall Study|Death|0|||
23270973|NCT00591630|64735407|FG002|Overall Study|Death|1|||
23270974|NCT00591630|64735408|FG003|Overall Study|Death|0|||
23270975|NCT01179048|64735415|FG000|Overall Study|Withdrawn - does not allow contact|4|||
23270976|NCT01179048|64735416|FG001|Overall Study|Withdrawn - does not allow contact|8|||
23270977|NCT01179048|64735415|FG000|Overall Study|Lost to Follow-up|8|||
23270978|NCT01179048|64735416|FG001|Overall Study|Lost to Follow-up|9|||
23270979|NCT01179048|64735415|FG000|Overall Study|Alive|127|||
23270980|NCT01179048|64735416|FG001|Overall Study|Alive|142|||
23270981|NCT00282048|64735418|FG000|Overall Study|Lack of Efficacy|30|||
23270982|NCT00282048|64735418|FG000|Overall Study|Adverse Event|22|||
23270983|NCT00282048|64735418|FG000|Overall Study|Withdrawal by Subject|1|||
23270984|NCT00282048|64735418|FG000|Overall Study|Other|8|||
23270985|NCT00282048|64735418|FG000|Overall Study|Ongoing|1|||
23270986|NCT03471078|64735419|FG000|Overall Study|Withdrawal by Subject|9|||
23270987|NCT03471078|64735420|FG001|Overall Study|Withdrawal by Subject|1|||
23270988|NCT03471078|64735419|FG000|Overall Study|Adverse Event|4|||
23270989|NCT03471078|64735420|FG001|Overall Study|Adverse Event|1|||
23270990|NCT03471078|64735419|FG000|Overall Study|Physician Decision|3|||
23270991|NCT03471078|64735420|FG001|Overall Study|Physician Decision|2|||
23270992|NCT03471078|64735419|FG000|Overall Study|Death|2|||
23270993|NCT03471078|64735420|FG001|Overall Study|Death|0|||
23270994|NCT03471078|64735419|FG000|Overall Study|Other|3|||
23270995|NCT03471078|64735420|FG001|Overall Study|Other|2|||
23270996|NCT01546545|64735422|FG000|Overall Study|Withdrawal by Subject|1|||
23270997|NCT00184600|64735423|FG000|Overall Study|Adverse Event|9|||
23270998|NCT00184600|64735424|FG001|Overall Study|Adverse Event|0|||
23270999|NCT00184600|64735425|FG002|Overall Study|Adverse Event|5|||
23271000|NCT00184600|64735423|FG000|Overall Study|Death|3|||
23271001|NCT00184600|64735424|FG001|Overall Study|Death|9|||
23271002|NCT00184600|64735425|FG002|Overall Study|Death|7|||
23271003|NCT00184600|64735423|FG000|Overall Study|Lack of Efficacy|3|||
23271004|NCT00184600|64735424|FG001|Overall Study|Lack of Efficacy|1|||
23271005|NCT00184600|64735425|FG002|Overall Study|Lack of Efficacy|3|||
23271006|NCT00184600|64735423|FG000|Overall Study|Lost to Follow-up|4|||
23271007|NCT00184600|64735424|FG001|Overall Study|Lost to Follow-up|6|||
23271008|NCT00184600|64735425|FG002|Overall Study|Lost to Follow-up|1|||
23271009|NCT00184600|64735423|FG000|Overall Study|Protocol Violation|2|||
23271010|NCT00184600|64735424|FG001|Overall Study|Protocol Violation|2|||
23483457|NCT01390220|65513063|FG002|Test Dose Phase|Caregiver no longer available|0|||
23271011|NCT00184600|64735425|FG002|Overall Study|Protocol Violation|3|||
23271012|NCT00184600|64735423|FG000|Overall Study|Withdrawal by Subject|20|||
23271013|NCT00184600|64735424|FG001|Overall Study|Withdrawal by Subject|28|||
23271014|NCT00184600|64735425|FG002|Overall Study|Withdrawal by Subject|12|||
23271015|NCT00184600|64735423|FG000|Overall Study|Unclassified|4|||
23271016|NCT00184600|64735424|FG001|Overall Study|Unclassified|5|||
23271017|NCT00184600|64735425|FG002|Overall Study|Unclassified|3|||
23271018|NCT01697696|64735426|FG000|Overall Study|Study terminated by sponsor|0|||
23271019|NCT01697696|64735427|FG001|Overall Study|Study terminated by sponsor|3|||
23271020|NCT01697696|64735426|FG000|Overall Study|Protocol deviation|1|||
23271021|NCT01697696|64735427|FG001|Overall Study|Protocol deviation|0|||
23271022|NCT01697696|64735426|FG000|Overall Study|Physician Decision|1|||
23271023|NCT01697696|64735427|FG001|Overall Study|Physician Decision|0|||
23271024|NCT01697696|64735426|FG000|Overall Study|Death|4|||
23271025|NCT01697696|64735427|FG001|Overall Study|Death|2|||
23271026|NCT01697696|64735426|FG000|Overall Study|Lost to Follow-up|10|||
23271027|NCT01697696|64735427|FG001|Overall Study|Lost to Follow-up|7|||
23271028|NCT01697696|64735426|FG000|Overall Study|Subject/guardian decision|31|||
23271029|NCT01697696|64735427|FG001|Overall Study|Subject/guardian decision|35|||
23271030|NCT02395822|64735430|FG000|Overall Study|Withdrawal by Subject|1|||
23271031|NCT02395822|64735430|FG000|Overall Study|Death|1|||
23271032|NCT03586726|64735431|FG000|Overall Study|Withdrawal by Subject|1|||
23271033|NCT01027143|64735432|FG000|Overall Study|Lost to Follow-up|9|||
23271034|NCT01027143|64735433|FG001|Overall Study|Lost to Follow-up|4|||
23271035|NCT04109222|64735434|FG000|Overall Study|Adverse Event|1|||
23271036|NCT04109222|64735435|FG001|Overall Study|Adverse Event|0|||
23271037|NCT04109222|64735436|FG002|Overall Study|Adverse Event|0|||
23271038|NCT01367457|64735437|FG000|Overall Study|Death|2|||
23271039|NCT01367457|64735438|FG001|Overall Study|Death|0|||
23271040|NCT01367457|64735439|FG002|Overall Study|Death|0|||
23271041|NCT01367457|64735437|FG000|Overall Study|Investigator's decision|2|||
23271042|NCT01367457|64735438|FG001|Overall Study|Investigator's decision|0|||
23271043|NCT01367457|64735439|FG002|Overall Study|Investigator's decision|0|||
23271044|NCT01367457|64735437|FG000|Overall Study|Clinical decline (CD)|2|||
23271045|NCT01367457|64735438|FG001|Overall Study|Clinical decline (CD)|0|||
23271046|NCT01367457|64735439|FG002|Overall Study|Clinical decline (CD)|0|||
23271047|NCT01367457|64735437|FG000|Overall Study|Progression and death|8|||
23271048|NCT01367457|64735438|FG001|Overall Study|Progression and death|0|||
23271049|NCT01367457|64735439|FG002|Overall Study|Progression and death|0|||
23271050|NCT01367457|64735437|FG000|Overall Study|Toxicity|16|||
23271051|NCT01367457|64735438|FG001|Overall Study|Toxicity|0|||
23271052|NCT01367457|64735439|FG002|Overall Study|Toxicity|0|||
23271053|NCT01367457|64735437|FG000|Overall Study|Progression|137|||
23271054|NCT01367457|64735438|FG001|Overall Study|Progression|0|||
23271055|NCT01367457|64735439|FG002|Overall Study|Progression|0|||
23271056|NCT01367457|64735437|FG000|Overall Study|Patient asks for rest + slow progression|1|||
23271057|NCT01367457|64735438|FG001|Overall Study|Patient asks for rest + slow progression|0|||
23271058|NCT01367457|64735439|FG002|Overall Study|Patient asks for rest + slow progression|0|||
23271059|NCT01367457|64735437|FG000|Overall Study|Investigator's opinion, stable disease|1|||
23271060|NCT01367457|64735438|FG001|Overall Study|Investigator's opinion, stable disease|0|||
23271061|NCT01367457|64735439|FG002|Overall Study|Investigator's opinion, stable disease|0|||
23271062|NCT01367457|64735437|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
23271063|NCT01367457|64735438|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
23271064|NCT01367457|64735439|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
23271065|NCT01367457|64735437|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
23271066|NCT01367457|64735438|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
23271067|NCT01367457|64735439|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
23271068|NCT01367457|64735437|FG000|Overall Study|low grade toxicities + stable disease|1|||
23271069|NCT01367457|64735438|FG001|Overall Study|low grade toxicities + stable disease|0|||
23271070|NCT01367457|64735439|FG002|Overall Study|low grade toxicities + stable disease|0|||
23271071|NCT01367457|64735437|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
23271072|NCT01367457|64735438|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
23271073|NCT01367457|64735439|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
23271074|NCT01367457|64735437|FG000|Overall Study|Withdrawal by Subject|1|||
23366594|NCT00643760|65088954|FG002|Overall Study|Withdrawal by Subject|2|||
23366595|NCT00643760|65088955|FG003|Overall Study|Withdrawal by Subject|4|||
23366596|NCT00643760|65088956|FG004|Overall Study|Withdrawal by Subject|1|||
23366597|NCT04771013|65088961|FG000|Overall Study|Withdrawal by Subject|2|||
23271075|NCT01367457|64735438|FG001|Overall Study|Withdrawal by Subject|0|||
23271076|NCT01367457|64735439|FG002|Overall Study|Withdrawal by Subject|0|||
23366598|NCT04771013|65088962|FG001|Overall Study|Withdrawal by Subject|0|||
23366599|NCT04771013|65088961|FG000|Overall Study|Death|0|||
23271077|NCT01367457|64735437|FG000|Overall Study|CD, associated leukaemia|1|||
23271078|NCT01367457|64735438|FG001|Overall Study|CD, associated leukaemia|0|||
23271079|NCT01367457|64735439|FG002|Overall Study|CD, associated leukaemia|0|||
23271080|NCT01367457|64735437|FG000|Overall Study|Uncontrolled pain|1|||
23271081|NCT01367457|64735438|FG001|Overall Study|Uncontrolled pain|0|||
23271082|NCT01367457|64735439|FG002|Overall Study|Uncontrolled pain|0|||
23271083|NCT01367457|64735437|FG000|Overall Study|Overall status worsens to grade 4|1|||
23366600|NCT04771013|65088962|FG001|Overall Study|Death|5|||
23271084|NCT01367457|64735438|FG001|Overall Study|Overall status worsens to grade 4|0|||
23271085|NCT01367457|64735439|FG002|Overall Study|Overall status worsens to grade 4|0|||
23271086|NCT01367457|64735437|FG000|Overall Study|Stabilisation + frequent infections|1|||
23271087|NCT01367457|64735438|FG001|Overall Study|Stabilisation + frequent infections|0|||
23271088|NCT01367457|64735439|FG002|Overall Study|Stabilisation + frequent infections|0|||
23271089|NCT01367457|64735437|FG000|Overall Study|No clinical benefit|1|||
23271090|NCT01367457|64735438|FG001|Overall Study|No clinical benefit|0|||
23271091|NCT01367457|64735439|FG002|Overall Study|No clinical benefit|0|||
23271092|NCT01367457|64735437|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
23271093|NCT01367457|64735438|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
23271094|NCT01367457|64735439|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
23271095|NCT01367457|64735437|FG000|Overall Study|Overall decline|1|||
23271096|NCT01367457|64735438|FG001|Overall Study|Overall decline|0|||
23271097|NCT01367457|64735439|FG002|Overall Study|Overall decline|0|||
23271098|NCT01367457|64735437|FG000|Overall Study|Rejection of treatment|1|||
23271099|NCT01367457|64735438|FG001|Overall Study|Rejection of treatment|0|||
23271100|NCT01367457|64735439|FG002|Overall Study|Rejection of treatment|0|||
23271101|NCT01367457|64735437|FG000|Overall Study|Lost to Follow-up|1|||
23271102|NCT01367457|64735438|FG001|Overall Study|Lost to Follow-up|0|||
23271103|NCT01367457|64735439|FG002|Overall Study|Lost to Follow-up|0|||
23271104|NCT01367457|64735437|FG000|Overall Study|Death from septic shock|1|||
23271105|NCT01367457|64735438|FG001|Overall Study|Death from septic shock|0|||
23271106|NCT01367457|64735439|FG002|Overall Study|Death from septic shock|0|||
23271107|NCT01367457|64735437|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
23271108|NCT01367457|64735438|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
23271109|NCT01367457|64735439|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
23271110|NCT01367457|64735437|FG000|Overall Study|Patient's Wish|1|||
23271111|NCT01367457|64735438|FG001|Overall Study|Patient's Wish|0|||
23271112|NCT01367457|64735439|FG002|Overall Study|Patient's Wish|0|||
23271113|NCT01367457|64735437|FG000|Overall Study|Palliative. Overall decline|1|||
23271114|NCT01367457|64735438|FG001|Overall Study|Palliative. Overall decline|0|||
23271115|NCT01367457|64735439|FG002|Overall Study|Palliative. Overall decline|0|||
23271116|NCT01367457|64735437|FG000|Overall Study|Suspected DP/suspected active infection|1|||
23271117|NCT01367457|64735438|FG001|Overall Study|Suspected DP/suspected active infection|0|||
23271118|NCT01367457|64735439|FG002|Overall Study|Suspected DP/suspected active infection|0|||
23271119|NCT02458638|64735440|FG000|Overall Study|Death|309|||
23271120|NCT02458638|64735440|FG000|Overall Study|End of Cohort/End of Study|67|||
23271121|NCT02458638|64735440|FG000|Overall Study|Lost to Follow-up|31|||
23271122|NCT02458638|64735440|FG000|Overall Study|Other Reasons|4|||
23271123|NCT02458638|64735440|FG000|Overall Study|Physician Decision|1|||
23271124|NCT02458638|64735440|FG000|Overall Study|Withdrawal by Subject|47|||
23271125|NCT01626079|64735443|FG000|Overall Study|Death|167|||
23271126|NCT01626079|64735444|FG001|Overall Study|Death|192|||
23271127|NCT01626079|64735445|FG002|Overall Study|Death|39|||
23271128|NCT01626079|64735443|FG000|Overall Study|Withdrawal by Subject|23|||
23271129|NCT01626079|64735444|FG001|Overall Study|Withdrawal by Subject|37|||
23271130|NCT01626079|64735445|FG002|Overall Study|Withdrawal by Subject|5|||
23271131|NCT01626079|64735443|FG000|Overall Study|Lost to Follow-up|7|||
23271132|NCT01626079|64735444|FG001|Overall Study|Lost to Follow-up|4|||
23271133|NCT01626079|64735445|FG002|Overall Study|Lost to Follow-up|2|||
23271134|NCT01626079|64735443|FG000|Overall Study|Missed Visits|1|||
23271135|NCT01626079|64735444|FG001|Overall Study|Missed Visits|4|||
23271136|NCT01626079|64735445|FG002|Overall Study|Missed Visits|6|||
23271137|NCT00912288|64735446|FG000|Overall Study|Death|0|||
23271138|NCT00912288|64735447|FG001|Overall Study|Death|1|||
23271139|NCT00912288|64735446|FG000|Overall Study|Adverse Event|1|||
23271140|NCT00912288|64735447|FG001|Overall Study|Adverse Event|1|||
23271141|NCT00912288|64735446|FG000|Overall Study|Lost to Follow-up|1|||
23271142|NCT00912288|64735447|FG001|Overall Study|Lost to Follow-up|0|||
23271143|NCT00912288|64735446|FG000|Overall Study|Protocol Violation|1|||
23271144|NCT00912288|64735447|FG001|Overall Study|Protocol Violation|0|||
23271145|NCT00912288|64735446|FG000|Overall Study|Withdrawal by Subject|3|||
23271146|NCT00912288|64735447|FG001|Overall Study|Withdrawal by Subject|3|||
23601889|NCT01105975|65933928|FG004|Overall Study|Physician Decision|0|||
23601890|NCT01105975|65933929|FG005|Overall Study|Physician Decision|0|||
23271147|NCT00912288|64735446|FG000|Overall Study|Study terminated by sponsor|34|||
23271148|NCT00912288|64735447|FG001|Overall Study|Study terminated by sponsor|35|||
23271149|NCT00912288|64735446|FG000|Overall Study|Other|1|||
23271150|NCT00912288|64735447|FG001|Overall Study|Other|0|||
23271151|NCT00822926|64735448|FG000|Second Injection Visit|Lost to Follow-up|1|||
23271152|NCT00822926|64735449|FG001|Second Injection Visit|Lost to Follow-up|0|||
23271153|NCT00822926|64735448|FG000|Second Injection Visit|Withdrawal by Subject|0|||
23271154|NCT00822926|64735449|FG001|Second Injection Visit|Withdrawal by Subject|1|||
23271155|NCT03733925|64735450|FG000|Overall Study|Lost to Follow-up|1|||
23271156|NCT03733925|64735450|FG000|Overall Study|Withdrawal by Subject|2|||
23271157|NCT03733925|64735450|FG000|Overall Study|Adverse Event|2|||
23271158|NCT03733925|64735450|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23271159|NCT03122457|64735452|FG000|Overall Study|Withdrawal by Subject|6|||
23271160|NCT00454909|64735453|FG000|Overall Study|Withdrawal by Subject|1|||
23271161|NCT00454909|64735454|FG001|Overall Study|Withdrawal by Subject|0|||
23271162|NCT00454909|64735455|FG002|Overall Study|Withdrawal by Subject|0|||
23271163|NCT00454909|64735453|FG000|Overall Study|Migrated/moved from study area|0|||
23271164|NCT00454909|64735454|FG001|Overall Study|Migrated/moved from study area|0|||
23271165|NCT00454909|64735455|FG002|Overall Study|Migrated/moved from study area|1|||
23271166|NCT00454909|64735453|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
23271167|NCT00454909|64735454|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
23271168|NCT00454909|64735455|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
23271169|NCT00454909|64735453|FG000|Overall Study|Others|1|||
23271170|NCT00454909|64735454|FG001|Overall Study|Others|0|||
23271171|NCT00454909|64735455|FG002|Overall Study|Others|0|||
23271172|NCT00565448|64735456|FG000|Overall Study|Adverse Event|1|||
23271173|NCT00565448|64735457|FG001|Overall Study|Adverse Event|2|||
23271174|NCT00565448|64735456|FG000|Overall Study|Disease progression|1|||
23271175|NCT00565448|64735457|FG001|Overall Study|Disease progression|0|||
23271176|NCT00565448|64735456|FG000|Overall Study|Withdrawal by Subject|1|||
23271177|NCT00565448|64735457|FG001|Overall Study|Withdrawal by Subject|0|||
23271178|NCT00105196|64735458|FG000|Overall Study|Lack of Efficacy|2|||
23271179|NCT00105196|64735459|FG001|Overall Study|Lack of Efficacy|3|||
23271180|NCT00105196|64735458|FG000|Overall Study|Adverse Event|11|||
23271181|NCT00105196|64735459|FG001|Overall Study|Adverse Event|3|||
23271182|NCT00105196|64735458|FG000|Overall Study|Withdrawal by Subject|6|||
23271183|NCT00105196|64735459|FG001|Overall Study|Withdrawal by Subject|6|||
23271184|NCT00105196|64735458|FG000|Overall Study|Lost to Follow-up|3|||
23271185|NCT00105196|64735459|FG001|Overall Study|Lost to Follow-up|2|||
23271186|NCT00105196|64735458|FG000|Overall Study|Poor/noncompliance|3|||
23271187|NCT00105196|64735459|FG001|Overall Study|Poor/noncompliance|4|||
23271188|NCT00105196|64735458|FG000|Overall Study|Protocol Violation|5|||
23271189|NCT00105196|64735459|FG001|Overall Study|Protocol Violation|2|||
23271190|NCT00105196|64735458|FG000|Overall Study|pending surgery|0|||
23271191|NCT00105196|64735459|FG001|Overall Study|pending surgery|1|||
23271192|NCT00105196|64735458|FG000|Overall Study|marijuana use|0|||
23271193|NCT00105196|64735459|FG001|Overall Study|marijuana use|1|||
23271194|NCT00105196|64735458|FG000|Overall Study|Subject became unblinded|0|||
23271195|NCT00105196|64735459|FG001|Overall Study|Subject became unblinded|1|||
23271196|NCT01052116|64735461|FG000|Overall Study|Lost to Follow-up|11|||
23271197|NCT01052116|64735462|FG001|Overall Study|Lost to Follow-up|17|||
23271198|NCT01052116|64735461|FG000|Overall Study|Withdrawal by Subject|3|||
23271199|NCT01052116|64735462|FG001|Overall Study|Withdrawal by Subject|6|||
23271200|NCT01052116|64735461|FG000|Overall Study|Spirometry not performed|0|||
23271201|NCT01052116|64735462|FG001|Overall Study|Spirometry not performed|4|||
23271202|NCT02272777|64735470|FG000|Overall Study|Adverse Event|0|||
23271203|NCT02272777|64735471|FG001|Overall Study|Adverse Event|1|||
23271204|NCT02272777|64735470|FG000|Overall Study|Withdrawal by Subject|0|||
23271205|NCT02272777|64735471|FG001|Overall Study|Withdrawal by Subject|3|||
23271206|NCT02272777|64735470|FG000|Overall Study|Lost to Follow-up|2|||
23271207|NCT02272777|64735471|FG001|Overall Study|Lost to Follow-up|0|||
23271208|NCT02272777|64735470|FG000|Overall Study|Other|2|||
23271209|NCT02272777|64735471|FG001|Overall Study|Other|0|||
23271210|NCT02726581|64735472|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
23271211|NCT02726581|64735473|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
23271212|NCT02726581|64735474|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
23271213|NCT02726581|64735472|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
23271214|NCT02726581|64735473|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
23271215|NCT02726581|64735474|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
23271216|NCT02726581|64735472|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23271217|NCT02726581|64735473|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23271218|NCT02726581|64735474|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23271219|NCT02726581|64735472|FG000|Treatment Period|Disease progression|47|||
23271220|NCT02726581|64735473|FG001|Treatment Period|Disease progression|50|||
23271221|NCT02726581|64735474|FG002|Treatment Period|Disease progression|16|||
23271222|NCT02726581|64735472|FG000|Treatment Period|Other reasons|9|||
23271223|NCT02726581|64735473|FG001|Treatment Period|Other reasons|8|||
23271224|NCT02726581|64735474|FG002|Treatment Period|Other reasons|2|||
23271225|NCT02726581|64735472|FG000|Treatment Period|Study drug toxicity|6|||
23271226|NCT02726581|64735473|FG001|Treatment Period|Study drug toxicity|3|||
23271227|NCT02726581|64735474|FG002|Treatment Period|Study drug toxicity|2|||
23271228|NCT02726581|64735472|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
23271229|NCT02726581|64735473|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
23271230|NCT02726581|64735474|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
23271231|NCT02726581|64735472|FG000|Treatment Period|Participant withdrew consent|3|||
23271232|NCT02726581|64735473|FG001|Treatment Period|Participant withdrew consent|1|||
23271233|NCT02726581|64735474|FG002|Treatment Period|Participant withdrew consent|1|||
23271234|NCT02726581|64735472|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
23271235|NCT02726581|64735473|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
23271236|NCT02726581|64735474|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
23271237|NCT02726581|64735472|FG000|Treatment Period|Maximum clinical benefit|0|||
23271238|NCT02726581|64735473|FG001|Treatment Period|Maximum clinical benefit|2|||
23271239|NCT02726581|64735474|FG002|Treatment Period|Maximum clinical benefit|0|||
23271240|NCT02726581|64735472|FG000|Treatment Period|Death|1|||
23271241|NCT02726581|64735473|FG001|Treatment Period|Death|0|||
23271242|NCT02726581|64735474|FG002|Treatment Period|Death|0|||
23271243|NCT02726581|64735472|FG000|Treatment Period|Poor/non-compliance|1|||
23271244|NCT02726581|64735473|FG001|Treatment Period|Poor/non-compliance|0|||
23271245|NCT02726581|64735474|FG002|Treatment Period|Poor/non-compliance|0|||
23271246|NCT02726581|64735472|FG000|Treatment Period|Participant no longer meets study criteria|0|||
23271247|NCT02726581|64735473|FG001|Treatment Period|Participant no longer meets study criteria|1|||
23271248|NCT02726581|64735474|FG002|Treatment Period|Participant no longer meets study criteria|0|||
23271249|NCT01001208|64735478|FG000|Overall Study|Adverse Event|10|||
23271250|NCT01001208|64735479|FG001|Overall Study|Adverse Event|5|||
23271251|NCT01001208|64735478|FG000|Overall Study|Lost to Follow-up|5|||
23271252|NCT01001208|64735479|FG001|Overall Study|Lost to Follow-up|9|||
23271253|NCT01001208|64735478|FG000|Overall Study|Physician Decision|1|||
23271254|NCT01001208|64735479|FG001|Overall Study|Physician Decision|0|||
23271255|NCT01001208|64735478|FG000|Overall Study|Withdrawal by Subject|4|||
23271256|NCT01001208|64735479|FG001|Overall Study|Withdrawal by Subject|5|||
23271257|NCT01001208|64735478|FG000|Overall Study|Ineligibility Determined|4|||
23271258|NCT01001208|64735479|FG001|Overall Study|Ineligibility Determined|2|||
23271259|NCT01001208|64735478|FG000|Overall Study|Noncompliance|4|||
23271260|NCT01001208|64735479|FG001|Overall Study|Noncompliance|7|||
23271261|NCT01001208|64735478|FG000|Overall Study|Disease Progression|0|||
23271262|NCT01001208|64735479|FG001|Overall Study|Disease Progression|3|||
23271263|NCT01001208|64735478|FG000|Overall Study|Other|0|||
23271264|NCT01001208|64735479|FG001|Overall Study|Other|2|||
23271265|NCT01010542|64735483|FG000|Overall Study|Adverse Event|0|||
23271266|NCT01010542|64735484|FG001|Overall Study|Adverse Event|1|||
23271267|NCT01010542|64735485|FG002|Overall Study|Adverse Event|0|||
23271268|NCT01010542|64735483|FG000|Overall Study|Lost to Follow-up|0|||
23271269|NCT01010542|64735484|FG001|Overall Study|Lost to Follow-up|1|||
23271270|NCT01010542|64735485|FG002|Overall Study|Lost to Follow-up|0|||
23271271|NCT01010542|64735483|FG000|Overall Study|Withdrawal by Subject|0|||
23271272|NCT01010542|64735484|FG001|Overall Study|Withdrawal by Subject|3|||
23271273|NCT01010542|64735485|FG002|Overall Study|Withdrawal by Subject|2|||
23271274|NCT03100903|64738198|FG000|Overall Study|Withdrawal by Subject|0|||
23271275|NCT03100903|64738199|FG001|Overall Study|Withdrawal by Subject|0|||
23271276|NCT03100903|64738200|FG002|Overall Study|Withdrawal by Subject|1|||
23271277|NCT01544127|64738205|FG000|Overall Study|Lost to Follow-up|4|||
23271278|NCT01544127|64738206|FG001|Overall Study|Lost to Follow-up|2|||
23271279|NCT01544127|64738207|FG002|Overall Study|Lost to Follow-up|9|||
23271280|NCT01544127|64738205|FG000|Overall Study|Withdrawal by Subject|2|||
23271281|NCT01544127|64738206|FG001|Overall Study|Withdrawal by Subject|2|||
23271282|NCT01544127|64738207|FG002|Overall Study|Withdrawal by Subject|1|||
23271283|NCT01544127|64738205|FG000|Overall Study|Discharged out of catchment area|1|||
23271284|NCT01544127|64738206|FG001|Overall Study|Discharged out of catchment area|1|||
23271285|NCT01544127|64738207|FG002|Overall Study|Discharged out of catchment area|1|||
23271286|NCT01544127|64738205|FG000|Overall Study|Death|1|||
23271287|NCT01544127|64738206|FG001|Overall Study|Death|0|||
23271288|NCT01544127|64738207|FG002|Overall Study|Death|0|||
23271289|NCT01544127|64738205|FG000|Overall Study|Jail or Prison|1|||
23271290|NCT01544127|64738206|FG001|Overall Study|Jail or Prison|1|||
23271291|NCT01544127|64738207|FG002|Overall Study|Jail or Prison|2|||
23271292|NCT01544127|64738205|FG000|Overall Study|Became Psychotic|1|||
23271293|NCT01544127|64738206|FG001|Overall Study|Became Psychotic|0|||
23271294|NCT01544127|64738207|FG002|Overall Study|Became Psychotic|0|||
23271295|NCT01544127|64738205|FG000|Overall Study|Researcher withdrew|1|||
23271296|NCT01544127|64738206|FG001|Overall Study|Researcher withdrew|0|||
23271297|NCT01544127|64738207|FG002|Overall Study|Researcher withdrew|0|||
23271298|NCT01544127|64738205|FG000|Overall Study|Went active duty|0|||
23271299|NCT01544127|64738206|FG001|Overall Study|Went active duty|0|||
23271300|NCT01544127|64738207|FG002|Overall Study|Went active duty|1|||
23271301|NCT01273805|64738208|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
23271302|NCT01273805|64738209|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
23271303|NCT02475954|64738211|FG000|Overall Study|Withdrawal by Subject|2|||
23271304|NCT02475954|64738212|FG001|Overall Study|Withdrawal by Subject|2|||
23271305|NCT02475954|64738211|FG000|Overall Study|Lost to Follow-up|11|||
23271306|NCT02475954|64738212|FG001|Overall Study|Lost to Follow-up|9|||
23271307|NCT02475954|64738211|FG000|Overall Study|Death|1|||
23271308|NCT02475954|64738212|FG001|Overall Study|Death|1|||
23271309|NCT02670525|64738213|FG000|Overall Study|Death|94|||
23271310|NCT02670525|64738214|FG001|Overall Study|Death|14|||
23271311|NCT02670525|64738213|FG000|Overall Study|Lost to Follow-up|4|||
23271312|NCT02670525|64738214|FG001|Overall Study|Lost to Follow-up|1|||
23271313|NCT02670525|64738213|FG000|Overall Study|Subject withdrew consent|1|||
23271314|NCT02670525|64738214|FG001|Overall Study|Subject withdrew consent|0|||
23271315|NCT02670525|64738213|FG000|Overall Study|Unknown, data entry delayed|123|||
23271316|NCT02670525|64738214|FG001|Overall Study|Unknown, data entry delayed|78|||
23271317|NCT05017480|64738215|FG000|Stage 1 Study|Withdrawal by Subject|8|||
23271318|NCT05017480|64738216|FG001|Stage 1 Study|Withdrawal by Subject|6|||
23271319|NCT05017480|64738217|FG002|Stage 1 Study|Withdrawal by Subject|0|||
23271320|NCT05017480|64738218|FG003|Stage 1 Study|Withdrawal by Subject|0|||
23271321|NCT05017480|64738219|FG004|Stage 1 Study|Withdrawal by Subject|0|||
23271322|NCT05017480|64738215|FG000|Stage 1 Study|Adverse Event|1|||
23271323|NCT05017480|64738216|FG001|Stage 1 Study|Adverse Event|1|||
23271324|NCT05017480|64738217|FG002|Stage 1 Study|Adverse Event|0|||
23271325|NCT05017480|64738218|FG003|Stage 1 Study|Adverse Event|0|||
23271326|NCT05017480|64738219|FG004|Stage 1 Study|Adverse Event|0|||
23271327|NCT05017480|64738215|FG000|Stage 1 Study|Poor Compliance|1|||
23271328|NCT05017480|64738216|FG001|Stage 1 Study|Poor Compliance|1|||
23271329|NCT05017480|64738217|FG002|Stage 1 Study|Poor Compliance|0|||
23271330|NCT05017480|64738218|FG003|Stage 1 Study|Poor Compliance|0|||
23271331|NCT05017480|64738219|FG004|Stage 1 Study|Poor Compliance|0|||
23271332|NCT05017480|64738215|FG000|Stage 1 Study|Physician Decision|0|||
23271333|NCT05017480|64738216|FG001|Stage 1 Study|Physician Decision|1|||
23271334|NCT05017480|64738217|FG002|Stage 1 Study|Physician Decision|0|||
23271335|NCT05017480|64738218|FG003|Stage 1 Study|Physician Decision|0|||
23271336|NCT05017480|64738219|FG004|Stage 1 Study|Physician Decision|0|||
23271337|NCT05017480|64738215|FG000|Stage 2 Study|Withdrawal by Subject|0|||
23271338|NCT05017480|64738216|FG001|Stage 2 Study|Withdrawal by Subject|0|||
23271339|NCT05017480|64738217|FG002|Stage 2 Study|Withdrawal by Subject|6|||
23366601|NCT04771013|65088961|FG000|Overall Study|Referred to another hospital before day 20|0|||
23366602|NCT04771013|65088962|FG001|Overall Study|Referred to another hospital before day 20|1|||
23366603|NCT01939314|65088963|FG000|Overall Study|Withdrawal by Subject|3|||
23366604|NCT01939314|65088964|FG001|Overall Study|Withdrawal by Subject|1|||
23366605|NCT01939314|65088963|FG000|Overall Study|Protocol Violation|1|||
23366606|NCT01939314|65088964|FG001|Overall Study|Protocol Violation|0|||
23366607|NCT01939314|65088963|FG000|Overall Study|Pregnancy|0|||
23271340|NCT05017480|64738218|FG003|Stage 2 Study|Withdrawal by Subject|9|||
23271341|NCT05017480|64738219|FG004|Stage 2 Study|Withdrawal by Subject|11|||
23271342|NCT05017480|64738215|FG000|Stage 2 Study|Lost to Follow-up|0|||
23271343|NCT05017480|64738216|FG001|Stage 2 Study|Lost to Follow-up|0|||
23271344|NCT05017480|64738217|FG002|Stage 2 Study|Lost to Follow-up|0|||
23271345|NCT05017480|64738218|FG003|Stage 2 Study|Lost to Follow-up|2|||
23271346|NCT05017480|64738219|FG004|Stage 2 Study|Lost to Follow-up|1|||
23271347|NCT05017480|64738215|FG000|Stage 2 Study|Adverse Event|0|||
23271348|NCT05017480|64738216|FG001|Stage 2 Study|Adverse Event|0|||
23271349|NCT05017480|64738217|FG002|Stage 2 Study|Adverse Event|0|||
23271350|NCT05017480|64738218|FG003|Stage 2 Study|Adverse Event|1|||
23271351|NCT05017480|64738219|FG004|Stage 2 Study|Adverse Event|0|||
23271352|NCT05017480|64738215|FG000|Stage 2 Study|COVID-19|0|||
23271353|NCT05017480|64738216|FG001|Stage 2 Study|COVID-19|0|||
23271354|NCT05017480|64738217|FG002|Stage 2 Study|COVID-19|0|||
23271355|NCT05017480|64738218|FG003|Stage 2 Study|COVID-19|1|||
23271356|NCT05017480|64738219|FG004|Stage 2 Study|COVID-19|0|||
23271357|NCT05017480|64738215|FG000|Stage 2 Study|Pregnancy|0|||
23271358|NCT05017480|64738216|FG001|Stage 2 Study|Pregnancy|0|||
23271359|NCT05017480|64738217|FG002|Stage 2 Study|Pregnancy|0|||
23271360|NCT05017480|64738218|FG003|Stage 2 Study|Pregnancy|0|||
23271361|NCT05017480|64738219|FG004|Stage 2 Study|Pregnancy|1|||
23271362|NCT01458405|64738220|FG000|Phase 1 (up to 12 Months)|Other|0|||
23271363|NCT01458405|64738221|FG001|Phase 1 (up to 12 Months)|Other|1|||
23366608|NCT01939314|65088964|FG001|Overall Study|Pregnancy|1|||
23366609|NCT01939314|65088963|FG000|Overall Study|Lost to Follow-up|5|||
23366610|NCT01939314|65088964|FG001|Overall Study|Lost to Follow-up|6|||
23271364|NCT01458405|64738222|FG002|Phase 1 (up to 12 Months)|Other|0|||
23366611|NCT00570401|65088965|FG000|Overall Study|Adverse Event|2|||
23366612|NCT01817075|65088968|FG000|Overall Study|Adverse Event|7|||
23366613|NCT01817075|65088969|FG001|Overall Study|Adverse Event|5|||
23366614|NCT01817075|65088968|FG000|Overall Study|Physician Decision|9|||
23271365|NCT01458405|64738223|FG003|Phase 1 (up to 12 Months)|Other|0|||
23271366|NCT01458405|64738220|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
23366615|NCT01817075|65088969|FG001|Overall Study|Physician Decision|12|||
23271367|NCT01458405|64738221|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
23271368|NCT01458405|64738222|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
23366616|NCT01817075|65088968|FG000|Overall Study|Withdrawal by Subject|31|||
23366617|NCT01817075|65088969|FG001|Overall Study|Withdrawal by Subject|15|||
23366618|NCT01817075|65088968|FG000|Overall Study|Received Sorafenib after enrollment|0|||
23271369|NCT01458405|64738223|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
23271370|NCT01458405|64738220|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
23366619|NCT01817075|65088969|FG001|Overall Study|Received Sorafenib after enrollment|1|||
23366620|NCT01817075|65088968|FG000|Overall Study|Ineligible|0|||
23366621|NCT01817075|65088969|FG001|Overall Study|Ineligible|2|||
23366622|NCT00315445|65088972|FG000|Overall Study|Adverse Event|7|||
23366623|NCT00315445|65088973|FG001|Overall Study|Adverse Event|12|||
23366624|NCT00315445|65088974|FG002|Overall Study|Adverse Event|15|||
23366625|NCT00315445|65088972|FG000|Overall Study|Lack of Efficacy|16|||
23366626|NCT00315445|65088973|FG001|Overall Study|Lack of Efficacy|1|||
23366627|NCT00315445|65088974|FG002|Overall Study|Lack of Efficacy|7|||
23366628|NCT00315445|65088972|FG000|Overall Study|Lost to Follow-up|1|||
23366629|NCT00315445|65088973|FG001|Overall Study|Lost to Follow-up|0|||
23366630|NCT00315445|65088974|FG002|Overall Study|Lost to Follow-up|1|||
23271371|NCT01458405|64738221|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
23271372|NCT01458405|64738222|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
23271373|NCT01458405|64738223|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
23271374|NCT01458405|64738220|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
23271375|NCT01458405|64738221|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
23271376|NCT01458405|64738222|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
23271377|NCT01458405|64738223|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
23271378|NCT03482882|64738228|FG000|Overall Study|Adverse Event|3|||
23271379|NCT03482882|64738228|FG000|Overall Study|Lost to Follow-up|1|||
23271380|NCT03482882|64738228|FG000|Overall Study|Protocol Violation|2|||
23271381|NCT03482882|64738228|FG000|Overall Study|Not further specified|1|||
23271382|NCT01448057|64738231|FG000|Overall Study|Protocol Violation|3|||
23271383|NCT01448057|64738232|FG001|Overall Study|Protocol Violation|2|||
23271384|NCT01448057|64738231|FG000|Overall Study|Lost to Follow-up|3|||
23271385|NCT01448057|64738232|FG001|Overall Study|Lost to Follow-up|0|||
23271386|NCT01448057|64738231|FG000|Overall Study|Adverse Event|0|||
23271387|NCT01448057|64738232|FG001|Overall Study|Adverse Event|2|||
23271388|NCT01448057|64738231|FG000|Overall Study|Withdrawal by Subject|2|||
23271389|NCT01448057|64738232|FG001|Overall Study|Withdrawal by Subject|0|||
23271390|NCT01457053|64738233|FG000|Overall Study|Unable to undergo selected treatment|1|||
23271391|NCT01457053|64738234|FG001|Overall Study|Unable to undergo selected treatment|1|||
23271392|NCT03603314|64738237|FG000|Overall Study|Lost to Follow-up|0|||
23271393|NCT03603314|64738238|FG001|Overall Study|Lost to Follow-up|3|||
23271394|NCT03603314|64738239|FG002|Overall Study|Lost to Follow-up|0|||
23271395|NCT03603314|64738237|FG000|Overall Study|Protocol Violation|0|||
23271396|NCT03603314|64738238|FG001|Overall Study|Protocol Violation|1|||
23271397|NCT03603314|64738239|FG002|Overall Study|Protocol Violation|0|||
23271398|NCT03603314|64738237|FG000|Overall Study|Adverse Event|2|||
23271399|NCT03603314|64738238|FG001|Overall Study|Adverse Event|0|||
23271400|NCT03603314|64738239|FG002|Overall Study|Adverse Event|0|||
23271401|NCT03603314|64738237|FG000|Overall Study|Physician Decision|1|||
23271402|NCT03603314|64738238|FG001|Overall Study|Physician Decision|1|||
23271403|NCT03603314|64738239|FG002|Overall Study|Physician Decision|0|||
23271404|NCT03603314|64738237|FG000|Overall Study|Withdrawal by Subject|4|||
23271405|NCT03603314|64738238|FG001|Overall Study|Withdrawal by Subject|5|||
23271406|NCT03603314|64738239|FG002|Overall Study|Withdrawal by Subject|3|||
23271407|NCT03603314|64738237|FG000|Overall Study|Other|0|||
23271408|NCT03603314|64738238|FG001|Overall Study|Other|1|||
23271409|NCT03603314|64738239|FG002|Overall Study|Other|0|||
23271410|NCT02781727|64738245|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
23271411|NCT02781727|64738246|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
23271412|NCT02781727|64738245|FG000|Treatment Period|Withdrawal by Subject|1|||
23271413|NCT02781727|64738246|FG001|Treatment Period|Withdrawal by Subject|0|||
23271414|NCT02781727|64738245|FG000|Treatment Period|Lost to Follow-up|0|||
23271415|NCT02781727|64738246|FG001|Treatment Period|Lost to Follow-up|1|||
23271416|NCT01396278|64738247|FG000|Overall Study|Adverse Event|0|||
23271417|NCT01396278|64738248|FG001|Overall Study|Adverse Event|0|||
23271418|NCT01396278|64738249|FG002|Overall Study|Adverse Event|0|||
23271419|NCT01396278|64738250|FG003|Overall Study|Adverse Event|2|||
23271420|NCT01396278|64738251|FG004|Overall Study|Adverse Event|0|||
23271421|NCT01396278|64738247|FG000|Overall Study|Withdraw due to trial termination|2|||
23271422|NCT01396278|64738248|FG001|Overall Study|Withdraw due to trial termination|1|||
23271423|NCT01396278|64738249|FG002|Overall Study|Withdraw due to trial termination|1|||
23271424|NCT01396278|64738250|FG003|Overall Study|Withdraw due to trial termination|0|||
23271425|NCT01396278|64738251|FG004|Overall Study|Withdraw due to trial termination|2|||
23271426|NCT03134222|64738252|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
23271427|NCT03134222|64738253|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
23271428|NCT03134222|64738254|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
23271429|NCT03134222|64738255|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
23271430|NCT03134222|64738256|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
23271431|NCT03134222|64738252|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
23366631|NCT00315445|65088972|FG000|Overall Study|Protocol Violation|2|||
23366632|NCT00315445|65088973|FG001|Overall Study|Protocol Violation|0|||
23601891|NCT01105975|65933930|FG006|Overall Study|Physician Decision|2|||
23366633|NCT00315445|65088974|FG002|Overall Study|Protocol Violation|1|||
23366634|NCT00315445|65088972|FG000|Overall Study|Other|1|||
23271432|NCT03134222|64738253|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
23271433|NCT03134222|64738254|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
23271434|NCT03134222|64738255|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
23271435|NCT03134222|64738256|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
23271436|NCT03134222|64738252|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
23271437|NCT03134222|64738253|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
23271438|NCT03134222|64738254|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
23271439|NCT03134222|64738255|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
23271440|NCT03134222|64738256|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
23271441|NCT03134222|64738252|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
23271442|NCT03134222|64738253|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
23271443|NCT03134222|64738254|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
23271444|NCT03134222|64738255|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
23271445|NCT03134222|64738256|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
23271446|NCT03134222|64738252|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
23271447|NCT03134222|64738253|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
23271448|NCT03134222|64738254|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
23271449|NCT03134222|64738255|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
23271450|NCT03134222|64738256|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
23271451|NCT03134222|64738252|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
23271452|NCT03134222|64738253|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
23271453|NCT03134222|64738254|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
23271454|NCT03134222|64738255|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
23271455|NCT03134222|64738256|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
23271456|NCT03134222|64738252|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
23271457|NCT03134222|64738253|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
23271458|NCT03134222|64738254|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
23271459|NCT03134222|64738255|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
23271460|NCT03134222|64738256|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
23271461|NCT03134222|64738252|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
23271462|NCT03134222|64738253|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
23271463|NCT03134222|64738254|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
23271464|NCT03134222|64738255|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
23271465|NCT03134222|64738256|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
23271466|NCT00424047|64738257|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
23271467|NCT00424047|64738258|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
23271468|NCT00424047|64738257|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
23271469|NCT00424047|64738258|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
23271470|NCT00424047|64738257|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
23271471|NCT00424047|64738258|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
23271472|NCT00424047|64738257|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
23271473|NCT00424047|64738258|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
23271474|NCT00424047|64738257|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
23271475|NCT00424047|64738258|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
23271476|NCT00424047|64738257|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
23271477|NCT00424047|64738258|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
23271478|NCT00424047|64738257|FG000|On Study at Time of Unblinding|Adverse Event|22|||
23271479|NCT00424047|64738258|FG001|On Study at Time of Unblinding|Adverse Event|12|||
23271480|NCT00424047|64738257|FG000|On Study at Time of Unblinding|Progression of disease|92|||
23271481|NCT00424047|64738258|FG001|On Study at Time of Unblinding|Progression of disease|128|||
23271482|NCT00424047|64738257|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
23271483|NCT00424047|64738258|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
23271484|NCT00424047|64738257|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
23271485|NCT00424047|64738258|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
23271486|NCT00424047|64738257|FG000|On Study at Time of Unblinding|Death|11|||
23271487|NCT00424047|64738258|FG001|On Study at Time of Unblinding|Death|11|||
23271488|NCT00424047|64738257|FG000|On Study at Time of Unblinding|Other|5|||
23271489|NCT00424047|64738258|FG001|On Study at Time of Unblinding|Other|4|||
23271490|NCT00424047|64738257|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
23271491|NCT00424047|64738258|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
23271492|NCT00424047|64738257|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
23271493|NCT00424047|64738258|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
23271494|NCT00424047|64738257|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
23271495|NCT00424047|64738258|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
23271496|NCT00424047|64738257|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
23483458|NCT01390220|65513061|FG000|Test Dose Phase|Noncompliance|2|||
23483459|NCT01390220|65513062|FG001|Test Dose Phase|Noncompliance|0|||
23366635|NCT00315445|65088973|FG001|Overall Study|Other|3|||
23366636|NCT00315445|65088974|FG002|Overall Study|Other|0|||
23366637|NCT01499810|65088975|FG000|Overall Study|Lost to Follow-up|10|||
23366638|NCT01499810|65088975|FG000|Overall Study|Protocol Violation|1|||
23366639|NCT01499810|65088975|FG000|Overall Study|Withdrawal by Subject|1|||
23366640|NCT01806168|65088979|FG000|Overall Study|Adverse Event|1|||
23366641|NCT01806168|65088980|FG001|Overall Study|Adverse Event|0|||
23366642|NCT01806168|65088981|FG002|Overall Study|Adverse Event|0|||
23366643|NCT01806168|65088979|FG000|Overall Study|Withdrawal by Subject|0|||
23366644|NCT01806168|65088980|FG001|Overall Study|Withdrawal by Subject|1|||
23366645|NCT01806168|65088981|FG002|Overall Study|Withdrawal by Subject|2|||
23366646|NCT01806168|65088979|FG000|Overall Study|Protocol Violation|0|||
23366647|NCT01806168|65088980|FG001|Overall Study|Protocol Violation|0|||
23366648|NCT01806168|65088981|FG002|Overall Study|Protocol Violation|1|||
23366649|NCT03528551|65088984|FG000|Overall Study|Lost to Follow-up|0|||
23366650|NCT03528551|65088985|FG001|Overall Study|Lost to Follow-up|1|||
23366651|NCT03528551|65088986|FG002|Overall Study|Lost to Follow-up|0|||
23366652|NCT03528551|65088984|FG000|Overall Study|Transferred to other arm/group|2|||
23366653|NCT03528551|65088985|FG001|Overall Study|Transferred to other arm/group|3|||
23366654|NCT03528551|65088986|FG002|Overall Study|Transferred to other arm/group|0|||
23366655|NCT03528551|65088984|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23366656|NCT03528551|65088985|FG001|Overall Study|Withdrawal by parent/guardian|5|||
23366657|NCT03528551|65088986|FG002|Overall Study|Withdrawal by parent/guardian|0|||
23366658|NCT03528551|65088984|FG000|Overall Study|Protocol Violation|0|||
23366659|NCT03528551|65088985|FG001|Overall Study|Protocol Violation|3|||
23366660|NCT03528551|65088986|FG002|Overall Study|Protocol Violation|0|||
23366661|NCT03528551|65088984|FG000|Overall Study|Withdrawal by Subject|0|||
23366662|NCT03528551|65088985|FG001|Overall Study|Withdrawal by Subject|7|||
23366663|NCT03528551|65088986|FG002|Overall Study|Withdrawal by Subject|0|||
23366664|NCT00141518|65088991|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
23366665|NCT00141518|65088992|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
23366666|NCT00141518|65088993|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
23366667|NCT00141518|65088991|FG000|Overall Study|Adverse Event|7|||
23366668|NCT00141518|65088992|FG001|Overall Study|Adverse Event|5|||
23366669|NCT00141518|65088993|FG002|Overall Study|Adverse Event|2|||
23366670|NCT00141518|65088991|FG000|Overall Study|Withdrawal by Subject|2|||
23366671|NCT00141518|65088992|FG001|Overall Study|Withdrawal by Subject|0|||
23366672|NCT00141518|65088993|FG002|Overall Study|Withdrawal by Subject|2|||
23366673|NCT00141518|65088991|FG000|Overall Study|Protocol Violation|1|||
23366674|NCT00141518|65088992|FG001|Overall Study|Protocol Violation|1|||
23366675|NCT00141518|65088993|FG002|Overall Study|Protocol Violation|2|||
23366676|NCT00141518|65088991|FG000|Overall Study|Lack of Efficacy|5|||
23366677|NCT00141518|65088992|FG001|Overall Study|Lack of Efficacy|0|||
23366678|NCT00141518|65088993|FG002|Overall Study|Lack of Efficacy|0|||
23366679|NCT01064479|65088994|FG000|Overall Study|Death|10|||
23366680|NCT01064479|65088995|FG001|Overall Study|Death|11|||
23366681|NCT01064479|65088994|FG000|Overall Study|Withdrawal by Subject|2|||
23366682|NCT01064479|65088995|FG001|Overall Study|Withdrawal by Subject|2|||
23366683|NCT01064479|65088994|FG000|Overall Study|Disease progression|1|||
23366684|NCT01064479|65088995|FG001|Overall Study|Disease progression|1|||
23366685|NCT01064479|65088994|FG000|Overall Study|Toxicity|1|||
23366686|NCT01064479|65088995|FG001|Overall Study|Toxicity|1|||
23366687|NCT01064479|65088994|FG000|Overall Study|Other|1|||
23366688|NCT01064479|65088995|FG001|Overall Study|Other|2|||
23366689|NCT00327340|65088996|FG000|Overall Study|Withdrawal by Subject|1|||
23366690|NCT00327340|65088997|FG001|Overall Study|Withdrawal by Subject|5|||
23366691|NCT00327340|65088996|FG000|Overall Study|Physician Decision|1|||
23366692|NCT00327340|65088997|FG001|Overall Study|Physician Decision|1|||
23366693|NCT00327340|65088996|FG000|Overall Study|Disease Progression|10|||
23366694|NCT00327340|65088997|FG001|Overall Study|Disease Progression|19|||
23366695|NCT00327340|65088996|FG000|Overall Study|Symptomatic Disease|0|||
23366696|NCT00327340|65088997|FG001|Overall Study|Symptomatic Disease|2|||
23366697|NCT00327340|65088996|FG000|Overall Study|Adverse Event|3|||
23366698|NCT00327340|65088997|FG001|Overall Study|Adverse Event|3|||
23366699|NCT03322293|65088998|FG000|Overall Study|Lost to Follow-up|0|||
23366700|NCT03322293|65088999|FG001|Overall Study|Lost to Follow-up|0|||
23366701|NCT03322293|65089000|FG002|Overall Study|Lost to Follow-up|1|||
23366702|NCT03118518|65089001|FG000|Overall Study|Early Exit after treatment|2|||
23366703|NCT03118518|65089002|FG001|Overall Study|Early Exit after treatment|8|||
23366704|NCT03118518|65089001|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
23366705|NCT03118518|65089002|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
23366706|NCT03131167|65089006|FG000|Overall Study|Other (Unspecified)|0|||
23366707|NCT03131167|65089007|FG001|Overall Study|Other (Unspecified)|0|||
23366708|NCT03131167|65089008|FG002|Overall Study|Other (Unspecified)|0|||
23366709|NCT03131167|65089009|FG003|Overall Study|Other (Unspecified)|0|||
23366710|NCT03131167|65089010|FG004|Overall Study|Other (Unspecified)|0|||
23366711|NCT03131167|65089011|FG005|Overall Study|Other (Unspecified)|1|||
23366712|NCT03131167|65089012|FG006|Overall Study|Other (Unspecified)|0|||
23271497|NCT00424047|64738258|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
23271498|NCT00424047|64738257|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
23271499|NCT00424047|64738258|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
23483460|NCT01390220|65513063|FG002|Test Dose Phase|Noncompliance|0|||
23366713|NCT03131167|65089013|FG007|Overall Study|Other (Unspecified)|0|||
23366714|NCT03131167|65089014|FG008|Overall Study|Other (Unspecified)|0|||
23366715|NCT03131167|65089015|FG009|Overall Study|Other (Unspecified)|0|||
23366716|NCT03131167|65089016|FG010|Overall Study|Other (Unspecified)|0|||
23366717|NCT03131167|65089017|FG011|Overall Study|Other (Unspecified)|0|||
23271500|NCT01066143|64738259|FG000|Overall Study|ineligible for the study|8|||
23366718|NCT03131167|65089018|FG012|Overall Study|Other (Unspecified)|0|||
23366719|NCT01286129|65089022|FG000|Overall Study|Withdrawal by Subject|4|||
23271501|NCT02674477|64738260|FG000|Overall Study|Protocol Violation|8|||
23271502|NCT02674477|64738261|FG001|Overall Study|Protocol Violation|2|||
23271503|NCT00819741|64738270|FG000|Overall Study|Adverse Event|5|||
23271504|NCT00819741|64738271|FG001|Overall Study|Adverse Event|2|||
23271505|NCT00819741|64738270|FG000|Overall Study|Lack of Efficacy|0|||
23271506|NCT00819741|64738271|FG001|Overall Study|Lack of Efficacy|2|||
23271507|NCT00819741|64738270|FG000|Overall Study|Lost to Follow-up|3|||
23271508|NCT00819741|64738271|FG001|Overall Study|Lost to Follow-up|1|||
23271509|NCT00819741|64738270|FG000|Overall Study|Protocol Violation|3|||
23271510|NCT00819741|64738271|FG001|Overall Study|Protocol Violation|4|||
23271511|NCT00819741|64738270|FG000|Overall Study|Withdrawal by Subject|2|||
23271512|NCT00819741|64738271|FG001|Overall Study|Withdrawal by Subject|2|||
23271513|NCT00819741|64738270|FG000|Overall Study|Unclassified|6|||
23271514|NCT00819741|64738271|FG001|Overall Study|Unclassified|0|||
23271515|NCT00819741|64738270|FG000|Overall Study|Reasons unknown|3|||
23271516|NCT00819741|64738271|FG001|Overall Study|Reasons unknown|3|||
23271517|NCT01424644|64738272|FG000|Overall Study|Adverse Event|2|||
23271518|NCT01424644|64738273|FG001|Overall Study|Adverse Event|0|||
23271519|NCT01424644|64738272|FG000|Overall Study|Withdrawal by Subject|9|||
23271520|NCT01424644|64738273|FG001|Overall Study|Withdrawal by Subject|12|||
23271521|NCT01424644|64738272|FG000|Overall Study|Lost to Follow-up|16|||
23271522|NCT01424644|64738273|FG001|Overall Study|Lost to Follow-up|12|||
23271523|NCT01424644|64738272|FG000|Overall Study|Protocol Violation|4|||
23271524|NCT01424644|64738273|FG001|Overall Study|Protocol Violation|3|||
23271525|NCT01424644|64738272|FG000|Overall Study|Administrative Reason|1|||
23271526|NCT01424644|64738273|FG001|Overall Study|Administrative Reason|0|||
23271527|NCT01424644|64738272|FG000|Overall Study|Unable to Classify|1|||
23271528|NCT01424644|64738273|FG001|Overall Study|Unable to Classify|0|||
23271529|NCT02865538|64738278|FG000|Overall Study|Withdrawal by Subject|0|||
23271530|NCT02865538|64738279|FG001|Overall Study|Withdrawal by Subject|0|||
23271531|NCT02865538|64738280|FG002|Overall Study|Withdrawal by Subject|1|||
23271532|NCT02865538|64738281|FG003|Overall Study|Withdrawal by Subject|0|||
23271533|NCT02865538|64738282|FG004|Overall Study|Withdrawal by Subject|0|||
23271534|NCT02865538|64738278|FG000|Overall Study|Lost to Follow-up|1|||
23271535|NCT02865538|64738279|FG001|Overall Study|Lost to Follow-up|0|||
23271536|NCT02865538|64738280|FG002|Overall Study|Lost to Follow-up|0|||
23271537|NCT02865538|64738281|FG003|Overall Study|Lost to Follow-up|0|||
23271538|NCT02865538|64738282|FG004|Overall Study|Lost to Follow-up|0|||
23271539|NCT02087904|64738283|FG000|Overall Study|Did Not Receive Study Drug|0|||
23271540|NCT02087904|64738284|FG001|Overall Study|Did Not Receive Study Drug|0|||
23271541|NCT02087904|64738285|FG002|Overall Study|Did Not Receive Study Drug|2|||
23271542|NCT02087904|64738286|FG003|Overall Study|Did Not Receive Study Drug|1|||
23271543|NCT02087904|64738283|FG000|Overall Study|Adverse Event|8|||
23271544|NCT02087904|64738284|FG001|Overall Study|Adverse Event|4|||
23271545|NCT02087904|64738285|FG002|Overall Study|Adverse Event|4|||
23271546|NCT02087904|64738286|FG003|Overall Study|Adverse Event|12|||
23271547|NCT02087904|64738283|FG000|Overall Study|Lack of Efficacy|3|||
23271548|NCT02087904|64738284|FG001|Overall Study|Lack of Efficacy|6|||
23271549|NCT02087904|64738285|FG002|Overall Study|Lack of Efficacy|3|||
23271550|NCT02087904|64738286|FG003|Overall Study|Lack of Efficacy|2|||
23271551|NCT02087904|64738283|FG000|Overall Study|Other|6|||
23271552|NCT02087904|64738284|FG001|Overall Study|Other|2|||
23271553|NCT02087904|64738285|FG002|Overall Study|Other|4|||
23271554|NCT02087904|64738286|FG003|Overall Study|Other|4|||
23271555|NCT02087904|64738283|FG000|Overall Study|Withdrawal by Subject|8|||
23271556|NCT02087904|64738284|FG001|Overall Study|Withdrawal by Subject|3|||
23271557|NCT02087904|64738285|FG002|Overall Study|Withdrawal by Subject|7|||
23271558|NCT02087904|64738286|FG003|Overall Study|Withdrawal by Subject|4|||
23271559|NCT02087904|64738283|FG000|Overall Study|Lost to Follow-up|0|||
23271560|NCT02087904|64738284|FG001|Overall Study|Lost to Follow-up|4|||
23271561|NCT02087904|64738285|FG002|Overall Study|Lost to Follow-up|2|||
23271562|NCT02087904|64738286|FG003|Overall Study|Lost to Follow-up|2|||
23271563|NCT04453202|64738288|FG000|Overall Study|Adverse Event|0|||
23271564|NCT04453202|64738289|FG001|Overall Study|Adverse Event|0|||
23271565|NCT04453202|64738290|FG002|Overall Study|Adverse Event|0|||
23271566|NCT04453202|64738291|FG003|Overall Study|Adverse Event|0|||
23271567|NCT04453202|64738292|FG004|Overall Study|Adverse Event|0|||
23271568|NCT04453202|64738293|FG005|Overall Study|Adverse Event|0|||
23271569|NCT04453202|64738294|FG006|Overall Study|Adverse Event|1|||
23271570|NCT04453202|64738295|FG007|Overall Study|Adverse Event|0|||
23271571|NCT04453202|64738296|FG008|Overall Study|Adverse Event|0|||
23271572|NCT04453202|64738297|FG009|Overall Study|Adverse Event|0|||
23271573|NCT04453202|64738298|FG010|Overall Study|Adverse Event|0|||
23271574|NCT04453202|64738288|FG000|Overall Study|Death|0|||
23271575|NCT04453202|64738289|FG001|Overall Study|Death|0|||
23271576|NCT04453202|64738290|FG002|Overall Study|Death|0|||
23271577|NCT04453202|64738291|FG003|Overall Study|Death|0|||
23271578|NCT04453202|64738292|FG004|Overall Study|Death|0|||
23271579|NCT04453202|64738293|FG005|Overall Study|Death|0|||
23271580|NCT04453202|64738294|FG006|Overall Study|Death|0|||
23271581|NCT04453202|64738295|FG007|Overall Study|Death|0|||
23271582|NCT04453202|64738296|FG008|Overall Study|Death|0|||
23601892|NCT01105975|65933931|FG007|Overall Study|Physician Decision|0|||
23601893|NCT01105975|65933932|FG008|Overall Study|Physician Decision|0|||
23601894|NCT01105975|65933933|FG009|Overall Study|Physician Decision|0|||
23601895|NCT01105975|65933924|FG000|Overall Study|Protocol Violation|0|||
23601896|NCT01105975|65933925|FG001|Overall Study|Protocol Violation|2|||
23601897|NCT01105975|65933926|FG002|Overall Study|Protocol Violation|2|||
23601898|NCT01105975|65933927|FG003|Overall Study|Protocol Violation|0|||
23601899|NCT01105975|65933928|FG004|Overall Study|Protocol Violation|1|||
23601900|NCT01105975|65933929|FG005|Overall Study|Protocol Violation|1|||
23601901|NCT01105975|65933930|FG006|Overall Study|Protocol Violation|1|||
23601902|NCT01105975|65933931|FG007|Overall Study|Protocol Violation|1|||
23601903|NCT01105975|65933932|FG008|Overall Study|Protocol Violation|2|||
23601904|NCT01105975|65933933|FG009|Overall Study|Protocol Violation|2|||
23601905|NCT01105975|65933924|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601906|NCT01105975|65933925|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601907|NCT01105975|65933926|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23601908|NCT01105975|65933927|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601909|NCT01105975|65933928|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601910|NCT01105975|65933929|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
23601911|NCT01105975|65933930|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23601912|NCT01105975|65933931|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
23601913|NCT01105975|65933932|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
23601914|NCT01105975|65933933|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
23601915|NCT03476798|65933939|FG000|Overall Study|Death|1|||
23601916|NCT03476798|65933939|FG000|Overall Study|Withdrawal by Subject|2|||
23601917|NCT03476798|65933939|FG000|Overall Study|Protocol Violation|2|||
23601918|NCT02597920|65933942|FG000|Overall Study|Worsening of other pre-existing disease|0|||
23271583|NCT04453202|64738297|FG009|Overall Study|Death|1|||
23271584|NCT04453202|64738298|FG010|Overall Study|Death|0|||
23271585|NCT04453202|64738288|FG000|Overall Study|Lost to Follow-up|0|||
23271586|NCT04453202|64738289|FG001|Overall Study|Lost to Follow-up|1|||
23271587|NCT04453202|64738290|FG002|Overall Study|Lost to Follow-up|0|||
23271588|NCT04453202|64738291|FG003|Overall Study|Lost to Follow-up|1|||
23271589|NCT04453202|64738292|FG004|Overall Study|Lost to Follow-up|0|||
23271590|NCT04453202|64738293|FG005|Overall Study|Lost to Follow-up|0|||
23271591|NCT04453202|64738294|FG006|Overall Study|Lost to Follow-up|0|||
23271592|NCT04453202|64738295|FG007|Overall Study|Lost to Follow-up|0|||
23271593|NCT04453202|64738296|FG008|Overall Study|Lost to Follow-up|0|||
23271594|NCT04453202|64738297|FG009|Overall Study|Lost to Follow-up|1|||
23271595|NCT04453202|64738298|FG010|Overall Study|Lost to Follow-up|1|||
23271596|NCT04453202|64738288|FG000|Overall Study|Withdrawal by Subject|1|||
23271597|NCT04453202|64738289|FG001|Overall Study|Withdrawal by Subject|2|||
23271598|NCT04453202|64738290|FG002|Overall Study|Withdrawal by Subject|1|||
23271599|NCT04453202|64738291|FG003|Overall Study|Withdrawal by Subject|2|||
23271600|NCT04453202|64738292|FG004|Overall Study|Withdrawal by Subject|1|||
23271601|NCT04453202|64738293|FG005|Overall Study|Withdrawal by Subject|1|||
23271602|NCT04453202|64738294|FG006|Overall Study|Withdrawal by Subject|0|||
23271603|NCT04453202|64738295|FG007|Overall Study|Withdrawal by Subject|0|||
23271604|NCT04453202|64738296|FG008|Overall Study|Withdrawal by Subject|0|||
23271605|NCT04453202|64738297|FG009|Overall Study|Withdrawal by Subject|1|||
23271606|NCT04453202|64738298|FG010|Overall Study|Withdrawal by Subject|0|||
23271607|NCT04453202|64738288|FG000|Overall Study|Adverse Event|0|||
23271608|NCT04453202|64738289|FG001|Overall Study|Adverse Event|0|||
23271609|NCT04453202|64738290|FG002|Overall Study|Adverse Event|0|||
23271610|NCT04453202|64738291|FG003|Overall Study|Adverse Event|0|||
23271611|NCT04453202|64738292|FG004|Overall Study|Adverse Event|0|||
23271612|NCT04453202|64738293|FG005|Overall Study|Adverse Event|1|||
23271613|NCT04453202|64738294|FG006|Overall Study|Adverse Event|0|||
23271614|NCT04453202|64738295|FG007|Overall Study|Adverse Event|0|||
23271615|NCT04453202|64738296|FG008|Overall Study|Adverse Event|0|||
23271616|NCT04453202|64738297|FG009|Overall Study|Adverse Event|0|||
23271617|NCT04453202|64738298|FG010|Overall Study|Adverse Event|0|||
23271618|NCT01772537|64738299|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
23271619|NCT01772537|64738300|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
23271620|NCT01772537|64738301|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
23271621|NCT03497897|64738302|FG000|Overall Study|Adverse Event|1|||
23271622|NCT03497897|64738303|FG001|Overall Study|Adverse Event|1|||
23271623|NCT03497897|64738304|FG002|Overall Study|Adverse Event|1|||
23271624|NCT03497897|64738302|FG000|Overall Study|Lost to Follow-up|2|||
23271625|NCT03497897|64738303|FG001|Overall Study|Lost to Follow-up|0|||
23271626|NCT03497897|64738304|FG002|Overall Study|Lost to Follow-up|2|||
23271627|NCT03497897|64738302|FG000|Overall Study|Physician Decision|1|||
23271628|NCT03497897|64738303|FG001|Overall Study|Physician Decision|0|||
23271629|NCT03497897|64738304|FG002|Overall Study|Physician Decision|0|||
23601919|NCT02597920|65933943|FG001|Overall Study|Worsening of other pre-existing disease|1|||
23601920|NCT02597920|65933944|FG002|Overall Study|Worsening of other pre-existing disease|0|||
23366720|NCT01286129|65089023|FG001|Overall Study|Withdrawal by Subject|1|||
23366721|NCT01286129|65089022|FG000|Overall Study|Could not comply with study requirements|4|||
23366722|NCT01286129|65089023|FG001|Overall Study|Could not comply with study requirements|4|||
23366723|NCT03904420|65089024|FG000|Overall Study|Study terminated|2|||
23366724|NCT03904420|65089025|FG001|Overall Study|Study terminated|2|||
23366725|NCT01545388|65089026|FG000|Overall Study|Adverse Event|2|||
23366726|NCT01545388|65089027|FG001|Overall Study|Adverse Event|4|||
23601921|NCT02597920|65933942|FG000|Overall Study|Other adverse event|20|||
23271630|NCT03497897|64738302|FG000|Overall Study|Subject/Guardian Decision|2|||
23271631|NCT03497897|64738303|FG001|Overall Study|Subject/Guardian Decision|1|||
23271632|NCT03497897|64738304|FG002|Overall Study|Subject/Guardian Decision|3|||
23271633|NCT00528606|64738308|FG000|Overall Study|Withdrew consent|4|||
23271634|NCT00528606|64738309|FG001|Overall Study|Withdrew consent|3|||
23271635|NCT00528606|64738308|FG000|Overall Study|Lost to Follow-up|4|||
23271636|NCT00528606|64738309|FG001|Overall Study|Lost to Follow-up|1|||
23271637|NCT00528606|64738308|FG000|Overall Study|Adverse Event|3|||
23271638|NCT00528606|64738309|FG001|Overall Study|Adverse Event|0|||
23271639|NCT00528606|64738308|FG000|Overall Study|Other|2|||
23271640|NCT00528606|64738309|FG001|Overall Study|Other|0|||
23271641|NCT04407806|64738310|FG000|Overall Study|Withdrawal by Subject|1|||
23271642|NCT04407806|64738311|FG001|Overall Study|Withdrawal by Subject|2|||
23271643|NCT01294917|64738312|FG000|Overall Study|Relocation|5|||
23271644|NCT01294917|64738312|FG000|Overall Study|Inconvenience|1|||
23271645|NCT03018249|64738313|FG000|Overall Study|Withdrawal by Subject|2|||
23271646|NCT03018249|64738314|FG001|Overall Study|Withdrawal by Subject|2|||
23271647|NCT00984126|64738319|FG000|Overall Study|Protocol Violation|0|||
23271648|NCT00984126|64738320|FG001|Overall Study|Protocol Violation|0|||
23271649|NCT00984126|64738321|FG002|Overall Study|Protocol Violation|1|||
23271650|NCT00984126|64738322|FG003|Overall Study|Protocol Violation|2|||
23271651|NCT00984126|64738319|FG000|Overall Study|Adverse Event|0|||
23271652|NCT00984126|64738320|FG001|Overall Study|Adverse Event|0|||
23271653|NCT00984126|64738321|FG002|Overall Study|Adverse Event|0|||
23271654|NCT00984126|64738322|FG003|Overall Study|Adverse Event|2|||
23271655|NCT00984126|64738319|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
23271656|NCT00984126|64738320|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
23271657|NCT00984126|64738321|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
23271658|NCT00984126|64738322|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
23271659|NCT00984126|64738319|FG000|Overall Study|Withdrawal criteria|0|||
23271660|NCT00984126|64738320|FG001|Overall Study|Withdrawal criteria|1|||
23271661|NCT00984126|64738321|FG002|Overall Study|Withdrawal criteria|3|||
23271662|NCT00984126|64738322|FG003|Overall Study|Withdrawal criteria|9|||
23271663|NCT01263704|64738323|FG000|Overall Study|Progressive disease|18|||
23271664|NCT01263704|64738323|FG000|Overall Study|Adverse Event|3|||
23366727|NCT01545388|65089028|FG002|Overall Study|Adverse Event|1|||
23366728|NCT01545388|65089026|FG000|Overall Study|Lack of Efficacy|3|||
23601922|NCT02597920|65933943|FG001|Overall Study|Other adverse event|30|||
23601923|NCT02597920|65933944|FG002|Overall Study|Other adverse event|0|||
23601924|NCT02597920|65933942|FG000|Overall Study|Lost to Follow-up|7|||
23601925|NCT02597920|65933943|FG001|Overall Study|Lost to Follow-up|9|||
23601926|NCT02597920|65933944|FG002|Overall Study|Lost to Follow-up|0|||
23601927|NCT02597920|65933942|FG000|Overall Study|Refuse to continue in the study|3|||
23601928|NCT02597920|65933943|FG001|Overall Study|Refuse to continue in the study|13|||
23601929|NCT02597920|65933944|FG002|Overall Study|Refuse to continue in the study|1|||
23601930|NCT02597920|65933942|FG000|Overall Study|Other than specified|10|||
23601931|NCT02597920|65933943|FG001|Overall Study|Other than specified|31|||
23601932|NCT02597920|65933944|FG002|Overall Study|Other than specified|5|||
23601933|NCT02597920|65933942|FG000|Overall Study|Other|1|||
23601934|NCT02597920|65933943|FG001|Overall Study|Other|0|||
23271665|NCT01263704|64738323|FG000|Overall Study|Death|2|||
23271666|NCT01263704|64738323|FG000|Overall Study|Patient withdrew consent|2|||
23271667|NCT01263704|64738323|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
23271668|NCT01263704|64738323|FG000|Overall Study|Lost to Follow-up|1|||
23271669|NCT01263704|64738323|FG000|Overall Study|Colon metastases|1|||
23271670|NCT01263704|64738323|FG000|Overall Study|Principal Investigator (PI) decision|1|||
23271671|NCT01710657|64738330|FG000|Overall Study|Lost to Follow-up|2|||
23601935|NCT02597920|65933944|FG002|Overall Study|Other|0|||
23601936|NCT01171976|65933945|FG000|Overall Study|Protocol Violation|0|||
23366729|NCT01545388|65089027|FG001|Overall Study|Lack of Efficacy|2|||
23366730|NCT01545388|65089028|FG002|Overall Study|Lack of Efficacy|5|||
23366731|NCT01545388|65089026|FG000|Overall Study|Participant moved or relocated|1|||
23366732|NCT01545388|65089027|FG001|Overall Study|Participant moved or relocated|0|||
23366733|NCT01545388|65089028|FG002|Overall Study|Participant moved or relocated|0|||
23366734|NCT01545388|65089026|FG000|Overall Study|Withdrawal by Subject|1|||
23366735|NCT01545388|65089027|FG001|Overall Study|Withdrawal by Subject|4|||
23366736|NCT01545388|65089028|FG002|Overall Study|Withdrawal by Subject|2|||
23366737|NCT01545388|65089026|FG000|Overall Study|Other|1|||
23366738|NCT01545388|65089027|FG001|Overall Study|Other|1|||
23366739|NCT01545388|65089028|FG002|Overall Study|Other|0|||
23366740|NCT02515630|65089029|FG000|Overall Study|Withdrawal by Subject|5|||
23366741|NCT02515630|65089029|FG000|Overall Study|Adverse Event|4|||
23366742|NCT02515630|65089029|FG000|Overall Study|Physician Decision|4|||
23366743|NCT02515630|65089029|FG000|Overall Study|Death|2|||
23366744|NCT02515630|65089029|FG000|Overall Study|Disease Progression|1|||
23366745|NCT05117060|65089030|FG000|Overall Study|Adverse Event|3|||
23366746|NCT05117060|65089031|FG001|Overall Study|Adverse Event|5|||
23366747|NCT05117060|65089032|FG002|Overall Study|Adverse Event|6|||
23366748|NCT05117060|65089033|FG003|Overall Study|Adverse Event|1|||
23366749|NCT05117060|65089030|FG000|Overall Study|Lost to Follow-up|0|||
23366750|NCT05117060|65089031|FG001|Overall Study|Lost to Follow-up|0|||
23366751|NCT05117060|65089032|FG002|Overall Study|Lost to Follow-up|0|||
23366752|NCT05117060|65089033|FG003|Overall Study|Lost to Follow-up|1|||
23483461|NCT01390220|65513061|FG000|Test Dose Phase|Logistical|6|||
23483462|NCT01390220|65513062|FG001|Test Dose Phase|Logistical|0|||
23483463|NCT01390220|65513063|FG002|Test Dose Phase|Logistical|0|||
23483464|NCT01390220|65513061|FG000|Comparative Phase|Withdrawal by Subject|0|||
23483465|NCT01390220|65513062|FG001|Comparative Phase|Withdrawal by Subject|1|||
23483466|NCT01390220|65513063|FG002|Comparative Phase|Withdrawal by Subject|0|||
23483467|NCT02793128|65513064|FG000|Overall Study|Death|4|||
23483468|NCT02793128|65513064|FG000|Overall Study|Withdrawal by Subject|2|||
23483469|NCT02793128|65513064|FG000|Overall Study|Physician Decision|1|||
23483470|NCT02793128|65513064|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
23483471|NCT02793128|65513064|FG000|Overall Study|Patient elected nephroureterectomy|1|||
23483472|NCT01916967|65513066|FG000|Overall Study|Adverse Event|0|||
23483473|NCT01916967|65513067|FG001|Overall Study|Adverse Event|0|||
23483474|NCT01916967|65513068|FG002|Overall Study|Adverse Event|2|||
23601937|NCT01171976|65933946|FG001|Overall Study|Protocol Violation|0|||
23601938|NCT01171976|65933947|FG002|Overall Study|Protocol Violation|1|||
23601939|NCT01171976|65933945|FG000|Overall Study|Death|2|||
23601940|NCT01171976|65933946|FG001|Overall Study|Death|4|||
23601941|NCT01171976|65933947|FG002|Overall Study|Death|1|||
23601942|NCT01171976|65933945|FG000|Overall Study|Lost to Follow-up|4|||
23601943|NCT01171976|65933946|FG001|Overall Study|Lost to Follow-up|0|||
23601944|NCT01171976|65933947|FG002|Overall Study|Lost to Follow-up|2|||
23601945|NCT01171976|65933945|FG000|Overall Study|Withdrawal by Subject|1|||
23601946|NCT01171976|65933946|FG001|Overall Study|Withdrawal by Subject|5|||
23601947|NCT01171976|65933947|FG002|Overall Study|Withdrawal by Subject|6|||
23601948|NCT01171976|65933945|FG000|Overall Study|Abnormal test result|1|||
23366753|NCT05117060|65089030|FG000|Overall Study|Lack of Efficacy|4|||
23366754|NCT05117060|65089031|FG001|Overall Study|Lack of Efficacy|5|||
23366755|NCT05117060|65089032|FG002|Overall Study|Lack of Efficacy|2|||
23366756|NCT05117060|65089033|FG003|Overall Study|Lack of Efficacy|6|||
23483475|NCT01916967|65513066|FG000|Overall Study|Lack of Efficacy|0|||
23483476|NCT01916967|65513067|FG001|Overall Study|Lack of Efficacy|0|||
23366757|NCT05117060|65089030|FG000|Overall Study|Withdrawal by Subject|8|||
23366758|NCT05117060|65089031|FG001|Overall Study|Withdrawal by Subject|5|||
23483477|NCT01916967|65513068|FG002|Overall Study|Lack of Efficacy|6|||
23601949|NCT01171976|65933946|FG001|Overall Study|Abnormal test result|0|||
23601950|NCT01171976|65933947|FG002|Overall Study|Abnormal test result|0|||
23601951|NCT01171976|65933945|FG000|Overall Study|Adverse Event|6|||
23601952|NCT01171976|65933946|FG001|Overall Study|Adverse Event|2|||
23483478|NCT01916967|65513066|FG000|Overall Study|Physician Decision|0|||
23483479|NCT01916967|65513067|FG001|Overall Study|Physician Decision|0|||
23271672|NCT01710657|64738331|FG001|Overall Study|Lost to Follow-up|0|||
23271673|NCT01710657|64738332|FG002|Overall Study|Lost to Follow-up|1|||
23271674|NCT01710657|64738330|FG000|Overall Study|Protocol Violation|2|||
23271675|NCT01710657|64738331|FG001|Overall Study|Protocol Violation|2|||
23271676|NCT01710657|64738332|FG002|Overall Study|Protocol Violation|0|||
23271677|NCT01710657|64738330|FG000|Overall Study|Adverse Event|14|||
23271678|NCT01710657|64738331|FG001|Overall Study|Adverse Event|8|||
23271679|NCT01710657|64738332|FG002|Overall Study|Adverse Event|28|||
23271680|NCT01710657|64738330|FG000|Overall Study|Withdrawal by Subject|0|||
23271681|NCT01710657|64738331|FG001|Overall Study|Withdrawal by Subject|1|||
23483480|NCT01916967|65513068|FG002|Overall Study|Physician Decision|1|||
23483481|NCT01916967|65513066|FG000|Overall Study|Protocol Violation|0|||
23483482|NCT01916967|65513067|FG001|Overall Study|Protocol Violation|1|||
23483483|NCT01916967|65513068|FG002|Overall Study|Protocol Violation|0|||
23483484|NCT01606878|65513069|FG000|Overall Study|Adverse Event|1|||
23483485|NCT01606878|65513070|FG001|Overall Study|Adverse Event|1|||
23483486|NCT01606878|65513071|FG002|Overall Study|Adverse Event|0|||
23483487|NCT01606878|65513072|FG003|Overall Study|Adverse Event|0|||
23483488|NCT01606878|65513073|FG004|Overall Study|Adverse Event|0|||
23483489|NCT01606878|65513074|FG005|Overall Study|Adverse Event|0|||
23483490|NCT01606878|65513075|FG006|Overall Study|Adverse Event|1|||
23483491|NCT01606878|65513076|FG007|Overall Study|Adverse Event|0|||
23483492|NCT01606878|65513077|FG008|Overall Study|Adverse Event|1|||
23483493|NCT01606878|65513078|FG009|Overall Study|Adverse Event|3|||
23483494|NCT01606878|65513079|FG010|Overall Study|Adverse Event|0|||
23483495|NCT01606878|65513069|FG000|Overall Study|Lack of Efficacy|1|||
23483496|NCT01606878|65513070|FG001|Overall Study|Lack of Efficacy|1|||
23483497|NCT01606878|65513071|FG002|Overall Study|Lack of Efficacy|1|||
23483498|NCT01606878|65513072|FG003|Overall Study|Lack of Efficacy|2|||
23601953|NCT01171976|65933947|FG002|Overall Study|Adverse Event|5|||
23601954|NCT00512252|65933949|FG000|Overall Study|Lost to Follow-up|0|||
23601955|NCT00512252|65933950|FG001|Overall Study|Lost to Follow-up|0|||
23601956|NCT00512252|65933951|FG002|Overall Study|Lost to Follow-up|1|||
23601957|NCT00512252|65933949|FG000|Overall Study|Protocol Violation|0|||
23601958|NCT00512252|65933950|FG001|Overall Study|Protocol Violation|0|||
23601959|NCT00512252|65933951|FG002|Overall Study|Protocol Violation|1|||
23601960|NCT00512252|65933949|FG000|Overall Study|Death|0|||
23601961|NCT00512252|65933950|FG001|Overall Study|Death|0|||
23601962|NCT00512252|65933951|FG002|Overall Study|Death|1|||
23601963|NCT01359150|65933954|FG000|Overall Study|Lack of Efficacy|1|||
23601964|NCT01359150|65933955|FG001|Overall Study|Lack of Efficacy|1|||
23601965|NCT01359150|65933954|FG000|Overall Study|Withdrawal by Subject|1|||
23601966|NCT01359150|65933955|FG001|Overall Study|Withdrawal by Subject|1|||
23601967|NCT01359150|65933954|FG000|Overall Study|Adverse Event|4|||
23601968|NCT01359150|65933955|FG001|Overall Study|Adverse Event|3|||
23601969|NCT01359150|65933954|FG000|Overall Study|Other|1|||
23601970|NCT01359150|65933955|FG001|Overall Study|Other|0|||
23601971|NCT01091168|65933960|FG000|Overall Study|Progressive disease|250|||
23601972|NCT01091168|65933961|FG001|Overall Study|Progressive disease|234|||
23601973|NCT01091168|65933960|FG000|Overall Study|Adverse Event|21|||
23601974|NCT01091168|65933961|FG001|Overall Study|Adverse Event|24|||
23601975|NCT01091168|65933960|FG000|Overall Study|Lost to Follow-up|0|||
23601976|NCT01091168|65933961|FG001|Overall Study|Lost to Follow-up|1|||
23601977|NCT01091168|65933960|FG000|Overall Study|Physician, patient's decision, other|27|||
23601978|NCT01091168|65933961|FG001|Overall Study|Physician, patient's decision, other|37|||
23601979|NCT03567616|65933964|FG000|Overall Study|Disease progression|4|||
23601980|NCT03567616|65933964|FG000|Overall Study|Withdrawal by Subject|1|||
23601981|NCT03567616|65933964|FG000|Overall Study|Physician Decision|1|||
23601982|NCT03567616|65933964|FG000|Overall Study|Death|1|||
23601983|NCT03567616|65933964|FG000|Overall Study|Adverse Event|1|||
23601984|NCT00895245|65933965|FG000|Overall Study|Lack of Efficacy|6|||
23601985|NCT02988713|65933966|FG000|Overall Study|Withdrawal by Subject|1|||
23601986|NCT02988713|65933966|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
23271682|NCT01710657|64738332|FG002|Overall Study|Withdrawal by Subject|2|||
23271683|NCT01710657|64738330|FG000|Overall Study|Lack of Efficacy|0|||
23271684|NCT01710657|64738331|FG001|Overall Study|Lack of Efficacy|1|||
23483499|NCT01606878|65513073|FG004|Overall Study|Lack of Efficacy|1|||
23483500|NCT01606878|65513074|FG005|Overall Study|Lack of Efficacy|2|||
23483501|NCT01606878|65513075|FG006|Overall Study|Lack of Efficacy|1|||
23271685|NCT01710657|64738332|FG002|Overall Study|Lack of Efficacy|1|||
23601987|NCT00582972|65933967|FG000|Overall Study|Protocol Violation|2|||
23601988|NCT02159352|65933969|FG000|Overall Study|Adverse Event|3|||
23601989|NCT02159352|65933970|FG001|Overall Study|Adverse Event|1|||
23601990|NCT02159352|65933969|FG000|Overall Study|Withdrawal by Subject|0|||
23601991|NCT02159352|65933970|FG001|Overall Study|Withdrawal by Subject|1|||
23601992|NCT00989196|65933971|FG000|Treatment Period|Lost to Follow-up|1|||
23483502|NCT01606878|65513076|FG007|Overall Study|Lack of Efficacy|2|||
23483503|NCT01606878|65513077|FG008|Overall Study|Lack of Efficacy|2|||
23483504|NCT01606878|65513078|FG009|Overall Study|Lack of Efficacy|0|||
23483505|NCT01606878|65513079|FG010|Overall Study|Lack of Efficacy|1|||
23483506|NCT01606878|65513069|FG000|Overall Study|Physician Decision|1|||
23483507|NCT01606878|65513070|FG001|Overall Study|Physician Decision|0|||
23483508|NCT01606878|65513071|FG002|Overall Study|Physician Decision|2|||
23483509|NCT01606878|65513072|FG003|Overall Study|Physician Decision|1|||
23483510|NCT01606878|65513073|FG004|Overall Study|Physician Decision|1|||
23483511|NCT01606878|65513074|FG005|Overall Study|Physician Decision|1|||
23483512|NCT01606878|65513075|FG006|Overall Study|Physician Decision|2|||
23483513|NCT01606878|65513076|FG007|Overall Study|Physician Decision|0|||
23483514|NCT01606878|65513077|FG008|Overall Study|Physician Decision|1|||
23483515|NCT01606878|65513078|FG009|Overall Study|Physician Decision|0|||
23483516|NCT01606878|65513079|FG010|Overall Study|Physician Decision|0|||
23483517|NCT01606878|65513069|FG000|Overall Study|Withdrawal by Subject|3|||
23483518|NCT01606878|65513070|FG001|Overall Study|Withdrawal by Subject|2|||
23483519|NCT01606878|65513071|FG002|Overall Study|Withdrawal by Subject|2|||
23483520|NCT01606878|65513072|FG003|Overall Study|Withdrawal by Subject|0|||
23483521|NCT01606878|65513073|FG004|Overall Study|Withdrawal by Subject|1|||
23483522|NCT01606878|65513074|FG005|Overall Study|Withdrawal by Subject|1|||
23483523|NCT01606878|65513075|FG006|Overall Study|Withdrawal by Subject|2|||
23483524|NCT01606878|65513076|FG007|Overall Study|Withdrawal by Subject|1|||
23483525|NCT01606878|65513077|FG008|Overall Study|Withdrawal by Subject|2|||
23483526|NCT01606878|65513078|FG009|Overall Study|Withdrawal by Subject|0|||
23483527|NCT01606878|65513079|FG010|Overall Study|Withdrawal by Subject|2|||
23483528|NCT00924170|65513080|FG000|Overall Study|Refused further treatment|0|||
23483529|NCT00924170|65513081|FG001|Overall Study|Refused further treatment|1|||
23483530|NCT00924170|65513080|FG000|Overall Study|Physician Decision|0|||
23483531|NCT00924170|65513081|FG001|Overall Study|Physician Decision|1|||
23483532|NCT00924170|65513080|FG000|Overall Study|Progressive disease|3|||
23483533|NCT00924170|65513081|FG001|Overall Study|Progressive disease|6|||
23483534|NCT00924170|65513080|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
23483535|NCT00924170|65513081|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
23483536|NCT00924170|65513080|FG000|Overall Study|Death|1|||
23483537|NCT00924170|65513081|FG001|Overall Study|Death|0|||
23483538|NCT03560739|65513087|FG000|Overall Study|Adverse Event|0|||
23483539|NCT03560739|65513088|FG001|Overall Study|Adverse Event|1|||
23483540|NCT03560739|65513089|FG002|Overall Study|Adverse Event|0|||
23483541|NCT03560739|65513090|FG003|Overall Study|Adverse Event|0|||
23483542|NCT01362595|65513093|FG000|Overall Study|Screen failure|10|||
23483543|NCT01362595|65513093|FG000|Overall Study|Withdrawal by Subject|2|||
23601993|NCT00989196|65933972|FG001|Treatment Period|Lost to Follow-up|0|||
23271686|NCT04274686|64738333|FG000|Overall Study|Physician Decision|1|||
23271687|NCT04274686|64738334|FG001|Overall Study|Physician Decision|0|||
23271688|NCT01706536|64738341|FG000|Overall Study|Withdrawal by Subject|1|||
23271689|NCT01706536|64738342|FG001|Overall Study|Withdrawal by Subject|0|||
23271690|NCT01706536|64738343|FG002|Overall Study|Withdrawal by Subject|1|||
23271691|NCT01706536|64738344|FG003|Overall Study|Withdrawal by Subject|0|||
23271692|NCT01706536|64738345|FG004|Overall Study|Withdrawal by Subject|0|||
23271693|NCT01706536|64738341|FG000|Overall Study|Adverse Event|2|||
23271694|NCT01706536|64738342|FG001|Overall Study|Adverse Event|3|||
23271695|NCT01706536|64738343|FG002|Overall Study|Adverse Event|4|||
23271696|NCT01706536|64738344|FG003|Overall Study|Adverse Event|3|||
23271697|NCT01706536|64738345|FG004|Overall Study|Adverse Event|2|||
23271698|NCT01706536|64738341|FG000|Overall Study|Lack of Efficacy|1|||
23271699|NCT01706536|64738342|FG001|Overall Study|Lack of Efficacy|0|||
23271700|NCT01706536|64738343|FG002|Overall Study|Lack of Efficacy|0|||
23271701|NCT01706536|64738344|FG003|Overall Study|Lack of Efficacy|1|||
23271702|NCT01706536|64738345|FG004|Overall Study|Lack of Efficacy|0|||
23271703|NCT01706536|64738341|FG000|Overall Study|non compliance|0|||
23483544|NCT00821327|65513098|FG000|Overall Study|Adverse Event|13|||
23483545|NCT00821327|65513098|FG000|Overall Study|Patient Request|1|||
23483546|NCT00821327|65513098|FG000|Overall Study|Investigator Request|2|||
23483547|NCT00821327|65513098|FG000|Overall Study|Sponsor Request|1|||
23483548|NCT00821327|65513098|FG000|Overall Study|Disease Progression|13|||
23601994|NCT03488719|65933973|FG000|Overall Study|Adverse Event|0|||
23271704|NCT01706536|64738342|FG001|Overall Study|non compliance|1|||
23271705|NCT01706536|64738343|FG002|Overall Study|non compliance|0|||
23271706|NCT01706536|64738344|FG003|Overall Study|non compliance|0|||
23483549|NCT00821327|65513098|FG000|Overall Study|Other/Unknown|5|||
23483550|NCT01736657|65513099|FG000|Overall Study|insufficient vascular access|1|||
23483551|NCT01445886|65513103|FG000|Overall Study|Lost to Follow-up|2|||
23483552|NCT01445886|65513103|FG000|Overall Study|Protocol Violation|3|||
23483553|NCT03442764|65513104|FG000|Overall Study|Adverse Event|1|||
23271707|NCT01706536|64738345|FG004|Overall Study|non compliance|0|||
23271708|NCT03292653|64738348|FG000|Overall Study|Adverse Event|0|||
23483554|NCT03442764|65513105|FG001|Overall Study|Adverse Event|0|||
23271709|NCT03292653|64738349|FG001|Overall Study|Adverse Event|0|||
23271710|NCT03292653|64738350|FG002|Overall Study|Adverse Event|1|||
23271711|NCT03292653|64738348|FG000|Overall Study|Did not Receive Treatment|1|||
23271712|NCT03292653|64738349|FG001|Overall Study|Did not Receive Treatment|0|||
23271713|NCT03292653|64738350|FG002|Overall Study|Did not Receive Treatment|0|||
23271714|NCT03546842|64738355|FG000|Overall Study|Protocol Violation|1|||
23271715|NCT03546842|64738355|FG000|Overall Study|Withdrawal by Subject|2|||
23271716|NCT00862979|64738356|FG000|Overall Study|Adverse Event|6|||
23271717|NCT00862979|64738357|FG001|Overall Study|Adverse Event|3|||
23271718|NCT00862979|64738356|FG000|Overall Study|Protocol Violation|0|||
23271719|NCT00862979|64738357|FG001|Overall Study|Protocol Violation|1|||
23271720|NCT00862979|64738356|FG000|Overall Study|Patient withdrew consent|2|||
23271721|NCT00862979|64738357|FG001|Overall Study|Patient withdrew consent|1|||
23271722|NCT00862979|64738356|FG000|Overall Study|Administrative problems|0|||
23271723|NCT00862979|64738357|FG001|Overall Study|Administrative problems|1|||
23271724|NCT00862979|64738356|FG000|Overall Study|Death|0|||
23271725|NCT00862979|64738357|FG001|Overall Study|Death|1|||
23271726|NCT01876706|64738358|FG000|Overall Study|BPH Intervention|9|||
23271727|NCT01876706|64738358|FG000|Overall Study|Lost to Follow-up|7|||
23271728|NCT01876706|64738358|FG000|Overall Study|Withdrawals|6|||
23271729|NCT01876706|64738358|FG000|Overall Study|Death|3|||
23271730|NCT00604500|64738363|FG000|Overall Study|Adverse Event|2|||
23271731|NCT00604500|64738363|FG000|Overall Study|Protocol Violation|2|||
23271732|NCT00604500|64738363|FG000|Overall Study|Treatment Failure|1|||
23271733|NCT00604500|64738363|FG000|Overall Study|Withdrawal by Subject|4|||
23271734|NCT00604500|64738363|FG000|Overall Study|Administrative|1|||
23271735|NCT00604500|64738363|FG000|Overall Study|Did not meet protocol eligibility|1|||
23271736|NCT01781286|64738366|FG000|Overall Study|Lost to Follow-up|0|||
23271737|NCT01781286|64738367|FG001|Overall Study|Lost to Follow-up|0|||
23271738|NCT01781286|64738368|FG002|Overall Study|Lost to Follow-up|0|||
23271739|NCT01781286|64738369|FG003|Overall Study|Lost to Follow-up|0|||
23271740|NCT01781286|64738370|FG004|Overall Study|Lost to Follow-up|0|||
23271741|NCT01781286|64738371|FG005|Overall Study|Lost to Follow-up|1|||
23271742|NCT01781286|64738366|FG000|Overall Study|Time Constraints|2|||
23271743|NCT01781286|64738367|FG001|Overall Study|Time Constraints|0|||
23271744|NCT01781286|64738368|FG002|Overall Study|Time Constraints|2|||
23271745|NCT01781286|64738369|FG003|Overall Study|Time Constraints|0|||
23271746|NCT01781286|64738370|FG004|Overall Study|Time Constraints|0|||
23271747|NCT01781286|64738371|FG005|Overall Study|Time Constraints|0|||
23271748|NCT01781286|64738366|FG000|Overall Study|Noncompliance|0|||
23271749|NCT01781286|64738367|FG001|Overall Study|Noncompliance|0|||
23271750|NCT01781286|64738368|FG002|Overall Study|Noncompliance|0|||
23271751|NCT01781286|64738369|FG003|Overall Study|Noncompliance|1|||
23271752|NCT01781286|64738370|FG004|Overall Study|Noncompliance|0|||
23271753|NCT01781286|64738371|FG005|Overall Study|Noncompliance|0|||
23271754|NCT00620022|64738373|FG000|Treatment Period 1|Adverse Event|4|||
23271755|NCT00620022|64738374|FG001|Treatment Period 1|Adverse Event|6|||
23271756|NCT00620022|64738373|FG000|Treatment Period 1|Subject withdrew consent|1|||
23271757|NCT00620022|64738374|FG001|Treatment Period 1|Subject withdrew consent|0|||
23271758|NCT00620022|64738373|FG000|Treatment Period 2|Adverse Event|2|||
23271759|NCT00620022|64738374|FG001|Treatment Period 2|Adverse Event|2|||
23271760|NCT03206177|64738380|FG000|Overall Study|Withdrawal by Subject|1|||
23271761|NCT02656706|64738381|FG000|Overall Study|Insurance Denial|1|||
23271762|NCT00615069|64738384|FG000|Overall Study|Death|10|||
23271763|NCT00615069|64738384|FG000|Overall Study|Physician Decision|2|||
23271764|NCT00615069|64738384|FG000|Overall Study|Withdrawal by Subject|4|||
23271765|NCT02100228|64738385|FG000|Overall Study|Other|19|||
23271766|NCT02100228|64738386|FG001|Overall Study|Other|19|||
23271767|NCT02100228|64738385|FG000|Overall Study|Administrative reason|0|||
23271768|NCT02100228|64738386|FG001|Overall Study|Administrative reason|1|||
23271769|NCT02100228|64738385|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
23271770|NCT02100228|64738386|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
23271771|NCT02100228|64738385|FG000|Overall Study|Non-compliance|0|||
23271772|NCT02100228|64738386|FG001|Overall Study|Non-compliance|3|||
23271773|NCT02100228|64738385|FG000|Overall Study|Lost to Follow-up|0|||
23271774|NCT02100228|64738386|FG001|Overall Study|Lost to Follow-up|1|||
23483555|NCT03442764|65513106|FG002|Overall Study|Adverse Event|0|||
23271775|NCT02100228|64738385|FG000|Overall Study|Withdrawal by Subject|27|||
23271776|NCT02100228|64738386|FG001|Overall Study|Withdrawal by Subject|37|||
23271777|NCT02100228|64738385|FG000|Overall Study|Adverse Event|16|||
23271778|NCT02100228|64738386|FG001|Overall Study|Adverse Event|12|||
23271779|NCT02100228|64738385|FG000|Overall Study|Death|1|||
23271780|NCT02100228|64738386|FG001|Overall Study|Death|1|||
23271781|NCT00874237|64738391|FG000|Overall Study|Physician Decision|0|||
23271782|NCT00874237|64738392|FG001|Overall Study|Physician Decision|1|||
23271783|NCT00874237|64738393|FG002|Overall Study|Physician Decision|0|||
23271784|NCT00874237|64738394|FG003|Overall Study|Physician Decision|0|||
23271785|NCT00874237|64738395|FG004|Overall Study|Physician Decision|0|||
23271786|NCT00874237|64738396|FG005|Overall Study|Physician Decision|0|||
23271787|NCT00874237|64738391|FG000|Overall Study|Withdrawal by Subject|0|||
23366759|NCT05117060|65089032|FG002|Overall Study|Withdrawal by Subject|5|||
23366760|NCT05117060|65089033|FG003|Overall Study|Withdrawal by Subject|6|||
23366761|NCT05117060|65089030|FG000|Overall Study|Other|2|||
23366762|NCT05117060|65089031|FG001|Overall Study|Other|1|||
23366763|NCT05117060|65089032|FG002|Overall Study|Other|3|||
23366764|NCT05117060|65089033|FG003|Overall Study|Other|1|||
23366765|NCT00297648|65089034|FG000|Overall Study|Adverse Event|13|||
23366766|NCT00297648|65089034|FG000|Overall Study|Lack of Efficacy|18|||
23366767|NCT00297648|65089034|FG000|Overall Study|Lost to Follow-up|1|||
23366768|NCT00297648|65089034|FG000|Overall Study|Withdrawal by Subject|3|||
23366769|NCT00297648|65089034|FG000|Overall Study|Other: Incompliance|1|||
23366770|NCT02062437|65089039|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
23366771|NCT02062437|65089039|FG000|Overall Study|Patient not available for the 2y visit|18|||
23366772|NCT02062437|65089039|FG000|Overall Study|Death|2|||
23601995|NCT03488719|65933974|FG001|Overall Study|Adverse Event|4|||
23601996|NCT03488719|65933975|FG002|Overall Study|Adverse Event|2|||
23601997|NCT03488719|65933973|FG000|Overall Study|Other|0|||
23601998|NCT03488719|65933974|FG001|Overall Study|Other|0|||
23601999|NCT03488719|65933975|FG002|Overall Study|Other|5|||
23602000|NCT02874534|65933983|FG000|Overall Study|Withdrawal by Subject|5|||
23602001|NCT02874534|65933984|FG001|Overall Study|Withdrawal by Subject|8|||
23602002|NCT02874534|65933983|FG000|Overall Study|Lost to Follow-up|2|||
23271788|NCT00874237|64738392|FG001|Overall Study|Withdrawal by Subject|0|||
23271789|NCT00874237|64738393|FG002|Overall Study|Withdrawal by Subject|1|||
23271790|NCT00874237|64738394|FG003|Overall Study|Withdrawal by Subject|0|||
23271791|NCT00874237|64738395|FG004|Overall Study|Withdrawal by Subject|0|||
23271792|NCT00874237|64738396|FG005|Overall Study|Withdrawal by Subject|0|||
23271793|NCT01404988|64738397|FG000|Overall Study|Death|2|||
23271794|NCT01404988|64738398|FG001|Overall Study|Death|0|||
23271795|NCT01404988|64738399|FG002|Overall Study|Death|2|||
23271796|NCT01404988|64738397|FG000|Overall Study|Adverse Event|1|||
23271797|NCT01404988|64738398|FG001|Overall Study|Adverse Event|0|||
23271798|NCT01404988|64738399|FG002|Overall Study|Adverse Event|0|||
23271799|NCT01404988|64738397|FG000|Overall Study|Withdrawal by Subject|2|||
23271800|NCT01404988|64738398|FG001|Overall Study|Withdrawal by Subject|2|||
23271801|NCT01404988|64738399|FG002|Overall Study|Withdrawal by Subject|0|||
23271802|NCT01404988|64738397|FG000|Overall Study|Lost to Follow-up|1|||
23271803|NCT01404988|64738398|FG001|Overall Study|Lost to Follow-up|2|||
23271804|NCT01404988|64738399|FG002|Overall Study|Lost to Follow-up|1|||
23366773|NCT02062437|65089039|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
23366774|NCT01656395|65089046|FG000|Overall Study|Adverse Event|1|||
23366775|NCT01656395|65089047|FG001|Overall Study|Adverse Event|14|||
23366776|NCT01656395|65089048|FG002|Overall Study|Adverse Event|5|||
23366777|NCT01656395|65089049|FG003|Overall Study|Adverse Event|4|||
23271805|NCT01880593|64738404|FG000|Overall Study|Adverse Event|1|||
23366778|NCT01656395|65089050|FG004|Overall Study|Adverse Event|5|||
23366779|NCT01656395|65089051|FG005|Overall Study|Adverse Event|7|||
23366780|NCT01656395|65089052|FG006|Overall Study|Adverse Event|0|||
23366781|NCT01656395|65089053|FG007|Overall Study|Adverse Event|0|||
23602003|NCT02874534|65933984|FG001|Overall Study|Lost to Follow-up|2|||
23602004|NCT02874534|65933983|FG000|Overall Study|Ongoing in study|1|||
23602005|NCT02874534|65933984|FG001|Overall Study|Ongoing in study|1|||
23271806|NCT01880593|64738405|FG001|Overall Study|Adverse Event|0|||
23271807|NCT01880593|64738404|FG000|Overall Study|Lack of Efficacy|1|||
23271808|NCT01880593|64738405|FG001|Overall Study|Lack of Efficacy|5|||
23271809|NCT01880593|64738404|FG000|Overall Study|Withdrawal by Subject|6|||
23271810|NCT01880593|64738405|FG001|Overall Study|Withdrawal by Subject|1|||
23271811|NCT00635492|64738406|FG000|Overall Study|Death|12|||
23271812|NCT00635492|64738407|FG001|Overall Study|Death|40|||
23271813|NCT00635492|64738406|FG000|Overall Study|Lost to Follow-up|151|||
23271814|NCT00635492|64738407|FG001|Overall Study|Lost to Follow-up|172|||
23271815|NCT00635492|64738406|FG000|Overall Study|Physician Decision|32|||
23271816|NCT00635492|64738407|FG001|Overall Study|Physician Decision|22|||
23271817|NCT00635492|64738406|FG000|Overall Study|Sponsor decision|2|||
23271818|NCT00635492|64738407|FG001|Overall Study|Sponsor decision|3|||
23271819|NCT00635492|64738406|FG000|Overall Study|Withdrawal by Subject|82|||
23271820|NCT00635492|64738407|FG001|Overall Study|Withdrawal by Subject|45|||
23271821|NCT00324168|64738408|FG000|Overall Study|Lost to Follow-up|19|||
23366782|NCT01656395|65089046|FG000|Overall Study|Lack of Efficacy|1|||
23366783|NCT01656395|65089047|FG001|Overall Study|Lack of Efficacy|8|||
23271822|NCT00324168|64738409|FG001|Overall Study|Lost to Follow-up|18|||
23271823|NCT00324168|64738408|FG000|Overall Study|Death|3|||
23366784|NCT01656395|65089048|FG002|Overall Study|Lack of Efficacy|6|||
23366785|NCT01656395|65089049|FG003|Overall Study|Lack of Efficacy|1|||
23366786|NCT01656395|65089050|FG004|Overall Study|Lack of Efficacy|1|||
23271824|NCT00324168|64738409|FG001|Overall Study|Death|3|||
23366787|NCT01656395|65089051|FG005|Overall Study|Lack of Efficacy|6|||
23602006|NCT01307800|65933988|FG000|Overall Study|Adverse Event|9|||
23271825|NCT00324168|64738408|FG000|Overall Study|Patient did not visit in f/u window|6|||
23271826|NCT00324168|64738409|FG001|Overall Study|Patient did not visit in f/u window|9|||
23271827|NCT04646213|64738410|FG000|Overall Study|Physician Decision|3|||
23271828|NCT04646213|64738410|FG000|Overall Study|Withdrawal by Subject|2|||
23271829|NCT02079766|64738411|FG000|Overall Study|Physician Decision|1|||
23271830|NCT02079766|64738412|FG001|Overall Study|Physician Decision|0|||
23271831|NCT02079766|64738411|FG000|Overall Study|Withdrawal by Subject|1|||
23271832|NCT02079766|64738412|FG001|Overall Study|Withdrawal by Subject|0|||
23271833|NCT01417078|64738413|FG000|Overall Study|Withdrawal by Subject|1|||
23271834|NCT02587962|64738414|FG000|Overall Study|Adverse Event|0|||
23271835|NCT02587962|64738415|FG001|Overall Study|Adverse Event|0|||
23271836|NCT02587962|64738416|FG002|Overall Study|Adverse Event|1|||
23271837|NCT02587962|64738417|FG003|Overall Study|Adverse Event|0|||
23271838|NCT02587962|64738418|FG004|Overall Study|Adverse Event|0|||
23271839|NCT02587962|64738414|FG000|Overall Study|Withdrawal by Subject|0|||
23271840|NCT02587962|64738415|FG001|Overall Study|Withdrawal by Subject|0|||
23271841|NCT02587962|64738416|FG002|Overall Study|Withdrawal by Subject|1|||
23271842|NCT02587962|64738417|FG003|Overall Study|Withdrawal by Subject|1|||
23271843|NCT02587962|64738418|FG004|Overall Study|Withdrawal by Subject|4|||
23271844|NCT02587962|64738414|FG000|Overall Study|Radiological progression|2|||
23271845|NCT02587962|64738415|FG001|Overall Study|Radiological progression|2|||
23271846|NCT02587962|64738416|FG002|Overall Study|Radiological progression|2|||
23271847|NCT02587962|64738417|FG003|Overall Study|Radiological progression|5|||
23271848|NCT02587962|64738418|FG004|Overall Study|Radiological progression|10|||
23271849|NCT02587962|64738414|FG000|Overall Study|Clinical progression|0|||
23271850|NCT02587962|64738415|FG001|Overall Study|Clinical progression|1|||
23271851|NCT02587962|64738416|FG002|Overall Study|Clinical progression|2|||
23271852|NCT02587962|64738417|FG003|Overall Study|Clinical progression|0|||
23271853|NCT02587962|64738418|FG004|Overall Study|Clinical progression|1|||
23271854|NCT02178722|64738420|FG000|Overall Study|Withdrawal by Subject|0|||
23271855|NCT02178722|64738421|FG001|Overall Study|Withdrawal by Subject|0|||
23271856|NCT02178722|64738422|FG002|Overall Study|Withdrawal by Subject|0|||
23271857|NCT02178722|64738423|FG003|Overall Study|Withdrawal by Subject|2|||
23271858|NCT02178722|64738424|FG004|Overall Study|Withdrawal by Subject|33|||
23271859|NCT02178722|64738420|FG000|Overall Study|Death|2|||
23271860|NCT02178722|64738421|FG001|Overall Study|Death|13|||
23271861|NCT02178722|64738422|FG002|Overall Study|Death|12|||
23271862|NCT02178722|64738423|FG003|Overall Study|Death|12|||
23271863|NCT02178722|64738424|FG004|Overall Study|Death|205|||
23271864|NCT02178722|64738420|FG000|Overall Study|Lost to Follow-up|0|||
23271865|NCT02178722|64738421|FG001|Overall Study|Lost to Follow-up|0|||
23271866|NCT02178722|64738422|FG002|Overall Study|Lost to Follow-up|0|||
23271867|NCT02178722|64738423|FG003|Overall Study|Lost to Follow-up|2|||
23271868|NCT02178722|64738424|FG004|Overall Study|Lost to Follow-up|11|||
23271869|NCT02178722|64738420|FG000|Overall Study|Study terminated by Sponsor|2|||
23271870|NCT02178722|64738421|FG001|Overall Study|Study terminated by Sponsor|7|||
23271871|NCT02178722|64738422|FG002|Overall Study|Study terminated by Sponsor|6|||
23271872|NCT02178722|64738423|FG003|Overall Study|Study terminated by Sponsor|4|||
23271873|NCT02178722|64738424|FG004|Overall Study|Study terminated by Sponsor|128|||
23271874|NCT02178722|64738420|FG000|Overall Study|Physician Decision|0|||
23271875|NCT02178722|64738421|FG001|Overall Study|Physician Decision|0|||
23271876|NCT02178722|64738422|FG002|Overall Study|Physician Decision|0|||
23271877|NCT02178722|64738423|FG003|Overall Study|Physician Decision|0|||
23271878|NCT02178722|64738424|FG004|Overall Study|Physician Decision|3|||
23271879|NCT02178722|64738420|FG000|Overall Study|Other|0|||
23271880|NCT02178722|64738421|FG001|Overall Study|Other|0|||
23271881|NCT02178722|64738422|FG002|Overall Study|Other|0|||
23271882|NCT02178722|64738423|FG003|Overall Study|Other|0|||
23271883|NCT02178722|64738424|FG004|Overall Study|Other|2|||
23271884|NCT00336479|64738427|FG000|Overall Study|Adverse Event|8|||
23271885|NCT00336479|64738428|FG001|Overall Study|Adverse Event|11|||
23271886|NCT00336479|64738429|FG002|Overall Study|Adverse Event|18|||
23271887|NCT00336479|64738430|FG003|Overall Study|Adverse Event|4|||
23271888|NCT00336479|64738427|FG000|Overall Study|Noncompliant|1|||
23271889|NCT00336479|64738428|FG001|Overall Study|Noncompliant|7|||
23271890|NCT00336479|64738429|FG002|Overall Study|Noncompliant|3|||
23271891|NCT00336479|64738430|FG003|Overall Study|Noncompliant|0|||
23271892|NCT00336479|64738427|FG000|Overall Study|Physician Decision|2|||
23271893|NCT00336479|64738428|FG001|Overall Study|Physician Decision|3|||
23271894|NCT00336479|64738429|FG002|Overall Study|Physician Decision|1|||
23366788|NCT01656395|65089052|FG006|Overall Study|Lack of Efficacy|0|||
23602007|NCT01307800|65933989|FG001|Overall Study|Adverse Event|8|||
23271895|NCT00336479|64738430|FG003|Overall Study|Physician Decision|0|||
23271896|NCT00336479|64738427|FG000|Overall Study|Lost to Follow-up|3|||
23271897|NCT00336479|64738428|FG001|Overall Study|Lost to Follow-up|2|||
23271898|NCT00336479|64738429|FG002|Overall Study|Lost to Follow-up|0|||
23271899|NCT00336479|64738430|FG003|Overall Study|Lost to Follow-up|0|||
23271900|NCT00336479|64738427|FG000|Overall Study|Withdrawal by Subject|3|||
23271901|NCT00336479|64738428|FG001|Overall Study|Withdrawal by Subject|2|||
23271902|NCT00336479|64738429|FG002|Overall Study|Withdrawal by Subject|3|||
23271903|NCT00336479|64738430|FG003|Overall Study|Withdrawal by Subject|0|||
23271904|NCT00336479|64738427|FG000|Overall Study|Other|0|||
23271905|NCT00336479|64738428|FG001|Overall Study|Other|0|||
23271906|NCT00336479|64738429|FG002|Overall Study|Other|1|||
23271907|NCT00336479|64738430|FG003|Overall Study|Other|0|||
23271908|NCT00336479|64738427|FG000|Overall Study|Virologic Stopping Rule|20|||
23271909|NCT00336479|64738428|FG001|Overall Study|Virologic Stopping Rule|0|||
23271910|NCT00336479|64738429|FG002|Overall Study|Virologic Stopping Rule|0|||
23271911|NCT00336479|64738430|FG003|Overall Study|Virologic Stopping Rule|0|||
23271912|NCT02648347|64738431|FG000|Overall Study|Death|174|||
23271913|NCT02648347|64738432|FG001|Overall Study|Death|167|||
23271914|NCT02648347|64738431|FG000|Overall Study|Withdrawal by Subject|16|||
23271915|NCT02648347|64738432|FG001|Overall Study|Withdrawal by Subject|9|||
23366789|NCT01656395|65089053|FG007|Overall Study|Lack of Efficacy|0|||
23366790|NCT01656395|65089046|FG000|Overall Study|Lost to Follow-up|1|||
23366791|NCT01656395|65089047|FG001|Overall Study|Lost to Follow-up|0|||
23366792|NCT01656395|65089048|FG002|Overall Study|Lost to Follow-up|0|||
23366793|NCT01656395|65089049|FG003|Overall Study|Lost to Follow-up|0|||
23366794|NCT01656395|65089050|FG004|Overall Study|Lost to Follow-up|0|||
23366795|NCT01656395|65089051|FG005|Overall Study|Lost to Follow-up|0|||
23366796|NCT01656395|65089052|FG006|Overall Study|Lost to Follow-up|0|||
23366797|NCT01656395|65089053|FG007|Overall Study|Lost to Follow-up|0|||
23366798|NCT01656395|65089046|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23483556|NCT00366340|65513107|FG000|Infant Series|Protocol Violation|3|||
23483557|NCT00366340|65513108|FG001|Infant Series|Protocol Violation|4|||
23483558|NCT00366340|65513107|FG000|Infant Series|Withdrawal by Subject|3|||
23483559|NCT00366340|65513108|FG001|Infant Series|Withdrawal by Subject|3|||
23602008|NCT01307800|65933990|FG002|Overall Study|Adverse Event|10|||
23602009|NCT01307800|65933991|FG003|Overall Study|Adverse Event|14|||
23602010|NCT01307800|65933988|FG000|Overall Study|Entry Criteria Not Met|0|||
23602011|NCT01307800|65933989|FG001|Overall Study|Entry Criteria Not Met|0|||
23602012|NCT01307800|65933990|FG002|Overall Study|Entry Criteria Not Met|0|||
23602013|NCT01307800|65933991|FG003|Overall Study|Entry Criteria Not Met|2|||
23602014|NCT01307800|65933988|FG000|Overall Study|Lost to Follow-up|5|||
23602015|NCT01307800|65933989|FG001|Overall Study|Lost to Follow-up|6|||
23602016|NCT01307800|65933990|FG002|Overall Study|Lost to Follow-up|2|||
23602017|NCT01307800|65933991|FG003|Overall Study|Lost to Follow-up|8|||
23602018|NCT01307800|65933988|FG000|Overall Study|Perceived Lack of Efficacy|24|||
23602019|NCT01307800|65933989|FG001|Overall Study|Perceived Lack of Efficacy|23|||
23602020|NCT01307800|65933990|FG002|Overall Study|Perceived Lack of Efficacy|20|||
23602021|NCT01307800|65933991|FG003|Overall Study|Perceived Lack of Efficacy|33|||
23602022|NCT01307800|65933988|FG000|Overall Study|Protocol Violation|0|||
23602023|NCT01307800|65933989|FG001|Overall Study|Protocol Violation|3|||
23602024|NCT01307800|65933990|FG002|Overall Study|Protocol Violation|4|||
23602025|NCT01307800|65933991|FG003|Overall Study|Protocol Violation|5|||
23602026|NCT01307800|65933988|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
23602027|NCT01307800|65933989|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
23602028|NCT01307800|65933990|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
23602029|NCT01307800|65933991|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
23602030|NCT01307800|65933988|FG000|Overall Study|Sponsor Decision|6|||
23602031|NCT01307800|65933989|FG001|Overall Study|Sponsor Decision|9|||
23602032|NCT01307800|65933990|FG002|Overall Study|Sponsor Decision|12|||
23602033|NCT01307800|65933991|FG003|Overall Study|Sponsor Decision|28|||
23602034|NCT01307800|65933988|FG000|Overall Study|Withdrawal by Subject|10|||
23602035|NCT01307800|65933989|FG001|Overall Study|Withdrawal by Subject|11|||
23602036|NCT01307800|65933990|FG002|Overall Study|Withdrawal by Subject|8|||
23602037|NCT01307800|65933991|FG003|Overall Study|Withdrawal by Subject|15|||
23602038|NCT01307800|65933988|FG000|Overall Study|Participant Moved|0|||
23602039|NCT01307800|65933989|FG001|Overall Study|Participant Moved|2|||
23271916|NCT02648347|64738431|FG000|Overall Study|Lost to Follow-up|18|||
23602040|NCT01307800|65933990|FG002|Overall Study|Participant Moved|1|||
23602041|NCT01307800|65933991|FG003|Overall Study|Participant Moved|3|||
23271917|NCT02648347|64738432|FG001|Overall Study|Lost to Follow-up|21|||
23366799|NCT01656395|65089047|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23366800|NCT01656395|65089048|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23366801|NCT01656395|65089049|FG003|Overall Study|Non-Compliance with Study Drug|0|||
23483560|NCT00366340|65513107|FG000|Infant Series|Adverse Event|0|||
23602042|NCT01561300|65933992|FG000|Run in on Placebo|Adverse Event|1|||
23602043|NCT01561300|65933993|FG001|Run in on Placebo|Adverse Event|0|||
23602044|NCT00734578|65933994|FG000|Overall Study|Adverse Event|4|||
23366802|NCT01656395|65089050|FG004|Overall Study|Non-Compliance with Study Drug|1|||
23271918|NCT02648347|64738431|FG000|Overall Study|Missing|1|||
23271919|NCT02648347|64738432|FG001|Overall Study|Missing|0|||
23271920|NCT03657160|64738434|FG000|Overall Study|Adverse Event|5|||
23366803|NCT01656395|65089051|FG005|Overall Study|Non-Compliance with Study Drug|1|||
23366804|NCT01656395|65089052|FG006|Overall Study|Non-Compliance with Study Drug|0|||
23366805|NCT01656395|65089053|FG007|Overall Study|Non-Compliance with Study Drug|0|||
23366806|NCT01656395|65089046|FG000|Overall Study|Other|0|||
23366807|NCT01656395|65089047|FG001|Overall Study|Other|0|||
23366808|NCT01656395|65089048|FG002|Overall Study|Other|1|||
23366809|NCT01656395|65089049|FG003|Overall Study|Other|0|||
23366810|NCT01656395|65089050|FG004|Overall Study|Other|0|||
23366811|NCT01656395|65089051|FG005|Overall Study|Other|1|||
23366812|NCT01656395|65089052|FG006|Overall Study|Other|0|||
23366813|NCT01656395|65089053|FG007|Overall Study|Other|0|||
23366814|NCT01656395|65089046|FG000|Overall Study|Physician Decision|2|||
23366815|NCT01656395|65089047|FG001|Overall Study|Physician Decision|3|||
23366816|NCT01656395|65089048|FG002|Overall Study|Physician Decision|3|||
23366817|NCT01656395|65089049|FG003|Overall Study|Physician Decision|2|||
23366818|NCT01656395|65089050|FG004|Overall Study|Physician Decision|3|||
23366819|NCT01656395|65089051|FG005|Overall Study|Physician Decision|3|||
23366820|NCT01656395|65089052|FG006|Overall Study|Physician Decision|0|||
23366821|NCT01656395|65089053|FG007|Overall Study|Physician Decision|0|||
23366822|NCT01656395|65089046|FG000|Overall Study|Pregnancy|0|||
23366823|NCT01656395|65089047|FG001|Overall Study|Pregnancy|0|||
23366824|NCT01656395|65089048|FG002|Overall Study|Pregnancy|1|||
23366825|NCT01656395|65089049|FG003|Overall Study|Pregnancy|0|||
23366826|NCT01656395|65089050|FG004|Overall Study|Pregnancy|0|||
23366827|NCT01656395|65089051|FG005|Overall Study|Pregnancy|0|||
23271921|NCT03657160|64738435|FG001|Overall Study|Adverse Event|6|||
23271922|NCT03657160|64738434|FG000|Overall Study|Protocol Deviation|3|||
23271923|NCT03657160|64738435|FG001|Overall Study|Protocol Deviation|0|||
23271924|NCT03657160|64738434|FG000|Overall Study|Withdrawal by Subject|18|||
23271925|NCT03657160|64738435|FG001|Overall Study|Withdrawal by Subject|16|||
23271926|NCT03657160|64738434|FG000|Overall Study|Site Termination|1|||
23271927|NCT03657160|64738435|FG001|Overall Study|Site Termination|0|||
23271928|NCT03657160|64738434|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
23271929|NCT03657160|64738435|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
23271930|NCT03657160|64738434|FG000|Overall Study|Death|33|||
23271931|NCT03657160|64738435|FG001|Overall Study|Death|26|||
23271932|NCT03657160|64738434|FG000|Overall Study|Death (COVID-19-Related)|1|||
23271933|NCT03657160|64738435|FG001|Overall Study|Death (COVID-19-Related)|0|||
23271934|NCT03657160|64738434|FG000|Overall Study|Reason Not Specified|5|||
23366828|NCT01656395|65089052|FG006|Overall Study|Pregnancy|0|||
23366829|NCT01656395|65089053|FG007|Overall Study|Pregnancy|0|||
23366830|NCT01656395|65089046|FG000|Overall Study|Progressive Disease|0|||
23366831|NCT01656395|65089047|FG001|Overall Study|Progressive Disease|0|||
23366832|NCT01656395|65089048|FG002|Overall Study|Progressive Disease|0|||
23366833|NCT01656395|65089049|FG003|Overall Study|Progressive Disease|0|||
23366834|NCT01656395|65089050|FG004|Overall Study|Progressive Disease|0|||
23366835|NCT01656395|65089051|FG005|Overall Study|Progressive Disease|1|||
23366836|NCT01656395|65089052|FG006|Overall Study|Progressive Disease|0|||
23366837|NCT01656395|65089053|FG007|Overall Study|Progressive Disease|0|||
23366838|NCT01656395|65089046|FG000|Overall Study|Protocol Violation|6|||
23366839|NCT01656395|65089047|FG001|Overall Study|Protocol Violation|6|||
23366840|NCT01656395|65089048|FG002|Overall Study|Protocol Violation|9|||
23366841|NCT01656395|65089049|FG003|Overall Study|Protocol Violation|2|||
23366842|NCT01656395|65089050|FG004|Overall Study|Protocol Violation|4|||
23366843|NCT01656395|65089051|FG005|Overall Study|Protocol Violation|10|||
23271935|NCT03657160|64738435|FG001|Overall Study|Reason Not Specified|5|||
23271936|NCT03657160|64738434|FG000|Overall Study|Other (COVID-19-Related)|0|||
23271937|NCT03657160|64738435|FG001|Overall Study|Other (COVID-19-Related)|1|||
23366844|NCT01656395|65089052|FG006|Overall Study|Protocol Violation|0|||
23366845|NCT01656395|65089053|FG007|Overall Study|Protocol Violation|0|||
23366846|NCT01656395|65089046|FG000|Overall Study|Screen Failure|2|||
23366847|NCT01656395|65089047|FG001|Overall Study|Screen Failure|1|||
23366848|NCT01656395|65089048|FG002|Overall Study|Screen Failure|7|||
23366849|NCT01656395|65089049|FG003|Overall Study|Screen Failure|1|||
23366850|NCT01656395|65089050|FG004|Overall Study|Screen Failure|0|||
23366851|NCT01656395|65089051|FG005|Overall Study|Screen Failure|8|||
23271938|NCT01387022|64738443|FG000|Overall Study|Death|1|||
23366852|NCT01656395|65089052|FG006|Overall Study|Screen Failure|0|||
23366853|NCT01656395|65089053|FG007|Overall Study|Screen Failure|0|||
23366854|NCT01656395|65089046|FG000|Overall Study|Withdrawal by Subject|3|||
23366855|NCT01656395|65089047|FG001|Overall Study|Withdrawal by Subject|1|||
23366856|NCT01656395|65089048|FG002|Overall Study|Withdrawal by Subject|4|||
23366857|NCT01656395|65089049|FG003|Overall Study|Withdrawal by Subject|2|||
23366858|NCT01656395|65089050|FG004|Overall Study|Withdrawal by Subject|0|||
23366859|NCT01656395|65089051|FG005|Overall Study|Withdrawal by Subject|3|||
23366860|NCT01656395|65089052|FG006|Overall Study|Withdrawal by Subject|0|||
23366861|NCT01656395|65089053|FG007|Overall Study|Withdrawal by Subject|0|||
23366862|NCT05222880|65089054|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
23366863|NCT05222880|65089054|FG000|Overall Study|Withdrew Consent during Study|1|||
23366864|NCT05222880|65089054|FG000|Overall Study|COVID-19 Related|1|||
23366865|NCT02662569|65089055|FG000|Overall Study|Withdrawal by Subject|6|||
23366866|NCT02662569|65089056|FG001|Overall Study|Withdrawal by Subject|1|||
23366867|NCT02662569|65089057|FG002|Overall Study|Withdrawal by Subject|6|||
23366868|NCT02662569|65089058|FG003|Overall Study|Withdrawal by Subject|4|||
23366869|NCT02662569|65089055|FG000|Overall Study|Lost to Follow-up|1|||
23271939|NCT01387022|64738444|FG001|Overall Study|Death|1|||
23271940|NCT01387022|64738443|FG000|Overall Study|Lost to Follow-up|0|||
23271941|NCT01387022|64738444|FG001|Overall Study|Lost to Follow-up|3|||
23366870|NCT02662569|65089056|FG001|Overall Study|Lost to Follow-up|0|||
23366871|NCT02662569|65089057|FG002|Overall Study|Lost to Follow-up|0|||
23366872|NCT02662569|65089058|FG003|Overall Study|Lost to Follow-up|0|||
23366873|NCT01841970|65089059|FG000|Overall Study|Withdrawal by Subject|1|||
23366874|NCT01841970|65089059|FG000|Overall Study|Physician Decision|2|||
23366875|NCT01841970|65089059|FG000|Overall Study|Lost to Follow-up|8|||
23366876|NCT01526785|65089060|FG000|Overall Study|Study Terminated by Sponsor|8|||
23366877|NCT01526785|65089060|FG000|Overall Study|Death|2|||
23366878|NCT01526785|65089060|FG000|Overall Study|Physician Decision|1|||
23366879|NCT01526785|65089060|FG000|Overall Study|Withdrawal by Subject|2|||
23366880|NCT01093846|65089061|FG000|Overall Study|Adverse Event|0|||
23366881|NCT01093846|65089062|FG001|Overall Study|Adverse Event|0|||
23366882|NCT01093846|65089063|FG002|Overall Study|Adverse Event|1|||
23366883|NCT01093846|65089061|FG000|Overall Study|Lack of Efficacy|0|||
23366884|NCT01093846|65089062|FG001|Overall Study|Lack of Efficacy|0|||
23366885|NCT01093846|65089063|FG002|Overall Study|Lack of Efficacy|4|||
23366886|NCT01093846|65089061|FG000|Overall Study|Condition no longer required study drug|1|||
23366887|NCT01093846|65089062|FG001|Overall Study|Condition no longer required study drug|1|||
23366888|NCT01093846|65089063|FG002|Overall Study|Condition no longer required study drug|1|||
23366889|NCT01093846|65089061|FG000|Overall Study|Administrative Problems|18|||
23366890|NCT01093846|65089062|FG001|Overall Study|Administrative Problems|17|||
23366891|NCT01093846|65089063|FG002|Overall Study|Administrative Problems|15|||
23366892|NCT00095979|65089064|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
23366893|NCT02457195|65089067|FG000|Overall Study|Adverse Event|3|||
23366894|NCT02457195|65089067|FG000|Overall Study|Protocol Violation|2|||
23366895|NCT02457195|65089067|FG000|Overall Study|Withdrawal by Subject|4|||
23366896|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
23366897|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
23366898|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Death|561|||
23366899|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Death|298|||
23366900|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
23366901|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
23366902|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
23366903|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
23366904|NCT00974311|65089068|FG000|DB Phase (up to 24 Months)|Other|1|||
23366905|NCT00974311|65089069|FG001|DB Phase (up to 24 Months)|Other|0|||
23366906|NCT00974311|65089068|FG000|OLE Phase (up to 77 Months)|Death|14|||
23366907|NCT00974311|65089069|FG001|OLE Phase (up to 77 Months)|Death|21|||
23366908|NCT00974311|65089068|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
23366909|NCT00974311|65089069|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
23366910|NCT00974311|65089068|FG000|OLE Phase (up to 77 Months)|Other|15|||
23271942|NCT04611789|64738446|FG000|Overall Study|Lost to Follow-up|1|||
23271943|NCT04611789|64738447|FG001|Overall Study|Lost to Follow-up|0|||
23271944|NCT04611789|64738448|FG002|Overall Study|Lost to Follow-up|0|||
23271945|NCT01691508|64738449|FG000|Overall Study|Adverse Event|3|||
23271946|NCT01691508|64738450|FG001|Overall Study|Adverse Event|3|||
23271947|NCT01691508|64738449|FG000|Overall Study|Withdrawal by Subject|1|||
23366911|NCT00974311|65089069|FG001|OLE Phase (up to 77 Months)|Other|2|||
23366912|NCT00974311|65089068|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
23602045|NCT00734578|65933995|FG001|Overall Study|Adverse Event|6|||
23602046|NCT00734578|65933996|FG002|Overall Study|Adverse Event|1|||
23602047|NCT00734578|65933994|FG000|Overall Study|Protocol Violation|8|||
23602048|NCT00734578|65933995|FG001|Overall Study|Protocol Violation|6|||
23602049|NCT00734578|65933996|FG002|Overall Study|Protocol Violation|3|||
23271948|NCT01691508|64738450|FG001|Overall Study|Withdrawal by Subject|0|||
23271949|NCT00496964|64738453|FG000|Overall Study|Withdrawal by Subject|0|||
23271950|NCT00496964|64738454|FG001|Overall Study|Withdrawal by Subject|1|||
23366913|NCT00974311|65089069|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
23366914|NCT00305227|65089070|FG000|Overall Study|Lost to Follow-up|7|||
23366915|NCT00305227|65089071|FG001|Overall Study|Lost to Follow-up|6|||
23366916|NCT00113295|65089072|FG000|Overall Study|Adverse Event|4|||
23366917|NCT00113295|65089073|FG001|Overall Study|Adverse Event|1|||
23366918|NCT00113295|65089072|FG000|Overall Study|Unrelated Medical Illness|1|||
23366919|NCT00113295|65089073|FG001|Overall Study|Unrelated Medical Illness|0|||
23366920|NCT00230048|65089076|FG000|Overall Study|Lost to Follow-up|13|||
23366921|NCT00230048|65089077|FG001|Overall Study|Lost to Follow-up|18|||
23366922|NCT03713684|65089078|FG000|Overall Study|Adverse Event|1|||
23366923|NCT03713684|65089079|FG001|Overall Study|Adverse Event|3|||
23366924|NCT03713684|65089080|FG002|Overall Study|Adverse Event|1|||
23366925|NCT03713684|65089081|FG003|Overall Study|Adverse Event|0|||
23366926|NCT03713684|65089078|FG000|Overall Study|Poor compliance to protocol|2|||
23271951|NCT01059903|64738455|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
23271952|NCT01059903|64738456|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
23271953|NCT04060147|64738457|FG000|Overall Study|Withdrew consent|1|||
23271954|NCT01079988|64738462|FG000|Overall Study|Lost to Follow-up|0|||
23366927|NCT03713684|65089079|FG001|Overall Study|Poor compliance to protocol|1|||
23366928|NCT03713684|65089080|FG002|Overall Study|Poor compliance to protocol|0|||
23366929|NCT03713684|65089081|FG003|Overall Study|Poor compliance to protocol|1|||
23366930|NCT03713684|65089078|FG000|Overall Study|Withdrawal by Subject|14|||
23366931|NCT03713684|65089079|FG001|Overall Study|Withdrawal by Subject|6|||
23366932|NCT03713684|65089080|FG002|Overall Study|Withdrawal by Subject|14|||
23271955|NCT01079988|64738463|FG001|Overall Study|Lost to Follow-up|0|||
23271956|NCT01079988|64738464|FG002|Overall Study|Lost to Follow-up|0|||
23271957|NCT01079988|64738465|FG003|Overall Study|Lost to Follow-up|1|||
23271958|NCT01079988|64738466|FG004|Overall Study|Lost to Follow-up|0|||
23271959|NCT01079988|64738462|FG000|Overall Study|Lack of Efficacy|1|||
23271960|NCT01079988|64738463|FG001|Overall Study|Lack of Efficacy|0|||
23271961|NCT01079988|64738464|FG002|Overall Study|Lack of Efficacy|0|||
23271962|NCT01079988|64738465|FG003|Overall Study|Lack of Efficacy|0|||
23271963|NCT01079988|64738466|FG004|Overall Study|Lack of Efficacy|0|||
23271964|NCT01079988|64738462|FG000|Overall Study|Other|0|||
23271965|NCT01079988|64738463|FG001|Overall Study|Other|0|||
23271966|NCT01079988|64738464|FG002|Overall Study|Other|0|||
23271967|NCT01079988|64738465|FG003|Overall Study|Other|2|||
23271968|NCT01079988|64738466|FG004|Overall Study|Other|1|||
23271969|NCT03952143|64738467|FG000|Lead-In Period|Adverse Event|2|||
23271970|NCT03952143|64738468|FG001|Lead-In Period|Adverse Event|0|||
23271971|NCT03952143|64738469|FG002|Lead-In Period|Adverse Event|0|||
23271972|NCT03952143|64738467|FG000|Lead-In Period|Lack of Efficacy|2|||
23271973|NCT03952143|64738468|FG001|Lead-In Period|Lack of Efficacy|0|||
23271974|NCT03952143|64738469|FG002|Lead-In Period|Lack of Efficacy|0|||
23271975|NCT03952143|64738467|FG000|Lead-In Period|Physician Decision|5|||
23271976|NCT03952143|64738468|FG001|Lead-In Period|Physician Decision|0|||
23271977|NCT03952143|64738469|FG002|Lead-In Period|Physician Decision|0|||
23271978|NCT03952143|64738467|FG000|Lead-In Period|Protocol Violation|5|||
23271979|NCT03952143|64738468|FG001|Lead-In Period|Protocol Violation|0|||
23271980|NCT03952143|64738469|FG002|Lead-In Period|Protocol Violation|0|||
23271981|NCT03952143|64738467|FG000|Lead-In Period|Withdrawal by Subject|19|||
23271982|NCT03952143|64738468|FG001|Lead-In Period|Withdrawal by Subject|0|||
23271983|NCT03952143|64738469|FG002|Lead-In Period|Withdrawal by Subject|0|||
23271984|NCT03952143|64738467|FG000|Treatment Period|Adverse Event|0|||
23271985|NCT03952143|64738468|FG001|Treatment Period|Adverse Event|0|||
23271986|NCT03952143|64738469|FG002|Treatment Period|Adverse Event|1|||
23271987|NCT03952143|64738467|FG000|Treatment Period|Lost to Follow-up|0|||
23271988|NCT03952143|64738468|FG001|Treatment Period|Lost to Follow-up|2|||
23271989|NCT03952143|64738469|FG002|Treatment Period|Lost to Follow-up|0|||
23271990|NCT03952143|64738467|FG000|Treatment Period|Physician Decision|0|||
23271991|NCT03952143|64738468|FG001|Treatment Period|Physician Decision|0|||
23271992|NCT03952143|64738469|FG002|Treatment Period|Physician Decision|2|||
23271993|NCT03952143|64738467|FG000|Treatment Period|Protocol Violation|0|||
23271994|NCT03952143|64738468|FG001|Treatment Period|Protocol Violation|0|||
23271995|NCT03952143|64738469|FG002|Treatment Period|Protocol Violation|1|||
23366933|NCT03713684|65089081|FG003|Overall Study|Withdrawal by Subject|16|||
23366934|NCT03713684|65089078|FG000|Overall Study|Other than specified|69|||
23271996|NCT03952143|64738467|FG000|Treatment Period|Withdrawal by Subject|0|||
23271997|NCT03952143|64738468|FG001|Treatment Period|Withdrawal by Subject|5|||
23271998|NCT03952143|64738469|FG002|Treatment Period|Withdrawal by Subject|26|||
23271999|NCT03952143|64738467|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
23272000|NCT03952143|64738468|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
23272001|NCT03952143|64738469|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
23272002|NCT03952143|64738467|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
23272003|NCT03952143|64738468|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
23272004|NCT03952143|64738469|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
23272005|NCT05067647|64738470|FG000|Overall Study|Lost to Follow-up|1|||
23366935|NCT03713684|65089079|FG001|Overall Study|Other than specified|77|||
23366936|NCT03713684|65089080|FG002|Overall Study|Other than specified|73|||
23366937|NCT03713684|65089081|FG003|Overall Study|Other than specified|70|||
23366938|NCT00909844|65089086|FG000|Overall Study|Adverse Event|1|||
23366939|NCT00909844|65089086|FG000|Overall Study|Withdrawal by Subject|1|||
23366940|NCT00909844|65089086|FG000|Overall Study|Lost to Follow-up|2|||
23366941|NCT00885118|65089087|FG000|Overall Study|Adverse Event|1|||
23366942|NCT00885118|65089088|FG001|Overall Study|Adverse Event|0|||
23366943|NCT00885118|65089089|FG002|Overall Study|Adverse Event|0|||
23366944|NCT00885118|65089090|FG003|Overall Study|Adverse Event|0|||
23366945|NCT00885118|65089091|FG004|Overall Study|Adverse Event|0|||
23366946|NCT00885118|65089087|FG000|Overall Study|Withdrawal by Subject|0|||
23366947|NCT00885118|65089088|FG001|Overall Study|Withdrawal by Subject|0|||
23366948|NCT00885118|65089089|FG002|Overall Study|Withdrawal by Subject|0|||
23366949|NCT00885118|65089090|FG003|Overall Study|Withdrawal by Subject|0|||
23366950|NCT00885118|65089091|FG004|Overall Study|Withdrawal by Subject|1|||
23366951|NCT00885118|65089087|FG000|Overall Study|Other reason not defined above|0|||
23366952|NCT00885118|65089088|FG001|Overall Study|Other reason not defined above|0|||
23366953|NCT00885118|65089089|FG002|Overall Study|Other reason not defined above|1|||
23366954|NCT00885118|65089090|FG003|Overall Study|Other reason not defined above|0|||
23366955|NCT00885118|65089091|FG004|Overall Study|Other reason not defined above|0|||
23366956|NCT00808067|65089092|FG000|Overall Study|Major/minor bleed|30|||
23366957|NCT00808067|65089093|FG001|Overall Study|Major/minor bleed|44|||
23366958|NCT00808067|65089092|FG000|Overall Study|Outcome event - other|33|||
23366959|NCT00808067|65089093|FG001|Overall Study|Outcome event - other|25|||
23366960|NCT00808067|65089092|FG000|Overall Study|Adverse Event|111|||
23602050|NCT00734578|65933994|FG000|Overall Study|Withdrawal by Subject|7|||
23272006|NCT00075478|64738473|FG000|Overall Study|not eligible|1|||
23272007|NCT00075478|64738474|FG001|Overall Study|not eligible|0|||
23272008|NCT00075478|64738473|FG000|Overall Study|Physician Decision|0|||
23272009|NCT00075478|64738474|FG001|Overall Study|Physician Decision|1|||
23272010|NCT00301366|64738475|FG000|Overall Study|Adverse Event|1|||
23272011|NCT00302952|64738484|FG000|Overall Study|Physician Decision|1|||
23272012|NCT00302952|64738485|FG001|Overall Study|Physician Decision|1|||
23272013|NCT00302952|64738484|FG000|Overall Study|Withdrawal by Subject|2|||
23272014|NCT00302952|64738485|FG001|Overall Study|Withdrawal by Subject|3|||
23272015|NCT00302952|64738484|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
23272016|NCT00302952|64738485|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
23272017|NCT02637232|64738487|FG000|Overall Study|Lost to Follow-up|42|||
23272018|NCT02637232|64738487|FG000|Overall Study|Adverse Event|11|||
23272019|NCT02637232|64738487|FG000|Overall Study|patient 's decision|2|||
23272020|NCT00259012|64738488|FG000|Overall Study|Adverse Event|0|||
23272021|NCT00259012|64738489|FG001|Overall Study|Adverse Event|1|||
23272022|NCT00259012|64738488|FG000|Overall Study|Withdrawal by Subject|1|||
23272023|NCT00259012|64738489|FG001|Overall Study|Withdrawal by Subject|0|||
23272024|NCT00259012|64738488|FG000|Overall Study|Physician Decision|0|||
23272025|NCT00259012|64738489|FG001|Overall Study|Physician Decision|1|||
23272026|NCT00259012|64738488|FG000|Overall Study|Lost to Follow-up|0|||
23272027|NCT00259012|64738489|FG001|Overall Study|Lost to Follow-up|1|||
23272028|NCT00259012|64738488|FG000|Overall Study|Protocol Violation|1|||
23272029|NCT00259012|64738489|FG001|Overall Study|Protocol Violation|1|||
23272030|NCT02645409|64738500|FG000|Overall Study|Withdrawal by Subject|3|||
23272031|NCT02645409|64738501|FG001|Overall Study|Withdrawal by Subject|0|||
23272032|NCT02645409|64738500|FG000|Overall Study|Physician Decision|1|||
23272033|NCT02645409|64738501|FG001|Overall Study|Physician Decision|0|||
23272034|NCT00694551|64738503|FG000|Overall Study|Disease Progression|1|||
23272035|NCT00694551|64738504|FG001|Overall Study|Disease Progression|0|||
23272036|NCT00694551|64738505|FG002|Overall Study|Disease Progression|1|||
23272037|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Adverse Event|11|||
23272038|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Adverse Event|23|||
23272039|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Adverse Event|29|||
23366961|NCT00808067|65089093|FG001|Overall Study|Adverse Event|121|||
23366962|NCT00808067|65089092|FG000|Overall Study|Hospitalization (not including surgery)|18|||
23366963|NCT00808067|65089093|FG001|Overall Study|Hospitalization (not including surgery)|17|||
23366964|NCT00808067|65089092|FG000|Overall Study|Hospitalization due to surgery|37|||
23602051|NCT00734578|65933995|FG001|Overall Study|Withdrawal by Subject|8|||
23602052|NCT00734578|65933996|FG002|Overall Study|Withdrawal by Subject|11|||
23272040|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Adverse Event|2|||
23272041|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Adverse Event|8|||
23272042|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
23272043|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
23272044|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
23272045|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
23272046|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
23272047|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
23366965|NCT00808067|65089093|FG001|Overall Study|Hospitalization due to surgery|40|||
23366966|NCT00808067|65089092|FG000|Overall Study|Reduced creatinine clearance|53|||
23366967|NCT00808067|65089093|FG001|Overall Study|Reduced creatinine clearance|55|||
23366968|NCT00808067|65089092|FG000|Overall Study|Elevated LFT results|7|||
23366969|NCT00808067|65089093|FG001|Overall Study|Elevated LFT results|3|||
23366970|NCT00808067|65089092|FG000|Overall Study|Patient refused to take study medication|65|||
23366971|NCT00808067|65089093|FG001|Overall Study|Patient refused to take study medication|76|||
23366972|NCT00808067|65089092|FG000|Overall Study|Missing|1|||
23366973|NCT00808067|65089093|FG001|Overall Study|Missing|0|||
23366974|NCT00808067|65089092|FG000|Overall Study|Death|1|||
23366975|NCT00808067|65089093|FG001|Overall Study|Death|1|||
23366976|NCT00808067|65089092|FG000|Overall Study|Procedure|6|||
23366977|NCT00808067|65089093|FG001|Overall Study|Procedure|7|||
23366978|NCT00808067|65089092|FG000|Overall Study|Withdrawal by Subject|21|||
23272048|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
23272049|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
23272050|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
23272051|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
23272052|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
23272053|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
23272054|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
23272055|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
23272056|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
23272057|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
23272058|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
23272059|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
23272060|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
23272061|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
23272062|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
23272063|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
23272064|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
23272065|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
23272066|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
23272067|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
23272068|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
23272069|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
23272070|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
23272071|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
23272072|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Move|0|||
23272073|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Move|1|||
23272074|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Move|0|||
23272075|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Move|0|||
23272076|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Move|0|||
23272077|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
23272078|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
23272079|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
23272080|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
23272081|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
23272082|NCT00318461|64738506|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
23272083|NCT00318461|64738507|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
23272084|NCT00318461|64738508|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
23272085|NCT00318461|64738509|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
23272086|NCT00318461|64738510|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
23272087|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Work commitment|0|||
23272088|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Work commitment|0|||
23272089|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Work commitment|0|||
23272090|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Work commitment|0|||
23272091|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Work commitment|1|||
23272092|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Investigator decision|0|||
23272093|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Investigator decision|0|||
23272094|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Investigator decision|0|||
23272095|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Investigator decision|0|||
23366979|NCT00808067|65089093|FG001|Overall Study|Withdrawal by Subject|25|||
23366980|NCT00808067|65089092|FG000|Overall Study|Site closed|4|||
23366981|NCT00808067|65089093|FG001|Overall Study|Site closed|3|||
23366982|NCT00808067|65089092|FG000|Overall Study|Physician Decision|47|||
23366983|NCT00808067|65089093|FG001|Overall Study|Physician Decision|38|||
23366984|NCT00808067|65089092|FG000|Overall Study|Protocol Violation|3|||
23272096|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Investigator decision|1|||
23272097|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Lack of time|1|||
23272098|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Lack of time|0|||
23272099|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Lack of time|0|||
23272100|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Lack of time|0|||
23366985|NCT00808067|65089093|FG001|Overall Study|Protocol Violation|11|||
23366986|NCT00808067|65089092|FG000|Overall Study|Patient elected|7|||
23272101|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Lack of time|0|||
23272102|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
23272103|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
23272104|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
23366987|NCT00808067|65089093|FG001|Overall Study|Patient elected|9|||
23366988|NCT00808067|65089092|FG000|Overall Study|Site closed for cause|19|||
23366989|NCT00808067|65089093|FG001|Overall Study|Site closed for cause|19|||
23366990|NCT00808067|65089092|FG000|Overall Study|Other reason not defined above|5|||
23366991|NCT00808067|65089093|FG001|Overall Study|Other reason not defined above|5|||
23366992|NCT00808067|65089092|FG000|Overall Study|Excluded from analysis|13|||
23366993|NCT00808067|65089093|FG001|Overall Study|Excluded from analysis|19|||
23366994|NCT01265498|65089095|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
23366995|NCT01265498|65089096|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
23272105|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
23272106|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
23272107|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
23272108|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
23272109|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
23272110|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
23272111|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
23272112|NCT00318461|64738506|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
23272113|NCT00318461|64738507|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
23272114|NCT00318461|64738508|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
23272115|NCT00318461|64738509|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
23272116|NCT00318461|64738510|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
23272117|NCT00318461|64738506|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
23272118|NCT00318461|64738507|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
23272119|NCT00318461|64738508|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
23272120|NCT00318461|64738509|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
23272121|NCT00318461|64738510|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
23272122|NCT00318461|64738506|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
23272123|NCT00318461|64738507|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
23272124|NCT00318461|64738508|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
23272125|NCT00318461|64738509|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
23272126|NCT00318461|64738510|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
23272127|NCT00318461|64738506|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
23272128|NCT00318461|64738507|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
23272129|NCT00318461|64738508|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
23272130|NCT00318461|64738509|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
23272131|NCT00318461|64738510|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
23272132|NCT00318461|64738506|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
23272133|NCT00318461|64738507|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
23272134|NCT00318461|64738508|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
23272135|NCT00318461|64738509|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
23272136|NCT00318461|64738510|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
23272137|NCT00318461|64738506|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
23272138|NCT00318461|64738507|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
23272139|NCT00318461|64738508|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
23272140|NCT00318461|64738509|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
23272141|NCT00318461|64738510|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
23366996|NCT00871234|65089103|FG000|Overall Study|Adverse Event|2|||
23366997|NCT00871234|65089103|FG000|Overall Study|Lost to Follow-up|3|||
23366998|NCT01716806|65089104|FG000|Overall Study|Patient withdrawal of consent|4|||
23272142|NCT03480425|64738511|FG000|Overall Study|Force transducer technical failure|1|||
23272143|NCT04419311|64738514|FG000|Overall Study|Lost to Follow-up|1|||
23272144|NCT04419311|64738515|FG001|Overall Study|Lost to Follow-up|0|||
23602053|NCT00734578|65933994|FG000|Overall Study|Lost to Follow-up|9|||
23272145|NCT02109042|64738516|FG000|Overall Study|Sponsor Decision|15|||
23272146|NCT02331394|64741997|FG000|Overall Study|Disease progression|1|||
23272147|NCT02549092|64741998|FG000|Treatment Period|Adverse Event|2|||
23272148|NCT02549092|64741999|FG001|Treatment Period|Adverse Event|2|||
23272149|NCT02549092|64741998|FG000|Treatment Period|Withdrawal by Subject|1|||
23272150|NCT02549092|64741999|FG001|Treatment Period|Withdrawal by Subject|3|||
23272151|NCT02549092|64741998|FG000|Treatment Period|Lack of Efficacy|0|||
23272152|NCT02549092|64741999|FG001|Treatment Period|Lack of Efficacy|2|||
23272153|NCT02549092|64741998|FG000|Extension/Transition Period|Adverse Event|1|||
23272154|NCT02549092|64741999|FG001|Extension/Transition Period|Adverse Event|1|||
23272155|NCT02549092|64741998|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
23272156|NCT02549092|64741999|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
23272157|NCT02549092|64741998|FG000|Extension/Transition Period|Other, Not Specified|4|||
23272158|NCT02549092|64741999|FG001|Extension/Transition Period|Other, Not Specified|2|||
23272159|NCT01042522|64742000|FG000|Overall Study|Adverse Event|1|||
23272160|NCT01042522|64742001|FG001|Overall Study|Adverse Event|2|||
23272161|NCT01042522|64742000|FG000|Overall Study|Disease Progression|5|||
23272162|NCT01042522|64742001|FG001|Overall Study|Disease Progression|0|||
23272163|NCT01042522|64742000|FG000|Overall Study|Death|1|||
23272164|NCT01042522|64742001|FG001|Overall Study|Death|0|||
23272165|NCT01042522|64742000|FG000|Overall Study|Patient Refused|0|||
23272166|NCT01042522|64742001|FG001|Overall Study|Patient Refused|3|||
23272167|NCT01042522|64742000|FG000|Overall Study|Withdrawal by Subject|1|||
23272168|NCT01042522|64742001|FG001|Overall Study|Withdrawal by Subject|1|||
23272169|NCT02682602|64742004|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
23272170|NCT02682602|64742005|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
23272171|NCT02682602|64742004|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
23272172|NCT02682602|64742005|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
23272173|NCT04885296|64742006|FG000|Period 1|Covid-19 Related|1|||
23272174|NCT04885296|64742007|FG001|Period 1|Covid-19 Related|0|||
23272175|NCT04885296|64742006|FG000|Period 1|Adverse Event|0|||
23272176|NCT04885296|64742007|FG001|Period 1|Adverse Event|1|||
23272177|NCT04885296|64742006|FG000|Period 1|Withdrawal by Subject|1|||
23272178|NCT04885296|64742007|FG001|Period 1|Withdrawal by Subject|1|||
23272179|NCT04885296|64742006|FG000|Period 1|Test Article No Longer Available|1|||
23272180|NCT04885296|64742007|FG001|Period 1|Test Article No Longer Available|0|||
23272181|NCT04885296|64742006|FG000|Period 1|Dispensed Study lens in Error|1|||
23272182|NCT04885296|64742007|FG001|Period 1|Dispensed Study lens in Error|0|||
23272183|NCT04885296|64742006|FG000|Period 1|Lost to Follow-up|1|||
23272184|NCT04885296|64742007|FG001|Period 1|Lost to Follow-up|0|||
23272185|NCT04885296|64742006|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
23272186|NCT04885296|64742007|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
23272187|NCT02457520|64742010|FG000|Active Treatment Phase|Adverse Event|10|||
23272188|NCT02457520|64742010|FG000|Active Treatment Phase|Lost to Follow-up|8|||
23272189|NCT02457520|64742010|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
23272190|NCT02457520|64742010|FG000|Active Treatment Phase|other|4|||
23272191|NCT02457520|64742010|FG000|Active Treatment Phase|Physician Decision|1|||
23272192|NCT02457520|64742010|FG000|Active Treatment Phase|Protocol Violation|1|||
23272193|NCT02457520|64742010|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
23272194|NCT02457520|64742010|FG000|Post-treatment Period|Other: Retreatment Required|7|||
23272195|NCT02457520|64742010|FG000|Post-treatment Period|Lost to Follow-up|23|||
23272196|NCT02457520|64742010|FG000|Post-treatment Period|Other|3|||
23272197|NCT02457520|64742010|FG000|Post-treatment Period|Physician Decision|1|||
23272198|NCT02457520|64742010|FG000|Post-treatment Period|Withdrawal by Subject|14|||
23272199|NCT04384978|64742011|FG000|Overall Study|Withdrawal by Subject|4|||
23272200|NCT04384978|64742012|FG001|Overall Study|Withdrawal by Subject|0|||
23272201|NCT02419937|64742013|FG000|Overall Study|Lost to Follow-up|1|||
23602054|NCT00734578|65933995|FG001|Overall Study|Lost to Follow-up|3|||
23602055|NCT00734578|65933996|FG002|Overall Study|Lost to Follow-up|5|||
23602056|NCT00734578|65933994|FG000|Overall Study|Lack of Efficacy|3|||
23602057|NCT00734578|65933995|FG001|Overall Study|Lack of Efficacy|2|||
23602058|NCT00734578|65933996|FG002|Overall Study|Lack of Efficacy|5|||
23602059|NCT00734578|65933994|FG000|Overall Study|Randomized in error|1|||
23602060|NCT00734578|65933995|FG001|Overall Study|Randomized in error|0|||
23602061|NCT00734578|65933996|FG002|Overall Study|Randomized in error|0|||
23602062|NCT00734578|65933994|FG000|Overall Study|Exclusion criteria|1|||
23602063|NCT00734578|65933995|FG001|Overall Study|Exclusion criteria|0|||
23272202|NCT02419937|64742014|FG001|Overall Study|Lost to Follow-up|0|||
23272203|NCT03693430|64742022|FG000|Overall Study|Lost to Follow-up|3|||
23272204|NCT03693430|64742023|FG001|Overall Study|Lost to Follow-up|14|||
23272205|NCT03693430|64742022|FG000|Overall Study|Death|1|||
23602064|NCT00734578|65933996|FG002|Overall Study|Exclusion criteria|0|||
23272206|NCT03693430|64742023|FG001|Overall Study|Death|0|||
23272207|NCT03693430|64742022|FG000|Overall Study|Withdrawal by Subject|0|||
23272208|NCT03693430|64742023|FG001|Overall Study|Withdrawal by Subject|4|||
23272209|NCT01900730|64742024|FG000|Overall Study|Withdrawal by Subject|1|||
23272210|NCT01900730|64742025|FG001|Overall Study|Withdrawal by Subject|0|||
23272211|NCT01900730|64742024|FG000|Overall Study|Screen Failure|1|||
23272212|NCT01900730|64742025|FG001|Overall Study|Screen Failure|0|||
23272213|NCT00576056|64742033|FG000|Overall Study|Adverse Event|1|||
23272214|NCT00576056|64742033|FG000|Overall Study|Death|1|||
23272215|NCT00576056|64742033|FG000|Overall Study|Lack of Efficacy|1|||
23272216|NCT00576056|64742033|FG000|Overall Study|Withdrawal by Subject|2|||
23272217|NCT00576056|64742033|FG000|Overall Study|did not meet eligibility criteria|8|||
23272218|NCT00576056|64742033|FG000|Overall Study|Physician Decision|1|||
23272219|NCT00995410|64742036|FG000|Overall Study|Adverse Event|51|||
23272220|NCT00995410|64742036|FG000|Overall Study|Withdrawal by Subject|7|||
23272221|NCT00995410|64742036|FG000|Overall Study|Lost to Follow-up|2|||
23272222|NCT00995410|64742036|FG000|Overall Study|Misc|28|||
23272223|NCT03616106|64742038|FG000|Overall Study|Removed by PI|6|||
23272224|NCT03616106|64742039|FG001|Overall Study|Removed by PI|0|||
23272225|NCT03616106|64742038|FG000|Overall Study|Withdrawal by Subject|1|||
23272226|NCT03616106|64742039|FG001|Overall Study|Withdrawal by Subject|1|||
23272227|NCT03616106|64742038|FG000|Overall Study|Lost to Follow-up|7|||
23272228|NCT03616106|64742039|FG001|Overall Study|Lost to Follow-up|0|||
23272229|NCT02780687|64742040|FG000|Overall Study|Adverse Event|1|||
23272230|NCT02780687|64742041|FG001|Overall Study|Adverse Event|1|||
23272231|NCT02780687|64742040|FG000|Overall Study|Withdrawal by Subject|2|||
23272232|NCT02780687|64742041|FG001|Overall Study|Withdrawal by Subject|1|||
23272233|NCT02780687|64742040|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
23272234|NCT02780687|64742041|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
23272235|NCT02780687|64742040|FG000|Overall Study|progressive disease|29|||
23272236|NCT02780687|64742041|FG001|Overall Study|progressive disease|6|||
23272237|NCT02682238|64742042|FG000|Overall Study|Lost to Follow-up|0|||
23272238|NCT02682238|64742043|FG001|Overall Study|Lost to Follow-up|2|||
23272239|NCT02682238|64742042|FG000|Overall Study|Withdrawal by Subject|1|||
23272240|NCT02682238|64742043|FG001|Overall Study|Withdrawal by Subject|0|||
23272241|NCT02682238|64742042|FG000|Overall Study|Adverse Event|1|||
23272242|NCT02682238|64742043|FG001|Overall Study|Adverse Event|0|||
23272243|NCT02682238|64742042|FG000|Overall Study|Non-compliance with Study Drug|1|||
23272244|NCT02682238|64742043|FG001|Overall Study|Non-compliance with Study Drug|0|||
23272245|NCT02682238|64742042|FG000|Overall Study|Non-compliance with Protocol|0|||
23272246|NCT02682238|64742043|FG001|Overall Study|Non-compliance with Protocol|2|||
23272247|NCT01496183|64742044|FG000|Overall Study|Physician Decision|3|||
23272248|NCT01496183|64742045|FG001|Overall Study|Physician Decision|1|||
23272249|NCT01496183|64742044|FG000|Overall Study|Withdrawal by Subject|0|||
23272250|NCT01496183|64742045|FG001|Overall Study|Withdrawal by Subject|1|||
23272251|NCT02937701|64742046|FG000|Day 1 to Week 22|Adverse Event|11|||
23272252|NCT02937701|64742047|FG001|Day 1 to Week 22|Adverse Event|14|||
23272253|NCT02937701|64742048|FG002|Day 1 to Week 22|Adverse Event|0|||
23272254|NCT02937701|64742049|FG003|Day 1 to Week 22|Adverse Event|0|||
23272255|NCT02937701|64742050|FG004|Day 1 to Week 22|Adverse Event|0|||
23272256|NCT02937701|64742046|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
23272257|NCT02937701|64742047|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
23272258|NCT02937701|64742048|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
23272259|NCT02937701|64742049|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
23272260|NCT02937701|64742050|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
23272261|NCT02937701|64742046|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
23272262|NCT02937701|64742047|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
23272263|NCT02937701|64742048|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
23272264|NCT02937701|64742049|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
23272265|NCT02937701|64742050|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
23272266|NCT02937701|64742046|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
23272267|NCT02937701|64742047|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
23272268|NCT02937701|64742048|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
23366999|NCT01716806|65089105|FG001|Overall Study|Patient withdrawal of consent|2|||
23367000|NCT01716806|65089106|FG002|Overall Study|Patient withdrawal of consent|4|||
23367001|NCT01716806|65089107|FG003|Overall Study|Patient withdrawal of consent|3|||
23367002|NCT01716806|65089108|FG004|Overall Study|Patient withdrawal of consent|2|||
23367003|NCT01716806|65089109|FG005|Overall Study|Patient withdrawal of consent|0|||
23272269|NCT02937701|64742049|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
23272270|NCT02937701|64742050|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
23272271|NCT02937701|64742046|FG000|Day 1 to Week 22|Death|1|||
23272272|NCT02937701|64742047|FG001|Day 1 to Week 22|Death|1|||
23272273|NCT02937701|64742048|FG002|Day 1 to Week 22|Death|0|||
23272274|NCT02937701|64742049|FG003|Day 1 to Week 22|Death|0|||
23272275|NCT02937701|64742050|FG004|Day 1 to Week 22|Death|0|||
23272276|NCT02937701|64742046|FG000|Day 1 to Week 22|Protocol Violation|1|||
23272277|NCT02937701|64742047|FG001|Day 1 to Week 22|Protocol Violation|1|||
23272278|NCT02937701|64742048|FG002|Day 1 to Week 22|Protocol Violation|0|||
23272279|NCT02937701|64742049|FG003|Day 1 to Week 22|Protocol Violation|0|||
23272280|NCT02937701|64742050|FG004|Day 1 to Week 22|Protocol Violation|0|||
23272281|NCT02937701|64742046|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
23272282|NCT02937701|64742047|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
23272283|NCT02937701|64742048|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
23272284|NCT02937701|64742049|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
23272285|NCT02937701|64742050|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
23272286|NCT02937701|64742046|FG000|Day 1 to Week 22|Physician Decision|2|||
23272287|NCT02937701|64742047|FG001|Day 1 to Week 22|Physician Decision|0|||
23272288|NCT02937701|64742048|FG002|Day 1 to Week 22|Physician Decision|0|||
23272289|NCT02937701|64742049|FG003|Day 1 to Week 22|Physician Decision|0|||
23272290|NCT02937701|64742050|FG004|Day 1 to Week 22|Physician Decision|0|||
23483561|NCT00366340|65513108|FG001|Infant Series|Adverse Event|2|||
23483562|NCT00366340|65513107|FG000|Infant Series|Lost to Follow-up|1|||
23483563|NCT00366340|65513108|FG001|Infant Series|Lost to Follow-up|1|||
23483564|NCT00366340|65513107|FG000|Infant Series|Failure to return|1|||
23483565|NCT00366340|65513108|FG001|Infant Series|Failure to return|0|||
23483566|NCT00366340|65513107|FG000|After the Infant Series|Parent/legal guardian request|1|||
23483567|NCT00366340|65513108|FG001|After the Infant Series|Parent/legal guardian request|1|||
23483568|NCT00366340|65513107|FG000|After the Infant Series|Failed to return|0|||
23272291|NCT02937701|64742046|FG000|Day 1 to Week 22|Other|1|||
23272292|NCT02937701|64742047|FG001|Day 1 to Week 22|Other|0|||
23272293|NCT02937701|64742048|FG002|Day 1 to Week 22|Other|0|||
23272294|NCT02937701|64742049|FG003|Day 1 to Week 22|Other|0|||
23272295|NCT02937701|64742050|FG004|Day 1 to Week 22|Other|0|||
23272296|NCT02937701|64742046|FG000|Week 22 to Week 50|Adverse Event|0|||
23272297|NCT02937701|64742047|FG001|Week 22 to Week 50|Adverse Event|0|||
23272298|NCT02937701|64742048|FG002|Week 22 to Week 50|Adverse Event|10|||
23272299|NCT02937701|64742049|FG003|Week 22 to Week 50|Adverse Event|3|||
23272300|NCT02937701|64742050|FG004|Week 22 to Week 50|Adverse Event|3|||
23272301|NCT02937701|64742046|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
23272302|NCT02937701|64742047|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
23272303|NCT02937701|64742048|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
23272304|NCT02937701|64742049|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
23272305|NCT02937701|64742050|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
23272306|NCT02937701|64742046|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
23272307|NCT02937701|64742047|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
23272308|NCT02937701|64742048|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
23272309|NCT02937701|64742049|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
23272310|NCT02937701|64742050|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
23272311|NCT02937701|64742046|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
23272312|NCT02937701|64742047|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
23272313|NCT02937701|64742048|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
23272314|NCT02937701|64742049|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
23272315|NCT02937701|64742050|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
23272316|NCT02937701|64742046|FG000|Week 22 to Week 50|Physician Decision|0|||
23272317|NCT02937701|64742047|FG001|Week 22 to Week 50|Physician Decision|0|||
23272318|NCT02937701|64742048|FG002|Week 22 to Week 50|Physician Decision|2|||
23272319|NCT02937701|64742049|FG003|Week 22 to Week 50|Physician Decision|0|||
23272320|NCT02937701|64742050|FG004|Week 22 to Week 50|Physician Decision|1|||
23272321|NCT02937701|64742046|FG000|Week 22 to Week 50|Other|0|||
23272322|NCT02937701|64742047|FG001|Week 22 to Week 50|Other|0|||
23272323|NCT02937701|64742048|FG002|Week 22 to Week 50|Other|0|||
23272324|NCT02937701|64742049|FG003|Week 22 to Week 50|Other|0|||
23272325|NCT02937701|64742050|FG004|Week 22 to Week 50|Other|1|||
23272326|NCT02770820|64742052|FG000|Overall Study|Death|1|||
23272327|NCT02770820|64742052|FG000|Overall Study|Physician Decision|2|||
23272328|NCT03725605|64742053|FG000|Overall Study|Unsuccessful TIL expansion|2|||
23272329|NCT01661686|64742054|FG000|Overall Study|Lost to Follow-up|2|||
23483569|NCT00366340|65513108|FG001|After the Infant Series|Failed to return|1|||
23483570|NCT00366340|65513107|FG000|After the Infant Series|Protocol Violation|2|||
23602065|NCT01766206|65933997|FG000|Overall Study|Withdrawal by Subject|22|||
23272330|NCT01661686|64742055|FG001|Overall Study|Lost to Follow-up|1|||
23272331|NCT01661686|64742054|FG000|Overall Study|did not receive allocated intervention|0|||
23272332|NCT01661686|64742055|FG001|Overall Study|did not receive allocated intervention|1|||
23272333|NCT01110005|64742056|FG000|Overall Study|ineligible|1|||
23272334|NCT01110005|64742057|FG001|Overall Study|ineligible|2|||
23272335|NCT01110005|64742056|FG000|Overall Study|missing consent|3|||
23272336|NCT01110005|64742057|FG001|Overall Study|missing consent|2|||
23272337|NCT01110005|64742056|FG000|Overall Study|Withdrawal by Subject|0|||
23272338|NCT01110005|64742057|FG001|Overall Study|Withdrawal by Subject|1|||
23272339|NCT02193178|64742058|FG000|Overall Study|Lost to Follow-up|1|||
23272340|NCT02193178|64742058|FG000|Overall Study|Dry eyes|1|||
23272341|NCT03025880|64742062|FG000|Overall Study|Adverse Event|1|||
23272342|NCT03025880|64742063|FG001|Overall Study|Adverse Event|0|||
23272343|NCT03025880|64742062|FG000|Overall Study|Death|1|||
23272344|NCT03025880|64742063|FG001|Overall Study|Death|1|||
23272345|NCT03025880|64742062|FG000|Overall Study|Withdrawal by Subject|0|||
23272346|NCT03025880|64742063|FG001|Overall Study|Withdrawal by Subject|1|||
23272347|NCT03025880|64742062|FG000|Overall Study|Physician Decision|0|||
23272348|NCT03025880|64742063|FG001|Overall Study|Physician Decision|1|||
23272349|NCT03025880|64742062|FG000|Overall Study|Progressive Disease|12|||
23272350|NCT03025880|64742063|FG001|Overall Study|Progressive Disease|19|||
23272351|NCT00386009|64742067|FG000|Overall Study|Adverse Event|0|||
23272352|NCT00386009|64742068|FG001|Overall Study|Adverse Event|2|||
23272353|NCT00386009|64742067|FG000|Overall Study|Death|1|||
23272354|NCT00386009|64742068|FG001|Overall Study|Death|0|||
23272355|NCT00386009|64742067|FG000|Overall Study|Entry Criteria Not Met|0|||
23272356|NCT00386009|64742068|FG001|Overall Study|Entry Criteria Not Met|2|||
23272357|NCT00386009|64742067|FG000|Overall Study|Lost to Follow-up|1|||
23272358|NCT00386009|64742068|FG001|Overall Study|Lost to Follow-up|1|||
23272359|NCT00386009|64742067|FG000|Overall Study|Protocol Violation|1|||
23272360|NCT00386009|64742068|FG001|Overall Study|Protocol Violation|0|||
23272361|NCT00386009|64742067|FG000|Overall Study|Sponsor Decision|1|||
23272362|NCT00386009|64742068|FG001|Overall Study|Sponsor Decision|1|||
23272363|NCT00386009|64742067|FG000|Overall Study|Withdrawal by Subject|5|||
23272364|NCT00386009|64742068|FG001|Overall Study|Withdrawal by Subject|4|||
23272365|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
23272366|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
23272367|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
23272368|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
23272369|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
23272370|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
23272371|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
23272372|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
23272373|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
23272374|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
23272375|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
23272376|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
23272377|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
23272378|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
23272379|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
23272380|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
23272381|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
23272382|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
23272383|NCT01667679|64742069|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
23272384|NCT01667679|64742070|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
23272385|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
23272386|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
23272387|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
23272388|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
23272389|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
23272390|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
23272391|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
23272392|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
23272393|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
23272394|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
23272395|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
23272396|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
23272397|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
23272398|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
23272399|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
23272400|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
23367004|NCT01716806|65089104|FG000|Overall Study|Lost to Follow-up|3|||
23272401|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
23272402|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
23272403|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
23272404|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
23272405|NCT01667679|64742069|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
23367005|NCT01716806|65089105|FG001|Overall Study|Lost to Follow-up|3|||
23367006|NCT01716806|65089106|FG002|Overall Study|Lost to Follow-up|0|||
23272406|NCT01667679|64742070|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
23272407|NCT00419770|64742071|FG000|Overall Study|Withdrawal by Subject|5|||
23272408|NCT00419770|64742072|FG001|Overall Study|Withdrawal by Subject|1|||
23272409|NCT01918397|64742074|FG000|Overall Study|Never started treatment|2|||
23272410|NCT01918397|64742075|FG001|Overall Study|Never started treatment|1|||
23272411|NCT01918397|64742076|FG002|Overall Study|Never started treatment|0|||
23272412|NCT01918397|64742077|FG003|Overall Study|Never started treatment|0|||
23272413|NCT01918397|64742074|FG000|Overall Study|Adverse Event|1|||
23272414|NCT01918397|64742075|FG001|Overall Study|Adverse Event|1|||
23272415|NCT01918397|64742076|FG002|Overall Study|Adverse Event|1|||
23272416|NCT01918397|64742077|FG003|Overall Study|Adverse Event|0|||
23272417|NCT01918397|64742074|FG000|Overall Study|Lack of compliance|2|||
23272418|NCT01918397|64742075|FG001|Overall Study|Lack of compliance|2|||
23272419|NCT01918397|64742076|FG002|Overall Study|Lack of compliance|3|||
23367007|NCT01716806|65089107|FG003|Overall Study|Lost to Follow-up|2|||
23367008|NCT01716806|65089108|FG004|Overall Study|Lost to Follow-up|1|||
23367009|NCT01716806|65089109|FG005|Overall Study|Lost to Follow-up|0|||
23367010|NCT01716806|65089104|FG000|Overall Study|Death|13|||
23367011|NCT01716806|65089105|FG001|Overall Study|Death|9|||
23367012|NCT01716806|65089106|FG002|Overall Study|Death|12|||
23367013|NCT01716806|65089107|FG003|Overall Study|Death|4|||
23367014|NCT01716806|65089108|FG004|Overall Study|Death|10|||
23367015|NCT01716806|65089109|FG005|Overall Study|Death|5|||
23367016|NCT01716806|65089104|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
23367017|NCT01716806|65089105|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
23367018|NCT01716806|65089106|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
23367019|NCT01716806|65089107|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
23272420|NCT01918397|64742077|FG003|Overall Study|Lack of compliance|0|||
23272421|NCT01918397|64742074|FG000|Overall Study|Pregnancy|0|||
23272422|NCT01918397|64742075|FG001|Overall Study|Pregnancy|1|||
23272423|NCT01918397|64742076|FG002|Overall Study|Pregnancy|0|||
23272424|NCT01918397|64742077|FG003|Overall Study|Pregnancy|0|||
23272425|NCT01918397|64742074|FG000|Overall Study|Rifampin susceptible|0|||
23272426|NCT01918397|64742075|FG001|Overall Study|Rifampin susceptible|0|||
23272427|NCT01918397|64742076|FG002|Overall Study|Rifampin susceptible|0|||
23272428|NCT01918397|64742077|FG003|Overall Study|Rifampin susceptible|2|||
23272429|NCT01918397|64742074|FG000|Overall Study|Treatment failure|0|||
23272430|NCT01918397|64742075|FG001|Overall Study|Treatment failure|0|||
23272431|NCT01918397|64742076|FG002|Overall Study|Treatment failure|0|||
23272432|NCT01918397|64742077|FG003|Overall Study|Treatment failure|1|||
23272433|NCT01918397|64742074|FG000|Overall Study|Withdrawal by Subject|3|||
23272434|NCT01918397|64742075|FG001|Overall Study|Withdrawal by Subject|2|||
23272435|NCT01918397|64742076|FG002|Overall Study|Withdrawal by Subject|1|||
23272436|NCT01918397|64742077|FG003|Overall Study|Withdrawal by Subject|1|||
23272437|NCT01918397|64742074|FG000|Overall Study|XDR at baseline|0|||
23272438|NCT01918397|64742075|FG001|Overall Study|XDR at baseline|0|||
23272439|NCT01918397|64742076|FG002|Overall Study|XDR at baseline|1|||
23272440|NCT01918397|64742077|FG003|Overall Study|XDR at baseline|0|||
23272441|NCT01918397|64742074|FG000|Overall Study|Lost to Follow-up|2|||
23272442|NCT01918397|64742075|FG001|Overall Study|Lost to Follow-up|1|||
23272443|NCT01918397|64742076|FG002|Overall Study|Lost to Follow-up|1|||
23272444|NCT01918397|64742077|FG003|Overall Study|Lost to Follow-up|1|||
23272445|NCT01918397|64742074|FG000|Overall Study|Increased QTc|1|||
23272446|NCT01918397|64742075|FG001|Overall Study|Increased QTc|0|||
23272447|NCT01918397|64742076|FG002|Overall Study|Increased QTc|0|||
23272448|NCT01918397|64742077|FG003|Overall Study|Increased QTc|1|||
23272449|NCT01918397|64742074|FG000|Overall Study|Death|0|||
23272450|NCT01918397|64742075|FG001|Overall Study|Death|0|||
23272451|NCT01918397|64742076|FG002|Overall Study|Death|1|||
23272452|NCT01918397|64742077|FG003|Overall Study|Death|0|||
23272453|NCT01918397|64742074|FG000|Overall Study|Involved in another investigative trial|0|||
23272454|NCT01918397|64742075|FG001|Overall Study|Involved in another investigative trial|0|||
23272455|NCT01918397|64742076|FG002|Overall Study|Involved in another investigative trial|0|||
23272456|NCT01918397|64742077|FG003|Overall Study|Involved in another investigative trial|1|||
23272457|NCT00485472|64742078|FG000|Overall Study|Adverse Event|8|||
23272458|NCT00485472|64742079|FG001|Overall Study|Adverse Event|5|||
23272459|NCT00485472|64742078|FG000|Overall Study|Lack of Efficacy|5|||
23272460|NCT00485472|64742079|FG001|Overall Study|Lack of Efficacy|4|||
23272461|NCT00485472|64742078|FG000|Overall Study|Withdrawal by Subject|1|||
23272462|NCT00485472|64742079|FG001|Overall Study|Withdrawal by Subject|0|||
23272463|NCT00485472|64742078|FG000|Overall Study|Protocol Violation|0|||
23272464|NCT00485472|64742079|FG001|Overall Study|Protocol Violation|1|||
23272465|NCT00485472|64742078|FG000|Overall Study|Other|2|||
23272466|NCT00485472|64742079|FG001|Overall Study|Other|1|||
23367020|NCT01716806|65089108|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
23272467|NCT00485472|64742078|FG000|Overall Study|Lost to Follow-up|0|||
23272468|NCT00485472|64742079|FG001|Overall Study|Lost to Follow-up|1|||
23272469|NCT03595657|64742080|FG000|Overall Study|Adverse Event|14|||
23272470|NCT03595657|64742080|FG000|Overall Study|Death|1|||
23272471|NCT03595657|64742080|FG000|Overall Study|Lack of Efficacy|40|||
23367021|NCT01716806|65089109|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
23367022|NCT01716806|65089104|FG000|Overall Study|PI decision|0|||
23367023|NCT01716806|65089105|FG001|Overall Study|PI decision|0|||
23367024|NCT01716806|65089106|FG002|Overall Study|PI decision|0|||
23367025|NCT01716806|65089107|FG003|Overall Study|PI decision|0|||
23367026|NCT01716806|65089108|FG004|Overall Study|PI decision|1|||
23367027|NCT01716806|65089109|FG005|Overall Study|PI decision|0|||
23367028|NCT01716806|65089104|FG000|Overall Study|Change in performance status|1|||
23367029|NCT01716806|65089105|FG001|Overall Study|Change in performance status|0|||
23367030|NCT01716806|65089106|FG002|Overall Study|Change in performance status|0|||
23367031|NCT01716806|65089107|FG003|Overall Study|Change in performance status|0|||
23367032|NCT01716806|65089108|FG004|Overall Study|Change in performance status|0|||
23367033|NCT01716806|65089109|FG005|Overall Study|Change in performance status|0|||
23367034|NCT01716806|65089104|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367035|NCT01716806|65089105|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367036|NCT01716806|65089106|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
23367037|NCT01716806|65089107|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367038|NCT01716806|65089108|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367039|NCT01716806|65089109|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
23367040|NCT01716806|65089104|FG000|Overall Study|Sponsor direction|7|||
23367041|NCT01716806|65089105|FG001|Overall Study|Sponsor direction|8|||
23367042|NCT01716806|65089106|FG002|Overall Study|Sponsor direction|5|||
23367043|NCT01716806|65089107|FG003|Overall Study|Sponsor direction|12|||
23367044|NCT01716806|65089108|FG004|Overall Study|Sponsor direction|16|||
23367045|NCT01716806|65089109|FG005|Overall Study|Sponsor direction|1|||
23367046|NCT03797898|65089111|FG000|Overall Study|Lost to Follow-up|60|||
23367047|NCT03797898|65089112|FG001|Overall Study|Lost to Follow-up|69|||
23367048|NCT03797898|65089111|FG000|Overall Study|Withdrawal by Subject|9|||
23367049|NCT03797898|65089112|FG001|Overall Study|Withdrawal by Subject|7|||
23367050|NCT03797898|65089111|FG000|Overall Study|Became ineligible|5|||
23367051|NCT03797898|65089112|FG001|Overall Study|Became ineligible|2|||
23367052|NCT00887484|65089113|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
23367053|NCT00887484|65089113|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
23367054|NCT00887484|65089113|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
23367055|NCT01676701|65089114|FG000|Overall Study|Protocol Violation|1|||
23367056|NCT01676701|65089115|FG001|Overall Study|Protocol Violation|0|||
23367057|NCT01676701|65089114|FG000|Overall Study|Sponsor Decision|3|||
23367058|NCT01676701|65089115|FG001|Overall Study|Sponsor Decision|4|||
23367059|NCT01783743|65089116|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
23367060|NCT01783743|65089117|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
23367061|NCT01783743|65089116|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
23272472|NCT03595657|64742080|FG000|Overall Study|Withdrawal by Subject|10|||
23272473|NCT03595657|64742080|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
23272474|NCT03595657|64742080|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
23272475|NCT03351335|64742081|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
23272476|NCT03351335|64742082|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
23272477|NCT03351335|64742083|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
23272478|NCT00863746|64742089|FG000|Treatment|Not treated|4|||
23272479|NCT00863746|64742090|FG001|Treatment|Not treated|2|||
23272480|NCT00863746|64742089|FG000|Treatment|Adverse Event|41|||
23272481|NCT00863746|64742090|FG001|Treatment|Adverse Event|16|||
23272482|NCT00863746|64742089|FG000|Treatment|non-compliant with study medication|4|||
23272483|NCT00863746|64742090|FG001|Treatment|non-compliant with study medication|0|||
23272484|NCT00863746|64742089|FG000|Treatment|Consent withdrawn|15|||
23272485|NCT00863746|64742090|FG001|Treatment|Consent withdrawn|14|||
23272486|NCT00863746|64742089|FG000|Treatment|Lost to Follow-up|1|||
23272487|NCT00863746|64742090|FG001|Treatment|Lost to Follow-up|0|||
23272488|NCT00863746|64742089|FG000|Treatment|Protocol Violation|5|||
23272489|NCT00863746|64742090|FG001|Treatment|Protocol Violation|3|||
23272490|NCT00863746|64742089|FG000|Treatment|Other|1|||
23272491|NCT00863746|64742090|FG001|Treatment|Other|0|||
23272492|NCT00863746|64742089|FG000|Survival Follow up|Death|244|||
23272493|NCT00863746|64742090|FG001|Survival Follow up|Death|271|||
23272494|NCT00863746|64742089|FG000|Survival Follow up|Lost to Follow-up|2|||
23272495|NCT00863746|64742090|FG001|Survival Follow up|Lost to Follow-up|1|||
23272496|NCT00863746|64742089|FG000|Survival Follow up|Consent Withdrawn|7|||
23272497|NCT00863746|64742090|FG001|Survival Follow up|Consent Withdrawn|8|||
23272498|NCT05341622|64742091|FG000|Overall Study|Death|0|||
23367062|NCT01783743|65089117|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
23367063|NCT01783743|65089116|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
23367064|NCT01783743|65089117|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
23272499|NCT05341622|64742092|FG001|Overall Study|Death|0|||
23367065|NCT02100124|65089118|FG000|Overall Study|Lost to Follow-up|5|||
23367066|NCT02100124|65089119|FG001|Overall Study|Lost to Follow-up|11|||
23367067|NCT02100124|65089120|FG002|Overall Study|Lost to Follow-up|3|||
23367068|NCT02100124|65089118|FG000|Overall Study|Withdrawal by Subject|1|||
23367069|NCT02100124|65089119|FG001|Overall Study|Withdrawal by Subject|0|||
23367070|NCT02100124|65089120|FG002|Overall Study|Withdrawal by Subject|0|||
23367071|NCT02532374|65089121|FG000|Overall Study|Withdrawal by Subject|1|||
23272500|NCT05341622|64742093|FG002|Overall Study|Death|0|||
23272501|NCT05341622|64742094|FG003|Overall Study|Death|0|||
23272502|NCT05341622|64742095|FG004|Overall Study|Death|1|||
23272503|NCT05341622|64742096|FG005|Overall Study|Death|0|||
23272504|NCT05341622|64742097|FG006|Overall Study|Death|0|||
23272505|NCT05341622|64742098|FG007|Overall Study|Death|1|||
23272506|NCT05341622|64742091|FG000|Overall Study|Invalid Address|0|||
23272507|NCT05341622|64742092|FG001|Overall Study|Invalid Address|1|||
23272508|NCT05341622|64742093|FG002|Overall Study|Invalid Address|0|||
23272509|NCT05341622|64742094|FG003|Overall Study|Invalid Address|0|||
23367072|NCT02532374|65089121|FG000|Overall Study|Physician Decision|1|||
23367073|NCT03704064|65089122|FG000|Overall Study|Lost to Follow-up|8|||
23367074|NCT03704064|65089123|FG001|Overall Study|Lost to Follow-up|4|||
23367075|NCT03704064|65089122|FG000|Overall Study|Withdrawal by Subject|1|||
23367076|NCT03704064|65089123|FG001|Overall Study|Withdrawal by Subject|1|||
23367077|NCT03704064|65089122|FG000|Overall Study|No longer available for study visits|0|||
23367078|NCT03704064|65089123|FG001|Overall Study|No longer available for study visits|1|||
23367079|NCT03704064|65089122|FG000|Overall Study|Censoring event|1|||
23367080|NCT03704064|65089123|FG001|Overall Study|Censoring event|0|||
23367081|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
23367082|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
23367083|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
23367084|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
23367085|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
23367086|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
23367087|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
23367088|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
23367089|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
23367090|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
23367091|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
23367092|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
23367093|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
23367094|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
23367095|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
23367096|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
23367097|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
23367098|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
23367099|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
23367100|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
23367101|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
23367102|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
23367103|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
23367104|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
23367105|NCT01198002|65089128|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
23367106|NCT01198002|65089129|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
23367107|NCT01198002|65089130|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
23367108|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
23367109|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
23367110|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
23367111|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
23367112|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
23367113|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
23602066|NCT01766206|65933997|FG000|Overall Study|Lost to Follow-up|10|||
23272510|NCT05341622|64742095|FG004|Overall Study|Invalid Address|0|||
23272511|NCT05341622|64742096|FG005|Overall Study|Invalid Address|0|||
23272512|NCT05341622|64742097|FG006|Overall Study|Invalid Address|0|||
23272513|NCT05341622|64742098|FG007|Overall Study|Invalid Address|0|||
23272514|NCT05341622|64742091|FG000|Overall Study|Ineligible|26|||
23272515|NCT05341622|64742092|FG001|Overall Study|Ineligible|21|||
23272516|NCT05341622|64742093|FG002|Overall Study|Ineligible|28|||
23272517|NCT05341622|64742094|FG003|Overall Study|Ineligible|24|||
23272518|NCT05341622|64742095|FG004|Overall Study|Ineligible|29|||
23272519|NCT05341622|64742096|FG005|Overall Study|Ineligible|31|||
23272520|NCT05341622|64742097|FG006|Overall Study|Ineligible|28|||
23272521|NCT05341622|64742098|FG007|Overall Study|Ineligible|26|||
23272522|NCT03136380|64742105|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23272523|NCT03136380|64742106|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
23272524|NCT03136380|64742107|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23272525|NCT03136380|64742108|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23272526|NCT03136380|64742109|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
23272527|NCT02438722|64742112|FG000|Overall Study|Adverse Event|12|||
23272528|NCT02438722|64742113|FG001|Overall Study|Adverse Event|9|||
23272529|NCT02438722|64742112|FG000|Overall Study|Refusal unrelated to AE|2|||
23272530|NCT02438722|64742113|FG001|Overall Study|Refusal unrelated to AE|5|||
23367114|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
23367115|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
23367116|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
23367117|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
23367118|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
23367119|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
23367120|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
23367121|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
23367122|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
23367123|NCT01198002|65089128|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
23367124|NCT01198002|65089129|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
23367125|NCT01198002|65089130|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
23367126|NCT01159574|65089135|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
23367127|NCT01159574|65089135|FG000|Treatment Phase|Adverse Event|3|||
23367128|NCT01159574|65089135|FG000|Treatment Phase|Death|6|||
23367129|NCT01159574|65089135|FG000|Treatment Phase|Physician Decision|2|||
23367130|NCT01159574|65089135|FG000|Treatment Phase|Withdrawal by Subject|7|||
23367131|NCT01159574|65089135|FG000|Treatment Phase|still on treatment|2|||
23367132|NCT01159574|65089135|FG000|Follow Up Phase|Lost to Follow-up|2|||
23367133|NCT01159574|65089135|FG000|Follow Up Phase|still being followed for overall surviva|18|||
23367134|NCT00964028|65089136|FG000|Overall Study|Withdrawal by Subject|0|||
23367135|NCT00964028|65089137|FG001|Overall Study|Withdrawal by Subject|1|||
23367136|NCT04210986|65092332|FG000|Overall Study|Lost to Follow-up|5|||
23367137|NCT04210986|65092333|FG001|Overall Study|Lost to Follow-up|2|||
23367138|NCT04210986|65092332|FG000|Overall Study|Withdrawal by Subject|3|||
23367139|NCT04210986|65092333|FG001|Overall Study|Withdrawal by Subject|1|||
23272531|NCT02438722|64742112|FG000|Overall Study|Disease progression/relapse|46|||
23272532|NCT02438722|64742113|FG001|Overall Study|Disease progression/relapse|51|||
23367140|NCT04210986|65092332|FG000|Overall Study|Protocol Violation|1|||
23367141|NCT04210986|65092333|FG001|Overall Study|Protocol Violation|1|||
23367142|NCT04210986|65092332|FG000|Overall Study|Physician Decision|0|||
23367143|NCT04210986|65092333|FG001|Overall Study|Physician Decision|1|||
23367144|NCT01255904|65092334|FG000|Overall Study|Physician Decision|1|||
23367145|NCT01255904|65092335|FG001|Overall Study|Physician Decision|4|||
23367146|NCT02899065|65092338|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
23367147|NCT02899065|65092339|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
23367148|NCT02899065|65092338|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
23367149|NCT02899065|65092339|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
23367150|NCT02899065|65092338|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
23367151|NCT02899065|65092339|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
23367152|NCT01774591|65092340|FG000|Overall Study|Physician Decision|1|||
23367153|NCT01774591|65092341|FG001|Overall Study|Physician Decision|1|||
23367154|NCT01774591|65092340|FG000|Overall Study|Withdrawal by Subject|0|||
23367155|NCT01774591|65092341|FG001|Overall Study|Withdrawal by Subject|1|||
23367156|NCT01774591|65092340|FG000|Overall Study|Adverse Event|0|||
23367157|NCT01774591|65092341|FG001|Overall Study|Adverse Event|2|||
23367158|NCT02063672|65092342|FG000|Overall Study|Ongoing Follow-up|27|||
23367159|NCT02063672|65092343|FG001|Overall Study|Ongoing Follow-up|14|||
23367160|NCT02063672|65092342|FG000|Overall Study|Death|5|||
23367161|NCT02063672|65092343|FG001|Overall Study|Death|3|||
23272533|NCT02438722|64742112|FG000|Overall Study|Death|0|||
23272534|NCT02438722|64742113|FG001|Overall Study|Death|3|||
23272535|NCT02438722|64742112|FG000|Overall Study|Physician Decision|2|||
23272536|NCT02438722|64742113|FG001|Overall Study|Physician Decision|2|||
23272537|NCT02438722|64742112|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
23272538|NCT02438722|64742113|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
23272539|NCT02438722|64742112|FG000|Overall Study|Withdrawal by Subject|0|||
23272540|NCT02438722|64742113|FG001|Overall Study|Withdrawal by Subject|1|||
23272541|NCT02438722|64742112|FG000|Overall Study|On protocol treatment|15|||
23272542|NCT02438722|64742113|FG001|Overall Study|On protocol treatment|14|||
23272543|NCT02438722|64742112|FG000|Overall Study|Did not receive protocol treatment|5|||
23272544|NCT02438722|64742113|FG001|Overall Study|Did not receive protocol treatment|0|||
23272545|NCT02189941|64742119|FG000|Overall Study|Non-compliance|0|||
23272546|NCT02189941|64742120|FG001|Overall Study|Non-compliance|0|||
23272547|NCT02189941|64742121|FG002|Overall Study|Non-compliance|1|||
23272548|NCT02421952|64742124|FG000|Overall Study|Diary Not Returned|93|||
23272549|NCT02421952|64742124|FG000|Overall Study|Failed seriation task|13|||
23272550|NCT02421952|64742124|FG000|Overall Study|Subject uncooperative for baseline test|2|||
23272551|NCT02421952|64742124|FG000|Overall Study|Surgery cancelled|1|||
23272552|NCT02458469|64742127|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23272553|NCT02458469|64742128|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23367162|NCT02063672|65092342|FG000|Overall Study|Lost to Follow-up|1|||
23367163|NCT02063672|65092343|FG001|Overall Study|Lost to Follow-up|3|||
23367164|NCT02063672|65092342|FG000|Overall Study|Withdrawal by Subject|2|||
23367165|NCT02063672|65092343|FG001|Overall Study|Withdrawal by Subject|2|||
23367166|NCT01566604|65092344|FG000|Overall Study|Patient's inability to use the device|1|||
23272554|NCT02458469|64742129|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
23272555|NCT02458469|64742130|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23272556|NCT02458469|64742131|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23272557|NCT02458469|64742132|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
23272558|NCT02458469|64742127|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
23367167|NCT01566604|65092345|FG001|Overall Study|Patient's inability to use the device|0|||
23272559|NCT02458469|64742128|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
23272560|NCT02458469|64742129|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
23272561|NCT02458469|64742130|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
23272562|NCT02458469|64742131|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
23272563|NCT02458469|64742132|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
23272564|NCT02458469|64742127|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23272565|NCT02458469|64742128|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23272566|NCT02458469|64742129|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23272567|NCT02458469|64742130|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23272568|NCT02458469|64742131|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
23272569|NCT02458469|64742132|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
23272570|NCT02883452|64742133|FG000|Overall Study|Withdrawal by Subject|1|||
23272571|NCT02883452|64742134|FG001|Overall Study|Withdrawal by Subject|1|||
23272572|NCT02883452|64742135|FG002|Overall Study|Withdrawal by Subject|3|||
23272573|NCT02883452|64742136|FG003|Overall Study|Withdrawal by Subject|0|||
23272574|NCT02883452|64742137|FG004|Overall Study|Withdrawal by Subject|2|||
23272575|NCT02883452|64742138|FG005|Overall Study|Withdrawal by Subject|5|||
23272576|NCT02883452|64742133|FG000|Overall Study|Disease progression|1|||
23272577|NCT02883452|64742134|FG001|Overall Study|Disease progression|0|||
23272578|NCT02883452|64742135|FG002|Overall Study|Disease progression|0|||
23367168|NCT01566604|65092344|FG000|Overall Study|Administrative problems|1|||
23272579|NCT02883452|64742136|FG003|Overall Study|Disease progression|1|||
23272580|NCT02883452|64742137|FG004|Overall Study|Disease progression|4|||
23272581|NCT02883452|64742138|FG005|Overall Study|Disease progression|5|||
23272582|NCT02883452|64742133|FG000|Overall Study|Adverse Event|2|||
23272583|NCT02883452|64742134|FG001|Overall Study|Adverse Event|1|||
23272584|NCT02883452|64742135|FG002|Overall Study|Adverse Event|1|||
23272585|NCT02883452|64742136|FG003|Overall Study|Adverse Event|1|||
23272586|NCT02883452|64742137|FG004|Overall Study|Adverse Event|1|||
23272587|NCT02883452|64742138|FG005|Overall Study|Adverse Event|3|||
23272588|NCT02883452|64742133|FG000|Overall Study|Physician Decision|0|||
23272589|NCT02883452|64742134|FG001|Overall Study|Physician Decision|0|||
23272590|NCT02883452|64742135|FG002|Overall Study|Physician Decision|0|||
23272591|NCT02883452|64742136|FG003|Overall Study|Physician Decision|0|||
23272592|NCT02883452|64742137|FG004|Overall Study|Physician Decision|4|||
23272593|NCT02883452|64742138|FG005|Overall Study|Physician Decision|1|||
23272594|NCT02883452|64742133|FG000|Overall Study|Death|1|||
23272595|NCT02883452|64742134|FG001|Overall Study|Death|0|||
23272596|NCT02883452|64742135|FG002|Overall Study|Death|1|||
23272597|NCT02883452|64742136|FG003|Overall Study|Death|0|||
23272598|NCT02883452|64742137|FG004|Overall Study|Death|0|||
23272599|NCT02883452|64742138|FG005|Overall Study|Death|0|||
23272600|NCT02883452|64742133|FG000|Overall Study|Other|0|||
23272601|NCT02883452|64742134|FG001|Overall Study|Other|0|||
23272602|NCT02883452|64742135|FG002|Overall Study|Other|0|||
23272603|NCT02883452|64742136|FG003|Overall Study|Other|0|||
23272604|NCT02883452|64742137|FG004|Overall Study|Other|0|||
23272605|NCT02883452|64742138|FG005|Overall Study|Other|1|||
23272606|NCT00617305|64742139|FG000|Overall Study|Adverse Event|4|||
23272607|NCT00617305|64742140|FG001|Overall Study|Adverse Event|0|||
23272608|NCT00617305|64742141|FG002|Overall Study|Adverse Event|0|||
23272609|NCT00617305|64742139|FG000|Overall Study|Death|1|||
23272610|NCT00617305|64742140|FG001|Overall Study|Death|0|||
23272611|NCT00617305|64742141|FG002|Overall Study|Death|0|||
23272612|NCT00617305|64742139|FG000|Overall Study|Physician Decision|1|||
23272613|NCT00617305|64742140|FG001|Overall Study|Physician Decision|0|||
23272614|NCT00617305|64742141|FG002|Overall Study|Physician Decision|0|||
23272615|NCT00617305|64742139|FG000|Overall Study|Protocol Violation|1|||
23272616|NCT00617305|64742140|FG001|Overall Study|Protocol Violation|0|||
23272617|NCT00617305|64742141|FG002|Overall Study|Protocol Violation|1|||
23272618|NCT00617305|64742139|FG000|Overall Study|Withdrawal by Subject|1|||
23272619|NCT00617305|64742140|FG001|Overall Study|Withdrawal by Subject|0|||
23272620|NCT00617305|64742141|FG002|Overall Study|Withdrawal by Subject|0|||
23272621|NCT01199861|64742142|FG000|Overall Study|Administrative problems|1|||
23272622|NCT01199861|64742143|FG001|Overall Study|Administrative problems|0|||
23272623|NCT01199861|64742142|FG000|Overall Study|Adverse Event|1|||
23272624|NCT01199861|64742143|FG001|Overall Study|Adverse Event|0|||
23367169|NCT01566604|65092345|FG001|Overall Study|Administrative problems|0|||
23367170|NCT01566604|65092344|FG000|Overall Study|Lack of Efficacy|1|||
23367171|NCT01566604|65092345|FG001|Overall Study|Lack of Efficacy|2|||
23367172|NCT01566604|65092344|FG000|Overall Study|Protocol deviation|2|||
23367173|NCT01566604|65092345|FG001|Overall Study|Protocol deviation|0|||
23367174|NCT01566604|65092344|FG000|Overall Study|Abnormal laboratory value|2|||
23367175|NCT01566604|65092345|FG001|Overall Study|Abnormal laboratory value|0|||
23367176|NCT01566604|65092344|FG000|Overall Study|Death|4|||
23367177|NCT01566604|65092345|FG001|Overall Study|Death|1|||
23367178|NCT01566604|65092344|FG000|Overall Study|Adverse Event|4|||
23367179|NCT01566604|65092345|FG001|Overall Study|Adverse Event|2|||
23367180|NCT01566604|65092344|FG000|Overall Study|Withdrawal by Subject|9|||
23367181|NCT01566604|65092345|FG001|Overall Study|Withdrawal by Subject|6|||
23367182|NCT00249834|65092350|FG000|Overall Study|Ovarian stimulation failed|1|||
23367183|NCT00249834|65092351|FG001|Overall Study|Ovarian stimulation failed|0|||
23367184|NCT00249834|65092352|FG002|Overall Study|Ovarian stimulation failed|0|||
23367185|NCT00249834|65092353|FG003|Overall Study|Ovarian stimulation failed|0|||
23367186|NCT00249834|65092354|FG004|Overall Study|Ovarian stimulation failed|0|||
23367187|NCT00249834|65092355|FG005|Overall Study|Ovarian stimulation failed|0|||
23367188|NCT00249834|65092356|FG006|Overall Study|Ovarian stimulation failed|0|||
23367189|NCT00249834|65092357|FG007|Overall Study|Ovarian stimulation failed|0|||
23367190|NCT00249834|65092350|FG000|Overall Study|Failure of down-regulation|0|||
23367191|NCT00249834|65092351|FG001|Overall Study|Failure of down-regulation|0|||
23367192|NCT00249834|65092352|FG002|Overall Study|Failure of down-regulation|0|||
23367193|NCT00249834|65092353|FG003|Overall Study|Failure of down-regulation|0|||
23367194|NCT00249834|65092354|FG004|Overall Study|Failure of down-regulation|0|||
23367195|NCT00249834|65092355|FG005|Overall Study|Failure of down-regulation|0|||
23367196|NCT00249834|65092356|FG006|Overall Study|Failure of down-regulation|1|||
23367197|NCT00249834|65092357|FG007|Overall Study|Failure of down-regulation|0|||
23367198|NCT00249834|65092350|FG000|Overall Study|Protocol Violation|0|||
23367199|NCT00249834|65092351|FG001|Overall Study|Protocol Violation|19|||
23367200|NCT00249834|65092352|FG002|Overall Study|Protocol Violation|14|||
23367201|NCT00249834|65092353|FG003|Overall Study|Protocol Violation|8|||
23367202|NCT00249834|65092354|FG004|Overall Study|Protocol Violation|5|||
23367203|NCT00249834|65092355|FG005|Overall Study|Protocol Violation|2|||
23367204|NCT00249834|65092356|FG006|Overall Study|Protocol Violation|0|||
23367205|NCT00249834|65092357|FG007|Overall Study|Protocol Violation|0|||
23367206|NCT02121210|65092358|FG000|Overall Study|Adverse Event|5|||
23367207|NCT02121210|65092359|FG001|Overall Study|Adverse Event|7|||
23367208|NCT02121210|65092358|FG000|Overall Study|Lack of Efficacy|2|||
23367209|NCT02121210|65092359|FG001|Overall Study|Lack of Efficacy|0|||
23367210|NCT02121210|65092358|FG000|Overall Study|Other than specified above|0|||
23367211|NCT02121210|65092359|FG001|Overall Study|Other than specified above|2|||
23367212|NCT00875563|65092360|FG000|Overall Study|Death|4|||
23367213|NCT00875563|65092360|FG000|Overall Study|Withdrawal by Subject|7|||
23367214|NCT00875563|65092360|FG000|Overall Study|No long-term (3-5 year) consent|6|||
23367215|NCT00875563|65092360|FG000|Overall Study|Still be eligible for follow-up|7|||
23367216|NCT00577772|65092361|FG000|Overall Study|Lost to Follow-up|0|||
23272625|NCT05275205|64742144|FG000|Overall Study|Adverse Event|1|||
23272626|NCT05275205|64742145|FG001|Overall Study|Adverse Event|2|||
23272627|NCT05275205|64742144|FG000|Overall Study|Physician Decision|1|||
23272628|NCT05275205|64742145|FG001|Overall Study|Physician Decision|1|||
23272629|NCT05275205|64742144|FG000|Overall Study|Withdrawal by Subject|2|||
23272630|NCT05275205|64742145|FG001|Overall Study|Withdrawal by Subject|3|||
23272631|NCT05275205|64742144|FG000|Overall Study|Death|1|||
23367217|NCT00577772|65092362|FG001|Overall Study|Lost to Follow-up|1|||
23367218|NCT01239797|65092365|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
23367219|NCT01239797|65092366|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
23367220|NCT01239797|65092365|FG000|Randomized Participants|Participant withdrew consent|1|||
23367221|NCT01239797|65092366|FG001|Randomized Participants|Participant withdrew consent|7|||
23367222|NCT01239797|65092365|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
23367223|NCT01239797|65092366|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
23602067|NCT01766206|65933997|FG000|Overall Study|Inappropriate enrollment|18|||
23602068|NCT01766206|65933997|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
23602069|NCT00452452|65934005|FG000|Overall Study|Protocol Violation|0|||
23602070|NCT00452452|65934006|FG001|Overall Study|Protocol Violation|0|||
23602071|NCT00452452|65934007|FG002|Overall Study|Protocol Violation|1|||
23602072|NCT00452452|65934005|FG000|Overall Study|Withdrawal by Subject|1|||
23602073|NCT00452452|65934006|FG001|Overall Study|Withdrawal by Subject|0|||
23602074|NCT00452452|65934007|FG002|Overall Study|Withdrawal by Subject|0|||
23602075|NCT00452452|65934005|FG000|Overall Study|Lost to Follow-up|1|||
23602076|NCT00452452|65934006|FG001|Overall Study|Lost to Follow-up|0|||
23602077|NCT00452452|65934007|FG002|Overall Study|Lost to Follow-up|0|||
23602078|NCT01972776|65934008|FG000|Part 1|Withdrawal by Subject|0|||
23602079|NCT01972776|65934009|FG001|Part 1|Withdrawal by Subject|0|||
23483571|NCT00366340|65513108|FG001|After the Infant Series|Protocol Violation|2|||
23483572|NCT00366340|65513107|FG000|After the Infant Series|Adverse Event|0|||
23483573|NCT00366340|65513108|FG001|After the Infant Series|Adverse Event|1|||
23483574|NCT00366340|65513107|FG000|After the Infant Series|Lost to Follow-up|0|||
23483575|NCT00366340|65513108|FG001|After the Infant Series|Lost to Follow-up|1|||
23272632|NCT05275205|64742145|FG001|Overall Study|Death|0|||
23272633|NCT05275205|64742144|FG000|Overall Study|Patient unable to attend visits|1|||
23272634|NCT05275205|64742145|FG001|Overall Study|Patient unable to attend visits|0|||
23272635|NCT04320849|64742172|FG000|Overall Study|Withdrawal by Subject|4|||
23272636|NCT04320849|64742172|FG000|Overall Study|Imaging data unavailable|2|||
23272637|NCT04320849|64742172|FG000|Overall Study|Incomplete imaging|2|||
23272638|NCT04753437|64742173|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
23272639|NCT04753437|64742174|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
23272640|NCT04753437|64742173|FG000|Overall Study|Liver Function Test Abnormalities|2|||
23272641|NCT04753437|64742174|FG001|Overall Study|Liver Function Test Abnormalities|4|||
23272642|NCT00119015|64742175|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
23272643|NCT00119015|64742176|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
23272644|NCT00119015|64742177|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
23272645|NCT00705536|64742178|FG000|Start Period 1|Withdrawal by Subject|0|||
23483576|NCT00366340|65513107|FG000|Toddler Dose|Failed to return|1|||
23483577|NCT00366340|65513108|FG001|Toddler Dose|Failed to return|0|||
23272646|NCT00705536|64742179|FG001|Start Period 1|Withdrawal by Subject|0|||
23483578|NCT00366340|65513107|FG000|Toddler Dose|Parent/legal guardian request|0|||
23483579|NCT00366340|65513108|FG001|Toddler Dose|Parent/legal guardian request|1|||
23483580|NCT00367770|65513109|FG000|Overall Study|Adverse Event|1|||
23483581|NCT00367770|65513109|FG000|Overall Study|Withdrawal by Subject|1|||
23483582|NCT03533686|65513110|FG000|Overall Study|Withdrawal by Subject|1|||
23483583|NCT03533686|65513111|FG001|Overall Study|Withdrawal by Subject|0|||
23483584|NCT03533686|65513112|FG002|Overall Study|Withdrawal by Subject|0|||
23483585|NCT03533686|65513113|FG003|Overall Study|Withdrawal by Subject|3|||
23483586|NCT03533686|65513114|FG004|Overall Study|Withdrawal by Subject|5|||
23483587|NCT03533686|65513115|FG005|Overall Study|Withdrawal by Subject|1|||
23483588|NCT03533686|65513110|FG000|Overall Study|Lost to Follow-up|0|||
23483589|NCT03533686|65513111|FG001|Overall Study|Lost to Follow-up|1|||
23483590|NCT03533686|65513112|FG002|Overall Study|Lost to Follow-up|0|||
23483591|NCT03533686|65513113|FG003|Overall Study|Lost to Follow-up|0|||
23483592|NCT03533686|65513114|FG004|Overall Study|Lost to Follow-up|2|||
23483593|NCT03533686|65513115|FG005|Overall Study|Lost to Follow-up|0|||
23483594|NCT03533686|65513110|FG000|Overall Study|Screen Failure|0|||
23483595|NCT03533686|65513111|FG001|Overall Study|Screen Failure|0|||
23483596|NCT03533686|65513112|FG002|Overall Study|Screen Failure|0|||
23483597|NCT03533686|65513113|FG003|Overall Study|Screen Failure|2|||
23483598|NCT03533686|65513114|FG004|Overall Study|Screen Failure|0|||
23483599|NCT03533686|65513115|FG005|Overall Study|Screen Failure|0|||
23602080|NCT01972776|65934010|FG002|Part 1|Withdrawal by Subject|1|||
23602081|NCT01972776|65934011|FG003|Part 1|Withdrawal by Subject|0|||
23602082|NCT01972776|65934012|FG004|Part 1|Withdrawal by Subject|0|||
23602083|NCT01972776|65934013|FG005|Part 1|Withdrawal by Subject|0|||
23602084|NCT01972776|65934008|FG000|Part 1|Adverse Event|0|||
23602085|NCT01972776|65934009|FG001|Part 1|Adverse Event|0|||
23602086|NCT01972776|65934010|FG002|Part 1|Adverse Event|1|||
23602087|NCT01972776|65934011|FG003|Part 1|Adverse Event|1|||
23272647|NCT00705536|64742180|FG002|Start Period 1|Withdrawal by Subject|0|||
23272648|NCT00705536|64742181|FG003|Start Period 1|Withdrawal by Subject|1|||
23483600|NCT03036800|65513117|FG000|Overall Study|Protocol Violation|1|||
23483601|NCT03036800|65513118|FG001|Overall Study|Protocol Violation|0|||
23272649|NCT00050778|64742182|FG000|Overall Study|Adverse Event|13|||
23483602|NCT03036800|65513117|FG000|Overall Study|Non-compliance|1|||
23483603|NCT03036800|65513118|FG001|Overall Study|Non-compliance|0|||
23483604|NCT03036800|65513117|FG000|Overall Study|Lost to Follow-up|1|||
23602088|NCT01972776|65934012|FG004|Part 1|Adverse Event|0|||
23483605|NCT03036800|65513118|FG001|Overall Study|Lost to Follow-up|0|||
23602089|NCT01972776|65934013|FG005|Part 1|Adverse Event|0|||
23483606|NCT03036800|65513117|FG000|Overall Study|Death|1|||
23602090|NCT01972776|65934008|FG000|Part 2|Adverse Event|0|||
23272650|NCT00050778|64742183|FG001|Overall Study|Adverse Event|3|||
23272651|NCT00050778|64742184|FG002|Overall Study|Adverse Event|2|||
23272652|NCT00050778|64742182|FG000|Overall Study|Death|0|||
23272653|NCT00050778|64742183|FG001|Overall Study|Death|1|||
23272654|NCT00050778|64742184|FG002|Overall Study|Death|1|||
23272655|NCT00050778|64742182|FG000|Overall Study|Lack of Efficacy|16|||
23272656|NCT00050778|64742183|FG001|Overall Study|Lack of Efficacy|2|||
23272657|NCT00050778|64742184|FG002|Overall Study|Lack of Efficacy|2|||
23272658|NCT00050778|64742182|FG000|Overall Study|Lost to Follow-up|0|||
23272659|NCT00050778|64742183|FG001|Overall Study|Lost to Follow-up|2|||
23272660|NCT00050778|64742184|FG002|Overall Study|Lost to Follow-up|4|||
23272661|NCT00050778|64742182|FG000|Overall Study|Physician Decision|3|||
23272662|NCT00050778|64742183|FG001|Overall Study|Physician Decision|0|||
23602091|NCT01972776|65934009|FG001|Part 2|Adverse Event|0|||
23602092|NCT01972776|65934010|FG002|Part 2|Adverse Event|0|||
23201201|NCT01242020|64476646|FG001|Overall Study|Withdrawal by Subject|0|||
23201202|NCT01242020|64476645|FG000|Overall Study|Failed screening|1|||
23201203|NCT01242020|64476646|FG001|Overall Study|Failed screening|0|||
23201204|NCT03141086|64476647|FG000|Overall Study|Study Terminated By Sponsor|1|||
23201205|NCT03141086|64476648|FG001|Overall Study|Study Terminated By Sponsor|1|||
23201206|NCT03141086|64476647|FG000|Overall Study|Withdrawal by Subject|0|||
23201207|NCT03141086|64476648|FG001|Overall Study|Withdrawal by Subject|1|||
23201208|NCT03141086|64476647|FG000|Overall Study|Protocol Violation|0|||
23201209|NCT03141086|64476648|FG001|Overall Study|Protocol Violation|1|||
23201210|NCT03141086|64476647|FG000|Overall Study|Adverse Event|0|||
23201211|NCT03141086|64476648|FG001|Overall Study|Adverse Event|2|||
23201212|NCT00718419|64476649|FG000|Overall Study|Adverse Event|2|||
23201213|NCT00718419|64476650|FG001|Overall Study|Adverse Event|1|||
23201214|NCT00718419|64476649|FG000|Overall Study|Physician Decision|1|||
23201215|NCT00718419|64476650|FG001|Overall Study|Physician Decision|6|||
23201216|NCT00718419|64476649|FG000|Overall Study|Sponsor decision|0|||
23201217|NCT00718419|64476650|FG001|Overall Study|Sponsor decision|1|||
23201218|NCT00718419|64476649|FG000|Overall Study|Withdrawal by Subject|0|||
23201219|NCT00718419|64476650|FG001|Overall Study|Withdrawal by Subject|5|||
23201220|NCT00718419|64476649|FG000|Overall Study|Progressive Disease|7|||
23201221|NCT00718419|64476650|FG001|Overall Study|Progressive Disease|25|||
23201222|NCT00718419|64476649|FG000|Overall Study|Death Due to Progressive Disease|2|||
23201223|NCT00718419|64476650|FG001|Overall Study|Death Due to Progressive Disease|0|||
23201224|NCT00718419|64476649|FG000|Overall Study|Death Due to Study Drug Related|0|||
23201225|NCT00718419|64476650|FG001|Overall Study|Death Due to Study Drug Related|1|||
23201226|NCT00718419|64476649|FG000|Overall Study|Death Due to Adverse Events|1|||
23201227|NCT00718419|64476650|FG001|Overall Study|Death Due to Adverse Events|0|||
23201228|NCT03158688|64476651|FG000|Overall Study|Withdrawal by Subject|14|||
23201229|NCT03158688|64476652|FG001|Overall Study|Withdrawal by Subject|28|||
23201230|NCT03158688|64476651|FG000|Overall Study|Decision by sponsor|13|||
23201231|NCT03158688|64476652|FG001|Overall Study|Decision by sponsor|37|||
23201232|NCT03158688|64476651|FG000|Overall Study|Lost to Follow-up|4|||
23201233|NCT03158688|64476652|FG001|Overall Study|Lost to Follow-up|3|||
23201234|NCT03158688|64476651|FG000|Overall Study|Death|74|||
23201235|NCT03158688|64476652|FG001|Overall Study|Death|142|||
23201236|NCT02993224|64476655|FG000|Core Phase - Period 1|Adverse Event|4|||
23201237|NCT02993224|64476655|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
23201238|NCT02993224|64476655|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
23201239|NCT02993224|64476655|FG000|Core Phase- Period 2|Adverse Event|1|||
23201240|NCT02993224|64476655|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
23201241|NCT02993224|64476655|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
23201242|NCT02993224|64476655|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
23201243|NCT02993224|64476655|FG000|Extension Phase|Adverse Event|3|||
23201244|NCT02993224|64476655|FG000|Extension Phase|Withdrawal by Subject|3|||
23201245|NCT02993224|64476655|FG000|Extension Phase|Lost to Follow-up|2|||
23201246|NCT02993224|64476655|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
23201247|NCT02742649|64476656|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
23201248|NCT02742649|64476657|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
23201249|NCT02742649|64476658|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
23201250|NCT02742649|64476659|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
23201251|NCT02742649|64476660|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
23201252|NCT02742649|64476656|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23201253|NCT02742649|64476657|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23201254|NCT02742649|64476658|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23201255|NCT02742649|64476659|FG003|Double-Blind Treatment Period|Adverse Event|0|||
23201256|NCT02742649|64476660|FG004|Double-Blind Treatment Period|Adverse Event|0|||
23201257|NCT02742649|64476656|FG000|Open-Label Period|Lost to Follow-up|0|||
23201258|NCT02742649|64476657|FG001|Open-Label Period|Lost to Follow-up|0|||
23201259|NCT02742649|64476658|FG002|Open-Label Period|Lost to Follow-up|0|||
23201260|NCT02742649|64476659|FG003|Open-Label Period|Lost to Follow-up|0|||
23272663|NCT00050778|64742184|FG002|Overall Study|Physician Decision|2|||
23272664|NCT00050778|64742182|FG000|Overall Study|Protocol Violation|2|||
23272665|NCT00050778|64742183|FG001|Overall Study|Protocol Violation|0|||
23272666|NCT00050778|64742184|FG002|Overall Study|Protocol Violation|1|||
23272667|NCT00050778|64742182|FG000|Overall Study|Withdrawal by Subject|6|||
23272668|NCT00050778|64742183|FG001|Overall Study|Withdrawal by Subject|8|||
23272669|NCT00050778|64742184|FG002|Overall Study|Withdrawal by Subject|4|||
23272670|NCT00050778|64742182|FG000|Overall Study|Randomized but not treated|4|||
23272671|NCT00050778|64742183|FG001|Overall Study|Randomized but not treated|5|||
23272672|NCT00050778|64742184|FG002|Overall Study|Randomized but not treated|2|||
23272673|NCT00050778|64742182|FG000|Overall Study|Familial and personal reasons|1|||
23272674|NCT00050778|64742183|FG001|Overall Study|Familial and personal reasons|0|||
23272675|NCT00050778|64742184|FG002|Overall Study|Familial and personal reasons|0|||
23272676|NCT01395030|64742185|FG000|Overall Study|Did not complete FCH PET/CT|7|||
23272677|NCT02373098|64742191|FG000|Overall Study|Lost to Follow-up|1|||
23272678|NCT02373098|64742192|FG001|Overall Study|Lost to Follow-up|0|||
23272679|NCT02373098|64742191|FG000|Overall Study|Protocol Violation|3|||
23272680|NCT02373098|64742192|FG001|Overall Study|Protocol Violation|0|||
23272681|NCT02373098|64742191|FG000|Overall Study|Withdrawal by Subject|5|||
23272682|NCT02373098|64742192|FG001|Overall Study|Withdrawal by Subject|0|||
23272683|NCT02373098|64742191|FG000|Overall Study|Adverse Event|3|||
23272684|NCT02373098|64742192|FG001|Overall Study|Adverse Event|0|||
23272685|NCT02719522|64742196|FG000|Overall Study|Implant Failure|4|||
23272686|NCT02719522|64742196|FG000|Overall Study|Death|2|||
23272687|NCT02719522|64742196|FG000|Overall Study|Lost to Follow-up|5|||
23272688|NCT00150462|64742197|FG000|Overall Study|Disease Progression or Relapse|3|||
23272689|NCT00150462|64742198|FG001|Overall Study|Disease Progression or Relapse|1|||
23272690|NCT00150462|64742199|FG002|Overall Study|Disease Progression or Relapse|2|||
23272691|NCT00150462|64742200|FG003|Overall Study|Disease Progression or Relapse|1|||
23272692|NCT00150462|64742201|FG004|Overall Study|Disease Progression or Relapse|2|||
23272693|NCT00150462|64742202|FG005|Overall Study|Disease Progression or Relapse|2|||
23272694|NCT00150462|64742203|FG006|Overall Study|Disease Progression or Relapse|3|||
23272695|NCT00150462|64742204|FG007|Overall Study|Disease Progression or Relapse|5|||
23272696|NCT00150462|64742205|FG008|Overall Study|Disease Progression or Relapse|5|||
23272697|NCT00150462|64742206|FG009|Overall Study|Disease Progression or Relapse|3|||
23272698|NCT00150462|64742207|FG010|Overall Study|Disease Progression or Relapse|2|||
23272699|NCT00150462|64742197|FG000|Overall Study|Withdrawal by Subject|0|||
23272700|NCT00150462|64742198|FG001|Overall Study|Withdrawal by Subject|1|||
23272701|NCT00150462|64742199|FG002|Overall Study|Withdrawal by Subject|1|||
23272702|NCT00150462|64742200|FG003|Overall Study|Withdrawal by Subject|0|||
23272703|NCT00150462|64742201|FG004|Overall Study|Withdrawal by Subject|1|||
23272704|NCT00150462|64742202|FG005|Overall Study|Withdrawal by Subject|2|||
23272705|NCT00150462|64742203|FG006|Overall Study|Withdrawal by Subject|0|||
23272706|NCT00150462|64742204|FG007|Overall Study|Withdrawal by Subject|1|||
23272707|NCT00150462|64742205|FG008|Overall Study|Withdrawal by Subject|0|||
23272708|NCT00150462|64742206|FG009|Overall Study|Withdrawal by Subject|1|||
23272709|NCT00150462|64742207|FG010|Overall Study|Withdrawal by Subject|0|||
23272710|NCT00150462|64742197|FG000|Overall Study|Death|0|||
23272711|NCT00150462|64742198|FG001|Overall Study|Death|1|||
23272712|NCT00150462|64742199|FG002|Overall Study|Death|0|||
23272713|NCT00150462|64742200|FG003|Overall Study|Death|0|||
23272714|NCT00150462|64742201|FG004|Overall Study|Death|0|||
23272715|NCT00150462|64742202|FG005|Overall Study|Death|0|||
23272716|NCT00150462|64742203|FG006|Overall Study|Death|0|||
23272717|NCT00150462|64742204|FG007|Overall Study|Death|0|||
23272718|NCT00150462|64742205|FG008|Overall Study|Death|1|||
23272719|NCT00150462|64742206|FG009|Overall Study|Death|0|||
23272720|NCT00150462|64742207|FG010|Overall Study|Death|0|||
23272721|NCT00150462|64742197|FG000|Overall Study|Adverse Event|0|||
23272722|NCT00150462|64742198|FG001|Overall Study|Adverse Event|0|||
23272723|NCT00150462|64742199|FG002|Overall Study|Adverse Event|0|||
23272724|NCT00150462|64742200|FG003|Overall Study|Adverse Event|1|||
23272725|NCT00150462|64742201|FG004|Overall Study|Adverse Event|0|||
23272726|NCT00150462|64742202|FG005|Overall Study|Adverse Event|0|||
23272727|NCT00150462|64742203|FG006|Overall Study|Adverse Event|0|||
23272728|NCT00150462|64742204|FG007|Overall Study|Adverse Event|2|||
23602093|NCT01972776|65934011|FG003|Part 2|Adverse Event|0|||
23602094|NCT01972776|65934012|FG004|Part 2|Adverse Event|3|||
23272729|NCT00150462|64742205|FG008|Overall Study|Adverse Event|0|||
23272730|NCT00150462|64742206|FG009|Overall Study|Adverse Event|1|||
23272731|NCT00150462|64742207|FG010|Overall Study|Adverse Event|0|||
23272732|NCT00150462|64742197|FG000|Overall Study|Physician Decision|0|||
23272733|NCT00150462|64742198|FG001|Overall Study|Physician Decision|0|||
23272734|NCT00150462|64742199|FG002|Overall Study|Physician Decision|1|||
23272735|NCT00150462|64742200|FG003|Overall Study|Physician Decision|1|||
23272736|NCT00150462|64742201|FG004|Overall Study|Physician Decision|0|||
23272737|NCT00150462|64742202|FG005|Overall Study|Physician Decision|0|||
23272738|NCT00150462|64742203|FG006|Overall Study|Physician Decision|0|||
23602095|NCT01972776|65934013|FG005|Part 2|Adverse Event|0|||
23272739|NCT00150462|64742204|FG007|Overall Study|Physician Decision|0|||
23272740|NCT00150462|64742205|FG008|Overall Study|Physician Decision|0|||
23272741|NCT00150462|64742206|FG009|Overall Study|Physician Decision|0|||
23272742|NCT00150462|64742207|FG010|Overall Study|Physician Decision|0|||
23272743|NCT00150462|64742197|FG000|Overall Study|Other|0|||
23272744|NCT00150462|64742198|FG001|Overall Study|Other|0|||
23272745|NCT00150462|64742199|FG002|Overall Study|Other|0|||
23272746|NCT00150462|64742200|FG003|Overall Study|Other|0|||
23272747|NCT00150462|64742201|FG004|Overall Study|Other|0|||
23272748|NCT00150462|64742202|FG005|Overall Study|Other|0|||
23272749|NCT00150462|64742203|FG006|Overall Study|Other|0|||
23272750|NCT00150462|64742204|FG007|Overall Study|Other|0|||
23272751|NCT00150462|64742205|FG008|Overall Study|Other|0|||
23272752|NCT00150462|64742206|FG009|Overall Study|Other|1|||
23272753|NCT00150462|64742207|FG010|Overall Study|Other|1|||
23272754|NCT03496623|64742208|FG000|Run-In Period (2 Weeks)|Death|1|||
23272755|NCT03496623|64742209|FG001|Run-In Period (2 Weeks)|Death|0|||
23272756|NCT03496623|64742210|FG002|Run-In Period (2 Weeks)|Death|0|||
23272757|NCT03496623|64742211|FG003|Run-In Period (2 Weeks)|Death|0|||
23272758|NCT03496623|64742212|FG004|Run-In Period (2 Weeks)|Death|0|||
23272759|NCT03496623|64742208|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
23272760|NCT03496623|64742209|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
23272761|NCT03496623|64742210|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
23272762|NCT03496623|64742211|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
23272763|NCT03496623|64742212|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
23272764|NCT03496623|64742208|FG000|Period 1 (12 Weeks)|Death|0|||
23272765|NCT03496623|64742209|FG001|Period 1 (12 Weeks)|Death|3|||
23272766|NCT03496623|64742210|FG002|Period 1 (12 Weeks)|Death|0|||
23272767|NCT03496623|64742211|FG003|Period 1 (12 Weeks)|Death|0|||
23272768|NCT03496623|64742212|FG004|Period 1 (12 Weeks)|Death|0|||
23272769|NCT03496623|64742208|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
23272770|NCT03496623|64742209|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
23272771|NCT03496623|64742210|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
23272772|NCT03496623|64742211|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
23272773|NCT03496623|64742212|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
23272774|NCT03496623|64742208|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23272775|NCT03496623|64742209|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
23272776|NCT03496623|64742210|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
23272777|NCT03496623|64742211|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23272778|NCT03496623|64742212|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
23272779|NCT03496623|64742208|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
23272780|NCT03496623|64742209|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
23272781|NCT03496623|64742210|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
23272782|NCT03496623|64742211|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
23272783|NCT03496623|64742212|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
23272784|NCT03496623|64742208|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23272785|NCT03496623|64742209|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23272786|NCT03496623|64742210|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
23272787|NCT03496623|64742211|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23272788|NCT03496623|64742212|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
23272789|NCT03496623|64742208|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
23272790|NCT03496623|64742209|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
23272791|NCT03496623|64742210|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
23272792|NCT03496623|64742211|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
23272793|NCT03496623|64742212|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
23272794|NCT03496623|64742208|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23272795|NCT03496623|64742209|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
23272796|NCT03496623|64742210|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
23272797|NCT03496623|64742211|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23272798|NCT03496623|64742212|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
23272799|NCT03991494|64742213|FG000|Overall Study|Progressive Disease|4|||
23272800|NCT00441467|64742215|FG000|Overall Study|Adverse Event|6|||
23272801|NCT00441467|64742215|FG000|Overall Study|Withdrawal by Subject|3|||
23272802|NCT00441467|64742215|FG000|Overall Study|Progressive disease|9|||
23272803|NCT00814463|64742216|FG000|Overall Study|Lost to Follow-up|1|||
23272804|NCT01363765|64742217|FG000|Overall Study|non-diagnostic|2621|||
23272805|NCT01363765|64742218|FG001|Overall Study|non-diagnostic|1124|||
23272806|NCT01363765|64742217|FG000|Overall Study|duplicate records|736|||
23272807|NCT01363765|64742218|FG001|Overall Study|duplicate records|3177|||
23272808|NCT01363765|64742217|FG000|Overall Study|non-resident|156|||
23272809|NCT01363765|64742218|FG001|Overall Study|non-resident|76|||
23272810|NCT01363765|64742217|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
23272811|NCT01363765|64742218|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
23272812|NCT01363765|64742217|FG000|Overall Study|smear during intervention|2170|||
23272813|NCT01363765|64742218|FG001|Overall Study|smear during intervention|0|||
23367224|NCT01239797|65092365|FG000|Treated Participants|Disease progression|185|||
23272814|NCT00056160|64742219|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
23272815|NCT00056160|64742220|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
23367225|NCT01239797|65092366|FG001|Treated Participants|Disease progression|185|||
23367226|NCT01239797|65092365|FG000|Treated Participants|Study drug toxicity|39|||
23367227|NCT01239797|65092366|FG001|Treated Participants|Study drug toxicity|45|||
23367228|NCT01239797|65092365|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
23367229|NCT01239797|65092366|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
23367230|NCT01239797|65092365|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
23367231|NCT01239797|65092366|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
23367232|NCT01239797|65092365|FG000|Treated Participants|Administrative reason by sponsor|13|||
23367233|NCT01239797|65092366|FG001|Treated Participants|Administrative reason by sponsor|4|||
23483607|NCT03036800|65513118|FG001|Overall Study|Death|0|||
23483608|NCT03036800|65513117|FG000|Overall Study|Tolerance|5|||
23483609|NCT03036800|65513118|FG001|Overall Study|Tolerance|0|||
23483610|NCT03036800|65513117|FG000|Overall Study|Unknown/no reason given|50|||
23483611|NCT03036800|65513118|FG001|Overall Study|Unknown/no reason given|39|||
23483612|NCT04449029|65513119|FG000|Overall Study|Adverse Event|0|||
23483613|NCT04449029|65513120|FG001|Overall Study|Adverse Event|1|||
23483614|NCT04449029|65513121|FG002|Overall Study|Adverse Event|1|||
23483615|NCT04449029|65513122|FG003|Overall Study|Adverse Event|0|||
23483616|NCT04449029|65513123|FG004|Overall Study|Adverse Event|1|||
23483617|NCT04449029|65513124|FG005|Overall Study|Adverse Event|0|||
23483618|NCT04449029|65513125|FG006|Overall Study|Adverse Event|1|||
23483619|NCT04449029|65513126|FG007|Overall Study|Adverse Event|0|||
23483620|NCT04449029|65513119|FG000|Overall Study|Lost to Follow-up|0|||
23483621|NCT04449029|65513120|FG001|Overall Study|Lost to Follow-up|1|||
23483622|NCT04449029|65513121|FG002|Overall Study|Lost to Follow-up|0|||
23483623|NCT04449029|65513122|FG003|Overall Study|Lost to Follow-up|0|||
23483624|NCT04449029|65513123|FG004|Overall Study|Lost to Follow-up|0|||
23483625|NCT04449029|65513124|FG005|Overall Study|Lost to Follow-up|0|||
23483626|NCT04449029|65513125|FG006|Overall Study|Lost to Follow-up|0|||
23483627|NCT04449029|65513126|FG007|Overall Study|Lost to Follow-up|0|||
23483628|NCT04449029|65513119|FG000|Overall Study|Protocol Violation|0|||
23483629|NCT04449029|65513120|FG001|Overall Study|Protocol Violation|1|||
23483630|NCT04449029|65513121|FG002|Overall Study|Protocol Violation|0|||
23272816|NCT00056160|64742219|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
23272817|NCT00056160|64742220|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
23272818|NCT00056160|64742219|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
23272819|NCT00056160|64742220|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
23272820|NCT00056160|64742219|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
23272821|NCT00056160|64742220|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
23272822|NCT00056160|64742219|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
23272823|NCT00056160|64742220|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
23272824|NCT00056160|64742219|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
23272825|NCT00056160|64742220|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
23272826|NCT00056160|64742219|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
23272827|NCT00056160|64742220|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
23272828|NCT00056160|64742219|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
23272829|NCT00056160|64742220|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
23272830|NCT00056160|64742219|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
23272831|NCT00056160|64742220|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
23272832|NCT00056160|64742219|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
23272833|NCT00056160|64742220|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
23272834|NCT00056160|64742219|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
23272835|NCT00056160|64742220|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
23272836|NCT00056160|64742219|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
23272837|NCT00056160|64742220|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
23272838|NCT00056160|64742219|FG000|Final Follow-up|Transferred into expanded access study.|3|||
23272839|NCT00056160|64742220|FG001|Final Follow-up|Transferred into expanded access study.|0|||
23272840|NCT00056160|64742219|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
23272841|NCT00056160|64742220|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
23272842|NCT00056160|64742219|FG000|Final Follow-up|Adverse Event|1|||
23272843|NCT00056160|64742220|FG001|Final Follow-up|Adverse Event|0|||
23272844|NCT03099538|64742221|FG000|Overall Study|Lack of Efficacy|3|||
23272845|NCT03420300|64742222|FG000|Overall Study|Death|2|||
23272846|NCT04185909|64742223|FG000|Overall Study|Lost to Follow-up|1|||
23272847|NCT00696020|64742226|FG000|Overall Study|Adverse Event|3|||
23272848|NCT00696020|64742227|FG001|Overall Study|Adverse Event|1|||
23483631|NCT04449029|65513122|FG003|Overall Study|Protocol Violation|0|||
23483632|NCT04449029|65513123|FG004|Overall Study|Protocol Violation|0|||
23483633|NCT04449029|65513124|FG005|Overall Study|Protocol Violation|0|||
23483634|NCT04449029|65513125|FG006|Overall Study|Protocol Violation|0|||
23483635|NCT04449029|65513126|FG007|Overall Study|Protocol Violation|0|||
23272849|NCT00696020|64742228|FG002|Overall Study|Adverse Event|2|||
23272850|NCT00696020|64742229|FG003|Overall Study|Adverse Event|1|||
23272851|NCT00696020|64742226|FG000|Overall Study|Lack of Efficacy|1|||
23272852|NCT00696020|64742227|FG001|Overall Study|Lack of Efficacy|0|||
23272853|NCT00696020|64742228|FG002|Overall Study|Lack of Efficacy|0|||
23272854|NCT00696020|64742229|FG003|Overall Study|Lack of Efficacy|0|||
23272855|NCT00696020|64742226|FG000|Overall Study|Protocol Violation|0|||
23602096|NCT01972776|65934008|FG000|Part 2|Administrative problems|0|||
23602097|NCT01972776|65934009|FG001|Part 2|Administrative problems|0|||
23272856|NCT00696020|64742227|FG001|Overall Study|Protocol Violation|0|||
23272857|NCT00696020|64742228|FG002|Overall Study|Protocol Violation|0|||
23272858|NCT00696020|64742229|FG003|Overall Study|Protocol Violation|1|||
23272859|NCT00696020|64742226|FG000|Overall Study|Withdrawal by Subject|0|||
23272860|NCT00696020|64742227|FG001|Overall Study|Withdrawal by Subject|1|||
23602098|NCT01972776|65934010|FG002|Part 2|Administrative problems|0|||
23602099|NCT01972776|65934011|FG003|Part 2|Administrative problems|0|||
23602100|NCT01972776|65934012|FG004|Part 2|Administrative problems|10|||
23602101|NCT01972776|65934013|FG005|Part 2|Administrative problems|7|||
23602102|NCT01500200|65934014|FG000|Stage 1|Adverse Event|1|||
23602103|NCT01500200|65934015|FG001|Stage 1|Adverse Event|4|||
23602104|NCT01500200|65934016|FG002|Stage 1|Adverse Event|5|||
23602105|NCT01500200|65934017|FG003|Stage 1|Adverse Event|0|||
23602106|NCT01500200|65934018|FG004|Stage 1|Adverse Event|0|||
23602107|NCT01500200|65934019|FG005|Stage 1|Adverse Event|0|||
23602108|NCT01500200|65934014|FG000|Stage 1|Lost to Follow-up|2|||
23602109|NCT01500200|65934015|FG001|Stage 1|Lost to Follow-up|2|||
23272861|NCT00696020|64742228|FG002|Overall Study|Withdrawal by Subject|0|||
23272862|NCT00696020|64742229|FG003|Overall Study|Withdrawal by Subject|1|||
23272863|NCT00696020|64742226|FG000|Overall Study|Other not stated above|0|||
23272864|NCT00696020|64742227|FG001|Overall Study|Other not stated above|0|||
23272865|NCT00696020|64742228|FG002|Overall Study|Other not stated above|1|||
23272866|NCT00696020|64742229|FG003|Overall Study|Other not stated above|1|||
23272867|NCT04006171|64742230|FG000|Overall Study|Withdrawal by Subject|8|||
23272868|NCT04006171|64742231|FG001|Overall Study|Withdrawal by Subject|7|||
23272869|NCT04006171|64742230|FG000|Overall Study|missing serum samples|2|||
23272870|NCT04006171|64742231|FG001|Overall Study|missing serum samples|2|||
23272871|NCT04006171|64742230|FG000|Overall Study|insufficient sample volume|2|||
23272872|NCT04006171|64742231|FG001|Overall Study|insufficient sample volume|3|||
23272873|NCT00414466|64742232|FG000|Overall Study|Adverse Event|0|||
23272874|NCT00414466|64742233|FG001|Overall Study|Adverse Event|0|||
23272875|NCT00414466|64742234|FG002|Overall Study|Adverse Event|1|||
23272876|NCT00414466|64742235|FG003|Overall Study|Adverse Event|1|||
23272877|NCT00414466|64742232|FG000|Overall Study|Lack of Efficacy|1|||
23272878|NCT00414466|64742233|FG001|Overall Study|Lack of Efficacy|0|||
23272879|NCT00414466|64742234|FG002|Overall Study|Lack of Efficacy|0|||
23272880|NCT00414466|64742235|FG003|Overall Study|Lack of Efficacy|0|||
23272881|NCT00414466|64742232|FG000|Overall Study|Withdrawn by Sponsor|1|||
23272882|NCT00414466|64742233|FG001|Overall Study|Withdrawn by Sponsor|0|||
23272883|NCT00414466|64742234|FG002|Overall Study|Withdrawn by Sponsor|0|||
23272884|NCT00414466|64742235|FG003|Overall Study|Withdrawn by Sponsor|0|||
23272885|NCT01974141|64742236|FG000|Overall Study|Other Reasons|28|||
23272886|NCT01974141|64742237|FG001|Overall Study|Other Reasons|18|||
23272887|NCT01974141|64742236|FG000|Overall Study|Protocol Violation|2|||
23272888|NCT01974141|64742237|FG001|Overall Study|Protocol Violation|6|||
23272889|NCT01974141|64742236|FG000|Overall Study|Personal Reasons|21|||
23272890|NCT01974141|64742237|FG001|Overall Study|Personal Reasons|20|||
23272891|NCT01974141|64742236|FG000|Overall Study|Lost to Follow-up|38|||
23272892|NCT01974141|64742237|FG001|Overall Study|Lost to Follow-up|29|||
23272893|NCT01974141|64742236|FG000|Overall Study|Pregnancy|3|||
23272894|NCT01974141|64742237|FG001|Overall Study|Pregnancy|3|||
23272895|NCT01974141|64742236|FG000|Overall Study|Lack of Efficacy|0|||
23272896|NCT01974141|64742237|FG001|Overall Study|Lack of Efficacy|1|||
23272897|NCT01974141|64742236|FG000|Overall Study|Adverse Event|4|||
23272898|NCT01974141|64742237|FG001|Overall Study|Adverse Event|5|||
23272899|NCT00214422|64742241|FG000|Overall Study|Physician Decision|2|||
23272900|NCT00214422|64742242|FG001|Overall Study|Physician Decision|0|||
23272901|NCT00214422|64742243|FG002|Overall Study|Physician Decision|0|||
23272902|NCT00214422|64742241|FG000|Overall Study|Developed esophageal ca|1|||
23272903|NCT00214422|64742242|FG001|Overall Study|Developed esophageal ca|0|||
23602110|NCT01500200|65934016|FG002|Stage 1|Lost to Follow-up|1|||
23602111|NCT01500200|65934017|FG003|Stage 1|Lost to Follow-up|0|||
23272904|NCT00214422|64742243|FG002|Overall Study|Developed esophageal ca|0|||
23272905|NCT00214422|64742241|FG000|Overall Study|Pt taken off study|1|||
23272906|NCT00214422|64742242|FG001|Overall Study|Pt taken off study|1|||
23272907|NCT00214422|64742243|FG002|Overall Study|Pt taken off study|0|||
23272908|NCT00214422|64742241|FG000|Overall Study|Disease progression on study|1|||
23602112|NCT01500200|65934018|FG004|Stage 1|Lost to Follow-up|0|||
23272909|NCT00214422|64742242|FG001|Overall Study|Disease progression on study|0|||
23602113|NCT01500200|65934019|FG005|Stage 1|Lost to Follow-up|0|||
23602114|NCT01500200|65934014|FG000|Stage 1|Withdrawal by Subject|3|||
23272910|NCT00214422|64742243|FG002|Overall Study|Disease progression on study|0|||
23272911|NCT00214422|64742241|FG000|Overall Study|Unable to make a radiation treatment|0|||
23272912|NCT00214422|64742242|FG001|Overall Study|Unable to make a radiation treatment|0|||
23272913|NCT00214422|64742243|FG002|Overall Study|Unable to make a radiation treatment|1|||
23272914|NCT00579670|64742244|FG000|Overall Study|Death|1|||
23272915|NCT00579670|64742245|FG001|Overall Study|Death|0|||
23272916|NCT00579670|64742246|FG002|Overall Study|Death|0|||
23272917|NCT00579670|64742247|FG003|Overall Study|Death|0|||
23272918|NCT00579670|64742248|FG004|Overall Study|Death|0|||
23272919|NCT00579670|64742244|FG000|Overall Study|Adverse Event|1|||
23272920|NCT00579670|64742245|FG001|Overall Study|Adverse Event|0|||
23272921|NCT00579670|64742246|FG002|Overall Study|Adverse Event|1|||
23272922|NCT00579670|64742247|FG003|Overall Study|Adverse Event|2|||
23272923|NCT00579670|64742248|FG004|Overall Study|Adverse Event|0|||
23272924|NCT00579670|64742244|FG000|Overall Study|Lack of Efficacy|0|||
23272925|NCT00579670|64742245|FG001|Overall Study|Lack of Efficacy|0|||
23272926|NCT00579670|64742246|FG002|Overall Study|Lack of Efficacy|1|||
23272927|NCT00579670|64742247|FG003|Overall Study|Lack of Efficacy|14|||
23272928|NCT00579670|64742248|FG004|Overall Study|Lack of Efficacy|0|||
23272929|NCT00579670|64742244|FG000|Overall Study|Lost to Follow-up|0|||
23272930|NCT00579670|64742245|FG001|Overall Study|Lost to Follow-up|1|||
23272931|NCT00579670|64742246|FG002|Overall Study|Lost to Follow-up|0|||
23272932|NCT00579670|64742247|FG003|Overall Study|Lost to Follow-up|4|||
23272933|NCT00579670|64742248|FG004|Overall Study|Lost to Follow-up|0|||
23272934|NCT00579670|64742244|FG000|Overall Study|Other|0|||
23272935|NCT00579670|64742245|FG001|Overall Study|Other|0|||
23272936|NCT00579670|64742246|FG002|Overall Study|Other|1|||
23272937|NCT00579670|64742247|FG003|Overall Study|Other|2|||
23272938|NCT00579670|64742248|FG004|Overall Study|Other|0|||
23272939|NCT00579670|64742244|FG000|Overall Study|Withdrawal by Subject|0|||
23272940|NCT00579670|64742245|FG001|Overall Study|Withdrawal by Subject|0|||
23272941|NCT00579670|64742246|FG002|Overall Study|Withdrawal by Subject|1|||
23272942|NCT00579670|64742247|FG003|Overall Study|Withdrawal by Subject|0|||
23272943|NCT00579670|64742248|FG004|Overall Study|Withdrawal by Subject|0|||
23272944|NCT02924883|64742251|FG000|Overall Study|Death|39|||
23272945|NCT02924883|64742252|FG001|Overall Study|Death|20|||
23272946|NCT02924883|64742251|FG000|Overall Study|Lost to Follow-up|1|||
23272947|NCT02924883|64742252|FG001|Overall Study|Lost to Follow-up|0|||
23272948|NCT02924883|64742251|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
23272949|NCT02924883|64742252|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
23272950|NCT02924883|64742251|FG000|Overall Study|Protocol Violation|1|||
23272951|NCT02924883|64742252|FG001|Overall Study|Protocol Violation|0|||
23272952|NCT02924883|64742251|FG000|Overall Study|Withdrawal by Subject|22|||
23272953|NCT02924883|64742252|FG001|Overall Study|Withdrawal by Subject|16|||
23272954|NCT02924883|64742251|FG000|Overall Study|Progressive Disease|1|||
23272955|NCT02924883|64742252|FG001|Overall Study|Progressive Disease|0|||
23272956|NCT02924883|64742251|FG000|Overall Study|Study Terminated by Sponsor|69|||
23272957|NCT02924883|64742252|FG001|Overall Study|Study Terminated by Sponsor|32|||
23272958|NCT04088760|64742255|FG000|Overall Study|Physician Decision|1|||
23272959|NCT03365375|64742256|FG000|Overall Study|Withdrawal by Subject|0|||
23272960|NCT03365375|64742257|FG001|Overall Study|Withdrawal by Subject|1|||
23272961|NCT03365375|64742256|FG000|Overall Study|Lost to Follow-up|0|||
23272962|NCT03365375|64742257|FG001|Overall Study|Lost to Follow-up|4|||
23272963|NCT02127281|64742258|FG000|Overall Study|Lost to Follow-up|1|||
23272964|NCT02127281|64742259|FG001|Overall Study|Lost to Follow-up|0|||
23272965|NCT01185821|64742261|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23272966|NCT01185821|64742262|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23272967|NCT01185821|64742263|FG002|Overall Study|Abnormal laboratory value(s)|1|||
23272968|NCT01185821|64742264|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23272969|NCT01185821|64742265|FG004|Overall Study|Abnormal laboratory value(s)|0|||
23272970|NCT01185821|64742261|FG000|Overall Study|Protocol Violation|0|||
23272971|NCT01185821|64742262|FG001|Overall Study|Protocol Violation|0|||
23272972|NCT01185821|64742263|FG002|Overall Study|Protocol Violation|0|||
23272973|NCT01185821|64742264|FG003|Overall Study|Protocol Violation|1|||
23272974|NCT01185821|64742265|FG004|Overall Study|Protocol Violation|1|||
23272975|NCT01185821|64742261|FG000|Overall Study|Abnormal test procedure result|0|||
23272976|NCT01185821|64742262|FG001|Overall Study|Abnormal test procedure result|0|||
23272977|NCT01185821|64742263|FG002|Overall Study|Abnormal test procedure result|0|||
23272978|NCT01185821|64742264|FG003|Overall Study|Abnormal test procedure result|0|||
23272979|NCT01185821|64742265|FG004|Overall Study|Abnormal test procedure result|1|||
23483636|NCT04449029|65513119|FG000|Overall Study|Physician Decision|0|||
23272980|NCT01185821|64742261|FG000|Overall Study|Death|0|||
23272981|NCT01185821|64742262|FG001|Overall Study|Death|1|||
23272982|NCT01185821|64742263|FG002|Overall Study|Death|0|||
23272983|NCT01185821|64742264|FG003|Overall Study|Death|0|||
23272984|NCT01185821|64742265|FG004|Overall Study|Death|0|||
23272985|NCT01185821|64742261|FG000|Overall Study|Condition no longer required study drug|0|||
23272986|NCT01185821|64742262|FG001|Overall Study|Condition no longer required study drug|0|||
23367234|NCT01239797|65092365|FG000|Treated Participants|Other reasons|14|||
23367235|NCT01239797|65092366|FG001|Treated Participants|Other reasons|14|||
23367236|NCT01239797|65092365|FG000|Treated Participants|Participant withdrew consent|6|||
23367237|NCT01239797|65092366|FG001|Treated Participants|Participant withdrew consent|11|||
23367238|NCT01239797|65092365|FG000|Treated Participants|Death|1|||
23367239|NCT01239797|65092366|FG001|Treated Participants|Death|1|||
23367240|NCT01239797|65092365|FG000|Treated Participants|Participant no longer meets study criteria|1|||
23367241|NCT01239797|65092366|FG001|Treated Participants|Participant no longer meets study criteria|1|||
23367242|NCT01239797|65092365|FG000|Treated Participants|Poor/non-compliance|0|||
23367243|NCT01239797|65092366|FG001|Treated Participants|Poor/non-compliance|1|||
23367244|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
23367245|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367246|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
23367247|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
23367248|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367249|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367250|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367251|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23483637|NCT04449029|65513120|FG001|Overall Study|Physician Decision|0|||
23483638|NCT04449029|65513121|FG002|Overall Study|Physician Decision|0|||
23483639|NCT04449029|65513122|FG003|Overall Study|Physician Decision|0|||
23483640|NCT04449029|65513123|FG004|Overall Study|Physician Decision|0|||
23483641|NCT04449029|65513124|FG005|Overall Study|Physician Decision|1|||
23483642|NCT04449029|65513125|FG006|Overall Study|Physician Decision|0|||
23483643|NCT04449029|65513126|FG007|Overall Study|Physician Decision|0|||
23483644|NCT04449029|65513119|FG000|Overall Study|Withdrawal by Subject|3|||
23483645|NCT04449029|65513120|FG001|Overall Study|Withdrawal by Subject|0|||
23483646|NCT04449029|65513121|FG002|Overall Study|Withdrawal by Subject|1|||
23483647|NCT04449029|65513122|FG003|Overall Study|Withdrawal by Subject|1|||
23483648|NCT04449029|65513123|FG004|Overall Study|Withdrawal by Subject|5|||
23483649|NCT04449029|65513124|FG005|Overall Study|Withdrawal by Subject|1|||
23483650|NCT04449029|65513125|FG006|Overall Study|Withdrawal by Subject|4|||
23483651|NCT04449029|65513126|FG007|Overall Study|Withdrawal by Subject|0|||
23483652|NCT05093790|65513127|FG000|Overall Study|Failure to meet continuation criteria|0|||
23483653|NCT05093790|65513128|FG001|Overall Study|Failure to meet continuation criteria|0|||
23483654|NCT05093790|65513129|FG002|Overall Study|Failure to meet continuation criteria|1|||
23483655|NCT05093790|65513130|FG003|Overall Study|Failure to meet continuation criteria|0|||
23483656|NCT05093790|65513127|FG000|Overall Study|Adverse Event|1|||
23367252|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367253|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367254|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367255|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367256|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367257|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367258|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367259|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367260|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367261|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367262|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
23367263|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
23367264|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
23367265|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
23367266|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
23367267|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367268|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367269|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367270|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367271|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367272|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367273|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367274|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367275|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367276|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367277|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367278|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367279|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367280|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367281|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
23367282|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367283|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
23367284|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
23367285|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367286|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367287|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367288|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367289|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367290|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367291|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367292|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367293|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367294|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367295|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367296|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367297|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367298|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367299|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367300|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
23367301|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
23367302|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367303|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367304|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367305|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367306|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367307|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367308|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367309|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367310|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367311|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367312|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23602115|NCT01500200|65934015|FG001|Stage 1|Withdrawal by Subject|0|||
23201261|NCT02742649|64476660|FG004|Open-Label Period|Lost to Follow-up|1|||
23272987|NCT01185821|64742263|FG002|Overall Study|Condition no longer required study drug|0|||
23272988|NCT01185821|64742264|FG003|Overall Study|Condition no longer required study drug|0|||
23272989|NCT01185821|64742265|FG004|Overall Study|Condition no longer required study drug|1|||
23272990|NCT01185821|64742261|FG000|Overall Study|Adverse Event|2|||
23272991|NCT01185821|64742262|FG001|Overall Study|Adverse Event|3|||
23272992|NCT01185821|64742263|FG002|Overall Study|Adverse Event|1|||
23272993|NCT01185821|64742264|FG003|Overall Study|Adverse Event|2|||
23272994|NCT01185821|64742265|FG004|Overall Study|Adverse Event|5|||
23272995|NCT01185821|64742261|FG000|Overall Study|Lack of Efficacy|0|||
23272996|NCT01185821|64742262|FG001|Overall Study|Lack of Efficacy|0|||
23272997|NCT01185821|64742263|FG002|Overall Study|Lack of Efficacy|3|||
23272998|NCT01185821|64742264|FG003|Overall Study|Lack of Efficacy|0|||
23272999|NCT01185821|64742265|FG004|Overall Study|Lack of Efficacy|9|||
23273000|NCT01185821|64742261|FG000|Overall Study|Withdrawal by Subject|3|||
23273001|NCT01185821|64742262|FG001|Overall Study|Withdrawal by Subject|2|||
23273002|NCT01185821|64742263|FG002|Overall Study|Withdrawal by Subject|2|||
23273003|NCT01185821|64742264|FG003|Overall Study|Withdrawal by Subject|1|||
23273004|NCT01185821|64742265|FG004|Overall Study|Withdrawal by Subject|3|||
23273005|NCT01185821|64742261|FG000|Overall Study|Lost to Follow-up|1|||
23273006|NCT01185821|64742262|FG001|Overall Study|Lost to Follow-up|1|||
23273007|NCT01185821|64742263|FG002|Overall Study|Lost to Follow-up|2|||
23273008|NCT01185821|64742264|FG003|Overall Study|Lost to Follow-up|1|||
23273009|NCT01185821|64742265|FG004|Overall Study|Lost to Follow-up|2|||
23273010|NCT01185821|64742261|FG000|Overall Study|Administrative problems|0|||
23273011|NCT01185821|64742262|FG001|Overall Study|Administrative problems|0|||
23273012|NCT01185821|64742263|FG002|Overall Study|Administrative problems|1|||
23273013|NCT01185821|64742264|FG003|Overall Study|Administrative problems|1|||
23273014|NCT01185821|64742265|FG004|Overall Study|Administrative problems|2|||
23273015|NCT01511939|64742267|FG000|Overall Study|Withdrawal by Subject|2|||
23273016|NCT01511939|64742268|FG001|Overall Study|Withdrawal by Subject|1|||
23273017|NCT01511939|64742269|FG002|Overall Study|Withdrawal by Subject|0|||
23273018|NCT02930005|64742272|FG000|Overall Study|Lost to Follow-up|1|||
23273019|NCT02930005|64742273|FG001|Overall Study|Lost to Follow-up|5|||
23273020|NCT02231749|64742276|FG000|Overall Study|Disease progression|229|||
23273021|NCT02231749|64742277|FG001|Overall Study|Disease progression|297|||
23273022|NCT02231749|64742276|FG000|Overall Study|Study Drug Toxicity|134|||
23273023|NCT02231749|64742277|FG001|Overall Study|Study Drug Toxicity|63|||
23273024|NCT02231749|64742276|FG000|Overall Study|Death|1|||
23273025|NCT02231749|64742277|FG001|Overall Study|Death|1|||
23273026|NCT02231749|64742276|FG000|Overall Study|AE unrelated to Study drug|32|||
23273027|NCT02231749|64742277|FG001|Overall Study|AE unrelated to Study drug|31|||
23273028|NCT02231749|64742276|FG000|Overall Study|Participant's request to discontinue|10|||
23273029|NCT02231749|64742277|FG001|Overall Study|Participant's request to discontinue|21|||
23273030|NCT02231749|64742276|FG000|Overall Study|Participant withdrew Consent|8|||
23273031|NCT02231749|64742277|FG001|Overall Study|Participant withdrew Consent|15|||
23273032|NCT02231749|64742276|FG000|Overall Study|Lost to Follow-up|1|||
23273033|NCT02231749|64742277|FG001|Overall Study|Lost to Follow-up|2|||
23273034|NCT02231749|64742276|FG000|Overall Study|Maximum Clinical Benefit|5|||
23273035|NCT02231749|64742277|FG001|Overall Study|Maximum Clinical Benefit|8|||
23273036|NCT02231749|64742276|FG000|Overall Study|Poor/Non-Compliance|0|||
23273037|NCT02231749|64742277|FG001|Overall Study|Poor/Non-Compliance|3|||
23273038|NCT02231749|64742276|FG000|Overall Study|Pregnancy|1|||
23273039|NCT02231749|64742277|FG001|Overall Study|Pregnancy|0|||
23273040|NCT02231749|64742276|FG000|Overall Study|other|0|||
23273041|NCT02231749|64742277|FG001|Overall Study|other|8|||
23273042|NCT02231749|64742276|FG000|Overall Study|No longer meets Study Criteria|1|||
23273043|NCT02231749|64742277|FG001|Overall Study|No longer meets Study Criteria|0|||
23273044|NCT04129346|64742278|FG000|Overall Study|Death|1|||
23273045|NCT04129346|64742279|FG001|Overall Study|Death|0|||
23273046|NCT00735904|64742280|FG000|Overall Study|Adverse Event|3|||
23273047|NCT00735904|64742280|FG000|Overall Study|Death|20|||
23273048|NCT00735904|64742280|FG000|Overall Study|Protocol Violation|1|||
23273049|NCT00735904|64742280|FG000|Overall Study|Withdrawal by Subject|1|||
23273050|NCT00735904|64742280|FG000|Overall Study|Study Terminated by Sponsor|5|||
23273051|NCT00735904|64742280|FG000|Overall Study|Other|8|||
23273052|NCT02530905|64742284|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
23273053|NCT02530905|64742285|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
23273054|NCT02530905|64742286|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
23273055|NCT02728102|64742287|FG000|Overall Study|Death|3|||
23273056|NCT02728102|64742288|FG001|Overall Study|Death|0|||
23273057|NCT02728102|64742289|FG002|Overall Study|Death|1|||
23273058|NCT02728102|64742287|FG000|Overall Study|Withdrawal by Subject|0|||
23273059|NCT02728102|64742288|FG001|Overall Study|Withdrawal by Subject|2|||
23273060|NCT02728102|64742289|FG002|Overall Study|Withdrawal by Subject|3|||
23273061|NCT02728102|64742287|FG000|Overall Study|Physician Decision|1|||
23273062|NCT02728102|64742288|FG001|Overall Study|Physician Decision|1|||
23273063|NCT02728102|64742289|FG002|Overall Study|Physician Decision|0|||
23483657|NCT05093790|65513128|FG001|Overall Study|Adverse Event|0|||
23483658|NCT05093790|65513129|FG002|Overall Study|Adverse Event|0|||
23483659|NCT05093790|65513130|FG003|Overall Study|Adverse Event|0|||
23483660|NCT00384111|65513134|FG000|Overall Study|Disease Progression|3|||
23483661|NCT00384111|65513134|FG000|Overall Study|Adverse Event|1|||
23483662|NCT00384111|65513134|FG000|Overall Study|Investigator Decision|3|||
23483663|NCT00384111|65513134|FG000|Overall Study|Study Terminated by the Sponsor|19|||
23483664|NCT01888003|65513135|FG000|Overall Study|Study Terminated|5|||
23483665|NCT01888003|65513136|FG001|Overall Study|Study Terminated|6|||
23483666|NCT01888003|65513137|FG002|Overall Study|Study Terminated|40|||
23483667|NCT01089361|65513138|FG000|Overall Study|Death|1|||
23483668|NCT01089361|65513139|FG001|Overall Study|Death|0|||
23483669|NCT02274038|65513140|FG000|Overall Study|Death|1|||
23483670|NCT03911843|65513141|FG000|Overall Study|Adverse Event|2|||
23483671|NCT03911843|65513142|FG001|Overall Study|Adverse Event|0|||
23483672|NCT03911843|65513141|FG000|Overall Study|Protocol Violation|2|||
23483673|NCT03911843|65513142|FG001|Overall Study|Protocol Violation|0|||
23483674|NCT03911843|65513141|FG000|Overall Study|Lost to Follow-up|0|||
23483675|NCT03911843|65513142|FG001|Overall Study|Lost to Follow-up|1|||
23483676|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
23483677|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
23483678|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Other|2|||
23483679|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Other|2|||
23483680|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Personal reasons|2|||
23602116|NCT01500200|65934016|FG002|Stage 1|Withdrawal by Subject|0|||
23273064|NCT02728102|64742287|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
23273065|NCT02728102|64742288|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
23273066|NCT02728102|64742289|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
23273067|NCT02728102|64742287|FG000|Overall Study|Covid|0|||
23273068|NCT02728102|64742288|FG001|Overall Study|Covid|0|||
23273069|NCT02728102|64742289|FG002|Overall Study|Covid|1|||
23273070|NCT00437658|64742290|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
23273071|NCT00437658|64742291|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
23273072|NCT00437658|64742292|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
23273073|NCT00437658|64742290|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
23273074|NCT00437658|64742291|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
23273075|NCT00437658|64742292|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
23273076|NCT00437658|64742290|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
23273077|NCT00437658|64742291|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
23273078|NCT00437658|64742292|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
23273079|NCT00437658|64742290|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
23273080|NCT00437658|64742291|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
23273081|NCT00437658|64742292|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
23273082|NCT00437658|64742290|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
23273083|NCT00437658|64742291|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
23273084|NCT00437658|64742292|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
23273085|NCT00437658|64742290|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
23273086|NCT00437658|64742291|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
23273087|NCT00437658|64742292|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
23273088|NCT00437658|64742290|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
23273089|NCT00437658|64742291|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
23273090|NCT00437658|64742292|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
23273091|NCT00437658|64742290|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
23273092|NCT00437658|64742291|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
23273093|NCT00437658|64742292|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
23273094|NCT00437658|64742290|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
23273095|NCT00437658|64742291|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
23273096|NCT00437658|64742292|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
23273097|NCT00437658|64742290|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
23273098|NCT00437658|64742291|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
23273099|NCT00437658|64742292|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
23273100|NCT00437658|64742290|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
23273101|NCT00437658|64742291|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
23273102|NCT00437658|64742292|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
23273103|NCT00437658|64742290|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
23273104|NCT00437658|64742291|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
23273105|NCT00437658|64742292|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
23273106|NCT01387737|64742293|FG000|Overall Study|Adverse Event|20|||
23273107|NCT01387737|64742294|FG001|Overall Study|Adverse Event|30|||
23273108|NCT01387737|64742293|FG000|Overall Study|Lack of Efficacy|1|||
23483681|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Personal reasons|2|||
23483682|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
23483683|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
23367313|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367314|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367315|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367316|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367317|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367318|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367319|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
23367320|NCT03428100|65092367|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367321|NCT03428100|65092368|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
23367322|NCT03428100|65092369|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367323|NCT03428100|65092370|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367324|NCT03428100|65092371|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367325|NCT03428100|65092372|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367326|NCT03428100|65092373|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367327|NCT03428100|65092374|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367328|NCT03428100|65092375|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367329|NCT03428100|65092376|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367330|NCT03428100|65092377|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367331|NCT03428100|65092378|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367332|NCT03428100|65092379|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367333|NCT03428100|65092380|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367334|NCT03428100|65092381|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367335|NCT03428100|65092382|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367336|NCT03428100|65092383|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367337|NCT03428100|65092384|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367338|NCT03428100|65092385|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
23367339|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367340|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367341|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367342|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367343|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367344|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
23367345|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367346|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
23367347|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367348|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367349|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367350|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367351|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
23367352|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367353|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367354|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
23367355|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
23367356|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367357|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
23367358|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
23367359|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
23367360|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
23367361|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
23367362|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
23367363|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
23367364|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
23367365|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
23367366|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
23201262|NCT00702052|64476661|FG000|Overall Study|Adverse Event|23|||
23201263|NCT00702052|64476661|FG000|Overall Study|Disease Progression|30|||
23201264|NCT00702052|64476661|FG000|Overall Study|Withdrawal by Subject|5|||
23201265|NCT01096446|64476667|FG000|Overall Study|Death|1|||
23483684|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
23483685|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
23483686|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
23483687|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
23483688|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
23483689|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
23483690|NCT00667446|65513145|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
23483691|NCT00667446|65513146|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
23483692|NCT00667446|65513145|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
23483693|NCT00667446|65513146|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
23483694|NCT01323920|65515802|FG000|Overall Study|Death|5|||
23483695|NCT01323920|65515802|FG000|Overall Study|Withdrawal by Subject|1|||
23483696|NCT02632838|65515805|FG000|Overall Study|Withdrawal by Subject|3|||
23483697|NCT02632838|65515806|FG001|Overall Study|Withdrawal by Subject|0|||
23483698|NCT02632838|65515805|FG000|Overall Study|Lost to Follow-up|0|||
23483699|NCT02632838|65515806|FG001|Overall Study|Lost to Follow-up|2|||
23483700|NCT01227564|65515809|FG000|Overall Study|No Longer Willing to Participate|4|||
23273109|NCT01387737|64742294|FG001|Overall Study|Lack of Efficacy|0|||
23273110|NCT01387737|64742293|FG000|Overall Study|Physician Decision|3|||
23273111|NCT01387737|64742294|FG001|Overall Study|Physician Decision|10|||
23273112|NCT01387737|64742293|FG000|Overall Study|Withdrawal by Subject|27|||
23273113|NCT01387737|64742294|FG001|Overall Study|Withdrawal by Subject|31|||
23273114|NCT01387737|64742293|FG000|Overall Study|Clearly not eligible for the study|1|||
23483701|NCT01227564|65515810|FG001|Overall Study|No Longer Willing to Participate|2|||
23483702|NCT01227564|65515811|FG002|Overall Study|No Longer Willing to Participate|5|||
23483703|NCT01227564|65515809|FG000|Overall Study|Participant moved to another town|0|||
23483704|NCT01227564|65515810|FG001|Overall Study|Participant moved to another town|0|||
23483705|NCT01227564|65515811|FG002|Overall Study|Participant moved to another town|1|||
23483706|NCT00466687|65515813|FG000|Overall Study|Adverse Event|1|||
23483707|NCT00466687|65515813|FG000|Overall Study|Other complicating illness|3|||
23483708|NCT00466687|65515813|FG000|Overall Study|Withdrawal by Subject|1|||
23483709|NCT00466687|65515813|FG000|Overall Study|Disease progression|29|||
23483710|NCT01277042|65515817|FG000|Overall Study|Adverse Event|4|||
23483711|NCT01277042|65515818|FG001|Overall Study|Adverse Event|3|||
23483712|NCT01277042|65515817|FG000|Overall Study|Lost to Follow-up|2|||
23483713|NCT01277042|65515818|FG001|Overall Study|Lost to Follow-up|2|||
23483714|NCT01277042|65515817|FG000|Overall Study|Withdrawal by Subject|2|||
23483715|NCT01277042|65515818|FG001|Overall Study|Withdrawal by Subject|0|||
23483716|NCT00256282|65515819|FG000|Overall Study|Disease progression, relapse during acti|12|||
23483717|NCT00256282|65515819|FG000|Overall Study|Adverse Event|3|||
23483718|NCT00256282|65515819|FG000|Overall Study|Physician Decision|1|||
23483719|NCT02360605|65515820|FG000|Overall Study|Withdrawal by Subject|4|||
23602117|NCT01500200|65934017|FG003|Stage 1|Withdrawal by Subject|0|||
23602118|NCT01500200|65934018|FG004|Stage 1|Withdrawal by Subject|0|||
23602119|NCT01500200|65934019|FG005|Stage 1|Withdrawal by Subject|0|||
23602120|NCT01500200|65934014|FG000|Stage 1|Noncompliance with Study Drug|1|||
23602121|NCT01500200|65934015|FG001|Stage 1|Noncompliance with Study Drug|0|||
23602122|NCT01500200|65934016|FG002|Stage 1|Noncompliance with Study Drug|0|||
23602123|NCT01500200|65934017|FG003|Stage 1|Noncompliance with Study Drug|0|||
23602124|NCT01500200|65934018|FG004|Stage 1|Noncompliance with Study Drug|0|||
23602125|NCT01500200|65934019|FG005|Stage 1|Noncompliance with Study Drug|0|||
23602126|NCT01500200|65934014|FG000|Stage 1|Physician Decision|1|||
23602127|NCT01500200|65934015|FG001|Stage 1|Physician Decision|0|||
23483720|NCT02360605|65515821|FG001|Overall Study|Withdrawal by Subject|9|||
23483721|NCT02360605|65515820|FG000|Overall Study|Lost to Follow-up|7|||
23483722|NCT02360605|65515821|FG001|Overall Study|Lost to Follow-up|8|||
23602128|NCT01500200|65934016|FG002|Stage 1|Physician Decision|0|||
23602129|NCT01500200|65934017|FG003|Stage 1|Physician Decision|0|||
23602130|NCT01500200|65934018|FG004|Stage 1|Physician Decision|0|||
23602131|NCT01500200|65934019|FG005|Stage 1|Physician Decision|0|||
23602132|NCT01500200|65934014|FG000|Stage 2|Adverse Event|0|||
23483723|NCT02360605|65515820|FG000|Overall Study|Death|0|||
23602133|NCT01500200|65934015|FG001|Stage 2|Adverse Event|0|||
23201266|NCT01096446|64476668|FG001|Overall Study|Death|0|||
23483724|NCT02360605|65515821|FG001|Overall Study|Death|1|||
23483725|NCT03418571|65515822|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
23273115|NCT01387737|64742294|FG001|Overall Study|Clearly not eligible for the study|3|||
23483726|NCT03418571|65515823|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
23483727|NCT02054481|65515824|FG000|Overall Study|Adverse Event|1|||
23483728|NCT02054481|65515825|FG001|Overall Study|Adverse Event|1|||
23483729|NCT02054481|65515826|FG002|Overall Study|Adverse Event|0|||
23483730|NCT02054481|65515827|FG003|Overall Study|Adverse Event|1|||
23483731|NCT02054481|65515824|FG000|Overall Study|Lost to Follow-up|1|||
23483732|NCT02054481|65515825|FG001|Overall Study|Lost to Follow-up|0|||
23483733|NCT02054481|65515826|FG002|Overall Study|Lost to Follow-up|0|||
23483734|NCT02054481|65515827|FG003|Overall Study|Lost to Follow-up|0|||
23483735|NCT02054481|65515824|FG000|Overall Study|Other reason|2|||
23483736|NCT02054481|65515825|FG001|Overall Study|Other reason|1|||
23483737|NCT02054481|65515826|FG002|Overall Study|Other reason|2|||
23483738|NCT02054481|65515827|FG003|Overall Study|Other reason|0|||
23483739|NCT02663687|65515830|FG000|Overall Study|Adverse Event|1|||
23483740|NCT02663687|65515831|FG001|Overall Study|Adverse Event|0|||
23483741|NCT02663687|65515832|FG002|Overall Study|Adverse Event|0|||
23483742|NCT02663687|65515833|FG003|Overall Study|Adverse Event|0|||
23483743|NCT02663687|65515834|FG004|Overall Study|Adverse Event|0|||
23483744|NCT02663687|65515830|FG000|Overall Study|Other|1|||
23483745|NCT02663687|65515831|FG001|Overall Study|Other|0|||
23483746|NCT02663687|65515832|FG002|Overall Study|Other|1|||
23483747|NCT02663687|65515833|FG003|Overall Study|Other|0|||
23483748|NCT02663687|65515834|FG004|Overall Study|Other|0|||
23483749|NCT04285580|65515839|FG000|Overall Study|Protocol Violation|0|||
23483750|NCT04285580|65515840|FG001|Overall Study|Protocol Violation|1|||
23483751|NCT00704522|65515841|FG000|Overall Study|Lack of Efficacy|65|||
23483752|NCT00704522|65515842|FG001|Overall Study|Lack of Efficacy|17|||
23483753|NCT00704522|65515841|FG000|Overall Study|Failure to appear again at hospital|56|||
23483754|NCT00704522|65515842|FG001|Overall Study|Failure to appear again at hospital|10|||
23483755|NCT00704522|65515841|FG000|Overall Study|Withdrawal by Subject|17|||
23483756|NCT00704522|65515842|FG001|Overall Study|Withdrawal by Subject|8|||
23483757|NCT00704522|65515841|FG000|Overall Study|Adverse Event|9|||
23483758|NCT00704522|65515842|FG001|Overall Study|Adverse Event|1|||
23483759|NCT00704522|65515841|FG000|Overall Study|Undefined causes|9|||
23483760|NCT00704522|65515842|FG001|Overall Study|Undefined causes|7|||
23483761|NCT00704522|65515841|FG000|Overall Study|No information on therapy end|27|||
23483762|NCT00704522|65515842|FG001|Overall Study|No information on therapy end|2|||
23483763|NCT00476047|65515843|FG000|Overall Study|Lost to Follow-up|1|||
23483764|NCT00214500|65515844|FG000|Treatment Period|Adverse Event|1|||
23483765|NCT00214500|65515844|FG000|Extension Period|Withdrawal by Subject|2|||
23483766|NCT01117051|65515847|FG000|Overall Study|Withdrawal by Subject|5|||
23483767|NCT01117051|65515848|FG001|Overall Study|Withdrawal by Subject|3|||
23483768|NCT01117051|65515847|FG000|Overall Study|Adverse Event|4|||
23483769|NCT01117051|65515848|FG001|Overall Study|Adverse Event|3|||
23483770|NCT01117051|65515847|FG000|Overall Study|Lost to Follow-up|0|||
23483771|NCT01117051|65515848|FG001|Overall Study|Lost to Follow-up|1|||
23483772|NCT01117051|65515847|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
23483773|NCT01117051|65515848|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
23483774|NCT01117051|65515847|FG000|Overall Study|Sponsor's decision|3|||
23483775|NCT01117051|65515848|FG001|Overall Study|Sponsor's decision|1|||
23483776|NCT01117051|65515847|FG000|Overall Study|Surgical procedure|0|||
23483777|NCT01117051|65515848|FG001|Overall Study|Surgical procedure|1|||
23602134|NCT01500200|65934016|FG002|Stage 2|Adverse Event|0|||
23602135|NCT01500200|65934017|FG003|Stage 2|Adverse Event|0|||
23273116|NCT03555305|64742295|FG000|Period 1|Physician Decision|0|||
23273117|NCT03555305|64742296|FG001|Period 1|Physician Decision|1|||
23273118|NCT03555305|64742295|FG000|Period 1|Adverse Event|0|||
23273119|NCT03555305|64742296|FG001|Period 1|Adverse Event|1|||
23273120|NCT00086996|64742302|FG000|Overall Study|Adverse Event|29|||
23273121|NCT00086996|64742302|FG000|Overall Study|Death|4|||
23273122|NCT00086996|64742302|FG000|Overall Study|progression/relapse|7|||
23273123|NCT00086996|64742302|FG000|Overall Study|Withdrawal by Subject|13|||
23273124|NCT00086996|64742302|FG000|Overall Study|Other|6|||
23273125|NCT00086996|64742302|FG000|Overall Study|not eligible|5|||
23483778|NCT01117051|65515847|FG000|Overall Study|Randomized by mistake|0|||
23483779|NCT01117051|65515848|FG001|Overall Study|Randomized by mistake|1|||
23483780|NCT01117051|65515847|FG000|Overall Study|Convenience issue|1|||
23483781|NCT01117051|65515848|FG001|Overall Study|Convenience issue|0|||
23483782|NCT00378079|65515849|FG000|Overall Study|Lost to Follow-up|6|||
23483783|NCT00378079|65515850|FG001|Overall Study|Lost to Follow-up|1|||
23483784|NCT00378079|65515851|FG002|Overall Study|Lost to Follow-up|0|||
23273126|NCT00669942|64742303|FG000|Parts 2 and 3|Adverse Event|0|||
23273127|NCT00669942|64742304|FG001|Parts 2 and 3|Adverse Event|0|||
23483785|NCT00667420|65515856|FG000|Overall Study|Adverse Event|2|||
23483786|NCT00667420|65515856|FG000|Overall Study|Lack of Efficacy|5|||
23483787|NCT00667420|65515856|FG000|Overall Study|Physician Decision|1|||
23483788|NCT00667420|65515856|FG000|Overall Study|Withdrawal by Subject|2|||
23483789|NCT01233687|65515859|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
23602136|NCT01500200|65934018|FG004|Stage 2|Adverse Event|5|||
23483790|NCT01233687|65515859|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
23483791|NCT01233687|65515859|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
23483792|NCT02711345|65515860|FG000|Overall Study|Adverse Event|0|||
23483793|NCT02711345|65515861|FG001|Overall Study|Adverse Event|0|||
23483794|NCT02711345|65515862|FG002|Overall Study|Adverse Event|0|||
23483795|NCT02711345|65515863|FG003|Overall Study|Adverse Event|1|||
23483796|NCT02711345|65515864|FG004|Overall Study|Adverse Event|1|||
23483797|NCT02711345|65515865|FG005|Overall Study|Adverse Event|2|||
23483798|NCT02711345|65515866|FG006|Overall Study|Adverse Event|1|||
23483799|NCT02711345|65515867|FG007|Overall Study|Adverse Event|0|||
23483800|NCT02711345|65515868|FG008|Overall Study|Adverse Event|0|||
23483801|NCT02711345|65515869|FG009|Overall Study|Adverse Event|2|||
23483802|NCT02711345|65515860|FG000|Overall Study|Physician Decision|0|||
23483803|NCT02711345|65515861|FG001|Overall Study|Physician Decision|0|||
23273128|NCT00669942|64742305|FG002|Parts 2 and 3|Adverse Event|0|||
23367367|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
23367368|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
23367369|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
23367370|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
23367371|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
23367372|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
23367373|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
23367374|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
23367375|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
23367376|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
23367377|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367378|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367379|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367380|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367381|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
23367382|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
23367383|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
23367384|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367385|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367386|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367387|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367388|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
23367389|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
23367390|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
23367391|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
23367392|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
23367393|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367394|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
23367395|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
23367396|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367397|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367398|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367399|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367400|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367401|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367402|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367403|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
23367404|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367405|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367406|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367407|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
23483804|NCT02711345|65515862|FG002|Overall Study|Physician Decision|1|||
23483805|NCT02711345|65515863|FG003|Overall Study|Physician Decision|0|||
23483806|NCT02711345|65515864|FG004|Overall Study|Physician Decision|0|||
23273129|NCT00669942|64742306|FG003|Parts 2 and 3|Adverse Event|0|||
23273130|NCT00669942|64742307|FG004|Parts 2 and 3|Adverse Event|0|||
23273131|NCT00669942|64742308|FG005|Parts 2 and 3|Adverse Event|0|||
23273132|NCT00669942|64742309|FG006|Parts 2 and 3|Adverse Event|0|||
23273133|NCT00669942|64742310|FG007|Parts 2 and 3|Adverse Event|2|||
23273134|NCT00669942|64742311|FG008|Parts 2 and 3|Adverse Event|1|||
23273135|NCT00669942|64742312|FG009|Parts 2 and 3|Adverse Event|0|||
23273136|NCT00669942|64742313|FG010|Parts 2 and 3|Adverse Event|0|||
23273137|NCT00669942|64742314|FG011|Parts 2 and 3|Adverse Event|0|||
23273138|NCT00669942|64742303|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
23273139|NCT00669942|64742304|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
23273140|NCT00669942|64742305|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
23273141|NCT00669942|64742306|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
23273142|NCT00669942|64742307|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
23273143|NCT00669942|64742308|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
23273144|NCT00669942|64742309|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
23483807|NCT02711345|65515865|FG005|Overall Study|Physician Decision|0|||
23483808|NCT02711345|65515866|FG006|Overall Study|Physician Decision|0|||
23483809|NCT02711345|65515867|FG007|Overall Study|Physician Decision|0|||
23483810|NCT02711345|65515868|FG008|Overall Study|Physician Decision|1|||
23483811|NCT02711345|65515869|FG009|Overall Study|Physician Decision|0|||
23483812|NCT02711345|65515860|FG000|Overall Study|Progressive disease|1|||
23483813|NCT02711345|65515861|FG001|Overall Study|Progressive disease|3|||
23483814|NCT02711345|65515862|FG002|Overall Study|Progressive disease|5|||
23483815|NCT02711345|65515863|FG003|Overall Study|Progressive disease|3|||
23483816|NCT02711345|65515864|FG004|Overall Study|Progressive disease|7|||
23483817|NCT02711345|65515865|FG005|Overall Study|Progressive disease|2|||
23483818|NCT02711345|65515866|FG006|Overall Study|Progressive disease|8|||
23483819|NCT02711345|65515867|FG007|Overall Study|Progressive disease|4|||
23483820|NCT02711345|65515868|FG008|Overall Study|Progressive disease|5|||
23483821|NCT02711345|65515869|FG009|Overall Study|Progressive disease|6|||
23483822|NCT02711345|65515860|FG000|Overall Study|Subject/guardian decision|0|||
23483823|NCT02711345|65515861|FG001|Overall Study|Subject/guardian decision|0|||
23483824|NCT02711345|65515862|FG002|Overall Study|Subject/guardian decision|0|||
23483825|NCT02711345|65515863|FG003|Overall Study|Subject/guardian decision|0|||
23483826|NCT02711345|65515864|FG004|Overall Study|Subject/guardian decision|0|||
23483827|NCT02711345|65515865|FG005|Overall Study|Subject/guardian decision|2|||
23483828|NCT02711345|65515866|FG006|Overall Study|Subject/guardian decision|3|||
23483829|NCT02711345|65515867|FG007|Overall Study|Subject/guardian decision|1|||
23483830|NCT02711345|65515868|FG008|Overall Study|Subject/guardian decision|0|||
23483831|NCT02711345|65515869|FG009|Overall Study|Subject/guardian decision|4|||
23483832|NCT02711345|65515860|FG000|Overall Study|Death|1|||
23483833|NCT02711345|65515861|FG001|Overall Study|Death|0|||
23483834|NCT02711345|65515862|FG002|Overall Study|Death|0|||
23483835|NCT02711345|65515863|FG003|Overall Study|Death|0|||
23483836|NCT02711345|65515864|FG004|Overall Study|Death|0|||
23483837|NCT02711345|65515865|FG005|Overall Study|Death|0|||
23483838|NCT02711345|65515866|FG006|Overall Study|Death|0|||
23483839|NCT02711345|65515867|FG007|Overall Study|Death|1|||
23483840|NCT02711345|65515868|FG008|Overall Study|Death|0|||
23483841|NCT02711345|65515869|FG009|Overall Study|Death|0|||
23483842|NCT01611454|65515871|FG000|Overall Study|Lack of Efficacy|18|||
23483843|NCT01611454|65515872|FG001|Overall Study|Lack of Efficacy|10|||
23483844|NCT01931670|65515873|FG000|Treatment Period|Exclusionary Medication Received|1|||
23483845|NCT01931670|65515874|FG001|Treatment Period|Exclusionary Medication Received|1|||
23483846|NCT01931670|65515875|FG002|Treatment Period|Exclusionary Medication Received|1|||
23483847|NCT01931670|65515873|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
23483848|NCT01931670|65515874|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
23483849|NCT01931670|65515875|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
23483850|NCT01931670|65515873|FG000|Treatment Period|Subject Noncompliant|4|||
23483851|NCT01931670|65515874|FG001|Treatment Period|Subject Noncompliant|9|||
23483852|NCT01931670|65515875|FG002|Treatment Period|Subject Noncompliant|5|||
23483853|NCT01931670|65515873|FG000|Treatment Period|Adverse Event|19|||
23483854|NCT01931670|65515874|FG001|Treatment Period|Adverse Event|8|||
23483855|NCT01931670|65515875|FG002|Treatment Period|Adverse Event|21|||
23483856|NCT01931670|65515873|FG000|Treatment Period|Lack of Efficacy|11|||
23483857|NCT01931670|65515874|FG001|Treatment Period|Lack of Efficacy|2|||
23483858|NCT01931670|65515875|FG002|Treatment Period|Lack of Efficacy|2|||
23483859|NCT01931670|65515873|FG000|Treatment Period|Pregnancy|7|||
23483860|NCT01931670|65515874|FG001|Treatment Period|Pregnancy|2|||
23483861|NCT01931670|65515875|FG002|Treatment Period|Pregnancy|0|||
23483862|NCT01931670|65515873|FG000|Treatment Period|Other|8|||
23483863|NCT01931670|65515874|FG001|Treatment Period|Other|7|||
23483864|NCT01931670|65515875|FG002|Treatment Period|Other|2|||
23483865|NCT01931670|65515873|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
23483866|NCT01931670|65515874|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
23483867|NCT01931670|65515875|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
23483868|NCT01931670|65515873|FG000|Treatment Period|Lost to Follow-up|19|||
23273145|NCT00669942|64742310|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
23273146|NCT00669942|64742311|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
23483869|NCT01931670|65515874|FG001|Treatment Period|Lost to Follow-up|5|||
23483870|NCT01931670|65515875|FG002|Treatment Period|Lost to Follow-up|7|||
23483871|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
23273147|NCT00669942|64742312|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
23273148|NCT00669942|64742313|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
23483872|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
23483873|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
23483874|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
23483875|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
23483876|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
23483877|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
23483878|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
23483879|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
23483880|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
23483881|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
23483882|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
23273149|NCT00669942|64742314|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
23273150|NCT00669942|64742303|FG000|Parts 2 and 3|Protocol Violation|0|||
23273151|NCT00669942|64742304|FG001|Parts 2 and 3|Protocol Violation|0|||
23483883|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
23483884|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
23483885|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
23483886|NCT01931670|65515873|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
23483887|NCT01931670|65515874|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
23483888|NCT01931670|65515875|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
23483889|NCT02496676|65515877|FG000|Phase 1 - Period 1|Adverse Event|0|||
23483890|NCT02496676|65515878|FG001|Phase 1 - Period 1|Adverse Event|1|||
23483891|NCT02496676|65515877|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
23483892|NCT02496676|65515878|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
23483893|NCT02025556|65515879|FG000|Overall Study|Adverse Event|0|||
23483894|NCT02025556|65515880|FG001|Overall Study|Adverse Event|4|||
23483895|NCT02025556|65515881|FG002|Overall Study|Adverse Event|2|||
23483896|NCT02025556|65515879|FG000|Overall Study|Lack of Efficacy|2|||
23483897|NCT02025556|65515880|FG001|Overall Study|Lack of Efficacy|1|||
23273152|NCT00669942|64742305|FG002|Parts 2 and 3|Protocol Violation|0|||
23273153|NCT00669942|64742306|FG003|Parts 2 and 3|Protocol Violation|0|||
23273154|NCT00669942|64742307|FG004|Parts 2 and 3|Protocol Violation|0|||
23273155|NCT00669942|64742308|FG005|Parts 2 and 3|Protocol Violation|1|||
23273156|NCT00669942|64742309|FG006|Parts 2 and 3|Protocol Violation|0|||
23273157|NCT00669942|64742310|FG007|Parts 2 and 3|Protocol Violation|0|||
23273158|NCT00669942|64742311|FG008|Parts 2 and 3|Protocol Violation|0|||
23273159|NCT00669942|64742312|FG009|Parts 2 and 3|Protocol Violation|0|||
23273160|NCT00669942|64742313|FG010|Parts 2 and 3|Protocol Violation|0|||
23273161|NCT00669942|64742314|FG011|Parts 2 and 3|Protocol Violation|0|||
23273162|NCT00320112|64742319|FG000|Overall Study|Lost to Follow-up|3|||
23273163|NCT00320112|64742320|FG001|Overall Study|Lost to Follow-up|4|||
23273164|NCT00320112|64742319|FG000|Overall Study|Withdrawal by Subject|3|||
23273165|NCT00320112|64742320|FG001|Overall Study|Withdrawal by Subject|0|||
23273166|NCT00320112|64742319|FG000|Overall Study|Death|2|||
23273167|NCT00320112|64742320|FG001|Overall Study|Death|1|||
23273168|NCT02739997|64742322|FG000|Overall Study|Death|1|||
23273169|NCT02739997|64742322|FG000|Overall Study|Withdrawal by Subject|1|||
23273170|NCT03880266|64742323|FG000|Overall Study|Withdrawal by Subject|0|||
23273171|NCT03880266|64742324|FG001|Overall Study|Withdrawal by Subject|1|||
23273172|NCT03880266|64742325|FG002|Overall Study|Withdrawal by Subject|1|||
23273173|NCT03880266|64742326|FG003|Overall Study|Withdrawal by Subject|0|||
23273174|NCT03880266|64742327|FG004|Overall Study|Withdrawal by Subject|0|||
23273175|NCT03880266|64742328|FG005|Overall Study|Withdrawal by Subject|0|||
23273176|NCT03880266|64742329|FG006|Overall Study|Withdrawal by Subject|0|||
23273177|NCT03880266|64742330|FG007|Overall Study|Withdrawal by Subject|0|||
23273178|NCT00877032|64742331|FG000|Overall Study|Did not meet entrance criteria|0|||
23273179|NCT00877032|64742332|FG001|Overall Study|Did not meet entrance criteria|0|||
23273180|NCT00877032|64742333|FG002|Overall Study|Did not meet entrance criteria|0|||
23273181|NCT00877032|64742334|FG003|Overall Study|Did not meet entrance criteria|1|||
23273182|NCT00877032|64742335|FG004|Overall Study|Did not meet entrance criteria|0|||
23273183|NCT00877032|64742336|FG005|Overall Study|Did not meet entrance criteria|0|||
23273184|NCT00877032|64742337|FG006|Overall Study|Did not meet entrance criteria|2|||
23273185|NCT01214850|64742338|FG000|Overall Study|Withdrawal by Subject|38|||
23273186|NCT01214850|64742339|FG001|Overall Study|Withdrawal by Subject|31|||
23273187|NCT01214850|64742340|FG002|Overall Study|Withdrawal by Subject|28|||
23273188|NCT01214850|64742338|FG000|Overall Study|Lost to Follow-up|124|||
23273189|NCT01214850|64742339|FG001|Overall Study|Lost to Follow-up|98|||
23273190|NCT01214850|64742340|FG002|Overall Study|Lost to Follow-up|123|||
23273191|NCT01214850|64742338|FG000|Overall Study|Protocol Violation|5|||
23483898|NCT02025556|65515881|FG002|Overall Study|Lack of Efficacy|0|||
23273192|NCT01214850|64742339|FG001|Overall Study|Protocol Violation|5|||
23483899|NCT02025556|65515879|FG000|Overall Study|Protocol Violation|2|||
23273193|NCT01214850|64742340|FG002|Overall Study|Protocol Violation|6|||
23273194|NCT01214850|64742338|FG000|Overall Study|Adverse event or death|11|||
23483900|NCT02025556|65515880|FG001|Overall Study|Protocol Violation|1|||
23483901|NCT02025556|65515881|FG002|Overall Study|Protocol Violation|0|||
23273195|NCT01214850|64742339|FG001|Overall Study|Adverse event or death|8|||
23273196|NCT01214850|64742340|FG002|Overall Study|Adverse event or death|3|||
23273197|NCT01214850|64742338|FG000|Overall Study|Inappropriate enrollment|2|||
23273198|NCT01214850|64742339|FG001|Overall Study|Inappropriate enrollment|1|||
23273199|NCT01214850|64742340|FG002|Overall Study|Inappropriate enrollment|0|||
23273200|NCT01214850|64742338|FG000|Overall Study|Administrative reason|1|||
23273201|NCT01214850|64742339|FG001|Overall Study|Administrative reason|0|||
23273202|NCT01214850|64742340|FG002|Overall Study|Administrative reason|0|||
23273203|NCT01214850|64742338|FG000|Overall Study|Unable to classify|2|||
23273204|NCT01214850|64742339|FG001|Overall Study|Unable to classify|1|||
23273205|NCT01214850|64742340|FG002|Overall Study|Unable to classify|1|||
23273206|NCT00096265|64742347|FG000|Overall Study|Ineligible|1|||
23273207|NCT00096265|64742348|FG001|Overall Study|Ineligible|0|||
23273208|NCT00096265|64742349|FG002|Overall Study|Ineligible|0|||
23273209|NCT01722877|64742350|FG000|Overall Study|Death|1|||
23273210|NCT01722877|64742350|FG000|Overall Study|Lost to Follow-up|1|||
23273211|NCT02910037|64742351|FG000|Overall Study|Withdrawal by Subject|4|||
23273212|NCT02910037|64742351|FG000|Overall Study|Lost to Follow-up|6|||
23367408|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
23367409|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367410|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
23367411|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367412|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367413|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
23367414|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
23367415|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
23367416|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
23367417|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
23367418|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
23367419|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
23367420|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
23367421|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
23367422|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
23367423|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
23367424|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
23367425|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
23367426|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
23367427|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
23367428|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
23367429|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
23367430|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
23367431|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
23367432|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
23367433|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
23367434|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367435|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367436|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367437|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367438|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367439|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367440|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
23367441|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367442|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367443|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367444|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367445|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367446|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367447|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367448|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367449|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367450|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23367451|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
23273213|NCT01035060|64745054|FG000|Overall Study|Lost to Follow-up|0|||
23273214|NCT01035060|64745055|FG001|Overall Study|Lost to Follow-up|7|||
23273215|NCT01035060|64745054|FG000|Overall Study|Did not quality after 2nd screening|14|||
23273216|NCT01035060|64745055|FG001|Overall Study|Did not quality after 2nd screening|1|||
23273217|NCT01035060|64745054|FG000|Overall Study|Withdrawal by Subject|8|||
23273218|NCT01035060|64745055|FG001|Overall Study|Withdrawal by Subject|6|||
23273219|NCT01035060|64745054|FG000|Overall Study|Physician Decision|2|||
23273220|NCT01035060|64745055|FG001|Overall Study|Physician Decision|0|||
23273221|NCT01838941|64745058|FG000|Overall Study|Adverse Event|1|||
23273222|NCT01838941|64745058|FG000|Overall Study|Withdrawal by Subject|1|||
23273223|NCT01439880|64745065|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
23273224|NCT01439880|64745066|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
23273225|NCT01439880|64745065|FG000|SOC-controlled Period (Year 1)|Death|2|||
23273226|NCT01439880|64745066|FG001|SOC-controlled Period (Year 1)|Death|1|||
23273227|NCT01439880|64745065|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
23367452|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
23367453|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
23367454|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
23367455|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
23367456|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
23367457|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
23367458|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
23367459|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
23367460|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
23367461|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
23367462|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
23367463|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
23367464|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
23367465|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
23367466|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
23367467|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
23367468|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
23367469|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
23367470|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
23367471|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
23367472|NCT03428100|65092367|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367473|NCT03428100|65092368|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367474|NCT03428100|65092369|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367475|NCT03428100|65092370|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367476|NCT03428100|65092371|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
23367477|NCT03428100|65092372|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367478|NCT03428100|65092373|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
23367479|NCT03428100|65092374|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
23367480|NCT03428100|65092375|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367481|NCT03428100|65092376|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
23367482|NCT03428100|65092377|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
23367483|NCT03428100|65092378|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
23367484|NCT03428100|65092379|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
23367485|NCT03428100|65092380|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
23367486|NCT03428100|65092381|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
23367487|NCT03428100|65092382|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367488|NCT03428100|65092383|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
23367489|NCT03428100|65092384|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
23367490|NCT03428100|65092385|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
23367491|NCT00676403|65092386|FG000|Overall Study|Adverse Event|1|||
23367492|NCT00676403|65092387|FG001|Overall Study|Adverse Event|2|||
23367493|NCT00676403|65092388|FG002|Overall Study|Adverse Event|0|||
23367494|NCT00676403|65092389|FG003|Overall Study|Adverse Event|5|||
23367495|NCT00676403|65092390|FG004|Overall Study|Adverse Event|1|||
23367496|NCT00676403|65092391|FG005|Overall Study|Adverse Event|2|||
23367497|NCT00676403|65092386|FG000|Overall Study|Lost to Follow-up|0|||
23367498|NCT00676403|65092387|FG001|Overall Study|Lost to Follow-up|0|||
23273228|NCT01439880|64745066|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
23273229|NCT01439880|64745065|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
23201267|NCT01096446|64476667|FG000|Overall Study|Protocol Violation|2|||
23367499|NCT00676403|65092388|FG002|Overall Study|Lost to Follow-up|0|||
23367500|NCT00676403|65092389|FG003|Overall Study|Lost to Follow-up|0|||
23367501|NCT00676403|65092390|FG004|Overall Study|Lost to Follow-up|0|||
23367502|NCT00676403|65092391|FG005|Overall Study|Lost to Follow-up|1|||
23367503|NCT00676403|65092386|FG000|Overall Study|Reason Unspecified|1|||
23367504|NCT00676403|65092387|FG001|Overall Study|Reason Unspecified|0|||
23367505|NCT00676403|65092388|FG002|Overall Study|Reason Unspecified|1|||
23367506|NCT00676403|65092389|FG003|Overall Study|Reason Unspecified|0|||
23367507|NCT00676403|65092390|FG004|Overall Study|Reason Unspecified|0|||
23483902|NCT02025556|65515879|FG000|Overall Study|Withdrawal by Subject|0|||
23483903|NCT02025556|65515880|FG001|Overall Study|Withdrawal by Subject|3|||
23483904|NCT02025556|65515881|FG002|Overall Study|Withdrawal by Subject|6|||
23483905|NCT02025556|65515879|FG000|Overall Study|Lost to Follow-up|2|||
23483906|NCT02025556|65515880|FG001|Overall Study|Lost to Follow-up|4|||
23483907|NCT02025556|65515881|FG002|Overall Study|Lost to Follow-up|0|||
23483908|NCT02025556|65515879|FG000|Overall Study|Reason not reported|0|||
23483909|NCT02025556|65515880|FG001|Overall Study|Reason not reported|0|||
23483910|NCT02025556|65515881|FG002|Overall Study|Reason not reported|1|||
23483911|NCT03612856|65515885|FG000|Pre-dose Period|Physician Decision|0|||
23483912|NCT03612856|65515886|FG001|Pre-dose Period|Physician Decision|1|||
23602137|NCT01500200|65934019|FG005|Stage 2|Adverse Event|4|||
23602138|NCT03066609|65934020|FG000|INDUCTION|Pregnancy|0|||
23602139|NCT03066609|65934021|FG001|INDUCTION|Pregnancy|0|||
23602140|NCT03066609|65934022|FG002|INDUCTION|Pregnancy|1|||
23602141|NCT03066609|65934023|FG003|INDUCTION|Pregnancy|0|||
23602142|NCT03066609|65934020|FG000|INDUCTION|Lack of Efficacy|0|||
23602143|NCT03066609|65934021|FG001|INDUCTION|Lack of Efficacy|0|||
23602144|NCT03066609|65934022|FG002|INDUCTION|Lack of Efficacy|1|||
23602145|NCT03066609|65934023|FG003|INDUCTION|Lack of Efficacy|0|||
23602146|NCT03066609|65934020|FG000|INDUCTION|Adverse Event|2|||
23602147|NCT03066609|65934021|FG001|INDUCTION|Adverse Event|2|||
23602148|NCT03066609|65934022|FG002|INDUCTION|Adverse Event|0|||
23602149|NCT03066609|65934023|FG003|INDUCTION|Adverse Event|0|||
23602150|NCT03066609|65934020|FG000|MAINTENANCE|Adverse Event|0|||
23602151|NCT03066609|65934021|FG001|MAINTENANCE|Adverse Event|0|||
23602152|NCT03066609|65934022|FG002|MAINTENANCE|Adverse Event|0|||
23602153|NCT03066609|65934023|FG003|MAINTENANCE|Adverse Event|1|||
23602154|NCT03066609|65934020|FG000|MAINTENANCE|Withdrawal by Subject|4|||
23602155|NCT03066609|65934021|FG001|MAINTENANCE|Withdrawal by Subject|2|||
23602156|NCT03066609|65934022|FG002|MAINTENANCE|Withdrawal by Subject|1|||
23602157|NCT03066609|65934023|FG003|MAINTENANCE|Withdrawal by Subject|1|||
23602158|NCT03066609|65934020|FG000|MAINTENANCE|Lost to Follow-up|0|||
23602159|NCT03066609|65934021|FG001|MAINTENANCE|Lost to Follow-up|1|||
23602160|NCT03066609|65934022|FG002|MAINTENANCE|Lost to Follow-up|1|||
23602161|NCT03066609|65934023|FG003|MAINTENANCE|Lost to Follow-up|0|||
23602162|NCT03066609|65934020|FG000|MAINTENANCE|Pregnancy|1|||
23602163|NCT03066609|65934021|FG001|MAINTENANCE|Pregnancy|0|||
23367508|NCT00676403|65092391|FG005|Overall Study|Reason Unspecified|1|||
23367509|NCT00676403|65092386|FG000|Overall Study|Withdrawal by Subject|0|||
23602164|NCT03066609|65934022|FG002|MAINTENANCE|Pregnancy|0|||
23602165|NCT03066609|65934023|FG003|MAINTENANCE|Pregnancy|0|||
23602166|NCT03066609|65934020|FG000|MAINTENANCE|Lack of Efficacy|2|||
23602167|NCT03066609|65934021|FG001|MAINTENANCE|Lack of Efficacy|1|||
23483913|NCT03612856|65515887|FG002|Pre-dose Period|Physician Decision|1|||
23602168|NCT03066609|65934022|FG002|MAINTENANCE|Lack of Efficacy|0|||
23602169|NCT03066609|65934023|FG003|MAINTENANCE|Lack of Efficacy|1|||
23602170|NCT03066609|65934020|FG000|OVERALL STUDY|Adverse Event|2|||
23602171|NCT03066609|65934021|FG001|OVERALL STUDY|Adverse Event|2|||
23602172|NCT03066609|65934022|FG002|OVERALL STUDY|Adverse Event|0|||
23602173|NCT03066609|65934023|FG003|OVERALL STUDY|Adverse Event|1|||
23602174|NCT03066609|65934020|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
23483914|NCT03612856|65515885|FG000|Pre-dose Period|Withdrawal by Subject|0|||
23483915|NCT03612856|65515886|FG001|Pre-dose Period|Withdrawal by Subject|1|||
23602175|NCT03066609|65934021|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
23602176|NCT03066609|65934022|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
23602177|NCT03066609|65934023|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
23602178|NCT03066609|65934020|FG000|OVERALL STUDY|Lost to Follow-up|1|||
23602179|NCT03066609|65934021|FG001|OVERALL STUDY|Lost to Follow-up|1|||
23602180|NCT03066609|65934022|FG002|OVERALL STUDY|Lost to Follow-up|1|||
23602181|NCT03066609|65934023|FG003|OVERALL STUDY|Lost to Follow-up|1|||
23602182|NCT03066609|65934020|FG000|OVERALL STUDY|Pregnancy|1|||
23602183|NCT03066609|65934021|FG001|OVERALL STUDY|Pregnancy|0|||
23602184|NCT03066609|65934022|FG002|OVERALL STUDY|Pregnancy|1|||
23602185|NCT03066609|65934023|FG003|OVERALL STUDY|Pregnancy|0|||
23602186|NCT03066609|65934020|FG000|OVERALL STUDY|Lack of Efficacy|2|||
23483916|NCT03612856|65515887|FG002|Pre-dose Period|Withdrawal by Subject|0|||
23483917|NCT01251146|65515888|FG000|Overall Study|Lost to Follow-up|3|||
23483918|NCT01251146|65515889|FG001|Overall Study|Lost to Follow-up|10|||
23483919|NCT00058539|65515890|FG000|Overall Study|Disease progression|24|||
23483920|NCT00058539|65515890|FG000|Overall Study|Adverse Event|3|||
23602187|NCT03066609|65934021|FG001|OVERALL STUDY|Lack of Efficacy|1|||
23602188|NCT03066609|65934022|FG002|OVERALL STUDY|Lack of Efficacy|1|||
23602189|NCT03066609|65934023|FG003|OVERALL STUDY|Lack of Efficacy|1|||
23602190|NCT03066609|65934020|FG000|OVERALL STUDY|discontinued follow up|0|||
23602191|NCT03066609|65934021|FG001|OVERALL STUDY|discontinued follow up|2|||
23201268|NCT01096446|64476668|FG001|Overall Study|Protocol Violation|0|||
23201269|NCT03521687|64476669|FG000|Overall Study|Adverse Event|4|||
23201270|NCT03521687|64476669|FG000|Overall Study|Physician Decision|1|||
23201271|NCT01240811|64476670|FG000|Overall Study|Physician Decision|0|||
23201272|NCT01240811|64476671|FG001|Overall Study|Physician Decision|1|||
23201273|NCT01240811|64476672|FG002|Overall Study|Physician Decision|0|||
23201274|NCT01240811|64476670|FG000|Overall Study|Withdrawal by Subject|0|||
23201275|NCT01240811|64476671|FG001|Overall Study|Withdrawal by Subject|0|||
23201276|NCT01240811|64476672|FG002|Overall Study|Withdrawal by Subject|1|||
23201277|NCT01228071|64476675|FG000|Overall Study|Protocol Violation|1|||
23602192|NCT03066609|65934022|FG002|OVERALL STUDY|discontinued follow up|0|||
23602193|NCT03066609|65934023|FG003|OVERALL STUDY|discontinued follow up|0|||
23602194|NCT03500549|65934024|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
23602195|NCT03500549|65934025|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
23602196|NCT03500549|65934024|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
23602197|NCT03500549|65934025|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
23602198|NCT00866619|65934026|FG000|Overall Study|Adverse Event|112|||
23602199|NCT00866619|65934027|FG001|Overall Study|Adverse Event|106|||
23602200|NCT00866619|65934028|FG002|Overall Study|Adverse Event|47|||
23602201|NCT00866619|65934029|FG003|Overall Study|Adverse Event|44|||
23602202|NCT00866619|65934026|FG000|Overall Study|Protocol Violation|2|||
23602203|NCT00866619|65934027|FG001|Overall Study|Protocol Violation|39|||
23201278|NCT01228071|64476675|FG000|Overall Study|Withdrawal by Subject|1|||
23602204|NCT00866619|65934028|FG002|Overall Study|Protocol Violation|2|||
23273230|NCT01439880|64745066|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
23273231|NCT01439880|64745065|FG000|SOC-controlled Period (Year 1)|Other|8|||
23273232|NCT01439880|64745066|FG001|SOC-controlled Period (Year 1)|Other|13|||
23273233|NCT01439880|64745065|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
23273234|NCT01439880|64745066|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
23273235|NCT01439880|64745065|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
23273236|NCT01439880|64745066|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
23273237|NCT01439880|64745065|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
23273238|NCT01439880|64745066|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
23273239|NCT01439880|64745065|FG000|All-IP Period (Years 2 to 5)|Death|3|||
23273240|NCT01439880|64745066|FG001|All-IP Period (Years 2 to 5)|Death|13|||
23273241|NCT01439880|64745065|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
23273242|NCT01439880|64745066|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
23273243|NCT01439880|64745065|FG000|All-IP Period (Years 2 to 5)|Other|14|||
23273244|NCT01439880|64745066|FG001|All-IP Period (Years 2 to 5)|Other|31|||
23273245|NCT01439880|64745065|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
23273246|NCT01439880|64745066|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
23273247|NCT00537030|64745067|FG000|Overall Study|Physician Decision|2|||
23273248|NCT00537030|64745067|FG000|Overall Study|Withdrawal by Subject|2|||
23273249|NCT00537030|64745067|FG000|Overall Study|≥ Grade 2 allergy|7|||
23273250|NCT00537030|64745067|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
23273251|NCT00537030|64745067|FG000|Overall Study|Ineligible|2|||
23273252|NCT00537030|64745067|FG000|Overall Study|Inevaluable|2|||
23273253|NCT01615198|64745068|FG000|Overall Study|Withdrawal by Subject|5|||
23273254|NCT01615198|64745069|FG001|Overall Study|Withdrawal by Subject|5|||
23273255|NCT01615198|64745068|FG000|Overall Study|Protocol deviation|1|||
23273256|NCT01615198|64745069|FG001|Overall Study|Protocol deviation|1|||
23273257|NCT01615198|64745068|FG000|Overall Study|Physician Decision|5|||
23602205|NCT00866619|65934029|FG003|Overall Study|Protocol Violation|17|||
23273258|NCT01615198|64745069|FG001|Overall Study|Physician Decision|1|||
23273259|NCT01615198|64745068|FG000|Overall Study|Lost to Follow-up|1|||
23367510|NCT00676403|65092387|FG001|Overall Study|Withdrawal by Subject|0|||
23367511|NCT00676403|65092388|FG002|Overall Study|Withdrawal by Subject|0|||
23367512|NCT00676403|65092389|FG003|Overall Study|Withdrawal by Subject|0|||
23273260|NCT01615198|64745069|FG001|Overall Study|Lost to Follow-up|1|||
23273261|NCT01615198|64745068|FG000|Overall Study|Lack of Efficacy|1|||
23273262|NCT01615198|64745069|FG001|Overall Study|Lack of Efficacy|6|||
23367513|NCT00676403|65092390|FG004|Overall Study|Withdrawal by Subject|0|||
23273263|NCT01615198|64745068|FG000|Overall Study|Adverse Event|11|||
23273264|NCT01615198|64745069|FG001|Overall Study|Adverse Event|5|||
23273265|NCT00323882|64745070|FG000|Overall Study|Adverse Event|2|||
23273266|NCT00323882|64745071|FG001|Overall Study|Adverse Event|1|||
23273267|NCT00323882|64745072|FG002|Overall Study|Adverse Event|1|||
23273268|NCT00323882|64745073|FG003|Overall Study|Adverse Event|1|||
23273269|NCT00323882|64745074|FG004|Overall Study|Adverse Event|3|||
23273270|NCT00323882|64745070|FG000|Overall Study|Disease Progression|6|||
23273271|NCT00323882|64745071|FG001|Overall Study|Disease Progression|4|||
23273272|NCT00323882|64745072|FG002|Overall Study|Disease Progression|10|||
23273273|NCT00323882|64745073|FG003|Overall Study|Disease Progression|5|||
23273274|NCT00323882|64745074|FG004|Overall Study|Disease Progression|22|||
23273275|NCT00323882|64745070|FG000|Overall Study|Death|0|||
23273276|NCT00323882|64745071|FG001|Overall Study|Death|1|||
23273277|NCT00323882|64745072|FG002|Overall Study|Death|1|||
23273278|NCT00323882|64745073|FG003|Overall Study|Death|0|||
23273279|NCT00323882|64745074|FG004|Overall Study|Death|5|||
23273280|NCT00323882|64745070|FG000|Overall Study|Lost to Follow-up|0|||
23273281|NCT00323882|64745071|FG001|Overall Study|Lost to Follow-up|0|||
23273282|NCT00323882|64745072|FG002|Overall Study|Lost to Follow-up|1|||
23273283|NCT00323882|64745073|FG003|Overall Study|Lost to Follow-up|0|||
23273284|NCT00323882|64745074|FG004|Overall Study|Lost to Follow-up|1|||
23273285|NCT00323882|64745070|FG000|Overall Study|Other|0|||
23273286|NCT00323882|64745071|FG001|Overall Study|Other|0|||
23273287|NCT00323882|64745072|FG002|Overall Study|Other|0|||
23273288|NCT00323882|64745073|FG003|Overall Study|Other|1|||
23273289|NCT00323882|64745074|FG004|Overall Study|Other|1|||
23273290|NCT02414152|64745075|FG000|Overall Study|Withdrawal by Subject|1|||
23273291|NCT02414152|64745075|FG000|Overall Study|Lack of Efficacy|1|||
23273292|NCT00933686|64745076|FG000|Overall Study|Protocol Violation|0|||
23273293|NCT00933686|64745077|FG001|Overall Study|Protocol Violation|1|||
23273294|NCT00933686|64745076|FG000|Overall Study|Lost to Follow-up|2|||
23273295|NCT00933686|64745077|FG001|Overall Study|Lost to Follow-up|2|||
23273296|NCT00933686|64745076|FG000|Overall Study|Withdrawal by Subject|6|||
23273297|NCT00933686|64745077|FG001|Overall Study|Withdrawal by Subject|5|||
23273298|NCT00933686|64745076|FG000|Overall Study|Adverse Event|1|||
23273299|NCT00933686|64745077|FG001|Overall Study|Adverse Event|1|||
23273300|NCT00933686|64745076|FG000|Overall Study|Physician Decision|1|||
23273301|NCT00933686|64745077|FG001|Overall Study|Physician Decision|0|||
23273302|NCT00933686|64745076|FG000|Overall Study|Failure to show up at endpoint visits|0|||
23273303|NCT00933686|64745077|FG001|Overall Study|Failure to show up at endpoint visits|2|||
23273304|NCT00263588|64745082|FG000|Overall Study|Death|54|||
23273305|NCT00263588|64745083|FG001|Overall Study|Death|90|||
23273306|NCT00263588|64745082|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
23273307|NCT00263588|64745083|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
23273308|NCT00263588|64745082|FG000|Overall Study|Lost to Follow-up|7|||
23273309|NCT00263588|64745083|FG001|Overall Study|Lost to Follow-up|10|||
23602206|NCT00866619|65934026|FG000|Overall Study|Withdrawal by Subject|587|||
23602207|NCT00866619|65934027|FG001|Overall Study|Withdrawal by Subject|295|||
23602208|NCT00866619|65934028|FG002|Overall Study|Withdrawal by Subject|272|||
23273310|NCT00263588|64745082|FG000|Overall Study|Withdrawal by Subject|3|||
23273311|NCT00263588|64745083|FG001|Overall Study|Withdrawal by Subject|4|||
23273312|NCT00263588|64745082|FG000|Overall Study|Protocol Violation|0|||
23273313|NCT00263588|64745083|FG001|Overall Study|Protocol Violation|1|||
23273314|NCT00263588|64745082|FG000|Overall Study|Investigator decision|7|||
23273315|NCT00263588|64745083|FG001|Overall Study|Investigator decision|15|||
23273316|NCT00263588|64745082|FG000|Overall Study|Sponsor terminated study|0|||
23273317|NCT00263588|64745083|FG001|Overall Study|Sponsor terminated study|1|||
23273318|NCT00858845|64745089|FG000|Overall Study|Patient underwent heart transplant.|0|||
23273319|NCT00858845|64745090|FG001|Overall Study|Patient underwent heart transplant.|1|||
23273320|NCT01604850|64745091|FG000|Overall Study|Enrolled but never treated|0|||
23273321|NCT01604850|64745092|FG001|Overall Study|Enrolled but never treated|1|||
23602209|NCT00866619|65934029|FG003|Overall Study|Withdrawal by Subject|144|||
23602210|NCT00866619|65934026|FG000|Overall Study|Lost to Follow-up|1145|||
23602211|NCT00866619|65934027|FG001|Overall Study|Lost to Follow-up|830|||
23602212|NCT00866619|65934028|FG002|Overall Study|Lost to Follow-up|568|||
23602213|NCT00866619|65934029|FG003|Overall Study|Lost to Follow-up|425|||
23602214|NCT00562094|65934034|FG000|Overall Study|Lost to Follow-up|62|||
23273322|NCT01604850|64745091|FG000|Overall Study|Efficacy Failure|50|||
23273323|NCT01604850|64745092|FG001|Overall Study|Efficacy Failure|29|||
23273324|NCT01604850|64745091|FG000|Overall Study|Lost to Follow-up|1|||
23273325|NCT01604850|64745092|FG001|Overall Study|Lost to Follow-up|0|||
23273326|NCT01604850|64745091|FG000|Overall Study|Subject withdrew consent|1|||
23273327|NCT01604850|64745092|FG001|Overall Study|Subject withdrew consent|0|||
23273328|NCT00657553|64745093|FG000|Overall Study|low accrual, no analysis run|5|||
23273329|NCT00657553|64745094|FG001|Overall Study|low accrual, no analysis run|5|||
23273330|NCT02089685|64745097|FG000|Overall Study|Adverse Event|1|||
23273331|NCT02089685|64745098|FG001|Overall Study|Adverse Event|0|||
23273332|NCT02089685|64745099|FG002|Overall Study|Adverse Event|0|||
23273333|NCT02089685|64745100|FG003|Overall Study|Adverse Event|0|||
23273334|NCT02089685|64745101|FG004|Overall Study|Adverse Event|1|||
23273335|NCT02089685|64745102|FG005|Overall Study|Adverse Event|0|||
23273336|NCT02089685|64745097|FG000|Overall Study|Clinical Progression|4|||
23273337|NCT02089685|64745098|FG001|Overall Study|Clinical Progression|0|||
23273338|NCT02089685|64745099|FG002|Overall Study|Clinical Progression|0|||
23273339|NCT02089685|64745100|FG003|Overall Study|Clinical Progression|5|||
23273340|NCT02089685|64745101|FG004|Overall Study|Clinical Progression|1|||
23273341|NCT02089685|64745102|FG005|Overall Study|Clinical Progression|2|||
23273342|NCT02089685|64745097|FG000|Overall Study|Excluded Medication|1|||
23273343|NCT02089685|64745098|FG001|Overall Study|Excluded Medication|0|||
23273344|NCT02089685|64745099|FG002|Overall Study|Excluded Medication|0|||
23273345|NCT02089685|64745100|FG003|Overall Study|Excluded Medication|11|||
23273346|NCT02089685|64745101|FG004|Overall Study|Excluded Medication|2|||
23273347|NCT02089685|64745102|FG005|Overall Study|Excluded Medication|1|||
23273348|NCT02089685|64745097|FG000|Overall Study|Progressive disease|13|||
23273349|NCT02089685|64745098|FG001|Overall Study|Progressive disease|10|||
23273350|NCT02089685|64745099|FG002|Overall Study|Progressive disease|3|||
23273351|NCT02089685|64745100|FG003|Overall Study|Progressive disease|51|||
23273352|NCT02089685|64745101|FG004|Overall Study|Progressive disease|17|||
23273353|NCT02089685|64745102|FG005|Overall Study|Progressive disease|12|||
23273354|NCT02089685|64745097|FG000|Overall Study|Follow up ended by sponsor|2|||
23273355|NCT02089685|64745098|FG001|Overall Study|Follow up ended by sponsor|2|||
23273356|NCT02089685|64745099|FG002|Overall Study|Follow up ended by sponsor|0|||
23273357|NCT02089685|64745100|FG003|Overall Study|Follow up ended by sponsor|70|||
23367514|NCT00676403|65092391|FG005|Overall Study|Withdrawal by Subject|1|||
23367515|NCT03044314|65092396|FG000|Overall Study|Physician Decision|2|||
23367516|NCT03044314|65092396|FG000|Overall Study|Withdrawal by Subject|1|||
23367517|NCT03044314|65092396|FG000|Overall Study|Connector tubing not available|1|||
23367518|NCT02498678|65092397|FG000|Overall Study|interference from the surgical team|0|||
23367519|NCT02498678|65092398|FG001|Overall Study|interference from the surgical team|2|||
23367520|NCT00705757|65092400|FG000|Overall Study|Lack of Efficacy|5|||
23602215|NCT00604669|65934035|FG000|Overall Study|lack of information in chart|7|||
23602216|NCT00857766|65934037|FG000|Overall Study|Adverse Event|13|||
23273358|NCT02089685|64745101|FG004|Overall Study|Follow up ended by sponsor|26|||
23273359|NCT02089685|64745102|FG005|Overall Study|Follow up ended by sponsor|26|||
23273360|NCT02089685|64745097|FG000|Overall Study|Withdrawal by Subject|0|||
23273361|NCT02089685|64745098|FG001|Overall Study|Withdrawal by Subject|2|||
23273362|NCT02089685|64745099|FG002|Overall Study|Withdrawal by Subject|0|||
23273363|NCT02089685|64745100|FG003|Overall Study|Withdrawal by Subject|8|||
23273364|NCT02089685|64745101|FG004|Overall Study|Withdrawal by Subject|1|||
23273365|NCT02089685|64745102|FG005|Overall Study|Withdrawal by Subject|1|||
23273366|NCT02089685|64745097|FG000|Overall Study|Status not recorded|1|||
23273367|NCT02089685|64745098|FG001|Overall Study|Status not recorded|0|||
23273368|NCT02089685|64745099|FG002|Overall Study|Status not recorded|0|||
23273369|NCT02089685|64745100|FG003|Overall Study|Status not recorded|0|||
23273370|NCT02089685|64745101|FG004|Overall Study|Status not recorded|1|||
23273371|NCT02089685|64745102|FG005|Overall Study|Status not recorded|0|||
23273372|NCT02089685|64745097|FG000|Overall Study|Death|0|||
23273373|NCT02089685|64745098|FG001|Overall Study|Death|0|||
23273374|NCT02089685|64745099|FG002|Overall Study|Death|0|||
23273375|NCT02089685|64745100|FG003|Overall Study|Death|7|||
23273376|NCT02089685|64745101|FG004|Overall Study|Death|2|||
23273377|NCT02089685|64745102|FG005|Overall Study|Death|5|||
23273378|NCT02089685|64745097|FG000|Overall Study|Lost to Follow-up|0|||
23273379|NCT02089685|64745098|FG001|Overall Study|Lost to Follow-up|0|||
23273380|NCT02089685|64745099|FG002|Overall Study|Lost to Follow-up|0|||
23273381|NCT02089685|64745100|FG003|Overall Study|Lost to Follow-up|1|||
23273382|NCT02089685|64745101|FG004|Overall Study|Lost to Follow-up|0|||
23273383|NCT02089685|64745102|FG005|Overall Study|Lost to Follow-up|0|||
23273384|NCT02089685|64745097|FG000|Overall Study|Physician Decision|0|||
23367521|NCT00705757|65092401|FG001|Overall Study|Lack of Efficacy|1|||
23273385|NCT02089685|64745098|FG001|Overall Study|Physician Decision|0|||
23273386|NCT02089685|64745099|FG002|Overall Study|Physician Decision|0|||
23367522|NCT00705757|65092402|FG002|Overall Study|Lack of Efficacy|3|||
23273387|NCT02089685|64745100|FG003|Overall Study|Physician Decision|0|||
23273388|NCT02089685|64745101|FG004|Overall Study|Physician Decision|0|||
23273389|NCT02089685|64745102|FG005|Overall Study|Physician Decision|4|||
23273390|NCT02089685|64745097|FG000|Overall Study|Screen failure|1|||
23273391|NCT02089685|64745098|FG001|Overall Study|Screen failure|0|||
23273392|NCT02089685|64745099|FG002|Overall Study|Screen failure|0|||
23273393|NCT02089685|64745100|FG003|Overall Study|Screen failure|0|||
23273394|NCT02089685|64745101|FG004|Overall Study|Screen failure|0|||
23273395|NCT02089685|64745102|FG005|Overall Study|Screen failure|0|||
23273396|NCT03567174|64745104|FG000|Overall Study|Death|24|||
23273397|NCT03567174|64745105|FG001|Overall Study|Death|31|||
23273398|NCT03567174|64745104|FG000|Overall Study|Lost to Follow-up|165|||
23367523|NCT00705757|65092400|FG000|Overall Study|Lost to Follow-up|7|||
23367524|NCT00705757|65092401|FG001|Overall Study|Lost to Follow-up|6|||
23367525|NCT00705757|65092402|FG002|Overall Study|Lost to Follow-up|6|||
23367526|NCT00705757|65092400|FG000|Overall Study|Withdrawal by Subject|1|||
23367527|NCT00705757|65092401|FG001|Overall Study|Withdrawal by Subject|1|||
23367528|NCT00705757|65092402|FG002|Overall Study|Withdrawal by Subject|2|||
23367529|NCT01228591|65092403|FG000|Baseline|Lack of Efficacy|1|||
23367530|NCT01228591|65092404|FG001|Baseline|Lack of Efficacy|2|||
23367531|NCT01063855|65092408|FG000|Overall Study|Adverse Event|4|||
23367532|NCT01063855|65092409|FG001|Overall Study|Adverse Event|4|||
23367533|NCT01063855|65092408|FG000|Overall Study|Death|0|||
23367534|NCT01063855|65092409|FG001|Overall Study|Death|1|||
23367535|NCT01063855|65092408|FG000|Overall Study|Lost to Follow-up|8|||
23367536|NCT01063855|65092409|FG001|Overall Study|Lost to Follow-up|4|||
23367537|NCT01063855|65092408|FG000|Overall Study|Pregnancy|1|||
23367538|NCT01063855|65092409|FG001|Overall Study|Pregnancy|0|||
23367539|NCT01063855|65092408|FG000|Overall Study|Lack of Efficacy|0|||
23367540|NCT01063855|65092409|FG001|Overall Study|Lack of Efficacy|1|||
23367541|NCT01063855|65092408|FG000|Overall Study|Withdrawal by Subject|11|||
23367542|NCT01063855|65092409|FG001|Overall Study|Withdrawal by Subject|8|||
23367543|NCT01063855|65092408|FG000|Overall Study|Reason not specified|13|||
23367544|NCT01063855|65092409|FG001|Overall Study|Reason not specified|11|||
23367545|NCT03154086|65092410|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367546|NCT03154086|65092411|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367547|NCT03154086|65092412|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367548|NCT03154086|65092413|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
23367549|NCT03154086|65092414|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367550|NCT03154086|65092415|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367551|NCT03154086|65092416|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367552|NCT03154086|65092417|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367553|NCT03154086|65092418|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367554|NCT03154086|65092419|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367555|NCT03154086|65092420|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367556|NCT03154086|65092421|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367557|NCT03154086|65092422|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367558|NCT03154086|65092423|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367559|NCT03154086|65092424|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
23367560|NCT03154086|65092410|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367561|NCT03154086|65092411|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
23367562|NCT03154086|65092412|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367563|NCT03154086|65092413|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367564|NCT03154086|65092414|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367565|NCT03154086|65092415|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367566|NCT03154086|65092416|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367567|NCT03154086|65092417|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367568|NCT03154086|65092418|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367569|NCT03154086|65092419|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367570|NCT03154086|65092420|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367571|NCT03154086|65092421|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367572|NCT03154086|65092422|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367573|NCT03154086|65092423|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367574|NCT03154086|65092424|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
23367575|NCT03154086|65092410|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367576|NCT03154086|65092411|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367577|NCT03154086|65092412|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
23367578|NCT03154086|65092413|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367579|NCT03154086|65092414|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367580|NCT03154086|65092415|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367581|NCT03154086|65092416|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23602217|NCT00857766|65934038|FG001|Overall Study|Adverse Event|12|||
23273399|NCT03567174|64745105|FG001|Overall Study|Lost to Follow-up|174|||
23273400|NCT01353664|64745108|FG000|Overall Study|Other|3|||
23367582|NCT03154086|65092417|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367583|NCT03154086|65092418|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367584|NCT03154086|65092419|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367585|NCT03154086|65092420|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367586|NCT03154086|65092421|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367587|NCT03154086|65092422|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367588|NCT03154086|65092423|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367589|NCT03154086|65092424|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
23367590|NCT03154086|65092410|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
23367591|NCT03154086|65092411|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367592|NCT03154086|65092412|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367593|NCT03154086|65092413|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367594|NCT03154086|65092414|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367595|NCT03154086|65092415|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367596|NCT03154086|65092416|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367597|NCT03154086|65092417|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367598|NCT03154086|65092418|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23483921|NCT00058539|65515890|FG000|Overall Study|Withdrawal by Subject|5|||
23483922|NCT00058539|65515890|FG000|Overall Study|Physician Decision|9|||
23483923|NCT00058539|65515890|FG000|Overall Study|Death|1|||
23483924|NCT02942576|65515891|FG000|Overall Study|Adverse Event|28|||
23483925|NCT02942576|65515892|FG001|Overall Study|Adverse Event|6|||
23483926|NCT02942576|65515891|FG000|Overall Study|Withdrawal by Subject|7|||
23483927|NCT02942576|65515892|FG001|Overall Study|Withdrawal by Subject|5|||
23483928|NCT02942576|65515891|FG000|Overall Study|Physician Decision|1|||
23483929|NCT02942576|65515892|FG001|Overall Study|Physician Decision|4|||
23483930|NCT02942576|65515891|FG000|Overall Study|Other|10|||
23483931|NCT02942576|65515892|FG001|Overall Study|Other|8|||
23483932|NCT02992132|65515894|FG000|Overall Study|Adverse Event|4|||
23483933|NCT02992132|65515895|FG001|Overall Study|Adverse Event|1|||
23602218|NCT00857766|65934037|FG000|Overall Study|Protocol Violation|11|||
23602219|NCT00857766|65934038|FG001|Overall Study|Protocol Violation|11|||
23602220|NCT00857766|65934037|FG000|Overall Study|Lost to Follow-up|1|||
23602221|NCT00857766|65934038|FG001|Overall Study|Lost to Follow-up|0|||
23602222|NCT00857766|65934037|FG000|Overall Study|Investigator Discretion|2|||
23602223|NCT00857766|65934038|FG001|Overall Study|Investigator Discretion|3|||
23602224|NCT00857766|65934037|FG000|Overall Study|Participant Withdrew Consent|4|||
23602225|NCT00857766|65934038|FG001|Overall Study|Participant Withdrew Consent|4|||
23602226|NCT02760654|65934040|FG000|Overall Study|Lost to Follow-up|3|||
23602227|NCT02760654|65934041|FG001|Overall Study|Lost to Follow-up|3|||
23602228|NCT02760654|65934040|FG000|Overall Study|Withdrawal by Subject|4|||
23602229|NCT02760654|65934041|FG001|Overall Study|Withdrawal by Subject|3|||
23602230|NCT03335488|65934042|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
23602231|NCT03335488|65934043|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
23602232|NCT03335488|65934042|FG000|Safety Extension Period|Adverse Event|1|||
23602233|NCT03335488|65934043|FG001|Safety Extension Period|Adverse Event|0|||
23602234|NCT03335488|65934042|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
23602235|NCT03335488|65934043|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
23602236|NCT00918333|65934044|FG000|Overall Study|Drug not taken per protocol|1|||
23602237|NCT00918333|65934045|FG001|Overall Study|Drug not taken per protocol|0|||
23602238|NCT00918333|65934044|FG000|Overall Study|Inadequate amount of drugs provided|1|||
23602239|NCT00918333|65934045|FG001|Overall Study|Inadequate amount of drugs provided|4|||
23602240|NCT00918333|65934044|FG000|Overall Study|Ineligible|1|||
23602241|NCT00918333|65934045|FG001|Overall Study|Ineligible|0|||
23602242|NCT00918333|65934044|FG000|Overall Study|Withdrawal by Subject|0|||
23602243|NCT00918333|65934045|FG001|Overall Study|Withdrawal by Subject|1|||
23602244|NCT01970007|65934046|FG000|Overall Study|Death|5|||
23602245|NCT01970007|65934046|FG000|Overall Study|Withdrawal by Subject|23|||
23602246|NCT01970007|65934046|FG000|Overall Study|Lost to Follow-up|24|||
23602247|NCT01970007|65934046|FG000|Overall Study|"Other endpoint"|3|||
23602248|NCT01898299|65934047|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
23602249|NCT01898299|65934048|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
23602250|NCT00580866|65934049|FG000|Overall Study|Lost to Follow-up|2|||
23602251|NCT00580866|65934050|FG001|Overall Study|Lost to Follow-up|2|||
23602252|NCT01998958|65934053|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602253|NCT01998958|65934054|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
23602254|NCT01998958|65934055|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602255|NCT01998958|65934056|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602256|NCT01998958|65934057|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602257|NCT01998958|65934058|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602258|NCT01998958|65934059|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602259|NCT01998958|65934060|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23367599|NCT03154086|65092419|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367600|NCT03154086|65092420|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367601|NCT03154086|65092421|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367602|NCT03154086|65092422|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367603|NCT03154086|65092423|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367604|NCT03154086|65092424|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
23367605|NCT03154086|65092410|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367606|NCT03154086|65092411|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367607|NCT03154086|65092412|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23201279|NCT01577160|64476676|FG000|Overall Study|Adverse Event|9|||
23273401|NCT01353664|64745108|FG000|Overall Study|Disease Progression|16|||
23273402|NCT00585689|64745109|FG000|Overall Study|Received different ABI-007 schedule|3|||
23273403|NCT00585689|64745109|FG000|Overall Study|Adverse Event|1|||
23273404|NCT00585689|64745109|FG000|Overall Study|Patient Declined Surgery|1|||
23273405|NCT00585689|64745109|FG000|Overall Study|Patient had unresectable disease|1|||
23367608|NCT03154086|65092413|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367609|NCT03154086|65092414|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367610|NCT03154086|65092415|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367611|NCT03154086|65092416|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367612|NCT03154086|65092417|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367613|NCT03154086|65092418|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
23367614|NCT03154086|65092419|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367615|NCT03154086|65092420|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367616|NCT03154086|65092421|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367617|NCT03154086|65092422|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23367618|NCT03154086|65092423|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23602260|NCT01998958|65934061|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23273406|NCT00585689|64745109|FG000|Overall Study|Death|1|||
23273407|NCT00450190|64745110|FG000|Overall Study|Withdrawal by Subject|2|||
23273408|NCT01520909|64745117|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
23273409|NCT01520909|64745118|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
23367619|NCT03154086|65092424|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
23602261|NCT01998958|65934062|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602262|NCT01998958|65934063|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602263|NCT01998958|65934064|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602264|NCT01998958|65934065|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602265|NCT01998958|65934066|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602266|NCT01998958|65934067|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602267|NCT01998958|65934068|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602268|NCT01998958|65934069|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602269|NCT01998958|65934070|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602270|NCT01998958|65934071|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602271|NCT01998958|65934072|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602272|NCT01998958|65934073|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602273|NCT01998958|65934074|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602274|NCT01998958|65934075|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602275|NCT01998958|65934076|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602276|NCT01998958|65934077|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602277|NCT01998958|65934078|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602278|NCT01998958|65934079|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602279|NCT01998958|65934080|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602280|NCT01998958|65934081|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602281|NCT01998958|65934082|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602282|NCT01998958|65934083|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602283|NCT01998958|65934084|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
23602284|NCT01998958|65934053|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602285|NCT01998958|65934054|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
23602286|NCT01998958|65934055|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602287|NCT01998958|65934056|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602288|NCT01998958|65934057|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602289|NCT01998958|65934058|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602290|NCT01998958|65934059|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602291|NCT01998958|65934060|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602292|NCT01998958|65934061|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23367620|NCT03154086|65092410|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367621|NCT03154086|65092411|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367622|NCT03154086|65092412|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23273410|NCT01520909|64745119|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
23273411|NCT01520909|64745117|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
23273412|NCT01520909|64745118|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
23273413|NCT01520909|64745119|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
23273414|NCT01520909|64745117|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
23273415|NCT01520909|64745118|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
23273416|NCT01520909|64745119|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
23273417|NCT01520909|64745117|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
23273418|NCT01520909|64745118|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
23273419|NCT01520909|64745119|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
23273420|NCT01313273|64745120|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
23273421|NCT01313273|64745121|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
23273422|NCT01313273|64745120|FG000|Overall Study|Withdrawal by Subject|1|||
23273423|NCT01313273|64745121|FG001|Overall Study|Withdrawal by Subject|0|||
23273424|NCT01313273|64745120|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
23273425|NCT01313273|64745121|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
23273426|NCT00467896|64745122|FG000|Overall Study|Consent Withdrawal|18|||
23273427|NCT00467896|64745122|FG000|Overall Study|Adverse Event|7|||
23273428|NCT00467896|64745122|FG000|Overall Study|Serious Adverse Event|13|||
23273429|NCT00467896|64745122|FG000|Overall Study|Non-compliance|3|||
23273430|NCT00467896|64745122|FG000|Overall Study|Changed therapy|2|||
23273431|NCT00467896|64745122|FG000|Overall Study|Patient received transplant|2|||
23273432|NCT00467896|64745122|FG000|Overall Study|Patient had atrial septostomy|1|||
23273433|NCT00467896|64745122|FG000|Overall Study|Patient weaned off iloprost|1|||
23273434|NCT00467896|64745122|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
23273435|NCT00467896|64745122|FG000|Overall Study|Started intravenous prostacyclin|1|||
23273436|NCT00467896|64745122|FG000|Overall Study|Started inhaled Remodulin|1|||
23273437|NCT00467896|64745122|FG000|Overall Study|Patient had no improvement|1|||
23273438|NCT02107092|64745124|FG000|Overall Study|Miscellaneous|3|||
23273439|NCT02107092|64745124|FG000|Overall Study|Subject compliance|3|||
23273440|NCT02107092|64745124|FG000|Overall Study|Hypo-or hyperkalemia|2|||
23273441|NCT02107092|64745124|FG000|Overall Study|Met ECG withdrawal criteria|3|||
23273442|NCT02107092|64745124|FG000|Overall Study|Physician Decision|3|||
23273443|NCT02107092|64745124|FG000|Overall Study|Lost to Follow-up|2|||
23273444|NCT02107092|64745124|FG000|Overall Study|Withdrawal by Subject|9|||
23273445|NCT02107092|64745124|FG000|Overall Study|Adverse Event|7|||
23273446|NCT02107092|64745124|FG000|Overall Study|Expected progression of CKD|12|||
23273447|NCT02605928|64745125|FG000|Overall Study|Model tuning phase|28|||
23273448|NCT02605928|64745125|FG000|Overall Study|Lack of Efficacy|5|||
23273449|NCT02942264|64745132|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23273450|NCT02942264|64745133|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
23273451|NCT02942264|64745134|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23273452|NCT02942264|64745135|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23273453|NCT02942264|64745136|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23273454|NCT02942264|64745137|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23273455|NCT02942264|64745138|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
23273456|NCT02942264|64745139|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23273457|NCT02942264|64745140|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
23273458|NCT02942264|64745132|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23273459|NCT02942264|64745133|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23273460|NCT02942264|64745134|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23273461|NCT02942264|64745135|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23273462|NCT02942264|64745136|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23273463|NCT02942264|64745137|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23273464|NCT02942264|64745138|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23273465|NCT02942264|64745139|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
23273466|NCT02942264|64745140|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
23273467|NCT04627038|64745141|FG000|Overall Study|Adverse Event|36|||
23273468|NCT04627038|64745142|FG001|Overall Study|Adverse Event|8|||
23273469|NCT04627038|64745141|FG000|Overall Study|Lost to Follow-up|1|||
23273470|NCT04627038|64745142|FG001|Overall Study|Lost to Follow-up|0|||
23273471|NCT04627038|64745141|FG000|Overall Study|Physician Decision|0|||
23273472|NCT04627038|64745142|FG001|Overall Study|Physician Decision|1|||
23367623|NCT03154086|65092413|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367624|NCT03154086|65092414|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367625|NCT03154086|65092415|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367626|NCT03154086|65092416|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367627|NCT03154086|65092417|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
23367628|NCT03154086|65092418|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367629|NCT03154086|65092419|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367630|NCT03154086|65092420|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367631|NCT03154086|65092421|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367632|NCT03154086|65092422|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367633|NCT03154086|65092423|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367634|NCT03154086|65092424|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
23367635|NCT03154086|65092410|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
23367636|NCT03154086|65092411|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
23367637|NCT03154086|65092412|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
23367638|NCT03154086|65092413|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
23367639|NCT03154086|65092414|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
23367640|NCT03154086|65092415|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
23367641|NCT03154086|65092416|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
23367642|NCT03154086|65092417|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
23367643|NCT03154086|65092418|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
23367644|NCT03154086|65092419|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
23367645|NCT03154086|65092420|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
23367646|NCT03154086|65092421|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
23367647|NCT03154086|65092422|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
23367648|NCT03154086|65092423|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
23367649|NCT03154086|65092424|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
23367650|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
23367651|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
23367652|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
23367653|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
23367654|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
23367655|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
23367656|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
23367657|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
23367658|NCT01573000|65092427|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
23367659|NCT01573000|65092428|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
23367660|NCT01573000|65092427|FG000|Crossover Phase|Lack of Efficacy|0|||
23367661|NCT01573000|65092428|FG001|Crossover Phase|Lack of Efficacy|13|||
23367662|NCT01573000|65092427|FG000|Crossover Phase|Lost to Follow-up|0|||
23367663|NCT01573000|65092428|FG001|Crossover Phase|Lost to Follow-up|2|||
23367664|NCT01573000|65092427|FG000|Crossover Phase|Death|0|||
23367665|NCT01573000|65092428|FG001|Crossover Phase|Death|3|||
23367666|NCT01573000|65092427|FG000|Long-Term Follow-Up|Death|3|||
23602293|NCT01998958|65934062|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602294|NCT01998958|65934063|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602295|NCT01998958|65934064|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602296|NCT01998958|65934065|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602297|NCT01998958|65934066|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602298|NCT01998958|65934067|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602299|NCT01998958|65934068|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602300|NCT01998958|65934069|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602301|NCT01998958|65934070|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602302|NCT01998958|65934071|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602303|NCT01998958|65934072|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602304|NCT01998958|65934073|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602305|NCT01998958|65934074|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602306|NCT01998958|65934075|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602307|NCT01998958|65934076|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602308|NCT01998958|65934077|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602309|NCT01998958|65934078|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602310|NCT01998958|65934079|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602311|NCT01998958|65934080|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602312|NCT01998958|65934081|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602313|NCT01998958|65934082|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602314|NCT01998958|65934083|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23367667|NCT01573000|65092428|FG001|Long-Term Follow-Up|Death|0|||
23367668|NCT01573000|65092427|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
23367669|NCT01573000|65092428|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
23367670|NCT00749398|65092429|FG000|Overall Study|Lack of Efficacy|7|||
23367671|NCT00749398|65092429|FG000|Overall Study|Adverse Event|4|||
23367672|NCT00749398|65092429|FG000|Overall Study|Serious adverse event|11|||
23602315|NCT01998958|65934084|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
23602316|NCT01998958|65934053|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
23602317|NCT01998958|65934054|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
23602318|NCT01998958|65934055|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
23602319|NCT01998958|65934056|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
23273473|NCT04627038|64745141|FG000|Overall Study|Protocol Violation|3|||
23273474|NCT04627038|64745142|FG001|Overall Study|Protocol Violation|1|||
23273475|NCT04627038|64745141|FG000|Overall Study|Withdrawal by Subject|13|||
23273476|NCT04627038|64745142|FG001|Overall Study|Withdrawal by Subject|3|||
23273477|NCT04627038|64745141|FG000|Overall Study|Non-compliance with study drug|0|||
23273478|NCT04627038|64745142|FG001|Overall Study|Non-compliance with study drug|1|||
23273479|NCT04627038|64745141|FG000|Overall Study|Prohibited Concomitant Medication|1|||
23273480|NCT04627038|64745142|FG001|Overall Study|Prohibited Concomitant Medication|0|||
23273481|NCT01804270|64745149|FG000|Overall Study|Withdrawal by Subject|1|||
23273482|NCT01804270|64745150|FG001|Overall Study|Withdrawal by Subject|1|||
23273483|NCT01602419|64745151|FG000|Overall Study|Not treated with Wilate|9|||
23273484|NCT01602419|64745151|FG000|Overall Study|Adverse Drug Reaction|4|||
23273485|NCT01602419|64745151|FG000|Overall Study|Insurance issues|3|||
23273486|NCT01602419|64745151|FG000|Overall Study|Changed treatment centre|1|||
23273487|NCT01602419|64745151|FG000|Overall Study|Treatment centre closed|1|||
23273488|NCT01602419|64745151|FG000|Overall Study|Withdrawal by Subject|5|||
23273489|NCT01602419|64745151|FG000|Overall Study|Lost to Follow-up|6|||
23273490|NCT01864174|64745152|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
23273491|NCT01864174|64745153|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
23273492|NCT01864174|64745152|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
23273493|NCT01864174|64745153|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
23273494|NCT01864174|64745152|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
23273495|NCT01864174|64745153|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
23273496|NCT01864174|64745152|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
23273497|NCT01864174|64745153|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
23273498|NCT01864174|64745152|FG000|Double Blind - Compliant Randomized|Death|1|||
23273499|NCT01864174|64745153|FG001|Double Blind - Compliant Randomized|Death|0|||
23273500|NCT01864174|64745152|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
23273501|NCT01864174|64745153|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
23273502|NCT01864174|64745152|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
23273503|NCT01864174|64745153|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
23273504|NCT01864174|64745152|FG000|Double Blind - Compliant Randomized|Other|6|||
23273505|NCT01864174|64745153|FG001|Double Blind - Compliant Randomized|Other|10|||
23273506|NCT01864174|64745152|FG000|Off Treatment Follow-Up|Other|2|||
23273507|NCT01864174|64745153|FG001|Off Treatment Follow-Up|Other|0|||
23273508|NCT01864174|64745152|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
23273509|NCT01864174|64745153|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
23273510|NCT00965185|64745154|FG000|Overall Study|Lost to Follow-up|2|||
23273511|NCT00965185|64745155|FG001|Overall Study|Lost to Follow-up|0|||
23273512|NCT00965185|64745154|FG000|Overall Study|Withdrawal by Subject|0|||
23273513|NCT00965185|64745155|FG001|Overall Study|Withdrawal by Subject|1|||
23273514|NCT01215981|64745159|FG000|Overall Study|Physician Decision|0|||
23273515|NCT01215981|64745160|FG001|Overall Study|Physician Decision|1|||
23273516|NCT01215981|64745159|FG000|Overall Study|Protocol Violation|1|||
23273517|NCT01215981|64745160|FG001|Overall Study|Protocol Violation|0|||
23273518|NCT01215981|64745159|FG000|Overall Study|Withdrawal by Subject|1|||
23273519|NCT01215981|64745160|FG001|Overall Study|Withdrawal by Subject|0|||
23273520|NCT01390844|64745161|FG000|Treatment Phase|Adverse Event|12|||
23273521|NCT01390844|64745162|FG001|Treatment Phase|Adverse Event|2|||
23273522|NCT01390844|64745163|FG002|Treatment Phase|Adverse Event|3|||
23273523|NCT01390844|64745164|FG003|Treatment Phase|Adverse Event|2|||
23273524|NCT01390844|64745161|FG000|Treatment Phase|Treatment Failure|23|||
23273525|NCT01390844|64745162|FG001|Treatment Phase|Treatment Failure|25|||
23273526|NCT01390844|64745163|FG002|Treatment Phase|Treatment Failure|10|||
23273527|NCT01390844|64745164|FG003|Treatment Phase|Treatment Failure|13|||
23273528|NCT01390844|64745161|FG000|Treatment Phase|Non-Medical Reasons|5|||
23273529|NCT01390844|64745162|FG001|Treatment Phase|Non-Medical Reasons|1|||
23273530|NCT01390844|64745163|FG002|Treatment Phase|Non-Medical Reasons|8|||
23273531|NCT01390844|64745164|FG003|Treatment Phase|Non-Medical Reasons|1|||
23273532|NCT01390844|64745161|FG000|Treatment Phase|Non-GCP Compliant|0|||
23273533|NCT01390844|64745162|FG001|Treatment Phase|Non-GCP Compliant|0|||
23273534|NCT01390844|64745163|FG002|Treatment Phase|Non-GCP Compliant|10|||
23273535|NCT01390844|64745164|FG003|Treatment Phase|Non-GCP Compliant|3|||
23273536|NCT01390844|64745161|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
23273537|NCT01390844|64745162|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
23273538|NCT01390844|64745163|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
23273539|NCT01390844|64745164|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
23273540|NCT02024932|64745165|FG000|Overall Study|Adverse Event|2|||
23273541|NCT02024932|64745166|FG001|Overall Study|Adverse Event|3|||
23273542|NCT02024932|64745167|FG002|Overall Study|Adverse Event|0|||
23273543|NCT02024932|64745168|FG003|Overall Study|Adverse Event|0|||
23273544|NCT02024932|64745169|FG004|Overall Study|Adverse Event|2|||
23273545|NCT02024932|64745170|FG005|Overall Study|Adverse Event|0|||
23367673|NCT00749398|65092429|FG000|Overall Study|Withdrawal by Subject|17|||
23367674|NCT00749398|65092429|FG000|Overall Study|Lost to Follow-up|11|||
23367675|NCT00749398|65092429|FG000|Overall Study|Reason not specified|2|||
23367676|NCT00749398|65092429|FG000|Overall Study|Unknown reason|1|||
23367677|NCT03118934|65092432|FG000|Overall Study|Adverse Event|0|||
23367678|NCT03118934|65092433|FG001|Overall Study|Adverse Event|0|||
23273546|NCT02024932|64745165|FG000|Overall Study|Abnormal laboratory value|0|||
23273547|NCT02024932|64745166|FG001|Overall Study|Abnormal laboratory value|0|||
23273548|NCT02024932|64745167|FG002|Overall Study|Abnormal laboratory value|0|||
23273549|NCT02024932|64745168|FG003|Overall Study|Abnormal laboratory value|2|||
23273550|NCT02024932|64745169|FG004|Overall Study|Abnormal laboratory value|0|||
23273551|NCT02024932|64745170|FG005|Overall Study|Abnormal laboratory value|0|||
23273552|NCT01403194|64745171|FG000|Overall Study|Screen Failure|2|||
23273553|NCT01403194|64745171|FG000|Overall Study|Lost to Follow-up|8|||
23273554|NCT00268905|64745172|FG000|Overall Study|Adverse Event|3|||
23273555|NCT00268905|64745173|FG001|Overall Study|Adverse Event|0|||
23273556|NCT00268905|64745174|FG002|Overall Study|Adverse Event|4|||
23273557|NCT00268905|64745172|FG000|Overall Study|Lost to Follow-up|0|||
23273558|NCT00268905|64745173|FG001|Overall Study|Lost to Follow-up|1|||
23273559|NCT00268905|64745174|FG002|Overall Study|Lost to Follow-up|0|||
23273560|NCT00268905|64745172|FG000|Overall Study|Withdrawal by Subject|0|||
23273561|NCT00268905|64745173|FG001|Overall Study|Withdrawal by Subject|0|||
23273562|NCT00268905|64745174|FG002|Overall Study|Withdrawal by Subject|3|||
23273563|NCT00268905|64745172|FG000|Overall Study|Progressive Disease|28|||
23273564|NCT00268905|64745173|FG001|Overall Study|Progressive Disease|4|||
23273565|NCT00268905|64745174|FG002|Overall Study|Progressive Disease|3|||
23273566|NCT00268905|64745172|FG000|Overall Study|Physician Decision|3|||
23273567|NCT00268905|64745173|FG001|Overall Study|Physician Decision|0|||
23273568|NCT00268905|64745174|FG002|Overall Study|Physician Decision|1|||
23273569|NCT00268905|64745172|FG000|Overall Study|Clinical Progression|9|||
23273570|NCT00268905|64745173|FG001|Overall Study|Clinical Progression|4|||
23273571|NCT00268905|64745174|FG002|Overall Study|Clinical Progression|1|||
23273572|NCT02327130|64745180|FG000|Overall Study|Discharged in less than 5 days|5|||
23367679|NCT03118934|65092434|FG002|Overall Study|Adverse Event|0|||
23367680|NCT03118934|65092435|FG003|Overall Study|Adverse Event|0|||
23367681|NCT03118934|65092436|FG004|Overall Study|Adverse Event|0|||
23367682|NCT03118934|65092437|FG005|Overall Study|Adverse Event|1|||
23367683|NCT03118934|65092432|FG000|Overall Study|Physician Decision|0|||
23367684|NCT03118934|65092433|FG001|Overall Study|Physician Decision|0|||
23367685|NCT03118934|65092434|FG002|Overall Study|Physician Decision|0|||
23367686|NCT03118934|65092435|FG003|Overall Study|Physician Decision|0|||
23367687|NCT03118934|65092436|FG004|Overall Study|Physician Decision|0|||
23367688|NCT03118934|65092437|FG005|Overall Study|Physician Decision|1|||
23367689|NCT03118934|65092432|FG000|Overall Study|Discontinued prior to exposure|0|||
23367690|NCT03118934|65092433|FG001|Overall Study|Discontinued prior to exposure|1|||
23367691|NCT03118934|65092434|FG002|Overall Study|Discontinued prior to exposure|1|||
23367692|NCT03118934|65092435|FG003|Overall Study|Discontinued prior to exposure|1|||
23367693|NCT03118934|65092436|FG004|Overall Study|Discontinued prior to exposure|2|||
23367694|NCT03118934|65092437|FG005|Overall Study|Discontinued prior to exposure|0|||
23367695|NCT00511810|65092438|FG000|Overall Study|Lost to Follow-up|1|||
23367696|NCT00511810|65092439|FG001|Overall Study|Lost to Follow-up|2|||
23367697|NCT00511810|65092438|FG000|Overall Study|Lack of Efficacy|0|||
23367698|NCT00511810|65092439|FG001|Overall Study|Lack of Efficacy|2|||
23367699|NCT00511810|65092438|FG000|Overall Study|Refused second scn|0|||
23367700|NCT00511810|65092439|FG001|Overall Study|Refused second scn|1|||
23367701|NCT00010257|65092442|FG000|Overall Study|Withdrawal by Subject|1|||
23367702|NCT00010257|65092443|FG001|Overall Study|Withdrawal by Subject|0|||
23367703|NCT02337491|65092444|FG000|Overall Study|Death|1|||
23367704|NCT02337491|65092445|FG001|Overall Study|Death|1|||
23273573|NCT02327130|64745180|FG000|Overall Study|Physician Decision|2|||
23273574|NCT02327130|64745180|FG000|Overall Study|Unable to provide breath sample|1|||
23273575|NCT02327130|64745180|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
23273576|NCT02327130|64745180|FG000|Overall Study|Met exclusion criteria|3|||
23273577|NCT04567186|64745184|FG000|Period 1|COVID-19 related|1|||
23367705|NCT02337491|65092444|FG000|Overall Study|Adverse Event|0|||
23273578|NCT04567186|64745185|FG001|Period 1|COVID-19 related|0|||
23273579|NCT04567186|64745184|FG000|Period 1|Protocol Violation|0|||
23273580|NCT04567186|64745185|FG001|Period 1|Protocol Violation|1|||
23367706|NCT02337491|65092445|FG001|Overall Study|Adverse Event|1|||
23367707|NCT02337491|65092444|FG000|Overall Study|Withdrawal by Subject|3|||
23367708|NCT02337491|65092445|FG001|Overall Study|Withdrawal by Subject|0|||
23483934|NCT02992132|65515896|FG002|Overall Study|Adverse Event|3|||
23273581|NCT04567186|64745184|FG000|Period 1|Adverse Event|0|||
23273582|NCT04567186|64745185|FG001|Period 1|Adverse Event|2|||
23273583|NCT04567186|64745184|FG000|Period 2|COVID-19 Related|0|||
23273584|NCT04567186|64745185|FG001|Period 2|COVID-19 Related|1|||
23273585|NCT04567186|64745184|FG000|Period 2|Protocol Violation|0|||
23273586|NCT04567186|64745185|FG001|Period 2|Protocol Violation|1|||
23367709|NCT02337491|65092444|FG000|Overall Study|Progressive Disease|44|||
23367710|NCT02337491|65092445|FG001|Overall Study|Progressive Disease|28|||
23367711|NCT02337491|65092444|FG000|Overall Study|On Treatment|2|||
23367712|NCT02337491|65092445|FG001|Overall Study|On Treatment|0|||
23273587|NCT04567186|64745184|FG000|Period 2|Lost to Follow-up|0|||
23273588|NCT04567186|64745185|FG001|Period 2|Lost to Follow-up|1|||
23273589|NCT04567186|64745184|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
23273590|NCT04567186|64745185|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
23273591|NCT00328926|64745186|FG000|Overall Study|Pregnancy|2|||
23273592|NCT00328926|64745187|FG001|Overall Study|Pregnancy|1|||
23273593|NCT00328926|64745188|FG002|Overall Study|Pregnancy|0|||
23273594|NCT00328926|64745186|FG000|Overall Study|Lost to Follow-up|0|||
23273595|NCT00328926|64745187|FG001|Overall Study|Lost to Follow-up|1|||
23273596|NCT00328926|64745188|FG002|Overall Study|Lost to Follow-up|0|||
23273597|NCT00328926|64745186|FG000|Overall Study|Death|0|||
23273598|NCT00328926|64745187|FG001|Overall Study|Death|0|||
23367713|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
23367714|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
23367715|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
23367716|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
23367717|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
23367718|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
23367719|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
23367720|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
23367721|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
23367722|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
23273599|NCT00328926|64745188|FG002|Overall Study|Death|1|||
23273600|NCT00328926|64745186|FG000|Overall Study|In vitro fertilization treatment|0|||
23273601|NCT00328926|64745187|FG001|Overall Study|In vitro fertilization treatment|0|||
23273602|NCT00328926|64745188|FG002|Overall Study|In vitro fertilization treatment|1|||
23273603|NCT00328926|64745186|FG000|Overall Study|Lack of ovarian response|0|||
23273604|NCT00328926|64745187|FG001|Overall Study|Lack of ovarian response|1|||
23273605|NCT00328926|64745188|FG002|Overall Study|Lack of ovarian response|0|||
23273606|NCT03699020|64745190|FG000|Overall Study|Withdrawal by Subject|3|||
23273607|NCT03699020|64745191|FG001|Overall Study|Withdrawal by Subject|2|||
23273608|NCT03243630|64745192|FG000|Overall Study|Protocol Violation|1|||
23367723|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
23367724|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
23367725|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
23367726|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
23367727|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
23367728|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
23367729|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
23367730|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
23367731|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
23367732|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
23367733|NCT01149655|65092447|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
23367734|NCT01149655|65092448|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
23367735|NCT01149655|65092449|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
23367736|NCT01149655|65092450|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
23367737|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
23483935|NCT02992132|65515894|FG000|Overall Study|Lack of Efficacy|2|||
23483936|NCT02992132|65515895|FG001|Overall Study|Lack of Efficacy|0|||
23483937|NCT02992132|65515896|FG002|Overall Study|Lack of Efficacy|0|||
23273609|NCT03243630|64745192|FG000|Overall Study|Physician Decision|1|||
23273610|NCT00448019|64745193|FG000|Overall Study|Withdrawal by Subject|3|||
23273611|NCT00448019|64745193|FG000|Overall Study|Disease progression|1|||
23273612|NCT00448019|64745193|FG000|Overall Study|Death|2|||
23273613|NCT00448019|64745193|FG000|Overall Study|Insurance Issues|1|||
23273614|NCT00358449|64745195|FG000|Overall Study|Adverse Event|1|||
23483938|NCT02992132|65515894|FG000|Overall Study|Non-compliance with study drug|2|||
23483939|NCT02992132|65515895|FG001|Overall Study|Non-compliance with study drug|0|||
23483940|NCT02992132|65515896|FG002|Overall Study|Non-compliance with study drug|0|||
23483941|NCT02992132|65515894|FG000|Overall Study|Progressive disease|1|||
23483942|NCT02992132|65515895|FG001|Overall Study|Progressive disease|0|||
23483943|NCT02992132|65515896|FG002|Overall Study|Progressive disease|0|||
23273615|NCT00358449|64745196|FG001|Overall Study|Adverse Event|0|||
23273616|NCT00358449|64745197|FG002|Overall Study|Adverse Event|1|||
23273617|NCT00358449|64745195|FG000|Overall Study|Lost to Follow-up|1|||
23367738|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
23367739|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
23367740|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
23273618|NCT00358449|64745196|FG001|Overall Study|Lost to Follow-up|0|||
23367741|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
23483944|NCT02992132|65515894|FG000|Overall Study|Protocol Violation|2|||
23273619|NCT00358449|64745197|FG002|Overall Study|Lost to Follow-up|0|||
23483945|NCT02992132|65515895|FG001|Overall Study|Protocol Violation|2|||
23483946|NCT02992132|65515896|FG002|Overall Study|Protocol Violation|0|||
23483947|NCT02992132|65515894|FG000|Overall Study|Caregiver withdrew consent|2|||
23483948|NCT02992132|65515895|FG001|Overall Study|Caregiver withdrew consent|3|||
23367742|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
23367743|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
23367744|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
23367745|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
23367746|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
23367747|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
23367748|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
23367749|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
23367750|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
23367751|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
23367752|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
23367753|NCT01149655|65092447|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
23367754|NCT01149655|65092448|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
23367755|NCT01149655|65092449|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
23367756|NCT01149655|65092450|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
23367757|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
23367758|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
23367759|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
23367760|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
23367761|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
23367762|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
23367763|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
23367764|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
23367765|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
23367766|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
23367767|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
23367768|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
23367769|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
23367770|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
23367771|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
23367772|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
23367773|NCT01149655|65092447|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
23367774|NCT01149655|65092448|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
23367775|NCT01149655|65092449|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
23367776|NCT01149655|65092450|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
23367777|NCT01462630|65092451|FG000|Overall Study|Did not initiate therapy|3|||
23367778|NCT01462630|65092451|FG000|Overall Study|Death|1|||
23367779|NCT01462630|65092451|FG000|Overall Study|Protocol Violation|2|||
23367780|NCT01462630|65092451|FG000|Overall Study|Adverse Event|1|||
23367781|NCT00496769|65092455|FG000|Double Blind|>=1 reason assigned per patient|558|||
23367782|NCT00496769|65092456|FG001|Double Blind|>=1 reason assigned per patient|649|||
23367783|NCT00496769|65092457|FG002|Double Blind|>=1 reason assigned per patient|0|||
23367784|NCT00496769|65092455|FG000|Open Label|>=1 reason assigned per patient|0|||
23367785|NCT00496769|65092456|FG001|Open Label|>=1 reason assigned per patient|0|||
23367786|NCT00496769|65092457|FG002|Open Label|>=1 reason assigned per patient|1011|||
23367787|NCT01365130|65092458|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
23367788|NCT01181167|65092462|FG000|Overall Study|Adverse Event|11|||
23367789|NCT01181167|65092463|FG001|Overall Study|Adverse Event|21|||
23367790|NCT01181167|65092462|FG000|Overall Study|Lost to Follow-up|1|||
23367791|NCT01181167|65092463|FG001|Overall Study|Lost to Follow-up|0|||
23367792|NCT01181167|65092462|FG000|Overall Study|Physician Decision|2|||
23367793|NCT01181167|65092463|FG001|Overall Study|Physician Decision|3|||
23367794|NCT01181167|65092462|FG000|Overall Study|Protocol Violation|3|||
23367795|NCT01181167|65092463|FG001|Overall Study|Protocol Violation|0|||
23367796|NCT01181167|65092462|FG000|Overall Study|Withdrawal by Subject|6|||
23367797|NCT01181167|65092463|FG001|Overall Study|Withdrawal by Subject|8|||
23367798|NCT01077323|65092468|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
23367799|NCT01077323|65092469|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
23367800|NCT01077323|65092470|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
23367801|NCT01077323|65092468|FG000|Overall Study|Dispensing of drug in baseline period|0|||
23367802|NCT01077323|65092469|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
23483949|NCT02992132|65515896|FG002|Overall Study|Caregiver withdrew consent|2|||
23483950|NCT02992132|65515894|FG000|Overall Study|Withdrawal by Subject|0|||
23201280|NCT01577160|64476676|FG000|Overall Study|Lack of Efficacy|15|||
23483951|NCT02992132|65515895|FG001|Overall Study|Withdrawal by Subject|2|||
23367803|NCT01077323|65092470|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
23367804|NCT01077323|65092468|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
23367805|NCT01077323|65092469|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
23367806|NCT01077323|65092470|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
23367807|NCT01325350|65092473|FG000|Overall Study|Adverse Event|3|||
23367808|NCT01325350|65092474|FG001|Overall Study|Adverse Event|3|||
23367809|NCT01325350|65092475|FG002|Overall Study|Adverse Event|3|||
23367810|NCT01325350|65092476|FG003|Overall Study|Adverse Event|1|||
23367811|NCT01325350|65092477|FG004|Overall Study|Adverse Event|2|||
23367812|NCT01325350|65092473|FG000|Overall Study|Pregnancy|0|||
23367813|NCT01325350|65092474|FG001|Overall Study|Pregnancy|0|||
23367814|NCT01325350|65092475|FG002|Overall Study|Pregnancy|1|||
23367815|NCT01325350|65092476|FG003|Overall Study|Pregnancy|0|||
23367816|NCT01325350|65092477|FG004|Overall Study|Pregnancy|1|||
23367817|NCT01325350|65092473|FG000|Overall Study|Lost to Follow-up|1|||
23367818|NCT01325350|65092474|FG001|Overall Study|Lost to Follow-up|0|||
23367819|NCT01325350|65092475|FG002|Overall Study|Lost to Follow-up|5|||
23367820|NCT01325350|65092476|FG003|Overall Study|Lost to Follow-up|1|||
23367821|NCT01325350|65092477|FG004|Overall Study|Lost to Follow-up|5|||
23367822|NCT01325350|65092473|FG000|Overall Study|Personal Reasons|2|||
23367823|NCT01325350|65092474|FG001|Overall Study|Personal Reasons|1|||
23367824|NCT01325350|65092475|FG002|Overall Study|Personal Reasons|6|||
23367825|NCT01325350|65092476|FG003|Overall Study|Personal Reasons|5|||
23367826|NCT01325350|65092477|FG004|Overall Study|Personal Reasons|3|||
23367827|NCT01325350|65092473|FG000|Overall Study|Protocol Violation|0|||
23367828|NCT01325350|65092474|FG001|Overall Study|Protocol Violation|0|||
23367829|NCT01325350|65092475|FG002|Overall Study|Protocol Violation|0|||
23367830|NCT01325350|65092476|FG003|Overall Study|Protocol Violation|1|||
23367831|NCT01325350|65092477|FG004|Overall Study|Protocol Violation|0|||
23367832|NCT01325350|65092473|FG000|Overall Study|Withdrawal by Subject|0|||
23273620|NCT00358449|64745195|FG000|Overall Study|Withdrawal by Subject|2|||
23273621|NCT00358449|64745196|FG001|Overall Study|Withdrawal by Subject|0|||
23273622|NCT00358449|64745197|FG002|Overall Study|Withdrawal by Subject|0|||
23273623|NCT00358449|64745195|FG000|Overall Study|Lack of Efficacy|0|||
23273624|NCT00358449|64745196|FG001|Overall Study|Lack of Efficacy|1|||
23273625|NCT00358449|64745197|FG002|Overall Study|Lack of Efficacy|0|||
23273626|NCT00358449|64745195|FG000|Overall Study|Steriod Inhaler was Increased|0|||
23273627|NCT00358449|64745196|FG001|Overall Study|Steriod Inhaler was Increased|0|||
23273628|NCT00358449|64745197|FG002|Overall Study|Steriod Inhaler was Increased|1|||
23273629|NCT00651820|64745198|FG000|Overall Study|Lost to Follow-up|2|||
23273630|NCT01185548|64745209|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
23273631|NCT02196675|64745211|FG000|Overall Study|Withdrawal by Subject|1|||
23367833|NCT01325350|65092474|FG001|Overall Study|Withdrawal by Subject|0|||
23367834|NCT01325350|65092475|FG002|Overall Study|Withdrawal by Subject|1|||
23367835|NCT01325350|65092476|FG003|Overall Study|Withdrawal by Subject|1|||
23367836|NCT01325350|65092477|FG004|Overall Study|Withdrawal by Subject|0|||
23367837|NCT01325350|65092473|FG000|Overall Study|Did Not Receive Treatment|0|||
23367838|NCT01325350|65092474|FG001|Overall Study|Did Not Receive Treatment|1|||
23367839|NCT01325350|65092475|FG002|Overall Study|Did Not Receive Treatment|1|||
23367840|NCT01325350|65092476|FG003|Overall Study|Did Not Receive Treatment|0|||
23367841|NCT01325350|65092477|FG004|Overall Study|Did Not Receive Treatment|1|||
23367842|NCT01765296|65092479|FG000|Overall Study|Protocol Violation|0|||
23483952|NCT02992132|65515896|FG002|Overall Study|Withdrawal by Subject|1|||
23273632|NCT02196675|64745212|FG001|Overall Study|Withdrawal by Subject|0|||
23273633|NCT02196675|64745213|FG002|Overall Study|Withdrawal by Subject|0|||
23273634|NCT02196675|64745211|FG000|Overall Study|Intra-operative surgical exclusion|1|||
23273635|NCT02196675|64745212|FG001|Overall Study|Intra-operative surgical exclusion|1|||
23273636|NCT02196675|64745213|FG002|Overall Study|Intra-operative surgical exclusion|0|||
23273637|NCT02196675|64745211|FG000|Overall Study|Protocol Violation|0|||
23273638|NCT02196675|64745212|FG001|Overall Study|Protocol Violation|1|||
23273639|NCT02196675|64745213|FG002|Overall Study|Protocol Violation|0|||
23483953|NCT02992132|65515894|FG000|Overall Study|Physician Decision|0|||
23483954|NCT02992132|65515895|FG001|Overall Study|Physician Decision|0|||
23483955|NCT02992132|65515896|FG002|Overall Study|Physician Decision|1|||
23483956|NCT02353143|65515898|FG000|Overall Study|Withdrawal by Subject|1|||
23483957|NCT02353143|65515899|FG001|Overall Study|Withdrawal by Subject|0|||
23483958|NCT02353143|65515900|FG002|Overall Study|Withdrawal by Subject|0|||
23483959|NCT02353143|65515901|FG003|Overall Study|Withdrawal by Subject|0|||
23483960|NCT02353143|65515902|FG004|Overall Study|Withdrawal by Subject|1|||
23483961|NCT02353143|65515903|FG005|Overall Study|Withdrawal by Subject|0|||
23483962|NCT02353143|65515904|FG006|Overall Study|Withdrawal by Subject|0|||
23483963|NCT02353143|65515905|FG007|Overall Study|Withdrawal by Subject|1|||
23483964|NCT02353143|65515906|FG008|Overall Study|Withdrawal by Subject|1|||
23483965|NCT02353143|65515898|FG000|Overall Study|Lack of Efficacy|2|||
23483966|NCT02353143|65515899|FG001|Overall Study|Lack of Efficacy|1|||
23483967|NCT02353143|65515900|FG002|Overall Study|Lack of Efficacy|2|||
23483968|NCT02353143|65515901|FG003|Overall Study|Lack of Efficacy|4|||
23483969|NCT02353143|65515902|FG004|Overall Study|Lack of Efficacy|13|||
23483970|NCT02353143|65515903|FG005|Overall Study|Lack of Efficacy|2|||
23483971|NCT02353143|65515904|FG006|Overall Study|Lack of Efficacy|2|||
23483972|NCT02353143|65515905|FG007|Overall Study|Lack of Efficacy|2|||
23483973|NCT02353143|65515906|FG008|Overall Study|Lack of Efficacy|1|||
23483974|NCT02353143|65515898|FG000|Overall Study|reason not specified|1|||
23483975|NCT02353143|65515899|FG001|Overall Study|reason not specified|2|||
23483976|NCT02353143|65515900|FG002|Overall Study|reason not specified|0|||
23483977|NCT02353143|65515901|FG003|Overall Study|reason not specified|0|||
23483978|NCT02353143|65515902|FG004|Overall Study|reason not specified|6|||
23483979|NCT02353143|65515903|FG005|Overall Study|reason not specified|1|||
23483980|NCT02353143|65515904|FG006|Overall Study|reason not specified|0|||
23483981|NCT02353143|65515905|FG007|Overall Study|reason not specified|3|||
23483982|NCT02353143|65515906|FG008|Overall Study|reason not specified|1|||
23483983|NCT02353143|65515898|FG000|Overall Study|Physician Decision|0|||
23483984|NCT02353143|65515899|FG001|Overall Study|Physician Decision|4|||
23483985|NCT02353143|65515900|FG002|Overall Study|Physician Decision|2|||
23483986|NCT02353143|65515901|FG003|Overall Study|Physician Decision|3|||
23483987|NCT02353143|65515902|FG004|Overall Study|Physician Decision|4|||
23483988|NCT02353143|65515903|FG005|Overall Study|Physician Decision|0|||
23483989|NCT02353143|65515904|FG006|Overall Study|Physician Decision|1|||
23483990|NCT02353143|65515905|FG007|Overall Study|Physician Decision|2|||
23483991|NCT02353143|65515906|FG008|Overall Study|Physician Decision|0|||
23483992|NCT02353143|65515898|FG000|Overall Study|Adverse Event|0|||
23483993|NCT02353143|65515899|FG001|Overall Study|Adverse Event|0|||
23483994|NCT02353143|65515900|FG002|Overall Study|Adverse Event|1|||
23483995|NCT02353143|65515901|FG003|Overall Study|Adverse Event|0|||
23483996|NCT02353143|65515902|FG004|Overall Study|Adverse Event|1|||
23602320|NCT01998958|65934057|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
23602321|NCT01998958|65934058|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
23273640|NCT02196675|64745211|FG000|Overall Study|Death|0|||
23273641|NCT02196675|64745212|FG001|Overall Study|Death|0|||
23367843|NCT01765296|65092480|FG001|Overall Study|Protocol Violation|5|||
23483997|NCT02353143|65515903|FG005|Overall Study|Adverse Event|1|||
23483998|NCT02353143|65515904|FG006|Overall Study|Adverse Event|0|||
23483999|NCT02353143|65515905|FG007|Overall Study|Adverse Event|0|||
23484000|NCT02353143|65515906|FG008|Overall Study|Adverse Event|0|||
23484001|NCT02353143|65515898|FG000|Overall Study|patient receiving other treatment for AML|0|||
23484002|NCT02353143|65515899|FG001|Overall Study|patient receiving other treatment for AML|0|||
23602322|NCT01998958|65934059|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
23484003|NCT02353143|65515900|FG002|Overall Study|patient receiving other treatment for AML|1|||
23484004|NCT02353143|65515901|FG003|Overall Study|patient receiving other treatment for AML|0|||
23602323|NCT01998958|65934060|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
23273642|NCT02196675|64745213|FG002|Overall Study|Death|1|||
23484005|NCT02353143|65515902|FG004|Overall Study|patient receiving other treatment for AML|0|||
23484006|NCT02353143|65515903|FG005|Overall Study|patient receiving other treatment for AML|0|||
23484007|NCT02353143|65515904|FG006|Overall Study|patient receiving other treatment for AML|0|||
23484008|NCT02353143|65515905|FG007|Overall Study|patient receiving other treatment for AML|0|||
23484009|NCT02353143|65515906|FG008|Overall Study|patient receiving other treatment for AML|0|||
23484010|NCT02353143|65515898|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
23484011|NCT02353143|65515899|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
23484012|NCT02353143|65515900|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
23484013|NCT02353143|65515901|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
23484014|NCT02353143|65515902|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
23484015|NCT02353143|65515903|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
23484016|NCT02353143|65515904|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
23484017|NCT02353143|65515905|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
23484018|NCT02353143|65515906|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
23484019|NCT00880165|65515908|FG000|Overall Study|Withdrawal by Subject|27|||
23484020|NCT00880165|65515909|FG001|Overall Study|Withdrawal by Subject|23|||
23484021|NCT00880165|65515908|FG000|Overall Study|Not diagnosed with OSA|14|||
23484022|NCT00880165|65515909|FG001|Overall Study|Not diagnosed with OSA|8|||
23484023|NCT00880165|65515908|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
23484024|NCT00880165|65515909|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
23484025|NCT00880165|65515908|FG000|Overall Study|Lost to follow|9|||
23484026|NCT00880165|65515909|FG001|Overall Study|Lost to follow|15|||
23484027|NCT00969280|65515910|FG000|Overall Study|Protocol Violation|2|||
23484028|NCT00969280|65515911|FG001|Overall Study|Protocol Violation|1|||
23484029|NCT00969280|65515910|FG000|Overall Study|Withdrawal by Subject|0|||
23484030|NCT00969280|65515911|FG001|Overall Study|Withdrawal by Subject|1|||
23484031|NCT00969280|65515910|FG000|Overall Study|infection of influenza A(H1N1)|0|||
23484032|NCT00969280|65515911|FG001|Overall Study|infection of influenza A(H1N1)|1|||
23484033|NCT02628769|65515912|FG000|First Intervention|Adverse Event|1|||
23484034|NCT02628769|65515913|FG001|First Intervention|Adverse Event|0|||
23484035|NCT02628769|65515912|FG000|First Intervention|Withdrawal by Subject|0|||
23484036|NCT02628769|65515913|FG001|First Intervention|Withdrawal by Subject|1|||
23484037|NCT02628769|65515912|FG000|Second Intervention|Adverse Event|2|||
23484038|NCT02628769|65515913|FG001|Second Intervention|Adverse Event|0|||
23484039|NCT02628769|65515912|FG000|Second Intervention|Physician Decision|0|||
23484040|NCT02628769|65515913|FG001|Second Intervention|Physician Decision|1|||
23484041|NCT01082640|65515914|FG000|Overall Study|Adverse Event|9|||
23484042|NCT01082640|65515915|FG001|Overall Study|Adverse Event|5|||
23484043|NCT01082640|65515916|FG002|Overall Study|Adverse Event|3|||
23484044|NCT01082640|65515914|FG000|Overall Study|Withdrawal by Subject|3|||
23484045|NCT01082640|65515915|FG001|Overall Study|Withdrawal by Subject|3|||
23484046|NCT01082640|65515916|FG002|Overall Study|Withdrawal by Subject|2|||
23484047|NCT01082640|65515914|FG000|Overall Study|Major protocol deviation|3|||
23484048|NCT01082640|65515915|FG001|Overall Study|Major protocol deviation|3|||
23484049|NCT01082640|65515916|FG002|Overall Study|Major protocol deviation|0|||
23484050|NCT01082640|65515914|FG000|Overall Study|Lost to Follow-up|0|||
23484051|NCT01082640|65515915|FG001|Overall Study|Lost to Follow-up|3|||
23484052|NCT01082640|65515916|FG002|Overall Study|Lost to Follow-up|0|||
23484053|NCT01082640|65515914|FG000|Overall Study|Other|2|||
23484054|NCT01082640|65515915|FG001|Overall Study|Other|1|||
23484055|NCT01082640|65515916|FG002|Overall Study|Other|3|||
23484056|NCT02486627|65515917|FG000|Overall Study|Death|1|||
23484057|NCT02486627|65515918|FG001|Overall Study|Death|0|||
23484058|NCT02486627|65515917|FG000|Overall Study|Other Unspecified|0|||
23484059|NCT02486627|65515918|FG001|Overall Study|Other Unspecified|2|||
23484060|NCT02486627|65515917|FG000|Overall Study|Consent Withdrawn by Participant|4|||
23484061|NCT02486627|65515918|FG001|Overall Study|Consent Withdrawn by Participant|3|||
23484062|NCT02486627|65515917|FG000|Overall Study|Significant Participant Noncompliance|1|||
23484063|NCT02486627|65515918|FG001|Overall Study|Significant Participant Noncompliance|1|||
23484064|NCT02486627|65515917|FG000|Overall Study|Lost to Follow-up|1|||
23484065|NCT02486627|65515918|FG001|Overall Study|Lost to Follow-up|3|||
23484066|NCT03783702|65515919|FG000|Overall Study|Lost to Follow-up|6|||
23484067|NCT03783702|65515920|FG001|Overall Study|Lost to Follow-up|8|||
23484068|NCT03783702|65515919|FG000|Overall Study|Protocol Violation|1|||
23484069|NCT03783702|65515920|FG001|Overall Study|Protocol Violation|3|||
23484070|NCT02582255|65515925|FG000|Overall Study|Protocol Violation|0|||
23484071|NCT02582255|65515926|FG001|Overall Study|Protocol Violation|3|||
23367844|NCT01765296|65092481|FG002|Overall Study|Protocol Violation|4|||
23484072|NCT01155479|65515929|FG000|Part I|Adverse Event|13|||
23484073|NCT01155479|65515930|FG001|Part I|Adverse Event|8|||
23484074|NCT01155479|65515931|FG002|Part I|Adverse Event|18|||
23602324|NCT01998958|65934061|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
23602325|NCT01998958|65934062|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
23484075|NCT01155479|65515932|FG003|Part I|Adverse Event|7|||
23484076|NCT01155479|65515933|FG004|Part I|Adverse Event|6|||
23484077|NCT01155479|65515929|FG000|Part I|Administrative|2|||
23484078|NCT01155479|65515930|FG001|Part I|Administrative|2|||
23273643|NCT03195491|64745214|FG000|Overall Study|Study drug toxicity|25|||
23273644|NCT03195491|64745215|FG001|Overall Study|Study drug toxicity|3|||
23273645|NCT03195491|64745214|FG000|Overall Study|Maximum clinical benefit|5|||
23273646|NCT03195491|64745215|FG001|Overall Study|Maximum clinical benefit|0|||
23273647|NCT03195491|64745214|FG000|Overall Study|Lost to Follow-up|1|||
23273648|NCT03195491|64745215|FG001|Overall Study|Lost to Follow-up|0|||
23273649|NCT03195491|64745214|FG000|Overall Study|Death|3|||
23273650|NCT03195491|64745215|FG001|Overall Study|Death|0|||
23273651|NCT03195491|64745214|FG000|Overall Study|Adverse event unrelated to study drug|19|||
23273652|NCT03195491|64745215|FG001|Overall Study|Adverse event unrelated to study drug|2|||
23273653|NCT03195491|64745214|FG000|Overall Study|Disease progression|266|||
23273654|NCT03195491|64745215|FG001|Overall Study|Disease progression|8|||
23273655|NCT03195491|64745214|FG000|Overall Study|Other reasons|10|||
23273656|NCT03195491|64745215|FG001|Overall Study|Other reasons|0|||
23273657|NCT03195491|64745214|FG000|Overall Study|Participant withdrew consent|8|||
23273658|NCT03195491|64745215|FG001|Overall Study|Participant withdrew consent|1|||
23273659|NCT03195491|64745214|FG000|Overall Study|Participant no longer meets study criteria|0|||
23273660|NCT03195491|64745215|FG001|Overall Study|Participant no longer meets study criteria|1|||
23273661|NCT03195491|64745214|FG000|Overall Study|Participant request to discontinue study treatment|10|||
23273662|NCT03195491|64745215|FG001|Overall Study|Participant request to discontinue study treatment|0|||
23273663|NCT01675622|64745216|FG000|Overall Study|Withdrawal by Subject|2|||
23273664|NCT01675622|64745217|FG001|Overall Study|Withdrawal by Subject|2|||
23273665|NCT01675622|64745216|FG000|Overall Study|Adverse Event|12|||
23273666|NCT01675622|64745217|FG001|Overall Study|Adverse Event|10|||
23273667|NCT01675622|64745216|FG000|Overall Study|Protocol Violation|4|||
23273668|NCT01675622|64745217|FG001|Overall Study|Protocol Violation|1|||
23273669|NCT01675622|64745216|FG000|Overall Study|Lack of Efficacy|2|||
23273670|NCT01675622|64745217|FG001|Overall Study|Lack of Efficacy|4|||
23273671|NCT01675622|64745216|FG000|Overall Study|Lost to Follow-up|1|||
23273672|NCT01675622|64745217|FG001|Overall Study|Lost to Follow-up|3|||
23273673|NCT01675622|64745216|FG000|Overall Study|Other|5|||
23273674|NCT01675622|64745217|FG001|Overall Study|Other|4|||
23273675|NCT01270503|64745218|FG000|Overall Study|Lost to Follow-up|1|||
23273676|NCT00624065|64745219|FG000|Overall Study|Adverse Event|5|||
23273677|NCT00624065|64745220|FG001|Overall Study|Adverse Event|6|||
23273678|NCT00624065|64745219|FG000|Overall Study|Lost to Follow-up|4|||
23273679|NCT00624065|64745220|FG001|Overall Study|Lost to Follow-up|1|||
23273680|NCT00624065|64745219|FG000|Overall Study|Consent withdrawn|6|||
23273681|NCT00624065|64745220|FG001|Overall Study|Consent withdrawn|5|||
23273682|NCT00624065|64745219|FG000|Overall Study|Lack of Efficacy|0|||
23273683|NCT00624065|64745220|FG001|Overall Study|Lack of Efficacy|3|||
23273684|NCT00624065|64745219|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
23273685|NCT00624065|64745220|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
23273686|NCT03447262|64745221|FG000|Overall Study|Adverse Event|7|||
23273687|NCT03447262|64745221|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
23273688|NCT03447262|64745221|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
23273689|NCT03447262|64745221|FG000|Overall Study|Death|2|||
23273690|NCT03447262|64745221|FG000|Overall Study|Study Termination by Sponsor|455|||
23273691|NCT03447262|64745221|FG000|Overall Study|Other|4|||
23273692|NCT04869787|64745226|FG000|Screening|Physician Decision|1|||
23273693|NCT04869787|64745226|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
23273694|NCT02996682|64745227|FG000|Overall Study|Death|0|||
23273695|NCT02996682|64745228|FG001|Overall Study|Death|3|||
23273696|NCT01921062|64745235|FG000|Overall Study|Withdrawal by Subject|0|||
23273697|NCT01921062|64745236|FG001|Overall Study|Withdrawal by Subject|7|||
23273698|NCT01921062|64745235|FG000|Overall Study|Adverse Event|5|||
23273699|NCT01921062|64745236|FG001|Overall Study|Adverse Event|6|||
23273700|NCT01921062|64745235|FG000|Overall Study|Protocol Violation|0|||
23273701|NCT01921062|64745236|FG001|Overall Study|Protocol Violation|1|||
23273702|NCT01921062|64745235|FG000|Overall Study|VMIQ score > 72|4|||
23273703|NCT01921062|64745236|FG001|Overall Study|VMIQ score > 72|1|||
23273704|NCT01921062|64745235|FG000|Overall Study|Logistic error|0|||
23273705|NCT01921062|64745236|FG001|Overall Study|Logistic error|1|||
23273706|NCT00520130|64745237|FG000|Overall Study|Disease progression on study|4|||
23484079|NCT01155479|65515931|FG002|Part I|Administrative|2|||
23367845|NCT01765296|65092479|FG000|Overall Study|Withdrawal by Subject|4|||
23484080|NCT01155479|65515932|FG003|Part I|Administrative|0|||
23273707|NCT00520130|64745238|FG001|Overall Study|Disease progression on study|0|||
23273708|NCT00520130|64745237|FG000|Overall Study|Physician Decision|1|||
23273709|NCT00520130|64745238|FG001|Overall Study|Physician Decision|1|||
23273710|NCT03164772|64745239|FG000|Overall Study|Death|4|||
23273711|NCT03164772|64745240|FG001|Overall Study|Death|2|||
23273712|NCT03164772|64745239|FG000|Overall Study|Adverse Event|1|||
23273713|NCT03164772|64745240|FG001|Overall Study|Adverse Event|4|||
23273714|NCT03164772|64745239|FG000|Overall Study|Progressive Disease|11|||
23273715|NCT03164772|64745240|FG001|Overall Study|Progressive Disease|21|||
23273716|NCT03164772|64745239|FG000|Overall Study|Physician Decision|2|||
23273717|NCT03164772|64745240|FG001|Overall Study|Physician Decision|0|||
23484081|NCT01155479|65515933|FG004|Part I|Administrative|0|||
23484082|NCT01155479|65515929|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
23484083|NCT01155479|65515930|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
23484084|NCT01155479|65515931|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
23484085|NCT01155479|65515932|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
23484086|NCT01155479|65515933|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
23484087|NCT01155479|65515929|FG000|Part I|Withdrawal by Subject|11|||
23484088|NCT01155479|65515930|FG001|Part I|Withdrawal by Subject|13|||
23484089|NCT01155479|65515931|FG002|Part I|Withdrawal by Subject|8|||
23484090|NCT01155479|65515932|FG003|Part I|Withdrawal by Subject|8|||
23484091|NCT01155479|65515933|FG004|Part I|Withdrawal by Subject|9|||
23484092|NCT01155479|65515929|FG000|Part I|Lost to Follow-up|0|||
23484093|NCT01155479|65515930|FG001|Part I|Lost to Follow-up|0|||
23484094|NCT01155479|65515931|FG002|Part I|Lost to Follow-up|1|||
23484095|NCT01155479|65515932|FG003|Part I|Lost to Follow-up|1|||
23484096|NCT01155479|65515933|FG004|Part I|Lost to Follow-up|0|||
23484097|NCT01155479|65515929|FG000|Part I|Treatment Failure|3|||
23484098|NCT01155479|65515930|FG001|Part I|Treatment Failure|0|||
23484099|NCT01155479|65515931|FG002|Part I|Treatment Failure|3|||
23484100|NCT01155479|65515932|FG003|Part I|Treatment Failure|1|||
23484101|NCT01155479|65515933|FG004|Part I|Treatment Failure|2|||
23484102|NCT01155479|65515929|FG000|Part I|Did Not Receive Treatment|4|||
23484103|NCT01155479|65515930|FG001|Part I|Did Not Receive Treatment|2|||
23484104|NCT01155479|65515931|FG002|Part I|Did Not Receive Treatment|2|||
23484105|NCT01155479|65515932|FG003|Part I|Did Not Receive Treatment|6|||
23484106|NCT01155479|65515933|FG004|Part I|Did Not Receive Treatment|1|||
23484107|NCT01155479|65515929|FG000|Part I|Non-Compliance with Protocol|2|||
23484108|NCT01155479|65515930|FG001|Part I|Non-Compliance with Protocol|1|||
23484109|NCT01155479|65515931|FG002|Part I|Non-Compliance with Protocol|3|||
23484110|NCT01155479|65515932|FG003|Part I|Non-Compliance with Protocol|3|||
23484111|NCT01155479|65515933|FG004|Part I|Non-Compliance with Protocol|2|||
23484112|NCT01155479|65515929|FG000|Part II|Adverse Event|7|||
23484113|NCT01155479|65515930|FG001|Part II|Adverse Event|6|||
23484114|NCT01155479|65515931|FG002|Part II|Adverse Event|8|||
23484115|NCT01155479|65515932|FG003|Part II|Adverse Event|3|||
23273718|NCT03164772|64745239|FG000|Overall Study|Withdrawal by Subject|0|||
23273719|NCT03164772|64745240|FG001|Overall Study|Withdrawal by Subject|4|||
23273720|NCT01118312|64745244|FG000|Overall Study|Lost to Follow-up|33|||
23273721|NCT01118312|64745245|FG001|Overall Study|Lost to Follow-up|32|||
23273722|NCT01118312|64745244|FG000|Overall Study|Withdrawal by Subject|1|||
23273723|NCT01118312|64745245|FG001|Overall Study|Withdrawal by Subject|3|||
23273724|NCT00550537|64745246|FG000|Overall Study|Death|18|||
23273725|NCT00550537|64745246|FG000|Overall Study|Adverse Event|20|||
23273726|NCT00550537|64745246|FG000|Overall Study|Disease progression before|46|||
23273727|NCT00550537|64745246|FG000|Overall Study|Withdrawal by Subject|7|||
23273728|NCT00550537|64745246|FG000|Overall Study|Change in treatment plan|4|||
23273729|NCT00550537|64745246|FG000|Overall Study|Other complicating ilness|3|||
23273730|NCT00550537|64745246|FG000|Overall Study|Declining performance status|2|||
23273731|NCT00550537|64745246|FG000|Overall Study|Treated closer to home|4|||
23273732|NCT00296647|64745247|FG000|Overall Study|Death|4|||
23273733|NCT00296647|64745248|FG001|Overall Study|Death|1|||
23273734|NCT00296647|64745249|FG002|Overall Study|Death|2|||
23273735|NCT00296647|64745250|FG003|Overall Study|Death|1|||
23273736|NCT00296647|64745251|FG004|Overall Study|Death|1|||
23273737|NCT00296647|64745247|FG000|Overall Study|Withdrawal by Subject|28|||
23273738|NCT00296647|64745248|FG001|Overall Study|Withdrawal by Subject|27|||
23484116|NCT01155479|65515933|FG004|Part II|Adverse Event|4|||
23484117|NCT01155479|65515929|FG000|Part II|Administrative|43|||
23484118|NCT01155479|65515930|FG001|Part II|Administrative|49|||
23484119|NCT01155479|65515931|FG002|Part II|Administrative|36|||
23484120|NCT01155479|65515932|FG003|Part II|Administrative|38|||
23602326|NCT01998958|65934063|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
23602327|NCT01998958|65934064|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
23273739|NCT00296647|64745249|FG002|Overall Study|Withdrawal by Subject|32|||
23273740|NCT00296647|64745250|FG003|Overall Study|Withdrawal by Subject|16|||
23273741|NCT00296647|64745251|FG004|Overall Study|Withdrawal by Subject|19|||
23273742|NCT01029340|64745252|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
23273743|NCT01029340|64745253|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
23484121|NCT01155479|65515933|FG004|Part II|Administrative|46|||
23484122|NCT01155479|65515929|FG000|Part II|Withdrawal by Subject|8|||
23484123|NCT01155479|65515930|FG001|Part II|Withdrawal by Subject|4|||
23484124|NCT01155479|65515931|FG002|Part II|Withdrawal by Subject|12|||
23201281|NCT01577160|64476676|FG000|Overall Study|Lost to Follow-up|40|||
23602328|NCT01998958|65934065|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
23602329|NCT01998958|65934066|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
23602330|NCT01998958|65934067|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
23602331|NCT01998958|65934068|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
23602332|NCT01998958|65934069|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
23273744|NCT01029340|64745254|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
23273745|NCT01029340|64745255|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
23273746|NCT01029340|64745256|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
23273747|NCT01029340|64745257|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
23273748|NCT01029340|64745252|FG000|Part B Treatment Period|Protocol Violation|0|||
23273749|NCT01029340|64745253|FG001|Part B Treatment Period|Protocol Violation|0|||
23273750|NCT01029340|64745254|FG002|Part B Treatment Period|Protocol Violation|1|||
23273751|NCT01029340|64745255|FG003|Part B Treatment Period|Protocol Violation|0|||
23273752|NCT01029340|64745256|FG004|Part B Treatment Period|Protocol Violation|0|||
23273753|NCT01029340|64745257|FG005|Part B Treatment Period|Protocol Violation|0|||
23273754|NCT01029340|64745252|FG000|Extension Period|Adverse Event|0|||
23273755|NCT01029340|64745253|FG001|Extension Period|Adverse Event|0|||
23273756|NCT01029340|64745254|FG002|Extension Period|Adverse Event|0|||
23273757|NCT01029340|64745255|FG003|Extension Period|Adverse Event|0|||
23273758|NCT01029340|64745256|FG004|Extension Period|Adverse Event|0|||
23273759|NCT01029340|64745257|FG005|Extension Period|Adverse Event|1|||
23273760|NCT01029340|64745252|FG000|Extension Period|starting another study|0|||
23273761|NCT01029340|64745253|FG001|Extension Period|starting another study|0|||
23273762|NCT01029340|64745254|FG002|Extension Period|starting another study|0|||
23273763|NCT01029340|64745255|FG003|Extension Period|starting another study|0|||
23273764|NCT01029340|64745256|FG004|Extension Period|starting another study|0|||
23484125|NCT01155479|65515932|FG003|Part II|Withdrawal by Subject|7|||
23484126|NCT01155479|65515933|FG004|Part II|Withdrawal by Subject|3|||
23484127|NCT01155479|65515929|FG000|Part II|Lost to Follow-up|1|||
23484128|NCT01155479|65515930|FG001|Part II|Lost to Follow-up|0|||
23484129|NCT01155479|65515931|FG002|Part II|Lost to Follow-up|0|||
23484130|NCT01155479|65515932|FG003|Part II|Lost to Follow-up|0|||
23484131|NCT01155479|65515933|FG004|Part II|Lost to Follow-up|1|||
23484132|NCT01155479|65515929|FG000|Part II|Treatment Failure|0|||
23484133|NCT01155479|65515930|FG001|Part II|Treatment Failure|1|||
23484134|NCT01155479|65515931|FG002|Part II|Treatment Failure|2|||
23484135|NCT01155479|65515932|FG003|Part II|Treatment Failure|0|||
23484136|NCT01155479|65515933|FG004|Part II|Treatment Failure|1|||
23484137|NCT01155479|65515929|FG000|Part II|Non-Compliance with Protocol|0|||
23484138|NCT01155479|65515930|FG001|Part II|Non-Compliance with Protocol|1|||
23484139|NCT01155479|65515931|FG002|Part II|Non-Compliance with Protocol|0|||
23484140|NCT01155479|65515932|FG003|Part II|Non-Compliance with Protocol|2|||
23484141|NCT01155479|65515933|FG004|Part II|Non-Compliance with Protocol|0|||
23484142|NCT02017171|65515936|FG000|Overall Study|Death|10|||
23484143|NCT02017171|65515937|FG001|Overall Study|Death|4|||
23484144|NCT02017171|65515936|FG000|Overall Study|Withdrawal by Subject|23|||
23484145|NCT02017171|65515937|FG001|Overall Study|Withdrawal by Subject|17|||
23484146|NCT02017171|65515936|FG000|Overall Study|Lost to Follow-up|21|||
23484147|NCT02017171|65515937|FG001|Overall Study|Lost to Follow-up|20|||
23484148|NCT02017171|65515936|FG000|Overall Study|ESKD|6|||
23484149|NCT02017171|65515937|FG001|Overall Study|ESKD|2|||
23484150|NCT02017171|65515936|FG000|Overall Study|Miscellaneous|2|||
23484151|NCT02017171|65515937|FG001|Overall Study|Miscellaneous|3|||
23484152|NCT02119676|65515941|FG000|Overall Study|Adverse Event|9|||
23484153|NCT02119676|65515942|FG001|Overall Study|Adverse Event|17|||
23484154|NCT02119676|65515943|FG002|Overall Study|Adverse Event|10|||
23484155|NCT02119676|65515944|FG003|Overall Study|Adverse Event|10|||
23484156|NCT02119676|65515941|FG000|Overall Study|Disease progression|53|||
23484157|NCT02119676|65515942|FG001|Overall Study|Disease progression|55|||
23484158|NCT02119676|65515943|FG002|Overall Study|Disease progression|68|||
23484159|NCT02119676|65515944|FG003|Overall Study|Disease progression|73|||
23484160|NCT02119676|65515941|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
23602333|NCT01998958|65934070|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
23602334|NCT01998958|65934071|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
23602335|NCT01998958|65934072|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
23602336|NCT01998958|65934073|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
23602337|NCT01998958|65934074|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
23602338|NCT01998958|65934075|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
23602339|NCT01998958|65934076|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
23602340|NCT01998958|65934077|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
23602341|NCT01998958|65934078|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
23602342|NCT01998958|65934079|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
23602343|NCT01998958|65934080|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
23602344|NCT01998958|65934081|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
23602345|NCT01998958|65934082|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
23602346|NCT01998958|65934083|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
23602347|NCT01998958|65934084|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
23602348|NCT01998958|65934053|FG000|Period 1 (Panel A and B)|Other|1|||
23602349|NCT01998958|65934054|FG001|Period 1 (Panel A and B)|Other|0|||
23602350|NCT01998958|65934055|FG002|Period 1 (Panel A and B)|Other|0|||
23602351|NCT01998958|65934056|FG003|Period 1 (Panel A and B)|Other|0|||
23602352|NCT01998958|65934057|FG004|Period 1 (Panel A and B)|Other|0|||
23602353|NCT01998958|65934058|FG005|Period 1 (Panel A and B)|Other|0|||
23602354|NCT01998958|65934059|FG006|Period 1 (Panel A and B)|Other|0|||
23602355|NCT01998958|65934060|FG007|Period 1 (Panel A and B)|Other|0|||
23602356|NCT01998958|65934061|FG008|Period 1 (Panel A and B)|Other|0|||
23602357|NCT01998958|65934062|FG009|Period 1 (Panel A and B)|Other|0|||
23602358|NCT01998958|65934063|FG010|Period 1 (Panel A and B)|Other|0|||
23484161|NCT02119676|65515942|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
23484162|NCT02119676|65515943|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
23484163|NCT02119676|65515944|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
23484164|NCT02119676|65515941|FG000|Overall Study|Physician Decision|4|||
23602359|NCT01998958|65934064|FG011|Period 1 (Panel A and B)|Other|0|||
23602360|NCT01998958|65934065|FG012|Period 1 (Panel A and B)|Other|0|||
23602361|NCT01998958|65934066|FG013|Period 1 (Panel A and B)|Other|0|||
23602362|NCT01998958|65934067|FG014|Period 1 (Panel A and B)|Other|0|||
23484165|NCT02119676|65515942|FG001|Overall Study|Physician Decision|2|||
23484166|NCT02119676|65515943|FG002|Overall Study|Physician Decision|3|||
23484167|NCT02119676|65515944|FG003|Overall Study|Physician Decision|2|||
23484168|NCT02119676|65515941|FG000|Overall Study|Death|9|||
23484169|NCT02119676|65515942|FG001|Overall Study|Death|3|||
23602363|NCT01998958|65934068|FG015|Period 1 (Panel A and B)|Other|0|||
23602364|NCT01998958|65934069|FG016|Period 1 (Panel A and B)|Other|0|||
23484170|NCT02119676|65515943|FG002|Overall Study|Death|2|||
23602365|NCT01998958|65934070|FG017|Period 1 (Panel A and B)|Other|0|||
23602366|NCT01998958|65934071|FG018|Period 1 (Panel A and B)|Other|0|||
23602367|NCT01998958|65934072|FG019|Period 1 (Panel A and B)|Other|0|||
23484171|NCT02119676|65515944|FG003|Overall Study|Death|1|||
23273765|NCT01029340|64745257|FG005|Extension Period|starting another study|8|||
23273766|NCT01029340|64745252|FG000|Extension Period|non-compliance|0|||
23273767|NCT01029340|64745253|FG001|Extension Period|non-compliance|0|||
23273768|NCT01029340|64745254|FG002|Extension Period|non-compliance|0|||
23273769|NCT01029340|64745255|FG003|Extension Period|non-compliance|0|||
23273770|NCT01029340|64745256|FG004|Extension Period|non-compliance|0|||
23273771|NCT01029340|64745257|FG005|Extension Period|non-compliance|1|||
23273772|NCT01029340|64745252|FG000|Extension Period|Withdrawal by Subject|0|||
23273773|NCT01029340|64745253|FG001|Extension Period|Withdrawal by Subject|0|||
23273774|NCT01029340|64745254|FG002|Extension Period|Withdrawal by Subject|0|||
23273775|NCT01029340|64745255|FG003|Extension Period|Withdrawal by Subject|0|||
23273776|NCT01029340|64745256|FG004|Extension Period|Withdrawal by Subject|0|||
23273777|NCT01029340|64745257|FG005|Extension Period|Withdrawal by Subject|1|||
23273778|NCT01029340|64745252|FG000|Extension Period|Physician Decision|0|||
23273779|NCT01029340|64745253|FG001|Extension Period|Physician Decision|0|||
23273780|NCT01029340|64745254|FG002|Extension Period|Physician Decision|0|||
23273781|NCT01029340|64745255|FG003|Extension Period|Physician Decision|0|||
23273782|NCT01029340|64745256|FG004|Extension Period|Physician Decision|0|||
23273783|NCT01029340|64745257|FG005|Extension Period|Physician Decision|1|||
23273784|NCT03329027|64745258|FG000|Overall Study|Lost to Follow-up|1|||
23273785|NCT03329027|64745259|FG001|Overall Study|Lost to Follow-up|0|||
23273786|NCT03329027|64745260|FG002|Overall Study|Lost to Follow-up|1|||
23273787|NCT03329027|64745258|FG000|Overall Study|Protocol Violation|9|||
23273788|NCT03329027|64745259|FG001|Overall Study|Protocol Violation|5|||
23273789|NCT03329027|64745260|FG002|Overall Study|Protocol Violation|7|||
23273790|NCT01839279|64745264|FG000|Overall Study|Adverse Event|4|||
23273791|NCT01839279|64745265|FG001|Overall Study|Adverse Event|1|||
23273792|NCT01839279|64745266|FG002|Overall Study|Adverse Event|1|||
23273793|NCT01839279|64745264|FG000|Overall Study|Withdrawal by Subject|4|||
23273794|NCT01839279|64745265|FG001|Overall Study|Withdrawal by Subject|1|||
23273795|NCT01839279|64745266|FG002|Overall Study|Withdrawal by Subject|1|||
23602368|NCT01998958|65934073|FG020|Period 1 (Panel A and B)|Other|0|||
23602369|NCT01998958|65934074|FG021|Period 1 (Panel A and B)|Other|0|||
23602370|NCT01998958|65934075|FG022|Period 1 (Panel A and B)|Other|0|||
23602371|NCT01998958|65934076|FG023|Period 1 (Panel A and B)|Other|0|||
23602372|NCT01998958|65934077|FG024|Period 1 (Panel A and B)|Other|0|||
23602373|NCT01998958|65934078|FG025|Period 1 (Panel A and B)|Other|0|||
23602374|NCT01998958|65934079|FG026|Period 1 (Panel A and B)|Other|0|||
23602375|NCT01998958|65934080|FG027|Period 1 (Panel A and B)|Other|0|||
23602376|NCT01998958|65934081|FG028|Period 1 (Panel A and B)|Other|0|||
23602377|NCT01998958|65934082|FG029|Period 1 (Panel A and B)|Other|0|||
23602378|NCT01998958|65934083|FG030|Period 1 (Panel A and B)|Other|0|||
23602379|NCT01998958|65934084|FG031|Period 1 (Panel A and B)|Other|0|||
23602380|NCT01998958|65934053|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
23602381|NCT01998958|65934054|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
23602382|NCT01998958|65934055|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
23602383|NCT01998958|65934056|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
23602384|NCT01998958|65934057|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
23602385|NCT01998958|65934058|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
23602386|NCT01998958|65934059|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
23602387|NCT01998958|65934060|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
23602388|NCT01998958|65934061|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
23602389|NCT01998958|65934062|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
23602390|NCT01998958|65934063|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
23602391|NCT01998958|65934064|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
23602392|NCT01998958|65934065|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
23602393|NCT01998958|65934066|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
23602394|NCT01998958|65934067|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
23273796|NCT01839279|64745264|FG000|Overall Study|Classified as 'Other'|5|||
23273797|NCT01839279|64745265|FG001|Overall Study|Classified as 'Other'|0|||
23273798|NCT01839279|64745266|FG002|Overall Study|Classified as 'Other'|0|||
23367846|NCT01765296|65092480|FG001|Overall Study|Withdrawal by Subject|2|||
23602395|NCT01998958|65934068|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
23602396|NCT01998958|65934069|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
23602397|NCT01998958|65934070|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
23602398|NCT01998958|65934071|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
23273799|NCT04526210|64745267|FG000|Overall Study|Sponsor decision|7|||
23273800|NCT04526210|64745268|FG001|Overall Study|Sponsor decision|5|||
23602399|NCT01998958|65934072|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
23602400|NCT01998958|65934073|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
23602401|NCT01998958|65934074|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
23602402|NCT01998958|65934075|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
23602403|NCT01998958|65934076|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
23602404|NCT01998958|65934077|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
23602405|NCT01998958|65934078|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
23602406|NCT01998958|65934079|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
23602407|NCT01998958|65934080|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
23367847|NCT01765296|65092481|FG002|Overall Study|Withdrawal by Subject|2|||
23367848|NCT01765296|65092479|FG000|Overall Study|Adverse Event|1|||
23367849|NCT01765296|65092480|FG001|Overall Study|Adverse Event|13|||
23367850|NCT01765296|65092481|FG002|Overall Study|Adverse Event|5|||
23367851|NCT01765296|65092479|FG000|Overall Study|Lack of Efficacy|0|||
23367852|NCT01765296|65092480|FG001|Overall Study|Lack of Efficacy|0|||
23367853|NCT01765296|65092481|FG002|Overall Study|Lack of Efficacy|2|||
23367854|NCT01065818|65092483|FG000|Overall Study|Withdrawal by Subject|1|||
23367855|NCT01065818|65092483|FG000|Overall Study|Not a candidate for surgery|1|||
23367856|NCT01776554|65092486|FG000|Overall Study|Adverse Event|1|||
23367857|NCT01776554|65092487|FG001|Overall Study|Adverse Event|0|||
23367858|NCT01776554|65092486|FG000|Overall Study|Withdrawal by Subject|3|||
23367859|NCT01776554|65092487|FG001|Overall Study|Withdrawal by Subject|8|||
23367860|NCT01776554|65092486|FG000|Overall Study|Lost to Follow-up|6|||
23367861|NCT01776554|65092487|FG001|Overall Study|Lost to Follow-up|9|||
23367862|NCT01776554|65092486|FG000|Overall Study|Administrative Reason|2|||
23367863|NCT01776554|65092487|FG001|Overall Study|Administrative Reason|5|||
23367864|NCT01776554|65092486|FG000|Overall Study|Protocol Violation|1|||
23367865|NCT01776554|65092487|FG001|Overall Study|Protocol Violation|0|||
23367866|NCT01776554|65092486|FG000|Overall Study|Unclassified|4|||
23367867|NCT01776554|65092487|FG001|Overall Study|Unclassified|1|||
23367868|NCT00452439|65092497|FG000|Overall Study|Lost to Follow-up|1|||
23367869|NCT00452439|65092498|FG001|Overall Study|Lost to Follow-up|1|||
23367870|NCT00452439|65092497|FG000|Overall Study|Refused Treatment|4|||
23367871|NCT00452439|65092498|FG001|Overall Study|Refused Treatment|3|||
23367872|NCT00452439|65092497|FG000|Overall Study|Death|3|||
23367873|NCT00452439|65092498|FG001|Overall Study|Death|1|||
23367874|NCT00452439|65092497|FG000|Overall Study|Bone Marrow Transplant|0|||
23367875|NCT00452439|65092498|FG001|Overall Study|Bone Marrow Transplant|1|||
23367876|NCT00452439|65092497|FG000|Overall Study|Too Ill to Continue|0|||
23367877|NCT00452439|65092498|FG001|Overall Study|Too Ill to Continue|1|||
23367878|NCT00452439|65092497|FG000|Overall Study|Failed to achieve complete response|2|||
23367879|NCT00452439|65092498|FG001|Overall Study|Failed to achieve complete response|0|||
23367880|NCT00452439|65092497|FG000|Overall Study|Relapse|3|||
23367881|NCT00452439|65092498|FG001|Overall Study|Relapse|0|||
23367882|NCT00452439|65092497|FG000|Overall Study|Fracture|1|||
23367883|NCT00452439|65092498|FG001|Overall Study|Fracture|0|||
23367884|NCT04085601|65092499|FG000|Overall Study|Lost to Follow-up|1|||
23367885|NCT04085601|65092500|FG001|Overall Study|Lost to Follow-up|0|||
23602408|NCT01998958|65934081|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
23602409|NCT01998958|65934082|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
23602410|NCT01998958|65934083|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
23602411|NCT01998958|65934084|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
23602412|NCT01998958|65934053|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602413|NCT01998958|65934054|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602414|NCT01998958|65934055|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602415|NCT01998958|65934056|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23367886|NCT04085601|65092499|FG000|Overall Study|Death|1|||
23367887|NCT04085601|65092500|FG001|Overall Study|Death|1|||
23367888|NCT05556148|65092501|FG000|Overall Study|Early Termination|29|||
23367889|NCT05556148|65092501|FG000|Overall Study|Baseline Tasks Expired|4|||
23367890|NCT05556148|65092501|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
23602416|NCT01998958|65934057|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23367891|NCT05556148|65092501|FG000|Overall Study|No Longer Wished to Participate|1|||
23367892|NCT05556148|65092501|FG000|Overall Study|Bacterial Conjunctivitis|1|||
23367893|NCT02812186|65092502|FG000|Period 1|Post randomization screen failure|5|||
23367894|NCT02812186|65092503|FG001|Period 1|Post randomization screen failure|9|||
23367895|NCT02812186|65092502|FG000|Period 1|nonevaluable data sets|6|||
23367896|NCT02812186|65092503|FG001|Period 1|nonevaluable data sets|6|||
23367897|NCT04644029|65092504|FG000|Overall Study|Death|1|||
23367898|NCT04644029|65092505|FG001|Overall Study|Death|0|||
23367899|NCT04644029|65092504|FG000|Overall Study|Physician Decision|1|||
23367900|NCT04644029|65092505|FG001|Overall Study|Physician Decision|2|||
23367901|NCT04644029|65092504|FG000|Overall Study|Withdrawal by Subject|21|||
23367902|NCT04644029|65092505|FG001|Overall Study|Withdrawal by Subject|19|||
23367903|NCT04644029|65092504|FG000|Overall Study|Lost to Follow-up|31|||
23367904|NCT04644029|65092505|FG001|Overall Study|Lost to Follow-up|34|||
23367905|NCT04644029|65092504|FG000|Overall Study|Study Terminated by Sponsor|305|||
23367906|NCT04644029|65092505|FG001|Overall Study|Study Terminated by Sponsor|301|||
23367907|NCT04644029|65092504|FG000|Overall Study|Status Not Recorded|3|||
23367908|NCT04644029|65092505|FG001|Overall Study|Status Not Recorded|8|||
23367909|NCT04644029|65092504|FG000|Overall Study|Randomized in Error|2|||
23367910|NCT04644029|65092505|FG001|Overall Study|Randomized in Error|1|||
23367911|NCT04644029|65092504|FG000|Overall Study|Other|0|||
23367912|NCT04644029|65092505|FG001|Overall Study|Other|1|||
23367913|NCT01418339|65092506|FG000|Overall Study|Adverse Event|5|||
23367914|NCT01418339|65092507|FG001|Overall Study|Adverse Event|2|||
23367915|NCT01418339|65092506|FG000|Overall Study|Subject Withdrew Consent|1|||
23367916|NCT01418339|65092507|FG001|Overall Study|Subject Withdrew Consent|2|||
23367917|NCT01418339|65092506|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
23367918|NCT01418339|65092507|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
23367919|NCT00161213|65092510|FG000|Overall Study|Withdrawal by Subject|1|||
23367920|NCT00161213|65092510|FG000|Overall Study|Evaluable for toxicity but not response|1|||
23367921|NCT01919164|65092511|FG000|Overall Study|Adverse Event|6|||
23367922|NCT01919164|65092512|FG001|Overall Study|Adverse Event|4|||
23367923|NCT01919164|65092513|FG002|Overall Study|Adverse Event|9|||
23273801|NCT04526210|64745267|FG000|Overall Study|Withdrawal by Subject|3|||
23273802|NCT04526210|64745268|FG001|Overall Study|Withdrawal by Subject|2|||
23273803|NCT00746798|64745271|FG000|Overall Study|Protocol Violation|0|||
23273804|NCT00746798|64745272|FG001|Overall Study|Protocol Violation|1|||
23273805|NCT00746798|64745273|FG002|Overall Study|Protocol Violation|0|||
23273806|NCT00746798|64745274|FG003|Overall Study|Protocol Violation|0|||
23273807|NCT00746798|64745271|FG000|Overall Study|Withdrawal by Subject|0|||
23273808|NCT00746798|64745272|FG001|Overall Study|Withdrawal by Subject|1|||
23367924|NCT01919164|65092514|FG003|Overall Study|Adverse Event|3|||
23367925|NCT01919164|65092515|FG004|Overall Study|Adverse Event|2|||
23367926|NCT01919164|65092511|FG000|Overall Study|Lost to Follow-up|2|||
23367927|NCT01919164|65092512|FG001|Overall Study|Lost to Follow-up|2|||
23367928|NCT01919164|65092513|FG002|Overall Study|Lost to Follow-up|2|||
23367929|NCT01919164|65092514|FG003|Overall Study|Lost to Follow-up|0|||
23367930|NCT01919164|65092515|FG004|Overall Study|Lost to Follow-up|4|||
23367931|NCT01919164|65092511|FG000|Overall Study|Death|1|||
23367932|NCT01919164|65092512|FG001|Overall Study|Death|0|||
23367933|NCT01919164|65092513|FG002|Overall Study|Death|0|||
23367934|NCT01919164|65092514|FG003|Overall Study|Death|0|||
23367935|NCT01919164|65092515|FG004|Overall Study|Death|0|||
23367936|NCT01919164|65092511|FG000|Overall Study|Protocol Violation|6|||
23367937|NCT01919164|65092512|FG001|Overall Study|Protocol Violation|0|||
23367938|NCT01919164|65092513|FG002|Overall Study|Protocol Violation|3|||
23367939|NCT01919164|65092514|FG003|Overall Study|Protocol Violation|2|||
23367940|NCT01919164|65092515|FG004|Overall Study|Protocol Violation|2|||
23367941|NCT01919164|65092511|FG000|Overall Study|Disease progression|2|||
23367942|NCT01919164|65092512|FG001|Overall Study|Disease progression|2|||
23367943|NCT01919164|65092513|FG002|Overall Study|Disease progression|1|||
23367944|NCT01919164|65092514|FG003|Overall Study|Disease progression|2|||
23367945|NCT01919164|65092515|FG004|Overall Study|Disease progression|1|||
23367946|NCT01919164|65092511|FG000|Overall Study|Withdrew consent|13|||
23367947|NCT01919164|65092512|FG001|Overall Study|Withdrew consent|13|||
23367948|NCT01919164|65092513|FG002|Overall Study|Withdrew consent|14|||
23367949|NCT01919164|65092514|FG003|Overall Study|Withdrew consent|14|||
23367950|NCT01919164|65092515|FG004|Overall Study|Withdrew consent|9|||
23367951|NCT01919164|65092511|FG000|Overall Study|Other Un-specified|13|||
23367952|NCT01919164|65092512|FG001|Overall Study|Other Un-specified|9|||
23367953|NCT01919164|65092513|FG002|Overall Study|Other Un-specified|8|||
23367954|NCT01919164|65092514|FG003|Overall Study|Other Un-specified|7|||
23367955|NCT01919164|65092515|FG004|Overall Study|Other Un-specified|15|||
23367956|NCT02723188|65092519|FG000|Overall Study|Withdrawal by Subject|1|||
23367957|NCT02723188|65092520|FG001|Overall Study|Withdrawal by Subject|0|||
23367958|NCT02723188|65092521|FG002|Overall Study|Withdrawal by Subject|0|||
23367959|NCT03718429|65092522|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
23273809|NCT00746798|64745273|FG002|Overall Study|Withdrawal by Subject|1|||
23367960|NCT03718429|65092523|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
23367961|NCT03718429|65092524|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
23367962|NCT03718429|65092525|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
23367963|NCT04805671|65092526|FG000|Overall Study|Death|2|||
23367964|NCT04805671|65092527|FG001|Overall Study|Death|7|||
23367965|NCT04805671|65092526|FG000|Overall Study|Lost to Follow-up|1|||
23367966|NCT04805671|65092527|FG001|Overall Study|Lost to Follow-up|0|||
23367967|NCT04805671|65092526|FG000|Overall Study|Withdrawal by Subject|9|||
23367968|NCT04805671|65092527|FG001|Overall Study|Withdrawal by Subject|7|||
23367969|NCT04805671|65092526|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
23367970|NCT04805671|65092527|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
23367971|NCT02976519|65092528|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367972|NCT02976519|65092529|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
23367973|NCT02976519|65092530|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367974|NCT02976519|65092531|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367975|NCT02976519|65092532|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367976|NCT02976519|65092533|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367977|NCT02976519|65092534|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
23367978|NCT02976519|65092528|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367979|NCT02976519|65092529|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367980|NCT02976519|65092530|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367981|NCT02976519|65092531|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
23367982|NCT02976519|65092532|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367983|NCT02976519|65092533|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367984|NCT02976519|65092534|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
23367985|NCT02976519|65092528|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367986|NCT02976519|65092529|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367987|NCT02976519|65092530|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367988|NCT02976519|65092531|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367989|NCT02976519|65092532|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367990|NCT02976519|65092533|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
23367991|NCT02976519|65092534|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
23367992|NCT02976519|65092528|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367993|NCT02976519|65092529|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367994|NCT02976519|65092530|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367995|NCT02976519|65092531|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367996|NCT02976519|65092532|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367997|NCT02976519|65092533|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
23367998|NCT02976519|65092534|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
23367999|NCT02976519|65092528|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23368000|NCT02976519|65092529|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23368001|NCT02976519|65092530|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23602417|NCT01998958|65934058|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602418|NCT01998958|65934059|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602419|NCT01998958|65934060|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602420|NCT01998958|65934061|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602421|NCT01998958|65934062|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602422|NCT01998958|65934063|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602423|NCT01998958|65934064|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602424|NCT01998958|65934065|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602425|NCT01998958|65934066|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602426|NCT01998958|65934067|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
23602427|NCT01998958|65934068|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602428|NCT01998958|65934069|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602429|NCT01998958|65934070|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602430|NCT01998958|65934071|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
23368002|NCT02976519|65092531|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23201282|NCT01577160|64476676|FG000|Overall Study|Withdrawal by Subject|18|||
23201283|NCT01577160|64476676|FG000|Overall Study|Subject Uncooperative|7|||
23201284|NCT01577160|64476676|FG000|Overall Study|Other|9|||
23201285|NCT03235544|64476690|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
23201286|NCT03235544|64476691|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
23201287|NCT03235544|64476692|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
23201288|NCT03235544|64476693|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
23201289|NCT03235544|64476690|FG000|Overall Study|Death|11|||
23201290|NCT03235544|64476691|FG001|Overall Study|Death|23|||
23201291|NCT03235544|64476692|FG002|Overall Study|Death|11|||
23201292|NCT03235544|64476693|FG003|Overall Study|Death|20|||
23201293|NCT03235544|64476690|FG000|Overall Study|Lost to Follow-up|0|||
23201294|NCT03235544|64476691|FG001|Overall Study|Lost to Follow-up|1|||
23201295|NCT03235544|64476692|FG002|Overall Study|Lost to Follow-up|0|||
23201296|NCT03235544|64476693|FG003|Overall Study|Lost to Follow-up|1|||
23201297|NCT03235544|64476690|FG000|Overall Study|Withdrawal by Participant|0|||
23201298|NCT03235544|64476691|FG001|Overall Study|Withdrawal by Participant|0|||
23201299|NCT03235544|64476692|FG002|Overall Study|Withdrawal by Participant|1|||
23201300|NCT03235544|64476693|FG003|Overall Study|Withdrawal by Participant|0|||
23201301|NCT03235544|64476690|FG000|Overall Study|Reason not Specified|0|||
23201302|NCT03235544|64476691|FG001|Overall Study|Reason not Specified|4|||
23201303|NCT03235544|64476692|FG002|Overall Study|Reason not Specified|0|||
23201304|NCT03235544|64476693|FG003|Overall Study|Reason not Specified|1|||
23201305|NCT03633227|64476694|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
23201306|NCT03633227|64476695|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
23201307|NCT03633227|64476694|FG000|Double Blind (DB), up to Week 48|Death|2|||
23201308|NCT03633227|64476695|FG001|Double Blind (DB), up to Week 48|Death|1|||
23201309|NCT03633227|64476694|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
23201310|NCT03633227|64476695|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
23201311|NCT03633227|64476694|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
23201312|NCT03633227|64476695|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
23201313|NCT03633227|64476694|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
23201314|NCT03633227|64476695|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
23201315|NCT03633227|64476694|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
23201316|NCT03633227|64476695|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
23201317|NCT03633227|64476694|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
23201318|NCT03633227|64476695|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
23273810|NCT00746798|64745274|FG003|Overall Study|Withdrawal by Subject|0|||
23273811|NCT00746798|64745271|FG000|Overall Study|Death|0|||
23273812|NCT00746798|64745272|FG001|Overall Study|Death|0|||
23273813|NCT00746798|64745273|FG002|Overall Study|Death|2|||
23273814|NCT00746798|64745274|FG003|Overall Study|Death|0|||
23368003|NCT02976519|65092532|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23368004|NCT02976519|65092533|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
23368005|NCT02976519|65092534|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
23368006|NCT03102762|65092537|FG000|Overall Study|Lost to Follow-up|1|||
23368007|NCT03102762|65092538|FG001|Overall Study|Lost to Follow-up|0|||
23368008|NCT00875810|65092539|FG000|Overall Study|Withdrawal by Subject|1|||
23368009|NCT00875810|65092539|FG000|Overall Study|Physician Decision|3|||
23273815|NCT00746798|64745271|FG000|Overall Study|Participant unable to return for visit|1|||
23273816|NCT00746798|64745272|FG001|Overall Study|Participant unable to return for visit|0|||
23368010|NCT00875810|65092539|FG000|Overall Study|Lost to Follow-up|39|||
23368011|NCT00875810|65092539|FG000|Overall Study|Patient enroled but not implanted|2|||
23368012|NCT00875810|65092539|FG000|Overall Study|Device explanted|1|||
23368013|NCT01296412|65092542|FG000|Overall Study|Adverse Event|8|||
23368014|NCT01296412|65092543|FG001|Overall Study|Adverse Event|29|||
23368015|NCT01296412|65092542|FG000|Overall Study|Lack of Efficacy|1|||
23368016|NCT01296412|65092543|FG001|Overall Study|Lack of Efficacy|0|||
23368017|NCT01296412|65092542|FG000|Overall Study|Lost to Follow-up|10|||
23368018|NCT01296412|65092543|FG001|Overall Study|Lost to Follow-up|7|||
23368019|NCT01296412|65092542|FG000|Overall Study|Non-compliance with study drug|1|||
23368020|NCT01296412|65092543|FG001|Overall Study|Non-compliance with study drug|2|||
23368021|NCT01296412|65092542|FG000|Overall Study|Other reason not specified|20|||
23273817|NCT00746798|64745273|FG002|Overall Study|Participant unable to return for visit|0|||
23273818|NCT00746798|64745274|FG003|Overall Study|Participant unable to return for visit|0|||
23273819|NCT00905840|64745275|FG000|Overall Study|Lost to Follow-up|11|||
23273820|NCT00905840|64745275|FG000|Overall Study|Death|3|||
23273821|NCT00905840|64745275|FG000|Overall Study|Withdrawal by Subject|1|||
23273822|NCT00905840|64745275|FG000|Overall Study|Adverse Event|1|||
23273823|NCT02188303|64745276|FG000|Overall Study|Adverse Event|0|||
23368022|NCT01296412|65092543|FG001|Overall Study|Other reason not specified|15|||
23368023|NCT01296412|65092542|FG000|Overall Study|Physician Decision|1|||
23368024|NCT01296412|65092543|FG001|Overall Study|Physician Decision|3|||
23368025|NCT01296412|65092542|FG000|Overall Study|Pregnancy|0|||
23368026|NCT01296412|65092543|FG001|Overall Study|Pregnancy|1|||
23368027|NCT01296412|65092542|FG000|Overall Study|Withdrawal by Subject|10|||
23368028|NCT01296412|65092543|FG001|Overall Study|Withdrawal by Subject|13|||
23368029|NCT03342001|65092544|FG000|Overall Study|Adverse Event|1|||
23484172|NCT02119676|65515941|FG000|Overall Study|Noncompliance|0|||
23484173|NCT02119676|65515942|FG001|Overall Study|Noncompliance|1|||
23484174|NCT02119676|65515943|FG002|Overall Study|Noncompliance|0|||
23484175|NCT02119676|65515944|FG003|Overall Study|Noncompliance|0|||
23484176|NCT02119676|65515941|FG000|Overall Study|Lost to Follow-up|0|||
23484177|NCT02119676|65515942|FG001|Overall Study|Lost to Follow-up|0|||
23484178|NCT02119676|65515943|FG002|Overall Study|Lost to Follow-up|1|||
23484179|NCT02119676|65515944|FG003|Overall Study|Lost to Follow-up|0|||
23484180|NCT02119676|65515941|FG000|Overall Study|Protocol deviation|0|||
23484181|NCT02119676|65515942|FG001|Overall Study|Protocol deviation|0|||
23273824|NCT02188303|64745277|FG001|Overall Study|Adverse Event|0|||
23273825|NCT02188303|64745278|FG002|Overall Study|Adverse Event|0|||
23273826|NCT02188303|64745279|FG003|Overall Study|Adverse Event|0|||
23484182|NCT02119676|65515943|FG002|Overall Study|Protocol deviation|1|||
23484183|NCT02119676|65515944|FG003|Overall Study|Protocol deviation|0|||
23273827|NCT02188303|64745280|FG004|Overall Study|Adverse Event|0|||
23368030|NCT03342001|65092544|FG000|Overall Study|Lost to Follow-up|1|||
23368031|NCT03902613|65092550|FG000|Overall Study|Physician Decision|1|||
23484184|NCT02119676|65515941|FG000|Overall Study|Other, unspecified|2|||
23368032|NCT00102596|65092551|FG000|Part A|Screen failures|6|||
23368033|NCT00102596|65092552|FG001|Part A|Screen failures|0|||
23368034|NCT00102596|65092551|FG000|Part A|Adverse Event|1|||
23368035|NCT00102596|65092552|FG001|Part A|Adverse Event|0|||
23368036|NCT02557295|65092556|FG000|Overall Study|Withdrawal by Subject|9|||
23368037|NCT02557295|65092557|FG001|Overall Study|Withdrawal by Subject|2|||
23273828|NCT02188303|64745281|FG005|Overall Study|Adverse Event|2|||
23273829|NCT02188303|64745282|FG006|Overall Study|Adverse Event|0|||
23273830|NCT02188303|64745283|FG007|Overall Study|Adverse Event|2|||
23273831|NCT02188303|64745276|FG000|Overall Study|Dose Termination Criteria Met|0|||
23273832|NCT02188303|64745277|FG001|Overall Study|Dose Termination Criteria Met|0|||
23273833|NCT02188303|64745278|FG002|Overall Study|Dose Termination Criteria Met|0|||
23273834|NCT02188303|64745279|FG003|Overall Study|Dose Termination Criteria Met|0|||
23368038|NCT02557295|65092558|FG002|Overall Study|Withdrawal by Subject|4|||
23368039|NCT02557295|65092559|FG003|Overall Study|Withdrawal by Subject|0|||
23368040|NCT02557295|65092560|FG004|Overall Study|Withdrawal by Subject|0|||
23368041|NCT02557295|65092561|FG005|Overall Study|Withdrawal by Subject|0|||
23368042|NCT02557295|65092562|FG006|Overall Study|Withdrawal by Subject|15|||
23273835|NCT02188303|64745280|FG004|Overall Study|Dose Termination Criteria Met|0|||
23273836|NCT02188303|64745281|FG005|Overall Study|Dose Termination Criteria Met|0|||
23273837|NCT02188303|64745282|FG006|Overall Study|Dose Termination Criteria Met|2|||
23273838|NCT02188303|64745283|FG007|Overall Study|Dose Termination Criteria Met|4|||
23273839|NCT00416520|64745293|FG000|Open-label Period|Adverse Event|28|||
23273840|NCT00416520|64745294|FG001|Open-label Period|Adverse Event|10|||
23368043|NCT02557295|65092563|FG007|Overall Study|Withdrawal by Subject|1|||
23368044|NCT02557295|65092564|FG008|Overall Study|Withdrawal by Subject|3|||
23368045|NCT02557295|65092556|FG000|Overall Study|Disease Progression|0|||
23368046|NCT02557295|65092557|FG001|Overall Study|Disease Progression|0|||
23368047|NCT02557295|65092558|FG002|Overall Study|Disease Progression|0|||
23368048|NCT02557295|65092559|FG003|Overall Study|Disease Progression|0|||
23368049|NCT02557295|65092560|FG004|Overall Study|Disease Progression|0|||
23368050|NCT02557295|65092561|FG005|Overall Study|Disease Progression|0|||
23602431|NCT01998958|65934072|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602432|NCT01998958|65934073|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602433|NCT01998958|65934074|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602434|NCT01998958|65934075|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23273841|NCT00416520|64745295|FG002|Open-label Period|Adverse Event|0|||
23273842|NCT00416520|64745296|FG003|Open-label Period|Adverse Event|0|||
23273843|NCT00416520|64745293|FG000|Open-label Period|Death|2|||
23273844|NCT00416520|64745294|FG001|Open-label Period|Death|1|||
23273845|NCT00416520|64745295|FG002|Open-label Period|Death|0|||
23273846|NCT00416520|64745296|FG003|Open-label Period|Death|0|||
23273847|NCT00416520|64745293|FG000|Open-label Period|Lack of Efficacy|8|||
23273848|NCT00416520|64745294|FG001|Open-label Period|Lack of Efficacy|1|||
23273849|NCT00416520|64745295|FG002|Open-label Period|Lack of Efficacy|0|||
23273850|NCT00416520|64745296|FG003|Open-label Period|Lack of Efficacy|0|||
23273851|NCT00416520|64745293|FG000|Open-label Period|Protocol Violation|3|||
23273852|NCT00416520|64745294|FG001|Open-label Period|Protocol Violation|3|||
23273853|NCT00416520|64745295|FG002|Open-label Period|Protocol Violation|0|||
23273854|NCT00416520|64745296|FG003|Open-label Period|Protocol Violation|0|||
23273855|NCT00416520|64745293|FG000|Open-label Period|Withdrawal by Subject|16|||
23273856|NCT00416520|64745294|FG001|Open-label Period|Withdrawal by Subject|5|||
23273857|NCT00416520|64745295|FG002|Open-label Period|Withdrawal by Subject|0|||
23273858|NCT00416520|64745296|FG003|Open-label Period|Withdrawal by Subject|0|||
23273859|NCT00416520|64745293|FG000|Open-label Period|Other Reasons|3|||
23273860|NCT00416520|64745294|FG001|Open-label Period|Other Reasons|12|||
23273861|NCT00416520|64745295|FG002|Open-label Period|Other Reasons|0|||
23273862|NCT00416520|64745296|FG003|Open-label Period|Other Reasons|0|||
23273863|NCT00416520|64745293|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
23273864|NCT00416520|64745294|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
23273865|NCT00416520|64745295|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
23368051|NCT02557295|65092562|FG006|Overall Study|Disease Progression|1|||
23602435|NCT01998958|65934076|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23273866|NCT00416520|64745296|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
23273867|NCT00416520|64745293|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
23273868|NCT00416520|64745294|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
23273869|NCT00416520|64745295|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
23273870|NCT00416520|64745296|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
23273871|NCT00416520|64745293|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
23273872|NCT00416520|64745294|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
23368052|NCT02557295|65092563|FG007|Overall Study|Disease Progression|0|||
23368053|NCT02557295|65092564|FG008|Overall Study|Disease Progression|0|||
23368054|NCT02557295|65092556|FG000|Overall Study|Lack of Efficacy|24|||
23273873|NCT00416520|64745295|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
23368055|NCT02557295|65092557|FG001|Overall Study|Lack of Efficacy|1|||
23484185|NCT02119676|65515942|FG001|Overall Study|Other, unspecified|1|||
23484186|NCT02119676|65515943|FG002|Overall Study|Other, unspecified|3|||
23273874|NCT00416520|64745296|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
23273875|NCT02760368|64745299|FG000|Overall Study|Withdrawal by Subject|8|||
23273876|NCT02760368|64745300|FG001|Overall Study|Withdrawal by Subject|12|||
23273877|NCT02760368|64745301|FG002|Overall Study|Withdrawal by Subject|9|||
23273878|NCT02760368|64745299|FG000|Overall Study|Screen Failure|0|||
23273879|NCT02760368|64745300|FG001|Overall Study|Screen Failure|0|||
23273880|NCT02760368|64745301|FG002|Overall Study|Screen Failure|1|||
23273881|NCT02760368|64745299|FG000|Overall Study|Death|0|||
23273882|NCT02760368|64745300|FG001|Overall Study|Death|1|||
23273883|NCT02760368|64745301|FG002|Overall Study|Death|0|||
23273884|NCT02760368|64745299|FG000|Overall Study|Withdrawal by Sponsor|0|||
23273885|NCT02760368|64745300|FG001|Overall Study|Withdrawal by Sponsor|0|||
23273886|NCT02760368|64745301|FG002|Overall Study|Withdrawal by Sponsor|1|||
23273887|NCT00274937|64745306|FG000|Overall Study|Physician Decision|10|||
23273888|NCT00274937|64745306|FG000|Overall Study|Withdrawal by Subject|6|||
23273889|NCT00274937|64745306|FG000|Overall Study|Progressive Disease|4|||
23273890|NCT03929393|64745308|FG000|Overall Study|Death|1|||
23273891|NCT03929393|64745309|FG001|Overall Study|Death|0|||
23273892|NCT03929393|64745308|FG000|Overall Study|Time Commitment|2|||
23273893|NCT03929393|64745309|FG001|Overall Study|Time Commitment|5|||
23273894|NCT03929393|64745308|FG000|Overall Study|Motor Vehicle Accident|0|||
23273895|NCT03929393|64745309|FG001|Overall Study|Motor Vehicle Accident|1|||
23273896|NCT03929393|64745308|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
23273897|NCT03929393|64745309|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
23273898|NCT03929393|64745308|FG000|Overall Study|Other|1|||
23273899|NCT03929393|64745309|FG001|Overall Study|Other|3|||
23273900|NCT00893464|64745312|FG000|Overall Study|Did not complete therapy/experience PD|0|||
23273901|NCT00893464|64745313|FG001|Overall Study|Did not complete therapy/experience PD|0|||
23273902|NCT00893464|64745314|FG002|Overall Study|Did not complete therapy/experience PD|0|||
23273903|NCT00893464|64745315|FG003|Overall Study|Did not complete therapy/experience PD|0|||
23273904|NCT00893464|64745316|FG004|Overall Study|Did not complete therapy/experience PD|0|||
23273905|NCT00893464|64745317|FG005|Overall Study|Did not complete therapy/experience PD|0|||
23273906|NCT00893464|64745318|FG006|Overall Study|Did not complete therapy/experience PD|2|||
23273907|NCT00893464|64745319|FG007|Overall Study|Did not complete therapy/experience PD|2|||
23273908|NCT02058498|64748057|FG000|Overall Study|Withdrawal by Subject|4|||
23273909|NCT02711852|64748063|FG000|Overall Study|Death|5|||
23273910|NCT02711852|64748063|FG000|Overall Study|Lost to Follow-up|1|||
23273911|NCT02711852|64748063|FG000|Overall Study|Completed follow-up|3|||
23273912|NCT02711852|64748063|FG000|Overall Study|Withdrawal by Subject|1|||
23273913|NCT03733730|64748064|FG000|Overall Study|Lost to Follow-up|1|||
23273914|NCT03733730|64748065|FG001|Overall Study|Lost to Follow-up|32|||
23273915|NCT03733730|64748064|FG000|Overall Study|Other|1|||
23273916|NCT03733730|64748065|FG001|Overall Study|Other|0|||
23273917|NCT03733730|64748064|FG000|Overall Study|Adverse Event|0|||
23273918|NCT03733730|64748065|FG001|Overall Study|Adverse Event|4|||
23273919|NCT03733730|64748064|FG000|Overall Study|Death|0|||
23273920|NCT03733730|64748065|FG001|Overall Study|Death|5|||
23273921|NCT03733730|64748064|FG000|Overall Study|Withdrawal by Subject|0|||
23273922|NCT03733730|64748065|FG001|Overall Study|Withdrawal by Subject|8|||
23273923|NCT02077465|64748068|FG000|Overall Study|Withdrew Consent|0|||
23273924|NCT02077465|64748069|FG001|Overall Study|Withdrew Consent|1|||
23273925|NCT02077465|64748068|FG000|Overall Study|Lost to Follow-up|1|||
23273926|NCT02077465|64748069|FG001|Overall Study|Lost to Follow-up|0|||
23273927|NCT01882257|64748072|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
23273928|NCT01882257|64748073|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
23273929|NCT01882257|64748074|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
23273930|NCT01882257|64748072|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
23273931|NCT01882257|64748073|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
23273932|NCT01882257|64748074|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
23273933|NCT03500341|64748075|FG000|Overall Study|Withdrawn prior to Completion|2|||
23273934|NCT00727961|64748076|FG000|Overall Study|Lost to Follow-up|1|||
23273935|NCT00727961|64748076|FG000|Overall Study|Adverse Event|4|||
23273936|NCT00727961|64748076|FG000|Overall Study|Patient's refusal|2|||
23273937|NCT00727961|64748076|FG000|Overall Study|Progression|30|||
23273938|NCT02459951|64748081|FG000|Overall Study|Unable to meet holding requirement|1|||
23273939|NCT01513174|64748083|FG000|Overall Study|Inclusion Error|1|||
23484187|NCT02119676|65515944|FG003|Overall Study|Other, unspecified|4|||
23273940|NCT01513174|64748084|FG001|Overall Study|Inclusion Error|7|||
23273941|NCT01513174|64748083|FG000|Overall Study|Not receive study treatment|3|||
23273942|NCT01513174|64748084|FG001|Overall Study|Not receive study treatment|1|||
23273943|NCT01037114|64748087|FG000|Year 20|Others|1|||
23273944|NCT00445003|64748092|FG000|Overall Study|Death|1|||
23273945|NCT00445003|64748093|FG001|Overall Study|Death|2|||
23273946|NCT00445003|64748094|FG002|Overall Study|Death|1|||
23273947|NCT00445003|64748092|FG000|Overall Study|Missed Visit|3|||
23273948|NCT00445003|64748093|FG001|Overall Study|Missed Visit|5|||
23273949|NCT00445003|64748094|FG002|Overall Study|Missed Visit|1|||
23273950|NCT00445003|64748092|FG000|Overall Study|Dropped|1|||
23273951|NCT00445003|64748093|FG001|Overall Study|Dropped|3|||
23273952|NCT00445003|64748094|FG002|Overall Study|Dropped|2|||
23273953|NCT02918877|64748095|FG000|Overall Study|Withdrawal by Subject|2|||
23273954|NCT02918877|64748096|FG001|Overall Study|Withdrawal by Subject|2|||
23273955|NCT02918877|64748095|FG000|Overall Study|Surgery cancelled|1|||
23273956|NCT02918877|64748096|FG001|Overall Study|Surgery cancelled|0|||
23273957|NCT02918877|64748095|FG000|Overall Study|Physician Decision|1|||
23273958|NCT02918877|64748096|FG001|Overall Study|Physician Decision|0|||
23273959|NCT02918877|64748095|FG000|Overall Study|Received intraoperative steroids|1|||
23273960|NCT02918877|64748096|FG001|Overall Study|Received intraoperative steroids|0|||
23273961|NCT02918877|64748095|FG000|Overall Study|Unable to obtain lab samples|1|||
23273962|NCT02918877|64748096|FG001|Overall Study|Unable to obtain lab samples|0|||
23273963|NCT02918877|64748095|FG000|Overall Study|Unsafe to perform BAL|0|||
23273964|NCT02918877|64748096|FG001|Overall Study|Unsafe to perform BAL|1|||
23273965|NCT02445339|64748097|FG000|Overall Study|Physician Decision|1|||
23273966|NCT02445339|64748098|FG001|Overall Study|Physician Decision|0|||
23273967|NCT02445339|64748097|FG000|Overall Study|Lost to Follow-up|11|||
23273968|NCT02445339|64748098|FG001|Overall Study|Lost to Follow-up|15|||
23273969|NCT03552393|64748105|FG000|Core Period|Kidney Transplant|1|||
23273970|NCT03552393|64748105|FG000|Core Period|Prohibited Medication|1|||
23273971|NCT03552393|64748105|FG000|Safety Extension Period|Kidney Transplant|4|||
23273972|NCT02481830|64748114|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
23273973|NCT02481830|64748115|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
23273974|NCT02481830|64748114|FG000|Pre-treatment|Withdrawal by Subject|0|||
23273975|NCT02481830|64748115|FG001|Pre-treatment|Withdrawal by Subject|10|||
23273976|NCT02481830|64748114|FG000|Pre-treatment|Disease Progression|1|||
23273977|NCT02481830|64748115|FG001|Pre-treatment|Disease Progression|1|||
23273978|NCT02481830|64748114|FG000|Pre-treatment|Other reasons|0|||
23273979|NCT02481830|64748115|FG001|Pre-treatment|Other reasons|1|||
23273980|NCT02481830|64748114|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
23273981|NCT02481830|64748115|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
23273982|NCT02481830|64748114|FG000|Treatment|Disease Progression|233|||
23273983|NCT02481830|64748115|FG001|Treatment|Disease Progression|171|||
23273984|NCT02481830|64748114|FG000|Treatment|Study drug toxicity|18|||
23273985|NCT02481830|64748115|FG001|Treatment|Study drug toxicity|38|||
23273986|NCT02481830|64748114|FG000|Treatment|Death|1|||
23273987|NCT02481830|64748115|FG001|Treatment|Death|1|||
23273988|NCT02481830|64748114|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
23273989|NCT02481830|64748115|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
23273990|NCT02481830|64748114|FG000|Treatment|Participants request to discontinue Study treatment|6|||
23273991|NCT02481830|64748115|FG001|Treatment|Participants request to discontinue Study treatment|34|||
23368056|NCT02557295|65092558|FG002|Overall Study|Lack of Efficacy|3|||
23368057|NCT02557295|65092559|FG003|Overall Study|Lack of Efficacy|0|||
23368058|NCT02557295|65092560|FG004|Overall Study|Lack of Efficacy|0|||
23368059|NCT02557295|65092561|FG005|Overall Study|Lack of Efficacy|0|||
23368060|NCT02557295|65092562|FG006|Overall Study|Lack of Efficacy|12|||
23368061|NCT02557295|65092563|FG007|Overall Study|Lack of Efficacy|1|||
23368062|NCT02557295|65092564|FG008|Overall Study|Lack of Efficacy|0|||
23368063|NCT02557295|65092556|FG000|Overall Study|Adverse Event|16|||
23368064|NCT02557295|65092557|FG001|Overall Study|Adverse Event|2|||
23368065|NCT02557295|65092558|FG002|Overall Study|Adverse Event|3|||
23368066|NCT02557295|65092559|FG003|Overall Study|Adverse Event|0|||
23368067|NCT02557295|65092560|FG004|Overall Study|Adverse Event|0|||
23273992|NCT02481830|64748114|FG000|Treatment|Withdrawal by Subject|2|||
23273993|NCT02481830|64748115|FG001|Treatment|Withdrawal by Subject|3|||
23273994|NCT02481830|64748114|FG000|Treatment|Lost to Follow-up|1|||
23273995|NCT02481830|64748115|FG001|Treatment|Lost to Follow-up|0|||
23273996|NCT02481830|64748114|FG000|Treatment|Maximum Clinical Benefit|0|||
23273997|NCT02481830|64748115|FG001|Treatment|Maximum Clinical Benefit|5|||
23273998|NCT02481830|64748114|FG000|Treatment|Administrative reason by sponsor|1|||
23273999|NCT02481830|64748115|FG001|Treatment|Administrative reason by sponsor|1|||
23274000|NCT02481830|64748114|FG000|Treatment|Other reasons|6|||
23368068|NCT02557295|65092561|FG005|Overall Study|Adverse Event|0|||
23274001|NCT02481830|64748115|FG001|Treatment|Other reasons|1|||
23274002|NCT02424097|64748120|FG000|Overall Study|Lost to Follow-up|1|||
23368069|NCT02557295|65092562|FG006|Overall Study|Adverse Event|2|||
23368070|NCT02557295|65092563|FG007|Overall Study|Adverse Event|1|||
23274003|NCT02424097|64748121|FG001|Overall Study|Lost to Follow-up|2|||
23274004|NCT03351244|64748122|FG000|Overall Study|Adverse Event|7|||
23274005|NCT03351244|64748123|FG001|Overall Study|Adverse Event|11|||
23274006|NCT03351244|64748124|FG002|Overall Study|Adverse Event|12|||
23274007|NCT03351244|64748122|FG000|Overall Study|Investigator's decision|0|||
23274008|NCT03351244|64748123|FG001|Overall Study|Investigator's decision|0|||
23274009|NCT03351244|64748124|FG002|Overall Study|Investigator's decision|2|||
23368071|NCT02557295|65092564|FG008|Overall Study|Adverse Event|1|||
23368072|NCT02557295|65092556|FG000|Overall Study|Lost to Follow-up|4|||
23368073|NCT02557295|65092557|FG001|Overall Study|Lost to Follow-up|0|||
23368074|NCT02557295|65092558|FG002|Overall Study|Lost to Follow-up|0|||
23368075|NCT02557295|65092559|FG003|Overall Study|Lost to Follow-up|0|||
23274010|NCT03351244|64748122|FG000|Overall Study|System error|0|||
23274011|NCT03351244|64748123|FG001|Overall Study|System error|0|||
23368076|NCT02557295|65092560|FG004|Overall Study|Lost to Follow-up|0|||
23368077|NCT02557295|65092561|FG005|Overall Study|Lost to Follow-up|0|||
23368078|NCT02557295|65092562|FG006|Overall Study|Lost to Follow-up|9|||
23368079|NCT02557295|65092563|FG007|Overall Study|Lost to Follow-up|0|||
23368080|NCT02557295|65092564|FG008|Overall Study|Lost to Follow-up|0|||
23274012|NCT03351244|64748124|FG002|Overall Study|System error|2|||
23274013|NCT03351244|64748122|FG000|Overall Study|COVID-19 restrictions|3|||
23274014|NCT03351244|64748123|FG001|Overall Study|COVID-19 restrictions|0|||
23274015|NCT03351244|64748124|FG002|Overall Study|COVID-19 restrictions|1|||
23274016|NCT03351244|64748122|FG000|Overall Study|Non-compliance|2|||
23274017|NCT03351244|64748123|FG001|Overall Study|Non-compliance|5|||
23368081|NCT02557295|65092556|FG000|Overall Study|Study Close|54|||
23368082|NCT02557295|65092557|FG001|Overall Study|Study Close|3|||
23368083|NCT02557295|65092558|FG002|Overall Study|Study Close|5|||
23368084|NCT02557295|65092559|FG003|Overall Study|Study Close|3|||
23368085|NCT02557295|65092560|FG004|Overall Study|Study Close|0|||
23368086|NCT02557295|65092561|FG005|Overall Study|Study Close|0|||
23368087|NCT02557295|65092562|FG006|Overall Study|Study Close|37|||
23484188|NCT02119676|65515941|FG000|Overall Study|Did not receive study med|2|||
23484189|NCT02119676|65515942|FG001|Overall Study|Did not receive study med|2|||
23484190|NCT02119676|65515943|FG002|Overall Study|Did not receive study med|4|||
23484191|NCT02119676|65515944|FG003|Overall Study|Did not receive study med|5|||
23484192|NCT01017575|65515949|FG000|Overall Study|Lack of Efficacy|0|||
23484193|NCT01017575|65515950|FG001|Overall Study|Lack of Efficacy|1|||
23484194|NCT01017575|65515951|FG002|Overall Study|Lack of Efficacy|0|||
23484195|NCT01017575|65515952|FG003|Overall Study|Lack of Efficacy|1|||
23484196|NCT01017575|65515953|FG004|Overall Study|Lack of Efficacy|1|||
23274018|NCT03351244|64748124|FG002|Overall Study|Non-compliance|0|||
23274019|NCT03351244|64748122|FG000|Overall Study|Withdrawal by Subject|11|||
23274020|NCT03351244|64748123|FG001|Overall Study|Withdrawal by Subject|16|||
23274021|NCT03351244|64748124|FG002|Overall Study|Withdrawal by Subject|13|||
23274022|NCT03351244|64748122|FG000|Overall Study|Lost to Follow-up|2|||
23274023|NCT03351244|64748123|FG001|Overall Study|Lost to Follow-up|6|||
23274024|NCT03351244|64748124|FG002|Overall Study|Lost to Follow-up|4|||
23274025|NCT03351244|64748122|FG000|Overall Study|Protocol Violation|2|||
23274026|NCT03351244|64748123|FG001|Overall Study|Protocol Violation|2|||
23274027|NCT03351244|64748124|FG002|Overall Study|Protocol Violation|0|||
23274028|NCT00468286|64748133|FG000|Overall Study|Adverse Event|1|||
23274029|NCT00468286|64748134|FG001|Overall Study|Adverse Event|6|||
23274030|NCT00468286|64748133|FG000|Overall Study|Protocol Violation|2|||
23274031|NCT00468286|64748134|FG001|Overall Study|Protocol Violation|2|||
23274032|NCT00468286|64748133|FG000|Overall Study|Withdrawal by Subject|4|||
23274033|NCT00468286|64748134|FG001|Overall Study|Withdrawal by Subject|3|||
23274034|NCT00468286|64748133|FG000|Overall Study|Physician Decision|0|||
23274035|NCT00468286|64748134|FG001|Overall Study|Physician Decision|1|||
23274036|NCT02817841|64748140|FG000|Overall Study|Lost to Follow-up|287|||
23274037|NCT02817841|64748140|FG000|Overall Study|Withdrawal by Subject|183|||
23274038|NCT02817841|64748140|FG000|Overall Study|Adverse event not related to bleeding|131|||
23274039|NCT02817841|64748140|FG000|Overall Study|Adverse event related to bleeding|51|||
23274040|NCT02817841|64748140|FG000|Overall Study|Pregnancy|32|||
23274041|NCT02817841|64748140|FG000|Overall Study|Pregnancy wish|17|||
23274042|NCT02817841|64748140|FG000|Overall Study|Other reasons|53|||
23484197|NCT01017575|65515949|FG000|Overall Study|Adverse Event|0|||
23274043|NCT02817841|64748140|FG000|Overall Study|Protocol Violation|94|||
23274044|NCT01171989|64748142|FG000|Overall Study|Lost to Follow-up|0|||
23368088|NCT02557295|65092563|FG007|Overall Study|Study Close|3|||
23368089|NCT02557295|65092564|FG008|Overall Study|Study Close|19|||
23484198|NCT01017575|65515950|FG001|Overall Study|Adverse Event|1|||
23484199|NCT01017575|65515951|FG002|Overall Study|Adverse Event|0|||
23484200|NCT01017575|65515952|FG003|Overall Study|Adverse Event|0|||
23274045|NCT01171989|64748143|FG001|Overall Study|Lost to Follow-up|0|||
23274046|NCT01171989|64748144|FG002|Overall Study|Lost to Follow-up|1|||
23274047|NCT01401647|64748146|FG000|Overall Study|Withdrawal by Subject|1|||
23274048|NCT01401647|64748147|FG001|Overall Study|Withdrawal by Subject|5|||
23368090|NCT02557295|65092556|FG000|Overall Study|except for study close|4|||
23484201|NCT01017575|65515953|FG004|Overall Study|Adverse Event|2|||
23484202|NCT01017575|65515949|FG000|Overall Study|Withdrawal by Subject|1|||
23484203|NCT01017575|65515950|FG001|Overall Study|Withdrawal by Subject|0|||
23484204|NCT01017575|65515951|FG002|Overall Study|Withdrawal by Subject|0|||
23484205|NCT01017575|65515952|FG003|Overall Study|Withdrawal by Subject|0|||
23484206|NCT01017575|65515953|FG004|Overall Study|Withdrawal by Subject|0|||
23484207|NCT01992159|65515954|FG000|Overall Study|Withdrawal by Subject|4|||
23484208|NCT01992159|65515955|FG001|Overall Study|Withdrawal by Subject|7|||
23484209|NCT01992159|65515956|FG002|Overall Study|Withdrawal by Subject|0|||
23484210|NCT01992159|65515957|FG003|Overall Study|Withdrawal by Subject|3|||
23484211|NCT01992159|65515954|FG000|Overall Study|Adverse Event|0|||
23484212|NCT01992159|65515955|FG001|Overall Study|Adverse Event|1|||
23484213|NCT01992159|65515956|FG002|Overall Study|Adverse Event|0|||
23484214|NCT01992159|65515957|FG003|Overall Study|Adverse Event|1|||
23484215|NCT01992159|65515954|FG000|Overall Study|Death|0|||
23484216|NCT01992159|65515955|FG001|Overall Study|Death|0|||
23484217|NCT01992159|65515956|FG002|Overall Study|Death|1|||
23484218|NCT01992159|65515957|FG003|Overall Study|Death|0|||
23484219|NCT02862600|65515958|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
23484220|NCT02862600|65515958|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
23484221|NCT02862600|65515958|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
23484222|NCT02862600|65515958|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
23484223|NCT00895011|65515962|FG000|Overall Study|Withdrawal by Subject|14|||
23484224|NCT00895011|65515963|FG001|Overall Study|Withdrawal by Subject|7|||
23484225|NCT00895011|65515964|FG002|Overall Study|Withdrawal by Subject|2|||
23274049|NCT01401647|64748148|FG002|Overall Study|Withdrawal by Subject|2|||
23274050|NCT01401647|64748146|FG000|Overall Study|Lost to Follow-up|3|||
23274051|NCT01401647|64748147|FG001|Overall Study|Lost to Follow-up|3|||
23274052|NCT01401647|64748148|FG002|Overall Study|Lost to Follow-up|1|||
23274053|NCT03600805|64748154|FG000|Overall Study|Adverse Event|2|||
23274054|NCT03600805|64748155|FG001|Overall Study|Adverse Event|1|||
23484226|NCT00895011|65515962|FG000|Overall Study|Lost to Follow-up|5|||
23484227|NCT00895011|65515963|FG001|Overall Study|Lost to Follow-up|4|||
23484228|NCT00895011|65515964|FG002|Overall Study|Lost to Follow-up|1|||
23484229|NCT00895011|65515962|FG000|Overall Study|Protocol Violation|3|||
23484230|NCT00895011|65515963|FG001|Overall Study|Protocol Violation|1|||
23484231|NCT00895011|65515964|FG002|Overall Study|Protocol Violation|3|||
23484232|NCT00895011|65515962|FG000|Overall Study|Adverse Event|1|||
23484233|NCT00895011|65515963|FG001|Overall Study|Adverse Event|2|||
23484234|NCT00895011|65515964|FG002|Overall Study|Adverse Event|2|||
23484235|NCT00895011|65515962|FG000|Overall Study|schedule conflict|1|||
23484236|NCT00895011|65515963|FG001|Overall Study|schedule conflict|0|||
23484237|NCT00895011|65515964|FG002|Overall Study|schedule conflict|0|||
23484238|NCT03355664|65515965|FG000|Overall Study|Adverse Event|1|||
23484239|NCT03355664|65515966|FG001|Overall Study|Adverse Event|2|||
23484240|NCT03355664|65515965|FG000|Overall Study|Lost to Follow-up|11|||
23484241|NCT03355664|65515966|FG001|Overall Study|Lost to Follow-up|7|||
23484242|NCT03355664|65515965|FG000|Overall Study|Protocol Violation|1|||
23484243|NCT03355664|65515966|FG001|Overall Study|Protocol Violation|2|||
23484244|NCT03355664|65515965|FG000|Overall Study|Withdrawal by Subject|2|||
23484245|NCT03355664|65515966|FG001|Overall Study|Withdrawal by Subject|1|||
23484246|NCT01475071|65515967|FG000|Overall Study|Physician Decision|1|||
23484247|NCT01475071|65515967|FG000|Overall Study|Withdrawal by Subject|6|||
23484248|NCT01475071|65515967|FG000|Overall Study|Lost to Follow-up|1|||
23484249|NCT00548405|65515969|FG000|Overall Study|Adverse Event|6|||
23484250|NCT00548405|65515970|FG001|Overall Study|Adverse Event|2|||
23484251|NCT00548405|65515971|FG002|Overall Study|Adverse Event|0|||
23484252|NCT00548405|65515969|FG000|Overall Study|Lack of Efficacy|6|||
23484253|NCT00548405|65515970|FG001|Overall Study|Lack of Efficacy|0|||
23274055|NCT03600805|64748156|FG002|Overall Study|Adverse Event|1|||
23274056|NCT03600805|64748157|FG003|Overall Study|Adverse Event|7|||
23274057|NCT03600805|64748154|FG000|Overall Study|Lack of Efficacy|2|||
23484254|NCT00548405|65515971|FG002|Overall Study|Lack of Efficacy|0|||
23484255|NCT00548405|65515969|FG000|Overall Study|Physician Decision|3|||
23484256|NCT00548405|65515970|FG001|Overall Study|Physician Decision|4|||
23484257|NCT00548405|65515971|FG002|Overall Study|Physician Decision|1|||
23484258|NCT00548405|65515969|FG000|Overall Study|Pregnancy|1|||
23484259|NCT00548405|65515970|FG001|Overall Study|Pregnancy|0|||
23484260|NCT00548405|65515971|FG002|Overall Study|Pregnancy|0|||
23484261|NCT00548405|65515969|FG000|Overall Study|Protocol Violation|1|||
23274058|NCT03600805|64748155|FG001|Overall Study|Lack of Efficacy|1|||
23274059|NCT03600805|64748156|FG002|Overall Study|Lack of Efficacy|0|||
23274060|NCT03600805|64748157|FG003|Overall Study|Lack of Efficacy|0|||
23274061|NCT03600805|64748154|FG000|Overall Study|Withdrawal by Subject|1|||
23274062|NCT03600805|64748155|FG001|Overall Study|Withdrawal by Subject|0|||
23274063|NCT03600805|64748156|FG002|Overall Study|Withdrawal by Subject|0|||
23274064|NCT03600805|64748157|FG003|Overall Study|Withdrawal by Subject|1|||
23274065|NCT03600805|64748154|FG000|Overall Study|Other unspecified|14|||
23274066|NCT03600805|64748155|FG001|Overall Study|Other unspecified|6|||
23274067|NCT03600805|64748156|FG002|Overall Study|Other unspecified|7|||
23274068|NCT03600805|64748157|FG003|Overall Study|Other unspecified|11|||
23274069|NCT01328093|64748158|FG000|Double-Blind Phase|Adverse Event|78|||
23274070|NCT01328093|64748159|FG001|Double-Blind Phase|Adverse Event|15|||
23274071|NCT01328093|64748158|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
23274072|NCT01328093|64748159|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
23274073|NCT01328093|64748158|FG000|Double-Blind Phase|Lost to Follow-up|39|||
23274074|NCT01328093|64748159|FG001|Double-Blind Phase|Lost to Follow-up|14|||
23274075|NCT01328093|64748158|FG000|Double-Blind Phase|Protocol Violation|30|||
23274076|NCT01328093|64748159|FG001|Double-Blind Phase|Protocol Violation|10|||
23274077|NCT01328093|64748158|FG000|Double-Blind Phase|Lack of Efficacy|55|||
23274078|NCT01328093|64748159|FG001|Double-Blind Phase|Lack of Efficacy|13|||
23274079|NCT01328093|64748158|FG000|Double-Blind Phase|Sponsor Decision|17|||
23274080|NCT01328093|64748159|FG001|Double-Blind Phase|Sponsor Decision|3|||
23274081|NCT01328093|64748158|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
23274082|NCT01328093|64748159|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
23274083|NCT01328093|64748158|FG000|Double-Blind Phase|Scheduling conflict|8|||
23274084|NCT01328093|64748159|FG001|Double-Blind Phase|Scheduling conflict|3|||
23274085|NCT01328093|64748158|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
23274086|NCT01328093|64748159|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
23274087|NCT01328093|64748158|FG000|Double-Blind Phase|Death|1|||
23274088|NCT01328093|64748159|FG001|Double-Blind Phase|Death|0|||
23274089|NCT01328093|64748158|FG000|Open-Label Phase|Sponsor Decision|98|||
23274090|NCT01328093|64748159|FG001|Open-Label Phase|Sponsor Decision|34|||
23274091|NCT01328093|64748158|FG000|Open-Label Phase|Protocol Violation|8|||
23274092|NCT01328093|64748159|FG001|Open-Label Phase|Protocol Violation|3|||
23274093|NCT01328093|64748158|FG000|Open-Label Phase|Lost to Follow-up|10|||
23274094|NCT01328093|64748159|FG001|Open-Label Phase|Lost to Follow-up|1|||
23274095|NCT01328093|64748158|FG000|Open-Label Phase|Adverse Event|10|||
23274096|NCT01328093|64748159|FG001|Open-Label Phase|Adverse Event|4|||
23274097|NCT01328093|64748158|FG000|Open-Label Phase|Lack of Efficacy|5|||
23274098|NCT01328093|64748159|FG001|Open-Label Phase|Lack of Efficacy|6|||
23274099|NCT01328093|64748158|FG000|Open-Label Phase|Withdrawal by Subject|4|||
23274100|NCT01328093|64748159|FG001|Open-Label Phase|Withdrawal by Subject|1|||
23274101|NCT01328093|64748158|FG000|Open-Label Phase|Scheduling conflict|2|||
23274102|NCT01328093|64748159|FG001|Open-Label Phase|Scheduling conflict|1|||
23274103|NCT01328093|64748158|FG000|Open-Label Phase|Subject is moving or has moved|2|||
23274104|NCT01328093|64748159|FG001|Open-Label Phase|Subject is moving or has moved|0|||
23274105|NCT01328093|64748158|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
23274106|NCT01328093|64748159|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
23274107|NCT02468778|64748162|FG000|Overall Study|Death|2|||
23274108|NCT02468778|64748163|FG001|Overall Study|Death|1|||
23274109|NCT02468778|64748164|FG002|Overall Study|Death|0|||
23274110|NCT02468778|64748162|FG000|Overall Study|Lost to Follow-up|1|||
23274111|NCT02468778|64748163|FG001|Overall Study|Lost to Follow-up|2|||
23274112|NCT02468778|64748164|FG002|Overall Study|Lost to Follow-up|2|||
23274113|NCT02468778|64748162|FG000|Overall Study|Withdrawal by Subject|0|||
23274114|NCT02468778|64748163|FG001|Overall Study|Withdrawal by Subject|1|||
23274115|NCT02468778|64748164|FG002|Overall Study|Withdrawal by Subject|1|||
23274116|NCT02043132|64748169|FG000|Overall Study|Lost to Follow-up|1|||
23274117|NCT02043132|64748170|FG001|Overall Study|Lost to Follow-up|1|||
23368091|NCT02557295|65092557|FG001|Overall Study|except for study close|0|||
23368092|NCT02557295|65092558|FG002|Overall Study|except for study close|0|||
23368093|NCT02557295|65092559|FG003|Overall Study|except for study close|0|||
23368094|NCT02557295|65092560|FG004|Overall Study|except for study close|0|||
23368095|NCT02557295|65092561|FG005|Overall Study|except for study close|0|||
23368096|NCT02557295|65092562|FG006|Overall Study|except for study close|5|||
23368097|NCT02557295|65092563|FG007|Overall Study|except for study close|1|||
23368098|NCT02557295|65092564|FG008|Overall Study|except for study close|0|||
23368099|NCT02692586|65092565|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
23274118|NCT02043132|64748169|FG000|Overall Study|screen failures|4|||
23274119|NCT02043132|64748170|FG001|Overall Study|screen failures|8|||
23368100|NCT02692586|65092565|FG000|Overall Study|Received adjunctive thrombolytics|2|||
23274120|NCT01435265|64748177|FG000|Overall Study|Lost to Follow-up|0|||
23274121|NCT01435265|64748178|FG001|Overall Study|Lost to Follow-up|1|||
23274122|NCT02622386|64748182|FG000|First Assignment|Withdrawal by Subject|3|||
23274123|NCT02622386|64748183|FG001|First Assignment|Withdrawal by Subject|2|||
23274124|NCT02622386|64748182|FG000|Washout|Withdrawal by Subject|4|||
23274125|NCT02622386|64748183|FG001|Washout|Withdrawal by Subject|4|||
23274126|NCT02622386|64748182|FG000|Second Assignment|Withdrawal by Subject|0|||
23274127|NCT02622386|64748183|FG001|Second Assignment|Withdrawal by Subject|2|||
23274128|NCT02914600|64748184|FG000|Overall Study|Adverse Event|298|||
23274129|NCT02914600|64748185|FG001|Overall Study|Adverse Event|35|||
23274130|NCT02914600|64748186|FG002|Overall Study|Adverse Event|25|||
23274131|NCT02914600|64748184|FG000|Overall Study|Sponsors decision|287|||
23274132|NCT02914600|64748185|FG001|Overall Study|Sponsors decision|41|||
23274133|NCT02914600|64748186|FG002|Overall Study|Sponsors decision|12|||
23274134|NCT02914600|64748184|FG000|Overall Study|Withdrawal by Subject|158|||
23274135|NCT02914600|64748185|FG001|Overall Study|Withdrawal by Subject|20|||
23274136|NCT02914600|64748186|FG002|Overall Study|Withdrawal by Subject|18|||
23274137|NCT02914600|64748184|FG000|Overall Study|Investigators discretion|169|||
23274138|NCT02914600|64748185|FG001|Overall Study|Investigators discretion|14|||
23274139|NCT02914600|64748186|FG002|Overall Study|Investigators discretion|13|||
23274140|NCT02914600|64748184|FG000|Overall Study|Lost to Follow-up|10|||
23274141|NCT02914600|64748185|FG001|Overall Study|Lost to Follow-up|4|||
23274142|NCT02914600|64748186|FG002|Overall Study|Lost to Follow-up|0|||
23274143|NCT02914600|64748184|FG000|Overall Study|Pregnancy|8|||
23274144|NCT02914600|64748185|FG001|Overall Study|Pregnancy|0|||
23274145|NCT02914600|64748186|FG002|Overall Study|Pregnancy|0|||
23274146|NCT02914600|64748184|FG000|Overall Study|Protocol Violation|5|||
23274147|NCT02914600|64748185|FG001|Overall Study|Protocol Violation|3|||
23274148|NCT02914600|64748186|FG002|Overall Study|Protocol Violation|0|||
23274149|NCT02914600|64748184|FG000|Overall Study|Non-compliance with study drug|6|||
23274150|NCT02914600|64748185|FG001|Overall Study|Non-compliance with study drug|1|||
23274151|NCT02914600|64748186|FG002|Overall Study|Non-compliance with study drug|0|||
23274152|NCT02914600|64748184|FG000|Overall Study|Death|3|||
23274153|NCT02914600|64748185|FG001|Overall Study|Death|1|||
23274154|NCT02914600|64748186|FG002|Overall Study|Death|1|||
23274155|NCT02914600|64748184|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
23274156|NCT02914600|64748185|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
23274157|NCT02914600|64748186|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
23274158|NCT02914600|64748184|FG000|Overall Study|Enrolled but not treated|1|||
23274159|NCT02914600|64748185|FG001|Overall Study|Enrolled but not treated|0|||
23274160|NCT02914600|64748186|FG002|Overall Study|Enrolled but not treated|0|||
23274161|NCT01576042|64748187|FG000|Overall Study|Physician Decision|2|||
23274162|NCT01576042|64748188|FG001|Overall Study|Physician Decision|0|||
23274163|NCT02098876|64748189|FG000|Overall Study|Withdrawal by Subject|5|||
23274164|NCT02098876|64748190|FG001|Overall Study|Withdrawal by Subject|5|||
23274165|NCT03478397|64748191|FG000|Overall Study|Refused to participate|31|||
23274166|NCT03478397|64748192|FG001|Overall Study|Refused to participate|7|||
23274167|NCT01866319|64748193|FG000|Overall Study|Adverse Event|12|||
23274168|NCT01866319|64748194|FG001|Overall Study|Adverse Event|5|||
23274169|NCT01866319|64748195|FG002|Overall Study|Adverse Event|9|||
23274170|NCT01866319|64748193|FG000|Overall Study|Clinical progression|3|||
23274171|NCT01866319|64748194|FG001|Overall Study|Clinical progression|2|||
23274172|NCT01866319|64748195|FG002|Overall Study|Clinical progression|2|||
23274173|NCT01866319|64748193|FG000|Overall Study|Death|153|||
23274174|NCT01866319|64748194|FG001|Overall Study|Death|154|||
23274175|NCT01866319|64748195|FG002|Overall Study|Death|147|||
23274176|NCT01866319|64748193|FG000|Overall Study|Lost to Follow-up|6|||
23274177|NCT01866319|64748194|FG001|Overall Study|Lost to Follow-up|3|||
23274178|NCT01866319|64748195|FG002|Overall Study|Lost to Follow-up|8|||
23274179|NCT01866319|64748193|FG000|Overall Study|Physician Decision|1|||
23274180|NCT01866319|64748194|FG001|Overall Study|Physician Decision|0|||
23274181|NCT01866319|64748195|FG002|Overall Study|Physician Decision|1|||
23274182|NCT01866319|64748193|FG000|Overall Study|Protocol Violation|0|||
23274183|NCT01866319|64748194|FG001|Overall Study|Protocol Violation|0|||
23274184|NCT01866319|64748195|FG002|Overall Study|Protocol Violation|1|||
23274185|NCT01866319|64748193|FG000|Overall Study|Withdrawal by Subject|32|||
23274186|NCT01866319|64748194|FG001|Overall Study|Withdrawal by Subject|14|||
23274187|NCT01866319|64748195|FG002|Overall Study|Withdrawal by Subject|12|||
23274188|NCT00864097|64748196|FG000|Overall Study|Death|0|||
23274189|NCT00864097|64748197|FG001|Overall Study|Death|1|||
23274190|NCT00864097|64748198|FG002|Overall Study|Death|0|||
23274191|NCT00864097|64748199|FG003|Overall Study|Death|0|||
23274192|NCT00864097|64748196|FG000|Overall Study|Adverse Event|6|||
23274193|NCT00864097|64748197|FG001|Overall Study|Adverse Event|8|||
23274194|NCT00864097|64748198|FG002|Overall Study|Adverse Event|11|||
23274195|NCT00864097|64748199|FG003|Overall Study|Adverse Event|9|||
23274196|NCT00864097|64748196|FG000|Overall Study|Lack of Efficacy|9|||
23274197|NCT00864097|64748197|FG001|Overall Study|Lack of Efficacy|3|||
23274198|NCT00864097|64748198|FG002|Overall Study|Lack of Efficacy|7|||
23274199|NCT00864097|64748199|FG003|Overall Study|Lack of Efficacy|2|||
23274200|NCT00864097|64748196|FG000|Overall Study|Lost to Follow-up|0|||
23274201|NCT00864097|64748197|FG001|Overall Study|Lost to Follow-up|1|||
23274202|NCT00864097|64748198|FG002|Overall Study|Lost to Follow-up|0|||
23274203|NCT00864097|64748199|FG003|Overall Study|Lost to Follow-up|1|||
23274204|NCT00864097|64748196|FG000|Overall Study|Withdrawal by Subject|15|||
23274205|NCT00864097|64748197|FG001|Overall Study|Withdrawal by Subject|11|||
23274206|NCT00864097|64748198|FG002|Overall Study|Withdrawal by Subject|11|||
23274207|NCT00864097|64748199|FG003|Overall Study|Withdrawal by Subject|12|||
23274208|NCT00864097|64748196|FG000|Overall Study|Protocol Violation|2|||
23274209|NCT00864097|64748197|FG001|Overall Study|Protocol Violation|1|||
23274210|NCT00864097|64748198|FG002|Overall Study|Protocol Violation|0|||
23274211|NCT00864097|64748199|FG003|Overall Study|Protocol Violation|1|||
23274212|NCT00864097|64748196|FG000|Overall Study|Terminated by sponsor|105|||
23274213|NCT00864097|64748197|FG001|Overall Study|Terminated by sponsor|112|||
23274214|NCT00864097|64748198|FG002|Overall Study|Terminated by sponsor|102|||
23274215|NCT00864097|64748199|FG003|Overall Study|Terminated by sponsor|99|||
23274216|NCT00864097|64748196|FG000|Overall Study|Randomized but not treated|2|||
23274217|NCT00864097|64748197|FG001|Overall Study|Randomized but not treated|0|||
23274218|NCT00864097|64748198|FG002|Overall Study|Randomized but not treated|1|||
23274219|NCT00864097|64748199|FG003|Overall Study|Randomized but not treated|0|||
23274220|NCT00864097|64748196|FG000|Overall Study|Other|0|||
23274221|NCT00864097|64748197|FG001|Overall Study|Other|0|||
23274222|NCT00864097|64748198|FG002|Overall Study|Other|0|||
23274223|NCT00864097|64748199|FG003|Overall Study|Other|1|||
23274224|NCT01085045|64748201|FG000|Part A|Withdrawal by Subject|4|||
23274225|NCT01085045|64748201|FG000|Part A|Adverse Event|6|||
23274226|NCT01085045|64748201|FG000|Part A|Protocol Violation|1|||
23274227|NCT01085045|64748201|FG000|Part A|Protocol Specified Criteria|7|||
23274228|NCT01085045|64748201|FG000|Part B|Withdrawal by Subject|2|||
23274229|NCT01085045|64748201|FG000|Part B|Protocol Specified Criteria|6|||
23274230|NCT01085045|64748201|FG000|Part B|Lost to Follow-up|1|||
23274231|NCT01085045|64748201|FG000|Part B|Adverse Event|6|||
23274232|NCT01471522|64748202|FG000|Overall Study|Withdrawal by Subject|28|||
23274233|NCT01471522|64748203|FG001|Overall Study|Withdrawal by Subject|22|||
23274234|NCT01471522|64748202|FG000|Overall Study|Lost to Follow-up|36|||
23274235|NCT01471522|64748203|FG001|Overall Study|Lost to Follow-up|26|||
23274236|NCT02646124|64748204|FG000|Overall Study|Lost to Follow-up|0|||
23274237|NCT02646124|64748205|FG001|Overall Study|Lost to Follow-up|2|||
23274238|NCT02511782|64748206|FG000|Overall Study|Withdrawal by Subject|1|||
23274239|NCT02511782|64748207|FG001|Overall Study|Withdrawal by Subject|0|||
23274240|NCT02511782|64748208|FG002|Overall Study|Withdrawal by Subject|0|||
23274241|NCT02612337|64748209|FG000|Overall Study|Lack of Efficacy|1|||
23274242|NCT02612337|64748210|FG001|Overall Study|Lack of Efficacy|0|||
23274243|NCT02612337|64748209|FG000|Overall Study|Withdrawal by Subject|2|||
23274244|NCT02612337|64748210|FG001|Overall Study|Withdrawal by Subject|2|||
23274245|NCT02612337|64748209|FG000|Overall Study|Did not receive study drug|0|||
23274246|NCT02612337|64748210|FG001|Overall Study|Did not receive study drug|1|||
23274247|NCT01391793|64748211|FG000|Overall Study|Ineligible|3|||
23274248|NCT01391793|64748212|FG001|Overall Study|Ineligible|0|||
23274249|NCT01391793|64748211|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
23274250|NCT01391793|64748212|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
23274251|NCT01391793|64748211|FG000|Overall Study|No DMSA|73|||
23274252|NCT01391793|64748212|FG001|Overall Study|No DMSA|57|||
23274253|NCT02732210|64748214|FG000|Overall Study|Site Closed|0|||
23274254|NCT02732210|64748215|FG001|Overall Study|Site Closed|11|||
23274255|NCT02732210|64748214|FG000|Overall Study|Study Ended|13|||
23274256|NCT02732210|64748215|FG001|Overall Study|Study Ended|13|||
23274257|NCT02732210|64748214|FG000|Overall Study|Withdrawal by Subject|28|||
23274258|NCT02732210|64748215|FG001|Overall Study|Withdrawal by Subject|87|||
23274259|NCT02732210|64748214|FG000|Overall Study|Lost to Follow-up|5|||
23274260|NCT02732210|64748215|FG001|Overall Study|Lost to Follow-up|57|||
23274261|NCT02732210|64748214|FG000|Overall Study|Death|4|||
23274262|NCT02732210|64748215|FG001|Overall Study|Death|15|||
23274263|NCT02732210|64748214|FG000|Overall Study|Other|35|||
23274264|NCT02732210|64748215|FG001|Overall Study|Other|103|||
23274265|NCT02732210|64748214|FG000|Overall Study|Missing|0|||
23274266|NCT02732210|64748215|FG001|Overall Study|Missing|8|||
23274267|NCT00102440|64748218|FG000|Overall Study|Lost to Follow-up|25|||
23274268|NCT00102440|64748219|FG001|Overall Study|Lost to Follow-up|18|||
23484262|NCT00548405|65515970|FG001|Overall Study|Protocol Violation|0|||
23274269|NCT00102440|64748220|FG002|Overall Study|Lost to Follow-up|21|||
23368101|NCT00735007|65092566|FG000|Overall Study|Adverse Event|4|||
23368102|NCT00735007|65092566|FG000|Overall Study|Protocol Violation|1|||
23484263|NCT00548405|65515971|FG002|Overall Study|Protocol Violation|0|||
23274270|NCT00102440|64748218|FG000|Overall Study|Adverse Event|16|||
23274271|NCT00102440|64748219|FG001|Overall Study|Adverse Event|23|||
23274272|NCT00102440|64748220|FG002|Overall Study|Adverse Event|8|||
23274273|NCT00102440|64748218|FG000|Overall Study|Gout Flare|10|||
23274274|NCT00102440|64748219|FG001|Overall Study|Gout Flare|28|||
23274275|NCT00102440|64748220|FG002|Overall Study|Gout Flare|9|||
23368103|NCT00468585|65092567|FG000|Overall Study|Patient not treated|1|||
23274276|NCT00102440|64748218|FG000|Overall Study|Personal Reason(s)|19|||
23274277|NCT00102440|64748219|FG001|Overall Study|Personal Reason(s)|13|||
23484264|NCT00548405|65515969|FG000|Overall Study|Withdrawal by Subject|36|||
23274278|NCT00102440|64748220|FG002|Overall Study|Personal Reason(s)|13|||
23274279|NCT00102440|64748218|FG000|Overall Study|Other|11|||
23274280|NCT00102440|64748219|FG001|Overall Study|Other|14|||
23274281|NCT00102440|64748220|FG002|Overall Study|Other|14|||
23274282|NCT00102440|64748218|FG000|Overall Study|Protocol Violation|7|||
23274283|NCT00102440|64748219|FG001|Overall Study|Protocol Violation|2|||
23274284|NCT00102440|64748220|FG002|Overall Study|Protocol Violation|1|||
23274285|NCT00855738|64748221|FG000|Overall Study|Lost to Follow-up|2|||
23274286|NCT00855738|64748221|FG000|Overall Study|Adverse Event|1|||
23274287|NCT00855738|64748221|FG000|Overall Study|Subject Defaulted|1|||
23274288|NCT00855738|64748221|FG000|Overall Study|Death|1|||
23274289|NCT00625443|64748222|FG000|Overall Study|Adverse Event|1|||
23274290|NCT00625443|64748223|FG001|Overall Study|Adverse Event|4|||
23274291|NCT00625443|64748224|FG002|Overall Study|Adverse Event|0|||
23274292|NCT00625443|64748222|FG000|Overall Study|Non-compliance with protocol|0|||
23274293|NCT00625443|64748223|FG001|Overall Study|Non-compliance with protocol|1|||
23274294|NCT00625443|64748224|FG002|Overall Study|Non-compliance with protocol|0|||
23274295|NCT00625443|64748222|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
23274296|NCT00625443|64748223|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
23274297|NCT00625443|64748224|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
23274298|NCT00625443|64748222|FG000|Overall Study|Withdrawal by Subject|0|||
23274299|NCT00625443|64748223|FG001|Overall Study|Withdrawal by Subject|1|||
23274300|NCT00625443|64748224|FG002|Overall Study|Withdrawal by Subject|2|||
23274301|NCT00625443|64748222|FG000|Overall Study|Physician Decision|0|||
23274302|NCT00625443|64748223|FG001|Overall Study|Physician Decision|4|||
23274303|NCT00625443|64748224|FG002|Overall Study|Physician Decision|2|||
23274304|NCT00625443|64748222|FG000|Overall Study|Other|0|||
23274305|NCT00625443|64748223|FG001|Overall Study|Other|1|||
23274306|NCT00625443|64748224|FG002|Overall Study|Other|1|||
23274307|NCT00473330|64748228|FG000|Core Study|Adverse Event|4|||
23274308|NCT00473330|64748229|FG001|Core Study|Adverse Event|4|||
23274309|NCT00473330|64748230|FG002|Core Study|Adverse Event|1|||
23274310|NCT00473330|64748228|FG000|Core Study|Death|6|||
23274311|NCT00473330|64748229|FG001|Core Study|Death|4|||
23274312|NCT00473330|64748230|FG002|Core Study|Death|4|||
23274313|NCT00473330|64748228|FG000|Core Study|Lost to Follow-up|5|||
23274314|NCT00473330|64748229|FG001|Core Study|Lost to Follow-up|5|||
23274315|NCT00473330|64748230|FG002|Core Study|Lost to Follow-up|10|||
23274316|NCT00473330|64748228|FG000|Core Study|Physician Decision|2|||
23274317|NCT00473330|64748229|FG001|Core Study|Physician Decision|1|||
23274318|NCT00473330|64748230|FG002|Core Study|Physician Decision|3|||
23274319|NCT00473330|64748228|FG000|Core Study|Subject Non-compliance|1|||
23274320|NCT00473330|64748229|FG001|Core Study|Subject Non-compliance|2|||
23274321|NCT00473330|64748230|FG002|Core Study|Subject Non-compliance|1|||
23274322|NCT00473330|64748228|FG000|Core Study|Subject Required Other Therapy|0|||
23274323|NCT00473330|64748229|FG001|Core Study|Subject Required Other Therapy|1|||
23274324|NCT00473330|64748230|FG002|Core Study|Subject Required Other Therapy|3|||
23274325|NCT00473330|64748228|FG000|Core Study|Subject's Decision|9|||
23274326|NCT00473330|64748229|FG001|Core Study|Subject's Decision|8|||
23274327|NCT00473330|64748230|FG002|Core Study|Subject's Decision|19|||
23274328|NCT00473330|64748228|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
23274329|NCT00473330|64748229|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
23274330|NCT00473330|64748230|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
23274331|NCT00473330|64748228|FG000|Open-label Extension Through Month 48|Death|2|||
23274332|NCT00473330|64748229|FG001|Open-label Extension Through Month 48|Death|0|||
23274333|NCT00473330|64748230|FG002|Open-label Extension Through Month 48|Death|0|||
23274334|NCT00473330|64748228|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
23274335|NCT00473330|64748229|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
23274336|NCT00473330|64748230|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
23274337|NCT00473330|64748228|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
23368104|NCT00468585|65092568|FG001|Overall Study|Patient not treated|0|||
23368105|NCT00468585|65092569|FG002|Overall Study|Patient not treated|1|||
23368106|NCT00468585|65092570|FG003|Overall Study|Patient not treated|0|||
23602436|NCT01998958|65934077|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602437|NCT01998958|65934078|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602438|NCT01998958|65934079|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602439|NCT01998958|65934080|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602440|NCT01998958|65934081|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602441|NCT01998958|65934082|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602442|NCT01998958|65934083|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602443|NCT01998958|65934084|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
23602444|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Adverse Event|0|||
23602445|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Adverse Event|0|||
23602446|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Adverse Event|0|||
23602447|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Adverse Event|0|||
23602448|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Adverse Event|0|||
23602449|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Adverse Event|0|||
23602450|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Adverse Event|0|||
23602451|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Adverse Event|0|||
23602452|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Adverse Event|0|||
23602453|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Adverse Event|0|||
23602454|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Adverse Event|0|||
23602455|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Adverse Event|0|||
23602456|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Adverse Event|0|||
23602457|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Adverse Event|0|||
23274338|NCT00473330|64748229|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
23274339|NCT00473330|64748230|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
23274340|NCT00473330|64748228|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
23274341|NCT00473330|64748229|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
23274342|NCT00473330|64748230|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
23274343|NCT00473330|64748228|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
23274344|NCT00473330|64748229|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
23274345|NCT00473330|64748230|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
23274346|NCT00473330|64748228|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
23274347|NCT00473330|64748229|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
23274348|NCT00473330|64748230|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
23274349|NCT00473330|64748228|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
23274350|NCT00473330|64748229|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
23274351|NCT00473330|64748230|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
23274352|NCT00473330|64748228|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
23274353|NCT00473330|64748229|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
23274354|NCT00473330|64748230|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
23274355|NCT00473330|64748228|FG000|Open-label Extension Through Month 60|Death|2|||
23274356|NCT00473330|64748229|FG001|Open-label Extension Through Month 60|Death|2|||
23274357|NCT00473330|64748230|FG002|Open-label Extension Through Month 60|Death|1|||
23274358|NCT00473330|64748228|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
23274359|NCT00473330|64748229|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
23274360|NCT00473330|64748230|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
23274361|NCT00473330|64748228|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
23274362|NCT00473330|64748229|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
23274363|NCT00473330|64748230|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
23274364|NCT00473330|64748228|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
23274365|NCT00473330|64748229|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
23274366|NCT00473330|64748230|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
23274367|NCT00473330|64748228|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
23274368|NCT00473330|64748229|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
23274369|NCT00473330|64748230|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
23274370|NCT00473330|64748228|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
23274371|NCT00473330|64748229|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
23274372|NCT00473330|64748230|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
23274373|NCT00473330|64748228|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
23368107|NCT00468585|65092567|FG000|Overall Study|Patient found to be ineligible|0|||
23602458|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Adverse Event|0|||
23602459|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Adverse Event|0|||
23368108|NCT00468585|65092568|FG001|Overall Study|Patient found to be ineligible|0|||
23368109|NCT00468585|65092569|FG002|Overall Study|Patient found to be ineligible|1|||
23368110|NCT00468585|65092570|FG003|Overall Study|Patient found to be ineligible|0|||
23368111|NCT00468585|65092567|FG000|Overall Study|Adverse Event|0|||
23368112|NCT00468585|65092568|FG001|Overall Study|Adverse Event|0|||
23368113|NCT00468585|65092569|FG002|Overall Study|Adverse Event|1|||
23368114|NCT00468585|65092570|FG003|Overall Study|Adverse Event|0|||
23368115|NCT00468585|65092567|FG000|Overall Study|Withdrawal by Subject|0|||
23368116|NCT00468585|65092568|FG001|Overall Study|Withdrawal by Subject|0|||
23368117|NCT00468585|65092569|FG002|Overall Study|Withdrawal by Subject|2|||
23368118|NCT00468585|65092570|FG003|Overall Study|Withdrawal by Subject|1|||
23368119|NCT00116688|65092571|FG000|Overall Study|Protocol deviation|1|||
23368120|NCT00116688|65092572|FG001|Overall Study|Protocol deviation|0|||
23368121|NCT00116688|65092571|FG000|Overall Study|Noncompliance|3|||
23368122|NCT00116688|65092572|FG001|Overall Study|Noncompliance|1|||
23368123|NCT00116688|65092571|FG000|Overall Study|Adverse Event|11|||
23368124|NCT00116688|65092572|FG001|Overall Study|Adverse Event|0|||
23484265|NCT00548405|65515970|FG001|Overall Study|Withdrawal by Subject|12|||
23484266|NCT00548405|65515971|FG002|Overall Study|Withdrawal by Subject|5|||
23484267|NCT00548405|65515969|FG000|Overall Study|Lost to Follow-up|1|||
23484268|NCT00548405|65515970|FG001|Overall Study|Lost to Follow-up|1|||
23484269|NCT00548405|65515971|FG002|Overall Study|Lost to Follow-up|2|||
23484270|NCT00548405|65515969|FG000|Overall Study|Death|0|||
23484271|NCT00548405|65515970|FG001|Overall Study|Death|1|||
23368125|NCT00116688|65092571|FG000|Overall Study|Withdrawal by Subject|26|||
23484272|NCT00548405|65515971|FG002|Overall Study|Death|1|||
23484273|NCT00548405|65515969|FG000|Overall Study|Sponsor decision|1|||
23484274|NCT00548405|65515970|FG001|Overall Study|Sponsor decision|0|||
23484275|NCT00548405|65515971|FG002|Overall Study|Sponsor decision|0|||
23484276|NCT00548405|65515969|FG000|Overall Study|Randomized but not treated|1|||
23484277|NCT00548405|65515970|FG001|Overall Study|Randomized but not treated|0|||
23484278|NCT00548405|65515971|FG002|Overall Study|Randomized but not treated|0|||
23484279|NCT01758289|65515973|FG000|Overall Study|Premature Study Termination|44|||
23484280|NCT01758289|65515973|FG000|Overall Study|Adverse Event|9|||
23484281|NCT04461600|65515977|FG000|Overall Study|Death|6|||
23484282|NCT04461600|65515978|FG001|Overall Study|Death|5|||
23484283|NCT04461600|65515977|FG000|Overall Study|Withdrawal by Subject|0|||
23484284|NCT04461600|65515978|FG001|Overall Study|Withdrawal by Subject|1|||
23484285|NCT03194490|65515979|FG000|Overall Study|Lost to Follow-up|1|||
23484286|NCT03194490|65515980|FG001|Overall Study|Lost to Follow-up|3|||
23484287|NCT03194490|65515979|FG000|Overall Study|participant developed specific neck pain|1|||
23484288|NCT03194490|65515980|FG001|Overall Study|participant developed specific neck pain|0|||
23602460|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Adverse Event|0|||
23602461|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Adverse Event|0|||
23602462|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Adverse Event|0|||
23602463|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Adverse Event|0|||
23602464|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Adverse Event|0|||
23602465|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Adverse Event|0|||
23602466|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Adverse Event|0|||
23602467|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Adverse Event|1|||
23602468|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Adverse Event|0|||
23602469|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Adverse Event|0|||
23602470|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Adverse Event|0|||
23602471|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Adverse Event|0|||
23602472|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Adverse Event|0|||
23602473|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Adverse Event|0|||
23602474|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Adverse Event|0|||
23602475|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Adverse Event|0|||
23602476|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Other|0|||
23602477|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Other|0|||
23602478|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Other|0|||
23602479|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Other|0|||
23602480|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Other|0|||
23602481|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Other|0|||
23274374|NCT00473330|64748229|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
23368126|NCT00116688|65092572|FG001|Overall Study|Withdrawal by Subject|2|||
23368127|NCT00116688|65092571|FG000|Overall Study|Requirement for alternative therapy|11|||
23484289|NCT04085367|65515983|FG000|Overall Study|Adverse Event|1|||
23484290|NCT04085367|65515984|FG001|Overall Study|Adverse Event|1|||
23484291|NCT04085367|65515983|FG000|Overall Study|Withdrawal by Subject|13|||
23484292|NCT04085367|65515984|FG001|Overall Study|Withdrawal by Subject|4|||
23484293|NCT04085367|65515983|FG000|Overall Study|Lost to Follow-up|3|||
23484294|NCT04085367|65515984|FG001|Overall Study|Lost to Follow-up|1|||
23274375|NCT00473330|64748230|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
23274376|NCT02932878|64748231|FG000|Overall Study|Due to Lab Results|2|||
23274377|NCT02932878|64748232|FG001|Overall Study|Due to Lab Results|1|||
23274378|NCT01175018|64748254|FG000|Overall Study|Adverse Event|3|||
23274379|NCT01175018|64748255|FG001|Overall Study|Adverse Event|1|||
23274380|NCT01959672|64748259|FG000|Overall Study|Death|1|||
23274381|NCT00630305|64748260|FG000|Overall Study|Withdrawal by Subject|1|||
23274382|NCT00630305|64748260|FG000|Overall Study|Inability to insert contact lens|1|||
23274383|NCT01848938|64748264|FG000|Overall Study|Lost to Follow-up|1|||
23274384|NCT01848938|64748265|FG001|Overall Study|Lost to Follow-up|1|||
23274385|NCT02057458|64748266|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
23274386|NCT02057458|64748267|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
23274387|NCT02057458|64748268|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
23274388|NCT02057458|64748266|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
23274389|NCT02057458|64748267|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
23274390|NCT02057458|64748268|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
23274391|NCT02057458|64748266|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
23274392|NCT02057458|64748267|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
23274393|NCT02057458|64748268|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
23274394|NCT01723397|64748269|FG000|Study Period 1|Protocol Violation|0|||
23274395|NCT01723397|64748270|FG001|Study Period 1|Protocol Violation|1|||
23274396|NCT01723397|64748269|FG000|Study Period 2|Protocol Violation|0|||
23274397|NCT01723397|64748270|FG001|Study Period 2|Protocol Violation|1|||
23274398|NCT03235739|64748271|FG000|Overall Study|Withdrawal by Subject|2|||
23274399|NCT03235739|64748272|FG001|Overall Study|Withdrawal by Subject|2|||
23274400|NCT03235739|64748271|FG000|Overall Study|Physician Decision|0|||
23274401|NCT03235739|64748272|FG001|Overall Study|Physician Decision|1|||
23274402|NCT00433147|64748273|FG000|Overall Study|Adverse Event|0|||
23274403|NCT00433147|64748274|FG001|Overall Study|Adverse Event|1|||
23274404|NCT00433147|64748275|FG002|Overall Study|Adverse Event|0|||
23274405|NCT00433147|64748276|FG003|Overall Study|Adverse Event|0|||
23274406|NCT00939003|64748277|FG000|Double-blind Treatment Period|Adverse Event|1|||
23274407|NCT00939003|64748278|FG001|Double-blind Treatment Period|Adverse Event|1|||
23274408|NCT00939003|64748277|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23274409|NCT00939003|64748278|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
23274410|NCT00939003|64748277|FG000|Double-blind Treatment Period|Pregnancy|0|||
23274411|NCT00939003|64748278|FG001|Double-blind Treatment Period|Pregnancy|1|||
23274412|NCT00939003|64748277|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
23274413|NCT00939003|64748278|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
23274414|NCT00939003|64748277|FG000|Open-label Treatment Period|Adverse Event|4|||
23274415|NCT00939003|64748278|FG001|Open-label Treatment Period|Adverse Event|8|||
23274416|NCT00939003|64748277|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
23274417|NCT00939003|64748278|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
23274418|NCT00939003|64748277|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
23274419|NCT00939003|64748278|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
23274420|NCT00939003|64748277|FG000|Open-label Treatment Period|Pregnancy|1|||
23274421|NCT00939003|64748278|FG001|Open-label Treatment Period|Pregnancy|1|||
23274422|NCT00939003|64748277|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
23274423|NCT00939003|64748278|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
23274424|NCT00939003|64748277|FG000|Open-label Treatment Period|Site Closure|3|||
23274425|NCT00939003|64748278|FG001|Open-label Treatment Period|Site Closure|4|||
23274426|NCT03020615|64748279|FG000|Overall Study|Physician Decision|3|||
23274427|NCT03020615|64748280|FG001|Overall Study|Physician Decision|1|||
23274428|NCT03020615|64748281|FG002|Overall Study|Physician Decision|2|||
23274429|NCT03020615|64748279|FG000|Overall Study|Parent/guardian/patient choice|3|||
23274430|NCT03020615|64748280|FG001|Overall Study|Parent/guardian/patient choice|0|||
23274431|NCT03020615|64748281|FG002|Overall Study|Parent/guardian/patient choice|4|||
23274432|NCT03020615|64748279|FG000|Overall Study|Screen failure|0|||
23274433|NCT03020615|64748280|FG001|Overall Study|Screen failure|0|||
23274434|NCT03020615|64748281|FG002|Overall Study|Screen failure|1|||
23274435|NCT03020615|64748279|FG000|Overall Study|Death|1|||
23274436|NCT03020615|64748280|FG001|Overall Study|Death|0|||
23274437|NCT03020615|64748281|FG002|Overall Study|Death|0|||
23274438|NCT03020615|64748279|FG000|Overall Study|Lost to Follow-up|0|||
23274439|NCT03020615|64748280|FG001|Overall Study|Lost to Follow-up|1|||
23274440|NCT03020615|64748281|FG002|Overall Study|Lost to Follow-up|0|||
23484295|NCT04085367|65515983|FG000|Overall Study|Other unspecified|2|||
23484296|NCT04085367|65515984|FG001|Overall Study|Other unspecified|1|||
23602482|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Other|0|||
23274441|NCT01383486|64748282|FG000|Overall Study|Lost to Follow-up|10|||
23274442|NCT01383486|64748282|FG000|Overall Study|Incomplete information for analysis|2|||
23274443|NCT01383486|64748282|FG000|Overall Study|Did not take any product|6|||
23274444|NCT01355081|64748283|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
23274445|NCT01355081|64748284|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
23484297|NCT04085367|65515983|FG000|Overall Study|Status Unknown|1|||
23274446|NCT01355081|64748285|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
23274447|NCT01355081|64748283|FG000|Overall Study|Major Protocol Deviation|0|||
23274448|NCT01355081|64748284|FG001|Overall Study|Major Protocol Deviation|1|||
23274449|NCT01355081|64748285|FG002|Overall Study|Major Protocol Deviation|0|||
23274450|NCT01355081|64748283|FG000|Overall Study|Lost to Follow-up|0|||
23274451|NCT01355081|64748284|FG001|Overall Study|Lost to Follow-up|0|||
23274452|NCT01355081|64748285|FG002|Overall Study|Lost to Follow-up|1|||
23274453|NCT01355081|64748283|FG000|Overall Study|Withdrawal of Consent|2|||
23274454|NCT01355081|64748284|FG001|Overall Study|Withdrawal of Consent|3|||
23274455|NCT01355081|64748285|FG002|Overall Study|Withdrawal of Consent|3|||
23274456|NCT01355081|64748283|FG000|Overall Study|Lack of Efficacy|2|||
23274457|NCT01355081|64748284|FG001|Overall Study|Lack of Efficacy|1|||
23274458|NCT01355081|64748285|FG002|Overall Study|Lack of Efficacy|1|||
23274459|NCT01355081|64748283|FG000|Overall Study|Non Compliance with Study Medication|0|||
23274460|NCT01355081|64748284|FG001|Overall Study|Non Compliance with Study Medication|1|||
23274461|NCT01355081|64748285|FG002|Overall Study|Non Compliance with Study Medication|0|||
23274462|NCT03247972|64748286|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
23274463|NCT03247972|64748286|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
23274464|NCT04605094|64748290|FG000|Overall Study|Adverse Event|2|||
23274465|NCT04605094|64748291|FG001|Overall Study|Adverse Event|2|||
23274466|NCT04605094|64748290|FG000|Overall Study|Lost to Follow-up|1|||
23274467|NCT04605094|64748291|FG001|Overall Study|Lost to Follow-up|4|||
23274468|NCT04605094|64748290|FG000|Overall Study|Physician Decision|2|||
23274469|NCT04605094|64748291|FG001|Overall Study|Physician Decision|2|||
23274470|NCT04605094|64748290|FG000|Overall Study|Study terminated by Sponsor|31|||
23274471|NCT04605094|64748291|FG001|Overall Study|Study terminated by Sponsor|33|||
23274472|NCT04605094|64748290|FG000|Overall Study|Withdrawal by Subject|22|||
23274473|NCT04605094|64748291|FG001|Overall Study|Withdrawal by Subject|19|||
23274474|NCT04605094|64748290|FG000|Overall Study|Other|1|||
23274475|NCT04605094|64748291|FG001|Overall Study|Other|1|||
23274476|NCT01591785|64748292|FG000|Overall Study|worsening condition|1|||
23274477|NCT01591785|64748293|FG001|Overall Study|worsening condition|2|||
23274478|NCT01591785|64748292|FG000|Overall Study|Protocol Violation|2|||
23274479|NCT01591785|64748293|FG001|Overall Study|Protocol Violation|0|||
23274480|NCT01591785|64748292|FG000|Overall Study|Lost to Follow-up|1|||
23274481|NCT01591785|64748293|FG001|Overall Study|Lost to Follow-up|0|||
23274482|NCT03233724|64748297|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
23274483|NCT03233724|64748298|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
23274484|NCT03233724|64748299|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
23274485|NCT03233724|64748300|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
23274486|NCT03233724|64748301|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
23274487|NCT03233724|64748297|FG000|Phase I Dose Escalation|Best interest of participant|1|||
23274488|NCT03233724|64748298|FG001|Phase I Dose Escalation|Best interest of participant|1|||
23274489|NCT03233724|64748299|FG002|Phase I Dose Escalation|Best interest of participant|1|||
23274490|NCT03233724|64748300|FG003|Phase I Dose Escalation|Best interest of participant|0|||
23274491|NCT03233724|64748301|FG004|Phase I Dose Escalation|Best interest of participant|0|||
23484298|NCT04085367|65515984|FG001|Overall Study|Status Unknown|1|||
23274492|NCT03233724|64748297|FG000|Phase I Dose Escalation|Physician Decision|0|||
23368128|NCT00116688|65092572|FG001|Overall Study|Requirement for alternative therapy|1|||
23368129|NCT00116688|65092571|FG000|Overall Study|Physician Decision|7|||
23368130|NCT00116688|65092572|FG001|Overall Study|Physician Decision|0|||
23368131|NCT00116688|65092571|FG000|Overall Study|Lost to Follow-up|3|||
23368132|NCT00116688|65092572|FG001|Overall Study|Lost to Follow-up|0|||
23368133|NCT00116688|65092571|FG000|Overall Study|Death|15|||
23368134|NCT00116688|65092572|FG001|Overall Study|Death|0|||
23368135|NCT00116688|65092571|FG000|Overall Study|Protocol-specified criteria|3|||
23368136|NCT00116688|65092572|FG001|Overall Study|Protocol-specified criteria|0|||
23368137|NCT00116688|65092571|FG000|Overall Study|Pregnancy|1|||
23368138|NCT00116688|65092572|FG001|Overall Study|Pregnancy|0|||
23368139|NCT00116688|65092571|FG000|Overall Study|Other|11|||
23368140|NCT00116688|65092572|FG001|Overall Study|Other|0|||
23368141|NCT02287038|65092575|FG000|Overall Study|Stopped attending appointments|3|||
23368142|NCT02287038|65092576|FG001|Overall Study|Stopped attending appointments|2|||
23368143|NCT02287038|65092575|FG000|Overall Study|Anxiety after starting medication|0|||
23368144|NCT02287038|65092576|FG001|Overall Study|Anxiety after starting medication|1|||
23368145|NCT02287038|65092575|FG000|Overall Study|Nausea after starting medication|1|||
23368146|NCT02287038|65092576|FG001|Overall Study|Nausea after starting medication|0|||
23368147|NCT02287038|65092575|FG000|Overall Study|Abnormal ECG after starting medication|1|||
23368148|NCT02287038|65092576|FG001|Overall Study|Abnormal ECG after starting medication|0|||
23368149|NCT00467519|65092577|FG000|Overall Study|Protocol Violation|8|||
23368150|NCT00467519|65092578|FG001|Overall Study|Protocol Violation|4|||
23368151|NCT00467519|65092577|FG000|Overall Study|Lost to Follow-up|2|||
23368152|NCT00467519|65092578|FG001|Overall Study|Lost to Follow-up|9|||
23368153|NCT00467519|65092577|FG000|Overall Study|Withdrawal by Subject|4|||
23368154|NCT00467519|65092578|FG001|Overall Study|Withdrawal by Subject|10|||
23368155|NCT01447407|65092579|FG000|Overall Study|Withdrawal by Subject|2|||
23368156|NCT01447407|65092580|FG001|Overall Study|Withdrawal by Subject|0|||
23368157|NCT01447407|65092581|FG002|Overall Study|Withdrawal by Subject|0|||
23368158|NCT01447407|65092582|FG003|Overall Study|Withdrawal by Subject|1|||
23368159|NCT01447407|65092579|FG000|Overall Study|Physician Decision|0|||
23368160|NCT01447407|65092580|FG001|Overall Study|Physician Decision|0|||
23368161|NCT01447407|65092581|FG002|Overall Study|Physician Decision|1|||
23368162|NCT01447407|65092582|FG003|Overall Study|Physician Decision|1|||
23368163|NCT02567188|65092584|FG000|Overall Study|Death|10|||
23368164|NCT02567188|65092584|FG000|Overall Study|Terminated Mircera Treatment|9|||
23368165|NCT02567188|65092584|FG000|Overall Study|Lost to Follow-up|5|||
23368166|NCT02567188|65092584|FG000|Overall Study|Adverse Event|1|||
23368167|NCT02567188|65092584|FG000|Overall Study|Withdrawal by Subject|1|||
23368168|NCT02567188|65092584|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
23368169|NCT02567188|65092584|FG000|Overall Study|Moved and Changed Clinic|1|||
23368170|NCT02567188|65092584|FG000|Overall Study|Started Hemodialysis|2|||
23368171|NCT02567188|65092584|FG000|Overall Study|Protocol Violation|5|||
23368172|NCT01714544|65092586|FG000|Overall Study|Lost to Follow-up|1|||
23368173|NCT01714544|65092586|FG000|Overall Study|Physician Decision|1|||
23368174|NCT01714544|65092586|FG000|Overall Study|Withdrawal by Subject|1|||
23368175|NCT00297167|65092587|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
23368176|NCT00297167|65092588|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
23368177|NCT00297167|65092589|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
23368178|NCT00297167|65092587|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
23368179|NCT00297167|65092588|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
23368180|NCT00297167|65092589|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
23368181|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
23368182|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
23274493|NCT03233724|64748298|FG001|Phase I Dose Escalation|Physician Decision|0|||
23274494|NCT03233724|64748299|FG002|Phase I Dose Escalation|Physician Decision|1|||
23274495|NCT03233724|64748300|FG003|Phase I Dose Escalation|Physician Decision|0|||
23274496|NCT03233724|64748301|FG004|Phase I Dose Escalation|Physician Decision|0|||
23274497|NCT03233724|64748297|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
23274498|NCT03233724|64748298|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
23274499|NCT03233724|64748299|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
23274500|NCT03233724|64748300|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
23274501|NCT03233724|64748301|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
23274502|NCT00089661|64748302|FG000|Overall Study|Adverse Event|0|||
23274503|NCT00089661|64748303|FG001|Overall Study|Adverse Event|2|||
23368183|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Adverse Event|57|||
23368184|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Adverse Event|49|||
23368185|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
23368186|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
23368187|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Site closure|3|||
23368188|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Site closure|2|||
23484299|NCT04389970|65515985|FG000|Overall Study|Lost to Follow-up|1|||
23368189|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
23368190|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
23368191|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Physician Decision|48|||
23368192|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Physician Decision|38|||
23368193|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
23368194|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
23368195|NCT01705977|65092590|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
23368196|NCT01705977|65092591|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
23368197|NCT01705977|65092590|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
23368198|NCT01705977|65092591|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
23368199|NCT01705977|65092590|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
23368200|NCT01705977|65092591|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
23368201|NCT01705977|65092590|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
23368202|NCT01705977|65092591|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
23368203|NCT01705977|65092590|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
23368204|NCT01705977|65092591|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
23368205|NCT00528424|65092594|FG000|Overall Study|Lost to Follow-up|13|||
23368206|NCT00528424|65092594|FG000|Overall Study|Withdrew consent|2|||
23368207|NCT00528424|65092594|FG000|Overall Study|Administrative reason|2|||
23368208|NCT00528424|65092594|FG000|Overall Study|Other|12|||
23368209|NCT01190813|65092597|FG000|Overall Study|Lost to Follow-up|1|||
23368210|NCT01190813|65092598|FG001|Overall Study|Lost to Follow-up|2|||
23368211|NCT01190813|65092597|FG000|Overall Study|Withdrawal by Subject|2|||
23368212|NCT01190813|65092598|FG001|Overall Study|Withdrawal by Subject|1|||
23368213|NCT01190813|65092597|FG000|Overall Study|Refused study treatment after randomized|1|||
23368214|NCT01190813|65092598|FG001|Overall Study|Refused study treatment after randomized|0|||
23368215|NCT01190813|65092597|FG000|Overall Study|Adverse Event|0|||
23368216|NCT01190813|65092598|FG001|Overall Study|Adverse Event|1|||
23368217|NCT01053741|65092599|FG000|2nd Study Intervention|Physician Decision|0|||
23368218|NCT01053741|65092600|FG001|2nd Study Intervention|Physician Decision|1|||
23368219|NCT03804268|65092603|FG000|Overall Study|Adverse Event|2|||
23368220|NCT03804268|65092604|FG001|Overall Study|Adverse Event|2|||
23368221|NCT03804268|65092603|FG000|Overall Study|Withdrawal by Subject|2|||
23368222|NCT03804268|65092604|FG001|Overall Study|Withdrawal by Subject|0|||
23368223|NCT03804268|65092603|FG000|Overall Study|Lost to Follow-up|1|||
23368224|NCT03804268|65092604|FG001|Overall Study|Lost to Follow-up|0|||
23368225|NCT03804268|65092603|FG000|Overall Study|Physician Decision|2|||
23368226|NCT03804268|65092604|FG001|Overall Study|Physician Decision|0|||
23368227|NCT02089347|65092605|FG000|Overall Study|Protocol Violation|1|||
23368228|NCT02089347|65092606|FG001|Overall Study|Protocol Violation|0|||
23368229|NCT03874013|65092607|FG000|Overall Study|Adverse Event|0|||
23368230|NCT03874013|65092608|FG001|Overall Study|Adverse Event|1|||
23368231|NCT02074514|65092609|FG000|Overall Study|Lack of Efficacy|3|||
23368232|NCT02074514|65092610|FG001|Overall Study|Lack of Efficacy|2|||
23368233|NCT02074514|65092609|FG000|Overall Study|Lost to Follow-up|0|||
23368234|NCT02074514|65092610|FG001|Overall Study|Lost to Follow-up|1|||
23368235|NCT02074514|65092609|FG000|Overall Study|Withdrew Consent|0|||
23368236|NCT02074514|65092610|FG001|Overall Study|Withdrew Consent|1|||
23368237|NCT02456727|65092615|FG000|Overall Study|Lost to Follow-up|63|||
23368238|NCT02456727|65092616|FG001|Overall Study|Lost to Follow-up|65|||
23368239|NCT02456727|65092615|FG000|Overall Study|Death|2|||
23368240|NCT02456727|65092616|FG001|Overall Study|Death|1|||
23368241|NCT02456727|65092615|FG000|Overall Study|Withdrawal by Subject|1|||
23368242|NCT02456727|65092616|FG001|Overall Study|Withdrawal by Subject|10|||
23368243|NCT02456727|65092615|FG000|Overall Study|Never Initiated Treatment|43|||
23368244|NCT02456727|65092616|FG001|Overall Study|Never Initiated Treatment|30|||
23368245|NCT05002972|65092617|FG000|Overall Study|Withdrawal by Subject|2|||
23368246|NCT01232790|65092621|FG000|Randomization|Withdrawal by Subject|2|||
23368247|NCT01232790|65092622|FG001|Randomization|Withdrawal by Subject|0|||
23368248|NCT01232790|65092621|FG000|Randomization|Protocol Violation|0|||
23368249|NCT01232790|65092622|FG001|Randomization|Protocol Violation|1|||
23368250|NCT01232790|65092621|FG000|Randomization|Physician Decision|0|||
23368251|NCT01232790|65092622|FG001|Randomization|Physician Decision|1|||
23368252|NCT01232790|65092621|FG000|Initial Assessment|Withdrawal by Subject|0|||
23368253|NCT01232790|65092622|FG001|Initial Assessment|Withdrawal by Subject|1|||
23368254|NCT01232790|65092621|FG000|First Crossover|Withdrawal by Subject|1|||
23368255|NCT01232790|65092622|FG001|First Crossover|Withdrawal by Subject|0|||
23368256|NCT01232790|65092621|FG000|Second Crossover|Withdrawal by Subject|1|||
23368257|NCT01232790|65092622|FG001|Second Crossover|Withdrawal by Subject|2|||
23368258|NCT03217591|65092624|FG000|Overall Study|Adverse Event|1|||
23368259|NCT03217591|65092625|FG001|Overall Study|Adverse Event|2|||
23368260|NCT03217591|65092626|FG002|Overall Study|Adverse Event|6|||
23368261|NCT03217591|65092624|FG000|Overall Study|Withdrawal by Subject|0|||
23368262|NCT03217591|65092625|FG001|Overall Study|Withdrawal by Subject|1|||
23368263|NCT03217591|65092626|FG002|Overall Study|Withdrawal by Subject|3|||
23368264|NCT03217591|65092624|FG000|Overall Study|Lost to Follow-up|1|||
23368265|NCT03217591|65092625|FG001|Overall Study|Lost to Follow-up|0|||
23368266|NCT03217591|65092626|FG002|Overall Study|Lost to Follow-up|0|||
23368267|NCT03217591|65092624|FG000|Overall Study|Protocol Violation|1|||
23368268|NCT03217591|65092625|FG001|Overall Study|Protocol Violation|0|||
23368269|NCT03217591|65092626|FG002|Overall Study|Protocol Violation|1|||
23368270|NCT01307787|65092629|FG000|Overall Study|Withdrawal by Subject|2|||
23368271|NCT01307787|65092630|FG001|Overall Study|Withdrawal by Subject|0|||
23368272|NCT00661089|65092631|FG000|Overall Study|1 subject withdrawal|0|||
23368273|NCT00661089|65092632|FG001|Overall Study|1 subject withdrawal|1|||
23368274|NCT00661089|65092631|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
23368275|NCT00661089|65092632|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
23368276|NCT03016169|65092633|FG000|Overall Study|Lost to Follow-up|4|||
23368277|NCT03016169|65092633|FG000|Overall Study|Death|54|||
23368278|NCT03016169|65092633|FG000|Overall Study|Device Explant|11|||
23368279|NCT03016169|65092633|FG000|Overall Study|Withdrawal by Subject|19|||
23368280|NCT03016169|65092633|FG000|Overall Study|Other Reasons|1|||
23368281|NCT01190891|65092634|FG000|Overall Study|Protocol Violation|1|||
23368282|NCT01190891|65092635|FG001|Overall Study|Protocol Violation|0|||
23368283|NCT01190891|65092634|FG000|Overall Study|Withdrawal by Subject|5|||
23368284|NCT01190891|65092635|FG001|Overall Study|Withdrawal by Subject|0|||
23368285|NCT01001429|65092636|FG000|Overall Study|surgery cancelled|0|||
23368286|NCT01001429|65092637|FG001|Overall Study|surgery cancelled|1|||
23368287|NCT01618968|65092642|FG000|Overall Study|Adverse Event|1|||
23368288|NCT01618968|65092643|FG001|Overall Study|Adverse Event|0|||
23368289|NCT01618968|65092644|FG002|Overall Study|Adverse Event|0|||
23368290|NCT01618968|65092645|FG003|Overall Study|Adverse Event|0|||
23368291|NCT01618968|65092642|FG000|Overall Study|Death|0|||
23368292|NCT01618968|65092643|FG001|Overall Study|Death|0|||
23274504|NCT00089661|64748302|FG000|Overall Study|Death|1|||
23274505|NCT00089661|64748303|FG001|Overall Study|Death|0|||
23274506|NCT00089661|64748302|FG000|Overall Study|Lost to Follow-up|0|||
23274507|NCT00089661|64748303|FG001|Overall Study|Lost to Follow-up|3|||
23274508|NCT00089661|64748302|FG000|Overall Study|Withdrawal by Subject|11|||
23274509|NCT00089661|64748303|FG001|Overall Study|Withdrawal by Subject|9|||
23274510|NCT00089661|64748302|FG000|Overall Study|Disease progression|1|||
23274511|NCT00089661|64748303|FG001|Overall Study|Disease progression|3|||
23274512|NCT00089661|64748302|FG000|Overall Study|Ineligibility determined|4|||
23274513|NCT00089661|64748303|FG001|Overall Study|Ineligibility determined|4|||
23274514|NCT00089661|64748302|FG000|Overall Study|Noncompliance|2|||
23274515|NCT00089661|64748303|FG001|Overall Study|Noncompliance|4|||
23274516|NCT00089661|64748302|FG000|Overall Study|Other|2|||
23274517|NCT00089661|64748303|FG001|Overall Study|Other|1|||
23274518|NCT00505622|64748308|FG000|Overall Study|Adverse Event|5|||
23274519|NCT00505622|64748309|FG001|Overall Study|Adverse Event|6|||
23274520|NCT00505622|64748310|FG002|Overall Study|Adverse Event|4|||
23274521|NCT00505622|64748308|FG000|Overall Study|Protocol Violation|1|||
23274522|NCT00505622|64748309|FG001|Overall Study|Protocol Violation|1|||
23274523|NCT00505622|64748310|FG002|Overall Study|Protocol Violation|0|||
23274524|NCT00505622|64748308|FG000|Overall Study|Withdrawal by Subject|0|||
23274525|NCT00505622|64748309|FG001|Overall Study|Withdrawal by Subject|3|||
23274526|NCT00505622|64748310|FG002|Overall Study|Withdrawal by Subject|2|||
23274527|NCT00505622|64748308|FG000|Overall Study|Study termination by sponsor|115|||
23274528|NCT00505622|64748309|FG001|Overall Study|Study termination by sponsor|98|||
23274529|NCT00505622|64748310|FG002|Overall Study|Study termination by sponsor|90|||
23274530|NCT03020641|64748311|FG000|Overall Study|Lost to Follow-up|0|||
23274531|NCT03020641|64748312|FG001|Overall Study|Lost to Follow-up|1|||
23368293|NCT01618968|65092644|FG002|Overall Study|Death|0|||
23368294|NCT01618968|65092645|FG003|Overall Study|Death|1|||
23368295|NCT01396083|65095984|FG000|Overall Study|Adverse Event|2|||
23602483|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Other|0|||
23602484|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Other|0|||
23602485|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Other|0|||
23602486|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Other|0|||
23602487|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Other|0|||
23602488|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Other|0|||
23602489|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Other|0|||
23602490|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Other|0|||
23274532|NCT03020641|64748311|FG000|Overall Study|Converted to open surgery|2|||
23274533|NCT03020641|64748312|FG001|Overall Study|Converted to open surgery|1|||
23274534|NCT03020641|64748311|FG000|Overall Study|for surgery not performed|0|||
23274535|NCT03020641|64748312|FG001|Overall Study|for surgery not performed|1|||
23368296|NCT01396083|65095985|FG001|Overall Study|Adverse Event|28|||
23274536|NCT02289963|64748313|FG000|Overall Study|Adverse Event|1|||
23274537|NCT02289963|64748314|FG001|Overall Study|Adverse Event|2|||
23368297|NCT01396083|65095984|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23602491|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Other|0|||
23602492|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Other|0|||
23602493|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Other|0|||
23274538|NCT02289963|64748313|FG000|Overall Study|Poor compliance to protocol|1|||
23274539|NCT02289963|64748314|FG001|Overall Study|Poor compliance to protocol|0|||
23274540|NCT02289963|64748313|FG000|Overall Study|Withdrawal by Subject|1|||
23368298|NCT01396083|65095985|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
23484300|NCT00622739|65515988|FG000|Overall Study|Physician Decision|1|||
23484301|NCT00622739|65515989|FG001|Overall Study|Physician Decision|0|||
23484302|NCT00622739|65515988|FG000|Overall Study|Adverse Event|1|||
23484303|NCT00622739|65515989|FG001|Overall Study|Adverse Event|2|||
23484304|NCT00622739|65515988|FG000|Overall Study|Lack of Efficacy|0|||
23602494|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Other|0|||
23368299|NCT01396083|65095984|FG000|Overall Study|Consent withdrawn|4|||
23368300|NCT01396083|65095985|FG001|Overall Study|Consent withdrawn|5|||
23368301|NCT01396083|65095984|FG000|Overall Study|Protocol deviation(s)|0|||
23368302|NCT01396083|65095985|FG001|Overall Study|Protocol deviation(s)|1|||
23274541|NCT02289963|64748314|FG001|Overall Study|Withdrawal by Subject|0|||
23274542|NCT02289963|64748313|FG000|Overall Study|Last injection missed|2|||
23274543|NCT02289963|64748314|FG001|Overall Study|Last injection missed|2|||
23274544|NCT02289963|64748313|FG000|Overall Study|End treatment visit outside visit window|0|||
23274545|NCT02289963|64748314|FG001|Overall Study|End treatment visit outside visit window|4|||
23602495|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Other|0|||
23602496|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Other|0|||
23274546|NCT02289963|64748313|FG000|Overall Study|Other than specified above|0|||
23274547|NCT02289963|64748314|FG001|Overall Study|Other than specified above|2|||
23274548|NCT02472366|64748316|FG000|Overall Study|Lost to Follow-up|1|||
23274549|NCT02472366|64748317|FG001|Overall Study|Lost to Follow-up|0|||
23274550|NCT01244126|64748318|FG000|Overall Study|Protocol Violation|3|||
23274551|NCT01244126|64748319|FG001|Overall Study|Protocol Violation|3|||
23274552|NCT01244126|64748320|FG002|Overall Study|Protocol Violation|9|||
23274553|NCT00794963|64748327|FG000|Overall Study|Withdrawal by Subject|1|||
23274554|NCT00794963|64748328|FG001|Overall Study|Withdrawal by Subject|4|||
23274555|NCT03752528|64748331|FG000|Part A|Lost to Follow-up|1|||
23274556|NCT03752528|64748331|FG000|Part A|Protocol Violation|1|||
23274557|NCT03752528|64748331|FG000|Part B|Protocol Violation|1|||
23274558|NCT03752528|64748331|FG000|Part B|Study terminated by sponsor|3|||
23274559|NCT01248247|64748332|FG000|Overall Study|Adverse Event|2|||
23274560|NCT01248247|64748333|FG001|Overall Study|Adverse Event|4|||
23274561|NCT01248247|64748334|FG002|Overall Study|Adverse Event|4|||
23274562|NCT01248247|64748335|FG003|Overall Study|Adverse Event|2|||
23274563|NCT01248247|64748332|FG000|Overall Study|Death|0|||
23274564|NCT01248247|64748333|FG001|Overall Study|Death|1|||
23274565|NCT01248247|64748334|FG002|Overall Study|Death|4|||
23274566|NCT01248247|64748335|FG003|Overall Study|Death|7|||
23274567|NCT01248247|64748332|FG000|Overall Study|Lost to Follow-up|0|||
23274568|NCT01248247|64748333|FG001|Overall Study|Lost to Follow-up|1|||
23274569|NCT01248247|64748334|FG002|Overall Study|Lost to Follow-up|1|||
23274570|NCT01248247|64748335|FG003|Overall Study|Lost to Follow-up|0|||
23274571|NCT01248247|64748332|FG000|Overall Study|Alternative treatment|0|||
23274572|NCT01248247|64748333|FG001|Overall Study|Alternative treatment|1|||
23274573|NCT01248247|64748334|FG002|Overall Study|Alternative treatment|0|||
23274574|NCT01248247|64748335|FG003|Overall Study|Alternative treatment|0|||
23274575|NCT01248247|64748332|FG000|Overall Study|Other|2|||
23274576|NCT01248247|64748333|FG001|Overall Study|Other|8|||
23274577|NCT01248247|64748334|FG002|Overall Study|Other|8|||
23274578|NCT01248247|64748335|FG003|Overall Study|Other|5|||
23274579|NCT01248247|64748332|FG000|Overall Study|Progression|18|||
23274580|NCT01248247|64748333|FG001|Overall Study|Progression|27|||
23274581|NCT01248247|64748334|FG002|Overall Study|Progression|56|||
23484305|NCT00622739|65515989|FG001|Overall Study|Lack of Efficacy|2|||
23602497|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Other|0|||
23602498|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Other|5|||
23274582|NCT01248247|64748335|FG003|Overall Study|Progression|44|||
23274583|NCT01248247|64748332|FG000|Overall Study|Refuse further treatment|0|||
23274584|NCT01248247|64748333|FG001|Overall Study|Refuse further treatment|0|||
23274585|NCT01248247|64748334|FG002|Overall Study|Refuse further treatment|1|||
23274586|NCT01248247|64748335|FG003|Overall Study|Refuse further treatment|2|||
23274587|NCT01248247|64748332|FG000|Overall Study|Complicating disease|0|||
23274588|NCT01248247|64748333|FG001|Overall Study|Complicating disease|0|||
23274589|NCT01248247|64748334|FG002|Overall Study|Complicating disease|1|||
23484306|NCT00622739|65515988|FG000|Overall Study|Withdrawal by Subject|0|||
23484307|NCT00622739|65515989|FG001|Overall Study|Withdrawal by Subject|1|||
23274590|NCT01248247|64748335|FG003|Overall Study|Complicating disease|1|||
23274591|NCT00707161|64751634|FG000|Overall Study|Physician Decision|6|||
23274592|NCT02301975|64751635|FG000|Overall Study|Adverse Event|8|||
23274593|NCT02301975|64751636|FG001|Overall Study|Adverse Event|3|||
23274594|NCT02301975|64751637|FG002|Overall Study|Adverse Event|2|||
23274595|NCT02301975|64751635|FG000|Overall Study|Lack of Efficacy|1|||
23368303|NCT01396083|65095984|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23602499|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Other|1|||
23484308|NCT00622739|65515988|FG000|Overall Study|Lost to Follow-up|0|||
23484309|NCT00622739|65515989|FG001|Overall Study|Lost to Follow-up|1|||
23274596|NCT02301975|64751636|FG001|Overall Study|Lack of Efficacy|1|||
23274597|NCT02301975|64751637|FG002|Overall Study|Lack of Efficacy|1|||
23602500|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Other|0|||
23274598|NCT02301975|64751635|FG000|Overall Study|Protocol Violation|3|||
23602501|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Other|0|||
23274599|NCT02301975|64751636|FG001|Overall Study|Protocol Violation|5|||
23274600|NCT02301975|64751637|FG002|Overall Study|Protocol Violation|3|||
23274601|NCT02301975|64751635|FG000|Overall Study|Lost to Follow-up|0|||
23274602|NCT02301975|64751636|FG001|Overall Study|Lost to Follow-up|2|||
23274603|NCT02301975|64751637|FG002|Overall Study|Lost to Follow-up|2|||
23274604|NCT02301975|64751635|FG000|Overall Study|Physician Decision|4|||
23274605|NCT02301975|64751636|FG001|Overall Study|Physician Decision|2|||
23274606|NCT02301975|64751637|FG002|Overall Study|Physician Decision|3|||
23274607|NCT02301975|64751635|FG000|Overall Study|Withdrawal by Subject|15|||
23274608|NCT02301975|64751636|FG001|Overall Study|Withdrawal by Subject|12|||
23274609|NCT02301975|64751637|FG002|Overall Study|Withdrawal by Subject|11|||
23274610|NCT03002077|64751642|FG000|Overall Study|Non-compliance with Study Drug|4|||
23274611|NCT03002077|64751642|FG000|Overall Study|Non-compliance w/Background ADT|1|||
23274612|NCT03002077|64751642|FG000|Overall Study|Study Terminated by Sponsor|257|||
23274613|NCT03002077|64751642|FG000|Overall Study|Site Terminated by Sponsor|5|||
23274614|NCT03002077|64751642|FG000|Overall Study|Miscellaneous Reasons|10|||
23602502|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Other|0|||
23602503|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Other|0|||
23602504|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Other|0|||
23602505|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Other|0|||
23602506|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Other|0|||
23602507|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Other|0|||
23602508|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602509|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602510|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602511|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602512|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602513|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602514|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602515|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602516|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602517|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
23274615|NCT03002077|64751642|FG000|Overall Study|Adverse Event|23|||
23274616|NCT03002077|64751642|FG000|Overall Study|Lack of Efficacy|20|||
23274617|NCT03002077|64751642|FG000|Overall Study|Withdrawal by Subject|72|||
23274618|NCT03002077|64751642|FG000|Overall Study|Lost to Follow-up|21|||
23602518|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602519|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602520|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602521|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
23484310|NCT03112590|65515990|FG000|Overall Study|Adverse Event|0|||
23484311|NCT03112590|65515991|FG001|Overall Study|Adverse Event|1|||
23484312|NCT03112590|65515992|FG002|Overall Study|Adverse Event|0|||
23274619|NCT03002077|64751642|FG000|Overall Study|Pregnancy|4|||
23274620|NCT03002077|64751642|FG000|Overall Study|Protocol Violation|21|||
23484313|NCT03505710|65515997|FG000|Overall Study|Progressive Disease|22|||
23484314|NCT03505710|65515998|FG001|Overall Study|Progressive Disease|9|||
23484315|NCT03505710|65515999|FG002|Overall Study|Progressive Disease|34|||
23484316|NCT03505710|65515997|FG000|Overall Study|Clinical Progression|6|||
23484317|NCT03505710|65515998|FG001|Overall Study|Clinical Progression|6|||
23484318|NCT03505710|65515999|FG002|Overall Study|Clinical Progression|3|||
23484319|NCT03505710|65515997|FG000|Overall Study|Adverse Event|12|||
23484320|NCT03505710|65515998|FG001|Overall Study|Adverse Event|5|||
23484321|NCT03505710|65515999|FG002|Overall Study|Adverse Event|27|||
23484322|NCT03505710|65515997|FG000|Overall Study|Withdrawal by Subject|1|||
23484323|NCT03505710|65515998|FG001|Overall Study|Withdrawal by Subject|3|||
23484324|NCT03505710|65515999|FG002|Overall Study|Withdrawal by Subject|3|||
23274621|NCT02441309|64751643|FG000|Overall Study|Disease progression|2|||
23484325|NCT03505710|65515997|FG000|Overall Study|Physician Decision|1|||
23484326|NCT03505710|65515998|FG001|Overall Study|Physician Decision|0|||
23484327|NCT03505710|65515999|FG002|Overall Study|Physician Decision|2|||
23484328|NCT03505710|65515997|FG000|Overall Study|Death|4|||
23484329|NCT03505710|65515998|FG001|Overall Study|Death|3|||
23484330|NCT03505710|65515999|FG002|Overall Study|Death|6|||
23484331|NCT03505710|65515997|FG000|Overall Study|Other Reasons|1|||
23484332|NCT03505710|65515998|FG001|Overall Study|Other Reasons|1|||
23484333|NCT03505710|65515999|FG002|Overall Study|Other Reasons|1|||
23484334|NCT02376829|65516000|FG000|Overall Study|Withdrawal by Subject|27|||
23274622|NCT02441309|64751644|FG001|Overall Study|Disease progression|1|||
23274623|NCT02441309|64751645|FG002|Overall Study|Disease progression|2|||
23274624|NCT02441309|64751643|FG000|Overall Study|Adverse Event|0|||
23274625|NCT02441309|64751644|FG001|Overall Study|Adverse Event|1|||
23274626|NCT02441309|64751645|FG002|Overall Study|Adverse Event|0|||
23274627|NCT02441309|64751643|FG000|Overall Study|Withdrawal by Subject|1|||
23274628|NCT02441309|64751644|FG001|Overall Study|Withdrawal by Subject|0|||
23274629|NCT02441309|64751645|FG002|Overall Study|Withdrawal by Subject|1|||
23274630|NCT00772941|64751647|FG000|Overall Study|CRFs not available|195|||
23274631|NCT00772941|64751647|FG000|Overall Study|Study not completed|16|||
23274632|NCT00772941|64751647|FG000|Overall Study|Missed Visits|374|||
23274633|NCT00772941|64751647|FG000|Overall Study|Poor Compliance|7|||
23274634|NCT00772941|64751647|FG000|Overall Study|GPSP Violation|90|||
23274635|NCT01675765|64751648|FG000|Overall Study|Progressive disease|4|||
23274636|NCT01675765|64751649|FG001|Overall Study|Progressive disease|4|||
23274637|NCT01675765|64751648|FG000|Overall Study|Adverse Event|1|||
23274638|NCT01675765|64751649|FG001|Overall Study|Adverse Event|2|||
23274639|NCT01675765|64751648|FG000|Overall Study|Withdrawal by Subject|2|||
23274640|NCT01675765|64751649|FG001|Overall Study|Withdrawal by Subject|0|||
23274641|NCT01675765|64751648|FG000|Overall Study|Death|1|||
23274642|NCT01675765|64751649|FG001|Overall Study|Death|0|||
23274643|NCT01675765|64751648|FG000|Overall Study|Clinical progression|3|||
23274644|NCT01675765|64751649|FG001|Overall Study|Clinical progression|2|||
23274645|NCT03135834|64751653|FG000|Stage 1|Adverse Event|1|||
23274646|NCT03135834|64751654|FG001|Stage 1|Adverse Event|2|||
23274647|NCT03135834|64751655|FG002|Stage 1|Adverse Event|2|||
23274648|NCT03135834|64751656|FG003|Stage 1|Adverse Event|1|||
23274649|NCT03135834|64751653|FG000|Stage 1|Death|1|||
23274650|NCT03135834|64751654|FG001|Stage 1|Death|0|||
23274651|NCT03135834|64751655|FG002|Stage 1|Death|0|||
23274652|NCT03135834|64751656|FG003|Stage 1|Death|0|||
23274653|NCT03135834|64751653|FG000|Stage 1|Lost to Follow-up|17|||
23274654|NCT03135834|64751654|FG001|Stage 1|Lost to Follow-up|24|||
23274655|NCT03135834|64751655|FG002|Stage 1|Lost to Follow-up|21|||
23484335|NCT02376829|65516001|FG001|Overall Study|Withdrawal by Subject|44|||
23484336|NCT00521001|65516002|FG000|Overall Study|Ineligible|1|||
23274656|NCT03135834|64751656|FG003|Stage 1|Lost to Follow-up|38|||
23484337|NCT01309893|65516005|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
23484338|NCT01309893|65516006|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
23484339|NCT01309893|65516005|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
23484340|NCT01309893|65516006|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
23484341|NCT01466595|65516007|FG000|Overall Study|Withdrawal by Subject|0|||
23484342|NCT01466595|65516008|FG001|Overall Study|Withdrawal by Subject|1|||
23484343|NCT02718300|65516010|FG000|Overall Study|Death|4|||
23484344|NCT02718300|65516011|FG001|Overall Study|Death|5|||
23274657|NCT03135834|64751653|FG000|Stage 1|No longer met eligibility criteria|1|||
23274658|NCT03135834|64751654|FG001|Stage 1|No longer met eligibility criteria|6|||
23274659|NCT03135834|64751655|FG002|Stage 1|No longer met eligibility criteria|2|||
23274660|NCT03135834|64751656|FG003|Stage 1|No longer met eligibility criteria|5|||
23274661|NCT03135834|64751653|FG000|Stage 1|Other|0|||
23274662|NCT03135834|64751654|FG001|Stage 1|Other|2|||
23274663|NCT03135834|64751655|FG002|Stage 1|Other|1|||
23484345|NCT02718300|65516012|FG002|Overall Study|Death|17|||
23484346|NCT02718300|65516010|FG000|Overall Study|Lost to Follow-up|1|||
23484347|NCT02718300|65516011|FG001|Overall Study|Lost to Follow-up|0|||
23484348|NCT02718300|65516012|FG002|Overall Study|Lost to Follow-up|2|||
23484349|NCT02718300|65516010|FG000|Overall Study|Physician Decision|1|||
23484350|NCT02718300|65516011|FG001|Overall Study|Physician Decision|0|||
23484351|NCT02718300|65516012|FG002|Overall Study|Physician Decision|2|||
23484352|NCT02718300|65516010|FG000|Overall Study|Study Terminated by Sponsor|6|||
23484353|NCT02718300|65516011|FG001|Overall Study|Study Terminated by Sponsor|3|||
23484354|NCT02718300|65516012|FG002|Overall Study|Study Terminated by Sponsor|4|||
23484355|NCT02718300|65516010|FG000|Overall Study|Withdrawal by Subject|0|||
23484356|NCT02718300|65516011|FG001|Overall Study|Withdrawal by Subject|4|||
23484357|NCT02718300|65516012|FG002|Overall Study|Withdrawal by Subject|3|||
23484358|NCT02718300|65516010|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
23484359|NCT02718300|65516011|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
23484360|NCT02718300|65516012|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
23484361|NCT01925989|65516013|FG000|Period 1|Sponsor Decision|1|||
23484362|NCT01925989|65516014|FG001|Period 1|Sponsor Decision|1|||
23484363|NCT01925989|65516015|FG002|Period 1|Sponsor Decision|0|||
23484364|NCT01925989|65516013|FG000|Period 1|Withdrawal by Subject|0|||
23484365|NCT01925989|65516014|FG001|Period 1|Withdrawal by Subject|1|||
23484366|NCT01925989|65516015|FG002|Period 1|Withdrawal by Subject|0|||
23484367|NCT01426789|65516018|FG000|Part 1|Protocol deviation|0|||
23484368|NCT01426789|65516019|FG001|Part 1|Protocol deviation|1|||
23484369|NCT01426789|65516020|FG002|Part 1|Protocol deviation|0|||
23484370|NCT01426789|65516021|FG003|Part 1|Protocol deviation|0|||
23484371|NCT01426789|65516022|FG004|Part 1|Protocol deviation|0|||
23484372|NCT01426789|65516023|FG005|Part 1|Protocol deviation|0|||
23484373|NCT01426789|65516018|FG000|Part 1|Lost to Follow-up|1|||
23484374|NCT01426789|65516019|FG001|Part 1|Lost to Follow-up|2|||
23484375|NCT01426789|65516020|FG002|Part 1|Lost to Follow-up|0|||
23484376|NCT01426789|65516021|FG003|Part 1|Lost to Follow-up|0|||
23484377|NCT01426789|65516022|FG004|Part 1|Lost to Follow-up|0|||
23484378|NCT01426789|65516023|FG005|Part 1|Lost to Follow-up|0|||
23484379|NCT01426789|65516018|FG000|Part 1|Lack of Efficacy|2|||
23484380|NCT01426789|65516019|FG001|Part 1|Lack of Efficacy|1|||
23484381|NCT01426789|65516020|FG002|Part 1|Lack of Efficacy|0|||
23484382|NCT01426789|65516021|FG003|Part 1|Lack of Efficacy|0|||
23484383|NCT01426789|65516022|FG004|Part 1|Lack of Efficacy|0|||
23484384|NCT01426789|65516023|FG005|Part 1|Lack of Efficacy|0|||
23484385|NCT01426789|65516018|FG000|Part 1|Adverse Event|3|||
23484386|NCT01426789|65516019|FG001|Part 1|Adverse Event|0|||
23484387|NCT01426789|65516020|FG002|Part 1|Adverse Event|0|||
23484388|NCT01426789|65516021|FG003|Part 1|Adverse Event|0|||
23484389|NCT01426789|65516022|FG004|Part 1|Adverse Event|0|||
23484390|NCT01426789|65516023|FG005|Part 1|Adverse Event|0|||
23484391|NCT01426789|65516018|FG000|Part 2|Protocol deviation|0|||
23484392|NCT01426789|65516019|FG001|Part 2|Protocol deviation|0|||
23484393|NCT01426789|65516020|FG002|Part 2|Protocol deviation|1|||
23484394|NCT01426789|65516021|FG003|Part 2|Protocol deviation|0|||
23484395|NCT01426789|65516022|FG004|Part 2|Protocol deviation|0|||
23484396|NCT01426789|65516023|FG005|Part 2|Protocol deviation|0|||
23484397|NCT01426789|65516018|FG000|Part 2|Death|0|||
23484398|NCT01426789|65516019|FG001|Part 2|Death|0|||
23484399|NCT01426789|65516020|FG002|Part 2|Death|1|||
23484400|NCT01426789|65516021|FG003|Part 2|Death|0|||
23484401|NCT01426789|65516022|FG004|Part 2|Death|1|||
23484402|NCT01426789|65516023|FG005|Part 2|Death|0|||
23484403|NCT01426789|65516018|FG000|Part 2|Administrative problems|0|||
23484404|NCT01426789|65516019|FG001|Part 2|Administrative problems|0|||
23484405|NCT01426789|65516020|FG002|Part 2|Administrative problems|2|||
23484406|NCT01426789|65516021|FG003|Part 2|Administrative problems|0|||
23484407|NCT01426789|65516022|FG004|Part 2|Administrative problems|1|||
23484408|NCT01426789|65516023|FG005|Part 2|Administrative problems|0|||
23484409|NCT01426789|65516018|FG000|Part 2|Lost to Follow-up|0|||
23484410|NCT01426789|65516019|FG001|Part 2|Lost to Follow-up|0|||
23484411|NCT01426789|65516020|FG002|Part 2|Lost to Follow-up|4|||
23484412|NCT01426789|65516021|FG003|Part 2|Lost to Follow-up|0|||
23368304|NCT01396083|65095985|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23368305|NCT01396083|65095984|FG000|Overall Study|Administrative problems|1|||
23484413|NCT01426789|65516022|FG004|Part 2|Lost to Follow-up|1|||
23484414|NCT01426789|65516023|FG005|Part 2|Lost to Follow-up|0|||
23484415|NCT01426789|65516018|FG000|Part 2|Withdrawal by Subject|0|||
23484416|NCT01426789|65516019|FG001|Part 2|Withdrawal by Subject|0|||
23484417|NCT01426789|65516020|FG002|Part 2|Withdrawal by Subject|0|||
23484418|NCT01426789|65516021|FG003|Part 2|Withdrawal by Subject|1|||
23484419|NCT01426789|65516022|FG004|Part 2|Withdrawal by Subject|2|||
23484420|NCT01426789|65516023|FG005|Part 2|Withdrawal by Subject|0|||
23484421|NCT01426789|65516018|FG000|Part 2|Lack of Efficacy|0|||
23484422|NCT01426789|65516019|FG001|Part 2|Lack of Efficacy|0|||
23484423|NCT01426789|65516020|FG002|Part 2|Lack of Efficacy|5|||
23484424|NCT01426789|65516021|FG003|Part 2|Lack of Efficacy|0|||
23484425|NCT01426789|65516022|FG004|Part 2|Lack of Efficacy|2|||
23484426|NCT01426789|65516023|FG005|Part 2|Lack of Efficacy|0|||
23274664|NCT03135834|64751656|FG003|Stage 1|Other|0|||
23274665|NCT03135834|64751653|FG000|Stage 1|Physician Decision|0|||
23274666|NCT03135834|64751654|FG001|Stage 1|Physician Decision|1|||
23274667|NCT03135834|64751655|FG002|Stage 1|Physician Decision|0|||
23274668|NCT03135834|64751656|FG003|Stage 1|Physician Decision|0|||
23274669|NCT03135834|64751653|FG000|Stage 1|Pregnancy|0|||
23274670|NCT03135834|64751654|FG001|Stage 1|Pregnancy|4|||
23274671|NCT03135834|64751655|FG002|Stage 1|Pregnancy|2|||
23274672|NCT03135834|64751656|FG003|Stage 1|Pregnancy|4|||
23274673|NCT03135834|64751653|FG000|Stage 1|Protocol Violation|1|||
23274674|NCT03135834|64751654|FG001|Stage 1|Protocol Violation|1|||
23274675|NCT03135834|64751655|FG002|Stage 1|Protocol Violation|2|||
23274676|NCT03135834|64751656|FG003|Stage 1|Protocol Violation|1|||
23274677|NCT03135834|64751653|FG000|Stage 1|Withdrawal by parent/guardian|2|||
23274678|NCT03135834|64751654|FG001|Stage 1|Withdrawal by parent/guardian|10|||
23274679|NCT03135834|64751655|FG002|Stage 1|Withdrawal by parent/guardian|2|||
23274680|NCT03135834|64751656|FG003|Stage 1|Withdrawal by parent/guardian|1|||
23274681|NCT03135834|64751653|FG000|Stage 1|Withdrawal by Subject|16|||
23274682|NCT03135834|64751654|FG001|Stage 1|Withdrawal by Subject|22|||
23274683|NCT03135834|64751655|FG002|Stage 1|Withdrawal by Subject|7|||
23274684|NCT03135834|64751656|FG003|Stage 1|Withdrawal by Subject|10|||
23274685|NCT03135834|64751653|FG000|Stage 1|Randomized but not Vaccinated|0|||
23274686|NCT03135834|64751654|FG001|Stage 1|Randomized but not Vaccinated|3|||
23274687|NCT03135834|64751655|FG002|Stage 1|Randomized but not Vaccinated|1|||
23274688|NCT03135834|64751656|FG003|Stage 1|Randomized but not Vaccinated|6|||
23274689|NCT03135834|64751653|FG000|Stage 2|Lost to Follow-up|0|||
23274690|NCT03135834|64751654|FG001|Stage 2|Lost to Follow-up|1|||
23274691|NCT03135834|64751655|FG002|Stage 2|Lost to Follow-up|0|||
23274692|NCT03135834|64751656|FG003|Stage 2|Lost to Follow-up|0|||
23274693|NCT03135834|64751653|FG000|Stage 2|Withdrawal by Subject|0|||
23274694|NCT03135834|64751654|FG001|Stage 2|Withdrawal by Subject|1|||
23274695|NCT03135834|64751655|FG002|Stage 2|Withdrawal by Subject|0|||
23274696|NCT03135834|64751656|FG003|Stage 2|Withdrawal by Subject|0|||
23274697|NCT03135834|64751653|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
23274698|NCT03135834|64751654|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
23274699|NCT03135834|64751655|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
23274700|NCT03135834|64751656|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
23274701|NCT03135834|64751653|FG000|Stage 2|Did not receive Booster Vaccination|1|||
23274702|NCT03135834|64751654|FG001|Stage 2|Did not receive Booster Vaccination|1|||
23274703|NCT03135834|64751655|FG002|Stage 2|Did not receive Booster Vaccination|0|||
23274704|NCT03135834|64751656|FG003|Stage 2|Did not receive Booster Vaccination|0|||
23274705|NCT02159950|64751657|FG000|Overall Study|Adverse Event|0|||
23274706|NCT02159950|64751658|FG001|Overall Study|Adverse Event|1|||
23274707|NCT02159950|64751657|FG000|Overall Study|Progression|0|||
23368306|NCT01396083|65095985|FG001|Overall Study|Administrative problems|0|||
23368307|NCT01396083|65095984|FG000|Overall Study|Lost to Follow-up|1|||
23274708|NCT02159950|64751658|FG001|Overall Study|Progression|1|||
23274709|NCT01136382|64751659|FG000|Overall Study|Other|8|||
23274710|NCT01136382|64751660|FG001|Overall Study|Other|3|||
23274711|NCT01136382|64751659|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
23274712|NCT01136382|64751660|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
23274713|NCT01136382|64751659|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
23274714|NCT01136382|64751660|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
23274715|NCT01136382|64751659|FG000|Overall Study|Withdrawal by Subject|4|||
23274716|NCT01136382|64751660|FG001|Overall Study|Withdrawal by Subject|1|||
23274717|NCT02794974|64751663|FG000|Overall Study|Physician Decision|0|||
23274718|NCT02794974|64751664|FG001|Overall Study|Physician Decision|1|||
23274719|NCT02937870|64751665|FG000|Overall Study|Adverse Event|1|||
23274720|NCT02937870|64751665|FG000|Overall Study|Protocol Deviation|2|||
23274721|NCT00609674|64751670|FG000|Overall Study|Adverse Event|1|||
23274722|NCT00609674|64751671|FG001|Overall Study|Adverse Event|1|||
23274723|NCT00609674|64751670|FG000|Overall Study|Protocol Violation|3|||
23274724|NCT00609674|64751671|FG001|Overall Study|Protocol Violation|5|||
23274725|NCT00609674|64751670|FG000|Overall Study|Lost to Follow-up|1|||
23274726|NCT00609674|64751671|FG001|Overall Study|Lost to Follow-up|0|||
23274727|NCT00609674|64751670|FG000|Overall Study|Withdrew consent|2|||
23274728|NCT00609674|64751671|FG001|Overall Study|Withdrew consent|1|||
23274729|NCT00004562|64751672|FG000|Overall Study|Lost to Follow-up|102|||
23274730|NCT00004562|64751673|FG001|Overall Study|Lost to Follow-up|91|||
23274731|NCT02246166|64751685|FG000|Overall Study|Protocol Violation|1|||
23274732|NCT02246166|64751686|FG001|Overall Study|Protocol Violation|0|||
23274733|NCT03435081|64751692|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
23274734|NCT03435081|64751693|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
23274735|NCT03435081|64751694|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
23274736|NCT03435081|64751692|FG000|Week 0 to Week 16|Adverse Event|2|||
23274737|NCT03435081|64751693|FG001|Week 0 to Week 16|Adverse Event|2|||
23274738|NCT03435081|64751694|FG002|Week 0 to Week 16|Adverse Event|2|||
23274739|NCT03435081|64751692|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
23274740|NCT03435081|64751693|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
23274741|NCT03435081|64751694|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
23274742|NCT03435081|64751692|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
23274743|NCT03435081|64751693|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
23274744|NCT03435081|64751694|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
23274745|NCT03435081|64751692|FG000|Week 0 to Week 16|Pregnancy|1|||
23274746|NCT03435081|64751693|FG001|Week 0 to Week 16|Pregnancy|0|||
23274747|NCT03435081|64751694|FG002|Week 0 to Week 16|Pregnancy|0|||
23274748|NCT03435081|64751692|FG000|Week 0 to Week 16|Non-compliance|1|||
23274749|NCT03435081|64751693|FG001|Week 0 to Week 16|Non-compliance|0|||
23274750|NCT03435081|64751694|FG002|Week 0 to Week 16|Non-compliance|2|||
23274751|NCT03435081|64751692|FG000|Week 0 to Week 16|Inadequate Response|0|||
23274752|NCT03435081|64751693|FG001|Week 0 to Week 16|Inadequate Response|1|||
23274753|NCT03435081|64751694|FG002|Week 0 to Week 16|Inadequate Response|0|||
23274754|NCT03435081|64751692|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
23274755|NCT03435081|64751693|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
23274756|NCT03435081|64751694|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
23274757|NCT03435081|64751692|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
23274758|NCT03435081|64751693|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
23274759|NCT03435081|64751694|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
23274760|NCT03435081|64751692|FG000|Week 16 to Week 104|Adverse Event|1|||
23274761|NCT03435081|64751693|FG001|Week 16 to Week 104|Adverse Event|0|||
23274762|NCT03435081|64751694|FG002|Week 16 to Week 104|Adverse Event|2|||
23274763|NCT03435081|64751692|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
23274764|NCT03435081|64751693|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
23274765|NCT03435081|64751694|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
23274766|NCT03435081|64751692|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
23274767|NCT03435081|64751693|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
23274768|NCT03435081|64751694|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
23274769|NCT03435081|64751692|FG000|Week 16 to Week 104|Non--Compliance|0|||
23274770|NCT03435081|64751693|FG001|Week 16 to Week 104|Non--Compliance|0|||
23274771|NCT03435081|64751694|FG002|Week 16 to Week 104|Non--Compliance|1|||
23274772|NCT00537979|64751695|FG000|Overall Study|Adverse Event|2|||
23602522|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
23274773|NCT00537979|64751696|FG001|Overall Study|Adverse Event|2|||
23274774|NCT00537979|64751695|FG000|Overall Study|Withdrawal by Subject|1|||
23274775|NCT00537979|64751696|FG001|Overall Study|Withdrawal by Subject|4|||
23274776|NCT00537979|64751695|FG000|Overall Study|Lost to Follow-up|1|||
23274777|NCT00537979|64751696|FG001|Overall Study|Lost to Follow-up|4|||
23274778|NCT00537979|64751695|FG000|Overall Study|Lack of Efficacy|0|||
23274779|NCT00537979|64751696|FG001|Overall Study|Lack of Efficacy|1|||
23602523|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602524|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602525|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602526|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602527|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
23274780|NCT00537979|64751695|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
23368308|NCT01396083|65095985|FG001|Overall Study|Lost to Follow-up|0|||
23274781|NCT00537979|64751696|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
23274782|NCT00537979|64751695|FG000|Overall Study|Death|0|||
23274783|NCT00537979|64751696|FG001|Overall Study|Death|3|||
23274784|NCT00537979|64751695|FG000|Overall Study|Kidney transplant|0|||
23274785|NCT00537979|64751696|FG001|Overall Study|Kidney transplant|3|||
23274786|NCT00537979|64751695|FG000|Overall Study|Heart failure|0|||
23368309|NCT00960193|65095986|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
23368310|NCT04609514|65095987|FG000|Overall Study|Lost to Follow-up|5|||
23368311|NCT04609514|65095988|FG001|Overall Study|Lost to Follow-up|4|||
23368312|NCT04609514|65095987|FG000|Overall Study|Withdrawal by PI|0|||
23368313|NCT04609514|65095988|FG001|Overall Study|Withdrawal by PI|2|||
23368314|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Early discharge|5|||
23368315|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Early discharge|5|||
23368316|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
23368317|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
23368318|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
23368319|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
23368320|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
23368321|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
23368322|NCT04460326|65095995|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
23368323|NCT04460326|65095996|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
23484427|NCT01426789|65516018|FG000|Part 2|Adverse Event|0|||
23484428|NCT01426789|65516019|FG001|Part 2|Adverse Event|0|||
23484429|NCT01426789|65516020|FG002|Part 2|Adverse Event|2|||
23484430|NCT01426789|65516021|FG003|Part 2|Adverse Event|0|||
23484431|NCT01426789|65516022|FG004|Part 2|Adverse Event|1|||
23484432|NCT01426789|65516023|FG005|Part 2|Adverse Event|0|||
23484433|NCT00938964|65516024|FG000|Overall Study|Death|3|||
23484434|NCT00938964|65516025|FG001|Overall Study|Death|3|||
23484435|NCT00938964|65516024|FG000|Overall Study|Lost to Follow-up|2|||
23484436|NCT00938964|65516025|FG001|Overall Study|Lost to Follow-up|3|||
23484437|NCT00938964|65516024|FG000|Overall Study|Withdrawal by Subject|22|||
23484438|NCT00938964|65516025|FG001|Overall Study|Withdrawal by Subject|18|||
23484439|NCT00938964|65516024|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
23484440|NCT00938964|65516025|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
23484441|NCT00817479|65516026|FG000|Overall Study|Physician Decision|1|||
23484442|NCT00817479|65516027|FG001|Overall Study|Physician Decision|1|||
23484443|NCT03119701|65516030|FG000|6-day Dosing|Death|4|||
23484444|NCT03119701|65516031|FG001|6-day Dosing|Death|1|||
23484445|NCT03119701|65516030|FG000|6-day Dosing|Adverse Event|3|||
23484446|NCT03119701|65516031|FG001|6-day Dosing|Adverse Event|0|||
23484447|NCT03119701|65516030|FG000|6-day Dosing|Physician Decision|0|||
23484448|NCT03119701|65516031|FG001|6-day Dosing|Physician Decision|1|||
23484449|NCT03119701|65516030|FG000|6-day Dosing|Withdrawal by Subject|0|||
23484450|NCT03119701|65516031|FG001|6-day Dosing|Withdrawal by Subject|1|||
23484451|NCT03119701|65516030|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
23484452|NCT03119701|65516031|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
23484453|NCT00761150|65516032|FG000|Open-label Period|Adverse Event|36|||
23484454|NCT00761150|65516033|FG001|Open-label Period|Adverse Event|0|||
23484455|NCT00761150|65516034|FG002|Open-label Period|Adverse Event|0|||
23484456|NCT00761150|65516032|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
23484457|NCT00761150|65516033|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
23484458|NCT00761150|65516034|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
23484459|NCT00761150|65516032|FG000|Open-label Period|Lost to Follow-up|7|||
23484460|NCT00761150|65516033|FG001|Open-label Period|Lost to Follow-up|0|||
23484461|NCT00761150|65516034|FG002|Open-label Period|Lost to Follow-up|0|||
23484462|NCT00761150|65516032|FG000|Open-label Period|Lack of Efficacy|4|||
23484463|NCT00761150|65516033|FG001|Open-label Period|Lack of Efficacy|0|||
23484464|NCT00761150|65516034|FG002|Open-label Period|Lack of Efficacy|0|||
23274787|NCT00537979|64751696|FG001|Overall Study|Heart failure|1|||
23274788|NCT04089735|64751700|FG000|Overall Study|Adverse Event|1|||
23274789|NCT04089735|64751701|FG001|Overall Study|Adverse Event|0|||
23274790|NCT04089735|64751702|FG002|Overall Study|Adverse Event|1|||
23274791|NCT04089735|64751703|FG003|Overall Study|Adverse Event|1|||
23274792|NCT04089735|64751704|FG004|Overall Study|Adverse Event|0|||
23274793|NCT04089735|64751705|FG005|Overall Study|Adverse Event|0|||
23274794|NCT04089735|64751700|FG000|Overall Study|Physician Decision|0|||
23274795|NCT04089735|64751701|FG001|Overall Study|Physician Decision|3|||
23274796|NCT04089735|64751702|FG002|Overall Study|Physician Decision|0|||
23274797|NCT04089735|64751703|FG003|Overall Study|Physician Decision|0|||
23274798|NCT04089735|64751704|FG004|Overall Study|Physician Decision|0|||
23274799|NCT04089735|64751705|FG005|Overall Study|Physician Decision|0|||
23274800|NCT04089735|64751700|FG000|Overall Study|Withdrawal by Subject|0|||
23274801|NCT04089735|64751701|FG001|Overall Study|Withdrawal by Subject|0|||
23274802|NCT04089735|64751702|FG002|Overall Study|Withdrawal by Subject|1|||
23274803|NCT04089735|64751703|FG003|Overall Study|Withdrawal by Subject|0|||
23274804|NCT04089735|64751704|FG004|Overall Study|Withdrawal by Subject|0|||
23368324|NCT04460326|65095995|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
23368325|NCT04460326|65095996|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
23274805|NCT04089735|64751705|FG005|Overall Study|Withdrawal by Subject|0|||
23368326|NCT00789321|65095997|FG000|Overall Study|Adverse Event|0|||
23368327|NCT00789321|65095998|FG001|Overall Study|Adverse Event|1|||
23368328|NCT02224625|65095999|FG000|Irritation|Adverse Event|6|||
23368329|NCT02224625|65095999|FG000|Sensitization|Adverse Event|55|||
23368330|NCT03006562|65096000|FG000|Overall Study|Lost to Follow-up|0|||
23368331|NCT03006562|65096001|FG001|Overall Study|Lost to Follow-up|1|||
23368332|NCT03074695|65096003|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
23368333|NCT03074695|65096004|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
23368334|NCT03074695|65096003|FG000|Overall Study|Research staff not available|1|||
23368335|NCT03074695|65096004|FG001|Overall Study|Research staff not available|2|||
23368336|NCT03074695|65096003|FG000|Overall Study|Did not receive neuraxial block|2|||
23368337|NCT03074695|65096004|FG001|Overall Study|Did not receive neuraxial block|2|||
23368338|NCT02163395|65096005|FG000|Overall Study|Withdrawal by Subject|1|||
23368339|NCT02163395|65096005|FG000|Overall Study|Lost to Follow-up|3|||
23368340|NCT02163395|65096005|FG000|Overall Study|Adverse Event|1|||
23368341|NCT03426345|65096006|FG000|Overall Study|Adverse Event|4|||
23368342|NCT03426345|65096007|FG001|Overall Study|Adverse Event|4|||
23368343|NCT03426345|65096006|FG000|Overall Study|Lack of Efficacy|1|||
23368344|NCT03426345|65096007|FG001|Overall Study|Lack of Efficacy|0|||
23368345|NCT03426345|65096006|FG000|Overall Study|Withdrawal by Subject|5|||
23368346|NCT03426345|65096007|FG001|Overall Study|Withdrawal by Subject|6|||
23368347|NCT03426345|65096006|FG000|Overall Study|Lost to Follow-up|3|||
23368348|NCT03426345|65096007|FG001|Overall Study|Lost to Follow-up|1|||
23368349|NCT03426345|65096006|FG000|Overall Study|Protocol Deviation|3|||
23368350|NCT03426345|65096007|FG001|Overall Study|Protocol Deviation|4|||
23368351|NCT03426345|65096006|FG000|Overall Study|Reason Not Specified|1|||
23368352|NCT03426345|65096007|FG001|Overall Study|Reason Not Specified|2|||
23368353|NCT03426345|65096006|FG000|Overall Study|Missing Completion Status|1|||
23368354|NCT03426345|65096007|FG001|Overall Study|Missing Completion Status|0|||
23368355|NCT02900352|65096008|FG000|Overall Study|Lost to Follow-up|28|||
23368356|NCT02900352|65096009|FG001|Overall Study|Lost to Follow-up|17|||
23368357|NCT04356937|65096010|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
23368358|NCT04356937|65096011|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
23368359|NCT03885908|65096012|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
23368360|NCT03885908|65096013|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
23368361|NCT03885908|65096012|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
23368362|NCT03885908|65096013|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
23368363|NCT03885908|65096012|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
23368364|NCT03885908|65096013|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
23274806|NCT04089735|64751700|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
23274807|NCT04089735|64751701|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
23274808|NCT04089735|64751702|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
23274809|NCT04089735|64751703|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
23274810|NCT04089735|64751704|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
23274811|NCT04089735|64751705|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
23274812|NCT04405570|64751713|FG000|Overall Study|Adverse Event|0|||
23274813|NCT04405570|64751714|FG001|Overall Study|Adverse Event|1|||
23274814|NCT04405570|64751715|FG002|Overall Study|Adverse Event|1|||
23274815|NCT04405570|64751716|FG003|Overall Study|Adverse Event|1|||
23274816|NCT04405570|64751713|FG000|Overall Study|Lost to Follow-up|0|||
23274817|NCT04405570|64751714|FG001|Overall Study|Lost to Follow-up|1|||
23274818|NCT04405570|64751715|FG002|Overall Study|Lost to Follow-up|0|||
23274819|NCT04405570|64751716|FG003|Overall Study|Lost to Follow-up|0|||
23274820|NCT04405570|64751713|FG000|Overall Study|Physician Decision|0|||
23274821|NCT04405570|64751714|FG001|Overall Study|Physician Decision|0|||
23274822|NCT04405570|64751715|FG002|Overall Study|Physician Decision|1|||
23274823|NCT04405570|64751716|FG003|Overall Study|Physician Decision|0|||
23274824|NCT04405570|64751713|FG000|Overall Study|Withdrawal by Subject|0|||
23274825|NCT04405570|64751714|FG001|Overall Study|Withdrawal by Subject|1|||
23274826|NCT04405570|64751715|FG002|Overall Study|Withdrawal by Subject|1|||
23274827|NCT04405570|64751716|FG003|Overall Study|Withdrawal by Subject|0|||
23274828|NCT04405570|64751713|FG000|Overall Study|Randomized not dosed|0|||
23402811|NCT00560508|65220014|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
23368365|NCT03885908|65096012|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
23368366|NCT03885908|65096013|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
23368367|NCT00617357|65096018|FG000|Overall Study|Lost to Follow-up|7|||
23368368|NCT00617357|65096018|FG000|Overall Study|Death|5|||
23368369|NCT00617357|65096018|FG000|Overall Study|insurance concerns|2|||
23368370|NCT00617357|65096018|FG000|Overall Study|Withdrawal by Subject|1|||
23368371|NCT00617357|65096018|FG000|Overall Study|Physician Decision|1|||
23368372|NCT01791985|65096020|FG000|Overall Study|Adverse Event|7|||
23368373|NCT01791985|65096020|FG000|Overall Study|Withdrawal by Subject|1|||
23368374|NCT04006145|65096021|FG000|Overall Study|Lost to Follow-up|0|||
23368375|NCT04006145|65096022|FG001|Overall Study|Lost to Follow-up|1|||
23368376|NCT04006145|65096021|FG000|Overall Study|Other|1|||
23368377|NCT04006145|65096022|FG001|Overall Study|Other|2|||
23368378|NCT00483652|65096023|FG000|Double-blind Treatment Period|Protocol Violation|2|||
23368379|NCT00483652|65096024|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23368380|NCT00483652|65096023|FG000|Double-blind Treatment Period|Adverse Event|3|||
23368381|NCT00483652|65096024|FG001|Double-blind Treatment Period|Adverse Event|4|||
23368382|NCT00483652|65096023|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
23368383|NCT00483652|65096024|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
23368384|NCT00483652|65096023|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
23368385|NCT00483652|65096024|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
23368386|NCT01619865|65096025|FG000|Overall Study|Adverse Event|1|||
23368387|NCT01619865|65096025|FG000|Overall Study|Death|2|||
23368388|NCT01619865|65096025|FG000|Overall Study|subject not able to comply|1|||
23368389|NCT02700048|65096026|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
23368390|NCT02700048|65096027|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
23368391|NCT00739648|65096028|FG000|Overall Study|Adverse Event|3|||
23368392|NCT00739648|65096029|FG001|Overall Study|Adverse Event|15|||
23368393|NCT00739648|65096028|FG000|Overall Study|Withdrawal by Subject|13|||
23368394|NCT00739648|65096029|FG001|Overall Study|Withdrawal by Subject|25|||
23368395|NCT00739648|65096028|FG000|Overall Study|Lost to Follow-up|4|||
23368396|NCT00739648|65096029|FG001|Overall Study|Lost to Follow-up|7|||
23368397|NCT00739648|65096028|FG000|Overall Study|Death|2|||
23368398|NCT00739648|65096029|FG001|Overall Study|Death|0|||
23368399|NCT00739648|65096028|FG000|Overall Study|Do not know|4|||
23368400|NCT00739648|65096029|FG001|Overall Study|Do not know|6|||
23368401|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
23368402|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
23368403|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
23368404|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
23368405|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
23368406|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
23368407|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
23368408|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23368409|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23368410|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
23368411|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
23368412|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
23368413|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
23368414|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
23368415|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
23368416|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
23368417|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
23368418|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23368419|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23368420|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
23368421|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
23368422|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
23368423|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23368424|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23368425|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
23368426|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
23368427|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
23368428|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
23368429|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
23368430|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
23368431|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
23368432|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
23368433|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
23368434|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
23368435|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
23368436|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
23368437|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
23368438|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
23368439|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
23368440|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
23368441|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
23368442|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
23368443|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
23368444|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
23368445|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
23368446|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
23602528|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602529|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
23274829|NCT04405570|64751714|FG001|Overall Study|Randomized not dosed|2|||
23274830|NCT04405570|64751715|FG002|Overall Study|Randomized not dosed|0|||
23274831|NCT04405570|64751716|FG003|Overall Study|Randomized not dosed|0|||
23274832|NCT02909907|64751719|FG000|Overall Study|Withdrawal by Subject|0|||
23274833|NCT02909907|64751720|FG001|Overall Study|Withdrawal by Subject|1|||
23274834|NCT01987765|64751721|FG000|Overall Study|Protocol Violation|65|||
23274835|NCT01987765|64751721|FG000|Overall Study|Lost to Follow-up|37|||
23274836|NCT00573066|64751724|FG000|Overall Study|Exclusion criteria|18|||
23274837|NCT00573066|64751724|FG000|Overall Study|IV malfunction|1|||
23274838|NCT00573066|64751724|FG000|Overall Study|Postoperative bleeding|1|||
23274839|NCT02563561|64751725|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
23274840|NCT02563561|64751726|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
23274841|NCT02563561|64751727|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
23274842|NCT02563561|64751725|FG000|Overall Study|Withdrew of Consent|1|||
23274843|NCT02563561|64751726|FG001|Overall Study|Withdrew of Consent|1|||
23274844|NCT02563561|64751727|FG002|Overall Study|Withdrew of Consent|2|||
23274845|NCT02563561|64751725|FG000|Overall Study|Lost to Follow-up|1|||
23274846|NCT02563561|64751726|FG001|Overall Study|Lost to Follow-up|1|||
23274847|NCT02563561|64751727|FG002|Overall Study|Lost to Follow-up|0|||
23274848|NCT02563561|64751725|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
23274849|NCT02563561|64751726|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
23274850|NCT02563561|64751727|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
23274851|NCT02563561|64751725|FG000|Overall Study|Investigator Decision|3|||
23274852|NCT02563561|64751726|FG001|Overall Study|Investigator Decision|4|||
23274853|NCT02563561|64751727|FG002|Overall Study|Investigator Decision|2|||
23274854|NCT02563561|64751725|FG000|Overall Study|Sponsor Decision|5|||
23274855|NCT02563561|64751726|FG001|Overall Study|Sponsor Decision|2|||
23274856|NCT02563561|64751727|FG002|Overall Study|Sponsor Decision|4|||
23274857|NCT02563561|64751725|FG000|Overall Study|Other|1|||
23602530|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
23602531|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602532|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602533|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602534|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602535|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602536|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602537|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602538|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602539|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
23602540|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602541|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602542|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602543|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602544|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602545|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
23274858|NCT02563561|64751726|FG001|Overall Study|Other|5|||
23274859|NCT02563561|64751727|FG002|Overall Study|Other|2|||
23274860|NCT01473953|64751728|FG000|Overall Study|Other|1|||
23274861|NCT01473953|64751729|FG001|Overall Study|Other|0|||
23274862|NCT01473953|64751730|FG002|Overall Study|Other|0|||
23274863|NCT01473953|64751731|FG003|Overall Study|Other|0|||
23368447|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
23368448|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
23368449|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
23368450|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
23368451|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
23368452|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
23368453|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
23368454|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
23368455|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
23368456|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
23368457|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
23368458|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
23368459|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
23368460|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
23368461|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
23274864|NCT01473953|64751732|FG004|Overall Study|Other|0|||
23274865|NCT01981720|64751734|FG000|Overall Study|Adverse Event|1|||
23274866|NCT01981720|64751734|FG000|Overall Study|Withdrawal by Subject|3|||
23368462|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
23368463|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
23368464|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
23368465|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
23368466|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
23368467|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
23368468|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
23368469|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
23368470|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
23368471|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
23368472|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
23368473|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
23368474|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
23368475|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
23368476|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
23368477|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
23368478|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
23368479|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
23368480|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
23368481|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
23274867|NCT01981720|64751734|FG000|Overall Study|Pregnancy|1|||
23274868|NCT00003659|64751737|FG000|Overall Study|Withdrawal by Subject|3|||
23274869|NCT00857623|64751738|FG000|Overall Study|Adverse Event|5|||
23274870|NCT00857623|64751739|FG001|Overall Study|Adverse Event|2|||
23274871|NCT00857623|64751738|FG000|Overall Study|Study-specific discontinuation criteria|5|||
23274872|NCT00857623|64751739|FG001|Overall Study|Study-specific discontinuation criteria|3|||
23274873|NCT00857623|64751738|FG000|Overall Study|Withdrawal by Subject|2|||
23368482|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
23368483|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
23368484|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
23368485|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
23368486|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
23368487|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
23368488|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
23368489|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
23368490|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
23274874|NCT00857623|64751739|FG001|Overall Study|Withdrawal by Subject|1|||
23274875|NCT00857623|64751738|FG000|Overall Study|Lack of Efficacy|1|||
23274876|NCT00857623|64751739|FG001|Overall Study|Lack of Efficacy|1|||
23274877|NCT00857623|64751738|FG000|Overall Study|Severe non-compliance to protocol|1|||
23274878|NCT00857623|64751739|FG001|Overall Study|Severe non-compliance to protocol|1|||
23274879|NCT00857623|64751738|FG000|Overall Study|Intake of prohibited medication|0|||
23274880|NCT00857623|64751739|FG001|Overall Study|Intake of prohibited medication|1|||
23274881|NCT00857623|64751738|FG000|Overall Study|Positive for HEP C|0|||
23368491|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
23368492|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
23368493|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
23368494|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
23368495|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
23368496|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
23368497|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
23368498|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
23368499|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
23368500|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
23368501|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
23368502|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
23368503|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
23368504|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
23368505|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
23368506|NCT02717195|65096030|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
23368507|NCT02717195|65096031|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
23368508|NCT02717195|65096032|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
23201319|NCT03633227|64476694|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
23274882|NCT00857623|64751739|FG001|Overall Study|Positive for HEP C|1|||
23274883|NCT01792635|64751740|FG000|Part B|Adverse Event|0|||
23274884|NCT01792635|64751741|FG001|Part B|Adverse Event|0|||
23274885|NCT01792635|64751742|FG002|Part B|Adverse Event|1|||
23274886|NCT01792635|64751740|FG000|Part B|Study terminated|0|||
23274887|NCT01792635|64751741|FG001|Part B|Study terminated|4|||
23274888|NCT01792635|64751742|FG002|Part B|Study terminated|3|||
23274889|NCT02159183|64751746|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
23274890|NCT02159183|64751747|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
23274891|NCT02159183|64751746|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
23274892|NCT02159183|64751747|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
23274893|NCT02159183|64751746|FG000|Analysis After the 36 Months Follow-up|Death|0|||
23274894|NCT02159183|64751747|FG001|Analysis After the 36 Months Follow-up|Death|1|||
23274895|NCT02159183|64751746|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
23274896|NCT02159183|64751747|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
23274897|NCT02159183|64751746|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
23274898|NCT02159183|64751747|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
23274899|NCT00488774|64751751|FG000|Overall Study|Withdrawal of consent|2|||
23274900|NCT00488774|64751752|FG001|Overall Study|Withdrawal of consent|2|||
23274901|NCT00488774|64751753|FG002|Overall Study|Withdrawal of consent|2|||
23274902|NCT00488774|64751754|FG003|Overall Study|Withdrawal of consent|0|||
23274903|NCT00488774|64751751|FG000|Overall Study|Other|6|||
23274904|NCT00488774|64751752|FG001|Overall Study|Other|3|||
23274905|NCT00488774|64751753|FG002|Overall Study|Other|2|||
23274906|NCT00488774|64751754|FG003|Overall Study|Other|2|||
23274907|NCT00488774|64751751|FG000|Overall Study|Lost to Follow-up|0|||
23274908|NCT00488774|64751752|FG001|Overall Study|Lost to Follow-up|0|||
23274909|NCT00488774|64751753|FG002|Overall Study|Lost to Follow-up|1|||
23274910|NCT00488774|64751754|FG003|Overall Study|Lost to Follow-up|1|||
23274911|NCT00001703|64751755|FG000|Overall Study|progressed disease|2|||
23274912|NCT00001703|64751755|FG000|Overall Study|No evidence of disease|1|||
23274913|NCT00001703|64751755|FG000|Overall Study|recurrent disease|2|||
23274914|NCT01370733|64751758|FG000|Overall Study|Withdrawal by Subject|8|||
23274915|NCT01370733|64751759|FG001|Overall Study|Withdrawal by Subject|8|||
23274916|NCT01370733|64751758|FG000|Overall Study|Lost to Follow-up|3|||
23274917|NCT01370733|64751759|FG001|Overall Study|Lost to Follow-up|0|||
23274918|NCT01370733|64751758|FG000|Overall Study|Adverse Event|2|||
23274919|NCT01370733|64751759|FG001|Overall Study|Adverse Event|4|||
23274920|NCT01370733|64751758|FG000|Overall Study|Lack of Efficacy|3|||
23274921|NCT01370733|64751759|FG001|Overall Study|Lack of Efficacy|5|||
23274922|NCT01370733|64751758|FG000|Overall Study|Physician Decision|0|||
23368509|NCT02717195|65096033|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
23484465|NCT00761150|65516032|FG000|Open-label Period|Withdrawal by Subject|5|||
23274923|NCT01370733|64751759|FG001|Overall Study|Physician Decision|2|||
23274924|NCT01370733|64751758|FG000|Overall Study|Protocol Violation|1|||
23274925|NCT01370733|64751759|FG001|Overall Study|Protocol Violation|3|||
23274926|NCT00448591|64751760|FG000|Overall Study|Withdrawal by Subject|178|||
23274927|NCT00448591|64751760|FG000|Overall Study|Progressive Disease|1382|||
23274928|NCT00448591|64751760|FG000|Overall Study|Adverse Event|382|||
23274929|NCT00448591|64751760|FG000|Overall Study|Protocol Violation|41|||
23274930|NCT00448591|64751760|FG000|Overall Study|Lost to Follow-up|19|||
23274931|NCT00448591|64751760|FG000|Overall Study|Treatment Regimen Completed|70|||
23274932|NCT00448591|64751760|FG000|Overall Study|Other|154|||
23274933|NCT00448591|64751760|FG000|Overall Study|Termination of Study|70|||
23274934|NCT00286754|64751761|FG000|Overall Study|Adverse Event|2|||
23274935|NCT00286754|64751762|FG001|Overall Study|Adverse Event|2|||
23274936|NCT00286754|64751763|FG002|Overall Study|Adverse Event|3|||
23274937|NCT00286754|64751761|FG000|Overall Study|Withdrawal by Subject|6|||
23274938|NCT00286754|64751762|FG001|Overall Study|Withdrawal by Subject|2|||
23274939|NCT00286754|64751763|FG002|Overall Study|Withdrawal by Subject|0|||
23274940|NCT00286754|64751761|FG000|Overall Study|Lost to Follow-up|12|||
23274941|NCT00286754|64751762|FG001|Overall Study|Lost to Follow-up|14|||
23274942|NCT00286754|64751763|FG002|Overall Study|Lost to Follow-up|6|||
23274943|NCT00286754|64751761|FG000|Overall Study|Moved out of state|0|||
23274944|NCT00286754|64751762|FG001|Overall Study|Moved out of state|0|||
23274945|NCT00286754|64751763|FG002|Overall Study|Moved out of state|1|||
23274946|NCT01841554|64751764|FG000|Overall Study|Death|7|||
23274947|NCT01841554|64751764|FG000|Overall Study|No Implantation|1|||
23368510|NCT02717195|65096034|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
23368511|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
23368512|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
23368513|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
23368514|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
23274948|NCT01841554|64751764|FG000|Overall Study|Discontinued Follow Up|5|||
23274949|NCT01841554|64751764|FG000|Overall Study|Study exit due to secondary intervention|6|||
23274950|NCT03161405|64751778|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
23274951|NCT00312663|64751779|FG000|Immunization Phase|Adverse Event|0|||
23274952|NCT00312663|64751780|FG001|Immunization Phase|Adverse Event|1|||
23274953|NCT00312663|64751781|FG002|Immunization Phase|Adverse Event|0|||
23274954|NCT00465270|64751782|FG000|Overall Study|Death|7|||
23274955|NCT00465270|64751783|FG001|Overall Study|Death|11|||
23274956|NCT00465270|64751782|FG000|Overall Study|Withdrawal by Subject|34|||
23274957|NCT00465270|64751783|FG001|Overall Study|Withdrawal by Subject|78|||
23274958|NCT00465270|64751782|FG000|Overall Study|Lost to Follow-up|60|||
23274959|NCT00465270|64751783|FG001|Overall Study|Lost to Follow-up|67|||
23274960|NCT00465270|64751782|FG000|Overall Study|Investigator request|3|||
23274961|NCT00465270|64751783|FG001|Overall Study|Investigator request|4|||
23274962|NCT02139826|64751785|FG000|Overall Study|Adverse Event|1|||
23274963|NCT02193165|64751786|FG000|4 Week Product Use|Lost to Follow-up|1|||
23274964|NCT02193165|64751787|FG001|4 Week Product Use|Lost to Follow-up|1|||
23274965|NCT02193165|64751788|FG002|4 Week Product Use|Lost to Follow-up|1|||
23274966|NCT02193165|64751786|FG000|6 Week Product Use|Lost to Follow-up|0|||
23274967|NCT02193165|64751787|FG001|6 Week Product Use|Lost to Follow-up|1|||
23274968|NCT02193165|64751788|FG002|6 Week Product Use|Lost to Follow-up|0|||
23274969|NCT04533594|64751789|FG000|Overall Study|Death|26|||
23274970|NCT01844375|64751792|FG000|Overall Study|Protocol Violation|1|||
23274971|NCT01844375|64751793|FG001|Overall Study|Protocol Violation|1|||
23274972|NCT00319735|64751794|FG000|Overall Study|Death|2|||
23274973|NCT00239577|64751795|FG000|Primary Phase|Adverse Event|0|||
23274974|NCT00239577|64751796|FG001|Primary Phase|Adverse Event|0|||
23274975|NCT00239577|64751797|FG002|Primary Phase|Adverse Event|1|||
23274976|NCT00239577|64751798|FG003|Primary Phase|Adverse Event|0|||
23274977|NCT00239577|64751795|FG000|Primary Phase|Other|5|||
23368515|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
23368516|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
23368517|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
23368518|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
23368519|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
23368520|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
23368521|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
23368522|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
23368523|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
23368524|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
23368525|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
23368526|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
23368527|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
23274978|NCT00239577|64751796|FG001|Primary Phase|Other|3|||
23274979|NCT00239577|64751797|FG002|Primary Phase|Other|2|||
23368528|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
23368529|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
23368530|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
23274980|NCT00239577|64751798|FG003|Primary Phase|Other|0|||
23274981|NCT01534520|64751799|FG000|Overall Study|Adverse Event|0|||
23274982|NCT01534520|64751800|FG001|Overall Study|Adverse Event|1|||
23274983|NCT00986245|64751801|FG000|First Intervention|Poor compliance|8|||
23274984|NCT00986245|64751802|FG001|First Intervention|Poor compliance|4|||
23274985|NCT00986245|64751801|FG000|First Intervention|Lack of Efficacy|1|||
23274986|NCT00986245|64751802|FG001|First Intervention|Lack of Efficacy|2|||
23274987|NCT00986245|64751801|FG000|First Intervention|Withdrawal by Subject|0|||
23274988|NCT00986245|64751802|FG001|First Intervention|Withdrawal by Subject|1|||
23274989|NCT00986245|64751801|FG000|First Intervention|Protocol Violation|0|||
23274990|NCT00986245|64751802|FG001|First Intervention|Protocol Violation|1|||
23274991|NCT00986245|64751801|FG000|First Intervention|Out of indication|1|||
23274992|NCT00986245|64751802|FG001|First Intervention|Out of indication|0|||
23274993|NCT00986245|64751801|FG000|Second Intervention|Poor compliance|1|||
23274994|NCT00986245|64751802|FG001|Second Intervention|Poor compliance|0|||
23274995|NCT00986245|64751801|FG000|Second Intervention|Lost to Follow-up|1|||
23274996|NCT00986245|64751802|FG001|Second Intervention|Lost to Follow-up|0|||
23274997|NCT00986245|64751801|FG000|Second Intervention|Protocol Violation|0|||
23274998|NCT00986245|64751802|FG001|Second Intervention|Protocol Violation|1|||
23274999|NCT03673670|64751803|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
23275000|NCT03673670|64751804|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23275001|NCT03673670|64751805|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23275002|NCT03673670|64751806|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23275003|NCT03673670|64751807|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23275004|NCT03673670|64751808|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
23275005|NCT03673670|64751803|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
23275006|NCT03673670|64751804|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
23275007|NCT03673670|64751805|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
23275008|NCT03673670|64751806|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
23275009|NCT03673670|64751807|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
23275010|NCT03673670|64751808|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
23275011|NCT03673670|64751803|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
23275012|NCT03673670|64751804|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
23275013|NCT03673670|64751805|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
23275014|NCT03673670|64751806|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
23275015|NCT03673670|64751807|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
23275016|NCT03673670|64751808|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
23275017|NCT03673670|64751803|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23275018|NCT03673670|64751804|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23275019|NCT03673670|64751805|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23275020|NCT03673670|64751806|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23275021|NCT03673670|64751807|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
23275022|NCT03673670|64751808|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
23275023|NCT03673670|64751803|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
23275024|NCT03673670|64751804|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
23275025|NCT03673670|64751805|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
23275026|NCT03673670|64751806|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
23368531|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23368532|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
23368533|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
23368534|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
23368535|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
23368536|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
23368537|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
23368538|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
23368539|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
23368540|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
23368541|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
23368542|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
23368543|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
23368544|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
23368545|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
23368546|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
23368547|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
23368548|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
23368549|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
23484466|NCT00761150|65516033|FG001|Open-label Period|Withdrawal by Subject|0|||
23484467|NCT00761150|65516034|FG002|Open-label Period|Withdrawal by Subject|0|||
23275027|NCT03673670|64751807|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
23275028|NCT03673670|64751808|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
23275029|NCT03673670|64751803|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23275030|NCT03673670|64751804|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23275031|NCT03673670|64751805|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23275032|NCT03673670|64751806|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23275033|NCT03673670|64751807|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
23368550|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
23368551|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
23368552|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
23368553|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
23368554|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
23368555|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
23368556|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
23368557|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
23368558|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
23368559|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
23368560|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
23368561|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
23368562|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
23368563|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
23368564|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
23368565|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
23368566|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
23368567|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
23368568|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
23368569|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
23368570|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
23368571|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
23368572|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
23368573|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
23368574|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
23368575|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
23368576|NCT02717195|65096030|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
23368577|NCT02717195|65096031|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
23368578|NCT02717195|65096032|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
23368579|NCT02717195|65096033|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
23368580|NCT02717195|65096034|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
23368581|NCT00264147|65096035|FG000|Treatment I Period|Adverse Event|3|||
23368582|NCT00264147|65096036|FG001|Treatment I Period|Adverse Event|6|||
23368583|NCT00264147|65096037|FG002|Treatment I Period|Adverse Event|3|||
23275034|NCT03673670|64751808|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
23275035|NCT03673670|64751803|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
23275036|NCT03673670|64751804|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
23275037|NCT03673670|64751805|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
23275038|NCT03673670|64751806|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
23275039|NCT03673670|64751807|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
23275040|NCT03673670|64751808|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
23602546|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
23275041|NCT01536574|64751810|FG000|Overall Study|Adverse Event|4|||
23275042|NCT01536574|64751811|FG001|Overall Study|Adverse Event|5|||
23275043|NCT01536574|64751810|FG000|Overall Study|Withdrawal by Subject|1|||
23275044|NCT01536574|64751811|FG001|Overall Study|Withdrawal by Subject|2|||
23275045|NCT01536574|64751810|FG000|Overall Study|Lack of Efficacy|1|||
23275046|NCT01536574|64751811|FG001|Overall Study|Lack of Efficacy|0|||
23275047|NCT00392665|64751812|FG000|Overall Study|Death|16|||
23275048|NCT00392665|64751813|FG001|Overall Study|Death|14|||
23602547|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602548|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602549|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602550|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602551|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602552|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
23275049|NCT00392665|64751812|FG000|Overall Study|Lost to Follow-up|1|||
23275050|NCT00392665|64751813|FG001|Overall Study|Lost to Follow-up|1|||
23275051|NCT02422264|64751819|FG000|Overall Study|Serious Adverse Event|1|||
23275052|NCT02422264|64751820|FG001|Overall Study|Serious Adverse Event|0|||
23275053|NCT02422264|64751819|FG000|Overall Study|Withdrawal by Subject|1|||
23368584|NCT00264147|65096038|FG003|Treatment I Period|Adverse Event|5|||
23368585|NCT00264147|65096039|FG004|Treatment I Period|Adverse Event|7|||
23368586|NCT00264147|65096040|FG005|Treatment I Period|Adverse Event|0|||
23368587|NCT00264147|65096035|FG000|Treatment I Period|Laboratory Adverse Event|0|||
23368588|NCT00264147|65096036|FG001|Treatment I Period|Laboratory Adverse Event|0|||
23368589|NCT00264147|65096037|FG002|Treatment I Period|Laboratory Adverse Event|0|||
23368590|NCT00264147|65096038|FG003|Treatment I Period|Laboratory Adverse Event|1|||
23368591|NCT00264147|65096039|FG004|Treatment I Period|Laboratory Adverse Event|0|||
23368592|NCT00264147|65096040|FG005|Treatment I Period|Laboratory Adverse Event|0|||
23368593|NCT00264147|65096035|FG000|Treatment I Period|Lack of Efficacy|6|||
23368594|NCT00264147|65096036|FG001|Treatment I Period|Lack of Efficacy|2|||
23368595|NCT00264147|65096037|FG002|Treatment I Period|Lack of Efficacy|8|||
23368596|NCT00264147|65096038|FG003|Treatment I Period|Lack of Efficacy|0|||
23368597|NCT00264147|65096039|FG004|Treatment I Period|Lack of Efficacy|1|||
23368598|NCT00264147|65096040|FG005|Treatment I Period|Lack of Efficacy|0|||
23368599|NCT00264147|65096035|FG000|Treatment I Period|Lost to Follow-up|1|||
23368600|NCT00264147|65096036|FG001|Treatment I Period|Lost to Follow-up|0|||
23368601|NCT00264147|65096037|FG002|Treatment I Period|Lost to Follow-up|0|||
23368602|NCT00264147|65096038|FG003|Treatment I Period|Lost to Follow-up|1|||
23368603|NCT00264147|65096039|FG004|Treatment I Period|Lost to Follow-up|1|||
23368604|NCT00264147|65096040|FG005|Treatment I Period|Lost to Follow-up|0|||
23368605|NCT00264147|65096035|FG000|Treatment I Period|Protocol Violation|2|||
23368606|NCT00264147|65096036|FG001|Treatment I Period|Protocol Violation|2|||
23368607|NCT00264147|65096037|FG002|Treatment I Period|Protocol Violation|0|||
23368608|NCT00264147|65096038|FG003|Treatment I Period|Protocol Violation|0|||
23368609|NCT00264147|65096039|FG004|Treatment I Period|Protocol Violation|0|||
23368610|NCT00264147|65096040|FG005|Treatment I Period|Protocol Violation|0|||
23368611|NCT00264147|65096035|FG000|Treatment I Period|Withdrawal by Subject|2|||
23368612|NCT00264147|65096036|FG001|Treatment I Period|Withdrawal by Subject|0|||
23368613|NCT00264147|65096037|FG002|Treatment I Period|Withdrawal by Subject|0|||
23368614|NCT00264147|65096038|FG003|Treatment I Period|Withdrawal by Subject|2|||
23368615|NCT00264147|65096039|FG004|Treatment I Period|Withdrawal by Subject|2|||
23368616|NCT00264147|65096040|FG005|Treatment I Period|Withdrawal by Subject|0|||
23275054|NCT02422264|64751820|FG001|Overall Study|Withdrawal by Subject|2|||
23275055|NCT02422264|64751819|FG000|Overall Study|Migrated/moved from study area|3|||
23275056|NCT02422264|64751820|FG001|Overall Study|Migrated/moved from study area|1|||
23275057|NCT02422264|64751819|FG000|Overall Study|Subject vaccinated outside of the study|0|||
23275058|NCT02422264|64751820|FG001|Overall Study|Subject vaccinated outside of the study|1|||
23275059|NCT01294787|64751821|FG000|Period 1|Adverse Event|0|||
23368617|NCT00264147|65096035|FG000|Treatment I Period|Patient out of town for an extended time|0|||
23368618|NCT00264147|65096036|FG001|Treatment I Period|Patient out of town for an extended time|1|||
23368619|NCT00264147|65096037|FG002|Treatment I Period|Patient out of town for an extended time|0|||
23275060|NCT01294787|64751822|FG001|Period 1|Adverse Event|0|||
23275061|NCT01294787|64751823|FG002|Period 1|Adverse Event|0|||
23275062|NCT01294787|64751824|FG003|Period 1|Adverse Event|0|||
23275063|NCT01294787|64751825|FG004|Period 1|Adverse Event|1|||
23275064|NCT01294787|64751826|FG005|Period 1|Adverse Event|0|||
23275065|NCT01294787|64751821|FG000|Period 1|Withdrawal by Subject|0|||
23275066|NCT01294787|64751822|FG001|Period 1|Withdrawal by Subject|0|||
23275067|NCT01294787|64751823|FG002|Period 1|Withdrawal by Subject|0|||
23275068|NCT01294787|64751824|FG003|Period 1|Withdrawal by Subject|1|||
23275069|NCT01294787|64751825|FG004|Period 1|Withdrawal by Subject|1|||
23275070|NCT01294787|64751826|FG005|Period 1|Withdrawal by Subject|1|||
23275071|NCT01294787|64751821|FG000|Period 1|Administrative problem|0|||
23275072|NCT01294787|64751822|FG001|Period 1|Administrative problem|0|||
23275073|NCT01294787|64751823|FG002|Period 1|Administrative problem|1|||
23275074|NCT01294787|64751824|FG003|Period 1|Administrative problem|0|||
23275075|NCT01294787|64751825|FG004|Period 1|Administrative problem|0|||
23368620|NCT00264147|65096038|FG003|Treatment I Period|Patient out of town for an extended time|0|||
23368621|NCT00264147|65096039|FG004|Treatment I Period|Patient out of town for an extended time|0|||
23275076|NCT01294787|64751826|FG005|Period 1|Administrative problem|1|||
23275077|NCT01294787|64751821|FG000|Period 2|Adverse Event|0|||
23275078|NCT01294787|64751822|FG001|Period 2|Adverse Event|3|||
23275079|NCT01294787|64751823|FG002|Period 2|Adverse Event|0|||
23275080|NCT01294787|64751824|FG003|Period 2|Adverse Event|1|||
23484468|NCT00761150|65516032|FG000|Open-label Period|Noncompliance|2|||
23275081|NCT01294787|64751825|FG004|Period 2|Adverse Event|0|||
23275082|NCT01294787|64751826|FG005|Period 2|Adverse Event|0|||
23275083|NCT01294787|64751821|FG000|Period 2|No longer needs study drug|0|||
23275084|NCT01294787|64751822|FG001|Period 2|No longer needs study drug|0|||
23368622|NCT00264147|65096040|FG005|Treatment I Period|Patient out of town for an extended time|0|||
23368623|NCT00264147|65096035|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23368624|NCT00264147|65096036|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23368625|NCT00264147|65096037|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
23368626|NCT00264147|65096038|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23484469|NCT00761150|65516033|FG001|Open-label Period|Noncompliance|0|||
23484470|NCT00761150|65516034|FG002|Open-label Period|Noncompliance|0|||
23484471|NCT00761150|65516032|FG000|Open-label Period|Other|5|||
23484472|NCT00761150|65516033|FG001|Open-label Period|Other|0|||
23484473|NCT00761150|65516034|FG002|Open-label Period|Other|0|||
23484474|NCT00761150|65516032|FG000|Double-blind Period|Lack of Efficacy|0|||
23484475|NCT00761150|65516033|FG001|Double-blind Period|Lack of Efficacy|2|||
23484476|NCT00761150|65516034|FG002|Double-blind Period|Lack of Efficacy|19|||
23484477|NCT00761150|65516032|FG000|Double-blind Period|Adverse Event|0|||
23484478|NCT00761150|65516033|FG001|Double-blind Period|Adverse Event|3|||
23484479|NCT00761150|65516034|FG002|Double-blind Period|Adverse Event|3|||
23484480|NCT00761150|65516032|FG000|Double-blind Period|Withdrawal by Subject|0|||
23484481|NCT00761150|65516033|FG001|Double-blind Period|Withdrawal by Subject|3|||
23484482|NCT00761150|65516034|FG002|Double-blind Period|Withdrawal by Subject|2|||
23484483|NCT00761150|65516032|FG000|Double-blind Period|Lost to Follow-up|0|||
23484484|NCT00761150|65516033|FG001|Double-blind Period|Lost to Follow-up|2|||
23484485|NCT00761150|65516034|FG002|Double-blind Period|Lost to Follow-up|1|||
23484486|NCT00761150|65516032|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
23484487|NCT00761150|65516033|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
23484488|NCT00761150|65516034|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
23484489|NCT00761150|65516032|FG000|Double-blind Period|Noncompliance|0|||
23484490|NCT00761150|65516033|FG001|Double-blind Period|Noncompliance|1|||
23484491|NCT00761150|65516034|FG002|Double-blind Period|Noncompliance|0|||
23484492|NCT00761150|65516032|FG000|Double-blind Period|Other|0|||
23484493|NCT00761150|65516033|FG001|Double-blind Period|Other|3|||
23484494|NCT00761150|65516034|FG002|Double-blind Period|Other|3|||
23484495|NCT00993044|65516038|FG000|Irinotecan 50 mg|Physician Decision|1|||
23484496|NCT00920907|65516039|FG000|Induction Period|Adverse Event|0|||
23484497|NCT00920907|65516040|FG001|Induction Period|Adverse Event|2|||
23484498|NCT00920907|65516039|FG000|Induction Period|Death|1|||
23484499|NCT00920907|65516040|FG001|Induction Period|Death|1|||
23484500|NCT00920907|65516039|FG000|Induction Period|Disease Progression|12|||
23484501|NCT00920907|65516040|FG001|Induction Period|Disease Progression|11|||
23484502|NCT00920907|65516039|FG000|Induction Period|Study Drug Toxicity|8|||
23484503|NCT00920907|65516040|FG001|Induction Period|Study Drug Toxicity|6|||
23275085|NCT01294787|64751823|FG002|Period 2|No longer needs study drug|0|||
23275086|NCT01294787|64751824|FG003|Period 2|No longer needs study drug|1|||
23275087|NCT01294787|64751825|FG004|Period 2|No longer needs study drug|0|||
23275088|NCT01294787|64751826|FG005|Period 2|No longer needs study drug|0|||
23275089|NCT01294787|64751821|FG000|Period 3|Adverse Event|0|||
23275090|NCT01294787|64751822|FG001|Period 3|Adverse Event|0|||
23275091|NCT01294787|64751823|FG002|Period 3|Adverse Event|0|||
23275092|NCT01294787|64751824|FG003|Period 3|Adverse Event|0|||
23275093|NCT01294787|64751825|FG004|Period 3|Adverse Event|1|||
23275094|NCT01294787|64751826|FG005|Period 3|Adverse Event|0|||
23275095|NCT03912337|64751829|FG000|Overall Study|Withdrawal of Consent From Study|1|||
23275096|NCT03912337|64751830|FG001|Overall Study|Withdrawal of Consent From Study|0|||
23275097|NCT03912337|64751829|FG000|Overall Study|Lost to Follow-up|1|||
23275098|NCT03912337|64751830|FG001|Overall Study|Lost to Follow-up|1|||
23275099|NCT02847650|64751833|FG000|Overall Study|Adverse Event|2|||
23275100|NCT02847650|64751834|FG001|Overall Study|Adverse Event|4|||
23275101|NCT02847650|64751833|FG000|Overall Study|Lost to Follow-up|1|||
23275102|NCT02847650|64751834|FG001|Overall Study|Lost to Follow-up|0|||
23275103|NCT02847650|64751833|FG000|Overall Study|Protocol Violation|0|||
23275104|NCT02847650|64751834|FG001|Overall Study|Protocol Violation|1|||
23275105|NCT02847650|64751833|FG000|Overall Study|Withdrawal by Subject|1|||
23275106|NCT02847650|64751834|FG001|Overall Study|Withdrawal by Subject|1|||
23275107|NCT03988803|64751835|FG000|Period 2|Prematurely discontinued from medication|2|||
23275108|NCT03988803|64751835|FG000|Period 2|Adverse Event|1|||
23275109|NCT02294786|64751836|FG000|Overall Study|Withdrawal by Subject|0|||
23275110|NCT02294786|64751837|FG001|Overall Study|Withdrawal by Subject|1|||
23275111|NCT02294786|64751836|FG000|Overall Study|Physician Decision|6|||
23484504|NCT00920907|65516039|FG000|Induction Period|No longer meets study criteria|0|||
23484505|NCT00920907|65516040|FG001|Induction Period|No longer meets study criteria|1|||
23275112|NCT02294786|64751837|FG001|Overall Study|Physician Decision|7|||
23275113|NCT02294786|64751836|FG000|Overall Study|Lost to Follow-up|1|||
23484506|NCT00920907|65516039|FG000|Induction Period|Withdrawal by Subject|1|||
23484507|NCT00920907|65516040|FG001|Induction Period|Withdrawal by Subject|1|||
23484508|NCT00920907|65516039|FG000|Maintenance Period|Disease Progression|3|||
23275114|NCT02294786|64751837|FG001|Overall Study|Lost to Follow-up|2|||
23275115|NCT02294786|64751836|FG000|Overall Study|Protocol Violation|1|||
23275116|NCT02294786|64751837|FG001|Overall Study|Protocol Violation|0|||
23484509|NCT00920907|65516040|FG001|Maintenance Period|Disease Progression|7|||
23484510|NCT00920907|65516039|FG000|Maintenance Period|Administrative (study closure)|7|||
23484511|NCT00920907|65516040|FG001|Maintenance Period|Administrative (study closure)|2|||
23484512|NCT00920907|65516039|FG000|Maintenance Period|Study Drug Toxicity|0|||
23484513|NCT00920907|65516040|FG001|Maintenance Period|Study Drug Toxicity|2|||
23484514|NCT00920907|65516039|FG000|Maintenance Period|Death|1|||
23484515|NCT00920907|65516040|FG001|Maintenance Period|Death|1|||
23484516|NCT00920907|65516039|FG000|Maintenance Period|Withdrawal by Subject|1|||
23484517|NCT00920907|65516040|FG001|Maintenance Period|Withdrawal by Subject|0|||
23484518|NCT00920907|65516039|FG000|Maintenance Period|Adverse Event|0|||
23484519|NCT00920907|65516040|FG001|Maintenance Period|Adverse Event|1|||
23484520|NCT00459979|65516041|FG000|Overall Study|Withdrawal by Subject|1|||
23484521|NCT00459979|65516041|FG000|Overall Study|Protocol Violation|1|||
23484522|NCT01117792|65518593|FG000|Overall Study|Death|1|||
23484523|NCT01117792|65518593|FG000|Overall Study|Adverse Event|3|||
23484524|NCT00504582|65518594|FG000|Overall Study|Lost to Follow-up|1|||
23484525|NCT00504582|65518595|FG001|Overall Study|Lost to Follow-up|0|||
23484526|NCT00504582|65518596|FG002|Overall Study|Lost to Follow-up|0|||
23484527|NCT04050371|65518600|FG000|Overall Study|Withdrawal by Subject|1|||
23484528|NCT04050371|65518601|FG001|Overall Study|Withdrawal by Subject|0|||
23484529|NCT04854642|65518602|FG000|Overall Study|Adverse Event|1|||
23484530|NCT04854642|65518603|FG001|Overall Study|Adverse Event|2|||
23484531|NCT04854642|65518602|FG000|Overall Study|Withdrawal by Subject|0|||
23484532|NCT04854642|65518603|FG001|Overall Study|Withdrawal by Subject|1|||
23484533|NCT02233946|65518604|FG000|Baseline|Withdrawal by Subject|2|||
23484534|NCT02233946|65518605|FG001|Baseline|Withdrawal by Subject|0|||
23484535|NCT02233946|65518604|FG000|3-months Follow-up|Lost to Follow-up|53|||
23484536|NCT02233946|65518605|FG001|3-months Follow-up|Lost to Follow-up|29|||
23484537|NCT02233946|65518604|FG000|6-months Follow-up|Lost to Follow-up|21|||
23484538|NCT02233946|65518605|FG001|6-months Follow-up|Lost to Follow-up|2|||
23484539|NCT02233946|65518604|FG000|9-month Follow-up|Lost to Follow-up|20|||
23484540|NCT02233946|65518605|FG001|9-month Follow-up|Lost to Follow-up|11|||
23275117|NCT02294786|64751836|FG000|Overall Study|Adverse Event|1|||
23275118|NCT02294786|64751837|FG001|Overall Study|Adverse Event|1|||
23275119|NCT02294786|64751836|FG000|Overall Study|Death|2|||
23275120|NCT02294786|64751837|FG001|Overall Study|Death|3|||
23275121|NCT01629381|64751838|FG000|Overall Study|Withdrawal by Subject|2|||
23275122|NCT01629381|64751839|FG001|Overall Study|Withdrawal by Subject|5|||
23275123|NCT02089997|64751840|FG000|Overall Study|Case report forms uncollected|99|||
23275124|NCT02089997|64751840|FG000|Overall Study|Protocol Violation|147|||
23275125|NCT02336165|64751848|FG000|Overall Study|Death|3|||
23275126|NCT02336165|64751849|FG001|Overall Study|Death|0|||
23275127|NCT02336165|64751850|FG002|Overall Study|Death|0|||
23275128|NCT02336165|64751851|FG003|Overall Study|Death|0|||
23275129|NCT02336165|64751852|FG004|Overall Study|Death|1|||
23275130|NCT02336165|64751848|FG000|Overall Study|Physician Decision|2|||
23275131|NCT02336165|64751849|FG001|Overall Study|Physician Decision|2|||
23275132|NCT02336165|64751850|FG002|Overall Study|Physician Decision|1|||
23275133|NCT02336165|64751851|FG003|Overall Study|Physician Decision|1|||
23275134|NCT02336165|64751852|FG004|Overall Study|Physician Decision|0|||
23275135|NCT02336165|64751848|FG000|Overall Study|Withdrawal by Subject|0|||
23275136|NCT02336165|64751849|FG001|Overall Study|Withdrawal by Subject|0|||
23275137|NCT02336165|64751850|FG002|Overall Study|Withdrawal by Subject|1|||
23275138|NCT02336165|64751851|FG003|Overall Study|Withdrawal by Subject|0|||
23275139|NCT02336165|64751852|FG004|Overall Study|Withdrawal by Subject|1|||
23275140|NCT02336165|64751848|FG000|Overall Study|Adverse Event|4|||
23275141|NCT02336165|64751849|FG001|Overall Study|Adverse Event|1|||
23275142|NCT02336165|64751850|FG002|Overall Study|Adverse Event|2|||
23275143|NCT02336165|64751851|FG003|Overall Study|Adverse Event|4|||
23275144|NCT02336165|64751852|FG004|Overall Study|Adverse Event|1|||
23275145|NCT02336165|64751848|FG000|Overall Study|Progressive disease|23|||
23275146|NCT02336165|64751849|FG001|Overall Study|Progressive disease|22|||
23275147|NCT02336165|64751850|FG002|Overall Study|Progressive disease|27|||
23484541|NCT02233946|65518604|FG000|12-month Follow-up|Lost to Follow-up|28|||
23484542|NCT02233946|65518605|FG001|12-month Follow-up|Lost to Follow-up|11|||
23484543|NCT01856023|65518606|FG000|Overall Study|Death|1|||
23484544|NCT01856023|65518607|FG001|Overall Study|Death|2|||
23484545|NCT01856023|65518606|FG000|Overall Study|Adverse Event|2|||
23484546|NCT01856023|65518607|FG001|Overall Study|Adverse Event|1|||
23484547|NCT01856023|65518606|FG000|Overall Study|Lack of Efficacy|5|||
23484548|NCT01856023|65518607|FG001|Overall Study|Lack of Efficacy|5|||
23275148|NCT02336165|64751851|FG003|Overall Study|Progressive disease|24|||
23275149|NCT02336165|64751852|FG004|Overall Study|Progressive disease|19|||
23275150|NCT02336165|64751848|FG000|Overall Study|Non-compliance|1|||
23275151|NCT02336165|64751849|FG001|Overall Study|Non-compliance|0|||
23275152|NCT02336165|64751850|FG002|Overall Study|Non-compliance|0|||
23275153|NCT02336165|64751851|FG003|Overall Study|Non-compliance|1|||
23484549|NCT01856023|65518606|FG000|Overall Study|non compliance, study closure|1|||
23484550|NCT01856023|65518607|FG001|Overall Study|non compliance, study closure|3|||
23275154|NCT02336165|64751852|FG004|Overall Study|Non-compliance|0|||
23275155|NCT02336165|64751848|FG000|Overall Study|Other|1|||
23275156|NCT02336165|64751849|FG001|Overall Study|Other|0|||
23484551|NCT01856023|65518606|FG000|Overall Study|Withdrawal by Subject|1|||
23484552|NCT01856023|65518607|FG001|Overall Study|Withdrawal by Subject|1|||
23484553|NCT01727700|65518609|FG000|Overall Study|Adverse Event|0|||
23484554|NCT01727700|65518610|FG001|Overall Study|Adverse Event|7|||
23484555|NCT01727700|65518611|FG002|Overall Study|Adverse Event|1|||
23484556|NCT01727700|65518609|FG000|Overall Study|Particpant withdrew consent|0|||
23484557|NCT01727700|65518610|FG001|Overall Study|Particpant withdrew consent|3|||
23484558|NCT01727700|65518611|FG002|Overall Study|Particpant withdrew consent|1|||
23484559|NCT01727700|65518609|FG000|Overall Study|Protocol Violation|2|||
23484560|NCT01727700|65518610|FG001|Overall Study|Protocol Violation|0|||
23275157|NCT02336165|64751850|FG002|Overall Study|Other|0|||
23275158|NCT02336165|64751851|FG003|Overall Study|Other|1|||
23275159|NCT02336165|64751852|FG004|Overall Study|Other|0|||
23275160|NCT02392000|64751854|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
23275161|NCT02392000|64751854|FG000|Overall Study|Withdrawal by Subject|1|||
23275162|NCT02392000|64751854|FG000|Overall Study|Lost to Follow-up|8|||
23275163|NCT01244620|64751859|FG000|Overall Study|Study terminated|4|||
23275164|NCT01244620|64751860|FG001|Overall Study|Study terminated|4|||
23275165|NCT01244620|64751861|FG002|Overall Study|Study terminated|4|||
23275166|NCT01244620|64751862|FG003|Overall Study|Study terminated|4|||
23275167|NCT03203447|64751865|FG000|Overall Study|Withdrawal by Subject|2|||
23275168|NCT03203447|64751866|FG001|Overall Study|Withdrawal by Subject|1|||
23484561|NCT01727700|65518611|FG002|Overall Study|Protocol Violation|0|||
23484562|NCT02469038|65518615|FG000|Overall Study|Physician Decision|4|||
23484563|NCT02469038|65518616|FG001|Overall Study|Physician Decision|5|||
23484564|NCT00510952|65518632|FG000|Overall Study|Adverse Event|1|||
23484565|NCT00510952|65518633|FG001|Overall Study|Adverse Event|0|||
23484566|NCT00510952|65518632|FG000|Overall Study|Entry Criteria Not Met|3|||
23484567|NCT00510952|65518633|FG001|Overall Study|Entry Criteria Not Met|1|||
23484568|NCT00510952|65518632|FG000|Overall Study|Lost to Follow-up|5|||
23484569|NCT00510952|65518633|FG001|Overall Study|Lost to Follow-up|3|||
23484570|NCT00510952|65518632|FG000|Overall Study|Physician Decision|1|||
23484571|NCT00510952|65518633|FG001|Overall Study|Physician Decision|1|||
23484572|NCT00510952|65518632|FG000|Overall Study|Protocol Violation|7|||
23484573|NCT00510952|65518633|FG001|Overall Study|Protocol Violation|4|||
23484574|NCT00510952|65518632|FG000|Overall Study|Sponsor Decision|1|||
23484575|NCT00510952|65518633|FG001|Overall Study|Sponsor Decision|0|||
23484576|NCT00510952|65518632|FG000|Overall Study|Withdrawal by Subject|6|||
23602553|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602554|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602555|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602556|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602557|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602558|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602559|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
23275169|NCT03203447|64751865|FG000|Overall Study|Lost to Follow-up|1|||
23275170|NCT03203447|64751866|FG001|Overall Study|Lost to Follow-up|10|||
23275171|NCT03203447|64751865|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
23275172|NCT03203447|64751866|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
23275173|NCT00834795|64751867|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
23275174|NCT00834795|64751868|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
23275175|NCT00834795|64751867|FG000|Second Intervention|Adverse Event|1|||
23275176|NCT00834795|64751868|FG001|Second Intervention|Adverse Event|0|||
23275177|NCT00415363|64751869|FG000|Overall Study|Withdrawal by Subject|4|||
23484577|NCT00510952|65518633|FG001|Overall Study|Withdrawal by Subject|7|||
23484578|NCT00510952|65518632|FG000|Overall Study|Did Not Receive Study Drug|2|||
23602560|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602561|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
23602562|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
23602563|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
23484579|NCT00510952|65518633|FG001|Overall Study|Did Not Receive Study Drug|0|||
23484580|NCT01347580|65518634|FG000|Overall Study|Withdrawal by Subject|13|||
23484581|NCT01347580|65518635|FG001|Overall Study|Withdrawal by Subject|23|||
23484582|NCT01347580|65518634|FG000|Overall Study|Death|30|||
23602564|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602565|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
23275178|NCT00415363|64751870|FG001|Overall Study|Withdrawal by Subject|4|||
23275179|NCT00415363|64751869|FG000|Overall Study|Adverse Event|4|||
23275180|NCT00415363|64751870|FG001|Overall Study|Adverse Event|4|||
23275181|NCT00415363|64751869|FG000|Overall Study|Lost to Follow-up|2|||
23484583|NCT01347580|65518635|FG001|Overall Study|Death|19|||
23484584|NCT01347580|65518634|FG000|Overall Study|Protocol Violation|10|||
23484585|NCT01347580|65518635|FG001|Overall Study|Protocol Violation|7|||
23602566|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
23275182|NCT00415363|64751870|FG001|Overall Study|Lost to Follow-up|1|||
23275183|NCT00415363|64751869|FG000|Overall Study|Physician Decision|3|||
23275184|NCT00415363|64751870|FG001|Overall Study|Physician Decision|1|||
23275185|NCT00415363|64751869|FG000|Overall Study|Death|16|||
23275186|NCT00415363|64751870|FG001|Overall Study|Death|12|||
23275187|NCT00415363|64751869|FG000|Overall Study|Progressive disease|26|||
23275188|NCT00415363|64751870|FG001|Overall Study|Progressive disease|32|||
23275189|NCT02294604|64751872|FG000|Overall Study|Did not provide samples for culture|0|||
23275190|NCT02294604|64751873|FG001|Overall Study|Did not provide samples for culture|1|||
23275191|NCT02294604|64751874|FG002|Overall Study|Did not provide samples for culture|0|||
23275192|NCT02294604|64751872|FG000|Overall Study|Culture contamination|1|||
23275193|NCT02294604|64751873|FG001|Overall Study|Culture contamination|2|||
23275194|NCT02294604|64751874|FG002|Overall Study|Culture contamination|0|||
23275195|NCT04510285|64751875|FG000|Overall Study|Death|1|||
23275196|NCT01045161|64751881|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
23275197|NCT01045161|64751882|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
23275198|NCT01045161|64751883|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
23275199|NCT01045161|64751881|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
23275200|NCT01045161|64751882|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
23275201|NCT01045161|64751883|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
23275202|NCT01045161|64751881|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
23275203|NCT01045161|64751882|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
23275204|NCT01045161|64751883|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
23275205|NCT01045161|64751881|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
23275206|NCT01045161|64751882|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
23275207|NCT01045161|64751883|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
23275208|NCT01045161|64751881|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
23275209|NCT01045161|64751882|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
23275210|NCT01045161|64751883|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
23275211|NCT01045161|64751881|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
23368627|NCT00264147|65096039|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23368628|NCT00264147|65096040|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
23275212|NCT01045161|64751882|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
23275213|NCT01045161|64751883|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
23275214|NCT01045161|64751881|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
23275215|NCT01045161|64751882|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
23275216|NCT01045161|64751883|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
23275217|NCT01045161|64751881|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
23275218|NCT01045161|64751882|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
23275219|NCT01045161|64751883|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
23275220|NCT01045161|64751881|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
23275221|NCT01045161|64751882|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
23275222|NCT01045161|64751883|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
23275223|NCT01045161|64751881|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
23275224|NCT01045161|64751882|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
23275225|NCT01045161|64751883|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
23275226|NCT01045161|64751881|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
23275227|NCT01045161|64751882|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
23275228|NCT01045161|64751883|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
23275229|NCT01045161|64751881|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
23275230|NCT01045161|64751882|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
23275231|NCT01045161|64751883|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
23275232|NCT01045161|64751881|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
23275233|NCT01045161|64751882|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
23275234|NCT01045161|64751883|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
23275235|NCT01045161|64751881|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
23275236|NCT01045161|64751882|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
23275237|NCT01045161|64751883|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
23275238|NCT05376319|64751888|FG000|Overall Study|Funding termination|2|||
23275239|NCT05376319|64751889|FG001|Overall Study|Funding termination|4|||
23275240|NCT01472341|64751890|FG000|Overall Study|Started insulin therapy|55|||
23275241|NCT01472341|64751890|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
23275242|NCT01472341|64751890|FG000|Overall Study|Withdrawal by Subject|39|||
23275243|NCT01472341|64751890|FG000|Overall Study|Lost to Follow-up|52|||
23368629|NCT00264147|65096035|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
23275244|NCT01472341|64751890|FG000|Overall Study|Laboratory parameters unavailable|25|||
23275245|NCT01472341|64751890|FG000|Overall Study|Death|9|||
23368630|NCT00264147|65096036|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
23275246|NCT03075761|64751892|FG000|Overall Study|Lost to Follow-up|1|||
23275247|NCT03075761|64751893|FG001|Overall Study|Lost to Follow-up|6|||
23275248|NCT02943447|64751894|FG000|Blinded Study Phase|Withdrew Consent|1|||
23275249|NCT02943447|64751895|FG001|Blinded Study Phase|Withdrew Consent|2|||
23275250|NCT02943447|64751896|FG002|Blinded Study Phase|Withdrew Consent|1|||
23275251|NCT02943447|64751894|FG000|Blinded Study Phase|Adverse Event|3|||
23275252|NCT02943447|64751895|FG001|Blinded Study Phase|Adverse Event|0|||
23275253|NCT02943447|64751896|FG002|Blinded Study Phase|Adverse Event|0|||
23275254|NCT02943447|64751894|FG000|Blinded Study Phase|Investigator's discretion|1|||
23275255|NCT02943447|64751895|FG001|Blinded Study Phase|Investigator's discretion|0|||
23275256|NCT02943447|64751896|FG002|Blinded Study Phase|Investigator's discretion|0|||
23275257|NCT02943447|64751894|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
23275258|NCT02943447|64751895|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
23275259|NCT02943447|64751896|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
23275260|NCT02943447|64751894|FG000|Open-Label Extension Phase|Adverse Event|4|||
23275261|NCT02943447|64751895|FG001|Open-Label Extension Phase|Adverse Event|7|||
23275262|NCT02943447|64751896|FG002|Open-Label Extension Phase|Adverse Event|3|||
23275263|NCT02943447|64751894|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
23275264|NCT02943447|64751895|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
23275265|NCT02943447|64751896|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
23275266|NCT02943447|64751894|FG000|Open-Label Extension Phase|Withdrew consent|1|||
23275267|NCT02943447|64751895|FG001|Open-Label Extension Phase|Withdrew consent|1|||
23275268|NCT02943447|64751896|FG002|Open-Label Extension Phase|Withdrew consent|1|||
23275269|NCT02943447|64751894|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23275270|NCT02943447|64751895|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
23275271|NCT02943447|64751896|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23275272|NCT03041025|64751897|FG000|Overall Study|Adverse Event|0|||
23275273|NCT03041025|64751898|FG001|Overall Study|Adverse Event|0|||
23275274|NCT03041025|64751899|FG002|Overall Study|Adverse Event|1|||
23275275|NCT03041025|64751897|FG000|Overall Study|Lost to Follow-up|1|||
23275276|NCT03041025|64751898|FG001|Overall Study|Lost to Follow-up|0|||
23275277|NCT03041025|64751899|FG002|Overall Study|Lost to Follow-up|0|||
23275278|NCT03041025|64751897|FG000|Overall Study|Withdrawal by Subject|0|||
23275279|NCT03041025|64751898|FG001|Overall Study|Withdrawal by Subject|0|||
23275280|NCT03041025|64751899|FG002|Overall Study|Withdrawal by Subject|1|||
23275281|NCT01279486|64751900|FG000|Overall Study|Lost to Follow-up|1|||
23275282|NCT00396279|64751902|FG000|Overall Study|Ongoing in study|26|||
23275283|NCT00396279|64751902|FG000|Overall Study|Disease progression|2|||
23275284|NCT00396279|64751902|FG000|Overall Study|Withdrawal by Subject|1|||
23275285|NCT00396279|64751902|FG000|Overall Study|Physician Decision|1|||
23275286|NCT00440518|64751905|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
23275287|NCT00440518|64751906|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
23275288|NCT00440518|64751907|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
23275289|NCT00440518|64751905|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
23275290|NCT00440518|64751906|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
23275291|NCT00440518|64751907|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
23275292|NCT00440518|64751905|FG000|Randomized /Titration Period|Protocol Deviation|1|||
23275293|NCT00440518|64751906|FG001|Randomized /Titration Period|Protocol Deviation|0|||
23275294|NCT00440518|64751907|FG002|Randomized /Titration Period|Protocol Deviation|0|||
23275295|NCT00440518|64751905|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
23275296|NCT00440518|64751906|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
23368631|NCT00264147|65096037|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
23201320|NCT03633227|64476695|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
23201321|NCT03633227|64476694|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
23201322|NCT03633227|64476695|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
23201323|NCT03633227|64476694|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
23201324|NCT03633227|64476695|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
23201325|NCT03633227|64476694|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
23201326|NCT03633227|64476695|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
23201327|NCT03633227|64476694|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
23201328|NCT03633227|64476695|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
23201329|NCT05515601|64476696|FG000|Overall Study|Withdrawal by Subject|1|||
23201330|NCT05515601|64476697|FG001|Overall Study|Withdrawal by Subject|3|||
23201331|NCT05515601|64476698|FG002|Overall Study|Withdrawal by Subject|2|||
23201332|NCT05515601|64476699|FG003|Overall Study|Withdrawal by Subject|1|||
23201333|NCT05515601|64476700|FG004|Overall Study|Withdrawal by Subject|1|||
23201334|NCT05515601|64476701|FG005|Overall Study|Withdrawal by Subject|1|||
23201335|NCT05515601|64476696|FG000|Overall Study|Lost to Follow-up|0|||
23201336|NCT05515601|64476697|FG001|Overall Study|Lost to Follow-up|0|||
23201337|NCT05515601|64476698|FG002|Overall Study|Lost to Follow-up|0|||
23201338|NCT05515601|64476699|FG003|Overall Study|Lost to Follow-up|0|||
23201339|NCT05515601|64476700|FG004|Overall Study|Lost to Follow-up|1|||
23275297|NCT00440518|64751907|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
23275298|NCT00440518|64751905|FG000|Randomized /Titration Period|Other|1|||
23275299|NCT00440518|64751906|FG001|Randomized /Titration Period|Other|0|||
23275300|NCT00440518|64751907|FG002|Randomized /Titration Period|Other|0|||
23275301|NCT00440518|64751905|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
23275302|NCT00440518|64751906|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
23275303|NCT00440518|64751907|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
23275304|NCT00440518|64751905|FG000|Randomized /Titration Period|Adverse Event|2|||
23275305|NCT00440518|64751906|FG001|Randomized /Titration Period|Adverse Event|3|||
23275306|NCT00440518|64751907|FG002|Randomized /Titration Period|Adverse Event|0|||
23275307|NCT00440518|64751905|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
23275308|NCT00440518|64751906|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
23275309|NCT00440518|64751907|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
23275310|NCT00440518|64751905|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
23275311|NCT00440518|64751906|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
23275312|NCT00440518|64751907|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
23275313|NCT00440518|64751905|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
23275314|NCT00440518|64751906|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
23275315|NCT00440518|64751907|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
23275316|NCT00440518|64751905|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
23275317|NCT00440518|64751906|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
23275318|NCT00440518|64751907|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
23275319|NCT00440518|64751905|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
23275320|NCT00440518|64751906|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
23275321|NCT00440518|64751907|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
23275322|NCT00440518|64751905|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
23275323|NCT00440518|64751906|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
23275324|NCT00440518|64751907|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
23275325|NCT00796653|64751908|FG000|Overall Study|Adverse Event|19|||
23275326|NCT00796653|64751909|FG001|Overall Study|Adverse Event|16|||
23275327|NCT00796653|64751910|FG002|Overall Study|Adverse Event|16|||
23275328|NCT00796653|64751911|FG003|Overall Study|Adverse Event|16|||
23275329|NCT00796653|64751908|FG000|Overall Study|Lost to Follow-up|2|||
23275330|NCT00796653|64751909|FG001|Overall Study|Lost to Follow-up|1|||
23275331|NCT00796653|64751910|FG002|Overall Study|Lost to Follow-up|2|||
23275332|NCT00796653|64751911|FG003|Overall Study|Lost to Follow-up|3|||
23275333|NCT00796653|64751908|FG000|Overall Study|Withdrawal by Subject|16|||
23275334|NCT00796653|64751909|FG001|Overall Study|Withdrawal by Subject|8|||
23275335|NCT00796653|64751910|FG002|Overall Study|Withdrawal by Subject|8|||
23275336|NCT00796653|64751911|FG003|Overall Study|Withdrawal by Subject|13|||
23275337|NCT00796653|64751908|FG000|Overall Study|Lack of Efficacy|8|||
23275338|NCT00796653|64751909|FG001|Overall Study|Lack of Efficacy|1|||
23275339|NCT00796653|64751910|FG002|Overall Study|Lack of Efficacy|3|||
23275340|NCT00796653|64751911|FG003|Overall Study|Lack of Efficacy|2|||
23275341|NCT00796653|64751908|FG000|Overall Study|Non compliance with protocol|2|||
23275342|NCT00796653|64751909|FG001|Overall Study|Non compliance with protocol|2|||
23275343|NCT00796653|64751910|FG002|Overall Study|Non compliance with protocol|0|||
23275344|NCT00796653|64751911|FG003|Overall Study|Non compliance with protocol|2|||
23275345|NCT00796653|64751908|FG000|Overall Study|Other reason not described above|4|||
23275346|NCT00796653|64751909|FG001|Overall Study|Other reason not described above|9|||
23275347|NCT00796653|64751910|FG002|Overall Study|Other reason not described above|7|||
23275348|NCT00796653|64751911|FG003|Overall Study|Other reason not described above|4|||
23275349|NCT03021018|64751912|FG000|Overall Study|Adverse Event|1|||
23275350|NCT03021018|64751913|FG001|Overall Study|Adverse Event|0|||
23275351|NCT03021018|64751914|FG002|Overall Study|Adverse Event|0|||
23275352|NCT03021018|64751912|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
23275353|NCT03021018|64751913|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
23275354|NCT03021018|64751914|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
23275355|NCT01518972|64751920|FG000|Overall Study|Lost to Follow-up|2|||
23275356|NCT01518972|64751921|FG001|Overall Study|Lost to Follow-up|1|||
23275357|NCT01518972|64751920|FG000|Overall Study|Withdrawal by Subject|1|||
23275358|NCT01518972|64751921|FG001|Overall Study|Withdrawal by Subject|0|||
23275359|NCT01518972|64751920|FG000|Overall Study|Moved from area|1|||
23368632|NCT00264147|65096038|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
23275360|NCT01518972|64751921|FG001|Overall Study|Moved from area|0|||
23275361|NCT01518972|64751920|FG000|Overall Study|Transportation problems|1|||
23275362|NCT01518972|64751921|FG001|Overall Study|Transportation problems|0|||
23275363|NCT01518972|64751920|FG000|Overall Study|Exclusionary medical condition|1|||
23275364|NCT01518972|64751921|FG001|Overall Study|Exclusionary medical condition|0|||
23275365|NCT01518972|64751920|FG000|Overall Study|Missed safety visits|0|||
23275366|NCT01518972|64751921|FG001|Overall Study|Missed safety visits|1|||
23275367|NCT01518972|64751920|FG000|Overall Study|Exclusionary medication|0|||
23275368|NCT01518972|64751921|FG001|Overall Study|Exclusionary medication|1|||
23275369|NCT01518972|64751920|FG000|Overall Study|Declined medication starting on day 12|0|||
23275370|NCT01518972|64751921|FG001|Overall Study|Declined medication starting on day 12|1|||
23275371|NCT01648582|64751922|FG000|Overall Study|Adverse Event|6|||
23275372|NCT01648582|64751923|FG001|Overall Study|Adverse Event|11|||
23275373|NCT01648582|64751924|FG002|Overall Study|Adverse Event|2|||
23275374|NCT01648582|64751922|FG000|Overall Study|Lost to Follow-up|9|||
23275375|NCT01648582|64751923|FG001|Overall Study|Lost to Follow-up|6|||
23275376|NCT01648582|64751924|FG002|Overall Study|Lost to Follow-up|8|||
23275377|NCT01648582|64751922|FG000|Overall Study|Protocol Violation|1|||
23275378|NCT01648582|64751923|FG001|Overall Study|Protocol Violation|2|||
23275379|NCT01648582|64751924|FG002|Overall Study|Protocol Violation|1|||
23275380|NCT01648582|64751922|FG000|Overall Study|Withdrawal by Subject|15|||
23275381|NCT01648582|64751923|FG001|Overall Study|Withdrawal by Subject|17|||
23275382|NCT01648582|64751924|FG002|Overall Study|Withdrawal by Subject|17|||
23275383|NCT01648582|64751922|FG000|Overall Study|Physician Decision|0|||
23275384|NCT01648582|64751923|FG001|Overall Study|Physician Decision|1|||
23275385|NCT01648582|64751924|FG002|Overall Study|Physician Decision|3|||
23275386|NCT01648582|64751922|FG000|Overall Study|Death|1|||
23275387|NCT01648582|64751923|FG001|Overall Study|Death|0|||
23275388|NCT01648582|64751924|FG002|Overall Study|Death|0|||
23275389|NCT01648582|64751922|FG000|Overall Study|Sponsor Decision|0|||
23275390|NCT01648582|64751923|FG001|Overall Study|Sponsor Decision|1|||
23275391|NCT01648582|64751924|FG002|Overall Study|Sponsor Decision|1|||
23275392|NCT01940341|64751925|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
23275393|NCT01940341|64751926|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
23275394|NCT01940341|64751927|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
23275395|NCT01940341|64751928|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
23275396|NCT01940341|64751925|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
23275397|NCT01940341|64751926|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
23275398|NCT01940341|64751927|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23275399|NCT01940341|64751928|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23275400|NCT01940341|64751925|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
23275401|NCT01940341|64751926|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
23275402|NCT01940341|64751927|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
23275403|NCT01940341|64751928|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
23275404|NCT01940341|64751925|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
23275405|NCT01940341|64751926|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
23275406|NCT01940341|64751927|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
23275407|NCT01940341|64751928|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
23275408|NCT01940341|64751925|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
23275409|NCT01940341|64751926|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
23275410|NCT01940341|64751927|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
23275411|NCT01940341|64751928|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
23275412|NCT01940341|64751925|FG000|Period 1: Double-blind Phase|Death|0|||
23275413|NCT01940341|64751926|FG001|Period 1: Double-blind Phase|Death|1|||
23275414|NCT01940341|64751927|FG002|Period 1: Double-blind Phase|Death|0|||
23275415|NCT01940341|64751928|FG003|Period 1: Double-blind Phase|Death|0|||
23275416|NCT01940341|64751925|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
23275417|NCT01940341|64751926|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
23275418|NCT01940341|64751927|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
23275419|NCT01940341|64751928|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
23275420|NCT01940341|64751925|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
23275421|NCT01940341|64751926|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
23275422|NCT01940341|64751927|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
23275423|NCT01940341|64751928|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
23275424|NCT01940341|64751925|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23275425|NCT01940341|64751926|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
23275426|NCT01940341|64751927|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23275427|NCT01940341|64751928|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
23201340|NCT05515601|64476701|FG005|Overall Study|Lost to Follow-up|0|||
23201341|NCT01058369|64476702|FG000|Overall Study|Adverse Event|1|||
23275428|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
23275429|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
23275430|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
23275431|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
23275432|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
23275433|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
23275434|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
23275435|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
23275436|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23275437|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23275438|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
23275439|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
23275440|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
23275441|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
23275442|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
23275443|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
23275444|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23275445|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23275446|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
23275447|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
23275448|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
23275449|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
23275450|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
23275451|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
23275452|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23275453|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23275454|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
23275455|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
23275456|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23275457|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23275458|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
23275459|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
23275460|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23275461|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23275462|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
23275463|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
23275464|NCT01940341|64751925|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
23275465|NCT01940341|64751926|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
23275466|NCT01940341|64751927|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
23275467|NCT01940341|64751928|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
23275468|NCT02131129|64751929|FG000|Overall Study|Withdrawal by Subject|1|||
23275469|NCT02131129|64751930|FG001|Overall Study|Withdrawal by Subject|0|||
23275470|NCT02017223|64754888|FG000|Overall Study|Algorithm problems|2|||
23602567|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602568|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602569|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602570|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
23275475|NCT00678639|64754892|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
23275476|NCT00678639|64754893|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
23275477|NCT01168856|64754894|FG000|Overall Study|Lost to Follow-up|4|||
23275478|NCT01168856|64754895|FG001|Overall Study|Lost to Follow-up|34|||
23275479|NCT01168856|64754894|FG000|Overall Study|Withdrawal by Subject|6|||
23275480|NCT01168856|64754895|FG001|Overall Study|Withdrawal by Subject|8|||
23275481|NCT01168856|64754894|FG000|Overall Study|Physician Decision|2|||
23275482|NCT01168856|64754895|FG001|Overall Study|Physician Decision|1|||
23275483|NCT01168856|64754894|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
23275484|NCT01168856|64754895|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
23275485|NCT01168856|64754894|FG000|Overall Study|Participant received anti-HCV treatment|1|||
23275486|NCT01168856|64754895|FG001|Overall Study|Participant received anti-HCV treatment|0|||
23275487|NCT01168856|64754894|FG000|Overall Study|Death|0|||
23275488|NCT01168856|64754895|FG001|Overall Study|Death|2|||
23275489|NCT01168856|64754894|FG000|Overall Study|Other|1|||
23275490|NCT01168856|64754895|FG001|Overall Study|Other|291|||
23368633|NCT00264147|65096039|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
23368634|NCT00264147|65096040|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
23368635|NCT00264147|65096035|FG000|Treatment II Period|Adverse Event|0|||
23368636|NCT00264147|65096036|FG001|Treatment II Period|Adverse Event|0|||
23368637|NCT00264147|65096037|FG002|Treatment II Period|Adverse Event|0|||
23368638|NCT00264147|65096038|FG003|Treatment II Period|Adverse Event|0|||
23368639|NCT00264147|65096039|FG004|Treatment II Period|Adverse Event|9|||
23275491|NCT01168856|64754894|FG000|Overall Study|Protocol Violation|4|||
23275492|NCT01168856|64754895|FG001|Overall Study|Protocol Violation|6|||
23275493|NCT00446563|64754896|FG000|Overall Study|Adverse Event|4|||
23275494|NCT00446563|64754897|FG001|Overall Study|Adverse Event|3|||
23368640|NCT00264147|65096040|FG005|Treatment II Period|Adverse Event|9|||
23368641|NCT00264147|65096035|FG000|Treatment II Period|Laboratory Adverse Event|0|||
23368642|NCT00264147|65096036|FG001|Treatment II Period|Laboratory Adverse Event|0|||
23368643|NCT00264147|65096037|FG002|Treatment II Period|Laboratory Adverse Event|0|||
23368644|NCT00264147|65096038|FG003|Treatment II Period|Laboratory Adverse Event|0|||
23368645|NCT00264147|65096039|FG004|Treatment II Period|Laboratory Adverse Event|0|||
23368646|NCT00264147|65096040|FG005|Treatment II Period|Laboratory Adverse Event|1|||
23368647|NCT00264147|65096035|FG000|Treatment II Period|Lack of Efficacy|0|||
23368648|NCT00264147|65096036|FG001|Treatment II Period|Lack of Efficacy|0|||
23368649|NCT00264147|65096037|FG002|Treatment II Period|Lack of Efficacy|0|||
23368650|NCT00264147|65096038|FG003|Treatment II Period|Lack of Efficacy|0|||
23368651|NCT00264147|65096039|FG004|Treatment II Period|Lack of Efficacy|20|||
23368652|NCT00264147|65096040|FG005|Treatment II Period|Lack of Efficacy|19|||
23368653|NCT00264147|65096035|FG000|Treatment II Period|Lost to Follow-up|0|||
23368654|NCT00264147|65096036|FG001|Treatment II Period|Lost to Follow-up|0|||
23368655|NCT00264147|65096037|FG002|Treatment II Period|Lost to Follow-up|0|||
23368656|NCT00264147|65096038|FG003|Treatment II Period|Lost to Follow-up|0|||
23368657|NCT00264147|65096039|FG004|Treatment II Period|Lost to Follow-up|1|||
23368658|NCT00264147|65096040|FG005|Treatment II Period|Lost to Follow-up|1|||
23368659|NCT00264147|65096035|FG000|Treatment II Period|Withdrawal by Subject|0|||
23368660|NCT00264147|65096036|FG001|Treatment II Period|Withdrawal by Subject|0|||
23368661|NCT00264147|65096037|FG002|Treatment II Period|Withdrawal by Subject|0|||
23368662|NCT00264147|65096038|FG003|Treatment II Period|Withdrawal by Subject|0|||
23368663|NCT00264147|65096039|FG004|Treatment II Period|Withdrawal by Subject|3|||
23368664|NCT00264147|65096040|FG005|Treatment II Period|Withdrawal by Subject|2|||
23368665|NCT00264147|65096035|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368666|NCT00264147|65096036|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368667|NCT00264147|65096037|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368668|NCT00264147|65096038|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368669|NCT00264147|65096039|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
23368670|NCT00264147|65096040|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
23368671|NCT00269152|65096041|FG000|Overall Study|Adverse Event|9|||
23368672|NCT00269152|65096042|FG001|Overall Study|Adverse Event|3|||
23368673|NCT00269152|65096041|FG000|Overall Study|Withdrawal by Subject|7|||
23368674|NCT00269152|65096042|FG001|Overall Study|Withdrawal by Subject|3|||
23368675|NCT00269152|65096041|FG000|Overall Study|Physician Decision|2|||
23368676|NCT00269152|65096042|FG001|Overall Study|Physician Decision|3|||
23368677|NCT00269152|65096041|FG000|Overall Study|Protocol Violation|0|||
23368678|NCT00269152|65096042|FG001|Overall Study|Protocol Violation|1|||
23368679|NCT00863707|65096043|FG000|Overall Study|Randomized, but drug not received|4|||
23368680|NCT00863707|65096044|FG001|Overall Study|Randomized, but drug not received|3|||
23368681|NCT00735709|65096047|FG000|Overall Study|Adverse Event|2|||
23368682|NCT00735709|65096048|FG001|Overall Study|Adverse Event|3|||
23368683|NCT00735709|65096049|FG002|Overall Study|Adverse Event|1|||
23484586|NCT01347580|65518634|FG000|Overall Study|Lost to Follow-up|3|||
23602571|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
23602572|NCT01998958|65934053|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602573|NCT01998958|65934054|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602574|NCT01998958|65934055|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602575|NCT01998958|65934056|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602576|NCT01998958|65934057|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602577|NCT01998958|65934058|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602578|NCT01998958|65934059|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602579|NCT01998958|65934060|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23368684|NCT00735709|65096050|FG003|Overall Study|Adverse Event|5|||
23368685|NCT00735709|65096047|FG000|Overall Study|Lack of Efficacy|8|||
23602580|NCT01998958|65934061|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602581|NCT01998958|65934062|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602582|NCT01998958|65934063|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602583|NCT01998958|65934064|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602584|NCT01998958|65934065|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23368686|NCT00735709|65096048|FG001|Overall Study|Lack of Efficacy|4|||
23368687|NCT00735709|65096049|FG002|Overall Study|Lack of Efficacy|2|||
23368688|NCT00735709|65096050|FG003|Overall Study|Lack of Efficacy|3|||
23368689|NCT00735709|65096047|FG000|Overall Study|Noncompliance|0|||
23368690|NCT00735709|65096048|FG001|Overall Study|Noncompliance|0|||
23368691|NCT00735709|65096049|FG002|Overall Study|Noncompliance|1|||
23368692|NCT00735709|65096050|FG003|Overall Study|Noncompliance|0|||
23368693|NCT00735709|65096047|FG000|Overall Study|Protocol deviations|1|||
23368694|NCT00735709|65096048|FG001|Overall Study|Protocol deviations|2|||
23602585|NCT01998958|65934066|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23275495|NCT00446563|64754896|FG000|Overall Study|Abnormal laboratory value(s)|0|||
23275496|NCT00446563|64754897|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23275497|NCT00446563|64754896|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23275498|NCT00446563|64754897|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23275499|NCT00446563|64754896|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23275500|NCT00446563|64754897|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23275501|NCT00446563|64754896|FG000|Overall Study|Withdrawal by Subject|2|||
23275502|NCT00446563|64754897|FG001|Overall Study|Withdrawal by Subject|1|||
23275503|NCT00446563|64754896|FG000|Overall Study|Administrative problems|0|||
23275504|NCT00446563|64754897|FG001|Overall Study|Administrative problems|1|||
23275505|NCT02392195|64754898|FG000|Overall Study|Lost to Follow-up|4|||
23275506|NCT02392195|64754898|FG000|Overall Study|Withdrawal by Subject|4|||
23275507|NCT01038856|64754904|FG000|Overall Study|Adverse Event|2|||
23275508|NCT01171963|64754909|FG000|Overall Study|Adverse Event|10|||
23275509|NCT01171963|64754910|FG001|Overall Study|Adverse Event|15|||
23275510|NCT01171963|64754909|FG000|Overall Study|Lost to Follow-up|23|||
23275511|NCT01171963|64754910|FG001|Overall Study|Lost to Follow-up|24|||
23275512|NCT01171963|64754909|FG000|Overall Study|Other - diarrhoea|1|||
23275513|NCT01171963|64754910|FG001|Overall Study|Other - diarrhoea|0|||
23275514|NCT01171963|64754909|FG000|Overall Study|Withdrawal by Subject|114|||
23275515|NCT01171963|64754910|FG001|Overall Study|Withdrawal by Subject|129|||
23275516|NCT04206332|64754911|FG000|Part A|Lost to Follow-up|0|||
23275517|NCT04206332|64754912|FG001|Part A|Lost to Follow-up|1|||
23275518|NCT04206332|64754913|FG002|Part A|Lost to Follow-up|0|||
23275519|NCT04206332|64754914|FG003|Part A|Lost to Follow-up|0|||
23275520|NCT04206332|64754915|FG004|Part A|Lost to Follow-up|0|||
23275521|NCT04206332|64754916|FG005|Part A|Lost to Follow-up|0|||
23275522|NCT04206332|64754917|FG006|Part A|Lost to Follow-up|0|||
23275523|NCT04206332|64754918|FG007|Part A|Lost to Follow-up|0|||
23275524|NCT04206332|64754919|FG008|Part A|Lost to Follow-up|0|||
23275525|NCT04206332|64754920|FG009|Part A|Lost to Follow-up|0|||
23275526|NCT04206332|64754921|FG010|Part A|Lost to Follow-up|0|||
23275527|NCT04206332|64754922|FG011|Part A|Lost to Follow-up|0|||
23275528|NCT04206332|64754923|FG012|Part A|Lost to Follow-up|0|||
23275529|NCT04206332|64754924|FG013|Part A|Lost to Follow-up|0|||
23275530|NCT04206332|64754925|FG014|Part A|Lost to Follow-up|0|||
23275531|NCT04206332|64754926|FG015|Part A|Lost to Follow-up|0|||
23275532|NCT04206332|64754927|FG016|Part A|Lost to Follow-up|0|||
23275533|NCT04206332|64754911|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275534|NCT04206332|64754912|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275535|NCT04206332|64754913|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275536|NCT04206332|64754914|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275537|NCT04206332|64754915|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275538|NCT04206332|64754916|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
23275539|NCT04206332|64754917|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275540|NCT04206332|64754918|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275541|NCT04206332|64754919|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275542|NCT04206332|64754920|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275543|NCT04206332|64754921|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275544|NCT04206332|64754922|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275545|NCT04206332|64754923|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275546|NCT04206332|64754924|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275547|NCT04206332|64754925|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275548|NCT04206332|64754926|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275549|NCT04206332|64754927|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
23275550|NCT04206332|64754911|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275551|NCT04206332|64754912|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275552|NCT04206332|64754913|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275553|NCT04206332|64754914|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275554|NCT04206332|64754915|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275555|NCT04206332|64754916|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275556|NCT04206332|64754917|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275557|NCT04206332|64754918|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
23275558|NCT04206332|64754919|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275559|NCT04206332|64754920|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275560|NCT04206332|64754921|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
23275561|NCT04206332|64754922|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275562|NCT04206332|64754923|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275563|NCT04206332|64754924|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275564|NCT04206332|64754925|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275565|NCT04206332|64754926|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275566|NCT04206332|64754927|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275567|NCT04206332|64754911|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23368695|NCT00735709|65096049|FG002|Overall Study|Protocol deviations|1|||
23368696|NCT00735709|65096050|FG003|Overall Study|Protocol deviations|1|||
23368697|NCT00735709|65096047|FG000|Overall Study|Voluntary Withdrawal|1|||
23368698|NCT00735709|65096048|FG001|Overall Study|Voluntary Withdrawal|3|||
23368699|NCT00735709|65096049|FG002|Overall Study|Voluntary Withdrawal|5|||
23368700|NCT00735709|65096050|FG003|Overall Study|Voluntary Withdrawal|7|||
23368701|NCT00735709|65096047|FG000|Overall Study|Lost to Follow-up|0|||
23368702|NCT00735709|65096048|FG001|Overall Study|Lost to Follow-up|1|||
23368703|NCT00735709|65096049|FG002|Overall Study|Lost to Follow-up|1|||
23368704|NCT00735709|65096050|FG003|Overall Study|Lost to Follow-up|1|||
23368705|NCT00735709|65096047|FG000|Overall Study|Excluded medication|1|||
23368706|NCT00735709|65096048|FG001|Overall Study|Excluded medication|0|||
23368707|NCT00735709|65096049|FG002|Overall Study|Excluded medication|0|||
23368708|NCT00735709|65096050|FG003|Overall Study|Excluded medication|1|||
23368709|NCT01924533|65096053|FG000|Overall Study|Death|181|||
23368710|NCT01924533|65096054|FG001|Overall Study|Death|200|||
23368711|NCT01924533|65096053|FG000|Overall Study|Lost to Follow-up|0|||
23368712|NCT01924533|65096054|FG001|Overall Study|Lost to Follow-up|1|||
23368713|NCT01924533|65096053|FG000|Overall Study|Withdrawal by Subject|7|||
23368714|NCT01924533|65096054|FG001|Overall Study|Withdrawal by Subject|3|||
23368715|NCT01924533|65096053|FG000|Overall Study|Other Eligibility criteria|1|||
23368716|NCT01924533|65096054|FG001|Overall Study|Other Eligibility criteria|1|||
23368717|NCT01386606|65096057|FG000|Overall Study|Adverse Event|0|||
23368718|NCT01386606|65096058|FG001|Overall Study|Adverse Event|1|||
23368719|NCT01386606|65096059|FG002|Overall Study|Adverse Event|0|||
23368720|NCT01386606|65096060|FG003|Overall Study|Adverse Event|0|||
23368721|NCT01386606|65096057|FG000|Overall Study|Withdrawal by Subject|0|||
23368722|NCT01386606|65096058|FG001|Overall Study|Withdrawal by Subject|1|||
23368723|NCT01386606|65096059|FG002|Overall Study|Withdrawal by Subject|1|||
23368724|NCT01386606|65096060|FG003|Overall Study|Withdrawal by Subject|0|||
23368725|NCT01386606|65096057|FG000|Overall Study|Protocol Violation|1|||
23368726|NCT01386606|65096058|FG001|Overall Study|Protocol Violation|0|||
23368727|NCT01386606|65096059|FG002|Overall Study|Protocol Violation|1|||
23368728|NCT01386606|65096060|FG003|Overall Study|Protocol Violation|1|||
23368729|NCT01386606|65096057|FG000|Overall Study|Lost to Follow-up|2|||
23368730|NCT01386606|65096058|FG001|Overall Study|Lost to Follow-up|0|||
23368731|NCT01386606|65096059|FG002|Overall Study|Lost to Follow-up|0|||
23368732|NCT01386606|65096060|FG003|Overall Study|Lost to Follow-up|0|||
23368733|NCT01386606|65096057|FG000|Overall Study|Subject incarcerated|0|||
23368734|NCT01386606|65096058|FG001|Overall Study|Subject incarcerated|1|||
23368735|NCT01386606|65096059|FG002|Overall Study|Subject incarcerated|0|||
23368736|NCT01386606|65096060|FG003|Overall Study|Subject incarcerated|0|||
23368737|NCT01386606|65096057|FG000|Overall Study|Unable to draw PK|1|||
23368738|NCT01386606|65096058|FG001|Overall Study|Unable to draw PK|0|||
23368739|NCT01386606|65096059|FG002|Overall Study|Unable to draw PK|0|||
23368740|NCT01386606|65096060|FG003|Overall Study|Unable to draw PK|0|||
23368741|NCT01386606|65096057|FG000|Overall Study|T levels too high|0|||
23368742|NCT01386606|65096058|FG001|Overall Study|T levels too high|1|||
23368743|NCT01386606|65096059|FG002|Overall Study|T levels too high|1|||
23368744|NCT01386606|65096060|FG003|Overall Study|T levels too high|0|||
23368745|NCT00830765|65096061|FG000|Overall Study|Protocol Violation|3|||
23368746|NCT00830765|65096062|FG001|Overall Study|Protocol Violation|2|||
23368747|NCT03903172|65096064|FG000|Overall Study|screen fail|4|||
23368748|NCT03903172|65096065|FG001|Overall Study|screen fail|1|||
23368749|NCT00838097|65096066|FG000|Overall Study|Ineligibility determined|6|||
23368750|NCT00838097|65096066|FG000|Overall Study|Adverse Event|2|||
23368751|NCT00838097|65096066|FG000|Overall Study|Withdrawal by Subject|3|||
23368752|NCT00838097|65096066|FG000|Overall Study|Requirement for alternative therapy|2|||
23368753|NCT00838097|65096066|FG000|Overall Study|Physician Decision|4|||
23368754|NCT00838097|65096066|FG000|Overall Study|Lost to Follow-up|11|||
23368755|NCT00838097|65096066|FG000|Overall Study|Death|6|||
23368756|NCT00838097|65096066|FG000|Overall Study|Protocol-specified criteria|142|||
23368757|NCT03644017|65096067|FG000|Overall Study|Access Abandonment|5|||
23368758|NCT03644017|65096067|FG000|Overall Study|Kidney Transplant|2|||
23368759|NCT03316586|65096070|FG000|Overall Study|Adverse Event|2|||
23484587|NCT01347580|65518635|FG001|Overall Study|Lost to Follow-up|1|||
23484588|NCT01347580|65518634|FG000|Overall Study|Had other reason|9|||
23484589|NCT01347580|65518635|FG001|Overall Study|Had other reason|6|||
23484590|NCT02889562|65518638|FG000|Overall Study|Physician Decision|0|||
23484591|NCT02889562|65518639|FG001|Overall Study|Physician Decision|1|||
23484592|NCT02889562|65518638|FG000|Overall Study|Withdrawal by Subject|0|||
23484593|NCT02889562|65518639|FG001|Overall Study|Withdrawal by Subject|1|||
23484594|NCT02829944|65518645|FG000|Overall Study|Physician Decision|0|||
23484595|NCT02829944|65518646|FG001|Overall Study|Physician Decision|1|||
23484596|NCT02829944|65518645|FG000|Overall Study|Screen Failure|2|||
23484597|NCT02829944|65518646|FG001|Overall Study|Screen Failure|2|||
23484598|NCT02829944|65518645|FG000|Overall Study|Inadequate Neuraxial Block|1|||
23484599|NCT02829944|65518646|FG001|Overall Study|Inadequate Neuraxial Block|1|||
23484600|NCT02829944|65518645|FG000|Overall Study|Withdrawal by Subject|2|||
23484601|NCT02829944|65518646|FG001|Overall Study|Withdrawal by Subject|1|||
23602586|NCT01998958|65934067|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23275568|NCT04206332|64754912|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275569|NCT04206332|64754913|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275570|NCT04206332|64754914|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275571|NCT04206332|64754915|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275572|NCT04206332|64754916|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275573|NCT04206332|64754917|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275574|NCT04206332|64754918|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275575|NCT04206332|64754919|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275576|NCT04206332|64754920|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275577|NCT04206332|64754921|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275578|NCT04206332|64754922|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275579|NCT04206332|64754923|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275580|NCT04206332|64754924|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275581|NCT04206332|64754925|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23368760|NCT03316586|65096070|FG000|Overall Study|Physician Decision|3|||
23368761|NCT03316586|65096070|FG000|Overall Study|Lack of Efficacy|10|||
23368762|NCT03316586|65096070|FG000|Overall Study|still on treatment|1|||
23368763|NCT03316586|65096070|FG000|Overall Study|Patient needed radiation therapy|1|||
23484602|NCT02829944|65518645|FG000|Overall Study|Catheter Displacement|1|||
23368764|NCT03316586|65096070|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
23368765|NCT03234465|65096071|FG000|Overall Study|Adverse Event|4|||
23368766|NCT03234465|65096072|FG001|Overall Study|Adverse Event|2|||
23368767|NCT03234465|65096071|FG000|Overall Study|Death|0|||
23368768|NCT03234465|65096072|FG001|Overall Study|Death|1|||
23368769|NCT03234465|65096071|FG000|Overall Study|Lost to Follow-up|1|||
23368770|NCT03234465|65096072|FG001|Overall Study|Lost to Follow-up|1|||
23368771|NCT03234465|65096071|FG000|Overall Study|Withdrawal by Subject|12|||
23368772|NCT03234465|65096072|FG001|Overall Study|Withdrawal by Subject|27|||
23368773|NCT03234465|65096071|FG000|Overall Study|Symptomatic deterioration|0|||
23368774|NCT03234465|65096072|FG001|Overall Study|Symptomatic deterioration|1|||
23368775|NCT03234465|65096071|FG000|Overall Study|Non-compliance|2|||
23368776|NCT03234465|65096072|FG001|Overall Study|Non-compliance|0|||
23368777|NCT03234465|65096071|FG000|Overall Study|Other|14|||
23368778|NCT03234465|65096072|FG001|Overall Study|Other|8|||
23368779|NCT01775670|65096075|FG000|Overall Study|Lost to Follow-up|1|||
23368780|NCT01775670|65096076|FG001|Overall Study|Lost to Follow-up|1|||
23368781|NCT03498521|65096077|FG000|Overall Study|Death|191|||
23368782|NCT03498521|65096078|FG001|Overall Study|Death|64|||
23368783|NCT03498521|65096079|FG002|Overall Study|Death|72|||
23368784|NCT03498521|65096077|FG000|Overall Study|Exclusion criteria|1|||
23368785|NCT03498521|65096078|FG001|Overall Study|Exclusion criteria|0|||
23368786|NCT03498521|65096079|FG002|Overall Study|Exclusion criteria|0|||
23368787|NCT03498521|65096077|FG000|Overall Study|Lost to Follow-up|3|||
23484603|NCT02829944|65518646|FG001|Overall Study|Catheter Displacement|0|||
23484604|NCT02829944|65518645|FG000|Overall Study|Catheter broke|0|||
23484605|NCT02829944|65518646|FG001|Overall Study|Catheter broke|1|||
23484606|NCT02829944|65518645|FG000|Overall Study|Staff unavailable|0|||
23484607|NCT02829944|65518646|FG001|Overall Study|Staff unavailable|1|||
23484608|NCT00371761|65518647|FG000|Overall Study|Adverse Event|1|||
23484609|NCT00371761|65518648|FG001|Overall Study|Adverse Event|1|||
23484610|NCT00371761|65518647|FG000|Overall Study|Withdrawal by Subject|1|||
23484611|NCT00371761|65518648|FG001|Overall Study|Withdrawal by Subject|3|||
23484612|NCT00371761|65518647|FG000|Overall Study|Investigator Judgment|2|||
23484613|NCT00371761|65518648|FG001|Overall Study|Investigator Judgment|3|||
23484614|NCT00371761|65518647|FG000|Overall Study|Study termination|4|||
23484615|NCT00371761|65518648|FG001|Overall Study|Study termination|3|||
23484616|NCT01298193|65518649|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
23484617|NCT01298193|65518649|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
23484618|NCT01298193|65518649|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
23484619|NCT01298193|65518649|FG000|Efficacy Phase (Second Cycle)|Death|1|||
23484620|NCT01028378|65518650|FG000|Overall Study|Lost to Follow-up|12|||
23484621|NCT01028378|65518650|FG000|Overall Study|Withdrawal by Subject|1|||
23484622|NCT01028378|65518650|FG000|Overall Study|Adminstrative Reasons|4|||
23484623|NCT00249288|65518655|FG000|Overall Study|Lost to Follow-up|3|||
23484624|NCT00249288|65518656|FG001|Overall Study|Lost to Follow-up|3|||
23484625|NCT00249288|65518655|FG000|Overall Study|Withdrawal by Subject|2|||
23602587|NCT01998958|65934068|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602588|NCT01998958|65934069|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602589|NCT01998958|65934070|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602590|NCT01998958|65934071|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602591|NCT01998958|65934072|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602592|NCT01998958|65934073|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602593|NCT01998958|65934074|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
23602594|NCT01998958|65934075|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
23602595|NCT01998958|65934076|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
23602596|NCT01998958|65934077|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602597|NCT01998958|65934078|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602598|NCT01998958|65934079|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602599|NCT01998958|65934080|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602600|NCT01998958|65934081|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602601|NCT01998958|65934082|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23201342|NCT01058369|64476702|FG000|Overall Study|Early termination study|1|||
23201343|NCT02214186|64476703|FG000|Overall Study|Lost to Follow-up|1|||
23484626|NCT00249288|65518656|FG001|Overall Study|Withdrawal by Subject|2|||
23602602|NCT01998958|65934083|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23368788|NCT03498521|65096078|FG001|Overall Study|Lost to Follow-up|3|||
23368789|NCT03498521|65096079|FG002|Overall Study|Lost to Follow-up|3|||
23368790|NCT03498521|65096077|FG000|Overall Study|No profile due to technical failure|1|||
23368791|NCT03498521|65096078|FG001|Overall Study|No profile due to technical failure|0|||
23368792|NCT03498521|65096079|FG002|Overall Study|No profile due to technical failure|0|||
23484627|NCT01439347|65518659|FG000|Overall Study|Death|10|||
23602603|NCT01998958|65934084|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
23602604|NCT00890591|65934085|FG000|Overall Study|Lack of Efficacy|20|||
23602605|NCT04009291|65934086|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
23602606|NCT04009291|65934087|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
23602607|NCT04009291|65934088|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
23602608|NCT04009291|65934089|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
23602609|NCT04009291|65934090|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
23602610|NCT04009291|65934086|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
23602611|NCT04009291|65934087|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
23602612|NCT04009291|65934088|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
23275582|NCT04206332|64754926|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
23275583|NCT04206332|64754927|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
23275584|NCT04206332|64754911|FG000|Part C|Withdrawal by Subject|0|||
23275585|NCT04206332|64754912|FG001|Part C|Withdrawal by Subject|0|||
23602613|NCT04009291|65934089|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
23368793|NCT03498521|65096077|FG000|Overall Study|Physician Decision|0|||
23368794|NCT03498521|65096078|FG001|Overall Study|Physician Decision|1|||
23368795|NCT03498521|65096079|FG002|Overall Study|Physician Decision|0|||
23368796|NCT03498521|65096077|FG000|Overall Study|Withdrawal by Subject|9|||
23368797|NCT03498521|65096078|FG001|Overall Study|Withdrawal by Subject|6|||
23368798|NCT03498521|65096079|FG002|Overall Study|Withdrawal by Subject|2|||
23368799|NCT03498521|65096077|FG000|Overall Study|Study ongoing|121|||
23368800|NCT03498521|65096078|FG001|Overall Study|Study ongoing|36|||
23368801|NCT03498521|65096079|FG002|Overall Study|Study ongoing|15|||
23368802|NCT03575702|65096084|FG000|Overall Study|Withdrawal by Subject|1|||
23368803|NCT03575702|65096085|FG001|Overall Study|Withdrawal by Subject|1|||
23368804|NCT03575702|65096084|FG000|Overall Study|Lost to Follow-up|1|||
23602614|NCT04009291|65934090|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
23602615|NCT04060212|65934092|FG000|Overall Study|Withdrawal by Subject|7|||
23602616|NCT03035942|65934095|FG000|Overall Study|Adverse Event|8|||
23602617|NCT03035942|65934096|FG001|Overall Study|Adverse Event|4|||
23602618|NCT03035942|65934097|FG002|Overall Study|Adverse Event|5|||
23602619|NCT02347332|65934100|FG000|Overall Study|Not treated|5|||
23602620|NCT02347332|65934101|FG001|Overall Study|Not treated|2|||
23602621|NCT02347332|65934100|FG000|Overall Study|Progressive disease|141|||
23602622|NCT02347332|65934101|FG001|Overall Study|Progressive disease|159|||
23602623|NCT02347332|65934100|FG000|Overall Study|Adverse Event|50|||
23602624|NCT02347332|65934101|FG001|Overall Study|Adverse Event|41|||
23602625|NCT02347332|65934100|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
23602626|NCT02347332|65934101|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
23602627|NCT02347332|65934100|FG000|Overall Study|Protocol Violation|1|||
23602628|NCT02347332|65934101|FG001|Overall Study|Protocol Violation|1|||
23602629|NCT02347332|65934100|FG000|Overall Study|Lost to Follow-up|2|||
23602630|NCT02347332|65934101|FG001|Overall Study|Lost to Follow-up|1|||
23602631|NCT02347332|65934100|FG000|Overall Study|Physician Decision|4|||
23602632|NCT02347332|65934101|FG001|Overall Study|Physician Decision|3|||
23602633|NCT02347332|65934100|FG000|Overall Study|Withdrawal by Subject|20|||
23602634|NCT02347332|65934101|FG001|Overall Study|Withdrawal by Subject|14|||
23602635|NCT02347332|65934100|FG000|Overall Study|Protocol requirement|1|||
23602636|NCT02347332|65934101|FG001|Overall Study|Protocol requirement|1|||
23602637|NCT02347332|65934100|FG000|Overall Study|Switch Post-Trial program|0|||
23602638|NCT02347332|65934101|FG001|Overall Study|Switch Post-Trial program|1|||
23602639|NCT00686595|65934104|FG000|Overall Study|Adverse Event|3|||
23602640|NCT00686595|65934104|FG000|Overall Study|Protocol Violation|1|||
23602641|NCT00686595|65934104|FG000|Overall Study|Lost to Follow-up|1|||
23602642|NCT00686595|65934104|FG000|Overall Study|Lack of Efficacy|1|||
23602643|NCT00686595|65934104|FG000|Overall Study|Poor Compliance|1|||
23602644|NCT03184987|65934105|FG000|Overall Study|Withdrawal by Subject|0|||
23602645|NCT03184987|65934106|FG001|Overall Study|Withdrawal by Subject|1|||
23602646|NCT03184987|65934107|FG002|Overall Study|Withdrawal by Subject|2|||
23602647|NCT03184987|65934105|FG000|Overall Study|Physician Decision|0|||
23602648|NCT03184987|65934106|FG001|Overall Study|Physician Decision|0|||
23602649|NCT03184987|65934107|FG002|Overall Study|Physician Decision|1|||
23602650|NCT03184987|65934105|FG000|Overall Study|Adverse Event|1|||
23602651|NCT03184987|65934106|FG001|Overall Study|Adverse Event|0|||
23602652|NCT03184987|65934107|FG002|Overall Study|Adverse Event|1|||
23602653|NCT00372775|65934108|FG000|Overall Study|Adverse Event|8|||
23602654|NCT00372775|65934108|FG000|Overall Study|Death|15|||
23602655|NCT00372775|65934108|FG000|Overall Study|Objective progression or relapse|30|||
23368805|NCT03575702|65096085|FG001|Overall Study|Lost to Follow-up|2|||
23602656|NCT00372775|65934108|FG000|Overall Study|Global deterioration of health status|6|||
23602657|NCT00372775|65934108|FG000|Overall Study|Withdrawal by Subject|1|||
23602658|NCT00372775|65934108|FG000|Overall Study|Other|1|||
23602659|NCT00372775|65934108|FG000|Overall Study|Not Treated|2|||
23602660|NCT00655499|65934109|FG000|Overall Study|not eligible|4|||
23602661|NCT00722046|65934110|FG000|Overall Study|Adverse Event|0|||
23602662|NCT00722046|65934111|FG001|Overall Study|Adverse Event|1|||
23602663|NCT00722046|65934112|FG002|Overall Study|Adverse Event|2|||
23602664|NCT00722046|65934113|FG003|Overall Study|Adverse Event|1|||
23602665|NCT00722046|65934114|FG004|Overall Study|Adverse Event|2|||
23602666|NCT00722046|65934115|FG005|Overall Study|Adverse Event|1|||
23602667|NCT00722046|65934116|FG006|Overall Study|Adverse Event|0|||
23602668|NCT00722046|65934110|FG000|Overall Study|Death|0|||
23602669|NCT00722046|65934111|FG001|Overall Study|Death|1|||
23602670|NCT00722046|65934112|FG002|Overall Study|Death|0|||
23602671|NCT00722046|65934113|FG003|Overall Study|Death|0|||
23602672|NCT00722046|65934114|FG004|Overall Study|Death|0|||
23602673|NCT00722046|65934115|FG005|Overall Study|Death|0|||
23602674|NCT00722046|65934116|FG006|Overall Study|Death|2|||
23602675|NCT00722046|65934110|FG000|Overall Study|Protocol Violation|1|||
23602676|NCT00722046|65934111|FG001|Overall Study|Protocol Violation|0|||
23602677|NCT00722046|65934112|FG002|Overall Study|Protocol Violation|0|||
23602678|NCT00722046|65934113|FG003|Overall Study|Protocol Violation|0|||
23602679|NCT00722046|65934114|FG004|Overall Study|Protocol Violation|0|||
23602680|NCT00722046|65934115|FG005|Overall Study|Protocol Violation|1|||
23602681|NCT00722046|65934116|FG006|Overall Study|Protocol Violation|0|||
23602682|NCT00722046|65934110|FG000|Overall Study|Withdrawal by Subject|3|||
23602683|NCT00722046|65934111|FG001|Overall Study|Withdrawal by Subject|3|||
23602684|NCT00722046|65934112|FG002|Overall Study|Withdrawal by Subject|4|||
23602685|NCT00722046|65934113|FG003|Overall Study|Withdrawal by Subject|4|||
23368806|NCT03575702|65096084|FG000|Overall Study|Protocol Violation|0|||
23602686|NCT00722046|65934114|FG004|Overall Study|Withdrawal by Subject|4|||
23602687|NCT00722046|65934115|FG005|Overall Study|Withdrawal by Subject|7|||
23602688|NCT00722046|65934116|FG006|Overall Study|Withdrawal by Subject|3|||
23602689|NCT00722046|65934110|FG000|Overall Study|Randomized, but not treated|1|||
23602690|NCT00722046|65934111|FG001|Overall Study|Randomized, but not treated|1|||
23602691|NCT00722046|65934112|FG002|Overall Study|Randomized, but not treated|0|||
23602692|NCT00722046|65934113|FG003|Overall Study|Randomized, but not treated|2|||
23602693|NCT00722046|65934114|FG004|Overall Study|Randomized, but not treated|0|||
23602694|NCT00722046|65934115|FG005|Overall Study|Randomized, but not treated|0|||
23602695|NCT00722046|65934116|FG006|Overall Study|Randomized, but not treated|0|||
23602696|NCT00722046|65934110|FG000|Overall Study|Other|0|||
23602697|NCT00722046|65934111|FG001|Overall Study|Other|0|||
23602698|NCT00722046|65934112|FG002|Overall Study|Other|1|||
23602699|NCT00722046|65934113|FG003|Overall Study|Other|1|||
23602700|NCT00722046|65934114|FG004|Overall Study|Other|3|||
23602701|NCT00722046|65934115|FG005|Overall Study|Other|2|||
23602702|NCT00722046|65934116|FG006|Overall Study|Other|1|||
23602703|NCT00309166|65934117|FG000|Overall Study|Adverse event, non-fatal|1|||
23602704|NCT00309166|65934118|FG001|Overall Study|Adverse event, non-fatal|0|||
23275586|NCT04206332|64754913|FG002|Part C|Withdrawal by Subject|0|||
23368807|NCT03575702|65096085|FG001|Overall Study|Protocol Violation|1|||
23368808|NCT03575702|65096084|FG000|Overall Study|Patient non compliance|4|||
23275587|NCT04206332|64754914|FG003|Part C|Withdrawal by Subject|0|||
23275588|NCT04206332|64754915|FG004|Part C|Withdrawal by Subject|0|||
23275589|NCT04206332|64754916|FG005|Part C|Withdrawal by Subject|0|||
23275590|NCT04206332|64754917|FG006|Part C|Withdrawal by Subject|0|||
23275591|NCT04206332|64754918|FG007|Part C|Withdrawal by Subject|0|||
23275592|NCT04206332|64754919|FG008|Part C|Withdrawal by Subject|0|||
23275593|NCT04206332|64754920|FG009|Part C|Withdrawal by Subject|0|||
23275594|NCT04206332|64754921|FG010|Part C|Withdrawal by Subject|0|||
23275595|NCT04206332|64754922|FG011|Part C|Withdrawal by Subject|0|||
23368809|NCT03575702|65096085|FG001|Overall Study|Patient non compliance|0|||
23368810|NCT02154139|65096087|FG000|Overall Study|Injection not administered|2|||
23602705|NCT00309166|65934117|FG000|Overall Study|Withdrawal by Subject|4|||
23602706|NCT00309166|65934118|FG001|Overall Study|Withdrawal by Subject|3|||
23602707|NCT02310581|65934119|FG000|Overall Study|Adverse Event|1|||
23602708|NCT02310581|65934120|FG001|Overall Study|Adverse Event|1|||
23602709|NCT02310581|65934121|FG002|Overall Study|Adverse Event|1|||
23602710|NCT02310581|65934122|FG003|Overall Study|Adverse Event|0|||
23602711|NCT02310581|65934119|FG000|Overall Study|Withdrawal by Subject|2|||
23602712|NCT02310581|65934120|FG001|Overall Study|Withdrawal by Subject|1|||
23602713|NCT02310581|65934121|FG002|Overall Study|Withdrawal by Subject|0|||
23484628|NCT01439347|65518660|FG001|Overall Study|Death|9|||
23484629|NCT01439347|65518659|FG000|Overall Study|Withdrawal by Subject|0|||
23484630|NCT01439347|65518660|FG001|Overall Study|Withdrawal by Subject|1|||
23484631|NCT01439347|65518659|FG000|Overall Study|Physician Decision|1|||
23484632|NCT01439347|65518660|FG001|Overall Study|Physician Decision|0|||
23484633|NCT01439347|65518659|FG000|Overall Study|Sponsor Terminated Study|2|||
23484634|NCT01439347|65518660|FG001|Overall Study|Sponsor Terminated Study|3|||
23484635|NCT01858636|65518661|FG000|Overall Study|No Device Deployment Attempted|24|||
23484636|NCT01858636|65518661|FG000|Overall Study|Physician Decision|1|||
23484637|NCT01858636|65518661|FG000|Overall Study|Death|1|||
23484638|NCT01858636|65518661|FG000|Overall Study|Lost to Follow-up|1|||
23484639|NCT01858636|65518661|FG000|Overall Study|Withdrawal by Subject|1|||
23484640|NCT01268683|65518666|FG000|Overall Study|Lost to Follow-up|1|||
23484641|NCT01268683|65518666|FG000|Overall Study|Death|1|||
23484642|NCT03945175|65518667|FG000|Overall Study|Did not meet inclusion criteria|31|||
23484643|NCT03945175|65518667|FG000|Overall Study|Withdrew consent|2|||
23484644|NCT03945175|65518667|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
23484645|NCT03945175|65518667|FG000|Overall Study|Early termination during Mydayis treatment|1|||
23484646|NCT02730208|65518668|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
23484647|NCT02730208|65518669|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
23484648|NCT05342532|65518670|FG000|Overall Study|Adverse Event|5|||
23484649|NCT05342532|65518671|FG001|Overall Study|Adverse Event|20|||
23484650|NCT05342532|65518670|FG000|Overall Study|Lost to Follow-up|10|||
23484651|NCT05342532|65518671|FG001|Overall Study|Lost to Follow-up|15|||
23484652|NCT00740051|65518672|FG000|Overall Study|Lack of Efficacy|2|||
23484653|NCT00740051|65518673|FG001|Overall Study|Lack of Efficacy|5|||
23484654|NCT00740051|65518672|FG000|Overall Study|Adverse Event|1|||
23484655|NCT00740051|65518673|FG001|Overall Study|Adverse Event|4|||
23484656|NCT00740051|65518672|FG000|Overall Study|Protocol Violation|2|||
23484657|NCT00740051|65518673|FG001|Overall Study|Protocol Violation|6|||
23484658|NCT00740051|65518672|FG000|Overall Study|Lost to Follow-up|3|||
23484659|NCT00740051|65518673|FG001|Overall Study|Lost to Follow-up|8|||
23484660|NCT00740051|65518672|FG000|Overall Study|Withdrawal by Subject|6|||
23484661|NCT00740051|65518673|FG001|Overall Study|Withdrawal by Subject|8|||
23484662|NCT00740051|65518672|FG000|Overall Study|Other reason (not specified)|4|||
23484663|NCT00740051|65518673|FG001|Overall Study|Other reason (not specified)|1|||
23484664|NCT00772070|65518674|FG000|Overall Study|Lost to Follow-up|0|||
23484665|NCT00772070|65518675|FG001|Overall Study|Lost to Follow-up|8|||
23484666|NCT00772070|65518674|FG000|Overall Study|Withdrawal by Subject|0|||
23484667|NCT00772070|65518675|FG001|Overall Study|Withdrawal by Subject|2|||
23484668|NCT00772070|65518674|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
23484669|NCT00772070|65518675|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
23484670|NCT00245583|65518677|FG000|Overall Study|Lost to Follow-up|1|||
23484671|NCT00245583|65518678|FG001|Overall Study|Lost to Follow-up|5|||
23484672|NCT00245583|65518677|FG000|Overall Study|Adverse Event|2|||
23484673|NCT00245583|65518678|FG001|Overall Study|Adverse Event|1|||
23484674|NCT00245583|65518677|FG000|Overall Study|Lack of Efficacy|1|||
23275596|NCT04206332|64754923|FG012|Part C|Withdrawal by Subject|0|||
23275597|NCT04206332|64754924|FG013|Part C|Withdrawal by Subject|0|||
23275598|NCT04206332|64754925|FG014|Part C|Withdrawal by Subject|2|||
23275599|NCT04206332|64754926|FG015|Part C|Withdrawal by Subject|0|||
23275600|NCT04206332|64754927|FG016|Part C|Withdrawal by Subject|0|||
23275601|NCT01108094|64754928|FG000|Overall Study|Adverse Event|2|||
23275602|NCT01108094|64754929|FG001|Overall Study|Adverse Event|0|||
23275603|NCT01108094|64754930|FG002|Overall Study|Adverse Event|0|||
23275604|NCT01108094|64754931|FG003|Overall Study|Adverse Event|0|||
23275605|NCT01108094|64754928|FG000|Overall Study|Withdrawal by Subject|1|||
23275606|NCT01108094|64754929|FG001|Overall Study|Withdrawal by Subject|0|||
23275607|NCT01108094|64754930|FG002|Overall Study|Withdrawal by Subject|0|||
23275608|NCT01108094|64754931|FG003|Overall Study|Withdrawal by Subject|0|||
23275609|NCT00252720|64754932|FG000|Overall Study|Withdrawal by Subject|95|||
23368811|NCT02154139|65096087|FG000|Overall Study|Other|2|||
23368812|NCT02154139|65096087|FG000|Overall Study|Investigator transferred|3|||
23484675|NCT00245583|65518678|FG001|Overall Study|Lack of Efficacy|0|||
23484676|NCT00245583|65518677|FG000|Overall Study|Withdrawal by Subject|2|||
23484677|NCT00245583|65518678|FG001|Overall Study|Withdrawal by Subject|3|||
23484678|NCT02775903|65518679|FG000|Overall Study|Death|7|||
23484679|NCT02775903|65518680|FG001|Overall Study|Death|11|||
23484680|NCT02775903|65518681|FG002|Overall Study|Death|12|||
23484681|NCT02775903|65518682|FG003|Overall Study|Death|11|||
23484682|NCT02775903|65518679|FG000|Overall Study|Adverse Event|0|||
23484683|NCT02775903|65518680|FG001|Overall Study|Adverse Event|1|||
23484684|NCT02775903|65518681|FG002|Overall Study|Adverse Event|12|||
23275610|NCT00252720|64754933|FG001|Overall Study|Withdrawal by Subject|97|||
23275611|NCT00252720|64754932|FG000|Overall Study|Death|7|||
23275612|NCT00252720|64754933|FG001|Overall Study|Death|8|||
23275613|NCT00252720|64754932|FG000|Overall Study|Moving|23|||
23275614|NCT00252720|64754933|FG001|Overall Study|Moving|42|||
23484685|NCT02775903|65518682|FG003|Overall Study|Adverse Event|3|||
23484686|NCT02775903|65518679|FG000|Overall Study|Progressive disease|15|||
23484687|NCT02775903|65518680|FG001|Overall Study|Progressive disease|14|||
23484688|NCT02775903|65518681|FG002|Overall Study|Progressive disease|30|||
23484689|NCT02775903|65518682|FG003|Overall Study|Progressive disease|20|||
23484690|NCT02775903|65518679|FG000|Overall Study|Lack of Efficacy|2|||
23484691|NCT02775903|65518680|FG001|Overall Study|Lack of Efficacy|2|||
23484692|NCT02775903|65518681|FG002|Overall Study|Lack of Efficacy|2|||
23484693|NCT02775903|65518682|FG003|Overall Study|Lack of Efficacy|6|||
23484694|NCT02775903|65518679|FG000|Overall Study|Withdrawal by Subject|7|||
23484695|NCT02775903|65518680|FG001|Overall Study|Withdrawal by Subject|5|||
23484696|NCT02775903|65518681|FG002|Overall Study|Withdrawal by Subject|5|||
23484697|NCT02775903|65518682|FG003|Overall Study|Withdrawal by Subject|8|||
23484698|NCT02775903|65518679|FG000|Overall Study|Other reasons|7|||
23484699|NCT02775903|65518680|FG001|Overall Study|Other reasons|8|||
23484700|NCT02775903|65518681|FG002|Overall Study|Other reasons|2|||
23484701|NCT02775903|65518682|FG003|Overall Study|Other reasons|12|||
23484702|NCT02314143|65518683|FG000|Overall Study|Adverse Event|0|||
23484703|NCT02314143|65518684|FG001|Overall Study|Adverse Event|6|||
23484704|NCT02314143|65518685|FG002|Overall Study|Adverse Event|4|||
23484705|NCT02314143|65518683|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
23484706|NCT02314143|65518684|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
23484707|NCT02314143|65518685|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
23484708|NCT02314143|65518683|FG000|Overall Study|Physician Decision|2|||
23275615|NCT00252720|64754932|FG000|Overall Study|Mainly patients lost to follow-up|7|||
23275616|NCT00252720|64754933|FG001|Overall Study|Mainly patients lost to follow-up|18|||
23275617|NCT01061866|64754935|FG000|Overall Study|Adverse Event|2|||
23275618|NCT02624050|64754941|FG000|Overall Study|Physician Decision|4|||
23275619|NCT02624050|64754942|FG001|Overall Study|Physician Decision|0|||
23275620|NCT02624050|64754941|FG000|Overall Study|Protocol Violation|2|||
23275621|NCT02624050|64754942|FG001|Overall Study|Protocol Violation|0|||
23275622|NCT01873586|64754943|FG000|Overall Study|Lost to Follow-up|3|||
23275623|NCT05038293|64754944|FG000|Overall Study|device was not operating properly for one subject.|1|||
23275624|NCT05038293|64754945|FG001|Overall Study|device was not operating properly for one subject.|0|||
23275625|NCT05038293|64754944|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
23275626|NCT05038293|64754945|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
23275627|NCT03084471|64754946|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
23275628|NCT03084471|64754946|FG000|Overall Study|Condition under investigation worsened|84|||
23275629|NCT03084471|64754946|FG000|Overall Study|Lack of therapeutic response|2|||
23275630|NCT03084471|64754946|FG000|Overall Study|Protocol Violation|1|||
23275631|NCT03084471|64754946|FG000|Overall Study|Adverse Event|73|||
23275632|NCT03084471|64754946|FG000|Overall Study|Withdrawal by Subject|12|||
23275633|NCT03084471|64754946|FG000|Overall Study|Disease relapse|181|||
23275634|NCT03084471|64754946|FG000|Overall Study|Subjective disease progression|359|||
23275635|NCT03084471|64754946|FG000|Overall Study|Other (as recorded)|33|||
23275636|NCT03084471|64754946|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
23275637|NCT03459807|64754948|FG000|Overall Study|Withdrawal due to transplant|0|||
23275638|NCT03459807|64754949|FG001|Overall Study|Withdrawal due to transplant|1|||
23275639|NCT00163657|64754953|FG000|Overall Study|Death|12|||
23275640|NCT00163657|64754954|FG001|Overall Study|Death|14|||
23275641|NCT00163657|64754955|FG002|Overall Study|Death|19|||
23275642|NCT00163657|64754953|FG000|Overall Study|graft loss|4|||
23275643|NCT00163657|64754954|FG001|Overall Study|graft loss|1|||
23275644|NCT00163657|64754955|FG002|Overall Study|graft loss|2|||
23275645|NCT00163657|64754953|FG000|Overall Study|Withdrawal by Subject|2|||
23275646|NCT00163657|64754954|FG001|Overall Study|Withdrawal by Subject|3|||
23484709|NCT02314143|65518684|FG001|Overall Study|Physician Decision|1|||
23484710|NCT02314143|65518685|FG002|Overall Study|Physician Decision|0|||
23484711|NCT02314143|65518683|FG000|Overall Study|Withdrawal by Subject|1|||
23484712|NCT02314143|65518684|FG001|Overall Study|Withdrawal by Subject|0|||
23602714|NCT02310581|65934122|FG003|Overall Study|Withdrawal by Subject|1|||
23602715|NCT00571649|65934123|FG000|Treatment Period|Adverse Event|438|||
23275647|NCT00163657|64754955|FG002|Overall Study|Withdrawal by Subject|2|||
23275648|NCT00163657|64754953|FG000|Overall Study|Physician Decision|0|||
23275649|NCT00163657|64754954|FG001|Overall Study|Physician Decision|1|||
23275650|NCT00163657|64754955|FG002|Overall Study|Physician Decision|1|||
23484713|NCT02314143|65518685|FG002|Overall Study|Withdrawal by Subject|1|||
23484714|NCT01484938|65518686|FG000|Overall Study|Adverse Event|2|||
23484715|NCT01484938|65518686|FG000|Overall Study|Lost to Follow-up|1|||
23484716|NCT01484938|65518686|FG000|Overall Study|Noncompliance|1|||
23484717|NCT01574079|65518687|FG000|Overall Study|Physician Decision|0|||
23484718|NCT01574079|65518688|FG001|Overall Study|Physician Decision|2|||
23275651|NCT00163657|64754953|FG000|Overall Study|Non Compliance|1|||
23275652|NCT00163657|64754954|FG001|Overall Study|Non Compliance|0|||
23275653|NCT00163657|64754955|FG002|Overall Study|Non Compliance|0|||
23275654|NCT00163657|64754953|FG000|Overall Study|Lost to Follow-up|1|||
23602716|NCT00571649|65934124|FG001|Treatment Period|Adverse Event|385|||
23484719|NCT01574079|65518687|FG000|Overall Study|Lost to Follow-up|1|||
23484720|NCT01574079|65518688|FG001|Overall Study|Lost to Follow-up|0|||
23484721|NCT03718299|65518689|FG000|Overall Study|Adverse Event|1|||
23484722|NCT03718299|65518689|FG000|Overall Study|Withdrawal by Subject|6|||
23484723|NCT03718299|65518689|FG000|Overall Study|Physician Decision|2|||
23484724|NCT03718299|65518689|FG000|Overall Study|Lost to Follow-up|1|||
23484725|NCT04352127|65518697|FG000|Overall Study|Unable to obtain readings|4|||
23484726|NCT04352127|65518698|FG001|Overall Study|Unable to obtain readings|1|||
23484727|NCT01011478|65518701|FG000|Overall Study|No follow up data|12|||
23484728|NCT01011478|65518702|FG001|Overall Study|No follow up data|7|||
23484729|NCT02011893|65518704|FG000|Enrollment to Randomization|Adverse Event|2|||
23484730|NCT02011893|65518705|FG001|Enrollment to Randomization|Adverse Event|0|||
23484731|NCT02011893|65518706|FG002|Enrollment to Randomization|Adverse Event|0|||
23484732|NCT02011893|65518704|FG000|Enrollment to Randomization|Physician Decision|10|||
23484733|NCT02011893|65518705|FG001|Enrollment to Randomization|Physician Decision|0|||
23484734|NCT02011893|65518706|FG002|Enrollment to Randomization|Physician Decision|0|||
23484735|NCT02011893|65518704|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
23275655|NCT00163657|64754954|FG001|Overall Study|Lost to Follow-up|3|||
23275656|NCT00163657|64754955|FG002|Overall Study|Lost to Follow-up|10|||
23484736|NCT02011893|65518705|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
23484737|NCT02011893|65518706|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
23484738|NCT02011893|65518704|FG000|Enrollment to Randomization|Screening Failure|29|||
23484739|NCT02011893|65518705|FG001|Enrollment to Randomization|Screening Failure|0|||
23484740|NCT02011893|65518706|FG002|Enrollment to Randomization|Screening Failure|0|||
23484741|NCT02011893|65518704|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
23484742|NCT02011893|65518705|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
23484743|NCT02011893|65518706|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
23484744|NCT02011893|65518704|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
23484745|NCT02011893|65518705|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
23484746|NCT02011893|65518706|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
23484747|NCT02011893|65518704|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
23484748|NCT02011893|65518705|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
23484749|NCT02011893|65518706|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
23484750|NCT02011893|65518704|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
23484751|NCT02011893|65518705|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
23484752|NCT02011893|65518706|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
23484753|NCT02011893|65518704|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
23484754|NCT02011893|65518705|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
23484755|NCT02011893|65518706|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
23484756|NCT04271280|65518707|FG000|Overall Study|Lost to Follow-up|300|||
23484757|NCT04271280|65518707|FG000|Overall Study|Death|153|||
23484758|NCT04271280|65518707|FG000|Overall Study|Withdrawal of consent by patient|59|||
23484759|NCT04271280|65518707|FG000|Overall Study|Other|51|||
23484760|NCT04271280|65518707|FG000|Overall Study|No end of study information|42|||
23484761|NCT00171054|65518709|FG000|Overall Study|Protocol Violation|1|||
23484762|NCT00171054|65518710|FG001|Overall Study|Protocol Violation|2|||
23484763|NCT00171054|65518709|FG000|Overall Study|Patient withdrew consent|1|||
23484764|NCT00171054|65518710|FG001|Overall Study|Patient withdrew consent|0|||
23484765|NCT00171054|65518709|FG000|Overall Study|Lost to Follow-up|0|||
23484766|NCT00171054|65518710|FG001|Overall Study|Lost to Follow-up|1|||
23484767|NCT00171054|65518709|FG000|Overall Study|Adverse Event|8|||
23484768|NCT00171054|65518710|FG001|Overall Study|Adverse Event|8|||
23484769|NCT00171054|65518709|FG000|Overall Study|Condition no longer required study drug|0|||
23484770|NCT00171054|65518710|FG001|Overall Study|Condition no longer required study drug|1|||
23484771|NCT02117414|65518711|FG000|Overall Study|Death|5|||
23484772|NCT02117414|65518712|FG001|Overall Study|Death|2|||
23484773|NCT02117414|65518711|FG000|Overall Study|Withdrawal by Subject|10|||
23484774|NCT02117414|65518712|FG001|Overall Study|Withdrawal by Subject|4|||
23484775|NCT00908011|65518713|FG000|Overall Study|Withdrawal by Subject|2|||
23484776|NCT00908011|65518714|FG001|Overall Study|Withdrawal by Subject|2|||
23484777|NCT01056380|65518717|FG000|Overall Study|Lost to Follow-up|2|||
23484778|NCT01056380|65518718|FG001|Overall Study|Lost to Follow-up|3|||
23484779|NCT02448680|65518719|FG000|Overall Study|Physician Decision|1|||
23484780|NCT02448680|65518720|FG001|Overall Study|Physician Decision|1|||
23484781|NCT02448680|65518719|FG000|Overall Study|Withdrawal by Subject|0|||
23484782|NCT02448680|65518720|FG001|Overall Study|Withdrawal by Subject|2|||
23484783|NCT01525901|65518721|FG000|Period 2: 12 Weeks|Adverse Event|0|||
23484784|NCT01525901|65518722|FG001|Period 2: 12 Weeks|Adverse Event|1|||
23275657|NCT00163657|64754953|FG000|Overall Study|Other reason|0|||
23275658|NCT00163657|64754954|FG001|Overall Study|Other reason|1|||
23484785|NCT01525901|65518723|FG002|Period 2: 12 Weeks|Adverse Event|0|||
23484786|NCT01525901|65518724|FG003|Period 2: 12 Weeks|Adverse Event|0|||
23484787|NCT01172275|65518728|FG000|Overall Study|Lost to Follow-up|1|||
23275659|NCT00163657|64754955|FG002|Overall Study|Other reason|3|||
23484788|NCT01172275|65518729|FG001|Overall Study|Lost to Follow-up|0|||
23484789|NCT01172275|65518728|FG000|Overall Study|Protocol Violation|1|||
23484790|NCT01172275|65518729|FG001|Overall Study|Protocol Violation|0|||
23484791|NCT01505647|65518734|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
23275660|NCT02412852|64754956|FG000|Overall Study|Withdrawal by Subject|0|||
23484792|NCT01505647|65518735|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
23484793|NCT01505647|65518734|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
23484794|NCT01505647|65518735|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
23484795|NCT01505647|65518734|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
23484796|NCT01505647|65518735|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
23484797|NCT01505647|65518734|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
23484798|NCT01505647|65518735|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
23484799|NCT01505647|65518734|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
23484800|NCT01505647|65518735|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
23484801|NCT00321893|65518737|FG000|Overall Study|Non-Compliance/Refusal|16|||
23484802|NCT00321893|65518738|FG001|Overall Study|Non-Compliance/Refusal|10|||
23484803|NCT00321893|65518737|FG000|Overall Study|Lost to Follow-up|2|||
23484804|NCT00321893|65518738|FG001|Overall Study|Lost to Follow-up|1|||
23484805|NCT00321893|65518737|FG000|Overall Study|Adverse Event|6|||
23484806|NCT00321893|65518738|FG001|Overall Study|Adverse Event|3|||
23484807|NCT01629706|65518739|FG000|Phase 1 PureVision|Screen Failure|4|||
23484808|NCT01629706|65518739|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
23484809|NCT01629706|65518739|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
23484810|NCT01629706|65518739|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
23484811|NCT01629706|65518739|FG000|Phase 2 Habitual|Screen Failure|6|||
23484812|NCT01629706|65518739|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
23484813|NCT01629706|65518739|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
23484814|NCT01629706|65518739|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
23484815|NCT01629706|65518739|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
23484816|NCT00686998|65518745|FG000|Overall Study|Adverse Event|3|||
23484817|NCT00686998|65518746|FG001|Overall Study|Adverse Event|2|||
23484818|NCT00686998|65518747|FG002|Overall Study|Adverse Event|1|||
23484819|NCT00686998|65518745|FG000|Overall Study|Withdrawal by Subject|2|||
23484820|NCT00686998|65518746|FG001|Overall Study|Withdrawal by Subject|1|||
23484821|NCT00686998|65518747|FG002|Overall Study|Withdrawal by Subject|2|||
23484822|NCT00686998|65518745|FG000|Overall Study|Lack of Efficacy|7|||
23484823|NCT00686998|65518746|FG001|Overall Study|Lack of Efficacy|5|||
23484824|NCT00686998|65518747|FG002|Overall Study|Lack of Efficacy|0|||
23484825|NCT00686998|65518745|FG000|Overall Study|Other|0|||
23484826|NCT00686998|65518746|FG001|Overall Study|Other|0|||
23484827|NCT00686998|65518747|FG002|Overall Study|Other|1|||
23484828|NCT00686998|65518745|FG000|Overall Study|Safety Reasons|1|||
23484829|NCT00686998|65518746|FG001|Overall Study|Safety Reasons|0|||
23484830|NCT00686998|65518747|FG002|Overall Study|Safety Reasons|0|||
23484831|NCT01205581|65518748|FG000|Overall Study|Withdrawal by Subject|1|||
23484832|NCT01205581|65518749|FG001|Overall Study|Withdrawal by Subject|0|||
23275661|NCT02412852|64754957|FG001|Overall Study|Withdrawal by Subject|1|||
23275662|NCT02412852|64754958|FG002|Overall Study|Withdrawal by Subject|0|||
23484833|NCT01205581|65518750|FG002|Overall Study|Withdrawal by Subject|0|||
23484834|NCT01205581|65518751|FG003|Overall Study|Withdrawal by Subject|0|||
23275663|NCT02412852|64754959|FG003|Overall Study|Withdrawal by Subject|0|||
23484835|NCT01205581|65518752|FG004|Overall Study|Withdrawal by Subject|0|||
23275664|NCT02412852|64754956|FG000|Overall Study|Physician Decision|0|||
23484836|NCT01205581|65518753|FG005|Overall Study|Withdrawal by Subject|0|||
23484837|NCT00812487|65518754|FG000|Overall Study|Lost to Follow-up|2|||
23484838|NCT00812487|65518755|FG001|Overall Study|Lost to Follow-up|0|||
23602717|NCT00571649|65934123|FG000|Treatment Period|Clinical endpoint reached|50|||
23602718|NCT00571649|65934124|FG001|Treatment Period|Clinical endpoint reached|56|||
23275665|NCT02412852|64754957|FG001|Overall Study|Physician Decision|0|||
23602719|NCT00571649|65934123|FG000|Treatment Period|Withdrawal by Subject|285|||
23602720|NCT00571649|65934124|FG001|Treatment Period|Withdrawal by Subject|255|||
23602721|NCT00571649|65934123|FG000|Treatment Period|Death|76|||
23602722|NCT00571649|65934124|FG001|Treatment Period|Death|59|||
23602723|NCT00571649|65934123|FG000|Treatment Period|Physician Decision|8|||
23602724|NCT00571649|65934124|FG001|Treatment Period|Physician Decision|9|||
23602725|NCT00571649|65934123|FG000|Treatment Period|Lost to Follow-up|43|||
23602726|NCT00571649|65934124|FG001|Treatment Period|Lost to Follow-up|41|||
23275666|NCT02412852|64754958|FG002|Overall Study|Physician Decision|0|||
23484839|NCT00812487|65518754|FG000|Overall Study|Withdrawal by Subject|3|||
23484840|NCT00812487|65518755|FG001|Overall Study|Withdrawal by Subject|2|||
23484841|NCT00812487|65518754|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
23484842|NCT00812487|65518755|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
23484843|NCT00812487|65518754|FG000|Overall Study|Protocol Violation|0|||
23602727|NCT00571649|65934123|FG000|Treatment Period|Non-compliant with study medication|88|||
23602728|NCT00571649|65934124|FG001|Treatment Period|Non-compliant with study medication|89|||
23484844|NCT00812487|65518755|FG001|Overall Study|Protocol Violation|1|||
23484845|NCT02117427|65518756|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
23484846|NCT02117427|65518757|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
23484847|NCT02117427|65518758|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
23484848|NCT02117427|65518756|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
23484849|NCT02117427|65518757|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
23484850|NCT02117427|65518758|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
23484851|NCT02117427|65518756|FG000|Overall Study|Physician Decision|0|||
23484852|NCT02117427|65518757|FG001|Overall Study|Physician Decision|2|||
23275667|NCT02412852|64754959|FG003|Overall Study|Physician Decision|1|||
23275668|NCT00950989|64754962|FG000|Overall Study|Death|0|||
23275669|NCT00950989|64754963|FG001|Overall Study|Death|0|||
23275670|NCT00950989|64754964|FG002|Overall Study|Death|1|||
23275671|NCT00950989|64754965|FG003|Overall Study|Death|0|||
23275672|NCT00950989|64754962|FG000|Overall Study|Administrative Decision|0|||
23275673|NCT00950989|64754963|FG001|Overall Study|Administrative Decision|1|||
23275674|NCT00950989|64754964|FG002|Overall Study|Administrative Decision|0|||
23275675|NCT00950989|64754965|FG003|Overall Study|Administrative Decision|0|||
23275676|NCT00950989|64754962|FG000|Overall Study|Disease Progression|0|||
23275677|NCT00950989|64754963|FG001|Overall Study|Disease Progression|0|||
23275678|NCT00950989|64754964|FG002|Overall Study|Disease Progression|1|||
23275679|NCT00950989|64754965|FG003|Overall Study|Disease Progression|0|||
23275680|NCT00950989|64754962|FG000|Overall Study|Withdrawal by Subject|2|||
23275681|NCT00950989|64754963|FG001|Overall Study|Withdrawal by Subject|1|||
23275682|NCT00950989|64754964|FG002|Overall Study|Withdrawal by Subject|0|||
23275683|NCT00950989|64754965|FG003|Overall Study|Withdrawal by Subject|0|||
23275684|NCT00950989|64754962|FG000|Overall Study|Adverse Event|2|||
23275685|NCT00950989|64754963|FG001|Overall Study|Adverse Event|1|||
23275686|NCT00950989|64754964|FG002|Overall Study|Adverse Event|1|||
23275687|NCT00950989|64754965|FG003|Overall Study|Adverse Event|0|||
23275688|NCT03375463|64754966|FG000|Period 1|Lost to Follow-up|0|||
23275689|NCT03375463|64754967|FG001|Period 1|Lost to Follow-up|0|||
23275690|NCT03375463|64754968|FG002|Period 1|Lost to Follow-up|1|||
23275691|NCT03375463|64754969|FG003|Period 1|Lost to Follow-up|0|||
23275692|NCT03375463|64754970|FG004|Period 1|Lost to Follow-up|0|||
23275693|NCT03375463|64754971|FG005|Period 1|Lost to Follow-up|0|||
23275694|NCT03375463|64754966|FG000|Period 1|Adverse Event|0|||
23275695|NCT03375463|64754967|FG001|Period 1|Adverse Event|0|||
23275696|NCT03375463|64754968|FG002|Period 1|Adverse Event|0|||
23275697|NCT03375463|64754969|FG003|Period 1|Adverse Event|0|||
23275698|NCT03375463|64754970|FG004|Period 1|Adverse Event|1|||
23275699|NCT03375463|64754971|FG005|Period 1|Adverse Event|0|||
23275700|NCT03375463|64754966|FG000|Period 2|Lost to Follow-up|1|||
23484853|NCT02117427|65518758|FG002|Overall Study|Physician Decision|0|||
23484854|NCT02117427|65518756|FG000|Overall Study|No longer meets inclusion criteria|0|||
23484855|NCT02117427|65518757|FG001|Overall Study|No longer meets inclusion criteria|1|||
23602729|NCT00571649|65934123|FG000|Treatment Period|Patient convenience|11|||
23602730|NCT00571649|65934124|FG001|Treatment Period|Patient convenience|13|||
23602731|NCT00571649|65934123|FG000|Treatment Period|Protocol Violation|90|||
23602732|NCT00571649|65934124|FG001|Treatment Period|Protocol Violation|92|||
23602733|NCT00571649|65934123|FG000|Treatment Period|Technical problems|3|||
23602734|NCT00571649|65934124|FG001|Treatment Period|Technical problems|5|||
23602735|NCT00571649|65934123|FG000|Follow-up Period|Adverse Event|46|||
23602736|NCT00571649|65934124|FG001|Follow-up Period|Adverse Event|40|||
23602737|NCT00571649|65934123|FG000|Follow-up Period|Clinical endpoint reached|5|||
23602738|NCT00571649|65934124|FG001|Follow-up Period|Clinical endpoint reached|2|||
23602739|NCT00571649|65934123|FG000|Follow-up Period|Withdrawal by Subject|119|||
23602740|NCT00571649|65934124|FG001|Follow-up Period|Withdrawal by Subject|115|||
23602741|NCT00571649|65934123|FG000|Follow-up Period|Death|132|||
23602742|NCT00571649|65934124|FG001|Follow-up Period|Death|133|||
23602743|NCT00571649|65934123|FG000|Follow-up Period|Physician Decision|7|||
23602744|NCT00571649|65934124|FG001|Follow-up Period|Physician Decision|13|||
23602745|NCT00571649|65934123|FG000|Follow-up Period|Lost to Follow-up|95|||
23602746|NCT00571649|65934124|FG001|Follow-up Period|Lost to Follow-up|92|||
23275701|NCT03375463|64754967|FG001|Period 2|Lost to Follow-up|1|||
23275702|NCT03375463|64754968|FG002|Period 2|Lost to Follow-up|0|||
23275703|NCT03375463|64754969|FG003|Period 2|Lost to Follow-up|0|||
23275704|NCT03375463|64754970|FG004|Period 2|Lost to Follow-up|0|||
23275705|NCT03375463|64754971|FG005|Period 2|Lost to Follow-up|0|||
23275706|NCT03649477|64754983|FG000|Overall Study|Adverse Event|2|||
23275707|NCT03649477|64754984|FG001|Overall Study|Adverse Event|0|||
23275708|NCT03649477|64754985|FG002|Overall Study|Adverse Event|0|||
23275709|NCT05041361|64754986|FG000|Overall Study|Lost to Follow-up|1|||
23275710|NCT05041361|64754987|FG001|Overall Study|Lost to Follow-up|3|||
23602747|NCT00571649|65934123|FG000|Follow-up Period|Patient convenience|136|||
23602748|NCT00571649|65934124|FG001|Follow-up Period|Patient convenience|121|||
23602749|NCT00571649|65934123|FG000|Follow-up Period|Protocol Violation|5|||
23602750|NCT00571649|65934124|FG001|Follow-up Period|Protocol Violation|12|||
23602751|NCT00273052|65934125|FG000|Overall Study|Withdrawal by Subject|16|||
23275711|NCT00467363|64754988|FG000|Overall Study|Lost to Follow-up|80|||
23275712|NCT00467363|64754989|FG001|Overall Study|Lost to Follow-up|70|||
23275713|NCT01746017|64754990|FG000|Period 1|Withdrawal by Subject|0|||
23275714|NCT01746017|64754991|FG001|Period 1|Withdrawal by Subject|0|||
23275715|NCT01746017|64754992|FG002|Period 1|Withdrawal by Subject|0|||
23275716|NCT01746017|64754993|FG003|Period 1|Withdrawal by Subject|0|||
23275717|NCT01746017|64754994|FG004|Period 1|Withdrawal by Subject|0|||
23275718|NCT01746017|64754995|FG005|Period 1|Withdrawal by Subject|0|||
23275719|NCT01746017|64754996|FG006|Period 1|Withdrawal by Subject|1|||
23275720|NCT01746017|64754997|FG007|Period 1|Withdrawal by Subject|0|||
23275721|NCT01746017|64754998|FG008|Period 1|Withdrawal by Subject|0|||
23275722|NCT01746017|64754999|FG009|Period 1|Withdrawal by Subject|0|||
23275723|NCT01746017|64755000|FG010|Period 1|Withdrawal by Subject|0|||
23275724|NCT01746017|64754990|FG000|Period 3|Withdrawal by Subject|0|||
23275725|NCT01746017|64754991|FG001|Period 3|Withdrawal by Subject|0|||
23275726|NCT01746017|64754992|FG002|Period 3|Withdrawal by Subject|0|||
23275727|NCT01746017|64754993|FG003|Period 3|Withdrawal by Subject|0|||
23275728|NCT01746017|64754994|FG004|Period 3|Withdrawal by Subject|0|||
23275729|NCT01746017|64754995|FG005|Period 3|Withdrawal by Subject|1|||
23275730|NCT01746017|64754996|FG006|Period 3|Withdrawal by Subject|0|||
23275731|NCT01746017|64754997|FG007|Period 3|Withdrawal by Subject|0|||
23275732|NCT01746017|64754998|FG008|Period 3|Withdrawal by Subject|0|||
23275733|NCT01746017|64754999|FG009|Period 3|Withdrawal by Subject|0|||
23275734|NCT01746017|64755000|FG010|Period 3|Withdrawal by Subject|0|||
23275735|NCT04175808|64755001|FG000|Part A|Miscellaneous|2|||
23275736|NCT04175808|64755002|FG001|Part A|Miscellaneous|0|||
23275737|NCT04175808|64755003|FG002|Part A|Miscellaneous|0|||
23275738|NCT04175808|64755004|FG003|Part A|Miscellaneous|0|||
23275739|NCT04175808|64755005|FG004|Part A|Miscellaneous|0|||
23275740|NCT04175808|64755006|FG005|Part A|Miscellaneous|0|||
23275741|NCT04175808|64755007|FG006|Part A|Miscellaneous|0|||
23275742|NCT03707912|64755008|FG000|Overall Study|Violation of inclusion criteria|1|||
23275743|NCT03707912|64755009|FG001|Overall Study|Violation of inclusion criteria|0|||
23275744|NCT04720664|64755010|FG000|Overall Study|Adverse Event|2|||
23275745|NCT04720664|64755010|FG000|Overall Study|Lack of Efficacy|9|||
23275746|NCT03236311|64755011|FG000|Overall Study|Study terminated by sponsor|0|||
23275747|NCT03236311|64755012|FG001|Overall Study|Study terminated by sponsor|2|||
23275748|NCT03236311|64755011|FG000|Overall Study|Adverse Event|0|||
23275749|NCT03236311|64755012|FG001|Overall Study|Adverse Event|1|||
23275750|NCT02724462|64755013|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
23275751|NCT02724462|64755014|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
23275752|NCT02724462|64755013|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
23275753|NCT02724462|64755014|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
23275754|NCT02724462|64755013|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
23275755|NCT02724462|64755014|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
23368813|NCT03608826|65096088|FG000|Overall Study|Death|3|||
23602752|NCT00273052|65934126|FG001|Overall Study|Withdrawal by Subject|19|||
23602753|NCT00273052|65934125|FG000|Overall Study|Adverse Event|21|||
23602754|NCT00273052|65934126|FG001|Overall Study|Adverse Event|19|||
23602755|NCT00273052|65934125|FG000|Overall Study|Protocol Violation|14|||
23602756|NCT00273052|65934126|FG001|Overall Study|Protocol Violation|18|||
23602757|NCT00273052|65934125|FG000|Overall Study|Lost to Follow-up|7|||
23602758|NCT00273052|65934126|FG001|Overall Study|Lost to Follow-up|25|||
23602759|NCT00273052|65934125|FG000|Overall Study|Lack of Efficacy|6|||
23602760|NCT00273052|65934126|FG001|Overall Study|Lack of Efficacy|4|||
23602761|NCT00273052|65934125|FG000|Overall Study|Non-Compliance|3|||
23602762|NCT00273052|65934126|FG001|Overall Study|Non-Compliance|1|||
23602763|NCT00273052|65934125|FG000|Overall Study|Other|2|||
23602764|NCT00273052|65934126|FG001|Overall Study|Other|0|||
23602765|NCT00273052|65934125|FG000|Overall Study|Worsening serum lipid levels|0|||
23602766|NCT00273052|65934126|FG001|Overall Study|Worsening serum lipid levels|2|||
23275756|NCT02724462|64755013|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
23275757|NCT02724462|64755014|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
23368814|NCT03608826|65096088|FG000|Overall Study|Heart Transplant|3|||
23368815|NCT03608826|65096088|FG000|Overall Study|Physician Decision|4|||
23275758|NCT02724462|64755013|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
23275759|NCT02724462|64755014|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
23275760|NCT02724462|64755013|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
23275761|NCT02724462|64755014|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
23602767|NCT01880736|65937143|FG000|Overall Study|Adverse Event|0|||
23602768|NCT01880736|65937144|FG001|Overall Study|Adverse Event|0|||
23275762|NCT01878292|64755015|FG000|Randomized|Protocol Violation|1|||
23275763|NCT01878292|64755016|FG001|Randomized|Protocol Violation|0|||
23602769|NCT01880736|65937145|FG002|Overall Study|Adverse Event|0|||
23602770|NCT01880736|65937146|FG003|Overall Study|Adverse Event|1|||
23602771|NCT01880736|65937143|FG000|Overall Study|Withdrawal Criteria|1|||
23602772|NCT01880736|65937144|FG001|Overall Study|Withdrawal Criteria|2|||
23602773|NCT01880736|65937145|FG002|Overall Study|Withdrawal Criteria|1|||
23275764|NCT01878292|64755017|FG002|Randomized|Protocol Violation|0|||
23275765|NCT01878292|64755015|FG000|Randomized|Lost to Follow-up|1|||
23275766|NCT01878292|64755016|FG001|Randomized|Lost to Follow-up|0|||
23368816|NCT01883895|65096089|FG000|Overall Study|Lost to Follow-up|2|||
23368817|NCT00232557|65096090|FG000|Overall Study|Lost to Follow-up|3|||
23368818|NCT00232557|65096091|FG001|Overall Study|Lost to Follow-up|5|||
23368819|NCT01089127|65096092|FG000|Overall Study|Adverse Event|5|||
23368820|NCT01089127|65096093|FG001|Overall Study|Adverse Event|1|||
23368821|NCT01089127|65096094|FG002|Overall Study|Adverse Event|1|||
23368822|NCT01089127|65096095|FG003|Overall Study|Adverse Event|0|||
23368823|NCT01089127|65096096|FG004|Overall Study|Adverse Event|0|||
23368824|NCT01089127|65096097|FG005|Overall Study|Adverse Event|1|||
23368825|NCT01089127|65096092|FG000|Overall Study|Subject withdrew consent|0|||
23368826|NCT01089127|65096093|FG001|Overall Study|Subject withdrew consent|1|||
23368827|NCT01089127|65096094|FG002|Overall Study|Subject withdrew consent|1|||
23368828|NCT01089127|65096095|FG003|Overall Study|Subject withdrew consent|1|||
23368829|NCT01089127|65096096|FG004|Overall Study|Subject withdrew consent|0|||
23368830|NCT01089127|65096097|FG005|Overall Study|Subject withdrew consent|2|||
23368831|NCT01089127|65096092|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23368832|NCT01089127|65096093|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23368833|NCT01089127|65096094|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23368834|NCT01089127|65096095|FG003|Overall Study|Abnormal test procedure result(s)|0|||
23368835|NCT01089127|65096096|FG004|Overall Study|Abnormal test procedure result(s)|0|||
23368836|NCT01089127|65096097|FG005|Overall Study|Abnormal test procedure result(s)|0|||
23368837|NCT01089127|65096092|FG000|Overall Study|Lost to Follow-up|1|||
23368838|NCT01089127|65096093|FG001|Overall Study|Lost to Follow-up|1|||
23368839|NCT01089127|65096094|FG002|Overall Study|Lost to Follow-up|0|||
23368840|NCT01089127|65096095|FG003|Overall Study|Lost to Follow-up|0|||
23368841|NCT01089127|65096096|FG004|Overall Study|Lost to Follow-up|1|||
23368842|NCT01089127|65096097|FG005|Overall Study|Lost to Follow-up|0|||
23368843|NCT01089127|65096092|FG000|Overall Study|Protocol deviation|0|||
23368844|NCT01089127|65096093|FG001|Overall Study|Protocol deviation|1|||
23368845|NCT01089127|65096094|FG002|Overall Study|Protocol deviation|0|||
23368846|NCT01089127|65096095|FG003|Overall Study|Protocol deviation|0|||
23368847|NCT01089127|65096096|FG004|Overall Study|Protocol deviation|1|||
23368848|NCT01089127|65096097|FG005|Overall Study|Protocol deviation|0|||
23368849|NCT01278342|65096098|FG000|Overall Study|Physician Decision|0|||
23368850|NCT01278342|65096099|FG001|Overall Study|Physician Decision|1|||
23368851|NCT01278342|65096100|FG002|Overall Study|Physician Decision|0|||
23368852|NCT01278342|65096098|FG000|Overall Study|Lost to Follow-up|1|||
23368853|NCT01278342|65096099|FG001|Overall Study|Lost to Follow-up|0|||
23368854|NCT01278342|65096100|FG002|Overall Study|Lost to Follow-up|0|||
23275767|NCT01878292|64755017|FG002|Randomized|Lost to Follow-up|0|||
23275768|NCT01878292|64755015|FG000|Randomized|Adverse Event|1|||
23275769|NCT01878292|64755016|FG001|Randomized|Adverse Event|0|||
23275770|NCT01878292|64755017|FG002|Randomized|Adverse Event|0|||
23275771|NCT01878292|64755015|FG000|Double-blind Treatment Period|Other Reasons|2|||
23275772|NCT01878292|64755016|FG001|Double-blind Treatment Period|Other Reasons|0|||
23275773|NCT01878292|64755017|FG002|Double-blind Treatment Period|Other Reasons|0|||
23275774|NCT01878292|64755015|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
23275775|NCT01878292|64755016|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
23275776|NCT01878292|64755017|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
23275777|NCT01878292|64755015|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
23275778|NCT01878292|64755016|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
23275779|NCT01878292|64755017|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
23275780|NCT01878292|64755015|FG000|Double-blind Treatment Period|Protocol Violation|3|||
23275781|NCT01878292|64755016|FG001|Double-blind Treatment Period|Protocol Violation|4|||
23368855|NCT01278342|65096098|FG000|Overall Study|Administrative problems|2|||
23368856|NCT01278342|65096099|FG001|Overall Study|Administrative problems|0|||
23275782|NCT01878292|64755017|FG002|Double-blind Treatment Period|Protocol Violation|2|||
23275783|NCT01878292|64755015|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
23275784|NCT01878292|64755016|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
23275785|NCT01878292|64755017|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
23275786|NCT01878292|64755015|FG000|Double-blind Treatment Period|Adverse Event|4|||
23368857|NCT01278342|65096100|FG002|Overall Study|Administrative problems|0|||
23602774|NCT01880736|65937146|FG003|Overall Study|Withdrawal Criteria|5|||
23602775|NCT00933270|65937148|FG000|Overall Study|Withdrawal by Subject|26|||
23484856|NCT02117427|65518758|FG002|Overall Study|No longer meets inclusion criteria|0|||
23484857|NCT02117427|65518756|FG000|Overall Study|Death|0|||
23484858|NCT02117427|65518757|FG001|Overall Study|Death|1|||
23484859|NCT02117427|65518758|FG002|Overall Study|Death|0|||
23484860|NCT02414139|65518759|FG000|Treatment Period|Adverse Event|11|||
23484861|NCT02414139|65518760|FG001|Treatment Period|Adverse Event|6|||
23484862|NCT02414139|65518761|FG002|Treatment Period|Adverse Event|8|||
23484863|NCT02414139|65518762|FG003|Treatment Period|Adverse Event|5|||
23484864|NCT02414139|65518763|FG004|Treatment Period|Adverse Event|14|||
23484865|NCT02414139|65518764|FG005|Treatment Period|Adverse Event|3|||
23484866|NCT02414139|65518765|FG006|Treatment Period|Adverse Event|6|||
23484867|NCT02414139|65518766|FG007|Treatment Period|Adverse Event|1|||
23484868|NCT02414139|65518767|FG008|Treatment Period|Adverse Event|6|||
23484869|NCT02414139|65518768|FG009|Treatment Period|Adverse Event|8|||
23484870|NCT02414139|65518759|FG000|Treatment Period|Death|0|||
23484871|NCT02414139|65518760|FG001|Treatment Period|Death|0|||
23484872|NCT02414139|65518761|FG002|Treatment Period|Death|1|||
23484873|NCT02414139|65518762|FG003|Treatment Period|Death|1|||
23484874|NCT02414139|65518763|FG004|Treatment Period|Death|0|||
23484875|NCT02414139|65518764|FG005|Treatment Period|Death|0|||
23484876|NCT02414139|65518765|FG006|Treatment Period|Death|0|||
23484877|NCT02414139|65518766|FG007|Treatment Period|Death|0|||
23484878|NCT02414139|65518767|FG008|Treatment Period|Death|0|||
23484879|NCT02414139|65518768|FG009|Treatment Period|Death|1|||
23484880|NCT02414139|65518759|FG000|Treatment Period|Physician Decision|5|||
23484881|NCT02414139|65518760|FG001|Treatment Period|Physician Decision|4|||
23484882|NCT02414139|65518761|FG002|Treatment Period|Physician Decision|6|||
23484883|NCT02414139|65518762|FG003|Treatment Period|Physician Decision|1|||
23484884|NCT02414139|65518763|FG004|Treatment Period|Physician Decision|4|||
23484885|NCT02414139|65518764|FG005|Treatment Period|Physician Decision|0|||
23484886|NCT02414139|65518765|FG006|Treatment Period|Physician Decision|2|||
23602776|NCT00933270|65937148|FG000|Overall Study|Insufficient Follow-up|10|||
23602777|NCT00933270|65937148|FG000|Overall Study|Lost to Follow-up|14|||
23602778|NCT00933270|65937148|FG000|Overall Study|Adverse Event|1|||
23602779|NCT00933270|65937148|FG000|Overall Study|Missed Visit|2|||
23602780|NCT00933270|65937148|FG000|Overall Study|Death|24|||
23602781|NCT00933270|65937148|FG000|Overall Study|Moved or would not return|10|||
23602782|NCT01218659|65937151|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
23602783|NCT01218659|65937152|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
23602784|NCT01218659|65937153|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
23275787|NCT01878292|64755016|FG001|Double-blind Treatment Period|Adverse Event|9|||
23275788|NCT01878292|64755017|FG002|Double-blind Treatment Period|Adverse Event|8|||
23602785|NCT01218659|65937151|FG000|18-Month Randomized Period|Did not receive study drug|0|||
23602786|NCT01218659|65937152|FG001|18-Month Randomized Period|Did not receive study drug|3|||
23602787|NCT01218659|65937153|FG002|18-Month Randomized Period|Did not receive study drug|0|||
23602788|NCT01218659|65937151|FG000|12-Month OLE|Withdrawal by Subject|0|||
23602789|NCT01218659|65937152|FG001|12-Month OLE|Withdrawal by Subject|0|||
23602790|NCT01218659|65937153|FG002|12-Month OLE|Withdrawal by Subject|2|||
23602791|NCT01218659|65937151|FG000|12-Month OLE|Physician Decision|0|||
23602792|NCT01218659|65937152|FG001|12-Month OLE|Physician Decision|0|||
23602793|NCT01218659|65937153|FG002|12-Month OLE|Physician Decision|1|||
23275789|NCT01878292|64755015|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
23275790|NCT01878292|64755016|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
23275791|NCT01878292|64755017|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
23275792|NCT03437265|64755018|FG000|Overall Study|Protocol Violation|6|||
23275793|NCT01498120|64755019|FG000|Overall Study|Lost to Follow-up|1|||
23275794|NCT01498120|64755019|FG000|Overall Study|Withdrawal by Subject|5|||
23275795|NCT01498120|64755019|FG000|Overall Study|AE, non-serious non-fatal|3|||
23275796|NCT01498120|64755019|FG000|Overall Study|Other|4|||
23275797|NCT00453362|64755024|FG000|Overall Study|Adverse Event|5|||
23275798|NCT00453362|64755024|FG000|Overall Study|Death|7|||
23275799|NCT00453362|64755024|FG000|Overall Study|Physician Decision|2|||
23275800|NCT00453362|64755024|FG000|Overall Study|Withdrawal by Subject|3|||
23484887|NCT02414139|65518766|FG007|Treatment Period|Physician Decision|0|||
23484888|NCT02414139|65518767|FG008|Treatment Period|Physician Decision|1|||
23484889|NCT02414139|65518768|FG009|Treatment Period|Physician Decision|4|||
23484890|NCT02414139|65518759|FG000|Treatment Period|Progressive disease|48|||
23484891|NCT02414139|65518760|FG001|Treatment Period|Progressive disease|31|||
23484892|NCT02414139|65518761|FG002|Treatment Period|Progressive disease|37|||
23484893|NCT02414139|65518762|FG003|Treatment Period|Progressive disease|21|||
23484894|NCT02414139|65518763|FG004|Treatment Period|Progressive disease|43|||
23602794|NCT01218659|65937151|FG000|12-Month OLE|Lost to Follow-up|0|||
23275801|NCT00453362|64755024|FG000|Overall Study|Progression of disease|56|||
23275802|NCT00453362|64755024|FG000|Overall Study|Screening Failure|14|||
23484895|NCT02414139|65518764|FG005|Treatment Period|Progressive disease|12|||
23484896|NCT02414139|65518765|FG006|Treatment Period|Progressive disease|16|||
23602795|NCT01218659|65937152|FG001|12-Month OLE|Lost to Follow-up|0|||
23602796|NCT01218659|65937153|FG002|12-Month OLE|Lost to Follow-up|1|||
23368858|NCT01278342|65096098|FG000|Overall Study|Other|1|||
23368859|NCT01278342|65096099|FG001|Overall Study|Other|0|||
23368860|NCT01278342|65096100|FG002|Overall Study|Other|0|||
23368861|NCT00671788|65096101|FG000|Overall Study|Adverse Event|8|||
23368862|NCT00671788|65096101|FG000|Overall Study|Refused further treatment|3|||
23368863|NCT00671788|65096101|FG000|Overall Study|Ineligible|1|||
23368864|NCT00671788|65096101|FG000|Overall Study|MD Decision|1|||
23368865|NCT00671788|65096101|FG000|Overall Study|Other|1|||
23368866|NCT02438280|65096102|FG000|Overall Study|Physician Decision|1|||
23368867|NCT02438280|65096103|FG001|Overall Study|Physician Decision|0|||
23368868|NCT02460289|65096119|FG000|Overall Study|Adverse Event|1|||
23368869|NCT02460289|65096119|FG000|Overall Study|Withdrawal by Subject|8|||
23368870|NCT02460289|65096119|FG000|Overall Study|Lost to Follow-up|1|||
23368871|NCT02121795|65096122|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
23368872|NCT02121795|65096123|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
23368873|NCT02121795|65096122|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
23368874|NCT02121795|65096123|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
23368875|NCT02121795|65096122|FG000|Double-Blind Phase|Lost to Follow-up|7|||
23275803|NCT02140060|64755028|FG000|Overall Study|Adverse Event|0|||
23275804|NCT02140060|64755029|FG001|Overall Study|Adverse Event|0|||
23275805|NCT02140060|64755030|FG002|Overall Study|Adverse Event|0|||
23275806|NCT02140060|64755031|FG003|Overall Study|Adverse Event|1|||
23275807|NCT02140060|64755032|FG004|Overall Study|Adverse Event|1|||
23275808|NCT02140060|64755033|FG005|Overall Study|Adverse Event|1|||
23275809|NCT02140060|64755028|FG000|Overall Study|Lack of Efficacy|0|||
23275810|NCT02140060|64755029|FG001|Overall Study|Lack of Efficacy|0|||
23275811|NCT02140060|64755030|FG002|Overall Study|Lack of Efficacy|0|||
23368876|NCT02121795|65096123|FG001|Double-Blind Phase|Lost to Follow-up|4|||
23368877|NCT02121795|65096122|FG000|Double-Blind Phase|Physician Decision|2|||
23368878|NCT02121795|65096123|FG001|Double-Blind Phase|Physician Decision|5|||
23368879|NCT02121795|65096122|FG000|Double-Blind Phase|Adverse Event|5|||
23368880|NCT02121795|65096123|FG001|Double-Blind Phase|Adverse Event|0|||
23602797|NCT01218659|65937151|FG000|12-Month OLE|Pregnancy|0|||
23602798|NCT01218659|65937152|FG001|12-Month OLE|Pregnancy|0|||
23602799|NCT01218659|65937153|FG002|12-Month OLE|Pregnancy|1|||
23602800|NCT01218659|65937151|FG000|12-Month OLE|Lack of Efficacy|0|||
23602801|NCT01218659|65937152|FG001|12-Month OLE|Lack of Efficacy|0|||
23602802|NCT01218659|65937153|FG002|12-Month OLE|Lack of Efficacy|1|||
23602803|NCT01218659|65937151|FG000|12-Month OLE|Declined to participate in the OLE|0|||
23602804|NCT01218659|65937152|FG001|12-Month OLE|Declined to participate in the OLE|0|||
23602805|NCT01218659|65937153|FG002|12-Month OLE|Declined to participate in the OLE|4|||
23602806|NCT01619059|65937154|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
23602807|NCT01619059|65937155|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
23602808|NCT01619059|65937154|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
23602809|NCT01619059|65937155|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
23602810|NCT01619059|65937154|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
23602811|NCT01619059|65937155|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
23602812|NCT01619059|65937154|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
23602813|NCT01619059|65937155|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
23368881|NCT02121795|65096122|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
23368882|NCT02121795|65096123|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
23368883|NCT02121795|65096122|FG000|Double-Blind Phase|Protocol Violation|0|||
23368884|NCT02121795|65096123|FG001|Double-Blind Phase|Protocol Violation|3|||
23368885|NCT02121795|65096122|FG000|Double-Blind Phase|Death|1|||
23368886|NCT02121795|65096123|FG001|Double-Blind Phase|Death|1|||
23368887|NCT02121795|65096122|FG000|Open-Label Phase|Physician Decision|8|||
23368888|NCT02121795|65096123|FG001|Open-Label Phase|Physician Decision|8|||
23368889|NCT02121795|65096122|FG000|Open-Label Phase|Withdrawal by Subject|3|||
23368890|NCT02121795|65096123|FG001|Open-Label Phase|Withdrawal by Subject|2|||
23602814|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
23602815|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
23602816|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
23602817|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
23275812|NCT02140060|64755031|FG003|Overall Study|Lack of Efficacy|1|||
23275813|NCT02140060|64755032|FG004|Overall Study|Lack of Efficacy|0|||
23275814|NCT02140060|64755033|FG005|Overall Study|Lack of Efficacy|0|||
23368891|NCT02121795|65096122|FG000|Open-Label Phase|Lost to Follow-up|1|||
23602818|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
23602819|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
23602820|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Death|1|||
23602821|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Death|0|||
23602822|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
23602823|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
23602824|NCT01619059|65937154|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
23602825|NCT01619059|65937155|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
23602826|NCT00605306|65937156|FG000|Overall Study|Adverse Event|0|||
23602827|NCT00605306|65937157|FG001|Overall Study|Adverse Event|1|||
23602828|NCT02063659|65937162|FG000|Double-Blind Treatment Period|Adverse Event|1|||
23602829|NCT02063659|65937163|FG001|Double-Blind Treatment Period|Adverse Event|2|||
23602830|NCT02063659|65937164|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23602831|NCT02063659|65937165|FG003|Double-Blind Treatment Period|Adverse Event|0|||
23602832|NCT02063659|65937162|FG000|Double-Blind Treatment Period|Physician Decision|1|||
23602833|NCT02063659|65937163|FG001|Double-Blind Treatment Period|Physician Decision|0|||
23602834|NCT02063659|65937164|FG002|Double-Blind Treatment Period|Physician Decision|0|||
23602835|NCT02063659|65937165|FG003|Double-Blind Treatment Period|Physician Decision|0|||
23602836|NCT02063659|65937162|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
23602837|NCT02063659|65937163|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
23275815|NCT03503318|64755039|FG000|Overall Study|Death|1|||
23275816|NCT03503318|64755040|FG001|Overall Study|Death|0|||
23368892|NCT02121795|65096123|FG001|Open-Label Phase|Lost to Follow-up|0|||
23368893|NCT02260817|65096127|FG000|Overall Study|Lost to Follow-up|0|||
23368894|NCT02260817|65096128|FG001|Overall Study|Lost to Follow-up|14|||
23602838|NCT02063659|65937164|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
23602839|NCT02063659|65937165|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
23602840|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
23275817|NCT03503318|64755041|FG002|Overall Study|Death|4|||
23275818|NCT03503318|64755039|FG000|Overall Study|Adverse Event|3|||
23368895|NCT02260817|65096127|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
23368896|NCT02260817|65096128|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
23275819|NCT03503318|64755040|FG001|Overall Study|Adverse Event|4|||
23275820|NCT03503318|64755041|FG002|Overall Study|Adverse Event|2|||
23275821|NCT03503318|64755039|FG000|Overall Study|Withdrawal by Subject|12|||
23275822|NCT03503318|64755040|FG001|Overall Study|Withdrawal by Subject|17|||
23275823|NCT03503318|64755041|FG002|Overall Study|Withdrawal by Subject|16|||
23275824|NCT03503318|64755039|FG000|Overall Study|Protocol Violation|5|||
23275825|NCT03503318|64755040|FG001|Overall Study|Protocol Violation|0|||
23275826|NCT03503318|64755041|FG002|Overall Study|Protocol Violation|3|||
23275827|NCT03503318|64755039|FG000|Overall Study|Lost to Follow-up|17|||
23275828|NCT03503318|64755040|FG001|Overall Study|Lost to Follow-up|15|||
23275829|NCT03503318|64755041|FG002|Overall Study|Lost to Follow-up|12|||
23275830|NCT03503318|64755039|FG000|Overall Study|Other than specified|1|||
23275831|NCT03503318|64755040|FG001|Overall Study|Other than specified|3|||
23368897|NCT02260817|65096127|FG000|Overall Study|Observation, no biopsy|0|||
23368898|NCT02260817|65096128|FG001|Overall Study|Observation, no biopsy|1|||
23368899|NCT02260817|65096127|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
23602841|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
23275832|NCT03503318|64755041|FG002|Overall Study|Other than specified|3|||
23275833|NCT03290781|64755042|FG000|Overall Study|Adverse Event|5|||
23275834|NCT03290781|64755043|FG001|Overall Study|Adverse Event|7|||
23275835|NCT03290781|64755044|FG002|Overall Study|Adverse Event|4|||
23602842|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
23602843|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
23602844|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23602845|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23602846|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
23602847|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
23602848|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23602849|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23602850|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
23602851|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
23602852|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
23602853|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
23602854|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
23602855|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
23602856|NCT02063659|65937162|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23602857|NCT02063659|65937163|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23602858|NCT02063659|65937164|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
23602859|NCT02063659|65937165|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
23602860|NCT01177670|65937166|FG000|Overall Study|Study Terminated|115|||
23602861|NCT01177670|65937166|FG000|Overall Study|Physician Decision|50|||
23602862|NCT01177670|65937166|FG000|Overall Study|Withdrawal by Subject|4|||
23602863|NCT03883828|65937170|FG000|Overall Study|Did not start radiotherapy|1|||
23602864|NCT03883828|65937171|FG001|Overall Study|Did not start radiotherapy|2|||
23602865|NCT01256359|65937172|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
23602866|NCT01256359|65937173|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
23602867|NCT01256359|65937172|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
23602868|NCT01256359|65937173|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
23602869|NCT01773993|65937179|FG000|Overall Study|No Visit After Treatment|35|||
23602870|NCT02167451|65937181|FG000|Overall Study|Withdrawal by Subject|1|||
23602871|NCT01604824|65937184|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602872|NCT01604824|65937185|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602873|NCT01604824|65937186|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602874|NCT01604824|65937187|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602875|NCT01604824|65937188|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
23275836|NCT03290781|64755045|FG003|Overall Study|Adverse Event|1|||
23275837|NCT03290781|64755046|FG004|Overall Study|Adverse Event|0|||
23275838|NCT03290781|64755047|FG005|Overall Study|Adverse Event|0|||
23275839|NCT03290781|64755048|FG006|Overall Study|Adverse Event|0|||
23275840|NCT03290781|64755042|FG000|Overall Study|Death|0|||
23275841|NCT03290781|64755043|FG001|Overall Study|Death|0|||
23275842|NCT03290781|64755044|FG002|Overall Study|Death|1|||
23275843|NCT03290781|64755045|FG003|Overall Study|Death|0|||
23275844|NCT03290781|64755046|FG004|Overall Study|Death|1|||
23275845|NCT03290781|64755047|FG005|Overall Study|Death|0|||
23275846|NCT03290781|64755048|FG006|Overall Study|Death|0|||
23275847|NCT03290781|64755042|FG000|Overall Study|Withdrawal by Subject|6|||
23275848|NCT03290781|64755043|FG001|Overall Study|Withdrawal by Subject|5|||
23275849|NCT03290781|64755044|FG002|Overall Study|Withdrawal by Subject|9|||
23275850|NCT03290781|64755045|FG003|Overall Study|Withdrawal by Subject|10|||
23275851|NCT03290781|64755046|FG004|Overall Study|Withdrawal by Subject|1|||
23275852|NCT03290781|64755047|FG005|Overall Study|Withdrawal by Subject|2|||
23275853|NCT03290781|64755048|FG006|Overall Study|Withdrawal by Subject|0|||
23275854|NCT03290781|64755042|FG000|Overall Study|Physician Decision|0|||
23275855|NCT03290781|64755043|FG001|Overall Study|Physician Decision|1|||
23275856|NCT03290781|64755044|FG002|Overall Study|Physician Decision|0|||
23275857|NCT03290781|64755045|FG003|Overall Study|Physician Decision|0|||
23275858|NCT03290781|64755046|FG004|Overall Study|Physician Decision|0|||
23275859|NCT03290781|64755047|FG005|Overall Study|Physician Decision|0|||
23275860|NCT03290781|64755048|FG006|Overall Study|Physician Decision|0|||
23275861|NCT03290781|64755042|FG000|Overall Study|Site Terminated by Sponsor|1|||
23275862|NCT03290781|64755043|FG001|Overall Study|Site Terminated by Sponsor|0|||
23275863|NCT03290781|64755044|FG002|Overall Study|Site Terminated by Sponsor|2|||
23275864|NCT03290781|64755045|FG003|Overall Study|Site Terminated by Sponsor|1|||
23275865|NCT03290781|64755046|FG004|Overall Study|Site Terminated by Sponsor|0|||
23275866|NCT03290781|64755047|FG005|Overall Study|Site Terminated by Sponsor|0|||
23275867|NCT03290781|64755048|FG006|Overall Study|Site Terminated by Sponsor|0|||
23275868|NCT03290781|64755042|FG000|Overall Study|Lost to Follow-up|0|||
23275869|NCT03290781|64755043|FG001|Overall Study|Lost to Follow-up|0|||
23275870|NCT03290781|64755044|FG002|Overall Study|Lost to Follow-up|0|||
23275871|NCT03290781|64755045|FG003|Overall Study|Lost to Follow-up|1|||
23275872|NCT03290781|64755046|FG004|Overall Study|Lost to Follow-up|0|||
23275873|NCT03290781|64755047|FG005|Overall Study|Lost to Follow-up|0|||
23275874|NCT03290781|64755048|FG006|Overall Study|Lost to Follow-up|0|||
23275875|NCT03290781|64755042|FG000|Overall Study|Protocol Deviation|2|||
23275876|NCT03290781|64755043|FG001|Overall Study|Protocol Deviation|0|||
23275877|NCT03290781|64755044|FG002|Overall Study|Protocol Deviation|0|||
23275878|NCT03290781|64755045|FG003|Overall Study|Protocol Deviation|1|||
23275879|NCT03290781|64755046|FG004|Overall Study|Protocol Deviation|0|||
23275880|NCT03290781|64755047|FG005|Overall Study|Protocol Deviation|0|||
23275881|NCT03290781|64755048|FG006|Overall Study|Protocol Deviation|0|||
23275882|NCT03290781|64755042|FG000|Overall Study|Disease Relapse|32|||
23275883|NCT03290781|64755043|FG001|Overall Study|Disease Relapse|5|||
23275884|NCT03290781|64755044|FG002|Overall Study|Disease Relapse|38|||
23275885|NCT03290781|64755045|FG003|Overall Study|Disease Relapse|7|||
23275886|NCT03290781|64755046|FG004|Overall Study|Disease Relapse|3|||
23275887|NCT03290781|64755047|FG005|Overall Study|Disease Relapse|1|||
23275888|NCT03290781|64755048|FG006|Overall Study|Disease Relapse|4|||
23275889|NCT03290781|64755042|FG000|Overall Study|Other|3|||
23275890|NCT03290781|64755043|FG001|Overall Study|Other|0|||
23275891|NCT03290781|64755044|FG002|Overall Study|Other|2|||
23275892|NCT03290781|64755045|FG003|Overall Study|Other|2|||
23275893|NCT03290781|64755046|FG004|Overall Study|Other|0|||
23275894|NCT03290781|64755047|FG005|Overall Study|Other|0|||
23275895|NCT03290781|64755048|FG006|Overall Study|Other|0|||
23275896|NCT02956460|64755049|FG000|Lens 1|Lost to Follow-up|1|||
23275897|NCT02956460|64755050|FG001|Lens 1|Lost to Follow-up|0|||
23275898|NCT01534663|64755053|FG000|Overall Study|Lost to Follow-up|0|||
23275899|NCT01534663|64755054|FG001|Overall Study|Lost to Follow-up|2|||
23275900|NCT01534663|64755053|FG000|Overall Study|Adverse Event|2|||
23275901|NCT01534663|64755054|FG001|Overall Study|Adverse Event|1|||
23275902|NCT00787254|64755055|FG000|Overall Study|Adverse Event|24|||
23275903|NCT00787254|64755056|FG001|Overall Study|Adverse Event|23|||
23275904|NCT00787254|64755055|FG000|Overall Study|Protocol Violation|26|||
23275905|NCT00787254|64755056|FG001|Overall Study|Protocol Violation|23|||
23275906|NCT00787254|64755055|FG000|Overall Study|Withdrawal by Subject|16|||
23275907|NCT00787254|64755056|FG001|Overall Study|Withdrawal by Subject|11|||
23275908|NCT00787254|64755055|FG000|Overall Study|Lack of Efficacy|4|||
23275909|NCT00787254|64755056|FG001|Overall Study|Lack of Efficacy|15|||
23275910|NCT00787254|64755055|FG000|Overall Study|NSAIDs discontinuation|1|||
23275911|NCT00787254|64755056|FG001|Overall Study|NSAIDs discontinuation|2|||
23275912|NCT00787254|64755055|FG000|Overall Study|Institution closed|1|||
23275913|NCT00787254|64755056|FG001|Overall Study|Institution closed|0|||
23275914|NCT00787254|64755055|FG000|Overall Study|Physician Decision|4|||
23275915|NCT00787254|64755056|FG001|Overall Study|Physician Decision|8|||
23275916|NCT00096447|64755057|FG000|Overall Study|Never treated|1|||
23275917|NCT00251979|64755059|FG000|Overall Study|Protocol Violation|3|||
23275918|NCT00251979|64755060|FG001|Overall Study|Protocol Violation|5|||
23275919|NCT00251979|64755059|FG000|Overall Study|Adverse Event|11|||
23275920|NCT00251979|64755060|FG001|Overall Study|Adverse Event|17|||
23275921|NCT00251979|64755059|FG000|Overall Study|Withdrawal by Subject|13|||
23275922|NCT00251979|64755060|FG001|Overall Study|Withdrawal by Subject|7|||
23275923|NCT00251979|64755059|FG000|Overall Study|Lost to Follow-up|8|||
23368900|NCT02260817|65096128|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
23368901|NCT02260817|65096127|FG000|Overall Study|Protocol Violation|0|||
23368902|NCT02260817|65096128|FG001|Overall Study|Protocol Violation|14|||
23368903|NCT00969228|65096130|FG000|Overall Study|Adverse Event|1|||
23368904|NCT00969228|65096131|FG001|Overall Study|Adverse Event|0|||
23368905|NCT00969228|65096130|FG000|Overall Study|Withdrawal by Subject|4|||
23368906|NCT00969228|65096131|FG001|Overall Study|Withdrawal by Subject|0|||
23368907|NCT00969228|65096130|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
23368908|NCT00969228|65096131|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
23368909|NCT00994110|65096134|FG000|Overall Study|Withdrawal by Subject|9|||
23368910|NCT00994110|65096135|FG001|Overall Study|Withdrawal by Subject|9|||
23368911|NCT00994110|65096134|FG000|Overall Study|Not Treated|4|||
23368912|NCT00994110|65096135|FG001|Overall Study|Not Treated|8|||
23368913|NCT00994110|65096134|FG000|Overall Study|Adverse Event|1|||
23368914|NCT00994110|65096135|FG001|Overall Study|Adverse Event|0|||
23368915|NCT00994110|65096134|FG000|Overall Study|Patient not resected|41|||
23368916|NCT00994110|65096135|FG001|Overall Study|Patient not resected|52|||
23368917|NCT00994110|65096134|FG000|Overall Study|Pt not eligible|10|||
23368918|NCT00994110|65096135|FG001|Overall Study|Pt not eligible|5|||
23368919|NCT02364388|65096137|FG000|Overall Study|Protocol Violation|1|||
23368920|NCT02364388|65096137|FG000|Overall Study|Technical Failure|3|||
23368921|NCT02364388|65096137|FG000|Overall Study|No OA/US data|2|||
23368922|NCT02364388|65096137|FG000|Overall Study|No Biopsy|2|||
23368923|NCT04161391|65096138|FG000|Overall Study|Adverse Event|0|||
23368924|NCT04161391|65096139|FG001|Overall Study|Adverse Event|1|||
23368925|NCT04161391|65096140|FG002|Overall Study|Adverse Event|0|||
23368926|NCT04161391|65096141|FG003|Overall Study|Adverse Event|1|||
23368927|NCT04161391|65096142|FG004|Overall Study|Adverse Event|0|||
23368928|NCT04161391|65096143|FG005|Overall Study|Adverse Event|0|||
23368929|NCT04161391|65096144|FG006|Overall Study|Adverse Event|0|||
23368930|NCT04161391|65096145|FG007|Overall Study|Adverse Event|3|||
23368931|NCT04161391|65096146|FG008|Overall Study|Adverse Event|0|||
23368932|NCT04161391|65096138|FG000|Overall Study|Death|0|||
23368933|NCT04161391|65096139|FG001|Overall Study|Death|0|||
23368934|NCT04161391|65096140|FG002|Overall Study|Death|0|||
23368935|NCT04161391|65096141|FG003|Overall Study|Death|0|||
23368936|NCT04161391|65096142|FG004|Overall Study|Death|0|||
23368937|NCT04161391|65096143|FG005|Overall Study|Death|0|||
23368938|NCT04161391|65096144|FG006|Overall Study|Death|0|||
23368939|NCT04161391|65096145|FG007|Overall Study|Death|1|||
23368940|NCT04161391|65096146|FG008|Overall Study|Death|0|||
23368941|NCT04161391|65096138|FG000|Overall Study|Physician Decision|0|||
23368942|NCT04161391|65096139|FG001|Overall Study|Physician Decision|0|||
23368943|NCT04161391|65096140|FG002|Overall Study|Physician Decision|1|||
23368944|NCT04161391|65096141|FG003|Overall Study|Physician Decision|2|||
23368945|NCT04161391|65096142|FG004|Overall Study|Physician Decision|0|||
23368946|NCT04161391|65096143|FG005|Overall Study|Physician Decision|0|||
23368947|NCT04161391|65096144|FG006|Overall Study|Physician Decision|2|||
23368948|NCT04161391|65096145|FG007|Overall Study|Physician Decision|0|||
23368949|NCT04161391|65096146|FG008|Overall Study|Physician Decision|0|||
23368950|NCT04161391|65096138|FG000|Overall Study|Progressive Disease|4|||
23368951|NCT04161391|65096139|FG001|Overall Study|Progressive Disease|3|||
23368952|NCT04161391|65096140|FG002|Overall Study|Progressive Disease|3|||
23368953|NCT04161391|65096141|FG003|Overall Study|Progressive Disease|5|||
23368954|NCT04161391|65096142|FG004|Overall Study|Progressive Disease|3|||
23484897|NCT02414139|65518766|FG007|Treatment Period|Progressive disease|2|||
23484898|NCT02414139|65518767|FG008|Treatment Period|Progressive disease|20|||
23484899|NCT02414139|65518768|FG009|Treatment Period|Progressive disease|14|||
23368955|NCT04161391|65096143|FG005|Overall Study|Progressive Disease|3|||
23368956|NCT04161391|65096144|FG006|Overall Study|Progressive Disease|5|||
23368957|NCT04161391|65096145|FG007|Overall Study|Progressive Disease|2|||
23368958|NCT04161391|65096146|FG008|Overall Study|Progressive Disease|2|||
23368959|NCT01719380|65096154|FG000|Overall Study|Adverse Event|0|||
23368960|NCT01719380|65096155|FG001|Overall Study|Adverse Event|0|||
23368961|NCT01719380|65096156|FG002|Overall Study|Adverse Event|1|||
23368962|NCT01719380|65096157|FG003|Overall Study|Adverse Event|2|||
23368963|NCT01719380|65096158|FG004|Overall Study|Adverse Event|0|||
23368964|NCT01719380|65096159|FG005|Overall Study|Adverse Event|1|||
23368965|NCT01719380|65096160|FG006|Overall Study|Adverse Event|0|||
23368966|NCT01719380|65096161|FG007|Overall Study|Adverse Event|1|||
23368967|NCT01719380|65096162|FG008|Overall Study|Adverse Event|4|||
23368968|NCT01719380|65096163|FG009|Overall Study|Adverse Event|3|||
23368969|NCT01719380|65096154|FG000|Overall Study|Death|0|||
23368970|NCT01719380|65096155|FG001|Overall Study|Death|1|||
23368971|NCT01719380|65096156|FG002|Overall Study|Death|0|||
23368972|NCT01719380|65096157|FG003|Overall Study|Death|0|||
23275924|NCT00251979|64755060|FG001|Overall Study|Lost to Follow-up|6|||
23368973|NCT01719380|65096158|FG004|Overall Study|Death|0|||
23368974|NCT01719380|65096159|FG005|Overall Study|Death|0|||
23368975|NCT01719380|65096160|FG006|Overall Study|Death|0|||
23484900|NCT02414139|65518759|FG000|Treatment Period|Protocol deviation|0|||
23368976|NCT01719380|65096161|FG007|Overall Study|Death|0|||
23368977|NCT01719380|65096162|FG008|Overall Study|Death|3|||
23368978|NCT01719380|65096163|FG009|Overall Study|Death|3|||
23368979|NCT01719380|65096154|FG000|Overall Study|Participant/Guardian Decision|0|||
23368980|NCT01719380|65096155|FG001|Overall Study|Participant/Guardian Decision|0|||
23368981|NCT01719380|65096156|FG002|Overall Study|Participant/Guardian Decision|1|||
23368982|NCT01719380|65096157|FG003|Overall Study|Participant/Guardian Decision|0|||
23368983|NCT01719380|65096158|FG004|Overall Study|Participant/Guardian Decision|0|||
23368984|NCT01719380|65096159|FG005|Overall Study|Participant/Guardian Decision|0|||
23368985|NCT01719380|65096160|FG006|Overall Study|Participant/Guardian Decision|0|||
23368986|NCT01719380|65096161|FG007|Overall Study|Participant/Guardian Decision|0|||
23368987|NCT01719380|65096162|FG008|Overall Study|Participant/Guardian Decision|2|||
23368988|NCT01719380|65096163|FG009|Overall Study|Participant/Guardian Decision|2|||
23368989|NCT01719380|65096154|FG000|Overall Study|Physician Decision|0|||
23368990|NCT01719380|65096155|FG001|Overall Study|Physician Decision|0|||
23368991|NCT01719380|65096156|FG002|Overall Study|Physician Decision|2|||
23368992|NCT01719380|65096157|FG003|Overall Study|Physician Decision|0|||
23368993|NCT01719380|65096158|FG004|Overall Study|Physician Decision|0|||
23368994|NCT01719380|65096159|FG005|Overall Study|Physician Decision|0|||
23368995|NCT01719380|65096160|FG006|Overall Study|Physician Decision|0|||
23368996|NCT01719380|65096161|FG007|Overall Study|Physician Decision|0|||
23368997|NCT01719380|65096162|FG008|Overall Study|Physician Decision|1|||
23368998|NCT01719380|65096163|FG009|Overall Study|Physician Decision|1|||
23368999|NCT01719380|65096154|FG000|Overall Study|Lack of Efficacy|2|||
23369000|NCT01719380|65096155|FG001|Overall Study|Lack of Efficacy|6|||
23484901|NCT02414139|65518760|FG001|Treatment Period|Protocol deviation|0|||
23484902|NCT02414139|65518761|FG002|Treatment Period|Protocol deviation|1|||
23484903|NCT02414139|65518762|FG003|Treatment Period|Protocol deviation|0|||
23484904|NCT02414139|65518763|FG004|Treatment Period|Protocol deviation|0|||
23484905|NCT02414139|65518764|FG005|Treatment Period|Protocol deviation|0|||
23484906|NCT02414139|65518765|FG006|Treatment Period|Protocol deviation|0|||
23484907|NCT02414139|65518766|FG007|Treatment Period|Protocol deviation|0|||
23484908|NCT02414139|65518767|FG008|Treatment Period|Protocol deviation|0|||
23484909|NCT02414139|65518768|FG009|Treatment Period|Protocol deviation|0|||
23275925|NCT00251979|64755059|FG000|Overall Study|Death|3|||
23275926|NCT00251979|64755060|FG001|Overall Study|Death|5|||
23275927|NCT01519661|64755061|FG000|Overall Study|Protocol deviation|6|||
23275928|NCT01519661|64755061|FG000|Overall Study|Lost to Follow-up|3|||
23275929|NCT01519661|64755061|FG000|Overall Study|Withdrawal by Subject|17|||
23275930|NCT01519661|64755061|FG000|Overall Study|Lack of Efficacy|6|||
23275931|NCT01519661|64755061|FG000|Overall Study|Adverse Event|29|||
23275932|NCT03606174|64755066|FG000|Overall Study|Death|37|||
23275933|NCT03606174|64755067|FG001|Overall Study|Death|15|||
23275934|NCT03606174|64755068|FG002|Overall Study|Death|15|||
23275935|NCT03606174|64755069|FG003|Overall Study|Death|7|||
23275936|NCT03606174|64755070|FG004|Overall Study|Death|35|||
23275937|NCT03606174|64755071|FG005|Overall Study|Death|12|||
23275938|NCT03606174|64755072|FG006|Overall Study|Death|35|||
23275939|NCT03606174|64755073|FG007|Overall Study|Death|8|||
23275940|NCT03606174|64755074|FG008|Overall Study|Death|5|||
23275941|NCT03606174|64755075|FG009|Overall Study|Death|3|||
23369001|NCT01719380|65096156|FG002|Overall Study|Lack of Efficacy|5|||
23369002|NCT01719380|65096157|FG003|Overall Study|Lack of Efficacy|6|||
23369003|NCT01719380|65096158|FG004|Overall Study|Lack of Efficacy|3|||
23369004|NCT01719380|65096159|FG005|Overall Study|Lack of Efficacy|7|||
23369005|NCT01719380|65096160|FG006|Overall Study|Lack of Efficacy|10|||
23369006|NCT01719380|65096161|FG007|Overall Study|Lack of Efficacy|6|||
23369007|NCT01719380|65096162|FG008|Overall Study|Lack of Efficacy|39|||
23369008|NCT01719380|65096163|FG009|Overall Study|Lack of Efficacy|42|||
23369009|NCT01719380|65096154|FG000|Overall Study|Progressive Disease|0|||
23275942|NCT03606174|64755076|FG010|Overall Study|Death|0|||
23275943|NCT03606174|64755066|FG000|Overall Study|Lost to Follow-up|0|||
23275944|NCT03606174|64755067|FG001|Overall Study|Lost to Follow-up|0|||
23275945|NCT03606174|64755068|FG002|Overall Study|Lost to Follow-up|0|||
23602876|NCT01604824|65937189|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
23602877|NCT01604824|65937184|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602878|NCT01604824|65937185|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602879|NCT01604824|65937186|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602880|NCT01604824|65937187|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602881|NCT01604824|65937188|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
23602882|NCT01604824|65937189|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
23602883|NCT01593020|65937190|FG000|Overall Study|Adverse Event|1|||
23602884|NCT01593020|65937191|FG001|Overall Study|Adverse Event|1|||
23602885|NCT01593020|65937190|FG000|Overall Study|Death|0|||
23602886|NCT01593020|65937191|FG001|Overall Study|Death|1|||
23602887|NCT01593020|65937190|FG000|Overall Study|Ineligible|1|||
23602888|NCT01593020|65937191|FG001|Overall Study|Ineligible|0|||
23602889|NCT01961609|65937193|FG000|Initiation|Missing|3|||
23602890|NCT01961609|65937194|FG001|Initiation|Missing|2|||
23602891|NCT01961609|65937195|FG002|Initiation|Missing|0|||
23602892|NCT01961609|65937196|FG003|Initiation|Missing|0|||
23275946|NCT03606174|64755069|FG003|Overall Study|Lost to Follow-up|0|||
23275947|NCT03606174|64755070|FG004|Overall Study|Lost to Follow-up|1|||
23275948|NCT03606174|64755071|FG005|Overall Study|Lost to Follow-up|1|||
23275949|NCT03606174|64755072|FG006|Overall Study|Lost to Follow-up|0|||
23275950|NCT03606174|64755073|FG007|Overall Study|Lost to Follow-up|0|||
23275951|NCT03606174|64755074|FG008|Overall Study|Lost to Follow-up|0|||
23275952|NCT03606174|64755075|FG009|Overall Study|Lost to Follow-up|0|||
23275953|NCT03606174|64755076|FG010|Overall Study|Lost to Follow-up|0|||
23275954|NCT03606174|64755066|FG000|Overall Study|Withdrawal by Subject|6|||
23275955|NCT03606174|64755067|FG001|Overall Study|Withdrawal by Subject|0|||
23275956|NCT03606174|64755068|FG002|Overall Study|Withdrawal by Subject|0|||
23369010|NCT01719380|65096155|FG001|Overall Study|Progressive Disease|0|||
23602893|NCT01961609|65937193|FG000|Initiation|Protocol deviation|1|||
23602894|NCT01961609|65937194|FG001|Initiation|Protocol deviation|0|||
23275957|NCT03606174|64755069|FG003|Overall Study|Withdrawal by Subject|1|||
23275958|NCT03606174|64755070|FG004|Overall Study|Withdrawal by Subject|2|||
23275959|NCT03606174|64755071|FG005|Overall Study|Withdrawal by Subject|1|||
23602895|NCT01961609|65937195|FG002|Initiation|Protocol deviation|0|||
23602896|NCT01961609|65937196|FG003|Initiation|Protocol deviation|0|||
23602897|NCT01961609|65937193|FG000|Initiation|Death|0|||
23602898|NCT01961609|65937194|FG001|Initiation|Death|1|||
23602899|NCT01961609|65937195|FG002|Initiation|Death|0|||
23602900|NCT01961609|65937196|FG003|Initiation|Death|0|||
23602901|NCT01961609|65937193|FG000|Initiation|Administrative problems|1|||
23602902|NCT01961609|65937194|FG001|Initiation|Administrative problems|0|||
23602903|NCT01961609|65937195|FG002|Initiation|Administrative problems|0|||
23602904|NCT01961609|65937196|FG003|Initiation|Administrative problems|0|||
23602905|NCT01961609|65937193|FG000|Initiation|Withdrawal by Subject|1|||
23602906|NCT01961609|65937194|FG001|Initiation|Withdrawal by Subject|2|||
23602907|NCT01961609|65937195|FG002|Initiation|Withdrawal by Subject|0|||
23602908|NCT01961609|65937196|FG003|Initiation|Withdrawal by Subject|0|||
23602909|NCT01961609|65937193|FG000|Initiation|Lack of Efficacy|2|||
23602910|NCT01961609|65937194|FG001|Initiation|Lack of Efficacy|1|||
23602911|NCT01961609|65937195|FG002|Initiation|Lack of Efficacy|0|||
23602912|NCT01961609|65937196|FG003|Initiation|Lack of Efficacy|0|||
23602913|NCT01961609|65937193|FG000|Initiation|Abnormal lab values|0|||
23602914|NCT01961609|65937194|FG001|Initiation|Abnormal lab values|1|||
23602915|NCT01961609|65937195|FG002|Initiation|Abnormal lab values|0|||
23602916|NCT01961609|65937196|FG003|Initiation|Abnormal lab values|0|||
23602917|NCT01961609|65937193|FG000|Initiation|Adverse Event|3|||
23602918|NCT01961609|65937194|FG001|Initiation|Adverse Event|5|||
23602919|NCT01961609|65937195|FG002|Initiation|Adverse Event|0|||
23602920|NCT01961609|65937196|FG003|Initiation|Adverse Event|0|||
23602921|NCT01961609|65937193|FG000|Initiation|Randomized but not treated|1|||
23602922|NCT01961609|65937194|FG001|Initiation|Randomized but not treated|1|||
23602923|NCT01961609|65937195|FG002|Initiation|Randomized but not treated|0|||
23602924|NCT01961609|65937196|FG003|Initiation|Randomized but not treated|0|||
23602925|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
23602926|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
23602927|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
23602928|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
23602929|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
23602930|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
23602931|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
23602932|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
23602933|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
23602934|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
23602935|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
23602936|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
23602937|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
23602938|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
23602939|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
23369011|NCT01719380|65096156|FG002|Overall Study|Progressive Disease|0|||
23602940|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
23602941|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
23602942|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
23602943|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
23602944|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
23602945|NCT01961609|65937193|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
23602946|NCT01961609|65937194|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
23602947|NCT01961609|65937195|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
23602948|NCT01961609|65937196|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
23602949|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
23602950|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
23602951|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
23602952|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
23369012|NCT01719380|65096157|FG003|Overall Study|Progressive Disease|0|||
23369013|NCT01719380|65096158|FG004|Overall Study|Progressive Disease|0|||
23369014|NCT01719380|65096159|FG005|Overall Study|Progressive Disease|0|||
23369015|NCT01719380|65096160|FG006|Overall Study|Progressive Disease|0|||
23369016|NCT01719380|65096161|FG007|Overall Study|Progressive Disease|0|||
23369017|NCT01719380|65096162|FG008|Overall Study|Progressive Disease|1|||
23369018|NCT01719380|65096163|FG009|Overall Study|Progressive Disease|0|||
23369019|NCT00192114|65096164|FG000|Overall Study|Objective Tumor Progression|19|||
23602953|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
23602954|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
23602955|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
23602956|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
23602957|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
23602958|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
23602959|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
23602960|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
23602961|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
23602962|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
23602963|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
23602964|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
23602965|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
23602966|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
23602967|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
23602968|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
23602969|NCT01961609|65937193|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
23602970|NCT01961609|65937194|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
23602971|NCT01961609|65937195|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
23602972|NCT01961609|65937196|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
23602973|NCT01728324|65937198|FG000|Termination of DBV|Adverse Event|14|||
23602974|NCT01728324|65937199|FG001|Termination of DBV|Adverse Event|13|||
23369020|NCT00192114|65096164|FG000|Overall Study|Adverse Event|2|||
23602975|NCT01728324|65937200|FG002|Termination of DBV|Adverse Event|4|||
23602976|NCT01728324|65937198|FG000|Termination of DBV|Lack of Efficacy|14|||
23602977|NCT01728324|65937199|FG001|Termination of DBV|Lack of Efficacy|12|||
23602978|NCT01728324|65937200|FG002|Termination of DBV|Lack of Efficacy|8|||
23602979|NCT01728324|65937198|FG000|Termination of DBV|Withdrawal by Subject|9|||
23602980|NCT01728324|65937199|FG001|Termination of DBV|Withdrawal by Subject|6|||
23602981|NCT01728324|65937200|FG002|Termination of DBV|Withdrawal by Subject|2|||
23602982|NCT01728324|65937198|FG000|Termination of DBV|Other than stated|1|||
23602983|NCT01728324|65937199|FG001|Termination of DBV|Other than stated|3|||
23602984|NCT01728324|65937200|FG002|Termination of DBV|Other than stated|0|||
23602985|NCT01728324|65937198|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
23602986|NCT01728324|65937199|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
23602987|NCT01728324|65937200|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
23602988|NCT01728324|65937198|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
23369021|NCT00192114|65096164|FG000|Overall Study|Clinical Progression|2|||
23369022|NCT00192114|65096164|FG000|Overall Study|Death|1|||
23369023|NCT01204671|65096165|FG000|Overall Study|Adverse Event|4|||
23369024|NCT01204671|65096166|FG001|Overall Study|Adverse Event|3|||
23369025|NCT01204671|65096167|FG002|Overall Study|Adverse Event|3|||
23369026|NCT01204671|65096168|FG003|Overall Study|Adverse Event|3|||
23369027|NCT01204671|65096169|FG004|Overall Study|Adverse Event|1|||
23369028|NCT01204671|65096165|FG000|Overall Study|Withdrawal by Subject|2|||
23369029|NCT01204671|65096166|FG001|Overall Study|Withdrawal by Subject|3|||
23369030|NCT01204671|65096167|FG002|Overall Study|Withdrawal by Subject|4|||
23369031|NCT01204671|65096168|FG003|Overall Study|Withdrawal by Subject|5|||
23369032|NCT01204671|65096169|FG004|Overall Study|Withdrawal by Subject|3|||
23369033|NCT01204671|65096165|FG000|Overall Study|Lost to Follow-up|7|||
23201344|NCT02214186|64476704|FG001|Overall Study|Lost to Follow-up|1|||
23369034|NCT01204671|65096166|FG001|Overall Study|Lost to Follow-up|8|||
23369035|NCT01204671|65096167|FG002|Overall Study|Lost to Follow-up|6|||
23369036|NCT01204671|65096168|FG003|Overall Study|Lost to Follow-up|4|||
23602989|NCT01728324|65937199|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
23602990|NCT01728324|65937200|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
23602991|NCT01728324|65937198|FG000|Termination of FDV|Adverse Event|14|||
23602992|NCT01728324|65937199|FG001|Termination of FDV|Adverse Event|13|||
23602993|NCT01728324|65937200|FG002|Termination of FDV|Adverse Event|4|||
23602994|NCT01728324|65937198|FG000|Termination of FDV|Lack of Efficacy|14|||
23602995|NCT01728324|65937199|FG001|Termination of FDV|Lack of Efficacy|12|||
23602996|NCT01728324|65937200|FG002|Termination of FDV|Lack of Efficacy|8|||
23602997|NCT01728324|65937198|FG000|Termination of FDV|Withdrawal by Subject|9|||
23602998|NCT01728324|65937199|FG001|Termination of FDV|Withdrawal by Subject|6|||
23602999|NCT01728324|65937200|FG002|Termination of FDV|Withdrawal by Subject|2|||
23603000|NCT01728324|65937198|FG000|Termination of FDV|Other than stated|1|||
23603001|NCT01728324|65937199|FG001|Termination of FDV|Other than stated|3|||
23603002|NCT01728324|65937200|FG002|Termination of FDV|Other than stated|0|||
23603003|NCT01728324|65937198|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
23603004|NCT01728324|65937199|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
23603005|NCT01728324|65937200|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
23603006|NCT01728324|65937198|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
23603007|NCT01728324|65937199|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
23603008|NCT01728324|65937200|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
23603009|NCT01728324|65937198|FG000|Termination of RBV|Adverse Event|15|||
23603010|NCT01728324|65937199|FG001|Termination of RBV|Adverse Event|16|||
23369037|NCT01204671|65096169|FG004|Overall Study|Lost to Follow-up|0|||
23369038|NCT01204671|65096165|FG000|Overall Study|Unknown Completion Status|1|||
23369039|NCT01204671|65096166|FG001|Overall Study|Unknown Completion Status|1|||
23369040|NCT01204671|65096167|FG002|Overall Study|Unknown Completion Status|0|||
23369041|NCT01204671|65096168|FG003|Overall Study|Unknown Completion Status|0|||
23369042|NCT01204671|65096169|FG004|Overall Study|Unknown Completion Status|0|||
23369043|NCT01204671|65096165|FG000|Overall Study|Physician Decision|0|||
23369044|NCT01204671|65096166|FG001|Overall Study|Physician Decision|0|||
23369045|NCT01204671|65096167|FG002|Overall Study|Physician Decision|0|||
23369046|NCT01204671|65096168|FG003|Overall Study|Physician Decision|1|||
23369047|NCT01204671|65096169|FG004|Overall Study|Physician Decision|0|||
23369048|NCT05081388|65096172|FG000|Overall Study|Adverse Event|1|||
23369049|NCT05081388|65096173|FG001|Overall Study|Adverse Event|0|||
23369050|NCT05081388|65096174|FG002|Overall Study|Adverse Event|0|||
23369051|NCT05081388|65096175|FG003|Overall Study|Adverse Event|0|||
23369052|NCT05081388|65096176|FG004|Overall Study|Adverse Event|0|||
23369053|NCT05081388|65096172|FG000|Overall Study|Lost to Follow-up|0|||
23369054|NCT05081388|65096173|FG001|Overall Study|Lost to Follow-up|1|||
23369055|NCT05081388|65096174|FG002|Overall Study|Lost to Follow-up|0|||
23369056|NCT05081388|65096175|FG003|Overall Study|Lost to Follow-up|0|||
23369057|NCT05081388|65096176|FG004|Overall Study|Lost to Follow-up|0|||
23369058|NCT05081388|65096172|FG000|Overall Study|Subject decision|0|||
23369059|NCT05081388|65096173|FG001|Overall Study|Subject decision|0|||
23369060|NCT05081388|65096174|FG002|Overall Study|Subject decision|0|||
23369061|NCT05081388|65096175|FG003|Overall Study|Subject decision|1|||
23369062|NCT05081388|65096176|FG004|Overall Study|Subject decision|0|||
23369063|NCT00492297|65096177|FG000|Treatment|Death|2|||
23369064|NCT00492297|65096177|FG000|Treatment|Study terminated by sponsor|3|||
23369065|NCT00492297|65096177|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
23369066|NCT00492297|65096177|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
23369067|NCT00492297|65096177|FG000|Survival Only Follow-up|Death|46|||
23603011|NCT01728324|65937200|FG002|Termination of RBV|Adverse Event|5|||
23369068|NCT00492297|65096177|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
23369069|NCT00492297|65096177|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
23369070|NCT01001910|65096192|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
23369071|NCT03234036|65096193|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
23369072|NCT03234036|65096194|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
23369073|NCT03234036|65096195|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
23369074|NCT03234036|65096196|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
23369075|NCT00785356|65096197|FG000|Overall Study|Study prematurely terminated|8|||
23369076|NCT03368807|65096198|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
23369077|NCT03368807|65096198|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
23369078|NCT03368807|65096198|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
23369079|NCT03368807|65096198|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
23369080|NCT00716456|65096201|FG000|Overall Study|Adverse Event|0|||
23369081|NCT00716456|65096202|FG001|Overall Study|Adverse Event|2|||
23369082|NCT00716456|65096203|FG002|Overall Study|Adverse Event|0|||
23484910|NCT02414139|65518759|FG000|Treatment Period|Subject/Guardian decision|5|||
23275960|NCT03606174|64755072|FG006|Overall Study|Withdrawal by Subject|4|||
23275961|NCT03606174|64755073|FG007|Overall Study|Withdrawal by Subject|0|||
23275962|NCT03606174|64755074|FG008|Overall Study|Withdrawal by Subject|0|||
23275963|NCT03606174|64755075|FG009|Overall Study|Withdrawal by Subject|0|||
23275964|NCT03606174|64755076|FG010|Overall Study|Withdrawal by Subject|1|||
23275965|NCT03606174|64755066|FG000|Overall Study|Study Terminated by Sponsor|5|||
23275966|NCT03606174|64755067|FG001|Overall Study|Study Terminated by Sponsor|7|||
23275967|NCT03606174|64755068|FG002|Overall Study|Study Terminated by Sponsor|3|||
23275968|NCT03606174|64755069|FG003|Overall Study|Study Terminated by Sponsor|0|||
23275969|NCT03606174|64755070|FG004|Overall Study|Study Terminated by Sponsor|11|||
23275970|NCT03606174|64755071|FG005|Overall Study|Study Terminated by Sponsor|6|||
23275971|NCT03606174|64755072|FG006|Overall Study|Study Terminated by Sponsor|12|||
23275972|NCT03606174|64755073|FG007|Overall Study|Study Terminated by Sponsor|1|||
23275973|NCT03606174|64755074|FG008|Overall Study|Study Terminated by Sponsor|3|||
23275974|NCT03606174|64755075|FG009|Overall Study|Study Terminated by Sponsor|1|||
23275975|NCT03606174|64755076|FG010|Overall Study|Study Terminated by Sponsor|2|||
23275976|NCT03606174|64755066|FG000|Overall Study|Miscellaneous|1|||
23275977|NCT03606174|64755067|FG001|Overall Study|Miscellaneous|1|||
23275978|NCT03606174|64755068|FG002|Overall Study|Miscellaneous|0|||
23275979|NCT03606174|64755069|FG003|Overall Study|Miscellaneous|1|||
23275980|NCT03606174|64755070|FG004|Overall Study|Miscellaneous|4|||
23275981|NCT03606174|64755071|FG005|Overall Study|Miscellaneous|7|||
23275982|NCT03606174|64755072|FG006|Overall Study|Miscellaneous|5|||
23275983|NCT03606174|64755073|FG007|Overall Study|Miscellaneous|0|||
23369083|NCT00072384|65096204|FG000|Overall Study|Physician Decision|1|||
23369084|NCT00072384|65096204|FG000|Overall Study|Ineligible|8|||
23369085|NCT03150082|65096205|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
23369086|NCT03150082|65096206|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
23369087|NCT00243919|65096216|FG000|Overall Study|Death|3|||
23369088|NCT00243919|65096217|FG001|Overall Study|Death|4|||
23369089|NCT00243919|65096218|FG002|Overall Study|Death|6|||
23369090|NCT00243919|65096216|FG000|Overall Study|Withdrawal by Subject|6|||
23369091|NCT00243919|65096217|FG001|Overall Study|Withdrawal by Subject|6|||
23369092|NCT00243919|65096218|FG002|Overall Study|Withdrawal by Subject|2|||
23369093|NCT00243919|65096216|FG000|Overall Study|Lost to Follow-up|6|||
23369094|NCT00243919|65096217|FG001|Overall Study|Lost to Follow-up|7|||
23369095|NCT00243919|65096218|FG002|Overall Study|Lost to Follow-up|3|||
23369096|NCT00243919|65096216|FG000|Overall Study|Administrative Error|1|||
23369097|NCT00243919|65096217|FG001|Overall Study|Administrative Error|0|||
23369098|NCT00243919|65096218|FG002|Overall Study|Administrative Error|0|||
23369099|NCT00243919|65096216|FG000|Overall Study|Physician Decision|1|||
23369100|NCT00243919|65096217|FG001|Overall Study|Physician Decision|1|||
23369101|NCT00243919|65096218|FG002|Overall Study|Physician Decision|0|||
23369102|NCT01128296|65096219|FG000|Overall Study|Physician Decision|0|||
23369103|NCT01128296|65096220|FG001|Overall Study|Physician Decision|0|||
23369104|NCT01128296|65096221|FG002|Overall Study|Physician Decision|0|||
23369105|NCT01128296|65096222|FG003|Overall Study|Physician Decision|0|||
23369106|NCT01128296|65096223|FG004|Overall Study|Physician Decision|0|||
23275984|NCT03606174|64755074|FG008|Overall Study|Miscellaneous|0|||
23275985|NCT03606174|64755075|FG009|Overall Study|Miscellaneous|0|||
23369107|NCT01128296|65096224|FG005|Overall Study|Physician Decision|3|||
23484911|NCT02414139|65518760|FG001|Treatment Period|Subject/Guardian decision|1|||
23275986|NCT03606174|64755076|FG010|Overall Study|Miscellaneous|1|||
23275987|NCT04349917|64755077|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
23275988|NCT04349917|64755078|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
23369108|NCT01128296|65096219|FG000|Overall Study|Withdrawal by Subject|0|||
23369109|NCT01128296|65096220|FG001|Overall Study|Withdrawal by Subject|0|||
23369110|NCT01128296|65096221|FG002|Overall Study|Withdrawal by Subject|0|||
23369111|NCT01128296|65096222|FG003|Overall Study|Withdrawal by Subject|0|||
23369112|NCT01128296|65096223|FG004|Overall Study|Withdrawal by Subject|0|||
23603012|NCT01728324|65937198|FG000|Termination of RBV|Lack of Efficacy|14|||
23275989|NCT04349917|64755077|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
23275990|NCT04349917|64755078|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
23275991|NCT01190930|64755080|FG000|Induction|Adverse Event|17|||
23275992|NCT01190930|64755081|FG001|Induction|Adverse Event|0|||
23275993|NCT01190930|64755082|FG002|Induction|Adverse Event|0|||
23275994|NCT01190930|64755083|FG003|Induction|Adverse Event|0|||
23275995|NCT01190930|64755084|FG004|Induction|Adverse Event|0|||
23275996|NCT01190930|64755085|FG005|Induction|Adverse Event|0|||
23275997|NCT01190930|64755086|FG006|Induction|Adverse Event|0|||
23275998|NCT01190930|64755087|FG007|Induction|Adverse Event|0|||
23275999|NCT01190930|64755088|FG008|Induction|Adverse Event|0|||
23276000|NCT01190930|64755089|FG009|Induction|Adverse Event|0|||
23276001|NCT01190930|64755080|FG000|Induction|Death|34|||
23276002|NCT01190930|64755081|FG001|Induction|Death|0|||
23276003|NCT01190930|64755082|FG002|Induction|Death|0|||
23276004|NCT01190930|64755083|FG003|Induction|Death|0|||
23276005|NCT01190930|64755084|FG004|Induction|Death|0|||
23276006|NCT01190930|64755085|FG005|Induction|Death|0|||
23276007|NCT01190930|64755086|FG006|Induction|Death|0|||
23276008|NCT01190930|64755087|FG007|Induction|Death|0|||
23276009|NCT01190930|64755088|FG008|Induction|Death|0|||
23276010|NCT01190930|64755089|FG009|Induction|Death|0|||
23276011|NCT01190930|64755080|FG000|Induction|Lost to Follow-up|1|||
23276012|NCT01190930|64755081|FG001|Induction|Lost to Follow-up|0|||
23276013|NCT01190930|64755082|FG002|Induction|Lost to Follow-up|0|||
23276014|NCT01190930|64755083|FG003|Induction|Lost to Follow-up|0|||
23276015|NCT01190930|64755084|FG004|Induction|Lost to Follow-up|0|||
23276016|NCT01190930|64755085|FG005|Induction|Lost to Follow-up|0|||
23276017|NCT01190930|64755086|FG006|Induction|Lost to Follow-up|0|||
23276018|NCT01190930|64755087|FG007|Induction|Lost to Follow-up|0|||
23276019|NCT01190930|64755088|FG008|Induction|Lost to Follow-up|0|||
23276020|NCT01190930|64755089|FG009|Induction|Lost to Follow-up|0|||
23276021|NCT01190930|64755080|FG000|Induction|Physician Decision|125|||
23276022|NCT01190930|64755081|FG001|Induction|Physician Decision|3|||
23276023|NCT01190930|64755082|FG002|Induction|Physician Decision|0|||
23276024|NCT01190930|64755083|FG003|Induction|Physician Decision|0|||
23276025|NCT01190930|64755084|FG004|Induction|Physician Decision|0|||
23276026|NCT01190930|64755085|FG005|Induction|Physician Decision|0|||
23276027|NCT01190930|64755086|FG006|Induction|Physician Decision|0|||
23276028|NCT01190930|64755087|FG007|Induction|Physician Decision|0|||
23276029|NCT01190930|64755088|FG008|Induction|Physician Decision|0|||
23276030|NCT01190930|64755089|FG009|Induction|Physician Decision|0|||
23276031|NCT01190930|64755080|FG000|Induction|Withdrawal by Subject|9|||
23276032|NCT01190930|64755081|FG001|Induction|Withdrawal by Subject|0|||
23276033|NCT01190930|64755082|FG002|Induction|Withdrawal by Subject|0|||
23276034|NCT01190930|64755083|FG003|Induction|Withdrawal by Subject|0|||
23276035|NCT01190930|64755084|FG004|Induction|Withdrawal by Subject|0|||
23276036|NCT01190930|64755085|FG005|Induction|Withdrawal by Subject|0|||
23276037|NCT01190930|64755086|FG006|Induction|Withdrawal by Subject|0|||
23276038|NCT01190930|64755087|FG007|Induction|Withdrawal by Subject|0|||
23276039|NCT01190930|64755088|FG008|Induction|Withdrawal by Subject|0|||
23276040|NCT01190930|64755089|FG009|Induction|Withdrawal by Subject|0|||
23276041|NCT01190930|64755080|FG000|Induction|Refusal|235|||
23276042|NCT01190930|64755081|FG001|Induction|Refusal|0|||
23276043|NCT01190930|64755082|FG002|Induction|Refusal|0|||
23276044|NCT01190930|64755083|FG003|Induction|Refusal|0|||
23276045|NCT01190930|64755084|FG004|Induction|Refusal|0|||
23276046|NCT01190930|64755085|FG005|Induction|Refusal|0|||
23276047|NCT01190930|64755086|FG006|Induction|Refusal|0|||
23276048|NCT01190930|64755087|FG007|Induction|Refusal|0|||
23276049|NCT01190930|64755088|FG008|Induction|Refusal|0|||
23276050|NCT01190930|64755089|FG009|Induction|Refusal|0|||
23276051|NCT01190930|64755080|FG000|Induction|Inevaluable|23|||
23276052|NCT01190930|64755081|FG001|Induction|Inevaluable|1|||
23276053|NCT01190930|64755082|FG002|Induction|Inevaluable|0|||
23276054|NCT01190930|64755083|FG003|Induction|Inevaluable|0|||
23603013|NCT01728324|65937199|FG001|Termination of RBV|Lack of Efficacy|11|||
23276055|NCT01190930|64755084|FG004|Induction|Inevaluable|0|||
23276056|NCT01190930|64755085|FG005|Induction|Inevaluable|0|||
23276057|NCT01190930|64755086|FG006|Induction|Inevaluable|0|||
23276058|NCT01190930|64755087|FG007|Induction|Inevaluable|0|||
23276059|NCT01190930|64755088|FG008|Induction|Inevaluable|0|||
23276060|NCT01190930|64755089|FG009|Induction|Inevaluable|0|||
23276061|NCT01190930|64755080|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
23276062|NCT01190930|64755081|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23603014|NCT01728324|65937200|FG002|Termination of RBV|Lack of Efficacy|7|||
23276063|NCT01190930|64755082|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23276064|NCT01190930|64755083|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23276065|NCT01190930|64755084|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23276066|NCT01190930|64755085|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23276067|NCT01190930|64755086|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23276068|NCT01190930|64755087|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23276069|NCT01190930|64755088|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23276070|NCT01190930|64755089|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
23276071|NCT01190930|64755080|FG000|Induction|High Risk Downs|80|||
23276072|NCT01190930|64755081|FG001|Induction|High Risk Downs|0|||
23276073|NCT01190930|64755082|FG002|Induction|High Risk Downs|0|||
23276074|NCT01190930|64755083|FG003|Induction|High Risk Downs|0|||
23276075|NCT01190930|64755084|FG004|Induction|High Risk Downs|0|||
23276076|NCT01190930|64755085|FG005|Induction|High Risk Downs|0|||
23276077|NCT01190930|64755086|FG006|Induction|High Risk Downs|0|||
23276078|NCT01190930|64755087|FG007|Induction|High Risk Downs|0|||
23276079|NCT01190930|64755088|FG008|Induction|High Risk Downs|0|||
23276080|NCT01190930|64755089|FG009|Induction|High Risk Downs|0|||
23276081|NCT01190930|64755080|FG000|Induction|Enrollment onto another COG Protocol|1|||
23276082|NCT01190930|64755081|FG001|Induction|Enrollment onto another COG Protocol|0|||
23276083|NCT01190930|64755082|FG002|Induction|Enrollment onto another COG Protocol|0|||
23276084|NCT01190930|64755083|FG003|Induction|Enrollment onto another COG Protocol|0|||
23276085|NCT01190930|64755084|FG004|Induction|Enrollment onto another COG Protocol|0|||
23276086|NCT01190930|64755085|FG005|Induction|Enrollment onto another COG Protocol|0|||
23484912|NCT02414139|65518761|FG002|Treatment Period|Subject/Guardian decision|1|||
23484913|NCT02414139|65518762|FG003|Treatment Period|Subject/Guardian decision|2|||
23484914|NCT02414139|65518763|FG004|Treatment Period|Subject/Guardian decision|5|||
23484915|NCT02414139|65518764|FG005|Treatment Period|Subject/Guardian decision|0|||
23484916|NCT02414139|65518765|FG006|Treatment Period|Subject/Guardian decision|2|||
23484917|NCT02414139|65518766|FG007|Treatment Period|Subject/Guardian decision|0|||
23484918|NCT02414139|65518767|FG008|Treatment Period|Subject/Guardian decision|1|||
23484919|NCT02414139|65518768|FG009|Treatment Period|Subject/Guardian decision|1|||
23484920|NCT02414139|65518759|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484921|NCT02414139|65518760|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484922|NCT02414139|65518761|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484923|NCT02414139|65518762|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484924|NCT02414139|65518763|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
23484925|NCT02414139|65518764|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484926|NCT02414139|65518765|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
23484927|NCT02414139|65518766|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
23484928|NCT02414139|65518767|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
23484929|NCT02414139|65518768|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
23484930|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
23484931|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484932|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484933|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484934|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
23484935|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484936|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484937|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484938|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484939|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
23484940|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Death|0|||
23484941|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Death|1|||
23484942|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Death|0|||
23484943|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Death|0|||
23484944|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Death|1|||
23201345|NCT02214186|64476703|FG000|Overall Study|Protocol Violation|1|||
23276087|NCT01190930|64755086|FG006|Induction|Enrollment onto another COG Protocol|0|||
23484945|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Death|0|||
23484946|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Death|0|||
23484947|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Death|0|||
23484948|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Death|0|||
23484949|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Death|1|||
23484950|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
23484951|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23201346|NCT02214186|64476704|FG001|Overall Study|Protocol Violation|1|||
23276088|NCT01190930|64755087|FG007|Induction|Enrollment onto another COG Protocol|0|||
23201347|NCT01543490|64476706|FG000|Overall Study|Adverse Event|4|||
23201348|NCT01543490|64476707|FG001|Overall Study|Adverse Event|0|||
23201349|NCT01543490|64476706|FG000|Overall Study|Physician Decision|1|||
23201350|NCT01543490|64476707|FG001|Overall Study|Physician Decision|0|||
23484952|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484953|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484954|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484955|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484956|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484957|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484958|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484959|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
23484960|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
23484961|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
23484962|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
23484963|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
23484964|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
23484965|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23484966|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23484967|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23484968|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23484969|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23484970|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
23484971|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
23484972|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
23484973|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
23484974|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
23484975|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
23201351|NCT01543490|64476706|FG000|Overall Study|Lack of Efficacy|3|||
23276089|NCT01190930|64755088|FG008|Induction|Enrollment onto another COG Protocol|0|||
23484976|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
23484977|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
23484978|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
23484979|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
23484980|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484981|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
23484982|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484983|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484984|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484985|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484986|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484987|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484988|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
23484989|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
23484990|NCT02414139|65518759|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
23484991|NCT02414139|65518760|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23484992|NCT02414139|65518761|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
23484993|NCT02414139|65518762|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
23484994|NCT02414139|65518763|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
23484995|NCT02414139|65518764|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
23484996|NCT02414139|65518765|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
23484997|NCT02414139|65518766|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
23484998|NCT02414139|65518767|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
23484999|NCT02414139|65518768|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
23485000|NCT02961218|65518771|FG000|Overall Study|Lost to Follow-up|0|||
23485001|NCT02961218|65518772|FG001|Overall Study|Lost to Follow-up|2|||
23485002|NCT02961218|65518771|FG000|Overall Study|Physician Decision|0|||
23485003|NCT02961218|65518772|FG001|Overall Study|Physician Decision|2|||
23485004|NCT02961218|65518771|FG000|Overall Study|Subject/Guardian Decision|3|||
23485005|NCT02961218|65518772|FG001|Overall Study|Subject/Guardian Decision|1|||
23276090|NCT01190930|64755089|FG009|Induction|Enrollment onto another COG Protocol|0|||
23276091|NCT01190930|64755080|FG000|Induction|Average Risk|1847|||
23276092|NCT01190930|64755081|FG001|Induction|Average Risk|0|||
23276093|NCT01190930|64755082|FG002|Induction|Average Risk|0|||
23276094|NCT01190930|64755083|FG003|Induction|Average Risk|0|||
23276095|NCT01190930|64755084|FG004|Induction|Average Risk|0|||
23276096|NCT01190930|64755085|FG005|Induction|Average Risk|0|||
23276097|NCT01190930|64755086|FG006|Induction|Average Risk|0|||
23276098|NCT01190930|64755087|FG007|Induction|Average Risk|0|||
23276099|NCT01190930|64755088|FG008|Induction|Average Risk|0|||
23276100|NCT01190930|64755089|FG009|Induction|Average Risk|0|||
23276101|NCT01190930|64755080|FG000|Induction|High Risk|1227|||
23276102|NCT01190930|64755081|FG001|Induction|High Risk|0|||
23276103|NCT01190930|64755082|FG002|Induction|High Risk|0|||
23276104|NCT01190930|64755083|FG003|Induction|High Risk|0|||
23276105|NCT01190930|64755084|FG004|Induction|High Risk|0|||
23276106|NCT01190930|64755085|FG005|Induction|High Risk|0|||
23276107|NCT01190930|64755086|FG006|Induction|High Risk|0|||
23276108|NCT01190930|64755087|FG007|Induction|High Risk|0|||
23276109|NCT01190930|64755088|FG008|Induction|High Risk|0|||
23276110|NCT01190930|64755089|FG009|Induction|High Risk|0|||
23276111|NCT01190930|64755080|FG000|Induction|Low Risk|443|||
23276112|NCT01190930|64755081|FG001|Induction|Low Risk|0|||
23276113|NCT01190930|64755082|FG002|Induction|Low Risk|0|||
23276114|NCT01190930|64755083|FG003|Induction|Low Risk|0|||
23276115|NCT01190930|64755084|FG004|Induction|Low Risk|0|||
23276116|NCT01190930|64755085|FG005|Induction|Low Risk|0|||
23276117|NCT01190930|64755086|FG006|Induction|Low Risk|0|||
23276118|NCT01190930|64755087|FG007|Induction|Low Risk|0|||
23276119|NCT01190930|64755088|FG008|Induction|Low Risk|0|||
23276120|NCT01190930|64755089|FG009|Induction|Low Risk|0|||
23276121|NCT01190930|64755080|FG000|Induction|Very High Risk|1012|||
23276122|NCT01190930|64755081|FG001|Induction|Very High Risk|0|||
23276123|NCT01190930|64755082|FG002|Induction|Very High Risk|0|||
23369113|NCT01128296|65096224|FG005|Overall Study|Withdrawal by Subject|2|||
23369114|NCT02666222|65096229|FG000|Overall Study|Death|2|||
23369115|NCT01079780|65096230|FG000|Overall Study|Disease progression|43|||
23369116|NCT01079780|65096231|FG001|Overall Study|Disease progression|7|||
23369117|NCT01079780|65096232|FG002|Overall Study|Disease progression|31|||
23369118|NCT01079780|65096230|FG000|Overall Study|Adverse Event|13|||
23369119|NCT01079780|65096231|FG001|Overall Study|Adverse Event|5|||
23369120|NCT01079780|65096232|FG002|Overall Study|Adverse Event|7|||
23369121|NCT01079780|65096230|FG000|Overall Study|Death|2|||
23485006|NCT02140775|65518774|FG000|Overall Study|Withdrawal by Subject|30|||
23485007|NCT02140775|65518775|FG001|Overall Study|Withdrawal by Subject|7|||
23276124|NCT01190930|64755083|FG003|Induction|Very High Risk|0|||
23276125|NCT01190930|64755084|FG004|Induction|Very High Risk|0|||
23276126|NCT01190930|64755085|FG005|Induction|Very High Risk|0|||
23276127|NCT01190930|64755086|FG006|Induction|Very High Risk|0|||
23276128|NCT01190930|64755087|FG007|Induction|Very High Risk|0|||
23276129|NCT01190930|64755088|FG008|Induction|Very High Risk|0|||
23276130|NCT01190930|64755089|FG009|Induction|Very High Risk|0|||
23276131|NCT01190930|64755080|FG000|Induction|Philadelphia chromosome-positive|99|||
23276132|NCT01190930|64755081|FG001|Induction|Philadelphia chromosome-positive|0|||
23276133|NCT01190930|64755082|FG002|Induction|Philadelphia chromosome-positive|0|||
23276134|NCT01190930|64755083|FG003|Induction|Philadelphia chromosome-positive|0|||
23276135|NCT01190930|64755084|FG004|Induction|Philadelphia chromosome-positive|0|||
23276136|NCT01190930|64755085|FG005|Induction|Philadelphia chromosome-positive|0|||
23276137|NCT01190930|64755086|FG006|Induction|Philadelphia chromosome-positive|0|||
23276138|NCT01190930|64755087|FG007|Induction|Philadelphia chromosome-positive|0|||
23276139|NCT01190930|64755088|FG008|Induction|Philadelphia chromosome-positive|0|||
23276140|NCT01190930|64755089|FG009|Induction|Philadelphia chromosome-positive|0|||
23276141|NCT01190930|64755080|FG000|Induction|Incomplete Induction data|63|||
23276142|NCT01190930|64755081|FG001|Induction|Incomplete Induction data|0|||
23276143|NCT01190930|64755082|FG002|Induction|Incomplete Induction data|0|||
23276144|NCT01190930|64755083|FG003|Induction|Incomplete Induction data|0|||
23276145|NCT01190930|64755084|FG004|Induction|Incomplete Induction data|0|||
23276146|NCT01190930|64755085|FG005|Induction|Incomplete Induction data|0|||
23276147|NCT01190930|64755086|FG006|Induction|Incomplete Induction data|0|||
23276148|NCT01190930|64755087|FG007|Induction|Incomplete Induction data|0|||
23276149|NCT01190930|64755088|FG008|Induction|Incomplete Induction data|0|||
23276150|NCT01190930|64755089|FG009|Induction|Incomplete Induction data|0|||
23369122|NCT01079780|65096231|FG001|Overall Study|Death|0|||
23369123|NCT01079780|65096232|FG002|Overall Study|Death|2|||
23276151|NCT01190930|64755080|FG000|Induction|Progressive disease|0|||
23276152|NCT01190930|64755081|FG001|Induction|Progressive disease|1|||
23369124|NCT01079780|65096230|FG000|Overall Study|Withdrawal by Subject|6|||
23369125|NCT01079780|65096231|FG001|Overall Study|Withdrawal by Subject|4|||
23369126|NCT01079780|65096232|FG002|Overall Study|Withdrawal by Subject|4|||
23369127|NCT01079780|65096230|FG000|Overall Study|Alternative therapy|2|||
23369128|NCT01079780|65096231|FG001|Overall Study|Alternative therapy|0|||
23369129|NCT01079780|65096232|FG002|Overall Study|Alternative therapy|2|||
23369130|NCT01079780|65096230|FG000|Overall Study|Physician Decision|1|||
23369131|NCT01079780|65096231|FG001|Overall Study|Physician Decision|0|||
23369132|NCT01079780|65096232|FG002|Overall Study|Physician Decision|1|||
23369133|NCT01079780|65096230|FG000|Overall Study|Error made in lesion measurement|1|||
23369134|NCT01079780|65096231|FG001|Overall Study|Error made in lesion measurement|0|||
23369135|NCT01079780|65096232|FG002|Overall Study|Error made in lesion measurement|0|||
23369136|NCT01079780|65096230|FG000|Overall Study|Patient had surgery|1|||
23369137|NCT01079780|65096231|FG001|Overall Study|Patient had surgery|0|||
23369138|NCT01079780|65096232|FG002|Overall Study|Patient had surgery|0|||
23603015|NCT01728324|65937198|FG000|Termination of RBV|Withdrawal by Subject|9|||
23603016|NCT01728324|65937199|FG001|Termination of RBV|Withdrawal by Subject|5|||
23603017|NCT01728324|65937200|FG002|Termination of RBV|Withdrawal by Subject|2|||
23603018|NCT01728324|65937198|FG000|Termination of RBV|Other than stated|1|||
23603019|NCT01728324|65937199|FG001|Termination of RBV|Other than stated|3|||
23603020|NCT01728324|65937200|FG002|Termination of RBV|Other than stated|1|||
23603021|NCT01728324|65937198|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
23603022|NCT01728324|65937199|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
23603023|NCT01728324|65937200|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
23603024|NCT01728324|65937198|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
23603025|NCT01728324|65937199|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
23603026|NCT01728324|65937200|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
23603027|NCT00705406|65937205|FG000|Overall Study|Lost to Follow-up|3|||
23603028|NCT00705406|65937206|FG001|Overall Study|Lost to Follow-up|3|||
23603029|NCT00705406|65937205|FG000|Overall Study|Did not receive study drug|1|||
23603030|NCT00705406|65937206|FG001|Overall Study|Did not receive study drug|2|||
23603031|NCT00403494|65937211|FG000|Overall Study|Adverse Event|10|||
23603032|NCT00403494|65937212|FG001|Overall Study|Adverse Event|8|||
23603033|NCT00403494|65937211|FG000|Overall Study|Withdrew Consent|3|||
23603034|NCT00403494|65937212|FG001|Overall Study|Withdrew Consent|2|||
23603035|NCT00403494|65937211|FG000|Overall Study|Inappropriately enrolled|0|||
23603036|NCT00403494|65937212|FG001|Overall Study|Inappropriately enrolled|1|||
23603037|NCT00403494|65937211|FG000|Overall Study|Lost to Follow-up|0|||
23369139|NCT01079780|65096230|FG000|Overall Study|Treatment cycle delay|0|||
23369140|NCT01079780|65096231|FG001|Overall Study|Treatment cycle delay|0|||
23369141|NCT01079780|65096232|FG002|Overall Study|Treatment cycle delay|1|||
23369142|NCT01079780|65096230|FG000|Overall Study|Never started treatment|1|||
23369143|NCT01079780|65096231|FG001|Overall Study|Never started treatment|0|||
23369144|NCT01079780|65096232|FG002|Overall Study|Never started treatment|2|||
23603038|NCT00403494|65937212|FG001|Overall Study|Lost to Follow-up|2|||
23603039|NCT00403494|65937211|FG000|Overall Study|Protocol noncompliance|0|||
23603040|NCT00403494|65937212|FG001|Overall Study|Protocol noncompliance|1|||
23603041|NCT00403494|65937211|FG000|Overall Study|Death|1|||
23603042|NCT00403494|65937212|FG001|Overall Study|Death|0|||
23603043|NCT00403494|65937211|FG000|Overall Study|Sponsor Request|1|||
23603044|NCT00403494|65937212|FG001|Overall Study|Sponsor Request|0|||
23603045|NCT02797132|65937213|FG000|Part A (15 Days)|Adverse Event|1|||
23603046|NCT02797132|65937213|FG000|Part B (24 Weeks)|Adverse Event|3|||
23603047|NCT03259568|65937214|FG000|Overall Study|Participant performance was low|3|||
23603048|NCT03589768|65937215|FG000|Overall Study|Death|1|||
23603049|NCT03589768|65937216|FG001|Overall Study|Death|0|||
23603050|NCT03589768|65937217|FG002|Overall Study|Death|8|||
23603051|NCT03589768|65937218|FG003|Overall Study|Death|3|||
23603052|NCT03589768|65937215|FG000|Overall Study|Withdrawal by Subject|2|||
23603053|NCT03589768|65937216|FG001|Overall Study|Withdrawal by Subject|0|||
23603054|NCT03589768|65937217|FG002|Overall Study|Withdrawal by Subject|0|||
23603055|NCT03589768|65937218|FG003|Overall Study|Withdrawal by Subject|0|||
23603056|NCT03589768|65937215|FG000|Overall Study|Protocol Violation|1|||
23603057|NCT03589768|65937216|FG001|Overall Study|Protocol Violation|0|||
23603058|NCT03589768|65937217|FG002|Overall Study|Protocol Violation|0|||
23603059|NCT03589768|65937218|FG003|Overall Study|Protocol Violation|0|||
23603060|NCT02923349|65937222|FG000|Overall Study|Other|1|||
23603061|NCT02923349|65937223|FG001|Overall Study|Other|2|||
23276153|NCT01190930|64755082|FG002|Induction|Progressive disease|0|||
23276154|NCT01190930|64755083|FG003|Induction|Progressive disease|0|||
23276155|NCT01190930|64755084|FG004|Induction|Progressive disease|0|||
23276156|NCT01190930|64755085|FG005|Induction|Progressive disease|0|||
23276157|NCT01190930|64755086|FG006|Induction|Progressive disease|0|||
23276158|NCT01190930|64755087|FG007|Induction|Progressive disease|0|||
23276159|NCT01190930|64755088|FG008|Induction|Progressive disease|0|||
23276160|NCT01190930|64755089|FG009|Induction|Progressive disease|0|||
23276161|NCT01190930|64755080|FG000|Induction|No treatment|3|||
23276162|NCT01190930|64755081|FG001|Induction|No treatment|0|||
23276163|NCT01190930|64755082|FG002|Induction|No treatment|0|||
23603062|NCT02923349|65937224|FG002|Overall Study|Other|4|||
23603063|NCT02923349|65937225|FG003|Overall Study|Other|1|||
23603064|NCT02923349|65937226|FG004|Overall Study|Other|3|||
23276164|NCT01190930|64755083|FG003|Induction|No treatment|0|||
23603065|NCT02923349|65937227|FG005|Overall Study|Other|0|||
23603066|NCT02923349|65937228|FG006|Overall Study|Other|1|||
23603067|NCT02923349|65937222|FG000|Overall Study|Withdrawal by Subject|2|||
23603068|NCT02923349|65937223|FG001|Overall Study|Withdrawal by Subject|2|||
23276165|NCT01190930|64755084|FG004|Induction|No treatment|0|||
23276166|NCT01190930|64755085|FG005|Induction|No treatment|0|||
23276167|NCT01190930|64755086|FG006|Induction|No treatment|0|||
23276168|NCT01190930|64755087|FG007|Induction|No treatment|0|||
23276169|NCT01190930|64755088|FG008|Induction|No treatment|0|||
23276170|NCT01190930|64755089|FG009|Induction|No treatment|0|||
23276171|NCT01190930|64755080|FG000|Induction|Ineligible|69|||
23276172|NCT01190930|64755081|FG001|Induction|Ineligible|4|||
23276173|NCT01190930|64755082|FG002|Induction|Ineligible|0|||
23276174|NCT01190930|64755083|FG003|Induction|Ineligible|0|||
23276175|NCT01190930|64755084|FG004|Induction|Ineligible|0|||
23276176|NCT01190930|64755085|FG005|Induction|Ineligible|0|||
23276177|NCT01190930|64755086|FG006|Induction|Ineligible|0|||
23276178|NCT01190930|64755087|FG007|Induction|Ineligible|0|||
23276179|NCT01190930|64755088|FG008|Induction|Ineligible|0|||
23276180|NCT01190930|64755089|FG009|Induction|Ineligible|0|||
23276181|NCT01190930|64755080|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
23276182|NCT01190930|64755081|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
23276183|NCT01190930|64755082|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
23276184|NCT01190930|64755083|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
23276185|NCT01190930|64755084|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
23201352|NCT01543490|64476707|FG001|Overall Study|Lack of Efficacy|3|||
23201353|NCT01543490|64476706|FG000|Overall Study|Lost to Follow-up|5|||
23201354|NCT01543490|64476707|FG001|Overall Study|Lost to Follow-up|0|||
23201355|NCT01543490|64476706|FG000|Overall Study|Withdrawal by Subject|2|||
23201356|NCT01543490|64476707|FG001|Overall Study|Withdrawal by Subject|0|||
23201357|NCT01543490|64476706|FG000|Overall Study|Other-Various Administrative Reasons|1|||
23201358|NCT01543490|64476707|FG001|Overall Study|Other-Various Administrative Reasons|2|||
23201359|NCT01258348|64476708|FG000|Overall Study|Adverse Event|1|||
23201360|NCT01258348|64476709|FG001|Overall Study|Adverse Event|1|||
23201361|NCT01258348|64476710|FG002|Overall Study|Adverse Event|3|||
23201362|NCT01258348|64476711|FG003|Overall Study|Adverse Event|2|||
23201363|NCT01258348|64476712|FG004|Overall Study|Adverse Event|4|||
23201364|NCT01258348|64476708|FG000|Overall Study|Progressive Disease|0|||
23201365|NCT01258348|64476709|FG001|Overall Study|Progressive Disease|3|||
23201366|NCT01258348|64476710|FG002|Overall Study|Progressive Disease|0|||
23201367|NCT01258348|64476711|FG003|Overall Study|Progressive Disease|2|||
23201368|NCT01258348|64476712|FG004|Overall Study|Progressive Disease|2|||
23201369|NCT01258348|64476708|FG000|Overall Study|Physician Decision|0|||
23201370|NCT01258348|64476709|FG001|Overall Study|Physician Decision|0|||
23201371|NCT01258348|64476710|FG002|Overall Study|Physician Decision|0|||
23201372|NCT01258348|64476711|FG003|Overall Study|Physician Decision|2|||
23201373|NCT01258348|64476712|FG004|Overall Study|Physician Decision|0|||
23201374|NCT01258348|64476708|FG000|Overall Study|Withdrawal by Subject|0|||
23201375|NCT01258348|64476709|FG001|Overall Study|Withdrawal by Subject|1|||
23201376|NCT01258348|64476710|FG002|Overall Study|Withdrawal by Subject|0|||
23201377|NCT01258348|64476711|FG003|Overall Study|Withdrawal by Subject|0|||
23201378|NCT01258348|64476712|FG004|Overall Study|Withdrawal by Subject|0|||
23201379|NCT01597557|64476713|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
23201380|NCT01597557|64476714|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
23201381|NCT02460822|64476715|FG000|Overall Study|Withdrawal by Subject|1|||
23201382|NCT02817555|64476716|FG000|Overall Study|Death|1|||
23276186|NCT01190930|64755085|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
23276187|NCT01190930|64755086|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
23276188|NCT01190930|64755087|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
23276189|NCT01190930|64755088|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
23276190|NCT01190930|64755089|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
23276191|NCT01190930|64755080|FG000|Post Induction Pre-Maintenance|Death|0|||
23276192|NCT01190930|64755081|FG001|Post Induction Pre-Maintenance|Death|0|||
23276193|NCT01190930|64755082|FG002|Post Induction Pre-Maintenance|Death|8|||
23276194|NCT01190930|64755083|FG003|Post Induction Pre-Maintenance|Death|4|||
23369145|NCT01746862|65096235|FG000|Overall Study|Withdrawal by Subject|1|||
23276195|NCT01190930|64755084|FG004|Post Induction Pre-Maintenance|Death|0|||
23276196|NCT01190930|64755085|FG005|Post Induction Pre-Maintenance|Death|0|||
23276197|NCT01190930|64755086|FG006|Post Induction Pre-Maintenance|Death|0|||
23276198|NCT01190930|64755087|FG007|Post Induction Pre-Maintenance|Death|0|||
23276199|NCT01190930|64755088|FG008|Post Induction Pre-Maintenance|Death|0|||
23276200|NCT01190930|64755089|FG009|Post Induction Pre-Maintenance|Death|0|||
23369146|NCT01746862|65096236|FG001|Overall Study|Withdrawal by Subject|1|||
23369147|NCT01746862|65096235|FG000|Overall Study|Protocol Violation|1|||
23369148|NCT01746862|65096236|FG001|Overall Study|Protocol Violation|0|||
23369149|NCT01746862|65096235|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
23369150|NCT01746862|65096236|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
23369151|NCT01746862|65096235|FG000|Overall Study|Entered puberty during the study|1|||
23369152|NCT01746862|65096236|FG001|Overall Study|Entered puberty during the study|0|||
23369153|NCT00617279|65096237|FG000|Overall Study|Study terminated by Sponsor|10|||
23369154|NCT00617279|65096238|FG001|Overall Study|Study terminated by Sponsor|15|||
23369155|NCT00617279|65096237|FG000|Overall Study|Graft abandonment|2|||
23369156|NCT00617279|65096238|FG001|Overall Study|Graft abandonment|0|||
23369157|NCT00617279|65096237|FG000|Overall Study|Lost to Follow-up|1|||
23369158|NCT00617279|65096238|FG001|Overall Study|Lost to Follow-up|0|||
23276201|NCT01190930|64755080|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
23276202|NCT01190930|64755081|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
23276203|NCT01190930|64755082|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
23276204|NCT01190930|64755083|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
23276205|NCT01190930|64755084|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
23276206|NCT01190930|64755085|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
23276207|NCT01190930|64755086|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
23276208|NCT01190930|64755087|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
23276209|NCT01190930|64755088|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
23276210|NCT01190930|64755089|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
23276211|NCT01190930|64755080|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23369159|NCT00617279|65096237|FG000|Overall Study|Death|1|||
23369160|NCT00617279|65096238|FG001|Overall Study|Death|2|||
23369161|NCT02801331|65096239|FG000|Overall Study|Transferred to another hospital|8|||
23276212|NCT01190930|64755081|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
23276213|NCT01190930|64755082|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
23276214|NCT01190930|64755083|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
23276215|NCT01190930|64755084|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23276216|NCT01190930|64755085|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23369162|NCT02801331|65096240|FG001|Overall Study|Transferred to another hospital|7|||
23369163|NCT02801331|65096239|FG000|Overall Study|Withdrawal by Subject|0|||
23276217|NCT01190930|64755086|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23276218|NCT01190930|64755087|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23276219|NCT01190930|64755088|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23276220|NCT01190930|64755089|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
23276221|NCT01190930|64755080|FG000|Post Induction Pre-Maintenance|Refusal|0|||
23276222|NCT01190930|64755081|FG001|Post Induction Pre-Maintenance|Refusal|2|||
23276223|NCT01190930|64755082|FG002|Post Induction Pre-Maintenance|Refusal|694|||
23276224|NCT01190930|64755083|FG003|Post Induction Pre-Maintenance|Refusal|4|||
23276225|NCT01190930|64755084|FG004|Post Induction Pre-Maintenance|Refusal|0|||
23276226|NCT01190930|64755085|FG005|Post Induction Pre-Maintenance|Refusal|3|||
23276227|NCT01190930|64755086|FG006|Post Induction Pre-Maintenance|Refusal|0|||
23276228|NCT01190930|64755087|FG007|Post Induction Pre-Maintenance|Refusal|0|||
23276229|NCT01190930|64755088|FG008|Post Induction Pre-Maintenance|Refusal|0|||
23276230|NCT01190930|64755089|FG009|Post Induction Pre-Maintenance|Refusal|0|||
23369164|NCT02801331|65096240|FG001|Overall Study|Withdrawal by Subject|4|||
23369165|NCT02801331|65096239|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
23369166|NCT02801331|65096240|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
23369167|NCT00728494|65096247|FG000|Overall Study|Adverse Event|7|||
23369168|NCT00728494|65096248|FG001|Overall Study|Adverse Event|0|||
23369169|NCT00728494|65096247|FG000|Overall Study|Withdrawal by Subject|0|||
23369170|NCT00728494|65096248|FG001|Overall Study|Withdrawal by Subject|2|||
23369171|NCT00728494|65096247|FG000|Overall Study|Lack of Efficacy|2|||
23369172|NCT00728494|65096248|FG001|Overall Study|Lack of Efficacy|4|||
23369173|NCT00728494|65096247|FG000|Overall Study|No data available|0|||
23369174|NCT00728494|65096248|FG001|Overall Study|No data available|1|||
23369175|NCT01494818|65096249|FG000|Overall Study|Relocation|1|||
23369176|NCT01494818|65096250|FG001|Overall Study|Relocation|2|||
23369177|NCT01494818|65096249|FG000|Overall Study|Lost to Follow-up|1|||
23369178|NCT01494818|65096250|FG001|Overall Study|Lost to Follow-up|0|||
23369179|NCT03769649|65096251|FG000|Overall Study|Lost to Follow-up|4|||
23276231|NCT01190930|64755080|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
23276232|NCT01190930|64755081|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
23276233|NCT01190930|64755082|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
23276234|NCT01190930|64755083|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
23276235|NCT01190930|64755084|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
23276236|NCT01190930|64755085|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
23276237|NCT01190930|64755086|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
23276238|NCT01190930|64755087|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
23276239|NCT01190930|64755088|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
23276240|NCT01190930|64755089|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
23276241|NCT01190930|64755080|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23369180|NCT01305564|65096252|FG000|Overall Study|Death|21|||
23369181|NCT01305564|65096252|FG000|Overall Study|Lost to Follow-up|12|||
23369182|NCT01305564|65096252|FG000|Overall Study|Withdrawal by Subject|1|||
23369183|NCT01305564|65096252|FG000|Overall Study|Physician Decision|3|||
23369184|NCT02087774|65096253|FG000|Overall Study|Were absent day of data collection|8|||
23369185|NCT02087774|65096254|FG001|Overall Study|Were absent day of data collection|20|||
23369186|NCT02100839|65096255|FG000|Multiple Ascending Dose|Adverse Event|2|||
23369187|NCT02100839|65096256|FG001|Multiple Ascending Dose|Adverse Event|0|||
23369188|NCT02100839|65096255|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
23369189|NCT02100839|65096256|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
23369190|NCT01825200|65096257|FG000|Overall Study|Lost to Follow-up|5|||
23369191|NCT01825200|65096258|FG001|Overall Study|Lost to Follow-up|6|||
23369192|NCT01825200|65096257|FG000|Overall Study|Withdrawal by Subject|0|||
23369193|NCT01825200|65096258|FG001|Overall Study|Withdrawal by Subject|1|||
23369194|NCT03163446|65096261|FG000|Overall Study|Unable to return for Day 180 visit|2|||
23369195|NCT03163446|65096262|FG001|Overall Study|Unable to return for Day 180 visit|0|||
23369196|NCT03163446|65096261|FG000|Overall Study|Withdrawal by Subject|2|||
23369197|NCT03163446|65096262|FG001|Overall Study|Withdrawal by Subject|6|||
23276242|NCT01190930|64755081|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
23369198|NCT03163446|65096261|FG000|Overall Study|Death|16|||
23369199|NCT03163446|65096262|FG001|Overall Study|Death|5|||
23369200|NCT03163446|65096261|FG000|Overall Study|Lost to Follow-up|6|||
23201383|NCT02817555|64476717|FG001|Overall Study|Death|3|||
23201384|NCT02817555|64476716|FG000|Overall Study|moved away|1|||
23201385|NCT02817555|64476717|FG001|Overall Study|moved away|0|||
23201386|NCT02817555|64476716|FG000|Overall Study|transplant|1|||
23201387|NCT02817555|64476717|FG001|Overall Study|transplant|1|||
23201388|NCT02817555|64476716|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
23201389|NCT02817555|64476717|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
23201390|NCT01675011|64476718|FG000|Overall Study|Trial terminated by Sponsor|3|||
23276243|NCT01190930|64755082|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23276244|NCT01190930|64755083|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23276245|NCT01190930|64755084|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23369201|NCT03163446|65096262|FG001|Overall Study|Lost to Follow-up|5|||
23369202|NCT03163446|65096261|FG000|Overall Study|Physician Decision|1|||
23369203|NCT03163446|65096262|FG001|Overall Study|Physician Decision|1|||
23369204|NCT03163446|65096261|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
23369205|NCT03163446|65096262|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
23369206|NCT03191799|65096267|FG000|Overall Study|Withdrawal by Subject|4|||
23369207|NCT03191799|65096267|FG000|Overall Study|Physician Decision|2|||
23369208|NCT03191799|65096267|FG000|Overall Study|Lost to Follow-up|1|||
23369209|NCT03191799|65096267|FG000|Overall Study|Death|2|||
23369210|NCT00111761|65096268|FG000|Part 1|Physician Decision|0|||
23369211|NCT00111761|65096269|FG001|Part 1|Physician Decision|1|||
23369212|NCT00111761|65096268|FG000|Part 1|Death|0|||
23369213|NCT00111761|65096269|FG001|Part 1|Death|2|||
23369214|NCT00111761|65096268|FG000|Part 1|Other|0|||
23369215|NCT00111761|65096269|FG001|Part 1|Other|1|||
23369216|NCT00111761|65096268|FG000|Part 1|Withdrawal by Subject|0|||
23369217|NCT00111761|65096269|FG001|Part 1|Withdrawal by Subject|1|||
23369218|NCT00111761|65096268|FG000|Part 2|Adverse Event|1|||
23369219|NCT00111761|65096269|FG001|Part 2|Adverse Event|0|||
23369220|NCT00111761|65096268|FG000|Part 2|Physician Decision|1|||
23369221|NCT00111761|65096269|FG001|Part 2|Physician Decision|0|||
23369222|NCT00111761|65096268|FG000|Part 2|Death|1|||
23369223|NCT00111761|65096269|FG001|Part 2|Death|0|||
23369224|NCT00111761|65096268|FG000|Part 2|Disease progression|3|||
23369225|NCT00111761|65096269|FG001|Part 2|Disease progression|0|||
23369226|NCT00111761|65096268|FG000|Part 2|Protocol-specified criteria|1|||
23369227|NCT00111761|65096269|FG001|Part 2|Protocol-specified criteria|0|||
23369228|NCT00111761|65096268|FG000|Part 2|Other|1|||
23369229|NCT00111761|65096269|FG001|Part 2|Other|0|||
23369230|NCT01614470|65096270|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
23276246|NCT01190930|64755085|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23276247|NCT01190930|64755086|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23276248|NCT01190930|64755087|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23276249|NCT01190930|64755088|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23276250|NCT01190930|64755089|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
23369231|NCT01614470|65096271|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23369232|NCT01614470|65096272|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
23369233|NCT01614470|65096270|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
23369234|NCT01614470|65096271|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
23369235|NCT01614470|65096272|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
23369236|NCT00073918|65096273|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
23369237|NCT00073918|65096273|FG000|Overall Study|Rapid disease progression|2|||
23369238|NCT00073918|65096273|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
23369239|NCT03321721|65096275|FG000|Overall Study|Lost to Follow-up|4|||
23369240|NCT03321721|65096276|FG001|Overall Study|Lost to Follow-up|8|||
23369241|NCT03321721|65096277|FG002|Overall Study|Lost to Follow-up|11|||
23276251|NCT01190930|64755080|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
23276252|NCT01190930|64755081|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
23276253|NCT01190930|64755082|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
23276254|NCT01190930|64755083|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
23276255|NCT01190930|64755084|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
23276256|NCT01190930|64755085|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
23276257|NCT01190930|64755086|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
23276258|NCT01190930|64755087|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
23369242|NCT01483118|65096278|FG000|Overall Study|Lost to Follow-up|12|||
23603069|NCT02923349|65937224|FG002|Overall Study|Withdrawal by Subject|8|||
23603070|NCT02923349|65937225|FG003|Overall Study|Withdrawal by Subject|10|||
23603071|NCT02923349|65937226|FG004|Overall Study|Withdrawal by Subject|12|||
23603072|NCT02923349|65937227|FG005|Overall Study|Withdrawal by Subject|3|||
23603073|NCT02923349|65937228|FG006|Overall Study|Withdrawal by Subject|0|||
23603074|NCT02923349|65937222|FG000|Overall Study|Physician Decision|0|||
23603075|NCT02923349|65937223|FG001|Overall Study|Physician Decision|0|||
23201391|NCT01675011|64476719|FG001|Overall Study|Trial terminated by Sponsor|1|||
23276259|NCT01190930|64755088|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
23369243|NCT01483118|65096279|FG001|Overall Study|Lost to Follow-up|16|||
23369244|NCT00641056|65096280|FG000|Overall Study|Adverse Event|12|||
23369245|NCT00641056|65096281|FG001|Overall Study|Adverse Event|2|||
23369246|NCT00641056|65096280|FG000|Overall Study|Lost to Follow-up|2|||
23603076|NCT02923349|65937224|FG002|Overall Study|Physician Decision|0|||
23369247|NCT00641056|65096281|FG001|Overall Study|Lost to Follow-up|1|||
23369248|NCT00641056|65096280|FG000|Overall Study|Physician Decision|3|||
23369249|NCT00641056|65096281|FG001|Overall Study|Physician Decision|1|||
23369250|NCT00641056|65096280|FG000|Overall Study|Protocol Violation|2|||
23369251|NCT00641056|65096281|FG001|Overall Study|Protocol Violation|0|||
23603077|NCT02923349|65937225|FG003|Overall Study|Physician Decision|1|||
23369252|NCT00641056|65096280|FG000|Overall Study|Entry Criteria Not Met|3|||
23369253|NCT00641056|65096281|FG001|Overall Study|Entry Criteria Not Met|0|||
23369254|NCT00641056|65096280|FG000|Overall Study|Subject Decision|6|||
23369255|NCT00641056|65096281|FG001|Overall Study|Subject Decision|19|||
23276260|NCT01190930|64755089|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
23276261|NCT01190930|64755080|FG000|Post Induction Pre-Maintenance|Relapse|0|||
23369256|NCT00641056|65096280|FG000|Overall Study|Sponsor Decision|1|||
23369257|NCT00641056|65096281|FG001|Overall Study|Sponsor Decision|2|||
23369258|NCT00492726|65096282|FG000|Overall Study|Adverse Event|10|||
23369259|NCT00492726|65096283|FG001|Overall Study|Adverse Event|6|||
23369260|NCT00492726|65096282|FG000|Overall Study|Death|7|||
23369261|NCT00492726|65096283|FG001|Overall Study|Death|2|||
23369262|NCT00492726|65096282|FG000|Overall Study|Lack of Efficacy|0|||
23369263|NCT00492726|65096283|FG001|Overall Study|Lack of Efficacy|2|||
23369264|NCT00492726|65096282|FG000|Overall Study|Lost to Follow-up|27|||
23369265|NCT00492726|65096283|FG001|Overall Study|Lost to Follow-up|19|||
23369266|NCT00492726|65096282|FG000|Overall Study|Physician Decision|0|||
23369267|NCT00492726|65096283|FG001|Overall Study|Physician Decision|1|||
23369268|NCT00492726|65096282|FG000|Overall Study|Withdrawal by Subject|6|||
23369269|NCT00492726|65096283|FG001|Overall Study|Withdrawal by Subject|3|||
23369270|NCT00492726|65096282|FG000|Overall Study|Non compliant with study medication|0|||
23369271|NCT00492726|65096283|FG001|Overall Study|Non compliant with study medication|3|||
23369272|NCT00619827|65096284|FG000|Overall Study|Adverse Event|1|||
23369273|NCT00619827|65096285|FG001|Overall Study|Adverse Event|2|||
23276262|NCT01190930|64755081|FG001|Post Induction Pre-Maintenance|Relapse|0|||
23276263|NCT01190930|64755082|FG002|Post Induction Pre-Maintenance|Relapse|1|||
23276264|NCT01190930|64755083|FG003|Post Induction Pre-Maintenance|Relapse|0|||
23276265|NCT01190930|64755084|FG004|Post Induction Pre-Maintenance|Relapse|0|||
23276266|NCT01190930|64755085|FG005|Post Induction Pre-Maintenance|Relapse|0|||
23276267|NCT01190930|64755086|FG006|Post Induction Pre-Maintenance|Relapse|0|||
23276268|NCT01190930|64755087|FG007|Post Induction Pre-Maintenance|Relapse|0|||
23276269|NCT01190930|64755088|FG008|Post Induction Pre-Maintenance|Relapse|0|||
23276270|NCT01190930|64755089|FG009|Post Induction Pre-Maintenance|Relapse|0|||
23276271|NCT01190930|64755080|FG000|Maintenance|Adverse Event|0|||
23276272|NCT01190930|64755081|FG001|Maintenance|Adverse Event|0|||
23276273|NCT01190930|64755082|FG002|Maintenance|Adverse Event|0|||
23276274|NCT01190930|64755083|FG003|Maintenance|Adverse Event|0|||
23276275|NCT01190930|64755084|FG004|Maintenance|Adverse Event|0|||
23276276|NCT01190930|64755085|FG005|Maintenance|Adverse Event|1|||
23276277|NCT01190930|64755086|FG006|Maintenance|Adverse Event|1|||
23276278|NCT01190930|64755087|FG007|Maintenance|Adverse Event|3|||
23276279|NCT01190930|64755088|FG008|Maintenance|Adverse Event|3|||
23369274|NCT00619827|65096284|FG000|Overall Study|Withdrawal by Subject|2|||
23369275|NCT00619827|65096285|FG001|Overall Study|Withdrawal by Subject|2|||
23369276|NCT02048722|65096286|FG000|2 Cycles of Treatment|Adverse Event|2|||
23369277|NCT02048722|65096286|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
23276280|NCT01190930|64755089|FG009|Maintenance|Adverse Event|0|||
23276281|NCT01190930|64755080|FG000|Maintenance|Death|0|||
23276282|NCT01190930|64755081|FG001|Maintenance|Death|0|||
23276283|NCT01190930|64755082|FG002|Maintenance|Death|0|||
23276284|NCT01190930|64755083|FG003|Maintenance|Death|1|||
23369278|NCT02048722|65096286|FG000|2 Cycles of Treatment|Progressive Disease|2|||
23369279|NCT02048722|65096286|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
23369280|NCT02048722|65096286|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
23369281|NCT02048722|65096286|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
23369282|NCT02033759|65096289|FG000|Overall Study|Withdrawal by Subject|2|||
23369283|NCT02033759|65096290|FG001|Overall Study|Withdrawal by Subject|1|||
23369284|NCT02033759|65096289|FG000|Overall Study|Protocol Violation|1|||
23369285|NCT02033759|65096290|FG001|Overall Study|Protocol Violation|1|||
23485008|NCT00718081|65518776|FG000|Overall Study|Adverse Event|0|||
23485009|NCT00718081|65518777|FG001|Overall Study|Adverse Event|1|||
23485010|NCT00718081|65518778|FG002|Overall Study|Adverse Event|0|||
23369286|NCT01245101|65096294|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
23603078|NCT02923349|65937226|FG004|Overall Study|Physician Decision|1|||
23603079|NCT02923349|65937227|FG005|Overall Study|Physician Decision|0|||
23603080|NCT02923349|65937228|FG006|Overall Study|Physician Decision|2|||
23603081|NCT02923349|65937222|FG000|Overall Study|Lost to Follow-up|0|||
23276285|NCT01190930|64755084|FG004|Maintenance|Death|0|||
23276286|NCT01190930|64755085|FG005|Maintenance|Death|0|||
23276287|NCT01190930|64755086|FG006|Maintenance|Death|2|||
23276288|NCT01190930|64755087|FG007|Maintenance|Death|2|||
23276289|NCT01190930|64755088|FG008|Maintenance|Death|2|||
23276290|NCT01190930|64755089|FG009|Maintenance|Death|2|||
23276291|NCT01190930|64755080|FG000|Maintenance|Lost to Follow-up|0|||
23276292|NCT01190930|64755081|FG001|Maintenance|Lost to Follow-up|0|||
23276293|NCT01190930|64755082|FG002|Maintenance|Lost to Follow-up|0|||
23276294|NCT01190930|64755083|FG003|Maintenance|Lost to Follow-up|0|||
23276295|NCT01190930|64755084|FG004|Maintenance|Lost to Follow-up|0|||
23276296|NCT01190930|64755085|FG005|Maintenance|Lost to Follow-up|0|||
23276297|NCT01190930|64755086|FG006|Maintenance|Lost to Follow-up|1|||
23276298|NCT01190930|64755087|FG007|Maintenance|Lost to Follow-up|1|||
23276299|NCT01190930|64755088|FG008|Maintenance|Lost to Follow-up|1|||
23276300|NCT01190930|64755089|FG009|Maintenance|Lost to Follow-up|0|||
23276301|NCT01190930|64755080|FG000|Maintenance|Physician Decision|0|||
23276302|NCT01190930|64755081|FG001|Maintenance|Physician Decision|1|||
23276303|NCT01190930|64755082|FG002|Maintenance|Physician Decision|0|||
23276304|NCT01190930|64755083|FG003|Maintenance|Physician Decision|5|||
23603082|NCT02923349|65937223|FG001|Overall Study|Lost to Follow-up|0|||
23369287|NCT01245101|65096295|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
23369288|NCT01245101|65096294|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
23369289|NCT01245101|65096295|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
23369290|NCT01245101|65096294|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
23369291|NCT01245101|65096295|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
23369292|NCT01928771|65096296|FG000|Overall Study|Adverse Event|6|||
23369293|NCT01928771|65096297|FG001|Overall Study|Adverse Event|5|||
23369294|NCT01928771|65096298|FG002|Overall Study|Adverse Event|1|||
23276305|NCT01190930|64755084|FG004|Maintenance|Physician Decision|9|||
23276306|NCT01190930|64755085|FG005|Maintenance|Physician Decision|4|||
23276307|NCT01190930|64755086|FG006|Maintenance|Physician Decision|8|||
23276308|NCT01190930|64755087|FG007|Maintenance|Physician Decision|8|||
23276309|NCT01190930|64755088|FG008|Maintenance|Physician Decision|10|||
23276310|NCT01190930|64755089|FG009|Maintenance|Physician Decision|17|||
23276311|NCT01190930|64755080|FG000|Maintenance|Withdrawal by Subject|0|||
23276312|NCT01190930|64755081|FG001|Maintenance|Withdrawal by Subject|0|||
23276313|NCT01190930|64755082|FG002|Maintenance|Withdrawal by Subject|0|||
23276314|NCT01190930|64755083|FG003|Maintenance|Withdrawal by Subject|0|||
23276315|NCT01190930|64755084|FG004|Maintenance|Withdrawal by Subject|0|||
23276316|NCT01190930|64755085|FG005|Maintenance|Withdrawal by Subject|0|||
23276317|NCT01190930|64755086|FG006|Maintenance|Withdrawal by Subject|2|||
23276318|NCT01190930|64755087|FG007|Maintenance|Withdrawal by Subject|1|||
23276319|NCT01190930|64755088|FG008|Maintenance|Withdrawal by Subject|4|||
23276320|NCT01190930|64755089|FG009|Maintenance|Withdrawal by Subject|1|||
23276321|NCT01190930|64755080|FG000|Maintenance|Refusal|0|||
23276322|NCT01190930|64755081|FG001|Maintenance|Refusal|1|||
23276323|NCT01190930|64755082|FG002|Maintenance|Refusal|0|||
23276324|NCT01190930|64755083|FG003|Maintenance|Refusal|2|||
23276325|NCT01190930|64755084|FG004|Maintenance|Refusal|0|||
23276326|NCT01190930|64755085|FG005|Maintenance|Refusal|4|||
23276327|NCT01190930|64755086|FG006|Maintenance|Refusal|5|||
23276328|NCT01190930|64755087|FG007|Maintenance|Refusal|17|||
23276329|NCT01190930|64755088|FG008|Maintenance|Refusal|13|||
23276330|NCT01190930|64755089|FG009|Maintenance|Refusal|6|||
23276331|NCT01190930|64755080|FG000|Maintenance|second malignant neoplasm|0|||
23276332|NCT01190930|64755081|FG001|Maintenance|second malignant neoplasm|0|||
23369295|NCT01928771|65096296|FG000|Overall Study|Death|2|||
23369296|NCT01928771|65096297|FG001|Overall Study|Death|2|||
23276333|NCT01190930|64755082|FG002|Maintenance|second malignant neoplasm|0|||
23276334|NCT01190930|64755083|FG003|Maintenance|second malignant neoplasm|1|||
23276335|NCT01190930|64755084|FG004|Maintenance|second malignant neoplasm|0|||
23276336|NCT01190930|64755085|FG005|Maintenance|second malignant neoplasm|1|||
23276337|NCT01190930|64755086|FG006|Maintenance|second malignant neoplasm|0|||
23276338|NCT01190930|64755087|FG007|Maintenance|second malignant neoplasm|0|||
23276339|NCT01190930|64755088|FG008|Maintenance|second malignant neoplasm|1|||
23276340|NCT01190930|64755089|FG009|Maintenance|second malignant neoplasm|0|||
23276341|NCT01190930|64755080|FG000|Maintenance|Inevaluable|0|||
23276342|NCT01190930|64755081|FG001|Maintenance|Inevaluable|0|||
23369297|NCT01928771|65096298|FG002|Overall Study|Death|2|||
23369298|NCT01928771|65096296|FG000|Overall Study|Lost to Follow-up|5|||
23369299|NCT01928771|65096297|FG001|Overall Study|Lost to Follow-up|6|||
23369300|NCT01928771|65096298|FG002|Overall Study|Lost to Follow-up|3|||
23369301|NCT01928771|65096296|FG000|Overall Study|Withdrawal by Subject|20|||
23369302|NCT01928771|65096297|FG001|Overall Study|Withdrawal by Subject|15|||
23369303|NCT01928771|65096298|FG002|Overall Study|Withdrawal by Subject|17|||
23369304|NCT01928771|65096296|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
23369305|NCT01928771|65096297|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
23369306|NCT01928771|65096298|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
23369307|NCT01928771|65096296|FG000|Overall Study|Other Reasons|9|||
23369308|NCT01928771|65096297|FG001|Overall Study|Other Reasons|9|||
23369309|NCT01928771|65096298|FG002|Overall Study|Other Reasons|14|||
23369310|NCT01928771|65096296|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
23369311|NCT01928771|65096297|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
23369312|NCT01928771|65096298|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
23369313|NCT03638128|65096302|FG000|Overall Study|Withdrawal by Subject|1|||
23276343|NCT01190930|64755082|FG002|Maintenance|Inevaluable|0|||
23276344|NCT01190930|64755083|FG003|Maintenance|Inevaluable|0|||
23276345|NCT01190930|64755084|FG004|Maintenance|Inevaluable|0|||
23369314|NCT03638128|65096303|FG001|Overall Study|Withdrawal by Subject|7|||
23369315|NCT03638128|65096304|FG002|Overall Study|Withdrawal by Subject|6|||
23369316|NCT03638128|65096302|FG000|Overall Study|Sponsor Decision|15|||
23369317|NCT03638128|65096303|FG001|Overall Study|Sponsor Decision|12|||
23369318|NCT03638128|65096304|FG002|Overall Study|Sponsor Decision|19|||
23369319|NCT03638128|65096302|FG000|Overall Study|Lost to Follow-up|0|||
23369320|NCT03638128|65096303|FG001|Overall Study|Lost to Follow-up|0|||
23369321|NCT03638128|65096304|FG002|Overall Study|Lost to Follow-up|1|||
23369322|NCT01309386|65099051|FG000|Overall Study|Other|2|||
23369323|NCT01309386|65099052|FG001|Overall Study|Other|0|||
23369324|NCT01309386|65099051|FG000|Overall Study|Withdrawal by Subject|2|||
23369325|NCT01309386|65099052|FG001|Overall Study|Withdrawal by Subject|0|||
23369326|NCT01309386|65099051|FG000|Overall Study|Progressive disease|9|||
23369327|NCT01309386|65099052|FG001|Overall Study|Progressive disease|11|||
23369328|NCT01309386|65099051|FG000|Overall Study|Physician Decision|1|||
23369329|NCT01309386|65099052|FG001|Overall Study|Physician Decision|1|||
23369330|NCT01309386|65099051|FG000|Overall Study|Lack of Efficacy|3|||
23369331|NCT01309386|65099052|FG001|Overall Study|Lack of Efficacy|1|||
23369332|NCT01309386|65099051|FG000|Overall Study|Adverse Event|5|||
23369333|NCT01309386|65099052|FG001|Overall Study|Adverse Event|8|||
23369334|NCT03642990|65099055|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
23276346|NCT01190930|64755085|FG005|Maintenance|Inevaluable|1|||
23276347|NCT01190930|64755086|FG006|Maintenance|Inevaluable|1|||
23276348|NCT01190930|64755087|FG007|Maintenance|Inevaluable|1|||
23276349|NCT01190930|64755088|FG008|Maintenance|Inevaluable|0|||
23276350|NCT01190930|64755089|FG009|Maintenance|Inevaluable|0|||
23276351|NCT01190930|64755080|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
23276352|NCT01190930|64755081|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
23369335|NCT03642990|65099055|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
23369336|NCT03368664|65099058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
23369337|NCT03368664|65099058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
23369338|NCT03368664|65099058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
23369339|NCT03368664|65099058|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
23369340|NCT00104052|65099064|FG000|Overall Study|Adverse Event|1|||
23369341|NCT00104052|65099064|FG000|Overall Study|Lack of Efficacy|26|||
23369342|NCT00104052|65099064|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
23276353|NCT01190930|64755082|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
23276354|NCT01190930|64755083|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
23276355|NCT01190930|64755084|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
23276356|NCT01190930|64755085|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
23369343|NCT01118052|65099068|FG000|Overall Study|Never treated|2|||
23369344|NCT02187783|65099069|FG000|Overall Study|Adverse Event|8|||
23369345|NCT02187783|65099069|FG000|Overall Study|Death|3|||
23369346|NCT02187783|65099069|FG000|Overall Study|Progressive disease|80|||
23369347|NCT02187783|65099069|FG000|Overall Study|Protocol Violation|3|||
23369348|NCT02187783|65099069|FG000|Overall Study|Physician Decision|2|||
23276357|NCT01190930|64755086|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
23369349|NCT02187783|65099069|FG000|Overall Study|Withdrawal by Subject|9|||
23369350|NCT02187783|65099069|FG000|Overall Study|Study terminated by sponsor|1|||
23369351|NCT02175225|65099070|FG000|Overall Study|Withdrawal by Subject|1|||
23369352|NCT02175225|65099071|FG001|Overall Study|Withdrawal by Subject|2|||
23369353|NCT02175225|65099070|FG000|Overall Study|Lost to Follow-up|6|||
23369354|NCT02175225|65099071|FG001|Overall Study|Lost to Follow-up|7|||
23369355|NCT02175225|65099070|FG000|Overall Study|Study drug not administered|1|||
23276358|NCT01190930|64755087|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
23276359|NCT01190930|64755088|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
23276360|NCT01190930|64755089|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
23276361|NCT01190930|64755080|FG000|Maintenance|Relapse|0|||
23276362|NCT01190930|64755081|FG001|Maintenance|Relapse|0|||
23276363|NCT01190930|64755082|FG002|Maintenance|Relapse|0|||
23276364|NCT01190930|64755083|FG003|Maintenance|Relapse|2|||
23276365|NCT01190930|64755084|FG004|Maintenance|Relapse|0|||
23276366|NCT01190930|64755085|FG005|Maintenance|Relapse|1|||
23369356|NCT02175225|65099071|FG001|Overall Study|Study drug not administered|2|||
23369357|NCT02849587|65099072|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
23369358|NCT02849587|65099073|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
23369359|NCT02849587|65099074|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
23369360|NCT02849587|65099072|FG000|Overall Study|Withdrawal by Subject|0|||
23369361|NCT02849587|65099073|FG001|Overall Study|Withdrawal by Subject|1|||
23369362|NCT02849587|65099074|FG002|Overall Study|Withdrawal by Subject|0|||
23369363|NCT00666237|65099087|FG000|Overall Study|Death|5|||
23369364|NCT00666237|65099088|FG001|Overall Study|Death|5|||
23369365|NCT00666237|65099087|FG000|Overall Study|Lost to Follow-up|29|||
23369366|NCT00666237|65099088|FG001|Overall Study|Lost to Follow-up|25|||
23369367|NCT02027025|65099089|FG000|Overall Study|Adverse Event|0|||
23369368|NCT02027025|65099090|FG001|Overall Study|Adverse Event|1|||
23369369|NCT02027025|65099091|FG002|Overall Study|Adverse Event|1|||
23369370|NCT02027025|65099089|FG000|Overall Study|Protocol Violation|1|||
23369371|NCT02027025|65099090|FG001|Overall Study|Protocol Violation|0|||
23369372|NCT02027025|65099091|FG002|Overall Study|Protocol Violation|0|||
23276367|NCT01190930|64755086|FG006|Maintenance|Relapse|6|||
23276368|NCT01190930|64755087|FG007|Maintenance|Relapse|13|||
23369373|NCT02027025|65099089|FG000|Overall Study|Lost to Follow-up|0|||
23276369|NCT01190930|64755088|FG008|Maintenance|Relapse|11|||
23276370|NCT01190930|64755089|FG009|Maintenance|Relapse|11|||
23369374|NCT02027025|65099090|FG001|Overall Study|Lost to Follow-up|2|||
23276371|NCT01190930|64755080|FG000|Maintenance|Still on therapy|0|||
23276372|NCT01190930|64755081|FG001|Maintenance|Still on therapy|8|||
23276373|NCT01190930|64755082|FG002|Maintenance|Still on therapy|0|||
23276374|NCT01190930|64755083|FG003|Maintenance|Still on therapy|29|||
23276375|NCT01190930|64755084|FG004|Maintenance|Still on therapy|0|||
23276376|NCT01190930|64755085|FG005|Maintenance|Still on therapy|0|||
23276377|NCT01190930|64755086|FG006|Maintenance|Still on therapy|0|||
23276378|NCT01190930|64755087|FG007|Maintenance|Still on therapy|0|||
23276379|NCT01190930|64755088|FG008|Maintenance|Still on therapy|0|||
23276380|NCT01190930|64755089|FG009|Maintenance|Still on therapy|0|||
23276381|NCT00359281|64755090|FG000|Overall Study|Adverse Event|1|||
23276382|NCT00359281|64755091|FG001|Overall Study|Adverse Event|0|||
23276383|NCT00359281|64755092|FG002|Overall Study|Adverse Event|0|||
23276384|NCT00359281|64755093|FG003|Overall Study|Adverse Event|0|||
23276385|NCT00359281|64755094|FG004|Overall Study|Adverse Event|0|||
23276386|NCT00359281|64755095|FG005|Overall Study|Adverse Event|0|||
23276387|NCT00359281|64755096|FG006|Overall Study|Adverse Event|1|||
23276388|NCT00359281|64755097|FG007|Overall Study|Adverse Event|0|||
23276389|NCT00359281|64755098|FG008|Overall Study|Adverse Event|0|||
23276390|NCT00359281|64755090|FG000|Overall Study|Withdrawal by Subject|0|||
23276391|NCT00359281|64755091|FG001|Overall Study|Withdrawal by Subject|0|||
23276392|NCT00359281|64755092|FG002|Overall Study|Withdrawal by Subject|0|||
23276393|NCT00359281|64755093|FG003|Overall Study|Withdrawal by Subject|0|||
23276394|NCT00359281|64755094|FG004|Overall Study|Withdrawal by Subject|0|||
23276395|NCT00359281|64755095|FG005|Overall Study|Withdrawal by Subject|0|||
23369375|NCT02027025|65099091|FG002|Overall Study|Lost to Follow-up|0|||
23276396|NCT00359281|64755096|FG006|Overall Study|Withdrawal by Subject|1|||
23276397|NCT00359281|64755097|FG007|Overall Study|Withdrawal by Subject|0|||
23276398|NCT00359281|64755098|FG008|Overall Study|Withdrawal by Subject|0|||
23276399|NCT00773253|64755099|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
23276400|NCT00773253|64755100|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
23276401|NCT04000815|64755101|FG000|Overall Study|Lost to Follow-up|9|||
23369376|NCT02027025|65099089|FG000|Overall Study|Withdrawal by Subject|0|||
23369377|NCT02027025|65099090|FG001|Overall Study|Withdrawal by Subject|1|||
23369378|NCT02027025|65099091|FG002|Overall Study|Withdrawal by Subject|0|||
23369379|NCT02027025|65099089|FG000|Overall Study|Sponsor's decision|0|||
23276402|NCT04000815|64755102|FG001|Overall Study|Lost to Follow-up|2|||
23276403|NCT04000815|64755103|FG002|Overall Study|Lost to Follow-up|3|||
23276404|NCT04000815|64755101|FG000|Overall Study|Withdrawal by Subject|4|||
23276405|NCT04000815|64755102|FG001|Overall Study|Withdrawal by Subject|3|||
23276406|NCT04000815|64755103|FG002|Overall Study|Withdrawal by Subject|2|||
23276407|NCT04000815|64755101|FG000|Overall Study|Right ovarian cyst occured|1|||
23276408|NCT04000815|64755102|FG001|Overall Study|Right ovarian cyst occured|0|||
23276409|NCT04000815|64755103|FG002|Overall Study|Right ovarian cyst occured|0|||
23276410|NCT04000815|64755101|FG000|Overall Study|Hypertension occured on follow up|0|||
23276411|NCT04000815|64755102|FG001|Overall Study|Hypertension occured on follow up|0|||
23276412|NCT04000815|64755103|FG002|Overall Study|Hypertension occured on follow up|2|||
23276413|NCT02255097|64755106|FG000|Overall Study|Death|151|||
23276414|NCT02255097|64755106|FG000|Overall Study|Lost to Follow-up|5|||
23276415|NCT02255097|64755106|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
23276416|NCT02255097|64755106|FG000|Overall Study|Withdrawal by Subject|7|||
23276417|NCT02255097|64755106|FG000|Overall Study|Allocated but not treated|1|||
23276418|NCT02543203|64755107|FG000|Overall Study|Unpalatable Fragrance|2|||
23276419|NCT02543203|64755108|FG001|Overall Study|Unpalatable Fragrance|2|||
23276420|NCT02543203|64755107|FG000|Overall Study|Lost to Follow-up|1|||
23276421|NCT02543203|64755108|FG001|Overall Study|Lost to Follow-up|0|||
23276422|NCT02543203|64755107|FG000|Overall Study|Increased Irritability|1|||
23276423|NCT02543203|64755108|FG001|Overall Study|Increased Irritability|0|||
23276424|NCT02543203|64755107|FG000|Overall Study|Family|1|||
23276425|NCT02543203|64755108|FG001|Overall Study|Family|2|||
23276426|NCT02543203|64755107|FG000|Overall Study|Negative Behavior|1|||
23276427|NCT02543203|64755108|FG001|Overall Study|Negative Behavior|0|||
23276428|NCT02543203|64755107|FG000|Overall Study|Withdrawal by Subject|0|||
23276429|NCT02543203|64755108|FG001|Overall Study|Withdrawal by Subject|1|||
23276430|NCT02409355|64755109|FG000|Overall Study|Withdrawal by Subject|1|||
23276431|NCT02409355|64755110|FG001|Overall Study|Withdrawal by Subject|0|||
23276432|NCT02409355|64755109|FG000|Overall Study|Death|1|||
23276433|NCT02409355|64755110|FG001|Overall Study|Death|1|||
23276434|NCT02409355|64755109|FG000|Overall Study|Study terminated by Sponsor|2|||
23276435|NCT02409355|64755110|FG001|Overall Study|Study terminated by Sponsor|3|||
23276436|NCT00519194|64755111|FG000|Overall Study|Withdrawal by Subject|9|||
23276437|NCT00519194|64755111|FG000|Overall Study|Death|9|||
23276438|NCT00519194|64755111|FG000|Overall Study|Lost to Follow-up|3|||
23276439|NCT03620747|64755112|FG000|Overall Study|Participant decision|7|||
23276440|NCT03620747|64755112|FG000|Overall Study|Adverse Event|6|||
23276441|NCT03620747|64755112|FG000|Overall Study|Lack of Efficacy|1|||
23276442|NCT03620747|64755112|FG000|Overall Study|Poor compliance to protocol|2|||
23276443|NCT03620747|64755112|FG000|Overall Study|Other-unspecified|3|||
23276444|NCT01182415|64755116|FG000|Overall Study|Lost to Follow-up|1|||
23276445|NCT02388191|64755118|FG000|Overall Study|Patient did not receive IUD|1|||
23276446|NCT02388191|64755119|FG001|Overall Study|Patient did not receive IUD|0|||
23276447|NCT01474551|64755120|FG000|Overall Study|Death|1|||
23276448|NCT00960297|64755121|FG000|Overall Study|Physician Decision|1|||
23276449|NCT00960297|64755121|FG000|Overall Study|Venous port infection|1|||
23276450|NCT00960297|64755121|FG000|Overall Study|Disease progression|1|||
23276451|NCT00316186|64755126|FG000|Overall Study|Adverse Event|6|||
23276452|NCT00316186|64755126|FG000|Overall Study|Disease Progression|4|||
23276453|NCT00316186|64755126|FG000|Overall Study|Lost to Follow-up|1|||
23276454|NCT00316186|64755126|FG000|Overall Study|Other|1|||
23276455|NCT00113386|64755127|FG000|Overall Study|Withdrawal by Subject|1|||
23276456|NCT00113386|64755128|FG001|Overall Study|Withdrawal by Subject|0|||
23276457|NCT00113386|64755127|FG000|Overall Study|Physician Decision|0|||
23276458|NCT00113386|64755128|FG001|Overall Study|Physician Decision|1|||
23276459|NCT00113386|64755127|FG000|Overall Study|Toxicity|3|||
23276460|NCT00113386|64755128|FG001|Overall Study|Toxicity|0|||
23276461|NCT00113386|64755127|FG000|Overall Study|Ineligible|1|||
23276462|NCT00113386|64755128|FG001|Overall Study|Ineligible|2|||
23276463|NCT00113386|64755127|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
23276464|NCT00113386|64755128|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
23276465|NCT03966365|64755129|FG000|Overall Study|Protocol Violation|1|||
23276466|NCT03966365|64755130|FG001|Overall Study|Protocol Violation|0|||
23276467|NCT00124618|64755133|FG000|Overall Study|Ineligible|1|||
23276468|NCT00837486|64755134|FG000|Blinded-treatment Phase|Physician Decision|1|||
23276469|NCT00837486|64755135|FG001|Blinded-treatment Phase|Physician Decision|0|||
23276470|NCT00837486|64755134|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
23276471|NCT00837486|64755135|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
23276472|NCT00837486|64755134|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
23276473|NCT00837486|64755135|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
23276474|NCT00837486|64755134|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
23276475|NCT00837486|64755135|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
23276476|NCT03100344|64755143|FG000|Overall Study|Adverse Event|0|||
23276477|NCT03100344|64755144|FG001|Overall Study|Adverse Event|3|||
23276478|NCT03100344|64755145|FG002|Overall Study|Adverse Event|2|||
23276479|NCT03100344|64755146|FG003|Overall Study|Adverse Event|3|||
23276480|NCT03100344|64755143|FG000|Overall Study|Lack of Efficacy|2|||
23276481|NCT03100344|64755144|FG001|Overall Study|Lack of Efficacy|0|||
23276482|NCT03100344|64755145|FG002|Overall Study|Lack of Efficacy|0|||
23276483|NCT03100344|64755146|FG003|Overall Study|Lack of Efficacy|0|||
23276484|NCT03100344|64755143|FG000|Overall Study|Protocol Violation|1|||
23276485|NCT03100344|64755144|FG001|Overall Study|Protocol Violation|0|||
23276486|NCT03100344|64755145|FG002|Overall Study|Protocol Violation|0|||
23276487|NCT03100344|64755146|FG003|Overall Study|Protocol Violation|0|||
23276488|NCT03100344|64755143|FG000|Overall Study|Withdrawal by Subject|10|||
23276489|NCT03100344|64755144|FG001|Overall Study|Withdrawal by Subject|7|||
23276490|NCT03100344|64755145|FG002|Overall Study|Withdrawal by Subject|4|||
23276491|NCT03100344|64755146|FG003|Overall Study|Withdrawal by Subject|8|||
23276492|NCT03100344|64755143|FG000|Overall Study|Lost to Follow-up|1|||
23276493|NCT03100344|64755144|FG001|Overall Study|Lost to Follow-up|1|||
23276494|NCT03100344|64755145|FG002|Overall Study|Lost to Follow-up|1|||
23276495|NCT03100344|64755146|FG003|Overall Study|Lost to Follow-up|1|||
23276496|NCT03925532|64755147|FG000|Overall Study|Lost to Follow-up|1|||
23276497|NCT01030133|64755148|FG000|Overall Study|failed to experience pain at level 7/10|2|||
23276498|NCT01030133|64755149|FG001|Overall Study|failed to experience pain at level 7/10|2|||
23276499|NCT01929863|64755150|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
23276500|NCT01929863|64755151|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
23276501|NCT01929863|64755150|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
23276502|NCT01929863|64755151|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
23276503|NCT01929863|64755150|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
23276504|NCT01929863|64755151|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
23276505|NCT03956862|64755152|FG000|Overall Study|Lost to Follow-up|1|||
23276506|NCT03956862|64755153|FG001|Overall Study|Lost to Follow-up|1|||
23276507|NCT03956862|64755152|FG000|Overall Study|Withdrawal by Subject|1|||
23276508|NCT03956862|64755153|FG001|Overall Study|Withdrawal by Subject|1|||
23276509|NCT03772522|64755154|FG000|Pre-intervention|Withdrawal by Subject|3|||
23276510|NCT03772522|64755155|FG001|Pre-intervention|Withdrawal by Subject|4|||
23276511|NCT03772522|64755154|FG000|Intervention|Withdrawal by Subject|1|||
23276512|NCT03772522|64755155|FG001|Intervention|Withdrawal by Subject|0|||
23276513|NCT03772522|64755154|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
23276514|NCT03772522|64755155|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
23276515|NCT04499963|64755156|FG000|Overall Study|Adverse Event|3|||
23276516|NCT04499963|64755157|FG001|Overall Study|Adverse Event|0|||
23276517|NCT04499963|64755156|FG000|Overall Study|Death|3|||
23276518|NCT04499963|64755157|FG001|Overall Study|Death|0|||
23276519|NCT04499963|64755156|FG000|Overall Study|Lack of Efficacy|7|||
23276520|NCT04499963|64755157|FG001|Overall Study|Lack of Efficacy|0|||
23276521|NCT04499963|64755156|FG000|Overall Study|Lost to Follow-up|2|||
23276522|NCT04499963|64755157|FG001|Overall Study|Lost to Follow-up|0|||
23276523|NCT01204294|64755158|FG000|Overall Study|Adverse Event|2|||
23276524|NCT01204294|64755159|FG001|Overall Study|Adverse Event|6|||
23276525|NCT01204294|64755160|FG002|Overall Study|Adverse Event|0|||
23276526|NCT01204294|64755161|FG003|Overall Study|Adverse Event|7|||
23276527|NCT01204294|64755162|FG004|Overall Study|Adverse Event|1|||
23276528|NCT01204294|64755163|FG005|Overall Study|Adverse Event|4|||
23276529|NCT01204294|64755164|FG006|Overall Study|Adverse Event|0|||
23276530|NCT01204294|64755158|FG000|Overall Study|Protocol Violation|1|||
23276531|NCT01204294|64755159|FG001|Overall Study|Protocol Violation|0|||
23276532|NCT01204294|64755160|FG002|Overall Study|Protocol Violation|2|||
23276533|NCT01204294|64755161|FG003|Overall Study|Protocol Violation|1|||
23276534|NCT01204294|64755162|FG004|Overall Study|Protocol Violation|0|||
23276535|NCT01204294|64755163|FG005|Overall Study|Protocol Violation|0|||
23276536|NCT01204294|64755164|FG006|Overall Study|Protocol Violation|0|||
23276537|NCT01204294|64755158|FG000|Overall Study|Withdrawal by Subject|0|||
23276538|NCT01204294|64755159|FG001|Overall Study|Withdrawal by Subject|2|||
23276539|NCT01204294|64755160|FG002|Overall Study|Withdrawal by Subject|2|||
23369380|NCT02027025|65099090|FG001|Overall Study|Sponsor's decision|1|||
23276540|NCT01204294|64755161|FG003|Overall Study|Withdrawal by Subject|1|||
23276541|NCT01204294|64755162|FG004|Overall Study|Withdrawal by Subject|1|||
23276542|NCT01204294|64755163|FG005|Overall Study|Withdrawal by Subject|1|||
23276543|NCT01204294|64755164|FG006|Overall Study|Withdrawal by Subject|2|||
23276544|NCT01204294|64755158|FG000|Overall Study|Lack of Efficacy|0|||
23276545|NCT01204294|64755159|FG001|Overall Study|Lack of Efficacy|0|||
23276546|NCT01204294|64755160|FG002|Overall Study|Lack of Efficacy|0|||
23276547|NCT01204294|64755161|FG003|Overall Study|Lack of Efficacy|2|||
23276548|NCT01204294|64755162|FG004|Overall Study|Lack of Efficacy|0|||
23276549|NCT01204294|64755163|FG005|Overall Study|Lack of Efficacy|0|||
23276550|NCT01204294|64755164|FG006|Overall Study|Lack of Efficacy|0|||
23276551|NCT01204294|64755158|FG000|Overall Study|Other (house moving)|0|||
23276552|NCT01204294|64755159|FG001|Overall Study|Other (house moving)|0|||
23276553|NCT01204294|64755160|FG002|Overall Study|Other (house moving)|1|||
23603083|NCT02923349|65937224|FG002|Overall Study|Lost to Follow-up|3|||
23276554|NCT01204294|64755161|FG003|Overall Study|Other (house moving)|0|||
23276555|NCT01204294|64755162|FG004|Overall Study|Other (house moving)|0|||
23276556|NCT01204294|64755163|FG005|Overall Study|Other (house moving)|0|||
23276557|NCT01204294|64755164|FG006|Overall Study|Other (house moving)|0|||
23276558|NCT00420238|64755165|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
23276559|NCT00420238|64755166|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
23276560|NCT00420238|64755165|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
23276561|NCT00420238|64755166|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
23276562|NCT00420238|64755165|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
23276563|NCT00420238|64755166|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
23276564|NCT00420238|64755165|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
23276565|NCT00420238|64755166|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
23276566|NCT00420238|64755165|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
23276567|NCT00420238|64755166|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
23276568|NCT00420238|64755165|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
23276569|NCT00420238|64755166|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
23276570|NCT03686033|64755167|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
23276571|NCT03686033|64755168|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
23276572|NCT03686033|64755169|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
23276573|NCT03686033|64755170|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
23276574|NCT03686033|64755171|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
23276575|NCT03686033|64755172|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
23276576|NCT02979522|64755173|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
23276577|NCT02979522|64755174|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
23276578|NCT02979522|64755173|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
23276579|NCT02979522|64755174|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
23276580|NCT03128723|64755175|FG000|Overall Study|Withdrawal by Subject|2|||
23276581|NCT01949662|64755176|FG000|Overall Study|Death|9|||
23276582|NCT01949662|64755177|FG001|Overall Study|Death|7|||
23276583|NCT01949662|64755176|FG000|Overall Study|Discharged before an agitation event|8|||
23276584|NCT01949662|64755177|FG001|Overall Study|Discharged before an agitation event|3|||
23276585|NCT01949662|64755176|FG000|Overall Study|Dropped out|1|||
23276586|NCT01949662|64755177|FG001|Overall Study|Dropped out|3|||
23276587|NCT01949662|64755176|FG000|Overall Study|Ineligible|0|||
23276588|NCT01949662|64755177|FG001|Overall Study|Ineligible|1|||
23276589|NCT01507051|64755178|FG000|Overall Study|Withdrawal by Subject|1|||
23276590|NCT01507051|64755179|FG001|Overall Study|Withdrawal by Subject|3|||
23276591|NCT01507051|64755180|FG002|Overall Study|Withdrawal by Subject|1|||
23276592|NCT01507051|64755181|FG003|Overall Study|Withdrawal by Subject|6|||
23276593|NCT01507051|64755178|FG000|Overall Study|Physician Decision|0|||
23276594|NCT01507051|64755179|FG001|Overall Study|Physician Decision|0|||
23276595|NCT01507051|64755180|FG002|Overall Study|Physician Decision|0|||
23276596|NCT01507051|64755181|FG003|Overall Study|Physician Decision|1|||
23276597|NCT01507051|64755178|FG000|Overall Study|Adverse Event|1|||
23276598|NCT01507051|64755179|FG001|Overall Study|Adverse Event|0|||
23276599|NCT01507051|64755180|FG002|Overall Study|Adverse Event|0|||
23276600|NCT01507051|64755181|FG003|Overall Study|Adverse Event|0|||
23276601|NCT01900626|64755184|FG000|Overall Study|study was closed due to low enrollment|1|||
23276602|NCT01900626|64755185|FG001|Overall Study|study was closed due to low enrollment|1|||
23276603|NCT00365846|64755186|FG000|Overall Study|Lost to Follow-up|1|||
23603084|NCT02923349|65937225|FG003|Overall Study|Lost to Follow-up|0|||
23603085|NCT02923349|65937226|FG004|Overall Study|Lost to Follow-up|1|||
23603086|NCT02923349|65937227|FG005|Overall Study|Lost to Follow-up|1|||
23603087|NCT02923349|65937228|FG006|Overall Study|Lost to Follow-up|0|||
23603088|NCT02923349|65937222|FG000|Overall Study|Death|1|||
23603089|NCT02923349|65937223|FG001|Overall Study|Death|0|||
23603090|NCT02923349|65937224|FG002|Overall Study|Death|2|||
23603091|NCT02923349|65937225|FG003|Overall Study|Death|4|||
23603092|NCT02923349|65937226|FG004|Overall Study|Death|2|||
23603093|NCT02923349|65937227|FG005|Overall Study|Death|3|||
23603094|NCT02923349|65937228|FG006|Overall Study|Death|0|||
23603095|NCT00738400|65937229|FG000|Overall Study|Adverse Event|3|||
23603096|NCT00738400|65937230|FG001|Overall Study|Adverse Event|1|||
23603097|NCT00738400|65937229|FG000|Overall Study|Withdrawal by Subject|0|||
23603098|NCT00738400|65937230|FG001|Overall Study|Withdrawal by Subject|1|||
23603099|NCT00738400|65937229|FG000|Overall Study|Lack of Efficacy|0|||
23603100|NCT00738400|65937230|FG001|Overall Study|Lack of Efficacy|1|||
23603101|NCT00738400|65937229|FG000|Overall Study|Lost to Follow-up|0|||
23276622|NCT01663233|64758651|FG000|Overall Study|Withdrawal by Subject|3|||
23276623|NCT01663233|64758652|FG001|Overall Study|Withdrawal by Subject|2|||
23276624|NCT01663233|64758651|FG000|Overall Study|Protocol Deviation|1|||
23276625|NCT01663233|64758652|FG001|Overall Study|Protocol Deviation|4|||
23276626|NCT01663233|64758651|FG000|Overall Study|Lost to Follow-up|0|||
23276627|NCT01663233|64758652|FG001|Overall Study|Lost to Follow-up|1|||
23276628|NCT00245063|64758653|FG000|Overall Study|Adverse Event|6|||
23276629|NCT00245063|64758654|FG001|Overall Study|Adverse Event|5|||
23276630|NCT00245063|64758653|FG000|Overall Study|Death|1|||
23276631|NCT00245063|64758654|FG001|Overall Study|Death|0|||
23603102|NCT00738400|65937230|FG001|Overall Study|Lost to Follow-up|3|||
23276632|NCT00833937|64758655|FG000|Washout|Withdrawal by Subject|1|||
23276633|NCT00833937|64758656|FG001|Washout|Withdrawal by Subject|0|||
23276634|NCT03104374|64758657|FG000|Overall Study|Adverse Event|7|||
23276635|NCT03104374|64758658|FG001|Overall Study|Adverse Event|6|||
23276636|NCT03104374|64758659|FG002|Overall Study|Adverse Event|12|||
23276637|NCT03104374|64758660|FG003|Overall Study|Adverse Event|15|||
23276638|NCT03104374|64758657|FG000|Overall Study|Withdrawal by Subject|18|||
23276639|NCT03104374|64758658|FG001|Overall Study|Withdrawal by Subject|10|||
23276640|NCT03104374|64758659|FG002|Overall Study|Withdrawal by Subject|10|||
23276641|NCT03104374|64758660|FG003|Overall Study|Withdrawal by Subject|17|||
23276642|NCT03104374|64758657|FG000|Overall Study|Lost to Follow-up|4|||
23276643|NCT03104374|64758658|FG001|Overall Study|Lost to Follow-up|4|||
23276644|NCT03104374|64758659|FG002|Overall Study|Lost to Follow-up|6|||
23276645|NCT03104374|64758660|FG003|Overall Study|Lost to Follow-up|8|||
23276646|NCT03104374|64758657|FG000|Overall Study|Lack of Efficacy|6|||
23276647|NCT03104374|64758658|FG001|Overall Study|Lack of Efficacy|7|||
23276648|NCT03104374|64758659|FG002|Overall Study|Lack of Efficacy|12|||
23276649|NCT03104374|64758660|FG003|Overall Study|Lack of Efficacy|6|||
23276650|NCT03104374|64758657|FG000|Overall Study|Other|2|||
23276651|NCT03104374|64758658|FG001|Overall Study|Other|2|||
23276652|NCT03104374|64758659|FG002|Overall Study|Other|4|||
23276653|NCT03104374|64758660|FG003|Overall Study|Other|7|||
23276654|NCT01963728|64758664|FG000|Overall Study|Study terminated early|0|||
23276655|NCT01963728|64758665|FG001|Overall Study|Study terminated early|1|||
23276656|NCT00834522|64758670|FG000|Washout|Adverse Event|1|||
23276657|NCT00834522|64758671|FG001|Washout|Adverse Event|0|||
23276658|NCT00834522|64758670|FG000|Washout|Withdrawal by Subject|2|||
23276659|NCT00834522|64758671|FG001|Washout|Withdrawal by Subject|1|||
23276660|NCT00610363|64758672|FG000|Overall Study|Non-compliance with protocol|0|||
23276661|NCT00610363|64758673|FG001|Overall Study|Non-compliance with protocol|1|||
23276662|NCT00610363|64758672|FG000|Overall Study|Adverse Event|3|||
23276663|NCT00610363|64758673|FG001|Overall Study|Adverse Event|1|||
23276664|NCT00610363|64758672|FG000|Overall Study|Lack of Efficacy|2|||
23276665|NCT00610363|64758673|FG001|Overall Study|Lack of Efficacy|0|||
23276666|NCT00610363|64758672|FG000|Overall Study|Lost to Follow-up|4|||
23276667|NCT00610363|64758673|FG001|Overall Study|Lost to Follow-up|0|||
23276668|NCT00610363|64758672|FG000|Overall Study|Withdrawal by Subject|1|||
23276669|NCT00610363|64758673|FG001|Overall Study|Withdrawal by Subject|0|||
23276670|NCT00610363|64758672|FG000|Overall Study|Other than specified above|1|||
23276671|NCT00610363|64758673|FG001|Overall Study|Other than specified above|1|||
23276672|NCT01190865|64758674|FG000|Overall Study|Withdrawal by Subject|1|||
23276673|NCT01190865|64758674|FG000|Overall Study|Non-compliance|2|||
23276674|NCT00934050|64758675|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
23276675|NCT00934050|64758676|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
23276676|NCT00934050|64758677|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
23276677|NCT00934050|64758678|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
23276678|NCT00934050|64758679|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
23276679|NCT00934050|64758680|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
23276680|NCT00934050|64758675|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
23276681|NCT00934050|64758676|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
23276682|NCT00934050|64758677|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
23276683|NCT00934050|64758678|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
23276684|NCT00934050|64758679|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
23276685|NCT00934050|64758680|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
23276686|NCT00934050|64758675|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23276687|NCT00934050|64758676|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23276688|NCT00934050|64758677|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
23276689|NCT00934050|64758678|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23276690|NCT00934050|64758679|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23276691|NCT00934050|64758680|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
23276692|NCT00934050|64758675|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
23276693|NCT00934050|64758676|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
23276694|NCT00934050|64758677|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
23276695|NCT00934050|64758678|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
23276696|NCT00934050|64758679|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
23276697|NCT00934050|64758680|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
23276698|NCT00934050|64758675|FG000|Enrolled After 15 Dec 2009|Death|0|||
23276699|NCT00934050|64758676|FG001|Enrolled After 15 Dec 2009|Death|0|||
23276700|NCT00934050|64758677|FG002|Enrolled After 15 Dec 2009|Death|0|||
23276701|NCT00934050|64758678|FG003|Enrolled After 15 Dec 2009|Death|0|||
23276702|NCT00934050|64758679|FG004|Enrolled After 15 Dec 2009|Death|0|||
23276703|NCT00934050|64758680|FG005|Enrolled After 15 Dec 2009|Death|1|||
23276704|NCT00934050|64758675|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23276705|NCT00934050|64758676|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23276706|NCT00934050|64758677|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23276707|NCT00934050|64758678|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23276708|NCT00934050|64758679|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
23276709|NCT00934050|64758680|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
23276710|NCT00934050|64758675|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
23276711|NCT00934050|64758676|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
23276712|NCT00934050|64758677|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
23276713|NCT00934050|64758678|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
23276714|NCT00934050|64758679|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
23276715|NCT00934050|64758680|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
23276716|NCT02714062|64758681|FG000|Overall Study|Adverse Event|0|||
23276717|NCT02714062|64758682|FG001|Overall Study|Adverse Event|0|||
23276718|NCT02714062|64758683|FG002|Overall Study|Adverse Event|2|||
23276719|NCT02714062|64758681|FG000|Overall Study|Withdrawal by Subject|1|||
23276720|NCT02714062|64758682|FG001|Overall Study|Withdrawal by Subject|0|||
23276721|NCT02714062|64758683|FG002|Overall Study|Withdrawal by Subject|1|||
23276722|NCT02714062|64758681|FG000|Overall Study|Protocol Violation|0|||
23276723|NCT02714062|64758682|FG001|Overall Study|Protocol Violation|1|||
23276724|NCT02714062|64758683|FG002|Overall Study|Protocol Violation|0|||
23276725|NCT02822235|64758695|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
23276726|NCT02822235|64758696|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
23276727|NCT02822235|64758695|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
23276728|NCT02822235|64758696|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
23276729|NCT02822235|64758695|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
23276730|NCT02822235|64758696|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
23276731|NCT02822235|64758695|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
23276732|NCT02822235|64758696|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
23276733|NCT02822235|64758695|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
23276734|NCT02822235|64758696|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
23276735|NCT02822235|64758695|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
23276736|NCT02822235|64758696|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
23276737|NCT00418561|64758697|FG000|Overall Study|Participant's (guardian's) decision|0|||
23276738|NCT00418561|64758698|FG001|Overall Study|Participant's (guardian's) decision|1|||
23276739|NCT00418561|64758699|FG002|Overall Study|Participant's (guardian's) decision|0|||
23276740|NCT00835991|64758700|FG000|First Intervention|Adverse Event|0|||
23276741|NCT00835991|64758701|FG001|First Intervention|Adverse Event|1|||
23276742|NCT00835991|64758700|FG000|Washout|Protocol Violation|0|||
23276743|NCT00835991|64758701|FG001|Washout|Protocol Violation|2|||
23276744|NCT00835991|64758700|FG000|Washout|Withdrawal by Subject|3|||
23276745|NCT00835991|64758701|FG001|Washout|Withdrawal by Subject|1|||
23276746|NCT03803774|64758702|FG000|Dose Escalation|Withdrawal by Subject|0|||
23276747|NCT03803774|64758703|FG001|Dose Escalation|Withdrawal by Subject|0|||
23276748|NCT03803774|64758704|FG002|Dose Escalation|Withdrawal by Subject|0|||
23276749|NCT03803774|64758705|FG003|Dose Escalation|Withdrawal by Subject|1|||
23276750|NCT03803774|64758706|FG004|Dose Escalation|Withdrawal by Subject|0|||
23276751|NCT03381274|64758708|FG000|Overall Study|Death|2|||
23276752|NCT03381274|64758709|FG001|Overall Study|Death|9|||
23276753|NCT03381274|64758710|FG002|Overall Study|Death|3|||
23276754|NCT03381274|64758711|FG003|Overall Study|Death|2|||
23276755|NCT03381274|64758712|FG004|Overall Study|Death|3|||
23276756|NCT03381274|64758708|FG000|Overall Study|Lost to Follow-up|0|||
23276757|NCT03381274|64758709|FG001|Overall Study|Lost to Follow-up|0|||
23276758|NCT03381274|64758710|FG002|Overall Study|Lost to Follow-up|0|||
23276759|NCT03381274|64758711|FG003|Overall Study|Lost to Follow-up|1|||
23276760|NCT03381274|64758712|FG004|Overall Study|Lost to Follow-up|0|||
23276761|NCT03381274|64758708|FG000|Overall Study|Withdrawal by Subject|2|||
23276762|NCT03381274|64758709|FG001|Overall Study|Withdrawal by Subject|1|||
23276763|NCT03381274|64758710|FG002|Overall Study|Withdrawal by Subject|3|||
23276764|NCT03381274|64758711|FG003|Overall Study|Withdrawal by Subject|1|||
23276765|NCT03381274|64758712|FG004|Overall Study|Withdrawal by Subject|0|||
23276766|NCT03381274|64758708|FG000|Overall Study|Other|1|||
23276767|NCT03381274|64758709|FG001|Overall Study|Other|11|||
23276768|NCT03381274|64758710|FG002|Overall Study|Other|0|||
23276769|NCT03381274|64758711|FG003|Overall Study|Other|2|||
23276770|NCT03381274|64758712|FG004|Overall Study|Other|2|||
23276771|NCT01111461|64758713|FG000|Overall Study|Adverse Event|32|||
23276772|NCT01111461|64758713|FG000|Overall Study|Participant choice|11|||
23276773|NCT01111461|64758713|FG000|Overall Study|Lost to Follow-up|1|||
23276774|NCT01111461|64758713|FG000|Overall Study|Withdrawal by Subject|1|||
23276775|NCT01111461|64758713|FG000|Overall Study|Other|6|||
23276776|NCT01686477|64758714|FG000|Feeding Intervention|Death|1|||
23276777|NCT01686477|64758715|FG001|Feeding Intervention|Death|0|||
23276778|NCT01686477|64758716|FG002|Feeding Intervention|Death|1|||
23276779|NCT01686477|64758714|FG000|Feeding Intervention|Withdrawal by Subject|0|||
23276780|NCT01686477|64758715|FG001|Feeding Intervention|Withdrawal by Subject|6|||
23369381|NCT02027025|65099091|FG002|Overall Study|Sponsor's decision|0|||
23369382|NCT01814007|65099092|FG000|Overall Study|Withdrawal by Subject|1|||
23369383|NCT00975416|65099093|FG000|Overall Study|early discharge from tx|3|||
23369384|NCT00975416|65099094|FG001|Overall Study|early discharge from tx|5|||
23369385|NCT00879658|65099099|FG000|Overall Study|Abnormal laboratory value(s)|3|||
23369386|NCT00879658|65099100|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23369387|NCT00879658|65099101|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23369388|NCT00879658|65099102|FG003|Overall Study|Abnormal laboratory value(s)|1|||
23369389|NCT00879658|65099103|FG004|Overall Study|Abnormal laboratory value(s)|0|||
23369390|NCT00879658|65099104|FG005|Overall Study|Abnormal laboratory value(s)|0|||
23369391|NCT00879658|65099105|FG006|Overall Study|Abnormal laboratory value(s)|0|||
23369392|NCT00879658|65099099|FG000|Overall Study|Administrative problems|2|||
23369393|NCT00879658|65099100|FG001|Overall Study|Administrative problems|1|||
23369394|NCT00879658|65099101|FG002|Overall Study|Administrative problems|0|||
23369395|NCT00879658|65099102|FG003|Overall Study|Administrative problems|1|||
23369396|NCT00879658|65099103|FG004|Overall Study|Administrative problems|0|||
23369397|NCT00879658|65099104|FG005|Overall Study|Administrative problems|0|||
23369398|NCT00879658|65099105|FG006|Overall Study|Administrative problems|0|||
23369399|NCT00879658|65099099|FG000|Overall Study|Adverse Event|6|||
23369400|NCT00879658|65099100|FG001|Overall Study|Adverse Event|4|||
23369401|NCT00879658|65099101|FG002|Overall Study|Adverse Event|3|||
23369402|NCT00879658|65099102|FG003|Overall Study|Adverse Event|1|||
23369403|NCT00879658|65099103|FG004|Overall Study|Adverse Event|2|||
23369404|NCT00879658|65099104|FG005|Overall Study|Adverse Event|0|||
23369405|NCT00879658|65099105|FG006|Overall Study|Adverse Event|0|||
23369406|NCT00879658|65099099|FG000|Overall Study|Protocol Violation|1|||
23369407|NCT00879658|65099100|FG001|Overall Study|Protocol Violation|0|||
23369408|NCT00879658|65099101|FG002|Overall Study|Protocol Violation|0|||
23369409|NCT00879658|65099102|FG003|Overall Study|Protocol Violation|0|||
23369410|NCT00879658|65099103|FG004|Overall Study|Protocol Violation|0|||
23276781|NCT01686477|64758716|FG002|Feeding Intervention|Withdrawal by Subject|0|||
23276782|NCT01686477|64758714|FG000|Feeding Intervention|Physician Decision|1|||
23276783|NCT01686477|64758715|FG001|Feeding Intervention|Physician Decision|2|||
23276784|NCT01686477|64758716|FG002|Feeding Intervention|Physician Decision|0|||
23276785|NCT01686477|64758714|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
23276786|NCT01686477|64758715|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
23276787|NCT01686477|64758716|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
23276788|NCT01686477|64758714|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
23276789|NCT01686477|64758715|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
23276790|NCT01686477|64758716|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
23276791|NCT01686477|64758714|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
23276792|NCT01686477|64758715|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
23276793|NCT01686477|64758716|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
23276794|NCT01686477|64758714|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
23276795|NCT01686477|64758715|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
23276796|NCT01686477|64758716|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
23276797|NCT01686477|64758714|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
23276798|NCT01686477|64758715|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
23276799|NCT01686477|64758716|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
23276800|NCT01686477|64758714|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
23369411|NCT00879658|65099104|FG005|Overall Study|Protocol Violation|0|||
23369412|NCT00879658|65099105|FG006|Overall Study|Protocol Violation|0|||
23369413|NCT00879658|65099099|FG000|Overall Study|Withdrawal by Subject|3|||
23369414|NCT00879658|65099100|FG001|Overall Study|Withdrawal by Subject|0|||
23369415|NCT00879658|65099101|FG002|Overall Study|Withdrawal by Subject|2|||
23369416|NCT00879658|65099102|FG003|Overall Study|Withdrawal by Subject|0|||
23369417|NCT00879658|65099103|FG004|Overall Study|Withdrawal by Subject|0|||
23369418|NCT00879658|65099104|FG005|Overall Study|Withdrawal by Subject|1|||
23369419|NCT00879658|65099105|FG006|Overall Study|Withdrawal by Subject|0|||
23369420|NCT00879658|65099099|FG000|Overall Study|Lack of Efficacy|0|||
23369421|NCT00879658|65099100|FG001|Overall Study|Lack of Efficacy|0|||
23369422|NCT00879658|65099101|FG002|Overall Study|Lack of Efficacy|2|||
23369423|NCT00879658|65099102|FG003|Overall Study|Lack of Efficacy|0|||
23276801|NCT01686477|64758715|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
23276802|NCT01686477|64758716|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
23276803|NCT01686477|64758714|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
23369424|NCT00879658|65099103|FG004|Overall Study|Lack of Efficacy|0|||
23369425|NCT00879658|65099104|FG005|Overall Study|Lack of Efficacy|0|||
23369426|NCT00879658|65099105|FG006|Overall Study|Lack of Efficacy|0|||
23369427|NCT00879658|65099099|FG000|Overall Study|misrandomized (never received study med)|0|||
23369428|NCT00879658|65099100|FG001|Overall Study|misrandomized (never received study med)|0|||
23276804|NCT01686477|64758715|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
23276805|NCT01686477|64758716|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
23276806|NCT01265056|64758720|FG000|Initial Study Period|Withdrawal by Subject|1|||
23276807|NCT01265056|64758721|FG001|Initial Study Period|Withdrawal by Subject|1|||
23276808|NCT01265056|64758720|FG000|Initial Study Period|Withdrawal by Subject|1|||
23276809|NCT01265056|64758721|FG001|Initial Study Period|Withdrawal by Subject|1|||
23276810|NCT01265056|64758720|FG000|Follow up|Lost to Follow-up|7|||
23276811|NCT01265056|64758721|FG001|Follow up|Lost to Follow-up|3|||
23276812|NCT03514017|64758722|FG000|Overall Study|Death|1|||
23276813|NCT03514017|64758722|FG000|Overall Study|Adverse Event|1|||
23276814|NCT00904215|64758724|FG000|Overall Study|Adverse Event|25|||
23276815|NCT00904215|64758724|FG000|Overall Study|Protocol Violation|10|||
23276816|NCT00904215|64758724|FG000|Overall Study|Lost to Follow-up|63|||
23276817|NCT00904215|64758724|FG000|Overall Study|Withdrawal by Subject|9|||
23276818|NCT00904215|64758724|FG000|Overall Study|Other|28|||
23276819|NCT05099380|64758725|FG000|Overall Study|Subject enrolled in error|1|||
23276820|NCT05099380|64758726|FG001|Overall Study|Subject enrolled in error|0|||
23276821|NCT05099380|64758725|FG000|Overall Study|Study Procedure|1|||
23276822|NCT05099380|64758726|FG001|Overall Study|Study Procedure|0|||
23276823|NCT05099380|64758725|FG000|Overall Study|Protocol Violation|1|||
23276824|NCT05099380|64758726|FG001|Overall Study|Protocol Violation|0|||
23276825|NCT05099380|64758725|FG000|Overall Study|Adverse Event|1|||
23276826|NCT05099380|64758726|FG001|Overall Study|Adverse Event|1|||
23276827|NCT05099380|64758725|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
23276828|NCT05099380|64758726|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
23276829|NCT03868891|64758729|FG000|Overall Study|Adverse Event|1|||
23276830|NCT03868891|64758730|FG001|Overall Study|Adverse Event|0|||
23276831|NCT03868891|64758729|FG000|Overall Study|Lost to Follow-up|2|||
23276832|NCT03868891|64758730|FG001|Overall Study|Lost to Follow-up|1|||
23276833|NCT03868891|64758729|FG000|Overall Study|COVID-19 Restrictions|1|||
23276834|NCT03868891|64758730|FG001|Overall Study|COVID-19 Restrictions|2|||
23276835|NCT01778010|64758731|FG000|Overall Study|Withdrawal by Subject|2|||
23276836|NCT01778010|64758731|FG000|Overall Study|abnormal ECG before meds|1|||
23276837|NCT01778010|64758731|FG000|Overall Study|Arrested|1|||
23276838|NCT01778010|64758731|FG000|Overall Study|rash while on placebo|1|||
23276839|NCT03600376|64758732|FG000|Overall Study|Adverse Event|1|||
23276840|NCT03600376|64758733|FG001|Overall Study|Adverse Event|1|||
23276841|NCT03600376|64758732|FG000|Overall Study|Transferred to other facility|1|||
23369429|NCT00879658|65099101|FG002|Overall Study|misrandomized (never received study med)|0|||
23276842|NCT03600376|64758733|FG001|Overall Study|Transferred to other facility|0|||
23276843|NCT03600376|64758732|FG000|Overall Study|Investigator Decision|0|||
23276844|NCT03600376|64758733|FG001|Overall Study|Investigator Decision|4|||
23276845|NCT03600376|64758732|FG000|Overall Study|Determined to be ineligible for study|0|||
23276846|NCT03600376|64758733|FG001|Overall Study|Determined to be ineligible for study|1|||
23276847|NCT02009163|64758734|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
23276848|NCT02009163|64758735|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
23276849|NCT02009163|64758736|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
23276850|NCT02009163|64758734|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
23276851|NCT02009163|64758735|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
23276852|NCT02009163|64758736|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
23276853|NCT02009163|64758734|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
23276854|NCT02009163|64758735|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
23276855|NCT02009163|64758736|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
23276856|NCT02009163|64758734|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
23276857|NCT02009163|64758735|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
23276858|NCT02009163|64758736|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
23276859|NCT02009163|64758734|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
23276860|NCT02009163|64758735|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
23276861|NCT02009163|64758736|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
23276862|NCT02009163|64758734|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
23276863|NCT02009163|64758735|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
23276864|NCT02009163|64758736|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
23276865|NCT02009163|64758734|FG000|Open-label Period (Non-randomized)|Other|13|||
23276866|NCT02009163|64758735|FG001|Open-label Period (Non-randomized)|Other|0|||
23276867|NCT02009163|64758736|FG002|Open-label Period (Non-randomized)|Other|0|||
23276868|NCT02009163|64758734|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
23276869|NCT02009163|64758735|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
23276870|NCT02009163|64758736|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
23276871|NCT02009163|64758734|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
23276872|NCT02009163|64758735|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
23276873|NCT02009163|64758736|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
23276874|NCT02009163|64758734|FG000|Randomized-withdrawal Period|Adverse Event|0|||
23276875|NCT02009163|64758735|FG001|Randomized-withdrawal Period|Adverse Event|0|||
23276876|NCT02009163|64758736|FG002|Randomized-withdrawal Period|Adverse Event|6|||
23276877|NCT02009163|64758734|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
23485011|NCT00718081|65518776|FG000|Overall Study|Lack of Efficacy|7|||
23369430|NCT00879658|65099102|FG003|Overall Study|misrandomized (never received study med)|1|||
23369431|NCT00879658|65099103|FG004|Overall Study|misrandomized (never received study med)|0|||
23485012|NCT00718081|65518777|FG001|Overall Study|Lack of Efficacy|3|||
23485013|NCT00718081|65518778|FG002|Overall Study|Lack of Efficacy|21|||
23485014|NCT00322153|65518779|FG000|Overall Study|Adverse Event|21|||
23485015|NCT00322153|65518780|FG001|Overall Study|Adverse Event|34|||
23603103|NCT00738400|65937229|FG000|Overall Study|Protocol Violation|1|||
23603104|NCT00738400|65937230|FG001|Overall Study|Protocol Violation|0|||
23603105|NCT00738400|65937229|FG000|Overall Study|Non-compliant with study medication|0|||
23603106|NCT00738400|65937230|FG001|Overall Study|Non-compliant with study medication|1|||
23603107|NCT00569166|65937231|FG000|Overall Study|Withdrawal by Subject|7|||
23603108|NCT00569166|65937232|FG001|Overall Study|Withdrawal by Subject|5|||
23603109|NCT00569166|65937233|FG002|Overall Study|Withdrawal by Subject|3|||
23603110|NCT00569166|65937231|FG000|Overall Study|Lost to Follow-up|2|||
23603111|NCT00569166|65937232|FG001|Overall Study|Lost to Follow-up|1|||
23603112|NCT00569166|65937233|FG002|Overall Study|Lost to Follow-up|1|||
23603113|NCT01719172|65937234|FG000|Overall Study|Lost to Follow-up|1|||
23603114|NCT01719172|65937234|FG000|Overall Study|Death|1|||
23603115|NCT01583166|65937235|FG000|Overall Study|Withdrawal by Subject|4|||
23603116|NCT01583166|65937236|FG001|Overall Study|Withdrawal by Subject|6|||
23603117|NCT01523392|65937237|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23603118|NCT01523392|65937238|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23603119|NCT01523392|65937237|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
23603120|NCT01523392|65937238|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
23603121|NCT01523392|65937237|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
23603122|NCT01523392|65937238|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
23603123|NCT00523419|65937239|FG000|Overall Study|Adverse Event|1|||
23603124|NCT00523419|65937239|FG000|Overall Study|Withdrawal by Subject|1|||
23276878|NCT02009163|64758735|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
23276879|NCT02009163|64758736|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
23276880|NCT02009163|64758734|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
23276881|NCT02009163|64758735|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
23276882|NCT02009163|64758736|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
23276883|NCT02009163|64758734|FG000|Randomized-withdrawal Period|Pregnancy|0|||
23276884|NCT02009163|64758735|FG001|Randomized-withdrawal Period|Pregnancy|0|||
23276885|NCT02009163|64758736|FG002|Randomized-withdrawal Period|Pregnancy|2|||
23276886|NCT02009163|64758734|FG000|Randomized-withdrawal Period|Other|0|||
23276887|NCT02009163|64758735|FG001|Randomized-withdrawal Period|Other|9|||
23603125|NCT00523419|65937239|FG000|Overall Study|Physician Decision|2|||
23603126|NCT00523419|65937239|FG000|Overall Study|Progressive Disease|22|||
23603127|NCT00523419|65937239|FG000|Overall Study|Death due to Study Disease|4|||
23369432|NCT00879658|65099104|FG005|Overall Study|misrandomized (never received study med)|0|||
23369433|NCT00879658|65099105|FG006|Overall Study|misrandomized (never received study med)|0|||
23369434|NCT01811732|65099106|FG000|Overall Study|Lost to Follow-up|24|||
23369435|NCT01811732|65099107|FG001|Overall Study|Lost to Follow-up|30|||
23369436|NCT01811732|65099106|FG000|Overall Study|Withdrawal by Subject|16|||
23369437|NCT01811732|65099107|FG001|Overall Study|Withdrawal by Subject|10|||
23369438|NCT01811732|65099106|FG000|Overall Study|Adverse Event|3|||
23369439|NCT01811732|65099107|FG001|Overall Study|Adverse Event|9|||
23369440|NCT01811732|65099106|FG000|Overall Study|Lack of Efficacy|3|||
23369441|NCT01811732|65099107|FG001|Overall Study|Lack of Efficacy|1|||
23369442|NCT01811732|65099106|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
23369443|NCT01811732|65099107|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
23369444|NCT01811732|65099106|FG000|Overall Study|Physician Decision|2|||
23369445|NCT01811732|65099107|FG001|Overall Study|Physician Decision|0|||
23369446|NCT01811732|65099106|FG000|Overall Study|Death|1|||
23369447|NCT01811732|65099107|FG001|Overall Study|Death|1|||
23369448|NCT01811732|65099106|FG000|Overall Study|Insufficient venous access|0|||
23369449|NCT01811732|65099107|FG001|Overall Study|Insufficient venous access|1|||
23369450|NCT01811732|65099106|FG000|Overall Study|Protocol Violation|0|||
23369451|NCT01811732|65099107|FG001|Overall Study|Protocol Violation|1|||
23369452|NCT01811732|65099106|FG000|Overall Study|Subject incarcerated|1|||
23603128|NCT00523419|65937239|FG000|Overall Study|Death due to Adverse Event|2|||
23603129|NCT02095678|65937242|FG000|Overall Study|Withdrawal by Subject|0|||
23603130|NCT02095678|65937243|FG001|Overall Study|Withdrawal by Subject|1|||
23603131|NCT02095678|65937242|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
23603132|NCT02095678|65937243|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
23603133|NCT02095678|65937242|FG000|Overall Study|lesion impacted by previous treatment|1|||
23603134|NCT02095678|65937243|FG001|Overall Study|lesion impacted by previous treatment|1|||
23603135|NCT02095678|65937242|FG000|Overall Study|No Confirmed Diagnosis|0|||
23603136|NCT02095678|65937243|FG001|Overall Study|No Confirmed Diagnosis|3|||
23603137|NCT02095678|65937242|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
23603138|NCT02095678|65937243|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
23603139|NCT02095678|65937242|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
23603140|NCT02095678|65937243|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
23603141|NCT01313663|65937248|FG000|Overall Study|Study Closed/Terminated|2|||
23603142|NCT01313663|65937249|FG001|Overall Study|Study Closed/Terminated|4|||
23603143|NCT01313663|65937248|FG000|Overall Study|Lost to Follow-up|0|||
23603144|NCT01313663|65937249|FG001|Overall Study|Lost to Follow-up|1|||
23603145|NCT01313663|65937248|FG000|Overall Study|Physician Decision|0|||
23603146|NCT01313663|65937249|FG001|Overall Study|Physician Decision|2|||
23603147|NCT01313663|65937248|FG000|Overall Study|Withdrawal by Subject|2|||
23603148|NCT01313663|65937249|FG001|Overall Study|Withdrawal by Subject|1|||
23603149|NCT00747006|65937256|FG000|Overall Study|Adverse Event|1|||
23603150|NCT00747006|65937257|FG001|Overall Study|Adverse Event|0|||
23603151|NCT00747006|65937258|FG002|Overall Study|Adverse Event|0|||
23603152|NCT00747006|65937256|FG000|Overall Study|Lost to Follow-up|0|||
23603153|NCT00747006|65937257|FG001|Overall Study|Lost to Follow-up|1|||
23603154|NCT00747006|65937258|FG002|Overall Study|Lost to Follow-up|0|||
23603155|NCT00747006|65937256|FG000|Overall Study|Physician Decision|2|||
23603156|NCT00747006|65937257|FG001|Overall Study|Physician Decision|0|||
23603157|NCT00747006|65937258|FG002|Overall Study|Physician Decision|1|||
23276888|NCT02009163|64758736|FG002|Randomized-withdrawal Period|Other|5|||
23276889|NCT02655679|64758737|FG000|Overall Study|Adverse Event|0|||
23276890|NCT02655679|64758738|FG001|Overall Study|Adverse Event|1|||
23276891|NCT02655679|64758739|FG002|Overall Study|Adverse Event|0|||
23276892|NCT02655679|64758740|FG003|Overall Study|Adverse Event|0|||
23276893|NCT02655679|64758741|FG004|Overall Study|Adverse Event|0|||
23276894|NCT02655679|64758737|FG000|Overall Study|Withdrawal by Subject|1|||
23276895|NCT02655679|64758738|FG001|Overall Study|Withdrawal by Subject|1|||
23276896|NCT02655679|64758739|FG002|Overall Study|Withdrawal by Subject|0|||
23276897|NCT02655679|64758740|FG003|Overall Study|Withdrawal by Subject|3|||
23276898|NCT02655679|64758741|FG004|Overall Study|Withdrawal by Subject|1|||
23276899|NCT02655679|64758737|FG000|Overall Study|Inability to Comply with the Protocol|1|||
23276900|NCT02655679|64758738|FG001|Overall Study|Inability to Comply with the Protocol|0|||
23276901|NCT02655679|64758739|FG002|Overall Study|Inability to Comply with the Protocol|0|||
23276902|NCT02655679|64758740|FG003|Overall Study|Inability to Comply with the Protocol|0|||
23276903|NCT02655679|64758741|FG004|Overall Study|Inability to Comply with the Protocol|0|||
23276904|NCT02655679|64758737|FG000|Overall Study|Lost to Follow-up|0|||
23369453|NCT01811732|65099107|FG001|Overall Study|Subject incarcerated|2|||
23369454|NCT01811732|65099106|FG000|Overall Study|Admitted to another facility|1|||
23603158|NCT01812759|65937259|FG000|Overall Study|Physician Decision|0|||
23485016|NCT00322153|65518779|FG000|Overall Study|Protocol Violation|6|||
23603159|NCT01812759|65937260|FG001|Overall Study|Physician Decision|0|||
23603160|NCT01812759|65937261|FG002|Overall Study|Physician Decision|1|||
23603161|NCT01092416|65937262|FG000|Enrollment|Atherectomy device not inserted|3|||
23603162|NCT01092416|65937262|FG000|30-Day Follow-up|Death|2|||
23603163|NCT01092416|65937262|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
23603164|NCT01092416|65937262|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
23369455|NCT01811732|65099107|FG001|Overall Study|Admitted to another facility|0|||
23369456|NCT01811732|65099106|FG000|Overall Study|Correct study drug not available on site|1|||
23369457|NCT01811732|65099107|FG001|Overall Study|Correct study drug not available on site|0|||
23369458|NCT00296244|65099110|FG000|Overall Study|Underwent retransplant|0|||
23369459|NCT00296244|65099111|FG001|Overall Study|Underwent retransplant|1|||
23369460|NCT00848497|65099112|FG000|Overall Study|Screen failure|2|||
23369461|NCT00848497|65099113|FG001|Overall Study|Screen failure|0|||
23369462|NCT00848497|65099112|FG000|Overall Study|Withdrawal by Subject|0|||
23369463|NCT00848497|65099113|FG001|Overall Study|Withdrawal by Subject|1|||
23369464|NCT01123655|65099114|FG000|Overall Study|Medication for RA had to be changed|1|||
23369465|NCT01123655|65099115|FG001|Overall Study|Medication for RA had to be changed|0|||
23369466|NCT01123655|65099116|FG002|Overall Study|Medication for RA had to be changed|0|||
23369467|NCT01123655|65099114|FG000|Overall Study|new illness|0|||
23485017|NCT00322153|65518780|FG001|Overall Study|Protocol Violation|14|||
23485018|NCT00322153|65518779|FG000|Overall Study|Withdrawal by Subject|18|||
23485019|NCT00322153|65518780|FG001|Overall Study|Withdrawal by Subject|10|||
23603165|NCT01092416|65937262|FG000|12-Month Follow-up|Death|16|||
23485020|NCT00322153|65518779|FG000|Overall Study|Lack of Efficacy|8|||
23485021|NCT00322153|65518780|FG001|Overall Study|Lack of Efficacy|3|||
23485022|NCT00322153|65518779|FG000|Overall Study|Lost to Follow-up|5|||
23485023|NCT00322153|65518780|FG001|Overall Study|Lost to Follow-up|4|||
23485024|NCT00322153|65518779|FG000|Overall Study|Withdrawn for other reasons|5|||
23485025|NCT00322153|65518780|FG001|Overall Study|Withdrawn for other reasons|4|||
23485026|NCT00442468|65518781|FG000|Overall Study|Adverse Event|4|||
23485027|NCT00442468|65518781|FG000|Overall Study|Withdrawal by Subject|91|||
23485028|NCT00442468|65518781|FG000|Overall Study|Did not complete all study procedures|88|||
23485029|NCT00194675|65518783|FG000|Overall Study|Lost to Follow-up|1|||
23485030|NCT00194675|65518784|FG001|Overall Study|Lost to Follow-up|1|||
23485031|NCT00194675|65518783|FG000|Overall Study|lack of interest|1|||
23485032|NCT00194675|65518784|FG001|Overall Study|lack of interest|1|||
23485033|NCT00194675|65518783|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
23485034|NCT00194675|65518784|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
23485035|NCT00194675|65518783|FG000|Overall Study|Protocol Violation|1|||
23485036|NCT00194675|65518784|FG001|Overall Study|Protocol Violation|0|||
23485037|NCT00194675|65518783|FG000|Overall Study|Death|1|||
23485038|NCT00194675|65518784|FG001|Overall Study|Death|0|||
23485039|NCT01673282|65518785|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
23485040|NCT01673282|65518786|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
23485041|NCT01673282|65518785|FG000|Overall Study|Lack of Efficacy|9|||
23485042|NCT01673282|65518786|FG001|Overall Study|Lack of Efficacy|2|||
23485043|NCT01673282|65518785|FG000|Overall Study|Lost to Follow-up|11|||
23485044|NCT01673282|65518786|FG001|Overall Study|Lost to Follow-up|10|||
23485045|NCT01673282|65518785|FG000|Overall Study|Withdrawal by Subject|3|||
23485046|NCT01673282|65518786|FG001|Overall Study|Withdrawal by Subject|3|||
23485047|NCT01673282|65518785|FG000|Overall Study|Other|1|||
23485048|NCT01673282|65518786|FG001|Overall Study|Other|6|||
23485049|NCT03475875|65518787|FG000|Period 1|Lost to Follow-up|1|||
23485050|NCT03475875|65518788|FG001|Period 1|Lost to Follow-up|0|||
23485051|NCT03475875|65518787|FG000|Period 1|Adverse Event|2|||
23485052|NCT03475875|65518788|FG001|Period 1|Adverse Event|1|||
23485053|NCT03475875|65518787|FG000|Period 2|Adverse Event|3|||
23485054|NCT03475875|65518788|FG001|Period 2|Adverse Event|0|||
23603166|NCT01092416|65937262|FG000|12-Month Follow-up|Lost to Follow-up|4|||
23603167|NCT01092416|65937262|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
23603168|NCT01092416|65937262|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
23603169|NCT01092416|65937262|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
23369468|NCT01123655|65099115|FG001|Overall Study|new illness|1|||
23485055|NCT03475875|65518787|FG000|Period 2|Protocol Violation|0|||
23485056|NCT03475875|65518788|FG001|Period 2|Protocol Violation|1|||
23369469|NCT01123655|65099116|FG002|Overall Study|new illness|0|||
23485057|NCT01479985|65518792|FG000|Overall Study|Tablet malfunction, no data saved|1|||
23485058|NCT01479985|65518793|FG001|Overall Study|Tablet malfunction, no data saved|1|||
23485059|NCT01479985|65518792|FG000|Overall Study|No decisional conflict scale responses|0|||
23603170|NCT01074242|65937265|FG000|Overall Study|Case report before date of contract|40|||
23603171|NCT01074242|65937265|FG000|Overall Study|Lost to Follow-up|1|||
23603172|NCT01074242|65937265|FG000|Overall Study|Case report unclear|6|||
23603173|NCT01074242|65937265|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
23603174|NCT01074242|65937265|FG000|Overall Study|Duplicate Case Report Form|5|||
23603175|NCT04867382|65937267|FG000|Overall Study|Did not complete the survey|2|||
23603176|NCT04867382|65937268|FG001|Overall Study|Did not complete the survey|1|||
23603177|NCT00845520|65937269|FG000|Overall Study|Death|1|||
23603178|NCT00845520|65937270|FG001|Overall Study|Death|2|||
23603179|NCT00845520|65937271|FG002|Overall Study|Death|0|||
23603180|NCT00845520|65937269|FG000|Overall Study|Lost to Follow-up|1|||
23603181|NCT00845520|65937270|FG001|Overall Study|Lost to Follow-up|0|||
23603182|NCT00845520|65937271|FG002|Overall Study|Lost to Follow-up|0|||
23485060|NCT01479985|65518793|FG001|Overall Study|No decisional conflict scale responses|2|||
23603183|NCT00845520|65937269|FG000|Overall Study|Adverse Event|0|||
23276905|NCT02655679|64758738|FG001|Overall Study|Lost to Follow-up|1|||
23485061|NCT01479985|65518792|FG000|Overall Study|No post-visit survey|5|||
23485062|NCT01479985|65518793|FG001|Overall Study|No post-visit survey|3|||
23485063|NCT04099251|65518794|FG000|Pre-Treatment|Other reasons|1|||
23485064|NCT04099251|65518795|FG001|Pre-Treatment|Other reasons|0|||
23485065|NCT04099251|65518794|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
23485066|NCT04099251|65518795|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
23485067|NCT04099251|65518794|FG000|Blinded Treatment Phase|Other reasons|16|||
23485068|NCT04099251|65518795|FG001|Blinded Treatment Phase|Other reasons|7|||
23485069|NCT04099251|65518794|FG000|Blinded Treatment Phase|Disease recurrence|26|||
23485070|NCT04099251|65518795|FG001|Blinded Treatment Phase|Disease recurrence|41|||
23485071|NCT04099251|65518794|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
23276906|NCT02655679|64758739|FG002|Overall Study|Lost to Follow-up|1|||
23276907|NCT02655679|64758740|FG003|Overall Study|Lost to Follow-up|1|||
23276908|NCT02655679|64758741|FG004|Overall Study|Lost to Follow-up|0|||
23276909|NCT02655679|64758737|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23276910|NCT02655679|64758738|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23276911|NCT02655679|64758739|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23276912|NCT02655679|64758740|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23276913|NCT02655679|64758741|FG004|Overall Study|Other Miscellaneous Reasons|0|||
23276914|NCT05214560|64758742|FG000|Overall Study|Screening Failure|1|||
23276915|NCT05214560|64758742|FG000|Overall Study|Physician Decision|4|||
23276916|NCT05214560|64758742|FG000|Overall Study|Withdrawal by Subject|1|||
23276917|NCT05214560|64758742|FG000|Overall Study|Lost to Follow-up|2|||
23276918|NCT05214560|64758742|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
23276919|NCT05214560|64758742|FG000|Overall Study|Study physician not available for the anesthesia|3|||
23276920|NCT05214560|64758742|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
23276921|NCT05214560|64758742|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
23276922|NCT05214560|64758742|FG000|Overall Study|Surgery not performed|3|||
23276923|NCT01802320|64758743|FG000|Overall Study|Death|1|||
23276924|NCT01802320|64758743|FG000|Overall Study|Withdrawal by Subject|1|||
23276925|NCT04278560|64758744|FG000|Overall Study|Adverse Event|1|||
23276926|NCT04278560|64758745|FG001|Overall Study|Adverse Event|2|||
23276927|NCT04278560|64758744|FG000|Overall Study|Withdrawal by Subject|0|||
23276928|NCT04278560|64758745|FG001|Overall Study|Withdrawal by Subject|1|||
23276929|NCT02152163|64758746|FG000|Overall Study|Physician Decision|12|||
23276930|NCT02152163|64758747|FG001|Overall Study|Physician Decision|13|||
23276931|NCT02865850|64758751|FG000|Overall Study|Death|15|||
23276932|NCT02865850|64758752|FG001|Overall Study|Death|19|||
23276933|NCT02865850|64758751|FG000|Overall Study|Withdrawal by Subject|3|||
23276934|NCT02865850|64758752|FG001|Overall Study|Withdrawal by Subject|2|||
23276935|NCT02865850|64758751|FG000|Overall Study|Lost to Follow-up|3|||
23276936|NCT02865850|64758752|FG001|Overall Study|Lost to Follow-up|2|||
23276937|NCT03154047|64758753|FG000|Overall Study|Death|1|||
23276938|NCT03154047|64758753|FG000|Overall Study|Study terminated by sponsor|76|||
23485072|NCT04099251|65518795|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
23485073|NCT04099251|65518794|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
23603184|NCT00845520|65937270|FG001|Overall Study|Adverse Event|0|||
23603185|NCT00845520|65937271|FG002|Overall Study|Adverse Event|1|||
23276939|NCT03154047|64758753|FG000|Overall Study|Withdrawal by Subject|3|||
23603186|NCT01450007|65937279|FG000|Overall Study|Late exclusion before treatment|2|||
23603187|NCT01450007|65937280|FG001|Overall Study|Late exclusion before treatment|3|||
23276940|NCT00834340|64758754|FG000|Washout|Adverse Event|1|||
23276941|NCT00834340|64758755|FG001|Washout|Adverse Event|0|||
23276942|NCT00834340|64758754|FG000|Washout|Withdrawal by Subject|1|||
23276943|NCT00834340|64758755|FG001|Washout|Withdrawal by Subject|0|||
23276944|NCT00574847|64758756|FG000|Overall Study|Adverse Event|2|||
23485074|NCT04099251|65518795|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
23603188|NCT01450007|65937281|FG002|Overall Study|Late exclusion before treatment|2|||
23603189|NCT01450007|65937279|FG000|Overall Study|Protocol Violation|0|||
23603190|NCT01450007|65937280|FG001|Overall Study|Protocol Violation|1|||
23603191|NCT01450007|65937281|FG002|Overall Study|Protocol Violation|1|||
23603192|NCT01450007|65937279|FG000|Overall Study|Adverse Event|0|||
23603193|NCT01450007|65937280|FG001|Overall Study|Adverse Event|1|||
23603194|NCT01450007|65937281|FG002|Overall Study|Adverse Event|0|||
23603195|NCT01436175|65937282|FG000|Overall Study|Adverse Event|111|||
23603196|NCT01436175|65937282|FG000|Overall Study|Protocol Violation|49|||
23603197|NCT01436175|65937282|FG000|Overall Study|Withdrawal by Subject|108|||
23603198|NCT01436175|65937282|FG000|Overall Study|Lost to Follow-up|89|||
23603199|NCT01436175|65937282|FG000|Overall Study|Lack of Efficacy|24|||
23603200|NCT01436175|65937282|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
23276945|NCT00574847|64758757|FG001|Overall Study|Adverse Event|0|||
23603201|NCT01436175|65937282|FG000|Overall Study|Other|826|||
23603202|NCT03987074|65937287|FG000|Overall Study|Withdrew Consent|1|||
23603203|NCT03987074|65937288|FG001|Overall Study|Withdrew Consent|1|||
23276946|NCT00574847|64758756|FG000|Overall Study|Death|1|||
23276947|NCT00574847|64758757|FG001|Overall Study|Death|0|||
23276948|NCT00574847|64758756|FG000|Overall Study|Withdrawal by Subject|2|||
23276949|NCT00574847|64758757|FG001|Overall Study|Withdrawal by Subject|2|||
23276950|NCT00574847|64758756|FG000|Overall Study|Physician Decision|1|||
23276951|NCT00574847|64758757|FG001|Overall Study|Physician Decision|0|||
23276952|NCT00574847|64758756|FG000|Overall Study|Did not receive medication (declined)|2|||
23276953|NCT00574847|64758757|FG001|Overall Study|Did not receive medication (declined)|5|||
23276954|NCT00556322|64758758|FG000|Overall Study|Insufficient therapeutic response|158|||
23276955|NCT00556322|64758759|FG001|Overall Study|Insufficient therapeutic response|168|||
23276956|NCT00556322|64758758|FG000|Overall Study|Adverse Event|7|||
23276957|NCT00556322|64758759|FG001|Overall Study|Adverse Event|4|||
23276958|NCT00556322|64758758|FG000|Overall Study|Other|4|||
23276959|NCT00556322|64758759|FG001|Overall Study|Other|1|||
23276960|NCT00556322|64758758|FG000|Overall Study|Lost to Follow-up|5|||
23276961|NCT00556322|64758759|FG001|Overall Study|Lost to Follow-up|3|||
23276962|NCT00556322|64758758|FG000|Overall Study|Withdrawal by Subject|19|||
23276963|NCT00556322|64758759|FG001|Overall Study|Withdrawal by Subject|7|||
23276964|NCT00556322|64758758|FG000|Overall Study|Protocol Violation|5|||
23276965|NCT00556322|64758759|FG001|Overall Study|Protocol Violation|1|||
23276966|NCT00556322|64758758|FG000|Overall Study|Ongoing at data cutoff|3|||
23276967|NCT00556322|64758759|FG001|Overall Study|Ongoing at data cutoff|5|||
23276968|NCT00556322|64758758|FG000|Overall Study|Death|20|||
23276969|NCT00556322|64758759|FG001|Overall Study|Death|14|||
23276970|NCT02146105|64758762|FG000|Overall Study|Adverse Event|1|||
23276971|NCT02146105|64758762|FG000|Overall Study|Withdrawal by Subject|5|||
23276972|NCT01139047|64758763|FG000|Overall Study|Withdrawal by Subject|1|||
23276973|NCT03450057|64758764|FG000|Overall Study|Death|17|||
23276974|NCT03450057|64758764|FG000|Overall Study|ICF withdrawal|4|||
23276975|NCT03450057|64758764|FG000|Overall Study|Lost to Follow-up|2|||
23276976|NCT00731783|64758765|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
23276977|NCT00731783|64758766|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
23276978|NCT00731783|64758765|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
23276979|NCT00731783|64758766|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
23276980|NCT00731783|64758765|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
23276981|NCT00731783|64758766|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
23276982|NCT00731783|64758765|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
23369470|NCT01123655|65099114|FG000|Overall Study|began prohibitive drug|0|||
23369471|NCT01123655|65099115|FG001|Overall Study|began prohibitive drug|0|||
23369472|NCT01123655|65099116|FG002|Overall Study|began prohibitive drug|1|||
23369473|NCT03191552|65099120|FG000|Overall Study|Lost to Follow-up|1|||
23369474|NCT03191552|65099121|FG001|Overall Study|Lost to Follow-up|0|||
23369475|NCT03191552|65099122|FG002|Overall Study|Lost to Follow-up|0|||
23369476|NCT03191552|65099120|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
23369477|NCT03191552|65099121|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
23369478|NCT03191552|65099122|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
23369479|NCT01100502|65099123|FG000|Overall Study|Withdrawal by Subject|18|||
23369480|NCT01100502|65099124|FG001|Overall Study|Withdrawal by Subject|25|||
23369481|NCT01100502|65099123|FG000|Overall Study|Lost to Follow-up|13|||
23369482|NCT01100502|65099124|FG001|Overall Study|Lost to Follow-up|28|||
23369483|NCT01100502|65099123|FG000|Overall Study|Site request to end participation in study|0|||
23369484|NCT01100502|65099124|FG001|Overall Study|Site request to end participation in study|1|||
23369485|NCT01100502|65099123|FG000|Overall Study|Death|45|||
23369486|NCT01100502|65099124|FG001|Overall Study|Death|40|||
23369487|NCT00828711|65099125|FG000|Overall Study|Lost to Follow-up|1|||
23369488|NCT00828711|65099126|FG001|Overall Study|Lost to Follow-up|0|||
23369489|NCT00828711|65099127|FG002|Overall Study|Lost to Follow-up|0|||
23369490|NCT03087058|65099128|FG000|Overall Study|Withdrawal by Subject|2|||
23369491|NCT03087058|65099129|FG001|Overall Study|Withdrawal by Subject|0|||
23369492|NCT03087058|65099130|FG002|Overall Study|Withdrawal by Subject|0|||
23369493|NCT02563899|65099131|FG000|Overall Study|Protocol Violation|1|||
23369494|NCT02563899|65099132|FG001|Overall Study|Protocol Violation|0|||
23369495|NCT02563899|65099133|FG002|Overall Study|Protocol Violation|0|||
23369496|NCT02563899|65099134|FG003|Overall Study|Protocol Violation|0|||
23603204|NCT03987074|65937289|FG002|Overall Study|Withdrew Consent|0|||
23603205|NCT03987074|65937290|FG003|Overall Study|Withdrew Consent|2|||
23603206|NCT03987074|65937291|FG004|Overall Study|Withdrew Consent|1|||
23603207|NCT03987074|65937287|FG000|Overall Study|Adverse Event|2|||
23603208|NCT03987074|65937288|FG001|Overall Study|Adverse Event|1|||
23603209|NCT03987074|65937289|FG002|Overall Study|Adverse Event|0|||
23603210|NCT03987074|65937290|FG003|Overall Study|Adverse Event|0|||
23603211|NCT03987074|65937291|FG004|Overall Study|Adverse Event|1|||
23603212|NCT03987074|65937287|FG000|Overall Study|Lost to Follow-up|0|||
23276983|NCT00731783|64758766|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
23276984|NCT00640562|64758767|FG000|Overall Study|Adverse Event|8|||
23276985|NCT00640562|64758768|FG001|Overall Study|Adverse Event|5|||
23276986|NCT00640562|64758767|FG000|Overall Study|Lack of Efficacy|1|||
23276987|NCT00640562|64758768|FG001|Overall Study|Lack of Efficacy|4|||
23276988|NCT00640562|64758767|FG000|Overall Study|Protocol Violation|2|||
23276989|NCT00640562|64758768|FG001|Overall Study|Protocol Violation|4|||
23276990|NCT00640562|64758767|FG000|Overall Study|Withdrawal by Subject|6|||
23276991|NCT00640562|64758768|FG001|Overall Study|Withdrawal by Subject|10|||
23276992|NCT00640562|64758767|FG000|Overall Study|Known risperidone intolerance|0|||
23276993|NCT00640562|64758768|FG001|Overall Study|Known risperidone intolerance|1|||
23276994|NCT00640562|64758767|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
23276995|NCT00640562|64758768|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
23276996|NCT00640562|64758767|FG000|Overall Study|Low study drug dose|0|||
23276997|NCT00640562|64758768|FG001|Overall Study|Low study drug dose|1|||
23276998|NCT00640562|64758767|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
23276999|NCT00640562|64758768|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
23277000|NCT02601560|64758769|FG000|Overall Study|Other|0|||
23277001|NCT02601560|64758770|FG001|Overall Study|Other|0|||
23277002|NCT02601560|64758771|FG002|Overall Study|Other|0|||
23277003|NCT02601560|64758772|FG003|Overall Study|Other|0|||
23277004|NCT02601560|64758773|FG004|Overall Study|Other|0|||
23277005|NCT02601560|64758774|FG005|Overall Study|Other|0|||
23277006|NCT02601560|64758775|FG006|Overall Study|Other|1|||
23277007|NCT02601560|64758776|FG007|Overall Study|Other|0|||
23277008|NCT02158663|64758777|FG000|Overall Study|Withdrawal by Subject|5|||
23277009|NCT02158663|64758778|FG001|Overall Study|Withdrawal by Subject|4|||
23277010|NCT03197883|64758779|FG000|Overall Study|Adverse Event|1|||
23277011|NCT03197883|64758780|FG001|Overall Study|Adverse Event|1|||
23277012|NCT03197883|64758779|FG000|Overall Study|Lost to Follow-up|1|||
23277013|NCT03197883|64758780|FG001|Overall Study|Lost to Follow-up|0|||
23277014|NCT03197883|64758779|FG000|Overall Study|Protocol Violation|1|||
23277015|NCT03197883|64758780|FG001|Overall Study|Protocol Violation|0|||
23277016|NCT03197883|64758779|FG000|Overall Study|Other (Not Specified)|0|||
23277017|NCT03197883|64758780|FG001|Overall Study|Other (Not Specified)|5|||
23277018|NCT02514122|64758786|FG000|Overall Study|Withdrawal by Subject|2|||
23277019|NCT02514122|64758787|FG001|Overall Study|Withdrawal by Subject|0|||
23277020|NCT00112463|64758791|FG000|Overall Study|Physician Decision|1|||
23277021|NCT00112463|64758791|FG000|Overall Study|Progression|30|||
23277022|NCT00112463|64758791|FG000|Overall Study|Second Primary|1|||
23277023|NCT00112463|64758791|FG000|Overall Study|Toxicity|3|||
23277024|NCT00112463|64758791|FG000|Overall Study|Withdrawal by Subject|2|||
23277025|NCT00112463|64758791|FG000|Overall Study|Never started treatment|2|||
23277026|NCT03017885|64758793|FG000|Overall Study|Adverse Event|2|||
23277027|NCT03017885|64758794|FG001|Overall Study|Adverse Event|0|||
23277028|NCT03017885|64758795|FG002|Overall Study|Adverse Event|0|||
23277029|NCT03017885|64758796|FG003|Overall Study|Adverse Event|0|||
23277030|NCT03017885|64758797|FG004|Overall Study|Adverse Event|0|||
23277031|NCT03017885|64758798|FG005|Overall Study|Adverse Event|0|||
23277032|NCT03017885|64758793|FG000|Overall Study|Progression of disease|4|||
23369497|NCT02563899|65099131|FG000|Overall Study|Withdrawal by Subject|0|||
23277033|NCT03017885|64758794|FG001|Overall Study|Progression of disease|3|||
23277034|NCT03017885|64758795|FG002|Overall Study|Progression of disease|4|||
23277035|NCT03017885|64758796|FG003|Overall Study|Progression of disease|0|||
23277036|NCT03017885|64758797|FG004|Overall Study|Progression of disease|0|||
23277037|NCT03017885|64758798|FG005|Overall Study|Progression of disease|0|||
23277038|NCT03017885|64758793|FG000|Overall Study|Other than listed|1|||
23369498|NCT02563899|65099132|FG001|Overall Study|Withdrawal by Subject|0|||
23485075|NCT04099251|65518794|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
23603213|NCT03987074|65937288|FG001|Overall Study|Lost to Follow-up|0|||
23277039|NCT03017885|64758794|FG001|Overall Study|Other than listed|2|||
23277040|NCT03017885|64758795|FG002|Overall Study|Other than listed|1|||
23277041|NCT03017885|64758796|FG003|Overall Study|Other than listed|0|||
23277042|NCT03017885|64758797|FG004|Overall Study|Other than listed|0|||
23603214|NCT03987074|65937289|FG002|Overall Study|Lost to Follow-up|1|||
23369499|NCT02563899|65099133|FG002|Overall Study|Withdrawal by Subject|1|||
23369500|NCT02563899|65099134|FG003|Overall Study|Withdrawal by Subject|0|||
23369501|NCT02247466|65099143|FG000|Overall Study|Procedure changed to open surgery|0|||
23369502|NCT02247466|65099144|FG001|Overall Study|Procedure changed to open surgery|3|||
23369503|NCT01294423|65099145|FG000|Overall Study|Adverse Event|1|||
23369504|NCT01294423|65099146|FG001|Overall Study|Adverse Event|2|||
23369505|NCT01294423|65099147|FG002|Overall Study|Adverse Event|3|||
23369506|NCT01294423|65099145|FG000|Overall Study|Withdrawal by Subject|1|||
23369507|NCT01294423|65099146|FG001|Overall Study|Withdrawal by Subject|2|||
23369508|NCT01294423|65099147|FG002|Overall Study|Withdrawal by Subject|2|||
23369509|NCT01294423|65099145|FG000|Overall Study|subject no longer meets study criteria|2|||
23369510|NCT01294423|65099146|FG001|Overall Study|subject no longer meets study criteria|5|||
23369511|NCT01294423|65099147|FG002|Overall Study|subject no longer meets study criteria|2|||
23369512|NCT01294423|65099145|FG000|Overall Study|poor/non-compliance|1|||
23369513|NCT01294423|65099146|FG001|Overall Study|poor/non-compliance|0|||
23603215|NCT03987074|65937290|FG003|Overall Study|Lost to Follow-up|1|||
23603216|NCT03987074|65937291|FG004|Overall Study|Lost to Follow-up|0|||
23603217|NCT03987074|65937287|FG000|Overall Study|Investigator's Discretion|0|||
23603218|NCT03987074|65937288|FG001|Overall Study|Investigator's Discretion|0|||
23603219|NCT03987074|65937289|FG002|Overall Study|Investigator's Discretion|0|||
23603220|NCT03987074|65937290|FG003|Overall Study|Investigator's Discretion|1|||
23603221|NCT03987074|65937291|FG004|Overall Study|Investigator's Discretion|0|||
23277043|NCT03017885|64758798|FG005|Overall Study|Other than listed|0|||
23277044|NCT03017885|64758793|FG000|Overall Study|Lost to Follow-up|2|||
23277045|NCT03017885|64758794|FG001|Overall Study|Lost to Follow-up|0|||
23603222|NCT01128595|65937292|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23603223|NCT01128595|65937293|FG001|Treatment Period 3|Withdrawal by Subject|1|||
23277046|NCT03017885|64758795|FG002|Overall Study|Lost to Follow-up|3|||
23277047|NCT03017885|64758796|FG003|Overall Study|Lost to Follow-up|0|||
23277048|NCT03017885|64758797|FG004|Overall Study|Lost to Follow-up|0|||
23277049|NCT03017885|64758798|FG005|Overall Study|Lost to Follow-up|0|||
23277050|NCT03017885|64758793|FG000|Overall Study|Change to other anti-cancer therapy|0|||
23277051|NCT03017885|64758794|FG001|Overall Study|Change to other anti-cancer therapy|0|||
23277052|NCT03017885|64758795|FG002|Overall Study|Change to other anti-cancer therapy|1|||
23277053|NCT03017885|64758796|FG003|Overall Study|Change to other anti-cancer therapy|0|||
23277054|NCT03017885|64758797|FG004|Overall Study|Change to other anti-cancer therapy|0|||
23277055|NCT03017885|64758798|FG005|Overall Study|Change to other anti-cancer therapy|0|||
23277056|NCT04400890|64758799|FG000|Overall Study|Withdrawal by Subject|3|||
23277057|NCT04400890|64758800|FG001|Overall Study|Withdrawal by Subject|2|||
23277058|NCT03522675|64758805|FG000|Overall Study|Screen fail|1|||
23277059|NCT03522675|64758805|FG000|Overall Study|Non-reactive to histamine|1|||
23277060|NCT01237054|64758806|FG000|Overall Study|imaging 10C0096|1|||
23277061|NCT03181594|64758807|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
23277062|NCT03181594|64758807|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
23277063|NCT03181594|64758807|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
23277064|NCT03181594|64758807|FG000|Initial Study Protocol (12-month FU)|Death|1|||
23369514|NCT01294423|65099147|FG002|Overall Study|poor/non-compliance|1|||
23603224|NCT01128595|65937294|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23603225|NCT01128595|65937295|FG003|Treatment Period 3|Withdrawal by Subject|0|||
23603226|NCT00391170|65937296|FG000|Overall Study|Withdrawal by Subject|1|||
23603227|NCT00391170|65937297|FG001|Overall Study|Withdrawal by Subject|0|||
23603228|NCT00391170|65937296|FG000|Overall Study|Adverse Event|3|||
23603229|NCT00391170|65937297|FG001|Overall Study|Adverse Event|2|||
23603230|NCT00391170|65937296|FG000|Overall Study|Physician Decision|2|||
23603231|NCT00391170|65937297|FG001|Overall Study|Physician Decision|2|||
23603232|NCT01989689|65937300|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
23603233|NCT01989689|65937301|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
23603234|NCT01989689|65937300|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
23603235|NCT01989689|65937301|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
23603236|NCT00312208|65937302|FG000|Overall Study|Adverse Event|97|||
23603237|NCT00312208|65937303|FG001|Overall Study|Adverse Event|61|||
23277065|NCT03181594|64758807|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
23277066|NCT03181594|64758807|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
23369515|NCT00909870|65099149|FG000|Overall Study|Adverse Event|13|||
23603238|NCT00312208|65937302|FG000|Overall Study|Protocol Violation|5|||
23603239|NCT00312208|65937303|FG001|Overall Study|Protocol Violation|3|||
23277067|NCT01745120|64758810|FG000|Overall Study|Investigator decision|1|||
23277068|NCT01745120|64758811|FG001|Overall Study|Investigator decision|0|||
23277069|NCT03987191|64758812|FG000|Overall Study|COVID-19 related research disruption|0|||
23277070|NCT03987191|64758813|FG001|Overall Study|COVID-19 related research disruption|2|||
23277071|NCT03804983|64758814|FG000|Overall Study|Adverse Event|0|||
23277072|NCT03804983|64758815|FG001|Overall Study|Adverse Event|1|||
23277073|NCT03804983|64758814|FG000|Overall Study|Family Obligation|1|||
23277074|NCT03804983|64758815|FG001|Overall Study|Family Obligation|0|||
23277075|NCT01854047|64758816|FG000|Overall Study|Lack of Efficacy|1|||
23277076|NCT01854047|64758817|FG001|Overall Study|Lack of Efficacy|0|||
23277077|NCT01854047|64758818|FG002|Overall Study|Lack of Efficacy|0|||
23277078|NCT01854047|64758819|FG003|Overall Study|Lack of Efficacy|0|||
23277079|NCT01854047|64758820|FG004|Overall Study|Lack of Efficacy|0|||
23277080|NCT01854047|64758816|FG000|Overall Study|Poor compliance to protocol|3|||
23277081|NCT01854047|64758817|FG001|Overall Study|Poor compliance to protocol|0|||
23277082|NCT01854047|64758818|FG002|Overall Study|Poor compliance to protocol|2|||
23277083|NCT01854047|64758819|FG003|Overall Study|Poor compliance to protocol|0|||
23277084|NCT01854047|64758820|FG004|Overall Study|Poor compliance to protocol|0|||
23277085|NCT01854047|64758816|FG000|Overall Study|Adverse Event|5|||
23277086|NCT01854047|64758817|FG001|Overall Study|Adverse Event|4|||
23277087|NCT01854047|64758818|FG002|Overall Study|Adverse Event|6|||
23277088|NCT01854047|64758819|FG003|Overall Study|Adverse Event|10|||
23277089|NCT01854047|64758820|FG004|Overall Study|Adverse Event|7|||
23277090|NCT01854047|64758816|FG000|Overall Study|Randomized but not treated|0|||
23277091|NCT01854047|64758817|FG001|Overall Study|Randomized but not treated|1|||
23277092|NCT01854047|64758818|FG002|Overall Study|Randomized but not treated|2|||
23277093|NCT01854047|64758819|FG003|Overall Study|Randomized but not treated|0|||
23277094|NCT01854047|64758820|FG004|Overall Study|Randomized but not treated|4|||
23277095|NCT01854047|64758816|FG000|Overall Study|Other than specified above|3|||
23277096|NCT01854047|64758817|FG001|Overall Study|Other than specified above|3|||
23277097|NCT01854047|64758818|FG002|Overall Study|Other than specified above|3|||
23277098|NCT01854047|64758819|FG003|Overall Study|Other than specified above|5|||
23277099|NCT01854047|64758820|FG004|Overall Study|Other than specified above|8|||
23277100|NCT01882647|64758825|FG000|Overall Study|Lost to Follow-up|2|||
23277101|NCT01882647|64758826|FG001|Overall Study|Lost to Follow-up|2|||
23277102|NCT01882647|64758825|FG000|Overall Study|Withdrawal by Subject|0|||
23277103|NCT01882647|64758826|FG001|Overall Study|Withdrawal by Subject|4|||
23277104|NCT00549718|64758827|FG000|Overall Study|Insufficient clinical response|20|||
23277105|NCT00549718|64758828|FG001|Overall Study|Insufficient clinical response|7|||
23277106|NCT00549718|64758829|FG002|Overall Study|Insufficient clinical response|18|||
23277107|NCT00549718|64758830|FG003|Overall Study|Insufficient clinical response|32|||
23277108|NCT00549718|64758827|FG000|Overall Study|Adverse Event|6|||
23277109|NCT00549718|64758828|FG001|Overall Study|Adverse Event|8|||
23277110|NCT00549718|64758829|FG002|Overall Study|Adverse Event|7|||
23277111|NCT00549718|64758830|FG003|Overall Study|Adverse Event|3|||
23277112|NCT00549718|64758827|FG000|Overall Study|Lost to Follow-up|4|||
23277113|NCT00549718|64758828|FG001|Overall Study|Lost to Follow-up|2|||
23277114|NCT00549718|64758829|FG002|Overall Study|Lost to Follow-up|0|||
23277115|NCT00549718|64758830|FG003|Overall Study|Lost to Follow-up|6|||
23277116|NCT00549718|64758827|FG000|Overall Study|Withdrawal by Subject|9|||
23277117|NCT00549718|64758828|FG001|Overall Study|Withdrawal by Subject|18|||
23277118|NCT00549718|64758829|FG002|Overall Study|Withdrawal by Subject|12|||
23277119|NCT00549718|64758830|FG003|Overall Study|Withdrawal by Subject|13|||
23277120|NCT00549718|64758827|FG000|Overall Study|Administrative|2|||
23277121|NCT00549718|64758828|FG001|Overall Study|Administrative|2|||
23277122|NCT00549718|64758829|FG002|Overall Study|Administrative|2|||
23277123|NCT00549718|64758830|FG003|Overall Study|Administrative|1|||
23277124|NCT02493868|64758840|FG000|Induction Phase: DE Participants|Adverse Event|22|||
23277125|NCT02493868|64758841|FG001|Induction Phase: DE Participants|Adverse Event|0|||
23277126|NCT02493868|64758840|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
23603240|NCT00312208|65937302|FG000|Overall Study|Death|2|||
23277127|NCT02493868|64758841|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
23277128|NCT02493868|64758840|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
23277129|NCT02493868|64758841|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
23277130|NCT02493868|64758840|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
23277131|NCT02493868|64758841|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
23277132|NCT02493868|64758840|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
23277133|NCT02493868|64758841|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
23277134|NCT02493868|64758840|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
23277135|NCT02493868|64758841|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
23277136|NCT02493868|64758840|FG000|Induction Phase: DE Participants|Other|8|||
23277137|NCT02493868|64758841|FG001|Induction Phase: DE Participants|Other|0|||
23277138|NCT02493868|64758840|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
23277139|NCT02493868|64758841|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
23369516|NCT00909870|65099150|FG001|Overall Study|Adverse Event|7|||
23277140|NCT02493868|64758840|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
23277141|NCT02493868|64758841|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
23277142|NCT02493868|64758840|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
23277143|NCT02493868|64758841|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
23277144|NCT02493868|64758840|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
23277145|NCT02493868|64758841|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
23277146|NCT02493868|64758840|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
23277147|NCT02493868|64758841|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
23277148|NCT02493868|64758840|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
23277149|NCT02493868|64758841|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
23277150|NCT02493868|64758840|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
23277151|NCT02493868|64758841|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
23277152|NCT02493868|64758840|FG000|Optimization Phase: DE+TE Participants|Other|10|||
23277153|NCT02493868|64758841|FG001|Optimization Phase: DE+TE Participants|Other|2|||
23277154|NCT02493868|64758840|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
23277155|NCT02493868|64758841|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
23277156|NCT02493868|64758840|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
23277157|NCT02493868|64758841|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
23277158|NCT02493868|64758840|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
23277159|NCT02493868|64758841|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
23277160|NCT02493868|64758840|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
23277161|NCT02493868|64758841|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
23277162|NCT02493868|64758840|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
23277163|NCT02493868|64758841|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
23277164|NCT02493868|64758840|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
23277165|NCT02493868|64758841|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
23277166|NCT02493868|64758840|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
23277167|NCT02493868|64758841|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
23277168|NCT02493868|64758840|FG000|Follow-up Phase|Lost to Follow-up|1|||
23277169|NCT02493868|64758841|FG001|Follow-up Phase|Lost to Follow-up|0|||
23277170|NCT02493868|64758840|FG000|Follow-up Phase|Withdrawal by Subject|3|||
23277171|NCT02493868|64758841|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23277172|NCT02493868|64758840|FG000|Follow-up Phase|Investigator Decision|5|||
23277173|NCT02493868|64758841|FG001|Follow-up Phase|Investigator Decision|1|||
23277174|NCT02493868|64758840|FG000|Follow-up Phase|Other|2|||
23277175|NCT02493868|64758841|FG001|Follow-up Phase|Other|1|||
23277176|NCT03194217|64758842|FG000|Overall Study|Adverse Event|0|||
23277177|NCT03194217|64758843|FG001|Overall Study|Adverse Event|2|||
23277178|NCT03194217|64758844|FG002|Overall Study|Adverse Event|3|||
23277179|NCT03194217|64758845|FG003|Overall Study|Adverse Event|3|||
23277180|NCT03194217|64758842|FG000|Overall Study|Failure to meet randomisation criteria|0|||
23277181|NCT03194217|64758843|FG001|Overall Study|Failure to meet randomisation criteria|0|||
23277182|NCT03194217|64758844|FG002|Overall Study|Failure to meet randomisation criteria|0|||
23603241|NCT00312208|65937303|FG001|Overall Study|Death|1|||
23277183|NCT03194217|64758845|FG003|Overall Study|Failure to meet randomisation criteria|1|||
23277184|NCT03194217|64758842|FG000|Overall Study|Other|0|||
23277185|NCT03194217|64758843|FG001|Overall Study|Other|1|||
23277186|NCT03194217|64758844|FG002|Overall Study|Other|1|||
23277187|NCT03194217|64758845|FG003|Overall Study|Other|0|||
23277188|NCT03107091|64758850|FG000|Overall Study|Physician Decision|1|||
23277189|NCT00838630|64758851|FG000|First Intervention|Adverse Event|1|||
23277190|NCT00838630|64758852|FG001|First Intervention|Adverse Event|0|||
23277191|NCT00838630|64758851|FG000|Washout: 7 Days|Protocol Violation|1|||
23277192|NCT00838630|64758852|FG001|Washout: 7 Days|Protocol Violation|0|||
23277193|NCT01188681|64758857|FG000|Overall Study|bladder cancer|0|||
23277194|NCT01188681|64758858|FG001|Overall Study|bladder cancer|0|||
23277195|NCT01188681|64758859|FG002|Overall Study|bladder cancer|1|||
23277196|NCT01188681|64758860|FG003|Overall Study|bladder cancer|0|||
23277197|NCT01188681|64758857|FG000|Overall Study|Withdrawal by Subject|0|||
23277198|NCT01188681|64758858|FG001|Overall Study|Withdrawal by Subject|0|||
23277199|NCT01188681|64758859|FG002|Overall Study|Withdrawal by Subject|0|||
23277200|NCT01188681|64758860|FG003|Overall Study|Withdrawal by Subject|1|||
23603242|NCT00312208|65937302|FG000|Overall Study|Lack of Efficacy|7|||
23603243|NCT00312208|65937303|FG001|Overall Study|Lack of Efficacy|4|||
23603244|NCT00312208|65937302|FG000|Overall Study|Lost to Follow-up|3|||
23603245|NCT00312208|65937303|FG001|Overall Study|Lost to Follow-up|5|||
23603246|NCT00312208|65937302|FG000|Overall Study|Withdrawal by Subject|53|||
23603247|NCT00312208|65937303|FG001|Overall Study|Withdrawal by Subject|42|||
23603248|NCT00312208|65937302|FG000|Overall Study|Other|5|||
23603249|NCT00312208|65937303|FG001|Overall Study|Other|7|||
23603250|NCT00360269|65937304|FG000|Overall Study|Lost to Follow-up|7|||
23603251|NCT00360269|65937305|FG001|Overall Study|Lost to Follow-up|9|||
23603252|NCT00360269|65937304|FG000|Overall Study|Physician Decision|1|||
23603253|NCT00360269|65937305|FG001|Overall Study|Physician Decision|2|||
23603254|NCT00360269|65937304|FG000|Overall Study|Adverse Event|1|||
23603255|NCT00360269|65937305|FG001|Overall Study|Adverse Event|0|||
23603256|NCT00360269|65937304|FG000|Overall Study|Withdrawal by Subject|1|||
23603257|NCT00360269|65937305|FG001|Overall Study|Withdrawal by Subject|1|||
23603258|NCT00776009|65937309|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
23603259|NCT00776009|65937310|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
23603260|NCT00776009|65937311|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
23603261|NCT00776009|65937312|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
23603262|NCT00776009|65937313|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
23603263|NCT00776009|65937314|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
23603264|NCT00776009|65937309|FG000|Period 1: First Intervention|Protocol Violation|0|||
23603265|NCT00776009|65937310|FG001|Period 1: First Intervention|Protocol Violation|1|||
23603266|NCT00776009|65937311|FG002|Period 1: First Intervention|Protocol Violation|0|||
23603267|NCT00776009|65937312|FG003|Period 1: First Intervention|Protocol Violation|0|||
23603268|NCT00776009|65937313|FG004|Period 1: First Intervention|Protocol Violation|1|||
23603269|NCT00776009|65937314|FG005|Period 1: First Intervention|Protocol Violation|0|||
23603270|NCT00776009|65937309|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603271|NCT00776009|65937310|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603272|NCT00776009|65937311|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603273|NCT00776009|65937312|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603274|NCT00776009|65937313|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
23603275|NCT00776009|65937314|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
23603276|NCT00776009|65937309|FG000|Period 2: Second Intervention|Protocol Violation|1|||
23603277|NCT00776009|65937310|FG001|Period 2: Second Intervention|Protocol Violation|0|||
23277201|NCT02453386|64758862|FG000|Overall Study|Adverse Event|22|||
23277202|NCT02453386|64758863|FG001|Overall Study|Adverse Event|30|||
23277203|NCT02453386|64758864|FG002|Overall Study|Adverse Event|15|||
23277204|NCT02453386|64758862|FG000|Overall Study|Protocol Violation|1|||
23277205|NCT02453386|64758863|FG001|Overall Study|Protocol Violation|0|||
23603278|NCT00776009|65937311|FG002|Period 2: Second Intervention|Protocol Violation|1|||
23603279|NCT00776009|65937312|FG003|Period 2: Second Intervention|Protocol Violation|0|||
23603280|NCT00776009|65937313|FG004|Period 2: Second Intervention|Protocol Violation|0|||
23603281|NCT00776009|65937314|FG005|Period 2: Second Intervention|Protocol Violation|0|||
23603282|NCT00776009|65937309|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
23603283|NCT00776009|65937310|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
23369517|NCT00909870|65099149|FG000|Overall Study|Protocol Violation|1|||
23369518|NCT00909870|65099150|FG001|Overall Study|Protocol Violation|2|||
23369519|NCT00909870|65099149|FG000|Overall Study|Withdrawal by Subject|5|||
23369520|NCT00909870|65099150|FG001|Overall Study|Withdrawal by Subject|8|||
23369521|NCT00909870|65099149|FG000|Overall Study|Lost to Follow-up|3|||
23369522|NCT00909870|65099150|FG001|Overall Study|Lost to Follow-up|3|||
23369523|NCT00909870|65099149|FG000|Overall Study|Physician Decision|0|||
23369524|NCT00909870|65099150|FG001|Overall Study|Physician Decision|2|||
23369525|NCT00909870|65099149|FG000|Overall Study|Other|1|||
23369526|NCT00909870|65099150|FG001|Overall Study|Other|5|||
23369527|NCT01075048|65099151|FG000|Overall Study|Death|4|||
23369528|NCT01075048|65099152|FG001|Overall Study|Death|17|||
23369529|NCT01075048|65099153|FG002|Overall Study|Death|12|||
23369530|NCT01075048|65099151|FG000|Overall Study|Start of other or new therapy|4|||
23369531|NCT01075048|65099152|FG001|Overall Study|Start of other or new therapy|36|||
23369532|NCT01075048|65099153|FG002|Overall Study|Start of other or new therapy|46|||
23369533|NCT01075048|65099151|FG000|Overall Study|Withdrawal by Subject|1|||
23369534|NCT01075048|65099152|FG001|Overall Study|Withdrawal by Subject|6|||
23369535|NCT01075048|65099153|FG002|Overall Study|Withdrawal by Subject|3|||
23369536|NCT01075048|65099151|FG000|Overall Study|Lost to Follow-up|0|||
23369537|NCT01075048|65099152|FG001|Overall Study|Lost to Follow-up|1|||
23369538|NCT01075048|65099153|FG002|Overall Study|Lost to Follow-up|1|||
23369539|NCT01324102|65099154|FG000|Overall Study|illness|1|||
23369540|NCT01324102|65099155|FG001|Overall Study|illness|6|||
23369541|NCT01926028|65099164|FG000|Overall Study|Lost to Follow-up|7|||
23369542|NCT01926028|65099165|FG001|Overall Study|Lost to Follow-up|6|||
23603284|NCT00776009|65937311|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
23603285|NCT00776009|65937312|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
23603286|NCT00776009|65937313|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
23603287|NCT00776009|65937314|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
23603288|NCT02628626|65937315|FG000|Overall Study|Withdrawal by Subject|2|||
23603289|NCT02628626|65937316|FG001|Overall Study|Withdrawal by Subject|2|||
23603290|NCT00724126|65937320|FG000|Overall Study|Adverse Event|2|||
23603291|NCT00724126|65937321|FG001|Overall Study|Adverse Event|0|||
23603292|NCT00724126|65937320|FG000|Overall Study|Withdrawal by Subject|8|||
23603293|NCT00724126|65937321|FG001|Overall Study|Withdrawal by Subject|6|||
23603294|NCT00724126|65937320|FG000|Overall Study|Lost to Follow-up|6|||
23603295|NCT00724126|65937321|FG001|Overall Study|Lost to Follow-up|6|||
23603296|NCT00724126|65937320|FG000|Overall Study|Noncompliance|2|||
23603297|NCT00724126|65937321|FG001|Overall Study|Noncompliance|1|||
23603298|NCT00724126|65937320|FG000|Overall Study|Subject randomized although ineligible|1|||
23603299|NCT00724126|65937321|FG001|Overall Study|Subject randomized although ineligible|1|||
23603300|NCT00724126|65937320|FG000|Overall Study|Subject had to leave vicinity of site|0|||
23603301|NCT00724126|65937321|FG001|Overall Study|Subject had to leave vicinity of site|1|||
23603302|NCT01227421|65937324|FG000|Overall Study|Lost to Follow-up|6|||
23603303|NCT01227421|65937325|FG001|Overall Study|Lost to Follow-up|7|||
23603304|NCT01227421|65937326|FG002|Overall Study|Lost to Follow-up|5|||
23603305|NCT01227421|65937324|FG000|Overall Study|Adverse Event|2|||
23603306|NCT01227421|65937325|FG001|Overall Study|Adverse Event|7|||
23603307|NCT01227421|65937326|FG002|Overall Study|Adverse Event|2|||
23603308|NCT01227421|65937324|FG000|Overall Study|Withdrawal by Subject|1|||
23369543|NCT01926028|65099166|FG002|Overall Study|Lost to Follow-up|0|||
23369544|NCT01926028|65099164|FG000|Overall Study|Physician Decision|1|||
23369545|NCT01926028|65099165|FG001|Overall Study|Physician Decision|5|||
23369546|NCT01926028|65099166|FG002|Overall Study|Physician Decision|0|||
23603309|NCT01227421|65937325|FG001|Overall Study|Withdrawal by Subject|2|||
23277206|NCT02453386|64758864|FG002|Overall Study|Protocol Violation|1|||
23277207|NCT02453386|64758862|FG000|Overall Study|Withdrawal by Subject|10|||
23277208|NCT02453386|64758863|FG001|Overall Study|Withdrawal by Subject|9|||
23277209|NCT02453386|64758864|FG002|Overall Study|Withdrawal by Subject|9|||
23277210|NCT02453386|64758862|FG000|Overall Study|Sponsor Terminated Study|14|||
23277211|NCT02453386|64758863|FG001|Overall Study|Sponsor Terminated Study|8|||
23277212|NCT02453386|64758864|FG002|Overall Study|Sponsor Terminated Study|11|||
23277213|NCT02453386|64758862|FG000|Overall Study|Subject Terminated by Sponsor|1|||
23277214|NCT02453386|64758863|FG001|Overall Study|Subject Terminated by Sponsor|1|||
23277215|NCT02453386|64758864|FG002|Overall Study|Subject Terminated by Sponsor|1|||
23277216|NCT02453386|64758862|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
23277217|NCT02453386|64758863|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
23277218|NCT02453386|64758864|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
23277219|NCT02453386|64758862|FG000|Overall Study|Lost to Follow-up|0|||
23277220|NCT02453386|64758863|FG001|Overall Study|Lost to Follow-up|0|||
23277221|NCT02453386|64758864|FG002|Overall Study|Lost to Follow-up|1|||
23277222|NCT02453386|64758862|FG000|Overall Study|Other|1|||
23277223|NCT02453386|64758863|FG001|Overall Study|Other|0|||
23277224|NCT02453386|64758864|FG002|Overall Study|Other|1|||
23369547|NCT01926028|65099164|FG000|Overall Study|Withdrawal by Subject|9|||
23277225|NCT01725529|64758867|FG000|Overall Study|Adverse Event|1|||
23277226|NCT01725529|64758868|FG001|Overall Study|Adverse Event|0|||
23277227|NCT01725529|64758869|FG002|Overall Study|Adverse Event|0|||
23277228|NCT01725529|64758867|FG000|Overall Study|Lost to Follow-up|2|||
23369548|NCT01926028|65099165|FG001|Overall Study|Withdrawal by Subject|9|||
23277229|NCT01725529|64758868|FG001|Overall Study|Lost to Follow-up|1|||
23277230|NCT01725529|64758869|FG002|Overall Study|Lost to Follow-up|1|||
23277231|NCT01725529|64758867|FG000|Overall Study|Protocol Violation|0|||
23277232|NCT01725529|64758868|FG001|Overall Study|Protocol Violation|1|||
23277233|NCT01725529|64758869|FG002|Overall Study|Protocol Violation|1|||
23277234|NCT01725529|64758867|FG000|Overall Study|Withdrawal by Subject|12|||
23277235|NCT01725529|64758868|FG001|Overall Study|Withdrawal by Subject|14|||
23277236|NCT01725529|64758869|FG002|Overall Study|Withdrawal by Subject|8|||
23277237|NCT03965091|64758870|FG000|Overall Study|Adverse Event|0|||
23277238|NCT03965091|64758871|FG001|Overall Study|Adverse Event|2|||
23277239|NCT03965091|64758872|FG002|Overall Study|Adverse Event|3|||
23277240|NCT03965091|64758870|FG000|Overall Study|Withdrawal by Subject|11|||
23277241|NCT03965091|64758871|FG001|Overall Study|Withdrawal by Subject|3|||
23277242|NCT03965091|64758872|FG002|Overall Study|Withdrawal by Subject|5|||
23277243|NCT03965091|64758870|FG000|Overall Study|Non-compliance with study drug|0|||
23277244|NCT03965091|64758871|FG001|Overall Study|Non-compliance with study drug|0|||
23277245|NCT03965091|64758872|FG002|Overall Study|Non-compliance with study drug|1|||
23369549|NCT01926028|65099166|FG002|Overall Study|Withdrawal by Subject|2|||
23369550|NCT01926028|65099164|FG000|Overall Study|Non compliance or other reasons|4|||
23369551|NCT01926028|65099165|FG001|Overall Study|Non compliance or other reasons|2|||
23369552|NCT01926028|65099166|FG002|Overall Study|Non compliance or other reasons|0|||
23369553|NCT00087178|65099167|FG000|Overall Study|No follow up data|5|||
23369554|NCT00087178|65099168|FG001|Overall Study|No follow up data|15|||
23369555|NCT00087178|65099167|FG000|Overall Study|No clinical assessment|1|||
23369556|NCT00087178|65099168|FG001|Overall Study|No clinical assessment|2|||
23369557|NCT00087178|65099167|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
23369558|NCT00087178|65099168|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
23369559|NCT00977197|65099169|FG000|Overall Study|Withdrawal by Subject|3|||
23369560|NCT00977197|65099170|FG001|Overall Study|Withdrawal by Subject|4|||
23369561|NCT00977197|65099169|FG000|Overall Study|Adverse Event|3|||
23369562|NCT00977197|65099170|FG001|Overall Study|Adverse Event|1|||
23369563|NCT00977197|65099169|FG000|Overall Study|Lack of Efficacy|1|||
23369564|NCT00977197|65099170|FG001|Overall Study|Lack of Efficacy|0|||
23369565|NCT00977197|65099169|FG000|Overall Study|Lost to Follow-up|1|||
23369566|NCT00977197|65099170|FG001|Overall Study|Lost to Follow-up|3|||
23369567|NCT00977197|65099169|FG000|Overall Study|Nonadherence|1|||
23369568|NCT00977197|65099170|FG001|Overall Study|Nonadherence|1|||
23369569|NCT00746551|65099171|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
23369570|NCT00746551|65099172|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
23369571|NCT00746551|65099171|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
23369572|NCT00746551|65099172|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
23369573|NCT00746551|65099171|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
23369574|NCT00746551|65099172|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
23369575|NCT01774981|65099173|FG000|Overall Study|Adverse Event|0|||
23369576|NCT01774981|65099174|FG001|Overall Study|Adverse Event|0|||
23369577|NCT01774981|65099175|FG002|Overall Study|Adverse Event|0|||
23369578|NCT01774981|65099176|FG003|Overall Study|Adverse Event|0|||
23369579|NCT01774981|65099177|FG004|Overall Study|Adverse Event|0|||
23369580|NCT01774981|65099178|FG005|Overall Study|Adverse Event|1|||
23369581|NCT01774981|65099179|FG006|Overall Study|Adverse Event|0|||
23369582|NCT01774981|65099180|FG007|Overall Study|Adverse Event|0|||
23369583|NCT01774981|65099173|FG000|Overall Study|Withdrawal by Subject|0|||
23369584|NCT01774981|65099174|FG001|Overall Study|Withdrawal by Subject|0|||
23369585|NCT01774981|65099175|FG002|Overall Study|Withdrawal by Subject|0|||
23369586|NCT01774981|65099176|FG003|Overall Study|Withdrawal by Subject|0|||
23369587|NCT01774981|65099177|FG004|Overall Study|Withdrawal by Subject|0|||
23369588|NCT01774981|65099178|FG005|Overall Study|Withdrawal by Subject|0|||
23369589|NCT01774981|65099179|FG006|Overall Study|Withdrawal by Subject|0|||
23369590|NCT01774981|65099180|FG007|Overall Study|Withdrawal by Subject|1|||
23369591|NCT01774981|65099173|FG000|Overall Study|Death|0|||
23369592|NCT01774981|65099174|FG001|Overall Study|Death|0|||
23369593|NCT01774981|65099175|FG002|Overall Study|Death|0|||
23369594|NCT01774981|65099176|FG003|Overall Study|Death|0|||
23369595|NCT01774981|65099177|FG004|Overall Study|Death|1|||
23369596|NCT01774981|65099178|FG005|Overall Study|Death|0|||
23369597|NCT01774981|65099179|FG006|Overall Study|Death|0|||
23369598|NCT01774981|65099180|FG007|Overall Study|Death|0|||
23369599|NCT01268267|65099181|FG000|Overall Study|Protocol Violation|1|||
23369600|NCT01965327|65099182|FG000|Overall Study|Physician Decision|2|||
23369601|NCT01172873|65099183|FG000|Overall Study|Withdrawal by Subject|3|||
23369602|NCT01172873|65099184|FG001|Overall Study|Withdrawal by Subject|2|||
23369603|NCT00368251|65099185|FG000|Overall Study|SAE, non-fatal|1|||
23369604|NCT00368251|65099186|FG001|Overall Study|SAE, non-fatal|0|||
23369605|NCT00368251|65099187|FG002|Overall Study|SAE, non-fatal|0|||
23369606|NCT00368251|65099185|FG000|Overall Study|AE, non-serious non-fatal|0|||
23369607|NCT00368251|65099186|FG001|Overall Study|AE, non-serious non-fatal|0|||
23369608|NCT00368251|65099187|FG002|Overall Study|AE, non-serious non-fatal|1|||
23369609|NCT00113607|65099188|FG000|Overall Study|Adverse Event|40|||
23369610|NCT00113607|65099189|FG001|Overall Study|Adverse Event|71|||
23369611|NCT00113607|65099188|FG000|Overall Study|Death|8|||
23369612|NCT00113607|65099189|FG001|Overall Study|Death|8|||
23369613|NCT00113607|65099188|FG000|Overall Study|Withdrawal by Subject|50|||
23369614|NCT00113607|65099189|FG001|Overall Study|Withdrawal by Subject|58|||
23369615|NCT00113607|65099188|FG000|Overall Study|Lost to Follow-up|0|||
23369616|NCT00113607|65099189|FG001|Overall Study|Lost to Follow-up|2|||
23369617|NCT00113607|65099188|FG000|Overall Study|Disease Progression|180|||
23369618|NCT00113607|65099189|FG001|Overall Study|Disease Progression|142|||
23369619|NCT00113607|65099188|FG000|Overall Study|Complete Response (Confirmed)|14|||
23485076|NCT04099251|65518795|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
23603310|NCT01227421|65937326|FG002|Overall Study|Withdrawal by Subject|1|||
23369620|NCT00113607|65099189|FG001|Overall Study|Complete Response (Confirmed)|24|||
23603311|NCT01227421|65937324|FG000|Overall Study|Protocol Violation|1|||
23369621|NCT00113607|65099188|FG000|Overall Study|Other|43|||
23369622|NCT00113607|65099189|FG001|Overall Study|Other|32|||
23369623|NCT01022203|65099190|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
23369624|NCT01022203|65099191|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
23369625|NCT01022203|65099190|FG000|Post Treatment Assessment|Physician Decision|2|||
23369626|NCT01022203|65099191|FG001|Post Treatment Assessment|Physician Decision|0|||
23369627|NCT01022203|65099190|FG000|Post Treatment Assessment|Adverse Event|0|||
23369628|NCT01022203|65099191|FG001|Post Treatment Assessment|Adverse Event|2|||
23369629|NCT01022203|65099190|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
23369630|NCT01022203|65099191|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
23369631|NCT00521365|65099192|FG000|Overall Study|Adverse Event|3|||
23369632|NCT00521365|65099192|FG000|Overall Study|Lost to Follow-up|6|||
23369633|NCT00521365|65099192|FG000|Overall Study|Protocol deviation|2|||
23369634|NCT00521365|65099192|FG000|Overall Study|Drug compliance|3|||
23369635|NCT00521365|65099192|FG000|Overall Study|Usage of not allowed drugs|6|||
23369636|NCT01041859|65099193|FG000|Open-Label Titration|Adverse Event|69|||
23369637|NCT01041859|65099194|FG001|Open-Label Titration|Adverse Event|0|||
23369638|NCT01041859|65099195|FG002|Open-Label Titration|Adverse Event|0|||
23369639|NCT01041859|65099193|FG000|Open-Label Titration|Lack of Efficacy|3|||
23369640|NCT01041859|65099194|FG001|Open-Label Titration|Lack of Efficacy|0|||
23369641|NCT01041859|65099195|FG002|Open-Label Titration|Lack of Efficacy|0|||
23369642|NCT01041859|65099193|FG000|Open-Label Titration|Lost to Follow-up|1|||
23369643|NCT01041859|65099194|FG001|Open-Label Titration|Lost to Follow-up|0|||
23369644|NCT01041859|65099195|FG002|Open-Label Titration|Lost to Follow-up|0|||
23369645|NCT01041859|65099193|FG000|Open-Label Titration|Physician Decision|1|||
23369646|NCT01041859|65099194|FG001|Open-Label Titration|Physician Decision|0|||
23369647|NCT01041859|65099195|FG002|Open-Label Titration|Physician Decision|0|||
23369648|NCT01041859|65099193|FG000|Open-Label Titration|Protocol Violation|1|||
23369649|NCT01041859|65099194|FG001|Open-Label Titration|Protocol Violation|0|||
23369650|NCT01041859|65099195|FG002|Open-Label Titration|Protocol Violation|0|||
23369651|NCT01041859|65099193|FG000|Open-Label Titration|Other|7|||
23369652|NCT01041859|65099194|FG001|Open-Label Titration|Other|0|||
23369653|NCT01041859|65099195|FG002|Open-Label Titration|Other|0|||
23369654|NCT01041859|65099193|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
23369655|NCT01041859|65099194|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
23369656|NCT01041859|65099195|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
23369657|NCT01041859|65099193|FG000|Open-Label Titration|Withdrawal by Subject|11|||
23369658|NCT01041859|65099194|FG001|Open-Label Titration|Withdrawal by Subject|0|||
23369659|NCT01041859|65099195|FG002|Open-Label Titration|Withdrawal by Subject|0|||
23369660|NCT01041859|65099193|FG000|Double-Blind Maintenance|Adverse Event|0|||
23369661|NCT01041859|65099194|FG001|Double-Blind Maintenance|Adverse Event|23|||
23369662|NCT01041859|65099195|FG002|Double-Blind Maintenance|Adverse Event|13|||
23369663|NCT01041859|65099193|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
23369664|NCT01041859|65099194|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
23369665|NCT01041859|65099195|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
23369666|NCT01041859|65099193|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
23369667|NCT01041859|65099194|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
23369668|NCT01041859|65099195|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
23369669|NCT01041859|65099193|FG000|Double-Blind Maintenance|Physician Decision|0|||
23369670|NCT01041859|65099194|FG001|Double-Blind Maintenance|Physician Decision|2|||
23369671|NCT01041859|65099195|FG002|Double-Blind Maintenance|Physician Decision|1|||
23369672|NCT01041859|65099193|FG000|Double-Blind Maintenance|Protocol Violation|0|||
23369673|NCT01041859|65099194|FG001|Double-Blind Maintenance|Protocol Violation|1|||
23369674|NCT01041859|65099195|FG002|Double-Blind Maintenance|Protocol Violation|3|||
23369675|NCT01041859|65099193|FG000|Double-Blind Maintenance|Other|0|||
23369676|NCT01041859|65099194|FG001|Double-Blind Maintenance|Other|6|||
23369677|NCT01041859|65099195|FG002|Double-Blind Maintenance|Other|2|||
23369678|NCT01041859|65099193|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
23369679|NCT01041859|65099194|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
23369680|NCT01041859|65099195|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
23369681|NCT01041859|65099193|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
23369682|NCT01041859|65099194|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
23369683|NCT01041859|65099195|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
23485077|NCT04099251|65518794|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
23485078|NCT04099251|65518795|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
23485079|NCT04099251|65518794|FG000|Blinded Treatment Phase|Death|6|||
23369684|NCT01604785|65099196|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
23369685|NCT01604785|65099197|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
23369686|NCT01603277|65099198|FG000|Overall Study|Adverse Event|1|||
23369687|NCT01603277|65099199|FG001|Overall Study|Adverse Event|2|||
23369688|NCT01603277|65099198|FG000|Overall Study|Physician Decision|0|||
23369689|NCT01603277|65099199|FG001|Overall Study|Physician Decision|1|||
23369690|NCT01603277|65099198|FG000|Overall Study|Protocol Violation|6|||
23369691|NCT01603277|65099199|FG001|Overall Study|Protocol Violation|10|||
23485080|NCT04099251|65518795|FG001|Blinded Treatment Phase|Death|2|||
23485081|NCT04099251|65518794|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
23369692|NCT01603277|65099198|FG000|Overall Study|Withdrawal by Subject|5|||
23369693|NCT01603277|65099199|FG001|Overall Study|Withdrawal by Subject|4|||
23369694|NCT01603277|65099198|FG000|Overall Study|Non-Compliance|2|||
23369695|NCT01603277|65099199|FG001|Overall Study|Non-Compliance|1|||
23369696|NCT00449163|65099200|FG000|Overall Study|Physician Decision|3|||
23369697|NCT03722576|65099201|FG000|Overall Study|Withdrawal by Subject|3|||
23369698|NCT03722576|65099201|FG000|Overall Study|Adverse Event|2|||
23369699|NCT03722576|65099201|FG000|Overall Study|Physician Decision|1|||
23369700|NCT03722576|65099201|FG000|Overall Study|Lost to Follow-up|1|||
23369701|NCT02806713|65099204|FG000|Overall Study|Urethral injury during procedure|1|||
23369702|NCT02806713|65099205|FG001|Overall Study|Urethral injury during procedure|0|||
23369703|NCT02806713|65099204|FG000|Overall Study|cancelled surgery|1|||
23369704|NCT02806713|65099205|FG001|Overall Study|cancelled surgery|2|||
23485082|NCT04099251|65518795|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
23485083|NCT04099251|65518794|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
23485084|NCT04099251|65518795|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
23485085|NCT04099251|65518794|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
23485086|NCT04099251|65518795|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
23485087|NCT04099251|65518794|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
23485088|NCT04099251|65518795|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
23485089|NCT04099251|65518794|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
23485090|NCT04099251|65518795|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
23485091|NCT04099251|65518794|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
23485092|NCT04099251|65518795|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
23485093|NCT04099251|65518794|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
23485094|NCT04099251|65518795|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
23603312|NCT01227421|65937325|FG001|Overall Study|Protocol Violation|1|||
23603313|NCT01227421|65937326|FG002|Overall Study|Protocol Violation|2|||
23369705|NCT01401322|65099206|FG000|Overall Study|Withdrawal by Subject|1|||
23603314|NCT01227421|65937324|FG000|Overall Study|Randomized in error|1|||
23603315|NCT01227421|65937325|FG001|Overall Study|Randomized in error|1|||
23603316|NCT01227421|65937326|FG002|Overall Study|Randomized in error|0|||
23603317|NCT01128959|65937327|FG000|Lead in Period|Adverse Event|3|||
23603318|NCT01128959|65937327|FG000|Treatment Period|Adverse Event|3|||
23603319|NCT01128959|65937327|FG000|Treatment Period|Withdrawal by Subject|1|||
23603320|NCT01822756|65937328|FG000|Overall Study|Adverse Event|0|||
23603321|NCT01822756|65937329|FG001|Overall Study|Adverse Event|0|||
23603322|NCT01822756|65937330|FG002|Overall Study|Adverse Event|0|||
23603323|NCT01822756|65937331|FG003|Overall Study|Adverse Event|2|||
23603324|NCT01822756|65937332|FG004|Overall Study|Adverse Event|0|||
23369706|NCT01401322|65099206|FG000|Overall Study|Physician Decision|1|||
23369707|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
23369708|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369709|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369710|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369711|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369712|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369713|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
23369714|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
23369715|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369716|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369717|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369718|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369719|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369720|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
23369721|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369722|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
23369723|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369724|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369725|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369726|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369727|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
23369728|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369729|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369730|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
23369731|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369732|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369733|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369734|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
23369735|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369736|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369737|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
23369738|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369739|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369740|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369741|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
23369742|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369743|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369744|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
23369745|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369746|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369747|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369748|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
23369749|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369750|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369751|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369752|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
23369753|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369754|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369755|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
23369756|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369757|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369758|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369759|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
23369760|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369761|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23369762|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
23485095|NCT04099251|65518794|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
23485096|NCT04099251|65518795|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
23485097|NCT04099251|65518794|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
23485098|NCT04099251|65518795|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
23603325|NCT01822756|65937328|FG000|Overall Study|Disease progression|11|||
23603326|NCT01822756|65937329|FG001|Overall Study|Disease progression|1|||
23603327|NCT01822756|65937330|FG002|Overall Study|Disease progression|7|||
23603328|NCT01822756|65937331|FG003|Overall Study|Disease progression|2|||
23603329|NCT01822756|65937332|FG004|Overall Study|Disease progression|6|||
23603330|NCT01822756|65937328|FG000|Overall Study|Death|2|||
23603331|NCT01822756|65937329|FG001|Overall Study|Death|2|||
23277246|NCT03965091|64758870|FG000|Overall Study|Lost to Follow-up|1|||
23277247|NCT03965091|64758871|FG001|Overall Study|Lost to Follow-up|1|||
23277248|NCT03965091|64758872|FG002|Overall Study|Lost to Follow-up|1|||
23277249|NCT03965091|64758870|FG000|Overall Study|Lack of Efficacy|2|||
23277250|NCT03965091|64758871|FG001|Overall Study|Lack of Efficacy|0|||
23277251|NCT03965091|64758872|FG002|Overall Study|Lack of Efficacy|0|||
23277252|NCT03965091|64758870|FG000|Overall Study|Other than specified|9|||
23277253|NCT03965091|64758871|FG001|Overall Study|Other than specified|11|||
23277254|NCT03965091|64758872|FG002|Overall Study|Other than specified|8|||
23277255|NCT02865122|64758873|FG000|Overall Study|Adverse Event|1|||
23277256|NCT02865122|64758874|FG001|Overall Study|Adverse Event|0|||
23277257|NCT02865122|64758875|FG002|Overall Study|Adverse Event|0|||
23277258|NCT02890992|64758878|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23277259|NCT02890992|64758879|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
23277260|NCT02890992|64758880|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23369763|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369764|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369765|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369766|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369767|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
23369768|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369769|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
23369770|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369771|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369772|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369773|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369774|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
23369775|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369776|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
23369777|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369778|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369779|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369780|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369781|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
23369782|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369783|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
23369784|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369785|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369786|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369787|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369788|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
23369789|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23369790|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
23603332|NCT01822756|65937330|FG002|Overall Study|Death|1|||
23603333|NCT01822756|65937331|FG003|Overall Study|Death|0|||
23603334|NCT01822756|65937332|FG004|Overall Study|Death|0|||
23603335|NCT01822756|65937328|FG000|Overall Study|Lost to Follow-up|1|||
23603336|NCT01822756|65937329|FG001|Overall Study|Lost to Follow-up|0|||
23603337|NCT01822756|65937330|FG002|Overall Study|Lost to Follow-up|1|||
23603338|NCT01822756|65937331|FG003|Overall Study|Lost to Follow-up|0|||
23603339|NCT01822756|65937332|FG004|Overall Study|Lost to Follow-up|1|||
23603340|NCT01822756|65937328|FG000|Overall Study|Physician Decision|0|||
23603341|NCT01822756|65937329|FG001|Overall Study|Physician Decision|1|||
23603342|NCT01822756|65937330|FG002|Overall Study|Physician Decision|0|||
23603343|NCT01822756|65937331|FG003|Overall Study|Physician Decision|0|||
23277261|NCT02890992|64758881|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23603344|NCT01822756|65937332|FG004|Overall Study|Physician Decision|0|||
23277262|NCT02890992|64758882|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23277263|NCT02890992|64758883|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23485099|NCT00768469|65518798|FG000|Overall Study|Adverse Event|0|||
23485100|NCT00768469|65518799|FG001|Overall Study|Adverse Event|2|||
23485101|NCT00768469|65518798|FG000|Overall Study|Disease Progression|3|||
23485102|NCT00768469|65518799|FG001|Overall Study|Disease Progression|4|||
23485103|NCT00768469|65518798|FG000|Overall Study|Withdrawal by Subject|0|||
23485104|NCT00768469|65518799|FG001|Overall Study|Withdrawal by Subject|1|||
23485105|NCT01739400|65518800|FG000|Overall Study|Physician Decision|3|||
23485106|NCT01739400|65518801|FG001|Overall Study|Physician Decision|0|||
23485107|NCT01739400|65518800|FG000|Overall Study|Lost to Follow-up|2|||
23485108|NCT01739400|65518801|FG001|Overall Study|Lost to Follow-up|0|||
23485109|NCT01739400|65518800|FG000|Overall Study|Death|5|||
23485110|NCT01739400|65518801|FG001|Overall Study|Death|2|||
23485111|NCT01739400|65518800|FG000|Overall Study|Withdrawal by Subject|7|||
23485112|NCT01739400|65518801|FG001|Overall Study|Withdrawal by Subject|7|||
23485113|NCT00815516|65518805|FG000|Overall Study|Death|3|||
23485114|NCT00815516|65518806|FG001|Overall Study|Death|1|||
23485115|NCT00815516|65518805|FG000|Overall Study|Physician Decision|1|||
23485116|NCT00815516|65518806|FG001|Overall Study|Physician Decision|0|||
23485117|NCT02497976|65518807|FG000|Overall Study|Withdrawal by Subject|2|||
23485118|NCT02497976|65518808|FG001|Overall Study|Withdrawal by Subject|0|||
23485119|NCT02497976|65518807|FG000|Overall Study|Moved out of area|0|||
23485120|NCT02497976|65518808|FG001|Overall Study|Moved out of area|1|||
23485121|NCT01860846|65518809|FG000|Overall Study|Lost to Follow-up|33|||
23485122|NCT02537574|65518811|FG000|Overall Study|Adverse Event|1|||
23485123|NCT02537574|65518812|FG001|Overall Study|Adverse Event|3|||
23485124|NCT02537574|65518813|FG002|Overall Study|Adverse Event|2|||
23485125|NCT02537574|65518811|FG000|Overall Study|Lost to Follow-up|40|||
23485126|NCT02537574|65518812|FG001|Overall Study|Lost to Follow-up|51|||
23485127|NCT02537574|65518813|FG002|Overall Study|Lost to Follow-up|55|||
23485128|NCT02537574|65518811|FG000|Overall Study|Noncompliance with study drug|0|||
23485129|NCT02537574|65518812|FG001|Overall Study|Noncompliance with study drug|1|||
23485130|NCT02537574|65518813|FG002|Overall Study|Noncompliance with study drug|1|||
23485131|NCT02537574|65518811|FG000|Overall Study|Physician Decision|2|||
23485132|NCT02537574|65518812|FG001|Overall Study|Physician Decision|0|||
23485133|NCT02537574|65518813|FG002|Overall Study|Physician Decision|0|||
23485134|NCT02537574|65518811|FG000|Overall Study|Protocol Violation|4|||
23485135|NCT02537574|65518812|FG001|Overall Study|Protocol Violation|2|||
23485136|NCT02537574|65518813|FG002|Overall Study|Protocol Violation|3|||
23485137|NCT02537574|65518811|FG000|Overall Study|Withdrawal by Subject|37|||
23485138|NCT02537574|65518812|FG001|Overall Study|Withdrawal by Subject|27|||
23485139|NCT02537574|65518813|FG002|Overall Study|Withdrawal by Subject|29|||
23485140|NCT02537574|65518811|FG000|Overall Study|Lack of Efficacy|14|||
23485141|NCT02537574|65518812|FG001|Overall Study|Lack of Efficacy|16|||
23485142|NCT02537574|65518813|FG002|Overall Study|Lack of Efficacy|15|||
23485143|NCT02537574|65518811|FG000|Overall Study|Duplicate Patient|1|||
23485144|NCT02537574|65518812|FG001|Overall Study|Duplicate Patient|0|||
23485145|NCT02537574|65518813|FG002|Overall Study|Duplicate Patient|0|||
23485146|NCT02537574|65518811|FG000|Overall Study|Patient not Stable|0|||
23485147|NCT02537574|65518812|FG001|Overall Study|Patient not Stable|1|||
23485148|NCT02537574|65518813|FG002|Overall Study|Patient not Stable|0|||
23485149|NCT02537574|65518811|FG000|Overall Study|Incarceration|0|||
23485150|NCT02537574|65518812|FG001|Overall Study|Incarceration|1|||
23485151|NCT02537574|65518813|FG002|Overall Study|Incarceration|0|||
23485152|NCT02537574|65518811|FG000|Overall Study|Failed Naloxone Challenge|0|||
23485153|NCT02537574|65518812|FG001|Overall Study|Failed Naloxone Challenge|1|||
23485154|NCT02537574|65518813|FG002|Overall Study|Failed Naloxone Challenge|0|||
23485155|NCT02537574|65518811|FG000|Overall Study|Transportation Issues|0|||
23485156|NCT02537574|65518812|FG001|Overall Study|Transportation Issues|0|||
23485157|NCT02537574|65518813|FG002|Overall Study|Transportation Issues|1|||
23485158|NCT02537574|65518811|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
23485159|NCT02537574|65518812|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
23485160|NCT02537574|65518813|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
23485161|NCT02537574|65518811|FG000|Overall Study|Noncompliance with Protocol|0|||
23485162|NCT02537574|65518812|FG001|Overall Study|Noncompliance with Protocol|0|||
23485163|NCT02537574|65518813|FG002|Overall Study|Noncompliance with Protocol|1|||
23485164|NCT00510874|65518815|FG000|Overall Study|Withdrawal by Subject|1|||
23485165|NCT00510874|65518816|FG001|Overall Study|Withdrawal by Subject|1|||
23485166|NCT00510874|65518817|FG002|Overall Study|Withdrawal by Subject|0|||
23485167|NCT00510874|65518818|FG003|Overall Study|Withdrawal by Subject|0|||
23485168|NCT00510874|65518819|FG004|Overall Study|Withdrawal by Subject|3|||
23485169|NCT00510874|65518820|FG005|Overall Study|Withdrawal by Subject|0|||
23485170|NCT00510874|65518821|FG006|Overall Study|Withdrawal by Subject|0|||
23485171|NCT00510874|65518815|FG000|Overall Study|Lost to Follow-up|2|||
23485172|NCT00510874|65518816|FG001|Overall Study|Lost to Follow-up|3|||
23485173|NCT00510874|65518817|FG002|Overall Study|Lost to Follow-up|1|||
23485174|NCT00510874|65518818|FG003|Overall Study|Lost to Follow-up|3|||
23369791|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369792|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369793|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369794|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369795|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369796|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
23369797|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
23369798|NCT01791595|65099211|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369799|NCT01791595|65099212|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369800|NCT01791595|65099213|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369801|NCT01791595|65099214|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369802|NCT01791595|65099215|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369803|NCT01791595|65099216|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
23369804|NCT01791595|65099217|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
23369805|NCT01791595|65099211|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369806|NCT01791595|65099212|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369807|NCT01791595|65099213|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369808|NCT01791595|65099214|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369809|NCT01791595|65099215|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369810|NCT01791595|65099216|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
23369811|NCT01791595|65099217|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
23369812|NCT01791595|65099211|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369813|NCT01791595|65099212|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369814|NCT01791595|65099213|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369815|NCT01791595|65099214|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369816|NCT01791595|65099215|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369817|NCT01791595|65099216|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
23369818|NCT01791595|65099217|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
23369819|NCT01791595|65099211|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369820|NCT01791595|65099212|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369821|NCT01791595|65099213|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369822|NCT01791595|65099214|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369823|NCT01791595|65099215|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369824|NCT01791595|65099216|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
23369825|NCT01791595|65099217|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
23369826|NCT01791595|65099211|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369827|NCT01791595|65099212|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369828|NCT01791595|65099213|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369829|NCT01791595|65099214|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369830|NCT01791595|65099215|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369831|NCT01791595|65099216|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
23369832|NCT01791595|65099217|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
23369833|NCT03558516|65099230|FG000|Overall Study|Protocol Violation|2|||
23369834|NCT03558516|65099231|FG001|Overall Study|Protocol Violation|2|||
23369835|NCT02314728|65099232|FG000|Overall Study|Protocol Violation|1|||
23369836|NCT02314728|65099233|FG001|Overall Study|Protocol Violation|0|||
23369837|NCT02314728|65099232|FG000|Overall Study|Lost to Follow-up|0|||
23369838|NCT02314728|65099233|FG001|Overall Study|Lost to Follow-up|1|||
23369839|NCT03964207|65099235|FG000|First Treatment|Withdrawal by Subject|1|||
23369840|NCT03964207|65099236|FG001|First Treatment|Withdrawal by Subject|2|||
23369841|NCT03964207|65099235|FG000|First Treatment|Protocol Violation|1|||
23369842|NCT03964207|65099236|FG001|First Treatment|Protocol Violation|0|||
23369843|NCT03964207|65099235|FG000|First Treatment|Lost to Follow-up|1|||
23369844|NCT03964207|65099236|FG001|First Treatment|Lost to Follow-up|0|||
23369845|NCT03964207|65099235|FG000|Second Treatment|Lost to Follow-up|0|||
23369846|NCT03964207|65099236|FG001|Second Treatment|Lost to Follow-up|1|||
23369847|NCT03964207|65099235|FG000|Second Treatment|Adverse Event|1|||
23369848|NCT03964207|65099236|FG001|Second Treatment|Adverse Event|2|||
23369849|NCT01710020|65099237|FG000|Period 1|Protocol Violation|1|||
23369850|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
23485175|NCT00510874|65518819|FG004|Overall Study|Lost to Follow-up|4|||
23485176|NCT00510874|65518820|FG005|Overall Study|Lost to Follow-up|0|||
23369851|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
23369852|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369853|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369854|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369855|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369856|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23277264|NCT02890992|64758884|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23277265|NCT02890992|64758885|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
23277266|NCT02890992|64758878|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23277267|NCT02890992|64758879|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23277268|NCT02890992|64758880|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23277269|NCT02890992|64758881|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23277270|NCT02890992|64758882|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23277271|NCT02890992|64758883|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
23277272|NCT02890992|64758884|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
23277273|NCT02890992|64758885|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
23277274|NCT02890992|64758878|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
23277275|NCT02890992|64758879|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
23277276|NCT02890992|64758880|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
23277277|NCT02890992|64758881|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
23277278|NCT02890992|64758882|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
23277279|NCT02890992|64758883|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
23277280|NCT02890992|64758884|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
23277281|NCT02890992|64758885|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
23277282|NCT01705574|64758886|FG000|Double-Blind Phase|Lost to Follow-up|12|||
23277283|NCT01705574|64758887|FG001|Double-Blind Phase|Lost to Follow-up|16|||
23277284|NCT01705574|64758888|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23369857|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369858|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369859|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
23369860|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
23369861|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
23369862|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369863|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369864|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369865|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369866|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369867|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369868|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369869|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
23369870|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
23369871|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369872|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369873|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369874|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369875|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369876|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369877|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369878|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369879|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
23369880|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
23369881|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
23369882|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369883|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369884|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369885|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23603345|NCT01822756|65937328|FG000|Overall Study|disease progression & patient preference|2|||
23603346|NCT01822756|65937329|FG001|Overall Study|disease progression & patient preference|0|||
23603347|NCT01822756|65937330|FG002|Overall Study|disease progression & patient preference|1|||
23603348|NCT01822756|65937331|FG003|Overall Study|disease progression & patient preference|0|||
23603349|NCT01822756|65937332|FG004|Overall Study|disease progression & patient preference|0|||
23603350|NCT01409837|65937334|FG000|Overall Study|Withdrawal by Subject|2|||
23603351|NCT01409837|65937335|FG001|Overall Study|Withdrawal by Subject|1|||
23603352|NCT01409837|65937334|FG000|Overall Study|Lost to Follow-up|1|||
23603353|NCT01409837|65937335|FG001|Overall Study|Lost to Follow-up|0|||
23603354|NCT01409837|65937334|FG000|Overall Study|Physician Decision|0|||
23603355|NCT01409837|65937335|FG001|Overall Study|Physician Decision|1|||
23369886|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369887|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369888|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369889|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
23369890|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
23369891|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
23369892|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369893|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369894|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369895|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369896|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369897|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369898|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369899|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
23369900|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
23369901|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
23369902|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369903|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369904|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369905|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369906|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369907|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369908|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369909|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
23369910|NCT01232283|65099238|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
23369911|NCT01232283|65099239|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
23369912|NCT01232283|65099240|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369913|NCT01232283|65099241|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369914|NCT01232283|65099242|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369915|NCT01232283|65099243|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369916|NCT01232283|65099244|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369917|NCT01232283|65099245|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369918|NCT01232283|65099246|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369919|NCT01232283|65099247|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
23369920|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23603356|NCT00960206|65937338|FG000|Overall Study|Death|7|||
23603357|NCT00960206|65937339|FG001|Overall Study|Death|4|||
23603358|NCT00960206|65937340|FG002|Overall Study|Death|1|||
23603359|NCT00960206|65937338|FG000|Overall Study|Unwilling/Unable to return|1|||
23603360|NCT00960206|65937339|FG001|Overall Study|Unwilling/Unable to return|2|||
23603361|NCT00960206|65937340|FG002|Overall Study|Unwilling/Unable to return|0|||
23603362|NCT00960206|65937338|FG000|Overall Study|Lost to Follow-up|8|||
23603363|NCT00960206|65937339|FG001|Overall Study|Lost to Follow-up|14|||
23603364|NCT00960206|65937340|FG002|Overall Study|Lost to Follow-up|8|||
23603365|NCT00960206|65937338|FG000|Overall Study|Withdrawal by Subject|2|||
23603366|NCT00960206|65937339|FG001|Overall Study|Withdrawal by Subject|4|||
23603367|NCT00960206|65937340|FG002|Overall Study|Withdrawal by Subject|0|||
23603368|NCT00960206|65937338|FG000|Overall Study|Revision of study component|2|||
23603369|NCT00960206|65937339|FG001|Overall Study|Revision of study component|2|||
23603370|NCT00960206|65937340|FG002|Overall Study|Revision of study component|2|||
23603371|NCT00960206|65937338|FG000|Overall Study|Missing 10 year data|20|||
23603372|NCT00960206|65937339|FG001|Overall Study|Missing 10 year data|1|||
23603373|NCT00960206|65937340|FG002|Overall Study|Missing 10 year data|1|||
23603374|NCT00491400|65937341|FG000|Overall Study|Withdrawal by Subject|5|||
23603375|NCT00491400|65937342|FG001|Overall Study|Withdrawal by Subject|4|||
23603376|NCT01399099|65937345|FG000|Overall Study|Lost to Follow-up|11|||
23603377|NCT01399099|65937345|FG000|Overall Study|Physician Decision|1|||
23603378|NCT01399099|65937345|FG000|Overall Study|Protocol Violation|1|||
23603379|NCT01399099|65937345|FG000|Overall Study|Skin Irritation|13|||
23603380|NCT01399099|65937345|FG000|Overall Study|Infection|1|||
23603381|NCT01399099|65937345|FG000|Overall Study|Miscellaneous|4|||
23603382|NCT00337610|65937346|FG000|Overall Study|Adverse Event|2|||
23603383|NCT00337610|65937347|FG001|Overall Study|Adverse Event|2|||
23603384|NCT00337610|65937346|FG000|Overall Study|Death|0|||
23603385|NCT00337610|65937347|FG001|Overall Study|Death|1|||
23485177|NCT00510874|65518821|FG006|Overall Study|Lost to Follow-up|1|||
23603386|NCT00337610|65937346|FG000|Overall Study|Lack of Efficacy|6|||
23603387|NCT00337610|65937347|FG001|Overall Study|Lack of Efficacy|3|||
23603388|NCT00337610|65937346|FG000|Overall Study|Lost to Follow-up|3|||
23603389|NCT00337610|65937347|FG001|Overall Study|Lost to Follow-up|3|||
23603390|NCT00337610|65937346|FG000|Overall Study|Withdrawal by Subject|6|||
23603391|NCT00337610|65937347|FG001|Overall Study|Withdrawal by Subject|5|||
23277285|NCT01705574|64758889|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23277286|NCT01705574|64758886|FG000|Double-Blind Phase|Adverse Event|3|||
23277287|NCT01705574|64758887|FG001|Double-Blind Phase|Adverse Event|10|||
23277288|NCT01705574|64758888|FG002|Double-Blind Phase|Adverse Event|0|||
23277289|NCT01705574|64758889|FG003|Double-Blind Phase|Adverse Event|0|||
23277290|NCT01705574|64758886|FG000|Double-Blind Phase|Withdrew Consent|8|||
23277291|NCT01705574|64758887|FG001|Double-Blind Phase|Withdrew Consent|5|||
23277292|NCT01705574|64758888|FG002|Double-Blind Phase|Withdrew Consent|0|||
23277293|NCT01705574|64758889|FG003|Double-Blind Phase|Withdrew Consent|0|||
23277294|NCT01705574|64758886|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
23277295|NCT01705574|64758887|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
23277296|NCT01705574|64758888|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
23277297|NCT01705574|64758889|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
23277298|NCT01705574|64758886|FG000|Double-Blind Phase|Pregnancy|1|||
23277299|NCT01705574|64758887|FG001|Double-Blind Phase|Pregnancy|1|||
23277300|NCT01705574|64758888|FG002|Double-Blind Phase|Pregnancy|0|||
23277301|NCT01705574|64758889|FG003|Double-Blind Phase|Pregnancy|0|||
23277302|NCT01705574|64758886|FG000|Double-Blind Phase|Protocol Violation|1|||
23277303|NCT01705574|64758887|FG001|Double-Blind Phase|Protocol Violation|0|||
23277304|NCT01705574|64758888|FG002|Double-Blind Phase|Protocol Violation|0|||
23277305|NCT01705574|64758889|FG003|Double-Blind Phase|Protocol Violation|0|||
23277306|NCT01705574|64758886|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
23277307|NCT01705574|64758887|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
23277308|NCT01705574|64758888|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
23277309|NCT01705574|64758889|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
23277310|NCT01705574|64758886|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
23277311|NCT01705574|64758887|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23277312|NCT01705574|64758888|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
23277313|NCT01705574|64758889|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
23277314|NCT01705574|64758886|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
23277315|NCT01705574|64758887|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
23277316|NCT01705574|64758888|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
23277317|NCT01705574|64758889|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
23277318|NCT01705574|64758886|FG000|Open-Label Extension Phase|Adverse Event|3|||
23277319|NCT01705574|64758887|FG001|Open-Label Extension Phase|Adverse Event|0|||
23277320|NCT01705574|64758888|FG002|Open-Label Extension Phase|Adverse Event|0|||
23277321|NCT01705574|64758889|FG003|Open-Label Extension Phase|Adverse Event|1|||
23277322|NCT01705574|64758886|FG000|Open-Label Extension Phase|Death|2|||
23277323|NCT01705574|64758887|FG001|Open-Label Extension Phase|Death|0|||
23277324|NCT01705574|64758888|FG002|Open-Label Extension Phase|Death|1|||
23277325|NCT01705574|64758889|FG003|Open-Label Extension Phase|Death|0|||
23277326|NCT01705574|64758886|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
23603392|NCT02091752|65937350|FG000|Overall Study|Study terminated by Sponsor|2|||
23603393|NCT02091752|65937350|FG000|Overall Study|Adverse Event|1|||
23369921|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369922|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
23369923|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
23369924|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369925|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369926|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369927|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369928|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369929|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
23369930|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23277327|NCT01705574|64758887|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
23277328|NCT01705574|64758888|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
23277329|NCT01705574|64758889|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
23277330|NCT01705574|64758886|FG000|Open-Label Extension Phase|Physician Decision|0|||
23277331|NCT01705574|64758887|FG001|Open-Label Extension Phase|Physician Decision|0|||
23277332|NCT01705574|64758888|FG002|Open-Label Extension Phase|Physician Decision|2|||
23277333|NCT01705574|64758889|FG003|Open-Label Extension Phase|Physician Decision|0|||
23277334|NCT01705574|64758886|FG000|Open-Label Extension Phase|Pregnancy|0|||
23277335|NCT01705574|64758887|FG001|Open-Label Extension Phase|Pregnancy|0|||
23369931|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369932|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
23369933|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
23369934|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369935|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369936|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369937|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369938|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369939|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
23369940|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369941|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369942|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
23369943|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369944|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369945|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369946|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369947|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369948|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369949|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
23369950|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369951|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369952|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
23369953|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
23369954|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369955|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369956|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369957|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369958|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369959|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
23369960|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369961|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369962|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
23369963|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
23369964|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369965|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369966|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369967|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369968|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23369969|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
23277336|NCT01705574|64758888|FG002|Open-Label Extension Phase|Pregnancy|1|||
23369970|NCT01232283|65099238|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
23369971|NCT01232283|65099239|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
23369972|NCT01232283|65099240|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
23603394|NCT01263496|65937351|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
23277337|NCT01705574|64758889|FG003|Open-Label Extension Phase|Pregnancy|1|||
23277338|NCT02880761|64758892|FG000|Overall Study|Death|6|||
23277339|NCT02880761|64758893|FG001|Overall Study|Death|8|||
23277340|NCT02880761|64758892|FG000|Overall Study|Withdrawal by Subject|3|||
23277341|NCT02880761|64758893|FG001|Overall Study|Withdrawal by Subject|6|||
23277342|NCT02880761|64758892|FG000|Overall Study|Protocol Violation|4|||
23277343|NCT02880761|64758893|FG001|Overall Study|Protocol Violation|3|||
23277344|NCT02880761|64758892|FG000|Overall Study|Lost to Follow-up|3|||
23277345|NCT02880761|64758893|FG001|Overall Study|Lost to Follow-up|4|||
23277346|NCT03173547|64758896|FG000|Overall Study|Adverse Event|2|||
23277347|NCT03173547|64758897|FG001|Overall Study|Adverse Event|0|||
23277348|NCT03173547|64758896|FG000|Overall Study|Withdrawal by Subject|2|||
23277349|NCT03173547|64758897|FG001|Overall Study|Withdrawal by Subject|2|||
23277350|NCT00910663|64758898|FG000|Period 1|Withdrawal by Subject|0|||
23277351|NCT00910663|64758899|FG001|Period 1|Withdrawal by Subject|1|||
23277352|NCT01313780|64758900|FG000|Overall Study|Lack of Efficacy|4|||
23277353|NCT01313780|64758901|FG001|Overall Study|Lack of Efficacy|2|||
23277354|NCT01313780|64758900|FG000|Overall Study|Adverse Event|6|||
23277355|NCT01313780|64758901|FG001|Overall Study|Adverse Event|11|||
23277356|NCT01313780|64758900|FG000|Overall Study|Withdrawal by Subject|2|||
23277357|NCT01313780|64758901|FG001|Overall Study|Withdrawal by Subject|8|||
23277358|NCT01313780|64758900|FG000|Overall Study|Protocol Violation|10|||
23277359|NCT01313780|64758901|FG001|Overall Study|Protocol Violation|4|||
23277360|NCT01313780|64758900|FG000|Overall Study|missing data|3|||
23277361|NCT01313780|64758901|FG001|Overall Study|missing data|3|||
23277362|NCT01597245|64758903|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
23277363|NCT01597245|64758904|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
23277364|NCT01597245|64758905|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
23277365|NCT01597245|64758906|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
23277366|NCT01597245|64758907|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277367|NCT01597245|64758908|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277368|NCT01597245|64758909|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277369|NCT01597245|64758910|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277370|NCT01597245|64758911|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277371|NCT01597245|64758912|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277372|NCT01597245|64758913|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277373|NCT01597245|64758914|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277374|NCT01597245|64758915|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277375|NCT01597245|64758916|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277376|NCT01597245|64758917|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277377|NCT01597245|64758918|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277378|NCT01597245|64758919|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277379|NCT01597245|64758920|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277380|NCT01597245|64758921|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277381|NCT01597245|64758922|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23277382|NCT01597245|64758923|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
23369973|NCT01232283|65099241|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
23369974|NCT01232283|65099242|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
23369975|NCT01232283|65099243|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
23369976|NCT01232283|65099244|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
23369977|NCT01232283|65099245|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
23369978|NCT01232283|65099246|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
23369979|NCT01232283|65099247|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
23369980|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369981|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369982|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369983|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23277383|NCT01597245|64758903|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
23369984|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
23369985|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
23277384|NCT01597245|64758904|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
23603395|NCT01263496|65937352|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23277385|NCT01597245|64758905|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
23277386|NCT01597245|64758906|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
23277387|NCT01597245|64758907|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277388|NCT01597245|64758908|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277389|NCT01597245|64758909|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23369986|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369987|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
23369988|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23369989|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
23277390|NCT01597245|64758910|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23369990|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369991|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369992|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369993|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369994|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
23369995|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369996|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
23369997|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
23369998|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23369999|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
23370000|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370001|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370002|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370003|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370004|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
23370005|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
23370006|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
23370007|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
23370008|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370009|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
23370010|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370011|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370012|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370013|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370014|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
23370015|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370016|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370017|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370018|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370019|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
23370020|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370021|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370022|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370023|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370024|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
23277391|NCT01597245|64758911|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277392|NCT01597245|64758912|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277393|NCT01597245|64758913|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277394|NCT01597245|64758914|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277395|NCT01597245|64758915|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277396|NCT01597245|64758916|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277397|NCT01597245|64758917|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277398|NCT01597245|64758918|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277399|NCT01597245|64758919|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277400|NCT01597245|64758920|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277401|NCT01597245|64758921|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277402|NCT01597245|64758922|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277403|NCT01597245|64758923|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
23277404|NCT01597245|64758903|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
23277405|NCT01597245|64758904|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
23370025|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23485178|NCT01222403|65518824|FG000|Overall Study|Inappropriate enrollment|0|||
23485179|NCT01222403|65518825|FG001|Overall Study|Inappropriate enrollment|2|||
23485180|NCT04535167|65518826|FG000|Treatment|Adverse Event|0|||
23485181|NCT04535167|65518827|FG001|Treatment|Adverse Event|0|||
23277406|NCT01597245|64758905|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
23277407|NCT01597245|64758906|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
23277408|NCT01597245|64758907|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277409|NCT01597245|64758908|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277410|NCT01597245|64758909|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277411|NCT01597245|64758910|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277412|NCT01597245|64758911|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277413|NCT01597245|64758912|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23370026|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
23370027|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
23485182|NCT04535167|65518828|FG002|Treatment|Adverse Event|0|||
23370028|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370029|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
23370030|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370031|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23277414|NCT01597245|64758913|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277415|NCT01597245|64758914|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277416|NCT01597245|64758915|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277417|NCT01597245|64758916|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277418|NCT01597245|64758917|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277419|NCT01597245|64758918|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277420|NCT01597245|64758919|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277421|NCT01597245|64758920|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277422|NCT01597245|64758921|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277423|NCT01597245|64758922|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277424|NCT01597245|64758923|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
23277425|NCT01597245|64758903|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
23277426|NCT01597245|64758904|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
23277427|NCT01597245|64758905|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
23277428|NCT01597245|64758906|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277429|NCT01597245|64758907|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277430|NCT01597245|64758908|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277431|NCT01597245|64758909|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277432|NCT01597245|64758910|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277433|NCT01597245|64758911|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277434|NCT01597245|64758912|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277435|NCT01597245|64758913|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277436|NCT01597245|64758914|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277437|NCT01597245|64758915|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277438|NCT01597245|64758916|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277439|NCT01597245|64758917|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277440|NCT01597245|64758918|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277441|NCT01597245|64758919|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23485183|NCT04535167|65518829|FG003|Treatment|Adverse Event|0|||
23485184|NCT04535167|65518830|FG004|Treatment|Adverse Event|0|||
23485185|NCT04535167|65518831|FG005|Treatment|Adverse Event|0|||
23485186|NCT04535167|65518832|FG006|Treatment|Adverse Event|1|||
23485187|NCT04535167|65518826|FG000|Follow-Up|Death|0|||
23485188|NCT04535167|65518827|FG001|Follow-Up|Death|0|||
23485189|NCT04535167|65518828|FG002|Follow-Up|Death|0|||
23485190|NCT04535167|65518829|FG003|Follow-Up|Death|0|||
23485191|NCT04535167|65518830|FG004|Follow-Up|Death|0|||
23485192|NCT04535167|65518831|FG005|Follow-Up|Death|0|||
23485193|NCT04535167|65518832|FG006|Follow-Up|Death|1|||
23485194|NCT04535167|65518826|FG000|Follow-Up|Lost to Follow-up|0|||
23485195|NCT04535167|65518827|FG001|Follow-Up|Lost to Follow-up|0|||
23485196|NCT04535167|65518828|FG002|Follow-Up|Lost to Follow-up|0|||
23485197|NCT04535167|65518829|FG003|Follow-Up|Lost to Follow-up|1|||
23485198|NCT04535167|65518830|FG004|Follow-Up|Lost to Follow-up|0|||
23485199|NCT04535167|65518831|FG005|Follow-Up|Lost to Follow-up|0|||
23603396|NCT01263496|65937353|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23603397|NCT01263496|65937354|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23277442|NCT01597245|64758920|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277443|NCT01597245|64758921|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277444|NCT01597245|64758922|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277445|NCT01597245|64758923|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
23277446|NCT01597245|64758903|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
23277447|NCT01597245|64758904|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277448|NCT01597245|64758905|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277449|NCT01597245|64758906|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
23277450|NCT01597245|64758907|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277451|NCT01597245|64758908|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277452|NCT01597245|64758909|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277453|NCT01597245|64758910|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277454|NCT01597245|64758911|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277455|NCT01597245|64758912|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277456|NCT01597245|64758913|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277457|NCT01597245|64758914|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277458|NCT01597245|64758915|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277459|NCT01597245|64758916|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277460|NCT01597245|64758917|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277461|NCT01597245|64758918|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277462|NCT01597245|64758919|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277463|NCT01597245|64758920|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277464|NCT01597245|64758921|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277465|NCT01597245|64758922|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277466|NCT01597245|64758923|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
23277467|NCT01597245|64758903|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
23277468|NCT01597245|64758904|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
23277469|NCT01597245|64758905|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
23277470|NCT01597245|64758906|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277471|NCT01597245|64758907|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277472|NCT01597245|64758908|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277473|NCT01597245|64758909|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277474|NCT01597245|64758910|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23485200|NCT04535167|65518832|FG006|Follow-Up|Lost to Follow-up|0|||
23485201|NCT00773383|65518840|FG000|Overall Study|Adverse Event|4|||
23485202|NCT00773383|65518840|FG000|Overall Study|Death|1|||
23603398|NCT01263496|65937355|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23485203|NCT00773383|65518840|FG000|Overall Study|Progression of Disease|23|||
23277475|NCT01597245|64758911|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277476|NCT01597245|64758912|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277477|NCT01597245|64758913|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277478|NCT01597245|64758914|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277479|NCT01597245|64758915|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277480|NCT01597245|64758916|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277481|NCT01597245|64758917|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277482|NCT01597245|64758918|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277483|NCT01597245|64758919|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277484|NCT01597245|64758920|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277485|NCT01597245|64758921|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277486|NCT01597245|64758922|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277487|NCT01597245|64758923|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
23277488|NCT01597245|64758903|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277489|NCT01597245|64758904|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277490|NCT01597245|64758905|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277491|NCT01597245|64758906|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277492|NCT01597245|64758907|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277493|NCT01597245|64758908|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
23277494|NCT01597245|64758909|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
23277495|NCT01597245|64758910|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277496|NCT01597245|64758911|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277497|NCT01597245|64758912|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277498|NCT01597245|64758913|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277499|NCT01597245|64758914|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277500|NCT01597245|64758915|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277501|NCT01597245|64758916|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277502|NCT01597245|64758917|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277503|NCT01597245|64758918|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277504|NCT01597245|64758919|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277505|NCT01597245|64758920|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277506|NCT01597245|64758921|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277507|NCT01597245|64758922|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277508|NCT01597245|64758923|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
23277509|NCT01597245|64758903|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277510|NCT01597245|64758904|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277511|NCT01597245|64758905|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277512|NCT01597245|64758906|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23485204|NCT00773383|65518840|FG000|Overall Study|Other|2|||
23485205|NCT00773383|65518840|FG000|Overall Study|No study dose received|1|||
23485206|NCT01306877|65518841|FG000|Overall Study|Lost to Follow-up|3|||
23485207|NCT01306877|65518842|FG001|Overall Study|Lost to Follow-up|3|||
23485208|NCT01306877|65518841|FG000|Overall Study|Physician Decision|0|||
23277513|NCT01597245|64758907|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
23277514|NCT01597245|64758908|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
23277515|NCT01597245|64758909|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
23277516|NCT01597245|64758910|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
23277517|NCT01597245|64758911|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277518|NCT01597245|64758912|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
23370032|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23485209|NCT01306877|65518842|FG001|Overall Study|Physician Decision|1|||
23485210|NCT04571515|65518843|FG000|Overall Study|Physician Decision|0|||
23485211|NCT04571515|65518844|FG001|Overall Study|Physician Decision|0|||
23370033|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23277519|NCT01597245|64758913|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277520|NCT01597245|64758914|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277521|NCT01597245|64758915|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277522|NCT01597245|64758916|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277523|NCT01597245|64758917|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277524|NCT01597245|64758918|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277525|NCT01597245|64758919|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277526|NCT01597245|64758920|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277527|NCT01597245|64758921|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277528|NCT01597245|64758922|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277529|NCT01597245|64758923|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
23277530|NCT01597245|64758903|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277531|NCT01597245|64758904|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277532|NCT01597245|64758905|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277533|NCT01597245|64758906|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277534|NCT01597245|64758907|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277535|NCT01597245|64758908|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
23277536|NCT01597245|64758909|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277537|NCT01597245|64758910|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277538|NCT01597245|64758911|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
23277539|NCT01597245|64758912|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277540|NCT01597245|64758913|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
23277541|NCT01597245|64758914|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
23277542|NCT01597245|64758915|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
23277543|NCT01597245|64758916|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277544|NCT01597245|64758917|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277545|NCT01597245|64758918|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277546|NCT01597245|64758919|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277547|NCT01597245|64758920|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277548|NCT01597245|64758921|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277549|NCT01597245|64758922|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277550|NCT01597245|64758923|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
23277551|NCT01597245|64758903|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277552|NCT01597245|64758904|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277553|NCT01597245|64758905|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277554|NCT01597245|64758906|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277555|NCT01597245|64758907|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
23277556|NCT01597245|64758908|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
23485212|NCT04571515|65518845|FG002|Overall Study|Physician Decision|0|||
23485213|NCT04571515|65518846|FG003|Overall Study|Physician Decision|0|||
23277557|NCT01597245|64758909|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
23277558|NCT01597245|64758910|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
23277559|NCT01597245|64758911|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
23277560|NCT01597245|64758912|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
23277561|NCT01597245|64758913|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
23277562|NCT01597245|64758914|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
23277563|NCT01597245|64758915|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
23277564|NCT01597245|64758916|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277565|NCT01597245|64758917|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277566|NCT01597245|64758918|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277567|NCT01597245|64758919|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277568|NCT01597245|64758920|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277569|NCT01597245|64758921|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277570|NCT01597245|64758922|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277571|NCT01597245|64758923|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
23277572|NCT01597245|64758903|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277573|NCT01597245|64758904|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277574|NCT01597245|64758905|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277575|NCT01597245|64758906|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277576|NCT01597245|64758907|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
23277577|NCT01597245|64758908|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
23277578|NCT01597245|64758909|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
23277579|NCT01597245|64758910|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277580|NCT01597245|64758911|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
23277581|NCT01597245|64758912|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
23277582|NCT01597245|64758913|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
23277583|NCT01597245|64758914|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
23277584|NCT01597245|64758915|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
23277585|NCT01597245|64758916|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277586|NCT01597245|64758917|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277587|NCT01597245|64758918|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277588|NCT01597245|64758919|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277589|NCT01597245|64758920|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277590|NCT01597245|64758921|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277591|NCT01597245|64758922|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277592|NCT01597245|64758923|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
23277593|NCT01597245|64758903|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277594|NCT01597245|64758904|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277595|NCT01597245|64758905|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277596|NCT01597245|64758906|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277597|NCT01597245|64758907|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
23277598|NCT01597245|64758908|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277599|NCT01597245|64758909|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277600|NCT01597245|64758910|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23485214|NCT04571515|65518847|FG004|Overall Study|Physician Decision|1|||
23277601|NCT01597245|64758911|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
23277602|NCT01597245|64758912|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
23277603|NCT01597245|64758913|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
23277604|NCT01597245|64758914|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277605|NCT01597245|64758915|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
23277606|NCT01597245|64758916|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277607|NCT01597245|64758917|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277608|NCT01597245|64758918|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277609|NCT01597245|64758919|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277610|NCT01597245|64758920|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277611|NCT01597245|64758921|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277612|NCT01597245|64758922|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277613|NCT01597245|64758923|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
23277614|NCT01597245|64758903|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277615|NCT01597245|64758904|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277616|NCT01597245|64758905|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277617|NCT01597245|64758906|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277618|NCT01597245|64758907|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
23277619|NCT01597245|64758908|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
23277620|NCT01597245|64758909|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
23277621|NCT01597245|64758910|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277622|NCT01597245|64758911|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
23277623|NCT01597245|64758912|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
23277624|NCT01597245|64758913|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
23277625|NCT01597245|64758914|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
23277626|NCT01597245|64758915|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
23277627|NCT01597245|64758916|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277628|NCT01597245|64758917|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277629|NCT01597245|64758918|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277630|NCT01597245|64758919|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277631|NCT01597245|64758920|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277632|NCT01597245|64758921|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277633|NCT01597245|64758922|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277634|NCT01597245|64758923|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
23277635|NCT01597245|64758903|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277636|NCT01597245|64758904|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277637|NCT01597245|64758905|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277638|NCT01597245|64758906|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277639|NCT01597245|64758907|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277640|NCT01597245|64758908|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23277641|NCT01597245|64758909|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277642|NCT01597245|64758910|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277643|NCT01597245|64758911|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23277644|NCT01597245|64758912|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23277645|NCT01597245|64758913|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23277646|NCT01597245|64758914|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
23277647|NCT01597245|64758915|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277648|NCT01597245|64758916|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277649|NCT01597245|64758917|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277650|NCT01597245|64758918|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23201392|NCT02234583|64476720|FG000|Overall Study|Adverse Event|172|||
23201393|NCT02234583|64476721|FG001|Overall Study|Adverse Event|156|||
23201394|NCT02234583|64476720|FG000|Overall Study|Withdrawal by Subject|109|||
23201395|NCT02234583|64476721|FG001|Overall Study|Withdrawal by Subject|157|||
23277651|NCT01597245|64758919|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277652|NCT01597245|64758920|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277653|NCT01597245|64758921|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277654|NCT01597245|64758922|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277655|NCT01597245|64758923|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
23277656|NCT01597245|64758903|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277657|NCT01597245|64758904|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277658|NCT01597245|64758905|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277659|NCT01597245|64758906|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277660|NCT01597245|64758907|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277661|NCT01597245|64758908|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277662|NCT01597245|64758909|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277663|NCT01597245|64758910|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277664|NCT01597245|64758911|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277665|NCT01597245|64758912|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277666|NCT01597245|64758913|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
23277667|NCT01597245|64758914|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277668|NCT01597245|64758915|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277669|NCT01597245|64758916|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277670|NCT01597245|64758917|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277671|NCT01597245|64758918|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277672|NCT01597245|64758919|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277673|NCT01597245|64758920|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277674|NCT01597245|64758921|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277675|NCT01597245|64758922|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277676|NCT01597245|64758923|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
23277677|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277678|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277679|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277680|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277681|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277682|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23370034|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370035|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370036|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370037|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
23370038|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370039|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
23370040|NCT01232283|65099238|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370041|NCT01232283|65099239|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370042|NCT01232283|65099240|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370043|NCT01232283|65099241|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370044|NCT01232283|65099242|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370045|NCT01232283|65099243|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
23370046|NCT01232283|65099244|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370047|NCT01232283|65099245|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370048|NCT01232283|65099246|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23277683|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277684|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277685|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277686|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23370049|NCT01232283|65099247|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
23370050|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370051|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370052|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370053|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23277687|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23370054|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370055|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23485215|NCT04571515|65518843|FG000|Overall Study|Withdrawal by Subject|0|||
23370056|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370057|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
23370058|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
23370059|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
23370060|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370061|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370062|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370063|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370064|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370065|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370066|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370067|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
23370068|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
23370069|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
23277688|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277689|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277690|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
23277691|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
23277692|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
23277693|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277694|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277695|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277696|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277697|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
23277698|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277699|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277700|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277701|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277702|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277703|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277704|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277705|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277706|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277707|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277708|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277709|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277710|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277711|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
23277712|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
23277713|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
23277714|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277715|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277716|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277717|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277718|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
23277719|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277720|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277721|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277722|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277723|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277724|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277725|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277726|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277727|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277728|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277729|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277730|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277731|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277732|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277733|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
23370070|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23485216|NCT04571515|65518844|FG001|Overall Study|Withdrawal by Subject|0|||
23485217|NCT04571515|65518845|FG002|Overall Study|Withdrawal by Subject|0|||
23370071|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370072|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370073|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370074|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370075|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370076|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370077|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
23370078|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
23370079|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
23370080|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370081|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370082|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370083|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370084|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370085|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370086|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370087|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
23370088|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
23370089|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
23277734|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
23277735|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277736|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277737|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277738|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277739|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
23277740|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277741|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277742|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277743|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277744|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277745|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277746|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277747|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277748|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277749|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277750|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277751|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277752|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277753|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277754|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
23277755|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
23277756|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23370090|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370091|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370092|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23277757|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277758|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277759|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277760|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
23277761|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23370093|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370094|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370095|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370096|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370097|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
23370098|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
23370099|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
23370100|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370101|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370102|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370103|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370104|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23277762|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277763|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277764|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277765|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277766|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23370105|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370106|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370107|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23370108|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
23277767|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277768|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277769|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277770|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277771|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277772|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277773|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277774|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
23370109|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
23277775|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
23277776|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
23277777|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277778|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277779|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277780|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277781|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
23277782|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277783|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277784|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277785|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277786|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277787|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277788|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277789|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277790|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277791|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277792|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277793|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277794|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277795|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277796|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
23277797|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
23277798|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277799|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277800|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
23370110|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370111|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370112|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370113|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370114|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370115|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370116|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370117|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370118|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
23370119|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
23370120|NCT01232283|65099238|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370121|NCT01232283|65099239|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370122|NCT01232283|65099240|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370123|NCT01232283|65099241|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370124|NCT01232283|65099242|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370125|NCT01232283|65099243|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23370126|NCT01232283|65099244|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23277801|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277802|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
23277803|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277804|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277805|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277806|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277807|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277808|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277809|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277810|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277811|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277812|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277813|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277814|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277815|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277816|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277817|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
23277818|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
23277819|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277820|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277821|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277822|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277823|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
23277824|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277825|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277826|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277827|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277828|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277829|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277830|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277831|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277832|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277833|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277834|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277835|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23370127|NCT01232283|65099245|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
23201396|NCT02234583|64476720|FG000|Overall Study|Lost to Follow-up|0|||
23370128|NCT01232283|65099246|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
23370129|NCT01232283|65099247|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
23370130|NCT02823470|65099248|FG000|Overall Study|Adverse Event|1|||
23370131|NCT02823470|65099249|FG001|Overall Study|Adverse Event|0|||
23370132|NCT02823470|65099248|FG000|Overall Study|Study terminated by sponsor|8|||
23370133|NCT02823470|65099249|FG001|Overall Study|Study terminated by sponsor|15|||
23370134|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
23370135|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
23370136|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
23370137|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
23370138|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
23370139|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
23370140|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
23370141|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
23370142|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
23370143|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
23370144|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
23370145|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
23370146|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
23370147|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
23370148|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
23370149|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
23370150|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
23370151|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
23277836|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277837|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277838|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
23277839|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
23277840|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277841|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277842|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277843|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277844|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
23277845|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277846|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277847|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23370152|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
23370153|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
23370154|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
23370155|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
23370156|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
23370157|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
23277848|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277849|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277850|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277851|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277852|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277853|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277854|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277855|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277856|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277857|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277858|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277859|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
23277860|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
23277861|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277862|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277863|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23370158|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
23370159|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
23277864|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277865|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
23277866|NCT01597245|64758903|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277867|NCT01597245|64758904|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23370160|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
23370161|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
23603399|NCT01263496|65937356|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23370162|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
23277868|NCT01597245|64758905|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277869|NCT01597245|64758906|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277870|NCT01597245|64758907|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277871|NCT01597245|64758908|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277872|NCT01597245|64758909|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277873|NCT01597245|64758910|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277874|NCT01597245|64758911|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277875|NCT01597245|64758912|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277876|NCT01597245|64758913|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277877|NCT01597245|64758914|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277878|NCT01597245|64758915|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277879|NCT01597245|64758916|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
23277880|NCT01597245|64758917|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277881|NCT01597245|64758918|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277882|NCT01597245|64758919|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277883|NCT01597245|64758920|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277884|NCT01597245|64758921|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277885|NCT01597245|64758922|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277886|NCT01597245|64758923|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
23277887|NCT01597245|64758903|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277888|NCT01597245|64758904|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277889|NCT01597245|64758905|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277890|NCT01597245|64758906|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277891|NCT01597245|64758907|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277892|NCT01597245|64758908|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277893|NCT01597245|64758909|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277894|NCT01597245|64758910|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277895|NCT01597245|64758911|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23370163|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
23370164|NCT01111565|65099253|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
23370165|NCT01111565|65099254|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
23370166|NCT01111565|65099255|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
23370167|NCT01111565|65099256|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
23370168|NCT01111565|65099257|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
23370169|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23370170|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23370171|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23370172|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
23370173|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
23370174|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23370175|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23370176|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
23370177|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23370178|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23370179|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
23370180|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
23370181|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
23370182|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
23370183|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
23603400|NCT01263496|65937357|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23603401|NCT01263496|65937358|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23603402|NCT01263496|65937359|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
23603403|NCT01263496|65937351|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603404|NCT01263496|65937352|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603405|NCT01263496|65937353|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603406|NCT01263496|65937354|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
23603407|NCT01263496|65937355|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
23603408|NCT01263496|65937356|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603409|NCT01263496|65937357|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603410|NCT01263496|65937358|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603411|NCT01263496|65937359|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
23603412|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
23603413|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
23603414|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
23370184|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
23370185|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
23370186|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
23370187|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
23370188|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
23370189|NCT01111565|65099253|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
23370190|NCT01111565|65099254|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
23370191|NCT01111565|65099255|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
23370192|NCT01111565|65099256|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
23370193|NCT01111565|65099257|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
23370194|NCT02668640|65099258|FG000|Overall Study|Lost to Follow-up|13|||
23370195|NCT02668640|65099258|FG000|Overall Study|Other, not specified|1|||
23370196|NCT02771275|65099259|FG000|Overall Study|Reoperation|3|||
23370197|NCT02771275|65099259|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
23277896|NCT01597245|64758912|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277897|NCT01597245|64758913|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277898|NCT01597245|64758914|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277899|NCT01597245|64758915|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277900|NCT01597245|64758916|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277901|NCT01597245|64758917|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23370198|NCT01100853|65099260|FG000|Overall Study|Lost to Follow-up|11|||
23370199|NCT01100853|65099261|FG001|Overall Study|Lost to Follow-up|6|||
23370200|NCT01100853|65099260|FG000|Overall Study|Received <4 study injections|10|||
23370201|NCT01100853|65099261|FG001|Overall Study|Received <4 study injections|13|||
23603415|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
23603416|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
23603417|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
23603418|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
23603419|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
23603420|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
23603421|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603422|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
23603423|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603424|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603425|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603426|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603427|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603428|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603429|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
23603430|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23603431|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23603432|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23201397|NCT02234583|64476721|FG001|Overall Study|Lost to Follow-up|1|||
23201398|NCT02234583|64476720|FG000|Overall Study|Lack of Efficacy|58|||
23201399|NCT02234583|64476721|FG001|Overall Study|Lack of Efficacy|103|||
23201400|NCT02234583|64476720|FG000|Overall Study|Protocol Violation|35|||
23201401|NCT02234583|64476721|FG001|Overall Study|Protocol Violation|42|||
23201402|NCT02234583|64476720|FG000|Overall Study|Other|39|||
23201403|NCT02234583|64476721|FG001|Overall Study|Other|97|||
23201404|NCT04657016|64476722|FG000|Overall Study|Adverse Event|2|||
23201405|NCT04657016|64476723|FG001|Overall Study|Adverse Event|4|||
23201406|NCT04657016|64476722|FG000|Overall Study|Death|1|||
23201407|NCT04657016|64476723|FG001|Overall Study|Death|1|||
23201408|NCT04657016|64476722|FG000|Overall Study|Lost to Follow-up|24|||
23201409|NCT04657016|64476723|FG001|Overall Study|Lost to Follow-up|12|||
23201410|NCT04657016|64476722|FG000|Overall Study|Physician Decision|1|||
23201411|NCT04657016|64476723|FG001|Overall Study|Physician Decision|2|||
23201412|NCT04657016|64476722|FG000|Overall Study|Pregnancy|2|||
23201413|NCT04657016|64476723|FG001|Overall Study|Pregnancy|2|||
23277902|NCT01597245|64758918|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
23277903|NCT01597245|64758919|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
23277904|NCT01597245|64758920|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
23277905|NCT01597245|64758921|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
23277906|NCT01597245|64758922|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
23277907|NCT01597245|64758923|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
23277908|NCT01597245|64758903|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277909|NCT01597245|64758904|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277910|NCT01597245|64758905|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277911|NCT01597245|64758906|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277912|NCT01597245|64758907|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277913|NCT01597245|64758908|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277914|NCT01597245|64758909|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277915|NCT01597245|64758910|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277916|NCT01597245|64758911|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277917|NCT01597245|64758912|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277918|NCT01597245|64758913|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277919|NCT01597245|64758914|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23485218|NCT04571515|65518846|FG003|Overall Study|Withdrawal by Subject|0|||
23485219|NCT04571515|65518847|FG004|Overall Study|Withdrawal by Subject|1|||
23485220|NCT04571515|65518843|FG000|Overall Study|insufficient pain|1|||
23485221|NCT04571515|65518844|FG001|Overall Study|insufficient pain|0|||
23485222|NCT04571515|65518845|FG002|Overall Study|insufficient pain|0|||
23485223|NCT04571515|65518846|FG003|Overall Study|insufficient pain|0|||
23485224|NCT04571515|65518847|FG004|Overall Study|insufficient pain|1|||
23485225|NCT00761748|65518848|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
23485226|NCT00761748|65518849|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
23485227|NCT00761748|65518848|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
23485228|NCT00761748|65518849|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
23485229|NCT01058265|65518852|FG000|Overall Study|Lost to Follow-up|11|||
23485230|NCT01058265|65518853|FG001|Overall Study|Lost to Follow-up|12|||
23485231|NCT04706416|65518854|FG000|Overall Study|Lost to Follow-up|2|||
23485232|NCT04706416|65518855|FG001|Overall Study|Lost to Follow-up|0|||
23485233|NCT01315236|65521681|FG000|Double-blind Phase|Death|1|||
23485234|NCT01315236|65521682|FG001|Double-blind Phase|Death|0|||
23485235|NCT01315236|65521681|FG000|Double-blind Phase|Adverse Event|1|||
23485236|NCT01315236|65521682|FG001|Double-blind Phase|Adverse Event|0|||
23485237|NCT01315236|65521681|FG000|Double-blind Phase|Withdrawal of Consent|1|||
23485238|NCT01315236|65521682|FG001|Double-blind Phase|Withdrawal of Consent|0|||
23485239|NCT01315236|65521681|FG000|Double-blind Phase|Lost to Follow-up|1|||
23485240|NCT01315236|65521682|FG001|Double-blind Phase|Lost to Follow-up|0|||
23485241|NCT01315236|65521681|FG000|Open-label Phase|Death|1|||
23485242|NCT01315236|65521682|FG001|Open-label Phase|Death|0|||
23485243|NCT01315236|65521681|FG000|Open-label Phase|Adverse Event|0|||
23485244|NCT01315236|65521682|FG001|Open-label Phase|Adverse Event|1|||
23485245|NCT01315236|65521681|FG000|Open-label Phase|Other|0|||
23485246|NCT01315236|65521682|FG001|Open-label Phase|Other|1|||
23485247|NCT01315236|65521681|FG000|12-Month Follow-up Period|Death|0|||
23485248|NCT01315236|65521682|FG001|12-Month Follow-up Period|Death|1|||
23485249|NCT01315236|65521681|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
23485250|NCT01315236|65521682|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
23485251|NCT01255787|65521683|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
23485252|NCT01255787|65521684|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
23485253|NCT01255787|65521685|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
23485254|NCT01255787|65521686|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
23485255|NCT01255787|65521683|FG000|Overall Study|Major Protocol Deviation|1|||
23485256|NCT01255787|65521684|FG001|Overall Study|Major Protocol Deviation|1|||
23485257|NCT01255787|65521685|FG002|Overall Study|Major Protocol Deviation|0|||
23485258|NCT01255787|65521686|FG003|Overall Study|Major Protocol Deviation|4|||
23485259|NCT01255787|65521683|FG000|Overall Study|Lost to Follow-up|1|||
23485260|NCT01255787|65521684|FG001|Overall Study|Lost to Follow-up|2|||
23485261|NCT01255787|65521685|FG002|Overall Study|Lost to Follow-up|4|||
23485262|NCT01255787|65521686|FG003|Overall Study|Lost to Follow-up|2|||
23485263|NCT01255787|65521683|FG000|Overall Study|Withdrawal of Consent|3|||
23485264|NCT01255787|65521684|FG001|Overall Study|Withdrawal of Consent|9|||
23485265|NCT01255787|65521685|FG002|Overall Study|Withdrawal of Consent|3|||
23485266|NCT01255787|65521686|FG003|Overall Study|Withdrawal of Consent|4|||
23485267|NCT01255787|65521683|FG000|Overall Study|Pregnancy|0|||
23485268|NCT01255787|65521684|FG001|Overall Study|Pregnancy|0|||
23485269|NCT01255787|65521685|FG002|Overall Study|Pregnancy|0|||
23485270|NCT01255787|65521686|FG003|Overall Study|Pregnancy|1|||
23485271|NCT01255787|65521683|FG000|Overall Study|Lack of Efficacy|2|||
23485272|NCT01255787|65521684|FG001|Overall Study|Lack of Efficacy|2|||
23277920|NCT01597245|64758915|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277921|NCT01597245|64758916|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277922|NCT01597245|64758917|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277923|NCT01597245|64758918|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277924|NCT01597245|64758919|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
23277925|NCT01597245|64758920|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
23277926|NCT01597245|64758921|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
23277927|NCT01597245|64758922|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
23277928|NCT01597245|64758923|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
23277929|NCT01597245|64758903|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277930|NCT01597245|64758904|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277931|NCT01597245|64758905|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277932|NCT01597245|64758906|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277933|NCT01597245|64758907|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277934|NCT01597245|64758908|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277935|NCT01597245|64758909|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277936|NCT01597245|64758910|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277937|NCT01597245|64758911|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277938|NCT01597245|64758912|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277939|NCT01597245|64758913|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277940|NCT01597245|64758914|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277941|NCT01597245|64758915|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277942|NCT01597245|64758916|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277943|NCT01597245|64758917|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277944|NCT01597245|64758918|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277945|NCT01597245|64758919|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
23277946|NCT01597245|64758920|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277947|NCT01597245|64758921|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
23277948|NCT01597245|64758922|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
23277949|NCT01597245|64758923|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
23277950|NCT01597245|64758903|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277951|NCT01597245|64758904|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277952|NCT01597245|64758905|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277953|NCT01597245|64758906|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277954|NCT01597245|64758907|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277955|NCT01597245|64758908|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277956|NCT01597245|64758909|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277957|NCT01597245|64758910|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277958|NCT01597245|64758911|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277959|NCT01597245|64758912|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277960|NCT01597245|64758913|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277961|NCT01597245|64758914|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277962|NCT01597245|64758915|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277963|NCT01597245|64758916|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277964|NCT01597245|64758917|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277965|NCT01597245|64758918|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277966|NCT01597245|64758919|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277967|NCT01597245|64758920|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
23277968|NCT01597245|64758921|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
23277969|NCT01597245|64758922|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
23277970|NCT01597245|64758923|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
23277971|NCT01597245|64758903|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277972|NCT01597245|64758904|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277973|NCT01597245|64758905|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277974|NCT01597245|64758906|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277975|NCT01597245|64758907|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277976|NCT01597245|64758908|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277977|NCT01597245|64758909|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277978|NCT01597245|64758910|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277979|NCT01597245|64758911|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277980|NCT01597245|64758912|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277981|NCT01597245|64758913|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277982|NCT01597245|64758914|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277983|NCT01597245|64758915|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277984|NCT01597245|64758916|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277985|NCT01597245|64758917|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277986|NCT01597245|64758918|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277987|NCT01597245|64758919|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
23277988|NCT01597245|64758920|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277989|NCT01597245|64758921|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
23277990|NCT01597245|64758922|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
23277991|NCT01597245|64758923|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
23277992|NCT01597245|64758903|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23277993|NCT01597245|64758904|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23277994|NCT01597245|64758905|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23277995|NCT01597245|64758906|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23277996|NCT01597245|64758907|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23277997|NCT01597245|64758908|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23277998|NCT01597245|64758909|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23277999|NCT01597245|64758910|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278000|NCT01597245|64758911|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278001|NCT01597245|64758912|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278002|NCT01597245|64758913|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278003|NCT01597245|64758914|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278004|NCT01597245|64758915|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278005|NCT01597245|64758916|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278006|NCT01597245|64758917|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278007|NCT01597245|64758918|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278008|NCT01597245|64758919|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
23278009|NCT01597245|64758920|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278010|NCT01597245|64758921|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
23278011|NCT01597245|64758922|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
23370202|NCT01100853|65099260|FG000|Overall Study|Withdrawal by Subject|6|||
23370203|NCT01100853|65099261|FG001|Overall Study|Withdrawal by Subject|4|||
23370204|NCT01317940|65099264|FG000|Overall Study|Death|1|||
23370205|NCT01317940|65099265|FG001|Overall Study|Death|0|||
23370206|NCT01317940|65099266|FG002|Overall Study|Death|1|||
23370207|NCT01317940|65099267|FG003|Overall Study|Death|0|||
23370208|NCT01317940|65099268|FG004|Overall Study|Death|0|||
23370209|NCT01317940|65099269|FG005|Overall Study|Death|0|||
23370210|NCT01317940|65099264|FG000|Overall Study|Lost to Follow-up|0|||
23370211|NCT01317940|65099265|FG001|Overall Study|Lost to Follow-up|0|||
23370212|NCT01317940|65099266|FG002|Overall Study|Lost to Follow-up|1|||
23370213|NCT01317940|65099267|FG003|Overall Study|Lost to Follow-up|1|||
23370214|NCT01317940|65099268|FG004|Overall Study|Lost to Follow-up|1|||
23370215|NCT01317940|65099269|FG005|Overall Study|Lost to Follow-up|0|||
23370216|NCT01317940|65099264|FG000|Overall Study|Change in therapy plan|0|||
23370217|NCT01317940|65099265|FG001|Overall Study|Change in therapy plan|0|||
23370218|NCT01317940|65099266|FG002|Overall Study|Change in therapy plan|3|||
23370219|NCT01317940|65099267|FG003|Overall Study|Change in therapy plan|0|||
23370220|NCT01317940|65099268|FG004|Overall Study|Change in therapy plan|0|||
23370221|NCT01317940|65099269|FG005|Overall Study|Change in therapy plan|0|||
23370222|NCT02308046|65099270|FG000|Overall Study|Negative yeast culture at Baseline|32|||
23485273|NCT01255787|65521685|FG002|Overall Study|Lack of Efficacy|2|||
23370223|NCT02308046|65099271|FG001|Overall Study|Negative yeast culture at Baseline|33|||
23370224|NCT02308046|65099270|FG000|Overall Study|Positive for STD at Baseline|1|||
23370225|NCT02308046|65099271|FG001|Overall Study|Positive for STD at Baseline|2|||
23370226|NCT02308046|65099270|FG000|Overall Study|Lost to Follow-up|1|||
23370227|NCT02308046|65099271|FG001|Overall Study|Lost to Follow-up|3|||
23370228|NCT03669588|65099281|FG000|Overall Study|Adverse Event|1|||
23370229|NCT03669588|65099282|FG001|Overall Study|Adverse Event|0|||
23370230|NCT03669588|65099281|FG000|Overall Study|Physician Decision|0|||
23370231|NCT03669588|65099282|FG001|Overall Study|Physician Decision|1|||
23370232|NCT03669588|65099281|FG000|Overall Study|Protocol Violation|1|||
23370233|NCT03669588|65099282|FG001|Overall Study|Protocol Violation|0|||
23370234|NCT03669588|65099281|FG000|Overall Study|Sponsor Decision|1|||
23370235|NCT03669588|65099282|FG001|Overall Study|Sponsor Decision|1|||
23370236|NCT03669588|65099281|FG000|Overall Study|Withdrawal by Subject|1|||
23370237|NCT03669588|65099282|FG001|Overall Study|Withdrawal by Subject|4|||
23370238|NCT03669588|65099281|FG000|Overall Study|Rescue Therapy Needed|0|||
23370239|NCT03669588|65099282|FG001|Overall Study|Rescue Therapy Needed|1|||
23370240|NCT02914834|65099285|FG000|Overall Study|Study halted due to COVID|1|||
23370241|NCT02914834|65099286|FG001|Overall Study|Study halted due to COVID|1|||
23370242|NCT02914834|65099285|FG000|Overall Study|1 subject withdrew|0|||
23370243|NCT02914834|65099286|FG001|Overall Study|1 subject withdrew|1|||
23370244|NCT02736617|65099295|FG000|Treatment|Adverse Event|1|||
23370245|NCT02736617|65099295|FG000|Treatment|Lack of Efficacy|1|||
23370246|NCT02736617|65099295|FG000|Treatment|Withdrawal by Subject|1|||
23370247|NCT02736617|65099295|FG000|Maintenance|Lack of Efficacy|4|||
23370248|NCT02736617|65099295|FG000|Maintenance|Physician Decision|1|||
23370249|NCT00379834|65099297|FG000|Overall Study|Time constraints|2|||
23370250|NCT02792504|65099298|FG000|Overall Study|Lost to Follow-up|24|||
23370251|NCT02792504|65099298|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
23370252|NCT02999789|65099299|FG000|Overall Study|Withdrawal by Subject|0|||
23370253|NCT02999789|65099300|FG001|Overall Study|Withdrawal by Subject|1|||
23370254|NCT02999789|65099299|FG000|Overall Study|Became ineligible|1|||
23370255|NCT02999789|65099300|FG001|Overall Study|Became ineligible|2|||
23370256|NCT01619852|65099301|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
23370257|NCT01619852|65099302|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
23370258|NCT01619852|65099301|FG000|3 Month Follow up|Lost to Follow-up|31|||
23370259|NCT01619852|65099302|FG001|3 Month Follow up|Lost to Follow-up|34|||
23370260|NCT00983372|65099303|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
23370261|NCT00983372|65099303|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
23370262|NCT00983372|65099303|FG000|Diltiazem ER Alone|Adverse Event|1|||
23370263|NCT04350827|65099306|FG000|Overall Study|Lost to Follow-up|1|||
23370264|NCT04350827|65099307|FG001|Overall Study|Lost to Follow-up|2|||
23370265|NCT04494646|65099308|FG000|Overall Study|Adverse Event|0|||
23370266|NCT04494646|65099309|FG001|Overall Study|Adverse Event|1|||
23370267|NCT04494646|65099308|FG000|Overall Study|Withdrawal by Subject|0|||
23370268|NCT04494646|65099309|FG001|Overall Study|Withdrawal by Subject|1|||
23370269|NCT03555149|65099313|FG000|Overall Study|Death|18|||
23370270|NCT03555149|65099314|FG001|Overall Study|Death|15|||
23370271|NCT03555149|65099315|FG002|Overall Study|Death|15|||
23370272|NCT03555149|65099316|FG003|Overall Study|Death|4|||
23370273|NCT03555149|65099317|FG004|Overall Study|Death|4|||
23370274|NCT03555149|65099318|FG005|Overall Study|Death|11|||
23370275|NCT03555149|65099319|FG006|Overall Study|Death|12|||
23370276|NCT03555149|65099320|FG007|Overall Study|Death|1|||
23370277|NCT03555149|65099313|FG000|Overall Study|Lost to Follow-up|1|||
23370278|NCT03555149|65099314|FG001|Overall Study|Lost to Follow-up|0|||
23370279|NCT03555149|65099315|FG002|Overall Study|Lost to Follow-up|0|||
23370280|NCT03555149|65099316|FG003|Overall Study|Lost to Follow-up|0|||
23370281|NCT03555149|65099317|FG004|Overall Study|Lost to Follow-up|0|||
23370282|NCT03555149|65099318|FG005|Overall Study|Lost to Follow-up|1|||
23370283|NCT03555149|65099319|FG006|Overall Study|Lost to Follow-up|0|||
23485274|NCT01255787|65521686|FG003|Overall Study|Lack of Efficacy|2|||
23485275|NCT01255787|65521683|FG000|Overall Study|Noncompliance with Study Drug|3|||
23370284|NCT03555149|65099320|FG007|Overall Study|Lost to Follow-up|0|||
23370285|NCT03555149|65099313|FG000|Overall Study|Physician Decision|1|||
23370286|NCT03555149|65099314|FG001|Overall Study|Physician Decision|0|||
23370287|NCT03555149|65099315|FG002|Overall Study|Physician Decision|0|||
23370288|NCT03555149|65099316|FG003|Overall Study|Physician Decision|0|||
23370289|NCT03555149|65099317|FG004|Overall Study|Physician Decision|0|||
23370290|NCT03555149|65099318|FG005|Overall Study|Physician Decision|0|||
23485276|NCT01255787|65521684|FG001|Overall Study|Noncompliance with Study Drug|1|||
23370291|NCT03555149|65099319|FG006|Overall Study|Physician Decision|0|||
23370292|NCT03555149|65099320|FG007|Overall Study|Physician Decision|0|||
23370293|NCT03555149|65099313|FG000|Overall Study|Study Terminated By Sponsor|1|||
23370294|NCT03555149|65099314|FG001|Overall Study|Study Terminated By Sponsor|0|||
23370295|NCT03555149|65099315|FG002|Overall Study|Study Terminated By Sponsor|0|||
23201414|NCT04657016|64476722|FG000|Overall Study|Protocol Deviation|1|||
23370296|NCT03555149|65099316|FG003|Overall Study|Study Terminated By Sponsor|0|||
23370297|NCT03555149|65099317|FG004|Overall Study|Study Terminated By Sponsor|0|||
23370298|NCT03555149|65099318|FG005|Overall Study|Study Terminated By Sponsor|2|||
23370299|NCT03555149|65099319|FG006|Overall Study|Study Terminated By Sponsor|3|||
23370300|NCT03555149|65099320|FG007|Overall Study|Study Terminated By Sponsor|1|||
23370301|NCT03555149|65099313|FG000|Overall Study|Withdrawal by Subject|3|||
23370302|NCT03555149|65099314|FG001|Overall Study|Withdrawal by Subject|0|||
23603433|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
23603434|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
23603435|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23603436|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23603437|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
23603438|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
23603439|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
23603440|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
23603441|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
23603442|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23603443|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
23603444|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23603445|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23603446|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
23603447|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
23278012|NCT01597245|64758923|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
23278013|NCT01597245|64758903|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278014|NCT01597245|64758904|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278015|NCT01597245|64758905|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278016|NCT01597245|64758906|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278017|NCT01597245|64758907|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278018|NCT01597245|64758908|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278019|NCT01597245|64758909|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278020|NCT01597245|64758910|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278021|NCT01597245|64758911|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278022|NCT01597245|64758912|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278023|NCT01597245|64758913|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278024|NCT01597245|64758914|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278025|NCT01597245|64758915|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278026|NCT01597245|64758916|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278027|NCT01597245|64758917|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278028|NCT01597245|64758918|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278029|NCT01597245|64758919|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
23278030|NCT01597245|64758920|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278031|NCT01597245|64758921|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278032|NCT01597245|64758922|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
23278033|NCT01597245|64758923|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
23278034|NCT01597245|64758903|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278035|NCT01597245|64758904|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278036|NCT01597245|64758905|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278037|NCT01597245|64758906|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278038|NCT01597245|64758907|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23370303|NCT03555149|65099315|FG002|Overall Study|Withdrawal by Subject|0|||
23370304|NCT03555149|65099316|FG003|Overall Study|Withdrawal by Subject|2|||
23370305|NCT03555149|65099317|FG004|Overall Study|Withdrawal by Subject|0|||
23370306|NCT03555149|65099318|FG005|Overall Study|Withdrawal by Subject|1|||
23370307|NCT03555149|65099319|FG006|Overall Study|Withdrawal by Subject|0|||
23370308|NCT03555149|65099320|FG007|Overall Study|Withdrawal by Subject|0|||
23370309|NCT03713281|65099321|FG000|Overall Study|Lens handling difficuluties|2|||
23370310|NCT03713281|65099321|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
23370311|NCT01285518|65099322|FG000|Overall Study|Lost to Follow-up|0|||
23370312|NCT01285518|65099323|FG001|Overall Study|Lost to Follow-up|0|||
23370313|NCT01285518|65099324|FG002|Overall Study|Lost to Follow-up|0|||
23370314|NCT01285518|65099325|FG003|Overall Study|Lost to Follow-up|0|||
23370315|NCT01285518|65099326|FG004|Overall Study|Lost to Follow-up|0|||
23370316|NCT01285518|65099327|FG005|Overall Study|Lost to Follow-up|1|||
23370317|NCT01285518|65099328|FG006|Overall Study|Lost to Follow-up|0|||
23370318|NCT01285518|65099329|FG007|Overall Study|Lost to Follow-up|0|||
23370319|NCT01165307|65099330|FG000|Overall Study|Lost to Follow-up|11|||
23370320|NCT01165307|65099331|FG001|Overall Study|Lost to Follow-up|3|||
23370321|NCT01165307|65099330|FG000|Overall Study|Withdrawal by Subject|2|||
23370322|NCT01165307|65099331|FG001|Overall Study|Withdrawal by Subject|0|||
23370323|NCT01165307|65099330|FG000|Overall Study|Subject not available for contact|1|||
23370324|NCT01165307|65099331|FG001|Overall Study|Subject not available for contact|0|||
23370325|NCT01178294|65099338|FG000|Overall Study|Adverse Event|4|||
23370326|NCT01178294|65099338|FG000|Overall Study|Lost to Follow-up|2|||
23370327|NCT01178294|65099338|FG000|Overall Study|Lack of Efficacy|1|||
23370328|NCT01178294|65099338|FG000|Overall Study|Death|1|||
23370329|NCT01178294|65099338|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
23370330|NCT01178294|65099338|FG000|Overall Study|Subject status is terminal|1|||
23370331|NCT01178294|65099338|FG000|Overall Study|Completion status could not be verified|1|||
23370332|NCT01433159|65099339|FG000|Overall Study|Adverse Event|1|||
23370333|NCT01433159|65099340|FG001|Overall Study|Adverse Event|0|||
23370334|NCT01433159|65099339|FG000|Overall Study|Physician Decision|1|||
23370335|NCT01433159|65099340|FG001|Overall Study|Physician Decision|0|||
23370336|NCT01433159|65099339|FG000|Overall Study|Protocol Violation|0|||
23370337|NCT01433159|65099340|FG001|Overall Study|Protocol Violation|1|||
23370338|NCT01107925|65099345|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
23370339|NCT01107925|65099346|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
23370340|NCT01107925|65099347|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
23370341|NCT01107925|65099348|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
23370342|NCT01107925|65099349|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
23370343|NCT01107925|65099350|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
23370344|NCT01107925|65099345|FG000|Period 2|Withdrawal by Subject|0|||
23370345|NCT01107925|65099346|FG001|Period 2|Withdrawal by Subject|1|||
23370346|NCT01107925|65099347|FG002|Period 2|Withdrawal by Subject|0|||
23370347|NCT01107925|65099348|FG003|Period 2|Withdrawal by Subject|0|||
23370348|NCT01107925|65099349|FG004|Period 2|Withdrawal by Subject|0|||
23370349|NCT01107925|65099350|FG005|Period 2|Withdrawal by Subject|1|||
23370350|NCT01884597|65099351|FG000|Overall Study|Adverse Event|0|||
23370351|NCT01884597|65099352|FG001|Overall Study|Adverse Event|0|||
23370352|NCT01884597|65099353|FG002|Overall Study|Adverse Event|1|||
23370353|NCT01884597|65099351|FG000|Overall Study|Lack of Efficacy|1|||
23370354|NCT01884597|65099352|FG001|Overall Study|Lack of Efficacy|0|||
23278039|NCT01597245|64758908|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278040|NCT01597245|64758909|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278041|NCT01597245|64758910|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278042|NCT01597245|64758911|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278043|NCT01597245|64758912|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278044|NCT01597245|64758913|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278045|NCT01597245|64758914|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278046|NCT01597245|64758915|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278047|NCT01597245|64758916|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278048|NCT01597245|64758917|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278049|NCT01597245|64758918|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278050|NCT01597245|64758919|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
23370355|NCT01884597|65099353|FG002|Overall Study|Lack of Efficacy|0|||
23370356|NCT01884597|65099351|FG000|Overall Study|Death|0|||
23370357|NCT01884597|65099352|FG001|Overall Study|Death|1|||
23370358|NCT01884597|65099353|FG002|Overall Study|Death|0|||
23370359|NCT02000921|65099360|FG000|Overall Study|Withdrawal by Subject|3|||
23370360|NCT02000921|65099361|FG001|Overall Study|Withdrawal by Subject|10|||
23370361|NCT02000921|65099362|FG002|Overall Study|Withdrawal by Subject|5|||
23370362|NCT02000921|65099360|FG000|Overall Study|Lost to Follow-up|2|||
23370363|NCT02000921|65099361|FG001|Overall Study|Lost to Follow-up|4|||
23370364|NCT02000921|65099362|FG002|Overall Study|Lost to Follow-up|5|||
23370365|NCT02000921|65099360|FG000|Overall Study|Physician Decision|0|||
23370366|NCT02000921|65099361|FG001|Overall Study|Physician Decision|2|||
23370367|NCT02000921|65099362|FG002|Overall Study|Physician Decision|0|||
23370368|NCT03106077|65099363|FG000|Overall Study|Screen Failure|94|||
23370369|NCT03106077|65099364|FG001|Overall Study|Screen Failure|0|||
23370370|NCT01274533|65102660|FG000|Overall Study|Withdrawal by Subject|1|||
23370371|NCT01274533|65102660|FG000|Overall Study|Non-compliance|1|||
23370372|NCT01274533|65102660|FG000|Overall Study|Disease progression|2|||
23370373|NCT03533751|65102665|FG000|Overall Study|Withdrawal by Subject|12|||
23370374|NCT03533751|65102666|FG001|Overall Study|Withdrawal by Subject|6|||
23370375|NCT03533751|65102667|FG002|Overall Study|Withdrawal by Subject|11|||
23370376|NCT03533751|65102668|FG003|Overall Study|Withdrawal by Subject|9|||
23370377|NCT03533751|65102669|FG004|Overall Study|Withdrawal by Subject|10|||
23370378|NCT03533751|65102665|FG000|Overall Study|Adverse Event|4|||
23370379|NCT03533751|65102666|FG001|Overall Study|Adverse Event|7|||
23370380|NCT03533751|65102667|FG002|Overall Study|Adverse Event|2|||
23370381|NCT03533751|65102668|FG003|Overall Study|Adverse Event|4|||
23370382|NCT03533751|65102669|FG004|Overall Study|Adverse Event|5|||
23370383|NCT03533751|65102665|FG000|Overall Study|Physician Decision|0|||
23370384|NCT03533751|65102666|FG001|Overall Study|Physician Decision|2|||
23370385|NCT03533751|65102667|FG002|Overall Study|Physician Decision|1|||
23370386|NCT03533751|65102668|FG003|Overall Study|Physician Decision|2|||
23370387|NCT03533751|65102669|FG004|Overall Study|Physician Decision|1|||
23370388|NCT03533751|65102665|FG000|Overall Study|Sponsor Decision|0|||
23370389|NCT03533751|65102666|FG001|Overall Study|Sponsor Decision|0|||
23370390|NCT03533751|65102667|FG002|Overall Study|Sponsor Decision|1|||
23370391|NCT03533751|65102668|FG003|Overall Study|Sponsor Decision|1|||
23370392|NCT03533751|65102669|FG004|Overall Study|Sponsor Decision|0|||
23370393|NCT03533751|65102665|FG000|Overall Study|Lost to Follow-up|3|||
23370394|NCT03533751|65102666|FG001|Overall Study|Lost to Follow-up|7|||
23370395|NCT03533751|65102667|FG002|Overall Study|Lost to Follow-up|6|||
23370396|NCT03533751|65102668|FG003|Overall Study|Lost to Follow-up|4|||
23370397|NCT03533751|65102669|FG004|Overall Study|Lost to Follow-up|3|||
23370398|NCT03533751|65102665|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
23370399|NCT03533751|65102666|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
23370400|NCT03533751|65102667|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
23370401|NCT03533751|65102668|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
23370402|NCT03533751|65102669|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
23370403|NCT03533751|65102665|FG000|Overall Study|Other|0|||
23370404|NCT03533751|65102666|FG001|Overall Study|Other|2|||
23370405|NCT03533751|65102667|FG002|Overall Study|Other|1|||
23370406|NCT03533751|65102668|FG003|Overall Study|Other|0|||
23370407|NCT03533751|65102669|FG004|Overall Study|Other|3|||
23370408|NCT03934216|65102670|FG000|Overall Study|Other Reasons|5|||
23370409|NCT03934216|65102671|FG001|Overall Study|Other Reasons|5|||
23370410|NCT03934216|65102670|FG000|Overall Study|Adverse Event|22|||
23370411|NCT03934216|65102671|FG001|Overall Study|Adverse Event|11|||
23370412|NCT03934216|65102670|FG000|Overall Study|Lack of Efficacy|8|||
23370413|NCT03934216|65102671|FG001|Overall Study|Lack of Efficacy|7|||
23370414|NCT03934216|65102670|FG000|Overall Study|Lost to Follow-up|2|||
23370415|NCT03934216|65102671|FG001|Overall Study|Lost to Follow-up|0|||
23370416|NCT03934216|65102670|FG000|Overall Study|Non-Compliance with Study Drug|1|||
23370417|NCT03934216|65102671|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23370418|NCT03934216|65102670|FG000|Overall Study|Pregnancy|1|||
23370419|NCT03934216|65102671|FG001|Overall Study|Pregnancy|0|||
23370420|NCT03934216|65102670|FG000|Overall Study|Withdrawal by Subject|18|||
23370421|NCT03934216|65102671|FG001|Overall Study|Withdrawal by Subject|6|||
23370422|NCT03934216|65102670|FG000|Overall Study|Randomized but not treated|1|||
23370423|NCT03934216|65102671|FG001|Overall Study|Randomized but not treated|1|||
23370424|NCT00385840|65102672|FG000|Overall Study|Adverse Event|1|||
23370425|NCT00385840|65102673|FG001|Overall Study|Adverse Event|1|||
23370426|NCT00385840|65102672|FG000|Overall Study|Lost to Follow-up|3|||
23370427|NCT00385840|65102673|FG001|Overall Study|Lost to Follow-up|13|||
23370428|NCT02765035|65102674|FG000|First Intervention (90 Days)|Adverse Event|1|||
23370429|NCT02765035|65102675|FG001|First Intervention (90 Days)|Adverse Event|1|||
23370430|NCT02765035|65102674|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
23370431|NCT02765035|65102675|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
23370432|NCT02273167|65102676|FG000|Overall Study|Adverse Event|1|||
23370433|NCT02273167|65102677|FG001|Overall Study|Adverse Event|0|||
23370434|NCT02273167|65102678|FG002|Overall Study|Adverse Event|0|||
23370435|NCT02273167|65102676|FG000|Overall Study|Protocol Violation|3|||
23370436|NCT02273167|65102677|FG001|Overall Study|Protocol Violation|1|||
23370437|NCT02273167|65102678|FG002|Overall Study|Protocol Violation|1|||
23370438|NCT02273167|65102676|FG000|Overall Study|Lost to Follow-up|0|||
23370439|NCT02273167|65102677|FG001|Overall Study|Lost to Follow-up|1|||
23370440|NCT02273167|65102678|FG002|Overall Study|Lost to Follow-up|1|||
23370441|NCT02273167|65102676|FG000|Overall Study|Withdrawal by Subject|10|||
23370442|NCT02273167|65102677|FG001|Overall Study|Withdrawal by Subject|12|||
23370443|NCT02273167|65102678|FG002|Overall Study|Withdrawal by Subject|11|||
23370444|NCT02273167|65102676|FG000|Overall Study|Various|10|||
23370445|NCT02273167|65102677|FG001|Overall Study|Various|9|||
23370446|NCT02273167|65102678|FG002|Overall Study|Various|8|||
23370447|NCT01900444|65102679|FG000|Overall Study|Protocol Violation|2|||
23370448|NCT01900444|65102679|FG000|Overall Study|Lost to Follow-up|1|||
23370449|NCT02351934|65102680|FG000|Allocation|POD weight<pre-op weight|3|||
23278051|NCT01597245|64758920|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278052|NCT01597245|64758921|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278053|NCT01597245|64758922|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
23278054|NCT01597245|64758923|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
23278055|NCT01597245|64758903|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278056|NCT01597245|64758904|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278057|NCT01597245|64758905|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278058|NCT01597245|64758906|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278059|NCT01597245|64758907|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23370450|NCT02351934|65102681|FG001|Allocation|POD weight<pre-op weight|0|||
23370451|NCT02351934|65102680|FG000|Allocation|Hypotension preventing administration|2|||
23370452|NCT02351934|65102681|FG001|Allocation|Hypotension preventing administration|0|||
23370453|NCT02351934|65102680|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
23278060|NCT01597245|64758908|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278061|NCT01597245|64758909|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278062|NCT01597245|64758910|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278063|NCT01597245|64758911|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23370454|NCT02351934|65102681|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
23370455|NCT02351934|65102680|FG000|Follow-Up|POD weight<pre-op weight|3|||
23370456|NCT02351934|65102681|FG001|Follow-Up|POD weight<pre-op weight|0|||
23370457|NCT02351934|65102680|FG000|Follow-Up|Acute Kidney Injury|1|||
23370458|NCT02351934|65102681|FG001|Follow-Up|Acute Kidney Injury|0|||
23370459|NCT02351934|65102680|FG000|Follow-Up|Early dismissal|3|||
23370460|NCT02351934|65102681|FG001|Follow-Up|Early dismissal|0|||
23370461|NCT02351934|65102680|FG000|Follow-Up|Hypotension|3|||
23370462|NCT02351934|65102681|FG001|Follow-Up|Hypotension|0|||
23370463|NCT02351934|65102680|FG000|Follow-Up|No documentation|2|||
23370464|NCT02351934|65102681|FG001|Follow-Up|No documentation|0|||
23370465|NCT02351934|65102680|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
23370466|NCT02351934|65102681|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
23370467|NCT02351934|65102680|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
23370468|NCT02351934|65102681|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
23370469|NCT02378662|65102682|FG000|Overall Study|Early Discontinuation|2|||
23370470|NCT02378662|65102683|FG001|Overall Study|Early Discontinuation|0|||
23370471|NCT03652818|65102686|FG000|Overall Study|Adverse Event|1|||
23370472|NCT03652818|65102687|FG001|Overall Study|Adverse Event|0|||
23370473|NCT03652818|65102688|FG002|Overall Study|Adverse Event|0|||
23370474|NCT03652818|65102689|FG003|Overall Study|Adverse Event|0|||
23370475|NCT03652818|65102690|FG004|Overall Study|Adverse Event|0|||
23370476|NCT03652818|65102686|FG000|Overall Study|Physician Decision|1|||
23370477|NCT03652818|65102687|FG001|Overall Study|Physician Decision|0|||
23370478|NCT03652818|65102688|FG002|Overall Study|Physician Decision|0|||
23370479|NCT03652818|65102689|FG003|Overall Study|Physician Decision|0|||
23370480|NCT03652818|65102690|FG004|Overall Study|Physician Decision|0|||
23370481|NCT03652818|65102686|FG000|Overall Study|Lost to Follow-up|0|||
23485277|NCT01255787|65521685|FG002|Overall Study|Noncompliance with Study Drug|0|||
23278064|NCT01597245|64758912|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278065|NCT01597245|64758913|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23370482|NCT03652818|65102687|FG001|Overall Study|Lost to Follow-up|1|||
23370483|NCT03652818|65102688|FG002|Overall Study|Lost to Follow-up|2|||
23278066|NCT01597245|64758914|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278067|NCT01597245|64758915|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278068|NCT01597245|64758916|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23370484|NCT03652818|65102689|FG003|Overall Study|Lost to Follow-up|1|||
23370485|NCT03652818|65102690|FG004|Overall Study|Lost to Follow-up|1|||
23370486|NCT01855958|65102693|FG000|Overall Study|Withdrawal by Subject|1|||
23370487|NCT01855958|65102694|FG001|Overall Study|Withdrawal by Subject|0|||
23370488|NCT02814526|65102696|FG000|Overall Study|Adverse Event|4|||
23370489|NCT02814526|65102697|FG001|Overall Study|Adverse Event|3|||
23370490|NCT02814526|65102696|FG000|Overall Study|Death|1|||
23370491|NCT02814526|65102697|FG001|Overall Study|Death|1|||
23370492|NCT02814526|65102696|FG000|Overall Study|Lost to Follow-up|3|||
23370493|NCT02814526|65102697|FG001|Overall Study|Lost to Follow-up|4|||
23370494|NCT02814526|65102696|FG000|Overall Study|non site physician decision|1|||
23370495|NCT02814526|65102697|FG001|Overall Study|non site physician decision|0|||
23370496|NCT02814526|65102696|FG000|Overall Study|participant noncompliance|1|||
23370497|NCT02814526|65102697|FG001|Overall Study|participant noncompliance|1|||
23370498|NCT02814526|65102696|FG000|Overall Study|Withdrawal by Subject|20|||
23370499|NCT02814526|65102697|FG001|Overall Study|Withdrawal by Subject|14|||
23370500|NCT02814526|65102696|FG000|Overall Study|safety risk|2|||
23370501|NCT02814526|65102697|FG001|Overall Study|safety risk|1|||
23370502|NCT02814526|65102696|FG000|Overall Study|early termination-study terminated|1|||
23370503|NCT02814526|65102697|FG001|Overall Study|early termination-study terminated|2|||
23370504|NCT02814526|65102696|FG000|Overall Study|Other|0|||
23370505|NCT02814526|65102697|FG001|Overall Study|Other|4|||
23370506|NCT02008526|65102701|FG000|Overall Study|Death|0|||
23370507|NCT02008526|65102702|FG001|Overall Study|Death|2|||
23370508|NCT02008526|65102703|FG002|Overall Study|Death|1|||
23370509|NCT02008526|65102701|FG000|Overall Study|Withdrawal by Subject|3|||
23370510|NCT02008526|65102702|FG001|Overall Study|Withdrawal by Subject|3|||
23370511|NCT02008526|65102703|FG002|Overall Study|Withdrawal by Subject|2|||
23370512|NCT02008526|65102701|FG000|Overall Study|Lost to Follow-up|5|||
23370513|NCT02008526|65102702|FG001|Overall Study|Lost to Follow-up|9|||
23370514|NCT02008526|65102703|FG002|Overall Study|Lost to Follow-up|6|||
23370515|NCT02410629|65102705|FG000|Overall Study|Family cannot commit to the study|2|||
23370516|NCT02410629|65102706|FG001|Overall Study|Family cannot commit to the study|1|||
23370517|NCT02410629|65102705|FG000|Overall Study|Subject returned to work|1|||
23370518|NCT02410629|65102706|FG001|Overall Study|Subject returned to work|0|||
23370519|NCT02410629|65102705|FG000|Overall Study|Subject moved back to home country|0|||
23370520|NCT02410629|65102706|FG001|Overall Study|Subject moved back to home country|1|||
23370521|NCT02410629|65102705|FG000|Overall Study|Subject underwent heart surgery|0|||
23370522|NCT02410629|65102706|FG001|Overall Study|Subject underwent heart surgery|1|||
23370523|NCT00720499|65102712|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
23370524|NCT00720499|65102713|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
23370525|NCT00720499|65102712|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
23370526|NCT00720499|65102713|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
23370527|NCT00720499|65102712|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
23370528|NCT00720499|65102713|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
23370529|NCT04275336|65102714|FG000|Overall Study|First venipuncture failed|4|||
23370530|NCT04275336|65102715|FG001|Overall Study|First venipuncture failed|6|||
23370531|NCT04275336|65102716|FG002|Overall Study|First venipuncture failed|5|||
23485278|NCT01255787|65521686|FG003|Overall Study|Noncompliance with Study Drug|0|||
23603448|NCT01263496|65937351|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603449|NCT01263496|65937352|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603450|NCT01263496|65937353|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603451|NCT01263496|65937354|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603452|NCT01263496|65937355|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603453|NCT01263496|65937356|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603454|NCT01263496|65937357|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603455|NCT01263496|65937358|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
23603456|NCT01263496|65937359|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
23603457|NCT01613417|65937364|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
23603458|NCT01613417|65937365|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
23603459|NCT01641900|65937366|FG000|Overall Study|Withdrawal by Subject|2|||
23603460|NCT01641900|65937367|FG001|Overall Study|Withdrawal by Subject|2|||
23603461|NCT01160354|65937370|FG000|Overall Study|Death|0|||
23603462|NCT01160354|65937371|FG001|Overall Study|Death|1|||
23603463|NCT01160354|65937372|FG002|Overall Study|Death|1|||
23370532|NCT04275336|65102714|FG000|Overall Study|Unscheduled venipuncture|9|||
23370533|NCT04275336|65102715|FG001|Overall Study|Unscheduled venipuncture|13|||
23370534|NCT04275336|65102716|FG002|Overall Study|Unscheduled venipuncture|7|||
23370535|NCT04275336|65102714|FG000|Overall Study|Failed specimen of saliva|4|||
23370536|NCT04275336|65102715|FG001|Overall Study|Failed specimen of saliva|3|||
23370537|NCT04275336|65102716|FG002|Overall Study|Failed specimen of saliva|4|||
23370538|NCT01384877|65102717|FG000|Treatment 2|Lost to Follow-up|2|||
23370539|NCT01384877|65102718|FG001|Treatment 2|Lost to Follow-up|2|||
23370540|NCT02984982|65102719|FG000|Overall Study|Adverse Event|2|||
23278069|NCT01597245|64758917|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278070|NCT01597245|64758918|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278071|NCT01597245|64758919|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278072|NCT01597245|64758920|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278073|NCT01597245|64758921|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278074|NCT01597245|64758922|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
23278075|NCT01597245|64758923|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
23278076|NCT01444378|64758924|FG000|Overall Study|Lost to Follow-up|1|||
23278077|NCT01444378|64758924|FG000|Overall Study|Withdrawal by Subject|1|||
23278078|NCT01444378|64758924|FG000|Overall Study|Death|3|||
23278079|NCT01444378|64758924|FG000|Overall Study|Administrative Closure Of The Study|2|||
23370541|NCT02984982|65102720|FG001|Overall Study|Adverse Event|5|||
23370542|NCT02984982|65102719|FG000|Overall Study|Poor Compliance to Protocol|4|||
23370543|NCT02984982|65102720|FG001|Overall Study|Poor Compliance to Protocol|4|||
23278080|NCT01444378|64758924|FG000|Overall Study|Missed Visits|10|||
23278081|NCT00840632|64758925|FG000|First Intervention|Withdrawal by Subject|0|||
23278082|NCT00840632|64758926|FG001|First Intervention|Withdrawal by Subject|1|||
23278083|NCT00840632|64758925|FG000|Washout|Withdrawal by Subject|1|||
23278084|NCT00840632|64758926|FG001|Washout|Withdrawal by Subject|1|||
23278085|NCT02128997|64758927|FG000|Overall Study|Lost to Follow-up|6|||
23278086|NCT02128997|64758928|FG001|Overall Study|Lost to Follow-up|11|||
23278087|NCT03031847|64758929|FG000|Overall Study|Death|1|||
23278088|NCT03031847|64758930|FG001|Overall Study|Death|1|||
23278089|NCT03031847|64758931|FG002|Overall Study|Death|2|||
23278090|NCT03031847|64758932|FG003|Overall Study|Death|3|||
23370544|NCT02984982|65102719|FG000|Overall Study|Withdrawal by Subject|2|||
23370545|NCT02984982|65102720|FG001|Overall Study|Withdrawal by Subject|0|||
23370546|NCT02984982|65102719|FG000|Overall Study|Randomized but not treated|0|||
23370547|NCT02984982|65102720|FG001|Overall Study|Randomized but not treated|1|||
23370548|NCT03176771|65102721|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
23278091|NCT03031847|64758929|FG000|Overall Study|Lost to Follow-up|1|||
23278092|NCT03031847|64758930|FG001|Overall Study|Lost to Follow-up|1|||
23278093|NCT03031847|64758931|FG002|Overall Study|Lost to Follow-up|2|||
23278094|NCT03031847|64758932|FG003|Overall Study|Lost to Follow-up|3|||
23370549|NCT03176771|65102722|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
23485279|NCT04041700|65521687|FG000|Overall Study|Pregnancy|1|||
23278095|NCT02647944|64758934|FG000|Overall Study|Withdrawal by Subject|0|||
23278096|NCT02647944|64758935|FG001|Overall Study|Withdrawal by Subject|3|||
23370550|NCT03176771|65102723|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
23370551|NCT03176771|65102724|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
23370552|NCT03176771|65102725|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
23370553|NCT03176771|65102721|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
23370554|NCT03176771|65102722|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
23370555|NCT03176771|65102723|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
23370556|NCT03176771|65102724|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
23370557|NCT03176771|65102725|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
23370558|NCT03176771|65102721|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
23370559|NCT03176771|65102722|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
23370560|NCT03176771|65102723|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
23370561|NCT03176771|65102724|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
23370562|NCT03176771|65102725|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
23370563|NCT03176771|65102721|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
23370564|NCT03176771|65102722|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
23370565|NCT03176771|65102723|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
23370566|NCT03176771|65102724|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
23370567|NCT03176771|65102725|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
23370568|NCT03176771|65102721|FG000|Double-Blind Extension Period|Adverse Event|0|||
23370569|NCT03176771|65102722|FG001|Double-Blind Extension Period|Adverse Event|0|||
23370570|NCT03176771|65102723|FG002|Double-Blind Extension Period|Adverse Event|0|||
23370571|NCT03176771|65102724|FG003|Double-Blind Extension Period|Adverse Event|15|||
23370572|NCT03176771|65102725|FG004|Double-Blind Extension Period|Adverse Event|18|||
23370573|NCT03176771|65102721|FG000|Double-Blind Extension Period|Death|0|||
23370574|NCT03176771|65102722|FG001|Double-Blind Extension Period|Death|0|||
23370575|NCT03176771|65102723|FG002|Double-Blind Extension Period|Death|0|||
23370576|NCT03176771|65102724|FG003|Double-Blind Extension Period|Death|3|||
23370577|NCT03176771|65102725|FG004|Double-Blind Extension Period|Death|4|||
23370578|NCT03176771|65102721|FG000|Double-Blind Extension Period|Physician Decision|0|||
23370579|NCT03176771|65102722|FG001|Double-Blind Extension Period|Physician Decision|0|||
23370580|NCT03176771|65102723|FG002|Double-Blind Extension Period|Physician Decision|0|||
23370581|NCT03176771|65102724|FG003|Double-Blind Extension Period|Physician Decision|3|||
23370582|NCT03176771|65102725|FG004|Double-Blind Extension Period|Physician Decision|1|||
23370583|NCT03176771|65102721|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
23370584|NCT03176771|65102722|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
23370585|NCT03176771|65102723|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
23370586|NCT03176771|65102724|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
23370587|NCT03176771|65102725|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
23370588|NCT03353792|65102726|FG000|Overall Study|Lost to Follow-up|1|||
23370589|NCT03353792|65102727|FG001|Overall Study|Lost to Follow-up|0|||
23370590|NCT03353792|65102726|FG000|Overall Study|Participant Unable to Manage Device|1|||
23370591|NCT03353792|65102727|FG001|Overall Study|Participant Unable to Manage Device|0|||
23370592|NCT01718483|65102728|FG000|Overall Study|Withdrawal by Subject|14|||
23370593|NCT01718483|65102729|FG001|Overall Study|Withdrawal by Subject|12|||
23370594|NCT01718483|65102728|FG000|Overall Study|Adverse Event|5|||
23370595|NCT01718483|65102729|FG001|Overall Study|Adverse Event|12|||
23370596|NCT01718483|65102728|FG000|Overall Study|Lost to Follow-up|8|||
23370597|NCT01718483|65102729|FG001|Overall Study|Lost to Follow-up|3|||
23370598|NCT01718483|65102728|FG000|Overall Study|Protocol Violation|4|||
23370599|NCT01718483|65102729|FG001|Overall Study|Protocol Violation|2|||
23370600|NCT01718483|65102728|FG000|Overall Study|Other|1|||
23370601|NCT01718483|65102729|FG001|Overall Study|Other|4|||
23370602|NCT01718483|65102728|FG000|Overall Study|Pregnancy|1|||
23370603|NCT01718483|65102729|FG001|Overall Study|Pregnancy|1|||
23370604|NCT01718483|65102728|FG000|Overall Study|Lack of Efficacy|1|||
23370605|NCT01718483|65102729|FG001|Overall Study|Lack of Efficacy|0|||
23370606|NCT03248037|65102730|FG000|Overall Study|Withdrawal by Subject|6|||
23370607|NCT03248037|65102731|FG001|Overall Study|Withdrawal by Subject|9|||
23370608|NCT03248037|65102730|FG000|Overall Study|Adverse Event|15|||
23370609|NCT03248037|65102731|FG001|Overall Study|Adverse Event|0|||
23370610|NCT01863771|65102732|FG000|Induction Phase|Adverse Event|9|||
23370611|NCT01863771|65102733|FG001|Induction Phase|Adverse Event|0|||
23370612|NCT01863771|65102734|FG002|Induction Phase|Adverse Event|0|||
23370613|NCT01863771|65102735|FG003|Induction Phase|Adverse Event|0|||
23370614|NCT01863771|65102732|FG000|Induction Phase|Lack of Efficacy|10|||
23370615|NCT01863771|65102733|FG001|Induction Phase|Lack of Efficacy|0|||
23370616|NCT01863771|65102734|FG002|Induction Phase|Lack of Efficacy|0|||
23370617|NCT01863771|65102735|FG003|Induction Phase|Lack of Efficacy|0|||
23370618|NCT01863771|65102732|FG000|Induction Phase|Withdrawal by Subject|2|||
23370619|NCT01863771|65102733|FG001|Induction Phase|Withdrawal by Subject|0|||
23370620|NCT01863771|65102734|FG002|Induction Phase|Withdrawal by Subject|0|||
23603464|NCT01787032|65937373|FG000|Overall Study|Protocol Violation|0|||
23370621|NCT01863771|65102735|FG003|Induction Phase|Withdrawal by Subject|0|||
23370622|NCT01863771|65102732|FG000|Maintenance Phase|Adverse Event|0|||
23370623|NCT01863771|65102733|FG001|Maintenance Phase|Adverse Event|0|||
23370624|NCT01863771|65102734|FG002|Maintenance Phase|Adverse Event|1|||
23370625|NCT01863771|65102735|FG003|Maintenance Phase|Adverse Event|1|||
23370626|NCT01863771|65102732|FG000|Maintenance Phase|Lack of Efficacy|0|||
23370627|NCT01863771|65102733|FG001|Maintenance Phase|Lack of Efficacy|3|||
23370628|NCT01863771|65102734|FG002|Maintenance Phase|Lack of Efficacy|7|||
23370629|NCT01863771|65102735|FG003|Maintenance Phase|Lack of Efficacy|38|||
23370630|NCT01863771|65102732|FG000|Maintenance Phase|Physician Decision|0|||
23370631|NCT01863771|65102733|FG001|Maintenance Phase|Physician Decision|0|||
23370632|NCT01863771|65102734|FG002|Maintenance Phase|Physician Decision|2|||
23370633|NCT01863771|65102735|FG003|Maintenance Phase|Physician Decision|1|||
23370634|NCT01863771|65102732|FG000|Maintenance Phase|Pregnancy|0|||
23370635|NCT01863771|65102733|FG001|Maintenance Phase|Pregnancy|1|||
23370636|NCT01863771|65102734|FG002|Maintenance Phase|Pregnancy|0|||
23370637|NCT01863771|65102735|FG003|Maintenance Phase|Pregnancy|0|||
23370638|NCT01863771|65102732|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23370639|NCT01863771|65102733|FG001|Maintenance Phase|Withdrawal by Subject|1|||
23370640|NCT01863771|65102734|FG002|Maintenance Phase|Withdrawal by Subject|2|||
23370641|NCT01863771|65102735|FG003|Maintenance Phase|Withdrawal by Subject|3|||
23370642|NCT01241279|65102742|FG000|Overall Study|Lost to Follow-up|0|||
23370643|NCT01241279|65102743|FG001|Overall Study|Lost to Follow-up|1|||
23370644|NCT00313846|65102744|FG000|Overall Study|Withdrawal by Subject|2|||
23370645|NCT00313846|65102745|FG001|Overall Study|Withdrawal by Subject|0|||
23370646|NCT00313846|65102744|FG000|Overall Study|Adverse Event|1|||
23370647|NCT00313846|65102745|FG001|Overall Study|Adverse Event|8|||
23370648|NCT00313846|65102744|FG000|Overall Study|Administrative|2|||
23370649|NCT00313846|65102745|FG001|Overall Study|Administrative|3|||
23370650|NCT00062166|65102748|FG000|Overall Study|Withdrawal by Subject|6|||
23370651|NCT03439137|65102758|FG000|Overall Study|Adverse Event|16|||
23370652|NCT03439137|65102759|FG001|Overall Study|Adverse Event|12|||
23370653|NCT03439137|65102758|FG000|Overall Study|Physician Decision|0|||
23370654|NCT03439137|65102759|FG001|Overall Study|Physician Decision|5|||
23370655|NCT03439137|65102758|FG000|Overall Study|Withdrawal by Subject|14|||
23370656|NCT03439137|65102759|FG001|Overall Study|Withdrawal by Subject|4|||
23370657|NCT03439137|65102758|FG000|Overall Study|Conducting rescue therapy|2|||
23370658|NCT03439137|65102759|FG001|Overall Study|Conducting rescue therapy|1|||
23370659|NCT03439137|65102758|FG000|Overall Study|Difficult to control Hb|10|||
23370660|NCT03439137|65102759|FG001|Overall Study|Difficult to control Hb|2|||
23370661|NCT03439137|65102758|FG000|Overall Study|Initiation of a renal transplant|0|||
23370662|NCT03439137|65102759|FG001|Overall Study|Initiation of a renal transplant|2|||
23370663|NCT01420536|65102760|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
23370664|NCT01420536|65102761|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
23370665|NCT00086190|65102762|FG000|Overall Study|Adverse Event|6|||
23370666|NCT00086190|65102763|FG001|Overall Study|Adverse Event|2|||
23370667|NCT00086190|65102764|FG002|Overall Study|Adverse Event|2|||
23370668|NCT00086190|65102762|FG000|Overall Study|Withdrawal by Subject|0|||
23370669|NCT00086190|65102763|FG001|Overall Study|Withdrawal by Subject|2|||
23370670|NCT00086190|65102764|FG002|Overall Study|Withdrawal by Subject|2|||
23370671|NCT00086190|65102762|FG000|Overall Study|Protocol Violation|1|||
23370672|NCT00086190|65102763|FG001|Overall Study|Protocol Violation|0|||
23370673|NCT00086190|65102764|FG002|Overall Study|Protocol Violation|0|||
23370674|NCT00086190|65102762|FG000|Overall Study|Moved|1|||
23370675|NCT00086190|65102763|FG001|Overall Study|Moved|0|||
23370676|NCT00086190|65102764|FG002|Overall Study|Moved|0|||
23370677|NCT00086190|65102762|FG000|Overall Study|Worsening depression|0|||
23370678|NCT00086190|65102763|FG001|Overall Study|Worsening depression|0|||
23370679|NCT00086190|65102764|FG002|Overall Study|Worsening depression|2|||
23370680|NCT02051296|65102765|FG000|Overall Study|Lost to Follow-up|1|||
23370681|NCT02051296|65102766|FG001|Overall Study|Lost to Follow-up|2|||
23370682|NCT02051296|65102765|FG000|Overall Study|withdraw prior to treatment|7|||
23370683|NCT02051296|65102766|FG001|Overall Study|withdraw prior to treatment|7|||
23370684|NCT00794664|65102768|FG000|Treatment Period|Withdrawal by Subject|0|||
23370685|NCT00794664|65102769|FG001|Treatment Period|Withdrawal by Subject|2|||
23370686|NCT00794664|65102768|FG000|Treatment Period|Protocol non-compliance|0|||
23603465|NCT01787032|65937374|FG001|Overall Study|Protocol Violation|0|||
23370687|NCT00794664|65102769|FG001|Treatment Period|Protocol non-compliance|1|||
23370688|NCT00794664|65102768|FG000|Treatment Period|Other|0|||
23370689|NCT00794664|65102769|FG001|Treatment Period|Other|1|||
23603466|NCT01787032|65937375|FG002|Overall Study|Protocol Violation|0|||
23603467|NCT01787032|65937376|FG003|Overall Study|Protocol Violation|0|||
23370690|NCT00794664|65102768|FG000|Treatment Period|Adverse Event|1|||
23370691|NCT00794664|65102769|FG001|Treatment Period|Adverse Event|8|||
23370692|NCT00794664|65102768|FG000|Follow-up Period|Other|1|||
23370693|NCT00794664|65102769|FG001|Follow-up Period|Other|2|||
23370694|NCT00794664|65102768|FG000|Follow-up Period|Withdrawal by Subject|0|||
23370695|NCT00794664|65102769|FG001|Follow-up Period|Withdrawal by Subject|2|||
23370696|NCT00794664|65102768|FG000|Follow-up Period|Protocol non-compliance|0|||
23370697|NCT00794664|65102769|FG001|Follow-up Period|Protocol non-compliance|1|||
23370698|NCT01677741|65102770|FG000|Overall Study|Death|0|||
23370699|NCT01677741|65102771|FG001|Overall Study|Death|0|||
23370700|NCT01677741|65102772|FG002|Overall Study|Death|0|||
23370701|NCT01677741|65102773|FG003|Overall Study|Death|1|||
23370702|NCT01677741|65102774|FG004|Overall Study|Death|0|||
23370703|NCT01677741|65102775|FG005|Overall Study|Death|1|||
23370704|NCT01677741|65102776|FG006|Overall Study|Death|0|||
23370705|NCT01677741|65102777|FG007|Overall Study|Death|0|||
23370706|NCT01677741|65102770|FG000|Overall Study|Withdrawal by Subject|2|||
23370707|NCT01677741|65102771|FG001|Overall Study|Withdrawal by Subject|7|||
23370708|NCT01677741|65102772|FG002|Overall Study|Withdrawal by Subject|5|||
23370709|NCT01677741|65102773|FG003|Overall Study|Withdrawal by Subject|4|||
23370710|NCT01677741|65102774|FG004|Overall Study|Withdrawal by Subject|11|||
23370711|NCT01677741|65102775|FG005|Overall Study|Withdrawal by Subject|20|||
23370712|NCT01677741|65102776|FG006|Overall Study|Withdrawal by Subject|4|||
23370713|NCT01677741|65102777|FG007|Overall Study|Withdrawal by Subject|2|||
23370714|NCT01677741|65102770|FG000|Overall Study|Enrolled in a rollover study|0|||
23370715|NCT01677741|65102771|FG001|Overall Study|Enrolled in a rollover study|3|||
23370716|NCT01677741|65102772|FG002|Overall Study|Enrolled in a rollover study|2|||
23370717|NCT01677741|65102773|FG003|Overall Study|Enrolled in a rollover study|1|||
23370718|NCT01677741|65102774|FG004|Overall Study|Enrolled in a rollover study|6|||
23370719|NCT01677741|65102775|FG005|Overall Study|Enrolled in a rollover study|6|||
23370720|NCT01677741|65102776|FG006|Overall Study|Enrolled in a rollover study|7|||
23370721|NCT01677741|65102777|FG007|Overall Study|Enrolled in a rollover study|0|||
23370722|NCT01677741|65102770|FG000|Overall Study|Progressive disease|1|||
23370723|NCT01677741|65102771|FG001|Overall Study|Progressive disease|0|||
23370724|NCT01677741|65102772|FG002|Overall Study|Progressive disease|1|||
23370725|NCT01677741|65102773|FG003|Overall Study|Progressive disease|0|||
23370726|NCT01677741|65102774|FG004|Overall Study|Progressive disease|0|||
23370727|NCT01677741|65102775|FG005|Overall Study|Progressive disease|1|||
23370728|NCT01677741|65102776|FG006|Overall Study|Progressive disease|0|||
23370729|NCT01677741|65102777|FG007|Overall Study|Progressive disease|0|||
23370730|NCT00262119|65102784|FG000|Overall Study|Lost to Follow-up|38|||
23370731|NCT00262119|65102785|FG001|Overall Study|Lost to Follow-up|51|||
23370732|NCT00262119|65102786|FG002|Overall Study|Lost to Follow-up|42|||
23370733|NCT00262119|65102784|FG000|Overall Study|Death|20|||
23370734|NCT00262119|65102785|FG001|Overall Study|Death|19|||
23370735|NCT00262119|65102786|FG002|Overall Study|Death|16|||
23370736|NCT02997163|65102787|FG000|Overall Study|Adverse Event|1|||
23370737|NCT02997163|65102788|FG001|Overall Study|Adverse Event|0|||
23370738|NCT02997163|65102789|FG002|Overall Study|Adverse Event|0|||
23370739|NCT02997163|65102790|FG003|Overall Study|Adverse Event|1|||
23370740|NCT03506477|65102803|FG000|Overall Study|Withdrawal by Subject|1|||
23370741|NCT03506477|65102804|FG001|Overall Study|Withdrawal by Subject|0|||
23370742|NCT01867008|65102805|FG000|Overall Study|Withdrawal by Subject|1|||
23370743|NCT00288912|65102807|FG000|Overall Study|Developed exclusion criterion|4|||
23370744|NCT00288912|65102808|FG001|Overall Study|Developed exclusion criterion|6|||
23370745|NCT00288912|65102809|FG002|Overall Study|Developed exclusion criterion|7|||
23370746|NCT00288912|65102807|FG000|Overall Study|Lost to Follow-up|9|||
23370747|NCT00288912|65102808|FG001|Overall Study|Lost to Follow-up|6|||
23370748|NCT00288912|65102809|FG002|Overall Study|Lost to Follow-up|9|||
23370749|NCT00288912|65102807|FG000|Overall Study|Withdrawal by Subject|4|||
23370750|NCT00288912|65102808|FG001|Overall Study|Withdrawal by Subject|5|||
23370751|NCT00288912|65102809|FG002|Overall Study|Withdrawal by Subject|12|||
23370752|NCT01764841|65102814|FG000|Overall Study|Logistical Difficulties|0|||
23370753|NCT01764841|65102815|FG001|Overall Study|Logistical Difficulties|1|||
23370754|NCT01764841|65102816|FG002|Overall Study|Logistical Difficulties|0|||
23370755|NCT01764841|65102817|FG003|Overall Study|Logistical Difficulties|0|||
23370756|NCT01764841|65102814|FG000|Overall Study|Death|3|||
23370757|NCT01764841|65102815|FG001|Overall Study|Death|0|||
23485280|NCT04041700|65521687|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
23485281|NCT02734433|65521688|FG000|Overall Study|Disease progression|1|||
23603468|NCT01787032|65937377|FG004|Overall Study|Protocol Violation|1|||
23370758|NCT01764841|65102816|FG002|Overall Study|Death|1|||
23370759|NCT01764841|65102817|FG003|Overall Study|Death|4|||
23370760|NCT01764841|65102814|FG000|Overall Study|No Follow Up|1|||
23370761|NCT01764841|65102815|FG001|Overall Study|No Follow Up|0|||
23370762|NCT01764841|65102816|FG002|Overall Study|No Follow Up|1|||
23370763|NCT01764841|65102817|FG003|Overall Study|No Follow Up|0|||
23370764|NCT01764841|65102814|FG000|Overall Study|Protocol Violation|0|||
23370765|NCT01764841|65102815|FG001|Overall Study|Protocol Violation|1|||
23370766|NCT01764841|65102816|FG002|Overall Study|Protocol Violation|0|||
23370767|NCT01764841|65102817|FG003|Overall Study|Protocol Violation|0|||
23370768|NCT01764841|65102814|FG000|Overall Study|Withdrawal by Subject|16|||
23370769|NCT01764841|65102815|FG001|Overall Study|Withdrawal by Subject|24|||
23370770|NCT01764841|65102816|FG002|Overall Study|Withdrawal by Subject|11|||
23370771|NCT01764841|65102817|FG003|Overall Study|Withdrawal by Subject|15|||
23370772|NCT01764841|65102814|FG000|Overall Study|Lost to Follow-up|3|||
23370773|NCT01764841|65102815|FG001|Overall Study|Lost to Follow-up|0|||
23370774|NCT01764841|65102816|FG002|Overall Study|Lost to Follow-up|1|||
23370775|NCT01764841|65102817|FG003|Overall Study|Lost to Follow-up|0|||
23370776|NCT03074500|65102818|FG000|Overall Study|Lost to Follow-up|1|||
23370777|NCT03074500|65102819|FG001|Overall Study|Lost to Follow-up|0|||
23370778|NCT03074500|65102820|FG002|Overall Study|Lost to Follow-up|0|||
23370779|NCT03074500|65102818|FG000|Overall Study|Lack of Efficacy|0|||
23370780|NCT03074500|65102819|FG001|Overall Study|Lack of Efficacy|1|||
23370781|NCT03074500|65102820|FG002|Overall Study|Lack of Efficacy|0|||
23370782|NCT03074500|65102818|FG000|Overall Study|Adverse Event|0|||
23370783|NCT03074500|65102819|FG001|Overall Study|Adverse Event|0|||
23370784|NCT03074500|65102820|FG002|Overall Study|Adverse Event|1|||
23370785|NCT00402831|65102821|FG000|Overall Study|Lost to Follow-up|1|||
23370786|NCT00402831|65102822|FG001|Overall Study|Lost to Follow-up|2|||
23370787|NCT00402831|65102821|FG000|Overall Study|Non-compliance with protocol|0|||
23370788|NCT00402831|65102822|FG001|Overall Study|Non-compliance with protocol|1|||
23370789|NCT02696616|65102823|FG000|Overall Study|Adverse Event|0|||
23370790|NCT02696616|65102824|FG001|Overall Study|Adverse Event|1|||
23370791|NCT02696616|65102825|FG002|Overall Study|Adverse Event|0|||
23370792|NCT02696616|65102826|FG003|Overall Study|Adverse Event|0|||
23370793|NCT02696616|65102827|FG004|Overall Study|Adverse Event|0|||
23370794|NCT02696616|65102828|FG005|Overall Study|Adverse Event|0|||
23370795|NCT02696616|65102829|FG006|Overall Study|Adverse Event|0|||
23370796|NCT03435055|65102830|FG000|Screening|Physician Decision|2|||
23370797|NCT03435055|65102830|FG000|Received Intervention|Did not complete nitrous administration|3|||
23370798|NCT01103323|65102831|FG000|Without/Before Drug Switch|Adverse Event|50|||
23370799|NCT01103323|65102832|FG001|Without/Before Drug Switch|Adverse Event|7|||
23370800|NCT01103323|65102831|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
23370801|NCT01103323|65102832|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
23370802|NCT01103323|65102831|FG000|Without/Before Drug Switch|Protocol Violation|2|||
23370803|NCT01103323|65102832|FG001|Without/Before Drug Switch|Protocol Violation|0|||
23370804|NCT01103323|65102831|FG000|Without/Before Drug Switch|Physician Decision|2|||
23370805|NCT01103323|65102832|FG001|Without/Before Drug Switch|Physician Decision|0|||
23370806|NCT01103323|65102831|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
23370807|NCT01103323|65102832|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
23370808|NCT01103323|65102831|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
23370809|NCT01103323|65102832|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
23370810|NCT01103323|65102831|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
23370811|NCT01103323|65102832|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
23370812|NCT00726609|65102841|FG000|Overall Study|Adverse Event|10|||
23370813|NCT00726609|65102841|FG000|Overall Study|Withdrawal by Subject|2|||
23370814|NCT00726609|65102841|FG000|Overall Study|Lack of Efficacy|25|||
23370815|NCT00726609|65102841|FG000|Overall Study|Other|16|||
23370816|NCT00726609|65102841|FG000|Overall Study|Missing|42|||
23370817|NCT00726609|65102841|FG000|Overall Study|Other|3|||
23370818|NCT03933449|65102842|FG000|Overall Study|Adverse Event|6|||
23370819|NCT03933449|65102843|FG001|Overall Study|Adverse Event|4|||
23370820|NCT03933449|65102842|FG000|Overall Study|Death|55|||
23370821|NCT03933449|65102843|FG001|Overall Study|Death|57|||
23370822|NCT03933449|65102842|FG000|Overall Study|Sponsor Decision|1|||
23370823|NCT03933449|65102843|FG001|Overall Study|Sponsor Decision|0|||
23370824|NCT03054428|65102844|FG000|Overall Study|Physician Decision|0|||
23370825|NCT03054428|65102845|FG001|Overall Study|Physician Decision|1|||
23370826|NCT03054428|65102846|FG002|Overall Study|Physician Decision|1|||
23370827|NCT03054428|65102844|FG000|Overall Study|Lack of Efficacy|3|||
23370828|NCT03054428|65102845|FG001|Overall Study|Lack of Efficacy|1|||
23278097|NCT02647944|64758934|FG000|Overall Study|Adverse Event|2|||
23278098|NCT02647944|64758935|FG001|Overall Study|Adverse Event|0|||
23278099|NCT01136174|64758936|FG000|Overall Study|Adverse Event|0|||
23278100|NCT01136174|64758937|FG001|Overall Study|Adverse Event|0|||
23278101|NCT01136174|64758938|FG002|Overall Study|Adverse Event|0|||
23278102|NCT01136174|64758939|FG003|Overall Study|Adverse Event|4|||
23278103|NCT02659150|64758940|FG000|Subject Enrollment|Physician Decision|3|||
23278104|NCT02659150|64758940|FG000|Subject Enrollment|Withdrawal by Subject|2|||
23370829|NCT03054428|65102846|FG002|Overall Study|Lack of Efficacy|0|||
23370830|NCT03054428|65102844|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
23370831|NCT03054428|65102845|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
23370832|NCT03054428|65102846|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
23370833|NCT03054428|65102844|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
23370834|NCT03054428|65102845|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
23370835|NCT03054428|65102846|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
23370836|NCT03054428|65102844|FG000|Overall Study|Transitioned to OLE study|76|||
23370837|NCT03054428|65102845|FG001|Overall Study|Transitioned to OLE study|76|||
23278105|NCT02659150|64758940|FG000|Baseline Imaging|Withdrawal by Subject|1|||
23370838|NCT03054428|65102846|FG002|Overall Study|Transitioned to OLE study|73|||
23370839|NCT03054428|65102844|FG000|Overall Study|Withdrawal by Subject|3|||
23370840|NCT03054428|65102845|FG001|Overall Study|Withdrawal by Subject|2|||
23370841|NCT03054428|65102846|FG002|Overall Study|Withdrawal by Subject|3|||
23370842|NCT03054428|65102844|FG000|Overall Study|Lost to Follow-up|0|||
23370843|NCT03054428|65102845|FG001|Overall Study|Lost to Follow-up|0|||
23370844|NCT03054428|65102846|FG002|Overall Study|Lost to Follow-up|1|||
23370845|NCT03573297|65102847|FG000|Open Label Treatment Period|Adverse Event|67|||
23370846|NCT03573297|65102848|FG001|Open Label Treatment Period|Adverse Event|0|||
23370847|NCT03573297|65102849|FG002|Open Label Treatment Period|Adverse Event|0|||
23370848|NCT03573297|65102850|FG003|Open Label Treatment Period|Adverse Event|0|||
23370849|NCT03573297|65102847|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
23370850|NCT03573297|65102848|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
23370851|NCT03573297|65102849|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
23278106|NCT02659150|64758940|FG000|Baseline Imaging|Physician Decision|1|||
23278107|NCT02659150|64758940|FG000|Study Drug Dosing|Adverse Event|1|||
23278108|NCT00147498|64758941|FG000|Overall Study|Adverse Event|1|||
23278109|NCT00147498|64758942|FG001|Overall Study|Adverse Event|6|||
23278110|NCT00147498|64758943|FG002|Overall Study|Adverse Event|7|||
23278111|NCT00147498|64758944|FG003|Overall Study|Adverse Event|3|||
23278112|NCT00147498|64758941|FG000|Overall Study|Lack of Efficacy|1|||
23278113|NCT00147498|64758942|FG001|Overall Study|Lack of Efficacy|1|||
23278114|NCT00147498|64758943|FG002|Overall Study|Lack of Efficacy|1|||
23278115|NCT00147498|64758944|FG003|Overall Study|Lack of Efficacy|8|||
23278116|NCT00147498|64758941|FG000|Overall Study|Laboratory abnormality|0|||
23278117|NCT00147498|64758942|FG001|Overall Study|Laboratory abnormality|0|||
23278118|NCT00147498|64758943|FG002|Overall Study|Laboratory abnormality|2|||
23278119|NCT00147498|64758944|FG003|Overall Study|Laboratory abnormality|0|||
23278120|NCT00147498|64758941|FG000|Overall Study|Participant defaulted|0|||
23278121|NCT00147498|64758942|FG001|Overall Study|Participant defaulted|1|||
23278122|NCT00147498|64758943|FG002|Overall Study|Participant defaulted|4|||
23278123|NCT00147498|64758944|FG003|Overall Study|Participant defaulted|3|||
23278124|NCT00147498|64758941|FG000|Overall Study|Other|1|||
23278125|NCT00147498|64758942|FG001|Overall Study|Other|1|||
23278126|NCT00147498|64758943|FG002|Overall Study|Other|3|||
23278127|NCT00147498|64758944|FG003|Overall Study|Other|3|||
23278128|NCT01768858|64758947|FG000|Overall Study|Lost to Follow-up|9|||
23278129|NCT01768858|64758947|FG000|Overall Study|Lack of Efficacy|8|||
23370852|NCT03573297|65102850|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
23485282|NCT02734433|65521689|FG001|Overall Study|Disease progression|5|||
23485283|NCT02734433|65521688|FG000|Overall Study|Clinical progression|0|||
23485284|NCT02734433|65521689|FG001|Overall Study|Clinical progression|1|||
23485285|NCT02734433|65521688|FG000|Overall Study|Withdrawal by Subject|1|||
23485286|NCT02734433|65521689|FG001|Overall Study|Withdrawal by Subject|2|||
23485287|NCT03055858|65521693|FG000|Overall Study|Death|9|||
23485288|NCT03055858|65521693|FG000|Overall Study|Withdrawal by Subject|11|||
23485289|NCT03055858|65521693|FG000|Overall Study|Lost to Follow-up|6|||
23485290|NCT03055858|65521693|FG000|Overall Study|Missed Follow-Up Visits|18|||
23485291|NCT00589784|65521694|FG000|Overall Study|Withdrawal by Subject|0|||
23485292|NCT00589784|65521695|FG001|Overall Study|Withdrawal by Subject|6|||
23485293|NCT00589784|65521694|FG000|Overall Study|Patient inevaluable|1|||
23485294|NCT00589784|65521695|FG001|Overall Study|Patient inevaluable|0|||
23485295|NCT00589784|65521694|FG000|Overall Study|Adverse Event|0|||
23485296|NCT00589784|65521695|FG001|Overall Study|Adverse Event|4|||
23485297|NCT01920555|65521698|FG000|Overall Study|Physician Decision|1|||
23485298|NCT01920555|65521699|FG001|Overall Study|Physician Decision|2|||
23485299|NCT01920555|65521700|FG002|Overall Study|Physician Decision|1|||
23485300|NCT01920555|65521701|FG003|Overall Study|Physician Decision|2|||
23485301|NCT01920555|65521702|FG004|Overall Study|Physician Decision|0|||
23485302|NCT01920555|65521698|FG000|Overall Study|Lack of Efficacy|2|||
23485303|NCT01920555|65521699|FG001|Overall Study|Lack of Efficacy|0|||
23485304|NCT01920555|65521700|FG002|Overall Study|Lack of Efficacy|0|||
23278130|NCT01768858|64758947|FG000|Overall Study|Serious Adverse Event|1|||
23278131|NCT01768858|64758947|FG000|Overall Study|Participant moved to Germany|1|||
23278132|NCT01768858|64758947|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
23278133|NCT01768858|64758947|FG000|Overall Study|Exanthema|1|||
23278134|NCT01768858|64758947|FG000|Overall Study|Withdrawal by Subject|1|||
23370853|NCT03573297|65102847|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
23485305|NCT01920555|65521701|FG003|Overall Study|Lack of Efficacy|0|||
23485306|NCT01920555|65521702|FG004|Overall Study|Lack of Efficacy|0|||
23485307|NCT01920555|65521698|FG000|Overall Study|Travel Difficulties|1|||
23485308|NCT01920555|65521699|FG001|Overall Study|Travel Difficulties|1|||
23278135|NCT05652140|64758948|FG000|Overall Study|Lost to Follow-up|7|||
23278136|NCT05652140|64758949|FG001|Overall Study|Lost to Follow-up|16|||
23278137|NCT05652140|64758950|FG002|Overall Study|Lost to Follow-up|22|||
23278138|NCT05652140|64758951|FG003|Overall Study|Lost to Follow-up|31|||
23485309|NCT01920555|65521700|FG002|Overall Study|Travel Difficulties|0|||
23485310|NCT01920555|65521701|FG003|Overall Study|Travel Difficulties|0|||
23370854|NCT03573297|65102848|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
23370855|NCT03573297|65102849|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
23370856|NCT03573297|65102850|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
23370857|NCT03573297|65102847|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
23370858|NCT03573297|65102848|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
23370859|NCT03573297|65102849|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
23370860|NCT03573297|65102850|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
23370861|NCT03573297|65102847|FG000|Open Label Treatment Period|Pregnancy|1|||
23370862|NCT03573297|65102848|FG001|Open Label Treatment Period|Pregnancy|0|||
23370863|NCT03573297|65102849|FG002|Open Label Treatment Period|Pregnancy|0|||
23370864|NCT03573297|65102850|FG003|Open Label Treatment Period|Pregnancy|0|||
23370865|NCT03573297|65102847|FG000|Open Label Treatment Period|Protocol Violation|17|||
23370866|NCT03573297|65102848|FG001|Open Label Treatment Period|Protocol Violation|0|||
23370867|NCT03573297|65102849|FG002|Open Label Treatment Period|Protocol Violation|0|||
23370868|NCT03573297|65102850|FG003|Open Label Treatment Period|Protocol Violation|0|||
23370869|NCT03573297|65102847|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
23370870|NCT03573297|65102848|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
23370871|NCT03573297|65102849|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
23370872|NCT03573297|65102850|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
23370873|NCT03573297|65102847|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
23370874|NCT03573297|65102848|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
23370875|NCT03573297|65102849|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
23370876|NCT03573297|65102850|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
23370877|NCT03573297|65102847|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
23370878|NCT03573297|65102848|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
23370879|NCT03573297|65102849|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
23370880|NCT03573297|65102850|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
23370881|NCT03573297|65102847|FG000|Open Label Treatment Period|Other, Not Specified|7|||
23370882|NCT03573297|65102848|FG001|Open Label Treatment Period|Other, Not Specified|0|||
23370883|NCT03573297|65102849|FG002|Open Label Treatment Period|Other, Not Specified|0|||
23370884|NCT03573297|65102850|FG003|Open Label Treatment Period|Other, Not Specified|0|||
23370885|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
23370886|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
23370887|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
23370888|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
23370889|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23370890|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23370891|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Adverse Event|5|||
23370892|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Adverse Event|1|||
23370893|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23370894|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
23370895|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
23370896|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
23370897|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23370898|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
23370899|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
23370900|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
23370901|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
23370902|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
23370903|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
23370904|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
23370905|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
23370906|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
23370907|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
23370908|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
23370909|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
23370910|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
23370911|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
23370912|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
23370913|NCT03573297|65102847|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
23370914|NCT03573297|65102848|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
23370915|NCT03573297|65102849|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
23370916|NCT03573297|65102850|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
23370917|NCT01405560|65102856|FG000|Overall Study|Physician Decision|1|||
23370918|NCT00266708|65102857|FG000|Overall Study|No renal function|1|||
23370919|NCT00266708|65102858|FG001|Overall Study|No renal function|1|||
23370920|NCT00266708|65102857|FG000|Overall Study|Refused biopsy|3|||
23278139|NCT00436163|64758952|FG000|Overall Study|Lost to Follow-up|2|||
23278140|NCT00436163|64758952|FG000|Overall Study|Adverse Event|1|||
23278141|NCT01149473|64758956|FG000|First Intervention|Adverse Event|1|||
23278142|NCT01149473|64758957|FG001|First Intervention|Adverse Event|1|||
23278143|NCT01149473|64758956|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23278144|NCT01149473|64758957|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23278145|NCT01954394|64758958|FG000|Overall Study|Enrolled but not treated|1|||
23278146|NCT01954394|64758959|FG001|Overall Study|Enrolled but not treated|0|||
23278147|NCT01954394|64758958|FG000|Overall Study|Adverse Event|10|||
23278148|NCT01954394|64758959|FG001|Overall Study|Adverse Event|23|||
23278149|NCT01954394|64758958|FG000|Overall Study|Poor compliance to protocol|7|||
23278150|NCT01954394|64758959|FG001|Overall Study|Poor compliance to protocol|7|||
23278151|NCT01954394|64758958|FG000|Overall Study|Participant Moved|0|||
23278152|NCT01954394|64758959|FG001|Overall Study|Participant Moved|4|||
23278153|NCT01954394|64758958|FG000|Overall Study|Related to Study Drug administration|2|||
23278154|NCT01954394|64758959|FG001|Overall Study|Related to Study Drug administration|2|||
23278155|NCT01954394|64758958|FG000|Overall Study|Other than specified above|10|||
23278156|NCT01954394|64758959|FG001|Overall Study|Other than specified above|21|||
23278157|NCT01566721|64758960|FG000|Treatment Period|Withdrawal by Subject|35|||
23278158|NCT01566721|64758961|FG001|Treatment Period|Withdrawal by Subject|9|||
23278159|NCT01566721|64758960|FG000|Treatment Period|Disease Progression/Recurrence|37|||
23278160|NCT01566721|64758961|FG001|Treatment Period|Disease Progression/Recurrence|13|||
23278161|NCT01566721|64758960|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
23278162|NCT01566721|64758961|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
23278163|NCT01566721|64758960|FG000|Treatment Period|Other|13|||
23278164|NCT01566721|64758961|FG001|Treatment Period|Other|2|||
23278165|NCT01566721|64758960|FG000|Treatment Period|Lack of Compliance|5|||
23278166|NCT01566721|64758961|FG001|Treatment Period|Lack of Compliance|1|||
23278167|NCT01566721|64758960|FG000|Treatment Period|Adverse Event|100|||
23278168|NCT01566721|64758961|FG001|Treatment Period|Adverse Event|30|||
23278169|NCT01566721|64758960|FG000|Treatment Period|Pregnancy|1|||
23278170|NCT01566721|64758961|FG001|Treatment Period|Pregnancy|0|||
23278171|NCT01566721|64758960|FG000|Safety Follow-up|Physician Decision|6|||
23278172|NCT01566721|64758961|FG001|Safety Follow-up|Physician Decision|4|||
23278173|NCT01566721|64758960|FG000|Safety Follow-up|Lost to Follow-up|101|||
23278174|NCT01566721|64758961|FG001|Safety Follow-up|Lost to Follow-up|48|||
23278175|NCT01566721|64758960|FG000|Safety Follow-up|Withdrawal by Subject|155|||
23278176|NCT01566721|64758961|FG001|Safety Follow-up|Withdrawal by Subject|49|||
23278177|NCT01566721|64758960|FG000|Safety Follow-up|Death|28|||
23278178|NCT01566721|64758961|FG001|Safety Follow-up|Death|4|||
23278179|NCT01566721|64758960|FG000|Safety Follow-up|Non-compliance|7|||
23278180|NCT01566721|64758961|FG001|Safety Follow-up|Non-compliance|3|||
23278181|NCT01566721|64758960|FG000|Safety Follow-up|Protocol Violation|7|||
23278182|NCT01566721|64758961|FG001|Safety Follow-up|Protocol Violation|0|||
23278183|NCT01566721|64758960|FG000|Safety Follow-up|Site closure|2|||
23278184|NCT01566721|64758961|FG001|Safety Follow-up|Site closure|3|||
23278185|NCT01566721|64758960|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
23278186|NCT01566721|64758961|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
23278187|NCT01566721|64758960|FG000|Safety Follow-up|Missing|7|||
23278188|NCT01566721|64758961|FG001|Safety Follow-up|Missing|2|||
23278189|NCT01566721|64758960|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
23278190|NCT01566721|64758961|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
23278191|NCT01566721|64758960|FG000|Safety Follow-up|Sponsor decision|1|||
23278192|NCT01566721|64758961|FG001|Safety Follow-up|Sponsor decision|0|||
23278193|NCT01566721|64758960|FG000|Safety Follow-up|Adverse Event|8|||
23278194|NCT01566721|64758961|FG001|Safety Follow-up|Adverse Event|4|||
23278195|NCT05327491|64758962|FG000|Periods 1 & 2|Miscellaneous|0|||
23370921|NCT00266708|65102858|FG001|Overall Study|Refused biopsy|6|||
23603469|NCT01787032|65937378|FG005|Overall Study|Protocol Violation|1|||
23278196|NCT05327491|64758963|FG001|Periods 1 & 2|Miscellaneous|1|||
23370922|NCT00266708|65102857|FG000|Overall Study|Asthma|0|||
23370923|NCT00266708|65102858|FG001|Overall Study|Asthma|2|||
23370924|NCT01408706|65102859|FG000|Overall Study|Physician Decision|1|||
23370925|NCT01408706|65102860|FG001|Overall Study|Physician Decision|0|||
23370926|NCT01387269|65102861|FG000|Overall Study|Death|38|||
23370927|NCT01387269|65102862|FG001|Overall Study|Death|20|||
23370928|NCT01387269|65102861|FG000|Overall Study|Other|8|||
23370929|NCT01387269|65102862|FG001|Overall Study|Other|7|||
23370930|NCT01387269|65102861|FG000|Overall Study|Unrelated AE|12|||
23370931|NCT01387269|65102862|FG001|Overall Study|Unrelated AE|3|||
23370932|NCT01387269|65102861|FG000|Overall Study|Withdrawal by patient|32|||
23370933|NCT01387269|65102862|FG001|Overall Study|Withdrawal by patient|10|||
23370934|NCT01387269|65102861|FG000|Overall Study|Study drug-related AE|1|||
23370935|NCT01387269|65102862|FG001|Overall Study|Study drug-related AE|0|||
23370936|NCT01387269|65102861|FG000|Overall Study|Lost to Follow-up|1|||
23370937|NCT01387269|65102862|FG001|Overall Study|Lost to Follow-up|0|||
23370938|NCT03122171|65102863|FG000|Overall Study|Withdrawal by Subject|1|||
23370939|NCT04076917|65102864|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
23370940|NCT04076917|65102864|FG000|Overall Study|Study closure|13|||
23370941|NCT04076917|65102864|FG000|Overall Study|Physician Decision|3|||
23370942|NCT04076917|65102864|FG000|Overall Study|Death|1|||
23370943|NCT04076917|65102864|FG000|Overall Study|Lost to Follow-up|1|||
23370944|NCT04076917|65102864|FG000|Overall Study|Withdrawal by Subject|1|||
23370945|NCT04076917|65102864|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
23370946|NCT00183430|65102865|FG000|Overall Study|Adverse Event|1|||
23370947|NCT00183430|65102866|FG001|Overall Study|Adverse Event|0|||
23370948|NCT00183430|65102865|FG000|Overall Study|Lost to Follow-up|3|||
23370949|NCT00183430|65102866|FG001|Overall Study|Lost to Follow-up|0|||
23370950|NCT00183430|65102865|FG000|Overall Study|did not meet inclusion criteria|1|||
23370951|NCT00183430|65102866|FG001|Overall Study|did not meet inclusion criteria|0|||
23370952|NCT00183430|65102865|FG000|Overall Study|Withdrawal by Subject|1|||
23370953|NCT00183430|65102866|FG001|Overall Study|Withdrawal by Subject|0|||
23370954|NCT01302899|65102869|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
23370955|NCT01302899|65102870|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
23370956|NCT01302899|65102869|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
23370957|NCT01302899|65102870|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
23370958|NCT00830128|65102871|FG000|Overall Study|Adverse Event|5|||
23370959|NCT00830128|65102871|FG000|Overall Study|Lack of Efficacy|7|||
23370960|NCT00830128|65102871|FG000|Overall Study|Protocol Violation|1|||
23370961|NCT00830128|65102871|FG000|Overall Study|Withdrawal by Subject|2|||
23370962|NCT00830128|65102871|FG000|Overall Study|Family obligation|1|||
23370963|NCT00830128|65102871|FG000|Overall Study|Relocation|1|||
23370964|NCT00830128|65102871|FG000|Overall Study|Work obligation|1|||
23370965|NCT00830128|65102871|FG000|Overall Study|Operating a vehicle|1|||
23370966|NCT03257436|65102872|FG000|Overall Study|Withdrawal by Subject|76|||
23370967|NCT03257436|65102872|FG000|Overall Study|Death|19|||
23370968|NCT02204917|65102873|FG000|Overall Study|Protocol Violation|1|||
23370969|NCT00721799|65102874|FG000|Overall Study|Withdrawal by Subject|7|||
23370970|NCT00721799|65102874|FG000|Overall Study|withdraw by subject after scan 1|1|||
23370971|NCT01914393|65102875|FG000|Overall Study|Protocol Violation|11|||
23370972|NCT01914393|65102876|FG001|Overall Study|Protocol Violation|3|||
23370973|NCT01914393|65102877|FG002|Overall Study|Protocol Violation|19|||
23370974|NCT01914393|65102875|FG000|Overall Study|Lack of Efficacy|11|||
23370975|NCT01914393|65102876|FG001|Overall Study|Lack of Efficacy|16|||
23370976|NCT01914393|65102877|FG002|Overall Study|Lack of Efficacy|5|||
23370977|NCT01914393|65102875|FG000|Overall Study|no reason given|14|||
23370978|NCT01914393|65102876|FG001|Overall Study|no reason given|8|||
23370979|NCT01914393|65102877|FG002|Overall Study|no reason given|16|||
23370980|NCT01914393|65102875|FG000|Overall Study|Adverse Event|29|||
23370981|NCT01914393|65102876|FG001|Overall Study|Adverse Event|18|||
23370982|NCT01914393|65102877|FG002|Overall Study|Adverse Event|31|||
23370983|NCT01914393|65102875|FG000|Overall Study|Withdrawal by Subject|38|||
23370984|NCT01914393|65102876|FG001|Overall Study|Withdrawal by Subject|20|||
23370985|NCT01914393|65102877|FG002|Overall Study|Withdrawal by Subject|47|||
23370986|NCT01914393|65102875|FG000|Overall Study|Lost to Follow-up|12|||
23370987|NCT01914393|65102876|FG001|Overall Study|Lost to Follow-up|6|||
23370988|NCT01914393|65102877|FG002|Overall Study|Lost to Follow-up|19|||
23370989|NCT01914393|65102875|FG000|Overall Study|subject never dosed|0|||
23370990|NCT01914393|65102876|FG001|Overall Study|subject never dosed|0|||
23370991|NCT01914393|65102877|FG002|Overall Study|subject never dosed|1|||
23370992|NCT01287936|65102878|FG000|Overall Study|Lost to Follow-up|0|||
23370993|NCT01287936|65102879|FG001|Overall Study|Lost to Follow-up|1|||
23370994|NCT01287936|65102880|FG002|Overall Study|Lost to Follow-up|1|||
23370995|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
23370996|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
23370997|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
23370998|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
23370999|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
23371000|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
23371001|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
23371002|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
23371003|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
23371004|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
23371005|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
23371006|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
23371007|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
23371008|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
23371009|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
23371010|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
23371011|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
23371012|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
23371013|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
23371014|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
23371015|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
23371016|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
23371017|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
23278197|NCT05327491|64758964|FG002|Periods 1 & 2|Miscellaneous|0|||
23278198|NCT05327491|64758965|FG003|Periods 1 & 2|Miscellaneous|0|||
23371018|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
23371019|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
23371020|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
23278199|NCT05327491|64758962|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
23278200|NCT05327491|64758963|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
23278201|NCT05327491|64758964|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
23371021|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
23371022|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
23371023|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
23371024|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
23371025|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
23371026|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
23371027|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
23371028|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
23485311|NCT01920555|65521702|FG004|Overall Study|Travel Difficulties|1|||
23278202|NCT05327491|64758965|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
23278203|NCT01702987|64758966|FG000|Overall Study|Withdrawal by Subject|1|||
23278204|NCT01702987|64758967|FG001|Overall Study|Withdrawal by Subject|0|||
23278205|NCT02682784|64758968|FG000|Overall Study|Withdrawal by Subject|0|||
23278206|NCT02682784|64758969|FG001|Overall Study|Withdrawal by Subject|2|||
23278207|NCT02682784|64758970|FG002|Overall Study|Withdrawal by Subject|1|||
23278208|NCT02682784|64758971|FG003|Overall Study|Withdrawal by Subject|2|||
23278209|NCT02682784|64758968|FG000|Overall Study|Physician Decision|1|||
23485312|NCT01920555|65521698|FG000|Overall Study|Lost to Follow-up|0|||
23485313|NCT01920555|65521699|FG001|Overall Study|Lost to Follow-up|1|||
23485314|NCT01920555|65521700|FG002|Overall Study|Lost to Follow-up|0|||
23485315|NCT01920555|65521701|FG003|Overall Study|Lost to Follow-up|1|||
23485316|NCT01920555|65521702|FG004|Overall Study|Lost to Follow-up|0|||
23485317|NCT00900601|65521706|FG000|Overall Study|Physician Decision|1|||
23485318|NCT03350984|65521707|FG000|Overall Study|Death|1|||
23485319|NCT03350984|65521708|FG001|Overall Study|Death|0|||
23485320|NCT03350984|65521707|FG000|Overall Study|Lost to Follow-up|5|||
23485321|NCT03350984|65521708|FG001|Overall Study|Lost to Follow-up|6|||
23485322|NCT03350984|65521707|FG000|Overall Study|Protocol Violation|1|||
23485323|NCT03350984|65521708|FG001|Overall Study|Protocol Violation|2|||
23485324|NCT03350984|65521707|FG000|Overall Study|Physician Decision|1|||
23485325|NCT03350984|65521708|FG001|Overall Study|Physician Decision|0|||
23485326|NCT00381381|65521711|FG000|Overall Study|Adverse Event|3|||
23485327|NCT00381381|65521711|FG000|Overall Study|Lost to Follow-up|52|||
23603470|NCT00071799|65937379|FG000|Overall Study|Adverse Event|19|||
23603471|NCT00071799|65937380|FG001|Overall Study|Adverse Event|10|||
23278210|NCT02682784|64758969|FG001|Overall Study|Physician Decision|0|||
23603472|NCT00071799|65937379|FG000|Overall Study|Protocol Violation|1|||
23603473|NCT00071799|65937380|FG001|Overall Study|Protocol Violation|7|||
23603474|NCT00071799|65937379|FG000|Overall Study|Lost to Follow-up|1|||
23278211|NCT02682784|64758970|FG002|Overall Study|Physician Decision|1|||
23278212|NCT02682784|64758971|FG003|Overall Study|Physician Decision|1|||
23278213|NCT04123548|64758974|FG000|Overall Study|Withdrawal by Subject|1|||
23485328|NCT00381381|65521711|FG000|Overall Study|Withdrawal by Subject|9|||
23603475|NCT00071799|65937380|FG001|Overall Study|Lost to Follow-up|1|||
23603476|NCT00071799|65937379|FG000|Overall Study|Withdrawal by Subject|15|||
23371029|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
23371030|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
23371031|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
23485329|NCT02180724|65521712|FG000|Overall Study|Death|26|||
23485330|NCT02180724|65521713|FG001|Overall Study|Death|1|||
23371032|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
23371033|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
23371034|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
23603477|NCT00071799|65937380|FG001|Overall Study|Withdrawal by Subject|37|||
23603478|NCT00071799|65937379|FG000|Overall Study|Physician Decision|0|||
23603479|NCT00071799|65937380|FG001|Overall Study|Physician Decision|2|||
23603480|NCT00071799|65937379|FG000|Overall Study|Lack of Efficacy|11|||
23603481|NCT00071799|65937380|FG001|Overall Study|Lack of Efficacy|18|||
23603482|NCT00071799|65937379|FG000|Overall Study|Disease Progression|23|||
23603483|NCT00071799|65937380|FG001|Overall Study|Disease Progression|20|||
23603484|NCT00071799|65937379|FG000|Overall Study|Different Central+Local Pathology Review|0|||
23603485|NCT00071799|65937380|FG001|Overall Study|Different Central+Local Pathology Review|1|||
23603486|NCT00071799|65937379|FG000|Overall Study|Not Documented|0|||
23603487|NCT00071799|65937380|FG001|Overall Study|Not Documented|2|||
23603488|NCT03244800|65937381|FG000|Overall Study|Adverse Event|0|||
23603489|NCT03244800|65937382|FG001|Overall Study|Adverse Event|1|||
23603490|NCT03244800|65937383|FG002|Overall Study|Adverse Event|0|||
23603491|NCT03244800|65937384|FG003|Overall Study|Adverse Event|1|||
23603492|NCT03244800|65937381|FG000|Overall Study|Withdrew treatment|0|||
23603493|NCT03244800|65937382|FG001|Overall Study|Withdrew treatment|0|||
23603494|NCT03244800|65937383|FG002|Overall Study|Withdrew treatment|0|||
23603495|NCT03244800|65937384|FG003|Overall Study|Withdrew treatment|1|||
23485331|NCT02180724|65521712|FG000|Overall Study|Lost to Follow-up|3|||
23485332|NCT02180724|65521713|FG001|Overall Study|Lost to Follow-up|1|||
23485333|NCT02180724|65521712|FG000|Overall Study|Withdrawal by Subject|4|||
23485334|NCT02180724|65521713|FG001|Overall Study|Withdrawal by Subject|2|||
23485335|NCT02180724|65521712|FG000|Overall Study|PI Decision|5|||
23485336|NCT02180724|65521713|FG001|Overall Study|PI Decision|2|||
23485337|NCT02180724|65521712|FG000|Overall Study|Study terminated by sponsor|54|||
23485338|NCT02180724|65521713|FG001|Overall Study|Study terminated by sponsor|8|||
23485339|NCT03026088|65521714|FG000|Overall Study|Study termination|20|||
23485340|NCT01280955|65521715|FG000|Overall Study|Death|2|||
23371035|NCT02709746|65102881|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
23371036|NCT02709746|65102882|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
23371037|NCT02709746|65102883|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
23371038|NCT02709746|65102884|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
23371039|NCT02709746|65102885|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
23371040|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
23371041|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
23371042|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
23371043|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
23485341|NCT01280955|65521715|FG000|Overall Study|Withdrawal by Subject|1|||
23485342|NCT02480712|65521718|FG000|Overall Study|Enrolled but Never Treated|1|||
23485343|NCT02480712|65521718|FG000|Overall Study|Lost to Follow-up|5|||
23485344|NCT02480712|65521718|FG000|Overall Study|Withdrew Consent|3|||
23485345|NCT02480712|65521718|FG000|Overall Study|Death|1|||
23485346|NCT02480712|65521718|FG000|Overall Study|Lack of Efficacy|1|||
23485347|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
23485348|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
23485349|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
23485350|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
23485351|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
23485352|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
23485353|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485354|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
23485355|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485356|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485357|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485358|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
23485359|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
23603496|NCT02255474|65937385|FG000|Overall Study|Lost to Follow-up|1|||
23278214|NCT04123548|64758974|FG000|Overall Study|Lost to Follow-up|8|||
23278215|NCT04123548|64758974|FG000|Overall Study|Death|4|||
23278216|NCT04123548|64758974|FG000|Overall Study|Reason Not Specified|1|||
23278217|NCT00579345|64758979|FG000|Overall Study|Withdrawal by Subject|2|||
23278218|NCT00579345|64758980|FG001|Overall Study|Withdrawal by Subject|0|||
23278219|NCT00579345|64758981|FG002|Overall Study|Withdrawal by Subject|0|||
23278220|NCT00579345|64758982|FG003|Overall Study|Withdrawal by Subject|0|||
23371044|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
23371045|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
23278221|NCT00579345|64758983|FG004|Overall Study|Withdrawal by Subject|0|||
23278222|NCT00579345|64758984|FG005|Overall Study|Withdrawal by Subject|0|||
23278223|NCT00579345|64758985|FG006|Overall Study|Withdrawal by Subject|0|||
23278224|NCT00579345|64758986|FG007|Overall Study|Withdrawal by Subject|1|||
23278225|NCT00579345|64758979|FG000|Overall Study|Lost to Follow-up|1|||
23278226|NCT00579345|64758980|FG001|Overall Study|Lost to Follow-up|0|||
23485360|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
23485361|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
23485362|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
23485363|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
23485364|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
23485365|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23485366|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
23485367|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23485368|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23485369|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23485370|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
23603497|NCT02255474|65937386|FG001|Overall Study|Lost to Follow-up|1|||
23603498|NCT02255474|65937387|FG002|Overall Study|Lost to Follow-up|3|||
23485371|NCT00745615|65521730|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485372|NCT00745615|65521731|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
23485373|NCT00745615|65521732|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485374|NCT00745615|65521733|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485375|NCT00745615|65521734|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485376|NCT00745615|65521735|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
23485377|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
23485378|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
23485379|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
23485380|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
23485381|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
23485382|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
23485383|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
23485384|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
23485385|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
23485386|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
23485387|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
23485388|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
23485389|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
23485390|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
23485391|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
23485392|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
23485393|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
23485394|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
23485395|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
23485396|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
23485397|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
23485398|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
23485399|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
23485400|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
23485401|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
23485402|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
23485403|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
23485404|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
23485405|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
23485406|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
23485407|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
23485408|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
23485409|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
23485410|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
23485411|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
23485412|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
23485413|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485414|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485415|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485416|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485417|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
23485418|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
23485419|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485420|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485421|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485422|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485423|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
23485424|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
23485425|NCT00745615|65521730|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
23485426|NCT00745615|65521731|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
23278227|NCT00579345|64758981|FG002|Overall Study|Lost to Follow-up|0|||
23278228|NCT00579345|64758982|FG003|Overall Study|Lost to Follow-up|0|||
23278229|NCT00579345|64758983|FG004|Overall Study|Lost to Follow-up|0|||
23278230|NCT00579345|64758984|FG005|Overall Study|Lost to Follow-up|0|||
23278231|NCT00579345|64758985|FG006|Overall Study|Lost to Follow-up|0|||
23278232|NCT00579345|64758986|FG007|Overall Study|Lost to Follow-up|0|||
23278233|NCT00579345|64758979|FG000|Overall Study|Adverse Event|0|||
23278234|NCT00579345|64758980|FG001|Overall Study|Adverse Event|0|||
23485427|NCT00745615|65521732|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
23278235|NCT00579345|64758981|FG002|Overall Study|Adverse Event|1|||
23371046|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
23485428|NCT00745615|65521733|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
23485429|NCT00745615|65521734|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
23485430|NCT00745615|65521735|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
23485431|NCT02581943|65521740|FG000|Overall Study|Death|5|||
23485432|NCT02581943|65521741|FG001|Overall Study|Death|2|||
23485433|NCT02581943|65521740|FG000|Overall Study|Disease Progression|12|||
23485434|NCT02581943|65521741|FG001|Overall Study|Disease Progression|15|||
23485435|NCT02581943|65521740|FG000|Overall Study|Withdrawal by Subject|1|||
23485436|NCT02581943|65521741|FG001|Overall Study|Withdrawal by Subject|2|||
23485437|NCT02605837|65521742|FG000|Overall Study|Adverse Event|3|||
23485438|NCT02605837|65521743|FG001|Overall Study|Adverse Event|1|||
23485439|NCT02605837|65521742|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23485440|NCT02605837|65521743|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23278236|NCT00579345|64758982|FG003|Overall Study|Adverse Event|0|||
23485441|NCT02605837|65521742|FG000|Overall Study|Withdrawal by Subject|8|||
23485442|NCT02605837|65521743|FG001|Overall Study|Withdrawal by Subject|8|||
23485443|NCT02605837|65521742|FG000|Overall Study|Physician Decision|0|||
23485444|NCT02605837|65521743|FG001|Overall Study|Physician Decision|1|||
23485445|NCT05867342|65521746|FG000|Overall Study|Investigator Decision|3|||
23485446|NCT05867342|65521747|FG001|Overall Study|Investigator Decision|3|||
23485447|NCT00450112|65521748|FG000|Overall Study|Other Treatment Required|5|||
23485448|NCT00450112|65521749|FG001|Overall Study|Other Treatment Required|1|||
23485449|NCT00450112|65521748|FG000|Overall Study|Withdrawal by Subject|4|||
23485450|NCT00450112|65521749|FG001|Overall Study|Withdrawal by Subject|1|||
23485451|NCT00450112|65521748|FG000|Overall Study|Lost to Follow-up|2|||
23485452|NCT00450112|65521749|FG001|Overall Study|Lost to Follow-up|1|||
23485453|NCT00450112|65521748|FG000|Overall Study|Others|2|||
23485454|NCT00450112|65521749|FG001|Overall Study|Others|3|||
23485455|NCT01076075|65521750|FG000|Overall Study|Adverse Event|3|||
23485456|NCT01076075|65521751|FG001|Overall Study|Adverse Event|9|||
23485457|NCT01076075|65521750|FG000|Overall Study|Lack of Efficacy|5|||
23485458|NCT01076075|65521751|FG001|Overall Study|Lack of Efficacy|4|||
23485459|NCT01076075|65521750|FG000|Overall Study|Lost to Follow-up|6|||
23485460|NCT01076075|65521751|FG001|Overall Study|Lost to Follow-up|5|||
23485461|NCT01076075|65521750|FG000|Overall Study|other|19|||
23485462|NCT01076075|65521751|FG001|Overall Study|other|9|||
23485463|NCT01076075|65521750|FG000|Overall Study|Protocol Violation|0|||
23485464|NCT01076075|65521751|FG001|Overall Study|Protocol Violation|1|||
23485465|NCT01076075|65521750|FG000|Overall Study|Withdrawal by Subject|8|||
23485466|NCT01076075|65521751|FG001|Overall Study|Withdrawal by Subject|19|||
23485467|NCT04618770|65521752|FG000|Overall Study|Censored from Analysis|12|||
23485468|NCT04618770|65521752|FG000|Overall Study|Early Termination|25|||
23485469|NCT01721577|65521758|FG000|Overall Study|Lack of Efficacy|1|||
23485470|NCT01721577|65521759|FG001|Overall Study|Lack of Efficacy|0|||
23485471|NCT01721577|65521758|FG000|Overall Study|Death|1|||
23485472|NCT01721577|65521759|FG001|Overall Study|Death|0|||
23485473|NCT01721577|65521758|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
23485474|NCT01721577|65521759|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
23485475|NCT01721577|65521758|FG000|Overall Study|Adverse Event|0|||
23485476|NCT01721577|65521759|FG001|Overall Study|Adverse Event|2|||
23485477|NCT00608543|65521760|FG000|Overall Study|Adverse Event|4|||
23485478|NCT01007253|65521765|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
23485479|NCT01007253|65521766|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
23485480|NCT01007253|65521767|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
23485481|NCT01007253|65521768|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
23485482|NCT00117286|65521776|FG000|Overall Study|Adverse Event|12|||
23485483|NCT00117286|65521777|FG001|Overall Study|Adverse Event|6|||
23485484|NCT00117286|65521776|FG000|Overall Study|Lost to Follow-up|2|||
23485485|NCT00117286|65521777|FG001|Overall Study|Lost to Follow-up|0|||
23485486|NCT00117286|65521776|FG000|Overall Study|Protocol Violation|3|||
23485487|NCT00117286|65521777|FG001|Overall Study|Protocol Violation|3|||
23485488|NCT00117286|65521776|FG000|Overall Study|Withdrawal by Subject|6|||
23485489|NCT00117286|65521777|FG001|Overall Study|Withdrawal by Subject|2|||
23278237|NCT00579345|64758983|FG004|Overall Study|Adverse Event|0|||
23485490|NCT00117286|65521776|FG000|Overall Study|Physician Decision|3|||
23485491|NCT00117286|65521777|FG001|Overall Study|Physician Decision|7|||
23485492|NCT00117286|65521776|FG000|Overall Study|Lack of Efficacy|2|||
23485493|NCT00117286|65521777|FG001|Overall Study|Lack of Efficacy|1|||
23485494|NCT00117286|65521776|FG000|Overall Study|Research site closing|0|||
23485495|NCT00117286|65521777|FG001|Overall Study|Research site closing|2|||
23485496|NCT03823378|65521780|FG000|Overall Study|Adverse Event|2|||
23485497|NCT03823378|65521781|FG001|Overall Study|Adverse Event|2|||
23485498|NCT03823378|65521782|FG002|Overall Study|Adverse Event|0|||
23485499|NCT03823378|65521783|FG003|Overall Study|Adverse Event|0|||
23603499|NCT02255474|65937385|FG000|Overall Study|Withdrawal by Subject|1|||
23485500|NCT03823378|65521784|FG004|Overall Study|Adverse Event|0|||
23485501|NCT03823378|65521785|FG005|Overall Study|Adverse Event|0|||
23485502|NCT03823378|65521780|FG000|Overall Study|Lost to Follow-up|0|||
23485503|NCT03823378|65521781|FG001|Overall Study|Lost to Follow-up|1|||
23485504|NCT03823378|65521782|FG002|Overall Study|Lost to Follow-up|0|||
23485505|NCT03823378|65521783|FG003|Overall Study|Lost to Follow-up|0|||
23485506|NCT03823378|65521784|FG004|Overall Study|Lost to Follow-up|1|||
23485507|NCT03823378|65521785|FG005|Overall Study|Lost to Follow-up|0|||
23485508|NCT03823378|65521780|FG000|Overall Study|Withdrawal by Subject|0|||
23485509|NCT03823378|65521781|FG001|Overall Study|Withdrawal by Subject|1|||
23485510|NCT03823378|65521782|FG002|Overall Study|Withdrawal by Subject|4|||
23485511|NCT03823378|65521783|FG003|Overall Study|Withdrawal by Subject|2|||
23485512|NCT03823378|65521784|FG004|Overall Study|Withdrawal by Subject|0|||
23485513|NCT03823378|65521785|FG005|Overall Study|Withdrawal by Subject|1|||
23485514|NCT03823378|65521780|FG000|Overall Study|Other, not specified|19|||
23485515|NCT03823378|65521781|FG001|Overall Study|Other, not specified|12|||
23485516|NCT03823378|65521782|FG002|Overall Study|Other, not specified|6|||
23485517|NCT03823378|65521783|FG003|Overall Study|Other, not specified|8|||
23485518|NCT03823378|65521784|FG004|Overall Study|Other, not specified|17|||
23485519|NCT03823378|65521785|FG005|Overall Study|Other, not specified|7|||
23485520|NCT03370289|65521786|FG000|Overall Study|Screen Failure|1|||
23485521|NCT03370289|65521786|FG000|Overall Study|Sample Size Sufficient|4|||
23485522|NCT00843726|65521801|FG000|Overall Study|Death|1|||
23485523|NCT00843726|65521802|FG001|Overall Study|Death|0|||
23485524|NCT00843726|65521801|FG000|Overall Study|Withdrawal by Subject|0|||
23485525|NCT00843726|65521802|FG001|Overall Study|Withdrawal by Subject|1|||
23485526|NCT01249118|65521807|FG000|First Washout Period|Physician Decision|0|||
23485527|NCT01249118|65521808|FG001|First Washout Period|Physician Decision|1|||
23485528|NCT01249118|65521809|FG002|First Washout Period|Physician Decision|0|||
23485529|NCT01055496|65521813|FG000|Overall Study|Withdrawal by Subject|2|||
23485530|NCT01055496|65521814|FG001|Overall Study|Withdrawal by Subject|4|||
23485531|NCT01055496|65521813|FG000|Overall Study|Death|13|||
23485532|NCT01055496|65521814|FG001|Overall Study|Death|23|||
23485533|NCT01055496|65521813|FG000|Overall Study|Lost to Follow-up|0|||
23485534|NCT01055496|65521814|FG001|Overall Study|Lost to Follow-up|2|||
23485535|NCT01055496|65521813|FG000|Overall Study|Other - Unspecified|0|||
23485536|NCT01055496|65521814|FG001|Overall Study|Other - Unspecified|1|||
23485537|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Adverse Event|1|||
23485538|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Adverse Event|0|||
23485539|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Adverse Event|0|||
23485540|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Adverse Event|0|||
23485541|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Adverse Event|0|||
23485542|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
23485543|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
23485544|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
23485545|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
23485546|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
23485547|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
23485548|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
23485549|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
23485550|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
23485551|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
23485552|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
23485553|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
23485554|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
23485555|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
23485556|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
23485557|NCT00473746|65521815|FG000|Period 1 (Phase 1)|Reason not specified|0|||
23485558|NCT00473746|65521816|FG001|Period 1 (Phase 1)|Reason not specified|1|||
23485559|NCT00473746|65521817|FG002|Period 1 (Phase 1)|Reason not specified|0|||
23485560|NCT00473746|65521818|FG003|Period 1 (Phase 1)|Reason not specified|0|||
23485561|NCT00473746|65521819|FG004|Period 1 (Phase 1)|Reason not specified|0|||
23485562|NCT00473746|65521815|FG000|Period 2 (Phase 2)|Adverse Event|0|||
23485563|NCT00473746|65521816|FG001|Period 2 (Phase 2)|Adverse Event|0|||
23485564|NCT00473746|65521817|FG002|Period 2 (Phase 2)|Adverse Event|0|||
23485565|NCT00473746|65521818|FG003|Period 2 (Phase 2)|Adverse Event|0|||
23485566|NCT00473746|65521819|FG004|Period 2 (Phase 2)|Adverse Event|3|||
23485567|NCT00473746|65521815|FG000|Period 2 (Phase 2)|Death|0|||
23485568|NCT00473746|65521816|FG001|Period 2 (Phase 2)|Death|0|||
23485569|NCT00473746|65521817|FG002|Period 2 (Phase 2)|Death|0|||
23485570|NCT00473746|65521818|FG003|Period 2 (Phase 2)|Death|0|||
23485571|NCT00473746|65521819|FG004|Period 2 (Phase 2)|Death|1|||
23485572|NCT00473746|65521815|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
23485573|NCT00473746|65521816|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
23485574|NCT00473746|65521817|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
23485575|NCT00473746|65521818|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
23485576|NCT00473746|65521819|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
23485577|NCT00473746|65521815|FG000|Period 2 (Phase 2)|Reason not specified|0|||
23485578|NCT00473746|65521816|FG001|Period 2 (Phase 2)|Reason not specified|0|||
23485579|NCT00473746|65521817|FG002|Period 2 (Phase 2)|Reason not specified|0|||
23485580|NCT00473746|65521818|FG003|Period 2 (Phase 2)|Reason not specified|0|||
23485581|NCT00473746|65521819|FG004|Period 2 (Phase 2)|Reason not specified|3|||
23485582|NCT01857310|65521820|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
23485583|NCT01857310|65521821|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
23485584|NCT01514370|65521823|FG000|Overall Study|Protocol Violation|2|||
23485585|NCT01514370|65521824|FG001|Overall Study|Protocol Violation|3|||
23485586|NCT01514370|65521823|FG000|Overall Study|Lost to Follow-up|0|||
23485587|NCT01514370|65521824|FG001|Overall Study|Lost to Follow-up|2|||
23485588|NCT01514370|65521823|FG000|Overall Study|Withdrawal by Subject|2|||
23485589|NCT01514370|65521824|FG001|Overall Study|Withdrawal by Subject|1|||
23485590|NCT01514370|65521823|FG000|Overall Study|Adverse Event|1|||
23485591|NCT01514370|65521824|FG001|Overall Study|Adverse Event|3|||
23485592|NCT01514370|65521823|FG000|Overall Study|Other|6|||
23485593|NCT01514370|65521824|FG001|Overall Study|Other|7|||
23485594|NCT02398227|65521825|FG000|Overall Study|Lost to Follow-up|21|||
23485595|NCT02398227|65521826|FG001|Overall Study|Lost to Follow-up|12|||
23485596|NCT02398227|65521825|FG000|Overall Study|Withdrawal by Subject|5|||
23485597|NCT02398227|65521826|FG001|Overall Study|Withdrawal by Subject|6|||
23485598|NCT02398227|65521825|FG000|Overall Study|Removed from treatment and dropped out|1|||
23485599|NCT02398227|65521826|FG001|Overall Study|Removed from treatment and dropped out|0|||
23485600|NCT02425644|65521827|FG000|Overall Study|Lost to Follow-up|2|||
23485601|NCT02425644|65521828|FG001|Overall Study|Lost to Follow-up|3|||
23485602|NCT02425644|65521827|FG000|Overall Study|Withdrawal by Subject|41|||
23485603|NCT02425644|65521828|FG001|Overall Study|Withdrawal by Subject|36|||
23485604|NCT02425644|65521827|FG000|Overall Study|Lack of Efficacy|3|||
23485605|NCT02425644|65521828|FG001|Overall Study|Lack of Efficacy|10|||
23485606|NCT02425644|65521827|FG000|Overall Study|Adverse Event|13|||
23485607|NCT02425644|65521828|FG001|Overall Study|Adverse Event|3|||
23485608|NCT02425644|65521827|FG000|Overall Study|Death|0|||
23485609|NCT02425644|65521828|FG001|Overall Study|Death|2|||
23485610|NCT02425644|65521827|FG000|Overall Study|Other|18|||
23485611|NCT02425644|65521828|FG001|Overall Study|Other|17|||
23485612|NCT01757691|65521833|FG000|Overall Study|Administrative problems|2|||
23485613|NCT01757691|65521834|FG001|Overall Study|Administrative problems|0|||
23485614|NCT00873860|65521835|FG000|Overall Study|Lost to Follow-up|1|||
23485615|NCT00873860|65521836|FG001|Overall Study|Lost to Follow-up|0|||
23485616|NCT00873860|65521837|FG002|Overall Study|Lost to Follow-up|0|||
23485617|NCT00873860|65521838|FG003|Overall Study|Lost to Follow-up|1|||
23485618|NCT00873860|65521835|FG000|Overall Study|Withdrawal by Subject|1|||
23485619|NCT00873860|65521836|FG001|Overall Study|Withdrawal by Subject|0|||
23485620|NCT00873860|65521837|FG002|Overall Study|Withdrawal by Subject|2|||
23485621|NCT00873860|65521838|FG003|Overall Study|Withdrawal by Subject|0|||
23485622|NCT00873860|65521835|FG000|Overall Study|Death|1|||
23485623|NCT00873860|65521836|FG001|Overall Study|Death|0|||
23485624|NCT00873860|65521837|FG002|Overall Study|Death|0|||
23485625|NCT00873860|65521838|FG003|Overall Study|Death|0|||
23485626|NCT00873860|65521835|FG000|Overall Study|Other|1|||
23485627|NCT00873860|65521836|FG001|Overall Study|Other|0|||
23485628|NCT00873860|65521837|FG002|Overall Study|Other|1|||
23485629|NCT00873860|65521838|FG003|Overall Study|Other|0|||
23485630|NCT04179890|65521839|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
23485631|NCT04179890|65521840|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
23485632|NCT04179890|65521839|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
23485633|NCT04179890|65521840|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
23485634|NCT04179890|65521839|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
23485635|NCT04179890|65521840|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
23485636|NCT04179890|65521839|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
23485637|NCT04179890|65521840|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
23485638|NCT04179890|65521839|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
23485639|NCT04179890|65521840|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
23485640|NCT04179890|65521839|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
23485641|NCT04179890|65521840|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
23485642|NCT04179890|65521839|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
23485643|NCT04179890|65521840|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
23485644|NCT04179890|65521839|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
23485645|NCT04179890|65521840|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
23485646|NCT04179890|65521839|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
23485647|NCT04179890|65521840|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
23485648|NCT03435640|65521841|FG000|Overall Study|Withdrawal by Subject|0|||
23278238|NCT00579345|64758984|FG005|Overall Study|Adverse Event|0|||
23278239|NCT00579345|64758985|FG006|Overall Study|Adverse Event|0|||
23278240|NCT00579345|64758986|FG007|Overall Study|Adverse Event|0|||
23278241|NCT00579345|64758979|FG000|Overall Study|Protocol Violation|1|||
23278242|NCT00579345|64758980|FG001|Overall Study|Protocol Violation|0|||
23278243|NCT00579345|64758981|FG002|Overall Study|Protocol Violation|0|||
23278244|NCT00579345|64758982|FG003|Overall Study|Protocol Violation|0|||
23278245|NCT00579345|64758983|FG004|Overall Study|Protocol Violation|0|||
23278246|NCT00579345|64758984|FG005|Overall Study|Protocol Violation|0|||
23278247|NCT00579345|64758985|FG006|Overall Study|Protocol Violation|0|||
23278248|NCT00579345|64758986|FG007|Overall Study|Protocol Violation|1|||
23278249|NCT00579345|64758979|FG000|Overall Study|Death|1|||
23278250|NCT00579345|64758980|FG001|Overall Study|Death|1|||
23278251|NCT00579345|64758981|FG002|Overall Study|Death|1|||
23278252|NCT00579345|64758982|FG003|Overall Study|Death|1|||
23278253|NCT00579345|64758983|FG004|Overall Study|Death|0|||
23278254|NCT00579345|64758984|FG005|Overall Study|Death|0|||
23278255|NCT00579345|64758985|FG006|Overall Study|Death|0|||
23278256|NCT00579345|64758986|FG007|Overall Study|Death|0|||
23278257|NCT01370317|64758987|FG000|Overall Study|Participant withdrew consent|1|||
23278258|NCT01370317|64758988|FG001|Overall Study|Participant withdrew consent|0|||
23278259|NCT01370317|64758987|FG000|Overall Study|Protocol deviation|0|||
23278260|NCT01370317|64758988|FG001|Overall Study|Protocol deviation|1|||
23278261|NCT00968812|64758991|FG000|Overall Study|Adverse Event|30|||
23278262|NCT00968812|64758992|FG001|Overall Study|Adverse Event|46|||
23278263|NCT00968812|64758993|FG002|Overall Study|Adverse Event|33|||
23278264|NCT00968812|64758991|FG000|Overall Study|Death|2|||
23278265|NCT00968812|64758992|FG001|Overall Study|Death|2|||
23278266|NCT00968812|64758993|FG002|Overall Study|Death|1|||
23278267|NCT00968812|64758991|FG000|Overall Study|Lack of Efficacy|9|||
23278268|NCT00968812|64758992|FG001|Overall Study|Lack of Efficacy|7|||
23278269|NCT00968812|64758993|FG002|Overall Study|Lack of Efficacy|16|||
23278270|NCT00968812|64758991|FG000|Overall Study|Lost to Follow-up|17|||
23278271|NCT00968812|64758992|FG001|Overall Study|Lost to Follow-up|12|||
23278272|NCT00968812|64758993|FG002|Overall Study|Lost to Follow-up|11|||
23278273|NCT00968812|64758991|FG000|Overall Study|Physician Decision|8|||
23278274|NCT00968812|64758992|FG001|Overall Study|Physician Decision|5|||
23278275|NCT00968812|64758993|FG002|Overall Study|Physician Decision|9|||
23278276|NCT00968812|64758991|FG000|Overall Study|Protocol Violation|7|||
23278277|NCT00968812|64758992|FG001|Overall Study|Protocol Violation|4|||
23278278|NCT00968812|64758993|FG002|Overall Study|Protocol Violation|3|||
23278279|NCT00968812|64758991|FG000|Overall Study|Withdrawal by Subject|17|||
23278280|NCT00968812|64758992|FG001|Overall Study|Withdrawal by Subject|23|||
23278281|NCT00968812|64758993|FG002|Overall Study|Withdrawal by Subject|25|||
23278282|NCT00968812|64758991|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
23278283|NCT00968812|64758992|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
23278284|NCT00968812|64758993|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
23278285|NCT00968812|64758991|FG000|Overall Study|Noncompliance with study drug|4|||
23278286|NCT00968812|64758992|FG001|Overall Study|Noncompliance with study drug|1|||
23278287|NCT00968812|64758993|FG002|Overall Study|Noncompliance with study drug|6|||
23278288|NCT00968812|64758991|FG000|Overall Study|Unable to take rescue therapy|12|||
23278289|NCT00968812|64758992|FG001|Overall Study|Unable to take rescue therapy|12|||
23278290|NCT00968812|64758993|FG002|Overall Study|Unable to take rescue therapy|17|||
23278291|NCT00968812|64758991|FG000|Overall Study|Other|25|||
23278292|NCT00968812|64758992|FG001|Overall Study|Other|37|||
23278293|NCT00968812|64758993|FG002|Overall Study|Other|40|||
23278294|NCT02632344|64758996|FG000|Overall Study|Adverse Event|3|||
23278295|NCT02632344|64758996|FG000|Overall Study|Lack of Efficacy|3|||
23278296|NCT02632344|64758996|FG000|Overall Study|Withdrawal by Subject|2|||
23603500|NCT02255474|65937386|FG001|Overall Study|Withdrawal by Subject|1|||
23603501|NCT02255474|65937387|FG002|Overall Study|Withdrawal by Subject|0|||
23603502|NCT05270460|65937388|FG000|Overall Study|Adverse Event|0|||
23603503|NCT05270460|65937389|FG001|Overall Study|Adverse Event|1|||
23603504|NCT05270460|65937390|FG002|Overall Study|Adverse Event|0|||
23603505|NCT05270460|65937388|FG000|Overall Study|Early Termination|0|||
23603506|NCT05270460|65937389|FG001|Overall Study|Early Termination|1|||
23603507|NCT05270460|65937390|FG002|Overall Study|Early Termination|0|||
23278305|NCT03165994|64759001|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
23278306|NCT03165994|64759001|FG000|Overall Study|Death|2|||
23278307|NCT03165994|64759001|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
23278308|NCT03165994|64759001|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
23278309|NCT03165994|64759001|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
23278310|NCT03165994|64759001|FG000|Overall Study|Miscellaneous|1|||
23278311|NCT00830206|64759002|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
23278312|NCT00830206|64759003|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
23278313|NCT00312897|64759004|FG000|Overall Study|Adverse Event|1|||
23278314|NCT00312897|64759005|FG001|Overall Study|Adverse Event|0|||
23278315|NCT00312897|64759004|FG000|Overall Study|Lost to Follow-up|2|||
23278316|NCT00312897|64759005|FG001|Overall Study|Lost to Follow-up|0|||
23278317|NCT00312897|64759004|FG000|Overall Study|Physician Decision|1|||
23278318|NCT00312897|64759005|FG001|Overall Study|Physician Decision|0|||
23278319|NCT00312897|64759004|FG000|Overall Study|Withdrawal by Subject|1|||
23278320|NCT00312897|64759005|FG001|Overall Study|Withdrawal by Subject|3|||
23278321|NCT00312897|64759004|FG000|Overall Study|Pregnancy|1|||
23278322|NCT00312897|64759005|FG001|Overall Study|Pregnancy|0|||
23278323|NCT00312897|64759004|FG000|Overall Study|discontinued prior to getting treatment|0|||
23278324|NCT00312897|64759005|FG001|Overall Study|discontinued prior to getting treatment|3|||
23278325|NCT02849457|64761851|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
23278326|NCT02849457|64761852|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
23278327|NCT02849457|64761853|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
23278328|NCT02849457|64761854|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
23278329|NCT00824291|64761857|FG000|Overall Study|Adverse Event|15|||
23278330|NCT00824291|64761858|FG001|Overall Study|Adverse Event|6|||
23278331|NCT00824291|64761857|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
23278332|NCT00824291|64761858|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
23278333|NCT00824291|64761857|FG000|Overall Study|Lost to Follow-up|11|||
23278334|NCT00824291|64761858|FG001|Overall Study|Lost to Follow-up|9|||
23278335|NCT00824291|64761857|FG000|Overall Study|Non-compliance|1|||
23278336|NCT00824291|64761858|FG001|Overall Study|Non-compliance|1|||
23278337|NCT00824291|64761857|FG000|Overall Study|Protocol Violation|4|||
23278338|NCT00824291|64761858|FG001|Overall Study|Protocol Violation|1|||
23278339|NCT00824291|64761857|FG000|Overall Study|Withdrawal by Subject|14|||
23278340|NCT00824291|64761858|FG001|Overall Study|Withdrawal by Subject|8|||
23278341|NCT00824291|64761857|FG000|Overall Study|Lack of Efficacy|7|||
23278342|NCT00824291|64761858|FG001|Overall Study|Lack of Efficacy|8|||
23278343|NCT00824291|64761857|FG000|Overall Study|Participant on prohibited medication|1|||
23278344|NCT00824291|64761858|FG001|Overall Study|Participant on prohibited medication|0|||
23278345|NCT01250912|64761862|FG000|Overall Study|Lost to Follow-up|1|||
23278346|NCT04166630|64761865|FG000|Overall Study|Withdrawal by Subject|0|||
23278347|NCT04166630|64761866|FG001|Overall Study|Withdrawal by Subject|1|||
23278348|NCT03769025|64761867|FG000|Overall Study|Withdrawal by Subject|1|||
23278349|NCT03769025|64761868|FG001|Overall Study|Withdrawal by Subject|1|||
23278350|NCT03769025|64761867|FG000|Overall Study|Lost to Follow-up|4|||
23278351|NCT03769025|64761868|FG001|Overall Study|Lost to Follow-up|3|||
23278352|NCT00859430|64761869|FG000|First Intervention|Withdrawal by Subject|0|||
23278353|NCT00859430|64761870|FG001|First Intervention|Withdrawal by Subject|1|||
23278354|NCT01535222|64761879|FG000|Overall Study|Inclusion/exclusion|0|||
23278355|NCT01535222|64761880|FG001|Overall Study|Inclusion/exclusion|0|||
23278356|NCT01535222|64761881|FG002|Overall Study|Inclusion/exclusion|1|||
23278357|NCT01535222|64761882|FG003|Overall Study|Inclusion/exclusion|0|||
23278358|NCT01535222|64761883|FG004|Overall Study|Inclusion/exclusion|0|||
23278359|NCT01535222|64761884|FG005|Overall Study|Inclusion/exclusion|0|||
23278360|NCT01097577|64761885|FG000|Overall Study|Adverse Event|0|||
23278361|NCT01097577|64761886|FG001|Overall Study|Adverse Event|1|||
23278362|NCT03204539|64761887|FG000|Overall Study|Loss of funding|0|||
23278363|NCT03204539|64761888|FG001|Overall Study|Loss of funding|1|||
23278364|NCT01175135|64761891|FG000|Overall Study|Adverse Event|2|||
23278365|NCT01175135|64761892|FG001|Overall Study|Adverse Event|5|||
23278366|NCT01175135|64761893|FG002|Overall Study|Adverse Event|3|||
23278367|NCT01175135|64761894|FG003|Overall Study|Adverse Event|4|||
23278368|NCT01175135|64761891|FG000|Overall Study|Death|1|||
23278369|NCT01175135|64761892|FG001|Overall Study|Death|0|||
23278370|NCT01175135|64761893|FG002|Overall Study|Death|0|||
23278371|NCT01175135|64761894|FG003|Overall Study|Death|0|||
23278372|NCT01175135|64761891|FG000|Overall Study|Lack of Efficacy|4|||
23278373|NCT01175135|64761892|FG001|Overall Study|Lack of Efficacy|5|||
23278374|NCT01175135|64761893|FG002|Overall Study|Lack of Efficacy|0|||
23278375|NCT01175135|64761894|FG003|Overall Study|Lack of Efficacy|5|||
23278376|NCT01175135|64761891|FG000|Overall Study|Lost to Follow-up|1|||
23371047|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
23371048|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
23485649|NCT03435640|65521842|FG001|Overall Study|Withdrawal by Subject|1|||
23485650|NCT03435640|65521843|FG002|Overall Study|Withdrawal by Subject|0|||
23603508|NCT01976507|65937391|FG000|Overall Study|Adverse Event|6|||
23278377|NCT01175135|64761892|FG001|Overall Study|Lost to Follow-up|2|||
23278378|NCT01175135|64761893|FG002|Overall Study|Lost to Follow-up|0|||
23278379|NCT01175135|64761894|FG003|Overall Study|Lost to Follow-up|0|||
23278380|NCT01175135|64761891|FG000|Overall Study|Protocol Violation|1|||
23278381|NCT01175135|64761892|FG001|Overall Study|Protocol Violation|1|||
23278382|NCT01175135|64761893|FG002|Overall Study|Protocol Violation|0|||
23278383|NCT01175135|64761894|FG003|Overall Study|Protocol Violation|0|||
23278384|NCT01175135|64761891|FG000|Overall Study|Withdrawal by Subject|4|||
23278385|NCT01175135|64761892|FG001|Overall Study|Withdrawal by Subject|8|||
23485651|NCT03435640|65521844|FG003|Overall Study|Withdrawal by Subject|2|||
23485652|NCT03435640|65521845|FG004|Overall Study|Withdrawal by Subject|0|||
23485653|NCT03435640|65521846|FG005|Overall Study|Withdrawal by Subject|0|||
23485654|NCT03435640|65521847|FG006|Overall Study|Withdrawal by Subject|3|||
23485655|NCT03435640|65521848|FG007|Overall Study|Withdrawal by Subject|0|||
23485656|NCT03435640|65521849|FG008|Overall Study|Withdrawal by Subject|0|||
23485657|NCT03435640|65521850|FG009|Overall Study|Withdrawal by Subject|2|||
23485658|NCT03435640|65521851|FG010|Overall Study|Withdrawal by Subject|3|||
23485659|NCT03435640|65521841|FG000|Overall Study|Lost to Follow-up|0|||
23485660|NCT03435640|65521842|FG001|Overall Study|Lost to Follow-up|0|||
23485661|NCT03435640|65521843|FG002|Overall Study|Lost to Follow-up|1|||
23485662|NCT03435640|65521844|FG003|Overall Study|Lost to Follow-up|0|||
23485663|NCT03435640|65521845|FG004|Overall Study|Lost to Follow-up|0|||
23485664|NCT03435640|65521846|FG005|Overall Study|Lost to Follow-up|0|||
23485665|NCT03435640|65521847|FG006|Overall Study|Lost to Follow-up|0|||
23485666|NCT03435640|65521848|FG007|Overall Study|Lost to Follow-up|0|||
23603509|NCT01976507|65937391|FG000|Overall Study|ablation not done, drug not given|1|||
23485667|NCT03435640|65521849|FG008|Overall Study|Lost to Follow-up|0|||
23485668|NCT03435640|65521850|FG009|Overall Study|Lost to Follow-up|0|||
23485669|NCT03435640|65521851|FG010|Overall Study|Lost to Follow-up|0|||
23485670|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
23485671|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
23485672|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
23485673|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
23485674|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
23485675|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
23485676|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
23485677|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
23485678|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
23485679|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
23485680|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
23485681|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
23485682|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
23485683|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
23485684|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
23485685|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
23485686|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
23485687|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
23485688|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
23485689|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
23485690|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
23485691|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
23485692|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
23485693|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
23485694|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
23485695|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
23485696|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
23485697|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
23485698|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
23485699|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
23485700|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
23485701|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
23485702|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
23485703|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
23485704|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
23485705|NCT01898494|65521855|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
23485706|NCT01898494|65521856|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
23485707|NCT01898494|65521857|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
23485708|NCT01898494|65521858|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
23485709|NCT01898494|65521859|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
23485710|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
23485711|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
23485712|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
23485713|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
23485714|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
23485715|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
23485716|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
23485717|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
23485718|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
23485719|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
23485720|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
23485721|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
23485722|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
23485723|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
23485724|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
23485725|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
23485726|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
23485727|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
23485728|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
23485729|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
23485730|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
23485731|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
23485732|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
23485733|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
23485734|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
23485735|NCT01898494|65521855|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
23278386|NCT01175135|64761893|FG002|Overall Study|Withdrawal by Subject|5|||
23278387|NCT01175135|64761894|FG003|Overall Study|Withdrawal by Subject|5|||
23278388|NCT01175135|64761891|FG000|Overall Study|Other|3|||
23278389|NCT01175135|64761892|FG001|Overall Study|Other|1|||
23278390|NCT01175135|64761893|FG002|Overall Study|Other|3|||
23278391|NCT01175135|64761894|FG003|Overall Study|Other|0|||
23278392|NCT01175135|64761891|FG000|Overall Study|Randomized But Not Treated|0|||
23278393|NCT01175135|64761892|FG001|Overall Study|Randomized But Not Treated|0|||
23278394|NCT01175135|64761893|FG002|Overall Study|Randomized But Not Treated|1|||
23278395|NCT01175135|64761894|FG003|Overall Study|Randomized But Not Treated|0|||
23278396|NCT00834418|64761895|FG000|Overall Study|Adverse Event|0|||
23278397|NCT00834418|64761896|FG001|Overall Study|Adverse Event|2|||
23278398|NCT01975948|64761897|FG000|Overall Study|Withdrawal by Subject|17|||
23278399|NCT01975948|64761898|FG001|Overall Study|Withdrawal by Subject|21|||
23278400|NCT01975948|64761899|FG002|Overall Study|Withdrawal by Subject|7|||
23278401|NCT01975948|64761900|FG003|Overall Study|Withdrawal by Subject|6|||
23278402|NCT04239872|64761901|FG000|Overall Study|Lost to Follow-up|0|||
23278403|NCT04239872|64761902|FG001|Overall Study|Lost to Follow-up|1|||
23278404|NCT02736721|64761903|FG000|Overall Study|Adverse Event|8|||
23278405|NCT02736721|64761903|FG000|Overall Study|Lost to Follow-up|3|||
23278406|NCT02736721|64761903|FG000|Overall Study|Other|5|||
23278407|NCT00849901|64761904|FG000|Acute Treatment Phase|Adverse Event|9|||
23278408|NCT00849901|64761905|FG001|Acute Treatment Phase|Adverse Event|1|||
23278409|NCT00849901|64761906|FG002|Acute Treatment Phase|Adverse Event|3|||
23278410|NCT00849901|64761904|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
23278411|NCT00849901|64761905|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
23278412|NCT00849901|64761906|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
23278413|NCT00849901|64761904|FG000|Acute Treatment Phase|Protocol Violation|0|||
23278414|NCT00849901|64761905|FG001|Acute Treatment Phase|Protocol Violation|2|||
23278415|NCT00849901|64761906|FG002|Acute Treatment Phase|Protocol Violation|1|||
23278416|NCT00849901|64761904|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
23278417|NCT00849901|64761905|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
23278418|NCT00849901|64761906|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
23278419|NCT00849901|64761904|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
23278420|NCT00849901|64761905|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
23278421|NCT00849901|64761906|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
23278422|NCT00849901|64761904|FG000|Acute Treatment Phase|Physician Decision|1|||
23278423|NCT00849901|64761905|FG001|Acute Treatment Phase|Physician Decision|1|||
23278424|NCT00849901|64761906|FG002|Acute Treatment Phase|Physician Decision|1|||
23278425|NCT00849901|64761904|FG000|Acute Treatment Phase|Sponsor Decision|1|||
23278426|NCT00849901|64761905|FG001|Acute Treatment Phase|Sponsor Decision|0|||
23278427|NCT00849901|64761906|FG002|Acute Treatment Phase|Sponsor Decision|0|||
23278428|NCT00849901|64761904|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
23278429|NCT00849901|64761905|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
23278430|NCT00849901|64761906|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
23278431|NCT00849901|64761904|FG000|Extension Phase|Adverse Event|2|||
23278432|NCT00849901|64761905|FG001|Extension Phase|Adverse Event|8|||
23278433|NCT00849901|64761906|FG002|Extension Phase|Adverse Event|4|||
23278434|NCT00849901|64761904|FG000|Extension Phase|Lost to Follow-up|3|||
23278435|NCT00849901|64761905|FG001|Extension Phase|Lost to Follow-up|0|||
23278436|NCT00849901|64761906|FG002|Extension Phase|Lost to Follow-up|1|||
23278437|NCT00849901|64761904|FG000|Extension Phase|Protocol Violation|2|||
23278438|NCT00849901|64761905|FG001|Extension Phase|Protocol Violation|2|||
23278439|NCT00849901|64761906|FG002|Extension Phase|Protocol Violation|4|||
23278440|NCT00849901|64761904|FG000|Extension Phase|Withdrawal by Subject|7|||
23278441|NCT00849901|64761905|FG001|Extension Phase|Withdrawal by Subject|6|||
23278442|NCT00849901|64761906|FG002|Extension Phase|Withdrawal by Subject|3|||
23278443|NCT00849901|64761904|FG000|Extension Phase|Parent or Caregiver Decision|10|||
23278444|NCT00849901|64761905|FG001|Extension Phase|Parent or Caregiver Decision|4|||
23278445|NCT00849901|64761906|FG002|Extension Phase|Parent or Caregiver Decision|4|||
23278446|NCT00849901|64761904|FG000|Extension Phase|Physician Decision|1|||
23278447|NCT00849901|64761905|FG001|Extension Phase|Physician Decision|2|||
23278448|NCT00849901|64761906|FG002|Extension Phase|Physician Decision|0|||
23371049|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
23278449|NCT00849901|64761904|FG000|Extension Phase|Lack of Efficacy|2|||
23278450|NCT00849901|64761905|FG001|Extension Phase|Lack of Efficacy|4|||
23278451|NCT00849901|64761906|FG002|Extension Phase|Lack of Efficacy|1|||
23278452|NCT04827394|64761907|FG000|Overall Study|Physician Decision|0|||
23278453|NCT04827394|64761908|FG001|Overall Study|Physician Decision|2|||
23371050|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
23278454|NCT01319383|64761915|FG000|Overall Study|No ex vivo or in vivo response|4|||
23278455|NCT01319383|64761916|FG001|Overall Study|No ex vivo or in vivo response|0|||
23278456|NCT01319383|64761915|FG000|Overall Study|Physician Decision|3|||
23278457|NCT01319383|64761916|FG001|Overall Study|Physician Decision|0|||
23278458|NCT01319383|64761915|FG000|Overall Study|Lack of Efficacy|5|||
23278459|NCT01319383|64761916|FG001|Overall Study|Lack of Efficacy|9|||
23278460|NCT01319383|64761915|FG000|Overall Study|No in vivo response to interval doses|0|||
23278461|NCT01319383|64761916|FG001|Overall Study|No in vivo response to interval doses|1|||
23278462|NCT01701063|64761917|FG000|Overall Study|Lost to Follow-up|0|||
23278463|NCT01701063|64761918|FG001|Overall Study|Lost to Follow-up|1|||
23278464|NCT01701063|64761919|FG002|Overall Study|Lost to Follow-up|0|||
23278465|NCT01701063|64761917|FG000|Overall Study|Withdrawal by Subject|0|||
23278466|NCT01701063|64761918|FG001|Overall Study|Withdrawal by Subject|0|||
23278467|NCT01701063|64761919|FG002|Overall Study|Withdrawal by Subject|1|||
23278468|NCT01701063|64761917|FG000|Overall Study|Other|0|||
23278469|NCT01701063|64761918|FG001|Overall Study|Other|0|||
23278470|NCT01701063|64761919|FG002|Overall Study|Other|1|||
23278471|NCT03872128|64761920|FG000|Overall Study|Dropped out before treatment|1|||
23278472|NCT03872128|64761921|FG001|Overall Study|Dropped out before treatment|0|||
23278473|NCT03872128|64761922|FG002|Overall Study|Dropped out before treatment|4|||
23278474|NCT03872128|64761920|FG000|Overall Study|Lost to Follow-up|2|||
23278475|NCT03872128|64761921|FG001|Overall Study|Lost to Follow-up|5|||
23278476|NCT03872128|64761922|FG002|Overall Study|Lost to Follow-up|8|||
23278477|NCT00185458|64761925|FG000|Contraception Phase|Adverse Event|37|||
23278478|NCT00185458|64761925|FG000|Contraception Phase|Lost to Follow-up|10|||
23278479|NCT00185458|64761925|FG000|Contraception Phase|Protocol Violation|2|||
23278480|NCT00185458|64761925|FG000|Contraception Phase|Physician Decision|2|||
23278481|NCT00185458|64761925|FG000|Contraception Phase|Withdrawal by Subject|7|||
23278482|NCT00185458|64761925|FG000|HRT Phase|Adverse Event|18|||
23278483|NCT00185458|64761925|FG000|HRT Phase|Lost to Follow-up|4|||
23278484|NCT00185458|64761925|FG000|HRT Phase|Protocol Violation|2|||
23278485|NCT00185458|64761925|FG000|HRT Phase|Withdrawal by Subject|3|||
23278486|NCT00477594|64761926|FG000|Year 1 and Year 2|Adverse Event|4|||
23278487|NCT00477594|64761927|FG001|Year 1 and Year 2|Adverse Event|2|||
23278488|NCT00477594|64761926|FG000|Year 1 and Year 2|Physician Decision|2|||
23278489|NCT00477594|64761927|FG001|Year 1 and Year 2|Physician Decision|1|||
23278490|NCT00477594|64761926|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
23278491|NCT00477594|64761927|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
23278492|NCT00477594|64761926|FG000|Year 1 and Year 2|Other|1|||
23278493|NCT00477594|64761927|FG001|Year 1 and Year 2|Other|0|||
23278494|NCT00477594|64761926|FG000|Year 3|Adverse Event|1|||
23278495|NCT00477594|64761927|FG001|Year 3|Adverse Event|0|||
23278496|NCT00477594|64761926|FG000|Year 3|Withdrawal by Subject|1|||
23278497|NCT00477594|64761927|FG001|Year 3|Withdrawal by Subject|0|||
23278498|NCT00477594|64761926|FG000|Follow-up Period|Withdrawal by Subject|2|||
23278499|NCT00477594|64761927|FG001|Follow-up Period|Withdrawal by Subject|1|||
23278500|NCT00477594|64761926|FG000|Follow-up Period|Other|1|||
23278501|NCT00477594|64761927|FG001|Follow-up Period|Other|0|||
23278502|NCT02321098|64761928|FG000|12 Weeks Treament|Lost to Follow-up|1|||
23278503|NCT02321098|64761929|FG001|12 Weeks Treament|Lost to Follow-up|1|||
23278504|NCT02321098|64761930|FG002|12 Weeks Treament|Lost to Follow-up|0|||
23278505|NCT02321098|64761928|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
23278506|NCT02321098|64761929|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
23278507|NCT02321098|64761930|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
23278508|NCT02321098|64761928|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
23278509|NCT02321098|64761929|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
23278510|NCT02321098|64761930|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
23278511|NCT02321098|64761928|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
23278512|NCT02321098|64761929|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
23278513|NCT02321098|64761930|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
23278514|NCT04022954|64761939|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
23278515|NCT04022954|64761939|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
23278516|NCT04022954|64761939|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
23278517|NCT02601625|64761946|FG000|Overall Study|Lost to Follow-up|0|||
23278518|NCT02601625|64761947|FG001|Overall Study|Lost to Follow-up|0|||
23278519|NCT02601625|64761948|FG002|Overall Study|Lost to Follow-up|1|||
23278520|NCT02601625|64761949|FG003|Overall Study|Lost to Follow-up|1|||
23278521|NCT02558491|64761950|FG000|First Invention|Withdrawal by Subject|3|||
23278522|NCT02558491|64761951|FG001|First Invention|Withdrawal by Subject|1|||
23278523|NCT02558491|64761950|FG000|First Invention|Data collection issues|1|||
23278524|NCT02558491|64761951|FG001|First Invention|Data collection issues|0|||
23278525|NCT02558491|64761950|FG000|First Invention|Stopping criteria|0|||
23278526|NCT02558491|64761951|FG001|First Invention|Stopping criteria|1|||
23603510|NCT03802994|65937392|FG000|Overall Study|Lost to Follow-up|0|||
23603511|NCT03802994|65937393|FG001|Overall Study|Lost to Follow-up|2|||
23603512|NCT03802994|65937394|FG002|Overall Study|Lost to Follow-up|3|||
23278527|NCT02558491|64761950|FG000|First Invention|Changed parameters during trial|1|||
23278528|NCT02558491|64761951|FG001|First Invention|Changed parameters during trial|0|||
23278529|NCT02558491|64761950|FG000|Second Intervention|Withdrawal by Subject|1|||
23278530|NCT02558491|64761951|FG001|Second Intervention|Withdrawal by Subject|0|||
23278531|NCT02558491|64761950|FG000|Second Intervention|Stopping Criteria|1|||
23278532|NCT02558491|64761951|FG001|Second Intervention|Stopping Criteria|0|||
23278533|NCT04173247|64761952|FG000|Overall Study|Withdrawal by Subject|0|||
23278534|NCT04173247|64761953|FG001|Overall Study|Withdrawal by Subject|2|||
23278535|NCT04173247|64761952|FG000|Overall Study|Death|1|||
23278536|NCT04173247|64761953|FG001|Overall Study|Death|0|||
23278537|NCT04173247|64761952|FG000|Overall Study|Physician Decision|1|||
23278538|NCT04173247|64761953|FG001|Overall Study|Physician Decision|0|||
23278539|NCT00365365|64761954|FG000|Overall Study|Randomized but not treated|0|||
23278540|NCT00365365|64761955|FG001|Overall Study|Randomized but not treated|2|||
23278541|NCT00365365|64761956|FG002|Overall Study|Randomized but not treated|0|||
23278542|NCT00365365|64761954|FG000|Overall Study|Poor compliance to protocol|0|||
23278543|NCT00365365|64761955|FG001|Overall Study|Poor compliance to protocol|1|||
23278544|NCT00365365|64761956|FG002|Overall Study|Poor compliance to protocol|0|||
23278545|NCT00365365|64761954|FG000|Overall Study|Lost to Follow-up|3|||
23278546|NCT00365365|64761955|FG001|Overall Study|Lost to Follow-up|3|||
23278547|NCT00365365|64761956|FG002|Overall Study|Lost to Follow-up|3|||
23278548|NCT00365365|64761954|FG000|Overall Study|Death|1|||
23371051|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
23371052|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
23371053|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
23371054|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
23371055|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
23371056|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
23371057|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
23371058|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
23371059|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
23371060|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
23371061|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
23371062|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
23485736|NCT01898494|65521856|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
23485737|NCT01898494|65521857|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
23485738|NCT01898494|65521858|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
23485739|NCT01898494|65521859|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
23485740|NCT02278471|65521860|FG000|Overall Study|Lost to Follow-up|6|||
23485741|NCT02278471|65521861|FG001|Overall Study|Lost to Follow-up|15|||
23485742|NCT02278471|65521860|FG000|Overall Study|Death|2|||
23485743|NCT02278471|65521861|FG001|Overall Study|Death|2|||
23485744|NCT02278471|65521860|FG000|Overall Study|Withdrawal by Subject|0|||
23485745|NCT02278471|65521861|FG001|Overall Study|Withdrawal by Subject|3|||
23485746|NCT00076024|65521862|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
23485747|NCT00076024|65521863|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
23485748|NCT00076024|65521864|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
23485749|NCT00076024|65521865|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
23485750|NCT00076024|65521862|FG000|Phase 1, Lead-in|Adverse Event|1|||
23485751|NCT00076024|65521863|FG001|Phase 1, Lead-in|Adverse Event|0|||
23485752|NCT00076024|65521864|FG002|Phase 1, Lead-in|Adverse Event|0|||
23485753|NCT00076024|65521865|FG003|Phase 1, Lead-in|Adverse Event|0|||
23485754|NCT00076024|65521862|FG000|Phase 1, Lead-in|Clinical progression|1|||
23485755|NCT00076024|65521863|FG001|Phase 1, Lead-in|Clinical progression|0|||
23485756|NCT00076024|65521864|FG002|Phase 1, Lead-in|Clinical progression|0|||
23485757|NCT00076024|65521865|FG003|Phase 1, Lead-in|Clinical progression|0|||
23485758|NCT00076024|65521862|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
23485759|NCT00076024|65521863|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
23485760|NCT00076024|65521864|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
23485761|NCT00076024|65521865|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
23485762|NCT00076024|65521862|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
23485763|NCT00076024|65521863|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
23485764|NCT00076024|65521864|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
23603513|NCT03802994|65937395|FG003|Overall Study|Lost to Follow-up|2|||
23603514|NCT03802994|65937396|FG004|Overall Study|Lost to Follow-up|2|||
23278549|NCT00365365|64761955|FG001|Overall Study|Death|3|||
23278550|NCT00365365|64761956|FG002|Overall Study|Death|0|||
23278551|NCT00365365|64761954|FG000|Overall Study|Subject's request|11|||
23278552|NCT00365365|64761955|FG001|Overall Study|Subject's request|13|||
23278553|NCT00365365|64761956|FG002|Overall Study|Subject's request|1|||
23278554|NCT00365365|64761954|FG000|Overall Study|Disease progression/relapse|9|||
23485765|NCT00076024|65521865|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
23485766|NCT00076024|65521862|FG000|Phase 2, Double-blind|Adverse Event|0|||
23485767|NCT00076024|65521863|FG001|Phase 2, Double-blind|Adverse Event|25|||
23485768|NCT00076024|65521864|FG002|Phase 2, Double-blind|Adverse Event|6|||
23485769|NCT00076024|65521865|FG003|Phase 2, Double-blind|Adverse Event|0|||
23485770|NCT00076024|65521862|FG000|Phase 2, Double-blind|Un-specified|0|||
23485771|NCT00076024|65521863|FG001|Phase 2, Double-blind|Un-specified|14|||
23485772|NCT00076024|65521864|FG002|Phase 2, Double-blind|Un-specified|6|||
23603515|NCT00266656|65937397|FG000|Overall Study|Death|1|||
23371063|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
23371064|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
23371065|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
23371066|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
23371067|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
23371068|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
23371069|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
23371070|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
23371071|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
23371072|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
23371073|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
23371074|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
23371075|NCT02709746|65102881|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
23371076|NCT02709746|65102882|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
23371077|NCT02709746|65102883|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
23371078|NCT02709746|65102884|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
23371079|NCT02709746|65102885|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
23371080|NCT00427908|65102886|FG000|Primary Phase|Lost to Follow-up|4|||
23371081|NCT00427908|65102887|FG001|Primary Phase|Lost to Follow-up|0|||
23371082|NCT00427908|65102888|FG002|Primary Phase|Lost to Follow-up|2|||
23371083|NCT00427908|65102889|FG003|Primary Phase|Lost to Follow-up|0|||
23371084|NCT00427908|65102886|FG000|Primary Phase|Withdrawal by Subject|1|||
23371085|NCT00427908|65102887|FG001|Primary Phase|Withdrawal by Subject|2|||
23371086|NCT00427908|65102888|FG002|Primary Phase|Withdrawal by Subject|1|||
23371087|NCT00427908|65102889|FG003|Primary Phase|Withdrawal by Subject|0|||
23371088|NCT00427908|65102886|FG000|Primary Phase|Adverse Event|0|||
23371089|NCT00427908|65102887|FG001|Primary Phase|Adverse Event|1|||
23371090|NCT00427908|65102888|FG002|Primary Phase|Adverse Event|0|||
23371091|NCT00427908|65102889|FG003|Primary Phase|Adverse Event|0|||
23371092|NCT00473655|65102890|FG000|Overall Study|Lost to Follow-up|9|||
23371093|NCT00473655|65102891|FG001|Overall Study|Lost to Follow-up|5|||
23371094|NCT00473655|65102892|FG002|Overall Study|Lost to Follow-up|8|||
23371095|NCT01147822|65102893|FG000|Overall Study|Death|66|||
23371096|NCT01147822|65102894|FG001|Overall Study|Death|59|||
23371097|NCT01147822|65102893|FG000|Overall Study|Protocol Violation|0|||
23371098|NCT01147822|65102894|FG001|Overall Study|Protocol Violation|1|||
23371099|NCT01147822|65102893|FG000|Overall Study|Lost to Follow-up|3|||
23371100|NCT01147822|65102894|FG001|Overall Study|Lost to Follow-up|2|||
23371101|NCT01147822|65102893|FG000|Overall Study|Physician Decision|0|||
23371102|NCT01147822|65102894|FG001|Overall Study|Physician Decision|2|||
23371103|NCT01147822|65102893|FG000|Overall Study|Withdrawal by Subject|8|||
23371104|NCT01147822|65102894|FG001|Overall Study|Withdrawal by Subject|13|||
23371105|NCT01147822|65102893|FG000|Overall Study|Not Completed/Ongoing|111|||
23371106|NCT01147822|65102894|FG001|Overall Study|Not Completed/Ongoing|102|||
23371107|NCT00551369|65102895|FG000|Overall Study|Protocol Violation|5|||
23371108|NCT00551369|65102895|FG000|Overall Study|Withdrawal by Subject|1|||
23371109|NCT00551369|65102895|FG000|Overall Study|Not treated per protocol and re|1|||
23371110|NCT03353220|65102896|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
23201415|NCT04657016|64476723|FG001|Overall Study|Protocol Deviation|0|||
23371111|NCT03353220|65102897|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
23371112|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
23371113|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
23371114|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
23371115|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Death|0|||
23371116|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Death|1|||
23371117|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Death|0|||
23371118|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
23371119|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
23371120|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
23371121|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
23371122|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
23371123|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
23371124|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23371125|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
23371126|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
23371127|NCT01064414|65102898|FG000|Core Period: Baseline to Week 26|Other|4|||
23371128|NCT01064414|65102899|FG001|Core Period: Baseline to Week 26|Other|7|||
23371129|NCT01064414|65102900|FG002|Core Period: Baseline to Week 26|Other|2|||
23371130|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
23371131|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
23371132|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
23371133|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Death|0|||
23371134|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Death|1|||
23371135|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Death|0|||
23371136|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
23371137|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23371138|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
23371139|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
23371140|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23371141|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
23371142|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23371143|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
23371144|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
23371145|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
23371146|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
23371147|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
23371148|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23371149|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23371150|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
23371151|NCT01064414|65102898|FG000|Extension Period: Week 26 to Week 52|Other|5|||
23371152|NCT01064414|65102899|FG001|Extension Period: Week 26 to Week 52|Other|2|||
23371153|NCT01064414|65102900|FG002|Extension Period: Week 26 to Week 52|Other|1|||
23371154|NCT01035138|65102901|FG000|Overall Study|Adverse Event|4|||
23371155|NCT01035138|65102902|FG001|Overall Study|Adverse Event|0|||
23371156|NCT01035138|65102903|FG002|Overall Study|Adverse Event|2|||
23371157|NCT01035138|65102901|FG000|Overall Study|Caregiver Decision|2|||
23371158|NCT01035138|65102902|FG001|Overall Study|Caregiver Decision|0|||
23371159|NCT01035138|65102903|FG002|Overall Study|Caregiver Decision|1|||
23371160|NCT01035138|65102901|FG000|Overall Study|Withdrawal by Subject|1|||
23371161|NCT01035138|65102902|FG001|Overall Study|Withdrawal by Subject|0|||
23371162|NCT01035138|65102903|FG002|Overall Study|Withdrawal by Subject|0|||
23371163|NCT01035138|65102901|FG000|Overall Study|Physician Decision|0|||
23371164|NCT01035138|65102902|FG001|Overall Study|Physician Decision|0|||
23371165|NCT01035138|65102903|FG002|Overall Study|Physician Decision|1|||
23371166|NCT01035138|65102901|FG000|Overall Study|Sponsor Decision|66|||
23371167|NCT01035138|65102902|FG001|Overall Study|Sponsor Decision|60|||
23371168|NCT01035138|65102903|FG002|Overall Study|Sponsor Decision|42|||
23371169|NCT01035138|65102901|FG000|Overall Study|Lost to Follow-up|0|||
23371170|NCT01035138|65102902|FG001|Overall Study|Lost to Follow-up|0|||
23371171|NCT01035138|65102903|FG002|Overall Study|Lost to Follow-up|1|||
23371172|NCT01317641|65102906|FG000|Overall Study|Not treated|0|||
23371173|NCT01317641|65102907|FG001|Overall Study|Not treated|0|||
23371174|NCT01317641|65102908|FG002|Overall Study|Not treated|0|||
23371175|NCT01317641|65102909|FG003|Overall Study|Not treated|0|||
23371176|NCT01317641|65102910|FG004|Overall Study|Not treated|0|||
23371177|NCT01317641|65102911|FG005|Overall Study|Not treated|0|||
23371178|NCT01317641|65102912|FG006|Overall Study|Not treated|0|||
23371179|NCT01317641|65102913|FG007|Overall Study|Not treated|1|||
23371180|NCT01317641|65102914|FG008|Overall Study|Not treated|1|||
23371181|NCT01317641|65102906|FG000|Overall Study|Adverse Event|0|||
23371182|NCT01317641|65102907|FG001|Overall Study|Adverse Event|1|||
23371183|NCT01317641|65102908|FG002|Overall Study|Adverse Event|0|||
23371184|NCT01317641|65102909|FG003|Overall Study|Adverse Event|1|||
23371185|NCT01317641|65102910|FG004|Overall Study|Adverse Event|0|||
23371186|NCT01317641|65102911|FG005|Overall Study|Adverse Event|0|||
23371187|NCT01317641|65102912|FG006|Overall Study|Adverse Event|2|||
23371188|NCT01317641|65102913|FG007|Overall Study|Adverse Event|1|||
23371189|NCT01317641|65102914|FG008|Overall Study|Adverse Event|0|||
23371190|NCT01317641|65102906|FG000|Overall Study|Protocol Violation|1|||
23371191|NCT01317641|65102907|FG001|Overall Study|Protocol Violation|0|||
23371192|NCT01317641|65102908|FG002|Overall Study|Protocol Violation|0|||
23371193|NCT01317641|65102909|FG003|Overall Study|Protocol Violation|0|||
23371194|NCT01317641|65102910|FG004|Overall Study|Protocol Violation|0|||
23371195|NCT01317641|65102911|FG005|Overall Study|Protocol Violation|0|||
23371196|NCT01317641|65102912|FG006|Overall Study|Protocol Violation|0|||
23371197|NCT01317641|65102913|FG007|Overall Study|Protocol Violation|0|||
23278555|NCT00365365|64761955|FG001|Overall Study|Disease progression/relapse|6|||
23371198|NCT01317641|65102914|FG008|Overall Study|Protocol Violation|0|||
23371199|NCT01317641|65102906|FG000|Overall Study|Disease progression|0|||
23371200|NCT01317641|65102907|FG001|Overall Study|Disease progression|0|||
23371201|NCT01317641|65102908|FG002|Overall Study|Disease progression|0|||
23371202|NCT01317641|65102909|FG003|Overall Study|Disease progression|0|||
23371203|NCT01317641|65102910|FG004|Overall Study|Disease progression|0|||
23371204|NCT01317641|65102911|FG005|Overall Study|Disease progression|0|||
23371205|NCT01317641|65102912|FG006|Overall Study|Disease progression|0|||
23371206|NCT01317641|65102913|FG007|Overall Study|Disease progression|3|||
23371207|NCT01317641|65102914|FG008|Overall Study|Disease progression|4|||
23371208|NCT01317641|65102906|FG000|Overall Study|Withdrawal by Subject|0|||
23371209|NCT01317641|65102907|FG001|Overall Study|Withdrawal by Subject|0|||
23371210|NCT01317641|65102908|FG002|Overall Study|Withdrawal by Subject|0|||
23371211|NCT01317641|65102909|FG003|Overall Study|Withdrawal by Subject|0|||
23371212|NCT01317641|65102910|FG004|Overall Study|Withdrawal by Subject|0|||
23371213|NCT01317641|65102911|FG005|Overall Study|Withdrawal by Subject|0|||
23485773|NCT00076024|65521865|FG003|Phase 2, Double-blind|Un-specified|0|||
23485774|NCT00076024|65521862|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
23485775|NCT00076024|65521863|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
23485776|NCT00076024|65521864|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
23485777|NCT00076024|65521865|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
23485778|NCT00076024|65521862|FG000|Phase 2, Open-label|Adverse Event|0|||
23485779|NCT00076024|65521863|FG001|Phase 2, Open-label|Adverse Event|0|||
23485780|NCT00076024|65521864|FG002|Phase 2, Open-label|Adverse Event|0|||
23485781|NCT00076024|65521865|FG003|Phase 2, Open-label|Adverse Event|2|||
23603516|NCT00266656|65937398|FG001|Overall Study|Death|0|||
23278556|NCT00365365|64761956|FG002|Overall Study|Disease progression/relapse|7|||
23278557|NCT00365365|64761954|FG000|Overall Study|Adverse Event|6|||
23278558|NCT00365365|64761955|FG001|Overall Study|Adverse Event|6|||
23278559|NCT00365365|64761956|FG002|Overall Study|Adverse Event|3|||
23278560|NCT00365365|64761954|FG000|Overall Study|Moved|2|||
23278561|NCT00365365|64761955|FG001|Overall Study|Moved|0|||
23278562|NCT00365365|64761956|FG002|Overall Study|Moved|0|||
23278563|NCT00365365|64761954|FG000|Overall Study|New cancer|1|||
23278564|NCT00365365|64761955|FG001|Overall Study|New cancer|0|||
23278565|NCT00365365|64761956|FG002|Overall Study|New cancer|0|||
23278566|NCT00365365|64761954|FG000|Overall Study|Withdrew consent|1|||
23278567|NCT00365365|64761955|FG001|Overall Study|Withdrew consent|1|||
23278568|NCT00365365|64761956|FG002|Overall Study|Withdrew consent|0|||
23278569|NCT00365365|64761954|FG000|Overall Study|Second malignancy|0|||
23278570|NCT00365365|64761955|FG001|Overall Study|Second malignancy|1|||
23278571|NCT00365365|64761956|FG002|Overall Study|Second malignancy|0|||
23278572|NCT00365365|64761954|FG000|Overall Study|Patient/physician decision|0|||
23278573|NCT00365365|64761955|FG001|Overall Study|Patient/physician decision|0|||
23278574|NCT00365365|64761956|FG002|Overall Study|Patient/physician decision|1|||
23278575|NCT03733444|64761957|FG000|Overall Study|Adverse Event|8|||
23278576|NCT03733444|64761958|FG001|Overall Study|Adverse Event|10|||
23278577|NCT03733444|64761959|FG002|Overall Study|Adverse Event|5|||
23371214|NCT01317641|65102912|FG006|Overall Study|Withdrawal by Subject|1|||
23371215|NCT01317641|65102913|FG007|Overall Study|Withdrawal by Subject|0|||
23371216|NCT01317641|65102914|FG008|Overall Study|Withdrawal by Subject|0|||
23371217|NCT03103503|65102915|FG000|Overall Study|Death|64|||
23371218|NCT03103503|65102915|FG000|Overall Study|Physician Decision|57|||
23485782|NCT00076024|65521862|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
23485783|NCT00076024|65521863|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
23485784|NCT00076024|65521864|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
23485785|NCT00076024|65521865|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
23603517|NCT00266656|65937397|FG000|Overall Study|Lost to Follow-up|4|||
23278578|NCT03733444|64761957|FG000|Overall Study|Death|20|||
23278579|NCT03733444|64761958|FG001|Overall Study|Death|19|||
23278580|NCT03733444|64761959|FG002|Overall Study|Death|11|||
23278581|NCT03733444|64761957|FG000|Overall Study|Lost to Follow-up|3|||
23371219|NCT03103503|65102915|FG000|Overall Study|Withdrawal by Subject|10|||
23278582|NCT03733444|64761958|FG001|Overall Study|Lost to Follow-up|0|||
23278583|NCT03733444|64761959|FG002|Overall Study|Lost to Follow-up|1|||
23278584|NCT03733444|64761957|FG000|Overall Study|Lack of Efficacy|0|||
23278585|NCT03733444|64761958|FG001|Overall Study|Lack of Efficacy|1|||
23278586|NCT03733444|64761959|FG002|Overall Study|Lack of Efficacy|1|||
23278587|NCT03733444|64761957|FG000|Overall Study|Physician Decision|2|||
23278588|NCT03733444|64761958|FG001|Overall Study|Physician Decision|1|||
23278589|NCT03733444|64761959|FG002|Overall Study|Physician Decision|0|||
23278590|NCT03733444|64761957|FG000|Overall Study|Protocol Violation|2|||
23278591|NCT03733444|64761958|FG001|Overall Study|Protocol Violation|1|||
23278592|NCT03733444|64761959|FG002|Overall Study|Protocol Violation|0|||
23278593|NCT03733444|64761957|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
23278594|NCT03733444|64761958|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
23278595|NCT03733444|64761959|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
23278596|NCT03733444|64761957|FG000|Overall Study|Study Terminated by Sponsor|203|||
23278597|NCT03733444|64761958|FG001|Overall Study|Study Terminated by Sponsor|209|||
23371220|NCT03103503|65102915|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
23371221|NCT03103503|65102915|FG000|Overall Study|Lost to Follow-up|3|||
23371222|NCT03103503|65102915|FG000|Overall Study|Study Closure|757|||
23371223|NCT02481050|65102918|FG000|Overall Study|Adverse Event|1|||
23371224|NCT02481050|65102918|FG000|Overall Study|Disease Progression|47|||
23371225|NCT02481050|65102918|FG000|Overall Study|Withdrawal by Subject|7|||
23371226|NCT02481050|65102918|FG000|Overall Study|Other|3|||
23371227|NCT00372424|65102919|FG000|Overall Study|Adverse Event|2|||
23278598|NCT03733444|64761959|FG002|Overall Study|Study Terminated by Sponsor|221|||
23278599|NCT03733444|64761957|FG000|Overall Study|Withdrawal by Subject|19|||
23278600|NCT03733444|64761958|FG001|Overall Study|Withdrawal by Subject|18|||
23278601|NCT03733444|64761959|FG002|Overall Study|Withdrawal by Subject|16|||
23278602|NCT03733444|64761957|FG000|Overall Study|Miscellaneous|1|||
23278603|NCT03733444|64761958|FG001|Overall Study|Miscellaneous|0|||
23278604|NCT03733444|64761959|FG002|Overall Study|Miscellaneous|1|||
23278605|NCT03733444|64761957|FG000|Overall Study|Not Treated|1|||
23278606|NCT03733444|64761958|FG001|Overall Study|Not Treated|2|||
23278607|NCT03733444|64761959|FG002|Overall Study|Not Treated|1|||
23278608|NCT01208337|64761962|FG000|Overall Study|Death|3|||
23278609|NCT02832063|64761964|FG000|Overall Study|Adverse Event|2|||
23278610|NCT02832063|64761965|FG001|Overall Study|Adverse Event|1|||
23278611|NCT02832063|64761964|FG000|Overall Study|Physician Decision|5|||
23278612|NCT02832063|64761965|FG001|Overall Study|Physician Decision|7|||
23278613|NCT02832063|64761964|FG000|Overall Study|Lost to Follow-up|15|||
23278614|NCT02832063|64761965|FG001|Overall Study|Lost to Follow-up|8|||
23278615|NCT02832063|64761964|FG000|Overall Study|Withdrawal by Subject|10|||
23278616|NCT02832063|64761965|FG001|Overall Study|Withdrawal by Subject|21|||
23278617|NCT02832063|64761964|FG000|Overall Study|Other|2|||
23278618|NCT02832063|64761965|FG001|Overall Study|Other|1|||
23278619|NCT03935880|64761969|FG000|Overall Study|Lost to Follow-up|0|||
23371228|NCT00372424|65102919|FG000|Overall Study|Withdrawal by Subject|1|||
23371229|NCT00372424|65102919|FG000|Overall Study|Death|1|||
23371230|NCT00372424|65102919|FG000|Overall Study|Objective Progression or Relapse|14|||
23371231|NCT00372424|65102919|FG000|Overall Study|Other|7|||
23371232|NCT00372424|65102919|FG000|Overall Study|Enrolled, Not Treated|1|||
23371233|NCT01200329|65102920|FG000|Overall Study|Lack of financial coverage|2|||
23371234|NCT01200329|65102920|FG000|Overall Study|Progressive disease|1|||
23371235|NCT01692119|65102921|FG000|Overall Study|Protocol Violation|3|||
23371236|NCT01692119|65102922|FG001|Overall Study|Protocol Violation|1|||
23371237|NCT01692119|65102921|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
23371238|NCT01692119|65102922|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
23371239|NCT00386334|65102929|FG000|Double Blind Period|Adverse Event|9|||
23371240|NCT00386334|65102930|FG001|Double Blind Period|Adverse Event|14|||
23371241|NCT00386334|65102929|FG000|Double Blind Period|Protocol Violation|1|||
23371242|NCT00386334|65102930|FG001|Double Blind Period|Protocol Violation|1|||
23371243|NCT00386334|65102929|FG000|Double Blind Period|Withdrawal by Subject|9|||
23371244|NCT00386334|65102930|FG001|Double Blind Period|Withdrawal by Subject|13|||
23371245|NCT00386334|65102929|FG000|Double Blind Period|Lack of Efficacy|20|||
23278620|NCT03935880|64761970|FG001|Overall Study|Lost to Follow-up|1|||
23278621|NCT04032977|64761974|FG000|Overall Study|Withdrawal by Subject|6|||
23278622|NCT04032977|64761975|FG001|Overall Study|Withdrawal by Subject|1|||
23371246|NCT00386334|65102930|FG001|Double Blind Period|Lack of Efficacy|11|||
23603518|NCT00266656|65937398|FG001|Overall Study|Lost to Follow-up|1|||
23278623|NCT04032977|64761974|FG000|Overall Study|Lost to Follow-up|2|||
23278624|NCT04032977|64761975|FG001|Overall Study|Lost to Follow-up|7|||
23278625|NCT04032977|64761974|FG000|Overall Study|Pregnancy|1|||
23278626|NCT04032977|64761975|FG001|Overall Study|Pregnancy|0|||
23278627|NCT00073307|64761983|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
23278628|NCT00073307|64761984|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
23278629|NCT00073307|64761985|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
23278630|NCT00073307|64761983|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
23278631|NCT00073307|64761984|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
23278632|NCT00073307|64761985|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
23371247|NCT00386334|65102929|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
23371248|NCT00386334|65102930|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
23371249|NCT00386334|65102929|FG000|Double Blind Period|Other|3|||
23371250|NCT00386334|65102930|FG001|Double Blind Period|Other|3|||
23371251|NCT00386334|65102929|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
23371252|NCT00386334|65102930|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
23371253|NCT00869960|65102932|FG000|Overall Study|Lost to Follow-up|2|||
23371254|NCT01981616|65102933|FG000|Overall Study|Adverse Event|0|||
23371255|NCT01981616|65102934|FG001|Overall Study|Adverse Event|1|||
23371256|NCT01981616|65102933|FG000|Overall Study|Protocol Violation|1|||
23371257|NCT01981616|65102934|FG001|Overall Study|Protocol Violation|0|||
23371258|NCT04919317|65102936|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
23371259|NCT04919317|65102937|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
23371260|NCT04919317|65102936|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
23371261|NCT04919317|65102937|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
23371262|NCT03886272|65102942|FG000|Period 1|Withdrawal by Subject|0|||
23371263|NCT03886272|65102943|FG001|Period 1|Withdrawal by Subject|0|||
23371264|NCT03886272|65102944|FG002|Period 1|Withdrawal by Subject|0|||
23371265|NCT03886272|65102945|FG003|Period 1|Withdrawal by Subject|0|||
23371266|NCT03886272|65102946|FG004|Period 1|Withdrawal by Subject|0|||
23371267|NCT03886272|65102947|FG005|Period 1|Withdrawal by Subject|1|||
23371268|NCT03886272|65102948|FG006|Period 1|Withdrawal by Subject|0|||
23371269|NCT00748241|65102949|FG000|Overall Study|Implant failure|1|||
23278633|NCT00073307|64761983|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
23278634|NCT00073307|64761984|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
23278635|NCT00073307|64761985|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
23278636|NCT00073307|64761983|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
23278637|NCT00073307|64761984|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
23278638|NCT00073307|64761985|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
23278639|NCT00073307|64761983|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
23278640|NCT00073307|64761984|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
23278641|NCT00073307|64761985|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
23278642|NCT00073307|64761983|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
23278643|NCT00073307|64761984|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
23371270|NCT00748241|65102949|FG000|Overall Study|Lost to Follow-up|5|||
23371271|NCT00748241|65102949|FG000|Overall Study|Death|2|||
23371272|NCT04584788|65102950|FG000|Overall Study|Physician Decision|8|||
23278644|NCT00073307|64761985|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
23371273|NCT04584788|65102950|FG000|Overall Study|Withdrawal by Subject|1|||
23371274|NCT04584788|65102950|FG000|Overall Study|Adverse Event|3|||
23371275|NCT02611882|65106077|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
23485786|NCT00076024|65521862|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
23485787|NCT00076024|65521863|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
23485788|NCT00076024|65521864|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
23485789|NCT00076024|65521865|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
23485790|NCT00076024|65521862|FG000|Phase 2, Open-label|Other|0|||
23485791|NCT00076024|65521863|FG001|Phase 2, Open-label|Other|0|||
23485792|NCT00076024|65521864|FG002|Phase 2, Open-label|Other|0|||
23485793|NCT00076024|65521865|FG003|Phase 2, Open-label|Other|2|||
23485794|NCT01709578|65521866|FG000|Overall Study|Rescued and entered in long term safety|63|||
23485795|NCT01709578|65521867|FG001|Overall Study|Rescued and entered in long term safety|25|||
23278645|NCT00073307|64761983|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
23278646|NCT00073307|64761984|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
23278647|NCT00073307|64761985|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
23278648|NCT00073307|64761983|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
23278649|NCT00073307|64761984|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
23278650|NCT00073307|64761985|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
23278651|NCT00073307|64761983|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
23278652|NCT00073307|64761984|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
23278653|NCT00073307|64761985|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
23278654|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
23278655|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
23278656|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
23278657|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
23278658|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
23278659|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
23278660|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
23278661|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
23278662|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
23278663|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
23278664|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
23485796|NCT01709578|65521868|FG002|Overall Study|Rescued and entered in long term safety|26|||
23485797|NCT01709578|65521866|FG000|Overall Study|Adverse Event|9|||
23485798|NCT01709578|65521867|FG001|Overall Study|Adverse Event|18|||
23485799|NCT01709578|65521868|FG002|Overall Study|Adverse Event|17|||
23485800|NCT01709578|65521866|FG000|Overall Study|Lack of Efficacy|5|||
23485801|NCT01709578|65521867|FG001|Overall Study|Lack of Efficacy|4|||
23485802|NCT01709578|65521868|FG002|Overall Study|Lack of Efficacy|2|||
23485803|NCT01709578|65521866|FG000|Overall Study|Poor compliance to protocol|1|||
23485804|NCT01709578|65521867|FG001|Overall Study|Poor compliance to protocol|2|||
23485805|NCT01709578|65521868|FG002|Overall Study|Poor compliance to protocol|1|||
23485806|NCT01709578|65521866|FG000|Overall Study|Other, not related to safety or efficacy|2|||
23485807|NCT01709578|65521867|FG001|Overall Study|Other, not related to safety or efficacy|7|||
23278665|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
23278666|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
23278667|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
23278668|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
23278669|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
23278670|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
23278671|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
23278672|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
23278673|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
23278674|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
23278675|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
23278676|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
23278677|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
23278678|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
23278679|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
23278680|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
23278681|NCT00073307|64761983|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
23278682|NCT00073307|64761984|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
23278683|NCT00073307|64761985|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
23278684|NCT02554877|64761986|FG000|Overall Study|Adverse Event|2|||
23278685|NCT02554877|64761987|FG001|Overall Study|Adverse Event|0|||
23278686|NCT02554877|64761988|FG002|Overall Study|Adverse Event|0|||
23278687|NCT02554877|64761989|FG003|Overall Study|Adverse Event|1|||
23278688|NCT02554877|64761986|FG000|Overall Study|Lost to Follow-up|1|||
23278689|NCT02554877|64761987|FG001|Overall Study|Lost to Follow-up|1|||
23278690|NCT02554877|64761988|FG002|Overall Study|Lost to Follow-up|1|||
23278691|NCT02554877|64761989|FG003|Overall Study|Lost to Follow-up|2|||
23278692|NCT02554877|64761986|FG000|Overall Study|Did not meet entrance criteria|0|||
23278693|NCT02554877|64761987|FG001|Overall Study|Did not meet entrance criteria|0|||
23278694|NCT02554877|64761988|FG002|Overall Study|Did not meet entrance criteria|1|||
23278695|NCT02554877|64761989|FG003|Overall Study|Did not meet entrance criteria|0|||
23278696|NCT02554877|64761986|FG000|Overall Study|No longer met eligibility criteria|1|||
23278697|NCT02554877|64761987|FG001|Overall Study|No longer met eligibility criteria|0|||
23278698|NCT02554877|64761988|FG002|Overall Study|No longer met eligibility criteria|1|||
23278699|NCT02554877|64761989|FG003|Overall Study|No longer met eligibility criteria|1|||
23278700|NCT02554877|64761986|FG000|Overall Study|Protocol Violation|3|||
23278701|NCT02554877|64761987|FG001|Overall Study|Protocol Violation|1|||
23278702|NCT02554877|64761988|FG002|Overall Study|Protocol Violation|1|||
23278703|NCT02554877|64761989|FG003|Overall Study|Protocol Violation|0|||
23278704|NCT02554877|64761986|FG000|Overall Study|Other|1|||
23278705|NCT02554877|64761987|FG001|Overall Study|Other|3|||
23278706|NCT02554877|64761988|FG002|Overall Study|Other|0|||
23278707|NCT02554877|64761989|FG003|Overall Study|Other|3|||
23278708|NCT02554877|64761986|FG000|Overall Study|Insufficient clinical response|4|||
23278709|NCT02554877|64761987|FG001|Overall Study|Insufficient clinical response|0|||
23278710|NCT02554877|64761988|FG002|Overall Study|Insufficient clinical response|0|||
23278711|NCT02554877|64761989|FG003|Overall Study|Insufficient clinical response|0|||
23278712|NCT02554877|64761986|FG000|Overall Study|No longer willing to participate|0|||
23278713|NCT02554877|64761987|FG001|Overall Study|No longer willing to participate|2|||
23278714|NCT02554877|64761988|FG002|Overall Study|No longer willing to participate|2|||
23278715|NCT02554877|64761989|FG003|Overall Study|No longer willing to participate|0|||
23278716|NCT01926119|64761990|FG000|Overall Study|Withdrawal by Subject|1|||
23278717|NCT00850174|64761991|FG000|Washout: One Week|Withdrawal by Subject|0|||
23278718|NCT00850174|64761992|FG001|Washout: One Week|Withdrawal by Subject|2|||
23278719|NCT00850174|64761991|FG000|Second Intervention|Withdrawal by Subject|1|||
23278720|NCT00850174|64761992|FG001|Second Intervention|Withdrawal by Subject|0|||
23278721|NCT01577381|64761993|FG000|Overall Study|Discontinued|2|||
23485808|NCT01709578|65521868|FG002|Overall Study|Other, not related to safety or efficacy|5|||
23485809|NCT01562873|65521869|FG000|Overall Study|Disease Progression per RECIST|10|||
23485810|NCT01562873|65521870|FG001|Overall Study|Disease Progression per RECIST|0|||
23485811|NCT01562873|65521869|FG000|Overall Study|Adverse Event|1|||
23485812|NCT01562873|65521870|FG001|Overall Study|Adverse Event|0|||
23485813|NCT01562873|65521869|FG000|Overall Study|Clinical Disease Progression|9|||
23485814|NCT01562873|65521870|FG001|Overall Study|Clinical Disease Progression|0|||
23485815|NCT01562873|65521869|FG000|Overall Study|Clinical PD and adverse event|1|||
23485816|NCT01562873|65521870|FG001|Overall Study|Clinical PD and adverse event|0|||
23485817|NCT03463031|65521871|FG000|Overall Study|Withdrawal by Subject|4|||
23485818|NCT03463031|65521872|FG001|Overall Study|Withdrawal by Subject|2|||
23485819|NCT03463031|65521871|FG000|Overall Study|Investigator/Sponsor Decision|0|||
23485820|NCT03463031|65521872|FG001|Overall Study|Investigator/Sponsor Decision|1|||
23485821|NCT03463031|65521871|FG000|Overall Study|Lost to Follow-up|1|||
23485822|NCT03463031|65521872|FG001|Overall Study|Lost to Follow-up|1|||
23485823|NCT03463031|65521871|FG000|Overall Study|Adverse Event|4|||
23485824|NCT03463031|65521872|FG001|Overall Study|Adverse Event|1|||
23485825|NCT03463031|65521871|FG000|Overall Study|Use of prohibited medication by subject|1|||
23485826|NCT03463031|65521872|FG001|Overall Study|Use of prohibited medication by subject|0|||
23485827|NCT01624870|65521880|FG000|Overall Study|Death|19|||
23485828|NCT01624870|65521880|FG000|Overall Study|Withdrawal by Subject|1|||
23485829|NCT01624870|65521880|FG000|Overall Study|CoreValve not implanted|6|||
23485830|NCT01624870|65521880|FG000|Overall Study|Lost to follow up|1|||
23485831|NCT00417482|65521886|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
23485832|NCT00417482|65521887|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
23485833|NCT00417482|65521888|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
23485834|NCT00417482|65521886|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
23278722|NCT01577381|64761994|FG001|Overall Study|Discontinued|1|||
23278723|NCT01577381|64761995|FG002|Overall Study|Discontinued|2|||
23278724|NCT01577381|64761996|FG003|Overall Study|Discontinued|2|||
23278725|NCT01577381|64761993|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
23278726|NCT01577381|64761994|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
23278727|NCT01577381|64761995|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
23278728|NCT01577381|64761996|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
23278729|NCT00927069|64761997|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
23278730|NCT00927069|64761998|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
23278731|NCT00927069|64761999|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
23278732|NCT00927069|64762000|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
23278733|NCT00927069|64761997|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
23278734|NCT00927069|64761998|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
23278735|NCT00927069|64761999|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
23278736|NCT00927069|64762000|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
23278737|NCT00927069|64761997|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
23278738|NCT00927069|64761998|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
23278739|NCT00927069|64761999|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
23278740|NCT00927069|64762000|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
23278741|NCT00927069|64761997|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
23278742|NCT00927069|64761998|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
23278743|NCT00927069|64761999|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
23278744|NCT00927069|64762000|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
23278745|NCT00927069|64761997|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
23278746|NCT00927069|64761998|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
23278747|NCT00927069|64761999|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
23278748|NCT00927069|64762000|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
23278749|NCT03276754|64762003|FG000|Overall Study|Withdrawal of informed consent|4|||
23278750|NCT03276754|64762003|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
23278751|NCT03276754|64762003|FG000|Overall Study|Lost to Follow-up|27|||
23278752|NCT03276754|64762003|FG000|Overall Study|No data reported at Month 24|31|||
23278753|NCT03276754|64762003|FG000|Overall Study|Death|39|||
23278754|NCT00935012|64762006|FG000|Overall Study|Death|19|||
23278755|NCT00935012|64762006|FG000|Overall Study|Withdrawal by Subject|3|||
23278756|NCT00935012|64762006|FG000|Overall Study|Other|5|||
23278757|NCT00935012|64762006|FG000|Overall Study|Adverse Event|2|||
23278758|NCT00244764|64762012|FG000|Overall Study|Adverse Event|37|||
23278759|NCT00244764|64762012|FG000|Overall Study|Lost to Follow-up|23|||
23278760|NCT00244764|64762012|FG000|Overall Study|Withdrawal by Subject|12|||
23371276|NCT02611882|65106078|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
23485835|NCT00417482|65521887|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
23485836|NCT00417482|65521888|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
23485837|NCT00417482|65521886|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
23278761|NCT00244764|64762012|FG000|Overall Study|Disease Progression|13|||
23278762|NCT00244764|64762012|FG000|Overall Study|Protocol Violation|2|||
23278763|NCT00244764|64762012|FG000|Overall Study|Death|1|||
23278764|NCT00244764|64762012|FG000|Overall Study|Off Study Medication for >21 Days|1|||
23278765|NCT00244764|64762012|FG000|Overall Study|Declining Performance Status|1|||
23278766|NCT00244764|64762012|FG000|Overall Study|Participant was Hospitalized until Death|1|||
23278767|NCT00244764|64762012|FG000|Overall Study|Primary Investigator Discretion|2|||
23278768|NCT00244764|64762012|FG000|Overall Study|Sponsor Terminated Study|2|||
23278769|NCT00244764|64762012|FG000|Overall Study|Developed Secondary Malignancy|1|||
23278770|NCT00834743|64762018|FG000|Second Intervention|Withdrawal by Subject|1|||
23278771|NCT00834743|64762019|FG001|Second Intervention|Withdrawal by Subject|0|||
23278772|NCT00840411|64762022|FG000|First Intervention|Adverse Event|1|||
23278773|NCT00840411|64762023|FG001|First Intervention|Adverse Event|0|||
23278774|NCT00840411|64762022|FG000|Washout|Withdrawal by Subject|1|||
23278775|NCT00840411|64762023|FG001|Washout|Withdrawal by Subject|0|||
23278776|NCT01547286|64762024|FG000|Overall Study|Did not meet all eligibility criteria|1|||
23278777|NCT01547286|64762024|FG000|Overall Study|Physician Decision|1|||
23278778|NCT01056484|64762025|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
23278779|NCT01056484|64762026|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
23278780|NCT01056484|64762025|FG000|Randomized Controlled Trial|Physician Decision|1|||
23278781|NCT01056484|64762026|FG001|Randomized Controlled Trial|Physician Decision|0|||
23278782|NCT01056484|64762025|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
23278783|NCT01056484|64762026|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
23278784|NCT02186821|64762027|FG000|Overall Study|Adverse Event|9|||
23278785|NCT02186821|64762027|FG000|Overall Study|Death|2|||
23278786|NCT02186821|64762027|FG000|Overall Study|Disease progression|32|||
23278787|NCT02186821|64762027|FG000|Overall Study|Protocol Violation|1|||
23278788|NCT02186821|64762027|FG000|Overall Study|Physician Decision|1|||
23278789|NCT02186821|64762027|FG000|Overall Study|Study terminated by sponsor|2|||
23278790|NCT03122535|64762028|FG000|Overall Study|Lost to Follow-up|68|||
23278791|NCT03122535|64762029|FG001|Overall Study|Lost to Follow-up|68|||
23278792|NCT03122535|64762028|FG000|Overall Study|Physician Decision|3|||
23278793|NCT03122535|64762029|FG001|Overall Study|Physician Decision|3|||
23278794|NCT03122535|64762028|FG000|Overall Study|Withdrawal by Subject|2|||
23278795|NCT03122535|64762029|FG001|Overall Study|Withdrawal by Subject|2|||
23278796|NCT01855750|64762036|FG000|Overall Study|Death|78|||
23278797|NCT01855750|64762037|FG001|Overall Study|Death|78|||
23278798|NCT01855750|64762036|FG000|Overall Study|Lost to Follow-up|9|||
23278799|NCT01855750|64762037|FG001|Overall Study|Lost to Follow-up|23|||
23278800|NCT01855750|64762036|FG000|Overall Study|Withdrawal by Subject|35|||
23278801|NCT01855750|64762037|FG001|Overall Study|Withdrawal by Subject|28|||
23278802|NCT01855750|64762036|FG000|Overall Study|Sponsor ends the study|297|||
23278803|NCT01855750|64762037|FG001|Overall Study|Sponsor ends the study|290|||
23278804|NCT00834756|64762038|FG000|First Intervention|Adverse Event|1|||
23278805|NCT00834756|64762039|FG001|First Intervention|Adverse Event|0|||
23278806|NCT00834756|64762038|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
23278807|NCT00834756|64762039|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
23278808|NCT03098394|64762041|FG000|Overall Study|Pregnancy|0|||
23278809|NCT03098394|64762042|FG001|Overall Study|Pregnancy|1|||
23485838|NCT00417482|65521887|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
23485839|NCT00417482|65521888|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
23485840|NCT00417482|65521886|FG000|Phase B 1st 16 Weeks|Death|1|||
23485841|NCT00417482|65521887|FG001|Phase B 1st 16 Weeks|Death|0|||
23485842|NCT00417482|65521888|FG002|Phase B 1st 16 Weeks|Death|0|||
23485843|NCT00417482|65521886|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
23485844|NCT00417482|65521887|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
23485845|NCT00417482|65521888|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
23485846|NCT00417482|65521886|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
23485847|NCT00417482|65521887|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
23485848|NCT00417482|65521888|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
23485849|NCT00417482|65521886|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
23485850|NCT00417482|65521887|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
23485851|NCT00417482|65521888|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
23485852|NCT00417482|65521886|FG000|Phase B 2nd 16 Weeks|Death|1|||
23485853|NCT00417482|65521887|FG001|Phase B 2nd 16 Weeks|Death|1|||
23485854|NCT00417482|65521888|FG002|Phase B 2nd 16 Weeks|Death|0|||
23485855|NCT00640835|65521892|FG000|Overall Study|Adverse Event|5|||
23485856|NCT00640835|65521893|FG001|Overall Study|Adverse Event|3|||
23485857|NCT00640835|65521892|FG000|Overall Study|Withdrawal by Subject|12|||
23485858|NCT00640835|65521893|FG001|Overall Study|Withdrawal by Subject|14|||
23485859|NCT00640835|65521892|FG000|Overall Study|Physician Decision|10|||
23485860|NCT00640835|65521893|FG001|Overall Study|Physician Decision|14|||
23485861|NCT00640835|65521892|FG000|Overall Study|Sponsor's Decision|11|||
23485862|NCT00640835|65521893|FG001|Overall Study|Sponsor's Decision|7|||
23485863|NCT00640835|65521892|FG000|Overall Study|Protocol Violation|2|||
23485864|NCT00640835|65521893|FG001|Overall Study|Protocol Violation|2|||
23485865|NCT00640835|65521892|FG000|Overall Study|Lost to Follow-up|17|||
23485866|NCT00640835|65521893|FG001|Overall Study|Lost to Follow-up|13|||
23485867|NCT00640835|65521892|FG000|Overall Study|Other Reason|19|||
23485868|NCT00640835|65521893|FG001|Overall Study|Other Reason|4|||
23485869|NCT02284178|65521895|FG000|Overall Study|Met exclusion criteria|49|||
23485870|NCT02284178|65521896|FG001|Overall Study|Met exclusion criteria|54|||
23485871|NCT00814801|65521899|FG000|Overall Study|Adverse Event|15|||
23485872|NCT00814801|65521900|FG001|Overall Study|Adverse Event|16|||
23485873|NCT00814801|65521901|FG002|Overall Study|Adverse Event|19|||
23485874|NCT00814801|65521899|FG000|Overall Study|Withdrawal by Subject|9|||
23485875|NCT00814801|65521900|FG001|Overall Study|Withdrawal by Subject|11|||
23485876|NCT00814801|65521901|FG002|Overall Study|Withdrawal by Subject|14|||
23485877|NCT00814801|65521899|FG000|Overall Study|Inappropriate as a subject|1|||
23485878|NCT00814801|65521900|FG001|Overall Study|Inappropriate as a subject|1|||
23485879|NCT00814801|65521901|FG002|Overall Study|Inappropriate as a subject|1|||
23485880|NCT00814801|65521899|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
23485881|NCT00814801|65521900|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
23485882|NCT00814801|65521901|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
23485883|NCT00814801|65521899|FG000|Overall Study|Missing or change of caregiver|6|||
23485884|NCT00814801|65521900|FG001|Overall Study|Missing or change of caregiver|2|||
23485885|NCT00814801|65521901|FG002|Overall Study|Missing or change of caregiver|4|||
23485886|NCT00814801|65521899|FG000|Overall Study|Non-compliance|0|||
23485887|NCT00814801|65521900|FG001|Overall Study|Non-compliance|1|||
23485888|NCT00814801|65521901|FG002|Overall Study|Non-compliance|1|||
23485889|NCT00814801|65521899|FG000|Overall Study|Other|2|||
23485890|NCT00814801|65521900|FG001|Overall Study|Other|6|||
23485891|NCT00814801|65521901|FG002|Overall Study|Other|4|||
23485892|NCT01697358|65521904|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
23485893|NCT01697358|65521905|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
23485894|NCT01697358|65521904|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
23485895|NCT01697358|65521905|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
23485896|NCT01697358|65521904|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
23485897|NCT01697358|65521905|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
23485898|NCT01697358|65521904|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
23485899|NCT01697358|65521905|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
23485900|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
23485901|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
23485902|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
23485903|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
23485904|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
23485905|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
23603519|NCT00266656|65937397|FG000|Overall Study|Withdrawal by Subject|4|||
23603520|NCT00266656|65937398|FG001|Overall Study|Withdrawal by Subject|2|||
23603521|NCT00266656|65937397|FG000|Overall Study|Did Not Reach Final Height|4|||
23603522|NCT00266656|65937398|FG001|Overall Study|Did Not Reach Final Height|8|||
23603523|NCT00266656|65937397|FG000|Overall Study|Parent/Caregiver Decision|1|||
23603524|NCT00266656|65937398|FG001|Overall Study|Parent/Caregiver Decision|2|||
23603525|NCT00999596|65937399|FG000|Overall Study|Statistical population not required|101|||
23603526|NCT00800176|65937402|FG000|Overall Study|Adverse Event|2|||
23603527|NCT00800176|65937403|FG001|Overall Study|Adverse Event|1|||
23603528|NCT00800176|65937404|FG002|Overall Study|Adverse Event|0|||
23603529|NCT00800176|65937405|FG003|Overall Study|Adverse Event|2|||
23278845|NCT00633594|64762049|FG000|Overall Study|Adverse Event|0|||
23278846|NCT00633594|64762050|FG001|Overall Study|Adverse Event|4|||
23278847|NCT00633594|64762051|FG002|Overall Study|Adverse Event|7|||
23278848|NCT00633594|64762049|FG000|Overall Study|Death|0|||
23278849|NCT00633594|64762050|FG001|Overall Study|Death|1|||
23278850|NCT00633594|64762051|FG002|Overall Study|Death|2|||
23278851|NCT00633594|64762049|FG000|Overall Study|Disease Progression|0|||
23278852|NCT00633594|64762050|FG001|Overall Study|Disease Progression|0|||
23278853|NCT00633594|64762051|FG002|Overall Study|Disease Progression|1|||
23278854|NCT00207090|64762052|FG000|Overall Study|Study drug toxicity|3|||
23278855|NCT00207090|64762052|FG000|Overall Study|Chest wall mass larger|1|||
23278856|NCT00207090|64762052|FG000|Overall Study|Disease progression/relapse|2|||
23278857|NCT00207090|64762052|FG000|Overall Study|Physician Decision|1|||
23371277|NCT02611882|65106079|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
23485906|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
23485907|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
23485908|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
23485909|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
23485910|NCT01697358|65521904|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
23603530|NCT00800176|65937406|FG004|Overall Study|Adverse Event|1|||
23278858|NCT00835536|64762055|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
23278859|NCT00835536|64762056|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
23278860|NCT03663179|64762057|FG000|Overall Study|Withdrawal by Subject|2|||
23278861|NCT03663179|64762058|FG001|Overall Study|Withdrawal by Subject|0|||
23278862|NCT03663179|64762057|FG000|Overall Study|Lost to Follow-up|1|||
23278863|NCT03663179|64762058|FG001|Overall Study|Lost to Follow-up|1|||
23278864|NCT03663179|64762057|FG000|Overall Study|Revealed exclusionary condition|1|||
23278865|NCT03663179|64762058|FG001|Overall Study|Revealed exclusionary condition|0|||
23278866|NCT02963259|64762059|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
23278867|NCT02963259|64762059|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
23278868|NCT02963259|64762059|FG000|Overall Study|Death|1|||
23278869|NCT02963259|64762059|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
23278870|NCT04238754|64762060|FG000|Washout - 1 Week|Lost to Follow-up|1|||
23278871|NCT04238754|64762061|FG001|Washout - 1 Week|Lost to Follow-up|0|||
23278872|NCT02545283|64762063|FG000|Overall Study|Lost to Follow-up|2|||
23278873|NCT02545283|64762064|FG001|Overall Study|Lost to Follow-up|4|||
23278874|NCT02545283|64762063|FG000|Overall Study|Withdrawal by Subject|5|||
23278875|NCT02545283|64762064|FG001|Overall Study|Withdrawal by Subject|9|||
23278876|NCT02545283|64762063|FG000|Overall Study|Death|109|||
23278877|NCT02545283|64762064|FG001|Overall Study|Death|211|||
23278878|NCT02545283|64762063|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
23278879|NCT02545283|64762064|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
23278880|NCT02545283|64762063|FG000|Overall Study|Study Terminated By Sponsor|33|||
23278881|NCT02545283|64762064|FG001|Overall Study|Study Terminated By Sponsor|71|||
23278882|NCT02039908|64762070|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
23278883|NCT02039908|64762071|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
23278884|NCT02039908|64762072|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
23278885|NCT02039908|64762073|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
23278886|NCT02039908|64762070|FG000|Phase 1-Summer|Protocol Violation|6|||
23278887|NCT02039908|64762071|FG001|Phase 1-Summer|Protocol Violation|0|||
23278888|NCT02039908|64762072|FG002|Phase 1-Summer|Protocol Violation|0|||
23278889|NCT02039908|64762073|FG003|Phase 1-Summer|Protocol Violation|0|||
23278890|NCT02039908|64762070|FG000|Phase 2-School Year|Lost to Follow-up|0|||
23278891|NCT02039908|64762071|FG001|Phase 2-School Year|Lost to Follow-up|0|||
23278892|NCT02039908|64762072|FG002|Phase 2-School Year|Lost to Follow-up|1|||
23278893|NCT02039908|64762073|FG003|Phase 2-School Year|Lost to Follow-up|3|||
23278894|NCT02039908|64762070|FG000|Phase 2-School Year|Protocol Violation|0|||
23278895|NCT02039908|64762071|FG001|Phase 2-School Year|Protocol Violation|0|||
23278896|NCT02039908|64762072|FG002|Phase 2-School Year|Protocol Violation|3|||
23278897|NCT02039908|64762073|FG003|Phase 2-School Year|Protocol Violation|0|||
23278898|NCT02039908|64762070|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
23278899|NCT02039908|64762071|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
23278900|NCT02039908|64762072|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
23278901|NCT02039908|64762073|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
23278902|NCT00909753|64762075|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
23278903|NCT00909753|64762076|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
23278904|NCT00909753|64762075|FG000|Period: Second Intervention|Protocol Violation|1|||
23278905|NCT00909753|64762076|FG001|Period: Second Intervention|Protocol Violation|0|||
23278906|NCT03792477|64762077|FG000|Overall Study|Adverse Event|0|||
23278907|NCT03792477|64762078|FG001|Overall Study|Adverse Event|0|||
23278908|NCT03792477|64762079|FG002|Overall Study|Adverse Event|0|||
23278909|NCT03792477|64762080|FG003|Overall Study|Adverse Event|1|||
23278910|NCT03792477|64762081|FG004|Overall Study|Adverse Event|0|||
23278911|NCT03792477|64762077|FG000|Overall Study|Lost to Follow-up|0|||
23278912|NCT03792477|64762078|FG001|Overall Study|Lost to Follow-up|0|||
23278913|NCT03792477|64762079|FG002|Overall Study|Lost to Follow-up|2|||
23278914|NCT03792477|64762080|FG003|Overall Study|Lost to Follow-up|0|||
23278915|NCT03792477|64762081|FG004|Overall Study|Lost to Follow-up|0|||
23278916|NCT03792477|64762077|FG000|Overall Study|Other|0|||
23278917|NCT03792477|64762078|FG001|Overall Study|Other|0|||
23278918|NCT03792477|64762079|FG002|Overall Study|Other|0|||
23278919|NCT03792477|64762080|FG003|Overall Study|Other|0|||
23278920|NCT03792477|64762081|FG004|Overall Study|Other|1|||
23278921|NCT00777023|64762083|FG000|Overall Study|Adverse Event|15|||
23278922|NCT00777023|64762084|FG001|Overall Study|Adverse Event|21|||
23278923|NCT00777023|64762085|FG002|Overall Study|Adverse Event|8|||
23278924|NCT00777023|64762083|FG000|Overall Study|Lack of Efficacy|1|||
23278925|NCT00777023|64762084|FG001|Overall Study|Lack of Efficacy|0|||
23278926|NCT00777023|64762085|FG002|Overall Study|Lack of Efficacy|14|||
23278927|NCT00777023|64762083|FG000|Overall Study|Protocol Violation|2|||
23278928|NCT00777023|64762084|FG001|Overall Study|Protocol Violation|1|||
23371278|NCT00499122|65106080|FG000|Overall Study|Withdrawal by Subject|2|||
23278929|NCT00777023|64762085|FG002|Overall Study|Protocol Violation|1|||
23278930|NCT00777023|64762083|FG000|Overall Study|Lost to Follow-up|2|||
23278931|NCT00777023|64762084|FG001|Overall Study|Lost to Follow-up|3|||
23371279|NCT01674725|65106081|FG000|Overall Study|Adverse Event|1|||
23278932|NCT00777023|64762085|FG002|Overall Study|Lost to Follow-up|3|||
23278933|NCT00777023|64762083|FG000|Overall Study|Death|0|||
23278934|NCT00777023|64762084|FG001|Overall Study|Death|1|||
23278935|NCT00777023|64762085|FG002|Overall Study|Death|0|||
23278936|NCT00777023|64762083|FG000|Overall Study|Withdrawal by Subject|7|||
23278937|NCT00777023|64762084|FG001|Overall Study|Withdrawal by Subject|7|||
23278938|NCT00777023|64762085|FG002|Overall Study|Withdrawal by Subject|8|||
23278939|NCT00777023|64762083|FG000|Overall Study|Missing data|1|||
23278940|NCT00777023|64762084|FG001|Overall Study|Missing data|1|||
23278941|NCT00777023|64762085|FG002|Overall Study|Missing data|0|||
23278942|NCT00777023|64762083|FG000|Overall Study|Reasons not specified|4|||
23278943|NCT00777023|64762084|FG001|Overall Study|Reasons not specified|4|||
23278944|NCT00777023|64762085|FG002|Overall Study|Reasons not specified|2|||
23278945|NCT00777023|64762083|FG000|Overall Study|Last dose date unknown|3|||
23278946|NCT00777023|64762084|FG001|Overall Study|Last dose date unknown|3|||
23278947|NCT00777023|64762085|FG002|Overall Study|Last dose date unknown|1|||
23278948|NCT04263649|64762086|FG000|Overall Study|Adverse Event|53|||
23278949|NCT04263649|64762086|FG000|Overall Study|Lost to Follow-up|3|||
23278950|NCT04263649|64762086|FG000|Overall Study|Death|29|||
23278951|NCT04263649|64762086|FG000|Overall Study|Device deficiency|19|||
23278952|NCT04263649|64762086|FG000|Overall Study|other reasons|11|||
23278953|NCT02566850|64762087|FG000|Overall Study|Protocol Violation|1|||
23278954|NCT03238781|64762090|FG000|Overall Study|Adverse Event|1|||
23278955|NCT03238781|64762091|FG001|Overall Study|Adverse Event|1|||
23278956|NCT03238781|64762092|FG002|Overall Study|Adverse Event|2|||
23278957|NCT03238781|64762090|FG000|Overall Study|Lost to Follow-up|2|||
23278958|NCT03238781|64762091|FG001|Overall Study|Lost to Follow-up|1|||
23278959|NCT03238781|64762092|FG002|Overall Study|Lost to Follow-up|2|||
23278960|NCT03238781|64762090|FG000|Overall Study|Withdrawal by Subject|23|||
23278961|NCT03238781|64762091|FG001|Overall Study|Withdrawal by Subject|14|||
23278962|NCT03238781|64762092|FG002|Overall Study|Withdrawal by Subject|16|||
23278963|NCT03238781|64762090|FG000|Overall Study|Decision by sponsor|0|||
23278964|NCT03238781|64762091|FG001|Overall Study|Decision by sponsor|1|||
23278965|NCT03238781|64762092|FG002|Overall Study|Decision by sponsor|0|||
23278966|NCT02178787|64762093|FG000|Overall Study|Lost to Follow-up|1|||
23278967|NCT02178787|64762094|FG001|Overall Study|Lost to Follow-up|0|||
23278968|NCT02178787|64762093|FG000|Overall Study|Withdrawal by Subject|0|||
23278969|NCT02178787|64762094|FG001|Overall Study|Withdrawal by Subject|2|||
23278970|NCT02178787|64762093|FG000|Overall Study|No TCD window|3|||
23278971|NCT02178787|64762094|FG001|Overall Study|No TCD window|7|||
23278972|NCT02178787|64762093|FG000|Overall Study|Physician Decision|1|||
23278973|NCT02178787|64762094|FG001|Overall Study|Physician Decision|0|||
23278974|NCT02576938|64762095|FG000|Overall Study|Adverse Event|5|||
23278975|NCT02576938|64762096|FG001|Overall Study|Adverse Event|3|||
23278976|NCT02576938|64762097|FG002|Overall Study|Adverse Event|6|||
23278977|NCT02576938|64762095|FG000|Overall Study|Protocol Violation|1|||
23278978|NCT02576938|64762096|FG001|Overall Study|Protocol Violation|1|||
23278979|NCT02576938|64762097|FG002|Overall Study|Protocol Violation|1|||
23278980|NCT02576938|64762095|FG000|Overall Study|Withdrawal by Subject|3|||
23278981|NCT02576938|64762096|FG001|Overall Study|Withdrawal by Subject|2|||
23278982|NCT02576938|64762097|FG002|Overall Study|Withdrawal by Subject|4|||
23278983|NCT02576938|64762095|FG000|Overall Study|Lack of Efficacy|9|||
23278984|NCT02576938|64762096|FG001|Overall Study|Lack of Efficacy|4|||
23278985|NCT02576938|64762097|FG002|Overall Study|Lack of Efficacy|0|||
23278986|NCT02576938|64762095|FG000|Overall Study|Lost to Follow-up|2|||
23278987|NCT02576938|64762096|FG001|Overall Study|Lost to Follow-up|0|||
23278988|NCT02576938|64762097|FG002|Overall Study|Lost to Follow-up|1|||
23278989|NCT02576938|64762095|FG000|Overall Study|Physician Decision|0|||
23278990|NCT02576938|64762096|FG001|Overall Study|Physician Decision|1|||
23278991|NCT02576938|64762097|FG002|Overall Study|Physician Decision|0|||
23278992|NCT02576938|64762095|FG000|Overall Study|Met Exclusion Criteria|0|||
23278993|NCT02576938|64762096|FG001|Overall Study|Met Exclusion Criteria|1|||
23278994|NCT02576938|64762097|FG002|Overall Study|Met Exclusion Criteria|0|||
23278995|NCT00909610|64762106|FG000|Period: First Intervention|Adverse Event|0|||
23278996|NCT00909610|64762107|FG001|Period: First Intervention|Adverse Event|1|||
23278997|NCT00909610|64762106|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
23278998|NCT00909610|64762107|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
23278999|NCT00909610|64762106|FG000|Period: Second Intervention|Adverse Event|1|||
23279000|NCT00909610|64762107|FG001|Period: Second Intervention|Adverse Event|0|||
23279001|NCT01289262|64765249|FG000|Overall Study|Lost to Follow-up|29|||
23279002|NCT01289262|64765250|FG001|Overall Study|Lost to Follow-up|16|||
23279003|NCT01289262|64765249|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
23279004|NCT01289262|64765250|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
23279005|NCT00712959|64765255|FG000|Overall Study|Protocol Violation|3|||
23279006|NCT00712959|64765256|FG001|Overall Study|Protocol Violation|1|||
23279007|NCT00712959|64765255|FG000|Overall Study|Lost to Follow-up|13|||
23279008|NCT00712959|64765256|FG001|Overall Study|Lost to Follow-up|2|||
23279009|NCT00712959|64765255|FG000|Overall Study|Withdrawal by Subject|3|||
23279010|NCT00712959|64765256|FG001|Overall Study|Withdrawal by Subject|0|||
23279011|NCT02151981|64765259|FG000|Overall Study|Death|184|||
23279012|NCT02151981|64765260|FG001|Overall Study|Death|88|||
23279013|NCT02151981|64765259|FG000|Overall Study|Lost to Follow-up|7|||
23279014|NCT02151981|64765260|FG001|Overall Study|Lost to Follow-up|1|||
23279015|NCT02151981|64765259|FG000|Overall Study|Withdrawal by Subject|27|||
23279016|NCT02151981|64765260|FG001|Overall Study|Withdrawal by Subject|21|||
23279017|NCT02151981|64765259|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
23279018|NCT02151981|64765260|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
23279019|NCT02151981|64765259|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23279020|NCT02151981|64765260|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23279021|NCT02151981|64765259|FG000|Overall Study|Patient had no clinical benefit|1|||
23279022|NCT02151981|64765260|FG001|Overall Study|Patient had no clinical benefit|0|||
23279023|NCT02151981|64765259|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
23279024|NCT02151981|64765260|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
23279025|NCT02151981|64765259|FG000|Overall Study|Study terminated|0|||
23279026|NCT02151981|64765260|FG001|Overall Study|Study terminated|1|||
23279027|NCT00624286|64765263|FG000|Overall Study|Protocol Deviation|7|||
23279028|NCT00624286|64765264|FG001|Overall Study|Protocol Deviation|9|||
23279029|NCT00624286|64765263|FG000|Overall Study|Adverse Event|6|||
23279030|NCT00624286|64765264|FG001|Overall Study|Adverse Event|3|||
23279031|NCT00624286|64765263|FG000|Overall Study|Withdrawal by Subject|5|||
23279032|NCT00624286|64765264|FG001|Overall Study|Withdrawal by Subject|4|||
23279033|NCT00624286|64765263|FG000|Overall Study|Lost to Follow-up|3|||
23279034|NCT00624286|64765264|FG001|Overall Study|Lost to Follow-up|2|||
23279035|NCT00624286|64765263|FG000|Overall Study|Administrative problems|3|||
23279036|NCT00624286|64765264|FG001|Overall Study|Administrative problems|0|||
23279037|NCT00624286|64765263|FG000|Overall Study|Lack of Efficacy|1|||
23279038|NCT00624286|64765264|FG001|Overall Study|Lack of Efficacy|6|||
23279039|NCT00624286|64765263|FG000|Overall Study|Not stated|0|||
23279040|NCT00624286|64765264|FG001|Overall Study|Not stated|1|||
23279041|NCT00624286|64765263|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23279042|NCT00624286|64765264|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23279043|NCT00624286|64765263|FG000|Overall Study|Death|0|||
23279044|NCT00624286|64765264|FG001|Overall Study|Death|1|||
23279045|NCT05133180|64765265|FG000|Overall Study|Withdrawal of consent|1|||
23279046|NCT05133180|64765266|FG001|Overall Study|Withdrawal of consent|1|||
23279047|NCT05133180|64765265|FG000|Overall Study|Lost to Follow-up|1|||
23279048|NCT05133180|64765266|FG001|Overall Study|Lost to Follow-up|1|||
23279049|NCT05133180|64765265|FG000|Overall Study|Documented disease progression|0|||
23279050|NCT05133180|64765266|FG001|Overall Study|Documented disease progression|1|||
23279051|NCT02269657|64765268|FG000|Overall Study|Protocol Violation|3|||
23279052|NCT01788423|64765269|FG000|Overall Study|See Comments in Completed (above)|0|||
23279053|NCT01788423|64765270|FG001|Overall Study|See Comments in Completed (above)|4|||
23279054|NCT01788423|64765271|FG002|Overall Study|See Comments in Completed (above)|5|||
23279055|NCT02476994|64765275|FG000|Overall Study|Based on feedback from FDA|1|||
23279056|NCT02476994|64765276|FG001|Overall Study|Based on feedback from FDA|0|||
23279057|NCT03447353|64765277|FG000|Overall Study|Failure at Screening Visit|2|||
23279058|NCT03447353|64765277|FG000|Overall Study|Lost to Follow-up|4|||
23279059|NCT03447353|64765277|FG000|Overall Study|Scheduling Conflicts|3|||
23279060|NCT03447353|64765277|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
23279061|NCT00123734|64765283|FG000|Overall Study|Death|3|||
23279062|NCT00123734|64765283|FG000|Overall Study|Lost to Follow-up|3|||
23279063|NCT00123734|64765283|FG000|Overall Study|Dropout|1|||
23279064|NCT00123734|64765283|FG000|Overall Study|Withdrawal by Subject|1|||
23279065|NCT00272779|64765285|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
23279066|NCT00272779|64765286|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
23279067|NCT00272779|64765285|FG000|Baseline Through Week 48|Death before Week 48|4|||
23279068|NCT00272779|64765286|FG001|Baseline Through Week 48|Death before Week 48|4|||
23279069|NCT00272779|64765285|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
23279070|NCT00272779|64765286|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
23279071|NCT00272779|64765285|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
23279072|NCT00272779|64765286|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
23279073|NCT00272779|64765285|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
23279074|NCT00272779|64765286|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
23279075|NCT00272779|64765285|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
23279076|NCT00272779|64765286|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
23279077|NCT00272779|64765285|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
23279078|NCT00272779|64765286|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
23279079|NCT00272779|64765285|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
23279080|NCT00272779|64765286|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
23279081|NCT00272779|64765285|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
23371280|NCT01674725|65106082|FG001|Overall Study|Adverse Event|0|||
23371281|NCT01674725|65106081|FG000|Overall Study|Did not receive study drug|1|||
23279082|NCT00272779|64765286|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
23279083|NCT00272779|64765285|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
23279084|NCT00272779|64765286|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
23371282|NCT01674725|65106082|FG001|Overall Study|Did not receive study drug|0|||
23279085|NCT00272779|64765285|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
23279086|NCT00272779|64765286|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
23279087|NCT00272779|64765285|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
23279088|NCT00272779|64765286|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
23279089|NCT00272779|64765285|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
23279090|NCT00272779|64765286|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
23279091|NCT00272779|64765285|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
23279092|NCT00272779|64765286|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
23279093|NCT00272779|64765285|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
23279094|NCT00272779|64765286|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
23279095|NCT00272779|64765285|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
23279096|NCT00272779|64765286|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
23279097|NCT00272779|64765285|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
23279098|NCT00272779|64765286|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
23279099|NCT00272779|64765285|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
23279100|NCT00272779|64765286|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
23279101|NCT00272779|64765285|FG000|Baseline Through Week 48|Continuing treatment|385|||
23279102|NCT00272779|64765286|FG001|Baseline Through Week 48|Continuing treatment|368|||
23279103|NCT00272779|64765285|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
23279104|NCT00272779|64765286|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
23279105|NCT00272779|64765285|FG000|Baseline Through Week 48|Never treated|2|||
23279106|NCT00272779|64765286|FG001|Baseline Through Week 48|Never treated|3|||
23279107|NCT00272779|64765285|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
23279108|NCT00272779|64765286|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
23279109|NCT00272779|64765285|FG000|Baseline Through Week 96|Death before Week 96|6|||
23279110|NCT00272779|64765286|FG001|Baseline Through Week 96|Death before Week 96|5|||
23279111|NCT00272779|64765285|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
23279112|NCT00272779|64765286|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
23279113|NCT00272779|64765285|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
23279114|NCT00272779|64765286|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
23279115|NCT00272779|64765285|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
23279116|NCT00272779|64765286|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
23279117|NCT00272779|64765285|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
23279118|NCT00272779|64765286|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
23279119|NCT00272779|64765285|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
23279120|NCT00272779|64765286|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
23279121|NCT00272779|64765285|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
23279122|NCT00272779|64765286|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
23279123|NCT00272779|64765285|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
23279124|NCT00272779|64765286|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
23279125|NCT00272779|64765285|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
23279126|NCT00272779|64765286|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
23279127|NCT00272779|64765285|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
23279128|NCT00272779|64765286|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
23279129|NCT00272779|64765285|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
23279130|NCT00272779|64765286|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
23279131|NCT00272779|64765285|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
23279132|NCT00272779|64765286|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
23279133|NCT00272779|64765285|FG000|Baseline Through Week 96|Never treated|2|||
23279134|NCT00272779|64765286|FG001|Baseline Through Week 96|Never treated|3|||
23279135|NCT00272779|64765285|FG000|Baseline Through Week 96|Continuing on treatment|61|||
23279136|NCT00272779|64765286|FG001|Baseline Through Week 96|Continuing on treatment|38|||
23279137|NCT00851877|64765287|FG000|Phase I-1|Death|1|||
23279138|NCT00851877|64765288|FG001|Phase I-1|Death|0|||
23279139|NCT00851877|64765289|FG002|Phase I-1|Death|0|||
23279140|NCT00851877|64765287|FG000|Phase II|Withdrawal by Subject|0|||
23279141|NCT00851877|64765288|FG001|Phase II|Withdrawal by Subject|0|||
23279142|NCT00851877|64765289|FG002|Phase II|Withdrawal by Subject|3|||
23279143|NCT01348789|64765291|FG000|Overall Study|Protocol Violation|2|||
23279144|NCT01348789|64765291|FG000|Overall Study|Withdrawal by Subject|2|||
23279145|NCT00984022|64765297|FG000|Overall Study|Lost to Follow-up|10|||
23279146|NCT00984022|64765298|FG001|Overall Study|Lost to Follow-up|14|||
23279147|NCT02819518|64765299|FG000|Overall Study|Death|9|||
23279148|NCT02819518|64765300|FG001|Overall Study|Death|11|||
23279149|NCT02819518|64765301|FG002|Overall Study|Death|9|||
23279150|NCT02819518|64765302|FG003|Overall Study|Death|447|||
23279151|NCT02819518|64765303|FG004|Overall Study|Death|233|||
23603531|NCT00800176|65937407|FG005|Overall Study|Adverse Event|1|||
23603532|NCT00800176|65937402|FG000|Overall Study|Refused treatment|3|||
23603533|NCT00800176|65937403|FG001|Overall Study|Refused treatment|2|||
23279152|NCT02819518|64765299|FG000|Overall Study|Withdrawal by Subject|0|||
23279153|NCT02819518|64765300|FG001|Overall Study|Withdrawal by Subject|0|||
23279154|NCT02819518|64765301|FG002|Overall Study|Withdrawal by Subject|0|||
23279155|NCT02819518|64765302|FG003|Overall Study|Withdrawal by Subject|21|||
23371283|NCT01674725|65106081|FG000|Overall Study|Withdrawal by Subject|1|||
23371284|NCT01674725|65106082|FG001|Overall Study|Withdrawal by Subject|0|||
23371285|NCT01674725|65106081|FG000|Overall Study|Lost to Follow-up|0|||
23371286|NCT01674725|65106082|FG001|Overall Study|Lost to Follow-up|1|||
23371287|NCT00408499|65106084|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
23371288|NCT00408499|65106085|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
23279156|NCT02819518|64765303|FG004|Overall Study|Withdrawal by Subject|6|||
23279157|NCT02819518|64765299|FG000|Overall Study|Ongoing in Study|2|||
23279158|NCT02819518|64765300|FG001|Overall Study|Ongoing in Study|3|||
23279159|NCT02819518|64765301|FG002|Overall Study|Ongoing in Study|1|||
23371289|NCT00408499|65106086|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
23371290|NCT00408499|65106087|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
23371291|NCT00408499|65106088|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
23371292|NCT00408499|65106084|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
23371293|NCT00408499|65106085|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
23371294|NCT00408499|65106086|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
23371295|NCT00408499|65106087|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
23371296|NCT00408499|65106088|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
23371297|NCT00408499|65106084|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
23371298|NCT00408499|65106085|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
23371299|NCT00408499|65106086|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
23371300|NCT00408499|65106087|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
23371301|NCT00408499|65106088|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
23371302|NCT00408499|65106084|FG000|Phase II- MTD Expansion|Adverse Event|0|||
23371303|NCT00408499|65106085|FG001|Phase II- MTD Expansion|Adverse Event|0|||
23371304|NCT00408499|65106086|FG002|Phase II- MTD Expansion|Adverse Event|0|||
23371305|NCT00408499|65106087|FG003|Phase II- MTD Expansion|Adverse Event|0|||
23371306|NCT00408499|65106088|FG004|Phase II- MTD Expansion|Adverse Event|9|||
23371307|NCT00408499|65106084|FG000|Phase II- MTD Expansion|Death|0|||
23371308|NCT00408499|65106085|FG001|Phase II- MTD Expansion|Death|0|||
23371309|NCT00408499|65106086|FG002|Phase II- MTD Expansion|Death|0|||
23371310|NCT00408499|65106087|FG003|Phase II- MTD Expansion|Death|0|||
23371311|NCT00408499|65106088|FG004|Phase II- MTD Expansion|Death|2|||
23371312|NCT00408499|65106084|FG000|Phase II- MTD Expansion|Physician Decision|0|||
23371313|NCT00408499|65106085|FG001|Phase II- MTD Expansion|Physician Decision|0|||
23371314|NCT00408499|65106086|FG002|Phase II- MTD Expansion|Physician Decision|0|||
23371315|NCT00408499|65106087|FG003|Phase II- MTD Expansion|Physician Decision|0|||
23371316|NCT00408499|65106088|FG004|Phase II- MTD Expansion|Physician Decision|1|||
23371317|NCT00408499|65106084|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
23485911|NCT01697358|65521905|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
23485912|NCT03345342|65521906|FG000|Open-Label Phase|Adverse Event|30|||
23485913|NCT03345342|65521907|FG001|Open-Label Phase|Adverse Event|0|||
23603534|NCT00800176|65937404|FG002|Overall Study|Refused treatment|0|||
23603535|NCT00800176|65937405|FG003|Overall Study|Refused treatment|0|||
23603536|NCT00800176|65937406|FG004|Overall Study|Refused treatment|1|||
23603537|NCT00800176|65937407|FG005|Overall Study|Refused treatment|4|||
23603538|NCT00800176|65937402|FG000|Overall Study|Failure to return|3|||
23603539|NCT00800176|65937403|FG001|Overall Study|Failure to return|3|||
23603540|NCT00800176|65937404|FG002|Overall Study|Failure to return|0|||
23603541|NCT00800176|65937405|FG003|Overall Study|Failure to return|2|||
23603542|NCT00800176|65937406|FG004|Overall Study|Failure to return|0|||
23603543|NCT00800176|65937407|FG005|Overall Study|Failure to return|0|||
23603544|NCT00800176|65937402|FG000|Overall Study|Other|1|||
23603545|NCT00800176|65937403|FG001|Overall Study|Other|0|||
23603546|NCT00800176|65937404|FG002|Overall Study|Other|0|||
23603547|NCT00800176|65937405|FG003|Overall Study|Other|0|||
23603548|NCT00800176|65937406|FG004|Overall Study|Other|2|||
23603549|NCT00800176|65937407|FG005|Overall Study|Other|0|||
23603550|NCT02824198|65937409|FG000|Overall Study|Non-compliance with the protocol|5|||
23603551|NCT02824198|65937410|FG001|Overall Study|Non-compliance with the protocol|1|||
23603552|NCT02824198|65937409|FG000|Overall Study|Lost to Follow-up|5|||
23603553|NCT02824198|65937410|FG001|Overall Study|Lost to Follow-up|2|||
23279160|NCT02819518|64765302|FG003|Overall Study|Ongoing in Study|98|||
23371318|NCT00408499|65106085|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
23371319|NCT00408499|65106086|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
23371320|NCT00408499|65106087|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
23371321|NCT00408499|65106088|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
23603554|NCT02824198|65937409|FG000|Overall Study|Withdrawal by Subject|5|||
23603555|NCT02824198|65937410|FG001|Overall Study|Withdrawal by Subject|0|||
23371322|NCT00408499|65106084|FG000|Phase II- MTD Expansion|treatment delay|0|||
23371323|NCT00408499|65106085|FG001|Phase II- MTD Expansion|treatment delay|0|||
23371324|NCT00408499|65106086|FG002|Phase II- MTD Expansion|treatment delay|0|||
23371325|NCT00408499|65106087|FG003|Phase II- MTD Expansion|treatment delay|0|||
23371326|NCT00408499|65106088|FG004|Phase II- MTD Expansion|treatment delay|3|||
23371327|NCT03409744|65106089|FG000|Overall Study|Death|2|||
23371328|NCT03409744|65106089|FG000|Overall Study|Physician Decision|5|||
23371329|NCT03409744|65106089|FG000|Overall Study|Pregnancy|1|||
23371330|NCT03409744|65106089|FG000|Overall Study|Lost to Follow-up|1|||
23371331|NCT03409744|65106089|FG000|Overall Study|Protocol Violation|1|||
23371332|NCT01186770|65106090|FG000|Overall Study|Ineligibility|0|||
23371333|NCT01186770|65106091|FG001|Overall Study|Ineligibility|0|||
23371334|NCT01186770|65106092|FG002|Overall Study|Ineligibility|2|||
23371335|NCT01186770|65106093|FG003|Overall Study|Ineligibility|0|||
23371336|NCT01186770|65106090|FG000|Overall Study|Protocol Violation|7|||
23371337|NCT01186770|65106091|FG001|Overall Study|Protocol Violation|9|||
23371338|NCT01186770|65106092|FG002|Overall Study|Protocol Violation|12|||
23371339|NCT01186770|65106093|FG003|Overall Study|Protocol Violation|14|||
23371340|NCT01186770|65106090|FG000|Overall Study|Adverse Event|2|||
23371341|NCT01186770|65106091|FG001|Overall Study|Adverse Event|9|||
23371342|NCT01186770|65106092|FG002|Overall Study|Adverse Event|7|||
23371343|NCT01186770|65106093|FG003|Overall Study|Adverse Event|9|||
23371344|NCT01186770|65106090|FG000|Overall Study|Withdrawal by Subject|15|||
23371345|NCT01186770|65106091|FG001|Overall Study|Withdrawal by Subject|13|||
23371346|NCT01186770|65106092|FG002|Overall Study|Withdrawal by Subject|11|||
23371347|NCT01186770|65106093|FG003|Overall Study|Withdrawal by Subject|17|||
23371348|NCT01186770|65106090|FG000|Overall Study|Lost to Follow-up|10|||
23371349|NCT01186770|65106091|FG001|Overall Study|Lost to Follow-up|6|||
23371350|NCT01186770|65106092|FG002|Overall Study|Lost to Follow-up|14|||
23371351|NCT01186770|65106093|FG003|Overall Study|Lost to Follow-up|9|||
23371352|NCT01186770|65106090|FG000|Overall Study|Insufficient response to treatment|7|||
23371353|NCT01186770|65106091|FG001|Overall Study|Insufficient response to treatment|8|||
23371354|NCT01186770|65106092|FG002|Overall Study|Insufficient response to treatment|5|||
23371355|NCT01186770|65106093|FG003|Overall Study|Insufficient response to treatment|7|||
23371356|NCT01186770|65106090|FG000|Overall Study|Other than specified|0|||
23371357|NCT01186770|65106091|FG001|Overall Study|Other than specified|1|||
23371358|NCT01186770|65106092|FG002|Overall Study|Other than specified|1|||
23371359|NCT01186770|65106093|FG003|Overall Study|Other than specified|2|||
23371360|NCT02160626|65106094|FG000|Overall Study|Adverse Event|1|||
23371361|NCT02160626|65106095|FG001|Overall Study|Adverse Event|0|||
23371362|NCT02160626|65106096|FG002|Overall Study|Adverse Event|0|||
23371363|NCT02160626|65106094|FG000|Overall Study|Schedule not conducive to study visits|0|||
23371364|NCT02160626|65106095|FG001|Overall Study|Schedule not conducive to study visits|0|||
23371365|NCT02160626|65106096|FG002|Overall Study|Schedule not conducive to study visits|1|||
23371366|NCT02160626|65106094|FG000|Overall Study|Withdrawal by Subject|0|||
23371367|NCT02160626|65106095|FG001|Overall Study|Withdrawal by Subject|1|||
23371368|NCT02160626|65106096|FG002|Overall Study|Withdrawal by Subject|0|||
23371369|NCT00094445|65106097|FG000|Overall Study|Withdrawal by Subject|3|||
23371370|NCT00094445|65106097|FG000|Overall Study|Lost to Follow-up|1|||
23371371|NCT00094445|65106097|FG000|Overall Study|Progressive Disease|2|||
23371372|NCT03817528|65106098|FG000|Overall Study|Withdrawal by Subject|1|||
23371373|NCT03817528|65106098|FG000|Overall Study|Adverse Event|2|||
23371374|NCT02295644|65106104|FG000|Overall Study|Did not meet inclusion criterion|0|||
23371375|NCT02295644|65106105|FG001|Overall Study|Did not meet inclusion criterion|0|||
23371376|NCT02295644|65106106|FG002|Overall Study|Did not meet inclusion criterion|1|||
23371377|NCT02295644|65106107|FG003|Overall Study|Did not meet inclusion criterion|2|||
23371378|NCT01026493|65106108|FG000|Overall Study|Protocol Violation|0|||
23371379|NCT01026493|65106109|FG001|Overall Study|Protocol Violation|1|||
23371380|NCT01026493|65106110|FG002|Overall Study|Protocol Violation|0|||
23371381|NCT01026493|65106111|FG003|Overall Study|Protocol Violation|0|||
23371382|NCT01026493|65106112|FG004|Overall Study|Protocol Violation|2|||
23371383|NCT01026493|65106113|FG005|Overall Study|Protocol Violation|3|||
23371384|NCT01026493|65106114|FG006|Overall Study|Protocol Violation|4|||
23485914|NCT03345342|65521908|FG002|Open-Label Phase|Adverse Event|0|||
23603556|NCT00597376|65937416|FG000|Overall Study|Withdrawal by Subject|4|||
23371385|NCT01026493|65106115|FG007|Overall Study|Protocol Violation|1|||
23371386|NCT01586195|65106116|FG000|Overall Study|Death|11|||
23371387|NCT01586195|65106116|FG000|Overall Study|Withdrawal of Consent|5|||
23371388|NCT01586195|65106116|FG000|Overall Study|Started new anti-melanoma therapy|1|||
23371389|NCT01586195|65106116|FG000|Overall Study|Reason not specified|9|||
23371390|NCT01701245|65106117|FG000|Overall Study|Protocol Violation|1|||
23371391|NCT01701245|65106118|FG001|Overall Study|Protocol Violation|3|||
23371392|NCT01701245|65106117|FG000|Overall Study|Did not complete the open label period|11|||
23371393|NCT01701245|65106118|FG001|Overall Study|Did not complete the open label period|12|||
23371394|NCT02897349|65106119|FG000|Overall Study|Lost to Follow-up|2|||
23371395|NCT02897349|65106120|FG001|Overall Study|Lost to Follow-up|2|||
23371396|NCT02897349|65106119|FG000|Overall Study|Adverse Event|3|||
23371397|NCT02897349|65106120|FG001|Overall Study|Adverse Event|3|||
23371398|NCT02897349|65106119|FG000|Overall Study|Other than listed above|0|||
23371399|NCT02897349|65106120|FG001|Overall Study|Other than listed above|1|||
23371400|NCT00472420|65106121|FG000|Induction Treatment Period|Physician Decision|9|||
23371401|NCT00472420|65106121|FG000|Induction Treatment Period|Adverse Event|3|||
23371402|NCT00472420|65106121|FG000|Induction Treatment Period|Non-compliance|1|||
23371403|NCT00472420|65106121|FG000|Induction Treatment Period|Death|3|||
23371404|NCT00472420|65106121|FG000|Follow-up Period|Death|5|||
23371405|NCT00472420|65106121|FG000|Follow-up Period|Physician Decision|9|||
23371406|NCT00472420|65106121|FG000|Follow-up Period|Lost to Follow-up|2|||
23371407|NCT00472420|65106121|FG000|Follow-up Period|Protocol Violation|1|||
23371408|NCT01631214|65106125|FG000|Overall Study|Withdrawal by Subject|276|||
23371409|NCT01631214|65106126|FG001|Overall Study|Withdrawal by Subject|290|||
23371410|NCT01631214|65106125|FG000|Overall Study|Death|113|||
23371411|NCT01631214|65106126|FG001|Overall Study|Death|106|||
23371412|NCT01631214|65106125|FG000|Overall Study|Lost to Follow-up|54|||
23371413|NCT01631214|65106126|FG001|Overall Study|Lost to Follow-up|40|||
23371414|NCT01631214|65106125|FG000|Overall Study|Adverse Event|45|||
23371415|NCT01631214|65106126|FG001|Overall Study|Adverse Event|45|||
23371416|NCT01631214|65106125|FG000|Overall Study|Other|22|||
23371417|NCT01631214|65106126|FG001|Overall Study|Other|19|||
23371418|NCT01631214|65106125|FG000|Overall Study|Noncompliance|16|||
23371419|NCT01631214|65106126|FG001|Overall Study|Noncompliance|15|||
23279161|NCT02819518|64765303|FG004|Overall Study|Ongoing in Study|42|||
23279162|NCT01421277|64765306|FG000|Overall Study|Lack of qualifying event|0|||
23279163|NCT01421277|64765307|FG001|Overall Study|Lack of qualifying event|61|||
23279164|NCT01421277|64765306|FG000|Overall Study|Incomplete baseline data|0|||
23279165|NCT01421277|64765307|FG001|Overall Study|Incomplete baseline data|31|||
23279166|NCT02286739|64765308|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
23279167|NCT02286739|64765309|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
23279168|NCT02286739|64765308|FG000|Overall Study|No Verasense type documented|0|||
23279169|NCT02286739|64765309|FG001|Overall Study|No Verasense type documented|23|||
23279170|NCT02286739|64765308|FG000|Overall Study|Adverse Event|1|||
23279171|NCT02286739|64765309|FG001|Overall Study|Adverse Event|2|||
23279172|NCT02286739|64765308|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
23279173|NCT02286739|64765309|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
23279174|NCT00682461|64765310|FG000|Overall Study|Adverse Event|5|||
23279175|NCT00682461|64765311|FG001|Overall Study|Adverse Event|7|||
23279176|NCT00682461|64765310|FG000|Overall Study|Lost to Follow-up|8|||
23279177|NCT00682461|64765311|FG001|Overall Study|Lost to Follow-up|5|||
23279178|NCT00682461|64765310|FG000|Overall Study|Withdrawal by Subject|12|||
23279179|NCT00682461|64765311|FG001|Overall Study|Withdrawal by Subject|19|||
23279180|NCT01913405|64765313|FG000|Overall Study|Withdrawal by Subject|1|||
23279181|NCT01913405|64765313|FG000|Overall Study|Adverse Event|1|||
23279182|NCT00723710|64765314|FG000|Overall Study|Disease progression|48|||
23279183|NCT00723710|64765314|FG000|Overall Study|Adverse Event|88|||
23279184|NCT00723710|64765314|FG000|Overall Study|Withdrawal by Subject|36|||
23279185|NCT00723710|64765314|FG000|Overall Study|Physician Decision|2|||
23279186|NCT02378935|64765315|FG000|Overall Study|Lack of Efficacy|10|||
23279187|NCT02378935|64765316|FG001|Overall Study|Lack of Efficacy|0|||
23279188|NCT02378935|64765317|FG002|Overall Study|Lack of Efficacy|2|||
23279189|NCT02378935|64765318|FG003|Overall Study|Lack of Efficacy|6|||
23279190|NCT02378935|64765319|FG004|Overall Study|Lack of Efficacy|0|||
23279191|NCT02378935|64765320|FG005|Overall Study|Lack of Efficacy|0|||
23279192|NCT02378935|64765321|FG006|Overall Study|Lack of Efficacy|0|||
23279193|NCT02378935|64765315|FG000|Overall Study|Death|0|||
23279194|NCT02378935|64765316|FG001|Overall Study|Death|0|||
23279195|NCT02378935|64765317|FG002|Overall Study|Death|1|||
23279196|NCT02378935|64765318|FG003|Overall Study|Death|0|||
23279197|NCT02378935|64765319|FG004|Overall Study|Death|0|||
23371420|NCT01631214|65106125|FG000|Overall Study|Requirement for Alternative Therapy|8|||
23371421|NCT01631214|65106126|FG001|Overall Study|Requirement for Alternative Therapy|3|||
23371422|NCT01631214|65106125|FG000|Overall Study|Protocol Deviation|4|||
23279198|NCT02378935|64765320|FG005|Overall Study|Death|0|||
23279199|NCT02378935|64765321|FG006|Overall Study|Death|0|||
23279200|NCT00443651|64765333|FG000|Overall Study|Death|1|||
23279201|NCT00443651|64765334|FG001|Overall Study|Death|5|||
23279202|NCT00443651|64765333|FG000|Overall Study|Adverse Event|5|||
23279203|NCT00443651|64765334|FG001|Overall Study|Adverse Event|6|||
23279204|NCT00443651|64765333|FG000|Overall Study|Lost to Follow-up|18|||
23279205|NCT00443651|64765334|FG001|Overall Study|Lost to Follow-up|12|||
23279206|NCT00443651|64765333|FG000|Overall Study|Patient's/Guardian's Decision|58|||
23279207|NCT00443651|64765334|FG001|Overall Study|Patient's/Guardian's Decision|30|||
23371423|NCT01631214|65106126|FG001|Overall Study|Protocol Deviation|3|||
23371424|NCT01631214|65106125|FG000|Overall Study|Ineligibility determined|5|||
23371425|NCT01631214|65106126|FG001|Overall Study|Ineligibility determined|2|||
23371426|NCT01631214|65106125|FG000|Overall Study|Administrative Decision|1|||
23371427|NCT01631214|65106126|FG001|Overall Study|Administrative Decision|0|||
23371428|NCT01225549|65106134|FG000|Period 4 - Washout|Disallowed medication|0|||
23371429|NCT01225549|65106135|FG001|Period 4 - Washout|Disallowed medication|1|||
23371430|NCT01225549|65106136|FG002|Period 4 - Washout|Disallowed medication|0|||
23371431|NCT01225549|65106137|FG003|Period 4 - Washout|Disallowed medication|0|||
23371432|NCT01225549|65106138|FG004|Period 4 - Washout|Disallowed medication|0|||
23371433|NCT01225549|65106139|FG005|Period 4 - Washout|Disallowed medication|0|||
23371434|NCT01225549|65106140|FG006|Period 4 - Washout|Disallowed medication|0|||
23371435|NCT01225549|65106141|FG007|Period 4 - Washout|Disallowed medication|0|||
23371436|NCT01225549|65106142|FG008|Period 4 - Washout|Disallowed medication|0|||
23371437|NCT01225549|65106143|FG009|Period 4 - Washout|Disallowed medication|0|||
23371438|NCT01225549|65106134|FG000|Period 6 - Washout|Disallowed medication|0|||
23371439|NCT01225549|65106135|FG001|Period 6 - Washout|Disallowed medication|0|||
23371440|NCT01225549|65106136|FG002|Period 6 - Washout|Disallowed medication|0|||
23371441|NCT01225549|65106137|FG003|Period 6 - Washout|Disallowed medication|1|||
23371442|NCT01225549|65106138|FG004|Period 6 - Washout|Disallowed medication|0|||
23371443|NCT01225549|65106139|FG005|Period 6 - Washout|Disallowed medication|0|||
23371444|NCT01225549|65106140|FG006|Period 6 - Washout|Disallowed medication|0|||
23371445|NCT01225549|65106141|FG007|Period 6 - Washout|Disallowed medication|0|||
23371446|NCT01225549|65106142|FG008|Period 6 - Washout|Disallowed medication|0|||
23371447|NCT01225549|65106143|FG009|Period 6 - Washout|Disallowed medication|0|||
23371448|NCT00336544|65106144|FG000|Overall Study|Lack of Efficacy|8|||
23371449|NCT00336544|65106145|FG001|Overall Study|Lack of Efficacy|5|||
23371450|NCT00336544|65106144|FG000|Overall Study|Adverse Event|4|||
23371451|NCT00336544|65106145|FG001|Overall Study|Adverse Event|9|||
23371452|NCT00336544|65106144|FG000|Overall Study|Withdrawal by Subject|4|||
23371453|NCT00336544|65106145|FG001|Overall Study|Withdrawal by Subject|3|||
23371454|NCT00336544|65106144|FG000|Overall Study|Other|3|||
23371455|NCT00336544|65106145|FG001|Overall Study|Other|5|||
23371456|NCT02674516|65106149|FG000|Overall Study|Lost to Follow-up|3|||
23371457|NCT02674516|65106150|FG001|Overall Study|Lost to Follow-up|0|||
23371458|NCT02674516|65106149|FG000|Overall Study|Protocol Violation|0|||
23371459|NCT02674516|65106150|FG001|Overall Study|Protocol Violation|4|||
23371460|NCT02674516|65106149|FG000|Overall Study|Knowledge of study hypothesis|1|||
23371461|NCT02674516|65106150|FG001|Overall Study|Knowledge of study hypothesis|0|||
23371462|NCT00001566|65106159|FG000|Overall Study|patients' choice to discontinue protocol|3|||
23371463|NCT00001566|65106159|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
23371464|NCT00001566|65106159|FG000|Overall Study|Death|13|||
23371465|NCT00001566|65106159|FG000|Overall Study|Lost to Follow-up|1|||
23371466|NCT00001566|65106159|FG000|Overall Study|unable to complete initial apheresis|1|||
23371467|NCT02579629|65106161|FG000|Overall Study|Withdrawal by Subject|0|||
23371468|NCT02579629|65106162|FG001|Overall Study|Withdrawal by Subject|1|||
23371469|NCT02579629|65106163|FG002|Overall Study|Withdrawal by Subject|0|||
23371470|NCT02579629|65106161|FG000|Overall Study|Screen Failure|2|||
23371471|NCT02579629|65106162|FG001|Overall Study|Screen Failure|0|||
23371472|NCT02579629|65106163|FG002|Overall Study|Screen Failure|2|||
23371473|NCT00731822|65106166|FG000|Overall Study|Adverse Event|2|||
23371474|NCT00731822|65106167|FG001|Overall Study|Adverse Event|1|||
23371475|NCT00731822|65106166|FG000|Overall Study|Protocol Violation|1|||
23371476|NCT00731822|65106167|FG001|Overall Study|Protocol Violation|0|||
23371477|NCT00731822|65106166|FG000|Overall Study|Lost to Follow-up|1|||
23371478|NCT00731822|65106167|FG001|Overall Study|Lost to Follow-up|0|||
23279208|NCT00443651|64765333|FG000|Overall Study|Physician Decision|13|||
23279209|NCT00443651|64765334|FG001|Overall Study|Physician Decision|4|||
23279210|NCT00443651|64765333|FG000|Overall Study|Pregnancy|0|||
23279211|NCT00443651|64765334|FG001|Overall Study|Pregnancy|1|||
23279212|NCT00859521|64765339|FG000|Washout|Withdrawal by Subject|0|||
23279213|NCT00859521|64765340|FG001|Washout|Withdrawal by Subject|1|||
23279214|NCT03769896|64765341|FG000|Open-label Phase|Lack of Efficacy|5|||
23279215|NCT03769896|64765342|FG001|Open-label Phase|Lack of Efficacy|0|||
23279216|NCT03769896|64765341|FG000|Open-label Phase|Adverse Event|3|||
23279217|NCT03769896|64765342|FG001|Open-label Phase|Adverse Event|0|||
23371479|NCT03627832|65106168|FG000|Overall Study|Withdrawal by Subject|10|||
23371480|NCT03627832|65106169|FG001|Overall Study|Withdrawal by Subject|1|||
23371481|NCT01529606|65106170|FG000|Overall Study|Lost to Follow-up|21|||
23371482|NCT01529606|65106171|FG001|Overall Study|Lost to Follow-up|18|||
23371483|NCT00611806|65106172|FG000|Overall Study|Withdrawal by Subject|8|||
23371484|NCT00611806|65106173|FG001|Overall Study|Withdrawal by Subject|2|||
23371485|NCT00611806|65106172|FG000|Overall Study|Adverse Event|2|||
23279218|NCT03769896|64765341|FG000|Open-label Phase|Withdrawal by Subject|1|||
23279219|NCT03769896|64765342|FG001|Open-label Phase|Withdrawal by Subject|0|||
23279220|NCT03719040|64765347|FG000|Overall Study|Withdrawal by Subject|177|||
23279221|NCT03719040|64765347|FG000|Overall Study|Lost to Follow-up|26|||
23279222|NCT03874715|64765348|FG000|Overall Study|Adverse Event|2|||
23279223|NCT03874715|64765349|FG001|Overall Study|Adverse Event|0|||
23371486|NCT00611806|65106173|FG001|Overall Study|Adverse Event|1|||
23371487|NCT00611806|65106172|FG000|Overall Study|Lost to Follow-up|6|||
23371488|NCT00611806|65106173|FG001|Overall Study|Lost to Follow-up|0|||
23371489|NCT00630916|65106174|FG000|Overall Study|Death|110|||
23371490|NCT00630916|65106174|FG000|Overall Study|Explant|8|||
23371491|NCT00630916|65106174|FG000|Overall Study|Lost to Follow-up|5|||
23371492|NCT00630916|65106174|FG000|Overall Study|Withdrawal by Subject|30|||
23371493|NCT00630916|65106174|FG000|Overall Study|Protocol Violation|7|||
23371494|NCT00630916|65106174|FG000|Overall Study|Physician Decision|47|||
23371495|NCT00630916|65106174|FG000|Overall Study|Lack of Efficacy|3|||
23371496|NCT01712178|65106191|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
23371497|NCT01712178|65106192|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
23279224|NCT03874715|64765348|FG000|Overall Study|Poor compliance to protocol|5|||
23279225|NCT03874715|64765349|FG001|Overall Study|Poor compliance to protocol|1|||
23279226|NCT03874715|64765348|FG000|Overall Study|Withdrawal by Subject|1|||
23279227|NCT03874715|64765349|FG001|Overall Study|Withdrawal by Subject|0|||
23279228|NCT03874715|64765348|FG000|Overall Study|Other-unspecified|1|||
23279229|NCT03874715|64765349|FG001|Overall Study|Other-unspecified|0|||
23279230|NCT00747565|64765352|FG000|Overall Study|Withdrawal by Subject|10|||
23279231|NCT00747565|64765353|FG001|Overall Study|Withdrawal by Subject|6|||
23279232|NCT00747565|64765352|FG000|Overall Study|Lost to Follow-up|4|||
23279233|NCT00747565|64765353|FG001|Overall Study|Lost to Follow-up|1|||
23279234|NCT03343535|64765354|FG000|Overall Study|Lost to Follow-up|1|||
23279235|NCT03343535|64765354|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
23279236|NCT03343535|64765354|FG000|Overall Study|Death|12|||
23279237|NCT02760927|64765360|FG000|Overall Study|Tube Slippage from Device|1|||
23279238|NCT02699463|64765361|FG000|Overall Study|Lost to Follow-up|11|||
23279239|NCT02699463|64765362|FG001|Overall Study|Lost to Follow-up|8|||
23279240|NCT02699463|64765361|FG000|Overall Study|Withdrawal by Subject|4|||
23279241|NCT02699463|64765362|FG001|Overall Study|Withdrawal by Subject|1|||
23279242|NCT01173692|64765363|FG000|Overall Study|Adverse Event|1|||
23279243|NCT01173692|64765364|FG001|Overall Study|Adverse Event|2|||
23279244|NCT01173692|64765363|FG000|Overall Study|Withdrawal by Subject|1|||
23279245|NCT01173692|64765364|FG001|Overall Study|Withdrawal by Subject|3|||
23279246|NCT02335658|64765365|FG000|Overall Study|Adverse Event|18|||
23279247|NCT02335658|64765366|FG001|Overall Study|Adverse Event|12|||
23279248|NCT02335658|64765365|FG000|Overall Study|Lack of Efficacy|4|||
23279249|NCT02335658|64765366|FG001|Overall Study|Lack of Efficacy|5|||
23279250|NCT02335658|64765365|FG000|Overall Study|Pregnancy|1|||
23279251|NCT02335658|64765366|FG001|Overall Study|Pregnancy|0|||
23279252|NCT02335658|64765365|FG000|Overall Study|Withdrawal by Subject|13|||
23279253|NCT02335658|64765366|FG001|Overall Study|Withdrawal by Subject|21|||
23279254|NCT02335658|64765365|FG000|Overall Study|non-compliance|2|||
23279255|NCT02335658|64765366|FG001|Overall Study|non-compliance|3|||
23279256|NCT02335658|64765365|FG000|Overall Study|other reason|2|||
23279257|NCT02335658|64765366|FG001|Overall Study|other reason|3|||
23279258|NCT00561015|64765367|FG000|Overall Study|Adverse Event|0|||
23279259|NCT00561015|64765368|FG001|Overall Study|Adverse Event|0|||
23279260|NCT00561015|64765369|FG002|Overall Study|Adverse Event|0|||
23279261|NCT00561015|64765370|FG003|Overall Study|Adverse Event|0|||
23279262|NCT00561015|64765371|FG004|Overall Study|Adverse Event|1|||
23279263|NCT00561015|64765372|FG005|Overall Study|Adverse Event|0|||
23279264|NCT00561015|64765367|FG000|Overall Study|Lost to Follow-up|2|||
23279265|NCT00561015|64765368|FG001|Overall Study|Lost to Follow-up|0|||
23279266|NCT00561015|64765369|FG002|Overall Study|Lost to Follow-up|0|||
23279267|NCT00561015|64765370|FG003|Overall Study|Lost to Follow-up|1|||
23279268|NCT00561015|64765371|FG004|Overall Study|Lost to Follow-up|0|||
23279269|NCT00561015|64765372|FG005|Overall Study|Lost to Follow-up|3|||
23279270|NCT00561015|64765367|FG000|Overall Study|Participant non-compliance|2|||
23279271|NCT00561015|64765368|FG001|Overall Study|Participant non-compliance|0|||
23279272|NCT00561015|64765369|FG002|Overall Study|Participant non-compliance|0|||
23279273|NCT00561015|64765370|FG003|Overall Study|Participant non-compliance|0|||
23279274|NCT00561015|64765371|FG004|Overall Study|Participant non-compliance|0|||
23279275|NCT00561015|64765372|FG005|Overall Study|Participant non-compliance|0|||
23279276|NCT03325881|64765373|FG000|Overall Study|Protocol Violation|0|||
23279277|NCT03325881|64765374|FG001|Overall Study|Protocol Violation|1|||
23279278|NCT03325881|64765373|FG000|Overall Study|Withdrawal by Subject|0|||
23279279|NCT03325881|64765374|FG001|Overall Study|Withdrawal by Subject|2|||
23279280|NCT03325881|64765373|FG000|Overall Study|Lack of Efficacy|2|||
23279281|NCT03325881|64765374|FG001|Overall Study|Lack of Efficacy|0|||
23279282|NCT03325881|64765373|FG000|Overall Study|Not treated|1|||
23279283|NCT03325881|64765374|FG001|Overall Study|Not treated|0|||
23279284|NCT01494532|64765375|FG000|Overall Study|Adverse Event|4|||
23279285|NCT01494532|64765376|FG001|Overall Study|Adverse Event|1|||
23371498|NCT01712178|65106191|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
23279286|NCT01494532|64765377|FG002|Overall Study|Adverse Event|8|||
23279287|NCT01494532|64765378|FG003|Overall Study|Adverse Event|6|||
23279288|NCT01494532|64765379|FG004|Overall Study|Adverse Event|5|||
23279289|NCT01494532|64765380|FG005|Overall Study|Adverse Event|0|||
23279290|NCT01494532|64765375|FG000|Overall Study|Lack of Efficacy|0|||
23279291|NCT01494532|64765376|FG001|Overall Study|Lack of Efficacy|0|||
23279292|NCT01494532|64765377|FG002|Overall Study|Lack of Efficacy|0|||
23371499|NCT01712178|65106192|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
23371500|NCT01712178|65106191|FG000|Overall Study|Lost to Follow-up|0|||
23371501|NCT01712178|65106192|FG001|Overall Study|Lost to Follow-up|1|||
23371502|NCT01832766|65106202|FG000|Washout|Lost to Follow-up|0|||
23371503|NCT01832766|65106203|FG001|Washout|Lost to Follow-up|1|||
23371504|NCT01443858|65106205|FG000|Overall Study|Withdrawal by Subject|9|||
23371505|NCT01443858|65106206|FG001|Overall Study|Withdrawal by Subject|8|||
23371506|NCT01443858|65106207|FG002|Overall Study|Withdrawal by Subject|5|||
23371507|NCT01443858|65106205|FG000|Overall Study|Lack of Efficacy|1|||
23371508|NCT01443858|65106206|FG001|Overall Study|Lack of Efficacy|0|||
23371509|NCT01443858|65106207|FG002|Overall Study|Lack of Efficacy|0|||
23371510|NCT01443858|65106205|FG000|Overall Study|Lost to Follow-up|5|||
23371511|NCT01443858|65106206|FG001|Overall Study|Lost to Follow-up|5|||
23371512|NCT01443858|65106207|FG002|Overall Study|Lost to Follow-up|2|||
23371513|NCT01004614|65106210|FG000|Washout|Withdrawal by Subject|0|||
23371514|NCT01004614|65106211|FG001|Washout|Withdrawal by Subject|1|||
23371515|NCT01004614|65106212|FG002|Washout|Withdrawal by Subject|0|||
23371516|NCT01004614|65106213|FG003|Washout|Withdrawal by Subject|0|||
23371517|NCT01715831|65106214|FG000|Overall Study|Adverse Event|1|||
23371518|NCT01474486|65106217|FG000|Overall Study|Death|2|||
23371519|NCT01474486|65106217|FG000|Overall Study|Withdrawal by Subject|4|||
23371520|NCT01474486|65106217|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
23371521|NCT02111083|65106229|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
23371522|NCT02111083|65106230|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
23371523|NCT01290718|65106231|FG000|Overall Study|Early termination of the study|4|||
23371524|NCT03167242|65106234|FG000|Overall Study|Patient/Guardian Decision|0|||
23371525|NCT03167242|65106235|FG001|Overall Study|Patient/Guardian Decision|1|||
23371526|NCT03167242|65106236|FG002|Overall Study|Patient/Guardian Decision|2|||
23371527|NCT03167242|65106237|FG003|Overall Study|Patient/Guardian Decision|1|||
23371528|NCT03167242|65106238|FG004|Overall Study|Patient/Guardian Decision|1|||
23371529|NCT03167242|65106239|FG005|Overall Study|Patient/Guardian Decision|1|||
23371530|NCT03167242|65106240|FG006|Overall Study|Patient/Guardian Decision|0|||
23371531|NCT03167242|65106241|FG007|Overall Study|Patient/Guardian Decision|0|||
23371532|NCT03167242|65106242|FG008|Overall Study|Patient/Guardian Decision|0|||
23371533|NCT03167242|65106243|FG009|Overall Study|Patient/Guardian Decision|0|||
23371534|NCT03167242|65106244|FG010|Overall Study|Patient/Guardian Decision|1|||
23371535|NCT03167242|65106245|FG011|Overall Study|Patient/Guardian Decision|0|||
23371536|NCT03167242|65106234|FG000|Overall Study|Lost to Follow-up|0|||
23371537|NCT03167242|65106235|FG001|Overall Study|Lost to Follow-up|0|||
23371538|NCT03167242|65106236|FG002|Overall Study|Lost to Follow-up|1|||
23279293|NCT01494532|64765378|FG003|Overall Study|Lack of Efficacy|0|||
23279294|NCT01494532|64765379|FG004|Overall Study|Lack of Efficacy|2|||
23279295|NCT01494532|64765380|FG005|Overall Study|Lack of Efficacy|0|||
23279296|NCT01494532|64765375|FG000|Overall Study|Protocol deviation|2|||
23279297|NCT01494532|64765376|FG001|Overall Study|Protocol deviation|1|||
23279298|NCT01494532|64765377|FG002|Overall Study|Protocol deviation|3|||
23279299|NCT01494532|64765378|FG003|Overall Study|Protocol deviation|2|||
23279300|NCT01494532|64765379|FG004|Overall Study|Protocol deviation|3|||
23279301|NCT01494532|64765380|FG005|Overall Study|Protocol deviation|0|||
23279302|NCT01494532|64765375|FG000|Overall Study|Protocol-defined stopping criteria|0|||
23279303|NCT01494532|64765376|FG001|Overall Study|Protocol-defined stopping criteria|0|||
23279304|NCT01494532|64765377|FG002|Overall Study|Protocol-defined stopping criteria|1|||
23279305|NCT01494532|64765378|FG003|Overall Study|Protocol-defined stopping criteria|0|||
23279306|NCT01494532|64765379|FG004|Overall Study|Protocol-defined stopping criteria|0|||
23279307|NCT01494532|64765380|FG005|Overall Study|Protocol-defined stopping criteria|0|||
23279308|NCT01494532|64765375|FG000|Overall Study|Lost to Follow-up|1|||
23279309|NCT01494532|64765376|FG001|Overall Study|Lost to Follow-up|0|||
23371539|NCT03167242|65106237|FG003|Overall Study|Lost to Follow-up|0|||
23371540|NCT03167242|65106238|FG004|Overall Study|Lost to Follow-up|0|||
23371541|NCT03167242|65106239|FG005|Overall Study|Lost to Follow-up|1|||
23485915|NCT03345342|65521909|FG003|Open-Label Phase|Adverse Event|0|||
23371542|NCT03167242|65106240|FG006|Overall Study|Lost to Follow-up|2|||
23485916|NCT03345342|65521910|FG004|Open-Label Phase|Adverse Event|0|||
23485917|NCT03345342|65521906|FG000|Open-Label Phase|Death|1|||
23485918|NCT03345342|65521907|FG001|Open-Label Phase|Death|0|||
23279310|NCT01494532|64765377|FG002|Overall Study|Lost to Follow-up|0|||
23279311|NCT01494532|64765378|FG003|Overall Study|Lost to Follow-up|2|||
23279312|NCT01494532|64765379|FG004|Overall Study|Lost to Follow-up|0|||
23279313|NCT01494532|64765380|FG005|Overall Study|Lost to Follow-up|0|||
23279314|NCT01494532|64765375|FG000|Overall Study|Physician Decision|0|||
23279315|NCT01494532|64765376|FG001|Overall Study|Physician Decision|1|||
23279316|NCT01494532|64765377|FG002|Overall Study|Physician Decision|1|||
23371543|NCT03167242|65106241|FG007|Overall Study|Lost to Follow-up|1|||
23371544|NCT03167242|65106242|FG008|Overall Study|Lost to Follow-up|0|||
23371545|NCT03167242|65106243|FG009|Overall Study|Lost to Follow-up|0|||
23371546|NCT03167242|65106244|FG010|Overall Study|Lost to Follow-up|1|||
23371547|NCT03167242|65106245|FG011|Overall Study|Lost to Follow-up|1|||
23371548|NCT03167242|65106234|FG000|Overall Study|Reason not provided|0|||
23371549|NCT03167242|65106235|FG001|Overall Study|Reason not provided|0|||
23371550|NCT03167242|65106236|FG002|Overall Study|Reason not provided|0|||
23371551|NCT03167242|65106237|FG003|Overall Study|Reason not provided|0|||
23371552|NCT03167242|65106238|FG004|Overall Study|Reason not provided|0|||
23371553|NCT03167242|65106239|FG005|Overall Study|Reason not provided|0|||
23371554|NCT03167242|65106240|FG006|Overall Study|Reason not provided|0|||
23371555|NCT03167242|65106241|FG007|Overall Study|Reason not provided|0|||
23371556|NCT03167242|65106242|FG008|Overall Study|Reason not provided|1|||
23371557|NCT03167242|65106243|FG009|Overall Study|Reason not provided|0|||
23371558|NCT03167242|65106244|FG010|Overall Study|Reason not provided|0|||
23371559|NCT03167242|65106245|FG011|Overall Study|Reason not provided|0|||
23371560|NCT02683109|65106246|FG000|Overall Study|Adverse Event|1|||
23371561|NCT02683109|65106247|FG001|Overall Study|Adverse Event|0|||
23371562|NCT01673386|65106250|FG000|Overall Study|Study terminated by sponsor|16|||
23371563|NCT01673386|65106251|FG001|Overall Study|Study terminated by sponsor|22|||
23371564|NCT01673386|65106250|FG000|Overall Study|Adverse Event|5|||
23371565|NCT01673386|65106251|FG001|Overall Study|Adverse Event|2|||
23371566|NCT01673386|65106250|FG000|Overall Study|Progressive disease|4|||
23371567|NCT01673386|65106251|FG001|Overall Study|Progressive disease|1|||
23371568|NCT01673386|65106250|FG000|Overall Study|Withdrawal by Subject|0|||
23371569|NCT01673386|65106251|FG001|Overall Study|Withdrawal by Subject|2|||
23371570|NCT01922934|65106254|FG000|Eligible Patients|Death|0|||
23371571|NCT01922934|65106255|FG001|Eligible Patients|Death|7|||
23371572|NCT01922934|65106254|FG000|Eligible Patients|Physician Decision|17|||
23371573|NCT01922934|65106255|FG001|Eligible Patients|Physician Decision|0|||
23371574|NCT01922934|65106254|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
23279317|NCT01494532|64765378|FG003|Overall Study|Physician Decision|2|||
23279318|NCT01494532|64765379|FG004|Overall Study|Physician Decision|0|||
23371575|NCT01922934|65106255|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
23371576|NCT01922934|65106254|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
23371577|NCT01922934|65106255|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
23371578|NCT01922934|65106254|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
23279319|NCT01494532|64765380|FG005|Overall Study|Physician Decision|0|||
23279320|NCT01494532|64765375|FG000|Overall Study|Withdrawal by Subject|3|||
23279321|NCT01494532|64765376|FG001|Overall Study|Withdrawal by Subject|1|||
23279322|NCT01494532|64765377|FG002|Overall Study|Withdrawal by Subject|4|||
23279323|NCT01494532|64765378|FG003|Overall Study|Withdrawal by Subject|3|||
23279324|NCT01494532|64765379|FG004|Overall Study|Withdrawal by Subject|2|||
23279325|NCT01494532|64765380|FG005|Overall Study|Withdrawal by Subject|0|||
23279326|NCT01838681|64765387|FG000|Period A|Adverse Event|39|||
23279327|NCT01838681|64765388|FG001|Period A|Adverse Event|0|||
23279328|NCT01838681|64765389|FG002|Period A|Adverse Event|0|||
23279329|NCT01838681|64765390|FG003|Period A|Adverse Event|0|||
23279330|NCT01838681|64765387|FG000|Period A|Lack of Efficacy|21|||
23279331|NCT01838681|64765388|FG001|Period A|Lack of Efficacy|0|||
23279332|NCT01838681|64765389|FG002|Period A|Lack of Efficacy|0|||
23279333|NCT01838681|64765390|FG003|Period A|Lack of Efficacy|0|||
23279334|NCT01838681|64765387|FG000|Period A|Early response|148|||
23279335|NCT01838681|64765388|FG001|Period A|Early response|0|||
23279336|NCT01838681|64765389|FG002|Period A|Early response|0|||
23279337|NCT01838681|64765390|FG003|Period A|Early response|0|||
23279338|NCT01838681|64765387|FG000|Period A|Withdrawal by Subject|70|||
23279339|NCT01838681|64765388|FG001|Period A|Withdrawal by Subject|0|||
23279340|NCT01838681|64765389|FG002|Period A|Withdrawal by Subject|0|||
23279341|NCT01838681|64765390|FG003|Period A|Withdrawal by Subject|0|||
23279342|NCT01838681|64765387|FG000|Period A|Protocol Violation|16|||
23279343|NCT01838681|64765388|FG001|Period A|Protocol Violation|0|||
23279344|NCT01838681|64765389|FG002|Period A|Protocol Violation|0|||
23279345|NCT01838681|64765390|FG003|Period A|Protocol Violation|0|||
23279346|NCT01838681|64765387|FG000|Period A|Non-compliance with IMP|6|||
23279347|NCT01838681|64765388|FG001|Period A|Non-compliance with IMP|0|||
23279348|NCT01838681|64765389|FG002|Period A|Non-compliance with IMP|0|||
23279349|NCT01838681|64765390|FG003|Period A|Non-compliance with IMP|0|||
23371579|NCT01922934|65106255|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
23371580|NCT01922934|65106254|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
23371581|NCT01922934|65106255|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
23371582|NCT01145482|65106266|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
23371583|NCT01145482|65106267|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
23279350|NCT01838681|64765387|FG000|Period A|Lost to Follow-up|4|||
23279351|NCT01838681|64765388|FG001|Period A|Lost to Follow-up|0|||
23371584|NCT02659943|65106268|FG000|Overall Study|Switched to alternative treatment|1|||
23371585|NCT02659943|65106269|FG001|Overall Study|Switched to alternative treatment|1|||
23279352|NCT01838681|64765389|FG002|Period A|Lost to Follow-up|0|||
23279353|NCT01838681|64765390|FG003|Period A|Lost to Follow-up|0|||
23279354|NCT01838681|64765387|FG000|Period A|Withdrawal before treatment|4|||
23279355|NCT01838681|64765388|FG001|Period A|Withdrawal before treatment|0|||
23279356|NCT01838681|64765389|FG002|Period A|Withdrawal before treatment|0|||
23279357|NCT01838681|64765390|FG003|Period A|Withdrawal before treatment|0|||
23371586|NCT02659943|65106270|FG002|Overall Study|Switched to alternative treatment|0|||
23371587|NCT02659943|65106271|FG003|Overall Study|Switched to alternative treatment|2|||
23371588|NCT02659943|65106272|FG004|Overall Study|Switched to alternative treatment|1|||
23371589|NCT02659943|65106273|FG005|Overall Study|Switched to alternative treatment|0|||
23371590|NCT02659943|65106274|FG006|Overall Study|Switched to alternative treatment|1|||
23371591|NCT02659943|65106268|FG000|Overall Study|Disease progression on study|0|||
23279358|NCT01838681|64765387|FG000|Period A|Administrative or other reasons|17|||
23279359|NCT01838681|64765388|FG001|Period A|Administrative or other reasons|0|||
23279360|NCT01838681|64765389|FG002|Period A|Administrative or other reasons|0|||
23279361|NCT01838681|64765390|FG003|Period A|Administrative or other reasons|0|||
23279362|NCT01838681|64765387|FG000|Period B/A+|Adverse Event|0|||
23279363|NCT01838681|64765388|FG001|Period B/A+|Adverse Event|13|||
23279364|NCT01838681|64765389|FG002|Period B/A+|Adverse Event|27|||
23279365|NCT01838681|64765390|FG003|Period B/A+|Adverse Event|16|||
23485919|NCT03345342|65521908|FG002|Open-Label Phase|Death|0|||
23485920|NCT03345342|65521909|FG003|Open-Label Phase|Death|0|||
23485921|NCT03345342|65521910|FG004|Open-Label Phase|Death|0|||
23485922|NCT03345342|65521906|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
23485923|NCT03345342|65521907|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
23485924|NCT03345342|65521908|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
23485925|NCT03345342|65521909|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
23485926|NCT03345342|65521910|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
23485927|NCT03345342|65521906|FG000|Open-Label Phase|Lack of Efficacy|6|||
23485928|NCT03345342|65521907|FG001|Open-Label Phase|Lack of Efficacy|0|||
23485929|NCT03345342|65521908|FG002|Open-Label Phase|Lack of Efficacy|0|||
23485930|NCT03345342|65521909|FG003|Open-Label Phase|Lack of Efficacy|0|||
23485931|NCT03345342|65521910|FG004|Open-Label Phase|Lack of Efficacy|0|||
23485932|NCT03345342|65521906|FG000|Open-Label Phase|Lost to Follow-up|9|||
23485933|NCT03345342|65521907|FG001|Open-Label Phase|Lost to Follow-up|0|||
23485934|NCT03345342|65521908|FG002|Open-Label Phase|Lost to Follow-up|0|||
23485935|NCT03345342|65521909|FG003|Open-Label Phase|Lost to Follow-up|0|||
23485936|NCT03345342|65521910|FG004|Open-Label Phase|Lost to Follow-up|0|||
23485937|NCT03345342|65521906|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
23485938|NCT03345342|65521907|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
23485939|NCT03345342|65521908|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
23485940|NCT03345342|65521909|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
23485941|NCT03345342|65521910|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
23485942|NCT03345342|65521906|FG000|Open-Label Phase|Physician Decision|4|||
23485943|NCT03345342|65521907|FG001|Open-Label Phase|Physician Decision|0|||
23485944|NCT03345342|65521908|FG002|Open-Label Phase|Physician Decision|0|||
23485945|NCT03345342|65521909|FG003|Open-Label Phase|Physician Decision|0|||
23485946|NCT03345342|65521910|FG004|Open-Label Phase|Physician Decision|0|||
23485947|NCT03345342|65521906|FG000|Open-Label Phase|Protocol Violation|8|||
23485948|NCT03345342|65521907|FG001|Open-Label Phase|Protocol Violation|0|||
23485949|NCT03345342|65521908|FG002|Open-Label Phase|Protocol Violation|0|||
23485950|NCT03345342|65521909|FG003|Open-Label Phase|Protocol Violation|0|||
23603557|NCT00597376|65937417|FG001|Overall Study|Withdrawal by Subject|3|||
23371592|NCT02659943|65106269|FG001|Overall Study|Disease progression on study|1|||
23371593|NCT02659943|65106270|FG002|Overall Study|Disease progression on study|1|||
23371594|NCT02659943|65106271|FG003|Overall Study|Disease progression on study|1|||
23371595|NCT02659943|65106272|FG004|Overall Study|Disease progression on study|1|||
23371596|NCT02659943|65106273|FG005|Overall Study|Disease progression on study|4|||
23371597|NCT02659943|65106274|FG006|Overall Study|Disease progression on study|0|||
23371598|NCT02659943|65106268|FG000|Overall Study|Patient's condition per principal investigator|0|||
23371599|NCT02659943|65106269|FG001|Overall Study|Patient's condition per principal investigator|0|||
23279366|NCT01838681|64765387|FG000|Period B/A+|Lack of Efficacy|0|||
23279367|NCT01838681|64765388|FG001|Period B/A+|Lack of Efficacy|9|||
23279368|NCT01838681|64765389|FG002|Period B/A+|Lack of Efficacy|11|||
23279369|NCT01838681|64765390|FG003|Period B/A+|Lack of Efficacy|6|||
23279370|NCT01838681|64765387|FG000|Period B/A+|Withdrawal by Subject|0|||
23279371|NCT01838681|64765388|FG001|Period B/A+|Withdrawal by Subject|28|||
23279372|NCT01838681|64765389|FG002|Period B/A+|Withdrawal by Subject|35|||
23279373|NCT01838681|64765390|FG003|Period B/A+|Withdrawal by Subject|47|||
23279374|NCT01838681|64765387|FG000|Period B/A+|Protocol Violation|0|||
23279375|NCT01838681|64765388|FG001|Period B/A+|Protocol Violation|1|||
23371600|NCT02659943|65106270|FG002|Overall Study|Patient's condition per principal investigator|0|||
23371601|NCT02659943|65106271|FG003|Overall Study|Patient's condition per principal investigator|0|||
23279376|NCT01838681|64765389|FG002|Period B/A+|Protocol Violation|4|||
23279377|NCT01838681|64765390|FG003|Period B/A+|Protocol Violation|6|||
23279378|NCT01838681|64765387|FG000|Period B/A+|Non-compliance with IMP|0|||
23371602|NCT02659943|65106272|FG004|Overall Study|Patient's condition per principal investigator|0|||
23485951|NCT03345342|65521910|FG004|Open-Label Phase|Protocol Violation|0|||
23485952|NCT03345342|65521906|FG000|Open-Label Phase|Withdrawal by Subject|57|||
23603558|NCT00597376|65937416|FG000|Overall Study|Adverse Event|4|||
23279379|NCT01838681|64765388|FG001|Period B/A+|Non-compliance with IMP|2|||
23279380|NCT01838681|64765389|FG002|Period B/A+|Non-compliance with IMP|3|||
23279381|NCT01838681|64765390|FG003|Period B/A+|Non-compliance with IMP|3|||
23279382|NCT01838681|64765387|FG000|Period B/A+|Lost to Follow-up|0|||
23279383|NCT01838681|64765388|FG001|Period B/A+|Lost to Follow-up|2|||
23279384|NCT01838681|64765389|FG002|Period B/A+|Lost to Follow-up|5|||
23279385|NCT01838681|64765390|FG003|Period B/A+|Lost to Follow-up|11|||
23279386|NCT01838681|64765387|FG000|Period B/A+|Withdrawal before treatment|0|||
23279387|NCT01838681|64765388|FG001|Period B/A+|Withdrawal before treatment|1|||
23279388|NCT01838681|64765389|FG002|Period B/A+|Withdrawal before treatment|0|||
23279389|NCT01838681|64765390|FG003|Period B/A+|Withdrawal before treatment|0|||
23279390|NCT01838681|64765387|FG000|Period B/A+|Administrative or other reasons|0|||
23279391|NCT01838681|64765388|FG001|Period B/A+|Administrative or other reasons|6|||
23279392|NCT01838681|64765389|FG002|Period B/A+|Administrative or other reasons|10|||
23279393|NCT01838681|64765390|FG003|Period B/A+|Administrative or other reasons|28|||
23279394|NCT00679081|64765394|FG000|Overall Study|Lost to Follow-up|1|||
23279395|NCT00461786|64765395|FG000|Overall Study|Entry Criteria Not Met|2|||
23279396|NCT00461786|64765395|FG000|Overall Study|Inevaluable (Never Treated)|1|||
23279397|NCT04466111|64765398|FG000|Prior to Trial Phase|Physician Decision|1|||
23279398|NCT01380782|64765402|FG000|Overall Study|Adverse Event|0|||
23279399|NCT01380782|64765403|FG001|Overall Study|Adverse Event|1|||
23279400|NCT01380782|64765404|FG002|Overall Study|Adverse Event|0|||
23371603|NCT02659943|65106273|FG005|Overall Study|Patient's condition per principal investigator|1|||
23371604|NCT02659943|65106274|FG006|Overall Study|Patient's condition per principal investigator|0|||
23371605|NCT02659943|65106268|FG000|Overall Study|Ineligible|0|||
23371606|NCT02659943|65106269|FG001|Overall Study|Ineligible|0|||
23371607|NCT02659943|65106270|FG002|Overall Study|Ineligible|0|||
23371608|NCT02659943|65106271|FG003|Overall Study|Ineligible|0|||
23371609|NCT02659943|65106272|FG004|Overall Study|Ineligible|0|||
23371610|NCT02659943|65106273|FG005|Overall Study|Ineligible|0|||
23371611|NCT02659943|65106274|FG006|Overall Study|Ineligible|1|||
23371612|NCT02659943|65106268|FG000|Overall Study|No longer meets eligibility|0|||
23371613|NCT02659943|65106269|FG001|Overall Study|No longer meets eligibility|0|||
23371614|NCT02659943|65106270|FG002|Overall Study|No longer meets eligibility|0|||
23371615|NCT02659943|65106271|FG003|Overall Study|No longer meets eligibility|0|||
23371616|NCT02659943|65106272|FG004|Overall Study|No longer meets eligibility|0|||
23371617|NCT02659943|65106273|FG005|Overall Study|No longer meets eligibility|0|||
23371618|NCT02659943|65106274|FG006|Overall Study|No longer meets eligibility|1|||
23371619|NCT02659943|65106268|FG000|Overall Study|No treatment, per protocol|0|||
23371620|NCT02659943|65106269|FG001|Overall Study|No treatment, per protocol|0|||
23371621|NCT02659943|65106270|FG002|Overall Study|No treatment, per protocol|0|||
23371622|NCT02659943|65106271|FG003|Overall Study|No treatment, per protocol|0|||
23371623|NCT02659943|65106272|FG004|Overall Study|No treatment, per protocol|0|||
23371624|NCT02659943|65106273|FG005|Overall Study|No treatment, per protocol|0|||
23371625|NCT02659943|65106274|FG006|Overall Study|No treatment, per protocol|3|||
23371626|NCT03712280|65106275|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
23371627|NCT03712280|65106276|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
23371628|NCT03712280|65106277|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
23371629|NCT03712280|65106278|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
23371630|NCT03712280|65106275|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
23371631|NCT03712280|65106276|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
23371632|NCT03712280|65106277|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
23371633|NCT03712280|65106278|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
23371634|NCT03712280|65106275|FG000|Overall Study|Adverse Event|0|||
23371635|NCT03712280|65106276|FG001|Overall Study|Adverse Event|0|||
23371636|NCT03712280|65106277|FG002|Overall Study|Adverse Event|1|||
23371637|NCT03712280|65106278|FG003|Overall Study|Adverse Event|0|||
23371638|NCT02497469|65106279|FG000|Overall Study|Randomized but not Treated|0|||
23371639|NCT02497469|65106280|FG001|Overall Study|Randomized but not Treated|2|||
23279401|NCT01380782|64765405|FG003|Overall Study|Adverse Event|0|||
23279402|NCT01380782|64765402|FG000|Overall Study|Death|1|||
23279403|NCT01380782|64765403|FG001|Overall Study|Death|0|||
23371640|NCT02497469|65106279|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
23371641|NCT02497469|65106280|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
23371642|NCT02497469|65106279|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
23371643|NCT02497469|65106280|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
23371644|NCT02497469|65106279|FG000|Overall Study|Significant Protocol Deviation|4|||
23371645|NCT02497469|65106280|FG001|Overall Study|Significant Protocol Deviation|5|||
23371646|NCT02497469|65106279|FG000|Overall Study|Lost to Follow-up|14|||
23279404|NCT01380782|64765404|FG002|Overall Study|Death|0|||
23279405|NCT01380782|64765405|FG003|Overall Study|Death|0|||
23279406|NCT01380782|64765402|FG000|Overall Study|Lack of Efficacy|10|||
23485953|NCT03345342|65521907|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23485954|NCT03345342|65521908|FG002|Open-Label Phase|Withdrawal by Subject|0|||
23485955|NCT03345342|65521909|FG003|Open-Label Phase|Withdrawal by Subject|0|||
23485956|NCT03345342|65521910|FG004|Open-Label Phase|Withdrawal by Subject|0|||
23485957|NCT03345342|65521906|FG000|Open-Label Phase|Other|15|||
23485958|NCT03345342|65521907|FG001|Open-Label Phase|Other|0|||
23485959|NCT03345342|65521908|FG002|Open-Label Phase|Other|0|||
23485960|NCT03345342|65521909|FG003|Open-Label Phase|Other|0|||
23485961|NCT03345342|65521910|FG004|Open-Label Phase|Other|0|||
23485962|NCT03345342|65521906|FG000|Double-Blind Phase|Adverse Event|0|||
23485963|NCT03345342|65521907|FG001|Double-Blind Phase|Adverse Event|1|||
23485964|NCT03345342|65521908|FG002|Double-Blind Phase|Adverse Event|6|||
23485965|NCT03345342|65521909|FG003|Double-Blind Phase|Adverse Event|0|||
23485966|NCT03345342|65521910|FG004|Double-Blind Phase|Adverse Event|0|||
23485967|NCT03345342|65521906|FG000|Double-Blind Phase|Death|0|||
23485968|NCT03345342|65521907|FG001|Double-Blind Phase|Death|2|||
23485969|NCT03345342|65521908|FG002|Double-Blind Phase|Death|1|||
23485970|NCT03345342|65521909|FG003|Double-Blind Phase|Death|0|||
23485971|NCT03345342|65521910|FG004|Double-Blind Phase|Death|0|||
23485972|NCT03345342|65521906|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
23485973|NCT03345342|65521907|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
23485974|NCT03345342|65521908|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
23485975|NCT03345342|65521909|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
23485976|NCT03345342|65521910|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
23485977|NCT03345342|65521906|FG000|Double-Blind Phase|Lost to Follow-up|0|||
23485978|NCT03345342|65521907|FG001|Double-Blind Phase|Lost to Follow-up|1|||
23485979|NCT03345342|65521908|FG002|Double-Blind Phase|Lost to Follow-up|7|||
23485980|NCT03345342|65521909|FG003|Double-Blind Phase|Lost to Follow-up|0|||
23485981|NCT03345342|65521910|FG004|Double-Blind Phase|Lost to Follow-up|0|||
23485982|NCT03345342|65521906|FG000|Double-Blind Phase|Physician Decision|0|||
23485983|NCT03345342|65521907|FG001|Double-Blind Phase|Physician Decision|1|||
23485984|NCT03345342|65521908|FG002|Double-Blind Phase|Physician Decision|4|||
23485985|NCT03345342|65521909|FG003|Double-Blind Phase|Physician Decision|0|||
23485986|NCT03345342|65521910|FG004|Double-Blind Phase|Physician Decision|0|||
23485987|NCT03345342|65521906|FG000|Double-Blind Phase|Protocol Violation|0|||
23485988|NCT03345342|65521907|FG001|Double-Blind Phase|Protocol Violation|0|||
23485989|NCT03345342|65521908|FG002|Double-Blind Phase|Protocol Violation|1|||
23485990|NCT03345342|65521909|FG003|Double-Blind Phase|Protocol Violation|0|||
23485991|NCT03345342|65521910|FG004|Double-Blind Phase|Protocol Violation|0|||
23485992|NCT03345342|65521906|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
23485993|NCT03345342|65521907|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
23485994|NCT03345342|65521908|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
23485995|NCT03345342|65521909|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
23485996|NCT03345342|65521910|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
23485997|NCT03345342|65521906|FG000|Double-Blind Phase|Other|0|||
23485998|NCT03345342|65521907|FG001|Double-Blind Phase|Other|1|||
23485999|NCT03345342|65521908|FG002|Double-Blind Phase|Other|3|||
23486000|NCT03345342|65521909|FG003|Double-Blind Phase|Other|0|||
23486001|NCT03345342|65521910|FG004|Double-Blind Phase|Other|0|||
23486002|NCT03345342|65521906|FG000|Follow-Up Phase|Adverse Event|0|||
23486003|NCT03345342|65521907|FG001|Follow-Up Phase|Adverse Event|0|||
23486004|NCT03345342|65521908|FG002|Follow-Up Phase|Adverse Event|0|||
23486005|NCT03345342|65521909|FG003|Follow-Up Phase|Adverse Event|0|||
23486006|NCT03345342|65521910|FG004|Follow-Up Phase|Adverse Event|4|||
23486007|NCT03345342|65521906|FG000|Follow-Up Phase|Lost to Follow-up|0|||
23486008|NCT03345342|65521907|FG001|Follow-Up Phase|Lost to Follow-up|0|||
23486009|NCT03345342|65521908|FG002|Follow-Up Phase|Lost to Follow-up|0|||
23486010|NCT03345342|65521909|FG003|Follow-Up Phase|Lost to Follow-up|0|||
23486011|NCT03345342|65521910|FG004|Follow-Up Phase|Lost to Follow-up|6|||
23486012|NCT03345342|65521906|FG000|Follow-Up Phase|Physician Decision|0|||
23486013|NCT03345342|65521907|FG001|Follow-Up Phase|Physician Decision|0|||
23486014|NCT03345342|65521908|FG002|Follow-Up Phase|Physician Decision|0|||
23486015|NCT03345342|65521909|FG003|Follow-Up Phase|Physician Decision|0|||
23486016|NCT03345342|65521910|FG004|Follow-Up Phase|Physician Decision|5|||
23486017|NCT03345342|65521906|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
23279407|NCT01380782|64765403|FG001|Overall Study|Lack of Efficacy|9|||
23279408|NCT01380782|64765404|FG002|Overall Study|Lack of Efficacy|10|||
23486018|NCT03345342|65521907|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
23279409|NCT01380782|64765405|FG003|Overall Study|Lack of Efficacy|3|||
23279410|NCT01380782|64765402|FG000|Overall Study|Physician Decision|1|||
23486019|NCT03345342|65521908|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
23486020|NCT03345342|65521909|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
23486021|NCT03345342|65521910|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
23486022|NCT03345342|65521906|FG000|Follow-Up Phase|Other|0|||
23486023|NCT03345342|65521907|FG001|Follow-Up Phase|Other|0|||
23486024|NCT03345342|65521908|FG002|Follow-Up Phase|Other|0|||
23486025|NCT03345342|65521909|FG003|Follow-Up Phase|Other|3|||
23486026|NCT03345342|65521910|FG004|Follow-Up Phase|Other|1|||
23486027|NCT03455764|65521915|FG000|Overall Study|Adverse Event|1|||
23486028|NCT03455764|65521916|FG001|Overall Study|Adverse Event|0|||
23486029|NCT03455764|65521917|FG002|Overall Study|Adverse Event|0|||
23486030|NCT03455764|65521918|FG003|Overall Study|Adverse Event|0|||
23486031|NCT03455764|65521919|FG004|Overall Study|Adverse Event|0|||
23486032|NCT03455764|65521915|FG000|Overall Study|Disease Progression|4|||
23486033|NCT03455764|65521916|FG001|Overall Study|Disease Progression|0|||
23486034|NCT03455764|65521917|FG002|Overall Study|Disease Progression|0|||
23486035|NCT03455764|65521918|FG003|Overall Study|Disease Progression|0|||
23486036|NCT03455764|65521919|FG004|Overall Study|Disease Progression|0|||
23486037|NCT03455764|65521915|FG000|Overall Study|On Treatment|1|||
23486038|NCT03455764|65521916|FG001|Overall Study|On Treatment|0|||
23486039|NCT03455764|65521917|FG002|Overall Study|On Treatment|0|||
23486040|NCT03455764|65521918|FG003|Overall Study|On Treatment|0|||
23486041|NCT03455764|65521919|FG004|Overall Study|On Treatment|0|||
23486042|NCT00543855|65521928|FG000|Overall Study|Adverse Event|3|||
23486043|NCT00543855|65521929|FG001|Overall Study|Adverse Event|1|||
23486044|NCT00543855|65521930|FG002|Overall Study|Adverse Event|3|||
23486045|NCT00543855|65521931|FG003|Overall Study|Adverse Event|4|||
23486046|NCT00543855|65521928|FG000|Overall Study|Lost to Follow-up|0|||
23279411|NCT01380782|64765403|FG001|Overall Study|Physician Decision|0|||
23279412|NCT01380782|64765404|FG002|Overall Study|Physician Decision|0|||
23279413|NCT01380782|64765405|FG003|Overall Study|Physician Decision|0|||
23279414|NCT01380782|64765402|FG000|Overall Study|Withdrawal by Subject|0|||
23279415|NCT01380782|64765403|FG001|Overall Study|Withdrawal by Subject|0|||
23279416|NCT01380782|64765404|FG002|Overall Study|Withdrawal by Subject|1|||
23279417|NCT01380782|64765405|FG003|Overall Study|Withdrawal by Subject|1|||
23279418|NCT03818581|64765407|FG000|Overall Study|Adverse Event|1|||
23279419|NCT03818581|64765408|FG001|Overall Study|Adverse Event|0|||
23279420|NCT03818581|64765409|FG002|Overall Study|Adverse Event|0|||
23279421|NCT03818581|64765410|FG003|Overall Study|Adverse Event|0|||
23279422|NCT03818581|64765411|FG004|Overall Study|Adverse Event|0|||
23279423|NCT03818581|64765407|FG000|Overall Study|Covid-19|2|||
23279424|NCT03818581|64765408|FG001|Overall Study|Covid-19|0|||
23279425|NCT03818581|64765409|FG002|Overall Study|Covid-19|0|||
23279426|NCT03818581|64765410|FG003|Overall Study|Covid-19|0|||
23279427|NCT03818581|64765411|FG004|Overall Study|Covid-19|1|||
23279428|NCT03818581|64765407|FG000|Overall Study|Withdrawal by Subject|0|||
23279429|NCT03818581|64765408|FG001|Overall Study|Withdrawal by Subject|0|||
23279430|NCT03818581|64765409|FG002|Overall Study|Withdrawal by Subject|0|||
23279431|NCT03818581|64765410|FG003|Overall Study|Withdrawal by Subject|0|||
23279432|NCT03818581|64765411|FG004|Overall Study|Withdrawal by Subject|1|||
23279433|NCT03818581|64765407|FG000|Overall Study|No longer met study criteria|0|||
23279434|NCT03818581|64765408|FG001|Overall Study|No longer met study criteria|0|||
23279435|NCT03818581|64765409|FG002|Overall Study|No longer met study criteria|0|||
23279436|NCT03818581|64765410|FG003|Overall Study|No longer met study criteria|0|||
23279437|NCT03818581|64765411|FG004|Overall Study|No longer met study criteria|1|||
23279438|NCT00985439|64765413|FG000|Overall Study|Adverse Event|0|||
23279439|NCT00985439|64765414|FG001|Overall Study|Adverse Event|0|||
23279440|NCT00985439|64765415|FG002|Overall Study|Adverse Event|1|||
23279441|NCT00985439|64765416|FG003|Overall Study|Adverse Event|0|||
23279442|NCT02106156|64765421|FG000|Overall Study|Patient Died|19|||
23279443|NCT02106156|64765422|FG001|Overall Study|Patient Died|0|||
23486047|NCT00543855|65521929|FG001|Overall Study|Lost to Follow-up|0|||
23486048|NCT00543855|65521930|FG002|Overall Study|Lost to Follow-up|1|||
23486049|NCT00543855|65521931|FG003|Overall Study|Lost to Follow-up|0|||
23279444|NCT02106156|64765423|FG002|Overall Study|Patient Died|0|||
23279445|NCT02106156|64765421|FG000|Overall Study|Lack of Tolerability|305|||
23279446|NCT02106156|64765422|FG001|Overall Study|Lack of Tolerability|3|||
23279447|NCT02106156|64765423|FG002|Overall Study|Lack of Tolerability|0|||
23279448|NCT02106156|64765421|FG000|Overall Study|Lack of Virological Response|1044|||
23279449|NCT02106156|64765422|FG001|Overall Study|Lack of Virological Response|8|||
23279450|NCT02106156|64765423|FG002|Overall Study|Lack of Virological Response|0|||
23279451|NCT02106156|64765421|FG000|Overall Study|Concomitant Disease|74|||
23486050|NCT00543855|65521928|FG000|Overall Study|Withdrawal by Subject|0|||
23486051|NCT00543855|65521929|FG001|Overall Study|Withdrawal by Subject|1|||
23486052|NCT00543855|65521930|FG002|Overall Study|Withdrawal by Subject|2|||
23486053|NCT00543855|65521931|FG003|Overall Study|Withdrawal by Subject|0|||
23486054|NCT00543855|65521928|FG000|Overall Study|Protocol Violation|1|||
23279452|NCT02106156|64765422|FG001|Overall Study|Concomitant Disease|2|||
23279453|NCT02106156|64765423|FG002|Overall Study|Concomitant Disease|0|||
23279454|NCT02106156|64765421|FG000|Overall Study|Lack of Compliance|211|||
23279455|NCT02106156|64765422|FG001|Overall Study|Lack of Compliance|7|||
23279456|NCT02106156|64765423|FG002|Overall Study|Lack of Compliance|0|||
23279457|NCT02106156|64765421|FG000|Overall Study|Patients Request|307|||
23279458|NCT02106156|64765422|FG001|Overall Study|Patients Request|9|||
23279459|NCT02106156|64765423|FG002|Overall Study|Patients Request|0|||
23279460|NCT02106156|64765421|FG000|Overall Study|Lost to Follow-up|451|||
23279461|NCT02106156|64765422|FG001|Overall Study|Lost to Follow-up|8|||
23603559|NCT00597376|65937417|FG001|Overall Study|Adverse Event|1|||
23279462|NCT02106156|64765423|FG002|Overall Study|Lost to Follow-up|0|||
23279463|NCT02106156|64765421|FG000|Overall Study|Unplanned Event|82|||
23279464|NCT02106156|64765422|FG001|Overall Study|Unplanned Event|2|||
23279465|NCT02106156|64765423|FG002|Overall Study|Unplanned Event|0|||
23279466|NCT02106156|64765421|FG000|Overall Study|Change of Laboratory Parameter|10|||
23279467|NCT02106156|64765422|FG001|Overall Study|Change of Laboratory Parameter|0|||
23279468|NCT02106156|64765423|FG002|Overall Study|Change of Laboratory Parameter|0|||
23279469|NCT02106156|64765421|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
23279470|NCT02106156|64765422|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
23279471|NCT02106156|64765423|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
23279472|NCT02106156|64765421|FG000|Overall Study|Relocation/Change of Physician|40|||
23279473|NCT02106156|64765422|FG001|Overall Study|Relocation/Change of Physician|1|||
23279474|NCT02106156|64765423|FG002|Overall Study|Relocation/Change of Physician|0|||
23279475|NCT03138967|64765424|FG000|Overall Study|Death|0|||
23279476|NCT03138967|64765425|FG001|Overall Study|Death|1|||
23279477|NCT03138967|64765424|FG000|Overall Study|Physician Decision|1|||
23279478|NCT03138967|64765425|FG001|Overall Study|Physician Decision|3|||
23279479|NCT00835081|64765428|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23279480|NCT00835081|64765429|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23279481|NCT02436005|64765430|FG000|Second Intervention|Adverse Event|0|||
23279482|NCT02436005|64765431|FG001|Second Intervention|Adverse Event|1|||
23279483|NCT01537887|64765438|FG000|Period 1|Physician Decision|0|||
23279484|NCT01537887|64765439|FG001|Period 1|Physician Decision|0|||
23279485|NCT01537887|64765440|FG002|Period 1|Physician Decision|0|||
23279486|NCT01537887|64765441|FG003|Period 1|Physician Decision|0|||
23279487|NCT01537887|64765442|FG004|Period 1|Physician Decision|1|||
23279488|NCT01537887|64765443|FG005|Period 1|Physician Decision|1|||
23279489|NCT01537887|64765438|FG000|Period 1|Did not receive treatment|0|||
23279490|NCT01537887|64765439|FG001|Period 1|Did not receive treatment|0|||
23279491|NCT01537887|64765440|FG002|Period 1|Did not receive treatment|1|||
23279492|NCT01537887|64765441|FG003|Period 1|Did not receive treatment|0|||
23279493|NCT01537887|64765442|FG004|Period 1|Did not receive treatment|0|||
23279494|NCT01537887|64765443|FG005|Period 1|Did not receive treatment|0|||
23279495|NCT01537887|64765438|FG000|Period 2|Withdrawal by Subject|0|||
23279496|NCT01537887|64765439|FG001|Period 2|Withdrawal by Subject|1|||
23279497|NCT01537887|64765440|FG002|Period 2|Withdrawal by Subject|0|||
23279498|NCT01537887|64765441|FG003|Period 2|Withdrawal by Subject|0|||
23279499|NCT01537887|64765442|FG004|Period 2|Withdrawal by Subject|0|||
23279500|NCT01537887|64765443|FG005|Period 2|Withdrawal by Subject|0|||
23279501|NCT01537887|64765438|FG000|Period 3|Adverse Event|0|||
23279502|NCT01537887|64765439|FG001|Period 3|Adverse Event|0|||
23279503|NCT01537887|64765440|FG002|Period 3|Adverse Event|1|||
23279504|NCT01537887|64765441|FG003|Period 3|Adverse Event|0|||
23279505|NCT01537887|64765442|FG004|Period 3|Adverse Event|0|||
23279506|NCT01537887|64765443|FG005|Period 3|Adverse Event|0|||
23279507|NCT01537887|64765438|FG000|Period 3|Withdrawal by Subject|0|||
23279508|NCT01537887|64765439|FG001|Period 3|Withdrawal by Subject|1|||
23279509|NCT01537887|64765440|FG002|Period 3|Withdrawal by Subject|0|||
23486055|NCT00543855|65521929|FG001|Overall Study|Protocol Violation|0|||
23603560|NCT00326183|65937418|FG000|Overall Study|Lost to Follow-up|104|||
23603561|NCT00326183|65937419|FG001|Overall Study|Lost to Follow-up|56|||
23603562|NCT00326183|65937418|FG000|Overall Study|Protocol Violation|6|||
23603563|NCT00326183|65937419|FG001|Overall Study|Protocol Violation|3|||
23279510|NCT01537887|64765441|FG003|Period 3|Withdrawal by Subject|0|||
23279511|NCT01537887|64765442|FG004|Period 3|Withdrawal by Subject|0|||
23279512|NCT01537887|64765443|FG005|Period 3|Withdrawal by Subject|0|||
23279513|NCT02075463|64765444|FG000|Overall Study|Adverse Event|3|||
23279514|NCT02075463|64765444|FG000|Overall Study|Par. reached stopping criteria|4|||
23279515|NCT02075463|64765444|FG000|Overall Study|Withdrawal by Subject|1|||
23279516|NCT00906399|64765445|FG000|Year 1|Randomized But Not Treated|0|||
23279517|NCT00906399|64765446|FG001|Year 1|Randomized But Not Treated|1|||
23279518|NCT00906399|64765447|FG002|Year 1|Randomized But Not Treated|3|||
23279519|NCT00906399|64765448|FG003|Year 1|Randomized But Not Treated|0|||
23279520|NCT00906399|64765449|FG004|Year 1|Randomized But Not Treated|0|||
23279521|NCT00906399|64765450|FG005|Year 1|Randomized But Not Treated|0|||
23279522|NCT00906399|64765451|FG006|Year 1|Randomized But Not Treated|0|||
23279523|NCT00906399|64765445|FG000|Year 1|Adverse Event|4|||
23486056|NCT00543855|65521930|FG002|Overall Study|Protocol Violation|0|||
23603564|NCT00326183|65937418|FG000|Overall Study|Withdrawal by Subject|35|||
23486057|NCT00543855|65521931|FG003|Overall Study|Protocol Violation|0|||
23486058|NCT02716896|65521932|FG000|Overall Study|Physician Decision|0|||
23486059|NCT02716896|65521933|FG001|Overall Study|Physician Decision|1|||
23486060|NCT00730028|65521934|FG000|Overall Study|Adverse Event|23|||
23486061|NCT00730028|65521935|FG001|Overall Study|Adverse Event|26|||
23486062|NCT00730028|65521936|FG002|Overall Study|Adverse Event|16|||
23486063|NCT00730028|65521937|FG003|Overall Study|Adverse Event|20|||
23486064|NCT00730028|65521938|FG004|Overall Study|Adverse Event|43|||
23486065|NCT00730028|65521934|FG000|Overall Study|Lost to Follow-up|13|||
23486066|NCT00730028|65521935|FG001|Overall Study|Lost to Follow-up|26|||
23486067|NCT00730028|65521936|FG002|Overall Study|Lost to Follow-up|22|||
23603565|NCT00326183|65937419|FG001|Overall Study|Withdrawal by Subject|7|||
23603566|NCT00326183|65937418|FG000|Overall Study|Subject Moved|7|||
23603567|NCT00326183|65937419|FG001|Overall Study|Subject Moved|4|||
23603568|NCT00326183|65937418|FG000|Overall Study|Other|47|||
23603569|NCT00326183|65937419|FG001|Overall Study|Other|13|||
23603570|NCT00326183|65937418|FG000|Overall Study|Adverse Event|1|||
23603571|NCT00326183|65937419|FG001|Overall Study|Adverse Event|0|||
23603572|NCT03392194|65937420|FG000|Overall Study|Withdrawal by Subject|1|||
23603573|NCT03392194|65937421|FG001|Overall Study|Withdrawal by Subject|2|||
23603574|NCT03392194|65937420|FG000|Overall Study|Conflicts with personal schedule|1|||
23603575|NCT03392194|65937421|FG001|Overall Study|Conflicts with personal schedule|0|||
23603576|NCT02892019|65937422|FG000|Overall Study|randomized but not treated|0|||
23371647|NCT02497469|65106280|FG001|Overall Study|Lost to Follow-up|4|||
23279524|NCT00906399|64765446|FG001|Year 1|Adverse Event|22|||
23279525|NCT00906399|64765447|FG002|Year 1|Adverse Event|24|||
23279526|NCT00906399|64765448|FG003|Year 1|Adverse Event|0|||
23279527|NCT00906399|64765449|FG004|Year 1|Adverse Event|0|||
23279528|NCT00906399|64765450|FG005|Year 1|Adverse Event|0|||
23279529|NCT00906399|64765451|FG006|Year 1|Adverse Event|0|||
23279530|NCT00906399|64765445|FG000|Year 1|Lost to Follow-up|4|||
23279531|NCT00906399|64765446|FG001|Year 1|Lost to Follow-up|4|||
23279532|NCT00906399|64765447|FG002|Year 1|Lost to Follow-up|2|||
23279533|NCT00906399|64765448|FG003|Year 1|Lost to Follow-up|0|||
23279534|NCT00906399|64765449|FG004|Year 1|Lost to Follow-up|0|||
23279535|NCT00906399|64765450|FG005|Year 1|Lost to Follow-up|0|||
23279536|NCT00906399|64765451|FG006|Year 1|Lost to Follow-up|0|||
23279537|NCT00906399|64765445|FG000|Year 1|Withdrawal by Subject|30|||
23279538|NCT00906399|64765446|FG001|Year 1|Withdrawal by Subject|32|||
23279539|NCT00906399|64765447|FG002|Year 1|Withdrawal by Subject|36|||
23279540|NCT00906399|64765448|FG003|Year 1|Withdrawal by Subject|0|||
23279541|NCT00906399|64765449|FG004|Year 1|Withdrawal by Subject|0|||
23279542|NCT00906399|64765450|FG005|Year 1|Withdrawal by Subject|0|||
23279543|NCT00906399|64765451|FG006|Year 1|Withdrawal by Subject|0|||
23371648|NCT02497469|65106279|FG000|Overall Study|Voluntary Withdrawal|39|||
23371649|NCT02497469|65106280|FG001|Overall Study|Voluntary Withdrawal|41|||
23279544|NCT00906399|64765445|FG000|Year 1|Physician Decision|0|||
23279545|NCT00906399|64765446|FG001|Year 1|Physician Decision|1|||
23279546|NCT00906399|64765447|FG002|Year 1|Physician Decision|3|||
23279547|NCT00906399|64765448|FG003|Year 1|Physician Decision|0|||
23279548|NCT00906399|64765449|FG004|Year 1|Physician Decision|0|||
23279549|NCT00906399|64765450|FG005|Year 1|Physician Decision|0|||
23279550|NCT00906399|64765451|FG006|Year 1|Physician Decision|0|||
23279551|NCT00906399|64765445|FG000|Year 1|Death|2|||
23279552|NCT00906399|64765446|FG001|Year 1|Death|1|||
23371650|NCT02497469|65106279|FG000|Overall Study|Pregnancy|1|||
23371651|NCT02497469|65106280|FG001|Overall Study|Pregnancy|1|||
23486068|NCT00730028|65521937|FG003|Overall Study|Lost to Follow-up|26|||
23486069|NCT00730028|65521938|FG004|Overall Study|Lost to Follow-up|25|||
23486070|NCT00730028|65521934|FG000|Overall Study|Protocol Violation|6|||
23603577|NCT02892019|65937423|FG001|Overall Study|randomized but not treated|1|||
23371652|NCT02497469|65106279|FG000|Overall Study|Lack of Efficacy|86|||
23371653|NCT02497469|65106280|FG001|Overall Study|Lack of Efficacy|40|||
23371654|NCT02497469|65106279|FG000|Overall Study|Reason not Specified|6|||
23371655|NCT02497469|65106280|FG001|Overall Study|Reason not Specified|6|||
23371656|NCT03641508|65106285|FG000|First Injection|Lost to Follow-up|2|||
23371657|NCT03641508|65106286|FG001|First Injection|Lost to Follow-up|0|||
23371658|NCT01576575|65106291|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
23371659|NCT01576575|65106291|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
23371660|NCT01576575|65106291|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
23371661|NCT01930539|65106292|FG000|Overall Study|Withdrawal by Subject|2|||
23371662|NCT01930539|65106293|FG001|Overall Study|Withdrawal by Subject|2|||
23371663|NCT03363906|65106294|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
23371664|NCT03363906|65106295|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
23371665|NCT03363906|65106294|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
23371666|NCT03363906|65106295|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
23371667|NCT03363906|65106294|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
23371668|NCT03363906|65106295|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
23371669|NCT03363906|65106294|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
23371670|NCT03363906|65106295|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
23371671|NCT02592824|65106296|FG000|Overall Study|Protocol Violation|5|||
23371672|NCT02592824|65106297|FG001|Overall Study|Protocol Violation|3|||
23371673|NCT02592824|65106296|FG000|Overall Study|Lost to Follow-up|2|||
23371674|NCT02592824|65106297|FG001|Overall Study|Lost to Follow-up|1|||
23371675|NCT02701634|65106298|FG000|Overall Study|Adverse Event|2|||
23371676|NCT02701634|65106299|FG001|Overall Study|Adverse Event|3|||
23371677|NCT02701634|65106298|FG000|Overall Study|Death|1|||
23371678|NCT02701634|65106299|FG001|Overall Study|Death|0|||
23371679|NCT02701634|65106298|FG000|Overall Study|Investigator's Discretion|7|||
23371680|NCT02701634|65106299|FG001|Overall Study|Investigator's Discretion|4|||
23371681|NCT02701634|65106298|FG000|Overall Study|Study terminated by Sponsor|15|||
23371682|NCT02701634|65106299|FG001|Overall Study|Study terminated by Sponsor|17|||
23371683|NCT02701634|65106298|FG000|Overall Study|Withdrew Consent|6|||
23371684|NCT02701634|65106299|FG001|Overall Study|Withdrew Consent|7|||
23371685|NCT02701634|65106298|FG000|Overall Study|Randomized but not treated|1|||
23371686|NCT02701634|65106299|FG001|Overall Study|Randomized but not treated|0|||
23371687|NCT02737358|65106300|FG000|Overall Study|Withdrawal by Subject|7|||
23371688|NCT02737358|65106301|FG001|Overall Study|Withdrawal by Subject|12|||
23371689|NCT02737358|65106300|FG000|Overall Study|Lost to Follow-up|2|||
23371690|NCT02737358|65106301|FG001|Overall Study|Lost to Follow-up|3|||
23371691|NCT00703534|65106302|FG000|Overall Study|Adverse Event|14|||
23371692|NCT00703534|65106303|FG001|Overall Study|Adverse Event|3|||
23371693|NCT00703534|65106302|FG000|Overall Study|Withdrawal by Subject|8|||
23371694|NCT00703534|65106303|FG001|Overall Study|Withdrawal by Subject|7|||
23371695|NCT00703534|65106302|FG000|Overall Study|Incorrect Enrollment|6|||
23371696|NCT00703534|65106303|FG001|Overall Study|Incorrect Enrollment|6|||
23371697|NCT00703534|65106302|FG000|Overall Study|Lost to Follow-up|1|||
23371698|NCT00703534|65106303|FG001|Overall Study|Lost to Follow-up|4|||
23371699|NCT00703534|65106302|FG000|Overall Study|Severe Non Compliance|1|||
23371700|NCT00703534|65106303|FG001|Overall Study|Severe Non Compliance|5|||
23371701|NCT02127658|65106312|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
23371702|NCT02127658|65106313|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
23371703|NCT02127658|65106312|FG000|Overall Study|Withdrawal by Subject|0|||
23371704|NCT02127658|65106313|FG001|Overall Study|Withdrawal by Subject|2|||
23371705|NCT02127658|65106312|FG000|Overall Study|Physician Decision|0|||
23371706|NCT02127658|65106313|FG001|Overall Study|Physician Decision|1|||
23371707|NCT01033136|65106314|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
23371708|NCT01033136|65106315|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
23371709|NCT04239924|65106316|FG000|Overall Study|Lost to Follow-up|2|||
23371710|NCT00706004|65106320|FG000|Overall Study|Did not meet eligibility criteria|2|||
23371711|NCT01255163|65106321|FG000|Overall Study|Withdrawal by Subject|1|||
23371712|NCT01255163|65106322|FG001|Overall Study|Withdrawal by Subject|0|||
23486071|NCT00730028|65521935|FG001|Overall Study|Protocol Violation|1|||
23486072|NCT00730028|65521936|FG002|Overall Study|Protocol Violation|1|||
23371713|NCT01255163|65106321|FG000|Overall Study|Lost to Follow-up|2|||
23371714|NCT01255163|65106322|FG001|Overall Study|Lost to Follow-up|0|||
23371715|NCT01255163|65106321|FG000|Overall Study|Adverse Event|0|||
23371716|NCT01255163|65106322|FG001|Overall Study|Adverse Event|2|||
23371717|NCT01255163|65106321|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
23371718|NCT01255163|65106322|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
23486073|NCT00730028|65521937|FG003|Overall Study|Protocol Violation|2|||
23486074|NCT00730028|65521938|FG004|Overall Study|Protocol Violation|0|||
23486075|NCT00730028|65521934|FG000|Overall Study|Withdrawal by Subject|9|||
23486076|NCT00730028|65521935|FG001|Overall Study|Withdrawal by Subject|5|||
23486077|NCT00730028|65521936|FG002|Overall Study|Withdrawal by Subject|4|||
23486078|NCT00730028|65521937|FG003|Overall Study|Withdrawal by Subject|5|||
23486079|NCT00730028|65521938|FG004|Overall Study|Withdrawal by Subject|9|||
23486080|NCT00730028|65521934|FG000|Overall Study|Physician Decision|3|||
23486081|NCT00730028|65521935|FG001|Overall Study|Physician Decision|3|||
23486082|NCT00730028|65521936|FG002|Overall Study|Physician Decision|2|||
23486083|NCT00730028|65521937|FG003|Overall Study|Physician Decision|3|||
23486084|NCT00730028|65521938|FG004|Overall Study|Physician Decision|2|||
23486085|NCT00730028|65521934|FG000|Overall Study|Treatment Failure|5|||
23486086|NCT00730028|65521935|FG001|Overall Study|Treatment Failure|5|||
23486087|NCT00730028|65521936|FG002|Overall Study|Treatment Failure|0|||
23486088|NCT00730028|65521937|FG003|Overall Study|Treatment Failure|0|||
23486089|NCT00730028|65521938|FG004|Overall Study|Treatment Failure|1|||
23486090|NCT00730028|65521934|FG000|Overall Study|Randomization Error|1|||
23486091|NCT00730028|65521935|FG001|Overall Study|Randomization Error|0|||
23201416|NCT04657016|64476722|FG000|Overall Study|Withdrawal by Subject|28|||
23201417|NCT04657016|64476723|FG001|Overall Study|Withdrawal by Subject|14|||
23201418|NCT04657016|64476722|FG000|Overall Study|Other - as reported by the investigator|6|||
23279553|NCT00906399|64765447|FG002|Year 1|Death|1|||
23279554|NCT00906399|64765448|FG003|Year 1|Death|0|||
23279555|NCT00906399|64765449|FG004|Year 1|Death|0|||
23279556|NCT00906399|64765450|FG005|Year 1|Death|0|||
23279557|NCT00906399|64765451|FG006|Year 1|Death|0|||
23279558|NCT00906399|64765445|FG000|Year 1|Other|4|||
23279559|NCT00906399|64765446|FG001|Year 1|Other|2|||
23279560|NCT00906399|64765447|FG002|Year 1|Other|7|||
23279561|NCT00906399|64765448|FG003|Year 1|Other|0|||
23279562|NCT00906399|64765449|FG004|Year 1|Other|0|||
23279563|NCT00906399|64765450|FG005|Year 1|Other|0|||
23279564|NCT00906399|64765451|FG006|Year 1|Other|0|||
23279565|NCT00906399|64765445|FG000|Year 2|Adverse Event|0|||
23279566|NCT00906399|64765446|FG001|Year 2|Adverse Event|0|||
23279567|NCT00906399|64765447|FG002|Year 2|Adverse Event|0|||
23279568|NCT00906399|64765448|FG003|Year 2|Adverse Event|9|||
23279569|NCT00906399|64765449|FG004|Year 2|Adverse Event|8|||
23279570|NCT00906399|64765450|FG005|Year 2|Adverse Event|11|||
23279571|NCT00906399|64765451|FG006|Year 2|Adverse Event|6|||
23279572|NCT00906399|64765445|FG000|Year 2|Lost to Follow-up|0|||
23279573|NCT00906399|64765446|FG001|Year 2|Lost to Follow-up|0|||
23279574|NCT00906399|64765447|FG002|Year 2|Lost to Follow-up|0|||
23279575|NCT00906399|64765448|FG003|Year 2|Lost to Follow-up|1|||
23279576|NCT00906399|64765449|FG004|Year 2|Lost to Follow-up|4|||
23279577|NCT00906399|64765450|FG005|Year 2|Lost to Follow-up|2|||
23279578|NCT00906399|64765451|FG006|Year 2|Lost to Follow-up|4|||
23279579|NCT00906399|64765445|FG000|Year 2|Withdrawal by Subject|0|||
23279580|NCT00906399|64765446|FG001|Year 2|Withdrawal by Subject|0|||
23279581|NCT00906399|64765447|FG002|Year 2|Withdrawal by Subject|0|||
23279582|NCT00906399|64765448|FG003|Year 2|Withdrawal by Subject|17|||
23279583|NCT00906399|64765449|FG004|Year 2|Withdrawal by Subject|18|||
23279584|NCT00906399|64765450|FG005|Year 2|Withdrawal by Subject|27|||
23279585|NCT00906399|64765451|FG006|Year 2|Withdrawal by Subject|13|||
23279586|NCT00906399|64765445|FG000|Year 2|Physician Decision|0|||
23279587|NCT00906399|64765446|FG001|Year 2|Physician Decision|0|||
23279588|NCT00906399|64765447|FG002|Year 2|Physician Decision|0|||
23486092|NCT00730028|65521936|FG002|Overall Study|Randomization Error|0|||
23486093|NCT00730028|65521937|FG003|Overall Study|Randomization Error|0|||
23201419|NCT04657016|64476723|FG001|Overall Study|Other - as reported by the investigator|0|||
23201420|NCT03196505|64476726|FG000|Overall Study|Physician Decision|26|||
23201421|NCT03196505|64476727|FG001|Overall Study|Physician Decision|26|||
23201422|NCT00431847|64476728|FG000|Overall Study|completion of less than two study visits|6|||
23201423|NCT00431847|64476729|FG001|Overall Study|completion of less than two study visits|3|||
23201424|NCT00431847|64476730|FG002|Overall Study|completion of less than two study visits|4|||
23201425|NCT00431847|64476731|FG003|Overall Study|completion of less than two study visits|14|||
23201426|NCT00431847|64476732|FG004|Overall Study|completion of less than two study visits|0|||
23201427|NCT00431847|64476728|FG000|Overall Study|Protocol Violation|0|||
23201428|NCT00431847|64476729|FG001|Overall Study|Protocol Violation|0|||
23201429|NCT00431847|64476730|FG002|Overall Study|Protocol Violation|0|||
23201430|NCT00431847|64476731|FG003|Overall Study|Protocol Violation|0|||
23201431|NCT00431847|64476732|FG004|Overall Study|Protocol Violation|1|||
23201432|NCT00634244|64476733|FG000|Overall Study|Never started treatment|0|||
23201433|NCT00634244|64476734|FG001|Overall Study|Never started treatment|1|||
23201434|NCT00634244|64476735|FG002|Overall Study|Never started treatment|0|||
23201435|NCT00634244|64476733|FG000|Overall Study|Death|1|||
23201436|NCT00634244|64476734|FG001|Overall Study|Death|6|||
23201437|NCT00634244|64476735|FG002|Overall Study|Death|0|||
23201438|NCT00634244|64476733|FG000|Overall Study|Adverse Event|0|||
23201439|NCT00634244|64476734|FG001|Overall Study|Adverse Event|2|||
23371719|NCT01162343|65106323|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
23371720|NCT01162343|65106323|FG000|Overall Study|Refused psychiatrist assessment|12|||
23371721|NCT00427934|65106324|FG000|Overall Study|Adverse Event|1|||
23371722|NCT00427934|65106325|FG001|Overall Study|Adverse Event|0|||
23371723|NCT00427934|65106326|FG002|Overall Study|Adverse Event|5|||
23371724|NCT00427934|65106327|FG003|Overall Study|Adverse Event|4|||
23371725|NCT00427934|65106324|FG000|Overall Study|Lack of Efficacy|0|||
23371726|NCT00427934|65106325|FG001|Overall Study|Lack of Efficacy|0|||
23371727|NCT00427934|65106326|FG002|Overall Study|Lack of Efficacy|5|||
23371728|NCT00427934|65106327|FG003|Overall Study|Lack of Efficacy|2|||
23371729|NCT00427934|65106324|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
23371730|NCT00427934|65106325|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
23371731|NCT00427934|65106326|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
23371732|NCT00427934|65106327|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
23371733|NCT00427934|65106324|FG000|Overall Study|Other|0|||
23371734|NCT00427934|65106325|FG001|Overall Study|Other|0|||
23279589|NCT00906399|64765448|FG003|Year 2|Physician Decision|0|||
23371735|NCT00427934|65106326|FG002|Overall Study|Other|11|||
23279590|NCT00906399|64765449|FG004|Year 2|Physician Decision|2|||
23279591|NCT00906399|64765450|FG005|Year 2|Physician Decision|6|||
23279592|NCT00906399|64765451|FG006|Year 2|Physician Decision|3|||
23279593|NCT00906399|64765445|FG000|Year 2|Death|0|||
23279594|NCT00906399|64765446|FG001|Year 2|Death|0|||
23279595|NCT00906399|64765447|FG002|Year 2|Death|0|||
23279596|NCT00906399|64765448|FG003|Year 2|Death|1|||
23279597|NCT00906399|64765449|FG004|Year 2|Death|0|||
23279598|NCT00906399|64765450|FG005|Year 2|Death|0|||
23279599|NCT00906399|64765451|FG006|Year 2|Death|3|||
23279600|NCT00906399|64765445|FG000|Year 2|Other|0|||
23279601|NCT00906399|64765446|FG001|Year 2|Other|0|||
23279602|NCT00906399|64765447|FG002|Year 2|Other|0|||
23279603|NCT00906399|64765448|FG003|Year 2|Other|2|||
23279604|NCT00906399|64765449|FG004|Year 2|Other|3|||
23279605|NCT00906399|64765450|FG005|Year 2|Other|1|||
23371736|NCT00427934|65106327|FG003|Overall Study|Other|5|||
23371737|NCT00427934|65106324|FG000|Overall Study|Withdrawal by Subject|0|||
23201440|NCT00634244|64476735|FG002|Overall Study|Adverse Event|0|||
23201441|NCT00634244|64476733|FG000|Overall Study|Withdrawal by Subject|0|||
23201442|NCT00634244|64476734|FG001|Overall Study|Withdrawal by Subject|1|||
23201443|NCT00634244|64476735|FG002|Overall Study|Withdrawal by Subject|0|||
23201444|NCT00634244|64476733|FG000|Overall Study|Physician Decision|0|||
23201445|NCT00634244|64476734|FG001|Overall Study|Physician Decision|1|||
23201446|NCT00634244|64476735|FG002|Overall Study|Physician Decision|0|||
23201447|NCT00634244|64476733|FG000|Overall Study|Disease progression/relapse|0|||
23201448|NCT00634244|64476734|FG001|Overall Study|Disease progression/relapse|1|||
23201449|NCT00634244|64476735|FG002|Overall Study|Disease progression/relapse|0|||
23201450|NCT00634244|64476733|FG000|Overall Study|Other complicating disease|0|||
23279606|NCT00906399|64765451|FG006|Year 2|Other|0|||
23486094|NCT00730028|65521938|FG004|Overall Study|Randomization Error|2|||
23486095|NCT03116347|65521939|FG000|Overall Study|Withdrawal by Subject|1|||
23486096|NCT03116347|65521940|FG001|Overall Study|Withdrawal by Subject|2|||
23486097|NCT00542451|65521941|FG000|Overall Study|Adverse Event|31|||
23486098|NCT00542451|65521941|FG000|Overall Study|Withdrawal by Subject|30|||
23486099|NCT00542451|65521941|FG000|Overall Study|Physician Decision|4|||
23486100|NCT00542451|65521941|FG000|Overall Study|Recurrent disease|1|||
23486101|NCT00542451|65521941|FG000|Overall Study|unknown reason|1|||
23486102|NCT00542451|65521941|FG000|Overall Study|Death|2|||
23486103|NCT00542451|65521941|FG000|Overall Study|Lost to Follow-up|10|||
23486104|NCT00568685|65521942|FG000|Overall Study|Adverse Event|2|||
23486105|NCT00568685|65521943|FG001|Overall Study|Adverse Event|3|||
23486106|NCT00568685|65521944|FG002|Overall Study|Adverse Event|3|||
23486107|NCT00568685|65521942|FG000|Overall Study|Withdrawal by Subject|7|||
23486108|NCT00568685|65521943|FG001|Overall Study|Withdrawal by Subject|2|||
23486109|NCT00568685|65521944|FG002|Overall Study|Withdrawal by Subject|2|||
23486110|NCT00568685|65521942|FG000|Overall Study|Protocol Violation|1|||
23486111|NCT00568685|65521943|FG001|Overall Study|Protocol Violation|0|||
23486112|NCT00568685|65521944|FG002|Overall Study|Protocol Violation|0|||
23486113|NCT03523000|65521945|FG000|Overall Study|Withdrawal by Subject|3|||
23486114|NCT03523000|65521946|FG001|Overall Study|Withdrawal by Subject|0|||
23486115|NCT03523000|65521945|FG000|Overall Study|Unsuccessful trial|2|||
23201451|NCT00634244|64476734|FG001|Overall Study|Other complicating disease|1|||
23279607|NCT00835263|64765452|FG000|Second Intervention|Adverse Event|1|||
23279608|NCT00835263|64765453|FG001|Second Intervention|Adverse Event|0|||
23371738|NCT00427934|65106325|FG001|Overall Study|Withdrawal by Subject|0|||
23371739|NCT00427934|65106326|FG002|Overall Study|Withdrawal by Subject|1|||
23371740|NCT00427934|65106327|FG003|Overall Study|Withdrawal by Subject|3|||
23279609|NCT01900691|64765459|FG000|Overall Study|Death|7|||
23279610|NCT01900691|64765459|FG000|Overall Study|Lost to Follow-up|4|||
23279611|NCT01900691|64765459|FG000|Overall Study|Study Device Not Placed|3|||
23279612|NCT01900691|64765459|FG000|Overall Study|Non study stent placed|2|||
23486116|NCT03523000|65521946|FG001|Overall Study|Unsuccessful trial|0|||
23279613|NCT01900691|64765459|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
23279614|NCT01900691|64765459|FG000|Overall Study|Complete stent migration through digestive tract|1|||
23279615|NCT00840073|64765460|FG000|Second Intervention|Missed 72 hour blood draw|1|||
23279616|NCT00840073|64765461|FG001|Second Intervention|Missed 72 hour blood draw|1|||
23279617|NCT03597256|64765464|FG000|Overall Study|Lost to Follow-up|3|||
23279618|NCT03597256|64765465|FG001|Overall Study|Lost to Follow-up|1|||
23279619|NCT03597256|64765464|FG000|Overall Study|Withdrawal by Subject|0|||
23279620|NCT03597256|64765465|FG001|Overall Study|Withdrawal by Subject|1|||
23279621|NCT03597256|64765464|FG000|Overall Study|Could not return for treatment|0|||
23279622|NCT03597256|64765465|FG001|Overall Study|Could not return for treatment|1|||
23279623|NCT03597256|64765464|FG000|Overall Study|Moved from location|0|||
23279624|NCT03597256|64765465|FG001|Overall Study|Moved from location|1|||
23279625|NCT03597256|64765464|FG000|Overall Study|Not accepted the treatment|0|||
23279626|NCT03597256|64765465|FG001|Overall Study|Not accepted the treatment|1|||
23279627|NCT00834067|64765469|FG000|Washout of 21 Days|Protocol Violation|0|||
23279628|NCT00834067|64765470|FG001|Washout of 21 Days|Protocol Violation|1|||
23279629|NCT06195579|64765473|FG000|Overall Study|Withdrawal by Subject|1|||
23279630|NCT00813592|64765474|FG000|Overall Study|Disease assessment was not completed per|2|||
23279631|NCT04408794|64765475|FG000|Overall Study|Adverse Event|43|||
23279632|NCT04408794|64765475|FG000|Overall Study|Infrequent study drug usage|43|||
23279633|NCT04408794|64765475|FG000|Overall Study|Lack of Efficacy|61|||
23279634|NCT04408794|64765475|FG000|Overall Study|Lost to Follow-up|33|||
23279635|NCT04408794|64765475|FG000|Overall Study|Non-compliance|6|||
23279636|NCT04408794|64765475|FG000|Overall Study|Physician Decision|1|||
23279637|NCT04408794|64765475|FG000|Overall Study|Pregnancy|6|||
23279638|NCT04408794|64765475|FG000|Overall Study|Protocol Deviation|9|||
23279639|NCT04408794|64765475|FG000|Overall Study|Sheehan-STS Result|1|||
23279640|NCT04408794|64765475|FG000|Overall Study|Withdrawal by Subject|57|||
23279641|NCT04408794|64765475|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
23279642|NCT04408794|64765475|FG000|Overall Study|Never Treated Migraine|5|||
23279643|NCT02213263|64765480|FG000|Overall Study|Insufficient clinical response|4|||
23279644|NCT02213263|64765481|FG001|Overall Study|Insufficient clinical response|3|||
23279645|NCT02213263|64765480|FG000|Overall Study|Lost to Follow-up|0|||
23279646|NCT02213263|64765481|FG001|Overall Study|Lost to Follow-up|1|||
23279647|NCT02213263|64765480|FG000|Overall Study|No longer willing to participate|3|||
23279648|NCT02213263|64765481|FG001|Overall Study|No longer willing to participate|4|||
23279649|NCT02213263|64765480|FG000|Overall Study|Progressive disease|20|||
23279650|NCT02213263|64765481|FG001|Overall Study|Progressive disease|14|||
23279651|NCT02213263|64765480|FG000|Overall Study|Protocol Violation|0|||
23279652|NCT02213263|64765481|FG001|Overall Study|Protocol Violation|1|||
23279653|NCT02213263|64765480|FG000|Overall Study|Adverse Event|1|||
23371741|NCT05379920|65106328|FG000|Overall Study|Lost to Follow-up|0|||
23371742|NCT05379920|65106329|FG001|Overall Study|Lost to Follow-up|5|||
23371743|NCT05379920|65106330|FG002|Overall Study|Lost to Follow-up|0|||
23371744|NCT05379920|65106331|FG003|Overall Study|Lost to Follow-up|0|||
23371745|NCT01114724|65106333|FG000|Overall Study|Death|8|||
23371746|NCT01114724|65106333|FG000|Overall Study|Lost to Follow-up|1|||
23371747|NCT01114724|65106333|FG000|Overall Study|Withdrawal by Subject|1|||
23371748|NCT03292016|65106334|FG000|Second Washout|Adverse Event|0|||
23371749|NCT03292016|65106335|FG001|Second Washout|Adverse Event|1|||
23371750|NCT03292016|65106336|FG002|Second Washout|Adverse Event|0|||
23371751|NCT03292016|65106337|FG003|Second Washout|Adverse Event|0|||
23371752|NCT03292016|65106338|FG004|Second Washout|Adverse Event|0|||
23371753|NCT03292016|65106339|FG005|Second Washout|Adverse Event|0|||
23371754|NCT01299909|65106340|FG000|Overall Study|Lost to Follow-up|22|||
23371755|NCT01299909|65106341|FG001|Overall Study|Lost to Follow-up|18|||
23371756|NCT01299909|65106342|FG002|Overall Study|Lost to Follow-up|17|||
23371757|NCT00744939|65106343|FG000|Overall Study|Withdrawal by Subject|9|||
23371758|NCT00744939|65106343|FG000|Overall Study|Protocol Violation|13|||
23371759|NCT00744939|65106343|FG000|Overall Study|Death|24|||
23371760|NCT00744939|65106343|FG000|Overall Study|distance|4|||
23371761|NCT00744939|65106343|FG000|Overall Study|Lost to Follow-up|12|||
23371762|NCT00744939|65106343|FG000|Overall Study|Medical history exclusionary|1|||
23371763|NCT00744939|65106343|FG000|Overall Study|Did not receive Magnevist|7|||
23279654|NCT02213263|64765481|FG001|Overall Study|Adverse Event|3|||
23279655|NCT01249651|64765482|FG000|Overall Study|Withdrawal by Subject|4|||
23279656|NCT01249651|64765482|FG000|Overall Study|Adverse Event|1|||
23279657|NCT01249651|64765482|FG000|Overall Study|Protocol Violation|1|||
23371764|NCT00744939|65106343|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
23371765|NCT00744939|65106343|FG000|Overall Study|coma|1|||
23371766|NCT00744939|65106343|FG000|Overall Study|incorrect race|1|||
23371767|NCT02466399|65106344|FG000|Overall Study|Adverse Event|1|||
23371768|NCT02466399|65106345|FG001|Overall Study|Adverse Event|0|||
23279658|NCT01249651|64765482|FG000|Overall Study|Sponsor Decision|1|||
23279659|NCT01442155|64765483|FG000|Overall Study|Complete remission|35|||
23279660|NCT01442155|64765483|FG000|Overall Study|Recurrence|26|||
23279661|NCT01442155|64765483|FG000|Overall Study|Adverse Event|2|||
23486117|NCT03481660|65521948|FG000|Overall Study|Adverse Event|5|||
23486118|NCT03481660|65521949|FG001|Overall Study|Adverse Event|4|||
23486119|NCT03481660|65521948|FG000|Overall Study|Death|13|||
23486120|NCT03481660|65521949|FG001|Overall Study|Death|9|||
23486121|NCT03481660|65521948|FG000|Overall Study|Lost to Follow-up|2|||
23486122|NCT03481660|65521949|FG001|Overall Study|Lost to Follow-up|2|||
23486123|NCT03481660|65521948|FG000|Overall Study|Physician Decision|2|||
23486124|NCT03481660|65521949|FG001|Overall Study|Physician Decision|3|||
23486125|NCT03481660|65521948|FG000|Overall Study|Withdrawal by Subject|14|||
23486126|NCT03481660|65521949|FG001|Overall Study|Withdrawal by Subject|7|||
23486127|NCT00107952|65524197|FG000|Overall Study|Death|75|||
23486128|NCT00107952|65524198|FG001|Overall Study|Death|61|||
23486129|NCT00107952|65524197|FG000|Overall Study|Lost to Follow-up|0|||
23486130|NCT00107952|65524198|FG001|Overall Study|Lost to Follow-up|3|||
23486131|NCT00107952|65524197|FG000|Overall Study|Withdrawal by Subject|9|||
23486132|NCT00107952|65524198|FG001|Overall Study|Withdrawal by Subject|6|||
23486133|NCT00107952|65524197|FG000|Overall Study|Other|2|||
23486134|NCT00107952|65524198|FG001|Overall Study|Other|5|||
23486135|NCT00107952|65524197|FG000|Overall Study|Never received study treatment|9|||
23486136|NCT00107952|65524198|FG001|Overall Study|Never received study treatment|6|||
23486137|NCT02038452|65524205|FG000|Overall Study|Withdrawal by Subject|7|||
23486138|NCT02038452|65524206|FG001|Overall Study|Withdrawal by Subject|9|||
23486139|NCT02038452|65524205|FG000|Overall Study|Lost to Follow-up|31|||
23486140|NCT02038452|65524206|FG001|Overall Study|Lost to Follow-up|28|||
23486141|NCT01314911|65524209|FG000|Overall Study|Lost to Follow-up|3|||
23486142|NCT01314911|65524210|FG001|Overall Study|Lost to Follow-up|2|||
23486143|NCT01314911|65524209|FG000|Overall Study|Withdrawal by Subject|1|||
23486144|NCT01314911|65524210|FG001|Overall Study|Withdrawal by Subject|3|||
23486145|NCT01314911|65524209|FG000|Overall Study|Received Non-randomized Study Drug|0|||
23486146|NCT01314911|65524210|FG001|Overall Study|Received Non-randomized Study Drug|1|||
23486147|NCT01314911|65524209|FG000|Overall Study|Never Started Treatment|1|||
23486148|NCT01314911|65524210|FG001|Overall Study|Never Started Treatment|0|||
23486149|NCT02567552|65524212|FG000|Overall Study|Adverse Event|0|||
23486150|NCT02567552|65524213|FG001|Overall Study|Adverse Event|1|||
23486151|NCT01285960|65524214|FG000|Overall Study|Withdrawal by Subject|2|||
23486152|NCT01285960|65524214|FG000|Overall Study|Lost to Follow-up|2|||
23371769|NCT02466399|65106344|FG000|Overall Study|Early exit due to family emergency|1|||
23371770|NCT02466399|65106345|FG001|Overall Study|Early exit due to family emergency|0|||
23371771|NCT02858401|65106352|FG000|Overall Study|Withdrew Consent|0|||
23371772|NCT02858401|65106353|FG001|Overall Study|Withdrew Consent|0|||
23371773|NCT02858401|65106354|FG002|Overall Study|Withdrew Consent|0|||
23371774|NCT02858401|65106355|FG003|Overall Study|Withdrew Consent|0|||
23371775|NCT02858401|65106356|FG004|Overall Study|Withdrew Consent|0|||
23371776|NCT02858401|65106357|FG005|Overall Study|Withdrew Consent|1|||
23371777|NCT02858401|65106358|FG006|Overall Study|Withdrew Consent|0|||
23371778|NCT02858401|65106352|FG000|Overall Study|Lost to Follow-up|0|||
23486153|NCT01285960|65524214|FG000|Overall Study|2 subjects received less 10 sonications|2|||
23486154|NCT01933789|65524224|FG000|Overall Study|Death|0|||
23486155|NCT01933789|65524225|FG001|Overall Study|Death|0|||
23486156|NCT01933789|65524226|FG002|Overall Study|Death|0|||
23486157|NCT01933789|65524227|FG003|Overall Study|Death|0|||
23486158|NCT01933789|65524228|FG004|Overall Study|Death|21|||
23486159|NCT01933789|65524229|FG005|Overall Study|Death|32|||
23486160|NCT01933789|65524230|FG006|Overall Study|Death|0|||
23279662|NCT01442155|64765483|FG000|Overall Study|Lost to Follow-up|2|||
23371779|NCT02858401|65106353|FG001|Overall Study|Lost to Follow-up|1|||
23371780|NCT02858401|65106354|FG002|Overall Study|Lost to Follow-up|0|||
23371781|NCT02858401|65106355|FG003|Overall Study|Lost to Follow-up|0|||
23279663|NCT01757392|64765484|FG000|Overall Study|Withdrawal by Subject|1|||
23279664|NCT01757392|64765484|FG000|Overall Study|Screen Fail|3|||
23279665|NCT01376167|64765494|FG000|Overall Study|Lost to Follow-up|2|||
23279666|NCT01376167|64765495|FG001|Overall Study|Lost to Follow-up|4|||
23279667|NCT01376167|64765496|FG002|Overall Study|Lost to Follow-up|2|||
23279668|NCT01376167|64765494|FG000|Overall Study|Physician Decision|1|||
23279669|NCT01376167|64765495|FG001|Overall Study|Physician Decision|1|||
23279670|NCT01376167|64765496|FG002|Overall Study|Physician Decision|0|||
23279671|NCT01376167|64765494|FG000|Overall Study|Withdrawal by Subject|1|||
23279672|NCT01376167|64765495|FG001|Overall Study|Withdrawal by Subject|5|||
23279673|NCT01376167|64765496|FG002|Overall Study|Withdrawal by Subject|4|||
23279674|NCT02588339|64765497|FG000|Overall Study|Withdrawal by Subject|1|||
23279675|NCT02588339|64765497|FG000|Overall Study|GVHD Progression prior to treatment|2|||
23371782|NCT02858401|65106356|FG004|Overall Study|Lost to Follow-up|0|||
23371783|NCT02858401|65106357|FG005|Overall Study|Lost to Follow-up|0|||
23371784|NCT02858401|65106358|FG006|Overall Study|Lost to Follow-up|0|||
23486161|NCT01933789|65524231|FG007|Overall Study|Death|0|||
23486162|NCT01933789|65524232|FG008|Overall Study|Death|0|||
23486163|NCT01933789|65524224|FG000|Overall Study|Lost to Follow-up|0|||
23486164|NCT01933789|65524225|FG001|Overall Study|Lost to Follow-up|0|||
23486165|NCT01933789|65524226|FG002|Overall Study|Lost to Follow-up|0|||
23486166|NCT01933789|65524227|FG003|Overall Study|Lost to Follow-up|1|||
23486167|NCT01933789|65524228|FG004|Overall Study|Lost to Follow-up|8|||
23486168|NCT01933789|65524229|FG005|Overall Study|Lost to Follow-up|9|||
23486169|NCT01933789|65524230|FG006|Overall Study|Lost to Follow-up|1|||
23486170|NCT01933789|65524231|FG007|Overall Study|Lost to Follow-up|4|||
23486171|NCT01933789|65524232|FG008|Overall Study|Lost to Follow-up|0|||
23486172|NCT01933789|65524224|FG000|Overall Study|Withdrawal by Subject|2|||
23486173|NCT01933789|65524225|FG001|Overall Study|Withdrawal by Subject|1|||
23279676|NCT01415986|64765499|FG000|Overall Study|Lost to Follow-up|1|||
23279677|NCT01471353|64765500|FG000|Overall Study|remain on study|3|||
23279678|NCT00905346|64765509|FG000|Period 1|Withdrawal by Subject|1|||
23279679|NCT00905346|64765510|FG001|Period 1|Withdrawal by Subject|0|||
23279680|NCT04608188|64765511|FG000|Overall Study|Withdrawal by Subject|4|||
23486174|NCT01933789|65524226|FG002|Overall Study|Withdrawal by Subject|0|||
23486175|NCT01933789|65524227|FG003|Overall Study|Withdrawal by Subject|0|||
23486176|NCT01933789|65524228|FG004|Overall Study|Withdrawal by Subject|17|||
23486177|NCT01933789|65524229|FG005|Overall Study|Withdrawal by Subject|16|||
23486178|NCT01933789|65524230|FG006|Overall Study|Withdrawal by Subject|1|||
23486179|NCT01933789|65524231|FG007|Overall Study|Withdrawal by Subject|4|||
23486180|NCT01933789|65524232|FG008|Overall Study|Withdrawal by Subject|0|||
23486181|NCT01933789|65524224|FG000|Overall Study|Became Ineligible|4|||
23486182|NCT01933789|65524225|FG001|Overall Study|Became Ineligible|0|||
23486183|NCT01933789|65524226|FG002|Overall Study|Became Ineligible|0|||
23486184|NCT01933789|65524227|FG003|Overall Study|Became Ineligible|0|||
23486185|NCT01933789|65524228|FG004|Overall Study|Became Ineligible|13|||
23486186|NCT01933789|65524229|FG005|Overall Study|Became Ineligible|10|||
23486187|NCT01933789|65524230|FG006|Overall Study|Became Ineligible|13|||
23486188|NCT01933789|65524231|FG007|Overall Study|Became Ineligible|6|||
23486189|NCT01933789|65524232|FG008|Overall Study|Became Ineligible|0|||
23486190|NCT02460458|65524236|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
23486191|NCT02460458|65524236|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
23486192|NCT02460458|65524236|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
23486193|NCT02460458|65524236|FG000|First Prospective Phase|Lost to Follow-up|16|||
23486194|NCT02460458|65524236|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
23486195|NCT03882008|65524237|FG000|Overall Study|Withdrawal by Subject|1|||
23486196|NCT03882008|65524237|FG000|Overall Study|Lost to Follow-up|1|||
23486197|NCT00426231|65524241|FG000|Overall Study|Withdrawal by Subject|9|||
23486198|NCT00426231|65524242|FG001|Overall Study|Withdrawal by Subject|12|||
23486199|NCT00470184|65524243|FG000|Overall Study|Not Treated(became ineligible)|4|||
23486200|NCT00470184|65524243|FG000|Overall Study|Not treated (other)|1|||
23486201|NCT00470184|65524243|FG000|Overall Study|disease Progression|4|||
23486202|NCT00470184|65524243|FG000|Overall Study|Adverse Event|3|||
23486203|NCT00470184|65524243|FG000|Overall Study|Withdrawal by Subject|4|||
23486204|NCT00470184|65524243|FG000|Overall Study|other|5|||
23486205|NCT00470184|65524243|FG000|Overall Study|recurrence|1|||
23486206|NCT02750943|65524245|FG000|Overall Study|Lost to Follow-up|1|||
23486207|NCT02750943|65524246|FG001|Overall Study|Lost to Follow-up|2|||
23486208|NCT02750943|65524245|FG000|Overall Study|Withdrawal by Subject|5|||
23486209|NCT02750943|65524246|FG001|Overall Study|Withdrawal by Subject|7|||
23486210|NCT00046891|65524247|FG000|Overall Study|Cancels|5|||
23279681|NCT04608188|64765512|FG001|Overall Study|Withdrawal by Subject|8|||
23279682|NCT00620074|64765515|FG000|Overall Study|Adverse Event|1|||
23279683|NCT03114891|64765518|FG000|First Treatment Round|Lost to Follow-up|0|||
23279684|NCT03114891|64765519|FG001|First Treatment Round|Lost to Follow-up|1|||
23279685|NCT03114891|64765520|FG002|First Treatment Round|Lost to Follow-up|1|||
23279686|NCT03114891|64765521|FG003|First Treatment Round|Lost to Follow-up|0|||
23279687|NCT03114891|64765518|FG000|First Treatment Round|Withdrawal by Subject|0|||
23279688|NCT03114891|64765519|FG001|First Treatment Round|Withdrawal by Subject|2|||
23279689|NCT03114891|64765520|FG002|First Treatment Round|Withdrawal by Subject|0|||
23279690|NCT03114891|64765521|FG003|First Treatment Round|Withdrawal by Subject|1|||
23371785|NCT02404545|65106365|FG000|Overall Study|Sponsor Termination|6|||
23371786|NCT02404545|65106366|FG001|Overall Study|Sponsor Termination|6|||
23371787|NCT01670292|65106367|FG000|Overall Study|Lost to Follow-up|14|||
23371788|NCT01787552|65106368|FG000|Overall Study|Withdrawal by Subject|2|||
23486211|NCT00046891|65524248|FG001|Overall Study|Cancels|9|||
23486212|NCT00046891|65524247|FG000|Overall Study|Ineligible|1|||
23279691|NCT03114891|64765518|FG000|3 Week Break|Lost to Follow-up|1|||
23279692|NCT03114891|64765519|FG001|3 Week Break|Lost to Follow-up|0|||
23486213|NCT00046891|65524248|FG001|Overall Study|Ineligible|1|||
23486214|NCT00046891|65524247|FG000|Overall Study|Withdrawal by Subject|18|||
23486215|NCT00046891|65524248|FG001|Overall Study|Withdrawal by Subject|15|||
23486216|NCT00046891|65524247|FG000|Overall Study|Adverse Event|5|||
23486217|NCT00046891|65524248|FG001|Overall Study|Adverse Event|5|||
23279693|NCT03114891|64765520|FG002|3 Week Break|Lost to Follow-up|0|||
23279694|NCT03114891|64765521|FG003|3 Week Break|Lost to Follow-up|1|||
23486218|NCT03023046|65524249|FG000|Overall Study|Withdrawal by Subject|1|||
23486219|NCT02359851|65524253|FG000|Overall Study|Death|1|||
23486220|NCT02359851|65524253|FG000|Overall Study|Disease progression|1|||
23279695|NCT03114891|64765518|FG000|3 Week Break|Withdrawal by Subject|0|||
23279696|NCT03114891|64765519|FG001|3 Week Break|Withdrawal by Subject|1|||
23279697|NCT03114891|64765520|FG002|3 Week Break|Withdrawal by Subject|0|||
23279698|NCT03114891|64765521|FG003|3 Week Break|Withdrawal by Subject|0|||
23279699|NCT03114891|64765518|FG000|Second Treatment Round|Lost to Follow-up|1|||
23279700|NCT03114891|64765519|FG001|Second Treatment Round|Lost to Follow-up|0|||
23279701|NCT03114891|64765520|FG002|Second Treatment Round|Lost to Follow-up|0|||
23279702|NCT03114891|64765521|FG003|Second Treatment Round|Lost to Follow-up|0|||
23279703|NCT03114891|64765518|FG000|Second Treatment Round|Physician Decision|1|||
23279704|NCT03114891|64765519|FG001|Second Treatment Round|Physician Decision|0|||
23279705|NCT03114891|64765520|FG002|Second Treatment Round|Physician Decision|0|||
23279706|NCT03114891|64765521|FG003|Second Treatment Round|Physician Decision|0|||
23279707|NCT02642653|64765522|FG000|Overall Study|Adverse Event|2|||
23279708|NCT02642653|64765523|FG001|Overall Study|Adverse Event|0|||
23279709|NCT03913377|64765524|FG000|Period 1|Test Article no longer available|0|||
23279710|NCT03913377|64765525|FG001|Period 1|Test Article no longer available|1|||
23279711|NCT03913377|64765526|FG002|Period 1|Test Article no longer available|0|||
23279712|NCT03913377|64765524|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
23279713|NCT03913377|64765525|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
23279714|NCT03913377|64765526|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
23279715|NCT00829673|64765530|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23279716|NCT00829673|64765531|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23279717|NCT01827163|64765532|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
23279718|NCT01827163|64765532|FG000|Overall Study|Adverse Event|9|||
23279719|NCT01796171|64765535|FG000|Enrolled|Death|0|||
23279720|NCT01796171|64765536|FG001|Enrolled|Death|0|||
23279721|NCT01796171|64765537|FG002|Enrolled|Death|0|||
23279722|NCT01796171|64765538|FG003|Enrolled|Death|0|||
23279723|NCT01796171|64765539|FG004|Enrolled|Death|0|||
23279724|NCT01796171|64765540|FG005|Enrolled|Death|0|||
23279725|NCT01796171|64765541|FG006|Enrolled|Death|0|||
23279726|NCT01796171|64765542|FG007|Enrolled|Death|0|||
23279727|NCT01796171|64765543|FG008|Enrolled|Death|0|||
23279728|NCT01796171|64765544|FG009|Enrolled|Death|0|||
23279729|NCT01796171|64765545|FG010|Enrolled|Death|0|||
23279730|NCT01796171|64765546|FG011|Enrolled|Death|0|||
23279731|NCT01796171|64765547|FG012|Enrolled|Death|0|||
23279732|NCT01796171|64765548|FG013|Enrolled|Death|0|||
23279733|NCT01796171|64765549|FG014|Enrolled|Death|1|||
23371789|NCT01787552|65106369|FG001|Overall Study|Withdrawal by Subject|0|||
23201452|NCT00634244|64476735|FG002|Overall Study|Other complicating disease|0|||
23201453|NCT03650452|64476736|FG000|Overall Study|Physician Decision|1|||
23279734|NCT01796171|64765535|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
23279735|NCT01796171|64765536|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
23279736|NCT01796171|64765537|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
23279737|NCT01796171|64765538|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
23279738|NCT01796171|64765539|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
23279739|NCT01796171|64765540|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
23279740|NCT01796171|64765541|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
23279741|NCT01796171|64765542|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
23279742|NCT01796171|64765543|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
23279743|NCT01796171|64765544|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
23279744|NCT01796171|64765545|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
23279745|NCT01796171|64765546|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
23279746|NCT01796171|64765547|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
23279747|NCT01796171|64765548|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
23279748|NCT01796171|64765549|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
23279749|NCT01796171|64765535|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279750|NCT01796171|64765536|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279751|NCT01796171|64765537|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279752|NCT01796171|64765538|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279753|NCT01796171|64765539|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279754|NCT01796171|64765540|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279755|NCT01796171|64765541|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279756|NCT01796171|64765542|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279757|NCT01796171|64765543|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279758|NCT01796171|64765544|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279759|NCT01796171|64765545|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279760|NCT01796171|64765546|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279761|NCT01796171|64765547|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279762|NCT01796171|64765548|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
23279763|NCT01796171|64765549|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
23279764|NCT01796171|64765535|FG000|Treatment Period With Betalutin|Progressive disease|0|||
23279765|NCT01796171|64765536|FG001|Treatment Period With Betalutin|Progressive disease|1|||
23279766|NCT01796171|64765537|FG002|Treatment Period With Betalutin|Progressive disease|0|||
23279767|NCT01796171|64765538|FG003|Treatment Period With Betalutin|Progressive disease|0|||
23279768|NCT01796171|64765539|FG004|Treatment Period With Betalutin|Progressive disease|0|||
23279769|NCT01796171|64765540|FG005|Treatment Period With Betalutin|Progressive disease|0|||
23279770|NCT01796171|64765541|FG006|Treatment Period With Betalutin|Progressive disease|0|||
23279771|NCT01796171|64765542|FG007|Treatment Period With Betalutin|Progressive disease|0|||
23279772|NCT01796171|64765543|FG008|Treatment Period With Betalutin|Progressive disease|0|||
23279773|NCT01796171|64765544|FG009|Treatment Period With Betalutin|Progressive disease|0|||
23279774|NCT01796171|64765545|FG010|Treatment Period With Betalutin|Progressive disease|0|||
23279775|NCT01796171|64765546|FG011|Treatment Period With Betalutin|Progressive disease|0|||
23279776|NCT01796171|64765547|FG012|Treatment Period With Betalutin|Progressive disease|0|||
23279777|NCT01796171|64765548|FG013|Treatment Period With Betalutin|Progressive disease|0|||
23279778|NCT01796171|64765549|FG014|Treatment Period With Betalutin|Progressive disease|0|||
23279779|NCT01796171|64765535|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279780|NCT01796171|64765536|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279781|NCT01796171|64765537|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279782|NCT01796171|64765538|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279783|NCT01796171|64765539|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279784|NCT01796171|64765540|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279785|NCT01796171|64765541|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279786|NCT01796171|64765542|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279787|NCT01796171|64765543|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
23279788|NCT01796171|64765544|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279789|NCT01796171|64765545|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
23279790|NCT01796171|64765546|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
23279791|NCT01796171|64765547|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279792|NCT01796171|64765548|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279793|NCT01796171|64765549|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
23279794|NCT01796171|64765535|FG000|Treatment Period With Betalutin|Physician Decision|0|||
23279795|NCT01796171|64765536|FG001|Treatment Period With Betalutin|Physician Decision|0|||
23279796|NCT01796171|64765537|FG002|Treatment Period With Betalutin|Physician Decision|0|||
23279797|NCT01796171|64765538|FG003|Treatment Period With Betalutin|Physician Decision|0|||
23279798|NCT01796171|64765539|FG004|Treatment Period With Betalutin|Physician Decision|0|||
23279799|NCT01796171|64765540|FG005|Treatment Period With Betalutin|Physician Decision|0|||
23279800|NCT01796171|64765541|FG006|Treatment Period With Betalutin|Physician Decision|0|||
23279801|NCT01796171|64765542|FG007|Treatment Period With Betalutin|Physician Decision|0|||
23279802|NCT01796171|64765543|FG008|Treatment Period With Betalutin|Physician Decision|0|||
23279803|NCT01796171|64765544|FG009|Treatment Period With Betalutin|Physician Decision|0|||
23279804|NCT01796171|64765545|FG010|Treatment Period With Betalutin|Physician Decision|5|||
23279805|NCT01796171|64765546|FG011|Treatment Period With Betalutin|Physician Decision|1|||
23279806|NCT01796171|64765547|FG012|Treatment Period With Betalutin|Physician Decision|1|||
23279807|NCT01796171|64765548|FG013|Treatment Period With Betalutin|Physician Decision|0|||
23486221|NCT00976573|65524254|FG000|Overall Study|Ineligible|0|||
23279808|NCT01796171|64765549|FG014|Treatment Period With Betalutin|Physician Decision|0|||
23279809|NCT01796171|64765535|FG000|Treatment Period With Betalutin|Death|0|||
23279810|NCT01796171|64765536|FG001|Treatment Period With Betalutin|Death|0|||
23279811|NCT01796171|64765537|FG002|Treatment Period With Betalutin|Death|0|||
23279812|NCT01796171|64765538|FG003|Treatment Period With Betalutin|Death|0|||
23279813|NCT01796171|64765539|FG004|Treatment Period With Betalutin|Death|0|||
23279814|NCT01796171|64765540|FG005|Treatment Period With Betalutin|Death|0|||
23279815|NCT01796171|64765541|FG006|Treatment Period With Betalutin|Death|0|||
23279816|NCT01796171|64765542|FG007|Treatment Period With Betalutin|Death|0|||
23279817|NCT01796171|64765543|FG008|Treatment Period With Betalutin|Death|0|||
23279818|NCT01796171|64765544|FG009|Treatment Period With Betalutin|Death|0|||
23279819|NCT01796171|64765545|FG010|Treatment Period With Betalutin|Death|2|||
23279820|NCT01796171|64765546|FG011|Treatment Period With Betalutin|Death|0|||
23279821|NCT01796171|64765547|FG012|Treatment Period With Betalutin|Death|0|||
23279822|NCT01796171|64765548|FG013|Treatment Period With Betalutin|Death|0|||
23279823|NCT01796171|64765549|FG014|Treatment Period With Betalutin|Death|0|||
23279824|NCT01796171|64765535|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
23279825|NCT01796171|64765536|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
23279826|NCT01796171|64765537|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
23279827|NCT01796171|64765538|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
23279828|NCT01796171|64765539|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
23279829|NCT01796171|64765540|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
23279830|NCT01796171|64765541|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
23279831|NCT01796171|64765542|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
23279832|NCT01796171|64765543|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
23279833|NCT01796171|64765544|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
23279834|NCT01796171|64765545|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
23279835|NCT01796171|64765546|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
23279836|NCT01796171|64765547|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
23279837|NCT01796171|64765548|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
23279838|NCT01796171|64765549|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
23279839|NCT01796171|64765535|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279840|NCT01796171|64765536|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279841|NCT01796171|64765537|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279842|NCT01796171|64765538|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279843|NCT01796171|64765539|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279844|NCT01796171|64765540|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279845|NCT01796171|64765541|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279846|NCT01796171|64765542|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279847|NCT01796171|64765543|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279848|NCT01796171|64765544|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279849|NCT01796171|64765545|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
23371790|NCT01787552|65106370|FG002|Overall Study|Withdrawal by Subject|0|||
23371791|NCT01787552|65106371|FG003|Overall Study|Withdrawal by Subject|4|||
23371792|NCT01787552|65106368|FG000|Overall Study|Physician Decision|2|||
23371793|NCT01787552|65106369|FG001|Overall Study|Physician Decision|2|||
23371794|NCT01787552|65106370|FG002|Overall Study|Physician Decision|1|||
23371795|NCT01787552|65106371|FG003|Overall Study|Physician Decision|2|||
23371796|NCT01787552|65106368|FG000|Overall Study|Death|0|||
23371797|NCT01787552|65106369|FG001|Overall Study|Death|0|||
23279850|NCT01796171|64765546|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
23279851|NCT01796171|64765547|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279852|NCT01796171|64765548|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23371798|NCT01787552|65106370|FG002|Overall Study|Death|0|||
23371799|NCT01787552|65106371|FG003|Overall Study|Death|1|||
23371800|NCT01787552|65106368|FG000|Overall Study|Adverse Event|2|||
23371801|NCT01787552|65106369|FG001|Overall Study|Adverse Event|5|||
23371802|NCT01787552|65106370|FG002|Overall Study|Adverse Event|2|||
23371803|NCT01787552|65106371|FG003|Overall Study|Adverse Event|16|||
23371804|NCT01787552|65106368|FG000|Overall Study|Study terminated by Sponsor|0|||
23371805|NCT01787552|65106369|FG001|Overall Study|Study terminated by Sponsor|0|||
23371806|NCT01787552|65106370|FG002|Overall Study|Study terminated by Sponsor|1|||
23371807|NCT01787552|65106371|FG003|Overall Study|Study terminated by Sponsor|3|||
23371808|NCT01787552|65106368|FG000|Overall Study|Progressive Disease|2|||
23371809|NCT01787552|65106369|FG001|Overall Study|Progressive Disease|2|||
23371810|NCT01787552|65106370|FG002|Overall Study|Progressive Disease|1|||
23371811|NCT01787552|65106371|FG003|Overall Study|Progressive Disease|1|||
23371812|NCT02765165|65106375|FG000|Treatment Period|Progressive disease|3|||
23371813|NCT02765165|65106376|FG001|Treatment Period|Progressive disease|2|||
23371814|NCT02765165|65106377|FG002|Treatment Period|Progressive disease|3|||
23371815|NCT02765165|65106378|FG003|Treatment Period|Progressive disease|3|||
23371816|NCT02765165|65106379|FG004|Treatment Period|Progressive disease|4|||
23371817|NCT02765165|65106380|FG005|Treatment Period|Progressive disease|2|||
23371818|NCT02765165|65106381|FG006|Treatment Period|Progressive disease|2|||
23371819|NCT02765165|65106375|FG000|Treatment Period|Physician Decision|0|||
23371820|NCT02765165|65106376|FG001|Treatment Period|Physician Decision|1|||
23371821|NCT02765165|65106377|FG002|Treatment Period|Physician Decision|0|||
23371822|NCT02765165|65106378|FG003|Treatment Period|Physician Decision|0|||
23371823|NCT02765165|65106379|FG004|Treatment Period|Physician Decision|0|||
23371824|NCT02765165|65106380|FG005|Treatment Period|Physician Decision|0|||
23371825|NCT02765165|65106381|FG006|Treatment Period|Physician Decision|0|||
23371826|NCT02765165|65106375|FG000|Treatment Period|Adverse Event|0|||
23371827|NCT02765165|65106376|FG001|Treatment Period|Adverse Event|1|||
23371828|NCT02765165|65106377|FG002|Treatment Period|Adverse Event|0|||
23371829|NCT02765165|65106378|FG003|Treatment Period|Adverse Event|0|||
23371830|NCT02765165|65106379|FG004|Treatment Period|Adverse Event|0|||
23371831|NCT02765165|65106380|FG005|Treatment Period|Adverse Event|0|||
23371832|NCT02765165|65106381|FG006|Treatment Period|Adverse Event|0|||
23371833|NCT02765165|65106375|FG000|Treatment Period|Withdrawal by Subject|0|||
23371834|NCT02765165|65106376|FG001|Treatment Period|Withdrawal by Subject|0|||
23371835|NCT02765165|65106377|FG002|Treatment Period|Withdrawal by Subject|0|||
23371836|NCT02765165|65106378|FG003|Treatment Period|Withdrawal by Subject|0|||
23371837|NCT02765165|65106379|FG004|Treatment Period|Withdrawal by Subject|2|||
23371838|NCT02765165|65106380|FG005|Treatment Period|Withdrawal by Subject|0|||
23371839|NCT02765165|65106381|FG006|Treatment Period|Withdrawal by Subject|0|||
23371840|NCT02765165|65106375|FG000|Treatment Period|Study terminated|0|||
23371841|NCT02765165|65106376|FG001|Treatment Period|Study terminated|0|||
23371842|NCT02765165|65106377|FG002|Treatment Period|Study terminated|0|||
23371843|NCT02765165|65106378|FG003|Treatment Period|Study terminated|0|||
23486222|NCT00976573|65524255|FG001|Overall Study|Ineligible|1|||
23371844|NCT02765165|65106379|FG004|Treatment Period|Study terminated|0|||
23371845|NCT02765165|65106380|FG005|Treatment Period|Study terminated|1|||
23371846|NCT02765165|65106381|FG006|Treatment Period|Study terminated|2|||
23371847|NCT02765165|65106375|FG000|Post-treatment Follow-up|Death|1|||
23486223|NCT00976573|65524254|FG000|Overall Study|Cancel prior to receiving treatment|4|||
23371848|NCT02765165|65106376|FG001|Post-treatment Follow-up|Death|2|||
23201454|NCT03650452|64476737|FG001|Overall Study|Physician Decision|0|||
23371849|NCT02765165|65106377|FG002|Post-treatment Follow-up|Death|1|||
23371850|NCT02765165|65106378|FG003|Post-treatment Follow-up|Death|1|||
23486224|NCT00976573|65524255|FG001|Overall Study|Cancel prior to receiving treatment|2|||
23371851|NCT02765165|65106379|FG004|Post-treatment Follow-up|Death|1|||
23371852|NCT02765165|65106380|FG005|Post-treatment Follow-up|Death|1|||
23371853|NCT02765165|65106381|FG006|Post-treatment Follow-up|Death|0|||
23371854|NCT02765165|65106375|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
23371855|NCT02765165|65106376|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
23371856|NCT02765165|65106377|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
23371857|NCT02765165|65106378|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
23371858|NCT02765165|65106379|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
23371859|NCT02765165|65106380|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
23371860|NCT02765165|65106381|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
23371861|NCT02765165|65106375|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371862|NCT02765165|65106376|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371863|NCT02765165|65106377|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
23371864|NCT02765165|65106378|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371865|NCT02765165|65106379|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371866|NCT02765165|65106380|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371867|NCT02765165|65106381|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
23371868|NCT02765165|65106375|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371869|NCT02765165|65106376|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371870|NCT02765165|65106377|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
23371871|NCT02765165|65106378|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
23371872|NCT02765165|65106379|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371873|NCT02765165|65106380|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371874|NCT02765165|65106381|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
23371875|NCT02765165|65106375|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
23486225|NCT00145600|65524256|FG000|Overall Study|Death|1|||
23486226|NCT00145600|65524257|FG001|Overall Study|Death|2|||
23486227|NCT00145600|65524258|FG002|Overall Study|Death|2|||
23486228|NCT00145600|65524259|FG003|Overall Study|Death|6|||
23486229|NCT00145600|65524256|FG000|Overall Study|Ineligible|3|||
23279853|NCT01796171|64765549|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
23279854|NCT01796171|64765535|FG000|Follow-up Period|Start of further anticancer therapy|4|||
23279855|NCT01796171|64765536|FG001|Follow-up Period|Start of further anticancer therapy|25|||
23279856|NCT01796171|64765537|FG002|Follow-up Period|Start of further anticancer therapy|2|||
23279857|NCT01796171|64765538|FG003|Follow-up Period|Start of further anticancer therapy|1|||
23279858|NCT01796171|64765539|FG004|Follow-up Period|Start of further anticancer therapy|2|||
23279859|NCT01796171|64765540|FG005|Follow-up Period|Start of further anticancer therapy|2|||
23279860|NCT01796171|64765541|FG006|Follow-up Period|Start of further anticancer therapy|1|||
23279861|NCT01796171|64765542|FG007|Follow-up Period|Start of further anticancer therapy|15|||
23279862|NCT01796171|64765543|FG008|Follow-up Period|Start of further anticancer therapy|2|||
23279863|NCT01796171|64765544|FG009|Follow-up Period|Start of further anticancer therapy|0|||
23279864|NCT01796171|64765545|FG010|Follow-up Period|Start of further anticancer therapy|0|||
23279865|NCT01796171|64765546|FG011|Follow-up Period|Start of further anticancer therapy|0|||
23279866|NCT01796171|64765547|FG012|Follow-up Period|Start of further anticancer therapy|0|||
23279867|NCT01796171|64765548|FG013|Follow-up Period|Start of further anticancer therapy|0|||
23279868|NCT01796171|64765549|FG014|Follow-up Period|Start of further anticancer therapy|0|||
23279869|NCT01796171|64765535|FG000|Follow-up Period|Progressive disease|0|||
23279870|NCT01796171|64765536|FG001|Follow-up Period|Progressive disease|1|||
23279871|NCT01796171|64765537|FG002|Follow-up Period|Progressive disease|0|||
23279872|NCT01796171|64765538|FG003|Follow-up Period|Progressive disease|0|||
23279873|NCT01796171|64765539|FG004|Follow-up Period|Progressive disease|0|||
23279874|NCT01796171|64765540|FG005|Follow-up Period|Progressive disease|0|||
23279875|NCT01796171|64765541|FG006|Follow-up Period|Progressive disease|0|||
23279876|NCT01796171|64765542|FG007|Follow-up Period|Progressive disease|3|||
23279877|NCT01796171|64765543|FG008|Follow-up Period|Progressive disease|0|||
23279878|NCT01796171|64765544|FG009|Follow-up Period|Progressive disease|0|||
23279879|NCT01796171|64765545|FG010|Follow-up Period|Progressive disease|0|||
23279880|NCT01796171|64765546|FG011|Follow-up Period|Progressive disease|0|||
23279881|NCT01796171|64765547|FG012|Follow-up Period|Progressive disease|0|||
23279882|NCT01796171|64765548|FG013|Follow-up Period|Progressive disease|0|||
23279883|NCT01796171|64765549|FG014|Follow-up Period|Progressive disease|0|||
23279884|NCT01796171|64765535|FG000|Follow-up Period|Physician Decision|0|||
23279885|NCT01796171|64765536|FG001|Follow-up Period|Physician Decision|2|||
23279886|NCT01796171|64765537|FG002|Follow-up Period|Physician Decision|0|||
23279887|NCT01796171|64765538|FG003|Follow-up Period|Physician Decision|0|||
23279888|NCT01796171|64765539|FG004|Follow-up Period|Physician Decision|0|||
23279889|NCT01796171|64765540|FG005|Follow-up Period|Physician Decision|0|||
23279890|NCT01796171|64765541|FG006|Follow-up Period|Physician Decision|0|||
23486230|NCT00145600|65524257|FG001|Overall Study|Ineligible|0|||
23486231|NCT00145600|65524258|FG002|Overall Study|Ineligible|1|||
23486232|NCT00145600|65524259|FG003|Overall Study|Ineligible|5|||
23371876|NCT02765165|65106376|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
23371877|NCT02765165|65106377|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371878|NCT02765165|65106378|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371879|NCT02765165|65106379|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371880|NCT02765165|65106380|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371881|NCT02765165|65106381|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
23371882|NCT02765165|65106375|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
23371883|NCT02765165|65106376|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
23371884|NCT02765165|65106377|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
23371885|NCT02765165|65106378|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
23371886|NCT02765165|65106379|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
23371887|NCT02765165|65106380|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
23371888|NCT02765165|65106381|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
23371889|NCT02966834|65106382|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371890|NCT02966834|65106383|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371891|NCT02966834|65106384|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371892|NCT02966834|65106385|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371893|NCT02966834|65106386|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
23371894|NCT02966834|65106387|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
23371895|NCT02966834|65106382|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
23371896|NCT02966834|65106383|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371897|NCT02966834|65106384|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371898|NCT02966834|65106385|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371899|NCT02966834|65106386|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371900|NCT02966834|65106387|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
23371901|NCT02966834|65106382|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
23371902|NCT02966834|65106383|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
23371903|NCT02966834|65106384|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
23371904|NCT02966834|65106385|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
23371905|NCT02966834|65106386|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
23371906|NCT02966834|65106387|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
23371907|NCT02966834|65106382|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
23371908|NCT02966834|65106383|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
23371909|NCT02966834|65106384|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
23371910|NCT02966834|65106385|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
23371911|NCT02966834|65106386|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
23371912|NCT02966834|65106387|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
23371913|NCT02966834|65106382|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371914|NCT02966834|65106383|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371915|NCT02966834|65106384|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371916|NCT02966834|65106385|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
23371917|NCT02966834|65106386|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371918|NCT02966834|65106387|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
23371919|NCT02966834|65106382|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371920|NCT02966834|65106383|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371921|NCT02966834|65106384|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371922|NCT02966834|65106385|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
23371923|NCT02966834|65106386|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371924|NCT02966834|65106387|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
23371925|NCT00843492|65106389|FG000|Overall Study|Adverse Event|0|||
23371926|NCT00843492|65106390|FG001|Overall Study|Adverse Event|3|||
23371927|NCT00843492|65106389|FG000|Overall Study|Lost to Follow-up|4|||
23371928|NCT00843492|65106390|FG001|Overall Study|Lost to Follow-up|4|||
23371929|NCT00843492|65106389|FG000|Overall Study|Withdrawal by Subject|0|||
23371930|NCT00843492|65106390|FG001|Overall Study|Withdrawal by Subject|4|||
23371931|NCT00843492|65106389|FG000|Overall Study|Immobilization Stopped|1|||
23371932|NCT00843492|65106390|FG001|Overall Study|Immobilization Stopped|0|||
23371933|NCT00843492|65106389|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
23371934|NCT00843492|65106390|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
23371935|NCT00843492|65106389|FG000|Overall Study|Orthopedic Surgery|0|||
23371936|NCT00843492|65106390|FG001|Overall Study|Orthopedic Surgery|2|||
23371937|NCT00843492|65106389|FG000|Overall Study|Visit Not Performed|1|||
23486233|NCT00145600|65524256|FG000|Overall Study|Lost to Follow-up|2|||
23371938|NCT00843492|65106390|FG001|Overall Study|Visit Not Performed|0|||
23371939|NCT00843492|65106389|FG000|Overall Study|Deep-vein Thrombosis|1|||
23371940|NCT00843492|65106390|FG001|Overall Study|Deep-vein Thrombosis|0|||
23371941|NCT00888654|65106391|FG000|Overall Study|Problems swallowing oral meds.|1|||
23371942|NCT00888654|65106391|FG000|Overall Study|Not enough oral meds before surgery|3|||
23486234|NCT00145600|65524257|FG001|Overall Study|Lost to Follow-up|6|||
23371943|NCT00888654|65106391|FG000|Overall Study|Surgery aborted|2|||
23371944|NCT00888654|65106391|FG000|Overall Study|Withdrawal by Subject|1|||
23371945|NCT00888654|65106391|FG000|Overall Study|Inelig. due to contraindication of med|1|||
23371946|NCT00888654|65106391|FG000|Overall Study|Change in surg date|1|||
23371947|NCT00888654|65106391|FG000|Overall Study|Stopped meds due to headaches|1|||
23371948|NCT02631941|65106392|FG000|Overall Study|Physician Decision|0|||
23371949|NCT02631941|65106393|FG001|Overall Study|Physician Decision|1|||
23371950|NCT02631941|65106394|FG002|Overall Study|Physician Decision|0|||
23371951|NCT02631941|65106395|FG003|Overall Study|Physician Decision|0|||
23371952|NCT02631941|65106396|FG004|Overall Study|Physician Decision|0|||
23371953|NCT02631941|65106397|FG005|Overall Study|Physician Decision|0|||
23371954|NCT02631941|65106398|FG006|Overall Study|Physician Decision|0|||
23371955|NCT02631941|65106399|FG007|Overall Study|Physician Decision|0|||
23371956|NCT02631941|65106400|FG008|Overall Study|Physician Decision|0|||
23371957|NCT02631941|65106401|FG009|Overall Study|Physician Decision|0|||
23371958|NCT02631941|65106392|FG000|Overall Study|Adverse Event|0|||
23371959|NCT02631941|65106393|FG001|Overall Study|Adverse Event|1|||
23371960|NCT02631941|65106394|FG002|Overall Study|Adverse Event|0|||
23371961|NCT02631941|65106395|FG003|Overall Study|Adverse Event|0|||
23371962|NCT02631941|65106396|FG004|Overall Study|Adverse Event|0|||
23371963|NCT02631941|65106397|FG005|Overall Study|Adverse Event|0|||
23371964|NCT02631941|65106398|FG006|Overall Study|Adverse Event|0|||
23371965|NCT02631941|65106399|FG007|Overall Study|Adverse Event|0|||
23371966|NCT02631941|65106400|FG008|Overall Study|Adverse Event|0|||
23371967|NCT02631941|65106401|FG009|Overall Study|Adverse Event|0|||
23371968|NCT02631941|65106392|FG000|Overall Study|Withdrawal by Subject|0|||
23371969|NCT02631941|65106393|FG001|Overall Study|Withdrawal by Subject|0|||
23371970|NCT02631941|65106394|FG002|Overall Study|Withdrawal by Subject|0|||
23371971|NCT02631941|65106395|FG003|Overall Study|Withdrawal by Subject|0|||
23371972|NCT02631941|65106396|FG004|Overall Study|Withdrawal by Subject|1|||
23371973|NCT02631941|65106397|FG005|Overall Study|Withdrawal by Subject|0|||
23371974|NCT02631941|65106398|FG006|Overall Study|Withdrawal by Subject|0|||
23371975|NCT02631941|65106399|FG007|Overall Study|Withdrawal by Subject|1|||
23371976|NCT02631941|65106400|FG008|Overall Study|Withdrawal by Subject|0|||
23371977|NCT02631941|65106401|FG009|Overall Study|Withdrawal by Subject|0|||
23371978|NCT02631941|65106392|FG000|Overall Study|Lost to Follow-up|0|||
23371979|NCT02631941|65106393|FG001|Overall Study|Lost to Follow-up|0|||
23371980|NCT02631941|65106394|FG002|Overall Study|Lost to Follow-up|0|||
23371981|NCT02631941|65106395|FG003|Overall Study|Lost to Follow-up|0|||
23371982|NCT02631941|65106396|FG004|Overall Study|Lost to Follow-up|0|||
23371983|NCT02631941|65106397|FG005|Overall Study|Lost to Follow-up|0|||
23371984|NCT02631941|65106398|FG006|Overall Study|Lost to Follow-up|0|||
23371985|NCT02631941|65106399|FG007|Overall Study|Lost to Follow-up|0|||
23371986|NCT02631941|65106400|FG008|Overall Study|Lost to Follow-up|1|||
23371987|NCT02631941|65106401|FG009|Overall Study|Lost to Follow-up|0|||
23371988|NCT01155570|65106404|FG000|Overall Study|Adverse Event|39|||
23371989|NCT01155570|65106404|FG000|Overall Study|Lack of Efficacy|46|||
23371990|NCT01155570|65106404|FG000|Overall Study|Participant's Economic Reasons|17|||
23371991|NCT01155570|65106404|FG000|Overall Study|No Hospital Visits|7|||
23371992|NCT01155570|65106404|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
23371993|NCT01155570|65106404|FG000|Overall Study|Adverse Event + Other Reasons|7|||
23371994|NCT01155570|65106404|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
23371995|NCT01155570|65106404|FG000|Overall Study|Other Reasons|23|||
23371996|NCT00486044|65106407|FG000|Overall Study|Withdrawal by Subject|2|||
23371997|NCT00486044|65106408|FG001|Overall Study|Withdrawal by Subject|1|||
23371998|NCT00486044|65106407|FG000|Overall Study|Adverse Event|0|||
23371999|NCT00486044|65106408|FG001|Overall Study|Adverse Event|1|||
23372000|NCT00486044|65106407|FG000|Overall Study|Lost to Follow-up|0|||
23372001|NCT00486044|65106408|FG001|Overall Study|Lost to Follow-up|1|||
23372002|NCT03470922|65106413|FG000|Overall Study|Death|107|||
23372003|NCT03470922|65106414|FG001|Overall Study|Death|118|||
23372004|NCT03470922|65106413|FG000|Overall Study|Lost to Follow-up|5|||
23372005|NCT03470922|65106414|FG001|Overall Study|Lost to Follow-up|5|||
23372006|NCT03470922|65106413|FG000|Overall Study|Participant Withdrew Consent|4|||
23372007|NCT03470922|65106414|FG001|Overall Study|Participant Withdrew Consent|9|||
23372008|NCT03470922|65106413|FG000|Overall Study|Other reasons|1|||
23372009|NCT03470922|65106414|FG001|Overall Study|Other reasons|0|||
23372010|NCT03470922|65106413|FG000|Overall Study|Not reported|1|||
23372011|NCT03470922|65106414|FG001|Overall Study|Not reported|0|||
23372012|NCT01977846|65109732|FG000|Total Study - Prospective|Death|0|||
23372013|NCT01977846|65109733|FG001|Total Study - Prospective|Death|1|||
23372014|NCT01977846|65109732|FG000|Total Study - Prospective|Lost to Follow-up|0|||
23372015|NCT01977846|65109733|FG001|Total Study - Prospective|Lost to Follow-up|8|||
23372016|NCT01977846|65109732|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
23372017|NCT01977846|65109733|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
23372018|NCT01977846|65109732|FG000|Total Study - Prospective|Not available at time of visit|0|||
23372019|NCT01977846|65109733|FG001|Total Study - Prospective|Not available at time of visit|5|||
23372020|NCT01977846|65109732|FG000|Total Study - Prospective|No show|0|||
23372021|NCT01977846|65109733|FG001|Total Study - Prospective|No show|1|||
23372022|NCT01977846|65109732|FG000|Total Study - Prospective|Protocol Violation|0|||
23372023|NCT01977846|65109733|FG001|Total Study - Prospective|Protocol Violation|1|||
23372024|NCT03585270|65109734|FG000|Overall Study|Withdrawal by Subject|2|||
23372025|NCT03585270|65109735|FG001|Overall Study|Withdrawal by Subject|6|||
23372026|NCT03585270|65109734|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
23372027|NCT03585270|65109735|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
23372028|NCT03585270|65109734|FG000|Overall Study|Adverse Event|5|||
23372029|NCT03585270|65109735|FG001|Overall Study|Adverse Event|2|||
23486235|NCT00145600|65524258|FG002|Overall Study|Lost to Follow-up|2|||
23279891|NCT01796171|64765542|FG007|Follow-up Period|Physician Decision|0|||
23279892|NCT01796171|64765543|FG008|Follow-up Period|Physician Decision|0|||
23279893|NCT01796171|64765544|FG009|Follow-up Period|Physician Decision|0|||
23279894|NCT01796171|64765545|FG010|Follow-up Period|Physician Decision|5|||
23279895|NCT01796171|64765546|FG011|Follow-up Period|Physician Decision|0|||
23279896|NCT01796171|64765547|FG012|Follow-up Period|Physician Decision|0|||
23279897|NCT01796171|64765548|FG013|Follow-up Period|Physician Decision|0|||
23279898|NCT01796171|64765549|FG014|Follow-up Period|Physician Decision|0|||
23279899|NCT01796171|64765535|FG000|Follow-up Period|Withdrawal by Subject|0|||
23279900|NCT01796171|64765536|FG001|Follow-up Period|Withdrawal by Subject|1|||
23279901|NCT01796171|64765537|FG002|Follow-up Period|Withdrawal by Subject|0|||
23279902|NCT01796171|64765538|FG003|Follow-up Period|Withdrawal by Subject|0|||
23279903|NCT01796171|64765539|FG004|Follow-up Period|Withdrawal by Subject|0|||
23279904|NCT01796171|64765540|FG005|Follow-up Period|Withdrawal by Subject|1|||
23279905|NCT01796171|64765541|FG006|Follow-up Period|Withdrawal by Subject|0|||
23279906|NCT01796171|64765542|FG007|Follow-up Period|Withdrawal by Subject|0|||
23279907|NCT01796171|64765543|FG008|Follow-up Period|Withdrawal by Subject|0|||
23279908|NCT01796171|64765544|FG009|Follow-up Period|Withdrawal by Subject|0|||
23279909|NCT01796171|64765545|FG010|Follow-up Period|Withdrawal by Subject|3|||
23279910|NCT01796171|64765546|FG011|Follow-up Period|Withdrawal by Subject|1|||
23279911|NCT01796171|64765547|FG012|Follow-up Period|Withdrawal by Subject|0|||
23279912|NCT01796171|64765548|FG013|Follow-up Period|Withdrawal by Subject|0|||
23279913|NCT01796171|64765549|FG014|Follow-up Period|Withdrawal by Subject|0|||
23279914|NCT01796171|64765535|FG000|Follow-up Period|Death|0|||
23279915|NCT01796171|64765536|FG001|Follow-up Period|Death|0|||
23279916|NCT01796171|64765537|FG002|Follow-up Period|Death|0|||
23486236|NCT00145600|65524259|FG003|Overall Study|Lost to Follow-up|4|||
23372030|NCT03585270|65109734|FG000|Overall Study|Lost to Follow-up|1|||
23372031|NCT03585270|65109735|FG001|Overall Study|Lost to Follow-up|4|||
23372032|NCT03585270|65109734|FG000|Overall Study|Death|5|||
23372033|NCT03585270|65109735|FG001|Overall Study|Death|3|||
23372034|NCT03585270|65109734|FG000|Overall Study|Other reasons|2|||
23372035|NCT03585270|65109735|FG001|Overall Study|Other reasons|2|||
23372036|NCT03980223|65109736|FG000|Overall Study|Lost to Follow-up|3|||
23372037|NCT03980223|65109737|FG001|Overall Study|Lost to Follow-up|7|||
23372038|NCT03980223|65109738|FG002|Overall Study|Lost to Follow-up|10|||
23372039|NCT03980223|65109739|FG003|Overall Study|Lost to Follow-up|8|||
23372040|NCT03980223|65109736|FG000|Overall Study|Withdrawal by Subject|0|||
23372041|NCT03980223|65109737|FG001|Overall Study|Withdrawal by Subject|0|||
23372042|NCT03980223|65109738|FG002|Overall Study|Withdrawal by Subject|1|||
23372043|NCT03980223|65109739|FG003|Overall Study|Withdrawal by Subject|2|||
23372044|NCT03980223|65109736|FG000|Overall Study|Physician Decision|0|||
23372045|NCT03980223|65109737|FG001|Overall Study|Physician Decision|0|||
23372046|NCT03980223|65109738|FG002|Overall Study|Physician Decision|1|||
23372047|NCT03980223|65109739|FG003|Overall Study|Physician Decision|0|||
23372048|NCT03980223|65109736|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
23372049|NCT03980223|65109737|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
23372050|NCT03980223|65109738|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
23372051|NCT03980223|65109739|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
23372052|NCT00301834|65109743|FG000|Overall Study|Death|1|||
23372053|NCT03834350|65109750|FG000|Overall Study|Withdrawal by Subject|1|||
23372054|NCT00737048|65109751|FG000|Overall Study|Physician Decision|0|||
23372055|NCT00737048|65109752|FG001|Overall Study|Physician Decision|0|||
23372056|NCT00737048|65109753|FG002|Overall Study|Physician Decision|1|||
23372057|NCT00737048|65109751|FG000|Overall Study|Adverse Event|0|||
23372058|NCT00737048|65109752|FG001|Overall Study|Adverse Event|1|||
23372059|NCT00737048|65109753|FG002|Overall Study|Adverse Event|0|||
23372060|NCT00737048|65109751|FG000|Overall Study|Worsening of the symptoms|3|||
23372061|NCT00737048|65109752|FG001|Overall Study|Worsening of the symptoms|5|||
23372062|NCT00737048|65109753|FG002|Overall Study|Worsening of the symptoms|3|||
23372063|NCT02732639|65109760|FG000|Overall Study|Lost to Follow-up|1|||
23372064|NCT04456686|65109761|FG000|Overall Study|Adverse Event|2|||
23372065|NCT04456686|65109762|FG001|Overall Study|Adverse Event|1|||
23372066|NCT04456686|65109761|FG000|Overall Study|Lack of Efficacy|3|||
23486237|NCT00145600|65524256|FG000|Overall Study|Noncompliance|1|||
23486238|NCT00145600|65524257|FG001|Overall Study|Noncompliance|0|||
23486239|NCT00145600|65524258|FG002|Overall Study|Noncompliance|0|||
23486240|NCT00145600|65524259|FG003|Overall Study|Noncompliance|0|||
23486241|NCT00145600|65524256|FG000|Overall Study|Withdrawal by Subject|1|||
23486242|NCT00145600|65524257|FG001|Overall Study|Withdrawal by Subject|2|||
23486243|NCT00145600|65524258|FG002|Overall Study|Withdrawal by Subject|0|||
23486244|NCT00145600|65524259|FG003|Overall Study|Withdrawal by Subject|1|||
23486245|NCT00723203|65524260|FG000|Overall Study|Withdrawal by Subject|3|||
23486246|NCT02435069|65524266|FG000|Dose Response - First Intervention|Adverse Event|0|||
23486247|NCT02435069|65524267|FG001|Dose Response - First Intervention|Adverse Event|1|||
23486248|NCT02435069|65524268|FG002|Dose Response - First Intervention|Adverse Event|1|||
23486249|NCT02435069|65524269|FG003|Dose Response - First Intervention|Adverse Event|0|||
23486250|NCT02435069|65524270|FG004|Dose Response - First Intervention|Adverse Event|0|||
23486251|NCT02435069|65524266|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
23486252|NCT02435069|65524267|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
23486253|NCT02435069|65524268|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
23486254|NCT02435069|65524269|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
23486255|NCT02435069|65524270|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
23486256|NCT00095628|65524271|FG000|Overall Study|Disease progression prior to treatment|1|||
23603578|NCT02892019|65937422|FG000|Overall Study|Withdrawal by Subject|0|||
23603579|NCT02892019|65937423|FG001|Overall Study|Withdrawal by Subject|1|||
23372067|NCT04456686|65109762|FG001|Overall Study|Lack of Efficacy|1|||
23603580|NCT02892019|65937422|FG000|Overall Study|Adverse Event|1|||
23603581|NCT02892019|65937423|FG001|Overall Study|Adverse Event|1|||
23372068|NCT04456686|65109761|FG000|Overall Study|Withdrew consent|3|||
23372069|NCT04456686|65109762|FG001|Overall Study|Withdrew consent|1|||
23603582|NCT01005914|65937428|FG000|Overall Study|Adverse Event|4|||
23603583|NCT01005914|65937428|FG000|Overall Study|Death|4|||
23603584|NCT01005914|65937428|FG000|Overall Study|Lack of Efficacy|1|||
23372070|NCT04456686|65109761|FG000|Overall Study|Physician Decision|2|||
23372071|NCT04456686|65109762|FG001|Overall Study|Physician Decision|2|||
23372072|NCT04456686|65109761|FG000|Overall Study|Withdrawal by Subject|5|||
23372073|NCT04456686|65109762|FG001|Overall Study|Withdrawal by Subject|1|||
23372074|NCT04456686|65109761|FG000|Overall Study|Protocol Violation|0|||
23372075|NCT04456686|65109762|FG001|Overall Study|Protocol Violation|1|||
23486257|NCT01467583|65524279|FG000|Overall Study|Death|1|||
23486258|NCT01467583|65524280|FG001|Overall Study|Death|1|||
23372076|NCT02452047|65109765|FG000|Overall Study|Adverse Event|0|||
23372077|NCT02452047|65109766|FG001|Overall Study|Adverse Event|1|||
23372078|NCT02452047|65109767|FG002|Overall Study|Adverse Event|1|||
23372079|NCT02452047|65109765|FG000|Overall Study|Death|1|||
23372080|NCT02452047|65109766|FG001|Overall Study|Death|3|||
23372081|NCT02452047|65109767|FG002|Overall Study|Death|1|||
23372082|NCT02452047|65109765|FG000|Overall Study|Physician Decision|1|||
23372083|NCT02452047|65109766|FG001|Overall Study|Physician Decision|0|||
23486259|NCT01467583|65524281|FG002|Overall Study|Death|0|||
23486260|NCT01467583|65524279|FG000|Overall Study|Withdrawal by Subject|1|||
23279917|NCT01796171|64765538|FG003|Follow-up Period|Death|0|||
23279918|NCT01796171|64765539|FG004|Follow-up Period|Death|0|||
23279919|NCT01796171|64765540|FG005|Follow-up Period|Death|0|||
23279920|NCT01796171|64765541|FG006|Follow-up Period|Death|1|||
23279921|NCT01796171|64765542|FG007|Follow-up Period|Death|0|||
23279922|NCT01796171|64765543|FG008|Follow-up Period|Death|0|||
23279923|NCT01796171|64765544|FG009|Follow-up Period|Death|0|||
23279924|NCT01796171|64765545|FG010|Follow-up Period|Death|17|||
23279925|NCT01796171|64765546|FG011|Follow-up Period|Death|9|||
23279926|NCT01796171|64765547|FG012|Follow-up Period|Death|1|||
23279927|NCT01796171|64765548|FG013|Follow-up Period|Death|0|||
23279928|NCT01796171|64765549|FG014|Follow-up Period|Death|0|||
23279929|NCT01796171|64765535|FG000|Follow-up Period|Patient transferred to other hospital|0|||
23279930|NCT01796171|64765536|FG001|Follow-up Period|Patient transferred to other hospital|1|||
23279931|NCT01796171|64765537|FG002|Follow-up Period|Patient transferred to other hospital|0|||
23279932|NCT01796171|64765538|FG003|Follow-up Period|Patient transferred to other hospital|0|||
23279933|NCT01796171|64765539|FG004|Follow-up Period|Patient transferred to other hospital|0|||
23603585|NCT01005914|65937428|FG000|Overall Study|Withdrawal by Subject|1|||
23279934|NCT01796171|64765540|FG005|Follow-up Period|Patient transferred to other hospital|0|||
23279935|NCT01796171|64765541|FG006|Follow-up Period|Patient transferred to other hospital|0|||
23279936|NCT01796171|64765542|FG007|Follow-up Period|Patient transferred to other hospital|0|||
23279937|NCT01796171|64765543|FG008|Follow-up Period|Patient transferred to other hospital|0|||
23279938|NCT01796171|64765544|FG009|Follow-up Period|Patient transferred to other hospital|0|||
23279939|NCT01796171|64765545|FG010|Follow-up Period|Patient transferred to other hospital|0|||
23279940|NCT01796171|64765546|FG011|Follow-up Period|Patient transferred to other hospital|0|||
23279941|NCT01796171|64765547|FG012|Follow-up Period|Patient transferred to other hospital|0|||
23279942|NCT01796171|64765548|FG013|Follow-up Period|Patient transferred to other hospital|0|||
23279943|NCT01796171|64765549|FG014|Follow-up Period|Patient transferred to other hospital|0|||
23279944|NCT01796171|64765535|FG000|Follow-up Period|Sponsor Decision|0|||
23279945|NCT01796171|64765536|FG001|Follow-up Period|Sponsor Decision|0|||
23279946|NCT01796171|64765537|FG002|Follow-up Period|Sponsor Decision|0|||
23279947|NCT01796171|64765538|FG003|Follow-up Period|Sponsor Decision|0|||
23279948|NCT01796171|64765539|FG004|Follow-up Period|Sponsor Decision|0|||
23279949|NCT01796171|64765540|FG005|Follow-up Period|Sponsor Decision|0|||
23279950|NCT01796171|64765541|FG006|Follow-up Period|Sponsor Decision|0|||
23279951|NCT01796171|64765542|FG007|Follow-up Period|Sponsor Decision|0|||
23279952|NCT01796171|64765543|FG008|Follow-up Period|Sponsor Decision|0|||
23279953|NCT01796171|64765544|FG009|Follow-up Period|Sponsor Decision|0|||
23279954|NCT01796171|64765545|FG010|Follow-up Period|Sponsor Decision|40|||
23279955|NCT01796171|64765546|FG011|Follow-up Period|Sponsor Decision|15|||
23279956|NCT01796171|64765547|FG012|Follow-up Period|Sponsor Decision|7|||
23279957|NCT01796171|64765548|FG013|Follow-up Period|Sponsor Decision|0|||
23279958|NCT01796171|64765549|FG014|Follow-up Period|Sponsor Decision|0|||
23279959|NCT00469417|64765552|FG000|Overall Study|Treatment failure all lesions|18|||
23279960|NCT00469417|64765553|FG001|Overall Study|Treatment failure all lesions|11|||
23279961|NCT00469417|64765552|FG000|Overall Study|Consent withdrawn|1|||
23279962|NCT00469417|64765553|FG001|Overall Study|Consent withdrawn|1|||
23279963|NCT00469417|64765552|FG000|Overall Study|Adverse Event|8|||
23279964|NCT00469417|64765553|FG001|Overall Study|Adverse Event|2|||
23279965|NCT00469417|64765552|FG000|Overall Study|Lost to Follow-up|1|||
23279966|NCT00469417|64765553|FG001|Overall Study|Lost to Follow-up|2|||
23279967|NCT00469417|64765552|FG000|Overall Study|Intercurrent disease|0|||
23279968|NCT00469417|64765553|FG001|Overall Study|Intercurrent disease|1|||
23486261|NCT01467583|65524280|FG001|Overall Study|Withdrawal by Subject|0|||
23279969|NCT00469417|64765552|FG000|Overall Study|Randomized but not treated|2|||
23279970|NCT00469417|64765553|FG001|Overall Study|Randomized but not treated|0|||
23279971|NCT01247701|64765554|FG000|Overall Study|Death|2|||
23279972|NCT01247701|64765554|FG000|Overall Study|Relapsed|8|||
23372084|NCT02452047|65109767|FG002|Overall Study|Physician Decision|0|||
23603586|NCT03340961|65937431|FG000|Overall Study|Adverse Event|1|||
23603587|NCT03340961|65937432|FG001|Overall Study|Adverse Event|3|||
23279973|NCT03214952|64765557|FG000|Overall Study|Protocol Deviation|45|||
23279974|NCT03214952|64765557|FG000|Overall Study|Case Report Forms Uncollected|13|||
23279975|NCT01218867|64765558|FG000|Overall Study|Death during treatment|0|||
23279976|NCT01218867|64765559|FG001|Overall Study|Death during treatment|0|||
23279977|NCT01218867|64765560|FG002|Overall Study|Death during treatment|0|||
23372085|NCT02452047|65109765|FG000|Overall Study|Lost to Follow-up|1|||
23372086|NCT02452047|65109766|FG001|Overall Study|Lost to Follow-up|1|||
23279978|NCT01218867|64765561|FG003|Overall Study|Death during treatment|0|||
23279979|NCT01218867|64765562|FG004|Overall Study|Death during treatment|0|||
23279980|NCT01218867|64765563|FG005|Overall Study|Death during treatment|0|||
23279981|NCT01218867|64765564|FG006|Overall Study|Death during treatment|1|||
23279982|NCT01218867|64765565|FG007|Overall Study|Death during treatment|0|||
23279983|NCT01218867|64765566|FG008|Overall Study|Death during treatment|0|||
23279984|NCT01218867|64765567|FG009|Overall Study|Death during treatment|0|||
23279985|NCT01218867|64765568|FG010|Overall Study|Death during treatment|0|||
23279986|NCT00463684|64765573|FG000|Overall Study|Withdrawal by Subject|1|||
23279987|NCT00463684|64765573|FG000|Overall Study|Lost to Follow-up|3|||
23279988|NCT01309672|64765574|FG000|Overall Study|Lack of Efficacy|20|||
23279989|NCT01309672|64765574|FG000|Overall Study|Other|9|||
23279990|NCT01309672|64765574|FG000|Overall Study|Adverse Event|5|||
23279991|NCT01309672|64765574|FG000|Overall Study|Withdrawal by Subject|3|||
23279992|NCT01015625|64765575|FG000|Overall Study|Lost to Follow-up|3|||
23279993|NCT01015625|64765576|FG001|Overall Study|Lost to Follow-up|1|||
23372087|NCT02452047|65109767|FG002|Overall Study|Lost to Follow-up|0|||
23372088|NCT02452047|65109765|FG000|Overall Study|Withdrawal by Subject|1|||
23372089|NCT02452047|65109766|FG001|Overall Study|Withdrawal by Subject|0|||
23372090|NCT02452047|65109767|FG002|Overall Study|Withdrawal by Subject|0|||
23372091|NCT01802385|65109782|FG000|Overall Study|Death|106|||
23372092|NCT01802385|65109783|FG001|Overall Study|Death|120|||
23372093|NCT01192178|65109784|FG000|Overall Study|Withdrawal by Subject|6|||
23372094|NCT01192178|65109785|FG001|Overall Study|Withdrawal by Subject|10|||
23372095|NCT01192178|65109784|FG000|Overall Study|Protocol Violation|10|||
23372096|NCT01192178|65109785|FG001|Overall Study|Protocol Violation|3|||
23372097|NCT01192178|65109784|FG000|Overall Study|Physician Decision|2|||
23372098|NCT01192178|65109785|FG001|Overall Study|Physician Decision|4|||
23372099|NCT01192178|65109784|FG000|Overall Study|Lost to Follow-up|3|||
23372100|NCT01192178|65109785|FG001|Overall Study|Lost to Follow-up|3|||
23372101|NCT01192178|65109784|FG000|Overall Study|Adverse Event|2|||
23372102|NCT01192178|65109785|FG001|Overall Study|Adverse Event|1|||
23372103|NCT01192178|65109784|FG000|Overall Study|Lack of Efficacy|1|||
23603588|NCT03340961|65937433|FG002|Overall Study|Adverse Event|2|||
23603589|NCT03340961|65937434|FG003|Overall Study|Adverse Event|4|||
23603590|NCT03340961|65937431|FG000|Overall Study|Lost to Follow-up|0|||
23603591|NCT03340961|65937432|FG001|Overall Study|Lost to Follow-up|1|||
23603592|NCT03340961|65937433|FG002|Overall Study|Lost to Follow-up|0|||
23603593|NCT03340961|65937434|FG003|Overall Study|Lost to Follow-up|1|||
23603594|NCT03340961|65937431|FG000|Overall Study|Withdrawal by Subject|3|||
23603595|NCT03340961|65937432|FG001|Overall Study|Withdrawal by Subject|2|||
23603596|NCT03340961|65937433|FG002|Overall Study|Withdrawal by Subject|4|||
23603597|NCT03340961|65937434|FG003|Overall Study|Withdrawal by Subject|7|||
23603598|NCT03340961|65937431|FG000|Overall Study|Use of prohibited treatment|0|||
23603599|NCT03340961|65937432|FG001|Overall Study|Use of prohibited treatment|3|||
23603600|NCT03340961|65937433|FG002|Overall Study|Use of prohibited treatment|2|||
23603601|NCT03340961|65937434|FG003|Overall Study|Use of prohibited treatment|4|||
23603602|NCT03340961|65937431|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
23603603|NCT03340961|65937432|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
23603604|NCT03340961|65937433|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
23603605|NCT03340961|65937434|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
23603606|NCT03340961|65937431|FG000|Overall Study|Subject developed an exclusion criterion|0|||
23603607|NCT03340961|65937432|FG001|Overall Study|Subject developed an exclusion criterion|1|||
23603608|NCT03340961|65937433|FG002|Overall Study|Subject developed an exclusion criterion|0|||
23603609|NCT03340961|65937434|FG003|Overall Study|Subject developed an exclusion criterion|0|||
23603610|NCT03340961|65937431|FG000|Overall Study|Protocol Violation|1|||
23603611|NCT03340961|65937432|FG001|Overall Study|Protocol Violation|0|||
23603612|NCT03340961|65937433|FG002|Overall Study|Protocol Violation|1|||
23603613|NCT03340961|65937434|FG003|Overall Study|Protocol Violation|0|||
23603614|NCT03340961|65937431|FG000|Overall Study|Adverse Event|1|||
23603615|NCT03340961|65937432|FG001|Overall Study|Adverse Event|1|||
23603616|NCT03340961|65937433|FG002|Overall Study|Adverse Event|0|||
23603617|NCT03340961|65937434|FG003|Overall Study|Adverse Event|0|||
23603618|NCT03340961|65937431|FG000|Overall Study|Lack of Efficacy|0|||
23603619|NCT03340961|65937432|FG001|Overall Study|Lack of Efficacy|0|||
23603620|NCT03340961|65937433|FG002|Overall Study|Lack of Efficacy|0|||
23603621|NCT03340961|65937434|FG003|Overall Study|Lack of Efficacy|1|||
23603622|NCT02470806|65937435|FG000|Overall Study|Lost to Follow-up|1|||
23603623|NCT02470806|65937436|FG001|Overall Study|Lost to Follow-up|1|||
23603624|NCT02470806|65937435|FG000|Overall Study|Adverse Event|5|||
23603625|NCT02470806|65937436|FG001|Overall Study|Adverse Event|2|||
23603626|NCT02470806|65937435|FG000|Overall Study|Protocol Violation|4|||
23603627|NCT02470806|65937436|FG001|Overall Study|Protocol Violation|11|||
23279994|NCT01015625|64765575|FG000|Overall Study|Withdrawal by Subject|2|||
23372104|NCT01192178|65109785|FG001|Overall Study|Lack of Efficacy|2|||
23372105|NCT03630393|65109786|FG000|Overall Study|Death|1|||
23372106|NCT03630393|65109787|FG001|Overall Study|Death|0|||
23372107|NCT02147626|65109789|FG000|Overall Study|Lost to Follow-up|4|||
23372108|NCT02147626|65109790|FG001|Overall Study|Lost to Follow-up|4|||
23372109|NCT02147626|65109789|FG000|Overall Study|Pregnancy|1|||
23372110|NCT02147626|65109790|FG001|Overall Study|Pregnancy|2|||
23372111|NCT02147626|65109789|FG000|Overall Study|Withdrawal by Subject|0|||
23372112|NCT02147626|65109790|FG001|Overall Study|Withdrawal by Subject|1|||
23372113|NCT01411852|65109792|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
23372114|NCT01411852|65109793|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
23372115|NCT01411852|65109792|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
23372116|NCT01411852|65109793|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
23372117|NCT01411852|65109792|FG000|Prehospital Intervention Phase|Found to be under age|0|||
23372118|NCT01411852|65109793|FG001|Prehospital Intervention Phase|Found to be under age|1|||
23372119|NCT01411852|65109792|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
23372120|NCT01411852|65109793|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
23372121|NCT01411852|65109792|FG000|Hospital Intervention Phase|Severe head injury|5|||
23372122|NCT01411852|65109793|FG001|Hospital Intervention Phase|Severe head injury|4|||
23372123|NCT01411852|65109792|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
23372124|NCT01411852|65109793|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
23372125|NCT01411852|65109792|FG000|Hospital Intervention Phase|Miscommunication error|1|||
23372126|NCT01411852|65109793|FG001|Hospital Intervention Phase|Miscommunication error|2|||
23372127|NCT01411852|65109792|FG000|Hospital Intervention Phase|CPR administered|3|||
23372128|NCT01411852|65109793|FG001|Hospital Intervention Phase|CPR administered|1|||
23372129|NCT01411852|65109792|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
23372130|NCT01411852|65109793|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
23372131|NCT01411852|65109792|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
23372132|NCT01411852|65109793|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
23372133|NCT01411852|65109792|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
23372134|NCT01411852|65109793|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
23372135|NCT01411852|65109792|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
23372136|NCT01411852|65109793|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
23372137|NCT01411852|65109792|FG000|Hospital Intervention Phase|Other ineligible|2|||
23372138|NCT01411852|65109793|FG001|Hospital Intervention Phase|Other ineligible|2|||
23372139|NCT01411852|65109792|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
23372140|NCT01411852|65109793|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
23372141|NCT01411852|65109792|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
23372142|NCT01411852|65109793|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
23372143|NCT01411852|65109792|FG000|Hospital Intervention Phase|Vascular access failed|1|||
23372144|NCT01411852|65109793|FG001|Hospital Intervention Phase|Vascular access failed|0|||
23279995|NCT01015625|64765576|FG001|Overall Study|Withdrawal by Subject|3|||
23279996|NCT01015625|64765575|FG000|Overall Study|Physician Decision|2|||
23279997|NCT01015625|64765576|FG001|Overall Study|Physician Decision|0|||
23279998|NCT01015625|64765575|FG000|Overall Study|Death|30|||
23279999|NCT01015625|64765576|FG001|Overall Study|Death|22|||
23280000|NCT03249454|64765577|FG000|Overall Study|Withdrawal by Subject|0|||
23280001|NCT03249454|64765578|FG001|Overall Study|Withdrawal by Subject|0|||
23280002|NCT03249454|64765579|FG002|Overall Study|Withdrawal by Subject|0|||
23280003|NCT03249454|64765580|FG003|Overall Study|Withdrawal by Subject|0|||
23280004|NCT03249454|64765581|FG004|Overall Study|Withdrawal by Subject|0|||
23280005|NCT03249454|64765582|FG005|Overall Study|Withdrawal by Subject|0|||
23280006|NCT03249454|64765583|FG006|Overall Study|Withdrawal by Subject|0|||
23280007|NCT03249454|64765584|FG007|Overall Study|Withdrawal by Subject|0|||
23280008|NCT03249454|64765585|FG008|Overall Study|Withdrawal by Subject|0|||
23280009|NCT03249454|64765586|FG009|Overall Study|Withdrawal by Subject|1|||
23280010|NCT03249454|64765587|FG010|Overall Study|Withdrawal by Subject|1|||
23280011|NCT02334722|64768863|FG000|Overall Study|Lost to Follow-up|4|||
23280012|NCT02334722|64768864|FG001|Overall Study|Lost to Follow-up|0|||
23280013|NCT02334722|64768863|FG000|Overall Study|6 week questionnaire not completed|2|||
23280014|NCT02334722|64768864|FG001|Overall Study|6 week questionnaire not completed|0|||
23280015|NCT02334722|64768863|FG000|Overall Study|Unable to obtain medication|1|||
23280016|NCT02334722|64768864|FG001|Overall Study|Unable to obtain medication|1|||
23280017|NCT02334722|64768863|FG000|Overall Study|Withdrawal by Subject|0|||
23280018|NCT02334722|64768864|FG001|Overall Study|Withdrawal by Subject|3|||
23280019|NCT02334722|64768863|FG000|Overall Study|Adverse Event|0|||
23280020|NCT02334722|64768864|FG001|Overall Study|Adverse Event|2|||
23280021|NCT02334722|64768863|FG000|Overall Study|Physician Decision|0|||
23280022|NCT02334722|64768864|FG001|Overall Study|Physician Decision|1|||
23280023|NCT00829790|64768865|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
23280024|NCT00829790|64768866|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
23280025|NCT00798603|64768868|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
23280026|NCT00798603|64768868|FG000|Overall Study|Withdrawal by Subject|10|||
23280027|NCT00798603|64768868|FG000|Overall Study|Adverse Event|22|||
23372145|NCT02078817|65109794|FG000|Overall Study|Withdrawal by Subject|1|||
23486262|NCT01467583|65524281|FG002|Overall Study|Withdrawal by Subject|0|||
23486263|NCT01467583|65524279|FG000|Overall Study|Protocol Violation|0|||
23486264|NCT01467583|65524280|FG001|Overall Study|Protocol Violation|0|||
23486265|NCT01467583|65524281|FG002|Overall Study|Protocol Violation|2|||
23486266|NCT00995865|65524282|FG000|Overall Study|Protocol Violation|2|||
23280028|NCT00798603|64768868|FG000|Overall Study|Physician Decision|1|||
23280029|NCT00798603|64768868|FG000|Overall Study|Lack of insurance coverage|1|||
23486267|NCT00995865|65524283|FG001|Overall Study|Protocol Violation|0|||
23280030|NCT00989950|64768872|FG000|Randomized Phase|Protocol Violation|1|||
23280031|NCT00989950|64768873|FG001|Randomized Phase|Protocol Violation|0|||
23280032|NCT00989950|64768874|FG002|Randomized Phase|Protocol Violation|0|||
23280033|NCT00989950|64768875|FG003|Randomized Phase|Protocol Violation|0|||
23280034|NCT00989950|64768872|FG000|Randomized Phase|Adverse Event|0|||
23280035|NCT00989950|64768873|FG001|Randomized Phase|Adverse Event|1|||
23486268|NCT00995865|65524284|FG002|Overall Study|Protocol Violation|0|||
23486269|NCT00995865|65524282|FG000|Overall Study|Lost to Follow-up|0|||
23486270|NCT00995865|65524283|FG001|Overall Study|Lost to Follow-up|0|||
23486271|NCT00995865|65524284|FG002|Overall Study|Lost to Follow-up|1|||
23486272|NCT01236118|65524285|FG000|Overall Study|Adverse Event|2|||
23486273|NCT01236118|65524286|FG001|Overall Study|Adverse Event|0|||
23486274|NCT01236118|65524287|FG002|Overall Study|Adverse Event|2|||
23486275|NCT01236118|65524285|FG000|Overall Study|Physician Decision|0|||
23280036|NCT00989950|64768874|FG002|Randomized Phase|Adverse Event|0|||
23280037|NCT00989950|64768875|FG003|Randomized Phase|Adverse Event|0|||
23280038|NCT00604162|64768876|FG000|Overall Study|Physician Decision|3|||
23280039|NCT00604162|64768876|FG000|Overall Study|Withdrawal by Subject|1|||
23280040|NCT02974621|64768877|FG000|Overall Study|Didn't receive study treatment|1|||
23280041|NCT02974621|64768878|FG001|Overall Study|Didn't receive study treatment|10|||
23280042|NCT02640235|64768879|FG000|Overall Study|Withdrawal by Subject|7|||
23280043|NCT02640235|64768880|FG001|Overall Study|Withdrawal by Subject|6|||
23280044|NCT02640235|64768879|FG000|Overall Study|Lost to Follow-up|4|||
23280045|NCT02640235|64768880|FG001|Overall Study|Lost to Follow-up|3|||
23280046|NCT02640235|64768879|FG000|Overall Study|Death|2|||
23280047|NCT02640235|64768880|FG001|Overall Study|Death|3|||
23280048|NCT02640235|64768879|FG000|Overall Study|Other|1|||
23280049|NCT02640235|64768880|FG001|Overall Study|Other|2|||
23280050|NCT03446768|64768881|FG000|Overall Study|Withdrawal by Subject|0|||
23280051|NCT03446768|64768882|FG001|Overall Study|Withdrawal by Subject|1|||
23486276|NCT01236118|65524286|FG001|Overall Study|Physician Decision|1|||
23280052|NCT01116739|64768883|FG000|Overall Study|Child had 2 years of HS|110|||
23280053|NCT01116739|64768884|FG001|Overall Study|Child had 2 years of HS|128|||
23280054|NCT01116739|64768883|FG000|Overall Study|Withdrawal by Subject|6|||
23486277|NCT01236118|65524287|FG002|Overall Study|Physician Decision|0|||
23486278|NCT01236118|65524285|FG000|Overall Study|Withdrawal by Subject|0|||
23486279|NCT01236118|65524286|FG001|Overall Study|Withdrawal by Subject|0|||
23280055|NCT01116739|64768884|FG001|Overall Study|Withdrawal by Subject|0|||
23280056|NCT01116739|64768883|FG000|Overall Study|child too young|2|||
23280057|NCT01116739|64768884|FG001|Overall Study|child too young|6|||
23486280|NCT01236118|65524287|FG002|Overall Study|Withdrawal by Subject|1|||
23372146|NCT00505921|65109796|FG000|Overall Study|Ineligible|1|||
23372147|NCT00505921|65109796|FG000|Overall Study|Failed to Mobilize|8|||
23372148|NCT01704261|65109799|FG000|Overall Study|Withdrawal by Subject|12|||
23372149|NCT01704261|65109800|FG001|Overall Study|Withdrawal by Subject|15|||
23372150|NCT01704261|65109799|FG000|Overall Study|Lost to Follow-up|1|||
23372151|NCT01704261|65109800|FG001|Overall Study|Lost to Follow-up|0|||
23372152|NCT03080935|65109818|FG000|Overall Study|Death|34|||
23372153|NCT03080935|65109819|FG001|Overall Study|Death|50|||
23372154|NCT03080935|65109818|FG000|Overall Study|Lost to Follow-up|5|||
23372155|NCT03080935|65109819|FG001|Overall Study|Lost to Follow-up|4|||
23372156|NCT03080935|65109818|FG000|Overall Study|Withdrawal by Subject|11|||
23372157|NCT03080935|65109819|FG001|Overall Study|Withdrawal by Subject|15|||
23372158|NCT02737722|65109820|FG000|Overall Study|Physician Decision|0|||
23486281|NCT01230710|65524288|FG000|Overall Study|Disease Progression|41|||
23486282|NCT01230710|65524288|FG000|Overall Study|Lost to Follow-up|3|||
23486283|NCT01230710|65524288|FG000|Overall Study|Death|4|||
23486284|NCT01230710|65524288|FG000|Overall Study|Withdrawal of Consent|1|||
23486285|NCT03468543|65524291|FG000|Overall Study|Protocol stopping rules met|3|||
23486286|NCT00084838|65524292|FG000|Overall Study|Death|1|||
23486287|NCT00084838|65524292|FG000|Overall Study|Adverse Event|2|||
23486288|NCT00084838|65524292|FG000|Overall Study|Withdrawal by Subject|1|||
23486289|NCT00084838|65524292|FG000|Overall Study|Progressive Disease|4|||
23486290|NCT00084838|65524292|FG000|Overall Study|Pt Non-Compliance|1|||
23486291|NCT00084838|65524292|FG000|Overall Study|Ineligible|4|||
23486292|NCT02514473|65524293|FG000|Overall Study|Adverse Event|0|||
23486293|NCT02514473|65524294|FG001|Overall Study|Adverse Event|2|||
23486294|NCT02514473|65524293|FG000|Overall Study|Withdrawal by Subject|2|||
23486295|NCT02514473|65524294|FG001|Overall Study|Withdrawal by Subject|1|||
23486296|NCT02514473|65524293|FG000|Overall Study|Lost to Follow-up|0|||
23486297|NCT02514473|65524294|FG001|Overall Study|Lost to Follow-up|1|||
23486298|NCT02514473|65524293|FG000|Overall Study|Other|1|||
23486299|NCT02514473|65524294|FG001|Overall Study|Other|1|||
23486300|NCT02280473|65524295|FG000|Overall Study|Adverse Event|1|||
23486301|NCT02280473|65524296|FG001|Overall Study|Adverse Event|1|||
23486302|NCT02280473|65524295|FG000|Overall Study|Lack of Efficacy|0|||
23486303|NCT02280473|65524296|FG001|Overall Study|Lack of Efficacy|1|||
23486304|NCT02280473|65524295|FG000|Overall Study|Lost to Follow-up|0|||
23486305|NCT02280473|65524296|FG001|Overall Study|Lost to Follow-up|1|||
23486306|NCT02821910|65524299|FG000|Overall Study|Withdrawal by Subject|0|||
23486307|NCT02821910|65524300|FG001|Overall Study|Withdrawal by Subject|0|||
23486308|NCT02821910|65524301|FG002|Overall Study|Withdrawal by Subject|1|||
23486309|NCT02821910|65524302|FG003|Overall Study|Withdrawal by Subject|0|||
23486310|NCT02821910|65524303|FG004|Overall Study|Withdrawal by Subject|0|||
23486311|NCT02821910|65524304|FG005|Overall Study|Withdrawal by Subject|1|||
23486312|NCT02821910|65524299|FG000|Overall Study|Other than specified|1|||
23486313|NCT02821910|65524300|FG001|Overall Study|Other than specified|0|||
23486314|NCT02821910|65524301|FG002|Overall Study|Other than specified|1|||
23486315|NCT02821910|65524302|FG003|Overall Study|Other than specified|0|||
23486316|NCT02821910|65524303|FG004|Overall Study|Other than specified|0|||
23486317|NCT02821910|65524304|FG005|Overall Study|Other than specified|0|||
23486318|NCT01151098|65524305|FG000|Overall Study|Adverse Event|82|||
23486319|NCT01151098|65524305|FG000|Overall Study|Lost to Follow-up|6|||
23486320|NCT01151098|65524305|FG000|Overall Study|Lack of Efficacy|15|||
23486321|NCT01151098|65524305|FG000|Overall Study|Protocol Violation|1|||
23486322|NCT01151098|65524305|FG000|Overall Study|Miscellaneous|13|||
23486323|NCT03150485|65524306|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
23486324|NCT03150485|65524307|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
23372159|NCT02737722|65109821|FG001|Overall Study|Physician Decision|0|||
23372160|NCT02737722|65109822|FG002|Overall Study|Physician Decision|1|||
23372161|NCT02737722|65109823|FG003|Overall Study|Physician Decision|0|||
23372162|NCT03499795|65109825|FG000|Overall Study|Adverse Event|1|||
23372163|NCT03499795|65109825|FG000|Overall Study|Lost to Follow-up|1|||
23372164|NCT01723072|65109826|FG000|Overall Study|Withdrawal by Subject|7|||
23486325|NCT03150485|65524308|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
23486326|NCT03150485|65524309|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
23486327|NCT03150485|65524310|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
23486328|NCT03150485|65524311|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
23486329|NCT00777205|65524312|FG000|Overall Study|Lost to Follow-up|25|||
23486330|NCT00777205|65524313|FG001|Overall Study|Lost to Follow-up|9|||
23486331|NCT00777205|65524312|FG000|Overall Study|Withdrawal by Subject|6|||
23486332|NCT00777205|65524313|FG001|Overall Study|Withdrawal by Subject|4|||
23486333|NCT00777205|65524312|FG000|Overall Study|Death|0|||
23486334|NCT00777205|65524313|FG001|Overall Study|Death|2|||
23486335|NCT00777205|65524312|FG000|Overall Study|Protocol Violation|0|||
23372165|NCT01723072|65109827|FG001|Overall Study|Withdrawal by Subject|13|||
23372166|NCT01723072|65109826|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
23486336|NCT00777205|65524313|FG001|Overall Study|Protocol Violation|56|||
23486337|NCT03282565|65524318|FG000|Overall Study|COVID-19 Research Shutdown|0|||
23486338|NCT03282565|65524319|FG001|Overall Study|COVID-19 Research Shutdown|2|||
23486339|NCT03282565|65524320|FG002|Overall Study|COVID-19 Research Shutdown|2|||
23486340|NCT00920829|65524324|FG000|Allocation|No post randomization data|3|||
23486341|NCT00920829|65524325|FG001|Allocation|No post randomization data|1|||
23486342|NCT00920829|65524326|FG002|Allocation|No post randomization data|0|||
23486343|NCT00920829|65524327|FG003|Allocation|No post randomization data|2|||
23486344|NCT00920829|65524324|FG000|Available for Analysis|Withdrawal by Subject|6|||
23486345|NCT00920829|65524325|FG001|Available for Analysis|Withdrawal by Subject|6|||
23486346|NCT00920829|65524326|FG002|Available for Analysis|Withdrawal by Subject|6|||
23486347|NCT00920829|65524327|FG003|Available for Analysis|Withdrawal by Subject|10|||
23486348|NCT00920829|65524324|FG000|Available for Analysis|Required Medical Treatment|0|||
23486349|NCT00920829|65524325|FG001|Available for Analysis|Required Medical Treatment|1|||
23486350|NCT00920829|65524326|FG002|Available for Analysis|Required Medical Treatment|2|||
23486351|NCT00920829|65524327|FG003|Available for Analysis|Required Medical Treatment|0|||
23486352|NCT00920829|65524324|FG000|Available for Analysis|Adverse Event|1|||
23486353|NCT00920829|65524325|FG001|Available for Analysis|Adverse Event|2|||
23280058|NCT01116739|64768883|FG000|Overall Study|child not enrolled in head start|10|||
23486354|NCT00920829|65524326|FG002|Available for Analysis|Adverse Event|1|||
23280059|NCT01116739|64768884|FG001|Overall Study|child not enrolled in head start|2|||
23280060|NCT01116739|64768883|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
23280061|NCT01116739|64768884|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
23280062|NCT01528696|64768889|FG000|Overall Study|See detailed description|18|||
23280063|NCT01528696|64768890|FG001|Overall Study|See detailed description|19|||
23280064|NCT01527006|64768891|FG000|Core Study|Adverse Event|0|||
23280065|NCT01527006|64768892|FG001|Core Study|Adverse Event|2|||
23280066|NCT01527006|64768891|FG000|Core Study|Lost to Follow-up|0|||
23280067|NCT01527006|64768892|FG001|Core Study|Lost to Follow-up|1|||
23280068|NCT01527006|64768891|FG000|Core Study|Subject Choice|1|||
23280069|NCT01527006|64768892|FG001|Core Study|Subject Choice|0|||
23280070|NCT01527006|64768891|FG000|Core Study|Inadequate Therapeutic Effect|1|||
23280071|NCT01527006|64768892|FG001|Core Study|Inadequate Therapeutic Effect|0|||
23280072|NCT01527006|64768891|FG000|Core Study|Withdrawal by Subject|0|||
23280073|NCT01527006|64768892|FG001|Core Study|Withdrawal by Subject|1|||
23280074|NCT01527006|64768891|FG000|Core Study|Other|0|||
23280075|NCT01527006|64768892|FG001|Core Study|Other|2|||
23280076|NCT01527006|64768891|FG000|Extension Phase|Adverse Event|4|||
23280077|NCT01527006|64768892|FG001|Extension Phase|Adverse Event|2|||
23280078|NCT01527006|64768891|FG000|Extension Phase|Lost to Follow-up|0|||
23280079|NCT01527006|64768892|FG001|Extension Phase|Lost to Follow-up|1|||
23280080|NCT01527006|64768891|FG000|Extension Phase|Subject Choice|1|||
23280081|NCT01527006|64768892|FG001|Extension Phase|Subject Choice|1|||
23280082|NCT01527006|64768891|FG000|Extension Phase|Inadequate therapeutic effect|1|||
23280083|NCT01527006|64768892|FG001|Extension Phase|Inadequate therapeutic effect|1|||
23280084|NCT01527006|64768891|FG000|Extension Phase|Other|0|||
23280085|NCT01527006|64768892|FG001|Extension Phase|Other|3|||
23280086|NCT00418145|64768893|FG000|Overall Study|study terminated|6|||
23280087|NCT04345653|64768894|FG000|Overall Study|Withdrawal by Subject|2|||
23280088|NCT00834444|64768896|FG000|First Intervention|Adverse Event|1|||
23280089|NCT00834444|64768897|FG001|First Intervention|Adverse Event|0|||
23486355|NCT00920829|65524327|FG003|Available for Analysis|Adverse Event|0|||
23486356|NCT00920829|65524324|FG000|Available for Analysis|Death|1|||
23486357|NCT00920829|65524325|FG001|Available for Analysis|Death|0|||
23280090|NCT00834444|64768896|FG000|First Intervention|Intolerance to Venopuncture|0|||
23280091|NCT00834444|64768897|FG001|First Intervention|Intolerance to Venopuncture|1|||
23280092|NCT00834444|64768896|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
23280093|NCT00834444|64768897|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23280094|NCT00834444|64768896|FG000|Second Intervention|Adverse Event|1|||
23280095|NCT00834444|64768897|FG001|Second Intervention|Adverse Event|0|||
23280096|NCT00316277|64768898|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
23280097|NCT00316277|64768899|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
23280098|NCT00316277|64768898|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
23280099|NCT00316277|64768899|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
23280100|NCT00316277|64768898|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
23280101|NCT00316277|64768899|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
23280102|NCT00316277|64768898|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
23280103|NCT00316277|64768899|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
23280104|NCT00316277|64768898|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
23280105|NCT00316277|64768899|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
23280106|NCT00745420|64768900|FG000|Overall Study|Ineligible|1|||
23280107|NCT01124175|64768901|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
23280108|NCT01124175|64768902|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
23280109|NCT00088829|64768903|FG000|Overall Study|PI left institution and study was close|22|||
23280110|NCT03364192|64768904|FG000|Overall Study|Ineligible|10|||
23280111|NCT03364192|64768904|FG000|Overall Study|Withdrawal by Subject|5|||
23280112|NCT03364192|64768904|FG000|Overall Study|Lost to Follow-up|1|||
23280113|NCT00571064|64768905|FG000|Overall Study|Adverse Event|13|||
23280114|NCT00571064|64768905|FG000|Overall Study|Protocol Violation|4|||
23280115|NCT00571064|64768905|FG000|Overall Study|Withdrawal by Subject|2|||
23280116|NCT00571064|64768905|FG000|Overall Study|Other|2|||
23280117|NCT00942968|64768909|FG000|Overall Study|Adverse Event|60|||
23280118|NCT00942968|64768909|FG000|Overall Study|Death|76|||
23280119|NCT00942968|64768909|FG000|Overall Study|Protocol Violation|9|||
23280120|NCT00942968|64768909|FG000|Overall Study|Lost to Follow-up|4|||
23280121|NCT00942968|64768909|FG000|Overall Study|Withdrawal by Subject|44|||
23280122|NCT00942968|64768909|FG000|Overall Study|Sponsor request|5|||
23280123|NCT00942968|64768909|FG000|Overall Study|Physician Decision|11|||
23280124|NCT00942968|64768909|FG000|Overall Study|Progression of disease|12|||
23280125|NCT00942968|64768909|FG000|Overall Study|Inferior vena cava filter placement|4|||
23280126|NCT00942968|64768909|FG000|Overall Study|Pulmonary embolism (PE)|1|||
23280127|NCT00942968|64768909|FG000|Overall Study|Participant required pancreatic biopsy|1|||
23280128|NCT00942968|64768909|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
23280129|NCT02671435|64768910|FG000|Overall Study|Death|1|||
23280130|NCT02671435|64768911|FG001|Overall Study|Death|3|||
23280131|NCT02671435|64768912|FG002|Overall Study|Death|0|||
23372167|NCT01723072|65109827|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
23372168|NCT01723072|65109826|FG000|Overall Study|Other|4|||
23372169|NCT01723072|65109827|FG001|Overall Study|Other|3|||
23372170|NCT02251275|65109835|FG000|Overall Study|Adverse Event|23|||
23372171|NCT02251275|65109836|FG001|Overall Study|Adverse Event|60|||
23372172|NCT02251275|65109837|FG002|Overall Study|Adverse Event|28|||
23372173|NCT02251275|65109838|FG003|Overall Study|Adverse Event|0|||
23372174|NCT02251275|65109839|FG004|Overall Study|Adverse Event|0|||
23372175|NCT02251275|65109835|FG000|Overall Study|Lost to Follow-up|5|||
23372176|NCT02251275|65109836|FG001|Overall Study|Lost to Follow-up|6|||
23372177|NCT02251275|65109837|FG002|Overall Study|Lost to Follow-up|4|||
23372178|NCT02251275|65109838|FG003|Overall Study|Lost to Follow-up|0|||
23372179|NCT02251275|65109839|FG004|Overall Study|Lost to Follow-up|0|||
23372180|NCT02251275|65109835|FG000|Overall Study|Physician Decision|19|||
23372181|NCT02251275|65109836|FG001|Overall Study|Physician Decision|30|||
23372182|NCT02251275|65109837|FG002|Overall Study|Physician Decision|26|||
23372183|NCT02251275|65109838|FG003|Overall Study|Physician Decision|0|||
23372184|NCT02251275|65109839|FG004|Overall Study|Physician Decision|1|||
23372185|NCT02251275|65109835|FG000|Overall Study|Protocol Deviation|0|||
23372186|NCT02251275|65109836|FG001|Overall Study|Protocol Deviation|0|||
23372187|NCT02251275|65109837|FG002|Overall Study|Protocol Deviation|1|||
23372188|NCT02251275|65109838|FG003|Overall Study|Protocol Deviation|0|||
23372189|NCT02251275|65109839|FG004|Overall Study|Protocol Deviation|0|||
23372190|NCT02251275|65109835|FG000|Overall Study|Withdrawal by Subject|25|||
23372191|NCT02251275|65109836|FG001|Overall Study|Withdrawal by Subject|51|||
23372192|NCT02251275|65109837|FG002|Overall Study|Withdrawal by Subject|35|||
23372193|NCT02251275|65109838|FG003|Overall Study|Withdrawal by Subject|1|||
23372194|NCT02251275|65109839|FG004|Overall Study|Withdrawal by Subject|0|||
23372195|NCT01101178|65109840|FG000|Period 1|Withdrawal by Subject|1|||
23372196|NCT01101178|65109841|FG001|Period 1|Withdrawal by Subject|2|||
23372197|NCT01101178|65109840|FG000|Period 1|Positive drug screen|1|||
23372198|NCT01101178|65109841|FG001|Period 1|Positive drug screen|1|||
23372199|NCT01101178|65109840|FG000|Period 1|Adverse Event|2|||
23372200|NCT01101178|65109841|FG001|Period 1|Adverse Event|1|||
23372201|NCT01101178|65109840|FG000|Period 2|Withdrawal by Subject|0|||
23372202|NCT01101178|65109841|FG001|Period 2|Withdrawal by Subject|1|||
23372203|NCT00656617|65109857|FG000|Overall Study|Adverse Event|1|||
23372204|NCT00656617|65109857|FG000|Overall Study|Death|2|||
23280132|NCT02671435|64768913|FG003|Overall Study|Death|16|||
23280133|NCT02671435|64768914|FG004|Overall Study|Death|14|||
23280134|NCT02671435|64768915|FG005|Overall Study|Death|29|||
23280135|NCT02671435|64768916|FG006|Overall Study|Death|34|||
23280136|NCT02671435|64768917|FG007|Overall Study|Death|28|||
23280137|NCT02671435|64768918|FG008|Overall Study|Death|19|||
23280138|NCT02671435|64768919|FG009|Overall Study|Death|10|||
23280139|NCT02671435|64768920|FG010|Overall Study|Death|8|||
23280140|NCT02671435|64768921|FG011|Overall Study|Death|29|||
23280141|NCT02671435|64768922|FG012|Overall Study|Death|29|||
23280142|NCT02671435|64768923|FG013|Overall Study|Death|29|||
23280143|NCT02671435|64768924|FG014|Overall Study|Death|27|||
23280144|NCT02671435|64768910|FG000|Overall Study|Lost to Follow-up|0|||
23280145|NCT02671435|64768911|FG001|Overall Study|Lost to Follow-up|0|||
23280146|NCT02671435|64768912|FG002|Overall Study|Lost to Follow-up|1|||
23280147|NCT02671435|64768913|FG003|Overall Study|Lost to Follow-up|0|||
23280148|NCT02671435|64768914|FG004|Overall Study|Lost to Follow-up|1|||
23280149|NCT02671435|64768915|FG005|Overall Study|Lost to Follow-up|1|||
23280150|NCT02671435|64768916|FG006|Overall Study|Lost to Follow-up|2|||
23280151|NCT02671435|64768917|FG007|Overall Study|Lost to Follow-up|2|||
23280152|NCT02671435|64768918|FG008|Overall Study|Lost to Follow-up|0|||
23280153|NCT02671435|64768919|FG009|Overall Study|Lost to Follow-up|2|||
23280154|NCT02671435|64768920|FG010|Overall Study|Lost to Follow-up|0|||
23280155|NCT02671435|64768921|FG011|Overall Study|Lost to Follow-up|3|||
23486358|NCT00920829|65524326|FG002|Available for Analysis|Death|0|||
23486359|NCT00920829|65524327|FG003|Available for Analysis|Death|0|||
23486360|NCT00920829|65524324|FG000|Available for Analysis|Protocol Violation|0|||
23486361|NCT00920829|65524325|FG001|Available for Analysis|Protocol Violation|0|||
23486362|NCT00920829|65524326|FG002|Available for Analysis|Protocol Violation|1|||
23486363|NCT00920829|65524327|FG003|Available for Analysis|Protocol Violation|0|||
23486364|NCT00920829|65524324|FG000|Available for Analysis|Required more treatment|0|||
23486365|NCT00920829|65524325|FG001|Available for Analysis|Required more treatment|2|||
23486366|NCT00920829|65524326|FG002|Available for Analysis|Required more treatment|0|||
23486367|NCT00920829|65524327|FG003|Available for Analysis|Required more treatment|1|||
23486368|NCT01163032|65524328|FG000|Randomization Phase|Withdrawal by Subject|2|||
23486369|NCT01163032|65524329|FG001|Randomization Phase|Withdrawal by Subject|3|||
23486370|NCT01163032|65524330|FG002|Randomization Phase|Withdrawal by Subject|0|||
23486371|NCT01163032|65524328|FG000|Randomization Phase|Adverse Event|3|||
23486372|NCT01163032|65524329|FG001|Randomization Phase|Adverse Event|3|||
23486373|NCT01163032|65524330|FG002|Randomization Phase|Adverse Event|0|||
23486374|NCT01163032|65524328|FG000|Randomization Phase|Protocol Violation|0|||
23486375|NCT01163032|65524329|FG001|Randomization Phase|Protocol Violation|1|||
23486376|NCT01163032|65524330|FG002|Randomization Phase|Protocol Violation|0|||
23486377|NCT01163032|65524328|FG000|Randomization Phase|Various*|5|||
23486378|NCT01163032|65524329|FG001|Randomization Phase|Various*|4|||
23486379|NCT01163032|65524330|FG002|Randomization Phase|Various*|0|||
23486380|NCT01163032|65524328|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
23486381|NCT01163032|65524329|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
23486382|NCT01163032|65524330|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
23486383|NCT01163032|65524328|FG000|Open Label Extension Phase|Adverse Event|0|||
23486384|NCT01163032|65524329|FG001|Open Label Extension Phase|Adverse Event|0|||
23486385|NCT01163032|65524330|FG002|Open Label Extension Phase|Adverse Event|3|||
23486386|NCT01163032|65524328|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
23486387|NCT01163032|65524329|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
23486388|NCT01163032|65524330|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
23486389|NCT01163032|65524328|FG000|Open Label Extension Phase|Protocol Violation|0|||
23486390|NCT01163032|65524329|FG001|Open Label Extension Phase|Protocol Violation|0|||
23486391|NCT01163032|65524330|FG002|Open Label Extension Phase|Protocol Violation|1|||
23486392|NCT01163032|65524328|FG000|Open Label Extension Phase|Study Termination|0|||
23486393|NCT01163032|65524329|FG001|Open Label Extension Phase|Study Termination|0|||
23486394|NCT01163032|65524330|FG002|Open Label Extension Phase|Study Termination|7|||
23486395|NCT01163032|65524328|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
23486396|NCT01163032|65524329|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
23486397|NCT01163032|65524330|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
23486398|NCT00287079|65524331|FG000|Overall Study|Qualifying relapse|12|||
23486399|NCT00287079|65524332|FG001|Overall Study|Qualifying relapse|1|||
23486400|NCT00287079|65524331|FG000|Overall Study|Non-qualifying relapse|1|||
23486401|NCT00287079|65524332|FG001|Overall Study|Non-qualifying relapse|0|||
23486402|NCT00287079|65524331|FG000|Overall Study|Adverse Event|5|||
23486403|NCT00287079|65524332|FG001|Overall Study|Adverse Event|0|||
23486404|NCT00287079|65524331|FG000|Overall Study|Protocol Violation|1|||
23486405|NCT00287079|65524332|FG001|Overall Study|Protocol Violation|0|||
23486406|NCT00287079|65524331|FG000|Overall Study|Other|3|||
23486407|NCT00287079|65524332|FG001|Overall Study|Other|0|||
23486408|NCT00006389|65524336|FG000|Overall Study|Adverse Event|1|||
23486409|NCT00122278|65524348|FG000|Overall Study|Lost to Follow-up|2|||
23486410|NCT00122278|65524349|FG001|Overall Study|Lost to Follow-up|0|||
23486411|NCT02301988|65524350|FG000|Overall Study|Withdrawal by Subject|2|||
23486412|NCT02301988|65524351|FG001|Overall Study|Withdrawal by Subject|1|||
23486413|NCT02301988|65524350|FG000|Overall Study|Physician Decision|2|||
23486414|NCT02301988|65524351|FG001|Overall Study|Physician Decision|2|||
23486415|NCT02301988|65524350|FG000|Overall Study|Unknown Reason|1|||
23486416|NCT02301988|65524351|FG001|Overall Study|Unknown Reason|3|||
23486417|NCT02301988|65524350|FG000|Overall Study|Lack of Efficacy|3|||
23486418|NCT02301988|65524351|FG001|Overall Study|Lack of Efficacy|2|||
23486419|NCT02301988|65524350|FG000|Overall Study|Death|1|||
23486420|NCT02301988|65524351|FG001|Overall Study|Death|0|||
23486421|NCT02301988|65524350|FG000|Overall Study|Adverse Event|1|||
23486422|NCT02301988|65524351|FG001|Overall Study|Adverse Event|1|||
23486423|NCT02283177|65524352|FG000|Overall Study|Withdrawal by Subject|1|||
23486424|NCT02283177|65524353|FG001|Overall Study|Withdrawal by Subject|1|||
23486425|NCT00470158|65524354|FG000|Overall Study|Death|0|||
23486426|NCT00470158|65524355|FG001|Overall Study|Death|0|||
23486427|NCT00470158|65524356|FG002|Overall Study|Death|0|||
23486428|NCT00470158|65524357|FG003|Overall Study|Death|0|||
23486429|NCT00470158|65524358|FG004|Overall Study|Death|2|||
23486430|NCT00470158|65524354|FG000|Overall Study|Lost to Follow-up|7|||
23486431|NCT00470158|65524355|FG001|Overall Study|Lost to Follow-up|8|||
23486432|NCT00470158|65524356|FG002|Overall Study|Lost to Follow-up|8|||
23486433|NCT00470158|65524357|FG003|Overall Study|Lost to Follow-up|5|||
23372205|NCT00656617|65109857|FG000|Overall Study|Insurance Issues|2|||
23372206|NCT00656617|65109857|FG000|Overall Study|Move to different clinical trial|2|||
23372207|NCT02119299|65109863|FG000|Overall Study|Withdrawal by Subject|7|||
23372208|NCT02119299|65109863|FG000|Overall Study|Lack of Efficacy|1|||
23372209|NCT02119299|65109863|FG000|Overall Study|Pregnancy|1|||
23372210|NCT03427411|65109864|FG000|Overall Study|Screen failure - platelets too low|0|||
23372211|NCT03427411|65109865|FG001|Overall Study|Screen failure - platelets too low|1|||
23372212|NCT00997334|65109866|FG000|Overall Study|still on therapy|12|||
23372213|NCT00997334|65109866|FG000|Overall Study|Adverse Event|3|||
23372214|NCT00997334|65109866|FG000|Overall Study|Patient non-compliance|1|||
23372215|NCT00997334|65109866|FG000|Overall Study|Withdrawal by Subject|3|||
23372216|NCT00997334|65109866|FG000|Overall Study|Death|2|||
23372217|NCT00997334|65109866|FG000|Overall Study|Urgent Palliative Care|2|||
23372218|NCT00997334|65109866|FG000|Overall Study|No lesion amenable|1|||
23372219|NCT00997334|65109866|FG000|Overall Study|Ineligible|1|||
23372220|NCT03538041|65109868|FG000|12-Week Treatment Period|Adverse Event|1|||
23372221|NCT03538041|65109869|FG001|12-Week Treatment Period|Adverse Event|1|||
23372222|NCT03538041|65109868|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
23372223|NCT03538041|65109869|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
23372224|NCT03538041|65109868|FG000|Treatment Extension Period|Adverse Event|4|||
23372225|NCT03538041|65109869|FG001|Treatment Extension Period|Adverse Event|0|||
23372226|NCT03538041|65109868|FG000|Treatment Extension Period|Physician Decision|1|||
23372227|NCT03538041|65109869|FG001|Treatment Extension Period|Physician Decision|0|||
23372228|NCT03538041|65109868|FG000|Treatment Extension Period|Lack of Efficacy|1|||
23372229|NCT03538041|65109869|FG001|Treatment Extension Period|Lack of Efficacy|3|||
23372230|NCT03538041|65109868|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
23372231|NCT03538041|65109869|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
23372232|NCT02870868|65109871|FG000|Overall Study|Withdrawal by Subject|2|||
23486434|NCT00470158|65524358|FG004|Overall Study|Lost to Follow-up|4|||
23486435|NCT00470158|65524354|FG000|Overall Study|Protocol Violation|1|||
23486436|NCT00470158|65524355|FG001|Overall Study|Protocol Violation|0|||
23372233|NCT02870868|65109872|FG001|Overall Study|Withdrawal by Subject|1|||
23372234|NCT01850641|65109873|FG000|Overall Study|Physician Decision|1|||
23372235|NCT01850641|65109873|FG000|Overall Study|Decrease in serum phosphorus|1|||
23372236|NCT01850641|65109873|FG000|Overall Study|Decrease in serum calcium|2|||
23372237|NCT01850641|65109873|FG000|Overall Study|Increase in serum ferritin|1|||
23372238|NCT02785939|65109883|FG000|Overall Study|Progression|25|||
23486437|NCT00470158|65524356|FG002|Overall Study|Protocol Violation|0|||
23201455|NCT03650452|64476736|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
23372239|NCT02785939|65109884|FG001|Overall Study|Progression|8|||
23372240|NCT02785939|65109883|FG000|Overall Study|Adverse Event|3|||
23372241|NCT02785939|65109884|FG001|Overall Study|Adverse Event|1|||
23372242|NCT02785939|65109883|FG000|Overall Study|Death|1|||
23372243|NCT02785939|65109884|FG001|Overall Study|Death|0|||
23372244|NCT02785939|65109883|FG000|Overall Study|Refusal|1|||
23372245|NCT02785939|65109884|FG001|Overall Study|Refusal|0|||
23372246|NCT02785939|65109883|FG000|Overall Study|Deteriorating health|1|||
23372247|NCT02785939|65109884|FG001|Overall Study|Deteriorating health|0|||
23372248|NCT02785939|65109883|FG000|Overall Study|Not protocol specified|0|||
23372249|NCT02785939|65109884|FG001|Overall Study|Not protocol specified|1|||
23372250|NCT00368108|65109886|FG000|Overall Study|Adverse Event|38|||
23372251|NCT00368108|65109887|FG001|Overall Study|Adverse Event|26|||
23372252|NCT00368108|65109888|FG002|Overall Study|Adverse Event|44|||
23372253|NCT00368108|65109886|FG000|Overall Study|Abnormal Laboratory Value|0|||
23372254|NCT00368108|65109887|FG001|Overall Study|Abnormal Laboratory Value|0|||
23372255|NCT00368108|65109888|FG002|Overall Study|Abnormal Laboratory Value|3|||
23372256|NCT00368108|65109886|FG000|Overall Study|Protocol Violation|5|||
23372257|NCT00368108|65109887|FG001|Overall Study|Protocol Violation|9|||
23372258|NCT00368108|65109888|FG002|Overall Study|Protocol Violation|9|||
23372259|NCT00368108|65109886|FG000|Overall Study|Withdrawal by Subject|9|||
23372260|NCT00368108|65109887|FG001|Overall Study|Withdrawal by Subject|3|||
23372261|NCT00368108|65109888|FG002|Overall Study|Withdrawal by Subject|5|||
23372262|NCT00368108|65109886|FG000|Overall Study|Lack of Efficacy|7|||
23372263|NCT00368108|65109887|FG001|Overall Study|Lack of Efficacy|8|||
23372264|NCT00368108|65109888|FG002|Overall Study|Lack of Efficacy|5|||
23372265|NCT00368108|65109886|FG000|Overall Study|Physician Decision|2|||
23372266|NCT00368108|65109887|FG001|Overall Study|Physician Decision|0|||
23372267|NCT00368108|65109888|FG002|Overall Study|Physician Decision|1|||
23372268|NCT00368108|65109886|FG000|Overall Study|Other|3|||
23372269|NCT00368108|65109887|FG001|Overall Study|Other|7|||
23372270|NCT00368108|65109888|FG002|Overall Study|Other|1|||
23372271|NCT00827567|65109893|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
23372272|NCT00856180|65109898|FG000|Overall Study|Adverse Event|4|||
23372273|NCT00856180|65109898|FG000|Overall Study|Progressive Disease|16|||
23372274|NCT00834041|65109900|FG000|Overall Study|Withdrawal by Subject|1|||
23372275|NCT00834041|65109901|FG001|Overall Study|Withdrawal by Subject|0|||
23372276|NCT00834041|65109900|FG000|Overall Study|Lost to Follow-up|0|||
23372277|NCT00834041|65109901|FG001|Overall Study|Lost to Follow-up|1|||
23372278|NCT02265510|65109902|FG000|Overall Study|Withdrawal by Subject|1|||
23372279|NCT02265510|65109903|FG001|Overall Study|Withdrawal by Subject|1|||
23372280|NCT02265510|65109904|FG002|Overall Study|Withdrawal by Subject|2|||
23372281|NCT02265510|65109905|FG003|Overall Study|Withdrawal by Subject|1|||
23372282|NCT02265510|65109906|FG004|Overall Study|Withdrawal by Subject|0|||
23372283|NCT02265510|65109907|FG005|Overall Study|Withdrawal by Subject|2|||
23372284|NCT02265510|65109908|FG006|Overall Study|Withdrawal by Subject|0|||
23372285|NCT02265510|65109909|FG007|Overall Study|Withdrawal by Subject|2|||
23372286|NCT02265510|65109910|FG008|Overall Study|Withdrawal by Subject|0|||
23372287|NCT02265510|65109911|FG009|Overall Study|Withdrawal by Subject|0|||
23372288|NCT02265510|65109912|FG010|Overall Study|Withdrawal by Subject|0|||
23372289|NCT02265510|65109913|FG011|Overall Study|Withdrawal by Subject|0|||
23372290|NCT02265510|65109914|FG012|Overall Study|Withdrawal by Subject|1|||
23372291|NCT02265510|65109915|FG013|Overall Study|Withdrawal by Subject|0|||
23372292|NCT02265510|65109902|FG000|Overall Study|Disease Progression|0|||
23372293|NCT02265510|65109903|FG001|Overall Study|Disease Progression|1|||
23372294|NCT02265510|65109904|FG002|Overall Study|Disease Progression|2|||
23372295|NCT02265510|65109905|FG003|Overall Study|Disease Progression|1|||
23372296|NCT02265510|65109906|FG004|Overall Study|Disease Progression|1|||
23372297|NCT02265510|65109907|FG005|Overall Study|Disease Progression|0|||
23603628|NCT02470806|65937435|FG000|Overall Study|Physician Decision|0|||
23372298|NCT02265510|65109908|FG006|Overall Study|Disease Progression|0|||
23603629|NCT02470806|65937436|FG001|Overall Study|Physician Decision|3|||
23603630|NCT02470806|65937435|FG000|Overall Study|Withdrawal by Subject|3|||
23603631|NCT02470806|65937436|FG001|Overall Study|Withdrawal by Subject|10|||
23603632|NCT02470806|65937435|FG000|Overall Study|Lack of Efficacy|5|||
23372299|NCT02265510|65109909|FG007|Overall Study|Disease Progression|0|||
23372300|NCT02265510|65109910|FG008|Overall Study|Disease Progression|0|||
23372301|NCT02265510|65109911|FG009|Overall Study|Disease Progression|0|||
23372302|NCT02265510|65109912|FG010|Overall Study|Disease Progression|0|||
23372303|NCT02265510|65109913|FG011|Overall Study|Disease Progression|0|||
23372304|NCT02265510|65109914|FG012|Overall Study|Disease Progression|0|||
23372305|NCT02265510|65109915|FG013|Overall Study|Disease Progression|0|||
23372306|NCT02265510|65109902|FG000|Overall Study|Death|2|||
23372307|NCT02265510|65109903|FG001|Overall Study|Death|0|||
23372308|NCT02265510|65109904|FG002|Overall Study|Death|2|||
23372309|NCT02265510|65109905|FG003|Overall Study|Death|2|||
23372310|NCT02265510|65109906|FG004|Overall Study|Death|1|||
23372311|NCT02265510|65109907|FG005|Overall Study|Death|3|||
23372312|NCT02265510|65109908|FG006|Overall Study|Death|2|||
23372313|NCT02265510|65109909|FG007|Overall Study|Death|1|||
23372314|NCT02265510|65109910|FG008|Overall Study|Death|3|||
23372315|NCT02265510|65109911|FG009|Overall Study|Death|3|||
23372316|NCT02265510|65109912|FG010|Overall Study|Death|4|||
23372317|NCT02265510|65109913|FG011|Overall Study|Death|12|||
23372318|NCT02265510|65109914|FG012|Overall Study|Death|7|||
23372319|NCT02265510|65109915|FG013|Overall Study|Death|6|||
23372320|NCT02265510|65109902|FG000|Overall Study|Lost to Follow-up|0|||
23372321|NCT02265510|65109903|FG001|Overall Study|Lost to Follow-up|0|||
23372322|NCT02265510|65109904|FG002|Overall Study|Lost to Follow-up|0|||
23372323|NCT02265510|65109905|FG003|Overall Study|Lost to Follow-up|0|||
23372324|NCT02265510|65109906|FG004|Overall Study|Lost to Follow-up|1|||
23372325|NCT02265510|65109907|FG005|Overall Study|Lost to Follow-up|0|||
23372326|NCT02265510|65109908|FG006|Overall Study|Lost to Follow-up|0|||
23372327|NCT02265510|65109909|FG007|Overall Study|Lost to Follow-up|0|||
23372328|NCT02265510|65109910|FG008|Overall Study|Lost to Follow-up|0|||
23372329|NCT02265510|65109911|FG009|Overall Study|Lost to Follow-up|2|||
23372330|NCT02265510|65109912|FG010|Overall Study|Lost to Follow-up|0|||
23372331|NCT02265510|65109913|FG011|Overall Study|Lost to Follow-up|0|||
23372332|NCT02265510|65109914|FG012|Overall Study|Lost to Follow-up|0|||
23372333|NCT02265510|65109915|FG013|Overall Study|Lost to Follow-up|2|||
23372334|NCT02265510|65109902|FG000|Overall Study|Other|0|||
23372335|NCT02265510|65109903|FG001|Overall Study|Other|1|||
23372336|NCT02265510|65109904|FG002|Overall Study|Other|0|||
23372337|NCT02265510|65109905|FG003|Overall Study|Other|0|||
23280156|NCT02671435|64768922|FG012|Overall Study|Lost to Follow-up|3|||
23280157|NCT02671435|64768923|FG013|Overall Study|Lost to Follow-up|2|||
23280158|NCT02671435|64768924|FG014|Overall Study|Lost to Follow-up|0|||
23280159|NCT02671435|64768910|FG000|Overall Study|Withdrawal by Subject|2|||
23280160|NCT02671435|64768911|FG001|Overall Study|Withdrawal by Subject|0|||
23280161|NCT02671435|64768912|FG002|Overall Study|Withdrawal by Subject|2|||
23280162|NCT02671435|64768913|FG003|Overall Study|Withdrawal by Subject|2|||
23280163|NCT02671435|64768914|FG004|Overall Study|Withdrawal by Subject|2|||
23280164|NCT02671435|64768915|FG005|Overall Study|Withdrawal by Subject|7|||
23280165|NCT02671435|64768916|FG006|Overall Study|Withdrawal by Subject|2|||
23280166|NCT02671435|64768917|FG007|Overall Study|Withdrawal by Subject|7|||
23280167|NCT02671435|64768918|FG008|Overall Study|Withdrawal by Subject|1|||
23280168|NCT02671435|64768919|FG009|Overall Study|Withdrawal by Subject|1|||
23280169|NCT02671435|64768920|FG010|Overall Study|Withdrawal by Subject|2|||
23372338|NCT02265510|65109906|FG004|Overall Study|Other|0|||
23372339|NCT02265510|65109907|FG005|Overall Study|Other|0|||
23372340|NCT02265510|65109908|FG006|Overall Study|Other|0|||
23372341|NCT02265510|65109909|FG007|Overall Study|Other|0|||
23372342|NCT02265510|65109910|FG008|Overall Study|Other|0|||
23372343|NCT02265510|65109911|FG009|Overall Study|Other|0|||
23603633|NCT02470806|65937436|FG001|Overall Study|Lack of Efficacy|15|||
23603634|NCT01262456|65937440|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
23603635|NCT01262456|65937441|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
23603636|NCT01262456|65937442|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
23603637|NCT01262456|65937440|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
23603638|NCT01262456|65937441|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
23603639|NCT01262456|65937442|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
23603640|NCT01262456|65937440|FG000|3-Month Double-Blind Period|Adverse Event|6|||
23603641|NCT01262456|65937441|FG001|3-Month Double-Blind Period|Adverse Event|4|||
23603642|NCT01262456|65937442|FG002|3-Month Double-Blind Period|Adverse Event|8|||
23603643|NCT01262456|65937440|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
23603644|NCT01262456|65937441|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
23603645|NCT01262456|65937442|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
23603646|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
23603647|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
23603648|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
23603649|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
23603650|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
23603651|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
23603652|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
23603653|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
23280170|NCT02671435|64768921|FG011|Overall Study|Withdrawal by Subject|4|||
23280171|NCT02671435|64768922|FG012|Overall Study|Withdrawal by Subject|4|||
23280172|NCT02671435|64768923|FG013|Overall Study|Withdrawal by Subject|4|||
23372344|NCT02265510|65109912|FG010|Overall Study|Other|0|||
23372345|NCT02265510|65109913|FG011|Overall Study|Other|0|||
23372346|NCT02265510|65109914|FG012|Overall Study|Other|0|||
23603654|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
23372347|NCT02265510|65109915|FG013|Overall Study|Other|0|||
23372348|NCT02265510|65109902|FG000|Overall Study|Study Terminated by Sponsor|0|||
23372349|NCT02265510|65109903|FG001|Overall Study|Study Terminated by Sponsor|0|||
23372350|NCT02265510|65109904|FG002|Overall Study|Study Terminated by Sponsor|0|||
23280173|NCT02671435|64768924|FG014|Overall Study|Withdrawal by Subject|2|||
23280174|NCT02671435|64768910|FG000|Overall Study|Un-specified|0|||
23372351|NCT02265510|65109905|FG003|Overall Study|Study Terminated by Sponsor|0|||
23372352|NCT02265510|65109906|FG004|Overall Study|Study Terminated by Sponsor|0|||
23372353|NCT02265510|65109907|FG005|Overall Study|Study Terminated by Sponsor|1|||
23372354|NCT02265510|65109908|FG006|Overall Study|Study Terminated by Sponsor|1|||
23372355|NCT02265510|65109909|FG007|Overall Study|Study Terminated by Sponsor|1|||
23372356|NCT02265510|65109910|FG008|Overall Study|Study Terminated by Sponsor|1|||
23372357|NCT02265510|65109911|FG009|Overall Study|Study Terminated by Sponsor|2|||
23372358|NCT02265510|65109912|FG010|Overall Study|Study Terminated by Sponsor|1|||
23372359|NCT02265510|65109913|FG011|Overall Study|Study Terminated by Sponsor|4|||
23372360|NCT02265510|65109914|FG012|Overall Study|Study Terminated by Sponsor|1|||
23372361|NCT02265510|65109915|FG013|Overall Study|Study Terminated by Sponsor|2|||
23372362|NCT00741611|65109916|FG000|Overall Study|Death|0|||
23372363|NCT00741611|65109917|FG001|Overall Study|Death|0|||
23280175|NCT02671435|64768911|FG001|Overall Study|Un-specified|0|||
23280176|NCT02671435|64768912|FG002|Overall Study|Un-specified|0|||
23280177|NCT02671435|64768913|FG003|Overall Study|Un-specified|0|||
23372364|NCT00741611|65109918|FG002|Overall Study|Death|1|||
23372365|NCT00741611|65109916|FG000|Overall Study|Withdrawal by Subject|0|||
23372366|NCT00741611|65109917|FG001|Overall Study|Withdrawal by Subject|2|||
23372367|NCT00741611|65109918|FG002|Overall Study|Withdrawal by Subject|2|||
23372368|NCT00325416|65109919|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
23372369|NCT00325416|65109920|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
23372370|NCT00325416|65109919|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
23372371|NCT00325416|65109920|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
23372372|NCT00325416|65109919|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
23372373|NCT00325416|65109920|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
23372374|NCT00325416|65109919|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
23372375|NCT00325416|65109920|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
23372376|NCT00325416|65109919|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
23372377|NCT00325416|65109920|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
23372378|NCT00325416|65109919|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
23372379|NCT00325416|65109920|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
23372380|NCT02669849|65109921|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
23372381|NCT02669849|65109922|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
23372382|NCT02669849|65109923|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
23372383|NCT02669849|65109921|FG000|Overall Study|Lost to Follow-up|1|||
23280178|NCT02671435|64768914|FG004|Overall Study|Un-specified|1|||
23280179|NCT02671435|64768915|FG005|Overall Study|Un-specified|3|||
23280180|NCT02671435|64768916|FG006|Overall Study|Un-specified|2|||
23280181|NCT02671435|64768917|FG007|Overall Study|Un-specified|3|||
23280182|NCT02671435|64768918|FG008|Overall Study|Un-specified|0|||
23280183|NCT02671435|64768919|FG009|Overall Study|Un-specified|5|||
23280184|NCT02671435|64768920|FG010|Overall Study|Un-specified|8|||
23280185|NCT02671435|64768921|FG011|Overall Study|Un-specified|4|||
23280186|NCT02671435|64768922|FG012|Overall Study|Un-specified|5|||
23280187|NCT02671435|64768923|FG013|Overall Study|Un-specified|9|||
23280188|NCT02671435|64768924|FG014|Overall Study|Un-specified|8|||
23280189|NCT04631562|64768925|FG000|Overall Study|Withdrawal by Subject|0|||
23280190|NCT04631562|64768926|FG001|Overall Study|Withdrawal by Subject|0|||
23280191|NCT04631562|64768927|FG002|Overall Study|Withdrawal by Subject|0|||
23280192|NCT04631562|64768928|FG003|Overall Study|Withdrawal by Subject|0|||
23280193|NCT04631562|64768929|FG004|Overall Study|Withdrawal by Subject|0|||
23280194|NCT04631562|64768930|FG005|Overall Study|Withdrawal by Subject|0|||
23280195|NCT04631562|64768931|FG006|Overall Study|Withdrawal by Subject|0|||
23280196|NCT04631562|64768932|FG007|Overall Study|Withdrawal by Subject|1|||
23280197|NCT04631562|64768933|FG008|Overall Study|Withdrawal by Subject|0|||
23372384|NCT02669849|65109922|FG001|Overall Study|Lost to Follow-up|0|||
23372385|NCT02669849|65109923|FG002|Overall Study|Lost to Follow-up|3|||
23372386|NCT02669849|65109921|FG000|Overall Study|Death|1|||
23372387|NCT02669849|65109922|FG001|Overall Study|Death|1|||
23372388|NCT02669849|65109923|FG002|Overall Study|Death|2|||
23372389|NCT02669849|65109921|FG000|Overall Study|Study terminated by sponsor|16|||
23372390|NCT02669849|65109922|FG001|Overall Study|Study terminated by sponsor|1|||
23280198|NCT04631562|64768925|FG000|Overall Study|Other|0|||
23280199|NCT04631562|64768926|FG001|Overall Study|Other|0|||
23280200|NCT04631562|64768927|FG002|Overall Study|Other|0|||
23280201|NCT04631562|64768928|FG003|Overall Study|Other|0|||
23280202|NCT04631562|64768929|FG004|Overall Study|Other|0|||
23280203|NCT04631562|64768930|FG005|Overall Study|Other|0|||
23280204|NCT04631562|64768931|FG006|Overall Study|Other|0|||
23280205|NCT04631562|64768932|FG007|Overall Study|Other|0|||
23372391|NCT02669849|65109923|FG002|Overall Study|Study terminated by sponsor|14|||
23372392|NCT02669849|65109921|FG000|Overall Study|Other|0|||
23372393|NCT02669849|65109922|FG001|Overall Study|Other|0|||
23372394|NCT02669849|65109923|FG002|Overall Study|Other|2|||
23372395|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
23372396|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
23372397|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
23372398|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
23372399|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
23372400|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
23372401|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
23372402|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
23372403|NCT03040726|65109929|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
23372404|NCT03040726|65109930|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
23372405|NCT02495389|65109931|FG000|Overall Study|Withdrawal by Subject|40|||
23372406|NCT00323063|65109932|FG000|Overall Study|Adverse Event|1|||
23372407|NCT00323063|65109933|FG001|Overall Study|Adverse Event|0|||
23372408|NCT00323063|65109932|FG000|Overall Study|brain mets discovered prior to treatment|1|||
23372409|NCT00323063|65109933|FG001|Overall Study|brain mets discovered prior to treatment|0|||
23372410|NCT00947544|65109934|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
23372411|NCT00947544|65109935|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
23372412|NCT00296517|65109936|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
23372413|NCT00296517|65109937|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
23372414|NCT00296517|65109936|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
23372415|NCT00296517|65109937|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
23372416|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
23372417|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
23372418|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
23372419|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
23372420|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
23372421|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
23372422|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
23372423|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
23372424|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
23372425|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
23372426|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
23372427|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
23372428|NCT00296517|65109936|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
23372429|NCT00296517|65109937|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
23372430|NCT03502798|65109938|FG000|Overall Study|equipment failure|0|||
23372431|NCT03502798|65109939|FG001|Overall Study|equipment failure|7|||
23372432|NCT01829347|65109940|FG000|VTI-210|Death|5|||
23372433|NCT01829347|65109941|FG001|VTI-210|Death|3|||
23372434|NCT01829347|65109940|FG000|VTI-210|Withdrawal by Subject|1|||
23372435|NCT01829347|65109941|FG001|VTI-210|Withdrawal by Subject|0|||
23372436|NCT01829347|65109940|FG000|VTI-210E|Death|2|||
23372437|NCT01829347|65109941|FG001|VTI-210E|Death|1|||
23372438|NCT01829347|65109940|FG000|VTI-210E|Study terminated prematurely|1|||
23372439|NCT01829347|65109941|FG001|VTI-210E|Study terminated prematurely|5|||
23372440|NCT00106002|65109942|FG000|Overall Study|Did not take any study drug|1|||
23372441|NCT00106002|65109942|FG000|Overall Study|Ineligible after Registration|1|||
23372442|NCT00529035|65109943|FG000|Overall Study|Withdrawal by Subject|1|||
23372443|NCT01663623|65109944|FG000|Overall Study|Adverse Event|3|||
23372444|NCT01663623|65109945|FG001|Overall Study|Adverse Event|7|||
23372445|NCT01663623|65109944|FG000|Overall Study|Lack of Efficacy|5|||
23372446|NCT01663623|65109945|FG001|Overall Study|Lack of Efficacy|6|||
23372447|NCT01663623|65109944|FG000|Overall Study|Protocol Violation|0|||
23372448|NCT01663623|65109945|FG001|Overall Study|Protocol Violation|1|||
23372449|NCT01663623|65109944|FG000|Overall Study|Other-Study closed/terminated|1|||
23372450|NCT01663623|65109945|FG001|Overall Study|Other-Study closed/terminated|1|||
23486438|NCT00470158|65524357|FG003|Overall Study|Protocol Violation|0|||
23486439|NCT00470158|65524358|FG004|Overall Study|Protocol Violation|0|||
23372451|NCT01663623|65109944|FG000|Overall Study|Physician Decision|1|||
23372452|NCT01663623|65109945|FG001|Overall Study|Physician Decision|4|||
23372453|NCT01663623|65109944|FG000|Overall Study|Withdrawal by Subject|2|||
23372454|NCT01663623|65109945|FG001|Overall Study|Withdrawal by Subject|1|||
23486440|NCT00596362|65524359|FG000|Overall Study|Progressive Disease|1|||
23372455|NCT03805841|65109948|FG000|Overall Study|Clinical Progression|2|||
23372456|NCT03805841|65109949|FG001|Overall Study|Clinical Progression|0|||
23372457|NCT03805841|65109950|FG002|Overall Study|Clinical Progression|0|||
23372458|NCT03805841|65109948|FG000|Overall Study|Death|0|||
23372459|NCT03805841|65109949|FG001|Overall Study|Death|3|||
23603655|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
23372460|NCT03805841|65109950|FG002|Overall Study|Death|1|||
23372461|NCT03805841|65109948|FG000|Overall Study|Lost to Follow-up|0|||
23372462|NCT03805841|65109949|FG001|Overall Study|Lost to Follow-up|0|||
23372463|NCT03805841|65109950|FG002|Overall Study|Lost to Follow-up|1|||
23372464|NCT03805841|65109948|FG000|Overall Study|Withdrawal by Subject|2|||
23372465|NCT03805841|65109949|FG001|Overall Study|Withdrawal by Subject|3|||
23372466|NCT03805841|65109950|FG002|Overall Study|Withdrawal by Subject|0|||
23372467|NCT03805841|65109948|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
23372468|NCT03805841|65109949|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
23372469|NCT03805841|65109950|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
23372470|NCT00984867|65109957|FG000|Overall Study|Adverse Event|3|||
23372471|NCT00984867|65109958|FG001|Overall Study|Adverse Event|7|||
23372472|NCT00984867|65109957|FG000|Overall Study|Death|1|||
23372473|NCT00984867|65109958|FG001|Overall Study|Death|0|||
23372474|NCT00984867|65109957|FG000|Overall Study|Withdrawal by Subject|13|||
23372475|NCT00984867|65109958|FG001|Overall Study|Withdrawal by Subject|4|||
23372476|NCT00984867|65109957|FG000|Overall Study|Lost to Follow-up|3|||
23372477|NCT00984867|65109958|FG001|Overall Study|Lost to Follow-up|4|||
23372478|NCT00984867|65109957|FG000|Overall Study|Poor/non-compliance|0|||
23372479|NCT00984867|65109958|FG001|Overall Study|Poor/non-compliance|1|||
23372480|NCT00984867|65109957|FG000|Overall Study|Subject no longer meets study criteria|1|||
23372481|NCT00984867|65109958|FG001|Overall Study|Subject no longer meets study criteria|1|||
23372482|NCT00984867|65109957|FG000|Overall Study|site closing|1|||
23372483|NCT00984867|65109958|FG001|Overall Study|site closing|0|||
23372484|NCT00984867|65109957|FG000|Overall Study|lack of efficacy and subject compliance|1|||
23372485|NCT00984867|65109958|FG001|Overall Study|lack of efficacy and subject compliance|0|||
23372486|NCT00846365|65109959|FG000|Overall Study|Adverse Event|20|||
23372487|NCT00846365|65109960|FG001|Overall Study|Adverse Event|30|||
23372488|NCT00846365|65109961|FG002|Overall Study|Adverse Event|11|||
23372489|NCT00846365|65109959|FG000|Overall Study|Protocol Violation|5|||
23372490|NCT00846365|65109960|FG001|Overall Study|Protocol Violation|4|||
23372491|NCT00846365|65109961|FG002|Overall Study|Protocol Violation|0|||
23372492|NCT00846365|65109959|FG000|Overall Study|Lost to Follow-up|8|||
23372493|NCT00846365|65109960|FG001|Overall Study|Lost to Follow-up|2|||
23372494|NCT00846365|65109961|FG002|Overall Study|Lost to Follow-up|5|||
23372495|NCT00846365|65109959|FG000|Overall Study|Withdrawal by Subject|11|||
23372496|NCT00846365|65109960|FG001|Overall Study|Withdrawal by Subject|11|||
23372497|NCT00846365|65109961|FG002|Overall Study|Withdrawal by Subject|9|||
23372498|NCT00846365|65109959|FG000|Overall Study|Pregnancy|1|||
23372499|NCT00846365|65109960|FG001|Overall Study|Pregnancy|0|||
23372500|NCT00846365|65109961|FG002|Overall Study|Pregnancy|0|||
23372501|NCT00846365|65109959|FG000|Overall Study|Lack of Efficacy|1|||
23372502|NCT00846365|65109960|FG001|Overall Study|Lack of Efficacy|1|||
23372503|NCT00846365|65109961|FG002|Overall Study|Lack of Efficacy|2|||
23372504|NCT00846365|65109959|FG000|Overall Study|Other|9|||
23372505|NCT00846365|65109960|FG001|Overall Study|Other|1|||
23372506|NCT00846365|65109961|FG002|Overall Study|Other|6|||
23372507|NCT00239720|65109962|FG000|Overall Study|Adverse Event|1|||
23372508|NCT00239720|65109963|FG001|Overall Study|Adverse Event|0|||
23372509|NCT00239720|65109962|FG000|Overall Study|Lost to Follow-up|0|||
23372510|NCT00239720|65109963|FG001|Overall Study|Lost to Follow-up|1|||
23372511|NCT01094288|65109964|FG000|Overall Study|Adverse Event|0|||
23372512|NCT01094288|65109965|FG001|Overall Study|Adverse Event|3|||
23372513|NCT01094288|65109966|FG002|Overall Study|Adverse Event|1|||
23372514|NCT01094288|65109967|FG003|Overall Study|Adverse Event|1|||
23372515|NCT01094288|65109968|FG004|Overall Study|Adverse Event|0|||
23372516|NCT01094288|65109969|FG005|Overall Study|Adverse Event|0|||
23372517|NCT01094288|65109970|FG006|Overall Study|Adverse Event|0|||
23486441|NCT02445391|65524360|FG000|Overall Study|No active protocol treatment|3|||
23486442|NCT02445391|65524361|FG001|Overall Study|No active protocol treatment|0|||
23603656|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
23372518|NCT01094288|65109971|FG007|Overall Study|Adverse Event|0|||
23372519|NCT01094288|65109964|FG000|Overall Study|Withdrawal by Subject|0|||
23372520|NCT01094288|65109965|FG001|Overall Study|Withdrawal by Subject|1|||
23372521|NCT01094288|65109966|FG002|Overall Study|Withdrawal by Subject|2|||
23372522|NCT01094288|65109967|FG003|Overall Study|Withdrawal by Subject|0|||
23372523|NCT01094288|65109968|FG004|Overall Study|Withdrawal by Subject|0|||
23372524|NCT01094288|65109969|FG005|Overall Study|Withdrawal by Subject|0|||
23372525|NCT01094288|65109970|FG006|Overall Study|Withdrawal by Subject|0|||
23372526|NCT01094288|65109971|FG007|Overall Study|Withdrawal by Subject|2|||
23372527|NCT01094288|65109964|FG000|Overall Study|Initiation of Alternative Therapy|0|||
23372528|NCT01094288|65109965|FG001|Overall Study|Initiation of Alternative Therapy|0|||
23372529|NCT01094288|65109966|FG002|Overall Study|Initiation of Alternative Therapy|1|||
23372530|NCT01094288|65109967|FG003|Overall Study|Initiation of Alternative Therapy|0|||
23372531|NCT01094288|65109968|FG004|Overall Study|Initiation of Alternative Therapy|0|||
23372532|NCT01094288|65109969|FG005|Overall Study|Initiation of Alternative Therapy|0|||
23486443|NCT02445391|65524362|FG002|Overall Study|No active protocol treatment|0|||
23486444|NCT02445391|65524360|FG000|Overall Study|Adverse Event|0|||
23486445|NCT02445391|65524361|FG001|Overall Study|Adverse Event|21|||
23486446|NCT02445391|65524362|FG002|Overall Study|Adverse Event|12|||
23486447|NCT02445391|65524360|FG000|Overall Study|Alternative therapy|0|||
23486448|NCT02445391|65524361|FG001|Overall Study|Alternative therapy|0|||
23486449|NCT02445391|65524362|FG002|Overall Study|Alternative therapy|1|||
23486450|NCT02445391|65524360|FG000|Overall Study|Disease progression|0|||
23486451|NCT02445391|65524361|FG001|Overall Study|Disease progression|7|||
23486452|NCT02445391|65524362|FG002|Overall Study|Disease progression|22|||
23486453|NCT02445391|65524360|FG000|Overall Study|Complicating disease|0|||
23486454|NCT02445391|65524361|FG001|Overall Study|Complicating disease|2|||
23486455|NCT02445391|65524362|FG002|Overall Study|Complicating disease|1|||
23486456|NCT02445391|65524360|FG000|Overall Study|Withdrawal by Subject|0|||
23486457|NCT02445391|65524361|FG001|Overall Study|Withdrawal by Subject|4|||
23486458|NCT02445391|65524362|FG002|Overall Study|Withdrawal by Subject|9|||
23486459|NCT02445391|65524360|FG000|Overall Study|Financial issue|0|||
23486460|NCT02445391|65524361|FG001|Overall Study|Financial issue|0|||
23486461|NCT02445391|65524362|FG002|Overall Study|Financial issue|2|||
23486462|NCT02445391|65524360|FG000|Overall Study|Still on treatment|0|||
23486463|NCT02445391|65524361|FG001|Overall Study|Still on treatment|7|||
23486464|NCT02445391|65524362|FG002|Overall Study|Still on treatment|16|||
23486465|NCT02445391|65524360|FG000|Overall Study|Not start protocol therapy|0|||
23486466|NCT02445391|65524361|FG001|Overall Study|Not start protocol therapy|12|||
23486467|NCT02445391|65524362|FG002|Overall Study|Not start protocol therapy|9|||
23486468|NCT02923427|65524364|FG000|Overall Study|convert to laparatomy|2|||
23486469|NCT02923427|65524365|FG001|Overall Study|convert to laparatomy|2|||
23486470|NCT02923427|65524364|FG000|Overall Study|destaturation|1|||
23486471|NCT02923427|65524365|FG001|Overall Study|destaturation|0|||
23486472|NCT02923427|65524364|FG000|Overall Study|can not replace LMA|1|||
23486473|NCT02923427|65524365|FG001|Overall Study|can not replace LMA|0|||
23486474|NCT00301821|65524366|FG000|Overall Study|Ineligible|25|||
23486475|NCT00301821|65524366|FG000|Overall Study|Cancel|1|||
23486476|NCT00989573|65524367|FG000|Overall Study|Adverse Event|8|||
23486477|NCT00989573|65524368|FG001|Overall Study|Adverse Event|12|||
23486478|NCT00989573|65524369|FG002|Overall Study|Adverse Event|4|||
23486479|NCT00989573|65524367|FG000|Overall Study|Physician Decision|0|||
23486480|NCT00989573|65524368|FG001|Overall Study|Physician Decision|2|||
23486481|NCT00989573|65524369|FG002|Overall Study|Physician Decision|0|||
23486482|NCT00989573|65524367|FG000|Overall Study|Protocol Violation|1|||
23486483|NCT00989573|65524368|FG001|Overall Study|Protocol Violation|1|||
23486484|NCT00989573|65524369|FG002|Overall Study|Protocol Violation|1|||
23486485|NCT00989573|65524367|FG000|Overall Study|Withdrawal by Subject|4|||
23486486|NCT00989573|65524368|FG001|Overall Study|Withdrawal by Subject|7|||
23486487|NCT00989573|65524369|FG002|Overall Study|Withdrawal by Subject|3|||
23486488|NCT04250714|65524377|FG000|Overall Study|Treatment - withdrawal by subject|14|||
23486489|NCT04250714|65524377|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
23486490|NCT04250714|65524377|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
23486491|NCT04250714|65524377|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
23486492|NCT04250714|65524377|FG000|Overall Study|Treatment - Death|1|||
23486493|NCT04250714|65524377|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
23486494|NCT04250714|65524377|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
23486495|NCT04250714|65524377|FG000|Overall Study|Attempt|2|||
23486496|NCT04250714|65524377|FG000|Overall Study|Intent|7|||
23486497|NCT02898116|65524379|FG000|Overall Study|Adverse Event|1|||
23486498|NCT02898116|65524379|FG000|Overall Study|Progressive disease|1|||
23486499|NCT02131532|65524380|FG000|Overall Study|Withdrawal by Subject|1|||
23486500|NCT02131532|65524380|FG000|Overall Study|Physician Decision|1|||
23486501|NCT02131532|65524380|FG000|Overall Study|Other health conditions|2|||
23486502|NCT00679055|65524388|FG000|Overall Study|Adverse Event|0|||
23486503|NCT00679055|65524389|FG001|Overall Study|Adverse Event|1|||
23486504|NCT00679055|65524388|FG000|Overall Study|Other|0|||
23486505|NCT00679055|65524389|FG001|Overall Study|Other|3|||
23486506|NCT00679055|65524388|FG000|Overall Study|Study Terminated|2|||
23486507|NCT00679055|65524389|FG001|Overall Study|Study Terminated|1|||
23486508|NCT01002482|65524393|FG000|Overall Study|Withdrawal by Subject|14|||
23486509|NCT01002482|65524394|FG001|Overall Study|Withdrawal by Subject|21|||
23486510|NCT01002482|65524393|FG000|Overall Study|Included twice|1|||
23486511|NCT01002482|65524394|FG001|Overall Study|Included twice|0|||
23486512|NCT00566501|65524395|FG000|Overall Study|Adverse Event|68|||
23486513|NCT00566501|65524396|FG001|Overall Study|Adverse Event|59|||
23486514|NCT00566501|65524395|FG000|Overall Study|Medication Non-compliance|5|||
23486515|NCT00566501|65524396|FG001|Overall Study|Medication Non-compliance|0|||
23486516|NCT00566501|65524395|FG000|Overall Study|Protocol Violation|2|||
23486517|NCT00566501|65524396|FG001|Overall Study|Protocol Violation|2|||
23486518|NCT00566501|65524395|FG000|Overall Study|Request of Investigator or Sponsor|6|||
23486519|NCT00566501|65524396|FG001|Overall Study|Request of Investigator or Sponsor|7|||
23486520|NCT00566501|65524395|FG000|Overall Study|Withdrawal by Subject|33|||
23486521|NCT00566501|65524396|FG001|Overall Study|Withdrawal by Subject|30|||
23486522|NCT00566501|65524395|FG000|Overall Study|Lack of Efficacy|8|||
23486523|NCT00566501|65524396|FG001|Overall Study|Lack of Efficacy|3|||
23486524|NCT00566501|65524395|FG000|Overall Study|Other|25|||
23486525|NCT00566501|65524396|FG001|Overall Study|Other|21|||
23486526|NCT01912963|65524397|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
23486527|NCT01912963|65524398|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
23486528|NCT01912963|65524399|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
23486529|NCT01912963|65524397|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
23486530|NCT01912963|65524398|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
23486531|NCT01912963|65524399|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
23486532|NCT01912963|65524397|FG000|Overall Study|Adverse Event|0|||
23486533|NCT01912963|65524398|FG001|Overall Study|Adverse Event|1|||
23486534|NCT01912963|65524399|FG002|Overall Study|Adverse Event|1|||
23486535|NCT01912963|65524397|FG000|Overall Study|Withdrawal by Subject|0|||
23486536|NCT01912963|65524398|FG001|Overall Study|Withdrawal by Subject|1|||
23486537|NCT01912963|65524399|FG002|Overall Study|Withdrawal by Subject|0|||
23486538|NCT01912963|65524397|FG000|Overall Study|Sought treatment locally|0|||
23486539|NCT01912963|65524398|FG001|Overall Study|Sought treatment locally|1|||
23486540|NCT01912963|65524399|FG002|Overall Study|Sought treatment locally|0|||
23486541|NCT04123665|65524400|FG000|Overall Study|Withdrawal by Subject|7|||
23486542|NCT04123665|65524401|FG001|Overall Study|Withdrawal by Subject|0|||
23486543|NCT04123665|65524400|FG000|Overall Study|Lost to Follow-up|1|||
23486544|NCT04123665|65524401|FG001|Overall Study|Lost to Follow-up|0|||
23486545|NCT03489551|65524402|FG000|Overall Study|Withdrawal by Subject|2|||
23486546|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Adverse Event|10|||
23486547|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Adverse Event|0|||
23486548|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
23486549|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
23486550|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
23486551|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
23486552|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
23486553|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
23486554|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
23486555|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
23486556|NCT02787551|65524408|FG000|Core Period: 26 Weeks|Other than specified|3|||
23486557|NCT02787551|65524409|FG001|Core Period: 26 Weeks|Other than specified|1|||
23486558|NCT02787551|65524408|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
23486559|NCT02787551|65524409|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
23486560|NCT02787551|65524408|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
23486561|NCT02787551|65524409|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
23486562|NCT02787551|65524408|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
23486563|NCT02787551|65524409|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
23486564|NCT01009281|65524410|FG000|Overall Study|Administrative problems|7|||
23486565|NCT01610271|65527198|FG000|Overall Study|Surgery not complete|0|||
23486566|NCT01610271|65527199|FG001|Overall Study|Surgery not complete|1|||
23486567|NCT01610271|65527198|FG000|Overall Study|Prosthesis not implanted|2|||
23486568|NCT01610271|65527199|FG001|Overall Study|Prosthesis not implanted|3|||
23486569|NCT03611010|65527200|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
23486570|NCT03611010|65527201|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
23486571|NCT03611010|65527202|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
23486572|NCT03611010|65527203|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
23486573|NCT03488927|65527204|FG000|Overall Study|Withdrawal by Subject|44|||
23486574|NCT03488927|65527205|FG001|Overall Study|Withdrawal by Subject|118|||
23486575|NCT03488927|65527206|FG002|Overall Study|Withdrawal by Subject|217|||
23486576|NCT01725308|65527213|FG000|Treatment Period I|Did Not Receive Drug|1|||
23486577|NCT01725308|65527214|FG001|Treatment Period I|Did Not Receive Drug|0|||
23486578|NCT01725308|65527215|FG002|Treatment Period I|Did Not Receive Drug|0|||
23486579|NCT01725308|65527213|FG000|Treatment Period I|Adverse Event|5|||
23486580|NCT01725308|65527214|FG001|Treatment Period I|Adverse Event|4|||
23486581|NCT01725308|65527215|FG002|Treatment Period I|Adverse Event|21|||
23486582|NCT01725308|65527213|FG000|Treatment Period I|Insufficient Response|7|||
23486583|NCT01725308|65527214|FG001|Treatment Period I|Insufficient Response|0|||
23486584|NCT01725308|65527215|FG002|Treatment Period I|Insufficient Response|5|||
23280206|NCT04631562|64768933|FG008|Overall Study|Other|1|||
23280207|NCT04631562|64768925|FG000|Overall Study|Lost to Follow-up|0|||
23486585|NCT01725308|65527213|FG000|Treatment Period I|Worsening of the Target Disease|8|||
23280208|NCT04631562|64768926|FG001|Overall Study|Lost to Follow-up|0|||
23486586|NCT01725308|65527214|FG001|Treatment Period I|Worsening of the Target Disease|0|||
23603657|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
23280209|NCT04631562|64768927|FG002|Overall Study|Lost to Follow-up|0|||
23280210|NCT04631562|64768928|FG003|Overall Study|Lost to Follow-up|1|||
23280211|NCT04631562|64768929|FG004|Overall Study|Lost to Follow-up|0|||
23486587|NCT01725308|65527215|FG002|Treatment Period I|Worsening of the Target Disease|2|||
23486588|NCT01725308|65527213|FG000|Treatment Period I|Changes in the Episodes|3|||
23486589|NCT01725308|65527214|FG001|Treatment Period I|Changes in the Episodes|0|||
23486590|NCT01725308|65527215|FG002|Treatment Period I|Changes in the Episodes|2|||
23486591|NCT01725308|65527213|FG000|Treatment Period I|Withdrawal of Consent|12|||
23486592|NCT01725308|65527214|FG001|Treatment Period I|Withdrawal of Consent|7|||
23486593|NCT01725308|65527215|FG002|Treatment Period I|Withdrawal of Consent|5|||
23486594|NCT01725308|65527213|FG000|Treatment Period I|Lost to Follow-up|3|||
23280212|NCT04631562|64768930|FG005|Overall Study|Lost to Follow-up|0|||
23280213|NCT04631562|64768931|FG006|Overall Study|Lost to Follow-up|0|||
23280214|NCT04631562|64768932|FG007|Overall Study|Lost to Follow-up|0|||
23280215|NCT04631562|64768933|FG008|Overall Study|Lost to Follow-up|0|||
23486595|NCT01725308|65527214|FG001|Treatment Period I|Lost to Follow-up|2|||
23486596|NCT01725308|65527215|FG002|Treatment Period I|Lost to Follow-up|2|||
23486597|NCT01725308|65527213|FG000|Treatment Period I|Protocol Deviations|3|||
23486598|NCT01725308|65527214|FG001|Treatment Period I|Protocol Deviations|1|||
23486599|NCT01725308|65527215|FG002|Treatment Period I|Protocol Deviations|1|||
23486600|NCT01725308|65527213|FG000|Treatment Period I|Miscellaneous|2|||
23486601|NCT01725308|65527214|FG001|Treatment Period I|Miscellaneous|0|||
23486602|NCT01725308|65527215|FG002|Treatment Period I|Miscellaneous|3|||
23486603|NCT01725308|65527213|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
23486604|NCT01725308|65527214|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
23486605|NCT01725308|65527215|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
23486606|NCT01725308|65527213|FG000|Treatment Period II|Did Not Receive Drug|4|||
23486607|NCT01725308|65527214|FG001|Treatment Period II|Did Not Receive Drug|0|||
23280216|NCT04631562|64768925|FG000|Overall Study|Adverse Event|0|||
23280217|NCT04631562|64768926|FG001|Overall Study|Adverse Event|0|||
23486608|NCT01725308|65527215|FG002|Treatment Period II|Did Not Receive Drug|0|||
23486609|NCT01725308|65527213|FG000|Treatment Period II|Adverse Event|13|||
23486610|NCT01725308|65527214|FG001|Treatment Period II|Adverse Event|8|||
23486611|NCT01725308|65527215|FG002|Treatment Period II|Adverse Event|20|||
23486612|NCT01725308|65527213|FG000|Treatment Period II|Insufficient Response|2|||
23486613|NCT01725308|65527214|FG001|Treatment Period II|Insufficient Response|4|||
23486614|NCT01725308|65527215|FG002|Treatment Period II|Insufficient Response|6|||
23486615|NCT01725308|65527213|FG000|Treatment Period II|Worsening of the Target Disease|1|||
23486616|NCT01725308|65527214|FG001|Treatment Period II|Worsening of the Target Disease|4|||
23486617|NCT01725308|65527215|FG002|Treatment Period II|Worsening of the Target Disease|2|||
23486618|NCT01725308|65527213|FG000|Treatment Period II|Changes in the Episodes|1|||
23486619|NCT01725308|65527214|FG001|Treatment Period II|Changes in the Episodes|0|||
23486620|NCT01725308|65527215|FG002|Treatment Period II|Changes in the Episodes|5|||
23486621|NCT01725308|65527213|FG000|Treatment Period II|Withdrawal of Consent|28|||
23486622|NCT01725308|65527214|FG001|Treatment Period II|Withdrawal of Consent|2|||
23486623|NCT01725308|65527215|FG002|Treatment Period II|Withdrawal of Consent|16|||
23486624|NCT01725308|65527213|FG000|Treatment Period II|Lost to Follow-up|1|||
23486625|NCT01725308|65527214|FG001|Treatment Period II|Lost to Follow-up|5|||
23486626|NCT01725308|65527215|FG002|Treatment Period II|Lost to Follow-up|3|||
23486627|NCT01725308|65527213|FG000|Treatment Period II|Protocol Deviations|0|||
23486628|NCT01725308|65527214|FG001|Treatment Period II|Protocol Deviations|0|||
23486629|NCT01725308|65527215|FG002|Treatment Period II|Protocol Deviations|1|||
23486630|NCT01725308|65527213|FG000|Treatment Period II|Miscellaneous|5|||
23486631|NCT01725308|65527214|FG001|Treatment Period II|Miscellaneous|3|||
23486632|NCT01725308|65527215|FG002|Treatment Period II|Miscellaneous|7|||
23486633|NCT00744471|65527220|FG000|Overall Study|Randomized but not treated|1|||
23486634|NCT00744471|65527221|FG001|Overall Study|Randomized but not treated|1|||
23486635|NCT00744471|65527222|FG002|Overall Study|Randomized but not treated|4|||
23486636|NCT00744471|65527223|FG003|Overall Study|Randomized but not treated|0|||
23486637|NCT00744471|65527220|FG000|Overall Study|Death|0|||
23486638|NCT00744471|65527221|FG001|Overall Study|Death|0|||
23486639|NCT00744471|65527222|FG002|Overall Study|Death|0|||
23486640|NCT00744471|65527223|FG003|Overall Study|Death|1|||
23486641|NCT00744471|65527220|FG000|Overall Study|Adverse Event|6|||
23486642|NCT00744471|65527221|FG001|Overall Study|Adverse Event|7|||
23486643|NCT00744471|65527222|FG002|Overall Study|Adverse Event|5|||
23486644|NCT00744471|65527223|FG003|Overall Study|Adverse Event|9|||
23486645|NCT00744471|65527220|FG000|Overall Study|Withdrawal by Subject|9|||
23486646|NCT00744471|65527221|FG001|Overall Study|Withdrawal by Subject|9|||
23486647|NCT00744471|65527222|FG002|Overall Study|Withdrawal by Subject|15|||
23486648|NCT00744471|65527223|FG003|Overall Study|Withdrawal by Subject|12|||
23486649|NCT00744471|65527220|FG000|Overall Study|Protocol Violation|1|||
23486650|NCT00744471|65527221|FG001|Overall Study|Protocol Violation|4|||
23486651|NCT00744471|65527222|FG002|Overall Study|Protocol Violation|1|||
23486652|NCT00744471|65527223|FG003|Overall Study|Protocol Violation|2|||
23486653|NCT00744471|65527220|FG000|Overall Study|Entered extension study|41|||
23486654|NCT00744471|65527221|FG001|Overall Study|Entered extension study|84|||
23486655|NCT00744471|65527222|FG002|Overall Study|Entered extension study|100|||
23486656|NCT00744471|65527223|FG003|Overall Study|Entered extension study|91|||
23486657|NCT00744471|65527220|FG000|Overall Study|Other|2|||
23486658|NCT00744471|65527221|FG001|Overall Study|Other|3|||
23372533|NCT01094288|65109970|FG006|Overall Study|Initiation of Alternative Therapy|0|||
23372534|NCT01094288|65109971|FG007|Overall Study|Initiation of Alternative Therapy|0|||
23372535|NCT01094288|65109964|FG000|Overall Study|Reason not Specified|2|||
23372536|NCT01094288|65109965|FG001|Overall Study|Reason not Specified|3|||
23372537|NCT01094288|65109966|FG002|Overall Study|Reason not Specified|0|||
23372538|NCT01094288|65109967|FG003|Overall Study|Reason not Specified|1|||
23372539|NCT01094288|65109968|FG004|Overall Study|Reason not Specified|0|||
23372540|NCT01094288|65109969|FG005|Overall Study|Reason not Specified|0|||
23372541|NCT01094288|65109970|FG006|Overall Study|Reason not Specified|0|||
23372542|NCT01094288|65109971|FG007|Overall Study|Reason not Specified|0|||
23372543|NCT01094288|65109964|FG000|Overall Study|Ongoing Participants|0|||
23372544|NCT01094288|65109965|FG001|Overall Study|Ongoing Participants|3|||
23372545|NCT01094288|65109966|FG002|Overall Study|Ongoing Participants|0|||
23372546|NCT01094288|65109967|FG003|Overall Study|Ongoing Participants|0|||
23372547|NCT01094288|65109968|FG004|Overall Study|Ongoing Participants|0|||
23372548|NCT01094288|65109969|FG005|Overall Study|Ongoing Participants|0|||
23372549|NCT01094288|65109970|FG006|Overall Study|Ongoing Participants|0|||
23372550|NCT01094288|65109971|FG007|Overall Study|Ongoing Participants|0|||
23372551|NCT00003537|65109979|FG000|Overall Study|Not evalauable|1|||
23372552|NCT03093181|65109980|FG000|Overall Study|Withdrawal by Subject|2|||
23486659|NCT00744471|65527222|FG002|Overall Study|Other|6|||
23486660|NCT00744471|65527223|FG003|Overall Study|Other|2|||
23486661|NCT00744471|65527220|FG000|Overall Study|Lack of Efficacy|83|||
23486662|NCT00744471|65527221|FG001|Overall Study|Lack of Efficacy|37|||
23486663|NCT00744471|65527222|FG002|Overall Study|Lack of Efficacy|19|||
23486664|NCT00744471|65527223|FG003|Overall Study|Lack of Efficacy|31|||
23280218|NCT04631562|64768927|FG002|Overall Study|Adverse Event|0|||
23280219|NCT04631562|64768928|FG003|Overall Study|Adverse Event|0|||
23280220|NCT04631562|64768929|FG004|Overall Study|Adverse Event|0|||
23280221|NCT04631562|64768930|FG005|Overall Study|Adverse Event|0|||
23280222|NCT04631562|64768931|FG006|Overall Study|Adverse Event|1|||
23280223|NCT04631562|64768932|FG007|Overall Study|Adverse Event|0|||
23280224|NCT04631562|64768933|FG008|Overall Study|Adverse Event|0|||
23280225|NCT00804856|64768934|FG000|Overall Study|Progressive Disease|3|||
23280226|NCT00804856|64768935|FG001|Overall Study|Progressive Disease|2|||
23280227|NCT00804856|64768936|FG002|Overall Study|Progressive Disease|4|||
23280228|NCT00804856|64768937|FG003|Overall Study|Progressive Disease|6|||
23280229|NCT00804856|64768938|FG004|Overall Study|Progressive Disease|4|||
23280230|NCT00804856|64768939|FG005|Overall Study|Progressive Disease|1|||
23280231|NCT00804856|64768940|FG006|Overall Study|Progressive Disease|8|||
23280232|NCT00804856|64768941|FG007|Overall Study|Progressive Disease|2|||
23280233|NCT00804856|64768942|FG008|Overall Study|Progressive Disease|4|||
23280234|NCT00804856|64768943|FG009|Overall Study|Progressive Disease|5|||
23280235|NCT00804856|64768944|FG010|Overall Study|Progressive Disease|12|||
23280236|NCT00804856|64768945|FG011|Overall Study|Progressive Disease|2|||
23280237|NCT00804856|64768946|FG012|Overall Study|Progressive Disease|2|||
23280238|NCT00804856|64768947|FG013|Overall Study|Progressive Disease|26|||
23280239|NCT00804856|64768948|FG014|Overall Study|Progressive Disease|20|||
23280240|NCT00804856|64768934|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280241|NCT00804856|64768935|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280242|NCT00804856|64768936|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280243|NCT00804856|64768937|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280244|NCT00804856|64768938|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23280245|NCT00804856|64768939|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280246|NCT00804856|64768940|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280247|NCT00804856|64768941|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280248|NCT00804856|64768942|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280249|NCT00804856|64768943|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280250|NCT00804856|64768944|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280251|NCT00804856|64768945|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280252|NCT00804856|64768946|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280253|NCT00804856|64768947|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
23280254|NCT00804856|64768948|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
23280255|NCT00804856|64768934|FG000|Overall Study|Other Adverse Event|1|||
23280256|NCT00804856|64768935|FG001|Overall Study|Other Adverse Event|1|||
23280257|NCT00804856|64768936|FG002|Overall Study|Other Adverse Event|1|||
23280258|NCT00804856|64768937|FG003|Overall Study|Other Adverse Event|2|||
23280259|NCT00804856|64768938|FG004|Overall Study|Other Adverse Event|2|||
23280260|NCT00804856|64768939|FG005|Overall Study|Other Adverse Event|1|||
23280261|NCT00804856|64768940|FG006|Overall Study|Other Adverse Event|3|||
23280262|NCT00804856|64768941|FG007|Overall Study|Other Adverse Event|0|||
23280263|NCT00804856|64768942|FG008|Overall Study|Other Adverse Event|0|||
23280264|NCT00804856|64768943|FG009|Overall Study|Other Adverse Event|1|||
23280265|NCT00804856|64768944|FG010|Overall Study|Other Adverse Event|5|||
23280266|NCT00804856|64768945|FG011|Overall Study|Other Adverse Event|2|||
23280267|NCT00804856|64768946|FG012|Overall Study|Other Adverse Event|0|||
23486665|NCT00744471|65527220|FG000|Overall Study|Lost to Follow-up|0|||
23280268|NCT00804856|64768947|FG013|Overall Study|Other Adverse Event|6|||
23280269|NCT00804856|64768948|FG014|Overall Study|Other Adverse Event|13|||
23280270|NCT00804856|64768934|FG000|Overall Study|Non compliance with protocol|0|||
23280271|NCT00804856|64768935|FG001|Overall Study|Non compliance with protocol|0|||
23280272|NCT00804856|64768936|FG002|Overall Study|Non compliance with protocol|0|||
23280273|NCT00804856|64768937|FG003|Overall Study|Non compliance with protocol|0|||
23280274|NCT00804856|64768938|FG004|Overall Study|Non compliance with protocol|0|||
23280275|NCT00804856|64768939|FG005|Overall Study|Non compliance with protocol|0|||
23280276|NCT00804856|64768940|FG006|Overall Study|Non compliance with protocol|0|||
23280277|NCT00804856|64768941|FG007|Overall Study|Non compliance with protocol|0|||
23280278|NCT00804856|64768942|FG008|Overall Study|Non compliance with protocol|0|||
23486666|NCT00744471|65527221|FG001|Overall Study|Lost to Follow-up|0|||
23486667|NCT00744471|65527222|FG002|Overall Study|Lost to Follow-up|2|||
23486668|NCT00744471|65527223|FG003|Overall Study|Lost to Follow-up|0|||
23486669|NCT04597918|65527224|FG000|Overall Study|Withdrawal by Subject|6|||
23486670|NCT04597918|65527224|FG000|Overall Study|Lost to Follow-up|3|||
23486671|NCT04597918|65527224|FG000|Overall Study|Death|1|||
23486672|NCT04073368|65527225|FG000|Overall Study|Adverse Event|2|||
23486673|NCT04073368|65527226|FG001|Overall Study|Adverse Event|0|||
23486674|NCT04073368|65527227|FG002|Overall Study|Adverse Event|1|||
23486675|NCT04073368|65527228|FG003|Overall Study|Adverse Event|1|||
23486676|NCT04073368|65527225|FG000|Overall Study|Withdrawal by Subject|2|||
23486677|NCT04073368|65527226|FG001|Overall Study|Withdrawal by Subject|2|||
23486678|NCT04073368|65527227|FG002|Overall Study|Withdrawal by Subject|1|||
23486679|NCT04073368|65527228|FG003|Overall Study|Withdrawal by Subject|1|||
23486680|NCT04073368|65527225|FG000|Overall Study|Lost to Follow-up|1|||
23486681|NCT04073368|65527226|FG001|Overall Study|Lost to Follow-up|1|||
23486682|NCT04073368|65527227|FG002|Overall Study|Lost to Follow-up|1|||
23486683|NCT04073368|65527228|FG003|Overall Study|Lost to Follow-up|0|||
23486684|NCT04073368|65527225|FG000|Overall Study|Protocol Violation|0|||
23486685|NCT04073368|65527226|FG001|Overall Study|Protocol Violation|1|||
23486686|NCT04073368|65527227|FG002|Overall Study|Protocol Violation|0|||
23486687|NCT04073368|65527228|FG003|Overall Study|Protocol Violation|0|||
23486688|NCT04073368|65527225|FG000|Overall Study|Subject noncompliance|7|||
23486689|NCT04073368|65527226|FG001|Overall Study|Subject noncompliance|4|||
23486690|NCT04073368|65527227|FG002|Overall Study|Subject noncompliance|0|||
23280279|NCT00804856|64768943|FG009|Overall Study|Non compliance with protocol|0|||
23280280|NCT00804856|64768944|FG010|Overall Study|Non compliance with protocol|0|||
23280281|NCT00804856|64768945|FG011|Overall Study|Non compliance with protocol|0|||
23280282|NCT00804856|64768946|FG012|Overall Study|Non compliance with protocol|0|||
23280283|NCT00804856|64768947|FG013|Overall Study|Non compliance with protocol|2|||
23280284|NCT00804856|64768948|FG014|Overall Study|Non compliance with protocol|0|||
23486691|NCT04073368|65527228|FG003|Overall Study|Subject noncompliance|0|||
23486692|NCT00761579|65527229|FG000|Overall Study|Adverse Event|10|||
23486693|NCT00761579|65527229|FG000|Overall Study|Death|2|||
23486694|NCT00761579|65527229|FG000|Overall Study|Lack of Efficacy|21|||
23486695|NCT00761579|65527229|FG000|Overall Study|Lost to Follow-up|16|||
23486696|NCT00761579|65527229|FG000|Overall Study|Pregnancy|1|||
23486697|NCT00761579|65527229|FG000|Overall Study|Withdrawal by Subject|34|||
23486698|NCT00761579|65527229|FG000|Overall Study|Lack of compliance|2|||
23486699|NCT00761579|65527229|FG000|Overall Study|Protocol deviation|1|||
23486700|NCT00761579|65527229|FG000|Overall Study|Drug overdose|1|||
23486701|NCT00761579|65527229|FG000|Overall Study|Aggravation of depression|1|||
23486702|NCT00761579|65527229|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
23486703|NCT00761579|65527229|FG000|Overall Study|Lost survey form|1|||
23486704|NCT00761579|65527229|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
23486705|NCT00072176|65527230|FG000|Overall Study|Withdrawal by Subject|1|||
23486706|NCT00072176|65527231|FG001|Overall Study|Withdrawal by Subject|0|||
23486707|NCT00072176|65527230|FG000|Overall Study|Protocol Violation|0|||
23486708|NCT00072176|65527231|FG001|Overall Study|Protocol Violation|1|||
23486709|NCT01711879|65527232|FG000|Overall Study|Death|1|||
23486710|NCT01711879|65527233|FG001|Overall Study|Death|0|||
23486711|NCT02294773|65527235|FG000|Overall Study|Withdrawal by Subject|0|||
23486712|NCT02294773|65527236|FG001|Overall Study|Withdrawal by Subject|2|||
23603658|NCT01262456|65937440|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
23280285|NCT00804856|64768934|FG000|Overall Study|Refused to continue medication|0|||
23280286|NCT00804856|64768935|FG001|Overall Study|Refused to continue medication|0|||
23280287|NCT00804856|64768936|FG002|Overall Study|Refused to continue medication|0|||
23280288|NCT00804856|64768937|FG003|Overall Study|Refused to continue medication|1|||
23280289|NCT00804856|64768938|FG004|Overall Study|Refused to continue medication|1|||
23280290|NCT00804856|64768939|FG005|Overall Study|Refused to continue medication|0|||
23280291|NCT00804856|64768940|FG006|Overall Study|Refused to continue medication|0|||
23280292|NCT00804856|64768941|FG007|Overall Study|Refused to continue medication|0|||
23280293|NCT00804856|64768942|FG008|Overall Study|Refused to continue medication|0|||
23280294|NCT00804856|64768943|FG009|Overall Study|Refused to continue medication|0|||
23486713|NCT02059005|65527238|FG000|Overall Study|Death|1|||
23486714|NCT02059005|65527239|FG001|Overall Study|Death|3|||
23486715|NCT02059005|65527238|FG000|Overall Study|Lost to Follow-up|19|||
23486716|NCT02059005|65527239|FG001|Overall Study|Lost to Follow-up|19|||
23486717|NCT02059005|65527238|FG000|Overall Study|Incarceration|0|||
23486718|NCT02059005|65527239|FG001|Overall Study|Incarceration|1|||
23486719|NCT02059005|65527238|FG000|Overall Study|Inpatient|0|||
23486720|NCT02059005|65527239|FG001|Overall Study|Inpatient|1|||
23486721|NCT00427960|65527240|FG000|Overall Study|Adverse Event|2|||
23486722|NCT00427960|65527241|FG001|Overall Study|Adverse Event|0|||
23486723|NCT00427960|65527240|FG000|Overall Study|Withdrawal by Subject|0|||
23280295|NCT00804856|64768944|FG010|Overall Study|Refused to continue medication|3|||
23280296|NCT00804856|64768945|FG011|Overall Study|Refused to continue medication|0|||
23280297|NCT00804856|64768946|FG012|Overall Study|Refused to continue medication|1|||
23280298|NCT00804856|64768947|FG013|Overall Study|Refused to continue medication|1|||
23280299|NCT00804856|64768948|FG014|Overall Study|Refused to continue medication|5|||
23280300|NCT00804856|64768934|FG000|Overall Study|Other reason than listed above|0|||
23280301|NCT00804856|64768935|FG001|Overall Study|Other reason than listed above|0|||
23280302|NCT00804856|64768936|FG002|Overall Study|Other reason than listed above|0|||
23280303|NCT00804856|64768937|FG003|Overall Study|Other reason than listed above|0|||
23280304|NCT00804856|64768938|FG004|Overall Study|Other reason than listed above|0|||
23280305|NCT00804856|64768939|FG005|Overall Study|Other reason than listed above|1|||
23280306|NCT00804856|64768940|FG006|Overall Study|Other reason than listed above|0|||
23280307|NCT00804856|64768941|FG007|Overall Study|Other reason than listed above|0|||
23280308|NCT00804856|64768942|FG008|Overall Study|Other reason than listed above|1|||
23280309|NCT00804856|64768943|FG009|Overall Study|Other reason than listed above|0|||
23280310|NCT00804856|64768944|FG010|Overall Study|Other reason than listed above|3|||
23280311|NCT00804856|64768945|FG011|Overall Study|Other reason than listed above|1|||
23280312|NCT00804856|64768946|FG012|Overall Study|Other reason than listed above|1|||
23280313|NCT00804856|64768947|FG013|Overall Study|Other reason than listed above|10|||
23280314|NCT00804856|64768948|FG014|Overall Study|Other reason than listed above|3|||
23280315|NCT02842853|64768951|FG000|Overall Study|Non-compliance with the protocol|3|||
23280316|NCT02842853|64768952|FG001|Overall Study|Non-compliance with the protocol|7|||
23280317|NCT02842853|64768953|FG002|Overall Study|Non-compliance with the protocol|2|||
23280318|NCT02842853|64768954|FG003|Overall Study|Non-compliance with the protocol|5|||
23280319|NCT02842853|64768951|FG000|Overall Study|Subject met exclusion criteria|0|||
23280320|NCT02842853|64768952|FG001|Overall Study|Subject met exclusion criteria|1|||
23280321|NCT02842853|64768953|FG002|Overall Study|Subject met exclusion criteria|0|||
23280322|NCT02842853|64768954|FG003|Overall Study|Subject met exclusion criteria|0|||
23280323|NCT02842853|64768951|FG000|Overall Study|Withdrawal by Subject|11|||
23280324|NCT02842853|64768952|FG001|Overall Study|Withdrawal by Subject|13|||
23280325|NCT02842853|64768953|FG002|Overall Study|Withdrawal by Subject|9|||
23280326|NCT02842853|64768954|FG003|Overall Study|Withdrawal by Subject|8|||
23280327|NCT02842853|64768951|FG000|Overall Study|Lost to Follow-up|9|||
23280328|NCT02842853|64768952|FG001|Overall Study|Lost to Follow-up|13|||
23280329|NCT02842853|64768953|FG002|Overall Study|Lost to Follow-up|10|||
23280330|NCT02842853|64768954|FG003|Overall Study|Lost to Follow-up|11|||
23280331|NCT00834249|64768958|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23280332|NCT00834249|64768959|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
23280333|NCT00834249|64768958|FG000|Second Intervention|Adverse Event|1|||
23280334|NCT00834249|64768959|FG001|Second Intervention|Adverse Event|0|||
23280335|NCT04633564|64768960|FG000|Period 1|Adverse Event|28|||
23280336|NCT04633564|64768961|FG001|Period 1|Adverse Event|19|||
23280337|NCT04633564|64768960|FG000|Period 1|Death|8|||
23280338|NCT04633564|64768961|FG001|Period 1|Death|7|||
23280339|NCT04633564|64768960|FG000|Period 1|Lost to Follow-up|3|||
23280340|NCT04633564|64768961|FG001|Period 1|Lost to Follow-up|5|||
23280341|NCT04633564|64768960|FG000|Period 1|Physician Decision|4|||
23280342|NCT04633564|64768961|FG001|Period 1|Physician Decision|12|||
23280343|NCT04633564|64768960|FG000|Period 1|Protocol Violation|0|||
23280344|NCT04633564|64768961|FG001|Period 1|Protocol Violation|1|||
23280345|NCT04633564|64768960|FG000|Period 1|Withdrawal by Subject|10|||
23280346|NCT04633564|64768961|FG001|Period 1|Withdrawal by Subject|8|||
23280347|NCT04633564|64768960|FG000|Period 1|Progressive disease|47|||
23280348|NCT04633564|64768961|FG001|Period 1|Progressive disease|51|||
23280349|NCT04633564|64768960|FG000|Period 1|Terminated by Sponsor|8|||
23280350|NCT04633564|64768961|FG001|Period 1|Terminated by Sponsor|6|||
23280351|NCT04633564|64768960|FG000|Period 2|Adverse Event|3|||
23280352|NCT04633564|64768961|FG001|Period 2|Adverse Event|4|||
23280353|NCT04633564|64768960|FG000|Period 2|Death|0|||
23280354|NCT04633564|64768961|FG001|Period 2|Death|2|||
23280355|NCT04633564|64768960|FG000|Period 2|Lost to Follow-up|0|||
23280356|NCT04633564|64768961|FG001|Period 2|Lost to Follow-up|1|||
23280357|NCT04633564|64768960|FG000|Period 2|Physician Decision|2|||
23280358|NCT04633564|64768961|FG001|Period 2|Physician Decision|4|||
23372553|NCT03093181|65109981|FG001|Overall Study|Withdrawal by Subject|1|||
23372554|NCT03093181|65109982|FG002|Overall Study|Withdrawal by Subject|2|||
23372555|NCT03093181|65109980|FG000|Overall Study|Other (Not specified)|1|||
23486724|NCT00427960|65527241|FG001|Overall Study|Withdrawal by Subject|3|||
23280359|NCT04633564|64768960|FG000|Period 2|Withdrawal by Subject|5|||
23280360|NCT04633564|64768961|FG001|Period 2|Withdrawal by Subject|1|||
23280361|NCT04633564|64768960|FG000|Period 2|Progressive Disease|74|||
23372556|NCT03093181|65109981|FG001|Overall Study|Other (Not specified)|0|||
23372557|NCT03093181|65109982|FG002|Overall Study|Other (Not specified)|0|||
23603659|NCT01262456|65937441|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
23280362|NCT04633564|64768961|FG001|Period 2|Progressive Disease|82|||
23280363|NCT04633564|64768960|FG000|Period 2|Terminated by Sponsor|9|||
23280364|NCT04633564|64768961|FG001|Period 2|Terminated by Sponsor|3|||
23280365|NCT01564394|64768962|FG000|Overall Study|Withdrawal by Subject|6|||
23280366|NCT01564394|64768963|FG001|Overall Study|Withdrawal by Subject|10|||
23280367|NCT01316055|64768964|FG000|Overall Study|Lost to Follow-up|1|||
23486725|NCT00427960|65527240|FG000|Overall Study|Other|0|||
23486726|NCT00427960|65527241|FG001|Overall Study|Other|1|||
23486727|NCT04163718|65527242|FG000|Overall Study|Study terminated|12|||
23486728|NCT00174291|65527249|FG000|Overall Study|Lost to Follow-up|1|||
23486729|NCT00174291|65527250|FG001|Overall Study|Lost to Follow-up|1|||
23486730|NCT00174291|65527249|FG000|Overall Study|Protocol Violation|0|||
23486731|NCT00174291|65527250|FG001|Overall Study|Protocol Violation|2|||
23486732|NCT00174291|65527249|FG000|Overall Study|Study terminated by sponsor|1|||
23486733|NCT00174291|65527250|FG001|Overall Study|Study terminated by sponsor|0|||
23486734|NCT00174291|65527249|FG000|Overall Study|Withdrawal by Subject|3|||
23486735|NCT00174291|65527250|FG001|Overall Study|Withdrawal by Subject|3|||
23486736|NCT00751621|65527251|FG000|Overall Study|Adverse Event|1|||
23486737|NCT00751621|65527251|FG000|Overall Study|Withdrawal by Subject|1|||
23486738|NCT00751621|65527251|FG000|Overall Study|Subject moved to another country|1|||
23486739|NCT00751621|65527251|FG000|Overall Study|Poor adherence to asthma treatment|1|||
23486740|NCT00433654|65527252|FG000|Overall Study|Death|4|||
23486741|NCT00433654|65527253|FG001|Overall Study|Death|0|||
23280368|NCT01316055|64768965|FG001|Overall Study|Lost to Follow-up|0|||
23486742|NCT00433654|65527252|FG000|Overall Study|Missed visit|6|||
23486743|NCT00433654|65527253|FG001|Overall Study|Missed visit|3|||
23486744|NCT00433654|65527252|FG000|Overall Study|Subject not yet due for visit|4|||
23280369|NCT01316055|64768966|FG002|Overall Study|Lost to Follow-up|0|||
23280370|NCT00840203|64768967|FG000|First Intervention|Protocol Violation|1|||
23280371|NCT00840203|64768968|FG001|First Intervention|Protocol Violation|1|||
23280372|NCT00840203|64768967|FG000|Washout|Protocol Violation|1|||
23280373|NCT00840203|64768968|FG001|Washout|Protocol Violation|0|||
23280374|NCT01735994|64768969|FG000|Overall Study|Withdrawal by Subject|6|||
23280375|NCT01735994|64768970|FG001|Overall Study|Withdrawal by Subject|4|||
23486745|NCT00433654|65527253|FG001|Overall Study|Subject not yet due for visit|0|||
23486746|NCT00433654|65527252|FG000|Overall Study|Withdrawal by Subject|1|||
23486747|NCT00433654|65527253|FG001|Overall Study|Withdrawal by Subject|2|||
23486748|NCT01903525|65527255|FG000|Overall Study|Lost to Follow-up|5|||
23486749|NCT01903525|65527256|FG001|Overall Study|Lost to Follow-up|9|||
23486750|NCT01903525|65527255|FG000|Overall Study|Adverse Event|0|||
23486751|NCT01903525|65527256|FG001|Overall Study|Adverse Event|1|||
23486752|NCT03224546|65527259|FG000|Overall Study|Lost to Follow-up|9|||
23486753|NCT03224546|65527260|FG001|Overall Study|Lost to Follow-up|8|||
23486754|NCT03224546|65527261|FG002|Overall Study|Lost to Follow-up|3|||
23486755|NCT03224546|65527259|FG000|Overall Study|Withdrawal by Subject|7|||
23486756|NCT03224546|65527260|FG001|Overall Study|Withdrawal by Subject|14|||
23486757|NCT03224546|65527261|FG002|Overall Study|Withdrawal by Subject|12|||
23280376|NCT01735994|64768969|FG000|Overall Study|Injury|2|||
23280377|NCT01735994|64768970|FG001|Overall Study|Injury|0|||
23280378|NCT01735994|64768969|FG000|Overall Study|Kicked off team|5|||
23280379|NCT01735994|64768970|FG001|Overall Study|Kicked off team|0|||
23280380|NCT01735994|64768969|FG000|Overall Study|Lost to Follow-up|50|||
23280381|NCT01735994|64768970|FG001|Overall Study|Lost to Follow-up|62|||
23280382|NCT03681470|64768971|FG000|Overall Study|Lack of Efficacy|3|||
23280383|NCT03681470|64768971|FG000|Overall Study|Lost to Follow-up|1|||
23280384|NCT03681470|64768971|FG000|Overall Study|Protocol Violation|3|||
23280385|NCT03681470|64768971|FG000|Overall Study|Withdrawal by Subject|1|||
23280386|NCT01340495|64768975|FG000|Overall Study|Withdrawal by Subject|1|||
23280387|NCT02718326|64768976|FG000|Overall Study|Adverse Event|4|||
23486758|NCT01931202|65527262|FG000|Overall Study|Withdrawal by Subject|0|||
23486759|NCT01931202|65527263|FG001|Overall Study|Withdrawal by Subject|0|||
23486760|NCT01931202|65527264|FG002|Overall Study|Withdrawal by Subject|2|||
23486761|NCT01931202|65527262|FG000|Overall Study|Lost to Follow-up|0|||
23486762|NCT01931202|65527263|FG001|Overall Study|Lost to Follow-up|5|||
23280388|NCT02718326|64768977|FG001|Overall Study|Adverse Event|9|||
23280389|NCT02718326|64768978|FG002|Overall Study|Adverse Event|0|||
23486763|NCT01931202|65527264|FG002|Overall Study|Lost to Follow-up|2|||
23486764|NCT00997438|65527265|FG000|Overall Study|Blood draw difficulty|2|||
23372558|NCT03093181|65109980|FG000|Overall Study|Adverse Event|0|||
23372559|NCT03093181|65109981|FG001|Overall Study|Adverse Event|1|||
23372560|NCT03093181|65109982|FG002|Overall Study|Adverse Event|0|||
23372561|NCT03093181|65109980|FG000|Overall Study|Other (Protocol violation)|0|||
23372562|NCT03093181|65109981|FG001|Overall Study|Other (Protocol violation)|0|||
23372563|NCT03093181|65109982|FG002|Overall Study|Other (Protocol violation)|1|||
23372564|NCT01787838|65109983|FG000|Overall Study|refused|1413|||
23372565|NCT02229084|65109984|FG000|Overall Study|Adverse Event|1|||
23372566|NCT02229084|65109985|FG001|Overall Study|Adverse Event|0|||
23486765|NCT00997438|65527266|FG001|Overall Study|Blood draw difficulty|0|||
23486766|NCT00997438|65527267|FG002|Overall Study|Blood draw difficulty|1|||
23486767|NCT00997438|65527265|FG000|Overall Study|Withdrawal by Subject|1|||
23486768|NCT00997438|65527266|FG001|Overall Study|Withdrawal by Subject|1|||
23486769|NCT00997438|65527267|FG002|Overall Study|Withdrawal by Subject|0|||
23486770|NCT00997438|65527265|FG000|Overall Study|Exclusion criteria at visit 1|2|||
23280390|NCT02718326|64768976|FG000|Overall Study|Death|8|||
23372567|NCT02229084|65109986|FG002|Overall Study|Adverse Event|0|||
23372568|NCT02229084|65109987|FG003|Overall Study|Adverse Event|0|||
23372569|NCT02229084|65109988|FG004|Overall Study|Adverse Event|0|||
23372570|NCT02229084|65109989|FG005|Overall Study|Adverse Event|0|||
23372571|NCT02229084|65109990|FG006|Overall Study|Adverse Event|0|||
23372572|NCT02229084|65109984|FG000|Overall Study|Lost to Follow-up|0|||
23372573|NCT02229084|65109985|FG001|Overall Study|Lost to Follow-up|0|||
23372574|NCT02229084|65109986|FG002|Overall Study|Lost to Follow-up|1|||
23372575|NCT02229084|65109987|FG003|Overall Study|Lost to Follow-up|1|||
23372576|NCT02229084|65109988|FG004|Overall Study|Lost to Follow-up|0|||
23372577|NCT02229084|65109989|FG005|Overall Study|Lost to Follow-up|0|||
23372578|NCT02229084|65109990|FG006|Overall Study|Lost to Follow-up|1|||
23372579|NCT02229084|65109984|FG000|Overall Study|Physician Decision|0|||
23372580|NCT02229084|65109985|FG001|Overall Study|Physician Decision|0|||
23372581|NCT02229084|65109986|FG002|Overall Study|Physician Decision|0|||
23372582|NCT02229084|65109987|FG003|Overall Study|Physician Decision|1|||
23372583|NCT02229084|65109988|FG004|Overall Study|Physician Decision|3|||
23372584|NCT02229084|65109989|FG005|Overall Study|Physician Decision|0|||
23372585|NCT02229084|65109990|FG006|Overall Study|Physician Decision|1|||
23486771|NCT00997438|65527266|FG001|Overall Study|Exclusion criteria at visit 1|2|||
23280391|NCT02718326|64768977|FG001|Overall Study|Death|1|||
23280392|NCT02718326|64768978|FG002|Overall Study|Death|2|||
23280393|NCT02718326|64768976|FG000|Overall Study|Withdrawal by Subject|4|||
23280394|NCT02718326|64768977|FG001|Overall Study|Withdrawal by Subject|9|||
23280395|NCT02718326|64768978|FG002|Overall Study|Withdrawal by Subject|6|||
23280396|NCT02718326|64768976|FG000|Overall Study|Lost to Follow-up|18|||
23280397|NCT02718326|64768977|FG001|Overall Study|Lost to Follow-up|5|||
23280398|NCT02718326|64768978|FG002|Overall Study|Lost to Follow-up|14|||
23280399|NCT02718326|64768976|FG000|Overall Study|Protocol Deviation|1|||
23280400|NCT02718326|64768977|FG001|Overall Study|Protocol Deviation|0|||
23280401|NCT02718326|64768978|FG002|Overall Study|Protocol Deviation|0|||
23280402|NCT02718326|64768976|FG000|Overall Study|Pregnancy|1|||
23280403|NCT02718326|64768977|FG001|Overall Study|Pregnancy|0|||
23280404|NCT02718326|64768978|FG002|Overall Study|Pregnancy|0|||
23280405|NCT00420303|64768988|FG000|Overall Study|Serious Adverse Event|1|||
23280406|NCT00420303|64768989|FG001|Overall Study|Serious Adverse Event|0|||
23280407|NCT00420303|64768988|FG000|Overall Study|Lack of Efficacy|0|||
23280408|NCT00420303|64768989|FG001|Overall Study|Lack of Efficacy|3|||
23280409|NCT00420303|64768988|FG000|Overall Study|Physician Decision|0|||
23280410|NCT00420303|64768989|FG001|Overall Study|Physician Decision|1|||
23280411|NCT00835666|64768993|FG000|Washout|Protocol Violation|1|||
23280412|NCT00835666|64768994|FG001|Washout|Protocol Violation|0|||
23280413|NCT00835666|64768993|FG000|Washout|Withdrawal by Subject|1|||
23280414|NCT00835666|64768994|FG001|Washout|Withdrawal by Subject|0|||
23280415|NCT00395694|64768996|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
23372586|NCT02229084|65109984|FG000|Overall Study|Withdrawal by Subject|0|||
23372587|NCT02229084|65109985|FG001|Overall Study|Withdrawal by Subject|0|||
23372588|NCT02229084|65109986|FG002|Overall Study|Withdrawal by Subject|1|||
23372589|NCT02229084|65109987|FG003|Overall Study|Withdrawal by Subject|0|||
23280416|NCT00395694|64768997|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
23280417|NCT00395694|64768996|FG000|Continuation Phase|Adverse Event|1|||
23372590|NCT02229084|65109988|FG004|Overall Study|Withdrawal by Subject|1|||
23372591|NCT02229084|65109989|FG005|Overall Study|Withdrawal by Subject|1|||
23372592|NCT02229084|65109990|FG006|Overall Study|Withdrawal by Subject|1|||
23372593|NCT02229084|65109984|FG000|Overall Study|Death|0|||
23372594|NCT02229084|65109985|FG001|Overall Study|Death|0|||
23372595|NCT02229084|65109986|FG002|Overall Study|Death|0|||
23372596|NCT02229084|65109987|FG003|Overall Study|Death|0|||
23280418|NCT00395694|64768997|FG001|Continuation Phase|Adverse Event|0|||
23280419|NCT00395694|64768996|FG000|Continuation Phase|Lack of Efficacy|12|||
23372597|NCT02229084|65109988|FG004|Overall Study|Death|0|||
23372598|NCT02229084|65109989|FG005|Overall Study|Death|0|||
23372599|NCT02229084|65109990|FG006|Overall Study|Death|1|||
23372600|NCT02340949|65109991|FG000|Overall Study|Adverse Event|4|||
23372601|NCT02340949|65109992|FG001|Overall Study|Adverse Event|2|||
23372602|NCT02340949|65109991|FG000|Overall Study|Withdrawal by Subject|2|||
23372603|NCT02340949|65109992|FG001|Overall Study|Withdrawal by Subject|0|||
23372604|NCT02340949|65109991|FG000|Overall Study|Progression disease|6|||
23372605|NCT02340949|65109992|FG001|Overall Study|Progression disease|2|||
23372606|NCT02340949|65109991|FG000|Overall Study|Death|3|||
23372607|NCT02340949|65109992|FG001|Overall Study|Death|0|||
23372608|NCT02340949|65109991|FG000|Overall Study|Physician Decision|1|||
23372609|NCT02340949|65109992|FG001|Overall Study|Physician Decision|0|||
23372610|NCT01122173|65109993|FG000|Overall Study|Lost to Follow-up|3|||
23372611|NCT01122173|65109993|FG000|Overall Study|Withdrawal by Subject|3|||
23372612|NCT01122173|65109993|FG000|Overall Study|Left study for other reasons|3|||
23372613|NCT04556760|65109996|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372614|NCT04556760|65109997|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
23372615|NCT04556760|65109998|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372616|NCT04556760|65109999|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372617|NCT04556760|65110000|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372618|NCT04556760|65110001|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
23372619|NCT04556760|65109996|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372620|NCT04556760|65109997|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372621|NCT04556760|65109998|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372622|NCT04556760|65109999|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
23372623|NCT04556760|65110000|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372624|NCT04556760|65110001|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
23372625|NCT00853762|65110009|FG000|Overall Study|Premature Termination|16|||
23372626|NCT00853762|65110010|FG001|Overall Study|Premature Termination|15|||
23372627|NCT00853762|65110011|FG002|Overall Study|Premature Termination|14|||
23372628|NCT00853762|65110012|FG003|Overall Study|Premature Termination|21|||
23372629|NCT00853762|65110009|FG000|Overall Study|Protocol Violation|0|||
23372630|NCT00853762|65110010|FG001|Overall Study|Protocol Violation|0|||
23372631|NCT00853762|65110011|FG002|Overall Study|Protocol Violation|0|||
23372632|NCT00853762|65110012|FG003|Overall Study|Protocol Violation|1|||
23372633|NCT00853762|65110009|FG000|Overall Study|Withdrawal by Subject|0|||
23372634|NCT00853762|65110010|FG001|Overall Study|Withdrawal by Subject|0|||
23280420|NCT00395694|64768997|FG001|Continuation Phase|Lack of Efficacy|11|||
23280421|NCT00395694|64768996|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
23280422|NCT00395694|64768997|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
23280423|NCT00395694|64768996|FG000|Continuation Phase|Poor Compliance|1|||
23280424|NCT00395694|64768997|FG001|Continuation Phase|Poor Compliance|0|||
23280425|NCT00395694|64768996|FG000|Continuation Phase|Withdrawal by Subject|0|||
23280426|NCT00395694|64768997|FG001|Continuation Phase|Withdrawal by Subject|2|||
23280427|NCT00905606|64769000|FG000|Period 1|Adverse Event|0|||
23280428|NCT00905606|64769001|FG001|Period 1|Adverse Event|1|||
23280429|NCT00905606|64769000|FG000|Washout|Withdrawal by Subject|1|||
23280430|NCT00905606|64769001|FG001|Washout|Withdrawal by Subject|0|||
23280431|NCT01101022|64769002|FG000|Overall Study|Adverse Event|6|||
23280432|NCT01101022|64769003|FG001|Overall Study|Adverse Event|2|||
23372635|NCT00853762|65110011|FG002|Overall Study|Withdrawal by Subject|1|||
23372636|NCT00853762|65110012|FG003|Overall Study|Withdrawal by Subject|0|||
23372637|NCT00853762|65110009|FG000|Overall Study|Other|0|||
23372638|NCT00853762|65110010|FG001|Overall Study|Other|2|||
23372639|NCT00853762|65110011|FG002|Overall Study|Other|0|||
23372640|NCT00853762|65110012|FG003|Overall Study|Other|0|||
23486772|NCT00997438|65527267|FG002|Overall Study|Exclusion criteria at visit 1|3|||
23280433|NCT01101022|64769002|FG000|Overall Study|Protocol Violation|4|||
23280434|NCT01101022|64769003|FG001|Overall Study|Protocol Violation|3|||
23372641|NCT00853762|65110009|FG000|Overall Study|Randomised but not Treated|0|||
23372642|NCT00853762|65110010|FG001|Overall Study|Randomised but not Treated|2|||
23372643|NCT00853762|65110011|FG002|Overall Study|Randomised but not Treated|2|||
23372644|NCT00853762|65110012|FG003|Overall Study|Randomised but not Treated|0|||
23372645|NCT02988661|65110013|FG000|Overall Study|Death|2|||
23372646|NCT02988661|65110014|FG001|Overall Study|Death|18|||
23372647|NCT02988661|65110013|FG000|Overall Study|Lost to Follow-up|0|||
23372648|NCT02988661|65110014|FG001|Overall Study|Lost to Follow-up|33|||
23372649|NCT02988661|65110013|FG000|Overall Study|Withdrawal by Subject|0|||
23372650|NCT02988661|65110014|FG001|Overall Study|Withdrawal by Subject|6|||
23372651|NCT02988661|65110013|FG000|Overall Study|Unable to complete the 18-month survey|1|||
23372652|NCT02988661|65110014|FG001|Overall Study|Unable to complete the 18-month survey|27|||
23372653|NCT02643693|65110021|FG000|Overall Study|Physician Decision|0|||
23280435|NCT01101022|64769002|FG000|Overall Study|Withdrawal by Subject|3|||
23280436|NCT01101022|64769003|FG001|Overall Study|Withdrawal by Subject|8|||
23280437|NCT01101022|64769002|FG000|Overall Study|Lost to Follow-up|1|||
23372654|NCT02643693|65110022|FG001|Overall Study|Physician Decision|1|||
23372655|NCT02643693|65110023|FG002|Overall Study|Physician Decision|0|||
23372656|NCT02643693|65110024|FG003|Overall Study|Physician Decision|0|||
23372657|NCT02643693|65110025|FG004|Overall Study|Physician Decision|0|||
23372658|NCT02643693|65110026|FG005|Overall Study|Physician Decision|0|||
23372659|NCT02643693|65110021|FG000|Overall Study|Withdrawal by Subject|0|||
23372660|NCT02643693|65110022|FG001|Overall Study|Withdrawal by Subject|1|||
23372661|NCT02643693|65110023|FG002|Overall Study|Withdrawal by Subject|0|||
23372662|NCT02643693|65110024|FG003|Overall Study|Withdrawal by Subject|0|||
23372663|NCT02643693|65110025|FG004|Overall Study|Withdrawal by Subject|0|||
23372664|NCT02643693|65110026|FG005|Overall Study|Withdrawal by Subject|0|||
23372665|NCT02643693|65110021|FG000|Overall Study|Protocol Adherence Issues|2|||
23372666|NCT02643693|65110022|FG001|Overall Study|Protocol Adherence Issues|0|||
23372667|NCT02643693|65110023|FG002|Overall Study|Protocol Adherence Issues|1|||
23372668|NCT02643693|65110024|FG003|Overall Study|Protocol Adherence Issues|0|||
23372669|NCT02643693|65110025|FG004|Overall Study|Protocol Adherence Issues|0|||
23372670|NCT02643693|65110026|FG005|Overall Study|Protocol Adherence Issues|1|||
23372671|NCT01020123|65110027|FG000|Main Period|Withdrawal by Subject|6|||
23372672|NCT01020123|65110028|FG001|Main Period|Withdrawal by Subject|5|||
23372673|NCT01020123|65110029|FG002|Main Period|Withdrawal by Subject|3|||
23372674|NCT01020123|65110030|FG003|Main Period|Withdrawal by Subject|1|||
23372675|NCT01020123|65110031|FG004|Main Period|Withdrawal by Subject|6|||
23372676|NCT01020123|65110032|FG005|Main Period|Withdrawal by Subject|3|||
23372677|NCT01020123|65110033|FG006|Main Period|Withdrawal by Subject|2|||
23372678|NCT01020123|65110027|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
23372679|NCT01020123|65110028|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
23372680|NCT01020123|65110029|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
23372681|NCT01020123|65110030|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
23372682|NCT01020123|65110031|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
23372683|NCT01020123|65110032|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
23372684|NCT01020123|65110033|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
23372685|NCT01020123|65110027|FG000|Main Period|Adverse Event|5|||
23372686|NCT01020123|65110028|FG001|Main Period|Adverse Event|2|||
23372687|NCT01020123|65110029|FG002|Main Period|Adverse Event|2|||
23372688|NCT01020123|65110030|FG003|Main Period|Adverse Event|1|||
23372689|NCT01020123|65110031|FG004|Main Period|Adverse Event|1|||
23372690|NCT01020123|65110032|FG005|Main Period|Adverse Event|2|||
23372691|NCT01020123|65110033|FG006|Main Period|Adverse Event|1|||
23372692|NCT01020123|65110027|FG000|Main Period|Protocol Violation|4|||
23372693|NCT01020123|65110028|FG001|Main Period|Protocol Violation|4|||
23372694|NCT01020123|65110029|FG002|Main Period|Protocol Violation|2|||
23372695|NCT01020123|65110030|FG003|Main Period|Protocol Violation|5|||
23372696|NCT01020123|65110031|FG004|Main Period|Protocol Violation|2|||
23372697|NCT01020123|65110032|FG005|Main Period|Protocol Violation|3|||
23372698|NCT01020123|65110033|FG006|Main Period|Protocol Violation|2|||
23372699|NCT01020123|65110027|FG000|Main Period|Lost to Follow-up|0|||
23372700|NCT01020123|65110028|FG001|Main Period|Lost to Follow-up|2|||
23372701|NCT01020123|65110029|FG002|Main Period|Lost to Follow-up|0|||
23372702|NCT01020123|65110030|FG003|Main Period|Lost to Follow-up|0|||
23372703|NCT01020123|65110031|FG004|Main Period|Lost to Follow-up|0|||
23372704|NCT01020123|65110032|FG005|Main Period|Lost to Follow-up|0|||
23372705|NCT01020123|65110033|FG006|Main Period|Lost to Follow-up|0|||
23372706|NCT01020123|65110027|FG000|Main Period|Unclasified|2|||
23372707|NCT01020123|65110028|FG001|Main Period|Unclasified|0|||
23372708|NCT01020123|65110029|FG002|Main Period|Unclasified|1|||
23372709|NCT01020123|65110030|FG003|Main Period|Unclasified|0|||
23372710|NCT01020123|65110031|FG004|Main Period|Unclasified|1|||
23372711|NCT01020123|65110032|FG005|Main Period|Unclasified|3|||
23372712|NCT01020123|65110033|FG006|Main Period|Unclasified|6|||
23372713|NCT01020123|65110027|FG000|Extention Period|Withdrawal by Subject|2|||
23372714|NCT01020123|65110028|FG001|Extention Period|Withdrawal by Subject|1|||
23372715|NCT01020123|65110029|FG002|Extention Period|Withdrawal by Subject|1|||
23372716|NCT01020123|65110030|FG003|Extention Period|Withdrawal by Subject|0|||
23372717|NCT01020123|65110031|FG004|Extention Period|Withdrawal by Subject|0|||
23372718|NCT01020123|65110032|FG005|Extention Period|Withdrawal by Subject|0|||
23372719|NCT01020123|65110033|FG006|Extention Period|Withdrawal by Subject|0|||
23372720|NCT01020123|65110027|FG000|Extention Period|Adverse Event|0|||
23372721|NCT01020123|65110028|FG001|Extention Period|Adverse Event|0|||
23372722|NCT01020123|65110029|FG002|Extention Period|Adverse Event|0|||
23372723|NCT01020123|65110030|FG003|Extention Period|Adverse Event|1|||
23372724|NCT01020123|65110031|FG004|Extention Period|Adverse Event|0|||
23372725|NCT01020123|65110032|FG005|Extention Period|Adverse Event|0|||
23372726|NCT01020123|65110033|FG006|Extention Period|Adverse Event|0|||
23372727|NCT01020123|65110027|FG000|Extention Period|Protocol Violation|1|||
23372728|NCT01020123|65110028|FG001|Extention Period|Protocol Violation|1|||
23372729|NCT01020123|65110029|FG002|Extention Period|Protocol Violation|1|||
23372730|NCT01020123|65110030|FG003|Extention Period|Protocol Violation|0|||
23372731|NCT01020123|65110031|FG004|Extention Period|Protocol Violation|0|||
23372732|NCT01020123|65110032|FG005|Extention Period|Protocol Violation|0|||
23280438|NCT01101022|64769003|FG001|Overall Study|Lost to Follow-up|4|||
23280439|NCT01101022|64769002|FG000|Overall Study|Lack of Efficacy|0|||
23280440|NCT01101022|64769003|FG001|Overall Study|Lack of Efficacy|7|||
23280441|NCT01101022|64769002|FG000|Overall Study|Sponsor decision|1|||
23280442|NCT01101022|64769003|FG001|Overall Study|Sponsor decision|1|||
23280443|NCT01101022|64769002|FG000|Overall Study|Non-compliance|1|||
23280444|NCT01101022|64769003|FG001|Overall Study|Non-compliance|0|||
23280445|NCT01101022|64769002|FG000|Overall Study|Work schedule|1|||
23280446|NCT01101022|64769003|FG001|Overall Study|Work schedule|1|||
23280447|NCT01101022|64769002|FG000|Overall Study|Vacation|0|||
23280448|NCT01101022|64769003|FG001|Overall Study|Vacation|1|||
23280449|NCT02157974|64769007|FG000|Overall Study|Withdrawal by Subject|0|||
23280450|NCT02157974|64769008|FG001|Overall Study|Withdrawal by Subject|1|||
23280451|NCT02157974|64769009|FG002|Overall Study|Withdrawal by Subject|0|||
23280452|NCT02157974|64769010|FG003|Overall Study|Withdrawal by Subject|0|||
23280453|NCT02157974|64769011|FG004|Overall Study|Withdrawal by Subject|0|||
23280454|NCT02157974|64769007|FG000|Overall Study|Screen Failure|0|||
23280455|NCT02157974|64769008|FG001|Overall Study|Screen Failure|1|||
23280456|NCT02157974|64769009|FG002|Overall Study|Screen Failure|0|||
23280457|NCT02157974|64769010|FG003|Overall Study|Screen Failure|0|||
23280458|NCT02157974|64769011|FG004|Overall Study|Screen Failure|0|||
23280459|NCT02157974|64769007|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
23280460|NCT02157974|64769008|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
23280461|NCT02157974|64769009|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
23280462|NCT02157974|64769010|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
23280463|NCT02157974|64769011|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
23280464|NCT03256695|64769012|FG000|Overall Study|Adverse Event|8|||
23280465|NCT03256695|64769012|FG000|Overall Study|Death|2|||
23280466|NCT03256695|64769012|FG000|Overall Study|Withdrawal by Subject|14|||
23280467|NCT03256695|64769012|FG000|Overall Study|Non-compliance with study drug|1|||
23280468|NCT03256695|64769012|FG000|Overall Study|Lost to Follow-up|3|||
23280469|NCT03256695|64769012|FG000|Overall Study|Lack of Efficacy|3|||
23280470|NCT03256695|64769012|FG000|Overall Study|Protocol Violation|5|||
23280471|NCT03256695|64769012|FG000|Overall Study|Other than specified|3|||
23280472|NCT01049334|64769022|FG000|Overall Study|Withdrawal by Subject|5|||
23280473|NCT01049334|64769023|FG001|Overall Study|Withdrawal by Subject|3|||
23280474|NCT01049334|64769022|FG000|Overall Study|Adverse Event|2|||
23280475|NCT01049334|64769023|FG001|Overall Study|Adverse Event|3|||
23280476|NCT01049334|64769022|FG000|Overall Study|Physician Decision|2|||
23280477|NCT01049334|64769023|FG001|Overall Study|Physician Decision|0|||
23280478|NCT01049334|64769022|FG000|Overall Study|Protocol Violation|0|||
23280479|NCT01049334|64769023|FG001|Overall Study|Protocol Violation|1|||
23280480|NCT00875524|64769024|FG000|Overall Study|Serious adverse event|0|||
23280481|NCT00875524|64769025|FG001|Overall Study|Serious adverse event|1|||
23280482|NCT00875524|64769024|FG000|Overall Study|Protocol Violation|4|||
23280483|NCT00875524|64769025|FG001|Overall Study|Protocol Violation|0|||
23280484|NCT00875524|64769024|FG000|Overall Study|Lost to Follow-up|1|||
23280485|NCT00875524|64769025|FG001|Overall Study|Lost to Follow-up|0|||
23280486|NCT00875524|64769024|FG000|Overall Study|Withdrawal by Subject|3|||
23280487|NCT00875524|64769025|FG001|Overall Study|Withdrawal by Subject|5|||
23280488|NCT01867658|64769026|FG000|Overall Study|Withdrawal by Subject|6|||
23486773|NCT00625742|65527270|FG000|Overall Study|Disease Progression|2|||
23280489|NCT01867658|64769026|FG000|Overall Study|Death|2|||
23280490|NCT01867658|64769026|FG000|Overall Study|Subject could not be contacted|1|||
23280491|NCT00829309|64769028|FG000|Washout: 7 Days|Protocol Violation|1|||
23280492|NCT00829309|64769029|FG001|Washout: 7 Days|Protocol Violation|0|||
23280493|NCT00545792|64769030|FG000|Overall Study|Withdrawal by Subject|1|||
23280494|NCT02820350|64769033|FG000|Overall Study|Withdrawal by Subject|3|||
23280495|NCT02820350|64769033|FG000|Overall Study|Death|4|||
23280496|NCT00835575|64769034|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
23280497|NCT00835575|64769035|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
23280498|NCT03406156|64769039|FG000|Overall Study|Death|9|||
23280499|NCT03406156|64769040|FG001|Overall Study|Death|3|||
23280500|NCT03406156|64769039|FG000|Overall Study|Withdrawal by Subject|1|||
23280501|NCT03406156|64769040|FG001|Overall Study|Withdrawal by Subject|2|||
23280502|NCT03406156|64769039|FG000|Overall Study|COVID-19 infection|1|||
23280503|NCT03406156|64769040|FG001|Overall Study|COVID-19 infection|0|||
23280504|NCT03406156|64769039|FG000|Overall Study|Non-compliance with study procedures|1|||
23280505|NCT03406156|64769040|FG001|Overall Study|Non-compliance with study procedures|1|||
23280506|NCT03406156|64769039|FG000|Overall Study|Lost to Follow-up|0|||
23280507|NCT03406156|64769040|FG001|Overall Study|Lost to Follow-up|2|||
23280508|NCT03406156|64769039|FG000|Overall Study|Other, not specified|72|||
23280509|NCT03406156|64769040|FG001|Overall Study|Other, not specified|28|||
23280510|NCT00830258|64769041|FG000|First Intervention|Adverse Event|1|||
23280511|NCT00830258|64769042|FG001|First Intervention|Adverse Event|0|||
23280512|NCT00830258|64769041|FG000|Washout: 7 Days|Protocol Violation|1|||
23280513|NCT00830258|64769042|FG001|Washout: 7 Days|Protocol Violation|0|||
23372733|NCT01020123|65110033|FG006|Extention Period|Protocol Violation|1|||
23372734|NCT01020123|65110027|FG000|Extention Period|Lost to Follow-up|0|||
23372735|NCT01020123|65110028|FG001|Extention Period|Lost to Follow-up|0|||
23372736|NCT01020123|65110029|FG002|Extention Period|Lost to Follow-up|0|||
23372737|NCT01020123|65110030|FG003|Extention Period|Lost to Follow-up|0|||
23372738|NCT01020123|65110031|FG004|Extention Period|Lost to Follow-up|0|||
23372739|NCT01020123|65110032|FG005|Extention Period|Lost to Follow-up|2|||
23372740|NCT01020123|65110033|FG006|Extention Period|Lost to Follow-up|0|||
23372741|NCT00764790|65110034|FG000|Overall Study|Protocol Violation|0|||
23372742|NCT00764790|65110035|FG001|Overall Study|Protocol Violation|0|||
23372743|NCT00764790|65110036|FG002|Overall Study|Protocol Violation|1|||
23372744|NCT00764790|65110034|FG000|Overall Study|Withdrawal by Subject|10|||
23372745|NCT00764790|65110035|FG001|Overall Study|Withdrawal by Subject|12|||
23372746|NCT00764790|65110036|FG002|Overall Study|Withdrawal by Subject|6|||
23372747|NCT00764790|65110034|FG000|Overall Study|Lost to Follow-up|28|||
23372748|NCT00764790|65110035|FG001|Overall Study|Lost to Follow-up|29|||
23372749|NCT00764790|65110036|FG002|Overall Study|Lost to Follow-up|23|||
23372750|NCT04889040|65110037|FG000|Overall Study|Withdrawal by Subject|3|||
23372751|NCT04889040|65110038|FG001|Overall Study|Withdrawal by Subject|3|||
23372752|NCT04889040|65110037|FG000|Overall Study|Lost to Follow-up|0|||
23372753|NCT04889040|65110038|FG001|Overall Study|Lost to Follow-up|1|||
23372754|NCT04889040|65110037|FG000|Overall Study|Adverse Event|2|||
23372755|NCT04889040|65110038|FG001|Overall Study|Adverse Event|1|||
23372756|NCT02513550|65110039|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
23372757|NCT02513550|65110040|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
23372758|NCT02513550|65110041|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
23372759|NCT02513550|65110042|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
23372760|NCT02513550|65110043|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
23372761|NCT02513550|65110044|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
23372762|NCT02513550|65110039|FG000|Double Blind Treatment Period|Adverse Event|5|||
23372763|NCT02513550|65110040|FG001|Double Blind Treatment Period|Adverse Event|13|||
23372764|NCT02513550|65110041|FG002|Double Blind Treatment Period|Adverse Event|17|||
23372765|NCT02513550|65110042|FG003|Double Blind Treatment Period|Adverse Event|0|||
23372766|NCT02513550|65110043|FG004|Double Blind Treatment Period|Adverse Event|1|||
23372767|NCT02513550|65110044|FG005|Double Blind Treatment Period|Adverse Event|0|||
23372768|NCT02513550|65110039|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
23372769|NCT02513550|65110040|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
23372770|NCT02513550|65110041|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
23372771|NCT02513550|65110042|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
23372772|NCT02513550|65110043|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
23372773|NCT02513550|65110044|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
23372774|NCT02513550|65110039|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
23372775|NCT02513550|65110040|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
23372776|NCT02513550|65110041|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
23372777|NCT02513550|65110042|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
23372778|NCT02513550|65110043|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
23372779|NCT02513550|65110044|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
23372780|NCT02513550|65110039|FG000|Double Blind Treatment Period|Protocol Violation|1|||
23372781|NCT02513550|65110040|FG001|Double Blind Treatment Period|Protocol Violation|1|||
23372782|NCT02513550|65110041|FG002|Double Blind Treatment Period|Protocol Violation|4|||
23372783|NCT02513550|65110042|FG003|Double Blind Treatment Period|Protocol Violation|0|||
23372784|NCT02513550|65110043|FG004|Double Blind Treatment Period|Protocol Violation|0|||
23372785|NCT02513550|65110044|FG005|Double Blind Treatment Period|Protocol Violation|0|||
23372786|NCT02513550|65110039|FG000|Double Blind Treatment Period|Physician Decision|2|||
23372787|NCT02513550|65110040|FG001|Double Blind Treatment Period|Physician Decision|0|||
23372788|NCT02513550|65110041|FG002|Double Blind Treatment Period|Physician Decision|4|||
23372789|NCT02513550|65110042|FG003|Double Blind Treatment Period|Physician Decision|0|||
23372790|NCT02513550|65110043|FG004|Double Blind Treatment Period|Physician Decision|0|||
23372791|NCT02513550|65110044|FG005|Double Blind Treatment Period|Physician Decision|0|||
23372792|NCT02513550|65110039|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
23372793|NCT02513550|65110040|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
23372794|NCT02513550|65110041|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
23372795|NCT02513550|65110042|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
23372796|NCT02513550|65110043|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
23372797|NCT02513550|65110044|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
23372798|NCT02513550|65110039|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23372799|NCT02513550|65110040|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23372800|NCT02513550|65110041|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
23372801|NCT02513550|65110042|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23372802|NCT02513550|65110043|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23486774|NCT00625742|65527270|FG000|Overall Study|Withdrawal by Subject|1|||
23486775|NCT00625742|65527270|FG000|Overall Study|Adverse Event|4|||
23280514|NCT04852978|64769045|FG000|Overall Study|Physician Decision|0|||
23280515|NCT04852978|64769046|FG001|Overall Study|Physician Decision|1|||
23280516|NCT04852978|64769047|FG002|Overall Study|Physician Decision|0|||
23280517|NCT04852978|64769048|FG003|Overall Study|Physician Decision|0|||
23280518|NCT04852978|64769049|FG004|Overall Study|Physician Decision|0|||
23280519|NCT04852978|64769050|FG005|Overall Study|Physician Decision|0|||
23280520|NCT04852978|64769051|FG006|Overall Study|Physician Decision|0|||
23280521|NCT04852978|64769052|FG007|Overall Study|Physician Decision|2|||
23280522|NCT04852978|64769053|FG008|Overall Study|Physician Decision|0|||
23280523|NCT04852978|64769045|FG000|Overall Study|Sponsor request|0|||
23280524|NCT04852978|64769046|FG001|Overall Study|Sponsor request|0|||
23280525|NCT04852978|64769047|FG002|Overall Study|Sponsor request|1|||
23280526|NCT04852978|64769048|FG003|Overall Study|Sponsor request|0|||
23280527|NCT04852978|64769049|FG004|Overall Study|Sponsor request|0|||
23280528|NCT04852978|64769050|FG005|Overall Study|Sponsor request|0|||
23280529|NCT04852978|64769051|FG006|Overall Study|Sponsor request|0|||
23280530|NCT04852978|64769052|FG007|Overall Study|Sponsor request|0|||
23280531|NCT04852978|64769053|FG008|Overall Study|Sponsor request|0|||
23280532|NCT04852978|64769045|FG000|Overall Study|Death|0|||
23280533|NCT04852978|64769046|FG001|Overall Study|Death|0|||
23280534|NCT04852978|64769047|FG002|Overall Study|Death|0|||
23280535|NCT04852978|64769048|FG003|Overall Study|Death|0|||
23280536|NCT04852978|64769049|FG004|Overall Study|Death|0|||
23280537|NCT04852978|64769050|FG005|Overall Study|Death|0|||
23280538|NCT04852978|64769051|FG006|Overall Study|Death|1|||
23280539|NCT04852978|64769052|FG007|Overall Study|Death|0|||
23280540|NCT04852978|64769053|FG008|Overall Study|Death|0|||
23280541|NCT04852978|64769045|FG000|Overall Study|Lost to Follow-up|3|||
23280542|NCT04852978|64769046|FG001|Overall Study|Lost to Follow-up|2|||
23280543|NCT04852978|64769047|FG002|Overall Study|Lost to Follow-up|2|||
23280544|NCT04852978|64769048|FG003|Overall Study|Lost to Follow-up|0|||
23280545|NCT04852978|64769049|FG004|Overall Study|Lost to Follow-up|2|||
23280546|NCT04852978|64769050|FG005|Overall Study|Lost to Follow-up|4|||
23280547|NCT04852978|64769051|FG006|Overall Study|Lost to Follow-up|1|||
23280548|NCT04852978|64769052|FG007|Overall Study|Lost to Follow-up|2|||
23280549|NCT04852978|64769053|FG008|Overall Study|Lost to Follow-up|2|||
23280550|NCT04852978|64769045|FG000|Overall Study|Withdrawal by Subject|4|||
23280551|NCT04852978|64769046|FG001|Overall Study|Withdrawal by Subject|2|||
23280552|NCT04852978|64769047|FG002|Overall Study|Withdrawal by Subject|2|||
23280553|NCT04852978|64769048|FG003|Overall Study|Withdrawal by Subject|1|||
23280554|NCT04852978|64769049|FG004|Overall Study|Withdrawal by Subject|5|||
23280555|NCT04852978|64769050|FG005|Overall Study|Withdrawal by Subject|3|||
23280556|NCT04852978|64769051|FG006|Overall Study|Withdrawal by Subject|2|||
23280557|NCT04852978|64769052|FG007|Overall Study|Withdrawal by Subject|2|||
23280558|NCT04852978|64769053|FG008|Overall Study|Withdrawal by Subject|1|||
23280559|NCT03196284|64769059|FG000|Main Part|Withdrawal by Subject|0|||
23280560|NCT03196284|64769060|FG001|Main Part|Withdrawal by Subject|1|||
23280561|NCT03196284|64769061|FG002|Main Part|Withdrawal by Subject|0|||
23280562|NCT03196284|64769059|FG000|Extension Part|Lack of Efficacy|0|||
23280563|NCT03196284|64769060|FG001|Extension Part|Lack of Efficacy|0|||
23280564|NCT03196284|64769061|FG002|Extension Part|Lack of Efficacy|1|||
23280565|NCT03196284|64769059|FG000|Extension Part|Withdrawal by Subject|0|||
23280566|NCT03196284|64769060|FG001|Extension Part|Withdrawal by Subject|0|||
23280567|NCT03196284|64769061|FG002|Extension Part|Withdrawal by Subject|1|||
23280568|NCT03196284|64769059|FG000|Extension Part|Physician Decision|0|||
23280569|NCT03196284|64769060|FG001|Extension Part|Physician Decision|0|||
23486776|NCT00625742|65527270|FG000|Overall Study|Lost to Follow-up|4|||
23486777|NCT00625742|65527270|FG000|Overall Study|Ineligible|1|||
23486778|NCT00749580|65527272|FG000|Overall Study|Lost to Follow-up|4|||
23280570|NCT03196284|64769061|FG002|Extension Part|Physician Decision|1|||
23280571|NCT02311361|64769066|FG000|Overall Study|Did not receive treatment|0|||
23486779|NCT00749580|65527273|FG001|Overall Study|Lost to Follow-up|8|||
23280572|NCT02311361|64769067|FG001|Overall Study|Did not receive treatment|1|||
23280573|NCT02311361|64769068|FG002|Overall Study|Did not receive treatment|0|||
23486780|NCT00749580|65527272|FG000|Overall Study|Adverse Event|0|||
23280574|NCT02311361|64769069|FG003|Overall Study|Did not receive treatment|1|||
23280575|NCT00583453|64769070|FG000|Overall Study|discontinued intervention|0|||
23280576|NCT00583453|64769071|FG001|Overall Study|discontinued intervention|2|||
23280577|NCT00835692|64769074|FG000|First Intervention|Withdrawal by Subject|1|||
23280578|NCT00835692|64769075|FG001|First Intervention|Withdrawal by Subject|0|||
23372803|NCT02513550|65110044|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
23372804|NCT02513550|65110039|FG000|Double Blind Treatment Period|Due to personal business|2|||
23372805|NCT02513550|65110040|FG001|Double Blind Treatment Period|Due to personal business|0|||
23372806|NCT02513550|65110041|FG002|Double Blind Treatment Period|Due to personal business|1|||
23372807|NCT02513550|65110042|FG003|Double Blind Treatment Period|Due to personal business|0|||
23372808|NCT02513550|65110043|FG004|Double Blind Treatment Period|Due to personal business|0|||
23372809|NCT02513550|65110044|FG005|Double Blind Treatment Period|Due to personal business|0|||
23372810|NCT02513550|65110039|FG000|Double Blind Treatment Period|Death|1|||
23372811|NCT02513550|65110040|FG001|Double Blind Treatment Period|Death|0|||
23372812|NCT02513550|65110041|FG002|Double Blind Treatment Period|Death|2|||
23372813|NCT02513550|65110042|FG003|Double Blind Treatment Period|Death|0|||
23372814|NCT02513550|65110043|FG004|Double Blind Treatment Period|Death|0|||
23372815|NCT02513550|65110044|FG005|Double Blind Treatment Period|Death|0|||
23372816|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
23372817|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
23372818|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
23372819|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23372820|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23372821|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
23372822|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
23372823|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
23372824|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
23372825|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
23372826|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
23372827|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
23372828|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
23372829|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
23372830|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
23372831|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23372832|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23372833|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
23372834|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
23372835|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
23372836|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
23372837|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
23372838|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
23372839|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
23372840|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
23372841|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
23372842|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
23372843|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
23372844|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
23372845|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
23372846|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Death|0|||
23372847|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Death|0|||
23372848|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Death|1|||
23372849|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Death|0|||
23372850|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Death|0|||
23372851|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Death|0|||
23372852|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372853|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372854|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
23372855|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372856|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372857|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
23372858|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372859|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372860|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
23372861|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372862|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372863|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
23372864|NCT02513550|65110039|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
23372865|NCT02513550|65110040|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
23486781|NCT00749580|65527273|FG001|Overall Study|Adverse Event|1|||
23486782|NCT03911154|65527274|FG000|Overall Study|Withdrawal by Subject|1|||
23486783|NCT02788474|65527278|FG000|Double Blind Treatment Period|Not treated|1|||
23372866|NCT02513550|65110041|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
23372867|NCT02513550|65110042|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
23372868|NCT02513550|65110043|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
23372869|NCT02513550|65110044|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
23372870|NCT00091819|65110048|FG000|Overall Study|Adverse Event|1|||
23372871|NCT00091819|65110049|FG001|Overall Study|Adverse Event|1|||
23372872|NCT00091819|65110048|FG000|Overall Study|Death|4|||
23372873|NCT00091819|65110049|FG001|Overall Study|Death|5|||
23372874|NCT00091819|65110048|FG000|Overall Study|Lost to Follow-up|26|||
23372875|NCT00091819|65110049|FG001|Overall Study|Lost to Follow-up|23|||
23372876|NCT00091819|65110048|FG000|Overall Study|Withdrawal by Subject|5|||
23372877|NCT00091819|65110049|FG001|Overall Study|Withdrawal by Subject|8|||
23372878|NCT00091819|65110048|FG000|Overall Study|Protocol Violation|1|||
23372879|NCT00091819|65110049|FG001|Overall Study|Protocol Violation|2|||
23372880|NCT00091819|65110048|FG000|Overall Study|Other|2|||
23372881|NCT00091819|65110049|FG001|Overall Study|Other|3|||
23372882|NCT00091819|65110048|FG000|Overall Study|Never received study treatment|3|||
23372883|NCT00091819|65110049|FG001|Overall Study|Never received study treatment|4|||
23372884|NCT01699750|65110050|FG000|Overall Study|Withdrew Consent|0|||
23372885|NCT01699750|65110051|FG001|Overall Study|Withdrew Consent|1|||
23372886|NCT01699750|65110050|FG000|Overall Study|Other|0|||
23372887|NCT01699750|65110051|FG001|Overall Study|Other|2|||
23372888|NCT00321763|65110052|FG000|Overall Study|Adverse Event|1|||
23372889|NCT00321763|65110053|FG001|Overall Study|Adverse Event|1|||
23372890|NCT00321763|65110054|FG002|Overall Study|Adverse Event|0|||
23372891|NCT00321763|65110055|FG003|Overall Study|Adverse Event|1|||
23372892|NCT00321763|65110052|FG000|Overall Study|Withdrawal by Subject|2|||
23372893|NCT00321763|65110053|FG001|Overall Study|Withdrawal by Subject|0|||
23372894|NCT00321763|65110054|FG002|Overall Study|Withdrawal by Subject|1|||
23372895|NCT00321763|65110055|FG003|Overall Study|Withdrawal by Subject|0|||
23372896|NCT00321763|65110052|FG000|Overall Study|Lost to Follow-up|3|||
23372897|NCT00321763|65110053|FG001|Overall Study|Lost to Follow-up|1|||
23372898|NCT00321763|65110054|FG002|Overall Study|Lost to Follow-up|5|||
23372899|NCT00321763|65110055|FG003|Overall Study|Lost to Follow-up|4|||
23372900|NCT03444584|65110056|FG000|Overall Study|Withdrawal by Subject|0|||
23372901|NCT03444584|65110057|FG001|Overall Study|Withdrawal by Subject|1|||
23372902|NCT03444584|65110056|FG000|Overall Study|Other|0|||
23372903|NCT03444584|65110057|FG001|Overall Study|Other|1|||
23372904|NCT03863353|65110058|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
23372905|NCT03863353|65110059|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
23372906|NCT03034967|65110060|FG000|Overall Study|Withdrawal by Subject|9|||
23372907|NCT03034967|65110061|FG001|Overall Study|Withdrawal by Subject|2|||
23372908|NCT03034967|65110062|FG002|Overall Study|Withdrawal by Subject|6|||
23372909|NCT03034967|65110063|FG003|Overall Study|Withdrawal by Subject|6|||
23372910|NCT03034967|65110064|FG004|Overall Study|Withdrawal by Subject|9|||
23372911|NCT03034967|65110065|FG005|Overall Study|Withdrawal by Subject|2|||
23372912|NCT03034967|65110060|FG000|Overall Study|Physician Decision|1|||
23372913|NCT03034967|65110061|FG001|Overall Study|Physician Decision|0|||
23372914|NCT03034967|65110062|FG002|Overall Study|Physician Decision|1|||
23372915|NCT03034967|65110063|FG003|Overall Study|Physician Decision|1|||
23372916|NCT03034967|65110064|FG004|Overall Study|Physician Decision|1|||
23372917|NCT03034967|65110065|FG005|Overall Study|Physician Decision|0|||
23372918|NCT03034967|65110060|FG000|Overall Study|Lost to Follow-up|0|||
23372919|NCT03034967|65110061|FG001|Overall Study|Lost to Follow-up|0|||
23372920|NCT03034967|65110062|FG002|Overall Study|Lost to Follow-up|0|||
23372921|NCT03034967|65110063|FG003|Overall Study|Lost to Follow-up|1|||
23372922|NCT03034967|65110064|FG004|Overall Study|Lost to Follow-up|0|||
23372923|NCT03034967|65110065|FG005|Overall Study|Lost to Follow-up|2|||
23372924|NCT03034967|65110060|FG000|Overall Study|Liver function test abnormality|0|||
23372925|NCT03034967|65110061|FG001|Overall Study|Liver function test abnormality|0|||
23372926|NCT03034967|65110062|FG002|Overall Study|Liver function test abnormality|1|||
23486784|NCT02788474|65527279|FG001|Double Blind Treatment Period|Not treated|0|||
23372927|NCT03034967|65110063|FG003|Overall Study|Liver function test abnormality|0|||
23372928|NCT03034967|65110064|FG004|Overall Study|Liver function test abnormality|0|||
23372929|NCT03034967|65110065|FG005|Overall Study|Liver function test abnormality|0|||
23372930|NCT03034967|65110060|FG000|Overall Study|Protocol Violation|1|||
23372931|NCT03034967|65110061|FG001|Overall Study|Protocol Violation|0|||
23372932|NCT03034967|65110062|FG002|Overall Study|Protocol Violation|0|||
23372933|NCT03034967|65110063|FG003|Overall Study|Protocol Violation|0|||
23372934|NCT03034967|65110064|FG004|Overall Study|Protocol Violation|0|||
23372935|NCT03034967|65110065|FG005|Overall Study|Protocol Violation|2|||
23372936|NCT03034967|65110060|FG000|Overall Study|Lack of Efficacy|0|||
23372937|NCT03034967|65110061|FG001|Overall Study|Lack of Efficacy|1|||
23372938|NCT03034967|65110062|FG002|Overall Study|Lack of Efficacy|2|||
23372939|NCT03034967|65110063|FG003|Overall Study|Lack of Efficacy|1|||
23372940|NCT03034967|65110064|FG004|Overall Study|Lack of Efficacy|1|||
23372941|NCT03034967|65110065|FG005|Overall Study|Lack of Efficacy|0|||
23486785|NCT02788474|65527278|FG000|Double Blind Treatment Period|Patient's refusal|3|||
23201456|NCT03650452|64476737|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23201457|NCT03650452|64476736|FG000|Overall Study|Adverse Event|3|||
23201458|NCT03650452|64476737|FG001|Overall Study|Adverse Event|4|||
23201459|NCT03650452|64476736|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
23201460|NCT03650452|64476737|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
23201461|NCT04439838|64476743|FG000|Overall Study|Withdrawal by Subject|0|||
23201462|NCT04439838|64476744|FG001|Overall Study|Withdrawal by Subject|0|||
23201463|NCT04439838|64476745|FG002|Overall Study|Withdrawal by Subject|0|||
23201464|NCT04439838|64476746|FG003|Overall Study|Withdrawal by Subject|0|||
23201465|NCT04439838|64476747|FG004|Overall Study|Withdrawal by Subject|0|||
23201466|NCT04439838|64476748|FG005|Overall Study|Withdrawal by Subject|0|||
23201467|NCT04439838|64476749|FG006|Overall Study|Withdrawal by Subject|0|||
23201468|NCT04439838|64476750|FG007|Overall Study|Withdrawal by Subject|0|||
23201469|NCT04439838|64476751|FG008|Overall Study|Withdrawal by Subject|1|||
23201470|NCT00789477|64476752|FG000|Overall Study|Withdrawal by Subject|2|||
23201471|NCT00789477|64476753|FG001|Overall Study|Withdrawal by Subject|1|||
23201472|NCT00789477|64476754|FG002|Overall Study|Withdrawal by Subject|3|||
23201473|NCT00789477|64476755|FG003|Overall Study|Withdrawal by Subject|2|||
23201474|NCT00789477|64476756|FG004|Overall Study|Withdrawal by Subject|3|||
23201475|NCT00789477|64476752|FG000|Overall Study|Protocol Violation|1|||
23201476|NCT00789477|64476753|FG001|Overall Study|Protocol Violation|0|||
23201477|NCT00789477|64476754|FG002|Overall Study|Protocol Violation|0|||
23201478|NCT00789477|64476755|FG003|Overall Study|Protocol Violation|1|||
23201479|NCT00789477|64476756|FG004|Overall Study|Protocol Violation|0|||
23201480|NCT00789477|64476752|FG000|Overall Study|Adverse Event|3|||
23201481|NCT00789477|64476753|FG001|Overall Study|Adverse Event|3|||
23201482|NCT00789477|64476754|FG002|Overall Study|Adverse Event|1|||
23201483|NCT00789477|64476755|FG003|Overall Study|Adverse Event|0|||
23201484|NCT00789477|64476756|FG004|Overall Study|Adverse Event|0|||
23201485|NCT00789477|64476752|FG000|Overall Study|Death|1|||
23372942|NCT03034967|65110060|FG000|Overall Study|Adverse Event, non-fatal|3|||
23372943|NCT03034967|65110061|FG001|Overall Study|Adverse Event, non-fatal|1|||
23372944|NCT03034967|65110062|FG002|Overall Study|Adverse Event, non-fatal|2|||
23280579|NCT03635320|64769076|FG000|Overall Study|not implanted the device|1|||
23280580|NCT03635320|64769077|FG001|Overall Study|not implanted the device|2|||
23280581|NCT03635320|64769076|FG000|Overall Study|Withdrawal by Subject|11|||
23280582|NCT03635320|64769077|FG001|Overall Study|Withdrawal by Subject|6|||
23280583|NCT00829452|64769079|FG000|First Intervention|Withdrawal by Subject|0|||
23280584|NCT00829452|64769080|FG001|First Intervention|Withdrawal by Subject|1|||
23280585|NCT00829452|64769079|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
23280586|NCT00829452|64769080|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
23280587|NCT00829452|64769079|FG000|Second Intervention|Physician Decision|0|||
23280588|NCT00829452|64769080|FG001|Second Intervention|Physician Decision|1|||
23372945|NCT03034967|65110063|FG003|Overall Study|Adverse Event, non-fatal|0|||
23372946|NCT03034967|65110064|FG004|Overall Study|Adverse Event, non-fatal|2|||
23372947|NCT03034967|65110065|FG005|Overall Study|Adverse Event, non-fatal|8|||
23372948|NCT03034967|65110060|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
23372949|NCT03034967|65110061|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
23372950|NCT03034967|65110062|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
23372951|NCT03034967|65110063|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
23372952|NCT03034967|65110064|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
23372953|NCT03034967|65110065|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
23372954|NCT03257267|65112520|FG000|Overall Study|Adverse Event|17|||
23372955|NCT03257267|65112521|FG001|Overall Study|Adverse Event|7|||
23372956|NCT03257267|65112520|FG000|Overall Study|Death|96|||
23372957|NCT03257267|65112521|FG001|Overall Study|Death|98|||
23372958|NCT03257267|65112520|FG000|Overall Study|Lost to Follow-up|2|||
23372959|NCT03257267|65112521|FG001|Overall Study|Lost to Follow-up|2|||
23372960|NCT03257267|65112520|FG000|Overall Study|Non-compliance with Study Drug|0|||
23372961|NCT03257267|65112521|FG001|Overall Study|Non-compliance with Study Drug|2|||
23372962|NCT03257267|65112520|FG000|Overall Study|Participant Decision|35|||
23372963|NCT03257267|65112521|FG001|Overall Study|Participant Decision|43|||
23372964|NCT03257267|65112520|FG000|Overall Study|Sponsor Decision|1|||
23372965|NCT03257267|65112521|FG001|Overall Study|Sponsor Decision|0|||
23372966|NCT03257267|65112520|FG000|Overall Study|Physician Decision|1|||
23372967|NCT03257267|65112521|FG001|Overall Study|Physician Decision|3|||
23372968|NCT03257267|65112520|FG000|Overall Study|Disease Progression|109|||
23372969|NCT03257267|65112521|FG001|Overall Study|Disease Progression|121|||
23372970|NCT03257267|65112520|FG000|Overall Study|Withdrawal by Subject|8|||
23372971|NCT03257267|65112521|FG001|Overall Study|Withdrawal by Subject|26|||
23372972|NCT03257267|65112520|FG000|Overall Study|Other|0|||
23372973|NCT03257267|65112521|FG001|Overall Study|Other|2|||
23372974|NCT01721798|65112528|FG000|Overall Study|Death|0|||
23372975|NCT01721798|65112529|FG001|Overall Study|Death|0|||
23372976|NCT01721798|65112530|FG002|Overall Study|Death|1|||
23372977|NCT01721798|65112531|FG003|Overall Study|Death|1|||
23372978|NCT01721798|65112528|FG000|Overall Study|Lost to Follow-up|2|||
23372979|NCT01721798|65112529|FG001|Overall Study|Lost to Follow-up|2|||
23372980|NCT01721798|65112530|FG002|Overall Study|Lost to Follow-up|9|||
23372981|NCT01721798|65112531|FG003|Overall Study|Lost to Follow-up|9|||
23372982|NCT01721798|65112528|FG000|Overall Study|Pregnancy|0|||
23372983|NCT01721798|65112529|FG001|Overall Study|Pregnancy|0|||
23372984|NCT01721798|65112530|FG002|Overall Study|Pregnancy|1|||
23372985|NCT01721798|65112531|FG003|Overall Study|Pregnancy|1|||
23372986|NCT01721798|65112528|FG000|Overall Study|Withdrawal by Subject|1|||
23372987|NCT01721798|65112529|FG001|Overall Study|Withdrawal by Subject|0|||
23372988|NCT01721798|65112530|FG002|Overall Study|Withdrawal by Subject|2|||
23372989|NCT01721798|65112531|FG003|Overall Study|Withdrawal by Subject|1|||
23372990|NCT01721798|65112528|FG000|Overall Study|Not eligible for 24 month visit|1|||
23372991|NCT01721798|65112529|FG001|Overall Study|Not eligible for 24 month visit|0|||
23372992|NCT01721798|65112530|FG002|Overall Study|Not eligible for 24 month visit|8|||
23372993|NCT01721798|65112531|FG003|Overall Study|Not eligible for 24 month visit|7|||
23372994|NCT01030900|65112536|FG000|Overall Study|Not treated due to congestive heart failure|1|||
23372995|NCT01030900|65112536|FG000|Overall Study|Not treated due to rapid disease|1|||
23372996|NCT01569022|65112541|FG000|First Intervention|Lost to Follow-up|2|||
23280589|NCT01466166|64769081|FG000|Overall Study|Death|1|||
23372997|NCT01569022|65112542|FG001|First Intervention|Lost to Follow-up|1|||
23280590|NCT01466166|64769081|FG000|Overall Study|Lost to Follow-up|7|||
23280591|NCT01466166|64769081|FG000|Overall Study|Infusion Reaction (IR)|27|||
23372998|NCT01569022|65112541|FG000|Second Intervention|Lost to Follow-up|2|||
23372999|NCT01569022|65112542|FG001|Second Intervention|Lost to Follow-up|2|||
23373000|NCT00537277|65112543|FG000|Overall Study|Adverse Event|1|||
23373001|NCT00537277|65112543|FG000|Overall Study|Lack of Efficacy|2|||
23373002|NCT00537277|65112543|FG000|Overall Study|Lost to Follow-up|12|||
23373003|NCT00537277|65112543|FG000|Overall Study|Protocol Violation|11|||
23373004|NCT00537277|65112543|FG000|Overall Study|Unclassified|4|||
23373005|NCT00537277|65112543|FG000|Overall Study|Inability to tolerate trial medication|4|||
23373006|NCT00537277|65112543|FG000|Overall Study|Non-compliance with trial procedures|15|||
23373007|NCT00171249|65112551|FG000|Overall Study|Withdrawal by Subject|2|||
23373008|NCT00171249|65112552|FG001|Overall Study|Withdrawal by Subject|0|||
23373009|NCT00171249|65112553|FG002|Overall Study|Withdrawal by Subject|0|||
23373010|NCT00171249|65112554|FG003|Overall Study|Withdrawal by Subject|6|||
23373011|NCT00171249|65112555|FG004|Overall Study|Withdrawal by Subject|0|||
23373012|NCT00171249|65112556|FG005|Overall Study|Withdrawal by Subject|0|||
23373013|NCT00171249|65112557|FG006|Overall Study|Withdrawal by Subject|0|||
23373014|NCT00171249|65112551|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
23373015|NCT00171249|65112552|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23373016|NCT00171249|65112553|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
23373017|NCT00171249|65112554|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
23373018|NCT00171249|65112555|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
23373019|NCT00171249|65112556|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
23373020|NCT00171249|65112557|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
23373021|NCT00171249|65112551|FG000|Overall Study|Death|7|||
23373022|NCT00171249|65112552|FG001|Overall Study|Death|1|||
23373023|NCT00171249|65112553|FG002|Overall Study|Death|0|||
23373024|NCT00171249|65112554|FG003|Overall Study|Death|4|||
23373025|NCT00171249|65112555|FG004|Overall Study|Death|0|||
23373026|NCT00171249|65112556|FG005|Overall Study|Death|3|||
23373027|NCT00171249|65112557|FG006|Overall Study|Death|1|||
23373028|NCT00171249|65112551|FG000|Overall Study|Other|10|||
23373029|NCT00171249|65112552|FG001|Overall Study|Other|0|||
23373030|NCT00171249|65112553|FG002|Overall Study|Other|0|||
23373031|NCT00171249|65112554|FG003|Overall Study|Other|43|||
23373032|NCT00171249|65112555|FG004|Overall Study|Other|0|||
23373033|NCT00171249|65112556|FG005|Overall Study|Other|2|||
23373034|NCT00171249|65112557|FG006|Overall Study|Other|0|||
23373035|NCT00171249|65112551|FG000|Overall Study|No Longer Requires Study Drug|4|||
23373036|NCT00171249|65112552|FG001|Overall Study|No Longer Requires Study Drug|0|||
23373037|NCT00171249|65112553|FG002|Overall Study|No Longer Requires Study Drug|0|||
23373038|NCT00171249|65112554|FG003|Overall Study|No Longer Requires Study Drug|3|||
23373039|NCT00171249|65112555|FG004|Overall Study|No Longer Requires Study Drug|0|||
23373040|NCT00171249|65112556|FG005|Overall Study|No Longer Requires Study Drug|5|||
23373041|NCT00171249|65112557|FG006|Overall Study|No Longer Requires Study Drug|0|||
23373042|NCT00171249|65112551|FG000|Overall Study|Administrative Problems|1|||
23373043|NCT00171249|65112552|FG001|Overall Study|Administrative Problems|0|||
23373044|NCT00171249|65112553|FG002|Overall Study|Administrative Problems|0|||
23373045|NCT00171249|65112554|FG003|Overall Study|Administrative Problems|2|||
23373046|NCT00171249|65112555|FG004|Overall Study|Administrative Problems|0|||
23373047|NCT00171249|65112556|FG005|Overall Study|Administrative Problems|0|||
23373048|NCT00171249|65112557|FG006|Overall Study|Administrative Problems|0|||
23373049|NCT00171249|65112551|FG000|Overall Study|Adverse Event|3|||
23373050|NCT00171249|65112552|FG001|Overall Study|Adverse Event|1|||
23373051|NCT00171249|65112553|FG002|Overall Study|Adverse Event|0|||
23373052|NCT00171249|65112554|FG003|Overall Study|Adverse Event|15|||
23373053|NCT00171249|65112555|FG004|Overall Study|Adverse Event|0|||
23373054|NCT00171249|65112556|FG005|Overall Study|Adverse Event|2|||
23373055|NCT00171249|65112557|FG006|Overall Study|Adverse Event|0|||
23373056|NCT00171249|65112551|FG000|Overall Study|Lost to Follow-up|5|||
23373057|NCT00171249|65112552|FG001|Overall Study|Lost to Follow-up|0|||
23373058|NCT00171249|65112553|FG002|Overall Study|Lost to Follow-up|0|||
23373059|NCT00171249|65112554|FG003|Overall Study|Lost to Follow-up|9|||
23373060|NCT00171249|65112555|FG004|Overall Study|Lost to Follow-up|0|||
23373061|NCT00171249|65112556|FG005|Overall Study|Lost to Follow-up|0|||
23373062|NCT00171249|65112557|FG006|Overall Study|Lost to Follow-up|0|||
23373063|NCT01868646|65112558|FG000|Overall Study|Do not meet inclusion criteria|3|||
23373064|NCT01868646|65112559|FG001|Overall Study|Do not meet inclusion criteria|5|||
23373065|NCT00719901|65112563|FG000|Overall Study|Adverse Event|5|||
23373066|NCT00719901|65112563|FG000|Overall Study|Withdrawal by Subject|1|||
23373067|NCT00719901|65112563|FG000|Overall Study|Alternate Treatment|1|||
23373068|NCT00719901|65112563|FG000|Overall Study|Disease Progression|3|||
23486786|NCT02788474|65527279|FG001|Double Blind Treatment Period|Patient's refusal|0|||
23373069|NCT00719901|65112563|FG000|Overall Study|Availability of Study Drug|1|||
23373070|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
23373071|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
23373072|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
23373073|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
23373074|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
23373075|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
23373076|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
23373077|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
23373078|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
23373079|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
23373080|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
23373081|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
23373082|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
23373083|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
23373084|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
23373085|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
23373086|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
23373087|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
23373088|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
23373089|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
23373090|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
23373091|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
23373092|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
23373093|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
23373094|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
23373095|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
23373096|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
23373097|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
23373098|NCT01668797|65112564|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
23373099|NCT01668797|65112565|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
23373100|NCT01668797|65112566|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
23373101|NCT01668797|65112567|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
23373102|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
23373103|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
23373104|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
23373105|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
23373106|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
23373107|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
23373108|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
23373109|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
23373110|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
23373111|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
23373112|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
23373113|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
23373114|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
23280592|NCT01466166|64769081|FG000|Overall Study|Adverse Event (Other than IR)|11|||
23280593|NCT01466166|64769081|FG000|Overall Study|Elevated Serum Uric Acid|78|||
23280594|NCT01466166|64769081|FG000|Overall Study|Withdrawal by Subject|13|||
23280595|NCT01466166|64769081|FG000|Overall Study|Sponsor Decision|4|||
23280596|NCT01466166|64769081|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
23280597|NCT01466166|64769081|FG000|Overall Study|Other|20|||
23280598|NCT00838279|64769083|FG000|Washout|Protocol Violation|1|||
23280599|NCT00838279|64769084|FG001|Washout|Protocol Violation|0|||
23280600|NCT00838279|64769083|FG000|Washout|Withdrawal by Subject|0|||
23280601|NCT00838279|64769084|FG001|Washout|Withdrawal by Subject|1|||
23280602|NCT02902211|64769085|FG000|First Three Months|Withdrawal by Subject|7|||
23280603|NCT02902211|64769086|FG001|First Three Months|Withdrawal by Subject|3|||
23280604|NCT03273153|64769089|FG000|Overall Study|Adverse Event|1|||
23280605|NCT03273153|64769090|FG001|Overall Study|Adverse Event|2|||
23280606|NCT03273153|64769089|FG000|Overall Study|Missing|0|||
23280607|NCT03273153|64769090|FG001|Overall Study|Missing|2|||
23280608|NCT03273153|64769089|FG000|Overall Study|Other|3|||
23280609|NCT03273153|64769090|FG001|Overall Study|Other|2|||
23280610|NCT03273153|64769089|FG000|Overall Study|Symptomatic Deterioration|0|||
23280611|NCT03273153|64769090|FG001|Overall Study|Symptomatic Deterioration|1|||
23280612|NCT03273153|64769089|FG000|Overall Study|Progressive Disease|6|||
23280613|NCT03273153|64769090|FG001|Overall Study|Progressive Disease|5|||
23280614|NCT03273153|64769089|FG000|Overall Study|Physician Decision|1|||
23280615|NCT03273153|64769090|FG001|Overall Study|Physician Decision|3|||
23280616|NCT03273153|64769089|FG000|Overall Study|Study Terminated by Sponsor|112|||
23280617|NCT03273153|64769090|FG001|Overall Study|Study Terminated by Sponsor|102|||
23280618|NCT03273153|64769089|FG000|Overall Study|Withdrawal by Subject|26|||
23280619|NCT03273153|64769090|FG001|Overall Study|Withdrawal by Subject|25|||
23280620|NCT03273153|64769089|FG000|Overall Study|Protocol Deviation|3|||
23280621|NCT03273153|64769090|FG001|Overall Study|Protocol Deviation|0|||
23280622|NCT03273153|64769089|FG000|Overall Study|Lost to Follow-up|6|||
23280623|NCT03273153|64769090|FG001|Overall Study|Lost to Follow-up|11|||
23280624|NCT03273153|64769089|FG000|Overall Study|Death|66|||
23280625|NCT03273153|64769090|FG001|Overall Study|Death|69|||
23373115|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
23373116|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
23280626|NCT01948258|64769091|FG000|Overall Study|Pregnancy|41|||
23280627|NCT01948258|64769091|FG000|Overall Study|Did not complete by cut-off date|35|||
23373117|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
23373118|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
23373119|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
23373120|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
23373121|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
23373122|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
23373123|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
23373124|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
23373125|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
23373126|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
23373127|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
23373128|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
23373129|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
23373130|NCT01668797|65112564|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
23373131|NCT01668797|65112565|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
23373132|NCT01668797|65112566|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
23373133|NCT01668797|65112567|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
23373134|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
23373135|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
23373136|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
23373137|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
23373138|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
23373139|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
23373140|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
23373141|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
23373142|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
23373143|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
23373144|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
23373145|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
23373146|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
23373147|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
23373148|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
23373149|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
23373150|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
23373151|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
23373152|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
23373153|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
23373154|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
23373155|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
23373156|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
23373157|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
23373158|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
23373159|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
23373160|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
23373161|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
23373162|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
23373163|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
23373164|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
23373165|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
23373166|NCT01668797|65112564|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
23373167|NCT01668797|65112565|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
23373168|NCT01668797|65112566|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
23373169|NCT01668797|65112567|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
23373170|NCT01349595|65112568|FG000|Overall Study|Lack of funding|2|||
23373171|NCT01349595|65112569|FG001|Overall Study|Lack of funding|2|||
23373172|NCT00069264|65112570|FG000|Overall Study|Adverse Event|3|||
23373173|NCT00069264|65112570|FG000|Overall Study|Progressive Disease|23|||
23373174|NCT00069264|65112570|FG000|Overall Study|Withdrawal by Subject|3|||
23373175|NCT00069264|65112570|FG000|Overall Study|Discon Therapy|3|||
23373176|NCT05412134|65112579|FG000|Overall Study|Lost to Follow-up|2|||
23373177|NCT05412134|65112580|FG001|Overall Study|Lost to Follow-up|0|||
23373178|NCT00487188|65112581|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
23373179|NCT00487188|65112582|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
23373180|NCT00487188|65112583|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
23373181|NCT00487188|65112581|FG000|Induction Phase|Adverse Event|5|||
23373182|NCT00487188|65112582|FG001|Induction Phase|Adverse Event|0|||
23373183|NCT00487188|65112583|FG002|Induction Phase|Adverse Event|0|||
23373184|NCT00487188|65112581|FG000|Induction Phase|Lack of Efficacy|0|||
23373185|NCT00487188|65112582|FG001|Induction Phase|Lack of Efficacy|1|||
23373186|NCT00487188|65112583|FG002|Induction Phase|Lack of Efficacy|0|||
23373187|NCT00487188|65112581|FG000|Induction Phase|Protocol Violation|1|||
23373188|NCT00487188|65112582|FG001|Induction Phase|Protocol Violation|0|||
23373189|NCT00487188|65112583|FG002|Induction Phase|Protocol Violation|0|||
23373190|NCT00487188|65112581|FG000|Induction Phase|Refused Treatment|1|||
23373191|NCT00487188|65112582|FG001|Induction Phase|Refused Treatment|2|||
23373192|NCT00487188|65112583|FG002|Induction Phase|Refused Treatment|0|||
23373193|NCT00487188|65112581|FG000|Induction Phase|Lost to Follow-up|2|||
23373194|NCT00487188|65112582|FG001|Induction Phase|Lost to Follow-up|2|||
23373195|NCT00487188|65112583|FG002|Induction Phase|Lost to Follow-up|0|||
23373196|NCT00487188|65112581|FG000|Induction Phase|Administrative|0|||
23373197|NCT00487188|65112582|FG001|Induction Phase|Administrative|1|||
23373198|NCT00487188|65112583|FG002|Induction Phase|Administrative|0|||
23373199|NCT00487188|65112581|FG000|Maintenance Phase|Adverse Event|1|||
23373200|NCT00487188|65112582|FG001|Maintenance Phase|Adverse Event|0|||
23373201|NCT00487188|65112583|FG002|Maintenance Phase|Adverse Event|0|||
23373202|NCT00487188|65112581|FG000|Maintenance Phase|Death|1|||
23373203|NCT00487188|65112582|FG001|Maintenance Phase|Death|0|||
23373204|NCT00487188|65112583|FG002|Maintenance Phase|Death|0|||
23373205|NCT00487188|65112581|FG000|Maintenance Phase|Lost to Follow-up|1|||
23373206|NCT00487188|65112582|FG001|Maintenance Phase|Lost to Follow-up|0|||
23373207|NCT00487188|65112583|FG002|Maintenance Phase|Lost to Follow-up|0|||
23373208|NCT00487188|65112581|FG000|Maintenance Phase|Administrative|0|||
23373209|NCT00487188|65112582|FG001|Maintenance Phase|Administrative|0|||
23373210|NCT00487188|65112583|FG002|Maintenance Phase|Administrative|1|||
23373211|NCT02164916|65112584|FG000|Overall Study|Adverse Event|3|||
23373212|NCT02164916|65112585|FG001|Overall Study|Adverse Event|8|||
23373213|NCT02164916|65112584|FG000|Overall Study|Death|1|||
23373214|NCT02164916|65112585|FG001|Overall Study|Death|1|||
23373215|NCT02164916|65112584|FG000|Overall Study|Refusal unrelated to adverse event|3|||
23373216|NCT02164916|65112585|FG001|Overall Study|Refusal unrelated to adverse event|7|||
23373217|NCT02164916|65112584|FG000|Overall Study|Progression|37|||
23373218|NCT02164916|65112585|FG001|Overall Study|Progression|26|||
23373219|NCT02164916|65112584|FG000|Overall Study|Not protocol specified|5|||
23373220|NCT02164916|65112585|FG001|Overall Study|Not protocol specified|1|||
23373221|NCT02164916|65112584|FG000|Overall Study|Reason under review|1|||
23373222|NCT02164916|65112585|FG001|Overall Study|Reason under review|6|||
23373223|NCT02164916|65112584|FG000|Overall Study|Not eligible|2|||
23373224|NCT02164916|65112585|FG001|Overall Study|Not eligible|5|||
23373225|NCT01799889|65112586|FG000|Overall Study|Adverse Event|4|||
23373226|NCT01799889|65112587|FG001|Overall Study|Adverse Event|4|||
23373227|NCT01799889|65112588|FG002|Overall Study|Adverse Event|5|||
23373228|NCT01799889|65112589|FG003|Overall Study|Adverse Event|1|||
23373229|NCT01799889|65112590|FG004|Overall Study|Adverse Event|11|||
23373230|NCT01799889|65112591|FG005|Overall Study|Adverse Event|1|||
23373231|NCT01799889|65112592|FG006|Overall Study|Adverse Event|5|||
23373232|NCT01799889|65112593|FG007|Overall Study|Adverse Event|2|||
23373233|NCT01799889|65112594|FG008|Overall Study|Adverse Event|3|||
23373234|NCT01799889|65112595|FG009|Overall Study|Adverse Event|1|||
23373235|NCT01799889|65112596|FG010|Overall Study|Adverse Event|1|||
23373236|NCT01799889|65112597|FG011|Overall Study|Adverse Event|0|||
23373237|NCT01799889|65112586|FG000|Overall Study|Death|1|||
23373238|NCT01799889|65112587|FG001|Overall Study|Death|0|||
23373239|NCT01799889|65112588|FG002|Overall Study|Death|5|||
23373240|NCT01799889|65112589|FG003|Overall Study|Death|3|||
23373241|NCT01799889|65112590|FG004|Overall Study|Death|1|||
23373242|NCT01799889|65112591|FG005|Overall Study|Death|0|||
23373243|NCT01799889|65112592|FG006|Overall Study|Death|0|||
23373244|NCT01799889|65112593|FG007|Overall Study|Death|0|||
23373245|NCT01799889|65112594|FG008|Overall Study|Death|1|||
23373246|NCT01799889|65112595|FG009|Overall Study|Death|0|||
23373247|NCT01799889|65112596|FG010|Overall Study|Death|1|||
23373248|NCT01799889|65112597|FG011|Overall Study|Death|0|||
23373249|NCT01799889|65112586|FG000|Overall Study|Lack of Efficacy|1|||
23373250|NCT01799889|65112587|FG001|Overall Study|Lack of Efficacy|1|||
23373251|NCT01799889|65112588|FG002|Overall Study|Lack of Efficacy|0|||
23603660|NCT01262456|65937442|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
23373252|NCT01799889|65112589|FG003|Overall Study|Lack of Efficacy|1|||
23373253|NCT01799889|65112590|FG004|Overall Study|Lack of Efficacy|2|||
23373254|NCT01799889|65112591|FG005|Overall Study|Lack of Efficacy|2|||
23373255|NCT01799889|65112592|FG006|Overall Study|Lack of Efficacy|0|||
23373256|NCT01799889|65112593|FG007|Overall Study|Lack of Efficacy|0|||
23373257|NCT01799889|65112594|FG008|Overall Study|Lack of Efficacy|2|||
23373258|NCT01799889|65112595|FG009|Overall Study|Lack of Efficacy|0|||
23373259|NCT01799889|65112596|FG010|Overall Study|Lack of Efficacy|1|||
23373260|NCT01799889|65112597|FG011|Overall Study|Lack of Efficacy|0|||
23373261|NCT01799889|65112586|FG000|Overall Study|Lost to Follow-up|0|||
23373262|NCT01799889|65112587|FG001|Overall Study|Lost to Follow-up|1|||
23373263|NCT01799889|65112588|FG002|Overall Study|Lost to Follow-up|0|||
23373264|NCT01799889|65112589|FG003|Overall Study|Lost to Follow-up|0|||
23373265|NCT01799889|65112590|FG004|Overall Study|Lost to Follow-up|0|||
23373266|NCT01799889|65112591|FG005|Overall Study|Lost to Follow-up|0|||
23373267|NCT01799889|65112592|FG006|Overall Study|Lost to Follow-up|0|||
23373268|NCT01799889|65112593|FG007|Overall Study|Lost to Follow-up|0|||
23373269|NCT01799889|65112594|FG008|Overall Study|Lost to Follow-up|0|||
23373270|NCT01799889|65112595|FG009|Overall Study|Lost to Follow-up|0|||
23373271|NCT01799889|65112596|FG010|Overall Study|Lost to Follow-up|0|||
23373272|NCT01799889|65112597|FG011|Overall Study|Lost to Follow-up|0|||
23373273|NCT01799889|65112586|FG000|Overall Study|Physician Decision|3|||
23603661|NCT02158806|65937443|FG000|Overall Study|Death|2|||
23603662|NCT02158806|65937444|FG001|Overall Study|Death|0|||
23603663|NCT02158806|65937443|FG000|Overall Study|Withdrawal by Subject|2|||
23603664|NCT02158806|65937444|FG001|Overall Study|Withdrawal by Subject|0|||
23280628|NCT01948258|64769091|FG000|Overall Study|Lost to Follow-up|27|||
23280629|NCT01948258|64769091|FG000|Overall Study|Withdrawal by SPD|8|||
23280630|NCT01948258|64769091|FG000|Overall Study|Withdrawal by Subject|6|||
23280631|NCT01948258|64769091|FG000|Overall Study|Health Care Professional|43|||
23280632|NCT01948258|64769091|FG000|Overall Study|Removed from statistical analysis|2|||
23280633|NCT01370083|64769096|FG000|Overall Study|Lost to Follow-up|2|||
23280634|NCT01370083|64769097|FG001|Overall Study|Lost to Follow-up|0|||
23280635|NCT01370083|64769096|FG000|Overall Study|Adverse Event|0|||
23280636|NCT01370083|64769097|FG001|Overall Study|Adverse Event|1|||
23280637|NCT00373256|64769098|FG000|Overall Study|Adverse Event (AE)|1|||
23280638|NCT00373256|64769099|FG001|Overall Study|Adverse Event (AE)|5|||
23280639|NCT00373256|64769098|FG000|Overall Study|Lost to Follow-up|2|||
23280640|NCT00373256|64769099|FG001|Overall Study|Lost to Follow-up|1|||
23280641|NCT00373256|64769098|FG000|Overall Study|Death|9|||
23280642|NCT00373256|64769099|FG001|Overall Study|Death|8|||
23280643|NCT00373256|64769098|FG000|Overall Study|Objective Progression or Relapse|111|||
23280644|NCT00373256|64769099|FG001|Overall Study|Objective Progression or Relapse|104|||
23280645|NCT00373256|64769098|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
23280646|NCT00373256|64769099|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
23280647|NCT00373256|64769098|FG000|Overall Study|Other|73|||
23280648|NCT00373256|64769099|FG001|Overall Study|Other|107|||
23280649|NCT00373256|64769098|FG000|Overall Study|Protocol Violation|0|||
23280650|NCT00373256|64769099|FG001|Overall Study|Protocol Violation|2|||
23280651|NCT00373256|64769098|FG000|Overall Study|Study Terminated by Sponsor|41|||
23280652|NCT00373256|64769099|FG001|Overall Study|Study Terminated by Sponsor|13|||
23280653|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
23280654|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
23280655|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
23280656|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
23280657|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
23280658|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
23280659|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
23280660|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
23280661|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
23280662|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
23280663|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
23280664|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
23280665|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
23280666|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
23280667|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
23280668|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
23280669|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
23280670|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
23280671|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
23280672|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
23280673|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
23280674|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
23280675|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
23280676|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
23373274|NCT01799889|65112587|FG001|Overall Study|Physician Decision|2|||
23373275|NCT01799889|65112588|FG002|Overall Study|Physician Decision|4|||
23373276|NCT01799889|65112589|FG003|Overall Study|Physician Decision|4|||
23373277|NCT01799889|65112590|FG004|Overall Study|Physician Decision|5|||
23373278|NCT01799889|65112591|FG005|Overall Study|Physician Decision|5|||
23373279|NCT01799889|65112592|FG006|Overall Study|Physician Decision|5|||
23373280|NCT01799889|65112593|FG007|Overall Study|Physician Decision|2|||
23373281|NCT01799889|65112594|FG008|Overall Study|Physician Decision|6|||
23373282|NCT01799889|65112595|FG009|Overall Study|Physician Decision|0|||
23373283|NCT01799889|65112596|FG010|Overall Study|Physician Decision|0|||
23373284|NCT01799889|65112597|FG011|Overall Study|Physician Decision|1|||
23373285|NCT01799889|65112586|FG000|Overall Study|Progressive Disease|30|||
23373286|NCT01799889|65112587|FG001|Overall Study|Progressive Disease|26|||
23373287|NCT01799889|65112588|FG002|Overall Study|Progressive Disease|25|||
23373288|NCT01799889|65112589|FG003|Overall Study|Progressive Disease|30|||
23373289|NCT01799889|65112590|FG004|Overall Study|Progressive Disease|23|||
23373290|NCT01799889|65112591|FG005|Overall Study|Progressive Disease|9|||
23373291|NCT01799889|65112592|FG006|Overall Study|Progressive Disease|8|||
23373292|NCT01799889|65112593|FG007|Overall Study|Progressive Disease|13|||
23373293|NCT01799889|65112594|FG008|Overall Study|Progressive Disease|18|||
23373294|NCT01799889|65112595|FG009|Overall Study|Progressive Disease|5|||
23373295|NCT01799889|65112596|FG010|Overall Study|Progressive Disease|3|||
23373296|NCT01799889|65112597|FG011|Overall Study|Progressive Disease|1|||
23373297|NCT01799889|65112586|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
23373298|NCT01799889|65112587|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
23373299|NCT01799889|65112588|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
23373300|NCT01799889|65112589|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
23373301|NCT01799889|65112590|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
23373302|NCT01799889|65112591|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
23373303|NCT01799889|65112592|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
23373304|NCT01799889|65112593|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
23373305|NCT01799889|65112594|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
23373306|NCT01799889|65112595|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
23373307|NCT01799889|65112596|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
23373308|NCT01799889|65112597|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
23373309|NCT01799889|65112586|FG000|Overall Study|Study Terminated By Sponsor|1|||
23373310|NCT01799889|65112587|FG001|Overall Study|Study Terminated By Sponsor|0|||
23373311|NCT01799889|65112588|FG002|Overall Study|Study Terminated By Sponsor|0|||
23373312|NCT01799889|65112589|FG003|Overall Study|Study Terminated By Sponsor|0|||
23373313|NCT01799889|65112590|FG004|Overall Study|Study Terminated By Sponsor|2|||
23373314|NCT01799889|65112591|FG005|Overall Study|Study Terminated By Sponsor|1|||
23373315|NCT01799889|65112592|FG006|Overall Study|Study Terminated By Sponsor|0|||
23373316|NCT01799889|65112593|FG007|Overall Study|Study Terminated By Sponsor|2|||
23373317|NCT01799889|65112594|FG008|Overall Study|Study Terminated By Sponsor|1|||
23373318|NCT01799889|65112595|FG009|Overall Study|Study Terminated By Sponsor|1|||
23373319|NCT01799889|65112596|FG010|Overall Study|Study Terminated By Sponsor|0|||
23373320|NCT01799889|65112597|FG011|Overall Study|Study Terminated By Sponsor|0|||
23373321|NCT01799889|65112586|FG000|Overall Study|Withdrawal by Subject|1|||
23373322|NCT01799889|65112587|FG001|Overall Study|Withdrawal by Subject|6|||
23373323|NCT01799889|65112588|FG002|Overall Study|Withdrawal by Subject|4|||
23373324|NCT01799889|65112589|FG003|Overall Study|Withdrawal by Subject|0|||
23486787|NCT02788474|65527278|FG000|Double Blind Treatment Period|Adverse Event|6|||
23486788|NCT02788474|65527279|FG001|Double Blind Treatment Period|Adverse Event|4|||
23486789|NCT02788474|65527278|FG000|Open Label Treatment Period|Adverse Event|29|||
23486790|NCT02788474|65527279|FG001|Open Label Treatment Period|Adverse Event|9|||
23486791|NCT02788474|65527278|FG000|Open Label Treatment Period|Other than reason specified|1|||
23486792|NCT02788474|65527279|FG001|Open Label Treatment Period|Other than reason specified|0|||
23486793|NCT02788474|65527278|FG000|Open Label Treatment Period|Patient's refusal|1|||
23486794|NCT02788474|65527279|FG001|Open Label Treatment Period|Patient's refusal|3|||
23486795|NCT02788474|65527278|FG000|Open Label Treatment Period|Non-compliance|1|||
23486796|NCT02788474|65527279|FG001|Open Label Treatment Period|Non-compliance|0|||
23486797|NCT00267189|65527280|FG000|Overall Study|Patient withdrew consent|1|||
23486798|NCT00267189|65527281|FG001|Overall Study|Patient withdrew consent|1|||
23486799|NCT00267189|65527280|FG000|Overall Study|Death|1|||
23486800|NCT00267189|65527281|FG001|Overall Study|Death|0|||
23486801|NCT00267189|65527280|FG000|Overall Study|Missing|3|||
23486802|NCT00267189|65527281|FG001|Overall Study|Missing|0|||
23486803|NCT01309308|65527290|FG000|Overall Study|Lost to Follow-up|6|||
23603665|NCT02158806|65937443|FG000|Overall Study|Lost to Follow-up|0|||
23603666|NCT02158806|65937444|FG001|Overall Study|Lost to Follow-up|3|||
23373325|NCT01799889|65112590|FG004|Overall Study|Withdrawal by Subject|5|||
23373326|NCT01799889|65112591|FG005|Overall Study|Withdrawal by Subject|1|||
23373327|NCT01799889|65112592|FG006|Overall Study|Withdrawal by Subject|3|||
23373328|NCT01799889|65112593|FG007|Overall Study|Withdrawal by Subject|1|||
23373329|NCT01799889|65112594|FG008|Overall Study|Withdrawal by Subject|2|||
23373330|NCT01799889|65112595|FG009|Overall Study|Withdrawal by Subject|1|||
23373331|NCT01799889|65112596|FG010|Overall Study|Withdrawal by Subject|1|||
23373332|NCT01799889|65112597|FG011|Overall Study|Withdrawal by Subject|1|||
23373333|NCT01799889|65112586|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23373334|NCT01799889|65112587|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23603667|NCT02158806|65937443|FG000|Overall Study|Moved out of area|0|||
23603668|NCT02158806|65937444|FG001|Overall Study|Moved out of area|1|||
23603669|NCT02158806|65937443|FG000|Overall Study|Transferred to palliative care|0|||
23280677|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
23280678|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
23280679|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
23280680|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
23280681|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
23280682|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
23280683|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
23280684|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
23280685|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
23280686|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
23280687|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
23280688|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
23280689|NCT04194801|64769100|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
23280690|NCT04194801|64769101|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
23280691|NCT04194801|64769102|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
23280692|NCT04194801|64769100|FG000|Part Ib/II End of Study|Death|2|||
23280693|NCT04194801|64769101|FG001|Part Ib/II End of Study|Death|3|||
23280694|NCT04194801|64769102|FG002|Part Ib/II End of Study|Death|3|||
23280695|NCT04194801|64769100|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
23280696|NCT04194801|64769101|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
23280697|NCT04194801|64769102|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
23280698|NCT04194801|64769100|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
23280699|NCT04194801|64769101|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
23280700|NCT04194801|64769102|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
23280701|NCT04194801|64769100|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
23280702|NCT04194801|64769101|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
23373335|NCT01799889|65112588|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23603670|NCT02158806|65937444|FG001|Overall Study|Transferred to palliative care|1|||
23373336|NCT01799889|65112589|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23373337|NCT01799889|65112590|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23373338|NCT01799889|65112591|FG005|Overall Study|Non-Compliance With Study Drug|1|||
23373339|NCT01799889|65112592|FG006|Overall Study|Non-Compliance With Study Drug|0|||
23373340|NCT01799889|65112593|FG007|Overall Study|Non-Compliance With Study Drug|0|||
23373341|NCT01799889|65112594|FG008|Overall Study|Non-Compliance With Study Drug|0|||
23373342|NCT01799889|65112595|FG009|Overall Study|Non-Compliance With Study Drug|0|||
23373343|NCT01799889|65112596|FG010|Overall Study|Non-Compliance With Study Drug|0|||
23373344|NCT01799889|65112597|FG011|Overall Study|Non-Compliance With Study Drug|0|||
23373345|NCT01249131|65112598|FG000|Washout Period of 10 Days|Adverse Event|0|||
23373346|NCT01249131|65112599|FG001|Washout Period of 10 Days|Adverse Event|0|||
23373347|NCT01249131|65112600|FG002|Washout Period of 10 Days|Adverse Event|0|||
23373348|NCT01249131|65112601|FG003|Washout Period of 10 Days|Adverse Event|0|||
23373349|NCT01249131|65112602|FG004|Washout Period of 10 Days|Adverse Event|1|||
23373350|NCT01249131|65112603|FG005|Washout Period of 10 Days|Adverse Event|0|||
23373351|NCT01548404|65112604|FG000|Overall Study|Adverse Event|3|||
23373352|NCT01548404|65112605|FG001|Overall Study|Adverse Event|1|||
23373353|NCT01548404|65112604|FG000|Overall Study|Physician Decision|2|||
23373354|NCT01548404|65112605|FG001|Overall Study|Physician Decision|1|||
23373355|NCT01548404|65112604|FG000|Overall Study|Inadequate response to study treatment|23|||
23373356|NCT01548404|65112605|FG001|Overall Study|Inadequate response to study treatment|7|||
23373357|NCT01548404|65112604|FG000|Overall Study|Lost to Follow-up|2|||
23373358|NCT01548404|65112605|FG001|Overall Study|Lost to Follow-up|0|||
23373359|NCT01548404|65112604|FG000|Overall Study|Withdrawal by Subject|0|||
23373360|NCT01548404|65112605|FG001|Overall Study|Withdrawal by Subject|3|||
23373361|NCT01548404|65112604|FG000|Overall Study|Other than specified above|0|||
23373362|NCT01548404|65112605|FG001|Overall Study|Other than specified above|2|||
23373363|NCT03238417|65112606|FG000|Overall|non-response|955|||
23373364|NCT03238417|65112607|FG001|Overall|non-response|1920|||
23373365|NCT03238417|65112606|FG000|Overall|partial completion|48|||
23373366|NCT03238417|65112607|FG001|Overall|partial completion|68|||
23373367|NCT03238417|65112606|FG000|Baseline|Partial completion|17|||
23373368|NCT03238417|65112607|FG001|Baseline|Partial completion|48|||
23373369|NCT03238417|65112606|FG000|Baseline|non-response|372|||
23603671|NCT03403036|65937445|FG000|Overall Study|Lack of Efficacy|5|||
23603672|NCT00949117|65937446|FG000|Overall Study|Lack of Efficacy|2|||
23280703|NCT04194801|64769102|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
23603673|NCT00949117|65937447|FG001|Overall Study|Lack of Efficacy|3|||
23280704|NCT04194801|64769100|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
23373370|NCT03238417|65112607|FG001|Baseline|non-response|669|||
23373371|NCT03238417|65112606|FG000|12-month|non-response|296|||
23373372|NCT03238417|65112607|FG001|12-month|non-response|669|||
23486804|NCT01309308|65527291|FG001|Overall Study|Lost to Follow-up|4|||
23486805|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Adverse Event|2|||
23486806|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Adverse Event|0|||
23486807|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
23486808|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
23486809|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
23486810|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
23486811|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
23486812|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23486813|NCT03052764|65527292|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
23486814|NCT03052764|65527293|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
23486815|NCT00925990|65527294|FG000|Overall Study|Adverse Event|1|||
23486816|NCT00925990|65527295|FG001|Overall Study|Adverse Event|3|||
23486817|NCT00925990|65527294|FG000|Overall Study|Withdrawal by Subject|2|||
23486818|NCT00925990|65527295|FG001|Overall Study|Withdrawal by Subject|2|||
23486819|NCT00925990|65527294|FG000|Overall Study|Lost to Follow-up|1|||
23486820|NCT00925990|65527295|FG001|Overall Study|Lost to Follow-up|3|||
23486821|NCT00925990|65527294|FG000|Overall Study|Physician Decision|1|||
23486822|NCT00925990|65527295|FG001|Overall Study|Physician Decision|1|||
23486823|NCT00925990|65527294|FG000|Overall Study|moved out of state, missed medication|0|||
23486824|NCT00925990|65527295|FG001|Overall Study|moved out of state, missed medication|2|||
23486825|NCT00586846|65527296|FG000|Overall Study|Physician Decision|1|||
23486826|NCT00586846|65527296|FG000|Overall Study|Death|1|||
23486827|NCT00586846|65527296|FG000|Overall Study|Evaluable for Toxicity Only|4|||
23486828|NCT01178073|65527297|FG000|Overall Study|Adverse Event|34|||
23486829|NCT01178073|65527298|FG001|Overall Study|Adverse Event|27|||
23486830|NCT01178073|65527299|FG002|Overall Study|Adverse Event|24|||
23486831|NCT01178073|65527297|FG000|Overall Study|Protocol Violation|1|||
23486832|NCT01178073|65527298|FG001|Overall Study|Protocol Violation|1|||
23486833|NCT01178073|65527299|FG002|Overall Study|Protocol Violation|1|||
23486834|NCT01178073|65527297|FG000|Overall Study|Lost to Follow-up|2|||
23486835|NCT01178073|65527298|FG001|Overall Study|Lost to Follow-up|0|||
23486836|NCT01178073|65527299|FG002|Overall Study|Lost to Follow-up|3|||
23486837|NCT01178073|65527297|FG000|Overall Study|Physician Decision|14|||
23486838|NCT01178073|65527298|FG001|Overall Study|Physician Decision|10|||
23486839|NCT01178073|65527299|FG002|Overall Study|Physician Decision|10|||
23486840|NCT01178073|65527297|FG000|Overall Study|Withdrawal by Subject|10|||
23486841|NCT01178073|65527298|FG001|Overall Study|Withdrawal by Subject|6|||
23486842|NCT01178073|65527299|FG002|Overall Study|Withdrawal by Subject|8|||
23486843|NCT01178073|65527297|FG000|Overall Study|Missing Completion Status|1|||
23486844|NCT01178073|65527298|FG001|Overall Study|Missing Completion Status|0|||
23486845|NCT01178073|65527299|FG002|Overall Study|Missing Completion Status|0|||
23486846|NCT00930982|65527305|FG000|Overall Study|Adverse Event|19|||
23486847|NCT00930982|65527306|FG001|Overall Study|Adverse Event|23|||
23486848|NCT00930982|65527305|FG000|Overall Study|Protocol Violation|1|||
23486849|NCT00930982|65527306|FG001|Overall Study|Protocol Violation|5|||
23486850|NCT00930982|65527305|FG000|Overall Study|Withdrawal by Subject|1|||
23280705|NCT04194801|64769101|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
23280706|NCT04194801|64769102|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
23280707|NCT00881751|64769103|FG000|Overall Study|Physician Decision|0|||
23280708|NCT00881751|64769104|FG001|Overall Study|Physician Decision|1|||
23486851|NCT00930982|65527306|FG001|Overall Study|Withdrawal by Subject|1|||
23486852|NCT01741012|65527307|FG000|Overall Study|Lost to Follow-up|1|||
23486853|NCT01741012|65527307|FG000|Overall Study|Withdrawal by Subject|2|||
23486854|NCT01570868|65527309|FG000|Overall Study|Adverse Event|8|||
23486855|NCT01570868|65527310|FG001|Overall Study|Adverse Event|1|||
23486856|NCT01570868|65527309|FG000|Overall Study|FDA Recommendation|23|||
23486857|NCT01570868|65527310|FG001|Overall Study|FDA Recommendation|3|||
23486858|NCT01570868|65527309|FG000|Overall Study|Physician Decision|10|||
23486859|NCT01570868|65527310|FG001|Overall Study|Physician Decision|4|||
23486860|NCT01570868|65527309|FG000|Overall Study|Lost to Follow-up|1|||
23486861|NCT01570868|65527310|FG001|Overall Study|Lost to Follow-up|0|||
23486862|NCT01570868|65527309|FG000|Overall Study|Withdrawal by Subject|1|||
23486863|NCT01570868|65527310|FG001|Overall Study|Withdrawal by Subject|0|||
23486864|NCT00055471|65527318|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
23486865|NCT00055471|65527319|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
23486866|NCT00055471|65527320|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
23486867|NCT00055471|65527318|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
23486868|NCT00055471|65527319|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
23486869|NCT00055471|65527320|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
23373373|NCT03238417|65112606|FG000|12-month|partial completion|23|||
23486870|NCT00055471|65527318|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
23486871|NCT00055471|65527319|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
23486872|NCT00055471|65527320|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
23486873|NCT03183778|65527322|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
23486874|NCT01484132|65527325|FG000|Overall Study|Lost to Follow-up|8|||
23486875|NCT01484132|65527325|FG000|Overall Study|Difficulty with time commitment|2|||
23486876|NCT01484132|65527325|FG000|Overall Study|Ineligible|1|||
23486877|NCT01484132|65527325|FG000|Overall Study|No pre-treatment urine sample collected|1|||
23486878|NCT01484132|65527325|FG000|Overall Study|No post-treatment urine sample collected|10|||
23486879|NCT02676466|65527326|FG000|Overall Study|Death|0|||
23486880|NCT02676466|65527327|FG001|Overall Study|Death|2|||
23486881|NCT02676466|65527328|FG002|Overall Study|Death|1|||
23486882|NCT02676466|65527329|FG003|Overall Study|Death|0|||
23486883|NCT02676466|65527330|FG004|Overall Study|Death|0|||
23603674|NCT00949117|65937446|FG000|Overall Study|Protocol Violation|1|||
23603675|NCT00949117|65937447|FG001|Overall Study|Protocol Violation|1|||
23603676|NCT00949117|65937446|FG000|Overall Study|Adverse Event|0|||
23603677|NCT00949117|65937447|FG001|Overall Study|Adverse Event|1|||
23603678|NCT00595959|65937448|FG000|Overall Study|Withdrawal by Subject|1|||
23603679|NCT00595959|65937448|FG000|Overall Study|Lost to Follow-up|1|||
23280709|NCT00881751|64769103|FG000|Overall Study|Adverse Event|0|||
23280710|NCT00881751|64769104|FG001|Overall Study|Adverse Event|2|||
23486884|NCT02676466|65527331|FG005|Overall Study|Death|0|||
23486885|NCT02676466|65527332|FG006|Overall Study|Death|0|||
23486886|NCT02676466|65527333|FG007|Overall Study|Death|0|||
23486887|NCT02676466|65527326|FG000|Overall Study|Withdrawal by Subject|4|||
23486888|NCT02676466|65527327|FG001|Overall Study|Withdrawal by Subject|3|||
23486889|NCT02676466|65527328|FG002|Overall Study|Withdrawal by Subject|1|||
23486890|NCT02676466|65527329|FG003|Overall Study|Withdrawal by Subject|0|||
23486891|NCT02676466|65527330|FG004|Overall Study|Withdrawal by Subject|3|||
23486892|NCT02676466|65527331|FG005|Overall Study|Withdrawal by Subject|1|||
23486893|NCT02676466|65527332|FG006|Overall Study|Withdrawal by Subject|1|||
23486894|NCT02676466|65527333|FG007|Overall Study|Withdrawal by Subject|1|||
23486895|NCT00764491|65527336|FG000|Overall Study|Lost to Follow-up|35|||
23486896|NCT00764491|65527337|FG001|Overall Study|Lost to Follow-up|17|||
23486897|NCT03711266|65527344|FG000|Overall Study|Lost to Follow-up|10|||
23486898|NCT01476644|65527346|FG000|Overall Study|Death|5|||
23486899|NCT01476644|65527346|FG000|Overall Study|moved to another state|2|||
23486900|NCT01476644|65527346|FG000|Overall Study|Lost to Follow-up|19|||
23486901|NCT01476644|65527346|FG000|Overall Study|Withdrawal by Subject|13|||
23486902|NCT05128773|65527347|FG000|Overall Study|Sponsor decision to terminate study|3|||
23486903|NCT00048061|65527348|FG000|Overall Study|Adverse Event|41|||
23603680|NCT01353274|65937449|FG000|Overall Study|No case report form (CRF) collected|28|||
23280711|NCT00881751|64769103|FG000|Overall Study|Withdrawal by Subject|0|||
23280712|NCT00881751|64769104|FG001|Overall Study|Withdrawal by Subject|2|||
23280713|NCT04594252|64769106|FG000|Overall Study|Adverse Event|0|||
23280714|NCT04594252|64769107|FG001|Overall Study|Adverse Event|2|||
23280715|NCT00829530|64769108|FG000|First Intervention|Adverse Event|0|||
23280716|NCT00829530|64769109|FG001|First Intervention|Adverse Event|1|||
23280717|NCT00829530|64769108|FG000|First Intervention|Intolerance to Venopuncture|0|||
23373374|NCT03238417|65112607|FG001|12-month|partial completion|37|||
23373375|NCT03238417|65112606|FG000|24-month|non-response|287|||
23486904|NCT00048061|65527349|FG001|Overall Study|Adverse Event|32|||
23486905|NCT00048061|65527350|FG002|Overall Study|Adverse Event|44|||
23486906|NCT00048061|65527351|FG003|Overall Study|Adverse Event|37|||
23486907|NCT00048061|65527348|FG000|Overall Study|Lost to Follow-up|3|||
23486908|NCT00048061|65527349|FG001|Overall Study|Lost to Follow-up|2|||
23486909|NCT00048061|65527350|FG002|Overall Study|Lost to Follow-up|4|||
23486910|NCT00048061|65527351|FG003|Overall Study|Lost to Follow-up|5|||
23201486|NCT00789477|64476753|FG001|Overall Study|Death|1|||
23201487|NCT00789477|64476754|FG002|Overall Study|Death|2|||
23201488|NCT00789477|64476755|FG003|Overall Study|Death|2|||
23201489|NCT00789477|64476756|FG004|Overall Study|Death|0|||
23201490|NCT00789477|64476752|FG000|Overall Study|Lost to Follow-up|0|||
23201491|NCT00789477|64476753|FG001|Overall Study|Lost to Follow-up|1|||
23201492|NCT00789477|64476754|FG002|Overall Study|Lost to Follow-up|4|||
23201493|NCT00789477|64476755|FG003|Overall Study|Lost to Follow-up|2|||
23201494|NCT00789477|64476756|FG004|Overall Study|Lost to Follow-up|4|||
23201495|NCT00789477|64476752|FG000|Overall Study|Lack of Efficacy|2|||
23201496|NCT00789477|64476753|FG001|Overall Study|Lack of Efficacy|0|||
23201497|NCT00789477|64476754|FG002|Overall Study|Lack of Efficacy|0|||
23201498|NCT00789477|64476755|FG003|Overall Study|Lack of Efficacy|0|||
23201499|NCT00789477|64476756|FG004|Overall Study|Lack of Efficacy|0|||
23201500|NCT00789477|64476752|FG000|Overall Study|Other|2|||
23201501|NCT00789477|64476753|FG001|Overall Study|Other|0|||
23201502|NCT00789477|64476754|FG002|Overall Study|Other|1|||
23201503|NCT00789477|64476755|FG003|Overall Study|Other|3|||
23201504|NCT00789477|64476756|FG004|Overall Study|Other|0|||
23201505|NCT02179515|64476760|FG000|Overall Study|switched to alternative treatment|0|||
23201506|NCT02179515|64476761|FG001|Overall Study|switched to alternative treatment|1|||
23201507|NCT02179515|64476762|FG002|Overall Study|switched to alternative treatment|1|||
23201508|NCT02179515|64476760|FG000|Overall Study|Death|0|||
23201509|NCT02179515|64476761|FG001|Overall Study|Death|1|||
23373376|NCT03238417|65112607|FG001|24-month|non-response|594|||
23373377|NCT03238417|65112606|FG000|24-month|partial completion|8|||
23373378|NCT03238417|65112607|FG001|24-month|partial completion|31|||
23373379|NCT01326871|65112608|FG000|Overall Study|Major surgery|0|||
23373380|NCT01326871|65112609|FG001|Overall Study|Major surgery|1|||
23280718|NCT00829530|64769109|FG001|First Intervention|Intolerance to Venopuncture|1|||
23280719|NCT00829530|64769108|FG000|Second Intervention|Intolerance to Venopuncture|1|||
23280720|NCT00829530|64769109|FG001|Second Intervention|Intolerance to Venopuncture|0|||
23280721|NCT01609257|64769110|FG000|Overall Study|Lost to Follow-up|2|||
23280722|NCT01609257|64769111|FG001|Overall Study|Lost to Follow-up|1|||
23280723|NCT01609257|64769110|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
23280724|NCT01609257|64769111|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
23280725|NCT01609257|64769110|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
23280726|NCT01609257|64769111|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
23280727|NCT02057835|64769112|FG000|Overall Study|Withdrawal by Subject|0|||
23280728|NCT02057835|64769113|FG001|Overall Study|Withdrawal by Subject|2|||
23280729|NCT02057835|64769114|FG002|Overall Study|Withdrawal by Subject|0|||
23280730|NCT02057835|64769115|FG003|Overall Study|Withdrawal by Subject|0|||
23280731|NCT02057835|64769116|FG004|Overall Study|Withdrawal by Subject|0|||
23280732|NCT02057835|64769117|FG005|Overall Study|Withdrawal by Subject|0|||
23280733|NCT02057835|64769118|FG006|Overall Study|Withdrawal by Subject|0|||
23280734|NCT02057835|64769119|FG007|Overall Study|Withdrawal by Subject|0|||
23280735|NCT02057835|64769120|FG008|Overall Study|Withdrawal by Subject|0|||
23280736|NCT02057835|64769121|FG009|Overall Study|Withdrawal by Subject|0|||
23280737|NCT00838539|64769122|FG000|Overall Study|Disease Progression|2|||
23280738|NCT00838539|64769123|FG001|Overall Study|Disease Progression|4|||
23280739|NCT00838539|64769124|FG002|Overall Study|Disease Progression|3|||
23280740|NCT00838539|64769125|FG003|Overall Study|Disease Progression|2|||
23280741|NCT00838539|64769126|FG004|Overall Study|Disease Progression|4|||
23280742|NCT00838539|64769127|FG005|Overall Study|Disease Progression|2|||
23280743|NCT00838539|64769128|FG006|Overall Study|Disease Progression|3|||
23280744|NCT00838539|64769129|FG007|Overall Study|Disease Progression|4|||
23280745|NCT00838539|64769130|FG008|Overall Study|Disease Progression|4|||
23280746|NCT00838539|64769131|FG009|Overall Study|Disease Progression|5|||
23280747|NCT00838539|64769132|FG010|Overall Study|Disease Progression|1|||
23280748|NCT00838539|64769133|FG011|Overall Study|Disease Progression|4|||
23280749|NCT00838539|64769122|FG000|Overall Study|Adverse Event|1|||
23280750|NCT00838539|64769123|FG001|Overall Study|Adverse Event|1|||
23280751|NCT00838539|64769124|FG002|Overall Study|Adverse Event|1|||
23280752|NCT00838539|64769125|FG003|Overall Study|Adverse Event|1|||
23280753|NCT00838539|64769126|FG004|Overall Study|Adverse Event|2|||
23280754|NCT00838539|64769127|FG005|Overall Study|Adverse Event|1|||
23280755|NCT00838539|64769128|FG006|Overall Study|Adverse Event|0|||
23280756|NCT00838539|64769129|FG007|Overall Study|Adverse Event|2|||
23280757|NCT00838539|64769130|FG008|Overall Study|Adverse Event|0|||
23280758|NCT00838539|64769131|FG009|Overall Study|Adverse Event|1|||
23280759|NCT00838539|64769132|FG010|Overall Study|Adverse Event|2|||
23280760|NCT00838539|64769133|FG011|Overall Study|Adverse Event|0|||
23280761|NCT00838539|64769122|FG000|Overall Study|Withdrawal by Subject|0|||
23280762|NCT00838539|64769123|FG001|Overall Study|Withdrawal by Subject|1|||
23280763|NCT00838539|64769124|FG002|Overall Study|Withdrawal by Subject|0|||
23280764|NCT00838539|64769125|FG003|Overall Study|Withdrawal by Subject|0|||
23280765|NCT00838539|64769126|FG004|Overall Study|Withdrawal by Subject|0|||
23280766|NCT00838539|64769127|FG005|Overall Study|Withdrawal by Subject|0|||
23280767|NCT00838539|64769128|FG006|Overall Study|Withdrawal by Subject|0|||
23280768|NCT00838539|64769129|FG007|Overall Study|Withdrawal by Subject|0|||
23280769|NCT00838539|64769130|FG008|Overall Study|Withdrawal by Subject|0|||
23280770|NCT00838539|64769131|FG009|Overall Study|Withdrawal by Subject|1|||
23280771|NCT00838539|64769132|FG010|Overall Study|Withdrawal by Subject|2|||
23280772|NCT00838539|64769133|FG011|Overall Study|Withdrawal by Subject|0|||
23280773|NCT00838539|64769122|FG000|Overall Study|Death|0|||
23280774|NCT00838539|64769123|FG001|Overall Study|Death|0|||
23280775|NCT00838539|64769124|FG002|Overall Study|Death|0|||
23280776|NCT00838539|64769125|FG003|Overall Study|Death|0|||
23373381|NCT01326871|65112610|FG002|Overall Study|Major surgery|0|||
23280777|NCT00838539|64769126|FG004|Overall Study|Death|0|||
23280778|NCT00838539|64769127|FG005|Overall Study|Death|0|||
23373382|NCT01326871|65112608|FG000|Overall Study|SAE and death|0|||
23373383|NCT01326871|65112609|FG001|Overall Study|SAE and death|2|||
23373384|NCT01326871|65112610|FG002|Overall Study|SAE and death|0|||
23280779|NCT00838539|64769128|FG006|Overall Study|Death|1|||
23280780|NCT00838539|64769129|FG007|Overall Study|Death|0|||
23280781|NCT00838539|64769130|FG008|Overall Study|Death|0|||
23280782|NCT00838539|64769131|FG009|Overall Study|Death|0|||
23280783|NCT00838539|64769132|FG010|Overall Study|Death|0|||
23280784|NCT00838539|64769133|FG011|Overall Study|Death|0|||
23373385|NCT01326871|65112608|FG000|Overall Study|Physician decision and decreased performance status|0|||
23280785|NCT00838539|64769122|FG000|Overall Study|Physician Decision|0|||
23280786|NCT00838539|64769123|FG001|Overall Study|Physician Decision|0|||
23486911|NCT00048061|65527348|FG000|Overall Study|Withdrawal by Subject|20|||
23486912|NCT00048061|65527349|FG001|Overall Study|Withdrawal by Subject|29|||
23486913|NCT00048061|65527350|FG002|Overall Study|Withdrawal by Subject|29|||
23486914|NCT00048061|65527351|FG003|Overall Study|Withdrawal by Subject|32|||
23486915|NCT00048061|65527348|FG000|Overall Study|Did not follow-up|5|||
23486916|NCT00048061|65527349|FG001|Overall Study|Did not follow-up|5|||
23486917|NCT00048061|65527350|FG002|Overall Study|Did not follow-up|4|||
23486918|NCT00048061|65527351|FG003|Overall Study|Did not follow-up|5|||
23486919|NCT00048061|65527348|FG000|Overall Study|Early improvement|6|||
23486920|NCT00048061|65527349|FG001|Overall Study|Early improvement|5|||
23486921|NCT00048061|65527350|FG002|Overall Study|Early improvement|3|||
23486922|NCT00048061|65527351|FG003|Overall Study|Early improvement|0|||
23486923|NCT01631812|65527352|FG000|Overall Study|Adverse Event|25|||
23486924|NCT01631812|65527352|FG000|Overall Study|Lack of Efficacy|5|||
23486925|NCT01631812|65527352|FG000|Overall Study|Withdrawal by Subject|4|||
23486926|NCT01631812|65527352|FG000|Overall Study|Physician Decision|3|||
23486927|NCT02987660|65527357|FG000|Overall Study|Study terminated by sponsor|10|||
23486928|NCT02987660|65527358|FG001|Overall Study|Study terminated by sponsor|10|||
23486929|NCT03960554|65527359|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
23486930|NCT03960554|65527360|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
23486931|NCT01229397|65527365|FG000|Overall Study|Withdrawal by Subject|3|||
23486932|NCT01229397|65527366|FG001|Overall Study|Withdrawal by Subject|3|||
23486933|NCT01229397|65527365|FG000|Overall Study|Lost to Follow-up|7|||
23486934|NCT01229397|65527366|FG001|Overall Study|Lost to Follow-up|6|||
23486935|NCT01229397|65527365|FG000|Overall Study|Migrated/moved from study area|1|||
23486936|NCT01229397|65527366|FG001|Overall Study|Migrated/moved from study area|0|||
23486937|NCT04738734|65527367|FG000|Overall Study|Withdrawal by Subject|2|||
23486938|NCT04738734|65527368|FG001|Overall Study|Withdrawal by Subject|4|||
23486939|NCT04738734|65527367|FG000|Overall Study|Lost to Follow-up|5|||
23486940|NCT04738734|65527368|FG001|Overall Study|Lost to Follow-up|2|||
23486941|NCT04738734|65527367|FG000|Overall Study|Physician Decision|0|||
23486942|NCT04738734|65527368|FG001|Overall Study|Physician Decision|1|||
23486943|NCT04738734|65527367|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
23486944|NCT04738734|65527368|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
23486945|NCT03500679|65527369|FG000|Overall Study|Lost to Follow-up|6|||
23486946|NCT03500679|65527370|FG001|Overall Study|Lost to Follow-up|3|||
23280787|NCT00838539|64769124|FG002|Overall Study|Physician Decision|0|||
23280788|NCT00838539|64769125|FG003|Overall Study|Physician Decision|0|||
23280789|NCT00838539|64769126|FG004|Overall Study|Physician Decision|0|||
23280790|NCT00838539|64769127|FG005|Overall Study|Physician Decision|0|||
23280791|NCT00838539|64769128|FG006|Overall Study|Physician Decision|0|||
23280792|NCT00838539|64769129|FG007|Overall Study|Physician Decision|0|||
23280793|NCT00838539|64769130|FG008|Overall Study|Physician Decision|1|||
23280794|NCT00838539|64769131|FG009|Overall Study|Physician Decision|0|||
23280795|NCT00838539|64769132|FG010|Overall Study|Physician Decision|0|||
23280796|NCT00838539|64769133|FG011|Overall Study|Physician Decision|0|||
23486947|NCT03500679|65527369|FG000|Overall Study|Withdrawal by Subject|3|||
23486948|NCT03500679|65527370|FG001|Overall Study|Withdrawal by Subject|0|||
23486949|NCT00495131|65527373|FG000|Overall Study|Adverse Event|6|||
23486950|NCT00495131|65527374|FG001|Overall Study|Adverse Event|2|||
23486951|NCT00495131|65527373|FG000|Overall Study|Lack of Efficacy|0|||
23486952|NCT00495131|65527374|FG001|Overall Study|Lack of Efficacy|2|||
23486953|NCT00495131|65527373|FG000|Overall Study|Lost to Follow-up|0|||
23486954|NCT00495131|65527374|FG001|Overall Study|Lost to Follow-up|2|||
23280797|NCT00838539|64769122|FG000|Overall Study|Clinical Progression|0|||
23280798|NCT00838539|64769123|FG001|Overall Study|Clinical Progression|0|||
23280799|NCT00838539|64769124|FG002|Overall Study|Clinical Progression|0|||
23280800|NCT00838539|64769125|FG003|Overall Study|Clinical Progression|0|||
23280801|NCT00838539|64769126|FG004|Overall Study|Clinical Progression|0|||
23280802|NCT00838539|64769127|FG005|Overall Study|Clinical Progression|0|||
23280803|NCT00838539|64769128|FG006|Overall Study|Clinical Progression|1|||
23373386|NCT01326871|65112609|FG001|Overall Study|Physician decision and decreased performance status|1|||
23373387|NCT01326871|65112610|FG002|Overall Study|Physician decision and decreased performance status|0|||
23486955|NCT00495131|65527373|FG000|Overall Study|Withdrawal by Subject|1|||
23486956|NCT00495131|65527374|FG001|Overall Study|Withdrawal by Subject|0|||
23280804|NCT00838539|64769129|FG007|Overall Study|Clinical Progression|0|||
23280805|NCT00838539|64769130|FG008|Overall Study|Clinical Progression|0|||
23280806|NCT00838539|64769131|FG009|Overall Study|Clinical Progression|0|||
23373388|NCT01326871|65112608|FG000|Overall Study|Disease progression|0|||
23486957|NCT00945555|65527375|FG000|Overall Study|Referred to another hospital|5|||
23486958|NCT00945555|65527375|FG000|Overall Study|Worsening condition, intensive care unit|1|||
23486959|NCT00945555|65527375|FG000|Overall Study|Withdrawal by Subject|2|||
23486960|NCT00945555|65527375|FG000|Overall Study|Participant continued treatment at home|1|||
23486961|NCT00945555|65527375|FG000|Overall Study|Death|18|||
23486962|NCT00945555|65527375|FG000|Overall Study|Other|1|||
23486963|NCT01325623|65527380|FG000|Overall Study|Withdrawal by Subject|3|||
23280807|NCT00838539|64769132|FG010|Overall Study|Clinical Progression|0|||
23280808|NCT00838539|64769133|FG011|Overall Study|Clinical Progression|0|||
23280809|NCT00838539|64769122|FG000|Overall Study|Symptomatic Deterioration|0|||
23280810|NCT00838539|64769123|FG001|Overall Study|Symptomatic Deterioration|0|||
23603681|NCT03100370|65937450|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23603682|NCT03100370|65937451|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23603683|NCT03100370|65937452|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23603684|NCT03100370|65937453|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
23603685|NCT03100370|65937454|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23603686|NCT03100370|65937455|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
23280811|NCT00838539|64769124|FG002|Overall Study|Symptomatic Deterioration|1|||
23280812|NCT00838539|64769125|FG003|Overall Study|Symptomatic Deterioration|1|||
23280813|NCT00838539|64769126|FG004|Overall Study|Symptomatic Deterioration|0|||
23280814|NCT00838539|64769127|FG005|Overall Study|Symptomatic Deterioration|1|||
23280815|NCT00838539|64769128|FG006|Overall Study|Symptomatic Deterioration|0|||
23280816|NCT00838539|64769129|FG007|Overall Study|Symptomatic Deterioration|0|||
23280817|NCT00838539|64769130|FG008|Overall Study|Symptomatic Deterioration|0|||
23280818|NCT00838539|64769131|FG009|Overall Study|Symptomatic Deterioration|1|||
23280819|NCT00838539|64769132|FG010|Overall Study|Symptomatic Deterioration|0|||
23280820|NCT00838539|64769133|FG011|Overall Study|Symptomatic Deterioration|0|||
23280821|NCT00377260|64769134|FG000|Overall Study|Lost to Follow-up|0|||
23280822|NCT00377260|64769135|FG001|Overall Study|Lost to Follow-up|1|||
23280823|NCT00377260|64769134|FG000|Overall Study|Withdrawal by Subject|2|||
23280824|NCT00377260|64769135|FG001|Overall Study|Withdrawal by Subject|4|||
23280825|NCT01020474|64769136|FG000|Overall Study|Adverse Event|4|||
23280826|NCT01020474|64769137|FG001|Overall Study|Adverse Event|4|||
23280827|NCT01020474|64769136|FG000|Overall Study|Protocol Violation|0|||
23280828|NCT01020474|64769137|FG001|Overall Study|Protocol Violation|2|||
23280829|NCT01020474|64769136|FG000|Overall Study|Withdrawal by Subject|5|||
23280830|NCT01020474|64769137|FG001|Overall Study|Withdrawal by Subject|7|||
23280831|NCT01020474|64769136|FG000|Overall Study|Other Reasons|1|||
23280832|NCT01020474|64769137|FG001|Overall Study|Other Reasons|1|||
23280833|NCT01020474|64769136|FG000|Overall Study|Insufficient Clinical Response|0|||
23280834|NCT01020474|64769137|FG001|Overall Study|Insufficient Clinical Response|3|||
23280835|NCT00218257|64769138|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
23280836|NCT00218257|64769139|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
23280837|NCT00836056|64769140|FG000|First Intervention|Adverse Event|1|||
23280838|NCT00836056|64769141|FG001|First Intervention|Adverse Event|0|||
23280839|NCT02281084|64769142|FG000|Overall Study|Death|21|||
23280840|NCT02281084|64769143|FG001|Overall Study|Death|18|||
23280841|NCT02281084|64769144|FG002|Overall Study|Death|3|||
23280842|NCT02281084|64769145|FG003|Overall Study|Death|5|||
23280843|NCT02281084|64769142|FG000|Overall Study|Adverse Event|1|||
23280844|NCT02281084|64769143|FG001|Overall Study|Adverse Event|0|||
23603687|NCT01034306|65937456|FG000|Overall Study|Adverse Event|1|||
23603688|NCT01034306|65937457|FG001|Overall Study|Adverse Event|0|||
23603689|NCT01034306|65937456|FG000|Overall Study|Lost to Follow-up|0|||
23603690|NCT01034306|65937457|FG001|Overall Study|Lost to Follow-up|1|||
23603691|NCT01034306|65937456|FG000|Overall Study|Withdrawal by Subject|2|||
23603692|NCT01034306|65937457|FG001|Overall Study|Withdrawal by Subject|2|||
23603693|NCT01034306|65937456|FG000|Overall Study|hospitalized and decided to stop|1|||
23603694|NCT01034306|65937457|FG001|Overall Study|hospitalized and decided to stop|0|||
23280845|NCT02281084|64769144|FG002|Overall Study|Adverse Event|0|||
23373389|NCT01326871|65112609|FG001|Overall Study|Disease progression|11|||
23280846|NCT02281084|64769145|FG003|Overall Study|Adverse Event|0|||
23280847|NCT02281084|64769142|FG000|Overall Study|Withdrawal by Subject|2|||
23280848|NCT02281084|64769143|FG001|Overall Study|Withdrawal by Subject|2|||
23280849|NCT02281084|64769144|FG002|Overall Study|Withdrawal by Subject|0|||
23280850|NCT02281084|64769145|FG003|Overall Study|Withdrawal by Subject|0|||
23280851|NCT02281084|64769142|FG000|Overall Study|Site Closure by Sponsor|5|||
23280852|NCT02281084|64769143|FG001|Overall Study|Site Closure by Sponsor|1|||
23280853|NCT02281084|64769144|FG002|Overall Study|Site Closure by Sponsor|2|||
23280854|NCT02281084|64769145|FG003|Overall Study|Site Closure by Sponsor|0|||
23280855|NCT03873272|64769146|FG000|Overall Study|Withdrawal by Subject|2|||
23280856|NCT03873272|64769147|FG001|Overall Study|Withdrawal by Subject|0|||
23280857|NCT03873272|64769148|FG002|Overall Study|Withdrawal by Subject|1|||
23280858|NCT03873272|64769146|FG000|Overall Study|Death|0|||
23280859|NCT03873272|64769147|FG001|Overall Study|Death|2|||
23280860|NCT03873272|64769148|FG002|Overall Study|Death|1|||
23280861|NCT01058668|64769149|FG000|Double-blind Treatment Phase|Adverse Event|8|||
23280862|NCT01058668|64769150|FG001|Double-blind Treatment Phase|Adverse Event|15|||
23280863|NCT01058668|64769151|FG002|Double-blind Treatment Phase|Adverse Event|25|||
23280864|NCT01058668|64769149|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
23280865|NCT01058668|64769150|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
23280866|NCT01058668|64769151|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
23280867|NCT01058668|64769149|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
23280868|NCT01058668|64769150|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
23280869|NCT01058668|64769151|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
23280870|NCT01058668|64769149|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
23280871|NCT01058668|64769150|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
23280872|NCT01058668|64769151|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
23280873|NCT01058668|64769149|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23280874|NCT01058668|64769150|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
23280875|NCT01058668|64769151|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
23280876|NCT01058668|64769149|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
23280877|NCT01058668|64769150|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
23280878|NCT01058668|64769151|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
23280879|NCT01895335|64769152|FG000|Overall Study|Adverse Event|106|||
23280880|NCT01895335|64769152|FG000|Overall Study|Lack of Efficacy|53|||
23280881|NCT01895335|64769152|FG000|Overall Study|Poor Compliance to Protocol|11|||
23280882|NCT01895335|64769152|FG000|Overall Study|Included But Not treated|1|||
23280883|NCT01895335|64769152|FG000|Overall Study|Other than Specified Above|44|||
23280884|NCT02222818|64769153|FG000|Period 1|Eligibility criteria not met|0|||
23280885|NCT02222818|64769154|FG001|Period 1|Eligibility criteria not met|3|||
23280886|NCT01531894|64769155|FG000|Overall Study|Physician Decision|8|||
23280887|NCT01531894|64769155|FG000|Overall Study|Death|1|||
23280888|NCT01200810|64769156|FG000|Overall Study|Physician Decision|1|||
23280889|NCT01200810|64769157|FG001|Overall Study|Physician Decision|0|||
23280890|NCT01200810|64769156|FG000|Overall Study|Withdrawal by Subject|1|||
23280891|NCT01200810|64769157|FG001|Overall Study|Withdrawal by Subject|2|||
23280892|NCT01200810|64769156|FG000|Overall Study|Sponsor stopped making study drug|3|||
23280893|NCT01200810|64769157|FG001|Overall Study|Sponsor stopped making study drug|3|||
23280894|NCT01010503|64769158|FG000|Overall Study|Adverse Event|1|||
23280895|NCT01010503|64769158|FG000|Overall Study|Death|1|||
23280896|NCT04078022|64769159|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
23280897|NCT04078022|64769160|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
23280898|NCT00881569|64769165|FG000|Overall Study|Disease progression|1|||
23280899|NCT00881569|64769166|FG001|Overall Study|Disease progression|1|||
23280900|NCT05093205|64769169|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
23280901|NCT05093205|64769170|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
23280902|NCT05093205|64769171|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
23280903|NCT05093205|64769172|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
23280904|NCT05093205|64769173|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
23280905|NCT05093205|64769174|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
23280906|NCT05093205|64769175|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
23373390|NCT01326871|65112610|FG002|Overall Study|Disease progression|5|||
23280907|NCT05093205|64769176|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
23280908|NCT05093205|64769177|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
23280909|NCT05093205|64769178|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
23280910|NCT05093205|64769179|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
23280911|NCT05093205|64769180|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
23280912|NCT05093205|64769181|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
23373391|NCT01326871|65112608|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
23373392|NCT01326871|65112609|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
23373393|NCT01326871|65112610|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
23373394|NCT01326871|65112608|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
23373395|NCT01326871|65112609|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
23373396|NCT01326871|65112610|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
23373397|NCT01326871|65112608|FG000|Overall Study|Withdrawal by Subject|0|||
23373398|NCT01326871|65112609|FG001|Overall Study|Withdrawal by Subject|1|||
23373399|NCT01326871|65112610|FG002|Overall Study|Withdrawal by Subject|0|||
23373400|NCT01326871|65112608|FG000|Overall Study|DLT|0|||
23373401|NCT01326871|65112609|FG001|Overall Study|DLT|2|||
23373402|NCT01326871|65112610|FG002|Overall Study|DLT|0|||
23373403|NCT01326871|65112608|FG000|Overall Study|SAE, disease progression and subject decision|0|||
23373404|NCT01326871|65112609|FG001|Overall Study|SAE, disease progression and subject decision|1|||
23373405|NCT01326871|65112610|FG002|Overall Study|SAE, disease progression and subject decision|0|||
23373406|NCT01326871|65112608|FG000|Overall Study|Death|0|||
23373407|NCT01326871|65112609|FG001|Overall Study|Death|1|||
23373408|NCT01326871|65112610|FG002|Overall Study|Death|0|||
23373409|NCT01326871|65112608|FG000|Overall Study|Other|0|||
23373410|NCT01326871|65112609|FG001|Overall Study|Other|3|||
23373411|NCT01326871|65112610|FG002|Overall Study|Other|0|||
23373412|NCT01326871|65112608|FG000|Overall Study|SAE and disease progression|0|||
23373413|NCT01326871|65112609|FG001|Overall Study|SAE and disease progression|0|||
23373414|NCT01326871|65112610|FG002|Overall Study|SAE and disease progression|1|||
23373415|NCT01326871|65112608|FG000|Overall Study|SAE and physician decision|0|||
23373416|NCT01326871|65112609|FG001|Overall Study|SAE and physician decision|0|||
23373417|NCT01326871|65112610|FG002|Overall Study|SAE and physician decision|1|||
23373418|NCT01326871|65112608|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
23373419|NCT01326871|65112609|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
23373420|NCT01326871|65112610|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
23373421|NCT01326871|65112608|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
23373422|NCT01326871|65112609|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
23373423|NCT01326871|65112610|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
23373424|NCT01326871|65112608|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
23373425|NCT01326871|65112609|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
23373426|NCT01326871|65112610|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
23373427|NCT01326871|65112608|FG000|Overall Study|Physician Decision|0|||
23373428|NCT01326871|65112609|FG001|Overall Study|Physician Decision|0|||
23373429|NCT01326871|65112610|FG002|Overall Study|Physician Decision|1|||
23373430|NCT01326871|65112608|FG000|Overall Study|SAE|0|||
23373431|NCT01326871|65112609|FG001|Overall Study|SAE|0|||
23373432|NCT01326871|65112610|FG002|Overall Study|SAE|1|||
23373433|NCT01326871|65112608|FG000|Overall Study|Disease progression and death|0|||
23373434|NCT01326871|65112609|FG001|Overall Study|Disease progression and death|0|||
23373435|NCT01326871|65112610|FG002|Overall Study|Disease progression and death|1|||
23373436|NCT01326871|65112608|FG000|Overall Study|Subject decision|0|||
23373437|NCT01326871|65112609|FG001|Overall Study|Subject decision|0|||
23373438|NCT01326871|65112610|FG002|Overall Study|Subject decision|1|||
23373439|NCT01648764|65112615|FG000|Overall Study|Progressive Disease|0|||
23373440|NCT01648764|65112616|FG001|Overall Study|Progressive Disease|1|||
23373441|NCT01648764|65112617|FG002|Overall Study|Progressive Disease|0|||
23373442|NCT01648764|65112618|FG003|Overall Study|Progressive Disease|0|||
23373443|NCT01648764|65112619|FG004|Overall Study|Progressive Disease|0|||
23373444|NCT01648764|65112620|FG005|Overall Study|Progressive Disease|1|||
23373445|NCT01648764|65112621|FG006|Overall Study|Progressive Disease|1|||
23373446|NCT01648764|65112622|FG007|Overall Study|Progressive Disease|0|||
23373447|NCT01648764|65112623|FG008|Overall Study|Progressive Disease|0|||
23373448|NCT01648764|65112624|FG009|Overall Study|Progressive Disease|2|||
23373449|NCT01648764|65112625|FG010|Overall Study|Progressive Disease|0|||
23373450|NCT01648764|65112626|FG011|Overall Study|Progressive Disease|1|||
23373451|NCT01648764|65112627|FG012|Overall Study|Progressive Disease|2|||
23373452|NCT01648764|65112628|FG013|Overall Study|Progressive Disease|1|||
23373453|NCT01648764|65112615|FG000|Overall Study|Adverse Event|0|||
23373454|NCT01648764|65112616|FG001|Overall Study|Adverse Event|0|||
23373455|NCT01648764|65112617|FG002|Overall Study|Adverse Event|0|||
23373456|NCT01648764|65112618|FG003|Overall Study|Adverse Event|0|||
23373457|NCT01648764|65112619|FG004|Overall Study|Adverse Event|0|||
23373458|NCT01648764|65112620|FG005|Overall Study|Adverse Event|1|||
23373459|NCT01648764|65112621|FG006|Overall Study|Adverse Event|0|||
23373460|NCT01648764|65112622|FG007|Overall Study|Adverse Event|0|||
23373461|NCT01648764|65112623|FG008|Overall Study|Adverse Event|0|||
23373462|NCT01648764|65112624|FG009|Overall Study|Adverse Event|1|||
23373463|NCT01648764|65112625|FG010|Overall Study|Adverse Event|0|||
23373464|NCT01648764|65112626|FG011|Overall Study|Adverse Event|3|||
23373465|NCT01648764|65112627|FG012|Overall Study|Adverse Event|1|||
23373466|NCT01648764|65112628|FG013|Overall Study|Adverse Event|1|||
23373467|NCT01648764|65112615|FG000|Overall Study|Death|0|||
23373468|NCT01648764|65112616|FG001|Overall Study|Death|0|||
23373469|NCT01648764|65112617|FG002|Overall Study|Death|0|||
23373470|NCT01648764|65112618|FG003|Overall Study|Death|0|||
23373471|NCT01648764|65112619|FG004|Overall Study|Death|0|||
23373472|NCT01648764|65112620|FG005|Overall Study|Death|0|||
23373473|NCT01648764|65112621|FG006|Overall Study|Death|1|||
23373474|NCT01648764|65112622|FG007|Overall Study|Death|0|||
23373475|NCT01648764|65112623|FG008|Overall Study|Death|0|||
23373476|NCT01648764|65112624|FG009|Overall Study|Death|0|||
23373477|NCT01648764|65112625|FG010|Overall Study|Death|0|||
23373478|NCT01648764|65112626|FG011|Overall Study|Death|0|||
23373479|NCT01648764|65112627|FG012|Overall Study|Death|0|||
23373480|NCT01648764|65112628|FG013|Overall Study|Death|1|||
23373481|NCT01648764|65112615|FG000|Overall Study|Withdrawal by Subject|0|||
23373482|NCT01648764|65112616|FG001|Overall Study|Withdrawal by Subject|0|||
23373483|NCT01648764|65112617|FG002|Overall Study|Withdrawal by Subject|0|||
23373484|NCT01648764|65112618|FG003|Overall Study|Withdrawal by Subject|0|||
23373485|NCT01648764|65112619|FG004|Overall Study|Withdrawal by Subject|0|||
23373486|NCT01648764|65112620|FG005|Overall Study|Withdrawal by Subject|0|||
23373487|NCT01648764|65112621|FG006|Overall Study|Withdrawal by Subject|2|||
23373488|NCT01648764|65112622|FG007|Overall Study|Withdrawal by Subject|0|||
23373489|NCT01648764|65112623|FG008|Overall Study|Withdrawal by Subject|0|||
23373490|NCT01648764|65112624|FG009|Overall Study|Withdrawal by Subject|0|||
23373491|NCT01648764|65112625|FG010|Overall Study|Withdrawal by Subject|0|||
23373492|NCT01648764|65112626|FG011|Overall Study|Withdrawal by Subject|0|||
23373493|NCT01648764|65112627|FG012|Overall Study|Withdrawal by Subject|1|||
23373494|NCT01648764|65112628|FG013|Overall Study|Withdrawal by Subject|0|||
23373495|NCT01648764|65112615|FG000|Overall Study|Investigator Decision|0|||
23373496|NCT01648764|65112616|FG001|Overall Study|Investigator Decision|0|||
23373497|NCT01648764|65112617|FG002|Overall Study|Investigator Decision|0|||
23373498|NCT01648764|65112618|FG003|Overall Study|Investigator Decision|0|||
23373499|NCT01648764|65112619|FG004|Overall Study|Investigator Decision|0|||
23373500|NCT01648764|65112620|FG005|Overall Study|Investigator Decision|0|||
23373501|NCT01648764|65112621|FG006|Overall Study|Investigator Decision|1|||
23373502|NCT01648764|65112622|FG007|Overall Study|Investigator Decision|0|||
23373503|NCT01648764|65112623|FG008|Overall Study|Investigator Decision|0|||
23373504|NCT01648764|65112624|FG009|Overall Study|Investigator Decision|0|||
23373505|NCT01648764|65112625|FG010|Overall Study|Investigator Decision|0|||
23373506|NCT01648764|65112626|FG011|Overall Study|Investigator Decision|1|||
23373507|NCT01648764|65112627|FG012|Overall Study|Investigator Decision|0|||
23373508|NCT01648764|65112628|FG013|Overall Study|Investigator Decision|0|||
23373509|NCT00626639|65112641|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
23373510|NCT00626639|65112642|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
23373511|NCT04018066|65112643|FG000|Overall Study|participants started taking medications during the study period|3|||
23373512|NCT04018066|65112643|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
23373513|NCT02020941|65112644|FG000|Overall Study|Adverse Event|1|||
23373514|NCT02020941|65112644|FG000|Overall Study|Physician Decision|2|||
23373515|NCT02020941|65112644|FG000|Overall Study|Withdrawal by Subject|1|||
23373516|NCT02020941|65112644|FG000|Overall Study|Disease Progression|4|||
23373517|NCT00465179|65112659|FG000|Overall Study|Adverse Event|4|||
23373518|NCT00465179|65112659|FG000|Overall Study|Withdrawal by Subject|2|||
23373519|NCT00465179|65112659|FG000|Overall Study|Progression of Disease|47|||
23373520|NCT03183908|65112665|FG000|Overall Study|Missing Symptom Diary Data|0|||
23373521|NCT03183908|65112666|FG001|Overall Study|Missing Symptom Diary Data|2|||
23373522|NCT04465422|65112667|FG000|Overall Study|Lost to Follow-up|0|||
23373523|NCT04465422|65112668|FG001|Overall Study|Lost to Follow-up|2|||
23373524|NCT00972478|65112669|FG000|Overall Study|Adverse Event|3|||
23373525|NCT00972478|65112670|FG001|Overall Study|Adverse Event|16|||
23373526|NCT00972478|65112669|FG000|Overall Study|Withdrawal by Subject|1|||
23373527|NCT00972478|65112670|FG001|Overall Study|Withdrawal by Subject|8|||
23373528|NCT00972478|65112669|FG000|Overall Study|Progression/Relapse|0|||
23373529|NCT00972478|65112670|FG001|Overall Study|Progression/Relapse|2|||
23373530|NCT00972478|65112669|FG000|Overall Study|Death|0|||
23373531|NCT00972478|65112670|FG001|Overall Study|Death|2|||
23373532|NCT00972478|65112669|FG000|Overall Study|Not protocol specified|1|||
23373533|NCT00972478|65112670|FG001|Overall Study|Not protocol specified|1|||
23373534|NCT00972478|65112669|FG000|Overall Study|Ineligible|1|||
23373535|NCT00972478|65112670|FG001|Overall Study|Ineligible|7|||
23373536|NCT00972478|65112669|FG000|Overall Study|Not start protocol treatment|1|||
23373537|NCT00972478|65112670|FG001|Overall Study|Not start protocol treatment|2|||
23373538|NCT02382939|65112671|FG000|Overall Study|Adverse Event|1|||
23373539|NCT02382939|65112672|FG001|Overall Study|Adverse Event|1|||
23373540|NCT02382939|65112671|FG000|Overall Study|Withdrawal by Subject|2|||
23373541|NCT02382939|65112672|FG001|Overall Study|Withdrawal by Subject|2|||
23373542|NCT00284856|65112676|FG000|Overall Study|Adverse Event|3|||
23373543|NCT00284856|65112677|FG001|Overall Study|Adverse Event|3|||
23373544|NCT00284856|65112678|FG002|Overall Study|Adverse Event|3|||
23373545|NCT00284856|65112676|FG000|Overall Study|Lack of Efficacy|2|||
23373546|NCT00284856|65112677|FG001|Overall Study|Lack of Efficacy|1|||
23373547|NCT00284856|65112678|FG002|Overall Study|Lack of Efficacy|8|||
23373548|NCT00284856|65112676|FG000|Overall Study|Lost to Follow-up|25|||
23373549|NCT00284856|65112677|FG001|Overall Study|Lost to Follow-up|21|||
23373550|NCT00284856|65112678|FG002|Overall Study|Lost to Follow-up|22|||
23373551|NCT00284856|65112676|FG000|Overall Study|Protocol Violation|5|||
23373552|NCT00284856|65112677|FG001|Overall Study|Protocol Violation|4|||
23373553|NCT00284856|65112678|FG002|Overall Study|Protocol Violation|5|||
23373554|NCT00284856|65112676|FG000|Overall Study|Withdrawal by Subject|12|||
23373555|NCT00284856|65112677|FG001|Overall Study|Withdrawal by Subject|16|||
23373556|NCT00284856|65112678|FG002|Overall Study|Withdrawal by Subject|18|||
23373557|NCT00284856|65112676|FG000|Overall Study|Other|4|||
23373558|NCT00284856|65112677|FG001|Overall Study|Other|5|||
23373559|NCT00284856|65112678|FG002|Overall Study|Other|4|||
23373560|NCT03810183|65112679|FG000|Overall Study|Study terminated by Sponsor|2|||
23373561|NCT03810183|65112680|FG001|Overall Study|Study terminated by Sponsor|1|||
23373562|NCT03440320|65112683|FG000|Overall Study|Withdrawal by Subject|0|||
23373563|NCT03440320|65112684|FG001|Overall Study|Withdrawal by Subject|1|||
23373564|NCT02873689|65112686|FG000|Overall Study|Lack of Efficacy|1|||
23373565|NCT02873689|65112687|FG001|Overall Study|Lack of Efficacy|0|||
23373566|NCT02873689|65112686|FG000|Overall Study|Withdrawal by Subject|2|||
23373567|NCT02873689|65112687|FG001|Overall Study|Withdrawal by Subject|2|||
23373568|NCT02873689|65112686|FG000|Overall Study|Protocol Violation|1|||
23373569|NCT02873689|65112687|FG001|Overall Study|Protocol Violation|0|||
23373570|NCT02873689|65112686|FG000|Overall Study|Adverse Event|2|||
23373571|NCT02873689|65112687|FG001|Overall Study|Adverse Event|2|||
23373572|NCT02873689|65112686|FG000|Overall Study|Randomized but not Treated|1|||
23373573|NCT02873689|65112687|FG001|Overall Study|Randomized but not Treated|1|||
23373574|NCT01027949|65112688|FG000|Overall Study|Death|174|||
23373575|NCT01027949|65112688|FG000|Overall Study|Progressive Disease|163|||
23373576|NCT01027949|65112688|FG000|Overall Study|Adverse Event|172|||
23373577|NCT01027949|65112688|FG000|Overall Study|Withdrawal by Subject|113|||
23486964|NCT00336583|65527381|FG000|Overall Study|Lost to Follow-up|1|||
23486965|NCT00336583|65527381|FG000|Overall Study|Death|1|||
23280913|NCT05093205|64769169|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280914|NCT05093205|64769170|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280915|NCT05093205|64769171|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
23280916|NCT05093205|64769172|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280917|NCT05093205|64769173|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280918|NCT05093205|64769174|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280919|NCT05093205|64769175|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280920|NCT05093205|64769176|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280921|NCT05093205|64769177|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23373578|NCT01027949|65112688|FG000|Overall Study|Lost to Follow-up|17|||
23486966|NCT04263454|65527384|FG000|Overall Study|Adverse Event|0|||
23373579|NCT01027949|65112688|FG000|Overall Study|Protocol Violation|13|||
23373580|NCT01027949|65112688|FG000|Overall Study|PI Decision|8|||
23373581|NCT01027949|65112688|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
23373582|NCT01027949|65112688|FG000|Overall Study|Non-compliance with Study Procedures|7|||
23373583|NCT01027949|65112688|FG000|Overall Study|Lung Transplant|5|||
23373584|NCT01027949|65112688|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
23373585|NCT01027949|65112688|FG000|Overall Study|Use of Excluded Medication|2|||
23373586|NCT01027949|65112688|FG000|Overall Study|Patient Self-discontinuation|1|||
23373587|NCT01027949|65112688|FG000|Overall Study|Pregnancy|1|||
23280922|NCT05093205|64769178|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280923|NCT05093205|64769179|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280924|NCT05093205|64769180|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280925|NCT05093205|64769181|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
23280926|NCT05093205|64769169|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
23280927|NCT05093205|64769170|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
23280928|NCT05093205|64769171|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
23280929|NCT05093205|64769172|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
23280930|NCT05093205|64769173|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
23280931|NCT05093205|64769174|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
23280932|NCT05093205|64769175|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
23280933|NCT05093205|64769176|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
23280934|NCT05093205|64769177|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
23280935|NCT05093205|64769178|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
23280936|NCT05093205|64769179|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
23280937|NCT05093205|64769180|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
23280938|NCT05093205|64769181|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
23280939|NCT05093205|64769169|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
23280940|NCT05093205|64769170|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
23280941|NCT05093205|64769171|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
23280942|NCT05093205|64769172|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
23280943|NCT05093205|64769173|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
23280944|NCT05093205|64769174|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
23280945|NCT05093205|64769175|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
23280946|NCT05093205|64769176|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
23280947|NCT05093205|64769177|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
23280948|NCT05093205|64769178|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
23280949|NCT05093205|64769179|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
23280950|NCT05093205|64769180|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
23280951|NCT05093205|64769181|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
23280952|NCT05093205|64769169|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
23280953|NCT05093205|64769170|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
23280954|NCT05093205|64769171|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
23280955|NCT05093205|64769172|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
23280956|NCT05093205|64769173|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
23280957|NCT05093205|64769174|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
23280958|NCT05093205|64769175|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
23280959|NCT05093205|64769176|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
23280960|NCT05093205|64769177|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
23280961|NCT05093205|64769178|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
23280962|NCT05093205|64769179|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
23280963|NCT05093205|64769180|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
23280964|NCT05093205|64769181|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
23280965|NCT05093205|64769169|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
23280966|NCT05093205|64769170|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
23280967|NCT05093205|64769171|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
23280968|NCT05093205|64769172|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
23280969|NCT05093205|64769173|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
23280970|NCT05093205|64769174|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
23280971|NCT05093205|64769175|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
23280972|NCT05093205|64769176|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
23280973|NCT05093205|64769177|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
23280974|NCT05093205|64769178|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
23280975|NCT05093205|64769179|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
23280976|NCT05093205|64769180|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
23280977|NCT05093205|64769181|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
23280978|NCT05093205|64769169|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
23280979|NCT05093205|64769170|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
23280980|NCT05093205|64769171|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
23280981|NCT05093205|64769172|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
23280982|NCT05093205|64769173|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
23280983|NCT05093205|64769174|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
23280984|NCT05093205|64769175|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
23280985|NCT05093205|64769176|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
23280986|NCT05093205|64769177|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
23280987|NCT05093205|64769178|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
23280988|NCT05093205|64769179|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
23280989|NCT05093205|64769180|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
23373588|NCT01027949|65112688|FG000|Overall Study|Surgery|1|||
23280990|NCT05093205|64769181|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
23280991|NCT05093205|64769169|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
23280992|NCT05093205|64769170|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
23280993|NCT05093205|64769171|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
23373589|NCT03311555|65112691|FG000|Overall Study|Adverse Event|1|||
23373590|NCT00896493|65112696|FG000|Overall Study|Early disease relapse|3|||
23373591|NCT02472353|65112697|FG000|Overall Study|Lost to Follow-up|1|||
23373592|NCT02472353|65112698|FG001|Overall Study|Lost to Follow-up|1|||
23373593|NCT02472353|65112697|FG000|Overall Study|Withdrawal by Subject|2|||
23373594|NCT02472353|65112698|FG001|Overall Study|Withdrawal by Subject|1|||
23373595|NCT02472353|65112697|FG000|Overall Study|Study Termination|1|||
23373596|NCT02472353|65112698|FG001|Overall Study|Study Termination|4|||
23373597|NCT01582451|65112700|FG000|Overall Study|Adverse Event|1|||
23373598|NCT01582451|65112701|FG001|Overall Study|Adverse Event|3|||
23486967|NCT04263454|65527385|FG001|Overall Study|Adverse Event|2|||
23486968|NCT04263454|65527384|FG000|Overall Study|Physician Decision|3|||
23486969|NCT04263454|65527385|FG001|Overall Study|Physician Decision|5|||
23486970|NCT04263454|65527384|FG000|Overall Study|Poor Data Quality|0|||
23486971|NCT04263454|65527385|FG001|Overall Study|Poor Data Quality|1|||
23486972|NCT01155219|65527386|FG000|Overall Study|Adverse Event|3|||
23486973|NCT01155219|65527387|FG001|Overall Study|Adverse Event|1|||
23486974|NCT01155219|65527386|FG000|Overall Study|non-medical reason|1|||
23486975|NCT01155219|65527387|FG001|Overall Study|non-medical reason|2|||
23486976|NCT00395538|65527390|FG000|Overall Study|Did not re-consent to revised protocol|1|||
23486977|NCT00395538|65527391|FG001|Overall Study|Did not re-consent to revised protocol|10|||
23486978|NCT00395538|65527392|FG002|Overall Study|Did not re-consent to revised protocol|0|||
23486979|NCT00395538|65527390|FG000|Overall Study|FDA partial hold on PTH|0|||
23486980|NCT00395538|65527391|FG001|Overall Study|FDA partial hold on PTH|0|||
23486981|NCT00395538|65527392|FG002|Overall Study|FDA partial hold on PTH|11|||
23486982|NCT00395538|65527390|FG000|Overall Study|Failed screening|0|||
23486983|NCT00395538|65527391|FG001|Overall Study|Failed screening|0|||
23486984|NCT00395538|65527392|FG002|Overall Study|Failed screening|4|||
23486985|NCT00395538|65527390|FG000|Overall Study|Switch to Natpara|0|||
23486986|NCT00395538|65527391|FG001|Overall Study|Switch to Natpara|0|||
23486987|NCT00395538|65527392|FG002|Overall Study|Switch to Natpara|3|||
23486988|NCT00395538|65527390|FG000|Overall Study|Adverse Event|1|||
23486989|NCT00395538|65527391|FG001|Overall Study|Adverse Event|0|||
23486990|NCT00395538|65527392|FG002|Overall Study|Adverse Event|2|||
23486991|NCT00395538|65527390|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
23486992|NCT00395538|65527391|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
23486993|NCT00395538|65527392|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
23486994|NCT00395538|65527390|FG000|Overall Study|Non-compliance with study protocol|0|||
23486995|NCT00395538|65527391|FG001|Overall Study|Non-compliance with study protocol|1|||
23486996|NCT00395538|65527392|FG002|Overall Study|Non-compliance with study protocol|0|||
23486997|NCT00395538|65527390|FG000|Overall Study|PTH resistance|0|||
23486998|NCT00395538|65527391|FG001|Overall Study|PTH resistance|0|||
23486999|NCT00395538|65527392|FG002|Overall Study|PTH resistance|1|||
23487000|NCT00395538|65527390|FG000|Overall Study|Pregnancy|1|||
23487001|NCT00395538|65527391|FG001|Overall Study|Pregnancy|0|||
23487002|NCT00395538|65527392|FG002|Overall Study|Pregnancy|0|||
23487003|NCT00395538|65527390|FG000|Overall Study|Partial recovery of parathyroid function|0|||
23487004|NCT00395538|65527391|FG001|Overall Study|Partial recovery of parathyroid function|0|||
23487005|NCT00395538|65527392|FG002|Overall Study|Partial recovery of parathyroid function|1|||
23487006|NCT00395538|65527390|FG000|Overall Study|Participant elected to discontinue|0|||
23487007|NCT00395538|65527391|FG001|Overall Study|Participant elected to discontinue|0|||
23487008|NCT00395538|65527392|FG002|Overall Study|Participant elected to discontinue|1|||
23487009|NCT01467427|65527399|FG000|Overall Study|Withdrawal by Subject|1|||
23487010|NCT01467427|65527400|FG001|Overall Study|Withdrawal by Subject|0|||
23487011|NCT01467427|65527399|FG000|Overall Study|Entered extension phase|11|||
23373599|NCT01582451|65112700|FG000|Overall Study|Death|3|||
23373600|NCT01582451|65112701|FG001|Overall Study|Death|3|||
23373601|NCT01582451|65112700|FG000|Overall Study|Lost to Follow-up|0|||
23373602|NCT01582451|65112701|FG001|Overall Study|Lost to Follow-up|2|||
23373603|NCT01582451|65112700|FG000|Overall Study|Protocol Violation|11|||
23373604|NCT01582451|65112701|FG001|Overall Study|Protocol Violation|3|||
23373605|NCT01582451|65112700|FG000|Overall Study|Withdrawal by Subject|13|||
23373606|NCT01582451|65112701|FG001|Overall Study|Withdrawal by Subject|9|||
23373607|NCT01582451|65112700|FG000|Overall Study|Physician Decision|3|||
23487012|NCT01467427|65527400|FG001|Overall Study|Entered extension phase|11|||
23487013|NCT01467427|65527399|FG000|Overall Study|Not continuing in extension phase|0|||
23487014|NCT01467427|65527400|FG001|Overall Study|Not continuing in extension phase|2|||
23373608|NCT01582451|65112701|FG001|Overall Study|Physician Decision|0|||
23373609|NCT01582451|65112700|FG000|Overall Study|Sponsor Decision|1|||
23373610|NCT01582451|65112701|FG001|Overall Study|Sponsor Decision|0|||
23487015|NCT01539317|65527401|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
23487016|NCT01539317|65527402|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
23487017|NCT00116428|65527403|FG000|Overall Study|Withdrawal by Subject|2|||
23487018|NCT00116428|65527404|FG001|Overall Study|Withdrawal by Subject|5|||
23373611|NCT02774889|65112704|FG000|Overall Study|Lost to Follow-up|2|||
23373612|NCT02774889|65112705|FG001|Overall Study|Lost to Follow-up|1|||
23487019|NCT00116428|65527403|FG000|Overall Study|Did not meet inclusion criteria|1|||
23487020|NCT00116428|65527404|FG001|Overall Study|Did not meet inclusion criteria|0|||
23487021|NCT00478881|65527405|FG000|Overall Study|Adverse Event|31|||
23487022|NCT00478881|65527406|FG001|Overall Study|Adverse Event|12|||
23487023|NCT00478881|65527405|FG000|Overall Study|Lack of Efficacy|0|||
23487024|NCT00478881|65527406|FG001|Overall Study|Lack of Efficacy|3|||
23487025|NCT00478881|65527405|FG000|Overall Study|Lost to Follow-up|0|||
23487026|NCT00478881|65527406|FG001|Overall Study|Lost to Follow-up|1|||
23487027|NCT00478881|65527405|FG000|Overall Study|Protocol Violation|2|||
23487028|NCT00478881|65527406|FG001|Overall Study|Protocol Violation|2|||
23487029|NCT00478881|65527405|FG000|Overall Study|Withdrawal by Subject|6|||
23487030|NCT00478881|65527406|FG001|Overall Study|Withdrawal by Subject|2|||
23487031|NCT00478881|65527405|FG000|Overall Study|Non-Compliance with Study Medication|0|||
23373613|NCT00830219|65112706|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
23373614|NCT00830219|65112707|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23373615|NCT02153918|65112709|FG000|Overall Study|Refused further treatment|1|||
23373616|NCT03256578|65112710|FG000|Overall Study|Excluded Post Randomization|66|||
23373617|NCT03256578|65112711|FG001|Overall Study|Excluded Post Randomization|56|||
23373618|NCT01811238|65112714|FG000|Overall Study|Withdrawal by Subject|42|||
23373619|NCT01811238|65112714|FG000|Overall Study|Adverse Event|25|||
23373620|NCT01811238|65112714|FG000|Overall Study|Protocol Violation|4|||
23373621|NCT01811238|65112714|FG000|Overall Study|Lack of Efficacy|4|||
23373622|NCT01811238|65112714|FG000|Overall Study|subject refused study medication|6|||
23373623|NCT02783066|65112715|FG000|Overall Study|Withdrawal by Subject|13|||
23373624|NCT00473083|65112719|FG000|Overall Study|Adverse Event|1|||
23373625|NCT00473083|65112720|FG001|Overall Study|Adverse Event|0|||
23373626|NCT00473083|65112721|FG002|Overall Study|Adverse Event|0|||
23373627|NCT01369433|65112722|FG000|Overall Study|Adverse Event|31|||
23373628|NCT01369433|65112723|FG001|Overall Study|Adverse Event|1|||
23373629|NCT01369433|65112722|FG000|Overall Study|Required significant surgical procedure|1|||
23373630|NCT01369433|65112723|FG001|Overall Study|Required significant surgical procedure|0|||
23487032|NCT00478881|65527406|FG001|Overall Study|Non-Compliance with Study Medication|2|||
23373631|NCT01369433|65112722|FG000|Overall Study|Non-compliance|1|||
23373632|NCT01369433|65112723|FG001|Overall Study|Non-compliance|0|||
23373633|NCT01369433|65112722|FG000|Overall Study|Withdrawal by Subject|5|||
23373634|NCT01369433|65112723|FG001|Overall Study|Withdrawal by Subject|2|||
23487033|NCT01278160|65527407|FG000|Overall Study|Adverse Event|1|||
23487034|NCT01278160|65527408|FG001|Overall Study|Adverse Event|1|||
23487035|NCT01278160|65527407|FG000|Overall Study|Lost to Follow-up|0|||
23487036|NCT01278160|65527408|FG001|Overall Study|Lost to Follow-up|1|||
23603695|NCT01034306|65937456|FG000|Overall Study|Noncomplience|1|||
23603696|NCT01034306|65937457|FG001|Overall Study|Noncomplience|0|||
23603697|NCT03138499|65940154|FG000|Overall Study|Lost to Follow-up|1|||
23603698|NCT03138499|65940155|FG001|Overall Study|Lost to Follow-up|0|||
23603699|NCT03138499|65940154|FG000|Overall Study|Participants withdrew consent|1|||
23603700|NCT03138499|65940155|FG001|Overall Study|Participants withdrew consent|0|||
23280994|NCT05093205|64769172|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
23280995|NCT05093205|64769173|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
23280996|NCT05093205|64769174|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
23280997|NCT05093205|64769175|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
23603701|NCT03138499|65940154|FG000|Overall Study|Participant discontinued study before treatment|0|||
23280998|NCT05093205|64769176|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
23280999|NCT05093205|64769177|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
23281000|NCT05093205|64769178|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
23281001|NCT05093205|64769179|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
23281002|NCT05093205|64769180|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
23281003|NCT05093205|64769181|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
23281004|NCT05093205|64769169|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281005|NCT05093205|64769170|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281006|NCT05093205|64769171|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281007|NCT05093205|64769172|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281008|NCT05093205|64769173|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281009|NCT05093205|64769174|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281010|NCT05093205|64769175|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281011|NCT05093205|64769176|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281012|NCT05093205|64769177|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281013|NCT05093205|64769178|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
23281014|NCT05093205|64769179|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281015|NCT05093205|64769180|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281016|NCT05093205|64769181|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
23281017|NCT05093205|64769169|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
23281018|NCT05093205|64769170|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
23281019|NCT05093205|64769171|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
23281020|NCT05093205|64769172|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
23281021|NCT05093205|64769173|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
23281022|NCT05093205|64769174|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
23281023|NCT05093205|64769175|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
23281024|NCT05093205|64769176|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
23281025|NCT05093205|64769177|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
23281026|NCT05093205|64769178|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
23281027|NCT05093205|64769179|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
23281028|NCT05093205|64769180|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
23281029|NCT05093205|64769181|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
23281030|NCT05093205|64769169|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281031|NCT05093205|64769170|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281032|NCT05093205|64769171|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281033|NCT05093205|64769172|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281034|NCT05093205|64769173|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23603702|NCT03138499|65940155|FG001|Overall Study|Participant discontinued study before treatment|1|||
23603703|NCT03138499|65940154|FG000|Overall Study|Disease Progression|2|||
23603704|NCT03138499|65940155|FG001|Overall Study|Disease Progression|6|||
23201510|NCT02179515|64476762|FG002|Overall Study|Death|1|||
23201511|NCT02179515|64476760|FG000|Overall Study|refused further treatment|0|||
23201512|NCT02179515|64476761|FG001|Overall Study|refused further treatment|3|||
23201513|NCT02179515|64476762|FG002|Overall Study|refused further treatment|4|||
23201514|NCT02179515|64476760|FG000|Overall Study|Disease progression on study|2|||
23201515|NCT02179515|64476761|FG001|Overall Study|Disease progression on study|11|||
23201516|NCT02179515|64476762|FG002|Overall Study|Disease progression on study|8|||
23201517|NCT02575079|64476763|FG000|Overall Study|Death|3|||
23201518|NCT02575079|64476764|FG001|Overall Study|Death|0|||
23201519|NCT02575079|64476763|FG000|Overall Study|Withdrawal by Subject|3|||
23201520|NCT02575079|64476764|FG001|Overall Study|Withdrawal by Subject|0|||
23281035|NCT05093205|64769174|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281036|NCT05093205|64769175|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281037|NCT05093205|64769176|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281038|NCT05093205|64769177|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281039|NCT05093205|64769178|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281040|NCT05093205|64769179|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
23281041|NCT05093205|64769180|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281042|NCT05093205|64769181|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
23281043|NCT05093205|64769169|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281044|NCT05093205|64769170|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281045|NCT05093205|64769171|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281046|NCT05093205|64769172|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281047|NCT05093205|64769173|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281048|NCT05093205|64769174|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281049|NCT05093205|64769175|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281050|NCT05093205|64769176|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281051|NCT05093205|64769177|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281052|NCT05093205|64769178|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281053|NCT05093205|64769179|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281054|NCT05093205|64769180|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
23281055|NCT05093205|64769181|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
23281056|NCT05093205|64769169|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
23281057|NCT05093205|64769170|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
23281058|NCT05093205|64769171|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
23281059|NCT05093205|64769172|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
23281060|NCT05093205|64769173|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
23281061|NCT05093205|64769174|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
23281062|NCT05093205|64769175|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
23281063|NCT05093205|64769176|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
23281064|NCT05093205|64769177|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
23281065|NCT05093205|64769178|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
23281066|NCT05093205|64769179|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
23281067|NCT05093205|64769180|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
23281068|NCT05093205|64769181|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
23281069|NCT05093205|64769169|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281070|NCT05093205|64769170|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281071|NCT05093205|64769171|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281072|NCT05093205|64769172|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281073|NCT05093205|64769173|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281074|NCT05093205|64769174|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281075|NCT05093205|64769175|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281076|NCT05093205|64769176|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281077|NCT05093205|64769177|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281078|NCT05093205|64769178|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281079|NCT05093205|64769179|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281080|NCT05093205|64769180|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
23281081|NCT05093205|64769181|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
23281082|NCT03504085|64772338|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
23281083|NCT03504085|64772339|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
23281084|NCT03504085|64772338|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
23281085|NCT03504085|64772339|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
23281086|NCT04994535|64772344|FG000|Overall Study|Lost to Follow-up|7|||
23281087|NCT04994535|64772345|FG001|Overall Study|Lost to Follow-up|7|||
23281088|NCT04994535|64772344|FG000|Overall Study|Withdrawal by Subject|10|||
23281089|NCT04994535|64772345|FG001|Overall Study|Withdrawal by Subject|7|||
23281090|NCT04994535|64772344|FG000|Overall Study|Other|1|||
23281091|NCT04994535|64772345|FG001|Overall Study|Other|1|||
23281092|NCT03605342|64772346|FG000|Overall Study|Withdrawal by Subject|9|||
23281093|NCT03605342|64772347|FG001|Overall Study|Withdrawal by Subject|7|||
23281094|NCT03605342|64772346|FG000|Overall Study|Lost to Follow-up|1|||
23281095|NCT03605342|64772347|FG001|Overall Study|Lost to Follow-up|1|||
23281096|NCT01440803|64772350|FG000|Overall Study|Met study stopping rule|2|||
23281097|NCT01440803|64772351|FG001|Overall Study|Met study stopping rule|1|||
23281098|NCT01440803|64772350|FG000|Overall Study|Lost to Follow-up|0|||
23281099|NCT01440803|64772351|FG001|Overall Study|Lost to Follow-up|2|||
23281100|NCT01440803|64772350|FG000|Overall Study|Withdrawal by Subject|0|||
23281101|NCT01440803|64772351|FG001|Overall Study|Withdrawal by Subject|1|||
23281102|NCT00834873|64772354|FG000|First Intervention|Adverse Event|0|||
23281103|NCT00834873|64772355|FG001|First Intervention|Adverse Event|1|||
23281104|NCT00462345|64772363|FG000|Overall Study|Withdrawal by Subject|2|||
23281105|NCT00462345|64772363|FG000|Overall Study|Did not complete second course|1|||
23487037|NCT01278160|65527407|FG000|Overall Study|Withdrawal by Subject|3|||
23487038|NCT01278160|65527408|FG001|Overall Study|Withdrawal by Subject|2|||
23281106|NCT02055547|64772364|FG000|Overall Study|Protocol Violation|0|||
23373635|NCT01369433|65112722|FG000|Overall Study|Study terminated by Sponsor|67|||
23373636|NCT01369433|65112723|FG001|Overall Study|Study terminated by Sponsor|0|||
23373637|NCT01369433|65112722|FG000|Overall Study|Lost to Follow-up|1|||
23373638|NCT01369433|65112723|FG001|Overall Study|Lost to Follow-up|0|||
23373639|NCT01369433|65112722|FG000|Overall Study|Death|5|||
23373640|NCT01369433|65112723|FG001|Overall Study|Death|0|||
23373641|NCT01369433|65112722|FG000|Overall Study|Investigator discretion|6|||
23373642|NCT01369433|65112723|FG001|Overall Study|Investigator discretion|1|||
23373643|NCT01369433|65112722|FG000|Overall Study|Progressive Disease|92|||
23373644|NCT01369433|65112723|FG001|Overall Study|Progressive Disease|12|||
23373645|NCT00964782|65112726|FG000|Overall Study|Lost to Follow-up|1|||
23373646|NCT00964782|65112727|FG001|Overall Study|Lost to Follow-up|0|||
23373647|NCT00921024|65112731|FG000|Overall Study|Lost to Follow-up|2|||
23373648|NCT00921024|65112732|FG001|Overall Study|Lost to Follow-up|0|||
23373649|NCT00921024|65112731|FG000|Overall Study|Received concomittant therapy|2|||
23373650|NCT00921024|65112732|FG001|Overall Study|Received concomittant therapy|0|||
23373651|NCT00921024|65112731|FG000|Overall Study|Withdrawal by Subject|0|||
23373652|NCT00921024|65112732|FG001|Overall Study|Withdrawal by Subject|3|||
23373653|NCT03427892|65112735|FG000|Overall Study|Lost to Follow-up|2|||
23373654|NCT00314145|65112738|FG000|Overall Study|Withdrawal by Subject|8|||
23373655|NCT00314145|65112739|FG001|Overall Study|Withdrawal by Subject|10|||
23373656|NCT00314145|65112738|FG000|Overall Study|Lost to Follow-up|5|||
23373657|NCT00314145|65112739|FG001|Overall Study|Lost to Follow-up|12|||
23373658|NCT00314145|65112738|FG000|Overall Study|Physician Decision|3|||
23373659|NCT00314145|65112739|FG001|Overall Study|Physician Decision|4|||
23373660|NCT00314145|65112738|FG000|Overall Study|Adverse Event|0|||
23373661|NCT00314145|65112739|FG001|Overall Study|Adverse Event|3|||
23373662|NCT00314145|65112738|FG000|Overall Study|Protocol Violation|3|||
23373663|NCT00314145|65112739|FG001|Overall Study|Protocol Violation|0|||
23281107|NCT02055547|64772365|FG001|Overall Study|Protocol Violation|0|||
23281108|NCT02055547|64772366|FG002|Overall Study|Protocol Violation|1|||
23281109|NCT02055547|64772367|FG003|Overall Study|Protocol Violation|0|||
23281110|NCT02055547|64772368|FG004|Overall Study|Protocol Violation|0|||
23281111|NCT02055547|64772369|FG005|Overall Study|Protocol Violation|0|||
23281112|NCT02055547|64772370|FG006|Overall Study|Protocol Violation|1|||
23281113|NCT02055547|64772371|FG007|Overall Study|Protocol Violation|0|||
23281114|NCT02055547|64772372|FG008|Overall Study|Protocol Violation|0|||
23281115|NCT02055547|64772373|FG009|Overall Study|Protocol Violation|0|||
23281116|NCT02055547|64772374|FG010|Overall Study|Protocol Violation|0|||
23281117|NCT02055547|64772375|FG011|Overall Study|Protocol Violation|0|||
23281118|NCT02055547|64772376|FG012|Overall Study|Protocol Violation|0|||
23281119|NCT02055547|64772377|FG013|Overall Study|Protocol Violation|0|||
23281120|NCT02055547|64772378|FG014|Overall Study|Protocol Violation|0|||
23281121|NCT02055547|64772379|FG015|Overall Study|Protocol Violation|0|||
23281122|NCT02055547|64772380|FG016|Overall Study|Protocol Violation|0|||
23281123|NCT02055547|64772381|FG017|Overall Study|Protocol Violation|0|||
23281124|NCT02055547|64772382|FG018|Overall Study|Protocol Violation|0|||
23281125|NCT02055547|64772364|FG000|Overall Study|Physician Decision|0|||
23281126|NCT02055547|64772365|FG001|Overall Study|Physician Decision|1|||
23281127|NCT02055547|64772366|FG002|Overall Study|Physician Decision|1|||
23281128|NCT02055547|64772367|FG003|Overall Study|Physician Decision|0|||
23281129|NCT02055547|64772368|FG004|Overall Study|Physician Decision|1|||
23281130|NCT02055547|64772369|FG005|Overall Study|Physician Decision|0|||
23281131|NCT02055547|64772370|FG006|Overall Study|Physician Decision|0|||
23281132|NCT02055547|64772371|FG007|Overall Study|Physician Decision|0|||
23281133|NCT02055547|64772372|FG008|Overall Study|Physician Decision|0|||
23281134|NCT02055547|64772373|FG009|Overall Study|Physician Decision|1|||
23281135|NCT02055547|64772374|FG010|Overall Study|Physician Decision|1|||
23281136|NCT02055547|64772375|FG011|Overall Study|Physician Decision|0|||
23281137|NCT02055547|64772376|FG012|Overall Study|Physician Decision|0|||
23281138|NCT02055547|64772377|FG013|Overall Study|Physician Decision|0|||
23373664|NCT00314145|65112738|FG000|Overall Study|Sponsor Decision|2|||
23373665|NCT00314145|65112739|FG001|Overall Study|Sponsor Decision|0|||
23281139|NCT02055547|64772378|FG014|Overall Study|Physician Decision|0|||
23281140|NCT02055547|64772379|FG015|Overall Study|Physician Decision|0|||
23373666|NCT00961064|65112740|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
23373667|NCT00961064|65112740|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
23373668|NCT00961064|65112740|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
23373669|NCT00961064|65112740|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
23373670|NCT00961064|65112740|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
23373671|NCT00961064|65112740|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
23373672|NCT00961064|65112740|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
23373673|NCT00961064|65112740|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
23281141|NCT02055547|64772380|FG016|Overall Study|Physician Decision|0|||
23281142|NCT02055547|64772381|FG017|Overall Study|Physician Decision|0|||
23281143|NCT02055547|64772382|FG018|Overall Study|Physician Decision|0|||
23281144|NCT02055547|64772364|FG000|Overall Study|Adverse Event|0|||
23373674|NCT00891813|65112741|FG000|Overall Study|Adverse Event|3|||
23373675|NCT00891813|65112741|FG000|Overall Study|Withdrawal by Subject|1|||
23373676|NCT00891813|65112741|FG000|Overall Study|Patient Noncompliance|6|||
23373677|NCT00891813|65112741|FG000|Overall Study|Protocol Violation|2|||
23373678|NCT01649765|65112742|FG000|Overall Study|Adverse Event|5|||
23373679|NCT01649765|65112743|FG001|Overall Study|Adverse Event|3|||
23373680|NCT01649765|65112742|FG000|Overall Study|Lack of Efficacy|1|||
23281145|NCT02055547|64772365|FG001|Overall Study|Adverse Event|0|||
23281146|NCT02055547|64772366|FG002|Overall Study|Adverse Event|0|||
23281147|NCT02055547|64772367|FG003|Overall Study|Adverse Event|0|||
23281148|NCT02055547|64772368|FG004|Overall Study|Adverse Event|0|||
23281149|NCT02055547|64772369|FG005|Overall Study|Adverse Event|0|||
23281150|NCT02055547|64772370|FG006|Overall Study|Adverse Event|1|||
23281151|NCT02055547|64772371|FG007|Overall Study|Adverse Event|0|||
23281152|NCT02055547|64772372|FG008|Overall Study|Adverse Event|1|||
23281153|NCT02055547|64772373|FG009|Overall Study|Adverse Event|0|||
23281154|NCT02055547|64772374|FG010|Overall Study|Adverse Event|0|||
23281155|NCT02055547|64772375|FG011|Overall Study|Adverse Event|0|||
23281156|NCT02055547|64772376|FG012|Overall Study|Adverse Event|0|||
23281157|NCT02055547|64772377|FG013|Overall Study|Adverse Event|0|||
23281158|NCT02055547|64772378|FG014|Overall Study|Adverse Event|0|||
23281159|NCT02055547|64772379|FG015|Overall Study|Adverse Event|0|||
23281160|NCT02055547|64772380|FG016|Overall Study|Adverse Event|0|||
23281161|NCT02055547|64772381|FG017|Overall Study|Adverse Event|0|||
23281162|NCT02055547|64772382|FG018|Overall Study|Adverse Event|0|||
23281163|NCT02055547|64772364|FG000|Overall Study|Withdrawal by Subject|0|||
23281164|NCT02055547|64772365|FG001|Overall Study|Withdrawal by Subject|0|||
23281165|NCT02055547|64772366|FG002|Overall Study|Withdrawal by Subject|0|||
23281166|NCT02055547|64772367|FG003|Overall Study|Withdrawal by Subject|0|||
23281167|NCT02055547|64772368|FG004|Overall Study|Withdrawal by Subject|0|||
23281168|NCT02055547|64772369|FG005|Overall Study|Withdrawal by Subject|1|||
23281169|NCT02055547|64772370|FG006|Overall Study|Withdrawal by Subject|0|||
23281170|NCT02055547|64772371|FG007|Overall Study|Withdrawal by Subject|0|||
23281171|NCT02055547|64772372|FG008|Overall Study|Withdrawal by Subject|1|||
23281172|NCT02055547|64772373|FG009|Overall Study|Withdrawal by Subject|0|||
23281173|NCT02055547|64772374|FG010|Overall Study|Withdrawal by Subject|0|||
23281174|NCT02055547|64772375|FG011|Overall Study|Withdrawal by Subject|0|||
23281175|NCT02055547|64772376|FG012|Overall Study|Withdrawal by Subject|0|||
23281176|NCT02055547|64772377|FG013|Overall Study|Withdrawal by Subject|1|||
23281177|NCT02055547|64772378|FG014|Overall Study|Withdrawal by Subject|0|||
23281178|NCT02055547|64772379|FG015|Overall Study|Withdrawal by Subject|1|||
23281179|NCT02055547|64772380|FG016|Overall Study|Withdrawal by Subject|0|||
23281180|NCT02055547|64772381|FG017|Overall Study|Withdrawal by Subject|0|||
23281181|NCT02055547|64772382|FG018|Overall Study|Withdrawal by Subject|0|||
23281182|NCT02055547|64772364|FG000|Overall Study|Lost to Follow-up|0|||
23281183|NCT02055547|64772365|FG001|Overall Study|Lost to Follow-up|0|||
23281184|NCT02055547|64772366|FG002|Overall Study|Lost to Follow-up|1|||
23281185|NCT02055547|64772367|FG003|Overall Study|Lost to Follow-up|0|||
23281186|NCT02055547|64772368|FG004|Overall Study|Lost to Follow-up|0|||
23281187|NCT02055547|64772369|FG005|Overall Study|Lost to Follow-up|0|||
23281188|NCT02055547|64772370|FG006|Overall Study|Lost to Follow-up|0|||
23281189|NCT02055547|64772371|FG007|Overall Study|Lost to Follow-up|0|||
23281190|NCT02055547|64772372|FG008|Overall Study|Lost to Follow-up|0|||
23281191|NCT02055547|64772373|FG009|Overall Study|Lost to Follow-up|0|||
23281192|NCT02055547|64772374|FG010|Overall Study|Lost to Follow-up|0|||
23281193|NCT02055547|64772375|FG011|Overall Study|Lost to Follow-up|0|||
23373681|NCT01649765|65112743|FG001|Overall Study|Lack of Efficacy|1|||
23373682|NCT01649765|65112742|FG000|Overall Study|Physician Decision|0|||
23373683|NCT01649765|65112743|FG001|Overall Study|Physician Decision|3|||
23373684|NCT01649765|65112742|FG000|Overall Study|Protocol Violation|1|||
23373685|NCT01649765|65112743|FG001|Overall Study|Protocol Violation|0|||
23373686|NCT01649765|65112742|FG000|Overall Study|Withdrawal by Subject|2|||
23373687|NCT01649765|65112743|FG001|Overall Study|Withdrawal by Subject|1|||
23373688|NCT00572832|65112747|FG000|Overall Study|Lost to Follow-up|0|||
23281194|NCT02055547|64772376|FG012|Overall Study|Lost to Follow-up|0|||
23281195|NCT02055547|64772377|FG013|Overall Study|Lost to Follow-up|0|||
23281196|NCT02055547|64772378|FG014|Overall Study|Lost to Follow-up|0|||
23281197|NCT02055547|64772379|FG015|Overall Study|Lost to Follow-up|0|||
23373689|NCT00572832|65112748|FG001|Overall Study|Lost to Follow-up|11|||
23373690|NCT00572832|65112747|FG000|Overall Study|Pregnancy|0|||
23373691|NCT00572832|65112748|FG001|Overall Study|Pregnancy|1|||
23281198|NCT02055547|64772380|FG016|Overall Study|Lost to Follow-up|0|||
23281199|NCT02055547|64772381|FG017|Overall Study|Lost to Follow-up|0|||
23281200|NCT02055547|64772382|FG018|Overall Study|Lost to Follow-up|0|||
23281201|NCT02025010|64772384|FG000|Overall Study|Symptomatic or radiographic progression|36|||
23281202|NCT02025010|64772384|FG000|Overall Study|Adverse Event|6|||
23281203|NCT02025010|64772384|FG000|Overall Study|Physician Decision|7|||
23373692|NCT01925417|65112750|FG000|Overall Study|Withdrawal by Subject|2|||
23373693|NCT01925417|65112750|FG000|Overall Study|Death|1|||
23281204|NCT02025010|64772384|FG000|Overall Study|Withdrawal by Subject|3|||
23281205|NCT02025010|64772384|FG000|Overall Study|Intercurrent illness|3|||
23281206|NCT02025010|64772384|FG000|Overall Study|Patients still on treatment|3|||
23281207|NCT02025010|64772384|FG000|Overall Study|Never initiate the treatment|2|||
23281208|NCT00811655|64772385|FG000|Overall Study|Physician Decision|1|||
23281209|NCT00829764|64772386|FG000|First Intervention|Adverse Event|1|||
23281210|NCT00829764|64772387|FG001|First Intervention|Adverse Event|0|||
23281211|NCT00829764|64772386|FG000|First Intervention|Withdrawal by Subject|1|||
23281212|NCT00829764|64772387|FG001|First Intervention|Withdrawal by Subject|1|||
23281213|NCT01863745|64772388|FG000|Overall Study|Disease Progression|9|||
23281214|NCT01863745|64772388|FG000|Overall Study|Adverse Event|2|||
23281215|NCT01863745|64772388|FG000|Overall Study|Death|1|||
23281216|NCT01863745|64772388|FG000|Overall Study|Withdrawal by Subject|1|||
23281217|NCT00829712|64772389|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
23281218|NCT00829712|64772390|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23281219|NCT00672984|64772392|FG000|First Intervention|Adverse Event|5|||
23281220|NCT00672984|64772393|FG001|First Intervention|Adverse Event|0|||
23281221|NCT00672984|64772394|FG002|First Intervention|Adverse Event|0|||
23281222|NCT00672984|64772392|FG000|First Intervention|Withdrawal by Subject|1|||
23281223|NCT00672984|64772393|FG001|First Intervention|Withdrawal by Subject|2|||
23281224|NCT00672984|64772394|FG002|First Intervention|Withdrawal by Subject|2|||
23281225|NCT00672984|64772392|FG000|First Intervention|Sponsor decision|3|||
23281226|NCT00672984|64772393|FG001|First Intervention|Sponsor decision|0|||
23281227|NCT00672984|64772394|FG002|First Intervention|Sponsor decision|0|||
23281228|NCT00672984|64772392|FG000|Second Intervention|Non-compliance with facility policies|0|||
23281229|NCT00672984|64772393|FG001|Second Intervention|Non-compliance with facility policies|2|||
23281230|NCT00672984|64772394|FG002|Second Intervention|Non-compliance with facility policies|0|||
23281231|NCT00672984|64772392|FG000|Second Intervention|Withdrawal by Subject|0|||
23281232|NCT00672984|64772393|FG001|Second Intervention|Withdrawal by Subject|3|||
23281233|NCT00672984|64772394|FG002|Second Intervention|Withdrawal by Subject|0|||
23281234|NCT00672984|64772392|FG000|Second Intervention|Protocol Violation|0|||
23281235|NCT00672984|64772393|FG001|Second Intervention|Protocol Violation|1|||
23281236|NCT00672984|64772394|FG002|Second Intervention|Protocol Violation|1|||
23281237|NCT00672984|64772392|FG000|Third Intervention|Adverse Event|1|||
23281238|NCT00672984|64772393|FG001|Third Intervention|Adverse Event|0|||
23281239|NCT00672984|64772394|FG002|Third Intervention|Adverse Event|1|||
23281240|NCT04442503|64772395|FG000|Overall Study|Adverse Event|1|||
23281241|NCT04442503|64772396|FG001|Overall Study|Adverse Event|1|||
23281242|NCT04442503|64772395|FG000|Overall Study|Lost to Follow-up|8|||
23281243|NCT04442503|64772396|FG001|Overall Study|Lost to Follow-up|6|||
23281244|NCT04442503|64772395|FG000|Overall Study|Physician Decision|0|||
23281245|NCT04442503|64772396|FG001|Overall Study|Physician Decision|2|||
23281246|NCT04442503|64772395|FG000|Overall Study|Withdrawal by Subject|3|||
23281247|NCT04442503|64772396|FG001|Overall Study|Withdrawal by Subject|4|||
23281248|NCT04442503|64772395|FG000|Overall Study|Reason not Specified|0|||
23373694|NCT00753519|65112751|FG000|Overall Study|Withdrawal by Subject|0|||
23373695|NCT00753519|65112752|FG001|Overall Study|Withdrawal by Subject|2|||
23373696|NCT01553851|65112753|FG000|Overall Study|Adverse Event|2|||
23373697|NCT01553851|65112753|FG000|Overall Study|constipation|1|||
23373698|NCT01277861|65112754|FG000|Overall Study|Physician Decision|2|||
23373699|NCT01277861|65112755|FG001|Overall Study|Physician Decision|2|||
23373700|NCT00407511|65112758|FG000|Overall Study|Adverse Event|9|||
23373701|NCT00407511|65112758|FG000|Overall Study|Lost to Follow-up|4|||
23373702|NCT00407511|65112758|FG000|Overall Study|Other|5|||
23373703|NCT00407511|65112758|FG000|Overall Study|Withdrawal by Subject|4|||
23373704|NCT01933594|65112761|FG000|Overall Study|Lost to Follow-up|1|||
23373705|NCT01933594|65112762|FG001|Overall Study|Lost to Follow-up|0|||
23373706|NCT01933594|65112763|FG002|Overall Study|Lost to Follow-up|0|||
23373707|NCT01933594|65112764|FG003|Overall Study|Lost to Follow-up|0|||
23373708|NCT01933594|65112765|FG004|Overall Study|Lost to Follow-up|1|||
23373709|NCT01933594|65112766|FG005|Overall Study|Lost to Follow-up|0|||
23373710|NCT01933594|65112761|FG000|Overall Study|Ineligible for subsequent study step|0|||
23373711|NCT01933594|65112762|FG001|Overall Study|Ineligible for subsequent study step|0|||
23373712|NCT01933594|65112763|FG002|Overall Study|Ineligible for subsequent study step|0|||
23487039|NCT01278160|65527407|FG000|Overall Study|Unclassified|1|||
23487040|NCT01278160|65527408|FG001|Overall Study|Unclassified|2|||
23487041|NCT01107418|65527414|FG000|Overall Study|Disease Progression|45|||
23487042|NCT01107418|65527414|FG000|Overall Study|Adverse Event|3|||
23487043|NCT01107418|65527414|FG000|Overall Study|Withdrawal by Subject|1|||
23487044|NCT01107418|65527414|FG000|Overall Study|Study Closing|1|||
23487045|NCT01107418|65527414|FG000|Overall Study|Started Other Therapy|1|||
23487046|NCT01107418|65527414|FG000|Overall Study|Entered Extension Study|1|||
23487047|NCT01606254|65527417|FG000|Overall Study|Withdrawal by Subject|1|||
23487048|NCT01606254|65527418|FG001|Overall Study|Withdrawal by Subject|3|||
23487049|NCT01606254|65527419|FG002|Overall Study|Withdrawal by Subject|0|||
23487050|NCT01606254|65527420|FG003|Overall Study|Withdrawal by Subject|2|||
23487051|NCT01606254|65527417|FG000|Overall Study|Adverse Event|1|||
23487052|NCT01606254|65527418|FG001|Overall Study|Adverse Event|1|||
23487053|NCT01606254|65527419|FG002|Overall Study|Adverse Event|0|||
23487054|NCT01606254|65527420|FG003|Overall Study|Adverse Event|1|||
23487055|NCT03766685|65527421|FG000|Overall Study|Lost to Follow-up|1|||
23487056|NCT03766685|65527422|FG001|Overall Study|Lost to Follow-up|1|||
23487057|NCT03766685|65527423|FG002|Overall Study|Lost to Follow-up|0|||
23487058|NCT03766685|65527424|FG003|Overall Study|Lost to Follow-up|0|||
23487059|NCT03766685|65527421|FG000|Overall Study|Adverse Event, not fatal|0|||
23487060|NCT03766685|65527422|FG001|Overall Study|Adverse Event, not fatal|1|||
23487061|NCT03766685|65527423|FG002|Overall Study|Adverse Event, not fatal|0|||
23487062|NCT03766685|65527424|FG003|Overall Study|Adverse Event, not fatal|1|||
23487063|NCT03766685|65527421|FG000|Overall Study|Withdrawal by Subject|0|||
23487064|NCT03766685|65527422|FG001|Overall Study|Withdrawal by Subject|2|||
23487065|NCT03766685|65527423|FG002|Overall Study|Withdrawal by Subject|0|||
23281249|NCT04442503|64772396|FG001|Overall Study|Reason not Specified|1|||
23487066|NCT03766685|65527424|FG003|Overall Study|Withdrawal by Subject|0|||
23281250|NCT04442503|64772395|FG000|Overall Study|Randomized but not Treated|3|||
23281251|NCT04442503|64772396|FG001|Overall Study|Randomized but not Treated|1|||
23281252|NCT04551066|64772397|FG000|Overall Study|Death|5|||
23281253|NCT04551066|64772398|FG001|Overall Study|Death|3|||
23281254|NCT04551066|64772397|FG000|Overall Study|Lost to Follow-up|1|||
23281255|NCT04551066|64772398|FG001|Overall Study|Lost to Follow-up|0|||
23281256|NCT04551066|64772397|FG000|Overall Study|Sponsor Decision|103|||
23281257|NCT04551066|64772398|FG001|Overall Study|Sponsor Decision|117|||
23281258|NCT04551066|64772397|FG000|Overall Study|Withdrawal by Subject|8|||
23281259|NCT04551066|64772398|FG001|Overall Study|Withdrawal by Subject|2|||
23281260|NCT04551066|64772397|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
23487067|NCT03766685|65527421|FG000|Overall Study|Protocol Violation|0|||
23487068|NCT03766685|65527422|FG001|Overall Study|Protocol Violation|1|||
23487069|NCT03766685|65527423|FG002|Overall Study|Protocol Violation|0|||
23487070|NCT03766685|65527424|FG003|Overall Study|Protocol Violation|0|||
23487071|NCT03766685|65527421|FG000|Overall Study|Non-compliance|0|||
23487072|NCT03766685|65527422|FG001|Overall Study|Non-compliance|2|||
23487073|NCT03766685|65527423|FG002|Overall Study|Non-compliance|0|||
23487074|NCT03766685|65527424|FG003|Overall Study|Non-compliance|0|||
23487075|NCT01859143|65527425|FG000|Overall Study|Lost to Follow-up|2|||
23487076|NCT01859143|65527426|FG001|Overall Study|Lost to Follow-up|0|||
23487077|NCT00237185|65527427|FG000|Core|Adverse Event|3|||
23487078|NCT00237185|65527428|FG001|Core|Adverse Event|4|||
23487079|NCT00237185|65527427|FG000|Core|Abnormal laboratory value|0|||
23487080|NCT00237185|65527428|FG001|Core|Abnormal laboratory value|4|||
23487081|NCT00237185|65527427|FG000|Core|Abnormal test procedure results|1|||
23487082|NCT00237185|65527428|FG001|Core|Abnormal test procedure results|0|||
23487083|NCT00237185|65527427|FG000|Core|Lack of Efficacy|30|||
23487084|NCT00237185|65527428|FG001|Core|Lack of Efficacy|23|||
23487085|NCT00237185|65527427|FG000|Core|Protocol Violation|1|||
23487086|NCT00237185|65527428|FG001|Core|Protocol Violation|1|||
23487087|NCT00237185|65527427|FG000|Core|Withdrawal by Subject|4|||
23487088|NCT00237185|65527428|FG001|Core|Withdrawal by Subject|4|||
23487089|NCT00237185|65527427|FG000|Core|Administrative problems|0|||
23487090|NCT00237185|65527428|FG001|Core|Administrative problems|1|||
23487091|NCT00237185|65527427|FG000|Core|Death|4|||
23487092|NCT00237185|65527428|FG001|Core|Death|0|||
23487093|NCT00237185|65527427|FG000|Core|Determined ineligible post randomization|1|||
23487094|NCT00237185|65527428|FG001|Core|Determined ineligible post randomization|0|||
23487095|NCT00237185|65527427|FG000|Extension|Adverse Event|1|||
23487096|NCT00237185|65527428|FG001|Extension|Adverse Event|0|||
23487097|NCT00237185|65527427|FG000|Extension|Abnormal laboratory value|0|||
23487098|NCT00237185|65527428|FG001|Extension|Abnormal laboratory value|1|||
23487099|NCT00237185|65527427|FG000|Extension|Lack of Efficacy|9|||
23487100|NCT00237185|65527428|FG001|Extension|Lack of Efficacy|14|||
23487101|NCT00237185|65527427|FG000|Extension|Condition no longer required study drug|0|||
23487102|NCT00237185|65527428|FG001|Extension|Condition no longer required study drug|1|||
23487103|NCT00237185|65527427|FG000|Extension|Withdrawal by Subject|3|||
23487104|NCT00237185|65527428|FG001|Extension|Withdrawal by Subject|2|||
23487105|NCT00237185|65527427|FG000|Extension|Lost to Follow-up|1|||
23487106|NCT00237185|65527428|FG001|Extension|Lost to Follow-up|0|||
23487107|NCT00237185|65527427|FG000|Extension|Administrative problems|1|||
23487108|NCT00237185|65527428|FG001|Extension|Administrative problems|0|||
23487109|NCT00237185|65527427|FG000|Extension|Death|1|||
23487110|NCT00237185|65527428|FG001|Extension|Death|1|||
23487111|NCT02962765|65527429|FG000|Overall Study|Protocol Violation|9|||
23487112|NCT02962765|65527429|FG000|Overall Study|Withdrawal by Subject|3|||
23487113|NCT02962765|65527429|FG000|Overall Study|Lost to Follow-up|1|||
23487114|NCT02962765|65527429|FG000|Overall Study|Death|1|||
23487115|NCT02962765|65527429|FG000|Overall Study|Limited access to study medication|3|||
23487116|NCT02203071|65527430|FG000|Overall Study|Lost to Follow-up|3|||
23487117|NCT02203071|65527431|FG001|Overall Study|Lost to Follow-up|1|||
23487118|NCT01367119|65527432|FG000|Overall Study|Adverse Event|1|||
23487119|NCT01367119|65527433|FG001|Overall Study|Adverse Event|0|||
23487120|NCT01367119|65527432|FG000|Overall Study|Withdrawal by Subject|1|||
23487121|NCT01367119|65527433|FG001|Overall Study|Withdrawal by Subject|1|||
23487122|NCT03977454|65527434|FG000|Overall Study|immediate postoperative revision|2|||
23487123|NCT03977454|65527435|FG001|Overall Study|immediate postoperative revision|2|||
23487124|NCT01272661|65527438|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
23487125|NCT01272661|65527439|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
23487126|NCT01272661|65527440|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
23281261|NCT04551066|64772398|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
23373713|NCT01933594|65112764|FG003|Overall Study|Ineligible for subsequent study step|0|||
23487127|NCT03505671|65527441|FG000|Overall Study|Withdrawal by Subject|2|||
23603705|NCT03138499|65940154|FG000|Overall Study|Study drug toxicity|2|||
23487128|NCT03505671|65527442|FG001|Overall Study|Withdrawal by Subject|1|||
23487129|NCT03505671|65527441|FG000|Overall Study|Lost to Follow-up|1|||
23487130|NCT03505671|65527442|FG001|Overall Study|Lost to Follow-up|0|||
23487131|NCT01336569|65527443|FG000|Overall Study|Lost to Follow-up|4|||
23487132|NCT02579928|65527444|FG000|Overall Study|Withdrawal by Subject|1|||
23487133|NCT02579928|65527445|FG001|Overall Study|Withdrawal by Subject|0|||
23487134|NCT01962922|65527448|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
23487135|NCT01962922|65527449|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
23487136|NCT01962922|65527448|FG000|PK Portion Day 7|non-compliance|1|||
23487137|NCT01962922|65527449|FG001|PK Portion Day 7|non-compliance|0|||
23487138|NCT01962922|65527448|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
23487139|NCT01962922|65527449|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
23281262|NCT04551066|64772397|FG000|Overall Study|Adverse Event|2|||
23281263|NCT04551066|64772398|FG001|Overall Study|Adverse Event|0|||
23281264|NCT04551066|64772397|FG000|Overall Study|Physician Decision|2|||
23281265|NCT04551066|64772398|FG001|Overall Study|Physician Decision|0|||
23281266|NCT04551066|64772397|FG000|Overall Study|Protocol Violation|1|||
23281267|NCT04551066|64772398|FG001|Overall Study|Protocol Violation|0|||
23281268|NCT04551066|64772397|FG000|Overall Study|Lack of Efficacy|0|||
23281269|NCT04551066|64772398|FG001|Overall Study|Lack of Efficacy|1|||
23281270|NCT04551066|64772397|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
23281271|NCT04551066|64772398|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
23281272|NCT05616728|64772399|FG000|Overall Study|Lost to Follow-up|0|||
23281273|NCT05616728|64772400|FG001|Overall Study|Lost to Follow-up|0|||
23281274|NCT05616728|64772401|FG002|Overall Study|Lost to Follow-up|1|||
23281275|NCT05616728|64772399|FG000|Overall Study|Withdrawal by Subject|1|||
23281276|NCT05616728|64772400|FG001|Overall Study|Withdrawal by Subject|1|||
23281277|NCT05616728|64772401|FG002|Overall Study|Withdrawal by Subject|0|||
23281278|NCT05616728|64772399|FG000|Overall Study|Physician Decision|1|||
23281279|NCT05616728|64772400|FG001|Overall Study|Physician Decision|1|||
23281280|NCT05616728|64772401|FG002|Overall Study|Physician Decision|1|||
23281281|NCT05616728|64772399|FG000|Overall Study|Other|0|||
23281282|NCT05616728|64772400|FG001|Overall Study|Other|2|||
23281283|NCT05616728|64772401|FG002|Overall Study|Other|0|||
23281284|NCT02267187|64772404|FG000|Overall Study|Physician Decision|2|||
23281285|NCT02267187|64772404|FG000|Overall Study|Screen fail|3|||
23281286|NCT00107991|64772410|FG000|Eligibility Assessment|Disease not severe enough|7|||
23281287|NCT00107991|64772410|FG000|Eligibility Assessment|Unwilling to participate|7|||
23281288|NCT00107991|64772410|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
23281289|NCT00107991|64772410|FG000|Eligibility Assessment|Abnormal labs|2|||
23281290|NCT00107991|64772410|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
23281291|NCT00107991|64772410|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
23281292|NCT00107991|64772410|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
23281293|NCT00107991|64772410|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
23281294|NCT00107991|64772410|FG000|12 Week Treatment Period|Adverse Event|1|||
23281295|NCT00107991|64772410|FG000|12 Week Treatment Period|Protocol Violation|1|||
23281296|NCT00107991|64772410|FG000|12 Week Treatment Period|Incarcerated|1|||
23281297|NCT00107991|64772410|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
23281298|NCT00402103|64772416|FG000|Overall Study|Adverse Event|60|||
23281299|NCT00402103|64772417|FG001|Overall Study|Adverse Event|7|||
23281300|NCT00402103|64772416|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23281301|NCT00402103|64772417|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23281302|NCT00402103|64772416|FG000|Overall Study|Condition no longer requires study drug|2|||
23281303|NCT00402103|64772417|FG001|Overall Study|Condition no longer requires study drug|0|||
23281304|NCT00402103|64772416|FG000|Overall Study|Protocol Deviation|8|||
23281305|NCT00402103|64772417|FG001|Overall Study|Protocol Deviation|0|||
23281306|NCT00402103|64772416|FG000|Overall Study|Patient withdrew consent|12|||
23281307|NCT00402103|64772417|FG001|Overall Study|Patient withdrew consent|1|||
23281308|NCT00402103|64772416|FG000|Overall Study|Lost to Follow-up|6|||
23281309|NCT00402103|64772417|FG001|Overall Study|Lost to Follow-up|3|||
23281310|NCT00402103|64772416|FG000|Overall Study|Administrative problems|2|||
23281311|NCT00402103|64772417|FG001|Overall Study|Administrative problems|0|||
23281312|NCT00840216|64772418|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23281313|NCT00840216|64772419|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23281314|NCT04236596|64772420|FG000|Overall Study|Withdrawal by Subject|1|||
23281315|NCT04236596|64772420|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
23281316|NCT04236596|64772420|FG000|Overall Study|Participants did not receive implant at all|4|||
23281317|NCT04966741|64772421|FG000|Overall Study|Lost to Follow-up|1|||
23281318|NCT04966741|64772422|FG001|Overall Study|Lost to Follow-up|0|||
23281319|NCT03106415|64772423|FG000|Phase 1|Withdrawal by Subject|1|||
23281320|NCT03106415|64772424|FG001|Phase 1|Withdrawal by Subject|0|||
23281321|NCT03106415|64772425|FG002|Phase 1|Withdrawal by Subject|0|||
23281322|NCT03106415|64772423|FG000|Phase 1|Adverse Event|1|||
23281323|NCT03106415|64772424|FG001|Phase 1|Adverse Event|1|||
23281324|NCT03106415|64772425|FG002|Phase 1|Adverse Event|0|||
23281325|NCT03106415|64772423|FG000|Phase 1|Protocol Violation|0|||
23281326|NCT03106415|64772424|FG001|Phase 1|Protocol Violation|1|||
23281327|NCT03106415|64772425|FG002|Phase 1|Protocol Violation|0|||
23281328|NCT00354835|64772449|FG000|Overall Study|Death|1|||
23281329|NCT00354835|64772450|FG001|Overall Study|Death|1|||
23487140|NCT01962922|65527448|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
23281330|NCT00354835|64772449|FG000|Overall Study|Physician Decision|8|||
23281331|NCT00354835|64772450|FG001|Overall Study|Physician Decision|13|||
23281332|NCT00354835|64772449|FG000|Overall Study|Withdrawal by Subject|2|||
23281333|NCT00354835|64772450|FG001|Overall Study|Withdrawal by Subject|1|||
23281334|NCT00354835|64772449|FG000|Overall Study|Ineligible|17|||
23281335|NCT00354835|64772450|FG001|Overall Study|Ineligible|16|||
23281336|NCT00354835|64772449|FG000|Overall Study|Disease progression or relapse|15|||
23487141|NCT01962922|65527449|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
23487142|NCT03206073|65527452|FG000|Overall Study|Participant Noncompliance|0|||
23487143|NCT03206073|65527453|FG001|Overall Study|Participant Noncompliance|1|||
23487144|NCT03206073|65527454|FG002|Overall Study|Participant Noncompliance|0|||
23487145|NCT03206073|65527455|FG003|Overall Study|Participant Noncompliance|0|||
23487146|NCT03206073|65527452|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
23487147|NCT03206073|65527453|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
23487148|NCT03206073|65527454|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
23487149|NCT03206073|65527455|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
23487150|NCT03206073|65527452|FG000|Overall Study|Death|0|||
23487151|NCT03206073|65527453|FG001|Overall Study|Death|0|||
23487152|NCT03206073|65527454|FG002|Overall Study|Death|1|||
23487153|NCT03206073|65527455|FG003|Overall Study|Death|0|||
23487154|NCT03206073|65527452|FG000|Overall Study|Taken off active treatment|0|||
23487155|NCT03206073|65527453|FG001|Overall Study|Taken off active treatment|0|||
23487156|NCT03206073|65527454|FG002|Overall Study|Taken off active treatment|3|||
23487157|NCT03206073|65527455|FG003|Overall Study|Taken off active treatment|0|||
23487158|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
23487159|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
23487160|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
23487161|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
23487162|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23487163|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
23487164|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
23487165|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
23487166|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
23487167|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
23487168|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
23487169|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
23487170|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
23487171|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
23487172|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
23487173|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
23487174|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Program Termination|3|||
23487175|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Program Termination|0|||
23487176|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Program Termination|1|||
23487177|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Program Termination|1|||
23487178|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
23487179|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
23487180|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
23487181|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
23487182|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
23487183|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
23487184|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
23487185|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
23487186|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
23487187|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
23487188|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
23487189|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
23487190|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
23487191|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
23487192|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
23487193|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
23487194|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
23487195|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
23487196|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
23487197|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
23487198|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
23487199|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
23487200|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
23487201|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
23487202|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
23487203|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
23487204|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
23487205|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
23487206|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
23487207|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
23487208|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
23281337|NCT00354835|64772450|FG001|Overall Study|Disease progression or relapse|22|||
23487209|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
23487210|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
23487211|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
23487212|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
23487213|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
23487214|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
23487215|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
23487216|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
23487217|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
23487218|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
23487219|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
23487220|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
23487221|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
23487222|NCT03739840|65527457|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
23487223|NCT03739840|65527458|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
23487224|NCT03739840|65527459|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
23487225|NCT03739840|65527460|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
23487226|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
23487227|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
23487228|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
23487229|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
23487230|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
23487231|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
23487232|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
23487233|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
23487234|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
23487235|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
23487236|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
23487237|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
23487238|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
23487239|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
23487240|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
23487241|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
23487242|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
23487243|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
23487244|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
23487245|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
23487246|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
23487247|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
23487248|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
23487249|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
23487250|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
23487251|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
23487252|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
23487253|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
23487254|NCT03739840|65527457|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
23487255|NCT03739840|65527458|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
23487256|NCT03739840|65527459|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
23487257|NCT03739840|65527460|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
23487258|NCT01756300|65527461|FG000|Overall Study|Death|1|||
23487259|NCT01756300|65527461|FG000|Overall Study|Withdrawal by Subject|1|||
23487260|NCT00560885|65527462|FG000|Overall Study|Death|7|||
23487261|NCT00560885|65527462|FG000|Overall Study|Withdrawal by Subject|1|||
23487262|NCT00292318|65527465|FG000|Overall Study|Study terminated by officials|2|||
23487263|NCT00292318|65527466|FG001|Overall Study|Study terminated by officials|1|||
23487264|NCT01721070|65527467|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
23487265|NCT04365257|65527470|FG000|Overall Study|Physician Decision|1|||
23487266|NCT04365257|65527471|FG001|Overall Study|Physician Decision|0|||
23487267|NCT04365257|65527470|FG000|Overall Study|Patient Noncompliance|1|||
23487268|NCT04365257|65527471|FG001|Overall Study|Patient Noncompliance|0|||
23487269|NCT04365257|65527470|FG000|Overall Study|Withdrawal by Subject|0|||
23487270|NCT04365257|65527471|FG001|Overall Study|Withdrawal by Subject|1|||
23487271|NCT00364130|65527472|FG000|Intervention Period|Lost to Follow-up|4|||
23487272|NCT00364130|65527473|FG001|Intervention Period|Lost to Follow-up|3|||
23487273|NCT00364130|65527472|FG000|Intervention Period|Pregnancy|1|||
23487274|NCT00364130|65527473|FG001|Intervention Period|Pregnancy|0|||
23487275|NCT00364130|65527472|FG000|Intervention Period|Withdrawal by Subject|4|||
23487276|NCT00364130|65527473|FG001|Intervention Period|Withdrawal by Subject|5|||
23487277|NCT00364130|65527472|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
23487278|NCT00364130|65527473|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
23487279|NCT02028871|65527474|FG000|Overall Study|Positive urine drug screen|1|||
23487280|NCT02028871|65527475|FG001|Overall Study|Positive urine drug screen|1|||
23487281|NCT02028871|65527474|FG000|Overall Study|Withdrawal by Subject|1|||
23487282|NCT02028871|65527475|FG001|Overall Study|Withdrawal by Subject|2|||
23487283|NCT02028871|65527474|FG000|Overall Study|IV placement difficulty|1|||
23487284|NCT02028871|65527475|FG001|Overall Study|IV placement difficulty|0|||
23487285|NCT02028871|65527474|FG000|Overall Study|Current Illness|1|||
23487286|NCT02028871|65527475|FG001|Overall Study|Current Illness|0|||
23487287|NCT01672736|65527476|FG000|Overall Study|Available drug expired on 31 May 16|3|||
23487288|NCT00597701|65527479|FG000|Overall Study|Withdrawal by Subject|5|||
23487289|NCT00597701|65527480|FG001|Overall Study|Withdrawal by Subject|5|||
23487290|NCT00597701|65527479|FG000|Overall Study|Death|0|||
23487291|NCT00597701|65527480|FG001|Overall Study|Death|1|||
23487292|NCT00597701|65527479|FG000|Overall Study|Physician Decision|2|||
23487293|NCT00597701|65527480|FG001|Overall Study|Physician Decision|0|||
23487294|NCT00597701|65527479|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
23487295|NCT00597701|65527480|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
23487296|NCT03693170|65527481|FG000|Overall Study|Disease Progression|48|||
23487297|NCT03693170|65527481|FG000|Overall Study|Adverse Event|16|||
23487298|NCT03693170|65527481|FG000|Overall Study|Physician Decision|6|||
23487299|NCT03693170|65527481|FG000|Overall Study|Protocol Violation|2|||
23487300|NCT03693170|65527481|FG000|Overall Study|Death|1|||
23487301|NCT03693170|65527481|FG000|Overall Study|Non compliance with study drug|1|||
23487302|NCT03693170|65527481|FG000|Overall Study|Withdrawal by Subject|1|||
23487303|NCT00700570|65527482|FG000|Overall Study|Adverse Event|2|||
23487304|NCT00700570|65527483|FG001|Overall Study|Adverse Event|6|||
23487305|NCT00700570|65527482|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
23487306|NCT00700570|65527483|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
23487307|NCT00700570|65527482|FG000|Overall Study|Disease Progression|8|||
23487308|NCT00700570|65527483|FG001|Overall Study|Disease Progression|11|||
23487309|NCT00700570|65527482|FG000|Overall Study|Withdrawal by Subject|1|||
23487310|NCT00700570|65527483|FG001|Overall Study|Withdrawal by Subject|6|||
23487311|NCT02393690|65527485|FG000|Overall Study|Ineligible|0|||
23487312|NCT02393690|65527486|FG001|Overall Study|Ineligible|1|||
23487313|NCT02038829|65530307|FG000|Washout Period 1|Death|0|||
23487314|NCT02038829|65530308|FG001|Washout Period 1|Death|0|||
23487315|NCT02038829|65530309|FG002|Washout Period 1|Death|0|||
23487316|NCT02038829|65530310|FG003|Washout Period 1|Death|0|||
23487317|NCT02038829|65530311|FG004|Washout Period 1|Death|1|||
23487318|NCT02038829|65530312|FG005|Washout Period 1|Death|0|||
23487319|NCT02038829|65530313|FG006|Washout Period 1|Death|0|||
23487320|NCT02038829|65530314|FG007|Washout Period 1|Death|0|||
23487321|NCT02038829|65530315|FG008|Washout Period 1|Death|0|||
23487322|NCT02038829|65530316|FG009|Washout Period 1|Death|0|||
23487323|NCT02038829|65530317|FG010|Washout Period 1|Death|0|||
23487324|NCT02038829|65530318|FG011|Washout Period 1|Death|0|||
23487325|NCT02038829|65530307|FG000|Treatment Period 2|Adverse Event|0|||
23487326|NCT02038829|65530308|FG001|Treatment Period 2|Adverse Event|0|||
23487327|NCT02038829|65530309|FG002|Treatment Period 2|Adverse Event|0|||
23487328|NCT02038829|65530310|FG003|Treatment Period 2|Adverse Event|0|||
23487329|NCT02038829|65530311|FG004|Treatment Period 2|Adverse Event|0|||
23487330|NCT02038829|65530312|FG005|Treatment Period 2|Adverse Event|0|||
23487331|NCT02038829|65530313|FG006|Treatment Period 2|Adverse Event|0|||
23487332|NCT02038829|65530314|FG007|Treatment Period 2|Adverse Event|0|||
23487333|NCT02038829|65530315|FG008|Treatment Period 2|Adverse Event|0|||
23487334|NCT02038829|65530316|FG009|Treatment Period 2|Adverse Event|0|||
23487335|NCT02038829|65530317|FG010|Treatment Period 2|Adverse Event|1|||
23487336|NCT02038829|65530318|FG011|Treatment Period 2|Adverse Event|0|||
23487337|NCT02038829|65530307|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23487338|NCT02038829|65530308|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23487339|NCT02038829|65530309|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23487340|NCT02038829|65530310|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23487341|NCT02038829|65530311|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23487342|NCT02038829|65530312|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23487343|NCT02038829|65530313|FG006|Treatment Period 2|Withdrawal by Subject|0|||
23487344|NCT02038829|65530314|FG007|Treatment Period 2|Withdrawal by Subject|0|||
23487345|NCT02038829|65530315|FG008|Treatment Period 2|Withdrawal by Subject|0|||
23487346|NCT02038829|65530316|FG009|Treatment Period 2|Withdrawal by Subject|0|||
23487347|NCT02038829|65530317|FG010|Treatment Period 2|Withdrawal by Subject|0|||
23487348|NCT02038829|65530318|FG011|Treatment Period 2|Withdrawal by Subject|0|||
23487349|NCT02038829|65530307|FG000|Washout Period 2|Adverse Event|0|||
23487350|NCT02038829|65530308|FG001|Washout Period 2|Adverse Event|0|||
23487351|NCT02038829|65530309|FG002|Washout Period 2|Adverse Event|0|||
23487352|NCT02038829|65530310|FG003|Washout Period 2|Adverse Event|0|||
23487353|NCT02038829|65530311|FG004|Washout Period 2|Adverse Event|0|||
23487354|NCT02038829|65530312|FG005|Washout Period 2|Adverse Event|0|||
23487355|NCT02038829|65530313|FG006|Washout Period 2|Adverse Event|0|||
23487356|NCT02038829|65530314|FG007|Washout Period 2|Adverse Event|0|||
23487357|NCT02038829|65530315|FG008|Washout Period 2|Adverse Event|1|||
23487358|NCT02038829|65530316|FG009|Washout Period 2|Adverse Event|0|||
23487359|NCT02038829|65530317|FG010|Washout Period 2|Adverse Event|0|||
23487360|NCT02038829|65530318|FG011|Washout Period 2|Adverse Event|0|||
23281338|NCT00354835|64772449|FG000|Overall Study|Adverse Event|6|||
23281339|NCT00354835|64772450|FG001|Overall Study|Adverse Event|0|||
23281340|NCT00354835|64772449|FG000|Overall Study|Refusal of further therapy|3|||
23281341|NCT00354835|64772450|FG001|Overall Study|Refusal of further therapy|8|||
23281342|NCT01650194|64772451|FG000|Overall Study|Progressive Disease (PD)|35|||
23281343|NCT01650194|64772451|FG000|Overall Study|Withdrawal by Subject|2|||
23281344|NCT01650194|64772451|FG000|Overall Study|Miscellaneous|10|||
23281345|NCT01693523|64772452|FG000|Overall Study|Adverse Event|2|||
23281346|NCT01693523|64772453|FG001|Overall Study|Adverse Event|1|||
23281347|NCT01693523|64772454|FG002|Overall Study|Adverse Event|0|||
23281348|NCT01693523|64772452|FG000|Overall Study|Death|0|||
23281349|NCT01693523|64772453|FG001|Overall Study|Death|1|||
23281350|NCT01693523|64772454|FG002|Overall Study|Death|1|||
23281351|NCT01693523|64772452|FG000|Overall Study|Lost to Follow-up|0|||
23281352|NCT01693523|64772453|FG001|Overall Study|Lost to Follow-up|0|||
23281353|NCT01693523|64772454|FG002|Overall Study|Lost to Follow-up|4|||
23281354|NCT01693523|64772452|FG000|Overall Study|Physician Decision|0|||
23281355|NCT01693523|64772453|FG001|Overall Study|Physician Decision|0|||
23281356|NCT01693523|64772454|FG002|Overall Study|Physician Decision|1|||
23281357|NCT01693523|64772452|FG000|Overall Study|Withdrawal by Subject|1|||
23281358|NCT01693523|64772453|FG001|Overall Study|Withdrawal by Subject|2|||
23281359|NCT01693523|64772454|FG002|Overall Study|Withdrawal by Subject|2|||
23281360|NCT01693523|64772452|FG000|Overall Study|Lack of compliance study medication|1|||
23281361|NCT01693523|64772453|FG001|Overall Study|Lack of compliance study medication|2|||
23281362|NCT01693523|64772454|FG002|Overall Study|Lack of compliance study medication|0|||
23281363|NCT01693523|64772452|FG000|Overall Study|Chemotherapy was held|1|||
23281364|NCT01693523|64772453|FG001|Overall Study|Chemotherapy was held|2|||
23281365|NCT01693523|64772454|FG002|Overall Study|Chemotherapy was held|0|||
23281366|NCT03131895|64772457|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
23281367|NCT03131895|64772458|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
23281368|NCT03131895|64772459|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
23281369|NCT03131895|64772460|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
23281370|NCT03131895|64772457|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
23281371|NCT03131895|64772458|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
23281372|NCT03131895|64772459|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
23281373|NCT03131895|64772460|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
23281374|NCT03131895|64772457|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23281375|NCT03131895|64772458|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
23281376|NCT03131895|64772459|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
23281377|NCT03131895|64772460|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
23281378|NCT03131895|64772457|FG000|Washout Period (at Least 5 Days)|Other|0|||
23281379|NCT03131895|64772458|FG001|Washout Period (at Least 5 Days)|Other|0|||
23281380|NCT03131895|64772459|FG002|Washout Period (at Least 5 Days)|Other|2|||
23281381|NCT03131895|64772460|FG003|Washout Period (at Least 5 Days)|Other|0|||
23281382|NCT03131895|64772457|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
23281383|NCT03131895|64772458|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
23281384|NCT03131895|64772459|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
23281385|NCT03131895|64772460|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
23281386|NCT03131895|64772457|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
23281387|NCT03131895|64772458|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
23281388|NCT03131895|64772459|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
23281389|NCT03131895|64772460|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
23487361|NCT02038829|65530307|FG000|Washout Period 2|Withdrawal by Subject|0|||
23487362|NCT02038829|65530308|FG001|Washout Period 2|Withdrawal by Subject|0|||
23487363|NCT02038829|65530309|FG002|Washout Period 2|Withdrawal by Subject|0|||
23487364|NCT02038829|65530310|FG003|Washout Period 2|Withdrawal by Subject|0|||
23603706|NCT03138499|65940155|FG001|Overall Study|Study drug toxicity|2|||
23281390|NCT02149420|64772461|FG000|Core Study|Administrative problems|0|||
23281391|NCT02149420|64772462|FG001|Core Study|Administrative problems|1|||
23281392|NCT02149420|64772463|FG002|Core Study|Administrative problems|2|||
23281393|NCT02149420|64772461|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
23281394|NCT02149420|64772462|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
23281395|NCT02149420|64772463|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
23281396|NCT03158727|64772464|FG000|Overall Study|Withdrawal by Subject|2|||
23281397|NCT03158727|64772465|FG001|Overall Study|Withdrawal by Subject|6|||
23281398|NCT03158727|64772464|FG000|Overall Study|Death|11|||
23487365|NCT02038829|65530311|FG004|Washout Period 2|Withdrawal by Subject|0|||
23487366|NCT02038829|65530312|FG005|Washout Period 2|Withdrawal by Subject|1|||
23281399|NCT03158727|64772465|FG001|Overall Study|Death|12|||
23281400|NCT03158727|64772464|FG000|Overall Study|Lost to Follow-up|1|||
23281401|NCT03158727|64772465|FG001|Overall Study|Lost to Follow-up|0|||
23281402|NCT03158727|64772464|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
23281403|NCT03158727|64772465|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
23281404|NCT03158727|64772464|FG000|Overall Study|Visit 11 not done by mistake|0|||
23281405|NCT03158727|64772465|FG001|Overall Study|Visit 11 not done by mistake|1|||
23281406|NCT03158727|64772464|FG000|Overall Study|Enrolled, not treated|1|||
23281407|NCT03158727|64772465|FG001|Overall Study|Enrolled, not treated|0|||
23281408|NCT00059332|64772469|FG000|Overall Study|Withdrawal by Subject|2|||
23281409|NCT00059332|64772470|FG001|Overall Study|Withdrawal by Subject|1|||
23281410|NCT00059332|64772469|FG000|Overall Study|Lost to Follow-up|1|||
23281411|NCT00059332|64772470|FG001|Overall Study|Lost to Follow-up|1|||
23281412|NCT02011945|64772476|FG000|Overall Study|Participant requested to Discontinue|0|||
23281413|NCT02011945|64772477|FG001|Overall Study|Participant requested to Discontinue|1|||
23281414|NCT02011945|64772478|FG002|Overall Study|Participant requested to Discontinue|1|||
23281415|NCT02011945|64772476|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
23281416|NCT02011945|64772477|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
23281417|NCT02011945|64772478|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
23281418|NCT02011945|64772476|FG000|Overall Study|Study Drug Toxicity|0|||
23281419|NCT02011945|64772477|FG001|Overall Study|Study Drug Toxicity|0|||
23281420|NCT02011945|64772478|FG002|Overall Study|Study Drug Toxicity|1|||
23281421|NCT02011945|64772476|FG000|Overall Study|Treatment Failure|0|||
23281422|NCT02011945|64772477|FG001|Overall Study|Treatment Failure|7|||
23281423|NCT02011945|64772478|FG002|Overall Study|Treatment Failure|6|||
23281424|NCT02011945|64772476|FG000|Overall Study|No Longer Meets Study Criteria|1|||
23281425|NCT02011945|64772477|FG001|Overall Study|No Longer Meets Study Criteria|0|||
23281426|NCT02011945|64772478|FG002|Overall Study|No Longer Meets Study Criteria|0|||
23281427|NCT02011945|64772476|FG000|Overall Study|Proceeded to stem cell transplant|0|||
23281428|NCT02011945|64772477|FG001|Overall Study|Proceeded to stem cell transplant|0|||
23281429|NCT02011945|64772478|FG002|Overall Study|Proceeded to stem cell transplant|1|||
23281430|NCT02011945|64772476|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
23281431|NCT02011945|64772477|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
23281432|NCT02011945|64772478|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
23281433|NCT01539239|64772479|FG000|Overall Study|Death|5|||
23281434|NCT01539239|64772480|FG001|Overall Study|Death|5|||
23281435|NCT01539239|64772479|FG000|Overall Study|Lost to Follow-up|7|||
23281436|NCT01539239|64772480|FG001|Overall Study|Lost to Follow-up|12|||
23281437|NCT00836472|64772481|FG000|Washout|Adverse Event|1|||
23281438|NCT00836472|64772482|FG001|Washout|Adverse Event|2|||
23281439|NCT00836472|64772481|FG000|Washout|Withdrawal by Subject|1|||
23281440|NCT00836472|64772482|FG001|Washout|Withdrawal by Subject|1|||
23281441|NCT01634139|64772485|FG000|Overall Study|Non compliant with protocol|1|||
23281442|NCT01634139|64772486|FG001|Overall Study|Non compliant with protocol|0|||
23281443|NCT01634139|64772487|FG002|Overall Study|Non compliant with protocol|0|||
23281444|NCT01634139|64772485|FG000|Overall Study|Consent withdrawn not due to AE|4|||
23281445|NCT01634139|64772486|FG001|Overall Study|Consent withdrawn not due to AE|3|||
23281446|NCT01634139|64772487|FG002|Overall Study|Consent withdrawn not due to AE|2|||
23281447|NCT01634139|64772485|FG000|Overall Study|Other|4|||
23281448|NCT01634139|64772486|FG001|Overall Study|Other|0|||
23281449|NCT01634139|64772487|FG002|Overall Study|Other|3|||
23281450|NCT01634139|64772485|FG000|Overall Study|Lost to Follow-up|0|||
23281451|NCT01634139|64772486|FG001|Overall Study|Lost to Follow-up|2|||
23281452|NCT01634139|64772487|FG002|Overall Study|Lost to Follow-up|0|||
23281453|NCT01634139|64772485|FG000|Overall Study|Not treated|1|||
23281454|NCT01634139|64772486|FG001|Overall Study|Not treated|1|||
23281455|NCT01634139|64772487|FG002|Overall Study|Not treated|0|||
23281456|NCT04887415|64772488|FG000|Overall Study|Lost to Follow-up|2|||
23281457|NCT02875392|64772491|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
23373714|NCT01933594|65112765|FG004|Overall Study|Ineligible for subsequent study step|1|||
23373715|NCT01933594|65112766|FG005|Overall Study|Ineligible for subsequent study step|0|||
23373716|NCT00717886|65112767|FG000|Overall Study|Withdrawal by Subject|3|||
23373717|NCT00717886|65112767|FG000|Overall Study|Treatment Failure|1|||
23373718|NCT03055936|65112768|FG000|Overall Study|Adverse Event|0|||
23373719|NCT03055936|65112769|FG001|Overall Study|Adverse Event|1|||
23373720|NCT03055936|65112770|FG002|Overall Study|Adverse Event|1|||
23373721|NCT03055936|65112771|FG003|Overall Study|Adverse Event|1|||
23373722|NCT03055936|65112768|FG000|Overall Study|Personal reason|2|||
23373723|NCT03055936|65112769|FG001|Overall Study|Personal reason|0|||
23373724|NCT03055936|65112770|FG002|Overall Study|Personal reason|1|||
23373725|NCT03055936|65112771|FG003|Overall Study|Personal reason|0|||
23373726|NCT02475369|65112772|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
23373727|NCT02475369|65112773|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
23373728|NCT01516216|65112774|FG000|Overall Study|Adverse Event|2|||
23373729|NCT01516216|65112775|FG001|Overall Study|Adverse Event|4|||
23373730|NCT01516216|65112774|FG000|Overall Study|Disease Progression|38|||
23373731|NCT01516216|65112775|FG001|Overall Study|Disease Progression|34|||
23373732|NCT01516216|65112774|FG000|Overall Study|Withdrawal by Subject|9|||
23373733|NCT01516216|65112775|FG001|Overall Study|Withdrawal by Subject|11|||
23373734|NCT01516216|65112774|FG000|Overall Study|Potentially Curative Resection|6|||
23373735|NCT01516216|65112775|FG001|Overall Study|Potentially Curative Resection|12|||
23373736|NCT01516216|65112774|FG000|Overall Study|Nonadherence|2|||
23373737|NCT01516216|65112775|FG001|Overall Study|Nonadherence|3|||
23373738|NCT01516216|65112774|FG000|Overall Study|Physician Decision|6|||
23373739|NCT01516216|65112775|FG001|Overall Study|Physician Decision|3|||
23373740|NCT01516216|65112774|FG000|Overall Study|Prolonged Treatment Delay|5|||
23373741|NCT01516216|65112775|FG001|Overall Study|Prolonged Treatment Delay|1|||
23373742|NCT01516216|65112774|FG000|Overall Study|Intercurrent Illness|1|||
23373743|NCT01516216|65112775|FG001|Overall Study|Intercurrent Illness|0|||
23373744|NCT01516216|65112774|FG000|Overall Study|Death|1|||
23603707|NCT03138499|65940154|FG000|Overall Study|Participant request to discontinue study treatment|1|||
23603708|NCT03138499|65940155|FG001|Overall Study|Participant request to discontinue study treatment|1|||
23603709|NCT03138499|65940154|FG000|Overall Study|Other reasons|2|||
23603710|NCT03138499|65940155|FG001|Overall Study|Other reasons|0|||
23603711|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
23603712|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
23603713|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
23603714|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
23603715|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
23603716|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
23603717|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
23603718|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
23603719|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23603720|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
23603721|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
23603722|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
23603723|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23603724|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
23603725|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
23603726|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
23603727|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
23603728|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
23603729|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
23603730|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
23603731|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
23603732|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
23603733|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
23603734|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
23603735|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
23603736|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
23603737|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
23603738|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
23603739|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
23603740|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
23373745|NCT01516216|65112775|FG001|Overall Study|Death|1|||
23373746|NCT03736967|65112776|FG000|Overall Study|Withdrawal by Subject|26|||
23373747|NCT03736967|65112777|FG001|Overall Study|Withdrawal by Subject|25|||
23373748|NCT03736967|65112778|FG002|Overall Study|Withdrawal by Subject|23|||
23373749|NCT03736967|65112779|FG003|Overall Study|Withdrawal by Subject|26|||
23373750|NCT03736967|65112776|FG000|Overall Study|Lost to Follow-up|3|||
23373751|NCT03736967|65112777|FG001|Overall Study|Lost to Follow-up|2|||
23373752|NCT03736967|65112778|FG002|Overall Study|Lost to Follow-up|1|||
23281458|NCT02875392|64772492|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
23281459|NCT02625974|64772493|FG000|Part 1|Lost to Follow-up|9|||
23281460|NCT02625974|64772494|FG001|Part 1|Lost to Follow-up|3|||
23281461|NCT02625974|64772493|FG000|Part 2|Lost to Follow-up|4|||
23281462|NCT02625974|64772494|FG001|Part 2|Lost to Follow-up|6|||
23281463|NCT02625974|64772493|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
23281464|NCT02625974|64772494|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
23281465|NCT00606281|64772497|FG000|Overall Study|Adverse Event|11|||
23281466|NCT00606281|64772498|FG001|Overall Study|Adverse Event|12|||
23281467|NCT00606281|64772497|FG000|Overall Study|Death|1|||
23281468|NCT00606281|64772498|FG001|Overall Study|Death|0|||
23281469|NCT00606281|64772497|FG000|Overall Study|Lack of Efficacy|28|||
23281470|NCT00606281|64772498|FG001|Overall Study|Lack of Efficacy|35|||
23281471|NCT00606281|64772497|FG000|Overall Study|Physician Decision|0|||
23281472|NCT00606281|64772498|FG001|Overall Study|Physician Decision|1|||
23281473|NCT00606281|64772497|FG000|Overall Study|Protocol Violation|3|||
23281474|NCT00606281|64772498|FG001|Overall Study|Protocol Violation|3|||
23281475|NCT00606281|64772497|FG000|Overall Study|Withdrawal by Subject|11|||
23281476|NCT00606281|64772498|FG001|Overall Study|Withdrawal by Subject|13|||
23281477|NCT00606281|64772497|FG000|Overall Study|Progression to depressive phase|1|||
23281478|NCT00606281|64772498|FG001|Overall Study|Progression to depressive phase|1|||
23281479|NCT00606281|64772497|FG000|Overall Study|Change of residence or other commitments|1|||
23281480|NCT00606281|64772498|FG001|Overall Study|Change of residence or other commitments|1|||
23281481|NCT03285594|64772499|FG000|Overall Study|At the Participant's Own Request|10|||
23281482|NCT03285594|64772500|FG001|Overall Study|At the Participant's Own Request|5|||
23281483|NCT03285594|64772501|FG002|Overall Study|At the Participant's Own Request|21|||
23281484|NCT03285594|64772499|FG000|Overall Study|Adverse Event|2|||
23281485|NCT03285594|64772500|FG001|Overall Study|Adverse Event|2|||
23281486|NCT03285594|64772501|FG002|Overall Study|Adverse Event|6|||
23281487|NCT03285594|64772499|FG000|Overall Study|Poor Compliance to Protocol|0|||
23281488|NCT03285594|64772500|FG001|Overall Study|Poor Compliance to Protocol|0|||
23281489|NCT03285594|64772501|FG002|Overall Study|Poor Compliance to Protocol|1|||
23281490|NCT03285594|64772499|FG000|Overall Study|Lost to Follow-up|0|||
23281491|NCT03285594|64772500|FG001|Overall Study|Lost to Follow-up|0|||
23281492|NCT03285594|64772501|FG002|Overall Study|Lost to Follow-up|1|||
23281493|NCT03285594|64772499|FG000|Overall Study|Reason Not Specified|3|||
23281494|NCT03285594|64772500|FG001|Overall Study|Reason Not Specified|4|||
23281495|NCT03285594|64772501|FG002|Overall Study|Reason Not Specified|8|||
23281496|NCT00455312|64772502|FG000|Overall Study|Death|0|||
23281497|NCT00455312|64772503|FG001|Overall Study|Death|1|||
23281498|NCT02854800|64772504|FG000|Overall Study|Protocol Violation|16|||
23281499|NCT02854800|64772505|FG001|Overall Study|Protocol Violation|11|||
23281500|NCT02854800|64772506|FG002|Overall Study|Protocol Violation|3|||
23281501|NCT02854800|64772504|FG000|Overall Study|Withdrawal by Subject|4|||
23281502|NCT02854800|64772505|FG001|Overall Study|Withdrawal by Subject|2|||
23281503|NCT02854800|64772506|FG002|Overall Study|Withdrawal by Subject|3|||
23281504|NCT05752721|64772515|FG000|Overall Study|Lost to Follow-up|22|||
23281505|NCT05752721|64772516|FG001|Overall Study|Lost to Follow-up|20|||
23281506|NCT05752721|64772515|FG000|Overall Study|Withdrawal by Subject|15|||
23281507|NCT05752721|64772516|FG001|Overall Study|Withdrawal by Subject|12|||
23281508|NCT00840879|64772519|FG000|Second Intervention|Withdrawal by Subject|1|||
23281509|NCT00840879|64772520|FG001|Second Intervention|Withdrawal by Subject|0|||
23281510|NCT03199963|64772521|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
23281511|NCT03199963|64772522|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
23281512|NCT03199963|64772521|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
23281513|NCT03199963|64772522|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
23281514|NCT03199963|64772521|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
23281515|NCT03199963|64772522|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
23281516|NCT03199963|64772521|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
23281517|NCT03199963|64772522|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
23281518|NCT03199963|64772521|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
23281519|NCT03199963|64772522|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
23603741|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
23603742|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
23281520|NCT03199963|64772521|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
23281521|NCT03199963|64772522|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
23281522|NCT03193021|64772533|FG000|Overall Study|Lost to Follow-up|1|||
23281523|NCT03193021|64772534|FG001|Overall Study|Lost to Follow-up|1|||
23281524|NCT00772603|64772535|FG000|Overall Study|Withdrawal by Subject|11|||
23281525|NCT00772603|64772536|FG001|Overall Study|Withdrawal by Subject|10|||
23603743|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
23281526|NCT00772603|64772537|FG002|Overall Study|Withdrawal by Subject|6|||
23373753|NCT03736967|65112779|FG003|Overall Study|Lost to Follow-up|1|||
23373754|NCT03736967|65112776|FG000|Overall Study|Physician Decision|1|||
23373755|NCT03736967|65112777|FG001|Overall Study|Physician Decision|0|||
23373756|NCT03736967|65112778|FG002|Overall Study|Physician Decision|0|||
23373757|NCT03736967|65112779|FG003|Overall Study|Physician Decision|1|||
23373758|NCT03736967|65112776|FG000|Overall Study|Adverse Event|0|||
23373759|NCT03736967|65112777|FG001|Overall Study|Adverse Event|1|||
23373760|NCT03736967|65112778|FG002|Overall Study|Adverse Event|0|||
23373761|NCT03736967|65112779|FG003|Overall Study|Adverse Event|1|||
23373762|NCT03736967|65112776|FG000|Overall Study|Death|0|||
23373763|NCT03736967|65112777|FG001|Overall Study|Death|0|||
23373764|NCT03736967|65112778|FG002|Overall Study|Death|0|||
23373765|NCT03736967|65112779|FG003|Overall Study|Death|1|||
23373766|NCT03736967|65112776|FG000|Overall Study|Randomized but never treated|1|||
23373767|NCT03736967|65112777|FG001|Overall Study|Randomized but never treated|0|||
23373768|NCT03736967|65112778|FG002|Overall Study|Randomized but never treated|0|||
23373769|NCT03736967|65112779|FG003|Overall Study|Randomized but never treated|0|||
23373770|NCT00761319|65112786|FG000|Overall Study|Protocol Violation|21|||
23373771|NCT00761319|65112787|FG001|Overall Study|Protocol Violation|14|||
23373772|NCT00761319|65112786|FG000|Overall Study|Adverse Event|11|||
23373773|NCT00761319|65112787|FG001|Overall Study|Adverse Event|7|||
23373774|NCT00761319|65112786|FG000|Overall Study|Withdrawal by Subject|8|||
23373775|NCT00761319|65112787|FG001|Overall Study|Withdrawal by Subject|7|||
23373776|NCT00761319|65112786|FG000|Overall Study|Noncompliance|4|||
23373777|NCT00761319|65112787|FG001|Overall Study|Noncompliance|3|||
23373778|NCT00761319|65112786|FG000|Overall Study|Lost to Follow-up|1|||
23373779|NCT00761319|65112787|FG001|Overall Study|Lost to Follow-up|1|||
23373780|NCT00761319|65112786|FG000|Overall Study|Nonspecified|2|||
23373781|NCT00761319|65112787|FG001|Overall Study|Nonspecified|2|||
23373782|NCT00761319|65112786|FG000|Overall Study|Missing|1|||
23373783|NCT00761319|65112787|FG001|Overall Study|Missing|0|||
23373784|NCT04635839|65112788|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
23373785|NCT04635839|65112789|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
23373786|NCT01963611|65112790|FG000|Overall Study|Adverse Event|1|||
23373787|NCT01963611|65112791|FG001|Overall Study|Adverse Event|1|||
23373788|NCT01963611|65112792|FG002|Overall Study|Adverse Event|3|||
23373789|NCT01963611|65112793|FG003|Overall Study|Adverse Event|4|||
23373790|NCT01963611|65112794|FG004|Overall Study|Adverse Event|3|||
23373791|NCT01963611|65112790|FG000|Overall Study|Protocol Violation|0|||
23373792|NCT01963611|65112791|FG001|Overall Study|Protocol Violation|0|||
23373793|NCT01963611|65112792|FG002|Overall Study|Protocol Violation|0|||
23373794|NCT01963611|65112793|FG003|Overall Study|Protocol Violation|1|||
23373795|NCT01963611|65112794|FG004|Overall Study|Protocol Violation|0|||
23373796|NCT01963611|65112790|FG000|Overall Study|Lack of Efficacy|0|||
23373797|NCT01963611|65112791|FG001|Overall Study|Lack of Efficacy|0|||
23373798|NCT01963611|65112792|FG002|Overall Study|Lack of Efficacy|0|||
23373799|NCT01963611|65112793|FG003|Overall Study|Lack of Efficacy|1|||
23373800|NCT01963611|65112794|FG004|Overall Study|Lack of Efficacy|0|||
23373801|NCT01963611|65112790|FG000|Overall Study|Withdrawal by Subject|3|||
23373802|NCT01963611|65112791|FG001|Overall Study|Withdrawal by Subject|2|||
23373803|NCT01963611|65112792|FG002|Overall Study|Withdrawal by Subject|1|||
23373804|NCT01963611|65112793|FG003|Overall Study|Withdrawal by Subject|1|||
23373805|NCT01963611|65112794|FG004|Overall Study|Withdrawal by Subject|3|||
23373806|NCT01963611|65112790|FG000|Overall Study|Other|47|||
23373807|NCT01963611|65112791|FG001|Overall Study|Other|46|||
23373808|NCT01963611|65112792|FG002|Overall Study|Other|48|||
23373809|NCT01963611|65112793|FG003|Overall Study|Other|45|||
23373810|NCT01963611|65112794|FG004|Overall Study|Other|45|||
23373811|NCT01160614|65115832|FG000|Overall Study|Withdrawal by Subject|0|||
23373812|NCT01160614|65115833|FG001|Overall Study|Withdrawal by Subject|2|||
23373813|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
23373814|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
23373815|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
23373816|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
23373817|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
23373818|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
23373819|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
23373820|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
23373821|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
23373822|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
23373823|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
23373824|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
23373825|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
23373826|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
23373827|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
23373828|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
23373829|NCT00410163|65115837|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
23373830|NCT00410163|65115838|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
23373831|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
23373832|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
23373833|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
23373834|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
23373835|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
23373836|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
23373837|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
23373838|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
23373839|NCT00410163|65115837|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
23373840|NCT00410163|65115838|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
23373841|NCT04181788|65115840|FG000|TREATMENT|Adverse Event|0|||
23373842|NCT04181788|65115841|FG001|TREATMENT|Adverse Event|2|||
23373843|NCT04181788|65115842|FG002|TREATMENT|Adverse Event|1|||
23373844|NCT04181788|65115843|FG003|TREATMENT|Adverse Event|0|||
23373845|NCT04181788|65115844|FG004|TREATMENT|Adverse Event|1|||
23373846|NCT04181788|65115845|FG005|TREATMENT|Adverse Event|3|||
23373847|NCT04181788|65115840|FG000|TREATMENT|Death|0|||
23373848|NCT04181788|65115841|FG001|TREATMENT|Death|0|||
23373849|NCT04181788|65115842|FG002|TREATMENT|Death|0|||
23373850|NCT04181788|65115843|FG003|TREATMENT|Death|0|||
23373851|NCT04181788|65115844|FG004|TREATMENT|Death|8|||
23373852|NCT04181788|65115845|FG005|TREATMENT|Death|8|||
23373853|NCT04181788|65115840|FG000|TREATMENT|Physician Decision|0|||
23373854|NCT04181788|65115841|FG001|TREATMENT|Physician Decision|0|||
23373855|NCT04181788|65115842|FG002|TREATMENT|Physician Decision|0|||
23373856|NCT04181788|65115843|FG003|TREATMENT|Physician Decision|0|||
23373857|NCT04181788|65115844|FG004|TREATMENT|Physician Decision|0|||
23373858|NCT04181788|65115845|FG005|TREATMENT|Physician Decision|1|||
23373859|NCT04181788|65115840|FG000|TREATMENT|Progressive disease|3|||
23373860|NCT04181788|65115841|FG001|TREATMENT|Progressive disease|3|||
23373861|NCT04181788|65115842|FG002|TREATMENT|Progressive disease|5|||
23373862|NCT04181788|65115843|FG003|TREATMENT|Progressive disease|7|||
23373863|NCT04181788|65115844|FG004|TREATMENT|Progressive disease|20|||
23373864|NCT04181788|65115845|FG005|TREATMENT|Progressive disease|38|||
23373865|NCT04181788|65115840|FG000|TREATMENT|Global deterioration of health status|0|||
23373866|NCT04181788|65115841|FG001|TREATMENT|Global deterioration of health status|2|||
23373867|NCT04181788|65115842|FG002|TREATMENT|Global deterioration of health status|0|||
23373868|NCT04181788|65115843|FG003|TREATMENT|Global deterioration of health status|0|||
23373869|NCT04181788|65115844|FG004|TREATMENT|Global deterioration of health status|2|||
23373870|NCT04181788|65115845|FG005|TREATMENT|Global deterioration of health status|8|||
23373871|NCT04181788|65115840|FG000|TREATMENT|Withdrawal by Subject|1|||
23373872|NCT04181788|65115841|FG001|TREATMENT|Withdrawal by Subject|2|||
23373873|NCT04181788|65115842|FG002|TREATMENT|Withdrawal by Subject|0|||
23373874|NCT04181788|65115843|FG003|TREATMENT|Withdrawal by Subject|0|||
23373875|NCT04181788|65115844|FG004|TREATMENT|Withdrawal by Subject|3|||
23373876|NCT04181788|65115845|FG005|TREATMENT|Withdrawal by Subject|5|||
23373877|NCT04181788|65115840|FG000|TREATMENT|Other unspecified|0|||
23373878|NCT04181788|65115841|FG001|TREATMENT|Other unspecified|0|||
23373879|NCT04181788|65115842|FG002|TREATMENT|Other unspecified|0|||
23373880|NCT04181788|65115843|FG003|TREATMENT|Other unspecified|0|||
23373881|NCT04181788|65115844|FG004|TREATMENT|Other unspecified|0|||
23373882|NCT04181788|65115845|FG005|TREATMENT|Other unspecified|2|||
23373883|NCT04181788|65115840|FG000|TREATMENT|Ongoing|0|||
23373884|NCT04181788|65115841|FG001|TREATMENT|Ongoing|3|||
23373885|NCT04181788|65115842|FG002|TREATMENT|Ongoing|0|||
23373886|NCT04181788|65115843|FG003|TREATMENT|Ongoing|5|||
23373887|NCT04181788|65115844|FG004|TREATMENT|Ongoing|7|||
23373888|NCT04181788|65115845|FG005|TREATMENT|Ongoing|15|||
23373889|NCT04181788|65115840|FG000|FOLLOW-UP|Death|0|||
23373890|NCT04181788|65115841|FG001|FOLLOW-UP|Death|0|||
23373891|NCT04181788|65115842|FG002|FOLLOW-UP|Death|1|||
23373892|NCT04181788|65115843|FG003|FOLLOW-UP|Death|2|||
23373893|NCT04181788|65115844|FG004|FOLLOW-UP|Death|8|||
23373894|NCT04181788|65115845|FG005|FOLLOW-UP|Death|20|||
23373895|NCT04181788|65115840|FG000|FOLLOW-UP|Lost to Follow-up|0|||
23373896|NCT04181788|65115841|FG001|FOLLOW-UP|Lost to Follow-up|0|||
23373897|NCT04181788|65115842|FG002|FOLLOW-UP|Lost to Follow-up|0|||
23373898|NCT04181788|65115843|FG003|FOLLOW-UP|Lost to Follow-up|0|||
23373899|NCT04181788|65115844|FG004|FOLLOW-UP|Lost to Follow-up|0|||
23373900|NCT04181788|65115845|FG005|FOLLOW-UP|Lost to Follow-up|2|||
23373901|NCT04181788|65115840|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
23373902|NCT04181788|65115841|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
23373903|NCT04181788|65115842|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
23373904|NCT04181788|65115843|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
23373905|NCT04181788|65115844|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
23373906|NCT04181788|65115845|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
23373907|NCT04181788|65115840|FG000|FOLLOW-UP|Other unspecified|0|||
23373908|NCT04181788|65115841|FG001|FOLLOW-UP|Other unspecified|1|||
23373909|NCT04181788|65115842|FG002|FOLLOW-UP|Other unspecified|0|||
23373910|NCT04181788|65115843|FG003|FOLLOW-UP|Other unspecified|0|||
23373911|NCT04181788|65115844|FG004|FOLLOW-UP|Other unspecified|0|||
23373912|NCT04181788|65115845|FG005|FOLLOW-UP|Other unspecified|3|||
23373913|NCT04181788|65115840|FG000|FOLLOW-UP|Ongoing|0|||
23373914|NCT04181788|65115841|FG001|FOLLOW-UP|Ongoing|0|||
23373915|NCT04181788|65115842|FG002|FOLLOW-UP|Ongoing|1|||
23373916|NCT04181788|65115843|FG003|FOLLOW-UP|Ongoing|3|||
23487367|NCT02038829|65530313|FG006|Washout Period 2|Withdrawal by Subject|0|||
23487368|NCT02038829|65530314|FG007|Washout Period 2|Withdrawal by Subject|0|||
23487369|NCT02038829|65530315|FG008|Washout Period 2|Withdrawal by Subject|0|||
23487370|NCT02038829|65530316|FG009|Washout Period 2|Withdrawal by Subject|0|||
23281527|NCT00772603|64772535|FG000|Overall Study|Adverse Event|37|||
23281528|NCT00772603|64772536|FG001|Overall Study|Adverse Event|18|||
23281529|NCT00772603|64772537|FG002|Overall Study|Adverse Event|10|||
23281530|NCT00772603|64772535|FG000|Overall Study|Subject Non-compliance|1|||
23281531|NCT00772603|64772536|FG001|Overall Study|Subject Non-compliance|6|||
23281532|NCT00772603|64772537|FG002|Overall Study|Subject Non-compliance|4|||
23281533|NCT00772603|64772535|FG000|Overall Study|Protocol Violation|0|||
23281534|NCT00772603|64772536|FG001|Overall Study|Protocol Violation|1|||
23281535|NCT00772603|64772537|FG002|Overall Study|Protocol Violation|1|||
23281536|NCT00772603|64772535|FG000|Overall Study|Lost to Follow-up|1|||
23281537|NCT00772603|64772536|FG001|Overall Study|Lost to Follow-up|5|||
23281538|NCT00772603|64772537|FG002|Overall Study|Lost to Follow-up|2|||
23281539|NCT00772603|64772535|FG000|Overall Study|Physician Decision|0|||
23281540|NCT00772603|64772536|FG001|Overall Study|Physician Decision|0|||
23281541|NCT00772603|64772537|FG002|Overall Study|Physician Decision|1|||
23281542|NCT00772603|64772535|FG000|Overall Study|Other|2|||
23281543|NCT00772603|64772536|FG001|Overall Study|Other|0|||
23281544|NCT00772603|64772537|FG002|Overall Study|Other|2|||
23281545|NCT02554890|64772543|FG000|Double-blind|Adverse Event|45|||
23281546|NCT02554890|64772544|FG001|Double-blind|Adverse Event|51|||
23281547|NCT02554890|64772543|FG000|Double-blind|Death|6|||
23281548|NCT02554890|64772544|FG001|Double-blind|Death|4|||
23281549|NCT02554890|64772543|FG000|Double-blind|Protocol Violation|1|||
23281550|NCT02554890|64772544|FG001|Double-blind|Protocol Violation|1|||
23281551|NCT02554890|64772543|FG000|Double-blind|Physician Decision|4|||
23281552|NCT02554890|64772544|FG001|Double-blind|Physician Decision|3|||
23281553|NCT02554890|64772543|FG000|Double-blind|Subject/Guardian decision|21|||
23281554|NCT02554890|64772544|FG001|Double-blind|Subject/Guardian decision|16|||
23281555|NCT02554890|64772543|FG000|Double-blind|Lost to Follow-up|7|||
23281556|NCT02554890|64772544|FG001|Double-blind|Lost to Follow-up|5|||
23281557|NCT02554890|64772543|FG000|Double-blind|Technical problems|1|||
23281558|NCT02554890|64772544|FG001|Double-blind|Technical problems|0|||
23281559|NCT02554890|64772543|FG000|Double-blind|Withdrawal by Subject|5|||
23281560|NCT02554890|64772544|FG001|Double-blind|Withdrawal by Subject|6|||
23281561|NCT02554890|64772543|FG000|Double-blind|Noncompliance with study treatment|6|||
23281562|NCT02554890|64772544|FG001|Double-blind|Noncompliance with study treatment|5|||
23281563|NCT02554890|64772543|FG000|Open-label|Adverse Event|0|||
23281564|NCT02554890|64772544|FG001|Open-label|Adverse Event|30|||
23281565|NCT02554890|64772543|FG000|Open-label|Death|0|||
23281566|NCT02554890|64772544|FG001|Open-label|Death|1|||
23281567|NCT02554890|64772543|FG000|Open-label|Physician Decision|0|||
23281568|NCT02554890|64772544|FG001|Open-label|Physician Decision|1|||
23281569|NCT02554890|64772543|FG000|Open-label|Subject/Guardian decision|0|||
23281570|NCT02554890|64772544|FG001|Open-label|Subject/Guardian decision|11|||
23281571|NCT02554890|64772543|FG000|Open-label|Lost to Follow-up|0|||
23281572|NCT02554890|64772544|FG001|Open-label|Lost to Follow-up|7|||
23281573|NCT02554890|64772543|FG000|Open-label|Technical problems|0|||
23281574|NCT02554890|64772544|FG001|Open-label|Technical problems|1|||
23281575|NCT02554890|64772543|FG000|Open-label|Withdrawal by Subject|0|||
23281576|NCT02554890|64772544|FG001|Open-label|Withdrawal by Subject|1|||
23373917|NCT04181788|65115844|FG004|FOLLOW-UP|Ongoing|2|||
23487371|NCT02038829|65530317|FG010|Washout Period 2|Withdrawal by Subject|0|||
23281577|NCT03499873|64772545|FG000|Overall Study|Withdrawal by Subject|4|||
23281578|NCT03499873|64772546|FG001|Overall Study|Withdrawal by Subject|6|||
23281579|NCT03499873|64772547|FG002|Overall Study|Withdrawal by Subject|1|||
23281580|NCT03499873|64772545|FG000|Overall Study|Subjects condition worsened|0|||
23281581|NCT03499873|64772546|FG001|Overall Study|Subjects condition worsened|3|||
23281582|NCT03499873|64772547|FG002|Overall Study|Subjects condition worsened|11|||
23281583|NCT03499873|64772545|FG000|Overall Study|Adverse Event|8|||
23281584|NCT03499873|64772546|FG001|Overall Study|Adverse Event|3|||
23281585|NCT03499873|64772547|FG002|Overall Study|Adverse Event|6|||
23281586|NCT03499873|64772545|FG000|Overall Study|Physician Decision|1|||
23281587|NCT03499873|64772546|FG001|Overall Study|Physician Decision|0|||
23373918|NCT04181788|65115845|FG005|FOLLOW-UP|Ongoing|2|||
23373919|NCT00959751|65115848|FG000|Overall Study|Lost to Follow-up|2|||
23373920|NCT00959751|65115849|FG001|Overall Study|Lost to Follow-up|3|||
23281588|NCT03499873|64772547|FG002|Overall Study|Physician Decision|0|||
23281589|NCT03499873|64772545|FG000|Overall Study|Administrative reasons|0|||
23603744|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
23603745|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
23603746|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
23603747|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
23603748|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
23603749|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
23603750|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
23603751|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
23603752|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
23603753|NCT03732807|65940156|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603754|NCT03732807|65940157|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603755|NCT03732807|65940158|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603756|NCT03732807|65940159|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603757|NCT03732807|65940160|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603758|NCT03732807|65940161|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
23603759|NCT03732807|65940162|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
23603760|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
23603761|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
23603762|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
23603763|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
23603764|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
23603765|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
23603766|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
23603767|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
23603768|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
23603769|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
23603770|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
23603771|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
23603772|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
23603773|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
23603774|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
23603775|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
23603776|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
23603777|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
23603778|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
23603779|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
23603780|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
23603781|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603782|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
23603783|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603784|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603785|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603786|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603787|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
23603788|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
23603789|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
23603790|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
23603791|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
23603792|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
23603793|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
23603794|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
23603795|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
23603796|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
23603797|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
23603798|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
23603799|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
23603800|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
23603801|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
23603802|NCT03732807|65940156|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
23603803|NCT03732807|65940157|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
23603804|NCT03732807|65940158|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
23603805|NCT03732807|65940159|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
23603806|NCT03732807|65940160|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
23603807|NCT03732807|65940161|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
23603808|NCT03732807|65940162|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
23603809|NCT00667732|65940163|FG000|Run -In (8 Weeks)|Adverse Event|4|||
23603810|NCT00667732|65940164|FG001|Run -In (8 Weeks)|Adverse Event|0|||
23603811|NCT00667732|65940165|FG002|Run -In (8 Weeks)|Adverse Event|0|||
23603812|NCT00667732|65940163|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
23603813|NCT00667732|65940164|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
23603814|NCT00667732|65940165|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
23603815|NCT00667732|65940163|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
23603816|NCT00667732|65940164|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
23603817|NCT00667732|65940165|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
23603818|NCT02038049|65940170|FG000|Overall Study|Lost to Follow-up|1|||
23603819|NCT02038049|65940171|FG001|Overall Study|Lost to Follow-up|0|||
23603820|NCT03418545|65940174|FG000|Overall Study|Withdrawal by Participant|2|||
23281590|NCT03499873|64772546|FG001|Overall Study|Administrative reasons|1|||
23281591|NCT03499873|64772547|FG002|Overall Study|Administrative reasons|0|||
23281592|NCT03499873|64772545|FG000|Overall Study|Concomitant therapy|5|||
23281593|NCT03499873|64772546|FG001|Overall Study|Concomitant therapy|4|||
23281594|NCT03499873|64772547|FG002|Overall Study|Concomitant therapy|7|||
23281595|NCT03499873|64772545|FG000|Overall Study|Miscellaneous|1|||
23281596|NCT03499873|64772546|FG001|Overall Study|Miscellaneous|2|||
23281597|NCT03499873|64772547|FG002|Overall Study|Miscellaneous|2|||
23281598|NCT03499873|64772545|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
23281599|NCT03499873|64772546|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
23281600|NCT03499873|64772547|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
23281601|NCT00573443|64772548|FG000|Double-Blind Phase|Lost to Follow-up|1|||
23281602|NCT00573443|64772549|FG001|Double-Blind Phase|Lost to Follow-up|3|||
23281603|NCT00573443|64772550|FG002|Double-Blind Phase|Lost to Follow-up|2|||
23281604|NCT00573443|64772548|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
23281605|NCT00573443|64772549|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
23281606|NCT00573443|64772550|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
23281607|NCT00573443|64772548|FG000|Double-Blind Phase|Adverse Event|1|||
23281608|NCT00573443|64772549|FG001|Double-Blind Phase|Adverse Event|5|||
23281609|NCT00573443|64772550|FG002|Double-Blind Phase|Adverse Event|0|||
23281610|NCT00573443|64772548|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
23281611|NCT00573443|64772549|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
23281612|NCT00573443|64772550|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
23281613|NCT00573443|64772548|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
23281614|NCT00573443|64772549|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
23281615|NCT00573443|64772550|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
23281616|NCT00573443|64772548|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
23281617|NCT00573443|64772549|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
23281618|NCT00573443|64772550|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
23281619|NCT00573443|64772548|FG000|Double-Blind Phase|Protocol Violation|0|||
23281620|NCT00573443|64772549|FG001|Double-Blind Phase|Protocol Violation|2|||
23281621|NCT00573443|64772550|FG002|Double-Blind Phase|Protocol Violation|1|||
23281622|NCT00573443|64772548|FG000|Double-Blind Phase|Other|0|||
23281623|NCT00573443|64772549|FG001|Double-Blind Phase|Other|2|||
23281624|NCT00573443|64772550|FG002|Double-Blind Phase|Other|3|||
23281625|NCT00573443|64772548|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
23281626|NCT00573443|64772549|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23281627|NCT00573443|64772550|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23281628|NCT00573443|64772548|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
23281629|NCT00573443|64772549|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
23281630|NCT00573443|64772550|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
23281631|NCT00573443|64772548|FG000|Open-Label Extension Phase|Adverse Event|3|||
23281632|NCT00573443|64772549|FG001|Open-Label Extension Phase|Adverse Event|0|||
23281633|NCT00573443|64772550|FG002|Open-Label Extension Phase|Adverse Event|0|||
23281634|NCT00573443|64772548|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
23281635|NCT00573443|64772549|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
23281636|NCT00573443|64772550|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
23281637|NCT00573443|64772548|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
23281638|NCT00573443|64772549|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
23281639|NCT00573443|64772550|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
23281640|NCT00573443|64772548|FG000|Open-Label Extension Phase|Protocol Violation|2|||
23281641|NCT00573443|64772549|FG001|Open-Label Extension Phase|Protocol Violation|0|||
23281642|NCT00573443|64772550|FG002|Open-Label Extension Phase|Protocol Violation|0|||
23281643|NCT00573443|64772548|FG000|Open-Label Extension Phase|Other|2|||
23281644|NCT00573443|64772549|FG001|Open-Label Extension Phase|Other|0|||
23281645|NCT00573443|64772550|FG002|Open-Label Extension Phase|Other|0|||
23281646|NCT00585286|64772551|FG000|Overall Study|Lost to Follow-up|1|||
23281647|NCT00841542|64772552|FG000|Period 1|Adverse Event|1|||
23281648|NCT00841542|64772553|FG001|Period 1|Adverse Event|0|||
23281649|NCT00841698|64772554|FG000|First Intervention|Withdrawal by Subject|1|||
23281650|NCT00841698|64772555|FG001|First Intervention|Withdrawal by Subject|0|||
23281651|NCT02627963|64772558|FG000|Overall Study|Randomized but not treated|2|||
23281652|NCT02627963|64772559|FG001|Overall Study|Randomized but not treated|6|||
23281653|NCT01642277|64772560|FG000|Overall Study|Adverse Event|10|||
23281654|NCT01642277|64772561|FG001|Overall Study|Adverse Event|0|||
23281655|NCT01642277|64772560|FG000|Overall Study|Physician Decision|2|||
23281656|NCT01642277|64772561|FG001|Overall Study|Physician Decision|0|||
23281657|NCT01642277|64772560|FG000|Overall Study|Protocol Violation|1|||
23281658|NCT01642277|64772561|FG001|Overall Study|Protocol Violation|0|||
23281659|NCT01642277|64772560|FG000|Overall Study|Withdrawal by Subject|11|||
23281660|NCT01642277|64772561|FG001|Overall Study|Withdrawal by Subject|0|||
23281661|NCT00819169|64772562|FG000|Overall Study|Withdrawal by Subject|2|||
23281662|NCT00819169|64772563|FG001|Overall Study|Withdrawal by Subject|0|||
23281663|NCT00819169|64772564|FG002|Overall Study|Withdrawal by Subject|0|||
23281664|NCT00819169|64772565|FG003|Overall Study|Withdrawal by Subject|1|||
23281665|NCT00819169|64772566|FG004|Overall Study|Withdrawal by Subject|1|||
23281666|NCT00819169|64772567|FG005|Overall Study|Withdrawal by Subject|1|||
23281667|NCT00819169|64772568|FG006|Overall Study|Withdrawal by Subject|5|||
23281668|NCT00819169|64772569|FG007|Overall Study|Withdrawal by Subject|1|||
23281669|NCT00819169|64772570|FG008|Overall Study|Withdrawal by Subject|4|||
23281670|NCT00819169|64772562|FG000|Overall Study|Lost to Follow-up|0|||
23281671|NCT00819169|64772563|FG001|Overall Study|Lost to Follow-up|2|||
23281672|NCT00819169|64772564|FG002|Overall Study|Lost to Follow-up|0|||
23281673|NCT00819169|64772565|FG003|Overall Study|Lost to Follow-up|1|||
23373921|NCT00959751|65115848|FG000|Overall Study|Consent Withdrawn|0|||
23373922|NCT00959751|65115849|FG001|Overall Study|Consent Withdrawn|1|||
23373923|NCT00959751|65115848|FG000|Overall Study|Non-compliance to Study Procedures|0|||
23373924|NCT00959751|65115849|FG001|Overall Study|Non-compliance to Study Procedures|1|||
23373925|NCT00959751|65115848|FG000|Overall Study|No migraine headache without aura|7|||
23373926|NCT00959751|65115849|FG001|Overall Study|No migraine headache without aura|7|||
23487372|NCT02038829|65530318|FG011|Washout Period 2|Withdrawal by Subject|0|||
23487373|NCT02038829|65530307|FG000|Treatment Period 4|Adverse Event|0|||
23487374|NCT02038829|65530308|FG001|Treatment Period 4|Adverse Event|1|||
23487375|NCT02038829|65530309|FG002|Treatment Period 4|Adverse Event|0|||
23487376|NCT02038829|65530310|FG003|Treatment Period 4|Adverse Event|0|||
23487377|NCT02038829|65530311|FG004|Treatment Period 4|Adverse Event|0|||
23487378|NCT02038829|65530312|FG005|Treatment Period 4|Adverse Event|0|||
23487379|NCT02038829|65530313|FG006|Treatment Period 4|Adverse Event|0|||
23487380|NCT02038829|65530314|FG007|Treatment Period 4|Adverse Event|0|||
23487381|NCT02038829|65530315|FG008|Treatment Period 4|Adverse Event|0|||
23487382|NCT02038829|65530316|FG009|Treatment Period 4|Adverse Event|0|||
23487383|NCT02038829|65530317|FG010|Treatment Period 4|Adverse Event|0|||
23487384|NCT02038829|65530318|FG011|Treatment Period 4|Adverse Event|0|||
23487385|NCT02038829|65530307|FG000|Washout Period 4|Adverse Event|0|||
23487386|NCT02038829|65530308|FG001|Washout Period 4|Adverse Event|0|||
23487387|NCT02038829|65530309|FG002|Washout Period 4|Adverse Event|0|||
23487388|NCT02038829|65530310|FG003|Washout Period 4|Adverse Event|0|||
23487389|NCT02038829|65530311|FG004|Washout Period 4|Adverse Event|0|||
23487390|NCT02038829|65530312|FG005|Washout Period 4|Adverse Event|0|||
23487391|NCT02038829|65530313|FG006|Washout Period 4|Adverse Event|1|||
23487392|NCT02038829|65530314|FG007|Washout Period 4|Adverse Event|0|||
23487393|NCT02038829|65530315|FG008|Washout Period 4|Adverse Event|0|||
23487394|NCT02038829|65530316|FG009|Washout Period 4|Adverse Event|0|||
23487395|NCT02038829|65530317|FG010|Washout Period 4|Adverse Event|0|||
23487396|NCT02038829|65530318|FG011|Washout Period 4|Adverse Event|0|||
23487397|NCT02038829|65530307|FG000|Treatment Period 6|Adverse Event|0|||
23487398|NCT02038829|65530308|FG001|Treatment Period 6|Adverse Event|0|||
23487399|NCT02038829|65530309|FG002|Treatment Period 6|Adverse Event|1|||
23487400|NCT02038829|65530310|FG003|Treatment Period 6|Adverse Event|0|||
23487401|NCT02038829|65530311|FG004|Treatment Period 6|Adverse Event|0|||
23487402|NCT02038829|65530312|FG005|Treatment Period 6|Adverse Event|0|||
23487403|NCT02038829|65530313|FG006|Treatment Period 6|Adverse Event|0|||
23487404|NCT02038829|65530314|FG007|Treatment Period 6|Adverse Event|0|||
23487405|NCT02038829|65530315|FG008|Treatment Period 6|Adverse Event|0|||
23487406|NCT02038829|65530316|FG009|Treatment Period 6|Adverse Event|0|||
23487407|NCT02038829|65530317|FG010|Treatment Period 6|Adverse Event|0|||
23487408|NCT02038829|65530318|FG011|Treatment Period 6|Adverse Event|0|||
23487409|NCT01143207|65530319|FG000|Overall Study|Lost to Follow-up|2|||
23487410|NCT05442775|65530333|FG000|Overall Study|Trial terminated|61|||
23487411|NCT05442775|65530333|FG000|Overall Study|Lack of Efficacy|4|||
23487412|NCT05442775|65530333|FG000|Overall Study|Withdrawal by Subject|4|||
23487413|NCT05442775|65530333|FG000|Overall Study|Death|1|||
23487414|NCT05442775|65530333|FG000|Overall Study|Participant removed at Sponsor request|1|||
23487415|NCT00096954|65530334|FG000|Overall Study|Adverse Event|3|||
23487416|NCT00096954|65530335|FG001|Overall Study|Adverse Event|1|||
23487417|NCT00096954|65530334|FG000|Overall Study|Withdrawal by Subject|9|||
23487418|NCT00096954|65530335|FG001|Overall Study|Withdrawal by Subject|8|||
23487419|NCT00096954|65530334|FG000|Overall Study|Physician Decision|1|||
23603821|NCT03418545|65940175|FG001|Overall Study|Withdrawal by Participant|4|||
23603822|NCT03418545|65940174|FG000|Overall Study|Lost to Follow-up|3|||
23603823|NCT03418545|65940175|FG001|Overall Study|Lost to Follow-up|5|||
23373927|NCT00547339|65115850|FG000|Overall Study|Physician Decision|0|||
23373928|NCT00547339|65115851|FG001|Overall Study|Physician Decision|0|||
23373929|NCT00547339|65115852|FG002|Overall Study|Physician Decision|1|||
23373930|NCT00547339|65115853|FG003|Overall Study|Physician Decision|0|||
23373931|NCT00433836|65115854|FG000|Overall Study|Adverse Event|7|||
23373932|NCT00433836|65115855|FG001|Overall Study|Adverse Event|0|||
23487420|NCT00096954|65530335|FG001|Overall Study|Physician Decision|1|||
23487421|NCT00096954|65530334|FG000|Overall Study|Sponsors Decision|1|||
23487422|NCT00096954|65530335|FG001|Overall Study|Sponsors Decision|1|||
23487423|NCT00096954|65530334|FG000|Overall Study|Pregnancy|1|||
23487424|NCT00096954|65530335|FG001|Overall Study|Pregnancy|1|||
23487425|NCT00096954|65530334|FG000|Overall Study|Initiation of immunotherapy|1|||
23487426|NCT00096954|65530335|FG001|Overall Study|Initiation of immunotherapy|0|||
23487427|NCT00096954|65530334|FG000|Overall Study|Non-compliance|0|||
23487428|NCT00096954|65530335|FG001|Overall Study|Non-compliance|3|||
23487429|NCT00096954|65530334|FG000|Overall Study|Lost to Follow-up|8|||
23487430|NCT00096954|65530335|FG001|Overall Study|Lost to Follow-up|5|||
23487431|NCT02634710|65530337|FG000|Overall Study|Death|4|||
23487432|NCT04533880|65530338|FG000|Overall Study|Lost to Follow-up|0|||
23373933|NCT00433836|65115854|FG000|Overall Study|Lost to Follow-up|3|||
23373934|NCT00433836|65115855|FG001|Overall Study|Lost to Follow-up|0|||
23487433|NCT04533880|65530339|FG001|Overall Study|Lost to Follow-up|1|||
23487434|NCT04533880|65530340|FG002|Overall Study|Lost to Follow-up|1|||
23487435|NCT01982331|65530341|FG000|Received Vaccination 2|Adverse Event|1|||
23487436|NCT01982331|65530342|FG001|Received Vaccination 2|Adverse Event|2|||
23487437|NCT01982331|65530341|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
23487438|NCT01982331|65530342|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
23487439|NCT01982331|65530341|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
23487440|NCT01982331|65530342|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
23487441|NCT05036369|65530343|FG000|Overall Study|Run In non compliance|1|||
23487442|NCT05036369|65530344|FG001|Overall Study|Run In non compliance|2|||
23487443|NCT05036369|65530343|FG000|Overall Study|Change in eligibility criteria|0|||
23487444|NCT05036369|65530344|FG001|Overall Study|Change in eligibility criteria|1|||
23281674|NCT00819169|64772566|FG004|Overall Study|Lost to Follow-up|0|||
23281675|NCT00819169|64772567|FG005|Overall Study|Lost to Follow-up|6|||
23281676|NCT00819169|64772568|FG006|Overall Study|Lost to Follow-up|2|||
23487445|NCT03956056|65530345|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
23487446|NCT03956056|65530345|FG000|Overall Study|Lack of Efficacy|1|||
23487447|NCT00518973|65530346|FG000|Overall Study|Withdrawal by Subject|3|||
23487448|NCT00518973|65530347|FG001|Overall Study|Withdrawal by Subject|2|||
23487449|NCT01163266|65530354|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
23487450|NCT01163266|65530355|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
23487451|NCT01163266|65530356|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
23487452|NCT01163266|65530354|FG000|Overall Study|Lack of Efficacy|1|||
23487453|NCT01163266|65530355|FG001|Overall Study|Lack of Efficacy|3|||
23487454|NCT01163266|65530356|FG002|Overall Study|Lack of Efficacy|1|||
23487455|NCT01163266|65530354|FG000|Overall Study|Noncompliance with Study Drug|0|||
23487456|NCT01163266|65530355|FG001|Overall Study|Noncompliance with Study Drug|2|||
23487457|NCT01163266|65530356|FG002|Overall Study|Noncompliance with Study Drug|0|||
23487458|NCT01163266|65530354|FG000|Overall Study|Protocol Deviations|2|||
23487459|NCT01163266|65530355|FG001|Overall Study|Protocol Deviations|2|||
23487460|NCT01163266|65530356|FG002|Overall Study|Protocol Deviations|5|||
23487461|NCT01163266|65530354|FG000|Overall Study|Withdrawal of Consent|5|||
23487462|NCT01163266|65530355|FG001|Overall Study|Withdrawal of Consent|7|||
23487463|NCT01163266|65530356|FG002|Overall Study|Withdrawal of Consent|3|||
23487464|NCT01163266|65530354|FG000|Overall Study|Lost to Follow-up|7|||
23487465|NCT01163266|65530355|FG001|Overall Study|Lost to Follow-up|7|||
23281677|NCT00819169|64772569|FG007|Overall Study|Lost to Follow-up|2|||
23281678|NCT00819169|64772570|FG008|Overall Study|Lost to Follow-up|1|||
23281679|NCT00819169|64772562|FG000|Overall Study|Death|1|||
23281680|NCT00819169|64772563|FG001|Overall Study|Death|1|||
23281681|NCT00819169|64772564|FG002|Overall Study|Death|3|||
23281682|NCT00819169|64772565|FG003|Overall Study|Death|8|||
23281683|NCT00819169|64772566|FG004|Overall Study|Death|5|||
23281684|NCT00819169|64772567|FG005|Overall Study|Death|7|||
23281685|NCT00819169|64772568|FG006|Overall Study|Death|9|||
23281686|NCT00819169|64772569|FG007|Overall Study|Death|4|||
23281687|NCT00819169|64772570|FG008|Overall Study|Death|7|||
23281688|NCT00819169|64772562|FG000|Overall Study|Ineligibility determined|0|||
23281689|NCT00819169|64772563|FG001|Overall Study|Ineligibility determined|0|||
23281690|NCT00819169|64772564|FG002|Overall Study|Ineligibility determined|0|||
23281691|NCT00819169|64772565|FG003|Overall Study|Ineligibility determined|2|||
23281692|NCT00819169|64772566|FG004|Overall Study|Ineligibility determined|0|||
23281693|NCT00819169|64772567|FG005|Overall Study|Ineligibility determined|0|||
23281694|NCT00819169|64772568|FG006|Overall Study|Ineligibility determined|0|||
23281695|NCT00819169|64772569|FG007|Overall Study|Ineligibility determined|0|||
23281696|NCT00819169|64772570|FG008|Overall Study|Ineligibility determined|1|||
23281697|NCT00819169|64772562|FG000|Overall Study|Adverse Event|0|||
23281698|NCT00819169|64772563|FG001|Overall Study|Adverse Event|0|||
23281699|NCT00819169|64772564|FG002|Overall Study|Adverse Event|0|||
23281700|NCT00819169|64772565|FG003|Overall Study|Adverse Event|0|||
23281701|NCT00819169|64772566|FG004|Overall Study|Adverse Event|1|||
23281702|NCT00819169|64772567|FG005|Overall Study|Adverse Event|0|||
23281703|NCT00819169|64772568|FG006|Overall Study|Adverse Event|0|||
23281704|NCT00819169|64772569|FG007|Overall Study|Adverse Event|0|||
23281705|NCT00819169|64772570|FG008|Overall Study|Adverse Event|0|||
23487466|NCT01163266|65530356|FG002|Overall Study|Lost to Follow-up|10|||
23281706|NCT00819169|64772562|FG000|Overall Study|Administrative Decision|0|||
23281707|NCT00819169|64772563|FG001|Overall Study|Administrative Decision|0|||
23281708|NCT00819169|64772564|FG002|Overall Study|Administrative Decision|0|||
23281709|NCT00819169|64772565|FG003|Overall Study|Administrative Decision|0|||
23281710|NCT00819169|64772566|FG004|Overall Study|Administrative Decision|1|||
23281711|NCT00819169|64772567|FG005|Overall Study|Administrative Decision|2|||
23281712|NCT00819169|64772568|FG006|Overall Study|Administrative Decision|0|||
23281713|NCT00819169|64772569|FG007|Overall Study|Administrative Decision|2|||
23487467|NCT01163266|65530354|FG000|Overall Study|Other|1|||
23487468|NCT01163266|65530355|FG001|Overall Study|Other|1|||
23487469|NCT01163266|65530356|FG002|Overall Study|Other|2|||
23487470|NCT03875118|65530364|FG000|Overall Study|Withdrawal by Subject|4|||
23281714|NCT00819169|64772570|FG008|Overall Study|Administrative Decision|0|||
23487471|NCT03875118|65530365|FG001|Overall Study|Withdrawal by Subject|4|||
23281715|NCT01034358|64772572|FG000|Overall Study|Withdrawal by Subject|1|||
23487472|NCT01675427|65530368|FG000|Overall Study|Withdrawal by Subject|7|||
23487473|NCT01675427|65530368|FG000|Overall Study|Participant Refused Sample Collection|18|||
23487474|NCT01675427|65530368|FG000|Overall Study|Sample not Collected by Mistake|2|||
23487475|NCT01675427|65530368|FG000|Overall Study|Lost to Follow-up|5|||
23487476|NCT01675427|65530368|FG000|Overall Study|Other|2|||
23487477|NCT03901456|65530370|FG000|Overall Study|Withdrawal by Subject|0|||
23487478|NCT03901456|65530371|FG001|Overall Study|Withdrawal by Subject|0|||
23487479|NCT03901456|65530372|FG002|Overall Study|Withdrawal by Subject|1|||
23487480|NCT03901456|65530370|FG000|Overall Study|Lost to Follow-up|0|||
23487481|NCT03901456|65530371|FG001|Overall Study|Lost to Follow-up|1|||
23487482|NCT03901456|65530372|FG002|Overall Study|Lost to Follow-up|0|||
23487483|NCT03332771|65530375|FG000|Overall Study|Adverse Event|6|||
23487484|NCT03332771|65530376|FG001|Overall Study|Adverse Event|4|||
23487485|NCT03332771|65530377|FG002|Overall Study|Adverse Event|1|||
23487486|NCT03332771|65530378|FG003|Overall Study|Adverse Event|3|||
23487487|NCT03332771|65530375|FG000|Overall Study|Poor Compliance to Protocol|0|||
23487488|NCT03332771|65530376|FG001|Overall Study|Poor Compliance to Protocol|1|||
23487489|NCT03332771|65530377|FG002|Overall Study|Poor Compliance to Protocol|0|||
23487490|NCT03332771|65530378|FG003|Overall Study|Poor Compliance to Protocol|1|||
23487491|NCT03332771|65530375|FG000|Overall Study|Lost to Follow-up|2|||
23487492|NCT03332771|65530376|FG001|Overall Study|Lost to Follow-up|2|||
23487493|NCT03332771|65530377|FG002|Overall Study|Lost to Follow-up|1|||
23487494|NCT03332771|65530378|FG003|Overall Study|Lost to Follow-up|2|||
23487495|NCT03332771|65530375|FG000|Overall Study|At the Participant's own request|20|||
23487496|NCT03332771|65530376|FG001|Overall Study|At the Participant's own request|26|||
23487497|NCT03332771|65530377|FG002|Overall Study|At the Participant's own request|14|||
23487498|NCT03332771|65530378|FG003|Overall Study|At the Participant's own request|23|||
23487499|NCT03332771|65530375|FG000|Overall Study|Reason Not Specified|6|||
23487500|NCT03332771|65530376|FG001|Overall Study|Reason Not Specified|18|||
23487501|NCT03332771|65530377|FG002|Overall Study|Reason Not Specified|16|||
23487502|NCT03332771|65530378|FG003|Overall Study|Reason Not Specified|19|||
23487503|NCT00116168|65530379|FG000|Overall Study|Lost to Follow-up|6|||
23487504|NCT00116168|65530380|FG001|Overall Study|Lost to Follow-up|5|||
23487505|NCT00116168|65530381|FG002|Overall Study|Lost to Follow-up|0|||
23487506|NCT00116168|65530382|FG003|Overall Study|Lost to Follow-up|0|||
23487507|NCT02939079|65530383|FG000|Overall Study|Adverse Event|2|||
23487508|NCT02939079|65530384|FG001|Overall Study|Adverse Event|1|||
23487509|NCT02939079|65530383|FG000|Overall Study|Lost to Follow-up|0|||
23487510|NCT02939079|65530384|FG001|Overall Study|Lost to Follow-up|2|||
23487511|NCT02939079|65530383|FG000|Overall Study|Protocol Violation|1|||
23603824|NCT03418545|65940174|FG000|Overall Study|Reason Not Specified|0|||
23603825|NCT03418545|65940175|FG001|Overall Study|Reason Not Specified|1|||
23281716|NCT01034358|64772572|FG000|Overall Study|Protocol Violation|1|||
23281717|NCT02911792|64772573|FG000|Overall Study|Lost to Follow-up|3|||
23281718|NCT02911792|64772574|FG001|Overall Study|Lost to Follow-up|3|||
23281719|NCT02911792|64772575|FG002|Overall Study|Lost to Follow-up|3|||
23281720|NCT02911792|64772576|FG003|Overall Study|Lost to Follow-up|3|||
23281721|NCT02362464|64772578|FG000|Overall Study|Switched to alternative therapy|1|||
23281722|NCT02362464|64772578|FG000|Overall Study|Refused further treatment|1|||
23281723|NCT02362464|64772578|FG000|Overall Study|Physician Decision|4|||
23487512|NCT02939079|65530384|FG001|Overall Study|Protocol Violation|0|||
23487513|NCT02939079|65530383|FG000|Overall Study|Withdrawal by Subject|0|||
23487514|NCT02939079|65530384|FG001|Overall Study|Withdrawal by Subject|1|||
23603826|NCT03418545|65940174|FG000|Overall Study|Missing Completion Status|0|||
23603827|NCT03418545|65940175|FG001|Overall Study|Missing Completion Status|1|||
23603828|NCT01549951|65940178|FG000|Overall Study|Adverse Event|15|||
23603829|NCT01549951|65940178|FG000|Overall Study|Withdrawal by Subject|2|||
23603830|NCT01549951|65940178|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
23603831|NCT01549951|65940178|FG000|Overall Study|Progressive disease|29|||
23603832|NCT01549951|65940178|FG000|Overall Study|Symptomatic deterioration|1|||
23603833|NCT01549951|65940178|FG000|Overall Study|Other|2|||
23603834|NCT01670526|65940181|FG000|Overall Study|Withdrawal by Subject|3|||
23281724|NCT00319696|64772581|FG000|Overall Study|Adverse Event|36|||
23281725|NCT00319696|64772581|FG000|Overall Study|withdrawal of consent|14|||
23487515|NCT02939079|65530383|FG000|Overall Study|relapse during the study|1|||
23281726|NCT00319696|64772581|FG000|Overall Study|administrative|7|||
23281727|NCT00319696|64772581|FG000|Overall Study|Lost to Follow-up|3|||
23487516|NCT02939079|65530384|FG001|Overall Study|relapse during the study|1|||
23487517|NCT01954342|65530385|FG000|Overall Study|Missing data from 13-16week study visit|0|||
23487518|NCT01954342|65530386|FG001|Overall Study|Missing data from 13-16week study visit|0|||
23281728|NCT00294047|64772588|FG000|Month 48|Adverse Event|28|||
23487519|NCT01954342|65530387|FG002|Overall Study|Missing data from 13-16week study visit|0|||
23487520|NCT01954342|65530388|FG003|Overall Study|Missing data from 13-16week study visit|1|||
23487521|NCT01954342|65530385|FG000|Overall Study|Miscarriage|0|||
23487522|NCT01954342|65530386|FG001|Overall Study|Miscarriage|0|||
23487523|NCT01954342|65530387|FG002|Overall Study|Miscarriage|0|||
23487524|NCT01954342|65530388|FG003|Overall Study|Miscarriage|3|||
23487525|NCT01954342|65530385|FG000|Overall Study|Lost to Follow-up|0|||
23487526|NCT01954342|65530386|FG001|Overall Study|Lost to Follow-up|0|||
23487527|NCT01954342|65530387|FG002|Overall Study|Lost to Follow-up|0|||
23487528|NCT01954342|65530388|FG003|Overall Study|Lost to Follow-up|5|||
23487529|NCT01954342|65530385|FG000|Overall Study|Preterm delivery|0|||
23487530|NCT01954342|65530386|FG001|Overall Study|Preterm delivery|0|||
23487531|NCT01954342|65530387|FG002|Overall Study|Preterm delivery|0|||
23487532|NCT01954342|65530388|FG003|Overall Study|Preterm delivery|3|||
23487533|NCT01954342|65530385|FG000|Overall Study|Pre-eclampsia|0|||
23487534|NCT01954342|65530386|FG001|Overall Study|Pre-eclampsia|0|||
23487535|NCT01954342|65530387|FG002|Overall Study|Pre-eclampsia|0|||
23487536|NCT01954342|65530388|FG003|Overall Study|Pre-eclampsia|4|||
23487537|NCT01954342|65530385|FG000|Overall Study|Unreliable Data|0|||
23487538|NCT01954342|65530386|FG001|Overall Study|Unreliable Data|0|||
23487539|NCT01954342|65530387|FG002|Overall Study|Unreliable Data|0|||
23487540|NCT01954342|65530388|FG003|Overall Study|Unreliable Data|2|||
23487541|NCT03953183|65530389|FG000|Overall Study|Physician Decision|0|||
23487542|NCT03953183|65530390|FG001|Overall Study|Physician Decision|1|||
23487543|NCT03953183|65530389|FG000|Overall Study|Withdrawal by Subject|0|||
23487544|NCT03953183|65530390|FG001|Overall Study|Withdrawal by Subject|1|||
23281729|NCT00294047|64772589|FG001|Month 48|Adverse Event|13|||
23281730|NCT00294047|64772588|FG000|Month 48|Protocol Violation|4|||
23281731|NCT00294047|64772589|FG001|Month 48|Protocol Violation|4|||
23281732|NCT00294047|64772588|FG000|Month 48|Withdrawal by Subject|111|||
23281733|NCT00294047|64772589|FG001|Month 48|Withdrawal by Subject|115|||
23281734|NCT00294047|64772588|FG000|Month 48|Lost to Follow-up|272|||
23281735|NCT00294047|64772589|FG001|Month 48|Lost to Follow-up|287|||
23281736|NCT00294047|64772588|FG000|Month 48|Other|10|||
23281737|NCT00294047|64772589|FG001|Month 48|Other|14|||
23281738|NCT00294047|64772588|FG000|Month 84|Adverse Event|4|||
23281739|NCT00294047|64772589|FG001|Month 84|Adverse Event|2|||
23281740|NCT00294047|64772588|FG000|Month 84|Protocol Violation|1|||
23281741|NCT00294047|64772589|FG001|Month 84|Protocol Violation|1|||
23281742|NCT00294047|64772588|FG000|Month 84|Withdrawal by Subject|33|||
23281743|NCT00294047|64772589|FG001|Month 84|Withdrawal by Subject|31|||
23281744|NCT00294047|64772588|FG000|Month 84|Lost to Follow-up|187|||
23281745|NCT00294047|64772589|FG001|Month 84|Lost to Follow-up|190|||
23281746|NCT00294047|64772588|FG000|Month 84|Absent Cervix|2|||
23281747|NCT00294047|64772589|FG001|Month 84|Absent Cervix|0|||
23281748|NCT00294047|64772588|FG000|Month 84|Work related reasons|4|||
23281749|NCT00294047|64772589|FG001|Month 84|Work related reasons|2|||
23281750|NCT00294047|64772588|FG000|Month 84|Center closed, subject did not transfer|1|||
23281751|NCT00294047|64772589|FG001|Month 84|Center closed, subject did not transfer|0|||
23281752|NCT00294047|64772588|FG000|Month 84|Family problems|2|||
23281753|NCT00294047|64772589|FG001|Month 84|Family problems|2|||
23281754|NCT00294047|64772588|FG000|Month 84|Lack of time|3|||
23281755|NCT00294047|64772589|FG001|Month 84|Lack of time|1|||
23281756|NCT00294047|64772588|FG000|Month 84|Personal reason|2|||
23281757|NCT00294047|64772589|FG001|Month 84|Personal reason|4|||
23281758|NCT00294047|64772588|FG000|Month 84|Subject does not want male physician|1|||
23281759|NCT00294047|64772589|FG001|Month 84|Subject does not want male physician|0|||
23281760|NCT00294047|64772588|FG000|Month 84|Transport reimbursement delayed|0|||
23281761|NCT00294047|64772589|FG001|Month 84|Transport reimbursement delayed|1|||
23281762|NCT00294047|64772588|FG000|Month 84|Unable to reach study site|1|||
23281763|NCT00294047|64772589|FG001|Month 84|Unable to reach study site|0|||
23281764|NCT00294047|64772588|FG000|Month 84|Under investigation locally|1|||
23281765|NCT00294047|64772589|FG001|Month 84|Under investigation locally|0|||
23281766|NCT00294047|64772588|FG000|Month 84|Visit missed|0|||
23281767|NCT00294047|64772589|FG001|Month 84|Visit missed|1|||
23281768|NCT00294047|64772588|FG000|Month 84|No consent for Month 84 Follow-up|731|||
23281769|NCT00294047|64772589|FG001|Month 84|No consent for Month 84 Follow-up|754|||
23281770|NCT04079296|64772590|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
23281771|NCT04079296|64772591|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
23281772|NCT04079296|64772592|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
23281773|NCT04079296|64772593|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
23281774|NCT04079296|64772594|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
23281775|NCT04079296|64772590|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
23281776|NCT04079296|64772591|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
23487545|NCT02963831|65530391|FG000|Overall Study|Progressive Disease|3|||
23487546|NCT02963831|65530392|FG001|Overall Study|Progressive Disease|3|||
23487547|NCT02963831|65530393|FG002|Overall Study|Progressive Disease|16|||
23487548|NCT02963831|65530394|FG003|Overall Study|Progressive Disease|27|||
23487549|NCT02963831|65530391|FG000|Overall Study|Withdrawal by Subject|1|||
23487550|NCT02963831|65530392|FG001|Overall Study|Withdrawal by Subject|0|||
23487551|NCT02963831|65530393|FG002|Overall Study|Withdrawal by Subject|2|||
23487552|NCT02963831|65530394|FG003|Overall Study|Withdrawal by Subject|4|||
23487553|NCT02963831|65530391|FG000|Overall Study|Adverse Event|0|||
23281777|NCT04079296|64772592|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
23281778|NCT04079296|64772593|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
23281779|NCT04079296|64772594|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
23281780|NCT04079296|64772590|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
23281781|NCT04079296|64772591|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
23281782|NCT04079296|64772592|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
23281783|NCT04079296|64772593|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
23281784|NCT04079296|64772594|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
23281785|NCT04079296|64772590|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
23281786|NCT04079296|64772591|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
23281787|NCT04079296|64772592|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
23281788|NCT04079296|64772593|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
23281789|NCT04079296|64772594|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
23281790|NCT04079296|64772590|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
23281791|NCT04079296|64772591|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
23281792|NCT04079296|64772592|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
23373935|NCT00433836|65115854|FG000|Overall Study|Withdrawal by Subject|2|||
23373936|NCT00433836|65115855|FG001|Overall Study|Withdrawal by Subject|1|||
23373937|NCT00433836|65115854|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23373938|NCT00433836|65115855|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23373939|NCT00433836|65115854|FG000|Overall Study|Protocol Violation|0|||
23373940|NCT00433836|65115855|FG001|Overall Study|Protocol Violation|2|||
23373941|NCT00433836|65115854|FG000|Overall Study|Condition no longer requires study drug|0|||
23373942|NCT00433836|65115855|FG001|Overall Study|Condition no longer requires study drug|1|||
23373943|NCT00433836|65115854|FG000|Overall Study|Abnormal laboratory values|0|||
23373944|NCT00433836|65115855|FG001|Overall Study|Abnormal laboratory values|1|||
23373945|NCT03408899|65115856|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
23373946|NCT03329989|65115861|FG000|Overall Study|Withdrawal by Subject|9|||
23373947|NCT03329989|65115861|FG000|Overall Study|Lost to Follow-up|8|||
23373948|NCT03329989|65115861|FG000|Overall Study|Adverse Event|5|||
23373949|NCT03329989|65115861|FG000|Overall Study|Protocol Violation|1|||
23373950|NCT03312738|65115862|FG000|Overall Study|Progressive disease|58|||
23373951|NCT03312738|65115863|FG001|Overall Study|Progressive disease|67|||
23373952|NCT03312738|65115862|FG000|Overall Study|Patient/guardian decision|13|||
23373953|NCT03312738|65115863|FG001|Overall Study|Patient/guardian decision|5|||
23373954|NCT03312738|65115862|FG000|Overall Study|Adverse Event|5|||
23373955|NCT03312738|65115863|FG001|Overall Study|Adverse Event|3|||
23373956|NCT03312738|65115862|FG000|Overall Study|Protocol deviation|2|||
23373957|NCT03312738|65115863|FG001|Overall Study|Protocol deviation|0|||
23373958|NCT03312738|65115862|FG000|Overall Study|Technical problems|0|||
23373959|NCT03312738|65115863|FG001|Overall Study|Technical problems|1|||
23373960|NCT03312738|65115862|FG000|Overall Study|Physician Decision|2|||
23373961|NCT03312738|65115863|FG001|Overall Study|Physician Decision|3|||
23373962|NCT02145390|65115865|FG000|Overall Study|Withdrawal by Subject|1|||
23373963|NCT02915835|65115868|FG000|Overall Study|Physician Decision|1|||
23373964|NCT02915835|65115869|FG001|Overall Study|Physician Decision|0|||
23373965|NCT02915835|65115868|FG000|Overall Study|Withdrawal by Subject|0|||
23373966|NCT02915835|65115869|FG001|Overall Study|Withdrawal by Subject|1|||
23373967|NCT04796415|65115875|FG000|Overall Study|not interested|12|||
23373968|NCT04796415|65115875|FG000|Overall Study|health issue|8|||
23373969|NCT04796415|65115875|FG000|Overall Study|Other|4|||
23373970|NCT04796415|65115875|FG000|Overall Study|discharged from home health service|3|||
23373971|NCT04796415|65115875|FG000|Overall Study|re-hospitalization|2|||
23373972|NCT04796415|65115875|FG000|Overall Study|moving to nursing home|1|||
23373973|NCT04796415|65115875|FG000|Overall Study|lost contact|1|||
23373974|NCT02059239|65115876|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
23373975|NCT02059239|65115877|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
23373976|NCT02059239|65115876|FG000|Overall Study|Physician Decision|1|||
23373977|NCT02059239|65115877|FG001|Overall Study|Physician Decision|0|||
23373978|NCT01142336|65115878|FG000|Overall Study|Adverse Event|1|||
23373979|NCT01142336|65115879|FG001|Overall Study|Adverse Event|1|||
23373980|NCT01142336|65115878|FG000|Overall Study|Lost to Follow-up|0|||
23373981|NCT01142336|65115879|FG001|Overall Study|Lost to Follow-up|1|||
23373982|NCT00374868|65115882|FG000|Overall Study|Adverse Event|12|||
23373983|NCT00374868|65115882|FG000|Overall Study|Progressive Disease|7|||
23373984|NCT00374868|65115882|FG000|Overall Study|Physician Decision|13|||
23373985|NCT00374868|65115882|FG000|Overall Study|Lost to Follow-up|1|||
23373986|NCT00374868|65115882|FG000|Overall Study|Death|2|||
23373987|NCT00374868|65115882|FG000|Overall Study|Other - Not Specified|1|||
23373988|NCT00423046|65115883|FG000|Overall Study|Other|340|||
23373989|NCT00423046|65115884|FG001|Overall Study|Other|345|||
23373990|NCT00116142|65115888|FG000|Overall Study|Adverse Event|8|||
23373991|NCT00116142|65115889|FG001|Overall Study|Adverse Event|7|||
23373992|NCT00116142|65115888|FG000|Overall Study|Protocol Violation|2|||
23373993|NCT00116142|65115889|FG001|Overall Study|Protocol Violation|1|||
23373994|NCT00116142|65115888|FG000|Overall Study|Withdrawal by Subject|5|||
23373995|NCT00116142|65115889|FG001|Overall Study|Withdrawal by Subject|5|||
23373996|NCT00116142|65115888|FG000|Overall Study|Physician Decision|3|||
23373997|NCT00116142|65115889|FG001|Overall Study|Physician Decision|1|||
23373998|NCT00116142|65115888|FG000|Overall Study|Delayed Radiation Therapy|1|||
23373999|NCT00116142|65115889|FG001|Overall Study|Delayed Radiation Therapy|0|||
23374000|NCT00116142|65115888|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
23374001|NCT00116142|65115889|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
23374002|NCT00116142|65115888|FG000|Overall Study|Patient stopped due to depression|0|||
23374003|NCT00116142|65115889|FG001|Overall Study|Patient stopped due to depression|1|||
23374004|NCT00116142|65115888|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
23374005|NCT00116142|65115889|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
23374006|NCT00116142|65115888|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
23374007|NCT00116142|65115889|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
23374008|NCT00116142|65115888|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
23374009|NCT00116142|65115889|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
23374010|NCT04219189|65115890|FG000|Overall Study|Withdrawal by Subject|1|||
23374011|NCT04219189|65115891|FG001|Overall Study|Withdrawal by Subject|2|||
23374012|NCT04219189|65115890|FG000|Overall Study|Protocol Violation|0|||
23374013|NCT04219189|65115891|FG001|Overall Study|Protocol Violation|1|||
23374014|NCT04219189|65115890|FG000|Overall Study|Lost to Follow-up|0|||
23374015|NCT04219189|65115891|FG001|Overall Study|Lost to Follow-up|1|||
23374016|NCT04219189|65115890|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
23374017|NCT04219189|65115891|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
23374018|NCT04539275|65115892|FG000|Overall Study|Death|2|||
23374019|NCT04539275|65115893|FG001|Overall Study|Death|4|||
23374020|NCT04539275|65115892|FG000|Overall Study|Lost to Follow-up|1|||
23374021|NCT04539275|65115893|FG001|Overall Study|Lost to Follow-up|1|||
23374022|NCT04539275|65115892|FG000|Overall Study|Withdrawal by Subject|3|||
23374023|NCT04539275|65115893|FG001|Overall Study|Withdrawal by Subject|0|||
23374024|NCT03307174|65115894|FG000|Overall Study|Unplanned ICU Administrion|5|||
23374025|NCT03307174|65115895|FG001|Overall Study|Unplanned ICU Administrion|3|||
23374026|NCT03307174|65115894|FG000|Overall Study|Aborted Surgery|1|||
23603835|NCT01670526|65940182|FG001|Overall Study|Withdrawal by Subject|1|||
23603836|NCT01670526|65940181|FG000|Overall Study|Lost to Follow-up|9|||
23603837|NCT01670526|65940182|FG001|Overall Study|Lost to Follow-up|5|||
23603838|NCT02392507|65940183|FG000|Induction Regimen|Death|3|||
23603839|NCT02392507|65940183|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
23603840|NCT02392507|65940183|FG000|Induction Regimen|Physician Decision|1|||
23603841|NCT02392507|65940183|FG000|Induction Regimen|Withdrawal by Subject|2|||
23603842|NCT02392507|65940183|FG000|Maintenance Regimen|Death|1|||
23281793|NCT04079296|64772593|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
23281794|NCT04079296|64772594|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
23281795|NCT04079296|64772590|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
23281796|NCT04079296|64772591|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
23281797|NCT04079296|64772592|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
23281798|NCT04079296|64772593|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
23281799|NCT04079296|64772594|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
23374027|NCT03307174|65115895|FG001|Overall Study|Aborted Surgery|2|||
23374028|NCT03307174|65115894|FG000|Overall Study|Hypotension|6|||
23281800|NCT04079296|64772590|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
23603843|NCT02392507|65940183|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
23374029|NCT03307174|65115895|FG001|Overall Study|Hypotension|0|||
23374030|NCT03307174|65115894|FG000|Overall Study|Nonfunctional epidural|1|||
23487554|NCT02963831|65530392|FG001|Overall Study|Adverse Event|1|||
23487555|NCT02963831|65530393|FG002|Overall Study|Adverse Event|1|||
23487556|NCT02963831|65530394|FG003|Overall Study|Adverse Event|2|||
23487557|NCT02963831|65530391|FG000|Overall Study|Death|0|||
23487558|NCT02963831|65530392|FG001|Overall Study|Death|0|||
23487559|NCT02963831|65530393|FG002|Overall Study|Death|0|||
23487560|NCT02963831|65530394|FG003|Overall Study|Death|2|||
23487561|NCT01994590|65530395|FG000|Overall Study|Adverse Event|1|||
23487562|NCT01994590|65530395|FG000|Overall Study|Trial Terminated|1|||
23487563|NCT01484054|65530396|FG000|Period 1|Withdrawal by Subject|0|||
23487564|NCT01484054|65530397|FG001|Period 1|Withdrawal by Subject|1|||
23487565|NCT01869725|65530398|FG000|Overall Study|ineligible after registration|1|||
23487566|NCT01869725|65530398|FG000|Overall Study|Death|1|||
23487567|NCT01869725|65530398|FG000|Overall Study|Lost to Follow-up|2|||
23487568|NCT01638819|65530399|FG000|Overall Study|Lost to Follow-up|1|||
23487569|NCT01638819|65530400|FG001|Overall Study|Lost to Follow-up|0|||
23487570|NCT02160782|65530407|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
23487571|NCT02160782|65530408|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
23487572|NCT02160782|65530409|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
23487573|NCT02160782|65530410|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
23487574|NCT02160782|65530411|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
23487575|NCT02160782|65530407|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
23487576|NCT02160782|65530408|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
23487577|NCT02160782|65530409|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
23487578|NCT02160782|65530410|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
23487579|NCT02160782|65530411|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
23487580|NCT02160782|65530407|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
23487581|NCT02160782|65530408|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
23487582|NCT02160782|65530409|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
23487583|NCT02160782|65530410|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
23487584|NCT02160782|65530411|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
23487585|NCT02160782|65530407|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
23487586|NCT02160782|65530408|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
23487587|NCT02160782|65530409|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
23487588|NCT02160782|65530410|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
23487589|NCT02160782|65530411|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
23487590|NCT02160782|65530407|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
23487591|NCT02160782|65530408|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
23487592|NCT02160782|65530409|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
23487593|NCT02160782|65530410|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
23487594|NCT02160782|65530411|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
23487595|NCT02160782|65530407|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
23487596|NCT02160782|65530408|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
23487597|NCT02160782|65530409|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
23487598|NCT02160782|65530410|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
23487599|NCT02160782|65530411|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
23487600|NCT02160782|65530407|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
23487601|NCT02160782|65530408|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
23487602|NCT02160782|65530409|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
23487603|NCT02160782|65530410|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
23487604|NCT02160782|65530411|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
23487605|NCT00736879|65530412|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
23487606|NCT00736879|65530413|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
23487607|NCT00736879|65530414|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
23487608|NCT00736879|65530415|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
23487609|NCT00736879|65530412|FG000|Double Blind Treatment Period|Adverse Event|0|||
23487610|NCT00736879|65530413|FG001|Double Blind Treatment Period|Adverse Event|1|||
23487611|NCT00736879|65530414|FG002|Double Blind Treatment Period|Adverse Event|1|||
23487612|NCT00736879|65530415|FG003|Double Blind Treatment Period|Adverse Event|0|||
23487613|NCT00736879|65530412|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
23487614|NCT00736879|65530413|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
23487615|NCT00736879|65530414|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
23487616|NCT00736879|65530415|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
23487617|NCT00736879|65530412|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
23603844|NCT00824408|65940190|FG000|Run-in Phase|Progressive disease|4|||
23374031|NCT03307174|65115895|FG001|Overall Study|Nonfunctional epidural|1|||
23374032|NCT03307174|65115894|FG000|Overall Study|Planned epidural removal|1|||
23374033|NCT03307174|65115895|FG001|Overall Study|Planned epidural removal|0|||
23374034|NCT03307174|65115894|FG000|Overall Study|Intrathecal catheter placement|0|||
23374035|NCT03307174|65115895|FG001|Overall Study|Intrathecal catheter placement|1|||
23374036|NCT00317369|65115896|FG000|Overall Study|Adverse Event|2|||
23374037|NCT00317369|65115897|FG001|Overall Study|Adverse Event|1|||
23374038|NCT00317369|65115898|FG002|Overall Study|Adverse Event|0|||
23374039|NCT00317369|65115896|FG000|Overall Study|Lack of Efficacy|0|||
23374040|NCT00317369|65115897|FG001|Overall Study|Lack of Efficacy|1|||
23374041|NCT00317369|65115898|FG002|Overall Study|Lack of Efficacy|1|||
23374042|NCT00317369|65115896|FG000|Overall Study|Withdrawal by Subject|0|||
23374043|NCT00317369|65115897|FG001|Overall Study|Withdrawal by Subject|0|||
23374044|NCT00317369|65115898|FG002|Overall Study|Withdrawal by Subject|1|||
23374045|NCT01901185|65115900|FG000|Overall Study|Withdrawal by Subject|2|||
23374046|NCT01496456|65115902|FG000|Overall Study|Protocol Violation|1|||
23374047|NCT01496456|65115902|FG000|Overall Study|Lost to Follow-up|7|||
23374048|NCT04009837|65115909|FG000|Overall Study|Withdrawal by Subject|5|||
23374049|NCT04009837|65115910|FG001|Overall Study|Withdrawal by Subject|4|||
23374050|NCT04009837|65115909|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
23374051|NCT04009837|65115910|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
23374052|NCT03738696|65115916|FG000|Overall Study|Withdrawal by Subject|0|||
23374053|NCT03738696|65115917|FG001|Overall Study|Withdrawal by Subject|1|||
23374054|NCT03738696|65115916|FG000|Overall Study|Lost to Follow-up|8|||
23374055|NCT03738696|65115917|FG001|Overall Study|Lost to Follow-up|14|||
23374056|NCT02349386|65115918|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
23374057|NCT02349386|65115919|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
23374058|NCT02349386|65115920|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
23374059|NCT02349386|65115921|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
23374060|NCT02349386|65115918|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
23374061|NCT02349386|65115919|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
23374062|NCT02349386|65115920|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
23374063|NCT02349386|65115921|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
23374064|NCT02349386|65115918|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
23374065|NCT02349386|65115919|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
23374066|NCT02349386|65115920|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
23374067|NCT02349386|65115921|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
23374068|NCT02349386|65115918|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
23374069|NCT02349386|65115919|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
23374070|NCT02349386|65115920|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
23374071|NCT02349386|65115921|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
23374072|NCT02349386|65115918|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
23374073|NCT02349386|65115919|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
23374074|NCT02349386|65115920|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
23374075|NCT02349386|65115921|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
23374076|NCT02349386|65115918|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
23374077|NCT02349386|65115919|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
23374078|NCT02349386|65115920|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
23374079|NCT02349386|65115921|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
23374080|NCT00701363|65115924|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
23374081|NCT00701363|65115925|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
23374082|NCT00701363|65115926|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
23374083|NCT00701363|65115927|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
23374084|NCT00701363|65115924|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
23603845|NCT00824408|65940191|FG001|Run-in Phase|Progressive disease|4|||
23603846|NCT00824408|65940192|FG002|Run-in Phase|Progressive disease|0|||
23603847|NCT00824408|65940193|FG003|Run-in Phase|Progressive disease|0|||
23603848|NCT00824408|65940194|FG004|Run-in Phase|Progressive disease|0|||
23603849|NCT00824408|65940190|FG000|Run-in Phase|Adverse Event|1|||
23603850|NCT00824408|65940191|FG001|Run-in Phase|Adverse Event|1|||
23603851|NCT00824408|65940192|FG002|Run-in Phase|Adverse Event|0|||
23603852|NCT00824408|65940193|FG003|Run-in Phase|Adverse Event|0|||
23603853|NCT00824408|65940194|FG004|Run-in Phase|Adverse Event|0|||
23374085|NCT00701363|65115925|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
23374086|NCT00701363|65115926|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
23374087|NCT00701363|65115927|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
23603854|NCT00824408|65940190|FG000|Run-in Phase|Refused to continue medication|1|||
23603855|NCT00824408|65940191|FG001|Run-in Phase|Refused to continue medication|0|||
23281801|NCT04079296|64772591|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
23281802|NCT04079296|64772592|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
23281803|NCT04079296|64772593|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
23374088|NCT00701363|65115924|FG000|Treatment Phase 1|Adverse Event|7|||
23374089|NCT00701363|65115925|FG001|Treatment Phase 1|Adverse Event|0|||
23374090|NCT00701363|65115926|FG002|Treatment Phase 1|Adverse Event|0|||
23374091|NCT00701363|65115927|FG003|Treatment Phase 1|Adverse Event|0|||
23374092|NCT00701363|65115924|FG000|Treatment Phase 1|Protocol Violation|1|||
23374093|NCT00701363|65115925|FG001|Treatment Phase 1|Protocol Violation|0|||
23374094|NCT00701363|65115926|FG002|Treatment Phase 1|Protocol Violation|0|||
23374095|NCT00701363|65115927|FG003|Treatment Phase 1|Protocol Violation|0|||
23374096|NCT00701363|65115924|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
23374097|NCT00701363|65115925|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
23374098|NCT00701363|65115926|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
23374099|NCT00701363|65115927|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
23374100|NCT00701363|65115924|FG000|Treatment Phase 1|Lack of Efficacy|1|||
23374101|NCT00701363|65115925|FG001|Treatment Phase 1|Lack of Efficacy|0|||
23374102|NCT00701363|65115926|FG002|Treatment Phase 1|Lack of Efficacy|0|||
23374103|NCT00701363|65115927|FG003|Treatment Phase 1|Lack of Efficacy|0|||
23374104|NCT00701363|65115924|FG000|Treatment Phase 2|Adverse Event|0|||
23374105|NCT00701363|65115925|FG001|Treatment Phase 2|Adverse Event|0|||
23374106|NCT00701363|65115926|FG002|Treatment Phase 2|Adverse Event|1|||
23374107|NCT00701363|65115927|FG003|Treatment Phase 2|Adverse Event|0|||
23374108|NCT00701363|65115924|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
23374109|NCT00701363|65115925|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
23281804|NCT04079296|64772594|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
23281805|NCT04079296|64772590|FG000|Dose Expansion Phase (168 Days)|Death|0|||
23281806|NCT04079296|64772591|FG001|Dose Expansion Phase (168 Days)|Death|0|||
23281807|NCT04079296|64772592|FG002|Dose Expansion Phase (168 Days)|Death|0|||
23281808|NCT04079296|64772593|FG003|Dose Expansion Phase (168 Days)|Death|1|||
23281809|NCT04079296|64772594|FG004|Dose Expansion Phase (168 Days)|Death|0|||
23281810|NCT02175095|64772601|FG000|Overall Study|Withdrawal by Subject|3|||
23281811|NCT05387408|64772602|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
23281812|NCT02316223|64772605|FG000|Overall Study|Lack of Efficacy|0|||
23281813|NCT02316223|64772606|FG001|Overall Study|Lack of Efficacy|1|||
23281814|NCT02316223|64772607|FG002|Overall Study|Lack of Efficacy|1|||
23281815|NCT02316223|64772605|FG000|Overall Study|Lost to Follow-up|27|||
23281816|NCT02316223|64772606|FG001|Overall Study|Lost to Follow-up|34|||
23281817|NCT02316223|64772607|FG002|Overall Study|Lost to Follow-up|36|||
23281818|NCT02316223|64772605|FG000|Overall Study|COPD Diagnosis|3|||
23281819|NCT02316223|64772606|FG001|Overall Study|COPD Diagnosis|2|||
23281820|NCT02316223|64772607|FG002|Overall Study|COPD Diagnosis|3|||
23281821|NCT02316223|64772605|FG000|Overall Study|Reside outside study area|1|||
23281822|NCT02316223|64772606|FG001|Overall Study|Reside outside study area|1|||
23281823|NCT02316223|64772607|FG002|Overall Study|Reside outside study area|1|||
23281824|NCT02316223|64772605|FG000|Overall Study|No asthma|2|||
23281825|NCT02316223|64772606|FG001|Overall Study|No asthma|0|||
23281826|NCT02316223|64772607|FG002|Overall Study|No asthma|0|||
23374110|NCT00701363|65115926|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
23281827|NCT02316223|64772605|FG000|Overall Study|Discontinued by PI|11|||
23281828|NCT02316223|64772606|FG001|Overall Study|Discontinued by PI|19|||
23281829|NCT02316223|64772607|FG002|Overall Study|Discontinued by PI|3|||
23281830|NCT03679598|64772608|FG000|Overall Study|Adverse Event|2|||
23281831|NCT03679598|64772609|FG001|Overall Study|Adverse Event|0|||
23281832|NCT04547192|64772617|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
23281833|NCT04547192|64772618|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
23281834|NCT04547192|64772619|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
23281835|NCT04547192|64772620|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
23374111|NCT00701363|65115927|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
23374112|NCT01294046|65115938|FG000|Overall Study|Infection and surgical explant|1|||
23374113|NCT01294046|65115938|FG000|Overall Study|Eligibility criteria expanded|1|||
23374114|NCT01294046|65115938|FG000|Overall Study|Stimulation response inadqequate|1|||
23374115|NCT04124965|65115939|FG000|Overall Study|Adverse event, non-fatal|3|||
23374116|NCT04124965|65115940|FG001|Overall Study|Adverse event, non-fatal|1|||
23281836|NCT04547192|64772617|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
23281837|NCT04547192|64772618|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
23281838|NCT04547192|64772619|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
23281839|NCT04547192|64772620|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
23281840|NCT04547192|64772617|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
23281841|NCT04547192|64772618|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
23281842|NCT04547192|64772619|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
23281843|NCT04547192|64772620|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
23281844|NCT04547192|64772617|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
23281845|NCT04547192|64772618|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
23281846|NCT04547192|64772619|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
23281847|NCT04547192|64772620|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
23281848|NCT04547192|64772617|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
23281849|NCT04547192|64772618|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
23281850|NCT04547192|64772619|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
23281851|NCT04547192|64772620|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
23281852|NCT00903877|64772624|FG000|Overall Study|Did not meet study criteria|33|||
23281853|NCT00903877|64772624|FG000|Overall Study|Withdrawal by Subject|3|||
23281854|NCT00903877|64772624|FG000|Overall Study|Adverse Event|2|||
23281855|NCT00903877|64772624|FG000|Overall Study|Lost to Follow-up|1|||
23281856|NCT00903877|64772624|FG000|Overall Study|Participation put on hold|4|||
23281857|NCT01983969|64772626|FG000|Overall Study|Disease Progression|0|||
23281858|NCT01983969|64772627|FG001|Overall Study|Disease Progression|1|||
23281859|NCT01983969|64772628|FG002|Overall Study|Disease Progression|0|||
23281860|NCT03049748|64776063|FG000|Overall Study|Lost to Follow-up|1|||
23281861|NCT03049748|64776064|FG001|Overall Study|Lost to Follow-up|0|||
23281862|NCT03049748|64776063|FG000|Overall Study|Death|3|||
23281863|NCT03049748|64776064|FG001|Overall Study|Death|0|||
23281864|NCT03049748|64776063|FG000|Overall Study|Withdrawal by Subject|0|||
23281865|NCT03049748|64776064|FG001|Overall Study|Withdrawal by Subject|3|||
23281866|NCT03049748|64776063|FG000|Overall Study|Protocol Violation|0|||
23281867|NCT03049748|64776064|FG001|Overall Study|Protocol Violation|2|||
23281868|NCT03049748|64776063|FG000|Overall Study|Moved out of state (relocation)|0|||
23281869|NCT03049748|64776064|FG001|Overall Study|Moved out of state (relocation)|1|||
23281870|NCT00665925|64776065|FG000|Overall Study|Lack of Efficacy|10|||
23281871|NCT00665925|64776066|FG001|Overall Study|Lack of Efficacy|8|||
23281872|NCT00665925|64776067|FG002|Overall Study|Lack of Efficacy|9|||
23281873|NCT00665925|64776068|FG003|Overall Study|Lack of Efficacy|8|||
23281874|NCT00665925|64776065|FG000|Overall Study|Lost to Follow-up|1|||
23281875|NCT00665925|64776066|FG001|Overall Study|Lost to Follow-up|2|||
23487618|NCT00736879|65530413|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
23487619|NCT00736879|65530414|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
23487620|NCT00736879|65530415|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
23487621|NCT00736879|65530412|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
23487622|NCT00736879|65530413|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
23487623|NCT00736879|65530414|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
23487624|NCT00736879|65530415|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
23487625|NCT00736879|65530412|FG000|Double Blind Treatment Period|No longer met criteria|0|||
23487626|NCT00736879|65530413|FG001|Double Blind Treatment Period|No longer met criteria|1|||
23487627|NCT00736879|65530414|FG002|Double Blind Treatment Period|No longer met criteria|0|||
23487628|NCT00736879|65530415|FG003|Double Blind Treatment Period|No longer met criteria|0|||
23603856|NCT00824408|65940192|FG002|Run-in Phase|Refused to continue medication|0|||
23603857|NCT00824408|65940193|FG003|Run-in Phase|Refused to continue medication|0|||
23603858|NCT00824408|65940194|FG004|Run-in Phase|Refused to continue medication|0|||
23603859|NCT00824408|65940190|FG000|Run-in Phase|Other reason not defined above|0|||
23603860|NCT00824408|65940191|FG001|Run-in Phase|Other reason not defined above|1|||
23603861|NCT00824408|65940192|FG002|Run-in Phase|Other reason not defined above|0|||
23603862|NCT00824408|65940193|FG003|Run-in Phase|Other reason not defined above|0|||
23603863|NCT00824408|65940194|FG004|Run-in Phase|Other reason not defined above|0|||
23603864|NCT00824408|65940190|FG000|Randomized Phase|Not treated|0|||
23281876|NCT00665925|64776067|FG002|Overall Study|Lost to Follow-up|2|||
23281877|NCT00665925|64776068|FG003|Overall Study|Lost to Follow-up|2|||
23281878|NCT00665925|64776065|FG000|Overall Study|Withdrawal by Subject|2|||
23281879|NCT00665925|64776066|FG001|Overall Study|Withdrawal by Subject|2|||
23281880|NCT00665925|64776067|FG002|Overall Study|Withdrawal by Subject|3|||
23281881|NCT00665925|64776068|FG003|Overall Study|Withdrawal by Subject|2|||
23281882|NCT00665925|64776065|FG000|Overall Study|Physician Decision|0|||
23281883|NCT00665925|64776066|FG001|Overall Study|Physician Decision|0|||
23281884|NCT00665925|64776067|FG002|Overall Study|Physician Decision|1|||
23281885|NCT00665925|64776068|FG003|Overall Study|Physician Decision|2|||
23487629|NCT00736879|65530412|FG000|Double Blind Treatment Period|non-specified|0|||
23603865|NCT00824408|65940191|FG001|Randomized Phase|Not treated|0|||
23487630|NCT00736879|65530413|FG001|Double Blind Treatment Period|non-specified|1|||
23487631|NCT00736879|65530414|FG002|Double Blind Treatment Period|non-specified|0|||
23487632|NCT00736879|65530415|FG003|Double Blind Treatment Period|non-specified|0|||
23487633|NCT00736879|65530412|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
23487634|NCT00736879|65530413|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
23487635|NCT00736879|65530414|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
23487636|NCT00736879|65530415|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
23487637|NCT00736879|65530412|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
23487638|NCT00736879|65530413|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
23487639|NCT00736879|65530414|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
23487640|NCT00736879|65530415|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
23487641|NCT00978432|65530416|FG000|Overall Study|Withdrawal by Subject|0|||
23487642|NCT00978432|65530417|FG001|Overall Study|Withdrawal by Subject|0|||
23487643|NCT00978432|65530418|FG002|Overall Study|Withdrawal by Subject|1|||
23487644|NCT00978432|65530416|FG000|Overall Study|Lack of Efficacy|1|||
23487645|NCT00978432|65530417|FG001|Overall Study|Lack of Efficacy|1|||
23487646|NCT00978432|65530418|FG002|Overall Study|Lack of Efficacy|3|||
23487647|NCT00978432|65530416|FG000|Overall Study|Adverse Event|2|||
23487648|NCT00978432|65530417|FG001|Overall Study|Adverse Event|0|||
23487649|NCT00978432|65530418|FG002|Overall Study|Adverse Event|1|||
23487650|NCT00471146|65530424|FG000|Overall Study|Adverse Event|32|||
23487651|NCT00471146|65530425|FG001|Overall Study|Adverse Event|33|||
23281886|NCT00665925|64776065|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
23281887|NCT00665925|64776066|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
23281888|NCT00665925|64776067|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
23281889|NCT00665925|64776068|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
23281890|NCT00665925|64776065|FG000|Overall Study|Adverse Event|1|||
23281891|NCT00665925|64776066|FG001|Overall Study|Adverse Event|5|||
23281892|NCT00665925|64776067|FG002|Overall Study|Adverse Event|10|||
23281893|NCT00665925|64776068|FG003|Overall Study|Adverse Event|5|||
23281894|NCT00665925|64776065|FG000|Overall Study|Enrolled by mistake|0|||
23281895|NCT00665925|64776066|FG001|Overall Study|Enrolled by mistake|0|||
23487652|NCT00471146|65530424|FG000|Overall Study|Withdrawal by Subject|14|||
23487653|NCT00471146|65530425|FG001|Overall Study|Withdrawal by Subject|11|||
23487654|NCT00471146|65530424|FG000|Overall Study|Death|11|||
23487655|NCT00471146|65530425|FG001|Overall Study|Death|12|||
23487656|NCT00471146|65530424|FG000|Overall Study|Lost to Follow-up|4|||
23487657|NCT00471146|65530425|FG001|Overall Study|Lost to Follow-up|2|||
23487658|NCT00471146|65530424|FG000|Overall Study|Protocol Violation|2|||
23487659|NCT00471146|65530425|FG001|Overall Study|Protocol Violation|2|||
23487660|NCT00471146|65530424|FG000|Overall Study|Objective progression or relapse|84|||
23487661|NCT00471146|65530425|FG001|Overall Study|Objective progression or relapse|87|||
23487662|NCT00471146|65530424|FG000|Overall Study|Global deterioration of health status|12|||
23487663|NCT00471146|65530425|FG001|Overall Study|Global deterioration of health status|14|||
23487664|NCT00471146|65530424|FG000|Overall Study|Randomized but not treated|9|||
23487665|NCT00471146|65530425|FG001|Overall Study|Randomized but not treated|8|||
23487666|NCT00471146|65530424|FG000|Overall Study|Other|4|||
23487667|NCT00471146|65530425|FG001|Overall Study|Other|5|||
23487668|NCT03416374|65530426|FG000|Between Treatment Period I and II|Other|0|||
23487669|NCT03416374|65530427|FG001|Between Treatment Period I and II|Other|9|||
23487670|NCT03416374|65530426|FG000|Treatment Period II|Lack of Efficacy|3|||
23487671|NCT03416374|65530427|FG001|Treatment Period II|Lack of Efficacy|11|||
23487672|NCT03416374|65530426|FG000|Treatment Period II|Adverse Event|1|||
23487673|NCT03416374|65530427|FG001|Treatment Period II|Adverse Event|4|||
23487674|NCT03416374|65530426|FG000|Treatment Period II|Death|0|||
23487675|NCT03416374|65530427|FG001|Treatment Period II|Death|1|||
23487676|NCT03416374|65530426|FG000|Treatment Period II|Other|0|||
23487677|NCT03416374|65530427|FG001|Treatment Period II|Other|2|||
23281896|NCT00665925|64776067|FG002|Overall Study|Enrolled by mistake|0|||
23281897|NCT00665925|64776068|FG003|Overall Study|Enrolled by mistake|1|||
23281898|NCT00665925|64776065|FG000|Overall Study|Due to exclusion criteria|1|||
23281899|NCT00665925|64776066|FG001|Overall Study|Due to exclusion criteria|0|||
23281900|NCT00665925|64776067|FG002|Overall Study|Due to exclusion criteria|0|||
23281901|NCT00665925|64776068|FG003|Overall Study|Due to exclusion criteria|0|||
23281902|NCT04723693|64776073|FG000|Overall Study|Withdrawal by Subject|2|||
23487678|NCT00923936|65530428|FG000|Overall Study|progressive disease on study|2|||
23487679|NCT00923936|65530429|FG001|Overall Study|progressive disease on study|1|||
23487680|NCT00923936|65530428|FG000|Overall Study|Adverse Event|2|||
23487681|NCT00923936|65530429|FG001|Overall Study|Adverse Event|1|||
23487682|NCT00923936|65530428|FG000|Overall Study|Lost to follow up|2|||
23487683|NCT00923936|65530429|FG001|Overall Study|Lost to follow up|0|||
23487684|NCT00923936|65530428|FG000|Overall Study|Continuing in follow up period|2|||
23487685|NCT00923936|65530429|FG001|Overall Study|Continuing in follow up period|1|||
23487686|NCT00932737|65530430|FG000|Overall Study|Not treated in second episode|1|||
23487687|NCT00932737|65530431|FG001|Overall Study|Not treated in second episode|0|||
23487688|NCT00932737|65530430|FG000|Overall Study|Adverse Event|0|||
23487689|NCT00932737|65530431|FG001|Overall Study|Adverse Event|1|||
23487690|NCT03538431|65530432|FG000|Overall Study|Physician Decision|0|||
23487691|NCT03538431|65530433|FG001|Overall Study|Physician Decision|1|||
23487692|NCT03538431|65530432|FG000|Overall Study|Withdrawal by Subject|1|||
23487693|NCT03538431|65530433|FG001|Overall Study|Withdrawal by Subject|0|||
23487694|NCT03161093|65530434|FG000|Overall Study|Protocol Violation|11|||
23487695|NCT03161093|65530435|FG001|Overall Study|Protocol Violation|14|||
23487696|NCT03161093|65530436|FG002|Overall Study|Protocol Violation|6|||
23487697|NCT03161093|65530437|FG003|Overall Study|Protocol Violation|13|||
23487698|NCT03161093|65530438|FG004|Overall Study|Protocol Violation|1|||
23487699|NCT03161093|65530439|FG005|Overall Study|Protocol Violation|0|||
23487700|NCT03161093|65530434|FG000|Overall Study|Adverse Event|5|||
23487701|NCT03161093|65530435|FG001|Overall Study|Adverse Event|21|||
23487702|NCT03161093|65530436|FG002|Overall Study|Adverse Event|16|||
23487703|NCT03161093|65530437|FG003|Overall Study|Adverse Event|35|||
23487704|NCT03161093|65530438|FG004|Overall Study|Adverse Event|2|||
23487705|NCT03161093|65530439|FG005|Overall Study|Adverse Event|1|||
23487706|NCT03161093|65530434|FG000|Overall Study|Lack of Efficacy|9|||
23487707|NCT03161093|65530435|FG001|Overall Study|Lack of Efficacy|13|||
23487708|NCT03161093|65530436|FG002|Overall Study|Lack of Efficacy|9|||
23487709|NCT03161093|65530437|FG003|Overall Study|Lack of Efficacy|24|||
23487710|NCT03161093|65530438|FG004|Overall Study|Lack of Efficacy|4|||
23487711|NCT03161093|65530439|FG005|Overall Study|Lack of Efficacy|1|||
23487712|NCT03161093|65530434|FG000|Overall Study|Physician Decision|0|||
23487713|NCT03161093|65530435|FG001|Overall Study|Physician Decision|1|||
23487714|NCT03161093|65530436|FG002|Overall Study|Physician Decision|0|||
23487715|NCT03161093|65530437|FG003|Overall Study|Physician Decision|2|||
23487716|NCT03161093|65530438|FG004|Overall Study|Physician Decision|17|||
23487717|NCT03161093|65530439|FG005|Overall Study|Physician Decision|15|||
23487718|NCT03161093|65530434|FG000|Overall Study|Withdrawal by Subject|24|||
23487719|NCT03161093|65530435|FG001|Overall Study|Withdrawal by Subject|73|||
23487720|NCT03161093|65530436|FG002|Overall Study|Withdrawal by Subject|44|||
23487721|NCT03161093|65530437|FG003|Overall Study|Withdrawal by Subject|97|||
23487722|NCT03161093|65530438|FG004|Overall Study|Withdrawal by Subject|11|||
23487723|NCT03161093|65530439|FG005|Overall Study|Withdrawal by Subject|10|||
23487724|NCT03161093|65530434|FG000|Overall Study|Lost to Follow-up|3|||
23281903|NCT03808376|64776074|FG000|Overall Study|Withdrawal by Subject|10|||
23281904|NCT00835705|64776077|FG000|First Intervention|Difficulty with vein|1|||
23281905|NCT00835705|64776078|FG001|First Intervention|Difficulty with vein|0|||
23281906|NCT00835705|64776077|FG000|Second Intervention|Difficulty with vein|1|||
23281907|NCT00835705|64776078|FG001|Second Intervention|Difficulty with vein|0|||
23487725|NCT03161093|65530435|FG001|Overall Study|Lost to Follow-up|12|||
23487726|NCT03161093|65530436|FG002|Overall Study|Lost to Follow-up|4|||
23487727|NCT03161093|65530437|FG003|Overall Study|Lost to Follow-up|7|||
23487728|NCT03161093|65530438|FG004|Overall Study|Lost to Follow-up|8|||
23487729|NCT03161093|65530439|FG005|Overall Study|Lost to Follow-up|13|||
23487730|NCT03161093|65530434|FG000|Overall Study|Death|3|||
23487731|NCT03161093|65530435|FG001|Overall Study|Death|9|||
23487732|NCT03161093|65530436|FG002|Overall Study|Death|7|||
23487733|NCT03161093|65530437|FG003|Overall Study|Death|9|||
23487734|NCT03161093|65530438|FG004|Overall Study|Death|0|||
23487735|NCT03161093|65530439|FG005|Overall Study|Death|0|||
23487736|NCT03161093|65530434|FG000|Overall Study|Unknown - Not reported|0|||
23487737|NCT03161093|65530435|FG001|Overall Study|Unknown - Not reported|1|||
23487738|NCT03161093|65530436|FG002|Overall Study|Unknown - Not reported|0|||
23487739|NCT03161093|65530437|FG003|Overall Study|Unknown - Not reported|0|||
23487740|NCT03161093|65530438|FG004|Overall Study|Unknown - Not reported|0|||
23487741|NCT03161093|65530439|FG005|Overall Study|Unknown - Not reported|1|||
23487742|NCT01439568|65530440|FG000|Overall Study|Lost to Follow-up|1|||
23487743|NCT01439568|65530441|FG001|Overall Study|Lost to Follow-up|0|||
23487744|NCT01439568|65530440|FG000|Overall Study|Withdrawal by Subject|2|||
23281908|NCT03214588|64776088|FG000|Overall Study|Adverse Event|1|||
23281909|NCT03214588|64776089|FG001|Overall Study|Adverse Event|0|||
23281910|NCT03214588|64776090|FG002|Overall Study|Adverse Event|2|||
23487745|NCT01439568|65530441|FG001|Overall Study|Withdrawal by Subject|2|||
23487746|NCT00704808|65530442|FG000|Overall Study|Discontinued prior to starting treatment|14|||
23487747|NCT00704808|65530442|FG000|Overall Study|Death|7|||
23487748|NCT00704808|65530442|FG000|Overall Study|Tumor progression|80|||
23487749|NCT00704808|65530442|FG000|Overall Study|Patient's decision|11|||
23487750|NCT00704808|65530442|FG000|Overall Study|Early therapy discontinuation|16|||
23487751|NCT00704808|65530442|FG000|Overall Study|Adverse Event|1|||
23487752|NCT00704808|65530442|FG000|Overall Study|Lost to Follow-up|1|||
23487753|NCT00704808|65530442|FG000|Overall Study|Treatment change|1|||
23487754|NCT00764504|65530446|FG000|Overall Study|Death|12|||
23487755|NCT00764504|65530447|FG001|Overall Study|Death|6|||
23281911|NCT03214588|64776088|FG000|Overall Study|Reason Not Specified|0|||
23487756|NCT00764504|65530448|FG002|Overall Study|Death|13|||
23487757|NCT00764504|65530446|FG000|Overall Study|Revision of Device|12|||
23487758|NCT00764504|65530447|FG001|Overall Study|Revision of Device|23|||
23487759|NCT00764504|65530448|FG002|Overall Study|Revision of Device|14|||
23487760|NCT00764504|65530446|FG000|Overall Study|Physician Decision|1|||
23487761|NCT00764504|65530447|FG001|Overall Study|Physician Decision|0|||
23487762|NCT00764504|65530448|FG002|Overall Study|Physician Decision|0|||
23487763|NCT00764504|65530446|FG000|Overall Study|Withdrawal by Subject|1|||
23487764|NCT00764504|65530447|FG001|Overall Study|Withdrawal by Subject|7|||
23487765|NCT00764504|65530448|FG002|Overall Study|Withdrawal by Subject|4|||
23487766|NCT00764504|65530446|FG000|Overall Study|Lost to Follow-up|40|||
23487767|NCT00764504|65530447|FG001|Overall Study|Lost to Follow-up|34|||
23487768|NCT00764504|65530448|FG002|Overall Study|Lost to Follow-up|72|||
23487769|NCT04072575|65530453|FG000|Overall Study|Physician Decision|1|||
23487770|NCT04072575|65530453|FG000|Overall Study|Adverse Event|7|||
23487771|NCT04072575|65530453|FG000|Overall Study|Withdrawal by Subject|14|||
23487772|NCT04072575|65530453|FG000|Overall Study|Other|2|||
23487773|NCT01483690|65530454|FG000|Overall Study|Adverse Event|1|||
23487774|NCT01483690|65530455|FG001|Overall Study|Adverse Event|2|||
23487775|NCT01483690|65530454|FG000|Overall Study|clinical deterioration|1|||
23487776|NCT01483690|65530455|FG001|Overall Study|clinical deterioration|0|||
23487777|NCT01483690|65530454|FG000|Overall Study|Physician Decision|0|||
23487778|NCT01483690|65530455|FG001|Overall Study|Physician Decision|2|||
23487779|NCT01483690|65530454|FG000|Overall Study|exclusionary procedure|0|||
23487780|NCT01483690|65530455|FG001|Overall Study|exclusionary procedure|1|||
23487781|NCT00423670|65530459|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
23487782|NCT00423670|65530460|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487783|NCT00423670|65530461|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487784|NCT00423670|65530462|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487785|NCT00423670|65530463|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487786|NCT00423670|65530464|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487787|NCT00423670|65530465|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487788|NCT00423670|65530466|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
23487789|NCT00423670|65530459|FG000|Treatment Period|Adverse Event|8|||
23487790|NCT00423670|65530460|FG001|Treatment Period|Adverse Event|12|||
23487791|NCT00423670|65530461|FG002|Treatment Period|Adverse Event|15|||
23487792|NCT00423670|65530462|FG003|Treatment Period|Adverse Event|20|||
23487793|NCT00423670|65530463|FG004|Treatment Period|Adverse Event|9|||
23487794|NCT00423670|65530464|FG005|Treatment Period|Adverse Event|4|||
23487795|NCT00423670|65530465|FG006|Treatment Period|Adverse Event|7|||
23487796|NCT00423670|65530466|FG007|Treatment Period|Adverse Event|2|||
23487797|NCT00423670|65530459|FG000|Treatment Period|Protocol-defined clinical event|0|||
23487798|NCT00423670|65530460|FG001|Treatment Period|Protocol-defined clinical event|7|||
23487799|NCT00423670|65530461|FG002|Treatment Period|Protocol-defined clinical event|4|||
23487800|NCT00423670|65530462|FG003|Treatment Period|Protocol-defined clinical event|12|||
23487801|NCT00423670|65530463|FG004|Treatment Period|Protocol-defined clinical event|5|||
23487802|NCT00423670|65530464|FG005|Treatment Period|Protocol-defined clinical event|4|||
23487803|NCT00423670|65530465|FG006|Treatment Period|Protocol-defined clinical event|16|||
23487804|NCT00423670|65530466|FG007|Treatment Period|Protocol-defined clinical event|15|||
23487805|NCT00423670|65530459|FG000|Treatment Period|Lost to Follow-up|2|||
23487806|NCT00423670|65530460|FG001|Treatment Period|Lost to Follow-up|1|||
23487807|NCT00423670|65530461|FG002|Treatment Period|Lost to Follow-up|3|||
23487808|NCT00423670|65530462|FG003|Treatment Period|Lost to Follow-up|1|||
23487809|NCT00423670|65530463|FG004|Treatment Period|Lost to Follow-up|6|||
23487810|NCT00423670|65530464|FG005|Treatment Period|Lost to Follow-up|0|||
23487811|NCT00423670|65530465|FG006|Treatment Period|Lost to Follow-up|3|||
23487812|NCT00423670|65530466|FG007|Treatment Period|Lost to Follow-up|1|||
23487813|NCT00423670|65530459|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
23487814|NCT00423670|65530460|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
23487815|NCT00423670|65530461|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
23487816|NCT00423670|65530462|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
23487817|NCT00423670|65530463|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
23487818|NCT00423670|65530464|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
23603866|NCT00824408|65940192|FG002|Randomized Phase|Not treated|1|||
23603867|NCT00824408|65940193|FG003|Randomized Phase|Not treated|1|||
23603868|NCT00824408|65940194|FG004|Randomized Phase|Not treated|1|||
23281912|NCT03214588|64776089|FG001|Overall Study|Reason Not Specified|1|||
23487819|NCT00423670|65530465|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
23487820|NCT00423670|65530466|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
23487821|NCT00423670|65530459|FG000|Treatment Period|Investigator decision|0|||
23487822|NCT00423670|65530460|FG001|Treatment Period|Investigator decision|0|||
23487823|NCT00423670|65530461|FG002|Treatment Period|Investigator decision|0|||
23487824|NCT00423670|65530462|FG003|Treatment Period|Investigator decision|0|||
23487825|NCT00423670|65530463|FG004|Treatment Period|Investigator decision|0|||
23487826|NCT00423670|65530464|FG005|Treatment Period|Investigator decision|0|||
23487827|NCT00423670|65530465|FG006|Treatment Period|Investigator decision|0|||
23487828|NCT00423670|65530466|FG007|Treatment Period|Investigator decision|1|||
23603869|NCT00824408|65940190|FG000|Randomized Phase|Progressive disease|0|||
23487829|NCT00423670|65530459|FG000|Treatment Period|Non-compliance with protocol|3|||
23487830|NCT00423670|65530460|FG001|Treatment Period|Non-compliance with protocol|1|||
23487831|NCT00423670|65530461|FG002|Treatment Period|Non-compliance with protocol|1|||
23487832|NCT00423670|65530462|FG003|Treatment Period|Non-compliance with protocol|3|||
23487833|NCT00423670|65530463|FG004|Treatment Period|Non-compliance with protocol|2|||
23487834|NCT00423670|65530464|FG005|Treatment Period|Non-compliance with protocol|0|||
23487835|NCT00423670|65530465|FG006|Treatment Period|Non-compliance with protocol|2|||
23487836|NCT00423670|65530466|FG007|Treatment Period|Non-compliance with protocol|2|||
23603870|NCT00824408|65940191|FG001|Randomized Phase|Progressive disease|0|||
23603871|NCT00824408|65940192|FG002|Randomized Phase|Progressive disease|25|||
23374117|NCT04124965|65115939|FG000|Overall Study|Withdrawal by Subject|1|||
23374118|NCT04124965|65115940|FG001|Overall Study|Withdrawal by Subject|1|||
23374119|NCT04124965|65115939|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
23374120|NCT04124965|65115940|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
23374121|NCT04124965|65115939|FG000|Overall Study|Pregnancy|1|||
23374122|NCT04124965|65115940|FG001|Overall Study|Pregnancy|0|||
23374123|NCT04124965|65115939|FG000|Overall Study|Sponsor and participant decision|0|||
23374124|NCT04124965|65115940|FG001|Overall Study|Sponsor and participant decision|1|||
23374125|NCT04124965|65115939|FG000|Overall Study|Personal surgery|0|||
23374126|NCT04124965|65115940|FG001|Overall Study|Personal surgery|1|||
23374127|NCT04124965|65115939|FG000|Overall Study|Physician Decision|0|||
23374128|NCT04124965|65115940|FG001|Overall Study|Physician Decision|1|||
23374129|NCT01218802|65115943|FG000|Overall Study|Lost to Follow-up|5|||
23374130|NCT01218802|65115944|FG001|Overall Study|Lost to Follow-up|6|||
23374131|NCT01218802|65115943|FG000|Overall Study|Withdrawal by Subject|3|||
23374132|NCT01218802|65115944|FG001|Overall Study|Withdrawal by Subject|10|||
23374133|NCT01218802|65115943|FG000|Overall Study|Adverse Event|0|||
23374134|NCT01218802|65115944|FG001|Overall Study|Adverse Event|2|||
23374135|NCT01218802|65115943|FG000|Overall Study|Incarcerated|2|||
23374136|NCT01218802|65115944|FG001|Overall Study|Incarcerated|0|||
23374137|NCT01206764|65115945|FG000|Overall Study|Adverse Event|20|||
23374138|NCT01206764|65115945|FG000|Overall Study|Abnormal laboratory value|2|||
23374139|NCT01206764|65115945|FG000|Overall Study|Abnormal test procedure result|1|||
23374140|NCT01206764|65115945|FG000|Overall Study|Patient withdrew consent|5|||
23374141|NCT01206764|65115945|FG000|Overall Study|Lost to Follow-up|6|||
23374142|NCT01206764|65115945|FG000|Overall Study|Death|11|||
23374143|NCT01206764|65115945|FG000|Overall Study|New cancer therapy|2|||
23374144|NCT01206764|65115945|FG000|Overall Study|Disease progression|88|||
23374145|NCT01206764|65115945|FG000|Overall Study|Protocol deviation|3|||
23374146|NCT01140906|65115947|FG000|Overall Study|Adverse Event|7|||
23374147|NCT01140906|65115948|FG001|Overall Study|Adverse Event|10|||
23374148|NCT01140906|65115949|FG002|Overall Study|Adverse Event|17|||
23374149|NCT01140906|65115950|FG003|Overall Study|Adverse Event|7|||
23374150|NCT01140906|65115947|FG000|Overall Study|Lack of Efficacy|6|||
23374151|NCT01140906|65115948|FG001|Overall Study|Lack of Efficacy|8|||
23374152|NCT01140906|65115949|FG002|Overall Study|Lack of Efficacy|2|||
23374153|NCT01140906|65115950|FG003|Overall Study|Lack of Efficacy|1|||
23374154|NCT01140906|65115947|FG000|Overall Study|Non-compliance|0|||
23374155|NCT01140906|65115948|FG001|Overall Study|Non-compliance|1|||
23374156|NCT01140906|65115949|FG002|Overall Study|Non-compliance|0|||
23374157|NCT01140906|65115950|FG003|Overall Study|Non-compliance|1|||
23374158|NCT01140906|65115947|FG000|Overall Study|Protocol Violation|5|||
23374159|NCT01140906|65115948|FG001|Overall Study|Protocol Violation|3|||
23374160|NCT01140906|65115949|FG002|Overall Study|Protocol Violation|2|||
23374161|NCT01140906|65115950|FG003|Overall Study|Protocol Violation|1|||
23374162|NCT01140906|65115947|FG000|Overall Study|Withdrawal of consent|6|||
23374163|NCT01140906|65115948|FG001|Overall Study|Withdrawal of consent|6|||
23374164|NCT01140906|65115949|FG002|Overall Study|Withdrawal of consent|2|||
23374165|NCT01140906|65115950|FG003|Overall Study|Withdrawal of consent|2|||
23374166|NCT01140906|65115947|FG000|Overall Study|Lost to Follow-up|1|||
23374167|NCT01140906|65115948|FG001|Overall Study|Lost to Follow-up|1|||
23487837|NCT00423670|65530459|FG000|Follow-up Period|Lost to Follow-up|0|||
23487838|NCT00423670|65530460|FG001|Follow-up Period|Lost to Follow-up|12|||
23487839|NCT00423670|65530461|FG002|Follow-up Period|Lost to Follow-up|8|||
23487840|NCT00423670|65530462|FG003|Follow-up Period|Lost to Follow-up|3|||
23374168|NCT01140906|65115949|FG002|Overall Study|Lost to Follow-up|0|||
23374169|NCT01140906|65115950|FG003|Overall Study|Lost to Follow-up|2|||
23374170|NCT01140906|65115947|FG000|Overall Study|Administrative or other reason|0|||
23374171|NCT01140906|65115948|FG001|Overall Study|Administrative or other reason|5|||
23374172|NCT01140906|65115949|FG002|Overall Study|Administrative or other reason|3|||
23374173|NCT01140906|65115950|FG003|Overall Study|Administrative or other reason|2|||
23374174|NCT00076570|65115951|FG000|Overall Study|Drug intolerance|8|||
23374175|NCT00076570|65115952|FG001|Overall Study|Drug intolerance|8|||
23374176|NCT02834975|65115953|FG000|Overall Study|Physician Decision|2|||
23374177|NCT02834975|65115953|FG000|Overall Study|Adverse Event|1|||
23374178|NCT02834975|65115953|FG000|Overall Study|Withdrawal by Subject|1|||
23374179|NCT02834975|65115953|FG000|Overall Study|Lack of Efficacy|1|||
23487841|NCT00423670|65530463|FG004|Follow-up Period|Lost to Follow-up|1|||
23487842|NCT00423670|65530464|FG005|Follow-up Period|Lost to Follow-up|0|||
23487843|NCT00423670|65530465|FG006|Follow-up Period|Lost to Follow-up|5|||
23487844|NCT00423670|65530466|FG007|Follow-up Period|Lost to Follow-up|0|||
23487845|NCT00423670|65530459|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487846|NCT00423670|65530460|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
23487847|NCT00423670|65530461|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
23487848|NCT00423670|65530462|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487849|NCT00423670|65530463|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487850|NCT00423670|65530464|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
23487851|NCT00423670|65530465|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487852|NCT00423670|65530466|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
23487853|NCT00423670|65530459|FG000|Follow-up Period|Non-compliance with protocol|2|||
23487854|NCT00423670|65530460|FG001|Follow-up Period|Non-compliance with protocol|0|||
23487855|NCT00423670|65530461|FG002|Follow-up Period|Non-compliance with protocol|1|||
23487856|NCT00423670|65530462|FG003|Follow-up Period|Non-compliance with protocol|1|||
23487857|NCT00423670|65530463|FG004|Follow-up Period|Non-compliance with protocol|0|||
23487858|NCT00423670|65530464|FG005|Follow-up Period|Non-compliance with protocol|0|||
23487859|NCT00423670|65530465|FG006|Follow-up Period|Non-compliance with protocol|3|||
23487860|NCT00423670|65530466|FG007|Follow-up Period|Non-compliance with protocol|2|||
23487861|NCT01070043|65530469|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
23487862|NCT01070043|65530470|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
23487863|NCT01070043|65530471|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
23487864|NCT01070043|65530469|FG000|Double-Blind Treatment|Adverse Event|0|||
23487865|NCT01070043|65530470|FG001|Double-Blind Treatment|Adverse Event|0|||
23487866|NCT01070043|65530471|FG002|Double-Blind Treatment|Adverse Event|2|||
23487867|NCT00737464|65530472|FG000|Overall Study|Adverse Event|1|||
23487868|NCT00737464|65530472|FG000|Overall Study|Death|6|||
23487869|NCT00737464|65530472|FG000|Overall Study|Other - Failure to Return|1|||
23487870|NCT00737464|65530472|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
23603872|NCT00824408|65940193|FG003|Randomized Phase|Progressive disease|36|||
23603873|NCT00824408|65940194|FG004|Randomized Phase|Progressive disease|34|||
23603874|NCT00824408|65940190|FG000|Randomized Phase|Adverse Event|0|||
23603875|NCT00824408|65940191|FG001|Randomized Phase|Adverse Event|0|||
23603876|NCT00824408|65940192|FG002|Randomized Phase|Adverse Event|4|||
23603877|NCT00824408|65940193|FG003|Randomized Phase|Adverse Event|5|||
23603878|NCT00824408|65940194|FG004|Randomized Phase|Adverse Event|5|||
23603879|NCT00824408|65940190|FG000|Randomized Phase|Refused to continue medication|0|||
23603880|NCT00824408|65940191|FG001|Randomized Phase|Refused to continue medication|0|||
23603881|NCT00824408|65940192|FG002|Randomized Phase|Refused to continue medication|2|||
23281913|NCT03214588|64776090|FG002|Overall Study|Reason Not Specified|0|||
23281914|NCT00191815|64776091|FG000|Overall Study|Adverse Event|2|||
23281915|NCT00191815|64776091|FG000|Overall Study|Disease progression or relapse|24|||
23487871|NCT00737464|65530472|FG000|Overall Study|Other reasons|4|||
23603882|NCT00824408|65940193|FG003|Randomized Phase|Refused to continue medication|2|||
23603883|NCT00824408|65940194|FG004|Randomized Phase|Refused to continue medication|2|||
23603884|NCT00824408|65940190|FG000|Randomized Phase|Other reason not defined above|0|||
23603885|NCT00824408|65940191|FG001|Randomized Phase|Other reason not defined above|0|||
23603886|NCT00824408|65940192|FG002|Randomized Phase|Other reason not defined above|4|||
23603887|NCT00824408|65940193|FG003|Randomized Phase|Other reason not defined above|2|||
23603888|NCT00824408|65940194|FG004|Randomized Phase|Other reason not defined above|4|||
23603889|NCT02384382|65940195|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
23603890|NCT02384382|65940195|FG000|Overall Study|Death|1|||
23603891|NCT02384382|65940195|FG000|Overall Study|Adverse Event|1|||
23603892|NCT02384382|65940195|FG000|Overall Study|Disease progression|16|||
23603893|NCT00655824|65940196|FG000|Overall Study|Adverse Event|3|||
23603894|NCT00655824|65940196|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
23603895|NCT00655824|65940196|FG000|Overall Study|Protocol Violation|1|||
23603896|NCT00655824|65940196|FG000|Overall Study|Withdrawal by Subject|4|||
23603897|NCT00655824|65940196|FG000|Overall Study|Deterioration of Trial Disease|2|||
23603898|NCT02000752|65940197|FG000|Overall Study|Dystocic delivery|19|||
23603899|NCT02000752|65940198|FG001|Overall Study|Dystocic delivery|8|||
23603900|NCT02000752|65940197|FG000|Overall Study|Shift Changes|12|||
23487872|NCT02713204|65530473|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
23487873|NCT02713204|65530474|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487874|NCT02713204|65530475|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
23487875|NCT02713204|65530476|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23603901|NCT02000752|65940198|FG001|Overall Study|Shift Changes|5|||
23603902|NCT02542943|65940205|FG000|Overall Study|Lost to Follow-up|1|||
23603903|NCT02542943|65940206|FG001|Overall Study|Lost to Follow-up|0|||
23603904|NCT02542943|65940207|FG002|Overall Study|Lost to Follow-up|0|||
23603905|NCT02542943|65940205|FG000|Overall Study|Withdrawal by Subject|0|||
23603906|NCT02542943|65940206|FG001|Overall Study|Withdrawal by Subject|1|||
23487876|NCT02713204|65530477|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487877|NCT02713204|65530478|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487878|NCT02713204|65530479|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487879|NCT02713204|65530480|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
23487880|NCT02713204|65530473|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487881|NCT02713204|65530474|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487882|NCT02713204|65530475|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
23487883|NCT02713204|65530476|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487884|NCT02713204|65530477|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487885|NCT02713204|65530478|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487886|NCT02713204|65530479|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487887|NCT02713204|65530480|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
23487888|NCT02713204|65530473|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23281916|NCT00191815|64776091|FG000|Overall Study|Death|2|||
23281917|NCT00191815|64776091|FG000|Overall Study|Protocol Violation|3|||
23487889|NCT02713204|65530474|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
23487890|NCT02713204|65530475|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487891|NCT02713204|65530476|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487892|NCT02713204|65530477|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487893|NCT02713204|65530478|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487894|NCT02713204|65530479|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487895|NCT02713204|65530480|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
23487896|NCT02713204|65530473|FG000|From Week 12 up to Week 36|Adverse Event|1|||
23487897|NCT02713204|65530474|FG001|From Week 12 up to Week 36|Adverse Event|0|||
23487898|NCT02713204|65530475|FG002|From Week 12 up to Week 36|Adverse Event|0|||
23487899|NCT02713204|65530476|FG003|From Week 12 up to Week 36|Adverse Event|1|||
23487900|NCT02713204|65530477|FG004|From Week 12 up to Week 36|Adverse Event|1|||
23487901|NCT02713204|65530478|FG005|From Week 12 up to Week 36|Adverse Event|0|||
23487902|NCT02713204|65530479|FG006|From Week 12 up to Week 36|Adverse Event|2|||
23487903|NCT02713204|65530480|FG007|From Week 12 up to Week 36|Adverse Event|1|||
23487904|NCT02713204|65530473|FG000|From Week 12 up to Week 36|Death|0|||
23487905|NCT02713204|65530474|FG001|From Week 12 up to Week 36|Death|0|||
23487906|NCT02713204|65530475|FG002|From Week 12 up to Week 36|Death|0|||
23487907|NCT02713204|65530476|FG003|From Week 12 up to Week 36|Death|1|||
23487908|NCT02713204|65530477|FG004|From Week 12 up to Week 36|Death|0|||
23374180|NCT00634504|65115956|FG000|Overall Study|Protocol Violation|1|||
23374181|NCT00634504|65115957|FG001|Overall Study|Protocol Violation|0|||
23374182|NCT05259917|65115958|FG000|Overall Study|Protocol Violation|0|||
23374183|NCT05259917|65115959|FG001|Overall Study|Protocol Violation|0|||
23374184|NCT05259917|65115960|FG002|Overall Study|Protocol Violation|1|||
23374185|NCT05259917|65115961|FG003|Overall Study|Protocol Violation|0|||
23374186|NCT05259917|65115962|FG004|Overall Study|Protocol Violation|0|||
23374187|NCT05259917|65115963|FG005|Overall Study|Protocol Violation|0|||
23374188|NCT05259917|65115958|FG000|Overall Study|Lost to Follow-up|0|||
23374189|NCT05259917|65115959|FG001|Overall Study|Lost to Follow-up|0|||
23374190|NCT05259917|65115960|FG002|Overall Study|Lost to Follow-up|1|||
23374191|NCT05259917|65115961|FG003|Overall Study|Lost to Follow-up|0|||
23487909|NCT02713204|65530478|FG005|From Week 12 up to Week 36|Death|1|||
23487910|NCT02713204|65530479|FG006|From Week 12 up to Week 36|Death|0|||
23603907|NCT02542943|65940207|FG002|Overall Study|Withdrawal by Subject|0|||
23603908|NCT00047385|65940208|FG000|Overall Study|Death before any screening|2|||
23603909|NCT00047385|65940209|FG001|Overall Study|Death before any screening|5|||
23603910|NCT00047385|65940208|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
23603911|NCT00047385|65940209|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
23374192|NCT05259917|65115962|FG004|Overall Study|Lost to Follow-up|0|||
23374193|NCT05259917|65115963|FG005|Overall Study|Lost to Follow-up|1|||
23374194|NCT05259917|65115958|FG000|Overall Study|Physician Decision|0|||
23374195|NCT05259917|65115959|FG001|Overall Study|Physician Decision|1|||
23487911|NCT02713204|65530480|FG007|From Week 12 up to Week 36|Death|3|||
23487912|NCT02713204|65530473|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487913|NCT02713204|65530474|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487914|NCT02713204|65530475|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487915|NCT02713204|65530476|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
23487916|NCT02713204|65530477|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487917|NCT02713204|65530478|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487918|NCT02713204|65530479|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487919|NCT02713204|65530480|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
23487920|NCT02713204|65530473|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
23487921|NCT02713204|65530474|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
23487922|NCT02713204|65530475|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
23487923|NCT02713204|65530476|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
23281918|NCT00191815|64776091|FG000|Overall Study|Physician Decision|2|||
23281919|NCT00191815|64776091|FG000|Overall Study|Withdrawal by Subject|7|||
23281920|NCT04025021|64776092|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
23281921|NCT04025021|64776093|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
23281922|NCT03480763|64776094|FG000|Overall Study|Withdrawal by Subject|18|||
23281923|NCT03480763|64776095|FG001|Overall Study|Withdrawal by Subject|10|||
23281924|NCT03480763|64776094|FG000|Overall Study|Lost to Follow-up|4|||
23281925|NCT03480763|64776095|FG001|Overall Study|Lost to Follow-up|7|||
23281926|NCT03480763|64776094|FG000|Overall Study|non-study pneumococcal vaccine|1|||
23281927|NCT03480763|64776095|FG001|Overall Study|non-study pneumococcal vaccine|0|||
23281928|NCT03480763|64776094|FG000|Overall Study|oncological treatment|0|||
23281929|NCT03480763|64776095|FG001|Overall Study|oncological treatment|2|||
23281930|NCT03480763|64776094|FG000|Overall Study|pain with vaccination|1|||
23281931|NCT03480763|64776095|FG001|Overall Study|pain with vaccination|0|||
23281932|NCT03789110|64776096|FG000|Overall Study|Adverse Event|2|||
23281933|NCT03789110|64776096|FG000|Overall Study|Physician Decision|1|||
23281934|NCT03789110|64776096|FG000|Overall Study|Withdrawal by Subject|2|||
23281935|NCT03789110|64776096|FG000|Overall Study|Lack of Efficacy|22|||
23281936|NCT03789110|64776096|FG000|Overall Study|still on treatment|3|||
23281937|NCT02635750|64776112|FG000|Part 1, Period 2|Adverse Event|1|||
23281938|NCT02635750|64776113|FG001|Part 1, Period 2|Adverse Event|0|||
23281939|NCT02635750|64776114|FG002|Part 1, Period 2|Adverse Event|0|||
23281940|NCT03599193|64776117|FG000|Overall Study|Adverse Event|0|||
23281941|NCT03599193|64776118|FG001|Overall Study|Adverse Event|2|||
23281942|NCT03599193|64776117|FG000|Overall Study|Withdrawal by Subject|1|||
23281943|NCT03599193|64776118|FG001|Overall Study|Withdrawal by Subject|0|||
23374196|NCT05259917|65115960|FG002|Overall Study|Physician Decision|0|||
23487924|NCT02713204|65530477|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
23603912|NCT00047385|65940208|FG000|Overall Study|Eligible for screening but had no screen|260|||
23281944|NCT03599193|64776117|FG000|Overall Study|Protocol Violation|1|||
23281945|NCT03599193|64776118|FG001|Overall Study|Protocol Violation|0|||
23281946|NCT03599193|64776117|FG000|Overall Study|Lost to Follow-up|0|||
23281947|NCT03599193|64776118|FG001|Overall Study|Lost to Follow-up|1|||
23374197|NCT05259917|65115961|FG003|Overall Study|Physician Decision|0|||
23281948|NCT01906372|64776120|FG000|Overall Study|Withdrawal by Subject|2|||
23281949|NCT00418938|64776121|FG000|Overall Study|Reimbursement|1|||
23281950|NCT00418938|64776122|FG001|Overall Study|Reimbursement|0|||
23281951|NCT00418938|64776121|FG000|Overall Study|Administrative decision|3|||
23281952|NCT00418938|64776122|FG001|Overall Study|Administrative decision|3|||
23281953|NCT00418938|64776121|FG000|Overall Study|Withdrawal by Subject|16|||
23281954|NCT00418938|64776122|FG001|Overall Study|Withdrawal by Subject|15|||
23281955|NCT00418938|64776121|FG000|Overall Study|Lost to Follow-up|1|||
23374198|NCT05259917|65115962|FG004|Overall Study|Physician Decision|0|||
23374199|NCT05259917|65115963|FG005|Overall Study|Physician Decision|0|||
23374200|NCT05259917|65115958|FG000|Overall Study|Withdrawal by Subject|0|||
23374201|NCT05259917|65115959|FG001|Overall Study|Withdrawal by Subject|1|||
23487925|NCT02713204|65530478|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
23374202|NCT05259917|65115960|FG002|Overall Study|Withdrawal by Subject|0|||
23374203|NCT05259917|65115961|FG003|Overall Study|Withdrawal by Subject|0|||
23374204|NCT05259917|65115962|FG004|Overall Study|Withdrawal by Subject|1|||
23374205|NCT05259917|65115963|FG005|Overall Study|Withdrawal by Subject|1|||
23374206|NCT05259917|65115958|FG000|Overall Study|Trial Termination by Sponsor|7|||
23374207|NCT05259917|65115959|FG001|Overall Study|Trial Termination by Sponsor|2|||
23374208|NCT05259917|65115960|FG002|Overall Study|Trial Termination by Sponsor|3|||
23374209|NCT05259917|65115961|FG003|Overall Study|Trial Termination by Sponsor|5|||
23374210|NCT05259917|65115962|FG004|Overall Study|Trial Termination by Sponsor|11|||
23374211|NCT05259917|65115963|FG005|Overall Study|Trial Termination by Sponsor|4|||
23374212|NCT05259917|65115958|FG000|Overall Study|Other|1|||
23374213|NCT05259917|65115959|FG001|Overall Study|Other|0|||
23374214|NCT05259917|65115960|FG002|Overall Study|Other|2|||
23374215|NCT05259917|65115961|FG003|Overall Study|Other|0|||
23374216|NCT05259917|65115962|FG004|Overall Study|Other|0|||
23374217|NCT05259917|65115963|FG005|Overall Study|Other|0|||
23374218|NCT03451045|65115966|FG000|Overall Study|Lack of Efficacy|3|||
23374219|NCT03451045|65115967|FG001|Overall Study|Lack of Efficacy|2|||
23374220|NCT03451045|65115968|FG002|Overall Study|Lack of Efficacy|2|||
23374221|NCT03451045|65115966|FG000|Overall Study|Physician Decision|1|||
23374222|NCT03451045|65115967|FG001|Overall Study|Physician Decision|1|||
23374223|NCT03451045|65115968|FG002|Overall Study|Physician Decision|1|||
23374224|NCT03451045|65115966|FG000|Overall Study|Withdrawal by Subject|4|||
23374225|NCT03451045|65115967|FG001|Overall Study|Withdrawal by Subject|0|||
23374226|NCT03451045|65115968|FG002|Overall Study|Withdrawal by Subject|5|||
23374227|NCT03451045|65115966|FG000|Overall Study|Pregnancy|0|||
23374228|NCT03451045|65115967|FG001|Overall Study|Pregnancy|0|||
23374229|NCT03451045|65115968|FG002|Overall Study|Pregnancy|2|||
23374230|NCT03451045|65115966|FG000|Overall Study|Adverse Event|7|||
23374231|NCT03451045|65115967|FG001|Overall Study|Adverse Event|1|||
23374232|NCT03451045|65115968|FG002|Overall Study|Adverse Event|3|||
23374233|NCT03451045|65115966|FG000|Overall Study|Non-compliance with study|2|||
23374234|NCT03451045|65115967|FG001|Overall Study|Non-compliance with study|0|||
23374235|NCT03451045|65115968|FG002|Overall Study|Non-compliance with study|1|||
23374236|NCT03451045|65115966|FG000|Overall Study|any other reason|10|||
23374237|NCT03451045|65115967|FG001|Overall Study|any other reason|2|||
23374238|NCT03451045|65115968|FG002|Overall Study|any other reason|13|||
23487926|NCT02713204|65530479|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
23487927|NCT02713204|65530480|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
23281956|NCT00418938|64776122|FG001|Overall Study|Lost to Follow-up|3|||
23281957|NCT00418938|64776121|FG000|Overall Study|Adverse Event|1|||
23281958|NCT00418938|64776122|FG001|Overall Study|Adverse Event|1|||
23281959|NCT00418938|64776121|FG000|Overall Study|On-going|1|||
23281960|NCT00418938|64776122|FG001|Overall Study|On-going|1|||
23281961|NCT00418938|64776121|FG000|Overall Study|Ineligibility Determined|1|||
23281962|NCT00418938|64776122|FG001|Overall Study|Ineligibility Determined|0|||
23281963|NCT00594035|64776125|FG000|Overall Study|Lost to Follow-up|1|||
23281964|NCT00594035|64776126|FG001|Overall Study|Lost to Follow-up|1|||
23281965|NCT00594035|64776125|FG000|Overall Study|Withdrawal by Subject|1|||
23374239|NCT02026141|65115969|FG000|Overall Study|Protocol Violation|0|||
23374240|NCT02026141|65115970|FG001|Overall Study|Protocol Violation|1|||
23374241|NCT01189266|65115971|FG000|Overall Study|Adverse Event|1|||
23374242|NCT01189266|65115972|FG001|Overall Study|Adverse Event|0|||
23374243|NCT01189266|65115973|FG002|Overall Study|Adverse Event|5|||
23374244|NCT01189266|65115971|FG000|Overall Study|Death|0|||
23374245|NCT01189266|65115972|FG001|Overall Study|Death|0|||
23374246|NCT01189266|65115973|FG002|Overall Study|Death|5|||
23374247|NCT01189266|65115971|FG000|Overall Study|Lack of Efficacy|4|||
23374248|NCT01189266|65115972|FG001|Overall Study|Lack of Efficacy|5|||
23281966|NCT00594035|64776126|FG001|Overall Study|Withdrawal by Subject|0|||
23281967|NCT00594035|64776125|FG000|Overall Study|Subject transferred to nursing home|0|||
23281968|NCT00594035|64776126|FG001|Overall Study|Subject transferred to nursing home|1|||
23281969|NCT00594035|64776125|FG000|Overall Study|Subject couldn't return due to job|0|||
23281970|NCT00594035|64776126|FG001|Overall Study|Subject couldn't return due to job|1|||
23281971|NCT03966911|64776127|FG000|Overall Study|Adverse Event|1|||
23281972|NCT03966911|64776128|FG001|Overall Study|Adverse Event|1|||
23374249|NCT01189266|65115973|FG002|Overall Study|Lack of Efficacy|44|||
23374250|NCT01189266|65115971|FG000|Overall Study|Physician Decision|0|||
23374251|NCT01189266|65115972|FG001|Overall Study|Physician Decision|0|||
23374252|NCT01189266|65115973|FG002|Overall Study|Physician Decision|1|||
23374253|NCT01189266|65115971|FG000|Overall Study|Protocol Violation|0|||
23374254|NCT01189266|65115972|FG001|Overall Study|Protocol Violation|1|||
23374255|NCT01189266|65115973|FG002|Overall Study|Protocol Violation|1|||
23374256|NCT01189266|65115971|FG000|Overall Study|Withdrawal by Subject|0|||
23374257|NCT01189266|65115972|FG001|Overall Study|Withdrawal by Subject|0|||
23374258|NCT01189266|65115973|FG002|Overall Study|Withdrawal by Subject|1|||
23374259|NCT01189266|65115971|FG000|Overall Study|Patient refuses further therapy|1|||
23374260|NCT01189266|65115972|FG001|Overall Study|Patient refuses further therapy|0|||
23374261|NCT01189266|65115973|FG002|Overall Study|Patient refuses further therapy|7|||
23281973|NCT03966911|64776127|FG000|Overall Study|Withdrawal by Subject|8|||
23281974|NCT03966911|64776128|FG001|Overall Study|Withdrawal by Subject|2|||
23281975|NCT03966911|64776127|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
23281976|NCT03966911|64776128|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
23281977|NCT00841659|64776129|FG000|Washout: 2 Weeks|Protocol Violation|1|||
23281978|NCT00841659|64776130|FG001|Washout: 2 Weeks|Protocol Violation|0|||
23281979|NCT01456221|64776133|FG000|Overall Study|Withdrawal by Subject|56|||
23281980|NCT01456221|64776134|FG001|Overall Study|Withdrawal by Subject|49|||
23281981|NCT01456221|64776133|FG000|Overall Study|Lost to Follow-up|1|||
23281982|NCT01456221|64776134|FG001|Overall Study|Lost to Follow-up|4|||
23281983|NCT01456221|64776133|FG000|Overall Study|Received medication|3|||
23281984|NCT01456221|64776134|FG001|Overall Study|Received medication|2|||
23281985|NCT01456221|64776133|FG000|Overall Study|Incomplete data|4|||
23281986|NCT01456221|64776134|FG001|Overall Study|Incomplete data|2|||
23281987|NCT03531827|64776137|FG000|Overall Study|Adverse Event|2|||
23281988|NCT03531827|64776138|FG001|Overall Study|Adverse Event|0|||
23281989|NCT03531827|64776137|FG000|Overall Study|Progressive disease|1|||
23374262|NCT01189266|65115971|FG000|Overall Study|No treatment|0|||
23374263|NCT01189266|65115972|FG001|Overall Study|No treatment|0|||
23374264|NCT01189266|65115973|FG002|Overall Study|No treatment|1|||
23374265|NCT01299584|65115974|FG000|Overall Study|Protocol Violation|9|||
23374266|NCT02722967|65115983|FG000|Overall Study|Adverse Event|1|||
23374267|NCT02722967|65115984|FG001|Overall Study|Adverse Event|0|||
23374268|NCT02722967|65115985|FG002|Overall Study|Adverse Event|0|||
23281990|NCT03531827|64776138|FG001|Overall Study|Progressive disease|0|||
23281991|NCT02440711|64776139|FG000|Second Intervention|Lost to Follow-up|1|||
23374269|NCT02722967|65115983|FG000|Overall Study|Lost to Follow-up|0|||
23374270|NCT02722967|65115984|FG001|Overall Study|Lost to Follow-up|1|||
23374271|NCT02722967|65115985|FG002|Overall Study|Lost to Follow-up|0|||
23374272|NCT02722967|65115983|FG000|Overall Study|Non-compliance with patch wearing|2|||
23374273|NCT02722967|65115984|FG001|Overall Study|Non-compliance with patch wearing|1|||
23374274|NCT02722967|65115985|FG002|Overall Study|Non-compliance with patch wearing|1|||
23374275|NCT02722967|65115983|FG000|Overall Study|Withdrawal by Subject|1|||
23374276|NCT02722967|65115984|FG001|Overall Study|Withdrawal by Subject|0|||
23603913|NCT00047385|65940209|FG001|Overall Study|Eligible for screening but had no screen|492|||
23603914|NCT03939897|65940210|FG000|Overall Study|Still receiving active treatment|0|||
23603915|NCT03939897|65940211|FG001|Overall Study|Still receiving active treatment|0|||
23603916|NCT03939897|65940212|FG002|Overall Study|Still receiving active treatment|1|||
23603917|NCT03939897|65940213|FG003|Overall Study|Still receiving active treatment|0|||
23603918|NCT03939897|65940214|FG004|Overall Study|Still receiving active treatment|0|||
23603919|NCT03939897|65940215|FG005|Overall Study|Still receiving active treatment|0|||
23603920|NCT01286311|65940216|FG000|Overall Study|Physician did not want outreach sent|14|||
23603921|NCT01286311|65940217|FG001|Overall Study|Physician did not want outreach sent|0|||
23603922|NCT00875706|65940221|FG000|Overall Study|Withdrawal by Subject|1|||
23603923|NCT00875706|65940222|FG001|Overall Study|Withdrawal by Subject|0|||
23603924|NCT00875706|65940223|FG002|Overall Study|Withdrawal by Subject|0|||
23603925|NCT00390884|65940224|FG000|Overall Study|Withdrawal by Subject|2|||
23603926|NCT00390884|65940225|FG001|Overall Study|Withdrawal by Subject|2|||
23603927|NCT01332266|65940228|FG000|Phase 1b|Death|3|||
23603928|NCT01332266|65940229|FG001|Phase 1b|Death|3|||
23603929|NCT01332266|65940230|FG002|Phase 1b|Death|2|||
23603930|NCT01332266|65940231|FG003|Phase 1b|Death|0|||
23603931|NCT01332266|65940232|FG004|Phase 1b|Death|0|||
23603932|NCT01332266|65940228|FG000|Phase 1b|Lost to Follow-up|0|||
23603933|NCT01332266|65940229|FG001|Phase 1b|Lost to Follow-up|1|||
23603934|NCT01332266|65940230|FG002|Phase 1b|Lost to Follow-up|0|||
23603935|NCT01332266|65940231|FG003|Phase 1b|Lost to Follow-up|0|||
23603936|NCT01332266|65940232|FG004|Phase 1b|Lost to Follow-up|0|||
23374277|NCT02722967|65115985|FG002|Overall Study|Withdrawal by Subject|1|||
23603937|NCT01332266|65940228|FG000|Phase 1b|Withdrawal by Subject|1|||
23603938|NCT01332266|65940229|FG001|Phase 1b|Withdrawal by Subject|1|||
23603939|NCT01332266|65940230|FG002|Phase 1b|Withdrawal by Subject|1|||
23603940|NCT01332266|65940231|FG003|Phase 1b|Withdrawal by Subject|0|||
23603941|NCT01332266|65940232|FG004|Phase 1b|Withdrawal by Subject|0|||
23281992|NCT02440711|64776140|FG001|Second Intervention|Lost to Follow-up|0|||
23281993|NCT00663234|64776141|FG000|Overall Study|Not willing to adhere to requirements|1|||
23281994|NCT03930732|64776144|FG000|Overall Study|Adverse Event|9|||
23281995|NCT03930732|64776145|FG001|Overall Study|Adverse Event|7|||
23374278|NCT02722967|65115983|FG000|Overall Study|Physician Decision|1|||
23603942|NCT01332266|65940228|FG000|Phase 2|Death|0|||
23374279|NCT02722967|65115984|FG001|Overall Study|Physician Decision|0|||
23374280|NCT02722967|65115985|FG002|Overall Study|Physician Decision|0|||
23374281|NCT02722967|65115983|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
23374282|NCT02722967|65115984|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
23374283|NCT02722967|65115985|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
23374284|NCT02471339|65115986|FG000|Overall Study|Did not provide follow-up data|2|||
23374285|NCT02471339|65115987|FG001|Overall Study|Did not provide follow-up data|0|||
23487928|NCT04228783|65530491|FG000|Overall Study|Adverse Event|1|||
23487929|NCT04228783|65530492|FG001|Overall Study|Adverse Event|0|||
23487930|NCT04228783|65530493|FG002|Overall Study|Adverse Event|2|||
23487931|NCT04228783|65530494|FG003|Overall Study|Adverse Event|0|||
23487932|NCT04228783|65530495|FG004|Overall Study|Adverse Event|0|||
23487933|NCT04228783|65530496|FG005|Overall Study|Adverse Event|1|||
23487934|NCT04228783|65530491|FG000|Overall Study|Death|0|||
23487935|NCT04228783|65530492|FG001|Overall Study|Death|0|||
23487936|NCT04228783|65530493|FG002|Overall Study|Death|0|||
23487937|NCT04228783|65530494|FG003|Overall Study|Death|0|||
23487938|NCT04228783|65530495|FG004|Overall Study|Death|1|||
23487939|NCT04228783|65530496|FG005|Overall Study|Death|0|||
23487940|NCT04228783|65530491|FG000|Overall Study|Lost to Follow-up|36|||
23487941|NCT04228783|65530492|FG001|Overall Study|Lost to Follow-up|36|||
23487942|NCT04228783|65530493|FG002|Overall Study|Lost to Follow-up|28|||
23487943|NCT04228783|65530494|FG003|Overall Study|Lost to Follow-up|6|||
23487944|NCT04228783|65530495|FG004|Overall Study|Lost to Follow-up|14|||
23487945|NCT04228783|65530496|FG005|Overall Study|Lost to Follow-up|3|||
23374286|NCT02371616|65115988|FG000|Overall Study|Protocol Violation|2|||
23374287|NCT02371616|65115989|FG001|Overall Study|Protocol Violation|1|||
23374288|NCT02371616|65115988|FG000|Overall Study|Adverse Event|0|||
23374289|NCT02371616|65115989|FG001|Overall Study|Adverse Event|1|||
23281996|NCT03930732|64776144|FG000|Overall Study|Poor compliance to protocol|0|||
23281997|NCT03930732|64776145|FG001|Overall Study|Poor compliance to protocol|1|||
23281998|NCT03930732|64776144|FG000|Overall Study|Withdrawal by Subject|23|||
23281999|NCT03930732|64776145|FG001|Overall Study|Withdrawal by Subject|11|||
23282000|NCT03930732|64776144|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
23282001|NCT03930732|64776145|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
23282002|NCT03930732|64776144|FG000|Overall Study|Other reason not related to COVID-19|5|||
23282003|NCT03930732|64776145|FG001|Overall Study|Other reason not related to COVID-19|8|||
23282004|NCT04112823|64776146|FG000|Overall Study|Lost to Follow-up|2|||
23282005|NCT04112823|64776147|FG001|Overall Study|Lost to Follow-up|3|||
23282006|NCT04035187|64776148|FG000|Overall Study|Withdrawal by Subject|2|||
23282007|NCT04035187|64776149|FG001|Overall Study|Withdrawal by Subject|1|||
23282008|NCT04035187|64776150|FG002|Overall Study|Withdrawal by Subject|0|||
23282009|NCT04035187|64776151|FG003|Overall Study|Withdrawal by Subject|0|||
23282010|NCT04035187|64776148|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
23282011|NCT04035187|64776149|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
23282012|NCT04035187|64776150|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
23282013|NCT04035187|64776151|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
23282014|NCT03629054|64776154|FG000|Period 2 (4 Days)|Not treated|0|||
23282015|NCT03629054|64776155|FG001|Period 2 (4 Days)|Not treated|1|||
23282016|NCT05394350|64776157|FG000|Overall Study|Death|2|||
23282017|NCT05394350|64776158|FG001|Overall Study|Death|2|||
23282018|NCT05394350|64776159|FG002|Overall Study|Death|4|||
23282019|NCT05394350|64776160|FG003|Overall Study|Death|0|||
23282020|NCT05394350|64776161|FG004|Overall Study|Death|1|||
23282021|NCT05394350|64776162|FG005|Overall Study|Death|0|||
23374290|NCT02371616|65115988|FG000|Overall Study|Withdrawal of Consent|1|||
23282022|NCT05394350|64776157|FG000|Overall Study|Study terminated by sponsor|1|||
23282023|NCT05394350|64776158|FG001|Overall Study|Study terminated by sponsor|1|||
23282024|NCT05394350|64776159|FG002|Overall Study|Study terminated by sponsor|7|||
23282025|NCT05394350|64776160|FG003|Overall Study|Study terminated by sponsor|3|||
23374291|NCT02371616|65115989|FG001|Overall Study|Withdrawal of Consent|0|||
23487946|NCT04228783|65530491|FG000|Overall Study|Physician Decision|1|||
23487947|NCT04228783|65530492|FG001|Overall Study|Physician Decision|2|||
23487948|NCT04228783|65530493|FG002|Overall Study|Physician Decision|0|||
23487949|NCT04228783|65530494|FG003|Overall Study|Physician Decision|0|||
23487950|NCT04228783|65530495|FG004|Overall Study|Physician Decision|0|||
23487951|NCT04228783|65530496|FG005|Overall Study|Physician Decision|0|||
23374292|NCT02371616|65115988|FG000|Overall Study|Other (Not specified)|1|||
23374293|NCT02371616|65115989|FG001|Overall Study|Other (Not specified)|5|||
23374294|NCT01572792|65115990|FG000|Lead-in Study|Lost to Follow-up|5|||
23374295|NCT01572792|65115991|FG001|Lead-in Study|Lost to Follow-up|9|||
23374296|NCT01572792|65115992|FG002|Lead-in Study|Lost to Follow-up|4|||
23374297|NCT01572792|65115993|FG003|Lead-in Study|Lost to Follow-up|2|||
23374298|NCT01572792|65115994|FG004|Lead-in Study|Lost to Follow-up|4|||
23374299|NCT01572792|65115990|FG000|Lead-in Study|Withdrawal by Subject|22|||
23374300|NCT01572792|65115991|FG001|Lead-in Study|Withdrawal by Subject|11|||
23374301|NCT01572792|65115992|FG002|Lead-in Study|Withdrawal by Subject|12|||
23374302|NCT01572792|65115993|FG003|Lead-in Study|Withdrawal by Subject|24|||
23374303|NCT01572792|65115994|FG004|Lead-in Study|Withdrawal by Subject|11|||
23374304|NCT01572792|65115990|FG000|Lead-in Study|Protocol Violation|19|||
23374305|NCT01572792|65115991|FG001|Lead-in Study|Protocol Violation|10|||
23374306|NCT01572792|65115992|FG002|Lead-in Study|Protocol Violation|12|||
23374307|NCT01572792|65115993|FG003|Lead-in Study|Protocol Violation|13|||
23374308|NCT01572792|65115994|FG004|Lead-in Study|Protocol Violation|21|||
23374309|NCT01572792|65115990|FG000|Lead-in Study|Lack of Efficacy|20|||
23374310|NCT01572792|65115991|FG001|Lead-in Study|Lack of Efficacy|5|||
23374311|NCT01572792|65115992|FG002|Lead-in Study|Lack of Efficacy|4|||
23374312|NCT01572792|65115993|FG003|Lead-in Study|Lack of Efficacy|8|||
23374313|NCT01572792|65115994|FG004|Lead-in Study|Lack of Efficacy|10|||
23374314|NCT01572792|65115990|FG000|Lead-in Study|Adverse Event|21|||
23374315|NCT01572792|65115991|FG001|Lead-in Study|Adverse Event|21|||
23374316|NCT01572792|65115992|FG002|Lead-in Study|Adverse Event|22|||
23374317|NCT01572792|65115993|FG003|Lead-in Study|Adverse Event|16|||
23374318|NCT01572792|65115994|FG004|Lead-in Study|Adverse Event|14|||
23374319|NCT01572792|65115990|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
23374320|NCT01572792|65115991|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
23374321|NCT01572792|65115992|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
23374322|NCT01572792|65115993|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
23374323|NCT01572792|65115994|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
23374324|NCT01572792|65115990|FG000|Extension Study|Lost to Follow-up|6|||
23374325|NCT01572792|65115991|FG001|Extension Study|Lost to Follow-up|2|||
23374326|NCT01572792|65115992|FG002|Extension Study|Lost to Follow-up|0|||
23374327|NCT01572792|65115993|FG003|Extension Study|Lost to Follow-up|3|||
23374328|NCT01572792|65115994|FG004|Extension Study|Lost to Follow-up|3|||
23374329|NCT01572792|65115990|FG000|Extension Study|Withdrawal by Subject|7|||
23374330|NCT01572792|65115991|FG001|Extension Study|Withdrawal by Subject|6|||
23374331|NCT01572792|65115992|FG002|Extension Study|Withdrawal by Subject|11|||
23374332|NCT01572792|65115993|FG003|Extension Study|Withdrawal by Subject|8|||
23374333|NCT01572792|65115994|FG004|Extension Study|Withdrawal by Subject|14|||
23374334|NCT01572792|65115990|FG000|Extension Study|Protocol Violation|0|||
23374335|NCT01572792|65115991|FG001|Extension Study|Protocol Violation|4|||
23374336|NCT01572792|65115992|FG002|Extension Study|Protocol Violation|3|||
23374337|NCT01572792|65115993|FG003|Extension Study|Protocol Violation|4|||
23374338|NCT01572792|65115994|FG004|Extension Study|Protocol Violation|3|||
23374339|NCT01572792|65115990|FG000|Extension Study|Lack of Efficacy|2|||
23374340|NCT01572792|65115991|FG001|Extension Study|Lack of Efficacy|3|||
23374341|NCT01572792|65115992|FG002|Extension Study|Lack of Efficacy|3|||
23374342|NCT01572792|65115993|FG003|Extension Study|Lack of Efficacy|2|||
23374343|NCT01572792|65115994|FG004|Extension Study|Lack of Efficacy|2|||
23374344|NCT01572792|65115990|FG000|Extension Study|Adverse Event|7|||
23374345|NCT01572792|65115991|FG001|Extension Study|Adverse Event|6|||
23374346|NCT01572792|65115992|FG002|Extension Study|Adverse Event|5|||
23374347|NCT01572792|65115993|FG003|Extension Study|Adverse Event|6|||
23374348|NCT01572792|65115994|FG004|Extension Study|Adverse Event|4|||
23374349|NCT01572792|65115990|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
23374350|NCT01572792|65115991|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
23487952|NCT04228783|65530491|FG000|Overall Study|Protocol Violation|0|||
23487953|NCT04228783|65530492|FG001|Overall Study|Protocol Violation|0|||
23487954|NCT04228783|65530493|FG002|Overall Study|Protocol Violation|0|||
23487955|NCT04228783|65530494|FG003|Overall Study|Protocol Violation|1|||
23487956|NCT04228783|65530495|FG004|Overall Study|Protocol Violation|0|||
23487957|NCT04228783|65530496|FG005|Overall Study|Protocol Violation|0|||
23487958|NCT04228783|65530491|FG000|Overall Study|Withdrawal by Subject|6|||
23487959|NCT04228783|65530492|FG001|Overall Study|Withdrawal by Subject|10|||
23487960|NCT04228783|65530493|FG002|Overall Study|Withdrawal by Subject|19|||
23487961|NCT04228783|65530494|FG003|Overall Study|Withdrawal by Subject|1|||
23487962|NCT04228783|65530495|FG004|Overall Study|Withdrawal by Subject|2|||
23487963|NCT04228783|65530496|FG005|Overall Study|Withdrawal by Subject|0|||
23374351|NCT01572792|65115992|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
23374352|NCT01572792|65115993|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
23374353|NCT01572792|65115994|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
23374354|NCT00490035|65115998|FG000|Overall Study|AE, non-serious non-fatal|3|||
23487964|NCT04228783|65530491|FG000|Overall Study|Other|4|||
23487965|NCT04228783|65530492|FG001|Overall Study|Other|3|||
23487966|NCT04228783|65530493|FG002|Overall Study|Other|2|||
23487967|NCT04228783|65530494|FG003|Overall Study|Other|1|||
23487968|NCT04228783|65530495|FG004|Overall Study|Other|0|||
23487969|NCT04228783|65530496|FG005|Overall Study|Other|0|||
23487970|NCT01243671|65530497|FG000|Overall Study|Adverse Event|3|||
23487971|NCT01243671|65530497|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
23487972|NCT01243671|65530497|FG000|Overall Study|Other|1|||
23487973|NCT02237911|65530498|FG000|Overall Study|Withdrawal by Subject|4|||
23487974|NCT02237911|65530499|FG001|Overall Study|Withdrawal by Subject|7|||
23487975|NCT02237911|65530500|FG002|Overall Study|Withdrawal by Subject|2|||
23487976|NCT02237911|65530498|FG000|Overall Study|Lost to Follow-up|3|||
23487977|NCT02237911|65530499|FG001|Overall Study|Lost to Follow-up|1|||
23487978|NCT02237911|65530500|FG002|Overall Study|Lost to Follow-up|1|||
23487979|NCT00901927|65530506|FG000|Overall Study|Lack of Efficacy|1|||
23487980|NCT00901927|65530506|FG000|Overall Study|Protocol Violation|3|||
23487981|NCT00901927|65530506|FG000|Overall Study|Withdrawal by Subject|2|||
23487982|NCT01086423|65530512|FG000|Overall Study|Protocol Violation|0|||
23487983|NCT01086423|65530513|FG001|Overall Study|Protocol Violation|0|||
23487984|NCT01086423|65530514|FG002|Overall Study|Protocol Violation|1|||
23487985|NCT01086423|65530512|FG000|Overall Study|Migrated/moved from study area|2|||
23487986|NCT01086423|65530513|FG001|Overall Study|Migrated/moved from study area|0|||
23487987|NCT01086423|65530514|FG002|Overall Study|Migrated/moved from study area|4|||
23487988|NCT01086423|65530512|FG000|Overall Study|Adverse event, fatal|1|||
23487989|NCT01086423|65530513|FG001|Overall Study|Adverse event, fatal|1|||
23487990|NCT01086423|65530514|FG002|Overall Study|Adverse event, fatal|0|||
23487991|NCT01086423|65530512|FG000|Overall Study|Adverse event, non-fatal|2|||
23487992|NCT01086423|65530513|FG001|Overall Study|Adverse event, non-fatal|1|||
23487993|NCT01086423|65530514|FG002|Overall Study|Adverse event, non-fatal|0|||
23487994|NCT01086423|65530512|FG000|Overall Study|Withdrawal by Subject|5|||
23487995|NCT01086423|65530513|FG001|Overall Study|Withdrawal by Subject|1|||
23487996|NCT01086423|65530514|FG002|Overall Study|Withdrawal by Subject|3|||
23487997|NCT01086423|65530512|FG000|Overall Study|Lost to Follow-up|0|||
23487998|NCT01086423|65530513|FG001|Overall Study|Lost to Follow-up|0|||
23487999|NCT01086423|65530514|FG002|Overall Study|Lost to Follow-up|1|||
23488000|NCT00144027|65530515|FG000|Overall Study|Lost to Follow-up|1|||
23488001|NCT00144027|65530516|FG001|Overall Study|Lost to Follow-up|3|||
23488002|NCT00144027|65530515|FG000|Overall Study|Withdrawal by Subject|2|||
23488003|NCT00144027|65530516|FG001|Overall Study|Withdrawal by Subject|2|||
23488004|NCT00144027|65530515|FG000|Overall Study|did not complete baseline assessment|0|||
23488005|NCT00144027|65530516|FG001|Overall Study|did not complete baseline assessment|6|||
23488006|NCT03053271|65530517|FG000|Overall Study|Did not meet randomization criteria|3|||
23488007|NCT03053271|65530517|FG000|Overall Study|Withdrawal by Subject|1|||
23488008|NCT02595970|65530518|FG000|Overall Study|Withdrawal by Subject|2|||
23488009|NCT02595970|65530518|FG000|Overall Study|Physician Decision|2|||
23488010|NCT02595970|65530518|FG000|Overall Study|Protocol Violation|4|||
23488011|NCT02595970|65530518|FG000|Overall Study|Adverse Event|5|||
23488012|NCT02595970|65530518|FG000|Overall Study|Lack of Efficacy|7|||
23488013|NCT02305888|65530520|FG000|Overall Study|Lost to Follow-up|0|||
23488014|NCT02305888|65530521|FG001|Overall Study|Lost to Follow-up|0|||
23488015|NCT02305888|65530522|FG002|Overall Study|Lost to Follow-up|1|||
23488016|NCT02305888|65530520|FG000|Overall Study|Adverse Event|0|||
23488017|NCT02305888|65530521|FG001|Overall Study|Adverse Event|1|||
23488018|NCT02305888|65530522|FG002|Overall Study|Adverse Event|0|||
23488019|NCT02966873|65530523|FG000|Overall Study|Lost to Follow-up|16|||
23488020|NCT02966873|65530524|FG001|Overall Study|Lost to Follow-up|15|||
23488021|NCT01282203|65530525|FG000|Overall Study|Adverse Event|1|||
23488022|NCT03238196|65530532|FG000|Overall Study|Adverse Event|3|||
23488023|NCT03238196|65530533|FG001|Overall Study|Adverse Event|0|||
23488024|NCT03238196|65530534|FG002|Overall Study|Adverse Event|2|||
23488025|NCT03238196|65530535|FG003|Overall Study|Adverse Event|2|||
23488026|NCT03238196|65530532|FG000|Overall Study|Withdrawal by Subject|4|||
23488027|NCT03238196|65530533|FG001|Overall Study|Withdrawal by Subject|1|||
23488028|NCT03238196|65530534|FG002|Overall Study|Withdrawal by Subject|1|||
23488029|NCT03238196|65530535|FG003|Overall Study|Withdrawal by Subject|0|||
23488030|NCT03238196|65530532|FG000|Overall Study|Disease progression|14|||
23488031|NCT03238196|65530533|FG001|Overall Study|Disease progression|2|||
23488032|NCT03238196|65530534|FG002|Overall Study|Disease progression|3|||
23488033|NCT03238196|65530535|FG003|Overall Study|Disease progression|2|||
23488034|NCT03238196|65530532|FG000|Overall Study|Still on treatment|1|||
23488035|NCT03238196|65530533|FG001|Overall Study|Still on treatment|0|||
23488036|NCT03238196|65530534|FG002|Overall Study|Still on treatment|0|||
23488037|NCT03238196|65530535|FG003|Overall Study|Still on treatment|0|||
23488038|NCT03384693|65530536|FG000|Overall Study|Adverse Event|3|||
23488039|NCT01400815|65530537|FG000|Overall Study|Adverse Event|3|||
23488040|NCT01400815|65530538|FG001|Overall Study|Adverse Event|0|||
23488041|NCT01400815|65530537|FG000|Overall Study|Death|0|||
23488042|NCT01400815|65530538|FG001|Overall Study|Death|1|||
23488043|NCT01400815|65530537|FG000|Overall Study|Lost to Follow-up|18|||
23488044|NCT01400815|65530538|FG001|Overall Study|Lost to Follow-up|11|||
23488045|NCT01400815|65530537|FG000|Overall Study|Protocol Violation|0|||
23488046|NCT01400815|65530538|FG001|Overall Study|Protocol Violation|1|||
23488047|NCT01400815|65530537|FG000|Overall Study|Physician Decision|1|||
23488048|NCT01400815|65530538|FG001|Overall Study|Physician Decision|0|||
23488049|NCT01400815|65530537|FG000|Overall Study|Withdrawal by Subject|15|||
23488050|NCT01400815|65530538|FG001|Overall Study|Withdrawal by Subject|8|||
23488051|NCT01400815|65530537|FG000|Overall Study|Subject in jail|1|||
23488052|NCT01400815|65530538|FG001|Overall Study|Subject in jail|0|||
23488053|NCT01394718|65530539|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
23488054|NCT01394718|65530540|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
23488055|NCT05274165|65530542|FG000|Overall Study|Withdrawal by Subject|3|||
23488056|NCT05274165|65530543|FG001|Overall Study|Withdrawal by Subject|3|||
23488057|NCT01067976|65530546|FG000|Overall Study|Study drug never administered|20|||
23488058|NCT01067976|65530546|FG000|Overall Study|Study prematurely discontinued|2|||
23488059|NCT01369615|65530558|FG000|Overall Study|Withdrawal by Subject|0|||
23488060|NCT01369615|65530559|FG001|Overall Study|Withdrawal by Subject|1|||
23488061|NCT01369615|65530558|FG000|Overall Study|Lost to Follow-up|0|||
23488062|NCT01369615|65530559|FG001|Overall Study|Lost to Follow-up|1|||
23488063|NCT03799211|65530561|FG000|Overall Study|Lost to Follow-up|2|||
23488064|NCT03799211|65530562|FG001|Overall Study|Lost to Follow-up|13|||
23488065|NCT03799211|65530561|FG000|Overall Study|Withdrawal by Subject|2|||
23488066|NCT03799211|65530562|FG001|Overall Study|Withdrawal by Subject|0|||
23488067|NCT00089284|65530563|FG000|Overall Study|Adverse event before starting treatment|0|||
23488068|NCT00089284|65530564|FG001|Overall Study|Adverse event before starting treatment|0|||
23488069|NCT00089284|65530565|FG002|Overall Study|Adverse event before starting treatment|0|||
23488070|NCT00089284|65530566|FG003|Overall Study|Adverse event before starting treatment|0|||
23488071|NCT00089284|65530567|FG004|Overall Study|Adverse event before starting treatment|0|||
23488072|NCT00089284|65530568|FG005|Overall Study|Adverse event before starting treatment|0|||
23488073|NCT00089284|65530569|FG006|Overall Study|Adverse event before starting treatment|1|||
23488074|NCT05080660|65530570|FG000|Overall Study|Adverse Event|4|||
23488075|NCT05080660|65530571|FG001|Overall Study|Adverse Event|0|||
23488076|NCT05080660|65530570|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
23488077|NCT05080660|65530571|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
23488078|NCT05080660|65530570|FG000|Overall Study|Physician Decision|1|||
23488079|NCT05080660|65530571|FG001|Overall Study|Physician Decision|0|||
23488080|NCT05080660|65530570|FG000|Overall Study|Protocol Deviation|2|||
23488081|NCT05080660|65530571|FG001|Overall Study|Protocol Deviation|0|||
23488082|NCT05080660|65530570|FG000|Overall Study|Withdrawal by Subject|5|||
23488083|NCT05080660|65530571|FG001|Overall Study|Withdrawal by Subject|2|||
23488084|NCT01437878|65530572|FG000|Overall Study|Withdrawal by Subject|1|||
23488085|NCT01437878|65530573|FG001|Overall Study|Withdrawal by Subject|0|||
23488086|NCT01462227|65530574|FG000|Second Assignment|Lost to Follow-up|1|||
23488087|NCT01462227|65530575|FG001|Second Assignment|Lost to Follow-up|0|||
23488088|NCT01462227|65530576|FG002|Second Assignment|Lost to Follow-up|0|||
23488089|NCT01462227|65530577|FG003|Second Assignment|Lost to Follow-up|0|||
23488090|NCT01462227|65530574|FG000|Second Assignment|Protocol Violation|0|||
23488091|NCT01462227|65530575|FG001|Second Assignment|Protocol Violation|1|||
23488092|NCT01462227|65530576|FG002|Second Assignment|Protocol Violation|1|||
23488093|NCT01462227|65530577|FG003|Second Assignment|Protocol Violation|0|||
23488094|NCT03131453|65530580|FG000|Overall Study|Study terminated by Sponsor|424|||
23488095|NCT03131453|65530581|FG001|Overall Study|Study terminated by Sponsor|222|||
23488096|NCT03131453|65530582|FG002|Overall Study|Study terminated by Sponsor|438|||
23488097|NCT03131453|65530580|FG000|Overall Study|Withdrawal by Subject|18|||
23488098|NCT03131453|65530581|FG001|Overall Study|Withdrawal by Subject|7|||
23488099|NCT03131453|65530582|FG002|Overall Study|Withdrawal by Subject|13|||
23488100|NCT03131453|65530580|FG000|Overall Study|Adverse Event|10|||
23488101|NCT03131453|65530581|FG001|Overall Study|Adverse Event|3|||
23488102|NCT03131453|65530582|FG002|Overall Study|Adverse Event|3|||
23488103|NCT03131453|65530580|FG000|Overall Study|Lost to Follow-up|1|||
23488104|NCT03131453|65530581|FG001|Overall Study|Lost to Follow-up|0|||
23488105|NCT03131453|65530582|FG002|Overall Study|Lost to Follow-up|1|||
23488106|NCT03131453|65530580|FG000|Overall Study|Physician Decision|1|||
23488107|NCT03131453|65530581|FG001|Overall Study|Physician Decision|0|||
23488108|NCT03131453|65530582|FG002|Overall Study|Physician Decision|1|||
23488109|NCT03131453|65530580|FG000|Overall Study|Non-compliance with study treatment|1|||
23488110|NCT03131453|65530581|FG001|Overall Study|Non-compliance with study treatment|0|||
23488111|NCT03131453|65530582|FG002|Overall Study|Non-compliance with study treatment|0|||
23488112|NCT03131453|65530580|FG000|Overall Study|Technical problems|1|||
23488113|NCT03131453|65530581|FG001|Overall Study|Technical problems|0|||
23488114|NCT03131453|65530582|FG002|Overall Study|Technical problems|0|||
23488115|NCT03131453|65530580|FG000|Overall Study|Protocol deviation|0|||
23488116|NCT03131453|65530581|FG001|Overall Study|Protocol deviation|1|||
23488117|NCT03131453|65530582|FG002|Overall Study|Protocol deviation|0|||
23488118|NCT03114488|65530585|FG000|Time Period 2|Withdrawal by Subject|1|||
23488119|NCT03114488|65530586|FG001|Time Period 2|Withdrawal by Subject|3|||
23488120|NCT00467610|65533735|FG000|Overall Study|Withdrawal by Subject|1|||
23488121|NCT02149875|65533738|FG000|Overall Study|Lost to Follow-up|3|||
23488122|NCT02149875|65533739|FG001|Overall Study|Lost to Follow-up|4|||
23488123|NCT02149875|65533740|FG002|Overall Study|Lost to Follow-up|5|||
23488124|NCT02149875|65533738|FG000|Overall Study|Withdrawal by Subject|3|||
23488125|NCT02149875|65533739|FG001|Overall Study|Withdrawal by Subject|2|||
23488126|NCT02149875|65533740|FG002|Overall Study|Withdrawal by Subject|2|||
23488127|NCT02149875|65533738|FG000|Overall Study|Physician Decision|1|||
23488128|NCT02149875|65533739|FG001|Overall Study|Physician Decision|2|||
23488129|NCT02149875|65533740|FG002|Overall Study|Physician Decision|2|||
23488130|NCT04223232|65533756|FG000|Overall Study|Withdrawal by Subject|1|||
23488131|NCT00567593|65533757|FG000|Overall Study|Adverse Event|1|||
23488132|NCT00567593|65533757|FG000|Overall Study|Physician Decision|1|||
23488133|NCT02063880|65533760|FG000|Overall Study|Death|21|||
23488134|NCT02063880|65533761|FG001|Overall Study|Death|18|||
23488135|NCT02063880|65533760|FG000|Overall Study|Lost to Follow-up|7|||
23488136|NCT02063880|65533761|FG001|Overall Study|Lost to Follow-up|7|||
23488137|NCT02063880|65533760|FG000|Overall Study|Ineligible|0|||
23488138|NCT02063880|65533761|FG001|Overall Study|Ineligible|2|||
23488139|NCT02806973|65533762|FG000|Period 1|Withdrawal by Subject|0|||
23488140|NCT02806973|65533763|FG001|Period 1|Withdrawal by Subject|2|||
23488141|NCT02806973|65533764|FG002|Period 1|Withdrawal by Subject|1|||
23488142|NCT02806973|65533765|FG003|Period 1|Withdrawal by Subject|1|||
23488143|NCT02806973|65533762|FG000|Period 1|Adverse Event|0|||
23488144|NCT02806973|65533763|FG001|Period 1|Adverse Event|0|||
23488145|NCT02806973|65533764|FG002|Period 1|Adverse Event|0|||
23488146|NCT02806973|65533765|FG003|Period 1|Adverse Event|1|||
23488147|NCT02806973|65533762|FG000|Period 3|Withdrawal by Subject|0|||
23488148|NCT02806973|65533763|FG001|Period 3|Withdrawal by Subject|0|||
23488149|NCT02806973|65533764|FG002|Period 3|Withdrawal by Subject|0|||
23488150|NCT02806973|65533765|FG003|Period 3|Withdrawal by Subject|3|||
23488151|NCT02806973|65533762|FG000|Period 3|Adverse Event|0|||
23488152|NCT02806973|65533763|FG001|Period 3|Adverse Event|0|||
23282026|NCT05394350|64776161|FG004|Overall Study|Study terminated by sponsor|2|||
23282027|NCT05394350|64776162|FG005|Overall Study|Study terminated by sponsor|4|||
23282028|NCT00834717|64776163|FG000|First Intervention|Adverse Event|1|||
23282029|NCT00834717|64776164|FG001|First Intervention|Adverse Event|0|||
23282030|NCT00834717|64776163|FG000|First Intervention|Withdrawal by Subject|0|||
23282031|NCT00834717|64776164|FG001|First Intervention|Withdrawal by Subject|1|||
23282032|NCT00725322|64776169|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
23282033|NCT00725322|64776170|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
23282034|NCT00725322|64776169|FG000|Washout (28 Days)|Protocol Violation|0|||
23282035|NCT00725322|64776170|FG001|Washout (28 Days)|Protocol Violation|1|||
23282036|NCT00849797|64776171|FG000|First Intervention|bad veins|1|||
23282037|NCT00849797|64776172|FG001|First Intervention|bad veins|0|||
23282038|NCT00849797|64776171|FG000|First Intervention|Adverse Event|0|||
23282039|NCT00849797|64776172|FG001|First Intervention|Adverse Event|1|||
23374355|NCT00490035|65115999|FG001|Overall Study|AE, non-serious non-fatal|4|||
23488153|NCT02806973|65533764|FG002|Period 3|Adverse Event|1|||
23488154|NCT02806973|65533765|FG003|Period 3|Adverse Event|0|||
23603943|NCT01332266|65940229|FG001|Phase 2|Death|0|||
23603944|NCT01332266|65940230|FG002|Phase 2|Death|0|||
23603945|NCT01332266|65940231|FG003|Phase 2|Death|33|||
23603946|NCT01332266|65940232|FG004|Phase 2|Death|36|||
23374356|NCT00490035|65116000|FG002|Overall Study|AE, non-serious non-fatal|4|||
23603947|NCT01332266|65940228|FG000|Phase 2|Lost to Follow-up|0|||
23603948|NCT01332266|65940229|FG001|Phase 2|Lost to Follow-up|0|||
23603949|NCT01332266|65940230|FG002|Phase 2|Lost to Follow-up|0|||
23603950|NCT01332266|65940231|FG003|Phase 2|Lost to Follow-up|2|||
23603951|NCT01332266|65940232|FG004|Phase 2|Lost to Follow-up|0|||
23603952|NCT01332266|65940228|FG000|Phase 2|Physician Decision|0|||
23603953|NCT01332266|65940229|FG001|Phase 2|Physician Decision|0|||
23603954|NCT01332266|65940230|FG002|Phase 2|Physician Decision|0|||
23603955|NCT01332266|65940231|FG003|Phase 2|Physician Decision|3|||
23282040|NCT00849797|64776171|FG000|Washout: One Week|Withdrawal by Subject|0|||
23282041|NCT00849797|64776172|FG001|Washout: One Week|Withdrawal by Subject|2|||
23282042|NCT01709903|64776173|FG000|Overall Study|administrative problems|2|||
23282043|NCT01709903|64776174|FG001|Overall Study|administrative problems|6|||
23374357|NCT00490035|65116001|FG003|Overall Study|AE, non-serious non-fatal|5|||
23488155|NCT03179761|65533766|FG000|Overall Study|Death|2|||
23488156|NCT03179761|65533767|FG001|Overall Study|Death|5|||
23488157|NCT03179761|65533766|FG000|Overall Study|Lost to Follow-up|2|||
23488158|NCT03179761|65533767|FG001|Overall Study|Lost to Follow-up|2|||
23488159|NCT03179761|65533766|FG000|Overall Study|Protocol Violation|1|||
23488160|NCT03179761|65533767|FG001|Overall Study|Protocol Violation|0|||
23488161|NCT03179761|65533766|FG000|Overall Study|Withdrawal by Subject|1|||
23488162|NCT03179761|65533767|FG001|Overall Study|Withdrawal by Subject|4|||
23603956|NCT01332266|65940232|FG004|Phase 2|Physician Decision|1|||
23603957|NCT01332266|65940228|FG000|Phase 2|Symptomatic deterioration|0|||
23603958|NCT01332266|65940229|FG001|Phase 2|Symptomatic deterioration|0|||
23603959|NCT01332266|65940230|FG002|Phase 2|Symptomatic deterioration|0|||
23282044|NCT01709903|64776173|FG000|Overall Study|Abnormal test procedure results|1|||
23282045|NCT01709903|64776174|FG001|Overall Study|Abnormal test procedure results|0|||
23282046|NCT01709903|64776173|FG000|Overall Study|In ability to use device|1|||
23282047|NCT01709903|64776174|FG001|Overall Study|In ability to use device|1|||
23282048|NCT01709903|64776173|FG000|Overall Study|no longer needed study drug|0|||
23282049|NCT01709903|64776174|FG001|Overall Study|no longer needed study drug|1|||
23282050|NCT01709903|64776173|FG000|Overall Study|Lost to Follow-up|0|||
23282051|NCT01709903|64776174|FG001|Overall Study|Lost to Follow-up|2|||
23282052|NCT01709903|64776173|FG000|Overall Study|Death|2|||
23282053|NCT01709903|64776174|FG001|Overall Study|Death|0|||
23282054|NCT01709903|64776173|FG000|Overall Study|Protocol Violation|3|||
23282055|NCT01709903|64776174|FG001|Overall Study|Protocol Violation|2|||
23282056|NCT01709903|64776173|FG000|Overall Study|Lack of Efficacy|3|||
23282057|NCT01709903|64776174|FG001|Overall Study|Lack of Efficacy|3|||
23282058|NCT01709903|64776173|FG000|Overall Study|Withdrawal by Subject|6|||
23282059|NCT01709903|64776174|FG001|Overall Study|Withdrawal by Subject|6|||
23282060|NCT01709903|64776173|FG000|Overall Study|Adverse Event|11|||
23282061|NCT01709903|64776174|FG001|Overall Study|Adverse Event|18|||
23282062|NCT01196390|64776175|FG000|Overall Study|Protocol Violation|4|||
23282063|NCT01196390|64776176|FG001|Overall Study|Protocol Violation|5|||
23282064|NCT01602380|64776177|FG000|Overall Study|Death|147|||
23282065|NCT01602380|64776178|FG001|Overall Study|Death|145|||
23282066|NCT01602380|64776177|FG000|Overall Study|Withdrawal by Subject|39|||
23282067|NCT01602380|64776178|FG001|Overall Study|Withdrawal by Subject|41|||
23282068|NCT01602380|64776177|FG000|Overall Study|Lost to Follow-up|15|||
23282069|NCT01602380|64776178|FG001|Overall Study|Lost to Follow-up|12|||
23282070|NCT01602380|64776177|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23282071|NCT01602380|64776178|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
23282072|NCT01602380|64776177|FG000|Overall Study|Other|2|||
23282073|NCT01602380|64776178|FG001|Overall Study|Other|0|||
23282074|NCT01075282|64776179|FG000|Overall Study|Withdrawal by Subject|11|||
23282075|NCT01075282|64776180|FG001|Overall Study|Withdrawal by Subject|7|||
23282076|NCT01075282|64776181|FG002|Overall Study|Withdrawal by Subject|11|||
23282077|NCT01075282|64776179|FG000|Overall Study|Adverse Event|9|||
23282078|NCT01075282|64776180|FG001|Overall Study|Adverse Event|8|||
23282079|NCT01075282|64776181|FG002|Overall Study|Adverse Event|5|||
23282080|NCT01075282|64776179|FG000|Overall Study|Entry Criteria Not Met|3|||
23282081|NCT01075282|64776180|FG001|Overall Study|Entry Criteria Not Met|2|||
23282082|NCT01075282|64776181|FG002|Overall Study|Entry Criteria Not Met|0|||
23282083|NCT01075282|64776179|FG000|Overall Study|Lost to Follow-up|3|||
23282084|NCT01075282|64776180|FG001|Overall Study|Lost to Follow-up|3|||
23282085|NCT01075282|64776181|FG002|Overall Study|Lost to Follow-up|3|||
23282086|NCT01075282|64776179|FG000|Overall Study|Physician Decision|3|||
23282087|NCT01075282|64776180|FG001|Overall Study|Physician Decision|3|||
23282088|NCT01075282|64776181|FG002|Overall Study|Physician Decision|3|||
23282089|NCT01075282|64776179|FG000|Overall Study|Lack of Efficacy|1|||
23282090|NCT01075282|64776180|FG001|Overall Study|Lack of Efficacy|1|||
23282091|NCT01075282|64776181|FG002|Overall Study|Lack of Efficacy|0|||
23282092|NCT01075282|64776179|FG000|Overall Study|Treatment Non-compliance|1|||
23282093|NCT01075282|64776180|FG001|Overall Study|Treatment Non-compliance|2|||
23282094|NCT01075282|64776181|FG002|Overall Study|Treatment Non-compliance|2|||
23282095|NCT01075282|64776179|FG000|Overall Study|Protocol Violation|0|||
23282096|NCT01075282|64776180|FG001|Overall Study|Protocol Violation|2|||
23282097|NCT01075282|64776181|FG002|Overall Study|Protocol Violation|1|||
23282098|NCT01075282|64776179|FG000|Overall Study|Death|0|||
23282099|NCT01075282|64776180|FG001|Overall Study|Death|1|||
23282100|NCT01075282|64776181|FG002|Overall Study|Death|2|||
23282101|NCT01794845|64776182|FG000|Overall Study|Withdrawal by Subject|1|||
23282102|NCT00858780|64776183|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
23282103|NCT00858780|64776184|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
23282104|NCT00858780|64776185|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
23282105|NCT00858780|64776186|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
23282106|NCT00858780|64776187|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
23282107|NCT00858780|64776183|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
23282108|NCT00858780|64776184|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
23282109|NCT00858780|64776185|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
23282110|NCT00858780|64776186|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
23282111|NCT00858780|64776187|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
23282112|NCT00858780|64776183|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
23282113|NCT00858780|64776184|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
23282114|NCT00858780|64776185|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
23282115|NCT00858780|64776186|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
23282116|NCT00858780|64776187|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
23282117|NCT00858780|64776183|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
23374358|NCT00490035|65115998|FG000|Overall Study|Lost to Follow-up|2|||
23374359|NCT00490035|65115999|FG001|Overall Study|Lost to Follow-up|0|||
23374360|NCT00490035|65116000|FG002|Overall Study|Lost to Follow-up|1|||
23374361|NCT00490035|65116001|FG003|Overall Study|Lost to Follow-up|0|||
23374362|NCT00490035|65115998|FG000|Overall Study|Withdrawal by Subject|2|||
23374363|NCT00490035|65115999|FG001|Overall Study|Withdrawal by Subject|1|||
23374364|NCT00490035|65116000|FG002|Overall Study|Withdrawal by Subject|1|||
23374365|NCT00490035|65116001|FG003|Overall Study|Withdrawal by Subject|0|||
23374366|NCT00490035|65115998|FG000|Overall Study|Other reason|0|||
23374367|NCT00490035|65115999|FG001|Overall Study|Other reason|1|||
23374368|NCT00490035|65116000|FG002|Overall Study|Other reason|3|||
23374369|NCT00490035|65116001|FG003|Overall Study|Other reason|1|||
23374370|NCT00490035|65115998|FG000|Overall Study|AE, serious fatal|1|||
23374371|NCT00490035|65115999|FG001|Overall Study|AE, serious fatal|0|||
23374372|NCT00490035|65116000|FG002|Overall Study|AE, serious fatal|0|||
23374373|NCT00490035|65116001|FG003|Overall Study|AE, serious fatal|0|||
23374374|NCT00490035|65115998|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
23374375|NCT00490035|65115999|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
23374376|NCT00490035|65116000|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
23374377|NCT00490035|65116001|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
23374378|NCT00490035|65115998|FG000|Overall Study|AE of unknown type|0|||
23374379|NCT00490035|65115999|FG001|Overall Study|AE of unknown type|0|||
23374380|NCT00490035|65116000|FG002|Overall Study|AE of unknown type|2|||
23374381|NCT00490035|65116001|FG003|Overall Study|AE of unknown type|0|||
23374382|NCT00375752|65116002|FG000|Overall Study|Lack of Efficacy|4|||
23374383|NCT00375752|65116003|FG001|Overall Study|Lack of Efficacy|4|||
23374384|NCT00375752|65116002|FG000|Overall Study|Adverse Event|1|||
23374385|NCT00375752|65116003|FG001|Overall Study|Adverse Event|6|||
23374386|NCT00375752|65116002|FG000|Overall Study|Withdrawal by Subject|6|||
23374387|NCT00375752|65116003|FG001|Overall Study|Withdrawal by Subject|1|||
23374388|NCT00375752|65116002|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
23374389|NCT00375752|65116003|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
23374390|NCT00375752|65116002|FG000|Overall Study|Protocol Violation|0|||
23374391|NCT00375752|65116003|FG001|Overall Study|Protocol Violation|2|||
23374392|NCT00375752|65116002|FG000|Overall Study|Administrative Problems|0|||
23374393|NCT00375752|65116003|FG001|Overall Study|Administrative Problems|1|||
23603960|NCT01332266|65940231|FG003|Phase 2|Symptomatic deterioration|0|||
23603961|NCT01332266|65940232|FG004|Phase 2|Symptomatic deterioration|1|||
23603962|NCT01332266|65940228|FG000|Phase 2|Progression Disease|0|||
23603963|NCT01332266|65940229|FG001|Phase 2|Progression Disease|0|||
23603964|NCT01332266|65940230|FG002|Phase 2|Progression Disease|0|||
23282118|NCT00858780|64776184|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
23603965|NCT01332266|65940231|FG003|Phase 2|Progression Disease|2|||
23282119|NCT00858780|64776185|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
23282120|NCT00858780|64776186|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
23282121|NCT00858780|64776187|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
23282122|NCT00858780|64776183|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
23282123|NCT00858780|64776184|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
23282124|NCT00858780|64776185|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
23282125|NCT00858780|64776186|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
23282126|NCT00858780|64776187|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
23282127|NCT00858780|64776183|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
23603966|NCT01332266|65940232|FG004|Phase 2|Progression Disease|1|||
23603967|NCT01332266|65940228|FG000|Phase 2|Withdrawal by Subject|0|||
23603968|NCT01332266|65940229|FG001|Phase 2|Withdrawal by Subject|0|||
23603969|NCT01332266|65940230|FG002|Phase 2|Withdrawal by Subject|0|||
23603970|NCT01332266|65940231|FG003|Phase 2|Withdrawal by Subject|2|||
23282128|NCT00858780|64776184|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
23282129|NCT00858780|64776185|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
23374394|NCT03839641|65116010|FG000|Overall Study|Withdrawal by Subject|1|||
23374395|NCT03839641|65116011|FG001|Overall Study|Withdrawal by Subject|1|||
23374396|NCT00424008|65116012|FG000|Overall Study|Adverse Event|8|||
23374397|NCT00424008|65116013|FG001|Overall Study|Adverse Event|6|||
23374398|NCT00424008|65116012|FG000|Overall Study|Lack of Efficacy|40|||
23374399|NCT00424008|65116013|FG001|Overall Study|Lack of Efficacy|34|||
23374400|NCT00424008|65116012|FG000|Overall Study|Lost to Follow-up|1|||
23374401|NCT00424008|65116013|FG001|Overall Study|Lost to Follow-up|2|||
23374402|NCT00424008|65116012|FG000|Overall Study|Withdrawal by Subject|5|||
23603971|NCT01332266|65940232|FG004|Phase 2|Withdrawal by Subject|2|||
23603972|NCT04248868|65940235|FG000|Overall Study|Death|1|||
23374403|NCT00424008|65116013|FG001|Overall Study|Withdrawal by Subject|8|||
23374404|NCT00424008|65116012|FG000|Overall Study|Noncompliance with protocol|13|||
23374405|NCT00424008|65116013|FG001|Overall Study|Noncompliance with protocol|7|||
23374406|NCT00424008|65116012|FG000|Overall Study|Did not meet protocol eligibility|16|||
23374407|NCT00424008|65116013|FG001|Overall Study|Did not meet protocol eligibility|21|||
23374408|NCT00424008|65116012|FG000|Overall Study|Administrative|266|||
23374409|NCT00424008|65116013|FG001|Overall Study|Administrative|257|||
23374410|NCT01294514|65116014|FG000|Overall Study|Excluded due to Arrhythmia|1|||
23374411|NCT01218308|65116015|FG000|Overall Study|Adverse Event|1|||
23374412|NCT01218308|65116016|FG001|Overall Study|Adverse Event|2|||
23374413|NCT01218308|65116015|FG000|Overall Study|Protocol Violation|0|||
23374414|NCT01218308|65116016|FG001|Overall Study|Protocol Violation|2|||
23374415|NCT01218308|65116015|FG000|Overall Study|Withdrawal by Subject|61|||
23374416|NCT01218308|65116016|FG001|Overall Study|Withdrawal by Subject|64|||
23374417|NCT01218308|65116015|FG000|Overall Study|Lost to Follow-up|27|||
23374418|NCT01218308|65116016|FG001|Overall Study|Lost to Follow-up|31|||
23374419|NCT01218308|65116015|FG000|Overall Study|Other|14|||
23374420|NCT01218308|65116016|FG001|Overall Study|Other|21|||
23374421|NCT02017717|65116020|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374422|NCT02017717|65116021|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374423|NCT02017717|65116022|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374424|NCT02017717|65116023|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
23374425|NCT02017717|65116024|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374426|NCT02017717|65116025|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374427|NCT02017717|65116026|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374428|NCT02017717|65116027|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374429|NCT02017717|65116028|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
23374430|NCT02017717|65116020|FG000|Before Treatment Period|Participant request to stop therapy|0|||
23374431|NCT02017717|65116021|FG001|Before Treatment Period|Participant request to stop therapy|0|||
23374432|NCT02017717|65116022|FG002|Before Treatment Period|Participant request to stop therapy|0|||
23374433|NCT02017717|65116023|FG003|Before Treatment Period|Participant request to stop therapy|0|||
23374434|NCT02017717|65116024|FG004|Before Treatment Period|Participant request to stop therapy|5|||
23374435|NCT02017717|65116025|FG005|Before Treatment Period|Participant request to stop therapy|0|||
23374436|NCT02017717|65116026|FG006|Before Treatment Period|Participant request to stop therapy|0|||
23374437|NCT02017717|65116027|FG007|Before Treatment Period|Participant request to stop therapy|0|||
23374438|NCT02017717|65116028|FG008|Before Treatment Period|Participant request to stop therapy|0|||
23374439|NCT02017717|65116020|FG000|Before Treatment Period|Participant withdrew consent|0|||
23488163|NCT03179761|65533766|FG000|Overall Study|Investigator Request|0|||
23488164|NCT03179761|65533767|FG001|Overall Study|Investigator Request|2|||
23488165|NCT01147172|65533768|FG000|Overall Study|Withdrawal by Subject|2|||
23488166|NCT01147172|65533768|FG000|Overall Study|Lost to Follow-up|2|||
23488167|NCT03698331|65533769|FG000|Overall Study|Adverse Event|2|||
23488168|NCT03698331|65533770|FG001|Overall Study|Adverse Event|3|||
23488169|NCT03698331|65533769|FG000|Overall Study|Withdrawal by Subject|1|||
23488170|NCT03698331|65533770|FG001|Overall Study|Withdrawal by Subject|1|||
23488171|NCT03698331|65533769|FG000|Overall Study|Lost to Follow-up|0|||
23488172|NCT03698331|65533770|FG001|Overall Study|Lost to Follow-up|2|||
23488173|NCT03698331|65533769|FG000|Overall Study|Non-compliance with study drug|1|||
23374440|NCT02017717|65116021|FG001|Before Treatment Period|Participant withdrew consent|0|||
23374441|NCT02017717|65116022|FG002|Before Treatment Period|Participant withdrew consent|0|||
23374442|NCT02017717|65116023|FG003|Before Treatment Period|Participant withdrew consent|0|||
23374443|NCT02017717|65116024|FG004|Before Treatment Period|Participant withdrew consent|11|||
23374444|NCT02017717|65116025|FG005|Before Treatment Period|Participant withdrew consent|0|||
23488174|NCT03698331|65533770|FG001|Overall Study|Non-compliance with study drug|0|||
23488175|NCT01614600|65533771|FG000|Overall Study|Unacceptable fit|1|||
23603973|NCT04248868|65940235|FG000|Overall Study|Lost to Follow-up|3|||
23374445|NCT02017717|65116026|FG006|Before Treatment Period|Participant withdrew consent|0|||
23374446|NCT02017717|65116027|FG007|Before Treatment Period|Participant withdrew consent|0|||
23374447|NCT02017717|65116028|FG008|Before Treatment Period|Participant withdrew consent|2|||
23374448|NCT02017717|65116020|FG000|Before Treatment Period|Lost to Follow-up|0|||
23374449|NCT02017717|65116021|FG001|Before Treatment Period|Lost to Follow-up|0|||
23374450|NCT02017717|65116022|FG002|Before Treatment Period|Lost to Follow-up|0|||
23374451|NCT02017717|65116023|FG003|Before Treatment Period|Lost to Follow-up|0|||
23374452|NCT02017717|65116024|FG004|Before Treatment Period|Lost to Follow-up|1|||
23374453|NCT02017717|65116025|FG005|Before Treatment Period|Lost to Follow-up|0|||
23374454|NCT02017717|65116026|FG006|Before Treatment Period|Lost to Follow-up|0|||
23374455|NCT02017717|65116027|FG007|Before Treatment Period|Lost to Follow-up|0|||
23374456|NCT02017717|65116028|FG008|Before Treatment Period|Lost to Follow-up|0|||
23374457|NCT02017717|65116020|FG000|Before Treatment Period|Participant no longer met criteria|0|||
23374458|NCT02017717|65116021|FG001|Before Treatment Period|Participant no longer met criteria|0|||
23374459|NCT02017717|65116022|FG002|Before Treatment Period|Participant no longer met criteria|0|||
23374460|NCT02017717|65116023|FG003|Before Treatment Period|Participant no longer met criteria|1|||
23374461|NCT02017717|65116024|FG004|Before Treatment Period|Participant no longer met criteria|2|||
23374462|NCT02017717|65116025|FG005|Before Treatment Period|Participant no longer met criteria|0|||
23374463|NCT02017717|65116026|FG006|Before Treatment Period|Participant no longer met criteria|0|||
23374464|NCT02017717|65116027|FG007|Before Treatment Period|Participant no longer met criteria|1|||
23374465|NCT02017717|65116028|FG008|Before Treatment Period|Participant no longer met criteria|0|||
23374466|NCT02017717|65116020|FG000|Before Treatment Period|other reason|0|||
23374467|NCT02017717|65116021|FG001|Before Treatment Period|other reason|0|||
23374468|NCT02017717|65116022|FG002|Before Treatment Period|other reason|0|||
23374469|NCT02017717|65116023|FG003|Before Treatment Period|other reason|0|||
23374470|NCT02017717|65116024|FG004|Before Treatment Period|other reason|1|||
23374471|NCT02017717|65116025|FG005|Before Treatment Period|other reason|0|||
23374472|NCT02017717|65116026|FG006|Before Treatment Period|other reason|0|||
23374473|NCT02017717|65116027|FG007|Before Treatment Period|other reason|0|||
23374474|NCT02017717|65116028|FG008|Before Treatment Period|other reason|0|||
23374475|NCT02017717|65116020|FG000|Treatment Period|Disease progression|7|||
23374476|NCT02017717|65116021|FG001|Treatment Period|Disease progression|9|||
23374477|NCT02017717|65116022|FG002|Treatment Period|Disease progression|12|||
23374478|NCT02017717|65116023|FG003|Treatment Period|Disease progression|165|||
23374479|NCT02017717|65116024|FG004|Treatment Period|Disease progression|134|||
23374480|NCT02017717|65116025|FG005|Treatment Period|Disease progression|20|||
23374481|NCT02017717|65116026|FG006|Treatment Period|Disease progression|26|||
23374482|NCT02017717|65116027|FG007|Treatment Period|Disease progression|17|||
23374483|NCT02017717|65116028|FG008|Treatment Period|Disease progression|22|||
23374484|NCT02017717|65116020|FG000|Treatment Period|Study drug toxicity|3|||
23374485|NCT02017717|65116021|FG001|Treatment Period|Study drug toxicity|0|||
23374486|NCT02017717|65116022|FG002|Treatment Period|Study drug toxicity|1|||
23374487|NCT02017717|65116023|FG003|Treatment Period|Study drug toxicity|7|||
23374488|NCT02017717|65116024|FG004|Treatment Period|Study drug toxicity|11|||
23374489|NCT02017717|65116025|FG005|Treatment Period|Study drug toxicity|4|||
23374490|NCT02017717|65116026|FG006|Treatment Period|Study drug toxicity|4|||
23374491|NCT02017717|65116027|FG007|Treatment Period|Study drug toxicity|5|||
23374492|NCT02017717|65116028|FG008|Treatment Period|Study drug toxicity|3|||
23374493|NCT02017717|65116020|FG000|Treatment Period|Death|0|||
23374494|NCT02017717|65116021|FG001|Treatment Period|Death|0|||
23374495|NCT02017717|65116022|FG002|Treatment Period|Death|1|||
23374496|NCT02017717|65116023|FG003|Treatment Period|Death|0|||
23374497|NCT02017717|65116024|FG004|Treatment Period|Death|0|||
23374498|NCT02017717|65116025|FG005|Treatment Period|Death|0|||
23374499|NCT02017717|65116026|FG006|Treatment Period|Death|0|||
23374500|NCT02017717|65116027|FG007|Treatment Period|Death|1|||
23374501|NCT02017717|65116028|FG008|Treatment Period|Death|0|||
23374502|NCT02017717|65116020|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
23374503|NCT02017717|65116021|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
23374504|NCT02017717|65116022|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
23374505|NCT02017717|65116023|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
23374506|NCT02017717|65116024|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
23374507|NCT02017717|65116025|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
23374508|NCT02017717|65116026|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
23374509|NCT02017717|65116027|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
23374510|NCT02017717|65116028|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
23374511|NCT02017717|65116020|FG000|Treatment Period|Participant request to stop therapy|0|||
23374512|NCT02017717|65116021|FG001|Treatment Period|Participant request to stop therapy|0|||
23374513|NCT02017717|65116022|FG002|Treatment Period|Participant request to stop therapy|3|||
23374514|NCT02017717|65116023|FG003|Treatment Period|Participant request to stop therapy|4|||
23603974|NCT04248868|65940235|FG000|Overall Study|Protocol Violation|2|||
23282130|NCT00858780|64776186|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
23282131|NCT00858780|64776187|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
23374515|NCT02017717|65116024|FG004|Treatment Period|Participant request to stop therapy|7|||
23374516|NCT02017717|65116025|FG005|Treatment Period|Participant request to stop therapy|5|||
23374517|NCT02017717|65116026|FG006|Treatment Period|Participant request to stop therapy|0|||
23374518|NCT02017717|65116027|FG007|Treatment Period|Participant request to stop therapy|2|||
23374519|NCT02017717|65116028|FG008|Treatment Period|Participant request to stop therapy|1|||
23374520|NCT02017717|65116020|FG000|Treatment Period|Participant withdrew consent|0|||
23374521|NCT02017717|65116021|FG001|Treatment Period|Participant withdrew consent|0|||
23374522|NCT02017717|65116022|FG002|Treatment Period|Participant withdrew consent|1|||
23374523|NCT02017717|65116023|FG003|Treatment Period|Participant withdrew consent|1|||
23374524|NCT02017717|65116024|FG004|Treatment Period|Participant withdrew consent|4|||
23374525|NCT02017717|65116025|FG005|Treatment Period|Participant withdrew consent|0|||
23282132|NCT02028715|64776188|FG000|Overall Study|Adverse Event|2|||
23282133|NCT02028715|64776189|FG001|Overall Study|Adverse Event|2|||
23282134|NCT02028715|64776188|FG000|Overall Study|Physician Decision|1|||
23282135|NCT02028715|64776189|FG001|Overall Study|Physician Decision|0|||
23282136|NCT02028715|64776188|FG000|Overall Study|Did not complete satisfaction surveys|2|||
23282137|NCT02028715|64776189|FG001|Overall Study|Did not complete satisfaction surveys|2|||
23282138|NCT00669162|64776196|FG000|Overall Study|Withdrawal by Subject|1|||
23282139|NCT01647828|64776197|FG000|Overall Study|Death|3|||
23282140|NCT01647828|64776198|FG001|Overall Study|Death|4|||
23282141|NCT01647828|64776199|FG002|Overall Study|Death|4|||
23282142|NCT01647828|64776200|FG003|Overall Study|Death|5|||
23282143|NCT01647828|64776201|FG004|Overall Study|Death|6|||
23282144|NCT01647828|64776202|FG005|Overall Study|Death|3|||
23282145|NCT01647828|64776203|FG006|Overall Study|Death|10|||
23282146|NCT01647828|64776204|FG007|Overall Study|Death|60|||
23282147|NCT01647828|64776205|FG008|Overall Study|Death|71|||
23282148|NCT01647828|64776197|FG000|Overall Study|Withdrawal by Subject|2|||
23282149|NCT01647828|64776198|FG001|Overall Study|Withdrawal by Subject|0|||
23282150|NCT01647828|64776199|FG002|Overall Study|Withdrawal by Subject|0|||
23282151|NCT01647828|64776200|FG003|Overall Study|Withdrawal by Subject|1|||
23282152|NCT01647828|64776201|FG004|Overall Study|Withdrawal by Subject|0|||
23282153|NCT01647828|64776202|FG005|Overall Study|Withdrawal by Subject|0|||
23282154|NCT01647828|64776203|FG006|Overall Study|Withdrawal by Subject|1|||
23282155|NCT01647828|64776204|FG007|Overall Study|Withdrawal by Subject|0|||
23282156|NCT01647828|64776205|FG008|Overall Study|Withdrawal by Subject|2|||
23282157|NCT01647828|64776197|FG000|Overall Study|Study terminated by Sponsor|0|||
23282158|NCT01647828|64776198|FG001|Overall Study|Study terminated by Sponsor|0|||
23282159|NCT01647828|64776199|FG002|Overall Study|Study terminated by Sponsor|0|||
23282160|NCT01647828|64776200|FG003|Overall Study|Study terminated by Sponsor|0|||
23282161|NCT01647828|64776201|FG004|Overall Study|Study terminated by Sponsor|0|||
23282162|NCT01647828|64776202|FG005|Overall Study|Study terminated by Sponsor|0|||
23282163|NCT01647828|64776203|FG006|Overall Study|Study terminated by Sponsor|1|||
23282164|NCT01647828|64776204|FG007|Overall Study|Study terminated by Sponsor|26|||
23282165|NCT01647828|64776205|FG008|Overall Study|Study terminated by Sponsor|16|||
23282166|NCT01647828|64776197|FG000|Overall Study|Lost to Follow-up|0|||
23282167|NCT01647828|64776198|FG001|Overall Study|Lost to Follow-up|0|||
23282168|NCT01647828|64776199|FG002|Overall Study|Lost to Follow-up|0|||
23282169|NCT01647828|64776200|FG003|Overall Study|Lost to Follow-up|0|||
23282170|NCT01647828|64776201|FG004|Overall Study|Lost to Follow-up|0|||
23282171|NCT01647828|64776202|FG005|Overall Study|Lost to Follow-up|0|||
23282172|NCT01647828|64776203|FG006|Overall Study|Lost to Follow-up|0|||
23282173|NCT01647828|64776204|FG007|Overall Study|Lost to Follow-up|2|||
23282174|NCT01647828|64776205|FG008|Overall Study|Lost to Follow-up|0|||
23282175|NCT03261167|64776206|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
23282176|NCT03261167|64776207|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
23282177|NCT03261167|64776206|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
23282178|NCT03261167|64776207|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
23282179|NCT03261167|64776206|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
23282180|NCT03261167|64776207|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
23282181|NCT03261167|64776206|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
23282182|NCT03261167|64776207|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
23282183|NCT03261167|64776206|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
23282184|NCT03261167|64776207|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
23282185|NCT00009945|64776208|FG000|Overall Study|no follow up data|7|||
23282186|NCT00009945|64776209|FG001|Overall Study|no follow up data|5|||
23282187|NCT05479058|64776216|FG000|Overall Study|Withdrawal by Subject|1|||
23282188|NCT05479058|64776217|FG001|Overall Study|Withdrawal by Subject|1|||
23282189|NCT05479058|64776216|FG000|Overall Study|Study terminated by sponsor|10|||
23282190|NCT05479058|64776217|FG001|Overall Study|Study terminated by sponsor|10|||
23374526|NCT02017717|65116026|FG006|Treatment Period|Participant withdrew consent|0|||
23488176|NCT01614600|65533771|FG000|Overall Study|Discomfort|1|||
23374527|NCT02017717|65116027|FG007|Treatment Period|Participant withdrew consent|2|||
23374528|NCT02017717|65116028|FG008|Treatment Period|Participant withdrew consent|0|||
23374529|NCT02017717|65116020|FG000|Treatment Period|Participant no longer met criteria|0|||
23374530|NCT02017717|65116021|FG001|Treatment Period|Participant no longer met criteria|0|||
23374531|NCT02017717|65116022|FG002|Treatment Period|Participant no longer met criteria|0|||
23374532|NCT02017717|65116023|FG003|Treatment Period|Participant no longer met criteria|0|||
23374533|NCT02017717|65116024|FG004|Treatment Period|Participant no longer met criteria|1|||
23374534|NCT02017717|65116025|FG005|Treatment Period|Participant no longer met criteria|0|||
23374535|NCT02017717|65116026|FG006|Treatment Period|Participant no longer met criteria|0|||
23374536|NCT02017717|65116027|FG007|Treatment Period|Participant no longer met criteria|0|||
23374537|NCT02017717|65116028|FG008|Treatment Period|Participant no longer met criteria|0|||
23374538|NCT02017717|65116020|FG000|Treatment Period|other reasons|0|||
23374539|NCT02017717|65116021|FG001|Treatment Period|other reasons|0|||
23374540|NCT02017717|65116022|FG002|Treatment Period|other reasons|0|||
23374541|NCT02017717|65116023|FG003|Treatment Period|other reasons|0|||
23374542|NCT02017717|65116024|FG004|Treatment Period|other reasons|1|||
23374543|NCT02017717|65116025|FG005|Treatment Period|other reasons|0|||
23374544|NCT02017717|65116026|FG006|Treatment Period|other reasons|0|||
23374545|NCT02017717|65116027|FG007|Treatment Period|other reasons|1|||
23374546|NCT02017717|65116028|FG008|Treatment Period|other reasons|1|||
23374547|NCT02017717|65116020|FG000|Treatment Period|Maximum clinical benefit|0|||
23374548|NCT02017717|65116021|FG001|Treatment Period|Maximum clinical benefit|0|||
23374549|NCT02017717|65116022|FG002|Treatment Period|Maximum clinical benefit|0|||
23374550|NCT02017717|65116023|FG003|Treatment Period|Maximum clinical benefit|0|||
23374551|NCT02017717|65116024|FG004|Treatment Period|Maximum clinical benefit|1|||
23374552|NCT02017717|65116025|FG005|Treatment Period|Maximum clinical benefit|0|||
23374553|NCT02017717|65116026|FG006|Treatment Period|Maximum clinical benefit|0|||
23374554|NCT02017717|65116027|FG007|Treatment Period|Maximum clinical benefit|0|||
23374555|NCT02017717|65116028|FG008|Treatment Period|Maximum clinical benefit|0|||
23374556|NCT00715208|65116029|FG000|Overall Study|Withdrawal by Subject|1|||
23374557|NCT00715208|65116030|FG001|Overall Study|Withdrawal by Subject|1|||
23374558|NCT00715208|65116029|FG000|Overall Study|Adverse Event|0|||
23374559|NCT00715208|65116030|FG001|Overall Study|Adverse Event|6|||
23374560|NCT00715208|65116029|FG000|Overall Study|Lack of Efficacy|0|||
23374561|NCT00715208|65116030|FG001|Overall Study|Lack of Efficacy|2|||
23374562|NCT00251758|65116033|FG000|Overall Study|Adverse Event|7|||
23374563|NCT00251758|65116034|FG001|Overall Study|Adverse Event|9|||
23374564|NCT00251758|65116035|FG002|Overall Study|Adverse Event|11|||
23374565|NCT00251758|65116033|FG000|Overall Study|Lost to Follow-up|4|||
23374566|NCT00251758|65116034|FG001|Overall Study|Lost to Follow-up|2|||
23374567|NCT00251758|65116035|FG002|Overall Study|Lost to Follow-up|5|||
23374568|NCT00251758|65116033|FG000|Overall Study|Withdrawal by Subject|13|||
23374569|NCT00251758|65116034|FG001|Overall Study|Withdrawal by Subject|7|||
23374570|NCT00251758|65116035|FG002|Overall Study|Withdrawal by Subject|3|||
23374571|NCT00251758|65116033|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
23374572|NCT00251758|65116034|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
23374573|NCT00251758|65116035|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
23374574|NCT00251758|65116033|FG000|Overall Study|Lack of Efficacy|3|||
23374575|NCT00251758|65116034|FG001|Overall Study|Lack of Efficacy|0|||
23374576|NCT00251758|65116035|FG002|Overall Study|Lack of Efficacy|0|||
23374577|NCT00251758|65116033|FG000|Overall Study|Noncompliant|0|||
23374578|NCT00251758|65116034|FG001|Overall Study|Noncompliant|2|||
23374579|NCT00251758|65116035|FG002|Overall Study|Noncompliant|2|||
23374580|NCT00251758|65116033|FG000|Overall Study|Pregnancy|0|||
23374581|NCT00251758|65116034|FG001|Overall Study|Pregnancy|1|||
23374582|NCT00251758|65116035|FG002|Overall Study|Pregnancy|0|||
23374583|NCT00251758|65116033|FG000|Overall Study|Per Subject Request|0|||
23374584|NCT00251758|65116034|FG001|Overall Study|Per Subject Request|0|||
23374585|NCT00251758|65116035|FG002|Overall Study|Per Subject Request|1|||
23374586|NCT00251758|65116033|FG000|Overall Study|Per Investigator Request|1|||
23374587|NCT00251758|65116034|FG001|Overall Study|Per Investigator Request|0|||
23374588|NCT00251758|65116035|FG002|Overall Study|Per Investigator Request|0|||
23374589|NCT00797563|65116036|FG000|Overall Study|Adverse Event|1|||
23374590|NCT01184872|65116037|FG000|Overall Study|Adverse Event|3|||
23374591|NCT01184872|65116038|FG001|Overall Study|Adverse Event|4|||
23374592|NCT01184872|65116037|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
23374593|NCT01184872|65116038|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23374594|NCT01184872|65116037|FG000|Overall Study|Withdrawal by Subject|2|||
23374595|NCT01184872|65116038|FG001|Overall Study|Withdrawal by Subject|0|||
23374596|NCT01184872|65116037|FG000|Overall Study|Lost to Follow-up|0|||
23374597|NCT01184872|65116038|FG001|Overall Study|Lost to Follow-up|1|||
23374598|NCT01184872|65116037|FG000|Overall Study|Administrative problems|1|||
23374599|NCT01184872|65116038|FG001|Overall Study|Administrative problems|1|||
23374600|NCT01184872|65116037|FG000|Overall Study|Protocol deviation|1|||
23374601|NCT01184872|65116038|FG001|Overall Study|Protocol deviation|0|||
23374602|NCT00855218|65116040|FG000|Overall Study|Adverse Event|43|||
23374603|NCT00855218|65116041|FG001|Overall Study|Adverse Event|27|||
23374604|NCT00855218|65116040|FG000|Overall Study|Withdrawal by Subject|10|||
23374605|NCT00855218|65116041|FG001|Overall Study|Withdrawal by Subject|6|||
23374606|NCT00855218|65116040|FG000|Overall Study|Physician Decision|18|||
23374607|NCT00855218|65116041|FG001|Overall Study|Physician Decision|11|||
23374608|NCT00855218|65116040|FG000|Overall Study|Lost to Follow-up|0|||
23374609|NCT00855218|65116041|FG001|Overall Study|Lost to Follow-up|1|||
23374610|NCT00855218|65116040|FG000|Overall Study|Protocol Violation|5|||
23374611|NCT00855218|65116041|FG001|Overall Study|Protocol Violation|9|||
23374612|NCT00855218|65116040|FG000|Overall Study|non-compliant with study drug|3|||
23374613|NCT00855218|65116041|FG001|Overall Study|non-compliant with study drug|1|||
23374614|NCT00855218|65116040|FG000|Overall Study|patient convenience|2|||
23374615|NCT00855218|65116041|FG001|Overall Study|patient convenience|0|||
23374616|NCT00855218|65116040|FG000|Overall Study|technical problems|2|||
23374617|NCT00855218|65116041|FG001|Overall Study|technical problems|1|||
23374618|NCT00855218|65116040|FG000|Overall Study|Still treated with study medication|0|||
23374619|NCT00855218|65116041|FG001|Overall Study|Still treated with study medication|1|||
23374620|NCT00855218|65116040|FG000|Overall Study|Untreatable disease progression|54|||
23374621|NCT00855218|65116041|FG001|Overall Study|Untreatable disease progression|67|||
23374622|NCT00855218|65116040|FG000|Overall Study|Second malignancy|0|||
23374623|NCT00855218|65116041|FG001|Overall Study|Second malignancy|1|||
23374624|NCT00855218|65116040|FG000|Overall Study|Progression measurement proven|7|||
23374625|NCT00855218|65116041|FG001|Overall Study|Progression measurement proven|15|||
23374626|NCT00855218|65116040|FG000|Overall Study|Clinical endpoint reached|10|||
23374627|NCT00855218|65116041|FG001|Overall Study|Clinical endpoint reached|13|||
23374628|NCT00903968|65116042|FG000|Overall Study|Adverse Event|0|||
23374629|NCT00903968|65116043|FG001|Overall Study|Adverse Event|0|||
23282191|NCT05034874|64776220|FG000|Overall Study|Withdrawal by Subject|6|||
23282192|NCT05034874|64776221|FG001|Overall Study|Withdrawal by Subject|6|||
23282193|NCT05034874|64776220|FG000|Overall Study|Lost to Follow-up|18|||
23282194|NCT05034874|64776221|FG001|Overall Study|Lost to Follow-up|8|||
23282195|NCT05034874|64776220|FG000|Overall Study|Physician Decision|0|||
23282196|NCT05034874|64776221|FG001|Overall Study|Physician Decision|1|||
23282197|NCT05034874|64776220|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
23374630|NCT00903968|65116044|FG002|Overall Study|Adverse Event|0|||
23374631|NCT00903968|65116045|FG003|Overall Study|Adverse Event|0|||
23282198|NCT05034874|64776221|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
23282199|NCT02905435|64776224|FG000|Overall Study|Death|2|||
23282200|NCT02905435|64776224|FG000|Overall Study|Physician Decision|1|||
23282201|NCT02905435|64776224|FG000|Overall Study|Lost to Follow-up|4|||
23282202|NCT01919112|64776225|FG000|Secondary Analysis-day 30|Death|1|||
23282203|NCT01919112|64776226|FG001|Secondary Analysis-day 30|Death|1|||
23374632|NCT00903968|65116046|FG004|Overall Study|Adverse Event|0|||
23374633|NCT00903968|65116047|FG005|Overall Study|Adverse Event|0|||
23374634|NCT00903968|65116048|FG006|Overall Study|Adverse Event|1|||
23374635|NCT00903968|65116049|FG007|Overall Study|Adverse Event|8|||
23374636|NCT00903968|65116042|FG000|Overall Study|DLT|0|||
23374637|NCT00903968|65116043|FG001|Overall Study|DLT|0|||
23374638|NCT00903968|65116044|FG002|Overall Study|DLT|0|||
23374639|NCT00903968|65116045|FG003|Overall Study|DLT|0|||
23374640|NCT00903968|65116046|FG004|Overall Study|DLT|0|||
23374641|NCT00903968|65116047|FG005|Overall Study|DLT|0|||
23374642|NCT00903968|65116048|FG006|Overall Study|DLT|2|||
23374643|NCT00903968|65116049|FG007|Overall Study|DLT|0|||
23374644|NCT00903968|65116042|FG000|Overall Study|Withdrawal by Subject|1|||
23374645|NCT00903968|65116043|FG001|Overall Study|Withdrawal by Subject|0|||
23374646|NCT00903968|65116044|FG002|Overall Study|Withdrawal by Subject|1|||
23374647|NCT00903968|65116045|FG003|Overall Study|Withdrawal by Subject|0|||
23374648|NCT00903968|65116046|FG004|Overall Study|Withdrawal by Subject|1|||
23374649|NCT00903968|65116047|FG005|Overall Study|Withdrawal by Subject|1|||
23374650|NCT00903968|65116048|FG006|Overall Study|Withdrawal by Subject|0|||
23374651|NCT00903968|65116049|FG007|Overall Study|Withdrawal by Subject|4|||
23374652|NCT00903968|65116042|FG000|Overall Study|Non-Compliance|0|||
23374653|NCT00903968|65116043|FG001|Overall Study|Non-Compliance|0|||
23374654|NCT00903968|65116044|FG002|Overall Study|Non-Compliance|0|||
23374655|NCT00903968|65116045|FG003|Overall Study|Non-Compliance|0|||
23374656|NCT00903968|65116046|FG004|Overall Study|Non-Compliance|0|||
23374657|NCT00903968|65116047|FG005|Overall Study|Non-Compliance|1|||
23374658|NCT00903968|65116048|FG006|Overall Study|Non-Compliance|0|||
23374659|NCT00903968|65116049|FG007|Overall Study|Non-Compliance|0|||
23374660|NCT00903968|65116042|FG000|Overall Study|Physician Decision|0|||
23374661|NCT00903968|65116043|FG001|Overall Study|Physician Decision|0|||
23374662|NCT00903968|65116044|FG002|Overall Study|Physician Decision|0|||
23282204|NCT01919112|64776227|FG002|Secondary Analysis-day 30|Death|1|||
23282205|NCT01919112|64776225|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
23374663|NCT00903968|65116045|FG003|Overall Study|Physician Decision|0|||
23374664|NCT00903968|65116046|FG004|Overall Study|Physician Decision|0|||
23374665|NCT00903968|65116047|FG005|Overall Study|Physician Decision|1|||
23374666|NCT00903968|65116048|FG006|Overall Study|Physician Decision|0|||
23374667|NCT00903968|65116049|FG007|Overall Study|Physician Decision|0|||
23374668|NCT00903968|65116042|FG000|Overall Study|Progressive Disease|2|||
23374669|NCT00903968|65116043|FG001|Overall Study|Progressive Disease|3|||
23374670|NCT00903968|65116044|FG002|Overall Study|Progressive Disease|2|||
23374671|NCT00903968|65116045|FG003|Overall Study|Progressive Disease|3|||
23374672|NCT00903968|65116046|FG004|Overall Study|Progressive Disease|3|||
23374673|NCT00903968|65116047|FG005|Overall Study|Progressive Disease|3|||
23374674|NCT00903968|65116048|FG006|Overall Study|Progressive Disease|0|||
23374675|NCT00903968|65116049|FG007|Overall Study|Progressive Disease|18|||
23374676|NCT00903968|65116042|FG000|Overall Study|Lack of Efficacy|0|||
23374677|NCT00903968|65116043|FG001|Overall Study|Lack of Efficacy|0|||
23374678|NCT00903968|65116044|FG002|Overall Study|Lack of Efficacy|0|||
23374679|NCT00903968|65116045|FG003|Overall Study|Lack of Efficacy|0|||
23374680|NCT00903968|65116046|FG004|Overall Study|Lack of Efficacy|0|||
23374681|NCT00903968|65116047|FG005|Overall Study|Lack of Efficacy|0|||
23374682|NCT00903968|65116048|FG006|Overall Study|Lack of Efficacy|0|||
23374683|NCT00903968|65116049|FG007|Overall Study|Lack of Efficacy|3|||
23374684|NCT01316614|65116052|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
23374685|NCT01316614|65116052|FG000|Overall Study|Cytology slides not available for review|4|||
23374686|NCT01316614|65116052|FG000|Overall Study|Cystic lesion|5|||
23374687|NCT01316614|65116052|FG000|Overall Study|Inadequate number of passes|2|||
23374688|NCT01316614|65116052|FG000|Overall Study|Medically unstable|1|||
23374689|NCT02990000|65116053|FG000|Overall Study|Failed to provide data beyond baseline|36|||
23374690|NCT02990000|65116054|FG001|Overall Study|Failed to provide data beyond baseline|34|||
23374691|NCT02014272|65116057|FG000|Intervention Period 1|Withdrawal by Subject|1|||
23374692|NCT02014272|65116058|FG001|Intervention Period 1|Withdrawal by Subject|0|||
23374693|NCT02014272|65116057|FG000|Intervention Period 1|Adverse Event|0|||
23374694|NCT02014272|65116058|FG001|Intervention Period 1|Adverse Event|1|||
23374695|NCT03883386|65116062|FG000|First Assignment|Lost to Follow-up|1|||
23374696|NCT03883386|65116063|FG001|First Assignment|Lost to Follow-up|0|||
23374697|NCT03883386|65116062|FG000|First Assignment|Withdrawal by Subject|1|||
23374698|NCT03883386|65116063|FG001|First Assignment|Withdrawal by Subject|1|||
23374699|NCT04745351|65116064|FG000|Overall Study|Death|51|||
23374700|NCT04745351|65116065|FG001|Overall Study|Death|25|||
23374701|NCT04745351|65116064|FG000|Overall Study|Lost to Follow-up|9|||
23374702|NCT04745351|65116065|FG001|Overall Study|Lost to Follow-up|3|||
23374703|NCT04745351|65116064|FG000|Overall Study|Randomized but Never Treated|3|||
23374704|NCT04745351|65116065|FG001|Overall Study|Randomized but Never Treated|3|||
23374705|NCT04745351|65116064|FG000|Overall Study|Adverse Event|4|||
23374706|NCT04745351|65116065|FG001|Overall Study|Adverse Event|0|||
23374707|NCT04745351|65116064|FG000|Overall Study|Withdrew Consent|1|||
23374708|NCT04745351|65116065|FG001|Overall Study|Withdrew Consent|2|||
23374709|NCT04745351|65116064|FG000|Overall Study|Investigator's Discretion|2|||
23374710|NCT04745351|65116065|FG001|Overall Study|Investigator's Discretion|0|||
23374711|NCT04745351|65116064|FG000|Overall Study|Protocol Violation|1|||
23374712|NCT04745351|65116065|FG001|Overall Study|Protocol Violation|0|||
23374713|NCT02391337|65116066|FG000|6 Months Follow-up|Death|5|||
23374714|NCT02391337|65116067|FG001|6 Months Follow-up|Death|4|||
23374715|NCT02391337|65116066|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
23374716|NCT02391337|65116067|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
23374717|NCT02391337|65116066|FG000|12 Months Follow-up|Death|2|||
23374718|NCT02391337|65116067|FG001|12 Months Follow-up|Death|0|||
23374719|NCT02391337|65116066|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
23374720|NCT02391337|65116067|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
23374721|NCT02391337|65116066|FG000|12 Months Follow-up|Lost to Follow-up|0|||
23374722|NCT02391337|65116067|FG001|12 Months Follow-up|Lost to Follow-up|2|||
23374723|NCT01130272|65116068|FG000|Overall Study|Adverse Event|2|||
23374724|NCT01130272|65116069|FG001|Overall Study|Adverse Event|5|||
23374725|NCT01130272|65116070|FG002|Overall Study|Adverse Event|6|||
23374726|NCT01130272|65116071|FG003|Overall Study|Adverse Event|22|||
23374727|NCT01130272|65116072|FG004|Overall Study|Adverse Event|7|||
23374728|NCT01130272|65116068|FG000|Overall Study|IVRS-confirmed constipation|0|||
23374729|NCT01130272|65116069|FG001|Overall Study|IVRS-confirmed constipation|1|||
23374730|NCT01130272|65116070|FG002|Overall Study|IVRS-confirmed constipation|1|||
23374731|NCT01130272|65116071|FG003|Overall Study|IVRS-confirmed constipation|2|||
23374732|NCT01130272|65116072|FG004|Overall Study|IVRS-confirmed constipation|0|||
23374733|NCT01130272|65116068|FG000|Overall Study|Rescue medications due to diarrhea|3|||
23374734|NCT01130272|65116069|FG001|Overall Study|Rescue medications due to diarrhea|5|||
23374735|NCT01130272|65116070|FG002|Overall Study|Rescue medications due to diarrhea|8|||
23374736|NCT01130272|65116071|FG003|Overall Study|Rescue medications due to diarrhea|8|||
23374737|NCT01130272|65116072|FG004|Overall Study|Rescue medications due to diarrhea|6|||
23603975|NCT03735849|65940236|FG000|Overall Study|Lost to Follow-up|1|||
23374738|NCT01130272|65116068|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
23374739|NCT01130272|65116069|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
23374740|NCT01130272|65116070|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
23603976|NCT03735849|65940237|FG001|Overall Study|Lost to Follow-up|0|||
23374741|NCT01130272|65116071|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
23603977|NCT03735849|65940238|FG002|Overall Study|Lost to Follow-up|0|||
23374742|NCT01130272|65116072|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
23374743|NCT01130272|65116068|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
23374744|NCT01130272|65116069|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
23374745|NCT01130272|65116070|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
23374746|NCT01130272|65116071|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
23374747|NCT01130272|65116072|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
23374748|NCT01130272|65116068|FG000|Overall Study|Protocol Violation|0|||
23374749|NCT01130272|65116069|FG001|Overall Study|Protocol Violation|0|||
23374750|NCT01130272|65116070|FG002|Overall Study|Protocol Violation|3|||
23374751|NCT01130272|65116071|FG003|Overall Study|Protocol Violation|5|||
23374752|NCT01130272|65116072|FG004|Overall Study|Protocol Violation|5|||
23374753|NCT01130272|65116068|FG000|Overall Study|Lost to Follow-up|4|||
23374754|NCT01130272|65116069|FG001|Overall Study|Lost to Follow-up|3|||
23374755|NCT01130272|65116070|FG002|Overall Study|Lost to Follow-up|4|||
23374756|NCT01130272|65116071|FG003|Overall Study|Lost to Follow-up|7|||
23374757|NCT01130272|65116072|FG004|Overall Study|Lost to Follow-up|6|||
23374758|NCT01130272|65116068|FG000|Overall Study|Withdrawal by Subject|4|||
23374759|NCT01130272|65116069|FG001|Overall Study|Withdrawal by Subject|11|||
23374760|NCT01130272|65116070|FG002|Overall Study|Withdrawal by Subject|10|||
23374761|NCT01130272|65116071|FG003|Overall Study|Withdrawal by Subject|9|||
23374762|NCT01130272|65116072|FG004|Overall Study|Withdrawal by Subject|8|||
23374763|NCT01130272|65116068|FG000|Overall Study|Physician Decision|1|||
23374764|NCT01130272|65116069|FG001|Overall Study|Physician Decision|1|||
23374765|NCT01130272|65116070|FG002|Overall Study|Physician Decision|0|||
23374766|NCT01130272|65116071|FG003|Overall Study|Physician Decision|1|||
23374767|NCT01130272|65116072|FG004|Overall Study|Physician Decision|2|||
23374768|NCT01130272|65116068|FG000|Overall Study|Sponsor decision|6|||
23374769|NCT01130272|65116069|FG001|Overall Study|Sponsor decision|15|||
23374770|NCT01130272|65116070|FG002|Overall Study|Sponsor decision|16|||
23374771|NCT01130272|65116071|FG003|Overall Study|Sponsor decision|13|||
23374772|NCT01130272|65116072|FG004|Overall Study|Sponsor decision|16|||
23374773|NCT01130272|65116068|FG000|Overall Study|Study arm discontinued|38|||
23374774|NCT01130272|65116069|FG001|Overall Study|Study arm discontinued|0|||
23374775|NCT01130272|65116070|FG002|Overall Study|Study arm discontinued|0|||
23374776|NCT01130272|65116071|FG003|Overall Study|Study arm discontinued|0|||
23374777|NCT01130272|65116072|FG004|Overall Study|Study arm discontinued|0|||
23374778|NCT02029417|65116073|FG000|Overall Study|Death|1|||
23374779|NCT02029417|65116073|FG000|Overall Study|Adverse Event|1|||
23374780|NCT00142415|65116074|FG000|Overall Study|Physician Decision|0|||
23374781|NCT00142415|65116075|FG001|Overall Study|Physician Decision|0|||
23374782|NCT00142415|65116076|FG002|Overall Study|Physician Decision|0|||
23374783|NCT00142415|65116077|FG003|Overall Study|Physician Decision|0|||
23374784|NCT00142415|65116078|FG004|Overall Study|Physician Decision|1|||
23374785|NCT00142415|65116079|FG005|Overall Study|Physician Decision|2|||
23374786|NCT01240746|65116080|FG000|Overall Study|Adverse Event|2|||
23374787|NCT01240746|65116081|FG001|Overall Study|Adverse Event|0|||
23374788|NCT01240746|65116082|FG002|Overall Study|Adverse Event|10|||
23374789|NCT01240746|65116080|FG000|Overall Study|Lost to Follow-up|23|||
23374790|NCT01240746|65116081|FG001|Overall Study|Lost to Follow-up|20|||
23374791|NCT01240746|65116082|FG002|Overall Study|Lost to Follow-up|102|||
23374792|NCT01240746|65116080|FG000|Overall Study|Protocol Violation|24|||
23374793|NCT01240746|65116081|FG001|Overall Study|Protocol Violation|15|||
23282206|NCT01919112|64776226|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
23282207|NCT01919112|64776227|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
23282208|NCT02450539|64776230|FG000|Overall Study|Withdrawal by Subject|12|||
23282209|NCT02450539|64776231|FG001|Overall Study|Withdrawal by Subject|6|||
23282210|NCT02450539|64776230|FG000|Overall Study|Lost to Follow-up|4|||
23374794|NCT01240746|65116082|FG002|Overall Study|Protocol Violation|72|||
23374795|NCT01240746|65116080|FG000|Overall Study|Withdrawal by Subject|10|||
23374796|NCT01240746|65116081|FG001|Overall Study|Withdrawal by Subject|13|||
23374797|NCT01240746|65116082|FG002|Overall Study|Withdrawal by Subject|59|||
23374798|NCT04748718|65116088|FG000|Overall Study|Lost to Follow-up|50|||
23374799|NCT01408641|65116090|FG000|Overall Study|Physician Decision|1|||
23488177|NCT01614600|65533771|FG000|Overall Study|Unable to remove lens at the end of day|1|||
23488178|NCT01614600|65533771|FG000|Overall Study|Protocol deviation|1|||
23488179|NCT03923738|65533774|FG000|Period 1|Adverse Event|1|||
23488180|NCT03923738|65533774|FG000|Period 1|Withdrawal by Subject|1|||
23374800|NCT01408641|65116091|FG001|Overall Study|Physician Decision|0|||
23374801|NCT02152007|65116094|FG000|Overall Study|Withdrawal by Subject|1|||
23374802|NCT02394756|65116105|FG000|Period 1|Lens Discomfort|0|||
23374803|NCT02394756|65116106|FG001|Period 1|Lens Discomfort|0|||
23374804|NCT02394756|65116107|FG002|Period 1|Lens Discomfort|0|||
23374805|NCT02394756|65116108|FG003|Period 1|Lens Discomfort|0|||
23374806|NCT02394756|65116109|FG004|Period 1|Lens Discomfort|0|||
23374807|NCT02394756|65116110|FG005|Period 1|Lens Discomfort|1|||
23374808|NCT02394756|65116105|FG000|Period 1|Withdrawal by Subject|0|||
23374809|NCT02394756|65116106|FG001|Period 1|Withdrawal by Subject|1|||
23374810|NCT02394756|65116107|FG002|Period 1|Withdrawal by Subject|1|||
23282211|NCT02450539|64776231|FG001|Overall Study|Lost to Follow-up|1|||
23374811|NCT02394756|65116108|FG003|Period 1|Withdrawal by Subject|1|||
23374812|NCT02394756|65116109|FG004|Period 1|Withdrawal by Subject|0|||
23374813|NCT02394756|65116110|FG005|Period 1|Withdrawal by Subject|0|||
23488181|NCT00880685|65533776|FG000|Memantine 10mg|Lost to Follow-up|2|||
23488182|NCT00880685|65533776|FG000|Memantine 20mg|Withdrawal by Subject|1|||
23488183|NCT02169284|65533782|FG000|Overall Study|Physician Decision|0|||
23488184|NCT02169284|65533783|FG001|Overall Study|Physician Decision|1|||
23488185|NCT01130103|65533784|FG000|Randomized Treatment|Adverse Event|1|||
23282212|NCT00540423|64776232|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23282213|NCT00540423|64776233|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23282214|NCT00540423|64776234|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23282215|NCT00540423|64776232|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
23282216|NCT00540423|64776233|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
23282217|NCT00540423|64776234|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
23282218|NCT02300103|64776241|FG000|Overall Study|Lack of Efficacy|3|||
23282219|NCT02300103|64776241|FG000|Overall Study|Protocol Violation|1|||
23374814|NCT02394756|65116105|FG000|Period 2|Unsatisfactory Visual Response|0|||
23374815|NCT02394756|65116106|FG001|Period 2|Unsatisfactory Visual Response|0|||
23374816|NCT02394756|65116107|FG002|Period 2|Unsatisfactory Visual Response|0|||
23374817|NCT02394756|65116108|FG003|Period 2|Unsatisfactory Visual Response|0|||
23374818|NCT02394756|65116109|FG004|Period 2|Unsatisfactory Visual Response|1|||
23374819|NCT02394756|65116110|FG005|Period 2|Unsatisfactory Visual Response|0|||
23488186|NCT01130103|65533785|FG001|Randomized Treatment|Adverse Event|1|||
23488187|NCT01130103|65533784|FG000|Randomized Treatment|Lost to Follow-up|1|||
23374820|NCT00817063|65116112|FG000|Overall Study|Adverse Event|32|||
23488188|NCT01130103|65533785|FG001|Randomized Treatment|Lost to Follow-up|0|||
23488189|NCT01130103|65533784|FG000|Randomized Treatment|Protocol Violation|3|||
23488190|NCT01130103|65533785|FG001|Randomized Treatment|Protocol Violation|2|||
23488191|NCT01130103|65533784|FG000|Randomized Treatment|Withdrawal by Subject|1|||
23488192|NCT01130103|65533785|FG001|Randomized Treatment|Withdrawal by Subject|2|||
23488193|NCT01130103|65533784|FG000|Maintenance Treatment|Lack of Efficacy|0|||
23488194|NCT01130103|65533785|FG001|Maintenance Treatment|Lack of Efficacy|1|||
23488195|NCT01130103|65533784|FG000|Maintenance Treatment|Lost to Follow-up|1|||
23488196|NCT01130103|65533785|FG001|Maintenance Treatment|Lost to Follow-up|1|||
23488197|NCT01130103|65533784|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
23488198|NCT01130103|65533785|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
23488199|NCT01736124|65533788|FG000|Post-intervention Assessment|Death|2|||
23488200|NCT01736124|65533789|FG001|Post-intervention Assessment|Death|2|||
23488201|NCT01736124|65533788|FG000|Post-intervention Assessment|lost computer access|1|||
23488202|NCT01736124|65533789|FG001|Post-intervention Assessment|lost computer access|1|||
23488203|NCT01736124|65533788|FG000|Post-intervention Assessment|Moved away|3|||
23488204|NCT01736124|65533789|FG001|Post-intervention Assessment|Moved away|1|||
23488205|NCT01736124|65533788|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
23488206|NCT01736124|65533789|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
23488207|NCT01736124|65533788|FG000|Post-intervention Assessment|Illness|3|||
23488208|NCT01736124|65533789|FG001|Post-intervention Assessment|Illness|2|||
23488209|NCT01736124|65533788|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
23488210|NCT01736124|65533789|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
23488211|NCT01736124|65533788|FG000|Post-intervention Assessment|Temporarily away|3|||
23488212|NCT01736124|65533789|FG001|Post-intervention Assessment|Temporarily away|1|||
23488213|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
23488214|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
23488215|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
23488216|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
23488217|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
23488218|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
23488219|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
23488220|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
23488221|NCT01736124|65533788|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
23488222|NCT01736124|65533789|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
23488223|NCT01736124|65533788|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
23488224|NCT01736124|65533789|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
23488225|NCT01736124|65533788|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
23488226|NCT01736124|65533789|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
23488227|NCT01736124|65533788|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
23488228|NCT01736124|65533789|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
23488229|NCT01736124|65533788|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
23488230|NCT01736124|65533789|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
23488231|NCT01674634|65533790|FG000|Overall Study|Withdrawal by Subject|3|||
23488232|NCT01674634|65533790|FG000|Overall Study|Lost to Follow-up|3|||
23488233|NCT01466179|65533793|FG000|Overall Study|Ongoing in core study|2|||
23488234|NCT01466179|65533793|FG000|Overall Study|Physician Decision|46|||
23488235|NCT01466179|65533793|FG000|Overall Study|Progressive disease|43|||
23488236|NCT01466179|65533793|FG000|Overall Study|Adverse Event|32|||
23488237|NCT01466179|65533793|FG000|Overall Study|Disease relapse|23|||
23488238|NCT01466179|65533793|FG000|Overall Study|Lack of Efficacy|14|||
23488239|NCT01466179|65533793|FG000|Overall Study|Death|7|||
23603978|NCT03735849|65940236|FG000|Overall Study|Participant unable to adhere to visit|1|||
23603979|NCT03735849|65940237|FG001|Overall Study|Participant unable to adhere to visit|0|||
23603980|NCT03735849|65940238|FG002|Overall Study|Participant unable to adhere to visit|0|||
23603981|NCT03735849|65940236|FG000|Overall Study|Not Randomized|0|||
23603982|NCT03735849|65940237|FG001|Overall Study|Not Randomized|0|||
23603983|NCT03735849|65940238|FG002|Overall Study|Not Randomized|4|||
23603984|NCT03009344|65940239|FG000|Overall Study|Lack of Efficacy|5|||
23603985|NCT03009344|65940239|FG000|Overall Study|Withdrawal by Subject|1|||
23603986|NCT03009344|65940239|FG000|Overall Study|Adverse Event|1|||
23603987|NCT02067663|65940241|FG000|Overall Study|Lost to Follow-up|13|||
23603988|NCT02067663|65940242|FG001|Overall Study|Lost to Follow-up|14|||
23488240|NCT01466179|65533793|FG000|Overall Study|Withdrawal by Subject|7|||
23488241|NCT01466179|65533793|FG000|Overall Study|Protocol Violation|2|||
23488242|NCT01466179|65533793|FG000|Overall Study|Other|3|||
23488243|NCT01104155|65533794|FG000|Overall Study|Adverse Event|15|||
23488244|NCT01104155|65533795|FG001|Overall Study|Adverse Event|8|||
23488245|NCT01104155|65533794|FG000|Overall Study|Participant choice|6|||
23488246|NCT01104155|65533795|FG001|Overall Study|Participant choice|5|||
23603989|NCT00019604|65940251|FG000|Overall Study|Death|1|||
23603990|NCT00019604|65940251|FG000|Overall Study|Progressive disease|23|||
23603991|NCT00019604|65940251|FG000|Overall Study|Refused treatment|1|||
23282220|NCT02300103|64776241|FG000|Overall Study|Withdrew Consent|2|||
23282221|NCT00834431|64776242|FG000|First Intervention|Adverse Event|0|||
23282222|NCT00834431|64776243|FG001|First Intervention|Adverse Event|1|||
23282223|NCT00834431|64776242|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
23282224|NCT00834431|64776243|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
23282225|NCT03499353|64776244|FG000|Treatment|Adverse Event|3|||
23282226|NCT03499353|64776244|FG000|Treatment|Progressive Disease|10|||
23282227|NCT03499353|64776244|FG000|Treatment|Other|1|||
23282228|NCT03499353|64776244|FG000|Treatment|Withdrawal by Subject|2|||
23282229|NCT03499353|64776244|FG000|Long-Term Follow-up|Death|2|||
23282230|NCT03499353|64776244|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
23282231|NCT03499353|64776244|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
23282232|NCT03669250|64776245|FG000|Overall Study|Adverse Event|0|||
23282233|NCT03669250|64776246|FG001|Overall Study|Adverse Event|0|||
23282234|NCT03669250|64776247|FG002|Overall Study|Adverse Event|0|||
23282235|NCT03669250|64776248|FG003|Overall Study|Adverse Event|0|||
23282236|NCT03669250|64776249|FG004|Overall Study|Adverse Event|1|||
23282237|NCT03669250|64776250|FG005|Overall Study|Adverse Event|0|||
23282238|NCT03669250|64776245|FG000|Overall Study|Withdrawal by Subject|0|||
23282239|NCT03669250|64776246|FG001|Overall Study|Withdrawal by Subject|1|||
23488247|NCT01104155|65533794|FG000|Overall Study|Withdrawal of consent|1|||
23488248|NCT01104155|65533795|FG001|Overall Study|Withdrawal of consent|1|||
23488249|NCT01104155|65533794|FG000|Overall Study|Other|3|||
23488250|NCT01104155|65533795|FG001|Overall Study|Other|4|||
23488251|NCT04399837|65533796|FG000|Overall Study|Other than listed|0|||
23488252|NCT04399837|65533797|FG001|Overall Study|Other than listed|2|||
23488253|NCT04399837|65533798|FG002|Overall Study|Other than listed|2|||
23282240|NCT03669250|64776247|FG002|Overall Study|Withdrawal by Subject|0|||
23282241|NCT03669250|64776248|FG003|Overall Study|Withdrawal by Subject|1|||
23282242|NCT03669250|64776249|FG004|Overall Study|Withdrawal by Subject|0|||
23282243|NCT03669250|64776250|FG005|Overall Study|Withdrawal by Subject|0|||
23282244|NCT02286466|64776251|FG000|Overall Study|Death|1|||
23282245|NCT02286466|64776252|FG001|Overall Study|Death|3|||
23374821|NCT00817063|65116113|FG001|Overall Study|Adverse Event|13|||
23374822|NCT00817063|65116112|FG000|Overall Study|Death|1|||
23374823|NCT00817063|65116113|FG001|Overall Study|Death|1|||
23374824|NCT00817063|65116112|FG000|Overall Study|Lack of Efficacy|33|||
23374825|NCT00817063|65116113|FG001|Overall Study|Lack of Efficacy|86|||
23374826|NCT00817063|65116112|FG000|Overall Study|Failure to Return|13|||
23374827|NCT00817063|65116113|FG001|Overall Study|Failure to Return|12|||
23374828|NCT00817063|65116112|FG000|Overall Study|Violation of Selection at Entry|7|||
23374829|NCT00817063|65116113|FG001|Overall Study|Violation of Selection at Entry|4|||
23374830|NCT00817063|65116112|FG000|Overall Study|Protocol Violation|3|||
23374831|NCT00817063|65116113|FG001|Overall Study|Protocol Violation|8|||
23374832|NCT00817063|65116112|FG000|Overall Study|Withdrawal by Subject|17|||
23374833|NCT00817063|65116113|FG001|Overall Study|Withdrawal by Subject|37|||
23374834|NCT00817063|65116112|FG000|Overall Study|Early Improvement|19|||
23374835|NCT00817063|65116113|FG001|Overall Study|Early Improvement|4|||
23374836|NCT00817063|65116112|FG000|Overall Study|Administrative|10|||
23374837|NCT00817063|65116113|FG001|Overall Study|Administrative|4|||
23374838|NCT00817063|65116112|FG000|Overall Study|Abnormality of Laboratory Test|2|||
23374839|NCT00817063|65116113|FG001|Overall Study|Abnormality of Laboratory Test|1|||
23488254|NCT04399837|65533799|FG003|Overall Study|Other than listed|3|||
23488255|NCT04399837|65533796|FG000|Overall Study|Withdrawal by Subject|1|||
23488256|NCT04399837|65533797|FG001|Overall Study|Withdrawal by Subject|2|||
23282246|NCT02286466|64776251|FG000|Overall Study|Withdrawal by Subject|5|||
23374840|NCT05172570|65116114|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
23374841|NCT05172570|65116115|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
23374842|NCT05172570|65116116|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
23374843|NCT05172570|65116114|FG000|Overall Study|PI Decision due to equipment shortages|0|||
23374844|NCT05172570|65116115|FG001|Overall Study|PI Decision due to equipment shortages|0|||
23488257|NCT04399837|65533798|FG002|Overall Study|Withdrawal by Subject|1|||
23488258|NCT04399837|65533799|FG003|Overall Study|Withdrawal by Subject|1|||
23488259|NCT04068610|65533800|FG000|Overall Study|Death|4|||
23488260|NCT04068610|65533801|FG001|Overall Study|Death|8|||
23488261|NCT04068610|65533802|FG002|Overall Study|Death|13|||
23488262|NCT04068610|65533800|FG000|Overall Study|Lost to Follow-up|0|||
23282247|NCT02286466|64776252|FG001|Overall Study|Withdrawal by Subject|2|||
23488263|NCT04068610|65533801|FG001|Overall Study|Lost to Follow-up|2|||
23488264|NCT04068610|65533802|FG002|Overall Study|Lost to Follow-up|0|||
23488265|NCT04068610|65533800|FG000|Overall Study|Withdrawal by Subject|0|||
23282248|NCT02286466|64776251|FG000|Overall Study|Lost to Follow-up|1|||
23282249|NCT02286466|64776252|FG001|Overall Study|Lost to Follow-up|4|||
23282250|NCT02286466|64776251|FG000|Overall Study|Declined Clinician Assessment|0|||
23282251|NCT02286466|64776252|FG001|Overall Study|Declined Clinician Assessment|1|||
23282252|NCT00957021|64776253|FG000|Overall Study|Death|5|||
23282253|NCT00957021|64776253|FG000|Overall Study|Lost to Follow-up|8|||
23488266|NCT04068610|65533801|FG001|Overall Study|Withdrawal by Subject|4|||
23488267|NCT04068610|65533802|FG002|Overall Study|Withdrawal by Subject|2|||
23488268|NCT04068610|65533800|FG000|Overall Study|Other|3|||
23488269|NCT04068610|65533801|FG001|Overall Study|Other|12|||
23488270|NCT04068610|65533802|FG002|Overall Study|Other|11|||
23488271|NCT01134731|65533803|FG000|Overall Study|Adverse Event|3|||
23488272|NCT01134731|65533804|FG001|Overall Study|Adverse Event|2|||
23488273|NCT01134731|65533805|FG002|Overall Study|Adverse Event|1|||
23488274|NCT01134731|65533803|FG000|Overall Study|Physician Decision|2|||
23603992|NCT00019604|65940251|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
23603993|NCT00019604|65940251|FG000|Overall Study|Going to have liver transplant|1|||
23603994|NCT00019604|65940251|FG000|Overall Study|Move to a different study|1|||
23603995|NCT00019604|65940251|FG000|Overall Study|Non compliant on systemic CH|1|||
23603996|NCT00019604|65940251|FG000|Overall Study|Non compliant|1|||
23603997|NCT00019604|65940251|FG000|Overall Study|Resectable disease|1|||
23603998|NCT00019604|65940251|FG000|Overall Study|Started new chemo regimen|1|||
23603999|NCT00019604|65940251|FG000|Overall Study|Pt going to immunotherapy study|1|||
23604000|NCT00019604|65940251|FG000|Overall Study|Too much disease|1|||
23604001|NCT00019604|65940251|FG000|Overall Study|Unable to evaluate|1|||
23604002|NCT00019604|65940251|FG000|Overall Study|Details for other not available|4|||
23604003|NCT02454959|65940253|FG000|Overall Study|Protocol-Specified Criteria|3|||
23604004|NCT02454959|65940253|FG000|Overall Study|Physician Decision|1|||
23604005|NCT02454959|65940253|FG000|Overall Study|Withdrawal by Subject|3|||
23282254|NCT00957021|64776253|FG000|Overall Study|Withdrawal by Subject|34|||
23282255|NCT00957021|64776253|FG000|Overall Study|No 2 yr ROM data|35|||
23282256|NCT00957021|64776253|FG000|Overall Study|Revised study component by 2 yr visit|8|||
23282257|NCT00957021|64776253|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
23282258|NCT00957021|64776253|FG000|Overall Study|Surgery Cancelled|9|||
23282259|NCT00957021|64776253|FG000|Overall Study|Termination due to language issue|2|||
23282260|NCT02272803|64776254|FG000|Overall Study|Disease progression|16|||
23282261|NCT02272803|64776255|FG001|Overall Study|Disease progression|8|||
23282262|NCT02272803|64776254|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
23282263|NCT02272803|64776255|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
23282264|NCT02272803|64776254|FG000|Overall Study|Study drug toxicity|4|||
23282265|NCT02272803|64776255|FG001|Overall Study|Study drug toxicity|9|||
23282266|NCT02272803|64776254|FG000|Overall Study|Participant request to discontinue study treatment|3|||
23282267|NCT02272803|64776255|FG001|Overall Study|Participant request to discontinue study treatment|7|||
23282268|NCT02272803|64776254|FG000|Overall Study|Maximum clinical benefit|4|||
23282269|NCT02272803|64776255|FG001|Overall Study|Maximum clinical benefit|2|||
23282270|NCT02272803|64776254|FG000|Overall Study|Poor/non-compliance|2|||
23282271|NCT02272803|64776255|FG001|Overall Study|Poor/non-compliance|2|||
23282272|NCT02272803|64776254|FG000|Overall Study|Withdrawal by Subject|2|||
23282273|NCT02272803|64776255|FG001|Overall Study|Withdrawal by Subject|1|||
23282274|NCT02272803|64776254|FG000|Overall Study|Death|0|||
23282275|NCT02272803|64776255|FG001|Overall Study|Death|1|||
23282276|NCT02272803|64776254|FG000|Overall Study|Other reasons|1|||
23282277|NCT02272803|64776255|FG001|Overall Study|Other reasons|3|||
23282278|NCT02272803|64776254|FG000|Overall Study|Administrative reason by sponsor|5|||
23282279|NCT02272803|64776255|FG001|Overall Study|Administrative reason by sponsor|4|||
23282280|NCT05604014|64776256|FG000|Overall Study|Lost to Follow-up|13|||
23282281|NCT04281472|64776257|FG000|Stage A|Lack of Efficacy|8|||
23282282|NCT04281472|64776258|FG001|Stage A|Lack of Efficacy|0|||
23282283|NCT04281472|64776259|FG002|Stage A|Lack of Efficacy|0|||
23282284|NCT04281472|64776257|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
23282285|NCT04281472|64776258|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
23282286|NCT04281472|64776259|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
23282287|NCT04281472|64776257|FG000|Stage A|Adverse Event|20|||
23282288|NCT04281472|64776258|FG001|Stage A|Adverse Event|0|||
23282289|NCT04281472|64776259|FG002|Stage A|Adverse Event|0|||
23282290|NCT04281472|64776257|FG000|Stage A|Death|1|||
23282291|NCT04281472|64776258|FG001|Stage A|Death|0|||
23282292|NCT04281472|64776259|FG002|Stage A|Death|0|||
23282293|NCT04281472|64776257|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
23282294|NCT04281472|64776258|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
23282295|NCT04281472|64776259|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
23488275|NCT01134731|65533804|FG001|Overall Study|Physician Decision|2|||
23604006|NCT02454959|65940253|FG000|Overall Study|Adverse Event|2|||
23282296|NCT04281472|64776257|FG000|Stage A|Lost to Follow-up|2|||
23488276|NCT01134731|65533805|FG002|Overall Study|Physician Decision|2|||
23488277|NCT01134731|65533803|FG000|Overall Study|Lack of Efficacy|0|||
23604007|NCT00761267|65940257|FG000|Overall Study|Death|1|||
23604008|NCT00761267|65940258|FG001|Overall Study|Death|2|||
23282297|NCT04281472|64776258|FG001|Stage A|Lost to Follow-up|0|||
23282298|NCT04281472|64776259|FG002|Stage A|Lost to Follow-up|0|||
23282299|NCT04281472|64776257|FG000|Stage A|Non-compliance with study drug|1|||
23282300|NCT04281472|64776258|FG001|Stage A|Non-compliance with study drug|0|||
23282301|NCT04281472|64776259|FG002|Stage A|Non-compliance with study drug|0|||
23282302|NCT04281472|64776257|FG000|Stage A|Physician Decision|1|||
23282303|NCT04281472|64776258|FG001|Stage A|Physician Decision|0|||
23282304|NCT04281472|64776259|FG002|Stage A|Physician Decision|0|||
23282305|NCT04281472|64776257|FG000|Stage A|Prohibited medications|2|||
23282306|NCT04281472|64776258|FG001|Stage A|Prohibited medications|0|||
23282307|NCT04281472|64776259|FG002|Stage A|Prohibited medications|0|||
23282308|NCT04281472|64776257|FG000|Stage A|Withdrawal by Subject|11|||
23282309|NCT04281472|64776258|FG001|Stage A|Withdrawal by Subject|0|||
23282310|NCT04281472|64776259|FG002|Stage A|Withdrawal by Subject|0|||
23282311|NCT04281472|64776257|FG000|Stage A|Other|5|||
23282312|NCT04281472|64776258|FG001|Stage A|Other|0|||
23282313|NCT04281472|64776259|FG002|Stage A|Other|0|||
23282314|NCT04281472|64776257|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
23282315|NCT04281472|64776258|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
23282316|NCT04281472|64776259|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
23282317|NCT04281472|64776257|FG000|Stage B|Adverse Event|0|||
23282318|NCT04281472|64776258|FG001|Stage B|Adverse Event|3|||
23282319|NCT04281472|64776259|FG002|Stage B|Adverse Event|0|||
23282320|NCT04281472|64776257|FG000|Stage B|Death|0|||
23282321|NCT04281472|64776258|FG001|Stage B|Death|0|||
23282322|NCT04281472|64776259|FG002|Stage B|Death|1|||
23282323|NCT04281472|64776257|FG000|Stage B|Lack of Efficacy|0|||
23282324|NCT04281472|64776258|FG001|Stage B|Lack of Efficacy|0|||
23282325|NCT04281472|64776259|FG002|Stage B|Lack of Efficacy|1|||
23282326|NCT04281472|64776257|FG000|Stage B|Lost to Follow-up|0|||
23282327|NCT04281472|64776258|FG001|Stage B|Lost to Follow-up|0|||
23282328|NCT04281472|64776259|FG002|Stage B|Lost to Follow-up|2|||
23282329|NCT04281472|64776257|FG000|Stage B|Prohibited medications|0|||
23282330|NCT04281472|64776258|FG001|Stage B|Prohibited medications|2|||
23282331|NCT04281472|64776259|FG002|Stage B|Prohibited medications|1|||
23282332|NCT04281472|64776257|FG000|Stage B|Protocol Violation|0|||
23282333|NCT04281472|64776258|FG001|Stage B|Protocol Violation|1|||
23282334|NCT04281472|64776259|FG002|Stage B|Protocol Violation|1|||
23282335|NCT04281472|64776257|FG000|Stage B|Sponsor decision|0|||
23282336|NCT04281472|64776258|FG001|Stage B|Sponsor decision|0|||
23282337|NCT04281472|64776259|FG002|Stage B|Sponsor decision|1|||
23374845|NCT05172570|65116116|FG002|Overall Study|PI Decision due to equipment shortages|1|||
23374846|NCT01739335|65116117|FG000|Overall Study|Lost to Follow-up|7|||
23488278|NCT01134731|65533804|FG001|Overall Study|Lack of Efficacy|0|||
23488279|NCT01134731|65533805|FG002|Overall Study|Lack of Efficacy|1|||
23488280|NCT01134731|65533803|FG000|Overall Study|Withdrawal by Subject|3|||
23488281|NCT01134731|65533804|FG001|Overall Study|Withdrawal by Subject|3|||
23488282|NCT01134731|65533805|FG002|Overall Study|Withdrawal by Subject|1|||
23488283|NCT01134731|65533803|FG000|Overall Study|Lost to Follow-up|5|||
23488284|NCT01134731|65533804|FG001|Overall Study|Lost to Follow-up|4|||
23488285|NCT01134731|65533805|FG002|Overall Study|Lost to Follow-up|3|||
23488286|NCT03078907|65533806|FG000|Overall Study|Adverse Event|2|||
23488287|NCT03078907|65533807|FG001|Overall Study|Adverse Event|0|||
23488288|NCT03078907|65533806|FG000|Overall Study|Other|1|||
23488289|NCT03078907|65533807|FG001|Overall Study|Other|0|||
23488290|NCT03078907|65533806|FG000|Overall Study|Protocol Violation|0|||
23488291|NCT03078907|65533807|FG001|Overall Study|Protocol Violation|1|||
23488292|NCT01539642|65533809|FG000|Overall Study|Lack of Efficacy|20|||
23488293|NCT01539642|65533810|FG001|Overall Study|Lack of Efficacy|18|||
23488294|NCT01539642|65533809|FG000|Overall Study|Patient ready for early discharge|8|||
23488295|NCT01539642|65533810|FG001|Overall Study|Patient ready for early discharge|7|||
23488296|NCT01539642|65533809|FG000|Overall Study|Adverse Event|6|||
23488297|NCT01539642|65533810|FG001|Overall Study|Adverse Event|4|||
23488298|NCT01539642|65533809|FG000|Overall Study|Withdrawal by Subject|2|||
23488299|NCT01539642|65533810|FG001|Overall Study|Withdrawal by Subject|2|||
23488300|NCT02787005|65533814|FG000|Overall Study|Adverse Event|24|||
23488301|NCT02787005|65533815|FG001|Overall Study|Adverse Event|9|||
23488302|NCT02787005|65533816|FG002|Overall Study|Adverse Event|9|||
23488303|NCT02787005|65533817|FG003|Overall Study|Adverse Event|7|||
23488304|NCT02787005|65533818|FG004|Overall Study|Adverse Event|2|||
23488305|NCT02787005|65533814|FG000|Overall Study|Death|100|||
23488306|NCT02787005|65533815|FG001|Overall Study|Death|53|||
23488307|NCT02787005|65533816|FG002|Overall Study|Death|48|||
23488308|NCT02787005|65533817|FG003|Overall Study|Death|69|||
23282338|NCT04281472|64776257|FG000|Stage B|Withdrawal by Subject|0|||
23282339|NCT04281472|64776258|FG001|Stage B|Withdrawal by Subject|3|||
23282340|NCT04281472|64776259|FG002|Stage B|Withdrawal by Subject|3|||
23282341|NCT04281472|64776257|FG000|Stage B|Other|0|||
23282342|NCT04281472|64776258|FG001|Stage B|Other|3|||
23282343|NCT04281472|64776259|FG002|Stage B|Other|0|||
23282344|NCT00152451|64776267|FG000|Overall Study|Adverse Event|4|||
23282345|NCT02061280|64776268|FG000|Overall Study|Protocol Violation|12|||
23282346|NCT02061280|64776269|FG001|Overall Study|Protocol Violation|8|||
23282347|NCT02061280|64776268|FG000|Overall Study|moved out of state|0|||
23282348|NCT02061280|64776269|FG001|Overall Study|moved out of state|1|||
23488309|NCT02787005|65533818|FG004|Overall Study|Death|38|||
23488310|NCT02787005|65533814|FG000|Overall Study|Sponsor Decision|7|||
23604009|NCT00761267|65940259|FG002|Overall Study|Death|5|||
23604010|NCT00761267|65940257|FG000|Overall Study|Lost to Follow-up|0|||
23604011|NCT00761267|65940258|FG001|Overall Study|Lost to Follow-up|0|||
23604012|NCT00761267|65940259|FG002|Overall Study|Lost to Follow-up|1|||
23282349|NCT02061280|64776268|FG000|Overall Study|Withdrawal by Subject|1|||
23282350|NCT02061280|64776269|FG001|Overall Study|Withdrawal by Subject|2|||
23282351|NCT02061280|64776268|FG000|Overall Study|Lost to Follow-up|5|||
23282352|NCT02061280|64776269|FG001|Overall Study|Lost to Follow-up|1|||
23282353|NCT05239195|64776271|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
23282354|NCT05239195|64776272|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
23282355|NCT05169710|64776273|FG000|Overall Study|Adverse Event|1|||
23282356|NCT05169710|64776274|FG001|Overall Study|Adverse Event|2|||
23282357|NCT05169710|64776275|FG002|Overall Study|Adverse Event|2|||
23282358|NCT05169710|64776273|FG000|Overall Study|Lost to Follow-up|0|||
23282359|NCT05169710|64776274|FG001|Overall Study|Lost to Follow-up|0|||
23488311|NCT02787005|65533815|FG001|Overall Study|Sponsor Decision|4|||
23488312|NCT02787005|65533816|FG002|Overall Study|Sponsor Decision|0|||
23488313|NCT02787005|65533817|FG003|Overall Study|Sponsor Decision|4|||
23488314|NCT02787005|65533818|FG004|Overall Study|Sponsor Decision|5|||
23488315|NCT02787005|65533814|FG000|Overall Study|Withdrawal by Subject|2|||
23488316|NCT02787005|65533815|FG001|Overall Study|Withdrawal by Subject|1|||
23488317|NCT02787005|65533816|FG002|Overall Study|Withdrawal by Subject|1|||
23488318|NCT02787005|65533817|FG003|Overall Study|Withdrawal by Subject|0|||
23488319|NCT02787005|65533818|FG004|Overall Study|Withdrawal by Subject|1|||
23488320|NCT02787005|65533814|FG000|Overall Study|Screen Failure|0|||
23488321|NCT02787005|65533815|FG001|Overall Study|Screen Failure|2|||
23488322|NCT02787005|65533816|FG002|Overall Study|Screen Failure|0|||
23488323|NCT02787005|65533817|FG003|Overall Study|Screen Failure|0|||
23488324|NCT02787005|65533818|FG004|Overall Study|Screen Failure|1|||
23488325|NCT02787005|65533814|FG000|Overall Study|Lost to Follow-up|0|||
23488326|NCT02787005|65533815|FG001|Overall Study|Lost to Follow-up|0|||
23488327|NCT02787005|65533816|FG002|Overall Study|Lost to Follow-up|0|||
23488328|NCT02787005|65533817|FG003|Overall Study|Lost to Follow-up|1|||
23488329|NCT02787005|65533818|FG004|Overall Study|Lost to Follow-up|0|||
23488330|NCT01083173|65533824|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
23488331|NCT01083173|65533825|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
23488332|NCT01083173|65533824|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
23488333|NCT01083173|65533825|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
23488334|NCT01083173|65533824|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
23488335|NCT01083173|65533825|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
23488336|NCT01083173|65533824|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
23488337|NCT01083173|65533825|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
23488338|NCT01083173|65533824|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
23488339|NCT01083173|65533825|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
23488340|NCT01083173|65533824|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
23488341|NCT01083173|65533825|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
23488342|NCT01083173|65533824|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
23488343|NCT01083173|65533825|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
23488344|NCT01083173|65533824|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
23488345|NCT01083173|65533825|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
23488346|NCT01083173|65533824|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
23488347|NCT01083173|65533825|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
23488348|NCT01083173|65533824|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
23488349|NCT01083173|65533825|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
23488350|NCT01083173|65533824|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
23488351|NCT01083173|65533825|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
23488352|NCT00857415|65533828|FG000|Overall Study|Image acquisition failure|2|||
23488353|NCT00857415|65533829|FG001|Overall Study|Image acquisition failure|0|||
23488354|NCT00857415|65533828|FG000|Overall Study|Invalid image or not imaged|3|||
23488355|NCT00857415|65533829|FG001|Overall Study|Invalid image or not imaged|0|||
23488356|NCT00857415|65533828|FG000|Overall Study|Subject still living at end of study|110|||
23488357|NCT00857415|65533829|FG001|Overall Study|Subject still living at end of study|0|||
23604013|NCT00761267|65940257|FG000|Overall Study|Randomized but not treated|1|||
23604014|NCT00761267|65940258|FG001|Overall Study|Randomized but not treated|1|||
23282360|NCT05169710|64776275|FG002|Overall Study|Lost to Follow-up|1|||
23488358|NCT00857415|65533828|FG000|Overall Study|Deceased with no autopsy|2|||
23488359|NCT00857415|65533829|FG001|Overall Study|Deceased with no autopsy|0|||
23488360|NCT00591266|65533830|FG000|Overall Study|Adverse Event|2|||
23282361|NCT05169710|64776273|FG000|Overall Study|Withdrawal by Subject|2|||
23488361|NCT00591266|65533831|FG001|Overall Study|Adverse Event|2|||
23488362|NCT00591266|65533832|FG002|Overall Study|Adverse Event|3|||
23488363|NCT00591266|65533830|FG000|Overall Study|Lost to Follow-up|0|||
23488364|NCT00591266|65533831|FG001|Overall Study|Lost to Follow-up|1|||
23488365|NCT00591266|65533832|FG002|Overall Study|Lost to Follow-up|0|||
23488366|NCT00591266|65533830|FG000|Overall Study|Protocol Violation|0|||
23488367|NCT00591266|65533831|FG001|Overall Study|Protocol Violation|0|||
23488368|NCT00591266|65533832|FG002|Overall Study|Protocol Violation|1|||
23488369|NCT00591266|65533830|FG000|Overall Study|Withdrawal by Subject|6|||
23488370|NCT00591266|65533831|FG001|Overall Study|Withdrawal by Subject|2|||
23488371|NCT00591266|65533832|FG002|Overall Study|Withdrawal by Subject|5|||
23488372|NCT00591266|65533830|FG000|Overall Study|Lack of Efficacy|0|||
23488373|NCT00591266|65533831|FG001|Overall Study|Lack of Efficacy|2|||
23488374|NCT00591266|65533832|FG002|Overall Study|Lack of Efficacy|0|||
23488375|NCT00591266|65533830|FG000|Overall Study|Other|1|||
23488376|NCT00591266|65533831|FG001|Overall Study|Other|4|||
23488377|NCT00591266|65533832|FG002|Overall Study|Other|5|||
23488378|NCT01442038|65533833|FG000|Overall Study|Death|35|||
23488379|NCT01442038|65533834|FG001|Overall Study|Death|29|||
23488380|NCT01442038|65533833|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
23488381|NCT01442038|65533834|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
23488382|NCT01442038|65533833|FG000|Overall Study|Participant Withdrew Consent|137|||
23488383|NCT01442038|65533834|FG001|Overall Study|Participant Withdrew Consent|102|||
23488384|NCT01442038|65533833|FG000|Overall Study|Lost to Follow-up|37|||
23488385|NCT01442038|65533834|FG001|Overall Study|Lost to Follow-up|51|||
23488386|NCT01442038|65533833|FG000|Overall Study|Adverse Event|26|||
23488387|NCT01442038|65533834|FG001|Overall Study|Adverse Event|15|||
23488388|NCT01442038|65533833|FG000|Overall Study|Protocol Deviation|9|||
23488389|NCT01442038|65533834|FG001|Overall Study|Protocol Deviation|20|||
23488390|NCT01442038|65533833|FG000|Overall Study|Investigator's Discretion|13|||
23488391|NCT01442038|65533834|FG001|Overall Study|Investigator's Discretion|16|||
23488392|NCT01442038|65533833|FG000|Overall Study|Study Terminated By Sponsor|2|||
23488393|NCT01442038|65533834|FG001|Overall Study|Study Terminated By Sponsor|3|||
23488394|NCT00620464|65533835|FG000|Overall Study|Adverse Event|15|||
23488395|NCT00620464|65533836|FG001|Overall Study|Adverse Event|17|||
23488396|NCT00620464|65533835|FG000|Overall Study|Lost to Follow-up|1|||
23488397|NCT00620464|65533836|FG001|Overall Study|Lost to Follow-up|1|||
23488398|NCT00620464|65533835|FG000|Overall Study|Planning Pregnancy|1|||
23488399|NCT00620464|65533836|FG001|Overall Study|Planning Pregnancy|4|||
23488400|NCT00620464|65533835|FG000|Overall Study|Personal|2|||
23488401|NCT00620464|65533836|FG001|Overall Study|Personal|2|||
23604015|NCT00761267|65940259|FG002|Overall Study|Randomized but not treated|0|||
23604016|NCT00761267|65940257|FG000|Overall Study|Withdrawal by Subject|0|||
23604017|NCT00761267|65940258|FG001|Overall Study|Withdrawal by Subject|1|||
23604018|NCT00761267|65940259|FG002|Overall Study|Withdrawal by Subject|0|||
23604019|NCT01328496|65940272|FG000|Overall Study|Significant Change in Health Status|1|||
23604020|NCT01328496|65940273|FG001|Overall Study|Significant Change in Health Status|0|||
23604021|NCT00645411|65940280|FG000|Overall Study|Adverse Event|0|||
23604022|NCT00645411|65940281|FG001|Overall Study|Adverse Event|0|||
23604023|NCT00645411|65940282|FG002|Overall Study|Adverse Event|0|||
23604024|NCT00645411|65940283|FG003|Overall Study|Adverse Event|2|||
23488402|NCT00620464|65533835|FG000|Overall Study|Used prohibited medication|1|||
23488403|NCT00620464|65533836|FG001|Overall Study|Used prohibited medication|0|||
23488404|NCT02130024|65533845|FG000|Overall Study|Adverse Event|10|||
23488405|NCT02130024|65533846|FG001|Overall Study|Adverse Event|11|||
23488406|NCT02130024|65533845|FG000|Overall Study|Death|2|||
23488407|NCT02130024|65533846|FG001|Overall Study|Death|2|||
23604025|NCT00645411|65940280|FG000|Overall Study|Withdrawal by Subject|2|||
23488408|NCT02130024|65533845|FG000|Overall Study|Lost to Follow-up|1|||
23488409|NCT02130024|65533846|FG001|Overall Study|Lost to Follow-up|1|||
23604026|NCT00645411|65940281|FG001|Overall Study|Withdrawal by Subject|1|||
23488410|NCT02130024|65533845|FG000|Overall Study|Physician Decision|1|||
23488411|NCT02130024|65533846|FG001|Overall Study|Physician Decision|3|||
23488412|NCT02130024|65533845|FG000|Overall Study|Protocol Deviation|4|||
23282362|NCT05169710|64776274|FG001|Overall Study|Withdrawal by Subject|1|||
23282363|NCT05169710|64776275|FG002|Overall Study|Withdrawal by Subject|0|||
23282364|NCT05169710|64776273|FG000|Overall Study|Other Study Discontinuation Reason|0|||
23282365|NCT05169710|64776274|FG001|Overall Study|Other Study Discontinuation Reason|2|||
23282366|NCT05169710|64776275|FG002|Overall Study|Other Study Discontinuation Reason|0|||
23282367|NCT00795821|64776279|FG000|Acute Treatment Phase|Adverse Event|23|||
23282368|NCT00795821|64776280|FG001|Acute Treatment Phase|Adverse Event|4|||
23282369|NCT00795821|64776279|FG000|Acute Treatment Phase|Death|1|||
23282370|NCT00795821|64776280|FG001|Acute Treatment Phase|Death|0|||
23282371|NCT00795821|64776279|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
23282372|NCT00795821|64776280|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
23282373|NCT00795821|64776279|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
23282374|NCT00795821|64776280|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
23282375|NCT00795821|64776279|FG000|Acute Treatment Phase|Physician Decision|1|||
23282376|NCT00795821|64776280|FG001|Acute Treatment Phase|Physician Decision|1|||
23282377|NCT00795821|64776279|FG000|Acute Treatment Phase|Protocol Violation|1|||
23282378|NCT00795821|64776280|FG001|Acute Treatment Phase|Protocol Violation|2|||
23282379|NCT00795821|64776279|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
23282380|NCT00795821|64776280|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
23282381|NCT00795821|64776279|FG000|Long-term Extension Phase|Adverse Event|25|||
23282382|NCT00795821|64776280|FG001|Long-term Extension Phase|Adverse Event|32|||
23282383|NCT00795821|64776279|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
23282384|NCT00795821|64776280|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
23282385|NCT00795821|64776279|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
23282386|NCT00795821|64776280|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
23282387|NCT00795821|64776279|FG000|Long-term Extension Phase|Physician Decision|1|||
23282388|NCT00795821|64776280|FG001|Long-term Extension Phase|Physician Decision|2|||
23282389|NCT00795821|64776279|FG000|Long-term Extension Phase|Protocol Violation|3|||
23282390|NCT00795821|64776280|FG001|Long-term Extension Phase|Protocol Violation|5|||
23282391|NCT00795821|64776279|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
23282392|NCT00795821|64776280|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
23282393|NCT00795821|64776279|FG000|Taper Phase|Adverse Event|2|||
23282394|NCT00795821|64776280|FG001|Taper Phase|Adverse Event|0|||
23282395|NCT00795821|64776279|FG000|Taper Phase|Lost to Follow-up|1|||
23282396|NCT00795821|64776280|FG001|Taper Phase|Lost to Follow-up|0|||
23282397|NCT00795821|64776279|FG000|Taper Phase|Physician Decision|2|||
23282398|NCT00795821|64776280|FG001|Taper Phase|Physician Decision|0|||
23282399|NCT00795821|64776279|FG000|Taper Phase|Withdrawal by Subject|4|||
23282400|NCT00795821|64776280|FG001|Taper Phase|Withdrawal by Subject|0|||
23282401|NCT02615249|64776281|FG000|Overall Study|Withdrawal by Subject|1|||
23282402|NCT00429416|64776282|FG000|Overall Study|Death|1|||
23282403|NCT02441686|64776283|FG000|Induction|Adverse Event|4|||
23282404|NCT02441686|64776283|FG000|Induction|Complicating disease|1|||
23282405|NCT02441686|64776283|FG000|Induction|Physician Decision|1|||
23282406|NCT02441686|64776283|FG000|Induction|Withdrawal by Subject|1|||
23282407|NCT02441686|64776283|FG000|Induction|Did not receive treatment|1|||
23282408|NCT02441686|64776283|FG000|Maintenance|Remaining on Treatment|23|||
23282409|NCT02441686|64776283|FG000|Maintenance|Physician Decision|1|||
23282410|NCT02441686|64776283|FG000|Maintenance|Adverse Event|3|||
23282411|NCT02441686|64776283|FG000|Maintenance|Progressive Disease|10|||
23282412|NCT02441686|64776283|FG000|Maintenance|Withdrawal by Subject|1|||
23282413|NCT01750294|64776287|FG000|Overall Study|Withdrawal by Subject|1|||
23282414|NCT01750294|64776287|FG000|Overall Study|Safety Endpoint|1|||
23282415|NCT01911676|64776288|FG000|Period 1 of Study|Withdrawal by Subject|4|||
23282416|NCT01911676|64776289|FG001|Period 1 of Study|Withdrawal by Subject|2|||
23282417|NCT01911676|64776290|FG002|Period 1 of Study|Withdrawal by Subject|1|||
23282418|NCT01911676|64776291|FG003|Period 1 of Study|Withdrawal by Subject|2|||
23282419|NCT01911676|64776288|FG000|Period 1 of Study|Physician Decision|2|||
23282420|NCT01911676|64776289|FG001|Period 1 of Study|Physician Decision|0|||
23282421|NCT01911676|64776290|FG002|Period 1 of Study|Physician Decision|0|||
23282422|NCT01911676|64776291|FG003|Period 1 of Study|Physician Decision|1|||
23282423|NCT01911676|64776288|FG000|Period 2 of Study|Physician Decision|2|||
23282424|NCT01911676|64776289|FG001|Period 2 of Study|Physician Decision|0|||
23282425|NCT01911676|64776290|FG002|Period 2 of Study|Physician Decision|0|||
23282426|NCT01911676|64776291|FG003|Period 2 of Study|Physician Decision|1|||
23282427|NCT01911676|64776288|FG000|Period 2 of Study|Lost to Follow-up|0|||
23282428|NCT01911676|64776289|FG001|Period 2 of Study|Lost to Follow-up|0|||
23282429|NCT01911676|64776290|FG002|Period 2 of Study|Lost to Follow-up|0|||
23282430|NCT01911676|64776291|FG003|Period 2 of Study|Lost to Follow-up|1|||
23282431|NCT02072096|64776296|FG000|Overall Study|Lack of Efficacy|18|||
23282432|NCT02072096|64776297|FG001|Overall Study|Lack of Efficacy|29|||
23282433|NCT02072096|64776296|FG000|Overall Study|Protocol Violation|7|||
23282434|NCT02072096|64776297|FG001|Overall Study|Protocol Violation|7|||
23282435|NCT02072096|64776296|FG000|Overall Study|Withdrawal by Subject|5|||
23374847|NCT01739335|65116118|FG001|Overall Study|Lost to Follow-up|4|||
23374848|NCT01739335|65116117|FG000|Overall Study|Ineligible patient randomized|0|||
23374849|NCT01739335|65116118|FG001|Overall Study|Ineligible patient randomized|1|||
23374850|NCT03504917|65116119|FG000|Blinded Treatment Period|Protocol Violation|1|||
23374851|NCT03504917|65116120|FG001|Blinded Treatment Period|Protocol Violation|0|||
23374852|NCT03504917|65116119|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
23374853|NCT03504917|65116120|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
23374854|NCT03504917|65116119|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
23374855|NCT03504917|65116120|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
23374856|NCT03504917|65116119|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
23374857|NCT03504917|65116120|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
23374858|NCT03504917|65116119|FG000|Blinded Treatment Period|Adverse Event|4|||
23374859|NCT03504917|65116120|FG001|Blinded Treatment Period|Adverse Event|4|||
23374860|NCT03504917|65116119|FG000|Blinded Treatment Period|Physician Decision|1|||
23374861|NCT03504917|65116120|FG001|Blinded Treatment Period|Physician Decision|0|||
23374862|NCT03504917|65116119|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
23374863|NCT03504917|65116120|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
23374864|NCT03504917|65116119|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
23488413|NCT02130024|65533846|FG001|Overall Study|Protocol Deviation|0|||
23488414|NCT02130024|65533845|FG000|Overall Study|Site Administration Problems|1|||
23488415|NCT02130024|65533846|FG001|Overall Study|Site Administration Problems|0|||
23488416|NCT02130024|65533845|FG000|Overall Study|Subject Withdrew Consent|6|||
23488417|NCT02130024|65533846|FG001|Overall Study|Subject Withdrew Consent|14|||
23488418|NCT01368432|65533850|FG000|Overall Study|Lost to Follow-up|0|||
23488419|NCT01368432|65533851|FG001|Overall Study|Lost to Follow-up|1|||
23282436|NCT02072096|64776297|FG001|Overall Study|Withdrawal by Subject|7|||
23282437|NCT02072096|64776296|FG000|Overall Study|Adverse Event|5|||
23374865|NCT03504917|65116120|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
23374866|NCT03504917|65116119|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
23374867|NCT03504917|65116120|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
23282438|NCT02072096|64776297|FG001|Overall Study|Adverse Event|2|||
23282439|NCT02072096|64776296|FG000|Overall Study|No Reason Provided|4|||
23282440|NCT02072096|64776297|FG001|Overall Study|No Reason Provided|2|||
23282441|NCT02072096|64776296|FG000|Overall Study|Death|2|||
23282442|NCT02072096|64776297|FG001|Overall Study|Death|0|||
23282443|NCT02072096|64776296|FG000|Overall Study|Physician Decision|0|||
23282444|NCT02072096|64776297|FG001|Overall Study|Physician Decision|1|||
23282445|NCT02072096|64776296|FG000|Overall Study|Study Terminated by Sponsor|43|||
23282446|NCT02072096|64776297|FG001|Overall Study|Study Terminated by Sponsor|30|||
23282447|NCT02072096|64776296|FG000|Overall Study|Lost to Follow-up|1|||
23282448|NCT02072096|64776297|FG001|Overall Study|Lost to Follow-up|0|||
23282449|NCT05755282|64776300|FG000|Overall Study|Protocol Violation|0|||
23282450|NCT05755282|64776301|FG001|Overall Study|Protocol Violation|1|||
23282451|NCT04223791|64776302|FG000|Overall Study|Lost to Follow-up|0|||
23282452|NCT04223791|64776303|FG001|Overall Study|Lost to Follow-up|4|||
23282453|NCT04223791|64776302|FG000|Overall Study|Physician Decision|5|||
23282454|NCT04223791|64776303|FG001|Overall Study|Physician Decision|1|||
23374868|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
23374869|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
23374870|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
23374871|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
23374872|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
23374873|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
23374874|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
23374875|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
23374876|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
23374877|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
23374878|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
23374879|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
23374880|NCT03504917|65116119|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
23374881|NCT03504917|65116120|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
23374882|NCT00350545|65116121|FG000|Overall Study|Withdrawal by Subject|2|||
23374883|NCT00720759|65116122|FG000|Overall Study|Lost to Follow-up|0|||
23374884|NCT00720759|65116123|FG001|Overall Study|Lost to Follow-up|1|||
23374885|NCT00720759|65116124|FG002|Overall Study|Lost to Follow-up|1|||
23374886|NCT00720759|65116125|FG003|Overall Study|Lost to Follow-up|0|||
23374887|NCT00141817|65116126|FG000|Overall Study|Protocol Violation|0|||
23374888|NCT00141817|65116127|FG001|Overall Study|Protocol Violation|0|||
23374889|NCT00141817|65116128|FG002|Overall Study|Protocol Violation|1|||
23374890|NCT00141817|65116129|FG003|Overall Study|Protocol Violation|0|||
23282455|NCT04223791|64776302|FG000|Overall Study|Protocol Violation|1|||
23374891|NCT00141817|65116126|FG000|Overall Study|Parent request|1|||
23282456|NCT04223791|64776303|FG001|Overall Study|Protocol Violation|1|||
23282457|NCT04223791|64776302|FG000|Overall Study|Withdrawal by Subject|10|||
23282458|NCT04223791|64776303|FG001|Overall Study|Withdrawal by Subject|12|||
23282459|NCT04223791|64776302|FG000|Overall Study|Pregnancy|1|||
23282460|NCT04223791|64776303|FG001|Overall Study|Pregnancy|1|||
23282461|NCT04223791|64776302|FG000|Overall Study|Ongoing in Study|305|||
23282462|NCT04223791|64776303|FG001|Overall Study|Ongoing in Study|302|||
23282463|NCT00205777|64776304|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
23282464|NCT00205777|64776305|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
23282465|NCT00205777|64776306|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
23282466|NCT00205777|64776307|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
23282467|NCT00205777|64776308|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
23282468|NCT00205777|64776309|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
23282469|NCT00205777|64776304|FG000|Core Study (Up to 3 Years)|Death|9|||
23282470|NCT00205777|64776305|FG001|Core Study (Up to 3 Years)|Death|7|||
23282471|NCT00205777|64776306|FG002|Core Study (Up to 3 Years)|Death|14|||
23282472|NCT00205777|64776307|FG003|Core Study (Up to 3 Years)|Death|7|||
23282473|NCT00205777|64776308|FG004|Core Study (Up to 3 Years)|Death|0|||
23282474|NCT00205777|64776309|FG005|Core Study (Up to 3 Years)|Death|0|||
23282475|NCT00205777|64776304|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
23282476|NCT00205777|64776305|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
23282477|NCT00205777|64776306|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
23282478|NCT00205777|64776307|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
23282479|NCT00205777|64776308|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
23282480|NCT00205777|64776309|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
23282481|NCT00205777|64776304|FG000|Core Study (Up to 3 Years)|Other Event|49|||
23282482|NCT00205777|64776305|FG001|Core Study (Up to 3 Years)|Other Event|52|||
23282483|NCT00205777|64776306|FG002|Core Study (Up to 3 Years)|Other Event|41|||
23282484|NCT00205777|64776307|FG003|Core Study (Up to 3 Years)|Other Event|58|||
23282485|NCT00205777|64776308|FG004|Core Study (Up to 3 Years)|Other Event|0|||
23282486|NCT00205777|64776309|FG005|Core Study (Up to 3 Years)|Other Event|0|||
23282487|NCT00205777|64776304|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
23282488|NCT00205777|64776305|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
23282489|NCT00205777|64776306|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
23282490|NCT00205777|64776307|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
23282491|NCT00205777|64776308|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
23282492|NCT00205777|64776309|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
23282493|NCT00205777|64776304|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
23282494|NCT00205777|64776305|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
23282495|NCT00205777|64776306|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
23282496|NCT00205777|64776307|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
23282497|NCT00205777|64776308|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
23374892|NCT00141817|65116127|FG001|Overall Study|Parent request|0|||
23282498|NCT00205777|64776309|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
23488420|NCT04502979|65533864|FG000|Overall Study|Lost to Follow-up|1|||
23488421|NCT04502979|65533865|FG001|Overall Study|Lost to Follow-up|3|||
23488422|NCT04502979|65533864|FG000|Overall Study|Withdrawal by Subject|2|||
23488423|NCT04502979|65533865|FG001|Overall Study|Withdrawal by Subject|1|||
23488424|NCT00057876|65533867|FG000|Overall Study|Adverse Event|8|||
23488425|NCT00057876|65533868|FG001|Overall Study|Adverse Event|8|||
23488426|NCT00057876|65533867|FG000|Overall Study|Death|2|||
23488427|NCT00057876|65533868|FG001|Overall Study|Death|1|||
23488428|NCT00057876|65533867|FG000|Overall Study|Withdrawal by Subject|5|||
23488429|NCT00057876|65533868|FG001|Overall Study|Withdrawal by Subject|6|||
23488430|NCT00057876|65533867|FG000|Overall Study|Lack of Efficacy|10|||
23488431|NCT00057876|65533868|FG001|Overall Study|Lack of Efficacy|8|||
23488432|NCT00057876|65533867|FG000|Overall Study|Ineligible|1|||
23488433|NCT00057876|65533868|FG001|Overall Study|Ineligible|2|||
23488434|NCT00057876|65533867|FG000|Overall Study|other reason|2|||
23488435|NCT00057876|65533868|FG001|Overall Study|other reason|2|||
23488436|NCT00057876|65533867|FG000|Overall Study|other complicating disease|1|||
23488437|NCT00057876|65533868|FG001|Overall Study|other complicating disease|0|||
23488438|NCT00943124|65533869|FG000|Period 1|Withdrawal by Subject|1|||
23488439|NCT00943124|65533870|FG001|Period 1|Withdrawal by Subject|1|||
23488440|NCT00943124|65533869|FG000|Period 1|Did Not Follow Study Procedures|1|||
23488441|NCT00943124|65533870|FG001|Period 1|Did Not Follow Study Procedures|0|||
23488442|NCT00943124|65533869|FG000|Period 1|Personal Reasons|0|||
23488443|NCT00943124|65533870|FG001|Period 1|Personal Reasons|1|||
23488444|NCT00950911|65533875|FG000|Overall Study|Adverse Event|0|||
23488445|NCT00950911|65533876|FG001|Overall Study|Adverse Event|2|||
23488446|NCT00950911|65533875|FG000|Overall Study|Death|4|||
23488447|NCT00950911|65533876|FG001|Overall Study|Death|6|||
23488448|NCT00950911|65533875|FG000|Overall Study|Disease progression|2|||
23488449|NCT00950911|65533876|FG001|Overall Study|Disease progression|2|||
23488450|NCT00950911|65533875|FG000|Overall Study|Consent withdrawn|1|||
23488451|NCT00950911|65533876|FG001|Overall Study|Consent withdrawn|3|||
23488452|NCT00950911|65533875|FG000|Overall Study|Administrative decision|3|||
23488453|NCT00950911|65533876|FG001|Overall Study|Administrative decision|1|||
23488454|NCT00950911|65533875|FG000|Overall Study|Ineligibility determined|1|||
23488455|NCT00950911|65533876|FG001|Overall Study|Ineligibility determined|0|||
23488456|NCT00950911|65533875|FG000|Overall Study|Noncompliance|1|||
23488457|NCT00950911|65533876|FG001|Overall Study|Noncompliance|0|||
23488458|NCT00950911|65533875|FG000|Overall Study|Poor performance status|0|||
23488459|NCT00950911|65533876|FG001|Overall Study|Poor performance status|1|||
23488460|NCT02057393|65533877|FG000|Overall Study|Withdrawal by Subject|1|||
23488461|NCT02057393|65533877|FG000|Overall Study|Patient did not meet criteria|1|||
23488462|NCT00532155|65533878|FG000|Overall Study|Adverse Event|66|||
23488463|NCT00532155|65533879|FG001|Overall Study|Adverse Event|123|||
23488464|NCT00532155|65533878|FG000|Overall Study|Lack of Efficacy|332|||
23488465|NCT00532155|65533879|FG001|Overall Study|Lack of Efficacy|255|||
23488466|NCT00532155|65533878|FG000|Overall Study|Protocol Violation|1|||
23488467|NCT00532155|65533879|FG001|Overall Study|Protocol Violation|3|||
23488468|NCT00532155|65533878|FG000|Overall Study|Lost to Follow-up|2|||
23488469|NCT00532155|65533879|FG001|Overall Study|Lost to Follow-up|0|||
23488470|NCT00532155|65533878|FG000|Overall Study|Physician Decision|16|||
23488471|NCT00532155|65533879|FG001|Overall Study|Physician Decision|15|||
23488472|NCT00532155|65533878|FG000|Overall Study|Withdrawal by Subject|23|||
23282499|NCT00205777|64776304|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
23282500|NCT00205777|64776305|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
23282501|NCT00205777|64776306|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
23282502|NCT00205777|64776307|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
23282503|NCT00205777|64776308|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
23282504|NCT00205777|64776309|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
23282505|NCT00205777|64776304|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
23282506|NCT00205777|64776305|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
23282507|NCT00205777|64776306|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
23282508|NCT00205777|64776307|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
23488473|NCT00532155|65533879|FG001|Overall Study|Withdrawal by Subject|44|||
23488474|NCT00532155|65533878|FG000|Overall Study|Consent withdrawn|5|||
23488475|NCT00532155|65533879|FG001|Overall Study|Consent withdrawn|7|||
23488476|NCT00532155|65533878|FG000|Overall Study|Moved|1|||
23488477|NCT00532155|65533879|FG001|Overall Study|Moved|0|||
23488478|NCT00532155|65533878|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
23488479|NCT00532155|65533879|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
23374893|NCT00141817|65116128|FG002|Overall Study|Parent request|0|||
23488480|NCT00532155|65533878|FG000|Overall Study|Occurence of a second cancer|0|||
23488481|NCT00532155|65533879|FG001|Overall Study|Occurence of a second cancer|1|||
23488482|NCT00532155|65533878|FG000|Overall Study|Occurence of a secondary cancer|0|||
23488483|NCT00532155|65533879|FG001|Overall Study|Occurence of a secondary cancer|1|||
23488484|NCT00532155|65533878|FG000|Overall Study|Promotor ended study|1|||
23282509|NCT00205777|64776308|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
23282510|NCT00205777|64776309|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
23282511|NCT00205777|64776304|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
23282512|NCT00205777|64776305|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
23282513|NCT00205777|64776306|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
23282514|NCT00205777|64776307|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
23282515|NCT00205777|64776308|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
23282516|NCT00205777|64776309|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
23282517|NCT00205777|64776304|FG000|Completed Core Study, Entered SE I|Other Event|52|||
23282518|NCT00205777|64776305|FG001|Completed Core Study, Entered SE I|Other Event|46|||
23282519|NCT00205777|64776306|FG002|Completed Core Study, Entered SE I|Other Event|47|||
23282520|NCT00205777|64776307|FG003|Completed Core Study, Entered SE I|Other Event|50|||
23282521|NCT00205777|64776308|FG004|Completed Core Study, Entered SE I|Other Event|0|||
23282522|NCT00205777|64776309|FG005|Completed Core Study, Entered SE I|Other Event|0|||
23282523|NCT00205777|64776304|FG000|Study Extension I|Adverse Event|57|||
23282524|NCT00205777|64776305|FG001|Study Extension I|Adverse Event|0|||
23282525|NCT00205777|64776306|FG002|Study Extension I|Adverse Event|0|||
23282526|NCT00205777|64776307|FG003|Study Extension I|Adverse Event|61|||
23282527|NCT00205777|64776308|FG004|Study Extension I|Adverse Event|58|||
23282528|NCT00205777|64776309|FG005|Study Extension I|Adverse Event|0|||
23282529|NCT00205777|64776304|FG000|Study Extension I|Death|5|||
23282530|NCT00205777|64776305|FG001|Study Extension I|Death|0|||
23282531|NCT00205777|64776306|FG002|Study Extension I|Death|0|||
23282532|NCT00205777|64776307|FG003|Study Extension I|Death|1|||
23282533|NCT00205777|64776308|FG004|Study Extension I|Death|2|||
23282534|NCT00205777|64776309|FG005|Study Extension I|Death|0|||
23282535|NCT00205777|64776304|FG000|Study Extension I|Withdrawal by Subject|99|||
23282536|NCT00205777|64776305|FG001|Study Extension I|Withdrawal by Subject|0|||
23374894|NCT00141817|65116129|FG003|Overall Study|Parent request|0|||
23374895|NCT03415178|65116134|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
23374896|NCT03415178|65116135|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
23374897|NCT03415178|65116134|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
23374898|NCT03415178|65116135|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
23402812|NCT00560508|65220013|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
23402813|NCT00560508|65220014|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
23402814|NCT00560508|65220013|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
23402815|NCT00560508|65220014|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
23402816|NCT04872569|65220015|FG000|Overall Study|Withdrawal by Subject|2|||
23402817|NCT02185534|65220017|FG000|First Period|Withdrawal by Subject|0|||
23402818|NCT02185534|65220018|FG001|First Period|Withdrawal by Subject|0|||
23402819|NCT02185534|65220019|FG002|First Period|Withdrawal by Subject|0|||
23402820|NCT02185534|65220020|FG003|First Period|Withdrawal by Subject|1|||
23402821|NCT02185534|65220021|FG004|First Period|Withdrawal by Subject|0|||
23402822|NCT02185534|65220022|FG005|First Period|Withdrawal by Subject|0|||
23402823|NCT02185534|65220017|FG000|First Washout Period|Withdrawal by Subject|1|||
23402824|NCT02185534|65220018|FG001|First Washout Period|Withdrawal by Subject|0|||
23402825|NCT02185534|65220019|FG002|First Washout Period|Withdrawal by Subject|0|||
23402826|NCT02185534|65220020|FG003|First Washout Period|Withdrawal by Subject|0|||
23402827|NCT02185534|65220021|FG004|First Washout Period|Withdrawal by Subject|1|||
23282537|NCT00205777|64776306|FG002|Study Extension I|Withdrawal by Subject|0|||
23282538|NCT00205777|64776307|FG003|Study Extension I|Withdrawal by Subject|106|||
23282539|NCT00205777|64776308|FG004|Study Extension I|Withdrawal by Subject|89|||
23282540|NCT00205777|64776309|FG005|Study Extension I|Withdrawal by Subject|0|||
23282541|NCT00205777|64776304|FG000|Study Extension I|Protocol Violation|4|||
23488485|NCT00532155|65533879|FG001|Overall Study|Promotor ended study|0|||
23488486|NCT00532155|65533878|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
23488487|NCT00532155|65533879|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
23488488|NCT00532155|65533878|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
23488489|NCT00532155|65533879|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
23488490|NCT00532155|65533878|FG000|Overall Study|Study stopped|1|||
23488491|NCT00532155|65533879|FG001|Overall Study|Study stopped|0|||
23488492|NCT00532155|65533878|FG000|Overall Study|Study terminated by sponsor|1|||
23488493|NCT00532155|65533879|FG001|Overall Study|Study terminated by sponsor|0|||
23488494|NCT00532155|65533878|FG000|Overall Study|Study termination stop further treatment|4|||
23488495|NCT00532155|65533879|FG001|Overall Study|Study termination stop further treatment|0|||
23488496|NCT00532155|65533878|FG000|Overall Study|Did not receive study medication|2|||
23488497|NCT00532155|65533879|FG001|Overall Study|Did not receive study medication|6|||
23488498|NCT00591344|65533880|FG000|Overall Study|Transportation issues|1|||
23488499|NCT00591344|65533881|FG001|Overall Study|Transportation issues|0|||
23488500|NCT00591344|65533880|FG000|Overall Study|Moved out of state|1|||
23488501|NCT00591344|65533881|FG001|Overall Study|Moved out of state|0|||
23488502|NCT00591344|65533880|FG000|Overall Study|Medical complications|1|||
23488503|NCT00591344|65533881|FG001|Overall Study|Medical complications|3|||
23488504|NCT00591344|65533880|FG000|Overall Study|Underwent DBS|2|||
23488505|NCT00591344|65533881|FG001|Overall Study|Underwent DBS|2|||
23488506|NCT00591344|65533880|FG000|Overall Study|Death|0|||
23488507|NCT00591344|65533881|FG001|Overall Study|Death|1|||
23488508|NCT00591344|65533880|FG000|Overall Study|Lost to Follow-up|0|||
23488509|NCT00591344|65533881|FG001|Overall Study|Lost to Follow-up|1|||
23488510|NCT00591344|65533880|FG000|Overall Study|Did not want to come off medication|0|||
23488511|NCT00591344|65533881|FG001|Overall Study|Did not want to come off medication|1|||
23488512|NCT01904058|65533882|FG000|Overall Study|Adverse Event|2|||
23488513|NCT01904058|65533883|FG001|Overall Study|Adverse Event|0|||
23488514|NCT01904058|65533884|FG002|Overall Study|Adverse Event|0|||
23488515|NCT01904058|65533885|FG003|Overall Study|Adverse Event|0|||
23488516|NCT01904058|65533882|FG000|Overall Study|Withdrawal by Subject|1|||
23488517|NCT01904058|65533883|FG001|Overall Study|Withdrawal by Subject|0|||
23488518|NCT01904058|65533884|FG002|Overall Study|Withdrawal by Subject|1|||
23488519|NCT01904058|65533885|FG003|Overall Study|Withdrawal by Subject|0|||
23488520|NCT01904058|65533882|FG000|Overall Study|Pregnancy|0|||
23488521|NCT01904058|65533883|FG001|Overall Study|Pregnancy|0|||
23488522|NCT01904058|65533884|FG002|Overall Study|Pregnancy|0|||
23488523|NCT01904058|65533885|FG003|Overall Study|Pregnancy|1|||
23488524|NCT01795638|65533889|FG000|Overall Study|Death|0|||
23488525|NCT01795638|65533890|FG001|Overall Study|Death|3|||
23488526|NCT01795638|65533889|FG000|Overall Study|transferred to quaternary hospital|2|||
23488527|NCT01795638|65533890|FG001|Overall Study|transferred to quaternary hospital|3|||
23488528|NCT01795638|65533889|FG000|Overall Study|Protocol Violation|3|||
23488529|NCT01795638|65533890|FG001|Overall Study|Protocol Violation|0|||
23488530|NCT01795638|65533889|FG000|Overall Study|discharged from hospital|7|||
23488531|NCT01795638|65533890|FG001|Overall Study|discharged from hospital|5|||
23488532|NCT01795638|65533889|FG000|Overall Study|Withdrawal by Subject|1|||
23488533|NCT01795638|65533890|FG001|Overall Study|Withdrawal by Subject|0|||
23488534|NCT01977937|65533891|FG000|Overall Study|Withdrawal by Subject|2|||
23488535|NCT01977937|65533892|FG001|Overall Study|Withdrawal by Subject|1|||
23488536|NCT01977937|65533891|FG000|Overall Study|Adverse Event|1|||
23488537|NCT01977937|65533892|FG001|Overall Study|Adverse Event|0|||
23488538|NCT01977937|65533891|FG000|Overall Study|Physician Decision|0|||
23488539|NCT01977937|65533892|FG001|Overall Study|Physician Decision|1|||
23488540|NCT03187756|65533893|FG000|Overall Study|Termination of study|4|||
23488541|NCT00598702|65533896|FG000|Overall Study|Other|0|||
23488542|NCT00598702|65533897|FG001|Overall Study|Other|2|||
23604027|NCT00645411|65940282|FG002|Overall Study|Withdrawal by Subject|19|||
23604028|NCT00645411|65940283|FG003|Overall Study|Withdrawal by Subject|21|||
23488543|NCT00598702|65533898|FG002|Overall Study|Other|0|||
23488544|NCT00598702|65533899|FG003|Overall Study|Other|0|||
23488545|NCT00598702|65533900|FG004|Overall Study|Other|0|||
23488546|NCT00598702|65533901|FG005|Overall Study|Other|1|||
23488547|NCT00598702|65533902|FG006|Overall Study|Other|0|||
23488548|NCT00598702|65533903|FG007|Overall Study|Other|0|||
23488549|NCT00598702|65533896|FG000|Overall Study|Early discharge from hospital|0|||
23488550|NCT00598702|65533897|FG001|Overall Study|Early discharge from hospital|0|||
23604029|NCT00645411|65940280|FG000|Overall Study|Lost to Follow-up|10|||
23488551|NCT00598702|65533898|FG002|Overall Study|Early discharge from hospital|2|||
23488552|NCT00598702|65533899|FG003|Overall Study|Early discharge from hospital|5|||
23488553|NCT00598702|65533900|FG004|Overall Study|Early discharge from hospital|0|||
23488554|NCT00598702|65533901|FG005|Overall Study|Early discharge from hospital|10|||
23488555|NCT00598702|65533902|FG006|Overall Study|Early discharge from hospital|1|||
23488556|NCT00598702|65533903|FG007|Overall Study|Early discharge from hospital|0|||
23488557|NCT00598702|65533896|FG000|Overall Study|Adverse Event|0|||
23488558|NCT00598702|65533897|FG001|Overall Study|Adverse Event|0|||
23488559|NCT00598702|65533898|FG002|Overall Study|Adverse Event|0|||
23488560|NCT00598702|65533899|FG003|Overall Study|Adverse Event|1|||
23488561|NCT00598702|65533900|FG004|Overall Study|Adverse Event|0|||
23488562|NCT00598702|65533901|FG005|Overall Study|Adverse Event|0|||
23488563|NCT00598702|65533902|FG006|Overall Study|Adverse Event|0|||
23488564|NCT00598702|65533903|FG007|Overall Study|Adverse Event|0|||
23488565|NCT00598702|65533896|FG000|Overall Study|Withdrawal by Subject|0|||
23488566|NCT00598702|65533897|FG001|Overall Study|Withdrawal by Subject|0|||
23488567|NCT00598702|65533898|FG002|Overall Study|Withdrawal by Subject|0|||
23488568|NCT00598702|65533899|FG003|Overall Study|Withdrawal by Subject|1|||
23488569|NCT00598702|65533900|FG004|Overall Study|Withdrawal by Subject|1|||
23488570|NCT00598702|65533901|FG005|Overall Study|Withdrawal by Subject|0|||
23488571|NCT00598702|65533902|FG006|Overall Study|Withdrawal by Subject|0|||
23488572|NCT00598702|65533903|FG007|Overall Study|Withdrawal by Subject|0|||
23488573|NCT00598702|65533896|FG000|Overall Study|Physician Decision|0|||
23488574|NCT00598702|65533897|FG001|Overall Study|Physician Decision|0|||
23488575|NCT00598702|65533898|FG002|Overall Study|Physician Decision|0|||
23488576|NCT00598702|65533899|FG003|Overall Study|Physician Decision|0|||
23488577|NCT00598702|65533900|FG004|Overall Study|Physician Decision|1|||
23488578|NCT00598702|65533901|FG005|Overall Study|Physician Decision|0|||
23488579|NCT00598702|65533902|FG006|Overall Study|Physician Decision|0|||
23488580|NCT00598702|65533903|FG007|Overall Study|Physician Decision|0|||
23488581|NCT00598702|65533896|FG000|Overall Study|Dose limiting toxicity|0|||
23488582|NCT00598702|65533897|FG001|Overall Study|Dose limiting toxicity|0|||
23282542|NCT00205777|64776305|FG001|Study Extension I|Protocol Violation|0|||
23282543|NCT00205777|64776306|FG002|Study Extension I|Protocol Violation|0|||
23282544|NCT00205777|64776307|FG003|Study Extension I|Protocol Violation|8|||
23282545|NCT00205777|64776308|FG004|Study Extension I|Protocol Violation|8|||
23282546|NCT00205777|64776309|FG005|Study Extension I|Protocol Violation|0|||
23282547|NCT00205777|64776304|FG000|Study Extension I|Lack of Efficacy|0|||
23282548|NCT00205777|64776305|FG001|Study Extension I|Lack of Efficacy|0|||
23282549|NCT00205777|64776306|FG002|Study Extension I|Lack of Efficacy|0|||
23282550|NCT00205777|64776307|FG003|Study Extension I|Lack of Efficacy|1|||
23282551|NCT00205777|64776308|FG004|Study Extension I|Lack of Efficacy|2|||
23282552|NCT00205777|64776309|FG005|Study Extension I|Lack of Efficacy|0|||
23282553|NCT00205777|64776304|FG000|Study Extension I|Failed to return|15|||
23282554|NCT00205777|64776305|FG001|Study Extension I|Failed to return|0|||
23282555|NCT00205777|64776306|FG002|Study Extension I|Failed to return|0|||
23282556|NCT00205777|64776307|FG003|Study Extension I|Failed to return|17|||
23282557|NCT00205777|64776308|FG004|Study Extension I|Failed to return|13|||
23282558|NCT00205777|64776309|FG005|Study Extension I|Failed to return|0|||
23282559|NCT00205777|64776304|FG000|Study Extension I|Other Event|34|||
23282560|NCT00205777|64776305|FG001|Study Extension I|Other Event|0|||
23282561|NCT00205777|64776306|FG002|Study Extension I|Other Event|0|||
23282562|NCT00205777|64776307|FG003|Study Extension I|Other Event|34|||
23282563|NCT00205777|64776308|FG004|Study Extension I|Other Event|29|||
23282564|NCT00205777|64776309|FG005|Study Extension I|Other Event|0|||
23282565|NCT00205777|64776304|FG000|Study Extension I|Withdrawn as per protocol|0|||
23282566|NCT00205777|64776305|FG001|Study Extension I|Withdrawn as per protocol|0|||
23282567|NCT00205777|64776306|FG002|Study Extension I|Withdrawn as per protocol|1070|||
23282568|NCT00205777|64776307|FG003|Study Extension I|Withdrawn as per protocol|0|||
23282569|NCT00205777|64776308|FG004|Study Extension I|Withdrawn as per protocol|0|||
23282570|NCT00205777|64776309|FG005|Study Extension I|Withdrawn as per protocol|0|||
23282571|NCT00205777|64776304|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
23282572|NCT00205777|64776305|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
23282573|NCT00205777|64776306|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
23282574|NCT00205777|64776307|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
23282575|NCT00205777|64776308|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
23282576|NCT00205777|64776309|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
23488583|NCT00598702|65533898|FG002|Overall Study|Dose limiting toxicity|0|||
23488584|NCT00598702|65533899|FG003|Overall Study|Dose limiting toxicity|1|||
23488585|NCT00598702|65533900|FG004|Overall Study|Dose limiting toxicity|1|||
23488586|NCT00598702|65533901|FG005|Overall Study|Dose limiting toxicity|1|||
23488587|NCT00598702|65533902|FG006|Overall Study|Dose limiting toxicity|0|||
23282577|NCT00205777|64776304|FG000|Study Extension II|Adverse Event|0|||
23488588|NCT00598702|65533903|FG007|Overall Study|Dose limiting toxicity|0|||
23282578|NCT00205777|64776305|FG001|Study Extension II|Adverse Event|0|||
23282579|NCT00205777|64776306|FG002|Study Extension II|Adverse Event|0|||
23282580|NCT00205777|64776307|FG003|Study Extension II|Adverse Event|14|||
23282581|NCT00205777|64776308|FG004|Study Extension II|Adverse Event|0|||
23282582|NCT00205777|64776309|FG005|Study Extension II|Adverse Event|30|||
23282583|NCT00205777|64776304|FG000|Study Extension II|Death|0|||
23282584|NCT00205777|64776305|FG001|Study Extension II|Death|0|||
23282585|NCT00205777|64776306|FG002|Study Extension II|Death|0|||
23282586|NCT00205777|64776307|FG003|Study Extension II|Death|2|||
23282587|NCT00205777|64776308|FG004|Study Extension II|Death|0|||
23282588|NCT00205777|64776309|FG005|Study Extension II|Death|5|||
23282589|NCT00205777|64776304|FG000|Study Extension II|Withdrawal by Subject|0|||
23282590|NCT00205777|64776305|FG001|Study Extension II|Withdrawal by Subject|0|||
23282591|NCT00205777|64776306|FG002|Study Extension II|Withdrawal by Subject|0|||
23282592|NCT00205777|64776307|FG003|Study Extension II|Withdrawal by Subject|35|||
23282593|NCT00205777|64776308|FG004|Study Extension II|Withdrawal by Subject|0|||
23282594|NCT00205777|64776309|FG005|Study Extension II|Withdrawal by Subject|59|||
23282595|NCT00205777|64776304|FG000|Study Extension II|Protocol Violation|0|||
23282596|NCT00205777|64776305|FG001|Study Extension II|Protocol Violation|0|||
23282597|NCT00205777|64776306|FG002|Study Extension II|Protocol Violation|0|||
23282598|NCT00205777|64776307|FG003|Study Extension II|Protocol Violation|1|||
23282599|NCT00205777|64776308|FG004|Study Extension II|Protocol Violation|0|||
23282600|NCT00205777|64776309|FG005|Study Extension II|Protocol Violation|10|||
23282601|NCT00205777|64776304|FG000|Study Extension II|Lack of Efficacy|0|||
23282602|NCT00205777|64776305|FG001|Study Extension II|Lack of Efficacy|0|||
23282603|NCT00205777|64776306|FG002|Study Extension II|Lack of Efficacy|0|||
23282604|NCT00205777|64776307|FG003|Study Extension II|Lack of Efficacy|0|||
23282605|NCT00205777|64776308|FG004|Study Extension II|Lack of Efficacy|0|||
23282606|NCT00205777|64776309|FG005|Study Extension II|Lack of Efficacy|1|||
23282607|NCT00205777|64776304|FG000|Study Extension II|Failed to return|0|||
23282608|NCT00205777|64776305|FG001|Study Extension II|Failed to return|0|||
23282609|NCT00205777|64776306|FG002|Study Extension II|Failed to return|0|||
23282610|NCT00205777|64776307|FG003|Study Extension II|Failed to return|14|||
23282611|NCT00205777|64776308|FG004|Study Extension II|Failed to return|0|||
23282612|NCT00205777|64776309|FG005|Study Extension II|Failed to return|26|||
23282613|NCT00205777|64776304|FG000|Study Extension II|Other Event|0|||
23282614|NCT00205777|64776305|FG001|Study Extension II|Other Event|0|||
23374899|NCT01047319|65119301|FG000|Overall Study|Teva requested participant withdrawal|3|||
23374900|NCT01047319|65119302|FG001|Overall Study|Teva requested participant withdrawal|0|||
23374901|NCT01047319|65119303|FG002|Overall Study|Teva requested participant withdrawal|1|||
23374902|NCT01047319|65119301|FG000|Overall Study|Protocol Violation|3|||
23374903|NCT01047319|65119302|FG001|Overall Study|Protocol Violation|2|||
23374904|NCT01047319|65119303|FG002|Overall Study|Protocol Violation|4|||
23374905|NCT01047319|65119301|FG000|Overall Study|Lack of Efficacy|4|||
23374906|NCT01047319|65119302|FG001|Overall Study|Lack of Efficacy|3|||
23374907|NCT01047319|65119303|FG002|Overall Study|Lack of Efficacy|3|||
23282615|NCT00205777|64776306|FG002|Study Extension II|Other Event|0|||
23282616|NCT00205777|64776307|FG003|Study Extension II|Other Event|12|||
23282617|NCT00205777|64776308|FG004|Study Extension II|Other Event|0|||
23282618|NCT00205777|64776309|FG005|Study Extension II|Other Event|20|||
23282619|NCT00205777|64776304|FG000|Study Extension II|Enrolled but not treated|0|||
23282620|NCT00205777|64776305|FG001|Study Extension II|Enrolled but not treated|0|||
23282621|NCT00205777|64776306|FG002|Study Extension II|Enrolled but not treated|0|||
23282622|NCT00205777|64776307|FG003|Study Extension II|Enrolled but not treated|71|||
23282623|NCT00205777|64776308|FG004|Study Extension II|Enrolled but not treated|0|||
23282624|NCT00205777|64776309|FG005|Study Extension II|Enrolled but not treated|131|||
23282625|NCT01015703|64776310|FG000|Overall Study|Withdrawal by Subject|0|||
23282626|NCT01015703|64776311|FG001|Overall Study|Withdrawal by Subject|1|||
23282627|NCT01015703|64776312|FG002|Overall Study|Withdrawal by Subject|0|||
23282628|NCT01015703|64776313|FG003|Overall Study|Withdrawal by Subject|0|||
23282629|NCT01015703|64776314|FG004|Overall Study|Withdrawal by Subject|0|||
23282630|NCT01015703|64776310|FG000|Overall Study|Adverse Event|1|||
23282631|NCT01015703|64776311|FG001|Overall Study|Adverse Event|0|||
23282632|NCT01015703|64776312|FG002|Overall Study|Adverse Event|0|||
23282633|NCT01015703|64776313|FG003|Overall Study|Adverse Event|0|||
23282634|NCT01015703|64776314|FG004|Overall Study|Adverse Event|0|||
23282635|NCT01015703|64776310|FG000|Overall Study|Protocol Violation|1|||
23282636|NCT01015703|64776311|FG001|Overall Study|Protocol Violation|0|||
23282637|NCT01015703|64776312|FG002|Overall Study|Protocol Violation|0|||
23374908|NCT01047319|65119301|FG000|Overall Study|Death|5|||
23374909|NCT01047319|65119302|FG001|Overall Study|Death|1|||
23374910|NCT01047319|65119303|FG002|Overall Study|Death|5|||
23374911|NCT01047319|65119301|FG000|Overall Study|Pregnancy|13|||
23374912|NCT01047319|65119302|FG001|Overall Study|Pregnancy|8|||
23488589|NCT02435147|65533908|FG000|Overall Study|non-evaluable DXA scan|11|||
23374913|NCT01047319|65119303|FG002|Overall Study|Pregnancy|8|||
23374914|NCT01047319|65119301|FG000|Overall Study|Physician Decision|12|||
23282638|NCT01015703|64776313|FG003|Overall Study|Protocol Violation|0|||
23282639|NCT01015703|64776314|FG004|Overall Study|Protocol Violation|0|||
23282640|NCT05098743|64776315|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
23374915|NCT01047319|65119302|FG001|Overall Study|Physician Decision|9|||
23374916|NCT01047319|65119303|FG002|Overall Study|Physician Decision|10|||
23374917|NCT01047319|65119301|FG000|Overall Study|Lost to Follow-up|14|||
23374918|NCT01047319|65119302|FG001|Overall Study|Lost to Follow-up|10|||
23374919|NCT01047319|65119303|FG002|Overall Study|Lost to Follow-up|10|||
23374920|NCT01047319|65119301|FG000|Overall Study|Adverse Event|16|||
23374921|NCT01047319|65119302|FG001|Overall Study|Adverse Event|27|||
23374922|NCT01047319|65119303|FG002|Overall Study|Adverse Event|21|||
23374923|NCT01047319|65119301|FG000|Overall Study|Withdrawal by Subject|77|||
23374924|NCT01047319|65119302|FG001|Overall Study|Withdrawal by Subject|75|||
23374925|NCT01047319|65119303|FG002|Overall Study|Withdrawal by Subject|87|||
23282641|NCT05098743|64776316|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
23282642|NCT05098743|64776315|FG000|Overall Study|Lost to Follow-up|1|||
23282643|NCT05098743|64776316|FG001|Overall Study|Lost to Follow-up|2|||
23282644|NCT00467597|64776319|FG000|Overall Study|Withdrawal by Subject|2|||
23374926|NCT01047319|65119301|FG000|Overall Study|Study terminated by Sponsor|198|||
23374927|NCT01047319|65119302|FG001|Overall Study|Study terminated by Sponsor|215|||
23374928|NCT01047319|65119303|FG002|Overall Study|Study terminated by Sponsor|203|||
23374929|NCT03095287|65119304|FG000|Overall Study|Treatment Failure|1|||
23374930|NCT03095287|65119304|FG000|Overall Study|Adverse Event|1|||
23374931|NCT01056536|65119311|FG000|Overall Study|Lost to Follow-up|202|||
23374932|NCT01056536|65119312|FG001|Overall Study|Lost to Follow-up|116|||
23282645|NCT00467597|64776320|FG001|Overall Study|Withdrawal by Subject|0|||
23282646|NCT00863330|64776321|FG000|Overall Study|study terminated early due to administra|6|||
23282647|NCT00371839|64776322|FG000|Overall Study|Death|4|||
23282648|NCT00371839|64776323|FG001|Overall Study|Death|0|||
23282649|NCT00371839|64776324|FG002|Overall Study|Death|0|||
23282650|NCT00371839|64776322|FG000|Overall Study|Withdrawal by Subject|7|||
23282651|NCT00371839|64776323|FG001|Overall Study|Withdrawal by Subject|4|||
23282652|NCT00371839|64776324|FG002|Overall Study|Withdrawal by Subject|0|||
23282653|NCT00371839|64776322|FG000|Overall Study|Lost to Follow-up|6|||
23282654|NCT00371839|64776323|FG001|Overall Study|Lost to Follow-up|3|||
23282655|NCT00371839|64776324|FG002|Overall Study|Lost to Follow-up|2|||
23282656|NCT04198363|64776327|FG000|Overall Study|Adverse Event|1|||
23374933|NCT01056536|65119313|FG002|Overall Study|Lost to Follow-up|248|||
23374934|NCT04919161|65119314|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
23374935|NCT04919161|65119315|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
23374936|NCT04919161|65119314|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
23374937|NCT04919161|65119315|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
23374938|NCT04919161|65119314|FG000|Overall Study|Acute ankle sprain after session 1|0|||
23374939|NCT04919161|65119315|FG001|Overall Study|Acute ankle sprain after session 1|1|||
23374940|NCT00658528|65119316|FG000|Overall Study|Adverse Event|5|||
23374941|NCT00658528|65119317|FG001|Overall Study|Adverse Event|7|||
23374942|NCT00658528|65119316|FG000|Overall Study|Lost to Follow-up|14|||
23374943|NCT00658528|65119317|FG001|Overall Study|Lost to Follow-up|22|||
23374944|NCT00658528|65119316|FG000|Overall Study|Withdrawal by Subject|8|||
23374945|NCT00658528|65119317|FG001|Overall Study|Withdrawal by Subject|6|||
23374946|NCT00658528|65119316|FG000|Overall Study|Withdrawal of consent|5|||
23374947|NCT00658528|65119317|FG001|Overall Study|Withdrawal of consent|6|||
23374948|NCT00658528|65119316|FG000|Overall Study|Other|8|||
23374949|NCT00658528|65119317|FG001|Overall Study|Other|4|||
23374950|NCT00423605|65119318|FG000|Overall Study|Adverse Event|129|||
23374951|NCT00423605|65119318|FG000|Overall Study|Withdrawal by Subject|36|||
23374952|NCT00423605|65119318|FG000|Overall Study|Lost to Follow-up|15|||
23374953|NCT00423605|65119318|FG000|Overall Study|Lack of Efficacy|38|||
23374954|NCT00423605|65119318|FG000|Overall Study|Sponsor Decision|3|||
23374955|NCT00423605|65119318|FG000|Overall Study|Physician Decision|8|||
23374956|NCT00423605|65119318|FG000|Overall Study|Protocol Violation|7|||
23374957|NCT00423605|65119318|FG000|Overall Study|Not one of the pre-specified options|5|||
23374958|NCT02369653|65119319|FG000|Overall Study|Lost to Follow-up|0|||
23282657|NCT04198363|64776328|FG001|Overall Study|Adverse Event|1|||
23374959|NCT02369653|65119320|FG001|Overall Study|Lost to Follow-up|1|||
23374960|NCT02369653|65119319|FG000|Overall Study|Administrative reason by sponsor|0|||
23374961|NCT02369653|65119320|FG001|Overall Study|Administrative reason by sponsor|1|||
23374962|NCT02369653|65119319|FG000|Overall Study|Death|1|||
23374963|NCT02369653|65119320|FG001|Overall Study|Death|2|||
23374964|NCT02369653|65119319|FG000|Overall Study|Participant withdrew consent|13|||
23374965|NCT02369653|65119320|FG001|Overall Study|Participant withdrew consent|3|||
23488590|NCT03190369|65533909|FG000|Overall Study|Poor compliance to protocol|0|||
23488591|NCT03190369|65533910|FG001|Overall Study|Poor compliance to protocol|1|||
23282658|NCT04198363|64776327|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
23282659|NCT04198363|64776328|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
23374966|NCT01799941|65119321|FG000|Overall Study|Adverse Event|34|||
23374967|NCT01799941|65119321|FG000|Overall Study|Withdrawal by Subject|21|||
23374968|NCT01799941|65119321|FG000|Overall Study|Death|2|||
23374969|NCT01799941|65119321|FG000|Overall Study|Investigator Decision|4|||
23374970|NCT01799941|65119321|FG000|Overall Study|Lack of Efficacy|3|||
23374971|NCT01799941|65119321|FG000|Overall Study|Lost to Follow-up|17|||
23282660|NCT04198363|64776327|FG000|Overall Study|Reason not Specified|1|||
23282661|NCT04198363|64776328|FG001|Overall Study|Reason not Specified|0|||
23282662|NCT01186458|64776329|FG000|Overall Study|Adverse Event|1|||
23282663|NCT01958294|64776330|FG000|Overall Study|Clinical Circumstances|2|||
23282664|NCT00354159|64776331|FG000|Randomized Study Period|Withdrawal by Subject|5|||
23282665|NCT00354159|64776332|FG001|Randomized Study Period|Withdrawal by Subject|3|||
23282666|NCT00354159|64776331|FG000|Randomized Study Period|Physician Decision|6|||
23282667|NCT00354159|64776332|FG001|Randomized Study Period|Physician Decision|10|||
23282668|NCT00354159|64776331|FG000|Randomized Study Period|Lost to Follow-up|4|||
23282669|NCT00354159|64776332|FG001|Randomized Study Period|Lost to Follow-up|0|||
23374972|NCT01799941|65119321|FG000|Overall Study|Other|15|||
23374973|NCT03861039|65119324|FG000|Overall Study|Adverse Event|2|||
23374974|NCT03861039|65119325|FG001|Overall Study|Adverse Event|5|||
23374975|NCT03861039|65119326|FG002|Overall Study|Adverse Event|11|||
23374976|NCT03861039|65119324|FG000|Overall Study|Withdrawal by Subject|1|||
23374977|NCT03861039|65119325|FG001|Overall Study|Withdrawal by Subject|3|||
23374978|NCT03861039|65119326|FG002|Overall Study|Withdrawal by Subject|4|||
23374979|NCT04400318|65119327|FG000|Overall Study|Adverse Event|1|||
23374980|NCT04400318|65119328|FG001|Overall Study|Adverse Event|0|||
23374981|NCT04400318|65119327|FG000|Overall Study|Withdrawal by Subject|1|||
23374982|NCT04400318|65119328|FG001|Overall Study|Withdrawal by Subject|1|||
23374983|NCT04400318|65119327|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
23374984|NCT04400318|65119328|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
23374985|NCT02034006|65119335|FG000|Overall Study|Withdrawal by Subject|7|||
23374986|NCT02034006|65119335|FG000|Overall Study|Lost to Follow-up|5|||
23374987|NCT02034006|65119335|FG000|Overall Study|Death|1|||
23374988|NCT02034006|65119335|FG000|Overall Study|Pregnancy|1|||
23374989|NCT01461551|65119336|FG000|Overall Study|Physician Decision|2|||
23374990|NCT01461551|65119337|FG001|Overall Study|Physician Decision|1|||
23374991|NCT01461551|65119338|FG002|Overall Study|Physician Decision|2|||
23374992|NCT02577029|65119343|FG000|Overall Study|Adverse Event|1|||
23374993|NCT02577029|65119344|FG001|Overall Study|Adverse Event|0|||
23374994|NCT02577029|65119345|FG002|Overall Study|Adverse Event|2|||
23374995|NCT02577029|65119346|FG003|Overall Study|Adverse Event|0|||
23374996|NCT02577029|65119347|FG004|Overall Study|Adverse Event|1|||
23374997|NCT02577029|65119348|FG005|Overall Study|Adverse Event|0|||
23374998|NCT02577029|65119349|FG006|Overall Study|Adverse Event|0|||
23374999|NCT02577029|65119350|FG007|Overall Study|Adverse Event|0|||
23375000|NCT02577029|65119343|FG000|Overall Study|Withdrawal by Subject|0|||
23375001|NCT02577029|65119344|FG001|Overall Study|Withdrawal by Subject|0|||
23375002|NCT02577029|65119345|FG002|Overall Study|Withdrawal by Subject|0|||
23375003|NCT02577029|65119346|FG003|Overall Study|Withdrawal by Subject|0|||
23375004|NCT02577029|65119347|FG004|Overall Study|Withdrawal by Subject|0|||
23375005|NCT02577029|65119348|FG005|Overall Study|Withdrawal by Subject|1|||
23375006|NCT02577029|65119349|FG006|Overall Study|Withdrawal by Subject|0|||
23375007|NCT02577029|65119350|FG007|Overall Study|Withdrawal by Subject|0|||
23375008|NCT02577029|65119343|FG000|Overall Study|Sponsor Termination of the Study|9|||
23375009|NCT02577029|65119344|FG001|Overall Study|Sponsor Termination of the Study|2|||
23375010|NCT02577029|65119345|FG002|Overall Study|Sponsor Termination of the Study|5|||
23375011|NCT02577029|65119346|FG003|Overall Study|Sponsor Termination of the Study|12|||
23375012|NCT02577029|65119347|FG004|Overall Study|Sponsor Termination of the Study|10|||
23375013|NCT02577029|65119348|FG005|Overall Study|Sponsor Termination of the Study|12|||
23375014|NCT02577029|65119349|FG006|Overall Study|Sponsor Termination of the Study|12|||
23375015|NCT02577029|65119350|FG007|Overall Study|Sponsor Termination of the Study|12|||
23375016|NCT02357459|65119351|FG000|Overall Study|Adverse Event|0|||
23375017|NCT02357459|65119352|FG001|Overall Study|Adverse Event|1|||
23375018|NCT02357459|65119353|FG002|Overall Study|Adverse Event|1|||
23375019|NCT02357459|65119351|FG000|Overall Study|Withdrawal by Subject|5|||
23375020|NCT02357459|65119352|FG001|Overall Study|Withdrawal by Subject|3|||
23282670|NCT00354159|64776331|FG000|Randomized Study Period|Death|7|||
23282671|NCT00354159|64776332|FG001|Randomized Study Period|Death|9|||
23375021|NCT02357459|65119353|FG002|Overall Study|Withdrawal by Subject|3|||
23375022|NCT02357459|65119351|FG000|Overall Study|Physician Decision|0|||
23375023|NCT02357459|65119352|FG001|Overall Study|Physician Decision|2|||
23375024|NCT02357459|65119353|FG002|Overall Study|Physician Decision|0|||
23375025|NCT02357459|65119351|FG000|Overall Study|Protocol Violation|1|||
23375026|NCT02357459|65119352|FG001|Overall Study|Protocol Violation|1|||
23375027|NCT02357459|65119353|FG002|Overall Study|Protocol Violation|0|||
23375028|NCT02357459|65119351|FG000|Overall Study|Lost to Follow-up|1|||
23282672|NCT00354159|64776331|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
23282673|NCT00354159|64776332|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
23282674|NCT00354159|64776331|FG000|Long-term Follow-up|Physician Decision|127|||
23375029|NCT02357459|65119352|FG001|Overall Study|Lost to Follow-up|3|||
23375030|NCT02357459|65119353|FG002|Overall Study|Lost to Follow-up|0|||
23375031|NCT02357459|65119351|FG000|Overall Study|Lack of Efficacy|7|||
23375032|NCT02357459|65119352|FG001|Overall Study|Lack of Efficacy|4|||
23282675|NCT00354159|64776332|FG001|Long-term Follow-up|Physician Decision|122|||
23282676|NCT00354159|64776331|FG000|Long-term Follow-up|Lost to Follow-up|1|||
23282677|NCT00354159|64776332|FG001|Long-term Follow-up|Lost to Follow-up|0|||
23282678|NCT00354159|64776331|FG000|Long-term Follow-up|Death|14|||
23282679|NCT00354159|64776332|FG001|Long-term Follow-up|Death|11|||
23282680|NCT00354159|64776331|FG000|Long-term Follow-up|Study Closed|29|||
23282681|NCT00354159|64776332|FG001|Long-term Follow-up|Study Closed|34|||
23282682|NCT00635648|64776333|FG000|Overall Study|Adverse Event|12|||
23282683|NCT00635648|64776333|FG000|Overall Study|Withdrawal by Subject|9|||
23282684|NCT00635648|64776333|FG000|Overall Study|Physician Decision|4|||
23282685|NCT00635648|64776333|FG000|Overall Study|Rapid progression of baseline disease|4|||
23282686|NCT00635648|64776333|FG000|Overall Study|Use of other antifungal agent needed|1|||
23375033|NCT02357459|65119353|FG002|Overall Study|Lack of Efficacy|4|||
23375034|NCT02357459|65119351|FG000|Overall Study|Patient Relocated|2|||
23375035|NCT02357459|65119352|FG001|Overall Study|Patient Relocated|0|||
23375036|NCT02357459|65119353|FG002|Overall Study|Patient Relocated|0|||
23375037|NCT02357459|65119351|FG000|Overall Study|Instruction from PCP|1|||
23375038|NCT02357459|65119352|FG001|Overall Study|Instruction from PCP|0|||
23375039|NCT02357459|65119353|FG002|Overall Study|Instruction from PCP|0|||
23375040|NCT02357459|65119351|FG000|Overall Study|Incarceration|0|||
23375041|NCT02357459|65119352|FG001|Overall Study|Incarceration|0|||
23282687|NCT00635648|64776333|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
23282688|NCT00635648|64776333|FG000|Overall Study|Noncompliance with protocol|1|||
23282689|NCT00635648|64776333|FG000|Overall Study|Other reason|2|||
23282690|NCT00268203|64776334|FG000|Overall Study|Lost to Follow-up|92|||
23282691|NCT00268203|64776334|FG000|Overall Study|Withdrawal by Subject|9|||
23282692|NCT00268203|64776334|FG000|Overall Study|Received Other NHL Therapy|7|||
23282693|NCT00268203|64776334|FG000|Overall Study|Progressive Disease|359|||
23282694|NCT00268203|64776334|FG000|Overall Study|Death|84|||
23282695|NCT00268203|64776334|FG000|Overall Study|Reason Not Specified|34|||
23282696|NCT00268203|64776334|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
23282697|NCT01559363|64776335|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
23282698|NCT01559363|64776336|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
23282699|NCT01559363|64776337|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
23282700|NCT01559363|64776338|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
23282701|NCT01559363|64776339|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
23375042|NCT02357459|65119353|FG002|Overall Study|Incarceration|1|||
23375043|NCT02357459|65119351|FG000|Overall Study|Pre-planned Knee surgery|0|||
23282702|NCT01559363|64776340|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
23488592|NCT03190369|65533909|FG000|Overall Study|Withdraw before treatment|1|||
23282703|NCT01559363|64776335|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
23282704|NCT01559363|64776336|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
23282705|NCT01559363|64776337|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
23282706|NCT01559363|64776338|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
23282707|NCT01559363|64776339|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
23282708|NCT01559363|64776340|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
23282709|NCT01559363|64776335|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
23282710|NCT01559363|64776336|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
23282711|NCT01559363|64776337|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
23282712|NCT01559363|64776338|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
23282713|NCT01559363|64776339|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
23282714|NCT01559363|64776340|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
23282715|NCT01559363|64776335|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
23282716|NCT01559363|64776336|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
23282717|NCT01559363|64776337|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
23282718|NCT01559363|64776338|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
23282719|NCT01559363|64776339|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
23282720|NCT01559363|64776340|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
23282721|NCT01559363|64776335|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23282722|NCT01559363|64776336|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
23375044|NCT02357459|65119352|FG001|Overall Study|Pre-planned Knee surgery|0|||
23375045|NCT02357459|65119353|FG002|Overall Study|Pre-planned Knee surgery|2|||
23375046|NCT02357459|65119351|FG000|Overall Study|Job Commitments|0|||
23375047|NCT02357459|65119352|FG001|Overall Study|Job Commitments|0|||
23375048|NCT02357459|65119353|FG002|Overall Study|Job Commitments|1|||
23375049|NCT03091439|65119354|FG000|Overall Study|Study Terminated by the Sponsor|1|||
23375050|NCT03091439|65119355|FG001|Overall Study|Study Terminated by the Sponsor|0|||
23488593|NCT03190369|65533910|FG001|Overall Study|Withdraw before treatment|5|||
23282723|NCT01559363|64776337|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23375051|NCT00700635|65119356|FG000|Overall Study|Adverse Event|1|||
23375052|NCT00700635|65119357|FG001|Overall Study|Adverse Event|0|||
23375053|NCT00700635|65119358|FG002|Overall Study|Adverse Event|0|||
23375054|NCT00700635|65119356|FG000|Overall Study|Lost to Follow-up|1|||
23375055|NCT00700635|65119357|FG001|Overall Study|Lost to Follow-up|3|||
23375056|NCT00700635|65119358|FG002|Overall Study|Lost to Follow-up|0|||
23375057|NCT00700635|65119356|FG000|Overall Study|Protocol Violation|2|||
23375058|NCT00700635|65119357|FG001|Overall Study|Protocol Violation|2|||
23375059|NCT00700635|65119358|FG002|Overall Study|Protocol Violation|0|||
23375060|NCT00700635|65119356|FG000|Overall Study|Withdrawal by Subject|7|||
23375061|NCT00700635|65119357|FG001|Overall Study|Withdrawal by Subject|3|||
23375062|NCT00700635|65119358|FG002|Overall Study|Withdrawal by Subject|1|||
23375063|NCT02337764|65119359|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
23375064|NCT02337764|65119359|FG000|Overall Study|Voluntary Withdrawal|12|||
23375065|NCT02337764|65119359|FG000|Overall Study|Lack of Efficacy|2|||
23282724|NCT01559363|64776338|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23282725|NCT01559363|64776339|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23282726|NCT01559363|64776340|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
23282727|NCT01559363|64776335|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
23282728|NCT01559363|64776336|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
23282729|NCT01559363|64776337|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
23282730|NCT01559363|64776338|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
23282731|NCT01559363|64776339|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
23282732|NCT01559363|64776340|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
23282733|NCT01559363|64776335|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23282734|NCT01559363|64776336|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23282735|NCT01559363|64776337|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23282736|NCT01559363|64776338|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
23282737|NCT01559363|64776339|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23282738|NCT01559363|64776340|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
23282739|NCT01075516|64778765|FG000|Overall Study|Death|5|||
23282740|NCT01075516|64778766|FG001|Overall Study|Death|9|||
23282741|NCT01075516|64778765|FG000|Overall Study|Lost to Follow-up|10|||
23282742|NCT01075516|64778766|FG001|Overall Study|Lost to Follow-up|2|||
23282743|NCT01075516|64778765|FG000|Overall Study|Withdrawal by Subject|3|||
23282744|NCT01075516|64778766|FG001|Overall Study|Withdrawal by Subject|5|||
23282745|NCT02535923|64778771|FG000|Overall Study|Lost to Follow-up|5|||
23282746|NCT02535923|64778772|FG001|Overall Study|Lost to Follow-up|5|||
23282747|NCT02535923|64778771|FG000|Overall Study|Withdrawal by Subject|4|||
23282748|NCT02535923|64778772|FG001|Overall Study|Withdrawal by Subject|3|||
23282749|NCT03827395|64778779|FG000|Overall Study|Lost to Follow-up|1|||
23282750|NCT03827395|64778780|FG001|Overall Study|Lost to Follow-up|0|||
23282751|NCT03827395|64778779|FG000|Overall Study|Protocol Violation|1|||
23282752|NCT03827395|64778780|FG001|Overall Study|Protocol Violation|0|||
23282753|NCT03827395|64778779|FG000|Overall Study|Became ineligible after enrollment|1|||
23282754|NCT03827395|64778780|FG001|Overall Study|Became ineligible after enrollment|2|||
23282755|NCT04773600|64778782|FG000|Overall Study|Withdrawal by Subject|15|||
23282756|NCT04773600|64778783|FG001|Overall Study|Withdrawal by Subject|9|||
23282757|NCT04773600|64778782|FG000|Overall Study|Lost to Follow-up|10|||
23282758|NCT04773600|64778783|FG001|Overall Study|Lost to Follow-up|6|||
23282759|NCT04773600|64778782|FG000|Overall Study|Adverse Event|8|||
23282760|NCT04773600|64778783|FG001|Overall Study|Adverse Event|2|||
23282761|NCT04773600|64778782|FG000|Overall Study|Lack of Efficacy|2|||
23282762|NCT04773600|64778783|FG001|Overall Study|Lack of Efficacy|3|||
23282763|NCT04773600|64778782|FG000|Overall Study|Noncompliance|2|||
23282764|NCT04773600|64778783|FG001|Overall Study|Noncompliance|0|||
23282765|NCT04773600|64778782|FG000|Overall Study|Protocol Violation|2|||
23282766|NCT04773600|64778783|FG001|Overall Study|Protocol Violation|0|||
23282767|NCT04773600|64778782|FG000|Overall Study|Physician Decision|0|||
23282768|NCT04773600|64778783|FG001|Overall Study|Physician Decision|1|||
23282769|NCT04773600|64778782|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
23282770|NCT04773600|64778783|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
23282771|NCT04773600|64778782|FG000|Overall Study|Emergency Travel Out of Country|1|||
23282772|NCT04773600|64778783|FG001|Overall Study|Emergency Travel Out of Country|0|||
23282773|NCT01442376|64778784|FG000|Overall Study|Adverse Event|0|||
23282774|NCT01442376|64778785|FG001|Overall Study|Adverse Event|3|||
23282775|NCT01442376|64778786|FG002|Overall Study|Adverse Event|2|||
23282776|NCT01442376|64778784|FG000|Overall Study|Death|0|||
23375066|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
23604030|NCT00645411|65940281|FG001|Overall Study|Lost to Follow-up|5|||
23375067|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
23375068|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
23282777|NCT01442376|64778785|FG001|Overall Study|Death|1|||
23282778|NCT01442376|64778786|FG002|Overall Study|Death|1|||
23282779|NCT01442376|64778784|FG000|Overall Study|Withdrawal of consent|0|||
23282780|NCT01442376|64778785|FG001|Overall Study|Withdrawal of consent|0|||
23282781|NCT01442376|64778786|FG002|Overall Study|Withdrawal of consent|1|||
23282782|NCT01442376|64778784|FG000|Overall Study|Patients not treated|2|||
23282783|NCT01442376|64778785|FG001|Overall Study|Patients not treated|3|||
23282784|NCT01442376|64778786|FG002|Overall Study|Patients not treated|1|||
23282785|NCT01442376|64778784|FG000|Overall Study|Not eligible for subsequent cycles|1|||
23282786|NCT01442376|64778785|FG001|Overall Study|Not eligible for subsequent cycles|2|||
23282787|NCT01442376|64778786|FG002|Overall Study|Not eligible for subsequent cycles|0|||
23282788|NCT00700739|64778789|FG000|Overall Study|Lost to Follow-up|4|||
23282789|NCT00700739|64778790|FG001|Overall Study|Lost to Follow-up|4|||
23282790|NCT00227370|64778791|FG000|Overall Study|Withdrawal by Subject|1|||
23282791|NCT00227370|64778792|FG001|Overall Study|Withdrawal by Subject|2|||
23282792|NCT00227370|64778791|FG000|Overall Study|Death|3|||
23282793|NCT00227370|64778792|FG001|Overall Study|Death|4|||
23282794|NCT00227370|64778791|FG000|Overall Study|Adverse Event|6|||
23282795|NCT00227370|64778792|FG001|Overall Study|Adverse Event|11|||
23282796|NCT00227370|64778791|FG000|Overall Study|Physician Decision|9|||
23282797|NCT00227370|64778792|FG001|Overall Study|Physician Decision|6|||
23282798|NCT00227370|64778791|FG000|Overall Study|Other reasons|2|||
23282799|NCT00227370|64778792|FG001|Overall Study|Other reasons|1|||
23282800|NCT03644550|64778793|FG000|Overall Study|Withdrawal by Subject|3|||
23282801|NCT03644550|64778793|FG000|Overall Study|Progressive disease|15|||
23375069|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
23375070|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
23375071|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
23375072|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
23375073|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
23375074|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
23375075|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
23375076|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
23375077|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
23375078|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
23375079|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
23375080|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
23375081|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
23375082|NCT00849056|65119360|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
23375083|NCT00849056|65119361|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
23375084|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
23375085|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
23375086|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
23375087|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
23375088|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
23375089|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
23375090|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
23375091|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
23375092|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
23375093|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
23282802|NCT02385708|64778794|FG000|Overall Study|Withdrawal by Subject|0|||
23282803|NCT02385708|64778795|FG001|Overall Study|Withdrawal by Subject|2|||
23282804|NCT02385708|64778794|FG000|Overall Study|Withdrawn - surgery canceled|2|||
23282805|NCT02385708|64778795|FG001|Overall Study|Withdrawn - surgery canceled|5|||
23282806|NCT02385708|64778794|FG000|Overall Study|Investigator decision|5|||
23282807|NCT02385708|64778795|FG001|Overall Study|Investigator decision|7|||
23282808|NCT02385708|64778794|FG000|Overall Study|Protocol Violation|1|||
23282809|NCT02385708|64778795|FG001|Overall Study|Protocol Violation|1|||
23282810|NCT02258074|64778796|FG000|Overall Study|Withdrawal by Subject|1|||
23282811|NCT02258074|64778797|FG001|Overall Study|Withdrawal by Subject|0|||
23282812|NCT02258074|64778798|FG002|Overall Study|Withdrawal by Subject|0|||
23282813|NCT02258074|64778799|FG003|Overall Study|Withdrawal by Subject|0|||
23282814|NCT03807440|64778802|FG000|Overall Study|No documentation of index date 2|320|||
23282815|NCT03807440|64778802|FG000|Overall Study|No informed consent for index date 2|117|||
23282816|NCT02313558|64778803|FG000|Overall Study|Withdrawal by Subject|2|||
23375094|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
23375095|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
23375096|NCT00849056|65119360|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
23375097|NCT00849056|65119361|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
23375098|NCT03329885|65119362|FG000|Overall Study|Sponsor discontinued the study early|0|||
23375099|NCT03329885|65119363|FG001|Overall Study|Sponsor discontinued the study early|0|||
23282817|NCT02313558|64778804|FG001|Overall Study|Withdrawal by Subject|0|||
23282818|NCT02313558|64778803|FG000|Overall Study|Lost to Follow-up|4|||
23282819|NCT02313558|64778804|FG001|Overall Study|Lost to Follow-up|4|||
23282820|NCT00840658|64778805|FG000|Overall Study|Death|2|||
23282821|NCT00840658|64778806|FG001|Overall Study|Death|2|||
23282822|NCT00840658|64778807|FG002|Overall Study|Death|3|||
23282823|NCT00840658|64778808|FG003|Overall Study|Death|3|||
23282824|NCT00840658|64778805|FG000|Overall Study|Lost to Follow-up|3|||
23282825|NCT00840658|64778806|FG001|Overall Study|Lost to Follow-up|1|||
23282826|NCT00840658|64778807|FG002|Overall Study|Lost to Follow-up|2|||
23282827|NCT00840658|64778808|FG003|Overall Study|Lost to Follow-up|1|||
23282828|NCT01169558|64778809|FG000|Overall Study|Disease progression|98|||
23282829|NCT01169558|64778809|FG000|Overall Study|Adverse Event|25|||
23282830|NCT01169558|64778809|FG000|Overall Study|Withdrawal of Consent|8|||
23282831|NCT01169558|64778809|FG000|Overall Study|Medical Decision|7|||
23282832|NCT01169558|64778809|FG000|Overall Study|Stable Disease|4|||
23282833|NCT01169558|64778809|FG000|Overall Study|Lost to Follow-up|4|||
23282834|NCT01169558|64778809|FG000|Overall Study|Need for Surgery|4|||
23282835|NCT01169558|64778809|FG000|Overall Study|Non-compliance|2|||
23282836|NCT01169558|64778809|FG000|Overall Study|Protocol Violation|2|||
23282837|NCT01169558|64778809|FG000|Overall Study|Partial response|2|||
23282838|NCT01117623|64778810|FG000|Overall Study|Adverse Event|0|||
23282839|NCT01117623|64778811|FG001|Overall Study|Adverse Event|2|||
23282840|NCT01117623|64778812|FG002|Overall Study|Adverse Event|4|||
23282841|NCT01117623|64778813|FG003|Overall Study|Adverse Event|0|||
23282842|NCT01117623|64778814|FG004|Overall Study|Adverse Event|2|||
23282843|NCT01117623|64778815|FG005|Overall Study|Adverse Event|0|||
23282844|NCT01117623|64778816|FG006|Overall Study|Adverse Event|0|||
23282845|NCT01117623|64778817|FG007|Overall Study|Adverse Event|2|||
23282846|NCT01117623|64778810|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
23282847|NCT01117623|64778811|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
23282848|NCT01117623|64778812|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
23282849|NCT01117623|64778813|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
23282850|NCT01117623|64778814|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
23282851|NCT01117623|64778815|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
23282852|NCT01117623|64778816|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
23282853|NCT01117623|64778817|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
23282854|NCT01117623|64778810|FG000|Overall Study|Withdrawal by Subject|0|||
23282855|NCT01117623|64778811|FG001|Overall Study|Withdrawal by Subject|0|||
23282856|NCT01117623|64778812|FG002|Overall Study|Withdrawal by Subject|2|||
23375100|NCT03329885|65119364|FG002|Overall Study|Sponsor discontinued the study early|0|||
23375101|NCT03329885|65119365|FG003|Overall Study|Sponsor discontinued the study early|0|||
23375102|NCT03329885|65119366|FG004|Overall Study|Sponsor discontinued the study early|0|||
23375103|NCT03329885|65119367|FG005|Overall Study|Sponsor discontinued the study early|0|||
23375104|NCT03329885|65119368|FG006|Overall Study|Sponsor discontinued the study early|1|||
23375105|NCT03329885|65119369|FG007|Overall Study|Sponsor discontinued the study early|1|||
23375106|NCT03329885|65119370|FG008|Overall Study|Sponsor discontinued the study early|0|||
23375107|NCT00695019|65119373|FG000|Overall Study|Withdrawal by Subject|8|||
23375108|NCT00695019|65119374|FG001|Overall Study|Withdrawal by Subject|6|||
23375109|NCT00695019|65119375|FG002|Overall Study|Withdrawal by Subject|4|||
23375110|NCT00695019|65119373|FG000|Overall Study|Protocol Violation|1|||
23375111|NCT00695019|65119374|FG001|Overall Study|Protocol Violation|3|||
23375112|NCT00695019|65119375|FG002|Overall Study|Protocol Violation|1|||
23375113|NCT00695019|65119373|FG000|Overall Study|Lack of Efficacy|0|||
23375114|NCT00695019|65119374|FG001|Overall Study|Lack of Efficacy|0|||
23375115|NCT00695019|65119375|FG002|Overall Study|Lack of Efficacy|1|||
23375116|NCT00695019|65119373|FG000|Overall Study|Various|4|||
23375117|NCT00695019|65119374|FG001|Overall Study|Various|5|||
23375118|NCT00695019|65119375|FG002|Overall Study|Various|4|||
23375119|NCT02783911|65119376|FG000|Overall Study|Lost to Follow-up|3|||
23375120|NCT02783911|65119377|FG001|Overall Study|Lost to Follow-up|32|||
23375121|NCT00157755|65119378|FG000|Overall Study|Death|2|||
23375122|NCT00157755|65119379|FG001|Overall Study|Death|3|||
23488594|NCT03190369|65533909|FG000|Overall Study|Randomized but not treated|0|||
23488595|NCT03190369|65533910|FG001|Overall Study|Randomized but not treated|2|||
23488596|NCT01180647|65533911|FG000|Overall Study|Lost to Follow-up|5|||
23488597|NCT01180647|65533912|FG001|Overall Study|Lost to Follow-up|6|||
23488598|NCT01528215|65533913|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
23488599|NCT01528215|65533914|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
23488600|NCT01528215|65533913|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
23488601|NCT01528215|65533914|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
23488602|NCT01528215|65533913|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
23282857|NCT01117623|64778813|FG003|Overall Study|Withdrawal by Subject|0|||
23375123|NCT00157755|65119380|FG002|Overall Study|Death|3|||
23488603|NCT01528215|65533914|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
23282858|NCT01117623|64778814|FG004|Overall Study|Withdrawal by Subject|0|||
23282859|NCT01117623|64778815|FG005|Overall Study|Withdrawal by Subject|1|||
23282860|NCT01117623|64778816|FG006|Overall Study|Withdrawal by Subject|1|||
23375124|NCT00157755|65119381|FG003|Overall Study|Death|2|||
23375125|NCT00157755|65119382|FG004|Overall Study|Death|0|||
23604031|NCT00645411|65940282|FG002|Overall Study|Lost to Follow-up|124|||
23604032|NCT00645411|65940283|FG003|Overall Study|Lost to Follow-up|75|||
23282861|NCT01117623|64778817|FG007|Overall Study|Withdrawal by Subject|1|||
23375126|NCT00157755|65119383|FG005|Overall Study|Death|0|||
23488604|NCT01528215|65533913|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
23488605|NCT01528215|65533914|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
23488606|NCT02853344|65533915|FG000|Overall Study|Lost to Follow-up|1|||
23488607|NCT02853344|65533916|FG001|Overall Study|Lost to Follow-up|1|||
23488608|NCT02853344|65533915|FG000|Overall Study|Withdrawal by Subject|2|||
23488609|NCT02853344|65533916|FG001|Overall Study|Withdrawal by Subject|4|||
23488610|NCT02853344|65533915|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
23488611|NCT02853344|65533916|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
23488612|NCT02853344|65533915|FG000|Overall Study|Death|70|||
23488613|NCT02853344|65533916|FG001|Overall Study|Death|112|||
23488614|NCT02106910|65533917|FG000|Overall Study|Lost to Follow-up|1|||
23488615|NCT02106910|65533918|FG001|Overall Study|Lost to Follow-up|1|||
23488616|NCT02507973|65533919|FG000|Overall Study|Adverse Event|1|||
23488617|NCT02204007|65533924|FG000|Overall Study|Surgery Canceled|1|||
23488618|NCT02204007|65533925|FG001|Overall Study|Surgery Canceled|1|||
23488619|NCT01865084|65533926|FG000|Double Blind Period (DB)|Adverse Event|2|||
23488620|NCT01865084|65533927|FG001|Double Blind Period (DB)|Adverse Event|2|||
23488621|NCT01865084|65533928|FG002|Double Blind Period (DB)|Adverse Event|1|||
23488622|NCT01865084|65533926|FG000|Double Blind Period (DB)|Protocol Violation|0|||
23488623|NCT01865084|65533927|FG001|Double Blind Period (DB)|Protocol Violation|0|||
23488624|NCT01865084|65533928|FG002|Double Blind Period (DB)|Protocol Violation|1|||
23488625|NCT01865084|65533926|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
23488626|NCT01865084|65533927|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
23488627|NCT01865084|65533928|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
23488628|NCT01865084|65533926|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
23488629|NCT01865084|65533927|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
23488630|NCT01865084|65533928|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
23488631|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
23488632|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
23488633|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
23488634|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
23488635|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
23488636|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
23488637|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
23488638|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
23488639|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
23488640|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
23488641|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
23488642|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
23488643|NCT01865084|65533926|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
23488644|NCT01865084|65533927|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
23488645|NCT01865084|65533928|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
23488646|NCT04447755|65533930|FG000|Overall Study|Death|8|||
23488647|NCT04447755|65533931|FG001|Overall Study|Death|14|||
23488648|NCT04447755|65533932|FG002|Overall Study|Death|8|||
23488649|NCT04447755|65533933|FG003|Overall Study|Death|9|||
23488650|NCT04447755|65533934|FG004|Overall Study|Death|7|||
23282862|NCT01117623|64778810|FG000|Overall Study|Non-compliance with study medication|0|||
23282863|NCT01117623|64778811|FG001|Overall Study|Non-compliance with study medication|0|||
23282864|NCT01117623|64778812|FG002|Overall Study|Non-compliance with study medication|0|||
23282865|NCT01117623|64778813|FG003|Overall Study|Non-compliance with study medication|0|||
23282866|NCT01117623|64778814|FG004|Overall Study|Non-compliance with study medication|0|||
23282867|NCT01117623|64778815|FG005|Overall Study|Non-compliance with study medication|0|||
23282868|NCT01117623|64778816|FG006|Overall Study|Non-compliance with study medication|0|||
23282869|NCT01117623|64778817|FG007|Overall Study|Non-compliance with study medication|1|||
23282870|NCT01117623|64778810|FG000|Overall Study|Invest. text: completed all planned txs|0|||
23282871|NCT01117623|64778811|FG001|Overall Study|Invest. text: completed all planned txs|0|||
23282872|NCT01117623|64778812|FG002|Overall Study|Invest. text: completed all planned txs|0|||
23282873|NCT01117623|64778813|FG003|Overall Study|Invest. text: completed all planned txs|0|||
23282874|NCT01117623|64778814|FG004|Overall Study|Invest. text: completed all planned txs|0|||
23282875|NCT01117623|64778815|FG005|Overall Study|Invest. text: completed all planned txs|1|||
23282876|NCT01117623|64778816|FG006|Overall Study|Invest. text: completed all planned txs|0|||
23282877|NCT01117623|64778817|FG007|Overall Study|Invest. text: completed all planned txs|0|||
23488651|NCT04447755|65533935|FG005|Overall Study|Death|7|||
23488652|NCT04447755|65533936|FG006|Overall Study|Death|40|||
23488653|NCT04447755|65533930|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23488654|NCT04447755|65533931|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23488655|NCT04447755|65533932|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23488656|NCT04447755|65533933|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
23488657|NCT04447755|65533934|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
23282878|NCT05315713|64778822|FG000|Overall Study|Death|5|||
23282879|NCT05315713|64778822|FG000|Overall Study|Progressive disease|1|||
23282880|NCT05315713|64778822|FG000|Overall Study|Withdrawal by Subject|1|||
23282881|NCT05315713|64778822|FG000|Overall Study|Study terminated by sponsor|1|||
23282882|NCT00736190|64778823|FG000|Overall Study|Pregnancy|1|||
23282883|NCT00736190|64778823|FG000|Overall Study|Withdrawal by Subject|1|||
23282884|NCT00736190|64778823|FG000|Overall Study|Adverse Event|1|||
23282885|NCT03502811|64778827|FG000|Overall Study|Death|157|||
23282886|NCT03502811|64778827|FG000|Overall Study|Withdrawal by Subject|105|||
23282887|NCT03502811|64778827|FG000|Overall Study|Lost to Follow-up|26|||
23282888|NCT03502811|64778827|FG000|Overall Study|No Visits (Missed)|31|||
23282889|NCT00705666|64778835|FG000|Overall Study|No post-treatment questionnaire|279|||
23282890|NCT00705666|64778835|FG000|Overall Study|Withdrawal by Subject|21|||
23282891|NCT00705666|64778835|FG000|Overall Study|Physician Decision|7|||
23282892|NCT00705666|64778835|FG000|Overall Study|Lost to Follow-up|5|||
23282893|NCT00705666|64778835|FG000|Overall Study|Death|1|||
23282894|NCT00705666|64778835|FG000|Overall Study|Adverse Event|4|||
23282895|NCT00705666|64778835|FG000|Overall Study|Other|12|||
23282896|NCT00705666|64778835|FG000|Overall Study|Other|2|||
23282897|NCT00705666|64778835|FG000|Overall Study|Lack of data|3|||
23282898|NCT00705666|64778835|FG000|Overall Study|Untreated|5|||
23282899|NCT04577651|64778840|FG000|Overall Study|Screen Failure|7|||
23282900|NCT04577651|64778840|FG000|Overall Study|Adverse Event|1|||
23282901|NCT04577651|64778840|FG000|Overall Study|Death|1|||
23282902|NCT04577651|64778840|FG000|Overall Study|Physician Decision|1|||
23282903|NCT04577651|64778840|FG000|Overall Study|Withdrawal by Subject|3|||
23282904|NCT00608322|64778843|FG000|Overall Study|Death|2|||
23282905|NCT00608322|64778844|FG001|Overall Study|Death|1|||
23282906|NCT01741545|64778845|FG000|Treatment Period|Lack of Efficacy|0|||
23375127|NCT00157755|65119378|FG000|Overall Study|Lost to Follow-up|0|||
23282907|NCT01741545|64778846|FG001|Treatment Period|Lack of Efficacy|1|||
23282908|NCT01741545|64778845|FG000|Treatment Period|Adverse event, non-fatal|1|||
23282909|NCT01741545|64778846|FG001|Treatment Period|Adverse event, non-fatal|3|||
23282910|NCT01741545|64778845|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
23375128|NCT00157755|65119379|FG001|Overall Study|Lost to Follow-up|0|||
23375129|NCT00157755|65119380|FG002|Overall Study|Lost to Follow-up|1|||
23375130|NCT00157755|65119381|FG003|Overall Study|Lost to Follow-up|0|||
23375131|NCT00157755|65119382|FG004|Overall Study|Lost to Follow-up|0|||
23375132|NCT00157755|65119383|FG005|Overall Study|Lost to Follow-up|0|||
23375133|NCT00157755|65119378|FG000|Overall Study|Withdrawal by Subject|0|||
23375134|NCT00157755|65119379|FG001|Overall Study|Withdrawal by Subject|0|||
23375135|NCT00157755|65119380|FG002|Overall Study|Withdrawal by Subject|1|||
23375136|NCT00157755|65119381|FG003|Overall Study|Withdrawal by Subject|1|||
23375137|NCT00157755|65119382|FG004|Overall Study|Withdrawal by Subject|1|||
23375138|NCT00157755|65119383|FG005|Overall Study|Withdrawal by Subject|2|||
23375139|NCT00157755|65119378|FG000|Overall Study|Explant due to infection|0|||
23375140|NCT00157755|65119379|FG001|Overall Study|Explant due to infection|0|||
23375141|NCT00157755|65119380|FG002|Overall Study|Explant due to infection|1|||
23375142|NCT00157755|65119381|FG003|Overall Study|Explant due to infection|0|||
23375143|NCT00157755|65119382|FG004|Overall Study|Explant due to infection|0|||
23375144|NCT00157755|65119383|FG005|Overall Study|Explant due to infection|0|||
23375145|NCT00157755|65119378|FG000|Overall Study|Medical reason|0|||
23375146|NCT00157755|65119379|FG001|Overall Study|Medical reason|0|||
23375147|NCT00157755|65119380|FG002|Overall Study|Medical reason|1|||
23375148|NCT00157755|65119381|FG003|Overall Study|Medical reason|1|||
23375149|NCT00157755|65119382|FG004|Overall Study|Medical reason|0|||
23375150|NCT00157755|65119383|FG005|Overall Study|Medical reason|0|||
23375151|NCT00157755|65119378|FG000|Overall Study|Study site closure|0|||
23375152|NCT00157755|65119379|FG001|Overall Study|Study site closure|1|||
23375153|NCT00157755|65119380|FG002|Overall Study|Study site closure|0|||
23375154|NCT00157755|65119381|FG003|Overall Study|Study site closure|0|||
23375155|NCT00157755|65119382|FG004|Overall Study|Study site closure|0|||
23375156|NCT00157755|65119383|FG005|Overall Study|Study site closure|0|||
23375157|NCT00157755|65119378|FG000|Overall Study|Subject non-compliance|0|||
23375158|NCT00157755|65119379|FG001|Overall Study|Subject non-compliance|0|||
23282911|NCT01741545|64778846|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
23282912|NCT01741545|64778845|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
23282913|NCT01741545|64778846|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
23282914|NCT00573313|64778847|FG000|Overall Study|Protocol Violation|5|||
23375159|NCT00157755|65119380|FG002|Overall Study|Subject non-compliance|0|||
23375160|NCT00157755|65119381|FG003|Overall Study|Subject non-compliance|0|||
23375161|NCT00157755|65119382|FG004|Overall Study|Subject non-compliance|0|||
23282915|NCT00573313|64778848|FG001|Overall Study|Protocol Violation|0|||
23282916|NCT00573313|64778849|FG002|Overall Study|Protocol Violation|6|||
23282917|NCT00573313|64778850|FG003|Overall Study|Protocol Violation|0|||
23375162|NCT00157755|65119383|FG005|Overall Study|Subject non-compliance|1|||
23375163|NCT00157755|65119378|FG000|Overall Study|Study completion|0|||
23375164|NCT00157755|65119379|FG001|Overall Study|Study completion|0|||
23375165|NCT00157755|65119380|FG002|Overall Study|Study completion|0|||
23282918|NCT02648438|64778852|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23282919|NCT02648438|64778853|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
23282920|NCT02648438|64778854|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
23282921|NCT02648438|64778852|FG000|Overall Study|Protocol Violation|2|||
23282922|NCT02648438|64778853|FG001|Overall Study|Protocol Violation|0|||
23282923|NCT02648438|64778854|FG002|Overall Study|Protocol Violation|0|||
23282924|NCT02648438|64778852|FG000|Overall Study|Withdrawal by Subject|1|||
23282925|NCT02648438|64778853|FG001|Overall Study|Withdrawal by Subject|1|||
23282926|NCT02648438|64778854|FG002|Overall Study|Withdrawal by Subject|0|||
23282927|NCT00446966|64778855|FG000|Overall Study|Lost to Follow-up|10|||
23282928|NCT00446966|64778856|FG001|Overall Study|Lost to Follow-up|7|||
23282929|NCT05068284|64778861|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
23282930|NCT05068284|64778862|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
23282931|NCT05068284|64778863|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23282932|NCT05068284|64778864|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23282933|NCT05068284|64778865|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23282934|NCT05068284|64778866|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23282935|NCT05068284|64778867|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23282936|NCT05068284|64778868|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
23282937|NCT05068284|64778861|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23282938|NCT05068284|64778862|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23282939|NCT05068284|64778863|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
23282940|NCT05068284|64778864|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23282941|NCT05068284|64778865|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23282942|NCT05068284|64778866|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23375166|NCT00157755|65119381|FG003|Overall Study|Study completion|0|||
23375167|NCT00157755|65119382|FG004|Overall Study|Study completion|1|||
23375168|NCT00157755|65119383|FG005|Overall Study|Study completion|2|||
23375169|NCT01125930|65119384|FG000|Overall Study|Adverse Event|0|||
23375170|NCT01125930|65119385|FG001|Overall Study|Adverse Event|1|||
23375171|NCT01125930|65119384|FG000|Overall Study|Withdrawal by Subject|1|||
23375172|NCT01125930|65119385|FG001|Overall Study|Withdrawal by Subject|6|||
23375173|NCT01125930|65119384|FG000|Overall Study|Protocol Violation|0|||
23375174|NCT01125930|65119385|FG001|Overall Study|Protocol Violation|1|||
23375175|NCT01125930|65119384|FG000|Overall Study|Lost to Follow-up|0|||
23375176|NCT01125930|65119385|FG001|Overall Study|Lost to Follow-up|2|||
23375177|NCT00109343|65119386|FG000|Overall Study|Adverse Event|1|||
23375178|NCT00109343|65119387|FG001|Overall Study|Adverse Event|0|||
23375179|NCT00109343|65119388|FG002|Overall Study|Adverse Event|2|||
23375180|NCT00109343|65119386|FG000|Overall Study|Lack of Efficacy|1|||
23375181|NCT00109343|65119387|FG001|Overall Study|Lack of Efficacy|0|||
23375182|NCT00109343|65119388|FG002|Overall Study|Lack of Efficacy|0|||
23375183|NCT00109343|65119386|FG000|Overall Study|Lost to Follow-up|35|||
23375184|NCT00109343|65119387|FG001|Overall Study|Lost to Follow-up|20|||
23375185|NCT00109343|65119388|FG002|Overall Study|Lost to Follow-up|14|||
23375186|NCT00109343|65119386|FG000|Overall Study|Protocol Violation|1|||
23375187|NCT00109343|65119387|FG001|Overall Study|Protocol Violation|2|||
23375188|NCT00109343|65119388|FG002|Overall Study|Protocol Violation|2|||
23375189|NCT00109343|65119386|FG000|Overall Study|Withdrawal by Subject|15|||
23375190|NCT00109343|65119387|FG001|Overall Study|Withdrawal by Subject|11|||
23375191|NCT00109343|65119388|FG002|Overall Study|Withdrawal by Subject|10|||
23375192|NCT00109343|65119386|FG000|Overall Study|Subject Moved|6|||
23375193|NCT00109343|65119387|FG001|Overall Study|Subject Moved|2|||
23375194|NCT00109343|65119388|FG002|Overall Study|Subject Moved|1|||
23375195|NCT00109343|65119386|FG000|Overall Study|Other|5|||
23375196|NCT00109343|65119387|FG001|Overall Study|Other|2|||
23375197|NCT00109343|65119388|FG002|Overall Study|Other|1|||
23488658|NCT04447755|65533935|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
23488659|NCT04447755|65533936|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
23488660|NCT04447755|65533930|FG000|Overall Study|Ongoing in Study|1|||
23282943|NCT05068284|64778867|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23282944|NCT05068284|64778868|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
23282945|NCT05068284|64778861|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
23282946|NCT05068284|64778862|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
23282947|NCT05068284|64778863|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
23282948|NCT05068284|64778864|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
23375198|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
23375199|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
23375200|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
23375201|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
23375202|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
23375203|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
23375204|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
23375205|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
23375206|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
23375207|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
23375208|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
23375209|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
23375210|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
23375211|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
23375212|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
23375213|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
23375214|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
23375215|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
23375216|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
23375217|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
23375218|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
23375219|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
23375220|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
23375221|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
23375222|NCT01715285|65119395|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
23375223|NCT01715285|65119396|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
23375224|NCT01715285|65119397|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
23375225|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
23375226|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
23375227|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
23375228|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
23375229|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
23375230|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
23282949|NCT05068284|64778865|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
23282950|NCT05068284|64778866|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
23375231|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
23488661|NCT04447755|65533931|FG001|Overall Study|Ongoing in Study|2|||
23488662|NCT04447755|65533932|FG002|Overall Study|Ongoing in Study|0|||
23488663|NCT04447755|65533933|FG003|Overall Study|Ongoing in Study|0|||
23488664|NCT04447755|65533934|FG004|Overall Study|Ongoing in Study|2|||
23488665|NCT04447755|65533935|FG005|Overall Study|Ongoing in Study|2|||
23488666|NCT04447755|65533936|FG006|Overall Study|Ongoing in Study|26|||
23488667|NCT00910988|65533938|FG000|Overall Study|Lost to Follow-up|2|||
23488668|NCT00910988|65533939|FG001|Overall Study|Lost to Follow-up|4|||
23488669|NCT00910988|65533940|FG002|Overall Study|Lost to Follow-up|3|||
23282951|NCT05068284|64778867|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
23282952|NCT05068284|64778868|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
23282953|NCT05068284|64778861|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23282954|NCT05068284|64778862|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23282955|NCT05068284|64778863|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
23282956|NCT05068284|64778864|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23282957|NCT05068284|64778865|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
23282958|NCT05068284|64778866|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23282959|NCT05068284|64778867|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23282960|NCT05068284|64778868|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
23282961|NCT05068284|64778861|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23282962|NCT05068284|64778862|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23282963|NCT05068284|64778863|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23282964|NCT05068284|64778864|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
23282965|NCT05068284|64778865|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23282966|NCT05068284|64778866|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23282967|NCT05068284|64778867|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23282968|NCT05068284|64778868|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
23282969|NCT05068284|64778861|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23282970|NCT05068284|64778862|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23282971|NCT05068284|64778863|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
23282972|NCT05068284|64778864|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
23282973|NCT05068284|64778865|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23282974|NCT05068284|64778866|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23282975|NCT05068284|64778867|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23282976|NCT05068284|64778868|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
23282977|NCT05068284|64778861|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23282978|NCT05068284|64778862|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23488670|NCT00910988|65533941|FG003|Overall Study|Lost to Follow-up|0|||
23488671|NCT00642473|65533942|FG000|Overall Study|Withdrawal by Subject|0|||
23375232|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
23375233|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
23375234|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
23375235|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
23375236|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
23375237|NCT01715285|65119395|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
23375238|NCT01715285|65119396|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
23375239|NCT01715285|65119397|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
23375240|NCT00862992|65119398|FG000|Overall Study|Adverse Event|2|||
23375241|NCT00862992|65119399|FG001|Overall Study|Adverse Event|1|||
23375242|NCT00862992|65119400|FG002|Overall Study|Adverse Event|1|||
23375243|NCT00862992|65119398|FG000|Overall Study|Physician Decision|1|||
23375244|NCT00862992|65119399|FG001|Overall Study|Physician Decision|0|||
23375245|NCT00862992|65119400|FG002|Overall Study|Physician Decision|0|||
23375246|NCT00862992|65119398|FG000|Overall Study|Withdrawal by Subject|0|||
23375247|NCT00862992|65119399|FG001|Overall Study|Withdrawal by Subject|0|||
23375248|NCT00862992|65119400|FG002|Overall Study|Withdrawal by Subject|2|||
23375249|NCT03617588|65119401|FG000|Overall Study|Withdrawal by Subject|1|||
23375250|NCT03617588|65119402|FG001|Overall Study|Withdrawal by Subject|0|||
23375251|NCT03937778|65119403|FG000|Overall Study|Withdrawal by Subject|1|||
23488672|NCT00642473|65533943|FG001|Overall Study|Withdrawal by Subject|5|||
23375252|NCT03937778|65119403|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
23375253|NCT01860989|65119404|FG000|Overall Study|Unsatisfactory therapeutic|5|||
23375254|NCT02566005|65119405|FG000|Overall Study|vaginal bleeding|0|||
23375255|NCT02566005|65119406|FG001|Overall Study|vaginal bleeding|1|||
23282979|NCT05068284|64778863|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
23282980|NCT05068284|64778864|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23488673|NCT00642473|65533942|FG000|Overall Study|Progression or death|2|||
23488674|NCT00642473|65533943|FG001|Overall Study|Progression or death|4|||
23282981|NCT05068284|64778865|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23282982|NCT05068284|64778866|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23282983|NCT05068284|64778867|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23282984|NCT05068284|64778868|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
23282985|NCT05068284|64778861|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
23282986|NCT05068284|64778862|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23282987|NCT05068284|64778863|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23375256|NCT02566005|65119405|FG000|Overall Study|received foley|8|||
23375257|NCT02566005|65119406|FG001|Overall Study|received foley|0|||
23488675|NCT00642473|65533942|FG000|Overall Study|Other|2|||
23488676|NCT00642473|65533943|FG001|Overall Study|Other|2|||
23488677|NCT02360111|65533944|FG000|Overall Study|Death|2|||
23488678|NCT01066000|65533949|FG000|Overall Study|Protocol Violation|4|||
23488679|NCT01066000|65533949|FG000|Overall Study|Death|3|||
23488680|NCT01066000|65533949|FG000|Overall Study|Withdrawal by Subject|1|||
23488681|NCT01066000|65533949|FG000|Overall Study|Adverse Event|1|||
23488682|NCT01069627|65533950|FG000|Overall Study|Disease progression|7|||
23488683|NCT01069627|65533950|FG000|Overall Study|Adverse Event|12|||
23488684|NCT01069627|65533950|FG000|Overall Study|Protocol Violation|1|||
23488685|NCT02810340|65533952|FG000|Overall Study|Withdrawal by Subject|1|||
23488686|NCT02810340|65533953|FG001|Overall Study|Withdrawal by Subject|0|||
23488687|NCT02810340|65533954|FG002|Overall Study|Withdrawal by Subject|0|||
23488688|NCT02810340|65533952|FG000|Overall Study|Incarceration|0|||
23488689|NCT02810340|65533953|FG001|Overall Study|Incarceration|1|||
23488690|NCT02810340|65533954|FG002|Overall Study|Incarceration|0|||
23488691|NCT02810340|65533952|FG000|Overall Study|Lost to Follow-up|0|||
23488692|NCT02810340|65533953|FG001|Overall Study|Lost to Follow-up|0|||
23488693|NCT02810340|65533954|FG002|Overall Study|Lost to Follow-up|1|||
23488694|NCT02452697|65533955|FG000|Overall Study|Physician Decision|4|||
23488695|NCT02452697|65533956|FG001|Overall Study|Physician Decision|4|||
23488696|NCT02452697|65533957|FG002|Overall Study|Physician Decision|3|||
23488697|NCT02452697|65533958|FG003|Overall Study|Physician Decision|2|||
23488698|NCT02452697|65533955|FG000|Overall Study|Withdrawal by Subject|1|||
23488699|NCT02452697|65533956|FG001|Overall Study|Withdrawal by Subject|0|||
23488700|NCT02452697|65533957|FG002|Overall Study|Withdrawal by Subject|0|||
23488701|NCT02452697|65533958|FG003|Overall Study|Withdrawal by Subject|0|||
23375258|NCT02566005|65119405|FG000|Overall Study|did not receive foley|0|||
23375259|NCT02566005|65119406|FG001|Overall Study|did not receive foley|1|||
23375260|NCT02566005|65119405|FG000|Overall Study|labor after randomization|0|||
23488702|NCT02452697|65533955|FG000|Overall Study|still in follow-up|2|||
23488703|NCT02452697|65533956|FG001|Overall Study|still in follow-up|2|||
23488704|NCT02452697|65533957|FG002|Overall Study|still in follow-up|1|||
23488705|NCT02452697|65533958|FG003|Overall Study|still in follow-up|3|||
23488706|NCT00589290|65533959|FG000|Overall Study|Withdrawal by Subject|1|||
23488707|NCT01927341|65533962|FG000|Phase 1b|Lost to Follow-up|1|||
23375261|NCT02566005|65119406|FG001|Overall Study|labor after randomization|4|||
23375262|NCT00143507|65119407|FG000|Overall Study|Death|572|||
23375263|NCT00143507|65119408|FG001|Overall Study|Death|547|||
23375264|NCT00143507|65119407|FG000|Overall Study|Withdrawal by Subject|114|||
23375265|NCT00143507|65119408|FG001|Overall Study|Withdrawal by Subject|102|||
23375266|NCT00143507|65119407|FG000|Overall Study|Lost to Follow-up|1|||
23375267|NCT00143507|65119408|FG001|Overall Study|Lost to Follow-up|0|||
23375268|NCT00143507|65119407|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
23375269|NCT00143507|65119408|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
23375270|NCT03620162|65119409|FG000|Overall Study|Physician Decision|4|||
23375271|NCT03620162|65119410|FG001|Overall Study|Physician Decision|0|||
23375272|NCT03620162|65119411|FG002|Overall Study|Physician Decision|1|||
23375273|NCT03620162|65119412|FG003|Overall Study|Physician Decision|0|||
23375274|NCT03620162|65119413|FG004|Overall Study|Physician Decision|2|||
23375275|NCT03620162|65119409|FG000|Overall Study|Lost to Follow-up|2|||
23375276|NCT03620162|65119410|FG001|Overall Study|Lost to Follow-up|6|||
23375277|NCT03620162|65119411|FG002|Overall Study|Lost to Follow-up|7|||
23375278|NCT03620162|65119412|FG003|Overall Study|Lost to Follow-up|3|||
23375279|NCT03620162|65119413|FG004|Overall Study|Lost to Follow-up|2|||
23375280|NCT03620162|65119409|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
23604033|NCT00645411|65940280|FG000|Overall Study|Protocol Violation|1|||
23604034|NCT00645411|65940281|FG001|Overall Study|Protocol Violation|0|||
23604035|NCT00645411|65940282|FG002|Overall Study|Protocol Violation|1|||
23604036|NCT00645411|65940283|FG003|Overall Study|Protocol Violation|0|||
23604037|NCT00645411|65940280|FG000|Overall Study|Inappropriate enrollment|0|||
23604038|NCT00645411|65940281|FG001|Overall Study|Inappropriate enrollment|0|||
23375281|NCT03620162|65119410|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
23282988|NCT05068284|64778864|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23282989|NCT05068284|64778865|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23282990|NCT05068284|64778866|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23282991|NCT05068284|64778867|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23282992|NCT05068284|64778868|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
23282993|NCT05068284|64778861|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
23282994|NCT05068284|64778862|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23282995|NCT05068284|64778863|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23282996|NCT05068284|64778864|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23282997|NCT05068284|64778865|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23282998|NCT05068284|64778866|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
23282999|NCT05068284|64778867|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
23283000|NCT05068284|64778868|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
23283001|NCT05068284|64778861|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
23283002|NCT05068284|64778862|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23283003|NCT05068284|64778863|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23283004|NCT05068284|64778864|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23283005|NCT05068284|64778865|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23283006|NCT05068284|64778866|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23283007|NCT05068284|64778867|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
23283008|NCT05068284|64778868|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
23283009|NCT05068284|64778861|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
23375282|NCT03620162|65119411|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
23375283|NCT03620162|65119412|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
23375284|NCT03620162|65119413|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
23375285|NCT01655901|65119420|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
23604039|NCT00645411|65940282|FG002|Overall Study|Inappropriate enrollment|4|||
23604040|NCT00645411|65940283|FG003|Overall Study|Inappropriate enrollment|1|||
23604041|NCT00645411|65940280|FG000|Overall Study|Unable to classify|0|||
23604042|NCT00645411|65940281|FG001|Overall Study|Unable to classify|0|||
23604043|NCT00645411|65940282|FG002|Overall Study|Unable to classify|3|||
23604044|NCT00645411|65940283|FG003|Overall Study|Unable to classify|4|||
23604045|NCT00689351|65940284|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
23375286|NCT01655901|65119421|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
23375287|NCT01655901|65119422|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
23375288|NCT01655901|65119423|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
23375289|NCT01655901|65119424|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
23375290|NCT01655901|65119425|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
23375291|NCT00655889|65119426|FG000|Overall Study|Inadequate cell growth|1|||
23375292|NCT00655889|65119426|FG000|Overall Study|Protocol Violation|1|||
23375293|NCT03479905|65119427|FG000|Overall Study|Other airway method used|4|||
23375294|NCT03479905|65119428|FG001|Overall Study|Other airway method used|5|||
23375295|NCT03479905|65119429|FG002|Overall Study|Other airway method used|5|||
23375296|NCT05166876|65119433|FG000|Overall Study|Withdrawal by Subject|1|||
23375297|NCT05166876|65119434|FG001|Overall Study|Withdrawal by Subject|0|||
23375298|NCT05166876|65119435|FG002|Overall Study|Withdrawal by Subject|0|||
23375299|NCT00207740|65119436|FG000|Overall Study|Adverse Event|4|||
23375300|NCT00207740|65119437|FG001|Overall Study|Adverse Event|14|||
23283010|NCT05068284|64778862|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23283011|NCT05068284|64778863|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23283012|NCT05068284|64778864|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23283013|NCT05068284|64778865|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23283014|NCT05068284|64778866|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23283015|NCT05068284|64778867|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23283016|NCT05068284|64778868|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
23283017|NCT05068284|64778861|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
23283018|NCT05068284|64778862|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23283019|NCT05068284|64778863|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23283020|NCT05068284|64778864|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23283021|NCT05068284|64778865|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23283022|NCT05068284|64778866|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23283023|NCT05068284|64778867|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23283024|NCT05068284|64778868|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
23283025|NCT05068284|64778861|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
23283026|NCT05068284|64778862|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
23283027|NCT05068284|64778863|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
23283028|NCT05068284|64778864|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
23283029|NCT05068284|64778865|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
23283030|NCT05068284|64778866|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
23283031|NCT05068284|64778867|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
23283032|NCT05068284|64778868|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
23283033|NCT05068284|64778861|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
23283034|NCT05068284|64778862|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
23283035|NCT05068284|64778863|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
23283036|NCT05068284|64778864|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
23283037|NCT05068284|64778865|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
23283038|NCT05068284|64778866|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
23283039|NCT05068284|64778867|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
23283040|NCT05068284|64778868|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
23283041|NCT04089553|64778869|FG000|Overall Study|Death|1|||
23283042|NCT04089553|64778870|FG001|Overall Study|Death|1|||
23283043|NCT04089553|64778869|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
23283044|NCT04089553|64778870|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
23283045|NCT04089553|64778869|FG000|Overall Study|Withdrawal by Subject|3|||
23283046|NCT04089553|64778870|FG001|Overall Study|Withdrawal by Subject|3|||
23283047|NCT04089553|64778869|FG000|Overall Study|Physician Decision|1|||
23283048|NCT04089553|64778870|FG001|Overall Study|Physician Decision|0|||
23283049|NCT04089553|64778869|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
23283050|NCT04089553|64778870|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
23283051|NCT04089553|64778869|FG000|Overall Study|Other|1|||
23283052|NCT04089553|64778870|FG001|Overall Study|Other|0|||
23283053|NCT04089553|64778869|FG000|Overall Study|Adverse Event|1|||
23283054|NCT04089553|64778870|FG001|Overall Study|Adverse Event|1|||
23283055|NCT01410227|64778871|FG000|Overall Study|Adverse Event|1|||
23283056|NCT01410227|64778872|FG001|Overall Study|Adverse Event|0|||
23283057|NCT01410227|64778873|FG002|Overall Study|Adverse Event|0|||
23283058|NCT01410227|64778874|FG003|Overall Study|Adverse Event|0|||
23283059|NCT01410227|64778871|FG000|Overall Study|Withdrawal by Subject|3|||
23283060|NCT01410227|64778872|FG001|Overall Study|Withdrawal by Subject|0|||
23283061|NCT01410227|64778873|FG002|Overall Study|Withdrawal by Subject|1|||
23375301|NCT00207740|65119438|FG002|Overall Study|Adverse Event|14|||
23375302|NCT00207740|65119439|FG003|Overall Study|Adverse Event|11|||
23488708|NCT01927341|65533963|FG001|Phase 1b|Lost to Follow-up|0|||
23488709|NCT01927341|65533964|FG002|Phase 1b|Lost to Follow-up|0|||
23488710|NCT01927341|65533965|FG003|Phase 1b|Lost to Follow-up|0|||
23375303|NCT00207740|65119436|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23283062|NCT01410227|64778874|FG003|Overall Study|Withdrawal by Subject|0|||
23283063|NCT01410227|64778871|FG000|Overall Study|Pregnancy|0|||
23283064|NCT01410227|64778872|FG001|Overall Study|Pregnancy|0|||
23283065|NCT01410227|64778873|FG002|Overall Study|Pregnancy|0|||
23283066|NCT01410227|64778874|FG003|Overall Study|Pregnancy|1|||
23283067|NCT01410227|64778871|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
23283068|NCT01410227|64778872|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
23283069|NCT01410227|64778873|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
23283070|NCT01410227|64778874|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
23283071|NCT03961204|64778876|FG000|Overall Study|Withdrawal by Subject|2|||
23283072|NCT03961204|64778876|FG000|Overall Study|Lost to Follow-up|3|||
23283073|NCT03961204|64778876|FG000|Overall Study|Other|1|||
23283074|NCT03961204|64778876|FG000|Overall Study|Missing|1|||
23604046|NCT00689351|65940285|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
23604047|NCT00689351|65940284|FG000|Infant Series of Dosing|Adverse Event|1|||
23604048|NCT00689351|65940285|FG001|Infant Series of Dosing|Adverse Event|0|||
23604049|NCT00689351|65940284|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
23604050|NCT00689351|65940285|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
23604051|NCT00689351|65940284|FG000|After Infant Series|Parent/legal guardian request|1|||
23604052|NCT00689351|65940285|FG001|After Infant Series|Parent/legal guardian request|0|||
23283083|NCT03497130|64778879|FG000|Overall Study|Lost to Follow-up|1|||
23283084|NCT03497130|64778880|FG001|Overall Study|Lost to Follow-up|1|||
23283085|NCT01087502|64778882|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
23283086|NCT01087502|64778883|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
23283087|NCT01087502|64778882|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
23283088|NCT01087502|64778883|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
23283089|NCT01087502|64778882|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
23283090|NCT01087502|64778883|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
23283091|NCT01087502|64778882|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
23283092|NCT01087502|64778883|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
23283093|NCT01087502|64778882|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
23283094|NCT01087502|64778883|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
23283095|NCT01087502|64778882|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
23283096|NCT01087502|64778883|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
23283097|NCT01087502|64778882|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
23283098|NCT01087502|64778883|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
23283099|NCT01087502|64778882|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
23283100|NCT01087502|64778883|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
23283101|NCT01087502|64778882|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
23283102|NCT01087502|64778883|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
23283103|NCT01087502|64778882|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
23283104|NCT01087502|64778883|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
23283105|NCT01087502|64778882|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
23283106|NCT01087502|64778883|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
23283107|NCT01087502|64778882|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
23283108|NCT01087502|64778883|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
23283109|NCT01811953|64778903|FG000|Overall Study|Adverse Event|0|||
23283110|NCT01811953|64778904|FG001|Overall Study|Adverse Event|0|||
23283111|NCT01811953|64778905|FG002|Overall Study|Adverse Event|0|||
23283112|NCT01811953|64778906|FG003|Overall Study|Adverse Event|1|||
23283113|NCT01811953|64778907|FG004|Overall Study|Adverse Event|0|||
23283114|NCT01811953|64778908|FG005|Overall Study|Adverse Event|1|||
23283115|NCT01811953|64778903|FG000|Overall Study|Protocol Violation|0|||
23283116|NCT01811953|64778904|FG001|Overall Study|Protocol Violation|0|||
23283117|NCT01811953|64778905|FG002|Overall Study|Protocol Violation|0|||
23283118|NCT01811953|64778906|FG003|Overall Study|Protocol Violation|0|||
23283119|NCT01811953|64778907|FG004|Overall Study|Protocol Violation|1|||
23283120|NCT01811953|64778908|FG005|Overall Study|Protocol Violation|0|||
23283121|NCT00177164|64778909|FG000|Overall Study|Protocol Violation|0|||
23283122|NCT00177164|64778910|FG001|Overall Study|Protocol Violation|7|||
23283123|NCT00177164|64778909|FG000|Overall Study|Lost to Follow-up|4|||
23283124|NCT00177164|64778910|FG001|Overall Study|Lost to Follow-up|5|||
23283125|NCT00177164|64778909|FG000|Overall Study|increase in alcohol and drug use|1|||
23283126|NCT00177164|64778910|FG001|Overall Study|increase in alcohol and drug use|2|||
23283127|NCT00177164|64778909|FG000|Overall Study|Adverse Event|1|||
23283128|NCT00177164|64778910|FG001|Overall Study|Adverse Event|0|||
23283129|NCT00177164|64778909|FG000|Overall Study|discharge from hospital|1|||
23283130|NCT00177164|64778910|FG001|Overall Study|discharge from hospital|0|||
23283131|NCT00177164|64778909|FG000|Overall Study|Lack of Efficacy|2|||
23283132|NCT00177164|64778910|FG001|Overall Study|Lack of Efficacy|1|||
23283133|NCT00177164|64778909|FG000|Overall Study|Pregnancy|0|||
23283134|NCT00177164|64778910|FG001|Overall Study|Pregnancy|1|||
23283135|NCT03259165|64778913|FG000|Overall Study|COVID 19 pandemic|1|||
23283136|NCT03259165|64778914|FG001|Overall Study|COVID 19 pandemic|1|||
23283137|NCT02452463|64778918|FG000|Overall Study|Death|1|||
23283138|NCT02452463|64778919|FG001|Overall Study|Death|0|||
23283139|NCT02452463|64778920|FG002|Overall Study|Death|0|||
23375304|NCT00207740|65119437|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23375305|NCT00207740|65119438|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
23375306|NCT00207740|65119439|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
23375307|NCT00207740|65119436|FG000|Overall Study|Lost to Follow-up|0|||
23375308|NCT00207740|65119437|FG001|Overall Study|Lost to Follow-up|2|||
23375309|NCT00207740|65119438|FG002|Overall Study|Lost to Follow-up|1|||
23375310|NCT00207740|65119439|FG003|Overall Study|Lost to Follow-up|1|||
23375311|NCT00207740|65119436|FG000|Overall Study|Death|0|||
23375312|NCT00207740|65119437|FG001|Overall Study|Death|0|||
23375313|NCT00207740|65119438|FG002|Overall Study|Death|0|||
23375314|NCT00207740|65119439|FG003|Overall Study|Death|1|||
23375315|NCT00207740|65119436|FG000|Overall Study|Sponsor Directive|22|||
23375316|NCT00207740|65119437|FG001|Overall Study|Sponsor Directive|15|||
23375317|NCT00207740|65119438|FG002|Overall Study|Sponsor Directive|16|||
23375318|NCT00207740|65119439|FG003|Overall Study|Sponsor Directive|21|||
23375319|NCT00207740|65119436|FG000|Overall Study|Other|2|||
23375320|NCT00207740|65119437|FG001|Overall Study|Other|10|||
23375321|NCT00207740|65119438|FG002|Overall Study|Other|7|||
23375322|NCT00207740|65119439|FG003|Overall Study|Other|5|||
23375323|NCT02313155|65119440|FG000|Overall Study|Lost to Follow-up|0|||
23283140|NCT02452463|64778918|FG000|Overall Study|Study Suspended|1|||
23283141|NCT02452463|64778919|FG001|Overall Study|Study Suspended|0|||
23283142|NCT02452463|64778920|FG002|Overall Study|Study Suspended|0|||
23283143|NCT02452463|64778918|FG000|Overall Study|Recommended by DSMB|0|||
23283144|NCT02452463|64778919|FG001|Overall Study|Recommended by DSMB|1|||
23283145|NCT02452463|64778920|FG002|Overall Study|Recommended by DSMB|0|||
23283146|NCT02452463|64778918|FG000|Overall Study|Withdrawal by Subject|0|||
23283147|NCT02452463|64778919|FG001|Overall Study|Withdrawal by Subject|1|||
23283148|NCT02452463|64778920|FG002|Overall Study|Withdrawal by Subject|0|||
23283149|NCT02264977|64778921|FG000|Overall Study|Death|3|||
23283150|NCT02264977|64778921|FG000|Overall Study|Physician Decision|1|||
23283151|NCT02264977|64778921|FG000|Overall Study|Refuse to return|1|||
23283152|NCT03602339|64778922|FG000|Overall Study|Withdrawal by Subject|9|||
23283153|NCT03602339|64778922|FG000|Overall Study|Physician Decision|2|||
23283154|NCT03602339|64778922|FG000|Overall Study|Other reason|4|||
23283155|NCT01597791|64778923|FG000|Overall Study|Physician Decision|2|||
23283156|NCT01597791|64778924|FG001|Overall Study|Physician Decision|1|||
23283157|NCT01597791|64778923|FG000|Overall Study|Cesarean Section|6|||
23283158|NCT01597791|64778924|FG001|Overall Study|Cesarean Section|7|||
23283159|NCT01597791|64778923|FG000|Overall Study|Subject withdrawal|0|||
23283160|NCT01597791|64778924|FG001|Overall Study|Subject withdrawal|1|||
23283161|NCT01597791|64778923|FG000|Overall Study|Protocol Violation|0|||
23283162|NCT01597791|64778924|FG001|Overall Study|Protocol Violation|1|||
23283163|NCT02658487|64778927|FG000|Overall Study|Death|2|||
23283164|NCT02658487|64778927|FG000|Overall Study|Disease progression|10|||
23283165|NCT02658487|64778927|FG000|Overall Study|Alternative therapy|1|||
23283166|NCT02658487|64778927|FG000|Overall Study|Adverse Event|1|||
23283167|NCT02658487|64778927|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
23283168|NCT02658487|64778927|FG000|Overall Study|Refractory AML|1|||
23283169|NCT02005276|64778928|FG000|Overall Study|No longer interested|5|||
23283170|NCT02005276|64778929|FG001|Overall Study|No longer interested|2|||
23375324|NCT02313155|65119441|FG001|Overall Study|Lost to Follow-up|1|||
23375325|NCT01548599|65119445|FG000|Overall Study|Lost to Follow-up|0|||
23375326|NCT01548599|65119446|FG001|Overall Study|Lost to Follow-up|1|||
23375327|NCT01548599|65119445|FG000|Overall Study|Withdrawal by Subject|4|||
23375328|NCT01548599|65119446|FG001|Overall Study|Withdrawal by Subject|0|||
23375329|NCT01548599|65119445|FG000|Overall Study|Death|2|||
23375330|NCT01548599|65119446|FG001|Overall Study|Death|1|||
23375331|NCT03587636|65119447|FG000|Overall Study|Lost to Follow-up|2|||
23375332|NCT03587636|65119448|FG001|Overall Study|Lost to Follow-up|5|||
23375333|NCT02550795|65119451|FG000|Overall Study|Physician Decision|0|||
23375334|NCT02550795|65119452|FG001|Overall Study|Physician Decision|1|||
23375335|NCT02550795|65119453|FG002|Overall Study|Physician Decision|0|||
23375336|NCT01652690|65119454|FG000|Overall Study|Withdrawal by Subject|16|||
23375337|NCT01652690|65119455|FG001|Overall Study|Withdrawal by Subject|4|||
23375338|NCT01652690|65119454|FG000|Overall Study|Other|8|||
23375339|NCT01652690|65119455|FG001|Overall Study|Other|9|||
23375340|NCT01652690|65119454|FG000|Overall Study|Lost to Follow-up|6|||
23375341|NCT01652690|65119455|FG001|Overall Study|Lost to Follow-up|6|||
23375342|NCT01652690|65119454|FG000|Overall Study|Death|5|||
23375343|NCT01652690|65119455|FG001|Overall Study|Death|2|||
23375344|NCT01654276|65119456|FG000|Overall Study|Lack of Efficacy|1|||
23375345|NCT01654276|65119456|FG000|Overall Study|Lost to Follow-up|4|||
23375346|NCT01654276|65119456|FG000|Overall Study|Withdrawal by Subject|1|||
23375347|NCT03010501|65119457|FG000|Study Week 1|Withdrawal by Subject|2|||
23375348|NCT03010501|65119458|FG001|Study Week 1|Withdrawal by Subject|1|||
23375349|NCT03010501|65119459|FG002|Study Week 1|Withdrawal by Subject|0|||
23375350|NCT03010501|65119460|FG003|Study Week 1|Withdrawal by Subject|2|||
23375351|NCT03010501|65119461|FG004|Study Week 1|Withdrawal by Subject|0|||
23375352|NCT03010501|65119462|FG005|Study Week 1|Withdrawal by Subject|0|||
23375353|NCT03010501|65119457|FG000|Study Week 3|Withdrawal by Subject|0|||
23375354|NCT03010501|65119458|FG001|Study Week 3|Withdrawal by Subject|0|||
23375355|NCT03010501|65119459|FG002|Study Week 3|Withdrawal by Subject|0|||
23375356|NCT03010501|65119460|FG003|Study Week 3|Withdrawal by Subject|1|||
23375357|NCT03010501|65119461|FG004|Study Week 3|Withdrawal by Subject|0|||
23375358|NCT03010501|65119462|FG005|Study Week 3|Withdrawal by Subject|0|||
23375359|NCT00607893|65119465|FG000|Overall Study|Lost to Follow-up|4|||
23375360|NCT00607893|65119466|FG001|Overall Study|Lost to Follow-up|0|||
23375361|NCT00607893|65119465|FG000|Overall Study|withdrew due to loss of interest|0|||
23375362|NCT00607893|65119466|FG001|Overall Study|withdrew due to loss of interest|1|||
23375363|NCT00607893|65119465|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
23375364|NCT00607893|65119466|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
23375365|NCT00607893|65119465|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
23375366|NCT00607893|65119466|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
23375367|NCT00607893|65119465|FG000|Overall Study|Declined to be treated|1|||
23375368|NCT00607893|65119466|FG001|Overall Study|Declined to be treated|0|||
23375369|NCT00607893|65119465|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
23375370|NCT00607893|65119466|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
23375371|NCT04040439|65119467|FG000|Overall Study|Invalid registration|11|||
23375372|NCT04040439|65119467|FG000|Overall Study|No IC* on publication of study results|2|||
23375373|NCT00686972|65119471|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
23375374|NCT03334175|65119472|FG000|Overall Study|Lost to Follow-up|0|||
23375375|NCT03334175|65119473|FG001|Overall Study|Lost to Follow-up|1|||
23375376|NCT03407482|65119474|FG000|Overall Study|Adverse Event|12|||
23375377|NCT03407482|65119474|FG000|Overall Study|Disease Relapse|1|||
23375378|NCT03407482|65119474|FG000|Overall Study|Lost to Follow-up|1|||
23375379|NCT03407482|65119474|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23375380|NCT03407482|65119474|FG000|Overall Study|Pregnancy|2|||
23375381|NCT03407482|65119474|FG000|Overall Study|Protocol Violation|1|||
23375382|NCT03407482|65119474|FG000|Overall Study|Study Terminated By Sponsor|106|||
23375383|NCT03407482|65119474|FG000|Overall Study|Withdrawal by Subject|6|||
23375384|NCT03407482|65119474|FG000|Overall Study|Data Entry Error|1|||
23375385|NCT02911116|65119487|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23375386|NCT02911116|65119488|FG001|Overall Study|Insufficient Therapeutic Response|0|||
23375387|NCT02911116|65119487|FG000|Overall Study|Lost to Follow-up|0|||
23375388|NCT02911116|65119488|FG001|Overall Study|Lost to Follow-up|1|||
23375389|NCT00352118|65119491|FG000|Overall Study|Physician Decision|4|||
23375390|NCT01937299|65119492|FG000|Overall Study|Adverse Event|13|||
23375391|NCT01937299|65119493|FG001|Overall Study|Adverse Event|0|||
23375392|NCT01937299|65119492|FG000|Overall Study|Lack of Efficacy|0|||
23375393|NCT01937299|65119493|FG001|Overall Study|Lack of Efficacy|4|||
23375394|NCT01937299|65119492|FG000|Overall Study|Withdrawal by Subject|1|||
23375395|NCT01937299|65119493|FG001|Overall Study|Withdrawal by Subject|0|||
23375396|NCT00644059|65119494|FG000|Overall Study|Lost to Follow-up|37|||
23375397|NCT00644059|65119495|FG001|Overall Study|Lost to Follow-up|34|||
23375398|NCT00644059|65119496|FG002|Overall Study|Lost to Follow-up|16|||
23488711|NCT01927341|65533966|FG004|Phase 1b|Lost to Follow-up|0|||
23488712|NCT01927341|65533962|FG000|Phase 1b|Death|2|||
23488713|NCT01927341|65533963|FG001|Phase 1b|Death|0|||
23375399|NCT00644059|65119494|FG000|Overall Study|Withdrawal by Subject|52|||
23375400|NCT00644059|65119495|FG001|Overall Study|Withdrawal by Subject|60|||
23375401|NCT00644059|65119496|FG002|Overall Study|Withdrawal by Subject|30|||
23375402|NCT00644059|65119494|FG000|Overall Study|Adverse Event|8|||
23375403|NCT00644059|65119495|FG001|Overall Study|Adverse Event|5|||
23375404|NCT00644059|65119496|FG002|Overall Study|Adverse Event|1|||
23375405|NCT00644059|65119494|FG000|Overall Study|Inappropriate Enrollment|1|||
23375406|NCT00644059|65119495|FG001|Overall Study|Inappropriate Enrollment|3|||
23375407|NCT00644059|65119496|FG002|Overall Study|Inappropriate Enrollment|0|||
23375408|NCT00644059|65119494|FG000|Overall Study|Protocol Deviation/violation|20|||
23375409|NCT00644059|65119495|FG001|Overall Study|Protocol Deviation/violation|19|||
23375410|NCT00644059|65119496|FG002|Overall Study|Protocol Deviation/violation|15|||
23375411|NCT00644059|65119494|FG000|Overall Study|Unable to classify|6|||
23375412|NCT00644059|65119495|FG001|Overall Study|Unable to classify|2|||
23375413|NCT00644059|65119496|FG002|Overall Study|Unable to classify|3|||
23375414|NCT01248455|65119497|FG000|Overall Study|switched to alternate treatment|1|||
23375415|NCT02530385|65119498|FG000|Overall Study|Withdrawal by Subject|0|||
23375416|NCT02530385|65119499|FG001|Overall Study|Withdrawal by Subject|1|||
23375417|NCT00833755|65119500|FG000|Overall Study|Physician Decision|4|||
23375418|NCT00833755|65119501|FG001|Overall Study|Physician Decision|4|||
23375419|NCT00833755|65119502|FG002|Overall Study|Physician Decision|2|||
23375420|NCT00833755|65119503|FG003|Overall Study|Physician Decision|6|||
23375421|NCT00833755|65119500|FG000|Overall Study|Subject had scheduling issues|0|||
23375422|NCT00833755|65119501|FG001|Overall Study|Subject had scheduling issues|1|||
23375423|NCT00833755|65119502|FG002|Overall Study|Subject had scheduling issues|0|||
23375424|NCT00833755|65119503|FG003|Overall Study|Subject had scheduling issues|0|||
23375425|NCT00606008|65119504|FG000|Overall Study|Adverse Event|1|||
23375426|NCT00606008|65119504|FG000|Overall Study|Withdrawal by Subject|4|||
23375427|NCT00420745|65119505|FG000|Overall Study|Adverse Event|2|||
23375428|NCT00420745|65119506|FG001|Overall Study|Adverse Event|2|||
23375429|NCT00420745|65119505|FG000|Overall Study|Lost to Follow-up|10|||
23375430|NCT00420745|65119506|FG001|Overall Study|Lost to Follow-up|2|||
23375431|NCT00420745|65119505|FG000|Overall Study|Protocol Violation|1|||
23375432|NCT00420745|65119506|FG001|Overall Study|Protocol Violation|0|||
23375433|NCT00420745|65119505|FG000|Overall Study|Physician Decision|1|||
23375434|NCT00420745|65119506|FG001|Overall Study|Physician Decision|1|||
23375435|NCT00420745|65119505|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
23375436|NCT00420745|65119506|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
23375437|NCT00420745|65119505|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
23375438|NCT00420745|65119506|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
23375439|NCT04424901|65119507|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
23375440|NCT04424901|65119508|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
23375441|NCT02030600|65119518|FG000|Treatment Period 1|Adverse Event|5|||
23375442|NCT02030600|65119519|FG001|Treatment Period 1|Adverse Event|7|||
23375443|NCT02030600|65119518|FG000|Treatment Period 1|Lack of Efficacy|0|||
23375444|NCT02030600|65119519|FG001|Treatment Period 1|Lack of Efficacy|1|||
23375445|NCT02030600|65119518|FG000|Treatment Period 1|Lost to Follow-up|11|||
23375446|NCT02030600|65119519|FG001|Treatment Period 1|Lost to Follow-up|3|||
23375447|NCT02030600|65119518|FG000|Treatment Period 1|Protocol Violation|22|||
23375448|NCT02030600|65119519|FG001|Treatment Period 1|Protocol Violation|17|||
23375449|NCT02030600|65119518|FG000|Treatment Period 1|Withdrawal by Subject|13|||
23375450|NCT02030600|65119519|FG001|Treatment Period 1|Withdrawal by Subject|17|||
23375451|NCT02030600|65119518|FG000|Treatment Period 1|Casebook Unsigned|1|||
23375452|NCT02030600|65119519|FG001|Treatment Period 1|Casebook Unsigned|0|||
23375453|NCT02030600|65119518|FG000|Treatment Period 1|Unclassified|1|||
23375454|NCT02030600|65119519|FG001|Treatment Period 1|Unclassified|0|||
23375455|NCT02030600|65119518|FG000|Treatment Period 2|Adverse Event|4|||
23375456|NCT02030600|65119519|FG001|Treatment Period 2|Adverse Event|4|||
23375457|NCT02030600|65119518|FG000|Treatment Period 2|Lack of Efficacy|2|||
23375458|NCT02030600|65119519|FG001|Treatment Period 2|Lack of Efficacy|1|||
23375459|NCT02030600|65119518|FG000|Treatment Period 2|Lost to Follow-up|4|||
23375460|NCT02030600|65119519|FG001|Treatment Period 2|Lost to Follow-up|2|||
23375461|NCT02030600|65119518|FG000|Treatment Period 2|Protocol Violation|1|||
23375462|NCT02030600|65119519|FG001|Treatment Period 2|Protocol Violation|2|||
23375463|NCT02030600|65119518|FG000|Treatment Period 2|Withdrawal by Subject|13|||
23375464|NCT02030600|65119519|FG001|Treatment Period 2|Withdrawal by Subject|9|||
23375465|NCT02030600|65119518|FG000|Treatment Period 2|Unclassified|1|||
23375466|NCT02030600|65119519|FG001|Treatment Period 2|Unclassified|0|||
23375467|NCT01452347|65119520|FG000|Overall Study|Adverse Event|2|||
23375468|NCT01452347|65119521|FG001|Overall Study|Adverse Event|1|||
23375469|NCT01452347|65119520|FG000|Overall Study|Non compliance protocol|2|||
23375470|NCT01452347|65119521|FG001|Overall Study|Non compliance protocol|0|||
23375471|NCT01452347|65119520|FG000|Overall Study|Lost to Follow-up|2|||
23375472|NCT01452347|65119521|FG001|Overall Study|Lost to Follow-up|0|||
23375473|NCT01452347|65119520|FG000|Overall Study|Withdrawal by Subject|3|||
23375474|NCT01452347|65119521|FG001|Overall Study|Withdrawal by Subject|3|||
23375475|NCT01452347|65119520|FG000|Overall Study|Not treated|6|||
23375476|NCT01452347|65119521|FG001|Overall Study|Not treated|3|||
23375477|NCT01452347|65119520|FG000|Overall Study|Other reason not defined above|2|||
23375478|NCT01452347|65119521|FG001|Overall Study|Other reason not defined above|0|||
23375479|NCT00549055|65119522|FG000|Overall Study|Adverse Event|4|||
23375480|NCT00549055|65119522|FG000|Overall Study|Lack of Efficacy|18|||
23375481|NCT00549055|65119522|FG000|Overall Study|Stabilization|5|||
23283171|NCT02005276|64778930|FG002|Overall Study|No longer interested|3|||
23283172|NCT02005276|64778931|FG003|Overall Study|No longer interested|3|||
23283173|NCT01576705|64778934|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
23283174|NCT01576705|64778935|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
23283175|NCT01576705|64778936|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
23283176|NCT01576705|64778937|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
23283177|NCT01576705|64778934|FG000|Overall Study|invalid ICF|0|||
23283178|NCT01576705|64778935|FG001|Overall Study|invalid ICF|1|||
23283179|NCT01576705|64778936|FG002|Overall Study|invalid ICF|0|||
23604053|NCT03132636|65940286|FG000|Overall Study|Adverse Event|1|||
23604054|NCT03132636|65940287|FG001|Overall Study|Adverse Event|2|||
23604055|NCT03132636|65940286|FG000|Overall Study|Death|4|||
23604056|NCT03132636|65940287|FG001|Overall Study|Death|7|||
23604057|NCT03132636|65940286|FG000|Overall Study|Lost to Follow-up|3|||
23604058|NCT03132636|65940287|FG001|Overall Study|Lost to Follow-up|2|||
23604059|NCT03132636|65940286|FG000|Overall Study|Non compliance with protocol by participant|1|||
23604060|NCT03132636|65940287|FG001|Overall Study|Non compliance with protocol by participant|1|||
23604061|NCT03132636|65940286|FG000|Overall Study|Subject decision|1|||
23604062|NCT03132636|65940287|FG001|Overall Study|Subject decision|9|||
23604063|NCT03132636|65940286|FG000|Overall Study|Sponsor decision|0|||
23604064|NCT03132636|65940287|FG001|Overall Study|Sponsor decision|1|||
23604065|NCT03132636|65940286|FG000|Overall Study|Physician Decision|1|||
23604066|NCT03132636|65940287|FG001|Overall Study|Physician Decision|0|||
23604067|NCT03132636|65940286|FG000|Overall Study|Progressive disease|33|||
23604068|NCT03132636|65940287|FG001|Overall Study|Progressive disease|36|||
23604069|NCT03132636|65940286|FG000|Overall Study|Withdrawal of consent|2|||
23604070|NCT03132636|65940287|FG001|Overall Study|Withdrawal of consent|5|||
23604071|NCT03132636|65940286|FG000|Overall Study|Did not re-consent|1|||
23604072|NCT03132636|65940287|FG001|Overall Study|Did not re-consent|0|||
23604073|NCT03132636|65940286|FG000|Overall Study|Lost insurance coverage|1|||
23604074|NCT03132636|65940287|FG001|Overall Study|Lost insurance coverage|0|||
23604075|NCT03132636|65940286|FG000|Overall Study|Related to radiological outcomes|0|||
23604076|NCT03132636|65940287|FG001|Overall Study|Related to radiological outcomes|1|||
23604077|NCT03132636|65940286|FG000|Overall Study|Unable to come to site for continued visits|0|||
23604078|NCT03132636|65940287|FG001|Overall Study|Unable to come to site for continued visits|1|||
23604079|NCT01218594|65940296|FG000|Overall Study|Death|1|||
23604080|NCT01218594|65940296|FG000|Overall Study|Withdrawal by Subject|3|||
23604081|NCT01218594|65940296|FG000|Overall Study|Adverse Event|2|||
23604082|NCT01218594|65940296|FG000|Overall Study|Physician Decision|6|||
23604083|NCT02502526|65940301|FG000|Overall Study|Lost to Follow-up|2|||
23604084|NCT02502526|65940302|FG001|Overall Study|Lost to Follow-up|2|||
23604085|NCT02502526|65940303|FG002|Overall Study|Lost to Follow-up|3|||
23604086|NCT02502526|65940301|FG000|Overall Study|Withdrawal by Subject|0|||
23604087|NCT02502526|65940302|FG001|Overall Study|Withdrawal by Subject|1|||
23604088|NCT02502526|65940303|FG002|Overall Study|Withdrawal by Subject|1|||
23604089|NCT02502526|65940301|FG000|Overall Study|Disqualified due to cataract grading|0|||
23604090|NCT02502526|65940302|FG001|Overall Study|Disqualified due to cataract grading|0|||
23604091|NCT02502526|65940303|FG002|Overall Study|Disqualified due to cataract grading|1|||
23604092|NCT02502526|65940301|FG000|Overall Study|Enrollment suspension|4|||
23604093|NCT02502526|65940302|FG001|Overall Study|Enrollment suspension|1|||
23604094|NCT02502526|65940303|FG002|Overall Study|Enrollment suspension|1|||
23604095|NCT03547154|65940305|FG000|Overall Study|Disease Progression/Recurrence|6|||
23604096|NCT03547154|65940306|FG001|Overall Study|Disease Progression/Recurrence|14|||
23604097|NCT03547154|65940305|FG000|Overall Study|Adverse Event|26|||
23604098|NCT03547154|65940306|FG001|Overall Study|Adverse Event|31|||
23604099|NCT03547154|65940305|FG000|Overall Study|Protocol Violation|6|||
23604100|NCT03547154|65940306|FG001|Overall Study|Protocol Violation|1|||
23604101|NCT03547154|65940305|FG000|Overall Study|Physician Decision|4|||
23283180|NCT01576705|64778937|FG003|Overall Study|invalid ICF|0|||
23283181|NCT00216736|64778938|FG000|Overall Study|Lost to Follow-up|1|||
23283182|NCT00216736|64778939|FG001|Overall Study|Lost to Follow-up|1|||
23283183|NCT02054715|64778940|FG000|Baseline/Follow-up 1|Refused|1|||
23283184|NCT02054715|64778941|FG001|Baseline/Follow-up 1|Refused|3|||
23283185|NCT02054715|64778940|FG000|Baseline/Follow-up 1|Medical|0|||
23283186|NCT02054715|64778941|FG001|Baseline/Follow-up 1|Medical|1|||
23283187|NCT02054715|64778940|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
23283188|NCT02054715|64778941|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
23283189|NCT02054715|64778940|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
23283190|NCT02054715|64778941|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
23283191|NCT02054715|64778940|FG000|Baseline/Follow-up 1|No Reason|0|||
23283192|NCT02054715|64778941|FG001|Baseline/Follow-up 1|No Reason|1|||
23283193|NCT02054715|64778940|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
23283194|NCT02054715|64778941|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
23283195|NCT02054715|64778940|FG000|Baseline/Follow-up 1|Ineligible|3|||
23283196|NCT02054715|64778941|FG001|Baseline/Follow-up 1|Ineligible|0|||
23283197|NCT02054715|64778940|FG000|Baseline/Follow-up 1|Hospitalization|1|||
23283198|NCT02054715|64778941|FG001|Baseline/Follow-up 1|Hospitalization|0|||
23283199|NCT02054715|64778940|FG000|Baseline/Follow-up 1|Changed Mind|1|||
23283200|NCT02054715|64778941|FG001|Baseline/Follow-up 1|Changed Mind|0|||
23283201|NCT02054715|64778940|FG000|Follow-up 2|Lost to Followup|3|||
23283202|NCT02054715|64778941|FG001|Follow-up 2|Lost to Followup|1|||
23283203|NCT02054715|64778940|FG000|Follow-up 2|Refused|3|||
23283204|NCT02054715|64778941|FG001|Follow-up 2|Refused|2|||
23283205|NCT02054715|64778940|FG000|Follow-up 2|Followup Not Completed|3|||
23283206|NCT02054715|64778941|FG001|Follow-up 2|Followup Not Completed|4|||
23283207|NCT02054715|64778940|FG000|Follow-up 2|Ineligible|4|||
23283208|NCT02054715|64778941|FG001|Follow-up 2|Ineligible|5|||
23283209|NCT02054715|64778940|FG000|Follow-up 2|Death|3|||
23283210|NCT02054715|64778941|FG001|Follow-up 2|Death|3|||
23283211|NCT02054715|64778940|FG000|Follow-up 2|Hospitalization|0|||
23283212|NCT02054715|64778941|FG001|Follow-up 2|Hospitalization|2|||
23283213|NCT02054715|64778940|FG000|Follow-up 2|Changed MD/Facility|0|||
23283214|NCT02054715|64778941|FG001|Follow-up 2|Changed MD/Facility|1|||
23283215|NCT02054715|64778940|FG000|Follow-up 2|Changed Mind|0|||
23283216|NCT02054715|64778941|FG001|Follow-up 2|Changed Mind|1|||
23283217|NCT02054715|64778940|FG000|Follow-up 2|No Reason|2|||
23283218|NCT02054715|64778941|FG001|Follow-up 2|No Reason|0|||
23283219|NCT02054715|64778940|FG000|Follow-up 2|Treatment Change or Delay|1|||
23604102|NCT03547154|65940306|FG001|Overall Study|Physician Decision|3|||
23604103|NCT03547154|65940305|FG000|Overall Study|Insufficient Therapeutic Response|13|||
23604104|NCT03547154|65940306|FG001|Overall Study|Insufficient Therapeutic Response|10|||
23604105|NCT03547154|65940305|FG000|Overall Study|Withdrawal by Subject|10|||
23604106|NCT03547154|65940306|FG001|Overall Study|Withdrawal by Subject|6|||
23604107|NCT03547154|65940305|FG000|Overall Study|Not Selected|0|||
23604108|NCT03547154|65940306|FG001|Overall Study|Not Selected|1|||
23604109|NCT03547154|65940305|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
23604110|NCT03547154|65940306|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
23604111|NCT03352713|65940308|FG000|Overall Study|Lost to Follow-up|8|||
23604112|NCT03352713|65940308|FG000|Overall Study|Withdrawn by investigator|5|||
23604113|NCT03352713|65940308|FG000|Overall Study|Completed 0 EMAs|8|||
23604114|NCT03352713|65940308|FG000|Overall Study|Device incompatible/stolen|5|||
23604115|NCT00705159|65940309|FG000|Overall Study|Withdrawal by Subject|0|||
23604116|NCT00705159|65940310|FG001|Overall Study|Withdrawal by Subject|1|||
23604117|NCT00705159|65940311|FG002|Overall Study|Withdrawal by Subject|1|||
23604118|NCT00705159|65940312|FG003|Overall Study|Withdrawal by Subject|1|||
23604119|NCT00705159|65940309|FG000|Overall Study|Protocol Violation|0|||
23604120|NCT00705159|65940310|FG001|Overall Study|Protocol Violation|1|||
23604121|NCT00705159|65940311|FG002|Overall Study|Protocol Violation|0|||
23604122|NCT00705159|65940312|FG003|Overall Study|Protocol Violation|0|||
23604123|NCT00705159|65940309|FG000|Overall Study|Adverse Event|0|||
23604124|NCT00705159|65940310|FG001|Overall Study|Adverse Event|0|||
23283220|NCT02054715|64778941|FG001|Follow-up 2|Treatment Change or Delay|0|||
23283221|NCT02294981|64778942|FG000|Overall Study|Lost to Follow-up|1|||
23283222|NCT02125461|64778944|FG000|Overall Study|Withdrawal by Subject|30|||
23283223|NCT02125461|64778945|FG001|Overall Study|Withdrawal by Subject|16|||
23283224|NCT02125461|64778944|FG000|Overall Study|Lost to Follow-up|8|||
23283225|NCT02125461|64778945|FG001|Overall Study|Lost to Follow-up|3|||
23375482|NCT00549055|65119522|FG000|Overall Study|Progression to fibrosis|2|||
23375483|NCT00549055|65119522|FG000|Overall Study|Decrease of size|1|||
23375484|NCT00549055|65119522|FG000|Overall Study|Active choroidal neovascula increased|1|||
23375485|NCT00549055|65119522|FG000|Overall Study|Vitreous hemorrhage|1|||
23375486|NCT00549055|65119522|FG000|Overall Study|Growth choroidal neovascularisation|1|||
23375487|NCT00549055|65119522|FG000|Overall Study|Choroidal neovascularization|1|||
23283226|NCT02125461|64778944|FG000|Overall Study|Death|260|||
23283227|NCT02125461|64778945|FG001|Overall Study|Death|149|||
23283228|NCT02125461|64778944|FG000|Overall Study|Missing Termination Reason|0|||
23283229|NCT02125461|64778945|FG001|Overall Study|Missing Termination Reason|1|||
23283230|NCT00645853|64778946|FG000|Overall Study|Adverse Event|18|||
23283231|NCT00645853|64778947|FG001|Overall Study|Adverse Event|7|||
23283232|NCT00645853|64778946|FG000|Overall Study|AZ study closure in Hungary|60|||
23283233|NCT00645853|64778947|FG001|Overall Study|AZ study closure in Hungary|40|||
23283234|NCT00645853|64778946|FG000|Overall Study|Withdrawal by Subject|5|||
23283235|NCT00645853|64778947|FG001|Overall Study|Withdrawal by Subject|2|||
23283236|NCT00645853|64778946|FG000|Overall Study|Protocol Violation|0|||
23283237|NCT00645853|64778947|FG001|Overall Study|Protocol Violation|2|||
23283238|NCT00645853|64778946|FG000|Overall Study|Discontinuation criteria|2|||
23283239|NCT00645853|64778947|FG001|Overall Study|Discontinuation criteria|2|||
23375488|NCT00549055|65119522|FG000|Overall Study|Very low visual acuity (VA)|1|||
23375489|NCT03451071|65119523|FG000|First Vaccine|Withdrawal by Subject|1|||
23375490|NCT03451071|65119523|FG000|Second Vaccine|Lost to Follow-up|19|||
23375491|NCT03451071|65119523|FG000|Third Vaccine|Lost to Follow-up|22|||
23375492|NCT03451071|65119523|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
23375493|NCT02426684|65119526|FG000|Overall Study|Physician Decision|1|||
23375494|NCT00997893|65119527|FG000|Overall Study|Adverse Event|1|||
23375495|NCT00997893|65119528|FG001|Overall Study|Adverse Event|0|||
23375496|NCT00997893|65119529|FG002|Overall Study|Adverse Event|0|||
23375497|NCT00997893|65119527|FG000|Overall Study|Unable to meet study timelines|1|||
23375498|NCT00997893|65119528|FG001|Overall Study|Unable to meet study timelines|0|||
23488714|NCT01927341|65533964|FG002|Phase 1b|Death|0|||
23488715|NCT01927341|65533965|FG003|Phase 1b|Death|0|||
23488716|NCT01927341|65533966|FG004|Phase 1b|Death|0|||
23488717|NCT01927341|65533962|FG000|Phase 1b|Follow-up completed|7|||
23488718|NCT01927341|65533963|FG001|Phase 1b|Follow-up completed|0|||
23488719|NCT01927341|65533964|FG002|Phase 1b|Follow-up completed|0|||
23488720|NCT01927341|65533965|FG003|Phase 1b|Follow-up completed|0|||
23488721|NCT01927341|65533966|FG004|Phase 1b|Follow-up completed|0|||
23488722|NCT01927341|65533962|FG000|Phase 2|Lost to Follow-up|0|||
23488723|NCT01927341|65533963|FG001|Phase 2|Lost to Follow-up|1|||
23488724|NCT01927341|65533964|FG002|Phase 2|Lost to Follow-up|0|||
23488725|NCT01927341|65533965|FG003|Phase 2|Lost to Follow-up|0|||
23488726|NCT01927341|65533966|FG004|Phase 2|Lost to Follow-up|0|||
23488727|NCT01927341|65533962|FG000|Phase 2|Participant withdrew consent|0|||
23488728|NCT01927341|65533963|FG001|Phase 2|Participant withdrew consent|2|||
23488729|NCT01927341|65533964|FG002|Phase 2|Participant withdrew consent|1|||
23488730|NCT01927341|65533965|FG003|Phase 2|Participant withdrew consent|2|||
23488731|NCT01927341|65533966|FG004|Phase 2|Participant withdrew consent|3|||
23488732|NCT01927341|65533962|FG000|Phase 2|Death|0|||
23488733|NCT01927341|65533963|FG001|Phase 2|Death|4|||
23488734|NCT01927341|65533964|FG002|Phase 2|Death|0|||
23488735|NCT01927341|65533965|FG003|Phase 2|Death|3|||
23488736|NCT01927341|65533966|FG004|Phase 2|Death|2|||
23488737|NCT01927341|65533962|FG000|Phase 2|New cancer therapy|0|||
23488738|NCT01927341|65533963|FG001|Phase 2|New cancer therapy|1|||
23488739|NCT01927341|65533964|FG002|Phase 2|New cancer therapy|0|||
23488740|NCT01927341|65533965|FG003|Phase 2|New cancer therapy|4|||
23488741|NCT01927341|65533966|FG004|Phase 2|New cancer therapy|1|||
23604125|NCT00705159|65940311|FG002|Overall Study|Adverse Event|1|||
23604126|NCT00705159|65940312|FG003|Overall Study|Adverse Event|0|||
23488742|NCT01927341|65533962|FG000|Phase 2|Disease progression|0|||
23604127|NCT00705159|65940309|FG000|Overall Study|Lost to Follow-up|0|||
23604128|NCT00705159|65940310|FG001|Overall Study|Lost to Follow-up|0|||
23604129|NCT00705159|65940311|FG002|Overall Study|Lost to Follow-up|3|||
23375499|NCT00997893|65119529|FG002|Overall Study|Unable to meet study timelines|0|||
23375500|NCT00997893|65119527|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
23375501|NCT00997893|65119528|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
23375502|NCT00997893|65119529|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
23488743|NCT01927341|65533963|FG001|Phase 2|Disease progression|1|||
23488744|NCT01927341|65533964|FG002|Phase 2|Disease progression|1|||
23488745|NCT01927341|65533965|FG003|Phase 2|Disease progression|1|||
23488746|NCT01927341|65533966|FG004|Phase 2|Disease progression|0|||
23488747|NCT01927341|65533962|FG000|Phase 2|Follow-up completed|0|||
23488748|NCT01927341|65533963|FG001|Phase 2|Follow-up completed|6|||
23604130|NCT00705159|65940312|FG003|Overall Study|Lost to Follow-up|2|||
23604131|NCT00705159|65940309|FG000|Overall Study|Screen Failure|0|||
23488749|NCT01927341|65533964|FG002|Phase 2|Follow-up completed|3|||
23488750|NCT01927341|65533965|FG003|Phase 2|Follow-up completed|5|||
23488751|NCT01927341|65533966|FG004|Phase 2|Follow-up completed|2|||
23488752|NCT01977651|65533967|FG000|4 Month Treatment Period|Adverse Event|34|||
23488753|NCT01977651|65533967|FG000|4 Month Treatment Period|Death|3|||
23488754|NCT01977651|65533967|FG000|4 Month Treatment Period|Progressive Disease|43|||
23488755|NCT01977651|65533967|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
23488756|NCT01977651|65533967|FG000|4 Month Treatment Period|Physician Decision|4|||
23488757|NCT01977651|65533967|FG000|1 Year Extension Period|Adverse Event|14|||
23488758|NCT01977651|65533967|FG000|1 Year Extension Period|Death|10|||
23488759|NCT01977651|65533967|FG000|1 Year Extension Period|Lost to Follow-up|2|||
23488760|NCT01977651|65533967|FG000|1 Year Extension Period|Progressive Disease|86|||
23488761|NCT01977651|65533967|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
23488762|NCT01977651|65533967|FG000|1 Year Extension Period|Physician Decision|6|||
23488763|NCT01977651|65533967|FG000|1 Year Extension Period|Miscellaneous|1|||
23488764|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Adverse Event|5|||
23488765|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Death|13|||
23488766|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
23488767|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
23488768|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Physician Decision|4|||
23488769|NCT01977651|65533967|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
23488770|NCT00054717|65533968|FG000|Overall Study|Randomized but not treated|2|||
23488771|NCT00054717|65533969|FG001|Overall Study|Randomized but not treated|8|||
23488772|NCT00054717|65533968|FG000|Overall Study|Adverse Event|70|||
23488773|NCT00054717|65533969|FG001|Overall Study|Adverse Event|22|||
23488774|NCT00054717|65533968|FG000|Overall Study|Protocol Violation|18|||
23488775|NCT00054717|65533969|FG001|Overall Study|Protocol Violation|19|||
23488776|NCT00054717|65533968|FG000|Overall Study|Lost to Follow-up|23|||
23488777|NCT00054717|65533969|FG001|Overall Study|Lost to Follow-up|13|||
23488778|NCT00054717|65533968|FG000|Overall Study|Withdrawal by Subject|32|||
23488779|NCT00054717|65533969|FG001|Overall Study|Withdrawal by Subject|20|||
23283240|NCT00645853|64778946|FG000|Overall Study|recall of ICF, planned operation, death|7|||
23283241|NCT00645853|64778947|FG001|Overall Study|recall of ICF, planned operation, death|4|||
23283242|NCT00537095|64778953|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
23488780|NCT00054717|65533968|FG000|Overall Study|Other reason not defined above|117|||
23488781|NCT00054717|65533969|FG001|Overall Study|Other reason not defined above|217|||
23488782|NCT00760214|65533972|FG000|Overall Study|Adverse Event|8|||
23488783|NCT00760214|65533973|FG001|Overall Study|Adverse Event|9|||
23488784|NCT00760214|65533974|FG002|Overall Study|Adverse Event|12|||
23488785|NCT00760214|65533972|FG000|Overall Study|Protocol Violation|3|||
23488786|NCT00760214|65533973|FG001|Overall Study|Protocol Violation|0|||
23488787|NCT00760214|65533974|FG002|Overall Study|Protocol Violation|3|||
23488788|NCT00760214|65533972|FG000|Overall Study|Lost to Follow-up|0|||
23488789|NCT00760214|65533973|FG001|Overall Study|Lost to Follow-up|0|||
23488790|NCT00760214|65533974|FG002|Overall Study|Lost to Follow-up|1|||
23488791|NCT00760214|65533972|FG000|Overall Study|Withdrawal by Subject|12|||
23488792|NCT00760214|65533973|FG001|Overall Study|Withdrawal by Subject|14|||
23488793|NCT00760214|65533974|FG002|Overall Study|Withdrawal by Subject|13|||
23488794|NCT00760214|65533972|FG000|Overall Study|Lack of Efficacy|3|||
23488795|NCT00760214|65533973|FG001|Overall Study|Lack of Efficacy|2|||
23488796|NCT00760214|65533974|FG002|Overall Study|Lack of Efficacy|4|||
23488797|NCT00760214|65533972|FG000|Overall Study|Pregnancy|0|||
23488798|NCT00760214|65533973|FG001|Overall Study|Pregnancy|0|||
23488799|NCT00760214|65533974|FG002|Overall Study|Pregnancy|1|||
23488800|NCT00760214|65533972|FG000|Overall Study|Physician Decision|1|||
23488801|NCT00760214|65533973|FG001|Overall Study|Physician Decision|1|||
23488802|NCT00760214|65533974|FG002|Overall Study|Physician Decision|1|||
23488803|NCT00760214|65533972|FG000|Overall Study|Other|3|||
23488804|NCT00760214|65533973|FG001|Overall Study|Other|4|||
23604132|NCT00705159|65940310|FG001|Overall Study|Screen Failure|0|||
23283243|NCT00537095|64778954|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
23283244|NCT00537095|64778953|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
23283245|NCT00537095|64778954|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
23283246|NCT00537095|64778953|FG000|Randomized Treatment Period (433 Days)|Death|3|||
23488805|NCT00760214|65533974|FG002|Overall Study|Other|6|||
23488806|NCT00053365|65533975|FG000|Overall Study|Incorrect cell type|1|||
23488807|NCT00053365|65533975|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
23488808|NCT00053365|65533975|FG000|Overall Study|Never treated|4|||
23488809|NCT02694523|65533978|FG000|Part A|Adverse Event|7|||
23488810|NCT02694523|65533979|FG001|Part A|Adverse Event|3|||
23488811|NCT02694523|65533980|FG002|Part A|Adverse Event|0|||
23488812|NCT02694523|65533981|FG003|Part A|Adverse Event|0|||
23604133|NCT00705159|65940311|FG002|Overall Study|Screen Failure|0|||
23488813|NCT02694523|65533982|FG004|Part A|Adverse Event|0|||
23488814|NCT02694523|65533983|FG005|Part A|Adverse Event|0|||
23488815|NCT02694523|65533984|FG006|Part A|Adverse Event|0|||
23488816|NCT02694523|65533978|FG000|Part A|Protocol Violation|1|||
23488817|NCT02694523|65533979|FG001|Part A|Protocol Violation|0|||
23488818|NCT02694523|65533980|FG002|Part A|Protocol Violation|0|||
23488819|NCT02694523|65533981|FG003|Part A|Protocol Violation|0|||
23488820|NCT02694523|65533982|FG004|Part A|Protocol Violation|0|||
23488821|NCT02694523|65533983|FG005|Part A|Protocol Violation|0|||
23488822|NCT02694523|65533984|FG006|Part A|Protocol Violation|0|||
23488823|NCT02694523|65533978|FG000|Part A|Lost to Follow-up|1|||
23488824|NCT02694523|65533979|FG001|Part A|Lost to Follow-up|2|||
23488825|NCT02694523|65533980|FG002|Part A|Lost to Follow-up|0|||
23488826|NCT02694523|65533981|FG003|Part A|Lost to Follow-up|0|||
23488827|NCT02694523|65533982|FG004|Part A|Lost to Follow-up|0|||
23488828|NCT02694523|65533983|FG005|Part A|Lost to Follow-up|0|||
23488829|NCT02694523|65533984|FG006|Part A|Lost to Follow-up|0|||
23488830|NCT02694523|65533978|FG000|Part A|Withdrawal by Subject|3|||
23488831|NCT02694523|65533979|FG001|Part A|Withdrawal by Subject|1|||
23488832|NCT02694523|65533980|FG002|Part A|Withdrawal by Subject|0|||
23488833|NCT02694523|65533981|FG003|Part A|Withdrawal by Subject|0|||
23488834|NCT02694523|65533982|FG004|Part A|Withdrawal by Subject|0|||
23488835|NCT02694523|65533983|FG005|Part A|Withdrawal by Subject|0|||
23488836|NCT02694523|65533984|FG006|Part A|Withdrawal by Subject|0|||
23488837|NCT02694523|65533978|FG000|Part A|Other|1|||
23488838|NCT02694523|65533979|FG001|Part A|Other|1|||
23488839|NCT02694523|65533980|FG002|Part A|Other|0|||
23488840|NCT02694523|65533981|FG003|Part A|Other|0|||
23488841|NCT02694523|65533982|FG004|Part A|Other|0|||
23488842|NCT02694523|65533983|FG005|Part A|Other|0|||
23488843|NCT02694523|65533984|FG006|Part A|Other|0|||
23488844|NCT02694523|65533978|FG000|Part B|Adverse Event|0|||
23488845|NCT02694523|65533979|FG001|Part B|Adverse Event|0|||
23488846|NCT02694523|65533980|FG002|Part B|Adverse Event|7|||
23488847|NCT02694523|65533981|FG003|Part B|Adverse Event|1|||
23488848|NCT02694523|65533982|FG004|Part B|Adverse Event|1|||
23488849|NCT02694523|65533983|FG005|Part B|Adverse Event|2|||
23488850|NCT02694523|65533984|FG006|Part B|Adverse Event|0|||
23488851|NCT02694523|65533978|FG000|Part B|Protocol Violation|0|||
23488852|NCT02694523|65533979|FG001|Part B|Protocol Violation|0|||
23488853|NCT02694523|65533980|FG002|Part B|Protocol Violation|1|||
23488854|NCT02694523|65533981|FG003|Part B|Protocol Violation|0|||
23488855|NCT02694523|65533982|FG004|Part B|Protocol Violation|0|||
23488856|NCT02694523|65533983|FG005|Part B|Protocol Violation|0|||
23488857|NCT02694523|65533984|FG006|Part B|Protocol Violation|0|||
23488858|NCT02694523|65533978|FG000|Part B|Lost to Follow-up|0|||
23488859|NCT02694523|65533979|FG001|Part B|Lost to Follow-up|0|||
23488860|NCT02694523|65533980|FG002|Part B|Lost to Follow-up|2|||
23488861|NCT02694523|65533981|FG003|Part B|Lost to Follow-up|3|||
23488862|NCT02694523|65533982|FG004|Part B|Lost to Follow-up|2|||
23488863|NCT02694523|65533983|FG005|Part B|Lost to Follow-up|0|||
23488864|NCT02694523|65533984|FG006|Part B|Lost to Follow-up|1|||
23488865|NCT02694523|65533978|FG000|Part B|Withdrawal by Subject|0|||
23488866|NCT02694523|65533979|FG001|Part B|Withdrawal by Subject|0|||
23488867|NCT02694523|65533980|FG002|Part B|Withdrawal by Subject|9|||
23488868|NCT02694523|65533981|FG003|Part B|Withdrawal by Subject|0|||
23488869|NCT02694523|65533982|FG004|Part B|Withdrawal by Subject|1|||
23488870|NCT02694523|65533983|FG005|Part B|Withdrawal by Subject|3|||
23488871|NCT02694523|65533984|FG006|Part B|Withdrawal by Subject|0|||
23488872|NCT02694523|65533978|FG000|Part B|Other|0|||
23488873|NCT02694523|65533979|FG001|Part B|Other|0|||
23488874|NCT02694523|65533980|FG002|Part B|Other|1|||
23488875|NCT02694523|65533981|FG003|Part B|Other|0|||
23488876|NCT02694523|65533982|FG004|Part B|Other|0|||
23488877|NCT02694523|65533983|FG005|Part B|Other|0|||
23488878|NCT02694523|65533984|FG006|Part B|Other|1|||
23488879|NCT02027376|65533985|FG000|Overall Study|Death|1|||
23488880|NCT02027376|65533986|FG001|Overall Study|Death|0|||
23488881|NCT02027376|65533987|FG002|Overall Study|Death|0|||
23488882|NCT04543409|65533991|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23488883|NCT04543409|65533992|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23488884|NCT04543409|65533991|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
23488885|NCT04543409|65533992|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
23488886|NCT04543409|65533991|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
23488887|NCT04543409|65533992|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
23488888|NCT04543409|65533991|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
23488889|NCT04543409|65533992|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
23488890|NCT04543409|65533991|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
23488891|NCT04543409|65533992|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
23488892|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
23488893|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
23488894|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
23488895|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
23488896|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
23488897|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
23488898|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
23488899|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
23488900|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
23488901|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
23488902|NCT04543409|65533991|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
23488903|NCT04543409|65533992|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
23488904|NCT00562627|65533997|FG000|Overall Study|Protocol Violation|1|||
23488905|NCT00562627|65533998|FG001|Overall Study|Protocol Violation|1|||
23488906|NCT00562627|65533999|FG002|Overall Study|Protocol Violation|1|||
23488907|NCT03387150|65534000|FG000|Overall Study|Withdrawal by Subject|3|||
23488908|NCT03387150|65534001|FG001|Overall Study|Withdrawal by Subject|0|||
23488909|NCT03387150|65534002|FG002|Overall Study|Withdrawal by Subject|3|||
23488910|NCT03387150|65534003|FG003|Overall Study|Withdrawal by Subject|4|||
23488911|NCT03387150|65534004|FG004|Overall Study|Withdrawal by Subject|1|||
23488912|NCT03387150|65534005|FG005|Overall Study|Withdrawal by Subject|2|||
23488913|NCT03387150|65534006|FG006|Overall Study|Withdrawal by Subject|0|||
23488914|NCT03387150|65534000|FG000|Overall Study|Lost to Follow-up|3|||
23488915|NCT03387150|65534001|FG001|Overall Study|Lost to Follow-up|2|||
23488916|NCT03387150|65534002|FG002|Overall Study|Lost to Follow-up|2|||
23488917|NCT03387150|65534003|FG003|Overall Study|Lost to Follow-up|3|||
23488918|NCT03387150|65534004|FG004|Overall Study|Lost to Follow-up|3|||
23488919|NCT03387150|65534005|FG005|Overall Study|Lost to Follow-up|3|||
23488920|NCT03387150|65534006|FG006|Overall Study|Lost to Follow-up|0|||
23488921|NCT03387150|65534000|FG000|Overall Study|Participant unable to adhere to visit|0|||
23488922|NCT03387150|65534001|FG001|Overall Study|Participant unable to adhere to visit|1|||
23488923|NCT03387150|65534002|FG002|Overall Study|Participant unable to adhere to visit|0|||
23488924|NCT03387150|65534003|FG003|Overall Study|Participant unable to adhere to visit|0|||
23488925|NCT03387150|65534004|FG004|Overall Study|Participant unable to adhere to visit|2|||
23488926|NCT03387150|65534005|FG005|Overall Study|Participant unable to adhere to visit|2|||
23488927|NCT03387150|65534006|FG006|Overall Study|Participant unable to adhere to visit|0|||
23488928|NCT01251744|65534007|FG000|Overall Study|Lost to Follow-up|1|||
23604134|NCT00705159|65940312|FG003|Overall Study|Screen Failure|1|||
23283247|NCT00537095|64778954|FG001|Randomized Treatment Period (433 Days)|Death|1|||
23283248|NCT00537095|64778953|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
23283249|NCT00537095|64778954|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
23283250|NCT00537095|64778953|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
23283251|NCT00537095|64778954|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
23283252|NCT00537095|64778953|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
23283253|NCT00537095|64778954|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
23375503|NCT04079790|65119535|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
23375504|NCT04079790|65119536|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
23375505|NCT04079790|65119537|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
23375506|NCT04079790|65119538|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
23488929|NCT01251744|65534008|FG001|Overall Study|Lost to Follow-up|0|||
23488930|NCT02484690|65534009|FG000|Overall Study|Adverse Event|1|||
23604135|NCT03683576|65940315|FG000|Overall Study|Withdrawal by Subject|2|||
23604136|NCT03683576|65940316|FG001|Overall Study|Withdrawal by Subject|0|||
23604137|NCT03683576|65940317|FG002|Overall Study|Withdrawal by Subject|8|||
23604138|NCT03683576|65940318|FG003|Overall Study|Withdrawal by Subject|3|||
23604139|NCT03683576|65940315|FG000|Overall Study|Adverse Event|3|||
23604140|NCT03683576|65940316|FG001|Overall Study|Adverse Event|0|||
23604141|NCT03683576|65940317|FG002|Overall Study|Adverse Event|0|||
23604142|NCT03683576|65940318|FG003|Overall Study|Adverse Event|4|||
23604143|NCT03683576|65940315|FG000|Overall Study|Lack of Efficacy|1|||
23604144|NCT03683576|65940316|FG001|Overall Study|Lack of Efficacy|0|||
23604145|NCT03683576|65940317|FG002|Overall Study|Lack of Efficacy|1|||
23604146|NCT03683576|65940318|FG003|Overall Study|Lack of Efficacy|1|||
23604147|NCT03683576|65940315|FG000|Overall Study|Lost to Follow-up|0|||
23604148|NCT03683576|65940316|FG001|Overall Study|Lost to Follow-up|1|||
23604149|NCT03683576|65940317|FG002|Overall Study|Lost to Follow-up|2|||
23604150|NCT03683576|65940318|FG003|Overall Study|Lost to Follow-up|0|||
23604151|NCT03683576|65940315|FG000|Overall Study|Other, Not Specified|0|||
23604152|NCT03683576|65940316|FG001|Overall Study|Other, Not Specified|2|||
23604153|NCT03683576|65940317|FG002|Overall Study|Other, Not Specified|0|||
23375507|NCT04079790|65119535|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
23375508|NCT04079790|65119536|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
23375509|NCT04079790|65119537|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
23375510|NCT04079790|65119538|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
23283254|NCT00537095|64778953|FG000|Open-label Period (590 Days)|Adverse Event|2|||
23283255|NCT00537095|64778954|FG001|Open-label Period (590 Days)|Adverse Event|11|||
23283256|NCT00537095|64778953|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
23375511|NCT04079790|65119535|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
23375512|NCT04079790|65119536|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
23375513|NCT04079790|65119537|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
23375514|NCT04079790|65119538|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
23375515|NCT02133508|65119539|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
23375516|NCT02133508|65119539|FG000|Overall Study|Death|12|||
23375517|NCT02133508|65119539|FG000|Overall Study|Lost to Follow-up|2|||
23375518|NCT02948400|65119542|FG000|Overall Study|Withdrawal by Subject|17|||
23375519|NCT02948400|65119543|FG001|Overall Study|Withdrawal by Subject|10|||
23375520|NCT02948400|65119542|FG000|Overall Study|failed to attend appointments|47|||
23375521|NCT02948400|65119543|FG001|Overall Study|failed to attend appointments|34|||
23375522|NCT02948400|65119542|FG000|Overall Study|COVID-related closure|6|||
23375523|NCT02948400|65119543|FG001|Overall Study|COVID-related closure|2|||
23283257|NCT00537095|64778954|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
23283258|NCT00537095|64778953|FG000|Open-label Period (590 Days)|Death|2|||
23283259|NCT00537095|64778954|FG001|Open-label Period (590 Days)|Death|2|||
23283260|NCT00537095|64778953|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
23283261|NCT00537095|64778954|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
23283262|NCT00537095|64778953|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
23283263|NCT00537095|64778954|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
23283264|NCT05740098|64778955|FG000|Overall Study|Lost to Follow-up|26|||
23283265|NCT05740098|64778956|FG001|Overall Study|Lost to Follow-up|17|||
23283266|NCT05740098|64778957|FG002|Overall Study|Lost to Follow-up|21|||
23283267|NCT00274651|64778958|FG000|Overall Study|Adverse Event|6|||
23283268|NCT00274651|64778959|FG001|Overall Study|Adverse Event|3|||
23283269|NCT00274651|64778958|FG000|Overall Study|Lack of Efficacy|13|||
23375524|NCT02948400|65119542|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
23375525|NCT02948400|65119543|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
23375526|NCT02948400|65119542|FG000|Overall Study|motion sickness in virtual reality|2|||
23488931|NCT02484690|65534010|FG001|Overall Study|Adverse Event|3|||
23283270|NCT00274651|64778959|FG001|Overall Study|Lack of Efficacy|6|||
23283271|NCT00274651|64778958|FG000|Overall Study|Death|1|||
23283272|NCT00274651|64778959|FG001|Overall Study|Death|3|||
23283273|NCT00274651|64778958|FG000|Overall Study|Withdrawal by Subject|0|||
23488932|NCT02484690|65534011|FG002|Overall Study|Adverse Event|0|||
23488933|NCT02484690|65534012|FG003|Overall Study|Adverse Event|0|||
23488934|NCT02484690|65534013|FG004|Overall Study|Adverse Event|5|||
23283274|NCT00274651|64778959|FG001|Overall Study|Withdrawal by Subject|1|||
23283275|NCT00274651|64778958|FG000|Overall Study|Physician Decision|8|||
23283276|NCT00274651|64778959|FG001|Overall Study|Physician Decision|7|||
23283277|NCT01751087|64778963|FG000|Overall Study|Withdrawal by Subject|1|||
23283278|NCT01751087|64778964|FG001|Overall Study|Withdrawal by Subject|0|||
23283279|NCT01751087|64778965|FG002|Overall Study|Withdrawal by Subject|0|||
23283280|NCT01751087|64778963|FG000|Overall Study|Physician Decision|0|||
23283281|NCT01751087|64778964|FG001|Overall Study|Physician Decision|0|||
23283282|NCT01751087|64778965|FG002|Overall Study|Physician Decision|1|||
23283283|NCT00070291|64778966|FG000|Step 1|Withdrawal by Subject|1|||
23283284|NCT00070291|64778966|FG000|Step 1|Adverse Event|1|||
23283285|NCT00070291|64778966|FG000|Step 2|Adverse Event|1|||
23283286|NCT01968551|64778967|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
23283287|NCT01968551|64778968|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
23283288|NCT01968551|64778969|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
23283289|NCT01968551|64778967|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
23283290|NCT01968551|64778968|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
23283291|NCT01968551|64778969|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
23283292|NCT01968551|64778967|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
23283293|NCT01968551|64778968|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
23283294|NCT01968551|64778969|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
23283295|NCT01968551|64778967|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
23283296|NCT01968551|64778968|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
23375527|NCT02948400|65119543|FG001|Overall Study|motion sickness in virtual reality|0|||
23604154|NCT03683576|65940318|FG003|Overall Study|Other, Not Specified|0|||
23604155|NCT03683576|65940315|FG000|Overall Study|Protocol Violation|0|||
23604156|NCT03683576|65940316|FG001|Overall Study|Protocol Violation|1|||
23604157|NCT03683576|65940317|FG002|Overall Study|Protocol Violation|1|||
23604158|NCT03683576|65940318|FG003|Overall Study|Protocol Violation|0|||
23604159|NCT01228734|65940320|FG000|Overall Study|Randomized, but not treated|0|||
23604160|NCT01228734|65940321|FG001|Overall Study|Randomized, but not treated|4|||
23604161|NCT03451422|65940322|FG000|Overall Study|Lost to Follow-up|0|||
23604162|NCT03451422|65940323|FG001|Overall Study|Lost to Follow-up|0|||
23604163|NCT03451422|65940324|FG002|Overall Study|Lost to Follow-up|0|||
23604164|NCT03451422|65940325|FG003|Overall Study|Lost to Follow-up|0|||
23604165|NCT03451422|65940326|FG004|Overall Study|Lost to Follow-up|0|||
23604166|NCT03451422|65940327|FG005|Overall Study|Lost to Follow-up|1|||
23604167|NCT03451422|65940322|FG000|Overall Study|Decision by sponsor|1|||
23604168|NCT03451422|65940323|FG001|Overall Study|Decision by sponsor|0|||
23604169|NCT03451422|65940324|FG002|Overall Study|Decision by sponsor|1|||
23604170|NCT03451422|65940325|FG003|Overall Study|Decision by sponsor|0|||
23604171|NCT03451422|65940326|FG004|Overall Study|Decision by sponsor|0|||
23604172|NCT03451422|65940327|FG005|Overall Study|Decision by sponsor|0|||
23604173|NCT03451422|65940322|FG000|Overall Study|Withdrawal by Subject|0|||
23604174|NCT03451422|65940323|FG001|Overall Study|Withdrawal by Subject|0|||
23604175|NCT03451422|65940324|FG002|Overall Study|Withdrawal by Subject|2|||
23604176|NCT03451422|65940325|FG003|Overall Study|Withdrawal by Subject|3|||
23604177|NCT03451422|65940326|FG004|Overall Study|Withdrawal by Subject|2|||
23604178|NCT03451422|65940327|FG005|Overall Study|Withdrawal by Subject|1|||
23604179|NCT00745875|65940328|FG000|Overall Study|Continuing study treatment|4|||
23604180|NCT00745875|65940329|FG001|Overall Study|Continuing study treatment|4|||
23604181|NCT00022672|65940332|FG000|Main Phase: 24 Months|Adverse Event|6|||
23604182|NCT00022672|65940333|FG001|Main Phase: 24 Months|Adverse Event|0|||
23604183|NCT00022672|65940332|FG000|Main Phase: 24 Months|Death|0|||
23604184|NCT00022672|65940333|FG001|Main Phase: 24 Months|Death|3|||
23604185|NCT00022672|65940332|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
23604186|NCT00022672|65940333|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
23604187|NCT00022672|65940332|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
23604188|NCT00022672|65940333|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
23604189|NCT00022672|65940332|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
23604190|NCT00022672|65940333|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
23604191|NCT00022672|65940332|FG000|Main Phase: 24 Months|Refused Treatment|3|||
23604192|NCT00022672|65940333|FG001|Main Phase: 24 Months|Refused Treatment|4|||
23604193|NCT00022672|65940332|FG000|Main Phase: 24 Months|Failure to Return|1|||
23604194|NCT00022672|65940333|FG001|Main Phase: 24 Months|Failure to Return|1|||
23604195|NCT00022672|65940332|FG000|Main Phase: 24 Months|Other|1|||
23604196|NCT00022672|65940333|FG001|Main Phase: 24 Months|Other|0|||
23604197|NCT00022672|65940332|FG000|Extension Phase|Adverse Event|1|||
23604198|NCT00022672|65940333|FG001|Extension Phase|Adverse Event|3|||
23604199|NCT00022672|65940332|FG000|Extension Phase|Death|0|||
23604200|NCT00022672|65940333|FG001|Extension Phase|Death|1|||
23604201|NCT00022672|65940332|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
23604202|NCT00022672|65940333|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
23604203|NCT00022672|65940332|FG000|Extension Phase|Refused Treatment|0|||
23604204|NCT00022672|65940333|FG001|Extension Phase|Refused Treatment|2|||
23604205|NCT00022672|65940332|FG000|Extension Phase|Other|1|||
23604206|NCT00022672|65940333|FG001|Extension Phase|Other|1|||
23604207|NCT02722434|65940338|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
23604208|NCT02722434|65940339|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
23604209|NCT02722434|65940338|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
23604210|NCT02722434|65940339|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
23604211|NCT01278030|65940340|FG000|Overall Study|Withdrawal by Subject|8|||
23604212|NCT01278030|65940341|FG001|Overall Study|Withdrawal by Subject|4|||
23375528|NCT01259245|65119544|FG000|Overall Study|Withdrawal by Subject|27|||
23375529|NCT01259245|65119545|FG001|Overall Study|Withdrawal by Subject|24|||
23375530|NCT01259245|65119544|FG000|Overall Study|Death|1|||
23604213|NCT01079806|65940344|FG000|Day 1 to Week 96|Adverse Event|0|||
23375531|NCT01259245|65119545|FG001|Overall Study|Death|2|||
23375532|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
23375533|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
23375534|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
23375535|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
23375536|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
23375537|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
23375538|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
23375539|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
23375540|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
23375541|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
23375542|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
23375543|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
23375544|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
23375545|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
23375546|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
23375547|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
23375548|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
23375549|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
23375550|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
23375551|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
23375552|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
23375553|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
23375554|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
23375555|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
23375556|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
23375557|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
23375558|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
23375559|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
23375560|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
23375561|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
23375562|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
23375563|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
23375564|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
23375565|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
23375566|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
23375567|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
23375568|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
23375569|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
23375570|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
23375571|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
23604214|NCT01079806|65940345|FG001|Day 1 to Week 96|Adverse Event|3|||
23604215|NCT01079806|65940344|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
23604216|NCT01079806|65940345|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
23604217|NCT01079806|65940344|FG000|Day 1 to Week 96|Pregnancy|0|||
23604218|NCT01079806|65940345|FG001|Day 1 to Week 96|Pregnancy|1|||
23604219|NCT01079806|65940344|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
23604220|NCT01079806|65940345|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
23604221|NCT01079806|65940344|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
23604222|NCT01079806|65940345|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
23283297|NCT01968551|64778969|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
23283298|NCT01968551|64778967|FG000|Extension Phase|Adverse Event|0|||
23283299|NCT01968551|64778968|FG001|Extension Phase|Adverse Event|0|||
23283300|NCT01968551|64778969|FG002|Extension Phase|Adverse Event|2|||
23283301|NCT01968551|64778967|FG000|Extension Phase|Death|0|||
23283302|NCT01968551|64778968|FG001|Extension Phase|Death|1|||
23283303|NCT01968551|64778969|FG002|Extension Phase|Death|0|||
23283304|NCT01968551|64778967|FG000|Extension Phase|Withdrew Consent|0|||
23283305|NCT01968551|64778968|FG001|Extension Phase|Withdrew Consent|0|||
23283306|NCT01968551|64778969|FG002|Extension Phase|Withdrew Consent|1|||
23283307|NCT01968551|64778967|FG000|Extension Phase|Lost to Follow-up|1|||
23283308|NCT01968551|64778968|FG001|Extension Phase|Lost to Follow-up|0|||
23283309|NCT01968551|64778969|FG002|Extension Phase|Lost to Follow-up|1|||
23375572|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
23375573|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
23375574|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
23375575|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
23375576|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
23375577|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
23375578|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
23375579|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
23375580|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
23375581|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
23375582|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
23375583|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
23375584|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
23375585|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
23375586|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
23375587|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
23375588|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
23375589|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
23375590|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
23375591|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
23375592|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
23375593|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
23375594|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
23375595|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
23375596|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
23375597|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
23375598|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
23375599|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
23375600|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
23375601|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
23375602|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
23375603|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
23375604|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
23375605|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
23375606|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
23375607|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
23375608|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
23375609|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
23375610|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
23375611|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
23375612|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
23375613|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
23375614|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
23375615|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
23375616|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
23375617|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
23375618|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
23375619|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
23375620|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
23375621|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
23375622|NCT00090103|65119546|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
23375623|NCT00090103|65119547|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
23375624|NCT00090103|65119548|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
23375625|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
23375626|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
23375627|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
23375628|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
23375629|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
23375630|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
23375631|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
23375632|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
23375633|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
23375634|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
23604223|NCT01079806|65940344|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
23604224|NCT01079806|65940345|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
23604225|NCT01079806|65940344|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
23604226|NCT01079806|65940345|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
23604227|NCT01079806|65940344|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
23604228|NCT01079806|65940345|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
23604229|NCT01079806|65940344|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
23604230|NCT01079806|65940345|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
23604231|NCT01079806|65940344|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
23604232|NCT01079806|65940345|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
23604233|NCT00536120|65940346|FG000|Overall Study|Lost to Follow-up|1|||
23604234|NCT00536120|65940347|FG001|Overall Study|Lost to Follow-up|0|||
23604235|NCT00536120|65940346|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
23604236|NCT00536120|65940347|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
23604237|NCT00536120|65940346|FG000|Overall Study|Non-compliance|1|||
23604238|NCT00536120|65940347|FG001|Overall Study|Non-compliance|0|||
23604239|NCT00536120|65940346|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
23604240|NCT00536120|65940347|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
23604241|NCT00536120|65940346|FG000|Overall Study|Steroid Use|0|||
23604242|NCT00536120|65940347|FG001|Overall Study|Steroid Use|2|||
23604243|NCT00536120|65940346|FG000|Overall Study|Missed Study Visit|0|||
23604244|NCT00536120|65940347|FG001|Overall Study|Missed Study Visit|1|||
23604245|NCT01478594|65940348|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
23604246|NCT01478594|65940349|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
23604247|NCT01478594|65940348|FG000|Overall Study|Death|45|||
23604248|NCT01478594|65940349|FG001|Overall Study|Death|18|||
23604249|NCT01478594|65940348|FG000|Overall Study|Lost to Follow-up|3|||
23604250|NCT01478594|65940349|FG001|Overall Study|Lost to Follow-up|1|||
23604251|NCT01478594|65940348|FG000|Overall Study|Withdrawal by Subject|9|||
23604252|NCT01478594|65940349|FG001|Overall Study|Withdrawal by Subject|3|||
23604253|NCT01478594|65940348|FG000|Overall Study|Study Closed by Sponsor|8|||
23604254|NCT01478594|65940349|FG001|Overall Study|Study Closed by Sponsor|5|||
23604255|NCT00070317|65940350|FG000|Overall Study|Inevaluable (Never Treated)|1|||
23604256|NCT00070317|65940350|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
23604257|NCT00070317|65940350|FG000|Overall Study|Ineligible required test not done|1|||
23604258|NCT00070317|65940350|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
23604259|NCT00070317|65940350|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
23604260|NCT02630186|65940359|FG000|Overall Study|Withdrawal by Subject|1|||
23604261|NCT01529632|65940360|FG000|Overall Study|Administrative problem|2|||
23604262|NCT01529632|65940361|FG001|Overall Study|Administrative problem|1|||
23604263|NCT01529632|65940360|FG000|Overall Study|Protocol Violation|0|||
23604264|NCT01529632|65940361|FG001|Overall Study|Protocol Violation|1|||
23375635|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
23375636|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
23375637|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
23375638|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
23375639|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
23375640|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
23375641|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
23375642|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
23375643|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
23375644|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
23375645|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
23604265|NCT01529632|65940360|FG000|Overall Study|Adverse Event|1|||
23604266|NCT01529632|65940361|FG001|Overall Study|Adverse Event|1|||
23604267|NCT05405244|65940362|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
23604268|NCT05405244|65940363|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
23604269|NCT05405244|65940362|FG000|Washout (2 Weeks)|Adverse Event|2|||
23604270|NCT05405244|65940363|FG001|Washout (2 Weeks)|Adverse Event|0|||
23283310|NCT01302548|64778972|FG000|Overall Study|Lost to Follow-up|2|||
23375646|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
23375647|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
23375648|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
23375649|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
23375650|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
23375651|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
23375652|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
23375653|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
23375654|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
23283311|NCT01302548|64778973|FG001|Overall Study|Lost to Follow-up|1|||
23283312|NCT00003470|64778977|FG000|Overall Study|Not evaluable|6|||
23283313|NCT01808651|64778981|FG000|Study Period 1|Lost to Follow-up|1|||
23283314|NCT01808651|64778982|FG001|Study Period 1|Lost to Follow-up|3|||
23283315|NCT01808651|64778983|FG002|Study Period 1|Lost to Follow-up|0|||
23283316|NCT01808651|64778981|FG000|Study Period 1|Protocol Violation|1|||
23283317|NCT01808651|64778982|FG001|Study Period 1|Protocol Violation|0|||
23283318|NCT01808651|64778983|FG002|Study Period 1|Protocol Violation|1|||
23283319|NCT01808651|64778981|FG000|Study Period 1|Physician Decision|3|||
23283320|NCT01808651|64778982|FG001|Study Period 1|Physician Decision|2|||
23283321|NCT01808651|64778983|FG002|Study Period 1|Physician Decision|0|||
23283322|NCT01808651|64778981|FG000|Study Period 1|Lack of Efficacy|2|||
23283323|NCT01808651|64778982|FG001|Study Period 1|Lack of Efficacy|1|||
23283324|NCT01808651|64778983|FG002|Study Period 1|Lack of Efficacy|0|||
23283325|NCT01808651|64778981|FG000|Study Period 1|Adverse Event|10|||
23283326|NCT01808651|64778982|FG001|Study Period 1|Adverse Event|4|||
23283327|NCT01808651|64778983|FG002|Study Period 1|Adverse Event|1|||
23283328|NCT01808651|64778981|FG000|Study Period 1|Participant Decision|9|||
23283329|NCT01808651|64778982|FG001|Study Period 1|Participant Decision|7|||
23283330|NCT01808651|64778983|FG002|Study Period 1|Participant Decision|3|||
23283331|NCT03599362|64778984|FG000|Overall Study|Screen Failure|3|||
23283332|NCT00857454|64778985|FG000|Overall Study|Withdrawal by Subject|2|||
23283333|NCT00857454|64778985|FG000|Overall Study|Lost to Follow-up|1|||
23283334|NCT00857454|64778985|FG000|Overall Study|Adverse Event|2|||
23283335|NCT00857454|64778985|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
23283336|NCT00857454|64778985|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
23283337|NCT00857454|64778985|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
23283338|NCT01456962|64778986|FG000|Overall Study|Lost to Follow-up|2|||
23283339|NCT01456962|64778987|FG001|Overall Study|Lost to Follow-up|1|||
23283340|NCT04277507|64778990|FG000|Overall Study|Lost to Follow-up|17|||
23283341|NCT04277507|64778990|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
23283342|NCT04277507|64778990|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
23283343|NCT04277507|64778990|FG000|Overall Study|Withdrawal by Subject|3|||
23283344|NCT04277507|64778990|FG000|Overall Study|Death due to COVID-19|1|||
23283345|NCT04277507|64778990|FG000|Overall Study|Data missing for full evaluation|5|||
23283346|NCT04583423|64778991|FG000|Overall Study|Lost to Follow-up|0|||
23283347|NCT04583423|64778992|FG001|Overall Study|Lost to Follow-up|1|||
23283348|NCT04583423|64778993|FG002|Overall Study|Lost to Follow-up|0|||
23283349|NCT04583423|64778994|FG003|Overall Study|Lost to Follow-up|2|||
23283350|NCT04583423|64778991|FG000|Overall Study|Study Terminated by Sponsor|32|||
23283351|NCT04583423|64778992|FG001|Overall Study|Study Terminated by Sponsor|35|||
23283352|NCT04583423|64778993|FG002|Overall Study|Study Terminated by Sponsor|36|||
23375655|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
23283353|NCT04583423|64778994|FG003|Overall Study|Study Terminated by Sponsor|33|||
23375656|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
23375657|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
23375658|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
23375659|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
23375660|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
23375661|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
23375662|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
23375663|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
23375664|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
23375665|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
23604271|NCT05405244|65940362|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
23604272|NCT05405244|65940363|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
23604273|NCT00263757|65940368|FG000|Overall Study|Withdrawal by Subject|5|||
23604274|NCT00263757|65940369|FG001|Overall Study|Withdrawal by Subject|4|||
23604275|NCT00263757|65940368|FG000|Overall Study|Screen failure|0|||
23604276|NCT00263757|65940369|FG001|Overall Study|Screen failure|1|||
23604277|NCT00263757|65940368|FG000|Overall Study|Adverse Event|3|||
23604278|NCT00263757|65940369|FG001|Overall Study|Adverse Event|3|||
23604279|NCT01567852|65940370|FG000|Overall Study|Withdrawal by Subject|3|||
23604280|NCT01567852|65940371|FG001|Overall Study|Withdrawal by Subject|6|||
23604281|NCT01567852|65940370|FG000|Overall Study|ECT discontinued|1|||
23283354|NCT04583423|64778991|FG000|Overall Study|Withdrawal by Subject|3|||
23283355|NCT04583423|64778992|FG001|Overall Study|Withdrawal by Subject|1|||
23283356|NCT04583423|64778993|FG002|Overall Study|Withdrawal by Subject|2|||
23283357|NCT04583423|64778994|FG003|Overall Study|Withdrawal by Subject|1|||
23283358|NCT00243347|64778995|FG000|Overall Study|Lack of Efficacy|4|||
23604282|NCT01567852|65940371|FG001|Overall Study|ECT discontinued|1|||
23283359|NCT00243347|64778995|FG000|Overall Study|Adverse Event|2|||
23283360|NCT00243347|64778995|FG000|Overall Study|Death|1|||
23283361|NCT00243347|64778995|FG000|Overall Study|Withdrawal by Subject|5|||
23283362|NCT00243347|64778995|FG000|Overall Study|Condition worsened|7|||
23283363|NCT03073798|64778996|FG000|Overall Study|Adverse Event|1|||
23283364|NCT03073798|64778996|FG000|Overall Study|Withdrawal by Subject|1|||
23283365|NCT00387153|64779002|FG000|Overall Study|Adverse Event|1|||
23283366|NCT00387153|64779002|FG000|Overall Study|Disease Progression|3|||
23283367|NCT00387153|64779002|FG000|Overall Study|Lack of Response|4|||
23283368|NCT01660243|64779003|FG000|Overall Study|Adverse Event|1|||
23283369|NCT01660243|64779004|FG001|Overall Study|Adverse Event|0|||
23283370|NCT01660243|64779005|FG002|Overall Study|Adverse Event|1|||
23283371|NCT01660243|64779006|FG003|Overall Study|Adverse Event|0|||
23283372|NCT01660243|64779003|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
23283373|NCT01660243|64779004|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
23283374|NCT01660243|64779005|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
23283375|NCT01660243|64779006|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
23283376|NCT01660243|64779003|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
23283377|NCT01660243|64779004|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
23283378|NCT01660243|64779005|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
23283379|NCT01660243|64779006|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
23375666|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
23604283|NCT00713596|65940374|FG000|Overall Study|Study was terminated|2|||
23604284|NCT00713596|65940375|FG001|Overall Study|Study was terminated|3|||
23604285|NCT00713596|65940376|FG002|Overall Study|Study was terminated|2|||
23604286|NCT00518206|65940381|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
23604287|NCT00518206|65940382|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
23604288|NCT00518206|65940381|FG000|Overall Study|Withdrawal by Subject|2|||
23604289|NCT00518206|65940382|FG001|Overall Study|Withdrawal by Subject|0|||
23375667|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
23375668|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
23375669|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
23375670|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
23375671|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
23375672|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
23375673|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Death|1|||
23375674|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Death|0|||
23375675|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Death|1|||
23375676|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
23375677|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
23375678|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
23375679|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
23375680|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
23375681|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
23375682|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
23375683|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
23375684|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
23375685|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
23375686|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
23375687|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
23375688|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
23375689|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
23375690|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
23375691|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
23375692|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
23375693|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
23375694|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
23375695|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
23375696|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
23375697|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Depression|0|||
23375698|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Depression|1|||
23375699|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Depression|0|||
23375700|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
23375701|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
23375702|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
23375703|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Jailed|0|||
23375704|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Jailed|1|||
23375705|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Jailed|0|||
23375706|NCT00090103|65119546|FG000|16-Week Safety Follow-up Period|Other|0|||
23375707|NCT00090103|65119547|FG001|16-Week Safety Follow-up Period|Other|1|||
23375708|NCT00090103|65119548|FG002|16-Week Safety Follow-up Period|Other|0|||
23375709|NCT01260948|65119553|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
23375710|NCT01260948|65119554|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
23283380|NCT01660243|64779003|FG000|Overall Study|Randomization error|0|||
23283381|NCT01660243|64779004|FG001|Overall Study|Randomization error|0|||
23283382|NCT01660243|64779005|FG002|Overall Study|Randomization error|0|||
23283383|NCT01660243|64779006|FG003|Overall Study|Randomization error|1|||
23283384|NCT00830024|64779007|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23283385|NCT00830024|64779008|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23283386|NCT00239005|64781762|FG000|Overall Study|Adverse Event|6|||
23283387|NCT00239005|64781763|FG001|Overall Study|Adverse Event|6|||
23283388|NCT00239005|64781762|FG000|Overall Study|Withdrawal by Subject|3|||
23283389|NCT00239005|64781763|FG001|Overall Study|Withdrawal by Subject|4|||
23283390|NCT00239005|64781762|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
23283391|NCT00239005|64781763|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
23283392|NCT00239005|64781762|FG000|Overall Study|Protocol Violation|1|||
23283393|NCT00239005|64781763|FG001|Overall Study|Protocol Violation|0|||
23283394|NCT00239005|64781762|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
23283395|NCT00239005|64781763|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
23283396|NCT00239005|64781762|FG000|Overall Study|Lost to Follow-up|0|||
23283397|NCT00239005|64781763|FG001|Overall Study|Lost to Follow-up|1|||
23283398|NCT02451358|64781764|FG000|Overall Study|Withdrawal by Subject|1|||
23283399|NCT02451358|64781765|FG001|Overall Study|Withdrawal by Subject|1|||
23283400|NCT02451358|64781766|FG002|Overall Study|Withdrawal by Subject|0|||
23283401|NCT02451358|64781767|FG003|Overall Study|Withdrawal by Subject|0|||
23283402|NCT02451358|64781764|FG000|Overall Study|Protocol Violation|0|||
23375711|NCT01260948|65119553|FG000|Second Intervention|Emesis|0|||
23375712|NCT01260948|65119554|FG001|Second Intervention|Emesis|1|||
23375713|NCT00750269|65119555|FG000|Overall Study|Protocol Violation|0|||
23375714|NCT00750269|65119556|FG001|Overall Study|Protocol Violation|1|||
23375715|NCT00750269|65119557|FG002|Overall Study|Protocol Violation|1|||
23375716|NCT00750269|65119558|FG003|Overall Study|Protocol Violation|2|||
23375717|NCT00750269|65119559|FG004|Overall Study|Protocol Violation|4|||
23375718|NCT00750269|65119555|FG000|Overall Study|Withdrawal by Subject|0|||
23375719|NCT00750269|65119556|FG001|Overall Study|Withdrawal by Subject|0|||
23375720|NCT00750269|65119557|FG002|Overall Study|Withdrawal by Subject|2|||
23375721|NCT00750269|65119558|FG003|Overall Study|Withdrawal by Subject|2|||
23375722|NCT00750269|65119559|FG004|Overall Study|Withdrawal by Subject|2|||
23375723|NCT00750269|65119555|FG000|Overall Study|Physician Decision|0|||
23375724|NCT00750269|65119556|FG001|Overall Study|Physician Decision|0|||
23375725|NCT00750269|65119557|FG002|Overall Study|Physician Decision|0|||
23375726|NCT00750269|65119558|FG003|Overall Study|Physician Decision|0|||
23375727|NCT00750269|65119559|FG004|Overall Study|Physician Decision|2|||
23375728|NCT00750269|65119555|FG000|Overall Study|Patient too large for positioning|0|||
23375729|NCT00750269|65119556|FG001|Overall Study|Patient too large for positioning|0|||
23375730|NCT00750269|65119557|FG002|Overall Study|Patient too large for positioning|1|||
23375731|NCT00750269|65119558|FG003|Overall Study|Patient too large for positioning|0|||
23375732|NCT00750269|65119559|FG004|Overall Study|Patient too large for positioning|0|||
23375733|NCT00750269|65119555|FG000|Overall Study|Site error|0|||
23375734|NCT00750269|65119556|FG001|Overall Study|Site error|0|||
23375735|NCT00750269|65119557|FG002|Overall Study|Site error|0|||
23375736|NCT00750269|65119558|FG003|Overall Study|Site error|1|||
23375737|NCT00750269|65119559|FG004|Overall Study|Site error|0|||
23375738|NCT00750269|65119555|FG000|Overall Study|SBRT plan could not be drawn|0|||
23375739|NCT00750269|65119556|FG001|Overall Study|SBRT plan could not be drawn|0|||
23375740|NCT00750269|65119557|FG002|Overall Study|SBRT plan could not be drawn|0|||
23375741|NCT00750269|65119558|FG003|Overall Study|SBRT plan could not be drawn|0|||
23375742|NCT00750269|65119559|FG004|Overall Study|SBRT plan could not be drawn|1|||
23375743|NCT00750269|65119555|FG000|Overall Study|Fiducials could not be placed|0|||
23375744|NCT00750269|65119556|FG001|Overall Study|Fiducials could not be placed|0|||
23375745|NCT00750269|65119557|FG002|Overall Study|Fiducials could not be placed|0|||
23375746|NCT00750269|65119558|FG003|Overall Study|Fiducials could not be placed|0|||
23375747|NCT00750269|65119559|FG004|Overall Study|Fiducials could not be placed|1|||
23375748|NCT00754741|65119560|FG000|Overall Study|Died or disenrolled|57|||
23375749|NCT00754741|65119561|FG001|Overall Study|Died or disenrolled|69|||
23375750|NCT00754741|65119562|FG002|Overall Study|Died or disenrolled|54|||
23375751|NCT01117870|65119564|FG000|Overall Study|Inability to place needle|1|||
23375752|NCT01117870|65119565|FG001|Overall Study|Inability to place needle|0|||
23375753|NCT01685437|65119566|FG000|Overall Study|Withdrawal by Subject|22|||
23375754|NCT01685437|65119566|FG000|Overall Study|Lost to Follow-up|3|||
23375755|NCT01685437|65119566|FG000|Overall Study|Adverse Event|1|||
23375756|NCT01685437|65119566|FG000|Overall Study|Protocol Violation|4|||
23375757|NCT01685437|65119566|FG000|Overall Study|Unable to make visits due to work|1|||
23375758|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
23375759|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
23375760|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
23375761|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Death|0|||
23375762|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Death|0|||
23375763|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Death|1|||
23375764|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
23375765|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
23375766|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
23375767|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
23375768|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
23375769|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
23375770|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
23375771|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
23375772|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
23375773|NCT02696798|65119567|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
23375774|NCT02696798|65119568|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
23375775|NCT02696798|65119569|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
23375776|NCT02696798|65119567|FG000|Extended Treatment Period|Adverse Event|1|||
23375777|NCT02696798|65119568|FG001|Extended Treatment Period|Adverse Event|4|||
23604290|NCT00518206|65940381|FG000|Overall Study|Drug Supply Issue|1|||
23375778|NCT02696798|65119569|FG002|Extended Treatment Period|Adverse Event|5|||
23375779|NCT02696798|65119567|FG000|Extended Treatment Period|Lack of Efficacy|7|||
23375780|NCT02696798|65119568|FG001|Extended Treatment Period|Lack of Efficacy|2|||
23375781|NCT02696798|65119569|FG002|Extended Treatment Period|Lack of Efficacy|2|||
23375782|NCT02696798|65119567|FG000|Extended Treatment Period|Lost to Follow-up|1|||
23375783|NCT02696798|65119568|FG001|Extended Treatment Period|Lost to Follow-up|0|||
23375784|NCT02696798|65119569|FG002|Extended Treatment Period|Lost to Follow-up|0|||
23375785|NCT02696798|65119567|FG000|Extended Treatment Period|Physician Decision|0|||
23375786|NCT02696798|65119568|FG001|Extended Treatment Period|Physician Decision|1|||
23375787|NCT02696798|65119569|FG002|Extended Treatment Period|Physician Decision|0|||
23375788|NCT02696798|65119567|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
23375789|NCT02696798|65119568|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
23375790|NCT02696798|65119569|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
23375791|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
23375792|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
23488935|NCT02484690|65534009|FG000|Overall Study|Death|0|||
23488936|NCT02484690|65534010|FG001|Overall Study|Death|0|||
23488937|NCT02484690|65534011|FG002|Overall Study|Death|0|||
23488938|NCT02484690|65534012|FG003|Overall Study|Death|0|||
23488939|NCT02484690|65534013|FG004|Overall Study|Death|1|||
23488940|NCT02484690|65534009|FG000|Overall Study|Withdrawal by Subject|1|||
23488941|NCT02484690|65534010|FG001|Overall Study|Withdrawal by Subject|3|||
23488942|NCT02484690|65534011|FG002|Overall Study|Withdrawal by Subject|1|||
23488943|NCT02484690|65534012|FG003|Overall Study|Withdrawal by Subject|2|||
23488944|NCT02484690|65534013|FG004|Overall Study|Withdrawal by Subject|0|||
23488945|NCT02484690|65534009|FG000|Overall Study|Physician Decision|2|||
23488946|NCT02484690|65534010|FG001|Overall Study|Physician Decision|0|||
23488947|NCT02484690|65534011|FG002|Overall Study|Physician Decision|1|||
23375793|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
23375794|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
23375795|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
23375796|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
23375797|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
23375798|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
23375799|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
23375800|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
23375801|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
23375802|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
23375803|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
23375804|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
23375805|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
23375806|NCT02696798|65119567|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
23283403|NCT02451358|64781765|FG001|Overall Study|Protocol Violation|1|||
23283404|NCT02451358|64781766|FG002|Overall Study|Protocol Violation|1|||
23283405|NCT02451358|64781767|FG003|Overall Study|Protocol Violation|0|||
23283406|NCT02255149|64781768|FG000|Overall Study|Lost to Follow-up|2|||
23283407|NCT02255149|64781768|FG000|Overall Study|Withdrawal by Subject|1|||
23283408|NCT02255149|64781768|FG000|Overall Study|Withdrawal by PI|1|||
23283409|NCT02255149|64781768|FG000|Overall Study|Implant Failure|1|||
23283410|NCT00474058|64781769|FG000|Overall Study|Adverse Event|11|||
23283411|NCT00474058|64781770|FG001|Overall Study|Adverse Event|6|||
23283412|NCT00474058|64781769|FG000|Overall Study|Lack of Efficacy|0|||
23283413|NCT00474058|64781770|FG001|Overall Study|Lack of Efficacy|4|||
23283414|NCT00474058|64781769|FG000|Overall Study|Withdrawal by Subject|11|||
23283415|NCT00474058|64781770|FG001|Overall Study|Withdrawal by Subject|7|||
23283416|NCT00474058|64781769|FG000|Overall Study|Other|2|||
23283417|NCT00474058|64781770|FG001|Overall Study|Other|0|||
23283418|NCT00714051|64781777|FG000|Overall Study|Withdrawal by Subject|1|||
23283419|NCT00714051|64781778|FG001|Overall Study|Withdrawal by Subject|0|||
23283420|NCT00714051|64781777|FG000|Overall Study|Death|0|||
23283421|NCT00714051|64781778|FG001|Overall Study|Death|1|||
23283422|NCT00876265|64781780|FG000|Overall Study|Miscellaneous reasons|4|||
23283423|NCT00876265|64781780|FG000|Overall Study|Lost to Follow-up|6|||
23283424|NCT00876265|64781780|FG000|Overall Study|Withdrawal by Subject|2|||
23283425|NCT04750239|64781785|FG000|Overall Study|Withdrawal by Subject|2|||
23375807|NCT02696798|65119568|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
23488948|NCT02484690|65534012|FG003|Overall Study|Physician Decision|0|||
23488949|NCT02484690|65534013|FG004|Overall Study|Physician Decision|0|||
23283426|NCT04750239|64781785|FG000|Overall Study|Trial terminated by sponsor|1|||
23283427|NCT00660660|64781786|FG000|Overall Study|Adverse Event|1|||
23283428|NCT00660660|64781787|FG001|Overall Study|Adverse Event|0|||
23283429|NCT00660660|64781786|FG000|Overall Study|Lost to Follow-up|0|||
23283430|NCT00660660|64781787|FG001|Overall Study|Lost to Follow-up|6|||
23375808|NCT02696798|65119569|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
23375809|NCT00671060|65119571|FG000|Overall Study|Protocol Violation|1|||
23488950|NCT02484690|65534009|FG000|Overall Study|Lost to Follow-up|0|||
23283431|NCT00660660|64781786|FG000|Overall Study|Lack of Efficacy|0|||
23283432|NCT00660660|64781787|FG001|Overall Study|Lack of Efficacy|2|||
23283433|NCT00660660|64781786|FG000|Overall Study|Withdrawal by Subject|3|||
23283434|NCT00660660|64781787|FG001|Overall Study|Withdrawal by Subject|0|||
23283435|NCT00660660|64781786|FG000|Overall Study|Incorrect enrollment and other|0|||
23283436|NCT00660660|64781787|FG001|Overall Study|Incorrect enrollment and other|1|||
23283437|NCT00660660|64781786|FG000|Overall Study|New medication after randomization|1|||
23283438|NCT00660660|64781787|FG001|Overall Study|New medication after randomization|0|||
23283439|NCT02653664|64781788|FG000|Post-Treatment|Withdrawal by Subject|6|||
23283440|NCT02653664|64781789|FG001|Post-Treatment|Withdrawal by Subject|5|||
23283441|NCT02653664|64781790|FG002|Post-Treatment|Withdrawal by Subject|7|||
23283442|NCT02653664|64781788|FG000|Post-Treatment|Lost to Follow-up|8|||
23283443|NCT02653664|64781789|FG001|Post-Treatment|Lost to Follow-up|1|||
23283444|NCT02653664|64781790|FG002|Post-Treatment|Lost to Follow-up|7|||
23283445|NCT02653664|64781788|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
23283446|NCT02653664|64781789|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
23283447|NCT02653664|64781790|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
23283448|NCT02653664|64781788|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
23283449|NCT02653664|64781789|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
23283450|NCT02653664|64781790|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
23283451|NCT02653664|64781788|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
23283452|NCT02653664|64781789|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
23283453|NCT02653664|64781790|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
23283454|NCT02653664|64781788|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
23283455|NCT02653664|64781789|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
23283456|NCT02653664|64781790|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
23283457|NCT02653664|64781788|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
23283458|NCT02653664|64781789|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
23283459|NCT02653664|64781790|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
23283460|NCT02653664|64781788|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
23283461|NCT02653664|64781789|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
23283462|NCT02653664|64781790|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
23283463|NCT02653664|64781788|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
23283464|NCT02653664|64781789|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
23604291|NCT00518206|65940382|FG001|Overall Study|Drug Supply Issue|0|||
23604292|NCT00518206|65940381|FG000|Overall Study|Reason Unknown|1|||
23604293|NCT00518206|65940382|FG001|Overall Study|Reason Unknown|0|||
23604294|NCT00518206|65940381|FG000|Overall Study|Completion Status Unknown|1|||
23604295|NCT00518206|65940382|FG001|Overall Study|Completion Status Unknown|0|||
23604296|NCT02202317|65940383|FG000|Overall Study|Lost to Follow-up|1|||
23604297|NCT01240590|65940385|FG000|Phase I|Refused further treatment|0|||
23604298|NCT01240590|65940386|FG001|Phase I|Refused further treatment|0|||
23604299|NCT01240590|65940387|FG002|Phase I|Refused further treatment|3|||
23604300|NCT01240590|65940388|FG003|Phase I|Refused further treatment|0|||
23604301|NCT01240590|65940389|FG004|Phase I|Refused further treatment|0|||
23604302|NCT01240590|65940385|FG000|Phase II|Refused further treatment|0|||
23604303|NCT01240590|65940386|FG001|Phase II|Refused further treatment|0|||
23604304|NCT01240590|65940387|FG002|Phase II|Refused further treatment|0|||
23604305|NCT01240590|65940388|FG003|Phase II|Refused further treatment|2|||
23604306|NCT01240590|65940389|FG004|Phase II|Refused further treatment|1|||
23604307|NCT01779700|65940390|FG000|Overall Study|Adverse Event|4|||
23604308|NCT01779700|65940391|FG001|Overall Study|Adverse Event|3|||
23604309|NCT01779700|65940390|FG000|Overall Study|Withdrawal by Subject|0|||
23604310|NCT01779700|65940391|FG001|Overall Study|Withdrawal by Subject|2|||
23604311|NCT00666705|65940395|FG000|Overall Study|Withdrawal by Subject|1|||
23604312|NCT01147471|65940396|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
23604313|NCT01147471|65940397|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
23604314|NCT01147471|65940396|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
23604315|NCT01147471|65940397|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
23604316|NCT01147471|65940396|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
23604317|NCT01147471|65940397|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
23604318|NCT01147471|65940396|FG000|3 Month Follow Up|Lost to Follow-up|1|||
23604319|NCT01147471|65940397|FG001|3 Month Follow Up|Lost to Follow-up|1|||
23283465|NCT02653664|64781790|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
23283466|NCT02653664|64781788|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
23283467|NCT02653664|64781789|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
23283468|NCT02653664|64781790|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
23283469|NCT01528735|64781793|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
23604320|NCT01147471|65940396|FG000|3 Month Follow Up|Physician Decision|0|||
23604321|NCT01147471|65940397|FG001|3 Month Follow Up|Physician Decision|1|||
23604322|NCT01147471|65940396|FG000|6 Month Follow Up|Lost to Follow-up|4|||
23604323|NCT01147471|65940397|FG001|6 Month Follow Up|Lost to Follow-up|2|||
23604324|NCT01429285|65940398|FG000|Overall Study|Protocol Violation|9|||
23604325|NCT01429285|65940399|FG001|Overall Study|Protocol Violation|4|||
23604326|NCT01429285|65940398|FG000|Overall Study|Missing Data|5|||
23604327|NCT01429285|65940399|FG001|Overall Study|Missing Data|3|||
23604328|NCT01429285|65940398|FG000|Overall Study|Erroneously Enrolled Twice|8|||
23604329|NCT01429285|65940399|FG001|Overall Study|Erroneously Enrolled Twice|2|||
23604330|NCT03909100|65940400|FG000|Overall Study|Protocol Deviation|2|||
23604331|NCT03909100|65940400|FG000|Overall Study|Technical Problems|4|||
23604332|NCT03909100|65940400|FG000|Overall Study|Withdrawal by Subject|4|||
23604333|NCT03909100|65940400|FG000|Overall Study|Lost to Follow-up|1|||
23604334|NCT03909100|65940400|FG000|Overall Study|Reason not Specified|4|||
23604335|NCT03960645|65940401|FG000|Overall Study|Protocol Violation|1|||
23375810|NCT00671060|65119572|FG001|Overall Study|Protocol Violation|0|||
23375811|NCT00671060|65119571|FG000|Overall Study|Physician Decision|0|||
23375812|NCT00671060|65119572|FG001|Overall Study|Physician Decision|1|||
23375813|NCT04113694|65119573|FG000|Overall Study|Adverse Event|2|||
23375814|NCT04113694|65119573|FG000|Overall Study|Lost to Follow-up|2|||
23375815|NCT04113694|65119573|FG000|Overall Study|Withdrawal by Subject|6|||
23375816|NCT04113694|65119573|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
23375817|NCT01525589|65119574|FG000|Overall Study|Non-treatment-related AE|1|||
23375818|NCT01525589|65119575|FG001|Overall Study|Non-treatment-related AE|0|||
23375819|NCT01525589|65119576|FG002|Overall Study|Non-treatment-related AE|0|||
23375820|NCT01525589|65119574|FG000|Overall Study|Progressive disease|48|||
23375821|NCT01525589|65119575|FG001|Overall Study|Progressive disease|15|||
23375822|NCT01525589|65119576|FG002|Overall Study|Progressive disease|29|||
23375823|NCT01525589|65119574|FG000|Overall Study|Never treated|2|||
23375824|NCT01525589|65119575|FG001|Overall Study|Never treated|0|||
23375825|NCT01525589|65119576|FG002|Overall Study|Never treated|0|||
23375826|NCT01525589|65119574|FG000|Overall Study|Physician Decision|4|||
23375827|NCT01525589|65119575|FG001|Overall Study|Physician Decision|2|||
23604336|NCT03960645|65940402|FG001|Overall Study|Protocol Violation|0|||
23375828|NCT01525589|65119576|FG002|Overall Study|Physician Decision|2|||
23375829|NCT01525589|65119574|FG000|Overall Study|Death|0|||
23375830|NCT01525589|65119575|FG001|Overall Study|Death|0|||
23375831|NCT01525589|65119576|FG002|Overall Study|Death|2|||
23604337|NCT00089791|65940403|FG000|Overall Study|Physician Decision|6|||
23604338|NCT00089791|65940404|FG001|Overall Study|Physician Decision|3|||
23604339|NCT00089791|65940403|FG000|Overall Study|Adverse Event|81|||
23375832|NCT01525589|65119574|FG000|Overall Study|Treatment-related AE|1|||
23375833|NCT01525589|65119575|FG001|Overall Study|Treatment-related AE|1|||
23375834|NCT01525589|65119576|FG002|Overall Study|Treatment-related AE|2|||
23375835|NCT01525589|65119574|FG000|Overall Study|Other reasons|0|||
23375836|NCT01525589|65119575|FG001|Overall Study|Other reasons|1|||
23375837|NCT01525589|65119576|FG002|Overall Study|Other reasons|0|||
23375838|NCT01525589|65119574|FG000|Overall Study|Withdrawal by Subject|0|||
23375839|NCT01525589|65119575|FG001|Overall Study|Withdrawal by Subject|1|||
23375840|NCT01525589|65119576|FG002|Overall Study|Withdrawal by Subject|0|||
23375841|NCT00819039|65119577|FG000|Overall Study|Physician Decision|1|||
23375842|NCT00819039|65119578|FG001|Overall Study|Physician Decision|0|||
23375843|NCT00819039|65119579|FG002|Overall Study|Physician Decision|1|||
23375844|NCT00819039|65119577|FG000|Overall Study|Protocol Violation|1|||
23375845|NCT00819039|65119578|FG001|Overall Study|Protocol Violation|0|||
23375846|NCT00819039|65119579|FG002|Overall Study|Protocol Violation|0|||
23375847|NCT01373164|65122942|FG000|Overall Study|Lost to Follow-up|0|||
23375848|NCT01373164|65122943|FG001|Overall Study|Lost to Follow-up|0|||
23375849|NCT01373164|65122944|FG002|Overall Study|Lost to Follow-up|1|||
23375850|NCT01373164|65122945|FG003|Overall Study|Lost to Follow-up|2|||
23283470|NCT01528735|64781794|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
23283471|NCT01528735|64781793|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
23375851|NCT01373164|65122946|FG004|Overall Study|Lost to Follow-up|0|||
23375852|NCT01373164|65122942|FG000|Overall Study|Withdrawal by Subject|0|||
23375853|NCT01373164|65122943|FG001|Overall Study|Withdrawal by Subject|1|||
23283472|NCT01528735|64781794|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
23283473|NCT03801707|64781801|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
23283474|NCT01103713|64781806|FG000|Overall Study|Lost to Follow-up|2|||
23283475|NCT01103713|64781806|FG000|Overall Study|Withdrawal by Subject|8|||
23283476|NCT01103713|64781806|FG000|Overall Study|Study terminated by sponsor|2|||
23283477|NCT01103713|64781806|FG000|Overall Study|Other|1|||
23283478|NCT00506831|64781809|FG000|Overall Study|Death|1|||
23283479|NCT00506831|64781809|FG000|Overall Study|Withdrawal by Subject|1|||
23283480|NCT03707587|64781810|FG000|Overall Study|Death|0|||
23283481|NCT03707587|64781811|FG001|Overall Study|Death|1|||
23283482|NCT01205035|64781814|FG000|Overall Study|Withdrawal by Subject|1|||
23283483|NCT01205035|64781815|FG001|Overall Study|Withdrawal by Subject|0|||
23283484|NCT01205035|64781814|FG000|Overall Study|Physician Decision|1|||
23283485|NCT01205035|64781815|FG001|Overall Study|Physician Decision|0|||
23283486|NCT04411680|64781817|FG000|Treatment Period|Adverse Event|3|||
23283487|NCT04411680|64781818|FG001|Treatment Period|Adverse Event|0|||
23283488|NCT04411680|64781817|FG000|Treatment Period|Discharged from hospital|18|||
23283489|NCT04411680|64781818|FG001|Treatment Period|Discharged from hospital|7|||
23283490|NCT04411680|64781817|FG000|Treatment Period|Missed 1 or more doses|8|||
23283491|NCT04411680|64781818|FG001|Treatment Period|Missed 1 or more doses|0|||
23283492|NCT04411680|64781817|FG000|Treatment Period|Transferred to another hospital|0|||
23283493|NCT04411680|64781818|FG001|Treatment Period|Transferred to another hospital|1|||
23283494|NCT04411680|64781817|FG000|Follow up Period|Withdrawal by Subject|2|||
23283495|NCT04411680|64781818|FG001|Follow up Period|Withdrawal by Subject|0|||
23283496|NCT04411680|64781817|FG000|Follow up Period|Lost to Follow-up|5|||
23283497|NCT04411680|64781818|FG001|Follow up Period|Lost to Follow-up|6|||
23283498|NCT04411680|64781817|FG000|Follow up Period|Death|11|||
23283499|NCT04411680|64781818|FG001|Follow up Period|Death|8|||
23283500|NCT03676634|64781819|FG000|Overall Study|Red blood cell loss|1|||
23375854|NCT01373164|65122944|FG002|Overall Study|Withdrawal by Subject|0|||
23283501|NCT03676634|64781819|FG000|Overall Study|Out-of-limit pulse|2|||
23283502|NCT01378962|64781820|FG000|Overall Study|Death|14|||
23283503|NCT01378962|64781820|FG000|Overall Study|Lost to Follow-up|1|||
23283504|NCT01378962|64781820|FG000|Overall Study|Other|2|||
23375855|NCT01373164|65122945|FG003|Overall Study|Withdrawal by Subject|10|||
23375856|NCT01373164|65122946|FG004|Overall Study|Withdrawal by Subject|2|||
23375857|NCT02349412|65122947|FG000|Overall Study|Withdrawal by Subject|7|||
23375858|NCT02349412|65122948|FG001|Overall Study|Withdrawal by Subject|7|||
23375859|NCT02207608|65122949|FG000|Overall Study|Adverse Event|1|||
23375860|NCT02207608|65122950|FG001|Overall Study|Adverse Event|0|||
23283505|NCT03415308|64781821|FG000|Overall Study|Lost to Follow-up|0|||
23283506|NCT03415308|64781822|FG001|Overall Study|Lost to Follow-up|0|||
23283507|NCT03415308|64781823|FG002|Overall Study|Lost to Follow-up|1|||
23283508|NCT03415308|64781821|FG000|Overall Study|Scheduling Conflicts|0|||
23283509|NCT03415308|64781822|FG001|Overall Study|Scheduling Conflicts|0|||
23283510|NCT03415308|64781823|FG002|Overall Study|Scheduling Conflicts|7|||
23283511|NCT00533507|64781824|FG000|Overall Study|Withdrawal by Subject|1|||
23283512|NCT00730691|64781825|FG000|Overall Study|Adverse Event|4|||
23283513|NCT00730691|64781826|FG001|Overall Study|Adverse Event|8|||
23283514|NCT00730691|64781827|FG002|Overall Study|Adverse Event|11|||
23283515|NCT00730691|64781828|FG003|Overall Study|Adverse Event|11|||
23283516|NCT00730691|64781829|FG004|Overall Study|Adverse Event|23|||
23283517|NCT00730691|64781825|FG000|Overall Study|Lack of Efficacy|4|||
23283518|NCT00730691|64781826|FG001|Overall Study|Lack of Efficacy|4|||
23283519|NCT00730691|64781827|FG002|Overall Study|Lack of Efficacy|2|||
23283520|NCT00730691|64781828|FG003|Overall Study|Lack of Efficacy|1|||
23283521|NCT00730691|64781829|FG004|Overall Study|Lack of Efficacy|1|||
23283522|NCT00730691|64781825|FG000|Overall Study|Non-compliance with Study Drug|6|||
23283523|NCT00730691|64781826|FG001|Overall Study|Non-compliance with Study Drug|1|||
23283524|NCT00730691|64781827|FG002|Overall Study|Non-compliance with Study Drug|6|||
23283525|NCT00730691|64781828|FG003|Overall Study|Non-compliance with Study Drug|3|||
23283526|NCT00730691|64781829|FG004|Overall Study|Non-compliance with Study Drug|3|||
23283527|NCT00730691|64781825|FG000|Overall Study|Protocol Deviations|3|||
23283528|NCT00730691|64781826|FG001|Overall Study|Protocol Deviations|5|||
23283529|NCT00730691|64781827|FG002|Overall Study|Protocol Deviations|3|||
23283530|NCT00730691|64781828|FG003|Overall Study|Protocol Deviations|7|||
23283531|NCT00730691|64781829|FG004|Overall Study|Protocol Deviations|5|||
23283532|NCT00730691|64781825|FG000|Overall Study|Withdrawal of Consent|7|||
23283533|NCT00730691|64781826|FG001|Overall Study|Withdrawal of Consent|9|||
23283534|NCT00730691|64781827|FG002|Overall Study|Withdrawal of Consent|3|||
23283535|NCT00730691|64781828|FG003|Overall Study|Withdrawal of Consent|6|||
23283536|NCT00730691|64781829|FG004|Overall Study|Withdrawal of Consent|3|||
23283537|NCT00730691|64781825|FG000|Overall Study|Lost to Follow-up|11|||
23283538|NCT00730691|64781826|FG001|Overall Study|Lost to Follow-up|8|||
23283539|NCT00730691|64781827|FG002|Overall Study|Lost to Follow-up|13|||
23283540|NCT00730691|64781828|FG003|Overall Study|Lost to Follow-up|15|||
23283541|NCT00730691|64781829|FG004|Overall Study|Lost to Follow-up|13|||
23283542|NCT00730691|64781825|FG000|Overall Study|Other|1|||
23283543|NCT00730691|64781826|FG001|Overall Study|Other|1|||
23283544|NCT00730691|64781827|FG002|Overall Study|Other|1|||
23283545|NCT00730691|64781828|FG003|Overall Study|Other|2|||
23604340|NCT00089791|65940404|FG001|Overall Study|Adverse Event|93|||
23604341|NCT00089791|65940403|FG000|Overall Study|Withdrawal by Subject|403|||
23604342|NCT00089791|65940404|FG001|Overall Study|Withdrawal by Subject|344|||
23604343|NCT00089791|65940403|FG000|Overall Study|Death|78|||
23604344|NCT00089791|65940404|FG001|Overall Study|Death|62|||
23283546|NCT00730691|64781829|FG004|Overall Study|Other|2|||
23283547|NCT01993186|64781830|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
23283548|NCT01993186|64781831|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
23283549|NCT01993186|64781830|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
23283550|NCT01993186|64781831|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
23283551|NCT01993186|64781830|FG000|Open-Label Extension Period|Other, Not Specified|0|||
23283552|NCT01993186|64781831|FG001|Open-Label Extension Period|Other, Not Specified|1|||
23283553|NCT01993186|64781830|FG000|Open-Label Extension Period|Adverse Event|1|||
23283554|NCT01993186|64781831|FG001|Open-Label Extension Period|Adverse Event|0|||
23283555|NCT01993186|64781830|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
23283556|NCT01993186|64781831|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
23283557|NCT01993186|64781830|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
23283558|NCT01993186|64781831|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
23283559|NCT01993186|64781830|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
23283560|NCT01993186|64781831|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
23283561|NCT03167606|64781833|FG000|Overall Study|Lost to Follow-up|73|||
23283562|NCT03167606|64781834|FG001|Overall Study|Lost to Follow-up|64|||
23283563|NCT03167606|64781833|FG000|Overall Study|Withdrawal by Subject|6|||
23375861|NCT00089648|65122953|FG000|Overall Study|Adverse Event|7|||
23375862|NCT00089648|65122953|FG000|Overall Study|Withdrawal by Subject|1|||
23375863|NCT00089648|65122953|FG000|Overall Study|Lack of Efficacy|33|||
23375864|NCT01697579|65122954|FG000|Base Study-Cycle 1|Adverse Event|1|||
23375865|NCT01697579|65122955|FG001|Base Study-Cycle 1|Adverse Event|0|||
23375866|NCT01697579|65122956|FG002|Base Study-Cycle 1|Adverse Event|0|||
23375867|NCT01697579|65122957|FG003|Base Study-Cycle 1|Adverse Event|0|||
23375868|NCT01697579|65122958|FG004|Base Study-Cycle 1|Adverse Event|0|||
23375869|NCT01697579|65122959|FG005|Base Study-Cycle 1|Adverse Event|0|||
23375870|NCT01697579|65122960|FG006|Base Study-Cycle 1|Adverse Event|0|||
23375871|NCT01697579|65122954|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
23375872|NCT01697579|65122955|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375873|NCT01697579|65122956|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375874|NCT01697579|65122957|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375875|NCT01697579|65122958|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375876|NCT01697579|65122959|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375877|NCT01697579|65122960|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
23375878|NCT01697579|65122954|FG000|Base Study-Cycle 1|Protocol Violation|0|||
23375879|NCT01697579|65122955|FG001|Base Study-Cycle 1|Protocol Violation|0|||
23375880|NCT01697579|65122956|FG002|Base Study-Cycle 1|Protocol Violation|0|||
23375881|NCT01697579|65122957|FG003|Base Study-Cycle 1|Protocol Violation|0|||
23375882|NCT01697579|65122958|FG004|Base Study-Cycle 1|Protocol Violation|3|||
23375883|NCT01697579|65122959|FG005|Base Study-Cycle 1|Protocol Violation|0|||
23375884|NCT01697579|65122960|FG006|Base Study-Cycle 1|Protocol Violation|0|||
23375885|NCT01697579|65122954|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375886|NCT01697579|65122955|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
23375887|NCT01697579|65122956|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375888|NCT01697579|65122957|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375889|NCT01697579|65122958|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375890|NCT01697579|65122959|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375891|NCT01697579|65122960|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
23375892|NCT01697579|65122954|FG000|Base Study-Cycle 1|Technical Problems|0|||
23375893|NCT01697579|65122955|FG001|Base Study-Cycle 1|Technical Problems|0|||
23375894|NCT01697579|65122956|FG002|Base Study-Cycle 1|Technical Problems|1|||
23375895|NCT01697579|65122957|FG003|Base Study-Cycle 1|Technical Problems|1|||
23375896|NCT01697579|65122958|FG004|Base Study-Cycle 1|Technical Problems|0|||
23375897|NCT01697579|65122959|FG005|Base Study-Cycle 1|Technical Problems|0|||
23375898|NCT01697579|65122960|FG006|Base Study-Cycle 1|Technical Problems|0|||
23375899|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Death|0|||
23375900|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Death|0|||
23375901|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Death|0|||
23375902|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Death|0|||
23375903|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Death|0|||
23375904|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Death|0|||
23375905|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Death|2|||
23375906|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375907|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375908|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375909|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375910|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23375911|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
23375912|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
23604345|NCT00089791|65940403|FG000|Overall Study|Disease progression|7|||
23604346|NCT00089791|65940404|FG001|Overall Study|Disease progression|3|||
23604347|NCT00089791|65940403|FG000|Overall Study|Ineligibility determined|12|||
23604348|NCT00089791|65940404|FG001|Overall Study|Ineligibility determined|9|||
23604349|NCT00089791|65940403|FG000|Overall Study|Lost to Follow-up|57|||
23604350|NCT00089791|65940404|FG001|Overall Study|Lost to Follow-up|57|||
23604351|NCT00089791|65940403|FG000|Overall Study|Noncompliance|17|||
23604352|NCT00089791|65940404|FG001|Overall Study|Noncompliance|13|||
23604353|NCT00089791|65940403|FG000|Overall Study|Other|20|||
23604354|NCT00089791|65940404|FG001|Overall Study|Other|32|||
23604355|NCT00089791|65940403|FG000|Overall Study|Protocol deviation|12|||
23604356|NCT00089791|65940404|FG001|Overall Study|Protocol deviation|10|||
23375913|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
23604357|NCT00089791|65940403|FG000|Overall Study|Requirement for alternative therapy|7|||
23604358|NCT00089791|65940404|FG001|Overall Study|Requirement for alternative therapy|4|||
23604359|NCT00739934|65940405|FG000|Voriconazole IV|Adverse Event|6|||
23375914|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
23375915|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
23375916|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
23375917|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
23488951|NCT02484690|65534010|FG001|Overall Study|Lost to Follow-up|0|||
23375918|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
23375919|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
23488952|NCT02484690|65534011|FG002|Overall Study|Lost to Follow-up|1|||
23604360|NCT00739934|65940405|FG000|Voriconazole Oral|Other|3|||
23604361|NCT00513071|65940406|FG000|Overall Study|Adverse Event|1|||
23604362|NCT00513071|65940406|FG000|Overall Study|Withdrawal by Subject|1|||
23604363|NCT00513071|65940406|FG000|Overall Study|Physician Decision|3|||
23604364|NCT00786188|65940407|FG000|Overall Study|Adverse Event|3|||
23604365|NCT00786188|65940408|FG001|Overall Study|Adverse Event|1|||
23604366|NCT00786188|65940407|FG000|Overall Study|Withdrawal by Subject|2|||
23604367|NCT00786188|65940408|FG001|Overall Study|Withdrawal by Subject|0|||
23604368|NCT02165202|65940409|FG000|Oral Phase|Refused further participation|5|||
23604369|NCT02165202|65940410|FG001|Oral Phase|Refused further participation|1|||
23604370|NCT02165202|65940409|FG000|Oral Phase|Study product Related Toxicity|1|||
23604371|NCT02165202|65940410|FG001|Oral Phase|Study product Related Toxicity|0|||
23604372|NCT02165202|65940409|FG000|Oral Phase|Unable to contact Participant|1|||
23604373|NCT02165202|65940410|FG001|Oral Phase|Unable to contact Participant|1|||
23604374|NCT02165202|65940409|FG000|Oral Phase|Clinical reasons|1|||
23604375|NCT02165202|65940410|FG001|Oral Phase|Clinical reasons|0|||
23604376|NCT02165202|65940409|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
23604377|NCT02165202|65940410|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
23604378|NCT02165202|65940409|FG000|Oral Phase|CMC advised termination|1|||
23604379|NCT02165202|65940410|FG001|Oral Phase|CMC advised termination|0|||
23604380|NCT02165202|65940409|FG000|Oral Phase|Relocated, no follow-up planned|1|||
23604381|NCT02165202|65940410|FG001|Oral Phase|Relocated, no follow-up planned|0|||
23604382|NCT02165202|65940409|FG000|Oral Phase|Abnormal EKG|0|||
23604383|NCT02165202|65940410|FG001|Oral Phase|Abnormal EKG|1|||
23604384|NCT02165202|65940409|FG000|Injection Phase|Abnormal Lab Value|5|||
23604385|NCT02165202|65940410|FG001|Injection Phase|Abnormal Lab Value|1|||
23604386|NCT02165202|65940409|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
23604387|NCT02165202|65940410|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
23604388|NCT02165202|65940409|FG000|Injection Phase|Unable to attend within Visit Window|1|||
23604389|NCT02165202|65940410|FG001|Injection Phase|Unable to attend within Visit Window|0|||
23375920|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375921|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375922|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375923|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375924|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375925|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
23375926|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
23375927|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375928|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375929|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375930|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375931|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
23375932|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
23375933|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
23375934|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375935|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375936|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375937|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375938|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375939|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
23375940|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
23375941|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375942|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375943|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375944|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375945|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
23375946|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
23375947|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
23375948|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375949|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375950|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375951|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375952|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
23375953|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
23375954|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
23375955|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375956|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375957|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375958|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375959|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23488953|NCT02484690|65534012|FG003|Overall Study|Lost to Follow-up|0|||
23488954|NCT02484690|65534013|FG004|Overall Study|Lost to Follow-up|0|||
23488955|NCT02239224|65534016|FG000|Overall Study|Administrative|0|||
23488956|NCT02239224|65534017|FG001|Overall Study|Administrative|0|||
23488957|NCT02239224|65534018|FG002|Overall Study|Administrative|3|||
23488958|NCT02239224|65534019|FG003|Overall Study|Administrative|1|||
23488959|NCT00191646|65534022|FG000|Overall Study|Toxicity|26|||
23488960|NCT00191646|65534023|FG001|Overall Study|Toxicity|37|||
23488961|NCT00191646|65534022|FG000|Overall Study|Disease Progression|5|||
23488962|NCT00191646|65534023|FG001|Overall Study|Disease Progression|6|||
23488963|NCT00191646|65534022|FG000|Overall Study|Physician Decision|20|||
23488964|NCT00191646|65534023|FG001|Overall Study|Physician Decision|11|||
23488965|NCT00191646|65534022|FG000|Overall Study|Withdrawal by Subject|58|||
23488966|NCT00191646|65534023|FG001|Overall Study|Withdrawal by Subject|39|||
23488967|NCT00191646|65534022|FG000|Overall Study|Protocol Violation|5|||
23488968|NCT00191646|65534023|FG001|Overall Study|Protocol Violation|7|||
23488969|NCT00191646|65534022|FG000|Overall Study|Death|6|||
23488970|NCT00191646|65534023|FG001|Overall Study|Death|8|||
23488971|NCT00191646|65534022|FG000|Overall Study|Other|33|||
23488972|NCT00191646|65534023|FG001|Overall Study|Other|34|||
23488973|NCT00191646|65534022|FG000|Overall Study|Missing Data|18|||
23375960|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
23375961|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
23375962|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
23488974|NCT00191646|65534023|FG001|Overall Study|Missing Data|11|||
23488975|NCT04043728|65534027|FG000|Overall Study|Lost to Follow-up|1|||
23488976|NCT04043728|65534028|FG001|Overall Study|Lost to Follow-up|2|||
23488977|NCT04043728|65534029|FG002|Overall Study|Lost to Follow-up|0|||
23488978|NCT01702571|65534035|FG000|Overall Study|Death|1067|||
23375963|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375964|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375965|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375966|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375967|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
23375968|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
23375969|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375970|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375971|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375972|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375973|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375974|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
23375975|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
23375976|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375977|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375978|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375979|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375980|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
23375981|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
23375982|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
23375983|NCT01697579|65122954|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375984|NCT01697579|65122955|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375985|NCT01697579|65122956|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375986|NCT01697579|65122957|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375987|NCT01697579|65122958|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375988|NCT01697579|65122959|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
23375989|NCT01697579|65122960|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
23375990|NCT03636256|65122963|FG000|Overall Study|Lost to Follow-up|3|||
23375991|NCT03636256|65122964|FG001|Overall Study|Lost to Follow-up|0|||
23375992|NCT03636256|65122965|FG002|Overall Study|Lost to Follow-up|2|||
23375993|NCT03636256|65122966|FG003|Overall Study|Lost to Follow-up|1|||
23375994|NCT03636256|65122967|FG004|Overall Study|Lost to Follow-up|0|||
23375995|NCT03636256|65122968|FG005|Overall Study|Lost to Follow-up|4|||
23375996|NCT03636256|65122969|FG006|Overall Study|Lost to Follow-up|2|||
23375997|NCT03636256|65122970|FG007|Overall Study|Lost to Follow-up|0|||
23375998|NCT03636256|65122971|FG008|Overall Study|Lost to Follow-up|4|||
23375999|NCT03636256|65122963|FG000|Overall Study|Withdrawal by Subject|0|||
23376000|NCT03636256|65122964|FG001|Overall Study|Withdrawal by Subject|0|||
23376001|NCT03636256|65122965|FG002|Overall Study|Withdrawal by Subject|0|||
23376002|NCT03636256|65122966|FG003|Overall Study|Withdrawal by Subject|0|||
23376003|NCT03636256|65122967|FG004|Overall Study|Withdrawal by Subject|0|||
23376004|NCT03636256|65122968|FG005|Overall Study|Withdrawal by Subject|0|||
23376005|NCT03636256|65122969|FG006|Overall Study|Withdrawal by Subject|0|||
23376006|NCT03636256|65122970|FG007|Overall Study|Withdrawal by Subject|0|||
23376007|NCT03636256|65122971|FG008|Overall Study|Withdrawal by Subject|1|||
23376008|NCT01163617|65122972|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376009|NCT01163617|65122973|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
23376010|NCT01163617|65122974|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376011|NCT01163617|65122975|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376012|NCT01163617|65122976|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376013|NCT01163617|65122977|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376014|NCT01163617|65122978|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376015|NCT01163617|65122979|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
23376016|NCT01163617|65122972|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376017|NCT01163617|65122973|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
23376018|NCT01163617|65122974|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376019|NCT01163617|65122975|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376020|NCT01163617|65122976|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376021|NCT01163617|65122977|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376022|NCT01163617|65122978|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376023|NCT01163617|65122979|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
23376024|NCT01163617|65122972|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376025|NCT01163617|65122973|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376026|NCT01163617|65122974|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
23376027|NCT01163617|65122975|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376028|NCT01163617|65122976|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23604390|NCT02165202|65940409|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
23604391|NCT02165202|65940410|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
23604392|NCT02165202|65940409|FG000|Injection Phase|End of Study|2|||
23604393|NCT02165202|65940410|FG001|Injection Phase|End of Study|1|||
23604394|NCT02165202|65940409|FG000|Injection Phase|Study Product related Toxicity|1|||
23604395|NCT02165202|65940410|FG001|Injection Phase|Study Product related Toxicity|0|||
23604396|NCT02165202|65940409|FG000|Injection Phase|No longer interested|0|||
23604397|NCT02165202|65940410|FG001|Injection Phase|No longer interested|1|||
23604398|NCT02165202|65940409|FG000|Injection Phase|Participant unwilling to comply|1|||
23604399|NCT02165202|65940410|FG001|Injection Phase|Participant unwilling to comply|0|||
23604400|NCT03601715|65940411|FG000|Second Intervention|Lost to Follow-up|1|||
23604401|NCT03601715|65940412|FG001|Second Intervention|Lost to Follow-up|1|||
23604402|NCT03601715|65940413|FG002|Second Intervention|Lost to Follow-up|0|||
23604403|NCT02022670|65940414|FG000|Overall Study|Adverse Event|1|||
23604404|NCT02022670|65940415|FG001|Overall Study|Adverse Event|0|||
23604405|NCT02022670|65940416|FG002|Overall Study|Adverse Event|1|||
23604406|NCT04895085|65940417|FG000|Overall Study|Death|1|||
23604407|NCT04895085|65940417|FG000|Overall Study|Withdrawal by Subject|1|||
23604408|NCT04895085|65940417|FG000|Overall Study|No longer eligible: Moved from area|1|||
23604409|NCT00622700|65940418|FG000|Core Treatment Period|Randomized but Not Treated|0|||
23604410|NCT00622700|65940419|FG001|Core Treatment Period|Randomized but Not Treated|2|||
23604411|NCT00622700|65940420|FG002|Core Treatment Period|Randomized but Not Treated|2|||
23604412|NCT00622700|65940421|FG003|Core Treatment Period|Randomized but Not Treated|0|||
23604413|NCT00622700|65940422|FG004|Core Treatment Period|Randomized but Not Treated|0|||
23604414|NCT00622700|65940423|FG005|Core Treatment Period|Randomized but Not Treated|0|||
23604415|NCT00622700|65940424|FG006|Core Treatment Period|Randomized but Not Treated|0|||
23604416|NCT00622700|65940418|FG000|Core Treatment Period|Adverse Event|18|||
23604417|NCT00622700|65940419|FG001|Core Treatment Period|Adverse Event|25|||
23604418|NCT00622700|65940420|FG002|Core Treatment Period|Adverse Event|18|||
23604419|NCT00622700|65940421|FG003|Core Treatment Period|Adverse Event|0|||
23604420|NCT00622700|65940422|FG004|Core Treatment Period|Adverse Event|0|||
23604421|NCT00622700|65940423|FG005|Core Treatment Period|Adverse Event|0|||
23604422|NCT00622700|65940424|FG006|Core Treatment Period|Adverse Event|0|||
23604423|NCT00622700|65940418|FG000|Core Treatment Period|Lack of Efficacy|19|||
23604424|NCT00622700|65940419|FG001|Core Treatment Period|Lack of Efficacy|6|||
23604425|NCT00622700|65940420|FG002|Core Treatment Period|Lack of Efficacy|12|||
23604426|NCT00622700|65940421|FG003|Core Treatment Period|Lack of Efficacy|0|||
23604427|NCT00622700|65940422|FG004|Core Treatment Period|Lack of Efficacy|0|||
23604428|NCT00622700|65940423|FG005|Core Treatment Period|Lack of Efficacy|0|||
23604429|NCT00622700|65940424|FG006|Core Treatment Period|Lack of Efficacy|0|||
23604430|NCT00622700|65940418|FG000|Core Treatment Period|Lost to Follow-up|1|||
23604431|NCT00622700|65940419|FG001|Core Treatment Period|Lost to Follow-up|1|||
23604432|NCT00622700|65940420|FG002|Core Treatment Period|Lost to Follow-up|1|||
23604433|NCT00622700|65940421|FG003|Core Treatment Period|Lost to Follow-up|0|||
23604434|NCT00622700|65940422|FG004|Core Treatment Period|Lost to Follow-up|0|||
23604435|NCT00622700|65940423|FG005|Core Treatment Period|Lost to Follow-up|0|||
23604436|NCT00622700|65940424|FG006|Core Treatment Period|Lost to Follow-up|0|||
23604437|NCT00622700|65940418|FG000|Core Treatment Period|Death|1|||
23283564|NCT03167606|64781834|FG001|Overall Study|Withdrawal by Subject|5|||
23283565|NCT03167606|64781833|FG000|Overall Study|Withdrawal by Investigator|0|||
23488979|NCT01702571|65534036|FG001|Overall Study|Death|76|||
23604438|NCT00622700|65940419|FG001|Core Treatment Period|Death|0|||
23604439|NCT00622700|65940420|FG002|Core Treatment Period|Death|0|||
23604440|NCT00622700|65940421|FG003|Core Treatment Period|Death|0|||
23604441|NCT00622700|65940422|FG004|Core Treatment Period|Death|0|||
23283566|NCT03167606|64781834|FG001|Overall Study|Withdrawal by Investigator|2|||
23283567|NCT02473393|64781835|FG000|Overall Study|Adverse Event|0|||
23604442|NCT00622700|65940423|FG005|Core Treatment Period|Death|0|||
23604443|NCT00622700|65940424|FG006|Core Treatment Period|Death|0|||
23604444|NCT00622700|65940418|FG000|Core Treatment Period|Progressive Disease|3|||
23604445|NCT00622700|65940419|FG001|Core Treatment Period|Progressive Disease|1|||
23604446|NCT00622700|65940420|FG002|Core Treatment Period|Progressive Disease|0|||
23604447|NCT00622700|65940421|FG003|Core Treatment Period|Progressive Disease|0|||
23604448|NCT00622700|65940422|FG004|Core Treatment Period|Progressive Disease|0|||
23604449|NCT00622700|65940423|FG005|Core Treatment Period|Progressive Disease|0|||
23604450|NCT00622700|65940424|FG006|Core Treatment Period|Progressive Disease|0|||
23376029|NCT01163617|65122977|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376030|NCT01163617|65122978|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376031|NCT01163617|65122979|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
23376032|NCT00729586|65122980|FG000|Overall Study|Ineligible|0|||
23376033|NCT00729586|65122981|FG001|Overall Study|Ineligible|1|||
23376034|NCT00729586|65122980|FG000|Overall Study|never treated|1|||
23376035|NCT00729586|65122981|FG001|Overall Study|never treated|0|||
23376036|NCT01240694|65122982|FG000|Overall Study|Adverse Event|9|||
23376037|NCT01240694|65122982|FG000|Overall Study|Lack of Efficacy|6|||
23376038|NCT01240694|65122982|FG000|Overall Study|Withdrawal by Subject|6|||
23376039|NCT01240694|65122982|FG000|Overall Study|Protocol Violation|2|||
23376040|NCT01240694|65122982|FG000|Overall Study|Lost to Follow-up|2|||
23376041|NCT01240694|65122982|FG000|Overall Study|Other than specified|3|||
23376042|NCT01240694|65122982|FG000|Overall Study|Withdrawn due to early study termination|107|||
23376043|NCT01155141|65122983|FG000|Overall Study|Withdrawal by Subject|1|||
23376044|NCT01155141|65122983|FG000|Overall Study|Screen Failure|1|||
23376045|NCT01192815|65122986|FG000|Overall Study|Withdrawal by Subject|1|||
23376046|NCT01192815|65122986|FG000|Overall Study|Lack of Efficacy|1|||
23376047|NCT02787304|65122987|FG000|Overall Study|Adverse Event|9|||
23376048|NCT02787304|65122988|FG001|Overall Study|Adverse Event|3|||
23376049|NCT02787304|65122989|FG002|Overall Study|Adverse Event|8|||
23376050|NCT02787304|65122990|FG003|Overall Study|Adverse Event|1|||
23376051|NCT02787304|65122987|FG000|Overall Study|Withdrawal by Subject|1|||
23376052|NCT02787304|65122988|FG001|Overall Study|Withdrawal by Subject|4|||
23376053|NCT02787304|65122989|FG002|Overall Study|Withdrawal by Subject|0|||
23376054|NCT02787304|65122990|FG003|Overall Study|Withdrawal by Subject|0|||
23376055|NCT02787304|65122987|FG000|Overall Study|Lost to Follow-up|1|||
23488980|NCT01702571|65534035|FG000|Overall Study|Lost to Follow-up|144|||
23488981|NCT01702571|65534036|FG001|Overall Study|Lost to Follow-up|10|||
23488982|NCT01702571|65534035|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
23488983|NCT01702571|65534036|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
23488984|NCT01702571|65534035|FG000|Overall Study|Investigator Decision|5|||
23488985|NCT01702571|65534036|FG001|Overall Study|Investigator Decision|0|||
23488986|NCT01702571|65534035|FG000|Overall Study|Not Classifiable|1|||
23488987|NCT01702571|65534036|FG001|Overall Study|Not Classifiable|0|||
23488988|NCT01702571|65534035|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
23488989|NCT01702571|65534036|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
23488990|NCT01702571|65534035|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
23376056|NCT02787304|65122988|FG001|Overall Study|Lost to Follow-up|0|||
23376057|NCT02787304|65122989|FG002|Overall Study|Lost to Follow-up|0|||
23488991|NCT01702571|65534036|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
23488992|NCT01702571|65534035|FG000|Overall Study|Progressive Disease|3|||
23488993|NCT01702571|65534036|FG001|Overall Study|Progressive Disease|0|||
23488994|NCT01702571|65534035|FG000|Overall Study|Protocol Violation|2|||
23488995|NCT01702571|65534036|FG001|Overall Study|Protocol Violation|0|||
23488996|NCT01702571|65534035|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
23488997|NCT01702571|65534036|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
23488998|NCT01702571|65534035|FG000|Overall Study|Termination By Sponsor|4|||
23488999|NCT01702571|65534036|FG001|Overall Study|Termination By Sponsor|0|||
23376058|NCT02787304|65122990|FG003|Overall Study|Lost to Follow-up|1|||
23376059|NCT02787304|65122987|FG000|Overall Study|Noncompliance with study drug|0|||
23376060|NCT02787304|65122988|FG001|Overall Study|Noncompliance with study drug|0|||
23376061|NCT02787304|65122989|FG002|Overall Study|Noncompliance with study drug|1|||
23376062|NCT02787304|65122990|FG003|Overall Study|Noncompliance with study drug|0|||
23376063|NCT02787304|65122987|FG000|Overall Study|Physician Decision|0|||
23376064|NCT02787304|65122988|FG001|Overall Study|Physician Decision|0|||
23376065|NCT02787304|65122989|FG002|Overall Study|Physician Decision|1|||
23376066|NCT02787304|65122990|FG003|Overall Study|Physician Decision|0|||
23376067|NCT02787304|65122987|FG000|Overall Study|Study terminated by sponsor|25|||
23376068|NCT02787304|65122988|FG001|Overall Study|Study terminated by sponsor|31|||
23376069|NCT02787304|65122989|FG002|Overall Study|Study terminated by sponsor|31|||
23376070|NCT02787304|65122990|FG003|Overall Study|Study terminated by sponsor|32|||
23376071|NCT00390013|65122993|FG000|Phase 1|tired|0|||
23376072|NCT00390013|65122994|FG001|Phase 1|tired|0|||
23376073|NCT00390013|65122995|FG002|Phase 1|tired|0|||
23376074|NCT00390013|65122996|FG003|Phase 1|tired|1|||
23376075|NCT00390013|65122993|FG000|Phase 2 First Treatment|tired|1|||
23376076|NCT00390013|65122994|FG001|Phase 2 First Treatment|tired|0|||
23376077|NCT00390013|65122995|FG002|Phase 2 First Treatment|tired|0|||
23376078|NCT00390013|65122996|FG003|Phase 2 First Treatment|tired|0|||
23376079|NCT00390013|65122993|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
23376080|NCT00390013|65122994|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
23489000|NCT01702571|65534035|FG000|Overall Study|Withdrawal by Subject|177|||
23489001|NCT01702571|65534036|FG001|Overall Study|Withdrawal by Subject|29|||
23489002|NCT03666624|65536941|FG000|Overall Study|participant grieving over recent death of parent|1|||
23489003|NCT03666624|65536942|FG001|Overall Study|participant grieving over recent death of parent|0|||
23489004|NCT01199731|65536943|FG000|Overall Study|Adverse Event|0|||
23489005|NCT01199731|65536944|FG001|Overall Study|Adverse Event|1|||
23489006|NCT01199731|65536945|FG002|Overall Study|Adverse Event|0|||
23489007|NCT01199731|65536943|FG000|Overall Study|Study closed/terminated|7|||
23489008|NCT01199731|65536944|FG001|Overall Study|Study closed/terminated|9|||
23489009|NCT01199731|65536945|FG002|Overall Study|Study closed/terminated|7|||
23489010|NCT01199731|65536943|FG000|Overall Study|Lost to Follow-up|0|||
23489011|NCT01199731|65536944|FG001|Overall Study|Lost to Follow-up|0|||
23489012|NCT01199731|65536945|FG002|Overall Study|Lost to Follow-up|2|||
23489013|NCT01199731|65536943|FG000|Overall Study|Physician Decision|0|||
23489014|NCT01199731|65536944|FG001|Overall Study|Physician Decision|1|||
23489015|NCT01199731|65536945|FG002|Overall Study|Physician Decision|1|||
23489016|NCT01199731|65536943|FG000|Overall Study|Withdrawal by Subject|2|||
23489017|NCT01199731|65536944|FG001|Overall Study|Withdrawal by Subject|0|||
23489018|NCT01199731|65536945|FG002|Overall Study|Withdrawal by Subject|0|||
23489019|NCT03971071|65536946|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
23489020|NCT03971071|65536947|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
23489021|NCT03971071|65536948|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
23489022|NCT03971071|65536949|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
23489023|NCT03971071|65536950|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
23489024|NCT03971071|65536946|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
23489025|NCT03971071|65536947|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
23489026|NCT03971071|65536948|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
23489027|NCT03971071|65536949|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23489028|NCT03971071|65536950|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
23489029|NCT03971071|65536946|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
23489030|NCT03971071|65536947|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
23489031|NCT03971071|65536948|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
23489032|NCT03971071|65536949|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
23489033|NCT03971071|65536950|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
23489034|NCT03971071|65536946|FG000|Open-label Treatment Period|Sponsor decision|0|||
23489035|NCT03971071|65536947|FG001|Open-label Treatment Period|Sponsor decision|0|||
23489036|NCT03971071|65536948|FG002|Open-label Treatment Period|Sponsor decision|0|||
23489037|NCT03971071|65536949|FG003|Open-label Treatment Period|Sponsor decision|0|||
23489038|NCT03971071|65536950|FG004|Open-label Treatment Period|Sponsor decision|1|||
23489039|NCT03971071|65536946|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
23489040|NCT03971071|65536947|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23489041|NCT03971071|65536948|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
23489042|NCT03971071|65536949|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
23489043|NCT03971071|65536950|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
23489044|NCT03971071|65536946|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23489045|NCT03971071|65536947|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
23489046|NCT03971071|65536948|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
23489047|NCT03971071|65536949|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
23489048|NCT03971071|65536950|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
23489049|NCT00747812|65536951|FG000|Overall Study|Research Site Staff Relocation|5|||
23489050|NCT00747812|65536952|FG001|Overall Study|Research Site Staff Relocation|3|||
23489051|NCT00750880|65536953|FG000|Overall Study|Adverse Event|76|||
23489052|NCT00750880|65536953|FG000|Overall Study|Death|4|||
23489053|NCT00750880|65536953|FG000|Overall Study|Lack of Efficacy|46|||
23489054|NCT00750880|65536953|FG000|Overall Study|Lost to Follow-up|10|||
23489055|NCT00750880|65536953|FG000|Overall Study|Protocol Violation|15|||
23489056|NCT00750880|65536953|FG000|Overall Study|Withdrawal by Subject|33|||
23489057|NCT00750880|65536953|FG000|Overall Study|Physician Decision|20|||
23489058|NCT00750880|65536953|FG000|Overall Study|Administrative|11|||
23489059|NCT04209348|65536954|FG000|Overall Study|Lost to Follow-up|1|||
23489060|NCT04209348|65536955|FG001|Overall Study|Lost to Follow-up|0|||
23489061|NCT00915356|65536956|FG000|Overall Study|Withdrawal by Subject|1|||
23489062|NCT00915356|65536957|FG001|Overall Study|Withdrawal by Subject|0|||
23489063|NCT00915356|65536958|FG002|Overall Study|Withdrawal by Subject|0|||
23489064|NCT00915356|65536959|FG003|Overall Study|Withdrawal by Subject|0|||
23489065|NCT00915356|65536960|FG004|Overall Study|Withdrawal by Subject|0|||
23489066|NCT04478123|65536961|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
23489067|NCT04478123|65536961|FG000|Overall Study|NE|1|||
23489068|NCT00697073|65536963|FG000|Overall Study|Withdrawal by Subject|2|||
23489069|NCT00697073|65536963|FG000|Overall Study|Pregnancy|1|||
23489070|NCT00697073|65536963|FG000|Overall Study|non compliance and other|6|||
23489071|NCT03181893|65536965|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489072|NCT03181893|65536966|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
23489073|NCT03181893|65536967|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23283568|NCT02473393|64781836|FG001|Overall Study|Adverse Event|0|||
23283569|NCT02473393|64781837|FG002|Overall Study|Adverse Event|1|||
23283570|NCT02473393|64781838|FG003|Overall Study|Adverse Event|0|||
23489074|NCT03181893|65536968|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23283571|NCT02473393|64781835|FG000|Overall Study|Withdrawal by Subject|0|||
23283572|NCT02473393|64781836|FG001|Overall Study|Withdrawal by Subject|0|||
23283573|NCT02473393|64781837|FG002|Overall Study|Withdrawal by Subject|1|||
23283574|NCT02473393|64781838|FG003|Overall Study|Withdrawal by Subject|1|||
23283575|NCT00081653|64781839|FG000|Overall Study|Adverse Event|23|||
23283576|NCT00081653|64781840|FG001|Overall Study|Adverse Event|17|||
23489075|NCT03181893|65536969|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489076|NCT03181893|65536970|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489077|NCT03181893|65536971|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489078|NCT03181893|65536972|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489079|NCT03181893|65536973|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489080|NCT03181893|65536974|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489081|NCT03181893|65536975|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
23489082|NCT03181893|65536965|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
23489083|NCT03181893|65536966|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
23489084|NCT03181893|65536967|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489085|NCT03181893|65536968|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489086|NCT03181893|65536969|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23283577|NCT00081653|64781839|FG000|Overall Study|Lost to Follow-up|2|||
23283578|NCT00081653|64781840|FG001|Overall Study|Lost to Follow-up|4|||
23283579|NCT00081653|64781839|FG000|Overall Study|Refused Treatment|18|||
23489087|NCT03181893|65536970|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489088|NCT03181893|65536971|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489089|NCT03181893|65536972|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489090|NCT03181893|65536973|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489091|NCT03181893|65536974|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489092|NCT03181893|65536975|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
23489093|NCT03181893|65536965|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23604451|NCT00622700|65940418|FG000|Core Treatment Period|Withdrawal by Subject|12|||
23604452|NCT00622700|65940419|FG001|Core Treatment Period|Withdrawal by Subject|18|||
23604453|NCT00622700|65940420|FG002|Core Treatment Period|Withdrawal by Subject|15|||
23604454|NCT00622700|65940421|FG003|Core Treatment Period|Withdrawal by Subject|0|||
23604455|NCT00622700|65940422|FG004|Core Treatment Period|Withdrawal by Subject|0|||
23604456|NCT00622700|65940423|FG005|Core Treatment Period|Withdrawal by Subject|0|||
23604457|NCT00622700|65940424|FG006|Core Treatment Period|Withdrawal by Subject|0|||
23604458|NCT00622700|65940418|FG000|Core Treatment Period|Other than specified above|2|||
23604459|NCT00622700|65940419|FG001|Core Treatment Period|Other than specified above|2|||
23604460|NCT00622700|65940420|FG002|Core Treatment Period|Other than specified above|5|||
23604461|NCT00622700|65940421|FG003|Core Treatment Period|Other than specified above|0|||
23604462|NCT00622700|65940422|FG004|Core Treatment Period|Other than specified above|0|||
23604463|NCT00622700|65940423|FG005|Core Treatment Period|Other than specified above|0|||
23604464|NCT00622700|65940424|FG006|Core Treatment Period|Other than specified above|0|||
23604465|NCT00622700|65940418|FG000|Extension Treatment Period|Adverse Event|0|||
23604466|NCT00622700|65940419|FG001|Extension Treatment Period|Adverse Event|0|||
23604467|NCT00622700|65940420|FG002|Extension Treatment Period|Adverse Event|0|||
23604468|NCT00622700|65940421|FG003|Extension Treatment Period|Adverse Event|5|||
23604469|NCT00622700|65940422|FG004|Extension Treatment Period|Adverse Event|9|||
23604470|NCT00622700|65940423|FG005|Extension Treatment Period|Adverse Event|6|||
23604471|NCT00622700|65940424|FG006|Extension Treatment Period|Adverse Event|8|||
23604472|NCT00622700|65940418|FG000|Extension Treatment Period|Lack of Efficacy|0|||
23604473|NCT00622700|65940419|FG001|Extension Treatment Period|Lack of Efficacy|0|||
23604474|NCT00622700|65940420|FG002|Extension Treatment Period|Lack of Efficacy|0|||
23604475|NCT00622700|65940421|FG003|Extension Treatment Period|Lack of Efficacy|2|||
23604476|NCT00622700|65940422|FG004|Extension Treatment Period|Lack of Efficacy|8|||
23604477|NCT00622700|65940423|FG005|Extension Treatment Period|Lack of Efficacy|1|||
23604478|NCT00622700|65940424|FG006|Extension Treatment Period|Lack of Efficacy|9|||
23604479|NCT00622700|65940418|FG000|Extension Treatment Period|Protocol Violation|0|||
23604480|NCT00622700|65940419|FG001|Extension Treatment Period|Protocol Violation|0|||
23604481|NCT00622700|65940420|FG002|Extension Treatment Period|Protocol Violation|0|||
23604482|NCT00622700|65940421|FG003|Extension Treatment Period|Protocol Violation|0|||
23604483|NCT00622700|65940422|FG004|Extension Treatment Period|Protocol Violation|0|||
23604484|NCT00622700|65940423|FG005|Extension Treatment Period|Protocol Violation|2|||
23489094|NCT03181893|65536966|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489095|NCT03181893|65536967|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489096|NCT03181893|65536968|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23283580|NCT00081653|64781840|FG001|Overall Study|Refused Treatment|14|||
23283581|NCT00081653|64781839|FG000|Overall Study|Low bone mineral density|1|||
23283582|NCT00081653|64781840|FG001|Overall Study|Low bone mineral density|0|||
23604485|NCT00622700|65940424|FG006|Extension Treatment Period|Protocol Violation|0|||
23604486|NCT00622700|65940418|FG000|Extension Treatment Period|Lost to Follow-up|0|||
23489097|NCT03181893|65536969|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489098|NCT03181893|65536970|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489099|NCT03181893|65536971|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489100|NCT03181893|65536972|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
23489101|NCT03181893|65536973|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
23489102|NCT03181893|65536974|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489103|NCT03181893|65536975|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
23489104|NCT03181893|65536965|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489105|NCT03181893|65536966|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489106|NCT03181893|65536967|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489107|NCT03181893|65536968|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489108|NCT03181893|65536969|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489109|NCT03181893|65536970|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489110|NCT03181893|65536971|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489111|NCT03181893|65536972|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489112|NCT03181893|65536973|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489113|NCT03181893|65536974|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
23489114|NCT03181893|65536975|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
23489115|NCT03181893|65536965|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489116|NCT03181893|65536966|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489117|NCT03181893|65536967|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489118|NCT03181893|65536968|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489119|NCT03181893|65536969|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489120|NCT03181893|65536970|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489121|NCT03181893|65536971|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489122|NCT03181893|65536972|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489123|NCT03181893|65536973|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489124|NCT03181893|65536974|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
23489125|NCT03181893|65536975|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
23489126|NCT00674973|65536976|FG000|Overall Study|Insufficient Therapeutic Response|77|||
23489127|NCT00674973|65536977|FG001|Overall Study|Insufficient Therapeutic Response|72|||
23489128|NCT00674973|65536976|FG000|Overall Study|Refused Treatment|1|||
23489129|NCT00674973|65536977|FG001|Overall Study|Refused Treatment|5|||
23489130|NCT00674973|65536976|FG000|Overall Study|Failure to Return|1|||
23489131|NCT00674973|65536977|FG001|Overall Study|Failure to Return|0|||
23489132|NCT00674973|65536976|FG000|Overall Study|Adverse Event|2|||
23489133|NCT00674973|65536977|FG001|Overall Study|Adverse Event|9|||
23489134|NCT00674973|65536976|FG000|Overall Study|Death|19|||
23489135|NCT00674973|65536977|FG001|Overall Study|Death|15|||
23489136|NCT00674973|65536976|FG000|Overall Study|Protocol Violation|0|||
23489137|NCT00674973|65536977|FG001|Overall Study|Protocol Violation|1|||
23489138|NCT02913612|65536978|FG000|Overall Study|Lost to Follow-up|6|||
23489139|NCT02913612|65536979|FG001|Overall Study|Lost to Follow-up|5|||
23489140|NCT02913612|65536980|FG002|Overall Study|Lost to Follow-up|2|||
23489141|NCT02913612|65536981|FG003|Overall Study|Lost to Follow-up|0|||
23489142|NCT02913612|65536978|FG000|Overall Study|Physician Decision|1|||
23489143|NCT02913612|65536979|FG001|Overall Study|Physician Decision|4|||
23489144|NCT02913612|65536980|FG002|Overall Study|Physician Decision|1|||
23489145|NCT02913612|65536981|FG003|Overall Study|Physician Decision|0|||
23489146|NCT02913612|65536978|FG000|Overall Study|Withdrawal by Subject|2|||
23489147|NCT02913612|65536979|FG001|Overall Study|Withdrawal by Subject|4|||
23489148|NCT02913612|65536980|FG002|Overall Study|Withdrawal by Subject|0|||
23489149|NCT02913612|65536981|FG003|Overall Study|Withdrawal by Subject|0|||
23489150|NCT02913612|65536978|FG000|Overall Study|Hemangioma resolved|1|||
23489151|NCT02913612|65536979|FG001|Overall Study|Hemangioma resolved|0|||
23489152|NCT02913612|65536980|FG002|Overall Study|Hemangioma resolved|0|||
23489153|NCT02913612|65536981|FG003|Overall Study|Hemangioma resolved|0|||
23489154|NCT02913612|65536978|FG000|Overall Study|Local IRB decision|1|||
23489155|NCT02913612|65536979|FG001|Overall Study|Local IRB decision|0|||
23489156|NCT02913612|65536980|FG002|Overall Study|Local IRB decision|0|||
23489157|NCT02913612|65536981|FG003|Overall Study|Local IRB decision|0|||
23489158|NCT02913612|65536978|FG000|Overall Study|Study drug non-compliance|1|||
23489159|NCT02913612|65536979|FG001|Overall Study|Study drug non-compliance|1|||
23489160|NCT02913612|65536980|FG002|Overall Study|Study drug non-compliance|0|||
23376081|NCT00390013|65122995|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
23489161|NCT02913612|65536981|FG003|Overall Study|Study drug non-compliance|0|||
23489162|NCT02913612|65536978|FG000|Overall Study|Insurance issues|0|||
23489163|NCT02913612|65536979|FG001|Overall Study|Insurance issues|1|||
23489164|NCT02913612|65536980|FG002|Overall Study|Insurance issues|0|||
23376082|NCT00390013|65122996|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
23489165|NCT02913612|65536981|FG003|Overall Study|Insurance issues|0|||
23489166|NCT02913612|65536978|FG000|Overall Study|Needed to treat second hemangioma|0|||
23489167|NCT02913612|65536979|FG001|Overall Study|Needed to treat second hemangioma|1|||
23489168|NCT02913612|65536980|FG002|Overall Study|Needed to treat second hemangioma|0|||
23489169|NCT02913612|65536981|FG003|Overall Study|Needed to treat second hemangioma|0|||
23489170|NCT02913612|65536978|FG000|Overall Study|Study completion criteria not met|0|||
23489171|NCT02913612|65536979|FG001|Overall Study|Study completion criteria not met|1|||
23489172|NCT02913612|65536980|FG002|Overall Study|Study completion criteria not met|0|||
23489173|NCT02913612|65536981|FG003|Overall Study|Study completion criteria not met|0|||
23489174|NCT02913612|65536978|FG000|Overall Study|Ineligible|0|||
23489175|NCT02913612|65536979|FG001|Overall Study|Ineligible|1|||
23489176|NCT02913612|65536980|FG002|Overall Study|Ineligible|0|||
23489177|NCT02913612|65536981|FG003|Overall Study|Ineligible|0|||
23489178|NCT02600351|65536984|FG000|Overall Study|Lack of Efficacy|3|||
23489179|NCT02600351|65536985|FG001|Overall Study|Lack of Efficacy|0|||
23489180|NCT02600351|65536986|FG002|Overall Study|Lack of Efficacy|5|||
23489181|NCT02600351|65536987|FG003|Overall Study|Lack of Efficacy|2|||
23489182|NCT02600351|65536984|FG000|Overall Study|Lost to Follow-up|1|||
23489183|NCT02600351|65536985|FG001|Overall Study|Lost to Follow-up|0|||
23489184|NCT02600351|65536986|FG002|Overall Study|Lost to Follow-up|0|||
23489185|NCT02600351|65536987|FG003|Overall Study|Lost to Follow-up|0|||
23489186|NCT02600351|65536984|FG000|Overall Study|Randomized but Not Treated|1|||
23489187|NCT02600351|65536985|FG001|Overall Study|Randomized but Not Treated|0|||
23489188|NCT02600351|65536986|FG002|Overall Study|Randomized but Not Treated|1|||
23489189|NCT02600351|65536987|FG003|Overall Study|Randomized but Not Treated|3|||
23489190|NCT03626168|65536988|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23489191|NCT03626168|65536989|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23489192|NCT03626168|65536988|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
23489193|NCT03626168|65536989|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
23489194|NCT03626168|65536988|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
23489195|NCT03626168|65536989|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
23489196|NCT01229371|65536990|FG000|Overall Study|Withdrawal by Subject|0|||
23489197|NCT01229371|65536991|FG001|Overall Study|Withdrawal by Subject|1|||
23489198|NCT01229371|65536992|FG002|Overall Study|Withdrawal by Subject|0|||
23489199|NCT01229371|65536993|FG003|Overall Study|Withdrawal by Subject|0|||
23489200|NCT04889222|65536994|FG000|Overall Study|Did not meet eligibility criteria|8|||
23489201|NCT04889222|65536994|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
23489202|NCT04889222|65536994|FG000|Overall Study|Did not proceed due to time constraints|5|||
23489203|NCT02517866|65536996|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23489204|NCT02517866|65536997|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
23489205|NCT02517866|65536998|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
23489206|NCT02517866|65536996|FG000|Overall Study|Significant Protocol Deviation|4|||
23489207|NCT02517866|65536997|FG001|Overall Study|Significant Protocol Deviation|1|||
23489208|NCT02517866|65536998|FG002|Overall Study|Significant Protocol Deviation|0|||
23489209|NCT02517866|65536996|FG000|Overall Study|Lost to Follow-up|1|||
23489210|NCT02517866|65536997|FG001|Overall Study|Lost to Follow-up|0|||
23489211|NCT02517866|65536998|FG002|Overall Study|Lost to Follow-up|0|||
23489212|NCT02517866|65536996|FG000|Overall Study|Voluntary Withdrawal|2|||
23489213|NCT02517866|65536997|FG001|Overall Study|Voluntary Withdrawal|2|||
23489214|NCT02517866|65536998|FG002|Overall Study|Voluntary Withdrawal|0|||
23489215|NCT02517866|65536996|FG000|Overall Study|Investigator Decision|2|||
23489216|NCT02517866|65536997|FG001|Overall Study|Investigator Decision|1|||
23489217|NCT02517866|65536998|FG002|Overall Study|Investigator Decision|0|||
23489218|NCT02517866|65536996|FG000|Overall Study|Reason not specified|2|||
23489219|NCT02517866|65536997|FG001|Overall Study|Reason not specified|0|||
23489220|NCT02517866|65536998|FG002|Overall Study|Reason not specified|0|||
23489221|NCT03139279|65536999|FG000|Overall Study|Physician Decision|2|||
23489222|NCT03139279|65537000|FG001|Overall Study|Physician Decision|0|||
23489223|NCT03139279|65536999|FG000|Overall Study|Protocol Violation|5|||
23489224|NCT03139279|65537000|FG001|Overall Study|Protocol Violation|4|||
23489225|NCT03139279|65536999|FG000|Overall Study|Withdrawal by Subject|0|||
23489226|NCT03139279|65537000|FG001|Overall Study|Withdrawal by Subject|2|||
23489227|NCT00678080|65537001|FG000|Overall Study|Physician Decision|2|||
23283583|NCT00081653|64781839|FG000|Overall Study|Bone loss|2|||
23283584|NCT00081653|64781840|FG001|Overall Study|Bone loss|0|||
23283585|NCT00081653|64781839|FG000|Overall Study|Participant leaving country|1|||
23489228|NCT00678080|65537002|FG001|Overall Study|Physician Decision|0|||
23489229|NCT00678080|65537001|FG000|Overall Study|Lost to Follow-up|1|||
23489230|NCT00678080|65537002|FG001|Overall Study|Lost to Follow-up|0|||
23489231|NCT00678080|65537001|FG000|Overall Study|Withdrawal by Subject|0|||
23489232|NCT00678080|65537002|FG001|Overall Study|Withdrawal by Subject|1|||
23489233|NCT01886716|65537003|FG000|Week 1|Lost to Follow-up|0|||
23489234|NCT01886716|65537004|FG001|Week 1|Lost to Follow-up|0|||
23283586|NCT00081653|64781840|FG001|Overall Study|Participant leaving country|0|||
23283587|NCT00081653|64781839|FG000|Overall Study|Loss of bone mass|0|||
23283588|NCT00081653|64781840|FG001|Overall Study|Loss of bone mass|2|||
23283589|NCT01215721|64781843|FG000|Overall Study|Adverse Event|2|||
23376083|NCT00769561|65122997|FG000|Overall Study|Withdrawal by Subject|2|||
23376084|NCT00769561|65122998|FG001|Overall Study|Withdrawal by Subject|2|||
23376085|NCT00769561|65122997|FG000|Overall Study|Lost to Follow-up|1|||
23376086|NCT00769561|65122998|FG001|Overall Study|Lost to Follow-up|3|||
23376087|NCT01991314|65122999|FG000|Overall Study|Adverse Event|5|||
23376088|NCT01991314|65123000|FG001|Overall Study|Adverse Event|1|||
23376089|NCT01991314|65122999|FG000|Overall Study|Lost to Follow-up|6|||
23376090|NCT01991314|65123000|FG001|Overall Study|Lost to Follow-up|10|||
23376091|NCT02747927|65123001|FG000|Overall Study|Adverse Event|5|||
23376092|NCT02747927|65123002|FG001|Overall Study|Adverse Event|14|||
23376093|NCT02747927|65123001|FG000|Overall Study|Lost to Follow-up|22|||
23376094|NCT02747927|65123002|FG001|Overall Study|Lost to Follow-up|43|||
23489235|NCT01886716|65537005|FG002|Week 1|Lost to Follow-up|2|||
23489236|NCT01886716|65537006|FG003|Week 1|Lost to Follow-up|2|||
23489237|NCT01886716|65537003|FG000|Week 2|Lost to Follow-up|3|||
23283590|NCT00627016|64781844|FG000|Overall Study|Adverse Event|1|||
23283591|NCT00627016|64781845|FG001|Overall Study|Adverse Event|1|||
23283592|NCT00627016|64781844|FG000|Overall Study|Protocol Violation|0|||
23283593|NCT00627016|64781845|FG001|Overall Study|Protocol Violation|2|||
23283594|NCT00627016|64781844|FG000|Overall Study|Lost to Follow-up|0|||
23283595|NCT00627016|64781845|FG001|Overall Study|Lost to Follow-up|1|||
23283596|NCT00627016|64781844|FG000|Overall Study|Withdrawal by Subject|2|||
23283597|NCT00627016|64781845|FG001|Overall Study|Withdrawal by Subject|1|||
23283598|NCT00627016|64781844|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
23283599|NCT00627016|64781845|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
23283600|NCT00627016|64781844|FG000|Overall Study|Lack of Efficacy|1|||
23283601|NCT00627016|64781845|FG001|Overall Study|Lack of Efficacy|0|||
23283602|NCT00627016|64781844|FG000|Overall Study|Placed on Excluded Drugs|1|||
23283603|NCT00627016|64781845|FG001|Overall Study|Placed on Excluded Drugs|0|||
23283604|NCT00627016|64781844|FG000|Overall Study|Pregnancy|1|||
23283605|NCT00627016|64781845|FG001|Overall Study|Pregnancy|0|||
23283606|NCT01484912|64781846|FG000|Overall Study|Withdrawal by Subject|1|||
23283607|NCT01484912|64781847|FG001|Overall Study|Withdrawal by Subject|0|||
23283608|NCT01484912|64781846|FG000|Overall Study|Physician Decision|0|||
23283609|NCT01484912|64781847|FG001|Overall Study|Physician Decision|1|||
23283610|NCT00295490|64781848|FG000|Overall Study|Protocol Violation|0|||
23283611|NCT00295490|64781849|FG001|Overall Study|Protocol Violation|0|||
23283612|NCT00295490|64781850|FG002|Overall Study|Protocol Violation|3|||
23283613|NCT00295490|64781851|FG003|Overall Study|Protocol Violation|3|||
23283614|NCT00295490|64781848|FG000|Overall Study|Withdrawal by Subject|0|||
23283615|NCT00295490|64781849|FG001|Overall Study|Withdrawal by Subject|2|||
23283616|NCT00295490|64781850|FG002|Overall Study|Withdrawal by Subject|0|||
23283617|NCT00295490|64781851|FG003|Overall Study|Withdrawal by Subject|1|||
23283618|NCT00295490|64781848|FG000|Overall Study|Lost to Follow-up|0|||
23283619|NCT00295490|64781849|FG001|Overall Study|Lost to Follow-up|0|||
23283620|NCT00295490|64781850|FG002|Overall Study|Lost to Follow-up|1|||
23283621|NCT00295490|64781851|FG003|Overall Study|Lost to Follow-up|0|||
23283622|NCT00295490|64781848|FG000|Overall Study|Adverse Event|1|||
23283623|NCT00295490|64781849|FG001|Overall Study|Adverse Event|0|||
23283624|NCT00295490|64781850|FG002|Overall Study|Adverse Event|0|||
23283625|NCT00295490|64781851|FG003|Overall Study|Adverse Event|0|||
23283626|NCT00295490|64781848|FG000|Overall Study|Other|0|||
23283627|NCT00295490|64781849|FG001|Overall Study|Other|2|||
23283628|NCT00295490|64781850|FG002|Overall Study|Other|0|||
23283629|NCT00295490|64781851|FG003|Overall Study|Other|1|||
23283630|NCT01943435|64781852|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
23283631|NCT01943435|64781853|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
23283632|NCT01943435|64781854|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
23283633|NCT01943435|64781852|FG000|Intervention Period|Withdrawal by Subject|3|||
23283634|NCT01943435|64781853|FG001|Intervention Period|Withdrawal by Subject|3|||
23283635|NCT01943435|64781854|FG002|Intervention Period|Withdrawal by Subject|4|||
23283636|NCT01943435|64781852|FG000|2 Month Follow up|Lost to Follow-up|2|||
23283637|NCT01943435|64781853|FG001|2 Month Follow up|Lost to Follow-up|3|||
23283638|NCT01943435|64781854|FG002|2 Month Follow up|Lost to Follow-up|0|||
23283639|NCT01943435|64781852|FG000|6 Month Follow up|Lost to Follow-up|12|||
23283640|NCT01943435|64781853|FG001|6 Month Follow up|Lost to Follow-up|7|||
23376095|NCT02747927|65123001|FG000|Overall Study|Pregnancy|34|||
23283641|NCT01943435|64781854|FG002|6 Month Follow up|Lost to Follow-up|15|||
23283642|NCT00425308|64781855|FG000|Overall Study|Adverse Event|2|||
23283643|NCT00425308|64781856|FG001|Overall Study|Adverse Event|1|||
23283644|NCT00425308|64781855|FG000|Overall Study|Withdrawal by Subject|1|||
23283645|NCT00425308|64781856|FG001|Overall Study|Withdrawal by Subject|0|||
23283646|NCT00425308|64781855|FG000|Overall Study|Death|1|||
23283647|NCT00425308|64781856|FG001|Overall Study|Death|0|||
23283648|NCT00728754|64781857|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
23283649|NCT00728754|64781858|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
23376096|NCT02747927|65123002|FG001|Overall Study|Pregnancy|66|||
23283650|NCT00728754|64781857|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
23489238|NCT01886716|65537004|FG001|Week 2|Lost to Follow-up|2|||
23604487|NCT00622700|65940419|FG001|Extension Treatment Period|Lost to Follow-up|0|||
23604488|NCT00622700|65940420|FG002|Extension Treatment Period|Lost to Follow-up|0|||
23604489|NCT00622700|65940421|FG003|Extension Treatment Period|Lost to Follow-up|0|||
23604490|NCT00622700|65940422|FG004|Extension Treatment Period|Lost to Follow-up|1|||
23604491|NCT00622700|65940423|FG005|Extension Treatment Period|Lost to Follow-up|0|||
23604492|NCT00622700|65940424|FG006|Extension Treatment Period|Lost to Follow-up|0|||
23604493|NCT00622700|65940418|FG000|Extension Treatment Period|Progressive Disease|0|||
23604494|NCT00622700|65940419|FG001|Extension Treatment Period|Progressive Disease|0|||
23604495|NCT00622700|65940420|FG002|Extension Treatment Period|Progressive Disease|0|||
23604496|NCT00622700|65940421|FG003|Extension Treatment Period|Progressive Disease|1|||
23604497|NCT00622700|65940422|FG004|Extension Treatment Period|Progressive Disease|2|||
23604498|NCT00622700|65940423|FG005|Extension Treatment Period|Progressive Disease|0|||
23604499|NCT00622700|65940424|FG006|Extension Treatment Period|Progressive Disease|2|||
23604500|NCT00622700|65940418|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
23604501|NCT00622700|65940419|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
23604502|NCT00622700|65940420|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
23604503|NCT00622700|65940421|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
23283651|NCT00728754|64781858|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
23283652|NCT00728754|64781857|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
23283653|NCT00728754|64781858|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
23283654|NCT00466167|64781860|FG000|Overall Study|Adverse Event|8|||
23283655|NCT00466167|64781861|FG001|Overall Study|Adverse Event|8|||
23283656|NCT00466167|64781862|FG002|Overall Study|Adverse Event|7|||
23283657|NCT00466167|64781860|FG000|Overall Study|Lack of Efficacy|2|||
23283658|NCT00466167|64781861|FG001|Overall Study|Lack of Efficacy|0|||
23283659|NCT00466167|64781862|FG002|Overall Study|Lack of Efficacy|3|||
23376097|NCT02747927|65123001|FG000|Overall Study|Protocol Violation|2|||
23489239|NCT01886716|65537005|FG002|Week 2|Lost to Follow-up|1|||
23489240|NCT01886716|65537006|FG003|Week 2|Lost to Follow-up|3|||
23489241|NCT01886716|65537003|FG000|Week 3|Lost to Follow-up|1|||
23489242|NCT01886716|65537004|FG001|Week 3|Lost to Follow-up|1|||
23489243|NCT01886716|65537005|FG002|Week 3|Lost to Follow-up|0|||
23489244|NCT01886716|65537006|FG003|Week 3|Lost to Follow-up|1|||
23604504|NCT00622700|65940422|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
23283660|NCT00466167|64781860|FG000|Overall Study|Protocol Violation|1|||
23283661|NCT00466167|64781861|FG001|Overall Study|Protocol Violation|1|||
23283662|NCT00466167|64781862|FG002|Overall Study|Protocol Violation|2|||
23283663|NCT00466167|64781860|FG000|Overall Study|Lost to Follow-up|3|||
23283664|NCT00466167|64781861|FG001|Overall Study|Lost to Follow-up|2|||
23283665|NCT00466167|64781862|FG002|Overall Study|Lost to Follow-up|2|||
23489245|NCT03422627|65537007|FG000|Overall Study|Protocol-specified Criteria|1|||
23283666|NCT00466167|64781860|FG000|Overall Study|Withdrawal by Subject|4|||
23283667|NCT00466167|64781861|FG001|Overall Study|Withdrawal by Subject|1|||
23283668|NCT00466167|64781862|FG002|Overall Study|Withdrawal by Subject|6|||
23283669|NCT00466167|64781860|FG000|Overall Study|patient did not meet inclusion criteria|1|||
23489246|NCT03422627|65537008|FG001|Overall Study|Protocol-specified Criteria|1|||
23489247|NCT03422627|65537009|FG002|Overall Study|Protocol-specified Criteria|0|||
23489248|NCT03422627|65537010|FG003|Overall Study|Protocol-specified Criteria|0|||
23283670|NCT00466167|64781861|FG001|Overall Study|patient did not meet inclusion criteria|0|||
23283671|NCT00466167|64781862|FG002|Overall Study|patient did not meet inclusion criteria|1|||
23283672|NCT00466167|64781860|FG000|Overall Study|Not treated|1|||
23283673|NCT00466167|64781861|FG001|Overall Study|Not treated|0|||
23283674|NCT00466167|64781862|FG002|Overall Study|Not treated|0|||
23283675|NCT01490190|64781863|FG000|Overall Study|Withdrawal by Subject|9|||
23283676|NCT01490190|64781863|FG000|Overall Study|Adverse Event|17|||
23283677|NCT01490190|64781863|FG000|Overall Study|Protocol Violation|5|||
23283678|NCT01490190|64781863|FG000|Overall Study|Lost to Follow-up|13|||
23283679|NCT01490190|64781863|FG000|Overall Study|Relocation|1|||
23283680|NCT01490190|64781863|FG000|Overall Study|Inconvenience|1|||
23283681|NCT01490190|64781863|FG000|Overall Study|Ring expulsion|2|||
23283682|NCT03552484|64781867|FG000|Overall Study|Death|6|||
23283683|NCT03552484|64781868|FG001|Overall Study|Death|4|||
23283684|NCT03552484|64781867|FG000|Overall Study|Lost to Follow-up|0|||
23283685|NCT03552484|64781868|FG001|Overall Study|Lost to Follow-up|16|||
23283686|NCT01024855|64781869|FG000|Overall Study|Inclusion/exclusion criteria|1|||
23283687|NCT02358538|64781871|FG000|Through Week 26|Adverse Event|0|||
23283688|NCT02358538|64781872|FG001|Through Week 26|Adverse Event|1|||
23283689|NCT02358538|64781873|FG002|Through Week 26|Adverse Event|1|||
23283690|NCT02358538|64781874|FG003|Through Week 26|Adverse Event|2|||
23283691|NCT02358538|64781871|FG000|Through Week 26|Lack of Efficacy|1|||
23283692|NCT02358538|64781872|FG001|Through Week 26|Lack of Efficacy|1|||
23283693|NCT02358538|64781873|FG002|Through Week 26|Lack of Efficacy|3|||
23283694|NCT02358538|64781874|FG003|Through Week 26|Lack of Efficacy|3|||
23283695|NCT02358538|64781871|FG000|Through Week 26|Withdrawal by Subject|1|||
23283696|NCT02358538|64781872|FG001|Through Week 26|Withdrawal by Subject|0|||
23283697|NCT02358538|64781873|FG002|Through Week 26|Withdrawal by Subject|0|||
23283698|NCT02358538|64781874|FG003|Through Week 26|Withdrawal by Subject|0|||
23283699|NCT02358538|64781871|FG000|Through Week 26|Non-Compliance|0|||
23283700|NCT02358538|64781872|FG001|Through Week 26|Non-Compliance|0|||
23283701|NCT02358538|64781873|FG002|Through Week 26|Non-Compliance|1|||
23283702|NCT02358538|64781874|FG003|Through Week 26|Non-Compliance|0|||
23283703|NCT02358538|64781871|FG000|Through Week 26|Family did not see benefit from IP|1|||
23283704|NCT02358538|64781872|FG001|Through Week 26|Family did not see benefit from IP|0|||
23283705|NCT02358538|64781873|FG002|Through Week 26|Family did not see benefit from IP|0|||
23283706|NCT02358538|64781874|FG003|Through Week 26|Family did not see benefit from IP|0|||
23283707|NCT02358538|64781871|FG000|52 Week Extension Period|Lack of Efficacy|0|||
23283708|NCT02358538|64781872|FG001|52 Week Extension Period|Lack of Efficacy|0|||
23283709|NCT02358538|64781873|FG002|52 Week Extension Period|Lack of Efficacy|2|||
23283710|NCT02358538|64781874|FG003|52 Week Extension Period|Lack of Efficacy|4|||
23283711|NCT01566435|64781875|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
23283712|NCT00848536|64781877|FG000|Overall Study|Adverse Event|2|||
23283713|NCT00848536|64781878|FG001|Overall Study|Adverse Event|2|||
23283714|NCT00848536|64781877|FG000|Overall Study|Withdrawal by Subject|0|||
23283715|NCT00848536|64781878|FG001|Overall Study|Withdrawal by Subject|1|||
23489249|NCT03422627|65537011|FG004|Overall Study|Protocol-specified Criteria|2|||
23489250|NCT03422627|65537007|FG000|Overall Study|Requirement for Alternative Therapy|1|||
23604505|NCT00622700|65940423|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
23604506|NCT00622700|65940424|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
23604507|NCT00622700|65940418|FG000|Extension Treatment Period|Missing|0|||
23604508|NCT00622700|65940419|FG001|Extension Treatment Period|Missing|0|||
23604509|NCT00622700|65940420|FG002|Extension Treatment Period|Missing|0|||
23604510|NCT00622700|65940421|FG003|Extension Treatment Period|Missing|2|||
23604511|NCT00622700|65940422|FG004|Extension Treatment Period|Missing|3|||
23604512|NCT00622700|65940423|FG005|Extension Treatment Period|Missing|1|||
23283716|NCT00848536|64781877|FG000|Overall Study|Protocol Violation|0|||
23489251|NCT03422627|65537008|FG001|Overall Study|Requirement for Alternative Therapy|1|||
23489252|NCT03422627|65537009|FG002|Overall Study|Requirement for Alternative Therapy|2|||
23283717|NCT00848536|64781878|FG001|Overall Study|Protocol Violation|1|||
23283718|NCT00848536|64781877|FG000|Overall Study|Noncompliance|1|||
23283719|NCT00848536|64781878|FG001|Overall Study|Noncompliance|0|||
23283720|NCT00848536|64781877|FG000|Overall Study|Inadequate Control of IOP|1|||
23283721|NCT00848536|64781878|FG001|Overall Study|Inadequate Control of IOP|1|||
23283722|NCT00848536|64781877|FG000|Overall Study|Patient Moved|0|||
23283723|NCT00848536|64781878|FG001|Overall Study|Patient Moved|2|||
23283724|NCT04474405|64781881|FG000|Overall Study|Withdrawal by Subject|0|||
23283725|NCT04474405|64781882|FG001|Overall Study|Withdrawal by Subject|0|||
23604513|NCT00622700|65940424|FG006|Extension Treatment Period|Missing|0|||
23604514|NCT00622700|65940418|FG000|Extension Treatment Period|Other than specified above|0|||
23604515|NCT00622700|65940419|FG001|Extension Treatment Period|Other than specified above|0|||
23604516|NCT00622700|65940420|FG002|Extension Treatment Period|Other than specified above|0|||
23604517|NCT00622700|65940421|FG003|Extension Treatment Period|Other than specified above|0|||
23604518|NCT00622700|65940422|FG004|Extension Treatment Period|Other than specified above|0|||
23283726|NCT04474405|64781883|FG002|Overall Study|Withdrawal by Subject|1|||
23283727|NCT04474405|64781884|FG003|Overall Study|Withdrawal by Subject|0|||
23489253|NCT03422627|65537010|FG003|Overall Study|Requirement for Alternative Therapy|0|||
23489254|NCT03422627|65537011|FG004|Overall Study|Requirement for Alternative Therapy|0|||
23489255|NCT03422627|65537007|FG000|Overall Study|Disease Progression|1|||
23489256|NCT03422627|65537008|FG001|Overall Study|Disease Progression|0|||
23489257|NCT03422627|65537009|FG002|Overall Study|Disease Progression|1|||
23489258|NCT03422627|65537010|FG003|Overall Study|Disease Progression|2|||
23489259|NCT03422627|65537011|FG004|Overall Study|Disease Progression|0|||
23489260|NCT03422627|65537007|FG000|Overall Study|Adverse Event|2|||
23283728|NCT04474405|64781885|FG004|Overall Study|Withdrawal by Subject|1|||
23283729|NCT04474405|64781886|FG005|Overall Study|Withdrawal by Subject|0|||
23283730|NCT04474405|64781881|FG000|Overall Study|Other|0|||
23283731|NCT04474405|64781882|FG001|Overall Study|Other|0|||
23283732|NCT04474405|64781883|FG002|Overall Study|Other|0|||
23283733|NCT04474405|64781884|FG003|Overall Study|Other|0|||
23283734|NCT04474405|64781885|FG004|Overall Study|Other|3|||
23376098|NCT02747927|65123002|FG001|Overall Study|Protocol Violation|4|||
23376099|NCT02747927|65123001|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
23376100|NCT02747927|65123002|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
23376101|NCT02747927|65123001|FG000|Overall Study|Reason not Specified|11|||
23376102|NCT02747927|65123002|FG001|Overall Study|Reason not Specified|27|||
23376103|NCT00639509|65123003|FG000|Overall Study|Death|1|||
23376104|NCT00587457|65123004|FG000|Overall Study|Adverse Event|1|||
23376105|NCT00587457|65123005|FG001|Overall Study|Adverse Event|2|||
23376106|NCT00587457|65123006|FG002|Overall Study|Adverse Event|1|||
23376107|NCT00587457|65123004|FG000|Overall Study|Disease progression|2|||
23376108|NCT00587457|65123005|FG001|Overall Study|Disease progression|0|||
23376109|NCT00587457|65123006|FG002|Overall Study|Disease progression|2|||
23376110|NCT00587457|65123004|FG000|Overall Study|Initiation of alternative therapy|0|||
23376111|NCT00587457|65123005|FG001|Overall Study|Initiation of alternative therapy|1|||
23376112|NCT00587457|65123006|FG002|Overall Study|Initiation of alternative therapy|0|||
23376113|NCT00587457|65123004|FG000|Overall Study|Undefined|0|||
23376114|NCT00587457|65123005|FG001|Overall Study|Undefined|0|||
23376115|NCT00587457|65123006|FG002|Overall Study|Undefined|1|||
23376116|NCT00587457|65123004|FG000|Overall Study|Development of neutralizing Abs|0|||
23376117|NCT00587457|65123005|FG001|Overall Study|Development of neutralizing Abs|0|||
23376118|NCT00587457|65123006|FG002|Overall Study|Development of neutralizing Abs|1|||
23376119|NCT00900562|65123007|FG000|Overall Study|Progressive disease|9|||
23376120|NCT00900562|65123008|FG001|Overall Study|Progressive disease|5|||
23376121|NCT00900562|65123007|FG000|Overall Study|Toxicity|1|||
23376122|NCT00900562|65123008|FG001|Overall Study|Toxicity|0|||
23376123|NCT00900562|65123007|FG000|Overall Study|Death|1|||
23376124|NCT00900562|65123008|FG001|Overall Study|Death|1|||
23376125|NCT00900562|65123007|FG000|Overall Study|Withdrawal by Subject|0|||
23376126|NCT00900562|65123008|FG001|Overall Study|Withdrawal by Subject|1|||
23376127|NCT00900562|65123007|FG000|Overall Study|Unrelated adverse event|1|||
23376128|NCT00900562|65123008|FG001|Overall Study|Unrelated adverse event|0|||
23376129|NCT00851591|65123012|FG000|Overall Study|Withdrawal by Subject|2|||
23376130|NCT00851591|65123013|FG001|Overall Study|Withdrawal by Subject|0|||
23376131|NCT01603602|65123017|FG000|Overall Study|Adverse Event|1|||
23376132|NCT01603602|65123018|FG001|Overall Study|Adverse Event|0|||
23376133|NCT01603602|65123019|FG002|Overall Study|Adverse Event|0|||
23376134|NCT01603602|65123017|FG000|Overall Study|Personal Reasons|1|||
23376135|NCT01603602|65123018|FG001|Overall Study|Personal Reasons|0|||
23376136|NCT01603602|65123019|FG002|Overall Study|Personal Reasons|1|||
23376137|NCT02101294|65123020|FG000|Overall Study|Withdrawal by Subject|5|||
23376138|NCT02101294|65123020|FG000|Overall Study|Lost to Follow-up|6|||
23489261|NCT03422627|65537008|FG001|Overall Study|Adverse Event|1|||
23604519|NCT00622700|65940423|FG005|Extension Treatment Period|Other than specified above|1|||
23604520|NCT00622700|65940424|FG006|Extension Treatment Period|Other than specified above|1|||
23376139|NCT03188822|65123027|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
23376140|NCT03188822|65123027|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
23376141|NCT00961415|65123028|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
23376142|NCT00961415|65123029|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
23489262|NCT03422627|65537009|FG002|Overall Study|Adverse Event|0|||
23489263|NCT03422627|65537010|FG003|Overall Study|Adverse Event|0|||
23283735|NCT04474405|64781886|FG005|Overall Study|Other|0|||
23283736|NCT01149057|64781889|FG000|Overall Study|Lack of Efficacy|16|||
23283737|NCT01149057|64781889|FG000|Overall Study|Adverse Event|13|||
23376143|NCT00961415|65123030|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
23376144|NCT00961415|65123028|FG000|Induction Treatment Phase|Death|77|||
23376145|NCT00961415|65123029|FG001|Induction Treatment Phase|Death|0|||
23376146|NCT00961415|65123030|FG002|Induction Treatment Phase|Death|0|||
23376147|NCT00961415|65123028|FG000|Induction Treatment Phase|Protocol Violation|1|||
23376148|NCT00961415|65123029|FG001|Induction Treatment Phase|Protocol Violation|0|||
23376149|NCT00961415|65123030|FG002|Induction Treatment Phase|Protocol Violation|0|||
23376150|NCT00961415|65123028|FG000|Induction Treatment Phase|Physician Decision|2|||
23376151|NCT00961415|65123029|FG001|Induction Treatment Phase|Physician Decision|0|||
23376152|NCT00961415|65123030|FG002|Induction Treatment Phase|Physician Decision|0|||
23376153|NCT00961415|65123028|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
23376154|NCT00961415|65123029|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
23376155|NCT00961415|65123030|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
23376156|NCT00961415|65123028|FG000|Induction Treatment Phase|Other Reason|5|||
23376157|NCT00961415|65123029|FG001|Induction Treatment Phase|Other Reason|0|||
23376158|NCT00961415|65123030|FG002|Induction Treatment Phase|Other Reason|0|||
23376159|NCT00961415|65123028|FG000|Maintenance Treatment Phase|Death|0|||
23376160|NCT00961415|65123029|FG001|Maintenance Treatment Phase|Death|42|||
23376161|NCT00961415|65123030|FG002|Maintenance Treatment Phase|Death|34|||
23376162|NCT00961415|65123028|FG000|Maintenance Treatment Phase|Investigators decision|0|||
23376163|NCT00961415|65123029|FG001|Maintenance Treatment Phase|Investigators decision|2|||
23376164|NCT00961415|65123030|FG002|Maintenance Treatment Phase|Investigators decision|0|||
23376165|NCT00961415|65123028|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
23376166|NCT00961415|65123029|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
23489264|NCT03422627|65537011|FG004|Overall Study|Adverse Event|2|||
23489265|NCT03422627|65537007|FG000|Overall Study|Ineligibility Determined|0|||
23489266|NCT03422627|65537008|FG001|Overall Study|Ineligibility Determined|1|||
23489267|NCT03422627|65537009|FG002|Overall Study|Ineligibility Determined|0|||
23489268|NCT03422627|65537010|FG003|Overall Study|Ineligibility Determined|0|||
23489269|NCT03422627|65537011|FG004|Overall Study|Ineligibility Determined|0|||
23489270|NCT03422627|65537007|FG000|Overall Study|Death|0|||
23376167|NCT00961415|65123030|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
23376168|NCT00961415|65123028|FG000|Maintenance Treatment Phase|Other reason|0|||
23376169|NCT00961415|65123029|FG001|Maintenance Treatment Phase|Other reason|1|||
23376170|NCT00961415|65123030|FG002|Maintenance Treatment Phase|Other reason|3|||
23376171|NCT00916578|65123031|FG000|Overall Study|Physician Decision|2|||
23604521|NCT01860079|65940425|FG000|Overall Study|Physician Decision|14|||
23604522|NCT01860079|65940426|FG001|Overall Study|Physician Decision|22|||
23604523|NCT01662505|65940429|FG000|Overall Study|Progressive disease|6|||
23604524|NCT01662505|65940430|FG001|Overall Study|Progressive disease|1|||
23604525|NCT01662505|65940431|FG002|Overall Study|Progressive disease|5|||
23604526|NCT01662505|65940429|FG000|Overall Study|Refused cont. medication|0|||
23604527|NCT01662505|65940430|FG001|Overall Study|Refused cont. medication|0|||
23604528|NCT01662505|65940431|FG002|Overall Study|Refused cont. medication|1|||
23604529|NCT01662505|65940429|FG000|Overall Study|Not specified above|1|||
23604530|NCT01662505|65940430|FG001|Overall Study|Not specified above|3|||
23604531|NCT01662505|65940431|FG002|Overall Study|Not specified above|2|||
23604532|NCT03775213|65940435|FG000|Overall Study|Withdrawal by Subject|51|||
23604533|NCT03775213|65940436|FG001|Overall Study|Withdrawal by Subject|53|||
23604534|NCT03775213|65940435|FG000|Overall Study|Incomplete Survey|7|||
23376172|NCT00916578|65123031|FG000|Overall Study|Withdrawal by Subject|3|||
23376173|NCT00916578|65123031|FG000|Overall Study|Insurance Denial|2|||
23376174|NCT01126424|65123032|FG000|Overall Study|Adverse Event|0|||
23489271|NCT03422627|65537008|FG001|Overall Study|Death|1|||
23489272|NCT03422627|65537009|FG002|Overall Study|Death|1|||
23489273|NCT03422627|65537010|FG003|Overall Study|Death|0|||
23604535|NCT03775213|65940436|FG001|Overall Study|Incomplete Survey|7|||
23604536|NCT02157948|65940437|FG000|Overall Study|Withdrawal by Subject|4|||
23604537|NCT02157948|65940438|FG001|Overall Study|Withdrawal by Subject|5|||
23604538|NCT02157948|65940437|FG000|Overall Study|Lost to Follow-up|3|||
23283738|NCT01149057|64781889|FG000|Overall Study|Withdrawal by Subject|9|||
23283739|NCT01149057|64781889|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
23283740|NCT01149057|64781889|FG000|Overall Study|B Cell Depletion|4|||
23283741|NCT01149057|64781889|FG000|Overall Study|Participant Non-Compliance|2|||
23283742|NCT01149057|64781889|FG000|Overall Study|Lost to Follow-up|1|||
23283743|NCT01149057|64781889|FG000|Overall Study|High Parathyroid Hormone Value|1|||
23283744|NCT01149057|64781889|FG000|Overall Study|Other|6|||
23283745|NCT01874535|64781890|FG000|Overall Study|Lost to Follow-up|10|||
23283746|NCT01874535|64781891|FG001|Overall Study|Lost to Follow-up|9|||
23283747|NCT01874535|64781890|FG000|Overall Study|incomplete symptom resolution|45|||
23283748|NCT01874535|64781891|FG001|Overall Study|incomplete symptom resolution|35|||
23283749|NCT01695239|64781892|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
23283750|NCT01695239|64781893|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
23283751|NCT01695239|64781894|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
23283752|NCT01695239|64781895|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
23283753|NCT01695239|64781896|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283754|NCT01695239|64781897|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283755|NCT01695239|64781898|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283756|NCT01695239|64781899|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283757|NCT01695239|64781900|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283758|NCT01695239|64781901|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283759|NCT01695239|64781902|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283760|NCT01695239|64781903|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283761|NCT01695239|64781904|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283762|NCT01695239|64781905|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
23283763|NCT01695239|64781892|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
23283764|NCT01695239|64781893|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
23283765|NCT01695239|64781894|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
23283766|NCT01695239|64781895|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
23283767|NCT01695239|64781896|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283768|NCT01695239|64781897|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283769|NCT01695239|64781898|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283770|NCT01695239|64781899|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283771|NCT01695239|64781900|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283772|NCT01695239|64781901|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283773|NCT01695239|64781902|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283774|NCT01695239|64781903|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283775|NCT01695239|64781904|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283776|NCT01695239|64781905|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
23283777|NCT01695239|64781892|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
23283778|NCT01695239|64781893|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283779|NCT01695239|64781894|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
23604539|NCT02157948|65940438|FG001|Overall Study|Lost to Follow-up|2|||
23283780|NCT01695239|64781895|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283781|NCT01695239|64781896|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283782|NCT01695239|64781897|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283783|NCT01695239|64781898|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283784|NCT01695239|64781899|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23376175|NCT01126424|65123033|FG001|Overall Study|Adverse Event|0|||
23376176|NCT01126424|65123034|FG002|Overall Study|Adverse Event|0|||
23376177|NCT01126424|65123035|FG003|Overall Study|Adverse Event|0|||
23604540|NCT02157948|65940437|FG000|Overall Study|Protocol Specified Criteria|2|||
23604541|NCT02157948|65940438|FG001|Overall Study|Protocol Specified Criteria|1|||
23604542|NCT02157948|65940437|FG000|Overall Study|Decision by Sponsor|0|||
23604543|NCT02157948|65940438|FG001|Overall Study|Decision by Sponsor|1|||
23604544|NCT03345095|65940443|FG000|Overall Study|Lack of Efficacy|184|||
23604545|NCT03345095|65940444|FG001|Overall Study|Lack of Efficacy|156|||
23604546|NCT03345095|65940443|FG000|Overall Study|Adverse Event|36|||
23604547|NCT03345095|65940444|FG001|Overall Study|Adverse Event|118|||
23604548|NCT03345095|65940443|FG000|Overall Study|Withdrawal by Subject|22|||
23604549|NCT03345095|65940444|FG001|Overall Study|Withdrawal by Subject|59|||
23604550|NCT03345095|65940443|FG000|Overall Study|Physician Decision|3|||
23604551|NCT03345095|65940444|FG001|Overall Study|Physician Decision|18|||
23604552|NCT03345095|65940443|FG000|Overall Study|Death|2|||
23604553|NCT03345095|65940444|FG001|Overall Study|Death|4|||
23604554|NCT03345095|65940443|FG000|Overall Study|Other reasons|2|||
23604555|NCT03345095|65940444|FG001|Overall Study|Other reasons|11|||
23604556|NCT03345095|65940443|FG000|Overall Study|Protocol Violation|0|||
23604557|NCT03345095|65940444|FG001|Overall Study|Protocol Violation|1|||
23604558|NCT04652869|65940447|FG000|Overall Study|Withdrawal by Subject|0|||
23604559|NCT04652869|65940448|FG001|Overall Study|Withdrawal by Subject|2|||
23604560|NCT04652869|65940449|FG002|Overall Study|Withdrawal by Subject|0|||
23604561|NCT02644122|65940450|FG000|Overall Study|Withdrawal by Subject|1|||
23604562|NCT00487240|65943441|FG000|Overall Study|Withdrawal by Subject|12|||
23604563|NCT00487240|65943442|FG001|Overall Study|Withdrawal by Subject|6|||
23604564|NCT00487240|65943441|FG000|Overall Study|Lost to Follow-up|7|||
23604565|NCT00487240|65943442|FG001|Overall Study|Lost to Follow-up|6|||
23604566|NCT00487240|65943441|FG000|Overall Study|Adverse Event|0|||
23604567|NCT00487240|65943442|FG001|Overall Study|Adverse Event|4|||
23604568|NCT00487240|65943441|FG000|Overall Study|Protocol Violation|5|||
23604569|NCT00487240|65943442|FG001|Overall Study|Protocol Violation|5|||
23604570|NCT00487240|65943441|FG000|Overall Study|Entry Criteria Not Met|3|||
23604571|NCT00487240|65943442|FG001|Overall Study|Entry Criteria Not Met|4|||
23604572|NCT00487240|65943441|FG000|Overall Study|Sponsor Decision|2|||
23604573|NCT00487240|65943442|FG001|Overall Study|Sponsor Decision|1|||
23283785|NCT01695239|64781900|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23376178|NCT01126424|65123036|FG004|Overall Study|Adverse Event|1|||
23604574|NCT00487240|65943441|FG000|Overall Study|Physician Decision|2|||
23604575|NCT00487240|65943442|FG001|Overall Study|Physician Decision|0|||
23283786|NCT01695239|64781901|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283787|NCT01695239|64781902|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283788|NCT01695239|64781903|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283789|NCT01695239|64781904|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283790|NCT01695239|64781905|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
23283791|NCT01695239|64781892|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
23283792|NCT01695239|64781893|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
23283793|NCT01695239|64781894|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
23283794|NCT01695239|64781895|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283795|NCT01695239|64781896|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283796|NCT01695239|64781897|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283797|NCT01695239|64781898|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283798|NCT01695239|64781899|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283799|NCT01695239|64781900|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283800|NCT01695239|64781901|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283801|NCT01695239|64781902|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23376179|NCT01126424|65123037|FG005|Overall Study|Adverse Event|0|||
23376180|NCT01126424|65123032|FG000|Overall Study|Withdrawal by Subject|0|||
23376181|NCT01126424|65123033|FG001|Overall Study|Withdrawal by Subject|0|||
23376182|NCT01126424|65123034|FG002|Overall Study|Withdrawal by Subject|1|||
23376183|NCT01126424|65123035|FG003|Overall Study|Withdrawal by Subject|3|||
23376184|NCT01126424|65123036|FG004|Overall Study|Withdrawal by Subject|1|||
23376185|NCT01126424|65123037|FG005|Overall Study|Withdrawal by Subject|0|||
23376186|NCT00883181|65123038|FG000|Overall Study|Hematological Adverse Event|26|||
23376187|NCT00883181|65123038|FG000|Overall Study|Non-hematological Adverse Event|55|||
23376188|NCT00883181|65123038|FG000|Overall Study|Disease Progression|94|||
23489274|NCT03422627|65537011|FG004|Overall Study|Death|0|||
23489275|NCT03422627|65537007|FG000|Overall Study|Withdrawal by Subject|0|||
23489276|NCT03422627|65537008|FG001|Overall Study|Withdrawal by Subject|0|||
23489277|NCT03422627|65537009|FG002|Overall Study|Withdrawal by Subject|0|||
23489278|NCT03422627|65537010|FG003|Overall Study|Withdrawal by Subject|1|||
23376189|NCT00883181|65123038|FG000|Overall Study|Administrative Reason|24|||
23376190|NCT00883181|65123038|FG000|Overall Study|Withdrawal by Subject|4|||
23376191|NCT00883181|65123038|FG000|Overall Study|Death|31|||
23376192|NCT00883181|65123038|FG000|Overall Study|Other|38|||
23376193|NCT00883181|65123038|FG000|Overall Study|Protocol Deviation|3|||
23604576|NCT01579318|65943444|FG000|Overall Study|Disease Progression|1|||
23604577|NCT00148122|65943445|FG000|Overall Study|Withdrawal by Subject|2|||
23604578|NCT01686152|65943446|FG000|Overall Study|Withdrawal by Subject|11|||
23604579|NCT01686152|65943447|FG001|Overall Study|Withdrawal by Subject|11|||
23604580|NCT01686152|65943448|FG002|Overall Study|Withdrawal by Subject|3|||
23604581|NCT01686152|65943446|FG000|Overall Study|Drug Code Unblinded|0|||
23604582|NCT01686152|65943447|FG001|Overall Study|Drug Code Unblinded|1|||
23604583|NCT01686152|65943448|FG002|Overall Study|Drug Code Unblinded|0|||
23604584|NCT01686152|65943446|FG000|Overall Study|Protocol Violation|6|||
23604585|NCT01686152|65943447|FG001|Overall Study|Protocol Violation|1|||
23604586|NCT01686152|65943448|FG002|Overall Study|Protocol Violation|0|||
23604587|NCT01686152|65943446|FG000|Overall Study|Adverse Event|12|||
23604588|NCT01686152|65943447|FG001|Overall Study|Adverse Event|11|||
23604589|NCT01686152|65943448|FG002|Overall Study|Adverse Event|0|||
23604590|NCT01686152|65943446|FG000|Overall Study|Lack of Efficacy|0|||
23604591|NCT01686152|65943447|FG001|Overall Study|Lack of Efficacy|0|||
23604592|NCT01686152|65943448|FG002|Overall Study|Lack of Efficacy|1|||
23604593|NCT01686152|65943446|FG000|Overall Study|IP Non-compliance|5|||
23604594|NCT01686152|65943447|FG001|Overall Study|IP Non-compliance|5|||
23604595|NCT01686152|65943448|FG002|Overall Study|IP Non-compliance|0|||
23604596|NCT01686152|65943446|FG000|Overall Study|Lost to Follow-up|7|||
23604597|NCT01686152|65943447|FG001|Overall Study|Lost to Follow-up|6|||
23604598|NCT01686152|65943448|FG002|Overall Study|Lost to Follow-up|5|||
23604599|NCT04183491|65943449|FG000|Overall Study|Withdrawal by Subject|0|||
23604600|NCT04183491|65943450|FG001|Overall Study|Withdrawal by Subject|0|||
23604601|NCT04183491|65943451|FG002|Overall Study|Withdrawal by Subject|1|||
23376194|NCT00883181|65123038|FG000|Overall Study|Noncompliance|3|||
23489279|NCT03422627|65537011|FG004|Overall Study|Withdrawal by Subject|0|||
23489280|NCT02808650|65537012|FG000|Overall Study|Death|0|||
23604602|NCT04183491|65943452|FG003|Overall Study|Withdrawal by Subject|0|||
23604603|NCT04183491|65943453|FG004|Overall Study|Withdrawal by Subject|0|||
23604604|NCT04183491|65943454|FG005|Overall Study|Withdrawal by Subject|1|||
23376195|NCT02555878|65123039|FG000|Overall Study|Lost to Follow-up|2|||
23376196|NCT02555878|65123040|FG001|Overall Study|Lost to Follow-up|3|||
23376197|NCT02555878|65123039|FG000|Overall Study|Withdrawal by Subject|48|||
23376198|NCT02555878|65123040|FG001|Overall Study|Withdrawal by Subject|48|||
23376199|NCT02555878|65123039|FG000|Overall Study|Adverse Event|12|||
23376200|NCT02555878|65123040|FG001|Overall Study|Adverse Event|8|||
23489281|NCT02808650|65537013|FG001|Overall Study|Death|0|||
23376201|NCT02555878|65123039|FG000|Overall Study|Death|74|||
23489282|NCT02808650|65537014|FG002|Overall Study|Death|0|||
23489283|NCT02808650|65537015|FG003|Overall Study|Death|0|||
23489284|NCT02808650|65537016|FG004|Overall Study|Death|1|||
23489285|NCT02808650|65537012|FG000|Overall Study|Lack of Efficacy|5|||
23489286|NCT02808650|65537013|FG001|Overall Study|Lack of Efficacy|5|||
23489287|NCT02808650|65537014|FG002|Overall Study|Lack of Efficacy|6|||
23489288|NCT02808650|65537015|FG003|Overall Study|Lack of Efficacy|5|||
23489289|NCT02808650|65537016|FG004|Overall Study|Lack of Efficacy|4|||
23489290|NCT02808650|65537012|FG000|Overall Study|Physician Decision|1|||
23489291|NCT02808650|65537013|FG001|Overall Study|Physician Decision|1|||
23489292|NCT02808650|65537014|FG002|Overall Study|Physician Decision|0|||
23489293|NCT02808650|65537015|FG003|Overall Study|Physician Decision|0|||
23489294|NCT02808650|65537016|FG004|Overall Study|Physician Decision|0|||
23489295|NCT02808650|65537012|FG000|Overall Study|Withdrawal by Subject|0|||
23489296|NCT02808650|65537013|FG001|Overall Study|Withdrawal by Subject|0|||
23489297|NCT02808650|65537014|FG002|Overall Study|Withdrawal by Subject|0|||
23489298|NCT02808650|65537015|FG003|Overall Study|Withdrawal by Subject|1|||
23489299|NCT02808650|65537016|FG004|Overall Study|Withdrawal by Subject|1|||
23489300|NCT02319837|65537020|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
23489301|NCT02319837|65537021|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
23489302|NCT02319837|65537022|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
23489303|NCT02319837|65537020|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
23283802|NCT01695239|64781903|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283803|NCT01695239|64781904|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283804|NCT01695239|64781905|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
23283805|NCT01695239|64781892|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
23283806|NCT01695239|64781893|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283807|NCT01695239|64781894|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
23376202|NCT02555878|65123040|FG001|Overall Study|Death|59|||
23376203|NCT02555878|65123039|FG000|Overall Study|Protocol Violation|1|||
23376204|NCT02555878|65123040|FG001|Overall Study|Protocol Violation|2|||
23376205|NCT02555878|65123039|FG000|Overall Study|Physician Decision|12|||
23376206|NCT02555878|65123040|FG001|Overall Study|Physician Decision|13|||
23376207|NCT02555878|65123039|FG000|Overall Study|Other|17|||
23376208|NCT02555878|65123040|FG001|Overall Study|Other|17|||
23376209|NCT03370302|65123041|FG000|Dose Escalation Phase|Other|0|||
23376210|NCT03370302|65123042|FG001|Dose Escalation Phase|Other|1|||
23489304|NCT02319837|65537021|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
23489305|NCT02319837|65537022|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
23489306|NCT02319837|65537020|FG000|Study Treatment Phase|Adverse Event|73|||
23489307|NCT02319837|65537021|FG001|Study Treatment Phase|Adverse Event|36|||
23489308|NCT02319837|65537022|FG002|Study Treatment Phase|Adverse Event|63|||
23283808|NCT01695239|64781895|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283809|NCT01695239|64781896|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283810|NCT01695239|64781897|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283811|NCT01695239|64781898|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283812|NCT01695239|64781899|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283813|NCT01695239|64781900|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283814|NCT01695239|64781901|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283815|NCT01695239|64781902|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283816|NCT01695239|64781903|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283817|NCT01695239|64781904|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283818|NCT01695239|64781905|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
23283819|NCT01695239|64781892|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
23283820|NCT01695239|64781893|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283821|NCT01695239|64781894|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
23283822|NCT01695239|64781895|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283823|NCT01695239|64781896|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283824|NCT01695239|64781897|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283825|NCT01695239|64781898|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283826|NCT01695239|64781899|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23376211|NCT03370302|65123043|FG002|Dose Escalation Phase|Other|1|||
23376212|NCT03370302|65123044|FG003|Dose Escalation Phase|Other|0|||
23376213|NCT03370302|65123045|FG004|Dose Escalation Phase|Other|0|||
23376214|NCT03370302|65123046|FG005|Dose Escalation Phase|Other|0|||
23376215|NCT03370302|65123041|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
23376216|NCT03370302|65123042|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
23283827|NCT01695239|64781900|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283828|NCT01695239|64781901|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283829|NCT01695239|64781902|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23376217|NCT03370302|65123043|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
23376218|NCT03370302|65123044|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
23376219|NCT03370302|65123045|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
23376220|NCT03370302|65123046|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
23376221|NCT03370302|65123041|FG000|Dose Escalation Phase|Adverse Event|1|||
23283830|NCT01695239|64781903|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283831|NCT01695239|64781904|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283832|NCT01695239|64781905|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
23283833|NCT01695239|64781892|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
23283834|NCT01695239|64781893|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23376222|NCT03370302|65123042|FG001|Dose Escalation Phase|Adverse Event|0|||
23376223|NCT03370302|65123043|FG002|Dose Escalation Phase|Adverse Event|2|||
23376224|NCT03370302|65123044|FG003|Dose Escalation Phase|Adverse Event|0|||
23376225|NCT03370302|65123045|FG004|Dose Escalation Phase|Adverse Event|0|||
23376226|NCT03370302|65123046|FG005|Dose Escalation Phase|Adverse Event|0|||
23376227|NCT03370302|65123041|FG000|Dose Escalation Phase|Progressive Disease|2|||
23376228|NCT03370302|65123042|FG001|Dose Escalation Phase|Progressive Disease|4|||
23376229|NCT03370302|65123043|FG002|Dose Escalation Phase|Progressive Disease|2|||
23376230|NCT03370302|65123044|FG003|Dose Escalation Phase|Progressive Disease|0|||
23376231|NCT03370302|65123045|FG004|Dose Escalation Phase|Progressive Disease|3|||
23376232|NCT03370302|65123046|FG005|Dose Escalation Phase|Progressive Disease|1|||
23376233|NCT03370302|65123041|FG000|Dose Expansion Phase|Progressive Disease|0|||
23376234|NCT03370302|65123042|FG001|Dose Expansion Phase|Progressive Disease|0|||
23376235|NCT03370302|65123043|FG002|Dose Expansion Phase|Progressive Disease|0|||
23489309|NCT02319837|65537020|FG000|Study Treatment Phase|Development of castration resistance|0|||
23604605|NCT04183491|65943455|FG006|Overall Study|Withdrawal by Subject|0|||
23604606|NCT00357994|65943456|FG000|Overall Study|Adverse Event|1|||
23604607|NCT00357994|65943457|FG001|Overall Study|Adverse Event|2|||
23604608|NCT00357994|65943456|FG000|Overall Study|Lack of Efficacy|0|||
23604609|NCT00357994|65943457|FG001|Overall Study|Lack of Efficacy|1|||
23604610|NCT00357994|65943456|FG000|Overall Study|Protocol Violation|1|||
23604611|NCT00357994|65943457|FG001|Overall Study|Protocol Violation|0|||
23604612|NCT02309294|65943458|FG000|Overall Study|Withdrawal by Subject|2|||
23604613|NCT01670877|65943459|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23604614|NCT01670877|65943460|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
23604615|NCT01670877|65943461|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23604616|NCT01670877|65943462|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23604617|NCT01670877|65943463|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23376236|NCT03370302|65123044|FG003|Dose Expansion Phase|Progressive Disease|6|||
23376237|NCT03370302|65123045|FG004|Dose Expansion Phase|Progressive Disease|0|||
23376238|NCT03370302|65123046|FG005|Dose Expansion Phase|Progressive Disease|0|||
23376239|NCT01838876|65123049|FG000|Overall Study|Adverse Event|49|||
23283835|NCT01695239|64781894|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283836|NCT01695239|64781895|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283837|NCT01695239|64781896|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283838|NCT01695239|64781897|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283839|NCT01695239|64781898|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283840|NCT01695239|64781899|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283841|NCT01695239|64781900|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283842|NCT01695239|64781901|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23376240|NCT01838876|65123049|FG000|Overall Study|Insufficient Therapeutic Response|10|||
23376241|NCT01838876|65123049|FG000|Overall Study|Protocol Violation|34|||
23376242|NCT01838876|65123049|FG000|Overall Study|Withdrawal of Consent|33|||
23376243|NCT01838876|65123049|FG000|Overall Study|Lost to Follow-up|21|||
23376244|NCT01838876|65123049|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
23376245|NCT01838876|65123049|FG000|Overall Study|Reason not Specified|7|||
23376246|NCT01838876|65123049|FG000|Overall Study|Did not meet eligibility criteria|78|||
23376247|NCT00630292|65123050|FG000|Overall Study|Withdrawal by Subject|1|||
23376248|NCT00300053|65123051|FG000|Overall Study|Patient/Caregiver Preference|2|||
23376249|NCT00300053|65123052|FG001|Overall Study|Patient/Caregiver Preference|2|||
23376250|NCT00300053|65123053|FG002|Overall Study|Patient/Caregiver Preference|3|||
23376251|NCT00300053|65123051|FG000|Overall Study|Death|0|||
23376252|NCT00300053|65123052|FG001|Overall Study|Death|0|||
23376253|NCT00300053|65123053|FG002|Overall Study|Death|3|||
23376254|NCT00300053|65123051|FG000|Overall Study|Lost to Follow-up|0|||
23489310|NCT02319837|65537021|FG001|Study Treatment Phase|Development of castration resistance|2|||
23489311|NCT02319837|65537022|FG002|Study Treatment Phase|Development of castration resistance|0|||
23604618|NCT01670877|65943464|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
23604619|NCT01670877|65943459|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23283843|NCT01695239|64781902|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283844|NCT01695239|64781903|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283845|NCT01695239|64781904|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283846|NCT01695239|64781905|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
23283847|NCT01695239|64781892|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283848|NCT01695239|64781893|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283849|NCT01695239|64781894|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283850|NCT01695239|64781895|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23604620|NCT01670877|65943460|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23604621|NCT01670877|65943461|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
23604622|NCT01670877|65943462|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23604623|NCT01670877|65943463|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23604624|NCT01670877|65943464|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
23604625|NCT01670877|65943459|FG000|Part I and Part 2|Grade 2 vomiting|0|||
23604626|NCT01670877|65943460|FG001|Part I and Part 2|Grade 2 vomiting|0|||
23604627|NCT01670877|65943461|FG002|Part I and Part 2|Grade 2 vomiting|0|||
23604628|NCT01670877|65943462|FG003|Part I and Part 2|Grade 2 vomiting|1|||
23604629|NCT01670877|65943463|FG004|Part I and Part 2|Grade 2 vomiting|0|||
23604630|NCT01670877|65943464|FG005|Part I and Part 2|Grade 2 vomiting|0|||
23604631|NCT01670877|65943459|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604632|NCT01670877|65943460|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604633|NCT01670877|65943461|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604634|NCT01670877|65943462|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
23604635|NCT01670877|65943463|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604636|NCT01670877|65943464|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
23604637|NCT01670877|65943459|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604638|NCT01670877|65943460|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604639|NCT01670877|65943461|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604640|NCT01670877|65943462|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
23604641|NCT01670877|65943463|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604642|NCT01670877|65943464|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
23604643|NCT01706159|65943465|FG000|Overall Study|Withdrawal Criteria|2|||
23604644|NCT01706159|65943466|FG001|Overall Study|Withdrawal Criteria|1|||
23604645|NCT01706159|65943465|FG000|Overall Study|Unclassified|6|||
23604646|NCT01706159|65943466|FG001|Overall Study|Unclassified|1|||
23604647|NCT02744066|65943469|FG000|Overall Study|Withdrawal by parent|0|||
23604648|NCT02744066|65943470|FG001|Overall Study|Withdrawal by parent|1|||
23604649|NCT02744066|65943469|FG000|Overall Study|Discharged from NICU prior to completion|0|||
23604650|NCT02744066|65943470|FG001|Overall Study|Discharged from NICU prior to completion|4|||
23604651|NCT03015220|65943472|FG000|Overall Study|Withdrawal by Subject|3|||
23376255|NCT00300053|65123052|FG001|Overall Study|Lost to Follow-up|1|||
23376256|NCT00300053|65123053|FG002|Overall Study|Lost to Follow-up|0|||
23376257|NCT02058095|65123056|FG000|Overall Study|Adverse Event|1|||
23376258|NCT02058095|65123057|FG001|Overall Study|Adverse Event|0|||
23376259|NCT02324153|65123060|FG000|Overall Study|Withdrawal by Subject|4|||
23376260|NCT02324153|65123061|FG001|Overall Study|Withdrawal by Subject|1|||
23376261|NCT02324153|65123060|FG000|Overall Study|Surgery postponed after randomization|3|||
23376262|NCT02324153|65123061|FG001|Overall Study|Surgery postponed after randomization|0|||
23376263|NCT02324153|65123060|FG000|Overall Study|Developed delirium preoperatively|1|||
23376264|NCT02324153|65123061|FG001|Overall Study|Developed delirium preoperatively|0|||
23376265|NCT00479232|65123070|FG000|Overall Study|Adverse Event|0|||
23376266|NCT00479232|65123071|FG001|Overall Study|Adverse Event|0|||
23376267|NCT00479232|65123072|FG002|Overall Study|Adverse Event|5|||
23376268|NCT00479232|65123073|FG003|Overall Study|Adverse Event|0|||
23376269|NCT00479232|65123074|FG004|Overall Study|Adverse Event|0|||
23376270|NCT00479232|65123075|FG005|Overall Study|Adverse Event|10|||
23376271|NCT00479232|65123070|FG000|Overall Study|Deviation from Protocol|0|||
23376272|NCT00479232|65123071|FG001|Overall Study|Deviation from Protocol|0|||
23376273|NCT00479232|65123072|FG002|Overall Study|Deviation from Protocol|1|||
23376274|NCT00479232|65123073|FG003|Overall Study|Deviation from Protocol|0|||
23376275|NCT00479232|65123074|FG004|Overall Study|Deviation from Protocol|0|||
23376276|NCT00479232|65123075|FG005|Overall Study|Deviation from Protocol|0|||
23376277|NCT00479232|65123070|FG000|Overall Study|Lack of Efficacy|0|||
23376278|NCT00479232|65123071|FG001|Overall Study|Lack of Efficacy|0|||
23376279|NCT00479232|65123072|FG002|Overall Study|Lack of Efficacy|2|||
23376280|NCT00479232|65123073|FG003|Overall Study|Lack of Efficacy|0|||
23376281|NCT00479232|65123074|FG004|Overall Study|Lack of Efficacy|0|||
23376282|NCT00479232|65123075|FG005|Overall Study|Lack of Efficacy|4|||
23376283|NCT00479232|65123070|FG000|Overall Study|Physician Decision|0|||
23376284|NCT00479232|65123071|FG001|Overall Study|Physician Decision|0|||
23376285|NCT00479232|65123072|FG002|Overall Study|Physician Decision|2|||
23376286|NCT00479232|65123073|FG003|Overall Study|Physician Decision|0|||
23376287|NCT00479232|65123074|FG004|Overall Study|Physician Decision|0|||
23376288|NCT00479232|65123075|FG005|Overall Study|Physician Decision|1|||
23376289|NCT00479232|65123070|FG000|Overall Study|Progressive Disease|3|||
23376290|NCT00479232|65123071|FG001|Overall Study|Progressive Disease|1|||
23376291|NCT00479232|65123072|FG002|Overall Study|Progressive Disease|12|||
23376292|NCT00479232|65123073|FG003|Overall Study|Progressive Disease|3|||
23376293|NCT00479232|65123074|FG004|Overall Study|Progressive Disease|3|||
23376294|NCT00479232|65123075|FG005|Overall Study|Progressive Disease|12|||
23376295|NCT00479232|65123070|FG000|Overall Study|Withdrew Consent|0|||
23376296|NCT00479232|65123071|FG001|Overall Study|Withdrew Consent|2|||
23376297|NCT00479232|65123072|FG002|Overall Study|Withdrew Consent|6|||
23376298|NCT00479232|65123073|FG003|Overall Study|Withdrew Consent|0|||
23376299|NCT00479232|65123074|FG004|Overall Study|Withdrew Consent|1|||
23376300|NCT00479232|65123075|FG005|Overall Study|Withdrew Consent|3|||
23376301|NCT05001620|65123076|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
23376302|NCT05001620|65123077|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
23376303|NCT04739709|65123078|FG000|Overall Study|Physician Decision|1|||
23376304|NCT04739709|65123079|FG001|Overall Study|Physician Decision|0|||
23376305|NCT01416571|65123083|FG000|Overall Study|Lost to Follow-up|2|||
23376306|NCT02515227|65123088|FG000|Overall Study|Adverse Event|0|||
23376307|NCT02515227|65123089|FG001|Overall Study|Adverse Event|2|||
23376308|NCT02515227|65123088|FG000|Overall Study|Progressive disease|2|||
23376309|NCT02515227|65123089|FG001|Overall Study|Progressive disease|9|||
23376310|NCT00303186|65123090|FG000|Overall Study|Other|52|||
23376311|NCT02362451|65123108|FG000|Overall Study|Withdrawal by Subject|0|||
23376312|NCT02362451|65123109|FG001|Overall Study|Withdrawal by Subject|1|||
23376313|NCT02362451|65123108|FG000|Overall Study|Lack of Efficacy|2|||
23376314|NCT02362451|65123109|FG001|Overall Study|Lack of Efficacy|0|||
23376315|NCT02362451|65123108|FG000|Overall Study|Progression|1|||
23376316|NCT02362451|65123109|FG001|Overall Study|Progression|0|||
23376317|NCT02362451|65123108|FG000|Overall Study|Participant chose other therapy.|1|||
23376318|NCT02362451|65123109|FG001|Overall Study|Participant chose other therapy.|0|||
23376319|NCT03846479|65123111|FG000|Overall Study|Death|8|||
23376320|NCT03846479|65123111|FG000|Overall Study|Lost to Follow-up|1|||
23376321|NCT00596635|65123113|FG000|Overall Study|Lost to Follow-up|0|||
23376322|NCT00596635|65123114|FG001|Overall Study|Lost to Follow-up|2|||
23376323|NCT00596635|65123115|FG002|Overall Study|Lost to Follow-up|0|||
23376324|NCT00596635|65123113|FG000|Overall Study|Treatment for symptomatic UTI|4|||
23376325|NCT00596635|65123114|FG001|Overall Study|Treatment for symptomatic UTI|6|||
23376326|NCT00596635|65123115|FG002|Overall Study|Treatment for symptomatic UTI|3|||
23376327|NCT00596635|65123113|FG000|Overall Study|Hip fracture|2|||
23376328|NCT00596635|65123114|FG001|Overall Study|Hip fracture|3|||
23376329|NCT00596635|65123115|FG002|Overall Study|Hip fracture|3|||
23376330|NCT00596635|65123113|FG000|Overall Study|Could not provide urine specimen|1|||
23376331|NCT00596635|65123114|FG001|Overall Study|Could not provide urine specimen|2|||
23376332|NCT00596635|65123115|FG002|Overall Study|Could not provide urine specimen|2|||
23376333|NCT02593864|65123119|FG000|Overall Study|Withdrawal by Subject|3|||
23376334|NCT02593864|65123119|FG000|Overall Study|Lost to Follow-up|3|||
23376335|NCT02194465|65123123|FG000|Overall Study|Adverse Event|6|||
23376336|NCT02194465|65123124|FG001|Overall Study|Adverse Event|1|||
23376337|NCT02194465|65123125|FG002|Overall Study|Adverse Event|4|||
23376338|NCT02194465|65123126|FG003|Overall Study|Adverse Event|4|||
23376339|NCT02194465|65123127|FG004|Overall Study|Adverse Event|4|||
23376340|NCT02194465|65123128|FG005|Overall Study|Adverse Event|2|||
23376341|NCT02194465|65123129|FG006|Overall Study|Adverse Event|0|||
23376342|NCT02194465|65123123|FG000|Overall Study|Lost to Follow-up|0|||
23376343|NCT02194465|65123124|FG001|Overall Study|Lost to Follow-up|0|||
23376344|NCT02194465|65123125|FG002|Overall Study|Lost to Follow-up|0|||
23376345|NCT02194465|65123126|FG003|Overall Study|Lost to Follow-up|1|||
23376346|NCT02194465|65123127|FG004|Overall Study|Lost to Follow-up|0|||
23376347|NCT02194465|65123128|FG005|Overall Study|Lost to Follow-up|1|||
23376348|NCT02194465|65123129|FG006|Overall Study|Lost to Follow-up|0|||
23376349|NCT02194465|65123123|FG000|Overall Study|Physician Decision|1|||
23376350|NCT02194465|65123124|FG001|Overall Study|Physician Decision|0|||
23376351|NCT02194465|65123125|FG002|Overall Study|Physician Decision|0|||
23376352|NCT02194465|65123126|FG003|Overall Study|Physician Decision|0|||
23376353|NCT02194465|65123127|FG004|Overall Study|Physician Decision|0|||
23376354|NCT02194465|65123128|FG005|Overall Study|Physician Decision|0|||
23376355|NCT02194465|65123129|FG006|Overall Study|Physician Decision|0|||
23376356|NCT02194465|65123123|FG000|Overall Study|Protocol Violation|1|||
23376357|NCT02194465|65123124|FG001|Overall Study|Protocol Violation|1|||
23376358|NCT02194465|65123125|FG002|Overall Study|Protocol Violation|2|||
23376359|NCT02194465|65123126|FG003|Overall Study|Protocol Violation|1|||
23376360|NCT02194465|65123127|FG004|Overall Study|Protocol Violation|1|||
23376361|NCT02194465|65123128|FG005|Overall Study|Protocol Violation|0|||
23376362|NCT02194465|65123129|FG006|Overall Study|Protocol Violation|0|||
23376363|NCT02194465|65123123|FG000|Overall Study|Withdrawal by Subject|1|||
23376364|NCT02194465|65123124|FG001|Overall Study|Withdrawal by Subject|3|||
23376365|NCT02194465|65123125|FG002|Overall Study|Withdrawal by Subject|1|||
23376366|NCT02194465|65123126|FG003|Overall Study|Withdrawal by Subject|2|||
23376367|NCT02194465|65123127|FG004|Overall Study|Withdrawal by Subject|2|||
23376368|NCT02194465|65123128|FG005|Overall Study|Withdrawal by Subject|1|||
23376369|NCT02194465|65123129|FG006|Overall Study|Withdrawal by Subject|2|||
23376370|NCT02194465|65123123|FG000|Overall Study|Discontinued follow-up period|0|||
23376371|NCT02194465|65123124|FG001|Overall Study|Discontinued follow-up period|2|||
23376372|NCT02194465|65123125|FG002|Overall Study|Discontinued follow-up period|1|||
23376373|NCT02194465|65123126|FG003|Overall Study|Discontinued follow-up period|0|||
23376374|NCT02194465|65123127|FG004|Overall Study|Discontinued follow-up period|2|||
23376375|NCT02194465|65123128|FG005|Overall Study|Discontinued follow-up period|0|||
23376376|NCT02194465|65123129|FG006|Overall Study|Discontinued follow-up period|0|||
23376377|NCT02969018|65123133|FG000|Overall Study|Adverse Event|2|||
23376378|NCT02969018|65123134|FG001|Overall Study|Adverse Event|4|||
23376379|NCT02969018|65123135|FG002|Overall Study|Adverse Event|1|||
23376380|NCT02969018|65123136|FG003|Overall Study|Adverse Event|2|||
23376381|NCT02969018|65123137|FG004|Overall Study|Adverse Event|0|||
23376382|NCT02969018|65123138|FG005|Overall Study|Adverse Event|1|||
23376383|NCT02969018|65123139|FG006|Overall Study|Adverse Event|2|||
23376384|NCT02969018|65123140|FG007|Overall Study|Adverse Event|0|||
23376385|NCT02969018|65123133|FG000|Overall Study|Lack of Efficacy|0|||
23376386|NCT02969018|65123134|FG001|Overall Study|Lack of Efficacy|1|||
23376387|NCT02969018|65123135|FG002|Overall Study|Lack of Efficacy|0|||
23376388|NCT02969018|65123136|FG003|Overall Study|Lack of Efficacy|0|||
23376389|NCT02969018|65123137|FG004|Overall Study|Lack of Efficacy|1|||
23376390|NCT02969018|65123138|FG005|Overall Study|Lack of Efficacy|1|||
23376391|NCT02969018|65123139|FG006|Overall Study|Lack of Efficacy|1|||
23376392|NCT02969018|65123140|FG007|Overall Study|Lack of Efficacy|1|||
23376393|NCT02969018|65123133|FG000|Overall Study|Lost to Follow-up|1|||
23376394|NCT02969018|65123134|FG001|Overall Study|Lost to Follow-up|2|||
23489312|NCT02319837|65537020|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
23489313|NCT02319837|65537021|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
23376395|NCT02969018|65123135|FG002|Overall Study|Lost to Follow-up|2|||
23376396|NCT02969018|65123136|FG003|Overall Study|Lost to Follow-up|0|||
23376397|NCT02969018|65123137|FG004|Overall Study|Lost to Follow-up|1|||
23376398|NCT02969018|65123138|FG005|Overall Study|Lost to Follow-up|1|||
23376399|NCT02969018|65123139|FG006|Overall Study|Lost to Follow-up|0|||
23376400|NCT02969018|65123140|FG007|Overall Study|Lost to Follow-up|1|||
23376401|NCT02969018|65123133|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376402|NCT02969018|65123134|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376403|NCT02969018|65123135|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376404|NCT02969018|65123136|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376405|NCT02969018|65123137|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
23489314|NCT02319837|65537022|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
23376406|NCT02969018|65123138|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376407|NCT02969018|65123139|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
23376408|NCT02969018|65123140|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
23376409|NCT02969018|65123133|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23376410|NCT02969018|65123134|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23376411|NCT02969018|65123135|FG002|Overall Study|Non-Compliance With Study Drug|0|||
23376412|NCT02969018|65123136|FG003|Overall Study|Non-Compliance With Study Drug|0|||
23376413|NCT02969018|65123137|FG004|Overall Study|Non-Compliance With Study Drug|0|||
23376414|NCT02969018|65123138|FG005|Overall Study|Non-Compliance With Study Drug|0|||
23376415|NCT02969018|65123139|FG006|Overall Study|Non-Compliance With Study Drug|0|||
23376416|NCT02969018|65123140|FG007|Overall Study|Non-Compliance With Study Drug|0|||
23376417|NCT02969018|65123133|FG000|Overall Study|Other|0|||
23376418|NCT02969018|65123134|FG001|Overall Study|Other|0|||
23376419|NCT02969018|65123135|FG002|Overall Study|Other|0|||
23376420|NCT02969018|65123136|FG003|Overall Study|Other|1|||
23283851|NCT01695239|64781896|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283852|NCT01695239|64781897|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283853|NCT01695239|64781898|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283854|NCT01695239|64781899|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
23283855|NCT01695239|64781900|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283856|NCT01695239|64781901|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23376421|NCT02969018|65123137|FG004|Overall Study|Other|0|||
23376422|NCT02969018|65123138|FG005|Overall Study|Other|0|||
23376423|NCT02969018|65123139|FG006|Overall Study|Other|0|||
23376424|NCT02969018|65123140|FG007|Overall Study|Other|2|||
23376425|NCT02969018|65123133|FG000|Overall Study|Pregnancy|0|||
23376426|NCT02969018|65123134|FG001|Overall Study|Pregnancy|0|||
23376427|NCT02969018|65123135|FG002|Overall Study|Pregnancy|0|||
23376428|NCT02969018|65123136|FG003|Overall Study|Pregnancy|0|||
23376429|NCT02969018|65123137|FG004|Overall Study|Pregnancy|0|||
23376430|NCT02969018|65123138|FG005|Overall Study|Pregnancy|1|||
23376431|NCT02969018|65123139|FG006|Overall Study|Pregnancy|0|||
23376432|NCT02969018|65123140|FG007|Overall Study|Pregnancy|0|||
23376433|NCT02969018|65123133|FG000|Overall Study|Protocol Violation|0|||
23376434|NCT02969018|65123134|FG001|Overall Study|Protocol Violation|0|||
23376435|NCT02969018|65123135|FG002|Overall Study|Protocol Violation|1|||
23376436|NCT02969018|65123136|FG003|Overall Study|Protocol Violation|1|||
23376437|NCT02969018|65123137|FG004|Overall Study|Protocol Violation|0|||
23604652|NCT03015220|65943473|FG001|Overall Study|Withdrawal by Subject|2|||
23283857|NCT01695239|64781902|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283858|NCT01695239|64781903|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283859|NCT01695239|64781904|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283860|NCT01695239|64781905|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
23283861|NCT01695239|64781892|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283862|NCT01695239|64781893|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283863|NCT01695239|64781894|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283864|NCT01695239|64781895|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283865|NCT01695239|64781896|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283866|NCT01695239|64781897|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283867|NCT01695239|64781898|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283868|NCT01695239|64781899|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
23283869|NCT01695239|64781900|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283870|NCT01695239|64781901|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283871|NCT01695239|64781902|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283872|NCT01695239|64781903|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283873|NCT01695239|64781904|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283874|NCT01695239|64781905|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
23283875|NCT01695239|64781892|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283876|NCT01695239|64781893|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283877|NCT01695239|64781894|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283878|NCT01695239|64781895|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23376438|NCT02969018|65123138|FG005|Overall Study|Protocol Violation|0|||
23376439|NCT02969018|65123139|FG006|Overall Study|Protocol Violation|0|||
23604653|NCT03015220|65943474|FG002|Overall Study|Withdrawal by Subject|2|||
23376440|NCT02969018|65123140|FG007|Overall Study|Protocol Violation|0|||
23604654|NCT03015220|65943475|FG003|Overall Study|Withdrawal by Subject|2|||
23376441|NCT02969018|65123133|FG000|Overall Study|Withdrawal by Subject|0|||
23376442|NCT02969018|65123134|FG001|Overall Study|Withdrawal by Subject|1|||
23376443|NCT02969018|65123135|FG002|Overall Study|Withdrawal by Subject|2|||
23376444|NCT02969018|65123136|FG003|Overall Study|Withdrawal by Subject|1|||
23283879|NCT01695239|64781896|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283880|NCT01695239|64781897|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283881|NCT01695239|64781898|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283882|NCT01695239|64781899|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
23283883|NCT01695239|64781900|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283884|NCT01695239|64781901|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283885|NCT01695239|64781902|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283886|NCT01695239|64781903|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283887|NCT01695239|64781904|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283888|NCT01695239|64781905|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
23283889|NCT01695239|64781892|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283890|NCT01695239|64781893|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283891|NCT01695239|64781894|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283892|NCT01695239|64781895|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283893|NCT01695239|64781896|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283894|NCT01695239|64781897|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283895|NCT01695239|64781898|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283896|NCT01695239|64781899|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283897|NCT01695239|64781900|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
23283898|NCT01695239|64781901|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
23283899|NCT01695239|64781902|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283900|NCT01695239|64781903|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283901|NCT01695239|64781904|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283902|NCT01695239|64781905|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
23283903|NCT01695239|64781892|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
23283904|NCT01695239|64781893|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
23283905|NCT01695239|64781894|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
23283906|NCT01695239|64781895|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
23283907|NCT01695239|64781896|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
23283908|NCT01695239|64781897|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
23283909|NCT01695239|64781898|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
23283910|NCT01695239|64781899|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
23376445|NCT02969018|65123137|FG004|Overall Study|Withdrawal by Subject|0|||
23376446|NCT02969018|65123138|FG005|Overall Study|Withdrawal by Subject|4|||
23489315|NCT02319837|65537020|FG000|Study Treatment Phase|Protocol Violation|2|||
23489316|NCT02319837|65537021|FG001|Study Treatment Phase|Protocol Violation|2|||
23489317|NCT02319837|65537022|FG002|Study Treatment Phase|Protocol Violation|1|||
23489318|NCT02319837|65537020|FG000|Study Treatment Phase|Lost to Follow-up|0|||
23489319|NCT02319837|65537021|FG001|Study Treatment Phase|Lost to Follow-up|1|||
23489320|NCT02319837|65537022|FG002|Study Treatment Phase|Lost to Follow-up|0|||
23489321|NCT02319837|65537020|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
23489322|NCT02319837|65537021|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
23489323|NCT02319837|65537022|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
23489324|NCT02319837|65537020|FG000|Study Treatment Phase|Other|0|||
23604655|NCT03015220|65943472|FG000|Overall Study|Lost to Follow-up|0|||
23283911|NCT01695239|64781900|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
23376447|NCT02969018|65123139|FG006|Overall Study|Withdrawal by Subject|4|||
23376448|NCT02969018|65123140|FG007|Overall Study|Withdrawal by Subject|3|||
23376449|NCT03250273|65123148|FG000|Overall Study|Disease Progression|2|||
23376450|NCT03250273|65123149|FG001|Overall Study|Disease Progression|11|||
23376451|NCT03250273|65123148|FG000|Overall Study|Death|0|||
23376452|NCT03250273|65123149|FG001|Overall Study|Death|1|||
23376453|NCT01715298|65123152|FG000|Overall Study|Lost to Follow-up|0|||
23376454|NCT01715298|65123153|FG001|Overall Study|Lost to Follow-up|2|||
23376455|NCT01715298|65123152|FG000|Overall Study|Patient/guardian decision|7|||
23376456|NCT01715298|65123153|FG001|Overall Study|Patient/guardian decision|9|||
23376457|NCT01664091|65123158|FG000|Overall Study|Death|1|||
23376458|NCT01664091|65123158|FG000|Overall Study|Disease Progression|2|||
23376459|NCT01664091|65123158|FG000|Overall Study|Lost to Follow-up|2|||
23376460|NCT01664091|65123158|FG000|Overall Study|Withdrawal by Subject|1|||
23376461|NCT03530696|65123159|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
23376462|NCT03530696|65123160|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
23376463|NCT00975923|65123161|FG000|Overall Study|Withdrawal by Subject|0|||
23376464|NCT00975923|65123162|FG001|Overall Study|Withdrawal by Subject|1|||
23376465|NCT00924898|65123163|FG000|Overall Study|Withdrawal by Subject|2|||
23604656|NCT03015220|65943473|FG001|Overall Study|Lost to Follow-up|0|||
23376466|NCT00922636|65123169|FG000|Overall Study|Adverse Event|3|||
23283912|NCT01695239|64781901|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
23283913|NCT01695239|64781902|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
23283914|NCT01695239|64781903|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
23283915|NCT01695239|64781904|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
23283916|NCT01695239|64781905|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
23283917|NCT01695239|64781892|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283918|NCT01695239|64781893|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283919|NCT01695239|64781894|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283920|NCT01695239|64781895|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283921|NCT01695239|64781896|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283922|NCT01695239|64781897|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283923|NCT01695239|64781898|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283924|NCT01695239|64781899|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283925|NCT01695239|64781900|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
23283926|NCT01695239|64781901|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
23283927|NCT01695239|64781902|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283928|NCT01695239|64781903|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283929|NCT01695239|64781904|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283930|NCT01695239|64781905|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
23283931|NCT01695239|64781892|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
23283932|NCT01695239|64781893|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
23283933|NCT01695239|64781894|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
23283934|NCT01695239|64781895|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
23283935|NCT01695239|64781896|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
23283936|NCT01695239|64781897|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
23283937|NCT01695239|64781898|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
23283938|NCT01695239|64781899|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
23283939|NCT01695239|64781900|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
23283940|NCT01695239|64781901|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
23283941|NCT01695239|64781902|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
23283942|NCT01695239|64781903|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
23283943|NCT01695239|64781904|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
23283944|NCT01695239|64781905|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
23283945|NCT01695239|64781892|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283946|NCT01695239|64781893|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283947|NCT01695239|64781894|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283948|NCT01695239|64781895|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283949|NCT01695239|64781896|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283950|NCT01695239|64781897|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283951|NCT01695239|64781898|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283952|NCT01695239|64781899|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283953|NCT01695239|64781900|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
23283954|NCT01695239|64781901|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
23283955|NCT01695239|64781902|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283956|NCT01695239|64781903|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283957|NCT01695239|64781904|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283958|NCT01695239|64781905|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
23283959|NCT01695239|64781892|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283960|NCT01695239|64781893|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283961|NCT01695239|64781894|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283962|NCT01695239|64781895|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283963|NCT01695239|64781896|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283964|NCT01695239|64781897|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283965|NCT01695239|64781898|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283966|NCT01695239|64781899|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283967|NCT01695239|64781900|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
23283968|NCT01695239|64781901|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
23283969|NCT01695239|64781902|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283970|NCT01695239|64781903|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283971|NCT01695239|64781904|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283972|NCT01695239|64781905|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
23283973|NCT01695239|64781892|FG000|Extension Long-Term Extension Periods|Death|0|||
23283974|NCT01695239|64781893|FG001|Extension Long-Term Extension Periods|Death|0|||
23283975|NCT01695239|64781894|FG002|Extension Long-Term Extension Periods|Death|0|||
23283976|NCT01695239|64781895|FG003|Extension Long-Term Extension Periods|Death|0|||
23376467|NCT00922636|65123170|FG001|Overall Study|Adverse Event|3|||
23376468|NCT00922636|65123171|FG002|Overall Study|Adverse Event|2|||
23376469|NCT00922636|65123172|FG003|Overall Study|Adverse Event|3|||
23376470|NCT00922636|65123173|FG004|Overall Study|Adverse Event|2|||
23376471|NCT00922636|65123169|FG000|Overall Study|Lack of Efficacy|1|||
23283977|NCT01695239|64781896|FG004|Extension Long-Term Extension Periods|Death|0|||
23376472|NCT00922636|65123170|FG001|Overall Study|Lack of Efficacy|7|||
23376473|NCT00922636|65123171|FG002|Overall Study|Lack of Efficacy|3|||
23376474|NCT00922636|65123172|FG003|Overall Study|Lack of Efficacy|2|||
23376475|NCT00922636|65123173|FG004|Overall Study|Lack of Efficacy|4|||
23376476|NCT00922636|65123169|FG000|Overall Study|Sponsor Decision|0|||
23376477|NCT00922636|65123170|FG001|Overall Study|Sponsor Decision|0|||
23376478|NCT00922636|65123171|FG002|Overall Study|Sponsor Decision|2|||
23489325|NCT02319837|65537021|FG001|Study Treatment Phase|Other|1|||
23489326|NCT02319837|65537022|FG002|Study Treatment Phase|Other|0|||
23489327|NCT02319837|65537020|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
23489328|NCT02319837|65537021|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
23489329|NCT02319837|65537022|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
23489330|NCT02319837|65537020|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
23489331|NCT02319837|65537021|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
23489332|NCT02319837|65537022|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
23489333|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
23489334|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
23489335|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
23489336|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
23489337|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
23489338|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
23489339|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
23489340|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
23489341|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
23489342|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
23489343|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
23489344|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
23489345|NCT02319837|65537020|FG000|Long-Term Follow-Up Phase|Death|33|||
23489346|NCT02319837|65537021|FG001|Long-Term Follow-Up Phase|Death|54|||
23489347|NCT02319837|65537022|FG002|Long-Term Follow-Up Phase|Death|42|||
23489348|NCT04093414|65537023|FG000|3 Month Follow up|Physician Decision|0|||
23489349|NCT04093414|65537024|FG001|3 Month Follow up|Physician Decision|1|||
23489350|NCT04093414|65537023|FG000|6month Follow up|Physician Decision|1|||
23489351|NCT04093414|65537024|FG001|6month Follow up|Physician Decision|3|||
23489352|NCT01646073|65537035|FG000|Period A (12 Weeks)|Adverse Event|0|||
23489353|NCT01646073|65537036|FG001|Period A (12 Weeks)|Adverse Event|2|||
23489354|NCT01646073|65537035|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
23489355|NCT01646073|65537036|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
23283978|NCT01695239|64781897|FG005|Extension Long-Term Extension Periods|Death|0|||
23283979|NCT01695239|64781898|FG006|Extension Long-Term Extension Periods|Death|0|||
23283980|NCT01695239|64781899|FG007|Extension Long-Term Extension Periods|Death|0|||
23283981|NCT01695239|64781900|FG008|Extension Long-Term Extension Periods|Death|1|||
23283982|NCT01695239|64781901|FG009|Extension Long-Term Extension Periods|Death|0|||
23283983|NCT01695239|64781902|FG010|Extension Long-Term Extension Periods|Death|0|||
23283984|NCT01695239|64781903|FG011|Extension Long-Term Extension Periods|Death|0|||
23283985|NCT01695239|64781904|FG012|Extension Long-Term Extension Periods|Death|0|||
23376479|NCT00922636|65123172|FG003|Overall Study|Sponsor Decision|0|||
23376480|NCT00922636|65123173|FG004|Overall Study|Sponsor Decision|0|||
23376481|NCT00922636|65123169|FG000|Overall Study|Withdrawal by Subject|0|||
23376482|NCT00922636|65123170|FG001|Overall Study|Withdrawal by Subject|0|||
23283986|NCT01695239|64781905|FG013|Extension Long-Term Extension Periods|Death|0|||
23283987|NCT01695239|64781892|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283988|NCT01695239|64781893|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283989|NCT01695239|64781894|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283990|NCT01695239|64781895|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283991|NCT01695239|64781896|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283992|NCT01695239|64781897|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283993|NCT01695239|64781898|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283994|NCT01695239|64781899|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283995|NCT01695239|64781900|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283996|NCT01695239|64781901|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23283997|NCT01695239|64781902|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
23376483|NCT00922636|65123171|FG002|Overall Study|Withdrawal by Subject|5|||
23376484|NCT00922636|65123172|FG003|Overall Study|Withdrawal by Subject|2|||
23376485|NCT00922636|65123173|FG004|Overall Study|Withdrawal by Subject|4|||
23376486|NCT00922636|65123169|FG000|Overall Study|Protocol Violation|0|||
23376487|NCT00922636|65123170|FG001|Overall Study|Protocol Violation|0|||
23376488|NCT00922636|65123171|FG002|Overall Study|Protocol Violation|2|||
23376489|NCT00922636|65123172|FG003|Overall Study|Protocol Violation|2|||
23376490|NCT00922636|65123173|FG004|Overall Study|Protocol Violation|0|||
23376491|NCT00922636|65123169|FG000|Overall Study|Entry Criteria Not Met|0|||
23376492|NCT00922636|65123170|FG001|Overall Study|Entry Criteria Not Met|0|||
23376493|NCT00922636|65123171|FG002|Overall Study|Entry Criteria Not Met|1|||
23376494|NCT00922636|65123172|FG003|Overall Study|Entry Criteria Not Met|1|||
23376495|NCT00922636|65123173|FG004|Overall Study|Entry Criteria Not Met|0|||
23376496|NCT00922636|65123169|FG000|Overall Study|Parent/Caregiver Decision|2|||
23376497|NCT00922636|65123170|FG001|Overall Study|Parent/Caregiver Decision|4|||
23376498|NCT00922636|65123171|FG002|Overall Study|Parent/Caregiver Decision|3|||
23376499|NCT00922636|65123172|FG003|Overall Study|Parent/Caregiver Decision|5|||
23376500|NCT00922636|65123173|FG004|Overall Study|Parent/Caregiver Decision|2|||
23376501|NCT00922636|65123169|FG000|Overall Study|Lost to Follow-up|1|||
23376502|NCT00922636|65123170|FG001|Overall Study|Lost to Follow-up|2|||
23376503|NCT00922636|65123171|FG002|Overall Study|Lost to Follow-up|2|||
23376504|NCT00922636|65123172|FG003|Overall Study|Lost to Follow-up|2|||
23376505|NCT00922636|65123173|FG004|Overall Study|Lost to Follow-up|4|||
23376506|NCT01240382|65123174|FG000|Overall Study|Adverse Event|2|||
23376507|NCT01240382|65123175|FG001|Overall Study|Adverse Event|1|||
23376508|NCT01240382|65123174|FG000|Overall Study|Lack of Efficacy|0|||
23376509|NCT01240382|65123175|FG001|Overall Study|Lack of Efficacy|2|||
23376510|NCT01240382|65123174|FG000|Overall Study|Fear of adverse events|0|||
23376511|NCT01240382|65123175|FG001|Overall Study|Fear of adverse events|1|||
23376512|NCT04969289|65123177|FG000|Overall Study|Lost to Follow-up|13|||
23376513|NCT04969289|65123178|FG001|Overall Study|Lost to Follow-up|9|||
23376514|NCT00294658|65123179|FG000|Overall Study|Death|0|||
23376515|NCT00294658|65123180|FG001|Overall Study|Death|1|||
23376516|NCT00294658|65123179|FG000|Overall Study|Lost to Follow-up|4|||
23376517|NCT00294658|65123180|FG001|Overall Study|Lost to Follow-up|0|||
23376518|NCT00294658|65123179|FG000|Overall Study|Physician Decision|1|||
23376519|NCT00294658|65123180|FG001|Overall Study|Physician Decision|2|||
23376520|NCT00294658|65123179|FG000|Overall Study|Pregnancy|0|||
23376521|NCT00294658|65123180|FG001|Overall Study|Pregnancy|1|||
23376522|NCT00294658|65123179|FG000|Overall Study|Withdrawal by Subject|0|||
23376523|NCT00294658|65123180|FG001|Overall Study|Withdrawal by Subject|4|||
23376524|NCT00294658|65123179|FG000|Overall Study|Found to have invasive thymoma|1|||
23376525|NCT00294658|65123180|FG001|Overall Study|Found to have invasive thymoma|0|||
23376526|NCT00294658|65123179|FG000|Overall Study|Patient and family were not satisfied|0|||
23376527|NCT00294658|65123180|FG001|Overall Study|Patient and family were not satisfied|1|||
23376528|NCT00481676|65123182|FG000|Overall Study|Adverse Event|0|||
23376529|NCT00481676|65123183|FG001|Overall Study|Adverse Event|1|||
23376530|NCT00481676|65123182|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23376531|NCT00481676|65123183|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
23376532|NCT00481676|65123182|FG000|Overall Study|Administrative problem|1|||
23376533|NCT00481676|65123183|FG001|Overall Study|Administrative problem|0|||
23376534|NCT03473197|65123188|FG000|Overall Study|Adverse Event|4|||
23376535|NCT03473197|65123188|FG000|Overall Study|Lost to Follow-up|1|||
23376536|NCT03473197|65123188|FG000|Overall Study|Withdrawal by Subject|5|||
23376537|NCT00112957|65123191|FG000|Overall Study|Progressive disease|18|||
23489356|NCT01646073|65537035|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
23283998|NCT01695239|64781903|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
23376538|NCT00112957|65123191|FG000|Overall Study|Physician Decision|1|||
23376539|NCT02802228|65123192|FG000|Overall Study|Withdrawal by Subject|2|||
23376540|NCT02802228|65123193|FG001|Overall Study|Withdrawal by Subject|0|||
23376541|NCT02802228|65123192|FG000|Overall Study|Lost to Follow-up|1|||
23376542|NCT02802228|65123193|FG001|Overall Study|Lost to Follow-up|0|||
23376543|NCT02802228|65123192|FG000|Overall Study|Adverse Event|1|||
23489357|NCT01646073|65537036|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
23489358|NCT01646073|65537035|FG000|Period A (12 Weeks)|Protocol Violation|0|||
23489359|NCT01646073|65537036|FG001|Period A (12 Weeks)|Protocol Violation|1|||
23489360|NCT01646073|65537035|FG000|Period A (12 Weeks)|Other|0|||
23489361|NCT01646073|65537036|FG001|Period A (12 Weeks)|Other|1|||
23489362|NCT01646073|65537035|FG000|Period B (12 Weeks)|Adverse Event|0|||
23489363|NCT01646073|65537036|FG001|Period B (12 Weeks)|Adverse Event|7|||
23376544|NCT02802228|65123193|FG001|Overall Study|Adverse Event|0|||
23376545|NCT02802228|65123192|FG000|Overall Study|Physician Decision|1|||
23376546|NCT02802228|65123193|FG001|Overall Study|Physician Decision|0|||
23376547|NCT02225587|65123194|FG000|Overall Study|Adverse Event|5|||
23376548|NCT02225587|65123195|FG001|Overall Study|Adverse Event|5|||
23376549|NCT02225587|65123194|FG000|Overall Study|Lost to Follow-up|5|||
23376550|NCT02225587|65123195|FG001|Overall Study|Lost to Follow-up|5|||
23376551|NCT02225587|65123194|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23376552|NCT02225587|65123195|FG001|Overall Study|Non-Compliance With Study Drug|0|||
23376553|NCT02225587|65123194|FG000|Overall Study|Physician Decision|2|||
23376554|NCT02225587|65123195|FG001|Overall Study|Physician Decision|0|||
23376555|NCT02225587|65123194|FG000|Overall Study|Protocol Violation|1|||
23376556|NCT02225587|65123195|FG001|Overall Study|Protocol Violation|0|||
23376557|NCT02225587|65123194|FG000|Overall Study|Participant Moved|1|||
23376558|NCT02225587|65123195|FG001|Overall Study|Participant Moved|0|||
23489364|NCT01646073|65537035|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
23489365|NCT01646073|65537036|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
23489366|NCT01646073|65537035|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
23489367|NCT01646073|65537036|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
23489368|NCT02337738|65537039|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
23489369|NCT02337738|65537040|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
23489370|NCT02337738|65537041|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
23489371|NCT02337738|65537039|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
23489372|NCT02337738|65537040|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
23376559|NCT02225587|65123194|FG000|Overall Study|Withdrawal by Subject|13|||
23376560|NCT02225587|65123195|FG001|Overall Study|Withdrawal by Subject|28|||
23376561|NCT00706797|65123198|FG000|Overall Study|Lack of Efficacy|3|||
23376562|NCT00706797|65123199|FG001|Overall Study|Lack of Efficacy|0|||
23376563|NCT00706797|65123198|FG000|Overall Study|Adverse Event|0|||
23376564|NCT00706797|65123199|FG001|Overall Study|Adverse Event|3|||
23376565|NCT00706797|65123198|FG000|Overall Study|Withdrawal by Subject|8|||
23376566|NCT00706797|65123199|FG001|Overall Study|Withdrawal by Subject|1|||
23376567|NCT00706797|65123198|FG000|Overall Study|Death|1|||
23376568|NCT00706797|65123199|FG001|Overall Study|Death|0|||
23376569|NCT00706797|65123198|FG000|Overall Study|Discontinuation of study by sponsor|52|||
23376570|NCT00706797|65123199|FG001|Overall Study|Discontinuation of study by sponsor|63|||
23376571|NCT00706797|65123198|FG000|Overall Study|Protocol Violation|3|||
23376572|NCT00706797|65123199|FG001|Overall Study|Protocol Violation|2|||
23376573|NCT00706797|65123198|FG000|Overall Study|Lost to Follow-up|1|||
23376574|NCT00706797|65123199|FG001|Overall Study|Lost to Follow-up|2|||
23376575|NCT00706797|65123198|FG000|Overall Study|Other|1|||
23376576|NCT00706797|65123199|FG001|Overall Study|Other|0|||
23376577|NCT01513590|65123202|FG000|Overall Study|Adverse Event|2|||
23376578|NCT01513590|65123203|FG001|Overall Study|Adverse Event|3|||
23376579|NCT01513590|65123202|FG000|Overall Study|Withdrawal Criteria|3|||
23376580|NCT01513590|65123203|FG001|Overall Study|Withdrawal Criteria|0|||
23376581|NCT01513590|65123202|FG000|Overall Study|Unclassified|5|||
23376582|NCT01513590|65123203|FG001|Overall Study|Unclassified|10|||
23376583|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
23376584|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
23376585|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
23376586|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
23489373|NCT02337738|65537041|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
23489374|NCT02337738|65537039|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
23489375|NCT02337738|65537040|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
23604657|NCT03015220|65943474|FG002|Overall Study|Lost to Follow-up|1|||
23376587|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
23376588|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23376589|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
23376590|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
23376591|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
23376592|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
23376593|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
23376594|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
23376595|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
23376596|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
23283999|NCT01695239|64781904|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
23284000|NCT01695239|64781905|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
23284001|NCT01695239|64781892|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284002|NCT01695239|64781893|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284003|NCT01695239|64781894|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284004|NCT01695239|64781895|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284005|NCT01695239|64781896|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284006|NCT01695239|64781897|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284007|NCT01695239|64781898|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284008|NCT01695239|64781899|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23376597|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
23376598|NCT03738215|65123205|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
23376599|NCT03738215|65123206|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
23376600|NCT03738215|65123207|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
23284009|NCT01695239|64781900|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284010|NCT01695239|64781901|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284011|NCT01695239|64781902|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284012|NCT01695239|64781903|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
23284013|NCT01695239|64781904|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
23376601|NCT03738215|65123205|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
23376602|NCT03738215|65123206|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
23376603|NCT03738215|65123207|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
23376604|NCT03738215|65123205|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
23376605|NCT03738215|65123206|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
23376606|NCT03738215|65123207|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
23284014|NCT01695239|64781905|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
23284015|NCT01695239|64781892|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284016|NCT01695239|64781893|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284017|NCT01695239|64781894|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284018|NCT01695239|64781895|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284019|NCT01695239|64781896|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284020|NCT01695239|64781897|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284021|NCT01695239|64781898|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284022|NCT01695239|64781899|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
23376607|NCT03738215|65123205|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
23376608|NCT03738215|65123206|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
23376609|NCT03738215|65123207|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
23376610|NCT03738215|65123205|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
23376611|NCT03738215|65123206|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
23376612|NCT03738215|65123207|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
23376613|NCT00963235|65123208|FG000|Overall Study|Withdrawal by Subject|22|||
23376614|NCT00963235|65123208|FG000|Overall Study|Lost to Follow-up|14|||
23376615|NCT00963235|65123208|FG000|Overall Study|Failed to return|9|||
23376616|NCT00963235|65123208|FG000|Overall Study|Protocol Violation|7|||
23376617|NCT00963235|65123208|FG000|Overall Study|Adverse Event|5|||
23376618|NCT00963235|65123208|FG000|Overall Study|Physician Decision|2|||
23376619|NCT00963235|65123208|FG000|Overall Study|Other|1|||
23376620|NCT02335944|65123209|FG000|Treatment Phase|Progressive Disease|2|||
23376621|NCT02335944|65123210|FG001|Treatment Phase|Progressive Disease|5|||
23376622|NCT02335944|65123211|FG002|Treatment Phase|Progressive Disease|2|||
23376623|NCT02335944|65123212|FG003|Treatment Phase|Progressive Disease|11|||
23376624|NCT02335944|65123213|FG004|Treatment Phase|Progressive Disease|4|||
23376625|NCT02335944|65123214|FG005|Treatment Phase|Progressive Disease|25|||
23376626|NCT02335944|65123215|FG006|Treatment Phase|Progressive Disease|2|||
23376627|NCT02335944|65123216|FG007|Treatment Phase|Progressive Disease|30|||
23376628|NCT02335944|65123217|FG008|Treatment Phase|Progressive Disease|27|||
23376629|NCT02335944|65123218|FG009|Treatment Phase|Progressive Disease|0|||
23284023|NCT01695239|64781900|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284024|NCT01695239|64781901|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
23376630|NCT02335944|65123209|FG000|Treatment Phase|Adverse Event|2|||
23376631|NCT02335944|65123210|FG001|Treatment Phase|Adverse Event|0|||
23376632|NCT02335944|65123211|FG002|Treatment Phase|Adverse Event|0|||
23376633|NCT02335944|65123212|FG003|Treatment Phase|Adverse Event|2|||
23376634|NCT02335944|65123213|FG004|Treatment Phase|Adverse Event|1|||
23376635|NCT02335944|65123214|FG005|Treatment Phase|Adverse Event|15|||
23376636|NCT02335944|65123215|FG006|Treatment Phase|Adverse Event|0|||
23376637|NCT02335944|65123216|FG007|Treatment Phase|Adverse Event|5|||
23376638|NCT02335944|65123217|FG008|Treatment Phase|Adverse Event|7|||
23376639|NCT02335944|65123218|FG009|Treatment Phase|Adverse Event|0|||
23376640|NCT02335944|65123209|FG000|Treatment Phase|Physician Decision|0|||
23376641|NCT02335944|65123210|FG001|Treatment Phase|Physician Decision|0|||
23376642|NCT02335944|65123211|FG002|Treatment Phase|Physician Decision|0|||
23376643|NCT02335944|65123212|FG003|Treatment Phase|Physician Decision|1|||
23376644|NCT02335944|65123213|FG004|Treatment Phase|Physician Decision|0|||
23376645|NCT02335944|65123214|FG005|Treatment Phase|Physician Decision|6|||
23376646|NCT02335944|65123215|FG006|Treatment Phase|Physician Decision|1|||
23376647|NCT02335944|65123216|FG007|Treatment Phase|Physician Decision|2|||
23376648|NCT02335944|65123217|FG008|Treatment Phase|Physician Decision|1|||
23376649|NCT02335944|65123218|FG009|Treatment Phase|Physician Decision|0|||
23376650|NCT02335944|65123209|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
23376651|NCT02335944|65123210|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
23376652|NCT02335944|65123211|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
23376653|NCT02335944|65123212|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
23376654|NCT02335944|65123213|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
23376655|NCT02335944|65123214|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
23376656|NCT02335944|65123215|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
23376657|NCT02335944|65123216|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
23376658|NCT02335944|65123217|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
23376659|NCT02335944|65123218|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
23376660|NCT02335944|65123209|FG000|Treatment Phase|Subject/Guardian Decision|0|||
23376661|NCT02335944|65123210|FG001|Treatment Phase|Subject/Guardian Decision|0|||
23376662|NCT02335944|65123211|FG002|Treatment Phase|Subject/Guardian Decision|1|||
23376663|NCT02335944|65123212|FG003|Treatment Phase|Subject/Guardian Decision|0|||
23376664|NCT02335944|65123213|FG004|Treatment Phase|Subject/Guardian Decision|0|||
23376665|NCT02335944|65123214|FG005|Treatment Phase|Subject/Guardian Decision|1|||
23376666|NCT02335944|65123215|FG006|Treatment Phase|Subject/Guardian Decision|0|||
23376667|NCT02335944|65123216|FG007|Treatment Phase|Subject/Guardian Decision|4|||
23376668|NCT02335944|65123217|FG008|Treatment Phase|Subject/Guardian Decision|0|||
23376669|NCT02335944|65123218|FG009|Treatment Phase|Subject/Guardian Decision|0|||
23376670|NCT02335944|65123209|FG000|Post-treatment Follow-up|Progressive Disease|0|||
23376671|NCT02335944|65123210|FG001|Post-treatment Follow-up|Progressive Disease|0|||
23376672|NCT02335944|65123211|FG002|Post-treatment Follow-up|Progressive Disease|0|||
23376673|NCT02335944|65123212|FG003|Post-treatment Follow-up|Progressive Disease|1|||
23376674|NCT02335944|65123213|FG004|Post-treatment Follow-up|Progressive Disease|0|||
23376675|NCT02335944|65123214|FG005|Post-treatment Follow-up|Progressive Disease|9|||
23376676|NCT02335944|65123215|FG006|Post-treatment Follow-up|Progressive Disease|0|||
23376677|NCT02335944|65123216|FG007|Post-treatment Follow-up|Progressive Disease|2|||
23376678|NCT02335944|65123217|FG008|Post-treatment Follow-up|Progressive Disease|3|||
23376679|NCT02335944|65123218|FG009|Post-treatment Follow-up|Progressive Disease|0|||
23376680|NCT02335944|65123209|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376681|NCT02335944|65123210|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376682|NCT02335944|65123211|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376683|NCT02335944|65123212|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376684|NCT02335944|65123213|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376685|NCT02335944|65123214|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
23376686|NCT02335944|65123215|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376687|NCT02335944|65123216|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376688|NCT02335944|65123217|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376689|NCT02335944|65123218|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
23376690|NCT02335944|65123209|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376691|NCT02335944|65123210|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376692|NCT02335944|65123211|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
23284025|NCT01695239|64781902|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284026|NCT01695239|64781903|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284027|NCT01695239|64781904|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
23284028|NCT01695239|64781905|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
23284029|NCT01695239|64781892|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284030|NCT01695239|64781893|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284031|NCT01695239|64781894|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284032|NCT01695239|64781895|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284033|NCT01695239|64781896|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284034|NCT01695239|64781897|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284035|NCT01695239|64781898|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23376693|NCT02335944|65123212|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376694|NCT02335944|65123213|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376695|NCT02335944|65123214|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376696|NCT02335944|65123215|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376697|NCT02335944|65123216|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
23376698|NCT02335944|65123217|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376699|NCT02335944|65123218|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
23376700|NCT02335944|65123209|FG000|Post-treatment Follow-up|Adverse Event|0|||
23376701|NCT02335944|65123210|FG001|Post-treatment Follow-up|Adverse Event|0|||
23376702|NCT02335944|65123211|FG002|Post-treatment Follow-up|Adverse Event|0|||
23376703|NCT02335944|65123212|FG003|Post-treatment Follow-up|Adverse Event|0|||
23376704|NCT02335944|65123213|FG004|Post-treatment Follow-up|Adverse Event|0|||
23376705|NCT02335944|65123214|FG005|Post-treatment Follow-up|Adverse Event|1|||
23376706|NCT02335944|65123215|FG006|Post-treatment Follow-up|Adverse Event|0|||
23376707|NCT02335944|65123216|FG007|Post-treatment Follow-up|Adverse Event|0|||
23376708|NCT02335944|65123217|FG008|Post-treatment Follow-up|Adverse Event|0|||
23376709|NCT02335944|65123218|FG009|Post-treatment Follow-up|Adverse Event|0|||
23376710|NCT02335944|65123209|FG000|Post-treatment Follow-up|Death|0|||
23376711|NCT02335944|65123210|FG001|Post-treatment Follow-up|Death|0|||
23376712|NCT02335944|65123211|FG002|Post-treatment Follow-up|Death|0|||
23376713|NCT02335944|65123212|FG003|Post-treatment Follow-up|Death|1|||
23376714|NCT02335944|65123213|FG004|Post-treatment Follow-up|Death|0|||
23376715|NCT02335944|65123214|FG005|Post-treatment Follow-up|Death|1|||
23376716|NCT02335944|65123215|FG006|Post-treatment Follow-up|Death|0|||
23376717|NCT02335944|65123216|FG007|Post-treatment Follow-up|Death|0|||
23376718|NCT02335944|65123217|FG008|Post-treatment Follow-up|Death|0|||
23376719|NCT02335944|65123218|FG009|Post-treatment Follow-up|Death|0|||
23376720|NCT02335944|65123209|FG000|Post-treatment Follow-up|Physician Decision|1|||
23376721|NCT02335944|65123210|FG001|Post-treatment Follow-up|Physician Decision|0|||
23376722|NCT02335944|65123211|FG002|Post-treatment Follow-up|Physician Decision|0|||
23376723|NCT02335944|65123212|FG003|Post-treatment Follow-up|Physician Decision|0|||
23376724|NCT02335944|65123213|FG004|Post-treatment Follow-up|Physician Decision|0|||
23376725|NCT02335944|65123214|FG005|Post-treatment Follow-up|Physician Decision|0|||
23376726|NCT02335944|65123215|FG006|Post-treatment Follow-up|Physician Decision|0|||
23376727|NCT02335944|65123216|FG007|Post-treatment Follow-up|Physician Decision|1|||
23376728|NCT02335944|65123217|FG008|Post-treatment Follow-up|Physician Decision|0|||
23376729|NCT02335944|65123218|FG009|Post-treatment Follow-up|Physician Decision|0|||
23376730|NCT01529268|65123219|FG000|Overall Study|Lost to Follow-up|9|||
23284036|NCT01695239|64781899|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284037|NCT01695239|64781900|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284038|NCT01695239|64781901|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284039|NCT01695239|64781902|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284040|NCT01695239|64781903|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284041|NCT01695239|64781904|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
23284042|NCT01695239|64781905|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
23284043|NCT00918645|64781906|FG000|Overall Study|Withdrawal by Subject|1|||
23284044|NCT00965757|64781907|FG000|Double-blind Phase|Progression of concomitant disease|1|||
23284045|NCT00965757|64781908|FG001|Double-blind Phase|Progression of concomitant disease|2|||
23284046|NCT00965757|64781909|FG002|Double-blind Phase|Progression of concomitant disease|0|||
23376731|NCT01529268|65123220|FG001|Overall Study|Lost to Follow-up|3|||
23376732|NCT01529268|65123219|FG000|Overall Study|Moved|3|||
23376733|NCT01529268|65123220|FG001|Overall Study|Moved|0|||
23376734|NCT02807259|65123221|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
23376735|NCT02807259|65123222|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
23376736|NCT02807259|65123221|FG000|Midline (3 Months)|migration, refusal, not available|30|||
23376737|NCT02807259|65123222|FG001|Midline (3 Months)|migration, refusal, not available|34|||
23376738|NCT02807259|65123221|FG000|Endline (3 Months)|migration, refusal, not available|35|||
23376739|NCT02807259|65123222|FG001|Endline (3 Months)|migration, refusal, not available|87|||
23376740|NCT03086343|65123227|FG000|Period 1|Adverse Event|7|||
23376741|NCT03086343|65123228|FG001|Period 1|Adverse Event|7|||
23376742|NCT03086343|65123229|FG002|Period 1|Adverse Event|0|||
23376743|NCT03086343|65123230|FG003|Period 1|Adverse Event|1|||
23376744|NCT03086343|65123227|FG000|Period 1|Withdrawal by Subject|6|||
23376745|NCT03086343|65123228|FG001|Period 1|Withdrawal by Subject|10|||
23376746|NCT03086343|65123229|FG002|Period 1|Withdrawal by Subject|0|||
23376747|NCT03086343|65123230|FG003|Period 1|Withdrawal by Subject|0|||
23376748|NCT03086343|65123227|FG000|Period 1|Lost to Follow-up|1|||
23604658|NCT03015220|65943475|FG003|Overall Study|Lost to Follow-up|0|||
23604659|NCT04559698|65943476|FG000|Overall Study|Lost to Follow-up|14|||
23604660|NCT04559698|65943477|FG001|Overall Study|Lost to Follow-up|15|||
23376749|NCT03086343|65123228|FG001|Period 1|Lost to Follow-up|3|||
23376750|NCT03086343|65123229|FG002|Period 1|Lost to Follow-up|1|||
23376751|NCT03086343|65123230|FG003|Period 1|Lost to Follow-up|0|||
23376752|NCT03086343|65123227|FG000|Period 1|Other, Not Specified|10|||
23376753|NCT03086343|65123228|FG001|Period 1|Other, Not Specified|12|||
23376754|NCT03086343|65123229|FG002|Period 1|Other, Not Specified|2|||
23376755|NCT03086343|65123230|FG003|Period 1|Other, Not Specified|1|||
23376756|NCT03086343|65123227|FG000|Period 1|Missing|1|||
23376757|NCT03086343|65123228|FG001|Period 1|Missing|0|||
23604661|NCT04559698|65943476|FG000|Overall Study|Withdrawal by Subject|0|||
23604662|NCT04559698|65943477|FG001|Overall Study|Withdrawal by Subject|1|||
23376758|NCT03086343|65123229|FG002|Period 1|Missing|0|||
23376759|NCT03086343|65123230|FG003|Period 1|Missing|0|||
23284047|NCT00965757|64781910|FG003|Double-blind Phase|Progression of concomitant disease|0|||
23284048|NCT00965757|64781907|FG000|Double-blind Phase|Adverse drug reaction|2|||
23284049|NCT00965757|64781908|FG001|Double-blind Phase|Adverse drug reaction|1|||
23284050|NCT00965757|64781909|FG002|Double-blind Phase|Adverse drug reaction|0|||
23284051|NCT00965757|64781910|FG003|Double-blind Phase|Adverse drug reaction|0|||
23284052|NCT00965757|64781907|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
23284053|NCT00965757|64781908|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
23284054|NCT00965757|64781909|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
23284055|NCT00965757|64781910|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
23284056|NCT00965757|64781907|FG000|Double-blind Phase|Lack of Efficacy|7|||
23284057|NCT00965757|64781908|FG001|Double-blind Phase|Lack of Efficacy|11|||
23284058|NCT00965757|64781909|FG002|Double-blind Phase|Lack of Efficacy|0|||
23284059|NCT00965757|64781910|FG003|Double-blind Phase|Lack of Efficacy|0|||
23284060|NCT00965757|64781907|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
23284061|NCT00965757|64781908|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
23284062|NCT00965757|64781909|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
23284063|NCT00965757|64781910|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
23284064|NCT00965757|64781907|FG000|Double-blind Phase|Lost to Follow-up|0|||
23284065|NCT00965757|64781908|FG001|Double-blind Phase|Lost to Follow-up|1|||
23284066|NCT00965757|64781909|FG002|Double-blind Phase|Lost to Follow-up|0|||
23284067|NCT00965757|64781910|FG003|Double-blind Phase|Lost to Follow-up|0|||
23284068|NCT00965757|64781907|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
23284069|NCT00965757|64781908|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
23284070|NCT00965757|64781909|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
23284071|NCT00965757|64781910|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
23284072|NCT00965757|64781907|FG000|Double-blind Phase|Other|1|||
23284073|NCT00965757|64781908|FG001|Double-blind Phase|Other|0|||
23284074|NCT00965757|64781909|FG002|Double-blind Phase|Other|0|||
23284075|NCT00965757|64781910|FG003|Double-blind Phase|Other|0|||
23284076|NCT00965757|64781907|FG000|Extension Phase|Progression of concomitant disease|0|||
23284077|NCT00965757|64781908|FG001|Extension Phase|Progression of concomitant disease|0|||
23284078|NCT00965757|64781909|FG002|Extension Phase|Progression of concomitant disease|4|||
23284079|NCT00965757|64781910|FG003|Extension Phase|Progression of concomitant disease|2|||
23284080|NCT00965757|64781907|FG000|Extension Phase|Adverse drug reaction|0|||
23284081|NCT00965757|64781908|FG001|Extension Phase|Adverse drug reaction|0|||
23284082|NCT00965757|64781909|FG002|Extension Phase|Adverse drug reaction|6|||
23284083|NCT00965757|64781910|FG003|Extension Phase|Adverse drug reaction|3|||
23284084|NCT00965757|64781907|FG000|Extension Phase|Abnormal Laboratory Value|0|||
23284085|NCT00965757|64781908|FG001|Extension Phase|Abnormal Laboratory Value|0|||
23284086|NCT00965757|64781909|FG002|Extension Phase|Abnormal Laboratory Value|6|||
23284087|NCT00965757|64781910|FG003|Extension Phase|Abnormal Laboratory Value|1|||
23284088|NCT00965757|64781907|FG000|Extension Phase|Lack of Efficacy|0|||
23284089|NCT00965757|64781908|FG001|Extension Phase|Lack of Efficacy|0|||
23284090|NCT00965757|64781909|FG002|Extension Phase|Lack of Efficacy|8|||
23284091|NCT00965757|64781910|FG003|Extension Phase|Lack of Efficacy|12|||
23284092|NCT00965757|64781907|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
23284093|NCT00965757|64781908|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
23284094|NCT00965757|64781909|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
23284095|NCT00965757|64781910|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
23284096|NCT00965757|64781907|FG000|Extension Phase|Lost to Follow-up|0|||
23284097|NCT00965757|64781908|FG001|Extension Phase|Lost to Follow-up|0|||
23284098|NCT00965757|64781909|FG002|Extension Phase|Lost to Follow-up|0|||
23284099|NCT00965757|64781910|FG003|Extension Phase|Lost to Follow-up|1|||
23284100|NCT00965757|64781907|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
23284101|NCT00965757|64781908|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
23284102|NCT00965757|64781909|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
23284103|NCT00965757|64781910|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
23284104|NCT00965757|64781907|FG000|Extension Phase|Protocol Violation|0|||
23284105|NCT00965757|64781908|FG001|Extension Phase|Protocol Violation|0|||
23284106|NCT00965757|64781909|FG002|Extension Phase|Protocol Violation|0|||
23284107|NCT00965757|64781910|FG003|Extension Phase|Protocol Violation|1|||
23284108|NCT00965757|64781907|FG000|Extension Phase|Other|0|||
23284109|NCT00965757|64781908|FG001|Extension Phase|Other|0|||
23284110|NCT00965757|64781909|FG002|Extension Phase|Other|2|||
23284111|NCT00965757|64781910|FG003|Extension Phase|Other|1|||
23284112|NCT00828321|64781911|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
23284113|NCT00828321|64781912|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
23284114|NCT00828321|64781911|FG000|Second Intervention|Protocol Violation|0|||
23284115|NCT00828321|64781912|FG001|Second Intervention|Protocol Violation|1|||
23284116|NCT02241551|64781913|FG000|Overall Study|Adverse Event|1|||
23284117|NCT02241551|64781914|FG001|Overall Study|Adverse Event|0|||
23284118|NCT01083693|64781915|FG000|Overall Study|Adverse Event|1|||
23376760|NCT03086343|65123227|FG000|Period 2|Adverse Event|20|||
23376761|NCT03086343|65123228|FG001|Period 2|Adverse Event|11|||
23376762|NCT03086343|65123229|FG002|Period 2|Adverse Event|1|||
23376763|NCT03086343|65123230|FG003|Period 2|Adverse Event|2|||
23376764|NCT03086343|65123227|FG000|Period 2|Withdrawal by Subject|15|||
23376765|NCT03086343|65123228|FG001|Period 2|Withdrawal by Subject|25|||
23376766|NCT03086343|65123229|FG002|Period 2|Withdrawal by Subject|2|||
23376767|NCT03086343|65123230|FG003|Period 2|Withdrawal by Subject|2|||
23376768|NCT03086343|65123227|FG000|Period 2|Lost to Follow-up|6|||
23376769|NCT03086343|65123228|FG001|Period 2|Lost to Follow-up|11|||
23376770|NCT03086343|65123229|FG002|Period 2|Lost to Follow-up|1|||
23376771|NCT03086343|65123230|FG003|Period 2|Lost to Follow-up|0|||
23376772|NCT03086343|65123227|FG000|Period 2|COVID-19 Infection|5|||
23376773|NCT03086343|65123228|FG001|Period 2|COVID-19 Infection|0|||
23376774|NCT03086343|65123229|FG002|Period 2|COVID-19 Infection|0|||
23376775|NCT03086343|65123230|FG003|Period 2|COVID-19 Infection|0|||
23376776|NCT03086343|65123227|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
23376777|NCT03086343|65123228|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
23376778|NCT03086343|65123229|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
23376779|NCT03086343|65123230|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
23376780|NCT03086343|65123227|FG000|Period 2|Other, Not Specified|23|||
23376781|NCT03086343|65123228|FG001|Period 2|Other, Not Specified|22|||
23376782|NCT03086343|65123229|FG002|Period 2|Other, Not Specified|2|||
23376783|NCT03086343|65123230|FG003|Period 2|Other, Not Specified|4|||
23376784|NCT00941928|65123234|FG000|Overall Study|Withdrawal by Subject|1|||
23376785|NCT00941928|65123234|FG000|Overall Study|Disease Progression|1|||
23376786|NCT01458587|65123238|FG000|Overall Study|Withdrawal by Subject|1|||
23376787|NCT01458587|65123239|FG001|Overall Study|Withdrawal by Subject|0|||
23376788|NCT00689936|65123240|FG000|Active Treatment Phase|Adverse Event|68|||
23376789|NCT00689936|65123241|FG001|Active Treatment Phase|Adverse Event|71|||
23376790|NCT00689936|65123242|FG002|Active Treatment Phase|Adverse Event|76|||
23376791|NCT00689936|65123240|FG000|Active Treatment Phase|Disease Progression|273|||
23376792|NCT00689936|65123241|FG001|Active Treatment Phase|Disease Progression|362|||
23376793|NCT00689936|65123242|FG002|Active Treatment Phase|Disease Progression|339|||
23376794|NCT00689936|65123240|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
23376795|NCT00689936|65123241|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
23376796|NCT00689936|65123242|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
23376797|NCT00689936|65123240|FG000|Active Treatment Phase|Death|60|||
23376798|NCT00689936|65123241|FG001|Active Treatment Phase|Death|28|||
23376799|NCT00689936|65123242|FG002|Active Treatment Phase|Death|37|||
23376800|NCT00689936|65123240|FG000|Active Treatment Phase|Lost to Follow-up|0|||
23376801|NCT00689936|65123241|FG001|Active Treatment Phase|Lost to Follow-up|2|||
23376802|NCT00689936|65123242|FG002|Active Treatment Phase|Lost to Follow-up|2|||
23376803|NCT00689936|65123240|FG000|Active Treatment Phase|Protocol Violation|2|||
23376804|NCT00689936|65123241|FG001|Active Treatment Phase|Protocol Violation|2|||
23376805|NCT00689936|65123242|FG002|Active Treatment Phase|Protocol Violation|4|||
23489376|NCT02337738|65537041|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
23284119|NCT01083693|64781916|FG001|Overall Study|Adverse Event|1|||
23284120|NCT01083693|64781917|FG002|Overall Study|Adverse Event|0|||
23284121|NCT01083693|64781915|FG000|Overall Study|Lost to Follow-up|2|||
23284122|NCT01083693|64781916|FG001|Overall Study|Lost to Follow-up|0|||
23284123|NCT01083693|64781917|FG002|Overall Study|Lost to Follow-up|2|||
23284124|NCT01083693|64781915|FG000|Overall Study|Lack of effectiveness|13|||
23284125|NCT01083693|64781916|FG001|Overall Study|Lack of effectiveness|2|||
23284126|NCT01083693|64781917|FG002|Overall Study|Lack of effectiveness|2|||
23284127|NCT01083693|64781915|FG000|Overall Study|Patient Moved|0|||
23284128|NCT01083693|64781916|FG001|Overall Study|Patient Moved|1|||
23284129|NCT01083693|64781917|FG002|Overall Study|Patient Moved|0|||
23284130|NCT01083693|64781915|FG000|Overall Study|Complete remission|0|||
23284131|NCT01083693|64781916|FG001|Overall Study|Complete remission|1|||
23284132|NCT01083693|64781917|FG002|Overall Study|Complete remission|0|||
23284133|NCT01083693|64781915|FG000|Overall Study|Other medical condition/surgery|1|||
23284134|NCT01083693|64781916|FG001|Overall Study|Other medical condition/surgery|1|||
23284135|NCT01083693|64781917|FG002|Overall Study|Other medical condition/surgery|0|||
23284136|NCT01083693|64781915|FG000|Overall Study|Withdrawal by Subject|3|||
23284137|NCT01083693|64781916|FG001|Overall Study|Withdrawal by Subject|0|||
23284138|NCT01083693|64781917|FG002|Overall Study|Withdrawal by Subject|2|||
23284139|NCT01083693|64781915|FG000|Overall Study|Reason unknown|0|||
23284140|NCT01083693|64781916|FG001|Overall Study|Reason unknown|0|||
23284141|NCT01083693|64781917|FG002|Overall Study|Reason unknown|1|||
23284142|NCT00472212|64781918|FG000|Overall Study|Lost to Follow-up|6|||
23376806|NCT00689936|65123240|FG000|Active Treatment Phase|Study Close Out|64|||
23376807|NCT00689936|65123241|FG001|Active Treatment Phase|Study Close Out|26|||
23376808|NCT00689936|65123242|FG002|Active Treatment Phase|Study Close Out|21|||
23376809|NCT00689936|65123240|FG000|Active Treatment Phase|Miscellaneous|52|||
23376810|NCT00689936|65123241|FG001|Active Treatment Phase|Miscellaneous|34|||
23376811|NCT00689936|65123242|FG002|Active Treatment Phase|Miscellaneous|47|||
23284143|NCT00472212|64781919|FG001|Overall Study|Lost to Follow-up|4|||
23284144|NCT03637764|64781928|FG000|Overall Study|Adverse Event|2|||
23284145|NCT03637764|64781929|FG001|Overall Study|Adverse Event|0|||
23284146|NCT03637764|64781930|FG002|Overall Study|Adverse Event|0|||
23284147|NCT03637764|64781931|FG003|Overall Study|Adverse Event|1|||
23284148|NCT03637764|64781928|FG000|Overall Study|Progressive Disease|23|||
23284149|NCT03637764|64781929|FG001|Overall Study|Progressive Disease|23|||
23604663|NCT04809623|65943478|FG000|Overall Study|Study Terminated by Sponsor|1|||
23604664|NCT04809623|65943479|FG001|Overall Study|Study Terminated by Sponsor|0|||
23284150|NCT03637764|64781930|FG002|Overall Study|Progressive Disease|18|||
23284151|NCT03637764|64781931|FG003|Overall Study|Progressive Disease|31|||
23376812|NCT00689936|65123240|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
23376813|NCT00689936|65123241|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
23376814|NCT00689936|65123242|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
23376815|NCT03482024|65123247|FG000|Overall Study|Physician Decision|1|||
23376816|NCT03482024|65123248|FG001|Overall Study|Physician Decision|0|||
23376817|NCT03482024|65123249|FG002|Overall Study|Physician Decision|0|||
23376818|NCT03482024|65123250|FG003|Overall Study|Physician Decision|0|||
23376819|NCT03482024|65123251|FG004|Overall Study|Physician Decision|0|||
23376820|NCT02832037|65123252|FG000|Overall Study|Administrative reasons|0|||
23376821|NCT02832037|65123253|FG001|Overall Study|Administrative reasons|0|||
23604665|NCT00786864|65943480|FG000|Overall Study|Lost to Follow-up|0|||
23604666|NCT00786864|65943481|FG001|Overall Study|Lost to Follow-up|1|||
23604667|NCT00786864|65943480|FG000|Overall Study|Sustained serious back injury|1|||
23604668|NCT00786864|65943481|FG001|Overall Study|Sustained serious back injury|0|||
23604669|NCT01021748|65943482|FG000|Overall Study|Adverse Event|2|||
23604670|NCT01021748|65943483|FG001|Overall Study|Adverse Event|1|||
23604671|NCT01021748|65943484|FG002|Overall Study|Adverse Event|2|||
23284152|NCT03637764|64781928|FG000|Overall Study|Withdrawal by Subject|1|||
23284153|NCT03637764|64781929|FG001|Overall Study|Withdrawal by Subject|3|||
23284154|NCT03637764|64781930|FG002|Overall Study|Withdrawal by Subject|0|||
23284155|NCT03637764|64781931|FG003|Overall Study|Withdrawal by Subject|1|||
23284156|NCT02654145|64781932|FG000|Overall Study|Lack of Efficacy|1|||
23284157|NCT02654145|64781932|FG000|Overall Study|Protocol Violation|1|||
23284158|NCT02654145|64781932|FG000|Overall Study|Withdrawal by Subject|5|||
23284159|NCT04002648|64781933|FG000|Overall Study|Lost to Follow-up|2|||
23284160|NCT04002648|64781934|FG001|Overall Study|Lost to Follow-up|0|||
23284161|NCT02611687|64781935|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
23284162|NCT02611687|64781936|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
23284163|NCT04060251|64781937|FG000|Overall Study|Study terminated due to low enrollment.|7|||
23284164|NCT04060251|64781938|FG001|Overall Study|Study terminated due to low enrollment.|5|||
23284165|NCT04060251|64781939|FG002|Overall Study|Study terminated due to low enrollment.|7|||
23284166|NCT04060251|64781937|FG000|Overall Study|Adverse Event|1|||
23284167|NCT04060251|64781938|FG001|Overall Study|Adverse Event|1|||
23284168|NCT04060251|64781939|FG002|Overall Study|Adverse Event|0|||
23284169|NCT02462837|64781940|FG000|Overall Study|pt developed hives|1|||
23284170|NCT02462837|64781941|FG001|Overall Study|pt developed hives|0|||
23284171|NCT02462837|64781940|FG000|Overall Study|Withdrawal by Subject|1|||
23284172|NCT02462837|64781941|FG001|Overall Study|Withdrawal by Subject|0|||
23284173|NCT04183335|64781947|FG000|Overall Study|Adverse Event|1|||
23284174|NCT04183335|64781948|FG001|Overall Study|Adverse Event|0|||
23284175|NCT04183335|64781947|FG000|Overall Study|Withdrawal by Subject|12|||
23284176|NCT04183335|64781948|FG001|Overall Study|Withdrawal by Subject|3|||
23284177|NCT00521586|64781949|FG000|Initial Vaccination (Year 0)|Subject request|8|||
23284178|NCT00521586|64781950|FG001|Initial Vaccination (Year 0)|Subject request|11|||
23284179|NCT00521586|64781949|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
23284180|NCT00521586|64781950|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
23284181|NCT00521586|64781949|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
23284182|NCT00521586|64781950|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
23604672|NCT01021748|65943485|FG003|Overall Study|Adverse Event|0|||
23604673|NCT01021748|65943486|FG004|Overall Study|Adverse Event|2|||
23604674|NCT01021748|65943487|FG005|Overall Study|Adverse Event|0|||
23284183|NCT00521586|64781949|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
23376822|NCT02832037|65123254|FG002|Overall Study|Administrative reasons|1|||
23604675|NCT01021748|65943488|FG006|Overall Study|Adverse Event|1|||
23284184|NCT00521586|64781950|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
23604676|NCT01021748|65943489|FG007|Overall Study|Adverse Event|0|||
23376823|NCT02832037|65123255|FG003|Overall Study|Administrative reasons|0|||
23284185|NCT00521586|64781949|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
23284186|NCT00521586|64781950|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
23284187|NCT00521586|64781949|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
23284188|NCT00521586|64781950|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
23284189|NCT00521586|64781949|FG000|Initial Vaccination (Year 0)|Death|1|||
23284190|NCT00521586|64781950|FG001|Initial Vaccination (Year 0)|Death|0|||
23284191|NCT00521586|64781949|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
23284192|NCT00521586|64781950|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
23284193|NCT00521586|64781949|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
23284194|NCT00521586|64781950|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
23284195|NCT00521586|64781949|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
23284196|NCT00521586|64781950|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
23284197|NCT00521586|64781949|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
23284198|NCT00521586|64781950|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
23284199|NCT00521586|64781949|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
23284200|NCT00521586|64781950|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
23284201|NCT00521586|64781949|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
23284202|NCT00521586|64781950|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
23284203|NCT00521586|64781949|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
23284204|NCT00521586|64781950|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
23284205|NCT00521586|64781949|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
23284206|NCT00521586|64781950|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
23284207|NCT00521586|64781949|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
23284208|NCT00521586|64781950|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
23284209|NCT00521586|64781949|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
23284210|NCT00521586|64781950|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
23284211|NCT00521586|64781949|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
23284212|NCT00521586|64781950|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
23284213|NCT00521586|64781949|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
23284214|NCT00521586|64781950|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
23284215|NCT00902538|64781951|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
23284216|NCT00902538|64781952|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23284217|NCT00902538|64781953|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23284218|NCT00902538|64781954|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23284219|NCT00902538|64781955|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23284220|NCT00902538|64781956|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
23284221|NCT00902538|64781951|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
23284222|NCT00902538|64781952|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23284223|NCT00902538|64781953|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23284224|NCT00902538|64781954|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23284225|NCT00902538|64781955|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23284226|NCT00902538|64781956|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
23284227|NCT00902538|64781951|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
23284228|NCT00902538|64781952|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23284229|NCT00902538|64781953|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23284230|NCT00902538|64781954|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23284231|NCT00902538|64781955|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23284232|NCT00902538|64781956|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
23376824|NCT02832037|65123256|FG004|Overall Study|Administrative reasons|0|||
23376825|NCT02832037|65123252|FG000|Overall Study|Protocol Violation|3|||
23376826|NCT02832037|65123253|FG001|Overall Study|Protocol Violation|0|||
23489377|NCT02337738|65537039|FG000|Overall Study|Voluntary Withdrawal|10|||
23489378|NCT02337738|65537040|FG001|Overall Study|Voluntary Withdrawal|5|||
23489379|NCT02337738|65537041|FG002|Overall Study|Voluntary Withdrawal|2|||
23489380|NCT02337738|65537039|FG000|Overall Study|Lack of Efficacy|2|||
23489381|NCT02337738|65537040|FG001|Overall Study|Lack of Efficacy|4|||
23489382|NCT02337738|65537041|FG002|Overall Study|Lack of Efficacy|0|||
23489383|NCT02337738|65537039|FG000|Overall Study|Investigator's Judgment|1|||
23489384|NCT02337738|65537040|FG001|Overall Study|Investigator's Judgment|1|||
23489385|NCT02337738|65537041|FG002|Overall Study|Investigator's Judgment|3|||
23489386|NCT01676727|65537042|FG000|Overall Study|Death|18|||
23489387|NCT01676727|65537042|FG000|Overall Study|Withdrawal by Subject|6|||
23489388|NCT01676727|65537042|FG000|Overall Study|Screening failure|5|||
23489389|NCT01676727|65537042|FG000|Overall Study|Not willing to attend 1-year visit|2|||
23489390|NCT01676727|65537042|FG000|Overall Study|Valve explanted|1|||
23489391|NCT00753766|65537046|FG000|Overall Study|Physician Decision|1|||
23489392|NCT00753766|65537047|FG001|Overall Study|Physician Decision|0|||
23489393|NCT01925274|65537048|FG000|Overall Study|Death|1|||
23489394|NCT01925274|65537049|FG001|Overall Study|Death|0|||
23489395|NCT01925274|65537050|FG002|Overall Study|Death|0|||
23489396|NCT01925274|65537048|FG000|Overall Study|Lost to Follow-up|0|||
23489397|NCT01925274|65537049|FG001|Overall Study|Lost to Follow-up|1|||
23489398|NCT01925274|65537050|FG002|Overall Study|Lost to Follow-up|0|||
23489399|NCT01925274|65537048|FG000|Overall Study|Withdrawal by Subject|1|||
23489400|NCT01925274|65537049|FG001|Overall Study|Withdrawal by Subject|2|||
23489401|NCT01925274|65537050|FG002|Overall Study|Withdrawal by Subject|0|||
23489402|NCT01925274|65537048|FG000|Overall Study|Study terminated by sponsor|4|||
23489403|NCT01925274|65537049|FG001|Overall Study|Study terminated by sponsor|0|||
23489404|NCT01925274|65537050|FG002|Overall Study|Study terminated by sponsor|0|||
23489405|NCT01925274|65537048|FG000|Overall Study|Protocol amendment|1|||
23489406|NCT01925274|65537049|FG001|Overall Study|Protocol amendment|3|||
23489407|NCT01925274|65537050|FG002|Overall Study|Protocol amendment|6|||
23489408|NCT04545554|65537051|FG000|Overall Study|Withdrawal by Subject|0|||
23489409|NCT04545554|65537052|FG001|Overall Study|Withdrawal by Subject|0|||
23489410|NCT04545554|65537053|FG002|Overall Study|Withdrawal by Subject|0|||
23489411|NCT04545554|65537054|FG003|Overall Study|Withdrawal by Subject|1|||
23489412|NCT04545554|65537055|FG004|Overall Study|Withdrawal by Subject|0|||
23489413|NCT04545554|65537056|FG005|Overall Study|Withdrawal by Subject|0|||
23489414|NCT03270644|65537057|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
23489415|NCT03270644|65537057|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
23489416|NCT02478372|65537058|FG000|Overall Study|Protocol Violation|12|||
23489417|NCT02478372|65537059|FG001|Overall Study|Protocol Violation|8|||
23489418|NCT02478372|65537058|FG000|Overall Study|Lost to Follow-up|1|||
23489419|NCT02478372|65537059|FG001|Overall Study|Lost to Follow-up|4|||
23489420|NCT02478372|65537058|FG000|Overall Study|Death|0|||
23489421|NCT02478372|65537059|FG001|Overall Study|Death|2|||
23489422|NCT03387683|65537060|FG000|Overall Study|In receipt of disallowed medication|1|||
23489423|NCT03387683|65537061|FG001|Overall Study|In receipt of disallowed medication|0|||
23489424|NCT03387683|65537060|FG000|Overall Study|Did not receive treatment|1|||
23489425|NCT03387683|65537061|FG001|Overall Study|Did not receive treatment|0|||
23489426|NCT01241240|65537065|FG000|Overall Study|Adverse Event|5|||
23284233|NCT00902538|64781951|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
23284234|NCT00902538|64781952|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23284235|NCT00902538|64781953|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23284236|NCT00902538|64781954|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23284237|NCT00902538|64781955|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23284238|NCT00902538|64781956|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
23284239|NCT00902538|64781951|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
23284240|NCT00902538|64781952|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23284241|NCT00902538|64781953|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23284242|NCT00902538|64781954|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23284243|NCT00902538|64781955|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23284244|NCT00902538|64781956|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
23284245|NCT00902538|64781951|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
23284246|NCT00902538|64781952|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
23376827|NCT02832037|65123254|FG002|Overall Study|Protocol Violation|4|||
23489427|NCT01241240|65537066|FG001|Overall Study|Adverse Event|4|||
23489428|NCT01241240|65537065|FG000|Overall Study|Lost to Follow-up|2|||
23489429|NCT01241240|65537066|FG001|Overall Study|Lost to Follow-up|4|||
23489430|NCT01241240|65537065|FG000|Overall Study|Personal Reasons|1|||
23489431|NCT01241240|65537066|FG001|Overall Study|Personal Reasons|1|||
23489432|NCT01031706|65537067|FG000|Overall Study|Adverse Event|1|||
23489433|NCT01031706|65537068|FG001|Overall Study|Adverse Event|0|||
23489434|NCT01031706|65537067|FG000|Overall Study|Withdrawal by Subject|1|||
23489435|NCT01031706|65537068|FG001|Overall Study|Withdrawal by Subject|1|||
23489436|NCT01193660|65537069|FG000|Overall Study|Withdrawal by Subject|2|||
23489437|NCT01193660|65537070|FG001|Overall Study|Withdrawal by Subject|3|||
23489438|NCT01193660|65537071|FG002|Overall Study|Withdrawal by Subject|1|||
23489439|NCT01193660|65537069|FG000|Overall Study|Death|1|||
23489440|NCT01193660|65537070|FG001|Overall Study|Death|0|||
23489441|NCT01193660|65537071|FG002|Overall Study|Death|0|||
23489442|NCT01193660|65537069|FG000|Overall Study|Physician Decision|1|||
23489443|NCT01193660|65537070|FG001|Overall Study|Physician Decision|0|||
23489444|NCT01193660|65537071|FG002|Overall Study|Physician Decision|1|||
23489445|NCT02413372|65537072|FG000|Treatment|Lost to Follow-up|0|||
23489446|NCT02413372|65537073|FG001|Treatment|Lost to Follow-up|2|||
23489447|NCT02413372|65537074|FG002|Treatment|Lost to Follow-up|1|||
23489448|NCT02413372|65537072|FG000|Treatment|Withdrawal by Subject|1|||
23489449|NCT02413372|65537073|FG001|Treatment|Withdrawal by Subject|0|||
23489450|NCT02413372|65537074|FG002|Treatment|Withdrawal by Subject|0|||
23489451|NCT02413372|65537072|FG000|Follow-up|Lost to Follow-up|1|||
23489452|NCT02413372|65537073|FG001|Follow-up|Lost to Follow-up|1|||
23489453|NCT02413372|65537074|FG002|Follow-up|Lost to Follow-up|0|||
23489454|NCT02413372|65537072|FG000|Follow-up|Subject Withdrew Consent|1|||
23489455|NCT02413372|65537073|FG001|Follow-up|Subject Withdrew Consent|0|||
23489456|NCT02413372|65537074|FG002|Follow-up|Subject Withdrew Consent|1|||
23489457|NCT02413372|65537072|FG000|Follow-up|Subject unable to return for visit|0|||
23489458|NCT02413372|65537073|FG001|Follow-up|Subject unable to return for visit|0|||
23489459|NCT02413372|65537074|FG002|Follow-up|Subject unable to return for visit|1|||
23489460|NCT00586066|65537075|FG000|Overall Study|Lost to Follow-up|6|||
23489461|NCT00586066|65537076|FG001|Overall Study|Lost to Follow-up|3|||
23489462|NCT00586066|65537075|FG000|Overall Study|Lack of Efficacy|5|||
23489463|NCT00586066|65537076|FG001|Overall Study|Lack of Efficacy|3|||
23489464|NCT00586066|65537075|FG000|Overall Study|Adverse Event|2|||
23489465|NCT00586066|65537076|FG001|Overall Study|Adverse Event|2|||
23489466|NCT00586066|65537075|FG000|Overall Study|Physician Decision|1|||
23489467|NCT00586066|65537076|FG001|Overall Study|Physician Decision|0|||
23489468|NCT00586066|65537075|FG000|Overall Study|Withdrawal of consent|4|||
23489469|NCT00586066|65537076|FG001|Overall Study|Withdrawal of consent|2|||
23489470|NCT04795622|65537077|FG000|Overall Study|Adverse Event|1|||
23489471|NCT04795622|65537078|FG001|Overall Study|Adverse Event|0|||
23489472|NCT04795622|65537077|FG000|Overall Study|Withdrawal by Subject|3|||
23489473|NCT04795622|65537078|FG001|Overall Study|Withdrawal by Subject|3|||
23489474|NCT04795622|65537077|FG000|Overall Study|Protocol Violation|0|||
23489475|NCT04795622|65537078|FG001|Overall Study|Protocol Violation|2|||
23489476|NCT04795622|65537077|FG000|Overall Study|Lost to Follow-up|2|||
23489477|NCT04795622|65537078|FG001|Overall Study|Lost to Follow-up|3|||
23489478|NCT04795622|65537077|FG000|Overall Study|Other|7|||
23489479|NCT04795622|65537078|FG001|Overall Study|Other|8|||
23489480|NCT01231347|65537080|FG000|Overall Study|Full Consent withdrawn|19|||
23489481|NCT01231347|65537081|FG001|Overall Study|Full Consent withdrawn|19|||
23489482|NCT01231347|65537082|FG002|Overall Study|Full Consent withdrawn|11|||
23489483|NCT01231347|65537080|FG000|Overall Study|Lost to Follow-up|4|||
23489484|NCT01231347|65537081|FG001|Overall Study|Lost to Follow-up|2|||
23489485|NCT01231347|65537082|FG002|Overall Study|Lost to Follow-up|2|||
23489486|NCT01231347|65537080|FG000|Overall Study|Death|202|||
23284247|NCT00902538|64781953|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
23284248|NCT00902538|64781954|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
23284249|NCT00902538|64781955|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
23284250|NCT00902538|64781956|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
23284251|NCT00902538|64781951|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
23284252|NCT00902538|64781952|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
23284253|NCT00902538|64781953|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
23284254|NCT00902538|64781954|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
23284255|NCT00902538|64781955|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
23284256|NCT00902538|64781956|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
23284257|NCT00902538|64781951|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
23284258|NCT00902538|64781952|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
23489487|NCT01231347|65537081|FG001|Overall Study|Death|210|||
23489488|NCT01231347|65537082|FG002|Overall Study|Death|101|||
23489489|NCT01231347|65537080|FG000|Overall Study|other event|7|||
23489490|NCT01231347|65537081|FG001|Overall Study|other event|9|||
23489491|NCT01231347|65537082|FG002|Overall Study|other event|3|||
23489492|NCT00667602|65537083|FG000|Overall Study|Withdrawal by Subject|4|||
23489493|NCT00667602|65537084|FG001|Overall Study|Withdrawal by Subject|9|||
23489494|NCT00667602|65537085|FG002|Overall Study|Withdrawal by Subject|10|||
23489495|NCT00667602|65537083|FG000|Overall Study|Lost to Follow-up|4|||
23284259|NCT00902538|64781953|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
23489496|NCT00667602|65537084|FG001|Overall Study|Lost to Follow-up|5|||
23489497|NCT00667602|65537085|FG002|Overall Study|Lost to Follow-up|6|||
23489498|NCT00667602|65537083|FG000|Overall Study|Administrative reason|0|||
23489499|NCT00667602|65537084|FG001|Overall Study|Administrative reason|0|||
23489500|NCT00667602|65537085|FG002|Overall Study|Administrative reason|2|||
23284260|NCT00902538|64781954|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
23284261|NCT00902538|64781955|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
23284262|NCT00902538|64781956|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
23284263|NCT00902538|64781951|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
23284264|NCT00902538|64781952|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
23284265|NCT00902538|64781953|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
23284266|NCT00902538|64781954|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
23284267|NCT00902538|64781955|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
23284268|NCT00902538|64781956|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
23284269|NCT00902538|64781951|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
23284270|NCT00902538|64781952|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
23284271|NCT00902538|64781953|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
23284272|NCT00902538|64781954|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
23284273|NCT00902538|64781955|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
23284274|NCT00902538|64781956|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
23284275|NCT00902538|64781951|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
23284276|NCT00902538|64781952|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
23284277|NCT00902538|64781953|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
23284278|NCT00902538|64781954|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
23284279|NCT00902538|64781955|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
23284280|NCT00902538|64781956|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
23284281|NCT00902538|64781951|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
23284282|NCT00902538|64781952|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
23284283|NCT00902538|64781953|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
23284284|NCT00902538|64781954|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
23284285|NCT00902538|64781955|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
23284286|NCT00902538|64781956|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
23284287|NCT00902538|64781951|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23284288|NCT00902538|64781952|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
23284289|NCT00902538|64781953|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23489501|NCT00667602|65537083|FG000|Overall Study|Protocol Violation|0|||
23489502|NCT00667602|65537084|FG001|Overall Study|Protocol Violation|1|||
23489503|NCT00667602|65537085|FG002|Overall Study|Protocol Violation|0|||
23489504|NCT03257371|65537088|FG000|Overall Study|Lost to Follow-up|1|||
23489505|NCT01180634|65537095|FG000|Overall Study|Adverse Event|4|||
23489506|NCT01180634|65537096|FG001|Overall Study|Adverse Event|1|||
23489507|NCT01180634|65537095|FG000|Overall Study|Miscellaneous|2|||
23489508|NCT01180634|65537096|FG001|Overall Study|Miscellaneous|0|||
23489509|NCT01180634|65537095|FG000|Overall Study|Withdrawal by Subject|4|||
23489510|NCT01180634|65537096|FG001|Overall Study|Withdrawal by Subject|0|||
23489511|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
23489512|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
23489513|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
23489514|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
23489515|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
23489516|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
23489517|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
23489518|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
23489519|NCT03347188|65537097|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
23489520|NCT03347188|65537098|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
23489521|NCT03347188|65537097|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
23489522|NCT03347188|65537098|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
23489523|NCT03347188|65537097|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
23489524|NCT03347188|65537098|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
23489525|NCT03347188|65537097|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
23489526|NCT03347188|65537098|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
23489527|NCT04251273|65537099|FG000|Overall Study|Lost to Follow-up|331|||
23489528|NCT04251273|65537100|FG001|Overall Study|Lost to Follow-up|290|||
23489529|NCT04447417|65537101|FG000|Overall Study|Withdrawal by Subject|1|||
23489530|NCT04447417|65537102|FG001|Overall Study|Withdrawal by Subject|0|||
23489531|NCT04447417|65537101|FG000|Overall Study|Failure to meet inclusion criteria|1|||
23489532|NCT04447417|65537102|FG001|Overall Study|Failure to meet inclusion criteria|0|||
23489533|NCT04447417|65537101|FG000|Overall Study|Lost to Follow-up|1|||
23489534|NCT04447417|65537102|FG001|Overall Study|Lost to Follow-up|0|||
23284290|NCT00902538|64781954|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23489535|NCT01986140|65537103|FG000|Overall Study|Withdrawal by Subject|31|||
23489536|NCT01986140|65537104|FG001|Overall Study|Withdrawal by Subject|25|||
23489537|NCT01986140|65537103|FG000|Overall Study|alternative treatment|1|||
23284291|NCT00902538|64781955|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23376828|NCT02832037|65123255|FG003|Overall Study|Protocol Violation|1|||
23376829|NCT02832037|65123256|FG004|Overall Study|Protocol Violation|2|||
23376830|NCT02832037|65123252|FG000|Overall Study|Lost to Follow-up|2|||
23376831|NCT02832037|65123253|FG001|Overall Study|Lost to Follow-up|0|||
23376832|NCT02832037|65123254|FG002|Overall Study|Lost to Follow-up|3|||
23376833|NCT02832037|65123255|FG003|Overall Study|Lost to Follow-up|0|||
23376834|NCT02832037|65123256|FG004|Overall Study|Lost to Follow-up|5|||
23376835|NCT02832037|65123252|FG000|Overall Study|Withdrawal by Subject|9|||
23376836|NCT02832037|65123253|FG001|Overall Study|Withdrawal by Subject|8|||
23376837|NCT02832037|65123254|FG002|Overall Study|Withdrawal by Subject|0|||
23376838|NCT02832037|65123255|FG003|Overall Study|Withdrawal by Subject|4|||
23376839|NCT02832037|65123256|FG004|Overall Study|Withdrawal by Subject|8|||
23376840|NCT02832037|65123252|FG000|Overall Study|Adverse Event|5|||
23376841|NCT02832037|65123253|FG001|Overall Study|Adverse Event|4|||
23376842|NCT02832037|65123254|FG002|Overall Study|Adverse Event|0|||
23376843|NCT02832037|65123255|FG003|Overall Study|Adverse Event|2|||
23376844|NCT02832037|65123256|FG004|Overall Study|Adverse Event|4|||
23376845|NCT00392223|65123263|FG000|Overall Study|Adverse Event|5|||
23376846|NCT00392223|65123264|FG001|Overall Study|Adverse Event|4|||
23376847|NCT00392223|65123263|FG000|Overall Study|Lost to Follow-up|1|||
23376848|NCT00392223|65123264|FG001|Overall Study|Lost to Follow-up|4|||
23376849|NCT00392223|65123263|FG000|Overall Study|Protocol Violation|0|||
23376850|NCT00392223|65123264|FG001|Overall Study|Protocol Violation|3|||
23376851|NCT00392223|65123263|FG000|Overall Study|Withdrawal by Subject|3|||
23376852|NCT00392223|65123264|FG001|Overall Study|Withdrawal by Subject|2|||
23376853|NCT00726453|65123265|FG000|Primary Enrollment Group|Death|18|||
23376854|NCT00726453|65123266|FG001|Primary Enrollment Group|Death|0|||
23376855|NCT00726453|65123265|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
23376856|NCT00726453|65123266|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
23376857|NCT00726453|65123265|FG000|38 mm Length Group|Death|0|||
23376858|NCT00726453|65123266|FG001|38 mm Length Group|Death|3|||
23376859|NCT00329108|65126433|FG000|Overall Study|Adverse Event|2|||
23376860|NCT00329108|65126434|FG001|Overall Study|Adverse Event|2|||
23376861|NCT00329108|65126433|FG000|Overall Study|Lack of Efficacy|3|||
23489538|NCT01986140|65537104|FG001|Overall Study|alternative treatment|1|||
23489539|NCT01986140|65537103|FG000|Overall Study|found not eligible|3|||
23284292|NCT00902538|64781956|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
23284293|NCT00902538|64781951|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23284294|NCT00902538|64781952|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
23284295|NCT00902538|64781953|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23284296|NCT00902538|64781954|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23284297|NCT00902538|64781955|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23284298|NCT00902538|64781956|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
23284299|NCT00902538|64781951|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
23284300|NCT00902538|64781952|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
23284301|NCT00902538|64781953|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
23284302|NCT00902538|64781954|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
23284303|NCT00902538|64781955|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
23284304|NCT00902538|64781956|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
23284305|NCT00902538|64781951|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
23284306|NCT00902538|64781952|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
23284307|NCT00902538|64781953|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
23284308|NCT00902538|64781954|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
23284309|NCT00902538|64781955|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
23284310|NCT00902538|64781956|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
23284311|NCT00902538|64781951|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23284312|NCT00902538|64781952|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23284313|NCT00902538|64781953|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23284314|NCT00902538|64781954|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
23284315|NCT00902538|64781955|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23284316|NCT00902538|64781956|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
23284317|NCT00487695|64781958|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
23284318|NCT00487695|64781959|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
23376862|NCT00329108|65126434|FG001|Overall Study|Lack of Efficacy|3|||
23376863|NCT00329108|65126433|FG000|Overall Study|Withdrawal by Subject|0|||
23376864|NCT00329108|65126434|FG001|Overall Study|Withdrawal by Subject|2|||
23376865|NCT00329108|65126433|FG000|Overall Study|symptomatic deterioration|1|||
23376866|NCT00329108|65126434|FG001|Overall Study|symptomatic deterioration|1|||
23376867|NCT00329108|65126433|FG000|Overall Study|Subject no longer willing to participate|2|||
23376868|NCT00329108|65126434|FG001|Overall Study|Subject no longer willing to participate|2|||
23604677|NCT01021748|65943490|FG008|Overall Study|Adverse Event|7|||
23604678|NCT01021748|65943482|FG000|Overall Study|Physician Decision|1|||
23604679|NCT01021748|65943483|FG001|Overall Study|Physician Decision|0|||
23604680|NCT01021748|65943484|FG002|Overall Study|Physician Decision|1|||
23604681|NCT01021748|65943485|FG003|Overall Study|Physician Decision|1|||
23604682|NCT01021748|65943486|FG004|Overall Study|Physician Decision|0|||
23604683|NCT01021748|65943487|FG005|Overall Study|Physician Decision|0|||
23604684|NCT01021748|65943488|FG006|Overall Study|Physician Decision|1|||
23604685|NCT01021748|65943489|FG007|Overall Study|Physician Decision|1|||
23604686|NCT01021748|65943490|FG008|Overall Study|Physician Decision|2|||
23604687|NCT01021748|65943482|FG000|Overall Study|Progressive Disease|3|||
23604688|NCT01021748|65943483|FG001|Overall Study|Progressive Disease|3|||
23604689|NCT01021748|65943484|FG002|Overall Study|Progressive Disease|4|||
23604690|NCT01021748|65943485|FG003|Overall Study|Progressive Disease|6|||
23604691|NCT01021748|65943486|FG004|Overall Study|Progressive Disease|7|||
23604692|NCT01021748|65943487|FG005|Overall Study|Progressive Disease|3|||
23604693|NCT01021748|65943488|FG006|Overall Study|Progressive Disease|0|||
23604694|NCT01021748|65943489|FG007|Overall Study|Progressive Disease|5|||
23604695|NCT01021748|65943490|FG008|Overall Study|Progressive Disease|6|||
23604696|NCT01021748|65943482|FG000|Overall Study|Withdrawal by Subject|0|||
23604697|NCT01021748|65943483|FG001|Overall Study|Withdrawal by Subject|0|||
23604698|NCT01021748|65943484|FG002|Overall Study|Withdrawal by Subject|0|||
23604699|NCT01021748|65943485|FG003|Overall Study|Withdrawal by Subject|0|||
23604700|NCT01021748|65943486|FG004|Overall Study|Withdrawal by Subject|0|||
23604701|NCT01021748|65943487|FG005|Overall Study|Withdrawal by Subject|0|||
23604702|NCT01021748|65943488|FG006|Overall Study|Withdrawal by Subject|1|||
23604703|NCT01021748|65943489|FG007|Overall Study|Withdrawal by Subject|0|||
23604704|NCT01021748|65943490|FG008|Overall Study|Withdrawal by Subject|1|||
23604705|NCT01021748|65943482|FG000|Overall Study|Not Treated|0|||
23604706|NCT01021748|65943483|FG001|Overall Study|Not Treated|1|||
23604707|NCT01021748|65943484|FG002|Overall Study|Not Treated|0|||
23604708|NCT01021748|65943485|FG003|Overall Study|Not Treated|0|||
23604709|NCT01021748|65943486|FG004|Overall Study|Not Treated|0|||
23604710|NCT01021748|65943487|FG005|Overall Study|Not Treated|0|||
23604711|NCT01021748|65943488|FG006|Overall Study|Not Treated|0|||
23604712|NCT01021748|65943489|FG007|Overall Study|Not Treated|0|||
23604713|NCT01021748|65943490|FG008|Overall Study|Not Treated|0|||
23604714|NCT03200574|65943491|FG000|Overall Study|Death|4|||
23604715|NCT03200574|65943491|FG000|Overall Study|Withdrawal by Subject|8|||
23604716|NCT03200574|65943491|FG000|Overall Study|Long-Term need for anticoagulation|1|||
23604717|NCT03200574|65943491|FG000|Overall Study|Relocation|2|||
23604718|NCT03200574|65943491|FG000|Overall Study|Lost to Follow-up|2|||
23604719|NCT03737110|65943496|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
23604720|NCT03737110|65943497|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
23604721|NCT03737110|65943498|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
23604722|NCT03737110|65943499|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
23604723|NCT03737110|65943500|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
23604724|NCT03737110|65943501|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
23604725|NCT03737110|65943496|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
23604726|NCT03737110|65943497|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604727|NCT03737110|65943498|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604728|NCT03737110|65943499|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604729|NCT03737110|65943500|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604730|NCT03737110|65943501|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
23604731|NCT03737110|65943496|FG000|Run-in (RI) Period|Adverse Event|4|||
23604732|NCT03737110|65943497|FG001|Run-in (RI) Period|Adverse Event|0|||
23604733|NCT03737110|65943498|FG002|Run-in (RI) Period|Adverse Event|0|||
23604734|NCT03737110|65943499|FG003|Run-in (RI) Period|Adverse Event|0|||
23604735|NCT03737110|65943500|FG004|Run-in (RI) Period|Adverse Event|0|||
23604736|NCT03737110|65943501|FG005|Run-in (RI) Period|Adverse Event|0|||
23604737|NCT03737110|65943496|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604738|NCT03737110|65943497|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
23604739|NCT03737110|65943498|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604740|NCT03737110|65943499|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604741|NCT03737110|65943500|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604742|NCT03737110|65943501|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
23604743|NCT03737110|65943496|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23604744|NCT03737110|65943497|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23604745|NCT03737110|65943498|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
23604746|NCT03737110|65943499|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23604747|NCT03737110|65943500|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23604748|NCT03737110|65943501|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23489540|NCT01986140|65537104|FG001|Overall Study|found not eligible|0|||
23489541|NCT01986140|65537103|FG000|Overall Study|Adverse Event|0|||
23489542|NCT01986140|65537104|FG001|Overall Study|Adverse Event|1|||
23489543|NCT01986140|65537103|FG000|Overall Study|progression disease|0|||
23489544|NCT01986140|65537104|FG001|Overall Study|progression disease|1|||
23489545|NCT05064735|65537107|FG000|Overall Study|Withdrawal by Subject|7|||
23489546|NCT05064735|65537108|FG001|Overall Study|Withdrawal by Subject|8|||
23489547|NCT05064735|65537107|FG000|Overall Study|Lost to Follow-up|7|||
23489548|NCT05064735|65537108|FG001|Overall Study|Lost to Follow-up|2|||
23489549|NCT05064735|65537107|FG000|Overall Study|Physician Decision|2|||
23489550|NCT05064735|65537108|FG001|Overall Study|Physician Decision|1|||
23489551|NCT05064735|65537107|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
23489552|NCT05064735|65537108|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
23489553|NCT05064735|65537107|FG000|Overall Study|Site Closure|7|||
23489554|NCT05064735|65537108|FG001|Overall Study|Site Closure|2|||
23376869|NCT00329108|65126433|FG000|Overall Study|study terminated by sponsor|1|||
23376870|NCT00329108|65126434|FG001|Overall Study|study terminated by sponsor|0|||
23376871|NCT00329108|65126433|FG000|Overall Study|withdrew patient after SAE resolved|1|||
23284319|NCT00487695|64781958|FG000|First Procedure|active wheezing (did not have procedure)|1|||
23376872|NCT00329108|65126434|FG001|Overall Study|withdrew patient after SAE resolved|0|||
23376873|NCT00329108|65126433|FG000|Overall Study|Protocol Violation|0|||
23489555|NCT01090973|65537112|FG000|Overall Study|Disease progression|1|||
23489556|NCT02367131|65537113|FG000|Overall Study|Adverse Event|64|||
23489557|NCT02367131|65537113|FG000|Overall Study|No visit since the first visit|3|||
23489558|NCT02367131|65537113|FG000|Overall Study|Request by patient|53|||
23284320|NCT00487695|64781959|FG001|First Procedure|active wheezing (did not have procedure)|0|||
23284321|NCT00487695|64781958|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
23284322|NCT00487695|64781959|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
23284323|NCT00487695|64781958|FG000|Second Procedure|active wheezing|0|||
23284324|NCT00487695|64781959|FG001|Second Procedure|active wheezing|1|||
23284325|NCT00487695|64781958|FG000|Second Procedure|Withdrawal by Subject|1|||
23284326|NCT00487695|64781959|FG001|Second Procedure|Withdrawal by Subject|2|||
23284327|NCT02911701|64781960|FG000|Overall Study|Withdrawal by Subject|2|||
23284328|NCT02911701|64781961|FG001|Overall Study|Withdrawal by Subject|4|||
23489559|NCT02367131|65537113|FG000|Overall Study|Improvement/remission|2|||
23489560|NCT02367131|65537113|FG000|Overall Study|No change/progressive disease|78|||
23489561|NCT02367131|65537113|FG000|Overall Study|Other than stated above|20|||
23489562|NCT02367131|65537113|FG000|Overall Study|Not treated|2|||
23489563|NCT00386607|65537114|FG000|Core|Adverse Event|40|||
23489564|NCT00386607|65537115|FG001|Core|Adverse Event|0|||
23489565|NCT00386607|65537114|FG000|Core|Abnormal laboratory value(s)|3|||
23489566|NCT00386607|65537115|FG001|Core|Abnormal laboratory value(s)|0|||
23284329|NCT02911701|64781960|FG000|Overall Study|Adverse Event|1|||
23284330|NCT02911701|64781961|FG001|Overall Study|Adverse Event|0|||
23284331|NCT01960296|64781962|FG000|Overall Study|Postponed surgery|1|||
23284332|NCT01960296|64781963|FG001|Overall Study|Postponed surgery|0|||
23284333|NCT01960296|64781962|FG000|Overall Study|Received different procedure|1|||
23284334|NCT01960296|64781963|FG001|Overall Study|Received different procedure|3|||
23284335|NCT04697173|64781967|FG000|Overall Study|Withdrawal by Subject|34|||
23284336|NCT04697173|64781968|FG001|Overall Study|Withdrawal by Subject|38|||
23284337|NCT03980522|64781969|FG000|Treatment Period|Adverse Event|1|||
23284338|NCT03980522|64781970|FG001|Treatment Period|Adverse Event|0|||
23284339|NCT03980522|64781971|FG002|Treatment Period|Adverse Event|0|||
23284340|NCT03980522|64781972|FG003|Treatment Period|Adverse Event|0|||
23284341|NCT03980522|64781973|FG004|Treatment Period|Adverse Event|0|||
23284342|NCT04692155|64781978|FG000|Overall Study|Death|1|||
23284343|NCT03067987|64781979|FG000|Overall Study|Lost to Follow-up|7|||
23284344|NCT03067987|64781980|FG001|Overall Study|Lost to Follow-up|10|||
23284345|NCT03067987|64781979|FG000|Overall Study|Protocol Violation|1|||
23284346|NCT03067987|64781980|FG001|Overall Study|Protocol Violation|2|||
23284347|NCT03067987|64781979|FG000|Overall Study|Withdrawal by Subject|2|||
23284348|NCT03067987|64781980|FG001|Overall Study|Withdrawal by Subject|1|||
23284349|NCT00867360|64781983|FG000|Overall Study|Withdrawal by Subject|1|||
23284350|NCT00867360|64781984|FG001|Overall Study|Withdrawal by Subject|0|||
23284351|NCT00867360|64781983|FG000|Overall Study|Physician Decision|0|||
23284352|NCT00867360|64781984|FG001|Overall Study|Physician Decision|1|||
23284353|NCT00367133|64781987|FG000|2 Years|Death|20|||
23284354|NCT00367133|64781988|FG001|2 Years|Death|12|||
23284355|NCT00367133|64781989|FG002|2 Years|Death|12|||
23284356|NCT00367133|64781987|FG000|2 Years|Dropped|34|||
23284357|NCT00367133|64781988|FG001|2 Years|Dropped|19|||
23284358|NCT00367133|64781989|FG002|2 Years|Dropped|33|||
23284359|NCT00367133|64781987|FG000|2 Years|Missed visit|4|||
23284360|NCT00367133|64781988|FG001|2 Years|Missed visit|5|||
23284361|NCT00367133|64781989|FG002|2 Years|Missed visit|4|||
23284362|NCT01492439|64781990|FG000|Overall Study|Withdrew from RTE|4|||
23284363|NCT01492439|64781991|FG001|Overall Study|Withdrew from RTE|9|||
23284364|NCT02105272|64781992|FG000|Overall Study|Adverse Event|1|||
23489567|NCT00386607|65537114|FG000|Core|Unsatisfactory therapeutic effect|23|||
23489568|NCT00386607|65537115|FG001|Core|Unsatisfactory therapeutic effect|0|||
23489569|NCT00386607|65537114|FG000|Core|Condition no longer requires study drug|4|||
23489570|NCT00386607|65537115|FG001|Core|Condition no longer requires study drug|0|||
23489571|NCT00386607|65537114|FG000|Core|Patient withdrew consent|15|||
23489572|NCT00386607|65537115|FG001|Core|Patient withdrew consent|0|||
23489573|NCT00386607|65537114|FG000|Core|Lost to Follow-up|23|||
23489574|NCT00386607|65537115|FG001|Core|Lost to Follow-up|0|||
23489575|NCT00386607|65537114|FG000|Core|Administrative problems|1|||
23489576|NCT00386607|65537115|FG001|Core|Administrative problems|0|||
23489577|NCT00386607|65537114|FG000|Core|Protocol Deviation|6|||
23489578|NCT00386607|65537115|FG001|Core|Protocol Deviation|0|||
23489579|NCT00386607|65537114|FG000|Extension|Adverse Event|0|||
23489580|NCT00386607|65537115|FG001|Extension|Adverse Event|6|||
23489581|NCT00386607|65537114|FG000|Extension|Abnormal laboratory value(s)|0|||
23284365|NCT02105272|64781993|FG001|Overall Study|Adverse Event|2|||
23284366|NCT02105272|64781992|FG000|Overall Study|Physician Decision|0|||
23284367|NCT02105272|64781993|FG001|Overall Study|Physician Decision|1|||
23284368|NCT02105272|64781992|FG000|Overall Study|Protocol Violation|2|||
23489582|NCT00386607|65537115|FG001|Extension|Abnormal laboratory value(s)|1|||
23489583|NCT00386607|65537114|FG000|Extension|Administrative problems|0|||
23489584|NCT00386607|65537115|FG001|Extension|Administrative problems|1|||
23489585|NCT00386607|65537114|FG000|Extension|Lost to Follow-up|0|||
23489586|NCT00386607|65537115|FG001|Extension|Lost to Follow-up|3|||
23284369|NCT02105272|64781993|FG001|Overall Study|Protocol Violation|0|||
23284370|NCT02105272|64781992|FG000|Overall Study|Withdrawal by Subject|2|||
23284371|NCT02105272|64781993|FG001|Overall Study|Withdrawal by Subject|0|||
23284372|NCT00731939|64781994|FG000|Overall Study|Adverse Event|6|||
23284373|NCT00731939|64781994|FG000|Overall Study|Lost to Follow-up|15|||
23376874|NCT00329108|65126434|FG001|Overall Study|Protocol Violation|2|||
23376875|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
23284374|NCT00731939|64781994|FG000|Overall Study|Not implanted with study device|9|||
23284375|NCT00731939|64781994|FG000|Overall Study|Withdrawal by Subject|2|||
23284376|NCT00731939|64781994|FG000|Overall Study|Did not meet enrollment criteria|2|||
23284377|NCT03123094|64781995|FG000|Overall Study|Withdrawal by Subject|0|||
23284378|NCT03123094|64781996|FG001|Overall Study|Withdrawal by Subject|2|||
23284379|NCT03123094|64781997|FG002|Overall Study|Withdrawal by Subject|1|||
23284380|NCT03123094|64781998|FG003|Overall Study|Withdrawal by Subject|0|||
23284381|NCT03123094|64781999|FG004|Overall Study|Withdrawal by Subject|1|||
23284382|NCT01395017|64782002|FG000|Overall Study|Lost to Follow-up|1|||
23284383|NCT01395017|64782003|FG001|Overall Study|Lost to Follow-up|0|||
23284384|NCT01395017|64782002|FG000|Overall Study|Adverse Event|26|||
23284385|NCT01395017|64782003|FG001|Overall Study|Adverse Event|12|||
23284386|NCT01395017|64782002|FG000|Overall Study|Physician Decision|11|||
23284387|NCT01395017|64782003|FG001|Overall Study|Physician Decision|15|||
23284388|NCT01395017|64782002|FG000|Overall Study|Withdrawal by Subject|14|||
23284389|NCT01395017|64782003|FG001|Overall Study|Withdrawal by Subject|8|||
23284390|NCT01395017|64782002|FG000|Overall Study|Protocol deviation|1|||
23284391|NCT01395017|64782003|FG001|Overall Study|Protocol deviation|2|||
23284392|NCT01395017|64782002|FG000|Overall Study|Death|4|||
23284393|NCT01395017|64782003|FG001|Overall Study|Death|3|||
23284394|NCT01395017|64782002|FG000|Overall Study|Disease progression|42|||
23284395|NCT01395017|64782003|FG001|Overall Study|Disease progression|58|||
23284396|NCT01395017|64782002|FG000|Overall Study|Sponsor discontinued study|1|||
23284397|NCT01395017|64782003|FG001|Overall Study|Sponsor discontinued study|4|||
23284398|NCT01183884|64782004|FG000|Overall Study|Progressive Disease|26|||
23284399|NCT01183884|64782004|FG000|Overall Study|Adverse Event|3|||
23376876|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
23376877|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Death|28|||
23376878|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Death|29|||
23376879|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
23376880|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
23376881|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Other|30|||
23376882|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Other|20|||
23376883|NCT00699751|65126435|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
23376884|NCT00699751|65126436|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
23376885|NCT00699751|65126435|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
23376886|NCT00699751|65126436|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
23376887|NCT00699751|65126435|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
23376888|NCT00699751|65126436|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
23376889|NCT00699751|65126435|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
23376890|NCT00699751|65126436|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
23376891|NCT02115386|65126441|FG000|Overall Study|Protocol Violation|1|||
23376892|NCT02115386|65126441|FG000|Overall Study|Administrative - trial was terminated|6|||
23376893|NCT01847209|65126445|FG000|Overall Study|Withdrawal by Subject|1|||
23376894|NCT01847209|65126445|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
23376895|NCT00676143|65126448|FG000|Overall Study|Adverse Event|34|||
23376896|NCT00676143|65126449|FG001|Overall Study|Adverse Event|60|||
23376897|NCT00676143|65126448|FG000|Overall Study|Death|4|||
23376898|NCT00676143|65126449|FG001|Overall Study|Death|4|||
23376899|NCT00676143|65126448|FG000|Overall Study|Lack of Efficacy|0|||
23376900|NCT00676143|65126449|FG001|Overall Study|Lack of Efficacy|6|||
23376901|NCT00676143|65126448|FG000|Overall Study|Lost to Follow-up|0|||
23376902|NCT00676143|65126449|FG001|Overall Study|Lost to Follow-up|13|||
23376903|NCT00676143|65126448|FG000|Overall Study|Physician Decision|5|||
23376904|NCT00676143|65126449|FG001|Overall Study|Physician Decision|8|||
23376905|NCT00676143|65126448|FG000|Overall Study|Protocol Violation|4|||
23376906|NCT00676143|65126449|FG001|Overall Study|Protocol Violation|8|||
23376907|NCT00676143|65126448|FG000|Overall Study|Withdrawal by Subject|24|||
23376908|NCT00676143|65126449|FG001|Overall Study|Withdrawal by Subject|42|||
23376909|NCT00676143|65126448|FG000|Overall Study|Discontinuation of study by sponsor|65|||
23376910|NCT00676143|65126449|FG001|Overall Study|Discontinuation of study by sponsor|88|||
23376911|NCT00676143|65126448|FG000|Overall Study|Failed to return|2|||
23376912|NCT00676143|65126449|FG001|Overall Study|Failed to return|1|||
23376913|NCT00676143|65126448|FG000|Overall Study|Loss of caregiver|5|||
23376914|NCT00676143|65126449|FG001|Overall Study|Loss of caregiver|3|||
23376915|NCT00676143|65126448|FG000|Overall Study|Other|11|||
23284400|NCT01183884|64782004|FG000|Overall Study|Withdrawal by Subject|1|||
23376916|NCT00676143|65126449|FG001|Overall Study|Other|20|||
23376917|NCT00676143|65126448|FG000|Overall Study|Participant participation unknown|1|||
23376918|NCT00676143|65126449|FG001|Overall Study|Participant participation unknown|4|||
23284401|NCT01183884|64782004|FG000|Overall Study|Other Complicating Disease|3|||
23284402|NCT01183884|64782004|FG000|Overall Study|Not Treated|1|||
23284403|NCT01183884|64782004|FG000|Overall Study|Other|4|||
23376919|NCT00676143|65126448|FG000|Overall Study|Vasogenic edema recurrence|1|||
23376920|NCT00676143|65126449|FG001|Overall Study|Vasogenic edema recurrence|3|||
23489587|NCT00386607|65537114|FG000|Extension|Patient withdrew consent|0|||
23489588|NCT00386607|65537115|FG001|Extension|Patient withdrew consent|5|||
23489589|NCT00386607|65537114|FG000|Extension|Unsatisfactory therapeutic effect|0|||
23489590|NCT00386607|65537115|FG001|Extension|Unsatisfactory therapeutic effect|1|||
23489591|NCT00937391|65537116|FG000|Stage 2|Withdrawal by Subject|1|||
23489592|NCT01822496|65537119|FG000|Overall Study|Protocol Violation|2|||
23489593|NCT01822496|65537120|FG001|Overall Study|Protocol Violation|2|||
23489594|NCT01822496|65537121|FG002|Overall Study|Protocol Violation|0|||
23489595|NCT01822496|65537122|FG003|Overall Study|Protocol Violation|1|||
23489596|NCT01822496|65537119|FG000|Overall Study|Withdrawal by Subject|0|||
23489597|NCT01822496|65537120|FG001|Overall Study|Withdrawal by Subject|0|||
23489598|NCT01822496|65537121|FG002|Overall Study|Withdrawal by Subject|0|||
23489599|NCT01822496|65537122|FG003|Overall Study|Withdrawal by Subject|3|||
23284404|NCT03366428|64782007|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
23489600|NCT01710046|65537124|FG000|Overall Study|Lost to Follow-up|1|||
23489601|NCT01710046|65537125|FG001|Overall Study|Lost to Follow-up|0|||
23489602|NCT00464269|65537135|FG000|Overall Study|Lack of Efficacy|1|||
23489603|NCT00464269|65537136|FG001|Overall Study|Lack of Efficacy|0|||
23489604|NCT00464269|65537137|FG002|Overall Study|Lack of Efficacy|0|||
23489605|NCT00464269|65537138|FG003|Overall Study|Lack of Efficacy|0|||
23489606|NCT00464269|65537135|FG000|Overall Study|Lost to Follow-up|0|||
23489607|NCT00464269|65537136|FG001|Overall Study|Lost to Follow-up|4|||
23489608|NCT00464269|65537137|FG002|Overall Study|Lost to Follow-up|0|||
23489609|NCT00464269|65537138|FG003|Overall Study|Lost to Follow-up|1|||
23489610|NCT00464269|65537135|FG000|Overall Study|Withdrawal by Subject|0|||
23489611|NCT00464269|65537136|FG001|Overall Study|Withdrawal by Subject|2|||
23489612|NCT00464269|65537137|FG002|Overall Study|Withdrawal by Subject|1|||
23489613|NCT00464269|65537138|FG003|Overall Study|Withdrawal by Subject|1|||
23489614|NCT00464269|65537135|FG000|Overall Study|Other reason|3|||
23489615|NCT00464269|65537136|FG001|Overall Study|Other reason|3|||
23489616|NCT00464269|65537137|FG002|Overall Study|Other reason|1|||
23489617|NCT00464269|65537138|FG003|Overall Study|Other reason|1|||
23489618|NCT00464269|65537135|FG000|Overall Study|AE, serious fatal|0|||
23489619|NCT00464269|65537136|FG001|Overall Study|AE, serious fatal|0|||
23489620|NCT00464269|65537137|FG002|Overall Study|AE, serious fatal|1|||
23489621|NCT00464269|65537138|FG003|Overall Study|AE, serious fatal|1|||
23489622|NCT00464269|65537135|FG000|Overall Study|SAE, non-fatal|0|||
23489623|NCT00464269|65537136|FG001|Overall Study|SAE, non-fatal|0|||
23489624|NCT00464269|65537137|FG002|Overall Study|SAE, non-fatal|0|||
23489625|NCT00464269|65537138|FG003|Overall Study|SAE, non-fatal|1|||
23489626|NCT00464269|65537135|FG000|Overall Study|AE, non-serious non-fatal|2|||
23489627|NCT00464269|65537136|FG001|Overall Study|AE, non-serious non-fatal|8|||
23489628|NCT00464269|65537137|FG002|Overall Study|AE, non-serious non-fatal|3|||
23489629|NCT00464269|65537138|FG003|Overall Study|AE, non-serious non-fatal|4|||
23489630|NCT00464269|65537135|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23489631|NCT00464269|65537136|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23489632|NCT00464269|65537137|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
23489633|NCT00464269|65537138|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
23489634|NCT00771316|65537139|FG000|Overall Study|Adverse Event|0|||
23284405|NCT03366428|64782007|FG000|Overall Study|Adverse Event|12|||
23284406|NCT03366428|64782007|FG000|Overall Study|Clinical progression|2|||
23284407|NCT03366428|64782007|FG000|Overall Study|Withdrawal by Subject|4|||
23284408|NCT00807495|64782010|FG000|Overall Study|Adverse Event|6|||
23284409|NCT00807495|64782011|FG001|Overall Study|Adverse Event|3|||
23284410|NCT00807495|64782012|FG002|Overall Study|Adverse Event|1|||
23284411|NCT00807495|64782013|FG003|Overall Study|Adverse Event|1|||
23284412|NCT00807495|64782014|FG004|Overall Study|Adverse Event|2|||
23284413|NCT00807495|64782010|FG000|Overall Study|Withdrawal by Patient|2|||
23284414|NCT00807495|64782011|FG001|Overall Study|Withdrawal by Patient|0|||
23284415|NCT00807495|64782012|FG002|Overall Study|Withdrawal by Patient|1|||
23284416|NCT00807495|64782013|FG003|Overall Study|Withdrawal by Patient|0|||
23284417|NCT00807495|64782014|FG004|Overall Study|Withdrawal by Patient|0|||
23489635|NCT00771316|65537140|FG001|Overall Study|Adverse Event|1|||
23489636|NCT00771316|65537139|FG000|Overall Study|Patient withdrew consent|1|||
23489637|NCT00771316|65537140|FG001|Overall Study|Patient withdrew consent|0|||
23489638|NCT00771316|65537139|FG000|Overall Study|Discontinued due to early termination|1|||
23284418|NCT00807495|64782010|FG000|Overall Study|Reason Not Specified|0|||
23284419|NCT00807495|64782011|FG001|Overall Study|Reason Not Specified|3|||
23284420|NCT00807495|64782012|FG002|Overall Study|Reason Not Specified|2|||
23284421|NCT00807495|64782013|FG003|Overall Study|Reason Not Specified|0|||
23376921|NCT00548327|65126450|FG000|Overall Study|Adverse Event|0|||
23489639|NCT00771316|65537140|FG001|Overall Study|Discontinued due to early termination|0|||
23489640|NCT03911713|65537149|FG000|Overall Study|Lost to Follow-up|0|||
23489641|NCT03911713|65537150|FG001|Overall Study|Lost to Follow-up|2|||
23489642|NCT03911713|65537151|FG002|Overall Study|Lost to Follow-up|0|||
23489643|NCT03911713|65537152|FG003|Overall Study|Lost to Follow-up|0|||
23489644|NCT03911713|65537153|FG004|Overall Study|Lost to Follow-up|0|||
23489645|NCT03911713|65537149|FG000|Overall Study|Other|0|||
23489646|NCT03911713|65537150|FG001|Overall Study|Other|0|||
23489647|NCT03911713|65537151|FG002|Overall Study|Other|0|||
23489648|NCT03911713|65537152|FG003|Overall Study|Other|1|||
23489649|NCT03911713|65537153|FG004|Overall Study|Other|0|||
23489650|NCT03911713|65537149|FG000|Overall Study|Randomized, Never Dosed|1|||
23489651|NCT03911713|65537150|FG001|Overall Study|Randomized, Never Dosed|0|||
23489652|NCT03911713|65537151|FG002|Overall Study|Randomized, Never Dosed|0|||
23489653|NCT03911713|65537152|FG003|Overall Study|Randomized, Never Dosed|1|||
23489654|NCT03911713|65537153|FG004|Overall Study|Randomized, Never Dosed|0|||
23489655|NCT01461980|65537154|FG000|Overall Study|Other|9|||
23489656|NCT01461980|65537155|FG001|Overall Study|Other|8|||
23489657|NCT01461980|65537156|FG002|Overall Study|Other|6|||
23604749|NCT03737110|65943496|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23284422|NCT00807495|64782014|FG004|Overall Study|Reason Not Specified|3|||
23284423|NCT03086460|64782015|FG000|Study Participants|Lost to Follow-up|2|||
23284424|NCT03086460|64782015|FG000|Study Participants|Protocol Violation|1|||
23284425|NCT03086460|64782015|FG000|Study Participants|Withdrawal by Subject|6|||
23284426|NCT03086460|64782015|FG000|Treatment A|Lost to Follow-up|1|||
23284427|NCT03086460|64782015|FG000|Treatment A|Protocol Violation|1|||
23284428|NCT03086460|64782015|FG000|Treatment A|Withdrawal by Subject|2|||
23284429|NCT03086460|64782015|FG000|Treatment C|Withdrawal by Subject|2|||
23284430|NCT03086460|64782015|FG000|Treatment E|Lost to Follow-up|1|||
23284431|NCT03086460|64782015|FG000|Treatment E|Withdrawal by Subject|3|||
23284432|NCT00834613|64782016|FG000|First Intervention|Protocol Violation|1|||
23284433|NCT00834613|64782017|FG001|First Intervention|Protocol Violation|0|||
23284434|NCT01686438|64782020|FG000|Overall Study|Lost to Follow-up|8|||
23284435|NCT01686438|64782021|FG001|Overall Study|Lost to Follow-up|9|||
23284436|NCT01686438|64782022|FG002|Overall Study|Lost to Follow-up|10|||
23284437|NCT01686438|64782020|FG000|Overall Study|Adverse Event|0|||
23284438|NCT01686438|64782021|FG001|Overall Study|Adverse Event|0|||
23284439|NCT01686438|64782022|FG002|Overall Study|Adverse Event|1|||
23376922|NCT00548327|65126451|FG001|Overall Study|Adverse Event|1|||
23376923|NCT01750346|65126454|FG000|Overall Study|Adverse Event|1|||
23376924|NCT01750346|65126455|FG001|Overall Study|Adverse Event|0|||
23376925|NCT01750346|65126456|FG002|Overall Study|Adverse Event|0|||
23376926|NCT02364557|65126457|FG000|Overall Study|Protocol Violation|3|||
23376927|NCT02364557|65126458|FG001|Overall Study|Protocol Violation|1|||
23376928|NCT00557466|65126459|FG000|Overall Study|Adverse Event|3|||
23376929|NCT00557466|65126460|FG001|Overall Study|Adverse Event|1|||
23376930|NCT00557466|65126461|FG002|Overall Study|Adverse Event|4|||
23376931|NCT00557466|65126462|FG003|Overall Study|Adverse Event|1|||
23376932|NCT00557466|65126463|FG004|Overall Study|Adverse Event|2|||
23376933|NCT00557466|65126464|FG005|Overall Study|Adverse Event|4|||
23376934|NCT00557466|65126459|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23376935|NCT00557466|65126460|FG001|Overall Study|Abnormal laboratory value(s)|2|||
23376936|NCT00557466|65126461|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23376937|NCT00557466|65126462|FG003|Overall Study|Abnormal laboratory value(s)|0|||
23376938|NCT00557466|65126463|FG004|Overall Study|Abnormal laboratory value(s)|0|||
23376939|NCT00557466|65126464|FG005|Overall Study|Abnormal laboratory value(s)|0|||
23376940|NCT00557466|65126459|FG000|Overall Study|Protocol deviation|0|||
23376941|NCT00557466|65126460|FG001|Overall Study|Protocol deviation|1|||
23376942|NCT00557466|65126461|FG002|Overall Study|Protocol deviation|0|||
23376943|NCT00557466|65126462|FG003|Overall Study|Protocol deviation|2|||
23376944|NCT00557466|65126463|FG004|Overall Study|Protocol deviation|0|||
23376945|NCT00557466|65126464|FG005|Overall Study|Protocol deviation|0|||
23376946|NCT00557466|65126459|FG000|Overall Study|Subject withdrew consent|0|||
23376947|NCT00557466|65126460|FG001|Overall Study|Subject withdrew consent|0|||
23376948|NCT00557466|65126461|FG002|Overall Study|Subject withdrew consent|0|||
23376949|NCT00557466|65126462|FG003|Overall Study|Subject withdrew consent|0|||
23376950|NCT00557466|65126463|FG004|Overall Study|Subject withdrew consent|1|||
23376951|NCT00557466|65126464|FG005|Overall Study|Subject withdrew consent|2|||
23376952|NCT00557466|65126459|FG000|Overall Study|Administrative problems|0|||
23376953|NCT00557466|65126460|FG001|Overall Study|Administrative problems|1|||
23604750|NCT03737110|65943497|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23284440|NCT01686438|64782020|FG000|Overall Study|Protocol Violation|0|||
23284441|NCT01686438|64782021|FG001|Overall Study|Protocol Violation|0|||
23376954|NCT00557466|65126461|FG002|Overall Study|Administrative problems|1|||
23376955|NCT00557466|65126462|FG003|Overall Study|Administrative problems|0|||
23376956|NCT00557466|65126463|FG004|Overall Study|Administrative problems|0|||
23376957|NCT00557466|65126464|FG005|Overall Study|Administrative problems|0|||
23376958|NCT00557466|65126459|FG000|Overall Study|Abnormal test procedure results|0|||
23376959|NCT00557466|65126460|FG001|Overall Study|Abnormal test procedure results|0|||
23489658|NCT01461980|65537154|FG000|Overall Study|Medication error|7|||
23284442|NCT01686438|64782022|FG002|Overall Study|Protocol Violation|1|||
23489659|NCT01461980|65537155|FG001|Overall Study|Medication error|5|||
23489660|NCT01461980|65537156|FG002|Overall Study|Medication error|6|||
23489661|NCT01461980|65537154|FG000|Overall Study|Adverse Event|12|||
23489662|NCT01461980|65537155|FG001|Overall Study|Adverse Event|5|||
23489663|NCT01461980|65537156|FG002|Overall Study|Adverse Event|6|||
23489664|NCT01461980|65537154|FG000|Overall Study|Protocol Violation|12|||
23489665|NCT01461980|65537155|FG001|Overall Study|Protocol Violation|19|||
23489666|NCT01461980|65537156|FG002|Overall Study|Protocol Violation|16|||
23489667|NCT01461980|65537154|FG000|Overall Study|No longer meets eligibility criteria|18|||
23489668|NCT01461980|65537155|FG001|Overall Study|No longer meets eligibility criteria|9|||
23489669|NCT01461980|65537156|FG002|Overall Study|No longer meets eligibility criteria|19|||
23489670|NCT01461980|65537154|FG000|Overall Study|Lost to Follow-up|52|||
23489671|NCT01461980|65537155|FG001|Overall Study|Lost to Follow-up|53|||
23489672|NCT01461980|65537156|FG002|Overall Study|Lost to Follow-up|51|||
23489673|NCT01461980|65537154|FG000|Overall Study|No longer willing to participate|52|||
23604751|NCT03737110|65943498|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23284443|NCT01686438|64782020|FG000|Overall Study|Withdrawal by Subject|0|||
23284444|NCT01686438|64782021|FG001|Overall Study|Withdrawal by Subject|0|||
23284445|NCT01686438|64782022|FG002|Overall Study|Withdrawal by Subject|1|||
23284446|NCT01698554|64782023|FG000|Overall Study|Adverse Event|2|||
23284447|NCT01698554|64782024|FG001|Overall Study|Adverse Event|5|||
23284448|NCT01698554|64782025|FG002|Overall Study|Adverse Event|0|||
23284449|NCT01698554|64782026|FG003|Overall Study|Adverse Event|1|||
23284450|NCT01698554|64782023|FG000|Overall Study|Lost to Follow-up|1|||
23284451|NCT01698554|64782024|FG001|Overall Study|Lost to Follow-up|0|||
23284452|NCT01698554|64782025|FG002|Overall Study|Lost to Follow-up|0|||
23284453|NCT01698554|64782026|FG003|Overall Study|Lost to Follow-up|0|||
23284454|NCT01698554|64782023|FG000|Overall Study|Personal Reasons|0|||
23284455|NCT01698554|64782024|FG001|Overall Study|Personal Reasons|5|||
23284456|NCT01698554|64782025|FG002|Overall Study|Personal Reasons|1|||
23284457|NCT01698554|64782026|FG003|Overall Study|Personal Reasons|1|||
23284458|NCT01698554|64782023|FG000|Overall Study|Protocol Violation|2|||
23284459|NCT01698554|64782024|FG001|Overall Study|Protocol Violation|0|||
23284460|NCT01698554|64782025|FG002|Overall Study|Protocol Violation|1|||
23284461|NCT01698554|64782026|FG003|Overall Study|Protocol Violation|0|||
23284462|NCT01698554|64782023|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23284463|NCT01698554|64782024|FG001|Overall Study|Other Miscellaneous Reasons|0|||
23284464|NCT01698554|64782025|FG002|Overall Study|Other Miscellaneous Reasons|0|||
23284465|NCT01698554|64782026|FG003|Overall Study|Other Miscellaneous Reasons|0|||
23284466|NCT00985751|64784778|FG000|Overall Study|Adverse Event|0|||
23284467|NCT00985751|64784779|FG001|Overall Study|Adverse Event|0|||
23284468|NCT00985751|64784780|FG002|Overall Study|Adverse Event|0|||
23604752|NCT03737110|65943499|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
23284469|NCT00985751|64784781|FG003|Overall Study|Adverse Event|0|||
23284470|NCT00985751|64784782|FG004|Overall Study|Adverse Event|1|||
23284471|NCT03541252|64784783|FG000|Overall Study|Withdrawal by Subject|1|||
23284472|NCT00406393|64784788|FG000|Overall Study|Did not undergo transplantation|2|||
23284473|NCT00406393|64784789|FG001|Overall Study|Did not undergo transplantation|1|||
23604753|NCT03737110|65943500|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23604754|NCT03737110|65943501|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
23604755|NCT03737110|65943496|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
23604756|NCT03737110|65943497|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
23604757|NCT03737110|65943498|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
23604758|NCT03737110|65943499|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
23604759|NCT03737110|65943500|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
23604760|NCT03737110|65943501|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
23604761|NCT03737110|65943496|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604762|NCT03737110|65943497|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604763|NCT03737110|65943498|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604764|NCT03737110|65943499|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604765|NCT03737110|65943500|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
23604766|NCT03737110|65943501|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
23604767|NCT02052440|65943502|FG000|Overall Study|Withdrawal by Subject|0|||
23604768|NCT02052440|65943503|FG001|Overall Study|Withdrawal by Subject|1|||
23604769|NCT01159600|65943504|FG000|Overall Study|Not treated|0|||
23604770|NCT01159600|65943505|FG001|Overall Study|Not treated|0|||
23284474|NCT02786953|64784790|FG000|Overall Study|Withdrawal by Subject|3|||
23284475|NCT02786953|64784791|FG001|Overall Study|Withdrawal by Subject|0|||
23284476|NCT02786953|64784790|FG000|Overall Study|Physician Decision|0|||
23284477|NCT02786953|64784791|FG001|Overall Study|Physician Decision|1|||
23284478|NCT01624233|64784792|FG000|Period 2 - Induction|Adverse Event|1|||
23284479|NCT01624233|64784792|FG000|Period 3 - Maintenance|Adverse Event|2|||
23284480|NCT01624233|64784792|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
23284481|NCT01624233|64784792|FG000|Period 3 - Maintenance|Physician Decision|2|||
23376960|NCT00557466|65126461|FG002|Overall Study|Abnormal test procedure results|1|||
23376961|NCT00557466|65126462|FG003|Overall Study|Abnormal test procedure results|0|||
23376962|NCT00557466|65126463|FG004|Overall Study|Abnormal test procedure results|0|||
23376963|NCT00557466|65126464|FG005|Overall Study|Abnormal test procedure results|0|||
23376964|NCT00557466|65126459|FG000|Overall Study|Lost to Follow-up|0|||
23376965|NCT00557466|65126460|FG001|Overall Study|Lost to Follow-up|0|||
23376966|NCT00557466|65126461|FG002|Overall Study|Lost to Follow-up|0|||
23376967|NCT00557466|65126462|FG003|Overall Study|Lost to Follow-up|1|||
23376968|NCT00557466|65126463|FG004|Overall Study|Lost to Follow-up|0|||
23376969|NCT00557466|65126464|FG005|Overall Study|Lost to Follow-up|0|||
23376970|NCT00845182|65126465|FG000|Overall Study|Lost to Follow-up|3|||
23376971|NCT00845182|65126466|FG001|Overall Study|Lost to Follow-up|3|||
23376972|NCT00845182|65126467|FG002|Overall Study|Lost to Follow-up|4|||
23376973|NCT00845182|65126465|FG000|Overall Study|Adverse Event|0|||
23376974|NCT00845182|65126466|FG001|Overall Study|Adverse Event|1|||
23376975|NCT00845182|65126467|FG002|Overall Study|Adverse Event|1|||
23376976|NCT00845182|65126465|FG000|Overall Study|Physician Decision|0|||
23376977|NCT00845182|65126466|FG001|Overall Study|Physician Decision|0|||
23376978|NCT00845182|65126467|FG002|Overall Study|Physician Decision|1|||
23376979|NCT01177410|65126469|FG000|Overall Study|Adverse Event|0|||
23376980|NCT01177410|65126470|FG001|Overall Study|Adverse Event|2|||
23376981|NCT01177410|65126471|FG002|Overall Study|Adverse Event|2|||
23376982|NCT01177410|65126469|FG000|Overall Study|Withdrawal by Subject|1|||
23376983|NCT01177410|65126470|FG001|Overall Study|Withdrawal by Subject|4|||
23376984|NCT01177410|65126471|FG002|Overall Study|Withdrawal by Subject|3|||
23376985|NCT01177410|65126469|FG000|Overall Study|Lost to Follow-up|0|||
23376986|NCT01177410|65126470|FG001|Overall Study|Lost to Follow-up|1|||
23376987|NCT01177410|65126471|FG002|Overall Study|Lost to Follow-up|0|||
23376988|NCT00945243|65126472|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
23376989|NCT00712920|65126473|FG000|Overall Study|Adverse Event|3|||
23376990|NCT00712920|65126474|FG001|Overall Study|Adverse Event|4|||
23376991|NCT00712920|65126475|FG002|Overall Study|Adverse Event|7|||
23376992|NCT00712920|65126473|FG000|Overall Study|Withdrawal by Subject|4|||
23376993|NCT00712920|65126474|FG001|Overall Study|Withdrawal by Subject|2|||
23376994|NCT00712920|65126475|FG002|Overall Study|Withdrawal by Subject|1|||
23376995|NCT00712920|65126473|FG000|Overall Study|Lost to Follow-up|1|||
23376996|NCT00712920|65126474|FG001|Overall Study|Lost to Follow-up|4|||
23376997|NCT00712920|65126475|FG002|Overall Study|Lost to Follow-up|0|||
23376998|NCT00712920|65126473|FG000|Overall Study|Lack of Efficacy|1|||
23376999|NCT00712920|65126474|FG001|Overall Study|Lack of Efficacy|0|||
23377000|NCT00712920|65126475|FG002|Overall Study|Lack of Efficacy|1|||
23377001|NCT00712920|65126473|FG000|Overall Study|Other|5|||
23377002|NCT00712920|65126474|FG001|Overall Study|Other|7|||
23377003|NCT00712920|65126475|FG002|Overall Study|Other|3|||
23377004|NCT00712920|65126473|FG000|Overall Study|Non-compliance|3|||
23377005|NCT00712920|65126474|FG001|Overall Study|Non-compliance|0|||
23377006|NCT00712920|65126475|FG002|Overall Study|Non-compliance|0|||
23377007|NCT00434252|65126476|FG000|Overall Study|Lack of Efficacy|50|||
23377008|NCT00434252|65126477|FG001|Overall Study|Lack of Efficacy|100|||
23377009|NCT00434252|65126476|FG000|Overall Study|Adverse Event|6|||
23377010|NCT00434252|65126477|FG001|Overall Study|Adverse Event|13|||
23377011|NCT00434252|65126476|FG000|Overall Study|Death|1|||
23377012|NCT00434252|65126477|FG001|Overall Study|Death|2|||
23377013|NCT00434252|65126476|FG000|Overall Study|Lost to Follow-up|0|||
23377014|NCT00434252|65126477|FG001|Overall Study|Lost to Follow-up|1|||
23377015|NCT00434252|65126476|FG000|Overall Study|Physician Decision|4|||
23377016|NCT00434252|65126477|FG001|Overall Study|Physician Decision|8|||
23377017|NCT00434252|65126476|FG000|Overall Study|Withdrawal by Subject|3|||
23377018|NCT00434252|65126477|FG001|Overall Study|Withdrawal by Subject|7|||
23377019|NCT00671749|65126478|FG000|Overall Study|Adverse Event|2|||
23377020|NCT00671749|65126478|FG000|Overall Study|Withdrawal by Subject|4|||
23377021|NCT00671749|65126478|FG000|Overall Study|Protocol Violation|1|||
23377022|NCT00671749|65126478|FG000|Overall Study|Lost to Follow-up|1|||
23377023|NCT03255187|65126479|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
23377024|NCT03255187|65126480|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
23377025|NCT03255187|65126479|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
23377026|NCT03255187|65126480|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
23377027|NCT02469857|65126481|FG000|Overall Study|Death|24|||
23377028|NCT02469857|65126482|FG001|Overall Study|Death|29|||
23377029|NCT02469857|65126481|FG000|Overall Study|Discontinuation|1|||
23377030|NCT02469857|65126482|FG001|Overall Study|Discontinuation|3|||
23377031|NCT03880565|65126483|FG000|Overall Study|Withdrawal by Subject|1|||
23377032|NCT03880565|65126484|FG001|Overall Study|Withdrawal by Subject|0|||
23377033|NCT04459338|65126489|FG000|Overall Study|Loss of IV during study|1|||
23377034|NCT04459338|65126490|FG001|Overall Study|Loss of IV during study|0|||
23377035|NCT01202591|65126495|FG000|Overall Study|Adverse Event|2|||
23377036|NCT01202591|65126496|FG001|Overall Study|Adverse Event|1|||
23377037|NCT01202591|65126497|FG002|Overall Study|Adverse Event|4|||
23284482|NCT01624233|64784792|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
23284483|NCT01624233|64784792|FG000|Period 4 - Drug Free Period|Relapsed|61|||
23284484|NCT01624233|64784792|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
23284485|NCT01624233|64784792|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
23284486|NCT01624233|64784792|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
23284487|NCT01624233|64784792|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
23284488|NCT01624233|64784792|FG000|Period 6: Follow-up|Adverse Event|3|||
23284489|NCT01624233|64784792|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
23284490|NCT01624233|64784792|FG000|Period 6: Follow-up|Physician Decision|1|||
23284491|NCT01624233|64784792|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
23284492|NCT02471807|64784799|FG000|Overall Study|Death|14|||
23284493|NCT02471807|64784799|FG000|Overall Study|Withdrawal by Subject|2|||
23284494|NCT02471807|64784799|FG000|Overall Study|Explant|5|||
23284495|NCT02471807|64784799|FG000|Overall Study|Lost to Follow-up|1|||
23284496|NCT02957942|64784804|FG000|Overall Study|Withdrawal by Subject|0|||
23284497|NCT02957942|64784805|FG001|Overall Study|Withdrawal by Subject|1|||
23284498|NCT02957942|64784804|FG000|Overall Study|Practicing experiment protocol|0|||
23284499|NCT02957942|64784805|FG001|Overall Study|Practicing experiment protocol|6|||
23284500|NCT00918684|64784806|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
23284501|NCT00918684|64784806|FG000|Treatment Phase|Lack of Efficacy|6|||
23284502|NCT00918684|64784806|FG000|Treatment Phase|Lost to Follow-up|2|||
23284503|NCT00918684|64784806|FG000|Treatment Phase|Physician Decision|8|||
23284504|NCT00918684|64784806|FG000|Treatment Phase|Protocol Violation|1|||
23284505|NCT00918684|64784806|FG000|Treatment Phase|Withdrawal by Subject|8|||
23284506|NCT00702507|64784807|FG000|Initial Treatment Phase|Adverse Event|2|||
23284507|NCT00702507|64784807|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
23284508|NCT00702507|64784807|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
23284509|NCT00702507|64784807|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
23284510|NCT00702507|64784807|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
23284511|NCT00702507|64784807|FG000|Follow-up Phase|Protocol Violation|2|||
23284512|NCT00702507|64784807|FG000|Follow-up Phase|Lost to Follow-up|23|||
23284513|NCT00702507|64784807|FG000|Follow-up Phase|Late Enrollment|1|||
23284514|NCT01046084|64784808|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
23284515|NCT01046084|64784809|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
23284516|NCT01986647|64784812|FG000|Overall Study|Lost to Follow-up|4|||
23284517|NCT01986647|64784813|FG001|Overall Study|Lost to Follow-up|1|||
23284518|NCT01986647|64784814|FG002|Overall Study|Lost to Follow-up|4|||
23284519|NCT01986647|64784815|FG003|Overall Study|Lost to Follow-up|4|||
23284520|NCT01986647|64784812|FG000|Overall Study|Withdrawal by Subject|1|||
23284521|NCT01986647|64784813|FG001|Overall Study|Withdrawal by Subject|3|||
23284522|NCT01986647|64784814|FG002|Overall Study|Withdrawal by Subject|2|||
23284523|NCT01986647|64784815|FG003|Overall Study|Withdrawal by Subject|3|||
23284524|NCT01986647|64784812|FG000|Overall Study|Health|5|||
23284525|NCT01986647|64784813|FG001|Overall Study|Health|3|||
23284526|NCT01986647|64784814|FG002|Overall Study|Health|6|||
23284527|NCT01986647|64784815|FG003|Overall Study|Health|4|||
23284528|NCT01018862|64784816|FG000|Overall Study|Adverse Event|2|||
23284529|NCT01018862|64784817|FG001|Overall Study|Adverse Event|0|||
23284530|NCT01018862|64784818|FG002|Overall Study|Adverse Event|6|||
23284531|NCT01018862|64784816|FG000|Overall Study|Lack of Efficacy|1|||
23284532|NCT01018862|64784817|FG001|Overall Study|Lack of Efficacy|0|||
23284533|NCT01018862|64784818|FG002|Overall Study|Lack of Efficacy|2|||
23284534|NCT01018862|64784816|FG000|Overall Study|Lost to Follow-up|3|||
23284535|NCT01018862|64784817|FG001|Overall Study|Lost to Follow-up|1|||
23284536|NCT01018862|64784818|FG002|Overall Study|Lost to Follow-up|0|||
23284537|NCT01018862|64784816|FG000|Overall Study|Protocol Violation|1|||
23284538|NCT01018862|64784817|FG001|Overall Study|Protocol Violation|3|||
23284539|NCT01018862|64784818|FG002|Overall Study|Protocol Violation|3|||
23284540|NCT01018862|64784816|FG000|Overall Study|Withdrawal by Subject|1|||
23284541|NCT01018862|64784817|FG001|Overall Study|Withdrawal by Subject|2|||
23284542|NCT01018862|64784818|FG002|Overall Study|Withdrawal by Subject|1|||
23284543|NCT01018862|64784816|FG000|Overall Study|administrative problems|5|||
23284544|NCT01018862|64784817|FG001|Overall Study|administrative problems|4|||
23284545|NCT01018862|64784818|FG002|Overall Study|administrative problems|4|||
23284546|NCT05004649|64784819|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
23284547|NCT05004649|64784819|FG000|Overall Study|Lost to Follow-up|1|||
23284548|NCT05004649|64784819|FG000|Overall Study|Withdrawal by Subject|2|||
23284549|NCT05004649|64784819|FG000|Overall Study|COVID-19|1|||
23284550|NCT02651987|64784820|FG000|Overall Study|Adverse Event|2|||
23284551|NCT02651987|64784821|FG001|Overall Study|Adverse Event|2|||
23284552|NCT02651987|64784820|FG000|Overall Study|Consent Withdrawn|2|||
23604771|NCT01159600|65943506|FG002|Overall Study|Not treated|1|||
23284553|NCT02651987|64784821|FG001|Overall Study|Consent Withdrawn|0|||
23284554|NCT02651987|64784820|FG000|Overall Study|Local PD|0|||
23284555|NCT02651987|64784821|FG001|Overall Study|Local PD|2|||
23284556|NCT02651987|64784820|FG000|Overall Study|Investigator Decision|1|||
23284557|NCT02651987|64784821|FG001|Overall Study|Investigator Decision|1|||
23284558|NCT04567329|64784834|FG000|Overall Study|Withdrawal by Subject|5|||
23284559|NCT04567329|64784835|FG001|Overall Study|Withdrawal by Subject|6|||
23377038|NCT01202591|65126498|FG003|Overall Study|Adverse Event|4|||
23377039|NCT01202591|65126499|FG004|Overall Study|Adverse Event|0|||
23377040|NCT01202591|65126500|FG005|Overall Study|Adverse Event|0|||
23377041|NCT01202591|65126495|FG000|Overall Study|Other reason as per investigator|3|||
23284560|NCT04567329|64784834|FG000|Overall Study|Protocol Violation|2|||
23284561|NCT04567329|64784835|FG001|Overall Study|Protocol Violation|3|||
23284562|NCT04567329|64784834|FG000|Overall Study|Discontinued|2|||
23284563|NCT04567329|64784835|FG001|Overall Study|Discontinued|2|||
23284564|NCT04567329|64784834|FG000|Overall Study|Lost to Follow-up|0|||
23284565|NCT04567329|64784835|FG001|Overall Study|Lost to Follow-up|1|||
23284566|NCT04567329|64784834|FG000|Overall Study|Lack of Efficacy|0|||
23284567|NCT04567329|64784835|FG001|Overall Study|Lack of Efficacy|1|||
23284568|NCT04299087|64784836|FG000|Overall Study|Lost to Follow-up|2|||
23284569|NCT04299087|64784837|FG001|Overall Study|Lost to Follow-up|1|||
23284570|NCT01675596|64784843|FG000|Overall Study|Death|6|||
23284571|NCT01675596|64784843|FG000|Overall Study|Exit with other reason|1|||
23284572|NCT01675596|64784843|FG000|Overall Study|Missed Visit|1|||
23284573|NCT04892147|64784844|FG000|Overall Study|Withdrawal by Subject|2|||
23284574|NCT04892147|64784845|FG001|Overall Study|Withdrawal by Subject|0|||
23284575|NCT00924638|64784846|FG000|Overall Study|Death|3|||
23284576|NCT00924638|64784847|FG001|Overall Study|Death|2|||
23284577|NCT00924638|64784846|FG000|Overall Study|Lost to Follow-up|1|||
23284578|NCT00924638|64784847|FG001|Overall Study|Lost to Follow-up|1|||
23284579|NCT00924638|64784846|FG000|Overall Study|Withdrawal by Subject|5|||
23284580|NCT00924638|64784847|FG001|Overall Study|Withdrawal by Subject|7|||
23284581|NCT00924638|64784846|FG000|Overall Study|Physician Decision|3|||
23284582|NCT00924638|64784847|FG001|Overall Study|Physician Decision|3|||
23284583|NCT02003391|64784855|FG000|Overall Study|Withdrawal by Subject|2|||
23284584|NCT02003391|64784856|FG001|Overall Study|Withdrawal by Subject|1|||
23284585|NCT02003391|64784855|FG000|Overall Study|Protocol Violation|0|||
23284586|NCT02003391|64784856|FG001|Overall Study|Protocol Violation|1|||
23284587|NCT02003391|64784855|FG000|Overall Study|Adverse Event|1|||
23284588|NCT02003391|64784856|FG001|Overall Study|Adverse Event|0|||
23284589|NCT01158118|64784857|FG000|Overall Study|Screen failure|1|||
23284590|NCT01158118|64784858|FG001|Overall Study|Screen failure|0|||
23284591|NCT01158118|64784857|FG000|Overall Study|Donor match was a screen failure|0|||
23284592|NCT01158118|64784858|FG001|Overall Study|Donor match was a screen failure|1|||
23284593|NCT01158118|64784857|FG000|Overall Study|Suffered stroke prior to transplant|0|||
23284594|NCT01158118|64784858|FG001|Overall Study|Suffered stroke prior to transplant|1|||
23284595|NCT01158118|64784857|FG000|Overall Study|Death|0|||
23284596|NCT01158118|64784858|FG001|Overall Study|Death|1|||
23284597|NCT02336074|64784869|FG000|Overall Study|Adverse Event|0|||
23284598|NCT02336074|64784870|FG001|Overall Study|Adverse Event|2|||
23377042|NCT01202591|65126496|FG001|Overall Study|Other reason as per investigator|4|||
23604772|NCT01159600|65943507|FG003|Overall Study|Not treated|0|||
23284599|NCT00654186|64784874|FG000|Overall Study|Withdrawal by Subject|5|||
23377043|NCT01202591|65126497|FG002|Overall Study|Other reason as per investigator|7|||
23604773|NCT01159600|65943508|FG004|Overall Study|Not treated|0|||
23604774|NCT01159600|65943509|FG005|Overall Study|Not treated|1|||
23604775|NCT01159600|65943510|FG006|Overall Study|Not treated|2|||
23604776|NCT01159600|65943511|FG007|Overall Study|Not treated|2|||
23604777|NCT01159600|65943504|FG000|Overall Study|Adverse Event|7|||
23604778|NCT01159600|65943505|FG001|Overall Study|Adverse Event|2|||
23604779|NCT01159600|65943506|FG002|Overall Study|Adverse Event|5|||
23604780|NCT01159600|65943507|FG003|Overall Study|Adverse Event|1|||
23604781|NCT01159600|65943508|FG004|Overall Study|Adverse Event|8|||
23377044|NCT01202591|65126498|FG003|Overall Study|Other reason as per investigator|3|||
23377045|NCT01202591|65126499|FG004|Overall Study|Other reason as per investigator|1|||
23377046|NCT01202591|65126500|FG005|Overall Study|Other reason as per investigator|3|||
23377047|NCT01202591|65126495|FG000|Overall Study|Withdrawal by Subject|0|||
23377048|NCT01202591|65126496|FG001|Overall Study|Withdrawal by Subject|0|||
23377049|NCT01202591|65126497|FG002|Overall Study|Withdrawal by Subject|0|||
23377050|NCT01202591|65126498|FG003|Overall Study|Withdrawal by Subject|0|||
23377051|NCT01202591|65126499|FG004|Overall Study|Withdrawal by Subject|2|||
23377052|NCT01202591|65126500|FG005|Overall Study|Withdrawal by Subject|1|||
23377053|NCT01202591|65126495|FG000|Overall Study|Objective Disease Progression|0|||
23377054|NCT01202591|65126496|FG001|Overall Study|Objective Disease Progression|0|||
23377055|NCT01202591|65126497|FG002|Overall Study|Objective Disease Progression|0|||
23377056|NCT01202591|65126498|FG003|Overall Study|Objective Disease Progression|0|||
23377057|NCT01202591|65126499|FG004|Overall Study|Objective Disease Progression|2|||
23377058|NCT01202591|65126500|FG005|Overall Study|Objective Disease Progression|0|||
23377059|NCT00262925|65126501|FG000|Overall Study|Lack of Efficacy|3|||
23377060|NCT00262925|65126501|FG000|Overall Study|Adverse Event|4|||
23377061|NCT00262925|65126501|FG000|Overall Study|Death|2|||
23604782|NCT01159600|65943509|FG005|Overall Study|Adverse Event|6|||
23604783|NCT01159600|65943510|FG006|Overall Study|Adverse Event|7|||
23284600|NCT04133311|64784875|FG000|Period 1 Double Masked Treatment Period|Death|1|||
23284601|NCT04133311|64784876|FG001|Period 1 Double Masked Treatment Period|Death|0|||
23284602|NCT04133311|64784877|FG002|Period 1 Double Masked Treatment Period|Death|0|||
23284603|NCT04133311|64784878|FG003|Period 1 Double Masked Treatment Period|Death|0|||
23284604|NCT04133311|64784875|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
23284605|NCT04133311|64784876|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
23284606|NCT04133311|64784877|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
23284607|NCT04133311|64784878|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
23284608|NCT04133311|64784875|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
23284609|NCT04133311|64784876|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
23284610|NCT04133311|64784877|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
23284611|NCT04133311|64784878|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
23284612|NCT04133311|64784875|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
23284613|NCT04133311|64784876|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
23284614|NCT04133311|64784877|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
23284615|NCT04133311|64784878|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
23284616|NCT04133311|64784875|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
23284617|NCT04133311|64784876|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
23284618|NCT04133311|64784877|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
23284619|NCT04133311|64784878|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
23284620|NCT04133311|64784875|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
23284621|NCT04133311|64784876|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
23284622|NCT04133311|64784877|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
23284623|NCT04133311|64784878|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
23284624|NCT04133311|64784875|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
23284625|NCT04133311|64784876|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
23284626|NCT04133311|64784877|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
23284627|NCT04133311|64784878|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
23284628|NCT04133311|64784875|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
23284629|NCT04133311|64784876|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
23284630|NCT04133311|64784877|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
23284631|NCT04133311|64784878|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
23284632|NCT03888235|64784884|FG000|Overall Study|Lost to Follow-up|1|||
23284633|NCT03888235|64784885|FG001|Overall Study|Lost to Follow-up|1|||
23284634|NCT03888235|64784886|FG002|Overall Study|Lost to Follow-up|0|||
23284635|NCT02488239|64784890|FG000|Overall Study|Death|3|||
23284636|NCT02488239|64784890|FG000|Overall Study|Withdrawal by Subject|3|||
23284637|NCT02488239|64784890|FG000|Overall Study|Physician Decision|2|||
23284638|NCT02488239|64784890|FG000|Overall Study|Consent ineligible|1|||
23284639|NCT02488239|64784890|FG000|Overall Study|Did not undergo implant procedure|1|||
23284640|NCT02179190|64784891|FG000|Enrollment|Exit Prior to Device Attempt|11|||
23284641|NCT02179190|64784891|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
23377062|NCT00262925|65126501|FG000|Overall Study|alternative therapy|1|||
23377063|NCT00262925|65126501|FG000|Overall Study|Other|1|||
23377064|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
23377065|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
23604784|NCT01159600|65943511|FG007|Overall Study|Adverse Event|5|||
23604785|NCT01159600|65943504|FG000|Overall Study|Lack of Efficacy|0|||
23284642|NCT02179190|64784891|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
23284643|NCT02179190|64784891|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
23284644|NCT02179190|64784891|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
23284645|NCT02179190|64784891|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
23284646|NCT02997176|64784892|FG000|Overall Study|Adverse Event|0|||
23284647|NCT02997176|64784893|FG001|Overall Study|Adverse Event|0|||
23284648|NCT02997176|64784894|FG002|Overall Study|Adverse Event|0|||
23284649|NCT02997176|64784895|FG003|Overall Study|Adverse Event|8|||
23284650|NCT02997176|64784892|FG000|Overall Study|Progressive Disease|1|||
23284651|NCT02997176|64784893|FG001|Overall Study|Progressive Disease|0|||
23284652|NCT02997176|64784894|FG002|Overall Study|Progressive Disease|1|||
23284653|NCT02997176|64784895|FG003|Overall Study|Progressive Disease|1|||
23284654|NCT02997176|64784892|FG000|Overall Study|Death|0|||
23284655|NCT02997176|64784893|FG001|Overall Study|Death|0|||
23284656|NCT02997176|64784894|FG002|Overall Study|Death|1|||
23284657|NCT02997176|64784895|FG003|Overall Study|Death|1|||
23284658|NCT02997176|64784892|FG000|Overall Study|Withdrawal by Subject|0|||
23284659|NCT02997176|64784893|FG001|Overall Study|Withdrawal by Subject|2|||
23284660|NCT02997176|64784894|FG002|Overall Study|Withdrawal by Subject|0|||
23284661|NCT02997176|64784895|FG003|Overall Study|Withdrawal by Subject|1|||
23284662|NCT01252953|64784896|FG000|Overall Study|Withdrawal by Subject|16|||
23284663|NCT01252953|64784897|FG001|Overall Study|Withdrawal by Subject|17|||
23284664|NCT01252953|64784896|FG000|Overall Study|Lost to Follow-up|22|||
23284665|NCT01252953|64784897|FG001|Overall Study|Lost to Follow-up|21|||
23284666|NCT01438060|64784898|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
23284667|NCT01438060|64784899|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
23284668|NCT01438060|64784898|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
23284669|NCT01438060|64784899|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
23284670|NCT01438060|64784898|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
23284671|NCT01438060|64784899|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
23284672|NCT01438060|64784898|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
23284673|NCT01438060|64784899|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
23284674|NCT01438060|64784898|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
23284675|NCT01438060|64784899|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
23284676|NCT01438060|64784898|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
23284677|NCT01438060|64784899|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
23284678|NCT01438060|64784898|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
23284679|NCT01438060|64784899|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
23284680|NCT01438060|64784898|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
23284681|NCT01438060|64784899|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
23284682|NCT01438060|64784898|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
23284683|NCT01438060|64784899|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
23284684|NCT01438060|64784898|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
23284685|NCT01438060|64784899|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
23284686|NCT01438060|64784898|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
23284687|NCT01438060|64784899|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
23284688|NCT01438060|64784898|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
23284689|NCT01438060|64784899|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
23284690|NCT01438060|64784898|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
23284691|NCT01438060|64784899|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
23284692|NCT01438060|64784898|FG000|On Study Beyond Week 140|Adverse Event|0|||
23284693|NCT01438060|64784899|FG001|On Study Beyond Week 140|Adverse Event|2|||
23284694|NCT01438060|64784898|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
23284695|NCT01438060|64784899|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
23284696|NCT01438060|64784898|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
23284697|NCT01438060|64784899|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
23284698|NCT01438060|64784898|FG000|On Study Beyond Week 140|Death|0|||
23284699|NCT01438060|64784899|FG001|On Study Beyond Week 140|Death|1|||
23284700|NCT01438060|64784898|FG000|On Study Beyond Week 140|Other Reason|0|||
23284701|NCT01438060|64784899|FG001|On Study Beyond Week 140|Other Reason|3|||
23284702|NCT00101439|64784901|FG000|Period 2|Withdrawal by Subject|0|||
23284703|NCT00101439|64784902|FG001|Period 2|Withdrawal by Subject|2|||
23284704|NCT03867760|64784903|FG000|Overall Study|Lost to Follow-up|2|||
23284705|NCT03867760|64784904|FG001|Overall Study|Lost to Follow-up|3|||
23489674|NCT01461980|65537155|FG001|Overall Study|No longer willing to participate|38|||
23489675|NCT01461980|65537156|FG002|Overall Study|No longer willing to participate|54|||
23489676|NCT01461980|65537154|FG000|Overall Study|Randomized but not vaccinated|4|||
23284706|NCT03867760|64784903|FG000|Overall Study|Withdrawal by Subject|1|||
23284707|NCT03867760|64784904|FG001|Overall Study|Withdrawal by Subject|2|||
23284708|NCT03867760|64784903|FG000|Overall Study|subject could not meet study logistics|3|||
23284709|NCT03867760|64784904|FG001|Overall Study|subject could not meet study logistics|3|||
23284710|NCT04203667|64784906|FG000|Overall Study|Withdrawal by Subject|1|||
23284711|NCT04203667|64784906|FG000|Overall Study|Lost to Follow-up|1|||
23377066|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
23377067|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
23377068|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
23377069|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
23377070|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
23377071|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
23377072|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
23377073|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
23377074|NCT03979313|65126502|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
23377075|NCT03979313|65126503|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
23377076|NCT03979313|65126502|FG000|All Subjects|Any Other Reason|16|||
23377077|NCT03979313|65126503|FG001|All Subjects|Any Other Reason|23|||
23377078|NCT03979313|65126502|FG000|All Subjects|Covid-19|1|||
23377079|NCT03979313|65126503|FG001|All Subjects|Covid-19|3|||
23377080|NCT03979313|65126502|FG000|All Subjects|Withdrawal by Subject|35|||
23377081|NCT03979313|65126503|FG001|All Subjects|Withdrawal by Subject|44|||
23377082|NCT03979313|65126502|FG000|All Subjects|Death|0|||
23377083|NCT03979313|65126503|FG001|All Subjects|Death|5|||
23377084|NCT03979313|65126502|FG000|All Subjects|Lost to Follow-up|28|||
23377085|NCT03979313|65126503|FG001|All Subjects|Lost to Follow-up|61|||
23377086|NCT02318940|65126505|FG000|Overall Study|lost the record|1|||
23377087|NCT02318940|65126506|FG001|Overall Study|lost the record|0|||
23377088|NCT02394275|65126507|FG000|Overall Study|Adverse Event|22|||
23377089|NCT02394275|65126507|FG000|Overall Study|Lost to Follow-up|7|||
23377090|NCT00593814|65126510|FG000|Overall Study|Death|7|||
23377091|NCT00593814|65126511|FG001|Overall Study|Death|0|||
23377092|NCT00593814|65126510|FG000|Overall Study|Withdrawal by Subject|7|||
23377093|NCT00593814|65126511|FG001|Overall Study|Withdrawal by Subject|0|||
23377094|NCT00593814|65126510|FG000|Overall Study|Lost to Follow-up|7|||
23377095|NCT00593814|65126511|FG001|Overall Study|Lost to Follow-up|0|||
23377096|NCT00593814|65126510|FG000|Overall Study|Physician Decision|3|||
23377097|NCT00593814|65126511|FG001|Overall Study|Physician Decision|0|||
23377098|NCT00134719|65126512|FG000|Primary Vaccination Phase|Adverse Event|4|||
23377099|NCT00134719|65126513|FG001|Primary Vaccination Phase|Adverse Event|0|||
23377100|NCT00134719|65126514|FG002|Primary Vaccination Phase|Adverse Event|0|||
23377101|NCT00134719|65126512|FG000|Primary Vaccination Phase|Protocol Violation|1|||
23377102|NCT00134719|65126513|FG001|Primary Vaccination Phase|Protocol Violation|0|||
23377103|NCT00134719|65126514|FG002|Primary Vaccination Phase|Protocol Violation|0|||
23377104|NCT00134719|65126512|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
23377105|NCT00134719|65126513|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
23377106|NCT00134719|65126514|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
23377107|NCT00134719|65126512|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
23377108|NCT00134719|65126513|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
23377109|NCT00134719|65126514|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
23377110|NCT00134719|65126512|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
23377111|NCT00134719|65126513|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
23377112|NCT00134719|65126514|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
23377113|NCT00134719|65126512|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
23377114|NCT00134719|65126513|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
23377115|NCT00134719|65126514|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
23377116|NCT00071981|65126515|FG000|Overall Study|Lack of Efficacy|37|||
23377117|NCT00071981|65126516|FG001|Overall Study|Lack of Efficacy|29|||
23377118|NCT00071981|65126517|FG002|Overall Study|Lack of Efficacy|30|||
23284712|NCT04203667|64784906|FG000|Overall Study|Death|1|||
23284713|NCT04203667|64784906|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
23284714|NCT00503867|64784907|FG000|Overall Study|Lost to Follow-up|1|||
23284715|NCT00503867|64784907|FG000|Overall Study|Adverse Event|1|||
23284716|NCT02167594|64784914|FG000|Overall Study|Withdrawal by Subject|2|||
23284717|NCT02167594|64784915|FG001|Overall Study|Withdrawal by Subject|0|||
23284718|NCT02167594|64784916|FG002|Overall Study|Withdrawal by Subject|0|||
23284719|NCT02167594|64784914|FG000|Overall Study|Death|0|||
23284720|NCT02167594|64784915|FG001|Overall Study|Death|1|||
23284721|NCT02167594|64784916|FG002|Overall Study|Death|0|||
23284722|NCT03694197|64784917|FG000|Overall Study|Adverse Event|9|||
23284723|NCT03694197|64784917|FG000|Overall Study|Protocol became inconvenient to participate|1|||
23284724|NCT03694197|64784917|FG000|Overall Study|Physician Decision|4|||
23284725|NCT03694197|64784917|FG000|Overall Study|Study terminated by sponsor|1350|||
23284726|NCT03694197|64784917|FG000|Overall Study|Participant moved|5|||
23284727|NCT03694197|64784917|FG000|Overall Study|Participant withdrew consent|10|||
23284728|NCT03694197|64784917|FG000|Overall Study|Related to IMP administration|1|||
23284729|NCT03694197|64784917|FG000|Overall Study|Not disclosed|5|||
23284730|NCT01120028|64784918|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
23284731|NCT01120028|64784919|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
23284732|NCT01120028|64784920|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
23284733|NCT01120028|64784921|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
23284734|NCT01120028|64784918|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
23377119|NCT00071981|65126518|FG003|Overall Study|Lack of Efficacy|43|||
23377120|NCT00071981|65126515|FG000|Overall Study|Adverse Event|4|||
23377121|NCT00071981|65126516|FG001|Overall Study|Adverse Event|4|||
23377122|NCT00071981|65126517|FG002|Overall Study|Adverse Event|3|||
23377123|NCT00071981|65126518|FG003|Overall Study|Adverse Event|1|||
23377124|NCT00071981|65126515|FG000|Overall Study|Death|0|||
23377125|NCT00071981|65126516|FG001|Overall Study|Death|0|||
23377126|NCT00071981|65126517|FG002|Overall Study|Death|1|||
23377127|NCT00071981|65126518|FG003|Overall Study|Death|1|||
23377128|NCT00071981|65126515|FG000|Overall Study|Withdrawal by Subject|3|||
23377129|NCT00071981|65126516|FG001|Overall Study|Withdrawal by Subject|1|||
23377130|NCT00071981|65126517|FG002|Overall Study|Withdrawal by Subject|0|||
23284735|NCT01120028|64784919|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
23284736|NCT01120028|64784920|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
23284737|NCT01120028|64784921|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
23284738|NCT00999687|64784922|FG000|First Intervention|Withdrawal by Subject|1|||
23377131|NCT00071981|65126518|FG003|Overall Study|Withdrawal by Subject|0|||
23284739|NCT00999687|64784922|FG000|Second Intervention|Withdrawal by Subject|2|||
23284740|NCT00999687|64784922|FG000|Second Intervention|Lack of Efficacy|1|||
23377132|NCT00071981|65126515|FG000|Overall Study|No protocol therapy|2|||
23377133|NCT00071981|65126516|FG001|Overall Study|No protocol therapy|5|||
23377134|NCT00071981|65126517|FG002|Overall Study|No protocol therapy|1|||
23377135|NCT00071981|65126518|FG003|Overall Study|No protocol therapy|0|||
23377136|NCT00071981|65126515|FG000|Overall Study|others (not specified in the study)|0|||
23377137|NCT00071981|65126516|FG001|Overall Study|others (not specified in the study)|2|||
23489677|NCT01461980|65537155|FG001|Overall Study|Randomized but not vaccinated|8|||
23377138|NCT00071981|65126517|FG002|Overall Study|others (not specified in the study)|2|||
23377139|NCT00071981|65126518|FG003|Overall Study|others (not specified in the study)|0|||
23377140|NCT00118287|65126525|FG000|Overall Study|Intracranial haemorrhage|1|||
23377141|NCT00118287|65126525|FG000|Overall Study|Muscle pain|1|||
23377142|NCT01541748|65126526|FG000|Overall Study|Lost to Follow-up|17|||
23377143|NCT01541748|65126526|FG000|Overall Study|Moved out of state|1|||
23377144|NCT01541748|65126526|FG000|Overall Study|Withdrawal by Subject|7|||
23377145|NCT01541748|65126526|FG000|Overall Study|Screen failure|5|||
23377146|NCT01541748|65126526|FG000|Overall Study|Did not receive study device|1|||
23377147|NCT01147458|65126527|FG000|First Intervention|Study terminated by sponsor|8|||
23377148|NCT01147458|65126528|FG001|First Intervention|Study terminated by sponsor|8|||
23377149|NCT01147458|65126529|FG002|First Intervention|Study terminated by sponsor|7|||
23377150|NCT01147458|65126530|FG003|First Intervention|Study terminated by sponsor|8|||
23377151|NCT01147458|65126527|FG000|First Intervention|Protocol Violation|2|||
23377152|NCT01147458|65126528|FG001|First Intervention|Protocol Violation|3|||
23377153|NCT01147458|65126529|FG002|First Intervention|Protocol Violation|2|||
23377154|NCT01147458|65126530|FG003|First Intervention|Protocol Violation|3|||
23377155|NCT01147458|65126527|FG000|First Intervention|Withdrawal by Subject|3|||
23377156|NCT01147458|65126528|FG001|First Intervention|Withdrawal by Subject|0|||
23377157|NCT01147458|65126529|FG002|First Intervention|Withdrawal by Subject|1|||
23377158|NCT01147458|65126530|FG003|First Intervention|Withdrawal by Subject|0|||
23377159|NCT01147458|65126527|FG000|First Intervention|Adverse Event|0|||
23377160|NCT01147458|65126528|FG001|First Intervention|Adverse Event|3|||
23377161|NCT01147458|65126529|FG002|First Intervention|Adverse Event|2|||
23377162|NCT01147458|65126530|FG003|First Intervention|Adverse Event|3|||
23377163|NCT01147458|65126527|FG000|First Intervention|Other|1|||
23377164|NCT01147458|65126528|FG001|First Intervention|Other|2|||
23377165|NCT01147458|65126529|FG002|First Intervention|Other|0|||
23377166|NCT01147458|65126530|FG003|First Intervention|Other|0|||
23377167|NCT01147458|65126527|FG000|Second Intervention|Study terminated by sponsor|7|||
23377168|NCT01147458|65126528|FG001|Second Intervention|Study terminated by sponsor|5|||
23377169|NCT01147458|65126529|FG002|Second Intervention|Study terminated by sponsor|5|||
23377170|NCT01147458|65126530|FG003|Second Intervention|Study terminated by sponsor|3|||
23377171|NCT01147458|65126527|FG000|Second Intervention|Protocol Violation|0|||
23377172|NCT01147458|65126528|FG001|Second Intervention|Protocol Violation|1|||
23377173|NCT01147458|65126529|FG002|Second Intervention|Protocol Violation|1|||
23377174|NCT01147458|65126530|FG003|Second Intervention|Protocol Violation|0|||
23377175|NCT01147458|65126527|FG000|Second Intervention|Withdrawal by Subject|0|||
23377176|NCT01147458|65126528|FG001|Second Intervention|Withdrawal by Subject|1|||
23377177|NCT01147458|65126529|FG002|Second Intervention|Withdrawal by Subject|0|||
23377178|NCT01147458|65126530|FG003|Second Intervention|Withdrawal by Subject|0|||
23377179|NCT01147458|65126527|FG000|Second Intervention|Adverse Event|2|||
23377180|NCT01147458|65126528|FG001|Second Intervention|Adverse Event|0|||
23377181|NCT01147458|65126529|FG002|Second Intervention|Adverse Event|1|||
23377182|NCT01147458|65126530|FG003|Second Intervention|Adverse Event|1|||
23377183|NCT01147458|65126527|FG000|Second Intervention|Other|0|||
23377184|NCT01147458|65126528|FG001|Second Intervention|Other|0|||
23377185|NCT01147458|65126529|FG002|Second Intervention|Other|1|||
23377186|NCT01147458|65126530|FG003|Second Intervention|Other|0|||
23377187|NCT02188160|65126533|FG000|Overall Study|Adverse Event|1|||
23377188|NCT02188160|65126534|FG001|Overall Study|Adverse Event|0|||
23377189|NCT02188160|65126533|FG000|Overall Study|Use of an excluded medication|0|||
23377190|NCT02188160|65126534|FG001|Overall Study|Use of an excluded medication|1|||
23377191|NCT00005047|65126535|FG000|Overall Study|Withdrawal by Subject|12|||
23377192|NCT00005047|65126536|FG001|Overall Study|Withdrawal by Subject|0|||
23377193|NCT00005047|65126537|FG002|Overall Study|Withdrawal by Subject|0|||
23377194|NCT00005047|65126538|FG003|Overall Study|Withdrawal by Subject|0|||
23377195|NCT00005047|65126535|FG000|Overall Study|Adverse Event|5|||
23377196|NCT00005047|65126536|FG001|Overall Study|Adverse Event|0|||
23377197|NCT00005047|65126537|FG002|Overall Study|Adverse Event|0|||
23377198|NCT00005047|65126538|FG003|Overall Study|Adverse Event|0|||
23377199|NCT00005047|65126535|FG000|Overall Study|Lost to Follow-up|1|||
23377200|NCT00005047|65126536|FG001|Overall Study|Lost to Follow-up|0|||
23377201|NCT00005047|65126537|FG002|Overall Study|Lost to Follow-up|0|||
23377202|NCT00005047|65126538|FG003|Overall Study|Lost to Follow-up|0|||
23377203|NCT00005047|65126535|FG000|Overall Study|Lack of Efficacy|1|||
23377204|NCT00005047|65126536|FG001|Overall Study|Lack of Efficacy|0|||
23377205|NCT00005047|65126537|FG002|Overall Study|Lack of Efficacy|0|||
23377206|NCT00005047|65126538|FG003|Overall Study|Lack of Efficacy|0|||
23377207|NCT02326883|65126540|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
23377208|NCT02326883|65126541|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
23377209|NCT02326883|65126542|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
23377210|NCT00324155|65126543|FG000|Enrolled and Randomized|No longer met study criteria|3|||
23377211|NCT00324155|65126544|FG001|Enrolled and Randomized|No longer met study criteria|0|||
23377212|NCT00324155|65126543|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
23377213|NCT00324155|65126544|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
23377214|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
23377215|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
23377216|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
23377217|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
23377218|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Death|8|||
23377219|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Death|15|||
23377220|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
23377221|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
23377222|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
23377223|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
23377224|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
23377225|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
23377226|NCT00324155|65126543|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
23377227|NCT00324155|65126544|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
23377228|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
23377229|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
23377230|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
23377231|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
23377232|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
23377233|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
23377234|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
23377235|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
23377236|NCT00324155|65126543|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
23377237|NCT00324155|65126544|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
23377238|NCT00324155|65126543|FG000|Follow-up Phase|On-going participants still on drug|11|||
23377239|NCT00324155|65126544|FG001|Follow-up Phase|On-going participants still on drug|6|||
23377240|NCT01118299|65126545|FG000|Overall Study|Death|7|||
23377241|NCT01118299|65126546|FG001|Overall Study|Death|5|||
23377242|NCT01118299|65126545|FG000|Overall Study|Withdrawal by Subject|8|||
23377243|NCT01118299|65126546|FG001|Overall Study|Withdrawal by Subject|8|||
23377244|NCT01118299|65126545|FG000|Overall Study|Lost to Follow-up|2|||
23377245|NCT01118299|65126546|FG001|Overall Study|Lost to Follow-up|1|||
23377246|NCT01118299|65126545|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
23377247|NCT01118299|65126546|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
23377248|NCT02921789|65126551|FG000|Overall Study|Adverse Event|0|||
23377249|NCT02921789|65126552|FG001|Overall Study|Adverse Event|1|||
23377250|NCT02921789|65126551|FG000|Overall Study|Lost to Follow-up|1|||
23377251|NCT02921789|65126552|FG001|Overall Study|Lost to Follow-up|0|||
23284741|NCT04768114|64784923|FG000|Overall Study|Lost to Follow-up|5|||
23284742|NCT04768114|64784924|FG001|Overall Study|Lost to Follow-up|10|||
23284743|NCT04768114|64784923|FG000|Overall Study|Withdrawal by Subject|0|||
23284744|NCT04768114|64784924|FG001|Overall Study|Withdrawal by Subject|1|||
23284745|NCT04561115|64784925|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
23284746|NCT04561115|64784926|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
23284747|NCT04561115|64784925|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
23284748|NCT04561115|64784926|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
23377252|NCT02921789|65126551|FG000|Overall Study|Protocol Deviation|2|||
23377253|NCT02921789|65126552|FG001|Overall Study|Protocol Deviation|0|||
23377254|NCT02921789|65126551|FG000|Overall Study|Withdrawal by Subject|2|||
23377255|NCT02921789|65126552|FG001|Overall Study|Withdrawal by Subject|1|||
23377256|NCT02921789|65126551|FG000|Overall Study|Miscellaneous|3|||
23377257|NCT02921789|65126552|FG001|Overall Study|Miscellaneous|2|||
23377258|NCT04591015|65126553|FG000|Overall Study|Death|6|||
23377259|NCT04591015|65126554|FG001|Overall Study|Death|4|||
23377260|NCT04591015|65126553|FG000|Overall Study|Withdrawal by Subject|6|||
23377261|NCT04591015|65126554|FG001|Overall Study|Withdrawal by Subject|3|||
23377262|NCT04591015|65126553|FG000|Overall Study|Lost to Follow-up|16|||
23377263|NCT04591015|65126554|FG001|Overall Study|Lost to Follow-up|11|||
23377264|NCT00426270|65126555|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
23377265|NCT00426270|65126555|FG000|Overall Study|Adverse Event|5|||
23377266|NCT01881425|65126556|FG000|Overall Study|Death|5|||
23377267|NCT01881425|65126557|FG001|Overall Study|Death|1|||
23377268|NCT01881425|65126556|FG000|Overall Study|Withdrawal by Subject|8|||
23377269|NCT01881425|65126557|FG001|Overall Study|Withdrawal by Subject|3|||
23377270|NCT01881425|65126556|FG000|Overall Study|Physician Decision|2|||
23377271|NCT01881425|65126557|FG001|Overall Study|Physician Decision|1|||
23377272|NCT01881425|65126556|FG000|Overall Study|Adverse Event|3|||
23489678|NCT01461980|65537156|FG002|Overall Study|Randomized but not vaccinated|7|||
23284749|NCT04561115|64784925|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
23284750|NCT04561115|64784926|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
23284751|NCT04388787|64784927|FG000|Blinded Period|Patient could not follow instructions|1|||
23284752|NCT04388787|64784927|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
23284753|NCT01513239|64784928|FG000|Period 1: Main Phase|Adverse Event|1|||
23284754|NCT01513239|64784929|FG001|Period 1: Main Phase|Adverse Event|1|||
23284755|NCT01513239|64784930|FG002|Period 1: Main Phase|Adverse Event|2|||
23284756|NCT01513239|64784931|FG003|Period 1: Main Phase|Adverse Event|0|||
23284757|NCT01513239|64784932|FG004|Period 1: Main Phase|Adverse Event|0|||
23284758|NCT01513239|64784933|FG005|Period 1: Main Phase|Adverse Event|0|||
23284759|NCT01513239|64784928|FG000|Period 1: Main Phase|Death|29|||
23284760|NCT01513239|64784929|FG001|Period 1: Main Phase|Death|22|||
23284761|NCT01513239|64784930|FG002|Period 1: Main Phase|Death|32|||
23284762|NCT01513239|64784931|FG003|Period 1: Main Phase|Death|0|||
23284763|NCT01513239|64784932|FG004|Period 1: Main Phase|Death|0|||
23284764|NCT01513239|64784933|FG005|Period 1: Main Phase|Death|0|||
23284765|NCT01513239|64784928|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
23377273|NCT01881425|65126557|FG001|Overall Study|Adverse Event|0|||
23377274|NCT01881425|65126556|FG000|Overall Study|General Anesthesia panic attack|0|||
23489679|NCT01134315|65537157|FG000|Overall Study|Adverse Event|1|||
23489680|NCT01134315|65537158|FG001|Overall Study|Adverse Event|2|||
23489681|NCT01134315|65537157|FG000|Overall Study|Other Reason|8|||
23489682|NCT01134315|65537158|FG001|Overall Study|Other Reason|17|||
23489683|NCT00629772|65537159|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
23489684|NCT00629772|65537160|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
23489685|NCT00629772|65537159|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
23489686|NCT00629772|65537160|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
23489687|NCT00958789|65537161|FG000|Overall Study|Death|5|||
23489688|NCT00958789|65537161|FG000|Overall Study|Lost to Follow-up|14|||
23489689|NCT00958789|65537161|FG000|Overall Study|Withdrawal by Subject|17|||
23489690|NCT00958789|65537161|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
23284766|NCT01513239|64784929|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
23284767|NCT01513239|64784930|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
23284768|NCT01513239|64784931|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
23284769|NCT01513239|64784932|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
23377275|NCT01881425|65126557|FG001|Overall Study|General Anesthesia panic attack|1|||
23377276|NCT01881425|65126556|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
23377277|NCT01881425|65126557|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
23284770|NCT01513239|64784933|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
23284771|NCT01513239|64784928|FG000|Period 1: Main Phase|Physician Decision|4|||
23377278|NCT01881425|65126556|FG000|Overall Study|Lost to Follow-up|7|||
23377279|NCT01881425|65126557|FG001|Overall Study|Lost to Follow-up|2|||
23377280|NCT01499511|65126561|FG000|Overall Study|Death|1|||
23377281|NCT01499511|65126562|FG001|Overall Study|Death|0|||
23284772|NCT01513239|64784929|FG001|Period 1: Main Phase|Physician Decision|4|||
23284773|NCT01513239|64784930|FG002|Period 1: Main Phase|Physician Decision|4|||
23284774|NCT01513239|64784931|FG003|Period 1: Main Phase|Physician Decision|0|||
23284775|NCT01513239|64784932|FG004|Period 1: Main Phase|Physician Decision|0|||
23377282|NCT00250588|65126563|FG000|Overall Study|Withdrawal by Subject|3|||
23377283|NCT00250588|65126564|FG001|Overall Study|Withdrawal by Subject|6|||
23377284|NCT00250588|65126565|FG002|Overall Study|Withdrawal by Subject|0|||
23377285|NCT00250588|65126563|FG000|Overall Study|Lost to Follow-up|6|||
23377286|NCT00250588|65126564|FG001|Overall Study|Lost to Follow-up|13|||
23377287|NCT00250588|65126565|FG002|Overall Study|Lost to Follow-up|13|||
23377288|NCT03098979|65126566|FG000|Overall Study|Adverse Event|1|||
23377289|NCT03098979|65126567|FG001|Overall Study|Adverse Event|0|||
23377290|NCT03098979|65126568|FG002|Overall Study|Adverse Event|1|||
23377291|NCT03098979|65126569|FG003|Overall Study|Adverse Event|4|||
23284776|NCT01513239|64784933|FG005|Period 1: Main Phase|Physician Decision|0|||
23284777|NCT01513239|64784928|FG000|Period 1: Main Phase|Protocol Violation|2|||
23284778|NCT01513239|64784929|FG001|Period 1: Main Phase|Protocol Violation|2|||
23284779|NCT01513239|64784930|FG002|Period 1: Main Phase|Protocol Violation|2|||
23284780|NCT01513239|64784931|FG003|Period 1: Main Phase|Protocol Violation|0|||
23284781|NCT01513239|64784932|FG004|Period 1: Main Phase|Protocol Violation|0|||
23284782|NCT01513239|64784933|FG005|Period 1: Main Phase|Protocol Violation|0|||
23284783|NCT01513239|64784928|FG000|Period 1: Main Phase|Technical Problems|1|||
23284784|NCT01513239|64784929|FG001|Period 1: Main Phase|Technical Problems|2|||
23284785|NCT01513239|64784930|FG002|Period 1: Main Phase|Technical Problems|0|||
23284786|NCT01513239|64784931|FG003|Period 1: Main Phase|Technical Problems|0|||
23284787|NCT01513239|64784932|FG004|Period 1: Main Phase|Technical Problems|0|||
23284788|NCT01513239|64784933|FG005|Period 1: Main Phase|Technical Problems|0|||
23284789|NCT01513239|64784928|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
23284790|NCT01513239|64784929|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
23284791|NCT01513239|64784930|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
23284792|NCT01513239|64784931|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
23284793|NCT01513239|64784932|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
23284794|NCT01513239|64784933|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
23284795|NCT01513239|64784928|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
23284796|NCT01513239|64784929|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
23284797|NCT01513239|64784930|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
23284798|NCT01513239|64784931|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
23284799|NCT01513239|64784932|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
23284800|NCT01513239|64784933|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
23284801|NCT01513239|64784928|FG000|Period 2: 9 Month Extension Phase|Death|0|||
23284802|NCT01513239|64784929|FG001|Period 2: 9 Month Extension Phase|Death|0|||
23284803|NCT01513239|64784930|FG002|Period 2: 9 Month Extension Phase|Death|0|||
23284804|NCT01513239|64784931|FG003|Period 2: 9 Month Extension Phase|Death|2|||
23284805|NCT01513239|64784932|FG004|Period 2: 9 Month Extension Phase|Death|5|||
23284806|NCT01513239|64784933|FG005|Period 2: 9 Month Extension Phase|Death|2|||
23284807|NCT01513239|64784928|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
23284808|NCT01513239|64784929|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
23284809|NCT01513239|64784930|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
23377292|NCT03098979|65126570|FG004|Overall Study|Adverse Event|6|||
23377293|NCT03098979|65126571|FG005|Overall Study|Adverse Event|1|||
23377294|NCT03098979|65126566|FG000|Overall Study|Withdrawal by Subject|2|||
23489691|NCT00958789|65537161|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
23489692|NCT00958789|65537161|FG000|Overall Study|Subject terminated|2|||
23489693|NCT00958789|65537161|FG000|Overall Study|Revision|7|||
23489694|NCT01147640|65537162|FG000|Overall Study|Adverse Event|2|||
23284810|NCT01513239|64784931|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
23284811|NCT01513239|64784932|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
23284812|NCT01513239|64784933|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
23284813|NCT01513239|64784928|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23284814|NCT01513239|64784929|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23284815|NCT01513239|64784930|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23284816|NCT01513239|64784931|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
23284817|NCT01513239|64784932|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23284818|NCT01513239|64784933|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
23284819|NCT01513239|64784928|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
23284820|NCT01513239|64784929|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
23284821|NCT01513239|64784930|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
23284822|NCT01513239|64784931|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
23284823|NCT01513239|64784932|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
23284824|NCT01513239|64784933|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
23284825|NCT03439085|64784934|FG000|Overall Study|Death|2|||
23284826|NCT03439085|64784934|FG000|Overall Study|Screen Failure|20|||
23284827|NCT02704091|64784935|FG000|Overall Study|Adverse Event|4|||
23489695|NCT01147640|65537163|FG001|Overall Study|Adverse Event|0|||
23489696|NCT01147640|65537162|FG000|Overall Study|Physician Decision|1|||
23489697|NCT01147640|65537163|FG001|Overall Study|Physician Decision|0|||
23489698|NCT01147640|65537162|FG000|Overall Study|Withdrawal by Subject|1|||
23489699|NCT01147640|65537163|FG001|Overall Study|Withdrawal by Subject|0|||
23489700|NCT01147640|65537162|FG000|Overall Study|Lost to Follow-up|0|||
23489701|NCT01147640|65537163|FG001|Overall Study|Lost to Follow-up|1|||
23489702|NCT01147640|65537162|FG000|Overall Study|Didn't meet eligibility criteria|1|||
23377295|NCT03098979|65126567|FG001|Overall Study|Withdrawal by Subject|1|||
23489703|NCT01147640|65537163|FG001|Overall Study|Didn't meet eligibility criteria|0|||
23489704|NCT01008150|65537164|FG000|Overall Study|did not receive study drug|1|||
23489705|NCT01008150|65537165|FG001|Overall Study|did not receive study drug|1|||
23489706|NCT01008150|65537166|FG002|Overall Study|did not receive study drug|1|||
23489707|NCT01008150|65537167|FG003|Overall Study|did not receive study drug|0|||
23489708|NCT01907100|65537168|FG000|Overall Study|PD based on modified RECIST criteria|31|||
23489709|NCT01907100|65537169|FG001|Overall Study|PD based on modified RECIST criteria|32|||
23489710|NCT01907100|65537170|FG002|Overall Study|PD based on modified RECIST criteria|95|||
23489711|NCT01907100|65537171|FG003|Overall Study|PD based on modified RECIST criteria|92|||
23489712|NCT01907100|65537168|FG000|Overall Study|Withdrawal by Subject|2|||
23489713|NCT01907100|65537169|FG001|Overall Study|Withdrawal by Subject|5|||
23489714|NCT01907100|65537170|FG002|Overall Study|Withdrawal by Subject|10|||
23489715|NCT01907100|65537171|FG003|Overall Study|Withdrawal by Subject|13|||
23489716|NCT01907100|65537168|FG000|Overall Study|Protocol Violation|0|||
23489717|NCT01907100|65537169|FG001|Overall Study|Protocol Violation|0|||
23489718|NCT01907100|65537170|FG002|Overall Study|Protocol Violation|1|||
23489719|NCT01907100|65537171|FG003|Overall Study|Protocol Violation|1|||
23489720|NCT01907100|65537168|FG000|Overall Study|Lost to Follow-up|0|||
23489721|NCT01907100|65537169|FG001|Overall Study|Lost to Follow-up|0|||
23489722|NCT01907100|65537170|FG002|Overall Study|Lost to Follow-up|0|||
23489723|NCT01907100|65537171|FG003|Overall Study|Lost to Follow-up|1|||
23489724|NCT01907100|65537168|FG000|Overall Study|Not treated|2|||
23489725|NCT01907100|65537169|FG001|Overall Study|Not treated|0|||
23489726|NCT01907100|65537170|FG002|Overall Study|Not treated|1|||
23489727|NCT01907100|65537171|FG003|Overall Study|Not treated|2|||
23489728|NCT01907100|65537168|FG000|Overall Study|Other than reasons specified|1|||
23489729|NCT01907100|65537169|FG001|Overall Study|Other than reasons specified|0|||
23489730|NCT01907100|65537170|FG002|Overall Study|Other than reasons specified|10|||
23489731|NCT01907100|65537171|FG003|Overall Study|Other than reasons specified|6|||
23489732|NCT01907100|65537168|FG000|Overall Study|Adverse event (AE)|6|||
23489733|NCT01907100|65537169|FG001|Overall Study|Adverse event (AE)|3|||
23489734|NCT01907100|65537170|FG002|Overall Study|Adverse event (AE)|22|||
23489735|NCT01907100|65537171|FG003|Overall Study|Adverse event (AE)|23|||
23489736|NCT01907100|65537168|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
23489737|NCT01907100|65537169|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
23489738|NCT01907100|65537170|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
23284828|NCT02704091|64784936|FG001|Overall Study|Adverse Event|3|||
23377296|NCT03098979|65126568|FG002|Overall Study|Withdrawal by Subject|1|||
23489739|NCT01907100|65537171|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
23489740|NCT00580970|65537173|FG000|Pre-treatment|Non-compliance|1|||
23284829|NCT02704091|64784935|FG000|Overall Study|Protocol Violation|5|||
23489741|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Non-compliance|6|||
23489742|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
23489743|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Physician Decision|4|||
23489744|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
23489745|NCT00580970|65537173|FG000|Treatment (Lovastatin)|Death|1|||
23489746|NCT02770170|65537179|FG000|Overall Study|Withdrawal by Subject|0|||
23489747|NCT02770170|65537180|FG001|Overall Study|Withdrawal by Subject|0|||
23284830|NCT02704091|64784936|FG001|Overall Study|Protocol Violation|3|||
23284831|NCT02704091|64784935|FG000|Overall Study|Consent withdrawn|4|||
23284832|NCT02704091|64784936|FG001|Overall Study|Consent withdrawn|4|||
23284833|NCT02704091|64784935|FG000|Overall Study|Lost to Follow-up|13|||
23284834|NCT02704091|64784936|FG001|Overall Study|Lost to Follow-up|5|||
23284835|NCT02704091|64784935|FG000|Overall Study|Other|2|||
23284836|NCT02704091|64784936|FG001|Overall Study|Other|8|||
23284837|NCT01562613|64784937|FG000|Overall Study|Lost to Follow-up|2|||
23284838|NCT01562613|64784937|FG000|Overall Study|Withdrawal by Subject|2|||
23377297|NCT03098979|65126569|FG003|Overall Study|Withdrawal by Subject|1|||
23377298|NCT03098979|65126570|FG004|Overall Study|Withdrawal by Subject|2|||
23377299|NCT03098979|65126571|FG005|Overall Study|Withdrawal by Subject|1|||
23377300|NCT03098979|65126566|FG000|Overall Study|Death|1|||
23377301|NCT03098979|65126567|FG001|Overall Study|Death|0|||
23377302|NCT03098979|65126568|FG002|Overall Study|Death|2|||
23377303|NCT03098979|65126569|FG003|Overall Study|Death|0|||
23377304|NCT03098979|65126570|FG004|Overall Study|Death|1|||
23377305|NCT03098979|65126571|FG005|Overall Study|Death|0|||
23377306|NCT03098979|65126566|FG000|Overall Study|Physician Decision|2|||
23377307|NCT03098979|65126567|FG001|Overall Study|Physician Decision|1|||
23377308|NCT03098979|65126568|FG002|Overall Study|Physician Decision|0|||
23377309|NCT03098979|65126569|FG003|Overall Study|Physician Decision|0|||
23284839|NCT01923740|64784938|FG000|Overall Study|Lost to Follow-up|4|||
23377310|NCT03098979|65126570|FG004|Overall Study|Physician Decision|0|||
23377311|NCT03098979|65126571|FG005|Overall Study|Physician Decision|0|||
23377312|NCT03098979|65126566|FG000|Overall Study|Non-compliance|0|||
23377313|NCT03098979|65126567|FG001|Overall Study|Non-compliance|0|||
23377314|NCT03098979|65126568|FG002|Overall Study|Non-compliance|0|||
23377315|NCT03098979|65126569|FG003|Overall Study|Non-compliance|0|||
23377316|NCT03098979|65126570|FG004|Overall Study|Non-compliance|0|||
23377317|NCT03098979|65126571|FG005|Overall Study|Non-compliance|1|||
23377318|NCT03098979|65126566|FG000|Overall Study|Protocol Violation|0|||
23377319|NCT03098979|65126567|FG001|Overall Study|Protocol Violation|0|||
23377320|NCT03098979|65126568|FG002|Overall Study|Protocol Violation|0|||
23377321|NCT03098979|65126569|FG003|Overall Study|Protocol Violation|0|||
23377322|NCT03098979|65126570|FG004|Overall Study|Protocol Violation|0|||
23377323|NCT03098979|65126571|FG005|Overall Study|Protocol Violation|1|||
23489748|NCT02770170|65537181|FG002|Overall Study|Withdrawal by Subject|0|||
23489749|NCT02770170|65537182|FG003|Overall Study|Withdrawal by Subject|2|||
23604786|NCT01159600|65943505|FG001|Overall Study|Lack of Efficacy|0|||
23284840|NCT01923740|64784939|FG001|Overall Study|Lost to Follow-up|9|||
23284841|NCT01923740|64784938|FG000|Overall Study|Withdrawal by Subject|2|||
23377324|NCT02583269|65126573|FG000|Overall Study|Patient hospitalized prior to start|1|||
23489750|NCT02770170|65537179|FG000|Overall Study|due to pregnancy|1|||
23377325|NCT02583269|65126574|FG001|Overall Study|Patient hospitalized prior to start|0|||
23377326|NCT02583269|65126575|FG002|Overall Study|Patient hospitalized prior to start|0|||
23377327|NCT02583269|65126576|FG003|Overall Study|Patient hospitalized prior to start|0|||
23377328|NCT02583269|65126577|FG004|Overall Study|Patient hospitalized prior to start|0|||
23377329|NCT00226655|65126578|FG000|Overall Study|Death|13|||
23377330|NCT00226655|65126578|FG000|Overall Study|Withdrawal by Subject|15|||
23377331|NCT00226655|65126578|FG000|Overall Study|Adverse Event|35|||
23377332|NCT00226655|65126578|FG000|Overall Study|Physician Decision|6|||
23377333|NCT00226655|65126578|FG000|Overall Study|Clinical deterioration|10|||
23377334|NCT01983930|65126582|FG000|Overall Study|Withdrawal by Subject|9|||
23377335|NCT01983930|65126583|FG001|Overall Study|Withdrawal by Subject|8|||
23377336|NCT01983930|65126582|FG000|Overall Study|Adverse Event|0|||
23377337|NCT01983930|65126583|FG001|Overall Study|Adverse Event|1|||
23377338|NCT01288430|65126584|FG000|Part 1|Progressive disease|2|||
23377339|NCT01288430|65126585|FG001|Part 1|Progressive disease|1|||
23377340|NCT01288430|65126586|FG002|Part 1|Progressive disease|1|||
23377341|NCT01288430|65126587|FG003|Part 1|Progressive disease|6|||
23377342|NCT01288430|65126588|FG004|Part 1|Progressive disease|2|||
23377343|NCT01288430|65126589|FG005|Part 1|Progressive disease|4|||
23377344|NCT01288430|65126590|FG006|Part 1|Progressive disease|2|||
23377345|NCT01288430|65126591|FG007|Part 1|Progressive disease|0|||
23377346|NCT01288430|65126592|FG008|Part 1|Progressive disease|0|||
23377347|NCT01288430|65126593|FG009|Part 1|Progressive disease|0|||
23377348|NCT01288430|65126584|FG000|Part 1|Clinical disease progression|0|||
23377349|NCT01288430|65126585|FG001|Part 1|Clinical disease progression|0|||
23377350|NCT01288430|65126586|FG002|Part 1|Clinical disease progression|1|||
23377351|NCT01288430|65126587|FG003|Part 1|Clinical disease progression|0|||
23377352|NCT01288430|65126588|FG004|Part 1|Clinical disease progression|0|||
23377353|NCT01288430|65126589|FG005|Part 1|Clinical disease progression|2|||
23377354|NCT01288430|65126590|FG006|Part 1|Clinical disease progression|2|||
23377355|NCT01288430|65126591|FG007|Part 1|Clinical disease progression|0|||
23377356|NCT01288430|65126592|FG008|Part 1|Clinical disease progression|0|||
23377357|NCT01288430|65126593|FG009|Part 1|Clinical disease progression|0|||
23377358|NCT01288430|65126584|FG000|Part 1|Death due to disease progression|0|||
23377359|NCT01288430|65126585|FG001|Part 1|Death due to disease progression|0|||
23377360|NCT01288430|65126586|FG002|Part 1|Death due to disease progression|0|||
23377361|NCT01288430|65126587|FG003|Part 1|Death due to disease progression|0|||
23377362|NCT01288430|65126588|FG004|Part 1|Death due to disease progression|1|||
23377363|NCT01288430|65126589|FG005|Part 1|Death due to disease progression|0|||
23489751|NCT02770170|65537180|FG001|Overall Study|due to pregnancy|0|||
23489752|NCT02770170|65537181|FG002|Overall Study|due to pregnancy|0|||
23489753|NCT02770170|65537182|FG003|Overall Study|due to pregnancy|0|||
23489754|NCT02770170|65537179|FG000|Overall Study|Lack of Efficacy|2|||
23377364|NCT01288430|65126590|FG006|Part 1|Death due to disease progression|0|||
23377365|NCT01288430|65126591|FG007|Part 1|Death due to disease progression|0|||
23377366|NCT01288430|65126592|FG008|Part 1|Death due to disease progression|0|||
23377367|NCT01288430|65126593|FG009|Part 1|Death due to disease progression|0|||
23377368|NCT01288430|65126584|FG000|Part 1|Adverse Event|0|||
23377369|NCT01288430|65126585|FG001|Part 1|Adverse Event|0|||
23377370|NCT01288430|65126586|FG002|Part 1|Adverse Event|3|||
23377371|NCT01288430|65126587|FG003|Part 1|Adverse Event|1|||
23377372|NCT01288430|65126588|FG004|Part 1|Adverse Event|0|||
23377373|NCT01288430|65126589|FG005|Part 1|Adverse Event|0|||
23377374|NCT01288430|65126590|FG006|Part 1|Adverse Event|2|||
23377375|NCT01288430|65126591|FG007|Part 1|Adverse Event|0|||
23377376|NCT01288430|65126592|FG008|Part 1|Adverse Event|0|||
23377377|NCT01288430|65126593|FG009|Part 1|Adverse Event|0|||
23377378|NCT01288430|65126584|FG000|Part 1|Other|0|||
23377379|NCT01288430|65126585|FG001|Part 1|Other|2|||
23377380|NCT01288430|65126586|FG002|Part 1|Other|0|||
23377381|NCT01288430|65126587|FG003|Part 1|Other|0|||
23377382|NCT01288430|65126588|FG004|Part 1|Other|0|||
23377383|NCT01288430|65126589|FG005|Part 1|Other|0|||
23377384|NCT01288430|65126590|FG006|Part 1|Other|1|||
23377385|NCT01288430|65126591|FG007|Part 1|Other|0|||
23377386|NCT01288430|65126592|FG008|Part 1|Other|0|||
23377387|NCT01288430|65126593|FG009|Part 1|Other|0|||
23377388|NCT01288430|65126584|FG000|Part 2|Progressive disease|0|||
23377389|NCT01288430|65126585|FG001|Part 2|Progressive disease|0|||
23377390|NCT01288430|65126586|FG002|Part 2|Progressive disease|0|||
23377391|NCT01288430|65126587|FG003|Part 2|Progressive disease|0|||
23377392|NCT01288430|65126588|FG004|Part 2|Progressive disease|0|||
23377393|NCT01288430|65126589|FG005|Part 2|Progressive disease|0|||
23377394|NCT01288430|65126590|FG006|Part 2|Progressive disease|0|||
23377395|NCT01288430|65126591|FG007|Part 2|Progressive disease|8|||
23377396|NCT01288430|65126592|FG008|Part 2|Progressive disease|7|||
23377397|NCT01288430|65126593|FG009|Part 2|Progressive disease|2|||
23377398|NCT01288430|65126584|FG000|Part 2|Clinical disease progression|0|||
23377399|NCT01288430|65126585|FG001|Part 2|Clinical disease progression|0|||
23377400|NCT01288430|65126586|FG002|Part 2|Clinical disease progression|0|||
23377401|NCT01288430|65126587|FG003|Part 2|Clinical disease progression|0|||
23377402|NCT01288430|65126588|FG004|Part 2|Clinical disease progression|0|||
23377403|NCT01288430|65126589|FG005|Part 2|Clinical disease progression|0|||
23377404|NCT01288430|65126590|FG006|Part 2|Clinical disease progression|0|||
23377405|NCT01288430|65126591|FG007|Part 2|Clinical disease progression|2|||
23377406|NCT01288430|65126592|FG008|Part 2|Clinical disease progression|0|||
23377407|NCT01288430|65126593|FG009|Part 2|Clinical disease progression|0|||
23377408|NCT01288430|65126584|FG000|Part 2|Withdrawal by Subject|0|||
23377409|NCT01288430|65126585|FG001|Part 2|Withdrawal by Subject|0|||
23377410|NCT01288430|65126586|FG002|Part 2|Withdrawal by Subject|0|||
23377411|NCT01288430|65126587|FG003|Part 2|Withdrawal by Subject|0|||
23377412|NCT01288430|65126588|FG004|Part 2|Withdrawal by Subject|0|||
23377413|NCT01288430|65126589|FG005|Part 2|Withdrawal by Subject|0|||
23377414|NCT01288430|65126590|FG006|Part 2|Withdrawal by Subject|0|||
23377415|NCT01288430|65126591|FG007|Part 2|Withdrawal by Subject|1|||
23377416|NCT01288430|65126592|FG008|Part 2|Withdrawal by Subject|4|||
23377417|NCT01288430|65126593|FG009|Part 2|Withdrawal by Subject|0|||
23377418|NCT01288430|65126584|FG000|Part 2|Adverse Event|0|||
23377419|NCT01288430|65126585|FG001|Part 2|Adverse Event|0|||
23377420|NCT01288430|65126586|FG002|Part 2|Adverse Event|0|||
23284842|NCT01923740|64784939|FG001|Overall Study|Withdrawal by Subject|0|||
23284843|NCT01977456|64784940|FG000|Overall Study|Death|5|||
23284844|NCT00421304|64784941|FG000|Overall Study|Lost to Follow-up|5|||
23284845|NCT00421304|64784942|FG001|Overall Study|Lost to Follow-up|2|||
23284846|NCT00421304|64784943|FG002|Overall Study|Lost to Follow-up|5|||
23284847|NCT00421304|64784941|FG000|Overall Study|Withdrawal by Subject|2|||
23377421|NCT01288430|65126587|FG003|Part 2|Adverse Event|0|||
23377422|NCT01288430|65126588|FG004|Part 2|Adverse Event|0|||
23377423|NCT01288430|65126589|FG005|Part 2|Adverse Event|0|||
23377424|NCT01288430|65126590|FG006|Part 2|Adverse Event|0|||
23377425|NCT01288430|65126591|FG007|Part 2|Adverse Event|1|||
23377426|NCT01288430|65126592|FG008|Part 2|Adverse Event|1|||
23377427|NCT01288430|65126593|FG009|Part 2|Adverse Event|0|||
23377428|NCT01288430|65126584|FG000|Part 2|Other|0|||
23377429|NCT01288430|65126585|FG001|Part 2|Other|0|||
23377430|NCT01288430|65126586|FG002|Part 2|Other|0|||
23377431|NCT01288430|65126587|FG003|Part 2|Other|0|||
23377432|NCT01288430|65126588|FG004|Part 2|Other|0|||
23377433|NCT01288430|65126589|FG005|Part 2|Other|0|||
23377434|NCT01288430|65126590|FG006|Part 2|Other|0|||
23377435|NCT01288430|65126591|FG007|Part 2|Other|0|||
23377436|NCT01288430|65126592|FG008|Part 2|Other|0|||
23377437|NCT01288430|65126593|FG009|Part 2|Other|1|||
23377438|NCT01431976|65126594|FG000|Overall Study|Adverse Event|6|||
23377439|NCT01431976|65126594|FG000|Overall Study|Lack of Efficacy|2|||
23377440|NCT01431976|65126594|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
23489755|NCT02770170|65537180|FG001|Overall Study|Lack of Efficacy|0|||
23284848|NCT00421304|64784942|FG001|Overall Study|Withdrawal by Subject|2|||
23284849|NCT00421304|64784943|FG002|Overall Study|Withdrawal by Subject|2|||
23284850|NCT00421304|64784941|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
23284851|NCT00421304|64784942|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
23284852|NCT00421304|64784943|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
23284853|NCT00421304|64784941|FG000|Overall Study|Did not attend Day 360 visit|0|||
23284854|NCT00421304|64784942|FG001|Overall Study|Did not attend Day 360 visit|0|||
23284855|NCT00421304|64784943|FG002|Overall Study|Did not attend Day 360 visit|1|||
23284856|NCT03669861|64784944|FG000|Overall Study|Disease Flare|5|||
23284857|NCT03669861|64784944|FG000|Overall Study|Lack of Efficacy|2|||
23284858|NCT03025087|64784950|FG000|Overall Study|Physician Decision|3|||
23284859|NCT03025087|64784951|FG001|Overall Study|Physician Decision|3|||
23284860|NCT03025087|64784952|FG002|Overall Study|Physician Decision|0|||
23284861|NCT03025087|64784953|FG003|Overall Study|Physician Decision|0|||
23284862|NCT03025087|64784954|FG004|Overall Study|Physician Decision|0|||
23284863|NCT03025087|64784950|FG000|Overall Study|Withdrawal by Subject|1|||
23489756|NCT02770170|65537181|FG002|Overall Study|Lack of Efficacy|0|||
23489757|NCT02770170|65537182|FG003|Overall Study|Lack of Efficacy|1|||
23489758|NCT02770170|65537179|FG000|Overall Study|Adverse Event|4|||
23489759|NCT02770170|65537180|FG001|Overall Study|Adverse Event|3|||
23489760|NCT02770170|65537181|FG002|Overall Study|Adverse Event|5|||
23284864|NCT03025087|64784951|FG001|Overall Study|Withdrawal by Subject|1|||
23489761|NCT02770170|65537182|FG003|Overall Study|Adverse Event|3|||
23489762|NCT02770170|65537179|FG000|Overall Study|due to disease worsening|0|||
23489763|NCT02770170|65537180|FG001|Overall Study|due to disease worsening|0|||
23489764|NCT02770170|65537181|FG002|Overall Study|due to disease worsening|0|||
23489765|NCT02770170|65537182|FG003|Overall Study|due to disease worsening|1|||
23489766|NCT01200524|65537185|FG000|Overall Study|Withdrawal by Subject|1|||
23377441|NCT01431976|65126594|FG000|Overall Study|Physician Decision|1|||
23377442|NCT01431976|65126594|FG000|Overall Study|Withdrawal by Subject|1|||
23377443|NCT00127803|65126595|FG000|Overall Study|Adverse Event|2|||
23377444|NCT00127803|65126596|FG001|Overall Study|Adverse Event|0|||
23489767|NCT01200524|65537186|FG001|Overall Study|Withdrawal by Subject|1|||
23377445|NCT00127803|65126597|FG002|Overall Study|Adverse Event|0|||
23377446|NCT00127803|65126598|FG003|Overall Study|Adverse Event|0|||
23377447|NCT00127803|65126595|FG000|Overall Study|Withdrawal by Subject|1|||
23377448|NCT00127803|65126596|FG001|Overall Study|Withdrawal by Subject|0|||
23377449|NCT00127803|65126597|FG002|Overall Study|Withdrawal by Subject|0|||
23377450|NCT00127803|65126598|FG003|Overall Study|Withdrawal by Subject|0|||
23377451|NCT00127803|65126595|FG000|Overall Study|Lost to Follow-up|0|||
23377452|NCT00127803|65126596|FG001|Overall Study|Lost to Follow-up|0|||
23377453|NCT00127803|65126597|FG002|Overall Study|Lost to Follow-up|0|||
23377454|NCT00127803|65126598|FG003|Overall Study|Lost to Follow-up|1|||
23377455|NCT02278354|65126600|FG000|Overall Study|Lost to Follow-up|2|||
23377456|NCT02278354|65126601|FG001|Overall Study|Lost to Follow-up|2|||
23377457|NCT02278354|65126600|FG000|Overall Study|Withdrawal by Subject|0|||
23377458|NCT02278354|65126601|FG001|Overall Study|Withdrawal by Subject|1|||
23377459|NCT02278354|65126600|FG000|Overall Study|<10 professional fights|2|||
23377460|NCT02278354|65126601|FG001|Overall Study|<10 professional fights|0|||
23377461|NCT04900272|65126606|FG000|Overall Study|Lost to Follow-up|2|||
23377462|NCT04900272|65126606|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
23377463|NCT04900272|65126606|FG000|Overall Study|Withdrawal by Subject|1|||
23377464|NCT01860404|65126608|FG000|Overall Study|Lost to Follow-up|3|||
23377465|NCT01860404|65126609|FG001|Overall Study|Lost to Follow-up|4|||
23377466|NCT01860404|65126610|FG002|Overall Study|Lost to Follow-up|1|||
23377467|NCT01860404|65126611|FG003|Overall Study|Lost to Follow-up|6|||
23377468|NCT01860404|65126612|FG004|Overall Study|Lost to Follow-up|4|||
23377469|NCT01860404|65126608|FG000|Overall Study|Withdrawal by Subject|0|||
23377470|NCT01860404|65126609|FG001|Overall Study|Withdrawal by Subject|0|||
23377471|NCT01860404|65126610|FG002|Overall Study|Withdrawal by Subject|4|||
23377472|NCT01860404|65126611|FG003|Overall Study|Withdrawal by Subject|0|||
23377473|NCT01860404|65126612|FG004|Overall Study|Withdrawal by Subject|0|||
23377474|NCT00484159|65126613|FG000|Overall Study|Lost to Follow-up|1|||
23377475|NCT00484159|65126614|FG001|Overall Study|Lost to Follow-up|1|||
23377476|NCT00484159|65126615|FG002|Overall Study|Lost to Follow-up|0|||
23377477|NCT01631188|65126617|FG000|Overall Study|Physician Decision|75|||
23377478|NCT00724945|65126628|FG000|Period 1|non-compliance|1|||
23377479|NCT00724945|65126629|FG001|Period 1|non-compliance|0|||
23377480|NCT00724945|65126628|FG000|Period 1|Adverse Event|1|||
23377481|NCT00724945|65126629|FG001|Period 1|Adverse Event|1|||
23377482|NCT00724945|65126628|FG000|Period 1|Lost to Follow-up|1|||
23377483|NCT00724945|65126629|FG001|Period 1|Lost to Follow-up|0|||
23377484|NCT00724945|65126628|FG000|Period 2|lens comfort issue|3|||
23377485|NCT00724945|65126629|FG001|Period 2|lens comfort issue|0|||
23377486|NCT00724945|65126628|FG000|Period 2|lens physiology issue|1|||
23377487|NCT00724945|65126629|FG001|Period 2|lens physiology issue|0|||
23377488|NCT01113749|65126630|FG000|Overall Study|Lost to Follow-up|1|||
23377489|NCT01113749|65126631|FG001|Overall Study|Lost to Follow-up|2|||
23377490|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
23377491|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
23377492|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
23377493|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
23377494|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
23377495|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
23377496|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
23377497|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
23377498|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
23377499|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
23377500|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
23377501|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
23377502|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
23377503|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
23377504|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
23377505|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
23377506|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
23377507|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
23377508|NCT01069939|65126634|FG000|Randomised and Included in the Analyses|Removal|1|||
23377509|NCT01069939|65126635|FG001|Randomised and Included in the Analyses|Removal|0|||
23377510|NCT00316004|65126636|FG000|Overall Study|Subject was not given study fluid.|14|||
23377511|NCT00316004|65126637|FG001|Overall Study|Subject was not given study fluid.|14|||
23377512|NCT00316004|65126638|FG002|Overall Study|Subject was not given study fluid.|21|||
23377513|NCT02714153|65126641|FG000|Overall Study|Death|1|||
23377514|NCT03915067|65126642|FG000|Overall Study|Adverse Event|0|||
23377515|NCT03915067|65126643|FG001|Overall Study|Adverse Event|0|||
23489768|NCT01200524|65537187|FG002|Overall Study|Withdrawal by Subject|3|||
23489769|NCT01200524|65537185|FG000|Overall Study|Adverse Event|1|||
23377516|NCT03915067|65126644|FG002|Overall Study|Adverse Event|1|||
23377517|NCT03915067|65126642|FG000|Overall Study|Withdrawal by Subject|4|||
23377518|NCT03915067|65126643|FG001|Overall Study|Withdrawal by Subject|3|||
23377519|NCT03915067|65126644|FG002|Overall Study|Withdrawal by Subject|0|||
23377520|NCT03915067|65126642|FG000|Overall Study|Lost to Follow-up|3|||
23377521|NCT03915067|65126643|FG001|Overall Study|Lost to Follow-up|2|||
23377522|NCT03915067|65126644|FG002|Overall Study|Lost to Follow-up|0|||
23377523|NCT03915067|65126642|FG000|Overall Study|Protocol Deviation|0|||
23377524|NCT03915067|65126643|FG001|Overall Study|Protocol Deviation|0|||
23377525|NCT03915067|65126644|FG002|Overall Study|Protocol Deviation|1|||
23377526|NCT03915067|65126642|FG000|Overall Study|Covid-19 Related Issues|2|||
23377527|NCT03915067|65126643|FG001|Overall Study|Covid-19 Related Issues|4|||
23377528|NCT03915067|65126644|FG002|Overall Study|Covid-19 Related Issues|4|||
23377529|NCT03915067|65126642|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
23377530|NCT03915067|65126643|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
23284865|NCT03025087|64784952|FG002|Overall Study|Withdrawal by Subject|0|||
23284866|NCT03025087|64784953|FG003|Overall Study|Withdrawal by Subject|0|||
23284867|NCT03025087|64784954|FG004|Overall Study|Withdrawal by Subject|0|||
23377531|NCT03915067|65126644|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
23377532|NCT04682301|65126645|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
23377533|NCT04682301|65126645|FG000|Overall Study|Death|2|||
23284868|NCT03025087|64784950|FG000|Overall Study|Unable to complete MRI|2|||
23284869|NCT03025087|64784951|FG001|Overall Study|Unable to complete MRI|2|||
23284870|NCT03025087|64784952|FG002|Overall Study|Unable to complete MRI|0|||
23284871|NCT03025087|64784953|FG003|Overall Study|Unable to complete MRI|0|||
23284872|NCT03025087|64784954|FG004|Overall Study|Unable to complete MRI|0|||
23284873|NCT00835796|64784963|FG000|First Intervention|Withdrawal by Subject|0|||
23284874|NCT00835796|64784964|FG001|First Intervention|Withdrawal by Subject|1|||
23284875|NCT03314857|64784967|FG000|Overall Study|Death|4|||
23284876|NCT03314857|64784967|FG000|Overall Study|Physician Decision|1|||
23284877|NCT00438633|64784968|FG000|Overall Study|Withdrawal by Subject|1|||
23284878|NCT00438633|64784969|FG001|Overall Study|Withdrawal by Subject|0|||
23284879|NCT00438633|64784968|FG000|Overall Study|Lost to Follow-up|15|||
23284880|NCT00438633|64784969|FG001|Overall Study|Lost to Follow-up|17|||
23284881|NCT01519947|64784970|FG000|Overall Study|Death|0|||
23377534|NCT02572167|65126650|FG000|Overall Study|Withdrawal by Subject|0|||
23377535|NCT02572167|65126651|FG001|Overall Study|Withdrawal by Subject|3|||
23377536|NCT02572167|65126652|FG002|Overall Study|Withdrawal by Subject|0|||
23284882|NCT01519947|64784971|FG001|Overall Study|Death|0|||
23284883|NCT01519947|64784972|FG002|Overall Study|Death|0|||
23284884|NCT01519947|64784973|FG003|Overall Study|Death|1|||
23284885|NCT01519947|64784970|FG000|Overall Study|Protocol Violation|0|||
23284886|NCT01519947|64784971|FG001|Overall Study|Protocol Violation|0|||
23284887|NCT01519947|64784972|FG002|Overall Study|Protocol Violation|2|||
23284888|NCT01519947|64784973|FG003|Overall Study|Protocol Violation|1|||
23284889|NCT01519947|64784970|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
23284890|NCT01519947|64784971|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
23284891|NCT01519947|64784972|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
23284892|NCT01519947|64784973|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
23284893|NCT01519947|64784970|FG000|Overall Study|Development of Anemia|0|||
23284894|NCT01519947|64784971|FG001|Overall Study|Development of Anemia|1|||
23284895|NCT01519947|64784972|FG002|Overall Study|Development of Anemia|0|||
23377537|NCT02572167|65126650|FG000|Overall Study|Lost to Follow-up|2|||
23377538|NCT02572167|65126651|FG001|Overall Study|Lost to Follow-up|5|||
23377539|NCT02572167|65126652|FG002|Overall Study|Lost to Follow-up|3|||
23377540|NCT02572167|65126650|FG000|Overall Study|Death|0|||
23604787|NCT01159600|65943506|FG002|Overall Study|Lack of Efficacy|0|||
23604788|NCT01159600|65943507|FG003|Overall Study|Lack of Efficacy|0|||
23604789|NCT01159600|65943508|FG004|Overall Study|Lack of Efficacy|2|||
23604790|NCT01159600|65943509|FG005|Overall Study|Lack of Efficacy|0|||
23604791|NCT01159600|65943510|FG006|Overall Study|Lack of Efficacy|0|||
23604792|NCT01159600|65943511|FG007|Overall Study|Lack of Efficacy|1|||
23604793|NCT01159600|65943504|FG000|Overall Study|Non compliant with protocol|2|||
23604794|NCT01159600|65943505|FG001|Overall Study|Non compliant with protocol|1|||
23604795|NCT01159600|65943506|FG002|Overall Study|Non compliant with protocol|0|||
23604796|NCT01159600|65943507|FG003|Overall Study|Non compliant with protocol|0|||
23604797|NCT01159600|65943508|FG004|Overall Study|Non compliant with protocol|2|||
23284896|NCT01519947|64784973|FG003|Overall Study|Development of Anemia|1|||
23284897|NCT01519947|64784970|FG000|Overall Study|Blood Transfusion|0|||
23284898|NCT01519947|64784971|FG001|Overall Study|Blood Transfusion|1|||
23284899|NCT01519947|64784972|FG002|Overall Study|Blood Transfusion|1|||
23284900|NCT01519947|64784973|FG003|Overall Study|Blood Transfusion|0|||
23284901|NCT01519947|64784970|FG000|Overall Study|Withdrawal by Subject|0|||
23284902|NCT01519947|64784971|FG001|Overall Study|Withdrawal by Subject|1|||
23284903|NCT01519947|64784972|FG002|Overall Study|Withdrawal by Subject|0|||
23284904|NCT01519947|64784973|FG003|Overall Study|Withdrawal by Subject|1|||
23284905|NCT01519947|64784970|FG000|Overall Study|Lost to Follow-up|0|||
23284906|NCT01519947|64784971|FG001|Overall Study|Lost to Follow-up|0|||
23284907|NCT01519947|64784972|FG002|Overall Study|Lost to Follow-up|3|||
23284908|NCT01519947|64784973|FG003|Overall Study|Lost to Follow-up|2|||
23284909|NCT01519947|64784970|FG000|Overall Study|Poor Response|1|||
23284910|NCT01519947|64784971|FG001|Overall Study|Poor Response|0|||
23284911|NCT01519947|64784972|FG002|Overall Study|Poor Response|0|||
23284912|NCT01519947|64784973|FG003|Overall Study|Poor Response|1|||
23284913|NCT01519947|64784970|FG000|Overall Study|Adverse Event|1|||
23284914|NCT01519947|64784971|FG001|Overall Study|Adverse Event|0|||
23284915|NCT01519947|64784972|FG002|Overall Study|Adverse Event|1|||
23377541|NCT02572167|65126651|FG001|Overall Study|Death|8|||
23377542|NCT02572167|65126652|FG002|Overall Study|Death|3|||
23377543|NCT02572167|65126650|FG000|Overall Study|Did not meet inclusion criteria|0|||
23377544|NCT02572167|65126651|FG001|Overall Study|Did not meet inclusion criteria|0|||
23377545|NCT02572167|65126652|FG002|Overall Study|Did not meet inclusion criteria|1|||
23377546|NCT02572167|65126650|FG000|Overall Study|Study closure by Sponsor|4|||
23377547|NCT02572167|65126651|FG001|Overall Study|Study closure by Sponsor|40|||
23377548|NCT02572167|65126652|FG002|Overall Study|Study closure by Sponsor|24|||
23377549|NCT03530293|65126653|FG000|Pre-randomization|Adverse Event|12|||
23377550|NCT03530293|65126654|FG001|Pre-randomization|Adverse Event|0|||
23377551|NCT03530293|65126655|FG002|Pre-randomization|Adverse Event|0|||
23377552|NCT03530293|65126653|FG000|Pre-randomization|Protocol Violation|2|||
23377553|NCT03530293|65126654|FG001|Pre-randomization|Protocol Violation|0|||
23377554|NCT03530293|65126655|FG002|Pre-randomization|Protocol Violation|0|||
23284916|NCT01519947|64784973|FG003|Overall Study|Adverse Event|1|||
23284917|NCT05274763|64784974|FG000|Overall Study|Lost to Follow-up|1|||
23284918|NCT03248128|64784977|FG000|Overall Study|Lost to Follow-up|1|||
23284919|NCT03248128|64784978|FG001|Overall Study|Lost to Follow-up|0|||
23284920|NCT03248128|64784977|FG000|Overall Study|Withdrawal by Subject|16|||
23284921|NCT03248128|64784978|FG001|Overall Study|Withdrawal by Subject|14|||
23377555|NCT03530293|65126653|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
23377556|NCT03530293|65126654|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
23284922|NCT03248128|64784977|FG000|Overall Study|Site Closed|4|||
23284923|NCT03248128|64784978|FG001|Overall Study|Site Closed|3|||
23284924|NCT03248128|64784977|FG000|Overall Study|Randomized, but did not receive treatment|1|||
23284925|NCT03248128|64784978|FG001|Overall Study|Randomized, but did not receive treatment|3|||
23284926|NCT00484679|64784979|FG000|Overall Study|Withdrawal by Subject|3|||
23284927|NCT02911025|64784981|FG000|Overall Study|Lost to Follow-up|3|||
23489770|NCT01200524|65537186|FG001|Overall Study|Adverse Event|0|||
23489771|NCT01200524|65537187|FG002|Overall Study|Adverse Event|0|||
23489772|NCT01200524|65537185|FG000|Overall Study|Non availability of study nurse|0|||
23489773|NCT01200524|65537186|FG001|Overall Study|Non availability of study nurse|0|||
23489774|NCT01200524|65537187|FG002|Overall Study|Non availability of study nurse|1|||
23489775|NCT02963935|65537188|FG000|Overall Study|Adverse Event|12|||
23489776|NCT02963935|65537189|FG001|Overall Study|Adverse Event|6|||
23489777|NCT02963935|65537188|FG000|Overall Study|Protocol Violation|2|||
23489778|NCT02963935|65537189|FG001|Overall Study|Protocol Violation|1|||
23489779|NCT02963935|65537188|FG000|Overall Study|Lack of Efficacy|0|||
23489780|NCT02963935|65537189|FG001|Overall Study|Lack of Efficacy|2|||
23489781|NCT02963935|65537188|FG000|Overall Study|Lost to Follow-up|1|||
23489782|NCT02963935|65537189|FG001|Overall Study|Lost to Follow-up|6|||
23489783|NCT02963935|65537188|FG000|Overall Study|Unclassified|13|||
23489784|NCT02963935|65537189|FG001|Overall Study|Unclassified|22|||
23489785|NCT01565642|65537190|FG000|Overall Study|Withdrawal by Subject|2|||
23489786|NCT01565642|65537191|FG001|Overall Study|Withdrawal by Subject|1|||
23489787|NCT00839852|65537194|FG000|Overall Study|Adverse Event|10|||
23489788|NCT00839852|65537194|FG000|Overall Study|Insufficient Therapeutic Response|3|||
23489789|NCT00839852|65537194|FG000|Overall Study|Protocol Violation|9|||
23489790|NCT00839852|65537194|FG000|Overall Study|Withdrawal of Consent|16|||
23489791|NCT00839852|65537194|FG000|Overall Study|Lost to Follow-up|7|||
23489792|NCT00839852|65537194|FG000|Overall Study|Lack of Compliance While in Jail|1|||
23489793|NCT00839852|65537194|FG000|Overall Study|Pregnancy|1|||
23489794|NCT01555983|65537197|FG000|Overall Study|Withdrawal by Subject|1|||
23489795|NCT01555983|65537198|FG001|Overall Study|Withdrawal by Subject|0|||
23489796|NCT01555983|65537199|FG002|Overall Study|Withdrawal by Subject|0|||
23489797|NCT01555983|65537200|FG003|Overall Study|Withdrawal by Subject|0|||
23489798|NCT01555983|65537201|FG004|Overall Study|Withdrawal by Subject|1|||
23489799|NCT01555983|65537202|FG005|Overall Study|Withdrawal by Subject|1|||
23489800|NCT03039192|65537203|FG000|Overall Study|Lost to Follow-up|4|||
23489801|NCT03039192|65537204|FG001|Overall Study|Lost to Follow-up|4|||
23489802|NCT03039192|65537203|FG000|Overall Study|Adverse event, serious fatal|0|||
23489803|NCT03039192|65537204|FG001|Overall Study|Adverse event, serious fatal|1|||
23489804|NCT03039192|65537203|FG000|Overall Study|Adverse event, non-fatal|0|||
23489805|NCT03039192|65537204|FG001|Overall Study|Adverse event, non-fatal|2|||
23489806|NCT03039192|65537203|FG000|Overall Study|Withdrawal by Subject|6|||
23489807|NCT03039192|65537204|FG001|Overall Study|Withdrawal by Subject|9|||
23489808|NCT03039192|65537203|FG000|Overall Study|Discontinued from treatment phase|19|||
23489809|NCT03039192|65537204|FG001|Overall Study|Discontinued from treatment phase|12|||
23489810|NCT03039192|65537203|FG000|Overall Study|Other|3|||
23489811|NCT03039192|65537204|FG001|Overall Study|Other|2|||
23489812|NCT02428608|65537206|FG000|Overall Study|Pregnancy|2|||
23489813|NCT02428608|65537206|FG000|Overall Study|Lost to Follow-up|37|||
23489814|NCT02428608|65537206|FG000|Overall Study|Withdrawal by Subject|2|||
23489815|NCT02428608|65537206|FG000|Overall Study|scheduling conflicts|15|||
23489816|NCT02428608|65537206|FG000|Overall Study|moved away|10|||
23284928|NCT04968925|64784982|FG000|Phase I- Period 1|COVID-19 related|0|||
23284929|NCT04968925|64784983|FG001|Phase I- Period 1|COVID-19 related|1|||
23489817|NCT02428608|65537206|FG000|Overall Study|Death|1|||
23489818|NCT02428608|65537206|FG000|Overall Study|various|16|||
23489819|NCT04137224|65537207|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
23489820|NCT04137224|65537208|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
23489821|NCT04137224|65537207|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
23489822|NCT04137224|65537208|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
23489823|NCT04137224|65537207|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
23489824|NCT04137224|65537208|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
23489825|NCT02024529|65537221|FG000|Overall Study|Withdrawal by Subject|11|||
23489826|NCT02024529|65537222|FG001|Overall Study|Withdrawal by Subject|21|||
23489827|NCT02024529|65537221|FG000|Overall Study|Lost to Follow-up|2|||
23489828|NCT02024529|65537222|FG001|Overall Study|Lost to Follow-up|4|||
23489829|NCT02035475|65537223|FG000|Overall Study|Withdrawal by Subject|4|||
23489830|NCT02035475|65537223|FG000|Overall Study|Physician Decision|1|||
23489831|NCT02035475|65537223|FG000|Overall Study|Equipment Error|1|||
23489832|NCT00986479|65537224|FG000|Period 1|Improved mood|1|||
23489833|NCT00986479|65537225|FG001|Period 1|Improved mood|0|||
23489834|NCT00986479|65537224|FG000|Period 1|Administrative reasons|1|||
23489835|NCT00986479|65537225|FG001|Period 1|Administrative reasons|0|||
23489836|NCT02545075|65537226|FG000|Randomization|Lost to Follow-up|0|||
23489837|NCT02545075|65537227|FG001|Randomization|Lost to Follow-up|1|||
23489838|NCT02545075|65537226|FG000|Randomization|Withdrawal by Subject|0|||
23489839|NCT02545075|65537227|FG001|Randomization|Withdrawal by Subject|6|||
23489840|NCT02545075|65537226|FG000|Treatment|Disease progression|71|||
23489841|NCT02545075|65537227|FG001|Treatment|Disease progression|32|||
23489842|NCT02545075|65537226|FG000|Treatment|Participant dicontinued study treatment|7|||
23489843|NCT02545075|65537227|FG001|Treatment|Participant dicontinued study treatment|9|||
23489844|NCT02545075|65537226|FG000|Treatment|Withdrawal by Subject|1|||
23489845|NCT02545075|65537227|FG001|Treatment|Withdrawal by Subject|0|||
23489846|NCT02545075|65537226|FG000|Treatment|Adverse event not related to study drug|1|||
23284930|NCT04968925|64784984|FG002|Phase I- Period 1|COVID-19 related|0|||
23284931|NCT04968925|64784985|FG003|Phase I- Period 1|COVID-19 related|0|||
23284932|NCT04968925|64784982|FG000|Phase I- Period 1|Subject enrolled in error|1|||
23284933|NCT04968925|64784983|FG001|Phase I- Period 1|Subject enrolled in error|1|||
23489847|NCT02545075|65537227|FG001|Treatment|Adverse event not related to study drug|0|||
23489848|NCT02545075|65537226|FG000|Treatment|Death|1|||
23489849|NCT02545075|65537227|FG001|Treatment|Death|0|||
23489850|NCT02545075|65537226|FG000|Treatment|Participant drug toxicity|1|||
23284934|NCT04968925|64784984|FG002|Phase I- Period 1|Subject enrolled in error|0|||
23284935|NCT04968925|64784985|FG003|Phase I- Period 1|Subject enrolled in error|0|||
23284936|NCT04968925|64784982|FG000|Phase II- Period 1|COVID-19 Related|0|||
23284937|NCT04968925|64784983|FG001|Phase II- Period 1|COVID-19 Related|0|||
23284938|NCT04968925|64784984|FG002|Phase II- Period 1|COVID-19 Related|6|||
23284939|NCT04968925|64784985|FG003|Phase II- Period 1|COVID-19 Related|6|||
23284940|NCT04968925|64784982|FG000|Phase II- Period 1|Subject enrolled in error|0|||
23284941|NCT04968925|64784983|FG001|Phase II- Period 1|Subject enrolled in error|0|||
23284942|NCT04968925|64784984|FG002|Phase II- Period 1|Subject enrolled in error|1|||
23284943|NCT04968925|64784985|FG003|Phase II- Period 1|Subject enrolled in error|0|||
23284944|NCT04968925|64784982|FG000|Phase II -Period 2|COVID-19 related|0|||
23284945|NCT04968925|64784983|FG001|Phase II -Period 2|COVID-19 related|0|||
23284946|NCT04968925|64784984|FG002|Phase II -Period 2|COVID-19 related|4|||
23284947|NCT04968925|64784985|FG003|Phase II -Period 2|COVID-19 related|3|||
23284948|NCT04968925|64784982|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
23284949|NCT04968925|64784983|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
23377557|NCT03530293|65126655|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
23377558|NCT03530293|65126653|FG000|Pre-randomization|Withdrawal by Subject|5|||
23377559|NCT03530293|65126654|FG001|Pre-randomization|Withdrawal by Subject|0|||
23377560|NCT03530293|65126655|FG002|Pre-randomization|Withdrawal by Subject|0|||
23377561|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
23377562|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
23377563|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
23377564|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
23377565|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
23377566|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
23377567|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
23377568|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
23377569|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
23377570|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
23377571|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
23377572|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
23377573|NCT03530293|65126653|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
23377574|NCT03530293|65126654|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
23377575|NCT03530293|65126655|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
23377576|NCT04711005|65126656|FG000|Overall Study|Withdrawal by Subject|0|||
23377577|NCT04711005|65126657|FG001|Overall Study|Withdrawal by Subject|0|||
23377578|NCT04711005|65126658|FG002|Overall Study|Withdrawal by Subject|0|||
23377579|NCT04711005|65126659|FG003|Overall Study|Withdrawal by Subject|0|||
23377580|NCT04711005|65126660|FG004|Overall Study|Withdrawal by Subject|0|||
23377581|NCT04711005|65126661|FG005|Overall Study|Withdrawal by Subject|0|||
23377582|NCT04711005|65126662|FG006|Overall Study|Withdrawal by Subject|0|||
23377583|NCT04711005|65126663|FG007|Overall Study|Withdrawal by Subject|1|||
23377584|NCT04711005|65126664|FG008|Overall Study|Withdrawal by Subject|0|||
23377585|NCT04711005|65126665|FG009|Overall Study|Withdrawal by Subject|0|||
23377586|NCT04711005|65126656|FG000|Overall Study|Physician Decision|0|||
23377587|NCT04711005|65126657|FG001|Overall Study|Physician Decision|0|||
23377588|NCT04711005|65126658|FG002|Overall Study|Physician Decision|0|||
23377589|NCT04711005|65126659|FG003|Overall Study|Physician Decision|0|||
23377590|NCT04711005|65126660|FG004|Overall Study|Physician Decision|0|||
23377591|NCT04711005|65126661|FG005|Overall Study|Physician Decision|0|||
23377592|NCT04711005|65126662|FG006|Overall Study|Physician Decision|0|||
23377593|NCT04711005|65126663|FG007|Overall Study|Physician Decision|2|||
23377594|NCT04711005|65126664|FG008|Overall Study|Physician Decision|1|||
23377595|NCT04711005|65126665|FG009|Overall Study|Physician Decision|0|||
23377596|NCT01006629|65126670|FG000|Overall Study|Adverse Event|1|||
23377597|NCT01006629|65126670|FG000|Overall Study|Parent refused to continue participation|1|||
23377598|NCT01006629|65126670|FG000|Overall Study|Parent unable to perform site visit|4|||
23377599|NCT03069989|65126671|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
23377600|NCT03069989|65126672|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
23377601|NCT02472405|65126673|FG000|Overall Study|Lost to Follow-up|9|||
23377602|NCT02472405|65126673|FG000|Overall Study|Adverse Event|1|||
23377603|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
23377604|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
23377605|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
23284950|NCT04968925|64784984|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
23284951|NCT04968925|64784985|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
23377606|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Death|1|||
23377607|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Death|0|||
23377608|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Death|0|||
23377609|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
23284952|NCT01558635|64784988|FG000|Overall Study|Death|1|||
23284953|NCT01558635|64784988|FG000|Overall Study|Withdrawal by Subject|2|||
23284954|NCT01558635|64784988|FG000|Overall Study|Physician Decision|1|||
23284955|NCT01558635|64784988|FG000|Overall Study|Subject received other treatment|1|||
23284956|NCT01558635|64784988|FG000|Overall Study|Reveal XT was explanted|1|||
23284957|NCT03246503|64784990|FG000|Overall Study|Lost to Follow-up|23|||
23284958|NCT03246503|64784990|FG000|Overall Study|Withdrawal by Subject|20|||
23284959|NCT03246503|64784990|FG000|Overall Study|Physician Decision|5|||
23284960|NCT03246503|64784990|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
23284961|NCT01592240|64784996|FG000|Overall Study|Adverse Event|1|||
23284962|NCT01592240|64784997|FG001|Overall Study|Adverse Event|0|||
23284963|NCT01592240|64784998|FG002|Overall Study|Adverse Event|0|||
23284964|NCT01592240|64784999|FG003|Overall Study|Adverse Event|1|||
23284965|NCT01592240|64785000|FG004|Overall Study|Adverse Event|1|||
23284966|NCT01592240|64785001|FG005|Overall Study|Adverse Event|0|||
23284967|NCT01592240|64785002|FG006|Overall Study|Adverse Event|0|||
23284968|NCT01592240|64784996|FG000|Overall Study|Death|0|||
23284969|NCT01592240|64784997|FG001|Overall Study|Death|1|||
23284970|NCT01592240|64784998|FG002|Overall Study|Death|0|||
23284971|NCT01592240|64784999|FG003|Overall Study|Death|0|||
23284972|NCT01592240|64785000|FG004|Overall Study|Death|0|||
23284973|NCT01592240|64785001|FG005|Overall Study|Death|0|||
23284974|NCT01592240|64785002|FG006|Overall Study|Death|0|||
23284975|NCT01592240|64784996|FG000|Overall Study|Lost to Follow-up|1|||
23284976|NCT01592240|64784997|FG001|Overall Study|Lost to Follow-up|3|||
23284977|NCT01592240|64784998|FG002|Overall Study|Lost to Follow-up|1|||
23284978|NCT01592240|64784999|FG003|Overall Study|Lost to Follow-up|0|||
23284979|NCT01592240|64785000|FG004|Overall Study|Lost to Follow-up|3|||
23284980|NCT01592240|64785001|FG005|Overall Study|Lost to Follow-up|2|||
23284981|NCT01592240|64785002|FG006|Overall Study|Lost to Follow-up|0|||
23284982|NCT01592240|64784996|FG000|Overall Study|Protocol Violation|0|||
23284983|NCT01592240|64784997|FG001|Overall Study|Protocol Violation|0|||
23284984|NCT01592240|64784998|FG002|Overall Study|Protocol Violation|0|||
23284985|NCT01592240|64784999|FG003|Overall Study|Protocol Violation|0|||
23284986|NCT01592240|64785000|FG004|Overall Study|Protocol Violation|0|||
23284987|NCT01592240|64785001|FG005|Overall Study|Protocol Violation|1|||
23284988|NCT01592240|64785002|FG006|Overall Study|Protocol Violation|0|||
23284989|NCT01592240|64784996|FG000|Overall Study|Withdrawal by Subject|0|||
23284990|NCT01592240|64784997|FG001|Overall Study|Withdrawal by Subject|4|||
23284991|NCT01592240|64784998|FG002|Overall Study|Withdrawal by Subject|4|||
23284992|NCT01592240|64784999|FG003|Overall Study|Withdrawal by Subject|1|||
23284993|NCT01592240|64785000|FG004|Overall Study|Withdrawal by Subject|3|||
23284994|NCT01592240|64785001|FG005|Overall Study|Withdrawal by Subject|0|||
23284995|NCT01592240|64785002|FG006|Overall Study|Withdrawal by Subject|2|||
23284996|NCT01592240|64784996|FG000|Overall Study|Other|0|||
23284997|NCT01592240|64784997|FG001|Overall Study|Other|3|||
23284998|NCT01592240|64784998|FG002|Overall Study|Other|1|||
23284999|NCT01592240|64784999|FG003|Overall Study|Other|1|||
23285000|NCT01592240|64785000|FG004|Overall Study|Other|0|||
23285001|NCT01592240|64785001|FG005|Overall Study|Other|0|||
23285002|NCT01592240|64785002|FG006|Overall Study|Other|1|||
23285003|NCT01592240|64784996|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
23285004|NCT01592240|64784997|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
23285005|NCT01592240|64784998|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
23285006|NCT01592240|64784999|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
23285007|NCT01592240|64785000|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
23285008|NCT01592240|64785001|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
23285009|NCT01592240|64785002|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
23285010|NCT01174186|64785004|FG000|Overall Study|Lost to Follow-up|0|||
23285011|NCT01174186|64785005|FG001|Overall Study|Lost to Follow-up|1|||
23285012|NCT01174186|64785004|FG000|Overall Study|Withdrawal by Subject|0|||
23285013|NCT01174186|64785005|FG001|Overall Study|Withdrawal by Subject|2|||
23285014|NCT00113919|64785012|FG000|Overall Study|Physician Decision|8|||
23285015|NCT00113919|64785012|FG000|Overall Study|Death|6|||
23285016|NCT02280863|64785020|FG000|Integrated Platform|Met stopping criteria|0|||
23377610|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
23377611|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
23377612|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
23285017|NCT02280863|64785021|FG001|Integrated Platform|Met stopping criteria|1|||
23285018|NCT00115063|64785023|FG000|Overall Study|Lost to Follow-up|98|||
23285019|NCT00115063|64785024|FG001|Overall Study|Lost to Follow-up|104|||
23285020|NCT00115063|64785023|FG000|Overall Study|Death|1|||
23285021|NCT00115063|64785024|FG001|Overall Study|Death|0|||
23285022|NCT03889639|64785025|FG000|Overall Study|Withdrawal by Subject|0|||
23285023|NCT03889639|64785026|FG001|Overall Study|Withdrawal by Subject|0|||
23285024|NCT03889639|64785027|FG002|Overall Study|Withdrawal by Subject|0|||
23377613|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
23604798|NCT01159600|65943509|FG005|Overall Study|Non compliant with protocol|0|||
23285025|NCT03889639|64785028|FG003|Overall Study|Withdrawal by Subject|0|||
23489851|NCT02545075|65537227|FG001|Treatment|Participant drug toxicity|0|||
23489852|NCT02545075|65537226|FG000|Treatment|Completed treatment|40|||
23489853|NCT02545075|65537227|FG001|Treatment|Completed treatment|12|||
23489854|NCT01759511|65537228|FG000|Overall Study|Adverse Event|4|||
23489855|NCT01759511|65537228|FG000|Overall Study|Death|2|||
23489856|NCT01759511|65537228|FG000|Overall Study|Lack of Efficacy|2|||
23489857|NCT01759511|65537228|FG000|Overall Study|Physician Decision|1|||
23489858|NCT01759511|65537228|FG000|Overall Study|Progressive Disease|5|||
23489859|NCT01759511|65537228|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
23489860|NCT01759511|65537228|FG000|Overall Study|Study Terminated by Sponsor|13|||
23489861|NCT01759511|65537228|FG000|Overall Study|Withdrawal by Subject|3|||
23377614|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
23377615|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
23377616|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
23489862|NCT01845818|65537231|FG000|Overall Study|Withdrawal by Subject|0|||
23285026|NCT03889639|64785029|FG004|Overall Study|Withdrawal by Subject|0|||
23285027|NCT03889639|64785030|FG005|Overall Study|Withdrawal by Subject|0|||
23285028|NCT03889639|64785031|FG006|Overall Study|Withdrawal by Subject|0|||
23285029|NCT03889639|64785032|FG007|Overall Study|Withdrawal by Subject|1|||
23285030|NCT00414726|64785033|FG000|Overall Study|Withdrawal by Subject|0|||
23285031|NCT00414726|64785034|FG001|Overall Study|Withdrawal by Subject|1|||
23285032|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
23285033|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
23285034|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
23285035|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
23285036|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
23285037|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
23285038|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
23285039|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
23285040|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
23285041|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
23285042|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
23285043|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
23285044|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
23285045|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
23285046|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
23285047|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
23285048|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
23285049|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
23285050|NCT00950300|64785036|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
23285051|NCT00950300|64785037|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
23285052|NCT00950300|64785036|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
23285053|NCT00950300|64785037|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
23285054|NCT00950300|64785036|FG000|TFFU Period|Death|4|||
23285055|NCT00950300|64785037|FG001|TFFU Period|Death|1|||
23285056|NCT00950300|64785036|FG000|TFFU Period|Refused Treatment|10|||
23285057|NCT00950300|64785037|FG001|TFFU Period|Refused Treatment|11|||
23285058|NCT00950300|64785036|FG000|TFFU Period|Failure to Return|16|||
23285059|NCT00950300|64785037|FG001|TFFU Period|Failure to Return|16|||
23285060|NCT00950300|64785036|FG000|TFFU Period|Recurrence of Disease|63|||
23285061|NCT00950300|64785037|FG001|TFFU Period|Recurrence of Disease|72|||
23489863|NCT01845818|65537232|FG001|Overall Study|Withdrawal by Subject|1|||
23489864|NCT01845818|65537231|FG000|Overall Study|Lost to Follow-up|7|||
23489865|NCT01845818|65537232|FG001|Overall Study|Lost to Follow-up|5|||
23489866|NCT01845818|65537231|FG000|Overall Study|Administrative Reasons|3|||
23489867|NCT01845818|65537232|FG001|Overall Study|Administrative Reasons|1|||
23489868|NCT01845818|65537231|FG000|Overall Study|Serious Adverse Event|1|||
23489869|NCT01845818|65537232|FG001|Overall Study|Serious Adverse Event|1|||
23489870|NCT01845818|65537231|FG000|Overall Study|Other|25|||
23489871|NCT01845818|65537232|FG001|Overall Study|Other|8|||
23489872|NCT01845818|65537231|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
23489873|NCT01845818|65537232|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
23489874|NCT01845818|65537231|FG000|Overall Study|No Follow-Up Data Available|4|||
23489875|NCT01845818|65537232|FG001|Overall Study|No Follow-Up Data Available|1|||
23489876|NCT02869438|65537233|FG000|Overall Study|Lost to Follow-up|1|||
23489877|NCT02869438|65537234|FG001|Overall Study|Lost to Follow-up|0|||
23489878|NCT02869438|65537233|FG000|Overall Study|Adverse Event|1|||
23489879|NCT02869438|65537234|FG001|Overall Study|Adverse Event|0|||
23489880|NCT02869438|65537233|FG000|Overall Study|Withdrawal by Subject|1|||
23489881|NCT02869438|65537234|FG001|Overall Study|Withdrawal by Subject|2|||
23489882|NCT02943460|65537235|FG000|Blinded Study Phase|Adverse Event|3|||
23489883|NCT02943460|65537236|FG001|Blinded Study Phase|Adverse Event|0|||
23489884|NCT02943460|65537237|FG002|Blinded Study Phase|Adverse Event|0|||
23489885|NCT02943460|65537235|FG000|Blinded Study Phase|Withdrew Consent|0|||
23489886|NCT02943460|65537236|FG001|Blinded Study Phase|Withdrew Consent|1|||
23489887|NCT02943460|65537237|FG002|Blinded Study Phase|Withdrew Consent|0|||
23489888|NCT02943460|65537235|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
23489889|NCT02943460|65537236|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
23489890|NCT02943460|65537237|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
23489891|NCT02943460|65537235|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
23489892|NCT02943460|65537236|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
23489893|NCT02943460|65537237|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
23489894|NCT02943460|65537235|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
23489895|NCT02943460|65537236|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
23489896|NCT02943460|65537237|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
23489897|NCT00853073|65537240|FG000|Overall Study|Withdrawal by Subject|3|||
23489898|NCT00853073|65537241|FG001|Overall Study|Withdrawal by Subject|2|||
23489899|NCT03360747|65537242|FG000|Overall Study|Voluntary Withdrawal|1|||
23489900|NCT05061966|65541231|FG000|Overall Study|Lost to Follow-up|13|||
23489901|NCT05061966|65541232|FG001|Overall Study|Lost to Follow-up|13|||
23489902|NCT01104701|65541233|FG000|Overall Study|Withdrawal by Subject|0|||
23489903|NCT01104701|65541234|FG001|Overall Study|Withdrawal by Subject|1|||
23489904|NCT01104701|65541235|FG002|Overall Study|Withdrawal by Subject|2|||
23489905|NCT01104701|65541236|FG003|Overall Study|Withdrawal by Subject|1|||
23489906|NCT01104701|65541233|FG000|Overall Study|Adverse Event|0|||
23489907|NCT01104701|65541234|FG001|Overall Study|Adverse Event|0|||
23489908|NCT01104701|65541235|FG002|Overall Study|Adverse Event|0|||
23604799|NCT01159600|65943510|FG006|Overall Study|Non compliant with protocol|2|||
23604800|NCT01159600|65943511|FG007|Overall Study|Non compliant with protocol|0|||
23604801|NCT01159600|65943504|FG000|Overall Study|Lost to Follow-up|2|||
23604802|NCT01159600|65943505|FG001|Overall Study|Lost to Follow-up|3|||
23604803|NCT01159600|65943506|FG002|Overall Study|Lost to Follow-up|4|||
23604804|NCT01159600|65943507|FG003|Overall Study|Lost to Follow-up|3|||
23604805|NCT01159600|65943508|FG004|Overall Study|Lost to Follow-up|3|||
23604806|NCT01159600|65943509|FG005|Overall Study|Lost to Follow-up|0|||
23604807|NCT01159600|65943510|FG006|Overall Study|Lost to Follow-up|3|||
23604808|NCT01159600|65943511|FG007|Overall Study|Lost to Follow-up|2|||
23604809|NCT01159600|65943504|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
23604810|NCT01159600|65943505|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
23604811|NCT01159600|65943506|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
23604812|NCT01159600|65943507|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
23604813|NCT01159600|65943508|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
23604814|NCT01159600|65943509|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
23604815|NCT01159600|65943510|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
23604816|NCT01159600|65943511|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
23604817|NCT01159600|65943504|FG000|Overall Study|Other reason not defined above|3|||
23604818|NCT01159600|65943505|FG001|Overall Study|Other reason not defined above|0|||
23604819|NCT01159600|65943506|FG002|Overall Study|Other reason not defined above|4|||
23604820|NCT01159600|65943507|FG003|Overall Study|Other reason not defined above|2|||
23604821|NCT01159600|65943508|FG004|Overall Study|Other reason not defined above|5|||
23604822|NCT01159600|65943509|FG005|Overall Study|Other reason not defined above|7|||
23489909|NCT01104701|65541236|FG003|Overall Study|Adverse Event|1|||
23489910|NCT01104701|65541233|FG000|Overall Study|Physician Decision|0|||
23604823|NCT01159600|65943510|FG006|Overall Study|Other reason not defined above|3|||
23604824|NCT01159600|65943511|FG007|Overall Study|Other reason not defined above|3|||
23604825|NCT01566890|65943512|FG000|Overall Study|Adverse Event|1|||
23489911|NCT01104701|65541234|FG001|Overall Study|Physician Decision|2|||
23489912|NCT01104701|65541235|FG002|Overall Study|Physician Decision|0|||
23489913|NCT01104701|65541236|FG003|Overall Study|Physician Decision|0|||
23489914|NCT02047227|65541238|FG000|Overall Study|Adverse Event|2|||
23285062|NCT00950300|64785036|FG000|TFFU Period|Other|4|||
23285063|NCT00950300|64785037|FG001|TFFU Period|Other|3|||
23285064|NCT00950300|64785036|FG000|SFU Period|Death|44|||
23285065|NCT00950300|64785037|FG001|SFU Period|Death|42|||
23285066|NCT00950300|64785036|FG000|SFU Period|Lost to Follow-up|30|||
23285067|NCT00950300|64785037|FG001|SFU Period|Lost to Follow-up|28|||
23285068|NCT00950300|64785036|FG000|SFU Period|Withdrawal by Subject|4|||
23285069|NCT00950300|64785037|FG001|SFU Period|Withdrawal by Subject|8|||
23285070|NCT01139762|64785038|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
23285071|NCT01139762|64785039|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
23285072|NCT01139762|64785040|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
23377617|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
23377618|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
23377619|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
23377620|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
23377621|NCT05073315|65126674|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
23377622|NCT05073315|65126675|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
23377623|NCT05073315|65126676|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
23377624|NCT05073315|65126674|FG000|Period 2|Adverse Event|0|||
23377625|NCT05073315|65126675|FG001|Period 2|Adverse Event|3|||
23377626|NCT05073315|65126676|FG002|Period 2|Adverse Event|6|||
23377627|NCT05073315|65126674|FG000|Period 2|Lost to Follow-up|0|||
23377628|NCT05073315|65126675|FG001|Period 2|Lost to Follow-up|5|||
23377629|NCT05073315|65126676|FG002|Period 2|Lost to Follow-up|5|||
23377630|NCT05073315|65126674|FG000|Period 2|Withdrawal by Subject|0|||
23377631|NCT05073315|65126675|FG001|Period 2|Withdrawal by Subject|4|||
23377632|NCT05073315|65126676|FG002|Period 2|Withdrawal by Subject|9|||
23377633|NCT05073315|65126674|FG000|Period 2|Protocol Violation|0|||
23377634|NCT05073315|65126675|FG001|Period 2|Protocol Violation|0|||
23377635|NCT05073315|65126676|FG002|Period 2|Protocol Violation|1|||
23377636|NCT02107898|65126680|FG000|Overall Study|Adverse Event|4|||
23377637|NCT02107898|65126681|FG001|Overall Study|Adverse Event|7|||
23377638|NCT02107898|65126680|FG000|Overall Study|Poor compliance to protocol|0|||
23377639|NCT02107898|65126681|FG001|Overall Study|Poor compliance to protocol|1|||
23377640|NCT02107898|65126680|FG000|Overall Study|Participant moved|0|||
23377641|NCT02107898|65126681|FG001|Overall Study|Participant moved|2|||
23377642|NCT02107898|65126680|FG000|Overall Study|Consent withdrawn by participant|2|||
23377643|NCT02107898|65126681|FG001|Overall Study|Consent withdrawn by participant|1|||
23377644|NCT02107898|65126680|FG000|Overall Study|Randomized but not treated|0|||
23377645|NCT02107898|65126681|FG001|Overall Study|Randomized but not treated|1|||
23377646|NCT00998946|65126682|FG000|Overall Study|Lost to Follow-up|1|||
23377647|NCT00998946|65126682|FG000|Overall Study|Withdrawal by Subject|1|||
23377648|NCT00998946|65126682|FG000|Overall Study|Death|2|||
23377649|NCT00998946|65126682|FG000|Overall Study|Reason Unspecified|3|||
23377650|NCT00998946|65126682|FG000|Overall Study|Enrolled but not Dosed|2|||
23377651|NCT03101020|65126683|FG000|Overall Study|Lack of time to participate|1|||
23377652|NCT03101020|65126684|FG001|Overall Study|Lack of time to participate|0|||
23377653|NCT03101020|65126683|FG000|Overall Study|Ran over by a car|0|||
23377654|NCT03101020|65126684|FG001|Overall Study|Ran over by a car|1|||
23377655|NCT03101020|65126683|FG000|Overall Study|Withdrawal by Subject|0|||
23377656|NCT03101020|65126684|FG001|Overall Study|Withdrawal by Subject|2|||
23489915|NCT02047227|65541239|FG001|Overall Study|Adverse Event|4|||
23489916|NCT02047227|65541238|FG000|Overall Study|Lost to Follow-up|0|||
23489917|NCT02047227|65541239|FG001|Overall Study|Lost to Follow-up|3|||
23489918|NCT02047227|65541238|FG000|Overall Study|Protocol Violation|1|||
23604826|NCT01566890|65943513|FG001|Overall Study|Adverse Event|0|||
23604827|NCT01566890|65943514|FG002|Overall Study|Adverse Event|0|||
23604828|NCT01566890|65943515|FG003|Overall Study|Adverse Event|0|||
23604829|NCT01566890|65943516|FG004|Overall Study|Adverse Event|0|||
23604830|NCT01566890|65943512|FG000|Overall Study|Withdrawal by Subject|3|||
23604831|NCT01566890|65943513|FG001|Overall Study|Withdrawal by Subject|1|||
23604832|NCT01566890|65943514|FG002|Overall Study|Withdrawal by Subject|1|||
23285073|NCT01139762|64785038|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
23285074|NCT01139762|64785039|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
23285075|NCT01139762|64785040|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
23285076|NCT01139762|64785038|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
23285077|NCT01139762|64785039|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
23377657|NCT00858988|65126685|FG000|Analysis|Lactulose unable to be detected in urine|2|||
23377658|NCT00858988|65126686|FG001|Analysis|Lactulose unable to be detected in urine|1|||
23489919|NCT02047227|65541239|FG001|Overall Study|Protocol Violation|0|||
23604833|NCT01566890|65943515|FG003|Overall Study|Withdrawal by Subject|1|||
23377659|NCT01405911|65126689|FG000|Overall Study|Pre-treatment lab AE|0|||
23377660|NCT01405911|65126690|FG001|Overall Study|Pre-treatment lab AE|1|||
23377661|NCT01405911|65126691|FG002|Overall Study|Pre-treatment lab AE|0|||
23377662|NCT01405911|65126689|FG000|Overall Study|Lost to Follow-up|0|||
23377663|NCT01405911|65126690|FG001|Overall Study|Lost to Follow-up|1|||
23377664|NCT01405911|65126691|FG002|Overall Study|Lost to Follow-up|0|||
23377665|NCT01405911|65126689|FG000|Overall Study|Protocol Violation|1|||
23377666|NCT01405911|65126690|FG001|Overall Study|Protocol Violation|0|||
23377667|NCT01405911|65126691|FG002|Overall Study|Protocol Violation|0|||
23377668|NCT01405911|65126689|FG000|Overall Study|Withdrawal by Subject|3|||
23377669|NCT01405911|65126690|FG001|Overall Study|Withdrawal by Subject|1|||
23377670|NCT01405911|65126691|FG002|Overall Study|Withdrawal by Subject|1|||
23377671|NCT00662259|65126700|FG000|Overall Study|Adverse Event|2|||
23377672|NCT00662259|65126701|FG001|Overall Study|Adverse Event|0|||
23377673|NCT02780388|65126702|FG000|Overall Study|Lost to Follow-up|0|||
23377674|NCT02780388|65126703|FG001|Overall Study|Lost to Follow-up|1|||
23377675|NCT02780388|65126704|FG002|Overall Study|Lost to Follow-up|0|||
23377676|NCT02780388|65126705|FG003|Overall Study|Lost to Follow-up|0|||
23377677|NCT02780388|65126706|FG004|Overall Study|Lost to Follow-up|0|||
23377678|NCT02780388|65126702|FG000|Overall Study|Withdrawal by Subject|1|||
23377679|NCT02780388|65126703|FG001|Overall Study|Withdrawal by Subject|1|||
23377680|NCT02780388|65126704|FG002|Overall Study|Withdrawal by Subject|0|||
23377681|NCT02780388|65126705|FG003|Overall Study|Withdrawal by Subject|0|||
23377682|NCT02780388|65126706|FG004|Overall Study|Withdrawal by Subject|0|||
23377683|NCT00576758|65126709|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
23377684|NCT00576758|65126710|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
23377685|NCT00576758|65126709|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
23377686|NCT00576758|65126710|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
23377687|NCT00576758|65126709|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
23377688|NCT00576758|65126710|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
23377689|NCT00576758|65126709|FG000|Induction Treatment Period|Death|1|||
23377690|NCT00576758|65126710|FG001|Induction Treatment Period|Death|0|||
23377691|NCT00576758|65126709|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
23377692|NCT00576758|65126710|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
23377693|NCT00576758|65126709|FG000|Induction Treatment Period|Withdrew consent|1|||
23377694|NCT00576758|65126710|FG001|Induction Treatment Period|Withdrew consent|0|||
23377695|NCT00576758|65126709|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
23377696|NCT00576758|65126710|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
23377697|NCT00576758|65126709|FG000|Extension Treatment Period|Death|1|||
23285078|NCT01139762|64785040|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
23285079|NCT01139762|64785038|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
23285080|NCT01139762|64785039|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
23285081|NCT01139762|64785040|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
23285082|NCT01139762|64785038|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
23285083|NCT01139762|64785039|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
23285084|NCT01139762|64785040|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
23285085|NCT01139762|64785038|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
23285086|NCT01139762|64785039|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
23285087|NCT01139762|64785040|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
23285088|NCT01139762|64785038|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
23285089|NCT01139762|64785039|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
23285090|NCT01139762|64785040|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
23285091|NCT01139762|64785038|FG000|Double-Blind Randomized Active Treatment|Death|0|||
23285092|NCT01139762|64785039|FG001|Double-Blind Randomized Active Treatment|Death|1|||
23285093|NCT01139762|64785040|FG002|Double-Blind Randomized Active Treatment|Death|1|||
23285094|NCT01139762|64785038|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
23285095|NCT01139762|64785039|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
23285096|NCT01139762|64785040|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
23285097|NCT01139762|64785038|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
23285098|NCT01139762|64785039|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
23285099|NCT01139762|64785040|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
23285100|NCT01139762|64785038|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
23285101|NCT01139762|64785039|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
23285102|NCT01139762|64785040|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
23285103|NCT01139762|64785038|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
23285104|NCT01139762|64785039|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
23285105|NCT01139762|64785040|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
23285106|NCT01139762|64785038|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
23285107|NCT01139762|64785039|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
23285108|NCT01139762|64785040|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
23285109|NCT01139762|64785038|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
23377698|NCT00576758|65126710|FG001|Extension Treatment Period|Death|1|||
23377699|NCT00576758|65126709|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
23377700|NCT00576758|65126710|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
23377701|NCT00576758|65126709|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
23377702|NCT00576758|65126710|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
23377703|NCT00576758|65126709|FG000|Extension Treatment Period|Administrative/Other|3|||
23377704|NCT00576758|65126710|FG001|Extension Treatment Period|Administrative/Other|1|||
23377705|NCT00576758|65126709|FG000|Follow-up Period|Administrative/Other|6|||
23377706|NCT00576758|65126710|FG001|Follow-up Period|Administrative/Other|8|||
23377707|NCT00576758|65126709|FG000|Follow-up Period|Death|3|||
23377708|NCT00576758|65126710|FG001|Follow-up Period|Death|3|||
23377709|NCT00576758|65126709|FG000|Follow-up Period|Insufficient therapeutic response|16|||
23377710|NCT00576758|65126710|FG001|Follow-up Period|Insufficient therapeutic response|5|||
23377711|NCT00576758|65126709|FG000|Follow-up Period|Withdrew consent|2|||
23377712|NCT00576758|65126710|FG001|Follow-up Period|Withdrew consent|1|||
23377713|NCT03416179|65126711|FG000|Overall Study|Death|90|||
23377714|NCT03416179|65126712|FG001|Overall Study|Death|87|||
23377715|NCT03416179|65126713|FG002|Overall Study|Death|117|||
23377716|NCT03416179|65126714|FG003|Overall Study|Death|113|||
23377717|NCT03416179|65126711|FG000|Overall Study|Withdrawal by Subject|15|||
23377718|NCT03416179|65126712|FG001|Overall Study|Withdrawal by Subject|20|||
23377719|NCT03416179|65126713|FG002|Overall Study|Withdrawal by Subject|6|||
23377720|NCT03416179|65126714|FG003|Overall Study|Withdrawal by Subject|9|||
23377721|NCT03416179|65126711|FG000|Overall Study|Lost to Follow-up|1|||
23377722|NCT03416179|65126712|FG001|Overall Study|Lost to Follow-up|1|||
23377723|NCT03416179|65126713|FG002|Overall Study|Lost to Follow-up|0|||
23377724|NCT03416179|65126714|FG003|Overall Study|Lost to Follow-up|3|||
23377725|NCT03416179|65126711|FG000|Overall Study|Study participation terminated by Sponsor|93|||
23377726|NCT03416179|65126712|FG001|Overall Study|Study participation terminated by Sponsor|91|||
23377727|NCT03416179|65126713|FG002|Overall Study|Study participation terminated by Sponsor|26|||
23377728|NCT03416179|65126714|FG003|Overall Study|Study participation terminated by Sponsor|31|||
23285110|NCT01139762|64785039|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
23285111|NCT01139762|64785040|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
23285112|NCT01139762|64785038|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
23285113|NCT01139762|64785039|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
23285114|NCT01139762|64785040|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
23285115|NCT01499043|64785042|FG000|Overall Study|Progressive disease (radiographic)|2|||
23285116|NCT01499043|64785042|FG000|Overall Study|Progressive disease (clinical)|1|||
23285117|NCT01499043|64785042|FG000|Overall Study|Withdrawal by Subject|2|||
23285118|NCT01499043|64785042|FG000|Overall Study|Adverse Event|1|||
23285119|NCT02096705|64787634|FG000|Treatment|Adverse Event|6|||
23285120|NCT02096705|64787635|FG001|Treatment|Adverse Event|3|||
23285121|NCT02096705|64787634|FG000|Treatment|Subject request to discontinue treatment|1|||
23285122|NCT02096705|64787635|FG001|Treatment|Subject request to discontinue treatment|1|||
23285123|NCT02096705|64787634|FG000|Treatment|Withdrawal by Subject|1|||
23285124|NCT02096705|64787635|FG001|Treatment|Withdrawal by Subject|0|||
23285125|NCT02096705|64787634|FG000|Treatment|Other|1|||
23377729|NCT03416179|65126711|FG000|Overall Study|Other|2|||
23604834|NCT01566890|65943516|FG004|Overall Study|Withdrawal by Subject|0|||
23604835|NCT01566890|65943512|FG000|Overall Study|Screen failure|6|||
23604836|NCT01566890|65943513|FG001|Overall Study|Screen failure|0|||
23604837|NCT01566890|65943514|FG002|Overall Study|Screen failure|1|||
23604838|NCT01566890|65943515|FG003|Overall Study|Screen failure|1|||
23604839|NCT01566890|65943516|FG004|Overall Study|Screen failure|0|||
23604840|NCT01566890|65943512|FG000|Overall Study|Incomplete CEU data|1|||
23604841|NCT01566890|65943513|FG001|Overall Study|Incomplete CEU data|3|||
23604842|NCT01566890|65943514|FG002|Overall Study|Incomplete CEU data|5|||
23604843|NCT01566890|65943515|FG003|Overall Study|Incomplete CEU data|8|||
23604844|NCT01566890|65943516|FG004|Overall Study|Incomplete CEU data|0|||
23604845|NCT01566890|65943512|FG000|Overall Study|Lost to Follow-up|0|||
23604846|NCT01566890|65943513|FG001|Overall Study|Lost to Follow-up|0|||
23604847|NCT01566890|65943514|FG002|Overall Study|Lost to Follow-up|4|||
23604848|NCT01566890|65943515|FG003|Overall Study|Lost to Follow-up|4|||
23285126|NCT02096705|64787635|FG001|Treatment|Other|1|||
23604849|NCT01566890|65943516|FG004|Overall Study|Lost to Follow-up|0|||
23604850|NCT01566890|65943512|FG000|Overall Study|Other|0|||
23604851|NCT01566890|65943513|FG001|Overall Study|Other|0|||
23604852|NCT01566890|65943514|FG002|Overall Study|Other|0|||
23285127|NCT02096705|64787634|FG000|Follow-up|Withdrawal by Subject|1|||
23377730|NCT03416179|65126712|FG001|Overall Study|Other|3|||
23377731|NCT03416179|65126713|FG002|Overall Study|Other|1|||
23377732|NCT03416179|65126714|FG003|Overall Study|Other|0|||
23377733|NCT01253161|65126717|FG000|Overall Study|Adverse Event|1|||
23377734|NCT00929669|65126726|FG000|Overall Study|elevated glucose levels|1|||
23604853|NCT01566890|65943515|FG003|Overall Study|Other|0|||
23285128|NCT02096705|64787635|FG001|Follow-up|Withdrawal by Subject|0|||
23285129|NCT02096705|64787634|FG000|Follow-up|Adverse Event|2|||
23285130|NCT02096705|64787635|FG001|Follow-up|Adverse Event|2|||
23604854|NCT01566890|65943516|FG004|Overall Study|Other|7|||
23604855|NCT00068107|65943519|FG000|Overall Study|end-stage renal disease|6|||
23285131|NCT02096705|64787634|FG000|Follow-up|Subjects not reporting status|1|||
23285132|NCT02096705|64787635|FG001|Follow-up|Subjects not reporting status|2|||
23285133|NCT01663896|64787641|FG000|Overall Study|Various reasons|43|||
23285134|NCT03684928|64787642|FG000|First Intervention|Lost to Follow-up|0|||
23285135|NCT03684928|64787643|FG001|First Intervention|Lost to Follow-up|1|||
23285136|NCT03684928|64787642|FG000|First Intervention|Withdrawal by Subject|0|||
23285137|NCT03684928|64787643|FG001|First Intervention|Withdrawal by Subject|2|||
23285138|NCT03684928|64787642|FG000|Second Intervention|Soft Tissue Injury|1|||
23285139|NCT03684928|64787643|FG001|Second Intervention|Soft Tissue Injury|0|||
23285140|NCT04364763|64787644|FG000|Overall Study|Death|1|||
23285141|NCT04364763|64787645|FG001|Overall Study|Death|2|||
23285142|NCT04364763|64787644|FG000|Overall Study|Lost to Follow-up|1|||
23285143|NCT04364763|64787645|FG001|Overall Study|Lost to Follow-up|0|||
23285144|NCT00487435|64787652|FG000|Overall Study|Adverse Event|146|||
23285145|NCT00487435|64787652|FG000|Overall Study|Death|2|||
23285146|NCT00487435|64787652|FG000|Overall Study|Lack of Efficacy|33|||
23285147|NCT00487435|64787652|FG000|Overall Study|Lost to Follow-up|54|||
23604856|NCT00068107|65943519|FG000|Overall Study|Death|2|||
23604857|NCT00068107|65943519|FG000|Overall Study|Withdrawal by Subject|1|||
23604858|NCT04660799|65943520|FG000|Overall Study|Progressive Disease|1|||
23604859|NCT04660799|65943521|FG001|Overall Study|Progressive Disease|1|||
23604860|NCT04660799|65943520|FG000|Overall Study|Death|2|||
23604861|NCT04660799|65943521|FG001|Overall Study|Death|1|||
23604862|NCT04660799|65943520|FG000|Overall Study|Adverse Event|2|||
23604863|NCT04660799|65943521|FG001|Overall Study|Adverse Event|1|||
23604864|NCT04660799|65943520|FG000|Overall Study|Withdrawal by Subject|2|||
23604865|NCT04660799|65943521|FG001|Overall Study|Withdrawal by Subject|5|||
23604866|NCT00065182|65943529|FG000|Overall Study|Adverse Event|24|||
23604867|NCT00065182|65943530|FG001|Overall Study|Adverse Event|17|||
23604868|NCT00065182|65943529|FG000|Overall Study|Lost to Follow-up|0|||
23604869|NCT00065182|65943530|FG001|Overall Study|Lost to Follow-up|4|||
23604870|NCT00065182|65943529|FG000|Overall Study|Protocol Violation|3|||
23604871|NCT00065182|65943530|FG001|Overall Study|Protocol Violation|4|||
23604872|NCT00065182|65943529|FG000|Overall Study|Serious adverse events (SAE)|1|||
23489920|NCT02047227|65541238|FG000|Overall Study|Spontaneous pregnancy|1|||
23489921|NCT02047227|65541239|FG001|Overall Study|Spontaneous pregnancy|0|||
23604873|NCT00065182|65943530|FG001|Overall Study|Serious adverse events (SAE)|0|||
23604874|NCT00065182|65943529|FG000|Overall Study|Sponsor Decision|11|||
23604875|NCT00065182|65943530|FG001|Overall Study|Sponsor Decision|7|||
23285148|NCT00487435|64787652|FG000|Overall Study|Pregnancy|2|||
23285149|NCT00487435|64787652|FG000|Overall Study|Withdrawal by Subject|132|||
23285150|NCT00487435|64787652|FG000|Overall Study|Resolution Of Pain|1|||
23285151|NCT00487435|64787652|FG000|Overall Study|Study Medication Non-Compliant|32|||
23285152|NCT00487435|64787652|FG000|Overall Study|Other|83|||
23604876|NCT00065182|65943529|FG000|Overall Study|Withdrawal by Subject|8|||
23604877|NCT00065182|65943530|FG001|Overall Study|Withdrawal by Subject|3|||
23604878|NCT00065182|65943529|FG000|Overall Study|No clinical benefit|1|||
23604879|NCT00065182|65943530|FG001|Overall Study|No clinical benefit|0|||
23604880|NCT00065182|65943529|FG000|Overall Study|Death|0|||
23604881|NCT00065182|65943530|FG001|Overall Study|Death|1|||
23604882|NCT00065182|65943529|FG000|Overall Study|Decline in Status|0|||
23604883|NCT00065182|65943530|FG001|Overall Study|Decline in Status|1|||
23604884|NCT00570505|65943531|FG000|Overall Study|Adverse Event|7|||
23604885|NCT00570505|65943531|FG000|Overall Study|Withdrawal by Subject|7|||
23604886|NCT00570505|65943531|FG000|Overall Study|Lost to Follow-up|23|||
23604887|NCT00570505|65943531|FG000|Overall Study|Other loss to follow-up|4|||
23604888|NCT03490032|65943532|FG000|Overall Study|family issue (child custody)|1|||
23604889|NCT03490032|65943533|FG001|Overall Study|family issue (child custody)|0|||
23604890|NCT03490032|65943534|FG002|Overall Study|family issue (child custody)|0|||
23604891|NCT00553332|65943535|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
23489922|NCT02047227|65541238|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
23489923|NCT02047227|65541239|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
23489924|NCT02047227|65541238|FG000|Overall Study|No oocytes retrieved|21|||
23489925|NCT02047227|65541239|FG001|Overall Study|No oocytes retrieved|20|||
23489926|NCT02047227|65541238|FG000|Overall Study|No fertilization|61|||
23489927|NCT02047227|65541239|FG001|Overall Study|No fertilization|51|||
23489928|NCT02047227|65541238|FG000|Overall Study|Intention to freeze all embryos|1|||
23489929|NCT02047227|65541239|FG001|Overall Study|Intention to freeze all embryos|0|||
23489930|NCT02047227|65541238|FG000|Overall Study|All embryos discarded|12|||
23489931|NCT02047227|65541239|FG001|Overall Study|All embryos discarded|11|||
23489932|NCT02047227|65541238|FG000|Overall Study|Other|10|||
23489933|NCT02047227|65541239|FG001|Overall Study|Other|9|||
23489934|NCT01051466|65541242|FG000|Overall Study|Adverse Event|1|||
23489935|NCT01051466|65541243|FG001|Overall Study|Adverse Event|0|||
23489936|NCT01051466|65541242|FG000|Overall Study|Lost to Follow-up|1|||
23489937|NCT01051466|65541243|FG001|Overall Study|Lost to Follow-up|1|||
23489938|NCT01051466|65541242|FG000|Overall Study|Withdrawal by Subject|5|||
23489939|NCT01051466|65541243|FG001|Overall Study|Withdrawal by Subject|1|||
23489940|NCT01051466|65541242|FG000|Overall Study|Entry Criteria Not Met|0|||
23489941|NCT01051466|65541243|FG001|Overall Study|Entry Criteria Not Met|3|||
23489942|NCT01051466|65541242|FG000|Overall Study|Physician Decision|1|||
23489943|NCT01051466|65541243|FG001|Overall Study|Physician Decision|0|||
23489944|NCT00470847|65541244|FG000|Overall Study|Pt still receiving treatment|1|||
23489945|NCT01609231|65541245|FG000|Overall Study|Adverse Event|1|||
23489946|NCT01609231|65541246|FG001|Overall Study|Adverse Event|3|||
23489947|NCT01609231|65541245|FG000|Overall Study|Physician Decision|1|||
23489948|NCT01609231|65541246|FG001|Overall Study|Physician Decision|0|||
23489949|NCT01609231|65541245|FG000|Overall Study|Withdrawal by Subject|1|||
23489950|NCT01609231|65541246|FG001|Overall Study|Withdrawal by Subject|0|||
23489951|NCT01858376|65541249|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
23604892|NCT03418922|65943536|FG000|Overall Study|Withdrawal by Subject|0|||
23285153|NCT01374451|64787660|FG000|Overall Study|Administrative problems|1|||
23285154|NCT01374451|64787661|FG001|Overall Study|Administrative problems|0|||
23285155|NCT00673660|64787664|FG000|Overall Study|Lost to Follow-up|107|||
23285156|NCT02046122|64787669|FG000|Overall Study|Physician Decision|8|||
23285157|NCT02046122|64787669|FG000|Overall Study|Withdrawal by Subject|1|||
23285158|NCT02679729|64787670|FG000|Overall Study|Lost to Follow-up|0|||
23285159|NCT02679729|64787671|FG001|Overall Study|Lost to Follow-up|1|||
23285160|NCT02679729|64787672|FG002|Overall Study|Lost to Follow-up|0|||
23285161|NCT02679729|64787673|FG003|Overall Study|Lost to Follow-up|0|||
23285162|NCT02679729|64787674|FG004|Overall Study|Lost to Follow-up|1|||
23285163|NCT02679729|64787675|FG005|Overall Study|Lost to Follow-up|0|||
23285164|NCT02679729|64787676|FG006|Overall Study|Lost to Follow-up|0|||
23285165|NCT02679729|64787677|FG007|Overall Study|Lost to Follow-up|0|||
23489952|NCT01068652|65541252|FG000|Overall Study|Adverse Event|4|||
23489953|NCT01068652|65541253|FG001|Overall Study|Adverse Event|0|||
23489954|NCT01068652|65541252|FG000|Overall Study|Lack of Efficacy|0|||
23489955|NCT01068652|65541253|FG001|Overall Study|Lack of Efficacy|2|||
23489956|NCT01068652|65541252|FG000|Overall Study|Lost to Follow-up|2|||
23489957|NCT01068652|65541253|FG001|Overall Study|Lost to Follow-up|1|||
23489958|NCT01068652|65541252|FG000|Overall Study|Protocol Violation|3|||
23489959|NCT01068652|65541253|FG001|Overall Study|Protocol Violation|6|||
23489960|NCT01068652|65541252|FG000|Overall Study|Withdrawal criteria|1|||
23489961|NCT01068652|65541253|FG001|Overall Study|Withdrawal criteria|2|||
23489962|NCT01068652|65541252|FG000|Overall Study|Patient was not eligible|1|||
23489963|NCT01068652|65541253|FG001|Overall Study|Patient was not eligible|0|||
23604893|NCT03418922|65943537|FG001|Overall Study|Withdrawal by Subject|2|||
23285166|NCT02679729|64787678|FG008|Overall Study|Lost to Follow-up|0|||
23285167|NCT02679729|64787670|FG000|Overall Study|Participant decision|0|||
23489964|NCT01068652|65541252|FG000|Overall Study|Unclassified|7|||
23489965|NCT01068652|65541253|FG001|Overall Study|Unclassified|4|||
23285168|NCT02679729|64787671|FG001|Overall Study|Participant decision|1|||
23604894|NCT03418922|65943536|FG000|Overall Study|Adverse Event|2|||
23604895|NCT03418922|65943537|FG001|Overall Study|Adverse Event|2|||
23604896|NCT03418922|65943536|FG000|Overall Study|Death|0|||
23604897|NCT03418922|65943537|FG001|Overall Study|Death|1|||
23604898|NCT03418922|65943536|FG000|Overall Study|Physician Decision|0|||
23604899|NCT03418922|65943537|FG001|Overall Study|Physician Decision|1|||
23604900|NCT04820491|65943538|FG000|Overall Study|Withdrawal by Subject|1|||
23604901|NCT04820491|65943539|FG001|Overall Study|Withdrawal by Subject|0|||
23604902|NCT02338999|65943541|FG000|First Intervention|Withdrawal by Subject|3|||
23604903|NCT02338999|65943542|FG001|First Intervention|Withdrawal by Subject|1|||
23604904|NCT02338999|65943541|FG000|Washout Period|Withdrawal by Subject|0|||
23604905|NCT02338999|65943542|FG001|Washout Period|Withdrawal by Subject|2|||
23604906|NCT02338999|65943541|FG000|Second Intervention|Withdrawal by Subject|0|||
23604907|NCT02338999|65943542|FG001|Second Intervention|Withdrawal by Subject|2|||
23604908|NCT03938272|65943552|FG000|Overall Study|Withdrawal by Subject|1|||
23604909|NCT03938272|65943553|FG001|Overall Study|Withdrawal by Subject|0|||
23604910|NCT03938272|65943552|FG000|Overall Study|Physician Decision|0|||
23604911|NCT03938272|65943553|FG001|Overall Study|Physician Decision|2|||
23604912|NCT03938272|65943552|FG000|Overall Study|Study termination by sponsor|10|||
23604913|NCT03938272|65943553|FG001|Overall Study|Study termination by sponsor|8|||
23604914|NCT02410278|65943556|FG000|Run-in Period|Adverse Event|5|||
23604915|NCT02410278|65943557|FG001|Run-in Period|Adverse Event|0|||
23604916|NCT02410278|65943558|FG002|Run-in Period|Adverse Event|0|||
23604917|NCT02410278|65943556|FG000|Run-in Period|GSRS Threshold Not Met|30|||
23377735|NCT01125748|65126727|FG000|Overall Study|Adverse Event|0|||
23377736|NCT01125748|65126728|FG001|Overall Study|Adverse Event|2|||
23377737|NCT01125748|65126727|FG000|Overall Study|Lost to Follow-up|0|||
23377738|NCT01125748|65126728|FG001|Overall Study|Lost to Follow-up|1|||
23377739|NCT01125748|65126727|FG000|Overall Study|Physician Decision|8|||
23377740|NCT01125748|65126728|FG001|Overall Study|Physician Decision|7|||
23377741|NCT01125748|65126727|FG000|Overall Study|Patient Decision to Withdraw|2|||
23377742|NCT01125748|65126728|FG001|Overall Study|Patient Decision to Withdraw|4|||
23377743|NCT03122106|65126729|FG000|Overall Study|Not enough tissue|1|||
23377744|NCT03122106|65126729|FG000|Overall Study|Disease progression during screening|2|||
23377745|NCT03122106|65126729|FG000|Overall Study|Poor RNA quality for vaccine|1|||
23377746|NCT00857389|65126730|FG000|Overall Study|Did not proceed to transplant|2|||
23377747|NCT00832975|65126731|FG000|Overall Study|Lost to Follow-up|7|||
23377748|NCT00832975|65126731|FG000|Overall Study|Protocol Violation|6|||
23377749|NCT00832975|65126731|FG000|Overall Study|Death|5|||
23377750|NCT00832975|65126731|FG000|Overall Study|Physician Decision|4|||
23377751|NCT00832975|65126731|FG000|Overall Study|Withdrawal by Subject|3|||
23377752|NCT00832975|65126731|FG000|Overall Study|Other reasons|14|||
23377753|NCT02114684|65126734|FG000|Overall Study|Death|6|||
23377754|NCT02114684|65126735|FG001|Overall Study|Death|4|||
23377755|NCT02114684|65126734|FG000|Overall Study|Lost to Follow-up|1|||
23377756|NCT02114684|65126735|FG001|Overall Study|Lost to Follow-up|2|||
23377757|NCT02114684|65126734|FG000|Overall Study|Withdrawal by Subject|1|||
23377758|NCT02114684|65126735|FG001|Overall Study|Withdrawal by Subject|2|||
23377759|NCT02114684|65126734|FG000|Overall Study|Relocation|3|||
23377760|NCT02114684|65126735|FG001|Overall Study|Relocation|1|||
23377761|NCT02114684|65126734|FG000|Overall Study|Rifampicin resistant on culture|0|||
23377762|NCT02114684|65126735|FG001|Overall Study|Rifampicin resistant on culture|1|||
23377763|NCT02114684|65126734|FG000|Overall Study|Patient Incarcerated|1|||
23377764|NCT02114684|65126735|FG001|Overall Study|Patient Incarcerated|0|||
23377765|NCT01039675|65126739|FG000|Overall Study|Adverse Event|0|||
23377766|NCT01039675|65126740|FG001|Overall Study|Adverse Event|2|||
23377767|NCT01039675|65126739|FG000|Overall Study|Lack of Efficacy|0|||
23377768|NCT01039675|65126740|FG001|Overall Study|Lack of Efficacy|2|||
23377769|NCT01039675|65126739|FG000|Overall Study|Withdrawal by Subject|0|||
23377770|NCT01039675|65126740|FG001|Overall Study|Withdrawal by Subject|1|||
23377771|NCT01039675|65126739|FG000|Overall Study|Lost to Follow-up|0|||
23377772|NCT01039675|65126740|FG001|Overall Study|Lost to Follow-up|1|||
23377773|NCT01039675|65126739|FG000|Overall Study|Physician Decision|0|||
23604918|NCT02410278|65943557|FG001|Run-in Period|GSRS Threshold Not Met|0|||
23604919|NCT02410278|65943558|FG002|Run-in Period|GSRS Threshold Not Met|0|||
23604920|NCT02410278|65943556|FG000|Run-in Period|Lost to Follow-up|1|||
23604921|NCT02410278|65943557|FG001|Run-in Period|Lost to Follow-up|0|||
23604922|NCT02410278|65943558|FG002|Run-in Period|Lost to Follow-up|0|||
23604923|NCT02410278|65943556|FG000|Run-in Period|Withdrawal by Subject|1|||
23377774|NCT01039675|65126740|FG001|Overall Study|Physician Decision|1|||
23377775|NCT02690727|65126743|FG000|Overall Study|Adverse Event|2|||
23377776|NCT02690727|65126744|FG001|Overall Study|Adverse Event|2|||
23377777|NCT05630196|65126748|FG000|Overall Study|Adverse Event|2|||
23377778|NCT05630196|65126749|FG001|Overall Study|Adverse Event|1|||
23377779|NCT05630196|65126748|FG000|Overall Study|Lost to Follow-up|1|||
23377780|NCT05630196|65126749|FG001|Overall Study|Lost to Follow-up|1|||
23377781|NCT05630196|65126748|FG000|Overall Study|Protocol Violation|2|||
23377782|NCT05630196|65126749|FG001|Overall Study|Protocol Violation|3|||
23604924|NCT02410278|65943557|FG001|Run-in Period|Withdrawal by Subject|0|||
23377783|NCT05630196|65126748|FG000|Overall Study|Physician Decision|1|||
23377784|NCT05630196|65126749|FG001|Overall Study|Physician Decision|0|||
23377785|NCT05630196|65126748|FG000|Overall Study|Withdrawal by Subject|3|||
23377786|NCT05630196|65126749|FG001|Overall Study|Withdrawal by Subject|4|||
23377787|NCT03157089|65126750|FG000|Overall Study|Treated only with pembrolizumab|1|||
23377788|NCT03157089|65126751|FG001|Overall Study|Treated only with pembrolizumab|0|||
23377789|NCT03157089|65126750|FG000|Overall Study|Adverse Event|5|||
23377790|NCT03157089|65126751|FG001|Overall Study|Adverse Event|4|||
23377791|NCT03157089|65126750|FG000|Overall Study|Progressive disease|6|||
23377792|NCT03157089|65126751|FG001|Overall Study|Progressive disease|8|||
23377793|NCT00390689|65126752|FG000|Overall Study|Adverse Event|2|||
23377794|NCT00390689|65126753|FG001|Overall Study|Adverse Event|5|||
23377795|NCT00390689|65126754|FG002|Overall Study|Adverse Event|2|||
23377796|NCT00390689|65126752|FG000|Overall Study|Lack of Efficacy|0|||
23377797|NCT00390689|65126753|FG001|Overall Study|Lack of Efficacy|0|||
23377798|NCT00390689|65126754|FG002|Overall Study|Lack of Efficacy|1|||
23377799|NCT00390689|65126752|FG000|Overall Study|Protocol Violation|1|||
23377800|NCT00390689|65126753|FG001|Overall Study|Protocol Violation|0|||
23377801|NCT00390689|65126754|FG002|Overall Study|Protocol Violation|0|||
23377802|NCT00390689|65126752|FG000|Overall Study|Investigator's judgement|2|||
23377803|NCT00390689|65126753|FG001|Overall Study|Investigator's judgement|0|||
23377804|NCT00390689|65126754|FG002|Overall Study|Investigator's judgement|0|||
23377805|NCT00903201|65126755|FG000|Overall Study|Adverse Event|1|||
23377806|NCT00903201|65126756|FG001|Overall Study|Adverse Event|4|||
23377807|NCT00903201|65126757|FG002|Overall Study|Adverse Event|0|||
23377808|NCT00903201|65126755|FG000|Overall Study|Protocol Violation|2|||
23377809|NCT00903201|65126756|FG001|Overall Study|Protocol Violation|1|||
23377810|NCT00903201|65126757|FG002|Overall Study|Protocol Violation|0|||
23377811|NCT00903201|65126755|FG000|Overall Study|Lost to Follow-up|0|||
23377812|NCT00903201|65126756|FG001|Overall Study|Lost to Follow-up|1|||
23377813|NCT00903201|65126757|FG002|Overall Study|Lost to Follow-up|0|||
23377814|NCT00903201|65126755|FG000|Overall Study|Physician Decision|1|||
23377815|NCT00903201|65126756|FG001|Overall Study|Physician Decision|0|||
23377816|NCT00903201|65126757|FG002|Overall Study|Physician Decision|1|||
23377817|NCT00903201|65126755|FG000|Overall Study|Withdrawal by Subject|1|||
23377818|NCT00903201|65126756|FG001|Overall Study|Withdrawal by Subject|0|||
23377819|NCT00903201|65126757|FG002|Overall Study|Withdrawal by Subject|1|||
23377820|NCT02811159|65126760|FG000|Treatment Course 1|Lost to Follow-up|1|||
23377821|NCT03188705|65126761|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
23377822|NCT03188705|65126761|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
23377823|NCT01706328|65126762|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
23377824|NCT01706328|65126763|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23377825|NCT01706328|65126764|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
23377826|NCT01706328|65126762|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
23377827|NCT01706328|65126763|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
23377828|NCT01706328|65126764|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
23377829|NCT01706328|65126762|FG000|2-week Run-in Period|Physician Decision|4|||
23377830|NCT01706328|65126763|FG001|2-week Run-in Period|Physician Decision|0|||
23377831|NCT01706328|65126764|FG002|2-week Run-in Period|Physician Decision|0|||
23377832|NCT01706328|65126762|FG000|2-week Run-in Period|Adverse Event|4|||
23377833|NCT01706328|65126763|FG001|2-week Run-in Period|Adverse Event|0|||
23377834|NCT01706328|65126764|FG002|2-week Run-in Period|Adverse Event|0|||
23377835|NCT01706328|65126762|FG000|2-week Run-in Period|Lost to Follow-up|2|||
23377836|NCT01706328|65126763|FG001|2-week Run-in Period|Lost to Follow-up|0|||
23377837|NCT01706328|65126764|FG002|2-week Run-in Period|Lost to Follow-up|0|||
23377838|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
23377839|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
23377840|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
23377841|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
23377842|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
23377843|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
23377844|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
23377845|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
23489966|NCT02758171|65541254|FG000|Wash-out|Withdrawal by Subject|1|||
23377846|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
23377847|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
23489967|NCT02758171|65541255|FG001|Wash-out|Withdrawal by Subject|0|||
23377848|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
23377849|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
23377850|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
23377851|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
23377852|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
23377853|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
23377854|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
23377855|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
23377856|NCT01706328|65126762|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
23377857|NCT01706328|65126763|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
23377858|NCT01706328|65126764|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
23377859|NCT02246777|65126765|FG000|Overall Study|Adverse Event|2|||
23377860|NCT02246777|65126765|FG000|Overall Study|Change of residence|1|||
23377861|NCT00937950|65126766|FG000|Overall Study|Withdrawal by Subject|23|||
23377862|NCT00937950|65126766|FG000|Overall Study|Migrated/moved from study area|27|||
23377863|NCT00937950|65126766|FG000|Overall Study|Lost to Follow-up|144|||
23377864|NCT00937950|65126766|FG000|Overall Study|Missing confirmed|4|||
23377865|NCT00937950|65126766|FG000|Overall Study|Other|18|||
23285169|NCT02679729|64787672|FG002|Overall Study|Participant decision|0|||
23285170|NCT02679729|64787673|FG003|Overall Study|Participant decision|0|||
23285171|NCT02679729|64787674|FG004|Overall Study|Participant decision|0|||
23285172|NCT02679729|64787675|FG005|Overall Study|Participant decision|0|||
23285173|NCT02679729|64787676|FG006|Overall Study|Participant decision|1|||
23285174|NCT02679729|64787677|FG007|Overall Study|Participant decision|0|||
23285175|NCT02679729|64787678|FG008|Overall Study|Participant decision|0|||
23285176|NCT03255733|64787683|FG000|Overall Study|Lost to Follow-up|4|||
23285177|NCT00252564|64787684|FG000|Overall Study|Adverse Event|17|||
23285178|NCT00252564|64787685|FG001|Overall Study|Adverse Event|13|||
23285179|NCT00252564|64787684|FG000|Overall Study|Unrelated Complication|2|||
23285180|NCT00252564|64787685|FG001|Overall Study|Unrelated Complication|1|||
23285181|NCT00252564|64787684|FG000|Overall Study|Disease Progression|14|||
23285182|NCT00252564|64787685|FG001|Overall Study|Disease Progression|20|||
23285183|NCT00252564|64787684|FG000|Overall Study|Death|0|||
23285184|NCT00252564|64787685|FG001|Overall Study|Death|3|||
23285185|NCT00252564|64787684|FG000|Overall Study|Physician Decision|1|||
23285186|NCT00252564|64787685|FG001|Overall Study|Physician Decision|0|||
23285187|NCT00252564|64787684|FG000|Overall Study|Lost to Follow-up|1|||
23285188|NCT00252564|64787685|FG001|Overall Study|Lost to Follow-up|0|||
23285189|NCT00252564|64787684|FG000|Overall Study|Patient Request|4|||
23285190|NCT00252564|64787685|FG001|Overall Study|Patient Request|5|||
23285191|NCT00252564|64787684|FG000|Overall Study|Withdrawal by Subject|0|||
23285192|NCT00252564|64787685|FG001|Overall Study|Withdrawal by Subject|2|||
23285193|NCT01942135|64787687|FG000|Overall Study|Adverse Event|21|||
23285194|NCT01942135|64787688|FG001|Overall Study|Adverse Event|7|||
23285195|NCT01942135|64787687|FG000|Overall Study|Global Deterioration of Health Status|9|||
23285196|NCT01942135|64787688|FG001|Overall Study|Global Deterioration of Health Status|6|||
23285197|NCT01942135|64787687|FG000|Overall Study|Randomized Not Treated|2|||
23285198|NCT01942135|64787688|FG001|Overall Study|Randomized Not Treated|2|||
23285199|NCT01942135|64787687|FG000|Overall Study|Death|2|||
23285200|NCT01942135|64787688|FG001|Overall Study|Death|1|||
23285201|NCT01942135|64787687|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
23285202|NCT01942135|64787688|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
23285203|NCT01942135|64787687|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
23285204|NCT01942135|64787688|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
23285205|NCT01942135|64787687|FG000|Overall Study|Withdrawal by Subject|4|||
23285206|NCT01942135|64787688|FG001|Overall Study|Withdrawal by Subject|3|||
23285207|NCT01942135|64787687|FG000|Overall Study|Protocol Violation|1|||
23285208|NCT01942135|64787688|FG001|Overall Study|Protocol Violation|0|||
23285209|NCT01942135|64787687|FG000|Overall Study|Other|19|||
23285210|NCT01942135|64787688|FG001|Overall Study|Other|4|||
23285211|NCT00633022|64787689|FG000|Overall Study|Adverse Event|1|||
23285212|NCT00633022|64787690|FG001|Overall Study|Adverse Event|0|||
23285213|NCT00633022|64787691|FG002|Overall Study|Adverse Event|5|||
23285214|NCT00633022|64787689|FG000|Overall Study|Physician Decision|0|||
23285215|NCT00633022|64787690|FG001|Overall Study|Physician Decision|1|||
23285216|NCT00633022|64787691|FG002|Overall Study|Physician Decision|0|||
23285217|NCT00385736|64787692|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
23285218|NCT00385736|64787693|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
23285219|NCT00385736|64787694|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
23285220|NCT00385736|64787692|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
23285221|NCT00385736|64787693|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
23285222|NCT00385736|64787694|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
23285223|NCT00385736|64787692|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
23285224|NCT00385736|64787693|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
23285225|NCT00385736|64787694|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
23285226|NCT00385736|64787692|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
23285227|NCT00385736|64787693|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
23377866|NCT02934178|65126767|FG000|Received Vaccination 2|Death|0|||
23377867|NCT02934178|65126768|FG001|Received Vaccination 2|Death|1|||
23377868|NCT02934178|65126767|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
23377869|NCT02934178|65126768|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
23377870|NCT01925794|65130321|FG000|180 Days|Death|2|||
23377871|NCT01925794|65130321|FG000|180 Days|Withdrawal by Subject|2|||
23377872|NCT01925794|65130321|FG000|270 Days|Death|2|||
23377873|NCT01925794|65130321|FG000|270 Days|Protocol Violation|3|||
23377874|NCT01462942|65130324|FG000|Overall Study|Adverse Event|7|||
23377875|NCT01462942|65130325|FG001|Overall Study|Adverse Event|12|||
23377876|NCT01462942|65130326|FG002|Overall Study|Adverse Event|10|||
23377877|NCT01462942|65130327|FG003|Overall Study|Adverse Event|11|||
23377878|NCT01462942|65130328|FG004|Overall Study|Adverse Event|11|||
23377879|NCT01462942|65130324|FG000|Overall Study|Other, including COPD exacerbation|3|||
23377880|NCT01462942|65130325|FG001|Overall Study|Other, including COPD exacerbation|5|||
23377881|NCT01462942|65130326|FG002|Overall Study|Other, including COPD exacerbation|2|||
23377882|NCT01462942|65130327|FG003|Overall Study|Other, including COPD exacerbation|8|||
23377883|NCT01462942|65130328|FG004|Overall Study|Other, including COPD exacerbation|5|||
23377884|NCT01462942|65130324|FG000|Overall Study|Withdrawal by Subject|14|||
23377885|NCT01462942|65130325|FG001|Overall Study|Withdrawal by Subject|10|||
23377886|NCT01462942|65130326|FG002|Overall Study|Withdrawal by Subject|14|||
23377887|NCT01462942|65130327|FG003|Overall Study|Withdrawal by Subject|16|||
23377888|NCT01462942|65130328|FG004|Overall Study|Withdrawal by Subject|19|||
23377889|NCT01462942|65130324|FG000|Overall Study|Lack of Efficacy|6|||
23377890|NCT01462942|65130325|FG001|Overall Study|Lack of Efficacy|0|||
23377891|NCT01462942|65130326|FG002|Overall Study|Lack of Efficacy|4|||
23377892|NCT01462942|65130327|FG003|Overall Study|Lack of Efficacy|5|||
23377893|NCT01462942|65130328|FG004|Overall Study|Lack of Efficacy|3|||
23377894|NCT01462942|65130324|FG000|Overall Study|Lost to Follow-up|0|||
23377895|NCT01462942|65130325|FG001|Overall Study|Lost to Follow-up|1|||
23377896|NCT01462942|65130326|FG002|Overall Study|Lost to Follow-up|1|||
23377897|NCT01462942|65130327|FG003|Overall Study|Lost to Follow-up|1|||
23604925|NCT02410278|65943558|FG002|Run-in Period|Withdrawal by Subject|0|||
23604926|NCT02410278|65943556|FG000|Run-in Period|Pregnancy|1|||
23604927|NCT02410278|65943557|FG001|Run-in Period|Pregnancy|0|||
23604928|NCT02410278|65943558|FG002|Run-in Period|Pregnancy|0|||
23604929|NCT02410278|65943556|FG000|Study Treatment Period|Adverse Event|0|||
23604930|NCT02410278|65943557|FG001|Study Treatment Period|Adverse Event|6|||
23604931|NCT02410278|65943558|FG002|Study Treatment Period|Adverse Event|3|||
23604932|NCT02410278|65943556|FG000|Study Treatment Period|Physician Decision|0|||
23604933|NCT02410278|65943557|FG001|Study Treatment Period|Physician Decision|0|||
23604934|NCT02410278|65943558|FG002|Study Treatment Period|Physician Decision|1|||
23604935|NCT02410278|65943556|FG000|Study Treatment Period|Withdrawal by Subject|0|||
23604936|NCT02410278|65943557|FG001|Study Treatment Period|Withdrawal by Subject|1|||
23604937|NCT02410278|65943558|FG002|Study Treatment Period|Withdrawal by Subject|0|||
23604938|NCT02410278|65943556|FG000|Study Treatment Period|Other|0|||
23604939|NCT02410278|65943557|FG001|Study Treatment Period|Other|3|||
23604940|NCT02410278|65943558|FG002|Study Treatment Period|Other|0|||
23604941|NCT02410278|65943556|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
23604942|NCT02410278|65943557|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
23604943|NCT02410278|65943558|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
23604944|NCT03140670|65943559|FG000|Overall Study|Withdrawal by Subject|2|||
23604945|NCT03140670|65943559|FG000|Overall Study|Lost to Follow-up|1|||
23604946|NCT03140670|65943559|FG000|Overall Study|Physician Decision|1|||
23604947|NCT04705051|65943560|FG000|Overall Study|Enrolled but not treated|1|||
23285228|NCT00385736|64787694|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
23285229|NCT00385736|64787692|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
23285230|NCT00385736|64787693|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
23285231|NCT00385736|64787694|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
23285232|NCT00385736|64787692|FG000|Efficacy Analysis Set - Induction|Other|0|||
23285233|NCT00385736|64787693|FG001|Efficacy Analysis Set - Induction|Other|0|||
23285234|NCT00385736|64787694|FG002|Efficacy Analysis Set - Induction|Other|1|||
23285235|NCT00385736|64787692|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
23285236|NCT00385736|64787693|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
23285237|NCT00385736|64787694|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
23285238|NCT00385736|64787692|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
23285239|NCT00385736|64787693|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
23285240|NCT00385736|64787694|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
23285241|NCT00385736|64787692|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
23377898|NCT01462942|65130328|FG004|Overall Study|Lost to Follow-up|1|||
23377899|NCT01462942|65130324|FG000|Overall Study|Protocol Violation|4|||
23377900|NCT01462942|65130325|FG001|Overall Study|Protocol Violation|6|||
23377901|NCT01462942|65130326|FG002|Overall Study|Protocol Violation|9|||
23377902|NCT01462942|65130327|FG003|Overall Study|Protocol Violation|9|||
23377903|NCT01462942|65130328|FG004|Overall Study|Protocol Violation|6|||
23377904|NCT01682031|65130329|FG000|Overall Study|Withdrawal by Subject|0|||
23377905|NCT01682031|65130330|FG001|Overall Study|Withdrawal by Subject|1|||
23604948|NCT04705051|65943560|FG000|Overall Study|Study terminated by sponsor|23|||
23604949|NCT03865732|65943561|FG000|Overall Study|Adverse Event|0|||
23604950|NCT03865732|65943562|FG001|Overall Study|Adverse Event|1|||
23604951|NCT02372799|65943563|FG000|Treatment Period|Adverse Event|3|||
23604952|NCT02372799|65943564|FG001|Treatment Period|Adverse Event|10|||
23604953|NCT02372799|65943565|FG002|Treatment Period|Adverse Event|6|||
23604954|NCT02372799|65943563|FG000|Treatment Period|Insufficient therapeutic response|2|||
23604955|NCT02372799|65943564|FG001|Treatment Period|Insufficient therapeutic response|2|||
23604956|NCT02372799|65943565|FG002|Treatment Period|Insufficient therapeutic response|0|||
23285242|NCT00385736|64787693|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
23285243|NCT00385736|64787694|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
23285244|NCT00385736|64787692|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
23285245|NCT00385736|64787693|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
23285246|NCT00385736|64787694|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
23285247|NCT00385736|64787692|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
23285248|NCT00385736|64787693|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
23285249|NCT00385736|64787694|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
23285250|NCT00385736|64787692|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
23285251|NCT00385736|64787693|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
23285252|NCT00385736|64787694|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
23285253|NCT00385736|64787692|FG000|Safety Analysis Set|Adverse Event|23|||
23285254|NCT00385736|64787693|FG001|Safety Analysis Set|Adverse Event|15|||
23285255|NCT00385736|64787694|FG002|Safety Analysis Set|Adverse Event|23|||
23285256|NCT00385736|64787692|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
23285257|NCT00385736|64787693|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
23285258|NCT00385736|64787694|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
23285259|NCT00385736|64787692|FG000|Safety Analysis Set|Lost to Follow-up|0|||
23285260|NCT00385736|64787693|FG001|Safety Analysis Set|Lost to Follow-up|2|||
23285261|NCT00385736|64787694|FG002|Safety Analysis Set|Lost to Follow-up|2|||
23285262|NCT00385736|64787692|FG000|Safety Analysis Set|Lack of Efficacy|38|||
23285263|NCT00385736|64787693|FG001|Safety Analysis Set|Lack of Efficacy|16|||
23285264|NCT00385736|64787694|FG002|Safety Analysis Set|Lack of Efficacy|31|||
23285265|NCT00385736|64787692|FG000|Safety Analysis Set|Protocol Violation|2|||
23285266|NCT00385736|64787693|FG001|Safety Analysis Set|Protocol Violation|1|||
23285267|NCT00385736|64787694|FG002|Safety Analysis Set|Protocol Violation|6|||
23285268|NCT00385736|64787692|FG000|Safety Analysis Set|Other|1|||
23285269|NCT00385736|64787693|FG001|Safety Analysis Set|Other|4|||
23285270|NCT00385736|64787694|FG002|Safety Analysis Set|Other|4|||
23285271|NCT02957331|64787695|FG000|Overall Study|Protocol Violation|1|||
23285272|NCT02957331|64787696|FG001|Overall Study|Protocol Violation|0|||
23285273|NCT02426918|64787699|FG000|Overall Study|Adverse Event|2|||
23285274|NCT02426918|64787700|FG001|Overall Study|Adverse Event|2|||
23285275|NCT02426918|64787701|FG002|Overall Study|Adverse Event|0|||
23285276|NCT02426918|64787699|FG000|Overall Study|Physician Decision|1|||
23285277|NCT02426918|64787700|FG001|Overall Study|Physician Decision|1|||
23285278|NCT02426918|64787701|FG002|Overall Study|Physician Decision|1|||
23285279|NCT02426918|64787699|FG000|Overall Study|Withdrawal by Subject|5|||
23285280|NCT02426918|64787700|FG001|Overall Study|Withdrawal by Subject|5|||
23285281|NCT02426918|64787701|FG002|Overall Study|Withdrawal by Subject|4|||
23285282|NCT02426918|64787699|FG000|Overall Study|Other|9|||
23285283|NCT02426918|64787700|FG001|Overall Study|Other|11|||
23604957|NCT02372799|65943563|FG000|Treatment Period|Withdrawal by Subject|10|||
23285284|NCT02426918|64787701|FG002|Overall Study|Other|9|||
23285285|NCT01726803|64787708|FG000|Overall Study|Lost to Follow-up|6|||
23285286|NCT01726803|64787709|FG001|Overall Study|Lost to Follow-up|1|||
23285287|NCT01726803|64787708|FG000|Overall Study|Withdrawal by Subject|1|||
23285288|NCT01726803|64787709|FG001|Overall Study|Withdrawal by Subject|0|||
23285289|NCT04535986|64787710|FG000|Overall Study|Death|4|||
23285290|NCT04535986|64787711|FG001|Overall Study|Death|5|||
23285291|NCT04535986|64787710|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
23377906|NCT01682031|65130329|FG000|Overall Study|Adverse Event|0|||
23285292|NCT04535986|64787711|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
23285293|NCT04535986|64787710|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
23285294|NCT04535986|64787711|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
23285295|NCT04535986|64787710|FG000|Overall Study|Adverse Event|10|||
23285296|NCT04535986|64787711|FG001|Overall Study|Adverse Event|1|||
23285297|NCT04535986|64787710|FG000|Overall Study|Lack of Efficacy|3|||
23285298|NCT04535986|64787711|FG001|Overall Study|Lack of Efficacy|2|||
23285299|NCT04535986|64787710|FG000|Overall Study|Investigator discretion|3|||
23285300|NCT04535986|64787711|FG001|Overall Study|Investigator discretion|0|||
23285301|NCT04535986|64787710|FG000|Overall Study|Withdrawal by Subject|32|||
23285302|NCT04535986|64787711|FG001|Overall Study|Withdrawal by Subject|14|||
23285303|NCT04535986|64787710|FG000|Overall Study|Lost to Follow-up|5|||
23285304|NCT04535986|64787711|FG001|Overall Study|Lost to Follow-up|3|||
23285305|NCT04535986|64787710|FG000|Overall Study|Other|7|||
23285306|NCT04535986|64787711|FG001|Overall Study|Other|3|||
23285307|NCT00516295|64787712|FG000|Overall Study|Lack of Efficacy|2|||
23285308|NCT00516295|64787713|FG001|Overall Study|Lack of Efficacy|0|||
23285309|NCT00516295|64787714|FG002|Overall Study|Lack of Efficacy|0|||
23285310|NCT00516295|64787712|FG000|Overall Study|Ineligible|1|||
23285311|NCT00516295|64787713|FG001|Overall Study|Ineligible|0|||
23285312|NCT00516295|64787714|FG002|Overall Study|Ineligible|0|||
23285313|NCT00847535|64787721|FG000|Overall Study|Withdrawal by Subject|2|||
23285314|NCT00847535|64787722|FG001|Overall Study|Withdrawal by Subject|1|||
23285315|NCT00847535|64787723|FG002|Overall Study|Withdrawal by Subject|1|||
23285316|NCT00847535|64787721|FG000|Overall Study|Lost to Follow-up|0|||
23285317|NCT00847535|64787722|FG001|Overall Study|Lost to Follow-up|1|||
23285318|NCT00847535|64787723|FG002|Overall Study|Lost to Follow-up|0|||
23285319|NCT00874276|64787727|FG000|Overall Study|Withdrawal by Subject|1|||
23285320|NCT00874276|64787728|FG001|Overall Study|Withdrawal by Subject|1|||
23285321|NCT00556673|64787729|FG000|Overall Study|Protocol deviation|3|||
23285322|NCT00556673|64787730|FG001|Overall Study|Protocol deviation|2|||
23285323|NCT01547728|64787732|FG000|Overall Study|Change in procedure and equipment|1|||
23285324|NCT01547728|64787732|FG000|Overall Study|Drug not ready for subject|1|||
23285325|NCT01547728|64787732|FG000|Overall Study|Screen failure|39|||
23285326|NCT01297504|64787733|FG000|Overall Study|Invalid Consent|1|||
23285327|NCT01297504|64787733|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
23285328|NCT01297504|64787733|FG000|Overall Study|No Study Visits|4|||
23285329|NCT01297504|64787733|FG000|Overall Study|Death|3|||
23285330|NCT01297504|64787733|FG000|Overall Study|Lost to Follow-up|43|||
23285331|NCT01297504|64787733|FG000|Overall Study|Withdrawal by Subject|9|||
23285332|NCT01297504|64787733|FG000|Overall Study|Site Closure|3|||
23285333|NCT01297504|64787733|FG000|Overall Study|Protocol Violation|3|||
23285334|NCT00087529|64787736|FG000|Overall Study|Death|1|||
23285335|NCT00087529|64787737|FG001|Overall Study|Death|0|||
23285336|NCT00087529|64787736|FG000|Overall Study|Adverse Event|0|||
23285337|NCT00087529|64787737|FG001|Overall Study|Adverse Event|8|||
23285338|NCT00087529|64787736|FG000|Overall Study|Pregnancy|0|||
23285339|NCT00087529|64787737|FG001|Overall Study|Pregnancy|1|||
23285340|NCT00087529|64787736|FG000|Overall Study|Lost to Follow-up|2|||
23285341|NCT00087529|64787737|FG001|Overall Study|Lost to Follow-up|3|||
23285342|NCT00087529|64787736|FG000|Overall Study|Participant Decision|14|||
23285343|NCT00087529|64787737|FG001|Overall Study|Participant Decision|37|||
23285344|NCT00087529|64787736|FG000|Overall Study|Physician Decision|4|||
23285345|NCT00087529|64787737|FG001|Overall Study|Physician Decision|8|||
23285346|NCT00087529|64787736|FG000|Overall Study|Initiation of Excluded Therapy|0|||
23285347|NCT00087529|64787737|FG001|Overall Study|Initiation of Excluded Therapy|1|||
23285348|NCT00087529|64787736|FG000|Overall Study|Participant Noncompliance|0|||
23285349|NCT00087529|64787737|FG001|Overall Study|Participant Noncompliance|1|||
23285350|NCT00087529|64787736|FG000|Overall Study|Disease Progression|5|||
23285351|NCT00087529|64787737|FG001|Overall Study|Disease Progression|4|||
23285352|NCT00087529|64787736|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
23285353|NCT00087529|64787737|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
23285354|NCT02858037|64787738|FG000|Overall Study|Death|1|||
23285355|NCT02858037|64787738|FG000|Overall Study|Withdrawal by Subject|18|||
23285356|NCT02858037|64787738|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
23285357|NCT02858037|64787738|FG000|Overall Study|Lost to Follow-up|3|||
23285358|NCT02858037|64787738|FG000|Overall Study|Other|4|||
23285359|NCT04435782|64787739|FG000|Overall Study|Study terminated by sponsor|4|||
23285360|NCT01320722|64787740|FG000|Overall Study|Did not Receive Intervention|3|||
23285361|NCT01320722|64787741|FG001|Overall Study|Did not Receive Intervention|2|||
23285362|NCT01320722|64787742|FG002|Overall Study|Did not Receive Intervention|1|||
23285363|NCT01320722|64787743|FG003|Overall Study|Did not Receive Intervention|1|||
23285364|NCT01320722|64787744|FG004|Overall Study|Did not Receive Intervention|2|||
23285365|NCT01320722|64787740|FG000|Overall Study|Lost to Follow-up|0|||
23285366|NCT01320722|64787741|FG001|Overall Study|Lost to Follow-up|1|||
23285367|NCT01320722|64787742|FG002|Overall Study|Lost to Follow-up|0|||
23285368|NCT01320722|64787743|FG003|Overall Study|Lost to Follow-up|1|||
23285369|NCT01320722|64787744|FG004|Overall Study|Lost to Follow-up|3|||
23285370|NCT01320722|64787740|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
23285371|NCT01320722|64787741|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
23285372|NCT01320722|64787742|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
23285373|NCT01320722|64787743|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
23285374|NCT01320722|64787744|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
23285375|NCT01320722|64787740|FG000|Overall Study|Participant Developed a Rash|0|||
23285376|NCT01320722|64787741|FG001|Overall Study|Participant Developed a Rash|0|||
23285377|NCT01320722|64787742|FG002|Overall Study|Participant Developed a Rash|2|||
23285378|NCT01320722|64787743|FG003|Overall Study|Participant Developed a Rash|1|||
23285379|NCT01320722|64787744|FG004|Overall Study|Participant Developed a Rash|1|||
23285380|NCT01320722|64787740|FG000|Overall Study|Non-compliant with Medication|0|||
23285381|NCT01320722|64787741|FG001|Overall Study|Non-compliant with Medication|0|||
23285382|NCT01320722|64787742|FG002|Overall Study|Non-compliant with Medication|1|||
23285383|NCT01320722|64787743|FG003|Overall Study|Non-compliant with Medication|0|||
23285384|NCT01320722|64787744|FG004|Overall Study|Non-compliant with Medication|0|||
23285385|NCT01320722|64787740|FG000|Overall Study|Adverse Event|0|||
23285386|NCT01320722|64787741|FG001|Overall Study|Adverse Event|0|||
23285387|NCT01320722|64787742|FG002|Overall Study|Adverse Event|3|||
23285388|NCT01320722|64787743|FG003|Overall Study|Adverse Event|6|||
23285389|NCT01320722|64787744|FG004|Overall Study|Adverse Event|0|||
23285390|NCT01320722|64787740|FG000|Overall Study|Not Compliant with Study Procedures|0|||
23489968|NCT02758171|65541254|FG000|Wash-out|Other reason|1|||
23489969|NCT02758171|65541255|FG001|Wash-out|Other reason|0|||
23489970|NCT03439657|65541256|FG000|Overall Study|Adverse Event|2|||
23489971|NCT03439657|65541257|FG001|Overall Study|Adverse Event|3|||
23285391|NCT01320722|64787741|FG001|Overall Study|Not Compliant with Study Procedures|0|||
23285392|NCT01320722|64787742|FG002|Overall Study|Not Compliant with Study Procedures|0|||
23285393|NCT01320722|64787743|FG003|Overall Study|Not Compliant with Study Procedures|4|||
23285394|NCT01320722|64787744|FG004|Overall Study|Not Compliant with Study Procedures|0|||
23285395|NCT01320722|64787740|FG000|Overall Study|Pregnancy|0|||
23285396|NCT01320722|64787741|FG001|Overall Study|Pregnancy|0|||
23285397|NCT01320722|64787742|FG002|Overall Study|Pregnancy|0|||
23285398|NCT01320722|64787743|FG003|Overall Study|Pregnancy|1|||
23377907|NCT01682031|65130330|FG001|Overall Study|Adverse Event|2|||
23377908|NCT01682031|65130329|FG000|Overall Study|MRI results indicate increased nodul|0|||
23377909|NCT01682031|65130330|FG001|Overall Study|MRI results indicate increased nodul|1|||
23377910|NCT01682031|65130329|FG000|Overall Study|Patient could not swallow tablets|1|||
23377911|NCT01682031|65130330|FG001|Overall Study|Patient could not swallow tablets|0|||
23377912|NCT01682031|65130329|FG000|Overall Study|Patient stopped selenium on his own|0|||
23377913|NCT01682031|65130330|FG001|Overall Study|Patient stopped selenium on his own|1|||
23377914|NCT03439839|65130332|FG000|Overall Study|Death|3|||
23377915|NCT03439839|65130333|FG001|Overall Study|Death|0|||
23377916|NCT00286455|65130334|FG000|Overall Study|Hyperglycemia rescue|19|||
23377917|NCT00286455|65130335|FG001|Overall Study|Hyperglycemia rescue|13|||
23377918|NCT00286455|65130336|FG002|Overall Study|Hyperglycemia rescue|10|||
23377919|NCT00286455|65130334|FG000|Overall Study|Adverse Event|1|||
23377920|NCT00286455|65130335|FG001|Overall Study|Adverse Event|3|||
23377921|NCT00286455|65130336|FG002|Overall Study|Adverse Event|2|||
23377922|NCT00286455|65130334|FG000|Overall Study|Lost to Follow-up|0|||
23377923|NCT00286455|65130335|FG001|Overall Study|Lost to Follow-up|3|||
23377924|NCT00286455|65130336|FG002|Overall Study|Lost to Follow-up|3|||
23377925|NCT00286455|65130334|FG000|Overall Study|Physician Decision|3|||
23377926|NCT00286455|65130335|FG001|Overall Study|Physician Decision|0|||
23377927|NCT00286455|65130336|FG002|Overall Study|Physician Decision|2|||
23377928|NCT00286455|65130334|FG000|Overall Study|Protocol Violation|1|||
23377929|NCT00286455|65130335|FG001|Overall Study|Protocol Violation|1|||
23377930|NCT00286455|65130336|FG002|Overall Study|Protocol Violation|0|||
23377931|NCT00286455|65130334|FG000|Overall Study|Participant Non-compliance|1|||
23377932|NCT00286455|65130335|FG001|Overall Study|Participant Non-compliance|0|||
23377933|NCT00286455|65130336|FG002|Overall Study|Participant Non-compliance|0|||
23377934|NCT00286455|65130334|FG000|Overall Study|Withdrawal by Subject|0|||
23377935|NCT00286455|65130335|FG001|Overall Study|Withdrawal by Subject|8|||
23377936|NCT00286455|65130336|FG002|Overall Study|Withdrawal by Subject|7|||
23489972|NCT03439657|65541256|FG000|Overall Study|Lost to Follow-up|1|||
23489973|NCT03439657|65541257|FG001|Overall Study|Lost to Follow-up|0|||
23285399|NCT01320722|64787744|FG004|Overall Study|Pregnancy|0|||
23285400|NCT01320722|64787740|FG000|Overall Study|Started an Exclusionary Medication|0|||
23285401|NCT01320722|64787741|FG001|Overall Study|Started an Exclusionary Medication|0|||
23285402|NCT01320722|64787742|FG002|Overall Study|Started an Exclusionary Medication|0|||
23377937|NCT01980888|65130342|FG000|Overall Study|Study Terminated by Sponsor|116|||
23377938|NCT01980888|65130343|FG001|Overall Study|Study Terminated by Sponsor|122|||
23377939|NCT01980888|65130342|FG000|Overall Study|Withdrew Consent|17|||
23377940|NCT01980888|65130343|FG001|Overall Study|Withdrew Consent|6|||
23377941|NCT01980888|65130342|FG000|Overall Study|Investigator's Discretion|8|||
23377942|NCT01980888|65130343|FG001|Overall Study|Investigator's Discretion|3|||
23489974|NCT03439657|65541256|FG000|Overall Study|Protocol Violation|1|||
23489975|NCT03439657|65541257|FG001|Overall Study|Protocol Violation|1|||
23489976|NCT03439657|65541256|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
23489977|NCT03439657|65541257|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
23489978|NCT00569270|65541260|FG000|Period: First Intervention|Protocol Violation|0|||
23489979|NCT00569270|65541261|FG001|Period: First Intervention|Protocol Violation|1|||
23489980|NCT01856907|65541262|FG000|Overall Study|Pregnancy|0|||
23489981|NCT01856907|65541263|FG001|Overall Study|Pregnancy|1|||
23489982|NCT01856907|65541264|FG002|Overall Study|Pregnancy|0|||
23489983|NCT01856907|65541262|FG000|Overall Study|Pregnancy|0|||
23489984|NCT01856907|65541263|FG001|Overall Study|Pregnancy|1|||
23489985|NCT01856907|65541264|FG002|Overall Study|Pregnancy|0|||
23489986|NCT01856907|65541262|FG000|Overall Study|Withdrawal by Subject|0|||
23489987|NCT01856907|65541263|FG001|Overall Study|Withdrawal by Subject|1|||
23489988|NCT01856907|65541264|FG002|Overall Study|Withdrawal by Subject|0|||
23489989|NCT01810432|65541265|FG000|Washout|Protocol Violation|0|||
23489990|NCT01810432|65541266|FG001|Washout|Protocol Violation|1|||
23489991|NCT01810432|65541265|FG000|Washout|Adverse Event|1|||
23489992|NCT01810432|65541266|FG001|Washout|Adverse Event|0|||
23489993|NCT01810432|65541265|FG000|Period 2|Withdrawal by Subject|2|||
23489994|NCT01810432|65541266|FG001|Period 2|Withdrawal by Subject|1|||
23489995|NCT01810432|65541265|FG000|Period 2|Physician Decision|1|||
23489996|NCT01810432|65541266|FG001|Period 2|Physician Decision|0|||
23489997|NCT01810432|65541265|FG000|Period 2|Lost to Follow-up|1|||
23489998|NCT01810432|65541266|FG001|Period 2|Lost to Follow-up|1|||
23489999|NCT00747461|65541267|FG000|Overall Study|study terminated by sponsor|5|||
23490000|NCT03589469|65541270|FG000|Overall Study|Withdrawal by Subject|8|||
23490001|NCT03589469|65541270|FG000|Overall Study|Physician Decision|20|||
23490002|NCT03589469|65541270|FG000|Overall Study|Death|97|||
23490003|NCT03589469|65541270|FG000|Overall Study|Lost to Follow-up|8|||
23490004|NCT03589469|65541270|FG000|Overall Study|Miscellaneous|1|||
23490005|NCT02231918|65541271|FG000|Overall Study|Withdrawal by Subject|0|||
23490006|NCT02231918|65541272|FG001|Overall Study|Withdrawal by Subject|1|||
23490007|NCT02231918|65541273|FG002|Overall Study|Withdrawal by Subject|0|||
23490008|NCT02231918|65541271|FG000|Overall Study|Adverse Event|0|||
23490009|NCT02231918|65541272|FG001|Overall Study|Adverse Event|0|||
23490010|NCT02231918|65541273|FG002|Overall Study|Adverse Event|1|||
23490011|NCT03452228|65541274|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
23490012|NCT03452228|65541275|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
23490013|NCT03452228|65541276|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
23490014|NCT03452228|65541274|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
23490015|NCT03452228|65541275|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
23490016|NCT03452228|65541276|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
23490017|NCT03452228|65541274|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
23490018|NCT03452228|65541275|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
23490019|NCT03452228|65541276|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
23490020|NCT03452228|65541274|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23285403|NCT01320722|64787743|FG003|Overall Study|Started an Exclusionary Medication|0|||
23285404|NCT01320722|64787744|FG004|Overall Study|Started an Exclusionary Medication|1|||
23285405|NCT01320722|64787740|FG000|Overall Study|Withdrew due to Health Condition|0|||
23285406|NCT01320722|64787741|FG001|Overall Study|Withdrew due to Health Condition|0|||
23285407|NCT01320722|64787742|FG002|Overall Study|Withdrew due to Health Condition|0|||
23490021|NCT03452228|65541275|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23490022|NCT03452228|65541276|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
23285408|NCT01320722|64787743|FG003|Overall Study|Withdrew due to Health Condition|0|||
23285409|NCT01320722|64787744|FG004|Overall Study|Withdrew due to Health Condition|1|||
23285410|NCT01604941|64787751|FG000|Overall Study|Adverse Event|1|||
23285411|NCT01604941|64787752|FG001|Overall Study|Adverse Event|2|||
23285412|NCT01604941|64787753|FG002|Overall Study|Adverse Event|0|||
23285413|NCT01604941|64787754|FG003|Overall Study|Adverse Event|0|||
23285414|NCT01604941|64787755|FG004|Overall Study|Adverse Event|1|||
23285415|NCT01604941|64787756|FG005|Overall Study|Adverse Event|5|||
23490023|NCT00333801|65541277|FG000|Overall Study|Moved to another state|5|||
23490024|NCT00333801|65541278|FG001|Overall Study|Moved to another state|3|||
23490025|NCT00333801|65541277|FG000|Overall Study|Lost to Follow-up|2|||
23285416|NCT01604941|64787751|FG000|Overall Study|Non-compliance|1|||
23490026|NCT00333801|65541278|FG001|Overall Study|Lost to Follow-up|0|||
23490027|NCT00333801|65541277|FG000|Overall Study|Incarcerated|1|||
23490028|NCT00333801|65541278|FG001|Overall Study|Incarcerated|2|||
23490029|NCT00333801|65541277|FG000|Overall Study|Withdrawal by Subject|0|||
23490030|NCT00333801|65541278|FG001|Overall Study|Withdrawal by Subject|1|||
23285417|NCT01604941|64787752|FG001|Overall Study|Non-compliance|0|||
23285418|NCT01604941|64787753|FG002|Overall Study|Non-compliance|0|||
23285419|NCT01604941|64787754|FG003|Overall Study|Non-compliance|0|||
23490031|NCT03917459|65541279|FG000|Overall Study|Adverse Event|1|||
23490032|NCT03917459|65541280|FG001|Overall Study|Adverse Event|0|||
23490033|NCT03917459|65541279|FG000|Overall Study|Withdrawal by Subject|0|||
23490034|NCT03917459|65541280|FG001|Overall Study|Withdrawal by Subject|1|||
23490035|NCT03906461|65541281|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
23490036|NCT03906461|65541281|FG000|Completed 12-month Follow-up|Missed Visit|6|||
23490037|NCT00702689|65541290|FG000|Overall Study|Withdrawal by Subject|4|||
23490038|NCT00702689|65541290|FG000|Overall Study|Recurrent malignancy|1|||
23490039|NCT00702689|65541290|FG000|Overall Study|Adverse Event|1|||
23490040|NCT01011738|65541291|FG000|Overall Study|Death|12|||
23490041|NCT01011738|65541292|FG001|Overall Study|Death|3|||
23490042|NCT01011738|65541293|FG002|Overall Study|Death|0|||
23490043|NCT01011738|65541291|FG000|Overall Study|Unknown reasons|312|||
23490044|NCT01011738|65541292|FG001|Overall Study|Unknown reasons|291|||
23490045|NCT01011738|65541293|FG002|Overall Study|Unknown reasons|17|||
23490046|NCT00410202|65541294|FG000|On-Treatment|Continuing treatment|69|||
23490047|NCT00410202|65541295|FG001|On-Treatment|Continuing treatment|71|||
23490048|NCT00410202|65541296|FG002|On-Treatment|Continuing treatment|66|||
23490049|NCT00410202|65541294|FG000|On-Treatment|Adverse Event|1|||
23490050|NCT00410202|65541295|FG001|On-Treatment|Adverse Event|3|||
23490051|NCT00410202|65541296|FG002|On-Treatment|Adverse Event|2|||
23490052|NCT00410202|65541294|FG000|On-Treatment|Death|1|||
23490053|NCT00410202|65541295|FG001|On-Treatment|Death|0|||
23490054|NCT00410202|65541296|FG002|On-Treatment|Death|0|||
23285420|NCT01604941|64787755|FG004|Overall Study|Non-compliance|0|||
23285421|NCT01604941|64787756|FG005|Overall Study|Non-compliance|0|||
23285422|NCT01604941|64787751|FG000|Overall Study|Participant Decision|0|||
23285423|NCT01604941|64787752|FG001|Overall Study|Participant Decision|0|||
23490055|NCT00410202|65541294|FG000|On-Treatment|Lost to Follow-up|1|||
23490056|NCT00410202|65541295|FG001|On-Treatment|Lost to Follow-up|0|||
23490057|NCT00410202|65541296|FG002|On-Treatment|Lost to Follow-up|1|||
23490058|NCT00410202|65541294|FG000|On-Treatment|Lack of Efficacy|1|||
23490059|NCT00410202|65541295|FG001|On-Treatment|Lack of Efficacy|4|||
23490060|NCT00410202|65541296|FG002|On-Treatment|Lack of Efficacy|0|||
23490061|NCT00410202|65541294|FG000|On-Treatment|Withdrawal by Subject|2|||
23490062|NCT00410202|65541295|FG001|On-Treatment|Withdrawal by Subject|1|||
23490063|NCT00410202|65541296|FG002|On-Treatment|Withdrawal by Subject|1|||
23490064|NCT00410202|65541294|FG000|On-Treatment|Other Reason|0|||
23490065|NCT00410202|65541295|FG001|On-Treatment|Other Reason|0|||
23490066|NCT00410202|65541296|FG002|On-Treatment|Other Reason|1|||
23490067|NCT00410202|65541294|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
23490068|NCT00410202|65541295|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
23490069|NCT00410202|65541296|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
23490070|NCT00410202|65541294|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
23490071|NCT00410202|65541295|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
23490072|NCT00410202|65541296|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
23490073|NCT00410202|65541294|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
23490074|NCT00410202|65541295|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
23490075|NCT00410202|65541296|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
23490076|NCT02777333|65541297|FG000|Overall Study|Withdrawal by Subject|0|||
23490077|NCT02777333|65541298|FG001|Overall Study|Withdrawal by Subject|1|||
23490078|NCT02777333|65541297|FG000|Overall Study|Lost to Follow-up|0|||
23490079|NCT02777333|65541298|FG001|Overall Study|Lost to Follow-up|1|||
23490080|NCT00828854|65541301|FG000|Overall Study|Disease Progression|17|||
23490081|NCT00828854|65541301|FG000|Overall Study|Adverse Event|9|||
23490082|NCT00828854|65541301|FG000|Overall Study|Reason not Specified|1|||
23490083|NCT02497612|65541302|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
23490084|NCT02497612|65541303|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
23490085|NCT02497612|65541304|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
23490086|NCT02497612|65541305|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
23285424|NCT01604941|64787753|FG002|Overall Study|Participant Decision|0|||
23285425|NCT01604941|64787754|FG003|Overall Study|Participant Decision|0|||
23285426|NCT01604941|64787755|FG004|Overall Study|Participant Decision|0|||
23285427|NCT01604941|64787756|FG005|Overall Study|Participant Decision|2|||
23285428|NCT01604941|64787751|FG000|Overall Study|Early Study Termination|9|||
23285429|NCT01604941|64787752|FG001|Overall Study|Early Study Termination|2|||
23490087|NCT02497612|65541302|FG000|Overall Study|Participant's request|2|||
23490088|NCT02497612|65541303|FG001|Overall Study|Participant's request|3|||
23490089|NCT02497612|65541304|FG002|Overall Study|Participant's request|4|||
23490090|NCT02497612|65541305|FG003|Overall Study|Participant's request|1|||
23490091|NCT02497612|65541302|FG000|Overall Study|Investigator's judgement|1|||
23604958|NCT02372799|65943564|FG001|Treatment Period|Withdrawal by Subject|10|||
23285430|NCT01604941|64787753|FG002|Overall Study|Early Study Termination|3|||
23285431|NCT01604941|64787754|FG003|Overall Study|Early Study Termination|3|||
23490092|NCT02497612|65541303|FG001|Overall Study|Investigator's judgement|0|||
23490093|NCT02497612|65541304|FG002|Overall Study|Investigator's judgement|0|||
23285432|NCT01604941|64787755|FG004|Overall Study|Early Study Termination|0|||
23285433|NCT01604941|64787756|FG005|Overall Study|Early Study Termination|0|||
23285434|NCT02340780|64787765|FG000|Overall Study|Ineligible|1|||
23285435|NCT03141151|64787766|FG000|Overall Study|Lost to Follow-up|3|||
23285436|NCT03141151|64787767|FG001|Overall Study|Lost to Follow-up|2|||
23285437|NCT03141151|64787766|FG000|Overall Study|Withdrawal by Subject|3|||
23285438|NCT03141151|64787767|FG001|Overall Study|Withdrawal by Subject|2|||
23285439|NCT01841060|64787772|FG000|Overall Study|Protocol Violation|10|||
23285440|NCT04408924|64787776|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
23285441|NCT04408924|64787776|FG000|Overall Study|Lost to Follow-up|3|||
23285442|NCT04408924|64787776|FG000|Overall Study|Withdrawal by Subject|5|||
23285443|NCT04408924|64787776|FG000|Overall Study|Sponsor Decision|2|||
23285444|NCT02964039|64787777|FG000|Overall Study|Medical reason unrelated to study participation|1|||
23285445|NCT02964039|64787778|FG001|Overall Study|Medical reason unrelated to study participation|0|||
23285446|NCT02964039|64787779|FG002|Overall Study|Medical reason unrelated to study participation|3|||
23285447|NCT02964039|64787777|FG000|Overall Study|Research shutdown due to pandemic|2|||
23285448|NCT02964039|64787778|FG001|Overall Study|Research shutdown due to pandemic|0|||
23285449|NCT02964039|64787779|FG002|Overall Study|Research shutdown due to pandemic|1|||
23377943|NCT01980888|65130342|FG000|Overall Study|Non-Compliance with Study Drug|3|||
23377944|NCT01980888|65130343|FG001|Overall Study|Non-Compliance with Study Drug|2|||
23377945|NCT01922011|65130344|FG000|Overall Study|Protocol Violation|0|||
23377946|NCT01922011|65130345|FG001|Overall Study|Protocol Violation|1|||
23490094|NCT02497612|65541305|FG003|Overall Study|Investigator's judgement|2|||
23490095|NCT02497612|65541302|FG000|Overall Study|Adverse Event|3|||
23285450|NCT02964039|64787777|FG000|Overall Study|Withdrawal by Subject|0|||
23285451|NCT02964039|64787778|FG001|Overall Study|Withdrawal by Subject|1|||
23285452|NCT02964039|64787779|FG002|Overall Study|Withdrawal by Subject|0|||
23285453|NCT02964039|64787777|FG000|Overall Study|Lost to Follow-up|1|||
23285454|NCT02964039|64787778|FG001|Overall Study|Lost to Follow-up|0|||
23285455|NCT02964039|64787779|FG002|Overall Study|Lost to Follow-up|1|||
23285456|NCT02416180|64787780|FG000|Overall Study|Withdrawal by Subject|1|||
23285457|NCT04473326|64787784|FG000|Overall Study|Death|0|||
23285458|NCT04473326|64787785|FG001|Overall Study|Death|1|||
23285459|NCT04473326|64787784|FG000|Overall Study|Withdrawal by Subject|1|||
23285460|NCT04473326|64787785|FG001|Overall Study|Withdrawal by Subject|2|||
23285461|NCT03419403|64787786|FG000|Overall Study|Withdrawal by Subject|5|||
23285462|NCT03419403|64787787|FG001|Overall Study|Withdrawal by Subject|2|||
23285463|NCT03419403|64787788|FG002|Overall Study|Withdrawal by Subject|5|||
23285464|NCT03419403|64787789|FG003|Overall Study|Withdrawal by Subject|1|||
23285465|NCT03419403|64787786|FG000|Overall Study|Progressive disease (per protocol)|0|||
23285466|NCT03419403|64787787|FG001|Overall Study|Progressive disease (per protocol)|2|||
23285467|NCT03419403|64787788|FG002|Overall Study|Progressive disease (per protocol)|2|||
23285468|NCT03419403|64787789|FG003|Overall Study|Progressive disease (per protocol)|0|||
23285469|NCT03419403|64787786|FG000|Overall Study|Other, not specified|6|||
23285470|NCT03419403|64787787|FG001|Overall Study|Other, not specified|4|||
23285471|NCT03419403|64787788|FG002|Overall Study|Other, not specified|5|||
23285472|NCT03419403|64787789|FG003|Overall Study|Other, not specified|1|||
23285473|NCT03419403|64787786|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
23285474|NCT03419403|64787787|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
23285475|NCT03419403|64787788|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
23285476|NCT03419403|64787789|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
23285477|NCT04878211|64787790|FG000|Overall Study|Lost to Follow-up|0|||
23285478|NCT04878211|64787791|FG001|Overall Study|Lost to Follow-up|0|||
23285479|NCT04878211|64787792|FG002|Overall Study|Lost to Follow-up|0|||
23285480|NCT04878211|64787793|FG003|Overall Study|Lost to Follow-up|1|||
23285481|NCT04878211|64787794|FG004|Overall Study|Lost to Follow-up|0|||
23285482|NCT04878211|64787795|FG005|Overall Study|Lost to Follow-up|1|||
23285483|NCT04878211|64787790|FG000|Overall Study|Protocol deviation|1|||
23285484|NCT04878211|64787791|FG001|Overall Study|Protocol deviation|0|||
23285485|NCT04878211|64787792|FG002|Overall Study|Protocol deviation|0|||
23285486|NCT04878211|64787793|FG003|Overall Study|Protocol deviation|0|||
23285487|NCT04878211|64787794|FG004|Overall Study|Protocol deviation|0|||
23285488|NCT04878211|64787795|FG005|Overall Study|Protocol deviation|0|||
23285489|NCT04878211|64787790|FG000|Overall Study|Study terminated by sponsor|0|||
23285490|NCT04878211|64787791|FG001|Overall Study|Study terminated by sponsor|0|||
23285491|NCT04878211|64787792|FG002|Overall Study|Study terminated by sponsor|0|||
23285492|NCT04878211|64787793|FG003|Overall Study|Study terminated by sponsor|0|||
23285493|NCT04878211|64787794|FG004|Overall Study|Study terminated by sponsor|9|||
23285494|NCT04878211|64787795|FG005|Overall Study|Study terminated by sponsor|4|||
23285495|NCT04878211|64787790|FG000|Overall Study|Subject decision|0|||
23285496|NCT04878211|64787791|FG001|Overall Study|Subject decision|0|||
23285497|NCT04878211|64787792|FG002|Overall Study|Subject decision|0|||
23285498|NCT04878211|64787793|FG003|Overall Study|Subject decision|0|||
23285499|NCT04878211|64787794|FG004|Overall Study|Subject decision|1|||
23377947|NCT01922011|65130344|FG000|Overall Study|Physician Decision|0|||
23490096|NCT02497612|65541303|FG001|Overall Study|Adverse Event|1|||
23285500|NCT04878211|64787795|FG005|Overall Study|Subject decision|0|||
23377948|NCT01922011|65130345|FG001|Overall Study|Physician Decision|1|||
23377949|NCT01922011|65130344|FG000|Overall Study|Parent/Guardian Decision|3|||
23377950|NCT01922011|65130345|FG001|Overall Study|Parent/Guardian Decision|0|||
23377951|NCT01922011|65130344|FG000|Overall Study|Lost to Follow-up|0|||
23377952|NCT01922011|65130345|FG001|Overall Study|Lost to Follow-up|1|||
23377953|NCT01922011|65130344|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
23377954|NCT01922011|65130345|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
23377955|NCT01922011|65130344|FG000|Overall Study|Not Treated|1|||
23377956|NCT01922011|65130345|FG001|Overall Study|Not Treated|0|||
23377957|NCT01922011|65130344|FG000|Overall Study|Lack of willing home health agency|1|||
23377958|NCT01922011|65130345|FG001|Overall Study|Lack of willing home health agency|0|||
23490097|NCT02497612|65541304|FG002|Overall Study|Adverse Event|4|||
23490098|NCT02497612|65541305|FG003|Overall Study|Adverse Event|1|||
23490099|NCT02497612|65541302|FG000|Overall Study|Lost to Follow-up|1|||
23490100|NCT02497612|65541303|FG001|Overall Study|Lost to Follow-up|1|||
23490101|NCT02497612|65541304|FG002|Overall Study|Lost to Follow-up|0|||
23490102|NCT02497612|65541305|FG003|Overall Study|Lost to Follow-up|1|||
23490103|NCT02497612|65541302|FG000|Overall Study|Other unspecified|1|||
23490104|NCT02497612|65541303|FG001|Overall Study|Other unspecified|1|||
23490105|NCT02497612|65541304|FG002|Overall Study|Other unspecified|2|||
23490106|NCT02497612|65541305|FG003|Overall Study|Other unspecified|0|||
23490107|NCT02497612|65541302|FG000|Overall Study|Not eligible|1|||
23490108|NCT02497612|65541303|FG001|Overall Study|Not eligible|0|||
23490109|NCT02497612|65541304|FG002|Overall Study|Not eligible|0|||
23490110|NCT02497612|65541305|FG003|Overall Study|Not eligible|1|||
23490111|NCT03583164|65541306|FG000|Overall Study|Death in Main Phase|35|||
23490112|NCT03583164|65541306|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
23285501|NCT02637141|64787796|FG000|Overall Study|Adverse Event|1|||
23285502|NCT02637141|64787797|FG001|Overall Study|Adverse Event|1|||
23285503|NCT02637141|64787798|FG002|Overall Study|Adverse Event|0|||
23285504|NCT02637141|64787796|FG000|Overall Study|Withdrawal by Subject|1|||
23285505|NCT02637141|64787797|FG001|Overall Study|Withdrawal by Subject|1|||
23285506|NCT02637141|64787798|FG002|Overall Study|Withdrawal by Subject|1|||
23285507|NCT00292227|64787799|FG000|Patch Period|Adverse Event|1|||
23285508|NCT00292227|64787800|FG001|Patch Period|Adverse Event|0|||
23285509|NCT00292227|64787801|FG002|Patch Period|Adverse Event|2|||
23285510|NCT00292227|64787799|FG000|Patch Period|Withdrawal by Subject|0|||
23285511|NCT00292227|64787800|FG001|Patch Period|Withdrawal by Subject|0|||
23285512|NCT00292227|64787801|FG002|Patch Period|Withdrawal by Subject|1|||
23285513|NCT00288704|64787802|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
23285514|NCT00288704|64787803|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
23285515|NCT00288704|64787804|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
23285516|NCT00288704|64787802|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
23285517|NCT00288704|64787803|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
23285518|NCT00288704|64787804|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
23285519|NCT00288704|64787802|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
23285520|NCT00288704|64787803|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
23285521|NCT00288704|64787804|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
23285522|NCT00288704|64787802|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
23377959|NCT01922011|65130344|FG000|Overall Study|Randomized in error|1|||
23377960|NCT01922011|65130345|FG001|Overall Study|Randomized in error|0|||
23490113|NCT03583164|65541306|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
23490114|NCT03583164|65541306|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
23490115|NCT03583164|65541306|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
23377961|NCT01732783|65130347|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
23377962|NCT01732783|65130348|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
23377963|NCT01732783|65130349|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
23377964|NCT01732783|65130347|FG000|Overall Study|Death|13|||
23377965|NCT01732783|65130348|FG001|Overall Study|Death|4|||
23377966|NCT01732783|65130349|FG002|Overall Study|Death|1|||
23377967|NCT01732783|65130347|FG000|Overall Study|Lost to Follow-up|7|||
23377968|NCT01732783|65130348|FG001|Overall Study|Lost to Follow-up|1|||
23377969|NCT01732783|65130349|FG002|Overall Study|Lost to Follow-up|1|||
23377970|NCT01732783|65130347|FG000|Overall Study|Administrative Decision|8|||
23377971|NCT01732783|65130348|FG001|Overall Study|Administrative Decision|2|||
23377972|NCT01732783|65130349|FG002|Overall Study|Administrative Decision|1|||
23377973|NCT01732783|65130347|FG000|Overall Study|Withdrawal by Subject|1|||
23377974|NCT01732783|65130348|FG001|Overall Study|Withdrawal by Subject|0|||
23377975|NCT01732783|65130349|FG002|Overall Study|Withdrawal by Subject|0|||
23377976|NCT02724644|65130350|FG000|Overall Study|Adverse Event|7|||
23377977|NCT02724644|65130351|FG001|Overall Study|Adverse Event|1|||
23377978|NCT02724644|65130350|FG000|Overall Study|Lost to Follow-up|6|||
23377979|NCT02724644|65130351|FG001|Overall Study|Lost to Follow-up|2|||
23377980|NCT02724644|65130350|FG000|Overall Study|Withdrawal by Subject|7|||
23604959|NCT02372799|65943565|FG002|Treatment Period|Withdrawal by Subject|2|||
23604960|NCT02372799|65943563|FG000|Treatment Period|Lost to Follow-up|11|||
23604961|NCT02372799|65943564|FG001|Treatment Period|Lost to Follow-up|5|||
23604962|NCT02372799|65943565|FG002|Treatment Period|Lost to Follow-up|3|||
23604963|NCT02372799|65943563|FG000|Treatment Period|Protocol Violation|3|||
23285523|NCT00288704|64787803|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
23285524|NCT00288704|64787804|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
23285525|NCT00288704|64787802|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
23285526|NCT00288704|64787803|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
23285527|NCT00288704|64787804|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
23285528|NCT00288704|64787802|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
23285529|NCT00288704|64787803|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
23285530|NCT00288704|64787804|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
23285531|NCT00288704|64787802|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
23285532|NCT00288704|64787803|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
23285533|NCT00288704|64787804|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
23285534|NCT00642993|64787805|FG000|Overall Study|Adverse Event|85|||
23285535|NCT00642993|64787806|FG001|Overall Study|Adverse Event|4|||
23285536|NCT00642993|64787805|FG000|Overall Study|Lost to Follow-up|8|||
23285537|NCT00642993|64787806|FG001|Overall Study|Lost to Follow-up|4|||
23285538|NCT00642993|64787805|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
23285539|NCT00642993|64787806|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
23285540|NCT00642993|64787805|FG000|Overall Study|Protocol Violation|1|||
23285541|NCT00642993|64787806|FG001|Overall Study|Protocol Violation|4|||
23285542|NCT00642993|64787805|FG000|Overall Study|Did not meet protocol eligibility|0|||
23285543|NCT00642993|64787806|FG001|Overall Study|Did not meet protocol eligibility|1|||
23285544|NCT00642993|64787805|FG000|Overall Study|Administrative|1|||
23285545|NCT00642993|64787806|FG001|Overall Study|Administrative|0|||
23604964|NCT02372799|65943564|FG001|Treatment Period|Protocol Violation|0|||
23604965|NCT02372799|65943565|FG002|Treatment Period|Protocol Violation|0|||
23604966|NCT02372799|65943563|FG000|Treatment Period|Non-compliance with study drug|4|||
23604967|NCT02372799|65943564|FG001|Treatment Period|Non-compliance with study drug|4|||
23604968|NCT02372799|65943565|FG002|Treatment Period|Non-compliance with study drug|4|||
23604969|NCT02372799|65943563|FG000|Treatment Period|Miscellaneous Reasons|1|||
23604970|NCT02372799|65943564|FG001|Treatment Period|Miscellaneous Reasons|1|||
23604971|NCT02372799|65943565|FG002|Treatment Period|Miscellaneous Reasons|0|||
23604972|NCT02372799|65943563|FG000|Down-taper Period|Lost to Follow-up|1|||
23604973|NCT02372799|65943564|FG001|Down-taper Period|Lost to Follow-up|2|||
23604974|NCT02372799|65943565|FG002|Down-taper Period|Lost to Follow-up|2|||
23604975|NCT03205488|65943566|FG000|Overall Study|Adverse Event|1|||
23604976|NCT03205488|65943567|FG001|Overall Study|Adverse Event|2|||
23604977|NCT03205488|65943568|FG002|Overall Study|Adverse Event|4|||
23285546|NCT00796562|64787815|FG000|Overall Study|Death|49|||
23285547|NCT04553406|64787823|FG000|Overall Study|Study Discontinuation|0|||
23377981|NCT02724644|65130351|FG001|Overall Study|Withdrawal by Subject|1|||
23604978|NCT03205488|65943566|FG000|Overall Study|Protocol Violation|0|||
23604979|NCT03205488|65943567|FG001|Overall Study|Protocol Violation|0|||
23604980|NCT03205488|65943568|FG002|Overall Study|Protocol Violation|1|||
23604981|NCT00736502|65943570|FG000|Overall Study|Adverse Event|22|||
23285548|NCT04553406|64787824|FG001|Overall Study|Study Discontinuation|1|||
23285549|NCT05065619|64787827|FG000|Up to Day 42|Lost to Follow-up|1|||
23377982|NCT02724644|65130350|FG000|Overall Study|Administrative|1|||
23377983|NCT02724644|65130351|FG001|Overall Study|Administrative|0|||
23377984|NCT01301092|65130352|FG000|Overall Study|Lost to Follow-up|0|||
23377985|NCT01301092|65130353|FG001|Overall Study|Lost to Follow-up|0|||
23604982|NCT00736502|65943570|FG000|Overall Study|Lack of Efficacy|16|||
23377986|NCT01301092|65130354|FG002|Overall Study|Lost to Follow-up|1|||
23377987|NCT00165698|65130364|FG000|Overall Study|Adverse Event|2|||
23377988|NCT00165698|65130365|FG001|Overall Study|Adverse Event|10|||
23377989|NCT00165698|65130364|FG000|Overall Study|Lost to Follow-up|2|||
23377990|NCT00165698|65130365|FG001|Overall Study|Lost to Follow-up|2|||
23377991|NCT00165698|65130364|FG000|Overall Study|Withdrawal by Subject|2|||
23377992|NCT00165698|65130365|FG001|Overall Study|Withdrawal by Subject|1|||
23377993|NCT00165698|65130364|FG000|Overall Study|Protocol Violation|1|||
23377994|NCT00165698|65130365|FG001|Overall Study|Protocol Violation|0|||
23377995|NCT00165698|65130364|FG000|Overall Study|Not Taken/Lost the medicine|1|||
23377996|NCT00165698|65130365|FG001|Overall Study|Not Taken/Lost the medicine|2|||
23377997|NCT03670628|65130368|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
23377998|NCT03670628|65130369|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
23377999|NCT03670628|65130368|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
23378000|NCT03670628|65130369|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
23378001|NCT01551173|65130370|FG000|Overall Study|Withdrawal by Subject|11|||
23378002|NCT01551173|65130371|FG001|Overall Study|Withdrawal by Subject|16|||
23378003|NCT01551173|65130370|FG000|Overall Study|Adverse Event|7|||
23378004|NCT01551173|65130371|FG001|Overall Study|Adverse Event|6|||
23378005|NCT01551173|65130370|FG000|Overall Study|Lost to Follow-up|5|||
23378006|NCT01551173|65130371|FG001|Overall Study|Lost to Follow-up|7|||
23378007|NCT01551173|65130370|FG000|Overall Study|Other|5|||
23378008|NCT01551173|65130371|FG001|Overall Study|Other|3|||
23378009|NCT02332707|65130381|FG000|Overall Study|Adverse Event|0|||
23378010|NCT02332707|65130382|FG001|Overall Study|Adverse Event|0|||
23378011|NCT02332707|65130383|FG002|Overall Study|Adverse Event|0|||
23378012|NCT02332707|65130384|FG003|Overall Study|Adverse Event|0|||
23378013|NCT02332707|65130385|FG004|Overall Study|Adverse Event|0|||
23378014|NCT02332707|65130386|FG005|Overall Study|Adverse Event|0|||
23378015|NCT02332707|65130387|FG006|Overall Study|Adverse Event|0|||
23378016|NCT02332707|65130388|FG007|Overall Study|Adverse Event|0|||
23378017|NCT02332707|65130389|FG008|Overall Study|Adverse Event|0|||
23378018|NCT02332707|65130390|FG009|Overall Study|Adverse Event|0|||
23378019|NCT02332707|65130391|FG010|Overall Study|Adverse Event|0|||
23378020|NCT02332707|65130392|FG011|Overall Study|Adverse Event|0|||
23378021|NCT02332707|65130393|FG012|Overall Study|Adverse Event|1|||
23378022|NCT02332707|65130394|FG013|Overall Study|Adverse Event|0|||
23378023|NCT02332707|65130395|FG014|Overall Study|Adverse Event|0|||
23378024|NCT02332707|65130396|FG015|Overall Study|Adverse Event|0|||
23378025|NCT02332707|65130397|FG016|Overall Study|Adverse Event|0|||
23378026|NCT02332707|65130398|FG017|Overall Study|Adverse Event|0|||
23378027|NCT02332707|65130381|FG000|Overall Study|Lost to Follow-up|0|||
23378028|NCT02332707|65130382|FG001|Overall Study|Lost to Follow-up|0|||
23378029|NCT02332707|65130383|FG002|Overall Study|Lost to Follow-up|0|||
23378030|NCT02332707|65130384|FG003|Overall Study|Lost to Follow-up|0|||
23378031|NCT02332707|65130385|FG004|Overall Study|Lost to Follow-up|0|||
23378032|NCT02332707|65130386|FG005|Overall Study|Lost to Follow-up|1|||
23378033|NCT02332707|65130387|FG006|Overall Study|Lost to Follow-up|0|||
23378034|NCT02332707|65130388|FG007|Overall Study|Lost to Follow-up|0|||
23378035|NCT02332707|65130389|FG008|Overall Study|Lost to Follow-up|0|||
23378036|NCT02332707|65130390|FG009|Overall Study|Lost to Follow-up|0|||
23378037|NCT02332707|65130391|FG010|Overall Study|Lost to Follow-up|2|||
23378038|NCT02332707|65130392|FG011|Overall Study|Lost to Follow-up|0|||
23490116|NCT03583164|65541306|FG000|Overall Study|Physician decision in Main Phase|1|||
23490117|NCT03583164|65541306|FG000|Overall Study|Physician decision in Extended Phase|2|||
23490118|NCT03583164|65541306|FG000|Overall Study|Death in Extended Phase|13|||
23490119|NCT03583164|65541306|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
23490120|NCT03583164|65541306|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
23490121|NCT03583164|65541306|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
23490122|NCT03583164|65541306|FG000|Overall Study|Treatment failure in Main Phase|2|||
23490123|NCT03583164|65541306|FG000|Overall Study|Treatment failure in Extended Phase|4|||
23490124|NCT03583164|65541306|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
23490125|NCT03583164|65541306|FG000|Overall Study|Other not specified reason in Main Phase|2|||
23604983|NCT00736502|65943570|FG000|Overall Study|Lost to Follow-up|27|||
23378039|NCT02332707|65130393|FG012|Overall Study|Lost to Follow-up|3|||
23378040|NCT02332707|65130394|FG013|Overall Study|Lost to Follow-up|0|||
23378041|NCT02332707|65130395|FG014|Overall Study|Lost to Follow-up|0|||
23378042|NCT02332707|65130396|FG015|Overall Study|Lost to Follow-up|0|||
23378043|NCT02332707|65130397|FG016|Overall Study|Lost to Follow-up|0|||
23378044|NCT02332707|65130398|FG017|Overall Study|Lost to Follow-up|0|||
23378045|NCT02332707|65130381|FG000|Overall Study|Physician Decision|0|||
23378046|NCT02332707|65130382|FG001|Overall Study|Physician Decision|0|||
23378047|NCT02332707|65130383|FG002|Overall Study|Physician Decision|0|||
23378048|NCT02332707|65130384|FG003|Overall Study|Physician Decision|1|||
23378049|NCT02332707|65130385|FG004|Overall Study|Physician Decision|0|||
23378050|NCT02332707|65130386|FG005|Overall Study|Physician Decision|0|||
23378051|NCT02332707|65130387|FG006|Overall Study|Physician Decision|0|||
23378052|NCT02332707|65130388|FG007|Overall Study|Physician Decision|0|||
23378053|NCT02332707|65130389|FG008|Overall Study|Physician Decision|0|||
23378054|NCT02332707|65130390|FG009|Overall Study|Physician Decision|0|||
23378055|NCT02332707|65130391|FG010|Overall Study|Physician Decision|0|||
23378056|NCT02332707|65130392|FG011|Overall Study|Physician Decision|0|||
23378057|NCT02332707|65130393|FG012|Overall Study|Physician Decision|1|||
23378058|NCT02332707|65130394|FG013|Overall Study|Physician Decision|0|||
23378059|NCT02332707|65130395|FG014|Overall Study|Physician Decision|0|||
23490126|NCT03265665|65541307|FG000|24-week Data Collection|Withdrawal by Subject|2|||
23490127|NCT03265665|65541308|FG001|24-week Data Collection|Withdrawal by Subject|2|||
23604984|NCT02102724|65943571|FG000|Overall Study|Lost to Follow-up|1|||
23604985|NCT02102724|65943572|FG001|Overall Study|Lost to Follow-up|0|||
23604986|NCT02102724|65943571|FG000|Overall Study|surgery for brain aneurysm|1|||
23604987|NCT02102724|65943572|FG001|Overall Study|surgery for brain aneurysm|1|||
23490128|NCT03265665|65541307|FG000|24-week Data Collection|Lost to Follow-up|4|||
23490129|NCT03265665|65541308|FG001|24-week Data Collection|Lost to Follow-up|5|||
23490130|NCT03265665|65541307|FG000|36-week Data Collection|Lost to Follow-up|6|||
23490131|NCT03265665|65541308|FG001|36-week Data Collection|Lost to Follow-up|8|||
23490132|NCT01933217|65541309|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
23490133|NCT01933217|65541310|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
23490134|NCT01933217|65541309|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
23490135|NCT01933217|65541310|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
23490136|NCT01691898|65541311|FG000|Overall Study|Death|34|||
23490137|NCT01691898|65541312|FG001|Overall Study|Death|32|||
23490138|NCT01691898|65541313|FG002|Overall Study|Death|6|||
23604988|NCT00701415|65943573|FG000|Overall Study|Adverse Event|0|||
23604989|NCT00701415|65943574|FG001|Overall Study|Adverse Event|1|||
23604990|NCT00701415|65943573|FG000|Overall Study|Social/family issues and needle phobia|1|||
23604991|NCT00701415|65943574|FG001|Overall Study|Social/family issues and needle phobia|0|||
23604992|NCT00756574|65943578|FG000|Overall Study|Withdrawal by Subject|9|||
23604993|NCT00756574|65943579|FG001|Overall Study|Withdrawal by Subject|7|||
23604994|NCT00756574|65943578|FG000|Overall Study|Lost to Follow-up|4|||
23604995|NCT00756574|65943579|FG001|Overall Study|Lost to Follow-up|4|||
23604996|NCT03026166|65943584|FG000|Overall Study|Death|22|||
23604997|NCT03026166|65943585|FG001|Overall Study|Death|7|||
23604998|NCT03026166|65943584|FG000|Overall Study|Physician Decision|2|||
23604999|NCT03026166|65943585|FG001|Overall Study|Physician Decision|0|||
23605000|NCT03026166|65943584|FG000|Overall Study|Withdrawal by Subject|1|||
23605001|NCT03026166|65943585|FG001|Overall Study|Withdrawal by Subject|2|||
23605002|NCT03026166|65943584|FG000|Overall Study|Lost to Follow-up|1|||
23605003|NCT03026166|65943585|FG001|Overall Study|Lost to Follow-up|0|||
23605004|NCT03026166|65943584|FG000|Overall Study|Study Terminated by Sponsor|3|||
23605005|NCT03026166|65943585|FG001|Overall Study|Study Terminated by Sponsor|3|||
23605006|NCT03026166|65943584|FG000|Overall Study|Other|1|||
23605007|NCT03026166|65943585|FG001|Overall Study|Other|0|||
23605008|NCT02066636|65943589|FG000|Overall Study|Disease progression|51|||
23605009|NCT02066636|65943590|FG001|Overall Study|Disease progression|60|||
23605010|NCT02066636|65943591|FG002|Overall Study|Disease progression|700|||
23605011|NCT02066636|65943589|FG000|Overall Study|Study drug toxicity|13|||
23605012|NCT02066636|65943590|FG001|Overall Study|Study drug toxicity|2|||
23605013|NCT02066636|65943591|FG002|Overall Study|Study drug toxicity|58|||
23605014|NCT02066636|65943589|FG000|Overall Study|Death|4|||
23605015|NCT02066636|65943590|FG001|Overall Study|Death|2|||
23605016|NCT02066636|65943591|FG002|Overall Study|Death|158|||
23605017|NCT02066636|65943589|FG000|Overall Study|Adverse event unrelated to study drug|6|||
23605018|NCT02066636|65943590|FG001|Overall Study|Adverse event unrelated to study drug|4|||
23605019|NCT02066636|65943591|FG002|Overall Study|Adverse event unrelated to study drug|45|||
23605020|NCT02066636|65943589|FG000|Overall Study|Participant request to discontinue treatment|12|||
23605021|NCT02066636|65943590|FG001|Overall Study|Participant request to discontinue treatment|12|||
23605022|NCT02066636|65943591|FG002|Overall Study|Participant request to discontinue treatment|70|||
23605023|NCT02066636|65943589|FG000|Overall Study|Participant withdrew consent|10|||
23605024|NCT02066636|65943590|FG001|Overall Study|Participant withdrew consent|18|||
23605025|NCT02066636|65943591|FG002|Overall Study|Participant withdrew consent|61|||
23605026|NCT02066636|65943589|FG000|Overall Study|Lost to Follow-up|0|||
23605027|NCT02066636|65943590|FG001|Overall Study|Lost to Follow-up|2|||
23605028|NCT02066636|65943591|FG002|Overall Study|Lost to Follow-up|2|||
23605029|NCT02066636|65943589|FG000|Overall Study|Maximum clinical benefit|2|||
23605030|NCT02066636|65943590|FG001|Overall Study|Maximum clinical benefit|2|||
23605031|NCT02066636|65943591|FG002|Overall Study|Maximum clinical benefit|3|||
23605032|NCT02066636|65943589|FG000|Overall Study|Poor/non-compliance|2|||
23605033|NCT02066636|65943590|FG001|Overall Study|Poor/non-compliance|1|||
23605034|NCT02066636|65943591|FG002|Overall Study|Poor/non-compliance|1|||
23378060|NCT02332707|65130396|FG015|Overall Study|Physician Decision|0|||
23378061|NCT02332707|65130397|FG016|Overall Study|Physician Decision|0|||
23378062|NCT02332707|65130398|FG017|Overall Study|Physician Decision|0|||
23378063|NCT02332707|65130381|FG000|Overall Study|Withdrawal by Subject|0|||
23378064|NCT02332707|65130382|FG001|Overall Study|Withdrawal by Subject|0|||
23378065|NCT02332707|65130383|FG002|Overall Study|Withdrawal by Subject|1|||
23378066|NCT02332707|65130384|FG003|Overall Study|Withdrawal by Subject|0|||
23378067|NCT02332707|65130385|FG004|Overall Study|Withdrawal by Subject|0|||
23490139|NCT01691898|65541314|FG003|Overall Study|Death|3|||
23490140|NCT01691898|65541315|FG004|Overall Study|Death|8|||
23605035|NCT02066636|65943589|FG000|Overall Study|Participant no loner meets study criteria|3|||
23605036|NCT02066636|65943590|FG001|Overall Study|Participant no loner meets study criteria|2|||
23605037|NCT02066636|65943591|FG002|Overall Study|Participant no loner meets study criteria|28|||
23605038|NCT02066636|65943589|FG000|Overall Study|Administrative reasons by sponsor|8|||
23605039|NCT02066636|65943590|FG001|Overall Study|Administrative reasons by sponsor|5|||
23605040|NCT02066636|65943591|FG002|Overall Study|Administrative reasons by sponsor|0|||
23605041|NCT02066636|65943589|FG000|Overall Study|Other reasons|16|||
23605042|NCT02066636|65943590|FG001|Overall Study|Other reasons|15|||
23605043|NCT02066636|65943591|FG002|Overall Study|Other reasons|50|||
23605044|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
23605045|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
23605046|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
23605047|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Death|0|||
23605048|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Death|2|||
23605049|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Death|1|||
23605050|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
23605051|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
23605052|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
23605053|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
23605054|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
23605055|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
23605056|NCT00790569|65943592|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
23605057|NCT00790569|65943593|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
23605058|NCT00790569|65943594|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
23605059|NCT00790569|65943592|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
23605060|NCT00790569|65943593|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
23605061|NCT00790569|65943594|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
23605062|NCT03292406|65943595|FG000|Overall Study|Progressive Disease|6|||
23605063|NCT03292406|65943596|FG001|Overall Study|Progressive Disease|3|||
23605064|NCT03292406|65943597|FG002|Overall Study|Progressive Disease|4|||
23605065|NCT03292406|65943595|FG000|Overall Study|Adverse Event|7|||
23605066|NCT03292406|65943596|FG001|Overall Study|Adverse Event|1|||
23605067|NCT03292406|65943597|FG002|Overall Study|Adverse Event|4|||
23605068|NCT03292406|65943595|FG000|Overall Study|Withdrawal by Subject|0|||
23605069|NCT03292406|65943596|FG001|Overall Study|Withdrawal by Subject|7|||
23605070|NCT03292406|65943597|FG002|Overall Study|Withdrawal by Subject|2|||
23605071|NCT03292406|65943595|FG000|Overall Study|Protocol Violation|0|||
23605072|NCT03292406|65943596|FG001|Overall Study|Protocol Violation|1|||
23605073|NCT03292406|65943597|FG002|Overall Study|Protocol Violation|1|||
23605074|NCT03292406|65943595|FG000|Overall Study|Other|0|||
23605075|NCT03292406|65943596|FG001|Overall Study|Other|1|||
23285550|NCT05065619|64787828|FG001|Up to Day 42|Lost to Follow-up|0|||
23285551|NCT05065619|64787827|FG000|Up to Day 42|Withdrawal by Subject|1|||
23285552|NCT05065619|64787828|FG001|Up to Day 42|Withdrawal by Subject|0|||
23285553|NCT05065619|64787827|FG000|After Day 43|Lost to Follow-up|1|||
23285554|NCT05065619|64787828|FG001|After Day 43|Lost to Follow-up|0|||
23285555|NCT05065619|64787827|FG000|After Day 43|Physician Decision|3|||
23285556|NCT05065619|64787828|FG001|After Day 43|Physician Decision|0|||
23285557|NCT05065619|64787827|FG000|After Day 43|Withdrawal by Subject|1|||
23285558|NCT05065619|64787828|FG001|After Day 43|Withdrawal by Subject|2|||
23285559|NCT05065619|64787827|FG000|After Day 43|Public vaccination|6|||
23285560|NCT05065619|64787828|FG001|After Day 43|Public vaccination|8|||
23285561|NCT05065619|64787827|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
23285562|NCT05065619|64787828|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
23285563|NCT05065619|64787827|FG000|After Day 43|Study Terminated by Sponsor|88|||
23285564|NCT05065619|64787828|FG001|After Day 43|Study Terminated by Sponsor|16|||
23285565|NCT03218787|64787829|FG000|Overall Study|Lost to Follow-up|12|||
23285566|NCT03218787|64787829|FG000|Overall Study|Withdrawal by Subject|72|||
23285567|NCT03218787|64787829|FG000|Overall Study|Physician Decision|11|||
23285568|NCT03218787|64787829|FG000|Overall Study|Death|111|||
23285569|NCT03306277|64787836|FG000|Overall Study|Death|1|||
23490141|NCT01691898|65541316|FG005|Overall Study|Death|31|||
23605076|NCT03292406|65943597|FG002|Overall Study|Other|2|||
23285570|NCT03306277|64787836|FG000|Overall Study|Adverse Event|1|||
23285571|NCT03306277|64787836|FG000|Overall Study|Withdrawal by Subject|1|||
23285572|NCT00715676|64787838|FG000|Overall Study|Adverse Event|3|||
23490142|NCT01691898|65541311|FG000|Overall Study|Adverse Event|0|||
23378068|NCT02332707|65130386|FG005|Overall Study|Withdrawal by Subject|0|||
23378069|NCT02332707|65130387|FG006|Overall Study|Withdrawal by Subject|0|||
23378070|NCT02332707|65130388|FG007|Overall Study|Withdrawal by Subject|0|||
23378071|NCT02332707|65130389|FG008|Overall Study|Withdrawal by Subject|0|||
23378072|NCT02332707|65130390|FG009|Overall Study|Withdrawal by Subject|3|||
23378073|NCT02332707|65130391|FG010|Overall Study|Withdrawal by Subject|0|||
23378074|NCT02332707|65130392|FG011|Overall Study|Withdrawal by Subject|0|||
23378075|NCT02332707|65130393|FG012|Overall Study|Withdrawal by Subject|0|||
23378076|NCT02332707|65130394|FG013|Overall Study|Withdrawal by Subject|0|||
23378077|NCT02332707|65130395|FG014|Overall Study|Withdrawal by Subject|0|||
23378078|NCT02332707|65130396|FG015|Overall Study|Withdrawal by Subject|0|||
23378079|NCT02332707|65130397|FG016|Overall Study|Withdrawal by Subject|0|||
23378080|NCT02332707|65130398|FG017|Overall Study|Withdrawal by Subject|0|||
23378081|NCT01712516|65130399|FG000|Overall Study|Technical problems|0|||
23378082|NCT01712516|65130400|FG001|Overall Study|Technical problems|0|||
23378083|NCT01712516|65130401|FG002|Overall Study|Technical problems|0|||
23378084|NCT01712516|65130402|FG003|Overall Study|Technical problems|2|||
23378085|NCT01712516|65130399|FG000|Overall Study|Lost to Follow-up|0|||
23378086|NCT01712516|65130400|FG001|Overall Study|Lost to Follow-up|0|||
23378087|NCT01712516|65130401|FG002|Overall Study|Lost to Follow-up|2|||
23378088|NCT01712516|65130402|FG003|Overall Study|Lost to Follow-up|1|||
23378089|NCT01712516|65130399|FG000|Overall Study|Death|0|||
23378090|NCT01712516|65130400|FG001|Overall Study|Death|1|||
23378091|NCT01712516|65130401|FG002|Overall Study|Death|0|||
23378092|NCT01712516|65130402|FG003|Overall Study|Death|0|||
23378093|NCT01712516|65130399|FG000|Overall Study|Protocol deviation|1|||
23378094|NCT01712516|65130400|FG001|Overall Study|Protocol deviation|0|||
23378095|NCT01712516|65130401|FG002|Overall Study|Protocol deviation|1|||
23378096|NCT01712516|65130402|FG003|Overall Study|Protocol deviation|0|||
23605077|NCT02224755|65943598|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
23605078|NCT02224755|65943599|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
23605079|NCT02224755|65943598|FG000|Two Year Follow up Post-implant|Death|103|||
23605080|NCT02224755|65943599|FG001|Two Year Follow up Post-implant|Death|98|||
23605081|NCT02224755|65943598|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
23605082|NCT02224755|65943599|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
23605083|NCT02224755|65943598|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
23605084|NCT02224755|65943599|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
23605085|NCT02224755|65943598|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
23605086|NCT02224755|65943599|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
23605087|NCT02630966|65943600|FG000|Overall Study|Adverse Event|1|||
23605088|NCT02630966|65943601|FG001|Overall Study|Adverse Event|3|||
23605089|NCT02630966|65943600|FG000|Overall Study|Significant Protocol Deviation|0|||
23605090|NCT02630966|65943601|FG001|Overall Study|Significant Protocol Deviation|2|||
23605091|NCT02630966|65943600|FG000|Overall Study|Voluntary Withdrawal|1|||
23605092|NCT02630966|65943601|FG001|Overall Study|Voluntary Withdrawal|1|||
23605093|NCT02630966|65943600|FG000|Overall Study|Lack of Efficacy|0|||
23605094|NCT02630966|65943601|FG001|Overall Study|Lack of Efficacy|2|||
23605095|NCT00590759|65943604|FG000|Overall Study|Death|52|||
23605096|NCT00590759|65943604|FG000|Overall Study|Lost to Follow-up|28|||
23378097|NCT01712516|65130399|FG000|Overall Study|Physician Decision|2|||
23378098|NCT01712516|65130400|FG001|Overall Study|Physician Decision|0|||
23378099|NCT01712516|65130401|FG002|Overall Study|Physician Decision|0|||
23378100|NCT01712516|65130402|FG003|Overall Study|Physician Decision|1|||
23378101|NCT01712516|65130399|FG000|Overall Study|Withdrawal by Subject|3|||
23378102|NCT01712516|65130400|FG001|Overall Study|Withdrawal by Subject|9|||
23378103|NCT01712516|65130401|FG002|Overall Study|Withdrawal by Subject|3|||
23605097|NCT04108858|65943605|FG000|Overall Study|Adverse Event|1|||
23605098|NCT01915914|65943606|FG000|Acute Phase|Withdrawal by Subject|4|||
23605099|NCT01915914|65943607|FG001|Acute Phase|Withdrawal by Subject|0|||
23605100|NCT01915914|65943608|FG002|Acute Phase|Withdrawal by Subject|0|||
23605101|NCT01915914|65943609|FG003|Acute Phase|Withdrawal by Subject|0|||
23605102|NCT01915914|65943606|FG000|Acute Phase|Lost to Follow-up|4|||
23605103|NCT01915914|65943607|FG001|Acute Phase|Lost to Follow-up|0|||
23605104|NCT01915914|65943608|FG002|Acute Phase|Lost to Follow-up|0|||
23605105|NCT01915914|65943609|FG003|Acute Phase|Lost to Follow-up|0|||
23605106|NCT01915914|65943606|FG000|Acute Phase|Physician Decision|1|||
23605107|NCT01915914|65943607|FG001|Acute Phase|Physician Decision|0|||
23605108|NCT01915914|65943608|FG002|Acute Phase|Physician Decision|0|||
23605109|NCT01915914|65943609|FG003|Acute Phase|Physician Decision|0|||
23605110|NCT01915914|65943606|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
23605111|NCT01915914|65943607|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
23605112|NCT01915914|65943608|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
23285573|NCT00715676|64787839|FG001|Overall Study|Adverse Event|5|||
23285574|NCT00715676|64787840|FG002|Overall Study|Adverse Event|21|||
23285575|NCT00715676|64787838|FG000|Overall Study|Withdrawal by Subject|1|||
23605113|NCT01915914|65943609|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
23605114|NCT01915914|65943606|FG000|Acute Phase|"Not Achieved treatment success"|1|||
23605115|NCT01915914|65943607|FG001|Acute Phase|"Not Achieved treatment success"|0|||
23605116|NCT01915914|65943608|FG002|Acute Phase|"Not Achieved treatment success"|0|||
23605117|NCT01915914|65943609|FG003|Acute Phase|"Not Achieved treatment success"|0|||
23605118|NCT01915914|65943606|FG000|Acute Phase|Missing|1|||
23605119|NCT01915914|65943607|FG001|Acute Phase|Missing|0|||
23605120|NCT01915914|65943608|FG002|Acute Phase|Missing|0|||
23605121|NCT01915914|65943609|FG003|Acute Phase|Missing|0|||
23605122|NCT01915914|65943606|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23605123|NCT01915914|65943607|FG001|Maintenance Phase|Withdrawal by Subject|1|||
23605124|NCT01915914|65943608|FG002|Maintenance Phase|Withdrawal by Subject|1|||
23605125|NCT01915914|65943609|FG003|Maintenance Phase|Withdrawal by Subject|0|||
23605126|NCT01915914|65943606|FG000|Maintenance Phase|Lost to Follow-up|0|||
23605127|NCT01915914|65943607|FG001|Maintenance Phase|Lost to Follow-up|4|||
23605128|NCT01915914|65943608|FG002|Maintenance Phase|Lost to Follow-up|1|||
23605129|NCT01915914|65943609|FG003|Maintenance Phase|Lost to Follow-up|0|||
23605130|NCT01915914|65943606|FG000|Maintenance Phase|Missing|0|||
23605131|NCT01915914|65943607|FG001|Maintenance Phase|Missing|1|||
23605132|NCT01915914|65943608|FG002|Maintenance Phase|Missing|0|||
23605133|NCT01915914|65943609|FG003|Maintenance Phase|Missing|0|||
23605134|NCT01915914|65943606|FG000|Follow-up Phase|Withdrawal by Subject|0|||
23605135|NCT01915914|65943607|FG001|Follow-up Phase|Withdrawal by Subject|0|||
23285576|NCT00715676|64787839|FG001|Overall Study|Withdrawal by Subject|3|||
23285577|NCT00715676|64787840|FG002|Overall Study|Withdrawal by Subject|8|||
23285578|NCT00715676|64787838|FG000|Overall Study|Lost to Follow-up|1|||
23285579|NCT00715676|64787839|FG001|Overall Study|Lost to Follow-up|2|||
23285580|NCT00715676|64787840|FG002|Overall Study|Lost to Follow-up|1|||
23285581|NCT00715676|64787838|FG000|Overall Study|Terminated by Sponsor|1|||
23285582|NCT00715676|64787839|FG001|Overall Study|Terminated by Sponsor|0|||
23285583|NCT00715676|64787840|FG002|Overall Study|Terminated by Sponsor|0|||
23285584|NCT00715676|64787838|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
23285585|NCT00715676|64787839|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
23285586|NCT00715676|64787840|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
23285587|NCT00715676|64787838|FG000|Overall Study|Use of Exclusionary Medication|0|||
23285588|NCT00715676|64787839|FG001|Overall Study|Use of Exclusionary Medication|0|||
23285589|NCT00715676|64787840|FG002|Overall Study|Use of Exclusionary Medication|1|||
23285590|NCT00715676|64787838|FG000|Overall Study|Elevated Blood Glucose|0|||
23605136|NCT01915914|65943608|FG002|Follow-up Phase|Withdrawal by Subject|0|||
23605137|NCT01915914|65943609|FG003|Follow-up Phase|Withdrawal by Subject|1|||
23605138|NCT01915914|65943606|FG000|Follow-up Phase|Physician Decision|0|||
23605139|NCT01915914|65943607|FG001|Follow-up Phase|Physician Decision|0|||
23605140|NCT01915914|65943608|FG002|Follow-up Phase|Physician Decision|0|||
23605141|NCT01915914|65943609|FG003|Follow-up Phase|Physician Decision|1|||
23285591|NCT00715676|64787839|FG001|Overall Study|Elevated Blood Glucose|1|||
23605142|NCT03032198|65943610|FG000|Overall Study|Screen Fail|1|||
23378104|NCT01712516|65130402|FG003|Overall Study|Withdrawal by Subject|9|||
23378105|NCT02471183|65130403|FG000|Main Treatment Period|Adverse Event|1|||
23378106|NCT02471183|65130403|FG000|Main Treatment Period|Withdrawal by Subject|1|||
23378107|NCT02471183|65130403|FG000|Extended Treatment Period|Lack of Efficacy|1|||
23378108|NCT01245062|65130406|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
23378109|NCT01245062|65130407|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
23378110|NCT01245062|65130408|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
23378111|NCT01245062|65130406|FG000|Randomization and Crossover Phase|Physician Decision|2|||
23378112|NCT01245062|65130407|FG001|Randomization and Crossover Phase|Physician Decision|4|||
23378113|NCT01245062|65130408|FG002|Randomization and Crossover Phase|Physician Decision|0|||
23378114|NCT01245062|65130406|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
23378115|NCT01245062|65130407|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
23378116|NCT01245062|65130408|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
23378117|NCT01245062|65130406|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
23378118|NCT01245062|65130407|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
23378119|NCT01245062|65130408|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
23378120|NCT01245062|65130406|FG000|Cross-over Phase|Lost to Follow-up|0|||
23378121|NCT01245062|65130407|FG001|Cross-over Phase|Lost to Follow-up|0|||
23378122|NCT01245062|65130408|FG002|Cross-over Phase|Lost to Follow-up|1|||
23378123|NCT01245062|65130406|FG000|Cross-over Phase|Physician Decision|0|||
23378124|NCT01245062|65130407|FG001|Cross-over Phase|Physician Decision|0|||
23378125|NCT01245062|65130408|FG002|Cross-over Phase|Physician Decision|1|||
23378126|NCT01245062|65130406|FG000|Cross-over Phase|Withdrew Consent|0|||
23378127|NCT01245062|65130407|FG001|Cross-over Phase|Withdrew Consent|0|||
23378128|NCT01245062|65130408|FG002|Cross-over Phase|Withdrew Consent|4|||
23378129|NCT01245062|65130406|FG000|Cross-over Phase|Study closed/ terminated|0|||
23378130|NCT01245062|65130407|FG001|Cross-over Phase|Study closed/ terminated|0|||
23378131|NCT01245062|65130408|FG002|Cross-over Phase|Study closed/ terminated|11|||
23378132|NCT02202616|65130409|FG000|Overall Study|Screen failed|24|||
23378133|NCT02202616|65130409|FG000|Overall Study|Adverse Event|32|||
23378134|NCT02202616|65130409|FG000|Overall Study|Protocol deviation|18|||
23378135|NCT02202616|65130409|FG000|Overall Study|Patient withdrew consent|12|||
23378136|NCT02202616|65130409|FG000|Overall Study|Lost to Follow-up|6|||
23378137|NCT02202616|65130409|FG000|Overall Study|Administrative problems|6|||
23378138|NCT02202616|65130409|FG000|Overall Study|Abnormal test procedure result|1|||
23378139|NCT02202616|65130409|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23378140|NCT04000724|65130426|FG000|Overall Study|Withdrawal by Subject|5|||
23378141|NCT04000724|65130427|FG001|Overall Study|Withdrawal by Subject|3|||
23378142|NCT04000724|65130428|FG002|Overall Study|Withdrawal by Subject|4|||
23378143|NCT04000724|65130426|FG000|Overall Study|Lost to Follow-up|11|||
23378144|NCT04000724|65130427|FG001|Overall Study|Lost to Follow-up|7|||
23378145|NCT04000724|65130428|FG002|Overall Study|Lost to Follow-up|13|||
23378146|NCT00640289|65130429|FG000|Overall Study|Death|3|||
23378147|NCT00640289|65130429|FG000|Overall Study|Withdrawal by Subject|1|||
23378148|NCT00640289|65130429|FG000|Overall Study|Lost to Follow-up|1|||
23378149|NCT00640289|65130429|FG000|Overall Study|Data collected under different amendment|2|||
23378150|NCT00640289|65130429|FG000|Overall Study|Transferred to another center|1|||
23378151|NCT00640289|65130429|FG000|Overall Study|Missing status|5|||
23378152|NCT01695772|65130430|FG000|Overall Study|Withdrawal by Subject|18|||
23378153|NCT01695772|65130430|FG000|Overall Study|Progressive Disease|8|||
23378154|NCT01695772|65130430|FG000|Overall Study|Investigator Decision|5|||
23378155|NCT01695772|65130430|FG000|Overall Study|Lost to Follow-up|4|||
23378156|NCT01695772|65130430|FG000|Overall Study|Protocol Violation|2|||
23378157|NCT01695772|65130430|FG000|Overall Study|Unspecified Reason|1|||
23378158|NCT02836769|65130432|FG000|Overall Study|Lost to Follow-up|10|||
23378159|NCT02836769|65130432|FG000|Overall Study|Medical withdrawal|2|||
23378160|NCT02836769|65130432|FG000|Overall Study|Withdrawal by Subject|3|||
23378161|NCT00724893|65130433|FG000|Overall Study|Adverse Event|76|||
23378162|NCT00724893|65130434|FG001|Overall Study|Adverse Event|142|||
23378163|NCT00724893|65130433|FG000|Overall Study|Withdrawal by Subject|0|||
23378164|NCT00724893|65130434|FG001|Overall Study|Withdrawal by Subject|1|||
23378165|NCT00724893|65130433|FG000|Overall Study|Lack of virologic response|94|||
23378166|NCT00724893|65130434|FG001|Overall Study|Lack of virologic response|202|||
23605143|NCT04070105|65943611|FG000|Overall Study|Lost to Follow-up|0|||
23605144|NCT04070105|65943612|FG001|Overall Study|Lost to Follow-up|0|||
23605145|NCT04070105|65943613|FG002|Overall Study|Lost to Follow-up|0|||
23378167|NCT00724893|65130433|FG000|Overall Study|Reason not specified|193|||
23378168|NCT00724893|65130434|FG001|Overall Study|Reason not specified|7|||
23378169|NCT00724893|65130433|FG000|Overall Study|Patient choice|0|||
23378170|NCT00724893|65130434|FG001|Overall Study|Patient choice|26|||
23378171|NCT00724893|65130433|FG000|Overall Study|Geographic reasons|0|||
23378172|NCT00724893|65130434|FG001|Overall Study|Geographic reasons|11|||
23378173|NCT00724893|65130433|FG000|Overall Study|Incarceration|0|||
23378174|NCT00724893|65130434|FG001|Overall Study|Incarceration|9|||
23378175|NCT00724893|65130433|FG000|Overall Study|Substance abuse|0|||
23490143|NCT01691898|65541312|FG001|Overall Study|Adverse Event|1|||
23490144|NCT01691898|65541313|FG002|Overall Study|Adverse Event|0|||
23490145|NCT01691898|65541314|FG003|Overall Study|Adverse Event|1|||
23490146|NCT01691898|65541315|FG004|Overall Study|Adverse Event|1|||
23490147|NCT01691898|65541316|FG005|Overall Study|Adverse Event|0|||
23490148|NCT01691898|65541311|FG000|Overall Study|Progression of Disease|1|||
23490149|NCT01691898|65541312|FG001|Overall Study|Progression of Disease|2|||
23490150|NCT01691898|65541313|FG002|Overall Study|Progression of Disease|1|||
23490151|NCT01691898|65541314|FG003|Overall Study|Progression of Disease|0|||
23490152|NCT01691898|65541315|FG004|Overall Study|Progression of Disease|0|||
23490153|NCT01691898|65541316|FG005|Overall Study|Progression of Disease|1|||
23490154|NCT01691898|65541311|FG000|Overall Study|Lost to Follow-up|3|||
23490155|NCT01691898|65541312|FG001|Overall Study|Lost to Follow-up|1|||
23490156|NCT01691898|65541313|FG002|Overall Study|Lost to Follow-up|0|||
23490157|NCT01691898|65541314|FG003|Overall Study|Lost to Follow-up|0|||
23490158|NCT01691898|65541315|FG004|Overall Study|Lost to Follow-up|1|||
23490159|NCT01691898|65541316|FG005|Overall Study|Lost to Follow-up|0|||
23490160|NCT01691898|65541311|FG000|Overall Study|Withdrawal by Subject|9|||
23490161|NCT01691898|65541312|FG001|Overall Study|Withdrawal by Subject|8|||
23490162|NCT01691898|65541313|FG002|Overall Study|Withdrawal by Subject|2|||
23490163|NCT01691898|65541314|FG003|Overall Study|Withdrawal by Subject|1|||
23490164|NCT01691898|65541315|FG004|Overall Study|Withdrawal by Subject|3|||
23490165|NCT01691898|65541316|FG005|Overall Study|Withdrawal by Subject|3|||
23490166|NCT01691898|65541311|FG000|Overall Study|Non-Compliance|0|||
23490167|NCT01691898|65541312|FG001|Overall Study|Non-Compliance|0|||
23490168|NCT01691898|65541313|FG002|Overall Study|Non-Compliance|0|||
23490169|NCT01691898|65541314|FG003|Overall Study|Non-Compliance|0|||
23490170|NCT01691898|65541315|FG004|Overall Study|Non-Compliance|1|||
23490171|NCT01691898|65541316|FG005|Overall Study|Non-Compliance|0|||
23490172|NCT00884377|65541324|FG000|Overall Study|Withdrawal by Subject|1|||
23490173|NCT00884377|65541325|FG001|Overall Study|Withdrawal by Subject|0|||
23490174|NCT00884377|65541324|FG000|Overall Study|Could not confirm diagnosis|1|||
23490175|NCT00884377|65541325|FG001|Overall Study|Could not confirm diagnosis|0|||
23490176|NCT00884377|65541324|FG000|Overall Study|Physician Decision|0|||
23490177|NCT00884377|65541325|FG001|Overall Study|Physician Decision|1|||
23490178|NCT02611960|65541333|FG000|Overall Study|Adverse Event|7|||
23490179|NCT02611960|65541334|FG001|Overall Study|Adverse Event|8|||
23490180|NCT02611960|65541333|FG000|Overall Study|Death|98|||
23490181|NCT02611960|65541334|FG001|Overall Study|Death|92|||
23490182|NCT02611960|65541333|FG000|Overall Study|Withdrawal by Subject|1|||
23490183|NCT02611960|65541334|FG001|Overall Study|Withdrawal by Subject|5|||
23490184|NCT02611960|65541333|FG000|Overall Study|Sponsor Decision|11|||
23490185|NCT02611960|65541334|FG001|Overall Study|Sponsor Decision|11|||
23490186|NCT01225887|65541335|FG000|Overall Study|Ineligible:required test not done|2|||
23490187|NCT01225887|65541335|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
23490188|NCT01225887|65541335|FG000|Overall Study|Ineligible:inadequate pathology|2|||
23490189|NCT00617851|65541339|FG000|Overall Study|Death|0|||
23490190|NCT00617851|65541340|FG001|Overall Study|Death|0|||
23490191|NCT00617851|65541341|FG002|Overall Study|Death|0|||
23490192|NCT00617851|65541342|FG003|Overall Study|Death|1|||
23490193|NCT00617851|65541339|FG000|Overall Study|Withdrawal by Subject|14|||
23490194|NCT00617851|65541340|FG001|Overall Study|Withdrawal by Subject|7|||
23490195|NCT00617851|65541341|FG002|Overall Study|Withdrawal by Subject|12|||
23490196|NCT00617851|65541342|FG003|Overall Study|Withdrawal by Subject|4|||
23490197|NCT00617851|65541339|FG000|Overall Study|Lost to Follow-up|27|||
23490198|NCT00617851|65541340|FG001|Overall Study|Lost to Follow-up|29|||
23490199|NCT00617851|65541341|FG002|Overall Study|Lost to Follow-up|31|||
23490200|NCT00617851|65541342|FG003|Overall Study|Lost to Follow-up|19|||
23490201|NCT00617851|65541339|FG000|Overall Study|Inappropriate Enrollment|5|||
23490202|NCT00617851|65541340|FG001|Overall Study|Inappropriate Enrollment|4|||
23490203|NCT00617851|65541341|FG002|Overall Study|Inappropriate Enrollment|1|||
23490204|NCT00617851|65541342|FG003|Overall Study|Inappropriate Enrollment|1|||
23490205|NCT00617851|65541339|FG000|Overall Study|Unable to classify|1|||
23490206|NCT00617851|65541340|FG001|Overall Study|Unable to classify|0|||
23490207|NCT00617851|65541341|FG002|Overall Study|Unable to classify|1|||
23490208|NCT00617851|65541342|FG003|Overall Study|Unable to classify|0|||
23490209|NCT01052844|65541343|FG000|Overall Study|Adverse Event|0|||
23490210|NCT01052844|65541344|FG001|Overall Study|Adverse Event|1|||
23490211|NCT02395016|65541345|FG000|Overall Study|Adverse Event|4|||
23490212|NCT02395016|65541346|FG001|Overall Study|Adverse Event|3|||
23490213|NCT02395016|65541345|FG000|Overall Study|Withdrawal by Subject|9|||
23490214|NCT02395016|65541346|FG001|Overall Study|Withdrawal by Subject|6|||
23490215|NCT02395016|65541345|FG000|Overall Study|Protocol Violation|2|||
23490216|NCT02395016|65541346|FG001|Overall Study|Protocol Violation|3|||
23490217|NCT04521777|65541347|FG000|Overall Study|Death|2|||
23490218|NCT04521777|65541347|FG000|Overall Study|Withdrawal by Subject|2|||
23490219|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
23490220|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
23490221|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
23490222|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
23490223|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
23490224|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
23490225|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
23490226|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
23490227|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
23490228|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
23490229|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
23490230|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
23490231|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
23490232|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
23490233|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
23490234|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
23490235|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
23490236|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
23490237|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
23490238|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
23490239|NCT01226043|65541349|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
23490240|NCT01226043|65541350|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
23490241|NCT01226043|65541351|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
23490242|NCT01226043|65541352|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
23490243|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Adverse Event|0|||
23490244|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Adverse Event|0|||
23490245|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Adverse Event|1|||
23490246|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Adverse Event|1|||
23490247|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
23490248|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
23490249|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
23490250|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
23490251|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
23490252|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
23490253|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
23490254|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
23490255|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
23490256|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
23490257|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
23490258|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
23490259|NCT01226043|65541349|FG000|6-week Re-randomization Phase|Physician Decision|0|||
23490260|NCT01226043|65541350|FG001|6-week Re-randomization Phase|Physician Decision|0|||
23490261|NCT01226043|65541351|FG002|6-week Re-randomization Phase|Physician Decision|3|||
23490262|NCT01226043|65541352|FG003|6-week Re-randomization Phase|Physician Decision|2|||
23490263|NCT01226043|65541349|FG000|6-week Re-randomization Phase|completed in error|0|||
23490264|NCT01226043|65541350|FG001|6-week Re-randomization Phase|completed in error|0|||
23490265|NCT01226043|65541351|FG002|6-week Re-randomization Phase|completed in error|0|||
23490266|NCT01226043|65541352|FG003|6-week Re-randomization Phase|completed in error|1|||
23490267|NCT01226043|65541349|FG000|30-week Observational Phase|Adverse Event|0|||
23490268|NCT01226043|65541350|FG001|30-week Observational Phase|Adverse Event|0|||
23490269|NCT01226043|65541351|FG002|30-week Observational Phase|Adverse Event|1|||
23605146|NCT04070105|65943614|FG003|Overall Study|Lost to Follow-up|0|||
23605147|NCT04070105|65943615|FG004|Overall Study|Lost to Follow-up|0|||
23605148|NCT04070105|65943616|FG005|Overall Study|Lost to Follow-up|1|||
23605149|NCT01229176|65943617|FG000|Overall Study|Withdrawal by Subject|0|||
23605150|NCT01229176|65943618|FG001|Overall Study|Withdrawal by Subject|0|||
23605151|NCT01229176|65943619|FG002|Overall Study|Withdrawal by Subject|0|||
23605152|NCT01229176|65943620|FG003|Overall Study|Withdrawal by Subject|1|||
23605153|NCT01229176|65943621|FG004|Overall Study|Withdrawal by Subject|1|||
23605154|NCT01229176|65943622|FG005|Overall Study|Withdrawal by Subject|1|||
23605155|NCT01229176|65943623|FG006|Overall Study|Withdrawal by Subject|0|||
23605156|NCT01229176|65943624|FG007|Overall Study|Withdrawal by Subject|1|||
23605157|NCT01229176|65943617|FG000|Overall Study|Lost to Follow-up|0|||
23605158|NCT01229176|65943618|FG001|Overall Study|Lost to Follow-up|3|||
23490270|NCT01226043|65541352|FG003|30-week Observational Phase|Adverse Event|1|||
23490271|NCT01226043|65541349|FG000|30-week Observational Phase|Protocol Violation|0|||
23490272|NCT01226043|65541350|FG001|30-week Observational Phase|Protocol Violation|0|||
23490273|NCT01226043|65541351|FG002|30-week Observational Phase|Protocol Violation|0|||
23490274|NCT01226043|65541352|FG003|30-week Observational Phase|Protocol Violation|1|||
23490275|NCT01226043|65541349|FG000|30-week Observational Phase|Lost to Follow-up|0|||
23490276|NCT01226043|65541350|FG001|30-week Observational Phase|Lost to Follow-up|0|||
23490277|NCT01226043|65541351|FG002|30-week Observational Phase|Lost to Follow-up|2|||
23490278|NCT01226043|65541352|FG003|30-week Observational Phase|Lost to Follow-up|2|||
23490279|NCT01226043|65541349|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
23490280|NCT01226043|65541350|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
23490281|NCT01226043|65541351|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
23490282|NCT01226043|65541352|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
23490283|NCT01226043|65541349|FG000|30-week Observational Phase|Physician Decision|0|||
23490284|NCT01226043|65541350|FG001|30-week Observational Phase|Physician Decision|0|||
23490285|NCT01226043|65541351|FG002|30-week Observational Phase|Physician Decision|2|||
23490286|NCT01226043|65541352|FG003|30-week Observational Phase|Physician Decision|2|||
23490287|NCT01346969|65541353|FG000|Overall Study|Withdrawal by Subject|0|||
23490288|NCT01346969|65541354|FG001|Overall Study|Withdrawal by Subject|0|||
23490289|NCT01346969|65541355|FG002|Overall Study|Withdrawal by Subject|1|||
23490290|NCT01346969|65541356|FG003|Overall Study|Withdrawal by Subject|0|||
23490291|NCT01346969|65541353|FG000|Overall Study|Lost to Follow-up|1|||
23490292|NCT01346969|65541354|FG001|Overall Study|Lost to Follow-up|0|||
23490293|NCT01346969|65541355|FG002|Overall Study|Lost to Follow-up|2|||
23490294|NCT01346969|65541356|FG003|Overall Study|Lost to Follow-up|0|||
23490295|NCT01346969|65541353|FG000|Overall Study|Physician Decision|0|||
23490296|NCT01346969|65541354|FG001|Overall Study|Physician Decision|0|||
23490297|NCT01346969|65541355|FG002|Overall Study|Physician Decision|0|||
23490298|NCT01346969|65541356|FG003|Overall Study|Physician Decision|1|||
23490299|NCT01346969|65541353|FG000|Overall Study|Randomized but not treated|1|||
23490300|NCT01346969|65541354|FG001|Overall Study|Randomized but not treated|0|||
23490301|NCT01346969|65541355|FG002|Overall Study|Randomized but not treated|0|||
23490302|NCT01346969|65541356|FG003|Overall Study|Randomized but not treated|0|||
23490303|NCT01193842|65541357|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
23285592|NCT00715676|64787840|FG002|Overall Study|Elevated Blood Glucose|0|||
23285593|NCT03382041|64787841|FG000|Overall Study|Consent Form Lost|2|||
23285594|NCT03382041|64787842|FG001|Overall Study|Consent Form Lost|1|||
23285595|NCT03382041|64787841|FG000|Overall Study|Withdrawal by Subject|1|||
23285596|NCT03382041|64787842|FG001|Overall Study|Withdrawal by Subject|4|||
23285597|NCT03382041|64787841|FG000|Overall Study|Lost to Follow-up|1|||
23285598|NCT03382041|64787842|FG001|Overall Study|Lost to Follow-up|4|||
23285599|NCT00909038|64787843|FG000|Overall Study|Protocol Violation|187|||
23378176|NCT00724893|65130434|FG001|Overall Study|Substance abuse|3|||
23490304|NCT01193842|65541358|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
23490305|NCT01193842|65541359|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
23490306|NCT01193842|65541360|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
23490307|NCT01193842|65541361|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
23490308|NCT01193842|65541357|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
23490309|NCT01193842|65541358|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
23490310|NCT01193842|65541359|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
23490311|NCT01193842|65541360|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
23490312|NCT01193842|65541361|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
23490313|NCT01193842|65541357|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
23490314|NCT01193842|65541358|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
23490315|NCT01193842|65541359|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
23490316|NCT01193842|65541360|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
23490317|NCT01193842|65541361|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
23490318|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Death|0|||
23490319|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Death|0|||
23490320|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Death|0|||
23490321|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Death|1|||
23490322|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Death|1|||
23490323|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Adverse Event|0|||
23490324|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Adverse Event|0|||
23490325|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Adverse Event|0|||
23490326|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Adverse Event|5|||
23285600|NCT00909038|64787843|FG000|Overall Study|Non-evaluable Subjects|230|||
23285601|NCT00515216|64787853|FG000|Overall Study|Withdrawal by Subject|1|||
23490327|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Adverse Event|3|||
23490328|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
23490329|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
23490330|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
23490331|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
23490332|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
23490333|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Ineligible|0|||
23490334|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Ineligible|0|||
23490335|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Ineligible|0|||
23490336|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Ineligible|0|||
23490337|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Ineligible|1|||
23490338|NCT01193842|65541357|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
23490339|NCT01193842|65541358|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
23490340|NCT01193842|65541359|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
23490341|NCT01193842|65541360|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
23490342|NCT01193842|65541361|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
23490343|NCT02556203|65541370|FG000|Overall Study|Withdrawal by Subject|21|||
23490344|NCT02556203|65541371|FG001|Overall Study|Withdrawal by Subject|21|||
23490345|NCT02556203|65541370|FG000|Overall Study|Lost to Follow-up|5|||
23490346|NCT02556203|65541371|FG001|Overall Study|Lost to Follow-up|5|||
23490347|NCT02556203|65541370|FG000|Overall Study|Adverse Event|1|||
23490348|NCT02556203|65541371|FG001|Overall Study|Adverse Event|0|||
23490349|NCT02979197|65541373|FG000|Overall Study|Adverse Event|4|||
23490350|NCT02979197|65541374|FG001|Overall Study|Adverse Event|2|||
23490351|NCT02979197|65541375|FG002|Overall Study|Adverse Event|0|||
23490352|NCT02979197|65541373|FG000|Overall Study|Protocol Violation|0|||
23490353|NCT02979197|65541374|FG001|Overall Study|Protocol Violation|1|||
23490354|NCT02979197|65541375|FG002|Overall Study|Protocol Violation|0|||
23490355|NCT02979197|65541373|FG000|Overall Study|Subject unable to commit to study dates|0|||
23490356|NCT02979197|65541374|FG001|Overall Study|Subject unable to commit to study dates|1|||
23490357|NCT02979197|65541375|FG002|Overall Study|Subject unable to commit to study dates|0|||
23490358|NCT00195273|65541376|FG000|Overall Study|Adverse Event|9|||
23490359|NCT00195273|65541377|FG001|Overall Study|Adverse Event|9|||
23490360|NCT00195273|65541376|FG000|Overall Study|Protocol deviation|0|||
23490361|NCT00195273|65541377|FG001|Overall Study|Protocol deviation|1|||
23490362|NCT00195273|65541376|FG000|Overall Study|Lack of Efficacy|3|||
23490363|NCT00195273|65541377|FG001|Overall Study|Lack of Efficacy|1|||
23490364|NCT00195273|65541376|FG000|Overall Study|Procedural complications|9|||
23490365|NCT00195273|65541377|FG001|Overall Study|Procedural complications|3|||
23490366|NCT00107783|65541378|FG000|Overall Study|Adverse Event|0|||
23490367|NCT00107783|65541379|FG001|Overall Study|Adverse Event|2|||
23490368|NCT00107783|65541378|FG000|Overall Study|Death|0|||
23490369|NCT00107783|65541379|FG001|Overall Study|Death|1|||
23490370|NCT00107783|65541378|FG000|Overall Study|Withdrawal by Subject|2|||
23490371|NCT00107783|65541379|FG001|Overall Study|Withdrawal by Subject|0|||
23490372|NCT00107783|65541378|FG000|Overall Study|Second hip replacement|1|||
23490373|NCT00107783|65541379|FG001|Overall Study|Second hip replacement|1|||
23490374|NCT05095454|65541380|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
23490375|NCT05095454|65541381|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
23490376|NCT01281137|65541384|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
23490377|NCT01281137|65541385|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
23490378|NCT01281137|65541384|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
23490379|NCT01281137|65541385|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
23490380|NCT01281137|65541384|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
23490381|NCT01281137|65541385|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
23490382|NCT01281137|65541384|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
23490383|NCT01281137|65541385|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
23490384|NCT01281137|65541384|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
23490385|NCT01281137|65541385|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
23490386|NCT04676412|65541386|FG000|Overall Study|Death|17|||
23490387|NCT04676412|65541387|FG001|Overall Study|Death|23|||
23490388|NCT04676412|65541386|FG000|Overall Study|Withdrawal by Subject|0|||
23490389|NCT04676412|65541387|FG001|Overall Study|Withdrawal by Subject|2|||
23490390|NCT04676412|65541386|FG000|Overall Study|Participants ongoing|32|||
23378177|NCT00724893|65130433|FG000|Overall Study|Financial reasons|0|||
23285602|NCT01944722|64787854|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
23285603|NCT01944722|64787854|FG000|Overall Study|Specimen Shipping Issues|34|||
23285604|NCT01944722|64787854|FG000|Overall Study|Improper Storage/Transport|5|||
23285605|NCT01944722|64787854|FG000|Overall Study|Insufficient Volume for Test|1|||
23378178|NCT00724893|65130434|FG001|Overall Study|Financial reasons|2|||
23378179|NCT00724893|65130433|FG000|Overall Study|Assigned shorter treatment|0|||
23378180|NCT00724893|65130434|FG001|Overall Study|Assigned shorter treatment|2|||
23378181|NCT00724893|65130433|FG000|Overall Study|Lost to Follow-up|0|||
23378182|NCT00724893|65130434|FG001|Overall Study|Lost to Follow-up|52|||
23378183|NCT00724893|65130433|FG000|Overall Study|Unknown, missing data|1|||
23378184|NCT00724893|65130434|FG001|Overall Study|Unknown, missing data|1|||
23378185|NCT01104766|65130435|FG000|Overall Study|Did not meet inc/exc criteria|1|||
23378186|NCT01104766|65130436|FG001|Overall Study|Did not meet inc/exc criteria|0|||
23378187|NCT01104766|65130437|FG002|Overall Study|Did not meet inc/exc criteria|0|||
23378188|NCT01104766|65130438|FG003|Overall Study|Did not meet inc/exc criteria|0|||
23378189|NCT01104766|65130435|FG000|Overall Study|Adverse Event|17|||
23378190|NCT01104766|65130436|FG001|Overall Study|Adverse Event|15|||
23378191|NCT01104766|65130437|FG002|Overall Study|Adverse Event|20|||
23378192|NCT01104766|65130438|FG003|Overall Study|Adverse Event|14|||
23378193|NCT01104766|65130435|FG000|Overall Study|Lack of Efficacy|20|||
23378194|NCT01104766|65130436|FG001|Overall Study|Lack of Efficacy|15|||
23378195|NCT01104766|65130437|FG002|Overall Study|Lack of Efficacy|14|||
23378196|NCT01104766|65130438|FG003|Overall Study|Lack of Efficacy|8|||
23378197|NCT01104766|65130435|FG000|Overall Study|Protocol Violation|2|||
23378198|NCT01104766|65130436|FG001|Overall Study|Protocol Violation|0|||
23378199|NCT01104766|65130437|FG002|Overall Study|Protocol Violation|0|||
23378200|NCT01104766|65130438|FG003|Overall Study|Protocol Violation|0|||
23378201|NCT01104766|65130435|FG000|Overall Study|Withdrawal by Subject|17|||
23378202|NCT01104766|65130436|FG001|Overall Study|Withdrawal by Subject|19|||
23378203|NCT01104766|65130437|FG002|Overall Study|Withdrawal by Subject|25|||
23378204|NCT01104766|65130438|FG003|Overall Study|Withdrawal by Subject|15|||
23378205|NCT01104766|65130435|FG000|Overall Study|Lost to Follow-up|1|||
23378206|NCT01104766|65130436|FG001|Overall Study|Lost to Follow-up|2|||
23378207|NCT01104766|65130437|FG002|Overall Study|Lost to Follow-up|1|||
23378208|NCT01104766|65130438|FG003|Overall Study|Lost to Follow-up|1|||
23378209|NCT03387046|65130441|FG000|Overall Study|Adverse Event|1|||
23378210|NCT03387046|65130442|FG001|Overall Study|Adverse Event|1|||
23378211|NCT02693418|65130443|FG000|Overall Study|Lost to Follow-up|1|||
23378212|NCT02693418|65130444|FG001|Overall Study|Lost to Follow-up|2|||
23285606|NCT01944722|64787854|FG000|Overall Study|Missing Specimens|3|||
23285607|NCT01944722|64787854|FG000|Overall Study|Specimens Mislabeled|2|||
23285608|NCT01944722|64787854|FG000|Overall Study|Withdrawal by Subject|8|||
23285609|NCT01944722|64787854|FG000|Overall Study|NILM Subjects <30 years old|8106|||
23285610|NCT01944722|64787854|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
23285611|NCT01944722|64787854|FG000|Overall Study|>ASCUS Cytology|1122|||
23285612|NCT02420353|64787855|FG000|Overall Study|Withdrawal by Subject|0|||
23285613|NCT02420353|64787856|FG001|Overall Study|Withdrawal by Subject|1|||
23285614|NCT01590563|64787857|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
23285615|NCT02676973|64787859|FG000|Overall Study|Withdrawal by Subject|9|||
23285616|NCT02676973|64787860|FG001|Overall Study|Withdrawal by Subject|8|||
23285617|NCT02676973|64787861|FG002|Overall Study|Withdrawal by Subject|11|||
23285618|NCT02676973|64787859|FG000|Overall Study|Lost to Follow-up|8|||
23285619|NCT02676973|64787860|FG001|Overall Study|Lost to Follow-up|12|||
23285620|NCT02676973|64787861|FG002|Overall Study|Lost to Follow-up|8|||
23285621|NCT02676973|64787859|FG000|Overall Study|Death|2|||
23285622|NCT02676973|64787860|FG001|Overall Study|Death|1|||
23285623|NCT02676973|64787861|FG002|Overall Study|Death|5|||
23285624|NCT01051349|64787862|FG000|Overall Study|Adverse Event|88|||
23285625|NCT01051349|64787862|FG000|Overall Study|Consent Withdrawn|54|||
23285626|NCT01051349|64787862|FG000|Overall Study|Investigator Decision|6|||
23285627|NCT01051349|64787862|FG000|Overall Study|Lost to Follow-up|6|||
23285628|NCT01051349|64787862|FG000|Overall Study|Subject non-compliance|7|||
23285629|NCT01051349|64787862|FG000|Overall Study|Reason not Specified|12|||
23285630|NCT00420095|64787864|FG000|Overall Study|Adverse Event|1|||
23285631|NCT00420095|64787865|FG001|Overall Study|Adverse Event|0|||
23285632|NCT00420095|64787864|FG000|Overall Study|Protocol Violation|1|||
23285633|NCT00420095|64787865|FG001|Overall Study|Protocol Violation|1|||
23285634|NCT00420095|64787864|FG000|Overall Study|Lost to Follow-up|1|||
23285635|NCT00420095|64787865|FG001|Overall Study|Lost to Follow-up|0|||
23285636|NCT03257254|64787866|FG000|Overall Study|Withdrawal by Subject|7|||
23378213|NCT02693418|65130445|FG002|Overall Study|Lost to Follow-up|0|||
23378214|NCT02693418|65130446|FG003|Overall Study|Lost to Follow-up|0|||
23378215|NCT02693418|65130447|FG004|Overall Study|Lost to Follow-up|0|||
23378216|NCT02693418|65130443|FG000|Overall Study|Menses during study period|0|||
23378217|NCT02693418|65130444|FG001|Overall Study|Menses during study period|0|||
23378218|NCT02693418|65130445|FG002|Overall Study|Menses during study period|2|||
23378219|NCT02693418|65130446|FG003|Overall Study|Menses during study period|0|||
23378220|NCT02693418|65130447|FG004|Overall Study|Menses during study period|0|||
23490391|NCT04676412|65541387|FG001|Overall Study|Participants ongoing|33|||
23490392|NCT02003365|65541388|FG000|Overall Study|Lost to Follow-up|0|||
23490393|NCT02003365|65541389|FG001|Overall Study|Lost to Follow-up|0|||
23490394|NCT02003365|65541390|FG002|Overall Study|Lost to Follow-up|1|||
23490395|NCT00131508|65541391|FG000|Overall Study|Disease progression|0|||
23490396|NCT00131508|65541392|FG001|Overall Study|Disease progression|2|||
23490397|NCT00131508|65541391|FG000|Overall Study|Non-Compliance|2|||
23490398|NCT00131508|65541392|FG001|Overall Study|Non-Compliance|4|||
23490399|NCT00131508|65541391|FG000|Overall Study|Withdrawal by Subject|1|||
23490400|NCT00131508|65541392|FG001|Overall Study|Withdrawal by Subject|2|||
23490401|NCT00737438|65541393|FG000|Overall Study|Withdrawal by Subject|2|||
23490402|NCT00737438|65541393|FG000|Overall Study|Patient ineligible|1|||
23490403|NCT04697056|65541396|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
23490404|NCT04697056|65541397|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
23490405|NCT02520661|65541400|FG000|Overall Study|Lost to Follow-up|7|||
23490406|NCT02520661|65541401|FG001|Overall Study|Lost to Follow-up|3|||
23490407|NCT02520661|65541400|FG000|Overall Study|Admitted from ED|49|||
23490408|NCT02520661|65541401|FG001|Overall Study|Admitted from ED|48|||
23490409|NCT02520661|65541400|FG000|Overall Study|ED greater than 24 hours|29|||
23490410|NCT02520661|65541401|FG001|Overall Study|ED greater than 24 hours|38|||
23490411|NCT02520661|65541400|FG000|Overall Study|other ineligibility|14|||
23490412|NCT02520661|65541401|FG001|Overall Study|other ineligibility|22|||
23490413|NCT02520661|65541400|FG000|Overall Study|Withdrawal by Subject|7|||
23490414|NCT02520661|65541401|FG001|Overall Study|Withdrawal by Subject|16|||
23490415|NCT03898960|65541402|FG000|Overall Study|Death|10|||
23490416|NCT02448810|65541403|FG000|Overall Study|Adverse Event|0|||
23490417|NCT02448810|65541404|FG001|Overall Study|Adverse Event|0|||
23490418|NCT02448810|65541405|FG002|Overall Study|Adverse Event|1|||
23490419|NCT02448810|65541406|FG003|Overall Study|Adverse Event|0|||
23285637|NCT03257254|64787866|FG000|Overall Study|Lost to Follow-up|9|||
23285638|NCT03257254|64787866|FG000|Overall Study|Study discontinued by sponsor|5|||
23285639|NCT00660387|64787871|FG000|Overall Study|Adverse Event|1|||
23285640|NCT00660387|64787872|FG001|Overall Study|Adverse Event|2|||
23285641|NCT00660387|64787871|FG000|Overall Study|Lack of Efficacy|0|||
23285642|NCT00660387|64787872|FG001|Overall Study|Lack of Efficacy|1|||
23285643|NCT00660387|64787871|FG000|Overall Study|Protocol Violation|1|||
23285644|NCT00660387|64787872|FG001|Overall Study|Protocol Violation|0|||
23285645|NCT03101358|64787873|FG000|Overall Study|Non-compliance with study schedule|1|||
23285646|NCT03101358|64787874|FG001|Overall Study|Non-compliance with study schedule|0|||
23285647|NCT03101358|64787875|FG002|Overall Study|Non-compliance with study schedule|0|||
23378221|NCT01179399|65130448|FG000|Overall Study|Adverse Event|1|||
23378222|NCT01179399|65130448|FG000|Overall Study|Lack of Efficacy|30|||
23378223|NCT01179399|65130448|FG000|Overall Study|Withdrawal by Subject|1|||
23378224|NCT01018979|65130449|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
23378225|NCT01018979|65130450|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
23378226|NCT01018979|65130449|FG000|Overall Study|Not received at least one dose|0|||
23378227|NCT01018979|65130450|FG001|Overall Study|Not received at least one dose|1|||
23378228|NCT00970944|65130456|FG000|Overall Study|Death|1|||
23378229|NCT00970944|65130457|FG001|Overall Study|Death|0|||
23490420|NCT02448810|65541407|FG004|Overall Study|Adverse Event|0|||
23490421|NCT02448810|65541408|FG005|Overall Study|Adverse Event|0|||
23490422|NCT02448810|65541409|FG006|Overall Study|Adverse Event|0|||
23605159|NCT01229176|65943619|FG002|Overall Study|Lost to Follow-up|0|||
23285648|NCT03101358|64787876|FG003|Overall Study|Non-compliance with study schedule|1|||
23285649|NCT03101358|64787873|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
23285650|NCT03101358|64787874|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
23285651|NCT03101358|64787875|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
23285652|NCT03101358|64787876|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
23285653|NCT03101358|64787873|FG000|Overall Study|Physician Decision|1|||
23285654|NCT03101358|64787874|FG001|Overall Study|Physician Decision|0|||
23285655|NCT03101358|64787875|FG002|Overall Study|Physician Decision|0|||
23285656|NCT03101358|64787876|FG003|Overall Study|Physician Decision|3|||
23285657|NCT03101358|64787873|FG000|Overall Study|Adverse Event|0|||
23285658|NCT03101358|64787874|FG001|Overall Study|Adverse Event|0|||
23285659|NCT03101358|64787875|FG002|Overall Study|Adverse Event|1|||
23285660|NCT03101358|64787876|FG003|Overall Study|Adverse Event|0|||
23285661|NCT03101358|64787873|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
23285662|NCT03101358|64787874|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
23490423|NCT02448810|65541410|FG007|Overall Study|Adverse Event|0|||
23490424|NCT02448810|65541403|FG000|Overall Study|Withdrawal by Subject|0|||
23490425|NCT02448810|65541404|FG001|Overall Study|Withdrawal by Subject|0|||
23490426|NCT02448810|65541405|FG002|Overall Study|Withdrawal by Subject|1|||
23378230|NCT00970944|65130456|FG000|Overall Study|Physician Decision|0|||
23378231|NCT00970944|65130457|FG001|Overall Study|Physician Decision|2|||
23378232|NCT01913353|65130458|FG000|Overall Study|Adverse Event|2|||
23378233|NCT01913353|65130459|FG001|Overall Study|Adverse Event|0|||
23378234|NCT01913353|65130458|FG000|Overall Study|Physician Decision|0|||
23378235|NCT01913353|65130459|FG001|Overall Study|Physician Decision|2|||
23605160|NCT01229176|65943620|FG003|Overall Study|Lost to Follow-up|0|||
23605161|NCT01229176|65943621|FG004|Overall Study|Lost to Follow-up|1|||
23605162|NCT01229176|65943622|FG005|Overall Study|Lost to Follow-up|1|||
23605163|NCT01229176|65943623|FG006|Overall Study|Lost to Follow-up|0|||
23605164|NCT01229176|65943624|FG007|Overall Study|Lost to Follow-up|2|||
23605165|NCT01989104|65943627|FG000|Overall Study|Withdrawal by Subject|3|||
23605166|NCT01989104|65943628|FG001|Overall Study|Withdrawal by Subject|0|||
23605167|NCT01989104|65943629|FG002|Overall Study|Withdrawal by Subject|0|||
23605168|NCT01989104|65943630|FG003|Overall Study|Withdrawal by Subject|0|||
23605169|NCT01989104|65943631|FG004|Overall Study|Withdrawal by Subject|0|||
23605170|NCT02188459|65943633|FG000|Overall Study|Lost to Follow-up|3|||
23605171|NCT02188459|65943634|FG001|Overall Study|Lost to Follow-up|4|||
23605172|NCT02188459|65943633|FG000|Overall Study|Early Termination|0|||
23605173|NCT02188459|65943634|FG001|Overall Study|Early Termination|3|||
23605174|NCT01794299|65943635|FG000|Overall Study|ATIR manufacturing not possible|1|||
23605175|NCT01794299|65943635|FG000|Overall Study|Death|14|||
23605176|NCT01794299|65943635|FG000|Overall Study|Graft failure|1|||
23285663|NCT03101358|64787875|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
23285664|NCT03101358|64787876|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
23285665|NCT03101358|64787873|FG000|Overall Study|Lost to Follow-up|1|||
23285666|NCT03101358|64787874|FG001|Overall Study|Lost to Follow-up|0|||
23285667|NCT03101358|64787875|FG002|Overall Study|Lost to Follow-up|0|||
23285668|NCT03101358|64787876|FG003|Overall Study|Lost to Follow-up|1|||
23285669|NCT01370863|64787877|FG000|Overall Study|Adverse Event|1|||
23285670|NCT01370863|64787878|FG001|Overall Study|Adverse Event|1|||
23285671|NCT01370863|64787877|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
23285672|NCT01370863|64787878|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
23285673|NCT01370863|64787877|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23285674|NCT01370863|64787878|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23285675|NCT03247686|64787879|FG000|Overall Study|Withdrawal by Subject|1|||
23285676|NCT03247686|64787880|FG001|Overall Study|Withdrawal by Subject|2|||
23285677|NCT00826241|64787881|FG000|Overall Study|Withdrawal from Follow-up|1|||
23285678|NCT00826241|64787881|FG000|Overall Study|Withdrew consent|2|||
23285679|NCT00826241|64787881|FG000|Overall Study|Death|4|||
23285680|NCT00826241|64787881|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
23285681|NCT00826241|64787881|FG000|Overall Study|Non-compliance|1|||
23285682|NCT00826241|64787881|FG000|Overall Study|Progression of disease|1|||
23285683|NCT00826241|64787881|FG000|Overall Study|Patient refused follow-up|3|||
23285684|NCT00826241|64787881|FG000|Overall Study|Lost to Follow-up|9|||
23285685|NCT00826241|64787881|FG000|Overall Study|Could not obtain records|1|||
23285686|NCT00826241|64787881|FG000|Overall Study|Screen failure|2|||
23285687|NCT00826241|64787881|FG000|Overall Study|Pt unable to proceed to registration|1|||
23285688|NCT00826241|64787881|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
23285689|NCT03366792|64787882|FG000|Overall Study|Withdrawal by Subject|7|||
23285690|NCT03366792|64787882|FG000|Overall Study|Lost to Follow-up|2|||
23285691|NCT03366792|64787882|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
23285692|NCT03366792|64787882|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
23285693|NCT01131260|64787884|FG000|Overall Study|Randomization error|5|||
23285694|NCT01131260|64787885|FG001|Overall Study|Randomization error|1|||
23285695|NCT01131260|64787884|FG000|Overall Study|Declined to continue participation|8|||
23285696|NCT01131260|64787885|FG001|Overall Study|Declined to continue participation|13|||
23285697|NCT01131260|64787884|FG000|Overall Study|Physician Decision|22|||
23285698|NCT01131260|64787885|FG001|Overall Study|Physician Decision|24|||
23285699|NCT01131260|64787884|FG000|Overall Study|Technical problems|7|||
23285700|NCT01131260|64787885|FG001|Overall Study|Technical problems|6|||
23285701|NCT01131260|64787884|FG000|Overall Study|Staff error|2|||
23285702|NCT01131260|64787885|FG001|Overall Study|Staff error|1|||
23285703|NCT01131260|64787884|FG000|Overall Study|Ineligible|0|||
23285704|NCT01131260|64787885|FG001|Overall Study|Ineligible|2|||
23285705|NCT04590027|64787886|FG000|Overall Study|Lost to Follow-up|17|||
23285706|NCT04590027|64787887|FG001|Overall Study|Lost to Follow-up|14|||
23285707|NCT04590027|64787886|FG000|Overall Study|Protocol Violation|0|||
23285708|NCT04590027|64787887|FG001|Overall Study|Protocol Violation|3|||
23285709|NCT01859598|64787893|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
23605177|NCT01794299|65943635|FG000|Overall Study|ATIR batch rejected|2|||
23285710|NCT01460628|64787894|FG000|Overall Study|Adverse Event|3|||
23285711|NCT01460628|64787894|FG000|Overall Study|Withdrawal by Subject|2|||
23285712|NCT01963260|64787897|FG000|Overall Study|Withdrawal by Subject|2|||
23285713|NCT01963260|64787898|FG001|Overall Study|Withdrawal by Subject|0|||
23285714|NCT01963260|64787899|FG002|Overall Study|Withdrawal by Subject|0|||
23285715|NCT01963260|64787900|FG003|Overall Study|Withdrawal by Subject|1|||
23378236|NCT01913353|65130458|FG000|Overall Study|Withdrawal by Subject|20|||
23605178|NCT01794299|65943635|FG000|Overall Study|Relapse|2|||
23378237|NCT01913353|65130459|FG001|Overall Study|Withdrawal by Subject|6|||
23378238|NCT01913353|65130458|FG000|Overall Study|multiple reasons|10|||
23378239|NCT01913353|65130459|FG001|Overall Study|multiple reasons|7|||
23378240|NCT00303953|65130466|FG000|Overall Study|Ineligible|1|||
23378241|NCT00303953|65130466|FG000|Overall Study|Death|1|||
23378242|NCT00303953|65130466|FG000|Overall Study|Adverse Event|4|||
23378243|NCT00303953|65130466|FG000|Overall Study|Lack of Efficacy|12|||
23378244|NCT00303953|65130466|FG000|Overall Study|Physician Decision|1|||
23378245|NCT02875080|65130473|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
23378246|NCT02875080|65130474|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
23378247|NCT02875080|65130475|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
23378248|NCT03704688|65130480|FG000|Overall Study|Adverse Event|0|||
23378249|NCT03704688|65130481|FG001|Overall Study|Adverse Event|0|||
23378250|NCT03704688|65130482|FG002|Overall Study|Adverse Event|0|||
23378251|NCT03704688|65130483|FG003|Overall Study|Adverse Event|4|||
23378252|NCT03704688|65130484|FG004|Overall Study|Adverse Event|1|||
23378253|NCT03704688|65130485|FG005|Overall Study|Adverse Event|0|||
23378254|NCT03704688|65130480|FG000|Overall Study|Disease Progression|0|||
23378255|NCT03704688|65130481|FG001|Overall Study|Disease Progression|0|||
23378256|NCT03704688|65130482|FG002|Overall Study|Disease Progression|0|||
23378257|NCT03704688|65130483|FG003|Overall Study|Disease Progression|3|||
23378258|NCT03704688|65130484|FG004|Overall Study|Disease Progression|1|||
23378259|NCT03704688|65130485|FG005|Overall Study|Disease Progression|0|||
23378260|NCT03704688|65130480|FG000|Overall Study|Death|0|||
23378261|NCT03704688|65130481|FG001|Overall Study|Death|0|||
23378262|NCT03704688|65130482|FG002|Overall Study|Death|0|||
23378263|NCT03704688|65130483|FG003|Overall Study|Death|0|||
23378264|NCT03704688|65130484|FG004|Overall Study|Death|3|||
23378265|NCT03704688|65130485|FG005|Overall Study|Death|0|||
23378266|NCT01389232|65130486|FG000|Overall Study|Had scaffold removed|15|||
23378267|NCT01389232|65130486|FG000|Overall Study|Personal reasons|2|||
23378268|NCT01389232|65130486|FG000|Overall Study|Adverse Event|1|||
23378269|NCT01389232|65130486|FG000|Overall Study|Death|1|||
23378270|NCT00177671|65130487|FG000|Overall Study|Withdrawal by Subject|5|||
23378271|NCT00177671|65130488|FG001|Overall Study|Withdrawal by Subject|6|||
23378272|NCT00177671|65130487|FG000|Overall Study|medical complications|2|||
23378273|NCT00177671|65130488|FG001|Overall Study|medical complications|0|||
23378274|NCT00177671|65130487|FG000|Overall Study|Adverse Event|6|||
23378275|NCT00177671|65130488|FG001|Overall Study|Adverse Event|0|||
23378276|NCT00177671|65130487|FG000|Overall Study|Physician Decision|12|||
23378277|NCT00177671|65130488|FG001|Overall Study|Physician Decision|8|||
23378278|NCT01898078|65130489|FG000|Overall Study|Progressive Disease|1|||
23378279|NCT01898078|65130490|FG001|Overall Study|Progressive Disease|5|||
23378280|NCT01898078|65130489|FG000|Overall Study|Adverse Event|2|||
23378281|NCT01898078|65130490|FG001|Overall Study|Adverse Event|1|||
23378282|NCT01898078|65130489|FG000|Overall Study|Withdrawal by Subject|1|||
23378283|NCT01898078|65130490|FG001|Overall Study|Withdrawal by Subject|1|||
23378284|NCT01898078|65130489|FG000|Overall Study|Symptomatic Deterioration|2|||
23378285|NCT01898078|65130490|FG001|Overall Study|Symptomatic Deterioration|0|||
23378286|NCT01898078|65130489|FG000|Overall Study|Reason not Specified|0|||
23378287|NCT01898078|65130490|FG001|Overall Study|Reason not Specified|1|||
23378288|NCT00768053|65130493|FG000|Overall Study|Adverse Event|10|||
23378289|NCT00768053|65130493|FG000|Overall Study|Lost to Follow-up|1|||
23378290|NCT02184156|65130494|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
23378291|NCT02184156|65130495|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
23378292|NCT02184156|65130494|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
23378293|NCT02184156|65130495|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
23378294|NCT02965833|65130496|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
23378295|NCT02965833|65130497|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
23378296|NCT02965833|65130496|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
23378297|NCT02965833|65130497|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
23605179|NCT01794299|65943635|FG000|Overall Study|Discontinued from active follow-up|1|||
23605180|NCT01794299|65943635|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
23605181|NCT02241785|65943637|FG000|Overall Study|Sponsor Termination|43|||
23605182|NCT02241785|65943637|FG000|Overall Study|Withdrawal by Subject|1|||
23378298|NCT02965833|65130496|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
23378299|NCT02965833|65130497|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
23378300|NCT02965833|65130496|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
23378301|NCT02965833|65130497|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
23378302|NCT02965833|65130496|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
23378303|NCT02965833|65130497|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
23378304|NCT01137812|65130498|FG000|Overall Study|Adverse Event|21|||
23378305|NCT01137812|65130499|FG001|Overall Study|Adverse Event|14|||
23378306|NCT01137812|65130498|FG000|Overall Study|Lost to Follow-up|6|||
23378307|NCT01137812|65130499|FG001|Overall Study|Lost to Follow-up|8|||
23378308|NCT01137812|65130498|FG000|Overall Study|Physician Decision|25|||
23378309|NCT01137812|65130499|FG001|Overall Study|Physician Decision|17|||
23378310|NCT01137812|65130498|FG000|Overall Study|Protocol Violation|5|||
23378311|NCT01137812|65130499|FG001|Overall Study|Protocol Violation|4|||
23378312|NCT01137812|65130498|FG000|Overall Study|Withdrawal by Subject|5|||
23378313|NCT01137812|65130499|FG001|Overall Study|Withdrawal by Subject|13|||
23378314|NCT01137812|65130498|FG000|Overall Study|Death|2|||
23378315|NCT01137812|65130499|FG001|Overall Study|Death|0|||
23378316|NCT01137812|65130498|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
23378317|NCT01137812|65130499|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
23378318|NCT01137812|65130498|FG000|Overall Study|Other|19|||
23378319|NCT01137812|65130499|FG001|Overall Study|Other|27|||
23378320|NCT01245751|65130500|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
23378321|NCT01245751|65130501|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
23378322|NCT01245751|65130502|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
23378323|NCT01245751|65130503|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
23378324|NCT01245751|65130500|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
23378325|NCT01245751|65130501|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
23378326|NCT01245751|65130502|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
23378327|NCT01245751|65130503|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
23378328|NCT01245751|65130500|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
23378329|NCT01245751|65130501|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
23378330|NCT01245751|65130502|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
23378331|NCT01245751|65130503|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
23378332|NCT01022580|65130504|FG000|Overall Study|Death|18|||
23378333|NCT01022580|65130505|FG001|Overall Study|Death|22|||
23378334|NCT04790201|65130506|FG000|Overall Study|Lost to Follow-up|0|||
23378335|NCT04790201|65130507|FG001|Overall Study|Lost to Follow-up|0|||
23378336|NCT04790201|65130508|FG002|Overall Study|Lost to Follow-up|2|||
23378337|NCT04790201|65130506|FG000|Overall Study|Death|0|||
23378338|NCT04790201|65130507|FG001|Overall Study|Death|1|||
23378339|NCT04790201|65130508|FG002|Overall Study|Death|0|||
23378340|NCT04790201|65130506|FG000|Overall Study|Protocol Violation|1|||
23378341|NCT04790201|65130507|FG001|Overall Study|Protocol Violation|0|||
23378342|NCT04790201|65130508|FG002|Overall Study|Protocol Violation|1|||
23378343|NCT03462680|65130511|FG000|Overall Study|Withdrawal by Subject|3|||
23378344|NCT03462680|65130512|FG001|Overall Study|Withdrawal by Subject|5|||
23378345|NCT03881371|65130515|FG000|Overall Study|Adverse Event|8|||
23285716|NCT01963260|64787901|FG004|Overall Study|Withdrawal by Subject|2|||
23285717|NCT01963260|64787902|FG005|Overall Study|Withdrawal by Subject|0|||
23285718|NCT01963260|64787903|FG006|Overall Study|Withdrawal by Subject|0|||
23285719|NCT01963260|64787904|FG007|Overall Study|Withdrawal by Subject|0|||
23285720|NCT01963260|64787905|FG008|Overall Study|Withdrawal by Subject|0|||
23285721|NCT01963260|64787906|FG009|Overall Study|Withdrawal by Subject|0|||
23285722|NCT00529763|64787907|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
23285723|NCT00529763|64787908|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
23285724|NCT00529763|64787909|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23285725|NCT00529763|64787907|FG000|Overall Study|Death|1|||
23285726|NCT00529763|64787908|FG001|Overall Study|Death|1|||
23285727|NCT00529763|64787909|FG002|Overall Study|Death|1|||
23285728|NCT00529763|64787907|FG000|Overall Study|Disease Progression|10|||
23285729|NCT00529763|64787908|FG001|Overall Study|Disease Progression|16|||
23285730|NCT00529763|64787909|FG002|Overall Study|Disease Progression|11|||
23285731|NCT00529763|64787907|FG000|Overall Study|Lost to Follow-up|1|||
23378346|NCT03881371|65130516|FG001|Overall Study|Adverse Event|9|||
23378347|NCT03881371|65130515|FG000|Overall Study|Death|1|||
23378348|NCT03881371|65130516|FG001|Overall Study|Death|0|||
23378349|NCT03881371|65130515|FG000|Overall Study|Lost to Follow-up|1|||
23378350|NCT03881371|65130516|FG001|Overall Study|Lost to Follow-up|0|||
23378351|NCT03881371|65130515|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23378352|NCT03881371|65130516|FG001|Overall Study|Non-Compliance with Study Drug|2|||
23378353|NCT03881371|65130515|FG000|Overall Study|Physician Decision|3|||
23378354|NCT03881371|65130516|FG001|Overall Study|Physician Decision|3|||
23285732|NCT00529763|64787908|FG001|Overall Study|Lost to Follow-up|2|||
23285733|NCT00529763|64787909|FG002|Overall Study|Lost to Follow-up|3|||
23285734|NCT00529763|64787907|FG000|Overall Study|Stem Cell Transplant|0|||
23285735|NCT00529763|64787908|FG001|Overall Study|Stem Cell Transplant|3|||
23285736|NCT00529763|64787909|FG002|Overall Study|Stem Cell Transplant|1|||
23378355|NCT03881371|65130515|FG000|Overall Study|Withdrawal by Subject|2|||
23378356|NCT03881371|65130516|FG001|Overall Study|Withdrawal by Subject|10|||
23378357|NCT03881371|65130515|FG000|Overall Study|Discontinuation from Study|1|||
23378358|NCT03881371|65130516|FG001|Overall Study|Discontinuation from Study|0|||
23378359|NCT02908347|65130520|FG000|Overall Study|Adverse Event|0|||
23378360|NCT02908347|65130521|FG001|Overall Study|Adverse Event|1|||
23378361|NCT02908347|65130520|FG000|Overall Study|Lost to Follow-up|1|||
23378362|NCT02908347|65130521|FG001|Overall Study|Lost to Follow-up|0|||
23378363|NCT00770367|65130522|FG000|First Intervention|Withdrawal by Subject|0|||
23378364|NCT00770367|65130523|FG001|First Intervention|Withdrawal by Subject|2|||
23378365|NCT00770367|65130522|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
23605183|NCT02241785|65943637|FG000|Overall Study|Lost to Follow-up|2|||
23605184|NCT02241785|65943637|FG000|Overall Study|Adverse Event|1|||
23605185|NCT01852045|65943638|FG000|Overall Study|Adverse Event|1|||
23605186|NCT01852045|65943639|FG001|Overall Study|Adverse Event|0|||
23605187|NCT01852045|65943640|FG002|Overall Study|Adverse Event|0|||
23605188|NCT01852045|65943638|FG000|Overall Study|Lack of Efficacy|3|||
23605189|NCT01852045|65943639|FG001|Overall Study|Lack of Efficacy|0|||
23605190|NCT01852045|65943640|FG002|Overall Study|Lack of Efficacy|0|||
23605191|NCT01852045|65943638|FG000|Overall Study|Lost to Follow-up|0|||
23605192|NCT01852045|65943639|FG001|Overall Study|Lost to Follow-up|1|||
23605193|NCT01852045|65943640|FG002|Overall Study|Lost to Follow-up|1|||
23605194|NCT01852045|65943638|FG000|Overall Study|Withdrawal by Subject|1|||
23605195|NCT01852045|65943639|FG001|Overall Study|Withdrawal by Subject|0|||
23605196|NCT01852045|65943640|FG002|Overall Study|Withdrawal by Subject|1|||
23605197|NCT01852045|65943638|FG000|Overall Study|Other Miscellaneous Reasons|1|||
23605198|NCT01852045|65943639|FG001|Overall Study|Other Miscellaneous Reasons|3|||
23605199|NCT01852045|65943640|FG002|Overall Study|Other Miscellaneous Reasons|2|||
23605200|NCT02114515|65943644|FG000|Overall Study|Lost to Follow-up|52|||
23605201|NCT02114515|65943645|FG001|Overall Study|Lost to Follow-up|55|||
23605202|NCT02114515|65943644|FG000|Overall Study|Death|12|||
23605203|NCT02114515|65943645|FG001|Overall Study|Death|12|||
23605204|NCT02114515|65943644|FG000|Overall Study|Withdrawal by Subject|4|||
23605205|NCT02114515|65943645|FG001|Overall Study|Withdrawal by Subject|22|||
23605206|NCT02114515|65943644|FG000|Overall Study|Other|65|||
23605207|NCT02114515|65943645|FG001|Overall Study|Other|61|||
23605208|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
23605209|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
23605210|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
23605211|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
23605212|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
23605213|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
23605214|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
23605215|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
23605216|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
23605217|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
23605218|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
23605219|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
23605220|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
23605221|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
23605222|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
23605223|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
23285737|NCT00529763|64787907|FG000|Overall Study|Study Drug Toxicity|3|||
23378366|NCT00770367|65130523|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
23378367|NCT00770367|65130522|FG000|Second Intervention|Lost to Follow-up|2|||
23378368|NCT00770367|65130523|FG001|Second Intervention|Lost to Follow-up|0|||
23378369|NCT01695746|65130526|FG000|Overall Study|Adverse Event|1|||
23378370|NCT01695746|65130526|FG000|Overall Study|Non-compliance by the participant|3|||
23378371|NCT01695746|65130526|FG000|Overall Study|Protocol Violation|5|||
23378372|NCT01695746|65130526|FG000|Overall Study|Participant not willing to participate|3|||
23378373|NCT03261401|65130527|FG000|Overall Study|Withdrawal by Subject|0|||
23378374|NCT03261401|65130528|FG001|Overall Study|Withdrawal by Subject|0|||
23378375|NCT03261401|65130529|FG002|Overall Study|Withdrawal by Subject|0|||
23378376|NCT03261401|65130530|FG003|Overall Study|Withdrawal by Subject|0|||
23378377|NCT03261401|65130531|FG004|Overall Study|Withdrawal by Subject|0|||
23378378|NCT03261401|65130532|FG005|Overall Study|Withdrawal by Subject|1|||
23378379|NCT03261401|65130533|FG006|Overall Study|Withdrawal by Subject|0|||
23378380|NCT03261401|65130534|FG007|Overall Study|Withdrawal by Subject|0|||
23378381|NCT03261401|65130535|FG008|Overall Study|Withdrawal by Subject|0|||
23378382|NCT03261401|65130536|FG009|Overall Study|Withdrawal by Subject|0|||
23378383|NCT03261401|65130537|FG010|Overall Study|Withdrawal by Subject|0|||
23378384|NCT03261401|65130538|FG011|Overall Study|Withdrawal by Subject|0|||
23378385|NCT03261401|65130539|FG012|Overall Study|Withdrawal by Subject|0|||
23378386|NCT03261401|65130527|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
23378387|NCT03261401|65130528|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
23378388|NCT03261401|65130529|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
23378389|NCT03261401|65130530|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
23378390|NCT03261401|65130531|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
23378391|NCT03261401|65130532|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
23378392|NCT03261401|65130533|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
23378393|NCT03261401|65130534|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
23378394|NCT03261401|65130535|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
23378395|NCT03261401|65130536|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
23378396|NCT03261401|65130537|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
23378397|NCT03261401|65130538|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
23378398|NCT03261401|65130539|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
23378399|NCT03801252|65130540|FG000|Overall Study|Protocol Violation|1|||
23378400|NCT03801252|65130541|FG001|Overall Study|Protocol Violation|2|||
23378401|NCT01033942|65130552|FG000|Overall Study|Withdrawal by Subject|1|||
23378402|NCT01033942|65130553|FG001|Overall Study|Withdrawal by Subject|1|||
23378403|NCT01033942|65130554|FG002|Overall Study|Withdrawal by Subject|1|||
23378404|NCT01033942|65130552|FG000|Overall Study|Lost to Follow-up|1|||
23378405|NCT01033942|65130553|FG001|Overall Study|Lost to Follow-up|0|||
23378406|NCT01033942|65130554|FG002|Overall Study|Lost to Follow-up|0|||
23605224|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
23605225|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
23605226|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
23605227|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
23605228|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
23605229|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
23605230|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
23605231|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
23378407|NCT01033942|65130552|FG000|Overall Study|Enrolled in Extension Study|0|||
23378408|NCT01033942|65130553|FG001|Overall Study|Enrolled in Extension Study|3|||
23378409|NCT01033942|65130554|FG002|Overall Study|Enrolled in Extension Study|0|||
23378410|NCT05417113|65130555|FG000|Overall Study|Lost to Follow-up|2|||
23378411|NCT05417113|65130556|FG001|Overall Study|Lost to Follow-up|2|||
23378412|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
23378413|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
23285738|NCT00529763|64787908|FG001|Overall Study|Study Drug Toxicity|6|||
23285739|NCT00529763|64787909|FG002|Overall Study|Study Drug Toxicity|4|||
23285740|NCT00529763|64787907|FG000|Overall Study|Participant Withdrew Consent|2|||
23285741|NCT00529763|64787908|FG001|Overall Study|Participant Withdrew Consent|3|||
23285742|NCT00529763|64787909|FG002|Overall Study|Participant Withdrew Consent|4|||
23285743|NCT00529763|64787907|FG000|Overall Study|Other reasons|2|||
23285744|NCT00529763|64787908|FG001|Overall Study|Other reasons|0|||
23285745|NCT00529763|64787909|FG002|Overall Study|Other reasons|2|||
23285746|NCT00529763|64787907|FG000|Overall Study|Participant request to discontinue treatment|1|||
23285747|NCT00529763|64787908|FG001|Overall Study|Participant request to discontinue treatment|1|||
23285748|NCT00529763|64787909|FG002|Overall Study|Participant request to discontinue treatment|3|||
23285749|NCT02694536|64787912|FG000|Overall Study|Progressive Disease|40|||
23285750|NCT02694536|64787912|FG000|Overall Study|Lost to Follow-up|1|||
23285751|NCT02694536|64787912|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
23285752|NCT02694536|64787912|FG000|Overall Study|Withdrawal by Subject|8|||
23285753|NCT02694536|64787912|FG000|Overall Study|Death|8|||
23285754|NCT02694536|64787912|FG000|Overall Study|Other|22|||
23285755|NCT02387762|64791219|FG000|Overall Study|Withdrawal by Subject|1|||
23285756|NCT02387762|64791220|FG001|Overall Study|Withdrawal by Subject|0|||
23285757|NCT02030535|64791221|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
23285758|NCT00787605|64791225|FG000|Overall Study|Administrative Problems|3|||
23285759|NCT00787605|64791226|FG001|Overall Study|Administrative Problems|0|||
23285760|NCT00787605|64791225|FG000|Overall Study|Adverse Event|14|||
23285761|NCT00787605|64791226|FG001|Overall Study|Adverse Event|25|||
23285762|NCT00787605|64791225|FG000|Overall Study|Lost to Follow-up|3|||
23285763|NCT00787605|64791226|FG001|Overall Study|Lost to Follow-up|6|||
23285764|NCT00787605|64791225|FG000|Overall Study|Protocol Violation|7|||
23285765|NCT00787605|64791226|FG001|Overall Study|Protocol Violation|3|||
23285766|NCT00787605|64791225|FG000|Overall Study|Withdrawal by Subject|6|||
23285767|NCT00787605|64791226|FG001|Overall Study|Withdrawal by Subject|13|||
23285768|NCT00787605|64791225|FG000|Overall Study|Lack of Efficacy|13|||
23285769|NCT00787605|64791226|FG001|Overall Study|Lack of Efficacy|9|||
23285770|NCT03828539|64791227|FG000|Overall Study|Adverse Event|3|||
23285771|NCT03828539|64791228|FG001|Overall Study|Adverse Event|12|||
23285772|NCT03828539|64791227|FG000|Overall Study|Patient's/guardian's decision|3|||
23285773|NCT03828539|64791228|FG001|Overall Study|Patient's/guardian's decision|5|||
23285774|NCT03828539|64791227|FG000|Overall Study|Lost to Follow-up|4|||
23285775|NCT03828539|64791228|FG001|Overall Study|Lost to Follow-up|2|||
23285776|NCT03828539|64791227|FG000|Overall Study|Protocol Violation|3|||
23285777|NCT03828539|64791228|FG001|Overall Study|Protocol Violation|2|||
23285778|NCT03828539|64791227|FG000|Overall Study|Withdrawal of informed consent|2|||
23285779|NCT03828539|64791228|FG001|Overall Study|Withdrawal of informed consent|1|||
23285780|NCT03828539|64791227|FG000|Overall Study|New therapy for study indication|1|||
23285781|NCT03828539|64791228|FG001|Overall Study|New therapy for study indication|0|||
23285782|NCT02611362|64791229|FG000|Overall Study|Withdrawal by Subject|7|||
23285783|NCT02611362|64791230|FG001|Overall Study|Withdrawal by Subject|2|||
23285784|NCT02611362|64791229|FG000|Overall Study|Lost to Follow-up|2|||
23285785|NCT02611362|64791230|FG001|Overall Study|Lost to Follow-up|4|||
23285786|NCT03950674|64791231|FG000|Overall Study|Death|16|||
23285787|NCT03950674|64791232|FG001|Overall Study|Death|15|||
23285788|NCT03950674|64791231|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
23285789|NCT03950674|64791232|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
23285790|NCT00450658|64791233|FG000|Overall Study|Adverse Event|24|||
23285791|NCT00450658|64791234|FG001|Overall Study|Adverse Event|15|||
23285792|NCT00450658|64791233|FG000|Overall Study|Withdrawal by Subject|43|||
23285793|NCT00450658|64791234|FG001|Overall Study|Withdrawal by Subject|26|||
23285794|NCT00450658|64791233|FG000|Overall Study|Lost to Follow-up|22|||
23285795|NCT00450658|64791234|FG001|Overall Study|Lost to Follow-up|5|||
23285796|NCT00450658|64791233|FG000|Overall Study|UGI ulcer|33|||
23285797|NCT00450658|64791234|FG001|Overall Study|UGI ulcer|34|||
23285798|NCT00450658|64791233|FG000|Overall Study|misc|21|||
23285799|NCT00450658|64791234|FG001|Overall Study|misc|10|||
23285800|NCT02699866|64791236|FG000|Overall Study|Withdrawal by Subject|3|||
23285801|NCT02699866|64791236|FG000|Overall Study|Physician Decision|2|||
23285802|NCT02699866|64791236|FG000|Overall Study|Adverse Event|3|||
23285803|NCT01971554|64791237|FG000|Overall Study|Lost to Follow-up|1|||
23285804|NCT01971554|64791238|FG001|Overall Study|Lost to Follow-up|0|||
23285805|NCT01971554|64791239|FG002|Overall Study|Lost to Follow-up|0|||
23285806|NCT01971554|64791240|FG003|Overall Study|Lost to Follow-up|0|||
23285807|NCT01685008|64791241|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
23285808|NCT01685008|64791242|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
23285809|NCT01685008|64791243|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
23285810|NCT01685008|64791244|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
23285811|NCT01685008|64791241|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
23285812|NCT01685008|64791242|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
23285813|NCT01685008|64791243|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
23378414|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Death|1|||
23378415|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Death|3|||
23378416|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
23378417|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
23378418|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
23378419|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
23378420|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
23378421|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
23378422|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
23378423|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
23378424|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
23378425|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
23378426|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
23378427|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
23378428|NCT00362232|65130559|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
23378429|NCT00362232|65130560|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
23378430|NCT00362232|65130559|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
23378431|NCT00362232|65130560|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
23378432|NCT00362232|65130559|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
23378433|NCT00362232|65130560|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
23378434|NCT00362232|65130559|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
23378435|NCT00362232|65130560|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
23378436|NCT00362232|65130559|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
23378437|NCT00362232|65130560|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
23378438|NCT01348269|65130561|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
23378439|NCT01348269|65130562|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
23378440|NCT01348269|65130561|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
23378441|NCT01348269|65130562|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
23378442|NCT01348269|65130561|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
23378443|NCT01348269|65130562|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
23378444|NCT01134042|65130563|FG000|Overall Study|Adverse Event|3|||
23378445|NCT01134042|65130564|FG001|Overall Study|Adverse Event|7|||
23378446|NCT01134042|65130565|FG002|Overall Study|Adverse Event|2|||
23378447|NCT01134042|65130563|FG000|Overall Study|Lack of Efficacy|21|||
23378448|NCT01134042|65130564|FG001|Overall Study|Lack of Efficacy|6|||
23378449|NCT01134042|65130565|FG002|Overall Study|Lack of Efficacy|18|||
23378450|NCT01134042|65130563|FG000|Overall Study|Protocol Violation|5|||
23378451|NCT01134042|65130564|FG001|Overall Study|Protocol Violation|3|||
23285814|NCT01685008|64791244|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
23285815|NCT01685008|64791241|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
23285816|NCT01685008|64791242|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
23285817|NCT01685008|64791243|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
23285818|NCT01685008|64791244|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
23285819|NCT01685008|64791241|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
23285820|NCT01685008|64791242|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
23285821|NCT01685008|64791243|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
23285822|NCT01685008|64791244|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
23285823|NCT01685008|64791241|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
23285824|NCT01685008|64791242|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
23285825|NCT01685008|64791243|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
23285826|NCT01685008|64791244|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
23285827|NCT04531527|64791245|FG000|Overall Study|Found to be Ineligible|3|||
23285828|NCT00160524|64791246|FG000|Overall Study|Adverse Event|119|||
23285829|NCT00160524|64791246|FG000|Overall Study|Adverse Event and Other|94|||
23285830|NCT00160524|64791246|FG000|Overall Study|Protocol Violation|16|||
23285831|NCT00160524|64791246|FG000|Overall Study|Protocol Violation and Other|2|||
23285832|NCT00160524|64791246|FG000|Overall Study|Withdrawal by Subject|141|||
23285833|NCT00160524|64791246|FG000|Overall Study|Withdrawal by Subject and Other|17|||
23285834|NCT00160524|64791246|FG000|Overall Study|Physician Decision|27|||
23285835|NCT00160524|64791246|FG000|Overall Study|Physician Decision and Other|6|||
23285836|NCT00160524|64791246|FG000|Overall Study|Lost to Follow-up|13|||
23285837|NCT00160524|64791246|FG000|Overall Study|Lost to Follow-up and Other|1|||
23285838|NCT00160524|64791246|FG000|Overall Study|Lack of Efficacy|21|||
23285839|NCT00160524|64791246|FG000|Overall Study|Lack of Efficacy and Other|1|||
23285840|NCT00160524|64791246|FG000|Overall Study|Other|20|||
23285841|NCT01583530|64791247|FG000|Overall Study|Adverse Event|0|||
23285842|NCT01583530|64791248|FG001|Overall Study|Adverse Event|0|||
23378452|NCT01134042|65130565|FG002|Overall Study|Protocol Violation|5|||
23378453|NCT01134042|65130563|FG000|Overall Study|Lost to Follow-up|2|||
23378454|NCT01134042|65130564|FG001|Overall Study|Lost to Follow-up|0|||
23378455|NCT01134042|65130565|FG002|Overall Study|Lost to Follow-up|1|||
23378456|NCT01134042|65130563|FG000|Overall Study|Physician Decision|4|||
23378457|NCT01134042|65130564|FG001|Overall Study|Physician Decision|8|||
23605232|NCT02203032|65943646|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
23605233|NCT02203032|65943647|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
23605234|NCT02203032|65943648|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
23605235|NCT02203032|65943649|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
23378458|NCT01134042|65130565|FG002|Overall Study|Physician Decision|1|||
23378459|NCT01134042|65130563|FG000|Overall Study|Withdrawal by Subject|13|||
23378460|NCT01134042|65130564|FG001|Overall Study|Withdrawal by Subject|4|||
23605236|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
23605237|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
23605238|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
23605239|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
23605240|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
23605241|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
23605242|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
23605243|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
23605244|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
23605245|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
23605246|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
23605247|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
23605248|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
23605249|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
23605250|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
23605251|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
23605252|NCT02203032|65943646|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
23605253|NCT02203032|65943647|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
23605254|NCT02203032|65943648|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
23378461|NCT01134042|65130565|FG002|Overall Study|Withdrawal by Subject|7|||
23378462|NCT01047501|65130566|FG000|Overall Study|Adverse Event|7|||
23378463|NCT01047501|65130567|FG001|Overall Study|Adverse Event|8|||
23378464|NCT01047501|65130568|FG002|Overall Study|Adverse Event|5|||
23378465|NCT01047501|65130566|FG000|Overall Study|Withdrew Consent|6|||
23378466|NCT01047501|65130567|FG001|Overall Study|Withdrew Consent|2|||
23378467|NCT01047501|65130568|FG002|Overall Study|Withdrew Consent|4|||
23378468|NCT01047501|65130566|FG000|Overall Study|Lost to Follow-up|0|||
23378469|NCT01047501|65130567|FG001|Overall Study|Lost to Follow-up|1|||
23378470|NCT01047501|65130568|FG002|Overall Study|Lost to Follow-up|1|||
23378471|NCT01047501|65130566|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
23378472|NCT01047501|65130567|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
23378473|NCT01047501|65130568|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
23378474|NCT01047501|65130566|FG000|Overall Study|Death|1|||
23605255|NCT02203032|65943649|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
23490427|NCT02448810|65541406|FG003|Overall Study|Withdrawal by Subject|0|||
23490428|NCT02448810|65541407|FG004|Overall Study|Withdrawal by Subject|3|||
23605256|NCT01970878|65943650|FG000|Overall Study|Withdrawal by Subject|11|||
23605257|NCT01970878|65943651|FG001|Overall Study|Withdrawal by Subject|10|||
23378475|NCT01047501|65130567|FG001|Overall Study|Death|0|||
23605258|NCT01970878|65943652|FG002|Overall Study|Withdrawal by Subject|14|||
23605259|NCT01970878|65943653|FG003|Overall Study|Withdrawal by Subject|7|||
23605260|NCT01970878|65943650|FG000|Overall Study|Lost to Follow-up|1|||
23605261|NCT01970878|65943651|FG001|Overall Study|Lost to Follow-up|3|||
23605262|NCT01970878|65943652|FG002|Overall Study|Lost to Follow-up|2|||
23605263|NCT01970878|65943653|FG003|Overall Study|Lost to Follow-up|4|||
23605264|NCT01970878|65943650|FG000|Overall Study|Administrative Reasons|1|||
23605265|NCT01970878|65943651|FG001|Overall Study|Administrative Reasons|0|||
23605266|NCT01970878|65943652|FG002|Overall Study|Administrative Reasons|0|||
23605267|NCT01970878|65943653|FG003|Overall Study|Administrative Reasons|4|||
23605268|NCT01970878|65943650|FG000|Overall Study|Lack of Efficacy|2|||
23605269|NCT01970878|65943651|FG001|Overall Study|Lack of Efficacy|1|||
23605270|NCT01970878|65943652|FG002|Overall Study|Lack of Efficacy|2|||
23605271|NCT01970878|65943653|FG003|Overall Study|Lack of Efficacy|0|||
23605272|NCT01970878|65943650|FG000|Overall Study|Adverse Event|12|||
23605273|NCT01970878|65943651|FG001|Overall Study|Adverse Event|7|||
23605274|NCT01970878|65943652|FG002|Overall Study|Adverse Event|4|||
23605275|NCT01970878|65943653|FG003|Overall Study|Adverse Event|3|||
23605276|NCT01970878|65943650|FG000|Overall Study|Protocol Specified Criteria|10|||
23605277|NCT01970878|65943651|FG001|Overall Study|Protocol Specified Criteria|4|||
23605278|NCT01970878|65943652|FG002|Overall Study|Protocol Specified Criteria|3|||
23605279|NCT01970878|65943653|FG003|Overall Study|Protocol Specified Criteria|6|||
23605280|NCT01970878|65943650|FG000|Overall Study|Physician Decision|0|||
23285843|NCT01583530|64791249|FG002|Overall Study|Adverse Event|0|||
23285844|NCT01583530|64791250|FG003|Overall Study|Adverse Event|0|||
23378476|NCT01047501|65130568|FG002|Overall Study|Death|0|||
23378477|NCT01047501|65130566|FG000|Overall Study|Other discontinuation|1|||
23378478|NCT01047501|65130567|FG001|Overall Study|Other discontinuation|0|||
23378479|NCT01047501|65130568|FG002|Overall Study|Other discontinuation|1|||
23378480|NCT01047501|65130566|FG000|Overall Study|Investigator judgement|0|||
23378481|NCT01047501|65130567|FG001|Overall Study|Investigator judgement|0|||
23378482|NCT01047501|65130568|FG002|Overall Study|Investigator judgement|1|||
23378483|NCT01500096|65130569|FG000|Overall Study|Lost to Follow-up|1|||
23285845|NCT01583530|64791251|FG004|Overall Study|Adverse Event|0|||
23378484|NCT01500096|65130570|FG001|Overall Study|Lost to Follow-up|0|||
23378485|NCT01500096|65130571|FG002|Overall Study|Lost to Follow-up|0|||
23378486|NCT01500096|65130572|FG003|Overall Study|Lost to Follow-up|2|||
23378487|NCT00831844|65130573|FG000|Overall Study|Adverse Event|2|||
23378488|NCT00831844|65130574|FG001|Overall Study|Adverse Event|0|||
23378489|NCT00831844|65130575|FG002|Overall Study|Adverse Event|0|||
23378490|NCT00831844|65130576|FG003|Overall Study|Adverse Event|0|||
23378491|NCT00831844|65130577|FG004|Overall Study|Adverse Event|1|||
23378492|NCT00831844|65130578|FG005|Overall Study|Adverse Event|1|||
23378493|NCT00831844|65130579|FG006|Overall Study|Adverse Event|2|||
23378494|NCT00831844|65130580|FG007|Overall Study|Adverse Event|0|||
23378495|NCT00831844|65130581|FG008|Overall Study|Adverse Event|0|||
23378496|NCT00831844|65130582|FG009|Overall Study|Adverse Event|0|||
23378497|NCT00831844|65130573|FG000|Overall Study|Death|0|||
23378498|NCT00831844|65130574|FG001|Overall Study|Death|0|||
23378499|NCT00831844|65130575|FG002|Overall Study|Death|0|||
23378500|NCT00831844|65130576|FG003|Overall Study|Death|1|||
23285846|NCT01583530|64791252|FG005|Overall Study|Adverse Event|1|||
23285847|NCT01583530|64791247|FG000|Overall Study|Withdrawal by Subject|0|||
23285848|NCT01583530|64791248|FG001|Overall Study|Withdrawal by Subject|3|||
23285849|NCT01583530|64791249|FG002|Overall Study|Withdrawal by Subject|0|||
23285850|NCT01583530|64791250|FG003|Overall Study|Withdrawal by Subject|1|||
23285851|NCT01583530|64791251|FG004|Overall Study|Withdrawal by Subject|1|||
23285852|NCT01583530|64791252|FG005|Overall Study|Withdrawal by Subject|2|||
23285853|NCT01583530|64791247|FG000|Overall Study|Lost to Follow-up|0|||
23285854|NCT01583530|64791248|FG001|Overall Study|Lost to Follow-up|0|||
23285855|NCT01583530|64791249|FG002|Overall Study|Lost to Follow-up|0|||
23285856|NCT01583530|64791250|FG003|Overall Study|Lost to Follow-up|0|||
23285857|NCT01583530|64791251|FG004|Overall Study|Lost to Follow-up|3|||
23285858|NCT01583530|64791252|FG005|Overall Study|Lost to Follow-up|0|||
23285859|NCT01583530|64791247|FG000|Overall Study|Lack of compliance|0|||
23378501|NCT00831844|65130577|FG004|Overall Study|Death|0|||
23378502|NCT00831844|65130578|FG005|Overall Study|Death|0|||
23605281|NCT01970878|65943651|FG001|Overall Study|Physician Decision|1|||
23605282|NCT01970878|65943652|FG002|Overall Study|Physician Decision|1|||
23605283|NCT01970878|65943653|FG003|Overall Study|Physician Decision|0|||
23605284|NCT01970878|65943650|FG000|Overall Study|No Completion Status|0|||
23378503|NCT00831844|65130579|FG006|Overall Study|Death|0|||
23378504|NCT00831844|65130580|FG007|Overall Study|Death|0|||
23378505|NCT00831844|65130581|FG008|Overall Study|Death|0|||
23378506|NCT00831844|65130582|FG009|Overall Study|Death|0|||
23605285|NCT01970878|65943651|FG001|Overall Study|No Completion Status|1|||
23605286|NCT01970878|65943652|FG002|Overall Study|No Completion Status|0|||
23605287|NCT01970878|65943653|FG003|Overall Study|No Completion Status|0|||
23285860|NCT01583530|64791248|FG001|Overall Study|Lack of compliance|0|||
23378507|NCT00831844|65130573|FG000|Overall Study|Lack of Efficacy|8|||
23378508|NCT00831844|65130574|FG001|Overall Study|Lack of Efficacy|10|||
23378509|NCT00831844|65130575|FG002|Overall Study|Lack of Efficacy|15|||
23378510|NCT00831844|65130576|FG003|Overall Study|Lack of Efficacy|8|||
23378511|NCT00831844|65130577|FG004|Overall Study|Lack of Efficacy|11|||
23378512|NCT00831844|65130578|FG005|Overall Study|Lack of Efficacy|17|||
23490429|NCT02448810|65541408|FG005|Overall Study|Withdrawal by Subject|5|||
23490430|NCT02448810|65541409|FG006|Overall Study|Withdrawal by Subject|0|||
23490431|NCT02448810|65541410|FG007|Overall Study|Withdrawal by Subject|2|||
23490432|NCT02448810|65541403|FG000|Overall Study|Other (study terminated by sponsor)|0|||
23490433|NCT02448810|65541404|FG001|Overall Study|Other (study terminated by sponsor)|0|||
23490434|NCT02448810|65541405|FG002|Overall Study|Other (study terminated by sponsor)|0|||
23285861|NCT01583530|64791249|FG002|Overall Study|Lack of compliance|0|||
23378513|NCT00831844|65130579|FG006|Overall Study|Lack of Efficacy|8|||
23378514|NCT00831844|65130580|FG007|Overall Study|Lack of Efficacy|9|||
23378515|NCT00831844|65130581|FG008|Overall Study|Lack of Efficacy|7|||
23378516|NCT00831844|65130582|FG009|Overall Study|Lack of Efficacy|0|||
23378517|NCT00831844|65130573|FG000|Overall Study|Physician Decision|0|||
23378518|NCT00831844|65130574|FG001|Overall Study|Physician Decision|1|||
23378519|NCT00831844|65130575|FG002|Overall Study|Physician Decision|3|||
23378520|NCT00831844|65130576|FG003|Overall Study|Physician Decision|1|||
23378521|NCT00831844|65130577|FG004|Overall Study|Physician Decision|1|||
23378522|NCT00831844|65130578|FG005|Overall Study|Physician Decision|1|||
23378523|NCT00831844|65130579|FG006|Overall Study|Physician Decision|0|||
23378524|NCT00831844|65130580|FG007|Overall Study|Physician Decision|0|||
23378525|NCT00831844|65130581|FG008|Overall Study|Physician Decision|1|||
23378526|NCT00831844|65130582|FG009|Overall Study|Physician Decision|0|||
23378527|NCT00831844|65130573|FG000|Overall Study|Withdrawal by Subject|0|||
23378528|NCT00831844|65130574|FG001|Overall Study|Withdrawal by Subject|0|||
23378529|NCT00831844|65130575|FG002|Overall Study|Withdrawal by Subject|1|||
23378530|NCT00831844|65130576|FG003|Overall Study|Withdrawal by Subject|0|||
23378531|NCT00831844|65130577|FG004|Overall Study|Withdrawal by Subject|0|||
23378532|NCT00831844|65130578|FG005|Overall Study|Withdrawal by Subject|0|||
23490435|NCT02448810|65541406|FG003|Overall Study|Other (study terminated by sponsor)|0|||
23490436|NCT02448810|65541407|FG004|Overall Study|Other (study terminated by sponsor)|4|||
23490437|NCT02448810|65541408|FG005|Overall Study|Other (study terminated by sponsor)|2|||
23285862|NCT01583530|64791250|FG003|Overall Study|Lack of compliance|0|||
23285863|NCT01583530|64791251|FG004|Overall Study|Lack of compliance|1|||
23285864|NCT01583530|64791252|FG005|Overall Study|Lack of compliance|0|||
23285865|NCT01049581|64791253|FG000|Overall Study|Lost to Follow-up|2|||
23285866|NCT01049581|64791254|FG001|Overall Study|Lost to Follow-up|1|||
23285867|NCT02761915|64791255|FG000|Overall Study|Death|3|||
23285868|NCT02761915|64791256|FG001|Overall Study|Death|1|||
23285869|NCT02761915|64791257|FG002|Overall Study|Death|1|||
23285870|NCT02761915|64791258|FG003|Overall Study|Death|1|||
23285871|NCT02761915|64791259|FG004|Overall Study|Death|0|||
23285872|NCT02761915|64791260|FG005|Overall Study|Death|1|||
23285873|NCT02761915|64791255|FG000|Overall Study|Withdrawal by Subject|1|||
23285874|NCT02761915|64791256|FG001|Overall Study|Withdrawal by Subject|0|||
23285875|NCT02761915|64791257|FG002|Overall Study|Withdrawal by Subject|0|||
23285876|NCT02761915|64791258|FG003|Overall Study|Withdrawal by Subject|0|||
23285877|NCT02761915|64791259|FG004|Overall Study|Withdrawal by Subject|1|||
23285878|NCT02761915|64791260|FG005|Overall Study|Withdrawal by Subject|2|||
23285879|NCT02761915|64791255|FG000|Overall Study|Disease Progression|0|||
23285880|NCT02761915|64791256|FG001|Overall Study|Disease Progression|0|||
23285881|NCT02761915|64791257|FG002|Overall Study|Disease Progression|0|||
23285882|NCT02761915|64791258|FG003|Overall Study|Disease Progression|2|||
23285883|NCT02761915|64791259|FG004|Overall Study|Disease Progression|2|||
23285884|NCT02761915|64791260|FG005|Overall Study|Disease Progression|2|||
23285885|NCT01971645|64791261|FG000|Overall Study|Adverse Event|1|||
23285886|NCT01971645|64791262|FG001|Overall Study|Adverse Event|0|||
23285887|NCT01971645|64791263|FG002|Overall Study|Adverse Event|0|||
23285888|NCT01971645|64791261|FG000|Overall Study|Lost to Follow-up|1|||
23285889|NCT01971645|64791262|FG001|Overall Study|Lost to Follow-up|0|||
23285890|NCT01971645|64791263|FG002|Overall Study|Lost to Follow-up|1|||
23285891|NCT01971645|64791261|FG000|Overall Study|Protocol Violation|0|||
23285892|NCT01971645|64791262|FG001|Overall Study|Protocol Violation|0|||
23285893|NCT01971645|64791263|FG002|Overall Study|Protocol Violation|1|||
23285894|NCT02623218|64791264|FG000|Overall Study|Lost to Follow-up|0|||
23285895|NCT02623218|64791265|FG001|Overall Study|Lost to Follow-up|1|||
23285896|NCT02623218|64791266|FG002|Overall Study|Lost to Follow-up|0|||
23378533|NCT00831844|65130579|FG006|Overall Study|Withdrawal by Subject|0|||
23378534|NCT00831844|65130580|FG007|Overall Study|Withdrawal by Subject|1|||
23378535|NCT00831844|65130581|FG008|Overall Study|Withdrawal by Subject|1|||
23378536|NCT00831844|65130582|FG009|Overall Study|Withdrawal by Subject|0|||
23378537|NCT00831844|65130573|FG000|Overall Study|Ineligible|0|||
23285897|NCT02623218|64791267|FG003|Overall Study|Lost to Follow-up|0|||
23285898|NCT02623218|64791268|FG004|Overall Study|Lost to Follow-up|0|||
23285899|NCT02436200|64791269|FG000|Overall Study|Significant outlier|1|||
23285900|NCT02933060|64791272|FG000|Overall Study|Withdrawal by Subject|0|||
23490438|NCT02448810|65541409|FG006|Overall Study|Other (study terminated by sponsor)|2|||
23490439|NCT02448810|65541410|FG007|Overall Study|Other (study terminated by sponsor)|1|||
23490440|NCT02448810|65541403|FG000|Overall Study|Death|1|||
23490441|NCT02448810|65541404|FG001|Overall Study|Death|0|||
23490442|NCT02448810|65541405|FG002|Overall Study|Death|1|||
23490443|NCT02448810|65541406|FG003|Overall Study|Death|0|||
23490444|NCT02448810|65541407|FG004|Overall Study|Death|1|||
23490445|NCT02448810|65541408|FG005|Overall Study|Death|0|||
23490446|NCT02448810|65541409|FG006|Overall Study|Death|0|||
23490447|NCT02448810|65541410|FG007|Overall Study|Death|0|||
23490448|NCT02448810|65541403|FG000|Overall Study|Other (Progressive disease)|2|||
23490449|NCT02448810|65541404|FG001|Overall Study|Other (Progressive disease)|2|||
23490450|NCT02448810|65541405|FG002|Overall Study|Other (Progressive disease)|0|||
23490451|NCT02448810|65541406|FG003|Overall Study|Other (Progressive disease)|3|||
23490452|NCT02448810|65541407|FG004|Overall Study|Other (Progressive disease)|23|||
23490453|NCT02448810|65541408|FG005|Overall Study|Other (Progressive disease)|9|||
23490454|NCT02448810|65541409|FG006|Overall Study|Other (Progressive disease)|14|||
23490455|NCT02448810|65541410|FG007|Overall Study|Other (Progressive disease)|5|||
23490456|NCT02448810|65541403|FG000|Overall Study|Lost to Follow-up|0|||
23490457|NCT02448810|65541404|FG001|Overall Study|Lost to Follow-up|1|||
23490458|NCT02448810|65541405|FG002|Overall Study|Lost to Follow-up|0|||
23490459|NCT02448810|65541406|FG003|Overall Study|Lost to Follow-up|0|||
23490460|NCT02448810|65541407|FG004|Overall Study|Lost to Follow-up|0|||
23490461|NCT02448810|65541408|FG005|Overall Study|Lost to Follow-up|0|||
23490462|NCT02448810|65541409|FG006|Overall Study|Lost to Follow-up|0|||
23490463|NCT02448810|65541410|FG007|Overall Study|Lost to Follow-up|0|||
23490464|NCT02448810|65541403|FG000|Overall Study|Other (unspecified)|0|||
23490465|NCT02448810|65541404|FG001|Overall Study|Other (unspecified)|0|||
23490466|NCT02448810|65541405|FG002|Overall Study|Other (unspecified)|0|||
23490467|NCT02448810|65541406|FG003|Overall Study|Other (unspecified)|0|||
23490468|NCT02448810|65541407|FG004|Overall Study|Other (unspecified)|0|||
23490469|NCT02448810|65541408|FG005|Overall Study|Other (unspecified)|0|||
23490470|NCT02448810|65541409|FG006|Overall Study|Other (unspecified)|2|||
23490471|NCT02448810|65541410|FG007|Overall Study|Other (unspecified)|0|||
23490472|NCT02633501|65541411|FG000|Overall Study|Adverse Event|0|||
23490473|NCT02633501|65541412|FG001|Overall Study|Adverse Event|0|||
23490474|NCT02633501|65541413|FG002|Overall Study|Adverse Event|1|||
23378538|NCT00831844|65130574|FG001|Overall Study|Ineligible|1|||
23490475|NCT02633501|65541414|FG003|Overall Study|Adverse Event|0|||
23490476|NCT02633501|65541415|FG004|Overall Study|Adverse Event|1|||
23490477|NCT02633501|65541416|FG005|Overall Study|Adverse Event|1|||
23490478|NCT02633501|65541411|FG000|Overall Study|Withdrawal by Subject|2|||
23490479|NCT02633501|65541412|FG001|Overall Study|Withdrawal by Subject|1|||
23490480|NCT02633501|65541413|FG002|Overall Study|Withdrawal by Subject|2|||
23490481|NCT02633501|65541414|FG003|Overall Study|Withdrawal by Subject|2|||
23490482|NCT02633501|65541415|FG004|Overall Study|Withdrawal by Subject|1|||
23285901|NCT02933060|64791273|FG001|Overall Study|Withdrawal by Subject|1|||
23285902|NCT00697827|64791276|FG000|Overall Study|enrolled but not treated|2|||
23285903|NCT00697827|64791277|FG001|Overall Study|enrolled but not treated|1|||
23285904|NCT00685334|64791278|FG000|Overall Study|Withdrawal by Subject|5|||
23378539|NCT00831844|65130575|FG002|Overall Study|Ineligible|1|||
23490483|NCT02633501|65541416|FG005|Overall Study|Withdrawal by Subject|3|||
23490484|NCT02633501|65541411|FG000|Overall Study|Various other reasons|0|||
23490485|NCT02633501|65541412|FG001|Overall Study|Various other reasons|2|||
23490486|NCT02633501|65541413|FG002|Overall Study|Various other reasons|4|||
23490487|NCT02633501|65541414|FG003|Overall Study|Various other reasons|1|||
23490488|NCT02633501|65541415|FG004|Overall Study|Various other reasons|7|||
23490489|NCT02633501|65541416|FG005|Overall Study|Various other reasons|11|||
23490490|NCT02633501|65541411|FG000|Overall Study|Lost to Follow-up|0|||
23490491|NCT02633501|65541412|FG001|Overall Study|Lost to Follow-up|0|||
23490492|NCT02633501|65541413|FG002|Overall Study|Lost to Follow-up|0|||
23490493|NCT02633501|65541414|FG003|Overall Study|Lost to Follow-up|1|||
23490494|NCT02633501|65541415|FG004|Overall Study|Lost to Follow-up|2|||
23490495|NCT02633501|65541416|FG005|Overall Study|Lost to Follow-up|0|||
23490496|NCT04128371|65541417|FG000|Overall Study|Lack of Efficacy|1|||
23490497|NCT01123850|65541418|FG000|Overall Study|Slow enrollment|45|||
23490498|NCT01262573|65541420|FG000|Overall Study|Withdrawal by Subject|0|||
23490499|NCT01262573|65541421|FG001|Overall Study|Withdrawal by Subject|1|||
23490500|NCT00902668|65541424|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
23490501|NCT00976677|65541427|FG000|Overall Study|Adverse Event|1|||
23490502|NCT00976677|65541428|FG001|Overall Study|Adverse Event|0|||
23605288|NCT02040870|65943654|FG000|Overall Study|Completed treatment phase|6|||
23605289|NCT02040870|65943654|FG000|Overall Study|Adverse Event|7|||
23605290|NCT02040870|65943654|FG000|Overall Study|Progressive disease|58|||
23605291|NCT02040870|65943654|FG000|Overall Study|Physician Decision|6|||
23605292|NCT02040870|65943654|FG000|Overall Study|Subject/guardian decision|10|||
23605293|NCT02040870|65943654|FG000|Overall Study|Lost to Follow-up|3|||
23605294|NCT02040870|65943654|FG000|Overall Study|Death|13|||
23605295|NCT01930188|65943655|FG000|Overall Study|unclassified|4|||
23605296|NCT01930188|65943656|FG001|Overall Study|unclassified|5|||
23605297|NCT01930188|65943657|FG002|Overall Study|unclassified|3|||
23605298|NCT01930188|65943655|FG000|Overall Study|Missing follow-up information|2|||
23605299|NCT01930188|65943656|FG001|Overall Study|Missing follow-up information|2|||
23605300|NCT01930188|65943657|FG002|Overall Study|Missing follow-up information|3|||
23605301|NCT01930188|65943655|FG000|Overall Study|Lost to Follow-up|5|||
23605302|NCT01930188|65943656|FG001|Overall Study|Lost to Follow-up|2|||
23605303|NCT01930188|65943657|FG002|Overall Study|Lost to Follow-up|2|||
23605304|NCT01930188|65943655|FG000|Overall Study|Death|2|||
23605305|NCT01930188|65943656|FG001|Overall Study|Death|1|||
23605306|NCT01930188|65943657|FG002|Overall Study|Death|3|||
23605307|NCT01930188|65943655|FG000|Overall Study|Withdrawal by Subject|9|||
23605308|NCT01930188|65943656|FG001|Overall Study|Withdrawal by Subject|11|||
23605309|NCT01930188|65943657|FG002|Overall Study|Withdrawal by Subject|8|||
23605310|NCT02326220|65943658|FG000|Double-blind Treatment Period|Adverse Event|1|||
23605311|NCT02326220|65943659|FG001|Double-blind Treatment Period|Adverse Event|2|||
23605312|NCT02326220|65943660|FG002|Double-blind Treatment Period|Adverse Event|0|||
23605313|NCT02326220|65943658|FG000|Double-blind Treatment Period|Protocol Violation|0|||
23605314|NCT02326220|65943659|FG001|Double-blind Treatment Period|Protocol Violation|1|||
23605315|NCT02326220|65943660|FG002|Double-blind Treatment Period|Protocol Violation|0|||
23605316|NCT02326220|65943658|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
23605317|NCT02326220|65943659|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
23605318|NCT02326220|65943660|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23605319|NCT02326220|65943658|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
23378540|NCT00831844|65130576|FG003|Overall Study|Ineligible|0|||
23490503|NCT00976677|65541427|FG000|Overall Study|Withdrawal by Subject|0|||
23490504|NCT00976677|65541428|FG001|Overall Study|Withdrawal by Subject|2|||
23378541|NCT00831844|65130577|FG004|Overall Study|Ineligible|1|||
23605320|NCT02326220|65943659|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23605321|NCT02326220|65943660|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
23605322|NCT02326220|65943658|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23605323|NCT02326220|65943659|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
23605324|NCT02326220|65943660|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
23605325|NCT01918033|65943672|FG000|Overall Study|Adverse Event|1|||
23605326|NCT01918033|65943673|FG001|Overall Study|Adverse Event|0|||
23490505|NCT00976677|65541427|FG000|Overall Study|Disease progression|1|||
23490506|NCT00976677|65541428|FG001|Overall Study|Disease progression|1|||
23490507|NCT00976677|65541427|FG000|Overall Study|Trial unblinded|2|||
23490508|NCT00976677|65541428|FG001|Overall Study|Trial unblinded|2|||
23490509|NCT00976677|65541427|FG000|Overall Study|Unknown/Missing|1|||
23490510|NCT00976677|65541428|FG001|Overall Study|Unknown/Missing|0|||
23490511|NCT00302107|65541429|FG000|Overall Study|Lost to Follow-up|6|||
23490512|NCT00302107|65541430|FG001|Overall Study|Lost to Follow-up|5|||
23490513|NCT00302107|65541429|FG000|Overall Study|Protocol Violation|1|||
23490514|NCT00302107|65541430|FG001|Overall Study|Protocol Violation|0|||
23490515|NCT00302107|65541429|FG000|Overall Study|Relocation|0|||
23490516|NCT00302107|65541430|FG001|Overall Study|Relocation|1|||
23490517|NCT00302107|65541429|FG000|Overall Study|Withdrawal by Subject|0|||
23490518|NCT00302107|65541430|FG001|Overall Study|Withdrawal by Subject|3|||
23490519|NCT00302107|65541429|FG000|Overall Study|Adverse Event|1|||
23490520|NCT00302107|65541430|FG001|Overall Study|Adverse Event|0|||
23490521|NCT00543543|65541431|FG000|Base Study|Adverse Event|1|||
23490522|NCT00543543|65541432|FG001|Base Study|Adverse Event|11|||
23490523|NCT00543543|65541433|FG002|Base Study|Adverse Event|0|||
23490524|NCT00543543|65541434|FG003|Base Study|Adverse Event|5|||
23490525|NCT00543543|65541431|FG000|Base Study|Lost to Follow-up|12|||
23490526|NCT00543543|65541432|FG001|Base Study|Lost to Follow-up|749|||
23490527|NCT00543543|65541433|FG002|Base Study|Lost to Follow-up|9|||
23490528|NCT00543543|65541434|FG003|Base Study|Lost to Follow-up|701|||
23285905|NCT00685334|64791279|FG001|Overall Study|Withdrawal by Subject|6|||
23285906|NCT00685334|64791278|FG000|Overall Study|Lost to Follow-up|4|||
23285907|NCT00685334|64791279|FG001|Overall Study|Lost to Follow-up|0|||
23490529|NCT00543543|65541431|FG000|Base Study|Physician Decision|0|||
23490530|NCT00543543|65541432|FG001|Base Study|Physician Decision|4|||
23490531|NCT00543543|65541433|FG002|Base Study|Physician Decision|0|||
23490532|NCT00543543|65541434|FG003|Base Study|Physician Decision|7|||
23490533|NCT00543543|65541431|FG000|Base Study|Protocol Violation|0|||
23490534|NCT00543543|65541432|FG001|Base Study|Protocol Violation|6|||
23490535|NCT00543543|65541433|FG002|Base Study|Protocol Violation|0|||
23490536|NCT00543543|65541434|FG003|Base Study|Protocol Violation|6|||
23490537|NCT00543543|65541431|FG000|Base Study|Withdrawal by Subject|7|||
23490538|NCT00543543|65541432|FG001|Base Study|Withdrawal by Subject|482|||
23490539|NCT00543543|65541433|FG002|Base Study|Withdrawal by Subject|5|||
23490540|NCT00543543|65541434|FG003|Base Study|Withdrawal by Subject|503|||
23490541|NCT00543543|65541431|FG000|Extension Study|Adverse Event|0|||
23490542|NCT00543543|65541432|FG001|Extension Study|Adverse Event|0|||
23490543|NCT00543543|65541433|FG002|Extension Study|Adverse Event|0|||
23490544|NCT00543543|65541434|FG003|Extension Study|Adverse Event|5|||
23490545|NCT00543543|65541431|FG000|Extension Study|Lost to Follow-up|0|||
23490546|NCT00543543|65541432|FG001|Extension Study|Lost to Follow-up|0|||
23490547|NCT00543543|65541433|FG002|Extension Study|Lost to Follow-up|0|||
23490548|NCT00543543|65541434|FG003|Extension Study|Lost to Follow-up|77|||
23490549|NCT00543543|65541431|FG000|Extension Study|Physician Decision|0|||
23490550|NCT00543543|65541432|FG001|Extension Study|Physician Decision|0|||
23605327|NCT01918033|65943674|FG002|Overall Study|Adverse Event|2|||
23605328|NCT01918033|65943672|FG000|Overall Study|Lost to Follow-up|0|||
23285908|NCT00685334|64791278|FG000|Overall Study|Chose to enter hospital|1|||
23285909|NCT00685334|64791279|FG001|Overall Study|Chose to enter hospital|1|||
23285910|NCT00396162|64791284|FG000|Overall Study|Withdrawal by Subject|2|||
23285911|NCT00396162|64791285|FG001|Overall Study|Withdrawal by Subject|3|||
23285912|NCT00757172|64791286|FG000|Overall Study|Withdrawal by Subject|4|||
23285913|NCT00757172|64791286|FG000|Overall Study|Physician Decision|3|||
23285914|NCT00757172|64791286|FG000|Overall Study|Progression|4|||
23285915|NCT00045162|64791287|FG000|Overall Study|Ineligible|12|||
23285916|NCT00045162|64791288|FG001|Overall Study|Ineligible|8|||
23285917|NCT00045162|64791287|FG000|Overall Study|Not treated|7|||
23285918|NCT00045162|64791288|FG001|Overall Study|Not treated|2|||
23285919|NCT00045162|64791287|FG000|Overall Study|Adverse Event|55|||
23490551|NCT00543543|65541433|FG002|Extension Study|Physician Decision|0|||
23490552|NCT00543543|65541434|FG003|Extension Study|Physician Decision|7|||
23490553|NCT00543543|65541431|FG000|Extension Study|Pregnancy|0|||
23490554|NCT00543543|65541432|FG001|Extension Study|Pregnancy|0|||
23490555|NCT00543543|65541433|FG002|Extension Study|Pregnancy|0|||
23490556|NCT00543543|65541434|FG003|Extension Study|Pregnancy|6|||
23605329|NCT01918033|65943673|FG001|Overall Study|Lost to Follow-up|1|||
23490557|NCT00543543|65541431|FG000|Extension Study|Protocol Violation|0|||
23490558|NCT00543543|65541432|FG001|Extension Study|Protocol Violation|0|||
23490559|NCT00543543|65541433|FG002|Extension Study|Protocol Violation|0|||
23490560|NCT00543543|65541434|FG003|Extension Study|Protocol Violation|11|||
23605330|NCT01918033|65943674|FG002|Overall Study|Lost to Follow-up|0|||
23605331|NCT01918033|65943672|FG000|Overall Study|Protocol Violation|2|||
23285920|NCT00045162|64791288|FG001|Overall Study|Adverse Event|50|||
23285921|NCT00045162|64791287|FG000|Overall Study|Lack of Efficacy|32|||
23285922|NCT00045162|64791288|FG001|Overall Study|Lack of Efficacy|29|||
23285923|NCT00045162|64791287|FG000|Overall Study|Death|10|||
23490561|NCT00543543|65541431|FG000|Extension Study|Withdrawal by Subject|0|||
23490562|NCT00543543|65541432|FG001|Extension Study|Withdrawal by Subject|0|||
23490563|NCT00543543|65541433|FG002|Extension Study|Withdrawal by Subject|0|||
23490564|NCT00543543|65541434|FG003|Extension Study|Withdrawal by Subject|120|||
23490565|NCT03021304|65541438|FG000|Overall Study|Lack of Efficacy|1|||
23490566|NCT00559754|65541441|FG000|Overall Study|Disease progression|1|||
23490567|NCT00559754|65541441|FG000|Overall Study|Adverse Event|5|||
23605332|NCT01918033|65943673|FG001|Overall Study|Protocol Violation|0|||
23605333|NCT01918033|65943674|FG002|Overall Study|Protocol Violation|1|||
23605334|NCT01918033|65943672|FG000|Overall Study|Withdrawal by Subject|2|||
23605335|NCT01918033|65943673|FG001|Overall Study|Withdrawal by Subject|1|||
23605336|NCT01918033|65943674|FG002|Overall Study|Withdrawal by Subject|0|||
23605337|NCT02203799|65943680|FG000|Overall Study|Withdrawal by Subject|3|||
23605338|NCT01885559|65943681|FG000|Overall Study|Lost to Follow-up|15|||
23605339|NCT01885559|65943682|FG001|Overall Study|Lost to Follow-up|16|||
23605340|NCT01885559|65943681|FG000|Overall Study|Less than full participation|9|||
23605341|NCT01885559|65943682|FG001|Overall Study|Less than full participation|19|||
23605342|NCT01885559|65943681|FG000|Overall Study|Protocol Violation|0|||
23605343|NCT01885559|65943682|FG001|Overall Study|Protocol Violation|1|||
23605344|NCT03288506|65943684|FG000|Overall Study|Withdrawal by Subject|52|||
23605345|NCT04803734|65943685|FG000|Overall Study|Withdrawal by Subject|0|||
23605346|NCT04803734|65943686|FG001|Overall Study|Withdrawal by Subject|1|||
23605347|NCT04803734|65943685|FG000|Overall Study|Protocol Violation|0|||
23285924|NCT00045162|64791288|FG001|Overall Study|Death|10|||
23285925|NCT00045162|64791287|FG000|Overall Study|Withdrawal by Subject|5|||
23605348|NCT04803734|65943686|FG001|Overall Study|Protocol Violation|1|||
23605349|NCT00805441|65943689|FG000|Overall Study|Adverse Event|5|||
23285926|NCT00045162|64791288|FG001|Overall Study|Withdrawal by Subject|3|||
23285927|NCT00045162|64791287|FG000|Overall Study|Other|21|||
23285928|NCT00045162|64791288|FG001|Overall Study|Other|16|||
23285929|NCT00860262|64791289|FG000|Overall Study|Adverse Event|9|||
23285930|NCT00860262|64791290|FG001|Overall Study|Adverse Event|6|||
23285931|NCT00860262|64791291|FG002|Overall Study|Adverse Event|7|||
23285932|NCT00860262|64791289|FG000|Overall Study|Protocol Violation|0|||
23285933|NCT00860262|64791290|FG001|Overall Study|Protocol Violation|1|||
23285934|NCT00860262|64791291|FG002|Overall Study|Protocol Violation|0|||
23285935|NCT00860262|64791289|FG000|Overall Study|Lost to Follow-up|2|||
23285936|NCT00860262|64791290|FG001|Overall Study|Lost to Follow-up|0|||
23285937|NCT00860262|64791291|FG002|Overall Study|Lost to Follow-up|1|||
23285938|NCT00860262|64791289|FG000|Overall Study|Withdrawal by Subject|4|||
23285939|NCT00860262|64791290|FG001|Overall Study|Withdrawal by Subject|8|||
23285940|NCT00860262|64791291|FG002|Overall Study|Withdrawal by Subject|6|||
23285941|NCT00860262|64791289|FG000|Overall Study|Lack of Efficacy|0|||
23285942|NCT00860262|64791290|FG001|Overall Study|Lack of Efficacy|4|||
23285943|NCT00860262|64791291|FG002|Overall Study|Lack of Efficacy|3|||
23285944|NCT00860262|64791289|FG000|Overall Study|Other|5|||
23285945|NCT00860262|64791290|FG001|Overall Study|Other|3|||
23285946|NCT00860262|64791291|FG002|Overall Study|Other|1|||
23285947|NCT01912807|64791292|FG000|Overall Study|Did not meet elegibility criteria|6|||
23285948|NCT01912807|64791293|FG001|Overall Study|Did not meet elegibility criteria|4|||
23490568|NCT00559754|65541441|FG000|Overall Study|Protocol Violation|1|||
23490569|NCT00559754|65541441|FG000|Overall Study|Investigator criteria|2|||
23490570|NCT00559754|65541441|FG000|Overall Study|Withdrawal by Subject|2|||
23605350|NCT00805441|65943690|FG001|Overall Study|Adverse Event|2|||
23605351|NCT00805441|65943689|FG000|Overall Study|Lack of Efficacy|0|||
23605352|NCT00805441|65943690|FG001|Overall Study|Lack of Efficacy|2|||
23285949|NCT01912807|64791292|FG000|Overall Study|Lost to Follow-up|36|||
23490571|NCT01309165|65541442|FG000|Overall Study|Lost to Follow-up|4|||
23285950|NCT01912807|64791293|FG001|Overall Study|Lost to Follow-up|37|||
23285951|NCT01962298|64791294|FG000|Overall Study|Protocol Violation|1|||
23285952|NCT01962298|64791295|FG001|Overall Study|Protocol Violation|0|||
23285953|NCT01962298|64791296|FG002|Overall Study|Protocol Violation|1|||
23285954|NCT01962298|64791297|FG003|Overall Study|Protocol Violation|1|||
23378542|NCT00831844|65130578|FG005|Overall Study|Ineligible|0|||
23490572|NCT01309165|65541443|FG001|Overall Study|Lost to Follow-up|3|||
23605353|NCT00805441|65943689|FG000|Overall Study|Protocol Violation|4|||
23605354|NCT00805441|65943690|FG001|Overall Study|Protocol Violation|8|||
23378543|NCT00831844|65130579|FG006|Overall Study|Ineligible|0|||
23378544|NCT00831844|65130580|FG007|Overall Study|Ineligible|0|||
23378545|NCT00831844|65130581|FG008|Overall Study|Ineligible|0|||
23378546|NCT00831844|65130582|FG009|Overall Study|Ineligible|0|||
23378547|NCT05399771|65130585|FG000|Overall Study|Physician Decision|3|||
23378548|NCT05399771|65130585|FG000|Overall Study|Adverse Event|1|||
23378549|NCT02774278|65130588|FG000|Overall Study|Lack of Efficacy|199|||
23378550|NCT02774278|65130588|FG000|Overall Study|Death|29|||
23378551|NCT02774278|65130588|FG000|Overall Study|Adverse event/intercurrent illness|16|||
23378552|NCT02774278|65130588|FG000|Overall Study|Refused treatment/did not cooperate|9|||
23378553|NCT02774278|65130588|FG000|Overall Study|Administrative reasons|6|||
23378554|NCT02774278|65130588|FG000|Overall Study|Withdrawal by Subject|3|||
23378555|NCT02774278|65130588|FG000|Overall Study|Protocol Violation|2|||
23378556|NCT02595749|65130601|FG000|Overall Study|Withdrawal by Subject|12|||
23378557|NCT02595749|65130602|FG001|Overall Study|Withdrawal by Subject|7|||
23378558|NCT01500083|65130603|FG000|Overall Study|Adverse Event|4|||
23378559|NCT01500083|65130604|FG001|Overall Study|Adverse Event|17|||
23378560|NCT01500083|65130603|FG000|Overall Study|Death|0|||
23378561|NCT01500083|65130604|FG001|Overall Study|Death|2|||
23378562|NCT01500083|65130603|FG000|Overall Study|Lost to Follow-up|1|||
23378563|NCT01500083|65130604|FG001|Overall Study|Lost to Follow-up|0|||
23378564|NCT01500083|65130603|FG000|Overall Study|Withdrawal of Consent|0|||
23378565|NCT01500083|65130604|FG001|Overall Study|Withdrawal of Consent|1|||
23378566|NCT01500083|65130603|FG000|Overall Study|Disease Progression|2|||
23378567|NCT01500083|65130604|FG001|Overall Study|Disease Progression|10|||
23378568|NCT01500083|65130603|FG000|Overall Study|Investigator Discretion|3|||
23378569|NCT01500083|65130604|FG001|Overall Study|Investigator Discretion|8|||
23378570|NCT01500083|65130603|FG000|Overall Study|Other Reasons|2|||
23378571|NCT01500083|65130604|FG001|Overall Study|Other Reasons|5|||
23490573|NCT01309165|65541442|FG000|Overall Study|Return to work|1|||
23490574|NCT01309165|65541443|FG001|Overall Study|Return to work|2|||
23490575|NCT01309165|65541442|FG000|Overall Study|Left country|0|||
23490576|NCT01309165|65541443|FG001|Overall Study|Left country|1|||
23490577|NCT01309165|65541442|FG000|Overall Study|No transportation|0|||
23490578|NCT01309165|65541443|FG001|Overall Study|No transportation|1|||
23490579|NCT01309165|65541442|FG000|Overall Study|Admitted to hospital for second stroke|1|||
23490580|NCT01309165|65541443|FG001|Overall Study|Admitted to hospital for second stroke|0|||
23490581|NCT02437513|65541444|FG000|Overall Study|Withdrawal by Subject|2|||
23605355|NCT00805441|65943689|FG000|Overall Study|Lost to Follow-up|10|||
23605356|NCT00805441|65943690|FG001|Overall Study|Lost to Follow-up|13|||
23285955|NCT01962298|64791298|FG004|Overall Study|Protocol Violation|0|||
23285956|NCT01962298|64791294|FG000|Overall Study|Data quality insufficient|2|||
23285957|NCT01962298|64791295|FG001|Overall Study|Data quality insufficient|0|||
23285958|NCT01962298|64791296|FG002|Overall Study|Data quality insufficient|3|||
23285959|NCT01962298|64791297|FG003|Overall Study|Data quality insufficient|1|||
23285960|NCT01962298|64791298|FG004|Overall Study|Data quality insufficient|4|||
23285961|NCT01962298|64791294|FG000|Overall Study|Insufficient data|0|||
23285962|NCT01962298|64791295|FG001|Overall Study|Insufficient data|2|||
23285963|NCT01962298|64791296|FG002|Overall Study|Insufficient data|1|||
23285964|NCT01962298|64791297|FG003|Overall Study|Insufficient data|0|||
23285965|NCT01962298|64791298|FG004|Overall Study|Insufficient data|1|||
23285966|NCT01962298|64791294|FG000|Overall Study|Incorrect data recorded|0|||
23285967|NCT01962298|64791295|FG001|Overall Study|Incorrect data recorded|1|||
23285968|NCT01962298|64791296|FG002|Overall Study|Incorrect data recorded|0|||
23285969|NCT01962298|64791297|FG003|Overall Study|Incorrect data recorded|0|||
23285970|NCT01962298|64791298|FG004|Overall Study|Incorrect data recorded|0|||
23285971|NCT01962298|64791294|FG000|Overall Study|Physician Decision|0|||
23285972|NCT01962298|64791295|FG001|Overall Study|Physician Decision|1|||
23285973|NCT01962298|64791296|FG002|Overall Study|Physician Decision|0|||
23378572|NCT01947933|65130605|FG000|Overall Study|Withdrawal by Subject|0|||
23378573|NCT01947933|65130606|FG001|Overall Study|Withdrawal by Subject|0|||
23378574|NCT01947933|65130607|FG002|Overall Study|Withdrawal by Subject|1|||
23285974|NCT01962298|64791297|FG003|Overall Study|Physician Decision|0|||
23285975|NCT01962298|64791298|FG004|Overall Study|Physician Decision|1|||
23378575|NCT01947933|65130608|FG003|Overall Study|Withdrawal by Subject|0|||
23378576|NCT01947933|65130609|FG004|Overall Study|Withdrawal by Subject|0|||
23490582|NCT00467857|65541445|FG000|Overall Study|Adverse Event|1|||
23490583|NCT00467857|65541446|FG001|Overall Study|Adverse Event|0|||
23378577|NCT01947933|65130610|FG005|Overall Study|Withdrawal by Subject|0|||
23378578|NCT01947933|65130611|FG006|Overall Study|Withdrawal by Subject|0|||
23378579|NCT01947933|65130612|FG007|Overall Study|Withdrawal by Subject|0|||
23378580|NCT01947933|65130613|FG008|Overall Study|Withdrawal by Subject|0|||
23378581|NCT01947933|65130605|FG000|Overall Study|Lost to Follow-up|0|||
23378582|NCT01947933|65130606|FG001|Overall Study|Lost to Follow-up|0|||
23378583|NCT01947933|65130607|FG002|Overall Study|Lost to Follow-up|0|||
23378584|NCT01947933|65130608|FG003|Overall Study|Lost to Follow-up|0|||
23378585|NCT01947933|65130609|FG004|Overall Study|Lost to Follow-up|0|||
23378586|NCT01947933|65130610|FG005|Overall Study|Lost to Follow-up|0|||
23378587|NCT01947933|65130611|FG006|Overall Study|Lost to Follow-up|0|||
23378588|NCT01947933|65130612|FG007|Overall Study|Lost to Follow-up|0|||
23378589|NCT01947933|65130613|FG008|Overall Study|Lost to Follow-up|1|||
23378590|NCT01179516|65130617|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
23378591|NCT01179516|65130618|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
23378592|NCT01179516|65130619|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
23378593|NCT01179516|65130617|FG000|Overall Study|Lack of Efficacy|4|||
23378594|NCT01179516|65130618|FG001|Overall Study|Lack of Efficacy|2|||
23378595|NCT01179516|65130619|FG002|Overall Study|Lack of Efficacy|0|||
23378596|NCT01179516|65130617|FG000|Overall Study|Noncompliance with Study Drug|2|||
23378597|NCT01179516|65130618|FG001|Overall Study|Noncompliance with Study Drug|0|||
23378598|NCT01179516|65130619|FG002|Overall Study|Noncompliance with Study Drug|1|||
23378599|NCT01179516|65130617|FG000|Overall Study|Protocol Deviations|4|||
23378600|NCT01179516|65130618|FG001|Overall Study|Protocol Deviations|3|||
23378601|NCT01179516|65130619|FG002|Overall Study|Protocol Deviations|3|||
23378602|NCT01179516|65130617|FG000|Overall Study|Withdrawal of Consent|2|||
23378603|NCT01179516|65130618|FG001|Overall Study|Withdrawal of Consent|6|||
23378604|NCT01179516|65130619|FG002|Overall Study|Withdrawal of Consent|10|||
23378605|NCT01179516|65130617|FG000|Overall Study|Lost to Follow-up|7|||
23378606|NCT01179516|65130618|FG001|Overall Study|Lost to Follow-up|7|||
23378607|NCT01179516|65130619|FG002|Overall Study|Lost to Follow-up|3|||
23378608|NCT01179516|65130617|FG000|Overall Study|Other|2|||
23378609|NCT01179516|65130618|FG001|Overall Study|Other|0|||
23378610|NCT01179516|65130619|FG002|Overall Study|Other|2|||
23378611|NCT00147238|65130620|FG000|Overall Study|Inevaluable|8|||
23378612|NCT01991795|65130625|FG000|Overall Study|Lost to Follow-up|6|||
23378613|NCT01991795|65130626|FG001|Overall Study|Lost to Follow-up|4|||
23378614|NCT01991795|65130625|FG000|Overall Study|Withdrawal by Subject|117|||
23378615|NCT01991795|65130626|FG001|Overall Study|Withdrawal by Subject|94|||
23378616|NCT01991795|65130625|FG000|Overall Study|Site prematurely closed by sponsor|26|||
23378617|NCT01991795|65130626|FG001|Overall Study|Site prematurely closed by sponsor|25|||
23378618|NCT02691572|65130627|FG000|Overall Study|Withdrawal by Subject|1|||
23378619|NCT02691572|65130628|FG001|Overall Study|Withdrawal by Subject|0|||
23378620|NCT02691572|65130627|FG000|Overall Study|Protocol Violation|0|||
23378621|NCT02691572|65130628|FG001|Overall Study|Protocol Violation|1|||
23378622|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
23378623|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
23378624|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
23378625|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
23378626|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
23378627|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
23378628|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
23378629|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
23378630|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
23378631|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
23378632|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Death|3|||
23378633|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Death|1|||
23378634|NCT01056276|65130631|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
23378635|NCT01056276|65130632|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
23378636|NCT01056276|65130631|FG000|Maintenance Therapy|Toxicity|0|||
23378637|NCT01056276|65130632|FG001|Maintenance Therapy|Toxicity|2|||
23378638|NCT01056276|65130631|FG000|Maintenance Therapy|Progressive Disease|0|||
23378639|NCT01056276|65130632|FG001|Maintenance Therapy|Progressive Disease|9|||
23378640|NCT01056276|65130631|FG000|Maintenance Therapy|Physician Decision|0|||
23378641|NCT01056276|65130632|FG001|Maintenance Therapy|Physician Decision|1|||
23378642|NCT01056276|65130631|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
23378643|NCT01056276|65130632|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
23378644|NCT01056276|65130631|FG000|Maintenance Therapy|Intercurrent Illness|0|||
23378645|NCT01056276|65130632|FG001|Maintenance Therapy|Intercurrent Illness|1|||
23378646|NCT01056276|65130631|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
23378647|NCT01056276|65130632|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
23378648|NCT00853385|65133995|FG000|Overall Study|Death|0|||
23378649|NCT00853385|65133996|FG001|Overall Study|Death|0|||
23378650|NCT00853385|65133997|FG002|Overall Study|Death|0|||
23378651|NCT00853385|65133998|FG003|Overall Study|Death|0|||
23378652|NCT00853385|65133999|FG004|Overall Study|Death|1|||
23378653|NCT00853385|65133995|FG000|Overall Study|Adverse Event|24|||
23378654|NCT00853385|65133996|FG001|Overall Study|Adverse Event|24|||
23378655|NCT00853385|65133997|FG002|Overall Study|Adverse Event|2|||
23378656|NCT00853385|65133998|FG003|Overall Study|Adverse Event|5|||
23378657|NCT00853385|65133999|FG004|Overall Study|Adverse Event|22|||
23378658|NCT00853385|65133995|FG000|Overall Study|Lack of Efficacy|6|||
23378659|NCT00853385|65133996|FG001|Overall Study|Lack of Efficacy|7|||
23378660|NCT00853385|65133997|FG002|Overall Study|Lack of Efficacy|3|||
23378661|NCT00853385|65133998|FG003|Overall Study|Lack of Efficacy|3|||
23378662|NCT00853385|65133999|FG004|Overall Study|Lack of Efficacy|6|||
23378663|NCT00853385|65133995|FG000|Overall Study|Lost to Follow-up|2|||
23378664|NCT00853385|65133996|FG001|Overall Study|Lost to Follow-up|1|||
23378665|NCT00853385|65133997|FG002|Overall Study|Lost to Follow-up|0|||
23378666|NCT00853385|65133998|FG003|Overall Study|Lost to Follow-up|0|||
23378667|NCT00853385|65133999|FG004|Overall Study|Lost to Follow-up|0|||
23378668|NCT00853385|65133995|FG000|Overall Study|Withdrawal by Subject|4|||
23378669|NCT00853385|65133996|FG001|Overall Study|Withdrawal by Subject|2|||
23378670|NCT00853385|65133997|FG002|Overall Study|Withdrawal by Subject|0|||
23378671|NCT00853385|65133998|FG003|Overall Study|Withdrawal by Subject|1|||
23378672|NCT00853385|65133999|FG004|Overall Study|Withdrawal by Subject|1|||
23378673|NCT00853385|65133995|FG000|Overall Study|Other|18|||
23378674|NCT00853385|65133996|FG001|Overall Study|Other|9|||
23378675|NCT00853385|65133997|FG002|Overall Study|Other|4|||
23378676|NCT00853385|65133998|FG003|Overall Study|Other|4|||
23378677|NCT00853385|65133999|FG004|Overall Study|Other|12|||
23378678|NCT02233413|65134000|FG000|Overall Study|Lost to Follow-up|7|||
23378679|NCT02233413|65134001|FG001|Overall Study|Lost to Follow-up|9|||
23378680|NCT02233413|65134000|FG000|Overall Study|Withdrawal by Subject|4|||
23378681|NCT02233413|65134001|FG001|Overall Study|Withdrawal by Subject|5|||
23378682|NCT03572218|65134003|FG000|Overall Study|Lost to Follow-up|3|||
23605357|NCT00805441|65943689|FG000|Overall Study|Withdrawal by Subject|15|||
23605358|NCT00805441|65943690|FG001|Overall Study|Withdrawal by Subject|9|||
23605359|NCT00805441|65943689|FG000|Overall Study|Physician Decision|0|||
23605360|NCT00805441|65943690|FG001|Overall Study|Physician Decision|1|||
23605361|NCT00805441|65943689|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
23605362|NCT00805441|65943690|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
23605363|NCT03695185|65943691|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
23605364|NCT03695185|65943691|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
23605365|NCT03695185|65943691|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
23285976|NCT02227238|64791299|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
23285977|NCT02227238|64791300|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
23285978|NCT02227238|64791301|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
23285979|NCT02227238|64791299|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
23285980|NCT02227238|64791300|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
23285981|NCT02227238|64791301|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
23285982|NCT02227238|64791299|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
23285983|NCT02227238|64791300|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
23378683|NCT03572218|65134004|FG001|Overall Study|Lost to Follow-up|2|||
23378684|NCT03572218|65134003|FG000|Overall Study|No longer available for study visits|2|||
23605366|NCT03695185|65943691|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
23285984|NCT02227238|64791301|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
23378685|NCT03572218|65134004|FG001|Overall Study|No longer available for study visits|1|||
23378686|NCT03572218|65134003|FG000|Overall Study|No longer interested|1|||
23378687|NCT03572218|65134004|FG001|Overall Study|No longer interested|2|||
23378688|NCT01373229|65134005|FG000|Overall Study|Death|3|||
23605367|NCT03695185|65943691|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
23605368|NCT03695185|65943691|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
23605369|NCT03851094|65943693|FG000|Overall Study|Withdrawal by Subject|0|||
23605370|NCT03851094|65943694|FG001|Overall Study|Withdrawal by Subject|1|||
23605371|NCT03851094|65943693|FG000|Overall Study|Participant lost device|0|||
23378689|NCT01373229|65134005|FG000|Overall Study|Physician Decision|3|||
23378690|NCT01303419|65134006|FG000|Overall Study|Discontinuation of study|60|||
23378691|NCT01303419|65134006|FG000|Overall Study|Did not complete both imaging methods|5|||
23378692|NCT01303419|65134006|FG000|Overall Study|Did not meet all I/E after screening|31|||
23378693|NCT04666298|65134016|FG000|Overall Study|Subject decision|1|||
23378694|NCT04666298|65134017|FG001|Overall Study|Subject decision|0|||
23378695|NCT04666298|65134018|FG002|Overall Study|Subject decision|0|||
23378696|NCT04666298|65134019|FG003|Overall Study|Subject decision|2|||
23378697|NCT04666298|65134016|FG000|Overall Study|Death|1|||
23378698|NCT04666298|65134017|FG001|Overall Study|Death|0|||
23378699|NCT04666298|65134018|FG002|Overall Study|Death|0|||
23378700|NCT04666298|65134019|FG003|Overall Study|Death|0|||
23378701|NCT04666298|65134016|FG000|Overall Study|Lost to Follow-up|0|||
23605372|NCT03851094|65943694|FG001|Overall Study|Participant lost device|1|||
23605373|NCT03851094|65943693|FG000|Overall Study|Participant returned device|0|||
23605374|NCT03851094|65943694|FG001|Overall Study|Participant returned device|2|||
23605375|NCT04017611|65943695|FG000|Overall Study|Withdrawn prior to completion|1|||
23605376|NCT03890484|65943696|FG000|Overall Study|Lost to Follow-up|1|||
23605377|NCT03890484|65943697|FG001|Overall Study|Lost to Follow-up|1|||
23605378|NCT01052272|65943700|FG000|Overall Study|Death|0|||
23605379|NCT01052272|65943701|FG001|Overall Study|Death|0|||
23605380|NCT01052272|65943702|FG002|Overall Study|Death|1|||
23605381|NCT01052272|65943703|FG003|Overall Study|Death|1|||
23605382|NCT01052272|65943700|FG000|Overall Study|Physician Decision|0|||
23605383|NCT01052272|65943701|FG001|Overall Study|Physician Decision|1|||
23605384|NCT01052272|65943702|FG002|Overall Study|Physician Decision|0|||
23605385|NCT01052272|65943703|FG003|Overall Study|Physician Decision|0|||
23605386|NCT01052272|65943700|FG000|Overall Study|patient refuses follow-up|5|||
23605387|NCT01052272|65943701|FG001|Overall Study|patient refuses follow-up|4|||
23605388|NCT01052272|65943702|FG002|Overall Study|patient refuses follow-up|2|||
23605389|NCT01052272|65943703|FG003|Overall Study|patient refuses follow-up|4|||
23605390|NCT01052272|65943700|FG000|Overall Study|Withdrawal by Subject|0|||
23605391|NCT01052272|65943701|FG001|Overall Study|Withdrawal by Subject|2|||
23605392|NCT01052272|65943702|FG002|Overall Study|Withdrawal by Subject|3|||
23605393|NCT01052272|65943703|FG003|Overall Study|Withdrawal by Subject|2|||
23378702|NCT04666298|65134017|FG001|Overall Study|Lost to Follow-up|0|||
23378703|NCT04666298|65134018|FG002|Overall Study|Lost to Follow-up|0|||
23378704|NCT04666298|65134019|FG003|Overall Study|Lost to Follow-up|1|||
23378705|NCT04666298|65134016|FG000|Overall Study|Physician Decision|0|||
23378706|NCT04666298|65134017|FG001|Overall Study|Physician Decision|0|||
23378707|NCT04666298|65134018|FG002|Overall Study|Physician Decision|0|||
23378708|NCT04666298|65134019|FG003|Overall Study|Physician Decision|1|||
23378709|NCT04666298|65134016|FG000|Overall Study|Protocol deviation|0|||
23378710|NCT04666298|65134017|FG001|Overall Study|Protocol deviation|0|||
23378711|NCT04666298|65134018|FG002|Overall Study|Protocol deviation|1|||
23378712|NCT04666298|65134019|FG003|Overall Study|Protocol deviation|0|||
23378713|NCT02711137|65134020|FG000|Overall Study|Death|1|||
23378714|NCT02711137|65134021|FG001|Overall Study|Death|4|||
23378715|NCT02711137|65134022|FG002|Overall Study|Death|5|||
23378716|NCT02711137|65134023|FG003|Overall Study|Death|5|||
23378717|NCT02711137|65134024|FG004|Overall Study|Death|3|||
23378718|NCT02711137|65134025|FG005|Overall Study|Death|1|||
23378719|NCT02711137|65134026|FG006|Overall Study|Death|61|||
23378720|NCT02711137|65134027|FG007|Overall Study|Death|3|||
23378721|NCT02711137|65134028|FG008|Overall Study|Death|0|||
23378722|NCT02711137|65134029|FG009|Overall Study|Death|1|||
23378723|NCT02711137|65134030|FG010|Overall Study|Death|1|||
23378724|NCT02711137|65134031|FG011|Overall Study|Death|1|||
23378725|NCT02711137|65134032|FG012|Overall Study|Death|0|||
23378726|NCT02711137|65134033|FG013|Overall Study|Death|0|||
23378727|NCT02711137|65134034|FG014|Overall Study|Death|0|||
23378728|NCT02711137|65134020|FG000|Overall Study|Study Terminated by Sponsor|0|||
23378729|NCT02711137|65134021|FG001|Overall Study|Study Terminated by Sponsor|0|||
23378730|NCT02711137|65134022|FG002|Overall Study|Study Terminated by Sponsor|1|||
23378731|NCT02711137|65134023|FG003|Overall Study|Study Terminated by Sponsor|0|||
23378732|NCT02711137|65134024|FG004|Overall Study|Study Terminated by Sponsor|0|||
23378733|NCT02711137|65134025|FG005|Overall Study|Study Terminated by Sponsor|0|||
23378734|NCT02711137|65134026|FG006|Overall Study|Study Terminated by Sponsor|1|||
23378735|NCT02711137|65134027|FG007|Overall Study|Study Terminated by Sponsor|0|||
23378736|NCT02711137|65134028|FG008|Overall Study|Study Terminated by Sponsor|0|||
23378737|NCT02711137|65134029|FG009|Overall Study|Study Terminated by Sponsor|0|||
23378738|NCT02711137|65134030|FG010|Overall Study|Study Terminated by Sponsor|0|||
23378739|NCT02711137|65134031|FG011|Overall Study|Study Terminated by Sponsor|0|||
23378740|NCT02711137|65134032|FG012|Overall Study|Study Terminated by Sponsor|0|||
23378741|NCT02711137|65134033|FG013|Overall Study|Study Terminated by Sponsor|0|||
23285985|NCT02227238|64791299|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
23285986|NCT02227238|64791300|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
23285987|NCT02227238|64791301|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
23285988|NCT02227238|64791299|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
23285989|NCT02227238|64791300|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
23285990|NCT02227238|64791301|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
23285991|NCT02227238|64791299|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
23285992|NCT02227238|64791300|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
23285993|NCT02227238|64791301|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
23285994|NCT02227238|64791299|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
23285995|NCT02227238|64791300|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
23285996|NCT02227238|64791301|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
23285997|NCT02227238|64791299|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
23378742|NCT02711137|65134034|FG014|Overall Study|Study Terminated by Sponsor|0|||
23378743|NCT02711137|65134020|FG000|Overall Study|Physician Decision|1|||
23378744|NCT02711137|65134021|FG001|Overall Study|Physician Decision|0|||
23378745|NCT02711137|65134022|FG002|Overall Study|Physician Decision|2|||
23378746|NCT02711137|65134023|FG003|Overall Study|Physician Decision|1|||
23378747|NCT02711137|65134024|FG004|Overall Study|Physician Decision|1|||
23378748|NCT02711137|65134025|FG005|Overall Study|Physician Decision|0|||
23378749|NCT02711137|65134026|FG006|Overall Study|Physician Decision|12|||
23378750|NCT02711137|65134027|FG007|Overall Study|Physician Decision|2|||
23378751|NCT02711137|65134028|FG008|Overall Study|Physician Decision|1|||
23378752|NCT02711137|65134029|FG009|Overall Study|Physician Decision|1|||
23378753|NCT02711137|65134030|FG010|Overall Study|Physician Decision|3|||
23378754|NCT02711137|65134031|FG011|Overall Study|Physician Decision|2|||
23378755|NCT02711137|65134032|FG012|Overall Study|Physician Decision|1|||
23378756|NCT02711137|65134033|FG013|Overall Study|Physician Decision|1|||
23378757|NCT02711137|65134034|FG014|Overall Study|Physician Decision|2|||
23378758|NCT02711137|65134020|FG000|Overall Study|Other|0|||
23378759|NCT02711137|65134021|FG001|Overall Study|Other|1|||
23378760|NCT02711137|65134022|FG002|Overall Study|Other|0|||
23378761|NCT02711137|65134023|FG003|Overall Study|Other|0|||
23378762|NCT02711137|65134024|FG004|Overall Study|Other|0|||
23378763|NCT02711137|65134025|FG005|Overall Study|Other|0|||
23378764|NCT02711137|65134026|FG006|Overall Study|Other|3|||
23378765|NCT02711137|65134027|FG007|Overall Study|Other|0|||
23378766|NCT02711137|65134028|FG008|Overall Study|Other|0|||
23378767|NCT02711137|65134029|FG009|Overall Study|Other|0|||
23378768|NCT02711137|65134030|FG010|Overall Study|Other|0|||
23605394|NCT01052272|65943700|FG000|Overall Study|placed in long-term care|0|||
23605395|NCT01052272|65943701|FG001|Overall Study|placed in long-term care|0|||
23605396|NCT01052272|65943702|FG002|Overall Study|placed in long-term care|1|||
23605397|NCT01052272|65943703|FG003|Overall Study|placed in long-term care|0|||
23605398|NCT01052272|65943700|FG000|Overall Study|decline in health|0|||
23605399|NCT01052272|65943701|FG001|Overall Study|decline in health|0|||
23605400|NCT01052272|65943702|FG002|Overall Study|decline in health|1|||
23605401|NCT01052272|65943703|FG003|Overall Study|decline in health|0|||
23605402|NCT03964974|65943704|FG000|Overall Study|Lost to Follow-up|3|||
23605403|NCT03964974|65943705|FG001|Overall Study|Lost to Follow-up|2|||
23605404|NCT03964974|65943704|FG000|Overall Study|Withdrawal by Subject|0|||
23605405|NCT03964974|65943705|FG001|Overall Study|Withdrawal by Subject|3|||
23605406|NCT02208843|65943706|FG000|Overall Study|Clinical symptoms of progression|2|||
23378769|NCT02711137|65134031|FG011|Overall Study|Other|0|||
23378770|NCT02711137|65134032|FG012|Overall Study|Other|0|||
23605407|NCT02208843|65943706|FG000|Overall Study|Progression disease according to RECIST|24|||
23605408|NCT02208843|65943706|FG000|Overall Study|Adverse Event|12|||
23605409|NCT02208843|65943706|FG000|Overall Study|Protocol Violation|1|||
23605410|NCT02208843|65943706|FG000|Overall Study|Withdrawal by Subject|1|||
23605411|NCT02208843|65943706|FG000|Overall Study|Switched to commercial afatinib|20|||
23605412|NCT02659540|65943719|FG000|Overall Study|Adverse Event|3|||
23378771|NCT02711137|65134033|FG013|Overall Study|Other|0|||
23378772|NCT02711137|65134034|FG014|Overall Study|Other|1|||
23378773|NCT02711137|65134020|FG000|Overall Study|Withdrawal by Subject|1|||
23378774|NCT02711137|65134021|FG001|Overall Study|Withdrawal by Subject|0|||
23378775|NCT02711137|65134022|FG002|Overall Study|Withdrawal by Subject|0|||
23378776|NCT02711137|65134023|FG003|Overall Study|Withdrawal by Subject|1|||
23378777|NCT02711137|65134024|FG004|Overall Study|Withdrawal by Subject|1|||
23378778|NCT02711137|65134025|FG005|Overall Study|Withdrawal by Subject|0|||
23378779|NCT02711137|65134026|FG006|Overall Study|Withdrawal by Subject|7|||
23378780|NCT02711137|65134027|FG007|Overall Study|Withdrawal by Subject|0|||
23378781|NCT02711137|65134028|FG008|Overall Study|Withdrawal by Subject|0|||
23378782|NCT02711137|65134029|FG009|Overall Study|Withdrawal by Subject|0|||
23378783|NCT02711137|65134030|FG010|Overall Study|Withdrawal by Subject|0|||
23378784|NCT02711137|65134031|FG011|Overall Study|Withdrawal by Subject|0|||
23378785|NCT02711137|65134032|FG012|Overall Study|Withdrawal by Subject|0|||
23378786|NCT02711137|65134033|FG013|Overall Study|Withdrawal by Subject|1|||
23378787|NCT02711137|65134034|FG014|Overall Study|Withdrawal by Subject|0|||
23378788|NCT02711137|65134020|FG000|Overall Study|Lost to Follow-up|1|||
23378789|NCT02711137|65134021|FG001|Overall Study|Lost to Follow-up|0|||
23378790|NCT02711137|65134022|FG002|Overall Study|Lost to Follow-up|0|||
23378791|NCT02711137|65134023|FG003|Overall Study|Lost to Follow-up|0|||
23378792|NCT02711137|65134024|FG004|Overall Study|Lost to Follow-up|0|||
23378793|NCT02711137|65134025|FG005|Overall Study|Lost to Follow-up|0|||
23378794|NCT02711137|65134026|FG006|Overall Study|Lost to Follow-up|2|||
23378795|NCT02711137|65134027|FG007|Overall Study|Lost to Follow-up|0|||
23378796|NCT02711137|65134028|FG008|Overall Study|Lost to Follow-up|0|||
23378797|NCT02711137|65134029|FG009|Overall Study|Lost to Follow-up|0|||
23378798|NCT02711137|65134030|FG010|Overall Study|Lost to Follow-up|0|||
23378799|NCT02711137|65134031|FG011|Overall Study|Lost to Follow-up|0|||
23378800|NCT02711137|65134032|FG012|Overall Study|Lost to Follow-up|0|||
23378801|NCT02711137|65134033|FG013|Overall Study|Lost to Follow-up|0|||
23378802|NCT02711137|65134034|FG014|Overall Study|Lost to Follow-up|0|||
23378803|NCT00421993|65134035|FG000|Overall Study|Withdrawal by Subject|22|||
23378804|NCT00421993|65134036|FG001|Overall Study|Withdrawal by Subject|23|||
23378805|NCT00421993|65134037|FG002|Overall Study|Withdrawal by Subject|23|||
23378806|NCT00421993|65134038|FG003|Overall Study|Withdrawal by Subject|24|||
23378807|NCT00421993|65134035|FG000|Overall Study|Lost to Follow-up|18|||
23378808|NCT00421993|65134036|FG001|Overall Study|Lost to Follow-up|19|||
23378809|NCT00421993|65134037|FG002|Overall Study|Lost to Follow-up|22|||
23490584|NCT00467857|65541445|FG000|Overall Study|Withdrew consent|2|||
23490585|NCT00467857|65541446|FG001|Overall Study|Withdrew consent|0|||
23490586|NCT00467857|65541445|FG000|Overall Study|Death|0|||
23490587|NCT00467857|65541446|FG001|Overall Study|Death|1|||
23490588|NCT00467857|65541445|FG000|Overall Study|Discharged from court service|0|||
23490589|NCT00467857|65541446|FG001|Overall Study|Discharged from court service|1|||
23490590|NCT00467857|65541445|FG000|Overall Study|Emergency care required|0|||
23490591|NCT00467857|65541446|FG001|Overall Study|Emergency care required|1|||
23490592|NCT00467857|65541445|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
23490593|NCT00467857|65541446|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
23490594|NCT00467857|65541445|FG000|Overall Study|Discontinuation reason missing|0|||
23490595|NCT00467857|65541446|FG001|Overall Study|Discontinuation reason missing|3|||
23490596|NCT01024231|65541447|FG000|Overall Study|Other Reasons|1|||
23490597|NCT01024231|65541448|FG001|Overall Study|Other Reasons|2|||
23378810|NCT00421993|65134038|FG003|Overall Study|Lost to Follow-up|20|||
23378811|NCT00421993|65134035|FG000|Overall Study|Adverse Event|11|||
23378812|NCT00421993|65134036|FG001|Overall Study|Adverse Event|1|||
23378813|NCT00421993|65134037|FG002|Overall Study|Adverse Event|6|||
23378814|NCT00421993|65134038|FG003|Overall Study|Adverse Event|4|||
23378815|NCT00421993|65134035|FG000|Overall Study|Protocol Violation|2|||
23378816|NCT00421993|65134036|FG001|Overall Study|Protocol Violation|2|||
23378817|NCT00421993|65134037|FG002|Overall Study|Protocol Violation|0|||
23490598|NCT01024231|65541449|FG002|Overall Study|Other Reasons|0|||
23490599|NCT01024231|65541450|FG003|Overall Study|Other Reasons|0|||
23285998|NCT02227238|64791300|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
23285999|NCT02227238|64791301|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
23286000|NCT02227238|64791299|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
23286001|NCT02227238|64791300|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
23286002|NCT02227238|64791301|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
23286003|NCT02227238|64791299|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
23286004|NCT02227238|64791300|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
23286005|NCT02227238|64791301|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
23286006|NCT02227238|64791299|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
23286007|NCT02227238|64791300|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
23286008|NCT02227238|64791301|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
23286009|NCT02227238|64791299|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
23286010|NCT02227238|64791300|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
23286011|NCT02227238|64791301|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
23286012|NCT02227238|64791299|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
23286013|NCT02227238|64791300|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
23286014|NCT02227238|64791301|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
23286015|NCT02227238|64791299|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
23286016|NCT02227238|64791300|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
23286017|NCT02227238|64791301|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
23286018|NCT01993940|64791302|FG000|Overall Study|Adverse Event|16|||
23286019|NCT01993940|64791303|FG001|Overall Study|Adverse Event|11|||
23286020|NCT01993940|64791302|FG000|Overall Study|Withdrawal by Subject|15|||
23286021|NCT01993940|64791303|FG001|Overall Study|Withdrawal by Subject|19|||
23286022|NCT01993940|64791302|FG000|Overall Study|Lost to Follow-up|2|||
23286023|NCT01993940|64791303|FG001|Overall Study|Lost to Follow-up|5|||
23605413|NCT02659540|65943720|FG001|Overall Study|Adverse Event|2|||
23605414|NCT02659540|65943719|FG000|Overall Study|Death|1|||
23605415|NCT02659540|65943720|FG001|Overall Study|Death|0|||
23605416|NCT02659540|65943719|FG000|Overall Study|Progressive disease|2|||
23605417|NCT02659540|65943720|FG001|Overall Study|Progressive disease|6|||
23605418|NCT05376397|65943724|FG000|Overall Study|Lost to Follow-up|1|||
23605419|NCT02161458|65943725|FG000|Overall Study|Withdrawal by Subject|0|||
23605420|NCT02161458|65943726|FG001|Overall Study|Withdrawal by Subject|4|||
23605421|NCT02161458|65943727|FG002|Overall Study|Withdrawal by Subject|4|||
23605422|NCT02161458|65943728|FG003|Overall Study|Withdrawal by Subject|0|||
23605423|NCT02161458|65943725|FG000|Overall Study|Lost to Follow-up|0|||
23605424|NCT02161458|65943726|FG001|Overall Study|Lost to Follow-up|2|||
23605425|NCT02161458|65943727|FG002|Overall Study|Lost to Follow-up|1|||
23605426|NCT02161458|65943728|FG003|Overall Study|Lost to Follow-up|0|||
23605427|NCT00428714|65943736|FG000|Overall Study|Progressive Disease|28|||
23605428|NCT00428714|65943737|FG001|Overall Study|Progressive Disease|36|||
23605429|NCT00428714|65943736|FG000|Overall Study|Withdrawal by Subject|0|||
23605430|NCT00428714|65943737|FG001|Overall Study|Withdrawal by Subject|3|||
23605431|NCT00428714|65943736|FG000|Overall Study|Adverse Event|0|||
23605432|NCT00428714|65943737|FG001|Overall Study|Adverse Event|2|||
23605433|NCT00428714|65943736|FG000|Overall Study|Physician Decision|1|||
23605434|NCT00428714|65943737|FG001|Overall Study|Physician Decision|1|||
23605435|NCT00428714|65943736|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
23605436|NCT00428714|65943737|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
23605437|NCT00428714|65943736|FG000|Overall Study|Death due to other then PD|1|||
23605438|NCT00428714|65943737|FG001|Overall Study|Death due to other then PD|0|||
23605439|NCT01828021|65943738|FG000|Overall Study|Adverse Event|5|||
23605440|NCT01828021|65943738|FG000|Overall Study|Lack of Efficacy|17|||
23605441|NCT01828021|65943738|FG000|Overall Study|Withdrawal by Subject|2|||
23605442|NCT01828021|65943738|FG000|Overall Study|Ileal obstruction, unrelated|1|||
23605443|NCT00853593|65943739|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
23605444|NCT00853593|65943739|FG000|Overall Study|Model 4396 lead not attempted|29|||
23605445|NCT00853593|65943739|FG000|Overall Study|Implant not attempted|4|||
23605446|NCT02991118|65943742|FG000|Overall Study|Death|3|||
23605447|NCT02991118|65943743|FG001|Overall Study|Death|8|||
23605448|NCT02991118|65943742|FG000|Overall Study|Protocol Violation|0|||
23378818|NCT00421993|65134038|FG003|Overall Study|Protocol Violation|1|||
23378819|NCT00421993|65134035|FG000|Overall Study|Lack of Efficacy|0|||
23378820|NCT00421993|65134036|FG001|Overall Study|Lack of Efficacy|3|||
23378821|NCT00421993|65134037|FG002|Overall Study|Lack of Efficacy|0|||
23378822|NCT00421993|65134038|FG003|Overall Study|Lack of Efficacy|5|||
23378823|NCT00421993|65134035|FG000|Overall Study|Pregnancy|0|||
23378824|NCT00421993|65134036|FG001|Overall Study|Pregnancy|1|||
23378825|NCT00421993|65134037|FG002|Overall Study|Pregnancy|1|||
23286024|NCT01993940|64791302|FG000|Overall Study|Protocol Violation|5|||
23286025|NCT01993940|64791303|FG001|Overall Study|Protocol Violation|8|||
23286026|NCT01993940|64791302|FG000|Overall Study|Death|1|||
23286027|NCT01993940|64791303|FG001|Overall Study|Death|0|||
23286028|NCT01993940|64791302|FG000|Overall Study|Other - Miscellaneous|1|||
23378826|NCT00421993|65134038|FG003|Overall Study|Pregnancy|2|||
23378827|NCT00421993|65134035|FG000|Overall Study|Subject transportation issues|0|||
23378828|NCT00421993|65134036|FG001|Overall Study|Subject transportation issues|0|||
23378829|NCT00421993|65134037|FG002|Overall Study|Subject transportation issues|0|||
23378830|NCT00421993|65134038|FG003|Overall Study|Subject transportation issues|1|||
23378831|NCT01001104|65134046|FG000|Overall Study|Adverse Event|2|||
23378832|NCT01001104|65134047|FG001|Overall Study|Adverse Event|1|||
23378833|NCT01001104|65134048|FG002|Overall Study|Adverse Event|0|||
23378834|NCT01001104|65134049|FG003|Overall Study|Adverse Event|0|||
23378835|NCT01001104|65134046|FG000|Overall Study|Lost to Follow-up|0|||
23378836|NCT01001104|65134047|FG001|Overall Study|Lost to Follow-up|0|||
23378837|NCT01001104|65134048|FG002|Overall Study|Lost to Follow-up|1|||
23378838|NCT01001104|65134049|FG003|Overall Study|Lost to Follow-up|0|||
23378839|NCT01001104|65134046|FG000|Overall Study|Entry Criteria Not Met|0|||
23490600|NCT01024231|65541451|FG004|Overall Study|Other Reasons|2|||
23605449|NCT02991118|65943743|FG001|Overall Study|Protocol Violation|3|||
23286029|NCT01993940|64791303|FG001|Overall Study|Other - Miscellaneous|1|||
23286030|NCT01488448|64791304|FG000|Overall Study|Withdrawal by Subject|3|||
23286031|NCT01488448|64791305|FG001|Overall Study|Withdrawal by Subject|1|||
23286032|NCT01488448|64791304|FG000|Overall Study|Adverse Event|9|||
23286033|NCT01488448|64791305|FG001|Overall Study|Adverse Event|4|||
23286034|NCT01488448|64791304|FG000|Overall Study|Physician Decision|4|||
23286035|NCT01488448|64791305|FG001|Overall Study|Physician Decision|9|||
23286036|NCT01488448|64791304|FG000|Overall Study|Protocol Violation|4|||
23286037|NCT01488448|64791305|FG001|Overall Study|Protocol Violation|3|||
23286038|NCT00452348|64791308|FG000|Overall Study|Adverse Event|6|||
23286039|NCT00452348|64791309|FG001|Overall Study|Adverse Event|9|||
23286040|NCT00452348|64791308|FG000|Overall Study|Lack of Efficacy|10|||
23286041|NCT00452348|64791309|FG001|Overall Study|Lack of Efficacy|9|||
23286042|NCT00452348|64791308|FG000|Overall Study|Lost to Follow-up|14|||
23286043|NCT00452348|64791309|FG001|Overall Study|Lost to Follow-up|8|||
23286044|NCT00452348|64791308|FG000|Overall Study|Protocol Violation|22|||
23286045|NCT00452348|64791309|FG001|Overall Study|Protocol Violation|28|||
23286046|NCT00452348|64791308|FG000|Overall Study|Withdrawal by Subject|18|||
23286047|NCT00452348|64791309|FG001|Overall Study|Withdrawal by Subject|21|||
23286048|NCT00452348|64791308|FG000|Overall Study|Other|9|||
23286049|NCT00452348|64791309|FG001|Overall Study|Other|9|||
23286050|NCT01929681|64791310|FG000|Overall Study|Withdrawal by Subject|1|||
23286051|NCT01929681|64791311|FG001|Overall Study|Withdrawal by Subject|0|||
23286052|NCT01929681|64791310|FG000|Overall Study|Physician Decision|1|||
23286053|NCT01929681|64791311|FG001|Overall Study|Physician Decision|1|||
23286054|NCT02218216|64791313|FG000|Overall Study|Study terminated before completed|6|||
23286055|NCT02218216|64791314|FG001|Overall Study|Study terminated before completed|0|||
23378840|NCT01001104|65134047|FG001|Overall Study|Entry Criteria Not Met|0|||
23378841|NCT01001104|65134048|FG002|Overall Study|Entry Criteria Not Met|0|||
23605450|NCT02991118|65943742|FG000|Overall Study|Physician Decision|0|||
23378842|NCT01001104|65134049|FG003|Overall Study|Entry Criteria Not Met|1|||
23378843|NCT01001104|65134046|FG000|Overall Study|Withdrawal by Subject|0|||
23378844|NCT01001104|65134047|FG001|Overall Study|Withdrawal by Subject|0|||
23490601|NCT01024231|65541452|FG005|Overall Study|Other Reasons|0|||
23286056|NCT02218216|64791315|FG002|Overall Study|Study terminated before completed|0|||
23378845|NCT01001104|65134048|FG002|Overall Study|Withdrawal by Subject|0|||
23286057|NCT00965731|64791318|FG000|Overall Study|Death|0|||
23286058|NCT00965731|64791319|FG001|Overall Study|Death|4|||
23286059|NCT00965731|64791318|FG000|Overall Study|Withdrawal by Subject|0|||
23286060|NCT00965731|64791319|FG001|Overall Study|Withdrawal by Subject|1|||
23286061|NCT00965731|64791318|FG000|Overall Study|Other|7|||
23286062|NCT00965731|64791319|FG001|Overall Study|Other|15|||
23286063|NCT03920280|64791322|FG000|Overall Study|Adverse Event|2|||
23286064|NCT03920280|64791323|FG001|Overall Study|Adverse Event|3|||
23286065|NCT03920280|64791322|FG000|Overall Study|Lost to Follow-up|0|||
23286066|NCT03920280|64791323|FG001|Overall Study|Lost to Follow-up|1|||
23286067|NCT03920280|64791322|FG000|Overall Study|Withdrawal by Subject|1|||
23286068|NCT03920280|64791323|FG001|Overall Study|Withdrawal by Subject|1|||
23286069|NCT03920280|64791322|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
23286070|NCT03920280|64791323|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
23286071|NCT04449341|64791324|FG000|Overall Study|Protocol Violation|1|||
23286072|NCT04449341|64791325|FG001|Overall Study|Protocol Violation|0|||
23286073|NCT05665387|64791326|FG000|Overall Study|Withdrawal by Subject|1|||
23286074|NCT05665387|64791327|FG001|Overall Study|Withdrawal by Subject|0|||
23286075|NCT05665387|64791328|FG002|Overall Study|Withdrawal by Subject|1|||
23286076|NCT03224624|64791331|FG000|Overall Study|Lost to Follow-up|9|||
23286077|NCT03224624|64791332|FG001|Overall Study|Lost to Follow-up|4|||
23286078|NCT03224624|64791331|FG000|Overall Study|Death|1|||
23286079|NCT03224624|64791332|FG001|Overall Study|Death|0|||
23286080|NCT02372006|64791333|FG000|Overall Study|Progressive disease|8|||
23286081|NCT02372006|64791334|FG001|Overall Study|Progressive disease|7|||
23286082|NCT02372006|64791335|FG002|Overall Study|Progressive disease|34|||
23286083|NCT02372006|64791333|FG000|Overall Study|Dose limiting toxicity|0|||
23286084|NCT02372006|64791334|FG001|Overall Study|Dose limiting toxicity|1|||
23286085|NCT02372006|64791335|FG002|Overall Study|Dose limiting toxicity|0|||
23286086|NCT02372006|64791333|FG000|Overall Study|Adverse Event|0|||
23286087|NCT02372006|64791334|FG001|Overall Study|Adverse Event|0|||
23286088|NCT02372006|64791335|FG002|Overall Study|Adverse Event|3|||
23286089|NCT02372006|64791333|FG000|Overall Study|Withdrawal by Subject|0|||
23286090|NCT02372006|64791334|FG001|Overall Study|Withdrawal by Subject|1|||
23286091|NCT02372006|64791335|FG002|Overall Study|Withdrawal by Subject|1|||
23286092|NCT02372006|64791333|FG000|Overall Study|Other reason for not completing|0|||
23286093|NCT02372006|64791334|FG001|Overall Study|Other reason for not completing|0|||
23378846|NCT01001104|65134049|FG003|Overall Study|Withdrawal by Subject|2|||
23378847|NCT01995201|65134054|FG000|From Baseline Until Week 24|Adverse Event|4|||
23378848|NCT01995201|65134055|FG001|From Baseline Until Week 24|Adverse Event|15|||
23378849|NCT01995201|65134056|FG002|From Baseline Until Week 24|Adverse Event|0|||
23378850|NCT01995201|65134057|FG003|From Baseline Until Week 24|Adverse Event|0|||
23378851|NCT01995201|65134058|FG004|From Baseline Until Week 24|Adverse Event|0|||
23378852|NCT01995201|65134059|FG005|From Baseline Until Week 24|Adverse Event|0|||
23378853|NCT01995201|65134060|FG006|From Baseline Until Week 24|Adverse Event|0|||
23378854|NCT01995201|65134054|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378855|NCT01995201|65134055|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
23378856|NCT01995201|65134056|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378857|NCT01995201|65134057|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378858|NCT01995201|65134058|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378859|NCT01995201|65134059|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378860|NCT01995201|65134060|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
23378861|NCT01995201|65134054|FG000|From Baseline Until Week 24|Death|0|||
23378862|NCT01995201|65134055|FG001|From Baseline Until Week 24|Death|1|||
23378863|NCT01995201|65134056|FG002|From Baseline Until Week 24|Death|0|||
23378864|NCT01995201|65134057|FG003|From Baseline Until Week 24|Death|0|||
23378865|NCT01995201|65134058|FG004|From Baseline Until Week 24|Death|0|||
23378866|NCT01995201|65134059|FG005|From Baseline Until Week 24|Death|0|||
23378867|NCT01995201|65134060|FG006|From Baseline Until Week 24|Death|0|||
23378868|NCT01995201|65134054|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
23378869|NCT01995201|65134055|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
23378870|NCT01995201|65134056|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
23378871|NCT01995201|65134057|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
23378872|NCT01995201|65134058|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
23490602|NCT01024231|65541453|FG006|Overall Study|Other Reasons|1|||
23490603|NCT01024231|65541447|FG000|Overall Study|Maximum Clinical Benefit|1|||
23490604|NCT01024231|65541448|FG001|Overall Study|Maximum Clinical Benefit|2|||
23490605|NCT01024231|65541449|FG002|Overall Study|Maximum Clinical Benefit|0|||
23490606|NCT01024231|65541450|FG003|Overall Study|Maximum Clinical Benefit|1|||
23490607|NCT01024231|65541451|FG004|Overall Study|Maximum Clinical Benefit|1|||
23286094|NCT02372006|64791335|FG002|Overall Study|Other reason for not completing|1|||
23286095|NCT03614728|64791336|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
23286096|NCT03614728|64791337|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
23286097|NCT03614728|64791338|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
23286098|NCT03614728|64791339|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
23286099|NCT03614728|64791336|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
23286100|NCT03614728|64791337|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
23286101|NCT03614728|64791338|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
23286102|NCT03614728|64791339|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
23286103|NCT02472639|64791341|FG000|Overall Study|Physician Decision|4|||
23286104|NCT02472639|64791342|FG001|Overall Study|Physician Decision|3|||
23286105|NCT04194008|64791343|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
23286106|NCT04194008|64791343|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
23286107|NCT04194008|64791343|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
23286108|NCT04194008|64791343|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
23286109|NCT04194008|64791343|FG000|Treatment Phase With Nerivio|Missing data|4|||
23286110|NCT04194008|64791343|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
23286111|NCT01266902|64791344|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
23286112|NCT01266902|64791345|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
23286113|NCT01266902|64791346|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
23286114|NCT01266902|64791344|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
23286115|NCT01266902|64791345|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
23286116|NCT01266902|64791346|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
23286117|NCT01266902|64791344|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
23286118|NCT01266902|64791345|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
23286119|NCT01266902|64791346|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
23286120|NCT01266902|64791344|FG000|Period 1 (Main Study)|Adverse Event|3|||
23286121|NCT01266902|64791345|FG001|Period 1 (Main Study)|Adverse Event|11|||
23286122|NCT01266902|64791346|FG002|Period 1 (Main Study)|Adverse Event|0|||
23286123|NCT01266902|64791344|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
23286124|NCT01266902|64791345|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
23286125|NCT01266902|64791346|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
23378873|NCT01995201|65134059|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
23378874|NCT01995201|65134060|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
23378875|NCT01995201|65134054|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
23378876|NCT01995201|65134055|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
23378877|NCT01995201|65134056|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
23378878|NCT01995201|65134057|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
23378879|NCT01995201|65134058|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
23378880|NCT01995201|65134059|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
23378881|NCT01995201|65134060|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
23378882|NCT01995201|65134054|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
23378883|NCT01995201|65134055|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
23378884|NCT01995201|65134056|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378885|NCT01995201|65134057|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378886|NCT01995201|65134058|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378887|NCT01995201|65134059|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378888|NCT01995201|65134060|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
23378889|NCT01995201|65134054|FG000|From Baseline Until Week 24|Physician Decision|0|||
23378890|NCT01995201|65134055|FG001|From Baseline Until Week 24|Physician Decision|2|||
23378891|NCT01995201|65134056|FG002|From Baseline Until Week 24|Physician Decision|0|||
23378892|NCT01995201|65134057|FG003|From Baseline Until Week 24|Physician Decision|0|||
23378893|NCT01995201|65134058|FG004|From Baseline Until Week 24|Physician Decision|0|||
23378894|NCT01995201|65134059|FG005|From Baseline Until Week 24|Physician Decision|0|||
23378895|NCT01995201|65134060|FG006|From Baseline Until Week 24|Physician Decision|0|||
23378896|NCT01995201|65134054|FG000|From Baseline Until Week 24|Protocol Violation|0|||
23378897|NCT01995201|65134055|FG001|From Baseline Until Week 24|Protocol Violation|9|||
23378898|NCT01995201|65134056|FG002|From Baseline Until Week 24|Protocol Violation|0|||
23378899|NCT01995201|65134057|FG003|From Baseline Until Week 24|Protocol Violation|0|||
23378900|NCT01995201|65134058|FG004|From Baseline Until Week 24|Protocol Violation|0|||
23378901|NCT01995201|65134059|FG005|From Baseline Until Week 24|Protocol Violation|0|||
23378902|NCT01995201|65134060|FG006|From Baseline Until Week 24|Protocol Violation|0|||
23378903|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Adverse Event|0|||
23378904|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Adverse Event|0|||
23378905|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Adverse Event|2|||
23378906|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Adverse Event|1|||
23378907|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Adverse Event|1|||
23378908|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Adverse Event|3|||
23378909|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Adverse Event|1|||
23378910|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Death|0|||
23378911|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Death|0|||
23378912|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Death|0|||
23378913|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Death|0|||
23378914|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Death|0|||
23490608|NCT01024231|65541452|FG005|Overall Study|Maximum Clinical Benefit|0|||
23490609|NCT01024231|65541453|FG006|Overall Study|Maximum Clinical Benefit|0|||
23490610|NCT01024231|65541447|FG000|Overall Study|Disease Progression|3|||
23490611|NCT01024231|65541448|FG001|Overall Study|Disease Progression|1|||
23490612|NCT01024231|65541449|FG002|Overall Study|Disease Progression|3|||
23490613|NCT01024231|65541450|FG003|Overall Study|Disease Progression|0|||
23490614|NCT01024231|65541451|FG004|Overall Study|Disease Progression|4|||
23490615|NCT01024231|65541452|FG005|Overall Study|Disease Progression|11|||
23490616|NCT01024231|65541453|FG006|Overall Study|Disease Progression|6|||
23490617|NCT01024231|65541447|FG000|Overall Study|AE unrelated to Study Drug|0|||
23490618|NCT01024231|65541448|FG001|Overall Study|AE unrelated to Study Drug|1|||
23490619|NCT01024231|65541449|FG002|Overall Study|AE unrelated to Study Drug|0|||
23490620|NCT01024231|65541450|FG003|Overall Study|AE unrelated to Study Drug|0|||
23490621|NCT01024231|65541451|FG004|Overall Study|AE unrelated to Study Drug|0|||
23490622|NCT01024231|65541452|FG005|Overall Study|AE unrelated to Study Drug|0|||
23490623|NCT01024231|65541453|FG006|Overall Study|AE unrelated to Study Drug|0|||
23490624|NCT01024231|65541447|FG000|Overall Study|No longer meets criteria|0|||
23490625|NCT01024231|65541448|FG001|Overall Study|No longer meets criteria|0|||
23490626|NCT01024231|65541449|FG002|Overall Study|No longer meets criteria|0|||
23490627|NCT01024231|65541450|FG003|Overall Study|No longer meets criteria|0|||
23490628|NCT01024231|65541451|FG004|Overall Study|No longer meets criteria|1|||
23490629|NCT01024231|65541452|FG005|Overall Study|No longer meets criteria|0|||
23490630|NCT01024231|65541453|FG006|Overall Study|No longer meets criteria|1|||
23490631|NCT01024231|65541447|FG000|Overall Study|Study Drug Toxicity|1|||
23490632|NCT01024231|65541448|FG001|Overall Study|Study Drug Toxicity|6|||
23490633|NCT01024231|65541449|FG002|Overall Study|Study Drug Toxicity|6|||
23490634|NCT01024231|65541450|FG003|Overall Study|Study Drug Toxicity|4|||
23490635|NCT01024231|65541451|FG004|Overall Study|Study Drug Toxicity|2|||
23490636|NCT01024231|65541452|FG005|Overall Study|Study Drug Toxicity|0|||
23490637|NCT01024231|65541453|FG006|Overall Study|Study Drug Toxicity|7|||
23490638|NCT01024231|65541447|FG000|Overall Study|Death|6|||
23490639|NCT01024231|65541448|FG001|Overall Study|Death|2|||
23490640|NCT01024231|65541449|FG002|Overall Study|Death|1|||
23490641|NCT01024231|65541450|FG003|Overall Study|Death|0|||
23490642|NCT01024231|65541451|FG004|Overall Study|Death|4|||
23490643|NCT01024231|65541452|FG005|Overall Study|Death|3|||
23490644|NCT01024231|65541453|FG006|Overall Study|Death|5|||
23490645|NCT01024231|65541447|FG000|Overall Study|Lost to Follow-up|0|||
23490646|NCT01024231|65541448|FG001|Overall Study|Lost to Follow-up|0|||
23490647|NCT01024231|65541449|FG002|Overall Study|Lost to Follow-up|0|||
23490648|NCT01024231|65541450|FG003|Overall Study|Lost to Follow-up|0|||
23490649|NCT01024231|65541451|FG004|Overall Study|Lost to Follow-up|0|||
23286126|NCT01266902|64791344|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
23490650|NCT01024231|65541452|FG005|Overall Study|Lost to Follow-up|0|||
23490651|NCT01024231|65541453|FG006|Overall Study|Lost to Follow-up|1|||
23490652|NCT01024231|65541447|FG000|Overall Study|Withdrew Consent|0|||
23490653|NCT01024231|65541448|FG001|Overall Study|Withdrew Consent|1|||
23490654|NCT01024231|65541449|FG002|Overall Study|Withdrew Consent|0|||
23490655|NCT01024231|65541450|FG003|Overall Study|Withdrew Consent|0|||
23490656|NCT01024231|65541451|FG004|Overall Study|Withdrew Consent|0|||
23490657|NCT01024231|65541452|FG005|Overall Study|Withdrew Consent|0|||
23490658|NCT01024231|65541453|FG006|Overall Study|Withdrew Consent|0|||
23490659|NCT01024231|65541447|FG000|Overall Study|Continuing on Treatment|0|||
23286127|NCT01266902|64791345|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
23490660|NCT01024231|65541448|FG001|Overall Study|Continuing on Treatment|0|||
23490661|NCT01024231|65541449|FG002|Overall Study|Continuing on Treatment|0|||
23490662|NCT01024231|65541450|FG003|Overall Study|Continuing on Treatment|0|||
23490663|NCT01024231|65541451|FG004|Overall Study|Continuing on Treatment|3|||
23490664|NCT01024231|65541452|FG005|Overall Study|Continuing on Treatment|2|||
23490665|NCT01024231|65541453|FG006|Overall Study|Continuing on Treatment|0|||
23490666|NCT00611533|65541454|FG000|First Intervention (6 Weeks)|Never started study|0|||
23490667|NCT00611533|65541455|FG001|First Intervention (6 Weeks)|Never started study|1|||
23490668|NCT00611533|65541454|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
23490669|NCT00611533|65541455|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
23490670|NCT00611533|65541454|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
23490671|NCT00611533|65541455|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
23490672|NCT00694707|65541456|FG000|Overall Study|Did Not Receive Treatment|0|||
23490673|NCT00694707|65541457|FG001|Overall Study|Did Not Receive Treatment|0|||
23490674|NCT00694707|65541458|FG002|Overall Study|Did Not Receive Treatment|1|||
23490675|NCT00694707|65541459|FG003|Overall Study|Did Not Receive Treatment|1|||
23490676|NCT00694707|65541460|FG004|Overall Study|Did Not Receive Treatment|1|||
23490677|NCT00694707|65541456|FG000|Overall Study|Adverse Event|22|||
23490678|NCT00694707|65541457|FG001|Overall Study|Adverse Event|14|||
23490679|NCT00694707|65541458|FG002|Overall Study|Adverse Event|8|||
23490680|NCT00694707|65541459|FG003|Overall Study|Adverse Event|12|||
23490681|NCT00694707|65541460|FG004|Overall Study|Adverse Event|13|||
23490682|NCT00694707|65541456|FG000|Overall Study|Insufficient Therapeutic Response|33|||
23490683|NCT00694707|65541457|FG001|Overall Study|Insufficient Therapeutic Response|18|||
23490684|NCT00694707|65541458|FG002|Overall Study|Insufficient Therapeutic Response|17|||
23490685|NCT00694707|65541459|FG003|Overall Study|Insufficient Therapeutic Response|15|||
23490686|NCT00694707|65541460|FG004|Overall Study|Insufficient Therapeutic Response|10|||
23490687|NCT00694707|65541456|FG000|Overall Study|Protocol Violation|1|||
23490688|NCT00694707|65541457|FG001|Overall Study|Protocol Violation|2|||
23490689|NCT00694707|65541458|FG002|Overall Study|Protocol Violation|1|||
23490690|NCT00694707|65541459|FG003|Overall Study|Protocol Violation|3|||
23490691|NCT00694707|65541460|FG004|Overall Study|Protocol Violation|1|||
23490692|NCT00694707|65541456|FG000|Overall Study|Withdrawal of Consent|14|||
23490693|NCT00694707|65541457|FG001|Overall Study|Withdrawal of Consent|18|||
23490694|NCT00694707|65541458|FG002|Overall Study|Withdrawal of Consent|22|||
23490695|NCT00694707|65541459|FG003|Overall Study|Withdrawal of Consent|16|||
23490696|NCT00694707|65541460|FG004|Overall Study|Withdrawal of Consent|15|||
23286128|NCT01266902|64791346|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
23286129|NCT01266902|64791344|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
23286130|NCT01266902|64791345|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
23286131|NCT01266902|64791346|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
23286132|NCT01266902|64791344|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
23286133|NCT01266902|64791345|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
23286134|NCT01266902|64791346|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
23286135|NCT01266902|64791344|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
23286136|NCT01266902|64791345|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
23286137|NCT01266902|64791346|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
23286138|NCT01266902|64791344|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
23286139|NCT01266902|64791345|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
23286140|NCT01266902|64791346|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
23286141|NCT03666143|64791349|FG000|Overall Study|Death|158|||
23490697|NCT00694707|65541456|FG000|Overall Study|Lost to Follow-up|0|||
23490698|NCT00694707|65541457|FG001|Overall Study|Lost to Follow-up|1|||
23490699|NCT00694707|65541458|FG002|Overall Study|Lost to Follow-up|2|||
23490700|NCT00694707|65541459|FG003|Overall Study|Lost to Follow-up|0|||
23490701|NCT00694707|65541460|FG004|Overall Study|Lost to Follow-up|0|||
23490702|NCT00694707|65541456|FG000|Overall Study|Jeopardizing Parole Status|1|||
23490703|NCT00694707|65541457|FG001|Overall Study|Jeopardizing Parole Status|0|||
23490704|NCT00694707|65541458|FG002|Overall Study|Jeopardizing Parole Status|0|||
23490705|NCT00694707|65541459|FG003|Overall Study|Jeopardizing Parole Status|0|||
23490706|NCT00694707|65541460|FG004|Overall Study|Jeopardizing Parole Status|0|||
23490707|NCT00694707|65541456|FG000|Overall Study|Death in the Family|1|||
23490708|NCT00694707|65541457|FG001|Overall Study|Death in the Family|0|||
23490709|NCT00694707|65541458|FG002|Overall Study|Death in the Family|0|||
23490710|NCT00694707|65541459|FG003|Overall Study|Death in the Family|0|||
23490711|NCT00694707|65541460|FG004|Overall Study|Death in the Family|0|||
23490712|NCT00694707|65541456|FG000|Overall Study|Arrest by Police|0|||
23490713|NCT00694707|65541457|FG001|Overall Study|Arrest by Police|1|||
23490714|NCT00694707|65541458|FG002|Overall Study|Arrest by Police|0|||
23490715|NCT00694707|65541459|FG003|Overall Study|Arrest by Police|0|||
23490716|NCT00694707|65541460|FG004|Overall Study|Arrest by Police|0|||
23490717|NCT00694707|65541456|FG000|Overall Study|Administrative Reasons|0|||
23490718|NCT00694707|65541457|FG001|Overall Study|Administrative Reasons|1|||
23490719|NCT00694707|65541458|FG002|Overall Study|Administrative Reasons|0|||
23286142|NCT03666143|64791349|FG000|Overall Study|Sponsor Decision|31|||
23286143|NCT03666143|64791349|FG000|Overall Study|Withdrawal by Subject|11|||
23286144|NCT03666143|64791349|FG000|Overall Study|Lost to Follow-up|5|||
23286145|NCT03666143|64791349|FG000|Overall Study|Physician Decision|1|||
23286146|NCT03666143|64791349|FG000|Overall Study|Rolled into extension study|9|||
23286147|NCT03666143|64791349|FG000|Overall Study|Progressive Disease|1|||
23286148|NCT02252016|64791350|FG000|Overall Study|Lost to Follow-up|2|||
23490720|NCT00694707|65541459|FG003|Overall Study|Administrative Reasons|2|||
23490721|NCT00694707|65541460|FG004|Overall Study|Administrative Reasons|0|||
23490722|NCT00694707|65541456|FG000|Overall Study|Notification of Past Head Injury|0|||
23286149|NCT02252016|64791351|FG001|Overall Study|Lost to Follow-up|1|||
23490723|NCT00694707|65541457|FG001|Overall Study|Notification of Past Head Injury|0|||
23490724|NCT00694707|65541458|FG002|Overall Study|Notification of Past Head Injury|0|||
23286150|NCT02252016|64791350|FG000|Overall Study|Physician Decision|1|||
23286151|NCT02252016|64791351|FG001|Overall Study|Physician Decision|0|||
23286152|NCT02252016|64791350|FG000|Overall Study|Withdrawal by Subject|0|||
23378915|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Death|2|||
23378916|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Death|0|||
23286153|NCT02252016|64791351|FG001|Overall Study|Withdrawal by Subject|2|||
23286154|NCT01426854|64791352|FG000|Overall Study|Adverse Event|1|||
23286155|NCT01426854|64791353|FG001|Overall Study|Adverse Event|5|||
23286156|NCT01426854|64791352|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
23286157|NCT01426854|64791353|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
23286158|NCT01426854|64791352|FG000|Overall Study|Lost to Follow-up|3|||
23286159|NCT01426854|64791353|FG001|Overall Study|Lost to Follow-up|0|||
23286160|NCT01426854|64791352|FG000|Overall Study|Noncompliance|0|||
23286161|NCT01426854|64791353|FG001|Overall Study|Noncompliance|1|||
23286162|NCT01426854|64791352|FG000|Overall Study|Treatment Failure|0|||
23378917|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
23378918|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
23378919|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
23378920|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
23378921|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
23378922|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
23378923|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
23378924|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378925|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378926|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378927|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378928|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
23378929|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
23378930|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
23378931|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378932|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378933|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
23378934|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378935|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
23378936|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378937|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
23378938|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Physician Decision|0|||
23378939|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Physician Decision|0|||
23378940|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Physician Decision|0|||
23378941|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Physician Decision|0|||
23378942|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Physician Decision|1|||
23378943|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Physician Decision|0|||
23378944|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Physician Decision|0|||
23378945|NCT01995201|65134054|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
23378946|NCT01995201|65134055|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
23378947|NCT01995201|65134056|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
23378948|NCT01995201|65134057|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
23378949|NCT01995201|65134058|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
23378950|NCT01995201|65134059|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
23378951|NCT01995201|65134060|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
23378952|NCT00958074|65134061|FG000|Overall Study|Withdrawal by Subject|0|||
23378953|NCT00958074|65134062|FG001|Overall Study|Withdrawal by Subject|1|||
23378954|NCT01454284|65134063|FG000|Overall Study|Adverse Event|20|||
23378955|NCT01454284|65134064|FG001|Overall Study|Adverse Event|7|||
23378956|NCT01454284|65134063|FG000|Overall Study|Death|0|||
23378957|NCT01454284|65134064|FG001|Overall Study|Death|3|||
23378958|NCT01454284|65134063|FG000|Overall Study|Lost to Follow-up|13|||
23490725|NCT00694707|65541459|FG003|Overall Study|Notification of Past Head Injury|1|||
23286163|NCT01426854|64791353|FG001|Overall Study|Treatment Failure|16|||
23378959|NCT01454284|65134064|FG001|Overall Study|Lost to Follow-up|8|||
23378960|NCT01454284|65134063|FG000|Overall Study|Protocol Violation|9|||
23490726|NCT00694707|65541460|FG004|Overall Study|Notification of Past Head Injury|0|||
23286164|NCT01426854|64791352|FG000|Overall Study|Protocol Deviation|0|||
23286165|NCT01426854|64791353|FG001|Overall Study|Protocol Deviation|1|||
23490727|NCT01187433|65541461|FG000|Overall Study|Protocol Violation|6|||
23490728|NCT01187433|65541462|FG001|Overall Study|Protocol Violation|2|||
23490729|NCT01187433|65541461|FG000|Overall Study|Withdrawal by Subject|5|||
23490730|NCT01187433|65541462|FG001|Overall Study|Withdrawal by Subject|2|||
23490731|NCT01385371|65541463|FG000|Overall Study|Adverse Event|54|||
23490732|NCT01385371|65541464|FG001|Overall Study|Adverse Event|19|||
23490733|NCT01385371|65541463|FG000|Overall Study|Lost to Follow-up|16|||
23490734|NCT01385371|65541464|FG001|Overall Study|Lost to Follow-up|16|||
23490735|NCT01385371|65541463|FG000|Overall Study|Withdrawal by Subject|52|||
23490736|NCT01385371|65541464|FG001|Overall Study|Withdrawal by Subject|39|||
23490737|NCT01385371|65541463|FG000|Overall Study|Protocol Violation|25|||
23490738|NCT01385371|65541464|FG001|Overall Study|Protocol Violation|21|||
23490739|NCT01385371|65541463|FG000|Overall Study|Administrative|2|||
23490740|NCT01385371|65541464|FG001|Overall Study|Administrative|2|||
23490741|NCT02805972|65541465|FG000|Washout Period|Lost to Follow-up|3|||
23490742|NCT02805972|65541466|FG001|Washout Period|Lost to Follow-up|0|||
23490743|NCT03063203|65541467|FG000|Overall Study|Chose alternative therapy|3|||
23490744|NCT03063203|65541467|FG000|Overall Study|Death|2|||
23490745|NCT03063203|65541467|FG000|Overall Study|Disease progression|4|||
23490746|NCT03063203|65541467|FG000|Overall Study|Physician Decision|5|||
23490747|NCT04122534|65541468|FG000|Overall Study|Lost to Follow-up|4|||
23490748|NCT01986907|65541471|FG000|Overall Study|Adverse Event|11|||
23490749|NCT01986907|65541471|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
23490750|NCT01986907|65541471|FG000|Overall Study|Protocol Violation|4|||
23490751|NCT01986907|65541471|FG000|Overall Study|Withdrawal by Subject|76|||
23490752|NCT01986907|65541471|FG000|Overall Study|Lost to Follow-up|38|||
23490753|NCT01986907|65541471|FG000|Overall Study|Death|9|||
23490754|NCT00447005|65541472|FG000|Overall Study|Adverse Event|1|||
23490755|NCT00447005|65541472|FG000|Overall Study|Lack of Efficacy|11|||
23490756|NCT00437320|65541478|FG000|Overall Study|Participant request|2|||
23490757|NCT00437320|65541479|FG001|Overall Study|Participant request|1|||
23490758|NCT00437320|65541480|FG002|Overall Study|Participant request|4|||
23490759|NCT01264016|65541483|FG000|Overall Study|Withdrawal by Subject|1|||
23490760|NCT01264016|65541483|FG000|Overall Study|Felt faint at sight of blood|1|||
23490761|NCT01460368|65541484|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490762|NCT01460368|65541485|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490763|NCT01460368|65541486|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490764|NCT01460368|65541487|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490765|NCT01460368|65541488|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
23490766|NCT01460368|65541489|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490767|NCT01460368|65541490|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
23490768|NCT01460368|65541484|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490769|NCT01460368|65541485|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
23490770|NCT01460368|65541486|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490771|NCT01460368|65541487|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490772|NCT01460368|65541488|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490773|NCT01460368|65541489|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
23490774|NCT01460368|65541490|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
23490775|NCT01460368|65541484|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490776|NCT01460368|65541485|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
23490777|NCT01460368|65541486|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490778|NCT01460368|65541487|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490779|NCT01460368|65541488|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23286166|NCT01426854|64791352|FG000|Overall Study|Other|3|||
23378961|NCT01454284|65134064|FG001|Overall Study|Protocol Violation|6|||
23490780|NCT01460368|65541489|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490781|NCT01460368|65541490|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
23490782|NCT01460368|65541484|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490783|NCT01460368|65541485|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490784|NCT01460368|65541486|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
23490785|NCT01460368|65541487|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23378962|NCT01454284|65134063|FG000|Overall Study|Withdrawal by Subject|58|||
23378963|NCT01454284|65134064|FG001|Overall Study|Withdrawal by Subject|36|||
23490786|NCT01460368|65541488|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490787|NCT01460368|65541489|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490788|NCT01460368|65541490|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
23490789|NCT01460368|65541484|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
23490790|NCT01460368|65541485|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
23490791|NCT01460368|65541486|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
23490792|NCT01460368|65541487|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
23490793|NCT01460368|65541488|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
23490794|NCT01460368|65541489|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
23490795|NCT01460368|65541490|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
23286167|NCT01426854|64791353|FG001|Overall Study|Other|2|||
23286168|NCT00396630|64791354|FG000|Overall Study|Lost to Follow-up|1|||
23286169|NCT00396630|64791355|FG001|Overall Study|Lost to Follow-up|1|||
23286170|NCT00396630|64791354|FG000|Overall Study|Withdrawal by Subject|1|||
23286171|NCT00396630|64791355|FG001|Overall Study|Withdrawal by Subject|1|||
23286172|NCT00396630|64791354|FG000|Overall Study|Not vaccinated at Visit 3|3|||
23286173|NCT00396630|64791355|FG001|Overall Study|Not vaccinated at Visit 3|3|||
23286174|NCT01891357|64791356|FG000|Overall Study|Protocol Violation|3|||
23286175|NCT01155531|64791358|FG000|Overall Study|Adverse Event|0|||
23286176|NCT01155531|64791359|FG001|Overall Study|Adverse Event|0|||
23286177|NCT01155531|64791360|FG002|Overall Study|Adverse Event|1|||
23286178|NCT01155531|64791361|FG003|Overall Study|Adverse Event|0|||
23286179|NCT01155531|64791358|FG000|Overall Study|Lost to Follow-up|0|||
23286180|NCT01155531|64791359|FG001|Overall Study|Lost to Follow-up|0|||
23286181|NCT01155531|64791360|FG002|Overall Study|Lost to Follow-up|0|||
23286182|NCT01155531|64791361|FG003|Overall Study|Lost to Follow-up|1|||
23286183|NCT01155531|64791358|FG000|Overall Study|Withdrawal by Subject|1|||
23286184|NCT01155531|64791359|FG001|Overall Study|Withdrawal by Subject|0|||
23286185|NCT01155531|64791360|FG002|Overall Study|Withdrawal by Subject|1|||
23286186|NCT01155531|64791361|FG003|Overall Study|Withdrawal by Subject|0|||
23286187|NCT01598896|64791362|FG000|Overall Study|Withdrawal by Subject|0|||
23286188|NCT01598896|64791363|FG001|Overall Study|Withdrawal by Subject|1|||
23286189|NCT01598896|64791362|FG000|Overall Study|Lack of Efficacy|0|||
23286190|NCT01598896|64791363|FG001|Overall Study|Lack of Efficacy|1|||
23286191|NCT03500094|64791364|FG000|Overall Study|Withdrawal by Subject|1|||
23286192|NCT03500094|64791364|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
23286193|NCT03500094|64791364|FG000|Overall Study|Lost to Follow-up|1|||
23286194|NCT00021541|64791365|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
23286195|NCT00021541|64791366|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
23286196|NCT00021541|64791365|FG000|Period 1-First Treatment|Adverse Event|2|||
23286197|NCT00021541|64791366|FG001|Period 1-First Treatment|Adverse Event|1|||
23286198|NCT00021541|64791365|FG000|Period 1-First Treatment|non-adherence|3|||
23286199|NCT00021541|64791366|FG001|Period 1-First Treatment|non-adherence|0|||
23286200|NCT00021541|64791365|FG000|Period 1-First Treatment|Death|1|||
23286201|NCT00021541|64791366|FG001|Period 1-First Treatment|Death|0|||
23286202|NCT00021541|64791365|FG000|Period 1-First Treatment|Pts that did not progress|2|||
23286203|NCT00021541|64791366|FG001|Period 1-First Treatment|Pts that did not progress|2|||
23286204|NCT00021541|64791365|FG000|Period 1-First Treatment|Ineligible|0|||
23286205|NCT00021541|64791366|FG001|Period 1-First Treatment|Ineligible|2|||
23286206|NCT00021541|64791365|FG000|Period 2-crossover|refused phase B|2|||
23286207|NCT00021541|64791366|FG001|Period 2-crossover|refused phase B|2|||
23286208|NCT00021541|64791365|FG000|Period 2-crossover|Withdrawal by Subject|3|||
23286209|NCT00021541|64791366|FG001|Period 2-crossover|Withdrawal by Subject|4|||
23286210|NCT00021541|64791365|FG000|Period 2-crossover|Adverse Event|2|||
23286211|NCT00021541|64791366|FG001|Period 2-crossover|Adverse Event|2|||
23286212|NCT00021541|64791365|FG000|Period 2-crossover|non-adherence|1|||
23286213|NCT00021541|64791366|FG001|Period 2-crossover|non-adherence|0|||
23286214|NCT00021541|64791365|FG000|Period 2-crossover|Pts that did not progress|2|||
23286215|NCT00021541|64791366|FG001|Period 2-crossover|Pts that did not progress|3|||
23286216|NCT01896934|64791367|FG000|Overall Study|Adverse Event|1|||
23286217|NCT01896934|64791367|FG000|Overall Study|Withdrawal by Subject|1|||
23286218|NCT02670551|64791368|FG000|Overall Study|Adverse Event|4|||
23286219|NCT02670551|64791369|FG001|Overall Study|Adverse Event|7|||
23286220|NCT02670551|64791370|FG002|Overall Study|Adverse Event|9|||
23286221|NCT02670551|64791368|FG000|Overall Study|Lack of Efficacy|2|||
23378964|NCT01454284|65134063|FG000|Overall Study|Physician Decision|16|||
23286222|NCT02670551|64791369|FG001|Overall Study|Lack of Efficacy|0|||
23286223|NCT02670551|64791370|FG002|Overall Study|Lack of Efficacy|3|||
23286224|NCT02670551|64791368|FG000|Overall Study|Withdrawal of Consent|6|||
23286225|NCT02670551|64791369|FG001|Overall Study|Withdrawal of Consent|3|||
23286226|NCT02670551|64791370|FG002|Overall Study|Withdrawal of Consent|8|||
23286227|NCT02670551|64791368|FG000|Overall Study|Lost to Follow-up|5|||
23378965|NCT01454284|65134064|FG001|Overall Study|Physician Decision|11|||
23378966|NCT01454284|65134063|FG000|Overall Study|Sponsor Decision|0|||
23378967|NCT01454284|65134064|FG001|Overall Study|Sponsor Decision|2|||
23378968|NCT02239328|65134065|FG000|Overall Study|Benign disease noted at time of surgery|6|||
23378969|NCT02239328|65134065|FG000|Overall Study|Equipment or website malfunction|2|||
23378970|NCT00972738|65134066|FG000|Overall Study|Adverse Event|7|||
23378971|NCT00972738|65134067|FG001|Overall Study|Adverse Event|1|||
23378972|NCT00972738|65134068|FG002|Overall Study|Adverse Event|8|||
23378973|NCT00972738|65134066|FG000|Overall Study|Protocol Violation|2|||
23378974|NCT00972738|65134067|FG001|Overall Study|Protocol Violation|1|||
23378975|NCT00972738|65134068|FG002|Overall Study|Protocol Violation|3|||
23378976|NCT00972738|65134066|FG000|Overall Study|Lost to Follow-up|1|||
23378977|NCT00972738|65134067|FG001|Overall Study|Lost to Follow-up|0|||
23378978|NCT00972738|65134068|FG002|Overall Study|Lost to Follow-up|1|||
23378979|NCT00972738|65134066|FG000|Overall Study|Lack of Efficacy|5|||
23378980|NCT00972738|65134067|FG001|Overall Study|Lack of Efficacy|1|||
23286228|NCT02670551|64791369|FG001|Overall Study|Lost to Follow-up|7|||
23286229|NCT02670551|64791370|FG002|Overall Study|Lost to Follow-up|6|||
23286230|NCT02670551|64791368|FG000|Overall Study|Protocol Violation|1|||
23286231|NCT02670551|64791369|FG001|Overall Study|Protocol Violation|0|||
23286232|NCT02670551|64791370|FG002|Overall Study|Protocol Violation|0|||
23286233|NCT02670551|64791368|FG000|Overall Study|Noncompliance with study drug|3|||
23286234|NCT02670551|64791369|FG001|Overall Study|Noncompliance with study drug|3|||
23286235|NCT02670551|64791370|FG002|Overall Study|Noncompliance with study drug|2|||
23286236|NCT02670551|64791368|FG000|Overall Study|Other Miscellaneous Reasons|2|||
23286237|NCT02670551|64791369|FG001|Overall Study|Other Miscellaneous Reasons|3|||
23286238|NCT02670551|64791370|FG002|Overall Study|Other Miscellaneous Reasons|3|||
23286239|NCT02670551|64791368|FG000|Overall Study|Did Not Receive Treatment|5|||
23286240|NCT02670551|64791369|FG001|Overall Study|Did Not Receive Treatment|3|||
23286241|NCT02670551|64791370|FG002|Overall Study|Did Not Receive Treatment|0|||
23286242|NCT01277510|64791371|FG000|Double-blind Phase|Non-compliance|0|||
23286243|NCT01277510|64791372|FG001|Double-blind Phase|Non-compliance|1|||
23286244|NCT01277510|64791371|FG000|Double-blind Phase|Adverse Event|1|||
23286245|NCT01277510|64791372|FG001|Double-blind Phase|Adverse Event|0|||
23286246|NCT01277510|64791371|FG000|Double-blind Phase|Withdrawal by Subject|2|||
23286247|NCT01277510|64791372|FG001|Double-blind Phase|Withdrawal by Subject|0|||
23286248|NCT01277510|64791371|FG000|Double-blind Phase|Administrative decision|7|||
23286249|NCT01277510|64791372|FG001|Double-blind Phase|Administrative decision|9|||
23286250|NCT01277510|64791371|FG000|Double-blind Phase|Death|0|||
23286251|NCT01277510|64791372|FG001|Double-blind Phase|Death|1|||
23286252|NCT01277510|64791371|FG000|Double-blind Phase|Protocol-specified criteria|2|||
23286253|NCT01277510|64791372|FG001|Double-blind Phase|Protocol-specified criteria|6|||
23286254|NCT01277510|64791371|FG000|Double-blind Phase|Other|1|||
23286255|NCT01277510|64791372|FG001|Double-blind Phase|Other|1|||
23286256|NCT01277510|64791371|FG000|Open-label Phase|Administrative decision|4|||
23286257|NCT01277510|64791372|FG001|Open-label Phase|Administrative decision|3|||
23286258|NCT01277510|64791371|FG000|Open-label Phase|Protocol-specified criteria|1|||
23286259|NCT01277510|64791372|FG001|Open-label Phase|Protocol-specified criteria|0|||
23286260|NCT01277510|64791371|FG000|Open-label Phase|Never received investigational product|2|||
23286261|NCT01277510|64791372|FG001|Open-label Phase|Never received investigational product|0|||
23286262|NCT01044433|64791373|FG000|Overall Study|Lost to Follow-up|3|||
23286263|NCT01044433|64791373|FG000|Overall Study|Withdrawal by Subject|3|||
23286264|NCT01151280|64791374|FG000|Overall Study|Adverse Event|1|||
23286265|NCT01151280|64791374|FG000|Overall Study|Lack of Efficacy|3|||
23286266|NCT00868998|64791376|FG000|Overall Study|Screen Failure|1|||
23286267|NCT00868998|64791376|FG000|Overall Study|Withdrawal by Subject|1|||
23286268|NCT00868998|64791376|FG000|Overall Study|Progression of disease|2|||
23286269|NCT00868998|64791376|FG000|Overall Study|Death|1|||
23286270|NCT05776901|64791377|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
23286271|NCT01717313|64791378|FG000|Phase A (Weeks 0 to 24)|Death|0|||
23286272|NCT01717313|64791379|FG001|Phase A (Weeks 0 to 24)|Death|1|||
23286273|NCT01717313|64791378|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
23286274|NCT01717313|64791379|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
23286275|NCT01717313|64791378|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
23286276|NCT01717313|64791379|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
23286277|NCT01717313|64791378|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
23286278|NCT01717313|64791379|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
23378981|NCT00972738|65134068|FG002|Overall Study|Lack of Efficacy|11|||
23378982|NCT00972738|65134066|FG000|Overall Study|Withdrawal by Subject|5|||
23378983|NCT00972738|65134067|FG001|Overall Study|Withdrawal by Subject|1|||
23286279|NCT01717313|64791378|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
23286280|NCT01717313|64791379|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
23286281|NCT01717313|64791378|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
23286282|NCT01717313|64791379|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
23378984|NCT00972738|65134068|FG002|Overall Study|Withdrawal by Subject|4|||
23378985|NCT00972738|65134066|FG000|Overall Study|Moved|0|||
23378986|NCT00972738|65134067|FG001|Overall Study|Moved|0|||
23378987|NCT00972738|65134068|FG002|Overall Study|Moved|1|||
23378988|NCT00972738|65134066|FG000|Overall Study|Other|1|||
23378989|NCT00972738|65134067|FG001|Overall Study|Other|2|||
23378990|NCT00972738|65134068|FG002|Overall Study|Other|1|||
23378991|NCT00393367|65134069|FG000|Overall Study|Protocol Violation|2|||
23378992|NCT00393367|65134070|FG001|Overall Study|Protocol Violation|5|||
23378993|NCT00393367|65134069|FG000|Overall Study|Withdrawal by Subject|0|||
23378994|NCT00393367|65134070|FG001|Overall Study|Withdrawal by Subject|2|||
23378995|NCT00876395|65134075|FG000|Overall Study|Untreated|8|||
23378996|NCT00876395|65134076|FG001|Overall Study|Untreated|1|||
23378997|NCT00876395|65134075|FG000|Overall Study|Adverse Event|63|||
23378998|NCT00876395|65134076|FG001|Overall Study|Adverse Event|11|||
23378999|NCT00876395|65134075|FG000|Overall Study|Abnormal test procedure result(s)|1|||
23379000|NCT00876395|65134076|FG001|Overall Study|Abnormal test procedure result(s)|0|||
23379001|NCT00876395|65134075|FG000|Overall Study|Disease progression|259|||
23379002|NCT00876395|65134076|FG001|Overall Study|Disease progression|162|||
23379003|NCT00876395|65134075|FG000|Overall Study|New cancer therapy|25|||
23379004|NCT00876395|65134076|FG001|Overall Study|New cancer therapy|7|||
23379005|NCT00876395|65134075|FG000|Overall Study|Protocol Violation|5|||
23379006|NCT00876395|65134076|FG001|Overall Study|Protocol Violation|2|||
23379007|NCT00876395|65134075|FG000|Overall Study|Withdrawal by Subject|66|||
23379008|NCT00876395|65134076|FG001|Overall Study|Withdrawal by Subject|33|||
23379009|NCT00876395|65134075|FG000|Overall Study|Lost to Follow-up|2|||
23379010|NCT00876395|65134076|FG001|Overall Study|Lost to Follow-up|0|||
23379011|NCT00876395|65134075|FG000|Overall Study|Administrative problems|39|||
23379012|NCT00876395|65134076|FG001|Overall Study|Administrative problems|23|||
23379013|NCT00876395|65134075|FG000|Overall Study|Death|12|||
23379014|NCT00876395|65134076|FG001|Overall Study|Death|0|||
23379015|NCT02421510|65134079|FG000|Overall Study|Other|4|||
23379016|NCT02421510|65134080|FG001|Overall Study|Other|2|||
23379017|NCT02421510|65134081|FG002|Overall Study|Other|3|||
23379018|NCT02421510|65134079|FG000|Overall Study|Protocol Violation|1|||
23379019|NCT02421510|65134080|FG001|Overall Study|Protocol Violation|2|||
23379020|NCT02421510|65134081|FG002|Overall Study|Protocol Violation|0|||
23379021|NCT02421510|65134079|FG000|Overall Study|Death|1|||
23379022|NCT02421510|65134080|FG001|Overall Study|Death|0|||
23379023|NCT02421510|65134081|FG002|Overall Study|Death|0|||
23379024|NCT02421510|65134079|FG000|Overall Study|Noncompliance with study drug|1|||
23379025|NCT02421510|65134080|FG001|Overall Study|Noncompliance with study drug|0|||
23379026|NCT02421510|65134081|FG002|Overall Study|Noncompliance with study drug|0|||
23379027|NCT02421510|65134079|FG000|Overall Study|Physician Decision|1|||
23379028|NCT02421510|65134080|FG001|Overall Study|Physician Decision|1|||
23379029|NCT02421510|65134081|FG002|Overall Study|Physician Decision|3|||
23379030|NCT02421510|65134079|FG000|Overall Study|Adverse Event|9|||
23379031|NCT02421510|65134080|FG001|Overall Study|Adverse Event|10|||
23379032|NCT02421510|65134081|FG002|Overall Study|Adverse Event|18|||
23379033|NCT02421510|65134079|FG000|Overall Study|Pregnancy|1|||
23379034|NCT02421510|65134080|FG001|Overall Study|Pregnancy|1|||
23379035|NCT02421510|65134081|FG002|Overall Study|Pregnancy|0|||
23379036|NCT02421510|65134079|FG000|Overall Study|Withdrawal by Subject|14|||
23379037|NCT02421510|65134080|FG001|Overall Study|Withdrawal by Subject|18|||
23379038|NCT02421510|65134081|FG002|Overall Study|Withdrawal by Subject|12|||
23379039|NCT02421510|65134079|FG000|Overall Study|Lost to Follow-up|1|||
23379040|NCT02421510|65134080|FG001|Overall Study|Lost to Follow-up|1|||
23490796|NCT03509467|65541491|FG000|Overall Study|Withdrawal by Subject|5|||
23379041|NCT02421510|65134081|FG002|Overall Study|Lost to Follow-up|0|||
23379042|NCT04470427|65134082|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
23379043|NCT04470427|65134083|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
23490797|NCT03509467|65541492|FG001|Overall Study|Withdrawal by Subject|1|||
23379044|NCT04470427|65134084|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
23379045|NCT04470427|65134085|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
23379046|NCT04470427|65134086|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
23286283|NCT01717313|64791378|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
23286284|NCT01717313|64791379|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
23286285|NCT01717313|64791378|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
23286286|NCT01717313|64791379|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
23286287|NCT01717313|64791378|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
23286288|NCT01717313|64791379|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
23286289|NCT02817828|64791382|FG000|Overall Study|Lost to Follow-up|41|||
23286290|NCT02817828|64791382|FG000|Overall Study|Adverse event not related to bleeding|104|||
23286291|NCT02817828|64791382|FG000|Overall Study|Adverse event related to bleeding|53|||
23286292|NCT02817828|64791382|FG000|Overall Study|Protocol Violation|11|||
23286293|NCT02817828|64791382|FG000|Overall Study|Pregnancy|7|||
23286294|NCT02817828|64791382|FG000|Overall Study|Pregnancy wish|15|||
23286295|NCT02817828|64791382|FG000|Overall Study|Withdrawal by Subject|78|||
23286296|NCT02817828|64791382|FG000|Overall Study|Other|26|||
23286297|NCT00691704|64791389|FG000|Induction Therapy|Disease Progression|1|||
23286298|NCT00691704|64791389|FG000|Induction Therapy|Active Hepatitis|1|||
23286299|NCT00691704|64791389|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
23286300|NCT00691704|64791389|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
23286301|NCT00691704|64791389|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
23286302|NCT00398073|64791390|FG000|Overall Study|Withdrawal by Subject|1|||
23286303|NCT00398073|64791391|FG001|Overall Study|Withdrawal by Subject|0|||
23286304|NCT01828112|64791392|FG000|Overall Study|Adverse Event|6|||
23286305|NCT01828112|64791393|FG001|Overall Study|Adverse Event|8|||
23286306|NCT01828112|64791392|FG000|Overall Study|Death|9|||
23286307|NCT01828112|64791393|FG001|Overall Study|Death|5|||
23286308|NCT01828112|64791392|FG000|Overall Study|Physician Decision|5|||
23286309|NCT01828112|64791393|FG001|Overall Study|Physician Decision|5|||
23286310|NCT01828112|64791392|FG000|Overall Study|Progressive disease|56|||
23286311|NCT01828112|64791393|FG001|Overall Study|Progressive disease|82|||
23286312|NCT01828112|64791392|FG000|Overall Study|Subject/guardian decision|6|||
23286313|NCT01828112|64791393|FG001|Overall Study|Subject/guardian decision|8|||
23286314|NCT03419962|64791398|FG000|Overall Study|Change to other medication|1|||
23286315|NCT03419962|64791398|FG000|Overall Study|Refusal of continuing with trial drug|1|||
23286316|NCT03419962|64791398|FG000|Overall Study|Lost to Follow-up|3|||
23286317|NCT03419962|64791398|FG000|Overall Study|Difficulty in inhaling the doses|1|||
23286318|NCT03419962|64791398|FG000|Overall Study|Missing completion data|31|||
23286319|NCT03183141|64791401|FG000|Overall Study|Withdrawal by Subject|2|||
23286320|NCT03183141|64791402|FG001|Overall Study|Withdrawal by Subject|4|||
23286321|NCT03183141|64791401|FG000|Overall Study|Death|0|||
23286322|NCT03183141|64791402|FG001|Overall Study|Death|8|||
23286323|NCT01243151|64791403|FG000|Overall Study|Adverse Event|0|||
23490798|NCT03509467|65541493|FG002|Overall Study|Withdrawal by Subject|6|||
23286324|NCT01243151|64791404|FG001|Overall Study|Adverse Event|1|||
23286325|NCT01243151|64791405|FG002|Overall Study|Adverse Event|0|||
23286326|NCT01243151|64791406|FG003|Overall Study|Adverse Event|0|||
23286327|NCT01243151|64791407|FG004|Overall Study|Adverse Event|0|||
23286328|NCT01243151|64791403|FG000|Overall Study|Protocol Violation|0|||
23286329|NCT01243151|64791404|FG001|Overall Study|Protocol Violation|0|||
23286330|NCT01243151|64791405|FG002|Overall Study|Protocol Violation|1|||
23605451|NCT02991118|65943743|FG001|Overall Study|Physician Decision|1|||
23286331|NCT01243151|64791406|FG003|Overall Study|Protocol Violation|0|||
23605452|NCT02991118|65943742|FG000|Overall Study|Moved out of the country|0|||
23605453|NCT02991118|65943743|FG001|Overall Study|Moved out of the country|1|||
23605454|NCT02991118|65943742|FG000|Overall Study|Adverse Event|2|||
23605455|NCT02991118|65943743|FG001|Overall Study|Adverse Event|2|||
23605456|NCT02991118|65943742|FG000|Overall Study|Withdrawal by Subject|1|||
23605457|NCT02991118|65943743|FG001|Overall Study|Withdrawal by Subject|7|||
23605458|NCT02991118|65943742|FG000|Overall Study|Could not attend study visits|0|||
23605459|NCT02991118|65943743|FG001|Overall Study|Could not attend study visits|1|||
23605460|NCT02991118|65943742|FG000|Overall Study|Lost to Follow-up|1|||
23605461|NCT02991118|65943743|FG001|Overall Study|Lost to Follow-up|9|||
23605462|NCT02538094|65943744|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
23605463|NCT02538094|65943745|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
23286332|NCT01243151|64791407|FG004|Overall Study|Protocol Violation|0|||
23286333|NCT01243151|64791403|FG000|Overall Study|Other|0|||
23286334|NCT01243151|64791404|FG001|Overall Study|Other|0|||
23605464|NCT02538094|65943744|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
23379047|NCT04470427|65134087|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
23379048|NCT04470427|65134082|FG000|Part B :Open-label|Other than specified|0|||
23379049|NCT04470427|65134083|FG001|Part B :Open-label|Other than specified|0|||
23379050|NCT04470427|65134084|FG002|Part B :Open-label|Other than specified|788|||
23379051|NCT04470427|65134085|FG003|Part B :Open-label|Other than specified|0|||
23379052|NCT04470427|65134086|FG004|Part B :Open-label|Other than specified|523|||
23379053|NCT04470427|65134087|FG005|Part B :Open-label|Other than specified|0|||
23379054|NCT04470427|65134082|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
23379055|NCT04470427|65134083|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
23379056|NCT04470427|65134084|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
23379057|NCT04470427|65134085|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
23605465|NCT02538094|65943745|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
23605466|NCT02707952|65943746|FG000|Overall Study|Adverse Event|1|||
23605467|NCT02707952|65943747|FG001|Overall Study|Adverse Event|0|||
23605468|NCT02707952|65943748|FG002|Overall Study|Adverse Event|0|||
23605469|NCT02707952|65943749|FG003|Overall Study|Adverse Event|0|||
23286335|NCT01243151|64791405|FG002|Overall Study|Other|0|||
23286336|NCT01243151|64791406|FG003|Overall Study|Other|1|||
23286337|NCT01243151|64791407|FG004|Overall Study|Other|0|||
23286338|NCT01243151|64791403|FG000|Overall Study|Randomized but not treated|0|||
23286339|NCT01243151|64791404|FG001|Overall Study|Randomized but not treated|0|||
23286340|NCT01243151|64791405|FG002|Overall Study|Randomized but not treated|0|||
23286341|NCT01243151|64791406|FG003|Overall Study|Randomized but not treated|1|||
23286342|NCT01243151|64791407|FG004|Overall Study|Randomized but not treated|0|||
23286343|NCT03119662|64791411|FG000|Overall Study|Withdrawal by Subject|0|||
23286344|NCT03119662|64791412|FG001|Overall Study|Withdrawal by Subject|1|||
23379058|NCT04470427|65134086|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
23379059|NCT04470427|65134087|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
23605470|NCT02707952|65943746|FG000|Overall Study|Lost to Follow-up|1|||
23286345|NCT01924364|64791415|FG000|Overall Study|Physician Decision|3|||
23286346|NCT00884390|64791416|FG000|Overall Study|Adverse Event|0|||
23286347|NCT00884390|64791417|FG001|Overall Study|Adverse Event|1|||
23286348|NCT00884390|64791416|FG000|Overall Study|Lost to Follow-up|0|||
23379060|NCT04470427|65134082|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
23605471|NCT02707952|65943747|FG001|Overall Study|Lost to Follow-up|0|||
23286349|NCT00884390|64791417|FG001|Overall Study|Lost to Follow-up|1|||
23286350|NCT00884390|64791416|FG000|Overall Study|Physician Decision|2|||
23286351|NCT00884390|64791417|FG001|Overall Study|Physician Decision|1|||
23286352|NCT00884390|64791416|FG000|Overall Study|Protocol Violation|4|||
23286353|NCT00884390|64791417|FG001|Overall Study|Protocol Violation|1|||
23286354|NCT00884390|64791416|FG000|Overall Study|Withdrawal by Subject|4|||
23605472|NCT02707952|65943748|FG002|Overall Study|Lost to Follow-up|0|||
23605473|NCT02707952|65943749|FG003|Overall Study|Lost to Follow-up|0|||
23605474|NCT02707952|65943746|FG000|Overall Study|Withdrawal by Subject|0|||
23605475|NCT02707952|65943747|FG001|Overall Study|Withdrawal by Subject|1|||
23605476|NCT02707952|65943748|FG002|Overall Study|Withdrawal by Subject|2|||
23490799|NCT03509467|65541494|FG003|Overall Study|Withdrawal by Subject|7|||
23490800|NCT03509467|65541495|FG004|Overall Study|Withdrawal by Subject|10|||
23490801|NCT03509467|65541496|FG005|Overall Study|Withdrawal by Subject|10|||
23490802|NCT03509467|65541497|FG006|Overall Study|Withdrawal by Subject|10|||
23490803|NCT03509467|65541498|FG007|Overall Study|Withdrawal by Subject|10|||
23490804|NCT03509467|65541491|FG000|Overall Study|Death|0|||
23490805|NCT03509467|65541492|FG001|Overall Study|Death|0|||
23490806|NCT03509467|65541493|FG002|Overall Study|Death|2|||
23490807|NCT03509467|65541494|FG003|Overall Study|Death|2|||
23490808|NCT03509467|65541495|FG004|Overall Study|Death|1|||
23490809|NCT03509467|65541496|FG005|Overall Study|Death|0|||
23605477|NCT02707952|65943749|FG003|Overall Study|Withdrawal by Subject|0|||
23605478|NCT03055988|65943750|FG000|Period 1|Adverse Event|0|||
23605479|NCT03055988|65943751|FG001|Period 1|Adverse Event|1|||
23605480|NCT03055988|65943750|FG000|Period 1|Lost to Follow-up|1|||
23605481|NCT03055988|65943751|FG001|Period 1|Lost to Follow-up|0|||
23605482|NCT03055988|65943750|FG000|Period 1|Withdrawal by Subject|0|||
23605483|NCT03055988|65943751|FG001|Period 1|Withdrawal by Subject|4|||
23605484|NCT03055988|65943750|FG000|Period 2|Adverse Event|0|||
23605485|NCT03055988|65943751|FG001|Period 2|Adverse Event|1|||
23605486|NCT03055988|65943750|FG000|Period 2|Other than listed|1|||
23605487|NCT03055988|65943751|FG001|Period 2|Other than listed|1|||
23605488|NCT02634307|65943752|FG000|Overall Study|Adverse Event|50|||
23605489|NCT02634307|65943753|FG001|Overall Study|Adverse Event|24|||
23605490|NCT02634307|65943754|FG002|Overall Study|Adverse Event|14|||
23605491|NCT02634307|65943752|FG000|Overall Study|Lost to Follow-up|21|||
23605492|NCT02634307|65943753|FG001|Overall Study|Lost to Follow-up|5|||
23605493|NCT02634307|65943754|FG002|Overall Study|Lost to Follow-up|6|||
23605494|NCT02634307|65943752|FG000|Overall Study|Pregnancy|5|||
23605495|NCT02634307|65943753|FG001|Overall Study|Pregnancy|1|||
23605496|NCT02634307|65943754|FG002|Overall Study|Pregnancy|3|||
23605497|NCT02634307|65943752|FG000|Overall Study|Withdrawal by Subject|38|||
23286355|NCT00884390|64791417|FG001|Overall Study|Withdrawal by Subject|1|||
23286356|NCT00884390|64791416|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
23286357|NCT00884390|64791417|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
23286358|NCT00884390|64791416|FG000|Overall Study|Other|11|||
23286359|NCT00884390|64791417|FG001|Overall Study|Other|1|||
23286360|NCT00651183|64791418|FG000|Overall Study|Lack of Efficacy|1|||
23286361|NCT00651183|64791419|FG001|Overall Study|Lack of Efficacy|0|||
23286362|NCT00651183|64791418|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
23286363|NCT00651183|64791419|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
23286364|NCT00651183|64791418|FG000|Overall Study|Tolerability insufficient|5|||
23286365|NCT00651183|64791419|FG001|Overall Study|Tolerability insufficient|2|||
23286366|NCT00651183|64791418|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
23286367|NCT00651183|64791419|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
23286368|NCT00651183|64791418|FG000|Overall Study|Withdrawal by Subject|6|||
23286369|NCT00651183|64791419|FG001|Overall Study|Withdrawal by Subject|3|||
23286370|NCT00651183|64791418|FG000|Overall Study|Lost to Follow-up|3|||
23286371|NCT00651183|64791419|FG001|Overall Study|Lost to Follow-up|1|||
23286372|NCT00651183|64791418|FG000|Overall Study|Other reasons|4|||
23605498|NCT02634307|65943753|FG001|Overall Study|Withdrawal by Subject|24|||
23605499|NCT02634307|65943754|FG002|Overall Study|Withdrawal by Subject|18|||
23605500|NCT02634307|65943752|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23286373|NCT00651183|64791419|FG001|Overall Study|Other reasons|2|||
23286374|NCT00651183|64791418|FG000|Overall Study|missing|1|||
23286375|NCT00651183|64791419|FG001|Overall Study|missing|0|||
23286376|NCT00323258|64791420|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
23490810|NCT03509467|65541497|FG006|Overall Study|Death|1|||
23490811|NCT03509467|65541498|FG007|Overall Study|Death|0|||
23490812|NCT03509467|65541491|FG000|Overall Study|Proxy Withdrawal|0|||
23490813|NCT03509467|65541492|FG001|Overall Study|Proxy Withdrawal|0|||
23605501|NCT02634307|65943753|FG001|Overall Study|Non-Compliance with Study Drug|2|||
23605502|NCT02634307|65943754|FG002|Overall Study|Non-Compliance with Study Drug|2|||
23605503|NCT02634307|65943752|FG000|Overall Study|Lack of Efficacy|1|||
23379061|NCT04470427|65134083|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
23379062|NCT04470427|65134084|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
23379063|NCT04470427|65134085|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
23379064|NCT04470427|65134086|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
23286377|NCT00323258|64791421|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
23286378|NCT00323258|64791420|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
23286379|NCT00323258|64791421|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
23286380|NCT00323258|64791420|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
23286381|NCT00323258|64791421|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
23286382|NCT00323258|64791420|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
23286383|NCT00323258|64791421|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
23286384|NCT00323258|64791420|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
23286385|NCT00323258|64791421|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
23286386|NCT00323258|64791420|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
23286387|NCT00323258|64791421|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
23286388|NCT00323258|64791420|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
23286389|NCT00323258|64791421|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
23286390|NCT02986139|64791422|FG000|Overall Study|Sponsor Decision|1|||
23286391|NCT02986139|64791423|FG001|Overall Study|Sponsor Decision|2|||
23286392|NCT02986139|64791422|FG000|Overall Study|Withdrawal by Subject|0|||
23286393|NCT02986139|64791423|FG001|Overall Study|Withdrawal by Subject|1|||
23286394|NCT02986139|64791422|FG000|Overall Study|Lost to Follow-up|0|||
23379065|NCT04470427|65134087|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
23379066|NCT02452190|65134088|FG000|Overall Study|Withdrawal by Sponsor|1|||
23379067|NCT02452190|65134089|FG001|Overall Study|Withdrawal by Sponsor|3|||
23379068|NCT02452190|65134088|FG000|Overall Study|Pregnancy|1|||
23379069|NCT02452190|65134089|FG001|Overall Study|Pregnancy|0|||
23379070|NCT02452190|65134088|FG000|Overall Study|Investigator's Decision|2|||
23379071|NCT02452190|65134089|FG001|Overall Study|Investigator's Decision|0|||
23379072|NCT02452190|65134088|FG000|Overall Study|Lack of Efficacy|3|||
23379073|NCT02452190|65134089|FG001|Overall Study|Lack of Efficacy|1|||
23379074|NCT02452190|65134088|FG000|Overall Study|Lost to Follow-up|4|||
23379075|NCT02452190|65134089|FG001|Overall Study|Lost to Follow-up|3|||
23379076|NCT02452190|65134088|FG000|Overall Study|Adverse Event|2|||
23379077|NCT02452190|65134089|FG001|Overall Study|Adverse Event|5|||
23379078|NCT02452190|65134088|FG000|Overall Study|Withdrawal by Subject|20|||
23379079|NCT02452190|65134089|FG001|Overall Study|Withdrawal by Subject|11|||
23379080|NCT02452190|65134088|FG000|Overall Study|Noncompliance with study drug|1|||
23379081|NCT02452190|65134089|FG001|Overall Study|Noncompliance with study drug|0|||
23379082|NCT02452190|65134088|FG000|Overall Study|Participant traveled abroad|1|||
23379083|NCT02452190|65134089|FG001|Overall Study|Participant traveled abroad|0|||
23379084|NCT02452190|65134088|FG000|Overall Study|Death|0|||
23379085|NCT02452190|65134089|FG001|Overall Study|Death|1|||
23379086|NCT01341470|65134090|FG000|Overall Study|Sponsor decision|0|||
23379087|NCT01341470|65134091|FG001|Overall Study|Sponsor decision|0|||
23379088|NCT01341470|65134092|FG002|Overall Study|Sponsor decision|1|||
23379089|NCT01341470|65134093|FG003|Overall Study|Sponsor decision|1|||
23379090|NCT01341470|65134094|FG004|Overall Study|Sponsor decision|0|||
23379091|NCT01341470|65134095|FG005|Overall Study|Sponsor decision|1|||
23286395|NCT02986139|64791423|FG001|Overall Study|Lost to Follow-up|1|||
23286396|NCT00372996|64791424|FG000|Overall Study|Death|11|||
23286397|NCT00372996|64791425|FG001|Overall Study|Death|4|||
23286398|NCT00372996|64791426|FG002|Overall Study|Death|8|||
23286399|NCT00372996|64791427|FG003|Overall Study|Death|7|||
23286400|NCT00372996|64791424|FG000|Overall Study|Lost to Follow-up|0|||
23286401|NCT00372996|64791425|FG001|Overall Study|Lost to Follow-up|2|||
23286402|NCT00372996|64791426|FG002|Overall Study|Lost to Follow-up|0|||
23286403|NCT00372996|64791427|FG003|Overall Study|Lost to Follow-up|1|||
23286404|NCT00372996|64791424|FG000|Overall Study|Withdrawal by Subject|12|||
23379092|NCT02323880|65134096|FG000|Overall Study|Adverse Event|2|||
23379093|NCT02323880|65134097|FG001|Overall Study|Adverse Event|0|||
23379094|NCT02323880|65134098|FG002|Overall Study|Adverse Event|1|||
23379095|NCT02323880|65134099|FG003|Overall Study|Adverse Event|1|||
23379096|NCT02323880|65134100|FG004|Overall Study|Adverse Event|1|||
23379097|NCT02323880|65134101|FG005|Overall Study|Adverse Event|0|||
23286405|NCT00372996|64791425|FG001|Overall Study|Withdrawal by Subject|6|||
23286406|NCT00372996|64791426|FG002|Overall Study|Withdrawal by Subject|9|||
23286407|NCT00372996|64791427|FG003|Overall Study|Withdrawal by Subject|5|||
23286408|NCT00372996|64791424|FG000|Overall Study|Study Terminated by Sponsor|4|||
23286409|NCT00372996|64791425|FG001|Overall Study|Study Terminated by Sponsor|0|||
23286410|NCT00372996|64791426|FG002|Overall Study|Study Terminated by Sponsor|4|||
23286411|NCT00372996|64791427|FG003|Overall Study|Study Terminated by Sponsor|0|||
23286412|NCT00372996|64791424|FG000|Overall Study|Other|10|||
23286413|NCT00372996|64791425|FG001|Overall Study|Other|2|||
23286414|NCT00372996|64791426|FG002|Overall Study|Other|7|||
23286415|NCT00372996|64791427|FG003|Overall Study|Other|7|||
23286416|NCT02614898|64791428|FG000|Overall Study|Participated until study termination|10|||
23286417|NCT02614898|64791429|FG001|Overall Study|Participated until study termination|26|||
23286418|NCT02614898|64791428|FG000|Overall Study|Lost to Follow-up|0|||
23286419|NCT02614898|64791429|FG001|Overall Study|Lost to Follow-up|2|||
23286420|NCT02614898|64791428|FG000|Overall Study|Physician Decision|1|||
23286421|NCT02614898|64791429|FG001|Overall Study|Physician Decision|8|||
23286422|NCT02614898|64791428|FG000|Overall Study|Study Terminated by Sponsor|3|||
23605504|NCT02634307|65943753|FG001|Overall Study|Lack of Efficacy|5|||
23605505|NCT02634307|65943754|FG002|Overall Study|Lack of Efficacy|3|||
23286423|NCT02614898|64791429|FG001|Overall Study|Study Terminated by Sponsor|0|||
23286424|NCT02614898|64791428|FG000|Overall Study|Withdrawal by Subject|0|||
23605506|NCT02634307|65943752|FG000|Overall Study|Physician Decision|7|||
23286425|NCT02614898|64791429|FG001|Overall Study|Withdrawal by Subject|2|||
23286426|NCT02614898|64791428|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23379098|NCT02323880|65134102|FG006|Overall Study|Adverse Event|1|||
23379099|NCT02323880|65134103|FG007|Overall Study|Adverse Event|0|||
23379100|NCT02323880|65134096|FG000|Overall Study|Death|0|||
23379101|NCT02323880|65134097|FG001|Overall Study|Death|0|||
23379102|NCT02323880|65134098|FG002|Overall Study|Death|0|||
23379103|NCT02323880|65134099|FG003|Overall Study|Death|0|||
23379104|NCT02323880|65134100|FG004|Overall Study|Death|0|||
23379105|NCT02323880|65134101|FG005|Overall Study|Death|1|||
23379106|NCT02323880|65134102|FG006|Overall Study|Death|0|||
23379107|NCT02323880|65134103|FG007|Overall Study|Death|0|||
23379108|NCT02323880|65134096|FG000|Overall Study|Lack of Efficacy|4|||
23379109|NCT02323880|65134097|FG001|Overall Study|Lack of Efficacy|11|||
23379110|NCT02323880|65134098|FG002|Overall Study|Lack of Efficacy|5|||
23379111|NCT02323880|65134099|FG003|Overall Study|Lack of Efficacy|5|||
23379112|NCT02323880|65134100|FG004|Overall Study|Lack of Efficacy|4|||
23379113|NCT02323880|65134101|FG005|Overall Study|Lack of Efficacy|8|||
23379114|NCT02323880|65134102|FG006|Overall Study|Lack of Efficacy|4|||
23379115|NCT02323880|65134103|FG007|Overall Study|Lack of Efficacy|6|||
23379116|NCT02323880|65134096|FG000|Overall Study|Physician Decision|0|||
23379117|NCT02323880|65134097|FG001|Overall Study|Physician Decision|0|||
23379118|NCT02323880|65134098|FG002|Overall Study|Physician Decision|0|||
23379119|NCT02323880|65134099|FG003|Overall Study|Physician Decision|0|||
23379120|NCT02323880|65134100|FG004|Overall Study|Physician Decision|1|||
23379121|NCT02323880|65134101|FG005|Overall Study|Physician Decision|1|||
23379122|NCT02323880|65134102|FG006|Overall Study|Physician Decision|1|||
23379123|NCT02323880|65134103|FG007|Overall Study|Physician Decision|0|||
23605507|NCT02634307|65943753|FG001|Overall Study|Physician Decision|5|||
23605508|NCT02634307|65943754|FG002|Overall Study|Physician Decision|5|||
23605509|NCT02634307|65943752|FG000|Overall Study|Reason not Specified|3|||
23605510|NCT02634307|65943753|FG001|Overall Study|Reason not Specified|5|||
23605511|NCT02634307|65943754|FG002|Overall Study|Reason not Specified|10|||
23605512|NCT02915783|65943755|FG000|Overall Study|Death|21|||
23605513|NCT02915783|65943755|FG000|Overall Study|Lost to Follow-up|1|||
23605514|NCT02915783|65943755|FG000|Overall Study|Withdrawal by Subject|2|||
23605515|NCT01584648|65946957|FG000|Overall Study|Death|136|||
23605516|NCT01584648|65946958|FG001|Overall Study|Death|146|||
23605517|NCT01584648|65946957|FG000|Overall Study|Lost to Follow-up|9|||
23605518|NCT01584648|65946958|FG001|Overall Study|Lost to Follow-up|9|||
23605519|NCT01584648|65946957|FG000|Overall Study|Investigator discretion|3|||
23605520|NCT01584648|65946958|FG001|Overall Study|Investigator discretion|2|||
23286427|NCT02614898|64791429|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
23286428|NCT02614898|64791428|FG000|Overall Study|Other-Additional Information Unavailable|0|||
23286429|NCT02614898|64791429|FG001|Overall Study|Other-Additional Information Unavailable|11|||
23379124|NCT02323880|65134096|FG000|Overall Study|Withdrawal by Subject|0|||
23379125|NCT02323880|65134097|FG001|Overall Study|Withdrawal by Subject|2|||
23379126|NCT02323880|65134098|FG002|Overall Study|Withdrawal by Subject|0|||
23605521|NCT01584648|65946957|FG000|Overall Study|Withdrew consent|13|||
23379127|NCT02323880|65134099|FG003|Overall Study|Withdrawal by Subject|0|||
23605522|NCT01584648|65946958|FG001|Overall Study|Withdrew consent|4|||
23605523|NCT01584648|65946957|FG000|Overall Study|Study closed/terminated|50|||
23286430|NCT02614898|64791428|FG000|Overall Study|Missing|0|||
23286431|NCT02614898|64791429|FG001|Overall Study|Missing|1|||
23379128|NCT02323880|65134100|FG004|Overall Study|Withdrawal by Subject|0|||
23379129|NCT02323880|65134101|FG005|Overall Study|Withdrawal by Subject|0|||
23379130|NCT02323880|65134102|FG006|Overall Study|Withdrawal by Subject|0|||
23379131|NCT02323880|65134103|FG007|Overall Study|Withdrawal by Subject|0|||
23379132|NCT02008370|65134104|FG000|Overall Study|Lost to Follow-up|7|||
23379133|NCT02181738|65134105|FG000|Overall Study|Participant Withdrew Consent|2|||
23379134|NCT02181738|65134106|FG001|Overall Study|Participant Withdrew Consent|1|||
23379135|NCT02181738|65134107|FG002|Overall Study|Participant Withdrew Consent|1|||
23379136|NCT02181738|65134108|FG003|Overall Study|Participant Withdrew Consent|1|||
23379137|NCT02181738|65134105|FG000|Overall Study|Lost to Follow-up|1|||
23379138|NCT02181738|65134106|FG001|Overall Study|Lost to Follow-up|2|||
23379139|NCT02181738|65134107|FG002|Overall Study|Lost to Follow-up|1|||
23379140|NCT02181738|65134108|FG003|Overall Study|Lost to Follow-up|1|||
23379141|NCT02181738|65134105|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
23379142|NCT02181738|65134106|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
23379143|NCT02181738|65134107|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
23379144|NCT02181738|65134108|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
23379145|NCT02181738|65134105|FG000|Overall Study|Poor/Non-Compliance|1|||
23379146|NCT02181738|65134106|FG001|Overall Study|Poor/Non-Compliance|0|||
23379147|NCT02181738|65134107|FG002|Overall Study|Poor/Non-Compliance|2|||
23379148|NCT02181738|65134108|FG003|Overall Study|Poor/Non-Compliance|1|||
23379149|NCT02181738|65134105|FG000|Overall Study|Disease Progression|28|||
23379150|NCT02181738|65134106|FG001|Overall Study|Disease Progression|35|||
23379151|NCT02181738|65134107|FG002|Overall Study|Disease Progression|40|||
23379152|NCT02181738|65134108|FG003|Overall Study|Disease Progression|0|||
23379153|NCT02181738|65134105|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
23379154|NCT02181738|65134106|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
23379155|NCT02181738|65134107|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
23379156|NCT02181738|65134108|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
23379157|NCT02181738|65134105|FG000|Overall Study|Study Drug Toxicity|6|||
23379158|NCT02181738|65134106|FG001|Overall Study|Study Drug Toxicity|11|||
23379159|NCT02181738|65134107|FG002|Overall Study|Study Drug Toxicity|8|||
23379160|NCT02181738|65134108|FG003|Overall Study|Study Drug Toxicity|1|||
23379161|NCT02181738|65134105|FG000|Overall Study|Other Reasons|14|||
23379162|NCT02181738|65134106|FG001|Overall Study|Other Reasons|16|||
23379163|NCT02181738|65134107|FG002|Overall Study|Other Reasons|28|||
23379164|NCT02181738|65134108|FG003|Overall Study|Other Reasons|0|||
23379165|NCT02181738|65134105|FG000|Overall Study|Maximum Clinical Benefit|3|||
23379166|NCT02181738|65134106|FG001|Overall Study|Maximum Clinical Benefit|0|||
23286432|NCT00695110|64791432|FG000|Treatment Period 1|Adverse Event|1|||
23286433|NCT00695110|64791432|FG000|Treatment Period 1|Withdrawal by Subject|2|||
23286434|NCT00695110|64791432|FG000|Treatment Period 3|Withdrawal by Subject|1|||
23286435|NCT00695110|64791432|FG000|Treatment Period 4|Adverse Event|1|||
23286436|NCT02219009|64791433|FG000|Overall Study|Withdrawal by Subject|5|||
23286437|NCT02219009|64791434|FG001|Overall Study|Withdrawal by Subject|1|||
23286438|NCT02219009|64791433|FG000|Overall Study|Adverse Event|2|||
23286439|NCT02219009|64791434|FG001|Overall Study|Adverse Event|4|||
23286440|NCT02219009|64791433|FG000|Overall Study|Lost to Follow-up|2|||
23286441|NCT02219009|64791434|FG001|Overall Study|Lost to Follow-up|2|||
23286442|NCT02219009|64791433|FG000|Overall Study|Protocol deviation|1|||
23286443|NCT02219009|64791434|FG001|Overall Study|Protocol deviation|0|||
23286444|NCT02219009|64791433|FG000|Overall Study|Physician Decision|0|||
23286445|NCT02219009|64791434|FG001|Overall Study|Physician Decision|1|||
23286446|NCT01972841|64791435|FG000|Overall Study|Randomized but Never Received Treatment|2|||
23286447|NCT01972841|64791436|FG001|Overall Study|Randomized but Never Received Treatment|5|||
23286448|NCT01972841|64791437|FG002|Overall Study|Randomized but Never Received Treatment|4|||
23286449|NCT01972841|64791438|FG003|Overall Study|Randomized but Never Received Treatment|2|||
23286450|NCT01972841|64791439|FG004|Overall Study|Randomized but Never Received Treatment|6|||
23286451|NCT01972841|64791440|FG005|Overall Study|Randomized but Never Received Treatment|13|||
23286452|NCT01972841|64791435|FG000|Overall Study|Adverse Event|13|||
23286453|NCT01972841|64791436|FG001|Overall Study|Adverse Event|8|||
23286454|NCT01972841|64791437|FG002|Overall Study|Adverse Event|12|||
23286455|NCT01972841|64791438|FG003|Overall Study|Adverse Event|9|||
23286456|NCT01972841|64791439|FG004|Overall Study|Adverse Event|21|||
23286457|NCT01972841|64791440|FG005|Overall Study|Adverse Event|26|||
23286458|NCT01972841|64791435|FG000|Overall Study|Lack of Efficacy|1|||
23286459|NCT01972841|64791436|FG001|Overall Study|Lack of Efficacy|0|||
23286460|NCT01972841|64791437|FG002|Overall Study|Lack of Efficacy|0|||
23379167|NCT02181738|65134107|FG002|Overall Study|Maximum Clinical Benefit|1|||
23286461|NCT01972841|64791438|FG003|Overall Study|Lack of Efficacy|2|||
23286462|NCT01972841|64791439|FG004|Overall Study|Lack of Efficacy|4|||
23286463|NCT01972841|64791440|FG005|Overall Study|Lack of Efficacy|1|||
23286464|NCT01972841|64791435|FG000|Overall Study|Lost to Follow-up|4|||
23286465|NCT01972841|64791436|FG001|Overall Study|Lost to Follow-up|2|||
23379168|NCT02181738|65134108|FG003|Overall Study|Maximum Clinical Benefit|0|||
23379169|NCT02181738|65134105|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23379170|NCT02181738|65134106|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
23490814|NCT03509467|65541493|FG002|Overall Study|Proxy Withdrawal|0|||
23286466|NCT01972841|64791437|FG002|Overall Study|Lost to Follow-up|4|||
23286467|NCT01972841|64791438|FG003|Overall Study|Lost to Follow-up|2|||
23286468|NCT01972841|64791439|FG004|Overall Study|Lost to Follow-up|9|||
23286469|NCT01972841|64791440|FG005|Overall Study|Lost to Follow-up|3|||
23286470|NCT01972841|64791435|FG000|Overall Study|Protocol Violation|2|||
23286471|NCT01972841|64791436|FG001|Overall Study|Protocol Violation|2|||
23286472|NCT01972841|64791437|FG002|Overall Study|Protocol Violation|3|||
23286473|NCT01972841|64791438|FG003|Overall Study|Protocol Violation|5|||
23286474|NCT01972841|64791439|FG004|Overall Study|Protocol Violation|9|||
23286475|NCT01972841|64791440|FG005|Overall Study|Protocol Violation|4|||
23286476|NCT01972841|64791435|FG000|Overall Study|Withdrawal by participants|21|||
23286477|NCT01972841|64791436|FG001|Overall Study|Withdrawal by participants|27|||
23286478|NCT01972841|64791437|FG002|Overall Study|Withdrawal by participants|23|||
23286479|NCT01972841|64791438|FG003|Overall Study|Withdrawal by participants|16|||
23286480|NCT01972841|64791439|FG004|Overall Study|Withdrawal by participants|33|||
23286481|NCT01972841|64791440|FG005|Overall Study|Withdrawal by participants|34|||
23286482|NCT01972841|64791435|FG000|Overall Study|Miscellaneous|0|||
23286483|NCT01972841|64791436|FG001|Overall Study|Miscellaneous|0|||
23286484|NCT01972841|64791437|FG002|Overall Study|Miscellaneous|4|||
23286485|NCT01972841|64791438|FG003|Overall Study|Miscellaneous|1|||
23286486|NCT01972841|64791439|FG004|Overall Study|Miscellaneous|0|||
23286487|NCT01972841|64791440|FG005|Overall Study|Miscellaneous|4|||
23286488|NCT01972841|64791435|FG000|Overall Study|Did not have end of treatment page|0|||
23286489|NCT01972841|64791436|FG001|Overall Study|Did not have end of treatment page|0|||
23286490|NCT01972841|64791437|FG002|Overall Study|Did not have end of treatment page|0|||
23286491|NCT01972841|64791438|FG003|Overall Study|Did not have end of treatment page|0|||
23286492|NCT01972841|64791439|FG004|Overall Study|Did not have end of treatment page|1|||
23286493|NCT01972841|64791440|FG005|Overall Study|Did not have end of treatment page|0|||
23286494|NCT01148225|64791441|FG000|Overall Study|Other|185|||
23379171|NCT02181738|65134107|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
23379172|NCT02181738|65134108|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
23379173|NCT02187055|65134111|FG000|Overall Study|Lack of Efficacy|10|||
23379174|NCT02187055|65134112|FG001|Overall Study|Lack of Efficacy|3|||
23379175|NCT02187055|65134113|FG002|Overall Study|Lack of Efficacy|7|||
23605524|NCT01584648|65946958|FG001|Overall Study|Study closed/terminated|23|||
23605525|NCT01584648|65946957|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
23286495|NCT01450800|64791442|FG000|Overall Study|Protocol Violation|1|||
23605526|NCT01584648|65946958|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
23605527|NCT00310037|65946960|FG000|Overall Study|Adverse Event|7|||
23605528|NCT00310037|65946961|FG001|Overall Study|Adverse Event|14|||
23605529|NCT00310037|65946960|FG000|Overall Study|Withdrawal by Subject|4|||
23605530|NCT00310037|65946961|FG001|Overall Study|Withdrawal by Subject|3|||
23605531|NCT00310037|65946960|FG000|Overall Study|Progression|6|||
23605532|NCT00310037|65946961|FG001|Overall Study|Progression|0|||
23605533|NCT00310037|65946960|FG000|Overall Study|Non-protocol treatment|1|||
23605534|NCT00310037|65946961|FG001|Overall Study|Non-protocol treatment|0|||
23605535|NCT03128099|65946962|FG000|Overall Study|High dose task was too long|0|||
23605536|NCT03128099|65946963|FG001|Overall Study|High dose task was too long|4|||
23605537|NCT03128099|65946964|FG002|Overall Study|High dose task was too long|0|||
23605538|NCT03128099|65946962|FG000|Overall Study|Participant got a full time job.|1|||
23605539|NCT03128099|65946963|FG001|Overall Study|Participant got a full time job.|0|||
23605540|NCT03128099|65946964|FG002|Overall Study|Participant got a full time job.|0|||
23286496|NCT01450800|64791443|FG001|Overall Study|Protocol Violation|3|||
23286497|NCT03250117|64791444|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
23286498|NCT03250117|64791445|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
23286499|NCT03250117|64791446|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
23286500|NCT03250117|64791447|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
23286501|NCT01559116|64791448|FG000|Overall Study|Adverse Event|10|||
23379176|NCT02187055|65134111|FG000|Overall Study|Lost to Follow-up|2|||
23605541|NCT03128099|65946962|FG000|Overall Study|Became homeless and lost contact|1|||
23605542|NCT03128099|65946963|FG001|Overall Study|Became homeless and lost contact|0|||
23490815|NCT03509467|65541494|FG003|Overall Study|Proxy Withdrawal|0|||
23490816|NCT03509467|65541495|FG004|Overall Study|Proxy Withdrawal|0|||
23490817|NCT03509467|65541496|FG005|Overall Study|Proxy Withdrawal|0|||
23490818|NCT03509467|65541497|FG006|Overall Study|Proxy Withdrawal|0|||
23490819|NCT03509467|65541498|FG007|Overall Study|Proxy Withdrawal|1|||
23490820|NCT00071396|65541499|FG000|Overall Study|Withdrawal by Subject|1|||
23490821|NCT00071396|65541499|FG000|Overall Study|Physician Decision|2|||
23490822|NCT01303861|65541500|FG000|Overall Study|Lost to Follow-up|34|||
23490823|NCT01303861|65541501|FG001|Overall Study|Lost to Follow-up|14|||
23490824|NCT01303861|65541502|FG002|Overall Study|Lost to Follow-up|27|||
23490825|NCT01303861|65541503|FG003|Overall Study|Lost to Follow-up|31|||
23490826|NCT01303861|65541500|FG000|Overall Study|Lack of Efficacy|3|||
23490827|NCT01303861|65541501|FG001|Overall Study|Lack of Efficacy|2|||
23490828|NCT01303861|65541502|FG002|Overall Study|Lack of Efficacy|1|||
23490829|NCT01303861|65541503|FG003|Overall Study|Lack of Efficacy|0|||
23490830|NCT01303861|65541500|FG000|Overall Study|Withdrawal by Subject|16|||
23490831|NCT01303861|65541501|FG001|Overall Study|Withdrawal by Subject|8|||
23490832|NCT01303861|65541502|FG002|Overall Study|Withdrawal by Subject|8|||
23490833|NCT01303861|65541503|FG003|Overall Study|Withdrawal by Subject|23|||
23490834|NCT01303861|65541500|FG000|Overall Study|Adverse Event|4|||
23490835|NCT01303861|65541501|FG001|Overall Study|Adverse Event|1|||
23490836|NCT01303861|65541502|FG002|Overall Study|Adverse Event|0|||
23490837|NCT01303861|65541503|FG003|Overall Study|Adverse Event|5|||
23490838|NCT01303861|65541500|FG000|Overall Study|Pregnancy|1|||
23605543|NCT03128099|65946964|FG002|Overall Study|Became homeless and lost contact|0|||
23605544|NCT03128099|65946962|FG000|Overall Study|Did not complete all the assessments|0|||
23605545|NCT03128099|65946963|FG001|Overall Study|Did not complete all the assessments|0|||
23605546|NCT03128099|65946964|FG002|Overall Study|Did not complete all the assessments|1|||
23605547|NCT03615404|65946965|FG000|Overall Study|Death|1|||
23605548|NCT03615404|65946965|FG000|Overall Study|vaccine did not pass quality assurance|1|||
23605549|NCT02039401|65946967|FG000|Overall Study|Adverse Event|0|||
23605550|NCT02039401|65946968|FG001|Overall Study|Adverse Event|1|||
23605551|NCT00983294|65946969|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
23605552|NCT00983294|65946969|FG000|Colchicine With Azithromycin|Adverse Event|1|||
23605553|NCT01801007|65946970|FG000|Overall Study|Adverse Event|2|||
23605554|NCT01801007|65946970|FG000|Overall Study|Lost to Follow-up|4|||
23605555|NCT01801007|65946970|FG000|Overall Study|Withdrawal by Subject|5|||
23605556|NCT02736188|65946974|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
23605557|NCT02736188|65946974|FG000|Overall Study|Adverse Event|1|||
23605558|NCT02736188|65946974|FG000|Overall Study|Withdrawal by Subject|1|||
23605559|NCT02736188|65946974|FG000|Overall Study|Other|6|||
23605560|NCT00929526|65946978|FG000|Overall Study|Withdrawal by Subject|1|||
23605561|NCT00929526|65946979|FG001|Overall Study|Withdrawal by Subject|11|||
23605562|NCT00929526|65946978|FG000|Overall Study|Lost to Follow-up|8|||
23605563|NCT00929526|65946979|FG001|Overall Study|Lost to Follow-up|12|||
23605564|NCT00929526|65946978|FG000|Overall Study|Other|8|||
23605565|NCT00929526|65946979|FG001|Overall Study|Other|6|||
23605566|NCT03137784|65946983|FG000|Overall Study|Adverse Event|1|||
23605567|NCT03137784|65946984|FG001|Overall Study|Adverse Event|1|||
23605568|NCT03137784|65946985|FG002|Overall Study|Adverse Event|0|||
23605569|NCT03137784|65946986|FG003|Overall Study|Adverse Event|0|||
23605570|NCT03137784|65946987|FG004|Overall Study|Adverse Event|0|||
23605571|NCT03137784|65946988|FG005|Overall Study|Adverse Event|0|||
23605572|NCT03137784|65946983|FG000|Overall Study|Subject/guardian decision|1|||
23605573|NCT03137784|65946984|FG001|Overall Study|Subject/guardian decision|0|||
23605574|NCT03137784|65946985|FG002|Overall Study|Subject/guardian decision|0|||
23605575|NCT03137784|65946986|FG003|Overall Study|Subject/guardian decision|0|||
23605576|NCT03137784|65946987|FG004|Overall Study|Subject/guardian decision|0|||
23605577|NCT03137784|65946988|FG005|Overall Study|Subject/guardian decision|0|||
23605578|NCT03137784|65946983|FG000|Overall Study|Non-compliance with study treatment|0|||
23605579|NCT03137784|65946984|FG001|Overall Study|Non-compliance with study treatment|0|||
23605580|NCT03137784|65946985|FG002|Overall Study|Non-compliance with study treatment|0|||
23605581|NCT03137784|65946986|FG003|Overall Study|Non-compliance with study treatment|0|||
23605582|NCT03137784|65946987|FG004|Overall Study|Non-compliance with study treatment|1|||
23490839|NCT01303861|65541501|FG001|Overall Study|Pregnancy|0|||
23490840|NCT01303861|65541502|FG002|Overall Study|Pregnancy|0|||
23490841|NCT01303861|65541503|FG003|Overall Study|Pregnancy|0|||
23490842|NCT03438383|65541504|FG000|Overall Study|Protocol Violation|9|||
23605583|NCT03137784|65946988|FG005|Overall Study|Non-compliance with study treatment|0|||
23605584|NCT00681109|65946989|FG000|Overall Study|Lost to Follow-up|2|||
23605585|NCT00681109|65946990|FG001|Overall Study|Lost to Follow-up|6|||
23605586|NCT00681109|65946991|FG002|Overall Study|Lost to Follow-up|0|||
23605587|NCT03345979|65946992|FG000|Overall Study|Withdrawal by Subject|20|||
23605588|NCT03345979|65946993|FG001|Overall Study|Withdrawal by Subject|31|||
23605589|NCT03345979|65946992|FG000|Overall Study|Adverse Event|10|||
23490843|NCT03438383|65541505|FG001|Overall Study|Protocol Violation|3|||
23490844|NCT00338104|65541506|FG000|Overall Study|Protocol Violation|2|||
23490845|NCT00338104|65541507|FG001|Overall Study|Protocol Violation|1|||
23490846|NCT00338104|65541508|FG002|Overall Study|Protocol Violation|3|||
23490847|NCT04761822|65541513|FG000|Overall Study|Adverse Event|3|||
23490848|NCT04761822|65541514|FG001|Overall Study|Adverse Event|1|||
23490849|NCT04761822|65541515|FG002|Overall Study|Adverse Event|1|||
23490850|NCT04761822|65541516|FG003|Overall Study|Adverse Event|3|||
23490851|NCT04761822|65541513|FG000|Overall Study|Lost to Follow-up|1|||
23490852|NCT04761822|65541514|FG001|Overall Study|Lost to Follow-up|0|||
23490853|NCT04761822|65541515|FG002|Overall Study|Lost to Follow-up|2|||
23490854|NCT04761822|65541516|FG003|Overall Study|Lost to Follow-up|3|||
23490855|NCT04761822|65541513|FG000|Overall Study|Physician Decision|0|||
23490856|NCT04761822|65541514|FG001|Overall Study|Physician Decision|1|||
23490857|NCT04761822|65541515|FG002|Overall Study|Physician Decision|0|||
23490858|NCT04761822|65541516|FG003|Overall Study|Physician Decision|0|||
23490859|NCT04761822|65541513|FG000|Overall Study|Withdrawal by Subject|3|||
23490860|NCT04761822|65541514|FG001|Overall Study|Withdrawal by Subject|8|||
23490861|NCT04761822|65541515|FG002|Overall Study|Withdrawal by Subject|1|||
23490862|NCT04761822|65541516|FG003|Overall Study|Withdrawal by Subject|11|||
23490863|NCT04761822|65541513|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
23490864|NCT04761822|65541514|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
23490865|NCT04761822|65541515|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
23490866|NCT04761822|65541516|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
23490867|NCT04761822|65541513|FG000|Overall Study|Participant requested unblinding|0|||
23490868|NCT04761822|65541514|FG001|Overall Study|Participant requested unblinding|0|||
23490869|NCT04761822|65541515|FG002|Overall Study|Participant requested unblinding|0|||
23490870|NCT04761822|65541516|FG003|Overall Study|Participant requested unblinding|1|||
23490871|NCT03605212|65541518|FG000|Treatment Period|Adverse Event|1|||
23490872|NCT03605212|65541519|FG001|Treatment Period|Adverse Event|0|||
23490873|NCT03605212|65541520|FG002|Treatment Period|Adverse Event|0|||
23490874|NCT03605212|65541521|FG003|Treatment Period|Adverse Event|0|||
23490875|NCT03605212|65541522|FG004|Treatment Period|Adverse Event|0|||
23490876|NCT03605212|65541518|FG000|Treatment Period|Physician Decision|0|||
23490877|NCT03605212|65541519|FG001|Treatment Period|Physician Decision|0|||
23490878|NCT03605212|65541520|FG002|Treatment Period|Physician Decision|0|||
23490879|NCT03605212|65541521|FG003|Treatment Period|Physician Decision|0|||
23490880|NCT03605212|65541522|FG004|Treatment Period|Physician Decision|1|||
23490881|NCT02322021|65541527|FG000|Core Phase|Adverse Event|1|||
23490882|NCT02322021|65541528|FG001|Core Phase|Adverse Event|3|||
23605590|NCT03345979|65946993|FG001|Overall Study|Adverse Event|11|||
23605591|NCT03345979|65946992|FG000|Overall Study|Lost to Follow-up|8|||
23605592|NCT03345979|65946993|FG001|Overall Study|Lost to Follow-up|9|||
23605593|NCT03345979|65946992|FG000|Overall Study|Lack of Efficacy|4|||
23605594|NCT03345979|65946993|FG001|Overall Study|Lack of Efficacy|2|||
23605595|NCT03345979|65946992|FG000|Overall Study|Protocol Violation|1|||
23605596|NCT03345979|65946993|FG001|Overall Study|Protocol Violation|3|||
23605597|NCT03345979|65946992|FG000|Overall Study|Physician Decision|0|||
23605598|NCT03345979|65946993|FG001|Overall Study|Physician Decision|2|||
23605599|NCT01683409|65947000|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
23605600|NCT01683409|65947001|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
23605601|NCT01683409|65947002|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
23605602|NCT01683409|65947003|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
23605603|NCT01683409|65947004|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
23605604|NCT01683409|65947000|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
23605605|NCT01683409|65947001|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
23605606|NCT01683409|65947002|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
23605607|NCT01683409|65947003|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
23605608|NCT01683409|65947004|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
23605609|NCT01683409|65947000|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
23605610|NCT01683409|65947001|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
23605611|NCT01683409|65947002|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
23605612|NCT01683409|65947003|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
23490883|NCT02322021|65541529|FG002|Core Phase|Adverse Event|4|||
23490884|NCT02322021|65541530|FG003|Core Phase|Adverse Event|2|||
23490885|NCT02322021|65541531|FG004|Core Phase|Adverse Event|0|||
23490886|NCT02322021|65541527|FG000|Core Phase|Participant Choice|4|||
23490887|NCT02322021|65541528|FG001|Core Phase|Participant Choice|5|||
23605613|NCT01683409|65947004|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
23490888|NCT02322021|65541529|FG002|Core Phase|Participant Choice|4|||
23490889|NCT02322021|65541530|FG003|Core Phase|Participant Choice|2|||
23490890|NCT02322021|65541531|FG004|Core Phase|Participant Choice|0|||
23490891|NCT02322021|65541527|FG000|Core Phase|Lost to Follow-up|0|||
23605614|NCT01683409|65947000|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
23605615|NCT01683409|65947001|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
23490892|NCT02322021|65541528|FG001|Core Phase|Lost to Follow-up|0|||
23490893|NCT02322021|65541529|FG002|Core Phase|Lost to Follow-up|0|||
23490894|NCT02322021|65541530|FG003|Core Phase|Lost to Follow-up|1|||
23490895|NCT02322021|65541531|FG004|Core Phase|Lost to Follow-up|0|||
23490896|NCT02322021|65541527|FG000|Core Phase|Other|0|||
23490897|NCT02322021|65541528|FG001|Core Phase|Other|0|||
23490898|NCT02322021|65541529|FG002|Core Phase|Other|1|||
23490899|NCT02322021|65541530|FG003|Core Phase|Other|0|||
23490900|NCT02322021|65541531|FG004|Core Phase|Other|0|||
23490901|NCT02322021|65541527|FG000|Extension Phase|Adverse Event|0|||
23490902|NCT02322021|65541528|FG001|Extension Phase|Adverse Event|0|||
23490903|NCT02322021|65541529|FG002|Extension Phase|Adverse Event|0|||
23490904|NCT02322021|65541530|FG003|Extension Phase|Adverse Event|0|||
23490905|NCT02322021|65541531|FG004|Extension Phase|Adverse Event|3|||
23490906|NCT02322021|65541527|FG000|Extension Phase|Participant Choice|0|||
23490907|NCT02322021|65541528|FG001|Extension Phase|Participant Choice|0|||
23490908|NCT02322021|65541529|FG002|Extension Phase|Participant Choice|0|||
23490909|NCT02322021|65541530|FG003|Extension Phase|Participant Choice|0|||
23490910|NCT02322021|65541531|FG004|Extension Phase|Participant Choice|6|||
23490911|NCT02322021|65541527|FG000|Extension Phase|Other|0|||
23490912|NCT02322021|65541528|FG001|Extension Phase|Other|0|||
23490913|NCT02322021|65541529|FG002|Extension Phase|Other|0|||
23490914|NCT02322021|65541530|FG003|Extension Phase|Other|0|||
23490915|NCT02322021|65541531|FG004|Extension Phase|Other|3|||
23490916|NCT02322021|65541527|FG000|Extension Phase|Lost to Follow-up|0|||
23490917|NCT02322021|65541528|FG001|Extension Phase|Lost to Follow-up|0|||
23490918|NCT02322021|65541529|FG002|Extension Phase|Lost to Follow-up|0|||
23490919|NCT02322021|65541530|FG003|Extension Phase|Lost to Follow-up|0|||
23490920|NCT02322021|65541531|FG004|Extension Phase|Lost to Follow-up|1|||
23490921|NCT02322021|65541527|FG000|Extension Phase|Study terminated by sponsor|0|||
23490922|NCT02322021|65541528|FG001|Extension Phase|Study terminated by sponsor|0|||
23490923|NCT02322021|65541529|FG002|Extension Phase|Study terminated by sponsor|0|||
23490924|NCT02322021|65541530|FG003|Extension Phase|Study terminated by sponsor|0|||
23490925|NCT02322021|65541531|FG004|Extension Phase|Study terminated by sponsor|28|||
23490926|NCT03516812|65541535|FG000|Overall Study|Adverse Event|4|||
23490927|NCT03516812|65541535|FG000|Overall Study|Lack of Efficacy|2|||
23490928|NCT00147251|65541536|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
23490929|NCT00147251|65541537|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
23490930|NCT03894046|65541538|FG000|Overall Study|Protocol Violation|1|||
23490931|NCT03894046|65541539|FG001|Overall Study|Protocol Violation|0|||
23490932|NCT03894046|65541540|FG002|Overall Study|Protocol Violation|0|||
23490933|NCT03894046|65541538|FG000|Overall Study|Adverse Event|0|||
23490934|NCT03894046|65541539|FG001|Overall Study|Adverse Event|1|||
23490935|NCT03894046|65541540|FG002|Overall Study|Adverse Event|0|||
23490936|NCT03894046|65541538|FG000|Overall Study|Withdrawal by Subject|2|||
23490937|NCT03894046|65541539|FG001|Overall Study|Withdrawal by Subject|3|||
23490938|NCT03894046|65541540|FG002|Overall Study|Withdrawal by Subject|1|||
23490939|NCT03894046|65541538|FG000|Overall Study|Death|15|||
23490940|NCT03894046|65541539|FG001|Overall Study|Death|21|||
23490941|NCT03894046|65541540|FG002|Overall Study|Death|4|||
23490942|NCT03894046|65541538|FG000|Overall Study|No growth of ABC|2|||
23490943|NCT03894046|65541539|FG001|Overall Study|No growth of ABC|1|||
23490944|NCT03894046|65541540|FG002|Overall Study|No growth of ABC|0|||
23490945|NCT03894046|65541538|FG000|Overall Study|Physician Decision|1|||
23490946|NCT03894046|65541539|FG001|Overall Study|Physician Decision|1|||
23490947|NCT03894046|65541540|FG002|Overall Study|Physician Decision|1|||
23490948|NCT03894046|65541538|FG000|Overall Study|Prohibited concomitant medication|1|||
23490949|NCT03894046|65541539|FG001|Overall Study|Prohibited concomitant medication|0|||
23490950|NCT03894046|65541540|FG002|Overall Study|Prohibited concomitant medication|0|||
23490951|NCT03894046|65541538|FG000|Overall Study|Transferred to other arm/group|1|||
23490952|NCT03894046|65541539|FG001|Overall Study|Transferred to other arm/group|1|||
23490953|NCT03894046|65541540|FG002|Overall Study|Transferred to other arm/group|0|||
23490954|NCT00573248|65541541|FG000|Overall Study|scheduling conflicts|15|||
23490955|NCT00573248|65541542|FG001|Overall Study|scheduling conflicts|11|||
23490956|NCT02155881|65541543|FG000|Overall Study|Withdrawal by Subject|0|||
23490957|NCT02155881|65541544|FG001|Overall Study|Withdrawal by Subject|2|||
23490958|NCT02155881|65541543|FG000|Overall Study|Inappropriately randomized|2|||
23490959|NCT02155881|65541544|FG001|Overall Study|Inappropriately randomized|2|||
23490960|NCT01601132|65541545|FG000|Overall Study|Patient withdrew consent|1|||
23490961|NCT01601132|65541545|FG000|Overall Study|Protocol deviation|1|||
23490962|NCT01397201|65541546|FG000|Overall Study|Not treated|0|||
23490963|NCT01397201|65541547|FG001|Overall Study|Not treated|0|||
23490964|NCT01397201|65541548|FG002|Overall Study|Not treated|1|||
23490965|NCT01397201|65541549|FG003|Overall Study|Not treated|0|||
23490966|NCT01397201|65541550|FG004|Overall Study|Not treated|0|||
23490967|NCT01397201|65541546|FG000|Overall Study|Not yet defined|3|||
23490968|NCT01397201|65541547|FG001|Overall Study|Not yet defined|6|||
23490969|NCT01397201|65541548|FG002|Overall Study|Not yet defined|5|||
23490970|NCT01397201|65541549|FG003|Overall Study|Not yet defined|5|||
23490971|NCT01397201|65541550|FG004|Overall Study|Not yet defined|4|||
23490972|NCT01397201|65541546|FG000|Overall Study|Adverse Event|2|||
23490973|NCT01397201|65541547|FG001|Overall Study|Adverse Event|0|||
23286502|NCT01559116|64791448|FG000|Overall Study|Lack of Efficacy|1|||
23286503|NCT01559116|64791448|FG000|Overall Study|Lost to Follow-up|1|||
23286504|NCT01559116|64791448|FG000|Overall Study|Protocol Violation|1|||
23286505|NCT01559116|64791448|FG000|Overall Study|Withdrawal by Subject|4|||
23286506|NCT01559116|64791448|FG000|Overall Study|other than stated above|9|||
23286507|NCT00688844|64791449|FG000|Overall Study|Lost to Follow-up|10|||
23286508|NCT01253564|64791450|FG000|Overall Study|Disease Progression|22|||
23286509|NCT01253564|64791450|FG000|Overall Study|Withdrawal by Subject|1|||
23490974|NCT01397201|65541548|FG002|Overall Study|Adverse Event|0|||
23605616|NCT01683409|65947002|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
23286510|NCT01253564|64791450|FG000|Overall Study|Serious Adverse Event|1|||
23286511|NCT04142658|64791451|FG000|Overall Study|Death|2|||
23379177|NCT02187055|65134112|FG001|Overall Study|Lost to Follow-up|7|||
23379178|NCT02187055|65134113|FG002|Overall Study|Lost to Follow-up|3|||
23379179|NCT02187055|65134111|FG000|Overall Study|No longer meets eligibility criteria|0|||
23379180|NCT02187055|65134112|FG001|Overall Study|No longer meets eligibility criteria|2|||
23379181|NCT02187055|65134113|FG002|Overall Study|No longer meets eligibility criteria|0|||
23379182|NCT02187055|65134111|FG000|Overall Study|No longer willing to participate|6|||
23379183|NCT02187055|65134112|FG001|Overall Study|No longer willing to participate|8|||
23379184|NCT02187055|65134113|FG002|Overall Study|No longer willing to participate|10|||
23379185|NCT02187055|65134111|FG000|Overall Study|Other|5|||
23379186|NCT02187055|65134112|FG001|Overall Study|Other|6|||
23379187|NCT02187055|65134113|FG002|Overall Study|Other|3|||
23379188|NCT02187055|65134111|FG000|Overall Study|Protocol Violation|9|||
23379189|NCT02187055|65134112|FG001|Overall Study|Protocol Violation|9|||
23379190|NCT02187055|65134113|FG002|Overall Study|Protocol Violation|4|||
23379191|NCT02187055|65134111|FG000|Overall Study|Pregnancy|3|||
23379192|NCT02187055|65134112|FG001|Overall Study|Pregnancy|1|||
23379193|NCT02187055|65134113|FG002|Overall Study|Pregnancy|0|||
23379194|NCT02187055|65134111|FG000|Overall Study|Withdrawal by Subject|11|||
23379195|NCT02187055|65134112|FG001|Overall Study|Withdrawal by Subject|11|||
23379196|NCT02187055|65134113|FG002|Overall Study|Withdrawal by Subject|11|||
23379197|NCT02187055|65134111|FG000|Overall Study|Adverse Event|21|||
23379198|NCT02187055|65134112|FG001|Overall Study|Adverse Event|26|||
23379199|NCT02187055|65134113|FG002|Overall Study|Adverse Event|36|||
23379200|NCT02187055|65134111|FG000|Overall Study|Death|2|||
23379201|NCT02187055|65134112|FG001|Overall Study|Death|0|||
23379202|NCT02187055|65134113|FG002|Overall Study|Death|0|||
23379203|NCT01078545|65134117|FG000|Overall Study|Lost to Follow-up|13|||
23379204|NCT01078545|65134117|FG000|Overall Study|Physician Decision|6|||
23379205|NCT01078545|65134117|FG000|Overall Study|Withdrawal by Subject|3|||
23379206|NCT01078545|65134117|FG000|Overall Study|Death|3|||
23379207|NCT01078545|65134117|FG000|Overall Study|Participant moved to another physician|1|||
23379208|NCT01407367|65134118|FG000|Overall Study|Death|24|||
23379209|NCT01407367|65134119|FG001|Overall Study|Death|32|||
23379210|NCT01407367|65134118|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
23379211|NCT01407367|65134119|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
23379212|NCT01407367|65134118|FG000|Overall Study|Withdrawal by Subject|4|||
23379213|NCT01407367|65134119|FG001|Overall Study|Withdrawal by Subject|15|||
23379214|NCT01407367|65134118|FG000|Overall Study|Lost to Follow-up|0|||
23379215|NCT01407367|65134119|FG001|Overall Study|Lost to Follow-up|2|||
23379216|NCT00976027|65134120|FG000|Overall Study|Serious Adverse Event|36|||
23379217|NCT00976027|65134121|FG001|Overall Study|Serious Adverse Event|17|||
23379218|NCT00976027|65134120|FG000|Overall Study|Adverse Event|0|||
23379219|NCT00976027|65134121|FG001|Overall Study|Adverse Event|2|||
23379220|NCT00976027|65134120|FG000|Overall Study|Protocol Violation|60|||
23379221|NCT00976027|65134121|FG001|Overall Study|Protocol Violation|27|||
23379222|NCT00976027|65134120|FG000|Overall Study|Lost to Follow-up|208|||
23379223|NCT00976027|65134121|FG001|Overall Study|Lost to Follow-up|103|||
23379224|NCT00976027|65134120|FG000|Overall Study|Withdrawal by Subject|107|||
23379225|NCT00976027|65134121|FG001|Overall Study|Withdrawal by Subject|66|||
23379226|NCT02100631|65134127|FG000|Overall Study|Withdrawal by Subject|1|||
23379227|NCT02100631|65134128|FG001|Overall Study|Withdrawal by Subject|0|||
23379228|NCT02100631|65134129|FG002|Overall Study|Withdrawal by Subject|0|||
23379229|NCT02100631|65134127|FG000|Overall Study|Lost to Follow-up|3|||
23379230|NCT02100631|65134128|FG001|Overall Study|Lost to Follow-up|4|||
23379231|NCT02100631|65134129|FG002|Overall Study|Lost to Follow-up|0|||
23286512|NCT04142658|64791452|FG001|Overall Study|Death|1|||
23286513|NCT04142658|64791451|FG000|Overall Study|Lost to Follow-up|4|||
23286514|NCT04142658|64791452|FG001|Overall Study|Lost to Follow-up|13|||
23286515|NCT04142658|64791451|FG000|Overall Study|Withdrawal by Subject|9|||
23379232|NCT02100631|65134127|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
23379233|NCT02100631|65134128|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
23490975|NCT01397201|65541549|FG003|Overall Study|Adverse Event|0|||
23490976|NCT01397201|65541550|FG004|Overall Study|Adverse Event|0|||
23379234|NCT02100631|65134129|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
23379235|NCT01143324|65134134|FG000|Overall Study|Lost to Follow-up|11|||
23379236|NCT01143324|65134134|FG000|Overall Study|Withdrawal by Subject|4|||
23379237|NCT01143324|65134134|FG000|Overall Study|Explant of the device|4|||
23379238|NCT01164475|65134135|FG000|Overall Study|Lack of Efficacy|1|||
23379239|NCT01164475|65134136|FG001|Overall Study|Lack of Efficacy|0|||
23379240|NCT01164475|65134135|FG000|Overall Study|Other|0|||
23379241|NCT01164475|65134136|FG001|Overall Study|Other|1|||
23379242|NCT01164475|65134135|FG000|Overall Study|Progressive disease|0|||
23379243|NCT01164475|65134136|FG001|Overall Study|Progressive disease|1|||
23379244|NCT01164475|65134135|FG000|Overall Study|Protocol Violation|1|||
23379245|NCT01164475|65134136|FG001|Overall Study|Protocol Violation|0|||
23379246|NCT00614393|65134137|FG000|Overall Study|Adverse Event|20|||
23379247|NCT00614393|65134138|FG001|Overall Study|Adverse Event|2|||
23379248|NCT00614393|65134139|FG002|Overall Study|Adverse Event|3|||
23379249|NCT00614393|65134140|FG003|Overall Study|Adverse Event|13|||
23379250|NCT00614393|65134141|FG004|Overall Study|Adverse Event|21|||
23379251|NCT00614393|65134137|FG000|Overall Study|Lost to Follow-up|0|||
23379252|NCT00614393|65134138|FG001|Overall Study|Lost to Follow-up|0|||
23379253|NCT00614393|65134139|FG002|Overall Study|Lost to Follow-up|0|||
23379254|NCT00614393|65134140|FG003|Overall Study|Lost to Follow-up|1|||
23379255|NCT00614393|65134141|FG004|Overall Study|Lost to Follow-up|2|||
23379256|NCT00614393|65134137|FG000|Overall Study|Physician Decision|17|||
23379257|NCT00614393|65134138|FG001|Overall Study|Physician Decision|0|||
23379258|NCT00614393|65134139|FG002|Overall Study|Physician Decision|1|||
23379259|NCT00614393|65134140|FG003|Overall Study|Physician Decision|8|||
23379260|NCT00614393|65134141|FG004|Overall Study|Physician Decision|9|||
23379261|NCT00614393|65134137|FG000|Overall Study|Progressive Disease|118|||
23379262|NCT00614393|65134138|FG001|Overall Study|Progressive Disease|5|||
23379263|NCT00614393|65134139|FG002|Overall Study|Progressive Disease|5|||
23379264|NCT00614393|65134140|FG003|Overall Study|Progressive Disease|138|||
23379265|NCT00614393|65134141|FG004|Overall Study|Progressive Disease|130|||
23379266|NCT00614393|65134137|FG000|Overall Study|Protocol Violation|1|||
23379267|NCT00614393|65134138|FG001|Overall Study|Protocol Violation|0|||
23379268|NCT00614393|65134139|FG002|Overall Study|Protocol Violation|0|||
23379269|NCT00614393|65134140|FG003|Overall Study|Protocol Violation|0|||
23379270|NCT00614393|65134141|FG004|Overall Study|Protocol Violation|0|||
23379271|NCT00614393|65134137|FG000|Overall Study|Terminated by Sponsor|0|||
23379272|NCT00614393|65134138|FG001|Overall Study|Terminated by Sponsor|0|||
23379273|NCT00614393|65134139|FG002|Overall Study|Terminated by Sponsor|0|||
23379274|NCT00614393|65134140|FG003|Overall Study|Terminated by Sponsor|0|||
23379275|NCT00614393|65134141|FG004|Overall Study|Terminated by Sponsor|1|||
23379276|NCT00614393|65134137|FG000|Overall Study|Withdrawal by Subject|20|||
23379277|NCT00614393|65134138|FG001|Overall Study|Withdrawal by Subject|1|||
23379278|NCT00614393|65134139|FG002|Overall Study|Withdrawal by Subject|1|||
23379279|NCT00614393|65134140|FG003|Overall Study|Withdrawal by Subject|16|||
23379280|NCT00614393|65134141|FG004|Overall Study|Withdrawal by Subject|13|||
23379281|NCT00614393|65134137|FG000|Overall Study|Other|4|||
23379282|NCT00614393|65134138|FG001|Overall Study|Other|0|||
23379283|NCT00614393|65134139|FG002|Overall Study|Other|0|||
23379284|NCT00614393|65134140|FG003|Overall Study|Other|4|||
23379285|NCT00614393|65134141|FG004|Overall Study|Other|2|||
23379286|NCT00614393|65134137|FG000|Overall Study|Not Treated|0|||
23379287|NCT00614393|65134138|FG001|Overall Study|Not Treated|0|||
23379288|NCT00614393|65134139|FG002|Overall Study|Not Treated|0|||
23379289|NCT00614393|65134140|FG003|Overall Study|Not Treated|0|||
23379290|NCT00614393|65134141|FG004|Overall Study|Not Treated|2|||
23379291|NCT01482221|65134142|FG000|Overall Study|Lack of Efficacy|1|||
23379292|NCT01482221|65134143|FG001|Overall Study|Lack of Efficacy|0|||
23379293|NCT01482221|65134144|FG002|Overall Study|Lack of Efficacy|1|||
23379294|NCT01482221|65134142|FG000|Overall Study|Lost to Follow-up|3|||
23379295|NCT01482221|65134143|FG001|Overall Study|Lost to Follow-up|2|||
23490977|NCT01323946|65541555|FG000|Overall Study|Lost to Follow-up|0|||
23490978|NCT01323946|65541556|FG001|Overall Study|Lost to Follow-up|1|||
23379296|NCT01482221|65134144|FG002|Overall Study|Lost to Follow-up|1|||
23379297|NCT01482221|65134142|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
23379298|NCT01482221|65134143|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
23379299|NCT01482221|65134144|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
23379300|NCT01482221|65134142|FG000|Overall Study|Condition under Investigation Worsened|3|||
23379301|NCT01482221|65134143|FG001|Overall Study|Condition under Investigation Worsened|2|||
23379302|NCT01482221|65134144|FG002|Overall Study|Condition under Investigation Worsened|4|||
23379303|NCT01482221|65134142|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
23379304|NCT01482221|65134143|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
23490979|NCT01323946|65541557|FG002|Overall Study|Lost to Follow-up|0|||
23379305|NCT01482221|65134144|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
23379306|NCT01482221|65134142|FG000|Overall Study|Adverse Event|1|||
23379307|NCT01482221|65134143|FG001|Overall Study|Adverse Event|7|||
23379308|NCT01482221|65134144|FG002|Overall Study|Adverse Event|3|||
23379309|NCT01482221|65134142|FG000|Overall Study|Withdrawal by Subject|10|||
23379310|NCT01482221|65134143|FG001|Overall Study|Withdrawal by Subject|7|||
23379311|NCT01482221|65134144|FG002|Overall Study|Withdrawal by Subject|12|||
23379312|NCT01482221|65134142|FG000|Overall Study|Incorrect randomization|0|||
23379313|NCT01482221|65134143|FG001|Overall Study|Incorrect randomization|1|||
23379314|NCT01482221|65134144|FG002|Overall Study|Incorrect randomization|0|||
23379315|NCT01482221|65134142|FG000|Overall Study|Physician Decision|0|||
23379316|NCT01482221|65134143|FG001|Overall Study|Physician Decision|1|||
23379317|NCT01482221|65134144|FG002|Overall Study|Physician Decision|0|||
23379318|NCT04871113|65134145|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379319|NCT04871113|65134146|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379320|NCT04871113|65134147|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379321|NCT04871113|65134148|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379322|NCT04871113|65134149|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379323|NCT04871113|65134150|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
23379324|NCT04871113|65134151|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379325|NCT04871113|65134152|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379326|NCT04871113|65134153|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379327|NCT04871113|65134154|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
23379328|NCT04871113|65134145|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379329|NCT04871113|65134146|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379330|NCT04871113|65134147|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379331|NCT04871113|65134148|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379332|NCT04871113|65134149|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379333|NCT04871113|65134150|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379334|NCT04871113|65134151|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
23379335|NCT04871113|65134152|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
23379336|NCT04871113|65134153|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379337|NCT04871113|65134154|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
23379338|NCT05177094|65134160|FG000|Overall Study|Adverse Event|5|||
23379339|NCT05177094|65134161|FG001|Overall Study|Adverse Event|5|||
23379340|NCT05177094|65134160|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
23379341|NCT05177094|65134161|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
23379342|NCT05177094|65134160|FG000|Overall Study|Protocol Deviation|3|||
23379343|NCT05177094|65134161|FG001|Overall Study|Protocol Deviation|0|||
23379344|NCT05177094|65134160|FG000|Overall Study|Withdrawal by Subject|6|||
23379345|NCT05177094|65134161|FG001|Overall Study|Withdrawal by Subject|3|||
23379346|NCT05177094|65134160|FG000|Overall Study|Participant could not tolerate long study visits|1|||
23379347|NCT05177094|65134161|FG001|Overall Study|Participant could not tolerate long study visits|0|||
23379348|NCT00580840|65134164|FG000|Run-in|Adverse Event|17|||
23379349|NCT00580840|65134165|FG001|Run-in|Adverse Event|0|||
23379350|NCT00580840|65134166|FG002|Run-in|Adverse Event|0|||
23379351|NCT00580840|65134167|FG003|Run-in|Adverse Event|0|||
23379352|NCT00580840|65134164|FG000|Run-in|Lack of Efficacy|93|||
23379353|NCT00580840|65134165|FG001|Run-in|Lack of Efficacy|0|||
23379354|NCT00580840|65134166|FG002|Run-in|Lack of Efficacy|0|||
23379355|NCT00580840|65134167|FG003|Run-in|Lack of Efficacy|0|||
23379356|NCT00580840|65134164|FG000|Run-in|Loss of Efficacy|1|||
23379357|NCT00580840|65134165|FG001|Run-in|Loss of Efficacy|0|||
23379358|NCT00580840|65134166|FG002|Run-in|Loss of Efficacy|0|||
23379359|NCT00580840|65134167|FG003|Run-in|Loss of Efficacy|0|||
23379360|NCT00580840|65134164|FG000|Run-in|Lost to Follow-up|4|||
23379361|NCT00580840|65134165|FG001|Run-in|Lost to Follow-up|0|||
23379362|NCT00580840|65134166|FG002|Run-in|Lost to Follow-up|0|||
23379363|NCT00580840|65134167|FG003|Run-in|Lost to Follow-up|0|||
23379364|NCT00580840|65134164|FG000|Run-in|Withdrawal by Subject|5|||
23379365|NCT00580840|65134165|FG001|Run-in|Withdrawal by Subject|0|||
23379366|NCT00580840|65134166|FG002|Run-in|Withdrawal by Subject|0|||
23490980|NCT01323946|65541555|FG000|Overall Study|Parents refused the last blood draw|1|||
23490981|NCT01323946|65541556|FG001|Overall Study|Parents refused the last blood draw|0|||
23490982|NCT01323946|65541557|FG002|Overall Study|Parents refused the last blood draw|0|||
23490983|NCT01323946|65541555|FG000|Overall Study|Withdrawal by Subject|2|||
23490984|NCT01323946|65541556|FG001|Overall Study|Withdrawal by Subject|2|||
23490985|NCT01323946|65541557|FG002|Overall Study|Withdrawal by Subject|0|||
23490986|NCT00537238|65541558|FG000|Overall Study|Death|1|||
23490987|NCT00537238|65541559|FG001|Overall Study|Death|2|||
23490988|NCT00537238|65541558|FG000|Overall Study|Adverse Event|31|||
23490989|NCT00537238|65541559|FG001|Overall Study|Adverse Event|22|||
23490990|NCT00537238|65541558|FG000|Overall Study|Lack of Efficacy|20|||
23490991|NCT00537238|65541559|FG001|Overall Study|Lack of Efficacy|21|||
23379367|NCT00580840|65134167|FG003|Run-in|Withdrawal by Subject|0|||
23379368|NCT00580840|65134164|FG000|Run-in|Other: Per Sponsor Request|2|||
23379369|NCT00580840|65134165|FG001|Run-in|Other: Per Sponsor Request|0|||
23379370|NCT00580840|65134166|FG002|Run-in|Other: Per Sponsor Request|0|||
23379371|NCT00580840|65134167|FG003|Run-in|Other: Per Sponsor Request|0|||
23605617|NCT01683409|65947003|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
23605618|NCT01683409|65947004|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
23605619|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
23286516|NCT04142658|64791452|FG001|Overall Study|Withdrawal by Subject|16|||
23286517|NCT02050321|64791454|FG000|Overall Study|Withdrawal by Subject|1|||
23286518|NCT02050321|64791454|FG000|Overall Study|Adverse Event|1|||
23286519|NCT01401062|64791457|FG000|Overall Study|Death|9|||
23286520|NCT01401062|64791458|FG001|Overall Study|Death|7|||
23286521|NCT01401062|64791457|FG000|Overall Study|Physician Decision|1|||
23286522|NCT01401062|64791458|FG001|Overall Study|Physician Decision|0|||
23286523|NCT01401062|64791457|FG000|Overall Study|Withdrawal by Subject|1|||
23286524|NCT01401062|64791458|FG001|Overall Study|Withdrawal by Subject|1|||
23286525|NCT01344018|64791459|FG000|Overall Study|Death|22|||
23286526|NCT01344018|64791460|FG001|Overall Study|Death|25|||
23286527|NCT01344018|64791459|FG000|Overall Study|Lost to Follow-up|4|||
23286528|NCT01344018|64791460|FG001|Overall Study|Lost to Follow-up|7|||
23286529|NCT03105297|64791461|FG000|Baseline Phase (Day 1)|Other|21|||
23286530|NCT03105297|64791461|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
23286531|NCT03105297|64791461|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
23286532|NCT02121184|64791462|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
23286533|NCT02121184|64791463|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
23286534|NCT02121184|64791462|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
23286535|NCT02121184|64791463|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
23286536|NCT02121184|64791462|FG000|Overall Study|Emergency cesarean section required|0|||
23286537|NCT02121184|64791463|FG001|Overall Study|Emergency cesarean section required|2|||
23286538|NCT02121184|64791462|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
23286539|NCT02121184|64791463|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
23286540|NCT02705716|64791464|FG000|Overall Study|Adverse Event|0|||
23286541|NCT02705716|64791465|FG001|Overall Study|Adverse Event|1|||
23286542|NCT02705716|64791464|FG000|Overall Study|Protocol Violation|3|||
23286543|NCT02705716|64791465|FG001|Overall Study|Protocol Violation|0|||
23286544|NCT02705716|64791464|FG000|Overall Study|Withdrawal of Consent|1|||
23286545|NCT02705716|64791465|FG001|Overall Study|Withdrawal of Consent|1|||
23286546|NCT00301964|64791466|FG000|Overall Study|Second primary|2|||
23286547|NCT00301964|64791466|FG000|Overall Study|Wrong primary|1|||
23286548|NCT00301964|64791466|FG000|Overall Study|Inadequate pathology|1|||
23286549|NCT00397254|64791467|FG000|Overall Study|Lost to Follow-up|2|||
23286550|NCT00397254|64791468|FG001|Overall Study|Lost to Follow-up|2|||
23286551|NCT01160640|64791477|FG000|Overall Study|Physician Decision|3|||
23286552|NCT01160640|64791478|FG001|Overall Study|Physician Decision|3|||
23286553|NCT01160640|64791477|FG000|Overall Study|Incarceration|1|||
23286554|NCT01160640|64791478|FG001|Overall Study|Incarceration|0|||
23286555|NCT01160640|64791477|FG000|Overall Study|Withdrawal by Subject|0|||
23286556|NCT01160640|64791478|FG001|Overall Study|Withdrawal by Subject|3|||
23286557|NCT01456949|64791479|FG000|Enrollment|PI death- incomplete data|6|||
23286558|NCT01456949|64791479|FG000|Enrollment|Death|1|||
23286559|NCT01456949|64791479|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
23286560|NCT01456949|64791479|FG000|Enrollment|Physician Decision|10|||
23286561|NCT01456949|64791479|FG000|Enrollment|Withdrawal by Subject|7|||
23286562|NCT01456949|64791479|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
23286563|NCT01456949|64791479|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
23286564|NCT01456949|64791479|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
23286565|NCT01456949|64791479|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
23286566|NCT01456949|64791479|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
23286567|NCT01456949|64791479|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
23286568|NCT01456949|64791479|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
23286569|NCT01456949|64791479|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
23286570|NCT03428750|64791480|FG000|Overall Study|Withdrawal by Subject|11|||
23286571|NCT03428750|64791481|FG001|Overall Study|Withdrawal by Subject|10|||
23286572|NCT03428750|64791480|FG000|Overall Study|Lost to Follow-up|3|||
23286573|NCT03428750|64791481|FG001|Overall Study|Lost to Follow-up|9|||
23286574|NCT03428750|64791480|FG000|Overall Study|Adverse Event|9|||
23286575|NCT03428750|64791481|FG001|Overall Study|Adverse Event|1|||
23286576|NCT03428750|64791480|FG000|Overall Study|Protocol Violation|1|||
23286577|NCT03428750|64791481|FG001|Overall Study|Protocol Violation|0|||
23286578|NCT03428750|64791480|FG000|Overall Study|Administrative|0|||
23286579|NCT03428750|64791481|FG001|Overall Study|Administrative|1|||
23605620|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
23605621|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
23605622|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
23605623|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
23605624|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
23605625|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
23605626|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
23605627|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
23605628|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
23605629|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
23605630|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
23605631|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
23605632|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
23605633|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
23605634|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
23605635|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
23605636|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
23605637|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
23605638|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
23605639|NCT01683409|65947000|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
23605640|NCT01683409|65947001|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
23605641|NCT01683409|65947002|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
23605642|NCT01683409|65947003|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
23286580|NCT03555695|64791482|FG000|Overall Study|Withdrawal by Subject|1|||
23286581|NCT03555695|64791482|FG000|Overall Study|Lost to Follow-up|1|||
23286582|NCT03555695|64791482|FG000|Overall Study|appendicitis (unrelated)|1|||
23286583|NCT03555695|64791482|FG000|Overall Study|pre-existing sciatica|1|||
23286584|NCT01968031|64791483|FG000|Overall Study|Adverse Event|13|||
23286585|NCT01968031|64791484|FG001|Overall Study|Adverse Event|10|||
23286586|NCT01968031|64791485|FG002|Overall Study|Adverse Event|22|||
23286587|NCT01968031|64791483|FG000|Overall Study|Withdrawal by Subject|3|||
23286588|NCT01968031|64791484|FG001|Overall Study|Withdrawal by Subject|7|||
23286589|NCT01968031|64791485|FG002|Overall Study|Withdrawal by Subject|3|||
23286590|NCT01968031|64791483|FG000|Overall Study|Did not meet entry criteria|1|||
23286591|NCT01968031|64791484|FG001|Overall Study|Did not meet entry criteria|1|||
23286592|NCT01968031|64791485|FG002|Overall Study|Did not meet entry criteria|1|||
23286593|NCT01968031|64791483|FG000|Overall Study|Noncompliance|0|||
23286594|NCT01968031|64791484|FG001|Overall Study|Noncompliance|0|||
23286595|NCT01968031|64791485|FG002|Overall Study|Noncompliance|2|||
23286596|NCT01968031|64791483|FG000|Overall Study|Failed inclusion criteria|0|||
23286597|NCT01968031|64791484|FG001|Overall Study|Failed inclusion criteria|2|||
23286598|NCT01968031|64791485|FG002|Overall Study|Failed inclusion criteria|0|||
23286599|NCT01968031|64791483|FG000|Overall Study|Death|0|||
23286600|NCT01968031|64791484|FG001|Overall Study|Death|0|||
23286601|NCT01968031|64791485|FG002|Overall Study|Death|1|||
23286602|NCT01968031|64791483|FG000|Overall Study|Prohibited concomitant medication|1|||
23286603|NCT01968031|64791484|FG001|Overall Study|Prohibited concomitant medication|0|||
23286604|NCT01968031|64791485|FG002|Overall Study|Prohibited concomitant medication|0|||
23286605|NCT03498560|64791488|FG000|Overall Study|Found Ineligible|2|||
23286606|NCT03498560|64791488|FG000|Overall Study|Withdrawal by Subject|14|||
23286607|NCT03498560|64791488|FG000|Overall Study|Lost to Follow-up|4|||
23286608|NCT03498560|64791488|FG000|Overall Study|Death|1|||
23286609|NCT00090753|64791491|FG000|First Treatment Period|Adverse Event|20|||
23286610|NCT00090753|64791492|FG001|First Treatment Period|Adverse Event|8|||
23286611|NCT00090753|64791491|FG000|First Treatment Period|Death|88|||
23286612|NCT00090753|64791492|FG001|First Treatment Period|Death|62|||
23286613|NCT00090753|64791491|FG000|First Treatment Period|Lack of Efficacy|2|||
23286614|NCT00090753|64791492|FG001|First Treatment Period|Lack of Efficacy|1|||
23286615|NCT00090753|64791491|FG000|First Treatment Period|Refused Treatment|32|||
23286616|NCT00090753|64791492|FG001|First Treatment Period|Refused Treatment|25|||
23286617|NCT00090753|64791491|FG000|First Treatment Period|Lost to Follow-up|4|||
23286618|NCT00090753|64791492|FG001|First Treatment Period|Lost to Follow-up|4|||
23286619|NCT00090753|64791491|FG000|First Treatment Period|Renal Transplant|70|||
23286620|NCT00090753|64791492|FG001|First Treatment Period|Renal Transplant|50|||
23286621|NCT00090753|64791491|FG000|First Treatment Period|Mircera Commercialization|1|||
23286622|NCT00090753|64791492|FG001|First Treatment Period|Mircera Commercialization|0|||
23286623|NCT00090753|64791491|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
23286624|NCT00090753|64791492|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
23286625|NCT00090753|64791491|FG000|Extended Treatment Period|Adverse Event|11|||
23605643|NCT01683409|65947004|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
23605644|NCT01683409|65947000|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
23605645|NCT01683409|65947001|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
23605646|NCT01683409|65947002|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
23605647|NCT01683409|65947003|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
23605648|NCT01683409|65947004|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
23605649|NCT01683409|65947000|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
23605650|NCT01683409|65947001|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
23605651|NCT01683409|65947002|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
23605652|NCT01683409|65947003|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
23605653|NCT01683409|65947004|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
23605654|NCT00620854|65947007|FG000|Washout 1|Withdrawal by Subject|0|||
23605655|NCT00620854|65947008|FG001|Washout 1|Withdrawal by Subject|0|||
23605656|NCT00620854|65947009|FG002|Washout 1|Withdrawal by Subject|1|||
23286626|NCT00090753|64791492|FG001|Extended Treatment Period|Adverse Event|0|||
23286627|NCT00090753|64791491|FG000|Extended Treatment Period|Death|58|||
23286628|NCT00090753|64791492|FG001|Extended Treatment Period|Death|30|||
23286629|NCT00090753|64791491|FG000|Extended Treatment Period|Lack of Efficacy|1|||
23286630|NCT00090753|64791492|FG001|Extended Treatment Period|Lack of Efficacy|0|||
23286631|NCT00090753|64791491|FG000|Extended Treatment Period|Refused Treatment|18|||
23605657|NCT00620854|65947010|FG003|Washout 1|Withdrawal by Subject|1|||
23605658|NCT00620854|65947011|FG004|Washout 1|Withdrawal by Subject|0|||
23605659|NCT00620854|65947012|FG005|Washout 1|Withdrawal by Subject|0|||
23605660|NCT01240785|65947016|FG000|Overall Study|Lost to Follow-up|1|||
23605661|NCT01240785|65947017|FG001|Overall Study|Lost to Follow-up|0|||
23605662|NCT01240785|65947016|FG000|Overall Study|Protocol Violation|0|||
23605663|NCT01240785|65947017|FG001|Overall Study|Protocol Violation|3|||
23286632|NCT00090753|64791492|FG001|Extended Treatment Period|Refused Treatment|12|||
23286633|NCT00090753|64791491|FG000|Extended Treatment Period|Lost to Follow-up|3|||
23286634|NCT00090753|64791492|FG001|Extended Treatment Period|Lost to Follow-up|1|||
23286635|NCT00090753|64791491|FG000|Extended Treatment Period|Renal Transplant|15|||
23286636|NCT00090753|64791492|FG001|Extended Treatment Period|Renal Transplant|12|||
23286637|NCT00090753|64791491|FG000|Extended Treatment Period|Mircera Commercialization|188|||
23286638|NCT00090753|64791492|FG001|Extended Treatment Period|Mircera Commercialization|93|||
23286639|NCT00090753|64791491|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
23286640|NCT00090753|64791492|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
23605664|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
23605665|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
23605666|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23286641|NCT00577655|64795539|FG000|Overall Study|Patient Request|0|||
23286642|NCT00577655|64795540|FG001|Overall Study|Patient Request|2|||
23286643|NCT00577655|64795539|FG000|Overall Study|Protocol Violation|0|||
23286644|NCT00577655|64795540|FG001|Overall Study|Protocol Violation|1|||
23286645|NCT00577655|64795539|FG000|Overall Study|Lost to Follow-up|1|||
23286646|NCT00577655|64795540|FG001|Overall Study|Lost to Follow-up|1|||
23286647|NCT02169336|64795544|FG000|Overall Study|Lack of Efficacy|1|||
23286648|NCT02169336|64795545|FG001|Overall Study|Lack of Efficacy|1|||
23286649|NCT02169336|64795546|FG002|Overall Study|Lack of Efficacy|0|||
23286650|NCT02169336|64795544|FG000|Overall Study|Adverse Event|2|||
23286651|NCT02169336|64795545|FG001|Overall Study|Adverse Event|3|||
23286652|NCT02169336|64795546|FG002|Overall Study|Adverse Event|1|||
23286653|NCT02169336|64795544|FG000|Overall Study|Withdrawal by Subject|1|||
23286654|NCT02169336|64795545|FG001|Overall Study|Withdrawal by Subject|0|||
23286655|NCT02169336|64795546|FG002|Overall Study|Withdrawal by Subject|0|||
23379372|NCT00580840|65134164|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
23379373|NCT00580840|65134165|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
23379374|NCT00580840|65134166|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
23379375|NCT00580840|65134167|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
23379376|NCT00580840|65134164|FG000|Run-in|Other: Exclusionary Lab Value|1|||
23286656|NCT02169336|64795544|FG000|Overall Study|Physician Decision|0|||
23490992|NCT00537238|65541558|FG000|Overall Study|Lost to Follow-up|12|||
23379377|NCT00580840|65134165|FG001|Run-in|Other: Exclusionary Lab Value|0|||
23379378|NCT00580840|65134166|FG002|Run-in|Other: Exclusionary Lab Value|0|||
23379379|NCT00580840|65134167|FG003|Run-in|Other: Exclusionary Lab Value|0|||
23379380|NCT00580840|65134164|FG000|Double-Blind|Adverse Event|0|||
23379381|NCT00580840|65134165|FG001|Double-Blind|Adverse Event|3|||
23379382|NCT00580840|65134166|FG002|Double-Blind|Adverse Event|4|||
23379383|NCT00580840|65134167|FG003|Double-Blind|Adverse Event|1|||
23379384|NCT00580840|65134164|FG000|Double-Blind|Loss of Efficacy|0|||
23379385|NCT00580840|65134165|FG001|Double-Blind|Loss of Efficacy|1|||
23286657|NCT02169336|64795545|FG001|Overall Study|Physician Decision|0|||
23286658|NCT02169336|64795546|FG002|Overall Study|Physician Decision|1|||
23286659|NCT02169336|64795544|FG000|Overall Study|Subject declined to continue dosing|0|||
23286660|NCT02169336|64795545|FG001|Overall Study|Subject declined to continue dosing|0|||
23286661|NCT02169336|64795546|FG002|Overall Study|Subject declined to continue dosing|1|||
23286662|NCT00724958|64795549|FG000|Overall Study|Adverse Event|28|||
23379386|NCT00580840|65134166|FG002|Double-Blind|Loss of Efficacy|2|||
23379387|NCT00580840|65134167|FG003|Double-Blind|Loss of Efficacy|10|||
23379388|NCT00580840|65134164|FG000|Double-Blind|Lost to Follow-up|0|||
23379389|NCT00580840|65134165|FG001|Double-Blind|Lost to Follow-up|1|||
23379390|NCT00580840|65134166|FG002|Double-Blind|Lost to Follow-up|0|||
23379391|NCT00580840|65134167|FG003|Double-Blind|Lost to Follow-up|2|||
23490993|NCT00537238|65541559|FG001|Overall Study|Lost to Follow-up|8|||
23490994|NCT00537238|65541558|FG000|Overall Study|Withdrawal by Subject|51|||
23490995|NCT00537238|65541559|FG001|Overall Study|Withdrawal by Subject|47|||
23490996|NCT00537238|65541558|FG000|Overall Study|Protocol Violation|15|||
23490997|NCT00537238|65541559|FG001|Overall Study|Protocol Violation|19|||
23490998|NCT00537238|65541558|FG000|Overall Study|Does not meet entrance criteria|0|||
23490999|NCT00537238|65541559|FG001|Overall Study|Does not meet entrance criteria|2|||
23491000|NCT00537238|65541558|FG000|Overall Study|Other|44|||
23491001|NCT00537238|65541559|FG001|Overall Study|Other|52|||
23491002|NCT02128932|65541560|FG000|Overall Study|Withdrawal by Subject|11|||
23491003|NCT02128932|65541561|FG001|Overall Study|Withdrawal by Subject|7|||
23491004|NCT02128932|65541562|FG002|Overall Study|Withdrawal by Subject|8|||
23491005|NCT02128932|65541560|FG000|Overall Study|Death|2|||
23491006|NCT02128932|65541561|FG001|Overall Study|Death|0|||
23491007|NCT02128932|65541562|FG002|Overall Study|Death|2|||
23491008|NCT02128932|65541560|FG000|Overall Study|Lost to Follow-up|2|||
23491009|NCT02128932|65541561|FG001|Overall Study|Lost to Follow-up|1|||
23491010|NCT02128932|65541562|FG002|Overall Study|Lost to Follow-up|1|||
23491011|NCT02128932|65541560|FG000|Overall Study|No reason for withdrawal|12|||
23491012|NCT02128932|65541561|FG001|Overall Study|No reason for withdrawal|11|||
23491013|NCT02128932|65541562|FG002|Overall Study|No reason for withdrawal|7|||
23491014|NCT02395666|65541565|FG000|Overall Study|Physician Decision|3|||
23491015|NCT02395666|65541566|FG001|Overall Study|Physician Decision|0|||
23491016|NCT02395666|65541565|FG000|Overall Study|Lost to Follow-up|1|||
23491017|NCT02395666|65541566|FG001|Overall Study|Lost to Follow-up|0|||
23491018|NCT02395666|65541565|FG000|Overall Study|Withdrawal by Subject|2|||
23491019|NCT02395666|65541566|FG001|Overall Study|Withdrawal by Subject|1|||
23491020|NCT01347307|65541567|FG000|Overall Study|Death|0|||
23491021|NCT01347307|65541568|FG001|Overall Study|Death|4|||
23491022|NCT01347307|65541567|FG000|Overall Study|Physician Decision|0|||
23491023|NCT01347307|65541568|FG001|Overall Study|Physician Decision|1|||
23491024|NCT03511664|65541569|FG000|Overall Study|Treatment ongoing|49|||
23491025|NCT03511664|65541570|FG001|Overall Study|Treatment ongoing|5|||
23491026|NCT03511664|65541569|FG000|Overall Study|Entered long-term follow-up|140|||
23491027|NCT03511664|65541570|FG001|Overall Study|Entered long-term follow-up|50|||
23491028|NCT03511664|65541569|FG000|Overall Study|Withdrawal by Subject|29|||
23491029|NCT03511664|65541570|FG001|Overall Study|Withdrawal by Subject|53|||
23491030|NCT03511664|65541569|FG000|Overall Study|Lost to Follow-up|4|||
23491031|NCT03511664|65541570|FG001|Overall Study|Lost to Follow-up|4|||
23491032|NCT03511664|65541569|FG000|Overall Study|Physician Decision|0|||
23491033|NCT03511664|65541570|FG001|Overall Study|Physician Decision|1|||
23491034|NCT02642029|65541577|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
23491035|NCT02642029|65541578|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23491036|NCT02642029|65541579|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23491037|NCT02642029|65541580|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23286663|NCT00724958|64795549|FG000|Overall Study|Loss of Response|40|||
23379392|NCT00580840|65134164|FG000|Double-Blind|Withdrawal by Subject|0|||
23379393|NCT00580840|65134165|FG001|Double-Blind|Withdrawal by Subject|1|||
23379394|NCT00580840|65134166|FG002|Double-Blind|Withdrawal by Subject|2|||
23379395|NCT00580840|65134167|FG003|Double-Blind|Withdrawal by Subject|2|||
23491038|NCT02642029|65541581|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23491039|NCT02642029|65541582|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
23491040|NCT02642029|65541577|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491041|NCT02642029|65541578|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
23379396|NCT00580840|65134164|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
23379397|NCT00580840|65134165|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
23379398|NCT00580840|65134166|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
23379399|NCT00580840|65134167|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
23379400|NCT00580840|65134164|FG000|Double-Blind|Other: Forbidden Medication|0|||
23379401|NCT00580840|65134165|FG001|Double-Blind|Other: Forbidden Medication|0|||
23379402|NCT00580840|65134166|FG002|Double-Blind|Other: Forbidden Medication|1|||
23379403|NCT00580840|65134167|FG003|Double-Blind|Other: Forbidden Medication|0|||
23379404|NCT00283959|65134168|FG000|Extension Period|Low Compliance|1|||
23379405|NCT03677401|65134169|FG000|Overall Study|Adverse Event|4|||
23379406|NCT03677401|65134170|FG001|Overall Study|Adverse Event|14|||
23379407|NCT03677401|65134169|FG000|Overall Study|Lack of Efficacy|3|||
23379408|NCT03677401|65134170|FG001|Overall Study|Lack of Efficacy|1|||
23379409|NCT03677401|65134169|FG000|Overall Study|Withdrawal by Subject|2|||
23379410|NCT03677401|65134170|FG001|Overall Study|Withdrawal by Subject|2|||
23379411|NCT03677401|65134169|FG000|Overall Study|Sponsor decision|0|||
23379412|NCT03677401|65134170|FG001|Overall Study|Sponsor decision|1|||
23379413|NCT03677401|65134169|FG000|Overall Study|Reason Unspecified|1|||
23379414|NCT03677401|65134170|FG001|Overall Study|Reason Unspecified|0|||
23379415|NCT02065557|65134171|FG000|Induction Period|Withdrawal by Subject|2|||
23379416|NCT02065557|65134172|FG001|Induction Period|Withdrawal by Subject|1|||
23379417|NCT02065557|65134173|FG002|Induction Period|Withdrawal by Subject|0|||
23379418|NCT02065557|65134174|FG003|Induction Period|Withdrawal by Subject|0|||
23379419|NCT02065557|65134175|FG004|Induction Period|Withdrawal by Subject|0|||
23379420|NCT02065557|65134176|FG005|Induction Period|Withdrawal by Subject|0|||
23379421|NCT02065557|65134171|FG000|Induction Period|Lack of Efficacy|2|||
23379422|NCT02065557|65134172|FG001|Induction Period|Lack of Efficacy|1|||
23379423|NCT02065557|65134173|FG002|Induction Period|Lack of Efficacy|1|||
23379424|NCT02065557|65134174|FG003|Induction Period|Lack of Efficacy|0|||
23379425|NCT02065557|65134175|FG004|Induction Period|Lack of Efficacy|0|||
23379426|NCT02065557|65134176|FG005|Induction Period|Lack of Efficacy|0|||
23379427|NCT02065557|65134171|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
23379428|NCT02065557|65134172|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
23379429|NCT02065557|65134173|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
23379430|NCT02065557|65134174|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
23379431|NCT02065557|65134175|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
23379432|NCT02065557|65134176|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
23379433|NCT02065557|65134171|FG000|Induction Period|Non-Responder at Week 8|4|||
23379434|NCT02065557|65134172|FG001|Induction Period|Non-Responder at Week 8|4|||
23379435|NCT02065557|65134173|FG002|Induction Period|Non-Responder at Week 8|0|||
23379436|NCT02065557|65134174|FG003|Induction Period|Non-Responder at Week 8|0|||
23379437|NCT02065557|65134175|FG004|Induction Period|Non-Responder at Week 8|0|||
23379438|NCT02065557|65134176|FG005|Induction Period|Non-Responder at Week 8|0|||
23379439|NCT02065557|65134171|FG000|Induction Period|Adverse Event|1|||
23379440|NCT02065557|65134172|FG001|Induction Period|Adverse Event|1|||
23379441|NCT02065557|65134173|FG002|Induction Period|Adverse Event|0|||
23379442|NCT02065557|65134174|FG003|Induction Period|Adverse Event|0|||
23379443|NCT02065557|65134175|FG004|Induction Period|Adverse Event|0|||
23379444|NCT02065557|65134176|FG005|Induction Period|Adverse Event|0|||
23379445|NCT02065557|65134171|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
23379446|NCT02065557|65134172|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
23379447|NCT02065557|65134173|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
23379448|NCT02065557|65134174|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
23379449|NCT02065557|65134175|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
23379450|NCT02065557|65134176|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
23379451|NCT02065557|65134171|FG000|Maintenance Period|Withdrawal by Subject|0|||
23379452|NCT02065557|65134172|FG001|Maintenance Period|Withdrawal by Subject|0|||
23379453|NCT02065557|65134173|FG002|Maintenance Period|Withdrawal by Subject|0|||
23379454|NCT02065557|65134174|FG003|Maintenance Period|Withdrawal by Subject|0|||
23379455|NCT02065557|65134175|FG004|Maintenance Period|Withdrawal by Subject|2|||
23379456|NCT02065557|65134176|FG005|Maintenance Period|Withdrawal by Subject|1|||
23379457|NCT02065557|65134171|FG000|Maintenance Period|Lack of Efficacy|0|||
23379458|NCT02065557|65134172|FG001|Maintenance Period|Lack of Efficacy|0|||
23379459|NCT02065557|65134173|FG002|Maintenance Period|Lack of Efficacy|0|||
23379460|NCT02065557|65134174|FG003|Maintenance Period|Lack of Efficacy|0|||
23379461|NCT02065557|65134175|FG004|Maintenance Period|Lack of Efficacy|5|||
23379462|NCT02065557|65134176|FG005|Maintenance Period|Lack of Efficacy|2|||
23379463|NCT02065557|65134171|FG000|Maintenance Period|Subject Non-Compliance|0|||
23379464|NCT02065557|65134172|FG001|Maintenance Period|Subject Non-Compliance|0|||
23379465|NCT02065557|65134173|FG002|Maintenance Period|Subject Non-Compliance|0|||
23379466|NCT02065557|65134174|FG003|Maintenance Period|Subject Non-Compliance|0|||
23379467|NCT02065557|65134175|FG004|Maintenance Period|Subject Non-Compliance|0|||
23379468|NCT02065557|65134176|FG005|Maintenance Period|Subject Non-Compliance|1|||
23379469|NCT01771913|65134177|FG000|Overall Study|Withdrawal by Subject|1|||
23379470|NCT01771913|65134178|FG001|Overall Study|Withdrawal by Subject|0|||
23379471|NCT02842866|65134179|FG000|Overall Study|Serious Adverse Event|0|||
23379472|NCT02842866|65134180|FG001|Overall Study|Serious Adverse Event|1|||
23379473|NCT02842866|65134179|FG000|Overall Study|Protocol Violation|4|||
23379474|NCT02842866|65134180|FG001|Overall Study|Protocol Violation|2|||
23379475|NCT02842866|65134179|FG000|Overall Study|Lost to Follow-up|2|||
23379476|NCT02842866|65134180|FG001|Overall Study|Lost to Follow-up|0|||
23379477|NCT02842866|65134179|FG000|Overall Study|Withdrawal by Subject|1|||
23379478|NCT02842866|65134180|FG001|Overall Study|Withdrawal by Subject|0|||
23379479|NCT02453048|65134181|FG000|Overall Study|Only part of initial 6 mo. study|0|||
23379480|NCT02453048|65134182|FG001|Overall Study|Only part of initial 6 mo. study|0|||
23379481|NCT02453048|65134183|FG002|Overall Study|Only part of initial 6 mo. study|0|||
23379482|NCT02453048|65134184|FG003|Overall Study|Only part of initial 6 mo. study|0|||
23379483|NCT02453048|65134185|FG004|Overall Study|Only part of initial 6 mo. study|6|||
23379484|NCT02453048|65134181|FG000|Overall Study|Lost to Follow-up|0|||
23379485|NCT02453048|65134182|FG001|Overall Study|Lost to Follow-up|1|||
23379486|NCT02453048|65134183|FG002|Overall Study|Lost to Follow-up|2|||
23379487|NCT02453048|65134184|FG003|Overall Study|Lost to Follow-up|0|||
23379488|NCT02453048|65134185|FG004|Overall Study|Lost to Follow-up|0|||
23379489|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
23379490|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
23379491|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
23379492|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
23379493|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
23379494|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
23379495|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379496|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379497|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
23379498|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
23379499|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
23379500|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
23379501|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
23379502|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
23379503|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
23379504|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
23379505|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379506|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
23379507|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379508|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
23379509|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
23379510|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
23379511|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
23379512|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
23379513|NCT00620542|65134186|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
23379514|NCT00620542|65134187|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
23379515|NCT00620542|65134188|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
23379516|NCT00620542|65134189|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
23379517|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
23379518|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
23379519|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
23379520|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
23379521|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
23379522|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
23379523|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
23379524|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
23379525|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
23379526|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
23286664|NCT00724958|64795549|FG000|Overall Study|No Response|18|||
23286665|NCT00724958|64795549|FG000|Overall Study|Remission|7|||
23286666|NCT00724958|64795549|FG000|Overall Study|Other Reason|76|||
23286667|NCT00724958|64795549|FG000|Overall Study|No documentation for end of therapy|13|||
23286668|NCT00283842|64795550|FG000|Overall Study|Adverse Event|8|||
23286669|NCT00283842|64795551|FG001|Overall Study|Adverse Event|7|||
23286670|NCT00283842|64795552|FG002|Overall Study|Adverse Event|21|||
23286671|NCT00283842|64795553|FG003|Overall Study|Adverse Event|21|||
23286672|NCT00283842|64795554|FG004|Overall Study|Adverse Event|5|||
23286673|NCT00283842|64795550|FG000|Overall Study|Protocol Violation|1|||
23286674|NCT00283842|64795551|FG001|Overall Study|Protocol Violation|5|||
23286675|NCT00283842|64795552|FG002|Overall Study|Protocol Violation|4|||
23286676|NCT00283842|64795553|FG003|Overall Study|Protocol Violation|0|||
23286677|NCT00283842|64795554|FG004|Overall Study|Protocol Violation|0|||
23286678|NCT00283842|64795550|FG000|Overall Study|Protocol deviation|0|||
23286679|NCT00283842|64795551|FG001|Overall Study|Protocol deviation|0|||
23286680|NCT00283842|64795552|FG002|Overall Study|Protocol deviation|0|||
23286681|NCT00283842|64795553|FG003|Overall Study|Protocol deviation|0|||
23491042|NCT02642029|65541579|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491043|NCT02642029|65541580|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491044|NCT02642029|65541581|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491045|NCT02642029|65541582|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
23491046|NCT02642029|65541577|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491047|NCT02642029|65541578|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491048|NCT02642029|65541579|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491049|NCT02642029|65541580|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491050|NCT02642029|65541581|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
23491051|NCT02642029|65541582|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
23491052|NCT02642029|65541577|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
23491053|NCT02642029|65541578|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
23491054|NCT02642029|65541579|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
23491055|NCT02642029|65541580|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
23491056|NCT02642029|65541581|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
23491057|NCT02642029|65541582|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
23286682|NCT00283842|64795554|FG004|Overall Study|Protocol deviation|2|||
23286683|NCT00283842|64795550|FG000|Overall Study|Withdrawal by Subject|2|||
23286684|NCT00283842|64795551|FG001|Overall Study|Withdrawal by Subject|1|||
23286685|NCT00283842|64795552|FG002|Overall Study|Withdrawal by Subject|1|||
23286686|NCT00283842|64795553|FG003|Overall Study|Withdrawal by Subject|5|||
23286687|NCT00283842|64795554|FG004|Overall Study|Withdrawal by Subject|4|||
23286688|NCT00283842|64795550|FG000|Overall Study|Lack of Efficacy|1|||
23286689|NCT00283842|64795551|FG001|Overall Study|Lack of Efficacy|3|||
23286690|NCT00283842|64795552|FG002|Overall Study|Lack of Efficacy|1|||
23286691|NCT00283842|64795553|FG003|Overall Study|Lack of Efficacy|0|||
23491058|NCT02642029|65541577|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
23491059|NCT02642029|65541578|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491060|NCT02642029|65541579|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491061|NCT02642029|65541580|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491062|NCT02642029|65541581|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491063|NCT02642029|65541582|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
23491064|NCT02642029|65541577|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
23491065|NCT02642029|65541578|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491066|NCT02642029|65541579|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491067|NCT02642029|65541580|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491068|NCT02642029|65541581|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491069|NCT02642029|65541582|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
23491070|NCT03575897|65541583|FG000|Overall Study|Lost to Follow-up|12|||
23491071|NCT03575897|65541584|FG001|Overall Study|Lost to Follow-up|13|||
23491072|NCT02635776|65541590|FG000|Overall Study|Physician Decision|1|||
23491073|NCT02635776|65541591|FG001|Overall Study|Physician Decision|0|||
23491074|NCT02635776|65541590|FG000|Overall Study|Adverse Event|51|||
23491075|NCT02635776|65541591|FG001|Overall Study|Adverse Event|3|||
23491076|NCT02635776|65541590|FG000|Overall Study|Withdrawal by Subject|41|||
23491077|NCT02635776|65541591|FG001|Overall Study|Withdrawal by Subject|7|||
23491078|NCT02635776|65541590|FG000|Overall Study|Lost to Follow-up|4|||
23491079|NCT02635776|65541591|FG001|Overall Study|Lost to Follow-up|0|||
23491080|NCT02635776|65541590|FG000|Overall Study|Other reasons|5|||
23491081|NCT02635776|65541591|FG001|Overall Study|Other reasons|1|||
23491082|NCT02436681|65541604|FG000|Overall Study|Lost to Follow-up|10|||
23491083|NCT02436681|65541604|FG000|Overall Study|Withdrawal by Subject|2|||
23491084|NCT02436681|65541604|FG000|Overall Study|Death|2|||
23491085|NCT04850313|65541605|FG000|Overall Study|Withdrawal by Subject|0|||
23491086|NCT04850313|65541606|FG001|Overall Study|Withdrawal by Subject|1|||
23491087|NCT02639546|65544873|FG000|Overall Study|Death|2|||
23491088|NCT02639546|65544874|FG001|Overall Study|Death|2|||
23491089|NCT02639546|65544875|FG002|Overall Study|Death|1|||
23491090|NCT02639546|65544876|FG003|Overall Study|Death|2|||
23491091|NCT02639546|65544877|FG004|Overall Study|Death|2|||
23491092|NCT02639546|65544878|FG005|Overall Study|Death|2|||
23491093|NCT02639546|65544879|FG006|Overall Study|Death|0|||
23491094|NCT02639546|65544880|FG007|Overall Study|Death|0|||
23491095|NCT02639546|65544873|FG000|Overall Study|Lost to Follow-up|0|||
23286692|NCT00283842|64795554|FG004|Overall Study|Lack of Efficacy|3|||
23286693|NCT00283842|64795550|FG000|Overall Study|Lost to Follow-up|0|||
23491096|NCT02639546|65544874|FG001|Overall Study|Lost to Follow-up|0|||
23286694|NCT00283842|64795551|FG001|Overall Study|Lost to Follow-up|2|||
23491097|NCT02639546|65544875|FG002|Overall Study|Lost to Follow-up|1|||
23491098|NCT02639546|65544876|FG003|Overall Study|Lost to Follow-up|0|||
23491099|NCT02639546|65544877|FG004|Overall Study|Lost to Follow-up|1|||
23491100|NCT02639546|65544878|FG005|Overall Study|Lost to Follow-up|1|||
23491101|NCT02639546|65544879|FG006|Overall Study|Lost to Follow-up|0|||
23491102|NCT02639546|65544880|FG007|Overall Study|Lost to Follow-up|1|||
23491103|NCT02639546|65544873|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
23491104|NCT02639546|65544874|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
23491105|NCT02639546|65544875|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
23491106|NCT02639546|65544876|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
23491107|NCT02639546|65544877|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
23491108|NCT02639546|65544878|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
23491109|NCT02639546|65544879|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
23491110|NCT02639546|65544880|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
23491111|NCT02639546|65544873|FG000|Overall Study|Study Terminated By Sponsor|0|||
23491112|NCT02639546|65544874|FG001|Overall Study|Study Terminated By Sponsor|2|||
23491113|NCT02639546|65544875|FG002|Overall Study|Study Terminated By Sponsor|3|||
23491114|NCT02639546|65544876|FG003|Overall Study|Study Terminated By Sponsor|4|||
23491115|NCT02639546|65544877|FG004|Overall Study|Study Terminated By Sponsor|4|||
23491116|NCT02639546|65544878|FG005|Overall Study|Study Terminated By Sponsor|3|||
23491117|NCT02639546|65544879|FG006|Overall Study|Study Terminated By Sponsor|3|||
23491118|NCT02639546|65544880|FG007|Overall Study|Study Terminated By Sponsor|9|||
23491119|NCT02639546|65544873|FG000|Overall Study|Withdrawal by Subject|2|||
23491120|NCT02639546|65544874|FG001|Overall Study|Withdrawal by Subject|2|||
23491121|NCT02639546|65544875|FG002|Overall Study|Withdrawal by Subject|1|||
23491122|NCT02639546|65544876|FG003|Overall Study|Withdrawal by Subject|0|||
23491123|NCT02639546|65544877|FG004|Overall Study|Withdrawal by Subject|0|||
23491124|NCT02639546|65544878|FG005|Overall Study|Withdrawal by Subject|1|||
23605667|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23605668|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23605669|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23286695|NCT00283842|64795552|FG002|Overall Study|Lost to Follow-up|4|||
23605670|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
23605671|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
23605672|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
23605673|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23286696|NCT00283842|64795553|FG003|Overall Study|Lost to Follow-up|1|||
23286697|NCT00283842|64795554|FG004|Overall Study|Lost to Follow-up|1|||
23286698|NCT00960154|64795559|FG000|Overall Study|Study termination|25|||
23286699|NCT00960154|64795560|FG001|Overall Study|Study termination|25|||
23379527|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
23379528|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
23491125|NCT02639546|65544879|FG006|Overall Study|Withdrawal by Subject|2|||
23491126|NCT02639546|65544880|FG007|Overall Study|Withdrawal by Subject|1|||
23491127|NCT05021081|65544885|FG000|Phase 2|Subject enrolled in error|1|||
23491128|NCT05021081|65544886|FG001|Phase 2|Subject enrolled in error|1|||
23491129|NCT05021081|65544887|FG002|Phase 2|Subject enrolled in error|0|||
23491130|NCT00891462|65544888|FG000|Overall Study|Withdrawal by Subject|9|||
23605674|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23605675|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23605676|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23605677|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
23605678|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
23605679|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
23605680|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23605681|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23286700|NCT01596127|64795562|FG000|Overall Study|Patient Ineligible|1|||
23286701|NCT00105157|64795573|FG000|Double-Blind (DB)|Never Treated|1|||
23286702|NCT00105157|64795574|FG001|Double-Blind (DB)|Never Treated|0|||
23286703|NCT00105157|64795575|FG002|Double-Blind (DB)|Never Treated|0|||
23286704|NCT00105157|64795576|FG003|Double-Blind (DB)|Never Treated|0|||
23286705|NCT00105157|64795573|FG000|Double-Blind (DB)|Adverse Event|2|||
23286706|NCT00105157|64795574|FG001|Double-Blind (DB)|Adverse Event|0|||
23286707|NCT00105157|64795575|FG002|Double-Blind (DB)|Adverse Event|1|||
23286708|NCT00105157|64795576|FG003|Double-Blind (DB)|Adverse Event|1|||
23286709|NCT00105157|64795573|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
23286710|NCT00105157|64795574|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
23491131|NCT00891462|65544889|FG001|Overall Study|Withdrawal by Subject|6|||
23491132|NCT00891462|65544890|FG002|Overall Study|Withdrawal by Subject|7|||
23491133|NCT00891462|65544888|FG000|Overall Study|Adverse Event|7|||
23491134|NCT00891462|65544889|FG001|Overall Study|Adverse Event|8|||
23491135|NCT00891462|65544890|FG002|Overall Study|Adverse Event|7|||
23491136|NCT00891462|65544888|FG000|Overall Study|Lack of Efficacy|10|||
23491137|NCT00891462|65544889|FG001|Overall Study|Lack of Efficacy|5|||
23491138|NCT00891462|65544890|FG002|Overall Study|Lack of Efficacy|1|||
23491139|NCT00891462|65544888|FG000|Overall Study|COPD exacerbation|7|||
23491140|NCT00891462|65544889|FG001|Overall Study|COPD exacerbation|4|||
23491141|NCT00891462|65544890|FG002|Overall Study|COPD exacerbation|1|||
23491142|NCT00891462|65544888|FG000|Overall Study|Other Reason|2|||
23491143|NCT00891462|65544889|FG001|Overall Study|Other Reason|5|||
23491144|NCT00891462|65544890|FG002|Overall Study|Other Reason|3|||
23491145|NCT00891462|65544888|FG000|Overall Study|Protocol Violation|2|||
23491146|NCT00891462|65544889|FG001|Overall Study|Protocol Violation|1|||
23491147|NCT00891462|65544890|FG002|Overall Study|Protocol Violation|3|||
23491148|NCT00891462|65544888|FG000|Overall Study|Inclusion/exclusion criteria|0|||
23286711|NCT00105157|64795575|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
23286712|NCT00105157|64795576|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
23286713|NCT00105157|64795573|FG000|Open-Label Continuation of DB|Adverse Event|3|||
23286714|NCT00105157|64795574|FG001|Open-Label Continuation of DB|Adverse Event|1|||
23286715|NCT00105157|64795575|FG002|Open-Label Continuation of DB|Adverse Event|0|||
23286716|NCT00105157|64795576|FG003|Open-Label Continuation of DB|Adverse Event|0|||
23286717|NCT00105157|64795573|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
23286718|NCT00105157|64795574|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
23286719|NCT00105157|64795575|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
23286720|NCT00105157|64795576|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
23286721|NCT00105157|64795573|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
23286722|NCT00105157|64795574|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
23286723|NCT00105157|64795575|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
23286724|NCT00105157|64795576|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
23286725|NCT00105157|64795573|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
23379529|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
23379530|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
23379531|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
23379532|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
23379533|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
23379534|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
23379535|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
23379536|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
23379537|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
23379538|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
23379539|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
23379540|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
23379541|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
23379542|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
23379543|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
23379544|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
23379545|NCT00620542|65134186|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
23379546|NCT00620542|65134187|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
23379547|NCT00620542|65134188|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
23379548|NCT00620542|65134189|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
23379549|NCT01033071|65134192|FG000|Overall Study|Adverse Event|28|||
23379550|NCT01033071|65134193|FG001|Overall Study|Adverse Event|51|||
23379551|NCT01033071|65134194|FG002|Overall Study|Adverse Event|26|||
23379552|NCT01033071|65134192|FG000|Overall Study|Protocol Violation|0|||
23286726|NCT00105157|64795574|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
23379553|NCT01033071|65134193|FG001|Overall Study|Protocol Violation|2|||
23379554|NCT01033071|65134194|FG002|Overall Study|Protocol Violation|1|||
23379555|NCT01033071|65134192|FG000|Overall Study|Lost to Follow-up|4|||
23379556|NCT01033071|65134193|FG001|Overall Study|Lost to Follow-up|5|||
23379557|NCT01033071|65134194|FG002|Overall Study|Lost to Follow-up|5|||
23379558|NCT01033071|65134192|FG000|Overall Study|Withdrawal by Subject|17|||
23379559|NCT01033071|65134193|FG001|Overall Study|Withdrawal by Subject|14|||
23379560|NCT01033071|65134194|FG002|Overall Study|Withdrawal by Subject|11|||
23379561|NCT01033071|65134192|FG000|Overall Study|Lack of Efficacy|0|||
23379562|NCT01033071|65134193|FG001|Overall Study|Lack of Efficacy|1|||
23379563|NCT01033071|65134194|FG002|Overall Study|Lack of Efficacy|1|||
23491149|NCT00891462|65544889|FG001|Overall Study|Inclusion/exclusion criteria|2|||
23491150|NCT00891462|65544890|FG002|Overall Study|Inclusion/exclusion criteria|2|||
23491151|NCT00891462|65544888|FG000|Overall Study|Lost to Follow-up|0|||
23491152|NCT00891462|65544889|FG001|Overall Study|Lost to Follow-up|2|||
23491153|NCT00891462|65544890|FG002|Overall Study|Lost to Follow-up|0|||
23379564|NCT01033071|65134192|FG000|Overall Study|Other|6|||
23379565|NCT01033071|65134193|FG001|Overall Study|Other|4|||
23379566|NCT01033071|65134194|FG002|Overall Study|Other|3|||
23379567|NCT01875237|65134197|FG000|Overall Study|GVDH before DLI|1|||
23379568|NCT01875237|65134198|FG001|Overall Study|GVDH before DLI|0|||
23379569|NCT01875237|65134197|FG000|Overall Study|DLI cells could not be produced|1|||
23379570|NCT01875237|65134198|FG001|Overall Study|DLI cells could not be produced|0|||
23379571|NCT00954538|65134199|FG000|Part III|Withdrawal by Subject|0|||
23379572|NCT00954538|65134200|FG001|Part III|Withdrawal by Subject|0|||
23379573|NCT00954538|65134201|FG002|Part III|Withdrawal by Subject|0|||
23379574|NCT00954538|65134202|FG003|Part III|Withdrawal by Subject|0|||
23379575|NCT00954538|65134203|FG004|Part III|Withdrawal by Subject|1|||
23379576|NCT00954538|65134204|FG005|Part III|Withdrawal by Subject|0|||
23379577|NCT02612155|65134207|FG000|Overall Study|Death|1|||
23379578|NCT02612155|65134208|FG001|Overall Study|Death|1|||
23379579|NCT02612155|65134207|FG000|Overall Study|Lost to Follow-up|2|||
23379580|NCT02612155|65134208|FG001|Overall Study|Lost to Follow-up|2|||
23379581|NCT00782067|65134209|FG000|Overall Study|Adverse Event|35|||
23379582|NCT00782067|65134209|FG000|Overall Study|Subject withdrew consent|11|||
23379583|NCT00782067|65134209|FG000|Overall Study|Lost to Follow-up|2|||
23379584|NCT00782067|65134209|FG000|Overall Study|Administrative problems|14|||
23379585|NCT00782067|65134209|FG000|Overall Study|Death|9|||
23379586|NCT00782067|65134209|FG000|Overall Study|Disease progression|43|||
23379587|NCT00782067|65134209|FG000|Overall Study|Protocol deviation|2|||
23379588|NCT00002874|65134210|FG000|Overall Study|Withdrawal by Subject|1|||
23379589|NCT00002874|65134211|FG001|Overall Study|Withdrawal by Subject|1|||
23379590|NCT00002874|65134210|FG000|Overall Study|Protocol Violation|44|||
23379591|NCT00002874|65134211|FG001|Overall Study|Protocol Violation|34|||
23379592|NCT00800540|65134212|FG000|Period One: 6 Weeks|Noncompliance|1|||
23379593|NCT00800540|65134213|FG001|Period One: 6 Weeks|Noncompliance|0|||
23379594|NCT00800540|65134212|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
23379595|NCT00800540|65134213|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
23379596|NCT00800540|65134212|FG000|Period 2: 6 Weeks|Adverse Event|0|||
23379597|NCT00800540|65134213|FG001|Period 2: 6 Weeks|Adverse Event|1|||
23379598|NCT02347787|65134216|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
23379599|NCT02347787|65134217|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
23379600|NCT02347787|65134216|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
23379601|NCT02347787|65134217|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
23379602|NCT02347787|65134216|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
23379603|NCT02347787|65134217|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
23379604|NCT02347787|65134216|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
23379605|NCT02347787|65134217|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
23379606|NCT00632359|65134218|FG000|Overall Study|Withdrawal by Subject|2|||
23379607|NCT01800058|65134220|FG000|Overall Study|Lost to Follow-up|1|||
23379608|NCT03807843|65134226|FG000|Overall Study|Lost to Follow-up|1|||
23379609|NCT03807843|65134227|FG001|Overall Study|Lost to Follow-up|0|||
23379610|NCT02260986|65134228|FG000|Overall Study|Adverse Event|24|||
23379611|NCT02260986|65134229|FG001|Overall Study|Adverse Event|0|||
23379612|NCT02260986|65134230|FG002|Overall Study|Adverse Event|11|||
23379613|NCT02260986|65134228|FG000|Overall Study|Lack of Efficacy|27|||
23379614|NCT02260986|65134229|FG001|Overall Study|Lack of Efficacy|3|||
23379615|NCT02260986|65134230|FG002|Overall Study|Lack of Efficacy|0|||
23379616|NCT02260986|65134228|FG000|Overall Study|Protocol Violation|14|||
23379617|NCT02260986|65134229|FG001|Overall Study|Protocol Violation|5|||
23379618|NCT02260986|65134230|FG002|Overall Study|Protocol Violation|16|||
23379619|NCT02260986|65134228|FG000|Overall Study|Car accident|0|||
23379620|NCT02260986|65134229|FG001|Overall Study|Car accident|0|||
23379621|NCT02260986|65134230|FG002|Overall Study|Car accident|1|||
23379622|NCT02260986|65134228|FG000|Overall Study|Withdrawal by Subject|17|||
23379623|NCT02260986|65134229|FG001|Overall Study|Withdrawal by Subject|4|||
23379624|NCT02260986|65134230|FG002|Overall Study|Withdrawal by Subject|9|||
23379625|NCT02260986|65134228|FG000|Overall Study|Incorrect randomization|0|||
23379626|NCT02260986|65134229|FG001|Overall Study|Incorrect randomization|1|||
23379627|NCT02260986|65134230|FG002|Overall Study|Incorrect randomization|0|||
23379628|NCT02260986|65134228|FG000|Overall Study|Lack of investigation product supply|2|||
23379629|NCT02260986|65134229|FG001|Overall Study|Lack of investigation product supply|0|||
23379630|NCT02260986|65134230|FG002|Overall Study|Lack of investigation product supply|1|||
23491154|NCT03437512|65544891|FG000|Randomized|Withdrawal by Subject|0|||
23379631|NCT02260986|65134228|FG000|Overall Study|Lost to Follow-up|4|||
23379632|NCT02260986|65134229|FG001|Overall Study|Lost to Follow-up|0|||
23379633|NCT02260986|65134230|FG002|Overall Study|Lost to Follow-up|3|||
23379634|NCT02260986|65134228|FG000|Overall Study|Pregnancy|2|||
23379635|NCT02260986|65134229|FG001|Overall Study|Pregnancy|0|||
23379636|NCT02260986|65134230|FG002|Overall Study|Pregnancy|0|||
23379637|NCT04327271|65134231|FG000|Overall Study|Death|1|||
23379638|NCT04327271|65134232|FG001|Overall Study|Death|0|||
23379639|NCT04327271|65134231|FG000|Overall Study|Withdrawal by Subject|1|||
23379640|NCT04327271|65134232|FG001|Overall Study|Withdrawal by Subject|0|||
23491155|NCT03437512|65544892|FG001|Randomized|Withdrawal by Subject|2|||
23379641|NCT04327271|65134231|FG000|Overall Study|randomization error (data capture)|4|||
23379642|NCT04327271|65134232|FG001|Overall Study|randomization error (data capture)|3|||
23379643|NCT02665117|65134233|FG000|Overall Study|Physician Decision|1|||
23379644|NCT02665117|65134234|FG001|Overall Study|Physician Decision|0|||
23379645|NCT01279200|65134235|FG000|Overall Study|Withdrawal by Subject|1|||
23379646|NCT01279200|65134236|FG001|Overall Study|Withdrawal by Subject|3|||
23379647|NCT01279200|65134235|FG000|Overall Study|Patient withdrawal due to high cost|0|||
23379648|NCT01279200|65134236|FG001|Overall Study|Patient withdrawal due to high cost|1|||
23379649|NCT01279200|65134235|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
23379650|NCT01279200|65134236|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
23379651|NCT01279200|65134235|FG000|Overall Study|ultrasound screening failure|0|||
23379652|NCT01279200|65134236|FG001|Overall Study|ultrasound screening failure|1|||
23379653|NCT01279200|65134235|FG000|Overall Study|Lost to Follow-up|0|||
23379654|NCT01279200|65134236|FG001|Overall Study|Lost to Follow-up|1|||
23379655|NCT01279200|65134235|FG000|Overall Study|Adverse Event|1|||
23379656|NCT01279200|65134236|FG001|Overall Study|Adverse Event|0|||
23379657|NCT02006654|65134237|FG000|Overall Study|Withdrawal before treatment|4|||
23379658|NCT02006654|65134238|FG001|Overall Study|Withdrawal before treatment|2|||
23379659|NCT02006654|65134237|FG000|Overall Study|Adverse Event|16|||
23379660|NCT02006654|65134238|FG001|Overall Study|Adverse Event|17|||
23379661|NCT02006654|65134237|FG000|Overall Study|Death|1|||
23379662|NCT02006654|65134238|FG001|Overall Study|Death|0|||
23379663|NCT02006654|65134237|FG000|Overall Study|Withdrawal by Subject|14|||
23379664|NCT02006654|65134238|FG001|Overall Study|Withdrawal by Subject|12|||
23379665|NCT02006654|65134237|FG000|Overall Study|Protocol Violation|5|||
23379666|NCT02006654|65134238|FG001|Overall Study|Protocol Violation|8|||
23379667|NCT02006654|65134237|FG000|Overall Study|Lost to Follow-up|1|||
23379668|NCT02006654|65134238|FG001|Overall Study|Lost to Follow-up|0|||
23379669|NCT02006654|65134237|FG000|Overall Study|patient's will|2|||
23379670|NCT02006654|65134238|FG001|Overall Study|patient's will|1|||
23379671|NCT02006654|65134237|FG000|Overall Study|insufficient compliance|1|||
23379672|NCT02006654|65134238|FG001|Overall Study|insufficient compliance|0|||
23379673|NCT02006654|65134237|FG000|Overall Study|worsening cognitive condition|0|||
23379674|NCT02006654|65134238|FG001|Overall Study|worsening cognitive condition|1|||
23379675|NCT02006654|65134237|FG000|Overall Study|faecal incontinence|0|||
23379676|NCT02006654|65134238|FG001|Overall Study|faecal incontinence|1|||
23379677|NCT02006654|65134237|FG000|Overall Study|mood disorder|0|||
23379678|NCT02006654|65134238|FG001|Overall Study|mood disorder|1|||
23379679|NCT02006654|65134237|FG000|Overall Study|disallowed medication|1|||
23379680|NCT02006654|65134238|FG001|Overall Study|disallowed medication|0|||
23379681|NCT02006654|65134237|FG000|Overall Study|moving out of state|0|||
23379682|NCT02006654|65134238|FG001|Overall Study|moving out of state|1|||
23379683|NCT01136954|65134243|FG000|Overall Study|Adverse Event|3|||
23379684|NCT01136954|65134244|FG001|Overall Study|Adverse Event|2|||
23379685|NCT01136954|65134243|FG000|Overall Study|Withdrawal by Subject|6|||
23379686|NCT01136954|65134244|FG001|Overall Study|Withdrawal by Subject|2|||
23379687|NCT01136954|65134243|FG000|Overall Study|Lack of Efficacy|14|||
23379688|NCT01136954|65134244|FG001|Overall Study|Lack of Efficacy|13|||
23379689|NCT01136954|65134243|FG000|Overall Study|Physician Decision|0|||
23379690|NCT01136954|65134244|FG001|Overall Study|Physician Decision|1|||
23379691|NCT01136954|65134243|FG000|Overall Study|Other|1|||
23379692|NCT01136954|65134244|FG001|Overall Study|Other|3|||
23286727|NCT00105157|64795575|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
23286728|NCT00105157|64795576|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
23286729|NCT00105157|64795573|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
23286730|NCT00105157|64795574|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
23286731|NCT00105157|64795575|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
23286732|NCT00105157|64795576|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
23286733|NCT00105157|64795573|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
23286734|NCT00105157|64795574|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
23286735|NCT00105157|64795575|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
23379693|NCT00274456|65134245|FG000|Overall Study|Still on treatment|2|||
23379694|NCT00274456|65134246|FG001|Overall Study|Still on treatment|3|||
23379695|NCT00274456|65134247|FG002|Overall Study|Still on treatment|5|||
23379696|NCT00274456|65134248|FG003|Overall Study|Still on treatment|1|||
23379697|NCT00274456|65134245|FG000|Overall Study|Unacceptable toxicity|10|||
23379698|NCT00274456|65134246|FG001|Overall Study|Unacceptable toxicity|5|||
23379699|NCT00274456|65134247|FG002|Overall Study|Unacceptable toxicity|12|||
23379700|NCT00274456|65134248|FG003|Overall Study|Unacceptable toxicity|16|||
23379701|NCT00274456|65134245|FG000|Overall Study|Adverse Event|0|||
23379702|NCT00274456|65134246|FG001|Overall Study|Adverse Event|1|||
23379703|NCT00274456|65134247|FG002|Overall Study|Adverse Event|2|||
23379704|NCT00274456|65134248|FG003|Overall Study|Adverse Event|2|||
23605682|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23379705|NCT00274456|65134245|FG000|Overall Study|Physician Decision|7|||
23379706|NCT00274456|65134246|FG001|Overall Study|Physician Decision|5|||
23379707|NCT00274456|65134247|FG002|Overall Study|Physician Decision|6|||
23379708|NCT00274456|65134248|FG003|Overall Study|Physician Decision|13|||
23379709|NCT00274456|65134245|FG000|Overall Study|Lost to Follow-up|0|||
23379710|NCT00274456|65134246|FG001|Overall Study|Lost to Follow-up|0|||
23379711|NCT00274456|65134247|FG002|Overall Study|Lost to Follow-up|1|||
23379712|NCT00274456|65134248|FG003|Overall Study|Lost to Follow-up|0|||
23379713|NCT00274456|65134245|FG000|Overall Study|Withdrawal by Subject|18|||
23379714|NCT00274456|65134246|FG001|Overall Study|Withdrawal by Subject|13|||
23379715|NCT00274456|65134247|FG002|Overall Study|Withdrawal by Subject|9|||
23379716|NCT00274456|65134248|FG003|Overall Study|Withdrawal by Subject|13|||
23379717|NCT03003468|65134249|FG000|Overall Study|Withdrawal by Subject|0|||
23379718|NCT03003468|65134250|FG001|Overall Study|Withdrawal by Subject|0|||
23379719|NCT03003468|65134251|FG002|Overall Study|Withdrawal by Subject|1|||
23379720|NCT03003468|65134249|FG000|Overall Study|No measurable lesions|0|||
23379721|NCT03003468|65134250|FG001|Overall Study|No measurable lesions|0|||
23379722|NCT03003468|65134251|FG002|Overall Study|No measurable lesions|1|||
23379723|NCT01044498|65134252|FG000|Overall Study|Withdrew consent|1|||
23379724|NCT01044498|65134253|FG001|Overall Study|Withdrew consent|1|||
23379725|NCT01044498|65134252|FG000|Overall Study|Adverse Event|1|||
23379726|NCT01044498|65134253|FG001|Overall Study|Adverse Event|1|||
23379727|NCT01044498|65134252|FG000|Overall Study|Other|1|||
23379728|NCT01044498|65134253|FG001|Overall Study|Other|0|||
23379729|NCT00915525|65134258|FG000|Overall Study|Protocol Violation|9|||
23379730|NCT00915525|65134259|FG001|Overall Study|Protocol Violation|4|||
23379731|NCT00915525|65134258|FG000|Overall Study|Withdrawal by Subject|59|||
23286736|NCT00105157|64795576|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
23286737|NCT00105157|64795573|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
23379732|NCT00915525|65134259|FG001|Overall Study|Withdrawal by Subject|21|||
23379733|NCT00915525|65134258|FG000|Overall Study|Lost to Follow-up|27|||
23379734|NCT00915525|65134259|FG001|Overall Study|Lost to Follow-up|16|||
23379735|NCT00915525|65134258|FG000|Overall Study|Pregnancy|2|||
23379736|NCT00915525|65134259|FG001|Overall Study|Pregnancy|0|||
23379737|NCT00915525|65134258|FG000|Overall Study|Lack of Efficacy|15|||
23379738|NCT00915525|65134259|FG001|Overall Study|Lack of Efficacy|32|||
23379739|NCT00915525|65134258|FG000|Overall Study|Adverse Event|29|||
23379740|NCT00915525|65134259|FG001|Overall Study|Adverse Event|13|||
23379741|NCT00915525|65134258|FG000|Overall Study|Missing|12|||
23379742|NCT00915525|65134259|FG001|Overall Study|Missing|1|||
23379743|NCT00915525|65134258|FG000|Overall Study|Other Reason|35|||
23379744|NCT00915525|65134259|FG001|Overall Study|Other Reason|12|||
23379745|NCT00915525|65134258|FG000|Overall Study|Site Closed|27|||
23379746|NCT00915525|65134259|FG001|Overall Study|Site Closed|9|||
23379747|NCT00915525|65134258|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
23379748|NCT00915525|65134259|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
23379749|NCT00915525|65134258|FG000|Overall Study|Study Burden|28|||
23379750|NCT00915525|65134259|FG001|Overall Study|Study Burden|12|||
23379751|NCT00915525|65134258|FG000|Overall Study|Non-Compliance|3|||
23379752|NCT00915525|65134259|FG001|Overall Study|Non-Compliance|1|||
23379753|NCT00915525|65134258|FG000|Overall Study|Patient Moved|15|||
23379754|NCT00915525|65134259|FG001|Overall Study|Patient Moved|9|||
23379755|NCT03720847|65134260|FG000|Washout|Physician Decision|1|||
23379756|NCT03720847|65134261|FG001|Washout|Physician Decision|2|||
23379757|NCT01432951|65134262|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
23379758|NCT00844519|65134266|FG000|Overall Study|Withdrawal by Subject|1|||
23379759|NCT00844519|65134267|FG001|Overall Study|Withdrawal by Subject|1|||
23379760|NCT00844519|65134266|FG000|Overall Study|Adverse Event|1|||
23379761|NCT00844519|65134267|FG001|Overall Study|Adverse Event|0|||
23379762|NCT02916927|65134268|FG000|Overall Study|Discharged prior to study drug receipt|0|||
23379763|NCT02916927|65134269|FG001|Overall Study|Discharged prior to study drug receipt|2|||
23379764|NCT02916927|65134268|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
23379765|NCT02916927|65134269|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
23379766|NCT02916927|65134268|FG000|Overall Study|Withdrawal before first time point|1|||
23379767|NCT02916927|65134269|FG001|Overall Study|Withdrawal before first time point|0|||
23379768|NCT01625182|65134272|FG000|Overall Study|Administrative problems|1|||
23379769|NCT01625182|65134273|FG001|Overall Study|Administrative problems|0|||
23379770|NCT01625182|65134272|FG000|Overall Study|Protocol deviation|0|||
23379771|NCT01625182|65134273|FG001|Overall Study|Protocol deviation|2|||
23379772|NCT01625182|65134272|FG000|Overall Study|Adverse Event|2|||
23379773|NCT01625182|65134273|FG001|Overall Study|Adverse Event|0|||
23379774|NCT01625182|65134272|FG000|Overall Study|Withdrawal by Subject|5|||
23379775|NCT01625182|65134273|FG001|Overall Study|Withdrawal by Subject|1|||
23379776|NCT01625182|65134272|FG000|Overall Study|Lack of Efficacy|12|||
23379777|NCT01625182|65134273|FG001|Overall Study|Lack of Efficacy|8|||
23379778|NCT00764517|65134274|FG000|Overall Study|Adverse Event|9|||
23379779|NCT00764517|65134275|FG001|Overall Study|Adverse Event|3|||
23379780|NCT00764517|65134274|FG000|Overall Study|Death|3|||
23379781|NCT00764517|65134275|FG001|Overall Study|Death|11|||
23379782|NCT00764517|65134274|FG000|Overall Study|Physician Decision|3|||
23286738|NCT00105157|64795574|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
23286739|NCT00105157|64795575|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
23286740|NCT00105157|64795576|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
23286741|NCT00105157|64795573|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
23286742|NCT00105157|64795574|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
23286743|NCT00105157|64795575|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
23286744|NCT00105157|64795576|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
23286745|NCT00105157|64795573|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
23286746|NCT00105157|64795574|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
23286747|NCT00105157|64795575|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
23286748|NCT00105157|64795576|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
23286749|NCT00105157|64795573|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
23286750|NCT00105157|64795574|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
23286751|NCT00105157|64795575|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
23286752|NCT00105157|64795576|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
23286753|NCT00105157|64795573|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
23286754|NCT00105157|64795574|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
23286755|NCT00105157|64795575|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
23286756|NCT00105157|64795576|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
23286757|NCT00613730|64795581|FG000|Overall Study|Disease progression|2|||
23286758|NCT00613730|64795581|FG000|Overall Study|Administrative decision|1|||
23286759|NCT02119936|64795582|FG000|Overall Study|Lost to Follow-up|10|||
23286760|NCT01091363|64795583|FG000|Overall Study|Withdrawal by Subject|11|||
23286761|NCT01091363|64795584|FG001|Overall Study|Withdrawal by Subject|15|||
23286762|NCT01091363|64795583|FG000|Overall Study|Lost to Follow-up|2|||
23286763|NCT01091363|64795584|FG001|Overall Study|Lost to Follow-up|2|||
23286764|NCT03234608|64795591|FG000|Overall Study|Lost to Follow-up|23|||
23286765|NCT03234608|64795592|FG001|Overall Study|Lost to Follow-up|21|||
23286766|NCT02218541|64795595|FG000|Overall Study|Lost to Follow-up|2|||
23286767|NCT02218541|64795596|FG001|Overall Study|Lost to Follow-up|1|||
23286768|NCT02218541|64795595|FG000|Overall Study|Implant Failure|4|||
23286769|NCT02218541|64795596|FG001|Overall Study|Implant Failure|1|||
23286770|NCT03234907|64795597|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
23286771|NCT03234907|64795598|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
23286772|NCT03234907|64795599|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
23286773|NCT03234907|64795600|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
23286774|NCT03234907|64795601|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
23286775|NCT03234907|64795602|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
23286776|NCT03234907|64795597|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
23286777|NCT03234907|64795598|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
23286778|NCT03234907|64795599|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
23286779|NCT03234907|64795600|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
23286780|NCT03234907|64795601|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
23286781|NCT03234907|64795602|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
23286782|NCT03234907|64795597|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
23286783|NCT03234907|64795598|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23286784|NCT03234907|64795599|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23286785|NCT03234907|64795600|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23286786|NCT03234907|64795601|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23286787|NCT03234907|64795602|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
23379783|NCT00764517|65134275|FG001|Overall Study|Physician Decision|0|||
23379784|NCT04115059|65134276|FG000|Overall Study|Withdrawal by Subject|1|||
23379785|NCT04115059|65134276|FG000|Overall Study|Lack of Efficacy|2|||
23379786|NCT01910441|65134281|FG000|Overall Study|Sponsor decision|0|||
23379787|NCT01910441|65134282|FG001|Overall Study|Sponsor decision|2|||
23286788|NCT03234907|64795597|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
23286789|NCT03234907|64795598|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
23286790|NCT03234907|64795599|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
23286791|NCT03234907|64795600|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
23286792|NCT03234907|64795601|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
23286793|NCT03234907|64795602|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
23286794|NCT03234907|64795597|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
23379788|NCT01910441|65134281|FG000|Overall Study|Lost to Follow-up|6|||
23605683|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23286795|NCT03234907|64795598|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
23286796|NCT03234907|64795599|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
23286797|NCT03234907|64795600|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
23286798|NCT03234907|64795601|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
23286799|NCT03234907|64795602|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
23286800|NCT03234907|64795597|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
23605684|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
23605685|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605686|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
23605687|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605688|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605689|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605690|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605691|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
23605692|NCT03136861|65947018|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
23605693|NCT03136861|65947019|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
23605694|NCT03136861|65947020|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605695|NCT03136861|65947021|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605696|NCT03136861|65947022|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605697|NCT03136861|65947023|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605698|NCT03136861|65947024|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
23605699|NCT03136861|65947018|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
23605700|NCT03136861|65947019|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
23605701|NCT03136861|65947020|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
23605702|NCT03136861|65947021|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
23605703|NCT03136861|65947022|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
23605704|NCT03136861|65947023|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
23605705|NCT03136861|65947024|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
23605706|NCT03136861|65947018|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605707|NCT03136861|65947019|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605708|NCT03136861|65947020|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
23605709|NCT03136861|65947021|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605710|NCT03136861|65947022|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605711|NCT03136861|65947023|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605712|NCT03136861|65947024|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
23605713|NCT03136861|65947018|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605714|NCT03136861|65947019|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605715|NCT03136861|65947020|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
23605716|NCT03136861|65947021|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605717|NCT03136861|65947022|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605718|NCT03136861|65947023|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605719|NCT03136861|65947024|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
23605720|NCT03146845|65947025|FG000|Overall Study|Reference ulcer healed|1|||
23605721|NCT03146845|65947026|FG001|Overall Study|Reference ulcer healed|0|||
23605722|NCT03146845|65947025|FG000|Overall Study|Physician Decision|1|||
23605723|NCT03146845|65947026|FG001|Overall Study|Physician Decision|0|||
23605724|NCT03146845|65947025|FG000|Overall Study|Adverse Event|1|||
23605725|NCT03146845|65947026|FG001|Overall Study|Adverse Event|0|||
23605726|NCT03146845|65947025|FG000|Overall Study|Withdrawal by Subject|2|||
23605727|NCT03146845|65947026|FG001|Overall Study|Withdrawal by Subject|0|||
23605728|NCT03146845|65947025|FG000|Overall Study|Noncompliance|0|||
23605729|NCT03146845|65947026|FG001|Overall Study|Noncompliance|1|||
23605730|NCT03146845|65947025|FG000|Overall Study|Protocol Violation|0|||
23605731|NCT03146845|65947026|FG001|Overall Study|Protocol Violation|2|||
23605732|NCT03146845|65947025|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
23605733|NCT03146845|65947026|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
23605734|NCT00599196|65947029|FG000|Overall Study|Lack of Efficacy|22|||
23605735|NCT00599196|65947029|FG000|Overall Study|Adverse Event|93|||
23605736|NCT00599196|65947029|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
23605737|NCT00599196|65947029|FG000|Overall Study|Subject withdrew consent|43|||
23605738|NCT00599196|65947029|FG000|Overall Study|Study ended per sponsor|197|||
23286801|NCT03234907|64795598|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
23286802|NCT03234907|64795599|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
23286803|NCT03234907|64795600|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
23286804|NCT03234907|64795601|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
23286805|NCT03234907|64795602|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
23286806|NCT03234907|64795597|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
23286807|NCT03234907|64795598|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
23286808|NCT03234907|64795599|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
23286809|NCT03234907|64795600|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
23286810|NCT03234907|64795601|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
23286811|NCT03234907|64795602|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
23286812|NCT03255980|64795603|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
23286813|NCT03255980|64795604|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
23286814|NCT03255980|64795605|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
23286815|NCT03255980|64795606|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
23286816|NCT03255980|64795603|FG000|Overall Study|Adverse Event|1|||
23286817|NCT03255980|64795604|FG001|Overall Study|Adverse Event|1|||
23286818|NCT03255980|64795605|FG002|Overall Study|Adverse Event|0|||
23286819|NCT03255980|64795606|FG003|Overall Study|Adverse Event|1|||
23286820|NCT03255980|64795603|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
23286821|NCT03255980|64795604|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
23286822|NCT03255980|64795605|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
23286823|NCT03255980|64795606|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
23286824|NCT03255980|64795603|FG000|Overall Study|Lost to Follow-up|1|||
23286825|NCT03255980|64795604|FG001|Overall Study|Lost to Follow-up|1|||
23286826|NCT03255980|64795605|FG002|Overall Study|Lost to Follow-up|0|||
23286827|NCT03255980|64795606|FG003|Overall Study|Lost to Follow-up|3|||
23286828|NCT03255980|64795603|FG000|Overall Study|Withdrawal by Subject|0|||
23286829|NCT03255980|64795604|FG001|Overall Study|Withdrawal by Subject|1|||
23286830|NCT03255980|64795605|FG002|Overall Study|Withdrawal by Subject|0|||
23286831|NCT03255980|64795606|FG003|Overall Study|Withdrawal by Subject|3|||
23286832|NCT00413049|64795608|FG000|Overall Study|Adverse Event|10|||
23286833|NCT00413049|64795609|FG001|Overall Study|Adverse Event|8|||
23286834|NCT00413049|64795608|FG000|Overall Study|Withdrawal by Subject|7|||
23286835|NCT00413049|64795609|FG001|Overall Study|Withdrawal by Subject|5|||
23286836|NCT00413049|64795608|FG000|Overall Study|Lost to Follow-up|2|||
23286837|NCT00413049|64795609|FG001|Overall Study|Lost to Follow-up|3|||
23286838|NCT00413049|64795608|FG000|Overall Study|Protocol Violation|3|||
23286839|NCT00413049|64795609|FG001|Overall Study|Protocol Violation|1|||
23286840|NCT00413049|64795608|FG000|Overall Study|Subject no longer requires study drug|0|||
23286841|NCT00413049|64795609|FG001|Overall Study|Subject no longer requires study drug|1|||
23286842|NCT00413049|64795608|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23286843|NCT00413049|64795609|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23286844|NCT00413049|64795608|FG000|Overall Study|Lack of Efficacy|1|||
23286845|NCT00413049|64795609|FG001|Overall Study|Lack of Efficacy|0|||
23286846|NCT00566722|64795612|FG000|Overall Study|Adverse Event|0|||
23286847|NCT00566722|64795613|FG001|Overall Study|Adverse Event|1|||
23286848|NCT00566722|64795614|FG002|Overall Study|Adverse Event|0|||
23286849|NCT00566722|64795612|FG000|Overall Study|Withdrawal by Subject|0|||
23286850|NCT00566722|64795613|FG001|Overall Study|Withdrawal by Subject|0|||
23286851|NCT00566722|64795614|FG002|Overall Study|Withdrawal by Subject|1|||
23286852|NCT00566722|64795612|FG000|Overall Study|Lost to Follow-up|1|||
23286853|NCT00566722|64795613|FG001|Overall Study|Lost to Follow-up|1|||
23286854|NCT00566722|64795614|FG002|Overall Study|Lost to Follow-up|1|||
23286855|NCT00566722|64795612|FG000|Overall Study|Lack of Efficacy|1|||
23286856|NCT00566722|64795613|FG001|Overall Study|Lack of Efficacy|2|||
23286857|NCT00566722|64795614|FG002|Overall Study|Lack of Efficacy|4|||
23286858|NCT00566722|64795612|FG000|Overall Study|Did not meet exclusion criteria|0|||
23286859|NCT00566722|64795613|FG001|Overall Study|Did not meet exclusion criteria|0|||
23286860|NCT00566722|64795614|FG002|Overall Study|Did not meet exclusion criteria|2|||
23286861|NCT00566722|64795612|FG000|Overall Study|Serious adverse event|0|||
23286862|NCT00566722|64795613|FG001|Overall Study|Serious adverse event|1|||
23379789|NCT01910441|65134282|FG001|Overall Study|Lost to Follow-up|5|||
23379790|NCT01910441|65134281|FG000|Overall Study|Withdrawal by Subject|0|||
23379791|NCT01910441|65134282|FG001|Overall Study|Withdrawal by Subject|1|||
23379792|NCT01910441|65134281|FG000|Overall Study|Non-compliance|0|||
23379793|NCT01910441|65134282|FG001|Overall Study|Non-compliance|1|||
23286863|NCT00566722|64795614|FG002|Overall Study|Serious adverse event|0|||
23286864|NCT00566722|64795612|FG000|Overall Study|Noncompliant with drug administration|0|||
23286865|NCT00566722|64795613|FG001|Overall Study|Noncompliant with drug administration|0|||
23286866|NCT00566722|64795614|FG002|Overall Study|Noncompliant with drug administration|1|||
23286867|NCT01572662|64795615|FG000|Overall Study|Withdrawal by Subject|1|||
23286868|NCT01572662|64795616|FG001|Overall Study|Withdrawal by Subject|0|||
23286869|NCT01572662|64795615|FG000|Overall Study|Physician Decision|0|||
23286870|NCT01572662|64795616|FG001|Overall Study|Physician Decision|1|||
23286871|NCT00198133|64795620|FG000|Overall Study|Disease progression|2|||
23379794|NCT01910441|65134281|FG000|Overall Study|Adverse Event|1|||
23286872|NCT00198133|64795621|FG001|Overall Study|Disease progression|5|||
23286873|NCT00198133|64795620|FG000|Overall Study|Adverse Event|1|||
23286874|NCT00198133|64795621|FG001|Overall Study|Adverse Event|3|||
23286875|NCT00198133|64795620|FG000|Overall Study|Withdrawal by Subject|1|||
23286876|NCT00198133|64795621|FG001|Overall Study|Withdrawal by Subject|0|||
23286877|NCT00198133|64795620|FG000|Overall Study|Physician Decision|1|||
23286878|NCT00198133|64795621|FG001|Overall Study|Physician Decision|0|||
23286879|NCT02664415|64795622|FG000|Overall Study|Adverse Event|1|||
23379795|NCT01910441|65134282|FG001|Overall Study|Adverse Event|0|||
23379796|NCT01910441|65134281|FG000|Overall Study|Physician Decision|0|||
23286880|NCT02664415|64795623|FG001|Overall Study|Adverse Event|0|||
23286881|NCT01507662|64795626|FG000|Overall Study|Death|26|||
23286882|NCT01507662|64795627|FG001|Overall Study|Death|18|||
23286883|NCT01507662|64795626|FG000|Overall Study|Withdrawal by Subject|290|||
23286884|NCT01507662|64795627|FG001|Overall Study|Withdrawal by Subject|287|||
23286885|NCT01507662|64795626|FG000|Overall Study|Lost to Follow-up|498|||
23286886|NCT01507662|64795627|FG001|Overall Study|Lost to Follow-up|523|||
23286887|NCT01507662|64795626|FG000|Overall Study|Proxy interview done|2|||
23286888|NCT01507662|64795627|FG001|Overall Study|Proxy interview done|3|||
23286889|NCT03277248|64795629|FG000|Overall Study|Adverse Event|3|||
23286890|NCT03277248|64795630|FG001|Overall Study|Adverse Event|1|||
23286891|NCT03277248|64795629|FG000|Overall Study|Subject Withdrawal of Consent|6|||
23286892|NCT03277248|64795630|FG001|Overall Study|Subject Withdrawal of Consent|23|||
23286893|NCT03277248|64795629|FG000|Overall Study|Investigator/Sponsor Decision|2|||
23286894|NCT03277248|64795630|FG001|Overall Study|Investigator/Sponsor Decision|2|||
23286895|NCT03277248|64795629|FG000|Overall Study|Pregnancy|4|||
23286896|NCT03277248|64795630|FG001|Overall Study|Pregnancy|1|||
23286897|NCT03277248|64795629|FG000|Overall Study|Lost to Follow-up|0|||
23286898|NCT03277248|64795630|FG001|Overall Study|Lost to Follow-up|2|||
23286899|NCT03277248|64795629|FG000|Overall Study|Lack of Efficacy|0|||
23286900|NCT03277248|64795630|FG001|Overall Study|Lack of Efficacy|2|||
23286901|NCT03277248|64795629|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
23286902|NCT03277248|64795630|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
23286903|NCT04404725|64795631|FG000|First Intervention|Withdrawal by Subject|0|||
23286904|NCT04404725|64795632|FG001|First Intervention|Withdrawal by Subject|2|||
23286905|NCT04404725|64795631|FG000|Second Intervention|Adverse Event|1|||
23286906|NCT04404725|64795632|FG001|Second Intervention|Adverse Event|1|||
23286907|NCT04404725|64795631|FG000|Second Intervention|Withdrawal by Subject|0|||
23286908|NCT04404725|64795632|FG001|Second Intervention|Withdrawal by Subject|1|||
23286909|NCT04164758|64795633|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
23286910|NCT04164758|64795634|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
23286911|NCT04164758|64795635|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
23286912|NCT04164758|64795633|FG000|Overall Study|Adverse Event|0|||
23286913|NCT04164758|64795634|FG001|Overall Study|Adverse Event|1|||
23286914|NCT04164758|64795635|FG002|Overall Study|Adverse Event|0|||
23286915|NCT02663349|64795636|FG000|Overall Study|Withdrawal by Subject|6|||
23286916|NCT00127166|64795637|FG000|Period I|Protocol Violation|0|||
23286917|NCT00127166|64795638|FG001|Period I|Protocol Violation|2|||
23286918|NCT00127166|64795637|FG000|Period I|Withdrawal by Subject|2|||
23286919|NCT00127166|64795638|FG001|Period I|Withdrawal by Subject|0|||
23286920|NCT00127166|64795637|FG000|Period I|Patient did not meet inclusion criteria|1|||
23286921|NCT00127166|64795638|FG001|Period I|Patient did not meet inclusion criteria|0|||
23379797|NCT01910441|65134282|FG001|Overall Study|Physician Decision|1|||
23491156|NCT03437512|65544891|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
23491157|NCT03437512|65544892|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
23605739|NCT00599196|65947029|FG000|Overall Study|Lost to Follow-up|17|||
23605740|NCT00599196|65947029|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
23605741|NCT00599196|65947029|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
23605742|NCT00599196|65947029|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
23605743|NCT00599196|65947029|FG000|Overall Study|Other: Pt Moved To Australia|1|||
23605744|NCT00599196|65947029|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
23605745|NCT00599196|65947029|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
23605746|NCT03131713|65947030|FG000|Overall Study|Lost to Follow-up|5|||
23605747|NCT03131713|65947031|FG001|Overall Study|Lost to Follow-up|0|||
23605748|NCT01536704|65947032|FG000|Washout Period 1|Withdrawal by Subject|1|||
23605749|NCT01536704|65947033|FG001|Washout Period 1|Withdrawal by Subject|2|||
23286922|NCT00127166|64795637|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
23286923|NCT00127166|64795638|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
23286924|NCT00127166|64795637|FG000|Period II|Withdrawal by Subject|2|||
23286925|NCT00127166|64795638|FG001|Period II|Withdrawal by Subject|0|||
23286926|NCT00127166|64795637|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
23286927|NCT00127166|64795638|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
23286928|NCT01670097|64795639|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
23286929|NCT01670097|64795640|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
23286930|NCT01670097|64795639|FG000|Overall Study|Study burden|1|||
23491158|NCT05246397|65544896|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
23491159|NCT04087213|65544897|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
23491160|NCT04087213|65544897|FG000|In-Facility Introduction|Adverse Event|1|||
23491161|NCT04087213|65544897|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
23491162|NCT04087213|65544897|FG000|Assisted Evaluable Period|Personal reasons|3|||
23491163|NCT04087213|65544897|FG000|Transition Period B|Renal Transplantation|1|||
23491164|NCT00494299|65544898|FG000|Overall Study|Adverse Event|93|||
23491165|NCT00494299|65544899|FG001|Overall Study|Adverse Event|13|||
23491166|NCT00494299|65544898|FG000|Overall Study|Lost to Follow-up|1|||
23491167|NCT00494299|65544899|FG001|Overall Study|Lost to Follow-up|0|||
23491168|NCT00494299|65544898|FG000|Overall Study|Physician Decision|0|||
23491169|NCT00494299|65544899|FG001|Overall Study|Physician Decision|2|||
23491170|NCT00494299|65544898|FG000|Overall Study|Protocol Violation|1|||
23491171|NCT00494299|65544899|FG001|Overall Study|Protocol Violation|2|||
23491172|NCT00494299|65544898|FG000|Overall Study|Withdrawal by Subject|8|||
23491173|NCT00494299|65544899|FG001|Overall Study|Withdrawal by Subject|3|||
23491174|NCT00494299|65544898|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
23491175|NCT00494299|65544899|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
23491176|NCT00494299|65544898|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
23491177|NCT00494299|65544899|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
23491178|NCT00494299|65544898|FG000|Overall Study|Site Closed by Sponsor|6|||
23491179|NCT00494299|65544899|FG001|Overall Study|Site Closed by Sponsor|0|||
23491180|NCT00494299|65544898|FG000|Overall Study|Protocol Driven Decision Point|11|||
23491181|NCT00494299|65544899|FG001|Overall Study|Protocol Driven Decision Point|22|||
23491182|NCT02761733|65544900|FG000|Overall Study|Death|3|||
23491183|NCT02761733|65544901|FG001|Overall Study|Death|5|||
23491184|NCT02761733|65544902|FG002|Overall Study|Death|1|||
23491185|NCT02761733|65544903|FG003|Overall Study|Death|1|||
23491186|NCT02761733|65544900|FG000|Overall Study|Lost to Follow-up|6|||
23491187|NCT02761733|65544901|FG001|Overall Study|Lost to Follow-up|7|||
23491188|NCT02761733|65544902|FG002|Overall Study|Lost to Follow-up|0|||
23491189|NCT02761733|65544903|FG003|Overall Study|Lost to Follow-up|3|||
23491190|NCT02761733|65544900|FG000|Overall Study|Physician Decision|4|||
23491191|NCT02761733|65544901|FG001|Overall Study|Physician Decision|0|||
23491192|NCT02761733|65544902|FG002|Overall Study|Physician Decision|0|||
23491193|NCT02761733|65544903|FG003|Overall Study|Physician Decision|0|||
23491194|NCT02761733|65544900|FG000|Overall Study|Withdrawal by Subject|2|||
23491195|NCT02761733|65544901|FG001|Overall Study|Withdrawal by Subject|0|||
23491196|NCT02761733|65544902|FG002|Overall Study|Withdrawal by Subject|0|||
23491197|NCT02761733|65544903|FG003|Overall Study|Withdrawal by Subject|0|||
23491198|NCT02761733|65544900|FG000|Overall Study|Discharged from Study Site|10|||
23491199|NCT02761733|65544901|FG001|Overall Study|Discharged from Study Site|9|||
23491200|NCT02761733|65544902|FG002|Overall Study|Discharged from Study Site|25|||
23491201|NCT02761733|65544903|FG003|Overall Study|Discharged from Study Site|11|||
23491202|NCT02761733|65544900|FG000|Overall Study|Cognitive Impairment|5|||
23491203|NCT02761733|65544901|FG001|Overall Study|Cognitive Impairment|0|||
23491204|NCT02761733|65544902|FG002|Overall Study|Cognitive Impairment|1|||
23491205|NCT02761733|65544903|FG003|Overall Study|Cognitive Impairment|0|||
23491206|NCT04806503|65544904|FG000|Overall Study|Lost to Follow-up|0|||
23491207|NCT04806503|65544905|FG001|Overall Study|Lost to Follow-up|0|||
23491208|NCT04806503|65544906|FG002|Overall Study|Lost to Follow-up|1|||
23491209|NCT04806503|65544907|FG003|Overall Study|Lost to Follow-up|0|||
23491210|NCT04806503|65544908|FG004|Overall Study|Lost to Follow-up|0|||
23491211|NCT04806503|65544904|FG000|Overall Study|Withdrawal by Subject|1|||
23491212|NCT04806503|65544905|FG001|Overall Study|Withdrawal by Subject|0|||
23491213|NCT04806503|65544906|FG002|Overall Study|Withdrawal by Subject|1|||
23491214|NCT04806503|65544907|FG003|Overall Study|Withdrawal by Subject|1|||
23491215|NCT04806503|65544908|FG004|Overall Study|Withdrawal by Subject|1|||
23491216|NCT04806503|65544904|FG000|Overall Study|Adverse Event|1|||
23491217|NCT04806503|65544905|FG001|Overall Study|Adverse Event|1|||
23491218|NCT04806503|65544906|FG002|Overall Study|Adverse Event|0|||
23491219|NCT04806503|65544907|FG003|Overall Study|Adverse Event|1|||
23491220|NCT04806503|65544908|FG004|Overall Study|Adverse Event|0|||
23491221|NCT02589405|65544909|FG000|Overall Study|Adverse Event|3|||
23605750|NCT01536704|65947034|FG002|Washout Period 1|Withdrawal by Subject|0|||
23491222|NCT02589405|65544909|FG000|Overall Study|Withdrawal by Subject|1|||
23491223|NCT03061097|65544911|FG000|Overall Study|Withdrawal by Subject|0|||
23491224|NCT03061097|65544912|FG001|Overall Study|Withdrawal by Subject|3|||
23491225|NCT04810481|65544913|FG000|Overall Study|Disqualified data sets|10|||
23491226|NCT04810481|65544914|FG001|Overall Study|Disqualified data sets|28|||
23605751|NCT01536704|65947035|FG003|Washout Period 1|Withdrawal by Subject|0|||
23491227|NCT00973674|65544921|FG000|Overall Study|Protocol Violation|2|||
23491228|NCT00973674|65544922|FG001|Overall Study|Protocol Violation|0|||
23491229|NCT01436396|65544923|FG000|Overall Study|Protocol Violation|7|||
23491230|NCT01436396|65544924|FG001|Overall Study|Protocol Violation|5|||
23491231|NCT01436396|65544923|FG000|Overall Study|Adverse Event|1|||
23491232|NCT01436396|65544924|FG001|Overall Study|Adverse Event|2|||
23286931|NCT01670097|64795640|FG001|Overall Study|Study burden|0|||
23286932|NCT01670097|64795639|FG000|Overall Study|COPD exacerbation|0|||
23286933|NCT01670097|64795640|FG001|Overall Study|COPD exacerbation|1|||
23286934|NCT01670097|64795639|FG000|Overall Study|Neutropenia|0|||
23379798|NCT00462462|65134288|FG000|Overall Study|Physician Decision|0|||
23379799|NCT00462462|65134289|FG001|Overall Study|Physician Decision|1|||
23379800|NCT04167670|65134290|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
23379801|NCT04167670|65134291|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
23379802|NCT04167670|65134292|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
23379803|NCT04167670|65134290|FG000|Overall Study|Significant protocol deviation|3|||
23379804|NCT04167670|65134291|FG001|Overall Study|Significant protocol deviation|1|||
23379805|NCT04167670|65134292|FG002|Overall Study|Significant protocol deviation|0|||
23379806|NCT04167670|65134290|FG000|Overall Study|Lost to Follow-up|0|||
23379807|NCT04167670|65134291|FG001|Overall Study|Lost to Follow-up|3|||
23379808|NCT04167670|65134292|FG002|Overall Study|Lost to Follow-up|3|||
23379809|NCT04167670|65134290|FG000|Overall Study|Voluntary Withdrawal|0|||
23379810|NCT04167670|65134291|FG001|Overall Study|Voluntary Withdrawal|1|||
23379811|NCT04167670|65134292|FG002|Overall Study|Voluntary Withdrawal|1|||
23379812|NCT04167670|65134290|FG000|Overall Study|Withdrawal of Consent|4|||
23379813|NCT04167670|65134291|FG001|Overall Study|Withdrawal of Consent|1|||
23379814|NCT04167670|65134292|FG002|Overall Study|Withdrawal of Consent|3|||
23379815|NCT04167670|65134290|FG000|Overall Study|Miscellaneous|7|||
23379816|NCT04167670|65134291|FG001|Overall Study|Miscellaneous|5|||
23379817|NCT04167670|65134292|FG002|Overall Study|Miscellaneous|3|||
23379818|NCT03301714|65137135|FG000|Overall Study|Lost to Follow-up|10|||
23379819|NCT03301714|65137136|FG001|Overall Study|Lost to Follow-up|4|||
23379820|NCT03301714|65137137|FG002|Overall Study|Lost to Follow-up|4|||
23379821|NCT03301714|65137135|FG000|Overall Study|Did not receive allocated intervention|0|||
23491233|NCT01436396|65544923|FG000|Overall Study|Withdrawal by Subject|19|||
23491234|NCT01436396|65544924|FG001|Overall Study|Withdrawal by Subject|29|||
23491235|NCT01436396|65544923|FG000|Overall Study|Serious adverse event|2|||
23491236|NCT01436396|65544924|FG001|Overall Study|Serious adverse event|3|||
23491237|NCT01436396|65544923|FG000|Overall Study|Lost to Follow-up|3|||
23491238|NCT01436396|65544924|FG001|Overall Study|Lost to Follow-up|3|||
23491239|NCT03643159|65544929|FG000|Overall Study|Adverse Event|1|||
23491240|NCT03643159|65544929|FG000|Overall Study|Withdrawal by Subject|1|||
23491241|NCT01863953|65544930|FG000|Overall Study|Adverse Event|0|||
23491242|NCT01863953|65544931|FG001|Overall Study|Adverse Event|0|||
23491243|NCT01863953|65544932|FG002|Overall Study|Adverse Event|1|||
23491244|NCT00299182|65544937|FG000|Overall Study|Withdrawal by Subject|0|||
23491245|NCT00299182|65544938|FG001|Overall Study|Withdrawal by Subject|0|||
23491246|NCT00299182|65544939|FG002|Overall Study|Withdrawal by Subject|1|||
23491247|NCT00299182|65544940|FG003|Overall Study|Withdrawal by Subject|0|||
23491248|NCT00299182|65544941|FG004|Overall Study|Withdrawal by Subject|1|||
23491249|NCT00299182|65544942|FG005|Overall Study|Withdrawal by Subject|2|||
23491250|NCT00299182|65544943|FG006|Overall Study|Withdrawal by Subject|0|||
23491251|NCT00299182|65544937|FG000|Overall Study|Chemotherapy Changed|0|||
23491252|NCT00299182|65544938|FG001|Overall Study|Chemotherapy Changed|0|||
23491253|NCT00299182|65544939|FG002|Overall Study|Chemotherapy Changed|1|||
23491254|NCT00299182|65544940|FG003|Overall Study|Chemotherapy Changed|0|||
23491255|NCT00299182|65544941|FG004|Overall Study|Chemotherapy Changed|1|||
23491256|NCT00299182|65544942|FG005|Overall Study|Chemotherapy Changed|0|||
23491257|NCT00299182|65544943|FG006|Overall Study|Chemotherapy Changed|1|||
23491258|NCT00299182|65544937|FG000|Overall Study|Adverse Event|0|||
23491259|NCT00299182|65544938|FG001|Overall Study|Adverse Event|0|||
23286935|NCT01670097|64795640|FG001|Overall Study|Neutropenia|1|||
23286936|NCT01670097|64795639|FG000|Overall Study|Clinical deterioration|0|||
23286937|NCT01670097|64795640|FG001|Overall Study|Clinical deterioration|1|||
23286938|NCT01670097|64795639|FG000|Overall Study|Disease progression|0|||
23286939|NCT01670097|64795640|FG001|Overall Study|Disease progression|1|||
23286940|NCT02834390|64795641|FG000|Induction Phase|Progressive disease|0|||
23286941|NCT02834390|64795642|FG001|Induction Phase|Progressive disease|1|||
23286942|NCT02834390|64795641|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
23286943|NCT02834390|64795642|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
23286944|NCT02834390|64795641|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
23286945|NCT02834390|64795642|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
23286946|NCT02834390|64795641|FG000|Consolidation Phase|Physician Decision|1|||
23286947|NCT02834390|64795642|FG001|Consolidation Phase|Physician Decision|1|||
23286948|NCT02614196|64795646|FG000|Double Blind Treatment Phase|Adverse Event|8|||
23286949|NCT02614196|64795647|FG001|Double Blind Treatment Phase|Adverse Event|5|||
23286950|NCT02614196|64795648|FG002|Double Blind Treatment Phase|Adverse Event|9|||
23286951|NCT02614196|64795649|FG003|Double Blind Treatment Phase|Adverse Event|0|||
23286952|NCT02614196|64795650|FG004|Double Blind Treatment Phase|Adverse Event|0|||
23286953|NCT02614196|64795651|FG005|Double Blind Treatment Phase|Adverse Event|0|||
23286954|NCT02614196|64795646|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
23286955|NCT02614196|64795647|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
23286956|NCT02614196|64795648|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
23286957|NCT02614196|64795649|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
23286958|NCT02614196|64795650|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
23286959|NCT02614196|64795651|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
23286960|NCT02614196|64795646|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
23286961|NCT02614196|64795647|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
23286962|NCT02614196|64795648|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
23286963|NCT02614196|64795649|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
23286964|NCT02614196|64795650|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
23286965|NCT02614196|64795651|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
23286966|NCT02614196|64795646|FG000|Double Blind Treatment Phase|Physician Decision|4|||
23286967|NCT02614196|64795647|FG001|Double Blind Treatment Phase|Physician Decision|0|||
23286968|NCT02614196|64795648|FG002|Double Blind Treatment Phase|Physician Decision|2|||
23286969|NCT02614196|64795649|FG003|Double Blind Treatment Phase|Physician Decision|0|||
23286970|NCT02614196|64795650|FG004|Double Blind Treatment Phase|Physician Decision|0|||
23286971|NCT02614196|64795651|FG005|Double Blind Treatment Phase|Physician Decision|0|||
23286972|NCT02614196|64795646|FG000|Double Blind Treatment Phase|Pregnancy|1|||
23379822|NCT03301714|65137136|FG001|Overall Study|Did not receive allocated intervention|2|||
23379823|NCT03301714|65137137|FG002|Overall Study|Did not receive allocated intervention|3|||
23379824|NCT01363076|65137138|FG000|Overall Study|Withdrawal by Subject|0|||
23379825|NCT01363076|65137139|FG001|Overall Study|Withdrawal by Subject|1|||
23379826|NCT01348698|65137140|FG000|Overall Study|Does not meet lesion size criteria|1|||
23379827|NCT01348698|65137140|FG000|Overall Study|Death|3|||
23379828|NCT01348698|65137140|FG000|Overall Study|PI decision to close study|68|||
23379829|NCT00765076|65137143|FG000|Overall Study|Adverse Event|1|||
23379830|NCT00765076|65137144|FG001|Overall Study|Adverse Event|0|||
23379831|NCT00765076|65137145|FG002|Overall Study|Adverse Event|0|||
23379832|NCT00765076|65137143|FG000|Overall Study|Withdrawal by Subject|0|||
23379833|NCT00765076|65137144|FG001|Overall Study|Withdrawal by Subject|0|||
23379834|NCT00765076|65137145|FG002|Overall Study|Withdrawal by Subject|1|||
23379835|NCT03595748|65137149|FG000|Overall Study|Death|11|||
23379836|NCT03595748|65137150|FG001|Overall Study|Death|12|||
23286973|NCT02614196|64795647|FG001|Double Blind Treatment Phase|Pregnancy|2|||
23286974|NCT02614196|64795648|FG002|Double Blind Treatment Phase|Pregnancy|0|||
23286975|NCT02614196|64795649|FG003|Double Blind Treatment Phase|Pregnancy|0|||
23286976|NCT02614196|64795650|FG004|Double Blind Treatment Phase|Pregnancy|0|||
23286977|NCT02614196|64795651|FG005|Double Blind Treatment Phase|Pregnancy|0|||
23286978|NCT02614196|64795646|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
23286979|NCT02614196|64795647|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
23286980|NCT02614196|64795648|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
23286981|NCT02614196|64795649|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
23286982|NCT02614196|64795650|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
23286983|NCT02614196|64795651|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
23286984|NCT02614196|64795646|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
23286985|NCT02614196|64795647|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
23286986|NCT02614196|64795648|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
23379837|NCT03595748|65137149|FG000|Overall Study|Withdrawal by Subject|28|||
23379838|NCT03595748|65137150|FG001|Overall Study|Withdrawal by Subject|29|||
23379839|NCT03595748|65137149|FG000|Overall Study|Protocol Violation|0|||
23379840|NCT03595748|65137150|FG001|Overall Study|Protocol Violation|1|||
23379841|NCT01145222|65137151|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
23379842|NCT01145222|65137152|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
23379843|NCT01145222|65137153|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
23379844|NCT01145222|65137154|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
23379845|NCT01145222|65137151|FG000|Overall Study|Poor bowel preparation|0|||
23379846|NCT01145222|65137152|FG001|Overall Study|Poor bowel preparation|0|||
23605752|NCT01536704|65947032|FG000|Washout Period 2|Adverse Event|1|||
23286987|NCT02614196|64795649|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
23286988|NCT02614196|64795650|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
23286989|NCT02614196|64795651|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
23286990|NCT02614196|64795646|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
23286991|NCT02614196|64795647|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
23286992|NCT02614196|64795648|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
23286993|NCT02614196|64795649|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
23286994|NCT02614196|64795650|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
23286995|NCT02614196|64795651|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
23286996|NCT02614196|64795646|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
23286997|NCT02614196|64795647|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
23286998|NCT02614196|64795648|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
23286999|NCT02614196|64795649|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
23287000|NCT02614196|64795650|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
23287001|NCT02614196|64795651|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
23287002|NCT02614196|64795646|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
23287003|NCT02614196|64795647|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
23287004|NCT02614196|64795648|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
23287005|NCT02614196|64795649|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
23287006|NCT02614196|64795650|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
23287007|NCT02614196|64795651|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
23287008|NCT02614196|64795646|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
23287009|NCT02614196|64795647|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
23287010|NCT02614196|64795648|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
23287011|NCT02614196|64795649|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
23287012|NCT02614196|64795650|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
23287013|NCT02614196|64795651|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
23287014|NCT02614196|64795646|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
23287015|NCT02614196|64795647|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
23287016|NCT02614196|64795648|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
23287017|NCT02614196|64795649|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
23287018|NCT02614196|64795650|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
23379847|NCT01145222|65137153|FG002|Overall Study|Poor bowel preparation|0|||
23379848|NCT01145222|65137154|FG003|Overall Study|Poor bowel preparation|1|||
23605753|NCT01536704|65947033|FG001|Washout Period 2|Adverse Event|0|||
23287019|NCT02614196|64795651|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
23605754|NCT01536704|65947034|FG002|Washout Period 2|Adverse Event|0|||
23605755|NCT01536704|65947035|FG003|Washout Period 2|Adverse Event|0|||
23605756|NCT01536704|65947032|FG000|Washout Period 2|Withdrawal by Subject|0|||
23605757|NCT01536704|65947033|FG001|Washout Period 2|Withdrawal by Subject|0|||
23605758|NCT01536704|65947034|FG002|Washout Period 2|Withdrawal by Subject|0|||
23605759|NCT01536704|65947035|FG003|Washout Period 2|Withdrawal by Subject|1|||
23605760|NCT01536704|65947032|FG000|Period 3|Adverse Event|0|||
23605761|NCT01536704|65947033|FG001|Period 3|Adverse Event|0|||
23605762|NCT01536704|65947034|FG002|Period 3|Adverse Event|0|||
23379849|NCT00294398|65137155|FG000|Overall Study|Lost to Follow-up|21|||
23379850|NCT00294398|65137156|FG001|Overall Study|Lost to Follow-up|26|||
23379851|NCT00441896|65137160|FG000|Overall Study|Withdrawal by Subject|0|||
23379852|NCT00441896|65137161|FG001|Overall Study|Withdrawal by Subject|0|||
23379853|NCT00441896|65137162|FG002|Overall Study|Withdrawal by Subject|0|||
23379854|NCT00441896|65137163|FG003|Overall Study|Withdrawal by Subject|1|||
23379855|NCT00441896|65137164|FG004|Overall Study|Withdrawal by Subject|0|||
23379856|NCT00441896|65137165|FG005|Overall Study|Withdrawal by Subject|0|||
23379857|NCT00441896|65137166|FG006|Overall Study|Withdrawal by Subject|0|||
23379858|NCT00441896|65137167|FG007|Overall Study|Withdrawal by Subject|0|||
23379859|NCT00441896|65137168|FG008|Overall Study|Withdrawal by Subject|0|||
23379860|NCT00441896|65137169|FG009|Overall Study|Withdrawal by Subject|0|||
23287020|NCT02614196|64795646|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
23287021|NCT02614196|64795647|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
23287022|NCT02614196|64795648|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
23287023|NCT02614196|64795649|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
23287024|NCT02614196|64795650|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
23287025|NCT02614196|64795651|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
23287026|NCT00210639|64795652|FG000|Overall Study|Lost to Follow-up|37|||
23287027|NCT00210639|64795653|FG001|Overall Study|Lost to Follow-up|29|||
23287028|NCT00210639|64795652|FG000|Overall Study|Withdrawal by Subject|8|||
23287029|NCT00210639|64795653|FG001|Overall Study|Withdrawal by Subject|1|||
23287030|NCT00210639|64795652|FG000|Overall Study|Other|18|||
23287031|NCT00210639|64795653|FG001|Overall Study|Other|12|||
23287032|NCT00928057|64795657|FG000|Overall Study|Adverse Event|1|||
23287033|NCT00928057|64795658|FG001|Overall Study|Adverse Event|2|||
23287034|NCT00928057|64795657|FG000|Overall Study|Withdrawal by Subject|1|||
23287035|NCT00928057|64795658|FG001|Overall Study|Withdrawal by Subject|0|||
23287036|NCT00928057|64795657|FG000|Overall Study|Lost to Follow-up|0|||
23379861|NCT00441896|65137160|FG000|Overall Study|Other|0|||
23379862|NCT00441896|65137161|FG001|Overall Study|Other|0|||
23605763|NCT01536704|65947035|FG003|Period 3|Adverse Event|1|||
23605764|NCT01536704|65947032|FG000|Washout Period 3|Adverse Event|0|||
23605765|NCT01536704|65947033|FG001|Washout Period 3|Adverse Event|0|||
23605766|NCT01536704|65947034|FG002|Washout Period 3|Adverse Event|1|||
23605767|NCT01536704|65947035|FG003|Washout Period 3|Adverse Event|0|||
23605768|NCT02542696|65947036|FG000|Overall Study|Adverse Event|167|||
23605769|NCT02542696|65947036|FG000|Overall Study|Lack of Efficacy|26|||
23605770|NCT02542696|65947036|FG000|Overall Study|Lost to Follow-up|6|||
23605771|NCT02542696|65947036|FG000|Overall Study|Withdrawal by Subject|104|||
23605772|NCT02542696|65947036|FG000|Overall Study|Protocol Violation|5|||
23605773|NCT02542696|65947036|FG000|Overall Study|Death|8|||
23605774|NCT02542696|65947036|FG000|Overall Study|DECREASED OFF TIME|1|||
23605775|NCT02542696|65947036|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
23605776|NCT02542696|65947036|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
23605777|NCT02542696|65947036|FG000|Overall Study|MEDICAL HISTORY|1|||
23605778|NCT02542696|65947036|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
23605779|NCT02542696|65947036|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
23605780|NCT02542696|65947036|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
23605781|NCT02542696|65947036|FG000|Overall Study|SPONSOR DECISION|3|||
23605782|NCT02542696|65947036|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
23605783|NCT02542696|65947036|FG000|Overall Study|SUBJECT DECISION|2|||
23605784|NCT03652610|65947039|FG000|Overall Study|Lost to Follow-up|1|||
23379863|NCT00441896|65137162|FG002|Overall Study|Other|0|||
23379864|NCT00441896|65137163|FG003|Overall Study|Other|0|||
23605785|NCT03652610|65947040|FG001|Overall Study|Lost to Follow-up|0|||
23605786|NCT03652610|65947039|FG000|Overall Study|Withdrawal by Subject|3|||
23605787|NCT03652610|65947040|FG001|Overall Study|Withdrawal by Subject|5|||
23605788|NCT02077374|65947041|FG000|Overall Study|Withdrawal by Subject|0|||
23605789|NCT02077374|65947042|FG001|Overall Study|Withdrawal by Subject|1|||
23287037|NCT00928057|64795658|FG001|Overall Study|Lost to Follow-up|1|||
23287038|NCT00928057|64795657|FG000|Overall Study|Protocol Violation|0|||
23287039|NCT00928057|64795658|FG001|Overall Study|Protocol Violation|1|||
23287040|NCT03488108|64795659|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
23287041|NCT03488108|64795660|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
23287042|NCT03488108|64795659|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
23287043|NCT03488108|64795660|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
23287044|NCT05889039|64795661|FG000|Overall Study|error in completing survey|0|||
23287045|NCT05889039|64795662|FG001|Overall Study|error in completing survey|2|||
23287046|NCT05889039|64795663|FG002|Overall Study|error in completing survey|0|||
23287047|NCT05889039|64795664|FG003|Overall Study|error in completing survey|0|||
23287048|NCT05889039|64795661|FG000|Overall Study|Lost to Follow-up|4|||
23287049|NCT05889039|64795662|FG001|Overall Study|Lost to Follow-up|0|||
23287050|NCT05889039|64795663|FG002|Overall Study|Lost to Follow-up|0|||
23287051|NCT05889039|64795664|FG003|Overall Study|Lost to Follow-up|0|||
23287052|NCT01881737|64795665|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
23287053|NCT01881737|64795665|FG000|Overall Study|Withdrawal by Subject|1|||
23287054|NCT01881737|64795665|FG000|Overall Study|Worsening of baseline behavior|1|||
23287055|NCT01835548|64795667|FG000|Dose Optimization Period|Adverse Event|0|||
23287056|NCT01835548|64795668|FG001|Dose Optimization Period|Adverse Event|0|||
23287057|NCT01835548|64795669|FG002|Dose Optimization Period|Adverse Event|1|||
23287058|NCT01835548|64795667|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
23287059|NCT01835548|64795668|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
23287060|NCT01835548|64795669|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
23287061|NCT01835548|64795667|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23287062|NCT01835548|64795668|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23287063|NCT01835548|64795669|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23287064|NCT01835548|64795667|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23287065|NCT01835548|64795668|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
23287066|NCT01835548|64795669|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
23287067|NCT04610580|64795670|FG000|Two-way Crossover Period|Adverse Event|1|||
23287068|NCT04610580|64795671|FG001|Two-way Crossover Period|Adverse Event|0|||
23287069|NCT04610580|64795672|FG002|Two-way Crossover Period|Adverse Event|0|||
23287070|NCT04610580|64795673|FG003|Two-way Crossover Period|Adverse Event|0|||
23287071|NCT04610580|64795674|FG004|Two-way Crossover Period|Adverse Event|0|||
23287072|NCT04610580|64795675|FG005|Two-way Crossover Period|Adverse Event|0|||
23287073|NCT04610580|64795670|FG000|Two-way Crossover Period|Physician Decision|1|||
23287074|NCT04610580|64795671|FG001|Two-way Crossover Period|Physician Decision|0|||
23287075|NCT04610580|64795672|FG002|Two-way Crossover Period|Physician Decision|0|||
23287076|NCT04610580|64795673|FG003|Two-way Crossover Period|Physician Decision|0|||
23287077|NCT04610580|64795674|FG004|Two-way Crossover Period|Physician Decision|0|||
23287078|NCT04610580|64795675|FG005|Two-way Crossover Period|Physician Decision|0|||
23287079|NCT04610580|64795670|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
23287080|NCT04610580|64795671|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
23287081|NCT04610580|64795672|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
23287082|NCT04610580|64795673|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
23287083|NCT04610580|64795674|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
23287084|NCT04610580|64795675|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
23287085|NCT04610580|64795670|FG000|Two-way Crossover Period|Other than specified|0|||
23287086|NCT04610580|64795671|FG001|Two-way Crossover Period|Other than specified|1|||
23287087|NCT04610580|64795672|FG002|Two-way Crossover Period|Other than specified|0|||
23287088|NCT04610580|64795673|FG003|Two-way Crossover Period|Other than specified|0|||
23287089|NCT04610580|64795674|FG004|Two-way Crossover Period|Other than specified|0|||
23287090|NCT04610580|64795675|FG005|Two-way Crossover Period|Other than specified|0|||
23287091|NCT04610580|64795670|FG000|Washout Before Extension Period|Other than specified|0|||
23287092|NCT04610580|64795671|FG001|Washout Before Extension Period|Other than specified|1|||
23287093|NCT04610580|64795672|FG002|Washout Before Extension Period|Other than specified|0|||
23287094|NCT04610580|64795673|FG003|Washout Before Extension Period|Other than specified|0|||
23287095|NCT04610580|64795674|FG004|Washout Before Extension Period|Other than specified|0|||
23287096|NCT04610580|64795675|FG005|Washout Before Extension Period|Other than specified|0|||
23287097|NCT04610580|64795670|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
23379865|NCT00441896|65137164|FG004|Overall Study|Other|1|||
23379866|NCT00441896|65137165|FG005|Overall Study|Other|0|||
23379867|NCT00441896|65137166|FG006|Overall Study|Other|0|||
23379868|NCT00441896|65137167|FG007|Overall Study|Other|0|||
23379869|NCT00441896|65137168|FG008|Overall Study|Other|0|||
23379870|NCT00441896|65137169|FG009|Overall Study|Other|0|||
23379871|NCT02178956|65137170|FG000|Overall Study|Lost to Follow-up|4|||
23379872|NCT02178956|65137171|FG001|Overall Study|Lost to Follow-up|4|||
23605790|NCT02077374|65947041|FG000|Overall Study|Protocol Violation|0|||
23605791|NCT02077374|65947042|FG001|Overall Study|Protocol Violation|1|||
23605792|NCT03075878|65947043|FG000|Overall Study|Physician Decision|1|||
23605793|NCT04658784|65947046|FG000|6-month Follow-up|Lost to Follow-up|2|||
23605794|NCT04658784|65947047|FG001|6-month Follow-up|Lost to Follow-up|5|||
23605795|NCT01951703|65947057|FG000|First Intervention|Withdrawal by Subject|1|||
23605796|NCT01951703|65947058|FG001|First Intervention|Withdrawal by Subject|0|||
23605797|NCT01951703|65947057|FG000|First Intervention|Subject was not compliant|1|||
23605798|NCT01951703|65947058|FG001|First Intervention|Subject was not compliant|1|||
23605799|NCT01951703|65947057|FG000|First Intervention|Physician Decision|1|||
23287098|NCT04610580|64795671|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
23287099|NCT04610580|64795672|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
23287100|NCT04610580|64795673|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
23287101|NCT04610580|64795674|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
23287102|NCT04610580|64795675|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
23287103|NCT04610580|64795670|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23287104|NCT04610580|64795671|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23287105|NCT04610580|64795672|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23287106|NCT04610580|64795673|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23287107|NCT04610580|64795674|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
23287108|NCT04610580|64795675|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
23287109|NCT01532908|64795683|FG000|Overall Study|Not Transplanted|1|||
23287110|NCT01532908|64795684|FG001|Overall Study|Not Transplanted|0|||
23287111|NCT01229150|64795685|FG000|Overall Study|Toxicity|2|||
23287112|NCT01229150|64795686|FG001|Overall Study|Toxicity|2|||
23287113|NCT01229150|64795687|FG002|Overall Study|Toxicity|0|||
23287114|NCT01229150|64795688|FG003|Overall Study|Toxicity|0|||
23287115|NCT00434590|64795689|FG000|Overall Study|Administrative problems|5|||
23287116|NCT00434590|64795690|FG001|Overall Study|Administrative problems|5|||
23287117|NCT00508651|64795691|FG000|Overall Study|Lost to Follow-up|3|||
23287118|NCT00508651|64795692|FG001|Overall Study|Lost to Follow-up|1|||
23287119|NCT00508651|64795691|FG000|Overall Study|Withdrawal by Subject|1|||
23287120|NCT00508651|64795692|FG001|Overall Study|Withdrawal by Subject|1|||
23287121|NCT04230876|64795695|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
23287122|NCT04230876|64795696|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
23287123|NCT01525628|64795700|FG000|Overall Study|Adverse Event|1|||
23379873|NCT02178956|65137170|FG000|Overall Study|Sponsor terminated study|49|||
23379874|NCT02178956|65137171|FG001|Overall Study|Sponsor terminated study|58|||
23287124|NCT01525628|64795701|FG001|Overall Study|Adverse Event|1|||
23287125|NCT01525628|64795702|FG002|Overall Study|Adverse Event|2|||
23379875|NCT02178956|65137170|FG000|Overall Study|Withdrawal by Subject|15|||
23379876|NCT02178956|65137171|FG001|Overall Study|Withdrawal by Subject|11|||
23379877|NCT02178956|65137170|FG000|Overall Study|Various Reasons|3|||
23379878|NCT02178956|65137171|FG001|Overall Study|Various Reasons|5|||
23379879|NCT03188185|65137172|FG000|Stage 1|Adverse Event|4|||
23379880|NCT03188185|65137173|FG001|Stage 1|Adverse Event|12|||
23379881|NCT03188185|65137174|FG002|Stage 1|Adverse Event|0|||
23379882|NCT03188185|65137175|FG003|Stage 1|Adverse Event|0|||
23379883|NCT03188185|65137172|FG000|Stage 1|Lack of Efficacy|0|||
23379884|NCT03188185|65137173|FG001|Stage 1|Lack of Efficacy|2|||
23379885|NCT03188185|65137174|FG002|Stage 1|Lack of Efficacy|0|||
23379886|NCT03188185|65137175|FG003|Stage 1|Lack of Efficacy|0|||
23379887|NCT03188185|65137172|FG000|Stage 1|Lost to Follow-up|6|||
23379888|NCT03188185|65137173|FG001|Stage 1|Lost to Follow-up|1|||
23379889|NCT03188185|65137174|FG002|Stage 1|Lost to Follow-up|0|||
23379890|NCT03188185|65137175|FG003|Stage 1|Lost to Follow-up|0|||
23379891|NCT03188185|65137172|FG000|Stage 1|Withdrawal by Subject|9|||
23379892|NCT03188185|65137173|FG001|Stage 1|Withdrawal by Subject|0|||
23379893|NCT03188185|65137174|FG002|Stage 1|Withdrawal by Subject|0|||
23379894|NCT03188185|65137175|FG003|Stage 1|Withdrawal by Subject|0|||
23379895|NCT03188185|65137172|FG000|Stage 1|Identified as a professional patient|0|||
23379896|NCT03188185|65137173|FG001|Stage 1|Identified as a professional patient|1|||
23379897|NCT03188185|65137174|FG002|Stage 1|Identified as a professional patient|0|||
23379898|NCT03188185|65137175|FG003|Stage 1|Identified as a professional patient|0|||
23379899|NCT03188185|65137172|FG000|Stage 2|Adverse Event|0|||
23379900|NCT03188185|65137173|FG001|Stage 2|Adverse Event|0|||
23379901|NCT03188185|65137174|FG002|Stage 2|Adverse Event|2|||
23379902|NCT03188185|65137175|FG003|Stage 2|Adverse Event|4|||
23379903|NCT03188185|65137172|FG000|Stage 2|Lack of Efficacy|0|||
23379904|NCT03188185|65137173|FG001|Stage 2|Lack of Efficacy|0|||
23379905|NCT03188185|65137174|FG002|Stage 2|Lack of Efficacy|3|||
23379906|NCT03188185|65137175|FG003|Stage 2|Lack of Efficacy|0|||
23379907|NCT03188185|65137172|FG000|Stage 2|Lost to Follow-up|0|||
23379908|NCT03188185|65137173|FG001|Stage 2|Lost to Follow-up|0|||
23379909|NCT03188185|65137174|FG002|Stage 2|Lost to Follow-up|1|||
23379910|NCT03188185|65137175|FG003|Stage 2|Lost to Follow-up|0|||
23379911|NCT03188185|65137172|FG000|Stage 2|Physician Decision|0|||
23379912|NCT03188185|65137173|FG001|Stage 2|Physician Decision|0|||
23379913|NCT03188185|65137174|FG002|Stage 2|Physician Decision|0|||
23379914|NCT03188185|65137175|FG003|Stage 2|Physician Decision|1|||
23379915|NCT03188185|65137172|FG000|Stage 2|Withdrawal by Subject|0|||
23379916|NCT03188185|65137173|FG001|Stage 2|Withdrawal by Subject|0|||
23379917|NCT03188185|65137174|FG002|Stage 2|Withdrawal by Subject|3|||
23379918|NCT03188185|65137175|FG003|Stage 2|Withdrawal by Subject|1|||
23379919|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379920|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
23379921|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
23379922|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379923|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379924|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379925|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
23379926|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
23379927|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379928|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
23379929|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379930|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379931|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379932|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
23379933|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379934|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379935|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
23379936|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379937|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379938|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379939|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
23379940|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
23379941|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379942|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379943|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379944|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379945|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379946|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
23379947|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379948|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379949|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
23379950|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379951|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379952|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23379953|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
23287126|NCT01525628|64795703|FG003|Overall Study|Adverse Event|0|||
23287127|NCT01525628|64795704|FG004|Overall Study|Adverse Event|1|||
23287128|NCT01525628|64795700|FG000|Overall Study|Lack of Efficacy|0|||
23287129|NCT01525628|64795701|FG001|Overall Study|Lack of Efficacy|2|||
23287130|NCT01525628|64795702|FG002|Overall Study|Lack of Efficacy|2|||
23287131|NCT01525628|64795703|FG003|Overall Study|Lack of Efficacy|1|||
23287132|NCT01525628|64795704|FG004|Overall Study|Lack of Efficacy|2|||
23287133|NCT01525628|64795700|FG000|Overall Study|Protocol Violation|0|||
23287134|NCT01525628|64795701|FG001|Overall Study|Protocol Violation|0|||
23287135|NCT01525628|64795702|FG002|Overall Study|Protocol Violation|1|||
23287136|NCT01525628|64795703|FG003|Overall Study|Protocol Violation|0|||
23287137|NCT01525628|64795704|FG004|Overall Study|Protocol Violation|0|||
23287138|NCT01525628|64795700|FG000|Overall Study|Lost to Follow-up|1|||
23287139|NCT01525628|64795701|FG001|Overall Study|Lost to Follow-up|1|||
23287140|NCT01525628|64795702|FG002|Overall Study|Lost to Follow-up|0|||
23287141|NCT01525628|64795703|FG003|Overall Study|Lost to Follow-up|0|||
23287142|NCT01525628|64795704|FG004|Overall Study|Lost to Follow-up|0|||
23287143|NCT01525628|64795700|FG000|Overall Study|Withdrawal by Subject|0|||
23287144|NCT01525628|64795701|FG001|Overall Study|Withdrawal by Subject|1|||
23287145|NCT01525628|64795702|FG002|Overall Study|Withdrawal by Subject|0|||
23287146|NCT01525628|64795703|FG003|Overall Study|Withdrawal by Subject|0|||
23287147|NCT01525628|64795704|FG004|Overall Study|Withdrawal by Subject|0|||
23287148|NCT01525628|64795700|FG000|Overall Study|Other reason not defined above|0|||
23287149|NCT01525628|64795701|FG001|Overall Study|Other reason not defined above|0|||
23287150|NCT01525628|64795702|FG002|Overall Study|Other reason not defined above|0|||
23287151|NCT01525628|64795703|FG003|Overall Study|Other reason not defined above|3|||
23287152|NCT01525628|64795704|FG004|Overall Study|Other reason not defined above|0|||
23379954|NCT01807520|65137176|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
23287153|NCT01567527|64795705|FG000|Conversion Phase.|Protocol deviation|3|||
23287154|NCT01567527|64795706|FG001|Conversion Phase.|Protocol deviation|0|||
23287155|NCT01567527|64795707|FG002|Conversion Phase.|Protocol deviation|0|||
23287156|NCT01567527|64795708|FG003|Conversion Phase.|Protocol deviation|0|||
23379955|NCT01807520|65137177|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379956|NCT01807520|65137178|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379957|NCT01807520|65137179|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379958|NCT01807520|65137180|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379959|NCT01807520|65137181|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379960|NCT01807520|65137182|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
23379961|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
23379962|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
23287157|NCT01567527|64795709|FG004|Conversion Phase.|Protocol deviation|0|||
23287158|NCT01567527|64795705|FG000|Conversion Phase.|Met withdrawal criteria|10|||
23287159|NCT01567527|64795706|FG001|Conversion Phase.|Met withdrawal criteria|0|||
23287160|NCT01567527|64795707|FG002|Conversion Phase.|Met withdrawal criteria|0|||
23287161|NCT01567527|64795708|FG003|Conversion Phase.|Met withdrawal criteria|0|||
23287162|NCT01567527|64795709|FG004|Conversion Phase.|Met withdrawal criteria|0|||
23287163|NCT01567527|64795705|FG000|Conversion Phase.|Withdrawal by Subject|32|||
23379963|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
23379964|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
23379965|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
23379966|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
23379967|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
23379968|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379969|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379970|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379971|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
23379972|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379973|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379974|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
23379975|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
23379976|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23287164|NCT01567527|64795706|FG001|Conversion Phase.|Withdrawal by Subject|0|||
23379977|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23379978|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23491260|NCT00299182|65544939|FG002|Overall Study|Adverse Event|0|||
23491261|NCT00299182|65544940|FG003|Overall Study|Adverse Event|0|||
23491262|NCT00299182|65544941|FG004|Overall Study|Adverse Event|0|||
23491263|NCT00299182|65544942|FG005|Overall Study|Adverse Event|1|||
23491264|NCT00299182|65544943|FG006|Overall Study|Adverse Event|0|||
23491265|NCT00299182|65544937|FG000|Overall Study|Not Eligible|0|||
23491266|NCT00299182|65544938|FG001|Overall Study|Not Eligible|0|||
23491267|NCT00299182|65544939|FG002|Overall Study|Not Eligible|0|||
23491268|NCT00299182|65544940|FG003|Overall Study|Not Eligible|0|||
23491269|NCT00299182|65544941|FG004|Overall Study|Not Eligible|1|||
23491270|NCT00299182|65544942|FG005|Overall Study|Not Eligible|0|||
23491271|NCT00299182|65544943|FG006|Overall Study|Not Eligible|0|||
23491272|NCT01297920|65544944|FG000|Overall Study|Adverse Event|42|||
23491273|NCT01297920|65544945|FG001|Overall Study|Adverse Event|10|||
23491274|NCT01297920|65544946|FG002|Overall Study|Adverse Event|38|||
23491275|NCT01297920|65544944|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
23491276|NCT01297920|65544945|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
23491277|NCT01297920|65544946|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
23491278|NCT01297920|65544944|FG000|Overall Study|Noncompliance|1|||
23491279|NCT01297920|65544945|FG001|Overall Study|Noncompliance|0|||
23491280|NCT01297920|65544946|FG002|Overall Study|Noncompliance|0|||
23491281|NCT01297920|65544944|FG000|Overall Study|Protocol Violation|1|||
23491282|NCT01297920|65544945|FG001|Overall Study|Protocol Violation|3|||
23491283|NCT01297920|65544946|FG002|Overall Study|Protocol Violation|0|||
23491284|NCT01297920|65544944|FG000|Overall Study|Inadequate Control of IOP|7|||
23491285|NCT01297920|65544945|FG001|Overall Study|Inadequate Control of IOP|9|||
23491286|NCT01297920|65544946|FG002|Overall Study|Inadequate Control of IOP|17|||
23491287|NCT01297920|65544944|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
23491288|NCT01297920|65544945|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
23491289|NCT01297920|65544946|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
23491290|NCT01642407|65544947|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
23491291|NCT01642407|65544947|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
23491292|NCT01642407|65544947|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
23491293|NCT02764697|65544952|FG000|Overall Study|Lack of Efficacy|3|||
23491294|NCT00057954|65544953|FG000|Overall Study|Death|1|||
23491295|NCT00057954|65544953|FG000|Overall Study|Disease progression|1|||
23491296|NCT00736957|65544957|FG000|Overall Study|Adverse Event|43|||
23491297|NCT00736957|65544957|FG000|Overall Study|Withdrawal by Subject|49|||
23491298|NCT00736957|65544957|FG000|Overall Study|violation of eligibility criteria|2|||
23491299|NCT00736957|65544957|FG000|Overall Study|did not attend hospital appointments|1|||
23491300|NCT00736957|65544957|FG000|Overall Study|not eligible for Treatment Period I|22|||
23491301|NCT00736957|65544957|FG000|Overall Study|Physician Decision|5|||
23491302|NCT05055128|65544958|FG000|Overall Study|Adverse Event|0|||
23491303|NCT05055128|65544959|FG001|Overall Study|Adverse Event|0|||
23491304|NCT05055128|65544960|FG002|Overall Study|Adverse Event|0|||
23491305|NCT05055128|65544961|FG003|Overall Study|Adverse Event|1|||
23491306|NCT05055128|65544962|FG004|Overall Study|Adverse Event|1|||
23491307|NCT05055128|65544958|FG000|Overall Study|Protocol Violation|0|||
23491308|NCT05055128|65544959|FG001|Overall Study|Protocol Violation|0|||
23287165|NCT01567527|64795707|FG002|Conversion Phase.|Withdrawal by Subject|0|||
23287166|NCT01567527|64795708|FG003|Conversion Phase.|Withdrawal by Subject|0|||
23287167|NCT01567527|64795709|FG004|Conversion Phase.|Withdrawal by Subject|0|||
23287168|NCT01567527|64795705|FG000|Conversion Phase.|Lost to Follow-up|16|||
23287169|NCT01567527|64795706|FG001|Conversion Phase.|Lost to Follow-up|0|||
23287170|NCT01567527|64795707|FG002|Conversion Phase.|Lost to Follow-up|0|||
23287171|NCT01567527|64795708|FG003|Conversion Phase.|Lost to Follow-up|0|||
23287172|NCT01567527|64795709|FG004|Conversion Phase.|Lost to Follow-up|0|||
23287173|NCT01567527|64795705|FG000|Conversion Phase.|Lack of Efficacy|2|||
23287174|NCT01567527|64795706|FG001|Conversion Phase.|Lack of Efficacy|0|||
23287175|NCT01567527|64795707|FG002|Conversion Phase.|Lack of Efficacy|0|||
23379979|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23379980|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23379981|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
23491309|NCT05055128|65544960|FG002|Overall Study|Protocol Violation|0|||
23491310|NCT05055128|65544961|FG003|Overall Study|Protocol Violation|1|||
23491311|NCT05055128|65544962|FG004|Overall Study|Protocol Violation|0|||
23491312|NCT05055128|65544958|FG000|Overall Study|Withdrawal by Subject|5|||
23491313|NCT05055128|65544959|FG001|Overall Study|Withdrawal by Subject|2|||
23287176|NCT01567527|64795708|FG003|Conversion Phase.|Lack of Efficacy|0|||
23491314|NCT05055128|65544960|FG002|Overall Study|Withdrawal by Subject|2|||
23491315|NCT05055128|65544961|FG003|Overall Study|Withdrawal by Subject|4|||
23491316|NCT05055128|65544962|FG004|Overall Study|Withdrawal by Subject|2|||
23491317|NCT05055128|65544958|FG000|Overall Study|Randomized By Mistake|0|||
23491318|NCT05055128|65544959|FG001|Overall Study|Randomized By Mistake|1|||
23491319|NCT05055128|65544960|FG002|Overall Study|Randomized By Mistake|0|||
23491320|NCT05055128|65544961|FG003|Overall Study|Randomized By Mistake|0|||
23491321|NCT05055128|65544962|FG004|Overall Study|Randomized By Mistake|0|||
23491322|NCT05055128|65544958|FG000|Overall Study|Other|1|||
23491323|NCT05055128|65544959|FG001|Overall Study|Other|0|||
23491324|NCT05055128|65544960|FG002|Overall Study|Other|0|||
23491325|NCT05055128|65544961|FG003|Overall Study|Other|0|||
23491326|NCT05055128|65544962|FG004|Overall Study|Other|0|||
23491327|NCT02572388|65544963|FG000|Overall Study|Withdrawal by Subject|1|||
23491328|NCT02572388|65544964|FG001|Overall Study|Withdrawal by Subject|1|||
23491329|NCT02572388|65544965|FG002|Overall Study|Withdrawal by Subject|2|||
23491330|NCT02572388|65544966|FG003|Overall Study|Withdrawal by Subject|2|||
23491331|NCT03570697|65544987|FG000|Overall Study|Lost to Follow-up|0|||
23491332|NCT03570697|65544988|FG001|Overall Study|Lost to Follow-up|1|||
23491333|NCT03570697|65544987|FG000|Overall Study|Death|2|||
23491334|NCT03570697|65544988|FG001|Overall Study|Death|0|||
23491335|NCT03570697|65544987|FG000|Overall Study|Withdrawal by Subject|4|||
23491336|NCT03570697|65544988|FG001|Overall Study|Withdrawal by Subject|2|||
23491337|NCT01013350|65544989|FG000|Overall Study|Lost to Follow-up|15|||
23491338|NCT01013350|65544990|FG001|Overall Study|Lost to Follow-up|95|||
23491339|NCT01013350|65544989|FG000|Overall Study|Adverse Event|0|||
23491340|NCT01013350|65544990|FG001|Overall Study|Adverse Event|1|||
23491341|NCT01013350|65544989|FG000|Overall Study|Physician Decision|4|||
23491342|NCT01013350|65544990|FG001|Overall Study|Physician Decision|20|||
23491343|NCT01013350|65544989|FG000|Overall Study|Withdrawal by Subject|15|||
23491344|NCT01013350|65544990|FG001|Overall Study|Withdrawal by Subject|38|||
23491345|NCT01013350|65544989|FG000|Overall Study|Death|3|||
23491346|NCT01013350|65544990|FG001|Overall Study|Death|5|||
23491347|NCT01013350|65544989|FG000|Overall Study|Participant entered interventional study|0|||
23491348|NCT01013350|65544990|FG001|Overall Study|Participant entered interventional study|8|||
23491349|NCT01013350|65544989|FG000|Overall Study|Other|1|||
23491350|NCT01013350|65544990|FG001|Overall Study|Other|25|||
23491351|NCT01497275|65544993|FG000|Overall Study|Death|1|||
23491352|NCT01497275|65544993|FG000|Overall Study|Adverse Event|1|||
23491353|NCT01254630|65544994|FG000|Overall Study|Adverse Event|36|||
23491354|NCT01254630|65544995|FG001|Overall Study|Adverse Event|15|||
23491355|NCT01254630|65544996|FG002|Overall Study|Adverse Event|40|||
23491356|NCT01254630|65544997|FG003|Overall Study|Adverse Event|8|||
23491357|NCT01254630|65544994|FG000|Overall Study|Death|461|||
23491358|NCT01254630|65544995|FG001|Overall Study|Death|151|||
23491359|NCT01254630|65544996|FG002|Overall Study|Death|478|||
23491360|NCT01254630|65544997|FG003|Overall Study|Death|139|||
23491361|NCT01254630|65544994|FG000|Overall Study|Lost to Follow-up|80|||
23491362|NCT01254630|65544995|FG001|Overall Study|Lost to Follow-up|26|||
23491363|NCT01254630|65544996|FG002|Overall Study|Lost to Follow-up|89|||
23491364|NCT01254630|65544997|FG003|Overall Study|Lost to Follow-up|32|||
23491365|NCT01254630|65544994|FG000|Overall Study|Physician Decision|24|||
23491366|NCT01254630|65544995|FG001|Overall Study|Physician Decision|8|||
23491367|NCT01254630|65544996|FG002|Overall Study|Physician Decision|16|||
23491368|NCT01254630|65544997|FG003|Overall Study|Physician Decision|7|||
23491369|NCT01254630|65544994|FG000|Overall Study|Withdrawal by Subject|201|||
23491370|NCT01254630|65544995|FG001|Overall Study|Withdrawal by Subject|94|||
23491371|NCT01254630|65544996|FG002|Overall Study|Withdrawal by Subject|188|||
23491372|NCT01254630|65544997|FG003|Overall Study|Withdrawal by Subject|89|||
23491373|NCT01254630|65544994|FG000|Overall Study|Study terminated by sponsor|0|||
23491374|NCT01254630|65544995|FG001|Overall Study|Study terminated by sponsor|994|||
23491375|NCT01254630|65544996|FG002|Overall Study|Study terminated by sponsor|0|||
23491376|NCT01254630|65544997|FG003|Overall Study|Study terminated by sponsor|1010|||
23491377|NCT01254630|65544994|FG000|Overall Study|Status not recorded|0|||
23491378|NCT01254630|65544995|FG001|Overall Study|Status not recorded|0|||
23491379|NCT01254630|65544996|FG002|Overall Study|Status not recorded|1|||
23491380|NCT01254630|65544997|FG003|Overall Study|Status not recorded|0|||
23491381|NCT00122109|65544998|FG000|Overall Study|Did not meet criteria|6|||
23491382|NCT00122109|65544999|FG001|Overall Study|Did not meet criteria|7|||
23491383|NCT02001181|65545002|FG000|Overall Study|Adverse Event|0|||
23491384|NCT02001181|65545003|FG001|Overall Study|Adverse Event|2|||
23491385|NCT02001181|65545002|FG000|Overall Study|Lost to Follow-up|1|||
23491386|NCT02001181|65545003|FG001|Overall Study|Lost to Follow-up|0|||
23491387|NCT02001181|65545002|FG000|Overall Study|Withdrawal by Subject|0|||
23491388|NCT02001181|65545003|FG001|Overall Study|Withdrawal by Subject|1|||
23491389|NCT02186873|65545004|FG000|Overall Study|Adverse Event|1|||
23491390|NCT02186873|65545005|FG001|Overall Study|Adverse Event|3|||
23491391|NCT02186873|65545004|FG000|Overall Study|Lack of Efficacy|0|||
23491392|NCT02186873|65545005|FG001|Overall Study|Lack of Efficacy|1|||
23491393|NCT02186873|65545004|FG000|Overall Study|Lost to Follow-up|1|||
23491394|NCT02186873|65545005|FG001|Overall Study|Lost to Follow-up|2|||
23491395|NCT02186873|65545004|FG000|Overall Study|Withdrawal by Subject|7|||
23491396|NCT02186873|65545005|FG001|Overall Study|Withdrawal by Subject|2|||
23491397|NCT00333840|65545006|FG000|First-line Treatment Period|Adverse Event|38|||
23491398|NCT00333840|65545007|FG001|First-line Treatment Period|Adverse Event|37|||
23491399|NCT00333840|65545008|FG002|First-line Treatment Period|Adverse Event|0|||
23491400|NCT00333840|65545009|FG003|First-line Treatment Period|Adverse Event|0|||
23491401|NCT00333840|65545006|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
23491402|NCT00333840|65545007|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
23491403|NCT00333840|65545008|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
23491404|NCT00333840|65545009|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
23491405|NCT00333840|65545006|FG000|First-line Treatment Period|Abnormal procedure|2|||
23491406|NCT00333840|65545007|FG001|First-line Treatment Period|Abnormal procedure|0|||
23491407|NCT00333840|65545008|FG002|First-line Treatment Period|Abnormal procedure|0|||
23491408|NCT00333840|65545009|FG003|First-line Treatment Period|Abnormal procedure|0|||
23491409|NCT00333840|65545006|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
23491410|NCT00333840|65545007|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
23491411|NCT00333840|65545008|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
23491412|NCT00333840|65545009|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
23491413|NCT00333840|65545006|FG000|First-line Treatment Period|No longer required study drug|21|||
23491414|NCT00333840|65545007|FG001|First-line Treatment Period|No longer required study drug|8|||
23491415|NCT00333840|65545008|FG002|First-line Treatment Period|No longer required study drug|0|||
23491416|NCT00333840|65545009|FG003|First-line Treatment Period|No longer required study drug|0|||
23491417|NCT00333840|65545006|FG000|First-line Treatment Period|Protocol Violation|17|||
23491418|NCT00333840|65545007|FG001|First-line Treatment Period|Protocol Violation|17|||
23491419|NCT00333840|65545008|FG002|First-line Treatment Period|Protocol Violation|0|||
23491420|NCT00333840|65545009|FG003|First-line Treatment Period|Protocol Violation|0|||
23491421|NCT00333840|65545006|FG000|First-line Treatment Period|Subject withdrew consent|57|||
23491422|NCT00333840|65545007|FG001|First-line Treatment Period|Subject withdrew consent|77|||
23491423|NCT00333840|65545008|FG002|First-line Treatment Period|Subject withdrew consent|0|||
23491424|NCT00333840|65545009|FG003|First-line Treatment Period|Subject withdrew consent|0|||
23491425|NCT00333840|65545006|FG000|First-line Treatment Period|Lost to Follow-up|15|||
23491426|NCT00333840|65545007|FG001|First-line Treatment Period|Lost to Follow-up|6|||
23491427|NCT00333840|65545008|FG002|First-line Treatment Period|Lost to Follow-up|0|||
23491428|NCT00333840|65545009|FG003|First-line Treatment Period|Lost to Follow-up|0|||
23491429|NCT00333840|65545006|FG000|First-line Treatment Period|Administrative problems|12|||
23491430|NCT00333840|65545007|FG001|First-line Treatment Period|Administrative problems|6|||
23491431|NCT00333840|65545008|FG002|First-line Treatment Period|Administrative problems|0|||
23491432|NCT00333840|65545009|FG003|First-line Treatment Period|Administrative problems|0|||
23491433|NCT00333840|65545006|FG000|First-line Treatment Period|Death|19|||
23491434|NCT00333840|65545007|FG001|First-line Treatment Period|Death|2|||
23491435|NCT00333840|65545008|FG002|First-line Treatment Period|Death|0|||
23491436|NCT00333840|65545009|FG003|First-line Treatment Period|Death|0|||
23491437|NCT00333840|65545006|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
23491438|NCT00333840|65545007|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
23491439|NCT00333840|65545008|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
23491440|NCT00333840|65545009|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
23491441|NCT00333840|65545006|FG000|Second-line Treatment Period|Adverse Event|0|||
23491442|NCT00333840|65545007|FG001|Second-line Treatment Period|Adverse Event|0|||
23491443|NCT00333840|65545008|FG002|Second-line Treatment Period|Adverse Event|3|||
23491444|NCT00333840|65545009|FG003|Second-line Treatment Period|Adverse Event|34|||
23491445|NCT00333840|65545006|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
23491446|NCT00333840|65545007|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
23491447|NCT00333840|65545008|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
23491448|NCT00333840|65545009|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
23491449|NCT00333840|65545006|FG000|Second-line Treatment Period|Abnormal procedure|0|||
23491450|NCT00333840|65545007|FG001|Second-line Treatment Period|Abnormal procedure|0|||
23379982|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379983|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
23379984|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379985|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379986|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379987|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379988|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
23379989|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
23379990|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23379991|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23379992|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
23491451|NCT00333840|65545008|FG002|Second-line Treatment Period|Abnormal procedure|0|||
23491452|NCT00333840|65545009|FG003|Second-line Treatment Period|Abnormal procedure|1|||
23287177|NCT01567527|64795709|FG004|Conversion Phase.|Lack of Efficacy|0|||
23287178|NCT01567527|64795705|FG000|Conversion Phase.|Adverse Event|33|||
23287179|NCT01567527|64795706|FG001|Conversion Phase.|Adverse Event|0|||
23287180|NCT01567527|64795707|FG002|Conversion Phase.|Adverse Event|0|||
23287181|NCT01567527|64795708|FG003|Conversion Phase.|Adverse Event|0|||
23287182|NCT01567527|64795709|FG004|Conversion Phase.|Adverse Event|0|||
23287183|NCT01567527|64795705|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
23287184|NCT01567527|64795706|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
23287185|NCT01567527|64795707|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
23287186|NCT01567527|64795708|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
23287187|NCT01567527|64795709|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
23287188|NCT01567527|64795705|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
23287189|NCT01567527|64795706|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
23287190|NCT01567527|64795707|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
23287191|NCT01567527|64795708|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
23287192|NCT01567527|64795709|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
23287193|NCT01567527|64795705|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
23287194|NCT01567527|64795706|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
23287195|NCT01567527|64795707|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
23287196|NCT01567527|64795708|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
23287197|NCT01567527|64795709|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
23287198|NCT01567527|64795705|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
23287199|NCT01567527|64795706|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
23287200|NCT01567527|64795707|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
23287201|NCT01567527|64795708|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
23287202|NCT01567527|64795709|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
23287203|NCT01567527|64795705|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
23287204|NCT01567527|64795706|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
23287205|NCT01567527|64795707|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
23287206|NCT01567527|64795708|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
23287207|NCT01567527|64795709|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
23287208|NCT01567527|64795705|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
23287209|NCT01567527|64795706|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
23287210|NCT01567527|64795707|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
23287211|NCT01567527|64795708|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
23287212|NCT01567527|64795709|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
23287213|NCT01567527|64795705|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
23287214|NCT01567527|64795706|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
23287215|NCT01567527|64795707|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
23287216|NCT01567527|64795708|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
23287217|NCT01567527|64795709|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
23287218|NCT01567527|64795705|FG000|IM Depot Stabilization.|Protocol deviation|0|||
23287219|NCT01567527|64795706|FG001|IM Depot Stabilization.|Protocol deviation|0|||
23287220|NCT01567527|64795707|FG002|IM Depot Stabilization.|Protocol deviation|5|||
23287221|NCT01567527|64795708|FG003|IM Depot Stabilization.|Protocol deviation|0|||
23287222|NCT01567527|64795709|FG004|IM Depot Stabilization.|Protocol deviation|0|||
23287223|NCT01567527|64795705|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
23287224|NCT01567527|64795706|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
23287225|NCT01567527|64795707|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
23287226|NCT01567527|64795708|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
23287227|NCT01567527|64795709|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
23287228|NCT01567527|64795705|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
23287229|NCT01567527|64795706|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
23287230|NCT01567527|64795707|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
23287231|NCT01567527|64795708|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
23287232|NCT01567527|64795709|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
23287233|NCT01567527|64795705|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
23287234|NCT01567527|64795706|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
23287235|NCT01567527|64795707|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
23287236|NCT01567527|64795708|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
23287237|NCT01567527|64795709|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
23287238|NCT01567527|64795705|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
23287239|NCT01567527|64795706|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
23287240|NCT01567527|64795707|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
23287241|NCT01567527|64795708|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
23287242|NCT01567527|64795709|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
23287243|NCT01567527|64795705|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
23379993|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23379994|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23287244|NCT01567527|64795706|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
23287245|NCT01567527|64795707|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
23379995|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
23379996|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
23379997|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
23379998|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
23379999|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
23380000|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
23380001|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
23380002|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
23380003|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
23380004|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
23380005|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
23380006|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
23380007|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
23380008|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
23380009|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
23380010|NCT01807520|65137176|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
23380011|NCT01807520|65137177|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
23380012|NCT01807520|65137178|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
23380013|NCT01807520|65137179|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
23380014|NCT01807520|65137180|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
23380015|NCT01807520|65137181|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
23380016|NCT01807520|65137182|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
23380017|NCT01807520|65137176|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380018|NCT01807520|65137177|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380019|NCT01807520|65137178|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380020|NCT01807520|65137179|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380021|NCT01807520|65137180|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380022|NCT01807520|65137181|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
23380023|NCT01807520|65137182|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
23380024|NCT01807520|65137176|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23287246|NCT01567527|64795708|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
23287247|NCT01567527|64795709|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
23287248|NCT01567527|64795705|FG000|IM Depot Stabilization.|Adverse Event|0|||
23287249|NCT01567527|64795706|FG001|IM Depot Stabilization.|Adverse Event|0|||
23287250|NCT01567527|64795707|FG002|IM Depot Stabilization.|Adverse Event|37|||
23287251|NCT01567527|64795708|FG003|IM Depot Stabilization.|Adverse Event|0|||
23287252|NCT01567527|64795709|FG004|IM Depot Stabilization.|Adverse Event|0|||
23287253|NCT01567527|64795705|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
23287254|NCT01567527|64795706|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
23287255|NCT01567527|64795707|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
23287256|NCT01567527|64795708|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
23287257|NCT01567527|64795709|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
23287258|NCT01567527|64795705|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
23287259|NCT01567527|64795706|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
23287260|NCT01567527|64795707|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
23287261|NCT01567527|64795708|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
23287262|NCT01567527|64795709|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
23287263|NCT01567527|64795705|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
23287264|NCT01567527|64795706|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
23287265|NCT01567527|64795707|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
23287266|NCT01567527|64795708|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
23287267|NCT01567527|64795709|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
23287268|NCT01567527|64795705|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
23287269|NCT01567527|64795706|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
23287270|NCT01567527|64795707|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
23287271|NCT01567527|64795708|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
23287272|NCT01567527|64795709|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
23287273|NCT01567527|64795705|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
23287274|NCT01567527|64795706|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
23287275|NCT01567527|64795707|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
23287276|NCT01567527|64795708|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
23380025|NCT01807520|65137177|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23287277|NCT01567527|64795709|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
23287278|NCT01567527|64795705|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23287279|NCT01567527|64795706|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23287280|NCT01567527|64795707|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
23287281|NCT01567527|64795708|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
23287282|NCT01567527|64795709|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
23287283|NCT01567527|64795705|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
23287284|NCT01567527|64795706|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
23287285|NCT01567527|64795707|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
23287286|NCT01567527|64795708|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
23287287|NCT01567527|64795709|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
23287288|NCT01567527|64795705|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
23287289|NCT01567527|64795706|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
23287290|NCT01567527|64795707|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
23287291|NCT01567527|64795708|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
23287292|NCT01567527|64795709|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
23287293|NCT01567527|64795705|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23287294|NCT01567527|64795706|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23287295|NCT01567527|64795707|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
23287296|NCT01567527|64795708|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
23287297|NCT01567527|64795709|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
23287298|NCT01451541|64795715|FG000|Overall Study|Adverse Event|4|||
23287299|NCT01451541|64795716|FG001|Overall Study|Adverse Event|3|||
23287300|NCT01451541|64795717|FG002|Overall Study|Adverse Event|6|||
23287301|NCT01451541|64795715|FG000|Overall Study|Lack of Efficacy|2|||
23287302|NCT01451541|64795716|FG001|Overall Study|Lack of Efficacy|0|||
23287303|NCT01451541|64795717|FG002|Overall Study|Lack of Efficacy|0|||
23287304|NCT01451541|64795715|FG000|Overall Study|Lost to Follow-up|4|||
23287305|NCT01451541|64795716|FG001|Overall Study|Lost to Follow-up|4|||
23287306|NCT01451541|64795717|FG002|Overall Study|Lost to Follow-up|7|||
23287307|NCT01451541|64795715|FG000|Overall Study|Withdrawal by Subject|15|||
23287308|NCT01451541|64795716|FG001|Overall Study|Withdrawal by Subject|8|||
23287309|NCT01451541|64795717|FG002|Overall Study|Withdrawal by Subject|6|||
23287310|NCT01451541|64795715|FG000|Overall Study|randomization error, noncompliance|11|||
23287311|NCT01451541|64795716|FG001|Overall Study|randomization error, noncompliance|10|||
23287312|NCT01451541|64795717|FG002|Overall Study|randomization error, noncompliance|8|||
23287313|NCT04129554|64795718|FG000|Overall Study|Withdrawal by Subject|4|||
23287314|NCT04129554|64795719|FG001|Overall Study|Withdrawal by Subject|3|||
23287315|NCT04129554|64795718|FG000|Overall Study|Other|0|||
23287316|NCT04129554|64795719|FG001|Overall Study|Other|2|||
23287317|NCT01077258|64795720|FG000|Overall Study|Lost to Follow-up|1390|||
23287318|NCT01077258|64795720|FG000|Overall Study|Adverse drug reaction|218|||
23380026|NCT01807520|65137178|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380027|NCT01807520|65137179|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380028|NCT01807520|65137180|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380029|NCT01807520|65137181|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
23380030|NCT01807520|65137182|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
23380031|NCT01807520|65137176|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380032|NCT01807520|65137177|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380033|NCT01807520|65137178|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380034|NCT01807520|65137179|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380035|NCT01807520|65137180|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
23380036|NCT01807520|65137181|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
23380037|NCT01807520|65137182|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
23380038|NCT00337194|65137189|FG000|Overall Study|Adverse Event|5|||
23380039|NCT00337194|65137190|FG001|Overall Study|Adverse Event|1|||
23380040|NCT00337194|65137189|FG000|Overall Study|Death|2|||
23380041|NCT00337194|65137190|FG001|Overall Study|Death|0|||
23380042|NCT00337194|65137189|FG000|Overall Study|Withdrawal by Subject|1|||
23380043|NCT00337194|65137190|FG001|Overall Study|Withdrawal by Subject|0|||
23380044|NCT00337194|65137189|FG000|Overall Study|Disease progression|1|||
23287319|NCT01077258|64795720|FG000|Overall Study|Lack of Efficacy|663|||
23287320|NCT01077258|64795720|FG000|Overall Study|Clinical remission|37|||
23380045|NCT00337194|65137190|FG001|Overall Study|Disease progression|2|||
23380046|NCT00337194|65137189|FG000|Overall Study|Subsequent non-protocol therapy|3|||
23380047|NCT00337194|65137190|FG001|Overall Study|Subsequent non-protocol therapy|1|||
23287321|NCT01077258|64795720|FG000|Overall Study|Other reasons|260|||
23380048|NCT01327703|65137193|FG000|Second Treatment Period|Adverse Event|1|||
23380049|NCT01327703|65137194|FG001|Second Treatment Period|Adverse Event|1|||
23380050|NCT01327703|65137193|FG000|Second Treatment Period|Protocol Violation|0|||
23380051|NCT01327703|65137194|FG001|Second Treatment Period|Protocol Violation|1|||
23380052|NCT00088153|65137198|FG000|Overall Study|Physician Decision|3|||
23380053|NCT00088153|65137199|FG001|Overall Study|Physician Decision|3|||
23380054|NCT00088153|65137198|FG000|Overall Study|Withdrawal by Subject|10|||
23380055|NCT00088153|65137199|FG001|Overall Study|Withdrawal by Subject|10|||
23380056|NCT00088153|65137198|FG000|Overall Study|Lost to Follow-up|11|||
23380057|NCT00088153|65137199|FG001|Overall Study|Lost to Follow-up|12|||
23380058|NCT00976898|65137202|FG000|Overall Study|Protocol Violation|1|||
23380059|NCT00976898|65137202|FG000|Overall Study|Adverse Event|1|||
23380060|NCT00976898|65137202|FG000|Overall Study|Physician Decision|1|||
23380061|NCT00976898|65137202|FG000|Overall Study|Liver Transplant|1|||
23380062|NCT00976898|65137202|FG000|Overall Study|Progressive Disease|1|||
23380063|NCT04333498|65137204|FG000|Overall Study|Lost to Follow-up|1|||
23380064|NCT04333498|65137205|FG001|Overall Study|Lost to Follow-up|0|||
23380065|NCT04333498|65137204|FG000|Overall Study|Lost to Follow-up|0|||
23380066|NCT04333498|65137205|FG001|Overall Study|Lost to Follow-up|1|||
23380067|NCT02447029|65137210|FG000|Overall Study|Withdrawal by Subject|3|||
23380068|NCT02447029|65137211|FG001|Overall Study|Withdrawal by Subject|2|||
23380069|NCT00313170|65137212|FG000|Overall Study|Death|2|||
23380070|NCT00313170|65137213|FG001|Overall Study|Death|4|||
23380071|NCT00313170|65137214|FG002|Overall Study|Death|2|||
23380072|NCT00313170|65137212|FG000|Overall Study|Adverse Event|1|||
23380073|NCT00313170|65137213|FG001|Overall Study|Adverse Event|2|||
23380074|NCT00313170|65137214|FG002|Overall Study|Adverse Event|0|||
23380075|NCT00313170|65137212|FG000|Overall Study|Disease progression|31|||
23380076|NCT00313170|65137213|FG001|Overall Study|Disease progression|26|||
23287322|NCT02311894|64795721|FG000|Overall Study|Discontinued in error|1|||
23287323|NCT02311894|64795721|FG000|Overall Study|Lost to Follow-up|1|||
23380077|NCT00313170|65137214|FG002|Overall Study|Disease progression|27|||
23380078|NCT00313170|65137212|FG000|Overall Study|Withdrawal by Subject|1|||
23491453|NCT00333840|65545006|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
23491454|NCT00333840|65545007|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
23491455|NCT00333840|65545008|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
23491456|NCT00333840|65545009|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
23491457|NCT00333840|65545006|FG000|Second-line Treatment Period|No longer required study drug|0|||
23491458|NCT00333840|65545007|FG001|Second-line Treatment Period|No longer required study drug|0|||
23491459|NCT00333840|65545008|FG002|Second-line Treatment Period|No longer required study drug|1|||
23491460|NCT00333840|65545009|FG003|Second-line Treatment Period|No longer required study drug|14|||
23491461|NCT00333840|65545006|FG000|Second-line Treatment Period|Protocol Violation|0|||
23491462|NCT00333840|65545007|FG001|Second-line Treatment Period|Protocol Violation|0|||
23491463|NCT00333840|65545008|FG002|Second-line Treatment Period|Protocol Violation|1|||
23491464|NCT00333840|65545009|FG003|Second-line Treatment Period|Protocol Violation|10|||
23491465|NCT00333840|65545006|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
23491466|NCT00333840|65545007|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
23491467|NCT00333840|65545008|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
23491468|NCT00333840|65545009|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
23491469|NCT00333840|65545006|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
23287324|NCT02311894|64795721|FG000|Overall Study|Adverse Event|1|||
23287325|NCT02311894|64795721|FG000|Overall Study|Withdrawal by Subject|1|||
23287326|NCT00674128|64795727|FG000|Overall Study|Withdrawal by Subject|25|||
23287327|NCT00674128|64795728|FG001|Overall Study|Withdrawal by Subject|23|||
23287328|NCT01483820|64795729|FG000|Overall Study|Lack of Efficacy|6|||
23287329|NCT01483820|64795729|FG000|Overall Study|Adverse Event|1|||
23287330|NCT01483820|64795729|FG000|Overall Study|Death|1|||
23287331|NCT04974580|64795730|FG000|Overall Study|Lost to Follow-up|33|||
23287332|NCT04974580|64795731|FG001|Overall Study|Lost to Follow-up|39|||
23287333|NCT04974580|64795732|FG002|Overall Study|Lost to Follow-up|30|||
23287334|NCT04974580|64795733|FG003|Overall Study|Lost to Follow-up|29|||
23287335|NCT01143337|64795734|FG000|Overall Study|Adverse Event|3|||
23287336|NCT01143337|64795735|FG001|Overall Study|Adverse Event|9|||
23287337|NCT01143337|64795736|FG002|Overall Study|Adverse Event|5|||
23287338|NCT01143337|64795734|FG000|Overall Study|Lack of Efficacy|6|||
23380079|NCT00313170|65137213|FG001|Overall Study|Withdrawal by Subject|0|||
23380080|NCT00313170|65137214|FG002|Overall Study|Withdrawal by Subject|1|||
23380081|NCT00313170|65137212|FG000|Overall Study|Incorrect enrollment|0|||
23380082|NCT00313170|65137213|FG001|Overall Study|Incorrect enrollment|2|||
23380083|NCT00313170|65137214|FG002|Overall Study|Incorrect enrollment|1|||
23380084|NCT00313170|65137212|FG000|Overall Study|Lost to Follow-up|0|||
23380085|NCT00313170|65137213|FG001|Overall Study|Lost to Follow-up|0|||
23287339|NCT01143337|64795735|FG001|Overall Study|Lack of Efficacy|2|||
23287340|NCT01143337|64795736|FG002|Overall Study|Lack of Efficacy|1|||
23380086|NCT00313170|65137214|FG002|Overall Study|Lost to Follow-up|1|||
23287341|NCT01143337|64795734|FG000|Overall Study|Protocol Violation|1|||
23287342|NCT01143337|64795735|FG001|Overall Study|Protocol Violation|0|||
23287343|NCT01143337|64795736|FG002|Overall Study|Protocol Violation|0|||
23287344|NCT01143337|64795734|FG000|Overall Study|Withdrawal by Subject|0|||
23287345|NCT01143337|64795735|FG001|Overall Study|Withdrawal by Subject|0|||
23287346|NCT01143337|64795736|FG002|Overall Study|Withdrawal by Subject|1|||
23287347|NCT01143337|64795734|FG000|Overall Study|Other reason|0|||
23287348|NCT01143337|64795735|FG001|Overall Study|Other reason|0|||
23287349|NCT01143337|64795736|FG002|Overall Study|Other reason|5|||
23287350|NCT03185741|64795739|FG000|Baseline|Withdrawal by Subject|1|||
23287351|NCT03185741|64795740|FG001|Baseline|Withdrawal by Subject|3|||
23287352|NCT03185741|64795741|FG002|Baseline|Withdrawal by Subject|2|||
23287353|NCT03185741|64795739|FG000|Baseline|Lost to Follow-up|1|||
23287354|NCT03185741|64795740|FG001|Baseline|Lost to Follow-up|2|||
23287355|NCT03185741|64795741|FG002|Baseline|Lost to Follow-up|3|||
23287356|NCT03185741|64795739|FG000|3Month|Death|1|||
23287357|NCT03185741|64795740|FG001|3Month|Death|1|||
23287358|NCT03185741|64795741|FG002|3Month|Death|2|||
23287359|NCT03185741|64795739|FG000|3Month|Withdrawal by Subject|1|||
23491470|NCT00333840|65545007|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
23491471|NCT00333840|65545008|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
23491472|NCT00333840|65545009|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
23491473|NCT00333840|65545006|FG000|Second-line Treatment Period|Administrative problems|0|||
23491474|NCT00333840|65545007|FG001|Second-line Treatment Period|Administrative problems|0|||
23491475|NCT00333840|65545008|FG002|Second-line Treatment Period|Administrative problems|0|||
23491476|NCT00333840|65545009|FG003|Second-line Treatment Period|Administrative problems|7|||
23491477|NCT00333840|65545006|FG000|Second-line Treatment Period|Death|0|||
23491478|NCT00333840|65545007|FG001|Second-line Treatment Period|Death|0|||
23491479|NCT00333840|65545008|FG002|Second-line Treatment Period|Death|0|||
23491480|NCT00333840|65545009|FG003|Second-line Treatment Period|Death|9|||
23287360|NCT03185741|64795740|FG001|3Month|Withdrawal by Subject|5|||
23287361|NCT03185741|64795741|FG002|3Month|Withdrawal by Subject|1|||
23287362|NCT03185741|64795739|FG000|3Month|Lost to Follow-up|7|||
23287363|NCT03185741|64795740|FG001|3Month|Lost to Follow-up|9|||
23287364|NCT03185741|64795741|FG002|3Month|Lost to Follow-up|8|||
23287365|NCT03185741|64795739|FG000|3Month|Unavailable for 3Month|11|||
23287366|NCT03185741|64795740|FG001|3Month|Unavailable for 3Month|10|||
23287367|NCT03185741|64795741|FG002|3Month|Unavailable for 3Month|11|||
23287368|NCT03185741|64795739|FG000|3Month|Protocol Violation|0|||
23287369|NCT03185741|64795740|FG001|3Month|Protocol Violation|0|||
23287370|NCT03185741|64795741|FG002|3Month|Protocol Violation|3|||
23287371|NCT03185741|64795739|FG000|6Month|Death|1|||
23287372|NCT03185741|64795740|FG001|6Month|Death|1|||
23287373|NCT03185741|64795741|FG002|6Month|Death|2|||
23287374|NCT03185741|64795739|FG000|6Month|Withdrawal by Subject|2|||
23287375|NCT03185741|64795740|FG001|6Month|Withdrawal by Subject|3|||
23287376|NCT03185741|64795741|FG002|6Month|Withdrawal by Subject|1|||
23287377|NCT03185741|64795739|FG000|6Month|Lost to Follow-up|16|||
23287378|NCT03185741|64795740|FG001|6Month|Lost to Follow-up|15|||
23287379|NCT03185741|64795741|FG002|6Month|Lost to Follow-up|16|||
23287380|NCT03008005|64795745|FG000|Overall Study|Physician Decision|1|||
23287381|NCT03008005|64795746|FG001|Overall Study|Physician Decision|0|||
23287382|NCT03008005|64795747|FG002|Overall Study|Physician Decision|0|||
23287383|NCT03008005|64795745|FG000|Overall Study|Withdrawal by Subject|1|||
23287384|NCT03008005|64795746|FG001|Overall Study|Withdrawal by Subject|0|||
23287385|NCT03008005|64795747|FG002|Overall Study|Withdrawal by Subject|0|||
23287386|NCT03008005|64795745|FG000|Overall Study|Ineligible|0|||
23287387|NCT03008005|64795746|FG001|Overall Study|Ineligible|1|||
23287388|NCT03008005|64795747|FG002|Overall Study|Ineligible|0|||
23287389|NCT02034513|64795748|FG000|Overall Study|Adverse Event|11|||
23491481|NCT01823146|65545010|FG000|Overall Study|Withdrawal by Subject|0|||
23287390|NCT02034513|64795749|FG001|Overall Study|Adverse Event|10|||
23491482|NCT01823146|65545011|FG001|Overall Study|Withdrawal by Subject|1|||
23491483|NCT01823146|65545010|FG000|Overall Study|Lost to Follow-up|2|||
23287391|NCT02034513|64795748|FG000|Overall Study|Lack of Efficacy|0|||
23287392|NCT02034513|64795749|FG001|Overall Study|Lack of Efficacy|1|||
23287393|NCT02034513|64795748|FG000|Overall Study|Lost to Follow-up|6|||
23287394|NCT02034513|64795749|FG001|Overall Study|Lost to Follow-up|7|||
23287395|NCT02034513|64795748|FG000|Overall Study|Pregnancy|0|||
23287396|NCT02034513|64795749|FG001|Overall Study|Pregnancy|3|||
23287397|NCT02034513|64795748|FG000|Overall Study|Protocol Violation|7|||
23287398|NCT02034513|64795749|FG001|Overall Study|Protocol Violation|10|||
23287399|NCT02034513|64795748|FG000|Overall Study|Withdrawal by Subject|25|||
23287400|NCT02034513|64795749|FG001|Overall Study|Withdrawal by Subject|25|||
23287401|NCT02034513|64795748|FG000|Overall Study|Unclassified|0|||
23287402|NCT02034513|64795749|FG001|Overall Study|Unclassified|1|||
23287403|NCT00874822|64795750|FG000|Overall Study|excluded by criteria|8|||
23287404|NCT00486434|64795751|FG000|Overall Study|Withdrawal by Subject|34|||
23287405|NCT00486434|64795752|FG001|Overall Study|Withdrawal by Subject|39|||
23287406|NCT00486434|64795751|FG000|Overall Study|Adverse Event|118|||
23287407|NCT00486434|64795752|FG001|Overall Study|Adverse Event|44|||
23287408|NCT00486434|64795751|FG000|Overall Study|Protocol Violation|22|||
23287409|NCT00486434|64795752|FG001|Overall Study|Protocol Violation|21|||
23287410|NCT00486434|64795751|FG000|Overall Study|Lack of Efficacy|12|||
23287411|NCT00486434|64795752|FG001|Overall Study|Lack of Efficacy|19|||
23287412|NCT00486434|64795751|FG000|Overall Study|Lost to Follow-up|2|||
23287413|NCT00486434|64795752|FG001|Overall Study|Lost to Follow-up|3|||
23287414|NCT00486434|64795751|FG000|Overall Study|Death|1|||
23287415|NCT00486434|64795752|FG001|Overall Study|Death|2|||
23287416|NCT00486434|64795751|FG000|Overall Study|Personal reasons|5|||
23287417|NCT00486434|64795752|FG001|Overall Study|Personal reasons|6|||
23287418|NCT00874549|64795753|FG000|Overall Study|Adverse Event|0|||
23287419|NCT00874549|64795754|FG001|Overall Study|Adverse Event|0|||
23287420|NCT00874549|64795755|FG002|Overall Study|Adverse Event|1|||
23287421|NCT00874549|64795756|FG003|Overall Study|Adverse Event|0|||
23287422|NCT00874549|64795753|FG000|Overall Study|Protocol Violation|1|||
23287423|NCT00874549|64795754|FG001|Overall Study|Protocol Violation|0|||
23287424|NCT00874549|64795755|FG002|Overall Study|Protocol Violation|2|||
23287425|NCT00874549|64795756|FG003|Overall Study|Protocol Violation|1|||
23287426|NCT00874549|64795753|FG000|Overall Study|Lost to Follow-up|0|||
23287427|NCT00874549|64795754|FG001|Overall Study|Lost to Follow-up|0|||
23287428|NCT00874549|64795755|FG002|Overall Study|Lost to Follow-up|1|||
23287429|NCT00874549|64795756|FG003|Overall Study|Lost to Follow-up|0|||
23287430|NCT00874549|64795753|FG000|Overall Study|Withdrawal by Subject|0|||
23287431|NCT00874549|64795754|FG001|Overall Study|Withdrawal by Subject|1|||
23287432|NCT00874549|64795755|FG002|Overall Study|Withdrawal by Subject|0|||
23287433|NCT00874549|64795756|FG003|Overall Study|Withdrawal by Subject|1|||
23287434|NCT00393705|64795757|FG000|Overall Study|Adverse Event|0|||
23287435|NCT00393705|64795758|FG001|Overall Study|Adverse Event|2|||
23287436|NCT00393705|64795757|FG000|Overall Study|Death|0|||
23287437|NCT00393705|64795758|FG001|Overall Study|Death|1|||
23287438|NCT00393705|64795757|FG000|Overall Study|Lost to Follow-up|2|||
23287439|NCT00393705|64795758|FG001|Overall Study|Lost to Follow-up|2|||
23287440|NCT00393705|64795757|FG000|Overall Study|Entry Criteria Not Met|10|||
23287441|NCT00393705|64795758|FG001|Overall Study|Entry Criteria Not Met|10|||
23287442|NCT00393705|64795757|FG000|Overall Study|Protocol Violation|4|||
23287443|NCT00393705|64795758|FG001|Overall Study|Protocol Violation|3|||
23287444|NCT00393705|64795757|FG000|Overall Study|Withdrawal by Subject|5|||
23287445|NCT00393705|64795758|FG001|Overall Study|Withdrawal by Subject|3|||
23287446|NCT00393705|64795757|FG000|Overall Study|Physician Decision|2|||
23287447|NCT00393705|64795758|FG001|Overall Study|Physician Decision|2|||
23491484|NCT01823146|65545011|FG001|Overall Study|Lost to Follow-up|1|||
23491485|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
23491486|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
23491487|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
23491488|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
23491489|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|Death|2|||
23491490|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|Death|2|||
23491491|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
23491492|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
23287448|NCT04476277|64795763|FG000|Overall Study|Withdrawal by Subject|0|||
23287449|NCT04476277|64795764|FG001|Overall Study|Withdrawal by Subject|0|||
23287450|NCT04476277|64795765|FG002|Overall Study|Withdrawal by Subject|1|||
23287451|NCT04476277|64795766|FG003|Overall Study|Withdrawal by Subject|0|||
23287452|NCT01824498|64795770|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
23287453|NCT01824498|64795771|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
23287454|NCT01824498|64795772|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
23287455|NCT01824498|64795773|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
23287456|NCT01824498|64795774|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
23287457|NCT01824498|64795775|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
23287458|NCT00735696|64795777|FG000|Overall Study|Withdrawal by Subject|1|||
23605800|NCT01951703|65947058|FG001|First Intervention|Physician Decision|0|||
23287459|NCT00735696|64795777|FG000|Overall Study|Enrolled but never Treated|1|||
23287460|NCT01949532|64795778|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
23605801|NCT01951703|65947057|FG000|Second Intervention|Protocol Violation|0|||
23605802|NCT01951703|65947058|FG001|Second Intervention|Protocol Violation|1|||
23605803|NCT01951703|65947057|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
23605804|NCT01951703|65947058|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
23605805|NCT01947491|65947059|FG000|Overall Study|Lost to Follow-up|5|||
23605806|NCT01947491|65947060|FG001|Overall Study|Lost to Follow-up|3|||
23287461|NCT01949532|64795779|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
23287462|NCT02888756|64795780|FG000|Analytical Treatment Interruption|Physician Decision|10|||
23287463|NCT02888756|64795781|FG001|Analytical Treatment Interruption|Physician Decision|6|||
23287464|NCT02888756|64795782|FG002|Analytical Treatment Interruption|Physician Decision|5|||
23287465|NCT03922750|64795783|FG000|Overall Study|Unclassified|0|||
23287466|NCT03922750|64795784|FG001|Overall Study|Unclassified|0|||
23287467|NCT03922750|64795785|FG002|Overall Study|Unclassified|1|||
23287468|NCT03922750|64795783|FG000|Overall Study|Adverse Event|0|||
23287469|NCT03922750|64795784|FG001|Overall Study|Adverse Event|1|||
23287470|NCT03922750|64795785|FG002|Overall Study|Adverse Event|0|||
23287471|NCT03573544|64795788|FG000|Overall Study|Adverse Event|0|||
23287472|NCT03573544|64795789|FG001|Overall Study|Adverse Event|0|||
23287473|NCT03573544|64795790|FG002|Overall Study|Adverse Event|0|||
23287474|NCT03573544|64795791|FG003|Overall Study|Adverse Event|3|||
23287475|NCT03573544|64795792|FG004|Overall Study|Adverse Event|1|||
23287476|NCT03573544|64795793|FG005|Overall Study|Adverse Event|0|||
23287477|NCT03573544|64795794|FG006|Overall Study|Adverse Event|2|||
23287478|NCT03573544|64795795|FG007|Overall Study|Adverse Event|0|||
23287479|NCT03573544|64795788|FG000|Overall Study|Physician Decision|0|||
23287480|NCT03573544|64795789|FG001|Overall Study|Physician Decision|0|||
23287481|NCT03573544|64795790|FG002|Overall Study|Physician Decision|0|||
23287482|NCT03573544|64795791|FG003|Overall Study|Physician Decision|0|||
23287483|NCT03573544|64795792|FG004|Overall Study|Physician Decision|0|||
23287484|NCT03573544|64795793|FG005|Overall Study|Physician Decision|0|||
23287485|NCT03573544|64795794|FG006|Overall Study|Physician Decision|1|||
23287486|NCT03573544|64795795|FG007|Overall Study|Physician Decision|0|||
23287487|NCT03573544|64795788|FG000|Overall Study|Withdrawal by Subject|2|||
23287488|NCT03573544|64795789|FG001|Overall Study|Withdrawal by Subject|0|||
23287489|NCT03573544|64795790|FG002|Overall Study|Withdrawal by Subject|0|||
23287490|NCT03573544|64795791|FG003|Overall Study|Withdrawal by Subject|1|||
23287491|NCT03573544|64795792|FG004|Overall Study|Withdrawal by Subject|1|||
23287492|NCT03573544|64795793|FG005|Overall Study|Withdrawal by Subject|1|||
23287493|NCT03573544|64795794|FG006|Overall Study|Withdrawal by Subject|0|||
23287494|NCT03573544|64795795|FG007|Overall Study|Withdrawal by Subject|1|||
23287495|NCT03573544|64795788|FG000|Overall Study|Disease progression|3|||
23287496|NCT03573544|64795789|FG001|Overall Study|Disease progression|3|||
23287497|NCT03573544|64795790|FG002|Overall Study|Disease progression|6|||
23287498|NCT03573544|64795791|FG003|Overall Study|Disease progression|4|||
23287499|NCT03573544|64795792|FG004|Overall Study|Disease progression|5|||
23287500|NCT03573544|64795793|FG005|Overall Study|Disease progression|7|||
23287501|NCT03573544|64795794|FG006|Overall Study|Disease progression|6|||
23287502|NCT03573544|64795795|FG007|Overall Study|Disease progression|7|||
23605807|NCT01947491|65947061|FG002|Overall Study|Lost to Follow-up|1|||
23605808|NCT01947491|65947062|FG003|Overall Study|Lost to Follow-up|2|||
23605809|NCT01947491|65947059|FG000|Overall Study|Lack of Efficacy|1|||
23605810|NCT01947491|65947060|FG001|Overall Study|Lack of Efficacy|0|||
23605811|NCT01947491|65947061|FG002|Overall Study|Lack of Efficacy|0|||
23605812|NCT01947491|65947062|FG003|Overall Study|Lack of Efficacy|1|||
23605813|NCT01947491|65947059|FG000|Overall Study|Protocol Violation|1|||
23605814|NCT01947491|65947060|FG001|Overall Study|Protocol Violation|0|||
23605815|NCT01947491|65947061|FG002|Overall Study|Protocol Violation|0|||
23605816|NCT01947491|65947062|FG003|Overall Study|Protocol Violation|0|||
23605817|NCT01947491|65947059|FG000|Overall Study|Withdrawal by Subject|1|||
23605818|NCT01947491|65947060|FG001|Overall Study|Withdrawal by Subject|1|||
23605819|NCT01947491|65947061|FG002|Overall Study|Withdrawal by Subject|1|||
23605820|NCT01947491|65947062|FG003|Overall Study|Withdrawal by Subject|0|||
23605821|NCT01947491|65947059|FG000|Overall Study|Worsening of condition|0|||
23605822|NCT01947491|65947060|FG001|Overall Study|Worsening of condition|1|||
23605823|NCT01947491|65947061|FG002|Overall Study|Worsening of condition|0|||
23605824|NCT01947491|65947062|FG003|Overall Study|Worsening of condition|0|||
23605825|NCT01947491|65947059|FG000|Overall Study|Adverse Event|0|||
23605826|NCT01947491|65947060|FG001|Overall Study|Adverse Event|1|||
23605827|NCT01947491|65947061|FG002|Overall Study|Adverse Event|0|||
23605828|NCT01947491|65947062|FG003|Overall Study|Adverse Event|2|||
23605829|NCT00600353|65947065|FG000|Overall Study|history of malignancy within 5 years|1|||
23605830|NCT00600353|65947066|FG001|Overall Study|history of malignancy within 5 years|0|||
23287527|NCT00562718|64795803|FG000|Overall Study|Death|1|||
23287528|NCT00562718|64795803|FG000|Overall Study|Withdrawal by Subject|3|||
23287529|NCT00562718|64795803|FG000|Overall Study|Adverse Event|4|||
23287530|NCT00562718|64795803|FG000|Overall Study|Lack of Efficacy|2|||
23287531|NCT00562718|64795803|FG000|Overall Study|not stated|1|||
23287532|NCT02250651|64795804|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
23287533|NCT02250651|64795805|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
23287534|NCT02250651|64795806|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
23287535|NCT02250651|64795804|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
23287536|NCT02250651|64795805|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
23287537|NCT02250651|64795806|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
23287538|NCT02250651|64795804|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
23287539|NCT02250651|64795805|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
23380087|NCT00313170|65137212|FG000|Overall Study|Progression (investigators opinion)|1|||
23380088|NCT00313170|65137213|FG001|Overall Study|Progression (investigators opinion)|0|||
23380089|NCT00313170|65137214|FG002|Overall Study|Progression (investigators opinion)|0|||
23380090|NCT02018887|65137215|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
23380091|NCT02018887|65137216|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380092|NCT02018887|65137217|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380093|NCT02018887|65137218|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380094|NCT02018887|65137219|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380095|NCT02018887|65137220|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380096|NCT02018887|65137221|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380097|NCT02018887|65137222|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380098|NCT02018887|65137223|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380099|NCT02018887|65137224|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380100|NCT02018887|65137225|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
23380101|NCT02018887|65137215|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380102|NCT02018887|65137216|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380103|NCT02018887|65137217|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380104|NCT02018887|65137218|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380105|NCT02018887|65137219|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
23380106|NCT02018887|65137220|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23287540|NCT02250651|64795806|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
23287541|NCT02250651|64795804|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
23287542|NCT02250651|64795805|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
23380107|NCT02018887|65137221|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
23380108|NCT02018887|65137222|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
23380109|NCT02018887|65137223|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380110|NCT02018887|65137224|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380111|NCT02018887|65137225|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
23380112|NCT02018887|65137215|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
23380113|NCT02018887|65137216|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
23380114|NCT02018887|65137217|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
23380115|NCT02018887|65137218|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
23380116|NCT02018887|65137219|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
23380117|NCT02018887|65137220|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
23287543|NCT02250651|64795806|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
23287544|NCT02250651|64795804|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
23287545|NCT02250651|64795805|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
23287546|NCT02250651|64795806|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
23287547|NCT02250651|64795804|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
23287548|NCT02250651|64795805|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
23287549|NCT02250651|64795806|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
23287550|NCT02250651|64795804|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
23287551|NCT02250651|64795805|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
23287552|NCT02250651|64795806|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
23287553|NCT02250651|64795804|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
23287554|NCT02250651|64795805|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
23287555|NCT02250651|64795806|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
23287556|NCT02250651|64795804|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
23287557|NCT02250651|64795805|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
23287558|NCT02250651|64795806|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
23287559|NCT02250651|64795804|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
23287560|NCT02250651|64795805|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
23287561|NCT02250651|64795806|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
23287562|NCT02250651|64795804|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
23380118|NCT02018887|65137221|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
23380119|NCT02018887|65137222|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
23380120|NCT02018887|65137223|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
23380121|NCT02018887|65137224|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
23380122|NCT02018887|65137225|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
23287563|NCT02250651|64795805|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
23287564|NCT02250651|64795806|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
23287565|NCT02250651|64795804|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
23287566|NCT02250651|64795805|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
23287567|NCT02250651|64795806|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
23287568|NCT02250651|64795804|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
23287569|NCT02250651|64795805|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
23287570|NCT02250651|64795806|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
23287571|NCT02250651|64795804|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
23287572|NCT02250651|64795805|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
23287573|NCT02250651|64795806|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
23287574|NCT02250651|64795804|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
23287575|NCT02250651|64795805|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
23287576|NCT02250651|64795806|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
23287577|NCT02760433|64795807|FG000|Overall Study|Lost to Follow-up|1|||
23287578|NCT02760433|64795808|FG001|Overall Study|Lost to Follow-up|0|||
23287579|NCT02760433|64795809|FG002|Overall Study|Lost to Follow-up|1|||
23287580|NCT02760433|64795810|FG003|Overall Study|Lost to Follow-up|0|||
23380123|NCT02018887|65137215|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
23380124|NCT02018887|65137216|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
23380125|NCT02018887|65137217|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
23605831|NCT00600353|65947065|FG000|Overall Study|History of prepartive regimen|0|||
23605832|NCT00600353|65947066|FG001|Overall Study|History of prepartive regimen|1|||
23605833|NCT01313884|65947069|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
23605834|NCT03072862|65947070|FG000|Overall Study|Withdrawal by Subject|4|||
23605835|NCT03072862|65947070|FG000|Overall Study|Lost to Follow-up|6|||
23605836|NCT03072862|65947070|FG000|Overall Study|Protocol Violation|4|||
23605837|NCT03072862|65947070|FG000|Overall Study|Physician Decision|2|||
23605838|NCT03072862|65947070|FG000|Overall Study|Death|1|||
23605839|NCT03072862|65947070|FG000|Overall Study|Adverse Event|1|||
23605840|NCT02827201|65947071|FG000|Overall Study|Death|1|||
23605841|NCT02827201|65947072|FG001|Overall Study|Death|2|||
23605842|NCT02827201|65947071|FG000|Overall Study|Patients not treated|1|||
23605843|NCT02827201|65947072|FG001|Overall Study|Patients not treated|1|||
23605844|NCT02169414|65947073|FG000|Overall Study|Withdrawal by Subject|1|||
23605845|NCT02169414|65947074|FG001|Overall Study|Withdrawal by Subject|0|||
23605846|NCT02169414|65947075|FG002|Overall Study|Withdrawal by Subject|0|||
23605847|NCT02169414|65947076|FG003|Overall Study|Withdrawal by Subject|0|||
23605848|NCT02169414|65947073|FG000|Overall Study|Adverse Event|0|||
23605849|NCT02169414|65947074|FG001|Overall Study|Adverse Event|1|||
23605850|NCT02169414|65947075|FG002|Overall Study|Adverse Event|0|||
23605851|NCT02169414|65947076|FG003|Overall Study|Adverse Event|0|||
23605852|NCT01138657|65947078|FG000|Overall Study|Adverse Event|3|||
23605853|NCT01138657|65947079|FG001|Overall Study|Adverse Event|10|||
23287581|NCT02760433|64795811|FG004|Overall Study|Lost to Follow-up|0|||
23287582|NCT02760433|64795807|FG000|Overall Study|Withdrawal by Subject|23|||
23287583|NCT02760433|64795808|FG001|Overall Study|Withdrawal by Subject|9|||
23287584|NCT02760433|64795809|FG002|Overall Study|Withdrawal by Subject|0|||
23287585|NCT02760433|64795810|FG003|Overall Study|Withdrawal by Subject|2|||
23287586|NCT02760433|64795811|FG004|Overall Study|Withdrawal by Subject|9|||
23287587|NCT02760433|64795807|FG000|Overall Study|Lack of Response At Week 14|0|||
23287588|NCT02760433|64795808|FG001|Overall Study|Lack of Response At Week 14|0|||
23287589|NCT02760433|64795809|FG002|Overall Study|Lack of Response At Week 14|0|||
23287590|NCT02760433|64795810|FG003|Overall Study|Lack of Response At Week 14|0|||
23287591|NCT02760433|64795811|FG004|Overall Study|Lack of Response At Week 14|1|||
23287592|NCT02760433|64795807|FG000|Overall Study|Subject refused to continue the study|1|||
23287593|NCT02760433|64795808|FG001|Overall Study|Subject refused to continue the study|0|||
23287594|NCT02760433|64795809|FG002|Overall Study|Subject refused to continue the study|0|||
23287595|NCT02760433|64795810|FG003|Overall Study|Subject refused to continue the study|0|||
23287596|NCT02760433|64795811|FG004|Overall Study|Subject refused to continue the study|0|||
23287597|NCT02760433|64795807|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
23287598|NCT02760433|64795808|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
23287599|NCT02760433|64795809|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
23287600|NCT02760433|64795810|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
23287601|NCT02760433|64795811|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
23287602|NCT02760433|64795807|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
23287603|NCT02760433|64795808|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
23287604|NCT02760433|64795809|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
23287605|NCT02760433|64795810|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
23287606|NCT02760433|64795811|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
23287607|NCT03885934|64795812|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
23287608|NCT03885934|64795813|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
23287609|NCT03885934|64795814|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
23287610|NCT03885934|64795815|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
23287611|NCT03885934|64795816|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
23287612|NCT03885934|64795817|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
23287613|NCT03750695|64795818|FG000|Overall Study|Lost to Follow-up|0|||
23287614|NCT03750695|64795819|FG001|Overall Study|Lost to Follow-up|1|||
23287615|NCT01899053|64795824|FG000|Overall Study|Progressive Disease|4|||
23287616|NCT01899053|64795825|FG001|Overall Study|Progressive Disease|0|||
23287617|NCT01899053|64795826|FG002|Overall Study|Progressive Disease|3|||
23287618|NCT01899053|64795827|FG003|Overall Study|Progressive Disease|0|||
23287619|NCT01899053|64795828|FG004|Overall Study|Progressive Disease|3|||
23287620|NCT01899053|64795829|FG005|Overall Study|Progressive Disease|1|||
23287621|NCT01899053|64795830|FG006|Overall Study|Progressive Disease|1|||
23287622|NCT01899053|64795831|FG007|Overall Study|Progressive Disease|1|||
23287623|NCT01899053|64795832|FG008|Overall Study|Progressive Disease|4|||
23287624|NCT01899053|64795833|FG009|Overall Study|Progressive Disease|3|||
23287625|NCT01899053|64795834|FG010|Overall Study|Progressive Disease|12|||
23287626|NCT01899053|64795835|FG011|Overall Study|Progressive Disease|5|||
23287627|NCT01899053|64795836|FG012|Overall Study|Progressive Disease|8|||
23287628|NCT01899053|64795837|FG013|Overall Study|Progressive Disease|17|||
23287629|NCT01899053|64795824|FG000|Overall Study|Adverse Event|1|||
23287630|NCT01899053|64795825|FG001|Overall Study|Adverse Event|1|||
23287631|NCT01899053|64795826|FG002|Overall Study|Adverse Event|1|||
23287632|NCT01899053|64795827|FG003|Overall Study|Adverse Event|3|||
23287633|NCT01899053|64795828|FG004|Overall Study|Adverse Event|1|||
23380126|NCT02018887|65137218|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
23380127|NCT02018887|65137219|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
23380128|NCT02018887|65137220|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
23380129|NCT02018887|65137221|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
23380130|NCT02018887|65137222|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
23380131|NCT02018887|65137223|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
23380132|NCT02018887|65137224|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
23380133|NCT02018887|65137225|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
23380134|NCT00690898|65137226|FG000|SCREENING|Screen failure|18|||
23380135|NCT00690898|65137226|FG000|TREATMENT|Adverse Event|3|||
23380136|NCT00690898|65137226|FG000|TREATMENT|Lack of Efficacy|18|||
23380137|NCT00690898|65137226|FG000|TREATMENT|Withdrawal by Subject|4|||
23380138|NCT00690898|65137226|FG000|TREATMENT|Other (not otherwise specified)|1|||
23380139|NCT00933933|65137228|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
23380140|NCT00933933|65137229|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
23380141|NCT00933933|65137230|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
23380142|NCT00933933|65137228|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
23380143|NCT00933933|65137229|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
23380144|NCT00933933|65137230|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
23380145|NCT02265744|65137231|FG000|Overall Study|Poor/Non-compliance|1|||
23380146|NCT02265744|65137232|FG001|Overall Study|Poor/Non-compliance|1|||
23491493|NCT01528033|65545012|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
23491494|NCT01528033|65545013|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
23491495|NCT01528033|65545012|FG000|Follow Up|No data available|46|||
23491496|NCT01528033|65545013|FG001|Follow Up|No data available|44|||
23491497|NCT01033851|65545014|FG000|Overall Study|Withdrawal by Subject|3|||
23491498|NCT01033851|65545015|FG001|Overall Study|Withdrawal by Subject|7|||
23491499|NCT03001882|65545018|FG000|Overall Study|Death|1|||
23491500|NCT03001882|65545019|FG001|Overall Study|Death|0|||
23491501|NCT03001882|65545020|FG002|Overall Study|Death|0|||
23491502|NCT03001882|65545021|FG003|Overall Study|Death|3|||
23491503|NCT03001882|65545018|FG000|Overall Study|Participant withdrew consent|0|||
23491504|NCT03001882|65545019|FG001|Overall Study|Participant withdrew consent|1|||
23491505|NCT03001882|65545020|FG002|Overall Study|Participant withdrew consent|0|||
23491506|NCT03001882|65545021|FG003|Overall Study|Participant withdrew consent|5|||
23491507|NCT03001882|65545018|FG000|Overall Study|Other reasons|1|||
23491508|NCT03001882|65545019|FG001|Overall Study|Other reasons|2|||
23491509|NCT03001882|65545020|FG002|Overall Study|Other reasons|0|||
23287634|NCT01899053|64795829|FG005|Overall Study|Adverse Event|1|||
23287635|NCT01899053|64795830|FG006|Overall Study|Adverse Event|1|||
23287636|NCT01899053|64795831|FG007|Overall Study|Adverse Event|0|||
23287637|NCT01899053|64795832|FG008|Overall Study|Adverse Event|2|||
23287638|NCT01899053|64795833|FG009|Overall Study|Adverse Event|0|||
23287639|NCT01899053|64795834|FG010|Overall Study|Adverse Event|3|||
23287640|NCT01899053|64795835|FG011|Overall Study|Adverse Event|1|||
23287641|NCT01899053|64795836|FG012|Overall Study|Adverse Event|2|||
23287642|NCT01899053|64795837|FG013|Overall Study|Adverse Event|2|||
23287643|NCT01899053|64795824|FG000|Overall Study|Reason Not Specified|0|||
23287644|NCT01899053|64795825|FG001|Overall Study|Reason Not Specified|0|||
23287645|NCT01899053|64795826|FG002|Overall Study|Reason Not Specified|0|||
23380147|NCT02265744|65137233|FG002|Overall Study|Poor/Non-compliance|0|||
23380148|NCT02265744|65137234|FG003|Overall Study|Poor/Non-compliance|0|||
23380149|NCT02265744|65137235|FG004|Overall Study|Poor/Non-compliance|2|||
23380150|NCT02265744|65137231|FG000|Overall Study|Lost to Follow-up|0|||
23380151|NCT02265744|65137232|FG001|Overall Study|Lost to Follow-up|0|||
23380152|NCT02265744|65137233|FG002|Overall Study|Lost to Follow-up|0|||
23380153|NCT02265744|65137234|FG003|Overall Study|Lost to Follow-up|1|||
23380154|NCT02265744|65137235|FG004|Overall Study|Lost to Follow-up|0|||
23380155|NCT02265744|65137231|FG000|Overall Study|Death|0|||
23380156|NCT02265744|65137232|FG001|Overall Study|Death|0|||
23380157|NCT02265744|65137233|FG002|Overall Study|Death|0|||
23380158|NCT02265744|65137234|FG003|Overall Study|Death|2|||
23380159|NCT02265744|65137235|FG004|Overall Study|Death|0|||
23380160|NCT02265744|65137231|FG000|Overall Study|Withdrawal by Subject|2|||
23380161|NCT02265744|65137232|FG001|Overall Study|Withdrawal by Subject|0|||
23380162|NCT02265744|65137233|FG002|Overall Study|Withdrawal by Subject|0|||
23380163|NCT02265744|65137234|FG003|Overall Study|Withdrawal by Subject|2|||
23380164|NCT02265744|65137235|FG004|Overall Study|Withdrawal by Subject|0|||
23380165|NCT02265744|65137231|FG000|Overall Study|Participant request to discontinue|2|||
23380166|NCT02265744|65137232|FG001|Overall Study|Participant request to discontinue|2|||
23380167|NCT02265744|65137233|FG002|Overall Study|Participant request to discontinue|2|||
23380168|NCT02265744|65137234|FG003|Overall Study|Participant request to discontinue|0|||
23380169|NCT02265744|65137235|FG004|Overall Study|Participant request to discontinue|0|||
23380170|NCT02265744|65137231|FG000|Overall Study|Adverse Event|8|||
23491510|NCT03001882|65545021|FG003|Overall Study|Other reasons|5|||
23287646|NCT01899053|64795827|FG003|Overall Study|Reason Not Specified|0|||
23287647|NCT01899053|64795828|FG004|Overall Study|Reason Not Specified|0|||
23287648|NCT01899053|64795829|FG005|Overall Study|Reason Not Specified|0|||
23287649|NCT01899053|64795830|FG006|Overall Study|Reason Not Specified|1|||
23287650|NCT01899053|64795831|FG007|Overall Study|Reason Not Specified|0|||
23287651|NCT01899053|64795832|FG008|Overall Study|Reason Not Specified|0|||
23287652|NCT01899053|64795833|FG009|Overall Study|Reason Not Specified|0|||
23287653|NCT01899053|64795834|FG010|Overall Study|Reason Not Specified|0|||
23287654|NCT01899053|64795835|FG011|Overall Study|Reason Not Specified|0|||
23287655|NCT01899053|64795836|FG012|Overall Study|Reason Not Specified|1|||
23287656|NCT01899053|64795837|FG013|Overall Study|Reason Not Specified|0|||
23287657|NCT01899053|64795824|FG000|Overall Study|Withdrawal by Subject|1|||
23287658|NCT01899053|64795825|FG001|Overall Study|Withdrawal by Subject|1|||
23287659|NCT01899053|64795826|FG002|Overall Study|Withdrawal by Subject|2|||
23287660|NCT01899053|64795827|FG003|Overall Study|Withdrawal by Subject|0|||
23287661|NCT01899053|64795828|FG004|Overall Study|Withdrawal by Subject|2|||
23287662|NCT01899053|64795829|FG005|Overall Study|Withdrawal by Subject|0|||
23287663|NCT01899053|64795830|FG006|Overall Study|Withdrawal by Subject|0|||
23287664|NCT01899053|64795831|FG007|Overall Study|Withdrawal by Subject|1|||
23380171|NCT02265744|65137232|FG001|Overall Study|Adverse Event|4|||
23380172|NCT02265744|65137233|FG002|Overall Study|Adverse Event|9|||
23380173|NCT02265744|65137234|FG003|Overall Study|Adverse Event|8|||
23380174|NCT02265744|65137235|FG004|Overall Study|Adverse Event|2|||
23380175|NCT02265744|65137231|FG000|Overall Study|Lack of Efficacy|2|||
23287665|NCT01899053|64795832|FG008|Overall Study|Withdrawal by Subject|0|||
23287666|NCT01899053|64795833|FG009|Overall Study|Withdrawal by Subject|0|||
23287667|NCT01899053|64795834|FG010|Overall Study|Withdrawal by Subject|0|||
23287668|NCT01899053|64795835|FG011|Overall Study|Withdrawal by Subject|0|||
23287669|NCT01899053|64795836|FG012|Overall Study|Withdrawal by Subject|1|||
23287670|NCT01899053|64795837|FG013|Overall Study|Withdrawal by Subject|1|||
23287671|NCT01899053|64795824|FG000|Overall Study|Protocol Violation|0|||
23287672|NCT01899053|64795825|FG001|Overall Study|Protocol Violation|0|||
23380176|NCT02265744|65137232|FG001|Overall Study|Lack of Efficacy|4|||
23380177|NCT02265744|65137233|FG002|Overall Study|Lack of Efficacy|3|||
23380178|NCT02265744|65137234|FG003|Overall Study|Lack of Efficacy|4|||
23380179|NCT02265744|65137235|FG004|Overall Study|Lack of Efficacy|5|||
23380180|NCT02265744|65137231|FG000|Overall Study|Reason not provided by Investigator|1|||
23380181|NCT02265744|65137232|FG001|Overall Study|Reason not provided by Investigator|0|||
23380182|NCT02265744|65137233|FG002|Overall Study|Reason not provided by Investigator|0|||
23380183|NCT02265744|65137234|FG003|Overall Study|Reason not provided by Investigator|2|||
23380184|NCT02265744|65137235|FG004|Overall Study|Reason not provided by Investigator|0|||
23380185|NCT02265744|65137231|FG000|Overall Study|Administrative reason by sponsor|3|||
23380186|NCT02265744|65137232|FG001|Overall Study|Administrative reason by sponsor|2|||
23380187|NCT02265744|65137233|FG002|Overall Study|Administrative reason by sponsor|2|||
23380188|NCT02265744|65137234|FG003|Overall Study|Administrative reason by sponsor|3|||
23380189|NCT02265744|65137235|FG004|Overall Study|Administrative reason by sponsor|3|||
23380190|NCT02265744|65137231|FG000|Overall Study|Subject no longer meets study criteria|0|||
23380191|NCT02265744|65137232|FG001|Overall Study|Subject no longer meets study criteria|0|||
23380192|NCT02265744|65137233|FG002|Overall Study|Subject no longer meets study criteria|0|||
23380193|NCT02265744|65137234|FG003|Overall Study|Subject no longer meets study criteria|0|||
23380194|NCT02265744|65137235|FG004|Overall Study|Subject no longer meets study criteria|1|||
23380195|NCT02265744|65137231|FG000|Overall Study|Pregnancy|1|||
23380196|NCT02265744|65137232|FG001|Overall Study|Pregnancy|2|||
23380197|NCT02265744|65137233|FG002|Overall Study|Pregnancy|1|||
23380198|NCT02265744|65137234|FG003|Overall Study|Pregnancy|1|||
23380199|NCT02265744|65137235|FG004|Overall Study|Pregnancy|0|||
23380200|NCT01588509|65137236|FG000|Overall Study|Lost to Follow-up|1|||
23380201|NCT01588509|65137237|FG001|Overall Study|Lost to Follow-up|0|||
23380202|NCT02110693|65137241|FG000|Overall Study|Withdrawal by Subject|6|||
23380203|NCT02110693|65137242|FG001|Overall Study|Withdrawal by Subject|7|||
23380204|NCT02110693|65137241|FG000|Overall Study|skipped assessment|15|||
23380205|NCT02110693|65137242|FG001|Overall Study|skipped assessment|18|||
23380206|NCT02110693|65137241|FG000|Overall Study|technical difficulties|6|||
23380207|NCT02110693|65137242|FG001|Overall Study|technical difficulties|4|||
23380208|NCT02110693|65137241|FG000|Overall Study|Other|1|||
23380209|NCT02110693|65137242|FG001|Overall Study|Other|0|||
23380210|NCT01239680|65137243|FG000|Overall Study|Withdrawal by Subject|2|||
23380211|NCT01239680|65137244|FG001|Overall Study|Withdrawal by Subject|0|||
23380212|NCT01257542|65137245|FG000|Overall Study|Protocol Violation|3|||
23380213|NCT01257542|65137246|FG001|Overall Study|Protocol Violation|5|||
23380214|NCT01257542|65137245|FG000|Overall Study|Withdrawal by Subject|0|||
23380215|NCT01257542|65137246|FG001|Overall Study|Withdrawal by Subject|2|||
23380216|NCT03822416|65137251|FG000|Overall Study|Lost to Follow-up|1|||
23380217|NCT03822416|65137252|FG001|Overall Study|Lost to Follow-up|0|||
23380218|NCT03822416|65137251|FG000|Overall Study|Withdrawal by Subject|0|||
23380219|NCT03822416|65137252|FG001|Overall Study|Withdrawal by Subject|1|||
23380220|NCT02782104|65137255|FG000|Overall Study|Other|215|||
23380221|NCT02782104|65137255|FG000|Overall Study|Induction Day 28 Non Responder|9|||
23380222|NCT02782104|65137255|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23380223|NCT02782104|65137255|FG000|Overall Study|Death|8|||
23380224|NCT02782104|65137255|FG000|Overall Study|Pregnancy|6|||
23380225|NCT02782104|65137255|FG000|Overall Study|Withdrawal by Subject|63|||
23380226|NCT02782104|65137255|FG000|Overall Study|Protocol Violation|7|||
23380227|NCT02782104|65137255|FG000|Overall Study|Lack of Efficacy|61|||
23380228|NCT02782104|65137255|FG000|Overall Study|Lost to Follow-up|23|||
23380229|NCT02782104|65137255|FG000|Overall Study|Adverse Event|74|||
23380230|NCT03329001|65137256|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380231|NCT03329001|65137257|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380232|NCT03329001|65137258|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
23380233|NCT03329001|65137259|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
23380234|NCT03329001|65137260|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380235|NCT03329001|65137261|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380236|NCT03329001|65137262|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380237|NCT03329001|65137263|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
23380238|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380239|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380240|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380241|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
23380242|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380243|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380244|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380245|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
23380246|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380247|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23287673|NCT01899053|64795826|FG002|Overall Study|Protocol Violation|1|||
23287674|NCT01899053|64795827|FG003|Overall Study|Protocol Violation|0|||
23287675|NCT01899053|64795828|FG004|Overall Study|Protocol Violation|0|||
23287676|NCT01899053|64795829|FG005|Overall Study|Protocol Violation|0|||
23380248|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380249|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
23380250|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380251|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380252|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23287677|NCT01899053|64795830|FG006|Overall Study|Protocol Violation|0|||
23380253|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
23380254|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380255|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23287678|NCT01899053|64795831|FG007|Overall Study|Protocol Violation|0|||
23380256|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380257|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
23380258|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380259|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380260|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380261|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
23380262|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23402828|NCT02185534|65220022|FG005|First Washout Period|Withdrawal by Subject|0|||
23287679|NCT01899053|64795832|FG008|Overall Study|Protocol Violation|0|||
23287680|NCT01899053|64795833|FG009|Overall Study|Protocol Violation|0|||
23287681|NCT01899053|64795834|FG010|Overall Study|Protocol Violation|0|||
23287682|NCT01899053|64795835|FG011|Overall Study|Protocol Violation|0|||
23287683|NCT01899053|64795836|FG012|Overall Study|Protocol Violation|0|||
23287684|NCT01899053|64795837|FG013|Overall Study|Protocol Violation|0|||
23287685|NCT01899053|64795824|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
23287686|NCT01899053|64795825|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
23287687|NCT01899053|64795826|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287688|NCT01899053|64795827|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287689|NCT01899053|64795828|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287690|NCT01899053|64795829|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287691|NCT01899053|64795830|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
23380263|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380264|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
23380265|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380266|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380267|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380268|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23287692|NCT01899053|64795831|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287693|NCT01899053|64795832|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287694|NCT01899053|64795833|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287695|NCT01899053|64795834|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
23287696|NCT01899053|64795835|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287697|NCT01899053|64795836|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287698|NCT01899053|64795837|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
23287699|NCT01899053|64795824|FG000|Overall Study|Symptomatic Deterioration|0|||
23287700|NCT01899053|64795825|FG001|Overall Study|Symptomatic Deterioration|0|||
23287701|NCT01899053|64795826|FG002|Overall Study|Symptomatic Deterioration|0|||
23287702|NCT01899053|64795827|FG003|Overall Study|Symptomatic Deterioration|0|||
23287703|NCT01899053|64795828|FG004|Overall Study|Symptomatic Deterioration|0|||
23287704|NCT01899053|64795829|FG005|Overall Study|Symptomatic Deterioration|1|||
23287705|NCT01899053|64795830|FG006|Overall Study|Symptomatic Deterioration|0|||
23287706|NCT01899053|64795831|FG007|Overall Study|Symptomatic Deterioration|1|||
23287707|NCT01899053|64795832|FG008|Overall Study|Symptomatic Deterioration|0|||
23287708|NCT01899053|64795833|FG009|Overall Study|Symptomatic Deterioration|0|||
23287709|NCT01899053|64795834|FG010|Overall Study|Symptomatic Deterioration|0|||
23287710|NCT01899053|64795835|FG011|Overall Study|Symptomatic Deterioration|1|||
23287711|NCT01899053|64795836|FG012|Overall Study|Symptomatic Deterioration|2|||
23287712|NCT01899053|64795837|FG013|Overall Study|Symptomatic Deterioration|0|||
23287713|NCT01055886|64795839|FG000|Overall Study|Withdrawal by Subject|4|||
23287714|NCT01055886|64795840|FG001|Overall Study|Withdrawal by Subject|9|||
23287715|NCT01055886|64795839|FG000|Overall Study|Lost to Follow-up|1|||
23287716|NCT01055886|64795840|FG001|Overall Study|Lost to Follow-up|1|||
23287717|NCT01055886|64795839|FG000|Overall Study|Withdrawal by PI|0|||
23287718|NCT01055886|64795840|FG001|Overall Study|Withdrawal by PI|1|||
23287719|NCT02751424|64795845|FG000|Part 2|Adverse Event|0|||
23287720|NCT02751424|64795846|FG001|Part 2|Adverse Event|0|||
23287721|NCT02751424|64795847|FG002|Part 2|Adverse Event|0|||
23380269|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
23380270|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380271|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380272|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
23380273|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380274|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380275|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380276|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380277|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
23380278|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380279|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380280|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
23380281|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380282|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23491511|NCT03001882|65545018|FG000|Overall Study|Administrative reason by sponsor|0|||
23287722|NCT02751424|64795848|FG003|Part 2|Adverse Event|0|||
23287723|NCT02751424|64795849|FG004|Part 2|Adverse Event|0|||
23287724|NCT02751424|64795850|FG005|Part 2|Adverse Event|0|||
23380283|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380284|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380285|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
23380286|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380287|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380288|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
23287725|NCT02751424|64795851|FG006|Part 2|Adverse Event|0|||
23287726|NCT02751424|64795852|FG007|Part 2|Adverse Event|5|||
23287727|NCT02751424|64795853|FG008|Part 2|Adverse Event|0|||
23287728|NCT01073631|64795854|FG000|Overall Study|Death|82|||
23287729|NCT01073631|64795854|FG000|Overall Study|Adverse Event|24|||
23287730|NCT01073631|64795854|FG000|Overall Study|Other|63|||
23287731|NCT00057941|64795858|FG000|Overall Study|Death|1|||
23287732|NCT00057941|64795859|FG001|Overall Study|Death|2|||
23287733|NCT00057941|64795858|FG000|Overall Study|Adverse Event|7|||
23287734|NCT00057941|64795859|FG001|Overall Study|Adverse Event|9|||
23380289|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380290|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380291|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380292|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380293|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
23380294|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23287735|NCT00057941|64795858|FG000|Overall Study|Lack of Efficacy|54|||
23287736|NCT00057941|64795859|FG001|Overall Study|Lack of Efficacy|53|||
23380295|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23380296|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
23380297|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
23380298|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23287737|NCT00057941|64795858|FG000|Overall Study|Withdrawal by Subject|6|||
23380299|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23380300|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23402829|NCT02185534|65220017|FG000|First Washout Period|Protocol Violation|0|||
23287738|NCT00057941|64795859|FG001|Overall Study|Withdrawal by Subject|1|||
23287739|NCT00057941|64795858|FG000|Overall Study|still on treatment|3|||
23287740|NCT00057941|64795859|FG001|Overall Study|still on treatment|1|||
23287741|NCT00057941|64795858|FG000|Overall Study|insurance, symptomatic deterioration|1|||
23491512|NCT03001882|65545019|FG001|Overall Study|Administrative reason by sponsor|0|||
23491513|NCT03001882|65545020|FG002|Overall Study|Administrative reason by sponsor|0|||
23491514|NCT03001882|65545021|FG003|Overall Study|Administrative reason by sponsor|1|||
23491515|NCT03001882|65545018|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
23491516|NCT03001882|65545019|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
23491517|NCT03001882|65545020|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
23491518|NCT03001882|65545021|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
23491519|NCT03001882|65545018|FG000|Overall Study|Not reported|0|||
23491520|NCT03001882|65545019|FG001|Overall Study|Not reported|0|||
23491521|NCT03001882|65545020|FG002|Overall Study|Not reported|0|||
23491522|NCT03001882|65545021|FG003|Overall Study|Not reported|6|||
23491523|NCT03001882|65545018|FG000|Overall Study|Maximum clinical benefit|2|||
23491524|NCT03001882|65545019|FG001|Overall Study|Maximum clinical benefit|3|||
23491525|NCT03001882|65545020|FG002|Overall Study|Maximum clinical benefit|0|||
23491526|NCT03001882|65545021|FG003|Overall Study|Maximum clinical benefit|10|||
23491527|NCT03001882|65545018|FG000|Overall Study|AE unrelated to study drug|3|||
23491528|NCT03001882|65545019|FG001|Overall Study|AE unrelated to study drug|3|||
23491529|NCT03001882|65545020|FG002|Overall Study|AE unrelated to study drug|0|||
23491530|NCT03001882|65545021|FG003|Overall Study|AE unrelated to study drug|11|||
23491531|NCT03001882|65545018|FG000|Overall Study|Study Drug Toxicity|8|||
23491532|NCT03001882|65545019|FG001|Overall Study|Study Drug Toxicity|5|||
23491533|NCT03001882|65545020|FG002|Overall Study|Study Drug Toxicity|0|||
23491534|NCT03001882|65545021|FG003|Overall Study|Study Drug Toxicity|37|||
23491535|NCT03001882|65545018|FG000|Overall Study|Disease progression|16|||
23491536|NCT03001882|65545019|FG001|Overall Study|Disease progression|14|||
23491537|NCT03001882|65545020|FG002|Overall Study|Disease progression|1|||
23491538|NCT03001882|65545021|FG003|Overall Study|Disease progression|90|||
23491539|NCT03800173|65545022|FG000|Overall Study|Lost to Follow-up|0|||
23491540|NCT03800173|65545023|FG001|Overall Study|Lost to Follow-up|0|||
23605854|NCT01138657|65947078|FG000|Overall Study|Lack of Efficacy|2|||
23605855|NCT01138657|65947079|FG001|Overall Study|Lack of Efficacy|1|||
23605856|NCT01138657|65947078|FG000|Overall Study|Lost to Follow-up|0|||
23605857|NCT01138657|65947079|FG001|Overall Study|Lost to Follow-up|3|||
23287742|NCT00057941|64795859|FG001|Overall Study|insurance, symptomatic deterioration|3|||
23287743|NCT00057941|64795858|FG000|Overall Study|Ineligible|2|||
23287744|NCT00057941|64795859|FG001|Overall Study|Ineligible|5|||
23287745|NCT00766493|64795862|FG000|30 Days Post-Procedure|Discontinued|7|||
23287746|NCT00766493|64795862|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
23287747|NCT00766493|64795862|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
23287748|NCT04203823|64795867|FG000|Overall Study|Withdrawal by Subject|2|||
23287749|NCT04203823|64795868|FG001|Overall Study|Withdrawal by Subject|2|||
23287750|NCT04203823|64795867|FG000|Overall Study|Adverse Event|1|||
23287751|NCT04203823|64795868|FG001|Overall Study|Adverse Event|1|||
23287752|NCT04203823|64795867|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23287753|NCT04203823|64795868|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
23287754|NCT02212457|64795885|FG000|Overall Study|Adverse Event|1|||
23287755|NCT02212457|64795886|FG001|Overall Study|Adverse Event|2|||
23287756|NCT02212457|64795887|FG002|Overall Study|Adverse Event|2|||
23287757|NCT02212457|64795888|FG003|Overall Study|Adverse Event|2|||
23287758|NCT02212457|64795889|FG004|Overall Study|Adverse Event|0|||
23287759|NCT02212457|64795890|FG005|Overall Study|Adverse Event|1|||
23287760|NCT02212457|64795885|FG000|Overall Study|Withdrawal by Subject|8|||
23605858|NCT01138657|65947078|FG000|Overall Study|Miscellaneous Reasons|3|||
23605859|NCT01138657|65947079|FG001|Overall Study|Miscellaneous Reasons|4|||
23605860|NCT02196259|65947080|FG000|Overall Study|Researcher choice|0|||
23605861|NCT02196259|65947081|FG001|Overall Study|Researcher choice|0|||
23605862|NCT02196259|65947082|FG002|Overall Study|Researcher choice|1|||
23605863|NCT02196259|65947080|FG000|Overall Study|Partial data analysis|0|||
23605864|NCT02196259|65947081|FG001|Overall Study|Partial data analysis|3|||
23287761|NCT02212457|64795886|FG001|Overall Study|Withdrawal by Subject|10|||
23491541|NCT03800173|65545024|FG002|Overall Study|Lost to Follow-up|0|||
23491542|NCT03800173|65545025|FG003|Overall Study|Lost to Follow-up|0|||
23491543|NCT03800173|65545026|FG004|Overall Study|Lost to Follow-up|1|||
23491544|NCT03228420|65545027|FG000|Overall Study|Lost to Follow-up|5|||
23491545|NCT03228420|65545028|FG001|Overall Study|Lost to Follow-up|3|||
23491546|NCT03228420|65545027|FG000|Overall Study|Withdrawal by Subject|10|||
23491547|NCT03228420|65545028|FG001|Overall Study|Withdrawal by Subject|0|||
23491548|NCT03228420|65545027|FG000|Overall Study|Adverse Event|5|||
23491549|NCT03228420|65545028|FG001|Overall Study|Adverse Event|2|||
23491550|NCT02905149|65545029|FG000|Overall Study|Lost to Follow-up|2|||
23491551|NCT02905149|65545030|FG001|Overall Study|Lost to Follow-up|0|||
23491552|NCT03004443|65545031|FG000|Overall Study|Pregnancy|0|||
23491553|NCT03004443|65545032|FG001|Overall Study|Pregnancy|1|||
23491554|NCT01298531|65545033|FG000|Overall Study|Lack of Efficacy|0|||
23491555|NCT01298531|65545034|FG001|Overall Study|Lack of Efficacy|1|||
23491556|NCT01298531|65545033|FG000|Overall Study|Lost to Follow-up|2|||
23491557|NCT01298531|65545034|FG001|Overall Study|Lost to Follow-up|0|||
23491558|NCT01298531|65545033|FG000|Overall Study|Protocol Violation|1|||
23491559|NCT01298531|65545034|FG001|Overall Study|Protocol Violation|1|||
23491560|NCT01298531|65545033|FG000|Overall Study|Adverse Event|4|||
23491561|NCT01298531|65545034|FG001|Overall Study|Adverse Event|3|||
23491562|NCT01298531|65545033|FG000|Overall Study|Does not meet entrance criteria|0|||
23491563|NCT01298531|65545034|FG001|Overall Study|Does not meet entrance criteria|1|||
23491564|NCT01298531|65545033|FG000|Overall Study|Other|2|||
23491565|NCT01298531|65545034|FG001|Overall Study|Other|1|||
23491566|NCT01927627|65545035|FG000|Overall Study|Adverse Event|3|||
23491567|NCT01927627|65545035|FG000|Overall Study|Lack of Efficacy|1|||
23491568|NCT01927627|65545035|FG000|Overall Study|Financial Concerns|1|||
23491569|NCT03633617|65545036|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
23491570|NCT03633617|65545037|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
23491571|NCT03633617|65545038|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491572|NCT03633617|65545039|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491573|NCT03633617|65545040|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491574|NCT03633617|65545041|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491575|NCT03633617|65545042|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491576|NCT03633617|65545043|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491577|NCT03633617|65545044|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491578|NCT03633617|65545045|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491579|NCT03633617|65545046|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
23491580|NCT03633617|65545036|FG000|Part A|Unconfirmed early termination visit|1|||
23491581|NCT03633617|65545037|FG001|Part A|Unconfirmed early termination visit|0|||
23491582|NCT03633617|65545038|FG002|Part A|Unconfirmed early termination visit|0|||
23491583|NCT03633617|65545039|FG003|Part A|Unconfirmed early termination visit|0|||
23491584|NCT03633617|65545040|FG004|Part A|Unconfirmed early termination visit|0|||
23491585|NCT03633617|65545041|FG005|Part A|Unconfirmed early termination visit|0|||
23491586|NCT03633617|65545042|FG006|Part A|Unconfirmed early termination visit|0|||
23491587|NCT03633617|65545043|FG007|Part A|Unconfirmed early termination visit|0|||
23491588|NCT03633617|65545044|FG008|Part A|Unconfirmed early termination visit|0|||
23491589|NCT03633617|65545045|FG009|Part A|Unconfirmed early termination visit|0|||
23491590|NCT03633617|65545046|FG010|Part A|Unconfirmed early termination visit|0|||
23491591|NCT03633617|65545036|FG000|Part A|Adverse Event|0|||
23491592|NCT03633617|65545037|FG001|Part A|Adverse Event|1|||
23605865|NCT02196259|65947082|FG002|Overall Study|Partial data analysis|0|||
23605866|NCT00871715|65947083|FG000|Overall Study|Withdrawal by Subject|6|||
23605867|NCT00871715|65947084|FG001|Overall Study|Withdrawal by Subject|10|||
23605868|NCT00871715|65947085|FG002|Overall Study|Withdrawal by Subject|15|||
23605869|NCT00871715|65947083|FG000|Overall Study|Physician Decision|6|||
23605870|NCT00871715|65947084|FG001|Overall Study|Physician Decision|0|||
23605871|NCT00871715|65947085|FG002|Overall Study|Physician Decision|2|||
23605872|NCT00871715|65947083|FG000|Overall Study|Lost to Follow-up|3|||
23605873|NCT00871715|65947084|FG001|Overall Study|Lost to Follow-up|6|||
23605874|NCT00871715|65947085|FG002|Overall Study|Lost to Follow-up|9|||
23605875|NCT02309515|65947086|FG000|Overall Study|Withdrawal by Subject|0|||
23605876|NCT02309515|65947087|FG001|Overall Study|Withdrawal by Subject|1|||
23605877|NCT01855399|65947090|FG000|6 Month|Lost to Follow-up|12|||
23605878|NCT01855399|65947091|FG001|6 Month|Lost to Follow-up|9|||
23605879|NCT01855399|65947090|FG000|6 Month|Withdrawal by Subject|8|||
23605880|NCT01855399|65947091|FG001|6 Month|Withdrawal by Subject|6|||
23605881|NCT01855399|65947090|FG000|12 Month|Lost to Follow-up|7|||
23605882|NCT01855399|65947091|FG001|12 Month|Lost to Follow-up|11|||
23605883|NCT01109979|65947092|FG000|Overall Study|Physician Decision|2|||
23605884|NCT01109979|65947093|FG001|Overall Study|Physician Decision|0|||
23605885|NCT01109979|65947092|FG000|Overall Study|Withdrawal by Subject|0|||
23491593|NCT03633617|65545038|FG002|Part A|Adverse Event|0|||
23491594|NCT03633617|65545039|FG003|Part A|Adverse Event|0|||
23491595|NCT03633617|65545040|FG004|Part A|Adverse Event|0|||
23491596|NCT03633617|65545041|FG005|Part A|Adverse Event|0|||
23491597|NCT03633617|65545042|FG006|Part A|Adverse Event|0|||
23491598|NCT03633617|65545043|FG007|Part A|Adverse Event|0|||
23605886|NCT01109979|65947093|FG001|Overall Study|Withdrawal by Subject|1|||
23287762|NCT02212457|64795887|FG002|Overall Study|Withdrawal by Subject|8|||
23287763|NCT02212457|64795888|FG003|Overall Study|Withdrawal by Subject|6|||
23287764|NCT02212457|64795889|FG004|Overall Study|Withdrawal by Subject|5|||
23287765|NCT02212457|64795890|FG005|Overall Study|Withdrawal by Subject|4|||
23287766|NCT02212457|64795885|FG000|Overall Study|Lost to Follow-up|6|||
23287767|NCT02212457|64795886|FG001|Overall Study|Lost to Follow-up|7|||
23287768|NCT02212457|64795887|FG002|Overall Study|Lost to Follow-up|4|||
23287769|NCT02212457|64795888|FG003|Overall Study|Lost to Follow-up|1|||
23287770|NCT02212457|64795889|FG004|Overall Study|Lost to Follow-up|8|||
23287771|NCT02212457|64795890|FG005|Overall Study|Lost to Follow-up|4|||
23287772|NCT02212457|64795885|FG000|Overall Study|Protocol Violation|2|||
23287773|NCT02212457|64795886|FG001|Overall Study|Protocol Violation|1|||
23287774|NCT02212457|64795887|FG002|Overall Study|Protocol Violation|0|||
23287775|NCT02212457|64795888|FG003|Overall Study|Protocol Violation|1|||
23287776|NCT02212457|64795889|FG004|Overall Study|Protocol Violation|2|||
23287777|NCT02212457|64795890|FG005|Overall Study|Protocol Violation|3|||
23287778|NCT02212457|64795885|FG000|Overall Study|Other|2|||
23287779|NCT02212457|64795886|FG001|Overall Study|Other|1|||
23287780|NCT02212457|64795887|FG002|Overall Study|Other|2|||
23287781|NCT02212457|64795888|FG003|Overall Study|Other|1|||
23287782|NCT02212457|64795889|FG004|Overall Study|Other|0|||
23287783|NCT02212457|64795890|FG005|Overall Study|Other|1|||
23287784|NCT00640926|64795891|FG000|Overall Study|Adverse Event|2|||
23287785|NCT00640926|64795892|FG001|Overall Study|Adverse Event|3|||
23287786|NCT00640926|64795893|FG002|Overall Study|Adverse Event|2|||
23287787|NCT00640926|64795891|FG000|Overall Study|Lack of Efficacy|0|||
23287788|NCT00640926|64795892|FG001|Overall Study|Lack of Efficacy|2|||
23287789|NCT00640926|64795893|FG002|Overall Study|Lack of Efficacy|1|||
23380301|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
23380302|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380303|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380304|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
23380305|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380306|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380307|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380308|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380309|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
23380310|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380311|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380312|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
23380313|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
23380314|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380315|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380316|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380317|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
23380318|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380319|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380320|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
23380321|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
23380322|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380323|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380324|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380325|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
23380326|NCT03329001|65137256|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380327|NCT03329001|65137257|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380328|NCT03329001|65137258|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
23380329|NCT03329001|65137259|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
23380330|NCT03329001|65137260|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380331|NCT03329001|65137261|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380332|NCT03329001|65137262|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380333|NCT03329001|65137263|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
23380334|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23491599|NCT03633617|65545044|FG008|Part A|Adverse Event|0|||
23491600|NCT03633617|65545045|FG009|Part A|Adverse Event|0|||
23605887|NCT00807599|65947094|FG000|Overall Study|Not treated on protocol study|0|||
23605888|NCT00807599|65947095|FG001|Overall Study|Not treated on protocol study|0|||
23605889|NCT00807599|65947096|FG002|Overall Study|Not treated on protocol study|2|||
23605890|NCT00807599|65947094|FG000|Overall Study|Adverse Event|0|||
23605891|NCT00807599|65947095|FG001|Overall Study|Adverse Event|0|||
23605892|NCT00807599|65947096|FG002|Overall Study|Adverse Event|5|||
23605893|NCT00807599|65947094|FG000|Overall Study|Inadequate response to induction|0|||
23605894|NCT00807599|65947095|FG001|Overall Study|Inadequate response to induction|0|||
23605895|NCT00807599|65947096|FG002|Overall Study|Inadequate response to induction|9|||
23605896|NCT00807599|65947094|FG000|Overall Study|Withdrawal by Subject|0|||
23605897|NCT00807599|65947095|FG001|Overall Study|Withdrawal by Subject|0|||
23605898|NCT00807599|65947096|FG002|Overall Study|Withdrawal by Subject|1|||
23605899|NCT02340806|65947097|FG000|Overall Study|Protocol Violation|2|||
23605900|NCT02340806|65947098|FG001|Overall Study|Protocol Violation|0|||
23605901|NCT02340806|65947097|FG000|Overall Study|epidural catheter replaced|2|||
23605902|NCT02340806|65947098|FG001|Overall Study|epidural catheter replaced|1|||
23287790|NCT00640926|64795891|FG000|Overall Study|Protocol Violation|2|||
23287791|NCT00640926|64795892|FG001|Overall Study|Protocol Violation|0|||
23287792|NCT00640926|64795893|FG002|Overall Study|Protocol Violation|2|||
23287793|NCT00640926|64795891|FG000|Overall Study|Lost to Follow-up|3|||
23287794|NCT00640926|64795892|FG001|Overall Study|Lost to Follow-up|1|||
23287795|NCT00640926|64795893|FG002|Overall Study|Lost to Follow-up|2|||
23287796|NCT00640926|64795891|FG000|Overall Study|Withdrawal by Subject|1|||
23287797|NCT00640926|64795892|FG001|Overall Study|Withdrawal by Subject|0|||
23605903|NCT02340806|65947097|FG000|Overall Study|history of chronic pain medication|1|||
23605904|NCT02340806|65947098|FG001|Overall Study|history of chronic pain medication|0|||
23605905|NCT02340806|65947097|FG000|Overall Study|re-dose < 90 min of CSE|1|||
23605906|NCT02340806|65947098|FG001|Overall Study|re-dose < 90 min of CSE|3|||
23605907|NCT01640951|65947101|FG000|Overall Study|Adverse Event|8|||
23605908|NCT01640951|65947102|FG001|Overall Study|Adverse Event|3|||
23605909|NCT01640951|65947103|FG002|Overall Study|Adverse Event|10|||
23605910|NCT01640951|65947104|FG003|Overall Study|Adverse Event|6|||
23605911|NCT01640951|65947105|FG004|Overall Study|Adverse Event|1|||
23605912|NCT01640951|65947106|FG005|Overall Study|Adverse Event|11|||
23287798|NCT00640926|64795893|FG002|Overall Study|Withdrawal by Subject|1|||
23287799|NCT01142908|64795894|FG000|Overall Study|Lost to Follow-up|19|||
23605913|NCT01640951|65947107|FG006|Overall Study|Adverse Event|1|||
23287800|NCT01142908|64795895|FG001|Overall Study|Lost to Follow-up|13|||
23287801|NCT01142908|64795894|FG000|Overall Study|Death|1|||
23287802|NCT01142908|64795895|FG001|Overall Study|Death|4|||
23287803|NCT01142908|64795894|FG000|Overall Study|Excluded - did not meet criteria|9|||
23287804|NCT01142908|64795895|FG001|Overall Study|Excluded - did not meet criteria|5|||
23287805|NCT01142908|64795894|FG000|Overall Study|Withdrawal by Subject|3|||
23287806|NCT01142908|64795895|FG001|Overall Study|Withdrawal by Subject|0|||
23287807|NCT04608448|64795900|FG000|Overall Study|Withdrawal by Subject|1|||
23287808|NCT04608448|64795900|FG000|Overall Study|Adverse Event|1|||
23287809|NCT02483416|64795906|FG000|Overall Study|Other reason|0|||
23287810|NCT02483416|64795907|FG001|Overall Study|Other reason|1|||
23287811|NCT02483416|64795906|FG000|Overall Study|Treatment stop|3|||
23287812|NCT02483416|64795907|FG001|Overall Study|Treatment stop|0|||
23287813|NCT02028455|64795912|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23287814|NCT02028455|64795913|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23491601|NCT03633617|65545046|FG010|Part A|Adverse Event|0|||
23380335|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380336|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380337|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
23380338|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380339|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380340|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380341|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
23380342|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380343|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380344|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380345|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
23380346|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380347|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380348|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380349|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
23380350|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380351|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380352|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
23380353|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380354|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380355|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380356|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23287815|NCT02028455|64795914|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23287816|NCT02028455|64795915|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23287817|NCT02028455|64795916|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23287818|NCT02028455|64795917|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
23287819|NCT02028455|64795918|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
23287820|NCT02028455|64795919|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
23287821|NCT02028455|64795912|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
23287822|NCT02028455|64795913|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
23287823|NCT02028455|64795914|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
23287824|NCT02028455|64795915|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
23287825|NCT02028455|64795916|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
23287826|NCT02028455|64795917|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
23287827|NCT02028455|64795918|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
23287828|NCT02028455|64795919|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
23287829|NCT02028455|64795912|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23287830|NCT02028455|64795913|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23287831|NCT02028455|64795914|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23287832|NCT02028455|64795915|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23287833|NCT02028455|64795916|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23287834|NCT02028455|64795917|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
23287835|NCT02028455|64795918|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
23380357|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
23380358|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380359|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380360|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
23380361|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
23380362|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380363|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380364|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380365|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
23380366|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380367|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380368|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
23380369|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380370|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380371|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380372|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380373|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
23380374|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380375|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380376|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
23380377|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380378|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380379|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380380|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23402830|NCT02185534|65220018|FG001|First Washout Period|Protocol Violation|0|||
23287836|NCT02028455|64795919|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
23287837|NCT02028455|64795912|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
23287838|NCT02028455|64795913|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
23287839|NCT02028455|64795914|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
23287840|NCT02028455|64795915|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
23287841|NCT02028455|64795916|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
23287842|NCT02028455|64795917|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
23287843|NCT02028455|64795918|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
23287844|NCT02028455|64795919|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
23287845|NCT00642811|64795920|FG000|Overall Study|Adverse Event|2|||
23287846|NCT00642811|64795921|FG001|Overall Study|Adverse Event|3|||
23287847|NCT00642811|64795922|FG002|Overall Study|Adverse Event|0|||
23287848|NCT00642811|64795923|FG003|Overall Study|Adverse Event|0|||
23287849|NCT00642811|64795924|FG004|Overall Study|Adverse Event|0|||
23287850|NCT00642811|64795925|FG005|Overall Study|Adverse Event|1|||
23287851|NCT00642811|64795920|FG000|Overall Study|Developement of discontinuation criteria|0|||
23287852|NCT00642811|64795921|FG001|Overall Study|Developement of discontinuation criteria|0|||
23287853|NCT00642811|64795922|FG002|Overall Study|Developement of discontinuation criteria|0|||
23287854|NCT00642811|64795923|FG003|Overall Study|Developement of discontinuation criteria|0|||
23287855|NCT00642811|64795924|FG004|Overall Study|Developement of discontinuation criteria|1|||
23287856|NCT00642811|64795925|FG005|Overall Study|Developement of discontinuation criteria|0|||
23287857|NCT00642811|64795920|FG000|Overall Study|Severe Non-compliance to protocol|1|||
23287858|NCT00642811|64795921|FG001|Overall Study|Severe Non-compliance to protocol|0|||
23287859|NCT00642811|64795922|FG002|Overall Study|Severe Non-compliance to protocol|0|||
23287860|NCT00642811|64795923|FG003|Overall Study|Severe Non-compliance to protocol|0|||
23287861|NCT00642811|64795924|FG004|Overall Study|Severe Non-compliance to protocol|0|||
23287862|NCT00642811|64795925|FG005|Overall Study|Severe Non-compliance to protocol|0|||
23287863|NCT00642811|64795920|FG000|Overall Study|Other|0|||
23287864|NCT00642811|64795921|FG001|Overall Study|Other|1|||
23287865|NCT00642811|64795922|FG002|Overall Study|Other|0|||
23287866|NCT00642811|64795923|FG003|Overall Study|Other|1|||
23287867|NCT00642811|64795924|FG004|Overall Study|Other|0|||
23287868|NCT00642811|64795925|FG005|Overall Study|Other|0|||
23287869|NCT02896296|64798839|FG000|Overall Study|Adverse Event|1|||
23287870|NCT02896296|64798839|FG000|Overall Study|Lost to Follow-up|19|||
23287871|NCT02896296|64798839|FG000|Overall Study|Pregnancy|1|||
23287872|NCT02896296|64798839|FG000|Overall Study|Physician Decision|2|||
23287873|NCT02896296|64798839|FG000|Overall Study|Withdrawal by Subject|10|||
23287874|NCT02896296|64798839|FG000|Overall Study|Site closing|7|||
23287875|NCT02896296|64798839|FG000|Overall Study|Incarceration|1|||
23287876|NCT02896296|64798839|FG000|Overall Study|Relocation|1|||
23287877|NCT01970592|64798842|FG000|Overall Study|Withdrawal by Subject|4|||
23287878|NCT01970592|64798842|FG000|Overall Study|Physician Decision|1|||
23287879|NCT01970592|64798842|FG000|Overall Study|Adverse Event|1|||
23287880|NCT01120691|64798843|FG000|Overall Study|Adverse Event|59|||
23287881|NCT01120691|64798844|FG001|Overall Study|Adverse Event|67|||
23287882|NCT01120691|64798845|FG002|Overall Study|Adverse Event|47|||
23287883|NCT01120691|64798843|FG000|Overall Study|Subject withdrew consent|33|||
23287884|NCT01120691|64798844|FG001|Overall Study|Subject withdrew consent|50|||
23287885|NCT01120691|64798845|FG002|Overall Study|Subject withdrew consent|44|||
23287886|NCT01120691|64798843|FG000|Overall Study|Death|21|||
23287887|NCT01120691|64798844|FG001|Overall Study|Death|22|||
23287888|NCT01120691|64798845|FG002|Overall Study|Death|24|||
23287889|NCT01120691|64798843|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
23287890|NCT01120691|64798844|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
23287891|NCT01120691|64798845|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
23287892|NCT01120691|64798843|FG000|Overall Study|Administrative problems|15|||
23287893|NCT01120691|64798844|FG001|Overall Study|Administrative problems|8|||
23287894|NCT01120691|64798845|FG002|Overall Study|Administrative problems|9|||
23287895|NCT01120691|64798843|FG000|Overall Study|Protocol deviation|13|||
23287896|NCT01120691|64798844|FG001|Overall Study|Protocol deviation|12|||
23287897|NCT01120691|64798845|FG002|Overall Study|Protocol deviation|12|||
23287898|NCT01120691|64798843|FG000|Overall Study|Lost to Follow-up|5|||
23287899|NCT01120691|64798844|FG001|Overall Study|Lost to Follow-up|6|||
23287900|NCT01120691|64798845|FG002|Overall Study|Lost to Follow-up|4|||
23287901|NCT01120691|64798843|FG000|Overall Study|Abnormal test procedure result(s)|3|||
23287902|NCT01120691|64798844|FG001|Overall Study|Abnormal test procedure result(s)|2|||
23287903|NCT01120691|64798845|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23287904|NCT01120691|64798843|FG000|Overall Study|Patient's inability to use the device|3|||
23287905|NCT01120691|64798844|FG001|Overall Study|Patient's inability to use the device|1|||
23287906|NCT01120691|64798845|FG002|Overall Study|Patient's inability to use the device|0|||
23287907|NCT01120691|64798843|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23287908|NCT01120691|64798844|FG001|Overall Study|Abnormal laboratory value(s)|3|||
23287909|NCT01120691|64798845|FG002|Overall Study|Abnormal laboratory value(s)|4|||
23287910|NCT01928615|64798848|FG000|Overall Study|Study Terminated by Sponsor|2|||
23287911|NCT02359864|64798849|FG000|Overall Study|Withdrawal by Subject|1|||
23287912|NCT02359864|64798850|FG001|Overall Study|Withdrawal by Subject|0|||
23287913|NCT02597049|64798851|FG000|Overall Study|Lost to Follow-up|0|||
23287914|NCT02597049|64798852|FG001|Overall Study|Lost to Follow-up|3|||
23287915|NCT02597049|64798853|FG002|Overall Study|Lost to Follow-up|2|||
23287916|NCT02597049|64798851|FG000|Overall Study|Withdrawal by Subject|2|||
23287917|NCT02597049|64798852|FG001|Overall Study|Withdrawal by Subject|2|||
23287918|NCT02597049|64798853|FG002|Overall Study|Withdrawal by Subject|1|||
23287919|NCT02597049|64798851|FG000|Overall Study|Adverse Event|2|||
23287920|NCT02597049|64798852|FG001|Overall Study|Adverse Event|0|||
23380381|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
23380382|NCT03329001|65137256|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380383|NCT03329001|65137257|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380384|NCT03329001|65137258|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380385|NCT03329001|65137259|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
23380386|NCT03329001|65137260|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380387|NCT03329001|65137261|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380388|NCT03329001|65137262|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380389|NCT03329001|65137263|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
23380390|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380391|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380392|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380393|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380394|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380395|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
23380396|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380397|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
23380398|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380399|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23287921|NCT02597049|64798853|FG002|Overall Study|Adverse Event|0|||
23287922|NCT02597049|64798851|FG000|Overall Study|Death|2|||
23380400|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380401|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380402|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
23380403|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380404|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380405|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
23380406|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380407|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380408|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380409|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380410|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
23380411|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
23380412|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380413|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
23380414|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23287923|NCT02597049|64798852|FG001|Overall Study|Death|0|||
23287924|NCT02597049|64798853|FG002|Overall Study|Death|0|||
23287925|NCT02597049|64798851|FG000|Overall Study|Noncompliant with Study Visits|1|||
23287926|NCT02597049|64798852|FG001|Overall Study|Noncompliant with Study Visits|0|||
23287927|NCT02597049|64798853|FG002|Overall Study|Noncompliant with Study Visits|0|||
23287928|NCT01617096|64798856|FG000|Overall Study|Withdrawal by Subject|96|||
23287929|NCT01617096|64798857|FG001|Overall Study|Withdrawal by Subject|81|||
23287930|NCT01617096|64798856|FG000|Overall Study|Lost to Follow-up|37|||
23287931|NCT01617096|64798857|FG001|Overall Study|Lost to Follow-up|32|||
23287932|NCT01617096|64798856|FG000|Overall Study|Physician Decision|10|||
23287933|NCT01617096|64798857|FG001|Overall Study|Physician Decision|18|||
23287934|NCT01617096|64798856|FG000|Overall Study|Death|4|||
23287935|NCT01617096|64798857|FG001|Overall Study|Death|3|||
23287936|NCT01617096|64798856|FG000|Overall Study|Other|1|||
23287937|NCT01617096|64798857|FG001|Overall Study|Other|3|||
23287938|NCT00112437|64798858|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
23287939|NCT00112437|64798859|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
23287940|NCT00112437|64798860|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
23287941|NCT00112437|64798861|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
23287942|NCT00112437|64798862|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
23287943|NCT00112437|64798863|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287944|NCT00112437|64798864|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287945|NCT00112437|64798865|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287946|NCT00112437|64798866|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287947|NCT00112437|64798867|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287948|NCT00112437|64798868|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287949|NCT00112437|64798869|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287950|NCT00112437|64798870|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287951|NCT00112437|64798871|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287952|NCT00112437|64798872|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287953|NCT00112437|64798873|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287954|NCT00112437|64798874|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287955|NCT00112437|64798875|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287956|NCT00112437|64798876|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287957|NCT00112437|64798877|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
23380415|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23380416|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23380417|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23380418|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
23380419|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23380420|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23491602|NCT03633617|65545036|FG000|Part A|Pregnancy|1|||
23491603|NCT03633617|65545037|FG001|Part A|Pregnancy|0|||
23491604|NCT03633617|65545038|FG002|Part A|Pregnancy|0|||
23287958|NCT00112437|64798878|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287959|NCT00112437|64798879|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
23491605|NCT03633617|65545039|FG003|Part A|Pregnancy|0|||
23491606|NCT03633617|65545040|FG004|Part A|Pregnancy|0|||
23491607|NCT03633617|65545041|FG005|Part A|Pregnancy|0|||
23491608|NCT03633617|65545042|FG006|Part A|Pregnancy|0|||
23491609|NCT03633617|65545043|FG007|Part A|Pregnancy|0|||
23491610|NCT03633617|65545044|FG008|Part A|Pregnancy|0|||
23287960|NCT00112437|64798880|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287961|NCT00112437|64798881|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287962|NCT00112437|64798882|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287963|NCT00112437|64798883|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
23287964|NCT00112437|64798858|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287965|NCT00112437|64798859|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
23287966|NCT00112437|64798860|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287967|NCT00112437|64798861|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287968|NCT00112437|64798862|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287969|NCT00112437|64798863|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287970|NCT00112437|64798864|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287971|NCT00112437|64798865|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287972|NCT00112437|64798866|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287973|NCT00112437|64798867|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287974|NCT00112437|64798868|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23380421|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
23491611|NCT03633617|65545045|FG009|Part A|Pregnancy|0|||
23491612|NCT03633617|65545046|FG010|Part A|Pregnancy|0|||
23491613|NCT03633617|65545036|FG000|Part A|Withdrawal by Subject|0|||
23491614|NCT03633617|65545037|FG001|Part A|Withdrawal by Subject|1|||
23491615|NCT03633617|65545038|FG002|Part A|Withdrawal by Subject|0|||
23491616|NCT03633617|65545039|FG003|Part A|Withdrawal by Subject|0|||
23491617|NCT03633617|65545040|FG004|Part A|Withdrawal by Subject|0|||
23491618|NCT03633617|65545041|FG005|Part A|Withdrawal by Subject|0|||
23491619|NCT03633617|65545042|FG006|Part A|Withdrawal by Subject|0|||
23491620|NCT03633617|65545043|FG007|Part A|Withdrawal by Subject|0|||
23491621|NCT03633617|65545044|FG008|Part A|Withdrawal by Subject|0|||
23491622|NCT03633617|65545045|FG009|Part A|Withdrawal by Subject|0|||
23491623|NCT03633617|65545046|FG010|Part A|Withdrawal by Subject|0|||
23491624|NCT03633617|65545036|FG000|Part B|Adverse Event|0|||
23491625|NCT03633617|65545037|FG001|Part B|Adverse Event|0|||
23491626|NCT03633617|65545038|FG002|Part B|Adverse Event|2|||
23491627|NCT03633617|65545039|FG003|Part B|Adverse Event|2|||
23491628|NCT03633617|65545040|FG004|Part B|Adverse Event|1|||
23491629|NCT03633617|65545041|FG005|Part B|Adverse Event|0|||
23491630|NCT03633617|65545042|FG006|Part B|Adverse Event|0|||
23491631|NCT03633617|65545043|FG007|Part B|Adverse Event|0|||
23491632|NCT03633617|65545044|FG008|Part B|Adverse Event|0|||
23491633|NCT03633617|65545045|FG009|Part B|Adverse Event|0|||
23491634|NCT03633617|65545046|FG010|Part B|Adverse Event|0|||
23491635|NCT03633617|65545036|FG000|Part B|Withdrawal by Subject|0|||
23491636|NCT03633617|65545037|FG001|Part B|Withdrawal by Subject|0|||
23491637|NCT03633617|65545038|FG002|Part B|Withdrawal by Subject|1|||
23491638|NCT03633617|65545039|FG003|Part B|Withdrawal by Subject|0|||
23491639|NCT03633617|65545040|FG004|Part B|Withdrawal by Subject|2|||
23491640|NCT03633617|65545041|FG005|Part B|Withdrawal by Subject|0|||
23287975|NCT00112437|64798869|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287976|NCT00112437|64798870|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287977|NCT00112437|64798871|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287978|NCT00112437|64798872|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287979|NCT00112437|64798873|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23491641|NCT03633617|65545042|FG006|Part B|Withdrawal by Subject|0|||
23491642|NCT03633617|65545043|FG007|Part B|Withdrawal by Subject|0|||
23491643|NCT03633617|65545044|FG008|Part B|Withdrawal by Subject|0|||
23491644|NCT03633617|65545045|FG009|Part B|Withdrawal by Subject|0|||
23491645|NCT03633617|65545046|FG010|Part B|Withdrawal by Subject|0|||
23491646|NCT03633617|65545036|FG000|Part B|Lost to Follow-up|0|||
23491647|NCT03633617|65545037|FG001|Part B|Lost to Follow-up|0|||
23491648|NCT03633617|65545038|FG002|Part B|Lost to Follow-up|0|||
23491649|NCT03633617|65545039|FG003|Part B|Lost to Follow-up|0|||
23491650|NCT03633617|65545040|FG004|Part B|Lost to Follow-up|1|||
23491651|NCT03633617|65545041|FG005|Part B|Lost to Follow-up|0|||
23380422|NCT03329001|65137256|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380423|NCT03329001|65137257|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380424|NCT03329001|65137258|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380425|NCT03329001|65137259|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380426|NCT03329001|65137260|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
23380427|NCT03329001|65137261|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
23380428|NCT03329001|65137262|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380429|NCT03329001|65137263|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
23380430|NCT03329001|65137256|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380431|NCT03329001|65137257|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380432|NCT03329001|65137258|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380433|NCT03329001|65137259|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380434|NCT03329001|65137260|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380435|NCT03329001|65137261|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
23380436|NCT03329001|65137262|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
23380437|NCT03329001|65137263|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
23380438|NCT03329001|65137256|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23287980|NCT00112437|64798874|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287981|NCT00112437|64798875|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287982|NCT00112437|64798876|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287983|NCT00112437|64798877|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287984|NCT00112437|64798878|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287985|NCT00112437|64798879|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287986|NCT00112437|64798880|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287987|NCT00112437|64798881|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287988|NCT00112437|64798882|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287989|NCT00112437|64798883|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
23287990|NCT00112437|64798858|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23287991|NCT00112437|64798859|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
23287992|NCT00112437|64798860|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23287993|NCT00112437|64798861|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23287994|NCT00112437|64798862|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23380439|NCT03329001|65137257|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380440|NCT03329001|65137258|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380441|NCT03329001|65137259|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380442|NCT03329001|65137260|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380443|NCT03329001|65137261|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380444|NCT03329001|65137262|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
23380445|NCT03329001|65137263|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
23380446|NCT03329001|65137256|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23287995|NCT00112437|64798863|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23287996|NCT00112437|64798864|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23287997|NCT00112437|64798865|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23287998|NCT00112437|64798866|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23287999|NCT00112437|64798867|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288000|NCT00112437|64798868|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288001|NCT00112437|64798869|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288002|NCT00112437|64798870|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288003|NCT00112437|64798871|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288004|NCT00112437|64798872|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288005|NCT00112437|64798873|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288006|NCT00112437|64798874|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288007|NCT00112437|64798875|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288008|NCT00112437|64798876|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288009|NCT00112437|64798877|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288010|NCT00112437|64798878|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288011|NCT00112437|64798879|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288012|NCT00112437|64798880|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288013|NCT00112437|64798881|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288014|NCT00112437|64798882|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288015|NCT00112437|64798883|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
23288016|NCT00112437|64798858|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
23288017|NCT00112437|64798859|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288018|NCT00112437|64798860|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
23288019|NCT00112437|64798861|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
23288020|NCT00112437|64798862|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
23288021|NCT00112437|64798863|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288022|NCT00112437|64798864|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288023|NCT00112437|64798865|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288024|NCT00112437|64798866|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288025|NCT00112437|64798867|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288026|NCT00112437|64798868|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288027|NCT00112437|64798869|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288028|NCT00112437|64798870|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288029|NCT00112437|64798871|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288030|NCT00112437|64798872|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288031|NCT00112437|64798873|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288032|NCT00112437|64798874|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288033|NCT00112437|64798875|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288034|NCT00112437|64798876|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288035|NCT00112437|64798877|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288036|NCT00112437|64798878|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288037|NCT00112437|64798879|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288038|NCT00112437|64798880|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288039|NCT00112437|64798881|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288040|NCT00112437|64798882|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288041|NCT00112437|64798883|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
23288042|NCT00112437|64798858|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
23288043|NCT00112437|64798859|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
23288044|NCT00112437|64798860|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
23288045|NCT00112437|64798861|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
23380447|NCT03329001|65137257|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23288046|NCT00112437|64798862|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
23288047|NCT00112437|64798863|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288048|NCT00112437|64798864|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288049|NCT00112437|64798865|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288050|NCT00112437|64798866|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288051|NCT00112437|64798867|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288052|NCT00112437|64798868|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288053|NCT00112437|64798869|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288054|NCT00112437|64798870|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288055|NCT00112437|64798871|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288056|NCT00112437|64798872|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288057|NCT00112437|64798873|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288058|NCT00112437|64798874|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288059|NCT00112437|64798875|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288060|NCT00112437|64798876|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288061|NCT00112437|64798877|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288062|NCT00112437|64798878|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288063|NCT00112437|64798879|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23380448|NCT03329001|65137258|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23380449|NCT03329001|65137259|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23380450|NCT03329001|65137260|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23380451|NCT03329001|65137261|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
23380452|NCT03329001|65137262|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
23380453|NCT03329001|65137263|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
23380454|NCT03329001|65137256|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380455|NCT03329001|65137257|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380456|NCT03329001|65137258|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380457|NCT03329001|65137259|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23288064|NCT00112437|64798880|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288065|NCT00112437|64798881|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288066|NCT00112437|64798882|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23288067|NCT00112437|64798883|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
23491652|NCT03633617|65545042|FG006|Part B|Lost to Follow-up|0|||
23491653|NCT03633617|65545043|FG007|Part B|Lost to Follow-up|0|||
23380458|NCT03329001|65137260|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380459|NCT03329001|65137261|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
23380460|NCT03329001|65137262|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
23380461|NCT03329001|65137263|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
23380462|NCT02328105|65137264|FG000|Overall Study|Death|6|||
23380463|NCT02328105|65137264|FG000|Overall Study|Withdrawal by Subject|1|||
23380464|NCT02328105|65137264|FG000|Overall Study|Still On Study in Follow-Up|4|||
23380465|NCT00485303|65137265|FG000|Overall Study|Adverse Event|5|||
23380466|NCT00485303|65137265|FG000|Overall Study|Progressive Disease|44|||
23380467|NCT00485303|65137265|FG000|Overall Study|Other|3|||
23380468|NCT00485303|65137265|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
23380469|NCT00485303|65137265|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
23380470|NCT02737618|65137267|FG000|Overall Study|Withdrawal by Subject|9|||
23380471|NCT04913675|65137270|FG000|Main Study (Up to Week 36)|Death|0|||
23491654|NCT03633617|65545044|FG008|Part B|Lost to Follow-up|0|||
23491655|NCT03633617|65545045|FG009|Part B|Lost to Follow-up|0|||
23491656|NCT03633617|65545046|FG010|Part B|Lost to Follow-up|0|||
23491657|NCT03633617|65545036|FG000|Part B|Physician Decision|0|||
23491658|NCT03633617|65545037|FG001|Part B|Physician Decision|0|||
23491659|NCT03633617|65545038|FG002|Part B|Physician Decision|0|||
23491660|NCT03633617|65545039|FG003|Part B|Physician Decision|0|||
23491661|NCT03633617|65545040|FG004|Part B|Physician Decision|1|||
23491662|NCT03633617|65545041|FG005|Part B|Physician Decision|0|||
23491663|NCT03633617|65545042|FG006|Part B|Physician Decision|0|||
23491664|NCT03633617|65545043|FG007|Part B|Physician Decision|0|||
23491665|NCT03633617|65545044|FG008|Part B|Physician Decision|0|||
23491666|NCT03633617|65545045|FG009|Part B|Physician Decision|0|||
23491667|NCT03633617|65545046|FG010|Part B|Physician Decision|0|||
23491668|NCT03633617|65545036|FG000|Part B|COVID-19 Restrictions|0|||
23491669|NCT03633617|65545037|FG001|Part B|COVID-19 Restrictions|0|||
23491670|NCT03633617|65545038|FG002|Part B|COVID-19 Restrictions|1|||
23491671|NCT03633617|65545039|FG003|Part B|COVID-19 Restrictions|0|||
23491672|NCT03633617|65545040|FG004|Part B|COVID-19 Restrictions|0|||
23491673|NCT03633617|65545041|FG005|Part B|COVID-19 Restrictions|0|||
23491674|NCT03633617|65545042|FG006|Part B|COVID-19 Restrictions|0|||
23491675|NCT03633617|65545043|FG007|Part B|COVID-19 Restrictions|0|||
23491676|NCT03633617|65545044|FG008|Part B|COVID-19 Restrictions|0|||
23491677|NCT03633617|65545045|FG009|Part B|COVID-19 Restrictions|0|||
23491678|NCT03633617|65545046|FG010|Part B|COVID-19 Restrictions|0|||
23491679|NCT03633617|65545036|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491680|NCT03633617|65545037|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491681|NCT03633617|65545038|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
23491682|NCT03633617|65545039|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491683|NCT03633617|65545040|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491684|NCT03633617|65545041|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23605914|NCT01640951|65947108|FG007|Overall Study|Adverse Event|3|||
23288068|NCT00112437|64798858|FG000|Year 1 (12-Month Base Study)|moved|0|||
23288069|NCT00112437|64798859|FG001|Year 1 (12-Month Base Study)|moved|1|||
23288070|NCT00112437|64798860|FG002|Year 1 (12-Month Base Study)|moved|1|||
23288071|NCT00112437|64798861|FG003|Year 1 (12-Month Base Study)|moved|0|||
23288072|NCT00112437|64798862|FG004|Year 1 (12-Month Base Study)|moved|0|||
23288073|NCT00112437|64798863|FG005|Year 1 (12-Month Base Study)|moved|0|||
23288074|NCT00112437|64798864|FG006|Year 1 (12-Month Base Study)|moved|0|||
23288075|NCT00112437|64798865|FG007|Year 1 (12-Month Base Study)|moved|0|||
23288076|NCT00112437|64798866|FG008|Year 1 (12-Month Base Study)|moved|0|||
23288077|NCT00112437|64798867|FG009|Year 1 (12-Month Base Study)|moved|0|||
23605915|NCT01640951|65947101|FG000|Overall Study|Lack of Efficacy|20|||
23288078|NCT00112437|64798868|FG010|Year 1 (12-Month Base Study)|moved|0|||
23380472|NCT04913675|65137271|FG001|Main Study (Up to Week 36)|Death|2|||
23491685|NCT03633617|65545042|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491686|NCT03633617|65545043|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23605916|NCT01640951|65947102|FG001|Overall Study|Lack of Efficacy|1|||
23605917|NCT01640951|65947103|FG002|Overall Study|Lack of Efficacy|7|||
23605918|NCT01640951|65947104|FG003|Overall Study|Lack of Efficacy|14|||
23605919|NCT01640951|65947105|FG004|Overall Study|Lack of Efficacy|0|||
23605920|NCT01640951|65947106|FG005|Overall Study|Lack of Efficacy|6|||
23288079|NCT00112437|64798869|FG011|Year 1 (12-Month Base Study)|moved|0|||
23288080|NCT00112437|64798870|FG012|Year 1 (12-Month Base Study)|moved|0|||
23288081|NCT00112437|64798871|FG013|Year 1 (12-Month Base Study)|moved|0|||
23288082|NCT00112437|64798872|FG014|Year 1 (12-Month Base Study)|moved|0|||
23288083|NCT00112437|64798873|FG015|Year 1 (12-Month Base Study)|moved|0|||
23288084|NCT00112437|64798874|FG016|Year 1 (12-Month Base Study)|moved|0|||
23288085|NCT00112437|64798875|FG017|Year 1 (12-Month Base Study)|moved|0|||
23288086|NCT00112437|64798876|FG018|Year 1 (12-Month Base Study)|moved|0|||
23288087|NCT00112437|64798877|FG019|Year 1 (12-Month Base Study)|moved|0|||
23288088|NCT00112437|64798878|FG020|Year 1 (12-Month Base Study)|moved|0|||
23288089|NCT00112437|64798879|FG021|Year 1 (12-Month Base Study)|moved|0|||
23288090|NCT00112437|64798880|FG022|Year 1 (12-Month Base Study)|moved|0|||
23288091|NCT00112437|64798881|FG023|Year 1 (12-Month Base Study)|moved|0|||
23288092|NCT00112437|64798882|FG024|Year 1 (12-Month Base Study)|moved|0|||
23288093|NCT00112437|64798883|FG025|Year 1 (12-Month Base Study)|moved|0|||
23288094|NCT00112437|64798858|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288095|NCT00112437|64798859|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288096|NCT00112437|64798860|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288097|NCT00112437|64798861|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
23288098|NCT00112437|64798862|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288099|NCT00112437|64798863|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288100|NCT00112437|64798864|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288101|NCT00112437|64798865|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288102|NCT00112437|64798866|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288103|NCT00112437|64798867|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288104|NCT00112437|64798868|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288105|NCT00112437|64798869|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288106|NCT00112437|64798870|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288107|NCT00112437|64798871|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288108|NCT00112437|64798872|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288109|NCT00112437|64798873|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288110|NCT00112437|64798874|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288111|NCT00112437|64798875|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288112|NCT00112437|64798876|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288113|NCT00112437|64798877|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288114|NCT00112437|64798878|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288115|NCT00112437|64798879|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288116|NCT00112437|64798880|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288117|NCT00112437|64798881|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288118|NCT00112437|64798882|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23288119|NCT00112437|64798883|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
23380473|NCT04913675|65137272|FG002|Main Study (Up to Week 36)|Death|2|||
23380474|NCT04913675|65137273|FG003|Main Study (Up to Week 36)|Death|0|||
23380475|NCT04913675|65137270|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
23380476|NCT04913675|65137271|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
23380477|NCT04913675|65137272|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
23380478|NCT04913675|65137273|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
23380479|NCT04913675|65137270|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
23380480|NCT04913675|65137271|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
23380481|NCT04913675|65137272|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
23380482|NCT04913675|65137273|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
23380483|NCT04913675|65137270|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
23380484|NCT04913675|65137271|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
23380485|NCT04913675|65137272|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
23380486|NCT04913675|65137273|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
23380487|NCT04913675|65137270|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
23380488|NCT04913675|65137271|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
23380489|NCT04913675|65137272|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
23380490|NCT04913675|65137273|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
23380491|NCT00083915|65137276|FG000|Overall Study|Death|6|||
23380492|NCT00083915|65137277|FG001|Overall Study|Death|3|||
23380493|NCT00083915|65137276|FG000|Overall Study|Physician Decision|11|||
23380494|NCT00083915|65137277|FG001|Overall Study|Physician Decision|6|||
23380495|NCT00083915|65137276|FG000|Overall Study|Withdrawal by Subject|8|||
23380496|NCT00083915|65137277|FG001|Overall Study|Withdrawal by Subject|3|||
23380497|NCT00083915|65137276|FG000|Overall Study|disease progression|18|||
23380498|NCT00083915|65137277|FG001|Overall Study|disease progression|23|||
23288120|NCT00112437|64798858|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288121|NCT00112437|64798859|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288122|NCT00112437|64798860|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288123|NCT00112437|64798861|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288124|NCT00112437|64798862|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
23288125|NCT00112437|64798863|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288126|NCT00112437|64798864|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23380499|NCT00083915|65137276|FG000|Overall Study|Failure to collect|3|||
23380500|NCT00083915|65137277|FG001|Overall Study|Failure to collect|0|||
23380501|NCT00083915|65137276|FG000|Overall Study|No response|3|||
23380502|NCT00083915|65137277|FG001|Overall Study|No response|1|||
23380503|NCT00083915|65137276|FG000|Overall Study|Insurance issues|1|||
23380504|NCT00083915|65137277|FG001|Overall Study|Insurance issues|1|||
23288127|NCT00112437|64798865|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288128|NCT00112437|64798866|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288129|NCT00112437|64798867|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288130|NCT00112437|64798868|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288131|NCT00112437|64798869|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288132|NCT00112437|64798870|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288133|NCT00112437|64798871|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288134|NCT00112437|64798872|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288135|NCT00112437|64798873|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288136|NCT00112437|64798874|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288137|NCT00112437|64798875|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288138|NCT00112437|64798876|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288139|NCT00112437|64798877|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288140|NCT00112437|64798878|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288141|NCT00112437|64798879|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23380505|NCT02378181|65137280|FG000|Overall Study|Lost to Follow-up|2|||
23380506|NCT02378181|65137281|FG001|Overall Study|Lost to Follow-up|5|||
23380507|NCT02378181|65137280|FG000|Overall Study|Withdrawal by Subject|1|||
23380508|NCT02378181|65137281|FG001|Overall Study|Withdrawal by Subject|1|||
23380509|NCT02378181|65137280|FG000|Overall Study|Incarcerated|0|||
23380510|NCT02378181|65137281|FG001|Overall Study|Incarcerated|1|||
23380511|NCT01510756|65137282|FG000|Overall Study|Death|1|||
23380512|NCT01510756|65137282|FG000|Overall Study|Lack of Efficacy|2|||
23380513|NCT01510756|65137282|FG000|Overall Study|Physician Decision|1|||
23380514|NCT01027845|65137291|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
23380515|NCT01027845|65137292|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
23380516|NCT01027845|65137293|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
23380517|NCT01027845|65137294|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
23380518|NCT01027845|65137291|FG000|Primary Vaccination Phase|Adverse Event|1|||
23380519|NCT01027845|65137292|FG001|Primary Vaccination Phase|Adverse Event|0|||
23380520|NCT01027845|65137293|FG002|Primary Vaccination Phase|Adverse Event|0|||
23380521|NCT01027845|65137294|FG003|Primary Vaccination Phase|Adverse Event|0|||
23380522|NCT01027845|65137291|FG000|Primary Vaccination Phase|Protocol Violation|1|||
23380523|NCT01027845|65137292|FG001|Primary Vaccination Phase|Protocol Violation|0|||
23380524|NCT01027845|65137293|FG002|Primary Vaccination Phase|Protocol Violation|0|||
23380525|NCT01027845|65137294|FG003|Primary Vaccination Phase|Protocol Violation|0|||
23380526|NCT01027845|65137291|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
23380527|NCT01027845|65137292|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
23380528|NCT01027845|65137293|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
23380529|NCT01027845|65137294|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
23380530|NCT01027845|65137291|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
23380531|NCT01027845|65137292|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
23380532|NCT01027845|65137293|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
23380533|NCT01027845|65137294|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
23380534|NCT01027845|65137291|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
23380535|NCT01027845|65137292|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
23380536|NCT01027845|65137293|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
23380537|NCT01027845|65137294|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
23380538|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
23380539|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
23380540|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
23380541|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
23605921|NCT01640951|65947107|FG006|Overall Study|Lack of Efficacy|5|||
23288142|NCT00112437|64798880|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23380542|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
23380543|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
23380544|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
23380545|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
23380546|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
23380547|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
23380548|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
23380549|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
23380550|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
23380551|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
23288143|NCT00112437|64798881|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288144|NCT00112437|64798882|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288145|NCT00112437|64798883|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
23288146|NCT00112437|64798858|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
23288147|NCT00112437|64798859|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
23288148|NCT00112437|64798860|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
23288149|NCT00112437|64798861|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
23288150|NCT00112437|64798862|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
23288151|NCT00112437|64798863|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
23288152|NCT00112437|64798864|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
23288153|NCT00112437|64798865|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
23288154|NCT00112437|64798866|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
23288155|NCT00112437|64798867|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
23288156|NCT00112437|64798868|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
23288157|NCT00112437|64798869|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
23288158|NCT00112437|64798870|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
23288159|NCT00112437|64798871|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
23288160|NCT00112437|64798872|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
23288161|NCT00112437|64798873|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
23288162|NCT00112437|64798874|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
23288163|NCT00112437|64798875|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
23288164|NCT00112437|64798876|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
23288165|NCT00112437|64798877|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
23380552|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
23380553|NCT02788045|65137295|FG000|Main Study (Up to Week 72)|Other|3|||
23380554|NCT02788045|65137296|FG001|Main Study (Up to Week 72)|Other|0|||
23380555|NCT02788045|65137297|FG002|Main Study (Up to Week 72)|Other|0|||
23288166|NCT00112437|64798878|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
23288167|NCT00112437|64798879|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
23288168|NCT00112437|64798880|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
23288169|NCT00112437|64798881|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
23288170|NCT00112437|64798882|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
23288171|NCT00112437|64798883|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
23288172|NCT00112437|64798858|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288173|NCT00112437|64798859|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288174|NCT00112437|64798860|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288175|NCT00112437|64798861|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288176|NCT00112437|64798862|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288177|NCT00112437|64798863|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
23288178|NCT00112437|64798864|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
23288179|NCT00112437|64798865|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288180|NCT00112437|64798866|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288181|NCT00112437|64798867|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
23288182|NCT00112437|64798868|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288183|NCT00112437|64798869|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288184|NCT00112437|64798870|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288185|NCT00112437|64798871|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288186|NCT00112437|64798872|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288187|NCT00112437|64798873|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288188|NCT00112437|64798874|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288189|NCT00112437|64798875|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288190|NCT00112437|64798876|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288191|NCT00112437|64798877|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288192|NCT00112437|64798878|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288193|NCT00112437|64798879|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288194|NCT00112437|64798880|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288195|NCT00112437|64798881|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288196|NCT00112437|64798882|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288197|NCT00112437|64798883|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
23288198|NCT00112437|64798858|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288199|NCT00112437|64798859|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288200|NCT00112437|64798860|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288201|NCT00112437|64798861|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288202|NCT00112437|64798862|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288203|NCT00112437|64798863|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288204|NCT00112437|64798864|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288205|NCT00112437|64798865|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288206|NCT00112437|64798866|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
23288207|NCT00112437|64798867|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288208|NCT00112437|64798868|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288209|NCT00112437|64798869|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288210|NCT00112437|64798870|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288211|NCT00112437|64798871|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288212|NCT00112437|64798872|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288213|NCT00112437|64798873|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288214|NCT00112437|64798874|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288215|NCT00112437|64798875|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288216|NCT00112437|64798876|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288217|NCT00112437|64798877|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288218|NCT00112437|64798878|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288219|NCT00112437|64798879|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288220|NCT00112437|64798880|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288221|NCT00112437|64798881|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288222|NCT00112437|64798882|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288223|NCT00112437|64798883|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
23288224|NCT00112437|64798858|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288225|NCT00112437|64798859|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288226|NCT00112437|64798860|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288227|NCT00112437|64798861|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288228|NCT00112437|64798862|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288229|NCT00112437|64798863|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288230|NCT00112437|64798864|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288231|NCT00112437|64798865|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288232|NCT00112437|64798866|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
23288233|NCT00112437|64798867|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288234|NCT00112437|64798868|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288235|NCT00112437|64798869|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288236|NCT00112437|64798870|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288237|NCT00112437|64798871|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288238|NCT00112437|64798872|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288239|NCT00112437|64798873|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
23605922|NCT01640951|65947108|FG007|Overall Study|Lack of Efficacy|6|||
23288240|NCT00112437|64798874|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288241|NCT00112437|64798875|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288242|NCT00112437|64798876|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288243|NCT00112437|64798877|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288244|NCT00112437|64798878|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288245|NCT00112437|64798879|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288246|NCT00112437|64798880|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
23605923|NCT01640951|65947101|FG000|Overall Study|Lost to Follow-up|1|||
23380556|NCT02788045|65137295|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
23380557|NCT02788045|65137296|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
23380558|NCT02788045|65137297|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
23380559|NCT02788045|65137295|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
23380560|NCT02788045|65137296|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
23380561|NCT02788045|65137297|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
23380562|NCT02788045|65137295|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
23380563|NCT02788045|65137296|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
23380564|NCT02788045|65137297|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
23380565|NCT01002105|65137298|FG000|Overall Study|Lost to Follow-up|10|||
23380566|NCT01002105|65137299|FG001|Overall Study|Lost to Follow-up|16|||
23380567|NCT01002105|65137298|FG000|Overall Study|non compliance|5|||
23380568|NCT01002105|65137299|FG001|Overall Study|non compliance|3|||
23380569|NCT01002105|65137298|FG000|Overall Study|condition worsened|4|||
23380570|NCT01002105|65137299|FG001|Overall Study|condition worsened|2|||
23380571|NCT00081458|65137301|FG000|Overall Study|Adverse Event|1|||
23380572|NCT00081458|65137302|FG001|Overall Study|Adverse Event|5|||
23380573|NCT00081458|65137303|FG002|Overall Study|Adverse Event|2|||
23380574|NCT00081458|65137301|FG000|Overall Study|Withdrawal by Subject|0|||
23380575|NCT00081458|65137302|FG001|Overall Study|Withdrawal by Subject|3|||
23380576|NCT00081458|65137303|FG002|Overall Study|Withdrawal by Subject|1|||
23380577|NCT00081458|65137301|FG000|Overall Study|Randomized but not dosed|0|||
23380578|NCT00081458|65137302|FG001|Overall Study|Randomized but not dosed|0|||
23380579|NCT00081458|65137303|FG002|Overall Study|Randomized but not dosed|1|||
23380580|NCT02232698|65137306|FG000|Overall Study|Pregnancy|1|||
23380581|NCT02232698|65137307|FG001|Overall Study|Pregnancy|1|||
23380582|NCT02232698|65137306|FG000|Overall Study|Met exclusion criteria|1|||
23380583|NCT02232698|65137307|FG001|Overall Study|Met exclusion criteria|1|||
23380584|NCT02232698|65137306|FG000|Overall Study|Had device-associated symptoms|7|||
23380585|NCT02232698|65137307|FG001|Overall Study|Had device-associated symptoms|0|||
23380586|NCT02232698|65137306|FG000|Overall Study|Non-compliance with study device|1|||
23380587|NCT02232698|65137307|FG001|Overall Study|Non-compliance with study device|4|||
23380588|NCT02232698|65137306|FG000|Overall Study|Allocated to control group|0|||
23380589|NCT02232698|65137307|FG001|Overall Study|Allocated to control group|3|||
23380590|NCT02232698|65137306|FG000|Overall Study|Withdrawal by Subject|0|||
23380591|NCT02232698|65137307|FG001|Overall Study|Withdrawal by Subject|11|||
23380592|NCT01562444|65137309|FG000|Overall Study|Did not meet entry criteria|2|||
23380593|NCT01562444|65137310|FG001|Overall Study|Did not meet entry criteria|0|||
23380594|NCT01562444|65137311|FG002|Overall Study|Did not meet entry criteria|3|||
23380595|NCT01562444|65137309|FG000|Overall Study|Did not comply with blood draw schedule|1|||
23380596|NCT01562444|65137310|FG001|Overall Study|Did not comply with blood draw schedule|0|||
23380597|NCT01562444|65137311|FG002|Overall Study|Did not comply with blood draw schedule|1|||
23380598|NCT01562444|65137309|FG000|Overall Study|Unavailable serological results|0|||
23380599|NCT01562444|65137310|FG001|Overall Study|Unavailable serological results|2|||
23380600|NCT01562444|65137311|FG002|Overall Study|Unavailable serological results|2|||
23380601|NCT01562444|65137309|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
23380602|NCT01562444|65137310|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
23380603|NCT01562444|65137311|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
23380604|NCT01562444|65137309|FG000|Overall Study|Protocol forbidden medication|1|||
23380605|NCT01562444|65137310|FG001|Overall Study|Protocol forbidden medication|0|||
23380606|NCT01562444|65137311|FG002|Overall Study|Protocol forbidden medication|0|||
23380607|NCT02300610|65137312|FG000|Overall Study|Withdrawal by Subject|1|||
23380608|NCT02300610|65137313|FG001|Overall Study|Withdrawal by Subject|0|||
23380609|NCT02300610|65137314|FG002|Overall Study|Withdrawal by Subject|1|||
23380610|NCT02311478|65137315|FG000|Overall Study|Withdrawal by Subject|1|||
23380611|NCT02311478|65137315|FG000|Overall Study|Lost to Follow-up|5|||
23380612|NCT02311478|65137315|FG000|Overall Study|Failed IUD Insertion|1|||
23380613|NCT01137786|65137318|FG000|Overall Study|Lost to Follow-up|0|||
23380614|NCT01137786|65137319|FG001|Overall Study|Lost to Follow-up|2|||
23380615|NCT01137786|65137318|FG000|Overall Study|Withdrawal by Subject|1|||
23380616|NCT01137786|65137319|FG001|Overall Study|Withdrawal by Subject|1|||
23380617|NCT01129128|65137320|FG000|Overall Study|Lost to Follow-up|2|||
23380618|NCT01129128|65137321|FG001|Overall Study|Lost to Follow-up|2|||
23380619|NCT01129128|65137322|FG002|Overall Study|Lost to Follow-up|1|||
23380620|NCT01129128|65137320|FG000|Overall Study|Protocol Violation|0|||
23380621|NCT01129128|65137321|FG001|Overall Study|Protocol Violation|1|||
23380622|NCT01129128|65137322|FG002|Overall Study|Protocol Violation|0|||
23380623|NCT01129128|65137320|FG000|Overall Study|Withdrawal by Subject|0|||
23380624|NCT01129128|65137321|FG001|Overall Study|Withdrawal by Subject|1|||
23380625|NCT01129128|65137322|FG002|Overall Study|Withdrawal by Subject|3|||
23380626|NCT01129128|65137320|FG000|Overall Study|Physician Decision|1|||
23380627|NCT01129128|65137321|FG001|Overall Study|Physician Decision|0|||
23380628|NCT01129128|65137322|FG002|Overall Study|Physician Decision|0|||
23380629|NCT03550209|65137323|FG000|Overall Study|Lost to Follow-up|1|||
23380630|NCT03550209|65137324|FG001|Overall Study|Lost to Follow-up|0|||
23380631|NCT03550209|65137325|FG002|Overall Study|Lost to Follow-up|1|||
23380632|NCT03550209|65137326|FG003|Overall Study|Lost to Follow-up|0|||
23380633|NCT03550209|65137323|FG000|Overall Study|Withdrawal by Subject|0|||
23380634|NCT03550209|65137324|FG001|Overall Study|Withdrawal by Subject|3|||
23491687|NCT03633617|65545044|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23380635|NCT03550209|65137325|FG002|Overall Study|Withdrawal by Subject|1|||
23380636|NCT03550209|65137326|FG003|Overall Study|Withdrawal by Subject|2|||
23605924|NCT01640951|65947102|FG001|Overall Study|Lost to Follow-up|0|||
23380637|NCT03550209|65137323|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
23380638|NCT03550209|65137324|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
23380639|NCT03550209|65137325|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
23380640|NCT03550209|65137326|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
23380641|NCT00435942|65137327|FG000|Overall Study|Death|17|||
23380642|NCT00435942|65137328|FG001|Overall Study|Death|10|||
23380643|NCT00435942|65137327|FG000|Overall Study|Withdrawal by Subject|2|||
23380644|NCT00435942|65137328|FG001|Overall Study|Withdrawal by Subject|0|||
23380645|NCT00435942|65137327|FG000|Overall Study|Lost to Follow-up|0|||
23380646|NCT00435942|65137328|FG001|Overall Study|Lost to Follow-up|16|||
23380647|NCT00435942|65137327|FG000|Overall Study|Conversion to Open Repair|1|||
23380648|NCT00435942|65137328|FG001|Overall Study|Conversion to Open Repair|0|||
23380649|NCT00435942|65137327|FG000|Overall Study|Technical Failure|3|||
23380650|NCT00435942|65137328|FG001|Overall Study|Technical Failure|0|||
23380651|NCT00435942|65137327|FG000|Overall Study|Other|0|||
23380652|NCT00435942|65137328|FG001|Overall Study|Other|1|||
23380653|NCT05436288|65137330|FG000|Overall Study|Lost to Follow-up|1|||
23380654|NCT05436288|65137330|FG000|Overall Study|Adverse Event|1|||
23380655|NCT01171534|65137331|FG000|Overall Study|Lost to Follow-up|0|||
23380656|NCT01171534|65137332|FG001|Overall Study|Lost to Follow-up|2|||
23380657|NCT01171534|65137331|FG000|Overall Study|screen failure|0|||
23380658|NCT01171534|65137332|FG001|Overall Study|screen failure|1|||
23380659|NCT02568423|65137333|FG000|Overall Study|Lost to Follow-up|0|||
23380660|NCT02568423|65137334|FG001|Overall Study|Lost to Follow-up|2|||
23380661|NCT02568423|65137335|FG002|Overall Study|Lost to Follow-up|0|||
23380662|NCT02568423|65137336|FG003|Overall Study|Lost to Follow-up|0|||
23380663|NCT02568423|65137337|FG004|Overall Study|Lost to Follow-up|0|||
23380664|NCT02568423|65137338|FG005|Overall Study|Lost to Follow-up|0|||
23380665|NCT02568423|65137339|FG006|Overall Study|Lost to Follow-up|0|||
23380666|NCT02568423|65137340|FG007|Overall Study|Lost to Follow-up|0|||
23380667|NCT02568423|65137333|FG000|Overall Study|Physician Decision|0|||
23380668|NCT02568423|65137334|FG001|Overall Study|Physician Decision|0|||
23380669|NCT02568423|65137335|FG002|Overall Study|Physician Decision|0|||
23380670|NCT02568423|65137336|FG003|Overall Study|Physician Decision|0|||
23380671|NCT02568423|65137337|FG004|Overall Study|Physician Decision|0|||
23380672|NCT02568423|65137338|FG005|Overall Study|Physician Decision|1|||
23380673|NCT02568423|65137339|FG006|Overall Study|Physician Decision|0|||
23380674|NCT02568423|65137340|FG007|Overall Study|Physician Decision|0|||
23380675|NCT03743194|65137342|FG000|Overall Study|Protocol Violation|7|||
23380676|NCT03743194|65137343|FG001|Overall Study|Protocol Violation|7|||
23380677|NCT03743194|65137342|FG000|Overall Study|Physician Decision|0|||
23380678|NCT03743194|65137343|FG001|Overall Study|Physician Decision|2|||
23380679|NCT02309359|65137352|FG000|Overall Study|Adverse Event|4|||
23380680|NCT02309359|65137353|FG001|Overall Study|Adverse Event|5|||
23380681|NCT02309359|65137354|FG002|Overall Study|Adverse Event|5|||
23380682|NCT02309359|65137355|FG003|Overall Study|Adverse Event|4|||
23380683|NCT02309359|65137356|FG004|Overall Study|Adverse Event|4|||
23380684|NCT02309359|65137352|FG000|Overall Study|Death|1|||
23380685|NCT02309359|65137353|FG001|Overall Study|Death|0|||
23288247|NCT00112437|64798881|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288248|NCT00112437|64798882|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288249|NCT00112437|64798883|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
23288250|NCT00112437|64798858|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288251|NCT00112437|64798859|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288252|NCT00112437|64798860|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288253|NCT00112437|64798861|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288254|NCT00112437|64798862|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288255|NCT00112437|64798863|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
23288256|NCT00112437|64798864|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
23288257|NCT00112437|64798865|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
23288258|NCT00112437|64798866|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
23288259|NCT00112437|64798867|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
23288260|NCT00112437|64798868|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288261|NCT00112437|64798869|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23380686|NCT02309359|65137354|FG002|Overall Study|Death|0|||
23380687|NCT02309359|65137355|FG003|Overall Study|Death|0|||
23380688|NCT02309359|65137356|FG004|Overall Study|Death|0|||
23380689|NCT02309359|65137352|FG000|Overall Study|Withdrawal by Subject|2|||
23288262|NCT00112437|64798870|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288263|NCT00112437|64798871|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23380690|NCT02309359|65137353|FG001|Overall Study|Withdrawal by Subject|2|||
23380691|NCT02309359|65137354|FG002|Overall Study|Withdrawal by Subject|4|||
23380692|NCT02309359|65137355|FG003|Overall Study|Withdrawal by Subject|4|||
23380693|NCT02309359|65137356|FG004|Overall Study|Withdrawal by Subject|0|||
23380694|NCT02309359|65137352|FG000|Overall Study|Lack of Efficacy|3|||
23380695|NCT02309359|65137353|FG001|Overall Study|Lack of Efficacy|1|||
23380696|NCT02309359|65137354|FG002|Overall Study|Lack of Efficacy|0|||
23380697|NCT02309359|65137355|FG003|Overall Study|Lack of Efficacy|0|||
23380698|NCT02309359|65137356|FG004|Overall Study|Lack of Efficacy|3|||
23380699|NCT02309359|65137352|FG000|Overall Study|Lost to Follow-up|0|||
23380700|NCT02309359|65137353|FG001|Overall Study|Lost to Follow-up|0|||
23288264|NCT00112437|64798872|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23380701|NCT02309359|65137354|FG002|Overall Study|Lost to Follow-up|0|||
23380702|NCT02309359|65137355|FG003|Overall Study|Lost to Follow-up|1|||
23380703|NCT02309359|65137356|FG004|Overall Study|Lost to Follow-up|0|||
23380704|NCT02309359|65137352|FG000|Overall Study|Other|2|||
23380705|NCT02309359|65137353|FG001|Overall Study|Other|0|||
23380706|NCT02309359|65137354|FG002|Overall Study|Other|2|||
23380707|NCT02309359|65137355|FG003|Overall Study|Other|3|||
23380708|NCT02309359|65137356|FG004|Overall Study|Other|2|||
23380709|NCT00720278|65137357|FG000|Overall Study|Adverse Event|5|||
23380710|NCT00720278|65137358|FG001|Overall Study|Adverse Event|3|||
23380711|NCT00720278|65137359|FG002|Overall Study|Adverse Event|4|||
23380712|NCT00720278|65137357|FG000|Overall Study|Withdrawal by Subject|0|||
23380713|NCT00720278|65137358|FG001|Overall Study|Withdrawal by Subject|1|||
23380714|NCT00720278|65137359|FG002|Overall Study|Withdrawal by Subject|0|||
23380715|NCT00720278|65137357|FG000|Overall Study|Lost to Follow-up|0|||
23380716|NCT00720278|65137358|FG001|Overall Study|Lost to Follow-up|0|||
23380717|NCT00720278|65137359|FG002|Overall Study|Lost to Follow-up|1|||
23380718|NCT00720278|65137357|FG000|Overall Study|Non-compliance|1|||
23380719|NCT00720278|65137358|FG001|Overall Study|Non-compliance|0|||
23380720|NCT00720278|65137359|FG002|Overall Study|Non-compliance|0|||
23288265|NCT00112437|64798873|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288266|NCT00112437|64798874|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288267|NCT00112437|64798875|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288268|NCT00112437|64798876|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288269|NCT00112437|64798877|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288270|NCT00112437|64798878|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288271|NCT00112437|64798879|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288272|NCT00112437|64798880|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288273|NCT00112437|64798881|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288274|NCT00112437|64798882|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288275|NCT00112437|64798883|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
23288276|NCT00112437|64798858|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288277|NCT00112437|64798859|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288278|NCT00112437|64798860|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288279|NCT00112437|64798861|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288280|NCT00112437|64798862|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288281|NCT00112437|64798863|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288282|NCT00112437|64798864|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288283|NCT00112437|64798865|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288284|NCT00112437|64798866|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23380721|NCT00720278|65137357|FG000|Overall Study|eligibility criteria violation|1|||
23380722|NCT00720278|65137358|FG001|Overall Study|eligibility criteria violation|0|||
23380723|NCT00720278|65137359|FG002|Overall Study|eligibility criteria violation|1|||
23380724|NCT01755637|65137362|FG000|Period 1|Adverse Event|0|||
23380725|NCT01755637|65137363|FG001|Period 1|Adverse Event|1|||
23380726|NCT03600350|65137364|FG000|Overall Study|Death|1|||
23380727|NCT03600350|65137364|FG000|Overall Study|On Follow Up|18|||
23605925|NCT01640951|65947103|FG002|Overall Study|Lost to Follow-up|6|||
23380728|NCT01091259|65137370|FG000|Overall Study|Adverse Event|3|||
23380729|NCT01091259|65137370|FG000|Overall Study|Lack of Efficacy|2|||
23380730|NCT03298061|65137372|FG000|Overall Study|Adverse Event|3|||
23380731|NCT03298061|65137372|FG000|Overall Study|Lack of Efficacy|6|||
23380732|NCT03298061|65137372|FG000|Overall Study|Protocol Violation|1|||
23380733|NCT03298061|65137372|FG000|Overall Study|Physician Decision|7|||
23380734|NCT03298061|65137372|FG000|Overall Study|Withdrawal by Subject|10|||
23380735|NCT03325439|65137373|FG000|Overall Study|Ineligibility|3|||
23380736|NCT03197129|65137374|FG000|Overall Study|did not answer the VPT: shyness|4|||
23380737|NCT03197129|65137375|FG001|Overall Study|did not answer the VPT: shyness|5|||
23380738|NCT03320369|65137376|FG000|Overall Study|Adverse Event|1|||
23380739|NCT03320369|65137376|FG000|Overall Study|Withdrawal by Subject|2|||
23380740|NCT02397837|65137377|FG000|Overall Study|Withdrawal by Subject|6|||
23380741|NCT02397837|65137378|FG001|Overall Study|Withdrawal by Subject|5|||
23380742|NCT02397837|65137377|FG000|Overall Study|Physician Decision|1|||
23380743|NCT02397837|65137378|FG001|Overall Study|Physician Decision|1|||
23380744|NCT00876343|65137379|FG000|Overall Study|Adverse Event|7|||
23380745|NCT00876343|65137380|FG001|Overall Study|Adverse Event|8|||
23380746|NCT00876343|65137381|FG002|Overall Study|Adverse Event|2|||
23380747|NCT00876343|65137379|FG000|Overall Study|Withdrawal by Subject|4|||
23380748|NCT00876343|65137380|FG001|Overall Study|Withdrawal by Subject|4|||
23380749|NCT00876343|65137381|FG002|Overall Study|Withdrawal by Subject|3|||
23380750|NCT00876343|65137379|FG000|Overall Study|Lack of Efficacy|0|||
23380751|NCT00876343|65137380|FG001|Overall Study|Lack of Efficacy|0|||
23380752|NCT00876343|65137381|FG002|Overall Study|Lack of Efficacy|1|||
23380753|NCT00876343|65137379|FG000|Overall Study|Protocol Violation|4|||
23380754|NCT00876343|65137380|FG001|Overall Study|Protocol Violation|1|||
23380755|NCT00876343|65137381|FG002|Overall Study|Protocol Violation|1|||
23380756|NCT00876343|65137379|FG000|Overall Study|Physician Decision|0|||
23380757|NCT00876343|65137380|FG001|Overall Study|Physician Decision|1|||
23380758|NCT00876343|65137381|FG002|Overall Study|Physician Decision|1|||
23380759|NCT00876343|65137379|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
23380760|NCT00876343|65137380|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
23380761|NCT00876343|65137381|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
23380762|NCT00876343|65137379|FG000|Overall Study|Change of residence or other commitments|2|||
23380763|NCT00876343|65137380|FG001|Overall Study|Change of residence or other commitments|2|||
23380764|NCT00876343|65137381|FG002|Overall Study|Change of residence or other commitments|3|||
23380765|NCT00866320|65137382|FG000|Overall Study|Withdrawal by Subject|4|||
23380766|NCT00866320|65137382|FG000|Overall Study|Death|2|||
23380767|NCT02448043|65137386|FG000|Overall Study|Withdrawal by Subject|2|||
23380768|NCT02448043|65137387|FG001|Overall Study|Withdrawal by Subject|2|||
23380769|NCT02448043|65137386|FG000|Overall Study|Protocol Violation|1|||
23380770|NCT02448043|65137387|FG001|Overall Study|Protocol Violation|2|||
23380771|NCT04766333|65137393|FG000|Overall Study|Lost to Follow-up|40|||
23380772|NCT04766333|65137394|FG001|Overall Study|Lost to Follow-up|826|||
23380773|NCT00927472|65137401|FG000|Overall Study|Withdrawal by Subject|10|||
23380774|NCT00927472|65137402|FG001|Overall Study|Withdrawal by Subject|11|||
23380775|NCT00927472|65137401|FG000|Overall Study|Lost to Follow-up|1|||
23380776|NCT00927472|65137402|FG001|Overall Study|Lost to Follow-up|6|||
23380777|NCT00927472|65137401|FG000|Overall Study|Protocol Violation|0|||
23380778|NCT00927472|65137402|FG001|Overall Study|Protocol Violation|1|||
23380779|NCT00927472|65137401|FG000|Overall Study|Post treatment Assessment out of window|0|||
23380780|NCT00927472|65137402|FG001|Overall Study|Post treatment Assessment out of window|4|||
23380781|NCT01200355|65137407|FG000|Overall Study|Death|7|||
23380782|NCT01200355|65137408|FG001|Overall Study|Death|2|||
23380783|NCT04925934|65137409|FG000|Overall Study|Adverse Event|1|||
23288285|NCT00112437|64798867|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
23288286|NCT00112437|64798868|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288287|NCT00112437|64798869|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288288|NCT00112437|64798870|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288289|NCT00112437|64798871|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288290|NCT00112437|64798872|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288291|NCT00112437|64798873|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288292|NCT00112437|64798874|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288293|NCT00112437|64798875|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288294|NCT00112437|64798876|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288295|NCT00112437|64798877|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288296|NCT00112437|64798878|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23380784|NCT04925934|65137410|FG001|Overall Study|Adverse Event|0|||
23380785|NCT04925934|65137411|FG002|Overall Study|Adverse Event|0|||
23380786|NCT04925934|65137409|FG000|Overall Study|Lost to Follow-up|2|||
23380787|NCT04925934|65137410|FG001|Overall Study|Lost to Follow-up|0|||
23380788|NCT04925934|65137411|FG002|Overall Study|Lost to Follow-up|1|||
23288297|NCT00112437|64798879|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288298|NCT00112437|64798880|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23380789|NCT04925934|65137409|FG000|Overall Study|Death|0|||
23380790|NCT04925934|65137410|FG001|Overall Study|Death|1|||
23380791|NCT04925934|65137411|FG002|Overall Study|Death|0|||
23380792|NCT04925934|65137409|FG000|Overall Study|Withdrawal by Subject|8|||
23380793|NCT04925934|65137410|FG001|Overall Study|Withdrawal by Subject|5|||
23380794|NCT04925934|65137411|FG002|Overall Study|Withdrawal by Subject|9|||
23380795|NCT04925934|65137409|FG000|Overall Study|Other|2|||
23380796|NCT04925934|65137410|FG001|Overall Study|Other|2|||
23380797|NCT04925934|65137411|FG002|Overall Study|Other|2|||
23288299|NCT00112437|64798881|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288300|NCT00112437|64798882|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288301|NCT00112437|64798883|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
23288302|NCT00112437|64798858|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288303|NCT00112437|64798859|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288304|NCT00112437|64798860|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288305|NCT00112437|64798861|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288306|NCT00112437|64798862|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288307|NCT00112437|64798863|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288308|NCT00112437|64798864|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288309|NCT00112437|64798865|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
23380798|NCT04925934|65137409|FG000|Overall Study|Eastern European Conflict|7|||
23380799|NCT04925934|65137410|FG001|Overall Study|Eastern European Conflict|3|||
23380800|NCT04925934|65137411|FG002|Overall Study|Eastern European Conflict|2|||
23380801|NCT03483103|65137414|FG000|Pre-Treatment Phase|Other reasons|1|||
23380802|NCT03483103|65137414|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
23380803|NCT03483103|65137414|FG000|Pre-Treatment Phase|Disease-related complications|1|||
23380804|NCT03483103|65137414|FG000|Pre-Treatment Phase|Death|5|||
23380805|NCT03483103|65137414|FG000|Treatment Phase|Withdrawal by Subject|7|||
23380806|NCT03483103|65137414|FG000|Treatment Phase|Other reasons|1|||
23380807|NCT03483103|65137414|FG000|Treatment Phase|Death|23|||
23380808|NCT03483103|65137414|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
23380809|NCT03483103|65137414|FG000|Treatment Phase|Received nonconforming product|1|||
23380810|NCT01668537|65140361|FG000|Overall Study|Request to Discontinue Prematurely|1|||
23380811|NCT01668537|65140362|FG001|Overall Study|Request to Discontinue Prematurely|1|||
23380812|NCT01668537|65140361|FG000|Overall Study|Subject unwilling/unable to comply|5|||
23380813|NCT01668537|65140362|FG001|Overall Study|Subject unwilling/unable to comply|0|||
23380814|NCT01668537|65140361|FG000|Overall Study|Reason Precludes Participation|1|||
23380815|NCT01668537|65140362|FG001|Overall Study|Reason Precludes Participation|0|||
23380816|NCT01668537|65140361|FG000|Overall Study|Lost to Follow-up|13|||
23380817|NCT01668537|65140362|FG001|Overall Study|Lost to Follow-up|6|||
23380818|NCT01668537|65140361|FG000|Overall Study|Other|2|||
23380819|NCT01668537|65140362|FG001|Overall Study|Other|3|||
23380820|NCT02513199|65140368|FG000|Treatment|Death|1|||
23380821|NCT02513199|65140368|FG000|Treatment|Lost to Follow-up|1|||
23380822|NCT02513199|65140368|FG000|Follow-Up|Death|11|||
23380823|NCT02412657|65140369|FG000|Overall Study|Lost to Follow-up|1|||
23380824|NCT02412657|65140370|FG001|Overall Study|Lost to Follow-up|0|||
23380825|NCT02412657|65140371|FG002|Overall Study|Lost to Follow-up|0|||
23380826|NCT02412657|65140369|FG000|Overall Study|Protocol Violation|0|||
23288310|NCT00112437|64798866|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288311|NCT00112437|64798867|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
23288312|NCT00112437|64798868|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288313|NCT00112437|64798869|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
23380827|NCT02412657|65140370|FG001|Overall Study|Protocol Violation|2|||
23380828|NCT02412657|65140371|FG002|Overall Study|Protocol Violation|3|||
23380829|NCT02609633|65140372|FG000|Overall Study|Consent Withdrawn|0|||
23380830|NCT02609633|65140373|FG001|Overall Study|Consent Withdrawn|1|||
23380831|NCT02609633|65140372|FG000|Overall Study|Protocol Deviation|1|||
23380832|NCT02609633|65140373|FG001|Overall Study|Protocol Deviation|0|||
23380833|NCT02609633|65140372|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
23380834|NCT02609633|65140373|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
23380835|NCT02609633|65140372|FG000|Overall Study|Reason not Specified|2|||
23380836|NCT02609633|65140373|FG001|Overall Study|Reason not Specified|1|||
23380837|NCT02293499|65140374|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
23380838|NCT02293499|65140375|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
23380839|NCT02293499|65140376|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
23380840|NCT02293499|65140374|FG000|Intervention - Camp|Withdrawal by Subject|3|||
23380841|NCT02293499|65140375|FG001|Intervention - Camp|Withdrawal by Subject|6|||
23380842|NCT02293499|65140376|FG002|Intervention - Camp|Withdrawal by Subject|2|||
23380843|NCT02293499|65140374|FG000|Intervention - Camp|these are those not showing up at camp|24|||
23380844|NCT02293499|65140375|FG001|Intervention - Camp|these are those not showing up at camp|28|||
23380845|NCT02293499|65140376|FG002|Intervention - Camp|these are those not showing up at camp|4|||
23380846|NCT02293499|65140374|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
23380847|NCT02293499|65140375|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
23380848|NCT02293499|65140376|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
23380849|NCT02293499|65140374|FG000|3 Month Follow Up|Lost to Follow-up|14|||
23380850|NCT02293499|65140375|FG001|3 Month Follow Up|Lost to Follow-up|15|||
23288314|NCT00112437|64798870|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288315|NCT00112437|64798871|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288316|NCT00112437|64798872|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288317|NCT00112437|64798873|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288318|NCT00112437|64798874|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288319|NCT00112437|64798875|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
23380851|NCT02293499|65140376|FG002|3 Month Follow Up|Lost to Follow-up|6|||
23380852|NCT02293499|65140374|FG000|6 Month Follow Up|Lost to Follow-up|17|||
23288320|NCT00112437|64798876|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288321|NCT00112437|64798877|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
23380853|NCT02293499|65140375|FG001|6 Month Follow Up|Lost to Follow-up|27|||
23380854|NCT02293499|65140376|FG002|6 Month Follow Up|Lost to Follow-up|6|||
23380855|NCT02293499|65140374|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
23380856|NCT02293499|65140375|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
23380857|NCT02293499|65140376|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
23380858|NCT02293499|65140374|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
23605926|NCT01640951|65947104|FG003|Overall Study|Lost to Follow-up|2|||
23380859|NCT02293499|65140375|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
23380860|NCT02293499|65140376|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
23491688|NCT03633617|65545045|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491689|NCT03633617|65545046|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
23491690|NCT03633617|65545036|FG000|Part C (& Follow-up)|Adverse Event|0|||
23491691|NCT03633617|65545037|FG001|Part C (& Follow-up)|Adverse Event|0|||
23491692|NCT03633617|65545038|FG002|Part C (& Follow-up)|Adverse Event|0|||
23491693|NCT03633617|65545039|FG003|Part C (& Follow-up)|Adverse Event|0|||
23491694|NCT03633617|65545040|FG004|Part C (& Follow-up)|Adverse Event|0|||
23491695|NCT03633617|65545041|FG005|Part C (& Follow-up)|Adverse Event|1|||
23491696|NCT03633617|65545042|FG006|Part C (& Follow-up)|Adverse Event|0|||
23491697|NCT03633617|65545043|FG007|Part C (& Follow-up)|Adverse Event|1|||
23491698|NCT03633617|65545044|FG008|Part C (& Follow-up)|Adverse Event|0|||
23491699|NCT03633617|65545045|FG009|Part C (& Follow-up)|Adverse Event|0|||
23491700|NCT03633617|65545046|FG010|Part C (& Follow-up)|Adverse Event|0|||
23491701|NCT03633617|65545036|FG000|Part C (& Follow-up)|Pregnancy|0|||
23491702|NCT03633617|65545037|FG001|Part C (& Follow-up)|Pregnancy|0|||
23491703|NCT03633617|65545038|FG002|Part C (& Follow-up)|Pregnancy|0|||
23491704|NCT03633617|65545039|FG003|Part C (& Follow-up)|Pregnancy|0|||
23491705|NCT03633617|65545040|FG004|Part C (& Follow-up)|Pregnancy|0|||
23491706|NCT03633617|65545041|FG005|Part C (& Follow-up)|Pregnancy|0|||
23491707|NCT03633617|65545042|FG006|Part C (& Follow-up)|Pregnancy|0|||
23491708|NCT03633617|65545043|FG007|Part C (& Follow-up)|Pregnancy|0|||
23491709|NCT03633617|65545044|FG008|Part C (& Follow-up)|Pregnancy|0|||
23491710|NCT03633617|65545045|FG009|Part C (& Follow-up)|Pregnancy|1|||
23491711|NCT03633617|65545046|FG010|Part C (& Follow-up)|Pregnancy|0|||
23491712|NCT03633617|65545036|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
23491713|NCT03633617|65545037|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
23491714|NCT03633617|65545038|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
23491715|NCT03633617|65545039|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
23491716|NCT03633617|65545040|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
23380861|NCT02293499|65140374|FG000|9 Month Follow Up|Lost to Follow-up|24|||
23380862|NCT02293499|65140375|FG001|9 Month Follow Up|Lost to Follow-up|28|||
23380863|NCT02293499|65140376|FG002|9 Month Follow Up|Lost to Follow-up|4|||
23380864|NCT02293499|65140374|FG000|12 Month Follow Up|Lost to Follow-up|26|||
23380865|NCT02293499|65140375|FG001|12 Month Follow Up|Lost to Follow-up|25|||
23380866|NCT02293499|65140376|FG002|12 Month Follow Up|Lost to Follow-up|6|||
23380867|NCT02293499|65140374|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
23380868|NCT02293499|65140375|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
23380869|NCT02293499|65140376|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
23380870|NCT02293499|65140374|FG000|15 Month Follow Up|Lost to Follow-up|22|||
23380871|NCT02293499|65140375|FG001|15 Month Follow Up|Lost to Follow-up|22|||
23380872|NCT02293499|65140376|FG002|15 Month Follow Up|Lost to Follow-up|7|||
23380873|NCT00629239|65140377|FG000|Overall Study|Adverse Event|7|||
23380874|NCT00629239|65140378|FG001|Overall Study|Adverse Event|4|||
23380875|NCT00629239|65140377|FG000|Overall Study|Physician Decision|1|||
23380876|NCT00629239|65140378|FG001|Overall Study|Physician Decision|0|||
23380877|NCT04398134|65140379|FG000|Overall Study|Adverse Event|0|||
23380878|NCT04398134|65140380|FG001|Overall Study|Adverse Event|0|||
23380879|NCT04398134|65140381|FG002|Overall Study|Adverse Event|1|||
23491717|NCT03633617|65545041|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
23491718|NCT03633617|65545042|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
23491719|NCT03633617|65545043|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
23380880|NCT04398134|65140382|FG003|Overall Study|Adverse Event|0|||
23380881|NCT04398134|65140379|FG000|Overall Study|Withdrawal by Subject|2|||
23380882|NCT04398134|65140380|FG001|Overall Study|Withdrawal by Subject|0|||
23380883|NCT04398134|65140381|FG002|Overall Study|Withdrawal by Subject|0|||
23380884|NCT04398134|65140382|FG003|Overall Study|Withdrawal by Subject|1|||
23380885|NCT04398134|65140379|FG000|Overall Study|Study Terminated by Sponsor|30|||
23380886|NCT04398134|65140380|FG001|Overall Study|Study Terminated by Sponsor|11|||
23380887|NCT04398134|65140381|FG002|Overall Study|Study Terminated by Sponsor|32|||
23380888|NCT04398134|65140382|FG003|Overall Study|Study Terminated by Sponsor|11|||
23380889|NCT00460798|65140383|FG000|Overall Study|Death|59|||
23380890|NCT00460798|65140383|FG000|Overall Study|Adverse Event|27|||
23380891|NCT00460798|65140383|FG000|Overall Study|Lost to Follow-up|19|||
23380892|NCT00460798|65140383|FG000|Overall Study|Progressive Disease|99|||
23380893|NCT00460798|65140383|FG000|Overall Study|Other|27|||
23380894|NCT00460798|65140383|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
23380895|NCT00460798|65140383|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
23380896|NCT00835978|65140387|FG000|Overall Study|Death|33|||
23380897|NCT00835978|65140388|FG001|Overall Study|Death|40|||
23380898|NCT00835978|65140389|FG002|Overall Study|Death|49|||
23380899|NCT00835978|65140390|FG003|Overall Study|Death|4|||
23380900|NCT00835978|65140387|FG000|Overall Study|Lost to Follow-up|3|||
23380901|NCT00835978|65140388|FG001|Overall Study|Lost to Follow-up|4|||
23288322|NCT00112437|64798878|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288323|NCT00112437|64798879|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288324|NCT00112437|64798880|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288325|NCT00112437|64798881|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288326|NCT00112437|64798882|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288327|NCT00112437|64798883|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
23288328|NCT00112437|64798858|FG000|Year 2 (12-Month Extension)|Moved|0|||
23380902|NCT00835978|65140389|FG002|Overall Study|Lost to Follow-up|2|||
23380903|NCT00835978|65140390|FG003|Overall Study|Lost to Follow-up|1|||
23380904|NCT00835978|65140387|FG000|Overall Study|Other|5|||
23380905|NCT00835978|65140388|FG001|Overall Study|Other|1|||
23380906|NCT00835978|65140389|FG002|Overall Study|Other|8|||
23380907|NCT00835978|65140390|FG003|Overall Study|Other|0|||
23380908|NCT00835978|65140387|FG000|Overall Study|Objective progression or relapse|2|||
23380909|NCT00835978|65140388|FG001|Overall Study|Objective progression or relapse|0|||
23288329|NCT00112437|64798859|FG001|Year 2 (12-Month Extension)|Moved|0|||
23288330|NCT00112437|64798860|FG002|Year 2 (12-Month Extension)|Moved|0|||
23380910|NCT00835978|65140389|FG002|Overall Study|Objective progression or relapse|1|||
23380911|NCT00835978|65140390|FG003|Overall Study|Objective progression or relapse|0|||
23380912|NCT00835978|65140387|FG000|Overall Study|Adverse Event|1|||
23380913|NCT00835978|65140388|FG001|Overall Study|Adverse Event|0|||
23380914|NCT00835978|65140389|FG002|Overall Study|Adverse Event|1|||
23380915|NCT00835978|65140390|FG003|Overall Study|Adverse Event|0|||
23380916|NCT00835978|65140387|FG000|Overall Study|Withdrawal by Subject|0|||
23380917|NCT00835978|65140388|FG001|Overall Study|Withdrawal by Subject|3|||
23288331|NCT00112437|64798861|FG003|Year 2 (12-Month Extension)|Moved|0|||
23288332|NCT00112437|64798862|FG004|Year 2 (12-Month Extension)|Moved|0|||
23288333|NCT00112437|64798863|FG005|Year 2 (12-Month Extension)|Moved|0|||
23288334|NCT00112437|64798864|FG006|Year 2 (12-Month Extension)|Moved|0|||
23288335|NCT00112437|64798865|FG007|Year 2 (12-Month Extension)|Moved|0|||
23288336|NCT00112437|64798866|FG008|Year 2 (12-Month Extension)|Moved|0|||
23380918|NCT00835978|65140389|FG002|Overall Study|Withdrawal by Subject|0|||
23380919|NCT00835978|65140390|FG003|Overall Study|Withdrawal by Subject|5|||
23380920|NCT00835978|65140387|FG000|Overall Study|Study terminated by sponsor|12|||
23380921|NCT00835978|65140388|FG001|Overall Study|Study terminated by sponsor|8|||
23380922|NCT00835978|65140389|FG002|Overall Study|Study terminated by sponsor|30|||
23380923|NCT00835978|65140390|FG003|Overall Study|Study terminated by sponsor|0|||
23380924|NCT00541229|65140391|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
23380925|NCT00541229|65140392|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
23380926|NCT00541229|65140393|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
23380927|NCT00541229|65140394|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
23380928|NCT00541229|65140395|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
23380929|NCT00541229|65140396|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
23380930|NCT00541229|65140391|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380931|NCT00541229|65140392|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380932|NCT00541229|65140393|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380933|NCT00541229|65140394|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380934|NCT00541229|65140395|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
23380935|NCT00541229|65140396|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
23380936|NCT00541229|65140391|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380937|NCT00541229|65140392|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380938|NCT00541229|65140393|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380939|NCT00541229|65140394|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380940|NCT00541229|65140395|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
23380941|NCT00541229|65140396|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
23380942|NCT00541229|65140391|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
23380943|NCT00541229|65140392|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
23380944|NCT00541229|65140393|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
23380945|NCT00541229|65140394|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
23380946|NCT00541229|65140395|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
23380947|NCT00541229|65140396|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
23380948|NCT00541229|65140391|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
23380949|NCT00541229|65140392|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
23380950|NCT00541229|65140393|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
23380951|NCT00541229|65140394|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
23380952|NCT00541229|65140395|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
23380953|NCT00541229|65140396|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
23380954|NCT00541229|65140391|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
23380955|NCT00541229|65140392|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
23380956|NCT00541229|65140393|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
23380957|NCT00541229|65140394|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
23380958|NCT00541229|65140395|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
23380959|NCT00541229|65140396|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
23380960|NCT00541229|65140391|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
23288337|NCT00112437|64798867|FG009|Year 2 (12-Month Extension)|Moved|1|||
23288338|NCT00112437|64798868|FG010|Year 2 (12-Month Extension)|Moved|0|||
23288339|NCT00112437|64798869|FG011|Year 2 (12-Month Extension)|Moved|0|||
23288340|NCT00112437|64798870|FG012|Year 2 (12-Month Extension)|Moved|0|||
23288341|NCT00112437|64798871|FG013|Year 2 (12-Month Extension)|Moved|0|||
23288342|NCT00112437|64798872|FG014|Year 2 (12-Month Extension)|Moved|0|||
23288343|NCT00112437|64798873|FG015|Year 2 (12-Month Extension)|Moved|0|||
23288344|NCT00112437|64798874|FG016|Year 2 (12-Month Extension)|Moved|0|||
23288345|NCT00112437|64798875|FG017|Year 2 (12-Month Extension)|Moved|0|||
23288346|NCT00112437|64798876|FG018|Year 2 (12-Month Extension)|Moved|0|||
23288347|NCT00112437|64798877|FG019|Year 2 (12-Month Extension)|Moved|0|||
23288348|NCT00112437|64798878|FG020|Year 2 (12-Month Extension)|Moved|0|||
23288349|NCT00112437|64798879|FG021|Year 2 (12-Month Extension)|Moved|0|||
23288350|NCT00112437|64798880|FG022|Year 2 (12-Month Extension)|Moved|0|||
23288351|NCT00112437|64798881|FG023|Year 2 (12-Month Extension)|Moved|0|||
23288352|NCT00112437|64798882|FG024|Year 2 (12-Month Extension)|Moved|0|||
23288353|NCT00112437|64798883|FG025|Year 2 (12-Month Extension)|Moved|0|||
23288354|NCT00112437|64798858|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
23288355|NCT00112437|64798859|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
23380961|NCT00541229|65140392|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
23380962|NCT00541229|65140393|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
23380963|NCT00541229|65140394|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
23380964|NCT00541229|65140395|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
23380965|NCT00541229|65140396|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
23380966|NCT00541229|65140391|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
23380967|NCT00541229|65140392|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
23380968|NCT00541229|65140393|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
23380969|NCT00541229|65140394|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
23380970|NCT00541229|65140395|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
23380971|NCT00541229|65140396|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
23380972|NCT00541229|65140391|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
23380973|NCT00541229|65140392|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
23380974|NCT00541229|65140393|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
23380975|NCT00541229|65140394|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
23380976|NCT00541229|65140395|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
23380977|NCT00541229|65140396|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
23380978|NCT00541229|65140391|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
23380979|NCT00541229|65140392|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
23380980|NCT00541229|65140393|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
23288356|NCT00112437|64798860|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
23288357|NCT00112437|64798861|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
23288358|NCT00112437|64798862|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
23288359|NCT00112437|64798863|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
23288360|NCT00112437|64798864|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
23288361|NCT00112437|64798865|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
23288362|NCT00112437|64798866|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
23288363|NCT00112437|64798867|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
23288364|NCT00112437|64798868|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
23288365|NCT00112437|64798869|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
23288366|NCT00112437|64798870|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
23288367|NCT00112437|64798871|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
23380981|NCT00541229|65140394|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
23380982|NCT00541229|65140395|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
23380983|NCT00541229|65140396|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
23380984|NCT00541229|65140391|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
23380985|NCT00541229|65140392|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
23380986|NCT00541229|65140393|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
23380987|NCT00541229|65140394|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
23380988|NCT00541229|65140395|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
23288368|NCT00112437|64798872|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
23288369|NCT00112437|64798873|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
23288370|NCT00112437|64798874|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
23288371|NCT00112437|64798875|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
23288372|NCT00112437|64798876|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
23288373|NCT00112437|64798877|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
23288374|NCT00112437|64798878|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
23380989|NCT00541229|65140396|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
23380990|NCT00541229|65140391|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23380991|NCT00541229|65140392|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23380992|NCT00541229|65140393|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23380993|NCT00541229|65140394|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23288375|NCT00112437|64798879|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
23288376|NCT00112437|64798880|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
23288377|NCT00112437|64798881|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
23288378|NCT00112437|64798882|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
23288379|NCT00112437|64798883|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
23288380|NCT00112437|64798858|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288381|NCT00112437|64798859|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288382|NCT00112437|64798860|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288383|NCT00112437|64798861|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288384|NCT00112437|64798862|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288385|NCT00112437|64798863|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288386|NCT00112437|64798864|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288387|NCT00112437|64798865|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288388|NCT00112437|64798866|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288389|NCT00112437|64798867|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288390|NCT00112437|64798868|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288391|NCT00112437|64798869|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
23380994|NCT00541229|65140395|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
23380995|NCT00541229|65140396|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
23380996|NCT00541229|65140391|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
23605927|NCT01640951|65947105|FG004|Overall Study|Lost to Follow-up|2|||
23288392|NCT00112437|64798870|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288393|NCT00112437|64798871|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
23288394|NCT00112437|64798872|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288395|NCT00112437|64798873|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
23288396|NCT00112437|64798874|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288397|NCT00112437|64798875|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288398|NCT00112437|64798876|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
23288399|NCT00112437|64798877|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288400|NCT00112437|64798878|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288401|NCT00112437|64798879|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288402|NCT00112437|64798880|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288403|NCT00112437|64798881|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288404|NCT00112437|64798882|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288405|NCT00112437|64798883|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
23288406|NCT00112437|64798858|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288407|NCT00112437|64798859|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288408|NCT00112437|64798860|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288409|NCT00112437|64798861|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23380997|NCT00541229|65140392|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
23380998|NCT00541229|65140393|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
23380999|NCT00541229|65140394|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
23381000|NCT00541229|65140395|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
23381001|NCT00541229|65140396|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
23381002|NCT00541229|65140391|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
23381003|NCT00541229|65140392|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
23381004|NCT00541229|65140393|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
23288410|NCT00112437|64798862|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288411|NCT00112437|64798863|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288412|NCT00112437|64798864|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288413|NCT00112437|64798865|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288414|NCT00112437|64798866|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288415|NCT00112437|64798867|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288416|NCT00112437|64798868|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288417|NCT00112437|64798869|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23381005|NCT00541229|65140394|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
23381006|NCT00541229|65140395|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
23381007|NCT00541229|65140396|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
23381008|NCT00541229|65140391|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381009|NCT00541229|65140392|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381010|NCT00541229|65140393|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381011|NCT00541229|65140394|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381012|NCT00541229|65140395|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
23381013|NCT00541229|65140396|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
23381014|NCT00541229|65140391|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381015|NCT00541229|65140392|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381016|NCT00541229|65140393|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
23381017|NCT00541229|65140394|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381018|NCT00541229|65140395|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381019|NCT00541229|65140396|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
23381020|NCT00514917|65140399|FG000|Overall Study|Death|4|||
23381021|NCT00514917|65140400|FG001|Overall Study|Death|10|||
23381022|NCT00514917|65140399|FG000|Overall Study|Protocol Violation|1|||
23381023|NCT00514917|65140400|FG001|Overall Study|Protocol Violation|0|||
23381024|NCT00514917|65140399|FG000|Overall Study|Lost to Follow-up|4|||
23381025|NCT00514917|65140400|FG001|Overall Study|Lost to Follow-up|3|||
23381026|NCT00514917|65140399|FG000|Overall Study|Withdrawal by Subject|18|||
23381027|NCT00514917|65140400|FG001|Overall Study|Withdrawal by Subject|16|||
23381028|NCT00514917|65140399|FG000|Overall Study|Discontinued due to study closure|88|||
23381029|NCT00514917|65140400|FG001|Overall Study|Discontinued due to study closure|81|||
23288418|NCT00112437|64798870|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288419|NCT00112437|64798871|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288420|NCT00112437|64798872|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23381030|NCT00514917|65140399|FG000|Overall Study|Undefined|11|||
23381031|NCT00514917|65140400|FG001|Overall Study|Undefined|5|||
23381032|NCT03600428|65140407|FG000|Overall Study|Not eligible|0|||
23381033|NCT03600428|65140408|FG001|Overall Study|Not eligible|1|||
23381034|NCT03600428|65140407|FG000|Overall Study|Lost to Follow-up|5|||
23381035|NCT03600428|65140408|FG001|Overall Study|Lost to Follow-up|4|||
23381036|NCT02134028|65140409|FG000|Overall Study|Lack of Efficacy|1|||
23381037|NCT02134028|65140410|FG001|Overall Study|Lack of Efficacy|0|||
23288421|NCT00112437|64798873|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
23288422|NCT00112437|64798874|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288423|NCT00112437|64798875|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288424|NCT00112437|64798876|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288425|NCT00112437|64798877|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288426|NCT00112437|64798878|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288427|NCT00112437|64798879|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23381038|NCT02134028|65140411|FG002|Overall Study|Lack of Efficacy|3|||
23381039|NCT02134028|65140412|FG003|Overall Study|Lack of Efficacy|2|||
23381040|NCT02134028|65140413|FG004|Overall Study|Lack of Efficacy|1|||
23381041|NCT02134028|65140414|FG005|Overall Study|Lack of Efficacy|2|||
23381042|NCT02134028|65140415|FG006|Overall Study|Lack of Efficacy|1|||
23381043|NCT02134028|65140416|FG007|Overall Study|Lack of Efficacy|0|||
23381044|NCT02134028|65140409|FG000|Overall Study|Poor compliance to protocol|1|||
23381045|NCT02134028|65140410|FG001|Overall Study|Poor compliance to protocol|1|||
23381046|NCT02134028|65140411|FG002|Overall Study|Poor compliance to protocol|3|||
23381047|NCT02134028|65140412|FG003|Overall Study|Poor compliance to protocol|7|||
23381048|NCT02134028|65140413|FG004|Overall Study|Poor compliance to protocol|1|||
23381049|NCT02134028|65140414|FG005|Overall Study|Poor compliance to protocol|1|||
23381050|NCT02134028|65140415|FG006|Overall Study|Poor compliance to protocol|0|||
23381051|NCT02134028|65140416|FG007|Overall Study|Poor compliance to protocol|0|||
23381052|NCT02134028|65140409|FG000|Overall Study|Other unspecified|4|||
23381053|NCT02134028|65140410|FG001|Overall Study|Other unspecified|22|||
23381054|NCT02134028|65140411|FG002|Overall Study|Other unspecified|33|||
23381055|NCT02134028|65140412|FG003|Overall Study|Other unspecified|64|||
23381056|NCT02134028|65140413|FG004|Overall Study|Other unspecified|8|||
23381057|NCT02134028|65140414|FG005|Overall Study|Other unspecified|6|||
23381058|NCT02134028|65140415|FG006|Overall Study|Other unspecified|2|||
23381059|NCT02134028|65140416|FG007|Overall Study|Other unspecified|1|||
23381060|NCT02134028|65140409|FG000|Overall Study|Adverse Event|3|||
23381061|NCT02134028|65140410|FG001|Overall Study|Adverse Event|19|||
23381062|NCT02134028|65140411|FG002|Overall Study|Adverse Event|13|||
23381063|NCT02134028|65140412|FG003|Overall Study|Adverse Event|32|||
23381064|NCT02134028|65140413|FG004|Overall Study|Adverse Event|4|||
23381065|NCT02134028|65140414|FG005|Overall Study|Adverse Event|5|||
23381066|NCT02134028|65140415|FG006|Overall Study|Adverse Event|1|||
23381067|NCT02134028|65140416|FG007|Overall Study|Adverse Event|2|||
23381068|NCT00962650|65140417|FG000|Overall Study|Transgastric DP was not completed|2|||
23381069|NCT00968968|65140420|FG000|Overall Study|Study closed/terminated|10|||
23381070|NCT00968968|65140421|FG001|Overall Study|Study closed/terminated|10|||
23381071|NCT00968968|65140420|FG000|Overall Study|Protocol defined stopping criteria|3|||
23381072|NCT00968968|65140421|FG001|Overall Study|Protocol defined stopping criteria|1|||
23381073|NCT00968968|65140420|FG000|Overall Study|Withdrawal by Subject|2|||
23381074|NCT00968968|65140421|FG001|Overall Study|Withdrawal by Subject|0|||
23381075|NCT00968968|65140420|FG000|Overall Study|Physician Decision|1|||
23381076|NCT00968968|65140421|FG001|Overall Study|Physician Decision|2|||
23381077|NCT00968968|65140420|FG000|Overall Study|Lost to Follow-up|0|||
23381078|NCT00968968|65140421|FG001|Overall Study|Lost to Follow-up|1|||
23381079|NCT01049828|65140422|FG000|Overall Study|Claustrophibia and Frustration|2|||
23381080|NCT01900314|65140425|FG000|Overall Study|Lost to Follow-up|1|||
23381081|NCT01900314|65140426|FG001|Overall Study|Lost to Follow-up|0|||
23381082|NCT01900314|65140425|FG000|Overall Study|Protocol Violation|0|||
23381083|NCT01900314|65140426|FG001|Overall Study|Protocol Violation|1|||
23381084|NCT01900314|65140425|FG000|Overall Study|Withdrawal by Subject|3|||
23381085|NCT01900314|65140426|FG001|Overall Study|Withdrawal by Subject|3|||
23381086|NCT01564407|65140427|FG000|Overall Study|Lost to Follow-up|0|||
23381087|NCT01564407|65140428|FG001|Overall Study|Lost to Follow-up|1|||
23381088|NCT01564407|65140429|FG002|Overall Study|Lost to Follow-up|0|||
23381089|NCT01564407|65140430|FG003|Overall Study|Lost to Follow-up|0|||
23381090|NCT01564407|65140431|FG004|Overall Study|Lost to Follow-up|0|||
23491720|NCT03633617|65545044|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
23491721|NCT03633617|65545045|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
23381091|NCT01564407|65140427|FG000|Overall Study|Withdrawal by Subject|0|||
23381092|NCT01564407|65140428|FG001|Overall Study|Withdrawal by Subject|1|||
23381093|NCT01564407|65140429|FG002|Overall Study|Withdrawal by Subject|0|||
23381094|NCT01564407|65140430|FG003|Overall Study|Withdrawal by Subject|0|||
23381095|NCT01564407|65140431|FG004|Overall Study|Withdrawal by Subject|0|||
23381096|NCT01564407|65140427|FG000|Overall Study|funding lost, study ended|0|||
23491722|NCT03633617|65545046|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
23381097|NCT01564407|65140428|FG001|Overall Study|funding lost, study ended|0|||
23381098|NCT01564407|65140429|FG002|Overall Study|funding lost, study ended|0|||
23381099|NCT01564407|65140430|FG003|Overall Study|funding lost, study ended|1|||
23381100|NCT01564407|65140431|FG004|Overall Study|funding lost, study ended|0|||
23381101|NCT02932943|65140432|FG000|Overall Study|Lost to Follow-up|0|||
23491723|NCT03633617|65545036|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
23491724|NCT03633617|65545037|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
23491725|NCT03633617|65545038|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
23491726|NCT03633617|65545039|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
23491727|NCT03633617|65545040|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
23491728|NCT03633617|65545041|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
23491729|NCT03633617|65545042|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
23491730|NCT03633617|65545043|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
23491731|NCT03633617|65545044|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
23491732|NCT03633617|65545045|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
23491733|NCT03633617|65545046|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
23491734|NCT03633617|65545036|FG000|Part C (& Follow-up)|Physician Decision|0|||
23491735|NCT03633617|65545037|FG001|Part C (& Follow-up)|Physician Decision|0|||
23491736|NCT03633617|65545038|FG002|Part C (& Follow-up)|Physician Decision|0|||
23491737|NCT03633617|65545039|FG003|Part C (& Follow-up)|Physician Decision|0|||
23491738|NCT03633617|65545040|FG004|Part C (& Follow-up)|Physician Decision|0|||
23491739|NCT03633617|65545041|FG005|Part C (& Follow-up)|Physician Decision|0|||
23491740|NCT03633617|65545042|FG006|Part C (& Follow-up)|Physician Decision|0|||
23491741|NCT03633617|65545043|FG007|Part C (& Follow-up)|Physician Decision|1|||
23491742|NCT03633617|65545044|FG008|Part C (& Follow-up)|Physician Decision|0|||
23491743|NCT03633617|65545045|FG009|Part C (& Follow-up)|Physician Decision|0|||
23491744|NCT03633617|65545046|FG010|Part C (& Follow-up)|Physician Decision|1|||
23491745|NCT03633617|65545036|FG000|Part C (& Follow-up)|COVID-19 related|0|||
23491746|NCT03633617|65545037|FG001|Part C (& Follow-up)|COVID-19 related|0|||
23491747|NCT03633617|65545038|FG002|Part C (& Follow-up)|COVID-19 related|0|||
23491748|NCT03633617|65545039|FG003|Part C (& Follow-up)|COVID-19 related|0|||
23491749|NCT03633617|65545040|FG004|Part C (& Follow-up)|COVID-19 related|0|||
23491750|NCT03633617|65545041|FG005|Part C (& Follow-up)|COVID-19 related|1|||
23491751|NCT03633617|65545042|FG006|Part C (& Follow-up)|COVID-19 related|0|||
23491752|NCT03633617|65545043|FG007|Part C (& Follow-up)|COVID-19 related|0|||
23491753|NCT03633617|65545044|FG008|Part C (& Follow-up)|COVID-19 related|0|||
23491754|NCT03633617|65545045|FG009|Part C (& Follow-up)|COVID-19 related|0|||
23491755|NCT03633617|65545046|FG010|Part C (& Follow-up)|COVID-19 related|0|||
23491756|NCT03633617|65545036|FG000|Part C (& Follow-up)|Protocol Violation|0|||
23491757|NCT03633617|65545037|FG001|Part C (& Follow-up)|Protocol Violation|0|||
23491758|NCT03633617|65545038|FG002|Part C (& Follow-up)|Protocol Violation|0|||
23491759|NCT03633617|65545039|FG003|Part C (& Follow-up)|Protocol Violation|0|||
23381102|NCT02932943|65140433|FG001|Overall Study|Lost to Follow-up|2|||
23491760|NCT03633617|65545040|FG004|Part C (& Follow-up)|Protocol Violation|0|||
23491761|NCT03633617|65545041|FG005|Part C (& Follow-up)|Protocol Violation|0|||
23491762|NCT03633617|65545042|FG006|Part C (& Follow-up)|Protocol Violation|0|||
23491763|NCT03633617|65545043|FG007|Part C (& Follow-up)|Protocol Violation|0|||
23491764|NCT03633617|65545044|FG008|Part C (& Follow-up)|Protocol Violation|0|||
23381103|NCT02932943|65140432|FG000|Overall Study|Adverse Event|2|||
23381104|NCT02932943|65140433|FG001|Overall Study|Adverse Event|2|||
23381105|NCT02932943|65140432|FG000|Overall Study|Withdrawal by Subject|3|||
23381106|NCT02932943|65140433|FG001|Overall Study|Withdrawal by Subject|3|||
23381107|NCT00367458|65140439|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
23381108|NCT00367458|65140440|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
23381109|NCT01901562|65140441|FG000|Overall Study|Protocol Violation|5|||
23381110|NCT01901562|65140441|FG000|Overall Study|Excluded intraoperatively|4|||
23381111|NCT03624036|65140442|FG000|Overall Study|Death|2|||
23381112|NCT03624036|65140443|FG001|Overall Study|Death|3|||
23381113|NCT03624036|65140444|FG002|Overall Study|Death|0|||
23381114|NCT03624036|65140445|FG003|Overall Study|Death|1|||
23381115|NCT03624036|65140442|FG000|Overall Study|Withdrawal by Subject|1|||
23381116|NCT03624036|65140443|FG001|Overall Study|Withdrawal by Subject|0|||
23381117|NCT03624036|65140444|FG002|Overall Study|Withdrawal by Subject|1|||
23381118|NCT03624036|65140445|FG003|Overall Study|Withdrawal by Subject|0|||
23381119|NCT03624036|65140442|FG000|Overall Study|Enrolled but Never Treated|1|||
23381120|NCT03624036|65140443|FG001|Overall Study|Enrolled but Never Treated|0|||
23381121|NCT03624036|65140444|FG002|Overall Study|Enrolled but Never Treated|0|||
23381122|NCT03624036|65140445|FG003|Overall Study|Enrolled but Never Treated|0|||
23381123|NCT03624036|65140442|FG000|Overall Study|Reason not Specified|3|||
23381124|NCT03624036|65140443|FG001|Overall Study|Reason not Specified|0|||
23381125|NCT03624036|65140444|FG002|Overall Study|Reason not Specified|2|||
23381126|NCT03624036|65140445|FG003|Overall Study|Reason not Specified|2|||
23381127|NCT01028391|65140446|FG000|Overall Study|Adverse Event|4|||
23381128|NCT01028391|65140447|FG001|Overall Study|Adverse Event|0|||
23381129|NCT01028391|65140446|FG000|Overall Study|Lack of Efficacy|0|||
23381130|NCT01028391|65140447|FG001|Overall Study|Lack of Efficacy|2|||
23381131|NCT01028391|65140446|FG000|Overall Study|Lost to Follow-up|3|||
23381132|NCT01028391|65140447|FG001|Overall Study|Lost to Follow-up|4|||
23381133|NCT01028391|65140446|FG000|Overall Study|Physician Decision|0|||
23381134|NCT01028391|65140447|FG001|Overall Study|Physician Decision|1|||
23381135|NCT01028391|65140446|FG000|Overall Study|Withdrawal by Subject|6|||
23381136|NCT01028391|65140447|FG001|Overall Study|Withdrawal by Subject|3|||
23381137|NCT01028391|65140446|FG000|Overall Study|Needed excluded medication|1|||
23381138|NCT01028391|65140447|FG001|Overall Study|Needed excluded medication|1|||
23381139|NCT00472641|65140448|FG000|Overall Study|Lack of Efficacy|3|||
23381140|NCT00472641|65140448|FG000|Overall Study|Adverse Event|3|||
23381141|NCT00472641|65140448|FG000|Overall Study|Lost to Follow-up|1|||
23381142|NCT02547935|65140451|FG000|Overall Study|Other|0|||
23381143|NCT02547935|65140452|FG001|Overall Study|Other|1|||
23381144|NCT02547935|65140453|FG002|Overall Study|Other|0|||
23381145|NCT02547935|65140451|FG000|Overall Study|Withdrawal by Subject|2|||
23381146|NCT02547935|65140452|FG001|Overall Study|Withdrawal by Subject|3|||
23381147|NCT02547935|65140453|FG002|Overall Study|Withdrawal by Subject|4|||
23381148|NCT02547935|65140451|FG000|Overall Study|Screen Failure|2|||
23381149|NCT02547935|65140452|FG001|Overall Study|Screen Failure|0|||
23381150|NCT02547935|65140453|FG002|Overall Study|Screen Failure|0|||
23381151|NCT02547935|65140451|FG000|Overall Study|Physician Decision|0|||
23381152|NCT02547935|65140452|FG001|Overall Study|Physician Decision|1|||
23381153|NCT02547935|65140453|FG002|Overall Study|Physician Decision|0|||
23381154|NCT02547935|65140451|FG000|Overall Study|Lost to Follow-up|0|||
23381155|NCT02547935|65140452|FG001|Overall Study|Lost to Follow-up|2|||
23381156|NCT02547935|65140453|FG002|Overall Study|Lost to Follow-up|1|||
23381157|NCT02547935|65140451|FG000|Overall Study|Death|1|||
23491765|NCT03633617|65545045|FG009|Part C (& Follow-up)|Protocol Violation|3|||
23491766|NCT03633617|65545046|FG010|Part C (& Follow-up)|Protocol Violation|1|||
23491767|NCT03633617|65545036|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
23491768|NCT03633617|65545037|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
23491769|NCT03633617|65545038|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
23491770|NCT03633617|65545039|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
23491771|NCT03633617|65545040|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
23491772|NCT03633617|65545041|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
23491773|NCT03633617|65545042|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
23491774|NCT03633617|65545043|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
23491775|NCT03633617|65545044|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
23491776|NCT03633617|65545045|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
23491777|NCT03633617|65545046|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
23491778|NCT03875768|65545047|FG000|Overall Study|Lost to Follow-up|16|||
23491779|NCT03875768|65545048|FG001|Overall Study|Lost to Follow-up|13|||
23491780|NCT03875768|65545047|FG000|Overall Study|Withdrawal by Subject|10|||
23491781|NCT03875768|65545048|FG001|Overall Study|Withdrawal by Subject|21|||
23491782|NCT03875768|65545047|FG000|Overall Study|Did not complete assessment|21|||
23491783|NCT03875768|65545048|FG001|Overall Study|Did not complete assessment|12|||
23491784|NCT03875768|65545047|FG000|Overall Study|Became ineligible|1|||
23491785|NCT03875768|65545048|FG001|Overall Study|Became ineligible|0|||
23491786|NCT03212690|65545049|FG000|Overall Study|Protocol Violation|1|||
23491787|NCT02955797|65545050|FG000|Overall Study|Protocol Violation|1|||
23491788|NCT02955797|65545051|FG001|Overall Study|Protocol Violation|0|||
23491789|NCT02955797|65545052|FG002|Overall Study|Protocol Violation|0|||
23491790|NCT02955797|65545053|FG003|Overall Study|Protocol Violation|1|||
23491791|NCT02955797|65545050|FG000|Overall Study|Withdrawal by Subject|2|||
23491792|NCT02955797|65545051|FG001|Overall Study|Withdrawal by Subject|2|||
23491793|NCT02955797|65545052|FG002|Overall Study|Withdrawal by Subject|0|||
23491794|NCT02955797|65545053|FG003|Overall Study|Withdrawal by Subject|1|||
23491795|NCT02955797|65545050|FG000|Overall Study|Lost to Follow-up|0|||
23491796|NCT02955797|65545051|FG001|Overall Study|Lost to Follow-up|1|||
23491797|NCT02955797|65545052|FG002|Overall Study|Lost to Follow-up|0|||
23491798|NCT02955797|65545053|FG003|Overall Study|Lost to Follow-up|0|||
23491799|NCT01669928|65545056|FG000|First Intervention|Withdrawal by Subject|3|||
23491800|NCT01669928|65545057|FG001|First Intervention|Withdrawal by Subject|5|||
23491801|NCT04879225|65545062|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
23491802|NCT04879225|65545062|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
23491803|NCT02357979|65545064|FG000|Overall Study|Lost to Follow-up|5|||
23491804|NCT02357979|65545065|FG001|Overall Study|Lost to Follow-up|5|||
23491805|NCT03793556|65545066|FG000|Overall Study|Withdrawal by Subject|12|||
23491806|NCT03793556|65545067|FG001|Overall Study|Withdrawal by Subject|1|||
23491807|NCT03793556|65545066|FG000|Overall Study|Lost to Follow-up|1|||
23491808|NCT03793556|65545067|FG001|Overall Study|Lost to Follow-up|1|||
23491809|NCT04327674|65545070|FG000|Overall Study|Protocol Violation|19|||
23491810|NCT02833350|65545074|FG000|Overall Study|Adverse Event|0|||
23491811|NCT02833350|65545075|FG001|Overall Study|Adverse Event|3|||
23491812|NCT02833350|65545076|FG002|Overall Study|Adverse Event|4|||
23288428|NCT00112437|64798880|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288429|NCT00112437|64798881|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288430|NCT00112437|64798882|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288431|NCT00112437|64798883|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
23288432|NCT00112437|64798858|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288433|NCT00112437|64798859|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288434|NCT00112437|64798860|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288435|NCT00112437|64798861|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288436|NCT00112437|64798862|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288437|NCT00112437|64798863|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288438|NCT00112437|64798864|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288439|NCT00112437|64798865|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288440|NCT00112437|64798866|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288441|NCT00112437|64798867|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288442|NCT00112437|64798868|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288443|NCT00112437|64798869|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288444|NCT00112437|64798870|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
23491813|NCT02833350|65545077|FG003|Overall Study|Adverse Event|4|||
23288445|NCT00112437|64798871|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
23491814|NCT02833350|65545078|FG004|Overall Study|Adverse Event|1|||
23491815|NCT02833350|65545079|FG005|Overall Study|Adverse Event|0|||
23491816|NCT02833350|65545080|FG006|Overall Study|Adverse Event|1|||
23491817|NCT02833350|65545074|FG000|Overall Study|Death|0|||
23491818|NCT02833350|65545075|FG001|Overall Study|Death|0|||
23491819|NCT02833350|65545076|FG002|Overall Study|Death|1|||
23491820|NCT02833350|65545077|FG003|Overall Study|Death|0|||
23491821|NCT02833350|65545078|FG004|Overall Study|Death|0|||
23288446|NCT00112437|64798872|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288447|NCT00112437|64798873|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
23288448|NCT00112437|64798874|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288449|NCT00112437|64798875|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288450|NCT00112437|64798876|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288451|NCT00112437|64798877|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288452|NCT00112437|64798878|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288453|NCT00112437|64798879|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288454|NCT00112437|64798880|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288455|NCT00112437|64798881|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288456|NCT00112437|64798882|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288457|NCT00112437|64798883|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
23288458|NCT00112437|64798858|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288459|NCT00112437|64798859|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288460|NCT00112437|64798860|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288461|NCT00112437|64798861|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288462|NCT00112437|64798862|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288463|NCT00112437|64798863|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288464|NCT00112437|64798864|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288465|NCT00112437|64798865|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288466|NCT00112437|64798866|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288467|NCT00112437|64798867|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288468|NCT00112437|64798868|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288469|NCT00112437|64798869|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
23288470|NCT00112437|64798870|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288471|NCT00112437|64798871|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288472|NCT00112437|64798872|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
23288473|NCT00112437|64798873|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288474|NCT00112437|64798874|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288475|NCT00112437|64798875|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288476|NCT00112437|64798876|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288477|NCT00112437|64798877|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288478|NCT00112437|64798878|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288479|NCT00112437|64798879|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288480|NCT00112437|64798880|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288481|NCT00112437|64798881|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288482|NCT00112437|64798882|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288483|NCT00112437|64798883|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
23288484|NCT00112437|64798858|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288485|NCT00112437|64798859|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288486|NCT00112437|64798860|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288487|NCT00112437|64798861|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288488|NCT00112437|64798862|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23381158|NCT02547935|65140452|FG001|Overall Study|Death|1|||
23381159|NCT02547935|65140453|FG002|Overall Study|Death|0|||
23381160|NCT00250718|65140454|FG000|Overall Study|Death|1|||
23381161|NCT00250718|65140454|FG000|Overall Study|Adverse Event|1|||
23381162|NCT00250718|65140454|FG000|Overall Study|Withdrawal by Subject|1|||
23381163|NCT01334515|65140455|FG000|Overall Study|Adverse Event|1|||
23381164|NCT01334515|65140456|FG001|Overall Study|Adverse Event|6|||
23381165|NCT01334515|65140455|FG000|Overall Study|Death|1|||
23381166|NCT01334515|65140456|FG001|Overall Study|Death|0|||
23381167|NCT01334515|65140455|FG000|Overall Study|Lack of Efficacy|8|||
23381168|NCT01334515|65140456|FG001|Overall Study|Lack of Efficacy|21|||
23381169|NCT01334515|65140455|FG000|Overall Study|Physician Decision|1|||
23381170|NCT01334515|65140456|FG001|Overall Study|Physician Decision|1|||
23381171|NCT01334515|65140455|FG000|Overall Study|Withdrawal by Subject|1|||
23381172|NCT01334515|65140456|FG001|Overall Study|Withdrawal by Subject|1|||
23381173|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
23381174|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
23381175|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
23381176|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
23381177|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
23381178|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
23381179|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
23381180|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
23381181|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
23381182|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
23381183|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Death|0|||
23381184|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Death|0|||
23381185|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Death|1|||
23381186|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Death|0|||
23288489|NCT00112437|64798863|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288490|NCT00112437|64798864|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288491|NCT00112437|64798865|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288492|NCT00112437|64798866|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288493|NCT00112437|64798867|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288494|NCT00112437|64798868|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
23288495|NCT00112437|64798869|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
23288496|NCT00112437|64798870|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288497|NCT00112437|64798871|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288498|NCT00112437|64798872|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288499|NCT00112437|64798873|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288500|NCT00112437|64798874|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288501|NCT00112437|64798875|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288502|NCT00112437|64798876|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288503|NCT00112437|64798877|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288504|NCT00112437|64798878|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288505|NCT00112437|64798879|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288506|NCT00112437|64798880|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23381187|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Death|0|||
23381188|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
23381189|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
23491822|NCT02833350|65545079|FG005|Overall Study|Death|0|||
23491823|NCT02833350|65545080|FG006|Overall Study|Death|0|||
23491824|NCT02833350|65545074|FG000|Overall Study|Lack of Efficacy|0|||
23491825|NCT02833350|65545075|FG001|Overall Study|Lack of Efficacy|2|||
23491826|NCT02833350|65545076|FG002|Overall Study|Lack of Efficacy|1|||
23491827|NCT02833350|65545077|FG003|Overall Study|Lack of Efficacy|4|||
23491828|NCT02833350|65545078|FG004|Overall Study|Lack of Efficacy|0|||
23491829|NCT02833350|65545079|FG005|Overall Study|Lack of Efficacy|1|||
23491830|NCT02833350|65545080|FG006|Overall Study|Lack of Efficacy|1|||
23491831|NCT02833350|65545074|FG000|Overall Study|Lost to Follow-up|0|||
23491832|NCT02833350|65545075|FG001|Overall Study|Lost to Follow-up|1|||
23491833|NCT02833350|65545076|FG002|Overall Study|Lost to Follow-up|0|||
23491834|NCT02833350|65545077|FG003|Overall Study|Lost to Follow-up|0|||
23491835|NCT02833350|65545078|FG004|Overall Study|Lost to Follow-up|0|||
23491836|NCT02833350|65545079|FG005|Overall Study|Lost to Follow-up|0|||
23491837|NCT02833350|65545080|FG006|Overall Study|Lost to Follow-up|1|||
23491838|NCT02833350|65545074|FG000|Overall Study|Withdrawal by Subject|3|||
23491839|NCT02833350|65545075|FG001|Overall Study|Withdrawal by Subject|3|||
23491840|NCT02833350|65545076|FG002|Overall Study|Withdrawal by Subject|2|||
23491841|NCT02833350|65545077|FG003|Overall Study|Withdrawal by Subject|0|||
23491842|NCT02833350|65545078|FG004|Overall Study|Withdrawal by Subject|2|||
23491843|NCT02833350|65545079|FG005|Overall Study|Withdrawal by Subject|0|||
23491844|NCT02833350|65545080|FG006|Overall Study|Withdrawal by Subject|2|||
23491845|NCT00004635|65545081|FG000|Period One|refused|2|||
23491846|NCT00004635|65545082|FG001|Period One|refused|1|||
23491847|NCT00004635|65545081|FG000|Period One|Withdrawal by Subject|1|||
23491848|NCT00004635|65545082|FG001|Period One|Withdrawal by Subject|1|||
23491849|NCT00004635|65545081|FG000|Period One|Protocol Violation|1|||
23288507|NCT00112437|64798881|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23491850|NCT00004635|65545082|FG001|Period One|Protocol Violation|0|||
23491851|NCT00004635|65545081|FG000|Period One|PSA did not go <5 ng/mL|1|||
23491852|NCT00004635|65545082|FG001|Period One|PSA did not go <5 ng/mL|0|||
23491853|NCT00004635|65545081|FG000|Period One|second malignancy|1|||
23491854|NCT00004635|65545082|FG001|Period One|second malignancy|0|||
23491855|NCT00004635|65545081|FG000|Period One|progressed|0|||
23491856|NCT00004635|65545082|FG001|Period One|progressed|2|||
23491857|NCT00004635|65545081|FG000|Period One|health problem|0|||
23491858|NCT00004635|65545082|FG001|Period One|health problem|1|||
23491859|NCT00004635|65545081|FG000|Period One|discrepancy in data entry|0|||
23491860|NCT00004635|65545082|FG001|Period One|discrepancy in data entry|1|||
23288508|NCT00112437|64798882|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288509|NCT00112437|64798883|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
23288510|NCT00112437|64798858|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288511|NCT00112437|64798859|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288512|NCT00112437|64798860|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288513|NCT00112437|64798861|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288514|NCT00112437|64798862|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288515|NCT00112437|64798863|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288516|NCT00112437|64798864|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288517|NCT00112437|64798865|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288518|NCT00112437|64798866|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288519|NCT00112437|64798867|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288520|NCT00112437|64798868|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288521|NCT00112437|64798869|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288522|NCT00112437|64798870|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288523|NCT00112437|64798871|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23491861|NCT00004635|65545081|FG000|Period Two|progression|2|||
23491862|NCT00004635|65545082|FG001|Period Two|progression|3|||
23491863|NCT00004635|65545081|FG000|Period Two|Adverse Event|1|||
23491864|NCT00004635|65545082|FG001|Period Two|Adverse Event|0|||
23491865|NCT00004635|65545081|FG000|Period Two|refused|0|||
23491866|NCT00004635|65545082|FG001|Period Two|refused|2|||
23491867|NCT00004635|65545081|FG000|Period Two|health problem|1|||
23491868|NCT00004635|65545082|FG001|Period Two|health problem|1|||
23491869|NCT00004635|65545081|FG000|Period Two|travel issues|0|||
23491870|NCT00004635|65545082|FG001|Period Two|travel issues|1|||
23491871|NCT00004635|65545081|FG000|Period Two|secondary malignancy|1|||
23491872|NCT00004635|65545082|FG001|Period Two|secondary malignancy|1|||
23491873|NCT00004635|65545081|FG000|Period Two|Lost to Follow-up|1|||
23491874|NCT00004635|65545082|FG001|Period Two|Lost to Follow-up|0|||
23491875|NCT00004635|65545081|FG000|Period Two|discrepancy in data entry|0|||
23491876|NCT00004635|65545082|FG001|Period Two|discrepancy in data entry|1|||
23491877|NCT00721123|65545091|FG000|Overall Study|Adverse Event|96|||
23491878|NCT00721123|65545091|FG000|Overall Study|Death|10|||
23491879|NCT00721123|65545091|FG000|Overall Study|Insufficient Therapeutic Response|21|||
23491880|NCT00721123|65545091|FG000|Overall Study|Protocol Violation|1|||
23491881|NCT00721123|65545091|FG000|Overall Study|Refused Treatment|41|||
23491882|NCT00721123|65545091|FG000|Overall Study|Failure to Return|9|||
23491883|NCT00721123|65545091|FG000|Overall Study|Withdrawal by Subject|5|||
23491884|NCT04171765|65545092|FG000|Overall Study|Adverse Event|2|||
23491885|NCT04171765|65545093|FG001|Overall Study|Adverse Event|0|||
23491886|NCT04171765|65545094|FG002|Overall Study|Adverse Event|1|||
23491887|NCT04171765|65545095|FG003|Overall Study|Adverse Event|0|||
23491888|NCT04171765|65545092|FG000|Overall Study|Lost to Follow-up|0|||
23491889|NCT04171765|65545093|FG001|Overall Study|Lost to Follow-up|2|||
23491890|NCT04171765|65545094|FG002|Overall Study|Lost to Follow-up|2|||
23491891|NCT04171765|65545095|FG003|Overall Study|Lost to Follow-up|2|||
23491892|NCT04171765|65545092|FG000|Overall Study|Week 58 visit missed|0|||
23491893|NCT04171765|65545093|FG001|Overall Study|Week 58 visit missed|0|||
23491894|NCT04171765|65545094|FG002|Overall Study|Week 58 visit missed|1|||
23491895|NCT04171765|65545095|FG003|Overall Study|Week 58 visit missed|0|||
23491896|NCT04171765|65545092|FG000|Overall Study|Study terminated by sponsor|2|||
23491897|NCT04171765|65545093|FG001|Overall Study|Study terminated by sponsor|0|||
23491898|NCT04171765|65545094|FG002|Overall Study|Study terminated by sponsor|0|||
23491899|NCT04171765|65545095|FG003|Overall Study|Study terminated by sponsor|0|||
23288524|NCT00112437|64798872|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288525|NCT00112437|64798873|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288526|NCT00112437|64798874|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288527|NCT00112437|64798875|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288528|NCT00112437|64798876|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23491900|NCT04171765|65545092|FG000|Overall Study|Withdrawal by Subject|1|||
23288529|NCT00112437|64798877|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23491901|NCT04171765|65545093|FG001|Overall Study|Withdrawal by Subject|0|||
23491902|NCT04171765|65545094|FG002|Overall Study|Withdrawal by Subject|0|||
23491903|NCT04171765|65545095|FG003|Overall Study|Withdrawal by Subject|3|||
23491904|NCT00932126|65545097|FG000|Overall Study|Adverse Event|0|||
23491905|NCT00932126|65545098|FG001|Overall Study|Adverse Event|0|||
23491906|NCT00932126|65545099|FG002|Overall Study|Adverse Event|0|||
23491907|NCT00932126|65545100|FG003|Overall Study|Adverse Event|0|||
23491908|NCT00932126|65545101|FG004|Overall Study|Adverse Event|0|||
23491909|NCT00932126|65545102|FG005|Overall Study|Adverse Event|0|||
23491910|NCT00932126|65545103|FG006|Overall Study|Adverse Event|1|||
23491911|NCT00932126|65545104|FG007|Overall Study|Adverse Event|2|||
23491912|NCT00932126|65545097|FG000|Overall Study|Protocol Violation|0|||
23491913|NCT00932126|65545098|FG001|Overall Study|Protocol Violation|0|||
23491914|NCT00932126|65545099|FG002|Overall Study|Protocol Violation|0|||
23491915|NCT00932126|65545100|FG003|Overall Study|Protocol Violation|0|||
23491916|NCT00932126|65545101|FG004|Overall Study|Protocol Violation|1|||
23491917|NCT00932126|65545102|FG005|Overall Study|Protocol Violation|0|||
23491918|NCT00932126|65545103|FG006|Overall Study|Protocol Violation|0|||
23491919|NCT00932126|65545104|FG007|Overall Study|Protocol Violation|0|||
23491920|NCT00932126|65545097|FG000|Overall Study|Withdrawal by Subject|0|||
23491921|NCT00932126|65545098|FG001|Overall Study|Withdrawal by Subject|0|||
23491922|NCT00932126|65545099|FG002|Overall Study|Withdrawal by Subject|1|||
23491923|NCT00932126|65545100|FG003|Overall Study|Withdrawal by Subject|0|||
23491924|NCT00932126|65545101|FG004|Overall Study|Withdrawal by Subject|0|||
23491925|NCT00932126|65545102|FG005|Overall Study|Withdrawal by Subject|0|||
23491926|NCT00932126|65545103|FG006|Overall Study|Withdrawal by Subject|0|||
23491927|NCT00932126|65545104|FG007|Overall Study|Withdrawal by Subject|1|||
23491928|NCT00932126|65545097|FG000|Overall Study|Objective progression or relapse|3|||
23491929|NCT00932126|65545098|FG001|Overall Study|Objective progression or relapse|3|||
23491930|NCT00932126|65545099|FG002|Overall Study|Objective progression or relapse|2|||
23491931|NCT00932126|65545100|FG003|Overall Study|Objective progression or relapse|3|||
23491932|NCT00932126|65545101|FG004|Overall Study|Objective progression or relapse|3|||
23491933|NCT00932126|65545102|FG005|Overall Study|Objective progression or relapse|3|||
23491934|NCT00932126|65545103|FG006|Overall Study|Objective progression or relapse|3|||
23491935|NCT00932126|65545104|FG007|Overall Study|Objective progression or relapse|5|||
23491936|NCT00932126|65545097|FG000|Overall Study|Other|0|||
23491937|NCT00932126|65545098|FG001|Overall Study|Other|0|||
23491938|NCT00932126|65545099|FG002|Overall Study|Other|0|||
23491939|NCT00932126|65545100|FG003|Overall Study|Other|0|||
23491940|NCT00932126|65545101|FG004|Overall Study|Other|1|||
23491941|NCT00932126|65545102|FG005|Overall Study|Other|0|||
23491942|NCT00932126|65545103|FG006|Overall Study|Other|1|||
23491943|NCT00932126|65545104|FG007|Overall Study|Other|2|||
23491944|NCT00810693|65545105|FG000|Treatment Period|Adverse Event|8|||
23491945|NCT00810693|65545106|FG001|Treatment Period|Adverse Event|1|||
23491946|NCT00810693|65545107|FG002|Treatment Period|Adverse Event|7|||
23491947|NCT00810693|65545105|FG000|Treatment Period|Death|0|||
23491948|NCT00810693|65545106|FG001|Treatment Period|Death|1|||
23491949|NCT00810693|65545107|FG002|Treatment Period|Death|2|||
23491950|NCT00810693|65545105|FG000|Treatment Period|Lack of Efficacy|0|||
23491951|NCT00810693|65545106|FG001|Treatment Period|Lack of Efficacy|0|||
23491952|NCT00810693|65545107|FG002|Treatment Period|Lack of Efficacy|1|||
23491953|NCT00810693|65545105|FG000|Treatment Period|Lost to Follow-up|1|||
23491954|NCT00810693|65545106|FG001|Treatment Period|Lost to Follow-up|0|||
23491955|NCT00810693|65545107|FG002|Treatment Period|Lost to Follow-up|0|||
23491956|NCT00810693|65545105|FG000|Treatment Period|Non-compliance|1|||
23491957|NCT00810693|65545106|FG001|Treatment Period|Non-compliance|0|||
23491958|NCT00810693|65545107|FG002|Treatment Period|Non-compliance|0|||
23491959|NCT00810693|65545105|FG000|Treatment Period|Protocol Violation|1|||
23491960|NCT00810693|65545106|FG001|Treatment Period|Protocol Violation|2|||
23491961|NCT00810693|65545107|FG002|Treatment Period|Protocol Violation|2|||
23288530|NCT00112437|64798878|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
23288531|NCT00112437|64798879|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
23288532|NCT00112437|64798880|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288533|NCT00112437|64798881|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23491962|NCT00810693|65545105|FG000|Treatment Period|Withdrawal by Subject|6|||
23491963|NCT00810693|65545106|FG001|Treatment Period|Withdrawal by Subject|2|||
23491964|NCT00810693|65545107|FG002|Treatment Period|Withdrawal by Subject|3|||
23491965|NCT00810693|65545105|FG000|Treatment Period|Not treated|0|||
23491966|NCT00810693|65545106|FG001|Treatment Period|Not treated|1|||
23491967|NCT00810693|65545107|FG002|Treatment Period|Not treated|1|||
23288534|NCT00112437|64798882|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23288535|NCT00112437|64798883|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
23491968|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Adverse Event|3|||
23491969|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Adverse Event|1|||
23491970|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Adverse Event|1|||
23491971|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Death|2|||
23491972|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Death|0|||
23491973|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Death|1|||
23491974|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
23491975|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
23491976|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
23491977|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
23491978|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
23491979|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
23491980|NCT00810693|65545105|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
23491981|NCT00810693|65545106|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
23491982|NCT00810693|65545107|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
23491983|NCT00002651|65545108|FG000|Induction|Adverse Event|44|||
23491984|NCT00002651|65545109|FG001|Induction|Adverse Event|0|||
23491985|NCT00002651|65545110|FG002|Induction|Adverse Event|0|||
23491986|NCT00002651|65545108|FG000|Induction|Refusal unrelated to adverse event|50|||
23491987|NCT00002651|65545109|FG001|Induction|Refusal unrelated to adverse event|0|||
23491988|NCT00002651|65545110|FG002|Induction|Refusal unrelated to adverse event|0|||
23491989|NCT00002651|65545108|FG000|Induction|Progression/relapse|274|||
23491990|NCT00002651|65545109|FG001|Induction|Progression/relapse|0|||
23491991|NCT00002651|65545110|FG002|Induction|Progression/relapse|0|||
23491992|NCT00002651|65545108|FG000|Induction|Death|62|||
23491993|NCT00002651|65545109|FG001|Induction|Death|0|||
23491994|NCT00002651|65545110|FG002|Induction|Death|0|||
23491995|NCT00002651|65545108|FG000|Induction|Other|823|||
23491996|NCT00002651|65545109|FG001|Induction|Other|0|||
23491997|NCT00002651|65545110|FG002|Induction|Other|0|||
23491998|NCT00002651|65545108|FG000|Induction|not eligible|90|||
23491999|NCT00002651|65545109|FG001|Induction|not eligible|0|||
23492000|NCT00002651|65545110|FG002|Induction|not eligible|0|||
23492001|NCT00002651|65545108|FG000|Consolidation and Randomization|Adverse Event|0|||
23492002|NCT00002651|65545109|FG001|Consolidation and Randomization|Adverse Event|36|||
23492003|NCT00002651|65545110|FG002|Consolidation and Randomization|Adverse Event|14|||
23492004|NCT00002651|65545108|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
23492005|NCT00002651|65545109|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
23492006|NCT00002651|65545110|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
23492007|NCT00002651|65545108|FG000|Consolidation and Randomization|Progression/relapse|0|||
23492008|NCT00002651|65545109|FG001|Consolidation and Randomization|Progression/relapse|295|||
23492009|NCT00002651|65545110|FG002|Consolidation and Randomization|Progression/relapse|298|||
23492010|NCT00002651|65545108|FG000|Consolidation and Randomization|Death|0|||
23492011|NCT00002651|65545109|FG001|Consolidation and Randomization|Death|38|||
23492012|NCT00002651|65545110|FG002|Consolidation and Randomization|Death|48|||
23492013|NCT00002651|65545108|FG000|Consolidation and Randomization|Other|0|||
23492014|NCT00002651|65545109|FG001|Consolidation and Randomization|Other|314|||
23492015|NCT00002651|65545110|FG002|Consolidation and Randomization|Other|313|||
23492016|NCT00002651|65545108|FG000|Consolidation and Randomization|not eligible|0|||
23492017|NCT00002651|65545109|FG001|Consolidation and Randomization|not eligible|102|||
23288536|NCT00112437|64798858|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288537|NCT00112437|64798859|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288538|NCT00112437|64798860|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288539|NCT00112437|64798861|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288540|NCT00112437|64798862|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23381190|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
23381191|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
23381192|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
23381193|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Other|2|||
23381194|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Other|1|||
23381195|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Other|0|||
23381196|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Other|0|||
23381197|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Other|0|||
23381198|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
23381199|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
23381200|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
23381201|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
23381202|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
23381203|NCT03317496|65140466|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
23381204|NCT03317496|65140467|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
23381205|NCT03317496|65140468|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
23492018|NCT00002651|65545110|FG002|Consolidation and Randomization|not eligible|112|||
23492019|NCT02476422|65545112|FG000|Overall Study|Subject/guardian decision|0|||
23492020|NCT02476422|65545113|FG001|Overall Study|Subject/guardian decision|1|||
23492021|NCT00369122|65545116|FG000|Overall Study|Ineligible|10|||
23492022|NCT00369122|65545116|FG000|Overall Study|No protocol treatment|1|||
23492023|NCT02215096|65545122|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
23492024|NCT02215096|65545123|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
23492025|NCT02215096|65545124|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
23492026|NCT02215096|65545125|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
23288541|NCT00112437|64798863|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288542|NCT00112437|64798864|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288543|NCT00112437|64798865|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288544|NCT00112437|64798866|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288545|NCT00112437|64798867|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288546|NCT00112437|64798868|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288547|NCT00112437|64798869|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288548|NCT00112437|64798870|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288549|NCT00112437|64798871|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288550|NCT00112437|64798872|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288551|NCT00112437|64798873|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288552|NCT00112437|64798874|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23381206|NCT03317496|65140469|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
23381207|NCT03317496|65140470|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
23492027|NCT02215096|65545126|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
23492028|NCT02215096|65545122|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
23605928|NCT01640951|65947106|FG005|Overall Study|Lost to Follow-up|3|||
23288553|NCT00112437|64798875|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288554|NCT00112437|64798876|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288555|NCT00112437|64798877|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288556|NCT00112437|64798878|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
23288557|NCT00112437|64798879|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288558|NCT00112437|64798880|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288559|NCT00112437|64798881|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288560|NCT00112437|64798882|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23381208|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
23381209|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
23381210|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
23381211|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
23381212|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
23381213|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
23381214|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
23381215|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
23381216|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
23381217|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
23381218|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
23381219|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
23381220|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
23381221|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
23381222|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
23381223|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
23381224|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
23381225|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
23381226|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
23381227|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
23381228|NCT03317496|65140466|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
23381229|NCT03317496|65140467|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
23381230|NCT03317496|65140468|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
23381231|NCT03317496|65140469|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
23381232|NCT03317496|65140470|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
23381233|NCT03317496|65140466|FG000|Phase 2: Treatment|Adverse Event|0|||
23381234|NCT03317496|65140467|FG001|Phase 2: Treatment|Adverse Event|0|||
23381235|NCT03317496|65140468|FG002|Phase 2: Treatment|Adverse Event|0|||
23381236|NCT03317496|65140469|FG003|Phase 2: Treatment|Adverse Event|0|||
23381237|NCT03317496|65140470|FG004|Phase 2: Treatment|Adverse Event|6|||
23381238|NCT03317496|65140466|FG000|Phase 2: Treatment|Progressive disease|0|||
23381239|NCT03317496|65140467|FG001|Phase 2: Treatment|Progressive disease|0|||
23381240|NCT03317496|65140468|FG002|Phase 2: Treatment|Progressive disease|0|||
23381241|NCT03317496|65140469|FG003|Phase 2: Treatment|Progressive disease|0|||
23381242|NCT03317496|65140470|FG004|Phase 2: Treatment|Progressive disease|22|||
23288561|NCT00112437|64798883|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
23288562|NCT00112437|64798858|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23381243|NCT03317496|65140466|FG000|Phase 2: Treatment|Other|0|||
23381244|NCT03317496|65140467|FG001|Phase 2: Treatment|Other|0|||
23288563|NCT00112437|64798859|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288564|NCT00112437|64798860|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288565|NCT00112437|64798861|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288566|NCT00112437|64798862|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288567|NCT00112437|64798863|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288568|NCT00112437|64798864|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288569|NCT00112437|64798865|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288570|NCT00112437|64798866|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288571|NCT00112437|64798867|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288572|NCT00112437|64798868|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288573|NCT00112437|64798869|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288574|NCT00112437|64798870|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288575|NCT00112437|64798871|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288576|NCT00112437|64798872|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288577|NCT00112437|64798873|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288578|NCT00112437|64798874|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288579|NCT00112437|64798875|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288580|NCT00112437|64798876|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288581|NCT00112437|64798877|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288582|NCT00112437|64798878|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288583|NCT00112437|64798879|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
23288584|NCT00112437|64798880|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288585|NCT00112437|64798881|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288586|NCT00112437|64798882|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288587|NCT00112437|64798883|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
23288588|NCT00112437|64798858|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288589|NCT00112437|64798859|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288590|NCT00112437|64798860|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288591|NCT00112437|64798861|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288592|NCT00112437|64798862|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288593|NCT00112437|64798863|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288594|NCT00112437|64798864|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288595|NCT00112437|64798865|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288596|NCT00112437|64798866|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288597|NCT00112437|64798867|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288598|NCT00112437|64798868|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
23381245|NCT03317496|65140468|FG002|Phase 2: Treatment|Other|0|||
23381246|NCT03317496|65140469|FG003|Phase 2: Treatment|Other|0|||
23381247|NCT03317496|65140470|FG004|Phase 2: Treatment|Other|4|||
23381248|NCT03317496|65140466|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
23381249|NCT03317496|65140467|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
23381250|NCT03317496|65140468|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
23381251|NCT03317496|65140469|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
23381252|NCT03317496|65140470|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
23381253|NCT03317496|65140466|FG000|Phase 2: Treatment|Physician Decision|0|||
23381254|NCT03317496|65140467|FG001|Phase 2: Treatment|Physician Decision|0|||
23381255|NCT03317496|65140468|FG002|Phase 2: Treatment|Physician Decision|0|||
23381256|NCT03317496|65140469|FG003|Phase 2: Treatment|Physician Decision|0|||
23381257|NCT03317496|65140470|FG004|Phase 2: Treatment|Physician Decision|1|||
23381258|NCT03317496|65140466|FG000|Phase 2: Treatment|Death|0|||
23381259|NCT03317496|65140467|FG001|Phase 2: Treatment|Death|0|||
23381260|NCT03317496|65140468|FG002|Phase 2: Treatment|Death|0|||
23288599|NCT00112437|64798869|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288600|NCT00112437|64798870|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288601|NCT00112437|64798871|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288602|NCT00112437|64798872|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288603|NCT00112437|64798873|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288604|NCT00112437|64798874|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
23381261|NCT03317496|65140469|FG003|Phase 2: Treatment|Death|0|||
23381262|NCT03317496|65140470|FG004|Phase 2: Treatment|Death|1|||
23381263|NCT03317496|65140466|FG000|Phase 2: Follow-up|Death|0|||
23381264|NCT03317496|65140467|FG001|Phase 2: Follow-up|Death|0|||
23381265|NCT03317496|65140468|FG002|Phase 2: Follow-up|Death|0|||
23381266|NCT03317496|65140469|FG003|Phase 2: Follow-up|Death|0|||
23288605|NCT00112437|64798875|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288606|NCT00112437|64798876|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288607|NCT00112437|64798877|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288608|NCT00112437|64798878|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
23381267|NCT03317496|65140470|FG004|Phase 2: Follow-up|Death|24|||
23381268|NCT03317496|65140466|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
23381269|NCT03317496|65140467|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
23381270|NCT03317496|65140468|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
23381271|NCT03317496|65140469|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
23381272|NCT03317496|65140470|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
23381273|NCT03317496|65140466|FG000|Phase 2: Follow-up|Other|0|||
23381274|NCT03317496|65140467|FG001|Phase 2: Follow-up|Other|0|||
23381275|NCT03317496|65140468|FG002|Phase 2: Follow-up|Other|0|||
23288609|NCT00112437|64798879|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
23288610|NCT00112437|64798880|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288611|NCT00112437|64798881|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288612|NCT00112437|64798882|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288613|NCT00112437|64798883|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
23288614|NCT00112437|64798858|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288615|NCT00112437|64798859|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288616|NCT00112437|64798860|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288617|NCT00112437|64798861|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288618|NCT00112437|64798862|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288619|NCT00112437|64798863|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288620|NCT00112437|64798864|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288621|NCT00112437|64798865|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288622|NCT00112437|64798866|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288623|NCT00112437|64798867|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288624|NCT00112437|64798868|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288625|NCT00112437|64798869|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288626|NCT00112437|64798870|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288627|NCT00112437|64798871|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288628|NCT00112437|64798872|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288629|NCT00112437|64798873|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288630|NCT00112437|64798874|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288631|NCT00112437|64798875|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288632|NCT00112437|64798876|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288633|NCT00112437|64798877|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288634|NCT00112437|64798878|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
23288635|NCT00112437|64798879|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
23288636|NCT00112437|64798880|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288637|NCT00112437|64798881|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288638|NCT00112437|64798882|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288639|NCT00112437|64798883|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
23288640|NCT00112437|64798858|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288641|NCT00112437|64798859|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288642|NCT00112437|64798860|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288643|NCT00112437|64798861|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288644|NCT00112437|64798862|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288645|NCT00112437|64798863|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288646|NCT00112437|64798864|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288647|NCT00112437|64798865|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288648|NCT00112437|64798866|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288649|NCT00112437|64798867|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23381276|NCT03317496|65140469|FG003|Phase 2: Follow-up|Other|0|||
23381277|NCT03317496|65140470|FG004|Phase 2: Follow-up|Other|1|||
23492029|NCT02215096|65545123|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
23288650|NCT00112437|64798868|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288651|NCT00112437|64798869|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288652|NCT00112437|64798870|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288653|NCT00112437|64798871|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288654|NCT00112437|64798872|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288655|NCT00112437|64798873|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23381278|NCT03317496|65140466|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
23288656|NCT00112437|64798874|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288657|NCT00112437|64798875|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288658|NCT00112437|64798876|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288659|NCT00112437|64798877|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288660|NCT00112437|64798878|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288661|NCT00112437|64798879|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288662|NCT00112437|64798880|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
23288663|NCT00112437|64798881|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
23288664|NCT00112437|64798882|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
23288665|NCT00112437|64798883|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
23288666|NCT00112437|64798858|FG000|Years 6-10 (60-Month Extension)|Death|0|||
23288667|NCT00112437|64798859|FG001|Years 6-10 (60-Month Extension)|Death|0|||
23288668|NCT00112437|64798860|FG002|Years 6-10 (60-Month Extension)|Death|0|||
23288669|NCT00112437|64798861|FG003|Years 6-10 (60-Month Extension)|Death|0|||
23381279|NCT03317496|65140467|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
23381280|NCT03317496|65140468|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
23381281|NCT03317496|65140469|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
23605929|NCT01640951|65947107|FG006|Overall Study|Lost to Follow-up|1|||
23605930|NCT01640951|65947108|FG007|Overall Study|Lost to Follow-up|1|||
23605931|NCT01640951|65947101|FG000|Overall Study|Non-compliance with study treatment|0|||
23605932|NCT01640951|65947102|FG001|Overall Study|Non-compliance with study treatment|0|||
23605933|NCT01640951|65947103|FG002|Overall Study|Non-compliance with study treatment|1|||
23605934|NCT01640951|65947104|FG003|Overall Study|Non-compliance with study treatment|1|||
23605935|NCT01640951|65947105|FG004|Overall Study|Non-compliance with study treatment|1|||
23605936|NCT01640951|65947106|FG005|Overall Study|Non-compliance with study treatment|4|||
23605937|NCT01640951|65947107|FG006|Overall Study|Non-compliance with study treatment|1|||
23605938|NCT01640951|65947108|FG007|Overall Study|Non-compliance with study treatment|0|||
23605939|NCT01640951|65947101|FG000|Overall Study|Physician Decision|2|||
23605940|NCT01640951|65947102|FG001|Overall Study|Physician Decision|5|||
23605941|NCT01640951|65947103|FG002|Overall Study|Physician Decision|2|||
23605942|NCT01640951|65947104|FG003|Overall Study|Physician Decision|2|||
23605943|NCT01640951|65947105|FG004|Overall Study|Physician Decision|2|||
23605944|NCT01640951|65947106|FG005|Overall Study|Physician Decision|3|||
23605945|NCT01640951|65947107|FG006|Overall Study|Physician Decision|3|||
23605946|NCT01640951|65947108|FG007|Overall Study|Physician Decision|0|||
23605947|NCT01640951|65947101|FG000|Overall Study|Pregnancy|3|||
23605948|NCT01640951|65947102|FG001|Overall Study|Pregnancy|0|||
23605949|NCT01640951|65947103|FG002|Overall Study|Pregnancy|0|||
23605950|NCT01640951|65947104|FG003|Overall Study|Pregnancy|4|||
23605951|NCT01640951|65947105|FG004|Overall Study|Pregnancy|0|||
23605952|NCT01640951|65947106|FG005|Overall Study|Pregnancy|0|||
23605953|NCT01640951|65947107|FG006|Overall Study|Pregnancy|2|||
23605954|NCT01640951|65947108|FG007|Overall Study|Pregnancy|0|||
23605955|NCT01640951|65947101|FG000|Overall Study|Protocol Deviation|0|||
23605956|NCT01640951|65947102|FG001|Overall Study|Protocol Deviation|1|||
23605957|NCT01640951|65947103|FG002|Overall Study|Protocol Deviation|2|||
23381282|NCT03317496|65140470|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
23381283|NCT00884949|65140471|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
23381284|NCT00884949|65140471|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
23288670|NCT00112437|64798862|FG004|Years 6-10 (60-Month Extension)|Death|0|||
23381285|NCT01013753|65140472|FG000|Overall Study|Adverse Event|8|||
23381286|NCT01013753|65140472|FG000|Overall Study|Protocol Violation|3|||
23381287|NCT01013753|65140472|FG000|Overall Study|Lost to Follow-up|1|||
23288671|NCT00112437|64798863|FG005|Years 6-10 (60-Month Extension)|Death|0|||
23288672|NCT00112437|64798864|FG006|Years 6-10 (60-Month Extension)|Death|0|||
23288673|NCT00112437|64798865|FG007|Years 6-10 (60-Month Extension)|Death|0|||
23288674|NCT00112437|64798866|FG008|Years 6-10 (60-Month Extension)|Death|0|||
23288675|NCT00112437|64798867|FG009|Years 6-10 (60-Month Extension)|Death|0|||
23288676|NCT00112437|64798868|FG010|Years 6-10 (60-Month Extension)|Death|0|||
23288677|NCT00112437|64798869|FG011|Years 6-10 (60-Month Extension)|Death|0|||
23288678|NCT00112437|64798870|FG012|Years 6-10 (60-Month Extension)|Death|0|||
23288679|NCT00112437|64798871|FG013|Years 6-10 (60-Month Extension)|Death|0|||
23288680|NCT00112437|64798872|FG014|Years 6-10 (60-Month Extension)|Death|0|||
23288681|NCT00112437|64798873|FG015|Years 6-10 (60-Month Extension)|Death|0|||
23288682|NCT00112437|64798874|FG016|Years 6-10 (60-Month Extension)|Death|0|||
23288683|NCT00112437|64798875|FG017|Years 6-10 (60-Month Extension)|Death|0|||
23288684|NCT00112437|64798876|FG018|Years 6-10 (60-Month Extension)|Death|0|||
23288685|NCT00112437|64798877|FG019|Years 6-10 (60-Month Extension)|Death|0|||
23288686|NCT00112437|64798878|FG020|Years 6-10 (60-Month Extension)|Death|0|||
23288687|NCT00112437|64798879|FG021|Years 6-10 (60-Month Extension)|Death|0|||
23288688|NCT00112437|64798880|FG022|Years 6-10 (60-Month Extension)|Death|0|||
23288689|NCT00112437|64798881|FG023|Years 6-10 (60-Month Extension)|Death|2|||
23288690|NCT00112437|64798882|FG024|Years 6-10 (60-Month Extension)|Death|0|||
23381288|NCT01013753|65140472|FG000|Overall Study|Withdrawal by Subject|2|||
23381289|NCT01013753|65140472|FG000|Overall Study|Other|2|||
23381290|NCT02927145|65140473|FG000|Initial Recruitment|Withdrawal by Subject|0|||
23381291|NCT02927145|65140474|FG001|Initial Recruitment|Withdrawal by Subject|1|||
23381292|NCT02927145|65140475|FG002|Initial Recruitment|Withdrawal by Subject|1|||
23381293|NCT02927145|65140476|FG003|Initial Recruitment|Withdrawal by Subject|4|||
23381294|NCT02927145|65140477|FG004|Initial Recruitment|Withdrawal by Subject|1|||
23381295|NCT02927145|65140478|FG005|Initial Recruitment|Withdrawal by Subject|1|||
23288691|NCT00112437|64798883|FG025|Years 6-10 (60-Month Extension)|Death|0|||
23288692|NCT00112437|64798858|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288693|NCT00112437|64798859|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288694|NCT00112437|64798860|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23381296|NCT02927145|65140479|FG006|Initial Recruitment|Withdrawal by Subject|0|||
23381297|NCT02927145|65140480|FG007|Initial Recruitment|Withdrawal by Subject|0|||
23381298|NCT02927145|65140481|FG008|Initial Recruitment|Withdrawal by Subject|2|||
23288695|NCT00112437|64798861|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288696|NCT00112437|64798862|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288697|NCT00112437|64798863|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288698|NCT00112437|64798864|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288699|NCT00112437|64798865|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288700|NCT00112437|64798866|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288701|NCT00112437|64798867|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288702|NCT00112437|64798868|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23381299|NCT02927145|65140473|FG000|Initial Recruitment|Adverse Event|0|||
23381300|NCT02927145|65140474|FG001|Initial Recruitment|Adverse Event|0|||
23381301|NCT02927145|65140475|FG002|Initial Recruitment|Adverse Event|0|||
23381302|NCT02927145|65140476|FG003|Initial Recruitment|Adverse Event|0|||
23381303|NCT02927145|65140477|FG004|Initial Recruitment|Adverse Event|2|||
23381304|NCT02927145|65140478|FG005|Initial Recruitment|Adverse Event|0|||
23381305|NCT02927145|65140479|FG006|Initial Recruitment|Adverse Event|0|||
23381306|NCT02927145|65140480|FG007|Initial Recruitment|Adverse Event|0|||
23381307|NCT02927145|65140481|FG008|Initial Recruitment|Adverse Event|0|||
23381308|NCT02927145|65140473|FG000|Invitation for Additional Challenge|Pregnancy|0|||
23381309|NCT02927145|65140474|FG001|Invitation for Additional Challenge|Pregnancy|0|||
23381310|NCT02927145|65140475|FG002|Invitation for Additional Challenge|Pregnancy|0|||
23381311|NCT02927145|65140476|FG003|Invitation for Additional Challenge|Pregnancy|0|||
23381312|NCT02927145|65140477|FG004|Invitation for Additional Challenge|Pregnancy|0|||
23381313|NCT02927145|65140478|FG005|Invitation for Additional Challenge|Pregnancy|0|||
23381314|NCT02927145|65140479|FG006|Invitation for Additional Challenge|Pregnancy|1|||
23381315|NCT02927145|65140480|FG007|Invitation for Additional Challenge|Pregnancy|0|||
23381316|NCT02927145|65140481|FG008|Invitation for Additional Challenge|Pregnancy|0|||
23381317|NCT00221104|65140482|FG000|Overall Study|Adverse Event|1|||
23381318|NCT00221104|65140483|FG001|Overall Study|Adverse Event|0|||
23381319|NCT00221104|65140482|FG000|Overall Study|Physician Decision|1|||
23381320|NCT00221104|65140483|FG001|Overall Study|Physician Decision|0|||
23381321|NCT00221104|65140482|FG000|Overall Study|Protocol Violation|2|||
23381322|NCT00221104|65140483|FG001|Overall Study|Protocol Violation|0|||
23381323|NCT00221104|65140482|FG000|Overall Study|Withdrawal by Subject|42|||
23381324|NCT00221104|65140483|FG001|Overall Study|Withdrawal by Subject|29|||
23381325|NCT00221104|65140482|FG000|Overall Study|Others|37|||
23381326|NCT00221104|65140483|FG001|Overall Study|Others|47|||
23381327|NCT01149538|65140484|FG000|Overall Study|Lost to Follow-up|0|||
23381328|NCT01149538|65140485|FG001|Overall Study|Lost to Follow-up|1|||
23381329|NCT01149538|65140484|FG000|Overall Study|Withdrawal by Subject|5|||
23381330|NCT01149538|65140485|FG001|Overall Study|Withdrawal by Subject|3|||
23381331|NCT04401293|65140486|FG000|Overall Study|Withdrawal by Subject|1|||
23381332|NCT04401293|65140487|FG001|Overall Study|Withdrawal by Subject|3|||
23381333|NCT02401230|65140488|FG000|Overall Study|Adverse Event|3|||
23381334|NCT02401230|65140489|FG001|Overall Study|Adverse Event|2|||
23381335|NCT02401230|65140490|FG002|Overall Study|Adverse Event|0|||
23381336|NCT02401230|65140488|FG000|Overall Study|Withdrawal by Subject|2|||
23381337|NCT02401230|65140489|FG001|Overall Study|Withdrawal by Subject|1|||
23381338|NCT02401230|65140490|FG002|Overall Study|Withdrawal by Subject|1|||
23381339|NCT02401230|65140488|FG000|Overall Study|Lost to Follow-up|1|||
23381340|NCT02401230|65140489|FG001|Overall Study|Lost to Follow-up|3|||
23381341|NCT02401230|65140490|FG002|Overall Study|Lost to Follow-up|3|||
23381342|NCT00455455|65140491|FG000|Washout|Withdrawal by Subject|0|||
23381343|NCT00455455|65140492|FG001|Washout|Withdrawal by Subject|1|||
23381344|NCT00455455|65140491|FG000|Washout|Withdrawal by Subject|1|||
23381345|NCT00455455|65140492|FG001|Washout|Withdrawal by Subject|0|||
23381346|NCT02709369|65140493|FG000|Overall Study|Lost to Follow-up|15|||
23381347|NCT02709369|65140493|FG000|Overall Study|Withdrawal by Subject|10|||
23381348|NCT02709369|65140493|FG000|Overall Study|Did not received intervention|2|||
23381349|NCT03349515|65140495|FG000|Overall Study|Lack of Efficacy|2|||
23381350|NCT03349515|65140496|FG001|Overall Study|Lack of Efficacy|0|||
23381351|NCT03349515|65140495|FG000|Overall Study|Physician Decision|3|||
23381352|NCT03349515|65140496|FG001|Overall Study|Physician Decision|1|||
23381353|NCT04810962|65140497|FG000|Overall Study|Adverse Event|0|||
23288703|NCT00112437|64798869|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23381354|NCT04810962|65140498|FG001|Overall Study|Adverse Event|1|||
23381355|NCT04810962|65140497|FG000|Overall Study|Lost to Follow-up|2|||
23381356|NCT04810962|65140498|FG001|Overall Study|Lost to Follow-up|1|||
23381357|NCT04810962|65140497|FG000|Overall Study|Physician Decision|1|||
23381358|NCT04810962|65140498|FG001|Overall Study|Physician Decision|0|||
23381359|NCT04810962|65140497|FG000|Overall Study|Withdrawal by Subject|1|||
23381360|NCT04810962|65140498|FG001|Overall Study|Withdrawal by Subject|3|||
23381361|NCT04810962|65140497|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
23381362|NCT04810962|65140498|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
23492030|NCT02215096|65545124|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
23492031|NCT02215096|65545125|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
23492032|NCT02215096|65545126|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
23492033|NCT02215096|65545122|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
23492034|NCT02215096|65545123|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
23492035|NCT02215096|65545124|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
23492036|NCT02215096|65545125|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
23492037|NCT02215096|65545126|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
23492038|NCT02215096|65545122|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
23492039|NCT02215096|65545123|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
23492040|NCT02215096|65545124|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
23492041|NCT02215096|65545125|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
23492042|NCT02215096|65545126|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
23492043|NCT01822678|65545127|FG000|Overall Study|Withdrawal by Subject|5|||
23492044|NCT01822678|65545128|FG001|Overall Study|Withdrawal by Subject|4|||
23492045|NCT01822678|65545129|FG002|Overall Study|Withdrawal by Subject|4|||
23492046|NCT01822678|65545127|FG000|Overall Study|Adverse Event|4|||
23492047|NCT01822678|65545128|FG001|Overall Study|Adverse Event|3|||
23492048|NCT01822678|65545129|FG002|Overall Study|Adverse Event|1|||
23492049|NCT01822678|65545127|FG000|Overall Study|Lack of Efficacy|3|||
23492050|NCT01822678|65545128|FG001|Overall Study|Lack of Efficacy|6|||
23492051|NCT01822678|65545129|FG002|Overall Study|Lack of Efficacy|5|||
23492052|NCT01822678|65545127|FG000|Overall Study|Lost to Follow-up|0|||
23492053|NCT01822678|65545128|FG001|Overall Study|Lost to Follow-up|2|||
23492054|NCT01822678|65545129|FG002|Overall Study|Lost to Follow-up|1|||
23492055|NCT02030938|65545130|FG000|Overall Study|Lost to Follow-up|4|||
23492056|NCT02030938|65545130|FG000|Overall Study|Withdrawal by Subject|1|||
23492057|NCT02846545|65545136|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
23492058|NCT02846545|65545137|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
23492059|NCT02846545|65545136|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
23492060|NCT02846545|65545137|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
23492061|NCT02846545|65545136|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
23492062|NCT02846545|65545137|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
23492063|NCT02846545|65545136|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
23492064|NCT02846545|65545137|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
23492065|NCT02846545|65545136|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
23492066|NCT02846545|65545137|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
23492067|NCT02663908|65545146|FG000|Overall Study|Withdrawal by Subject|8|||
23492068|NCT02663908|65545147|FG001|Overall Study|Withdrawal by Subject|5|||
23492069|NCT02663908|65545146|FG000|Overall Study|Lost to Follow-up|1|||
23492070|NCT02663908|65545147|FG001|Overall Study|Lost to Follow-up|5|||
23492071|NCT02663908|65545146|FG000|Overall Study|Adverse Event|13|||
23492072|NCT02663908|65545147|FG001|Overall Study|Adverse Event|11|||
23492073|NCT02663908|65545146|FG000|Overall Study|Protocol Violation|1|||
23492074|NCT02663908|65545147|FG001|Overall Study|Protocol Violation|2|||
23492075|NCT02663908|65545146|FG000|Overall Study|Lack of therapeutic response|2|||
23492076|NCT02663908|65545147|FG001|Overall Study|Lack of therapeutic response|0|||
23492077|NCT02663908|65545146|FG000|Overall Study|COVID-19|1|||
23492078|NCT02663908|65545147|FG001|Overall Study|COVID-19|0|||
23492079|NCT02663908|65545146|FG000|Overall Study|Site closed|1|||
23492080|NCT02663908|65545147|FG001|Overall Study|Site closed|0|||
23492081|NCT02663908|65545146|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
23492082|NCT02663908|65545147|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
23492083|NCT02663908|65545146|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
23492084|NCT02663908|65545147|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
23492085|NCT02663908|65545146|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
23492086|NCT02663908|65545147|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
23492087|NCT02663908|65545146|FG000|Overall Study|Death|1|||
23381363|NCT01774370|65140499|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
23492088|NCT02663908|65545147|FG001|Overall Study|Death|0|||
23492089|NCT02663908|65545146|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
23492090|NCT02663908|65545147|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
23492091|NCT02663908|65545146|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
23605958|NCT01640951|65947104|FG003|Overall Study|Protocol Deviation|1|||
23492092|NCT02663908|65545147|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
23492093|NCT00579098|65545148|FG000|Overall Study|Lost to Follow-up|2|||
23492094|NCT00579098|65545149|FG001|Overall Study|Lost to Follow-up|0|||
23492095|NCT00579098|65545148|FG000|Overall Study|Adverse Event|2|||
23492096|NCT00579098|65545149|FG001|Overall Study|Adverse Event|3|||
23492097|NCT00579098|65545148|FG000|Overall Study|Withdrawal by Subject|2|||
23492098|NCT00579098|65545149|FG001|Overall Study|Withdrawal by Subject|3|||
23492099|NCT00579098|65545148|FG000|Overall Study|AF returned after ablation|3|||
23492100|NCT00579098|65545149|FG001|Overall Study|AF returned after ablation|2|||
23492101|NCT01824342|65545150|FG000|Overall Study|Withdrawal by Subject|0|||
23492102|NCT01824342|65545151|FG001|Overall Study|Withdrawal by Subject|3|||
23492103|NCT01824342|65545150|FG000|Overall Study|Adverse Event|1|||
23492104|NCT01824342|65545151|FG001|Overall Study|Adverse Event|1|||
23492105|NCT01824342|65545150|FG000|Overall Study|Disease Progression|1|||
23492106|NCT01824342|65545151|FG001|Overall Study|Disease Progression|1|||
23492107|NCT01824342|65545150|FG000|Overall Study|Physician Decision|5|||
23492108|NCT01824342|65545151|FG001|Overall Study|Physician Decision|0|||
23492109|NCT01824342|65545150|FG000|Overall Study|Death|2|||
23492110|NCT01824342|65545151|FG001|Overall Study|Death|0|||
23492111|NCT01313312|65545154|FG000|Overall Study|Adverse Event|5|||
23492112|NCT01313312|65545154|FG000|Overall Study|Withdrawal by Subject|18|||
23492113|NCT01313312|65545154|FG000|Overall Study|Lack of Efficacy|3|||
23492114|NCT01313312|65545154|FG000|Overall Study|Investigator Decision|1|||
23288704|NCT00112437|64798870|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288705|NCT00112437|64798871|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288706|NCT00112437|64798872|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288707|NCT00112437|64798873|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288708|NCT00112437|64798874|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288709|NCT00112437|64798875|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288710|NCT00112437|64798876|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288711|NCT00112437|64798877|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288712|NCT00112437|64798878|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288713|NCT00112437|64798879|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288714|NCT00112437|64798880|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288715|NCT00112437|64798881|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288716|NCT00112437|64798882|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
23288717|NCT00112437|64798883|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
23288718|NCT00112437|64798858|FG000|Years 6-10 (60-Month Extension)|Other|0|||
23288719|NCT00112437|64798859|FG001|Years 6-10 (60-Month Extension)|Other|0|||
23288720|NCT00112437|64798860|FG002|Years 6-10 (60-Month Extension)|Other|0|||
23288721|NCT00112437|64798861|FG003|Years 6-10 (60-Month Extension)|Other|0|||
23288722|NCT00112437|64798862|FG004|Years 6-10 (60-Month Extension)|Other|0|||
23288723|NCT00112437|64798863|FG005|Years 6-10 (60-Month Extension)|Other|0|||
23288724|NCT00112437|64798864|FG006|Years 6-10 (60-Month Extension)|Other|0|||
23492115|NCT01313312|65545154|FG000|Overall Study|Observational Phase|1|||
23492116|NCT01313312|65545154|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
23492117|NCT01313312|65545154|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
23381364|NCT01774370|65140499|FG000|Overall Study|Administered prior to the contract date|4|||
23381365|NCT01774370|65140499|FG000|Overall Study|Subjects of contraindications|34|||
23381366|NCT01774370|65140499|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
23381367|NCT01774370|65140499|FG000|Overall Study|Follow-up failure|34|||
23381368|NCT02403271|65140500|FG000|Period 1|Other varied reasons|1|||
23381369|NCT02403271|65140501|FG001|Period 1|Other varied reasons|0|||
23381370|NCT02403271|65140500|FG000|Period 2|Withdrawal by Subject|0|||
23381371|NCT02403271|65140501|FG001|Period 2|Withdrawal by Subject|14|||
23381372|NCT02403271|65140500|FG000|Period 2|Death|0|||
23381373|NCT02403271|65140501|FG001|Period 2|Death|84|||
23381374|NCT02403271|65140500|FG000|Period 2|Lost to Follow-up|0|||
23381375|NCT02403271|65140501|FG001|Period 2|Lost to Follow-up|2|||
23381376|NCT02403271|65140500|FG000|Period 2|Study Terminated by Sponsor|0|||
23381377|NCT02403271|65140501|FG001|Period 2|Study Terminated by Sponsor|14|||
23381378|NCT02403271|65140500|FG000|Period 2|Other varied reasons|0|||
23381379|NCT02403271|65140501|FG001|Period 2|Other varied reasons|10|||
23381380|NCT01432327|65140502|FG000|Posttest 3 Months|depression|3|||
23381381|NCT01432327|65140503|FG001|Posttest 3 Months|depression|0|||
23381382|NCT01432327|65140504|FG002|Posttest 3 Months|depression|0|||
23381383|NCT01432327|65140505|FG003|Posttest 3 Months|depression|0|||
23381384|NCT01432327|65140502|FG000|Posttest 3 Months|Lost to Follow-up|1|||
23288725|NCT00112437|64798865|FG007|Years 6-10 (60-Month Extension)|Other|0|||
23288726|NCT00112437|64798866|FG008|Years 6-10 (60-Month Extension)|Other|0|||
23288727|NCT00112437|64798867|FG009|Years 6-10 (60-Month Extension)|Other|0|||
23288728|NCT00112437|64798868|FG010|Years 6-10 (60-Month Extension)|Other|0|||
23288729|NCT00112437|64798869|FG011|Years 6-10 (60-Month Extension)|Other|0|||
23288730|NCT00112437|64798870|FG012|Years 6-10 (60-Month Extension)|Other|0|||
23288731|NCT00112437|64798871|FG013|Years 6-10 (60-Month Extension)|Other|0|||
23288732|NCT00112437|64798872|FG014|Years 6-10 (60-Month Extension)|Other|0|||
23288733|NCT00112437|64798873|FG015|Years 6-10 (60-Month Extension)|Other|0|||
23288734|NCT00112437|64798874|FG016|Years 6-10 (60-Month Extension)|Other|0|||
23288735|NCT00112437|64798875|FG017|Years 6-10 (60-Month Extension)|Other|0|||
23288736|NCT00112437|64798876|FG018|Years 6-10 (60-Month Extension)|Other|0|||
23288737|NCT00112437|64798877|FG019|Years 6-10 (60-Month Extension)|Other|0|||
23288738|NCT00112437|64798878|FG020|Years 6-10 (60-Month Extension)|Other|0|||
23288739|NCT00112437|64798879|FG021|Years 6-10 (60-Month Extension)|Other|0|||
23288740|NCT00112437|64798880|FG022|Years 6-10 (60-Month Extension)|Other|0|||
23288741|NCT00112437|64798881|FG023|Years 6-10 (60-Month Extension)|Other|0|||
23288742|NCT00112437|64798882|FG024|Years 6-10 (60-Month Extension)|Other|1|||
23288743|NCT00112437|64798883|FG025|Years 6-10 (60-Month Extension)|Other|0|||
23288744|NCT00112437|64798858|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288745|NCT00112437|64798859|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288746|NCT00112437|64798860|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288747|NCT00112437|64798861|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288748|NCT00112437|64798862|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288749|NCT00112437|64798863|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288750|NCT00112437|64798864|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288751|NCT00112437|64798865|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288752|NCT00112437|64798866|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288753|NCT00112437|64798867|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288754|NCT00112437|64798868|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288755|NCT00112437|64798869|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288756|NCT00112437|64798870|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288757|NCT00112437|64798871|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288758|NCT00112437|64798872|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288759|NCT00112437|64798873|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288760|NCT00112437|64798874|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288761|NCT00112437|64798875|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23381385|NCT01432327|65140503|FG001|Posttest 3 Months|Lost to Follow-up|0|||
23288762|NCT00112437|64798876|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288763|NCT00112437|64798877|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23381386|NCT01432327|65140504|FG002|Posttest 3 Months|Lost to Follow-up|2|||
23381387|NCT01432327|65140505|FG003|Posttest 3 Months|Lost to Follow-up|1|||
23381388|NCT01432327|65140502|FG000|Posttest 3 Months|Allergic reaction|0|||
23381389|NCT01432327|65140503|FG001|Posttest 3 Months|Allergic reaction|2|||
23381390|NCT01432327|65140504|FG002|Posttest 3 Months|Allergic reaction|0|||
23381391|NCT01432327|65140505|FG003|Posttest 3 Months|Allergic reaction|0|||
23381392|NCT01432327|65140502|FG000|Posttest 6 Months|Lost to Follow-up|0|||
23381393|NCT01432327|65140503|FG001|Posttest 6 Months|Lost to Follow-up|0|||
23381394|NCT01432327|65140504|FG002|Posttest 6 Months|Lost to Follow-up|3|||
23381395|NCT01432327|65140505|FG003|Posttest 6 Months|Lost to Follow-up|2|||
23381396|NCT01432327|65140502|FG000|Posttest 6 Months|Allergic reaction|0|||
23381397|NCT01432327|65140503|FG001|Posttest 6 Months|Allergic reaction|0|||
23288764|NCT00112437|64798878|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288765|NCT00112437|64798879|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288766|NCT00112437|64798880|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23381398|NCT01432327|65140504|FG002|Posttest 6 Months|Allergic reaction|1|||
23381399|NCT01432327|65140505|FG003|Posttest 6 Months|Allergic reaction|0|||
23288767|NCT00112437|64798881|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
23288768|NCT00112437|64798882|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288769|NCT00112437|64798883|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
23288770|NCT00112437|64798858|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288771|NCT00112437|64798859|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288772|NCT00112437|64798860|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288773|NCT00112437|64798861|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288774|NCT00112437|64798862|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23381400|NCT01432327|65140502|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
23288775|NCT00112437|64798863|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288776|NCT00112437|64798864|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288777|NCT00112437|64798865|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23381401|NCT01432327|65140503|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
23381402|NCT01432327|65140504|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
23381403|NCT01432327|65140505|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
23288778|NCT00112437|64798866|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288779|NCT00112437|64798867|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288780|NCT00112437|64798868|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288781|NCT00112437|64798869|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288782|NCT00112437|64798870|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288783|NCT00112437|64798871|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23381404|NCT01432327|65140502|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
23381405|NCT01432327|65140503|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
23381406|NCT01432327|65140504|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
23288784|NCT00112437|64798872|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288785|NCT00112437|64798873|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288786|NCT00112437|64798874|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23381407|NCT01432327|65140505|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
23381408|NCT01432327|65140502|FG000|Posttest 1 Year|Lost to Follow-up|0|||
23381409|NCT01432327|65140503|FG001|Posttest 1 Year|Lost to Follow-up|0|||
23288787|NCT00112437|64798875|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288788|NCT00112437|64798876|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288789|NCT00112437|64798877|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288790|NCT00112437|64798878|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288791|NCT00112437|64798879|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288792|NCT00112437|64798880|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
23288793|NCT00112437|64798881|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
23288794|NCT00112437|64798882|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
23288795|NCT00112437|64798883|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
23288796|NCT05263505|64798884|FG000|Overall Study|Adverse Event|0|||
23288797|NCT05263505|64798885|FG001|Overall Study|Adverse Event|1|||
23288798|NCT02888743|64798886|FG000|Overall Study|Withdrawal by Subject|1|||
23288799|NCT02888743|64798887|FG001|Overall Study|Withdrawal by Subject|2|||
23288800|NCT02888743|64798888|FG002|Overall Study|Withdrawal by Subject|2|||
23288801|NCT02888743|64798889|FG003|Overall Study|Withdrawal by Subject|0|||
23288802|NCT02888743|64798890|FG004|Overall Study|Withdrawal by Subject|1|||
23288803|NCT02888743|64798886|FG000|Overall Study|Disease progression before treatment|2|||
23288804|NCT02888743|64798887|FG001|Overall Study|Disease progression before treatment|0|||
23288805|NCT02888743|64798888|FG002|Overall Study|Disease progression before treatment|2|||
23288806|NCT02888743|64798889|FG003|Overall Study|Disease progression before treatment|0|||
23288807|NCT02888743|64798890|FG004|Overall Study|Disease progression before treatment|0|||
23288808|NCT02888743|64798886|FG000|Overall Study|Patient ineligible|1|||
23288809|NCT02888743|64798887|FG001|Overall Study|Patient ineligible|2|||
23288810|NCT02888743|64798888|FG002|Overall Study|Patient ineligible|0|||
23288811|NCT02888743|64798889|FG003|Overall Study|Patient ineligible|0|||
23288812|NCT02888743|64798890|FG004|Overall Study|Patient ineligible|0|||
23492118|NCT04203498|65545155|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
23492119|NCT04203498|65545156|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
23492120|NCT04203498|65545155|FG000|Overall Study|Withdrawal of patient consent|7|||
23492121|NCT04203498|65545156|FG001|Overall Study|Withdrawal of patient consent|2|||
23492122|NCT04203498|65545155|FG000|Overall Study|Adverse Event|4|||
23492123|NCT04203498|65545156|FG001|Overall Study|Adverse Event|1|||
23492124|NCT04203498|65545155|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
23492125|NCT04203498|65545156|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
23492126|NCT04203498|65545155|FG000|Overall Study|Did not receive IMP|2|||
23492127|NCT04203498|65545156|FG001|Overall Study|Did not receive IMP|0|||
23492128|NCT00331422|65545157|FG000|Overall Study|Did not receive entire study regimen|5|||
23492129|NCT01419626|65545158|FG000|Overall Study|Protocol Violation|3|||
23492130|NCT01419626|65545159|FG001|Overall Study|Protocol Violation|2|||
23492131|NCT01419626|65545160|FG002|Overall Study|Protocol Violation|2|||
23492132|NCT01419626|65545158|FG000|Overall Study|Withdrawal by Subject|1|||
23492133|NCT01419626|65545159|FG001|Overall Study|Withdrawal by Subject|0|||
23492134|NCT01419626|65545160|FG002|Overall Study|Withdrawal by Subject|0|||
23288813|NCT04573309|64798891|FG000|Overall Study|Protocol Violation|1|||
23288814|NCT04573309|64798892|FG001|Overall Study|Protocol Violation|0|||
23288815|NCT02451696|64798893|FG000|Overall Study|Surgery postponed|1|||
23288816|NCT02451696|64798894|FG001|Overall Study|Surgery postponed|0|||
23288817|NCT02906917|64798895|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
23492135|NCT01419626|65545158|FG000|Overall Study|Lost to Follow-up|0|||
23492136|NCT01419626|65545159|FG001|Overall Study|Lost to Follow-up|1|||
23492137|NCT01419626|65545160|FG002|Overall Study|Lost to Follow-up|1|||
23288818|NCT02906917|64798896|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
23288819|NCT02906917|64798895|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
23288820|NCT02906917|64798896|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
23288821|NCT02906917|64798895|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
23288822|NCT02906917|64798896|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
23288823|NCT02906917|64798895|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
23288824|NCT02906917|64798896|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
23288825|NCT02906917|64798895|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
23288826|NCT02906917|64798896|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
23288827|NCT02906917|64798895|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
23288828|NCT02906917|64798896|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
23288829|NCT02906917|64798895|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
23288830|NCT02906917|64798896|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
23381410|NCT01432327|65140504|FG002|Posttest 1 Year|Lost to Follow-up|4|||
23288831|NCT02906917|64798895|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
23288832|NCT02906917|64798896|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
23288833|NCT00569777|64798897|FG000|Overall Study|Withdrawal by Subject|4|||
23288834|NCT00569777|64798898|FG001|Overall Study|Withdrawal by Subject|0|||
23288835|NCT00569777|64798897|FG000|Overall Study|Adverse Event|3|||
23288836|NCT00569777|64798898|FG001|Overall Study|Adverse Event|0|||
23288837|NCT00569777|64798897|FG000|Overall Study|Lost to Follow-up|1|||
23288838|NCT00569777|64798898|FG001|Overall Study|Lost to Follow-up|0|||
23288839|NCT00569777|64798897|FG000|Overall Study|scheduled eye surgery|0|||
23288840|NCT00569777|64798898|FG001|Overall Study|scheduled eye surgery|1|||
23288841|NCT00569777|64798897|FG000|Overall Study|did not meet exclusion criteria|1|||
23288842|NCT00569777|64798898|FG001|Overall Study|did not meet exclusion criteria|2|||
23288843|NCT00569777|64798897|FG000|Overall Study|pregnant|1|||
23288844|NCT00569777|64798898|FG001|Overall Study|pregnant|0|||
23288845|NCT01206439|64798900|FG000|Overall Study|subject did not meet inclusion criteria|1|||
23288846|NCT00640341|64798902|FG000|Overall Study|Adverse Event|0|||
23288847|NCT00640341|64798903|FG001|Overall Study|Adverse Event|0|||
23288848|NCT00640341|64798904|FG002|Overall Study|Adverse Event|1|||
23288849|NCT00640341|64798902|FG000|Overall Study|Positive Slit Lamp Findings|0|||
23288850|NCT00640341|64798903|FG001|Overall Study|Positive Slit Lamp Findings|0|||
23381411|NCT01432327|65140505|FG003|Posttest 1 Year|Lost to Follow-up|2|||
23381412|NCT01432327|65140502|FG000|Posttest 1 Year|Allergic reaction|0|||
23381413|NCT01432327|65140503|FG001|Posttest 1 Year|Allergic reaction|0|||
23288851|NCT00640341|64798904|FG002|Overall Study|Positive Slit Lamp Findings|1|||
23288852|NCT00640341|64798902|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
23288853|NCT00640341|64798903|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
23288854|NCT00640341|64798904|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
23288855|NCT00640341|64798902|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
23288856|NCT00640341|64798903|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
23288857|NCT00640341|64798904|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
23288858|NCT00640341|64798902|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
23288859|NCT00640341|64798903|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
23288860|NCT00640341|64798904|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
23288861|NCT00640341|64798902|FG000|Overall Study|Lost to Follow-up|2|||
23288862|NCT00640341|64798903|FG001|Overall Study|Lost to Follow-up|0|||
23288863|NCT00640341|64798904|FG002|Overall Study|Lost to Follow-up|0|||
23288864|NCT00640341|64798902|FG000|Overall Study|Withdrawal by Subject|4|||
23381414|NCT01432327|65140504|FG002|Posttest 1 Year|Allergic reaction|1|||
23288865|NCT00640341|64798903|FG001|Overall Study|Withdrawal by Subject|0|||
23288866|NCT00640341|64798904|FG002|Overall Study|Withdrawal by Subject|1|||
23288867|NCT00640341|64798902|FG000|Overall Study|Unacceptable Lens Movement|1|||
23288868|NCT00640341|64798903|FG001|Overall Study|Unacceptable Lens Movement|0|||
23288869|NCT00640341|64798904|FG002|Overall Study|Unacceptable Lens Movement|0|||
23381415|NCT01432327|65140505|FG003|Posttest 1 Year|Allergic reaction|1|||
23381416|NCT00141921|65140506|FG000|Overall Study|Remain on Study|28|||
23381417|NCT00141921|65140506|FG000|Overall Study|Withdrawal by Subject|42|||
23381418|NCT00141921|65140506|FG000|Overall Study|Lost to Follow-up|19|||
23381419|NCT00141921|65140506|FG000|Overall Study|Noncompliance|17|||
23381420|NCT00141921|65140506|FG000|Overall Study|Disease Progression|7|||
23381421|NCT00141921|65140506|FG000|Overall Study|Protocol Deviation|7|||
23381422|NCT00141921|65140506|FG000|Overall Study|Adverse Event|5|||
23381423|NCT00141921|65140506|FG000|Overall Study|Administrative Decision|2|||
23381424|NCT00141921|65140506|FG000|Overall Study|Pregnancy|4|||
23381425|NCT00141921|65140506|FG000|Overall Study|Ineligibility Determined|2|||
23381426|NCT00141921|65140506|FG000|Overall Study|Other|8|||
23381427|NCT02441283|65140507|FG000|Overall Study|Withdrew consent|15|||
23381428|NCT02441283|65140507|FG000|Overall Study|Lost to Follow-up|42|||
23381429|NCT02441283|65140507|FG000|Overall Study|Death|1|||
23381430|NCT02441283|65140507|FG000|Overall Study|Other, not specified|32|||
23381431|NCT03941483|65140508|FG000|Overall Study|Miscellaneous|2|||
23381432|NCT03941483|65140509|FG001|Overall Study|Miscellaneous|3|||
23381433|NCT03941483|65140510|FG002|Overall Study|Miscellaneous|0|||
23381434|NCT03941483|65140508|FG000|Overall Study|Study Terminated by Sponsor|1|||
23381435|NCT03941483|65140509|FG001|Overall Study|Study Terminated by Sponsor|0|||
23381436|NCT03941483|65140510|FG002|Overall Study|Study Terminated by Sponsor|0|||
23381437|NCT03941483|65140508|FG000|Overall Study|Withdrawal by Subject|1|||
23381438|NCT03941483|65140509|FG001|Overall Study|Withdrawal by Subject|4|||
23381439|NCT03941483|65140510|FG002|Overall Study|Withdrawal by Subject|1|||
23381440|NCT03941483|65140508|FG000|Overall Study|Lost to Follow-up|2|||
23381441|NCT03941483|65140509|FG001|Overall Study|Lost to Follow-up|1|||
23381442|NCT03941483|65140510|FG002|Overall Study|Lost to Follow-up|8|||
23288870|NCT00640341|64798902|FG000|Overall Study|Poor fit/Uncomfortable|4|||
23288871|NCT00640341|64798903|FG001|Overall Study|Poor fit/Uncomfortable|0|||
23288872|NCT00640341|64798904|FG002|Overall Study|Poor fit/Uncomfortable|0|||
23288873|NCT00640341|64798902|FG000|Overall Study|Ineligable at Baseline|5|||
23288874|NCT00640341|64798903|FG001|Overall Study|Ineligable at Baseline|3|||
23288875|NCT00640341|64798904|FG002|Overall Study|Ineligable at Baseline|2|||
23288876|NCT00640341|64798902|FG000|Overall Study|Adverse event and positive slit lamp|1|||
23288877|NCT00640341|64798903|FG001|Overall Study|Adverse event and positive slit lamp|0|||
23288878|NCT00640341|64798904|FG002|Overall Study|Adverse event and positive slit lamp|0|||
23288879|NCT03387462|64798905|FG000|Overall Study|Lost to Follow-up|1|||
23288880|NCT03110380|64798907|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
23288881|NCT03110380|64798908|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
23288882|NCT03110380|64798909|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
23288883|NCT03110380|64798910|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
23288884|NCT03110380|64798907|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
23288885|NCT03110380|64798908|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
23288886|NCT03110380|64798909|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23288887|NCT03110380|64798910|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23288888|NCT03110380|64798907|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
23288889|NCT03110380|64798908|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
23288890|NCT03110380|64798909|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
23288891|NCT03110380|64798910|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
23288892|NCT03110380|64798907|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
23288893|NCT03110380|64798908|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
23288894|NCT03110380|64798909|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
23288895|NCT03110380|64798910|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
23288896|NCT03110380|64798907|FG000|Double-Blind Treatment Phase|Death|2|||
23288897|NCT03110380|64798908|FG001|Double-Blind Treatment Phase|Death|1|||
23288898|NCT03110380|64798909|FG002|Double-Blind Treatment Phase|Death|0|||
23288899|NCT03110380|64798910|FG003|Double-Blind Treatment Phase|Death|0|||
23288900|NCT03110380|64798907|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
23288901|NCT03110380|64798908|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
23288902|NCT03110380|64798909|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
23288903|NCT03110380|64798910|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
23288904|NCT03110380|64798907|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
23288905|NCT03110380|64798908|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
23381443|NCT03941483|65140508|FG000|Overall Study|Death|3|||
23381444|NCT03941483|65140509|FG001|Overall Study|Death|2|||
23381445|NCT03941483|65140510|FG002|Overall Study|Death|6|||
23288906|NCT03110380|64798909|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
23288907|NCT03110380|64798910|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
23288908|NCT03110380|64798907|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
23381446|NCT04339972|65140511|FG000|Overall Study|Scheduling Issues|3|||
23381447|NCT04339972|65140512|FG001|Overall Study|Scheduling Issues|3|||
23381448|NCT04339972|65140511|FG000|Overall Study|dropout|1|||
23381449|NCT04339972|65140512|FG001|Overall Study|dropout|1|||
23288909|NCT03110380|64798908|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
23288910|NCT03110380|64798909|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
23288911|NCT03110380|64798910|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
23288912|NCT03110380|64798907|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
23288913|NCT03110380|64798908|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
23288914|NCT03110380|64798909|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
23288915|NCT03110380|64798910|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
23288916|NCT03110380|64798907|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
23288917|NCT03110380|64798908|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
23288918|NCT03110380|64798909|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
23288919|NCT03110380|64798910|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
23288920|NCT03110380|64798907|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
23288921|NCT03110380|64798908|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
23288922|NCT03110380|64798909|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
23288923|NCT03110380|64798910|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
23288924|NCT01292837|64798911|FG000|Overall Study|Adverse Event|1|||
23288925|NCT01292837|64798911|FG000|Overall Study|Further treatment determined|1|||
23288926|NCT03540160|64798912|FG000|Overall Study|Protocol Violation|1|||
23288927|NCT03540160|64798912|FG000|Overall Study|Physician Decision|8|||
23288928|NCT03540160|64798912|FG000|Overall Study|Lack of Efficacy|60|||
23288929|NCT03540160|64798912|FG000|Overall Study|Pregnancy|1|||
23288930|NCT03540160|64798912|FG000|Overall Study|Adverse Event|20|||
23288931|NCT03540160|64798912|FG000|Overall Study|Withdrawal by Subject|68|||
23288932|NCT03540160|64798912|FG000|Overall Study|COVID-19|2|||
23288933|NCT03540160|64798912|FG000|Overall Study|Study Closure|10|||
23288934|NCT03540160|64798912|FG000|Overall Study|Lost to Follow-up|18|||
23288935|NCT03540160|64798912|FG000|Overall Study|Sponsor decision|191|||
23288936|NCT02490800|64798915|FG000|Overall Study|Adverse Event|0|||
23288937|NCT02490800|64798916|FG001|Overall Study|Adverse Event|0|||
23288938|NCT02490800|64798917|FG002|Overall Study|Adverse Event|0|||
23288939|NCT02490800|64798918|FG003|Overall Study|Adverse Event|2|||
23288940|NCT02490800|64798919|FG004|Overall Study|Adverse Event|3|||
23288941|NCT02490800|64798920|FG005|Overall Study|Adverse Event|2|||
23288942|NCT02490800|64798921|FG006|Overall Study|Adverse Event|0|||
23288943|NCT02490800|64798922|FG007|Overall Study|Adverse Event|0|||
23288944|NCT02490800|64798923|FG008|Overall Study|Adverse Event|0|||
23288945|NCT02490800|64798924|FG009|Overall Study|Adverse Event|0|||
23288946|NCT02490800|64798925|FG010|Overall Study|Adverse Event|0|||
23288947|NCT02490800|64798926|FG011|Overall Study|Adverse Event|2|||
23288948|NCT02490800|64798927|FG012|Overall Study|Adverse Event|2|||
23288949|NCT02490800|64798915|FG000|Overall Study|Withdrawal by Subject|0|||
23288950|NCT02490800|64798916|FG001|Overall Study|Withdrawal by Subject|0|||
23288951|NCT02490800|64798917|FG002|Overall Study|Withdrawal by Subject|0|||
23288952|NCT02490800|64798918|FG003|Overall Study|Withdrawal by Subject|1|||
23288953|NCT02490800|64798919|FG004|Overall Study|Withdrawal by Subject|0|||
23288954|NCT02490800|64798920|FG005|Overall Study|Withdrawal by Subject|0|||
23288955|NCT02490800|64798921|FG006|Overall Study|Withdrawal by Subject|0|||
23288956|NCT02490800|64798922|FG007|Overall Study|Withdrawal by Subject|0|||
23288957|NCT02490800|64798923|FG008|Overall Study|Withdrawal by Subject|1|||
23288958|NCT02490800|64798924|FG009|Overall Study|Withdrawal by Subject|0|||
23288959|NCT02490800|64798925|FG010|Overall Study|Withdrawal by Subject|0|||
23492138|NCT03468985|65545167|FG000|Overall Study|Adverse Event|0|||
23492139|NCT03468985|65545168|FG001|Overall Study|Adverse Event|2|||
23492140|NCT03468985|65545169|FG002|Overall Study|Adverse Event|0|||
23288960|NCT02490800|64798926|FG011|Overall Study|Withdrawal by Subject|0|||
23288961|NCT02490800|64798927|FG012|Overall Study|Withdrawal by Subject|0|||
23288962|NCT02490800|64798915|FG000|Overall Study|Progressive disease|3|||
23288963|NCT02490800|64798916|FG001|Overall Study|Progressive disease|3|||
23288964|NCT02490800|64798917|FG002|Overall Study|Progressive disease|3|||
23288965|NCT02490800|64798918|FG003|Overall Study|Progressive disease|4|||
23288966|NCT02490800|64798919|FG004|Overall Study|Progressive disease|4|||
23288967|NCT02490800|64798920|FG005|Overall Study|Progressive disease|1|||
23492141|NCT03468985|65545170|FG003|Overall Study|Adverse Event|0|||
23288968|NCT02490800|64798921|FG006|Overall Study|Progressive disease|4|||
23288969|NCT02490800|64798922|FG007|Overall Study|Progressive disease|3|||
23492142|NCT03468985|65545167|FG000|Overall Study|Withdrawal by Subject|0|||
23381450|NCT04339972|65140511|FG000|Overall Study|Technical issues|1|||
23381451|NCT04339972|65140512|FG001|Overall Study|Technical issues|0|||
23381452|NCT04339972|65140511|FG000|Overall Study|Claustraphobia|0|||
23381453|NCT04339972|65140512|FG001|Overall Study|Claustraphobia|1|||
23381454|NCT03111732|65140513|FG000|Overall Study|Enrolled in different study|1|||
23381455|NCT03111732|65140513|FG000|Overall Study|Progressive disease|3|||
23381456|NCT03111732|65140513|FG000|Overall Study|Withdrawal by Subject|1|||
23381457|NCT01704079|65140514|FG000|Overall Study|Withdrawal by Subject|5|||
23381458|NCT01704079|65140515|FG001|Overall Study|Withdrawal by Subject|7|||
23381459|NCT01704079|65140514|FG000|Overall Study|Lost to Follow-up|2|||
23381460|NCT01704079|65140515|FG001|Overall Study|Lost to Follow-up|5|||
23381461|NCT01704079|65140514|FG000|Overall Study|Adverse Event|4|||
23381462|NCT01704079|65140515|FG001|Overall Study|Adverse Event|7|||
23381463|NCT01704079|65140514|FG000|Overall Study|Protocol Violation|1|||
23381464|NCT01704079|65140515|FG001|Overall Study|Protocol Violation|0|||
23381465|NCT01704079|65140514|FG000|Overall Study|Subject noncompliance|2|||
23381466|NCT01704079|65140515|FG001|Overall Study|Subject noncompliance|3|||
23381467|NCT01704079|65140514|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
23381468|NCT01704079|65140515|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
23381469|NCT04727749|65140516|FG000|Overall Study|Lost to Follow-up|10|||
23381470|NCT04727749|65140517|FG001|Overall Study|Lost to Follow-up|3|||
23381471|NCT02299167|65140518|FG000|Overall Study|patients were excluded from the study|11|||
23381472|NCT01312129|65140519|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
23288970|NCT02490800|64798923|FG008|Overall Study|Progressive disease|6|||
23288971|NCT02490800|64798924|FG009|Overall Study|Progressive disease|2|||
23381473|NCT01312129|65140520|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
23381474|NCT00774748|65140521|FG000|Overall Study|Lost to Follow-up|3|||
23381475|NCT02930941|65140524|FG000|Overall Study|Lost to Follow-up|1|||
23381476|NCT02930941|65140525|FG001|Overall Study|Lost to Follow-up|2|||
23381477|NCT00785629|65140526|FG000|Overall Study|Adverse Event|2|||
23381478|NCT00785629|65140527|FG001|Overall Study|Adverse Event|1|||
23381479|NCT00785629|65140528|FG002|Overall Study|Adverse Event|1|||
23381480|NCT00785629|65140529|FG003|Overall Study|Adverse Event|5|||
23381481|NCT00785629|65140526|FG000|Overall Study|Protocol Violation|1|||
23381482|NCT00785629|65140527|FG001|Overall Study|Protocol Violation|2|||
23381483|NCT00785629|65140528|FG002|Overall Study|Protocol Violation|4|||
23381484|NCT00785629|65140529|FG003|Overall Study|Protocol Violation|5|||
23288972|NCT02490800|64798925|FG010|Overall Study|Progressive disease|7|||
23288973|NCT02490800|64798926|FG011|Overall Study|Progressive disease|1|||
23288974|NCT02490800|64798927|FG012|Overall Study|Progressive disease|10|||
23288975|NCT02490800|64798915|FG000|Overall Study|Patient enrolled in post-trial access|0|||
23288976|NCT02490800|64798916|FG001|Overall Study|Patient enrolled in post-trial access|0|||
23288977|NCT02490800|64798917|FG002|Overall Study|Patient enrolled in post-trial access|0|||
23288978|NCT02490800|64798918|FG003|Overall Study|Patient enrolled in post-trial access|0|||
23288979|NCT02490800|64798919|FG004|Overall Study|Patient enrolled in post-trial access|0|||
23288980|NCT02490800|64798920|FG005|Overall Study|Patient enrolled in post-trial access|0|||
23288981|NCT02490800|64798921|FG006|Overall Study|Patient enrolled in post-trial access|0|||
23288982|NCT02490800|64798922|FG007|Overall Study|Patient enrolled in post-trial access|0|||
23288983|NCT02490800|64798923|FG008|Overall Study|Patient enrolled in post-trial access|0|||
23288984|NCT02490800|64798924|FG009|Overall Study|Patient enrolled in post-trial access|1|||
23288985|NCT02490800|64798925|FG010|Overall Study|Patient enrolled in post-trial access|1|||
23288986|NCT02490800|64798926|FG011|Overall Study|Patient enrolled in post-trial access|0|||
23288987|NCT02490800|64798927|FG012|Overall Study|Patient enrolled in post-trial access|6|||
23288988|NCT01541215|64798928|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
23288989|NCT01541215|64798929|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
23288990|NCT01541215|64798928|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
23288991|NCT01541215|64798929|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
23288992|NCT01541215|64798928|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
23288993|NCT01541215|64798929|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
23288994|NCT01541215|64798928|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
23288995|NCT01541215|64798929|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
23288996|NCT01541215|64798928|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
23288997|NCT01541215|64798929|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
23381485|NCT00785629|65140526|FG000|Overall Study|administrative decision|5|||
23381486|NCT00785629|65140527|FG001|Overall Study|administrative decision|1|||
23381487|NCT00785629|65140528|FG002|Overall Study|administrative decision|3|||
23288998|NCT01541215|64798928|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
23288999|NCT01541215|64798929|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
23289000|NCT01211262|64798934|FG000|Overall Study|Progressive Disease|18|||
23289001|NCT01211262|64798935|FG001|Overall Study|Progressive Disease|9|||
23381488|NCT00785629|65140529|FG003|Overall Study|administrative decision|4|||
23605959|NCT01640951|65947105|FG004|Overall Study|Protocol Deviation|0|||
23289002|NCT01211262|64798934|FG000|Overall Study|Adverse Event|4|||
23289003|NCT01211262|64798935|FG001|Overall Study|Adverse Event|0|||
23381489|NCT00785629|65140526|FG000|Overall Study|Withdrawal by Subject|0|||
23381490|NCT00785629|65140527|FG001|Overall Study|Withdrawal by Subject|1|||
23381491|NCT00785629|65140528|FG002|Overall Study|Withdrawal by Subject|2|||
23381492|NCT00785629|65140529|FG003|Overall Study|Withdrawal by Subject|2|||
23381493|NCT01138046|65140530|FG000|Overall Study|Withdrawal due to death|6|||
23381494|NCT03097315|65140533|FG000|Overall Study|Withdrawal by Subject|1|||
23381495|NCT04602000|65140534|FG000|Overall Study|Withdrawal by Subject|3|||
23381496|NCT04602000|65140535|FG001|Overall Study|Withdrawal by Subject|6|||
23381497|NCT04602000|65140536|FG002|Overall Study|Withdrawal by Subject|3|||
23381498|NCT04602000|65140537|FG003|Overall Study|Withdrawal by Subject|27|||
23381499|NCT04602000|65140538|FG004|Overall Study|Withdrawal by Subject|39|||
23381500|NCT04602000|65140534|FG000|Overall Study|Physician Decision|1|||
23381501|NCT04602000|65140535|FG001|Overall Study|Physician Decision|0|||
23381502|NCT04602000|65140536|FG002|Overall Study|Physician Decision|0|||
23381503|NCT04602000|65140537|FG003|Overall Study|Physician Decision|2|||
23381504|NCT04602000|65140538|FG004|Overall Study|Physician Decision|2|||
23381505|NCT04602000|65140534|FG000|Overall Study|Death|0|||
23381506|NCT04602000|65140535|FG001|Overall Study|Death|1|||
23381507|NCT04602000|65140536|FG002|Overall Study|Death|0|||
23381508|NCT04602000|65140537|FG003|Overall Study|Death|1|||
23289004|NCT01211262|64798934|FG000|Overall Study|Withdrawal of Consent|1|||
23289005|NCT01211262|64798935|FG001|Overall Study|Withdrawal of Consent|0|||
23289006|NCT01211262|64798934|FG000|Overall Study|Other|0|||
23289007|NCT01211262|64798935|FG001|Overall Study|Other|1|||
23289008|NCT01256060|64798937|FG000|Overall Study|Lost to Follow-up|0|||
23289009|NCT01256060|64798938|FG001|Overall Study|Lost to Follow-up|1|||
23289010|NCT01256060|64798939|FG002|Overall Study|Lost to Follow-up|0|||
23289011|NCT01256060|64798940|FG003|Overall Study|Lost to Follow-up|0|||
23289012|NCT02661022|64798941|FG000|Overall Study|Withdrawal by Subject|3|||
23289013|NCT02661022|64798942|FG001|Overall Study|Withdrawal by Subject|0|||
23289014|NCT02661022|64798941|FG000|Overall Study|Adverse Event|1|||
23289015|NCT02661022|64798942|FG001|Overall Study|Adverse Event|1|||
23289016|NCT02661022|64798941|FG000|Overall Study|Physician Decision|1|||
23289017|NCT02661022|64798942|FG001|Overall Study|Physician Decision|0|||
23289018|NCT02661022|64798941|FG000|Overall Study|Progressive Disease|2|||
23289019|NCT02661022|64798942|FG001|Overall Study|Progressive Disease|1|||
23289020|NCT00926367|64798943|FG000|Overall Study|Withdrawal by Subject|0|||
23289021|NCT00926367|64798944|FG001|Overall Study|Withdrawal by Subject|1|||
23492143|NCT03468985|65545168|FG001|Overall Study|Withdrawal by Subject|0|||
23289022|NCT00926367|64798943|FG000|Overall Study|Lost to Follow-up|1|||
23289023|NCT00926367|64798944|FG001|Overall Study|Lost to Follow-up|0|||
23289024|NCT00926367|64798943|FG000|Overall Study|Skin Irritation|1|||
23492144|NCT03468985|65545169|FG002|Overall Study|Withdrawal by Subject|0|||
23492145|NCT03468985|65545170|FG003|Overall Study|Withdrawal by Subject|1|||
23492146|NCT01898208|65545173|FG000|Overall Study|Positive blood culture|17|||
23492147|NCT01898208|65545174|FG001|Overall Study|Positive blood culture|23|||
23492148|NCT01898208|65545175|FG002|Overall Study|Positive blood culture|15|||
23492149|NCT01898208|65545173|FG000|Overall Study|Death/comfort care within 24 hours|10|||
23492150|NCT01898208|65545174|FG001|Overall Study|Death/comfort care within 24 hours|9|||
23492151|NCT01898208|65545175|FG002|Overall Study|Death/comfort care within 24 hours|8|||
23492152|NCT01898208|65545173|FG000|Overall Study|Negative Gram Stain|6|||
23492153|NCT01898208|65545174|FG001|Overall Study|Negative Gram Stain|9|||
23289025|NCT00926367|64798944|FG001|Overall Study|Skin Irritation|2|||
23289026|NCT02058160|64798945|FG000|Overall Study|Randomized but not treated|2|||
23289027|NCT02058160|64798946|FG001|Overall Study|Randomized but not treated|4|||
23289028|NCT02058160|64798945|FG000|Overall Study|Poor compliance to protocol|4|||
23289029|NCT02058160|64798946|FG001|Overall Study|Poor compliance to protocol|1|||
23289030|NCT02058160|64798945|FG000|Overall Study|Adverse Event|12|||
23289031|NCT02058160|64798946|FG001|Overall Study|Adverse Event|3|||
23381509|NCT04602000|65140538|FG004|Overall Study|Death|2|||
23289032|NCT02058160|64798945|FG000|Overall Study|Lost to Follow-up|1|||
23381510|NCT04602000|65140534|FG000|Overall Study|Lost to Follow-up|0|||
23289033|NCT02058160|64798946|FG001|Overall Study|Lost to Follow-up|0|||
23381511|NCT04602000|65140535|FG001|Overall Study|Lost to Follow-up|0|||
23492154|NCT01898208|65545175|FG002|Overall Study|Negative Gram Stain|6|||
23492155|NCT01898208|65545173|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
23289034|NCT02058160|64798945|FG000|Overall Study|Other than specified above|12|||
23492156|NCT01898208|65545174|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
23492157|NCT01898208|65545175|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
23492158|NCT01898208|65545173|FG000|Overall Study|System/Technical Error|1|||
23492159|NCT01898208|65545174|FG001|Overall Study|System/Technical Error|2|||
23492160|NCT01898208|65545175|FG002|Overall Study|System/Technical Error|3|||
23492161|NCT01898208|65545173|FG000|Overall Study|Lost to Follow-up|3|||
23492162|NCT01898208|65545174|FG001|Overall Study|Lost to Follow-up|1|||
23492163|NCT01898208|65545175|FG002|Overall Study|Lost to Follow-up|1|||
23492164|NCT02104752|65545177|FG000|Overall Study|Withdrawal by Subject|1|||
23289035|NCT02058160|64798946|FG001|Overall Study|Other than specified above|6|||
23492165|NCT02104752|65545178|FG001|Overall Study|Withdrawal by Subject|0|||
23492166|NCT02104752|65545177|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
23492167|NCT02104752|65545178|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
23492168|NCT00484094|65545181|FG000|Overall Study|Discontinued|39|||
23492169|NCT00484094|65545181|FG000|Overall Study|Other|3|||
23492170|NCT01626495|65545182|FG000|Overall Study|Adverse Event|3|||
23492171|NCT01626495|65545182|FG000|Overall Study|Disease progression|27|||
23492172|NCT01626495|65545182|FG000|Overall Study|Withdrawal by Subject|1|||
23492173|NCT01626495|65545182|FG000|Overall Study|Administrative problem|1|||
23492174|NCT01626495|65545182|FG000|Overall Study|Death|2|||
23492175|NCT01626495|65545182|FG000|Overall Study|Physician Decision|1|||
23492176|NCT01626495|65545182|FG000|Overall Study|New cancer therapy|16|||
23492177|NCT01626495|65545182|FG000|Overall Study|Manufacturing failure|1|||
23492178|NCT02020577|65545187|FG000|Overall Study|Progressive disease|3|||
23492179|NCT02020577|65545188|FG001|Overall Study|Progressive disease|38|||
23492180|NCT02020577|65545187|FG000|Overall Study|Other AE or clinical progression|0|||
23492181|NCT02020577|65545188|FG001|Overall Study|Other AE or clinical progression|15|||
23492182|NCT02020577|65545187|FG000|Overall Study|Withdrawal by Subject|0|||
23492183|NCT02020577|65545188|FG001|Overall Study|Withdrawal by Subject|1|||
23492184|NCT02020577|65545187|FG000|Overall Study|Other than stated above|0|||
23492185|NCT02020577|65545188|FG001|Overall Study|Other than stated above|1|||
23492186|NCT02081183|65545189|FG000|Overall Study|Lost to Follow-up|0|||
23492187|NCT02081183|65545190|FG001|Overall Study|Lost to Follow-up|1|||
23492188|NCT02081183|65545189|FG000|Overall Study|Protocol Violation|1|||
23492189|NCT02081183|65545190|FG001|Overall Study|Protocol Violation|0|||
23492190|NCT02081183|65545189|FG000|Overall Study|Other|3|||
23492191|NCT02081183|65545190|FG001|Overall Study|Other|3|||
23492192|NCT00215683|65545191|FG000|Overall Study|Adverse Event|15|||
23492193|NCT00215683|65545192|FG001|Overall Study|Adverse Event|16|||
23492194|NCT00215683|65545193|FG002|Overall Study|Adverse Event|15|||
23492195|NCT00215683|65545191|FG000|Overall Study|Lack of Efficacy|5|||
23492196|NCT00215683|65545192|FG001|Overall Study|Lack of Efficacy|1|||
23492197|NCT00215683|65545193|FG002|Overall Study|Lack of Efficacy|2|||
23492198|NCT00215683|65545191|FG000|Overall Study|Lost to Follow-up|0|||
23492199|NCT00215683|65545192|FG001|Overall Study|Lost to Follow-up|2|||
23492200|NCT00215683|65545193|FG002|Overall Study|Lost to Follow-up|1|||
23492201|NCT00215683|65545191|FG000|Overall Study|Withdrawal by Subject|9|||
23289036|NCT00757705|64798947|FG000|Overall Study|Adverse Event|19|||
23289037|NCT00757705|64798947|FG000|Overall Study|Lost to Follow-up|16|||
23492202|NCT00215683|65545192|FG001|Overall Study|Withdrawal by Subject|4|||
23492203|NCT00215683|65545193|FG002|Overall Study|Withdrawal by Subject|13|||
23492204|NCT00215683|65545191|FG000|Overall Study|Physician Decision|0|||
23492205|NCT00215683|65545192|FG001|Overall Study|Physician Decision|0|||
23492206|NCT00215683|65545193|FG002|Overall Study|Physician Decision|1|||
23492207|NCT00215683|65545191|FG000|Overall Study|Difficult to attend visits|0|||
23492208|NCT00215683|65545192|FG001|Overall Study|Difficult to attend visits|1|||
23492209|NCT00215683|65545193|FG002|Overall Study|Difficult to attend visits|0|||
23492210|NCT00215683|65545191|FG000|Overall Study|No study drug available|0|||
23492211|NCT00215683|65545192|FG001|Overall Study|No study drug available|1|||
23492212|NCT00215683|65545193|FG002|Overall Study|No study drug available|0|||
23492213|NCT00215683|65545191|FG000|Overall Study|Intermittent therapy required|0|||
23492214|NCT00215683|65545192|FG001|Overall Study|Intermittent therapy required|1|||
23492215|NCT00215683|65545193|FG002|Overall Study|Intermittent therapy required|0|||
23492216|NCT01092507|65545194|FG000|Overall Study|Withdrawal by Subject|2|||
23492217|NCT01092507|65545195|FG001|Overall Study|Withdrawal by Subject|0|||
23492218|NCT03595774|65545198|FG000|Overall Study|Adverse Event|1|||
23492219|NCT03595774|65545199|FG001|Overall Study|Adverse Event|0|||
23492220|NCT03595774|65545200|FG002|Overall Study|Adverse Event|1|||
23492221|NCT03595774|65545201|FG003|Overall Study|Adverse Event|0|||
23492222|NCT03595774|65545198|FG000|Overall Study|screen failure|0|||
23492223|NCT03595774|65545199|FG001|Overall Study|screen failure|1|||
23492224|NCT03595774|65545200|FG002|Overall Study|screen failure|0|||
23492225|NCT03595774|65545201|FG003|Overall Study|screen failure|1|||
23492226|NCT00113087|65545202|FG000|Overall Study|Death or Transplant|14|||
23492227|NCT00113087|65545203|FG001|Overall Study|Death or Transplant|16|||
23492228|NCT00113087|65545202|FG000|Overall Study|Family or MD withdrew subject|10|||
23492229|NCT00113087|65545203|FG001|Overall Study|Family or MD withdrew subject|5|||
23492230|NCT01680965|65545208|FG000|Overall Study|Death|0|||
23492231|NCT01680965|65545209|FG001|Overall Study|Death|0|||
23492232|NCT01680965|65545210|FG002|Overall Study|Death|0|||
23492233|NCT01680965|65545211|FG003|Overall Study|Death|6|||
23492234|NCT04587271|65547991|FG000|Overall Study|Lost to Follow-up|2|||
23492235|NCT04587271|65547992|FG001|Overall Study|Lost to Follow-up|2|||
23492236|NCT04587271|65547993|FG002|Overall Study|Lost to Follow-up|0|||
23492237|NCT04587271|65547994|FG003|Overall Study|Lost to Follow-up|2|||
23492238|NCT04587271|65547995|FG004|Overall Study|Lost to Follow-up|2|||
23492239|NCT04587271|65547996|FG005|Overall Study|Lost to Follow-up|0|||
23492240|NCT04587271|65547991|FG000|Overall Study|Caregiver brought child to visits|0|||
23492241|NCT04587271|65547992|FG001|Overall Study|Caregiver brought child to visits|0|||
23492242|NCT04587271|65547993|FG002|Overall Study|Caregiver brought child to visits|0|||
23492243|NCT04587271|65547994|FG003|Overall Study|Caregiver brought child to visits|1|||
23492244|NCT04587271|65547995|FG004|Overall Study|Caregiver brought child to visits|0|||
23492245|NCT04587271|65547996|FG005|Overall Study|Caregiver brought child to visits|0|||
23492246|NCT01032174|65547997|FG000|Overall Study|Adverse Event|0|||
23492247|NCT01032174|65547998|FG001|Overall Study|Adverse Event|1|||
23492248|NCT03386474|65548003|FG000|Overall Study|Death|1|||
23492249|NCT03386474|65548004|FG001|Overall Study|Death|0|||
23492250|NCT03386474|65548003|FG000|Overall Study|Adverse Event|0|||
23492251|NCT03386474|65548004|FG001|Overall Study|Adverse Event|1|||
23492252|NCT00910273|65548005|FG000|Overall Study|Lack of Efficacy|6|||
23492253|NCT00910273|65548006|FG001|Overall Study|Lack of Efficacy|9|||
23492254|NCT00910273|65548005|FG000|Overall Study|Adverse Event|1|||
23492255|NCT00910273|65548006|FG001|Overall Study|Adverse Event|1|||
23492256|NCT00910273|65548005|FG000|Overall Study|Withdrawal by Subject|1|||
23492257|NCT00910273|65548006|FG001|Overall Study|Withdrawal by Subject|0|||
23492258|NCT00910273|65548005|FG000|Overall Study|Discontinuation of study by sponsor|8|||
23492259|NCT00910273|65548006|FG001|Overall Study|Discontinuation of study by sponsor|2|||
23492260|NCT00910273|65548005|FG000|Overall Study|Protocol Violation|1|||
23492261|NCT00910273|65548006|FG001|Overall Study|Protocol Violation|0|||
23492262|NCT00910273|65548005|FG000|Overall Study|Lost to Follow-up|1|||
23492263|NCT00910273|65548006|FG001|Overall Study|Lost to Follow-up|1|||
23492264|NCT00936611|65548009|FG000|Overall Study|Progressive Disease|3|||
23492265|NCT00936611|65548009|FG000|Overall Study|New Systemic Therapy|22|||
23492266|NCT00936611|65548009|FG000|Overall Study|Lost to Follow-up|1|||
23492267|NCT00936611|65548009|FG000|Overall Study|Withdrawal by Subject|2|||
23492268|NCT00936611|65548009|FG000|Overall Study|Still on Follow-up|1|||
23289038|NCT00757705|64798947|FG000|Overall Study|Withdrawal by Subject|25|||
23492269|NCT00936611|65548009|FG000|Overall Study|Still on Active Therapy|7|||
23492270|NCT00936611|65548009|FG000|Overall Study|Ineligible for Study Drug|3|||
23492271|NCT02919696|65548010|FG000|Overall Study|Adverse Event|1|||
23492272|NCT02919696|65548011|FG001|Overall Study|Adverse Event|2|||
23492273|NCT02919696|65548010|FG000|Overall Study|Withdrawal by Subject|2|||
23492274|NCT02919696|65548011|FG001|Overall Study|Withdrawal by Subject|1|||
23492275|NCT02919696|65548010|FG000|Overall Study|Sponsor Decision|1|||
23492276|NCT02919696|65548011|FG001|Overall Study|Sponsor Decision|1|||
23492277|NCT02919696|65548010|FG000|Overall Study|Never Treated|0|||
23289039|NCT00757705|64798947|FG000|Overall Study|Insufficient Response|26|||
23492278|NCT02919696|65548011|FG001|Overall Study|Never Treated|1|||
23492279|NCT02247531|65548012|FG000|Overall Study|Adverse Event|3|||
23492280|NCT02247531|65548013|FG001|Overall Study|Adverse Event|4|||
23492281|NCT02247531|65548014|FG002|Overall Study|Adverse Event|9|||
23492282|NCT02247531|65548012|FG000|Overall Study|Death|8|||
23492283|NCT02247531|65548013|FG001|Overall Study|Death|9|||
23492284|NCT02247531|65548014|FG002|Overall Study|Death|5|||
23492285|NCT02247531|65548012|FG000|Overall Study|Lost to Follow-up|1|||
23492286|NCT02247531|65548013|FG001|Overall Study|Lost to Follow-up|8|||
23492287|NCT02247531|65548014|FG002|Overall Study|Lost to Follow-up|3|||
23492288|NCT02247531|65548012|FG000|Overall Study|Non-compliance|2|||
23492289|NCT02247531|65548013|FG001|Overall Study|Non-compliance|2|||
23492290|NCT02247531|65548014|FG002|Overall Study|Non-compliance|0|||
23492291|NCT02247531|65548012|FG000|Overall Study|Withdrawal by Subject|26|||
23492292|NCT02247531|65548013|FG001|Overall Study|Withdrawal by Subject|31|||
23492293|NCT02247531|65548014|FG002|Overall Study|Withdrawal by Subject|25|||
23492294|NCT02247531|65548012|FG000|Overall Study|Study Terminated by Sponsor|64|||
23492295|NCT02247531|65548013|FG001|Overall Study|Study Terminated by Sponsor|66|||
23492296|NCT02247531|65548014|FG002|Overall Study|Study Terminated by Sponsor|62|||
23492297|NCT02247531|65548012|FG000|Overall Study|Physician Decision|0|||
23492298|NCT02247531|65548013|FG001|Overall Study|Physician Decision|2|||
23492299|NCT02247531|65548014|FG002|Overall Study|Physician Decision|2|||
23492300|NCT02247531|65548012|FG000|Overall Study|Unspecified Reason|2|||
23492301|NCT02247531|65548013|FG001|Overall Study|Unspecified Reason|3|||
23492302|NCT02247531|65548014|FG002|Overall Study|Unspecified Reason|4|||
23492303|NCT01934972|65548015|FG000|Overall Study|Withdrawal by Subject|9|||
23492304|NCT01934972|65548016|FG001|Overall Study|Withdrawal by Subject|6|||
23492305|NCT02436304|65548017|FG000|Overall Study|Lost to Follow-up|0|||
23492306|NCT02436304|65548018|FG001|Overall Study|Lost to Follow-up|1|||
23492307|NCT02436304|65548019|FG002|Overall Study|Lost to Follow-up|0|||
23492308|NCT02436304|65548017|FG000|Overall Study|Withdrawal by Subject|0|||
23492309|NCT02436304|65548018|FG001|Overall Study|Withdrawal by Subject|1|||
23492310|NCT02436304|65548019|FG002|Overall Study|Withdrawal by Subject|0|||
23492311|NCT02436304|65548017|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
23492312|NCT02436304|65548018|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
23492313|NCT02436304|65548019|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
23492314|NCT02846324|65548020|FG000|Overall Study|Other|1|||
23492315|NCT02846324|65548021|FG001|Overall Study|Other|0|||
23492316|NCT02846324|65548022|FG002|Overall Study|Other|0|||
23492317|NCT02846324|65548023|FG003|Overall Study|Other|0|||
23492318|NCT02846324|65548020|FG000|Overall Study|Withdrawal by Subject|1|||
23492319|NCT02846324|65548021|FG001|Overall Study|Withdrawal by Subject|0|||
23492320|NCT02846324|65548022|FG002|Overall Study|Withdrawal by Subject|4|||
23492321|NCT02846324|65548023|FG003|Overall Study|Withdrawal by Subject|0|||
23492322|NCT02544074|65548030|FG000|Overall Study|Withdrawal by Subject|0|||
23492323|NCT02544074|65548031|FG001|Overall Study|Withdrawal by Subject|1|||
23492324|NCT02544074|65548032|FG002|Overall Study|Withdrawal by Subject|0|||
23289040|NCT00757705|64798947|FG000|Overall Study|Ineligible to continue|8|||
23289041|NCT00757705|64798947|FG000|Overall Study|Non-compliant|9|||
23289042|NCT00757705|64798947|FG000|Overall Study|Other|18|||
23289043|NCT00645944|64798950|FG000|Randomized|Withdrawal by Subject|1|||
23289044|NCT00645944|64798951|FG001|Randomized|Withdrawal by Subject|2|||
23289045|NCT00645944|64798950|FG000|Received Medication|Adverse Event|2|||
23289046|NCT00645944|64798951|FG001|Received Medication|Adverse Event|1|||
23289047|NCT00645944|64798950|FG000|Received Medication|Withdrawal by Subject|1|||
23289048|NCT00645944|64798951|FG001|Received Medication|Withdrawal by Subject|1|||
23289049|NCT00645944|64798950|FG000|Received Medication|Lost to Follow-up|1|||
23289050|NCT00645944|64798951|FG001|Received Medication|Lost to Follow-up|0|||
23289051|NCT00645944|64798950|FG000|Received Medication|Protocol Violation|2|||
23289052|NCT00645944|64798951|FG001|Received Medication|Protocol Violation|1|||
23289053|NCT02418754|64798956|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
23289054|NCT02418754|64798957|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
23289055|NCT02418754|64798958|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
23289056|NCT02418754|64798959|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
23289057|NCT02418754|64798960|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
23289058|NCT02418754|64798956|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
23492325|NCT02544074|65548033|FG003|Overall Study|Withdrawal by Subject|0|||
23492326|NCT02544074|65548034|FG004|Overall Study|Withdrawal by Subject|0|||
23492327|NCT02544074|65548035|FG005|Overall Study|Withdrawal by Subject|0|||
23289059|NCT02418754|64798957|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
23289060|NCT02418754|64798958|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
23289061|NCT02418754|64798959|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
23289062|NCT02418754|64798960|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
23492328|NCT02544074|65548036|FG006|Overall Study|Withdrawal by Subject|0|||
23492329|NCT02544074|65548037|FG007|Overall Study|Withdrawal by Subject|0|||
23492330|NCT02544074|65548038|FG008|Overall Study|Withdrawal by Subject|0|||
23492331|NCT02544074|65548039|FG009|Overall Study|Withdrawal by Subject|0|||
23492332|NCT02544074|65548040|FG010|Overall Study|Withdrawal by Subject|0|||
23492333|NCT02544074|65548041|FG011|Overall Study|Withdrawal by Subject|0|||
23492334|NCT02544074|65548042|FG012|Overall Study|Withdrawal by Subject|0|||
23289063|NCT02418754|64798956|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
23289064|NCT02418754|64798957|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
23289065|NCT02418754|64798958|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
23289066|NCT02418754|64798959|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
23289067|NCT02418754|64798960|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
23289068|NCT02418754|64798956|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
23289069|NCT02418754|64798957|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
23289070|NCT02418754|64798958|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
23289071|NCT02418754|64798959|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
23289072|NCT02418754|64798960|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
23289073|NCT02418754|64798956|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
23289074|NCT02418754|64798957|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
23289075|NCT02418754|64798958|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
23289076|NCT02418754|64798959|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
23289077|NCT02418754|64798960|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
23289078|NCT02418754|64798956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
23289079|NCT02418754|64798957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
23289080|NCT02418754|64798958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
23289081|NCT02418754|64798959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
23289082|NCT02418754|64798960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
23289083|NCT02418754|64798956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
23289084|NCT02418754|64798957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
23289085|NCT02418754|64798958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
23289086|NCT02418754|64798959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
23289087|NCT02418754|64798960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
23289088|NCT02418754|64798956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
23289089|NCT02418754|64798957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
23289090|NCT02418754|64798958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
23289091|NCT02418754|64798959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
23289092|NCT02418754|64798960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
23289093|NCT02418754|64798956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
23289094|NCT02418754|64798957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
23289095|NCT02418754|64798958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
23289096|NCT02418754|64798959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
23289097|NCT02418754|64798960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
23289098|NCT02418754|64798956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
23289099|NCT02418754|64798957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
23289100|NCT02418754|64798958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
23289101|NCT02418754|64798959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
23289102|NCT02418754|64798960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
23289103|NCT02418754|64798956|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
23289104|NCT02418754|64798957|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
23289105|NCT02418754|64798958|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
23289106|NCT02418754|64798959|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
23289107|NCT02418754|64798960|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
23289108|NCT00377156|64798962|FG000|Overall Study|Death|23|||
23289109|NCT00377156|64798963|FG001|Overall Study|Death|19|||
23289110|NCT00377156|64798962|FG000|Overall Study|Withdrawal by Subject|16|||
23289111|NCT00377156|64798963|FG001|Overall Study|Withdrawal by Subject|24|||
23289112|NCT00377156|64798962|FG000|Overall Study|Had follow-up <90 d|3|||
23289113|NCT00377156|64798963|FG001|Overall Study|Had follow-up <90 d|6|||
23289114|NCT00377156|64798962|FG000|Overall Study|Cancellation|1|||
23289115|NCT00377156|64798963|FG001|Overall Study|Cancellation|0|||
23289116|NCT00377156|64798962|FG000|Overall Study|Refused testing|0|||
23289117|NCT00377156|64798963|FG001|Overall Study|Refused testing|1|||
23289118|NCT00377156|64798962|FG000|Overall Study|Ineligible|0|||
23381512|NCT04602000|65140536|FG002|Overall Study|Lost to Follow-up|0|||
23492335|NCT02544074|65548043|FG013|Overall Study|Withdrawal by Subject|0|||
23289119|NCT00377156|64798963|FG001|Overall Study|Ineligible|1|||
23289120|NCT00377156|64798962|FG000|Overall Study|Disability or language problem|0|||
23289121|NCT00377156|64798963|FG001|Overall Study|Disability or language problem|1|||
23492336|NCT02544074|65548044|FG014|Overall Study|Withdrawal by Subject|0|||
23289122|NCT00377156|64798962|FG000|Overall Study|Other|5|||
23289123|NCT00377156|64798963|FG001|Overall Study|Other|2|||
23289124|NCT00530348|64798964|FG000|Overall Study|Adverse Event|5|||
23289125|NCT00530348|64798965|FG001|Overall Study|Adverse Event|1|||
23289126|NCT00530348|64798964|FG000|Overall Study|Death|0|||
23289127|NCT00530348|64798965|FG001|Overall Study|Death|1|||
23289128|NCT00530348|64798964|FG000|Overall Study|Lack of Efficacy|2|||
23289129|NCT00530348|64798965|FG001|Overall Study|Lack of Efficacy|0|||
23289130|NCT00530348|64798964|FG000|Overall Study|Lost to Follow-up|0|||
23289131|NCT00530348|64798965|FG001|Overall Study|Lost to Follow-up|2|||
23289132|NCT00530348|64798964|FG000|Overall Study|Physician Decision|1|||
23289133|NCT00530348|64798965|FG001|Overall Study|Physician Decision|2|||
23289134|NCT00530348|64798964|FG000|Overall Study|Pregnancy|1|||
23289135|NCT00530348|64798965|FG001|Overall Study|Pregnancy|0|||
23289136|NCT00530348|64798964|FG000|Overall Study|Withdrawal by Subject|12|||
23289137|NCT00530348|64798965|FG001|Overall Study|Withdrawal by Subject|12|||
23289138|NCT00530348|64798964|FG000|Overall Study|Randomised in error|1|||
23289139|NCT00530348|64798965|FG001|Overall Study|Randomised in error|0|||
23289140|NCT00530348|64798964|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
23289141|NCT00530348|64798965|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
23289142|NCT01023061|64798966|FG000|Overall Study|Withdrawal prior to treatment|2|||
23289143|NCT01923311|64798967|FG000|Overall Study|Pregnancy|1|||
23289144|NCT01923311|64798968|FG001|Overall Study|Pregnancy|0|||
23289145|NCT01923311|64798967|FG000|Overall Study|Investigator's Discretion|1|||
23289146|NCT01923311|64798968|FG001|Overall Study|Investigator's Discretion|0|||
23289147|NCT01923311|64798967|FG000|Overall Study|Non-Compliance with Study Drug|2|||
23289148|NCT01923311|64798968|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23289149|NCT01923311|64798967|FG000|Overall Study|Withdrew Consent|1|||
23289150|NCT01923311|64798968|FG001|Overall Study|Withdrew Consent|0|||
23289151|NCT01923311|64798967|FG000|Overall Study|Study Terminated by Sponsor|12|||
23289152|NCT01923311|64798968|FG001|Overall Study|Study Terminated by Sponsor|0|||
23289153|NCT01911429|64798970|FG000|Overall Study|Adverse Event|5|||
23289154|NCT01911429|64798971|FG001|Overall Study|Adverse Event|3|||
23289155|NCT01911429|64798972|FG002|Overall Study|Adverse Event|9|||
23289156|NCT01911429|64798970|FG000|Overall Study|Lack of Efficacy|1|||
23289157|NCT01911429|64798971|FG001|Overall Study|Lack of Efficacy|2|||
23289158|NCT01911429|64798972|FG002|Overall Study|Lack of Efficacy|4|||
23289159|NCT01911429|64798970|FG000|Overall Study|Lost to Follow-up|0|||
23289160|NCT01911429|64798971|FG001|Overall Study|Lost to Follow-up|0|||
23289161|NCT01911429|64798972|FG002|Overall Study|Lost to Follow-up|1|||
23289162|NCT01911429|64798970|FG000|Overall Study|Protocol Violation|0|||
23289163|NCT01911429|64798971|FG001|Overall Study|Protocol Violation|0|||
23289164|NCT01911429|64798972|FG002|Overall Study|Protocol Violation|1|||
23289165|NCT01911429|64798970|FG000|Overall Study|Withdrawal by Subject|5|||
23289166|NCT01911429|64798971|FG001|Overall Study|Withdrawal by Subject|5|||
23289167|NCT01911429|64798972|FG002|Overall Study|Withdrawal by Subject|4|||
23492337|NCT02544074|65548045|FG015|Overall Study|Withdrawal by Subject|0|||
23289168|NCT01911429|64798970|FG000|Overall Study|Accidental randomization|0|||
23289169|NCT01911429|64798971|FG001|Overall Study|Accidental randomization|0|||
23289170|NCT01911429|64798972|FG002|Overall Study|Accidental randomization|1|||
23289171|NCT01911429|64798970|FG000|Overall Study|subject left study|1|||
23289172|NCT01911429|64798971|FG001|Overall Study|subject left study|0|||
23289173|NCT01911429|64798972|FG002|Overall Study|subject left study|0|||
23289174|NCT01098539|64798974|FG000|Overall Study|Adverse Event|26|||
23289175|NCT01098539|64798975|FG001|Overall Study|Adverse Event|26|||
23289176|NCT01098539|64798974|FG000|Overall Study|Protocol Violation|1|||
23289177|NCT01098539|64798975|FG001|Overall Study|Protocol Violation|4|||
23381513|NCT04602000|65140537|FG003|Overall Study|Lost to Follow-up|3|||
23381514|NCT04602000|65140538|FG004|Overall Study|Lost to Follow-up|4|||
23381515|NCT04602000|65140534|FG000|Overall Study|Other|4|||
23381516|NCT04602000|65140535|FG001|Overall Study|Other|1|||
23381517|NCT04602000|65140536|FG002|Overall Study|Other|2|||
23381518|NCT04602000|65140537|FG003|Overall Study|Other|5|||
23381519|NCT04602000|65140538|FG004|Overall Study|Other|4|||
23381520|NCT04602000|65140534|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
23381521|NCT04602000|65140535|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
23381522|NCT04602000|65140536|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
23381523|NCT04602000|65140537|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
23381524|NCT04602000|65140538|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
23381525|NCT01970371|65140542|FG000|Overall Study|Death|8|||
23381526|NCT01970371|65140543|FG001|Overall Study|Death|13|||
23381527|NCT01970371|65140544|FG002|Overall Study|Death|12|||
23381528|NCT01970371|65140542|FG000|Overall Study|Lost to Follow-up|0|||
23381529|NCT01970371|65140543|FG001|Overall Study|Lost to Follow-up|0|||
23381530|NCT01970371|65140544|FG002|Overall Study|Lost to Follow-up|1|||
23381531|NCT01105130|65140545|FG000|Overall Study|Withdrawal by Subject|4|||
23381532|NCT01105130|65140546|FG001|Overall Study|Withdrawal by Subject|6|||
23381533|NCT01105130|65140547|FG002|Overall Study|Withdrawal by Subject|2|||
23381534|NCT01105130|65140545|FG000|Overall Study|Never Started|2|||
23381535|NCT01105130|65140546|FG001|Overall Study|Never Started|2|||
23381536|NCT01105130|65140547|FG002|Overall Study|Never Started|4|||
23381537|NCT01105130|65140545|FG000|Overall Study|Toxicity|1|||
23381538|NCT01105130|65140546|FG001|Overall Study|Toxicity|3|||
23381539|NCT01105130|65140547|FG002|Overall Study|Toxicity|2|||
23381540|NCT01105130|65140545|FG000|Overall Study|Multiple Reasons|3|||
23381541|NCT01105130|65140546|FG001|Overall Study|Multiple Reasons|0|||
23381542|NCT01105130|65140547|FG002|Overall Study|Multiple Reasons|2|||
23381543|NCT00853047|65140548|FG000|Core Phase|Participant Request|0|||
23381544|NCT00853047|65140549|FG001|Core Phase|Participant Request|0|||
23381545|NCT00853047|65140550|FG002|Core Phase|Participant Request|0|||
23381546|NCT00853047|65140551|FG003|Core Phase|Participant Request|1|||
23381547|NCT00853047|65140552|FG004|Core Phase|Participant Request|0|||
23381548|NCT00853047|65140553|FG005|Core Phase|Participant Request|0|||
23381549|NCT00853047|65140548|FG000|Open-Label Extension Phase|Participant Request|0|||
23381550|NCT00853047|65140549|FG001|Open-Label Extension Phase|Participant Request|0|||
23289178|NCT01098539|64798974|FG000|Overall Study|Noncompliance|3|||
23289179|NCT01098539|64798975|FG001|Overall Study|Noncompliance|5|||
23289180|NCT01098539|64798974|FG000|Overall Study|Lost to Follow-up|4|||
23289181|NCT01098539|64798975|FG001|Overall Study|Lost to Follow-up|4|||
23289182|NCT01098539|64798974|FG000|Overall Study|Withdrawal by Subject|12|||
23289183|NCT01098539|64798975|FG001|Overall Study|Withdrawal by Subject|26|||
23289184|NCT01098539|64798974|FG000|Overall Study|Physician Decision|5|||
23289185|NCT01098539|64798975|FG001|Overall Study|Physician Decision|3|||
23289186|NCT01086969|64798976|FG000|Overall Study|Withdrawal by Subject|1|||
23289187|NCT01086969|64798977|FG001|Overall Study|Withdrawal by Subject|2|||
23289188|NCT01086969|64798978|FG002|Overall Study|Withdrawal by Subject|0|||
23289189|NCT05562011|64798979|FG000|Overall Study|Withdrawal by Subject|3|||
23289190|NCT05562011|64798979|FG000|Overall Study|Lost to Follow-up|1|||
23289191|NCT05562011|64798979|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
23289192|NCT05562011|64798979|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
23289193|NCT05562011|64798979|FG000|Overall Study|Device malfunction|13|||
23381551|NCT00853047|65140550|FG002|Open-Label Extension Phase|Participant Request|0|||
23381552|NCT00853047|65140551|FG003|Open-Label Extension Phase|Participant Request|0|||
23381553|NCT00853047|65140552|FG004|Open-Label Extension Phase|Participant Request|0|||
23381554|NCT00853047|65140553|FG005|Open-Label Extension Phase|Participant Request|7|||
23289194|NCT02340962|64798980|FG000|Overall Study|Lost to Follow-up|1|||
23381555|NCT00853047|65140548|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23381556|NCT00853047|65140549|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
23381557|NCT00853047|65140550|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
23381558|NCT00853047|65140551|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
23492338|NCT02544074|65548046|FG016|Overall Study|Withdrawal by Subject|0|||
23492339|NCT02544074|65548047|FG017|Overall Study|Withdrawal by Subject|0|||
23492340|NCT02544074|65548048|FG018|Overall Study|Withdrawal by Subject|0|||
23492341|NCT02544074|65548049|FG019|Overall Study|Withdrawal by Subject|0|||
23289195|NCT02340962|64798981|FG001|Overall Study|Lost to Follow-up|0|||
23289196|NCT00858403|64798982|FG000|Overall Study|Withdrawal by Subject|1|||
23289197|NCT00858403|64798982|FG000|Overall Study|Death|3|||
23289198|NCT00858403|64798982|FG000|Overall Study|Disease Progression|1|||
23289199|NCT04129944|64798983|FG000|Overall Study|Death|0|||
23289200|NCT04129944|64798984|FG001|Overall Study|Death|0|||
23289201|NCT04129944|64798985|FG002|Overall Study|Death|0|||
23289202|NCT04129944|64798986|FG003|Overall Study|Death|1|||
23289203|NCT04129944|64798983|FG000|Overall Study|Lost to Follow-up|1|||
23289204|NCT04129944|64798984|FG001|Overall Study|Lost to Follow-up|0|||
23289205|NCT04129944|64798985|FG002|Overall Study|Lost to Follow-up|0|||
23289206|NCT04129944|64798986|FG003|Overall Study|Lost to Follow-up|0|||
23289207|NCT04129944|64798983|FG000|Overall Study|Withdrawal by Subject|1|||
23289208|NCT04129944|64798984|FG001|Overall Study|Withdrawal by Subject|0|||
23289209|NCT04129944|64798985|FG002|Overall Study|Withdrawal by Subject|1|||
23289210|NCT04129944|64798986|FG003|Overall Study|Withdrawal by Subject|2|||
23289211|NCT00474188|64798987|FG000|Overall Study|Withdrawal by Subject|1|||
23289212|NCT00474188|64798987|FG000|Overall Study|Study discontinued by sponsor|5|||
23289213|NCT01653704|64798993|FG000|Overall Study|Technical failure during recording|1|||
23289214|NCT01653704|64798994|FG001|Overall Study|Technical failure during recording|1|||
23289215|NCT01653704|64798993|FG000|Overall Study|Performance not reflective of training|1|||
23289216|NCT01653704|64798994|FG001|Overall Study|Performance not reflective of training|0|||
23289217|NCT00796328|64798995|FG000|Overall Study|experienced hypotension requiring tx|6|||
23289218|NCT01868243|64798998|FG000|Overall Study|Death|0|||
23289219|NCT01868243|64798999|FG001|Overall Study|Death|1|||
23289220|NCT00494013|64799000|FG000|Overall Study|Adverse Event|0|||
23289221|NCT00494013|64799001|FG001|Overall Study|Adverse Event|1|||
23289222|NCT00494013|64799000|FG000|Overall Study|Entry Criteria Not Met|1|||
23289223|NCT00494013|64799001|FG001|Overall Study|Entry Criteria Not Met|4|||
23289224|NCT00494013|64799000|FG000|Overall Study|Lost to Follow-up|5|||
23289225|NCT00494013|64799001|FG001|Overall Study|Lost to Follow-up|6|||
23289226|NCT00494013|64799000|FG000|Overall Study|Physician Decision|3|||
23289227|NCT00494013|64799001|FG001|Overall Study|Physician Decision|5|||
23289228|NCT00494013|64799000|FG000|Overall Study|Protocol Violation|8|||
23289229|NCT00494013|64799001|FG001|Overall Study|Protocol Violation|5|||
23289230|NCT00494013|64799000|FG000|Overall Study|Withdrawal by Subject|13|||
23289231|NCT00494013|64799001|FG001|Overall Study|Withdrawal by Subject|14|||
23289232|NCT00494013|64799000|FG000|Overall Study|Sponsor Decision|0|||
23289233|NCT00494013|64799001|FG001|Overall Study|Sponsor Decision|1|||
23289234|NCT00046839|64799002|FG000|Overall Study|Ineligible / No protocol treatment|0|||
23289235|NCT00046839|64799003|FG001|Overall Study|Ineligible / No protocol treatment|2|||
23289236|NCT00046839|64799002|FG000|Overall Study|Withdrawal of consent|1|||
23289237|NCT00046839|64799003|FG001|Overall Study|Withdrawal of consent|0|||
23289238|NCT02725515|64799006|FG000|Overall Study|Refused infusion (no study treatment)|1|||
23289239|NCT02725515|64799007|FG001|Overall Study|Refused infusion (no study treatment)|0|||
23289240|NCT02725515|64799006|FG000|Overall Study|Loss of Improvement per Protocol|14|||
23289241|NCT02725515|64799007|FG001|Overall Study|Loss of Improvement per Protocol|25|||
23289242|NCT02725515|64799006|FG000|Overall Study|Withdrawal by Subject|2|||
23289243|NCT02725515|64799007|FG001|Overall Study|Withdrawal by Subject|1|||
23289244|NCT02725515|64799006|FG000|Overall Study|Non-Compliance With Study Drug|0|||
23289245|NCT02725515|64799007|FG001|Overall Study|Non-Compliance With Study Drug|3|||
23289246|NCT02725515|64799006|FG000|Overall Study|Lost to Follow-up|1|||
23289247|NCT02725515|64799007|FG001|Overall Study|Lost to Follow-up|1|||
23289248|NCT02725515|64799006|FG000|Overall Study|Adverse Event|7|||
23289249|NCT02725515|64799007|FG001|Overall Study|Adverse Event|2|||
23289250|NCT02725515|64799006|FG000|Overall Study|No Documented Disease Improvement|0|||
23289251|NCT02725515|64799007|FG001|Overall Study|No Documented Disease Improvement|1|||
23289252|NCT02725515|64799006|FG000|Overall Study|Completed Study Under Original Protocol|0|||
23289253|NCT02725515|64799007|FG001|Overall Study|Completed Study Under Original Protocol|1|||
23289254|NCT02725515|64799006|FG000|Overall Study|Lack of Response|0|||
23289255|NCT02725515|64799007|FG001|Overall Study|Lack of Response|1|||
23289256|NCT01169038|64799008|FG000|Overall Study|Death|1|||
23289257|NCT01169038|64799008|FG000|Overall Study|Adverse Event|5|||
23289258|NCT01169038|64799008|FG000|Overall Study|Required antibiotic administration|1|||
23289259|NCT03206749|64799013|FG000|Overall Study|Withdrawal of consent|5|||
23289260|NCT03206749|64799014|FG001|Overall Study|Withdrawal of consent|3|||
23289261|NCT03206749|64799015|FG002|Overall Study|Withdrawal of consent|6|||
23289262|NCT03206749|64799013|FG000|Overall Study|Lost to Follow-up|0|||
23289263|NCT03206749|64799014|FG001|Overall Study|Lost to Follow-up|0|||
23289264|NCT03206749|64799015|FG002|Overall Study|Lost to Follow-up|1|||
23289265|NCT00659815|64799016|FG000|Overall Study|Study related symptoms and complaints|2|||
23381559|NCT00853047|65140552|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
23381560|NCT00853047|65140553|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
23381561|NCT00853047|65140548|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381562|NCT00853047|65140549|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381563|NCT00853047|65140550|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381564|NCT00853047|65140551|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381565|NCT00853047|65140552|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
23381566|NCT00853047|65140553|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
23381567|NCT00853047|65140548|FG000|Open-Label Extension Phase|Investigator Decision|0|||
23381568|NCT00853047|65140549|FG001|Open-Label Extension Phase|Investigator Decision|0|||
23381569|NCT00853047|65140550|FG002|Open-Label Extension Phase|Investigator Decision|0|||
23381570|NCT00853047|65140551|FG003|Open-Label Extension Phase|Investigator Decision|0|||
23381571|NCT00853047|65140552|FG004|Open-Label Extension Phase|Investigator Decision|0|||
23381572|NCT00853047|65140553|FG005|Open-Label Extension Phase|Investigator Decision|1|||
23381573|NCT00853047|65140548|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
23381574|NCT00853047|65140549|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
23381575|NCT00853047|65140550|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
23381576|NCT00853047|65140551|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
23381577|NCT00853047|65140552|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
23381578|NCT00853047|65140553|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
23381579|NCT00363467|65140554|FG000|Overall Study|Physician Decision|1|||
23381580|NCT04380753|65140556|FG000|Overall Study|Participants continuing study|4|||
23381581|NCT04380753|65140556|FG000|Overall Study|Death|2|||
23381582|NCT03601052|65140559|FG000|Overall Study|Lost to Follow-up|2|||
23381583|NCT02316613|65140560|FG000|Overall Study|Death|63|||
23381584|NCT02316613|65140560|FG000|Overall Study|Lost to Follow-up|9|||
23381585|NCT02316613|65140560|FG000|Overall Study|Lymphoma transformation|2|||
23381586|NCT02316613|65140560|FG000|Overall Study|Participant moved/changed medical team|11|||
23381587|NCT02316613|65140560|FG000|Overall Study|No data and duplicate cases|5|||
23381588|NCT02316613|65140560|FG000|Overall Study|Did not met selection criteria|14|||
23381589|NCT00870727|65140561|FG000|Overall Study|Lost to Follow-up|0|||
23381590|NCT00870727|65140562|FG001|Overall Study|Lost to Follow-up|1|||
23381591|NCT00870727|65140561|FG000|Overall Study|Lack of Efficacy|1|||
23381592|NCT00870727|65140562|FG001|Overall Study|Lack of Efficacy|3|||
23381593|NCT00870727|65140561|FG000|Overall Study|Adverse Event|0|||
23381594|NCT00870727|65140562|FG001|Overall Study|Adverse Event|1|||
23381595|NCT02949934|65140565|FG000|Natural Drinking Period|Adverse Event|1|||
23381596|NCT02949934|65140566|FG001|Natural Drinking Period|Adverse Event|0|||
23381597|NCT02949934|65140567|FG002|Natural Drinking Period|Adverse Event|0|||
23381598|NCT02949934|65140568|FG003|Natural Drinking Period|Adverse Event|1|||
23381599|NCT02949934|65140569|FG004|Natural Drinking Period|Adverse Event|0|||
23381600|NCT02949934|65140570|FG005|Natural Drinking Period|Adverse Event|0|||
23381601|NCT02949934|65140565|FG000|Natural Drinking Period|Lost to Follow-up|0|||
23289266|NCT00659815|64799017|FG001|Overall Study|Study related symptoms and complaints|1|||
23289267|NCT00659815|64799016|FG000|Overall Study|Inability to maintain wearing schedule|1|||
23289268|NCT00659815|64799017|FG001|Overall Study|Inability to maintain wearing schedule|2|||
23289269|NCT00659815|64799016|FG000|Overall Study|Withdrawal by Subject|1|||
23289270|NCT00659815|64799017|FG001|Overall Study|Withdrawal by Subject|1|||
23289271|NCT04148287|64799018|FG000|Overall Study|Death|2|||
23289272|NCT01688882|64799023|FG000|Overall Study|Adverse Event|1|||
23289273|NCT01688882|64799024|FG001|Overall Study|Adverse Event|0|||
23289274|NCT01688882|64799023|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23289275|NCT01688882|64799024|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23289276|NCT01688882|64799023|FG000|Overall Study|Administrative problems|1|||
23289277|NCT01688882|64799024|FG001|Overall Study|Administrative problems|0|||
23289278|NCT00258856|64799029|FG000|Overall Study|Lost to Follow-up|1|||
23289279|NCT00258856|64799030|FG001|Overall Study|Lost to Follow-up|0|||
23289280|NCT00258856|64799031|FG002|Overall Study|Lost to Follow-up|2|||
23381602|NCT02949934|65140566|FG001|Natural Drinking Period|Lost to Follow-up|0|||
23381603|NCT02949934|65140567|FG002|Natural Drinking Period|Lost to Follow-up|0|||
23381604|NCT02949934|65140568|FG003|Natural Drinking Period|Lost to Follow-up|0|||
23381605|NCT02949934|65140569|FG004|Natural Drinking Period|Lost to Follow-up|1|||
23381606|NCT02949934|65140570|FG005|Natural Drinking Period|Lost to Follow-up|0|||
23381607|NCT02949934|65140565|FG000|Neuroimaging|Protocol Violation|2|||
23381608|NCT02949934|65140566|FG001|Neuroimaging|Protocol Violation|0|||
23381609|NCT02949934|65140567|FG002|Neuroimaging|Protocol Violation|0|||
23381610|NCT02949934|65140568|FG003|Neuroimaging|Protocol Violation|0|||
23381611|NCT02949934|65140569|FG004|Neuroimaging|Protocol Violation|1|||
23381612|NCT02949934|65140570|FG005|Neuroimaging|Protocol Violation|0|||
23381613|NCT02949934|65140565|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
23381614|NCT02949934|65140566|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
23381615|NCT02949934|65140567|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
23381616|NCT02949934|65140568|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
23381617|NCT02949934|65140569|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
23381618|NCT02949934|65140570|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
23381619|NCT02949934|65140565|FG000|Neuroimaging|Not scanned|0|||
23381620|NCT02949934|65140566|FG001|Neuroimaging|Not scanned|0|||
23381621|NCT02949934|65140567|FG002|Neuroimaging|Not scanned|1|||
23381622|NCT02949934|65140568|FG003|Neuroimaging|Not scanned|0|||
23381623|NCT02949934|65140569|FG004|Neuroimaging|Not scanned|0|||
23381624|NCT02949934|65140570|FG005|Neuroimaging|Not scanned|2|||
23381625|NCT02949934|65140565|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
23381626|NCT02949934|65140566|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
23381627|NCT02949934|65140567|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
23381628|NCT02949934|65140568|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
23381629|NCT02949934|65140569|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
23381630|NCT02949934|65140570|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
23381631|NCT02949934|65140565|FG000|Bar Laboratory|Adverse Event|1|||
23381632|NCT02949934|65140566|FG001|Bar Laboratory|Adverse Event|0|||
23381633|NCT02949934|65140567|FG002|Bar Laboratory|Adverse Event|2|||
23381634|NCT02949934|65140568|FG003|Bar Laboratory|Adverse Event|0|||
23381635|NCT02949934|65140569|FG004|Bar Laboratory|Adverse Event|1|||
23492342|NCT02544074|65548050|FG020|Overall Study|Withdrawal by Subject|0|||
23381636|NCT02949934|65140570|FG005|Bar Laboratory|Adverse Event|0|||
23381637|NCT02949934|65140565|FG000|Bar Laboratory|Protocol Violation|0|||
23381638|NCT02949934|65140566|FG001|Bar Laboratory|Protocol Violation|0|||
23381639|NCT02949934|65140567|FG002|Bar Laboratory|Protocol Violation|0|||
23381640|NCT02949934|65140568|FG003|Bar Laboratory|Protocol Violation|1|||
23381641|NCT02949934|65140569|FG004|Bar Laboratory|Protocol Violation|0|||
23381642|NCT02949934|65140570|FG005|Bar Laboratory|Protocol Violation|0|||
23381643|NCT00992836|65140572|FG000|Overall Study|Lost to Follow-up|1|||
23381644|NCT00992836|65140572|FG000|Overall Study|Withdrawal by Subject|2|||
23381645|NCT00992836|65140572|FG000|Overall Study|Protocol Violation|2|||
23381646|NCT00805532|65140577|FG000|Overall Study|invalid data|0|||
23381647|NCT00805532|65140578|FG001|Overall Study|invalid data|1|||
23381648|NCT02405962|65140580|FG000|Overall Study|Lost to Follow-up|1|||
23381649|NCT02405962|65140581|FG001|Overall Study|Lost to Follow-up|4|||
23381650|NCT02405962|65140580|FG000|Overall Study|A participant has moved to another place|0|||
23381651|NCT02405962|65140581|FG001|Overall Study|A participant has moved to another place|1|||
23381652|NCT02530242|65140582|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
23381653|NCT02530242|65140583|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
23381654|NCT04575324|65140584|FG000|Overall Study|Lost to Follow-up|29|||
23381655|NCT04575324|65140585|FG001|Overall Study|Lost to Follow-up|25|||
23381656|NCT04575324|65140584|FG000|Overall Study|Death|1|||
23381657|NCT04575324|65140585|FG001|Overall Study|Death|2|||
23381658|NCT04575324|65140584|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
23381659|NCT04575324|65140585|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
23381660|NCT05607043|65140588|FG000|Overall Study|Lost to Follow-up|2|||
23492343|NCT02544074|65548030|FG000|Overall Study|Tablet error|0|||
23492344|NCT02544074|65548031|FG001|Overall Study|Tablet error|0|||
23492345|NCT02544074|65548032|FG002|Overall Study|Tablet error|0|||
23492346|NCT02544074|65548033|FG003|Overall Study|Tablet error|0|||
23492347|NCT02544074|65548034|FG004|Overall Study|Tablet error|0|||
23492348|NCT02544074|65548035|FG005|Overall Study|Tablet error|1|||
23492349|NCT02544074|65548036|FG006|Overall Study|Tablet error|0|||
23492350|NCT02544074|65548037|FG007|Overall Study|Tablet error|0|||
23492351|NCT02544074|65548038|FG008|Overall Study|Tablet error|0|||
23492352|NCT02544074|65548039|FG009|Overall Study|Tablet error|1|||
23492353|NCT02544074|65548040|FG010|Overall Study|Tablet error|0|||
23492354|NCT02544074|65548041|FG011|Overall Study|Tablet error|0|||
23381661|NCT02393755|65140589|FG000|Overall Study|Withdrawal by Subject|0|||
23492355|NCT02544074|65548042|FG012|Overall Study|Tablet error|0|||
23492356|NCT02544074|65548043|FG013|Overall Study|Tablet error|0|||
23381662|NCT02393755|65140590|FG001|Overall Study|Withdrawal by Subject|3|||
23381663|NCT02393755|65140589|FG000|Overall Study|Adverse Event|0|||
23492357|NCT02544074|65548044|FG014|Overall Study|Tablet error|0|||
23381664|NCT02393755|65140590|FG001|Overall Study|Adverse Event|2|||
23381665|NCT02393755|65140589|FG000|Overall Study|Physician Decision|0|||
23381666|NCT02393755|65140590|FG001|Overall Study|Physician Decision|2|||
23381667|NCT01107457|65140593|FG000|Part A|Adverse Event|1|||
23381668|NCT01107457|65140594|FG001|Part A|Adverse Event|2|||
23381669|NCT01107457|65140595|FG002|Part A|Adverse Event|1|||
23381670|NCT01107457|65140596|FG003|Part A|Adverse Event|0|||
23381671|NCT01107457|65140597|FG004|Part A|Adverse Event|0|||
23381672|NCT01107457|65140598|FG005|Part A|Adverse Event|0|||
23381673|NCT01107457|65140593|FG000|Part A|Withdrawal by Subject|3|||
23381674|NCT01107457|65140594|FG001|Part A|Withdrawal by Subject|3|||
23381675|NCT01107457|65140595|FG002|Part A|Withdrawal by Subject|0|||
23381676|NCT01107457|65140596|FG003|Part A|Withdrawal by Subject|3|||
23381677|NCT01107457|65140597|FG004|Part A|Withdrawal by Subject|1|||
23381678|NCT01107457|65140598|FG005|Part A|Withdrawal by Subject|0|||
23381679|NCT01107457|65140593|FG000|Part A|Lost to Follow-up|0|||
23381680|NCT01107457|65140594|FG001|Part A|Lost to Follow-up|1|||
23381681|NCT01107457|65140595|FG002|Part A|Lost to Follow-up|0|||
23381682|NCT01107457|65140596|FG003|Part A|Lost to Follow-up|0|||
23381683|NCT01107457|65140597|FG004|Part A|Lost to Follow-up|0|||
23381684|NCT01107457|65140598|FG005|Part A|Lost to Follow-up|0|||
23381685|NCT01107457|65140593|FG000|Part A|Lack of Efficacy|1|||
23381686|NCT01107457|65140594|FG001|Part A|Lack of Efficacy|0|||
23381687|NCT01107457|65140595|FG002|Part A|Lack of Efficacy|0|||
23381688|NCT01107457|65140596|FG003|Part A|Lack of Efficacy|0|||
23381689|NCT01107457|65140597|FG004|Part A|Lack of Efficacy|0|||
23381690|NCT01107457|65140598|FG005|Part A|Lack of Efficacy|0|||
23381691|NCT01107457|65140593|FG000|Part A|Protocol Violation|0|||
23381692|NCT01107457|65140594|FG001|Part A|Protocol Violation|1|||
23381693|NCT01107457|65140595|FG002|Part A|Protocol Violation|0|||
23381694|NCT01107457|65140596|FG003|Part A|Protocol Violation|0|||
23381695|NCT01107457|65140597|FG004|Part A|Protocol Violation|0|||
23381696|NCT01107457|65140598|FG005|Part A|Protocol Violation|0|||
23381697|NCT01107457|65140593|FG000|Part B and C|Adverse Event|0|||
23381698|NCT01107457|65140594|FG001|Part B and C|Adverse Event|0|||
23381699|NCT01107457|65140595|FG002|Part B and C|Adverse Event|0|||
23381700|NCT01107457|65140596|FG003|Part B and C|Adverse Event|0|||
23381701|NCT01107457|65140597|FG004|Part B and C|Adverse Event|0|||
23492358|NCT02544074|65548045|FG015|Overall Study|Tablet error|0|||
23492359|NCT02544074|65548046|FG016|Overall Study|Tablet error|0|||
23492360|NCT02544074|65548047|FG017|Overall Study|Tablet error|0|||
23492361|NCT02544074|65548048|FG018|Overall Study|Tablet error|0|||
23492362|NCT02544074|65548049|FG019|Overall Study|Tablet error|0|||
23492363|NCT02544074|65548050|FG020|Overall Study|Tablet error|0|||
23492364|NCT02601027|65548051|FG000|Registration to Surgery|Withdrawal by Subject|20|||
23492365|NCT02601027|65548052|FG001|Registration to Surgery|Withdrawal by Subject|10|||
23492366|NCT01683019|65548053|FG000|Overall Study|Withdrawal by Subject|2|||
23492367|NCT01683019|65548054|FG001|Overall Study|Withdrawal by Subject|1|||
23492368|NCT01683019|65548055|FG002|Overall Study|Withdrawal by Subject|4|||
23492369|NCT00423514|65548057|FG000|Overall Study|Ineligible|1|||
23492370|NCT00423514|65548058|FG001|Overall Study|Ineligible|0|||
23492371|NCT02019277|65548059|FG000|Overall Study|Withdrawal by Subject|3|||
23492372|NCT02019277|65548059|FG000|Overall Study|Death|7|||
23492373|NCT02019277|65548059|FG000|Overall Study|Did no Cooperate|1|||
23492374|NCT02019277|65548059|FG000|Overall Study|Adverse Event|1|||
23492375|NCT03308786|65548060|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
23492376|NCT04607980|65548063|FG000|Overall Study|Adverse Event|3|||
23492377|NCT04607980|65548064|FG001|Overall Study|Adverse Event|4|||
23492378|NCT04607980|65548063|FG000|Overall Study|Death|0|||
23492379|NCT04607980|65548064|FG001|Overall Study|Death|1|||
23381702|NCT01107457|65140598|FG005|Part B and C|Adverse Event|12|||
23381703|NCT01107457|65140593|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381704|NCT01107457|65140594|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381705|NCT01107457|65140595|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381706|NCT01107457|65140596|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381707|NCT01107457|65140597|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
23381708|NCT01107457|65140598|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
23381709|NCT01107457|65140593|FG000|Part B and C|Physician Decision|0|||
23381710|NCT01107457|65140594|FG001|Part B and C|Physician Decision|0|||
23492380|NCT04607980|65548063|FG000|Overall Study|Withdrawal by Subject|2|||
23381711|NCT01107457|65140595|FG002|Part B and C|Physician Decision|0|||
23289281|NCT00258856|64799032|FG003|Overall Study|Lost to Follow-up|0|||
23289282|NCT00258856|64799029|FG000|Overall Study|Non-compliance|2|||
23289283|NCT00258856|64799030|FG001|Overall Study|Non-compliance|0|||
23289284|NCT00258856|64799031|FG002|Overall Study|Non-compliance|0|||
23492381|NCT04607980|65548064|FG001|Overall Study|Withdrawal by Subject|5|||
23289285|NCT00258856|64799032|FG003|Overall Study|Non-compliance|1|||
23289286|NCT03201003|64799036|FG000|Overall Study|Adverse Event|14|||
23289287|NCT03201003|64799037|FG001|Overall Study|Adverse Event|1|||
23289288|NCT03201003|64799036|FG000|Overall Study|Other reasons|5|||
23289289|NCT03201003|64799037|FG001|Overall Study|Other reasons|1|||
23289290|NCT03201003|64799036|FG000|Overall Study|Withdrawal by Subject|4|||
23289291|NCT03201003|64799037|FG001|Overall Study|Withdrawal by Subject|1|||
23289292|NCT03201003|64799036|FG000|Overall Study|Lost to Follow-up|2|||
23289293|NCT03201003|64799037|FG001|Overall Study|Lost to Follow-up|0|||
23289294|NCT03201003|64799036|FG000|Overall Study|Protocol Violation|1|||
23289295|NCT03201003|64799037|FG001|Overall Study|Protocol Violation|0|||
23289296|NCT03428945|64799057|FG000|Overall Study|Lost to Follow-up|5|||
23289297|NCT03428945|64799058|FG001|Overall Study|Lost to Follow-up|3|||
23289298|NCT03428945|64799057|FG000|Overall Study|Withdrawal by Subject|10|||
23289299|NCT03428945|64799058|FG001|Overall Study|Withdrawal by Subject|10|||
23289300|NCT04049097|64799059|FG000|Overall Study|Adverse Event|18|||
23289301|NCT04049097|64799059|FG000|Overall Study|Death|2|||
23381712|NCT01107457|65140596|FG003|Part B and C|Physician Decision|0|||
23492382|NCT04607980|65548063|FG000|Overall Study|Lost to Follow-up|4|||
23492383|NCT04607980|65548064|FG001|Overall Study|Lost to Follow-up|8|||
23492384|NCT04607980|65548063|FG000|Overall Study|Protocol Violation|0|||
23492385|NCT04607980|65548064|FG001|Overall Study|Protocol Violation|3|||
23492386|NCT04607980|65548063|FG000|Overall Study|Other|3|||
23492387|NCT04607980|65548064|FG001|Overall Study|Other|0|||
23492388|NCT04402060|65548071|FG000|Overall Study|Death|1|||
23492389|NCT04402060|65548072|FG001|Overall Study|Death|12|||
23492390|NCT04402060|65548073|FG002|Overall Study|Death|7|||
23492391|NCT04402060|65548071|FG000|Overall Study|Adverse Event|0|||
23492392|NCT04402060|65548072|FG001|Overall Study|Adverse Event|0|||
23492393|NCT04402060|65548073|FG002|Overall Study|Adverse Event|1|||
23492394|NCT04402060|65548071|FG000|Overall Study|Withdrawal by Subject|0|||
23492395|NCT04402060|65548072|FG001|Overall Study|Withdrawal by Subject|1|||
23492396|NCT04402060|65548073|FG002|Overall Study|Withdrawal by Subject|2|||
23492397|NCT04402060|65548071|FG000|Overall Study|Sponsor Request|0|||
23492398|NCT04402060|65548072|FG001|Overall Study|Sponsor Request|2|||
23492399|NCT04402060|65548073|FG002|Overall Study|Sponsor Request|0|||
23492400|NCT04402060|65548071|FG000|Overall Study|Physician Decision|0|||
23492401|NCT04402060|65548072|FG001|Overall Study|Physician Decision|0|||
23492402|NCT04402060|65548073|FG002|Overall Study|Physician Decision|1|||
23492403|NCT04402060|65548071|FG000|Overall Study|Other|0|||
23381713|NCT01107457|65140597|FG004|Part B and C|Physician Decision|0|||
23381714|NCT01107457|65140598|FG005|Part B and C|Physician Decision|3|||
23381715|NCT01107457|65140593|FG000|Part B and C|Lack of Efficacy|0|||
23381716|NCT01107457|65140594|FG001|Part B and C|Lack of Efficacy|0|||
23381717|NCT01107457|65140595|FG002|Part B and C|Lack of Efficacy|0|||
23381718|NCT01107457|65140596|FG003|Part B and C|Lack of Efficacy|0|||
23381719|NCT01107457|65140597|FG004|Part B and C|Lack of Efficacy|0|||
23381720|NCT01107457|65140598|FG005|Part B and C|Lack of Efficacy|7|||
23381721|NCT01107457|65140593|FG000|Part B and C|Lost to Follow-up|0|||
23381722|NCT01107457|65140594|FG001|Part B and C|Lost to Follow-up|0|||
23381723|NCT01107457|65140595|FG002|Part B and C|Lost to Follow-up|0|||
23381724|NCT01107457|65140596|FG003|Part B and C|Lost to Follow-up|0|||
23381725|NCT01107457|65140597|FG004|Part B and C|Lost to Follow-up|0|||
23381726|NCT01107457|65140598|FG005|Part B and C|Lost to Follow-up|10|||
23381727|NCT01107457|65140593|FG000|Part B and C|Protocol Violation|0|||
23381728|NCT01107457|65140594|FG001|Part B and C|Protocol Violation|0|||
23381729|NCT01107457|65140595|FG002|Part B and C|Protocol Violation|0|||
23381730|NCT01107457|65140596|FG003|Part B and C|Protocol Violation|0|||
23381731|NCT01107457|65140597|FG004|Part B and C|Protocol Violation|0|||
23381732|NCT01107457|65140598|FG005|Part B and C|Protocol Violation|1|||
23381733|NCT01107457|65140593|FG000|Part B and C|Sponsor Decision|0|||
23381734|NCT01107457|65140594|FG001|Part B and C|Sponsor Decision|0|||
23381735|NCT01107457|65140595|FG002|Part B and C|Sponsor Decision|0|||
23381736|NCT01107457|65140596|FG003|Part B and C|Sponsor Decision|0|||
23381737|NCT01107457|65140597|FG004|Part B and C|Sponsor Decision|0|||
23381738|NCT01107457|65140598|FG005|Part B and C|Sponsor Decision|66|||
23381739|NCT01107457|65140593|FG000|Part B and C|Withdrawal by Subject|0|||
23381740|NCT01107457|65140594|FG001|Part B and C|Withdrawal by Subject|0|||
23381741|NCT01107457|65140595|FG002|Part B and C|Withdrawal by Subject|0|||
23381742|NCT01107457|65140596|FG003|Part B and C|Withdrawal by Subject|0|||
23381743|NCT01107457|65140597|FG004|Part B and C|Withdrawal by Subject|0|||
23381744|NCT01107457|65140598|FG005|Part B and C|Withdrawal by Subject|16|||
23381745|NCT01107457|65140593|FG000|Part B and C|Clinical Relapse|0|||
23381746|NCT01107457|65140594|FG001|Part B and C|Clinical Relapse|0|||
23381747|NCT01107457|65140595|FG002|Part B and C|Clinical Relapse|0|||
23492404|NCT04402060|65548072|FG001|Overall Study|Other|1|||
23492405|NCT04402060|65548073|FG002|Overall Study|Other|0|||
23492406|NCT02298023|65548074|FG000|Overall Study|Withdrawal by Subject|1|||
23492407|NCT02298023|65548075|FG001|Overall Study|Withdrawal by Subject|0|||
23492408|NCT02298023|65548076|FG002|Overall Study|Withdrawal by Subject|0|||
23492409|NCT01025154|65548077|FG000|Overall Study|Lost to Follow-up|1|||
23492410|NCT01025154|65548077|FG000|Overall Study|Withdrawal by Subject|1|||
23381748|NCT01107457|65140596|FG003|Part B and C|Clinical Relapse|0|||
23381749|NCT01107457|65140597|FG004|Part B and C|Clinical Relapse|0|||
23381750|NCT01107457|65140598|FG005|Part B and C|Clinical Relapse|4|||
23381751|NCT00191100|65140599|FG000|Overall Study|Adverse Event|18|||
23381752|NCT00191100|65140600|FG001|Overall Study|Adverse Event|1|||
23381753|NCT00191100|65140599|FG000|Overall Study|Lost to Follow-up|2|||
23381754|NCT00191100|65140600|FG001|Overall Study|Lost to Follow-up|0|||
23381755|NCT00191100|65140599|FG000|Overall Study|Patient Moved|0|||
23381756|NCT00191100|65140600|FG001|Overall Study|Patient Moved|1|||
23381757|NCT00191100|65140599|FG000|Overall Study|Withdrawal by Subject|9|||
23381758|NCT00191100|65140600|FG001|Overall Study|Withdrawal by Subject|3|||
23381759|NCT00191100|65140599|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
23381760|NCT00191100|65140600|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
23492411|NCT01973569|65548079|FG000|Overall Study|Adverse Event|9|||
23492412|NCT01973569|65548080|FG001|Overall Study|Adverse Event|2|||
23492413|NCT01973569|65548081|FG002|Overall Study|Adverse Event|4|||
23492414|NCT01973569|65548079|FG000|Overall Study|Protocol Violation|2|||
23492415|NCT01973569|65548080|FG001|Overall Study|Protocol Violation|1|||
23492416|NCT01973569|65548081|FG002|Overall Study|Protocol Violation|3|||
23492417|NCT01973569|65548079|FG000|Overall Study|Withdrawal by Subject|7|||
23492418|NCT01973569|65548080|FG001|Overall Study|Withdrawal by Subject|5|||
23492419|NCT01973569|65548081|FG002|Overall Study|Withdrawal by Subject|2|||
23492420|NCT01973569|65548079|FG000|Overall Study|Invasive dental treatment|3|||
23492421|NCT01973569|65548080|FG001|Overall Study|Invasive dental treatment|5|||
23492422|NCT01973569|65548081|FG002|Overall Study|Invasive dental treatment|6|||
23492423|NCT01973569|65548079|FG000|Overall Study|Prohibited concomitant d|1|||
23492424|NCT01973569|65548080|FG001|Overall Study|Prohibited concomitant d|5|||
23492425|NCT01973569|65548081|FG002|Overall Study|Prohibited concomitant d|0|||
23492426|NCT01973569|65548079|FG000|Overall Study|Disease progression|0|||
23492427|NCT01973569|65548080|FG001|Overall Study|Disease progression|3|||
23492428|NCT01973569|65548081|FG002|Overall Study|Disease progression|0|||
23492429|NCT01973569|65548079|FG000|Overall Study|Other|1|||
23492430|NCT01973569|65548080|FG001|Overall Study|Other|1|||
23492431|NCT01973569|65548081|FG002|Overall Study|Other|0|||
23492432|NCT01973569|65548079|FG000|Overall Study|Did not receive study drug|6|||
23492433|NCT01973569|65548080|FG001|Overall Study|Did not receive study drug|3|||
23492434|NCT01973569|65548081|FG002|Overall Study|Did not receive study drug|3|||
23492435|NCT01146912|65548082|FG000|Overall Study|Already received influenza vaccination|817|||
23492436|NCT01146912|65548083|FG001|Overall Study|Already received influenza vaccination|822|||
23492437|NCT01146912|65548084|FG002|Overall Study|Already received influenza vaccination|13|||
23492438|NCT01146912|65548085|FG003|Overall Study|Already received influenza vaccination|15|||
23492439|NCT01146912|65548086|FG004|Overall Study|Already received influenza vaccination|41|||
23492440|NCT01146912|65548087|FG005|Overall Study|Already received influenza vaccination|61|||
23492441|NCT01146912|65548088|FG006|Overall Study|Already received influenza vaccination|56|||
23492442|NCT01146912|65548089|FG007|Overall Study|Already received influenza vaccination|0|||
23492443|NCT01146912|65548082|FG000|Overall Study|< 14 weeks gestational age|0|||
23492444|NCT01146912|65548083|FG001|Overall Study|< 14 weeks gestational age|0|||
23492445|NCT01146912|65548084|FG002|Overall Study|< 14 weeks gestational age|3|||
23492446|NCT01146912|65548085|FG003|Overall Study|< 14 weeks gestational age|2|||
23492447|NCT01146912|65548086|FG004|Overall Study|< 14 weeks gestational age|0|||
23492448|NCT01146912|65548087|FG005|Overall Study|< 14 weeks gestational age|0|||
23289302|NCT04049097|64799059|FG000|Overall Study|Lost to Follow-up|1|||
23289303|NCT04049097|64799059|FG000|Overall Study|Physician Decision|2|||
23289304|NCT04049097|64799059|FG000|Overall Study|Withdrawal by Subject|9|||
23289305|NCT04049097|64799059|FG000|Overall Study|Protocol Violation|2|||
23289306|NCT04049097|64799059|FG000|Overall Study|Other|1|||
23289307|NCT04049097|64799059|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
23289308|NCT02161549|64799060|FG000|Overall Study|Physician Decision|6|||
23289309|NCT02161549|64799061|FG001|Overall Study|Physician Decision|2|||
23289310|NCT04010227|64799066|FG000|Overall Study|Death|1|||
23289311|NCT04010227|64799067|FG001|Overall Study|Death|2|||
23289312|NCT04010227|64799066|FG000|Overall Study|Medical Reasons|4|||
23289313|NCT04010227|64799067|FG001|Overall Study|Medical Reasons|3|||
23289314|NCT04010227|64799066|FG000|Overall Study|Withdrawal by Subject|2|||
23289315|NCT04010227|64799067|FG001|Overall Study|Withdrawal by Subject|0|||
23289316|NCT04010227|64799066|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
23289317|NCT04010227|64799067|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
23289318|NCT01435928|64799068|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
23492449|NCT01146912|65548088|FG006|Overall Study|< 14 weeks gestational age|0|||
23492450|NCT01146912|65548089|FG007|Overall Study|< 14 weeks gestational age|0|||
23492451|NCT01146912|65548082|FG000|Overall Study|Duplicate patient|0|||
23492452|NCT01146912|65548083|FG001|Overall Study|Duplicate patient|0|||
23492453|NCT01146912|65548084|FG002|Overall Study|Duplicate patient|1|||
23492454|NCT01146912|65548085|FG003|Overall Study|Duplicate patient|0|||
23492455|NCT01146912|65548086|FG004|Overall Study|Duplicate patient|0|||
23492456|NCT01146912|65548087|FG005|Overall Study|Duplicate patient|0|||
23492457|NCT01146912|65548088|FG006|Overall Study|Duplicate patient|0|||
23492458|NCT01146912|65548089|FG007|Overall Study|Duplicate patient|0|||
23492459|NCT00474760|65548093|FG000|Overall Study|Death|0|||
23492460|NCT00474760|65548094|FG001|Overall Study|Death|0|||
23492461|NCT00474760|65548095|FG002|Overall Study|Death|0|||
23492462|NCT00474760|65548096|FG003|Overall Study|Death|0|||
23381761|NCT00191100|65140599|FG000|Overall Study|Clinical Relapse|2|||
23492463|NCT00474760|65548097|FG004|Overall Study|Death|2|||
23492464|NCT00474760|65548098|FG005|Overall Study|Death|0|||
23492465|NCT00474760|65548099|FG006|Overall Study|Death|0|||
23492466|NCT00474760|65548093|FG000|Overall Study|Adverse Event|0|||
23289319|NCT01435928|64799069|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
23289320|NCT01435928|64799070|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
23289321|NCT01435928|64799068|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
23289322|NCT01435928|64799069|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
23289323|NCT01435928|64799070|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
23289324|NCT01435928|64799068|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
23289325|NCT01435928|64799069|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
23289326|NCT01435928|64799070|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
23289327|NCT01435928|64799068|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
23289328|NCT01435928|64799069|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
23289329|NCT01435928|64799070|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
23289330|NCT01435928|64799068|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
23289331|NCT01435928|64799069|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
23289332|NCT01435928|64799070|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
23289333|NCT01435928|64799068|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
23289334|NCT01435928|64799069|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
23289335|NCT01435928|64799070|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
23289336|NCT01435928|64799068|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
23289337|NCT01435928|64799069|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
23289338|NCT01435928|64799070|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
23289339|NCT01435928|64799068|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
23289340|NCT01435928|64799069|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
23381762|NCT00191100|65140600|FG001|Overall Study|Clinical Relapse|1|||
23381763|NCT00191100|65140599|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
23381764|NCT00191100|65140600|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
23381765|NCT00191100|65140599|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
23381766|NCT00191100|65140600|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
23381767|NCT00191100|65140599|FG000|Overall Study|Physician Decision|3|||
23381768|NCT00191100|65140600|FG001|Overall Study|Physician Decision|1|||
23381769|NCT00191100|65140599|FG000|Overall Study|Death from Study Drug Toxicity|2|||
23381770|NCT00191100|65140600|FG001|Overall Study|Death from Study Drug Toxicity|0|||
23381771|NCT00191100|65140599|FG000|Overall Study|Protocol Violation|1|||
23381772|NCT00191100|65140600|FG001|Overall Study|Protocol Violation|1|||
23381773|NCT00191100|65140599|FG000|Overall Study|Death from Other Cause|1|||
23381774|NCT00191100|65140600|FG001|Overall Study|Death from Other Cause|0|||
23381775|NCT00191100|65140599|FG000|Overall Study|Reason Not Specified|0|||
23381776|NCT00191100|65140600|FG001|Overall Study|Reason Not Specified|1|||
23289341|NCT01435928|64799070|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
23492467|NCT00474760|65548094|FG001|Overall Study|Adverse Event|0|||
23381777|NCT02497755|65140601|FG000|Overall Study|Protocol Violation|1|||
23381778|NCT02497755|65140602|FG001|Overall Study|Protocol Violation|0|||
23381779|NCT03607695|65140603|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
23381780|NCT03607695|65140603|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
23381781|NCT03723070|65140604|FG000|Overall Study|Lost to Follow-up|2|||
23381782|NCT03723070|65140604|FG000|Overall Study|Physician Decision|1|||
23381783|NCT03723070|65140604|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
23381784|NCT00296335|65140607|FG000|Overall Study|Recurrence|3|||
23381785|NCT00296335|65140608|FG001|Overall Study|Recurrence|51|||
23381786|NCT00296335|65140607|FG000|Overall Study|Adverse Event|17|||
23381787|NCT00296335|65140608|FG001|Overall Study|Adverse Event|27|||
23381788|NCT00296335|65140607|FG000|Overall Study|Lost to Follow-up|7|||
23381789|NCT00296335|65140608|FG001|Overall Study|Lost to Follow-up|33|||
23381790|NCT00296335|65140607|FG000|Overall Study|Physician Decision|3|||
23381791|NCT00296335|65140608|FG001|Overall Study|Physician Decision|11|||
23381792|NCT01671059|65140609|FG000|Overall Study|Adverse Event|4|||
23381793|NCT01671059|65140609|FG000|Overall Study|Lack of Efficacy|1|||
23381794|NCT03770455|65140610|FG000|Overall Study|Screen failures|3|||
23381795|NCT00498485|65140614|FG000|Overall Study|Adverse Event|1|||
23381796|NCT00498485|65140615|FG001|Overall Study|Adverse Event|5|||
23381797|NCT01174459|65140618|FG000|Overall Study|case report form (CRF) not collected|5|||
23381798|NCT00450749|65140619|FG000|Overall Study|Withdrawal by Subject|0|||
23381799|NCT00450749|65140620|FG001|Overall Study|Withdrawal by Subject|0|||
23381800|NCT00450749|65140621|FG002|Overall Study|Withdrawal by Subject|2|||
23381801|NCT00450749|65140619|FG000|Overall Study|Noncompliant|0|||
23381802|NCT00450749|65140620|FG001|Overall Study|Noncompliant|1|||
23381803|NCT00450749|65140621|FG002|Overall Study|Noncompliant|0|||
23381804|NCT01311661|65140625|FG000|Overall Study|Adverse Event|2|||
23381805|NCT01311661|65140625|FG000|Overall Study|Protocol Violation|3|||
23381806|NCT01311661|65140625|FG000|Overall Study|Withdrawal by Subject|2|||
23381807|NCT02336503|65140628|FG000|Overall Study|Lost to Follow-up|0|||
23381808|NCT02336503|65140629|FG001|Overall Study|Lost to Follow-up|3|||
23381809|NCT02336503|65140630|FG002|Overall Study|Lost to Follow-up|0|||
23381810|NCT02336503|65140631|FG003|Overall Study|Lost to Follow-up|2|||
23381811|NCT02336503|65140628|FG000|Overall Study|Withdrawal by Subject|2|||
23381812|NCT02336503|65140629|FG001|Overall Study|Withdrawal by Subject|0|||
23381813|NCT02336503|65140630|FG002|Overall Study|Withdrawal by Subject|0|||
23381814|NCT02336503|65140631|FG003|Overall Study|Withdrawal by Subject|4|||
23381815|NCT02336503|65140628|FG000|Overall Study|Adverse Event|0|||
23381816|NCT02336503|65140629|FG001|Overall Study|Adverse Event|0|||
23381817|NCT02336503|65140630|FG002|Overall Study|Adverse Event|1|||
23381818|NCT02336503|65140631|FG003|Overall Study|Adverse Event|0|||
23381819|NCT00433537|65140632|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
23381820|NCT00433537|65140633|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
23381821|NCT00433537|65140634|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
23381822|NCT00433537|65140632|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
23381823|NCT00433537|65140633|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
23381824|NCT00433537|65140634|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
23381825|NCT00433537|65140632|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
23381826|NCT00433537|65140633|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
23381827|NCT00433537|65140634|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
23381828|NCT00433537|65140632|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
23381829|NCT00433537|65140633|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
23381830|NCT00433537|65140634|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
23381831|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
23381832|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
23381833|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
23381834|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
23381835|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
23381836|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
23381837|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
23381838|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
23381839|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
23381840|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
23381841|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
23492468|NCT00474760|65548095|FG002|Overall Study|Adverse Event|0|||
23492469|NCT00474760|65548096|FG003|Overall Study|Adverse Event|0|||
23492470|NCT00474760|65548097|FG004|Overall Study|Adverse Event|1|||
23381842|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
23381843|NCT00433537|65140632|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
23381844|NCT00433537|65140633|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
23381845|NCT00433537|65140634|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
23381846|NCT01181128|65140635|FG000|Overall Study|Withdrawal by Subject|2|||
23381847|NCT01181128|65140636|FG001|Overall Study|Withdrawal by Subject|2|||
23381848|NCT01181128|65140637|FG002|Overall Study|Withdrawal by Subject|0|||
23381849|NCT01181128|65140635|FG000|Overall Study|Death|1|||
23381850|NCT01181128|65140636|FG001|Overall Study|Death|0|||
23381851|NCT01181128|65140637|FG002|Overall Study|Death|0|||
23381852|NCT01181128|65140635|FG000|Overall Study|Physician Decision|2|||
23381853|NCT01181128|65140636|FG001|Overall Study|Physician Decision|0|||
23381854|NCT01181128|65140637|FG002|Overall Study|Physician Decision|0|||
23381855|NCT01181128|65140635|FG000|Overall Study|Adverse Event|0|||
23381856|NCT01181128|65140636|FG001|Overall Study|Adverse Event|2|||
23381857|NCT01181128|65140637|FG002|Overall Study|Adverse Event|0|||
23381858|NCT01181128|65140635|FG000|Overall Study|Other|1|||
23381859|NCT01181128|65140636|FG001|Overall Study|Other|1|||
23381860|NCT01181128|65140637|FG002|Overall Study|Other|1|||
23381861|NCT01132755|65140642|FG000|Overall Study|Procedure not done due to medical reason|23|||
23381862|NCT01132755|65140642|FG000|Overall Study|Protocol Violation|15|||
23381863|NCT01132755|65140642|FG000|Overall Study|Withdrawal by Subject|4|||
23381864|NCT00368550|65140643|FG000|Overall Study|Adverse Event|7|||
23381865|NCT00368550|65140644|FG001|Overall Study|Adverse Event|4|||
23381866|NCT00368550|65140643|FG000|Overall Study|Lack of Efficacy|4|||
23381867|NCT00368550|65140644|FG001|Overall Study|Lack of Efficacy|9|||
23381868|NCT00368550|65140643|FG000|Overall Study|Withdrawal by Subject|17|||
23381869|NCT00368550|65140644|FG001|Overall Study|Withdrawal by Subject|10|||
23381870|NCT00827242|65144870|FG000|Overall Study|Withdrawal by Subject|2|||
23381871|NCT00827242|65144871|FG001|Overall Study|Withdrawal by Subject|4|||
23381872|NCT00827242|65144870|FG000|Overall Study|Protocol Violation|1|||
23381873|NCT00827242|65144871|FG001|Overall Study|Protocol Violation|3|||
23381874|NCT00827242|65144870|FG000|Overall Study|Lost to Follow-up|0|||
23381875|NCT00827242|65144871|FG001|Overall Study|Lost to Follow-up|3|||
23381876|NCT00827242|65144870|FG000|Overall Study|Adverse Event Excluding Death|2|||
23381877|NCT00827242|65144871|FG001|Overall Study|Adverse Event Excluding Death|1|||
23381878|NCT00827242|65144870|FG000|Overall Study|Entry Criteria Not Met|4|||
23381879|NCT00827242|65144871|FG001|Overall Study|Entry Criteria Not Met|1|||
23381880|NCT00827242|65144870|FG000|Overall Study|Physician Decision|2|||
23381881|NCT00827242|65144871|FG001|Overall Study|Physician Decision|0|||
23381882|NCT00827242|65144870|FG000|Overall Study|Death|1|||
23381883|NCT00827242|65144871|FG001|Overall Study|Death|0|||
23381884|NCT00827242|65144870|FG000|Overall Study|Lack of Efficacy|1|||
23381885|NCT00827242|65144871|FG001|Overall Study|Lack of Efficacy|0|||
23381886|NCT01696968|65144874|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
23381887|NCT01696968|65144875|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
23381888|NCT01696968|65144874|FG000|Overall Study|Died Before Randomization|3|||
23381889|NCT01696968|65144875|FG001|Overall Study|Died Before Randomization|8|||
23381890|NCT01696968|65144874|FG000|Overall Study|Died Before ASU (Control)|278|||
23381891|NCT01696968|65144875|FG001|Overall Study|Died Before ASU (Control)|0|||
23381892|NCT01696968|65144874|FG000|Overall Study|Refused ASU (Control)|920|||
23381893|NCT01696968|65144875|FG001|Overall Study|Refused ASU (Control)|0|||
23381894|NCT01696968|65144874|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
23381895|NCT01696968|65144875|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
23381896|NCT00356590|65144878|FG000|Overall Study|Adverse Event|54|||
23381897|NCT00356590|65144878|FG000|Overall Study|Death|10|||
23381898|NCT00356590|65144878|FG000|Overall Study|Lost to Follow-up|35|||
23381899|NCT00356590|65144878|FG000|Overall Study|Physician Decision|46|||
23381900|NCT00356590|65144878|FG000|Overall Study|Withdrawal by Subject|41|||
23381901|NCT00356590|65144878|FG000|Overall Study|Completed month 12 only|2|||
23381902|NCT00356590|65144878|FG000|Overall Study|Protocol issues|6|||
23381903|NCT00356590|65144878|FG000|Overall Study|Response status|28|||
23381904|NCT00356590|65144878|FG000|Overall Study|Other|52|||
23381905|NCT01370538|65144882|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
23381906|NCT01370538|65144883|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
23381907|NCT01370538|65144882|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23381908|NCT01370538|65144883|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
23381909|NCT01370538|65144882|FG000|Overall Study|Adverse Event|1|||
23381910|NCT01370538|65144883|FG001|Overall Study|Adverse Event|0|||
23381911|NCT01370538|65144882|FG000|Overall Study|Protocol Violation|8|||
23381912|NCT01370538|65144883|FG001|Overall Study|Protocol Violation|5|||
23381913|NCT01370538|65144882|FG000|Overall Study|Development of study specific withdrawal|1|||
23381914|NCT01370538|65144883|FG001|Overall Study|Development of study specific withdrawal|1|||
23381915|NCT01370538|65144882|FG000|Overall Study|Lost to follow up|6|||
23381916|NCT01370538|65144883|FG001|Overall Study|Lost to follow up|10|||
23381917|NCT04137887|65144884|FG000|Overall Study|Death|102|||
23381918|NCT04137887|65144885|FG001|Overall Study|Death|92|||
23381919|NCT04137887|65144884|FG000|Overall Study|Withdrawal by Subject|2|||
23381920|NCT04137887|65144885|FG001|Overall Study|Withdrawal by Subject|3|||
23381921|NCT04137887|65144884|FG000|Overall Study|Randomized but not treated|0|||
23381922|NCT04137887|65144885|FG001|Overall Study|Randomized but not treated|1|||
23381923|NCT00920816|65144888|FG000|Overall Study|Death|116|||
23381924|NCT00920816|65144889|FG001|Overall Study|Death|63|||
23381925|NCT00920816|65144890|FG002|Overall Study|Death|8|||
23381926|NCT00920816|65144891|FG003|Overall Study|Death|3|||
23381927|NCT00920816|65144888|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
23381928|NCT00920816|65144889|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
23381929|NCT00920816|65144890|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
23381930|NCT00920816|65144891|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
23381931|NCT00920816|65144888|FG000|Overall Study|Global deterioration of health status|2|||
23381932|NCT00920816|65144889|FG001|Overall Study|Global deterioration of health status|0|||
23381933|NCT00920816|65144890|FG002|Overall Study|Global deterioration of health status|0|||
23381934|NCT00920816|65144891|FG003|Overall Study|Global deterioration of health status|0|||
23381935|NCT00920816|65144888|FG000|Overall Study|Objective progression or relapse|6|||
23381936|NCT00920816|65144889|FG001|Overall Study|Objective progression or relapse|2|||
23381937|NCT00920816|65144890|FG002|Overall Study|Objective progression or relapse|0|||
23381938|NCT00920816|65144891|FG003|Overall Study|Objective progression or relapse|0|||
23381939|NCT00920816|65144888|FG000|Overall Study|Other|26|||
23381940|NCT00920816|65144889|FG001|Overall Study|Other|15|||
23381941|NCT00920816|65144890|FG002|Overall Study|Other|1|||
23381942|NCT00920816|65144891|FG003|Overall Study|Other|2|||
23381943|NCT00920816|65144888|FG000|Overall Study|Lost to Follow-up|11|||
23381944|NCT00920816|65144889|FG001|Overall Study|Lost to Follow-up|2|||
23381945|NCT00920816|65144890|FG002|Overall Study|Lost to Follow-up|0|||
23381946|NCT00920816|65144891|FG003|Overall Study|Lost to Follow-up|0|||
23381947|NCT00920816|65144888|FG000|Overall Study|Adverse Event|1|||
23381948|NCT00920816|65144889|FG001|Overall Study|Adverse Event|1|||
23381949|NCT00920816|65144890|FG002|Overall Study|Adverse Event|1|||
23381950|NCT00920816|65144891|FG003|Overall Study|Adverse Event|0|||
23381951|NCT00920816|65144888|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
23381952|NCT00920816|65144889|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
23381953|NCT00920816|65144890|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
23381954|NCT00920816|65144891|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
23381955|NCT00920816|65144888|FG000|Overall Study|Randomized but not treated|3|||
23381956|NCT00920816|65144889|FG001|Overall Study|Randomized but not treated|0|||
23381957|NCT00920816|65144890|FG002|Overall Study|Randomized but not treated|0|||
23381958|NCT00920816|65144891|FG003|Overall Study|Randomized but not treated|0|||
23381959|NCT02536794|65144892|FG000|Reached 1st Response Assessment|Adverse Event|2|||
23381960|NCT02536794|65144892|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
23381961|NCT02536794|65144892|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
23381962|NCT02536794|65144892|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
23381963|NCT02536794|65144892|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
23381964|NCT02536794|65144892|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
23381965|NCT00986232|65144893|FG000|Overall Study|Adverse Event|1|||
23381966|NCT00986232|65144894|FG001|Overall Study|Adverse Event|2|||
23381967|NCT00986232|65144895|FG002|Overall Study|Adverse Event|3|||
23381968|NCT00986232|65144896|FG003|Overall Study|Adverse Event|0|||
23381969|NCT00986232|65144893|FG000|Overall Study|Lost to Follow-up|19|||
23381970|NCT00986232|65144894|FG001|Overall Study|Lost to Follow-up|12|||
23381971|NCT00986232|65144895|FG002|Overall Study|Lost to Follow-up|12|||
23381972|NCT00986232|65144896|FG003|Overall Study|Lost to Follow-up|7|||
23381973|NCT00986232|65144893|FG000|Overall Study|Protocol Violation|2|||
23381974|NCT00986232|65144894|FG001|Overall Study|Protocol Violation|3|||
23381975|NCT00986232|65144895|FG002|Overall Study|Protocol Violation|0|||
23381976|NCT00986232|65144896|FG003|Overall Study|Protocol Violation|1|||
23381977|NCT00986232|65144893|FG000|Overall Study|Withdrawal by Subject|13|||
23381978|NCT00986232|65144894|FG001|Overall Study|Withdrawal by Subject|16|||
23381979|NCT00986232|65144895|FG002|Overall Study|Withdrawal by Subject|12|||
23381980|NCT00986232|65144896|FG003|Overall Study|Withdrawal by Subject|3|||
23381981|NCT00986232|65144893|FG000|Overall Study|Missed one or more bleeds|13|||
23381982|NCT00986232|65144894|FG001|Overall Study|Missed one or more bleeds|10|||
23381983|NCT00986232|65144895|FG002|Overall Study|Missed one or more bleeds|6|||
23381984|NCT00986232|65144896|FG003|Overall Study|Missed one or more bleeds|7|||
23381985|NCT00986232|65144893|FG000|Overall Study|Incomplete safety follow-up|3|||
23381986|NCT00986232|65144894|FG001|Overall Study|Incomplete safety follow-up|7|||
23381987|NCT00986232|65144895|FG002|Overall Study|Incomplete safety follow-up|2|||
23381988|NCT00986232|65144896|FG003|Overall Study|Incomplete safety follow-up|2|||
23381989|NCT02606253|65144897|FG000|Overall Study|Adverse Event|2|||
23381990|NCT02606253|65144898|FG001|Overall Study|Adverse Event|0|||
23381991|NCT02606253|65144899|FG002|Overall Study|Adverse Event|0|||
23381992|NCT02606253|65144897|FG000|Overall Study|Protocol Violation|2|||
23381993|NCT02606253|65144898|FG001|Overall Study|Protocol Violation|1|||
23381994|NCT02606253|65144899|FG002|Overall Study|Protocol Violation|0|||
23381995|NCT02606253|65144897|FG000|Overall Study|Physician Decision|1|||
23381996|NCT02606253|65144898|FG001|Overall Study|Physician Decision|1|||
23381997|NCT02606253|65144899|FG002|Overall Study|Physician Decision|0|||
23289342|NCT01435928|64799068|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
23289343|NCT01435928|64799069|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
23289344|NCT01435928|64799070|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
23289345|NCT01435928|64799068|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
23289346|NCT01435928|64799069|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
23289347|NCT01435928|64799070|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
23289348|NCT01435928|64799068|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
23289349|NCT01435928|64799069|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
23289350|NCT01435928|64799070|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
23289351|NCT01435928|64799068|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
23289352|NCT01435928|64799069|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
23289353|NCT01435928|64799070|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
23289354|NCT01435928|64799068|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
23289355|NCT01435928|64799069|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
23289356|NCT01435928|64799070|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
23289357|NCT01435928|64799068|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
23289358|NCT01435928|64799069|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
23289359|NCT01435928|64799070|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
23289360|NCT01435928|64799068|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
23289361|NCT01435928|64799069|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
23289362|NCT01435928|64799070|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
23289363|NCT01435928|64799068|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
23289364|NCT01435928|64799069|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
23289365|NCT01435928|64799070|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
23289366|NCT02107196|64799087|FG000|12-week Treatment Period|Adverse Event|6|||
23289367|NCT02107196|64799088|FG001|12-week Treatment Period|Adverse Event|3|||
23289368|NCT02107196|64799087|FG000|12-week Treatment Period|Lack of Efficacy|2|||
23289369|NCT02107196|64799088|FG001|12-week Treatment Period|Lack of Efficacy|1|||
23289370|NCT02107196|64799087|FG000|12-week Treatment Period|Lost to Follow-up|3|||
23289371|NCT02107196|64799088|FG001|12-week Treatment Period|Lost to Follow-up|6|||
23289372|NCT02107196|64799087|FG000|12-week Treatment Period|Physician Decision|0|||
23381998|NCT01859741|65144907|FG000|Overall Study|Death|3|||
23381999|NCT01859741|65144908|FG001|Overall Study|Death|2|||
23382000|NCT01859741|65144909|FG002|Overall Study|Death|4|||
23492471|NCT00474760|65548098|FG005|Overall Study|Adverse Event|7|||
23382001|NCT01859741|65144910|FG003|Overall Study|Death|3|||
23382002|NCT01859741|65144911|FG004|Overall Study|Death|5|||
23382003|NCT01859741|65144912|FG005|Overall Study|Death|4|||
23382004|NCT01859741|65144913|FG006|Overall Study|Death|51|||
23382005|NCT01859741|65144914|FG007|Overall Study|Death|51|||
23382006|NCT01859741|65144907|FG000|Overall Study|Lost to Follow-up|0|||
23382007|NCT01859741|65144908|FG001|Overall Study|Lost to Follow-up|0|||
23382008|NCT01859741|65144909|FG002|Overall Study|Lost to Follow-up|0|||
23382009|NCT01859741|65144910|FG003|Overall Study|Lost to Follow-up|0|||
23382010|NCT01859741|65144911|FG004|Overall Study|Lost to Follow-up|0|||
23382011|NCT01859741|65144912|FG005|Overall Study|Lost to Follow-up|1|||
23382012|NCT01859741|65144913|FG006|Overall Study|Lost to Follow-up|0|||
23382013|NCT01859741|65144914|FG007|Overall Study|Lost to Follow-up|4|||
23382014|NCT01859741|65144907|FG000|Overall Study|Withdrawal by Subject|0|||
23382015|NCT01859741|65144908|FG001|Overall Study|Withdrawal by Subject|1|||
23382016|NCT01859741|65144909|FG002|Overall Study|Withdrawal by Subject|2|||
23382017|NCT01859741|65144910|FG003|Overall Study|Withdrawal by Subject|0|||
23382018|NCT01859741|65144911|FG004|Overall Study|Withdrawal by Subject|0|||
23382019|NCT01859741|65144912|FG005|Overall Study|Withdrawal by Subject|1|||
23382020|NCT01859741|65144913|FG006|Overall Study|Withdrawal by Subject|1|||
23382021|NCT01859741|65144914|FG007|Overall Study|Withdrawal by Subject|1|||
23382022|NCT01859741|65144907|FG000|Overall Study|Study Terminated by Sponsor|0|||
23382023|NCT01859741|65144908|FG001|Overall Study|Study Terminated by Sponsor|0|||
23382024|NCT01859741|65144909|FG002|Overall Study|Study Terminated by Sponsor|0|||
23382025|NCT01859741|65144910|FG003|Overall Study|Study Terminated by Sponsor|0|||
23382026|NCT01859741|65144911|FG004|Overall Study|Study Terminated by Sponsor|1|||
23382027|NCT01859741|65144912|FG005|Overall Study|Study Terminated by Sponsor|0|||
23492472|NCT00474760|65548099|FG006|Overall Study|Adverse Event|0|||
23289373|NCT02107196|64799088|FG001|12-week Treatment Period|Physician Decision|1|||
23289374|NCT02107196|64799087|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
23289375|NCT02107196|64799088|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
23289376|NCT02107196|64799087|FG000|12-week Treatment Period|Protocol Violation|7|||
23289377|NCT02107196|64799088|FG001|12-week Treatment Period|Protocol Violation|8|||
23289378|NCT02107196|64799087|FG000|12-week Treatment Period|Reason Missing|11|||
23289379|NCT02107196|64799088|FG001|12-week Treatment Period|Reason Missing|8|||
23289380|NCT02107196|64799087|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
23289381|NCT02107196|64799088|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
23289382|NCT02107196|64799087|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
23289383|NCT02107196|64799088|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
23289384|NCT02107196|64799087|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
23289385|NCT02107196|64799088|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
23289386|NCT02107196|64799087|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
23289387|NCT02107196|64799088|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
23289388|NCT00379353|64799089|FG000|Overall Study|Hospitalization|3|||
23289389|NCT00379353|64799090|FG001|Overall Study|Hospitalization|3|||
23289390|NCT00379353|64799089|FG000|Overall Study|Withdrawal by Subject|5|||
23289391|NCT00379353|64799090|FG001|Overall Study|Withdrawal by Subject|2|||
23382028|NCT01859741|65144913|FG006|Overall Study|Study Terminated by Sponsor|16|||
23289392|NCT00379353|64799089|FG000|Overall Study|Death|1|||
23382029|NCT01859741|65144914|FG007|Overall Study|Study Terminated by Sponsor|14|||
23492473|NCT00474760|65548093|FG000|Overall Study|Laboratory abnormality|0|||
23382030|NCT01859741|65144907|FG000|Overall Study|Other|0|||
23382031|NCT01859741|65144908|FG001|Overall Study|Other|0|||
23382032|NCT01859741|65144909|FG002|Overall Study|Other|0|||
23382033|NCT01859741|65144910|FG003|Overall Study|Other|0|||
23382034|NCT01859741|65144911|FG004|Overall Study|Other|0|||
23382035|NCT01859741|65144912|FG005|Overall Study|Other|0|||
23382036|NCT01859741|65144913|FG006|Overall Study|Other|2|||
23382037|NCT01859741|65144914|FG007|Overall Study|Other|0|||
23289393|NCT00379353|64799090|FG001|Overall Study|Death|0|||
23289394|NCT00379353|64799089|FG000|Overall Study|Cardiac Tamponade|1|||
23289395|NCT00379353|64799090|FG001|Overall Study|Cardiac Tamponade|0|||
23289396|NCT00379353|64799089|FG000|Overall Study|Non-compliance|1|||
23289397|NCT00379353|64799090|FG001|Overall Study|Non-compliance|0|||
23289398|NCT00379353|64799089|FG000|Overall Study|Conflicting drug treatment|0|||
23289399|NCT00379353|64799090|FG001|Overall Study|Conflicting drug treatment|1|||
23289400|NCT00721955|64799091|FG000|Overall Study|Adverse Event|0|||
23289401|NCT00721955|64799092|FG001|Overall Study|Adverse Event|0|||
23289402|NCT00721955|64799093|FG002|Overall Study|Adverse Event|2|||
23289403|NCT02845336|64799094|FG000|Overall Study|Lost to Follow-up|3|||
23289404|NCT02845336|64799095|FG001|Overall Study|Lost to Follow-up|1|||
23289405|NCT02845336|64799094|FG000|Overall Study|Inability to get medication|2|||
23289406|NCT02845336|64799095|FG001|Overall Study|Inability to get medication|0|||
23289407|NCT01710358|64799096|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
23289408|NCT01710358|64799097|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
23289409|NCT01710358|64799098|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
23289410|NCT01710358|64799096|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
23289411|NCT01710358|64799097|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
23289412|NCT01710358|64799098|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
23289413|NCT01710358|64799096|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
23289414|NCT01710358|64799097|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
23289415|NCT01710358|64799098|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
23289416|NCT01710358|64799096|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
23289417|NCT01710358|64799097|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
23289418|NCT01710358|64799098|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
23289419|NCT01710358|64799096|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
23289420|NCT01710358|64799097|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
23289421|NCT01710358|64799098|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
23289422|NCT01710358|64799096|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
23289423|NCT01710358|64799097|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
23289424|NCT01710358|64799098|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
23289425|NCT01710358|64799096|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
23289426|NCT01710358|64799097|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
23289427|NCT01710358|64799098|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
23289428|NCT01710358|64799096|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
23289429|NCT01710358|64799097|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
23289430|NCT01710358|64799098|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
23289431|NCT01710358|64799096|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
23289432|NCT01710358|64799097|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
23289433|NCT01710358|64799098|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
23289434|NCT01710358|64799096|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
23289435|NCT01710358|64799097|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
23289436|NCT01710358|64799098|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
23289437|NCT01710358|64799096|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
23289438|NCT01710358|64799097|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
23289439|NCT01710358|64799098|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
23289440|NCT01710358|64799096|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
23289441|NCT01710358|64799097|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
23289442|NCT01710358|64799098|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
23289443|NCT01710358|64799096|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
23289444|NCT01710358|64799097|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
23289445|NCT01710358|64799098|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
23289446|NCT01710358|64799096|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
23289447|NCT01710358|64799097|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
23289448|NCT01710358|64799098|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
23289449|NCT01710358|64799096|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
23289450|NCT01710358|64799097|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
23382038|NCT03422718|65144919|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
23382039|NCT03422718|65144920|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
23382040|NCT03422718|65144921|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
23289451|NCT01710358|64799098|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
23289452|NCT01710358|64799096|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
23289453|NCT01710358|64799097|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
23289454|NCT01710358|64799098|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
23289455|NCT01710358|64799096|FG000|Rescue Period|Adverse Event|0|||
23289456|NCT01710358|64799097|FG001|Rescue Period|Adverse Event|15|||
23289457|NCT01710358|64799098|FG002|Rescue Period|Adverse Event|0|||
23289458|NCT01710358|64799096|FG000|Rescue Period|Death|0|||
23289459|NCT01710358|64799097|FG001|Rescue Period|Death|1|||
23289460|NCT01710358|64799098|FG002|Rescue Period|Death|0|||
23289461|NCT01710358|64799096|FG000|Rescue Period|Lack of Efficacy|0|||
23289462|NCT01710358|64799097|FG001|Rescue Period|Lack of Efficacy|7|||
23289463|NCT01710358|64799098|FG002|Rescue Period|Lack of Efficacy|0|||
23289464|NCT01710358|64799096|FG000|Rescue Period|Withdrawal by Subject|0|||
23289465|NCT01710358|64799097|FG001|Rescue Period|Withdrawal by Subject|8|||
23289466|NCT01710358|64799098|FG002|Rescue Period|Withdrawal by Subject|0|||
23289467|NCT00469898|64799101|FG000|Overall Study|Adverse Event|7|||
23289468|NCT00469898|64799101|FG000|Overall Study|Withdrawal by Subject|4|||
23289469|NCT00469898|64799101|FG000|Overall Study|Death|4|||
23289470|NCT00469898|64799101|FG000|Overall Study|Disease progression|9|||
23289471|NCT00469898|64799101|FG000|Overall Study|Decreased performance status|1|||
23289472|NCT02151149|64799102|FG000|Treatment Period|Death|2|||
23289473|NCT02151149|64799103|FG001|Treatment Period|Death|3|||
23289474|NCT02151149|64799102|FG000|Treatment Period|Adverse Event|17|||
23289475|NCT02151149|64799103|FG001|Treatment Period|Adverse Event|14|||
23289476|NCT02151149|64799102|FG000|Treatment Period|Progressive Disease|25|||
23289477|NCT02151149|64799103|FG001|Treatment Period|Progressive Disease|24|||
23289478|NCT02151149|64799102|FG000|Treatment Period|Symptomatic Deterioration|2|||
23289479|NCT02151149|64799103|FG001|Treatment Period|Symptomatic Deterioration|10|||
23289480|NCT02151149|64799102|FG000|Treatment Period|Withdrawal by Subject|13|||
23289481|NCT02151149|64799103|FG001|Treatment Period|Withdrawal by Subject|11|||
23289482|NCT02151149|64799102|FG000|Treatment Period|Miscellaneous|8|||
23289483|NCT02151149|64799103|FG001|Treatment Period|Miscellaneous|7|||
23289484|NCT02151149|64799102|FG000|Treatment Period|Participants randomized but not treated|3|||
23289485|NCT02151149|64799103|FG001|Treatment Period|Participants randomized but not treated|2|||
23289486|NCT02151149|64799102|FG000|Follow-Up Period|Lost to Follow-up|2|||
23289487|NCT02151149|64799103|FG001|Follow-Up Period|Lost to Follow-up|3|||
23289488|NCT02151149|64799102|FG000|Follow-Up Period|Death|37|||
23289489|NCT02151149|64799103|FG001|Follow-Up Period|Death|34|||
23289490|NCT01041495|64799106|FG000|Overall Study|Withdrawal by Subject|2|||
23289491|NCT01041495|64799107|FG001|Overall Study|Withdrawal by Subject|5|||
23289492|NCT01041495|64799106|FG000|Overall Study|Adverse Event|2|||
23289493|NCT01041495|64799107|FG001|Overall Study|Adverse Event|1|||
23289494|NCT01041495|64799106|FG000|Overall Study|Lost to Follow-up|0|||
23289495|NCT01041495|64799107|FG001|Overall Study|Lost to Follow-up|1|||
23289496|NCT00725764|64799108|FG000|Overall Study|Withdrawal by Subject|2|||
23289497|NCT00725764|64799108|FG000|Overall Study|Physician Decision|1|||
23289498|NCT00725764|64799108|FG000|Overall Study|Progressive Disease|7|||
23289499|NCT00725764|64799108|FG000|Overall Study|Lost to Follow-up|1|||
23289500|NCT00725764|64799108|FG000|Overall Study|Death|1|||
23289501|NCT00725764|64799108|FG000|Overall Study|Participant non compliant with protocol|1|||
23289502|NCT00725764|64799108|FG000|Overall Study|Decline in performance status|1|||
23289503|NCT00274625|64799109|FG000|Overall Study|Lost to Follow-up|46|||
23289504|NCT00274625|64799110|FG001|Overall Study|Lost to Follow-up|54|||
23289505|NCT00274625|64799109|FG000|Overall Study|Excluded from analysis|14|||
23289506|NCT00274625|64799110|FG001|Overall Study|Excluded from analysis|8|||
23289507|NCT02616380|64799111|FG000|Overall Study|Lost to Follow-up|1|||
23289508|NCT02616380|64799111|FG000|Overall Study|Other|2|||
23289509|NCT02328040|64799114|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
23289510|NCT02328040|64799115|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
23289511|NCT01945580|64799116|FG000|Overall Study|Withdrawal by Subject|13|||
23289512|NCT01945580|64799117|FG001|Overall Study|Withdrawal by Subject|35|||
23289513|NCT01945580|64799116|FG000|Overall Study|Physician Decision|3|||
23289514|NCT01945580|64799117|FG001|Overall Study|Physician Decision|2|||
23289515|NCT01945580|64799116|FG000|Overall Study|Lost to Follow-up|26|||
23289516|NCT01945580|64799117|FG001|Overall Study|Lost to Follow-up|39|||
23382041|NCT03422718|65144922|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
23382042|NCT03422718|65144923|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
23382043|NCT03422718|65144924|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
23382044|NCT03422718|65144925|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
23382045|NCT03422718|65144926|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
23382046|NCT03422718|65144919|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
23382047|NCT03422718|65144920|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
23382048|NCT03422718|65144921|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
23382049|NCT03422718|65144922|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
23382050|NCT03422718|65144923|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
23382051|NCT03422718|65144924|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
23382052|NCT03422718|65144925|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
23382053|NCT03422718|65144926|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
23382054|NCT03422718|65144919|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
23382055|NCT03422718|65144920|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
23382056|NCT03422718|65144921|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
23382057|NCT03422718|65144922|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
23382058|NCT03422718|65144923|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
23382059|NCT03422718|65144924|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
23382060|NCT03422718|65144925|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
23382061|NCT03422718|65144926|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
23382062|NCT03422718|65144919|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382063|NCT03422718|65144920|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
23382064|NCT03422718|65144921|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382065|NCT03422718|65144922|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382066|NCT03422718|65144923|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
23382067|NCT03422718|65144924|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
23382068|NCT03422718|65144925|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382069|NCT03422718|65144926|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
23382070|NCT03422718|65144919|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
23382071|NCT03422718|65144920|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
23382072|NCT03422718|65144921|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
23382073|NCT03422718|65144922|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
23289517|NCT01945580|64799116|FG000|Overall Study|Death|7|||
23289518|NCT01945580|64799117|FG001|Overall Study|Death|2|||
23289519|NCT01945580|64799116|FG000|Overall Study|Patient moved out of state|0|||
23289520|NCT01945580|64799117|FG001|Overall Study|Patient moved out of state|1|||
23289521|NCT01945580|64799116|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
23289522|NCT01945580|64799117|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
23289523|NCT01945580|64799116|FG000|Overall Study|Family illness - unable to return|0|||
23289524|NCT01945580|64799117|FG001|Overall Study|Family illness - unable to return|1|||
23289525|NCT01945580|64799116|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
23289526|NCT01945580|64799117|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
23289527|NCT01945580|64799116|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
23289528|NCT01945580|64799117|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
23289529|NCT01945580|64799116|FG000|Overall Study|Noncompliance with 36 month visit|1|||
23289530|NCT01945580|64799117|FG001|Overall Study|Noncompliance with 36 month visit|0|||
23289531|NCT01945580|64799116|FG000|Overall Study|The patient moved.|1|||
23289532|NCT01945580|64799117|FG001|Overall Study|The patient moved.|0|||
23289533|NCT01945580|64799116|FG000|Overall Study|No data available|0|||
23289534|NCT01945580|64799117|FG001|Overall Study|No data available|2|||
23289535|NCT02587143|64799118|FG000|Overall Study|Adverse Event|1|||
23492474|NCT00474760|65548094|FG001|Overall Study|Laboratory abnormality|0|||
23492475|NCT00474760|65548095|FG002|Overall Study|Laboratory abnormality|0|||
23492476|NCT00474760|65548096|FG003|Overall Study|Laboratory abnormality|0|||
23492477|NCT00474760|65548097|FG004|Overall Study|Laboratory abnormality|0|||
23492478|NCT00474760|65548098|FG005|Overall Study|Laboratory abnormality|1|||
23492479|NCT00474760|65548099|FG006|Overall Study|Laboratory abnormality|0|||
23492480|NCT00474760|65548093|FG000|Overall Study|Withdrawal by Subject|0|||
23492481|NCT00474760|65548094|FG001|Overall Study|Withdrawal by Subject|0|||
23492482|NCT00474760|65548095|FG002|Overall Study|Withdrawal by Subject|0|||
23492483|NCT00474760|65548096|FG003|Overall Study|Withdrawal by Subject|1|||
23492484|NCT00474760|65548097|FG004|Overall Study|Withdrawal by Subject|0|||
23492485|NCT00474760|65548098|FG005|Overall Study|Withdrawal by Subject|1|||
23492486|NCT00474760|65548099|FG006|Overall Study|Withdrawal by Subject|1|||
23492487|NCT00474760|65548093|FG000|Overall Study|Other|0|||
23492488|NCT00474760|65548094|FG001|Overall Study|Other|1|||
23492489|NCT00474760|65548095|FG002|Overall Study|Other|0|||
23492490|NCT00474760|65548096|FG003|Overall Study|Other|0|||
23492491|NCT00474760|65548097|FG004|Overall Study|Other|1|||
23492492|NCT00474760|65548098|FG005|Overall Study|Other|0|||
23492493|NCT00474760|65548099|FG006|Overall Study|Other|0|||
23492494|NCT00474760|65548093|FG000|Overall Study|Progressive disease|3|||
23492495|NCT00474760|65548094|FG001|Overall Study|Progressive disease|2|||
23492496|NCT00474760|65548095|FG002|Overall Study|Progressive disease|3|||
23492497|NCT00474760|65548096|FG003|Overall Study|Progressive disease|2|||
23492498|NCT00474760|65548097|FG004|Overall Study|Progressive disease|8|||
23492499|NCT00474760|65548098|FG005|Overall Study|Progressive disease|20|||
23492500|NCT00474760|65548099|FG006|Overall Study|Progressive disease|7|||
23492501|NCT00474760|65548093|FG000|Overall Study|Terminated by sponsor|0|||
23492502|NCT00474760|65548094|FG001|Overall Study|Terminated by sponsor|0|||
23492503|NCT00474760|65548095|FG002|Overall Study|Terminated by sponsor|0|||
23492504|NCT00474760|65548096|FG003|Overall Study|Terminated by sponsor|0|||
23492505|NCT00474760|65548097|FG004|Overall Study|Terminated by sponsor|0|||
23492506|NCT00474760|65548098|FG005|Overall Study|Terminated by sponsor|0|||
23492507|NCT00474760|65548099|FG006|Overall Study|Terminated by sponsor|2|||
23492508|NCT00354614|65548102|FG000|Overall Study|Lack of Efficacy|28|||
23492509|NCT03343067|65548103|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
23492510|NCT03343067|65548104|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
23492511|NCT03343067|65548105|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
23492512|NCT04223973|65548111|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
23492513|NCT04223973|65548112|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
23492514|NCT04223973|65548111|FG000|Overall Study|Adverse Event|4|||
23492515|NCT04223973|65548112|FG001|Overall Study|Adverse Event|0|||
23492516|NCT04223973|65548111|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
23492517|NCT04223973|65548112|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
23492518|NCT04223973|65548111|FG000|Overall Study|Physician Decision|1|||
23492519|NCT04223973|65548112|FG001|Overall Study|Physician Decision|1|||
23492520|NCT04223973|65548111|FG000|Overall Study|Withdrawal by Subject|0|||
23492521|NCT04223973|65548112|FG001|Overall Study|Withdrawal by Subject|1|||
23492522|NCT03576495|65548116|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
23492523|NCT03576495|65548117|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
23492524|NCT01772160|65548126|FG000|Overall Study|Death|3|||
23492525|NCT01772160|65548126|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
23492526|NCT01772160|65548126|FG000|Overall Study|Consent withdrawal|3|||
23492527|NCT01772160|65548126|FG000|Overall Study|Migrated / moved from the study area|4|||
23492528|NCT01772160|65548126|FG000|Overall Study|Lost to Follow-up|30|||
23492529|NCT01772160|65548126|FG000|Overall Study|Other|5|||
23492530|NCT03848065|65548128|FG000|Overall Study|Death|0|||
23492531|NCT03848065|65548129|FG001|Overall Study|Death|1|||
23492532|NCT03848065|65548130|FG002|Overall Study|Death|0|||
23492533|NCT03848065|65548128|FG000|Overall Study|Lost to Follow-up|0|||
23492534|NCT03848065|65548129|FG001|Overall Study|Lost to Follow-up|0|||
23492535|NCT03848065|65548130|FG002|Overall Study|Lost to Follow-up|1|||
23492536|NCT03848065|65548128|FG000|Overall Study|Physician Decision|0|||
23492537|NCT03848065|65548129|FG001|Overall Study|Physician Decision|0|||
23492538|NCT03848065|65548130|FG002|Overall Study|Physician Decision|1|||
23492539|NCT02122458|65548131|FG000|Overall Study|Withdrawal by Subject|0|||
23492540|NCT02122458|65548132|FG001|Overall Study|Withdrawal by Subject|0|||
23492541|NCT02122458|65548133|FG002|Overall Study|Withdrawal by Subject|0|||
23492542|NCT02122458|65548134|FG003|Overall Study|Withdrawal by Subject|4|||
23492543|NCT02122458|65548135|FG004|Overall Study|Withdrawal by Subject|4|||
23492544|NCT02122458|65548136|FG005|Overall Study|Withdrawal by Subject|4|||
23492545|NCT02122458|65548137|FG006|Overall Study|Withdrawal by Subject|0|||
23492546|NCT02122458|65548131|FG000|Overall Study|Lost to Follow-up|1|||
23492547|NCT02122458|65548132|FG001|Overall Study|Lost to Follow-up|3|||
23492548|NCT02122458|65548133|FG002|Overall Study|Lost to Follow-up|0|||
23492549|NCT02122458|65548134|FG003|Overall Study|Lost to Follow-up|7|||
23492550|NCT02122458|65548135|FG004|Overall Study|Lost to Follow-up|5|||
23492551|NCT02122458|65548136|FG005|Overall Study|Lost to Follow-up|15|||
23492552|NCT02122458|65548137|FG006|Overall Study|Lost to Follow-up|1|||
23492553|NCT02122458|65548131|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
23492554|NCT02122458|65548132|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492555|NCT02122458|65548133|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492556|NCT02122458|65548134|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492557|NCT02122458|65548135|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492558|NCT02122458|65548136|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492559|NCT02122458|65548137|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
23492560|NCT02122458|65548131|FG000|Overall Study|Adverse Event|1|||
23492561|NCT02122458|65548132|FG001|Overall Study|Adverse Event|0|||
23492562|NCT02122458|65548133|FG002|Overall Study|Adverse Event|0|||
23492563|NCT02122458|65548134|FG003|Overall Study|Adverse Event|0|||
23492564|NCT02122458|65548135|FG004|Overall Study|Adverse Event|0|||
23492565|NCT02122458|65548136|FG005|Overall Study|Adverse Event|0|||
23492566|NCT02122458|65548137|FG006|Overall Study|Adverse Event|0|||
23492567|NCT02122458|65548131|FG000|Overall Study|Experimental Error|0|||
23492568|NCT02122458|65548132|FG001|Overall Study|Experimental Error|0|||
23492569|NCT02122458|65548133|FG002|Overall Study|Experimental Error|0|||
23492570|NCT02122458|65548134|FG003|Overall Study|Experimental Error|0|||
23492571|NCT02122458|65548135|FG004|Overall Study|Experimental Error|3|||
23492572|NCT02122458|65548136|FG005|Overall Study|Experimental Error|0|||
23492573|NCT02122458|65548137|FG006|Overall Study|Experimental Error|0|||
23492574|NCT02122458|65548131|FG000|Overall Study|Deployed or Moved|0|||
23492575|NCT02122458|65548132|FG001|Overall Study|Deployed or Moved|0|||
23492576|NCT02122458|65548133|FG002|Overall Study|Deployed or Moved|0|||
23492577|NCT02122458|65548134|FG003|Overall Study|Deployed or Moved|0|||
23492578|NCT02122458|65548135|FG004|Overall Study|Deployed or Moved|1|||
23492579|NCT02122458|65548136|FG005|Overall Study|Deployed or Moved|0|||
23492580|NCT02122458|65548137|FG006|Overall Study|Deployed or Moved|0|||
23492581|NCT02122458|65548131|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
23492582|NCT02122458|65548132|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
23492583|NCT02122458|65548133|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
23492584|NCT02122458|65548134|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
23492585|NCT02122458|65548135|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
23492586|NCT02122458|65548136|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
23492587|NCT02122458|65548137|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
23492588|NCT02122458|65548131|FG000|Overall Study|Noncompliance|0|||
23492589|NCT02122458|65548132|FG001|Overall Study|Noncompliance|1|||
23492590|NCT02122458|65548133|FG002|Overall Study|Noncompliance|0|||
23492591|NCT02122458|65548134|FG003|Overall Study|Noncompliance|0|||
23492592|NCT02122458|65548135|FG004|Overall Study|Noncompliance|0|||
23492593|NCT02122458|65548136|FG005|Overall Study|Noncompliance|0|||
23492594|NCT02122458|65548137|FG006|Overall Study|Noncompliance|0|||
23492595|NCT00304239|65548138|FG000|Overall Study|Protocol Deviations/Violations|15|||
23492596|NCT00304239|65548139|FG001|Overall Study|Protocol Deviations/Violations|0|||
23492597|NCT00304239|65548138|FG000|Overall Study|Adverse Event|2|||
23492598|NCT00304239|65548139|FG001|Overall Study|Adverse Event|0|||
23492599|NCT00191906|65548140|FG000|Study Period II|Adverse Event|0|||
23492600|NCT00191906|65548141|FG001|Study Period II|Adverse Event|1|||
23492601|NCT00191906|65548142|FG002|Study Period II|Adverse Event|0|||
23492602|NCT00191906|65548143|FG003|Study Period II|Adverse Event|0|||
23492603|NCT00191906|65548140|FG000|Study Period II|Withdrawal by Subject|0|||
23492604|NCT00191906|65548141|FG001|Study Period II|Withdrawal by Subject|3|||
23492605|NCT00191906|65548142|FG002|Study Period II|Withdrawal by Subject|0|||
23492606|NCT00191906|65548143|FG003|Study Period II|Withdrawal by Subject|0|||
23492607|NCT00191906|65548140|FG000|Study Period II|Parent/Caregiver Decision|0|||
23492608|NCT00191906|65548141|FG001|Study Period II|Parent/Caregiver Decision|1|||
23492609|NCT00191906|65548142|FG002|Study Period II|Parent/Caregiver Decision|0|||
23492610|NCT00191906|65548143|FG003|Study Period II|Parent/Caregiver Decision|0|||
23492611|NCT00191906|65548140|FG000|Study Period II|Entry Criteria Exclusion|0|||
23492612|NCT00191906|65548141|FG001|Study Period II|Entry Criteria Exclusion|0|||
23492613|NCT00191906|65548142|FG002|Study Period II|Entry Criteria Exclusion|1|||
23492614|NCT00191906|65548143|FG003|Study Period II|Entry Criteria Exclusion|0|||
23492615|NCT00191906|65548140|FG000|Study Period III|Adverse Event|1|||
23492616|NCT00191906|65548141|FG001|Study Period III|Adverse Event|0|||
23492617|NCT00191906|65548142|FG002|Study Period III|Adverse Event|0|||
23492618|NCT00191906|65548143|FG003|Study Period III|Adverse Event|0|||
23492619|NCT00191906|65548140|FG000|Study Period III|Lost to Follow-up|0|||
23492620|NCT00191906|65548141|FG001|Study Period III|Lost to Follow-up|1|||
23492621|NCT00191906|65548142|FG002|Study Period III|Lost to Follow-up|0|||
23492622|NCT00191906|65548143|FG003|Study Period III|Lost to Follow-up|0|||
23492623|NCT00191906|65548140|FG000|Study Period III|Parent/Caregiver Decision|1|||
23492624|NCT00191906|65548141|FG001|Study Period III|Parent/Caregiver Decision|0|||
23492625|NCT00191906|65548142|FG002|Study Period III|Parent/Caregiver Decision|0|||
23492626|NCT00191906|65548143|FG003|Study Period III|Parent/Caregiver Decision|0|||
23492627|NCT00191906|65548140|FG000|Study Period III|Lack of Efficacy|3|||
23492628|NCT00191906|65548141|FG001|Study Period III|Lack of Efficacy|3|||
23492629|NCT00191906|65548142|FG002|Study Period III|Lack of Efficacy|0|||
23492630|NCT00191906|65548143|FG003|Study Period III|Lack of Efficacy|0|||
23492631|NCT00810108|65548144|FG000|Overall Study|Withdrawal by Subject|1|||
23492632|NCT00810108|65548145|FG001|Overall Study|Withdrawal by Subject|0|||
23492633|NCT01160211|65548146|FG000|Overall Study|ongoing|90|||
23492634|NCT01160211|65548147|FG001|Overall Study|ongoing|75|||
23492635|NCT01160211|65548148|FG002|Overall Study|ongoing|79|||
23492636|NCT01160211|65548146|FG000|Overall Study|Withdrawal by Subject|3|||
23492637|NCT01160211|65548147|FG001|Overall Study|Withdrawal by Subject|5|||
23492638|NCT01160211|65548148|FG002|Overall Study|Withdrawal by Subject|3|||
23492639|NCT01160211|65548146|FG000|Overall Study|Physician Decision|2|||
23492640|NCT01160211|65548147|FG001|Overall Study|Physician Decision|0|||
23492641|NCT01160211|65548148|FG002|Overall Study|Physician Decision|0|||
23492642|NCT01160211|65548146|FG000|Overall Study|Lost to Follow-up|4|||
23492643|NCT01160211|65548147|FG001|Overall Study|Lost to Follow-up|7|||
23492644|NCT01160211|65548148|FG002|Overall Study|Lost to Follow-up|5|||
23492645|NCT03540030|65548151|FG000|Overall Study|Withdrawal by Subject|2|||
23492646|NCT03540030|65548152|FG001|Overall Study|Withdrawal by Subject|1|||
23492647|NCT03540030|65548151|FG000|Overall Study|screen fail|7|||
23492648|NCT03540030|65548152|FG001|Overall Study|screen fail|1|||
23492649|NCT03540030|65548151|FG000|Overall Study|never had surgery after signing consent|9|||
23492650|NCT03540030|65548152|FG001|Overall Study|never had surgery after signing consent|1|||
23492651|NCT00864721|65548153|FG000|Overall Study|Patient request|11|||
23289536|NCT02587143|64799119|FG001|Overall Study|Adverse Event|0|||
23289537|NCT05412121|64799120|FG000|Overall Study|Withdrawal by Subject|4|||
23289538|NCT05412121|64799120|FG000|Overall Study|Physician Decision|1|||
23289539|NCT05412121|64799120|FG000|Overall Study|Lost to Follow-up|5|||
23289540|NCT04428645|64799122|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
23289541|NCT00683592|64799125|FG000|Overall Study|Adverse Event|12|||
23289542|NCT00683592|64799126|FG001|Overall Study|Adverse Event|4|||
23289543|NCT00683592|64799125|FG000|Overall Study|Withdrawal by Subject|11|||
23289544|NCT00683592|64799126|FG001|Overall Study|Withdrawal by Subject|11|||
23289545|NCT00683592|64799125|FG000|Overall Study|Lost to Follow-up|17|||
23289546|NCT00683592|64799126|FG001|Overall Study|Lost to Follow-up|17|||
23289547|NCT00683592|64799125|FG000|Overall Study|Lack of Efficacy|3|||
23289548|NCT00683592|64799126|FG001|Overall Study|Lack of Efficacy|7|||
23289549|NCT00683592|64799125|FG000|Overall Study|Physician Decision|0|||
23289550|NCT00683592|64799126|FG001|Overall Study|Physician Decision|1|||
23289551|NCT00683592|64799125|FG000|Overall Study|Non-compliance|3|||
23289552|NCT00683592|64799126|FG001|Overall Study|Non-compliance|5|||
23289553|NCT00683592|64799125|FG000|Overall Study|Other|1|||
23492652|NCT00864721|65548153|FG000|Overall Study|Hospitalized|1|||
23492653|NCT00864721|65548153|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
23492654|NCT00864721|65548153|FG000|Overall Study|Adverse Event|21|||
23492655|NCT01967173|65548156|FG000|Overall Study|Lost to Follow-up|5|||
23492656|NCT01967173|65548157|FG001|Overall Study|Lost to Follow-up|3|||
23492657|NCT01967173|65548158|FG002|Overall Study|Lost to Follow-up|2|||
23492658|NCT01967173|65548159|FG003|Overall Study|Lost to Follow-up|4|||
23492659|NCT01967173|65548160|FG004|Overall Study|Lost to Follow-up|8|||
23289554|NCT00683592|64799126|FG001|Overall Study|Other|1|||
23289555|NCT01496118|64799132|FG000|Overall Study|Disease progression|3|||
23289556|NCT01496118|64799133|FG001|Overall Study|Disease progression|2|||
23289557|NCT01496118|64799134|FG002|Overall Study|Disease progression|3|||
23289558|NCT01496118|64799135|FG003|Overall Study|Disease progression|1|||
23289559|NCT01496118|64799136|FG004|Overall Study|Disease progression|2|||
23289560|NCT01496118|64799137|FG005|Overall Study|Disease progression|2|||
23289561|NCT01496118|64799138|FG006|Overall Study|Disease progression|14|||
23382074|NCT03422718|65144923|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
23382075|NCT03422718|65144924|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
23492660|NCT01967173|65548161|FG005|Overall Study|Lost to Follow-up|12|||
23492661|NCT01967173|65548162|FG006|Overall Study|Lost to Follow-up|6|||
23492662|NCT01967173|65548163|FG007|Overall Study|Lost to Follow-up|8|||
23492663|NCT01967173|65548156|FG000|Overall Study|Physician Decision|2|||
23492664|NCT01967173|65548157|FG001|Overall Study|Physician Decision|0|||
23289562|NCT01496118|64799139|FG007|Overall Study|Disease progression|10|||
23289563|NCT01496118|64799132|FG000|Overall Study|Physician Decision|0|||
23492665|NCT01967173|65548158|FG002|Overall Study|Physician Decision|2|||
23492666|NCT01967173|65548159|FG003|Overall Study|Physician Decision|1|||
23492667|NCT01967173|65548160|FG004|Overall Study|Physician Decision|1|||
23492668|NCT01967173|65548161|FG005|Overall Study|Physician Decision|1|||
23492669|NCT01967173|65548162|FG006|Overall Study|Physician Decision|1|||
23492670|NCT01967173|65548163|FG007|Overall Study|Physician Decision|0|||
23492671|NCT01967173|65548156|FG000|Overall Study|Lack of Efficacy|2|||
23492672|NCT01967173|65548157|FG001|Overall Study|Lack of Efficacy|0|||
23492673|NCT01967173|65548158|FG002|Overall Study|Lack of Efficacy|2|||
23492674|NCT01967173|65548159|FG003|Overall Study|Lack of Efficacy|2|||
23492675|NCT01967173|65548160|FG004|Overall Study|Lack of Efficacy|0|||
23289564|NCT01496118|64799133|FG001|Overall Study|Physician Decision|0|||
23289565|NCT01496118|64799134|FG002|Overall Study|Physician Decision|0|||
23289566|NCT01496118|64799135|FG003|Overall Study|Physician Decision|0|||
23289567|NCT01496118|64799136|FG004|Overall Study|Physician Decision|1|||
23289568|NCT01496118|64799137|FG005|Overall Study|Physician Decision|0|||
23289569|NCT01496118|64799138|FG006|Overall Study|Physician Decision|3|||
23289570|NCT01496118|64799139|FG007|Overall Study|Physician Decision|6|||
23289571|NCT01496118|64799132|FG000|Overall Study|Adverse Event|1|||
23289572|NCT01496118|64799133|FG001|Overall Study|Adverse Event|1|||
23382076|NCT03422718|65144925|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
23382077|NCT03422718|65144926|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
23382078|NCT03422718|65144919|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
23382079|NCT03422718|65144920|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
23382080|NCT03422718|65144921|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
23382081|NCT03422718|65144922|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
23382082|NCT03422718|65144923|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
23382083|NCT03422718|65144924|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
23382084|NCT03422718|65144925|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
23382085|NCT03422718|65144926|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
23382086|NCT03147287|65144927|FG000|Overall Study|Randomized Not Treated|2|||
23382087|NCT03147287|65144928|FG001|Overall Study|Randomized Not Treated|1|||
23382088|NCT03147287|65144929|FG002|Overall Study|Randomized Not Treated|1|||
23382089|NCT03147287|65144927|FG000|Overall Study|Progressive Disease RECIST|31|||
23382090|NCT03147287|65144928|FG001|Overall Study|Progressive Disease RECIST|72|||
23382091|NCT03147287|65144929|FG002|Overall Study|Progressive Disease RECIST|32|||
23382092|NCT03147287|65144927|FG000|Overall Study|Progressive Disease not RECIST|13|||
23382093|NCT03147287|65144928|FG001|Overall Study|Progressive Disease not RECIST|21|||
23382094|NCT03147287|65144929|FG002|Overall Study|Progressive Disease not RECIST|13|||
23382095|NCT03147287|65144927|FG000|Overall Study|Physician Decision|1|||
23382096|NCT03147287|65144928|FG001|Overall Study|Physician Decision|2|||
23382097|NCT03147287|65144929|FG002|Overall Study|Physician Decision|1|||
23382098|NCT03147287|65144927|FG000|Overall Study|Intercurrent illness|0|||
23382099|NCT03147287|65144928|FG001|Overall Study|Intercurrent illness|1|||
23382100|NCT03147287|65144929|FG002|Overall Study|Intercurrent illness|0|||
23382101|NCT03147287|65144927|FG000|Overall Study|Withdrawal by Subject|2|||
23382102|NCT03147287|65144928|FG001|Overall Study|Withdrawal by Subject|3|||
23382103|NCT03147287|65144929|FG002|Overall Study|Withdrawal by Subject|2|||
23382104|NCT03147287|65144927|FG000|Overall Study|Patient Non-Compliance|0|||
23382105|NCT03147287|65144928|FG001|Overall Study|Patient Non-Compliance|2|||
23382106|NCT03147287|65144929|FG002|Overall Study|Patient Non-Compliance|0|||
23382107|NCT03147287|65144927|FG000|Overall Study|Patient moved|0|||
23382108|NCT03147287|65144928|FG001|Overall Study|Patient moved|1|||
23382109|NCT03147287|65144929|FG002|Overall Study|Patient moved|0|||
23382110|NCT03147287|65144927|FG000|Overall Study|Arm A crossover without PD|1|||
23382111|NCT03147287|65144928|FG001|Overall Study|Arm A crossover without PD|0|||
23382112|NCT03147287|65144929|FG002|Overall Study|Arm A crossover without PD|0|||
23382113|NCT03147287|65144927|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
23382114|NCT03147287|65144928|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
23382115|NCT03147287|65144929|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
23382116|NCT01531153|65144930|FG000|Overall Study|Withdrawal by Subject|10|||
23382117|NCT01531153|65144931|FG001|Overall Study|Withdrawal by Subject|9|||
23382118|NCT01531153|65144932|FG002|Overall Study|Withdrawal by Subject|15|||
23382119|NCT02034591|65144936|FG000|Overall Study|Withdrawal by Subject|0|||
23382120|NCT02034591|65144937|FG001|Overall Study|Withdrawal by Subject|0|||
23492676|NCT01967173|65548161|FG005|Overall Study|Lack of Efficacy|1|||
23492677|NCT01967173|65548162|FG006|Overall Study|Lack of Efficacy|0|||
23289573|NCT01496118|64799134|FG002|Overall Study|Adverse Event|0|||
23289574|NCT01496118|64799135|FG003|Overall Study|Adverse Event|0|||
23382121|NCT02034591|65144938|FG002|Overall Study|Withdrawal by Subject|0|||
23382122|NCT02034591|65144939|FG003|Overall Study|Withdrawal by Subject|0|||
23382123|NCT02034591|65144940|FG004|Overall Study|Withdrawal by Subject|1|||
23382124|NCT02034591|65144941|FG005|Overall Study|Withdrawal by Subject|0|||
23382125|NCT00790036|65144942|FG000|Overall Study|Abnormal lab values|3|||
23382126|NCT00790036|65144943|FG001|Overall Study|Abnormal lab values|2|||
23492678|NCT01967173|65548163|FG007|Overall Study|Lack of Efficacy|2|||
23492679|NCT01967173|65548156|FG000|Overall Study|Pregnancy|0|||
23492680|NCT01967173|65548157|FG001|Overall Study|Pregnancy|0|||
23492681|NCT01967173|65548158|FG002|Overall Study|Pregnancy|0|||
23492682|NCT01967173|65548159|FG003|Overall Study|Pregnancy|0|||
23492683|NCT01967173|65548160|FG004|Overall Study|Pregnancy|0|||
23492684|NCT01967173|65548161|FG005|Overall Study|Pregnancy|0|||
23492685|NCT01967173|65548162|FG006|Overall Study|Pregnancy|1|||
23492686|NCT01967173|65548163|FG007|Overall Study|Pregnancy|1|||
23492687|NCT01967173|65548156|FG000|Overall Study|Adverse Event|0|||
23492688|NCT01967173|65548157|FG001|Overall Study|Adverse Event|0|||
23492689|NCT01967173|65548158|FG002|Overall Study|Adverse Event|0|||
23492690|NCT01967173|65548159|FG003|Overall Study|Adverse Event|0|||
23492691|NCT01967173|65548160|FG004|Overall Study|Adverse Event|0|||
23492692|NCT01967173|65548161|FG005|Overall Study|Adverse Event|0|||
23492693|NCT01967173|65548162|FG006|Overall Study|Adverse Event|0|||
23492694|NCT01967173|65548163|FG007|Overall Study|Adverse Event|1|||
23492695|NCT01967173|65548156|FG000|Overall Study|Withdrawal by Subject|15|||
23492696|NCT01967173|65548157|FG001|Overall Study|Withdrawal by Subject|14|||
23492697|NCT01967173|65548158|FG002|Overall Study|Withdrawal by Subject|10|||
23492698|NCT01967173|65548159|FG003|Overall Study|Withdrawal by Subject|7|||
23492699|NCT01967173|65548160|FG004|Overall Study|Withdrawal by Subject|8|||
23492700|NCT01967173|65548161|FG005|Overall Study|Withdrawal by Subject|9|||
23492701|NCT01967173|65548162|FG006|Overall Study|Withdrawal by Subject|10|||
23492702|NCT01967173|65548163|FG007|Overall Study|Withdrawal by Subject|12|||
23492703|NCT00735254|65548166|FG000|Overall Study|Protocol Violation|1|||
23492704|NCT00735254|65548167|FG001|Overall Study|Protocol Violation|1|||
23492705|NCT00735254|65548168|FG002|Overall Study|Protocol Violation|1|||
23492706|NCT00735254|65548169|FG003|Overall Study|Protocol Violation|0|||
23492707|NCT04357782|65548170|FG000|Overall Study|Discharged from hospital|1|||
23492708|NCT04357782|65548171|FG001|Overall Study|Discharged from hospital|0|||
23492709|NCT04357782|65548170|FG000|Overall Study|Death|0|||
23492710|NCT04357782|65548171|FG001|Overall Study|Death|2|||
23492711|NCT03113916|65548172|FG000|Overall Study|Withdrawal by Subject|9|||
23492712|NCT03113916|65548173|FG001|Overall Study|Withdrawal by Subject|7|||
23492713|NCT03113916|65548172|FG000|Overall Study|Pregnancy|1|||
23492714|NCT03113916|65548173|FG001|Overall Study|Pregnancy|3|||
23492715|NCT03113916|65548172|FG000|Overall Study|Lost to Follow-up|1|||
23492716|NCT03113916|65548173|FG001|Overall Study|Lost to Follow-up|2|||
23492717|NCT01578330|65548176|FG000|Overall Study|Adverse Event|2|||
23492718|NCT01578330|65548176|FG000|Overall Study|Protocol Violation|5|||
23289575|NCT01496118|64799136|FG004|Overall Study|Adverse Event|0|||
23289576|NCT01496118|64799137|FG005|Overall Study|Adverse Event|0|||
23289577|NCT01496118|64799138|FG006|Overall Study|Adverse Event|6|||
23289578|NCT01496118|64799139|FG007|Overall Study|Adverse Event|10|||
23289579|NCT01496118|64799132|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23289580|NCT01496118|64799133|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23289581|NCT01496118|64799134|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23289582|NCT01496118|64799135|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23289583|NCT01496118|64799136|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23289584|NCT01496118|64799137|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23289585|NCT01496118|64799138|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
23289586|NCT01496118|64799139|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
23289587|NCT01496118|64799132|FG000|Overall Study|Death|0|||
23289588|NCT01496118|64799133|FG001|Overall Study|Death|0|||
23289589|NCT01496118|64799134|FG002|Overall Study|Death|0|||
23289590|NCT01496118|64799135|FG003|Overall Study|Death|0|||
23289591|NCT01496118|64799136|FG004|Overall Study|Death|0|||
23289592|NCT01496118|64799137|FG005|Overall Study|Death|0|||
23289593|NCT01496118|64799138|FG006|Overall Study|Death|1|||
23289594|NCT01496118|64799139|FG007|Overall Study|Death|1|||
23492719|NCT02121522|65548177|FG000|Overall Study|Adverse Event|1|||
23289595|NCT01496118|64799132|FG000|Overall Study|Withdrawal by Subject|0|||
23289596|NCT01496118|64799133|FG001|Overall Study|Withdrawal by Subject|0|||
23289597|NCT01496118|64799134|FG002|Overall Study|Withdrawal by Subject|0|||
23289598|NCT01496118|64799135|FG003|Overall Study|Withdrawal by Subject|2|||
23289599|NCT01496118|64799136|FG004|Overall Study|Withdrawal by Subject|0|||
23492720|NCT01612858|65548178|FG000|Overall Study|Withdrawal by Subject|5|||
23492721|NCT01612858|65548179|FG001|Overall Study|Withdrawal by Subject|1|||
23289600|NCT01496118|64799137|FG005|Overall Study|Withdrawal by Subject|1|||
23492722|NCT01042678|65548180|FG000|Overall Study|Physician Decision|1|||
23492723|NCT01042678|65548181|FG001|Overall Study|Physician Decision|0|||
23492724|NCT01042678|65548182|FG002|Overall Study|Physician Decision|0|||
23492725|NCT01042678|65548183|FG003|Overall Study|Physician Decision|0|||
23492726|NCT01042678|65548184|FG004|Overall Study|Physician Decision|0|||
23492727|NCT01042678|65548185|FG005|Overall Study|Physician Decision|0|||
23492728|NCT04308304|65548188|FG000|Overall Study|Withdrawal by Subject|4|||
23492729|NCT04308304|65548189|FG001|Overall Study|Withdrawal by Subject|0|||
23289601|NCT01496118|64799138|FG006|Overall Study|Withdrawal by Subject|6|||
23289602|NCT01496118|64799139|FG007|Overall Study|Withdrawal by Subject|3|||
23289603|NCT04019054|64799140|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
23289604|NCT04019054|64799141|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
23289605|NCT04019054|64799140|FG000|Overall Study|Withdrawal by Subject|3|||
23289606|NCT04019054|64799141|FG001|Overall Study|Withdrawal by Subject|1|||
23289607|NCT01120899|64799142|FG000|Overall Study|Withdrawal by Subject|3|||
23289608|NCT04320745|64801839|FG000|Overall Study|Adverse Event|26|||
23289609|NCT04320745|64801839|FG000|Overall Study|Withdrawal by Subject|4|||
23289610|NCT04320745|64801839|FG000|Overall Study|Lost to Follow-up|12|||
23289611|NCT04320745|64801839|FG000|Overall Study|Protocol Deviation|2|||
23289612|NCT04320745|64801839|FG000|Overall Study|Non-compliance With Study Drug|2|||
23289613|NCT04320745|64801839|FG000|Overall Study|Reason Not Specified|1|||
23289614|NCT03942211|64801841|FG000|Overall Study|Death|1|||
23289615|NCT03942211|64801842|FG001|Overall Study|Death|0|||
23492730|NCT04308304|65548188|FG000|Overall Study|Protocol Violation|1|||
23492731|NCT04308304|65548189|FG001|Overall Study|Protocol Violation|0|||
23492732|NCT00595465|65548190|FG000|Overall Study|Adverse Event|4|||
23492733|NCT00595465|65548191|FG001|Overall Study|Adverse Event|3|||
23289616|NCT03942211|64801841|FG000|Overall Study|Study terminated by sponsor|5|||
23289617|NCT03942211|64801842|FG001|Overall Study|Study terminated by sponsor|3|||
23289618|NCT03942211|64801841|FG000|Overall Study|Adverse Event|0|||
23492734|NCT00595465|65548192|FG002|Overall Study|Adverse Event|3|||
23492735|NCT00595465|65548190|FG000|Overall Study|Pregnancy|0|||
23492736|NCT00595465|65548191|FG001|Overall Study|Pregnancy|0|||
23492737|NCT00595465|65548192|FG002|Overall Study|Pregnancy|1|||
23492738|NCT00595465|65548190|FG000|Overall Study|Protocol Violation|2|||
23492739|NCT00595465|65548191|FG001|Overall Study|Protocol Violation|1|||
23492740|NCT00595465|65548192|FG002|Overall Study|Protocol Violation|0|||
23492741|NCT00595465|65548190|FG000|Overall Study|Lost to Follow-up|0|||
23492742|NCT00595465|65548191|FG001|Overall Study|Lost to Follow-up|0|||
23492743|NCT00595465|65548192|FG002|Overall Study|Lost to Follow-up|2|||
23492744|NCT00595465|65548190|FG000|Overall Study|administrative reason|0|||
23492745|NCT00595465|65548191|FG001|Overall Study|administrative reason|0|||
23492746|NCT00595465|65548192|FG002|Overall Study|administrative reason|1|||
23492747|NCT00406718|65548195|FG000|Overall Study|Withdrawal by Subject|2|||
23289619|NCT03942211|64801842|FG001|Overall Study|Adverse Event|1|||
23289620|NCT03496298|64801843|FG000|Overall Study|Adverse Event|49|||
23492748|NCT00406718|65548196|FG001|Overall Study|Withdrawal by Subject|9|||
23492749|NCT00406718|65548197|FG002|Overall Study|Withdrawal by Subject|4|||
23492750|NCT00406718|65548195|FG000|Overall Study|Lost to Follow-up|2|||
23492751|NCT00406718|65548196|FG001|Overall Study|Lost to Follow-up|5|||
23492752|NCT00406718|65548197|FG002|Overall Study|Lost to Follow-up|4|||
23289621|NCT03496298|64801844|FG001|Overall Study|Adverse Event|68|||
23289622|NCT03496298|64801845|FG002|Overall Study|Adverse Event|79|||
23289623|NCT03496298|64801843|FG000|Overall Study|Study terminated by Sponsor|1050|||
23289624|NCT03496298|64801844|FG001|Overall Study|Study terminated by Sponsor|1063|||
23289625|NCT03496298|64801845|FG002|Overall Study|Study terminated by Sponsor|1071|||
23289626|NCT03496298|64801843|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
23289627|NCT03496298|64801844|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
23289628|NCT03496298|64801845|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
23289629|NCT03496298|64801843|FG000|Overall Study|Withdrawal by Subject|176|||
23289630|NCT03496298|64801844|FG001|Overall Study|Withdrawal by Subject|154|||
23492753|NCT01868503|65548198|FG000|Overall Study|Withdrawal by Subject|1|||
23492754|NCT01868503|65548198|FG000|Overall Study|Protocol Violation|1|||
23492755|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
23492756|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
23492757|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Physician Decision|1|||
23492758|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Physician Decision|0|||
23492759|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
23492760|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
23492761|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
23492762|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
23492763|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Adverse Event|15|||
23492764|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Adverse Event|0|||
23492765|NCT03277690|65548199|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
23492766|NCT03277690|65548200|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
23492767|NCT03277690|65548199|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
23492768|NCT03277690|65548200|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
23492769|NCT02038881|65548209|FG000|Overall Study|Withdrawal by Subject|0|||
23492770|NCT02038881|65548210|FG001|Overall Study|Withdrawal by Subject|0|||
23289631|NCT03496298|64801845|FG002|Overall Study|Withdrawal by Subject|151|||
23492771|NCT02038881|65548211|FG002|Overall Study|Withdrawal by Subject|1|||
23492772|NCT02038881|65548209|FG000|Overall Study|Lost to Follow-up|2|||
23492773|NCT02038881|65548210|FG001|Overall Study|Lost to Follow-up|0|||
23492774|NCT02038881|65548211|FG002|Overall Study|Lost to Follow-up|0|||
23492775|NCT02038881|65548209|FG000|Overall Study|incarcerated|1|||
23492776|NCT02038881|65548210|FG001|Overall Study|incarcerated|0|||
23492777|NCT02038881|65548211|FG002|Overall Study|incarcerated|0|||
23492778|NCT01254331|65548212|FG000|Initial Phase|Adverse Event|3|||
23492779|NCT01254331|65548212|FG000|Initial Phase|Withdrawal by Subject|1|||
23492780|NCT01254331|65548212|FG000|Initial Phase|Pregnancy|1|||
23492781|NCT01254331|65548212|FG000|Extension Phase|Lack of Efficacy|1|||
23492782|NCT01254331|65548212|FG000|Extension Phase|Lost to Follow-up|3|||
23492783|NCT00808483|65548213|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
23492784|NCT00808483|65548214|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
23492785|NCT00808483|65548213|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
23492786|NCT00808483|65548214|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
23492787|NCT00808483|65548213|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
23492788|NCT00808483|65548214|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
23492789|NCT02410551|65548215|FG000|Overall Study|Adverse Event|1|||
23492790|NCT02410551|65548215|FG000|Overall Study|Withdrawal by Subject|1|||
23492791|NCT02410551|65548215|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
23492792|NCT03096483|65548216|FG000|Overall Study|Withdrawal by site|1|||
23492793|NCT00354744|65548219|FG000|Overall Study|Adverse Event|2|||
23492794|NCT00354744|65548219|FG000|Overall Study|Death|2|||
23492795|NCT00354744|65548219|FG000|Overall Study|Lack of Efficacy|11|||
23492796|NCT00354744|65548219|FG000|Overall Study|Lost to Follow-up|2|||
23492797|NCT00354744|65548219|FG000|Overall Study|Physician Decision|11|||
23492798|NCT00354744|65548219|FG000|Overall Study|Withdrawal by Subject|14|||
23492799|NCT00445978|65548223|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
23492800|NCT00445978|65548223|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
23492801|NCT00445978|65548223|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
23492802|NCT00445978|65548223|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
23492803|NCT00445978|65548223|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
23492804|NCT00445978|65548223|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
23492805|NCT00445978|65548223|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
23492806|NCT00445978|65548223|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
23492807|NCT00445978|65548223|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
23492808|NCT03954132|65548226|FG000|Overall Study|Adverse Event|2|||
23492809|NCT03954132|65548227|FG001|Overall Study|Adverse Event|0|||
23492810|NCT03954132|65548226|FG000|Overall Study|Patient's wish|5|||
23492811|NCT03954132|65548227|FG001|Overall Study|Patient's wish|0|||
23492812|NCT03954132|65548226|FG000|Overall Study|Lost to Follow-up|10|||
23492813|NCT03954132|65548227|FG001|Overall Study|Lost to Follow-up|0|||
23492814|NCT03954132|65548226|FG000|Overall Study|Screening failure|0|||
23492815|NCT03954132|65548227|FG001|Overall Study|Screening failure|1|||
23492816|NCT03954132|65548226|FG000|Overall Study|No registration after Visit 1|5|||
23492817|NCT03954132|65548227|FG001|Overall Study|No registration after Visit 1|2|||
23492818|NCT03954132|65548226|FG000|Overall Study|Other reason than listed|2|||
23492819|NCT03954132|65548227|FG001|Overall Study|Other reason than listed|2|||
23492820|NCT03954132|65548226|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
23492821|NCT03954132|65548227|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
23289632|NCT03496298|64801843|FG000|Overall Study|Other|29|||
23289633|NCT03496298|64801844|FG001|Overall Study|Other|20|||
23289634|NCT03496298|64801845|FG002|Overall Study|Other|23|||
23289635|NCT03496298|64801843|FG000|Overall Study|Randomized and not treated|1|||
23289636|NCT03496298|64801844|FG001|Overall Study|Randomized and not treated|1|||
23289637|NCT03496298|64801845|FG002|Overall Study|Randomized and not treated|1|||
23289638|NCT01119625|64801851|FG000|Overall Study|Lost to Follow-up|1|||
23492822|NCT03954132|65548226|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
23492823|NCT03954132|65548227|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
23492824|NCT00331864|65548232|FG000|Overall Study|Adverse Event|30|||
23492825|NCT00331864|65548233|FG001|Overall Study|Adverse Event|1|||
23492826|NCT00331864|65548232|FG000|Overall Study|Lack of Efficacy|4|||
23492827|NCT00331864|65548233|FG001|Overall Study|Lack of Efficacy|0|||
23492828|NCT00331864|65548232|FG000|Overall Study|Protocol Violation|3|||
23492829|NCT00331864|65548233|FG001|Overall Study|Protocol Violation|0|||
23492830|NCT00331864|65548232|FG000|Overall Study|Withdrawal by Subject|10|||
23492831|NCT00331864|65548233|FG001|Overall Study|Withdrawal by Subject|0|||
23492832|NCT00331864|65548232|FG000|Overall Study|Lost to Follow-up|4|||
23492833|NCT00331864|65548233|FG001|Overall Study|Lost to Follow-up|3|||
23492834|NCT00331864|65548232|FG000|Overall Study|Administrative Problems|1|||
23492835|NCT00331864|65548233|FG001|Overall Study|Administrative Problems|0|||
23492836|NCT00331864|65548232|FG000|Overall Study|Death|6|||
23492837|NCT00331864|65548233|FG001|Overall Study|Death|0|||
23289639|NCT01119625|64801852|FG001|Overall Study|Lost to Follow-up|2|||
23289640|NCT01119625|64801851|FG000|Overall Study|Withdrawal by Subject|2|||
23289641|NCT01119625|64801852|FG001|Overall Study|Withdrawal by Subject|1|||
23289642|NCT01119625|64801851|FG000|Overall Study|Other|0|||
23492838|NCT02360995|65548234|FG000|Overall Study|Lost to Follow-up|2|||
23492839|NCT02360995|65548235|FG001|Overall Study|Lost to Follow-up|0|||
23492840|NCT02360995|65548236|FG002|Overall Study|Lost to Follow-up|2|||
23492841|NCT02360995|65548234|FG000|Overall Study|Withdrawal by Subject|0|||
23289643|NCT01119625|64801852|FG001|Overall Study|Other|1|||
23289644|NCT02448563|64801855|FG000|Overall Study|Lost to Follow-up|16|||
23289645|NCT02448563|64801856|FG001|Overall Study|Lost to Follow-up|10|||
23289646|NCT02448563|64801855|FG000|Overall Study|Withdrawal by Subject|0|||
23289647|NCT02448563|64801856|FG001|Overall Study|Withdrawal by Subject|1|||
23289648|NCT05070754|64801857|FG000|Overall Study|Withdrawal by Subject|0|||
23289649|NCT05070754|64801858|FG001|Overall Study|Withdrawal by Subject|0|||
23289650|NCT05070754|64801859|FG002|Overall Study|Withdrawal by Subject|0|||
23289651|NCT05070754|64801860|FG003|Overall Study|Withdrawal by Subject|1|||
23289652|NCT05070754|64801857|FG000|Overall Study|Protocol Violation|0|||
23289653|NCT05070754|64801858|FG001|Overall Study|Protocol Violation|0|||
23289654|NCT05070754|64801859|FG002|Overall Study|Protocol Violation|0|||
23289655|NCT05070754|64801860|FG003|Overall Study|Protocol Violation|1|||
23289656|NCT03573336|64801861|FG000|Overall Study|Study terminated|2|||
23289657|NCT03573336|64801862|FG001|Overall Study|Study terminated|4|||
23382127|NCT00790036|65144942|FG000|Overall Study|Administrative problems|5|||
23382128|NCT00790036|65144943|FG001|Overall Study|Administrative problems|9|||
23382129|NCT00790036|65144942|FG000|Overall Study|Adverse Event|113|||
23382130|NCT00790036|65144943|FG001|Overall Study|Adverse Event|44|||
23382131|NCT00790036|65144942|FG000|Overall Study|Death|1|||
23382132|NCT00790036|65144943|FG001|Overall Study|Death|0|||
23382133|NCT00790036|65144942|FG000|Overall Study|Disease progression|24|||
23382134|NCT00790036|65144943|FG001|Overall Study|Disease progression|48|||
23382135|NCT00790036|65144942|FG000|Overall Study|Lost to Follow-up|1|||
23382136|NCT00790036|65144943|FG001|Overall Study|Lost to Follow-up|2|||
23382137|NCT00790036|65144942|FG000|Overall Study|Protocol Violation|10|||
23382138|NCT00790036|65144943|FG001|Overall Study|Protocol Violation|2|||
23382139|NCT00790036|65144942|FG000|Overall Study|Withdrawal by Subject|18|||
23382140|NCT00790036|65144943|FG001|Overall Study|Withdrawal by Subject|7|||
23382141|NCT00790036|65144942|FG000|Overall Study|Subject/guardian decision|20|||
23382142|NCT00790036|65144943|FG001|Overall Study|Subject/guardian decision|7|||
23382143|NCT01068912|65144946|FG000|Overall Study|Adverse Event|2|||
23492842|NCT02360995|65548235|FG001|Overall Study|Withdrawal by Subject|1|||
23492843|NCT02360995|65548236|FG002|Overall Study|Withdrawal by Subject|0|||
23492844|NCT01756053|65548237|FG000|Period 1 (10 Days)|Protocol Violation|1|||
23492845|NCT01756053|65548238|FG001|Period 1 (10 Days)|Protocol Violation|1|||
23492846|NCT01756053|65548237|FG000|Period 2 (10 Days)|Protocol Violation|0|||
23492847|NCT01756053|65548238|FG001|Period 2 (10 Days)|Protocol Violation|2|||
23492848|NCT02651467|65548239|FG000|Overall Study|Withdrawal by Subject|0|||
23492849|NCT02651467|65548240|FG001|Overall Study|Withdrawal by Subject|0|||
23492850|NCT02651467|65548241|FG002|Overall Study|Withdrawal by Subject|2|||
23492851|NCT02651467|65548239|FG000|Overall Study|Other (Not specified)|1|||
23492852|NCT02651467|65548240|FG001|Overall Study|Other (Not specified)|0|||
23492853|NCT02651467|65548241|FG002|Overall Study|Other (Not specified)|2|||
23289658|NCT03573336|64801863|FG002|Overall Study|Study terminated|2|||
23289659|NCT01833169|64801865|FG000|Overall Study|Disease Progression|99|||
23382144|NCT01068912|65144947|FG001|Overall Study|Adverse Event|3|||
23382145|NCT01068912|65144948|FG002|Overall Study|Adverse Event|2|||
23382146|NCT01068912|65144946|FG000|Overall Study|Withdrawal by Subject|5|||
23289660|NCT01833169|64801865|FG000|Overall Study|Adverse Event|33|||
23289661|NCT01833169|64801865|FG000|Overall Study|Withdrawal by Subject|9|||
23289662|NCT01833169|64801865|FG000|Overall Study|Death|3|||
23382147|NCT01068912|65144947|FG001|Overall Study|Withdrawal by Subject|6|||
23492854|NCT02764333|65548242|FG000|Overall Study|Ineligible|1|||
23382148|NCT01068912|65144948|FG002|Overall Study|Withdrawal by Subject|6|||
23382149|NCT01068912|65144946|FG000|Overall Study|Lost to Follow-up|3|||
23382150|NCT01068912|65144947|FG001|Overall Study|Lost to Follow-up|7|||
23382151|NCT01068912|65144948|FG002|Overall Study|Lost to Follow-up|3|||
23382152|NCT01068912|65144946|FG000|Overall Study|Protocol Violation|0|||
23382153|NCT01068912|65144947|FG001|Overall Study|Protocol Violation|2|||
23382154|NCT01068912|65144948|FG002|Overall Study|Protocol Violation|0|||
23382155|NCT01068912|65144946|FG000|Overall Study|aggravation influenza|1|||
23382156|NCT01068912|65144947|FG001|Overall Study|aggravation influenza|1|||
23382157|NCT01068912|65144948|FG002|Overall Study|aggravation influenza|1|||
23382158|NCT01068912|65144946|FG000|Overall Study|other underlying illness|0|||
23382159|NCT01068912|65144947|FG001|Overall Study|other underlying illness|3|||
23382160|NCT01068912|65144948|FG002|Overall Study|other underlying illness|3|||
23382161|NCT01058005|65144949|FG000|Overall Study|Adverse Event|0|||
23382162|NCT01058005|65144950|FG001|Overall Study|Adverse Event|2|||
23382163|NCT01058005|65144951|FG002|Overall Study|Adverse Event|1|||
23382164|NCT01058005|65144949|FG000|Overall Study|Physician Decision|2|||
23382165|NCT01058005|65144950|FG001|Overall Study|Physician Decision|2|||
23382166|NCT01058005|65144951|FG002|Overall Study|Physician Decision|0|||
23382167|NCT01058005|65144949|FG000|Overall Study|Withdrawal by Subject|4|||
23382168|NCT01058005|65144950|FG001|Overall Study|Withdrawal by Subject|5|||
23382169|NCT01058005|65144951|FG002|Overall Study|Withdrawal by Subject|11|||
23382170|NCT01058005|65144949|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
23382171|NCT01058005|65144950|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
23382172|NCT01058005|65144951|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
23382173|NCT01058005|65144949|FG000|Overall Study|Reason Missing|5|||
23382174|NCT01058005|65144950|FG001|Overall Study|Reason Missing|3|||
23382175|NCT01058005|65144951|FG002|Overall Study|Reason Missing|1|||
23382176|NCT00456612|65144959|FG000|Overall Study|Withdrawal by Subject|3|||
23382177|NCT01214720|65144960|FG000|Overall Study|Alive and still on treatment|34|||
23382178|NCT01214720|65144961|FG001|Overall Study|Alive and still on treatment|18|||
23382179|NCT01214720|65144960|FG000|Overall Study|Alive and in follow-up|45|||
23382180|NCT01214720|65144961|FG001|Overall Study|Alive and in follow-up|48|||
23382181|NCT01214720|65144960|FG000|Overall Study|Lost to Follow-up|6|||
23382182|NCT01214720|65144961|FG001|Overall Study|Lost to Follow-up|2|||
23382183|NCT03339453|65144962|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
23382184|NCT03339453|65144963|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
23382185|NCT04795323|65144970|FG000|Overall Study|Did not interact with TARA|1|||
23382186|NCT04795323|65144971|FG001|Overall Study|Did not interact with TARA|0|||
23382187|NCT00855582|65144972|FG000|Overall Study|Adverse Event|2|||
23382188|NCT00855582|65144973|FG001|Overall Study|Adverse Event|6|||
23382189|NCT00855582|65144974|FG002|Overall Study|Adverse Event|3|||
23382190|NCT00855582|65144972|FG000|Overall Study|Death|1|||
23382191|NCT00855582|65144973|FG001|Overall Study|Death|0|||
23382192|NCT00855582|65144974|FG002|Overall Study|Death|0|||
23382193|NCT00855582|65144972|FG000|Overall Study|Lack of Efficacy|1|||
23382194|NCT00855582|65144973|FG001|Overall Study|Lack of Efficacy|3|||
23382195|NCT00855582|65144974|FG002|Overall Study|Lack of Efficacy|8|||
23382196|NCT00855582|65144972|FG000|Overall Study|Lost to Follow-up|1|||
23382197|NCT00855582|65144973|FG001|Overall Study|Lost to Follow-up|3|||
23492855|NCT02281773|65548243|FG000|Overall Study|Adverse Event|6|||
23492856|NCT02281773|65548244|FG001|Overall Study|Adverse Event|1|||
23492857|NCT02281773|65548245|FG002|Overall Study|Adverse Event|4|||
23492858|NCT02281773|65548246|FG003|Overall Study|Adverse Event|8|||
23492859|NCT02281773|65548247|FG004|Overall Study|Adverse Event|9|||
23492860|NCT02281773|65548243|FG000|Overall Study|Protocol Violation|1|||
23492861|NCT02281773|65548244|FG001|Overall Study|Protocol Violation|0|||
23492862|NCT02281773|65548245|FG002|Overall Study|Protocol Violation|0|||
23382198|NCT00855582|65144974|FG002|Overall Study|Lost to Follow-up|1|||
23492863|NCT02281773|65548246|FG003|Overall Study|Protocol Violation|2|||
23492864|NCT02281773|65548247|FG004|Overall Study|Protocol Violation|2|||
23492865|NCT02281773|65548243|FG000|Overall Study|Lost to Follow-up|2|||
23492866|NCT02281773|65548244|FG001|Overall Study|Lost to Follow-up|2|||
23382199|NCT00855582|65144972|FG000|Overall Study|Physician Decision|0|||
23382200|NCT00855582|65144973|FG001|Overall Study|Physician Decision|0|||
23382201|NCT00855582|65144974|FG002|Overall Study|Physician Decision|1|||
23382202|NCT00855582|65144972|FG000|Overall Study|Protocol Violation|6|||
23382203|NCT00855582|65144973|FG001|Overall Study|Protocol Violation|2|||
23492867|NCT02281773|65548245|FG002|Overall Study|Lost to Follow-up|6|||
23492868|NCT02281773|65548246|FG003|Overall Study|Lost to Follow-up|2|||
23492869|NCT02281773|65548247|FG004|Overall Study|Lost to Follow-up|10|||
23382204|NCT00855582|65144974|FG002|Overall Study|Protocol Violation|6|||
23382205|NCT00855582|65144972|FG000|Overall Study|Entry Criteria Not Met|8|||
23382206|NCT00855582|65144973|FG001|Overall Study|Entry Criteria Not Met|6|||
23382207|NCT00855582|65144974|FG002|Overall Study|Entry Criteria Not Met|3|||
23605960|NCT01640951|65947106|FG005|Overall Study|Protocol Deviation|1|||
23289663|NCT01833169|64801865|FG000|Overall Study|Physician Decision|2|||
23289664|NCT03868631|64801869|FG000|Baseline to Week 6|Adverse Event|0|||
23289665|NCT03868631|64801870|FG001|Baseline to Week 6|Adverse Event|3|||
23289666|NCT03868631|64801869|FG000|Baseline to Week 6|Protocol Violation|1|||
23289667|NCT03868631|64801870|FG001|Baseline to Week 6|Protocol Violation|1|||
23289668|NCT03868631|64801869|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
23289669|NCT03868631|64801870|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
23289670|NCT03868631|64801869|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
23289671|NCT03868631|64801870|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
23289672|NCT03868631|64801869|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
23289673|NCT03868631|64801870|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
23289674|NCT03868631|64801869|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
23289675|NCT03868631|64801870|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
23289676|NCT00522041|64801878|FG000|Overall Study|Adverse Event|9|||
23289677|NCT00522041|64801879|FG001|Overall Study|Adverse Event|3|||
23289678|NCT00522041|64801878|FG000|Overall Study|Protocol Violation|2|||
23289679|NCT00522041|64801879|FG001|Overall Study|Protocol Violation|0|||
23289680|NCT00522041|64801878|FG000|Overall Study|Lost to Follow-up|1|||
23289681|NCT00522041|64801879|FG001|Overall Study|Lost to Follow-up|4|||
23289682|NCT00522041|64801878|FG000|Overall Study|Voluntary withdrawal|5|||
23289683|NCT00522041|64801879|FG001|Overall Study|Voluntary withdrawal|4|||
23289684|NCT00522041|64801878|FG000|Overall Study|Did not receive treatment|0|||
23289685|NCT00522041|64801879|FG001|Overall Study|Did not receive treatment|1|||
23289686|NCT01557920|64801885|FG000|Overall Study|Withdrawal by Subject|2|||
23289687|NCT01557920|64801886|FG001|Overall Study|Withdrawal by Subject|3|||
23289688|NCT01557920|64801885|FG000|Overall Study|Lack of Efficacy|1|||
23289689|NCT01557920|64801886|FG001|Overall Study|Lack of Efficacy|0|||
23289690|NCT01808248|64801887|FG000|Overall Study|Lack of Efficacy|3|||
23289691|NCT01808248|64801887|FG000|Overall Study|Withdrawal by Subject|1|||
23289692|NCT01808248|64801887|FG000|Overall Study|Lost to Follow-up|1|||
23289693|NCT01728116|64801888|FG000|Overall Study|Sponsor Terminated Study|106|||
23289694|NCT01728116|64801889|FG001|Overall Study|Sponsor Terminated Study|35|||
23289695|NCT01728116|64801888|FG000|Overall Study|Withdrawal by Subject|16|||
23289696|NCT01728116|64801889|FG001|Overall Study|Withdrawal by Subject|9|||
23289697|NCT01728116|64801888|FG000|Overall Study|Adverse Event|13|||
23289698|NCT01728116|64801889|FG001|Overall Study|Adverse Event|0|||
23289699|NCT01728116|64801888|FG000|Overall Study|Procedure/device failure|7|||
23289700|NCT01728116|64801889|FG001|Overall Study|Procedure/device failure|0|||
23289701|NCT01728116|64801888|FG000|Overall Study|Lost to Follow-up|9|||
23289702|NCT01728116|64801889|FG001|Overall Study|Lost to Follow-up|2|||
23289703|NCT01728116|64801888|FG000|Overall Study|Physician Decision|2|||
23289704|NCT01728116|64801889|FG001|Overall Study|Physician Decision|0|||
23289705|NCT01728116|64801888|FG000|Overall Study|Subject Non-Compliance|2|||
23289706|NCT01728116|64801889|FG001|Overall Study|Subject Non-Compliance|0|||
23289707|NCT01728116|64801888|FG000|Overall Study|Inter-current finding at procedure|1|||
23289708|NCT01728116|64801889|FG001|Overall Study|Inter-current finding at procedure|0|||
23289709|NCT01728116|64801888|FG000|Overall Study|Incorrectly enrolled in Study|0|||
23289710|NCT01728116|64801889|FG001|Overall Study|Incorrectly enrolled in Study|1|||
23289711|NCT01728116|64801888|FG000|Overall Study|various not noted previously|5|||
23289712|NCT01728116|64801889|FG001|Overall Study|various not noted previously|0|||
23289713|NCT01198873|64801890|FG000|Overall Study|Adverse Event|4|||
23289714|NCT01198873|64801891|FG001|Overall Study|Adverse Event|7|||
23289715|NCT01198873|64801890|FG000|Overall Study|Study closure|29|||
23289716|NCT01198873|64801891|FG001|Overall Study|Study closure|23|||
23289717|NCT01198873|64801890|FG000|Overall Study|Other than above|4|||
23289718|NCT01198873|64801891|FG001|Overall Study|Other than above|2|||
23289719|NCT05278858|64801895|FG000|Overall Study|Withdrawal by Subject|1|||
23289720|NCT03343639|64801896|FG000|Overall Study|Withdrawal by Subject|10|||
23289721|NCT03343639|64801897|FG001|Overall Study|Withdrawal by Subject|6|||
23289722|NCT03343639|64801896|FG000|Overall Study|Lost to Follow-up|4|||
23289723|NCT03343639|64801897|FG001|Overall Study|Lost to Follow-up|5|||
23289724|NCT03343639|64801896|FG000|Overall Study|Protocol Violation|0|||
23289725|NCT03343639|64801897|FG001|Overall Study|Protocol Violation|1|||
23289726|NCT01964950|64801900|FG000|Overall Study|Protocol Violation|25|||
23289727|NCT04158687|64801901|FG000|Overall Study|Adverse Event|2|||
23289728|NCT04158687|64801902|FG001|Overall Study|Adverse Event|3|||
23289729|NCT04158687|64801903|FG002|Overall Study|Adverse Event|0|||
23382208|NCT00855582|65144972|FG000|Overall Study|Withdrawal by Subject|7|||
23382209|NCT00855582|65144973|FG001|Overall Study|Withdrawal by Subject|4|||
23382210|NCT00855582|65144974|FG002|Overall Study|Withdrawal by Subject|8|||
23382211|NCT02762604|65144980|FG000|Overall Study|Lost to Follow-up|2|||
23382212|NCT02762604|65144981|FG001|Overall Study|Lost to Follow-up|7|||
23382213|NCT02762604|65144980|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
23382214|NCT02762604|65144981|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
23382215|NCT00784875|65144982|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
23382216|NCT00784875|65144983|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
23382217|NCT00784875|65144984|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
23382218|NCT00784875|65144985|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
23382219|NCT00784875|65144982|FG000|Period A - Baseline|Adverse Event|0|||
23382220|NCT00784875|65144983|FG001|Period A - Baseline|Adverse Event|0|||
23382221|NCT00784875|65144984|FG002|Period A - Baseline|Adverse Event|0|||
23382222|NCT00784875|65144985|FG003|Period A - Baseline|Adverse Event|8|||
23382223|NCT00784875|65144982|FG000|Period A - Baseline|Protocol Violation|0|||
23382224|NCT00784875|65144983|FG001|Period A - Baseline|Protocol Violation|0|||
23382225|NCT00784875|65144984|FG002|Period A - Baseline|Protocol Violation|0|||
23382226|NCT00784875|65144985|FG003|Period A - Baseline|Protocol Violation|25|||
23382227|NCT00784875|65144982|FG000|Period A - Baseline|Withdrawal by Subject|0|||
23382228|NCT00784875|65144983|FG001|Period A - Baseline|Withdrawal by Subject|0|||
23382229|NCT00784875|65144984|FG002|Period A - Baseline|Withdrawal by Subject|0|||
23382230|NCT00784875|65144985|FG003|Period A - Baseline|Withdrawal by Subject|27|||
23382231|NCT00784875|65144982|FG000|Period A - Baseline|Physician Decision|0|||
23382232|NCT00784875|65144983|FG001|Period A - Baseline|Physician Decision|0|||
23382233|NCT00784875|65144984|FG002|Period A - Baseline|Physician Decision|0|||
23382234|NCT00784875|65144985|FG003|Period A - Baseline|Physician Decision|2|||
23382235|NCT00784875|65144982|FG000|Period A - Baseline|Sponsor Decision|0|||
23382236|NCT00784875|65144983|FG001|Period A - Baseline|Sponsor Decision|0|||
23382237|NCT00784875|65144984|FG002|Period A - Baseline|Sponsor Decision|0|||
23382238|NCT00784875|65144985|FG003|Period A - Baseline|Sponsor Decision|113|||
23382239|NCT00784875|65144982|FG000|Period A - Baseline|Lost to Follow-up|0|||
23382240|NCT00784875|65144983|FG001|Period A - Baseline|Lost to Follow-up|0|||
23382241|NCT00784875|65144984|FG002|Period A - Baseline|Lost to Follow-up|0|||
23382242|NCT00784875|65144985|FG003|Period A - Baseline|Lost to Follow-up|2|||
23382243|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
23382244|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
23382245|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
23382246|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
23382247|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
23382248|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
23382249|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
23382250|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
23382251|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
23382252|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
23382253|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
23382254|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
23382255|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
23382256|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
23382257|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
23382258|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
23382259|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
23382260|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
23382261|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
23382262|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
23382263|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
23382264|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
23382265|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
23382266|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
23382267|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
23382268|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
23382269|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
23382270|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
23382271|NCT00784875|65144982|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
23382272|NCT00784875|65144983|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
23382273|NCT00784875|65144984|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
23382274|NCT00784875|65144985|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
23382275|NCT00784875|65144982|FG000|Period C|Adverse Event|1|||
23382276|NCT00784875|65144983|FG001|Period C|Adverse Event|0|||
23382277|NCT00784875|65144984|FG002|Period C|Adverse Event|4|||
23382278|NCT00784875|65144985|FG003|Period C|Adverse Event|2|||
23382279|NCT00784875|65144982|FG000|Period C|Protocol Violation|0|||
23382280|NCT00784875|65144983|FG001|Period C|Protocol Violation|0|||
23382281|NCT00784875|65144984|FG002|Period C|Protocol Violation|1|||
23382282|NCT00784875|65144985|FG003|Period C|Protocol Violation|2|||
23382283|NCT00784875|65144982|FG000|Period C|Lack of Efficacy|0|||
23382284|NCT00784875|65144983|FG001|Period C|Lack of Efficacy|0|||
23382285|NCT00784875|65144984|FG002|Period C|Lack of Efficacy|1|||
23382286|NCT00784875|65144985|FG003|Period C|Lack of Efficacy|0|||
23382287|NCT00784875|65144982|FG000|Period C|Withdrawal by Subject|1|||
23382288|NCT00784875|65144983|FG001|Period C|Withdrawal by Subject|1|||
23382289|NCT00784875|65144984|FG002|Period C|Withdrawal by Subject|2|||
23382290|NCT00784875|65144985|FG003|Period C|Withdrawal by Subject|0|||
23382291|NCT00784875|65144982|FG000|Period C|Physician Decision|0|||
23382292|NCT00784875|65144983|FG001|Period C|Physician Decision|0|||
23382293|NCT00784875|65144984|FG002|Period C|Physician Decision|1|||
23382294|NCT00784875|65144985|FG003|Period C|Physician Decision|1|||
23382295|NCT00784875|65144982|FG000|Period C|Sponsor Decision|5|||
23382296|NCT00784875|65144983|FG001|Period C|Sponsor Decision|5|||
23382297|NCT00784875|65144984|FG002|Period C|Sponsor Decision|4|||
23382298|NCT00784875|65144985|FG003|Period C|Sponsor Decision|2|||
23382299|NCT00784875|65144982|FG000|Period D|Adverse Event|0|||
23382300|NCT00784875|65144983|FG001|Period D|Adverse Event|2|||
23382301|NCT00784875|65144984|FG002|Period D|Adverse Event|2|||
23382302|NCT00784875|65144985|FG003|Period D|Adverse Event|0|||
23382303|NCT00784875|65144982|FG000|Period D|Protocol Violation|1|||
23382304|NCT00784875|65144983|FG001|Period D|Protocol Violation|0|||
23382305|NCT00784875|65144984|FG002|Period D|Protocol Violation|0|||
23382306|NCT00784875|65144985|FG003|Period D|Protocol Violation|0|||
23382307|NCT00784875|65144982|FG000|Period D|Withdrawal by Subject|2|||
23382308|NCT00784875|65144983|FG001|Period D|Withdrawal by Subject|0|||
23382309|NCT00784875|65144984|FG002|Period D|Withdrawal by Subject|2|||
23382310|NCT00784875|65144985|FG003|Period D|Withdrawal by Subject|0|||
23382311|NCT00784875|65144982|FG000|Period D|Physician Decision|0|||
23382312|NCT00784875|65144983|FG001|Period D|Physician Decision|1|||
23382313|NCT00784875|65144984|FG002|Period D|Physician Decision|0|||
23382314|NCT00784875|65144985|FG003|Period D|Physician Decision|0|||
23382315|NCT00784875|65144982|FG000|Period D|Sponsor Decision|1|||
23382316|NCT00784875|65144983|FG001|Period D|Sponsor Decision|1|||
23382317|NCT00784875|65144984|FG002|Period D|Sponsor Decision|1|||
23382318|NCT00784875|65144985|FG003|Period D|Sponsor Decision|0|||
23382319|NCT00784875|65144982|FG000|Period D|Lost to Follow-up|1|||
23382320|NCT00784875|65144983|FG001|Period D|Lost to Follow-up|0|||
23382321|NCT00784875|65144984|FG002|Period D|Lost to Follow-up|1|||
23382322|NCT00784875|65144985|FG003|Period D|Lost to Follow-up|1|||
23382323|NCT02852434|65144993|FG000|Overall Study|Withdrawal by Subject|0|||
23382324|NCT02852434|65144994|FG001|Overall Study|Withdrawal by Subject|1|||
23382325|NCT02852434|65144993|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
23382326|NCT02852434|65144994|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
23382327|NCT03684057|65145001|FG000|Overall Study|Withdrawal by Subject|4|||
23382328|NCT03684057|65145002|FG001|Overall Study|Withdrawal by Subject|5|||
23382329|NCT00530075|65145005|FG000|Overall Study|Adverse Event|1|||
23382330|NCT00530075|65145005|FG000|Overall Study|Death|1|||
23382331|NCT00530075|65145005|FG000|Overall Study|Lack of Efficacy|3|||
23382332|NCT00530075|65145005|FG000|Overall Study|Protocol Violation|1|||
23382333|NCT00530075|65145005|FG000|Overall Study|Withdrawal by Subject|1|||
23382334|NCT00888849|65145012|FG000|Overall Study|Death|4|||
23382335|NCT00888849|65145013|FG001|Overall Study|Death|7|||
23382336|NCT00888849|65145012|FG000|Overall Study|Lost to Follow-up|1|||
23382337|NCT00888849|65145013|FG001|Overall Study|Lost to Follow-up|2|||
23382338|NCT01555931|65145014|FG000|Overall Study|Lost to Follow-up|2|||
23382339|NCT01555931|65145015|FG001|Overall Study|Lost to Follow-up|5|||
23382340|NCT01967277|65145019|FG000|Overall Study|Lost to Follow-up|1|||
23382341|NCT01967277|65145020|FG001|Overall Study|Lost to Follow-up|2|||
23382342|NCT01967277|65145019|FG000|Overall Study|Unrelated illness|0|||
23382343|NCT01967277|65145020|FG001|Overall Study|Unrelated illness|1|||
23382344|NCT01136915|65145021|FG000|Overall Study|Lost to Follow-up|2|||
23382345|NCT01136915|65145022|FG001|Overall Study|Lost to Follow-up|0|||
23382346|NCT01136915|65145021|FG000|Overall Study|Exclusion criterion met|0|||
23382347|NCT01136915|65145022|FG001|Overall Study|Exclusion criterion met|1|||
23382348|NCT02638493|65145024|FG000|Overall Study|Inability to provide semen samples|2|||
23382349|NCT02638493|65145025|FG001|Overall Study|Inability to provide semen samples|0|||
23382350|NCT02638493|65145026|FG002|Overall Study|Inability to provide semen samples|0|||
23382351|NCT03286504|65145029|FG000|Overall Study|Lost to Follow-up|19|||
23382352|NCT03286504|65145030|FG001|Overall Study|Lost to Follow-up|16|||
23382353|NCT00266812|65145035|FG000|Overall Study|Disease Progression|9|||
23382354|NCT00266812|65145036|FG001|Overall Study|Disease Progression|3|||
23382355|NCT00266812|65145035|FG000|Overall Study|Death|5|||
23382356|NCT00266812|65145036|FG001|Overall Study|Death|4|||
23382357|NCT00266812|65145035|FG000|Overall Study|Adverse Event|3|||
23382358|NCT00266812|65145036|FG001|Overall Study|Adverse Event|1|||
23382359|NCT00266812|65145035|FG000|Overall Study|Protocol Violation|0|||
23382360|NCT00266812|65145036|FG001|Overall Study|Protocol Violation|1|||
23382361|NCT00266812|65145035|FG000|Overall Study|Withdrawal by Subject|0|||
23382362|NCT00266812|65145036|FG001|Overall Study|Withdrawal by Subject|2|||
23382363|NCT00266812|65145035|FG000|Overall Study|Discontinued before starting study drug|4|||
23382364|NCT00266812|65145036|FG001|Overall Study|Discontinued before starting study drug|0|||
23382365|NCT01121926|65145037|FG000|First Intervention Period|Adverse Event|1|||
23382366|NCT01121926|65145038|FG001|First Intervention Period|Adverse Event|0|||
23382367|NCT01121926|65145037|FG000|Washout Period|Adverse Event|0|||
23382368|NCT01121926|65145038|FG001|Washout Period|Adverse Event|1|||
23382369|NCT01121926|65145037|FG000|Washout Period|Positive pregnancy test|0|||
23382370|NCT01121926|65145038|FG001|Washout Period|Positive pregnancy test|1|||
23382371|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
23382372|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
23382373|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
23382374|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
23382375|NCT00849472|65145041|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
23382376|NCT00849472|65145041|FG000|Weekly Paclitaxel|Disease Progression|1|||
23382377|NCT00849472|65145041|FG000|Weekly Paclitaxel|Adverse Event|11|||
23382378|NCT00849472|65145041|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
23382379|NCT00849472|65145041|FG000|Weekly Paclitaxel|Physician Decision|3|||
23382380|NCT00849472|65145041|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
23382381|NCT00849472|65145041|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
23382382|NCT00849472|65145041|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
23382383|NCT00849472|65145041|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
23382384|NCT00849472|65145041|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
23605961|NCT01640951|65947107|FG006|Overall Study|Protocol Deviation|0|||
23382385|NCT00849472|65145041|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
23382386|NCT00849472|65145041|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
23382387|NCT00849472|65145041|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
23382388|NCT01363440|65145042|FG000|Overall Study|Adverse Event|5|||
23382389|NCT01363440|65145043|FG001|Overall Study|Adverse Event|4|||
23382390|NCT01363440|65145044|FG002|Overall Study|Adverse Event|4|||
23382391|NCT01363440|65145042|FG000|Overall Study|Death|3|||
23382392|NCT01363440|65145043|FG001|Overall Study|Death|7|||
23382393|NCT01363440|65145044|FG002|Overall Study|Death|5|||
23382394|NCT01363440|65145042|FG000|Overall Study|Withdrawal by Subject|9|||
23382395|NCT01363440|65145043|FG001|Overall Study|Withdrawal by Subject|11|||
23382396|NCT01363440|65145044|FG002|Overall Study|Withdrawal by Subject|11|||
23382397|NCT01363440|65145042|FG000|Overall Study|Lost to Follow-up|2|||
23382398|NCT01363440|65145043|FG001|Overall Study|Lost to Follow-up|4|||
23382399|NCT01363440|65145044|FG002|Overall Study|Lost to Follow-up|5|||
23382400|NCT01363440|65145042|FG000|Overall Study|Other|4|||
23382401|NCT01363440|65145043|FG001|Overall Study|Other|5|||
23382402|NCT01363440|65145044|FG002|Overall Study|Other|2|||
23382403|NCT02323334|65145046|FG000|Period 3|Lost to Follow-up|0|||
23382404|NCT02323334|65145047|FG001|Period 3|Lost to Follow-up|0|||
23382405|NCT02323334|65145048|FG002|Period 3|Lost to Follow-up|1|||
23382406|NCT02323334|65145049|FG003|Period 3|Lost to Follow-up|0|||
23492870|NCT02281773|65548243|FG000|Overall Study|Withdrawal by Subject|2|||
23492871|NCT02281773|65548244|FG001|Overall Study|Withdrawal by Subject|8|||
23492872|NCT02281773|65548245|FG002|Overall Study|Withdrawal by Subject|6|||
23492873|NCT02281773|65548246|FG003|Overall Study|Withdrawal by Subject|6|||
23492874|NCT02281773|65548247|FG004|Overall Study|Withdrawal by Subject|8|||
23492875|NCT02281773|65548243|FG000|Overall Study|Other Reason|0|||
23492876|NCT02281773|65548244|FG001|Overall Study|Other Reason|4|||
23492877|NCT02281773|65548245|FG002|Overall Study|Other Reason|2|||
23492878|NCT02281773|65548246|FG003|Overall Study|Other Reason|3|||
23492879|NCT02281773|65548247|FG004|Overall Study|Other Reason|1|||
23492880|NCT02213042|65548248|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
23492881|NCT02213042|65548249|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
23492882|NCT02213042|65548250|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
23492883|NCT02213042|65548248|FG000|Overall Study|Adverse Event|2|||
23492884|NCT02213042|65548249|FG001|Overall Study|Adverse Event|1|||
23492885|NCT02213042|65548250|FG002|Overall Study|Adverse Event|0|||
23492886|NCT02213042|65548248|FG000|Overall Study|Withdrawal by Subject|0|||
23492887|NCT02213042|65548249|FG001|Overall Study|Withdrawal by Subject|1|||
23492888|NCT02213042|65548250|FG002|Overall Study|Withdrawal by Subject|1|||
23492889|NCT02213042|65548248|FG000|Overall Study|Protocol Violation|1|||
23492890|NCT02213042|65548249|FG001|Overall Study|Protocol Violation|0|||
23492891|NCT02213042|65548250|FG002|Overall Study|Protocol Violation|0|||
23492892|NCT02213042|65548248|FG000|Overall Study|Investigator discretion|0|||
23492893|NCT02213042|65548249|FG001|Overall Study|Investigator discretion|0|||
23492894|NCT02213042|65548250|FG002|Overall Study|Investigator discretion|1|||
23492895|NCT02147184|65548255|FG000|Overall Study|Lost to Follow-up|28|||
23492896|NCT02147184|65548256|FG001|Overall Study|Lost to Follow-up|15|||
23492897|NCT02147184|65548255|FG000|Overall Study|Study Burden|11|||
23382407|NCT02323334|65145050|FG004|Period 3|Lost to Follow-up|0|||
23492898|NCT02147184|65548256|FG001|Overall Study|Study Burden|7|||
23492899|NCT02147184|65548255|FG000|Overall Study|Pregnancy|6|||
23492900|NCT02147184|65548256|FG001|Overall Study|Pregnancy|0|||
23492901|NCT02147184|65548255|FG000|Overall Study|Moved out of state|3|||
23492902|NCT02147184|65548256|FG001|Overall Study|Moved out of state|3|||
23492903|NCT02147184|65548255|FG000|Overall Study|Physician Decision|0|||
23382408|NCT02323334|65145051|FG005|Period 3|Lost to Follow-up|0|||
23492904|NCT02147184|65548256|FG001|Overall Study|Physician Decision|2|||
23492905|NCT02147184|65548255|FG000|Overall Study|Other|1|||
23492906|NCT02147184|65548256|FG001|Overall Study|Other|0|||
23382409|NCT02323334|65145052|FG006|Period 3|Lost to Follow-up|0|||
23492907|NCT00370071|65548260|FG000|Overall Study|Withdrawal by Subject|2|||
23492908|NCT03643575|65548261|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
23382410|NCT02323334|65145053|FG007|Period 3|Lost to Follow-up|0|||
23382411|NCT02323334|65145054|FG008|Period 3|Lost to Follow-up|0|||
23382412|NCT02323334|65145055|FG009|Period 3|Lost to Follow-up|0|||
23382413|NCT02323334|65145056|FG010|Period 3|Lost to Follow-up|0|||
23382414|NCT02323334|65145057|FG011|Period 3|Lost to Follow-up|0|||
23382415|NCT02323334|65145058|FG012|Period 3|Lost to Follow-up|0|||
23382416|NCT02323334|65145059|FG013|Period 3|Lost to Follow-up|0|||
23382417|NCT02323334|65145060|FG014|Period 3|Lost to Follow-up|0|||
23382418|NCT02323334|65145061|FG015|Period 3|Lost to Follow-up|0|||
23382419|NCT02323334|65145062|FG016|Period 3|Lost to Follow-up|0|||
23382420|NCT02323334|65145046|FG000|Period 3|Withdrawal by Subject|1|||
23382421|NCT02323334|65145047|FG001|Period 3|Withdrawal by Subject|0|||
23382422|NCT02323334|65145048|FG002|Period 3|Withdrawal by Subject|0|||
23382423|NCT02323334|65145049|FG003|Period 3|Withdrawal by Subject|0|||
23382424|NCT02323334|65145050|FG004|Period 3|Withdrawal by Subject|0|||
23382425|NCT02323334|65145051|FG005|Period 3|Withdrawal by Subject|0|||
23382426|NCT02323334|65145052|FG006|Period 3|Withdrawal by Subject|0|||
23382427|NCT02323334|65145053|FG007|Period 3|Withdrawal by Subject|0|||
23382428|NCT02323334|65145054|FG008|Period 3|Withdrawal by Subject|0|||
23382429|NCT02323334|65145055|FG009|Period 3|Withdrawal by Subject|0|||
23382430|NCT02323334|65145056|FG010|Period 3|Withdrawal by Subject|0|||
23382431|NCT02323334|65145057|FG011|Period 3|Withdrawal by Subject|0|||
23382432|NCT02323334|65145058|FG012|Period 3|Withdrawal by Subject|0|||
23382433|NCT02323334|65145059|FG013|Period 3|Withdrawal by Subject|0|||
23382434|NCT02323334|65145060|FG014|Period 3|Withdrawal by Subject|0|||
23382435|NCT02323334|65145061|FG015|Period 3|Withdrawal by Subject|0|||
23382436|NCT02323334|65145062|FG016|Period 3|Withdrawal by Subject|0|||
23382437|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
23382438|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
23382439|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
23382440|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
23382441|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
23382442|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
23382443|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
23382444|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
23382445|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
23382446|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
23382447|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
23382448|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
23382449|NCT00447278|65145063|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
23382450|NCT00447278|65145064|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
23382451|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
23382452|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
23382453|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
23492909|NCT03643575|65548262|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
23492910|NCT03643575|65548263|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
23492911|NCT03643575|65548264|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
23492912|NCT03643575|65548265|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
23492913|NCT03643575|65548266|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
23492914|NCT03643575|65548261|FG000|Washout: 7 Days|Adverse Event|1|||
23492915|NCT03643575|65548262|FG001|Washout: 7 Days|Adverse Event|0|||
23492916|NCT03643575|65548263|FG002|Washout: 7 Days|Adverse Event|0|||
23492917|NCT03643575|65548264|FG003|Washout: 7 Days|Adverse Event|0|||
23492918|NCT03643575|65548265|FG004|Washout: 7 Days|Adverse Event|0|||
23492919|NCT03643575|65548266|FG005|Washout: 7 Days|Adverse Event|0|||
23492920|NCT03643575|65548261|FG000|Washout: 7 Days|Non compliance check in|0|||
23492921|NCT03643575|65548262|FG001|Washout: 7 Days|Non compliance check in|1|||
23492922|NCT03643575|65548263|FG002|Washout: 7 Days|Non compliance check in|0|||
23492923|NCT03643575|65548264|FG003|Washout: 7 Days|Non compliance check in|0|||
23492924|NCT03643575|65548265|FG004|Washout: 7 Days|Non compliance check in|0|||
23492925|NCT03643575|65548266|FG005|Washout: 7 Days|Non compliance check in|0|||
23382454|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
23382455|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
23382456|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
23382457|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
23382458|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
23382459|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
23492926|NCT02405780|65548267|FG000|Period I|Adverse Event|8|||
23492927|NCT02405780|65548268|FG001|Period I|Adverse Event|0|||
23492928|NCT02405780|65548269|FG002|Period I|Adverse Event|3|||
23492929|NCT02405780|65548270|FG003|Period I|Adverse Event|7|||
23492930|NCT02405780|65548267|FG000|Period I|Medical reasons|1|||
23492931|NCT02405780|65548268|FG001|Period I|Medical reasons|1|||
23382460|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
23382461|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
23382462|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
23382463|NCT00447278|65145063|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
23382464|NCT00447278|65145064|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
23382465|NCT02315625|65145065|FG000|First Intervention|Disease Progression|1|||
23382466|NCT02315625|65145066|FG001|First Intervention|Disease Progression|0|||
23382467|NCT02315625|65145065|FG000|Second Intervention|Physician Decision|2|||
23382468|NCT02315625|65145066|FG001|Second Intervention|Physician Decision|1|||
23382469|NCT02315625|65145065|FG000|Second Intervention|Study closure|1|||
23382470|NCT02315625|65145066|FG001|Second Intervention|Study closure|0|||
23382471|NCT02315625|65145065|FG000|Second Intervention|Disease Progression|1|||
23382472|NCT02315625|65145066|FG001|Second Intervention|Disease Progression|0|||
23382473|NCT01617967|65145067|FG000|Overall Study|Protocol Violation|0|||
23382474|NCT01617967|65145068|FG001|Overall Study|Protocol Violation|0|||
23382475|NCT01617967|65145069|FG002|Overall Study|Protocol Violation|0|||
23382476|NCT01617967|65145070|FG003|Overall Study|Protocol Violation|1|||
23382477|NCT01617967|65145071|FG004|Overall Study|Protocol Violation|0|||
23382478|NCT01617967|65145072|FG005|Overall Study|Protocol Violation|0|||
23382479|NCT01617967|65145067|FG000|Overall Study|Withdrawal by Subject|0|||
23289730|NCT04158687|64801904|FG003|Overall Study|Adverse Event|3|||
23289731|NCT04158687|64801901|FG000|Overall Study|Lost to Follow-up|5|||
23289732|NCT04158687|64801902|FG001|Overall Study|Lost to Follow-up|12|||
23289733|NCT04158687|64801903|FG002|Overall Study|Lost to Follow-up|4|||
23289734|NCT04158687|64801904|FG003|Overall Study|Lost to Follow-up|5|||
23289735|NCT04158687|64801901|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
23289736|NCT04158687|64801902|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
23289737|NCT04158687|64801903|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
23289738|NCT04158687|64801904|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
23289739|NCT04158687|64801901|FG000|Overall Study|Non-Compliance with Study Medication|2|||
23289740|NCT04158687|64801902|FG001|Overall Study|Non-Compliance with Study Medication|2|||
23289741|NCT04158687|64801903|FG002|Overall Study|Non-Compliance with Study Medication|3|||
23289742|NCT04158687|64801904|FG003|Overall Study|Non-Compliance with Study Medication|0|||
23289743|NCT04158687|64801901|FG000|Overall Study|Investigator Decision|0|||
23289744|NCT04158687|64801902|FG001|Overall Study|Investigator Decision|0|||
23382480|NCT01617967|65145068|FG001|Overall Study|Withdrawal by Subject|0|||
23382481|NCT01617967|65145069|FG002|Overall Study|Withdrawal by Subject|0|||
23382482|NCT01617967|65145070|FG003|Overall Study|Withdrawal by Subject|0|||
23492932|NCT02405780|65548269|FG002|Period I|Medical reasons|0|||
23382483|NCT01617967|65145071|FG004|Overall Study|Withdrawal by Subject|0|||
23382484|NCT01617967|65145072|FG005|Overall Study|Withdrawal by Subject|1|||
23382485|NCT01617967|65145067|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
23382486|NCT01617967|65145068|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
23382487|NCT01617967|65145069|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
23382488|NCT01617967|65145070|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
23382489|NCT01617967|65145071|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
23382490|NCT01617967|65145072|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
23382491|NCT01290731|65145073|FG000|Overall Study|Withdrawal by Subject|1|||
23382492|NCT03679884|65145078|FG000|Overall Study|Other|12|||
23382493|NCT03679884|65145079|FG001|Overall Study|Other|12|||
23382494|NCT03679884|65145080|FG002|Overall Study|Other|12|||
23382495|NCT03679884|65145081|FG003|Overall Study|Other|7|||
23382496|NCT03679884|65145082|FG004|Overall Study|Other|8|||
23382497|NCT03679884|65145078|FG000|Overall Study|Lack of Efficacy|15|||
23382498|NCT03679884|65145079|FG001|Overall Study|Lack of Efficacy|29|||
23382499|NCT03679884|65145080|FG002|Overall Study|Lack of Efficacy|13|||
23382500|NCT03679884|65145081|FG003|Overall Study|Lack of Efficacy|29|||
23382501|NCT03679884|65145082|FG004|Overall Study|Lack of Efficacy|10|||
23382502|NCT03679884|65145078|FG000|Overall Study|Death|1|||
23382503|NCT03679884|65145079|FG001|Overall Study|Death|0|||
23382504|NCT03679884|65145080|FG002|Overall Study|Death|0|||
23382505|NCT03679884|65145081|FG003|Overall Study|Death|0|||
23382506|NCT03679884|65145082|FG004|Overall Study|Death|0|||
23382507|NCT03679884|65145078|FG000|Overall Study|Adverse Event|2|||
23382508|NCT03679884|65145079|FG001|Overall Study|Adverse Event|10|||
23382509|NCT03679884|65145080|FG002|Overall Study|Adverse Event|9|||
23382510|NCT03679884|65145081|FG003|Overall Study|Adverse Event|6|||
23382511|NCT03679884|65145082|FG004|Overall Study|Adverse Event|6|||
23382512|NCT03679884|65145078|FG000|Overall Study|Withdrawal by Subject|12|||
23382513|NCT03679884|65145079|FG001|Overall Study|Withdrawal by Subject|23|||
23382514|NCT03679884|65145080|FG002|Overall Study|Withdrawal by Subject|8|||
23382515|NCT03679884|65145081|FG003|Overall Study|Withdrawal by Subject|8|||
23382516|NCT03679884|65145082|FG004|Overall Study|Withdrawal by Subject|9|||
23382517|NCT03679884|65145078|FG000|Overall Study|Lost to Follow-up|1|||
23382518|NCT03679884|65145079|FG001|Overall Study|Lost to Follow-up|4|||
23382519|NCT03679884|65145080|FG002|Overall Study|Lost to Follow-up|2|||
23382520|NCT03679884|65145081|FG003|Overall Study|Lost to Follow-up|0|||
23382521|NCT03679884|65145082|FG004|Overall Study|Lost to Follow-up|3|||
23382522|NCT03655470|65145083|FG000|Overall Study|Lost to Follow-up|6|||
23382523|NCT03655470|65145084|FG001|Overall Study|Lost to Follow-up|7|||
23382524|NCT01481779|65145092|FG000|Overall Study|Adverse Event|23|||
23382525|NCT01481779|65145093|FG001|Overall Study|Adverse Event|5|||
23382526|NCT01481779|65145092|FG000|Overall Study|Lost to Follow-up|3|||
23382527|NCT01481779|65145093|FG001|Overall Study|Lost to Follow-up|2|||
23382528|NCT01481779|65145092|FG000|Overall Study|Protocol Violation|2|||
23382529|NCT01481779|65145093|FG001|Overall Study|Protocol Violation|3|||
23382530|NCT01481779|65145092|FG000|Overall Study|Withdrawal by Subject|26|||
23382531|NCT01481779|65145093|FG001|Overall Study|Withdrawal by Subject|13|||
23382532|NCT01481779|65145092|FG000|Overall Study|Physician Decision|13|||
23382533|NCT01481779|65145093|FG001|Overall Study|Physician Decision|4|||
23382534|NCT01481779|65145092|FG000|Overall Study|Sponsor Decision|3|||
23382535|NCT01481779|65145093|FG001|Overall Study|Sponsor Decision|1|||
23382536|NCT00471354|65145094|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
23382537|NCT00471354|65145094|FG000|Overall Study|Adverse Event|13|||
23382538|NCT00471354|65145094|FG000|Overall Study|Protocol Violation|12|||
23382539|NCT00471354|65145094|FG000|Overall Study|Withdrawal by Subject|1|||
23382540|NCT00471354|65145094|FG000|Overall Study|Physician Decision|4|||
23382541|NCT00471354|65145094|FG000|Overall Study|Sponsor Decision|1|||
23382542|NCT00471354|65145094|FG000|Overall Study|Lost to Follow-up|3|||
23382543|NCT00471354|65145094|FG000|Overall Study|Lack of Efficacy|5|||
23382544|NCT00471354|65145094|FG000|Overall Study|Patient/Caregiver Decision|12|||
23382545|NCT01483651|65145096|FG000|Overall Study|Withdrawal by Subject|0|||
23382546|NCT01483651|65145097|FG001|Overall Study|Withdrawal by Subject|1|||
23382547|NCT01483651|65145098|FG002|Overall Study|Withdrawal by Subject|1|||
23382548|NCT01483651|65145099|FG003|Overall Study|Withdrawal by Subject|0|||
23382549|NCT01483651|65145100|FG004|Overall Study|Withdrawal by Subject|0|||
23382550|NCT01483651|65145101|FG005|Overall Study|Withdrawal by Subject|1|||
23382551|NCT00676052|65145104|FG000|Overall Study|Adverse Event|0|||
23382552|NCT00676052|65145105|FG001|Overall Study|Adverse Event|1|||
23382553|NCT00676052|65145106|FG002|Overall Study|Adverse Event|1|||
23382554|NCT00676052|65145107|FG003|Overall Study|Adverse Event|2|||
23382555|NCT00676052|65145108|FG004|Overall Study|Adverse Event|2|||
23382556|NCT00676052|65145109|FG005|Overall Study|Adverse Event|2|||
23382557|NCT00676052|65145104|FG000|Overall Study|Lack of Efficacy|2|||
23382558|NCT00676052|65145105|FG001|Overall Study|Lack of Efficacy|2|||
23382559|NCT00676052|65145106|FG002|Overall Study|Lack of Efficacy|1|||
23382560|NCT00676052|65145107|FG003|Overall Study|Lack of Efficacy|1|||
23382561|NCT00676052|65145108|FG004|Overall Study|Lack of Efficacy|2|||
23382562|NCT00676052|65145109|FG005|Overall Study|Lack of Efficacy|1|||
23382563|NCT00676052|65145104|FG000|Overall Study|Protocol Violation|5|||
23382564|NCT00676052|65145105|FG001|Overall Study|Protocol Violation|3|||
23382565|NCT00676052|65145106|FG002|Overall Study|Protocol Violation|2|||
23382566|NCT00676052|65145107|FG003|Overall Study|Protocol Violation|2|||
23382567|NCT00676052|65145108|FG004|Overall Study|Protocol Violation|1|||
23382568|NCT00676052|65145109|FG005|Overall Study|Protocol Violation|2|||
23382569|NCT00676052|65145104|FG000|Overall Study|Lost to Follow-up|0|||
23382570|NCT00676052|65145105|FG001|Overall Study|Lost to Follow-up|0|||
23382571|NCT00676052|65145106|FG002|Overall Study|Lost to Follow-up|0|||
23382572|NCT00676052|65145107|FG003|Overall Study|Lost to Follow-up|0|||
23382573|NCT00676052|65145108|FG004|Overall Study|Lost to Follow-up|1|||
23382574|NCT00676052|65145109|FG005|Overall Study|Lost to Follow-up|0|||
23382575|NCT00676052|65145104|FG000|Overall Study|Physician Decision|1|||
23382576|NCT00676052|65145105|FG001|Overall Study|Physician Decision|1|||
23382577|NCT00676052|65145106|FG002|Overall Study|Physician Decision|1|||
23382578|NCT00676052|65145107|FG003|Overall Study|Physician Decision|0|||
23382579|NCT00676052|65145108|FG004|Overall Study|Physician Decision|0|||
23382580|NCT00676052|65145109|FG005|Overall Study|Physician Decision|1|||
23382581|NCT00676052|65145104|FG000|Overall Study|Withdrawal by Subject|1|||
23382582|NCT00676052|65145105|FG001|Overall Study|Withdrawal by Subject|0|||
23382583|NCT00676052|65145106|FG002|Overall Study|Withdrawal by Subject|1|||
23382584|NCT00676052|65145107|FG003|Overall Study|Withdrawal by Subject|0|||
23382585|NCT00676052|65145108|FG004|Overall Study|Withdrawal by Subject|0|||
23382586|NCT00676052|65145109|FG005|Overall Study|Withdrawal by Subject|0|||
23382587|NCT01185366|65145114|FG000|First Line Therapy|Insurance Coverage Denied|1|||
23382588|NCT01185366|65145115|FG001|First Line Therapy|Insurance Coverage Denied|1|||
23382589|NCT01185366|65145114|FG000|First Line Therapy|Withdrawal by Subject|1|||
23382590|NCT01185366|65145115|FG001|First Line Therapy|Withdrawal by Subject|0|||
23382591|NCT01185366|65145114|FG000|First Line Therapy|Lack of Metastatic Site|1|||
23382592|NCT01185366|65145115|FG001|First Line Therapy|Lack of Metastatic Site|0|||
23382593|NCT01185366|65145114|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
23382594|NCT01185366|65145115|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
23382595|NCT01185366|65145114|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
23382596|NCT01185366|65145115|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
23382597|NCT01185366|65145114|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
23382598|NCT01185366|65145115|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
23289745|NCT04158687|64801903|FG002|Overall Study|Investigator Decision|2|||
23289746|NCT04158687|64801904|FG003|Overall Study|Investigator Decision|0|||
23289747|NCT04158687|64801901|FG000|Overall Study|Protocol Violation|0|||
23289748|NCT04158687|64801902|FG001|Overall Study|Protocol Violation|2|||
23289749|NCT04158687|64801903|FG002|Overall Study|Protocol Violation|1|||
23289750|NCT04158687|64801904|FG003|Overall Study|Protocol Violation|0|||
23289751|NCT04158687|64801901|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
23289752|NCT04158687|64801902|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
23289753|NCT04158687|64801903|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
23289754|NCT04158687|64801904|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
23289755|NCT04158687|64801901|FG000|Overall Study|Reason not Specified|3|||
23289756|NCT04158687|64801902|FG001|Overall Study|Reason not Specified|2|||
23289757|NCT04158687|64801903|FG002|Overall Study|Reason not Specified|4|||
23289758|NCT04158687|64801904|FG003|Overall Study|Reason not Specified|4|||
23289759|NCT03727139|64801905|FG000|Overall Study|Protocol Violation|60|||
23289760|NCT00640393|64801909|FG000|Part 1|Lost to Follow-up|2|||
23289761|NCT00640393|64801910|FG001|Part 1|Lost to Follow-up|0|||
23289762|NCT00640393|64801911|FG002|Part 1|Lost to Follow-up|0|||
23289763|NCT00640393|64801909|FG000|Part 1|Withdrawal by Subject|3|||
23289764|NCT00640393|64801910|FG001|Part 1|Withdrawal by Subject|0|||
23289765|NCT00640393|64801911|FG002|Part 1|Withdrawal by Subject|0|||
23289766|NCT00640393|64801909|FG000|Randomization|Withdrawn per protocol|17|||
23289767|NCT00640393|64801910|FG001|Randomization|Withdrawn per protocol|0|||
23289768|NCT00640393|64801911|FG002|Randomization|Withdrawn per protocol|0|||
23289769|NCT00640393|64801909|FG000|Randomization|Never randomized by site|2|||
23289770|NCT00640393|64801910|FG001|Randomization|Never randomized by site|0|||
23289771|NCT00640393|64801911|FG002|Randomization|Never randomized by site|0|||
23289772|NCT00640393|64801909|FG000|Part 2|Lost to Follow-up|0|||
23289773|NCT00640393|64801910|FG001|Part 2|Lost to Follow-up|2|||
23289774|NCT00640393|64801911|FG002|Part 2|Lost to Follow-up|2|||
23289775|NCT00640393|64801909|FG000|Part 2|Withdrawal by Subject|0|||
23289776|NCT00640393|64801910|FG001|Part 2|Withdrawal by Subject|6|||
23289777|NCT00640393|64801911|FG002|Part 2|Withdrawal by Subject|1|||
23289778|NCT00640393|64801909|FG000|Part 2|Non-adherence|0|||
23289779|NCT00640393|64801910|FG001|Part 2|Non-adherence|1|||
23289780|NCT00640393|64801911|FG002|Part 2|Non-adherence|0|||
23289781|NCT00640393|64801909|FG000|Part 2|Adverse Event|0|||
23289782|NCT00640393|64801910|FG001|Part 2|Adverse Event|1|||
23382599|NCT01185366|65145114|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
23382600|NCT01185366|65145115|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
23382601|NCT03123588|65145116|FG000|Overall Study|Study Terminated by Sponsor|2|||
23382602|NCT03123588|65145117|FG001|Overall Study|Study Terminated by Sponsor|5|||
23382603|NCT03123588|65145116|FG000|Overall Study|Withdrawal by Subject|1|||
23289783|NCT00640393|64801911|FG002|Part 2|Adverse Event|0|||
23289784|NCT00562120|64801914|FG000|First Intervention Period|Adverse Event|1|||
23289785|NCT00562120|64801915|FG001|First Intervention Period|Adverse Event|0|||
23382604|NCT03123588|65145117|FG001|Overall Study|Withdrawal by Subject|0|||
23382605|NCT03123588|65145116|FG000|Overall Study|Adverse Event|1|||
23382606|NCT03123588|65145117|FG001|Overall Study|Adverse Event|0|||
23382607|NCT03123588|65145116|FG000|Overall Study|Physician Decision|2|||
23382608|NCT03123588|65145117|FG001|Overall Study|Physician Decision|1|||
23382609|NCT02487199|65145120|FG000|Overall Study|Withdrew Consent|0|||
23382610|NCT02487199|65145121|FG001|Overall Study|Withdrew Consent|1|||
23382611|NCT01905683|65145122|FG000|Overall Study|Protocol Violation|1|||
23382612|NCT01905683|65145122|FG000|Overall Study|Re-injection criteria not met; others|13|||
23382613|NCT01905683|65145122|FG000|Overall Study|Physician Decision|1|||
23382614|NCT01905683|65145122|FG000|Overall Study|Lack of Efficacy|8|||
23382615|NCT01905683|65145122|FG000|Overall Study|Withdrawal by Subject|20|||
23382616|NCT01905683|65145122|FG000|Overall Study|Adverse Event|4|||
23382617|NCT01905683|65145122|FG000|Overall Study|Lost to Follow-up|4|||
23382618|NCT03033901|65145125|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
23382619|NCT03033901|65145125|FG000|Overall Study|Refused PSG|23|||
23382620|NCT03033901|65145125|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
23382621|NCT03033901|65145125|FG000|Overall Study|Missing Oximetry Data|3|||
23382622|NCT00544882|65145128|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
23382623|NCT00544882|65145129|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
23382624|NCT00544882|65145130|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
23382625|NCT00544882|65145128|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
23382626|NCT00544882|65145129|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
23382627|NCT00544882|65145130|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
23382628|NCT00544882|65145128|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
23289786|NCT00562120|64801916|FG002|First Intervention Period|Adverse Event|0|||
23289787|NCT00562120|64801917|FG003|First Intervention Period|Adverse Event|0|||
23289788|NCT00562120|64801914|FG000|First Intervention Period|Randomized but not Treated|1|||
23289789|NCT00562120|64801915|FG001|First Intervention Period|Randomized but not Treated|0|||
23289790|NCT00562120|64801916|FG002|First Intervention Period|Randomized but not Treated|0|||
23289791|NCT00562120|64801917|FG003|First Intervention Period|Randomized but not Treated|0|||
23289792|NCT04668274|64801918|FG000|Part 1 Study Period 1|Adverse Event|3|||
23289793|NCT04668274|64801919|FG001|Part 1 Study Period 1|Adverse Event|0|||
23289794|NCT04668274|64801920|FG002|Part 1 Study Period 1|Adverse Event|0|||
23289795|NCT04668274|64801921|FG003|Part 1 Study Period 1|Adverse Event|0|||
23289796|NCT04668274|64801918|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
23289797|NCT04668274|64801919|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
23289798|NCT04668274|64801920|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
23289799|NCT04668274|64801921|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
23289800|NCT04668274|64801918|FG000|Part 1 Study Period 2|Other|0|||
23289801|NCT04668274|64801919|FG001|Part 1 Study Period 2|Other|1|||
23289802|NCT04668274|64801920|FG002|Part 1 Study Period 2|Other|0|||
23289803|NCT04668274|64801921|FG003|Part 1 Study Period 2|Other|0|||
23289804|NCT04668274|64801918|FG000|Part 1 Study Period 3|Adverse Event|0|||
23289805|NCT04668274|64801919|FG001|Part 1 Study Period 3|Adverse Event|0|||
23289806|NCT04668274|64801920|FG002|Part 1 Study Period 3|Adverse Event|1|||
23289807|NCT04668274|64801921|FG003|Part 1 Study Period 3|Adverse Event|0|||
23289808|NCT04668274|64801918|FG000|Part 1 Study Period 3|Other|0|||
23289809|NCT04668274|64801919|FG001|Part 1 Study Period 3|Other|0|||
23289810|NCT04668274|64801920|FG002|Part 1 Study Period 3|Other|2|||
23289811|NCT04668274|64801921|FG003|Part 1 Study Period 3|Other|0|||
23289812|NCT04668274|64801918|FG000|Part 2 Study Period 4|Other|0|||
23289813|NCT04668274|64801919|FG001|Part 2 Study Period 4|Other|0|||
23289814|NCT04668274|64801920|FG002|Part 2 Study Period 4|Other|0|||
23289815|NCT04668274|64801921|FG003|Part 2 Study Period 4|Other|1|||
23289816|NCT00697619|64801922|FG000|Overall Study|Lack of Efficacy|2|||
23289817|NCT00697619|64801923|FG001|Overall Study|Lack of Efficacy|2|||
23289818|NCT00697619|64801922|FG000|Overall Study|Adverse Event|4|||
23289819|NCT00697619|64801923|FG001|Overall Study|Adverse Event|6|||
23289820|NCT05497557|64801924|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
23382629|NCT00544882|65145129|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
23382630|NCT00544882|65145130|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
23382631|NCT00544882|65145128|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
23382632|NCT00544882|65145129|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
23382633|NCT00544882|65145130|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
23382634|NCT00544882|65145128|FG000|Cycle 3: Follow-up|Noncompliance|0|||
23289821|NCT05497557|64801925|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
23289822|NCT05497557|64801926|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
23289823|NCT01050764|64801930|FG000|Overall Study|Death, before HSCT|1|||
23289824|NCT01050764|64801930|FG000|Overall Study|Donor mobilization failure, death|1|||
23289825|NCT01050764|64801930|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
23289826|NCT02377349|64801934|FG000|Overall Study|Serious Adverse Event|1|||
23289827|NCT02377349|64801935|FG001|Overall Study|Serious Adverse Event|0|||
23289828|NCT02377349|64801934|FG000|Overall Study|Protocol Violation|3|||
23289829|NCT02377349|64801935|FG001|Overall Study|Protocol Violation|2|||
23289830|NCT02377349|64801934|FG000|Overall Study|Withdrawal by Subject|5|||
23289831|NCT02377349|64801935|FG001|Overall Study|Withdrawal by Subject|3|||
23289832|NCT02377349|64801934|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
23289833|NCT02377349|64801935|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
23289834|NCT02377349|64801934|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
23382635|NCT00544882|65145129|FG001|Cycle 3: Follow-up|Noncompliance|1|||
23382636|NCT00544882|65145130|FG002|Cycle 3: Follow-up|Noncompliance|0|||
23382637|NCT00544882|65145128|FG000|Cycle 3: Follow-up|Pregnancy|0|||
23382638|NCT00544882|65145129|FG001|Cycle 3: Follow-up|Pregnancy|1|||
23382639|NCT00544882|65145130|FG002|Cycle 3: Follow-up|Pregnancy|0|||
23382640|NCT02582632|65145131|FG000|Overall Study|Other|1|||
23382641|NCT01180777|65145132|FG000|Overall Study|Protocol Violation|6|||
23382642|NCT01180777|65145132|FG000|Overall Study|Poor lens fit|4|||
23382643|NCT01180777|65145132|FG000|Overall Study|Lost to Follow-up|1|||
23382644|NCT01180777|65145132|FG000|Overall Study|Adverse Event|1|||
23382645|NCT04615507|65145135|FG000|Period 1|Covid-19 exposure|2|||
23382646|NCT04615507|65145136|FG001|Period 1|Covid-19 exposure|1|||
23382647|NCT04615507|65145135|FG000|Period 2|Covid-19 exposure|0|||
23492933|NCT02405780|65548270|FG003|Period I|Medical reasons|1|||
23492934|NCT02405780|65548267|FG000|Period I|Screening Failure|1|||
23492935|NCT02405780|65548268|FG001|Period I|Screening Failure|0|||
23492936|NCT02405780|65548269|FG002|Period I|Screening Failure|1|||
23492937|NCT02405780|65548270|FG003|Period I|Screening Failure|0|||
23492938|NCT02405780|65548267|FG000|Period I|Withdrawal by Subject|9|||
23492939|NCT02405780|65548268|FG001|Period I|Withdrawal by Subject|1|||
23492940|NCT02405780|65548269|FG002|Period I|Withdrawal by Subject|3|||
23492941|NCT02405780|65548270|FG003|Period I|Withdrawal by Subject|4|||
23492942|NCT02405780|65548267|FG000|Period I|Non-compliance with study procedures|8|||
23492943|NCT02405780|65548268|FG001|Period I|Non-compliance with study procedures|6|||
23492944|NCT02405780|65548269|FG002|Period I|Non-compliance with study procedures|8|||
23492945|NCT02405780|65548270|FG003|Period I|Non-compliance with study procedures|11|||
23492946|NCT02405780|65548267|FG000|Period II|Adverse Event|3|||
23492947|NCT02405780|65548268|FG001|Period II|Adverse Event|5|||
23492948|NCT02405780|65548269|FG002|Period II|Adverse Event|4|||
23492949|NCT02405780|65548270|FG003|Period II|Adverse Event|11|||
23492950|NCT02405780|65548267|FG000|Period II|Medical reason|0|||
23492951|NCT02405780|65548268|FG001|Period II|Medical reason|1|||
23492952|NCT02405780|65548269|FG002|Period II|Medical reason|0|||
23492953|NCT02405780|65548270|FG003|Period II|Medical reason|0|||
23492954|NCT02405780|65548267|FG000|Period II|Pregnancy|0|||
23492955|NCT02405780|65548268|FG001|Period II|Pregnancy|0|||
23492956|NCT02405780|65548269|FG002|Period II|Pregnancy|1|||
23492957|NCT02405780|65548270|FG003|Period II|Pregnancy|0|||
23492958|NCT02405780|65548267|FG000|Period II|Withdrawal by Subject|7|||
23492959|NCT02405780|65548268|FG001|Period II|Withdrawal by Subject|4|||
23492960|NCT02405780|65548269|FG002|Period II|Withdrawal by Subject|0|||
23492961|NCT02405780|65548270|FG003|Period II|Withdrawal by Subject|3|||
23492962|NCT02405780|65548267|FG000|Period II|Non-compliance with study procedures|5|||
23492963|NCT02405780|65548268|FG001|Period II|Non-compliance with study procedures|2|||
23492964|NCT02405780|65548269|FG002|Period II|Non-compliance with study procedures|7|||
23492965|NCT02405780|65548270|FG003|Period II|Non-compliance with study procedures|4|||
23492966|NCT02282358|65548271|FG000|Overall Study|Nonevaluable|1|||
23289835|NCT02377349|64801935|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
23382648|NCT04615507|65145136|FG001|Period 2|Covid-19 exposure|1|||
23382649|NCT04615507|65145135|FG000|Period 2|Protocol Violation|1|||
23382650|NCT04615507|65145136|FG001|Period 2|Protocol Violation|0|||
23382651|NCT04615507|65145135|FG000|Period 2|Withdrawal by Subject|1|||
23492967|NCT02586064|65548273|FG000|Overall Study|Other Obligations|6|||
23492968|NCT02586064|65548274|FG001|Overall Study|Other Obligations|6|||
23492969|NCT02586064|65548273|FG000|Overall Study|Other|3|||
23492970|NCT02586064|65548274|FG001|Overall Study|Other|7|||
23492971|NCT02586064|65548273|FG000|Overall Study|Never Started|3|||
23289836|NCT02377349|64801934|FG000|Overall Study|Other|0|||
23289837|NCT02377349|64801935|FG001|Overall Study|Other|1|||
23382652|NCT04615507|65145136|FG001|Period 2|Withdrawal by Subject|0|||
23382653|NCT04615507|65145135|FG000|Period 2|Adverse Event|0|||
23382654|NCT04615507|65145136|FG001|Period 2|Adverse Event|1|||
23382655|NCT04615507|65145135|FG000|Period 3|Covid-19 exposure|0|||
23382656|NCT04615507|65145136|FG001|Period 3|Covid-19 exposure|1|||
23492972|NCT02586064|65548274|FG001|Overall Study|Never Started|3|||
23492973|NCT02586064|65548273|FG000|Overall Study|Lost Interest|1|||
23492974|NCT02586064|65548274|FG001|Overall Study|Lost Interest|4|||
23492975|NCT02586064|65548273|FG000|Overall Study|Miscellaneous Life Issues|0|||
23492976|NCT02586064|65548274|FG001|Overall Study|Miscellaneous Life Issues|5|||
23492977|NCT02586064|65548273|FG000|Overall Study|Infrequent Attendance|2|||
23492978|NCT02586064|65548274|FG001|Overall Study|Infrequent Attendance|1|||
23492979|NCT02586064|65548273|FG000|Overall Study|Timed Out|2|||
23492980|NCT02586064|65548274|FG001|Overall Study|Timed Out|0|||
23492981|NCT02586064|65548273|FG000|Overall Study|AUD relapse|0|||
23492982|NCT02586064|65548274|FG001|Overall Study|AUD relapse|2|||
23492983|NCT02586064|65548273|FG000|Overall Study|Legal Issue|1|||
23492984|NCT02586064|65548274|FG001|Overall Study|Legal Issue|0|||
23492985|NCT00573937|65548275|FG000|Overall Study|Study Terminated|0|||
23492986|NCT00573937|65548276|FG001|Overall Study|Study Terminated|1|||
23492987|NCT00395733|65548277|FG000|Period 2|Withdrawal by Subject|1|||
23492988|NCT00395733|65548278|FG001|Period 2|Withdrawal by Subject|2|||
23492989|NCT00395733|65548277|FG000|Period 2|Protocol Violation|0|||
23492990|NCT00395733|65548278|FG001|Period 2|Protocol Violation|1|||
23492991|NCT00395733|65548277|FG000|Period 2|Adverse Event|0|||
23492992|NCT00395733|65548278|FG001|Period 2|Adverse Event|2|||
23492993|NCT00395733|65548277|FG000|Period 2|Technical problems|1|||
23492994|NCT00395733|65548278|FG001|Period 2|Technical problems|0|||
23492995|NCT02202837|65548281|FG000|Overall Study|Enbrel treatment discontinued|36|||
23492996|NCT02202837|65548282|FG001|Overall Study|Enbrel treatment discontinued|4|||
23492997|NCT02202837|65548281|FG000|Overall Study|Other|10|||
23492998|NCT02202837|65548282|FG001|Overall Study|Other|0|||
23492999|NCT02202837|65548281|FG000|Overall Study|Lost to Follow-up|7|||
23493000|NCT02202837|65548282|FG001|Overall Study|Lost to Follow-up|1|||
23493001|NCT03208127|65548283|FG000|Overall Study|Death|1|||
23493002|NCT03398200|65548284|FG000|Overall Study|Withdrawal by Subject|0|||
23493003|NCT03398200|65548285|FG001|Overall Study|Withdrawal by Subject|1|||
23493004|NCT02106975|65548286|FG000|Overall Study|Death|25|||
23493005|NCT02106975|65548287|FG001|Overall Study|Death|39|||
23493006|NCT03608254|65548288|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
23493007|NCT03608254|65548288|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
23493008|NCT01758523|65551328|FG000|Overall Study|Adverse Event|2|||
23493009|NCT01758523|65551329|FG001|Overall Study|Adverse Event|1|||
23289838|NCT01721772|64801936|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
23289839|NCT01721772|64801937|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
23493010|NCT01758523|65551328|FG000|Overall Study|Lack of Efficacy|4|||
23493011|NCT01758523|65551329|FG001|Overall Study|Lack of Efficacy|2|||
23493012|NCT01758523|65551328|FG000|Overall Study|Lost to Follow-up|3|||
23493013|NCT01758523|65551329|FG001|Overall Study|Lost to Follow-up|4|||
23493014|NCT01758523|65551328|FG000|Overall Study|Withdrawal by Subject|12|||
23493015|NCT01758523|65551329|FG001|Overall Study|Withdrawal by Subject|7|||
23493016|NCT02609828|65551330|FG000|Overall Study|Adverse Event|8|||
23493017|NCT02609828|65551331|FG001|Overall Study|Adverse Event|1|||
23493018|NCT02609828|65551332|FG002|Overall Study|Adverse Event|0|||
23493019|NCT02609828|65551333|FG003|Overall Study|Adverse Event|6|||
23493020|NCT02609828|65551330|FG000|Overall Study|Death|15|||
23493021|NCT02609828|65551331|FG001|Overall Study|Death|1|||
23493022|NCT02609828|65551332|FG002|Overall Study|Death|1|||
23493023|NCT02609828|65551333|FG003|Overall Study|Death|19|||
23493024|NCT02609828|65551330|FG000|Overall Study|Insufficient clinical response|2|||
23493025|NCT02609828|65551331|FG001|Overall Study|Insufficient clinical response|1|||
23493026|NCT02609828|65551332|FG002|Overall Study|Insufficient clinical response|0|||
23493027|NCT02609828|65551333|FG003|Overall Study|Insufficient clinical response|0|||
23493028|NCT02609828|65551330|FG000|Overall Study|Lost to Follow-up|0|||
23493029|NCT02609828|65551331|FG001|Overall Study|Lost to Follow-up|0|||
23493030|NCT02609828|65551332|FG002|Overall Study|Lost to Follow-up|0|||
23493031|NCT02609828|65551333|FG003|Overall Study|Lost to Follow-up|1|||
23493032|NCT02609828|65551330|FG000|Overall Study|Protocol Violation|2|||
23493033|NCT02609828|65551331|FG001|Overall Study|Protocol Violation|0|||
23493034|NCT02609828|65551332|FG002|Overall Study|Protocol Violation|0|||
23493035|NCT02609828|65551333|FG003|Overall Study|Protocol Violation|1|||
23493036|NCT02609828|65551330|FG000|Overall Study|Withdrawal by Subject|12|||
23493037|NCT02609828|65551331|FG001|Overall Study|Withdrawal by Subject|1|||
23493038|NCT02609828|65551332|FG002|Overall Study|Withdrawal by Subject|0|||
23493039|NCT02609828|65551333|FG003|Overall Study|Withdrawal by Subject|10|||
23493040|NCT02609828|65551330|FG000|Overall Study|Other|3|||
23493041|NCT02609828|65551331|FG001|Overall Study|Other|0|||
23493042|NCT02609828|65551332|FG002|Overall Study|Other|0|||
23289840|NCT01721772|64801936|FG000|Pre-Treatment|Poor/non-compliance|0|||
23289841|NCT01721772|64801937|FG001|Pre-Treatment|Poor/non-compliance|1|||
23382657|NCT00433290|65145138|FG000|Overall Study|Adverse Event|24|||
23493043|NCT02609828|65551333|FG003|Overall Study|Other|6|||
23493044|NCT02609828|65551330|FG000|Overall Study|Randomized but not treated|1|||
23493045|NCT02609828|65551331|FG001|Overall Study|Randomized but not treated|0|||
23493046|NCT02609828|65551332|FG002|Overall Study|Randomized but not treated|0|||
23493047|NCT02609828|65551333|FG003|Overall Study|Randomized but not treated|0|||
23493048|NCT02477839|65551335|FG000|Overall Study|Adverse Event|0|||
23382658|NCT00433290|65145139|FG001|Overall Study|Adverse Event|7|||
23493049|NCT02477839|65551336|FG001|Overall Study|Adverse Event|1|||
23493050|NCT02477839|65551335|FG000|Overall Study|Protocol Violation|0|||
23493051|NCT02477839|65551336|FG001|Overall Study|Protocol Violation|2|||
23493052|NCT02477839|65551335|FG000|Overall Study|Withdrawal by Subject|3|||
23493053|NCT02477839|65551336|FG001|Overall Study|Withdrawal by Subject|3|||
23493054|NCT02477839|65551335|FG000|Overall Study|Participant had PGS during V6|0|||
23493055|NCT02477839|65551336|FG001|Overall Study|Participant had PGS during V6|1|||
23493056|NCT02477839|65551335|FG000|Overall Study|Parents decided to stop medication|0|||
23493057|NCT02477839|65551336|FG001|Overall Study|Parents decided to stop medication|1|||
23493058|NCT02477839|65551335|FG000|Overall Study|Lack of tolerability|0|||
23493059|NCT02477839|65551336|FG001|Overall Study|Lack of tolerability|1|||
23493060|NCT02477839|65551335|FG000|Overall Study|Exclusion criterion|0|||
23493061|NCT02477839|65551336|FG001|Overall Study|Exclusion criterion|1|||
23493062|NCT01696071|65551353|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
23493063|NCT01696071|65551354|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
23493064|NCT00810355|65551357|FG000|Overall Study|Lost to Follow-up|13|||
23493065|NCT00810355|65551358|FG001|Overall Study|Lost to Follow-up|17|||
23493066|NCT00810355|65551359|FG002|Overall Study|Lost to Follow-up|11|||
23493067|NCT00810355|65551357|FG000|Overall Study|Withdrawal by Subject|1|||
23493068|NCT00810355|65551358|FG001|Overall Study|Withdrawal by Subject|0|||
23493069|NCT00810355|65551359|FG002|Overall Study|Withdrawal by Subject|0|||
23493070|NCT00406354|65551360|FG000|All Randomized Patients|Protocol Violation|0|||
23493071|NCT00406354|65551361|FG001|All Randomized Patients|Protocol Violation|0|||
23493072|NCT00406354|65551362|FG002|All Randomized Patients|Protocol Violation|1|||
23493073|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
23493074|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
23493075|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
23493076|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Adverse Event|6|||
23493077|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Adverse Event|2|||
23493078|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Adverse Event|1|||
23493079|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
23493080|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
23493081|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
23493082|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
23493083|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
23493084|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
23493085|NCT00406354|65551360|FG000|All Randomized and Treated Patients|Physician Decision|0|||
23493086|NCT00406354|65551361|FG001|All Randomized and Treated Patients|Physician Decision|0|||
23493087|NCT00406354|65551362|FG002|All Randomized and Treated Patients|Physician Decision|1|||
23493088|NCT00621959|65551363|FG000|Overall Study|Adverse Event|4|||
23493089|NCT00621959|65551364|FG001|Overall Study|Adverse Event|2|||
23493090|NCT00621959|65551363|FG000|Overall Study|Lack of Efficacy|1|||
23493091|NCT00621959|65551364|FG001|Overall Study|Lack of Efficacy|1|||
23493092|NCT00621959|65551363|FG000|Overall Study|Lost to Follow-up|0|||
23493093|NCT00621959|65551364|FG001|Overall Study|Lost to Follow-up|2|||
23493094|NCT00621959|65551363|FG000|Overall Study|Withdrawal by Subject|1|||
23493095|NCT00621959|65551364|FG001|Overall Study|Withdrawal by Subject|1|||
23493096|NCT00621959|65551363|FG000|Overall Study|Other|1|||
23493097|NCT00621959|65551364|FG001|Overall Study|Other|3|||
23493098|NCT01897714|65551365|FG000|Phase I (Dose Escalation)|Disease progression|3|||
23493099|NCT01897714|65551366|FG001|Phase I (Dose Escalation)|Disease progression|5|||
23493100|NCT01897714|65551367|FG002|Phase I (Dose Escalation)|Disease progression|1|||
23289842|NCT01721772|64801936|FG000|Pre-Treatment|Participant withdrew consent|0|||
23289843|NCT01721772|64801937|FG001|Pre-Treatment|Participant withdrew consent|1|||
23289844|NCT01721772|64801936|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
23289845|NCT01721772|64801937|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
23289846|NCT01721772|64801936|FG000|Treatment|Disease progression|119|||
23289847|NCT01721772|64801937|FG001|Treatment|Disease progression|168|||
23289848|NCT01721772|64801936|FG000|Treatment|Study drug toxicity|19|||
23289849|NCT01721772|64801937|FG001|Treatment|Study drug toxicity|10|||
23289850|NCT01721772|64801936|FG000|Treatment|Adverse event unrelated to study drug|7|||
23289851|NCT01721772|64801937|FG001|Treatment|Adverse event unrelated to study drug|7|||
23289852|NCT01721772|64801936|FG000|Treatment|Maximum clinical benefit|16|||
23289853|NCT01721772|64801937|FG001|Treatment|Maximum clinical benefit|4|||
23289854|NCT01721772|64801936|FG000|Treatment|Other|19|||
23289855|NCT01721772|64801937|FG001|Treatment|Other|2|||
23289856|NCT01721772|64801936|FG000|Treatment|Participant withdrew consent|2|||
23289857|NCT01721772|64801937|FG001|Treatment|Participant withdrew consent|5|||
23493101|NCT01897714|65551368|FG003|Phase I (Dose Escalation)|Disease progression|3|||
23493102|NCT01897714|65551369|FG004|Phase I (Dose Escalation)|Disease progression|0|||
23493103|NCT01897714|65551370|FG005|Phase I (Dose Escalation)|Disease progression|0|||
23493104|NCT01897714|65551365|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
23289858|NCT01721772|64801936|FG000|Treatment|Participant request to discontinue study treatment|21|||
23289859|NCT01721772|64801937|FG001|Treatment|Participant request to discontinue study treatment|8|||
23289860|NCT01721772|64801936|FG000|Treatment|Death|1|||
23289861|NCT01721772|64801937|FG001|Treatment|Death|0|||
23289862|NCT01721772|64801936|FG000|Treatment|Not reported|1|||
23289863|NCT01721772|64801937|FG001|Treatment|Not reported|0|||
23289864|NCT01721772|64801936|FG000|Treatment|Poor/non-compliance|1|||
23289865|NCT01721772|64801937|FG001|Treatment|Poor/non-compliance|0|||
23289866|NCT01721772|64801936|FG000|Treatment|Lost to Follow-up|0|||
23289867|NCT01721772|64801937|FG001|Treatment|Lost to Follow-up|1|||
23289868|NCT01958476|64801939|FG000|Overall Study|Parent requested exclusion from analysis|1|||
23289869|NCT01958476|64801940|FG001|Overall Study|Parent requested exclusion from analysis|0|||
23289870|NCT00919711|64801945|FG000|Overall Study|Withdrawal by Subject|15|||
23289871|NCT00919711|64801946|FG001|Overall Study|Withdrawal by Subject|7|||
23289872|NCT00919711|64801945|FG000|Overall Study|Adverse Event|13|||
23289873|NCT00919711|64801946|FG001|Overall Study|Adverse Event|3|||
23289874|NCT00919711|64801945|FG000|Overall Study|Other|1|||
23289875|NCT00919711|64801946|FG001|Overall Study|Other|2|||
23289876|NCT00919711|64801945|FG000|Overall Study|Administrative Decision|0|||
23289877|NCT00919711|64801946|FG001|Overall Study|Administrative Decision|1|||
23289878|NCT00919711|64801945|FG000|Overall Study|Lost to Follow-up|2|||
23289879|NCT00919711|64801946|FG001|Overall Study|Lost to Follow-up|0|||
23289880|NCT00919711|64801945|FG000|Overall Study|Death|1|||
23289881|NCT00919711|64801946|FG001|Overall Study|Death|0|||
23289882|NCT00919711|64801945|FG000|Overall Study|Noncompliance|1|||
23289883|NCT00919711|64801946|FG001|Overall Study|Noncompliance|0|||
23289884|NCT01097694|64801948|FG000|Overall Study|Adverse Event|5|||
23289885|NCT01097694|64801949|FG001|Overall Study|Adverse Event|0|||
23289886|NCT01097694|64801948|FG000|Overall Study|Lost to Follow-up|0|||
23289887|NCT01097694|64801949|FG001|Overall Study|Lost to Follow-up|3|||
23289888|NCT01097694|64801948|FG000|Overall Study|Withdrawal by Subject|3|||
23289889|NCT01097694|64801949|FG001|Overall Study|Withdrawal by Subject|1|||
23289890|NCT01824576|64801950|FG000|Overall Study|Device deficiency|2|||
23289891|NCT03712124|64801953|FG000|Overall Study|Protocol Violation|1|||
23289892|NCT03712124|64801954|FG001|Overall Study|Protocol Violation|0|||
23289893|NCT01067521|64801955|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
23289894|NCT01067521|64801956|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
23289895|NCT01067521|64801955|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
23289896|NCT01067521|64801956|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
23289897|NCT01067521|64801955|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
23289898|NCT01067521|64801956|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
23289899|NCT01067521|64801955|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
23289900|NCT01067521|64801956|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
23289901|NCT01067521|64801955|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
23289902|NCT01067521|64801956|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
23289903|NCT01067521|64801955|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
23289904|NCT01067521|64801956|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
23289905|NCT01067521|64801955|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
23289906|NCT01067521|64801956|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
23289907|NCT01067521|64801955|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
23289908|NCT01067521|64801956|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
23289909|NCT01067521|64801955|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
23289910|NCT01067521|64801956|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
23289911|NCT01067521|64801955|FG000|Open-Label Period|Death|3|||
23289912|NCT01067521|64801956|FG001|Open-Label Period|Death|1|||
23289913|NCT01067521|64801955|FG000|Open-Label Period|Adverse Event|30|||
23289914|NCT01067521|64801956|FG001|Open-Label Period|Adverse Event|28|||
23289915|NCT01067521|64801955|FG000|Open-Label Period|Withdrawal by Subject|160|||
23289916|NCT01067521|64801956|FG001|Open-Label Period|Withdrawal by Subject|88|||
23289917|NCT01067521|64801955|FG000|Open-Label Period|Physician Decision|13|||
23289918|NCT01067521|64801956|FG001|Open-Label Period|Physician Decision|11|||
23289919|NCT01067521|64801955|FG000|Open-Label Period|Non-compliance with study drug|5|||
23289920|NCT01067521|64801956|FG001|Open-Label Period|Non-compliance with study drug|0|||
23493105|NCT01897714|65551366|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
23382659|NCT00433290|65145138|FG000|Overall Study|Lack of Efficacy|1|||
23382660|NCT00433290|65145139|FG001|Overall Study|Lack of Efficacy|5|||
23382661|NCT00433290|65145138|FG000|Overall Study|Withdrawal by Subject|4|||
23289921|NCT01067521|64801955|FG000|Open-Label Period|Protocol Violation|3|||
23289922|NCT01067521|64801956|FG001|Open-Label Period|Protocol Violation|0|||
23289923|NCT01067521|64801955|FG000|Open-Label Period|Pregnancy|14|||
23289924|NCT01067521|64801956|FG001|Open-Label Period|Pregnancy|8|||
23289925|NCT01067521|64801955|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
23289926|NCT01067521|64801956|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
23289927|NCT01067521|64801955|FG000|Open-Label Period|Lost to Follow-up|21|||
23289928|NCT01067521|64801956|FG001|Open-Label Period|Lost to Follow-up|20|||
23289929|NCT02727192|64801957|FG000|Overall Study|Lost to Follow-up|1|||
23289930|NCT02727192|64801958|FG001|Overall Study|Lost to Follow-up|0|||
23289931|NCT02727192|64801959|FG002|Overall Study|Lost to Follow-up|0|||
23382662|NCT00433290|65145139|FG001|Overall Study|Withdrawal by Subject|2|||
23382663|NCT00433290|65145138|FG000|Overall Study|Protocol Violation|3|||
23382664|NCT00433290|65145139|FG001|Overall Study|Protocol Violation|2|||
23382665|NCT00433290|65145138|FG000|Overall Study|Physician Decision|2|||
23382666|NCT00433290|65145139|FG001|Overall Study|Physician Decision|0|||
23382667|NCT00433290|65145138|FG000|Overall Study|Entry Criteria Not Met|0|||
23382668|NCT00433290|65145139|FG001|Overall Study|Entry Criteria Not Met|1|||
23382669|NCT00433290|65145138|FG000|Overall Study|Lost to Follow-up|1|||
23382670|NCT00433290|65145139|FG001|Overall Study|Lost to Follow-up|0|||
23382671|NCT00103506|65145140|FG000|Overall Study|Study closed by sponsor|34|||
23382672|NCT00103506|65145141|FG001|Overall Study|Study closed by sponsor|37|||
23382673|NCT00103506|65145140|FG000|Overall Study|Death|257|||
23382674|NCT00103506|65145141|FG001|Overall Study|Death|253|||
23382675|NCT00103506|65145140|FG000|Overall Study|Lost to Follow-up|13|||
23382676|NCT00103506|65145141|FG001|Overall Study|Lost to Follow-up|13|||
23382677|NCT00103506|65145140|FG000|Overall Study|Withdrawal by Subject|18|||
23382678|NCT00103506|65145141|FG001|Overall Study|Withdrawal by Subject|21|||
23382679|NCT00790933|65145142|FG000|Overall Study|Adverse Event|94|||
23382680|NCT00790933|65145143|FG001|Overall Study|Adverse Event|119|||
23382681|NCT00790933|65145144|FG002|Overall Study|Adverse Event|65|||
23382682|NCT00790933|65145145|FG003|Overall Study|Adverse Event|5|||
23382683|NCT00790933|65145146|FG004|Overall Study|Adverse Event|69|||
23382684|NCT00790933|65145142|FG000|Overall Study|Protocol Violation(s)|8|||
23382685|NCT00790933|65145143|FG001|Overall Study|Protocol Violation(s)|18|||
23382686|NCT00790933|65145144|FG002|Overall Study|Protocol Violation(s)|7|||
23382687|NCT00790933|65145145|FG003|Overall Study|Protocol Violation(s)|0|||
23382688|NCT00790933|65145146|FG004|Overall Study|Protocol Violation(s)|12|||
23382689|NCT00790933|65145142|FG000|Overall Study|Lack of Efficacy|192|||
23382690|NCT00790933|65145143|FG001|Overall Study|Lack of Efficacy|176|||
23382691|NCT00790933|65145144|FG002|Overall Study|Lack of Efficacy|130|||
23382692|NCT00790933|65145145|FG003|Overall Study|Lack of Efficacy|1|||
23382693|NCT00790933|65145146|FG004|Overall Study|Lack of Efficacy|121|||
23382694|NCT00790933|65145142|FG000|Overall Study|Study Terminated by Sponsor|0|||
23382695|NCT00790933|65145143|FG001|Overall Study|Study Terminated by Sponsor|0|||
23382696|NCT00790933|65145144|FG002|Overall Study|Study Terminated by Sponsor|1|||
23382697|NCT00790933|65145145|FG003|Overall Study|Study Terminated by Sponsor|0|||
23382698|NCT00790933|65145146|FG004|Overall Study|Study Terminated by Sponsor|0|||
23382699|NCT00790933|65145142|FG000|Overall Study|Withdrawal by Subject|123|||
23382700|NCT00790933|65145143|FG001|Overall Study|Withdrawal by Subject|120|||
23382701|NCT00790933|65145144|FG002|Overall Study|Withdrawal by Subject|52|||
23382702|NCT00790933|65145145|FG003|Overall Study|Withdrawal by Subject|6|||
23382703|NCT00790933|65145146|FG004|Overall Study|Withdrawal by Subject|50|||
23382704|NCT00790933|65145142|FG000|Overall Study|Lost to Follow-up|13|||
23382705|NCT00790933|65145143|FG001|Overall Study|Lost to Follow-up|31|||
23382706|NCT00790933|65145144|FG002|Overall Study|Lost to Follow-up|10|||
23382707|NCT00790933|65145145|FG003|Overall Study|Lost to Follow-up|1|||
23289932|NCT00842309|64801960|FG000|Overall Study|Withdrawal by Subject|3|||
23289933|NCT00842309|64801961|FG001|Overall Study|Withdrawal by Subject|1|||
23289934|NCT00856349|64801965|FG000|Overall Study|Death|418|||
23382708|NCT00790933|65145146|FG004|Overall Study|Lost to Follow-up|15|||
23382709|NCT00790933|65145142|FG000|Overall Study|Reason Not Specified|8|||
23382710|NCT00790933|65145143|FG001|Overall Study|Reason Not Specified|16|||
23382711|NCT00790933|65145144|FG002|Overall Study|Reason Not Specified|4|||
23382712|NCT00790933|65145145|FG003|Overall Study|Reason Not Specified|1|||
23382713|NCT00790933|65145146|FG004|Overall Study|Reason Not Specified|9|||
23382714|NCT02697422|65145151|FG000|Overall Study|Declined exit survey|9|||
23382715|NCT02697422|65145152|FG001|Overall Study|Declined exit survey|2|||
23382716|NCT02697422|65145151|FG000|Overall Study|Lost to Follow-up|13|||
23382717|NCT02697422|65145152|FG001|Overall Study|Lost to Follow-up|8|||
23382718|NCT02697422|65145151|FG000|Overall Study|Death|2|||
23382719|NCT02697422|65145152|FG001|Overall Study|Death|1|||
23382720|NCT02697422|65145151|FG000|Overall Study|Withdrawal by Subject|0|||
23289935|NCT00856349|64801965|FG000|Overall Study|Withdrawal by Subject|116|||
23289936|NCT00856349|64801965|FG000|Overall Study|Lost to Follow-up|91|||
23289937|NCT00856349|64801965|FG000|Overall Study|Protocol Violation|38|||
23289938|NCT00856349|64801965|FG000|Overall Study|Physician Decision|13|||
23289939|NCT00856349|64801965|FG000|Overall Study|Subject relocation|104|||
23289940|NCT00856349|64801965|FG000|Overall Study|Device explant|33|||
23289941|NCT00856349|64801965|FG000|Overall Study|Site closure|78|||
23289942|NCT00856349|64801965|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
23289943|NCT02435433|64801968|FG000|Overall Study|Withdrawal by Subject|2|||
23289944|NCT02435433|64801969|FG001|Overall Study|Withdrawal by Subject|3|||
23289945|NCT02435433|64801970|FG002|Overall Study|Withdrawal by Subject|1|||
23289946|NCT02435433|64801971|FG003|Overall Study|Withdrawal by Subject|0|||
23289947|NCT02435433|64801972|FG004|Overall Study|Withdrawal by Subject|0|||
23289948|NCT02435433|64801968|FG000|Overall Study|Lost to Follow-up|2|||
23289949|NCT02435433|64801969|FG001|Overall Study|Lost to Follow-up|2|||
23289950|NCT02435433|64801970|FG002|Overall Study|Lost to Follow-up|4|||
23289951|NCT02435433|64801971|FG003|Overall Study|Lost to Follow-up|1|||
23289952|NCT02435433|64801972|FG004|Overall Study|Lost to Follow-up|0|||
23289953|NCT00743145|64801973|FG000|Overall Study|Withdrawal by Subject|1|||
23382721|NCT02697422|65145152|FG001|Overall Study|Withdrawal by Subject|1|||
23382722|NCT02697422|65145151|FG000|Overall Study|Physician Decision|1|||
23382723|NCT02697422|65145152|FG001|Overall Study|Physician Decision|1|||
23382724|NCT02697422|65145151|FG000|Overall Study|Exit survey data lost|1|||
23382725|NCT02697422|65145152|FG001|Overall Study|Exit survey data lost|0|||
23382726|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
23382727|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
23382728|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
23382729|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
23382730|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
23382731|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
23382732|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
23382733|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
23382734|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
23382735|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
23382736|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
23382737|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
23382738|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
23382739|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
23382740|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
23382741|NCT00407030|65145153|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
23382742|NCT00407030|65145154|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
23382743|NCT00407030|65145155|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
23382744|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
23382745|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
23382746|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
23382747|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
23382748|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
23382749|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
23382750|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
23382751|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
23382752|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
23382753|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
23289954|NCT00743145|64801973|FG000|Overall Study|Adverse Event|2|||
23382754|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
23382755|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
23382756|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
23382757|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
23289955|NCT00743145|64801973|FG000|Overall Study|Pregnancy|1|||
23289956|NCT02260258|64801974|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
23289957|NCT02260258|64801975|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
23289958|NCT02105701|64801976|FG000|Overall Study|Lost to Follow-up|1|||
23289959|NCT02105701|64801977|FG001|Overall Study|Lost to Follow-up|0|||
23289960|NCT02105701|64801978|FG002|Overall Study|Lost to Follow-up|2|||
23289961|NCT02105701|64801979|FG003|Overall Study|Lost to Follow-up|1|||
23289962|NCT02105701|64801976|FG000|Overall Study|Protocol Violation|0|||
23289963|NCT02105701|64801977|FG001|Overall Study|Protocol Violation|0|||
23289964|NCT02105701|64801978|FG002|Overall Study|Protocol Violation|1|||
23289965|NCT02105701|64801979|FG003|Overall Study|Protocol Violation|0|||
23289966|NCT02105701|64801976|FG000|Overall Study|Withdrawal by Subject|2|||
23289967|NCT02105701|64801977|FG001|Overall Study|Withdrawal by Subject|1|||
23289968|NCT02105701|64801978|FG002|Overall Study|Withdrawal by Subject|0|||
23289969|NCT02105701|64801979|FG003|Overall Study|Withdrawal by Subject|1|||
23289970|NCT02105701|64801976|FG000|Overall Study|Death|1|||
23289971|NCT02105701|64801977|FG001|Overall Study|Death|0|||
23289972|NCT02105701|64801978|FG002|Overall Study|Death|0|||
23289973|NCT02105701|64801979|FG003|Overall Study|Death|0|||
23289974|NCT02754492|64801980|FG000|Overall Study|Protocol Violation|2|||
23289975|NCT02754492|64801981|FG001|Overall Study|Protocol Violation|2|||
23289976|NCT02754492|64801982|FG002|Overall Study|Protocol Violation|0|||
23289977|NCT02754492|64801983|FG003|Overall Study|Protocol Violation|1|||
23289978|NCT02754492|64801980|FG000|Overall Study|Withdrawal by Subject|2|||
23289979|NCT02754492|64801981|FG001|Overall Study|Withdrawal by Subject|0|||
23289980|NCT02754492|64801982|FG002|Overall Study|Withdrawal by Subject|0|||
23289981|NCT02754492|64801983|FG003|Overall Study|Withdrawal by Subject|0|||
23382758|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
23382759|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
23382760|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
23382761|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
23382762|NCT00407030|65145153|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
23382763|NCT00407030|65145154|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
23382764|NCT00407030|65145155|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
23382765|NCT04491994|65145170|FG000|Overall Study|Withdrawal by Subject|10|||
23382766|NCT04491994|65145171|FG001|Overall Study|Withdrawal by Subject|5|||
23382767|NCT04491994|65145170|FG000|Overall Study|developed fever > 3 days|4|||
23382768|NCT04491994|65145171|FG001|Overall Study|developed fever > 3 days|1|||
23382769|NCT04491994|65145170|FG000|Overall Study|Protocol Violation|11|||
23382770|NCT04491994|65145171|FG001|Overall Study|Protocol Violation|2|||
23382771|NCT04491994|65145170|FG000|Overall Study|Lost to Follow-up|4|||
23382772|NCT04491994|65145171|FG001|Overall Study|Lost to Follow-up|3|||
23382773|NCT05350423|65145176|FG000|Overall Study|Lost to Follow-up|3|||
23382774|NCT05350423|65145177|FG001|Overall Study|Lost to Follow-up|3|||
23382775|NCT05350423|65145176|FG000|Overall Study|screen failure|5|||
23382776|NCT05350423|65145177|FG001|Overall Study|screen failure|6|||
23382777|NCT03093870|65145178|FG000|Overall Study|Withdrawal by Subject|2|||
23382778|NCT03093870|65145179|FG001|Overall Study|Withdrawal by Subject|6|||
23382779|NCT03093870|65145180|FG002|Overall Study|Withdrawal by Subject|5|||
23382780|NCT03093870|65145178|FG000|Overall Study|Death|1|||
23382781|NCT03093870|65145179|FG001|Overall Study|Death|35|||
23382782|NCT03093870|65145180|FG002|Overall Study|Death|35|||
23382783|NCT03093870|65145178|FG000|Overall Study|Radiographic disease progression|10|||
23382784|NCT03093870|65145179|FG001|Overall Study|Radiographic disease progression|0|||
23382785|NCT03093870|65145180|FG002|Overall Study|Radiographic disease progression|0|||
23382786|NCT03093870|65145178|FG000|Overall Study|Clinical disease progression|1|||
23382787|NCT03093870|65145179|FG001|Overall Study|Clinical disease progression|0|||
23382788|NCT03093870|65145180|FG002|Overall Study|Clinical disease progression|0|||
23382789|NCT03093870|65145178|FG000|Overall Study|Physician Decision|2|||
23382790|NCT03093870|65145179|FG001|Overall Study|Physician Decision|0|||
23382791|NCT03093870|65145180|FG002|Overall Study|Physician Decision|0|||
23382792|NCT03093870|65145178|FG000|Overall Study|Adverse Event|7|||
23382793|NCT03093870|65145179|FG001|Overall Study|Adverse Event|0|||
23382794|NCT03093870|65145180|FG002|Overall Study|Adverse Event|0|||
23382795|NCT03093870|65145178|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
23382796|NCT03093870|65145179|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
23382797|NCT03093870|65145180|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
23382798|NCT03093870|65145178|FG000|Overall Study|Lost to Follow-up|0|||
23382799|NCT03093870|65145179|FG001|Overall Study|Lost to Follow-up|0|||
23382800|NCT03093870|65145180|FG002|Overall Study|Lost to Follow-up|1|||
23382801|NCT01111292|65145181|FG000|Treatment|Physician Decision|1|||
23382802|NCT01111292|65145182|FG001|Treatment|Physician Decision|1|||
23493106|NCT01897714|65551367|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
23382803|NCT00552058|65145183|FG000|Overall Study|Adverse Event|8|||
23382804|NCT00552058|65145184|FG001|Overall Study|Adverse Event|7|||
23382805|NCT00552058|65145183|FG000|Overall Study|Lack of Efficacy|1|||
23382806|NCT00552058|65145184|FG001|Overall Study|Lack of Efficacy|5|||
23382807|NCT00552058|65145183|FG000|Overall Study|Lost to Follow-up|1|||
23382808|NCT00552058|65145184|FG001|Overall Study|Lost to Follow-up|0|||
23382809|NCT00552058|65145183|FG000|Overall Study|Withdrawal by Subject|4|||
23382810|NCT00552058|65145184|FG001|Overall Study|Withdrawal by Subject|4|||
23382811|NCT00552058|65145183|FG000|Overall Study|Other: Protocol Violation|0|||
23382812|NCT00552058|65145184|FG001|Overall Study|Other: Protocol Violation|1|||
23382813|NCT00552058|65145183|FG000|Overall Study|Other: Non Compliance|1|||
23382814|NCT00552058|65145184|FG001|Overall Study|Other: Non Compliance|2|||
23382815|NCT00552058|65145183|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
23382816|NCT00552058|65145184|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
23382817|NCT00552058|65145183|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
23382818|NCT00552058|65145184|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
23382819|NCT00552058|65145183|FG000|Overall Study|Other: Positive Stool Result|0|||
23382820|NCT00552058|65145184|FG001|Overall Study|Other: Positive Stool Result|1|||
23382821|NCT00552058|65145183|FG000|Overall Study|Other: Randomized in error|0|||
23382822|NCT00552058|65145184|FG001|Overall Study|Other: Randomized in error|1|||
23382823|NCT00552058|65145183|FG000|Overall Study|Other: Sponsors Decision|0|||
23382824|NCT00552058|65145184|FG001|Overall Study|Other: Sponsors Decision|1|||
23382825|NCT00552058|65145183|FG000|Overall Study|Other: Early Roll Over|1|||
23382826|NCT00552058|65145184|FG001|Overall Study|Other: Early Roll Over|0|||
23382827|NCT00981175|65145185|FG000|Primary Dose Vaccination|Adverse Event|1|||
23382828|NCT00981175|65145186|FG001|Primary Dose Vaccination|Adverse Event|0|||
23382829|NCT00981175|65145185|FG000|Primary Dose Vaccination|Protocol Violation|0|||
23382830|NCT00981175|65145186|FG001|Primary Dose Vaccination|Protocol Violation|1|||
23493107|NCT01897714|65551368|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
23493108|NCT01897714|65551369|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
23493109|NCT01897714|65551370|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
23493110|NCT01897714|65551365|FG000|Phase I (Dose Escalation)|Other|0|||
23493111|NCT01897714|65551366|FG001|Phase I (Dose Escalation)|Other|1|||
23493112|NCT01897714|65551367|FG002|Phase I (Dose Escalation)|Other|0|||
23493113|NCT01897714|65551368|FG003|Phase I (Dose Escalation)|Other|0|||
23493114|NCT01897714|65551369|FG004|Phase I (Dose Escalation)|Other|0|||
23493115|NCT01897714|65551370|FG005|Phase I (Dose Escalation)|Other|0|||
23493116|NCT01897714|65551365|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
23493117|NCT01897714|65551366|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
23493118|NCT01897714|65551367|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
23493119|NCT01897714|65551368|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
23493120|NCT01897714|65551369|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
23493121|NCT01897714|65551370|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
23493122|NCT01897714|65551365|FG000|Phase II (MTD)|Lost to Follow-up|0|||
23493123|NCT01897714|65551366|FG001|Phase II (MTD)|Lost to Follow-up|0|||
23493124|NCT01897714|65551367|FG002|Phase II (MTD)|Lost to Follow-up|0|||
23493125|NCT01897714|65551368|FG003|Phase II (MTD)|Lost to Follow-up|0|||
23493126|NCT01897714|65551369|FG004|Phase II (MTD)|Lost to Follow-up|1|||
23493127|NCT01897714|65551370|FG005|Phase II (MTD)|Lost to Follow-up|0|||
23493128|NCT01897714|65551365|FG000|Phase II (MTD)|Death|0|||
23493129|NCT01897714|65551366|FG001|Phase II (MTD)|Death|0|||
23493130|NCT01897714|65551367|FG002|Phase II (MTD)|Death|0|||
23493131|NCT01897714|65551368|FG003|Phase II (MTD)|Death|0|||
23493132|NCT01897714|65551369|FG004|Phase II (MTD)|Death|25|||
23382831|NCT00981175|65145185|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
23382832|NCT00981175|65145186|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
23493133|NCT01897714|65551370|FG005|Phase II (MTD)|Death|10|||
23493134|NCT01897714|65551365|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
23382833|NCT00981175|65145185|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
23382834|NCT00981175|65145186|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
23382835|NCT02068599|65145196|FG000|Overall Study|Adverse Event|4|||
23382836|NCT02068599|65145197|FG001|Overall Study|Adverse Event|1|||
23382837|NCT02068599|65145198|FG002|Overall Study|Adverse Event|1|||
23382838|NCT02068599|65145196|FG000|Overall Study|Withdrawal by Subject|2|||
23382839|NCT02068599|65145197|FG001|Overall Study|Withdrawal by Subject|7|||
23382840|NCT02068599|65145198|FG002|Overall Study|Withdrawal by Subject|5|||
23382841|NCT02068599|65145196|FG000|Overall Study|Protocol Violation|4|||
23382842|NCT02068599|65145197|FG001|Overall Study|Protocol Violation|2|||
23382843|NCT02068599|65145198|FG002|Overall Study|Protocol Violation|3|||
23382844|NCT02068599|65145196|FG000|Overall Study|Lost to Follow-up|1|||
23382845|NCT02068599|65145197|FG001|Overall Study|Lost to Follow-up|0|||
23382846|NCT02068599|65145198|FG002|Overall Study|Lost to Follow-up|0|||
23382847|NCT02068599|65145196|FG000|Overall Study|Lack of Efficacy|0|||
23382848|NCT02068599|65145197|FG001|Overall Study|Lack of Efficacy|0|||
23382849|NCT02068599|65145198|FG002|Overall Study|Lack of Efficacy|3|||
23382850|NCT02068599|65145196|FG000|Overall Study|Noncompliance|0|||
23382851|NCT02068599|65145197|FG001|Overall Study|Noncompliance|0|||
23382852|NCT02068599|65145198|FG002|Overall Study|Noncompliance|1|||
23382853|NCT01227395|65145200|FG000|Overall Study|Protocol Violation|0|||
23382854|NCT01227395|65145201|FG001|Overall Study|Protocol Violation|1|||
23382855|NCT01567085|65145207|FG000|Overall Study|Death|6|||
23382856|NCT01567085|65145207|FG000|Overall Study|Adverse Event|6|||
23382857|NCT01567085|65145207|FG000|Overall Study|Lost to Follow-up|3|||
23382858|NCT01567085|65145207|FG000|Overall Study|Graft loss|2|||
23382859|NCT01567085|65145207|FG000|Overall Study|Renal transplantectomy|1|||
23382860|NCT01567085|65145207|FG000|Overall Study|Returned to chronic dialysis|1|||
23382861|NCT01567085|65145207|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
23382862|NCT00153920|65145208|FG000|Overall Study|Adverse Event|9|||
23382863|NCT00153920|65145208|FG000|Overall Study|Progressive Disease|9|||
23382864|NCT00153920|65145208|FG000|Overall Study|Physician Decision|3|||
23382865|NCT00153920|65145208|FG000|Overall Study|Lack of Response|3|||
23382866|NCT00153920|65145208|FG000|Overall Study|Death|2|||
23382867|NCT00153920|65145208|FG000|Overall Study|Withdrawal by Subject|1|||
23382868|NCT00153920|65145208|FG000|Overall Study|Non-Protocol Therapy|1|||
23382869|NCT00153920|65145208|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
23382870|NCT00153920|65145208|FG000|Overall Study|Progressive Disease before Trt|1|||
23382871|NCT03022630|65145209|FG000|Overall Study|Death|9|||
23382872|NCT03022630|65145210|FG001|Overall Study|Death|7|||
23382873|NCT03022630|65145209|FG000|Overall Study|Withdrawal by Subject|0|||
23382874|NCT03022630|65145210|FG001|Overall Study|Withdrawal by Subject|5|||
23382875|NCT00694161|65145211|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
23382876|NCT00694161|65145211|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
23382877|NCT00694161|65145211|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
23382878|NCT00837330|65145212|FG000|Overall Study|Lost to Follow-up|1|||
23382879|NCT00837330|65145213|FG001|Overall Study|Lost to Follow-up|3|||
23382880|NCT04518410|65145221|FG000|Overall Study|Lost to Follow-up|1|||
23382881|NCT04518410|65145222|FG001|Overall Study|Lost to Follow-up|1|||
23382882|NCT04518410|65145223|FG002|Overall Study|Lost to Follow-up|8|||
23382883|NCT04518410|65145224|FG003|Overall Study|Lost to Follow-up|5|||
23382884|NCT04518410|65145225|FG004|Overall Study|Lost to Follow-up|92|||
23382885|NCT04518410|65145226|FG005|Overall Study|Lost to Follow-up|25|||
23382886|NCT04518410|65145227|FG006|Overall Study|Lost to Follow-up|25|||
23382887|NCT04518410|65145228|FG007|Overall Study|Lost to Follow-up|3|||
23382888|NCT04518410|65145229|FG008|Overall Study|Lost to Follow-up|2|||
23382889|NCT04518410|65145230|FG009|Overall Study|Lost to Follow-up|13|||
23382890|NCT04518410|65145231|FG010|Overall Study|Lost to Follow-up|9|||
23382891|NCT04518410|65145232|FG011|Overall Study|Lost to Follow-up|13|||
23382892|NCT04518410|65145233|FG012|Overall Study|Lost to Follow-up|9|||
23382893|NCT04518410|65145234|FG013|Overall Study|Lost to Follow-up|13|||
23382894|NCT04518410|65145235|FG014|Overall Study|Lost to Follow-up|8|||
23382895|NCT04518410|65145236|FG015|Overall Study|Lost to Follow-up|10|||
23382896|NCT04518410|65145237|FG016|Overall Study|Lost to Follow-up|6|||
23382897|NCT04518410|65145238|FG017|Overall Study|Lost to Follow-up|13|||
23382898|NCT04518410|65145239|FG018|Overall Study|Lost to Follow-up|21|||
23382899|NCT04518410|65145240|FG019|Overall Study|Lost to Follow-up|6|||
23382900|NCT04518410|65145241|FG020|Overall Study|Lost to Follow-up|7|||
23382901|NCT04518410|65145242|FG021|Overall Study|Lost to Follow-up|21|||
23382902|NCT04518410|65145243|FG022|Overall Study|Lost to Follow-up|1|||
23382903|NCT04518410|65145244|FG023|Overall Study|Lost to Follow-up|7|||
23382904|NCT04518410|65145245|FG024|Overall Study|Lost to Follow-up|6|||
23382905|NCT04518410|65145221|FG000|Overall Study|Withdrawal by Subject|1|||
23382906|NCT04518410|65145222|FG001|Overall Study|Withdrawal by Subject|2|||
23382907|NCT04518410|65145223|FG002|Overall Study|Withdrawal by Subject|2|||
23382908|NCT04518410|65145224|FG003|Overall Study|Withdrawal by Subject|3|||
23382909|NCT04518410|65145225|FG004|Overall Study|Withdrawal by Subject|20|||
23382910|NCT04518410|65145226|FG005|Overall Study|Withdrawal by Subject|20|||
23382911|NCT04518410|65145227|FG006|Overall Study|Withdrawal by Subject|25|||
23382912|NCT04518410|65145228|FG007|Overall Study|Withdrawal by Subject|6|||
23382913|NCT04518410|65145229|FG008|Overall Study|Withdrawal by Subject|1|||
23382914|NCT04518410|65145230|FG009|Overall Study|Withdrawal by Subject|12|||
23382915|NCT04518410|65145231|FG010|Overall Study|Withdrawal by Subject|5|||
23382916|NCT04518410|65145232|FG011|Overall Study|Withdrawal by Subject|7|||
23382917|NCT04518410|65145233|FG012|Overall Study|Withdrawal by Subject|2|||
23382918|NCT04518410|65145234|FG013|Overall Study|Withdrawal by Subject|13|||
23382919|NCT04518410|65145235|FG014|Overall Study|Withdrawal by Subject|4|||
23382920|NCT04518410|65145236|FG015|Overall Study|Withdrawal by Subject|9|||
23382921|NCT04518410|65145237|FG016|Overall Study|Withdrawal by Subject|0|||
23382922|NCT04518410|65145238|FG017|Overall Study|Withdrawal by Subject|15|||
23382923|NCT04518410|65145239|FG018|Overall Study|Withdrawal by Subject|12|||
23382924|NCT04518410|65145240|FG019|Overall Study|Withdrawal by Subject|9|||
23382925|NCT04518410|65145241|FG020|Overall Study|Withdrawal by Subject|14|||
23382926|NCT04518410|65145242|FG021|Overall Study|Withdrawal by Subject|3|||
23382927|NCT04518410|65145243|FG022|Overall Study|Withdrawal by Subject|2|||
23382928|NCT04518410|65145244|FG023|Overall Study|Withdrawal by Subject|9|||
23382929|NCT04518410|65145245|FG024|Overall Study|Withdrawal by Subject|8|||
23382930|NCT04518410|65145221|FG000|Overall Study|Other|1|||
23382931|NCT04518410|65145222|FG001|Overall Study|Other|0|||
23382932|NCT04518410|65145223|FG002|Overall Study|Other|0|||
23382933|NCT04518410|65145224|FG003|Overall Study|Other|1|||
23382934|NCT04518410|65145225|FG004|Overall Study|Other|6|||
23382935|NCT04518410|65145226|FG005|Overall Study|Other|6|||
23382936|NCT04518410|65145227|FG006|Overall Study|Other|5|||
23382937|NCT04518410|65145228|FG007|Overall Study|Other|2|||
23605962|NCT01640951|65947108|FG007|Overall Study|Protocol Deviation|0|||
23382938|NCT04518410|65145229|FG008|Overall Study|Other|0|||
23382939|NCT04518410|65145230|FG009|Overall Study|Other|1|||
23382940|NCT04518410|65145231|FG010|Overall Study|Other|0|||
23382941|NCT04518410|65145232|FG011|Overall Study|Other|2|||
23382942|NCT04518410|65145233|FG012|Overall Study|Other|0|||
23382943|NCT04518410|65145234|FG013|Overall Study|Other|0|||
23382944|NCT04518410|65145235|FG014|Overall Study|Other|0|||
23382945|NCT04518410|65145236|FG015|Overall Study|Other|3|||
23382946|NCT04518410|65145237|FG016|Overall Study|Other|1|||
23382947|NCT04518410|65145238|FG017|Overall Study|Other|1|||
23382948|NCT04518410|65145239|FG018|Overall Study|Other|1|||
23382949|NCT04518410|65145240|FG019|Overall Study|Other|0|||
23382950|NCT04518410|65145241|FG020|Overall Study|Other|1|||
23382951|NCT04518410|65145242|FG021|Overall Study|Other|0|||
23382952|NCT04518410|65145243|FG022|Overall Study|Other|1|||
23382953|NCT04518410|65145244|FG023|Overall Study|Other|2|||
23382954|NCT04518410|65145245|FG024|Overall Study|Other|2|||
23382955|NCT04518410|65145221|FG000|Overall Study|Protocol Violation|0|||
23382956|NCT04518410|65145222|FG001|Overall Study|Protocol Violation|0|||
23382957|NCT04518410|65145223|FG002|Overall Study|Protocol Violation|0|||
23382958|NCT04518410|65145224|FG003|Overall Study|Protocol Violation|2|||
23382959|NCT04518410|65145225|FG004|Overall Study|Protocol Violation|17|||
23382960|NCT04518410|65145226|FG005|Overall Study|Protocol Violation|1|||
23382961|NCT04518410|65145227|FG006|Overall Study|Protocol Violation|2|||
23382962|NCT04518410|65145228|FG007|Overall Study|Protocol Violation|1|||
23382963|NCT04518410|65145229|FG008|Overall Study|Protocol Violation|0|||
23382964|NCT04518410|65145230|FG009|Overall Study|Protocol Violation|0|||
23382965|NCT04518410|65145231|FG010|Overall Study|Protocol Violation|0|||
23382966|NCT04518410|65145232|FG011|Overall Study|Protocol Violation|0|||
23382967|NCT04518410|65145233|FG012|Overall Study|Protocol Violation|0|||
23382968|NCT04518410|65145234|FG013|Overall Study|Protocol Violation|0|||
23382969|NCT04518410|65145235|FG014|Overall Study|Protocol Violation|0|||
23382970|NCT04518410|65145236|FG015|Overall Study|Protocol Violation|0|||
23605963|NCT01640951|65947101|FG000|Overall Study|Subject/Guardian decision|12|||
23605964|NCT01640951|65947102|FG001|Overall Study|Subject/Guardian decision|4|||
23605965|NCT01640951|65947103|FG002|Overall Study|Subject/Guardian decision|13|||
23605966|NCT01640951|65947104|FG003|Overall Study|Subject/Guardian decision|15|||
23605967|NCT01640951|65947105|FG004|Overall Study|Subject/Guardian decision|7|||
23605968|NCT01640951|65947106|FG005|Overall Study|Subject/Guardian decision|19|||
23605969|NCT01640951|65947107|FG006|Overall Study|Subject/Guardian decision|5|||
23605970|NCT01640951|65947108|FG007|Overall Study|Subject/Guardian decision|4|||
23605971|NCT01640951|65947101|FG000|Overall Study|Death|0|||
23605972|NCT01640951|65947102|FG001|Overall Study|Death|1|||
23605973|NCT01640951|65947103|FG002|Overall Study|Death|1|||
23605974|NCT01640951|65947104|FG003|Overall Study|Death|0|||
23605975|NCT01640951|65947105|FG004|Overall Study|Death|0|||
23605976|NCT01640951|65947106|FG005|Overall Study|Death|0|||
23605977|NCT01640951|65947107|FG006|Overall Study|Death|0|||
23382971|NCT04518410|65145237|FG016|Overall Study|Protocol Violation|1|||
23382972|NCT04518410|65145238|FG017|Overall Study|Protocol Violation|1|||
23382973|NCT04518410|65145239|FG018|Overall Study|Protocol Violation|0|||
23382974|NCT04518410|65145240|FG019|Overall Study|Protocol Violation|0|||
23382975|NCT04518410|65145241|FG020|Overall Study|Protocol Violation|1|||
23382976|NCT04518410|65145242|FG021|Overall Study|Protocol Violation|2|||
23382977|NCT04518410|65145243|FG022|Overall Study|Protocol Violation|0|||
23382978|NCT04518410|65145244|FG023|Overall Study|Protocol Violation|3|||
23382979|NCT04518410|65145245|FG024|Overall Study|Protocol Violation|0|||
23382980|NCT04518410|65145221|FG000|Overall Study|Death|0|||
23382981|NCT04518410|65145222|FG001|Overall Study|Death|0|||
23382982|NCT04518410|65145223|FG002|Overall Study|Death|0|||
23382983|NCT04518410|65145224|FG003|Overall Study|Death|0|||
23382984|NCT04518410|65145225|FG004|Overall Study|Death|12|||
23382985|NCT04518410|65145226|FG005|Overall Study|Death|2|||
23382986|NCT04518410|65145227|FG006|Overall Study|Death|11|||
23382987|NCT04518410|65145228|FG007|Overall Study|Death|0|||
23382988|NCT04518410|65145229|FG008|Overall Study|Death|1|||
23382989|NCT04518410|65145230|FG009|Overall Study|Death|0|||
23382990|NCT04518410|65145231|FG010|Overall Study|Death|0|||
23382991|NCT04518410|65145232|FG011|Overall Study|Death|0|||
23382992|NCT04518410|65145233|FG012|Overall Study|Death|0|||
23382993|NCT04518410|65145234|FG013|Overall Study|Death|1|||
23382994|NCT04518410|65145235|FG014|Overall Study|Death|1|||
23382995|NCT04518410|65145236|FG015|Overall Study|Death|0|||
23382996|NCT04518410|65145237|FG016|Overall Study|Death|0|||
23382997|NCT04518410|65145238|FG017|Overall Study|Death|1|||
23382998|NCT04518410|65145239|FG018|Overall Study|Death|4|||
23382999|NCT04518410|65145240|FG019|Overall Study|Death|4|||
23383000|NCT04518410|65145241|FG020|Overall Study|Death|1|||
23383001|NCT04518410|65145242|FG021|Overall Study|Death|0|||
23383002|NCT04518410|65145243|FG022|Overall Study|Death|0|||
23383003|NCT04518410|65145244|FG023|Overall Study|Death|0|||
23383004|NCT04518410|65145245|FG024|Overall Study|Death|0|||
23383005|NCT04518410|65145221|FG000|Overall Study|Requirement to start alternative therapy|0|||
23383006|NCT04518410|65145222|FG001|Overall Study|Requirement to start alternative therapy|0|||
23383007|NCT04518410|65145223|FG002|Overall Study|Requirement to start alternative therapy|1|||
23383008|NCT04518410|65145224|FG003|Overall Study|Requirement to start alternative therapy|0|||
23383009|NCT04518410|65145225|FG004|Overall Study|Requirement to start alternative therapy|0|||
23383010|NCT04518410|65145226|FG005|Overall Study|Requirement to start alternative therapy|0|||
23605978|NCT01640951|65947108|FG007|Overall Study|Death|2|||
23383011|NCT04518410|65145227|FG006|Overall Study|Requirement to start alternative therapy|0|||
23383012|NCT04518410|65145228|FG007|Overall Study|Requirement to start alternative therapy|0|||
23383013|NCT04518410|65145229|FG008|Overall Study|Requirement to start alternative therapy|0|||
23383014|NCT04518410|65145230|FG009|Overall Study|Requirement to start alternative therapy|0|||
23383015|NCT04518410|65145231|FG010|Overall Study|Requirement to start alternative therapy|0|||
23383016|NCT04518410|65145232|FG011|Overall Study|Requirement to start alternative therapy|0|||
23383017|NCT04518410|65145233|FG012|Overall Study|Requirement to start alternative therapy|0|||
23383018|NCT04518410|65145234|FG013|Overall Study|Requirement to start alternative therapy|0|||
23383019|NCT04518410|65145235|FG014|Overall Study|Requirement to start alternative therapy|0|||
23383020|NCT04518410|65145236|FG015|Overall Study|Requirement to start alternative therapy|0|||
23383021|NCT04518410|65145237|FG016|Overall Study|Requirement to start alternative therapy|0|||
23383022|NCT04518410|65145238|FG017|Overall Study|Requirement to start alternative therapy|0|||
23383023|NCT04518410|65145239|FG018|Overall Study|Requirement to start alternative therapy|0|||
23289982|NCT02754492|64801980|FG000|Overall Study|Equipment malfuntion|0|||
23289983|NCT02754492|64801981|FG001|Overall Study|Equipment malfuntion|0|||
23289984|NCT02754492|64801982|FG002|Overall Study|Equipment malfuntion|2|||
23289985|NCT02754492|64801983|FG003|Overall Study|Equipment malfuntion|5|||
23289986|NCT02754492|64801980|FG000|Overall Study|Adverse Event|0|||
23289987|NCT02754492|64801981|FG001|Overall Study|Adverse Event|0|||
23289988|NCT02754492|64801982|FG002|Overall Study|Adverse Event|0|||
23289989|NCT02754492|64801983|FG003|Overall Study|Adverse Event|13|||
23289990|NCT02754492|64801980|FG000|Overall Study|Venous access issues not resulting in AE|0|||
23289991|NCT02754492|64801981|FG001|Overall Study|Venous access issues not resulting in AE|0|||
23289992|NCT02754492|64801982|FG002|Overall Study|Venous access issues not resulting in AE|0|||
23289993|NCT02754492|64801983|FG003|Overall Study|Venous access issues not resulting in AE|4|||
23289994|NCT01151618|64801984|FG000|Overall Study|Adverse Event|2|||
23289995|NCT01151618|64801984|FG000|Overall Study|Withdrawal by Subject|7|||
23289996|NCT01781234|64801985|FG000|Overall Study|Adverse Event|2|||
23289997|NCT01781234|64801986|FG001|Overall Study|Adverse Event|0|||
23289998|NCT01781234|64801985|FG000|Overall Study|Protocol Violation|3|||
23289999|NCT01781234|64801986|FG001|Overall Study|Protocol Violation|0|||
23290000|NCT01781234|64801985|FG000|Overall Study|Withdrawal by Subject|4|||
23290001|NCT01781234|64801986|FG001|Overall Study|Withdrawal by Subject|3|||
23290002|NCT04660032|64801988|FG000|Overall Study|Protocol Violation|1|||
23290003|NCT04660032|64801989|FG001|Overall Study|Protocol Violation|1|||
23290004|NCT01630616|64801990|FG000|Overall Study|Adverse Event|0|||
23290005|NCT01630616|64801991|FG001|Overall Study|Adverse Event|0|||
23290006|NCT01630616|64801992|FG002|Overall Study|Adverse Event|0|||
23290007|NCT01630616|64801993|FG003|Overall Study|Adverse Event|1|||
23290008|NCT01630616|64801994|FG004|Overall Study|Adverse Event|0|||
23290009|NCT01630616|64801995|FG005|Overall Study|Adverse Event|0|||
23290010|NCT01630616|64801990|FG000|Overall Study|Withdrawal by Subject|0|||
23290011|NCT01630616|64801991|FG001|Overall Study|Withdrawal by Subject|0|||
23290012|NCT01630616|64801992|FG002|Overall Study|Withdrawal by Subject|0|||
23290013|NCT01630616|64801993|FG003|Overall Study|Withdrawal by Subject|2|||
23290014|NCT01630616|64801994|FG004|Overall Study|Withdrawal by Subject|0|||
23290015|NCT01630616|64801995|FG005|Overall Study|Withdrawal by Subject|0|||
23290016|NCT03023137|64801999|FG000|Overall Study|Multiple pregnancy|2|||
23290017|NCT03023137|64802000|FG001|Overall Study|Multiple pregnancy|4|||
23290018|NCT03023137|64801999|FG000|Overall Study|Lost to Follow-up|1|||
23290019|NCT03023137|64802000|FG001|Overall Study|Lost to Follow-up|1|||
23290020|NCT03023137|64801999|FG000|Overall Study|Protocol Violation|0|||
23290021|NCT03023137|64802000|FG001|Overall Study|Protocol Violation|4|||
23290022|NCT03023137|64801999|FG000|Overall Study|Lost the baby in a car accident|1|||
23290023|NCT03023137|64802000|FG001|Overall Study|Lost the baby in a car accident|0|||
23290024|NCT02412722|64802001|FG000|Overall Study|Adverse Event|0|||
23290025|NCT02412722|64802002|FG001|Overall Study|Adverse Event|2|||
23290026|NCT02412722|64802003|FG002|Overall Study|Adverse Event|0|||
23290027|NCT02412722|64802004|FG003|Overall Study|Adverse Event|3|||
23383024|NCT04518410|65145240|FG019|Overall Study|Requirement to start alternative therapy|0|||
23383025|NCT04518410|65145241|FG020|Overall Study|Requirement to start alternative therapy|0|||
23290028|NCT02412722|64802005|FG004|Overall Study|Adverse Event|0|||
23290029|NCT02412722|64802006|FG005|Overall Study|Adverse Event|3|||
23290030|NCT02412722|64802001|FG000|Overall Study|Progressive Disease|6|||
23290031|NCT02412722|64802002|FG001|Overall Study|Progressive Disease|4|||
23290032|NCT02412722|64802003|FG002|Overall Study|Progressive Disease|4|||
23290033|NCT02412722|64802004|FG003|Overall Study|Progressive Disease|9|||
23290034|NCT02412722|64802005|FG004|Overall Study|Progressive Disease|3|||
23383026|NCT04518410|65145242|FG021|Overall Study|Requirement to start alternative therapy|0|||
23383027|NCT04518410|65145243|FG022|Overall Study|Requirement to start alternative therapy|0|||
23383028|NCT04518410|65145244|FG023|Overall Study|Requirement to start alternative therapy|0|||
23383029|NCT04518410|65145245|FG024|Overall Study|Requirement to start alternative therapy|0|||
23383030|NCT04518410|65145221|FG000|Overall Study|Randomized but not treated|0|||
23383031|NCT04518410|65145222|FG001|Overall Study|Randomized but not treated|0|||
23383032|NCT04518410|65145223|FG002|Overall Study|Randomized but not treated|0|||
23383033|NCT04518410|65145224|FG003|Overall Study|Randomized but not treated|2|||
23383034|NCT04518410|65145225|FG004|Overall Study|Randomized but not treated|6|||
23383035|NCT04518410|65145226|FG005|Overall Study|Randomized but not treated|4|||
23383036|NCT04518410|65145227|FG006|Overall Study|Randomized but not treated|3|||
23383037|NCT04518410|65145228|FG007|Overall Study|Randomized but not treated|3|||
23383038|NCT04518410|65145229|FG008|Overall Study|Randomized but not treated|0|||
23383039|NCT04518410|65145230|FG009|Overall Study|Randomized but not treated|4|||
23383040|NCT04518410|65145231|FG010|Overall Study|Randomized but not treated|0|||
23383041|NCT04518410|65145232|FG011|Overall Study|Randomized but not treated|0|||
23383042|NCT04518410|65145233|FG012|Overall Study|Randomized but not treated|1|||
23383043|NCT04518410|65145234|FG013|Overall Study|Randomized but not treated|3|||
23383044|NCT04518410|65145235|FG014|Overall Study|Randomized but not treated|3|||
23383045|NCT04518410|65145236|FG015|Overall Study|Randomized but not treated|3|||
23383046|NCT04518410|65145237|FG016|Overall Study|Randomized but not treated|4|||
23383047|NCT04518410|65145238|FG017|Overall Study|Randomized but not treated|5|||
23383048|NCT04518410|65145239|FG018|Overall Study|Randomized but not treated|4|||
23383049|NCT04518410|65145240|FG019|Overall Study|Randomized but not treated|0|||
23383050|NCT04518410|65145241|FG020|Overall Study|Randomized but not treated|0|||
23383051|NCT04518410|65145242|FG021|Overall Study|Randomized but not treated|5|||
23383052|NCT04518410|65145243|FG022|Overall Study|Randomized but not treated|0|||
23383053|NCT04518410|65145244|FG023|Overall Study|Randomized but not treated|3|||
23383054|NCT04518410|65145245|FG024|Overall Study|Randomized but not treated|1|||
23383055|NCT04518410|65145221|FG000|Overall Study|Screen Fail but Randomized|0|||
23383056|NCT04518410|65145222|FG001|Overall Study|Screen Fail but Randomized|0|||
23383057|NCT04518410|65145223|FG002|Overall Study|Screen Fail but Randomized|0|||
23383058|NCT04518410|65145224|FG003|Overall Study|Screen Fail but Randomized|0|||
23383059|NCT04518410|65145225|FG004|Overall Study|Screen Fail but Randomized|2|||
23383060|NCT04518410|65145226|FG005|Overall Study|Screen Fail but Randomized|0|||
23383061|NCT04518410|65145227|FG006|Overall Study|Screen Fail but Randomized|0|||
23383062|NCT04518410|65145228|FG007|Overall Study|Screen Fail but Randomized|0|||
23383063|NCT04518410|65145229|FG008|Overall Study|Screen Fail but Randomized|0|||
23383064|NCT04518410|65145230|FG009|Overall Study|Screen Fail but Randomized|0|||
23383065|NCT04518410|65145231|FG010|Overall Study|Screen Fail but Randomized|0|||
23383066|NCT04518410|65145232|FG011|Overall Study|Screen Fail but Randomized|0|||
23383067|NCT04518410|65145233|FG012|Overall Study|Screen Fail but Randomized|0|||
23383068|NCT04518410|65145234|FG013|Overall Study|Screen Fail but Randomized|0|||
23383069|NCT04518410|65145235|FG014|Overall Study|Screen Fail but Randomized|0|||
23383070|NCT04518410|65145236|FG015|Overall Study|Screen Fail but Randomized|0|||
23383071|NCT04518410|65145237|FG016|Overall Study|Screen Fail but Randomized|0|||
23383072|NCT04518410|65145238|FG017|Overall Study|Screen Fail but Randomized|0|||
23383073|NCT04518410|65145239|FG018|Overall Study|Screen Fail but Randomized|0|||
23383074|NCT04518410|65145240|FG019|Overall Study|Screen Fail but Randomized|0|||
23383075|NCT04518410|65145241|FG020|Overall Study|Screen Fail but Randomized|0|||
23383076|NCT04518410|65145242|FG021|Overall Study|Screen Fail but Randomized|0|||
23383077|NCT04518410|65145243|FG022|Overall Study|Screen Fail but Randomized|0|||
23383078|NCT04518410|65145244|FG023|Overall Study|Screen Fail but Randomized|0|||
23383079|NCT04518410|65145245|FG024|Overall Study|Screen Fail but Randomized|0|||
23383080|NCT04518410|65145221|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383081|NCT04518410|65145222|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383082|NCT04518410|65145223|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383083|NCT04518410|65145224|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383084|NCT04518410|65145225|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
23383085|NCT04518410|65145226|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
23402831|NCT02185534|65220019|FG002|First Washout Period|Protocol Violation|0|||
23493135|NCT01897714|65551366|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
23493136|NCT01897714|65551367|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
23493137|NCT01897714|65551368|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
23493138|NCT01897714|65551369|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
23290035|NCT02412722|64802006|FG005|Overall Study|Progressive Disease|3|||
23290036|NCT02412722|64802001|FG000|Overall Study|Withdrawal by Subject|2|||
23290037|NCT02412722|64802002|FG001|Overall Study|Withdrawal by Subject|0|||
23290038|NCT02412722|64802003|FG002|Overall Study|Withdrawal by Subject|1|||
23290039|NCT02412722|64802004|FG003|Overall Study|Withdrawal by Subject|2|||
23290040|NCT02412722|64802005|FG004|Overall Study|Withdrawal by Subject|1|||
23290041|NCT02412722|64802006|FG005|Overall Study|Withdrawal by Subject|1|||
23290042|NCT02412722|64802001|FG000|Overall Study|Lost to Follow-up|0|||
23290043|NCT02412722|64802002|FG001|Overall Study|Lost to Follow-up|0|||
23290044|NCT02412722|64802003|FG002|Overall Study|Lost to Follow-up|0|||
23290045|NCT02412722|64802004|FG003|Overall Study|Lost to Follow-up|0|||
23290046|NCT02412722|64802005|FG004|Overall Study|Lost to Follow-up|1|||
23290047|NCT02412722|64802006|FG005|Overall Study|Lost to Follow-up|0|||
23290048|NCT02412722|64802001|FG000|Overall Study|Received drug in run-in and discontinued|0|||
23290049|NCT02412722|64802002|FG001|Overall Study|Received drug in run-in and discontinued|2|||
23290050|NCT02412722|64802003|FG002|Overall Study|Received drug in run-in and discontinued|0|||
23290051|NCT02412722|64802004|FG003|Overall Study|Received drug in run-in and discontinued|0|||
23290052|NCT02412722|64802005|FG004|Overall Study|Received drug in run-in and discontinued|0|||
23290053|NCT02412722|64802006|FG005|Overall Study|Received drug in run-in and discontinued|0|||
23290054|NCT02412722|64802001|FG000|Overall Study|Reason not Specified|3|||
23290055|NCT02412722|64802002|FG001|Overall Study|Reason not Specified|0|||
23290056|NCT02412722|64802003|FG002|Overall Study|Reason not Specified|2|||
23290057|NCT02412722|64802004|FG003|Overall Study|Reason not Specified|1|||
23290058|NCT02412722|64802005|FG004|Overall Study|Reason not Specified|2|||
23290059|NCT02412722|64802006|FG005|Overall Study|Reason not Specified|6|||
23290060|NCT00748566|64802009|FG000|Overall Study|Adverse Event|49|||
23290061|NCT00748566|64802009|FG000|Overall Study|Death|1|||
23290062|NCT00748566|64802009|FG000|Overall Study|Lack of Efficacy|12|||
23290063|NCT00748566|64802009|FG000|Overall Study|Lost to Follow-up|1|||
23493139|NCT01897714|65551370|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
23493140|NCT01897714|65551365|FG000|Phase II (MTD)|Other|0|||
23493141|NCT01897714|65551366|FG001|Phase II (MTD)|Other|0|||
23493142|NCT01897714|65551367|FG002|Phase II (MTD)|Other|0|||
23493143|NCT01897714|65551368|FG003|Phase II (MTD)|Other|0|||
23493144|NCT01897714|65551369|FG004|Phase II (MTD)|Other|3|||
23493145|NCT01897714|65551370|FG005|Phase II (MTD)|Other|0|||
23493146|NCT00660673|65551371|FG000|Overall Study|Adverse Event|84|||
23493147|NCT00660673|65551371|FG000|Overall Study|Lack of Efficacy|7|||
23290064|NCT00748566|64802009|FG000|Overall Study|Protocol Violation|13|||
23493148|NCT00660673|65551371|FG000|Overall Study|Withdrawal by Subject|22|||
23493149|NCT00660673|65551371|FG000|Overall Study|Administrative|2|||
23493150|NCT00660673|65551371|FG000|Overall Study|Protocol Violation|2|||
23290065|NCT00748566|64802009|FG000|Overall Study|Withdrawal by Subject|22|||
23290066|NCT00748566|64802009|FG000|Overall Study|Study terminated by sponsor|5|||
23290067|NCT00748566|64802009|FG000|Overall Study|Other|9|||
23290068|NCT02943096|64802010|FG000|Overall Study|Lack of Efficacy|0|||
23290069|NCT02943096|64802011|FG001|Overall Study|Lack of Efficacy|1|||
23290070|NCT03303417|64802012|FG000|Overall Study|Withdrawal by Subject|1|||
23290071|NCT03303417|64802013|FG001|Overall Study|Withdrawal by Subject|1|||
23290072|NCT02914457|64802014|FG000|Overall Study|Withdrawal by Subject|1|||
23290073|NCT02914457|64802014|FG000|Overall Study|Physician Decision|1|||
23290074|NCT02914457|64802014|FG000|Overall Study|No veins available for lead placement|1|||
23290075|NCT02914457|64802014|FG000|Overall Study|Electrical instability of patient|1|||
23290076|NCT02914457|64802014|FG000|Overall Study|ECG acquisition error due to sweating|1|||
23290077|NCT02914457|64802014|FG000|Overall Study|Protocol Violation|1|||
23290078|NCT03450629|64802015|FG000|Overall Study|Adverse Event|15|||
23290079|NCT03450629|64802016|FG001|Overall Study|Adverse Event|14|||
23290080|NCT03450629|64802015|FG000|Overall Study|Physician Decision|2|||
23290081|NCT03450629|64802016|FG001|Overall Study|Physician Decision|2|||
23290082|NCT03450629|64802015|FG000|Overall Study|Lack of Efficacy|2|||
23290083|NCT03450629|64802016|FG001|Overall Study|Lack of Efficacy|0|||
23290084|NCT03450629|64802015|FG000|Overall Study|Lost to Follow-up|4|||
23290085|NCT03450629|64802016|FG001|Overall Study|Lost to Follow-up|2|||
23290086|NCT03450629|64802015|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23290087|NCT03450629|64802016|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
23383086|NCT04518410|65145227|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
23383087|NCT04518410|65145228|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
23383088|NCT04518410|65145229|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
23383089|NCT04518410|65145230|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
23383090|NCT04518410|65145231|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
23383091|NCT04518410|65145232|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383092|NCT04518410|65145233|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383093|NCT04518410|65145234|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
23383094|NCT04518410|65145235|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
23383095|NCT04518410|65145236|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
23383096|NCT04518410|65145237|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
23383097|NCT04518410|65145238|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
23383098|NCT04518410|65145239|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
23383099|NCT04518410|65145240|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
23383100|NCT04518410|65145241|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
23383101|NCT04518410|65145242|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
23383102|NCT04518410|65145243|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
23383103|NCT04518410|65145244|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
23383104|NCT04518410|65145245|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
23383105|NCT04518410|65145221|FG000|Overall Study|Dual Enrolled Subject|0|||
23383106|NCT04518410|65145222|FG001|Overall Study|Dual Enrolled Subject|0|||
23383107|NCT04518410|65145223|FG002|Overall Study|Dual Enrolled Subject|0|||
23383108|NCT04518410|65145224|FG003|Overall Study|Dual Enrolled Subject|0|||
23383109|NCT04518410|65145225|FG004|Overall Study|Dual Enrolled Subject|0|||
23383110|NCT04518410|65145226|FG005|Overall Study|Dual Enrolled Subject|0|||
23383111|NCT04518410|65145227|FG006|Overall Study|Dual Enrolled Subject|0|||
23383112|NCT04518410|65145228|FG007|Overall Study|Dual Enrolled Subject|0|||
23383113|NCT04518410|65145229|FG008|Overall Study|Dual Enrolled Subject|0|||
23383114|NCT04518410|65145230|FG009|Overall Study|Dual Enrolled Subject|0|||
23383115|NCT04518410|65145231|FG010|Overall Study|Dual Enrolled Subject|0|||
23605979|NCT00452114|65947112|FG000|Overall Study|Physician Decision|3|||
23290088|NCT03450629|64802015|FG000|Overall Study|Non-Compliance With Study Drug|2|||
23290089|NCT03450629|64802016|FG001|Overall Study|Non-Compliance With Study Drug|1|||
23290090|NCT03450629|64802015|FG000|Overall Study|Protocol Violation|11|||
23290091|NCT03450629|64802016|FG001|Overall Study|Protocol Violation|8|||
23290092|NCT03450629|64802015|FG000|Overall Study|Withdrawal by Subject|12|||
23290093|NCT03450629|64802016|FG001|Overall Study|Withdrawal by Subject|6|||
23290094|NCT01898598|64802017|FG000|Overall Study|Adverse Event|1|||
23290095|NCT01898598|64802018|FG001|Overall Study|Adverse Event|0|||
23290096|NCT01898598|64802017|FG000|Overall Study|Withdrawal by Subject|3|||
23290097|NCT01898598|64802018|FG001|Overall Study|Withdrawal by Subject|0|||
23290098|NCT01898598|64802017|FG000|Overall Study|Lost to Follow-up|0|||
23290099|NCT01898598|64802018|FG001|Overall Study|Lost to Follow-up|1|||
23290100|NCT01898598|64802017|FG000|Overall Study|Other|0|||
23290101|NCT01898598|64802018|FG001|Overall Study|Other|1|||
23290102|NCT00958724|64802019|FG000|Overall Study|Disease Progression|6|||
23290103|NCT00654641|64802020|FG000|Overall Study|Lost to Follow-up|2|||
23290104|NCT00654641|64802021|FG001|Overall Study|Lost to Follow-up|3|||
23290105|NCT05061992|64802024|FG000|Overall Study|Excess bowel movements|1|||
23290106|NCT05061992|64802025|FG001|Overall Study|Excess bowel movements|0|||
23290107|NCT05061992|64802024|FG000|Overall Study|Complications of Medical Care|1|||
23290108|NCT05061992|64802025|FG001|Overall Study|Complications of Medical Care|0|||
23290109|NCT05061992|64802024|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
23290110|NCT05061992|64802025|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
23290111|NCT05061992|64802024|FG000|Overall Study|Withdrawal by Subject|0|||
23290112|NCT05061992|64802025|FG001|Overall Study|Withdrawal by Subject|1|||
23290113|NCT00152516|64802026|FG000|Overall Study|Adverse Event|18|||
23290114|NCT00152516|64802026|FG000|Overall Study|Lack and Loss of Efficacy|30|||
23290115|NCT00152516|64802026|FG000|Overall Study|Lost to Follow-up|5|||
23290116|NCT00152516|64802026|FG000|Overall Study|Withdrawal by Subject|8|||
23290117|NCT00152516|64802026|FG000|Overall Study|Protocol Violation|3|||
23290118|NCT00152516|64802026|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
23290119|NCT00152516|64802026|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
23290120|NCT00152516|64802026|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
23290121|NCT00152516|64802026|FG000|Overall Study|Other: Non-Compliance|2|||
23383116|NCT04518410|65145232|FG011|Overall Study|Dual Enrolled Subject|0|||
23383117|NCT04518410|65145233|FG012|Overall Study|Dual Enrolled Subject|0|||
23383118|NCT04518410|65145234|FG013|Overall Study|Dual Enrolled Subject|0|||
23383119|NCT04518410|65145235|FG014|Overall Study|Dual Enrolled Subject|0|||
23383120|NCT04518410|65145236|FG015|Overall Study|Dual Enrolled Subject|0|||
23383121|NCT04518410|65145237|FG016|Overall Study|Dual Enrolled Subject|0|||
23383122|NCT04518410|65145238|FG017|Overall Study|Dual Enrolled Subject|1|||
23383123|NCT04518410|65145239|FG018|Overall Study|Dual Enrolled Subject|0|||
23383124|NCT04518410|65145240|FG019|Overall Study|Dual Enrolled Subject|0|||
23383125|NCT04518410|65145241|FG020|Overall Study|Dual Enrolled Subject|0|||
23383126|NCT04518410|65145242|FG021|Overall Study|Dual Enrolled Subject|0|||
23383127|NCT04518410|65145243|FG022|Overall Study|Dual Enrolled Subject|0|||
23383128|NCT04518410|65145244|FG023|Overall Study|Dual Enrolled Subject|0|||
23383129|NCT04518410|65145245|FG024|Overall Study|Dual Enrolled Subject|0|||
23383130|NCT00898807|65145246|FG000|Overall Study|Withdrawal by Subject|5|||
23383131|NCT00898807|65145247|FG001|Overall Study|Withdrawal by Subject|3|||
23383132|NCT00898807|65145246|FG000|Overall Study|Family pressure to discontinue|2|||
23383133|NCT00898807|65145247|FG001|Overall Study|Family pressure to discontinue|2|||
23383134|NCT00898807|65145246|FG000|Overall Study|Lost to Follow-up|1|||
23383135|NCT00898807|65145247|FG001|Overall Study|Lost to Follow-up|3|||
23383136|NCT00898807|65145246|FG000|Overall Study|Death|0|||
23383137|NCT00898807|65145247|FG001|Overall Study|Death|1|||
23383138|NCT00114777|65145248|FG000|Randomization to Month 36|Death|10|||
23383139|NCT00114777|65145249|FG001|Randomization to Month 36|Death|4|||
23383140|NCT00114777|65145250|FG002|Randomization to Month 36|Death|3|||
23383141|NCT00114777|65145248|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
23383142|NCT00114777|65145249|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
23383143|NCT00114777|65145250|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
23383144|NCT00114777|65145248|FG000|Randomization to Month 36|Lack of Efficacy|19|||
23383145|NCT00114777|65145249|FG001|Randomization to Month 36|Lack of Efficacy|15|||
23383146|NCT00114777|65145250|FG002|Randomization to Month 36|Lack of Efficacy|17|||
23383147|NCT00114777|65145248|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
23383148|NCT00114777|65145249|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
23383149|NCT00114777|65145250|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
23383150|NCT00114777|65145248|FG000|Randomization to Month 36|Adverse Event|34|||
23383151|NCT00114777|65145249|FG001|Randomization to Month 36|Adverse Event|35|||
23383152|NCT00114777|65145250|FG002|Randomization to Month 36|Adverse Event|44|||
23383153|NCT00114777|65145248|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
23383154|NCT00114777|65145249|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
23383155|NCT00114777|65145250|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
23383156|NCT00114777|65145248|FG000|Randomization to Month 36|Other|9|||
23383157|NCT00114777|65145249|FG001|Randomization to Month 36|Other|3|||
23383158|NCT00114777|65145250|FG002|Randomization to Month 36|Other|12|||
23383159|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Death|8|||
23383160|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Death|13|||
23290122|NCT00152516|64802026|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
23290123|NCT00152516|64802026|FG000|Overall Study|Other: Moved Out Of State|1|||
23290124|NCT00152516|64802026|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
23383161|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Death|7|||
23383162|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
23383163|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
23605980|NCT00452114|65947113|FG001|Overall Study|Physician Decision|3|||
23605981|NCT02771366|65947115|FG000|Period 1|Withdrawal by Subject|0|||
23605982|NCT02771366|65947116|FG001|Period 1|Withdrawal by Subject|2|||
23605983|NCT02771366|65947115|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
23605984|NCT02771366|65947116|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
23605985|NCT02993926|65947117|FG000|Enantone Treatment Phase|Adverse Event|1|||
23605986|NCT02993926|65947118|FG001|Enantone Treatment Phase|Adverse Event|0|||
23605987|NCT02993926|65947119|FG002|Enantone Treatment Phase|Adverse Event|0|||
23605988|NCT02993926|65947117|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
23605989|NCT02993926|65947118|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
23605990|NCT02993926|65947119|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
23605991|NCT02993926|65947117|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
23605992|NCT02993926|65947118|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
23605993|NCT02993926|65947119|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
23605994|NCT02993926|65947117|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
23605995|NCT02993926|65947118|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
23605996|NCT02993926|65947119|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
23605997|NCT02113449|65947120|FG000|Overall Study|Adverse Event|4|||
23605998|NCT01190124|65947122|FG000|Overall Study|Death|3|||
23605999|NCT01190124|65947123|FG001|Overall Study|Death|0|||
23606000|NCT01190124|65947124|FG002|Overall Study|Death|0|||
23606001|NCT01190124|65947122|FG000|Overall Study|Therapeutic Failure|12|||
23606002|NCT01190124|65947123|FG001|Overall Study|Therapeutic Failure|0|||
23606003|NCT01190124|65947124|FG002|Overall Study|Therapeutic Failure|1|||
23606004|NCT01190124|65947122|FG000|Overall Study|Lost to Follow-up|2|||
23606005|NCT01190124|65947123|FG001|Overall Study|Lost to Follow-up|0|||
23606006|NCT01190124|65947124|FG002|Overall Study|Lost to Follow-up|0|||
23606007|NCT03622580|65947125|FG000|Overall Study|Death|16|||
23606008|NCT03622580|65947126|FG001|Overall Study|Death|21|||
23606009|NCT03622580|65947127|FG002|Overall Study|Death|13|||
23606010|NCT03622580|65947125|FG000|Overall Study|Adverse Event|6|||
23606011|NCT03622580|65947126|FG001|Overall Study|Adverse Event|6|||
23606012|NCT03622580|65947127|FG002|Overall Study|Adverse Event|5|||
23606013|NCT03622580|65947125|FG000|Overall Study|Withdrawal by Subject|12|||
23606014|NCT03622580|65947126|FG001|Overall Study|Withdrawal by Subject|7|||
23606015|NCT03622580|65947127|FG002|Overall Study|Withdrawal by Subject|19|||
23606016|NCT03622580|65947125|FG000|Overall Study|Lost to Follow-up|12|||
23606017|NCT03622580|65947126|FG001|Overall Study|Lost to Follow-up|9|||
23606018|NCT03622580|65947127|FG002|Overall Study|Lost to Follow-up|9|||
23606019|NCT03622580|65947125|FG000|Overall Study|Protocol Violation|1|||
23606020|NCT03622580|65947126|FG001|Overall Study|Protocol Violation|0|||
23606021|NCT03622580|65947127|FG002|Overall Study|Protocol Violation|1|||
23606022|NCT03622580|65947125|FG000|Overall Study|Physician Decision|3|||
23606023|NCT03622580|65947126|FG001|Overall Study|Physician Decision|0|||
23606024|NCT03622580|65947127|FG002|Overall Study|Physician Decision|1|||
23606025|NCT03622580|65947125|FG000|Overall Study|Pregnancy|0|||
23606026|NCT03622580|65947126|FG001|Overall Study|Pregnancy|1|||
23606027|NCT03622580|65947127|FG002|Overall Study|Pregnancy|0|||
23383164|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
23383165|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
23383166|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
23383167|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
23383168|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
23383169|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
23383170|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
23383171|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
23383172|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
23383173|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
23383174|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
23383175|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
23383176|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
23383177|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
23383178|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
23383179|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
23383180|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
23383181|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
23383182|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
23383183|NCT00114777|65145248|FG000|Long-Term Extension to Month 84|Other|2|||
23383184|NCT00114777|65145249|FG001|Long-Term Extension to Month 84|Other|0|||
23383185|NCT00114777|65145250|FG002|Long-Term Extension to Month 84|Other|2|||
23383186|NCT01397747|65145251|FG000|Overall Study|Multitarget DNA test excluded|689|||
23383187|NCT01397747|65145251|FG000|Overall Study|Colonoscopy excluded|304|||
23383188|NCT01397747|65145251|FG000|Overall Study|FIT excluded|34|||
23383189|NCT04625972|65145252|FG000|Overall Study|Death|3|||
23383190|NCT04625972|65145253|FG001|Overall Study|Death|2|||
23383191|NCT04625972|65145252|FG000|Overall Study|Lost to Follow-up|82|||
23383192|NCT04625972|65145253|FG001|Overall Study|Lost to Follow-up|38|||
23383193|NCT04625972|65145252|FG000|Overall Study|Physician Decision|2|||
23383194|NCT04625972|65145253|FG001|Overall Study|Physician Decision|0|||
23383195|NCT04625972|65145252|FG000|Overall Study|Protocol Violation|0|||
23383196|NCT04625972|65145253|FG001|Overall Study|Protocol Violation|1|||
23383197|NCT04625972|65145252|FG000|Overall Study|Withdrawal by Subject|37|||
23383198|NCT04625972|65145253|FG001|Overall Study|Withdrawal by Subject|24|||
23383199|NCT04625972|65145252|FG000|Overall Study|Not specified elsewhere|8|||
23383200|NCT04625972|65145253|FG001|Overall Study|Not specified elsewhere|6|||
23383201|NCT00382070|65145254|FG000|Overall Study|No follow up data mapped to Other|17|||
23383202|NCT00382070|65145255|FG001|Overall Study|No follow up data mapped to Other|19|||
23383203|NCT00382070|65145254|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
23383204|NCT00382070|65145255|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
23383205|NCT00382070|65145254|FG000|Overall Study|No clinical assessment|9|||
23383206|NCT00382070|65145255|FG001|Overall Study|No clinical assessment|11|||
23383207|NCT00875667|65148045|FG000|Overall Study|Adverse Event|29|||
23383208|NCT00875667|65148046|FG001|Overall Study|Adverse Event|10|||
23383209|NCT00875667|65148045|FG000|Overall Study|Withdrawal by Subject|17|||
23383210|NCT00875667|65148046|FG001|Overall Study|Withdrawal by Subject|5|||
23383211|NCT00875667|65148045|FG000|Overall Study|Death|7|||
23383212|NCT00875667|65148046|FG001|Overall Study|Death|2|||
23383213|NCT00875667|65148045|FG000|Overall Study|Protocol Violation|2|||
23383214|NCT00875667|65148046|FG001|Overall Study|Protocol Violation|0|||
23383215|NCT00875667|65148045|FG000|Overall Study|Disease Progression|100|||
23383216|NCT00875667|65148046|FG001|Overall Study|Disease Progression|49|||
23383217|NCT00875667|65148045|FG000|Overall Study|Miscellaneous|12|||
23383218|NCT00875667|65148046|FG001|Overall Study|Miscellaneous|6|||
23383219|NCT00875667|65148045|FG000|Overall Study|Randomized but no Study Drug Given|3|||
23383220|NCT00875667|65148046|FG001|Overall Study|Randomized but no Study Drug Given|1|||
23383221|NCT00549328|65148051|FG000|Overall Study|Adverse Event|2|||
23383222|NCT00549328|65148051|FG000|Overall Study|Disease Progression|10|||
23383223|NCT00549328|65148051|FG000|Overall Study|Death|1|||
23383224|NCT00549328|65148051|FG000|Overall Study|Use of Prohibited Medication|1|||
23383225|NCT03695094|65148054|FG000|Overall Study|Adverse Event|1|||
23383226|NCT03695094|65148055|FG001|Overall Study|Adverse Event|1|||
23383227|NCT03695094|65148054|FG000|Overall Study|Withdrawal by Subject|1|||
23383228|NCT03695094|65148055|FG001|Overall Study|Withdrawal by Subject|0|||
23383229|NCT03994120|65148056|FG000|Overall Study|Lost to Follow-up|3|||
23383230|NCT03994120|65148057|FG001|Overall Study|Lost to Follow-up|1|||
23383231|NCT00726557|65148058|FG000|Overall Study|Screening failure|4|||
23383232|NCT00726557|65148058|FG000|Overall Study|No end of treatment documentation|37|||
23383233|NCT00726557|65148058|FG000|Overall Study|No follow-up documentation available|55|||
23383234|NCT00726557|65148058|FG000|Overall Study|Treatment less than 3 months|17|||
23383235|NCT00726557|65148058|FG000|Overall Study|Inclusion criteria not met|15|||
23383236|NCT00541775|65148059|FG000|Overall Study|Adverse Event|3|||
23383237|NCT00541775|65148060|FG001|Overall Study|Adverse Event|2|||
23290125|NCT00152516|64802026|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
23290126|NCT03493919|64802027|FG000|Overall Study|Other|2|||
23290127|NCT03493919|64802028|FG001|Overall Study|Other|0|||
23290128|NCT03493919|64802029|FG002|Overall Study|Other|1|||
23290129|NCT03493919|64802030|FG003|Overall Study|Other|0|||
23290130|NCT03493919|64802027|FG000|Overall Study|Withdrawal by Subject|9|||
23290131|NCT03493919|64802028|FG001|Overall Study|Withdrawal by Subject|3|||
23290132|NCT03493919|64802029|FG002|Overall Study|Withdrawal by Subject|1|||
23290133|NCT03493919|64802030|FG003|Overall Study|Withdrawal by Subject|1|||
23290134|NCT03493919|64802027|FG000|Overall Study|Lost to Follow-up|5|||
23290135|NCT03493919|64802028|FG001|Overall Study|Lost to Follow-up|0|||
23290136|NCT03493919|64802029|FG002|Overall Study|Lost to Follow-up|0|||
23290137|NCT03493919|64802030|FG003|Overall Study|Lost to Follow-up|3|||
23290138|NCT03493919|64802027|FG000|Overall Study|Adverse Event|0|||
23290139|NCT03493919|64802028|FG001|Overall Study|Adverse Event|1|||
23290140|NCT03493919|64802029|FG002|Overall Study|Adverse Event|0|||
23290141|NCT03493919|64802030|FG003|Overall Study|Adverse Event|0|||
23290142|NCT03433703|64802033|FG000|Overall Study|Study terminated by Sponsor|2|||
23290143|NCT01992094|64802034|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
23290144|NCT01992094|64802035|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
23290145|NCT01992094|64802036|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
23290146|NCT01992094|64802034|FG000|Overall Study|Adverse Event|1|||
23290147|NCT01992094|64802035|FG001|Overall Study|Adverse Event|0|||
23290148|NCT01992094|64802036|FG002|Overall Study|Adverse Event|0|||
23290149|NCT01992094|64802034|FG000|Overall Study|Death|5|||
23290150|NCT01992094|64802035|FG001|Overall Study|Death|5|||
23290151|NCT01992094|64802036|FG002|Overall Study|Death|2|||
23290152|NCT01992094|64802034|FG000|Overall Study|Lost to Follow-up|26|||
23290153|NCT01992094|64802035|FG001|Overall Study|Lost to Follow-up|9|||
23290154|NCT01992094|64802036|FG002|Overall Study|Lost to Follow-up|13|||
23290155|NCT01992094|64802034|FG000|Overall Study|OTHER|4|||
23290156|NCT01992094|64802035|FG001|Overall Study|OTHER|0|||
23290157|NCT01992094|64802036|FG002|Overall Study|OTHER|0|||
23290158|NCT01992094|64802034|FG000|Overall Study|Protocol Violation|1|||
23290159|NCT01992094|64802035|FG001|Overall Study|Protocol Violation|0|||
23290160|NCT01992094|64802036|FG002|Overall Study|Protocol Violation|1|||
23290161|NCT01992094|64802034|FG000|Overall Study|Withdrawal by Subject|7|||
23290162|NCT01992094|64802035|FG001|Overall Study|Withdrawal by Subject|3|||
23290163|NCT01992094|64802036|FG002|Overall Study|Withdrawal by Subject|4|||
23290164|NCT01691430|64802037|FG000|Overall Study|Death|17|||
23290165|NCT01691430|64802038|FG001|Overall Study|Death|16|||
23290166|NCT01691430|64802037|FG000|Overall Study|Withdrawal by Subject|5|||
23290167|NCT01691430|64802038|FG001|Overall Study|Withdrawal by Subject|1|||
23290168|NCT01691430|64802037|FG000|Overall Study|Lost to Follow-up|0|||
23290169|NCT01691430|64802038|FG001|Overall Study|Lost to Follow-up|3|||
23290170|NCT02308241|64802039|FG000|Overall Study|Withdrawal by Subject|3|||
23290171|NCT00084864|64802043|FG000|Overall Study|Adverse Event|1|||
23290172|NCT00084864|64802044|FG001|Overall Study|Adverse Event|0|||
23290173|NCT00084864|64802045|FG002|Overall Study|Adverse Event|0|||
23290174|NCT00084864|64802046|FG003|Overall Study|Adverse Event|0|||
23290175|NCT02941523|64802053|FG000|Monotherapy|Withdrawal by Subject|0|||
23290176|NCT02941523|64802054|FG001|Monotherapy|Withdrawal by Subject|1|||
23290177|NCT02941523|64802053|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
23290178|NCT02941523|64802054|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
23290179|NCT02941523|64802053|FG000|Carboplatin Combination Therapy|Death|1|||
23290180|NCT02941523|64802054|FG001|Carboplatin Combination Therapy|Death|2|||
23290181|NCT02941523|64802053|FG000|Carboplatin Combination Therapy|Disease progression|2|||
23290182|NCT02941523|64802054|FG001|Carboplatin Combination Therapy|Disease progression|0|||
23290183|NCT02941523|64802053|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
23290184|NCT02941523|64802054|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
23290185|NCT02583048|64802057|FG000|Overall Study|Withdrawal by Subject|0|||
23290186|NCT02583048|64802058|FG001|Overall Study|Withdrawal by Subject|1|||
23290187|NCT02583048|64802059|FG002|Overall Study|Withdrawal by Subject|0|||
23290188|NCT02583048|64802057|FG000|Overall Study|Failed to meet eligibility criterion|0|||
23290189|NCT02583048|64802058|FG001|Overall Study|Failed to meet eligibility criterion|0|||
23290190|NCT02583048|64802059|FG002|Overall Study|Failed to meet eligibility criterion|1|||
23290191|NCT00089973|64802060|FG000|Overall Study|Adverse Event|3|||
23290192|NCT00089973|64802060|FG000|Overall Study|Withdrawal by Subject|1|||
23290193|NCT00089973|64802060|FG000|Overall Study|Disease progression|45|||
23383238|NCT00541775|65148061|FG002|Overall Study|Adverse Event|1|||
23290194|NCT00089973|64802060|FG000|Overall Study|Death|1|||
23290195|NCT00250705|64802063|FG000|Overall Study|Lack of Efficacy|2|||
23290196|NCT02369458|64802066|FG000|Overall Study|Determined to be not eligible|1|||
23290197|NCT02369458|64802067|FG001|Overall Study|Determined to be not eligible|0|||
23290198|NCT01475487|64802068|FG000|Overall Study|had to leave early for personal reasons|2|||
23383239|NCT00541775|65148059|FG000|Overall Study|Lack of Efficacy|0|||
23383240|NCT00541775|65148060|FG001|Overall Study|Lack of Efficacy|0|||
23383241|NCT00541775|65148061|FG002|Overall Study|Lack of Efficacy|3|||
23383242|NCT00541775|65148059|FG000|Overall Study|Lost to Follow-up|0|||
23383243|NCT00541775|65148060|FG001|Overall Study|Lost to Follow-up|0|||
23383244|NCT00541775|65148061|FG002|Overall Study|Lost to Follow-up|2|||
23383245|NCT00541775|65148059|FG000|Overall Study|Protocol Violation|1|||
23383246|NCT00541775|65148060|FG001|Overall Study|Protocol Violation|0|||
23383247|NCT00541775|65148061|FG002|Overall Study|Protocol Violation|0|||
23383248|NCT00541775|65148059|FG000|Overall Study|Withdrawal by Subject and Other|5|||
23383249|NCT00541775|65148060|FG001|Overall Study|Withdrawal by Subject and Other|0|||
23383250|NCT00541775|65148061|FG002|Overall Study|Withdrawal by Subject and Other|2|||
23383251|NCT00504309|65148062|FG000|Overall Study|Death|0|||
23383252|NCT00504309|65148063|FG001|Overall Study|Death|0|||
23383253|NCT00504309|65148064|FG002|Overall Study|Death|0|||
23383254|NCT00504309|65148065|FG003|Overall Study|Death|0|||
23383255|NCT00504309|65148066|FG004|Overall Study|Death|1|||
23383256|NCT00504309|65148067|FG005|Overall Study|Death|0|||
23383257|NCT00504309|65148062|FG000|Overall Study|Withdrawal by Subject|0|||
23383258|NCT00504309|65148063|FG001|Overall Study|Withdrawal by Subject|0|||
23383259|NCT00504309|65148064|FG002|Overall Study|Withdrawal by Subject|1|||
23383260|NCT00504309|65148065|FG003|Overall Study|Withdrawal by Subject|0|||
23383261|NCT00504309|65148066|FG004|Overall Study|Withdrawal by Subject|0|||
23383262|NCT00504309|65148067|FG005|Overall Study|Withdrawal by Subject|0|||
23383263|NCT01756235|65148068|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
23383264|NCT05064800|65148069|FG000|Period 3|Withdrawal by Subject|0|||
23383265|NCT05064800|65148070|FG001|Period 3|Withdrawal by Subject|0|||
23383266|NCT05064800|65148071|FG002|Period 3|Withdrawal by Subject|0|||
23383267|NCT05064800|65148072|FG003|Period 3|Withdrawal by Subject|0|||
23383268|NCT05064800|65148073|FG004|Period 3|Withdrawal by Subject|1|||
23383269|NCT05064800|65148074|FG005|Period 3|Withdrawal by Subject|0|||
23383270|NCT03767894|65148077|FG000|Overall Study|Withdrawal by Subject|1|||
23383271|NCT00021255|65148078|FG000|Overall Study|Death|1|||
23383272|NCT00021255|65148079|FG001|Overall Study|Death|0|||
23383273|NCT00021255|65148080|FG002|Overall Study|Death|2|||
23383274|NCT00021255|65148078|FG000|Overall Study|Breast cancer relapse|5|||
23383275|NCT00021255|65148079|FG001|Overall Study|Breast cancer relapse|18|||
23383276|NCT00021255|65148080|FG002|Overall Study|Breast cancer relapse|11|||
23383277|NCT00021255|65148078|FG000|Overall Study|Second primary malignancy|0|||
23383278|NCT00021255|65148079|FG001|Overall Study|Second primary malignancy|4|||
23290199|NCT01475487|64802069|FG001|Overall Study|had to leave early for personal reasons|1|||
23290200|NCT02611323|64802070|FG000|Overall Study|Death|3|||
23290201|NCT02611323|64802071|FG001|Overall Study|Death|1|||
23290202|NCT02611323|64802072|FG002|Overall Study|Death|0|||
23290203|NCT02611323|64802073|FG003|Overall Study|Death|0|||
23290204|NCT02611323|64802074|FG004|Overall Study|Death|1|||
23290205|NCT02611323|64802075|FG005|Overall Study|Death|1|||
23290206|NCT02611323|64802076|FG006|Overall Study|Death|8|||
23383279|NCT00021255|65148080|FG002|Overall Study|Second primary malignancy|1|||
23383280|NCT00021255|65148078|FG000|Overall Study|Withdrawal by Subject|41|||
23383281|NCT00021255|65148079|FG001|Overall Study|Withdrawal by Subject|64|||
23383282|NCT00021255|65148080|FG002|Overall Study|Withdrawal by Subject|26|||
23383283|NCT00021255|65148078|FG000|Overall Study|Lost to Follow-up|0|||
23383284|NCT00021255|65148079|FG001|Overall Study|Lost to Follow-up|2|||
23383285|NCT00021255|65148080|FG002|Overall Study|Lost to Follow-up|3|||
23383286|NCT00021255|65148078|FG000|Overall Study|Cardiac toxicity|0|||
23383287|NCT00021255|65148079|FG001|Overall Study|Cardiac toxicity|61|||
23383288|NCT00021255|65148080|FG002|Overall Study|Cardiac toxicity|32|||
23383289|NCT00021255|65148078|FG000|Overall Study|Herceptin toxicity|0|||
23383290|NCT00021255|65148079|FG001|Overall Study|Herceptin toxicity|22|||
23290207|NCT02611323|64802077|FG007|Overall Study|Death|0|||
23290208|NCT02611323|64802078|FG008|Overall Study|Death|4|||
23383291|NCT00021255|65148080|FG002|Overall Study|Herceptin toxicity|6|||
23383292|NCT00021255|65148078|FG000|Overall Study|Adverse Event|46|||
23383293|NCT00021255|65148079|FG001|Overall Study|Adverse Event|30|||
23290209|NCT02611323|64802079|FG009|Overall Study|Death|6|||
23290210|NCT02611323|64802080|FG010|Overall Study|Death|26|||
23290211|NCT02611323|64802070|FG000|Overall Study|Lost to Follow-up|1|||
23290212|NCT02611323|64802071|FG001|Overall Study|Lost to Follow-up|0|||
23290213|NCT02611323|64802072|FG002|Overall Study|Lost to Follow-up|0|||
23290214|NCT02611323|64802073|FG003|Overall Study|Lost to Follow-up|0|||
23290215|NCT02611323|64802074|FG004|Overall Study|Lost to Follow-up|0|||
23290216|NCT02611323|64802075|FG005|Overall Study|Lost to Follow-up|0|||
23290217|NCT02611323|64802076|FG006|Overall Study|Lost to Follow-up|3|||
23290218|NCT02611323|64802077|FG007|Overall Study|Lost to Follow-up|0|||
23290219|NCT02611323|64802078|FG008|Overall Study|Lost to Follow-up|0|||
23290220|NCT02611323|64802079|FG009|Overall Study|Lost to Follow-up|0|||
23290221|NCT02611323|64802080|FG010|Overall Study|Lost to Follow-up|2|||
23290222|NCT02611323|64802070|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290223|NCT02611323|64802071|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290224|NCT02611323|64802072|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290225|NCT02611323|64802073|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290226|NCT02611323|64802074|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290227|NCT02611323|64802075|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290228|NCT02611323|64802076|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290229|NCT02611323|64802077|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290230|NCT02611323|64802078|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290231|NCT02611323|64802079|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
23290232|NCT02611323|64802080|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
23290233|NCT02611323|64802070|FG000|Overall Study|Progressive Disease|0|||
23290234|NCT02611323|64802071|FG001|Overall Study|Progressive Disease|0|||
23290235|NCT02611323|64802072|FG002|Overall Study|Progressive Disease|0|||
23290236|NCT02611323|64802073|FG003|Overall Study|Progressive Disease|0|||
23290237|NCT02611323|64802074|FG004|Overall Study|Progressive Disease|0|||
23290238|NCT02611323|64802075|FG005|Overall Study|Progressive Disease|0|||
23290239|NCT02611323|64802076|FG006|Overall Study|Progressive Disease|0|||
23290240|NCT02611323|64802077|FG007|Overall Study|Progressive Disease|0|||
23290241|NCT02611323|64802078|FG008|Overall Study|Progressive Disease|0|||
23290242|NCT02611323|64802079|FG009|Overall Study|Progressive Disease|0|||
23290243|NCT02611323|64802080|FG010|Overall Study|Progressive Disease|1|||
23290244|NCT02611323|64802070|FG000|Overall Study|Withdrawal by Subject|1|||
23290245|NCT02611323|64802071|FG001|Overall Study|Withdrawal by Subject|0|||
23290246|NCT02611323|64802072|FG002|Overall Study|Withdrawal by Subject|0|||
23290247|NCT02611323|64802073|FG003|Overall Study|Withdrawal by Subject|0|||
23290248|NCT02611323|64802074|FG004|Overall Study|Withdrawal by Subject|0|||
23290249|NCT02611323|64802075|FG005|Overall Study|Withdrawal by Subject|0|||
23290250|NCT02611323|64802076|FG006|Overall Study|Withdrawal by Subject|0|||
23290251|NCT02611323|64802077|FG007|Overall Study|Withdrawal by Subject|1|||
23290252|NCT02611323|64802078|FG008|Overall Study|Withdrawal by Subject|0|||
23290253|NCT02611323|64802079|FG009|Overall Study|Withdrawal by Subject|1|||
23290254|NCT02611323|64802080|FG010|Overall Study|Withdrawal by Subject|0|||
23290255|NCT02795676|64802081|FG000|Overall Study|Adverse Event|2|||
23290256|NCT02795676|64802082|FG001|Overall Study|Adverse Event|0|||
23290257|NCT02795676|64802081|FG000|Overall Study|Withdrawal by Subject|3|||
23290258|NCT02795676|64802082|FG001|Overall Study|Withdrawal by Subject|1|||
23290259|NCT04254809|64802083|FG000|Overall Study|Lost to Follow-up|5|||
23290260|NCT04254809|64802084|FG001|Overall Study|Lost to Follow-up|10|||
23290261|NCT00772148|64802085|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
23290262|NCT00772148|64802086|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
23290263|NCT00772148|64802085|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
23290264|NCT00772148|64802086|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
23290265|NCT00772148|64802085|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
23290266|NCT00772148|64802086|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
23290267|NCT00772148|64802085|FG000|Maintenance Phase (Week 52)|Death|2|||
23290268|NCT00772148|64802086|FG001|Maintenance Phase (Week 52)|Death|2|||
23290269|NCT00772148|64802085|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
23290270|NCT00772148|64802086|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
23290271|NCT00772148|64802085|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
23383294|NCT00021255|65148080|FG002|Overall Study|Adverse Event|18|||
23290272|NCT00772148|64802086|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
23290273|NCT00772148|64802085|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
23290274|NCT00772148|64802086|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
23290275|NCT04194151|64802089|FG000|Overall Study|Physician Decision|1|||
23290276|NCT04194151|64802090|FG001|Overall Study|Physician Decision|1|||
23290277|NCT04194151|64802091|FG002|Overall Study|Physician Decision|1|||
23290278|NCT04194151|64802092|FG003|Overall Study|Physician Decision|1|||
23290279|NCT04194151|64802093|FG004|Overall Study|Physician Decision|0|||
23383295|NCT00021255|65148078|FG000|Overall Study|Protocol Violation|0|||
23383296|NCT00021255|65148079|FG001|Overall Study|Protocol Violation|2|||
23383297|NCT00021255|65148080|FG002|Overall Study|Protocol Violation|0|||
23383298|NCT00021255|65148078|FG000|Overall Study|Other than specified above|0|||
23383299|NCT00021255|65148079|FG001|Overall Study|Other than specified above|38|||
23383300|NCT00021255|65148080|FG002|Overall Study|Other than specified above|19|||
23383301|NCT00021255|65148078|FG000|Overall Study|Missing|0|||
23383302|NCT00021255|65148079|FG001|Overall Study|Missing|27|||
23383303|NCT00021255|65148080|FG002|Overall Study|Missing|13|||
23383304|NCT00021255|65148078|FG000|Overall Study|Randomized but not treated|28|||
23383305|NCT00021255|65148079|FG001|Overall Study|Randomized but not treated|2|||
23383306|NCT00021255|65148080|FG002|Overall Study|Randomized but not treated|18|||
23383307|NCT00509600|65148081|FG000|Overall Study|Adverse Event|1|||
23383308|NCT00308685|65148082|FG000|Overall Study|Lost to Follow-up|1|||
23383309|NCT00308685|65148083|FG001|Overall Study|Lost to Follow-up|0|||
23383310|NCT00308685|65148082|FG000|Overall Study|Need to administer prohibited medication|1|||
23383311|NCT00308685|65148083|FG001|Overall Study|Need to administer prohibited medication|2|||
23383312|NCT00308685|65148082|FG000|Overall Study|Other than specified|1|||
23383313|NCT00308685|65148083|FG001|Overall Study|Other than specified|3|||
23383314|NCT01751685|65148086|FG000|6-mo Followup|Missed study visit|1|||
23383315|NCT01751685|65148087|FG001|6-mo Followup|Missed study visit|0|||
23383316|NCT01751685|65148086|FG000|6-mo Followup|Withdrawal by Subject|2|||
23383317|NCT01751685|65148087|FG001|6-mo Followup|Withdrawal by Subject|2|||
23383318|NCT01751685|65148086|FG000|6-mo Followup|Lost to Follow-up|0|||
23383319|NCT01751685|65148087|FG001|6-mo Followup|Lost to Follow-up|1|||
23383320|NCT01751685|65148086|FG000|12-mo Followup|Lost to Follow-up|5|||
23383321|NCT01751685|65148087|FG001|12-mo Followup|Lost to Follow-up|0|||
23383322|NCT02070991|65148088|FG000|Overall Study|Death|2|||
23383323|NCT02070991|65148089|FG001|Overall Study|Death|0|||
23383324|NCT02070991|65148088|FG000|Overall Study|Withdrawal by Subject|1|||
23383325|NCT02070991|65148089|FG001|Overall Study|Withdrawal by Subject|0|||
23383326|NCT01436500|65148091|FG000|Overall Study|Death|1|||
23383327|NCT01436500|65148092|FG001|Overall Study|Death|0|||
23383328|NCT01436500|65148093|FG002|Overall Study|Death|0|||
23383329|NCT01436500|65148094|FG003|Overall Study|Death|0|||
23383330|NCT01436500|65148095|FG004|Overall Study|Death|0|||
23383331|NCT01436500|65148091|FG000|Overall Study|Adverse Event|0|||
23383332|NCT01436500|65148092|FG001|Overall Study|Adverse Event|2|||
23383333|NCT01436500|65148093|FG002|Overall Study|Adverse Event|2|||
23383334|NCT01436500|65148094|FG003|Overall Study|Adverse Event|0|||
23383335|NCT01436500|65148095|FG004|Overall Study|Adverse Event|1|||
23383336|NCT01436500|65148091|FG000|Overall Study|Withdrawal by Subject|0|||
23383337|NCT01436500|65148092|FG001|Overall Study|Withdrawal by Subject|0|||
23383338|NCT01436500|65148093|FG002|Overall Study|Withdrawal by Subject|2|||
23383339|NCT01436500|65148094|FG003|Overall Study|Withdrawal by Subject|0|||
23383340|NCT01436500|65148095|FG004|Overall Study|Withdrawal by Subject|2|||
23383341|NCT01436500|65148091|FG000|Overall Study|Physician Decision|0|||
23383342|NCT01436500|65148092|FG001|Overall Study|Physician Decision|0|||
23383343|NCT01436500|65148093|FG002|Overall Study|Physician Decision|1|||
23383344|NCT01436500|65148094|FG003|Overall Study|Physician Decision|0|||
23383345|NCT01436500|65148095|FG004|Overall Study|Physician Decision|0|||
23493151|NCT01903031|65551372|FG000|Overall Study|Not Able to Attend Clinic|1|||
23383346|NCT01436500|65148091|FG000|Overall Study|liver transplant|1|||
23383347|NCT01436500|65148092|FG001|Overall Study|liver transplant|0|||
23383348|NCT01436500|65148093|FG002|Overall Study|liver transplant|0|||
23383349|NCT01436500|65148094|FG003|Overall Study|liver transplant|0|||
23383350|NCT01436500|65148095|FG004|Overall Study|liver transplant|0|||
23383351|NCT01436500|65148091|FG000|Overall Study|initiation of dialysis|0|||
23383352|NCT01436500|65148092|FG001|Overall Study|initiation of dialysis|0|||
23383353|NCT01436500|65148093|FG002|Overall Study|initiation of dialysis|0|||
23383354|NCT01436500|65148094|FG003|Overall Study|initiation of dialysis|0|||
23383355|NCT01436500|65148095|FG004|Overall Study|initiation of dialysis|1|||
23383356|NCT01436500|65148091|FG000|Overall Study|discontinued study drug|1|||
23383357|NCT01436500|65148092|FG001|Overall Study|discontinued study drug|0|||
23383358|NCT01436500|65148093|FG002|Overall Study|discontinued study drug|0|||
23383359|NCT01436500|65148094|FG003|Overall Study|discontinued study drug|0|||
23383360|NCT01436500|65148095|FG004|Overall Study|discontinued study drug|0|||
23383361|NCT01436500|65148091|FG000|Overall Study|Other|0|||
23383362|NCT01436500|65148092|FG001|Overall Study|Other|1|||
23383363|NCT01436500|65148093|FG002|Overall Study|Other|0|||
23383364|NCT01436500|65148094|FG003|Overall Study|Other|1|||
23383365|NCT01436500|65148095|FG004|Overall Study|Other|0|||
23383366|NCT03501277|65148096|FG000|Intervention Period 1 (4 Days)|Other|0|||
23383367|NCT03501277|65148097|FG001|Intervention Period 1 (4 Days)|Other|0|||
23383368|NCT03501277|65148098|FG002|Intervention Period 1 (4 Days)|Other|1|||
23383369|NCT03501277|65148099|FG003|Intervention Period 1 (4 Days)|Other|0|||
23383370|NCT03501277|65148096|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
23383371|NCT03501277|65148097|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
23290280|NCT04194151|64802094|FG005|Overall Study|Physician Decision|1|||
23290281|NCT04194151|64802089|FG000|Overall Study|Monitorization problem|0|||
23290282|NCT04194151|64802090|FG001|Overall Study|Monitorization problem|1|||
23290283|NCT04194151|64802091|FG002|Overall Study|Monitorization problem|0|||
23290284|NCT04194151|64802092|FG003|Overall Study|Monitorization problem|0|||
23290285|NCT04194151|64802093|FG004|Overall Study|Monitorization problem|0|||
23290286|NCT04194151|64802094|FG005|Overall Study|Monitorization problem|0|||
23290287|NCT02416934|64802095|FG000|Overall Study|given steroids|1|||
23290288|NCT02416934|64802096|FG001|Overall Study|given steroids|2|||
23290289|NCT02416934|64802095|FG000|Overall Study|Lost to Follow-up|0|||
23290290|NCT02416934|64802096|FG001|Overall Study|Lost to Follow-up|2|||
23290291|NCT02416934|64802095|FG000|Overall Study|Withdrawal by Subject|1|||
23290292|NCT02416934|64802096|FG001|Overall Study|Withdrawal by Subject|0|||
23290293|NCT02416934|64802095|FG000|Overall Study|recruited during continuing renewal proc|0|||
23290294|NCT02416934|64802096|FG001|Overall Study|recruited during continuing renewal proc|1|||
23290295|NCT02416934|64802095|FG000|Overall Study|Protocol Violation|0|||
23290296|NCT02416934|64802096|FG001|Overall Study|Protocol Violation|1|||
23290297|NCT02416934|64802095|FG000|Overall Study|surgery started late|0|||
23290298|NCT02416934|64802096|FG001|Overall Study|surgery started late|1|||
23290299|NCT02416934|64802095|FG000|Overall Study|re-operation|1|||
23290300|NCT02416934|64802096|FG001|Overall Study|re-operation|0|||
23383372|NCT03501277|65148098|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
23383373|NCT03501277|65148099|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
23383374|NCT03501277|65148096|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
23290301|NCT00550147|64802097|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
23290302|NCT00550147|64802097|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
23290303|NCT00550147|64802097|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
23290304|NCT00550147|64802097|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
23290305|NCT00550147|64802097|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
23383375|NCT03501277|65148097|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
23383376|NCT03501277|65148098|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
23383377|NCT03501277|65148099|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
23383378|NCT03501277|65148096|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
23383379|NCT03501277|65148097|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
23383380|NCT03501277|65148098|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
23383381|NCT03501277|65148099|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
23383382|NCT00025233|65148100|FG000|Overall Study|Ineligible: wrong cell type|1|||
23383383|NCT00025233|65148100|FG000|Overall Study|Ineligible: wrong primary|1|||
23383384|NCT00025233|65148100|FG000|Overall Study|Ineligible: improper prior treatment|1|||
23383385|NCT00025233|65148100|FG000|Overall Study|Never treated|1|||
23383386|NCT00454142|65148101|FG000|Overall Study|Withdrawal by Subject|1|||
23383387|NCT01027416|65148102|FG000|Overall Study|Withdrawal by Subject|0|||
23383388|NCT01027416|65148103|FG001|Overall Study|Withdrawal by Subject|1|||
23383389|NCT01027416|65148102|FG000|Overall Study|Physician Decision|1|||
23383390|NCT01027416|65148103|FG001|Overall Study|Physician Decision|4|||
23383391|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
23383392|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
23383393|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
23383394|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
23383395|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
23383396|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
23383397|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
23383398|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
23383399|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
23383400|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
23383401|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
23383402|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
23383403|NCT01243424|65148104|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
23383404|NCT01243424|65148105|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
23383405|NCT01243424|65148104|FG000|Discontinuation From Treatment|Not treated|5|||
23383406|NCT01243424|65148105|FG001|Discontinuation From Treatment|Not treated|4|||
23383407|NCT01243424|65148104|FG000|Discontinuation From Treatment|Adverse Event|457|||
23383408|NCT01243424|65148105|FG001|Discontinuation From Treatment|Adverse Event|523|||
23383409|NCT01243424|65148104|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
23383410|NCT01243424|65148105|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
23383411|NCT01243424|65148104|FG000|Discontinuation From Treatment|Protocol Violation|46|||
23383412|NCT01243424|65148105|FG001|Discontinuation From Treatment|Protocol Violation|47|||
23383413|NCT01243424|65148104|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
23383414|NCT01243424|65148105|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
23383415|NCT01243424|65148104|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
23383416|NCT01243424|65148105|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
23383417|NCT01243424|65148104|FG000|Discontinuation From Treatment|Other than listed above|230|||
23383418|NCT01243424|65148105|FG001|Discontinuation From Treatment|Other than listed above|211|||
23383419|NCT04073407|65148107|FG000|Part 1|Withdrawal by Subject|1|||
23383420|NCT04073407|65148108|FG001|Part 1|Withdrawal by Subject|0|||
23383421|NCT04073407|65148107|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
23383422|NCT04073407|65148108|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
23383423|NCT04073407|65148107|FG000|Part 2|Withdrawal by Subject|0|||
23383424|NCT04073407|65148108|FG001|Part 2|Withdrawal by Subject|1|||
23383425|NCT04964388|65148109|FG000|Overall Study|Lost to Follow-up|3|||
23290306|NCT00751023|64802098|FG000|Overall Study|Lost to Follow-up|11|||
23290307|NCT00751023|64802099|FG001|Overall Study|Lost to Follow-up|7|||
23290308|NCT01691612|64802108|FG000|Overall Study|deemed ineligible after 1st visit|6|||
23290309|NCT01691612|64802108|FG000|Overall Study|Adverse Event|1|||
23290310|NCT02174276|64802109|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
23290311|NCT02174276|64802110|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
23290312|NCT02174276|64802111|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
23290313|NCT02174276|64802112|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
23290314|NCT02174276|64802109|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
23290315|NCT02174276|64802110|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
23290316|NCT02174276|64802111|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
23290317|NCT02174276|64802112|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
23290318|NCT02174276|64802109|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
23383426|NCT04964388|65148110|FG001|Overall Study|Lost to Follow-up|2|||
23383427|NCT01913470|65148111|FG000|Overall Study|Lost to Follow-up|0|||
23383428|NCT01913470|65148112|FG001|Overall Study|Lost to Follow-up|1|||
23383429|NCT01913470|65148111|FG000|Overall Study|Physician Decision|0|||
23383430|NCT01913470|65148112|FG001|Overall Study|Physician Decision|1|||
23383431|NCT01913470|65148111|FG000|Overall Study|Withdrawal by Subject|0|||
23383432|NCT01913470|65148112|FG001|Overall Study|Withdrawal by Subject|1|||
23383433|NCT02406612|65148113|FG000|Overall Study|Screening Failure|3|||
23383434|NCT02406612|65148114|FG001|Overall Study|Screening Failure|0|||
23383435|NCT02406612|65148113|FG000|Overall Study|Intra-procedural Exclusion|1|||
23383436|NCT02406612|65148114|FG001|Overall Study|Intra-procedural Exclusion|3|||
23383437|NCT02406612|65148113|FG000|Overall Study|Guidewire Failure|0|||
23383438|NCT02406612|65148114|FG001|Overall Study|Guidewire Failure|1|||
23383439|NCT03637374|65148115|FG000|Overall Study|Death|2|||
23383440|NCT03637374|65148116|FG001|Overall Study|Death|0|||
23383441|NCT01757847|65148121|FG000|Overall Study|Withdrawal by Subject|3|||
23383442|NCT01757847|65148122|FG001|Overall Study|Withdrawal by Subject|4|||
23383443|NCT02112552|65148124|FG000|Overall Study|Withdrawal by Subject|1|||
23383444|NCT02112552|65148124|FG000|Overall Study|Adverse Event|1|||
23383445|NCT02506036|65148125|FG000|First Intervention (4-6 Weeks)|Death|1|||
23383446|NCT02506036|65148126|FG001|First Intervention (4-6 Weeks)|Death|0|||
23383447|NCT02506036|65148125|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
23383448|NCT02506036|65148126|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
23383449|NCT02506036|65148125|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
23383450|NCT02506036|65148126|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
23383451|NCT02097277|65148127|FG000|Overall Study|Subject no longer meets study criteria|0|||
23383452|NCT02097277|65148128|FG001|Overall Study|Subject no longer meets study criteria|1|||
23383453|NCT02097277|65148129|FG002|Overall Study|Subject no longer meets study criteria|0|||
23383454|NCT02097277|65148130|FG003|Overall Study|Subject no longer meets study criteria|1|||
23383455|NCT02097277|65148131|FG004|Overall Study|Subject no longer meets study criteria|0|||
23383456|NCT02097277|65148127|FG000|Overall Study|Subject request to discontinue treatment|0|||
23383457|NCT02097277|65148128|FG001|Overall Study|Subject request to discontinue treatment|0|||
23383458|NCT02097277|65148129|FG002|Overall Study|Subject request to discontinue treatment|0|||
23383459|NCT02097277|65148130|FG003|Overall Study|Subject request to discontinue treatment|0|||
23383460|NCT02097277|65148131|FG004|Overall Study|Subject request to discontinue treatment|1|||
23383461|NCT02097277|65148127|FG000|Overall Study|Lost to Follow-up|0|||
23383462|NCT02097277|65148128|FG001|Overall Study|Lost to Follow-up|1|||
23383463|NCT02097277|65148129|FG002|Overall Study|Lost to Follow-up|1|||
23290319|NCT02174276|64802110|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
23290320|NCT02174276|64802111|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
23290321|NCT02174276|64802112|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
23290322|NCT02174276|64802109|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
23290323|NCT02174276|64802110|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
23290324|NCT02174276|64802111|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
23290325|NCT02174276|64802112|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
23290326|NCT02174276|64802109|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
23290327|NCT02174276|64802110|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
23290328|NCT02174276|64802111|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
23290329|NCT02174276|64802112|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
23290330|NCT02174276|64802109|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
23290331|NCT02174276|64802110|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
23290332|NCT02174276|64802111|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
23290333|NCT02174276|64802112|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
23290334|NCT01223027|64802113|FG000|Overall Study|Adverse Event|20|||
23290335|NCT01223027|64802114|FG001|Overall Study|Adverse Event|10|||
23383464|NCT02097277|65148130|FG003|Overall Study|Lost to Follow-up|0|||
23383465|NCT02097277|65148131|FG004|Overall Study|Lost to Follow-up|0|||
23383466|NCT02097277|65148127|FG000|Overall Study|Withdrawal by Subject|2|||
23383467|NCT02097277|65148128|FG001|Overall Study|Withdrawal by Subject|1|||
23383468|NCT02097277|65148129|FG002|Overall Study|Withdrawal by Subject|0|||
23383469|NCT02097277|65148130|FG003|Overall Study|Withdrawal by Subject|1|||
23383470|NCT02097277|65148131|FG004|Overall Study|Withdrawal by Subject|0|||
23383471|NCT02097277|65148127|FG000|Overall Study|Adverse Event|0|||
23383472|NCT02097277|65148128|FG001|Overall Study|Adverse Event|0|||
23383473|NCT02097277|65148129|FG002|Overall Study|Adverse Event|1|||
23383474|NCT02097277|65148130|FG003|Overall Study|Adverse Event|2|||
23383475|NCT02097277|65148131|FG004|Overall Study|Adverse Event|0|||
23383476|NCT00683384|65148132|FG000|Overall Study|Death|1|||
23383477|NCT00683384|65148132|FG000|Overall Study|Adverse Event|1|||
23290336|NCT01223027|64802113|FG000|Overall Study|Death|42|||
23290337|NCT01223027|64802114|FG001|Overall Study|Death|42|||
23290338|NCT01223027|64802113|FG000|Overall Study|Lost to Follow-up|2|||
23290339|NCT01223027|64802114|FG001|Overall Study|Lost to Follow-up|1|||
23290340|NCT01223027|64802113|FG000|Overall Study|Physician Decision|4|||
23290341|NCT01223027|64802114|FG001|Overall Study|Physician Decision|8|||
23290342|NCT01223027|64802113|FG000|Overall Study|Progressive Disease|167|||
23290343|NCT01223027|64802114|FG001|Overall Study|Progressive Disease|183|||
23290344|NCT01223027|64802113|FG000|Overall Study|Protocol Violation|2|||
23290345|NCT01223027|64802114|FG001|Overall Study|Protocol Violation|1|||
23290346|NCT01223027|64802113|FG000|Overall Study|Subject/guardian decicion|18|||
23290347|NCT01223027|64802114|FG001|Overall Study|Subject/guardian decicion|16|||
23290348|NCT01223027|64802113|FG000|Overall Study|New therapy for study indication|17|||
23290349|NCT01223027|64802114|FG001|Overall Study|New therapy for study indication|8|||
23290350|NCT01223027|64802113|FG000|Overall Study|Study terminated by sponsor|2|||
23290351|NCT01223027|64802114|FG001|Overall Study|Study terminated by sponsor|8|||
23290352|NCT01499160|64802115|FG000|Overall Study|Adverse Event|1|||
23290353|NCT01499160|64802115|FG000|Overall Study|Withdrawal by Subject|1|||
23290354|NCT00570128|64802116|FG000|Overall Study|Adverse Event|1|||
23290355|NCT00570128|64802117|FG001|Overall Study|Adverse Event|0|||
23290356|NCT00570128|64802116|FG000|Overall Study|Lost to Follow-up|1|||
23290357|NCT00570128|64802117|FG001|Overall Study|Lost to Follow-up|0|||
23290358|NCT00570128|64802116|FG000|Overall Study|Withdrawal by Subject|2|||
23290359|NCT00570128|64802117|FG001|Overall Study|Withdrawal by Subject|0|||
23290360|NCT03366194|64802118|FG000|Overall Study|Lost to Follow-up|2|||
23290361|NCT03693950|64802125|FG000|Overall Study|Withdrawal by Subject|1|||
23290362|NCT03693950|64802126|FG001|Overall Study|Withdrawal by Subject|0|||
23290363|NCT00544167|64802127|FG000|Overall Study|Adverse Event|21|||
23290364|NCT00544167|64802127|FG000|Overall Study|Physician Decision|8|||
23290365|NCT00762411|64802128|FG000|Initial Treatment|Death|7|||
23290366|NCT00762411|64802129|FG001|Initial Treatment|Death|6|||
23290367|NCT00762411|64802128|FG000|Initial Treatment|Adverse Event|132|||
23290368|NCT00762411|64802129|FG001|Initial Treatment|Adverse Event|40|||
23290369|NCT00762411|64802128|FG000|Initial Treatment|Protocol Violation|4|||
23290370|NCT00762411|64802129|FG001|Initial Treatment|Protocol Violation|1|||
23290371|NCT00762411|64802128|FG000|Initial Treatment|Withdrawal by Subject|65|||
23290372|NCT00762411|64802129|FG001|Initial Treatment|Withdrawal by Subject|52|||
23290373|NCT00762411|64802128|FG000|Initial Treatment|Physician Decision|1|||
23290374|NCT00762411|64802129|FG001|Initial Treatment|Physician Decision|0|||
23290375|NCT00762411|64802128|FG000|Initial Treatment|Sponsor Decision|293|||
23290376|NCT00762411|64802129|FG001|Initial Treatment|Sponsor Decision|401|||
23290377|NCT00762411|64802128|FG000|Initial Treatment|Lost to Follow-up|5|||
23290378|NCT00762411|64802129|FG001|Initial Treatment|Lost to Follow-up|0|||
23290379|NCT00762411|64802128|FG000|Initial Treatment|Caregiver Decision|21|||
23290380|NCT00762411|64802129|FG001|Initial Treatment|Caregiver Decision|16|||
23290381|NCT00762411|64802128|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
23290382|NCT00762411|64802129|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
23290383|NCT00762411|64802128|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
23290384|NCT00762411|64802129|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
23290385|NCT00762411|64802128|FG000|Delayed Start|Adverse Event|0|||
23290386|NCT00762411|64802129|FG001|Delayed Start|Adverse Event|4|||
23290387|NCT00762411|64802128|FG000|Delayed Start|Protocol Violation|0|||
23290388|NCT00762411|64802129|FG001|Delayed Start|Protocol Violation|1|||
23290389|NCT00762411|64802128|FG000|Delayed Start|Sponsor Decision|16|||
23290390|NCT00762411|64802129|FG001|Delayed Start|Sponsor Decision|20|||
23290391|NCT00762411|64802128|FG000|Delayed Start|Caregiver Decision|1|||
23290392|NCT00762411|64802129|FG001|Delayed Start|Caregiver Decision|1|||
23290393|NCT00762411|64802128|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
23290394|NCT00762411|64802129|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
23290395|NCT00762411|64802128|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
23290396|NCT00762411|64802129|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
23290397|NCT00762411|64802128|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
23290398|NCT00762411|64802129|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
23290399|NCT00762411|64802128|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
23290400|NCT00762411|64802129|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
23290401|NCT00762411|64802128|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
23290402|NCT00762411|64802129|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
23290403|NCT00762411|64802128|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
23290404|NCT00762411|64802129|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
23290405|NCT01341405|64805065|FG000|Overall Study|Adverse Event|0|||
23290406|NCT01341405|64805066|FG001|Overall Study|Adverse Event|1|||
23290407|NCT01341405|64805067|FG002|Overall Study|Adverse Event|1|||
23290408|NCT01341405|64805065|FG000|Overall Study|Withdrawal by Subject|3|||
23290409|NCT01341405|64805066|FG001|Overall Study|Withdrawal by Subject|2|||
23290410|NCT01341405|64805067|FG002|Overall Study|Withdrawal by Subject|1|||
23290411|NCT03480022|64805072|FG000|Overall Study|Pregnancy|2|||
23290412|NCT03480022|64805073|FG001|Overall Study|Pregnancy|0|||
23290413|NCT03480022|64805072|FG000|Overall Study|Adverse Event|6|||
23290414|NCT03480022|64805073|FG001|Overall Study|Adverse Event|0|||
23290415|NCT03480022|64805072|FG000|Overall Study|Lack of Efficacy|0|||
23290416|NCT03480022|64805073|FG001|Overall Study|Lack of Efficacy|2|||
23290417|NCT03480022|64805072|FG000|Overall Study|Physician Decision|0|||
23290418|NCT03480022|64805073|FG001|Overall Study|Physician Decision|1|||
23290419|NCT03480022|64805072|FG000|Overall Study|Withdrawal by Subject|2|||
23290420|NCT03480022|64805073|FG001|Overall Study|Withdrawal by Subject|0|||
23290421|NCT03480022|64805072|FG000|Overall Study|Medication concerns|1|||
23290422|NCT03480022|64805073|FG001|Overall Study|Medication concerns|0|||
23290423|NCT03480022|64805072|FG000|Overall Study|Family member COVID exposure|0|||
23290424|NCT03480022|64805073|FG001|Overall Study|Family member COVID exposure|1|||
23290425|NCT01609582|64805074|FG000|Overall Study|Adverse Event|20|||
23290426|NCT01609582|64805075|FG001|Overall Study|Adverse Event|18|||
23290427|NCT01609582|64805074|FG000|Overall Study|Lost to Follow-up|10|||
23290428|NCT01609582|64805075|FG001|Overall Study|Lost to Follow-up|10|||
23290429|NCT01609582|64805074|FG000|Overall Study|Withdrawal by Subject|21|||
23290430|NCT01609582|64805075|FG001|Overall Study|Withdrawal by Subject|15|||
23290431|NCT01609582|64805074|FG000|Overall Study|Study Terminated by Sponsor|1543|||
23290432|NCT01609582|64805075|FG001|Overall Study|Study Terminated by Sponsor|1548|||
23290433|NCT01609582|64805074|FG000|Overall Study|Other|9|||
23290434|NCT01609582|64805075|FG001|Overall Study|Other|10|||
23290435|NCT01609582|64805074|FG000|Overall Study|Randomized, but not treated|0|||
23290436|NCT01609582|64805075|FG001|Overall Study|Randomized, but not treated|3|||
23290437|NCT04661202|64805078|FG000|Overall Study|Withdrawal by Subject|1|||
23290438|NCT04661202|64805079|FG001|Overall Study|Withdrawal by Subject|1|||
23290439|NCT04661202|64805078|FG000|Overall Study|Lack of Efficacy|2|||
23290440|NCT04661202|64805079|FG001|Overall Study|Lack of Efficacy|0|||
23290441|NCT01386125|64805080|FG000|Overall Study|Lost to Follow-up|3|||
23290442|NCT01386125|64805081|FG001|Overall Study|Lost to Follow-up|9|||
23290443|NCT01386125|64805080|FG000|Overall Study|Physician Decision|0|||
23290444|NCT01386125|64805081|FG001|Overall Study|Physician Decision|1|||
23290445|NCT01386125|64805080|FG000|Overall Study|Protocol Violation|5|||
23290446|NCT01386125|64805081|FG001|Overall Study|Protocol Violation|7|||
23290447|NCT01386125|64805080|FG000|Overall Study|Disease Progress|1|||
23290448|NCT01386125|64805081|FG001|Overall Study|Disease Progress|2|||
23290449|NCT01386125|64805080|FG000|Overall Study|Withdrawal by Subject|13|||
23290450|NCT01386125|64805081|FG001|Overall Study|Withdrawal by Subject|12|||
23290451|NCT01386125|64805080|FG000|Overall Study|Adverse Event|2|||
23290452|NCT01386125|64805081|FG001|Overall Study|Adverse Event|5|||
23290453|NCT01386125|64805080|FG000|Overall Study|Lack of Efficacy|0|||
23290454|NCT01386125|64805081|FG001|Overall Study|Lack of Efficacy|1|||
23290455|NCT01386125|64805080|FG000|Overall Study|Participant Leaving Country|1|||
23290456|NCT01386125|64805081|FG001|Overall Study|Participant Leaving Country|0|||
23290457|NCT01634854|64805082|FG000|Overall Study|Cesarean delivery|2|||
23290458|NCT01634854|64805083|FG001|Overall Study|Cesarean delivery|7|||
23290459|NCT03294317|64805084|FG000|Overall Study|Physician Decision|1|||
23290460|NCT03294317|64805084|FG000|Overall Study|Withdrawal by Subject|6|||
23290461|NCT03294317|64805084|FG000|Overall Study|Lost to Follow-up|1|||
23290462|NCT03294317|64805084|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
23290463|NCT03294317|64805084|FG000|Overall Study|Failed HB lead implant|8|||
23290464|NCT03294317|64805084|FG000|Overall Study|Received CRT instead|1|||
23290465|NCT03294317|64805084|FG000|Overall Study|Exited after lead revision|2|||
23290466|NCT02725411|64805085|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
23290467|NCT02725411|64805086|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
23290468|NCT02725411|64805087|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
23290469|NCT02725411|64805085|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
23290470|NCT02725411|64805086|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
23606028|NCT03622580|65947125|FG000|Overall Study|Lack of Efficacy|0|||
23290471|NCT02725411|64805087|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
23290472|NCT02725411|64805085|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
23606029|NCT03622580|65947126|FG001|Overall Study|Lack of Efficacy|0|||
23606030|NCT03622580|65947127|FG002|Overall Study|Lack of Efficacy|1|||
23606031|NCT03622580|65947125|FG000|Overall Study|Other|2|||
23606032|NCT03622580|65947126|FG001|Overall Study|Other|0|||
23606033|NCT03622580|65947127|FG002|Overall Study|Other|3|||
23606034|NCT02506192|65947128|FG000|Overall Study|Withdrawal by Subject|1|||
23606035|NCT02506192|65947129|FG001|Overall Study|Withdrawal by Subject|1|||
23606036|NCT01853384|65947130|FG000|Randomized|Adverse Event|5|||
23606037|NCT01853384|65947131|FG001|Randomized|Adverse Event|3|||
23606038|NCT01853384|65947130|FG000|Randomized|Death|1|||
23606039|NCT01853384|65947131|FG001|Randomized|Death|2|||
23606040|NCT01853384|65947130|FG000|Randomized|Lost to Follow-up|1|||
23606041|NCT01853384|65947131|FG001|Randomized|Lost to Follow-up|1|||
23606042|NCT01853384|65947130|FG000|Randomized|Withdrawal by Subject|5|||
23606043|NCT01853384|65947131|FG001|Randomized|Withdrawal by Subject|3|||
23606044|NCT01853384|65947130|FG000|Randomized|Sponsor Decision|47|||
23606045|NCT01853384|65947131|FG001|Randomized|Sponsor Decision|34|||
23606046|NCT01853384|65947130|FG000|Randomized|Other|3|||
23606047|NCT01853384|65947131|FG001|Randomized|Other|3|||
23606048|NCT01853384|65947130|FG000|Completed Follow up Visit 1|Early Termination|13|||
23606049|NCT01853384|65947131|FG001|Completed Follow up Visit 1|Early Termination|9|||
23606050|NCT01853384|65947130|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
23606051|NCT01853384|65947131|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
23606052|NCT01853384|65947130|FG000|Completed Follow up Visit 2|Adverse Event|1|||
23290473|NCT02725411|64805086|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
23290474|NCT02725411|64805087|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
23290475|NCT02725411|64805085|FG000|Treatment Period (56 Weeks)|Other|1|||
23290476|NCT02725411|64805086|FG001|Treatment Period (56 Weeks)|Other|4|||
23290477|NCT02725411|64805087|FG002|Treatment Period (56 Weeks)|Other|5|||
23290478|NCT02725411|64805085|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
23290479|NCT02725411|64805086|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
23290480|NCT02725411|64805087|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
23290481|NCT02725411|64805085|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
23290482|NCT02725411|64805086|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
23290483|NCT02725411|64805087|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
23290484|NCT02725411|64805085|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
23290485|NCT02725411|64805086|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
23290486|NCT02725411|64805087|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
23383478|NCT01410604|65148136|FG000|Overall Study|Adverse Event|2|||
23383479|NCT01410604|65148137|FG001|Overall Study|Adverse Event|1|||
23383480|NCT01410604|65148136|FG000|Overall Study|Lost to Follow-up|1|||
23383481|NCT01410604|65148137|FG001|Overall Study|Lost to Follow-up|0|||
23383482|NCT01410604|65148136|FG000|Overall Study|Physician Decision|0|||
23383483|NCT01410604|65148137|FG001|Overall Study|Physician Decision|1|||
23383484|NCT02827708|65148145|FG000|Overall Study|Lost to Follow-up|3|||
23383485|NCT02827708|65148146|FG001|Overall Study|Lost to Follow-up|1|||
23383486|NCT02827708|65148145|FG000|Overall Study|Withdrawal by Subject|1|||
23383487|NCT02827708|65148146|FG001|Overall Study|Withdrawal by Subject|2|||
23383488|NCT02827708|65148145|FG000|Overall Study|Death|1|||
23383489|NCT02827708|65148146|FG001|Overall Study|Death|2|||
23383490|NCT00003456|65148147|FG000|Overall Study|Not evaluable|8|||
23383491|NCT03018938|65148148|FG000|Overall Study|Death|0|||
23383492|NCT03018938|65148149|FG001|Overall Study|Death|1|||
23383493|NCT03018938|65148148|FG000|Overall Study|Lost to Follow-up|21|||
23383494|NCT03018938|65148149|FG001|Overall Study|Lost to Follow-up|32|||
23383495|NCT03018938|65148148|FG000|Overall Study|Withdrawal by Subject|38|||
23383496|NCT03018938|65148149|FG001|Overall Study|Withdrawal by Subject|45|||
23383497|NCT03018938|65148148|FG000|Overall Study|Physician Decision|3|||
23383498|NCT03018938|65148149|FG001|Overall Study|Physician Decision|2|||
23383499|NCT03018938|65148148|FG000|Overall Study|Sponsor Decision|0|||
23383500|NCT03018938|65148149|FG001|Overall Study|Sponsor Decision|1|||
23383501|NCT03018938|65148148|FG000|Overall Study|Screen failure-After randomization|4|||
23290487|NCT02725411|64805085|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
23290488|NCT02725411|64805086|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
23290489|NCT02725411|64805087|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
23290490|NCT02725411|64805085|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
23290491|NCT02725411|64805086|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
23290492|NCT02725411|64805087|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
23290493|NCT02725411|64805085|FG000|Follow-up Period (24 Weeks)|Other|1|||
23290494|NCT02725411|64805086|FG001|Follow-up Period (24 Weeks)|Other|4|||
23383502|NCT03018938|65148149|FG001|Overall Study|Screen failure-After randomization|2|||
23383503|NCT03018938|65148148|FG000|Overall Study|Not recorded|0|||
23383504|NCT03018938|65148149|FG001|Overall Study|Not recorded|2|||
23383505|NCT01851369|65148154|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383506|NCT01851369|65148155|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383507|NCT01851369|65148156|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383508|NCT01851369|65148157|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383509|NCT01851369|65148158|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383510|NCT01851369|65148159|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
23383511|NCT01851369|65148160|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383512|NCT01851369|65148161|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383513|NCT01851369|65148162|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383514|NCT01851369|65148163|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383515|NCT01851369|65148164|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383516|NCT01851369|65148165|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383517|NCT01851369|65148166|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
23383518|NCT00601107|65148169|FG000|Overall Study|Adverse Event|0|||
23383519|NCT00601107|65148170|FG001|Overall Study|Adverse Event|1|||
23383520|NCT00601107|65148171|FG002|Overall Study|Adverse Event|3|||
23383521|NCT00601107|65148172|FG003|Overall Study|Adverse Event|0|||
23383522|NCT00601107|65148169|FG000|Overall Study|Withdrawal by Subject|5|||
23383523|NCT00601107|65148170|FG001|Overall Study|Withdrawal by Subject|4|||
23383524|NCT00601107|65148171|FG002|Overall Study|Withdrawal by Subject|7|||
23383525|NCT00601107|65148172|FG003|Overall Study|Withdrawal by Subject|4|||
23383526|NCT00601107|65148169|FG000|Overall Study|Lost to Follow-up|3|||
23383527|NCT00601107|65148170|FG001|Overall Study|Lost to Follow-up|3|||
23383528|NCT00601107|65148171|FG002|Overall Study|Lost to Follow-up|0|||
23383529|NCT00601107|65148172|FG003|Overall Study|Lost to Follow-up|3|||
23383530|NCT00601107|65148169|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
23383531|NCT00601107|65148170|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
23383532|NCT00601107|65148171|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
23383533|NCT00601107|65148172|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
23383534|NCT00601107|65148169|FG000|Overall Study|Worsening of Psoriasis|4|||
23383535|NCT00601107|65148170|FG001|Overall Study|Worsening of Psoriasis|1|||
23383536|NCT00601107|65148171|FG002|Overall Study|Worsening of Psoriasis|1|||
23383537|NCT00601107|65148172|FG003|Overall Study|Worsening of Psoriasis|4|||
23383538|NCT00601107|65148169|FG000|Overall Study|Undefined|1|||
23383539|NCT00601107|65148170|FG001|Overall Study|Undefined|0|||
23383540|NCT00601107|65148171|FG002|Overall Study|Undefined|1|||
23383541|NCT00601107|65148172|FG003|Overall Study|Undefined|0|||
23383542|NCT01783938|65148173|FG000|Overall Study|Disease Progression|18|||
23383543|NCT01783938|65148174|FG001|Overall Study|Disease Progression|41|||
23383544|NCT01783938|65148173|FG000|Overall Study|Study Drug Toxicity|27|||
23383545|NCT01783938|65148174|FG001|Overall Study|Study Drug Toxicity|14|||
23383546|NCT01783938|65148173|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
23383547|NCT01783938|65148174|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
23383548|NCT01783938|65148173|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
23383549|NCT01783938|65148174|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
23383550|NCT01783938|65148173|FG000|Overall Study|Participant Withdrew Consent|2|||
23383551|NCT01783938|65148174|FG001|Overall Study|Participant Withdrew Consent|0|||
23383552|NCT01783938|65148173|FG000|Overall Study|Maximum Clinical Benefit|1|||
23383553|NCT01783938|65148174|FG001|Overall Study|Maximum Clinical Benefit|0|||
23383554|NCT01783938|65148173|FG000|Overall Study|Other Reasons|3|||
23383555|NCT01783938|65148174|FG001|Overall Study|Other Reasons|1|||
23383556|NCT00429299|65148180|FG000|Overall Study|Disease Progression|1|||
23383557|NCT00429299|65148181|FG001|Overall Study|Disease Progression|1|||
23383558|NCT00429299|65148182|FG002|Overall Study|Disease Progression|0|||
23383559|NCT00429299|65148180|FG000|Overall Study|Adverse Event|2|||
23383560|NCT00429299|65148181|FG001|Overall Study|Adverse Event|5|||
23383561|NCT00429299|65148182|FG002|Overall Study|Adverse Event|1|||
23383562|NCT00429299|65148180|FG000|Overall Study|Protocol Violation|1|||
23383563|NCT00429299|65148181|FG001|Overall Study|Protocol Violation|0|||
23383564|NCT00429299|65148182|FG002|Overall Study|Protocol Violation|0|||
23290495|NCT02725411|64805087|FG002|Follow-up Period (24 Weeks)|Other|2|||
23290496|NCT02725411|64805085|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
23290497|NCT02725411|64805086|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
23290498|NCT02725411|64805087|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
23290499|NCT01475786|64805100|FG000|Overall Study|Adverse Event|0|||
23290500|NCT01475786|64805101|FG001|Overall Study|Adverse Event|1|||
23290501|NCT01475786|64805102|FG002|Overall Study|Adverse Event|0|||
23290502|NCT01475786|64805100|FG000|Overall Study|Lost to Follow-up|1|||
23290503|NCT01475786|64805101|FG001|Overall Study|Lost to Follow-up|2|||
23290504|NCT01475786|64805102|FG002|Overall Study|Lost to Follow-up|1|||
23290505|NCT01475786|64805100|FG000|Overall Study|Withdrawal by Subject|0|||
23290506|NCT01475786|64805101|FG001|Overall Study|Withdrawal by Subject|1|||
23290507|NCT01475786|64805102|FG002|Overall Study|Withdrawal by Subject|1|||
23290508|NCT01475786|64805100|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
23290509|NCT01475786|64805101|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
23290510|NCT01475786|64805102|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
23290511|NCT00526162|64805103|FG000|Overall Study|Device not implanted|3|||
23290512|NCT00024258|64805104|FG000|Overall Study|Withdrawal by Subject|1|||
23290513|NCT00024258|64805104|FG000|Overall Study|Disease Progression|8|||
23290514|NCT01398787|64805105|FG000|Overall Study|Adverse Event|1|||
23493152|NCT01903031|65551373|FG001|Overall Study|Not Able to Attend Clinic|1|||
23383565|NCT00429299|65148180|FG000|Overall Study|Withdrawal by Subject|0|||
23383566|NCT00429299|65148181|FG001|Overall Study|Withdrawal by Subject|1|||
23383567|NCT00429299|65148182|FG002|Overall Study|Withdrawal by Subject|3|||
23383568|NCT04914000|65148183|FG000|Overall Study|Lost to Follow-up|8|||
23383569|NCT04914000|65148183|FG000|Overall Study|Withdrawal by Subject|1|||
23383570|NCT04069520|65148184|FG000|Overall Study|Lost to Follow-up|0|||
23383571|NCT04069520|65148185|FG001|Overall Study|Lost to Follow-up|2|||
23383572|NCT04069520|65148184|FG000|Overall Study|Withdrawal by Subject|0|||
23383573|NCT04069520|65148185|FG001|Overall Study|Withdrawal by Subject|1|||
23383574|NCT04069520|65148184|FG000|Overall Study|Prior Injury|1|||
23383575|NCT04069520|65148185|FG001|Overall Study|Prior Injury|0|||
23383576|NCT04069520|65148184|FG000|Overall Study|Orthodontia|1|||
23383577|NCT04069520|65148185|FG001|Overall Study|Orthodontia|0|||
23383578|NCT04069520|65148184|FG000|Overall Study|Cut from team|0|||
23383579|NCT04069520|65148185|FG001|Overall Study|Cut from team|2|||
23383580|NCT01732692|65148186|FG000|Overall Study|Adverse Event|0|||
23383581|NCT01732692|65148187|FG001|Overall Study|Adverse Event|1|||
23383582|NCT01945242|65148194|FG000|Overall Study|Physician Decision|3|||
23383583|NCT01945242|65148195|FG001|Overall Study|Physician Decision|3|||
23383584|NCT00997126|65148196|FG000|Overall Study|Physician Decision|7|||
23383585|NCT00997126|65148197|FG001|Overall Study|Physician Decision|11|||
23383586|NCT00574951|65148198|FG000|Overall Study|Ineligible - improper prior treatment|1|||
23383587|NCT01108796|65148202|FG000|Overall Study|Adverse Event|0|||
23383588|NCT01108796|65148203|FG001|Overall Study|Adverse Event|1|||
23383589|NCT01108796|65148202|FG000|Overall Study|Lost to Follow-up|7|||
23383590|NCT01108796|65148203|FG001|Overall Study|Lost to Follow-up|6|||
23383591|NCT01331005|65148204|FG000|Overall Study|Lost to Follow-up|2|||
23383592|NCT01331005|65148205|FG001|Overall Study|Lost to Follow-up|1|||
23383593|NCT01331005|65148204|FG000|Overall Study|Withdrawal by Subject|2|||
23383594|NCT01331005|65148205|FG001|Overall Study|Withdrawal by Subject|3|||
23383595|NCT01131585|65148206|FG000|Overall Study|Adverse Event|0|||
23383596|NCT01131585|65148207|FG001|Overall Study|Adverse Event|2|||
23383597|NCT01131585|65148206|FG000|Overall Study|Abnormal laboratory value|1|||
23383598|NCT01131585|65148207|FG001|Overall Study|Abnormal laboratory value|0|||
23383599|NCT01131585|65148206|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23383600|NCT01131585|65148207|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
23383601|NCT01131585|65148206|FG000|Overall Study|Protocol Violation|2|||
23383602|NCT01131585|65148207|FG001|Overall Study|Protocol Violation|1|||
23383603|NCT01131585|65148206|FG000|Overall Study|Withdrawal by Subject|3|||
23383604|NCT01131585|65148207|FG001|Overall Study|Withdrawal by Subject|3|||
23383605|NCT01131585|65148206|FG000|Overall Study|Lost to Follow-up|0|||
23383606|NCT01131585|65148207|FG001|Overall Study|Lost to Follow-up|1|||
23383607|NCT01131585|65148206|FG000|Overall Study|Administrative problems|1|||
23383608|NCT01131585|65148207|FG001|Overall Study|Administrative problems|1|||
23383609|NCT01131585|65148206|FG000|Overall Study|Study termination|78|||
23383610|NCT01131585|65148207|FG001|Overall Study|Study termination|32|||
23383611|NCT02153827|65148211|FG000|Overall Study|Lost to Follow-up|3|||
23383612|NCT02153827|65148212|FG001|Overall Study|Lost to Follow-up|9|||
23383613|NCT00585585|65148213|FG000|Overall Study|Adverse Event|1|||
23383614|NCT00599313|65148214|FG000|Overall Study|Adverse Event|19|||
23383615|NCT00599313|65148214|FG000|Overall Study|Disease Progression|12|||
23383616|NCT00599313|65148214|FG000|Overall Study|Patient Request|4|||
23383617|NCT00599313|65148214|FG000|Overall Study|Ineligible|1|||
23383618|NCT01350973|65148215|FG000|Overall Study|Adverse Event|4|||
23383619|NCT01350973|65148216|FG001|Overall Study|Adverse Event|7|||
23383620|NCT01350973|65148217|FG002|Overall Study|Adverse Event|7|||
23383621|NCT01350973|65148215|FG000|Overall Study|Voluntary Withdrawal|2|||
23383622|NCT01350973|65148216|FG001|Overall Study|Voluntary Withdrawal|1|||
23383623|NCT01350973|65148217|FG002|Overall Study|Voluntary Withdrawal|1|||
23383624|NCT04167462|65148218|FG000|Overall Study|Other reasons|3|||
23383625|NCT04167462|65148219|FG001|Overall Study|Other reasons|2|||
23383626|NCT04167462|65148218|FG000|Overall Study|Withdrawal by Subject|6|||
23383627|NCT04167462|65148219|FG001|Overall Study|Withdrawal by Subject|7|||
23383628|NCT04167462|65148218|FG000|Overall Study|Adverse Event|4|||
23383629|NCT04167462|65148219|FG001|Overall Study|Adverse Event|0|||
23383630|NCT04167462|65148218|FG000|Overall Study|Pregnancy|1|||
23383631|NCT04167462|65148219|FG001|Overall Study|Pregnancy|0|||
23383632|NCT04167462|65148218|FG000|Overall Study|Lack of Efficacy|0|||
23383633|NCT04167462|65148219|FG001|Overall Study|Lack of Efficacy|1|||
23383634|NCT02314247|65148226|FG000|Overall Study|Adverse Event|2|||
23383635|NCT02314247|65148227|FG001|Overall Study|Adverse Event|1|||
23383636|NCT02314247|65148228|FG002|Overall Study|Adverse Event|0|||
23383637|NCT02314247|65148226|FG000|Overall Study|Withdrawal by Subject|1|||
23290515|NCT00440115|64805106|FG000|Overall Study|Death|7|||
23383638|NCT02314247|65148227|FG001|Overall Study|Withdrawal by Subject|3|||
23383639|NCT02314247|65148228|FG002|Overall Study|Withdrawal by Subject|1|||
23383640|NCT02314247|65148226|FG000|Overall Study|Progression of Disease|6|||
23383641|NCT02314247|65148227|FG001|Overall Study|Progression of Disease|2|||
23383642|NCT02314247|65148228|FG002|Overall Study|Progression of Disease|0|||
23383643|NCT04307394|65148229|FG000|Overall Study|Lost to Follow-up|3|||
23383644|NCT04307394|65148229|FG000|Overall Study|Withdrawal by Subject|2|||
23383645|NCT00387127|65148235|FG000|Overall Study|Lost to Follow-up|0|||
23383646|NCT00387127|65148236|FG001|Overall Study|Lost to Follow-up|4|||
23290516|NCT00440115|64805107|FG001|Overall Study|Death|9|||
23290517|NCT00440115|64805108|FG002|Overall Study|Death|5|||
23290518|NCT00440115|64805106|FG000|Overall Study|Incarceration|0|||
23290519|NCT00440115|64805107|FG001|Overall Study|Incarceration|2|||
23290520|NCT00440115|64805108|FG002|Overall Study|Incarceration|1|||
23290521|NCT03365791|64805118|FG000|Overall Study|Adverse Event|5|||
23290522|NCT03365791|64805118|FG000|Overall Study|Death|1|||
23290523|NCT03365791|64805118|FG000|Overall Study|Lost to Follow-up|1|||
23290524|NCT03365791|64805118|FG000|Overall Study|Physician Decision|9|||
23290525|NCT03365791|64805118|FG000|Overall Study|Progressive disease|51|||
23290526|NCT03365791|64805118|FG000|Overall Study|Subject/guardian decision|5|||
23290527|NCT01115933|64805119|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
23290528|NCT00749411|64805120|FG000|Overall Study|Adverse Event|0|||
23290529|NCT00749411|64805121|FG001|Overall Study|Adverse Event|2|||
23290530|NCT00749411|64805120|FG000|Overall Study|Lack of Efficacy|0|||
23290531|NCT00749411|64805121|FG001|Overall Study|Lack of Efficacy|1|||
23290532|NCT00749411|64805120|FG000|Overall Study|Protocol Violation|1|||
23290533|NCT00749411|64805121|FG001|Overall Study|Protocol Violation|1|||
23290534|NCT00749411|64805120|FG000|Overall Study|Protocol-defined stopping criteria|0|||
23290535|NCT00749411|64805121|FG001|Overall Study|Protocol-defined stopping criteria|1|||
23290536|NCT02308696|64805125|FG000|Overall Study|Lost to Follow-up|28|||
23290537|NCT02308696|64805126|FG001|Overall Study|Lost to Follow-up|21|||
23290538|NCT02308696|64805125|FG000|Overall Study|Death|8|||
23290539|NCT02308696|64805126|FG001|Overall Study|Death|4|||
23290540|NCT02308696|64805125|FG000|Overall Study|Moved to a Higher Level of Care|17|||
23290541|NCT02308696|64805126|FG001|Overall Study|Moved to a Higher Level of Care|6|||
23290542|NCT01872715|64805129|FG000|Overall Study|Adverse Event|1|||
23290543|NCT01872715|64805129|FG000|Overall Study|Protocol Violation|1|||
23290544|NCT01872715|64805129|FG000|Overall Study|Withdrawal by Subject|2|||
23290545|NCT04499482|64805135|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
23290546|NCT03358147|64805139|FG000|Overall Study|Withdrawal by Subject|13|||
23383647|NCT00387127|65148235|FG000|Overall Study|Death|16|||
23290547|NCT03358147|64805140|FG001|Overall Study|Withdrawal by Subject|19|||
23290548|NCT03358147|64805141|FG002|Overall Study|Withdrawal by Subject|16|||
23290549|NCT03358147|64805142|FG003|Overall Study|Withdrawal by Subject|10|||
23290550|NCT03358147|64805143|FG004|Overall Study|Withdrawal by Subject|5|||
23290551|NCT03358147|64805139|FG000|Overall Study|Adverse Event|3|||
23383648|NCT00387127|65148236|FG001|Overall Study|Death|16|||
23383649|NCT00387127|65148235|FG000|Overall Study|Physician Decision|0|||
23383650|NCT00387127|65148236|FG001|Overall Study|Physician Decision|1|||
23383651|NCT00387127|65148235|FG000|Overall Study|Withdrawal by Subject|3|||
23383652|NCT00387127|65148236|FG001|Overall Study|Withdrawal by Subject|2|||
23383653|NCT00387127|65148235|FG000|Overall Study|Required by Protocol Amendment #4|12|||
23383654|NCT00387127|65148236|FG001|Overall Study|Required by Protocol Amendment #4|10|||
23383655|NCT00387127|65148235|FG000|Overall Study|Serious Adverse Event|1|||
23383656|NCT00387127|65148236|FG001|Overall Study|Serious Adverse Event|1|||
23383657|NCT00387127|65148235|FG000|Overall Study|Sponsor Unblinded|1|||
23383658|NCT00387127|65148236|FG001|Overall Study|Sponsor Unblinded|0|||
23383659|NCT00864513|65148237|FG000|Overall Study|Withdrawal by Subject|3|||
23383660|NCT04090749|65148238|FG000|Open Label Pilot|Lost to Follow-up|1|||
23383661|NCT04090749|65148239|FG001|Open Label Pilot|Lost to Follow-up|0|||
23383662|NCT04090749|65148240|FG002|Open Label Pilot|Lost to Follow-up|0|||
23383663|NCT04090749|65148238|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
23383664|NCT04090749|65148239|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
23383665|NCT04090749|65148240|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
23290552|NCT03358147|64805140|FG001|Overall Study|Adverse Event|9|||
23290553|NCT03358147|64805141|FG002|Overall Study|Adverse Event|7|||
23290554|NCT03358147|64805142|FG003|Overall Study|Adverse Event|5|||
23290555|NCT03358147|64805143|FG004|Overall Study|Adverse Event|2|||
23290556|NCT03358147|64805139|FG000|Overall Study|Lost to Follow-up|4|||
23290557|NCT03358147|64805140|FG001|Overall Study|Lost to Follow-up|3|||
23290558|NCT03358147|64805141|FG002|Overall Study|Lost to Follow-up|7|||
23290559|NCT03358147|64805142|FG003|Overall Study|Lost to Follow-up|6|||
23290560|NCT03358147|64805143|FG004|Overall Study|Lost to Follow-up|4|||
23290561|NCT03358147|64805139|FG000|Overall Study|Major Protocol Deviation|11|||
23290562|NCT03358147|64805140|FG001|Overall Study|Major Protocol Deviation|3|||
23290563|NCT03358147|64805141|FG002|Overall Study|Major Protocol Deviation|2|||
23290564|NCT03358147|64805142|FG003|Overall Study|Major Protocol Deviation|3|||
23290565|NCT03358147|64805143|FG004|Overall Study|Major Protocol Deviation|1|||
23290566|NCT03358147|64805139|FG000|Overall Study|Protocol specified criteria|2|||
23290567|NCT03358147|64805140|FG001|Overall Study|Protocol specified criteria|3|||
23290568|NCT03358147|64805141|FG002|Overall Study|Protocol specified criteria|0|||
23290569|NCT03358147|64805142|FG003|Overall Study|Protocol specified criteria|3|||
23290570|NCT03358147|64805143|FG004|Overall Study|Protocol specified criteria|1|||
23290571|NCT03358147|64805139|FG000|Overall Study|Physician Decision|1|||
23290572|NCT03358147|64805140|FG001|Overall Study|Physician Decision|0|||
23290573|NCT03358147|64805141|FG002|Overall Study|Physician Decision|1|||
23290574|NCT03358147|64805142|FG003|Overall Study|Physician Decision|6|||
23290575|NCT03358147|64805143|FG004|Overall Study|Physician Decision|1|||
23290576|NCT03358147|64805139|FG000|Overall Study|Administrative reasons|0|||
23290577|NCT03358147|64805140|FG001|Overall Study|Administrative reasons|1|||
23290578|NCT03358147|64805141|FG002|Overall Study|Administrative reasons|0|||
23290579|NCT03358147|64805142|FG003|Overall Study|Administrative reasons|3|||
23290580|NCT03358147|64805143|FG004|Overall Study|Administrative reasons|0|||
23290581|NCT03358147|64805139|FG000|Overall Study|Lack of Efficacy|0|||
23290582|NCT03358147|64805140|FG001|Overall Study|Lack of Efficacy|1|||
23290583|NCT03358147|64805141|FG002|Overall Study|Lack of Efficacy|1|||
23290584|NCT03358147|64805142|FG003|Overall Study|Lack of Efficacy|0|||
23383666|NCT04090749|65148238|FG000|Pilot Trial|Lost to Follow-up|0|||
23290585|NCT03358147|64805143|FG004|Overall Study|Lack of Efficacy|0|||
23290586|NCT00559637|64805144|FG000|Overall Study|Adverse Event|22|||
23383667|NCT04090749|65148239|FG001|Pilot Trial|Lost to Follow-up|1|||
23383668|NCT04090749|65148240|FG002|Pilot Trial|Lost to Follow-up|1|||
23290587|NCT00559637|64805144|FG000|Overall Study|Withdrawal by Subject|4|||
23290588|NCT00559637|64805144|FG000|Overall Study|Protocol Violation|6|||
23290589|NCT00559637|64805144|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
23290590|NCT00559637|64805144|FG000|Overall Study|Failure to return|6|||
23290591|NCT00559637|64805144|FG000|Overall Study|Insufficient response|3|||
23383669|NCT05161936|65148241|FG000|Overall Study|Study terminated by Sponsor|1|||
23383670|NCT05161936|65148242|FG001|Overall Study|Study terminated by Sponsor|0|||
23383671|NCT05161936|65148243|FG002|Overall Study|Study terminated by Sponsor|0|||
23290592|NCT00559637|64805144|FG000|Overall Study|Started requiring dialysis after month 7|2|||
23290593|NCT00559637|64805144|FG000|Overall Study|Suspected lung cancer|1|||
23290594|NCT00559637|64805144|FG000|Overall Study|Participation in another study|1|||
23493153|NCT01903031|65551374|FG002|Overall Study|Not Able to Attend Clinic|0|||
23493154|NCT01903031|65551372|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
23493155|NCT01903031|65551373|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
23493156|NCT01903031|65551374|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
23493157|NCT01903031|65551372|FG000|Overall Study|Adverse Event|0|||
23493158|NCT01903031|65551373|FG001|Overall Study|Adverse Event|1|||
23493159|NCT01903031|65551374|FG002|Overall Study|Adverse Event|0|||
23493160|NCT01903031|65551372|FG000|Overall Study|Withdrawal by Subject|0|||
23493161|NCT01903031|65551373|FG001|Overall Study|Withdrawal by Subject|1|||
23493162|NCT01903031|65551374|FG002|Overall Study|Withdrawal by Subject|1|||
23493163|NCT01903031|65551372|FG000|Overall Study|Protocol Violation|0|||
23493164|NCT01903031|65551373|FG001|Overall Study|Protocol Violation|0|||
23493165|NCT01903031|65551374|FG002|Overall Study|Protocol Violation|2|||
23493166|NCT01903031|65551372|FG000|Overall Study|Lost to Follow-up|0|||
23493167|NCT01903031|65551373|FG001|Overall Study|Lost to Follow-up|0|||
23493168|NCT01903031|65551374|FG002|Overall Study|Lost to Follow-up|1|||
23493169|NCT01903031|65551372|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
23493170|NCT01903031|65551373|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
23493171|NCT01903031|65551374|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
23493172|NCT01871142|65551375|FG000|Overall Study|Adverse Event|1|||
23290595|NCT00559637|64805144|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
23493173|NCT01050543|65551376|FG000|Overall Study|Withdrawal by Subject|0|||
23383672|NCT05161936|65148241|FG000|Overall Study|Withdrawal by Subject|0|||
23383673|NCT05161936|65148242|FG001|Overall Study|Withdrawal by Subject|0|||
23383674|NCT05161936|65148243|FG002|Overall Study|Withdrawal by Subject|1|||
23383675|NCT01245049|65148244|FG000|Overall Study|Migrated/moved from study area|0|||
23383676|NCT01245049|65148245|FG001|Overall Study|Migrated/moved from study area|1|||
23383677|NCT01245049|65148244|FG000|Overall Study|Withdrawal by Subject|0|||
23383678|NCT01245049|65148245|FG001|Overall Study|Withdrawal by Subject|1|||
23383679|NCT01245049|65148244|FG000|Overall Study|Lost to Follow-up|1|||
23383680|NCT01245049|65148245|FG001|Overall Study|Lost to Follow-up|2|||
23383681|NCT01011283|65148252|FG000|Overall Study|Adverse Event|4|||
23383682|NCT01011283|65148253|FG001|Overall Study|Adverse Event|2|||
23383683|NCT01011283|65148252|FG000|Overall Study|Progressive Disease|0|||
23383684|NCT01011283|65148253|FG001|Overall Study|Progressive Disease|2|||
23383685|NCT01011283|65148252|FG000|Overall Study|Terminated by Sponsor|5|||
23383686|NCT01011283|65148253|FG001|Overall Study|Terminated by Sponsor|5|||
23383687|NCT01011283|65148252|FG000|Overall Study|Other|2|||
23383688|NCT01011283|65148253|FG001|Overall Study|Other|2|||
23383689|NCT01093885|65148254|FG000|Overall Study|Adverse Event|4|||
23383690|NCT01093885|65148254|FG000|Overall Study|Lost to Follow-up|1|||
23383691|NCT01112267|65148255|FG000|Overall Study|Adverse Event|24|||
23383692|NCT01112267|65148256|FG001|Overall Study|Adverse Event|6|||
23383693|NCT01112267|65148255|FG000|Overall Study|Withdrawal by Subject|3|||
23383694|NCT01112267|65148256|FG001|Overall Study|Withdrawal by Subject|5|||
23383695|NCT01112267|65148255|FG000|Overall Study|Protocol Violation|5|||
23383696|NCT01112267|65148256|FG001|Overall Study|Protocol Violation|3|||
23383697|NCT01112267|65148255|FG000|Overall Study|Participants not compliant|1|||
23383698|NCT01112267|65148256|FG001|Overall Study|Participants not compliant|2|||
23383699|NCT01112267|65148255|FG000|Overall Study|Participants not receive any study drug|1|||
23383700|NCT01112267|65148256|FG001|Overall Study|Participants not receive any study drug|2|||
23383701|NCT00326495|65148257|FG000|Overall Study|Switched to alternative treatment|1|||
23383702|NCT00326495|65148257|FG000|Overall Study|Disease progression before treatment|1|||
23383703|NCT00326495|65148257|FG000|Overall Study|Refused further treatment|2|||
23383704|NCT00326495|65148257|FG000|Overall Study|Subject off study before assessment|1|||
23383705|NCT02413346|65148258|FG000|Overall Study|Adverse Event|6|||
23383706|NCT02413346|65148259|FG001|Overall Study|Adverse Event|6|||
23383707|NCT02413346|65148258|FG000|Overall Study|Withdrawal by Subject|30|||
23383708|NCT02413346|65148259|FG001|Overall Study|Withdrawal by Subject|40|||
23383709|NCT02413346|65148258|FG000|Overall Study|Lost to Follow-up|17|||
23383710|NCT02413346|65148259|FG001|Overall Study|Lost to Follow-up|21|||
23383711|NCT02413346|65148258|FG000|Overall Study|Protocol Violation|2|||
23383712|NCT02413346|65148259|FG001|Overall Study|Protocol Violation|0|||
23383713|NCT02413346|65148258|FG000|Overall Study|Other Miscellaneous Reasons|4|||
23383714|NCT02413346|65148259|FG001|Overall Study|Other Miscellaneous Reasons|3|||
23383715|NCT01699685|65148260|FG000|Period 1|Adverse Event|1|||
23383716|NCT01699685|65148261|FG001|Period 1|Adverse Event|1|||
23383717|NCT01699685|65148260|FG000|Period 1|Medical or ethical, noncompliance|2|||
23383718|NCT01699685|65148261|FG001|Period 1|Medical or ethical, noncompliance|0|||
23383719|NCT01699685|65148260|FG000|Period 1|Other|0|||
23383720|NCT01699685|65148261|FG001|Period 1|Other|1|||
23383721|NCT01699685|65148260|FG000|Period 1|Patient request|0|||
23383722|NCT01699685|65148261|FG001|Period 1|Patient request|1|||
23383723|NCT01699685|65148260|FG000|Period 2|Lost to Follow-up|1|||
23383724|NCT01699685|65148261|FG001|Period 2|Lost to Follow-up|0|||
23383725|NCT03345004|65148268|FG000|Overall Study|Physician Decision|1|||
23383726|NCT03345004|65148269|FG001|Overall Study|Physician Decision|0|||
23383727|NCT03345004|65148268|FG000|Overall Study|Withdrawal by Subject|0|||
23383728|NCT03345004|65148269|FG001|Overall Study|Withdrawal by Subject|1|||
23383729|NCT01727154|65148270|FG000|Overall Study|Death|17|||
23383730|NCT01727154|65148270|FG000|Overall Study|Withdrawal by Subject|14|||
23383731|NCT01727154|65148270|FG000|Overall Study|Subject Withdrew Consent|18|||
23383732|NCT01727154|65148270|FG000|Overall Study|Study Terminated|6|||
23383733|NCT01727154|65148270|FG000|Overall Study|No Discontinuation Documentation|4|||
23383734|NCT00871000|65148271|FG000|Overall Study|Withdrawal by Subject|1|||
23383735|NCT00871000|65148272|FG001|Overall Study|Withdrawal by Subject|0|||
23383736|NCT01362270|65148273|FG000|Overall Study|Withdrawal by Subject|1|||
23383737|NCT01362270|65148274|FG001|Overall Study|Withdrawal by Subject|0|||
23383738|NCT01362270|65148273|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
23383739|NCT01362270|65148274|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
23383740|NCT01362270|65148273|FG000|Overall Study|Met excl. criteria before 1st session|1|||
23383741|NCT01362270|65148274|FG001|Overall Study|Met excl. criteria before 1st session|1|||
23383742|NCT01026038|65148275|FG000|Overall Study|Lost to Follow-up|1|||
23383743|NCT01026038|65148276|FG001|Overall Study|Lost to Follow-up|1|||
23383744|NCT01026038|65148277|FG002|Overall Study|Lost to Follow-up|0|||
23383745|NCT01793935|65148278|FG000|Overall Study|Pregnancy|1|||
23383746|NCT01793935|65148279|FG001|Overall Study|Pregnancy|0|||
23383747|NCT01793935|65148278|FG000|Overall Study|Protocol Violation|2|||
23383748|NCT01793935|65148279|FG001|Overall Study|Protocol Violation|1|||
23383749|NCT01793935|65148278|FG000|Overall Study|Adverse Event|2|||
23383750|NCT01793935|65148279|FG001|Overall Study|Adverse Event|0|||
23383751|NCT01793935|65148278|FG000|Overall Study|Patient did not take study medication|1|||
23383752|NCT01793935|65148279|FG001|Overall Study|Patient did not take study medication|1|||
23383753|NCT01793935|65148278|FG000|Overall Study|Lost to Follow-up|0|||
23383754|NCT01793935|65148279|FG001|Overall Study|Lost to Follow-up|1|||
23383755|NCT02782468|65148280|FG000|Overall Study|Progressive Disease|2|||
23383756|NCT02782468|65148281|FG001|Overall Study|Progressive Disease|5|||
23383757|NCT02782468|65148282|FG002|Overall Study|Progressive Disease|0|||
23383758|NCT02782468|65148283|FG003|Overall Study|Progressive Disease|4|||
23383759|NCT02782468|65148280|FG000|Overall Study|Adverse Event|0|||
23383760|NCT02782468|65148281|FG001|Overall Study|Adverse Event|2|||
23383761|NCT02782468|65148282|FG002|Overall Study|Adverse Event|2|||
23383762|NCT02782468|65148283|FG003|Overall Study|Adverse Event|3|||
23383763|NCT02782468|65148280|FG000|Overall Study|Other|0|||
23383764|NCT02782468|65148281|FG001|Overall Study|Other|0|||
23383765|NCT02782468|65148282|FG002|Overall Study|Other|1|||
23383766|NCT02782468|65148283|FG003|Overall Study|Other|1|||
23383767|NCT02782468|65148280|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
23383768|NCT02782468|65148281|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
23383769|NCT02782468|65148282|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
23383770|NCT02782468|65148283|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
23383771|NCT02782468|65148280|FG000|Overall Study|Symptomatic Deterioration|0|||
23383772|NCT02782468|65148281|FG001|Overall Study|Symptomatic Deterioration|0|||
23383773|NCT02782468|65148282|FG002|Overall Study|Symptomatic Deterioration|0|||
23383774|NCT02782468|65148283|FG003|Overall Study|Symptomatic Deterioration|1|||
23383775|NCT02782468|65148280|FG000|Overall Study|Withdrawal by Subject|1|||
23383776|NCT02782468|65148281|FG001|Overall Study|Withdrawal by Subject|0|||
23383777|NCT02782468|65148282|FG002|Overall Study|Withdrawal by Subject|0|||
23383778|NCT02782468|65148283|FG003|Overall Study|Withdrawal by Subject|0|||
23383779|NCT00290238|65148288|FG000|Overall Study|Study terminated|27|||
23383780|NCT00290238|65148289|FG001|Overall Study|Study terminated|27|||
23383781|NCT00290238|65148288|FG000|Overall Study|Lost to Follow-up|0|||
23383782|NCT00290238|65148289|FG001|Overall Study|Lost to Follow-up|1|||
23383783|NCT00290238|65148288|FG000|Overall Study|Withdrawal by Subject|15|||
23383784|NCT00290238|65148289|FG001|Overall Study|Withdrawal by Subject|13|||
23383785|NCT03142750|65148293|FG000|Overall Study|Lost to Follow-up|4|||
23383786|NCT03142750|65148294|FG001|Overall Study|Lost to Follow-up|1|||
23383787|NCT03520387|65148299|FG000|Pre-Randomization|Withdrawal by Subject|1|||
23383788|NCT03520387|65148300|FG001|Pre-Randomization|Withdrawal by Subject|0|||
23383789|NCT03520387|65148301|FG002|Pre-Randomization|Withdrawal by Subject|0|||
23383790|NCT03520387|65148302|FG003|Pre-Randomization|Withdrawal by Subject|0|||
23383791|NCT03520387|65148303|FG004|Pre-Randomization|Withdrawal by Subject|0|||
23383792|NCT03520387|65148299|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
23383793|NCT03520387|65148300|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
23383794|NCT03520387|65148301|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
23383795|NCT03520387|65148302|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
23383796|NCT03520387|65148303|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
23383797|NCT03259308|65148304|FG000|Overall Study|Adverse Event|5|||
23383798|NCT03259308|65148305|FG001|Overall Study|Adverse Event|4|||
23383799|NCT03259308|65148306|FG002|Overall Study|Adverse Event|1|||
23383800|NCT03259308|65148304|FG000|Overall Study|Withdrawal by Subject|2|||
23383801|NCT03259308|65148305|FG001|Overall Study|Withdrawal by Subject|1|||
23383802|NCT03259308|65148306|FG002|Overall Study|Withdrawal by Subject|3|||
23383803|NCT03259308|65148304|FG000|Overall Study|Lost to Follow-up|0|||
23493174|NCT01050543|65551377|FG001|Overall Study|Withdrawal by Subject|2|||
23290596|NCT00559637|64805144|FG000|Overall Study|Change of center|1|||
23290597|NCT00559637|64805144|FG000|Overall Study|Change of home|1|||
23290598|NCT00559637|64805144|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
23290599|NCT01015287|64805145|FG000|Overall Study|Death|21|||
23290600|NCT01015287|64805146|FG001|Overall Study|Death|16|||
23290601|NCT01015287|64805145|FG000|Overall Study|Adverse Event|1|||
23290602|NCT01015287|64805146|FG001|Overall Study|Adverse Event|0|||
23290603|NCT01015287|64805145|FG000|Overall Study|Sponsor Decision|3|||
23290604|NCT01015287|64805146|FG001|Overall Study|Sponsor Decision|7|||
23290605|NCT01015287|64805145|FG000|Overall Study|Physician Decision|19|||
23383804|NCT03259308|65148305|FG001|Overall Study|Lost to Follow-up|0|||
23383805|NCT03259308|65148306|FG002|Overall Study|Lost to Follow-up|1|||
23383806|NCT03259308|65148304|FG000|Overall Study|Pregnancy|0|||
23383807|NCT03259308|65148305|FG001|Overall Study|Pregnancy|0|||
23383808|NCT03259308|65148306|FG002|Overall Study|Pregnancy|1|||
23383809|NCT03259308|65148304|FG000|Overall Study|Protocol Deviation|0|||
23383810|NCT03259308|65148305|FG001|Overall Study|Protocol Deviation|3|||
23383811|NCT03259308|65148306|FG002|Overall Study|Protocol Deviation|0|||
23383812|NCT03259308|65148304|FG000|Overall Study|Lack of Efficacy|0|||
23383813|NCT03259308|65148305|FG001|Overall Study|Lack of Efficacy|0|||
23383814|NCT03259308|65148306|FG002|Overall Study|Lack of Efficacy|1|||
23383815|NCT00663351|65148307|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
23383816|NCT00663351|65148308|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
23383817|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
23383818|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
23383819|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
23383820|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
23383821|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
23383822|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
23383823|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
23383824|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
23383825|NCT00663351|65148307|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
23383826|NCT00663351|65148308|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
23383827|NCT00577408|65148309|FG000|Overall Study|Stopped attending study visits|9|||
23383828|NCT00577408|65148310|FG001|Overall Study|Stopped attending study visits|11|||
23383829|NCT00577408|65148309|FG000|Overall Study|Continued opioid use|3|||
23383830|NCT00577408|65148310|FG001|Overall Study|Continued opioid use|2|||
23383831|NCT00577408|65148309|FG000|Overall Study|Non-compliance with study meds|0|||
23383832|NCT00577408|65148310|FG001|Overall Study|Non-compliance with study meds|3|||
23290606|NCT01015287|64805146|FG001|Overall Study|Physician Decision|21|||
23290607|NCT01015287|64805145|FG000|Overall Study|Withdrawal by Subject|14|||
23290608|NCT01015287|64805146|FG001|Overall Study|Withdrawal by Subject|19|||
23290609|NCT01015287|64805145|FG000|Overall Study|Entry Criteria not Met|11|||
23290610|NCT01015287|64805146|FG001|Overall Study|Entry Criteria not Met|14|||
23290611|NCT01015287|64805145|FG000|Overall Study|Lost to Follow-up|2|||
23290612|NCT01015287|64805146|FG001|Overall Study|Lost to Follow-up|1|||
23290613|NCT01015287|64805145|FG000|Overall Study|Protocol Violation|1|||
23290614|NCT01015287|64805146|FG001|Overall Study|Protocol Violation|1|||
23290615|NCT02197416|64805148|FG000|Overall Study|Other reasons|0|||
23290616|NCT02197416|64805149|FG001|Overall Study|Other reasons|2|||
23290617|NCT02197416|64805150|FG002|Overall Study|Other reasons|5|||
23290618|NCT02197416|64805148|FG000|Overall Study|Withdrawal by Subject|0|||
23290619|NCT02197416|64805149|FG001|Overall Study|Withdrawal by Subject|2|||
23290620|NCT02197416|64805150|FG002|Overall Study|Withdrawal by Subject|1|||
23290621|NCT02197416|64805148|FG000|Overall Study|Protocol Violation|1|||
23290622|NCT02197416|64805149|FG001|Overall Study|Protocol Violation|0|||
23290623|NCT02197416|64805150|FG002|Overall Study|Protocol Violation|1|||
23290624|NCT02197416|64805148|FG000|Overall Study|Adverse Event|0|||
23290625|NCT02197416|64805149|FG001|Overall Study|Adverse Event|0|||
23290626|NCT02197416|64805150|FG002|Overall Study|Adverse Event|1|||
23290627|NCT00381849|64805157|FG000|Wash Out|Withdrawal by Subject|0|||
23290628|NCT00381849|64805158|FG001|Wash Out|Withdrawal by Subject|1|||
23290629|NCT04599166|64805161|FG000|Overall Study|Technological failure connecting to study app|80|||
23290630|NCT01557751|64805162|FG000|Overall Study|Physician Decision|3|||
23290631|NCT00265785|64805163|FG000|Overall Study|Adverse Event|4|||
23290632|NCT00265785|64805163|FG000|Overall Study|Withdrawal by Subject|3|||
23290633|NCT00265785|64805163|FG000|Overall Study|Progression/Relapse|15|||
23290634|NCT00265785|64805163|FG000|Overall Study|Not protocol specified|2|||
23290635|NCT00265785|64805163|FG000|Overall Study|Ineligible|1|||
23290636|NCT00265785|64805163|FG000|Overall Study|Did not receive protocol treatment|2|||
23290637|NCT02129062|64805183|FG000|Overall Study|Death|1|||
23290638|NCT02129062|64805183|FG000|Overall Study|Disease Progression|2|||
23290639|NCT01207492|64805184|FG000|Overall Study|Still on study|1|||
23290640|NCT01207492|64805184|FG000|Overall Study|Withdrawal by Subject|9|||
23290641|NCT01207492|64805184|FG000|Overall Study|Physician Decision|1|||
23290642|NCT01207492|64805184|FG000|Overall Study|Progressive disease|3|||
23290643|NCT01207492|64805184|FG000|Overall Study|Toxicity|1|||
23290644|NCT03370510|64805186|FG000|Overall Study|COVID-19|2|||
23290645|NCT03370510|64805187|FG001|Overall Study|COVID-19|0|||
23383833|NCT00577408|65148309|FG000|Overall Study|Refused Oral Naltrexone|0|||
23383834|NCT00577408|65148310|FG001|Overall Study|Refused Oral Naltrexone|1|||
23383835|NCT00577408|65148309|FG000|Overall Study|Moved out of state|0|||
23383836|NCT00577408|65148310|FG001|Overall Study|Moved out of state|1|||
23383837|NCT00577408|65148309|FG000|Overall Study|Scheduling Issues|0|||
23383838|NCT00577408|65148310|FG001|Overall Study|Scheduling Issues|3|||
23383839|NCT00577408|65148309|FG000|Overall Study|Death|0|||
23383840|NCT00577408|65148310|FG001|Overall Study|Death|1|||
23383841|NCT00577408|65148309|FG000|Overall Study|Psychiatric hospitalization|0|||
23383842|NCT00577408|65148310|FG001|Overall Study|Psychiatric hospitalization|1|||
23383843|NCT00724503|65148311|FG000|Overall Study|Lost to Follow-up|4|||
23383844|NCT00724503|65148312|FG001|Overall Study|Lost to Follow-up|8|||
23383845|NCT00724503|65148311|FG000|Overall Study|Withdrawal by Subject|11|||
23383846|NCT00724503|65148312|FG001|Overall Study|Withdrawal by Subject|23|||
23383847|NCT00724503|65148311|FG000|Overall Study|Death|190|||
23383848|NCT00724503|65148312|FG001|Overall Study|Death|182|||
23383849|NCT00724503|65148311|FG000|Overall Study|Adverse Event|1|||
23383850|NCT00724503|65148312|FG001|Overall Study|Adverse Event|0|||
23383851|NCT00724503|65148311|FG000|Overall Study|Not otherwise specified|4|||
23383852|NCT00724503|65148312|FG001|Overall Study|Not otherwise specified|7|||
23383853|NCT00694122|65148315|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
23383854|NCT00694122|65148316|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
23383855|NCT00694122|65148315|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
23383856|NCT00694122|65148316|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
23383857|NCT00694122|65148315|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
23383858|NCT00694122|65148316|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
23383859|NCT03983109|65148319|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
23383860|NCT03983109|65148320|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
23383861|NCT01943825|65148321|FG000|Overall Study|Lost to Follow-up|9|||
23383862|NCT01943825|65148322|FG001|Overall Study|Lost to Follow-up|3|||
23383863|NCT01943825|65148323|FG002|Overall Study|Lost to Follow-up|12|||
23383864|NCT01943825|65148324|FG003|Overall Study|Lost to Follow-up|8|||
23383865|NCT01943825|65148321|FG000|Overall Study|Withdrawal by Subject|1|||
23383866|NCT01943825|65148322|FG001|Overall Study|Withdrawal by Subject|0|||
23383867|NCT01943825|65148323|FG002|Overall Study|Withdrawal by Subject|3|||
23383868|NCT01943825|65148324|FG003|Overall Study|Withdrawal by Subject|2|||
23383869|NCT01943825|65148321|FG000|Overall Study|Other than specified above|0|||
23383870|NCT01943825|65148322|FG001|Overall Study|Other than specified above|1|||
23383871|NCT01943825|65148323|FG002|Overall Study|Other than specified above|0|||
23383872|NCT01943825|65148324|FG003|Overall Study|Other than specified above|1|||
23383873|NCT01452789|65148327|FG000|Overall Study|Withdrawal by Subject|3|||
23383874|NCT01452789|65148328|FG001|Overall Study|Withdrawal by Subject|2|||
23383875|NCT00604383|65148329|FG000|Overall Study|Withdrawal by Subject|33|||
23383876|NCT00604383|65148330|FG001|Overall Study|Withdrawal by Subject|31|||
23383877|NCT00604383|65148329|FG000|Overall Study|Lost to Follow-up|24|||
23383878|NCT00604383|65148330|FG001|Overall Study|Lost to Follow-up|19|||
23383879|NCT00604383|65148329|FG000|Overall Study|Death|14|||
23383880|NCT00604383|65148330|FG001|Overall Study|Death|22|||
23383881|NCT00604383|65148329|FG000|Overall Study|Adverse Event|16|||
23383882|NCT00604383|65148330|FG001|Overall Study|Adverse Event|9|||
23383883|NCT00604383|65148329|FG000|Overall Study|Physician Decision|0|||
23383884|NCT00604383|65148330|FG001|Overall Study|Physician Decision|3|||
23383885|NCT01198548|65148333|FG000|Overall Study|Disease Progression|9|||
23383886|NCT01198548|65148333|FG000|Overall Study|Administrative Decision|1|||
23383887|NCT04706403|65148336|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
23383888|NCT04706403|65148337|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
23383889|NCT04706403|65148338|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
23383890|NCT04706403|65148339|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
23383891|NCT04706403|65148340|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
23383892|NCT00309244|65148341|FG000|Overall Study|Adverse Event|29|||
23383893|NCT00309244|65148342|FG001|Overall Study|Adverse Event|12|||
23383894|NCT00309244|65148341|FG000|Overall Study|Lost to Follow-up|6|||
23383895|NCT00309244|65148342|FG001|Overall Study|Lost to Follow-up|22|||
23383896|NCT00309244|65148341|FG000|Overall Study|Physician Decision|5|||
23383897|NCT00309244|65148342|FG001|Overall Study|Physician Decision|8|||
23383898|NCT00309244|65148341|FG000|Overall Study|Protocol Violation|6|||
23383899|NCT00309244|65148342|FG001|Overall Study|Protocol Violation|3|||
23383900|NCT00309244|65148341|FG000|Overall Study|Withdrawal by Subject|50|||
23383901|NCT00309244|65148342|FG001|Overall Study|Withdrawal by Subject|32|||
23383902|NCT00309244|65148341|FG000|Overall Study|Various|7|||
23383903|NCT00309244|65148342|FG001|Overall Study|Various|7|||
23383904|NCT00309244|65148341|FG000|Overall Study|Randomized but not dosed|11|||
23383905|NCT00309244|65148342|FG001|Overall Study|Randomized but not dosed|12|||
23383906|NCT00309244|65148341|FG000|Overall Study|Death|4|||
23383907|NCT00309244|65148342|FG001|Overall Study|Death|1|||
23383908|NCT03828383|65151433|FG000|Overall Study|Lost to Follow-up|3|||
23383909|NCT03828383|65151434|FG001|Overall Study|Lost to Follow-up|2|||
23383910|NCT03828383|65151433|FG000|Overall Study|Withdrawal by Subject|4|||
23383911|NCT03828383|65151434|FG001|Overall Study|Withdrawal by Subject|5|||
23383912|NCT02320396|65151442|FG000|Overall Study|Adverse Event|2|||
23383913|NCT02320396|65151443|FG001|Overall Study|Adverse Event|2|||
23383914|NCT02320396|65151442|FG000|Overall Study|Pregnancy|0|||
23383915|NCT02320396|65151443|FG001|Overall Study|Pregnancy|1|||
23383916|NCT02320396|65151442|FG000|Overall Study|Protocol Violation|0|||
23383917|NCT02320396|65151443|FG001|Overall Study|Protocol Violation|1|||
23383918|NCT02320396|65151442|FG000|Overall Study|Withdrawal by Subject|2|||
23383919|NCT02320396|65151443|FG001|Overall Study|Withdrawal by Subject|0|||
23383920|NCT00977561|65151444|FG000|Overall Study|Death|3|||
23383921|NCT00977561|65151445|FG001|Overall Study|Death|2|||
23383922|NCT00977561|65151444|FG000|Overall Study|Study terminated|0|||
23383923|NCT00977561|65151445|FG001|Overall Study|Study terminated|2|||
23383924|NCT00977561|65151444|FG000|Overall Study|Other|2|||
23383925|NCT00977561|65151445|FG001|Overall Study|Other|0|||
23383926|NCT03722030|65151446|FG000|Overall Study|Withdrawal by Subject|1|||
23383927|NCT03722030|65151447|FG001|Overall Study|Withdrawal by Subject|0|||
23383928|NCT00032487|65151453|FG000|Overall Study|Withdrawal by Subject|67|||
23383929|NCT00032487|65151454|FG001|Overall Study|Withdrawal by Subject|43|||
23383930|NCT00032487|65151453|FG000|Overall Study|Adverse Event|3|||
23383931|NCT00032487|65151454|FG001|Overall Study|Adverse Event|7|||
23383932|NCT00032487|65151453|FG000|Overall Study|Lost to Follow-up|57|||
23383933|NCT00032487|65151454|FG001|Overall Study|Lost to Follow-up|58|||
23383934|NCT00032487|65151453|FG000|Overall Study|Had other reason|12|||
23383935|NCT00032487|65151454|FG001|Overall Study|Had other reason|12|||
23383936|NCT00560404|65151459|FG000|Overall Study|Adverse Event|2|||
23383937|NCT00560404|65151460|FG001|Overall Study|Adverse Event|3|||
23383938|NCT00560404|65151459|FG000|Overall Study|Death|3|||
23383939|NCT00560404|65151460|FG001|Overall Study|Death|3|||
23383940|NCT00560404|65151459|FG000|Overall Study|Protocol Violation|12|||
23383941|NCT00560404|65151460|FG001|Overall Study|Protocol Violation|7|||
23383942|NCT00560404|65151459|FG000|Overall Study|Administrative Reasons|1|||
23383943|NCT00560404|65151460|FG001|Overall Study|Administrative Reasons|1|||
23383944|NCT00560404|65151459|FG000|Overall Study|Withdrew Consent|4|||
23383945|NCT00560404|65151460|FG001|Overall Study|Withdrew Consent|0|||
23383946|NCT00560404|65151459|FG000|Overall Study|Failure to return|1|||
23383947|NCT00560404|65151460|FG001|Overall Study|Failure to return|2|||
23383948|NCT00560404|65151459|FG000|Overall Study|Other withdrawal reason|13|||
23383949|NCT00560404|65151460|FG001|Overall Study|Other withdrawal reason|5|||
23383950|NCT00004859|65151461|FG000|Overall Study|Lack of Efficacy|43|||
23383951|NCT00004859|65151462|FG001|Overall Study|Lack of Efficacy|113|||
23383952|NCT00004859|65151461|FG000|Overall Study|Adverse Event|31|||
23383953|NCT00004859|65151462|FG001|Overall Study|Adverse Event|93|||
23383954|NCT00004859|65151461|FG000|Overall Study|Death|5|||
23383955|NCT00004859|65151462|FG001|Overall Study|Death|5|||
23290646|NCT00329160|64805191|FG000|Overall Study|Adverse Event|27|||
23290647|NCT00329160|64805191|FG000|Overall Study|Withdrawal by Subject|13|||
23290648|NCT00329160|64805191|FG000|Overall Study|Protocol Violation|2|||
23290649|NCT00329160|64805191|FG000|Overall Study|Did not Receive Study Drug|1|||
23290650|NCT00329160|64805191|FG000|Overall Study|Incomplete IVUS|45|||
23290651|NCT02005562|64805194|FG000|Overall Study|Death|2|||
23290652|NCT02005562|64805195|FG001|Overall Study|Death|2|||
23290653|NCT02005562|64805194|FG000|Overall Study|Graft loss|7|||
23290654|NCT02005562|64805195|FG001|Overall Study|Graft loss|6|||
23290655|NCT02005562|64805194|FG000|Overall Study|Withdrawal by Subject|2|||
23290656|NCT02005562|64805195|FG001|Overall Study|Withdrawal by Subject|2|||
23290657|NCT02005562|64805194|FG000|Overall Study|No transplant|1|||
23290658|NCT02005562|64805195|FG001|Overall Study|No transplant|4|||
23290659|NCT02005562|64805194|FG000|Overall Study|Physician Decision|0|||
23290660|NCT02005562|64805195|FG001|Overall Study|Physician Decision|1|||
23290661|NCT03843125|64805196|FG000|Overall Study|Adverse Event|17|||
23290662|NCT03843125|64805197|FG001|Overall Study|Adverse Event|13|||
23290663|NCT03843125|64805198|FG002|Overall Study|Adverse Event|5|||
23290664|NCT03843125|64805199|FG003|Overall Study|Adverse Event|9|||
23290665|NCT03843125|64805196|FG000|Overall Study|Death|0|||
23290666|NCT03843125|64805197|FG001|Overall Study|Death|6|||
23290667|NCT03843125|64805198|FG002|Overall Study|Death|2|||
23290668|NCT03843125|64805199|FG003|Overall Study|Death|0|||
23290669|NCT03843125|64805196|FG000|Overall Study|Lack of Efficacy|14|||
23290670|NCT03843125|64805197|FG001|Overall Study|Lack of Efficacy|11|||
23290671|NCT03843125|64805198|FG002|Overall Study|Lack of Efficacy|9|||
23290672|NCT03843125|64805199|FG003|Overall Study|Lack of Efficacy|4|||
23290673|NCT03843125|64805196|FG000|Overall Study|Lost to Follow-up|3|||
23290674|NCT03843125|64805197|FG001|Overall Study|Lost to Follow-up|4|||
23290675|NCT03843125|64805198|FG002|Overall Study|Lost to Follow-up|0|||
23290676|NCT03843125|64805199|FG003|Overall Study|Lost to Follow-up|2|||
23290677|NCT03843125|64805196|FG000|Overall Study|Other|12|||
23290678|NCT03843125|64805197|FG001|Overall Study|Other|14|||
23290679|NCT03843125|64805198|FG002|Overall Study|Other|3|||
23290680|NCT03843125|64805199|FG003|Overall Study|Other|4|||
23290681|NCT03843125|64805196|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
23290682|NCT03843125|64805197|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
23290683|NCT03843125|64805198|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
23290684|NCT03843125|64805199|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
23290685|NCT03843125|64805196|FG000|Overall Study|Study Terminated by Sponsor|318|||
23290686|NCT03843125|64805197|FG001|Overall Study|Study Terminated by Sponsor|318|||
23290687|NCT03843125|64805198|FG002|Overall Study|Study Terminated by Sponsor|163|||
23290688|NCT03843125|64805199|FG003|Overall Study|Study Terminated by Sponsor|163|||
23290689|NCT03843125|64805196|FG000|Overall Study|Withdrawal by Subject|23|||
23290690|NCT03843125|64805197|FG001|Overall Study|Withdrawal by Subject|12|||
23290691|NCT03843125|64805198|FG002|Overall Study|Withdrawal by Subject|6|||
23290692|NCT03843125|64805199|FG003|Overall Study|Withdrawal by Subject|9|||
23290693|NCT03843125|64805196|FG000|Overall Study|Missing data|0|||
23290694|NCT03843125|64805197|FG001|Overall Study|Missing data|1|||
23290695|NCT03843125|64805198|FG002|Overall Study|Missing data|1|||
23290696|NCT03843125|64805199|FG003|Overall Study|Missing data|0|||
23290697|NCT01685216|64805200|FG000|Overall Study|Did not receive study drug|1|||
23290698|NCT02166606|64805203|FG000|Overall Study|Adverse Event|3|||
23290699|NCT02166606|64805203|FG000|Overall Study|Death|31|||
23290700|NCT02166606|64805203|FG000|Overall Study|Protocol Violation|7|||
23290701|NCT02166606|64805203|FG000|Overall Study|Lost to Follow-up|30|||
23290702|NCT02166606|64805203|FG000|Overall Study|Withdrawal by Subject|1|||
23290703|NCT02166606|64805203|FG000|Overall Study|Physician Decision|1|||
23290704|NCT02166606|64805203|FG000|Overall Study|Device upgrade|1|||
23290705|NCT02166606|64805203|FG000|Overall Study|Enrolled after End of Enrollment|4|||
23290706|NCT03168906|64805207|FG000|Overall Study|Lack of Efficacy|6|||
23290707|NCT03168906|64805208|FG001|Overall Study|Lack of Efficacy|6|||
23290708|NCT00939523|64805209|FG000|Overall Study|Lack of Efficacy|1|||
23290709|NCT00939523|64805209|FG000|Overall Study|Physician Decision|2|||
23290710|NCT01109849|64805210|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
23290711|NCT01109849|64805211|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
23290712|NCT01109849|64805212|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
23290713|NCT01109849|64805213|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
23290714|NCT01109849|64805214|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
23290715|NCT01109849|64805210|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
23290716|NCT01109849|64805211|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
23290717|NCT01109849|64805212|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
23290718|NCT01109849|64805213|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
23493175|NCT01050543|65551376|FG000|Overall Study|Protocol Violation|0|||
23290719|NCT01109849|64805214|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
23290720|NCT01109849|64805210|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
23290721|NCT01109849|64805211|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
23493176|NCT01050543|65551377|FG001|Overall Study|Protocol Violation|1|||
23383956|NCT00004859|65151461|FG000|Overall Study|Withdrawal by Subject|7|||
23383957|NCT00004859|65151462|FG001|Overall Study|Withdrawal by Subject|33|||
23383958|NCT00004859|65151461|FG000|Overall Study|Protocol Violation|2|||
23383959|NCT00004859|65151462|FG001|Overall Study|Protocol Violation|2|||
23383960|NCT00004859|65151461|FG000|Overall Study|other disease|0|||
23383961|NCT00004859|65151462|FG001|Overall Study|other disease|3|||
23383962|NCT00004859|65151461|FG000|Overall Study|error|3|||
23383963|NCT00004859|65151462|FG001|Overall Study|error|1|||
23383964|NCT00004859|65151461|FG000|Overall Study|missing data|14|||
23383965|NCT00004859|65151462|FG001|Overall Study|missing data|11|||
23383966|NCT00004859|65151461|FG000|Overall Study|Other|13|||
23383967|NCT00004859|65151462|FG001|Overall Study|Other|21|||
23383968|NCT01316900|65151482|FG000|Overall Study|Adverse Event|10|||
23383969|NCT01316900|65151483|FG001|Overall Study|Adverse Event|10|||
23383970|NCT01316900|65151484|FG002|Overall Study|Adverse Event|15|||
23383971|NCT01316900|65151485|FG003|Overall Study|Adverse Event|9|||
23383972|NCT01316900|65151482|FG000|Overall Study|Lack of Efficacy|17|||
23383973|NCT01316900|65151483|FG001|Overall Study|Lack of Efficacy|9|||
23383974|NCT01316900|65151484|FG002|Overall Study|Lack of Efficacy|5|||
23383975|NCT01316900|65151485|FG003|Overall Study|Lack of Efficacy|7|||
23383976|NCT01316900|65151482|FG000|Overall Study|Protocol Violation|7|||
23383977|NCT01316900|65151483|FG001|Overall Study|Protocol Violation|1|||
23383978|NCT01316900|65151484|FG002|Overall Study|Protocol Violation|4|||
23383979|NCT01316900|65151485|FG003|Overall Study|Protocol Violation|0|||
23383980|NCT01316900|65151482|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
23383981|NCT01316900|65151483|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
23383982|NCT01316900|65151484|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
23383983|NCT01316900|65151485|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
23383984|NCT01316900|65151482|FG000|Overall Study|Lost to Follow-up|1|||
23383985|NCT01316900|65151483|FG001|Overall Study|Lost to Follow-up|0|||
23383986|NCT01316900|65151484|FG002|Overall Study|Lost to Follow-up|1|||
23383987|NCT01316900|65151485|FG003|Overall Study|Lost to Follow-up|1|||
23383988|NCT01316900|65151482|FG000|Overall Study|Withdrawal by Subject|7|||
23383989|NCT01316900|65151483|FG001|Overall Study|Withdrawal by Subject|8|||
23383990|NCT01316900|65151484|FG002|Overall Study|Withdrawal by Subject|6|||
23383991|NCT01316900|65151485|FG003|Overall Study|Withdrawal by Subject|9|||
23383992|NCT02370394|65151498|FG000|Overall Study|Lost to Follow-up|2|||
23383993|NCT02370394|65151499|FG001|Overall Study|Lost to Follow-up|1|||
23383994|NCT02370394|65151498|FG000|Overall Study|Withdrawal by Subject|0|||
23383995|NCT02370394|65151499|FG001|Overall Study|Withdrawal by Subject|1|||
23383996|NCT01121575|65151502|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
23383997|NCT01121575|65151503|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
23290722|NCT01109849|64805212|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
23290723|NCT01109849|64805213|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
23290724|NCT01109849|64805214|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
23290725|NCT01109849|64805210|FG000|Initial Randomization: ADHD Treatment|move away|2|||
23290726|NCT01109849|64805211|FG001|Initial Randomization: ADHD Treatment|move away|7|||
23290727|NCT01109849|64805212|FG002|Initial Randomization: ADHD Treatment|move away|0|||
23290728|NCT01109849|64805213|FG003|Initial Randomization: ADHD Treatment|move away|0|||
23290729|NCT01109849|64805214|FG004|Initial Randomization: ADHD Treatment|move away|0|||
23290730|NCT01109849|64805210|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
23290731|NCT01109849|64805211|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
23383998|NCT01121575|65151504|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
23383999|NCT01121575|65151505|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
23384000|NCT01121575|65151506|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
23384001|NCT01121575|65151507|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
23384002|NCT01121575|65151502|FG000|Overall Study|Unspecified Reasons|8|||
23384003|NCT01121575|65151503|FG001|Overall Study|Unspecified Reasons|6|||
23384004|NCT01121575|65151504|FG002|Overall Study|Unspecified Reasons|7|||
23384005|NCT01121575|65151505|FG003|Overall Study|Unspecified Reasons|5|||
23384006|NCT01121575|65151506|FG004|Overall Study|Unspecified Reasons|13|||
23384007|NCT01121575|65151507|FG005|Overall Study|Unspecified Reasons|10|||
23384008|NCT01121575|65151502|FG000|Overall Study|Death|6|||
23384009|NCT01121575|65151503|FG001|Overall Study|Death|0|||
23384010|NCT01121575|65151504|FG002|Overall Study|Death|0|||
23384011|NCT01121575|65151505|FG003|Overall Study|Death|1|||
23384012|NCT01121575|65151506|FG004|Overall Study|Death|7|||
23384013|NCT01121575|65151507|FG005|Overall Study|Death|1|||
23384014|NCT02280499|65151509|FG000|Overall Study|Death|14|||
23384015|NCT02280499|65151509|FG000|Overall Study|Lost to Follow-up|42|||
23384016|NCT02280499|65151509|FG000|Overall Study|Adverse Event|5|||
23384017|NCT03558672|65151510|FG000|Overall Study|Study Early Termination|10|||
23384018|NCT01186419|65151511|FG000|Overall Study|Withdrawal by Subject|5|||
23384019|NCT01186419|65151512|FG001|Overall Study|Withdrawal by Subject|3|||
23384020|NCT01186419|65151511|FG000|Overall Study|Adverse Event|1|||
23384021|NCT01186419|65151512|FG001|Overall Study|Adverse Event|2|||
23384022|NCT01186419|65151511|FG000|Overall Study|Physician Decision|0|||
23384023|NCT01186419|65151512|FG001|Overall Study|Physician Decision|3|||
23384024|NCT01186419|65151511|FG000|Overall Study|Other|1|||
23384025|NCT01186419|65151512|FG001|Overall Study|Other|1|||
23384026|NCT01666314|65151513|FG000|Overall Study|Adverse Event|3|||
23384027|NCT01666314|65151514|FG001|Overall Study|Adverse Event|13|||
23384028|NCT01666314|65151515|FG002|Overall Study|Adverse Event|7|||
23384029|NCT01666314|65151516|FG003|Overall Study|Adverse Event|7|||
23384030|NCT01666314|65151513|FG000|Overall Study|Progressive Disease|11|||
23384031|NCT01666314|65151514|FG001|Overall Study|Progressive Disease|9|||
23384032|NCT01666314|65151515|FG002|Overall Study|Progressive Disease|19|||
23384033|NCT01666314|65151516|FG003|Overall Study|Progressive Disease|20|||
23384034|NCT01666314|65151513|FG000|Overall Study|Symptomatic Deterioration|1|||
23384035|NCT01666314|65151514|FG001|Overall Study|Symptomatic Deterioration|0|||
23384036|NCT01666314|65151515|FG002|Overall Study|Symptomatic Deterioration|2|||
23384037|NCT01666314|65151516|FG003|Overall Study|Symptomatic Deterioration|0|||
23384038|NCT01666314|65151513|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
23384039|NCT01666314|65151514|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
23384040|NCT01666314|65151515|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
23384041|NCT01666314|65151516|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
23384042|NCT01666314|65151513|FG000|Overall Study|Withdrawal by Subject|1|||
23384043|NCT01666314|65151514|FG001|Overall Study|Withdrawal by Subject|1|||
23384044|NCT01666314|65151515|FG002|Overall Study|Withdrawal by Subject|2|||
23384045|NCT01666314|65151516|FG003|Overall Study|Withdrawal by Subject|3|||
23384046|NCT01666314|65151513|FG000|Overall Study|Reason not Specified|10|||
23290732|NCT01109849|64805212|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
23384047|NCT01666314|65151514|FG001|Overall Study|Reason not Specified|7|||
23290733|NCT01109849|64805213|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
23290734|NCT01109849|64805214|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
23290735|NCT01109849|64805210|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
23290736|NCT01109849|64805211|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
23290737|NCT01109849|64805212|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
23290738|NCT01109849|64805213|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
23290739|NCT01109849|64805214|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
23290740|NCT00880334|64805215|FG000|Randomized Phase|Physician Decision|1|||
23290741|NCT00880334|64805216|FG001|Randomized Phase|Physician Decision|0|||
23290742|NCT00880334|64805215|FG000|Randomized Phase|Withdrawal by Subject|2|||
23290743|NCT00880334|64805216|FG001|Randomized Phase|Withdrawal by Subject|1|||
23290744|NCT00880334|64805215|FG000|Randomized Phase|Inadequate Labs|1|||
23290745|NCT00880334|64805216|FG001|Randomized Phase|Inadequate Labs|1|||
23290746|NCT00880334|64805215|FG000|Randomized Phase|Brain Metastasis|0|||
23290747|NCT00880334|64805216|FG001|Randomized Phase|Brain Metastasis|1|||
23290748|NCT00880334|64805215|FG000|Randomized Phase|Crossover Participants|0|||
23290749|NCT00880334|64805216|FG001|Randomized Phase|Crossover Participants|37|||
23290750|NCT04801420|64805217|FG000|Overall Study|Other|1|||
23290751|NCT04801420|64805218|FG001|Overall Study|Other|2|||
23290752|NCT04801420|64805219|FG002|Overall Study|Other|1|||
23290753|NCT04801420|64805217|FG000|Overall Study|Lost to Follow-up|7|||
23290754|NCT04801420|64805218|FG001|Overall Study|Lost to Follow-up|9|||
23290755|NCT04801420|64805219|FG002|Overall Study|Lost to Follow-up|10|||
23290756|NCT04801420|64805217|FG000|Overall Study|Moved from study area|0|||
23290757|NCT04801420|64805218|FG001|Overall Study|Moved from study area|1|||
23290758|NCT04801420|64805219|FG002|Overall Study|Moved from study area|1|||
23290759|NCT04801420|64805217|FG000|Overall Study|Withdrawal by Subject|5|||
23290760|NCT04801420|64805218|FG001|Overall Study|Withdrawal by Subject|1|||
23493177|NCT01050543|65551376|FG000|Overall Study|Administrative|4|||
23384048|NCT01666314|65151515|FG002|Overall Study|Reason not Specified|5|||
23384049|NCT01666314|65151516|FG003|Overall Study|Reason not Specified|5|||
23384050|NCT01898091|65151517|FG000|Overall Study|Lost to Follow-up|1|||
23384051|NCT01898091|65151518|FG001|Overall Study|Lost to Follow-up|1|||
23384052|NCT01898091|65151517|FG000|Overall Study|Withdrawal by Subject|1|||
23384053|NCT01898091|65151518|FG001|Overall Study|Withdrawal by Subject|5|||
23384054|NCT01479530|65151519|FG000|Overall Study|Adverse Event|5|||
23384055|NCT01479530|65151520|FG001|Overall Study|Adverse Event|6|||
23384056|NCT01479530|65151519|FG000|Overall Study|Lack of Efficacy|0|||
23384057|NCT01479530|65151520|FG001|Overall Study|Lack of Efficacy|1|||
23384058|NCT01479530|65151519|FG000|Overall Study|Protocol Violation|2|||
23384059|NCT01479530|65151520|FG001|Overall Study|Protocol Violation|3|||
23384060|NCT01479530|65151519|FG000|Overall Study|Withdrawal of Consent|3|||
23384061|NCT01479530|65151520|FG001|Overall Study|Withdrawal of Consent|2|||
23384062|NCT00416949|65151521|FG000|Overall Study|Patients refused to participate|5|||
23384063|NCT01108055|65151523|FG000|Overall Study|Ineligible|11|||
23384064|NCT01108055|65151523|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
23384065|NCT01968785|65151524|FG000|Overall Study|Withdrawal by Subject|1|||
23384066|NCT01968785|65151525|FG001|Overall Study|Withdrawal by Subject|0|||
23384067|NCT02547987|65151526|FG000|Overall Study|Withdrawal by Subject|1|||
23384068|NCT02547987|65151526|FG000|Overall Study|Adverse Event|2|||
23384069|NCT03336866|65151527|FG000|Overall Study|Lost to Follow-up|2|||
23384070|NCT03336866|65151528|FG001|Overall Study|Lost to Follow-up|0|||
23384071|NCT03336866|65151529|FG002|Overall Study|Lost to Follow-up|3|||
23384072|NCT03336866|65151527|FG000|Overall Study|Withdrawal by Subject|1|||
23384073|NCT03336866|65151528|FG001|Overall Study|Withdrawal by Subject|1|||
23384074|NCT03336866|65151529|FG002|Overall Study|Withdrawal by Subject|0|||
23384075|NCT03336866|65151527|FG000|Overall Study|Noncompliance with clinic house rules|0|||
23384076|NCT03336866|65151528|FG001|Overall Study|Noncompliance with clinic house rules|0|||
23384077|NCT03336866|65151529|FG002|Overall Study|Noncompliance with clinic house rules|1|||
23384078|NCT00284934|65151530|FG000|Overall Study|Adverse Event|1|||
23384079|NCT00284934|65151531|FG001|Overall Study|Adverse Event|2|||
23384080|NCT00284934|65151530|FG000|Overall Study|Other reasons|3|||
23384081|NCT00284934|65151531|FG001|Overall Study|Other reasons|1|||
23384082|NCT02384460|65151532|FG000|Overall Study|Protocol Violation|0|||
23384083|NCT02384460|65151533|FG001|Overall Study|Protocol Violation|1|||
23290761|NCT04801420|64805219|FG002|Overall Study|Withdrawal by Subject|4|||
23290762|NCT04801420|64805217|FG000|Overall Study|Individual stopping criteria reached|0|||
23290763|NCT04801420|64805218|FG001|Overall Study|Individual stopping criteria reached|1|||
23290764|NCT04801420|64805219|FG002|Overall Study|Individual stopping criteria reached|0|||
23290765|NCT04801420|64805217|FG000|Overall Study|Ongoing in the study|195|||
23290766|NCT04801420|64805218|FG001|Overall Study|Ongoing in the study|195|||
23290767|NCT04801420|64805219|FG002|Overall Study|Ongoing in the study|192|||
23290768|NCT01958060|64805222|FG000|Overall Study|Not treated|2|||
23290769|NCT01958060|64805223|FG001|Overall Study|Not treated|0|||
23290770|NCT01958060|64805224|FG002|Overall Study|Not treated|0|||
23290771|NCT01958060|64805225|FG003|Overall Study|Not treated|0|||
23290772|NCT01958060|64805226|FG004|Overall Study|Not treated|1|||
23290773|NCT01958060|64805227|FG005|Overall Study|Not treated|0|||
23290774|NCT04232540|64805228|FG000|Overall Study|Lost to Follow-up|1|||
23290775|NCT04232540|64805229|FG001|Overall Study|Lost to Follow-up|0|||
23290776|NCT03407729|64805239|FG000|Overall Study|Lost to Follow-up|2|||
23290777|NCT03407729|64805240|FG001|Overall Study|Lost to Follow-up|0|||
23290778|NCT03407729|64805239|FG000|Overall Study|Unable to schedule|0|||
23384084|NCT02384460|65151532|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
23384085|NCT02384460|65151533|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
23384086|NCT02384460|65151532|FG000|Overall Study|Adverse Event|5|||
23384087|NCT02384460|65151533|FG001|Overall Study|Adverse Event|2|||
23384088|NCT02384460|65151532|FG000|Overall Study|Withdrawal by Subject|0|||
23384089|NCT02384460|65151533|FG001|Overall Study|Withdrawal by Subject|3|||
23384090|NCT02384460|65151532|FG000|Overall Study|Elective medical treatment|1|||
23384091|NCT02384460|65151533|FG001|Overall Study|Elective medical treatment|0|||
23384092|NCT02384460|65151532|FG000|Overall Study|Non-compliance|1|||
23384093|NCT02384460|65151533|FG001|Overall Study|Non-compliance|0|||
23384094|NCT00474968|65151534|FG000|Overall Study|Withdrawal by Subject|8|||
23384095|NCT00474968|65151535|FG001|Overall Study|Withdrawal by Subject|7|||
23384096|NCT00474968|65151534|FG000|Overall Study|Protocol Violation|9|||
23384097|NCT00474968|65151535|FG001|Overall Study|Protocol Violation|8|||
23384098|NCT00474968|65151534|FG000|Overall Study|Sample not collected|1|||
23384099|NCT00474968|65151535|FG001|Overall Study|Sample not collected|1|||
23384100|NCT00127933|65151540|FG000|Overall Study|Randomized but not dosed|1|||
23384101|NCT00127933|65151541|FG001|Overall Study|Randomized but not dosed|0|||
23384102|NCT00964678|65151542|FG000|Overall Study|Physician Decision|4|||
23384103|NCT00327171|65151546|FG000|Overall Study|Did not receive study medication|3|||
23384104|NCT00327171|65151547|FG001|Overall Study|Did not receive study medication|0|||
23384105|NCT00327171|65151546|FG000|Overall Study|Adverse Event|23|||
23384106|NCT00327171|65151547|FG001|Overall Study|Adverse Event|23|||
23384107|NCT00327171|65151546|FG000|Overall Study|Disease progression/lack of efficacy|68|||
23384108|NCT00327171|65151547|FG001|Overall Study|Disease progression/lack of efficacy|69|||
23384109|NCT00327171|65151546|FG000|Overall Study|Investigator/participant request|1|||
23384110|NCT00327171|65151547|FG001|Overall Study|Investigator/participant request|8|||
23384111|NCT00327171|65151546|FG000|Overall Study|Clinical progression|12|||
23384112|NCT00327171|65151547|FG001|Overall Study|Clinical progression|8|||
23384113|NCT00327171|65151546|FG000|Overall Study|Undisclosed history of ischemia|0|||
23493178|NCT01050543|65551377|FG001|Overall Study|Administrative|1|||
23493179|NCT01206166|65551379|FG000|Overall Study|No evaluable data|2|||
23290779|NCT03407729|64805240|FG001|Overall Study|Unable to schedule|3|||
23290780|NCT00879684|64805241|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
23290781|NCT00879684|64805242|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
23290782|NCT00879684|64805243|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
23290783|NCT00879684|64805244|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
23493180|NCT01206166|65551380|FG001|Overall Study|No evaluable data|3|||
23290784|NCT00879684|64805245|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
23290785|NCT00879684|64805246|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
23290786|NCT00879684|64805247|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
23493181|NCT03650556|65551383|FG000|Overall Study|Death|2|||
23493182|NCT03650556|65551383|FG000|Overall Study|Withdrawal by Subject|20|||
23384114|NCT00327171|65151547|FG001|Overall Study|Undisclosed history of ischemia|1|||
23384115|NCT00327171|65151546|FG000|Overall Study|Other|1|||
23384116|NCT00327171|65151547|FG001|Overall Study|Other|0|||
23384117|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
23384118|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
23384119|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
23384120|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
23384121|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
23384122|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
23384123|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
23384124|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
23384125|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
23384126|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
23384127|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
23384128|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
23384129|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
23384130|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
23384131|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
23384132|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
23384133|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
23384134|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
23384135|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
23384136|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
23384137|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
23384138|NCT02337946|65151549|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
23384139|NCT02337946|65151550|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
23384140|NCT02337946|65151551|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
23384141|NCT02337946|65151549|FG000|In-between Period|Without Informed Consent|1|||
23384142|NCT02337946|65151550|FG001|In-between Period|Without Informed Consent|0|||
23384143|NCT02337946|65151551|FG002|In-between Period|Without Informed Consent|0|||
23384144|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
23384145|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
23384146|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
23384147|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
23384148|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
23384149|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
23384150|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
23384151|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
23384152|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
23384153|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
23384154|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
23384155|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
23384156|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
23384157|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
23384158|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
23384159|NCT02337946|65151549|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
23384160|NCT02337946|65151550|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
23384161|NCT02337946|65151551|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
23384162|NCT00105508|65151552|FG000|Overall Study|Prephase Dropout|1|||
23384163|NCT00105508|65151553|FG001|Overall Study|Prephase Dropout|0|||
23384164|NCT00105508|65151552|FG000|Overall Study|Adverse Event|16|||
23384165|NCT00105508|65151553|FG001|Overall Study|Adverse Event|19|||
23384166|NCT00105508|65151552|FG000|Overall Study|Insufficient Efficacy|1|||
23384167|NCT00105508|65151553|FG001|Overall Study|Insufficient Efficacy|0|||
23384168|NCT00105508|65151552|FG000|Overall Study|Withdrawal by Subject|10|||
23384169|NCT00105508|65151553|FG001|Overall Study|Withdrawal by Subject|6|||
23384170|NCT00105508|65151552|FG000|Overall Study|Lost to Follow-up|3|||
23384171|NCT00105508|65151553|FG001|Overall Study|Lost to Follow-up|0|||
23384172|NCT00105508|65151552|FG000|Overall Study|Protocol Violation|1|||
23384173|NCT00105508|65151553|FG001|Overall Study|Protocol Violation|2|||
23384174|NCT00105508|65151552|FG000|Overall Study|Other|8|||
23384175|NCT00105508|65151553|FG001|Overall Study|Other|9|||
23384176|NCT01814332|65151554|FG000|Overall Study|Adverse Event|8|||
23384177|NCT01814332|65151555|FG001|Overall Study|Adverse Event|3|||
23384178|NCT01814332|65151554|FG000|Overall Study|Withdrawal by Subject|3|||
23384179|NCT01814332|65151555|FG001|Overall Study|Withdrawal by Subject|8|||
23384180|NCT01814332|65151554|FG000|Overall Study|Protocol Violation|0|||
23384181|NCT01814332|65151555|FG001|Overall Study|Protocol Violation|4|||
23384182|NCT01814332|65151554|FG000|Overall Study|Lost to Follow-up|5|||
23384183|NCT01814332|65151555|FG001|Overall Study|Lost to Follow-up|1|||
23384184|NCT03312907|65151556|FG000|Overall Study|Adverse Event|1|||
23384185|NCT03312907|65151557|FG001|Overall Study|Adverse Event|6|||
23384186|NCT03312907|65151558|FG002|Overall Study|Adverse Event|1|||
23384187|NCT03312907|65151556|FG000|Overall Study|Protocol Violation|2|||
23384188|NCT03312907|65151557|FG001|Overall Study|Protocol Violation|3|||
23384189|NCT03312907|65151558|FG002|Overall Study|Protocol Violation|4|||
23384190|NCT03312907|65151556|FG000|Overall Study|Lost to Follow-up|2|||
23384191|NCT03312907|65151557|FG001|Overall Study|Lost to Follow-up|3|||
23384192|NCT03312907|65151558|FG002|Overall Study|Lost to Follow-up|2|||
23384193|NCT03312907|65151556|FG000|Overall Study|Physician Decision|3|||
23384194|NCT03312907|65151557|FG001|Overall Study|Physician Decision|4|||
23384195|NCT03312907|65151558|FG002|Overall Study|Physician Decision|2|||
23384196|NCT03312907|65151556|FG000|Overall Study|Withdrawal by Subject|9|||
23384197|NCT03312907|65151557|FG001|Overall Study|Withdrawal by Subject|14|||
23384198|NCT03312907|65151558|FG002|Overall Study|Withdrawal by Subject|10|||
23384199|NCT01691482|65151560|FG000|Treatment Period 2|Adverse Event|0|||
23384200|NCT01691482|65151561|FG001|Treatment Period 2|Adverse Event|1|||
23384201|NCT01691482|65151560|FG000|Treatment Period 2|Protocol Violation|1|||
23384202|NCT01691482|65151561|FG001|Treatment Period 2|Protocol Violation|1|||
23384203|NCT04027946|65151564|FG000|Overall Study|Screen failures|3|||
23384204|NCT04149353|65151565|FG000|Overall Study|Study terminated|1|||
23384205|NCT01127061|65151566|FG000|Overall Study|Lost to Follow-up|7|||
23384206|NCT01127061|65151567|FG001|Overall Study|Lost to Follow-up|10|||
23384207|NCT01127061|65151566|FG000|Overall Study|Physician Decision|3|||
23384208|NCT01127061|65151567|FG001|Overall Study|Physician Decision|3|||
23384209|NCT04389671|65151568|FG000|Overall Study|Death|7|||
23384210|NCT01750281|65151569|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
23384211|NCT01750281|65151570|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
23384212|NCT01750281|65151571|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
23384213|NCT01750281|65151569|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
23384214|NCT01750281|65151570|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
23384215|NCT01750281|65151571|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
23384216|NCT01750281|65151569|FG000|Overall Study|Did not receive treatment|0|||
23384217|NCT01750281|65151570|FG001|Overall Study|Did not receive treatment|1|||
23384218|NCT01750281|65151571|FG002|Overall Study|Did not receive treatment|0|||
23384219|NCT01281306|65151572|FG000|Overall Study|Lack of Efficacy|0|||
23384220|NCT01281306|65151573|FG001|Overall Study|Lack of Efficacy|1|||
23384221|NCT01281306|65151574|FG002|Overall Study|Lack of Efficacy|3|||
23384222|NCT01281306|65151575|FG003|Overall Study|Lack of Efficacy|0|||
23384223|NCT01281306|65151576|FG004|Overall Study|Lack of Efficacy|2|||
23384224|NCT01281306|65151577|FG005|Overall Study|Lack of Efficacy|0|||
23384225|NCT01281306|65151578|FG006|Overall Study|Lack of Efficacy|1|||
23384226|NCT01281306|65151572|FG000|Overall Study|Withdrawal by Subject|1|||
23493183|NCT03650556|65551383|FG000|Overall Study|Physician Decision|2|||
23384227|NCT01281306|65151573|FG001|Overall Study|Withdrawal by Subject|0|||
23384228|NCT01281306|65151574|FG002|Overall Study|Withdrawal by Subject|2|||
23384229|NCT01281306|65151575|FG003|Overall Study|Withdrawal by Subject|4|||
23384230|NCT01281306|65151576|FG004|Overall Study|Withdrawal by Subject|1|||
23384231|NCT01281306|65151577|FG005|Overall Study|Withdrawal by Subject|3|||
23384232|NCT01281306|65151578|FG006|Overall Study|Withdrawal by Subject|1|||
23384233|NCT01281306|65151572|FG000|Overall Study|Protocol deviation|0|||
23384234|NCT01281306|65151573|FG001|Overall Study|Protocol deviation|1|||
23384235|NCT01281306|65151574|FG002|Overall Study|Protocol deviation|1|||
23384236|NCT01281306|65151575|FG003|Overall Study|Protocol deviation|1|||
23384237|NCT01281306|65151576|FG004|Overall Study|Protocol deviation|1|||
23384238|NCT01281306|65151577|FG005|Overall Study|Protocol deviation|0|||
23384239|NCT01281306|65151578|FG006|Overall Study|Protocol deviation|0|||
23290787|NCT00879684|64805241|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
23290788|NCT00879684|64805242|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
23290789|NCT00879684|64805243|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
23290790|NCT00879684|64805244|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
23290791|NCT00879684|64805245|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
23290792|NCT00879684|64805246|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
23290793|NCT00879684|64805247|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
23290794|NCT00879684|64805241|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
23384240|NCT01281306|65151572|FG000|Overall Study|Condition no longer requires study drug|1|||
23384241|NCT01281306|65151573|FG001|Overall Study|Condition no longer requires study drug|0|||
23384242|NCT01281306|65151574|FG002|Overall Study|Condition no longer requires study drug|0|||
23384243|NCT01281306|65151575|FG003|Overall Study|Condition no longer requires study drug|0|||
23384244|NCT01281306|65151576|FG004|Overall Study|Condition no longer requires study drug|0|||
23384245|NCT01281306|65151577|FG005|Overall Study|Condition no longer requires study drug|1|||
23384246|NCT01281306|65151578|FG006|Overall Study|Condition no longer requires study drug|1|||
23384247|NCT01281306|65151572|FG000|Overall Study|Lost to Follow-up|1|||
23384248|NCT01281306|65151573|FG001|Overall Study|Lost to Follow-up|0|||
23290795|NCT00879684|64805242|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
23290796|NCT00879684|64805243|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
23290797|NCT00879684|64805244|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
23290798|NCT00879684|64805245|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
23290799|NCT00879684|64805246|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
23290800|NCT00879684|64805247|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
23290801|NCT00879684|64805241|FG000|Stage 1: Dose Escalation|Death|0|||
23290802|NCT00879684|64805242|FG001|Stage 1: Dose Escalation|Death|0|||
23290803|NCT00879684|64805243|FG002|Stage 1: Dose Escalation|Death|1|||
23290804|NCT00879684|64805244|FG003|Stage 1: Dose Escalation|Death|0|||
23290805|NCT00879684|64805245|FG004|Stage 1: Dose Escalation|Death|0|||
23290806|NCT00879684|64805246|FG005|Stage 1: Dose Escalation|Death|0|||
23290807|NCT00879684|64805247|FG006|Stage 1: Dose Escalation|Death|0|||
23290808|NCT00879684|64805241|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23290809|NCT00879684|64805242|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23290810|NCT00879684|64805243|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23290811|NCT00879684|64805244|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23290812|NCT00879684|64805245|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23290813|NCT00879684|64805246|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
23290814|NCT00879684|64805247|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
23290815|NCT00879684|64805241|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
23290816|NCT00879684|64805242|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
23290817|NCT00879684|64805243|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
23290818|NCT00879684|64805244|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
23290819|NCT00879684|64805245|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
23290820|NCT00879684|64805246|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
23290821|NCT00879684|64805247|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
23290822|NCT00879684|64805241|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23290823|NCT00879684|64805242|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23290824|NCT00879684|64805243|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23384249|NCT01281306|65151574|FG002|Overall Study|Lost to Follow-up|0|||
23290825|NCT00879684|64805244|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23290826|NCT00879684|64805245|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23290827|NCT00879684|64805246|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
23290828|NCT00879684|64805247|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
23290829|NCT02786927|64805257|FG000|Overall Study|Adverse Event|1|||
23290830|NCT02786927|64805257|FG000|Overall Study|Protocol Violation|4|||
23290831|NCT01055834|64805258|FG000|Treatment Period I|Adverse Event|1|||
23290832|NCT01055834|64805259|FG001|Treatment Period I|Adverse Event|0|||
23290833|NCT02697617|64805260|FG000|Overall Study|Withdrawal by Subject|0|||
23290834|NCT02697617|64805261|FG001|Overall Study|Withdrawal by Subject|2|||
23290835|NCT02697617|64805260|FG000|Overall Study|Pregnancy|1|||
23290836|NCT02697617|64805261|FG001|Overall Study|Pregnancy|0|||
23290837|NCT00820599|64805262|FG000|Overall Study|Death|129|||
23290838|NCT00820599|64805262|FG000|Overall Study|Withdrawal by Subject|2|||
23290839|NCT01175473|64805263|FG000|Overall Study|Adverse Event|2|||
23290840|NCT01175473|64805264|FG001|Overall Study|Adverse Event|2|||
23290841|NCT01390948|64805265|FG000|Overall Study|End of Study|1|||
23290842|NCT01390948|64805266|FG001|Overall Study|End of Study|0|||
23290843|NCT01390948|64805267|FG002|Overall Study|End of Study|0|||
23290844|NCT01390948|64805265|FG000|Overall Study|Withdrew consent|2|||
23290845|NCT01390948|64805266|FG001|Overall Study|Withdrew consent|2|||
23290846|NCT01390948|64805267|FG002|Overall Study|Withdrew consent|0|||
23290847|NCT01390948|64805265|FG000|Overall Study|Progressive Disease|2|||
23290848|NCT01390948|64805266|FG001|Overall Study|Progressive Disease|5|||
23290849|NCT01390948|64805267|FG002|Overall Study|Progressive Disease|0|||
23290850|NCT01390948|64805265|FG000|Overall Study|Death during follow-up|10|||
23290851|NCT01390948|64805266|FG001|Overall Study|Death during follow-up|11|||
23290852|NCT01390948|64805267|FG002|Overall Study|Death during follow-up|1|||
23290853|NCT01579006|64805271|FG000|Overall Study|Lack of Efficacy|10|||
23290854|NCT01579006|64805271|FG000|Overall Study|Adverse Event|13|||
23290855|NCT01579006|64805271|FG000|Overall Study|Withdrawal by Subject|5|||
23290856|NCT01579006|64805271|FG000|Overall Study|Non-compliance|3|||
23290857|NCT01579006|64805271|FG000|Overall Study|Due to participant's health fund|1|||
23290858|NCT01579006|64805271|FG000|Overall Study|Scheduled surgery|1|||
23290859|NCT01622660|64805274|FG000|Overall Study|Adverse Event|1|||
23290860|NCT02940522|64805275|FG000|Overall Study|Lost to Follow-up|1|||
23290861|NCT02940522|64805276|FG001|Overall Study|Lost to Follow-up|2|||
23290862|NCT02940522|64805275|FG000|Overall Study|Withdrawal by Subject|1|||
23290863|NCT02940522|64805276|FG001|Overall Study|Withdrawal by Subject|0|||
23290864|NCT03108820|64805277|FG000|Overall Study|Lost to Follow-up|30|||
23290865|NCT03108820|64805278|FG001|Overall Study|Lost to Follow-up|28|||
23290866|NCT03108820|64805277|FG000|Overall Study|Withdrawal by Subject|32|||
23290867|NCT03108820|64805278|FG001|Overall Study|Withdrawal by Subject|24|||
23290868|NCT03108820|64805277|FG000|Overall Study|Death|6|||
23290869|NCT03108820|64805278|FG001|Overall Study|Death|11|||
23290870|NCT01802216|64805288|FG000|4 Month Visit|Participant did not show to visit|3|||
23290871|NCT01802216|64805289|FG001|4 Month Visit|Participant did not show to visit|4|||
23290872|NCT01802216|64805288|FG000|8 Month Visit|Participant did not show to visit|3|||
23290873|NCT01802216|64805289|FG001|8 Month Visit|Participant did not show to visit|5|||
23290874|NCT01802216|64805288|FG000|12 Month Visit|Participant did not show to visit|3|||
23290875|NCT01802216|64805289|FG001|12 Month Visit|Participant did not show to visit|4|||
23290876|NCT01501110|64805290|FG000|Overall Study|Death|0|||
23290877|NCT01501110|64805291|FG001|Overall Study|Death|1|||
23290878|NCT01214239|64805294|FG000|Overall Study|Adverse Event|3|||
23290879|NCT01214239|64805295|FG001|Overall Study|Adverse Event|4|||
23290880|NCT01214239|64805294|FG000|Overall Study|Protocol Violation|2|||
23290881|NCT01214239|64805295|FG001|Overall Study|Protocol Violation|1|||
23290882|NCT01214239|64805294|FG000|Overall Study|Lost to Follow-up|1|||
23290883|NCT01214239|64805295|FG001|Overall Study|Lost to Follow-up|1|||
23290884|NCT01214239|64805294|FG000|Overall Study|Withdrawal by Subject|4|||
23290885|NCT01214239|64805295|FG001|Overall Study|Withdrawal by Subject|9|||
23290886|NCT01214239|64805294|FG000|Overall Study|Lack of Efficacy|1|||
23290887|NCT01214239|64805295|FG001|Overall Study|Lack of Efficacy|2|||
23290888|NCT01214239|64805294|FG000|Overall Study|patient's private reason|1|||
23290889|NCT01214239|64805295|FG001|Overall Study|patient's private reason|1|||
23290890|NCT03448692|64805296|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
23290891|NCT03448692|64805297|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
23290892|NCT03448692|64805296|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
23290893|NCT03448692|64805297|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
23290894|NCT03448692|64805296|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
23290895|NCT03448692|64805297|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
23290896|NCT03448692|64805296|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
23290897|NCT03448692|64805297|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
23290898|NCT03448692|64805296|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
23290899|NCT03448692|64805297|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
23384250|NCT01281306|65151575|FG003|Overall Study|Lost to Follow-up|2|||
23493184|NCT03650556|65551383|FG000|Overall Study|Lost to Follow-up|8|||
23290900|NCT02832167|64805298|FG000|Treatment Period 1|Disease progression|90|||
23290901|NCT02832167|64805298|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
23290902|NCT02832167|64805298|FG000|Treatment Period 1|Death|2|||
23290903|NCT02832167|64805298|FG000|Treatment Period 1|Study Drug Toxicity|6|||
23290904|NCT02832167|64805298|FG000|Treatment Period 1|Participant request to discontinue|9|||
23290905|NCT02832167|64805298|FG000|Treatment Period 1|No longer meet study criteria|1|||
23290906|NCT02832167|64805298|FG000|Treatment Period 1|Participant withdrew consent|3|||
23290907|NCT02832167|64805298|FG000|Treatment Period 1|Other reasons|6|||
23290908|NCT02832167|64805298|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
23290909|NCT02832167|64805298|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
23384251|NCT01281306|65151576|FG004|Overall Study|Lost to Follow-up|0|||
23384252|NCT01281306|65151577|FG005|Overall Study|Lost to Follow-up|0|||
23384253|NCT01281306|65151578|FG006|Overall Study|Lost to Follow-up|1|||
23384254|NCT01281306|65151572|FG000|Overall Study|Death|1|||
23384255|NCT01281306|65151573|FG001|Overall Study|Death|0|||
23384256|NCT01281306|65151574|FG002|Overall Study|Death|0|||
23384257|NCT01281306|65151575|FG003|Overall Study|Death|0|||
23384258|NCT01281306|65151576|FG004|Overall Study|Death|0|||
23384259|NCT01281306|65151577|FG005|Overall Study|Death|0|||
23384260|NCT01281306|65151578|FG006|Overall Study|Death|0|||
23384261|NCT01281306|65151572|FG000|Overall Study|Adverse Event|3|||
23384262|NCT01281306|65151573|FG001|Overall Study|Adverse Event|2|||
23384263|NCT01281306|65151574|FG002|Overall Study|Adverse Event|2|||
23384264|NCT01281306|65151575|FG003|Overall Study|Adverse Event|3|||
23384265|NCT01281306|65151576|FG004|Overall Study|Adverse Event|5|||
23384266|NCT01281306|65151577|FG005|Overall Study|Adverse Event|3|||
23384267|NCT01281306|65151578|FG006|Overall Study|Adverse Event|3|||
23384268|NCT01281306|65151572|FG000|Overall Study|Randomized in error|1|||
23384269|NCT01281306|65151573|FG001|Overall Study|Randomized in error|0|||
23493185|NCT03650556|65551383|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
23290910|NCT02832167|64805298|FG000|Transition From Period 1 to Period 2|Death|2|||
23384270|NCT01281306|65151574|FG002|Overall Study|Randomized in error|0|||
23384271|NCT01281306|65151575|FG003|Overall Study|Randomized in error|1|||
23384272|NCT01281306|65151576|FG004|Overall Study|Randomized in error|0|||
23384273|NCT01281306|65151577|FG005|Overall Study|Randomized in error|0|||
23384274|NCT01281306|65151578|FG006|Overall Study|Randomized in error|0|||
23384275|NCT02939781|65151583|FG000|Overall Study|Protocol Violation|8|||
23384276|NCT02939781|65151583|FG000|Overall Study|Withdrawal by Subject|1|||
23384277|NCT00191152|65151589|FG000|Initial Treatment|Adverse Event|43|||
23384278|NCT00191152|65151590|FG001|Initial Treatment|Adverse Event|67|||
23384279|NCT00191152|65151589|FG000|Initial Treatment|Physician Decision|40|||
23384280|NCT00191152|65151590|FG001|Initial Treatment|Physician Decision|31|||
23384281|NCT00191152|65151589|FG000|Initial Treatment|Withdrawal by Subject|40|||
23384282|NCT00191152|65151590|FG001|Initial Treatment|Withdrawal by Subject|28|||
23384283|NCT00191152|65151589|FG000|Initial Treatment|Lost to Follow-up|0|||
23384284|NCT00191152|65151590|FG001|Initial Treatment|Lost to Follow-up|6|||
23384285|NCT00191152|65151589|FG000|Initial Treatment|Other|18|||
23384286|NCT00191152|65151590|FG001|Initial Treatment|Other|21|||
23384287|NCT00191152|65151589|FG000|Crossover Treatment|Adverse Event|8|||
23384288|NCT00191152|65151590|FG001|Crossover Treatment|Adverse Event|8|||
23384289|NCT00191152|65151589|FG000|Crossover Treatment|Physician Decision|7|||
23384290|NCT00191152|65151590|FG001|Crossover Treatment|Physician Decision|7|||
23384291|NCT00191152|65151589|FG000|Crossover Treatment|Withdrawal by Subject|6|||
23384292|NCT00191152|65151590|FG001|Crossover Treatment|Withdrawal by Subject|9|||
23384293|NCT00191152|65151589|FG000|Crossover Treatment|Lost to Follow-up|2|||
23384294|NCT00191152|65151590|FG001|Crossover Treatment|Lost to Follow-up|1|||
23384295|NCT00191152|65151589|FG000|Crossover Treatment|Other|4|||
23384296|NCT00191152|65151590|FG001|Crossover Treatment|Other|3|||
23384297|NCT01946802|65151591|FG000|Overall Study|Death|1|||
23384298|NCT01946802|65151591|FG000|Overall Study|Withdrawal by Subject|2|||
23384299|NCT01946802|65151591|FG000|Overall Study|Combined septic shock|1|||
23384300|NCT01946802|65151591|FG000|Overall Study|Protocol Violation|1|||
23384301|NCT02989389|65151593|FG000|Period 1|Lost to Follow-up|0|||
23384302|NCT02989389|65151594|FG001|Period 1|Lost to Follow-up|1|||
23384303|NCT02989389|65151595|FG002|Period 1|Lost to Follow-up|0|||
23384304|NCT02989389|65151596|FG003|Period 1|Lost to Follow-up|0|||
23384305|NCT02989389|65151597|FG004|Period 1|Lost to Follow-up|0|||
23384306|NCT02989389|65151598|FG005|Period 1|Lost to Follow-up|0|||
23384307|NCT02989389|65151599|FG006|Period 1|Lost to Follow-up|0|||
23290911|NCT02832167|64805298|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
23290912|NCT02832167|64805298|FG000|Treatment Period 2|Disease progression|69|||
23290913|NCT02832167|64805298|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
23290914|NCT02832167|64805298|FG000|Treatment Period 2|Maximum clinical benefit|1|||
23290915|NCT02832167|64805298|FG000|Treatment Period 2|Study Drug Toxicity|5|||
23290916|NCT02832167|64805298|FG000|Treatment Period 2|Participant request to discontinue|2|||
23290917|NCT02832167|64805298|FG000|Treatment Period 2|Participant withdrew consent|3|||
23290918|NCT02832167|64805298|FG000|Treatment Period 2|Other reasons|3|||
23290919|NCT01853176|64805301|FG000|Overall Study|Study terminated|4|||
23290920|NCT01853176|64805302|FG001|Overall Study|Study terminated|0|||
23290921|NCT00609154|64805303|FG000|Overall Study|Protocol Violation|1|||
23290922|NCT00609154|64805304|FG001|Overall Study|Protocol Violation|2|||
23290923|NCT00609154|64805303|FG000|Overall Study|Unable to establish IV access|0|||
23290924|NCT00609154|64805304|FG001|Overall Study|Unable to establish IV access|4|||
23290925|NCT00609154|64805303|FG000|Overall Study|Adverse Event|0|||
23290926|NCT00609154|64805304|FG001|Overall Study|Adverse Event|2|||
23290927|NCT02654015|64805305|FG000|Overall Study|Death|12|||
23290928|NCT02654015|64805305|FG000|Overall Study|Lost to Follow-up|3|||
23290929|NCT02169791|64805310|FG000|Overall Study|Death|6|||
23290930|NCT02169791|64805310|FG000|Overall Study|patient withdrew consent|1|||
23290931|NCT01863433|64805311|FG000|Overall Study|Protocol Violation|1|||
23290932|NCT01719562|64805312|FG000|Overall Study|Lost to Follow-up|1|||
23290933|NCT01719562|64805313|FG001|Overall Study|Lost to Follow-up|0|||
23290934|NCT01719562|64805312|FG000|Overall Study|Death|1|||
23290935|NCT01719562|64805313|FG001|Overall Study|Death|0|||
23290936|NCT01719562|64805312|FG000|Overall Study|New cancer diagnosis|1|||
23290937|NCT01719562|64805313|FG001|Overall Study|New cancer diagnosis|0|||
23290938|NCT00942734|64805314|FG000|Overall Study|Adverse Event|2|||
23384308|NCT02989389|65151600|FG007|Period 1|Lost to Follow-up|0|||
23384309|NCT02989389|65151601|FG008|Period 1|Lost to Follow-up|0|||
23384310|NCT02989389|65151602|FG009|Period 1|Lost to Follow-up|0|||
23290939|NCT00942734|64805314|FG000|Overall Study|Protocol Violation|3|||
23290940|NCT00942734|64805314|FG000|Overall Study|Disease Progression|2|||
23290941|NCT00942734|64805314|FG000|Overall Study|Physician Decision|1|||
23290942|NCT00676650|64805315|FG000|Overall Study|Death|45|||
23290943|NCT00676650|64805316|FG001|Overall Study|Death|14|||
23384311|NCT02989389|65151593|FG000|Period 1|Physician Decision|0|||
23384312|NCT02989389|65151594|FG001|Period 1|Physician Decision|0|||
23384313|NCT02989389|65151595|FG002|Period 1|Physician Decision|0|||
23384314|NCT02989389|65151596|FG003|Period 1|Physician Decision|0|||
23384315|NCT02989389|65151597|FG004|Period 1|Physician Decision|0|||
23384316|NCT02989389|65151598|FG005|Period 1|Physician Decision|0|||
23384317|NCT02989389|65151599|FG006|Period 1|Physician Decision|0|||
23384318|NCT02989389|65151600|FG007|Period 1|Physician Decision|0|||
23384319|NCT02989389|65151601|FG008|Period 1|Physician Decision|1|||
23384320|NCT02989389|65151602|FG009|Period 1|Physician Decision|0|||
23384321|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
23384322|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
23290944|NCT00676650|64805315|FG000|Overall Study|Adverse Event|159|||
23290945|NCT00676650|64805316|FG001|Overall Study|Adverse Event|21|||
23290946|NCT00676650|64805315|FG000|Overall Study|Global deterioration of health status|66|||
23290947|NCT00676650|64805316|FG001|Overall Study|Global deterioration of health status|31|||
23290948|NCT00676650|64805315|FG000|Overall Study|Lost to Follow-up|0|||
23290949|NCT00676650|64805316|FG001|Overall Study|Lost to Follow-up|1|||
23290950|NCT00676650|64805315|FG000|Overall Study|Objective progression or relapse|189|||
23290951|NCT00676650|64805316|FG001|Overall Study|Objective progression or relapse|140|||
23290952|NCT00676650|64805315|FG000|Overall Study|Other|14|||
23290953|NCT00676650|64805316|FG001|Overall Study|Other|10|||
23290954|NCT00676650|64805315|FG000|Overall Study|Protocol Violation|3|||
23290955|NCT00676650|64805316|FG001|Overall Study|Protocol Violation|1|||
23290956|NCT00676650|64805315|FG000|Overall Study|Study terminated by sponsor|57|||
23290957|NCT00676650|64805316|FG001|Overall Study|Study terminated by sponsor|43|||
23290958|NCT00676650|64805315|FG000|Overall Study|Withdrawal by Subject|48|||
23384323|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
23290959|NCT00676650|64805316|FG001|Overall Study|Withdrawal by Subject|24|||
23290960|NCT00676650|64805315|FG000|Overall Study|Randomized but not treated|3|||
23290961|NCT00676650|64805316|FG001|Overall Study|Randomized but not treated|4|||
23290962|NCT03732833|64805322|FG000|Overall Study|Adverse Event|0|||
23290963|NCT03732833|64805323|FG001|Overall Study|Adverse Event|3|||
23290964|NCT03732833|64805324|FG002|Overall Study|Adverse Event|1|||
23290965|NCT03732833|64805322|FG000|Overall Study|Withdrawal by Subject|11|||
23290966|NCT03732833|64805323|FG001|Overall Study|Withdrawal by Subject|13|||
23290967|NCT03732833|64805324|FG002|Overall Study|Withdrawal by Subject|8|||
23290968|NCT03732833|64805322|FG000|Overall Study|Lost to Follow-up|3|||
23290969|NCT03732833|64805323|FG001|Overall Study|Lost to Follow-up|5|||
23290970|NCT03732833|64805324|FG002|Overall Study|Lost to Follow-up|4|||
23290971|NCT03732833|64805322|FG000|Overall Study|Pregnancy|0|||
23290972|NCT03732833|64805323|FG001|Overall Study|Pregnancy|2|||
23290973|NCT03732833|64805324|FG002|Overall Study|Pregnancy|0|||
23290974|NCT03732833|64805322|FG000|Overall Study|Physician Decision|2|||
23290975|NCT03732833|64805323|FG001|Overall Study|Physician Decision|3|||
23290976|NCT03732833|64805324|FG002|Overall Study|Physician Decision|1|||
23290977|NCT03732833|64805322|FG000|Overall Study|Covid-19 related and other reasons|2|||
23290978|NCT03732833|64805323|FG001|Overall Study|Covid-19 related and other reasons|7|||
23290979|NCT03732833|64805324|FG002|Overall Study|Covid-19 related and other reasons|3|||
23290980|NCT01952691|64805328|FG000|Overall Study|Lost to Follow-up|2|||
23290981|NCT04729101|64805329|FG000|Overall Study|Adverse Event|1|||
23290982|NCT04729101|64805330|FG001|Overall Study|Adverse Event|0|||
23290983|NCT04729101|64805329|FG000|Overall Study|Physician Decision|1|||
23290984|NCT04729101|64805330|FG001|Overall Study|Physician Decision|0|||
23290985|NCT04729101|64805329|FG000|Overall Study|Withdrawal by Subject|1|||
23290986|NCT04729101|64805330|FG001|Overall Study|Withdrawal by Subject|0|||
23290987|NCT00716625|64805332|FG000|Overall Study|Safety was not Assessable|1|||
23290988|NCT01520987|64805333|FG000|Overall Study|Withdrawal by Subject|1|||
23290989|NCT01520987|64805334|FG001|Overall Study|Withdrawal by Subject|0|||
23290990|NCT01520987|64805335|FG002|Overall Study|Withdrawal by Subject|0|||
23290991|NCT01520987|64805336|FG003|Overall Study|Withdrawal by Subject|0|||
23290992|NCT01520987|64805337|FG004|Overall Study|Withdrawal by Subject|0|||
23290993|NCT01520987|64805338|FG005|Overall Study|Withdrawal by Subject|1|||
23290994|NCT01520987|64805339|FG006|Overall Study|Withdrawal by Subject|0|||
23290995|NCT01520987|64805340|FG007|Overall Study|Withdrawal by Subject|0|||
23290996|NCT01876368|64805352|FG000|Overall Study|Adverse Event|2|||
23290997|NCT01876368|64805353|FG001|Overall Study|Adverse Event|5|||
23290998|NCT01876368|64805352|FG000|Overall Study|Lack of Efficacy|1|||
23290999|NCT01876368|64805353|FG001|Overall Study|Lack of Efficacy|0|||
23291000|NCT01876368|64805352|FG000|Overall Study|Lost to Follow-up|0|||
23291001|NCT01876368|64805353|FG001|Overall Study|Lost to Follow-up|1|||
23384324|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
23384325|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
23384326|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
23384327|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
23384328|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
23384329|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
23384330|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
23384331|NCT00973973|65151603|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
23384332|NCT00973973|65151604|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
23384333|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
23384334|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
23384335|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
23384336|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
23384337|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
23384338|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
23384339|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
23384340|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
23384341|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
23384342|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
23384343|NCT00973973|65151603|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
23384344|NCT00973973|65151604|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
23384345|NCT02460380|65151605|FG000|Overall Study|Withdrawal by Subject|10|||
23384346|NCT02460380|65151606|FG001|Overall Study|Withdrawal by Subject|5|||
23384347|NCT01018953|65151607|FG000|Overall Study|Adverse Event|2|||
23384348|NCT01018953|65151607|FG000|Overall Study|Withdrawal by Subject|1|||
23384349|NCT01018953|65151607|FG000|Overall Study|Study termination by sponsor|5|||
23384350|NCT03718000|65151608|FG000|Overall Study|Relocation|2|||
23384351|NCT03718000|65151609|FG001|Overall Study|Relocation|4|||
23384352|NCT03718000|65151608|FG000|Overall Study|Pregnancy|0|||
23384353|NCT03718000|65151609|FG001|Overall Study|Pregnancy|1|||
23384354|NCT01646216|65151612|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
23384355|NCT01646216|65151613|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
23384356|NCT01646216|65151612|FG000|Overall Study|Did not complete training|0|||
23384357|NCT01646216|65151613|FG001|Overall Study|Did not complete training|2|||
23384358|NCT01646216|65151612|FG000|Overall Study|Investigator decision|1|||
23384359|NCT01646216|65151613|FG001|Overall Study|Investigator decision|1|||
23384360|NCT03418675|65151614|FG000|Overall Study|Lost to Follow-up|13|||
23384361|NCT03418675|65151615|FG001|Overall Study|Lost to Follow-up|10|||
23384362|NCT03418675|65151614|FG000|Overall Study|Adverse Event|2|||
23384363|NCT03418675|65151615|FG001|Overall Study|Adverse Event|0|||
23384364|NCT01016015|65151616|FG000|Overall Study|Not Treated|3|||
23384365|NCT01016015|65151616|FG000|Overall Study|Withdrawal by Subject|1|||
23384366|NCT01016015|65151616|FG000|Overall Study|Adverse Event|15|||
23384367|NCT01684033|65151618|FG000|Period 1, First 30 Days|Adverse Event|1|||
23384368|NCT01684033|65151619|FG001|Period 1, First 30 Days|Adverse Event|1|||
23384369|NCT01684033|65151618|FG000|Period 1, First 30 Days|Noncompliance|1|||
23384370|NCT01684033|65151619|FG001|Period 1, First 30 Days|Noncompliance|0|||
23384371|NCT01684033|65151618|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
23384372|NCT01684033|65151619|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
23384373|NCT01684033|65151618|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
23384374|NCT01684033|65151619|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
23384375|NCT01684033|65151618|FG000|Period 2, Second 30 Days|Adverse Event|1|||
23384376|NCT01684033|65151619|FG001|Period 2, Second 30 Days|Adverse Event|0|||
23384377|NCT00927082|65151620|FG000|Overall Study|Lost to Follow-up|9|||
23384378|NCT00927082|65151621|FG001|Overall Study|Lost to Follow-up|8|||
23384379|NCT00927082|65151622|FG002|Overall Study|Lost to Follow-up|12|||
23384380|NCT00927082|65151623|FG003|Overall Study|Lost to Follow-up|16|||
23384381|NCT00927082|65151620|FG000|Overall Study|Withdrawal by Subject|3|||
23384382|NCT00927082|65151621|FG001|Overall Study|Withdrawal by Subject|2|||
23384383|NCT00927082|65151622|FG002|Overall Study|Withdrawal by Subject|7|||
23384384|NCT00927082|65151623|FG003|Overall Study|Withdrawal by Subject|2|||
23384385|NCT00927082|65151620|FG000|Overall Study|Death|0|||
23384386|NCT00927082|65151621|FG001|Overall Study|Death|0|||
23384387|NCT00927082|65151622|FG002|Overall Study|Death|1|||
23384388|NCT00927082|65151623|FG003|Overall Study|Death|0|||
23384389|NCT00927082|65151620|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
23384390|NCT00927082|65151621|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
23384391|NCT00927082|65151622|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
23384392|NCT00927082|65151623|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
23384393|NCT02318277|65151624|FG000|Overall Study|Physician Decision|0|||
23384394|NCT02318277|65151625|FG001|Overall Study|Physician Decision|0|||
23291002|NCT01876368|64805352|FG000|Overall Study|Non-compliance with study treatment|0|||
23291003|NCT01876368|64805353|FG001|Overall Study|Non-compliance with study treatment|1|||
23291004|NCT01876368|64805352|FG000|Overall Study|Physician Decision|0|||
23291005|NCT01876368|64805353|FG001|Overall Study|Physician Decision|2|||
23291006|NCT01876368|64805352|FG000|Overall Study|Protocol deviation|3|||
23291007|NCT01876368|64805353|FG001|Overall Study|Protocol deviation|3|||
23291008|NCT01876368|64805352|FG000|Overall Study|Subject/guardian decision|3|||
23291009|NCT01876368|64805353|FG001|Overall Study|Subject/guardian decision|1|||
23291010|NCT00668395|64805355|FG000|Overall Study|Withdrawal by Subject|4|||
23291011|NCT00668395|64805356|FG001|Overall Study|Withdrawal by Subject|4|||
23291012|NCT00668395|64805357|FG002|Overall Study|Withdrawal by Subject|1|||
23291013|NCT00668395|64805355|FG000|Overall Study|Adverse Event|1|||
23291014|NCT00668395|64805356|FG001|Overall Study|Adverse Event|1|||
23291015|NCT00668395|64805357|FG002|Overall Study|Adverse Event|0|||
23291016|NCT00668395|64805355|FG000|Overall Study|Physician Decision|1|||
23291017|NCT00668395|64805356|FG001|Overall Study|Physician Decision|1|||
23291018|NCT00668395|64805357|FG002|Overall Study|Physician Decision|0|||
23291019|NCT01664039|64805358|FG000|Overall Study|Adverse Event|3|||
23291020|NCT01664039|64805359|FG001|Overall Study|Adverse Event|4|||
23291021|NCT01664039|64805358|FG000|Overall Study|Lost to Follow-up|1|||
23291022|NCT01664039|64805359|FG001|Overall Study|Lost to Follow-up|1|||
23291023|NCT01664039|64805358|FG000|Overall Study|Withdrawal by Subject|1|||
23291024|NCT01664039|64805359|FG001|Overall Study|Withdrawal by Subject|3|||
23291025|NCT01664039|64805358|FG000|Overall Study|Noncompliance|1|||
23291026|NCT01664039|64805359|FG001|Overall Study|Noncompliance|1|||
23291027|NCT02726386|64808188|FG000|Overall Study|Adverse Event|17|||
23291028|NCT02726386|64808189|FG001|Overall Study|Adverse Event|20|||
23291029|NCT02726386|64808188|FG000|Overall Study|Withdrawal by Subject|14|||
23291030|NCT02726386|64808189|FG001|Overall Study|Withdrawal by Subject|28|||
23291031|NCT02726386|64808188|FG000|Overall Study|Other reasons|7|||
23291032|NCT02726386|64808189|FG001|Overall Study|Other reasons|8|||
23291033|NCT05766787|64808190|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
23291034|NCT05766787|64808191|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
23291035|NCT05766787|64808190|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
23291036|NCT05766787|64808191|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
23291037|NCT05766787|64808190|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
23291038|NCT05766787|64808191|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
23291039|NCT02578641|64808197|FG000|Overall Study|Adverse Event|5|||
23384395|NCT02318277|65151626|FG002|Overall Study|Physician Decision|0|||
23384396|NCT02318277|65151627|FG003|Overall Study|Physician Decision|0|||
23384397|NCT02318277|65151628|FG004|Overall Study|Physician Decision|0|||
23384398|NCT02318277|65151629|FG005|Overall Study|Physician Decision|0|||
23384399|NCT02318277|65151630|FG006|Overall Study|Physician Decision|0|||
23384400|NCT02318277|65151631|FG007|Overall Study|Physician Decision|1|||
23384401|NCT02318277|65151624|FG000|Overall Study|Other|0|||
23384402|NCT02318277|65151625|FG001|Overall Study|Other|0|||
23384403|NCT02318277|65151626|FG002|Overall Study|Other|0|||
23384404|NCT02318277|65151627|FG003|Overall Study|Other|0|||
23384405|NCT02318277|65151628|FG004|Overall Study|Other|0|||
23384406|NCT02318277|65151629|FG005|Overall Study|Other|0|||
23384407|NCT02318277|65151630|FG006|Overall Study|Other|1|||
23384408|NCT02318277|65151631|FG007|Overall Study|Other|0|||
23384409|NCT02318277|65151624|FG000|Overall Study|Withdrawal by Subject|0|||
23384410|NCT02318277|65151625|FG001|Overall Study|Withdrawal by Subject|0|||
23384411|NCT02318277|65151626|FG002|Overall Study|Withdrawal by Subject|1|||
23384412|NCT02318277|65151627|FG003|Overall Study|Withdrawal by Subject|0|||
23384413|NCT02318277|65151628|FG004|Overall Study|Withdrawal by Subject|1|||
23384414|NCT02318277|65151629|FG005|Overall Study|Withdrawal by Subject|1|||
23384415|NCT02318277|65151630|FG006|Overall Study|Withdrawal by Subject|6|||
23384416|NCT02318277|65151631|FG007|Overall Study|Withdrawal by Subject|14|||
23384417|NCT02318277|65151624|FG000|Overall Study|Participant trial terminated by sponsor|0|||
23384418|NCT02318277|65151625|FG001|Overall Study|Participant trial terminated by sponsor|0|||
23384419|NCT02318277|65151626|FG002|Overall Study|Participant trial terminated by sponsor|1|||
23384420|NCT02318277|65151627|FG003|Overall Study|Participant trial terminated by sponsor|0|||
23384421|NCT02318277|65151628|FG004|Overall Study|Participant trial terminated by sponsor|1|||
23384422|NCT02318277|65151629|FG005|Overall Study|Participant trial terminated by sponsor|2|||
23384423|NCT02318277|65151630|FG006|Overall Study|Participant trial terminated by sponsor|5|||
23384424|NCT02318277|65151631|FG007|Overall Study|Participant trial terminated by sponsor|16|||
23384425|NCT02318277|65151624|FG000|Overall Study|Lost to Follow-up|1|||
23384426|NCT02318277|65151625|FG001|Overall Study|Lost to Follow-up|0|||
23384427|NCT02318277|65151626|FG002|Overall Study|Lost to Follow-up|1|||
23384428|NCT02318277|65151627|FG003|Overall Study|Lost to Follow-up|0|||
23384429|NCT02318277|65151628|FG004|Overall Study|Lost to Follow-up|0|||
23384430|NCT02318277|65151629|FG005|Overall Study|Lost to Follow-up|0|||
23384431|NCT02318277|65151630|FG006|Overall Study|Lost to Follow-up|3|||
23384432|NCT02318277|65151631|FG007|Overall Study|Lost to Follow-up|4|||
23384433|NCT02318277|65151624|FG000|Overall Study|Death|5|||
23384434|NCT02318277|65151625|FG001|Overall Study|Death|3|||
23384435|NCT02318277|65151626|FG002|Overall Study|Death|1|||
23384436|NCT02318277|65151627|FG003|Overall Study|Death|4|||
23384437|NCT02318277|65151628|FG004|Overall Study|Death|6|||
23384438|NCT02318277|65151629|FG005|Overall Study|Death|5|||
23384439|NCT02318277|65151630|FG006|Overall Study|Death|34|||
23384440|NCT02318277|65151631|FG007|Overall Study|Death|58|||
23384441|NCT02318277|65151624|FG000|Overall Study|Transitioned to Hospice|0|||
23384442|NCT02318277|65151625|FG001|Overall Study|Transitioned to Hospice|0|||
23384443|NCT02318277|65151626|FG002|Overall Study|Transitioned to Hospice|0|||
23384444|NCT02318277|65151627|FG003|Overall Study|Transitioned to Hospice|0|||
23384445|NCT02318277|65151628|FG004|Overall Study|Transitioned to Hospice|0|||
23384446|NCT02318277|65151629|FG005|Overall Study|Transitioned to Hospice|1|||
23384447|NCT02318277|65151630|FG006|Overall Study|Transitioned to Hospice|0|||
23384448|NCT02318277|65151631|FG007|Overall Study|Transitioned to Hospice|0|||
23291040|NCT02578641|64808198|FG001|Overall Study|Adverse Event|15|||
23291041|NCT02578641|64808197|FG000|Overall Study|Death|16|||
23291042|NCT02578641|64808198|FG001|Overall Study|Death|8|||
23291043|NCT02578641|64808197|FG000|Overall Study|Lost to Follow-up|0|||
23291044|NCT02578641|64808198|FG001|Overall Study|Lost to Follow-up|1|||
23291045|NCT02578641|64808197|FG000|Overall Study|Withdrawal by Subject|14|||
23291046|NCT02578641|64808198|FG001|Overall Study|Withdrawal by Subject|7|||
23384449|NCT01178411|65151632|FG000|Overall Study|Adverse Event|5|||
23384450|NCT01178411|65151632|FG000|Overall Study|Withdrawal by Subject|4|||
23291047|NCT02578641|64808197|FG000|Overall Study|Progressive Disease|69|||
23291048|NCT02578641|64808198|FG001|Overall Study|Progressive Disease|21|||
23384451|NCT01178411|65151632|FG000|Overall Study|Protocol Violation|1|||
23384452|NCT01178411|65151632|FG000|Overall Study|Progressive disease per RECIST|32|||
23291049|NCT02578641|64808197|FG000|Overall Study|No Study Drug|2|||
23291050|NCT02578641|64808198|FG001|Overall Study|No Study Drug|0|||
23291051|NCT02578641|64808197|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
23291052|NCT02578641|64808198|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
23291053|NCT02578641|64808197|FG000|Overall Study|Non-compliance with Study Schedule|1|||
23291054|NCT02578641|64808198|FG001|Overall Study|Non-compliance with Study Schedule|0|||
23291055|NCT02578641|64808197|FG000|Overall Study|Other|1|||
23291056|NCT02578641|64808198|FG001|Overall Study|Other|10|||
23291057|NCT02578641|64808197|FG000|Overall Study|Not treated|1|||
23291058|NCT02578641|64808198|FG001|Overall Study|Not treated|4|||
23291059|NCT01332968|64808207|FG000|Induction Period|Adverse Event|23|||
23291060|NCT01332968|64808208|FG001|Induction Period|Adverse Event|26|||
23291061|NCT01332968|64808209|FG002|Induction Period|Adverse Event|0|||
23291062|NCT01332968|64808210|FG003|Induction Period|Adverse Event|0|||
23291063|NCT01332968|64808211|FG004|Induction Period|Adverse Event|0|||
23291064|NCT01332968|64808212|FG005|Induction Period|Adverse Event|0|||
23291065|NCT01332968|64808213|FG006|Induction Period|Adverse Event|0|||
23291066|NCT01332968|64808214|FG007|Induction Period|Adverse Event|0|||
23291067|NCT01332968|64808207|FG000|Induction Period|Death|1|||
23291068|NCT01332968|64808208|FG001|Induction Period|Death|4|||
23291069|NCT01332968|64808209|FG002|Induction Period|Death|0|||
23291070|NCT01332968|64808210|FG003|Induction Period|Death|0|||
23291071|NCT01332968|64808211|FG004|Induction Period|Death|0|||
23291072|NCT01332968|64808212|FG005|Induction Period|Death|0|||
23291073|NCT01332968|64808213|FG006|Induction Period|Death|0|||
23291074|NCT01332968|64808214|FG007|Induction Period|Death|0|||
23291075|NCT01332968|64808207|FG000|Induction Period|Non-compliance|1|||
23291076|NCT01332968|64808208|FG001|Induction Period|Non-compliance|0|||
23291077|NCT01332968|64808209|FG002|Induction Period|Non-compliance|0|||
23291078|NCT01332968|64808210|FG003|Induction Period|Non-compliance|0|||
23291079|NCT01332968|64808211|FG004|Induction Period|Non-compliance|0|||
23291080|NCT01332968|64808212|FG005|Induction Period|Non-compliance|0|||
23291081|NCT01332968|64808213|FG006|Induction Period|Non-compliance|0|||
23291082|NCT01332968|64808214|FG007|Induction Period|Non-compliance|0|||
23291083|NCT01332968|64808207|FG000|Induction Period|Other|2|||
23291084|NCT01332968|64808208|FG001|Induction Period|Other|2|||
23291085|NCT01332968|64808209|FG002|Induction Period|Other|0|||
23291086|NCT01332968|64808210|FG003|Induction Period|Other|0|||
23291087|NCT01332968|64808211|FG004|Induction Period|Other|0|||
23291088|NCT01332968|64808212|FG005|Induction Period|Other|0|||
23291089|NCT01332968|64808213|FG006|Induction Period|Other|0|||
23291090|NCT01332968|64808214|FG007|Induction Period|Other|0|||
23291091|NCT01332968|64808207|FG000|Induction Period|Physician Decision|6|||
23291092|NCT01332968|64808208|FG001|Induction Period|Physician Decision|1|||
23291093|NCT01332968|64808209|FG002|Induction Period|Physician Decision|0|||
23291094|NCT01332968|64808210|FG003|Induction Period|Physician Decision|0|||
23291095|NCT01332968|64808211|FG004|Induction Period|Physician Decision|0|||
23291096|NCT01332968|64808212|FG005|Induction Period|Physician Decision|0|||
23291097|NCT01332968|64808213|FG006|Induction Period|Physician Decision|0|||
23291098|NCT01332968|64808214|FG007|Induction Period|Physician Decision|0|||
23291099|NCT01332968|64808207|FG000|Induction Period|Progressive Disease|15|||
23291100|NCT01332968|64808208|FG001|Induction Period|Progressive Disease|7|||
23384453|NCT01178411|65151632|FG000|Overall Study|Progressive disease per clinician|9|||
23291101|NCT01332968|64808209|FG002|Induction Period|Progressive Disease|0|||
23291102|NCT01332968|64808210|FG003|Induction Period|Progressive Disease|0|||
23291103|NCT01332968|64808211|FG004|Induction Period|Progressive Disease|0|||
23291104|NCT01332968|64808212|FG005|Induction Period|Progressive Disease|0|||
23291105|NCT01332968|64808213|FG006|Induction Period|Progressive Disease|0|||
23291106|NCT01332968|64808214|FG007|Induction Period|Progressive Disease|0|||
23291107|NCT01332968|64808207|FG000|Induction Period|Protocol Violation|3|||
23291108|NCT01332968|64808208|FG001|Induction Period|Protocol Violation|4|||
23291109|NCT01332968|64808209|FG002|Induction Period|Protocol Violation|0|||
23291110|NCT01332968|64808210|FG003|Induction Period|Protocol Violation|0|||
23291111|NCT01332968|64808211|FG004|Induction Period|Protocol Violation|0|||
23291112|NCT01332968|64808212|FG005|Induction Period|Protocol Violation|0|||
23291113|NCT01332968|64808213|FG006|Induction Period|Protocol Violation|0|||
23291114|NCT01332968|64808214|FG007|Induction Period|Protocol Violation|0|||
23291115|NCT01332968|64808207|FG000|Induction Period|Withdrawal by Subject|3|||
23291116|NCT01332968|64808208|FG001|Induction Period|Withdrawal by Subject|5|||
23291117|NCT01332968|64808209|FG002|Induction Period|Withdrawal by Subject|0|||
23291118|NCT01332968|64808210|FG003|Induction Period|Withdrawal by Subject|0|||
23291119|NCT01332968|64808211|FG004|Induction Period|Withdrawal by Subject|0|||
23291120|NCT01332968|64808212|FG005|Induction Period|Withdrawal by Subject|0|||
23291121|NCT01332968|64808213|FG006|Induction Period|Withdrawal by Subject|0|||
23291122|NCT01332968|64808214|FG007|Induction Period|Withdrawal by Subject|0|||
23291123|NCT01332968|64808207|FG000|Induction Period|Randomised but not treated|4|||
23291124|NCT01332968|64808208|FG001|Induction Period|Randomised but not treated|7|||
23291125|NCT01332968|64808209|FG002|Induction Period|Randomised but not treated|0|||
23291126|NCT01332968|64808210|FG003|Induction Period|Randomised but not treated|0|||
23291127|NCT01332968|64808211|FG004|Induction Period|Randomised but not treated|0|||
23291128|NCT01332968|64808212|FG005|Induction Period|Randomised but not treated|0|||
23291129|NCT01332968|64808213|FG006|Induction Period|Randomised but not treated|0|||
23291130|NCT01332968|64808214|FG007|Induction Period|Randomised but not treated|0|||
23291131|NCT01332968|64808207|FG000|Maintenance/Observation Period|Adverse Event|0|||
23291132|NCT01332968|64808208|FG001|Maintenance/Observation Period|Adverse Event|0|||
23291133|NCT01332968|64808209|FG002|Maintenance/Observation Period|Adverse Event|53|||
23291134|NCT01332968|64808210|FG003|Maintenance/Observation Period|Adverse Event|66|||
23291135|NCT01332968|64808211|FG004|Maintenance/Observation Period|Adverse Event|0|||
23291136|NCT01332968|64808212|FG005|Maintenance/Observation Period|Adverse Event|0|||
23291137|NCT01332968|64808213|FG006|Maintenance/Observation Period|Adverse Event|0|||
23291138|NCT01332968|64808214|FG007|Maintenance/Observation Period|Adverse Event|0|||
23291139|NCT01332968|64808207|FG000|Maintenance/Observation Period|Death|0|||
23291140|NCT01332968|64808208|FG001|Maintenance/Observation Period|Death|0|||
23291141|NCT01332968|64808209|FG002|Maintenance/Observation Period|Death|5|||
23291142|NCT01332968|64808210|FG003|Maintenance/Observation Period|Death|6|||
23291143|NCT01332968|64808211|FG004|Maintenance/Observation Period|Death|0|||
23291144|NCT01332968|64808212|FG005|Maintenance/Observation Period|Death|0|||
23291145|NCT01332968|64808213|FG006|Maintenance/Observation Period|Death|0|||
23291146|NCT01332968|64808214|FG007|Maintenance/Observation Period|Death|0|||
23291147|NCT01332968|64808207|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
23291148|NCT01332968|64808208|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
23291149|NCT01332968|64808209|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
23291150|NCT01332968|64808210|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
23291151|NCT01332968|64808211|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
23291152|NCT01332968|64808212|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
23291153|NCT01332968|64808213|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
23291154|NCT01332968|64808214|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
23291155|NCT01332968|64808207|FG000|Maintenance/Observation Period|Non-compliance|0|||
23291156|NCT01332968|64808208|FG001|Maintenance/Observation Period|Non-compliance|0|||
23291157|NCT01332968|64808209|FG002|Maintenance/Observation Period|Non-compliance|4|||
23291158|NCT01332968|64808210|FG003|Maintenance/Observation Period|Non-compliance|3|||
23291159|NCT01332968|64808211|FG004|Maintenance/Observation Period|Non-compliance|0|||
23291160|NCT01332968|64808212|FG005|Maintenance/Observation Period|Non-compliance|0|||
23291161|NCT01332968|64808213|FG006|Maintenance/Observation Period|Non-compliance|0|||
23291162|NCT01332968|64808214|FG007|Maintenance/Observation Period|Non-compliance|0|||
23291163|NCT01332968|64808207|FG000|Maintenance/Observation Period|Other|0|||
23291164|NCT01332968|64808208|FG001|Maintenance/Observation Period|Other|0|||
23291165|NCT01332968|64808209|FG002|Maintenance/Observation Period|Other|4|||
23291166|NCT01332968|64808210|FG003|Maintenance/Observation Period|Other|7|||
23291167|NCT01332968|64808211|FG004|Maintenance/Observation Period|Other|0|||
23291168|NCT01332968|64808212|FG005|Maintenance/Observation Period|Other|0|||
23291169|NCT01332968|64808213|FG006|Maintenance/Observation Period|Other|0|||
23291170|NCT01332968|64808214|FG007|Maintenance/Observation Period|Other|0|||
23384454|NCT01178411|65151632|FG000|Overall Study|Physician Decision|6|||
23291171|NCT01332968|64808207|FG000|Maintenance/Observation Period|Physician Decision|0|||
23291172|NCT01332968|64808208|FG001|Maintenance/Observation Period|Physician Decision|0|||
23291173|NCT01332968|64808209|FG002|Maintenance/Observation Period|Physician Decision|14|||
23291174|NCT01332968|64808210|FG003|Maintenance/Observation Period|Physician Decision|19|||
23291175|NCT01332968|64808211|FG004|Maintenance/Observation Period|Physician Decision|0|||
23291176|NCT01332968|64808212|FG005|Maintenance/Observation Period|Physician Decision|1|||
23291177|NCT01332968|64808213|FG006|Maintenance/Observation Period|Physician Decision|0|||
23291178|NCT01332968|64808214|FG007|Maintenance/Observation Period|Physician Decision|0|||
23291179|NCT01332968|64808207|FG000|Maintenance/Observation Period|Progressive Disease|0|||
23291180|NCT01332968|64808208|FG001|Maintenance/Observation Period|Progressive Disease|0|||
23291181|NCT01332968|64808209|FG002|Maintenance/Observation Period|Progressive Disease|72|||
23291182|NCT01332968|64808210|FG003|Maintenance/Observation Period|Progressive Disease|40|||
23291183|NCT01332968|64808211|FG004|Maintenance/Observation Period|Progressive Disease|0|||
23291184|NCT01332968|64808212|FG005|Maintenance/Observation Period|Progressive Disease|0|||
23291185|NCT01332968|64808213|FG006|Maintenance/Observation Period|Progressive Disease|0|||
23291186|NCT01332968|64808214|FG007|Maintenance/Observation Period|Progressive Disease|0|||
23291187|NCT01332968|64808207|FG000|Maintenance/Observation Period|Protocol Violation|0|||
23291188|NCT01332968|64808208|FG001|Maintenance/Observation Period|Protocol Violation|0|||
23291189|NCT01332968|64808209|FG002|Maintenance/Observation Period|Protocol Violation|1|||
23291190|NCT01332968|64808210|FG003|Maintenance/Observation Period|Protocol Violation|1|||
23384455|NCT01178411|65151632|FG000|Overall Study|Death|1|||
23384456|NCT01178411|65151632|FG000|Overall Study|No reason provided|1|||
23384457|NCT01178411|65151632|FG000|Overall Study|Drug manufacturing ended|1|||
23384458|NCT01797185|65151633|FG000|Overall Study|Adverse Event|5|||
23384459|NCT01797185|65151634|FG001|Overall Study|Adverse Event|15|||
23384460|NCT01797185|65151635|FG002|Overall Study|Adverse Event|6|||
23384461|NCT01797185|65151633|FG000|Overall Study|Withdrawal by Subject|6|||
23384462|NCT01797185|65151634|FG001|Overall Study|Withdrawal by Subject|9|||
23384463|NCT01797185|65151635|FG002|Overall Study|Withdrawal by Subject|5|||
23384464|NCT01797185|65151633|FG000|Overall Study|Site terminated|8|||
23384465|NCT01797185|65151634|FG001|Overall Study|Site terminated|4|||
23384466|NCT01797185|65151635|FG002|Overall Study|Site terminated|0|||
23384467|NCT01797185|65151633|FG000|Overall Study|Lost to Follow-up|2|||
23384468|NCT01797185|65151634|FG001|Overall Study|Lost to Follow-up|6|||
23384469|NCT01797185|65151635|FG002|Overall Study|Lost to Follow-up|1|||
23384470|NCT01797185|65151633|FG000|Overall Study|Withdrawn per sponsor|5|||
23384471|NCT01797185|65151634|FG001|Overall Study|Withdrawn per sponsor|0|||
23384472|NCT01797185|65151635|FG002|Overall Study|Withdrawn per sponsor|0|||
23384473|NCT01797185|65151633|FG000|Overall Study|Physician Decision|1|||
23384474|NCT01797185|65151634|FG001|Overall Study|Physician Decision|3|||
23384475|NCT01797185|65151635|FG002|Overall Study|Physician Decision|0|||
23384476|NCT01797185|65151633|FG000|Overall Study|Protocol Violation|1|||
23384477|NCT01797185|65151634|FG001|Overall Study|Protocol Violation|1|||
23384478|NCT01797185|65151635|FG002|Overall Study|Protocol Violation|0|||
23384479|NCT01698008|65151645|FG000|Overall Study|Withdrawal by Subject|1|||
23384480|NCT01698008|65151646|FG001|Overall Study|Withdrawal by Subject|2|||
23384481|NCT00397930|65151647|FG000|Overall Study|Personal reasons|14|||
23384482|NCT00397930|65151648|FG001|Overall Study|Personal reasons|8|||
23384483|NCT00397930|65151647|FG000|Overall Study|Other medical|9|||
23384484|NCT00397930|65151648|FG001|Overall Study|Other medical|4|||
23384485|NCT00397930|65151647|FG000|Overall Study|Unknown reasons|9|||
23291191|NCT01332968|64808211|FG004|Maintenance/Observation Period|Protocol Violation|0|||
23291192|NCT01332968|64808212|FG005|Maintenance/Observation Period|Protocol Violation|0|||
23291193|NCT01332968|64808213|FG006|Maintenance/Observation Period|Protocol Violation|0|||
23291194|NCT01332968|64808214|FG007|Maintenance/Observation Period|Protocol Violation|0|||
23291195|NCT01332968|64808207|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
23291196|NCT01332968|64808208|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
23291197|NCT01332968|64808209|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
23291198|NCT01332968|64808210|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
23291199|NCT01332968|64808211|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
23291200|NCT01332968|64808212|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
23291201|NCT01332968|64808213|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
23291202|NCT01332968|64808214|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
23291203|NCT01332968|64808207|FG000|Follow-Up Period|Adverse Event|0|||
23291204|NCT01332968|64808208|FG001|Follow-Up Period|Adverse Event|0|||
23291205|NCT01332968|64808209|FG002|Follow-Up Period|Adverse Event|0|||
23291206|NCT01332968|64808210|FG003|Follow-Up Period|Adverse Event|0|||
23291207|NCT01332968|64808211|FG004|Follow-Up Period|Adverse Event|0|||
23291208|NCT01332968|64808212|FG005|Follow-Up Period|Adverse Event|0|||
23291209|NCT01332968|64808213|FG006|Follow-Up Period|Adverse Event|0|||
23291210|NCT01332968|64808214|FG007|Follow-Up Period|Adverse Event|4|||
23291211|NCT01332968|64808207|FG000|Follow-Up Period|Death|0|||
23291212|NCT01332968|64808208|FG001|Follow-Up Period|Death|0|||
23291213|NCT01332968|64808209|FG002|Follow-Up Period|Death|0|||
23291214|NCT01332968|64808210|FG003|Follow-Up Period|Death|0|||
23291215|NCT01332968|64808211|FG004|Follow-Up Period|Death|0|||
23291216|NCT01332968|64808212|FG005|Follow-Up Period|Death|0|||
23291217|NCT01332968|64808213|FG006|Follow-Up Period|Death|27|||
23291218|NCT01332968|64808214|FG007|Follow-Up Period|Death|30|||
23291219|NCT01332968|64808207|FG000|Follow-Up Period|Lost to Follow-up|0|||
23291220|NCT01332968|64808208|FG001|Follow-Up Period|Lost to Follow-up|0|||
23291221|NCT01332968|64808209|FG002|Follow-Up Period|Lost to Follow-up|0|||
23291222|NCT01332968|64808210|FG003|Follow-Up Period|Lost to Follow-up|0|||
23291223|NCT01332968|64808211|FG004|Follow-Up Period|Lost to Follow-up|0|||
23291224|NCT01332968|64808212|FG005|Follow-Up Period|Lost to Follow-up|0|||
23291225|NCT01332968|64808213|FG006|Follow-Up Period|Lost to Follow-up|11|||
23291226|NCT01332968|64808214|FG007|Follow-Up Period|Lost to Follow-up|15|||
23291227|NCT01332968|64808207|FG000|Follow-Up Period|Non-compliance|0|||
23291228|NCT01332968|64808208|FG001|Follow-Up Period|Non-compliance|0|||
23291229|NCT01332968|64808209|FG002|Follow-Up Period|Non-compliance|0|||
23291230|NCT01332968|64808210|FG003|Follow-Up Period|Non-compliance|0|||
23291231|NCT01332968|64808211|FG004|Follow-Up Period|Non-compliance|0|||
23291232|NCT01332968|64808212|FG005|Follow-Up Period|Non-compliance|0|||
23291233|NCT01332968|64808213|FG006|Follow-Up Period|Non-compliance|4|||
23291234|NCT01332968|64808214|FG007|Follow-Up Period|Non-compliance|9|||
23291235|NCT01332968|64808207|FG000|Follow-Up Period|Other|0|||
23291236|NCT01332968|64808208|FG001|Follow-Up Period|Other|0|||
23291237|NCT01332968|64808209|FG002|Follow-Up Period|Other|0|||
23291238|NCT01332968|64808210|FG003|Follow-Up Period|Other|0|||
23291239|NCT01332968|64808211|FG004|Follow-Up Period|Other|0|||
23291240|NCT01332968|64808212|FG005|Follow-Up Period|Other|0|||
23291241|NCT01332968|64808213|FG006|Follow-Up Period|Other|18|||
23291242|NCT01332968|64808214|FG007|Follow-Up Period|Other|21|||
23291243|NCT01332968|64808207|FG000|Follow-Up Period|Physician Decision|0|||
23291244|NCT01332968|64808208|FG001|Follow-Up Period|Physician Decision|0|||
23291245|NCT01332968|64808209|FG002|Follow-Up Period|Physician Decision|0|||
23291246|NCT01332968|64808210|FG003|Follow-Up Period|Physician Decision|0|||
23291247|NCT01332968|64808211|FG004|Follow-Up Period|Physician Decision|0|||
23291248|NCT01332968|64808212|FG005|Follow-Up Period|Physician Decision|0|||
23291249|NCT01332968|64808213|FG006|Follow-Up Period|Physician Decision|12|||
23291250|NCT01332968|64808214|FG007|Follow-Up Period|Physician Decision|15|||
23291251|NCT01332968|64808207|FG000|Follow-Up Period|Progressive Disease|0|||
23291252|NCT01332968|64808208|FG001|Follow-Up Period|Progressive Disease|0|||
23291253|NCT01332968|64808209|FG002|Follow-Up Period|Progressive Disease|0|||
23291254|NCT01332968|64808210|FG003|Follow-Up Period|Progressive Disease|0|||
23291255|NCT01332968|64808211|FG004|Follow-Up Period|Progressive Disease|0|||
23291256|NCT01332968|64808212|FG005|Follow-Up Period|Progressive Disease|0|||
23291257|NCT01332968|64808213|FG006|Follow-Up Period|Progressive Disease|126|||
23291258|NCT01332968|64808214|FG007|Follow-Up Period|Progressive Disease|106|||
23291259|NCT01332968|64808207|FG000|Follow-Up Period|Protocol Violation|0|||
23291260|NCT01332968|64808208|FG001|Follow-Up Period|Protocol Violation|0|||
23291261|NCT01332968|64808209|FG002|Follow-Up Period|Protocol Violation|0|||
23291262|NCT01332968|64808210|FG003|Follow-Up Period|Protocol Violation|0|||
23291263|NCT01332968|64808211|FG004|Follow-Up Period|Protocol Violation|0|||
23291264|NCT01332968|64808212|FG005|Follow-Up Period|Protocol Violation|0|||
23291265|NCT01332968|64808213|FG006|Follow-Up Period|Protocol Violation|1|||
23291266|NCT01332968|64808214|FG007|Follow-Up Period|Protocol Violation|0|||
23291267|NCT01332968|64808207|FG000|Follow-Up Period|Withdrawal by Subject|0|||
23291268|NCT01332968|64808208|FG001|Follow-Up Period|Withdrawal by Subject|0|||
23291269|NCT01332968|64808209|FG002|Follow-Up Period|Withdrawal by Subject|0|||
23291270|NCT01332968|64808210|FG003|Follow-Up Period|Withdrawal by Subject|0|||
23384486|NCT00397930|65151648|FG001|Overall Study|Unknown reasons|14|||
23384487|NCT00397930|65151647|FG000|Overall Study|Noncompliant|3|||
23384488|NCT00397930|65151648|FG001|Overall Study|Noncompliant|2|||
23384489|NCT00397930|65151647|FG000|Overall Study|Too time-consuming|2|||
23384490|NCT00397930|65151648|FG001|Overall Study|Too time-consuming|9|||
23291271|NCT01332968|64808211|FG004|Follow-Up Period|Withdrawal by Subject|0|||
23291272|NCT01332968|64808212|FG005|Follow-Up Period|Withdrawal by Subject|0|||
23291273|NCT01332968|64808213|FG006|Follow-Up Period|Withdrawal by Subject|29|||
23291274|NCT01332968|64808214|FG007|Follow-Up Period|Withdrawal by Subject|32|||
23291275|NCT01332968|64808207|FG000|Follow-Up Period|No reason provided|0|||
23291276|NCT01332968|64808208|FG001|Follow-Up Period|No reason provided|0|||
23291277|NCT01332968|64808209|FG002|Follow-Up Period|No reason provided|0|||
23291278|NCT01332968|64808210|FG003|Follow-Up Period|No reason provided|0|||
23291279|NCT01332968|64808211|FG004|Follow-Up Period|No reason provided|0|||
23291280|NCT01332968|64808212|FG005|Follow-Up Period|No reason provided|0|||
23291281|NCT01332968|64808213|FG006|Follow-Up Period|No reason provided|2|||
23291282|NCT01332968|64808214|FG007|Follow-Up Period|No reason provided|3|||
23291283|NCT01004510|64808215|FG000|Overall Study|Adverse Event|1|||
23291284|NCT03578809|64808222|FG000|Overall Study|Death|0|||
23291285|NCT03578809|64808223|FG001|Overall Study|Death|2|||
23291286|NCT03578809|64808224|FG002|Overall Study|Death|0|||
23291287|NCT03578809|64808225|FG003|Overall Study|Death|1|||
23291288|NCT03578809|64808222|FG000|Overall Study|Lost to Follow-up|0|||
23291289|NCT03578809|64808223|FG001|Overall Study|Lost to Follow-up|1|||
23291290|NCT03578809|64808224|FG002|Overall Study|Lost to Follow-up|0|||
23291291|NCT03578809|64808225|FG003|Overall Study|Lost to Follow-up|0|||
23291292|NCT03578809|64808222|FG000|Overall Study|Withdrawal by Subject|3|||
23291293|NCT03578809|64808223|FG001|Overall Study|Withdrawal by Subject|5|||
23291294|NCT03578809|64808224|FG002|Overall Study|Withdrawal by Subject|2|||
23291295|NCT03578809|64808225|FG003|Overall Study|Withdrawal by Subject|0|||
23291296|NCT03578809|64808222|FG000|Overall Study|Other|3|||
23291297|NCT03578809|64808223|FG001|Overall Study|Other|6|||
23291298|NCT03578809|64808224|FG002|Overall Study|Other|2|||
23291299|NCT03578809|64808225|FG003|Overall Study|Other|8|||
23291300|NCT01466036|64808226|FG000|Overall Study|Death|1|||
23291301|NCT01466036|64808227|FG001|Overall Study|Death|1|||
23291302|NCT01466036|64808226|FG000|Overall Study|Physician Decision|0|||
23291303|NCT01466036|64808227|FG001|Overall Study|Physician Decision|4|||
23291304|NCT01466036|64808226|FG000|Overall Study|Adverse Event|2|||
23291305|NCT01466036|64808227|FG001|Overall Study|Adverse Event|6|||
23291306|NCT01466036|64808226|FG000|Overall Study|Withdrawal by Subject|2|||
23291307|NCT01466036|64808227|FG001|Overall Study|Withdrawal by Subject|8|||
23291308|NCT01466036|64808226|FG000|Overall Study|progression/relapse|14|||
23291309|NCT01466036|64808227|FG001|Overall Study|progression/relapse|21|||
23291310|NCT01466036|64808226|FG000|Overall Study|prolonged treatment delay|1|||
23291311|NCT01466036|64808227|FG001|Overall Study|prolonged treatment delay|1|||
23291312|NCT02310763|64808230|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
23291313|NCT02310763|64808231|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
23291314|NCT02310763|64808232|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
23291315|NCT02310763|64808230|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
23291316|NCT02310763|64808231|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
23291317|NCT02310763|64808232|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
23291318|NCT02310763|64808230|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
23291319|NCT02310763|64808231|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
23291320|NCT02310763|64808232|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
23291321|NCT02310763|64808230|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
23291322|NCT02310763|64808231|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
23291323|NCT02310763|64808232|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
23291324|NCT02310763|64808230|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
23291325|NCT02310763|64808231|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
23291326|NCT02310763|64808232|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
23291327|NCT03203642|64808235|FG000|Overall Study|Adverse Event|3|||
23291328|NCT03203642|64808236|FG001|Overall Study|Adverse Event|1|||
23291329|NCT03203642|64808235|FG000|Overall Study|Withdrawal by Subject|6|||
23291330|NCT03203642|64808236|FG001|Overall Study|Withdrawal by Subject|6|||
23384491|NCT00397930|65151647|FG000|Overall Study|Started own yoga program|1|||
23291331|NCT03203642|64808235|FG000|Overall Study|Lost to Follow-up|2|||
23291332|NCT03203642|64808236|FG001|Overall Study|Lost to Follow-up|1|||
23291333|NCT03203642|64808235|FG000|Overall Study|Termination of the study by sponsor|1|||
23291334|NCT03203642|64808236|FG001|Overall Study|Termination of the study by sponsor|1|||
23291335|NCT03203642|64808235|FG000|Overall Study|Participant moved|0|||
23384492|NCT00397930|65151648|FG001|Overall Study|Started own yoga program|1|||
23384493|NCT00397930|65151647|FG000|Overall Study|Did not want to be in control group|0|||
23384494|NCT00397930|65151648|FG001|Overall Study|Did not want to be in control group|1|||
23384495|NCT00397930|65151647|FG000|Overall Study|Withdrawal by Subject|0|||
23384496|NCT00397930|65151648|FG001|Overall Study|Withdrawal by Subject|8|||
23384497|NCT00397930|65151647|FG000|Overall Study|Missing data|0|||
23384498|NCT00397930|65151648|FG001|Overall Study|Missing data|4|||
23384499|NCT01716156|65151650|FG000|Overall Study|Protocol Violation|1|||
23384500|NCT01716156|65151651|FG001|Overall Study|Protocol Violation|0|||
23384501|NCT01716156|65151652|FG002|Overall Study|Protocol Violation|0|||
23384502|NCT01716156|65151650|FG000|Overall Study|Withdrawal by Subject|0|||
23384503|NCT01716156|65151651|FG001|Overall Study|Withdrawal by Subject|1|||
23384504|NCT01716156|65151652|FG002|Overall Study|Withdrawal by Subject|2|||
23384505|NCT01716156|65151650|FG000|Overall Study|Lost to Follow-up|1|||
23384506|NCT01716156|65151651|FG001|Overall Study|Lost to Follow-up|0|||
23384507|NCT01716156|65151652|FG002|Overall Study|Lost to Follow-up|0|||
23384508|NCT02082483|65151653|FG000|Overall Study|Lost to Follow-up|1|||
23384509|NCT02082483|65151654|FG001|Overall Study|Lost to Follow-up|1|||
23384510|NCT02082483|65151653|FG000|Overall Study|Withdrawal by Subject|2|||
23384511|NCT02082483|65151654|FG001|Overall Study|Withdrawal by Subject|1|||
23384512|NCT02082483|65151653|FG000|Overall Study|Physician Decision|1|||
23384513|NCT02082483|65151654|FG001|Overall Study|Physician Decision|1|||
23384514|NCT02082483|65151653|FG000|Overall Study|Death|2|||
23384515|NCT02082483|65151654|FG001|Overall Study|Death|3|||
23384516|NCT00368849|65151659|FG000|Overall Study|Withdrawal by Subject|0|||
23384517|NCT00368849|65151660|FG001|Overall Study|Withdrawal by Subject|1|||
23384518|NCT00368849|65151659|FG000|Overall Study|Physician Decision|0|||
23384519|NCT00368849|65151660|FG001|Overall Study|Physician Decision|1|||
23384520|NCT01896986|65151661|FG000|Overall Study|samples lost|14|||
23384521|NCT01896986|65151662|FG001|Overall Study|samples lost|23|||
23384522|NCT02218268|65151663|FG000|24 Hour Washout|Physician Decision|11|||
23384523|NCT02218268|65151664|FG001|24 Hour Washout|Physician Decision|9|||
23384524|NCT00639379|65151665|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
23384525|NCT00639379|65151666|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
23384526|NCT00639379|65151665|FG000|Period 1 - 2 Weeks|lens issue|3|||
23384527|NCT00639379|65151666|FG001|Period 1 - 2 Weeks|lens issue|0|||
23384528|NCT02541903|65151669|FG000|Overall Study|Death|1|||
23384529|NCT03178942|65151670|FG000|Overall Study|Withdrawal by Subject|2|||
23384530|NCT03178942|65151671|FG001|Overall Study|Withdrawal by Subject|0|||
23384531|NCT03178942|65151670|FG000|Overall Study|Lost to Follow-up|1|||
23384532|NCT03178942|65151671|FG001|Overall Study|Lost to Follow-up|2|||
23384533|NCT02493855|65151672|FG000|Overall Study|Non-compliance|1|||
23384534|NCT02493855|65151673|FG001|Overall Study|Non-compliance|0|||
23384535|NCT02493855|65151674|FG002|Overall Study|Non-compliance|0|||
23384536|NCT02493855|65151672|FG000|Overall Study|Adverse Event|0|||
23384537|NCT02493855|65151673|FG001|Overall Study|Adverse Event|1|||
23384538|NCT02493855|65151674|FG002|Overall Study|Adverse Event|0|||
23384539|NCT02493855|65151672|FG000|Overall Study|Withdrawal by Subject|1|||
23384540|NCT02493855|65151673|FG001|Overall Study|Withdrawal by Subject|0|||
23384541|NCT02493855|65151674|FG002|Overall Study|Withdrawal by Subject|0|||
23384542|NCT02533674|65151677|FG000|Dose Level I|Progressive disease|1|||
23384543|NCT02533674|65151678|FG001|Dose Level I|Progressive disease|0|||
23384544|NCT02533674|65151679|FG002|Dose Level I|Progressive disease|0|||
23384545|NCT02533674|65151680|FG003|Dose Level I|Progressive disease|0|||
23384546|NCT02533674|65151681|FG004|Dose Level I|Progressive disease|0|||
23384547|NCT02533674|65151682|FG005|Dose Level I|Progressive disease|0|||
23384548|NCT02533674|65151683|FG006|Dose Level I|Progressive disease|0|||
23384549|NCT02533674|65151684|FG007|Dose Level I|Progressive disease|0|||
23384550|NCT02533674|65151677|FG000|Dose Level I|Withdrawal by Subject|1|||
23384551|NCT02533674|65151678|FG001|Dose Level I|Withdrawal by Subject|0|||
23384552|NCT02533674|65151679|FG002|Dose Level I|Withdrawal by Subject|0|||
23384553|NCT02533674|65151680|FG003|Dose Level I|Withdrawal by Subject|0|||
23384554|NCT02533674|65151681|FG004|Dose Level I|Withdrawal by Subject|0|||
23384555|NCT02533674|65151682|FG005|Dose Level I|Withdrawal by Subject|0|||
23384556|NCT02533674|65151683|FG006|Dose Level I|Withdrawal by Subject|0|||
23384557|NCT02533674|65151684|FG007|Dose Level I|Withdrawal by Subject|0|||
23384558|NCT02533674|65151677|FG000|Dose Level I|Physician Decision|1|||
23384559|NCT02533674|65151678|FG001|Dose Level I|Physician Decision|0|||
23384560|NCT02533674|65151679|FG002|Dose Level I|Physician Decision|0|||
23291336|NCT03203642|64808236|FG001|Overall Study|Participant moved|1|||
23291337|NCT03203642|64808235|FG000|Overall Study|Investigator's decision|3|||
23291338|NCT03203642|64808236|FG001|Overall Study|Investigator's decision|0|||
23291339|NCT03203642|64808235|FG000|Overall Study|Other than above specified|0|||
23291340|NCT03203642|64808236|FG001|Overall Study|Other than above specified|1|||
23291341|NCT01142661|64808241|FG000|Overall Study|Adverse Event|2|||
23291342|NCT01142661|64808241|FG000|Overall Study|Withdrawal by Subject|1|||
23291343|NCT01142661|64808241|FG000|Overall Study|Physician Decision|1|||
23291344|NCT01192399|64808244|FG000|Overall Study|Lack of Efficacy|2|||
23291345|NCT00585312|64808245|FG000|Overall Study|Adverse Event|3|||
23291346|NCT00585312|64808246|FG001|Overall Study|Adverse Event|0|||
23291347|NCT00585312|64808245|FG000|Overall Study|Lack of Efficacy|6|||
23291348|NCT00585312|64808246|FG001|Overall Study|Lack of Efficacy|11|||
23291349|NCT00585312|64808245|FG000|Overall Study|Lost to Follow-up|1|||
23291350|NCT00585312|64808246|FG001|Overall Study|Lost to Follow-up|1|||
23291351|NCT00585312|64808245|FG000|Overall Study|Reason not specified|2|||
23384561|NCT02533674|65151680|FG003|Dose Level I|Physician Decision|0|||
23384562|NCT02533674|65151681|FG004|Dose Level I|Physician Decision|0|||
23384563|NCT02533674|65151682|FG005|Dose Level I|Physician Decision|0|||
23384564|NCT02533674|65151683|FG006|Dose Level I|Physician Decision|0|||
23384565|NCT02533674|65151684|FG007|Dose Level I|Physician Decision|0|||
23384566|NCT02533674|65151677|FG000|Dose Level I|Death|1|||
23384567|NCT02533674|65151678|FG001|Dose Level I|Death|0|||
23384568|NCT02533674|65151679|FG002|Dose Level I|Death|0|||
23384569|NCT02533674|65151680|FG003|Dose Level I|Death|0|||
23384570|NCT02533674|65151681|FG004|Dose Level I|Death|0|||
23384571|NCT02533674|65151682|FG005|Dose Level I|Death|0|||
23384572|NCT02533674|65151683|FG006|Dose Level I|Death|0|||
23384573|NCT02533674|65151684|FG007|Dose Level I|Death|0|||
23606053|NCT01853384|65947131|FG001|Completed Follow up Visit 2|Adverse Event|0|||
23291352|NCT00585312|64808246|FG001|Overall Study|Reason not specified|0|||
23291353|NCT00585312|64808245|FG000|Overall Study|Withdrawal by Subject|5|||
23291354|NCT00585312|64808246|FG001|Overall Study|Withdrawal by Subject|1|||
23291355|NCT00585312|64808245|FG000|Overall Study|Study terminated by the sponsor|34|||
23384574|NCT02533674|65151677|FG000|Dose Level I|Never Treated|1|||
23291356|NCT00585312|64808246|FG001|Overall Study|Study terminated by the sponsor|31|||
23384575|NCT02533674|65151678|FG001|Dose Level I|Never Treated|0|||
23291357|NCT00220727|64808247|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
23291358|NCT00220727|64808248|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
23291359|NCT03686215|64808251|FG000|Overall Study|Adverse Event|0|||
23291360|NCT03686215|64808252|FG001|Overall Study|Adverse Event|0|||
23291361|NCT03686215|64808253|FG002|Overall Study|Adverse Event|7|||
23291362|NCT03686215|64808251|FG000|Overall Study|Physician Decision|0|||
23291363|NCT03686215|64808252|FG001|Overall Study|Physician Decision|0|||
23291364|NCT03686215|64808253|FG002|Overall Study|Physician Decision|1|||
23291365|NCT03686215|64808251|FG000|Overall Study|Protocol Violation|0|||
23291366|NCT03686215|64808252|FG001|Overall Study|Protocol Violation|0|||
23291367|NCT03686215|64808253|FG002|Overall Study|Protocol Violation|4|||
23291368|NCT03686215|64808251|FG000|Overall Study|Device issue|1|||
23291369|NCT03686215|64808252|FG001|Overall Study|Device issue|0|||
23291370|NCT03686215|64808253|FG002|Overall Study|Device issue|2|||
23291371|NCT00685750|64808254|FG000|Overall Study|Tumor sampling failure|0|||
23291372|NCT00685750|64808255|FG001|Overall Study|Tumor sampling failure|0|||
23291373|NCT00685750|64808256|FG002|Overall Study|Tumor sampling failure|1|||
23291374|NCT00685750|64808257|FG003|Overall Study|Tumor sampling failure|0|||
23291375|NCT00685750|64808258|FG004|Overall Study|Tumor sampling failure|0|||
23291376|NCT00685750|64808259|FG005|Overall Study|Tumor sampling failure|0|||
23291377|NCT00685750|64808260|FG006|Overall Study|Tumor sampling failure|0|||
23291378|NCT00685750|64808254|FG000|Overall Study|Patient didn't receive the treatment|0|||
23291379|NCT00685750|64808255|FG001|Overall Study|Patient didn't receive the treatment|0|||
23291380|NCT00685750|64808256|FG002|Overall Study|Patient didn't receive the treatment|0|||
23291381|NCT00685750|64808257|FG003|Overall Study|Patient didn't receive the treatment|0|||
23291382|NCT00685750|64808258|FG004|Overall Study|Patient didn't receive the treatment|0|||
23291383|NCT00685750|64808259|FG005|Overall Study|Patient didn't receive the treatment|0|||
23291384|NCT00685750|64808260|FG006|Overall Study|Patient didn't receive the treatment|1|||
23291385|NCT00685750|64808254|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
23291386|NCT00685750|64808255|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23291387|NCT00685750|64808256|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
23291388|NCT00685750|64808257|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
23291389|NCT00685750|64808258|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
23291390|NCT00685750|64808259|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
23291391|NCT00685750|64808260|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
23291392|NCT01186016|64808263|FG000|Overall Study|Withdrawal by Subject|46|||
23291393|NCT01186016|64808264|FG001|Overall Study|Withdrawal by Subject|29|||
23291394|NCT03761056|64808265|FG000|Overall Study|Still on Study|34|||
23291395|NCT03761056|64808265|FG000|Overall Study|Death|6|||
23291396|NCT03761056|64808265|FG000|Overall Study|Investigator Decision|1|||
23291397|NCT03761056|64808265|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
23291398|NCT03180528|64808266|FG000|Overall Study|Adverse Event|1|||
23291399|NCT03180528|64808266|FG000|Overall Study|Withdrawal by Subject|1|||
23291400|NCT03180528|64808266|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
23291401|NCT03431337|64808267|FG000|Overall Study|Lost to Follow-up|21|||
23291402|NCT03431337|64808268|FG001|Overall Study|Lost to Follow-up|19|||
23291403|NCT03431337|64808267|FG000|Overall Study|Withdrawal by Subject|8|||
23291404|NCT03431337|64808268|FG001|Overall Study|Withdrawal by Subject|3|||
23291405|NCT01341587|64808269|FG000|Overall Study|Lost to Follow-up|2|||
23291406|NCT01341587|64808270|FG001|Overall Study|Lost to Follow-up|0|||
23291407|NCT01341587|64808269|FG000|Overall Study|stopped using the meters|2|||
23291408|NCT01341587|64808270|FG001|Overall Study|stopped using the meters|10|||
23291409|NCT00603512|64808271|FG000|Overall Study|Adverse Event|0|||
23291410|NCT00603512|64808272|FG001|Overall Study|Adverse Event|2|||
23291411|NCT00603512|64808273|FG002|Overall Study|Adverse Event|4|||
23291412|NCT00603512|64808274|FG003|Overall Study|Adverse Event|4|||
23291413|NCT00603512|64808275|FG004|Overall Study|Adverse Event|2|||
23291414|NCT00603512|64808271|FG000|Overall Study|Lack of Efficacy|0|||
23291415|NCT00603512|64808272|FG001|Overall Study|Lack of Efficacy|1|||
23291416|NCT00603512|64808273|FG002|Overall Study|Lack of Efficacy|0|||
23291417|NCT00603512|64808274|FG003|Overall Study|Lack of Efficacy|0|||
23291418|NCT00603512|64808275|FG004|Overall Study|Lack of Efficacy|1|||
23291419|NCT00603512|64808271|FG000|Overall Study|Other|2|||
23493186|NCT03650556|65551383|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
23291420|NCT00603512|64808272|FG001|Overall Study|Other|1|||
23291421|NCT00603512|64808273|FG002|Overall Study|Other|0|||
23291422|NCT00603512|64808274|FG003|Overall Study|Other|1|||
23384576|NCT02533674|65151679|FG002|Dose Level I|Never Treated|0|||
23291423|NCT00603512|64808275|FG004|Overall Study|Other|1|||
23291424|NCT00603512|64808271|FG000|Overall Study|Withdrawal by Subject|0|||
23291425|NCT00603512|64808272|FG001|Overall Study|Withdrawal by Subject|0|||
23291426|NCT00603512|64808273|FG002|Overall Study|Withdrawal by Subject|0|||
23291427|NCT00603512|64808274|FG003|Overall Study|Withdrawal by Subject|0|||
23291428|NCT00603512|64808275|FG004|Overall Study|Withdrawal by Subject|1|||
23291429|NCT00603512|64808271|FG000|Overall Study|Randomized but not treated|0|||
23291430|NCT00603512|64808272|FG001|Overall Study|Randomized but not treated|1|||
23291431|NCT00603512|64808273|FG002|Overall Study|Randomized but not treated|1|||
23291432|NCT00603512|64808274|FG003|Overall Study|Randomized but not treated|2|||
23291433|NCT00603512|64808275|FG004|Overall Study|Randomized but not treated|0|||
23291434|NCT04330157|64808276|FG000|Overall Study|Protocol Violation|4|||
23291435|NCT04330157|64808276|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
23291436|NCT01908205|64808277|FG000|Overall Study|Lost to Follow-up|2|||
23291437|NCT01908205|64808278|FG001|Overall Study|Lost to Follow-up|0|||
23291438|NCT01908205|64808277|FG000|Overall Study|Withdrawal by Subject|3|||
23291439|NCT01908205|64808278|FG001|Overall Study|Withdrawal by Subject|1|||
23291440|NCT01849458|64808279|FG000|Overall Study|Lost to Follow-up|4|||
23291441|NCT01098851|64808280|FG000|Overall Study|Equipment failure|1|||
23291442|NCT01098851|64808281|FG001|Overall Study|Equipment failure|0|||
23291443|NCT04556734|64808282|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
23291444|NCT04556734|64808283|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
23291445|NCT04556734|64808284|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
23291446|NCT04556734|64808285|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23291447|NCT04556734|64808286|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23291448|NCT04556734|64808287|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23384577|NCT02533674|65151680|FG003|Dose Level I|Never Treated|0|||
23384578|NCT02533674|65151681|FG004|Dose Level I|Never Treated|0|||
23384579|NCT02533674|65151682|FG005|Dose Level I|Never Treated|0|||
23384580|NCT02533674|65151683|FG006|Dose Level I|Never Treated|0|||
23384581|NCT02533674|65151684|FG007|Dose Level I|Never Treated|0|||
23384582|NCT02533674|65151677|FG000|Dose Level II|Progressive disease|0|||
23384583|NCT02533674|65151678|FG001|Dose Level II|Progressive disease|3|||
23384584|NCT02533674|65151679|FG002|Dose Level II|Progressive disease|0|||
23384585|NCT02533674|65151680|FG003|Dose Level II|Progressive disease|0|||
23384586|NCT02533674|65151681|FG004|Dose Level II|Progressive disease|0|||
23384587|NCT02533674|65151682|FG005|Dose Level II|Progressive disease|0|||
23384588|NCT02533674|65151683|FG006|Dose Level II|Progressive disease|0|||
23384589|NCT02533674|65151684|FG007|Dose Level II|Progressive disease|0|||
23384590|NCT02533674|65151677|FG000|Dose Level II|Withdrawal by Subject|0|||
23384591|NCT02533674|65151678|FG001|Dose Level II|Withdrawal by Subject|1|||
23384592|NCT02533674|65151679|FG002|Dose Level II|Withdrawal by Subject|0|||
23384593|NCT02533674|65151680|FG003|Dose Level II|Withdrawal by Subject|0|||
23384594|NCT02533674|65151681|FG004|Dose Level II|Withdrawal by Subject|0|||
23384595|NCT02533674|65151682|FG005|Dose Level II|Withdrawal by Subject|0|||
23384596|NCT02533674|65151683|FG006|Dose Level II|Withdrawal by Subject|0|||
23384597|NCT02533674|65151684|FG007|Dose Level II|Withdrawal by Subject|0|||
23384598|NCT02533674|65151677|FG000|Dose Level II|Treatment-related AE|0|||
23384599|NCT02533674|65151678|FG001|Dose Level II|Treatment-related AE|1|||
23384600|NCT02533674|65151679|FG002|Dose Level II|Treatment-related AE|0|||
23384601|NCT02533674|65151680|FG003|Dose Level II|Treatment-related AE|0|||
23384602|NCT02533674|65151681|FG004|Dose Level II|Treatment-related AE|0|||
23384603|NCT02533674|65151682|FG005|Dose Level II|Treatment-related AE|0|||
23384604|NCT02533674|65151683|FG006|Dose Level II|Treatment-related AE|0|||
23384605|NCT02533674|65151684|FG007|Dose Level II|Treatment-related AE|0|||
23384606|NCT02533674|65151677|FG000|Dose Level II|Physician Decision|0|||
23384607|NCT02533674|65151678|FG001|Dose Level II|Physician Decision|1|||
23384608|NCT02533674|65151679|FG002|Dose Level II|Physician Decision|0|||
23384609|NCT02533674|65151680|FG003|Dose Level II|Physician Decision|0|||
23384610|NCT02533674|65151681|FG004|Dose Level II|Physician Decision|0|||
23384611|NCT02533674|65151682|FG005|Dose Level II|Physician Decision|0|||
23384612|NCT02533674|65151683|FG006|Dose Level II|Physician Decision|0|||
23384613|NCT02533674|65151684|FG007|Dose Level II|Physician Decision|0|||
23384614|NCT02533674|65151677|FG000|Dose Level II|Non-treatment-related AE|0|||
23291449|NCT04556734|64808288|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23291450|NCT04556734|64808289|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
23291451|NCT04556734|64808282|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
23291452|NCT04556734|64808283|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23291453|NCT04556734|64808284|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23291454|NCT04556734|64808285|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23291455|NCT04556734|64808286|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23291456|NCT04556734|64808287|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23384615|NCT02533674|65151678|FG001|Dose Level II|Non-treatment-related AE|1|||
23384616|NCT02533674|65151679|FG002|Dose Level II|Non-treatment-related AE|0|||
23384617|NCT02533674|65151680|FG003|Dose Level II|Non-treatment-related AE|0|||
23384618|NCT02533674|65151681|FG004|Dose Level II|Non-treatment-related AE|0|||
23291457|NCT04556734|64808288|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23291458|NCT04556734|64808289|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
23291459|NCT04556734|64808282|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23291460|NCT04556734|64808283|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23291461|NCT04556734|64808284|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
23291462|NCT04556734|64808285|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23291463|NCT04556734|64808286|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23291464|NCT04556734|64808287|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23291465|NCT04556734|64808288|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23291466|NCT04556734|64808289|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
23291467|NCT04556734|64808282|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
23291468|NCT04556734|64808283|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23291469|NCT04556734|64808284|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23291470|NCT04556734|64808285|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23291471|NCT04556734|64808286|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23291472|NCT04556734|64808287|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23291473|NCT04556734|64808288|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23291474|NCT04556734|64808289|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
23291475|NCT04556734|64808282|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23291476|NCT04556734|64808283|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23291477|NCT04556734|64808284|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
23291478|NCT04556734|64808285|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23291479|NCT04556734|64808286|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23291480|NCT04556734|64808287|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23291481|NCT04556734|64808288|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23291482|NCT04556734|64808289|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
23291483|NCT04556734|64808282|FG000|OLE Period (28 Weeks)|Not reported|0|||
23291484|NCT04556734|64808283|FG001|OLE Period (28 Weeks)|Not reported|0|||
23291485|NCT04556734|64808284|FG002|OLE Period (28 Weeks)|Not reported|0|||
23291486|NCT04556734|64808285|FG003|OLE Period (28 Weeks)|Not reported|0|||
23291487|NCT04556734|64808286|FG004|OLE Period (28 Weeks)|Not reported|0|||
23291488|NCT04556734|64808287|FG005|OLE Period (28 Weeks)|Not reported|1|||
23291489|NCT04556734|64808288|FG006|OLE Period (28 Weeks)|Not reported|0|||
23291490|NCT04556734|64808289|FG007|OLE Period (28 Weeks)|Not reported|0|||
23291491|NCT04556734|64808282|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23291492|NCT04556734|64808283|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23291493|NCT04556734|64808284|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23291494|NCT04556734|64808285|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23291495|NCT04556734|64808286|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23291496|NCT04556734|64808287|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23291497|NCT04556734|64808288|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
23291498|NCT04556734|64808289|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
23291499|NCT04556734|64808282|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
23291500|NCT04556734|64808283|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
23291501|NCT04556734|64808284|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
23291502|NCT04556734|64808285|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
23291503|NCT04556734|64808286|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
23291504|NCT04556734|64808287|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
23291505|NCT04556734|64808288|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
23291506|NCT04556734|64808289|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
23291507|NCT04556734|64808282|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23384619|NCT02533674|65151682|FG005|Dose Level II|Non-treatment-related AE|0|||
23384620|NCT02533674|65151683|FG006|Dose Level II|Non-treatment-related AE|0|||
23384621|NCT02533674|65151684|FG007|Dose Level II|Non-treatment-related AE|0|||
23384622|NCT02533674|65151677|FG000|Dose Level III|Progressive disease|0|||
23384623|NCT02533674|65151678|FG001|Dose Level III|Progressive disease|0|||
23384624|NCT02533674|65151679|FG002|Dose Level III|Progressive disease|2|||
23384625|NCT02533674|65151680|FG003|Dose Level III|Progressive disease|0|||
23291508|NCT04556734|64808283|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23291509|NCT04556734|64808284|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23291510|NCT04556734|64808285|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
23291511|NCT04556734|64808286|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
23291512|NCT04556734|64808287|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
23291513|NCT04556734|64808288|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
23291514|NCT04556734|64808289|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
23291515|NCT02224053|64808290|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
23291516|NCT02224053|64808290|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
23291517|NCT02224053|64808290|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
23291518|NCT02224053|64808290|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
23291519|NCT02224053|64808290|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
23291520|NCT00756717|64808293|FG000|Overall Study|Withdrawal by Subject|2|||
23291521|NCT00380588|64808294|FG000|Overall Study|Unequivocal Disease Progression|25|||
23291522|NCT00380588|64808295|FG001|Overall Study|Unequivocal Disease Progression|34|||
23291523|NCT00380588|64808294|FG000|Overall Study|Next Cycle Not Started|4|||
23291524|NCT00380588|64808295|FG001|Overall Study|Next Cycle Not Started|0|||
23291525|NCT00380588|64808294|FG000|Overall Study|Adverse Event|7|||
23291526|NCT00380588|64808295|FG001|Overall Study|Adverse Event|3|||
23291527|NCT00380588|64808294|FG000|Overall Study|Withdrawal by Subject|1|||
23291528|NCT00380588|64808295|FG001|Overall Study|Withdrawal by Subject|3|||
23291529|NCT00380588|64808294|FG000|Overall Study|Physician Decision|2|||
23291530|NCT00380588|64808295|FG001|Overall Study|Physician Decision|0|||
23291531|NCT02289820|64808298|FG000|Overall Study|Withdrawal by Subject|2|||
23291532|NCT02289820|64808299|FG001|Overall Study|Withdrawal by Subject|1|||
23291533|NCT02289820|64808300|FG002|Overall Study|Withdrawal by Subject|2|||
23291534|NCT02289820|64808301|FG003|Overall Study|Withdrawal by Subject|1|||
23291535|NCT02289820|64808302|FG004|Overall Study|Withdrawal by Subject|0|||
23291536|NCT02289820|64808303|FG005|Overall Study|Withdrawal by Subject|0|||
23291537|NCT02289820|64808304|FG006|Overall Study|Withdrawal by Subject|1|||
23291538|NCT02289820|64808298|FG000|Overall Study|Death|0|||
23291539|NCT02289820|64808299|FG001|Overall Study|Death|0|||
23291540|NCT02289820|64808300|FG002|Overall Study|Death|1|||
23291541|NCT02289820|64808301|FG003|Overall Study|Death|0|||
23291542|NCT02289820|64808302|FG004|Overall Study|Death|0|||
23291543|NCT02289820|64808303|FG005|Overall Study|Death|0|||
23291544|NCT02289820|64808304|FG006|Overall Study|Death|0|||
23291545|NCT02289820|64808298|FG000|Overall Study|Lost to Follow-up|0|||
23291546|NCT02289820|64808299|FG001|Overall Study|Lost to Follow-up|0|||
23291547|NCT02289820|64808300|FG002|Overall Study|Lost to Follow-up|3|||
23291548|NCT02289820|64808301|FG003|Overall Study|Lost to Follow-up|1|||
23291549|NCT02289820|64808302|FG004|Overall Study|Lost to Follow-up|0|||
23291550|NCT02289820|64808303|FG005|Overall Study|Lost to Follow-up|1|||
23291551|NCT02289820|64808304|FG006|Overall Study|Lost to Follow-up|1|||
23291552|NCT02289820|64808298|FG000|Overall Study|withdrawal of consent|0|||
23291553|NCT02289820|64808299|FG001|Overall Study|withdrawal of consent|1|||
23291554|NCT02289820|64808300|FG002|Overall Study|withdrawal of consent|0|||
23291555|NCT02289820|64808301|FG003|Overall Study|withdrawal of consent|0|||
23291556|NCT02289820|64808302|FG004|Overall Study|withdrawal of consent|0|||
23291557|NCT02289820|64808303|FG005|Overall Study|withdrawal of consent|0|||
23291558|NCT02289820|64808304|FG006|Overall Study|withdrawal of consent|0|||
23291559|NCT01483625|64808306|FG000|Overall Study|Adverse Event|1|||
23291560|NCT01483625|64808307|FG001|Overall Study|Adverse Event|1|||
23291561|NCT01483625|64808306|FG000|Overall Study|Refused to continue medication|2|||
23291562|NCT01483625|64808307|FG001|Overall Study|Refused to continue medication|1|||
23291563|NCT01483625|64808306|FG000|Overall Study|Due to other reason|1|||
23291564|NCT01483625|64808307|FG001|Overall Study|Due to other reason|0|||
23291565|NCT05692154|64808311|FG000|Overall Study|Adverse Event|0|||
23291566|NCT05692154|64808312|FG001|Overall Study|Adverse Event|1|||
23291567|NCT02000115|64808315|FG000|Overall Study|Death|56|||
23291568|NCT02000115|64808316|FG001|Overall Study|Death|45|||
23291569|NCT02000115|64808317|FG002|Overall Study|Death|0|||
23291570|NCT02000115|64808318|FG003|Overall Study|Death|0|||
23291571|NCT02000115|64808315|FG000|Overall Study|Missed Visit|6|||
23291572|NCT02000115|64808316|FG001|Overall Study|Missed Visit|8|||
23384626|NCT02533674|65151681|FG004|Dose Level III|Progressive disease|0|||
23384627|NCT02533674|65151682|FG005|Dose Level III|Progressive disease|0|||
23384628|NCT02533674|65151683|FG006|Dose Level III|Progressive disease|0|||
23384629|NCT02533674|65151684|FG007|Dose Level III|Progressive disease|0|||
23384630|NCT02533674|65151677|FG000|Dose Level III|Withdrawal by Subject|0|||
23384631|NCT02533674|65151678|FG001|Dose Level III|Withdrawal by Subject|0|||
23384632|NCT02533674|65151679|FG002|Dose Level III|Withdrawal by Subject|1|||
23384633|NCT02533674|65151680|FG003|Dose Level III|Withdrawal by Subject|0|||
23384634|NCT02533674|65151681|FG004|Dose Level III|Withdrawal by Subject|0|||
23384635|NCT02533674|65151682|FG005|Dose Level III|Withdrawal by Subject|0|||
23384636|NCT02533674|65151683|FG006|Dose Level III|Withdrawal by Subject|0|||
23384637|NCT02533674|65151684|FG007|Dose Level III|Withdrawal by Subject|0|||
23384638|NCT02533674|65151677|FG000|Dose Level III|Treatment-related AE|0|||
23384639|NCT02533674|65151678|FG001|Dose Level III|Treatment-related AE|0|||
23384640|NCT02533674|65151679|FG002|Dose Level III|Treatment-related AE|1|||
23384641|NCT02533674|65151680|FG003|Dose Level III|Treatment-related AE|0|||
23384642|NCT02533674|65151681|FG004|Dose Level III|Treatment-related AE|0|||
23384643|NCT02533674|65151682|FG005|Dose Level III|Treatment-related AE|0|||
23384644|NCT02533674|65151683|FG006|Dose Level III|Treatment-related AE|0|||
23384645|NCT02533674|65151684|FG007|Dose Level III|Treatment-related AE|0|||
23384646|NCT02533674|65151677|FG000|Dose Level IV|Progressive disease|0|||
23384647|NCT02533674|65151678|FG001|Dose Level IV|Progressive disease|0|||
23384648|NCT02533674|65151679|FG002|Dose Level IV|Progressive disease|0|||
23384649|NCT02533674|65151680|FG003|Dose Level IV|Progressive disease|3|||
23384650|NCT02533674|65151681|FG004|Dose Level IV|Progressive disease|0|||
23384651|NCT02533674|65151682|FG005|Dose Level IV|Progressive disease|0|||
23384652|NCT02533674|65151683|FG006|Dose Level IV|Progressive disease|0|||
23384653|NCT02533674|65151684|FG007|Dose Level IV|Progressive disease|0|||
23384654|NCT02533674|65151677|FG000|Dose Level IV|Withdrawal by Subject|0|||
23384655|NCT02533674|65151678|FG001|Dose Level IV|Withdrawal by Subject|0|||
23384656|NCT02533674|65151679|FG002|Dose Level IV|Withdrawal by Subject|0|||
23384657|NCT02533674|65151680|FG003|Dose Level IV|Withdrawal by Subject|1|||
23384658|NCT02533674|65151681|FG004|Dose Level IV|Withdrawal by Subject|0|||
23384659|NCT02533674|65151682|FG005|Dose Level IV|Withdrawal by Subject|0|||
23384660|NCT02533674|65151683|FG006|Dose Level IV|Withdrawal by Subject|0|||
23384661|NCT02533674|65151684|FG007|Dose Level IV|Withdrawal by Subject|0|||
23384662|NCT02533674|65151677|FG000|Dose Level IV|Physician Decision|0|||
23384663|NCT02533674|65151678|FG001|Dose Level IV|Physician Decision|0|||
23384664|NCT02533674|65151679|FG002|Dose Level IV|Physician Decision|0|||
23384665|NCT02533674|65151680|FG003|Dose Level IV|Physician Decision|1|||
23384666|NCT02533674|65151681|FG004|Dose Level IV|Physician Decision|0|||
23384667|NCT02533674|65151682|FG005|Dose Level IV|Physician Decision|0|||
23384668|NCT02533674|65151683|FG006|Dose Level IV|Physician Decision|0|||
23384669|NCT02533674|65151684|FG007|Dose Level IV|Physician Decision|0|||
23384670|NCT02533674|65151677|FG000|Dose Level V|Progressive disease|0|||
23384671|NCT02533674|65151678|FG001|Dose Level V|Progressive disease|0|||
23384672|NCT02533674|65151679|FG002|Dose Level V|Progressive disease|0|||
23384673|NCT02533674|65151680|FG003|Dose Level V|Progressive disease|0|||
23384674|NCT02533674|65151681|FG004|Dose Level V|Progressive disease|3|||
23384675|NCT02533674|65151682|FG005|Dose Level V|Progressive disease|0|||
23384676|NCT02533674|65151683|FG006|Dose Level V|Progressive disease|0|||
23384677|NCT02533674|65151684|FG007|Dose Level V|Progressive disease|0|||
23384678|NCT02533674|65151677|FG000|Dose Level V|Withdrawal by Subject|0|||
23384679|NCT02533674|65151678|FG001|Dose Level V|Withdrawal by Subject|0|||
23384680|NCT02533674|65151679|FG002|Dose Level V|Withdrawal by Subject|0|||
23384681|NCT02533674|65151680|FG003|Dose Level V|Withdrawal by Subject|0|||
23384682|NCT02533674|65151681|FG004|Dose Level V|Withdrawal by Subject|1|||
23384683|NCT02533674|65151682|FG005|Dose Level V|Withdrawal by Subject|0|||
23384684|NCT02533674|65151683|FG006|Dose Level V|Withdrawal by Subject|0|||
23384685|NCT02533674|65151684|FG007|Dose Level V|Withdrawal by Subject|0|||
23384686|NCT02533674|65151677|FG000|Dose Level V|Physician Decision|0|||
23384687|NCT02533674|65151678|FG001|Dose Level V|Physician Decision|0|||
23384688|NCT02533674|65151679|FG002|Dose Level V|Physician Decision|0|||
23384689|NCT02533674|65151680|FG003|Dose Level V|Physician Decision|0|||
23384690|NCT02533674|65151681|FG004|Dose Level V|Physician Decision|1|||
23384691|NCT02533674|65151682|FG005|Dose Level V|Physician Decision|0|||
23384692|NCT02533674|65151683|FG006|Dose Level V|Physician Decision|0|||
23384693|NCT02533674|65151684|FG007|Dose Level V|Physician Decision|0|||
23384694|NCT02533674|65151677|FG000|Dose Level VI|Progressive disease|0|||
23384695|NCT02533674|65151678|FG001|Dose Level VI|Progressive disease|0|||
23493187|NCT00917501|65551384|FG000|Overall Study|Lost to Follow-up|4|||
23384696|NCT02533674|65151679|FG002|Dose Level VI|Progressive disease|0|||
23384697|NCT02533674|65151680|FG003|Dose Level VI|Progressive disease|0|||
23384698|NCT02533674|65151681|FG004|Dose Level VI|Progressive disease|0|||
23384699|NCT02533674|65151682|FG005|Dose Level VI|Progressive disease|7|||
23384700|NCT02533674|65151683|FG006|Dose Level VI|Progressive disease|0|||
23384701|NCT02533674|65151684|FG007|Dose Level VI|Progressive disease|0|||
23384702|NCT02533674|65151677|FG000|Dose Level VI|Withdrawal by Subject|0|||
23384703|NCT02533674|65151678|FG001|Dose Level VI|Withdrawal by Subject|0|||
23384704|NCT02533674|65151679|FG002|Dose Level VI|Withdrawal by Subject|0|||
23291573|NCT02000115|64808317|FG002|Overall Study|Missed Visit|1|||
23291574|NCT02000115|64808318|FG003|Overall Study|Missed Visit|0|||
23291575|NCT02000115|64808315|FG000|Overall Study|Protocol Violation|2|||
23291576|NCT02000115|64808316|FG001|Overall Study|Protocol Violation|1|||
23291577|NCT02000115|64808317|FG002|Overall Study|Protocol Violation|0|||
23291578|NCT02000115|64808318|FG003|Overall Study|Protocol Violation|0|||
23291579|NCT02000115|64808315|FG000|Overall Study|Physician Decision|2|||
23291580|NCT02000115|64808316|FG001|Overall Study|Physician Decision|0|||
23291581|NCT02000115|64808317|FG002|Overall Study|Physician Decision|0|||
23291582|NCT02000115|64808318|FG003|Overall Study|Physician Decision|0|||
23291583|NCT02000115|64808315|FG000|Overall Study|Withdrawal by Subject|11|||
23291584|NCT02000115|64808316|FG001|Overall Study|Withdrawal by Subject|11|||
23291585|NCT02000115|64808317|FG002|Overall Study|Withdrawal by Subject|0|||
23291586|NCT02000115|64808318|FG003|Overall Study|Withdrawal by Subject|0|||
23291587|NCT02000115|64808315|FG000|Overall Study|Lost to Follow-up|0|||
23291588|NCT02000115|64808316|FG001|Overall Study|Lost to Follow-up|1|||
23291589|NCT02000115|64808317|FG002|Overall Study|Lost to Follow-up|0|||
23291590|NCT02000115|64808318|FG003|Overall Study|Lost to Follow-up|0|||
23291591|NCT02000115|64808315|FG000|Overall Study|Non-compliance|2|||
23291592|NCT02000115|64808316|FG001|Overall Study|Non-compliance|1|||
23291593|NCT02000115|64808317|FG002|Overall Study|Non-compliance|0|||
23291594|NCT02000115|64808318|FG003|Overall Study|Non-compliance|0|||
23291595|NCT02000115|64808315|FG000|Overall Study|Withdrawn on day of randomization|0|||
23291596|NCT02000115|64808316|FG001|Overall Study|Withdrawn on day of randomization|1|||
23291597|NCT02000115|64808317|FG002|Overall Study|Withdrawn on day of randomization|0|||
23291598|NCT02000115|64808318|FG003|Overall Study|Withdrawn on day of randomization|0|||
23291599|NCT02000115|64808315|FG000|Overall Study|Still on Study|0|||
23291600|NCT02000115|64808316|FG001|Overall Study|Still on Study|0|||
23291601|NCT02000115|64808317|FG002|Overall Study|Still on Study|0|||
23291602|NCT02000115|64808318|FG003|Overall Study|Still on Study|53|||
23291603|NCT01263561|64808321|FG000|Overall Study|Death|1|||
23291604|NCT01263561|64808322|FG001|Overall Study|Death|2|||
23291605|NCT03139240|64808323|FG000|Overall Study|Lost to Follow-up|0|||
23291606|NCT03139240|64808324|FG001|Overall Study|Lost to Follow-up|1|||
23291607|NCT03139240|64808325|FG002|Overall Study|Lost to Follow-up|1|||
23291608|NCT03139240|64808326|FG003|Overall Study|Lost to Follow-up|0|||
23291609|NCT01801917|64808329|FG000|Period 1 - Randomized|Adverse Event|1|||
23291610|NCT01801917|64808330|FG001|Period 1 - Randomized|Adverse Event|0|||
23291611|NCT01801917|64808331|FG002|Period 1 - Randomized|Adverse Event|1|||
23291612|NCT01801917|64808332|FG003|Period 1 - Randomized|Adverse Event|0|||
23291613|NCT00593827|64808335|FG000|Overall Study|On Active Treatment/Pending|0|||
23291614|NCT00593827|64808336|FG001|Overall Study|On Active Treatment/Pending|2|||
23291615|NCT03619876|64808339|FG000|Overall Study|Withdrawal by Subject|1|||
23384705|NCT02533674|65151680|FG003|Dose Level VI|Withdrawal by Subject|0|||
23384706|NCT02533674|65151681|FG004|Dose Level VI|Withdrawal by Subject|0|||
23291616|NCT03619876|64808340|FG001|Overall Study|Withdrawal by Subject|2|||
23291617|NCT03619876|64808339|FG000|Overall Study|Withdrawal due to incidental finding|0|||
23291618|NCT03619876|64808340|FG001|Overall Study|Withdrawal due to incidental finding|2|||
23291619|NCT03969641|64808341|FG000|Overall Study|Lost to Follow-up|5|||
23291620|NCT03969641|64808342|FG001|Overall Study|Lost to Follow-up|3|||
23291621|NCT03969641|64808341|FG000|Overall Study|Withdrawal by Subject|1|||
23291622|NCT03969641|64808342|FG001|Overall Study|Withdrawal by Subject|2|||
23291623|NCT03969641|64808341|FG000|Overall Study|Found to be ineligible|1|||
23291624|NCT03969641|64808342|FG001|Overall Study|Found to be ineligible|1|||
23291625|NCT03969641|64808341|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
23291626|NCT03969641|64808342|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
23291627|NCT03969641|64808341|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
23291628|NCT03969641|64808342|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
23291629|NCT03969641|64808341|FG000|Overall Study|Elective termination|0|||
23291630|NCT03969641|64808342|FG001|Overall Study|Elective termination|1|||
23291631|NCT04501094|64808343|FG000|Overall Study|Death (unrelated to research)|1|||
23291632|NCT04501094|64808344|FG001|Overall Study|Death (unrelated to research)|0|||
23291633|NCT02488824|64808349|FG000|Overall Study|Adverse Event|1|||
23291634|NCT02488824|64808350|FG001|Overall Study|Adverse Event|1|||
23291635|NCT04640194|64808354|FG000|Overall Study|Adverse Event|3|||
23291636|NCT04640194|64808355|FG001|Overall Study|Adverse Event|7|||
23291637|NCT04640194|64808356|FG002|Overall Study|Adverse Event|0|||
23291638|NCT04640194|64808357|FG003|Overall Study|Adverse Event|5|||
23291639|NCT04640194|64808358|FG004|Overall Study|Adverse Event|0|||
23291640|NCT04640194|64808359|FG005|Overall Study|Adverse Event|4|||
23291641|NCT04640194|64808360|FG006|Overall Study|Adverse Event|0|||
23291642|NCT04640194|64808354|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
23291643|NCT04640194|64808355|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
23291644|NCT04640194|64808356|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
23291645|NCT04640194|64808357|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
23291646|NCT04640194|64808358|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
23384707|NCT02533674|65151682|FG005|Dose Level VI|Withdrawal by Subject|1|||
23384708|NCT02533674|65151683|FG006|Dose Level VI|Withdrawal by Subject|0|||
23384709|NCT02533674|65151684|FG007|Dose Level VI|Withdrawal by Subject|0|||
23384710|NCT02533674|65151677|FG000|Dose Level VI|Treatment-related AE|0|||
23384711|NCT02533674|65151678|FG001|Dose Level VI|Treatment-related AE|0|||
23384712|NCT02533674|65151679|FG002|Dose Level VI|Treatment-related AE|0|||
23384713|NCT02533674|65151680|FG003|Dose Level VI|Treatment-related AE|0|||
23384714|NCT02533674|65151681|FG004|Dose Level VI|Treatment-related AE|0|||
23384715|NCT02533674|65151682|FG005|Dose Level VI|Treatment-related AE|1|||
23384716|NCT02533674|65151683|FG006|Dose Level VI|Treatment-related AE|0|||
23384717|NCT02533674|65151684|FG007|Dose Level VI|Treatment-related AE|0|||
23384718|NCT02533674|65151677|FG000|Dose Level VII|Progressive disease|0|||
23384719|NCT02533674|65151678|FG001|Dose Level VII|Progressive disease|0|||
23384720|NCT02533674|65151679|FG002|Dose Level VII|Progressive disease|0|||
23384721|NCT02533674|65151680|FG003|Dose Level VII|Progressive disease|0|||
23384722|NCT02533674|65151681|FG004|Dose Level VII|Progressive disease|0|||
23384723|NCT02533674|65151682|FG005|Dose Level VII|Progressive disease|0|||
23384724|NCT02533674|65151683|FG006|Dose Level VII|Progressive disease|10|||
23384725|NCT02533674|65151684|FG007|Dose Level VII|Progressive disease|0|||
23384726|NCT02533674|65151677|FG000|Dose Level VII|Withdrawal by Subject|0|||
23384727|NCT02533674|65151678|FG001|Dose Level VII|Withdrawal by Subject|0|||
23384728|NCT02533674|65151679|FG002|Dose Level VII|Withdrawal by Subject|0|||
23291647|NCT04640194|64808359|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
23291648|NCT04640194|64808360|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
23291649|NCT04640194|64808354|FG000|Overall Study|fibrinogen level too low|0|||
23291650|NCT04640194|64808355|FG001|Overall Study|fibrinogen level too low|0|||
23291651|NCT04640194|64808356|FG002|Overall Study|fibrinogen level too low|0|||
23291652|NCT04640194|64808357|FG003|Overall Study|fibrinogen level too low|1|||
23291653|NCT04640194|64808358|FG004|Overall Study|fibrinogen level too low|0|||
23291654|NCT04640194|64808359|FG005|Overall Study|fibrinogen level too low|0|||
23291655|NCT04640194|64808360|FG006|Overall Study|fibrinogen level too low|0|||
23291656|NCT04640194|64808354|FG000|Overall Study|mild bleeding|0|||
23291657|NCT04640194|64808355|FG001|Overall Study|mild bleeding|0|||
23291658|NCT04640194|64808356|FG002|Overall Study|mild bleeding|0|||
23291659|NCT04640194|64808357|FG003|Overall Study|mild bleeding|1|||
23291660|NCT04640194|64808358|FG004|Overall Study|mild bleeding|0|||
23291661|NCT04640194|64808359|FG005|Overall Study|mild bleeding|0|||
23291662|NCT04640194|64808360|FG006|Overall Study|mild bleeding|0|||
23291663|NCT04640194|64808354|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23291664|NCT04640194|64808355|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
23291665|NCT04640194|64808356|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23291666|NCT04640194|64808357|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23291667|NCT04640194|64808358|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23291668|NCT04640194|64808359|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23291669|NCT04640194|64808360|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
23291670|NCT00605176|64808372|FG000|Overall Study|Adverse Event|2|||
23291671|NCT00605176|64808373|FG001|Overall Study|Adverse Event|1|||
23291672|NCT00605176|64808374|FG002|Overall Study|Adverse Event|3|||
23291673|NCT00605176|64808372|FG000|Overall Study|Withdrawal by Subject|4|||
23291674|NCT00605176|64808373|FG001|Overall Study|Withdrawal by Subject|2|||
23291675|NCT00605176|64808374|FG002|Overall Study|Withdrawal by Subject|4|||
23291676|NCT00605176|64808372|FG000|Overall Study|Lost to Follow-up|2|||
23291677|NCT00605176|64808373|FG001|Overall Study|Lost to Follow-up|2|||
23291678|NCT00605176|64808374|FG002|Overall Study|Lost to Follow-up|1|||
23291679|NCT00605176|64808372|FG000|Overall Study|Non-complicance with study procedures|1|||
23291680|NCT00605176|64808373|FG001|Overall Study|Non-complicance with study procedures|0|||
23291681|NCT00605176|64808374|FG002|Overall Study|Non-complicance with study procedures|0|||
23291682|NCT00605176|64808372|FG000|Overall Study|Use of concomitant therapy|1|||
23291683|NCT00605176|64808373|FG001|Overall Study|Use of concomitant therapy|0|||
23291684|NCT00605176|64808374|FG002|Overall Study|Use of concomitant therapy|1|||
23291685|NCT00605176|64808372|FG000|Overall Study|Other (not due to AE)|1|||
23291686|NCT00605176|64808373|FG001|Overall Study|Other (not due to AE)|1|||
23291687|NCT00605176|64808374|FG002|Overall Study|Other (not due to AE)|0|||
23384729|NCT02533674|65151680|FG003|Dose Level VII|Withdrawal by Subject|0|||
23384730|NCT02533674|65151681|FG004|Dose Level VII|Withdrawal by Subject|0|||
23291688|NCT02063217|64808375|FG000|Overall Study|Withdrawal by Subject|1|||
23291689|NCT02063217|64808376|FG001|Overall Study|Withdrawal by Subject|0|||
23291690|NCT02063217|64808377|FG002|Overall Study|Withdrawal by Subject|0|||
23291691|NCT00360490|64808380|FG000|Overall Study|Adverse Event|4|||
23493188|NCT00917501|65551385|FG001|Overall Study|Lost to Follow-up|1|||
23291692|NCT00360490|64808381|FG001|Overall Study|Adverse Event|2|||
23291693|NCT00360490|64808380|FG000|Overall Study|Lost to Follow-up|2|||
23384731|NCT02533674|65151682|FG005|Dose Level VII|Withdrawal by Subject|0|||
23384732|NCT02533674|65151683|FG006|Dose Level VII|Withdrawal by Subject|3|||
23384733|NCT02533674|65151684|FG007|Dose Level VII|Withdrawal by Subject|0|||
23384734|NCT02533674|65151677|FG000|Dose Level VII|Treatment-related AE|0|||
23384735|NCT02533674|65151678|FG001|Dose Level VII|Treatment-related AE|0|||
23384736|NCT02533674|65151679|FG002|Dose Level VII|Treatment-related AE|0|||
23384737|NCT02533674|65151680|FG003|Dose Level VII|Treatment-related AE|0|||
23384738|NCT02533674|65151681|FG004|Dose Level VII|Treatment-related AE|0|||
23384739|NCT02533674|65151682|FG005|Dose Level VII|Treatment-related AE|0|||
23384740|NCT02533674|65151683|FG006|Dose Level VII|Treatment-related AE|1|||
23384741|NCT02533674|65151684|FG007|Dose Level VII|Treatment-related AE|0|||
23384742|NCT02533674|65151677|FG000|Dose Level VII|Death|0|||
23384743|NCT02533674|65151678|FG001|Dose Level VII|Death|0|||
23384744|NCT02533674|65151679|FG002|Dose Level VII|Death|0|||
23384745|NCT02533674|65151680|FG003|Dose Level VII|Death|0|||
23384746|NCT02533674|65151681|FG004|Dose Level VII|Death|0|||
23384747|NCT02533674|65151682|FG005|Dose Level VII|Death|0|||
23384748|NCT02533674|65151683|FG006|Dose Level VII|Death|2|||
23384749|NCT02533674|65151684|FG007|Dose Level VII|Death|0|||
23384750|NCT02533674|65151677|FG000|Dose Level VIII|Progressive disease|0|||
23384751|NCT02533674|65151678|FG001|Dose Level VIII|Progressive disease|0|||
23384752|NCT02533674|65151679|FG002|Dose Level VIII|Progressive disease|0|||
23384753|NCT02533674|65151680|FG003|Dose Level VIII|Progressive disease|0|||
23384754|NCT02533674|65151681|FG004|Dose Level VIII|Progressive disease|0|||
23384755|NCT02533674|65151682|FG005|Dose Level VIII|Progressive disease|0|||
23384756|NCT02533674|65151683|FG006|Dose Level VIII|Progressive disease|0|||
23384757|NCT02533674|65151684|FG007|Dose Level VIII|Progressive disease|3|||
23384758|NCT02533674|65151677|FG000|Dose Level VIII|Withdrawal by Subject|0|||
23384759|NCT02533674|65151678|FG001|Dose Level VIII|Withdrawal by Subject|0|||
23384760|NCT02533674|65151679|FG002|Dose Level VIII|Withdrawal by Subject|0|||
23384761|NCT02533674|65151680|FG003|Dose Level VIII|Withdrawal by Subject|0|||
23384762|NCT02533674|65151681|FG004|Dose Level VIII|Withdrawal by Subject|0|||
23384763|NCT02533674|65151682|FG005|Dose Level VIII|Withdrawal by Subject|0|||
23384764|NCT02533674|65151683|FG006|Dose Level VIII|Withdrawal by Subject|0|||
23384765|NCT02533674|65151684|FG007|Dose Level VIII|Withdrawal by Subject|1|||
23384766|NCT02533674|65151677|FG000|Dose Level VIII|Treatment-related AE|0|||
23384767|NCT02533674|65151678|FG001|Dose Level VIII|Treatment-related AE|0|||
23384768|NCT02533674|65151679|FG002|Dose Level VIII|Treatment-related AE|0|||
23384769|NCT02533674|65151680|FG003|Dose Level VIII|Treatment-related AE|0|||
23384770|NCT02533674|65151681|FG004|Dose Level VIII|Treatment-related AE|0|||
23384771|NCT02533674|65151682|FG005|Dose Level VIII|Treatment-related AE|0|||
23384772|NCT02533674|65151683|FG006|Dose Level VIII|Treatment-related AE|0|||
23384773|NCT02533674|65151684|FG007|Dose Level VIII|Treatment-related AE|1|||
23384774|NCT02533674|65151677|FG000|Dose Level VIII|Never treated|0|||
23384775|NCT02533674|65151678|FG001|Dose Level VIII|Never treated|0|||
23384776|NCT02533674|65151679|FG002|Dose Level VIII|Never treated|0|||
23384777|NCT02533674|65151680|FG003|Dose Level VIII|Never treated|0|||
23384778|NCT02533674|65151681|FG004|Dose Level VIII|Never treated|0|||
23384779|NCT02533674|65151682|FG005|Dose Level VIII|Never treated|0|||
23384780|NCT02533674|65151683|FG006|Dose Level VIII|Never treated|0|||
23384781|NCT02533674|65151684|FG007|Dose Level VIII|Never treated|1|||
23384782|NCT01472835|65151687|FG000|Overall Study|Lost to Follow-up|2|||
23384783|NCT01472835|65151688|FG001|Overall Study|Lost to Follow-up|0|||
23384784|NCT00927186|65151690|FG000|12 Months Primary Study|Adverse Event|5|||
23384785|NCT00927186|65151691|FG001|12 Months Primary Study|Adverse Event|2|||
23384786|NCT00927186|65151690|FG000|12 Months Primary Study|Lost to Follow-up|1|||
23384787|NCT00927186|65151691|FG001|12 Months Primary Study|Lost to Follow-up|0|||
23384788|NCT00927186|65151690|FG000|12 Months Primary Study|Protocol Violation|0|||
23384789|NCT00927186|65151691|FG001|12 Months Primary Study|Protocol Violation|1|||
23384790|NCT00927186|65151690|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
23384791|NCT00927186|65151691|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
23384792|NCT01902303|65151692|FG000|Overall Study|Adverse Event|0|||
23384793|NCT01902303|65151693|FG001|Overall Study|Adverse Event|1|||
23384794|NCT01902303|65151692|FG000|Overall Study|Lost to Follow-up|0|||
23384795|NCT01902303|65151693|FG001|Overall Study|Lost to Follow-up|1|||
23384796|NCT01902303|65151692|FG000|Overall Study|Protocol Violation|2|||
23384797|NCT01902303|65151693|FG001|Overall Study|Protocol Violation|2|||
23384798|NCT01902303|65151692|FG000|Overall Study|subject lost investigational product|0|||
23384799|NCT01902303|65151693|FG001|Overall Study|subject lost investigational product|1|||
23384800|NCT01902303|65151692|FG000|Overall Study|Did not develop a cold sore|21|||
23384801|NCT01902303|65151693|FG001|Overall Study|Did not develop a cold sore|19|||
23384802|NCT01390584|65151705|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
23384803|NCT01390584|65151706|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
23384804|NCT01390584|65151707|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
23384805|NCT02205359|65151708|FG000|Overall Study|Death|293|||
23384806|NCT02205359|65151709|FG001|Overall Study|Death|327|||
23384807|NCT02205359|65151708|FG000|Overall Study|Lost to Follow-up|182|||
23384808|NCT02205359|65151709|FG001|Overall Study|Lost to Follow-up|162|||
23291694|NCT00360490|64808381|FG001|Overall Study|Lost to Follow-up|1|||
23291695|NCT00360490|64808380|FG000|Overall Study|Physician Decision|2|||
23291696|NCT00360490|64808381|FG001|Overall Study|Physician Decision|1|||
23291697|NCT00360490|64808380|FG000|Overall Study|Protocol Violation|0|||
23291698|NCT00360490|64808381|FG001|Overall Study|Protocol Violation|4|||
23291699|NCT00360490|64808380|FG000|Overall Study|Withdrawal by Subject|1|||
23291700|NCT00360490|64808381|FG001|Overall Study|Withdrawal by Subject|3|||
23291701|NCT00183196|64808382|FG000|Overall Study|Withdrawal by Subject|18|||
23291702|NCT00183196|64808383|FG001|Overall Study|Withdrawal by Subject|11|||
23291703|NCT00183196|64808384|FG002|Overall Study|Withdrawal by Subject|13|||
23291704|NCT00183196|64808382|FG000|Overall Study|Adverse Event|1|||
23291705|NCT00183196|64808383|FG001|Overall Study|Adverse Event|2|||
23291706|NCT00183196|64808384|FG002|Overall Study|Adverse Event|2|||
23291707|NCT00183196|64808382|FG000|Overall Study|Legal event|1|||
23291708|NCT00183196|64808383|FG001|Overall Study|Legal event|1|||
23291709|NCT00183196|64808384|FG002|Overall Study|Legal event|1|||
23291710|NCT00183196|64808382|FG000|Overall Study|Required more intensive care|0|||
23291711|NCT00183196|64808383|FG001|Overall Study|Required more intensive care|1|||
23291712|NCT00183196|64808384|FG002|Overall Study|Required more intensive care|2|||
23291713|NCT00927251|64808385|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
23291714|NCT02259348|64808386|FG000|Overall Study|Donors|6|||
23291715|NCT02259348|64808386|FG000|Overall Study|Death|4|||
23291716|NCT01896505|64808390|FG000|Overall Study|Adverse Event|1|||
23291717|NCT01896505|64808391|FG001|Overall Study|Adverse Event|0|||
23291718|NCT01896505|64808392|FG002|Overall Study|Adverse Event|2|||
23291719|NCT01896505|64808393|FG003|Overall Study|Adverse Event|1|||
23291720|NCT01896505|64808394|FG004|Overall Study|Adverse Event|1|||
23291721|NCT01896505|64808395|FG005|Overall Study|Adverse Event|0|||
23291722|NCT01896505|64808390|FG000|Overall Study|Physician Decision|1|||
23291723|NCT01896505|64808391|FG001|Overall Study|Physician Decision|3|||
23291724|NCT01896505|64808392|FG002|Overall Study|Physician Decision|2|||
23291725|NCT01896505|64808393|FG003|Overall Study|Physician Decision|0|||
23291726|NCT01896505|64808394|FG004|Overall Study|Physician Decision|0|||
23291727|NCT01896505|64808395|FG005|Overall Study|Physician Decision|1|||
23384809|NCT02205359|65151708|FG000|Overall Study|Physician Decision|51|||
23384810|NCT02205359|65151709|FG001|Overall Study|Physician Decision|53|||
23291728|NCT01896505|64808390|FG000|Overall Study|Withdrawal by Subject|1|||
23291729|NCT01896505|64808391|FG001|Overall Study|Withdrawal by Subject|0|||
23291730|NCT01896505|64808392|FG002|Overall Study|Withdrawal by Subject|3|||
23291731|NCT01896505|64808393|FG003|Overall Study|Withdrawal by Subject|1|||
23384811|NCT02205359|65151708|FG000|Overall Study|Withdrawal by Subject|167|||
23291732|NCT01896505|64808394|FG004|Overall Study|Withdrawal by Subject|0|||
23291733|NCT01896505|64808395|FG005|Overall Study|Withdrawal by Subject|0|||
23291734|NCT01896505|64808390|FG000|Overall Study|Disease Progression|7|||
23384812|NCT02205359|65151709|FG001|Overall Study|Withdrawal by Subject|169|||
23384813|NCT00806026|65151710|FG000|Overall Study|Death|0|||
23384814|NCT00806026|65151711|FG001|Overall Study|Death|0|||
23384815|NCT00806026|65151712|FG002|Overall Study|Death|0|||
23291735|NCT01896505|64808391|FG001|Overall Study|Disease Progression|5|||
23291736|NCT01896505|64808392|FG002|Overall Study|Disease Progression|8|||
23291737|NCT01896505|64808393|FG003|Overall Study|Disease Progression|4|||
23291738|NCT01896505|64808394|FG004|Overall Study|Disease Progression|4|||
23291739|NCT01896505|64808395|FG005|Overall Study|Disease Progression|4|||
23291740|NCT01896505|64808390|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
23291741|NCT01896505|64808391|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
23291742|NCT01896505|64808392|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
23291743|NCT01896505|64808393|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
23291744|NCT01896505|64808394|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
23291745|NCT01896505|64808395|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
23291746|NCT01896505|64808390|FG000|Overall Study|Intercurrent illness|0|||
23291747|NCT01896505|64808391|FG001|Overall Study|Intercurrent illness|1|||
23291748|NCT01896505|64808392|FG002|Overall Study|Intercurrent illness|0|||
23384816|NCT00806026|65151713|FG003|Overall Study|Death|1|||
23384817|NCT00806026|65151714|FG004|Overall Study|Death|0|||
23384818|NCT00806026|65151715|FG005|Overall Study|Death|0|||
23384819|NCT00806026|65151710|FG000|Overall Study|Did not meet entrance criteria|4|||
23384820|NCT00806026|65151711|FG001|Overall Study|Did not meet entrance criteria|1|||
23384821|NCT00806026|65151712|FG002|Overall Study|Did not meet entrance criteria|2|||
23384822|NCT00806026|65151713|FG003|Overall Study|Did not meet entrance criteria|1|||
23384823|NCT00806026|65151714|FG004|Overall Study|Did not meet entrance criteria|0|||
23384824|NCT00806026|65151715|FG005|Overall Study|Did not meet entrance criteria|0|||
23384825|NCT00806026|65151710|FG000|Overall Study|Lack of Efficacy|5|||
23384826|NCT00806026|65151711|FG001|Overall Study|Lack of Efficacy|18|||
23384827|NCT00806026|65151712|FG002|Overall Study|Lack of Efficacy|13|||
23384828|NCT00806026|65151713|FG003|Overall Study|Lack of Efficacy|4|||
23384829|NCT00806026|65151714|FG004|Overall Study|Lack of Efficacy|8|||
23291749|NCT01896505|64808393|FG003|Overall Study|Intercurrent illness|0|||
23291750|NCT01896505|64808394|FG004|Overall Study|Intercurrent illness|0|||
23291751|NCT01896505|64808395|FG005|Overall Study|Intercurrent illness|0|||
23291752|NCT01896505|64808390|FG000|Overall Study|Death|0|||
23291753|NCT01896505|64808391|FG001|Overall Study|Death|0|||
23291754|NCT01896505|64808392|FG002|Overall Study|Death|1|||
23291755|NCT01896505|64808393|FG003|Overall Study|Death|1|||
23291756|NCT01896505|64808394|FG004|Overall Study|Death|0|||
23291757|NCT01896505|64808395|FG005|Overall Study|Death|1|||
23291758|NCT01560819|64808396|FG000|Overall Study|Physician Decision|1|||
23291759|NCT01560819|64808397|FG001|Overall Study|Physician Decision|0|||
23291760|NCT01264835|64808398|FG000|Overall Study|Lost to Follow-up|1|||
23291761|NCT00124462|64808403|FG000|Overall Study|Lost to Follow-up|3|||
23291762|NCT00124462|64808404|FG001|Overall Study|Lost to Follow-up|3|||
23291763|NCT00124462|64808403|FG000|Overall Study|Physician Decision|3|||
23291764|NCT00124462|64808404|FG001|Overall Study|Physician Decision|4|||
23291765|NCT00124462|64808403|FG000|Overall Study|Withdrawal by Subject|4|||
23291766|NCT00124462|64808404|FG001|Overall Study|Withdrawal by Subject|5|||
23291767|NCT00124462|64808403|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
23291768|NCT00124462|64808404|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
23291769|NCT02329431|64808408|FG000|Overall Study|Lost to Follow-up|20|||
23291770|NCT02329431|64808409|FG001|Overall Study|Lost to Follow-up|13|||
23291771|NCT03507686|64808410|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
23291772|NCT03507686|64808411|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
23291773|NCT03507686|64808410|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
23291774|NCT03507686|64808411|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
23291775|NCT03507686|64808410|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
23291776|NCT03507686|64808411|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
23291777|NCT03507686|64808410|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
23291778|NCT03507686|64808411|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
23384830|NCT00806026|65151715|FG005|Overall Study|Lack of Efficacy|7|||
23384831|NCT00806026|65151710|FG000|Overall Study|Lost to Follow-up|8|||
23493189|NCT00917501|65551384|FG000|Overall Study|Withdrawal by Subject|3|||
23384832|NCT00806026|65151711|FG001|Overall Study|Lost to Follow-up|15|||
23493190|NCT00917501|65551385|FG001|Overall Study|Withdrawal by Subject|1|||
23493191|NCT00917501|65551384|FG000|Overall Study|Lack of Efficacy|1|||
23291779|NCT03507686|64808410|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
23291780|NCT03507686|64808411|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
23291781|NCT03507686|64808410|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
23291782|NCT03507686|64808411|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
23291783|NCT04590781|64808412|FG000|Overall Study|Death|0|||
23291784|NCT04590781|64808413|FG001|Overall Study|Death|2|||
23384833|NCT00806026|65151712|FG002|Overall Study|Lost to Follow-up|8|||
23291785|NCT04590781|64808412|FG000|Overall Study|Withdrawal by Subject|2|||
23291786|NCT04590781|64808413|FG001|Overall Study|Withdrawal by Subject|0|||
23291787|NCT05135273|64808414|FG000|Overall Study|Recruited into the army|0|||
23291788|NCT05135273|64808415|FG001|Overall Study|Recruited into the army|0|||
23291789|NCT05135273|64808416|FG002|Overall Study|Recruited into the army|0|||
23291790|NCT05135273|64808417|FG003|Overall Study|Recruited into the army|0|||
23291791|NCT05135273|64808418|FG004|Overall Study|Recruited into the army|1|||
23291792|NCT05135273|64808419|FG005|Overall Study|Recruited into the army|0|||
23291793|NCT05135273|64808420|FG006|Overall Study|Recruited into the army|0|||
23291794|NCT05135273|64808421|FG007|Overall Study|Recruited into the army|0|||
23291795|NCT05135273|64808414|FG000|Overall Study|Moved away from study site|0|||
23384834|NCT00806026|65151713|FG003|Overall Study|Lost to Follow-up|2|||
23384835|NCT00806026|65151714|FG004|Overall Study|Lost to Follow-up|6|||
23384836|NCT00806026|65151715|FG005|Overall Study|Lost to Follow-up|6|||
23384837|NCT00806026|65151710|FG000|Overall Study|Withdrawal by Subject|14|||
23384838|NCT00806026|65151711|FG001|Overall Study|Withdrawal by Subject|17|||
23384839|NCT00806026|65151712|FG002|Overall Study|Withdrawal by Subject|9|||
23291796|NCT05135273|64808415|FG001|Overall Study|Moved away from study site|0|||
23291797|NCT05135273|64808416|FG002|Overall Study|Moved away from study site|0|||
23291798|NCT05135273|64808417|FG003|Overall Study|Moved away from study site|0|||
23291799|NCT05135273|64808418|FG004|Overall Study|Moved away from study site|0|||
23291800|NCT05135273|64808419|FG005|Overall Study|Moved away from study site|1|||
23291801|NCT05135273|64808420|FG006|Overall Study|Moved away from study site|1|||
23291802|NCT05135273|64808421|FG007|Overall Study|Moved away from study site|0|||
23291803|NCT05135273|64808414|FG000|Overall Study|Travel|0|||
23291804|NCT05135273|64808415|FG001|Overall Study|Travel|0|||
23291805|NCT05135273|64808416|FG002|Overall Study|Travel|0|||
23291806|NCT05135273|64808417|FG003|Overall Study|Travel|0|||
23291807|NCT05135273|64808418|FG004|Overall Study|Travel|0|||
23291808|NCT05135273|64808419|FG005|Overall Study|Travel|0|||
23291809|NCT05135273|64808420|FG006|Overall Study|Travel|0|||
23291810|NCT05135273|64808421|FG007|Overall Study|Travel|1|||
23291811|NCT01040793|64808422|FG000|Overall Study|Adverse Event|5|||
23291812|NCT01040793|64808423|FG001|Overall Study|Adverse Event|3|||
23291813|NCT01040793|64808424|FG002|Overall Study|Adverse Event|0|||
23291814|NCT01040793|64808425|FG003|Overall Study|Adverse Event|2|||
23291815|NCT01040793|64808426|FG004|Overall Study|Adverse Event|2|||
23291816|NCT01040793|64808427|FG005|Overall Study|Adverse Event|1|||
23291817|NCT01040793|64808422|FG000|Overall Study|Protocol Violation|1|||
23291818|NCT01040793|64808423|FG001|Overall Study|Protocol Violation|1|||
23291819|NCT01040793|64808424|FG002|Overall Study|Protocol Violation|1|||
23291820|NCT01040793|64808425|FG003|Overall Study|Protocol Violation|0|||
23291821|NCT01040793|64808426|FG004|Overall Study|Protocol Violation|1|||
23291822|NCT01040793|64808427|FG005|Overall Study|Protocol Violation|0|||
23291823|NCT01040793|64808422|FG000|Overall Study|Lost to Follow-up|0|||
23291824|NCT01040793|64808423|FG001|Overall Study|Lost to Follow-up|1|||
23291825|NCT01040793|64808424|FG002|Overall Study|Lost to Follow-up|1|||
23384840|NCT00806026|65151713|FG003|Overall Study|Withdrawal by Subject|2|||
23384841|NCT00806026|65151714|FG004|Overall Study|Withdrawal by Subject|5|||
23384842|NCT00806026|65151715|FG005|Overall Study|Withdrawal by Subject|3|||
23384843|NCT00806026|65151710|FG000|Overall Study|Other|3|||
23384844|NCT00806026|65151711|FG001|Overall Study|Other|6|||
23384845|NCT00806026|65151712|FG002|Overall Study|Other|8|||
23384846|NCT00806026|65151713|FG003|Overall Study|Other|2|||
23384847|NCT00806026|65151714|FG004|Overall Study|Other|0|||
23384848|NCT00806026|65151715|FG005|Overall Study|Other|4|||
23384849|NCT00806026|65151710|FG000|Overall Study|Protocol Violation|6|||
23384850|NCT00806026|65151711|FG001|Overall Study|Protocol Violation|9|||
23384851|NCT00806026|65151712|FG002|Overall Study|Protocol Violation|9|||
23384852|NCT00806026|65151713|FG003|Overall Study|Protocol Violation|0|||
23384853|NCT00806026|65151714|FG004|Overall Study|Protocol Violation|2|||
23384854|NCT00806026|65151715|FG005|Overall Study|Protocol Violation|3|||
23291826|NCT01040793|64808425|FG003|Overall Study|Lost to Follow-up|0|||
23291827|NCT01040793|64808426|FG004|Overall Study|Lost to Follow-up|0|||
23291828|NCT01040793|64808427|FG005|Overall Study|Lost to Follow-up|0|||
23291829|NCT01040793|64808422|FG000|Overall Study|Withdrawal by Subject|0|||
23291830|NCT01040793|64808423|FG001|Overall Study|Withdrawal by Subject|0|||
23291831|NCT01040793|64808424|FG002|Overall Study|Withdrawal by Subject|0|||
23291832|NCT01040793|64808425|FG003|Overall Study|Withdrawal by Subject|2|||
23291833|NCT01040793|64808426|FG004|Overall Study|Withdrawal by Subject|0|||
23291834|NCT01040793|64808427|FG005|Overall Study|Withdrawal by Subject|0|||
23291835|NCT01040793|64808422|FG000|Overall Study|Other reasons not listed above|0|||
23291836|NCT01040793|64808423|FG001|Overall Study|Other reasons not listed above|0|||
23291837|NCT01040793|64808424|FG002|Overall Study|Other reasons not listed above|1|||
23291838|NCT01040793|64808425|FG003|Overall Study|Other reasons not listed above|0|||
23291839|NCT01040793|64808426|FG004|Overall Study|Other reasons not listed above|1|||
23384855|NCT00806026|65151710|FG000|Overall Study|Adverse Event|52|||
23384856|NCT00806026|65151711|FG001|Overall Study|Adverse Event|35|||
23384857|NCT00806026|65151712|FG002|Overall Study|Adverse Event|44|||
23291840|NCT01040793|64808427|FG005|Overall Study|Other reasons not listed above|0|||
23291841|NCT04592419|64808428|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
23291842|NCT04592419|64808429|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
23291843|NCT04592419|64808428|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
23291844|NCT04592419|64808429|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
23291845|NCT04592419|64808428|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
23291846|NCT04592419|64808429|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
23291847|NCT04592419|64808428|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
23291848|NCT04592419|64808429|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
23291849|NCT04592419|64808428|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
23291850|NCT04592419|64808429|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
23291851|NCT04592419|64808428|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
23291852|NCT04592419|64808429|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
23291853|NCT04592419|64808428|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
23291854|NCT04592419|64808429|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
23384858|NCT00806026|65151713|FG003|Overall Study|Adverse Event|17|||
23384859|NCT00806026|65151714|FG004|Overall Study|Adverse Event|9|||
23384860|NCT00806026|65151715|FG005|Overall Study|Adverse Event|9|||
23384861|NCT01402700|65151716|FG000|Overall Study|Death|3|||
23384862|NCT01402700|65151716|FG000|Overall Study|Withdrawal by Subject|3|||
23384863|NCT01402700|65151716|FG000|Overall Study|Missed Visit|1|||
23384864|NCT01421134|65151717|FG000|Overall Study|Adverse Event|3|||
23384865|NCT01421134|65151718|FG001|Overall Study|Adverse Event|5|||
23384866|NCT01421134|65151717|FG000|Overall Study|Lack of Efficacy|2|||
23384867|NCT01421134|65151718|FG001|Overall Study|Lack of Efficacy|4|||
23384868|NCT01421134|65151717|FG000|Overall Study|Protocol Violation|0|||
23384869|NCT01421134|65151718|FG001|Overall Study|Protocol Violation|3|||
23384870|NCT01421134|65151717|FG000|Overall Study|Withdrawal by Subject|1|||
23384871|NCT01421134|65151718|FG001|Overall Study|Withdrawal by Subject|1|||
23384872|NCT01421134|65151717|FG000|Overall Study|Administrative|0|||
23384873|NCT01421134|65151718|FG001|Overall Study|Administrative|1|||
23384874|NCT01421134|65151717|FG000|Overall Study|Lost to Follow-up|1|||
23384875|NCT01421134|65151718|FG001|Overall Study|Lost to Follow-up|1|||
23384876|NCT02821000|65151720|FG000|Overall Study|Death|89|||
23384877|NCT02821000|65151720|FG000|Overall Study|Sponsor Decision|12|||
23384878|NCT02821000|65151720|FG000|Overall Study|Withdrawal by Subject|2|||
23384879|NCT04495478|65151721|FG000|Overall Study|Withdrawal by Subject|0|||
23384880|NCT04495478|65151722|FG001|Overall Study|Withdrawal by Subject|0|||
23384881|NCT04495478|65151723|FG002|Overall Study|Withdrawal by Subject|0|||
23384882|NCT04495478|65151724|FG003|Overall Study|Withdrawal by Subject|1|||
23384883|NCT04495478|65151725|FG004|Overall Study|Withdrawal by Subject|0|||
23384884|NCT04495478|65151726|FG005|Overall Study|Withdrawal by Subject|0|||
23384885|NCT04495478|65151727|FG006|Overall Study|Withdrawal by Subject|0|||
23384886|NCT04495478|65151721|FG000|Overall Study|Physician Decision|0|||
23384887|NCT04495478|65151722|FG001|Overall Study|Physician Decision|1|||
23384888|NCT04495478|65151723|FG002|Overall Study|Physician Decision|0|||
23384889|NCT04495478|65151724|FG003|Overall Study|Physician Decision|0|||
23384890|NCT04495478|65151725|FG004|Overall Study|Physician Decision|1|||
23384891|NCT04495478|65151726|FG005|Overall Study|Physician Decision|0|||
23384892|NCT04495478|65151727|FG006|Overall Study|Physician Decision|0|||
23384893|NCT03055195|65154901|FG000|Overall Study|Lack of Efficacy|1|||
23384894|NCT03055195|65154902|FG001|Overall Study|Lack of Efficacy|0|||
23384895|NCT03055195|65154901|FG000|Overall Study|Withdrawal by Subject|6|||
23384896|NCT03055195|65154902|FG001|Overall Study|Withdrawal by Subject|7|||
23384897|NCT03055195|65154901|FG000|Overall Study|Study Terminated by Sponsor|2|||
23384898|NCT03055195|65154902|FG001|Overall Study|Study Terminated by Sponsor|6|||
23384899|NCT03055195|65154901|FG000|Overall Study|Protocol Violation|2|||
23384900|NCT03055195|65154902|FG001|Overall Study|Protocol Violation|1|||
23384901|NCT03055195|65154901|FG000|Overall Study|Physician Decision|1|||
23384902|NCT03055195|65154902|FG001|Overall Study|Physician Decision|0|||
23384903|NCT03020888|65154903|FG000|Overall Study|Physician Decision|4|||
23493192|NCT00917501|65551385|FG001|Overall Study|Lack of Efficacy|2|||
23493193|NCT00917501|65551384|FG000|Overall Study|trouble swollowing capsules|0|||
23291855|NCT04592419|64808428|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
23291856|NCT04592419|64808429|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
23384904|NCT03020888|65154903|FG000|Overall Study|Withdrawal by Subject|6|||
23384905|NCT03020888|65154903|FG000|Overall Study|Insurance coverage|2|||
23493194|NCT00917501|65551385|FG001|Overall Study|trouble swollowing capsules|1|||
23384906|NCT03020888|65154903|FG000|Overall Study|Lost to Follow-up|1|||
23384907|NCT01208051|65154904|FG000|Total Enrollment|Withdrawal by Subject|0|||
23384908|NCT01208051|65154905|FG001|Total Enrollment|Withdrawal by Subject|1|||
23384909|NCT01208051|65154906|FG002|Total Enrollment|Withdrawal by Subject|0|||
23384910|NCT01208051|65154907|FG003|Total Enrollment|Withdrawal by Subject|0|||
23384911|NCT01208051|65154908|FG004|Total Enrollment|Withdrawal by Subject|2|||
23291857|NCT04592419|64808428|FG000|Open-Label Extension Period|Adverse Event|1|||
23291858|NCT04592419|64808429|FG001|Open-Label Extension Period|Adverse Event|2|||
23291859|NCT04592419|64808428|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
23291860|NCT04592419|64808429|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
23291861|NCT04592419|64808428|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
23291862|NCT04592419|64808429|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
23291863|NCT04592419|64808428|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
23291864|NCT04592419|64808429|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
23291865|NCT04592419|64808428|FG000|Open-Label Extension Period|Sponsor Request|73|||
23291866|NCT04592419|64808429|FG001|Open-Label Extension Period|Sponsor Request|84|||
23291867|NCT02875028|64808430|FG000|Washout Period|Withdrawal by Subject|0|||
23291868|NCT02875028|64808431|FG001|Washout Period|Withdrawal by Subject|1|||
23291869|NCT01337596|64808432|FG000|Overall Study|Withdrawal by Subject|0|||
23291870|NCT01337596|64808433|FG001|Overall Study|Withdrawal by Subject|0|||
23291871|NCT01337596|64808434|FG002|Overall Study|Withdrawal by Subject|0|||
23291872|NCT01337596|64808435|FG003|Overall Study|Withdrawal by Subject|0|||
23291873|NCT01337596|64808436|FG004|Overall Study|Withdrawal by Subject|2|||
23291874|NCT01337596|64808437|FG005|Overall Study|Withdrawal by Subject|0|||
23291875|NCT01337596|64808438|FG006|Overall Study|Withdrawal by Subject|0|||
23291876|NCT01337596|64808439|FG007|Overall Study|Withdrawal by Subject|0|||
23291877|NCT01337596|64808440|FG008|Overall Study|Withdrawal by Subject|0|||
23291878|NCT02805309|64808441|FG000|Overall Study|Lost to Follow-up|2|||
23291879|NCT02805309|64808442|FG001|Overall Study|Lost to Follow-up|2|||
23291880|NCT02805309|64808443|FG002|Overall Study|Lost to Follow-up|2|||
23291881|NCT02805309|64808441|FG000|Overall Study|Post-Randomization Exclusion|0|||
23291882|NCT02805309|64808442|FG001|Overall Study|Post-Randomization Exclusion|2|||
23291883|NCT02805309|64808443|FG002|Overall Study|Post-Randomization Exclusion|1|||
23291884|NCT00982228|64808444|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
23291885|NCT00982228|64808445|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
23291886|NCT00982228|64808444|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
23291887|NCT00982228|64808445|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
23291888|NCT00982228|64808444|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
23291889|NCT00982228|64808445|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
23291890|NCT00982228|64808444|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
23291891|NCT00982228|64808445|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
23291892|NCT00982228|64808444|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
23384912|NCT01208051|65154904|FG000|Total Enrollment|Brain metastases|0|||
23384913|NCT01208051|65154905|FG001|Total Enrollment|Brain metastases|0|||
23384914|NCT01208051|65154906|FG002|Total Enrollment|Brain metastases|1|||
23384915|NCT01208051|65154907|FG003|Total Enrollment|Brain metastases|0|||
23384916|NCT01208051|65154908|FG004|Total Enrollment|Brain metastases|0|||
23384917|NCT04243837|65154910|FG000|Overall Study|Adverse Event|2|||
23384918|NCT04243837|65154911|FG001|Overall Study|Adverse Event|1|||
23384919|NCT04243837|65154910|FG000|Overall Study|Withdrawal by Subject|4|||
23384920|NCT04243837|65154911|FG001|Overall Study|Withdrawal by Subject|2|||
23384921|NCT04243837|65154910|FG000|Overall Study|Covid-19 lock down|1|||
23384922|NCT04243837|65154911|FG001|Overall Study|Covid-19 lock down|0|||
23384923|NCT04243837|65154910|FG000|Overall Study|Study Terminated by Sponsor|11|||
23384924|NCT04243837|65154911|FG001|Overall Study|Study Terminated by Sponsor|12|||
23384925|NCT03478787|65154915|FG000|Overall Study|Adverse Event|5|||
23384926|NCT03478787|65154916|FG001|Overall Study|Adverse Event|1|||
23384927|NCT03478787|65154915|FG000|Overall Study|Protocol Violation|3|||
23384928|NCT03478787|65154916|FG001|Overall Study|Protocol Violation|0|||
23384929|NCT03478787|65154915|FG000|Overall Study|Lack of Efficacy|7|||
23384930|NCT03478787|65154916|FG001|Overall Study|Lack of Efficacy|1|||
23493195|NCT00100178|65551386|FG000|Overall Study|Lost to Follow-up|0|||
23291893|NCT00982228|64808445|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
23291894|NCT00982228|64808444|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
23291895|NCT00982228|64808445|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
23291896|NCT00982228|64808444|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
23291897|NCT00982228|64808445|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
23291898|NCT00982228|64808444|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
23291899|NCT00982228|64808445|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
23291900|NCT00982228|64808444|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
23291901|NCT00982228|64808445|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
23291902|NCT00982228|64808444|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
23291903|NCT00982228|64808445|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
23384931|NCT03478787|65154915|FG000|Overall Study|Lost to Follow-up|9|||
23384932|NCT03478787|65154916|FG001|Overall Study|Lost to Follow-up|5|||
23384933|NCT03478787|65154915|FG000|Overall Study|Withdrawal by Subject|2|||
23384934|NCT03478787|65154916|FG001|Overall Study|Withdrawal by Subject|6|||
23384935|NCT03478787|65154915|FG000|Overall Study|Other, Not Specified|3|||
23384936|NCT03478787|65154916|FG001|Overall Study|Other, Not Specified|0|||
23291904|NCT01261624|64808450|FG000|Week 0 to Week 12|Disease Progression|1|||
23291905|NCT01261624|64808451|FG001|Week 0 to Week 12|Disease Progression|1|||
23291906|NCT01261624|64808450|FG000|Week 0 to Week 12|Insufficient Response|0|||
23291907|NCT01261624|64808451|FG001|Week 0 to Week 12|Insufficient Response|2|||
23291908|NCT01261624|64808450|FG000|Week 13 to Week 24|Insufficient Response|0|||
23291909|NCT01261624|64808451|FG001|Week 13 to Week 24|Insufficient Response|1|||
23291910|NCT02539368|64808452|FG000|Overall Study|Death|4|||
23291911|NCT02539368|64808453|FG001|Overall Study|Death|2|||
23291912|NCT02539368|64808454|FG002|Overall Study|Death|1|||
23291913|NCT02539368|64808455|FG003|Overall Study|Death|0|||
23291914|NCT02539368|64808456|FG004|Overall Study|Death|0|||
23291915|NCT02539368|64808452|FG000|Overall Study|Withdrawal by Subject|44|||
23291916|NCT02539368|64808453|FG001|Overall Study|Withdrawal by Subject|35|||
23291917|NCT02539368|64808454|FG002|Overall Study|Withdrawal by Subject|9|||
23384937|NCT01524705|65154917|FG000|Overall Study|Adverse Event|2|||
23384938|NCT01524705|65154918|FG001|Overall Study|Adverse Event|0|||
23384939|NCT01524705|65154917|FG000|Overall Study|Death|1|||
23384940|NCT01524705|65154918|FG001|Overall Study|Death|0|||
23384941|NCT01524705|65154917|FG000|Overall Study|Lost to Follow-up|0|||
23384942|NCT01524705|65154918|FG001|Overall Study|Lost to Follow-up|1|||
23384943|NCT01524705|65154917|FG000|Overall Study|Withdrawal by Subject|0|||
23384944|NCT01524705|65154918|FG001|Overall Study|Withdrawal by Subject|1|||
23384945|NCT01524705|65154917|FG000|Overall Study|Pancreatic Cancer|0|||
23384946|NCT01524705|65154918|FG001|Overall Study|Pancreatic Cancer|1|||
23384947|NCT01734928|65154921|FG000|Randomization|Physician Decision|0|||
23384948|NCT01734928|65154922|FG001|Randomization|Physician Decision|1|||
23384949|NCT01734928|65154921|FG000|Randomization|clinical progression|0|||
23384950|NCT01734928|65154922|FG001|Randomization|clinical progression|1|||
23384951|NCT01734928|65154921|FG000|Randomization|progressive disease|0|||
23384952|NCT01734928|65154922|FG001|Randomization|progressive disease|2|||
23384953|NCT01734928|65154921|FG000|Randomization|Withdrew informed consent|0|||
23384954|NCT01734928|65154922|FG001|Randomization|Withdrew informed consent|4|||
23384955|NCT01734928|65154921|FG000|Randomization|Death|1|||
23384956|NCT01734928|65154922|FG001|Randomization|Death|0|||
23384957|NCT01734928|65154921|FG000|Randomization|Randomization error|1|||
23384958|NCT01734928|65154922|FG001|Randomization|Randomization error|0|||
23384959|NCT01734928|65154921|FG000|Randomization|Lost to Follow-up|1|||
23384960|NCT01734928|65154922|FG001|Randomization|Lost to Follow-up|0|||
23384961|NCT01734928|65154921|FG000|Treatment Period|Lost to Follow-up|0|||
23384962|NCT01734928|65154922|FG001|Treatment Period|Lost to Follow-up|2|||
23384963|NCT01734928|65154921|FG000|Treatment Period|Progressive Disease|167|||
23384964|NCT01734928|65154922|FG001|Treatment Period|Progressive Disease|165|||
23291918|NCT02539368|64808455|FG003|Overall Study|Withdrawal by Subject|1|||
23291919|NCT02539368|64808456|FG004|Overall Study|Withdrawal by Subject|3|||
23291920|NCT02539368|64808452|FG000|Overall Study|Physician Decision|49|||
23384965|NCT01734928|65154921|FG000|Treatment Period|Adverse Event|39|||
23384966|NCT01734928|65154922|FG001|Treatment Period|Adverse Event|52|||
23384967|NCT01734928|65154921|FG000|Treatment Period|Withdrawal of Consent|25|||
23291921|NCT02539368|64808453|FG001|Overall Study|Physician Decision|15|||
23291922|NCT02539368|64808454|FG002|Overall Study|Physician Decision|7|||
23291923|NCT02539368|64808455|FG003|Overall Study|Physician Decision|0|||
23291924|NCT02539368|64808456|FG004|Overall Study|Physician Decision|2|||
23384968|NCT01734928|65154922|FG001|Treatment Period|Withdrawal of Consent|22|||
23291925|NCT02539368|64808452|FG000|Overall Study|Lost to Follow-up|96|||
23384969|NCT01734928|65154921|FG000|Treatment Period|Death|20|||
23384970|NCT01734928|65154922|FG001|Treatment Period|Death|9|||
23384971|NCT01734928|65154921|FG000|Treatment Period|Other Reasons|27|||
23291926|NCT02539368|64808453|FG001|Overall Study|Lost to Follow-up|21|||
23291927|NCT02539368|64808454|FG002|Overall Study|Lost to Follow-up|16|||
23291928|NCT02539368|64808455|FG003|Overall Study|Lost to Follow-up|4|||
23291929|NCT02539368|64808456|FG004|Overall Study|Lost to Follow-up|3|||
23291930|NCT02539368|64808452|FG000|Overall Study|Adverse Event|44|||
23291931|NCT02539368|64808453|FG001|Overall Study|Adverse Event|5|||
23291932|NCT02539368|64808454|FG002|Overall Study|Adverse Event|9|||
23291933|NCT02539368|64808455|FG003|Overall Study|Adverse Event|0|||
23291934|NCT02539368|64808456|FG004|Overall Study|Adverse Event|3|||
23291935|NCT02539368|64808452|FG000|Overall Study|Participant Non-compliant|13|||
23291936|NCT02539368|64808453|FG001|Overall Study|Participant Non-compliant|2|||
23291937|NCT02539368|64808454|FG002|Overall Study|Participant Non-compliant|1|||
23291938|NCT02539368|64808455|FG003|Overall Study|Participant Non-compliant|1|||
23291939|NCT02539368|64808456|FG004|Overall Study|Participant Non-compliant|0|||
23291940|NCT02539368|64808452|FG000|Overall Study|Other|145|||
23291941|NCT02539368|64808453|FG001|Overall Study|Other|18|||
23291942|NCT02539368|64808454|FG002|Overall Study|Other|24|||
23291943|NCT02539368|64808455|FG003|Overall Study|Other|1|||
23291944|NCT02539368|64808456|FG004|Overall Study|Other|3|||
23291945|NCT02539368|64808452|FG000|Overall Study|Missing|10|||
23384972|NCT01734928|65154922|FG001|Treatment Period|Other Reasons|19|||
23384973|NCT01734928|65154921|FG000|Treatment Period|Pregnancy|0|||
23384974|NCT01734928|65154922|FG001|Treatment Period|Pregnancy|1|||
23384975|NCT01829165|65154924|FG000|Overall Study|Did not complete intervention|2|||
23384976|NCT01829165|65154925|FG001|Overall Study|Did not complete intervention|0|||
23384977|NCT01720602|65154929|FG000|Overall Study|Adverse Event|3|||
23384978|NCT01720602|65154929|FG000|Overall Study|Progressive disease on therapy|2|||
23384979|NCT01370642|65154930|FG000|Overall Study|Adverse Event|2|||
23384980|NCT01370642|65154931|FG001|Overall Study|Adverse Event|1|||
23384981|NCT01370642|65154932|FG002|Overall Study|Adverse Event|1|||
23384982|NCT01370642|65154930|FG000|Overall Study|Detectable HCV RNA|0|||
23384983|NCT01370642|65154931|FG001|Overall Study|Detectable HCV RNA|0|||
23384984|NCT01370642|65154932|FG002|Overall Study|Detectable HCV RNA|22|||
23384985|NCT01370642|65154930|FG000|Overall Study|Lost to Follow-up|0|||
23384986|NCT01370642|65154931|FG001|Overall Study|Lost to Follow-up|0|||
23384987|NCT01370642|65154932|FG002|Overall Study|Lost to Follow-up|1|||
23384988|NCT01370642|65154930|FG000|Overall Study|Physician Decision|4|||
23384989|NCT01370642|65154931|FG001|Overall Study|Physician Decision|1|||
23384990|NCT01370642|65154932|FG002|Overall Study|Physician Decision|2|||
23384991|NCT01370642|65154930|FG000|Overall Study|Withdrawal by Subject|2|||
23384992|NCT01370642|65154931|FG001|Overall Study|Withdrawal by Subject|4|||
23384993|NCT01370642|65154932|FG002|Overall Study|Withdrawal by Subject|3|||
23384994|NCT01283386|65154937|FG000|Overall Study|Death|2|||
23384995|NCT01283386|65154938|FG001|Overall Study|Death|0|||
23384996|NCT01283386|65154937|FG000|Overall Study|Withdrawal by Subject|2|||
23384997|NCT01283386|65154938|FG001|Overall Study|Withdrawal by Subject|1|||
23384998|NCT01283386|65154937|FG000|Overall Study|Relapse of underlying disease|1|||
23384999|NCT01283386|65154938|FG001|Overall Study|Relapse of underlying disease|3|||
23385000|NCT01283386|65154937|FG000|Overall Study|Progression of underlying disease|2|||
23385001|NCT01283386|65154938|FG001|Overall Study|Progression of underlying disease|7|||
23385002|NCT01283386|65154937|FG000|Overall Study|Reason not specified|1|||
23385003|NCT01283386|65154938|FG001|Overall Study|Reason not specified|0|||
23385004|NCT01283386|65154937|FG000|Overall Study|Protocol Violation|0|||
23385005|NCT01283386|65154938|FG001|Overall Study|Protocol Violation|1|||
23385006|NCT00176254|65154939|FG000|Overall Study|Lost to Follow-up|1|||
23385007|NCT03156621|65154944|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
23385008|NCT03156621|65154945|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
23385009|NCT03156621|65154944|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
23385010|NCT03156621|65154945|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
23385011|NCT02573467|65154947|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
23385012|NCT02573467|65154948|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
23385013|NCT02573467|65154949|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
23385014|NCT02573467|65154950|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
23385015|NCT02573467|65154947|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
23385016|NCT02573467|65154948|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
23385017|NCT02573467|65154949|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
23385018|NCT02573467|65154950|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
23385019|NCT02573467|65154947|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
23493196|NCT00100178|65551387|FG001|Overall Study|Lost to Follow-up|6|||
23385020|NCT02573467|65154948|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
23385021|NCT02573467|65154949|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
23385022|NCT02573467|65154950|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
23385023|NCT02573467|65154947|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
23385024|NCT02573467|65154948|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
23385025|NCT02573467|65154949|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
23385026|NCT02573467|65154950|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
23385027|NCT02573467|65154947|FG000|Post-treatment Follow up Epoch|Death|1|||
23385028|NCT02573467|65154948|FG001|Post-treatment Follow up Epoch|Death|1|||
23385029|NCT02573467|65154949|FG002|Post-treatment Follow up Epoch|Death|0|||
23385030|NCT02573467|65154950|FG003|Post-treatment Follow up Epoch|Death|1|||
23385031|NCT02573467|65154947|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
23385032|NCT02573467|65154948|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
23385033|NCT02573467|65154949|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
23385034|NCT02573467|65154950|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
23385035|NCT02573467|65154947|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
23385036|NCT02573467|65154948|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
23385037|NCT02573467|65154949|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
23385038|NCT02573467|65154950|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
23385039|NCT01429623|65154951|FG000|Overall Study|Death|1|||
23385040|NCT01429623|65154952|FG001|Overall Study|Death|0|||
23385041|NCT01429623|65154951|FG000|Overall Study|Adverse Event|7|||
23385042|NCT01429623|65154952|FG001|Overall Study|Adverse Event|14|||
23385043|NCT01429623|65154951|FG000|Overall Study|Withdrawal by Subject|19|||
23385044|NCT01429623|65154952|FG001|Overall Study|Withdrawal by Subject|13|||
23385045|NCT01429623|65154951|FG000|Overall Study|Physician Decision|2|||
23385046|NCT01429623|65154952|FG001|Overall Study|Physician Decision|3|||
23385047|NCT01429623|65154951|FG000|Overall Study|Protocol Violation|3|||
23385048|NCT01429623|65154952|FG001|Overall Study|Protocol Violation|2|||
23385049|NCT01429623|65154951|FG000|Overall Study|Assorted|1|||
23385050|NCT01429623|65154952|FG001|Overall Study|Assorted|2|||
23385051|NCT01429623|65154951|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
23385052|NCT01429623|65154952|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
23385053|NCT01429623|65154951|FG000|Overall Study|No post baseline data|4|||
23385054|NCT01429623|65154952|FG001|Overall Study|No post baseline data|4|||
23385055|NCT00834587|65154958|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
23385056|NCT00834587|65154959|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
23385057|NCT00414609|65154962|FG000|Core Study|Adverse Event|9|||
23385058|NCT00414609|65154963|FG001|Core Study|Adverse Event|11|||
23385059|NCT00414609|65154964|FG002|Core Study|Adverse Event|0|||
23385060|NCT00414609|65154962|FG000|Core Study|Abnormal laboratory values|0|||
23385061|NCT00414609|65154963|FG001|Core Study|Abnormal laboratory values|1|||
23385062|NCT00414609|65154964|FG002|Core Study|Abnormal laboratory values|0|||
23385063|NCT00414609|65154962|FG000|Core Study|Abnormal test procedure results|1|||
23385064|NCT00414609|65154963|FG001|Core Study|Abnormal test procedure results|1|||
23385065|NCT00414609|65154964|FG002|Core Study|Abnormal test procedure results|0|||
23385066|NCT00414609|65154962|FG000|Core Study|Protocol deviation|0|||
23385067|NCT00414609|65154963|FG001|Core Study|Protocol deviation|1|||
23385068|NCT00414609|65154964|FG002|Core Study|Protocol deviation|0|||
23385069|NCT00414609|65154962|FG000|Core Study|Patient withdrew consent|10|||
23385070|NCT00414609|65154963|FG001|Core Study|Patient withdrew consent|11|||
23385071|NCT00414609|65154964|FG002|Core Study|Patient withdrew consent|0|||
23385072|NCT00414609|65154962|FG000|Core Study|Lost to Follow-up|7|||
23385073|NCT00414609|65154963|FG001|Core Study|Lost to Follow-up|4|||
23385074|NCT00414609|65154964|FG002|Core Study|Lost to Follow-up|0|||
23385075|NCT00414609|65154962|FG000|Core Study|Administrative problems|0|||
23385076|NCT00414609|65154963|FG001|Core Study|Administrative problems|2|||
23385077|NCT00414609|65154964|FG002|Core Study|Administrative problems|0|||
23385078|NCT00414609|65154962|FG000|Core Study|Death|7|||
23385079|NCT00414609|65154963|FG001|Core Study|Death|14|||
23385080|NCT00414609|65154964|FG002|Core Study|Death|0|||
23385081|NCT00414609|65154962|FG000|Extension Study|Adverse Event|0|||
23385082|NCT00414609|65154963|FG001|Extension Study|Adverse Event|0|||
23385083|NCT00414609|65154964|FG002|Extension Study|Adverse Event|14|||
23385084|NCT00414609|65154962|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
23385085|NCT00414609|65154963|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
23385086|NCT00414609|65154964|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
23385087|NCT00414609|65154962|FG000|Extension Study|Withdrawal by Subject|0|||
23385088|NCT00414609|65154963|FG001|Extension Study|Withdrawal by Subject|0|||
23385089|NCT00414609|65154964|FG002|Extension Study|Withdrawal by Subject|13|||
23385090|NCT00414609|65154962|FG000|Extension Study|Lost to Follow-up|0|||
23385091|NCT00414609|65154963|FG001|Extension Study|Lost to Follow-up|0|||
23385092|NCT00414609|65154964|FG002|Extension Study|Lost to Follow-up|10|||
23385093|NCT00414609|65154962|FG000|Extension Study|Administrative problems|0|||
23385094|NCT00414609|65154963|FG001|Extension Study|Administrative problems|0|||
23385095|NCT00414609|65154964|FG002|Extension Study|Administrative problems|1|||
23385096|NCT00414609|65154962|FG000|Extension Study|Death|0|||
23385097|NCT00414609|65154963|FG001|Extension Study|Death|0|||
23385098|NCT00414609|65154964|FG002|Extension Study|Death|17|||
23385099|NCT00585169|65154965|FG000|Overall Study|Withdrawal by Subject|1|||
23385100|NCT02545127|65154971|FG000|Overall Study|Lost to Follow-up|1|||
23385101|NCT02545127|65154972|FG001|Overall Study|Lost to Follow-up|0|||
23385102|NCT03055221|65154973|FG000|Overall Study|Adverse Event|2|||
23385103|NCT03055221|65154973|FG000|Overall Study|Withdrawal by Subject|4|||
23385104|NCT03055221|65154973|FG000|Overall Study|Death|6|||
23385105|NCT03055221|65154973|FG000|Overall Study|Physician Decision|1|||
23385106|NCT03055221|65154973|FG000|Overall Study|Study terminated by Sponsor|3|||
23385107|NCT03055221|65154973|FG000|Overall Study|Lost to Follow-up|4|||
23385108|NCT01028053|65154977|FG000|Overall Study|Screen Failure|113|||
23385109|NCT01028053|65154977|FG000|Overall Study|Patient Request|11|||
23385110|NCT01028053|65154977|FG000|Overall Study|Protocol Violation|1|||
23385111|NCT01028053|65154977|FG000|Overall Study|Physician Decision|2|||
23385112|NCT01028053|65154977|FG000|Overall Study|Technical Problem|1|||
23385113|NCT01028053|65154977|FG000|Overall Study|Terminated by Sponsor|1|||
23385114|NCT01028053|65154977|FG000|Overall Study|Various reasons|4|||
23385115|NCT03753542|65154978|FG000|Overall Study|Lost to Follow-up|9|||
23385116|NCT03753542|65154979|FG001|Overall Study|Lost to Follow-up|14|||
23385117|NCT00520572|65154982|FG000|Overall Study|Adverse Event|9|||
23385118|NCT00520572|65154983|FG001|Overall Study|Adverse Event|3|||
23385119|NCT00520572|65154984|FG002|Overall Study|Adverse Event|6|||
23385120|NCT00520572|65154985|FG003|Overall Study|Adverse Event|9|||
23385121|NCT00520572|65154986|FG004|Overall Study|Adverse Event|7|||
23385122|NCT00520572|65154987|FG005|Overall Study|Adverse Event|2|||
23385123|NCT00520572|65154982|FG000|Overall Study|Withdrawal by Subject|0|||
23385124|NCT00520572|65154983|FG001|Overall Study|Withdrawal by Subject|9|||
23385125|NCT00520572|65154984|FG002|Overall Study|Withdrawal by Subject|5|||
23385126|NCT00520572|65154985|FG003|Overall Study|Withdrawal by Subject|2|||
23385127|NCT00520572|65154986|FG004|Overall Study|Withdrawal by Subject|2|||
23385128|NCT00520572|65154987|FG005|Overall Study|Withdrawal by Subject|0|||
23385129|NCT00520572|65154982|FG000|Overall Study|Protocol Violation|0|||
23385130|NCT00520572|65154983|FG001|Overall Study|Protocol Violation|0|||
23385131|NCT00520572|65154984|FG002|Overall Study|Protocol Violation|1|||
23385132|NCT00520572|65154985|FG003|Overall Study|Protocol Violation|0|||
23385133|NCT00520572|65154986|FG004|Overall Study|Protocol Violation|0|||
23385134|NCT00520572|65154987|FG005|Overall Study|Protocol Violation|0|||
23385135|NCT00520572|65154982|FG000|Overall Study|Lack of Efficacy|1|||
23385136|NCT00520572|65154983|FG001|Overall Study|Lack of Efficacy|1|||
23385137|NCT00520572|65154984|FG002|Overall Study|Lack of Efficacy|1|||
23385138|NCT00520572|65154985|FG003|Overall Study|Lack of Efficacy|2|||
23385139|NCT00520572|65154986|FG004|Overall Study|Lack of Efficacy|1|||
23385140|NCT00520572|65154987|FG005|Overall Study|Lack of Efficacy|0|||
23385141|NCT00520572|65154982|FG000|Overall Study|Lost to Follow-up|0|||
23385142|NCT00520572|65154983|FG001|Overall Study|Lost to Follow-up|0|||
23385143|NCT00520572|65154984|FG002|Overall Study|Lost to Follow-up|0|||
23385144|NCT00520572|65154985|FG003|Overall Study|Lost to Follow-up|0|||
23385145|NCT00520572|65154986|FG004|Overall Study|Lost to Follow-up|1|||
23385146|NCT00520572|65154987|FG005|Overall Study|Lost to Follow-up|0|||
23385147|NCT00520572|65154982|FG000|Overall Study|Incorrect enrollment|1|||
23385148|NCT00520572|65154983|FG001|Overall Study|Incorrect enrollment|0|||
23385149|NCT00520572|65154984|FG002|Overall Study|Incorrect enrollment|1|||
23385150|NCT00520572|65154985|FG003|Overall Study|Incorrect enrollment|0|||
23385151|NCT00520572|65154986|FG004|Overall Study|Incorrect enrollment|1|||
23291946|NCT02539368|64808453|FG001|Overall Study|Missing|3|||
23291947|NCT02539368|64808454|FG002|Overall Study|Missing|0|||
23291948|NCT02539368|64808455|FG003|Overall Study|Missing|0|||
23291949|NCT02539368|64808456|FG004|Overall Study|Missing|0|||
23291950|NCT02075840|64808457|FG000|Overall Study|Withdrawal by Subject|13|||
23291951|NCT02075840|64808458|FG001|Overall Study|Withdrawal by Subject|22|||
23291952|NCT02075840|64808457|FG000|Overall Study|Reason not specified|1|||
23291953|NCT02075840|64808458|FG001|Overall Study|Reason not specified|0|||
23291954|NCT02075840|64808457|FG000|Overall Study|Adverse Event|0|||
23291955|NCT02075840|64808458|FG001|Overall Study|Adverse Event|2|||
23291956|NCT02075840|64808457|FG000|Overall Study|Death|35|||
23291957|NCT02075840|64808458|FG001|Overall Study|Death|40|||
23291958|NCT02075840|64808457|FG000|Overall Study|Lost to Follow-up|3|||
23291959|NCT02075840|64808458|FG001|Overall Study|Lost to Follow-up|2|||
23291960|NCT02075840|64808457|FG000|Overall Study|Physician Decision|1|||
23291961|NCT02075840|64808458|FG001|Overall Study|Physician Decision|3|||
23385152|NCT00520572|65154987|FG005|Overall Study|Incorrect enrollment|0|||
23385153|NCT00520572|65154982|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
23385154|NCT00520572|65154983|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
23385155|NCT00520572|65154984|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
23385156|NCT00520572|65154985|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
23385157|NCT00520572|65154986|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
23291962|NCT02075840|64808457|FG000|Overall Study|Ongoing at CCOD|99|||
23291963|NCT02075840|64808458|FG001|Overall Study|Ongoing at CCOD|82|||
23385158|NCT00520572|65154987|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
23385159|NCT00520572|65154982|FG000|Overall Study|Long break in taking Medication|0|||
23385160|NCT00520572|65154983|FG001|Overall Study|Long break in taking Medication|0|||
23291964|NCT02427399|64808460|FG000|Overall Study|Protocol Violation|14|||
23385161|NCT00520572|65154984|FG002|Overall Study|Long break in taking Medication|0|||
23385162|NCT00520572|65154985|FG003|Overall Study|Long break in taking Medication|1|||
23385163|NCT00520572|65154986|FG004|Overall Study|Long break in taking Medication|0|||
23385164|NCT00520572|65154987|FG005|Overall Study|Long break in taking Medication|0|||
23385165|NCT00520572|65154982|FG000|Overall Study|Did not receive Treatment|1|||
23385166|NCT00520572|65154983|FG001|Overall Study|Did not receive Treatment|0|||
23385167|NCT00520572|65154984|FG002|Overall Study|Did not receive Treatment|1|||
23385168|NCT00520572|65154985|FG003|Overall Study|Did not receive Treatment|0|||
23385169|NCT00520572|65154986|FG004|Overall Study|Did not receive Treatment|0|||
23385170|NCT00520572|65154987|FG005|Overall Study|Did not receive Treatment|0|||
23385171|NCT00452400|65155003|FG000|Overall Study|Adverse Event|1|||
23385172|NCT00452400|65155004|FG001|Overall Study|Adverse Event|1|||
23385173|NCT00452400|65155005|FG002|Overall Study|Adverse Event|5|||
23385174|NCT00452400|65155006|FG003|Overall Study|Adverse Event|0|||
23385175|NCT00452400|65155007|FG004|Overall Study|Adverse Event|2|||
23385176|NCT00452400|65155003|FG000|Overall Study|Protocol Violation|0|||
23385177|NCT00452400|65155004|FG001|Overall Study|Protocol Violation|0|||
23385178|NCT00452400|65155005|FG002|Overall Study|Protocol Violation|1|||
23385179|NCT00452400|65155006|FG003|Overall Study|Protocol Violation|0|||
23385180|NCT00452400|65155007|FG004|Overall Study|Protocol Violation|0|||
23385181|NCT00452400|65155003|FG000|Overall Study|Lost to Follow-up|1|||
23385182|NCT00452400|65155004|FG001|Overall Study|Lost to Follow-up|0|||
23385183|NCT00452400|65155005|FG002|Overall Study|Lost to Follow-up|0|||
23385184|NCT00452400|65155006|FG003|Overall Study|Lost to Follow-up|0|||
23385185|NCT00452400|65155007|FG004|Overall Study|Lost to Follow-up|0|||
23385186|NCT00452400|65155003|FG000|Overall Study|Withdrawal by Subject|1|||
23385187|NCT00452400|65155004|FG001|Overall Study|Withdrawal by Subject|0|||
23385188|NCT00452400|65155005|FG002|Overall Study|Withdrawal by Subject|1|||
23385189|NCT00452400|65155006|FG003|Overall Study|Withdrawal by Subject|0|||
23385190|NCT00452400|65155007|FG004|Overall Study|Withdrawal by Subject|0|||
23385191|NCT00452400|65155003|FG000|Overall Study|Lack of Efficacy|2|||
23385192|NCT00452400|65155004|FG001|Overall Study|Lack of Efficacy|0|||
23385193|NCT00452400|65155005|FG002|Overall Study|Lack of Efficacy|0|||
23385194|NCT00452400|65155006|FG003|Overall Study|Lack of Efficacy|0|||
23385195|NCT00452400|65155007|FG004|Overall Study|Lack of Efficacy|0|||
23385196|NCT00452400|65155003|FG000|Overall Study|Other reasons not listed above|0|||
23385197|NCT00452400|65155004|FG001|Overall Study|Other reasons not listed above|0|||
23385198|NCT00452400|65155005|FG002|Overall Study|Other reasons not listed above|0|||
23385199|NCT00452400|65155006|FG003|Overall Study|Other reasons not listed above|1|||
23385200|NCT00452400|65155007|FG004|Overall Study|Other reasons not listed above|1|||
23385201|NCT01471574|65155008|FG000|Treatment Period|Lack of Efficacy|12|||
23385202|NCT01471574|65155009|FG001|Treatment Period|Lack of Efficacy|4|||
23291965|NCT02427399|64808461|FG001|Overall Study|Protocol Violation|16|||
23291966|NCT02427399|64808462|FG002|Overall Study|Protocol Violation|12|||
23291967|NCT02427399|64808463|FG003|Overall Study|Protocol Violation|18|||
23291968|NCT02427399|64808464|FG004|Overall Study|Protocol Violation|15|||
23291969|NCT01266603|64808465|FG000|Overall Study|Adverse Event|1|||
23291970|NCT01266603|64808465|FG000|Overall Study|Lack of Efficacy|14|||
23291971|NCT01266603|64808465|FG000|Overall Study|Withdrawal by Subject|1|||
23291972|NCT01266603|64808465|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
23291973|NCT01203917|64808466|FG000|Overall Study|Death|29|||
23291974|NCT01203917|64808466|FG000|Overall Study|Lost to Follow-up|2|||
23291975|NCT01203917|64808466|FG000|Overall Study|Withdrawal by Subject|3|||
23291976|NCT01203917|64808466|FG000|Overall Study|Due to objective disease progression|1|||
23291977|NCT01203917|64808466|FG000|Overall Study|Due to EGFR M+I patient|1|||
23291978|NCT02293460|64808467|FG000|Overall Study|Protocol Violation|1|||
23291979|NCT02293460|64808467|FG000|Overall Study|Lack of Efficacy|2|||
23291980|NCT02293460|64808467|FG000|Overall Study|Adverse Event|2|||
23291981|NCT02293460|64808467|FG000|Overall Study|Withdrawal by Subject|1|||
23291982|NCT00799708|64808469|FG000|Overall Study|non-compliance|1|||
23291983|NCT00799708|64808470|FG001|Overall Study|non-compliance|0|||
23291984|NCT00799708|64808471|FG002|Overall Study|non-compliance|0|||
23291985|NCT02462486|64808481|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
23291986|NCT02462486|64808482|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
23291987|NCT02462486|64808483|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
23291988|NCT02462486|64808481|FG000|Overall Study|Adverse Event|53|||
23291989|NCT02462486|64808482|FG001|Overall Study|Adverse Event|48|||
23291990|NCT02462486|64808483|FG002|Overall Study|Adverse Event|21|||
23291991|NCT02462486|64808481|FG000|Overall Study|Lack of Efficacy|6|||
23291992|NCT02462486|64808482|FG001|Overall Study|Lack of Efficacy|12|||
23291993|NCT02462486|64808483|FG002|Overall Study|Lack of Efficacy|3|||
23291994|NCT02462486|64808481|FG000|Overall Study|Lost to Follow-up|3|||
23291995|NCT02462486|64808482|FG001|Overall Study|Lost to Follow-up|4|||
23291996|NCT02462486|64808483|FG002|Overall Study|Lost to Follow-up|2|||
23291997|NCT02462486|64808481|FG000|Overall Study|Withdrawal by Subject|25|||
23291998|NCT02462486|64808482|FG001|Overall Study|Withdrawal by Subject|22|||
23291999|NCT02462486|64808483|FG002|Overall Study|Withdrawal by Subject|19|||
23292000|NCT02462486|64808481|FG000|Overall Study|Protocol Violation|3|||
23292001|NCT02462486|64808482|FG001|Overall Study|Protocol Violation|1|||
23292002|NCT02462486|64808483|FG002|Overall Study|Protocol Violation|1|||
23292003|NCT02462486|64808481|FG000|Overall Study|Reason not Specified|3|||
23292004|NCT02462486|64808482|FG001|Overall Study|Reason not Specified|4|||
23292005|NCT02462486|64808483|FG002|Overall Study|Reason not Specified|3|||
23292006|NCT02460835|64808484|FG000|Overall Study|Disease progression prior to treatment|3|||
23292007|NCT02460835|64808484|FG000|Overall Study|Unable to complete planning scans|2|||
23292008|NCT02460835|64808484|FG000|Overall Study|Decrease in performance status|1|||
23292009|NCT02460835|64808484|FG000|Overall Study|Withdrawal by Subject|3|||
23292010|NCT02460835|64808484|FG000|Overall Study|Underwent fractionated RT|10|||
23292011|NCT02460835|64808484|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
23292012|NCT01408888|64808492|FG000|First Intervention|Adverse Event|0|||
23292013|NCT01408888|64808493|FG001|First Intervention|Adverse Event|1|||
23292014|NCT01408888|64808492|FG000|First Intervention|Withdrawal by Subject|0|||
23292015|NCT01408888|64808493|FG001|First Intervention|Withdrawal by Subject|2|||
23292016|NCT01408888|64808492|FG000|Second Intervention|Withdrawal by Subject|1|||
23292017|NCT01408888|64808493|FG001|Second Intervention|Withdrawal by Subject|0|||
23292018|NCT01408888|64808492|FG000|Second Intervention|Adverse Event|1|||
23292019|NCT01408888|64808493|FG001|Second Intervention|Adverse Event|0|||
23292020|NCT00224484|64808494|FG000|Overall Study|Serious Adverse Event|1|||
23292021|NCT00224484|64808495|FG001|Overall Study|Serious Adverse Event|1|||
23292022|NCT00224484|64808496|FG002|Overall Study|Serious Adverse Event|0|||
23292023|NCT00224484|64808494|FG000|Overall Study|Non-Serious Adverse Event|5|||
23292024|NCT00224484|64808495|FG001|Overall Study|Non-Serious Adverse Event|7|||
23292025|NCT00224484|64808496|FG002|Overall Study|Non-Serious Adverse Event|3|||
23292026|NCT00224484|64808494|FG000|Overall Study|Protocol Violation|2|||
23292027|NCT00224484|64808495|FG001|Overall Study|Protocol Violation|2|||
23292028|NCT00224484|64808496|FG002|Overall Study|Protocol Violation|0|||
23292029|NCT00224484|64808494|FG000|Overall Study|Withdrawal by Subject|49|||
23292030|NCT00224484|64808495|FG001|Overall Study|Withdrawal by Subject|18|||
23292031|NCT00224484|64808496|FG002|Overall Study|Withdrawal by Subject|16|||
23292032|NCT00224484|64808494|FG000|Overall Study|Migrated/moved from study area|18|||
23292033|NCT00224484|64808495|FG001|Overall Study|Migrated/moved from study area|5|||
23493197|NCT00100178|65551388|FG002|Overall Study|Lost to Follow-up|5|||
23292034|NCT00224484|64808496|FG002|Overall Study|Migrated/moved from study area|5|||
23292035|NCT00224484|64808494|FG000|Overall Study|Lost to Follow-up|66|||
23292036|NCT00224484|64808495|FG001|Overall Study|Lost to Follow-up|28|||
23292037|NCT00224484|64808496|FG002|Overall Study|Lost to Follow-up|36|||
23292038|NCT00224484|64808494|FG000|Overall Study|Reason not specified|5|||
23292039|NCT00224484|64808495|FG001|Overall Study|Reason not specified|4|||
23385203|NCT01471574|65155010|FG002|Treatment Period|Lack of Efficacy|14|||
23292040|NCT00224484|64808496|FG002|Overall Study|Reason not specified|2|||
23292041|NCT01181531|64808497|FG000|Overall Study|Other|17|||
23292042|NCT01181531|64808498|FG001|Overall Study|Other|12|||
23292043|NCT01181531|64808497|FG000|Overall Study|Partial consent by subject withdrawn|0|||
23292044|NCT01181531|64808498|FG001|Overall Study|Partial consent by subject withdrawn|1|||
23292045|NCT01181531|64808497|FG000|Overall Study|Physician Decision|3|||
23292046|NCT01181531|64808498|FG001|Overall Study|Physician Decision|1|||
23292047|NCT01181531|64808497|FG000|Overall Study|Noncompliance|2|||
23292048|NCT01181531|64808498|FG001|Overall Study|Noncompliance|2|||
23292049|NCT01181531|64808497|FG000|Overall Study|Ineligibility determined|1|||
23292050|NCT01181531|64808498|FG001|Overall Study|Ineligibility determined|2|||
23292051|NCT01181531|64808497|FG000|Overall Study|Protocol Specified Criteria|15|||
23292052|NCT01181531|64808498|FG001|Overall Study|Protocol Specified Criteria|8|||
23292053|NCT01181531|64808497|FG000|Overall Study|Pregnancy|0|||
23292054|NCT01181531|64808498|FG001|Overall Study|Pregnancy|1|||
23292055|NCT01181531|64808497|FG000|Overall Study|Withdrawal by Subject|8|||
23292056|NCT01181531|64808498|FG001|Overall Study|Withdrawal by Subject|7|||
23292057|NCT01181531|64808497|FG000|Overall Study|Protocol Violation|6|||
23292058|NCT01181531|64808498|FG001|Overall Study|Protocol Violation|6|||
23292059|NCT01181531|64808497|FG000|Overall Study|Death|9|||
23292060|NCT01181531|64808498|FG001|Overall Study|Death|12|||
23292061|NCT01181531|64808497|FG000|Overall Study|Adverse Event|0|||
23292062|NCT01181531|64808498|FG001|Overall Study|Adverse Event|1|||
23292063|NCT01937117|64808501|FG000|Overall Study|Disease Progression|7|||
23292064|NCT01937117|64808501|FG000|Overall Study|Physician Decision|4|||
23292065|NCT01937117|64808501|FG000|Overall Study|Adverse Event|2|||
23292066|NCT01632306|64808504|FG000|Overall Study|Protocol Violation|1|||
23292067|NCT01632306|64808505|FG001|Overall Study|Protocol Violation|0|||
23292068|NCT01632306|64808506|FG002|Overall Study|Protocol Violation|0|||
23292069|NCT01745094|64808507|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
23292070|NCT01745094|64808508|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
23292071|NCT01745094|64808509|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
23292072|NCT01745094|64808510|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
23292073|NCT01745094|64808507|FG000|Overall Study|Adverse Event|0|||
23292074|NCT01745094|64808508|FG001|Overall Study|Adverse Event|0|||
23292075|NCT01745094|64808509|FG002|Overall Study|Adverse Event|3|||
23292076|NCT01745094|64808510|FG003|Overall Study|Adverse Event|0|||
23292077|NCT01745094|64808507|FG000|Overall Study|Withdrawal by Subject|2|||
23292078|NCT01745094|64808508|FG001|Overall Study|Withdrawal by Subject|0|||
23292079|NCT01745094|64808509|FG002|Overall Study|Withdrawal by Subject|1|||
23292080|NCT01745094|64808510|FG003|Overall Study|Withdrawal by Subject|2|||
23292081|NCT01745094|64808507|FG000|Overall Study|Protocol Violation|1|||
23292082|NCT01745094|64808508|FG001|Overall Study|Protocol Violation|0|||
23292083|NCT01745094|64808509|FG002|Overall Study|Protocol Violation|3|||
23385204|NCT01471574|65155011|FG003|Treatment Period|Lack of Efficacy|1|||
23292084|NCT01745094|64808510|FG003|Overall Study|Protocol Violation|1|||
23292085|NCT01745094|64808507|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
23292086|NCT01745094|64808508|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
23292087|NCT01745094|64808509|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
23292088|NCT01745094|64808510|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
23292089|NCT01745094|64808507|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
23385205|NCT01471574|65155008|FG000|Treatment Period|Adverse Event|7|||
23385206|NCT01471574|65155009|FG001|Treatment Period|Adverse Event|3|||
23385207|NCT01471574|65155010|FG002|Treatment Period|Adverse Event|6|||
23385208|NCT01471574|65155011|FG003|Treatment Period|Adverse Event|1|||
23385209|NCT01471574|65155008|FG000|Treatment Period|Withdrawal by Subject|5|||
23385210|NCT01471574|65155009|FG001|Treatment Period|Withdrawal by Subject|1|||
23385211|NCT01471574|65155010|FG002|Treatment Period|Withdrawal by Subject|1|||
23385212|NCT01471574|65155011|FG003|Treatment Period|Withdrawal by Subject|0|||
23385213|NCT01471574|65155008|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
23385214|NCT01471574|65155009|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
23385215|NCT01471574|65155010|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
23385216|NCT01471574|65155011|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
23385217|NCT01471574|65155008|FG000|Treatment Period|Lost to Follow-up|1|||
23385218|NCT01471574|65155009|FG001|Treatment Period|Lost to Follow-up|2|||
23385219|NCT01471574|65155010|FG002|Treatment Period|Lost to Follow-up|2|||
23385220|NCT01471574|65155011|FG003|Treatment Period|Lost to Follow-up|0|||
23385221|NCT01471574|65155008|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
23385222|NCT01471574|65155009|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
23385223|NCT01471574|65155010|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
23385224|NCT01471574|65155011|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
23385225|NCT01471574|65155008|FG000|Treatment Period|Other|1|||
23385226|NCT01471574|65155009|FG001|Treatment Period|Other|0|||
23385227|NCT01471574|65155010|FG002|Treatment Period|Other|0|||
23385228|NCT01471574|65155011|FG003|Treatment Period|Other|0|||
23385229|NCT01471574|65155008|FG000|Follow-up Period|Withdrawal by Subject|3|||
23385230|NCT01471574|65155009|FG001|Follow-up Period|Withdrawal by Subject|0|||
23385231|NCT01471574|65155010|FG002|Follow-up Period|Withdrawal by Subject|3|||
23385232|NCT01471574|65155011|FG003|Follow-up Period|Withdrawal by Subject|1|||
23385233|NCT01471574|65155008|FG000|Follow-up Period|Lost to Follow-up|4|||
23385234|NCT01471574|65155009|FG001|Follow-up Period|Lost to Follow-up|1|||
23385235|NCT01471574|65155010|FG002|Follow-up Period|Lost to Follow-up|3|||
23385236|NCT01471574|65155011|FG003|Follow-up Period|Lost to Follow-up|2|||
23385237|NCT01471574|65155008|FG000|Follow-up Period|Death|0|||
23385238|NCT01471574|65155009|FG001|Follow-up Period|Death|0|||
23385239|NCT01471574|65155010|FG002|Follow-up Period|Death|1|||
23385240|NCT01471574|65155011|FG003|Follow-up Period|Death|0|||
23292090|NCT01745094|64808508|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
23292091|NCT01745094|64808509|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
23292092|NCT01745094|64808510|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
23292093|NCT01745094|64808507|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
23292094|NCT01745094|64808508|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
23292095|NCT01745094|64808509|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
23292096|NCT01745094|64808510|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
23292097|NCT01235715|64811469|FG000|Overall Study|Physician Decision|0|||
23292098|NCT01235715|64811470|FG001|Overall Study|Physician Decision|2|||
23292099|NCT00089076|64811471|FG000|Overall Study|Alternate Therapy|1|||
23292100|NCT00089076|64811471|FG000|Overall Study|Withdrawal by Subject|2|||
23292101|NCT00089076|64811471|FG000|Overall Study|Progression|7|||
23292102|NCT04149535|64811472|FG000|Overall Study|Death|11|||
23292103|NCT04149535|64811473|FG001|Overall Study|Death|7|||
23385241|NCT01471574|65155008|FG000|Follow-up Period|Follow-up no longer required|0|||
23385242|NCT01471574|65155009|FG001|Follow-up Period|Follow-up no longer required|1|||
23385243|NCT01471574|65155010|FG002|Follow-up Period|Follow-up no longer required|0|||
23385244|NCT01471574|65155011|FG003|Follow-up Period|Follow-up no longer required|0|||
23385245|NCT00728182|65155012|FG000|Overall Study|Adverse Event|1|||
23385246|NCT00728182|65155013|FG001|Overall Study|Adverse Event|0|||
23385247|NCT00728182|65155012|FG000|Overall Study|Lost to Follow-up|2|||
23385248|NCT00728182|65155013|FG001|Overall Study|Lost to Follow-up|0|||
23292104|NCT04149535|64811472|FG000|Overall Study|Physician Decision|10|||
23292105|NCT04149535|64811473|FG001|Overall Study|Physician Decision|4|||
23292106|NCT04149535|64811472|FG000|Overall Study|Withdrawal by Subject|6|||
23292107|NCT04149535|64811473|FG001|Overall Study|Withdrawal by Subject|7|||
23292108|NCT04149535|64811472|FG000|Overall Study|Not described|2|||
23385249|NCT00728182|65155012|FG000|Overall Study|Death|0|||
23292109|NCT04149535|64811473|FG001|Overall Study|Not described|0|||
23385250|NCT00728182|65155013|FG001|Overall Study|Death|2|||
23385251|NCT00728182|65155012|FG000|Overall Study|Protocol Noncompliance|0|||
23385252|NCT00728182|65155013|FG001|Overall Study|Protocol Noncompliance|1|||
23385253|NCT02056288|65155014|FG000|In-Hospital Data|Surgery cancelled|1|||
23385254|NCT02056288|65155015|FG001|In-Hospital Data|Surgery cancelled|0|||
23385255|NCT02056288|65155014|FG000|In-Hospital Data|Protocol Violation|3|||
23292110|NCT03847194|64811477|FG000|Overall Study|Lost to Follow-up|2|||
23292111|NCT03847194|64811478|FG001|Overall Study|Lost to Follow-up|5|||
23292112|NCT03847194|64811477|FG000|Overall Study|Withdrawal by Subject|1|||
23292113|NCT03847194|64811478|FG001|Overall Study|Withdrawal by Subject|2|||
23292114|NCT03847194|64811477|FG000|Overall Study|Death|0|||
23292115|NCT03847194|64811478|FG001|Overall Study|Death|1|||
23292116|NCT01917084|64811480|FG000|Overall Study|Withdrawal by Subject|1|||
23292117|NCT00263887|64811481|FG000|Overall Study|Withdrawal by Subject|1|||
23292118|NCT00263887|64811482|FG001|Overall Study|Withdrawal by Subject|1|||
23292119|NCT00263887|64811481|FG000|Overall Study|Lung transplantation|1|||
23292120|NCT00263887|64811482|FG001|Overall Study|Lung transplantation|2|||
23292121|NCT00263887|64811481|FG000|Overall Study|Too ill to attend visit|1|||
23292122|NCT00263887|64811482|FG001|Overall Study|Too ill to attend visit|0|||
23292123|NCT00263887|64811481|FG000|Overall Study|Adverse Event|0|||
23292124|NCT00263887|64811482|FG001|Overall Study|Adverse Event|2|||
23292125|NCT00263887|64811481|FG000|Overall Study|Disease progression|0|||
23292126|NCT00263887|64811482|FG001|Overall Study|Disease progression|1|||
23292127|NCT00263887|64811481|FG000|Overall Study|Lack of Efficacy|0|||
23292128|NCT00263887|64811482|FG001|Overall Study|Lack of Efficacy|1|||
23292129|NCT03941834|64811485|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
23292130|NCT03941834|64811486|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
23292131|NCT03941834|64811487|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
23292132|NCT03941834|64811485|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
23292133|NCT03941834|64811486|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
23493198|NCT00100178|65551386|FG000|Overall Study|Adverse Event|2|||
23292134|NCT03941834|64811487|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
23292135|NCT03941834|64811485|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
23292136|NCT03941834|64811486|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
23292137|NCT03941834|64811487|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
23292138|NCT03941834|64811485|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
23292139|NCT03941834|64811486|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
23292140|NCT03941834|64811487|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
23292141|NCT03941834|64811485|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
23292142|NCT03941834|64811486|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
23292143|NCT03941834|64811487|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
23385256|NCT02056288|65155015|FG001|In-Hospital Data|Protocol Violation|0|||
23385257|NCT02056288|65155014|FG000|In-Hospital Data|Physician Decision|1|||
23292144|NCT03941834|64811485|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
23385258|NCT02056288|65155015|FG001|In-Hospital Data|Physician Decision|0|||
23385259|NCT02056288|65155014|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
23385260|NCT02056288|65155015|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
23385261|NCT02568254|65155019|FG000|Period 2|Adverse Event|0|||
23385262|NCT02568254|65155020|FG001|Period 2|Adverse Event|0|||
23385263|NCT02568254|65155021|FG002|Period 2|Adverse Event|1|||
23385264|NCT02568254|65155022|FG003|Period 2|Adverse Event|0|||
23385265|NCT02568254|65155023|FG004|Period 2|Adverse Event|0|||
23385266|NCT02568254|65155024|FG005|Period 2|Adverse Event|0|||
23385267|NCT02568254|65155019|FG000|Period 3|Unstatisfactory Lens fitting|0|||
23385268|NCT02568254|65155020|FG001|Period 3|Unstatisfactory Lens fitting|0|||
23385269|NCT02568254|65155021|FG002|Period 3|Unstatisfactory Lens fitting|0|||
23385270|NCT02568254|65155022|FG003|Period 3|Unstatisfactory Lens fitting|0|||
23385271|NCT02568254|65155023|FG004|Period 3|Unstatisfactory Lens fitting|1|||
23385272|NCT02568254|65155024|FG005|Period 3|Unstatisfactory Lens fitting|0|||
23292145|NCT03941834|64811486|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
23292146|NCT03941834|64811487|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
23292147|NCT03847974|64811492|FG000|Overall Study|relocated out of region|3|||
23385273|NCT03548415|65155025|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
23385274|NCT03548415|65155026|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
23292148|NCT03847974|64811492|FG000|Overall Study|Withdrawal by Subject|2|||
23385275|NCT03548415|65155027|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
23385276|NCT03548415|65155028|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
23385277|NCT03548415|65155029|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
23385278|NCT03309605|65155030|FG000|Overall Study|Adverse Event|0|||
23385279|NCT03309605|65155031|FG001|Overall Study|Adverse Event|0|||
23385280|NCT03309605|65155032|FG002|Overall Study|Adverse Event|0|||
23385281|NCT03309605|65155033|FG003|Overall Study|Adverse Event|1|||
23385282|NCT03309605|65155034|FG004|Overall Study|Adverse Event|0|||
23385283|NCT03309605|65155035|FG005|Overall Study|Adverse Event|0|||
23385284|NCT03309605|65155036|FG006|Overall Study|Adverse Event|2|||
23385285|NCT03309605|65155037|FG007|Overall Study|Adverse Event|1|||
23385286|NCT03309605|65155030|FG000|Overall Study|Withdrawal by Subject|0|||
23385287|NCT03309605|65155031|FG001|Overall Study|Withdrawal by Subject|0|||
23385288|NCT03309605|65155032|FG002|Overall Study|Withdrawal by Subject|0|||
23385289|NCT03309605|65155033|FG003|Overall Study|Withdrawal by Subject|0|||
23385290|NCT03309605|65155034|FG004|Overall Study|Withdrawal by Subject|1|||
23385291|NCT03309605|65155035|FG005|Overall Study|Withdrawal by Subject|0|||
23385292|NCT03309605|65155036|FG006|Overall Study|Withdrawal by Subject|1|||
23385293|NCT03309605|65155037|FG007|Overall Study|Withdrawal by Subject|1|||
23385294|NCT04289298|65155038|FG000|Overall Study|Lost to Follow-up|5|||
23385295|NCT04289298|65155039|FG001|Overall Study|Lost to Follow-up|0|||
23385296|NCT04289298|65155038|FG000|Overall Study|Withdrawal by Subject|2|||
23385297|NCT04289298|65155039|FG001|Overall Study|Withdrawal by Subject|0|||
23385298|NCT03019588|65155040|FG000|Overall Study|Death|44|||
23385299|NCT03019588|65155041|FG001|Overall Study|Death|46|||
23385300|NCT03019588|65155040|FG000|Overall Study|Study terminated by Sponsor|3|||
23385301|NCT03019588|65155041|FG001|Overall Study|Study terminated by Sponsor|1|||
23385302|NCT00120250|65155044|FG000|Overall Study|Lost to Follow-up|1|||
23385303|NCT00120250|65155045|FG001|Overall Study|Lost to Follow-up|1|||
23385304|NCT00120250|65155044|FG000|Overall Study|Protocol Violation|0|||
23385305|NCT00120250|65155045|FG001|Overall Study|Protocol Violation|1|||
23385306|NCT00289900|65155051|FG000|Overall Study|Adverse Event|28|||
23385307|NCT00289900|65155052|FG001|Overall Study|Adverse Event|40|||
23385308|NCT00289900|65155053|FG002|Overall Study|Adverse Event|13|||
23385309|NCT00289900|65155054|FG003|Overall Study|Adverse Event|19|||
23385310|NCT00289900|65155055|FG004|Overall Study|Adverse Event|20|||
23385311|NCT00289900|65155056|FG005|Overall Study|Adverse Event|33|||
23385312|NCT00289900|65155051|FG000|Overall Study|Lost to Follow-up|7|||
23385313|NCT00289900|65155052|FG001|Overall Study|Lost to Follow-up|7|||
23385314|NCT00289900|65155053|FG002|Overall Study|Lost to Follow-up|8|||
23385315|NCT00289900|65155054|FG003|Overall Study|Lost to Follow-up|8|||
23385316|NCT00289900|65155055|FG004|Overall Study|Lost to Follow-up|4|||
23385317|NCT00289900|65155056|FG005|Overall Study|Lost to Follow-up|8|||
23385318|NCT00289900|65155051|FG000|Overall Study|Participant had flushing|18|||
23385319|NCT00289900|65155052|FG001|Overall Study|Participant had flushing|42|||
23385320|NCT00289900|65155053|FG002|Overall Study|Participant had flushing|1|||
23385321|NCT00289900|65155054|FG003|Overall Study|Participant had flushing|2|||
23385322|NCT00289900|65155055|FG004|Overall Study|Participant had flushing|0|||
23385323|NCT00289900|65155056|FG005|Overall Study|Participant had flushing|4|||
23292149|NCT03847974|64811492|FG000|Overall Study|Adverse Event|1|||
23385324|NCT00289900|65155051|FG000|Overall Study|Other|0|||
23385325|NCT00289900|65155052|FG001|Overall Study|Other|0|||
23385326|NCT00289900|65155053|FG002|Overall Study|Other|0|||
23385327|NCT00289900|65155054|FG003|Overall Study|Other|5|||
23385328|NCT00289900|65155055|FG004|Overall Study|Other|1|||
23385329|NCT00289900|65155056|FG005|Overall Study|Other|0|||
23385330|NCT00289900|65155051|FG000|Overall Study|Participant moved|1|||
23385331|NCT00289900|65155052|FG001|Overall Study|Participant moved|0|||
23385332|NCT00289900|65155053|FG002|Overall Study|Participant moved|0|||
23385333|NCT00289900|65155054|FG003|Overall Study|Participant moved|1|||
23385334|NCT00289900|65155055|FG004|Overall Study|Participant moved|1|||
23385335|NCT00289900|65155056|FG005|Overall Study|Participant moved|1|||
23385336|NCT00289900|65155051|FG000|Overall Study|Withdrawal by Subject|10|||
23385337|NCT00289900|65155052|FG001|Overall Study|Withdrawal by Subject|21|||
23385338|NCT00289900|65155053|FG002|Overall Study|Withdrawal by Subject|8|||
23292150|NCT01989676|64811497|FG000|Overall Study|Death|52|||
23292151|NCT01989676|64811498|FG001|Overall Study|Death|60|||
23292152|NCT01989676|64811497|FG000|Overall Study|Protocol Violation|2|||
23292153|NCT01989676|64811498|FG001|Overall Study|Protocol Violation|1|||
23292154|NCT01989676|64811497|FG000|Overall Study|Lost to Follow-up|8|||
23292155|NCT01989676|64811498|FG001|Overall Study|Lost to Follow-up|18|||
23292156|NCT01989676|64811497|FG000|Overall Study|No longer willing to participate in study|26|||
23292157|NCT01989676|64811498|FG001|Overall Study|No longer willing to participate in study|26|||
23385339|NCT00289900|65155054|FG003|Overall Study|Withdrawal by Subject|18|||
23385340|NCT00289900|65155055|FG004|Overall Study|Withdrawal by Subject|12|||
23385341|NCT00289900|65155056|FG005|Overall Study|Withdrawal by Subject|11|||
23385342|NCT00289900|65155051|FG000|Overall Study|Protocol Violation|3|||
23385343|NCT00289900|65155052|FG001|Overall Study|Protocol Violation|9|||
23385344|NCT00289900|65155053|FG002|Overall Study|Protocol Violation|2|||
23385345|NCT00289900|65155054|FG003|Overall Study|Protocol Violation|6|||
23385346|NCT00289900|65155055|FG004|Overall Study|Protocol Violation|7|||
23385347|NCT00289900|65155056|FG005|Overall Study|Protocol Violation|4|||
23385348|NCT00289900|65155051|FG000|Overall Study|site terminated|1|||
23385349|NCT00289900|65155052|FG001|Overall Study|site terminated|0|||
23385350|NCT00289900|65155053|FG002|Overall Study|site terminated|1|||
23385351|NCT00289900|65155054|FG003|Overall Study|site terminated|0|||
23385352|NCT00289900|65155055|FG004|Overall Study|site terminated|0|||
23385353|NCT00289900|65155056|FG005|Overall Study|site terminated|0|||
23385354|NCT00289900|65155051|FG000|Overall Study|Not treated|0|||
23385355|NCT00289900|65155052|FG001|Overall Study|Not treated|1|||
23385356|NCT00289900|65155053|FG002|Overall Study|Not treated|0|||
23385357|NCT00289900|65155054|FG003|Overall Study|Not treated|0|||
23385358|NCT00289900|65155055|FG004|Overall Study|Not treated|0|||
23385359|NCT00289900|65155056|FG005|Overall Study|Not treated|0|||
23385360|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
23385361|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
23385362|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
23493199|NCT00100178|65551387|FG001|Overall Study|Adverse Event|2|||
23385363|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
23385364|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
23385365|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
23385366|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
23385367|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
23385368|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
23385369|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
23385370|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
23385371|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
23292158|NCT01989676|64811497|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
23292159|NCT01989676|64811498|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
23292160|NCT01989676|64811497|FG000|Overall Study|Other|4|||
23292161|NCT01989676|64811498|FG001|Overall Study|Other|3|||
23292162|NCT04703855|64811500|FG000|Overall Study|Heart Transplant|1|||
23292163|NCT01644149|64811501|FG000|Overall Study|Withdrawal by Subject|1|||
23292164|NCT01644149|64811502|FG001|Overall Study|Withdrawal by Subject|0|||
23292165|NCT01644149|64811501|FG000|Overall Study|Lost to Follow-up|3|||
23292166|NCT01644149|64811502|FG001|Overall Study|Lost to Follow-up|1|||
23292167|NCT02722616|64811518|FG000|Overall Study|Sponsor closed study after one month|2|||
23292168|NCT02722616|64811519|FG001|Overall Study|Sponsor closed study after one month|0|||
23292169|NCT02722616|64811520|FG002|Overall Study|Sponsor closed study after one month|0|||
23292170|NCT01029392|64811522|FG000|Overall Study|Withdrawal by Subject|18|||
23292171|NCT01029392|64811523|FG001|Overall Study|Withdrawal by Subject|11|||
23292172|NCT01029392|64811522|FG000|Overall Study|Physician Decision|2|||
23292173|NCT01029392|64811523|FG001|Overall Study|Physician Decision|0|||
23292174|NCT01628549|64811524|FG000|Overall Study|Adverse Event|1|||
23292175|NCT01628549|64811525|FG001|Overall Study|Adverse Event|1|||
23292176|NCT01628549|64811526|FG002|Overall Study|Adverse Event|0|||
23292177|NCT01628549|64811527|FG003|Overall Study|Adverse Event|4|||
23292178|NCT01628549|64811524|FG000|Overall Study|Lost to Follow-up|3|||
23292179|NCT01628549|64811525|FG001|Overall Study|Lost to Follow-up|4|||
23292180|NCT01628549|64811526|FG002|Overall Study|Lost to Follow-up|3|||
23292181|NCT01628549|64811527|FG003|Overall Study|Lost to Follow-up|3|||
23292182|NCT01628549|64811524|FG000|Overall Study|Withdrawal by Subject|3|||
23292183|NCT01628549|64811525|FG001|Overall Study|Withdrawal by Subject|4|||
23292184|NCT01628549|64811526|FG002|Overall Study|Withdrawal by Subject|4|||
23292185|NCT01628549|64811527|FG003|Overall Study|Withdrawal by Subject|1|||
23292186|NCT01628549|64811524|FG000|Overall Study|Protocol Violation|2|||
23292187|NCT01628549|64811525|FG001|Overall Study|Protocol Violation|1|||
23292188|NCT01628549|64811526|FG002|Overall Study|Protocol Violation|1|||
23292189|NCT01628549|64811527|FG003|Overall Study|Protocol Violation|0|||
23292190|NCT01628549|64811524|FG000|Overall Study|withdrawn for noncompliance|0|||
23292191|NCT01628549|64811525|FG001|Overall Study|withdrawn for noncompliance|2|||
23292192|NCT01628549|64811526|FG002|Overall Study|withdrawn for noncompliance|1|||
23292193|NCT01628549|64811527|FG003|Overall Study|withdrawn for noncompliance|0|||
23292194|NCT01628549|64811524|FG000|Overall Study|abnormal laboratory test results|0|||
23292195|NCT01628549|64811525|FG001|Overall Study|abnormal laboratory test results|0|||
23292196|NCT01628549|64811526|FG002|Overall Study|abnormal laboratory test results|1|||
23292197|NCT01628549|64811527|FG003|Overall Study|abnormal laboratory test results|0|||
23292198|NCT01628549|64811524|FG000|Overall Study|positive pregnancy test|0|||
23292199|NCT01628549|64811525|FG001|Overall Study|positive pregnancy test|0|||
23292200|NCT01628549|64811526|FG002|Overall Study|positive pregnancy test|0|||
23292201|NCT01628549|64811527|FG003|Overall Study|positive pregnancy test|1|||
23292202|NCT02510261|64811528|FG000|Overall Study|Adverse Event|5|||
23292203|NCT02510261|64811529|FG001|Overall Study|Adverse Event|8|||
23292204|NCT02510261|64811530|FG002|Overall Study|Adverse Event|0|||
23292205|NCT02510261|64811528|FG000|Overall Study|Physician Decision|1|||
23292206|NCT02510261|64811529|FG001|Overall Study|Physician Decision|5|||
23292207|NCT02510261|64811530|FG002|Overall Study|Physician Decision|0|||
23292208|NCT02510261|64811528|FG000|Overall Study|Death|19|||
23292209|NCT02510261|64811529|FG001|Overall Study|Death|19|||
23292210|NCT02510261|64811530|FG002|Overall Study|Death|0|||
23292211|NCT02510261|64811528|FG000|Overall Study|Withdrawal by Subject|3|||
23292212|NCT02510261|64811529|FG001|Overall Study|Withdrawal by Subject|10|||
23292213|NCT02510261|64811530|FG002|Overall Study|Withdrawal by Subject|3|||
23292214|NCT01436643|64811540|FG000|2-week Pre-treatment|Abnormal test result|0|||
23292215|NCT01436643|64811541|FG001|2-week Pre-treatment|Abnormal test result|0|||
23292216|NCT01436643|64811542|FG002|2-week Pre-treatment|Abnormal test result|0|||
23292217|NCT01436643|64811543|FG003|2-week Pre-treatment|Abnormal test result|1|||
23292218|NCT01436643|64811540|FG000|2-week Pre-treatment|Adverse Event|0|||
23385372|NCT00290758|65155058|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
23385373|NCT00290758|65155059|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
23292219|NCT01436643|64811541|FG001|2-week Pre-treatment|Adverse Event|0|||
23292220|NCT01436643|64811542|FG002|2-week Pre-treatment|Adverse Event|0|||
23292221|NCT01436643|64811543|FG003|2-week Pre-treatment|Adverse Event|5|||
23292222|NCT01436643|64811540|FG000|2-week Pre-treatment|Protocol Violation|0|||
23292223|NCT01436643|64811541|FG001|2-week Pre-treatment|Protocol Violation|0|||
23292224|NCT01436643|64811542|FG002|2-week Pre-treatment|Protocol Violation|0|||
23292225|NCT01436643|64811543|FG003|2-week Pre-treatment|Protocol Violation|4|||
23292226|NCT01436643|64811540|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
23292227|NCT01436643|64811541|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
23292228|NCT01436643|64811542|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
23292229|NCT01436643|64811543|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
23385374|NCT00290758|65155058|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
23385375|NCT00290758|65155059|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
23385376|NCT02400580|65155061|FG000|Overall Study|Withdrawal by Subject|1|||
23385377|NCT02400580|65155062|FG001|Overall Study|Withdrawal by Subject|1|||
23385378|NCT02400580|65155061|FG000|Overall Study|Adverse Event|1|||
23385379|NCT02400580|65155062|FG001|Overall Study|Adverse Event|0|||
23385380|NCT02923180|65155063|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
23385381|NCT02923180|65155063|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
23385382|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Other|4|||
23385383|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Other|1|||
23385384|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
23385385|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
23385386|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
23385387|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
23385388|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
23385389|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
23385390|NCT03439514|65155064|FG000|Double-Blind Treatment Period|Death|1|||
23385391|NCT03439514|65155065|FG001|Double-Blind Treatment Period|Death|2|||
23385392|NCT01879852|65155070|FG000|Overall Study|Withdrawal by Subject|2|||
23385393|NCT01879852|65155071|FG001|Overall Study|Withdrawal by Subject|0|||
23385394|NCT02665455|65155073|FG000|Overall Study|Withdrawal by Subject|6|||
23385395|NCT02665455|65155073|FG000|Overall Study|Lost to Follow-up|1|||
23385396|NCT02665455|65155073|FG000|Overall Study|Adverse Event|1|||
23385397|NCT02665455|65155073|FG000|Overall Study|Protocol Violation|1|||
23385398|NCT00086307|65155079|FG000|Overall Study|Lack of Efficacy|1|||
23385399|NCT00086307|65155080|FG001|Overall Study|Lack of Efficacy|1|||
23385400|NCT00086307|65155081|FG002|Overall Study|Lack of Efficacy|2|||
23385401|NCT00086307|65155079|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
23385402|NCT00086307|65155080|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
23385403|NCT00086307|65155081|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
23385404|NCT00086307|65155079|FG000|Overall Study|Nausea and headaches|0|||
23385405|NCT00086307|65155080|FG001|Overall Study|Nausea and headaches|0|||
23385406|NCT00086307|65155081|FG002|Overall Study|Nausea and headaches|1|||
23385407|NCT00086307|65155079|FG000|Overall Study|Constipation and sleepiness|0|||
23385408|NCT00086307|65155080|FG001|Overall Study|Constipation and sleepiness|0|||
23385409|NCT00086307|65155081|FG002|Overall Study|Constipation and sleepiness|1|||
23385410|NCT00086307|65155079|FG000|Overall Study|Suicidal ideation|0|||
23385411|NCT00086307|65155080|FG001|Overall Study|Suicidal ideation|0|||
23385412|NCT00086307|65155081|FG002|Overall Study|Suicidal ideation|1|||
23385413|NCT00086307|65155079|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
23385414|NCT00086307|65155080|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
23385415|NCT00086307|65155081|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
23385416|NCT00086307|65155079|FG000|Overall Study|Withdrawal by Subject|0|||
23385417|NCT00086307|65155080|FG001|Overall Study|Withdrawal by Subject|0|||
23385418|NCT00086307|65155081|FG002|Overall Study|Withdrawal by Subject|2|||
23385419|NCT00501085|65155082|FG000|Overall Study|Lost to Follow-up|195|||
23385420|NCT00501085|65155082|FG000|Overall Study|Withdrawal by Subject|34|||
23385421|NCT00501085|65155082|FG000|Overall Study|Subject Decision|1|||
23385422|NCT00501085|65155082|FG000|Overall Study|Revision Surgery|7|||
23385423|NCT00501085|65155082|FG000|Overall Study|Explantation Surgery|26|||
23385424|NCT00501085|65155082|FG000|Overall Study|Adverse Event|4|||
23385425|NCT00501085|65155082|FG000|Overall Study|Non-Compliance|24|||
23385426|NCT00501085|65155082|FG000|Overall Study|Study closed by sponsor|109|||
23385427|NCT00501085|65155082|FG000|Overall Study|Other loss to follow-up|32|||
23385428|NCT03528577|65155083|FG000|Sequence 1|Failed Spirometry|1|||
23385429|NCT03528577|65155083|FG000|Sequence 1|Restricted medication|1|||
23385430|NCT03528577|65155083|FG000|Sequence 2|Adverse Event|1|||
23385431|NCT03528577|65155083|FG000|Sequence 2|Withdrawal by Subject|1|||
23385432|NCT03528577|65155083|FG000|Sequence 2|Failed Spirometry|1|||
23385433|NCT03528577|65155083|FG000|Sequence 3|Failed Spirometry|1|||
23385434|NCT03528577|65155083|FG000|Sequence 4|Failed Spirometry|2|||
23385435|NCT03528577|65155083|FG000|Sequence 4|Adverse Event|1|||
23385436|NCT04193527|65155084|FG000|Overall Study|Other|1|||
23385437|NCT04193527|65155085|FG001|Overall Study|Other|1|||
23385438|NCT04193527|65155086|FG002|Overall Study|Other|0|||
23385439|NCT02755090|65155089|FG000|Overall Study|equipment malfunction|1|||
23385440|NCT02755090|65155090|FG001|Overall Study|equipment malfunction|0|||
23385441|NCT00710970|65155091|FG000|Overall Study|Never took drug|3|||
23385442|NCT01905267|65155094|FG000|Overall Study|Physician Decision|2|||
23385443|NCT01905267|65155095|FG001|Overall Study|Physician Decision|2|||
23385444|NCT00770484|65155096|FG000|Overall Study|Withdrawal by Subject|1|||
23493200|NCT00100178|65551388|FG002|Overall Study|Adverse Event|1|||
23385445|NCT00770484|65155097|FG001|Overall Study|Withdrawal by Subject|0|||
23385446|NCT00066170|65155098|FG000|Overall Study|Adverse Event|2|||
23385447|NCT00066170|65155099|FG001|Overall Study|Adverse Event|4|||
23385448|NCT00066170|65155100|FG002|Overall Study|Adverse Event|1|||
23385449|NCT00066170|65155101|FG003|Overall Study|Adverse Event|7|||
23385450|NCT00066170|65155098|FG000|Overall Study|Serious Adverse Event|0|||
23385451|NCT00066170|65155099|FG001|Overall Study|Serious Adverse Event|0|||
23385452|NCT00066170|65155100|FG002|Overall Study|Serious Adverse Event|1|||
23385453|NCT00066170|65155101|FG003|Overall Study|Serious Adverse Event|1|||
23385454|NCT00066170|65155098|FG000|Overall Study|Lost to Follow-up|0|||
23385455|NCT00066170|65155099|FG001|Overall Study|Lost to Follow-up|1|||
23385456|NCT00066170|65155100|FG002|Overall Study|Lost to Follow-up|0|||
23385457|NCT00066170|65155101|FG003|Overall Study|Lost to Follow-up|0|||
23385458|NCT00066170|65155098|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
23385459|NCT00066170|65155099|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
23385460|NCT00066170|65155100|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
23385461|NCT00066170|65155101|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
23385462|NCT00066170|65155098|FG000|Overall Study|Protocol Violation|3|||
23385463|NCT00066170|65155099|FG001|Overall Study|Protocol Violation|0|||
23385464|NCT00066170|65155100|FG002|Overall Study|Protocol Violation|0|||
23385465|NCT00066170|65155101|FG003|Overall Study|Protocol Violation|0|||
23385466|NCT00066170|65155098|FG000|Overall Study|Other|1|||
23385467|NCT00066170|65155099|FG001|Overall Study|Other|5|||
23385468|NCT00066170|65155100|FG002|Overall Study|Other|2|||
23385469|NCT00066170|65155101|FG003|Overall Study|Other|0|||
23385470|NCT02619812|65155102|FG000|Overall Study|Withdrawal by Subject|0|||
23385471|NCT02619812|65155103|FG001|Overall Study|Withdrawal by Subject|0|||
23385472|NCT02619812|65155104|FG002|Overall Study|Withdrawal by Subject|1|||
23385473|NCT02619812|65155105|FG003|Overall Study|Withdrawal by Subject|2|||
23385474|NCT01623752|65155108|FG000|Phase 1 (78 Weeks)|No Data|249|||
23385475|NCT01623752|65155109|FG001|Phase 1 (78 Weeks)|No Data|66|||
23385476|NCT01623752|65155110|FG002|Phase 1 (78 Weeks)|No Data|2|||
23385477|NCT01623752|65155108|FG000|Phase 1 (78 Weeks)|Other|33|||
23385478|NCT01623752|65155109|FG001|Phase 1 (78 Weeks)|Other|20|||
23385479|NCT01623752|65155110|FG002|Phase 1 (78 Weeks)|Other|0|||
23385480|NCT01623752|65155108|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
23385481|NCT01623752|65155109|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
23385482|NCT01623752|65155110|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
23385483|NCT01623752|65155108|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
23385484|NCT01623752|65155109|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
23385485|NCT01623752|65155110|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
23385486|NCT01623752|65155108|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
23385487|NCT01623752|65155109|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
23385488|NCT01623752|65155110|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
23385489|NCT01623752|65155108|FG000|Phase 2 (78 Weeks)|Other|5|||
23385490|NCT01623752|65155109|FG001|Phase 2 (78 Weeks)|Other|1|||
23385491|NCT01623752|65155110|FG002|Phase 2 (78 Weeks)|Other|0|||
23385492|NCT01623752|65155108|FG000|Phase 2 (78 Weeks)|No Data|43|||
23292230|NCT01436643|64811540|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
23292231|NCT01436643|64811541|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
23292232|NCT01436643|64811542|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
23292233|NCT01436643|64811543|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
23292234|NCT01436643|64811540|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
23292235|NCT01436643|64811541|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
23292236|NCT01436643|64811542|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
23292237|NCT01436643|64811543|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
23292238|NCT01321697|64811548|FG000|Overall Study|Study Terminated|7|||
23292239|NCT00708682|64811549|FG000|Infant Series|Adverse Event|1|||
23292240|NCT00708682|64811549|FG000|Infant Series|Lost to Follow-up|4|||
23292241|NCT00708682|64811549|FG000|Infant Series|Protocol Violation|1|||
23292242|NCT00708682|64811549|FG000|Infant Series|Parent/legal guardian request|6|||
23292243|NCT00708682|64811549|FG000|Infant Series|Failed to return|2|||
23292244|NCT00708682|64811549|FG000|Infant Series|Other|19|||
23292245|NCT00708682|64811549|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
23292246|NCT00708682|64811549|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
23292247|NCT00708682|64811549|FG000|Toddler Dose|Lost to Follow-up|3|||
23292248|NCT00708682|64811549|FG000|Toddler Dose|Failed to Return|4|||
23292249|NCT02654587|64811550|FG000|Overall Study|patient alive at end of study|22|||
23385493|NCT01623752|65155109|FG001|Phase 2 (78 Weeks)|No Data|11|||
23385494|NCT01623752|65155110|FG002|Phase 2 (78 Weeks)|No Data|0|||
23385495|NCT01623752|65155108|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
23385496|NCT01623752|65155109|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
23385497|NCT01623752|65155110|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
23385498|NCT02287025|65155111|FG000|Overall Study|Not treated|2|||
23385499|NCT02287025|65155112|FG001|Overall Study|Not treated|0|||
23385500|NCT02287025|65155111|FG000|Overall Study|Progression of disease|3|||
23292250|NCT02654587|64811551|FG001|Overall Study|patient alive at end of study|8|||
23385501|NCT02287025|65155112|FG001|Overall Study|Progression of disease|2|||
23385502|NCT02287025|65155111|FG000|Overall Study|Adverse Event|2|||
23385503|NCT02287025|65155112|FG001|Overall Study|Adverse Event|4|||
23385504|NCT02287025|65155111|FG000|Overall Study|Withdrawal by Subject|2|||
23385505|NCT02287025|65155112|FG001|Overall Study|Withdrawal by Subject|2|||
23292251|NCT02654587|64811550|FG000|Overall Study|Withdrawal by Subject|1|||
23292252|NCT02654587|64811551|FG001|Overall Study|Withdrawal by Subject|7|||
23292253|NCT00587431|64811552|FG000|Overall Study|Adverse Event|1|||
23292254|NCT00587431|64811553|FG001|Overall Study|Adverse Event|0|||
23292255|NCT00587431|64811552|FG000|Overall Study|Withdrawal by Subject|0|||
23292256|NCT00587431|64811553|FG001|Overall Study|Withdrawal by Subject|1|||
23292257|NCT02662582|64811557|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
23292258|NCT02662582|64811558|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
23292259|NCT02662582|64811557|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
23292260|NCT02662582|64811558|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
23292261|NCT02662582|64811557|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
23292262|NCT02662582|64811558|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
23385506|NCT02287025|65155111|FG000|Overall Study|Screening failed|1|||
23385507|NCT02287025|65155112|FG001|Overall Study|Screening failed|1|||
23385508|NCT03888482|65155114|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
23385509|NCT03888482|65155115|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
23385510|NCT03888482|65155114|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
23385511|NCT03888482|65155115|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
23385512|NCT00195429|65155117|FG000|Overall Study|Adverse Event|2|||
23385513|NCT00195429|65155118|FG001|Overall Study|Adverse Event|4|||
23385514|NCT00195429|65155117|FG000|Overall Study|Lack of Efficacy|2|||
23385515|NCT00195429|65155118|FG001|Overall Study|Lack of Efficacy|1|||
23385516|NCT00195429|65155117|FG000|Overall Study|Lost to Follow-up|1|||
23385517|NCT00195429|65155118|FG001|Overall Study|Lost to Follow-up|0|||
23385518|NCT01960842|65155131|FG000|Overall Study|Adverse Event|1|||
23385519|NCT01960842|65155131|FG000|Overall Study|Withdrawal by Subject|2|||
23385520|NCT00145327|65155133|FG000|Overall Study|Withdrawal by Subject|77|||
23385521|NCT00145327|65155134|FG001|Overall Study|Withdrawal by Subject|72|||
23385522|NCT00145327|65155135|FG002|Overall Study|Withdrawal by Subject|164|||
23385523|NCT00145327|65155133|FG000|Overall Study|Death|26|||
23385524|NCT00145327|65155134|FG001|Overall Study|Death|18|||
23385525|NCT00145327|65155135|FG002|Overall Study|Death|30|||
23385526|NCT00145327|65155133|FG000|Overall Study|Adverse Event|14|||
23385527|NCT00145327|65155134|FG001|Overall Study|Adverse Event|11|||
23385528|NCT00145327|65155135|FG002|Overall Study|Adverse Event|22|||
23385529|NCT00145327|65155133|FG000|Overall Study|Lost to Follow-up|9|||
23385530|NCT00145327|65155134|FG001|Overall Study|Lost to Follow-up|14|||
23385531|NCT00145327|65155135|FG002|Overall Study|Lost to Follow-up|14|||
23385532|NCT00145327|65155133|FG000|Overall Study|Administrative problems|12|||
23385533|NCT00145327|65155134|FG001|Overall Study|Administrative problems|9|||
23385534|NCT00145327|65155135|FG002|Overall Study|Administrative problems|13|||
23385535|NCT00145327|65155133|FG000|Overall Study|Protocol Violation|2|||
23385536|NCT00145327|65155134|FG001|Overall Study|Protocol Violation|0|||
23385537|NCT00145327|65155135|FG002|Overall Study|Protocol Violation|2|||
23385538|NCT00145327|65155133|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23385539|NCT00145327|65155134|FG001|Overall Study|Abnormal laboratory value(s)|0|||
23493201|NCT00100178|65551386|FG000|Overall Study|Withdrawal by Subject|1|||
23292263|NCT02662582|64811557|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23292264|NCT02662582|64811558|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
23385540|NCT00145327|65155135|FG002|Overall Study|Abnormal laboratory value(s)|2|||
23385541|NCT00145327|65155133|FG000|Overall Study|Missing - not stated|1|||
23385542|NCT00145327|65155134|FG001|Overall Study|Missing - not stated|0|||
23385543|NCT00145327|65155135|FG002|Overall Study|Missing - not stated|1|||
23385544|NCT03338023|65155136|FG000|Overall Study|Withdrawal by Subject|3|||
23385545|NCT03338023|65155137|FG001|Overall Study|Withdrawal by Subject|4|||
23385546|NCT03338023|65155136|FG000|Overall Study|Protocol Violation|3|||
23292265|NCT02762994|64811559|FG000|Overall Study|Withdrawal by Subject|0|||
23292266|NCT02762994|64811560|FG001|Overall Study|Withdrawal by Subject|1|||
23292267|NCT02762994|64811561|FG002|Overall Study|Withdrawal by Subject|2|||
23292268|NCT02762994|64811562|FG003|Overall Study|Withdrawal by Subject|0|||
23292269|NCT02762994|64811559|FG000|Overall Study|Protocol Violation|1|||
23292270|NCT02762994|64811560|FG001|Overall Study|Protocol Violation|0|||
23292271|NCT02762994|64811561|FG002|Overall Study|Protocol Violation|0|||
23292272|NCT02762994|64811562|FG003|Overall Study|Protocol Violation|2|||
23292273|NCT04979858|64811569|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
23292274|NCT04979858|64811570|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
23292275|NCT00271024|64811571|FG000|Overall Study|Lost Interest|3|||
23292276|NCT00271024|64811572|FG001|Overall Study|Lost Interest|4|||
23292277|NCT00271024|64811573|FG002|Overall Study|Lost Interest|2|||
23292278|NCT00271024|64811574|FG003|Overall Study|Lost Interest|3|||
23292279|NCT00271024|64811571|FG000|Overall Study|Unknown/Unspecified|11|||
23292280|NCT00271024|64811572|FG001|Overall Study|Unknown/Unspecified|11|||
23292281|NCT00271024|64811573|FG002|Overall Study|Unknown/Unspecified|8|||
23292282|NCT00271024|64811574|FG003|Overall Study|Unknown/Unspecified|4|||
23292283|NCT00271024|64811571|FG000|Overall Study|Protocol Violation|1|||
23385547|NCT03338023|65155137|FG001|Overall Study|Protocol Violation|3|||
23385548|NCT03338023|65155136|FG000|Overall Study|Lost to Follow-up|2|||
23385549|NCT03338023|65155137|FG001|Overall Study|Lost to Follow-up|1|||
23385550|NCT03338023|65155136|FG000|Overall Study|Physician Decision|1|||
23385551|NCT03338023|65155137|FG001|Overall Study|Physician Decision|2|||
23385552|NCT00122187|65155138|FG000|Overall Study|Withdrew because of resource limitations|2|||
23385553|NCT00122187|65155139|FG001|Overall Study|Withdrew because of resource limitations|2|||
23385554|NCT00182637|65155140|FG000|Overall Study|Adverse Event|2|||
23385555|NCT00182637|65155140|FG000|Overall Study|Disease Progression|1|||
23385556|NCT01716559|65155146|FG000|Overall Study|Adverse Event|11|||
23385557|NCT01716559|65155146|FG000|Overall Study|Death|21|||
23385558|NCT01716559|65155146|FG000|Overall Study|Withdrawal by Subject|4|||
23385559|NCT01716559|65155146|FG000|Overall Study|Other withdrawal reason|75|||
23385560|NCT01570192|65155147|FG000|Overall Study|no qualifying organism|6|||
23385561|NCT01570192|65155148|FG001|Overall Study|no qualifying organism|12|||
23385562|NCT01570192|65155147|FG000|Overall Study|changed to palliative care|1|||
23385563|NCT01570192|65155148|FG001|Overall Study|changed to palliative care|0|||
23385564|NCT01570192|65155147|FG000|Overall Study|Physician Decision|0|||
23385565|NCT01570192|65155148|FG001|Overall Study|Physician Decision|1|||
23385566|NCT02346370|65155149|FG000|Overall Study|Not treated|1|||
23385567|NCT02346370|65155150|FG001|Overall Study|Not treated|0|||
23385568|NCT02346370|65155151|FG002|Overall Study|Not treated|0|||
23385569|NCT02346370|65155149|FG000|Overall Study|Withdrawal of consent|1|||
23385570|NCT02346370|65155150|FG001|Overall Study|Withdrawal of consent|0|||
23385571|NCT02346370|65155151|FG002|Overall Study|Withdrawal of consent|0|||
23385572|NCT02346370|65155149|FG000|Overall Study|Death|1|||
23385573|NCT02346370|65155150|FG001|Overall Study|Death|3|||
23385574|NCT02346370|65155151|FG002|Overall Study|Death|1|||
23385575|NCT02346370|65155149|FG000|Overall Study|Sponsor discontinued study|5|||
23385576|NCT02346370|65155150|FG001|Overall Study|Sponsor discontinued study|0|||
23385577|NCT02346370|65155151|FG002|Overall Study|Sponsor discontinued study|2|||
23385578|NCT02346370|65155149|FG000|Overall Study|Radiologic progression|0|||
23385579|NCT02346370|65155150|FG001|Overall Study|Radiologic progression|0|||
23385580|NCT02346370|65155151|FG002|Overall Study|Radiologic progression|1|||
23385581|NCT02346370|65155149|FG000|Overall Study|Physician Decision|0|||
23385582|NCT02346370|65155150|FG001|Overall Study|Physician Decision|1|||
23385583|NCT02346370|65155151|FG002|Overall Study|Physician Decision|0|||
23385584|NCT01155323|65155152|FG000|First Intervention|exclusion criteria|1|||
23385585|NCT01155323|65155153|FG001|First Intervention|exclusion criteria|1|||
23385586|NCT01155323|65155152|FG000|Second Intervention|Lost to Follow-up|1|||
23385587|NCT01155323|65155153|FG001|Second Intervention|Lost to Follow-up|1|||
23385588|NCT03462563|65155156|FG000|Overall Study|Death|1|||
23385589|NCT03462563|65155157|FG001|Overall Study|Death|1|||
23385590|NCT03462563|65155156|FG000|Overall Study|Termination of study|2|||
23385591|NCT03462563|65155157|FG001|Overall Study|Termination of study|1|||
23385592|NCT03462563|65155156|FG000|Overall Study|Adverse Event|1|||
23385593|NCT03462563|65155157|FG001|Overall Study|Adverse Event|3|||
23385594|NCT03462563|65155156|FG000|Overall Study|Unspecified reason|10|||
23385595|NCT03462563|65155157|FG001|Overall Study|Unspecified reason|12|||
23385596|NCT03462563|65155156|FG000|Overall Study|Physician Decision|1|||
23385597|NCT03462563|65155157|FG001|Overall Study|Physician Decision|0|||
23385598|NCT02945046|65155158|FG000|Overall Study|Adverse Event|1|||
23385599|NCT02945046|65155159|FG001|Overall Study|Adverse Event|0|||
23385600|NCT02945046|65155160|FG002|Overall Study|Adverse Event|2|||
23385601|NCT02945046|65155158|FG000|Overall Study|Withdrawal by Subject|3|||
23385602|NCT02945046|65155159|FG001|Overall Study|Withdrawal by Subject|3|||
23385603|NCT02945046|65155160|FG002|Overall Study|Withdrawal by Subject|3|||
23385604|NCT02945046|65155158|FG000|Overall Study|Protocol Violation|2|||
23385605|NCT02945046|65155159|FG001|Overall Study|Protocol Violation|3|||
23385606|NCT02945046|65155160|FG002|Overall Study|Protocol Violation|2|||
23385607|NCT02945046|65155158|FG000|Overall Study|Lost to Follow-up|1|||
23385608|NCT02945046|65155159|FG001|Overall Study|Lost to Follow-up|1|||
23385609|NCT02945046|65155160|FG002|Overall Study|Lost to Follow-up|0|||
23385610|NCT02945046|65155158|FG000|Overall Study|Lack of Efficacy|1|||
23385611|NCT02945046|65155159|FG001|Overall Study|Lack of Efficacy|2|||
23385612|NCT02945046|65155160|FG002|Overall Study|Lack of Efficacy|1|||
23385613|NCT02945046|65155158|FG000|Overall Study|Other than specified|5|||
23385614|NCT02945046|65155159|FG001|Overall Study|Other than specified|4|||
23385615|NCT02945046|65155160|FG002|Overall Study|Other than specified|7|||
23385616|NCT02965976|65155161|FG000|Overall Study|Withdrawal by Subject|2|||
23385617|NCT02965976|65155162|FG001|Overall Study|Withdrawal by Subject|0|||
23385618|NCT02691663|65155163|FG000|Overall Study|Screen failure after baseline|2|||
23385619|NCT02691663|65155164|FG001|Overall Study|Screen failure after baseline|2|||
23385620|NCT02691663|65155163|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
23385621|NCT02691663|65155164|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
23385622|NCT02691663|65155163|FG000|Overall Study|Withdrawn after Follow up 2|1|||
23385623|NCT02691663|65155164|FG001|Overall Study|Withdrawn after Follow up 2|1|||
23385624|NCT02691663|65155163|FG000|Overall Study|Lost to Follow-up|3|||
23385625|NCT02691663|65155164|FG001|Overall Study|Lost to Follow-up|2|||
23385626|NCT05427916|65155179|FG000|Overall Study|Adverse Event|3|||
23385627|NCT05427916|65155180|FG001|Overall Study|Adverse Event|0|||
23385628|NCT05427916|65155179|FG000|Overall Study|Lack of Efficacy|6|||
23385629|NCT05427916|65155180|FG001|Overall Study|Lack of Efficacy|0|||
23385630|NCT05427916|65155179|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
23385631|NCT05427916|65155180|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
23385632|NCT01717859|65155182|FG000|Overall Study|Adverse Event|5|||
23385633|NCT01717859|65155182|FG000|Overall Study|Moved out of state|1|||
23385634|NCT01717859|65155182|FG000|Overall Study|Patient concerned about mental health|1|||
23385635|NCT01717859|65155182|FG000|Overall Study|Lost to Follow-up|1|||
23385636|NCT01717859|65155182|FG000|Overall Study|Withdrawal by Subject|2|||
23385637|NCT01953354|65155183|FG000|Overall Study|Withdrawal by Subject|0|||
23292284|NCT00271024|64811572|FG001|Overall Study|Protocol Violation|6|||
23292285|NCT00271024|64811573|FG002|Overall Study|Protocol Violation|5|||
23292286|NCT00271024|64811574|FG003|Overall Study|Protocol Violation|11|||
23292287|NCT00271024|64811571|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
23385638|NCT01953354|65155184|FG001|Overall Study|Withdrawal by Subject|1|||
23385639|NCT01953354|65155183|FG000|Overall Study|Decision of Sponsor|0|||
23385640|NCT01953354|65155184|FG001|Overall Study|Decision of Sponsor|1|||
23292288|NCT00271024|64811572|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
23292289|NCT00271024|64811573|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
23385641|NCT01953354|65155183|FG000|Overall Study|Disease Exacerbation|1|||
23385642|NCT01953354|65155184|FG001|Overall Study|Disease Exacerbation|0|||
23385643|NCT02739828|65155185|FG000|Overall Study|Adverse Event|1|||
23385644|NCT02739828|65155185|FG000|Overall Study|Lost to Follow-up|4|||
23385645|NCT05085405|65155186|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
23385646|NCT05085405|65155187|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
23385647|NCT05085405|65155188|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
23385648|NCT05085405|65155189|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
23385649|NCT05085405|65155190|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
23385650|NCT05085405|65155191|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
23385651|NCT05085405|65155186|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23292290|NCT00271024|64811574|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
23292291|NCT00271024|64811571|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
23292292|NCT00271024|64811572|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
23292293|NCT00271024|64811573|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
23292294|NCT00271024|64811574|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
23292295|NCT01680016|64811578|FG000|Overall Study|Adverse Event|0|||
23292296|NCT01680016|64811579|FG001|Overall Study|Adverse Event|0|||
23292297|NCT01680016|64811580|FG002|Overall Study|Adverse Event|1|||
23292298|NCT01680016|64811581|FG003|Overall Study|Adverse Event|4|||
23292299|NCT01680016|64811578|FG000|Overall Study|The Subject went out of The Trial|1|||
23292300|NCT01680016|64811579|FG001|Overall Study|The Subject went out of The Trial|0|||
23292301|NCT01680016|64811580|FG002|Overall Study|The Subject went out of The Trial|3|||
23292302|NCT01680016|64811581|FG003|Overall Study|The Subject went out of The Trial|0|||
23385652|NCT05085405|65155187|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23385653|NCT05085405|65155188|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23385654|NCT05085405|65155189|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
23385655|NCT05085405|65155190|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23385656|NCT05085405|65155191|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
23385657|NCT03142451|65155203|FG000|Overall Study|Adverse Event|5|||
23385658|NCT03142451|65155204|FG001|Overall Study|Adverse Event|2|||
23385659|NCT03142451|65155203|FG000|Overall Study|Lost to Follow-up|25|||
23385660|NCT03142451|65155204|FG001|Overall Study|Lost to Follow-up|8|||
23385661|NCT03142451|65155203|FG000|Overall Study|Participant request|24|||
23385662|NCT03142451|65155204|FG001|Overall Study|Participant request|12|||
23385663|NCT03142451|65155203|FG000|Overall Study|Protocol Violation|3|||
23385664|NCT03142451|65155204|FG001|Overall Study|Protocol Violation|1|||
23385665|NCT03142451|65155203|FG000|Overall Study|Other|1|||
23385666|NCT03142451|65155204|FG001|Overall Study|Other|1|||
23385667|NCT00366535|65155205|FG000|First Phase: 12 Weeks|Adverse Event|1|||
23385668|NCT00366535|65155206|FG001|First Phase: 12 Weeks|Adverse Event|3|||
23385669|NCT00366535|65155205|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
23385670|NCT00366535|65155206|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
23385671|NCT00366535|65155205|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
23385672|NCT00366535|65155206|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
23385673|NCT00366535|65155205|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
23385674|NCT00366535|65155206|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
23385675|NCT00655746|65155207|FG000|Overall Study|Withdrawal by Subject|1|||
23385676|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Adverse Event|14|||
23385677|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Adverse Event|27|||
23385678|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Adverse Event|60|||
23385679|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Adverse Event|0|||
23493202|NCT00100178|65551387|FG001|Overall Study|Withdrawal by Subject|1|||
23493203|NCT00100178|65551388|FG002|Overall Study|Withdrawal by Subject|1|||
23385680|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Adverse Event|0|||
23385681|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Pregnancy|0|||
23385682|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Pregnancy|7|||
23385683|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Pregnancy|9|||
23385684|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Pregnancy|0|||
23493204|NCT00100178|65551386|FG000|Overall Study|Physician Decision|6|||
23493205|NCT00100178|65551387|FG001|Overall Study|Physician Decision|1|||
23385685|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Pregnancy|0|||
23606054|NCT01853384|65947130|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
23606055|NCT01853384|65947131|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
23292303|NCT01680016|64811578|FG000|Overall Study|Protocol Violation|0|||
23292304|NCT01680016|64811579|FG001|Overall Study|Protocol Violation|1|||
23292305|NCT01680016|64811580|FG002|Overall Study|Protocol Violation|0|||
23292306|NCT01680016|64811581|FG003|Overall Study|Protocol Violation|0|||
23292307|NCT01680016|64811578|FG000|Overall Study|Withdrawal by Subject|5|||
23292308|NCT01680016|64811579|FG001|Overall Study|Withdrawal by Subject|7|||
23292309|NCT01680016|64811580|FG002|Overall Study|Withdrawal by Subject|1|||
23292310|NCT01680016|64811581|FG003|Overall Study|Withdrawal by Subject|1|||
23292311|NCT02998541|64811582|FG000|Overall Study|Adverse Event|4|||
23292312|NCT02998541|64811583|FG001|Overall Study|Adverse Event|5|||
23292313|NCT02998541|64811584|FG002|Overall Study|Adverse Event|1|||
23292314|NCT02998541|64811582|FG000|Overall Study|Protocol Violation|1|||
23292315|NCT02998541|64811583|FG001|Overall Study|Protocol Violation|0|||
23292316|NCT02998541|64811584|FG002|Overall Study|Protocol Violation|0|||
23292317|NCT02998541|64811582|FG000|Overall Study|Withdrawal by Subject|3|||
23606056|NCT01853384|65947130|FG000|Completed Follow up Visit 2|Death|1|||
23606057|NCT01853384|65947131|FG001|Completed Follow up Visit 2|Death|0|||
23606058|NCT01853384|65947130|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
23606059|NCT01853384|65947131|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
23606060|NCT03136159|65947134|FG000|Overall Study|chorioamnionitis|2|||
23606061|NCT03136159|65947135|FG001|Overall Study|chorioamnionitis|0|||
23606062|NCT03136159|65947134|FG000|Overall Study|vertical skin incision|1|||
23606063|NCT03136159|65947135|FG001|Overall Study|vertical skin incision|0|||
23606064|NCT03136159|65947134|FG000|Overall Study|additional dressing|1|||
23606065|NCT03136159|65947135|FG001|Overall Study|additional dressing|0|||
23606066|NCT03136159|65947134|FG000|Overall Study|never got dressing placed|1|||
23606067|NCT03136159|65947135|FG001|Overall Study|never got dressing placed|0|||
23292318|NCT02998541|64811583|FG001|Overall Study|Withdrawal by Subject|1|||
23292319|NCT02998541|64811584|FG002|Overall Study|Withdrawal by Subject|0|||
23292320|NCT02998541|64811582|FG000|Overall Study|Lost to Follow-up|0|||
23292321|NCT02998541|64811583|FG001|Overall Study|Lost to Follow-up|3|||
23292322|NCT02998541|64811584|FG002|Overall Study|Lost to Follow-up|1|||
23292323|NCT02998541|64811582|FG000|Overall Study|Physician Decision|0|||
23292324|NCT02998541|64811583|FG001|Overall Study|Physician Decision|0|||
23292325|NCT02998541|64811584|FG002|Overall Study|Physician Decision|3|||
23292326|NCT02998541|64811582|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23292327|NCT02998541|64811583|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23292328|NCT02998541|64811584|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
23292329|NCT00109850|64811586|FG000|Overall Study|Adverse Event|1|||
23292330|NCT00109850|64811586|FG000|Overall Study|Death|2|||
23292331|NCT00109850|64811586|FG000|Overall Study|Ineligible|1|||
23292332|NCT02658019|64811587|FG000|Overall Study|Adverse Event|1|||
23292333|NCT02618382|64811592|FG000|Overall Study|Physician Decision|1|||
23292334|NCT02618382|64811592|FG000|Overall Study|Withdrawal by Subject|1|||
23292335|NCT02618382|64811592|FG000|Overall Study|Protocol Violation|1|||
23292336|NCT02327325|64811593|FG000|Overall Study|Withdrawal by Subject|1|||
23292337|NCT02327325|64811594|FG001|Overall Study|Withdrawal by Subject|4|||
23292338|NCT02327325|64811595|FG002|Overall Study|Withdrawal by Subject|4|||
23292339|NCT02327325|64811593|FG000|Overall Study|Excluded by Study Team|0|||
23292340|NCT02327325|64811594|FG001|Overall Study|Excluded by Study Team|0|||
23292341|NCT02327325|64811595|FG002|Overall Study|Excluded by Study Team|1|||
23292342|NCT04167618|64811596|FG000|Overall Study|Trial terminated by sponsor|1|||
23292343|NCT04167618|64811597|FG001|Overall Study|Trial terminated by sponsor|1|||
23292344|NCT00179673|64811600|FG000|Overall Study|Adverse Event|7|||
23292345|NCT00179673|64811600|FG000|Overall Study|Lack of Efficacy|15|||
23292346|NCT00179673|64811600|FG000|Overall Study|Withdrawal by Subject|3|||
23292347|NCT00179673|64811600|FG000|Overall Study|Death|4|||
23292348|NCT00179673|64811600|FG000|Overall Study|Other Observations and options|14|||
23292349|NCT02302716|64811601|FG000|Overall Study|Adverse Event|1|||
23292350|NCT02302716|64811602|FG001|Overall Study|Adverse Event|1|||
23292351|NCT02302716|64811601|FG000|Overall Study|Death|0|||
23292352|NCT02302716|64811602|FG001|Overall Study|Death|1|||
23292353|NCT02302716|64811601|FG000|Overall Study|Lack of Efficacy|0|||
23292354|NCT02302716|64811602|FG001|Overall Study|Lack of Efficacy|1|||
23292355|NCT02302716|64811601|FG000|Overall Study|Lost to Follow-up|2|||
23292356|NCT02302716|64811602|FG001|Overall Study|Lost to Follow-up|4|||
23292357|NCT02302716|64811601|FG000|Overall Study|Physician Decision|3|||
23493206|NCT00100178|65551388|FG002|Overall Study|Physician Decision|3|||
23493207|NCT00413244|65551389|FG000|Overall Study|Withdrawal by Subject|10|||
23292358|NCT02302716|64811602|FG001|Overall Study|Physician Decision|4|||
23292359|NCT02302716|64811601|FG000|Overall Study|Withdrawal by Subject|13|||
23385686|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
23385687|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
23385688|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
23385689|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
23385690|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
23292360|NCT02302716|64811602|FG001|Overall Study|Withdrawal by Subject|7|||
23292361|NCT02302716|64811601|FG000|Overall Study|Protocol Violation|0|||
23292362|NCT02302716|64811602|FG001|Overall Study|Protocol Violation|1|||
23292363|NCT04205162|64811603|FG000|Overall Study|Lost to Follow-up|1|||
23292364|NCT04205162|64811604|FG001|Overall Study|Lost to Follow-up|0|||
23385691|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
23385692|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
23385693|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
23385694|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
23385695|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
23385696|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Death|1|||
23385697|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Death|2|||
23385698|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Death|2|||
23292365|NCT04205162|64811603|FG000|Overall Study|Withdrawal by Subject|2|||
23292366|NCT04205162|64811604|FG001|Overall Study|Withdrawal by Subject|0|||
23292367|NCT04205162|64811603|FG000|Overall Study|University closure due to COVID-19|1|||
23292368|NCT04205162|64811604|FG001|Overall Study|University closure due to COVID-19|0|||
23292369|NCT01955044|64811605|FG000|Overall Study|Death|1|||
23385699|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Death|0|||
23385700|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Death|0|||
23385701|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
23385702|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
23385703|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
23385704|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
23385705|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
23385706|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
23385707|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
23385708|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
23385709|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
23385710|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
23385711|NCT00098293|65155208|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
23385712|NCT00098293|65155209|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
23385713|NCT00098293|65155210|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
23385714|NCT00098293|65155211|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
23385715|NCT00098293|65155212|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
23385716|NCT00098293|65155208|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
23385717|NCT00098293|65155209|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
23606068|NCT00454194|65947137|FG000|Overall Study|Adverse Event|7|||
23606069|NCT00454194|65947138|FG001|Overall Study|Adverse Event|2|||
23606070|NCT00454194|65947137|FG000|Overall Study|Withdrawal by Subject|12|||
23292370|NCT01955044|64811606|FG001|Overall Study|Death|1|||
23292371|NCT01955044|64811607|FG002|Overall Study|Death|0|||
23606071|NCT00454194|65947138|FG001|Overall Study|Withdrawal by Subject|8|||
23606072|NCT00454194|65947137|FG000|Overall Study|Other Medical Problems|1|||
23606073|NCT00454194|65947138|FG001|Overall Study|Other Medical Problems|2|||
23606074|NCT00454194|65947137|FG000|Overall Study|Other Unspecified Reason|2|||
23606075|NCT00454194|65947138|FG001|Overall Study|Other Unspecified Reason|2|||
23606076|NCT04213807|65947139|FG000|Overall Study|Physician Decision|0|||
23606077|NCT04213807|65947140|FG001|Overall Study|Physician Decision|0|||
23606078|NCT04213807|65947141|FG002|Overall Study|Physician Decision|1|||
23606079|NCT02137785|65947146|FG000|Overall Study|Lost to Follow-up|1|||
23606080|NCT02137785|65947147|FG001|Overall Study|Lost to Follow-up|0|||
23606081|NCT02137785|65947146|FG000|Overall Study|Withdrawal by Subject|1|||
23606082|NCT02137785|65947147|FG001|Overall Study|Withdrawal by Subject|4|||
23606083|NCT02137785|65947146|FG000|Overall Study|subject moved out of state|1|||
23606084|NCT02137785|65947147|FG001|Overall Study|subject moved out of state|0|||
23606085|NCT00614614|65947148|FG000|Primary Vaccination Phase|Adverse Event|6|||
23606086|NCT00614614|65947149|FG001|Primary Vaccination Phase|Adverse Event|0|||
23606087|NCT00614614|65947150|FG002|Primary Vaccination Phase|Adverse Event|0|||
23606088|NCT00614614|65947151|FG003|Primary Vaccination Phase|Adverse Event|0|||
23606089|NCT00614614|65947152|FG004|Primary Vaccination Phase|Adverse Event|0|||
23493208|NCT00413244|65551390|FG001|Overall Study|Withdrawal by Subject|1|||
23292372|NCT02911935|64811610|FG000|Overall Study|Lost to Follow-up|5|||
23292373|NCT02911935|64811611|FG001|Overall Study|Lost to Follow-up|7|||
23292374|NCT04523480|64811612|FG000|Overall Study|Lost to Follow-up|30|||
23292375|NCT04523480|64811613|FG001|Overall Study|Lost to Follow-up|35|||
23292376|NCT04523480|64811614|FG002|Overall Study|Lost to Follow-up|0|||
23292377|NCT02426541|64811615|FG000|Overall Study|Protocol Violation|1|||
23292378|NCT02426541|64811616|FG001|Overall Study|Protocol Violation|0|||
23292379|NCT01636934|64811622|FG000|Overall Study|Withdrawal by Subject|3|||
23292380|NCT01636934|64811623|FG001|Overall Study|Withdrawal by Subject|2|||
23292381|NCT01636934|64811622|FG000|Overall Study|Chemo cancel|1|||
23292382|NCT01636934|64811623|FG001|Overall Study|Chemo cancel|0|||
23292383|NCT01636934|64811622|FG000|Overall Study|Too ill to continue|1|||
23292384|NCT01636934|64811623|FG001|Overall Study|Too ill to continue|0|||
23292385|NCT01636934|64811622|FG000|Overall Study|Never started study medication|1|||
23292386|NCT01636934|64811623|FG001|Overall Study|Never started study medication|1|||
23292387|NCT01588548|64811624|FG000|Overall Study|Withdrawal by Subject|0|||
23292388|NCT01588548|64811625|FG001|Overall Study|Withdrawal by Subject|1|||
23292389|NCT01588548|64811626|FG002|Overall Study|Withdrawal by Subject|1|||
23292390|NCT01588548|64811627|FG003|Overall Study|Withdrawal by Subject|1|||
23292391|NCT01588548|64811628|FG004|Overall Study|Withdrawal by Subject|2|||
23292392|NCT01588548|64811629|FG005|Overall Study|Withdrawal by Subject|3|||
23292393|NCT01588548|64811624|FG000|Overall Study|Adverse Event|0|||
23292394|NCT01588548|64811625|FG001|Overall Study|Adverse Event|0|||
23292395|NCT01588548|64811626|FG002|Overall Study|Adverse Event|1|||
23292396|NCT01588548|64811627|FG003|Overall Study|Adverse Event|2|||
23292397|NCT01588548|64811628|FG004|Overall Study|Adverse Event|1|||
23292398|NCT01588548|64811629|FG005|Overall Study|Adverse Event|0|||
23292399|NCT01588548|64811624|FG000|Overall Study|Condition Under Investigation Worsened|3|||
23292400|NCT01588548|64811625|FG001|Overall Study|Condition Under Investigation Worsened|6|||
23292401|NCT01588548|64811626|FG002|Overall Study|Condition Under Investigation Worsened|4|||
23292402|NCT01588548|64811627|FG003|Overall Study|Condition Under Investigation Worsened|4|||
23292403|NCT01588548|64811628|FG004|Overall Study|Condition Under Investigation Worsened|3|||
23292404|NCT01588548|64811629|FG005|Overall Study|Condition Under Investigation Worsened|3|||
23292405|NCT02363439|64811632|FG000|Overall Study|Lack of Efficacy|4|||
23292406|NCT02093923|64811633|FG000|Overall Study|Lost to Follow-up|0|||
23292407|NCT02093923|64811634|FG001|Overall Study|Lost to Follow-up|0|||
23385718|NCT00098293|65155210|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
23385719|NCT00098293|65155211|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
23385720|NCT00098293|65155212|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
23385721|NCT00098293|65155208|FG000|Open-label (OL) Phase|Adverse Event|0|||
23385722|NCT00098293|65155209|FG001|Open-label (OL) Phase|Adverse Event|3|||
23385723|NCT00098293|65155210|FG002|Open-label (OL) Phase|Adverse Event|7|||
23385724|NCT00098293|65155211|FG003|Open-label (OL) Phase|Adverse Event|6|||
23385725|NCT00098293|65155212|FG004|Open-label (OL) Phase|Adverse Event|0|||
23385726|NCT00098293|65155208|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
23385727|NCT00098293|65155209|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
23385728|NCT00098293|65155210|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
23385729|NCT00098293|65155211|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
23385730|NCT00098293|65155212|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
23385731|NCT00098293|65155208|FG000|Open-label (OL) Phase|Pregnancy|0|||
23385732|NCT00098293|65155209|FG001|Open-label (OL) Phase|Pregnancy|1|||
23385733|NCT00098293|65155210|FG002|Open-label (OL) Phase|Pregnancy|0|||
23385734|NCT00098293|65155211|FG003|Open-label (OL) Phase|Pregnancy|3|||
23292408|NCT02093923|64811635|FG002|Overall Study|Lost to Follow-up|0|||
23292409|NCT02093923|64811636|FG003|Overall Study|Lost to Follow-up|1|||
23292410|NCT02093923|64811637|FG004|Overall Study|Lost to Follow-up|0|||
23292411|NCT02093923|64811633|FG000|Overall Study|Screen failure after randomization|0|||
23292412|NCT02093923|64811634|FG001|Overall Study|Screen failure after randomization|0|||
23292413|NCT02093923|64811635|FG002|Overall Study|Screen failure after randomization|0|||
23385735|NCT00098293|65155212|FG004|Open-label (OL) Phase|Pregnancy|0|||
23385736|NCT00098293|65155208|FG000|Open-label (OL) Phase|Protocol Violation|0|||
23385737|NCT00098293|65155209|FG001|Open-label (OL) Phase|Protocol Violation|6|||
23385738|NCT00098293|65155210|FG002|Open-label (OL) Phase|Protocol Violation|13|||
23385739|NCT00098293|65155211|FG003|Open-label (OL) Phase|Protocol Violation|16|||
23385740|NCT00098293|65155212|FG004|Open-label (OL) Phase|Protocol Violation|0|||
23385741|NCT00098293|65155208|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
23385742|NCT00098293|65155209|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
23385743|NCT00098293|65155210|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
23385744|NCT00098293|65155211|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
23385745|NCT00098293|65155212|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
23385746|NCT00098293|65155208|FG000|Open-label (OL) Phase|Death|0|||
23385747|NCT00098293|65155209|FG001|Open-label (OL) Phase|Death|2|||
23385748|NCT00098293|65155210|FG002|Open-label (OL) Phase|Death|3|||
23292414|NCT02093923|64811636|FG003|Overall Study|Screen failure after randomization|1|||
23292415|NCT02093923|64811637|FG004|Overall Study|Screen failure after randomization|0|||
23385749|NCT00098293|65155211|FG003|Open-label (OL) Phase|Death|0|||
23385750|NCT00098293|65155212|FG004|Open-label (OL) Phase|Death|0|||
23385751|NCT00098293|65155208|FG000|Supplemental Phase (SP)|Death|0|||
23385752|NCT00098293|65155209|FG001|Supplemental Phase (SP)|Death|0|||
23385753|NCT00098293|65155210|FG002|Supplemental Phase (SP)|Death|0|||
23385754|NCT00098293|65155211|FG003|Supplemental Phase (SP)|Death|0|||
23385755|NCT00098293|65155212|FG004|Supplemental Phase (SP)|Death|1|||
23385756|NCT00098293|65155208|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
23385757|NCT00098293|65155209|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
23385758|NCT00098293|65155210|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
23385759|NCT00098293|65155211|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
23385760|NCT00098293|65155212|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
23385761|NCT00098293|65155208|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
23385762|NCT00098293|65155209|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
23385763|NCT00098293|65155210|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
23385764|NCT00098293|65155211|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
23385765|NCT00098293|65155212|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
23385766|NCT00098293|65155208|FG000|Supplemental Phase (SP)|Other|0|||
23385767|NCT00098293|65155209|FG001|Supplemental Phase (SP)|Other|0|||
23493209|NCT00397215|65551392|FG000|Month 0 (Day 0)|Adverse Event|0|||
23292416|NCT02246764|64811639|FG000|Overall Study|Adverse Event|15|||
23292417|NCT02246764|64811640|FG001|Overall Study|Adverse Event|29|||
23292418|NCT02246764|64811641|FG002|Overall Study|Adverse Event|1|||
23292419|NCT02246764|64811639|FG000|Overall Study|Withdrawal by Subject|0|||
23292420|NCT02246764|64811640|FG001|Overall Study|Withdrawal by Subject|0|||
23292421|NCT02246764|64811641|FG002|Overall Study|Withdrawal by Subject|1|||
23292422|NCT02246764|64811639|FG000|Overall Study|Disallowed Concomitant Medication|1|||
23292423|NCT02246764|64811640|FG001|Overall Study|Disallowed Concomitant Medication|0|||
23292424|NCT02246764|64811641|FG002|Overall Study|Disallowed Concomitant Medication|0|||
23292425|NCT02246764|64811639|FG000|Overall Study|Physician Decision|0|||
23385768|NCT00098293|65155210|FG002|Supplemental Phase (SP)|Other|0|||
23385769|NCT00098293|65155211|FG003|Supplemental Phase (SP)|Other|0|||
23385770|NCT00098293|65155212|FG004|Supplemental Phase (SP)|Other|22|||
23385771|NCT01428128|65155218|FG000|Overall Study|Withdrawal by Subject|4|||
23385772|NCT01428128|65155218|FG000|Overall Study|Screen failure by p53|10|||
23385773|NCT01428128|65155218|FG000|Overall Study|Received Neulasta in one cycle|2|||
23385774|NCT01428128|65155218|FG000|Overall Study|Adverse Event|1|||
23385775|NCT00923702|65155219|FG000|Overall Study|Ongoing enrollment|0|||
23385776|NCT00923702|65155220|FG001|Overall Study|Ongoing enrollment|0|||
23385777|NCT00923702|65155221|FG002|Overall Study|Ongoing enrollment|0|||
23385778|NCT00923702|65155222|FG003|Overall Study|Ongoing enrollment|0|||
23385779|NCT00923702|65155223|FG004|Overall Study|Ongoing enrollment|354|||
23385780|NCT00478140|65155225|FG000|Overall Study|Clinical Disease Progression|1|||
23385781|NCT03331562|65155226|FG000|Overall Study|Adverse Event|2|||
23292426|NCT02246764|64811640|FG001|Overall Study|Physician Decision|2|||
23292427|NCT02246764|64811641|FG002|Overall Study|Physician Decision|1|||
23292428|NCT02246764|64811639|FG000|Overall Study|Protocol Violation|2|||
23385782|NCT03331562|65155227|FG001|Overall Study|Adverse Event|0|||
23385783|NCT03331562|65155226|FG000|Overall Study|Death|1|||
23385784|NCT03331562|65155227|FG001|Overall Study|Death|0|||
23385785|NCT00812097|65155228|FG000|Overall Study|Death|3|||
23385786|NCT00812097|65155229|FG001|Overall Study|Death|10|||
23385787|NCT00812097|65155230|FG002|Overall Study|Death|3|||
23385788|NCT00812097|65155231|FG003|Overall Study|Death|3|||
23385789|NCT00812097|65155228|FG000|Overall Study|Withdrawal by Subject|14|||
23385790|NCT00812097|65155229|FG001|Overall Study|Withdrawal by Subject|12|||
23385791|NCT00812097|65155230|FG002|Overall Study|Withdrawal by Subject|8|||
23385792|NCT00812097|65155231|FG003|Overall Study|Withdrawal by Subject|2|||
23385793|NCT00812097|65155228|FG000|Overall Study|Lost to Follow-up|90|||
23385794|NCT00812097|65155229|FG001|Overall Study|Lost to Follow-up|14|||
23385795|NCT00812097|65155230|FG002|Overall Study|Lost to Follow-up|17|||
23385796|NCT00812097|65155231|FG003|Overall Study|Lost to Follow-up|5|||
23385797|NCT00812097|65155228|FG000|Overall Study|Explantation of study device(s)|27|||
23385798|NCT00812097|65155229|FG001|Overall Study|Explantation of study device(s)|29|||
23385799|NCT00812097|65155230|FG002|Overall Study|Explantation of study device(s)|14|||
23385800|NCT00812097|65155231|FG003|Overall Study|Explantation of study device(s)|20|||
23385801|NCT00812097|65155228|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
23385802|NCT00812097|65155229|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
23385803|NCT00812097|65155230|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
23385804|NCT00812097|65155231|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
23385805|NCT00992394|65155235|FG000|Overall Study|Lack of Efficacy|6|||
23385806|NCT00992394|65155236|FG001|Overall Study|Lack of Efficacy|3|||
23385807|NCT00992394|65155235|FG000|Overall Study|Adverse Event|4|||
23385808|NCT00992394|65155236|FG001|Overall Study|Adverse Event|5|||
23385809|NCT00992394|65155235|FG000|Overall Study|Withdrawal by Subject|8|||
23385810|NCT00992394|65155236|FG001|Overall Study|Withdrawal by Subject|2|||
23385811|NCT00992394|65155235|FG000|Overall Study|Physician Decision|1|||
23385812|NCT00992394|65155236|FG001|Overall Study|Physician Decision|0|||
23385813|NCT00992394|65155235|FG000|Overall Study|Protocol Violation|2|||
23385814|NCT00992394|65155236|FG001|Overall Study|Protocol Violation|4|||
23385815|NCT00992394|65155235|FG000|Overall Study|Lost to Follow-up|2|||
23385816|NCT00992394|65155236|FG001|Overall Study|Lost to Follow-up|0|||
23385817|NCT00992394|65155235|FG000|Overall Study|Other event|1|||
23385818|NCT00992394|65155236|FG001|Overall Study|Other event|0|||
23385819|NCT01521364|65155238|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
23385820|NCT01521364|65155238|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
23385821|NCT02400736|65155239|FG000|Overall Study|Lost to Follow-up|6|||
23385822|NCT02400736|65155240|FG001|Overall Study|Lost to Follow-up|6|||
23385823|NCT02400736|65155239|FG000|Overall Study|Withdrawal by Subject|2|||
23385824|NCT02400736|65155240|FG001|Overall Study|Withdrawal by Subject|1|||
23385825|NCT02400736|65155239|FG000|Overall Study|Moved from the area|3|||
23385826|NCT02400736|65155240|FG001|Overall Study|Moved from the area|1|||
23292429|NCT02246764|64811640|FG001|Overall Study|Protocol Violation|1|||
23292430|NCT02246764|64811641|FG002|Overall Study|Protocol Violation|1|||
23292431|NCT01463982|64811642|FG000|Overall Study|Withdrawal by Subject|0|||
23292432|NCT01463982|64811643|FG001|Overall Study|Withdrawal by Subject|1|||
23292433|NCT01463982|64811644|FG002|Overall Study|Withdrawal by Subject|1|||
23292434|NCT01463982|64811645|FG003|Overall Study|Withdrawal by Subject|0|||
23292435|NCT01463982|64811642|FG000|Overall Study|Treatment delay over 5 week|0|||
23292436|NCT01463982|64811643|FG001|Overall Study|Treatment delay over 5 week|0|||
23292437|NCT01463982|64811644|FG002|Overall Study|Treatment delay over 5 week|1|||
23292438|NCT01463982|64811645|FG003|Overall Study|Treatment delay over 5 week|0|||
23292439|NCT02820740|64811646|FG000|Overall Study|Did not have procedure|2|||
23292440|NCT02966340|64811649|FG000|Overall Study|Adverse Event|0|||
23292441|NCT02966340|64811650|FG001|Overall Study|Adverse Event|1|||
23292442|NCT02966340|64811649|FG000|Overall Study|Lost to Follow-up|0|||
23292443|NCT02966340|64811650|FG001|Overall Study|Lost to Follow-up|1|||
23292444|NCT02966340|64811649|FG000|Overall Study|Withdrawal by Subject|1|||
23292445|NCT02966340|64811650|FG001|Overall Study|Withdrawal by Subject|0|||
23292446|NCT02966340|64811649|FG000|Overall Study|data acquisition error|1|||
23292447|NCT02966340|64811650|FG001|Overall Study|data acquisition error|0|||
23292448|NCT02966340|64811649|FG000|Overall Study|startle non-responder|1|||
23385827|NCT03072875|65155241|FG000|Overall Study|Lost to Follow-up|1|||
23385828|NCT01060111|65155243|FG000|Overall Study|Adverse Event|9|||
23385829|NCT01060111|65155244|FG001|Overall Study|Adverse Event|5|||
23385830|NCT01060111|65155245|FG002|Overall Study|Adverse Event|18|||
23385831|NCT01060111|65155243|FG000|Overall Study|Lack of Efficacy|2|||
23385832|NCT01060111|65155244|FG001|Overall Study|Lack of Efficacy|1|||
23292449|NCT02966340|64811650|FG001|Overall Study|startle non-responder|1|||
23385833|NCT01060111|65155245|FG002|Overall Study|Lack of Efficacy|0|||
23385834|NCT01060111|65155243|FG000|Overall Study|Inappropriate participant|5|||
23385835|NCT01060111|65155244|FG001|Overall Study|Inappropriate participant|4|||
23385836|NCT01060111|65155245|FG002|Overall Study|Inappropriate participant|5|||
23292450|NCT04542694|64811651|FG000|Overall Study|The need for prohibited therapy|2|||
23385837|NCT01060111|65155243|FG000|Overall Study|Participants' evasion for hospital visit|0|||
23385838|NCT01060111|65155244|FG001|Overall Study|Participants' evasion for hospital visit|3|||
23385839|NCT01060111|65155245|FG002|Overall Study|Participants' evasion for hospital visit|2|||
23385840|NCT01060111|65155243|FG000|Overall Study|Participants' non-cooperation|8|||
23385841|NCT01060111|65155244|FG001|Overall Study|Participants' non-cooperation|6|||
23385842|NCT01060111|65155245|FG002|Overall Study|Participants' non-cooperation|6|||
23385843|NCT01060111|65155243|FG000|Overall Study|Adverse event and insufficient effect|0|||
23385844|NCT01060111|65155244|FG001|Overall Study|Adverse event and insufficient effect|1|||
23385845|NCT01060111|65155245|FG002|Overall Study|Adverse event and insufficient effect|0|||
23385846|NCT01060111|65155243|FG000|Overall Study|Participants' non-cooperation|1|||
23385847|NCT01060111|65155244|FG001|Overall Study|Participants' non-cooperation|0|||
23385848|NCT01060111|65155245|FG002|Overall Study|Participants' non-cooperation|0|||
23385849|NCT01060111|65155243|FG000|Overall Study|Other|2|||
23385850|NCT01060111|65155244|FG001|Overall Study|Other|3|||
23385851|NCT01060111|65155245|FG002|Overall Study|Other|4|||
23385852|NCT02916433|65158488|FG000|Overall Study|Withdrawal by Subject|1|||
23385853|NCT02916433|65158489|FG001|Overall Study|Withdrawal by Subject|0|||
23385854|NCT02916433|65158488|FG000|Overall Study|Physician Decision|1|||
23385855|NCT02916433|65158489|FG001|Overall Study|Physician Decision|0|||
23385856|NCT01986751|65158490|FG000|Overall Study|improperly consented|10|||
23385857|NCT01986751|65158491|FG001|Overall Study|improperly consented|2|||
23385858|NCT00500110|65158492|FG000|Overall Study|Withdrawal by Subject|3|||
23385859|NCT03197935|65158493|FG000|Overall Study|Death due to any cause|26|||
23385860|NCT03197935|65158494|FG001|Overall Study|Death due to any cause|15|||
23385861|NCT03197935|65158493|FG000|Overall Study|Lost to Follow-up|3|||
23385862|NCT03197935|65158494|FG001|Overall Study|Lost to Follow-up|5|||
23385863|NCT03197935|65158493|FG000|Overall Study|Physician Decision|2|||
23385864|NCT03197935|65158494|FG001|Overall Study|Physician Decision|1|||
23385865|NCT03197935|65158493|FG000|Overall Study|Withdrawal by Subject|16|||
23385866|NCT03197935|65158494|FG001|Overall Study|Withdrawal by Subject|8|||
23385867|NCT03016403|65158495|FG000|Baseline|Death|5|||
23385868|NCT03016403|65158496|FG001|Baseline|Death|8|||
23385869|NCT03016403|65158497|FG002|Baseline|Death|1|||
23385870|NCT03016403|65158498|FG003|Baseline|Death|0|||
23385871|NCT03016403|65158495|FG000|Baseline|Withdrawal by Subject|2|||
23385872|NCT03016403|65158496|FG001|Baseline|Withdrawal by Subject|8|||
23385873|NCT03016403|65158497|FG002|Baseline|Withdrawal by Subject|4|||
23385874|NCT03016403|65158498|FG003|Baseline|Withdrawal by Subject|10|||
23385875|NCT03016403|65158495|FG000|Baseline|Lost to Follow-up|9|||
23385876|NCT03016403|65158496|FG001|Baseline|Lost to Follow-up|11|||
23385877|NCT03016403|65158497|FG002|Baseline|Lost to Follow-up|6|||
23385878|NCT03016403|65158498|FG003|Baseline|Lost to Follow-up|24|||
23385879|NCT03016403|65158495|FG000|6-week Follow-up|Death|1|||
23385880|NCT03016403|65158496|FG001|6-week Follow-up|Death|4|||
23385881|NCT03016403|65158497|FG002|6-week Follow-up|Death|0|||
23385882|NCT03016403|65158498|FG003|6-week Follow-up|Death|0|||
23385883|NCT03016403|65158495|FG000|6-week Follow-up|Lost to Follow-up|2|||
23385884|NCT03016403|65158496|FG001|6-week Follow-up|Lost to Follow-up|7|||
23385885|NCT03016403|65158497|FG002|6-week Follow-up|Lost to Follow-up|4|||
23385886|NCT03016403|65158498|FG003|6-week Follow-up|Lost to Follow-up|8|||
23385887|NCT03016403|65158495|FG000|6-week Follow-up|Withdrawal by Subject|0|||
23385888|NCT03016403|65158496|FG001|6-week Follow-up|Withdrawal by Subject|2|||
23385889|NCT03016403|65158497|FG002|6-week Follow-up|Withdrawal by Subject|0|||
23385890|NCT03016403|65158498|FG003|6-week Follow-up|Withdrawal by Subject|1|||
23385891|NCT03016403|65158495|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
23385892|NCT03016403|65158496|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
23385893|NCT03016403|65158497|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
23385894|NCT03016403|65158498|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
23385895|NCT03016403|65158495|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
23385896|NCT03016403|65158496|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
23385897|NCT03016403|65158497|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
23385898|NCT03016403|65158498|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
23385899|NCT03016403|65158495|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
23385900|NCT03016403|65158496|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
23385901|NCT03016403|65158497|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
23385902|NCT03016403|65158498|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
23385903|NCT01630811|65158499|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
23385904|NCT01630811|65158500|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
23385905|NCT03566550|65158501|FG000|Overall Study|Withdrawal by Subject|0|||
23385906|NCT03566550|65158502|FG001|Overall Study|Withdrawal by Subject|1|||
23385907|NCT01489358|65158503|FG000|Overall Study|Lost to Follow-up|0|||
23493210|NCT00397215|65551393|FG001|Month 0 (Day 0)|Adverse Event|1|||
23385908|NCT01489358|65158504|FG001|Overall Study|Lost to Follow-up|0|||
23385909|NCT01489358|65158505|FG002|Overall Study|Lost to Follow-up|2|||
23385910|NCT01783015|65158506|FG000|Blinded Treatment|Adverse Event|0|||
23292451|NCT04542694|64811652|FG001|Overall Study|The need for prohibited therapy|0|||
23292452|NCT04542694|64811651|FG000|Overall Study|Adverse Event|1|||
23292453|NCT04542694|64811652|FG001|Overall Study|Adverse Event|0|||
23292454|NCT04542694|64811651|FG000|Overall Study|Protocol Violation|1|||
23292455|NCT04542694|64811652|FG001|Overall Study|Protocol Violation|0|||
23292456|NCT00726895|64811657|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23292457|NCT00726895|64811658|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23292458|NCT01857973|64811662|FG000|Overall Study|Subject did not meet required BG range|3|||
23292459|NCT01857973|64811662|FG000|Overall Study|drop out after 3 failed attempts|1|||
23292460|NCT01857973|64811662|FG000|Overall Study|Physician Decision|1|||
23292461|NCT01362296|64811667|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
23292462|NCT01362296|64811668|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
23292463|NCT01362296|64811669|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
23292464|NCT01362296|64811670|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
23292465|NCT01362296|64811667|FG000|Randomized Phase (RP)|Physician Decision|1|||
23292466|NCT01362296|64811668|FG001|Randomized Phase (RP)|Physician Decision|9|||
23292467|NCT01362296|64811669|FG002|Randomized Phase (RP)|Physician Decision|0|||
23292468|NCT01362296|64811670|FG003|Randomized Phase (RP)|Physician Decision|0|||
23292469|NCT01362296|64811667|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
23292470|NCT01362296|64811668|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
23292471|NCT01362296|64811669|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
23292472|NCT01362296|64811670|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
23292473|NCT01362296|64811667|FG000|Randomized Phase (RP)|Adverse Event|20|||
23292474|NCT01362296|64811668|FG001|Randomized Phase (RP)|Adverse Event|4|||
23292475|NCT01362296|64811669|FG002|Randomized Phase (RP)|Adverse Event|0|||
23292476|NCT01362296|64811670|FG003|Randomized Phase (RP)|Adverse Event|0|||
23292477|NCT01362296|64811667|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
23292478|NCT01362296|64811668|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
23292479|NCT01362296|64811669|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
23292480|NCT01362296|64811670|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
23292481|NCT01362296|64811667|FG000|Crossover Phase|PD including Death due to PD|0|||
23292482|NCT01362296|64811668|FG001|Crossover Phase|PD including Death due to PD|0|||
23292483|NCT01362296|64811669|FG002|Crossover Phase|PD including Death due to PD|16|||
23292484|NCT01362296|64811670|FG003|Crossover Phase|PD including Death due to PD|1|||
23292485|NCT01362296|64811667|FG000|Crossover Phase|Withdrawal by Subject|0|||
23292486|NCT01362296|64811668|FG001|Crossover Phase|Withdrawal by Subject|0|||
23292487|NCT01362296|64811669|FG002|Crossover Phase|Withdrawal by Subject|2|||
23292488|NCT01362296|64811670|FG003|Crossover Phase|Withdrawal by Subject|1|||
23292489|NCT01362296|64811667|FG000|Crossover Phase|Adverse Event|0|||
23292490|NCT01362296|64811668|FG001|Crossover Phase|Adverse Event|0|||
23292491|NCT01362296|64811669|FG002|Crossover Phase|Adverse Event|4|||
23292492|NCT01362296|64811670|FG003|Crossover Phase|Adverse Event|0|||
23292493|NCT01362296|64811667|FG000|Crossover Phase|Study Closed/Terminated|0|||
23292494|NCT01362296|64811668|FG001|Crossover Phase|Study Closed/Terminated|0|||
23292495|NCT01362296|64811669|FG002|Crossover Phase|Study Closed/Terminated|1|||
23292496|NCT01362296|64811670|FG003|Crossover Phase|Study Closed/Terminated|0|||
23292497|NCT00537017|64811672|FG000|Treatment Phase|Adverse Event|19|||
23292498|NCT00537017|64811672|FG000|Treatment Phase|Withdrawal by Subject|13|||
23292499|NCT00537017|64811672|FG000|Treatment Phase|Protocol Violation|2|||
23292500|NCT00537017|64811672|FG000|Follow-up Phase|Withdrawal by Subject|9|||
23292501|NCT01011556|64811673|FG000|Overall Study|Adverse Event|1|||
23292502|NCT01011556|64811674|FG001|Overall Study|Adverse Event|3|||
23292503|NCT01011556|64811675|FG002|Overall Study|Adverse Event|2|||
23292504|NCT01011556|64811676|FG003|Overall Study|Adverse Event|1|||
23292505|NCT01011556|64811673|FG000|Overall Study|Lost to Follow-up|1|||
23292506|NCT01011556|64811674|FG001|Overall Study|Lost to Follow-up|0|||
23385911|NCT01783015|65158507|FG001|Blinded Treatment|Adverse Event|1|||
23385912|NCT01783015|65158508|FG002|Blinded Treatment|Adverse Event|0|||
23292507|NCT01011556|64811675|FG002|Overall Study|Lost to Follow-up|0|||
23292508|NCT01011556|64811676|FG003|Overall Study|Lost to Follow-up|0|||
23292509|NCT01011556|64811673|FG000|Overall Study|Physician Decision|1|||
23292510|NCT01011556|64811674|FG001|Overall Study|Physician Decision|0|||
23292511|NCT01011556|64811675|FG002|Overall Study|Physician Decision|0|||
23292512|NCT01011556|64811676|FG003|Overall Study|Physician Decision|1|||
23292513|NCT01011556|64811673|FG000|Overall Study|Protocol Violation|0|||
23493211|NCT00397215|65551394|FG002|Month 0 (Day 0)|Adverse Event|0|||
23292514|NCT01011556|64811674|FG001|Overall Study|Protocol Violation|1|||
23292515|NCT01011556|64811675|FG002|Overall Study|Protocol Violation|0|||
23385913|NCT01783015|65158506|FG000|Blinded Treatment|Protocol Violation|0|||
23385914|NCT01783015|65158507|FG001|Blinded Treatment|Protocol Violation|1|||
23385915|NCT01783015|65158508|FG002|Blinded Treatment|Protocol Violation|0|||
23385916|NCT01783015|65158506|FG000|Blinded Treatment|Withdrawal by Subject|0|||
23385917|NCT01783015|65158507|FG001|Blinded Treatment|Withdrawal by Subject|1|||
23385918|NCT01783015|65158508|FG002|Blinded Treatment|Withdrawal by Subject|0|||
23385919|NCT01783015|65158506|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
23385920|NCT01783015|65158507|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
23385921|NCT01783015|65158508|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
23385922|NCT01783015|65158506|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
23385923|NCT01783015|65158507|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
23385924|NCT01783015|65158508|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
23385925|NCT00356421|65158512|FG000|Overall Study|Lack of Efficacy|3|||
23385926|NCT00356421|65158513|FG001|Overall Study|Lack of Efficacy|0|||
23385927|NCT00356421|65158512|FG000|Overall Study|Withdrawal by Subject|9|||
23385928|NCT00356421|65158513|FG001|Overall Study|Withdrawal by Subject|2|||
23385929|NCT00356421|65158512|FG000|Overall Study|Related to study drug|15|||
23385930|NCT00356421|65158513|FG001|Overall Study|Related to study drug|12|||
23385931|NCT00356421|65158512|FG000|Overall Study|Not related to study drug|5|||
23385932|NCT00356421|65158513|FG001|Overall Study|Not related to study drug|3|||
23385933|NCT00452530|65158514|FG000|Overall Study|Death|1|||
23385934|NCT00452530|65158515|FG001|Overall Study|Death|0|||
23385935|NCT00452530|65158514|FG000|Overall Study|Adverse Event|40|||
23385936|NCT00452530|65158515|FG001|Overall Study|Adverse Event|44|||
23385937|NCT00452530|65158514|FG000|Overall Study|Withdrawal by Subject|68|||
23385938|NCT00452530|65158515|FG001|Overall Study|Withdrawal by Subject|57|||
23385939|NCT00452530|65158514|FG000|Overall Study|Lost to Follow-up|1|||
23385940|NCT00452530|65158515|FG001|Overall Study|Lost to Follow-up|0|||
23385941|NCT00452530|65158514|FG000|Overall Study|Poor compliance/noncompliance|1|||
23385942|NCT00452530|65158515|FG001|Overall Study|Poor compliance/noncompliance|2|||
23385943|NCT00452530|65158514|FG000|Overall Study|No longer met study criteria|18|||
23385944|NCT00452530|65158515|FG001|Overall Study|No longer met study criteria|22|||
23385945|NCT00452530|65158514|FG000|Overall Study|Other|7|||
23385946|NCT00452530|65158515|FG001|Overall Study|Other|11|||
23385947|NCT00620035|65158516|FG000|Overall Study|Adverse Event|106|||
23385948|NCT00620035|65158516|FG000|Overall Study|Withdrawal of Informed Consent|1|||
23385949|NCT00620035|65158516|FG000|Overall Study|Other Reason|38|||
23385950|NCT00762788|65158517|FG000|Overall Study|Lost to Follow-up|26|||
23385951|NCT00762788|65158518|FG001|Overall Study|Lost to Follow-up|37|||
23385952|NCT00762788|65158519|FG002|Overall Study|Lost to Follow-up|21|||
23385953|NCT00762788|65158520|FG003|Overall Study|Lost to Follow-up|26|||
23385954|NCT00762788|65158521|FG004|Overall Study|Lost to Follow-up|13|||
23385955|NCT00762788|65158522|FG005|Overall Study|Lost to Follow-up|21|||
23385956|NCT02061592|65158523|FG000|Period 1|Withdrawal by Subject|1|||
23385957|NCT02061592|65158524|FG001|Period 1|Withdrawal by Subject|0|||
23385958|NCT02061592|65158523|FG000|Period 1|Protocol Violation|1|||
23385959|NCT02061592|65158524|FG001|Period 1|Protocol Violation|0|||
23385960|NCT02061592|65158523|FG000|Period 2|Lost to Follow-up|0|||
23292516|NCT01011556|64811676|FG003|Overall Study|Protocol Violation|0|||
23292517|NCT01011556|64811673|FG000|Overall Study|Withdrawal by Subject|1|||
23292518|NCT01011556|64811674|FG001|Overall Study|Withdrawal by Subject|2|||
23292519|NCT01011556|64811675|FG002|Overall Study|Withdrawal by Subject|4|||
23292520|NCT01011556|64811676|FG003|Overall Study|Withdrawal by Subject|4|||
23292521|NCT01011556|64811673|FG000|Overall Study|Sponsor decision|0|||
23292522|NCT01011556|64811674|FG001|Overall Study|Sponsor decision|1|||
23292523|NCT01011556|64811675|FG002|Overall Study|Sponsor decision|1|||
23292524|NCT01011556|64811676|FG003|Overall Study|Sponsor decision|2|||
23292525|NCT01011556|64811673|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
23385961|NCT02061592|65158524|FG001|Period 2|Lost to Follow-up|1|||
23385962|NCT01301001|65158526|FG000|First Intervention|Lost to Follow-up|4|||
23385963|NCT01301001|65158527|FG001|First Intervention|Lost to Follow-up|4|||
23385964|NCT01301001|65158526|FG000|First Intervention|Withdrawal by Subject|1|||
23385965|NCT01301001|65158527|FG001|First Intervention|Withdrawal by Subject|4|||
23385966|NCT01301001|65158526|FG000|First Intervention|Adverse Event|5|||
23385967|NCT01301001|65158527|FG001|First Intervention|Adverse Event|0|||
23385968|NCT01301001|65158526|FG000|First Intervention|Protocol Violation|0|||
23385969|NCT01301001|65158527|FG001|First Intervention|Protocol Violation|1|||
23385970|NCT01301001|65158526|FG000|Second Intervention|Adverse Event|2|||
23292526|NCT01011556|64811674|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
23292527|NCT01011556|64811675|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
23292528|NCT01011556|64811676|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
23385971|NCT01301001|65158527|FG001|Second Intervention|Adverse Event|0|||
23385972|NCT01301001|65158526|FG000|Second Intervention|Withdrawal by Subject|2|||
23385973|NCT01301001|65158527|FG001|Second Intervention|Withdrawal by Subject|0|||
23385974|NCT01451203|65158530|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
23292529|NCT04099641|64811679|FG000|Overall Study|Death|46|||
23292530|NCT04099641|64811680|FG001|Overall Study|Death|12|||
23292531|NCT04099641|64811679|FG000|Overall Study|Lost to Follow-up|1|||
23292532|NCT04099641|64811680|FG001|Overall Study|Lost to Follow-up|0|||
23292533|NCT04099641|64811679|FG000|Overall Study|Withdrawal by Subject|2|||
23292534|NCT04099641|64811680|FG001|Overall Study|Withdrawal by Subject|0|||
23292535|NCT03566238|64811681|FG000|Overall Study|Adverse Event|0|||
23292536|NCT03566238|64811682|FG001|Overall Study|Adverse Event|1|||
23292537|NCT03566238|64811683|FG002|Overall Study|Adverse Event|0|||
23292538|NCT03566238|64811681|FG000|Overall Study|Lack of Efficacy|4|||
23292539|NCT03566238|64811682|FG001|Overall Study|Lack of Efficacy|2|||
23292540|NCT03566238|64811683|FG002|Overall Study|Lack of Efficacy|5|||
23292541|NCT03566238|64811681|FG000|Overall Study|Other|1|||
23292542|NCT03566238|64811682|FG001|Overall Study|Other|0|||
23292543|NCT03566238|64811683|FG002|Overall Study|Other|0|||
23292544|NCT00575380|64811684|FG000|Overall Study|Withdrawal by Subject|1|||
23292545|NCT00575380|64811685|FG001|Overall Study|Withdrawal by Subject|0|||
23292546|NCT00575380|64811684|FG000|Overall Study|Adverse Event|0|||
23292547|NCT00575380|64811685|FG001|Overall Study|Adverse Event|1|||
23292548|NCT00575380|64811684|FG000|Overall Study|Various|0|||
23292549|NCT00575380|64811685|FG001|Overall Study|Various|2|||
23292550|NCT00480324|64811688|FG000|Overall Study|Adverse Event|1|||
23292551|NCT00480324|64811689|FG001|Overall Study|Adverse Event|1|||
23292552|NCT00480324|64811688|FG000|Overall Study|Protocol Violation|0|||
23292553|NCT00480324|64811689|FG001|Overall Study|Protocol Violation|1|||
23292554|NCT00480324|64811688|FG000|Overall Study|Withdrawal by Subject|14|||
23292555|NCT00480324|64811689|FG001|Overall Study|Withdrawal by Subject|5|||
23292556|NCT00480324|64811688|FG000|Overall Study|Lost to Follow-up|17|||
23292557|NCT00480324|64811689|FG001|Overall Study|Lost to Follow-up|8|||
23292558|NCT00480324|64811688|FG000|Overall Study|Subject's mother pregnant|0|||
23292559|NCT00480324|64811689|FG001|Overall Study|Subject's mother pregnant|1|||
23292560|NCT02927834|64811690|FG000|Overall Study|Lost to Follow-up|1|||
23292561|NCT02927834|64811691|FG001|Overall Study|Lost to Follow-up|2|||
23292562|NCT02927834|64811692|FG002|Overall Study|Lost to Follow-up|2|||
23292563|NCT00676494|64811695|FG000|Overall Study|Missed Visit|8|||
23292564|NCT00676494|64811695|FG000|Overall Study|Withdrawal by Subject|6|||
23292565|NCT04100096|64811696|FG000|Overall Study|Adverse Event|19|||
23292566|NCT04100096|64811697|FG001|Overall Study|Adverse Event|7|||
23292567|NCT04100096|64811696|FG000|Overall Study|Lack of Efficacy|0|||
23292568|NCT04100096|64811697|FG001|Overall Study|Lack of Efficacy|1|||
23292569|NCT04100096|64811696|FG000|Overall Study|Lost to Follow-up|13|||
23292570|NCT04100096|64811697|FG001|Overall Study|Lost to Follow-up|11|||
23292571|NCT04100096|64811696|FG000|Overall Study|Non-Compliance With Study Drug|1|||
23292572|NCT04100096|64811697|FG001|Overall Study|Non-Compliance With Study Drug|3|||
23292573|NCT04100096|64811696|FG000|Overall Study|Protocol Deviation|1|||
23292574|NCT04100096|64811697|FG001|Overall Study|Protocol Deviation|1|||
23292575|NCT04100096|64811696|FG000|Overall Study|Withdrawal by Participant|13|||
23292576|NCT04100096|64811697|FG001|Overall Study|Withdrawal by Participant|15|||
23292577|NCT03430011|64811698|FG000|Pre-Treatment|Death|1|||
23292578|NCT03430011|64811699|FG001|Pre-Treatment|Death|0|||
23292579|NCT03430011|64811700|FG002|Pre-Treatment|Death|0|||
23292580|NCT03430011|64811701|FG003|Pre-Treatment|Death|0|||
23292581|NCT03430011|64811702|FG004|Pre-Treatment|Death|1|||
23292582|NCT03430011|64811703|FG005|Pre-Treatment|Death|0|||
23292583|NCT03430011|64811704|FG006|Pre-Treatment|Death|1|||
23292584|NCT03430011|64811705|FG007|Pre-Treatment|Death|0|||
23292585|NCT03430011|64811698|FG000|Pre-Treatment|Screen Fail|0|||
23292586|NCT03430011|64811699|FG001|Pre-Treatment|Screen Fail|0|||
23385975|NCT01451203|65158531|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
23292587|NCT03430011|64811700|FG002|Pre-Treatment|Screen Fail|0|||
23292588|NCT03430011|64811701|FG003|Pre-Treatment|Screen Fail|0|||
23292589|NCT03430011|64811702|FG004|Pre-Treatment|Screen Fail|1|||
23292590|NCT03430011|64811703|FG005|Pre-Treatment|Screen Fail|0|||
23292591|NCT03430011|64811704|FG006|Pre-Treatment|Screen Fail|0|||
23292592|NCT03430011|64811705|FG007|Pre-Treatment|Screen Fail|0|||
23292593|NCT03430011|64811698|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
23292594|NCT03430011|64811699|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
23292595|NCT03430011|64811700|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
23292596|NCT03430011|64811701|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
23292597|NCT03430011|64811702|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
23292598|NCT03430011|64811703|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
23292599|NCT03430011|64811704|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
23292600|NCT03430011|64811705|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
23292601|NCT03430011|64811698|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
23292602|NCT03430011|64811699|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
23292603|NCT03430011|64811700|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
23292604|NCT03430011|64811701|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
23292605|NCT03430011|64811702|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
23292606|NCT03430011|64811703|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
23292607|NCT03430011|64811704|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
23292608|NCT03430011|64811705|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
23292609|NCT03430011|64811698|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
23292610|NCT03430011|64811699|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
23292611|NCT03430011|64811700|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
23292612|NCT03430011|64811701|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
23292613|NCT03430011|64811702|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
23292614|NCT03430011|64811703|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
23292615|NCT03430011|64811704|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
23292616|NCT03430011|64811705|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
23292617|NCT03430011|64811698|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
23292618|NCT03430011|64811699|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
23292619|NCT03430011|64811700|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
23292620|NCT03430011|64811701|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
23292621|NCT03430011|64811702|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
23292622|NCT03430011|64811703|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
23292623|NCT03430011|64811704|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
23292624|NCT03430011|64811705|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
23292625|NCT03430011|64811698|FG000|JCARH125 Treatment|Death|4|||
23292626|NCT03430011|64811699|FG001|JCARH125 Treatment|Death|19|||
23292627|NCT03430011|64811700|FG002|JCARH125 Treatment|Death|10|||
23292628|NCT03430011|64811701|FG003|JCARH125 Treatment|Death|8|||
23292629|NCT03430011|64811702|FG004|JCARH125 Treatment|Death|5|||
23292630|NCT03430011|64811703|FG005|JCARH125 Treatment|Death|3|||
23292631|NCT03430011|64811704|FG006|JCARH125 Treatment|Death|4|||
23292632|NCT03430011|64811705|FG007|JCARH125 Treatment|Death|2|||
23292633|NCT03430011|64811698|FG000|JCARH125 Treatment|Other reasons|1|||
23292634|NCT03430011|64811699|FG001|JCARH125 Treatment|Other reasons|0|||
23292635|NCT03430011|64811700|FG002|JCARH125 Treatment|Other reasons|4|||
23292636|NCT03430011|64811701|FG003|JCARH125 Treatment|Other reasons|2|||
23292637|NCT03430011|64811702|FG004|JCARH125 Treatment|Other reasons|2|||
23292638|NCT03430011|64811703|FG005|JCARH125 Treatment|Other reasons|1|||
23292639|NCT03430011|64811704|FG006|JCARH125 Treatment|Other reasons|3|||
23292640|NCT03430011|64811705|FG007|JCARH125 Treatment|Other reasons|2|||
23292641|NCT01606228|64811706|FG000|Overall Study|Lost to Follow-up|20|||
23292642|NCT01606228|64811706|FG000|Overall Study|Withdrawal by Subject|3|||
23292643|NCT01606228|64811706|FG000|Overall Study|Non-compliant|3|||
23292644|NCT01606228|64811706|FG000|Overall Study|Lack of Efficacy|2|||
23292645|NCT01606228|64811706|FG000|Overall Study|Adverse Event|1|||
23292646|NCT01011335|64811707|FG000|Overall Study|Lost to Follow-up|0|||
23292647|NCT01011335|64811708|FG001|Overall Study|Lost to Follow-up|0|||
23292648|NCT01011335|64811709|FG002|Overall Study|Lost to Follow-up|1|||
23292649|NCT01011335|64811710|FG003|Overall Study|Lost to Follow-up|1|||
23292650|NCT01011335|64811711|FG004|Overall Study|Lost to Follow-up|1|||
23292651|NCT01011335|64811712|FG005|Overall Study|Lost to Follow-up|1|||
23292652|NCT01011335|64811713|FG006|Overall Study|Lost to Follow-up|2|||
23292653|NCT01011335|64811714|FG007|Overall Study|Lost to Follow-up|2|||
23292654|NCT01011335|64811715|FG008|Overall Study|Lost to Follow-up|1|||
23292655|NCT01011335|64811716|FG009|Overall Study|Lost to Follow-up|0|||
23292656|NCT01011335|64811717|FG010|Overall Study|Lost to Follow-up|0|||
23292657|NCT01011335|64811718|FG011|Overall Study|Lost to Follow-up|1|||
23292658|NCT01011335|64811719|FG012|Overall Study|Lost to Follow-up|2|||
23292659|NCT01011335|64811707|FG000|Overall Study|Protocol Violation|0|||
23292660|NCT01011335|64811708|FG001|Overall Study|Protocol Violation|1|||
23292661|NCT01011335|64811709|FG002|Overall Study|Protocol Violation|0|||
23292662|NCT01011335|64811710|FG003|Overall Study|Protocol Violation|0|||
23292663|NCT01011335|64811711|FG004|Overall Study|Protocol Violation|0|||
23292664|NCT01011335|64811712|FG005|Overall Study|Protocol Violation|0|||
23292665|NCT01011335|64811713|FG006|Overall Study|Protocol Violation|0|||
23292666|NCT01011335|64811714|FG007|Overall Study|Protocol Violation|0|||
23292667|NCT01011335|64811715|FG008|Overall Study|Protocol Violation|0|||
23292668|NCT01011335|64811716|FG009|Overall Study|Protocol Violation|0|||
23292669|NCT01011335|64811717|FG010|Overall Study|Protocol Violation|0|||
23292670|NCT01011335|64811718|FG011|Overall Study|Protocol Violation|0|||
23292671|NCT01011335|64811719|FG012|Overall Study|Protocol Violation|0|||
23292672|NCT01011335|64811707|FG000|Overall Study|Moved/deployed or no booster|1|||
23292673|NCT01011335|64811708|FG001|Overall Study|Moved/deployed or no booster|0|||
23292674|NCT01011335|64811709|FG002|Overall Study|Moved/deployed or no booster|0|||
23292675|NCT01011335|64811710|FG003|Overall Study|Moved/deployed or no booster|1|||
23385976|NCT01451203|65158530|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
23292676|NCT01011335|64811711|FG004|Overall Study|Moved/deployed or no booster|0|||
23292677|NCT01011335|64811712|FG005|Overall Study|Moved/deployed or no booster|0|||
23292678|NCT01011335|64811713|FG006|Overall Study|Moved/deployed or no booster|1|||
23292679|NCT01011335|64811714|FG007|Overall Study|Moved/deployed or no booster|0|||
23292680|NCT01011335|64811715|FG008|Overall Study|Moved/deployed or no booster|1|||
23292681|NCT01011335|64811716|FG009|Overall Study|Moved/deployed or no booster|0|||
23292682|NCT01011335|64811717|FG010|Overall Study|Moved/deployed or no booster|2|||
23292683|NCT01011335|64811718|FG011|Overall Study|Moved/deployed or no booster|0|||
23292684|NCT01011335|64811719|FG012|Overall Study|Moved/deployed or no booster|0|||
23292685|NCT01011335|64811707|FG000|Overall Study|Adverse Event|0|||
23292686|NCT01011335|64811708|FG001|Overall Study|Adverse Event|0|||
23292687|NCT01011335|64811709|FG002|Overall Study|Adverse Event|0|||
23292688|NCT01011335|64811710|FG003|Overall Study|Adverse Event|0|||
23292689|NCT01011335|64811711|FG004|Overall Study|Adverse Event|0|||
23292690|NCT01011335|64811712|FG005|Overall Study|Adverse Event|0|||
23292691|NCT01011335|64811713|FG006|Overall Study|Adverse Event|0|||
23292692|NCT01011335|64811714|FG007|Overall Study|Adverse Event|0|||
23292693|NCT01011335|64811715|FG008|Overall Study|Adverse Event|0|||
23292694|NCT01011335|64811716|FG009|Overall Study|Adverse Event|0|||
23292695|NCT01011335|64811717|FG010|Overall Study|Adverse Event|4|||
23292696|NCT01011335|64811718|FG011|Overall Study|Adverse Event|0|||
23292697|NCT01011335|64811719|FG012|Overall Study|Adverse Event|1|||
23292698|NCT02300987|64811720|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
23292699|NCT02300987|64811721|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
23292700|NCT02300987|64811720|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
23292701|NCT02300987|64811721|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
23292702|NCT02300987|64811720|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
23385977|NCT01451203|65158531|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
23385978|NCT01451203|65158530|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
23385979|NCT01451203|65158531|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
23385980|NCT01451203|65158530|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
23385981|NCT01451203|65158531|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
23385982|NCT01451203|65158530|FG000|Double-blind Treatment Period|Adverse Event|6|||
23385983|NCT01451203|65158531|FG001|Double-blind Treatment Period|Adverse Event|9|||
23385984|NCT01451203|65158530|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
23385985|NCT01451203|65158531|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
23385986|NCT01451203|65158530|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
23385987|NCT01451203|65158531|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
23385988|NCT01451203|65158530|FG000|Double-blind Treatment Period|Investigator decision|2|||
23385989|NCT01451203|65158531|FG001|Double-blind Treatment Period|Investigator decision|0|||
23385990|NCT01451203|65158530|FG000|Post-treatment Period|Consent withdrawn|2|||
23385991|NCT01451203|65158531|FG001|Post-treatment Period|Consent withdrawn|4|||
23385992|NCT01451203|65158530|FG000|Post-treatment Period|Lack of Efficacy|12|||
23385993|NCT01451203|65158531|FG001|Post-treatment Period|Lack of Efficacy|28|||
23385994|NCT01451203|65158530|FG000|Post-treatment Period|Adverse Event|0|||
23385995|NCT01451203|65158531|FG001|Post-treatment Period|Adverse Event|1|||
23292703|NCT02300987|64811721|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
23385996|NCT01451203|65158530|FG000|Post-treatment Period|Investigator decision|0|||
23385997|NCT01451203|65158531|FG001|Post-treatment Period|Investigator decision|1|||
23385998|NCT01530256|65158532|FG000|Overall Study|Death|2|||
23385999|NCT02802865|65158533|FG000|Overall Study|Pregnancy|1|||
23386000|NCT02802865|65158534|FG001|Overall Study|Pregnancy|1|||
23386001|NCT02802865|65158533|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
23386002|NCT02802865|65158534|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
23386003|NCT02569242|65158535|FG000|Overall Study|Death|1|||
23386004|NCT02569242|65158536|FG001|Overall Study|Death|0|||
23386005|NCT02569242|65158535|FG000|Overall Study|Withdrawal by Subject|0|||
23386006|NCT02569242|65158536|FG001|Overall Study|Withdrawal by Subject|1|||
23292704|NCT02300987|64811720|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
23292705|NCT02300987|64811721|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
23292706|NCT02300987|64811720|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
23292707|NCT02300987|64811721|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
23292708|NCT00983528|64811724|FG000|Overall Study|Death|4|||
23292709|NCT00983528|64811724|FG000|Overall Study|Lost to Follow-up|1|||
23493212|NCT00397215|65551395|FG003|Month 0 (Day 0)|Adverse Event|0|||
23292710|NCT00983528|64811724|FG000|Overall Study|Study Terminated|1|||
23292711|NCT00979212|64811725|FG000|Overall Study|Protocol Violation|1|||
23292712|NCT00979212|64811726|FG001|Overall Study|Protocol Violation|8|||
23292713|NCT00979212|64811725|FG000|Overall Study|No protocol therapy received|1|||
23292714|NCT00979212|64811726|FG001|Overall Study|No protocol therapy received|0|||
23292715|NCT03877926|64811727|FG000|Overall Study|Adverse Event|1|||
23292716|NCT03877926|64811728|FG001|Overall Study|Adverse Event|0|||
23292717|NCT03877926|64811729|FG002|Overall Study|Adverse Event|0|||
23292718|NCT03877926|64811730|FG003|Overall Study|Adverse Event|0|||
23292719|NCT03877926|64811727|FG000|Overall Study|Death|2|||
23292720|NCT03877926|64811728|FG001|Overall Study|Death|2|||
23292721|NCT03877926|64811729|FG002|Overall Study|Death|2|||
23292722|NCT03877926|64811730|FG003|Overall Study|Death|0|||
23292723|NCT03877926|64811727|FG000|Overall Study|Lost to Follow-up|41|||
23292724|NCT03877926|64811728|FG001|Overall Study|Lost to Follow-up|52|||
23292725|NCT03877926|64811729|FG002|Overall Study|Lost to Follow-up|45|||
23386007|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
23386008|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
23292726|NCT03877926|64811730|FG003|Overall Study|Lost to Follow-up|17|||
23292727|NCT03877926|64811727|FG000|Overall Study|Physician Decision|2|||
23292728|NCT03877926|64811728|FG001|Overall Study|Physician Decision|0|||
23292729|NCT03877926|64811729|FG002|Overall Study|Physician Decision|2|||
23292730|NCT03877926|64811730|FG003|Overall Study|Physician Decision|0|||
23292731|NCT03877926|64811727|FG000|Overall Study|Withdrawal by Subject|18|||
23292732|NCT03877926|64811728|FG001|Overall Study|Withdrawal by Subject|21|||
23292733|NCT03877926|64811729|FG002|Overall Study|Withdrawal by Subject|12|||
23292734|NCT03877926|64811730|FG003|Overall Study|Withdrawal by Subject|4|||
23292735|NCT03877926|64811727|FG000|Overall Study|Other - Various|4|||
23292736|NCT03877926|64811728|FG001|Overall Study|Other - Various|1|||
23292737|NCT03877926|64811729|FG002|Overall Study|Other - Various|1|||
23292738|NCT03877926|64811730|FG003|Overall Study|Other - Various|0|||
23292739|NCT03877926|64811727|FG000|Overall Study|Not Treated|3|||
23292740|NCT03877926|64811728|FG001|Overall Study|Not Treated|1|||
23292741|NCT03877926|64811729|FG002|Overall Study|Not Treated|1|||
23292742|NCT03877926|64811730|FG003|Overall Study|Not Treated|0|||
23292743|NCT01470417|64811731|FG000|Overall Study|Disease progression|0|||
23292744|NCT01470417|64811732|FG001|Overall Study|Disease progression|2|||
23292745|NCT02488109|64811735|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
23292746|NCT02488109|64811736|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
23292747|NCT02488109|64811735|FG000|12-month Follow-Up|Lost to Follow-up|4|||
23292748|NCT02488109|64811736|FG001|12-month Follow-Up|Lost to Follow-up|7|||
23386009|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
23386010|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
23386011|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
23386012|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
23386013|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
23386014|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
23386015|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
23386016|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
23386017|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
23386018|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
23386019|NCT03446573|65158537|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
23292749|NCT03170869|64811737|FG000|Overall Study|Protocol Violation|5|||
23292750|NCT03170869|64811737|FG000|Overall Study|Early study termination|3|||
23292751|NCT01592721|64811744|FG000|Long-term Follow-up|Death|1|||
23292752|NCT00460109|64811745|FG000|Overall Study|Death|1|||
23493213|NCT00397215|65551392|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
23493214|NCT00397215|65551393|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
23493215|NCT00397215|65551394|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
23493216|NCT00397215|65551395|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
23493217|NCT00397215|65551392|FG000|Month 0 (Day 0)|Other|4|||
23292753|NCT01999894|64811749|FG000|Overall Study|Adverse Event|9|||
23292754|NCT01999894|64811749|FG000|Overall Study|Lack of Efficacy|5|||
23292755|NCT01999894|64811749|FG000|Overall Study|Protocol Violation|1|||
23292756|NCT01999894|64811749|FG000|Overall Study|Withdrawal by Subject|7|||
23292757|NCT01999894|64811749|FG000|Overall Study|Lost to Follow-up|10|||
23292758|NCT01999894|64811749|FG000|Overall Study|Other Reason|3|||
23292759|NCT01999894|64811749|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
23292760|NCT00683787|64811752|FG000|Overall Study|Progression|3|||
23292761|NCT00683787|64811753|FG001|Overall Study|Progression|3|||
23292762|NCT00683787|64811754|FG002|Overall Study|Progression|0|||
23292763|NCT00683787|64811752|FG000|Overall Study|Adverse Event|0|||
23292764|NCT00683787|64811753|FG001|Overall Study|Adverse Event|0|||
23292765|NCT00683787|64811754|FG002|Overall Study|Adverse Event|2|||
23292766|NCT01785615|64811759|FG000|Dietary Phase|Lost to Follow-up|0|||
23292767|NCT01785615|64811760|FG001|Dietary Phase|Lost to Follow-up|0|||
23292768|NCT01785615|64811761|FG002|Dietary Phase|Lost to Follow-up|0|||
23292769|NCT01785615|64811762|FG003|Dietary Phase|Lost to Follow-up|24|||
23292770|NCT00557245|64811764|FG000|Overall Study|Lost to Follow-up|7|||
23292771|NCT00557245|64811765|FG001|Overall Study|Lost to Follow-up|8|||
23292772|NCT00557245|64811766|FG002|Overall Study|Lost to Follow-up|10|||
23292773|NCT00557245|64811764|FG000|Overall Study|Ineligible|5|||
23292774|NCT00557245|64811765|FG001|Overall Study|Ineligible|4|||
23292775|NCT00557245|64811766|FG002|Overall Study|Ineligible|2|||
23292776|NCT02004691|64811767|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
23292777|NCT02004691|64811768|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
23292778|NCT02004691|64811767|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
23292779|NCT02004691|64811768|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
23292780|NCT02004691|64811767|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
23292781|NCT02004691|64811768|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
23292782|NCT02004691|64811767|FG000|ETP: Ongoing From Week 52|Other|0|||
23386020|NCT03446573|65158538|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
23386021|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
23292783|NCT02004691|64811768|FG001|ETP: Ongoing From Week 52|Other|1|||
23292784|NCT02004691|64811767|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
23292785|NCT02004691|64811768|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
23292786|NCT01144403|64811773|FG000|Overall Study|Lost to Follow-up|3|||
23292787|NCT01144403|64811773|FG000|Overall Study|Death|1|||
23386022|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
23386023|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
23386024|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
23386025|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
23386026|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
23386027|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
23386028|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
23386029|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
23386030|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
23386031|NCT03446573|65158537|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
23386032|NCT03446573|65158538|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
23386033|NCT01657500|65158539|FG000|Overall Study|set impropperly matched|3|||
23386034|NCT01657500|65158540|FG001|Overall Study|set impropperly matched|3|||
23386035|NCT01657500|65158539|FG000|Overall Study|Lost to Follow-up|2|||
23386036|NCT01657500|65158540|FG001|Overall Study|Lost to Follow-up|2|||
23386037|NCT02294019|65158543|FG000|Overall Study|Adverse Event|2|||
23386038|NCT02294019|65158543|FG000|Overall Study|Protocol Violation|68|||
23386039|NCT02294019|65158543|FG000|Overall Study|Lost to Follow-up|31|||
23386040|NCT02294019|65158543|FG000|Overall Study|Other|1|||
23386041|NCT02294019|65158543|FG000|Overall Study|Withdrawal by Subject|1|||
23386042|NCT03164356|65158544|FG000|Overall Study|Lost to Follow-up|1|||
23386043|NCT03164356|65158545|FG001|Overall Study|Lost to Follow-up|1|||
23386044|NCT03164356|65158546|FG002|Overall Study|Lost to Follow-up|2|||
23386045|NCT03164356|65158547|FG003|Overall Study|Lost to Follow-up|1|||
23386046|NCT03164356|65158544|FG000|Overall Study|Physician Decision|0|||
23386047|NCT03164356|65158545|FG001|Overall Study|Physician Decision|0|||
23386048|NCT03164356|65158546|FG002|Overall Study|Physician Decision|3|||
23386049|NCT03164356|65158547|FG003|Overall Study|Physician Decision|0|||
23386050|NCT03164356|65158544|FG000|Overall Study|Protocol Violation|2|||
23386051|NCT03164356|65158545|FG001|Overall Study|Protocol Violation|1|||
23386052|NCT03164356|65158546|FG002|Overall Study|Protocol Violation|0|||
23386053|NCT03164356|65158547|FG003|Overall Study|Protocol Violation|0|||
23386054|NCT03164356|65158544|FG000|Overall Study|Withdrawal by Subject|1|||
23386055|NCT03164356|65158545|FG001|Overall Study|Withdrawal by Subject|0|||
23386056|NCT03164356|65158546|FG002|Overall Study|Withdrawal by Subject|0|||
23386057|NCT03164356|65158547|FG003|Overall Study|Withdrawal by Subject|0|||
23386058|NCT03164356|65158544|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
23386059|NCT03164356|65158545|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
23386060|NCT03164356|65158546|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
23386061|NCT03164356|65158547|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
23386062|NCT03164356|65158544|FG000|Overall Study|Subject Incarcerated|0|||
23386063|NCT03164356|65158545|FG001|Overall Study|Subject Incarcerated|1|||
23386064|NCT03164356|65158546|FG002|Overall Study|Subject Incarcerated|0|||
23386065|NCT03164356|65158547|FG003|Overall Study|Subject Incarcerated|0|||
23386066|NCT03164356|65158544|FG000|Overall Study|Prosthetist unable to participate|0|||
23386067|NCT03164356|65158545|FG001|Overall Study|Prosthetist unable to participate|2|||
23386068|NCT03164356|65158546|FG002|Overall Study|Prosthetist unable to participate|1|||
23386069|NCT03164356|65158547|FG003|Overall Study|Prosthetist unable to participate|0|||
23386070|NCT04359680|65158548|FG000|Overall Study|Withdrawal by Subject|29|||
23386071|NCT04359680|65158549|FG001|Overall Study|Withdrawal by Subject|24|||
23386072|NCT04359680|65158548|FG000|Overall Study|Adverse Event|6|||
23386073|NCT04359680|65158549|FG001|Overall Study|Adverse Event|2|||
23386074|NCT04359680|65158548|FG000|Overall Study|Lost to Follow-up|56|||
23386075|NCT04359680|65158549|FG001|Overall Study|Lost to Follow-up|59|||
23386076|NCT04359680|65158548|FG000|Overall Study|Protocol Violation|3|||
23386077|NCT04359680|65158549|FG001|Overall Study|Protocol Violation|5|||
23386078|NCT04359680|65158548|FG000|Overall Study|Physician Decision|1|||
23386079|NCT04359680|65158549|FG001|Overall Study|Physician Decision|1|||
23386080|NCT04359680|65158548|FG000|Overall Study|Sponsor Decision|0|||
23386081|NCT04359680|65158549|FG001|Overall Study|Sponsor Decision|1|||
23386082|NCT00784927|65158550|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
23386083|NCT00784927|65158550|FG000|Overall Study|Protocol Violation|1|||
23386084|NCT00784927|65158550|FG000|Overall Study|Ineligible|1|||
23386085|NCT01618708|65158551|FG000|Overall Study|Adverse Event|10|||
23386086|NCT01618708|65158552|FG001|Overall Study|Adverse Event|10|||
23386087|NCT01618708|65158551|FG000|Overall Study|Lost to Follow-up|3|||
23386088|NCT01618708|65158552|FG001|Overall Study|Lost to Follow-up|3|||
23386089|NCT01618708|65158551|FG000|Overall Study|Withdrawal by Subject|17|||
23386090|NCT01618708|65158552|FG001|Overall Study|Withdrawal by Subject|22|||
23493218|NCT00397215|65551393|FG001|Month 0 (Day 0)|Other|1|||
23493219|NCT00397215|65551394|FG002|Month 0 (Day 0)|Other|3|||
23493220|NCT00397215|65551395|FG003|Month 0 (Day 0)|Other|3|||
23493221|NCT00397215|65551392|FG000|Month 6 (Day 180)|Adverse Event|0|||
23493222|NCT00397215|65551393|FG001|Month 6 (Day 180)|Adverse Event|3|||
23493223|NCT00397215|65551394|FG002|Month 6 (Day 180)|Adverse Event|2|||
23493224|NCT00397215|65551395|FG003|Month 6 (Day 180)|Adverse Event|0|||
23493225|NCT00397215|65551392|FG000|Month 6 (Day 180)|Other|2|||
23493226|NCT00397215|65551393|FG001|Month 6 (Day 180)|Other|0|||
23493227|NCT00397215|65551394|FG002|Month 6 (Day 180)|Other|3|||
23493228|NCT00397215|65551395|FG003|Month 6 (Day 180)|Other|0|||
23493229|NCT03403374|65551397|FG000|Overall Study|Lost to Follow-up|1|||
23493230|NCT02423109|65551402|FG000|Lens 1|Adverse Event|1|||
23493231|NCT02423109|65551403|FG001|Lens 1|Adverse Event|0|||
23493232|NCT00422097|65551416|FG000|Dose Level 2|Still on treatment|0|||
23493233|NCT00422097|65551417|FG001|Dose Level 2|Still on treatment|1|||
23493234|NCT00422097|65551418|FG002|Dose Level 2|Still on treatment|0|||
23493235|NCT00422097|65551419|FG003|Dose Level 2|Still on treatment|0|||
23493236|NCT00422097|65551420|FG004|Dose Level 2|Still on treatment|0|||
23493237|NCT00422097|65551421|FG005|Dose Level 2|Still on treatment|0|||
23493238|NCT00422097|65551422|FG006|Dose Level 2|Still on treatment|0|||
23493239|NCT00422097|65551423|FG007|Dose Level 2|Still on treatment|0|||
23493240|NCT01786148|65551424|FG000|Overall Study|Lost to Follow-up|21|||
23493241|NCT01786148|65551425|FG001|Overall Study|Lost to Follow-up|13|||
23493242|NCT01786148|65551424|FG000|Overall Study|Death|0|||
23493243|NCT01786148|65551425|FG001|Overall Study|Death|1|||
23493244|NCT01786148|65551424|FG000|Overall Study|Withdrawal by Subject|0|||
23493245|NCT01786148|65551425|FG001|Overall Study|Withdrawal by Subject|7|||
23493246|NCT01786148|65551424|FG000|Overall Study|Incarceration|1|||
23493247|NCT01786148|65551425|FG001|Overall Study|Incarceration|1|||
23493248|NCT01705730|65551426|FG000|Overall Study|Lack of Efficacy|1|||
23493249|NCT01705730|65551426|FG000|Overall Study|Adverse Event|3|||
23493250|NCT01705730|65551426|FG000|Overall Study|Lost to Follow-up|1|||
23493251|NCT01705730|65551426|FG000|Overall Study|Reason not Specified|4|||
23493252|NCT01058655|65551429|FG000|Overall Study|Withdrawal by Subject|1|||
23493253|NCT01058655|65551430|FG001|Overall Study|Withdrawal by Subject|0|||
23493254|NCT01058655|65551431|FG002|Overall Study|Withdrawal by Subject|3|||
23493255|NCT01058655|65551432|FG003|Overall Study|Withdrawal by Subject|4|||
23493256|NCT01058655|65551429|FG000|Overall Study|Prolonged Treatment Delay|0|||
23493257|NCT01058655|65551430|FG001|Overall Study|Prolonged Treatment Delay|0|||
23493258|NCT01058655|65551431|FG002|Overall Study|Prolonged Treatment Delay|0|||
23493259|NCT01058655|65551432|FG003|Overall Study|Prolonged Treatment Delay|2|||
23493260|NCT01058655|65551429|FG000|Overall Study|Symptomatic Deterioration|0|||
23493261|NCT01058655|65551430|FG001|Overall Study|Symptomatic Deterioration|0|||
23493262|NCT01058655|65551431|FG002|Overall Study|Symptomatic Deterioration|0|||
23493263|NCT01058655|65551432|FG003|Overall Study|Symptomatic Deterioration|1|||
23493264|NCT01058655|65551429|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
23493265|NCT01058655|65551430|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
23493266|NCT01058655|65551431|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
23493267|NCT01058655|65551432|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
23493268|NCT01058655|65551429|FG000|Overall Study|Death|0|||
23493269|NCT01058655|65551430|FG001|Overall Study|Death|1|||
23493270|NCT01058655|65551431|FG002|Overall Study|Death|1|||
23493271|NCT01058655|65551432|FG003|Overall Study|Death|0|||
23493272|NCT01058655|65551429|FG000|Overall Study|Disease Progression|1|||
23493273|NCT01058655|65551430|FG001|Overall Study|Disease Progression|2|||
23493274|NCT01058655|65551431|FG002|Overall Study|Disease Progression|4|||
23386091|NCT01618708|65158551|FG000|Overall Study|Lack of Efficacy|8|||
23386092|NCT01618708|65158552|FG001|Overall Study|Lack of Efficacy|8|||
23386093|NCT01618708|65158551|FG000|Overall Study|Technical problems|2|||
23386094|NCT01618708|65158552|FG001|Overall Study|Technical problems|0|||
23292788|NCT01144403|64811773|FG000|Overall Study|Adverse Event|1|||
23292789|NCT00860743|64811774|FG000|Overall Study|Withdrawal by Subject|3|||
23292790|NCT00860743|64811775|FG001|Overall Study|Withdrawal by Subject|0|||
23292791|NCT02688387|64811777|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292792|NCT02688387|64811778|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292793|NCT02688387|64811779|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
23292794|NCT02688387|64811780|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292795|NCT02688387|64811781|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292796|NCT02688387|64811782|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292797|NCT02688387|64811783|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292798|NCT02688387|64811784|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292799|NCT02688387|64811785|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292800|NCT02688387|64811786|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292801|NCT02688387|64811787|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292802|NCT02688387|64811788|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292803|NCT02688387|64811789|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292804|NCT02688387|64811790|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292805|NCT02688387|64811791|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292806|NCT02688387|64811792|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292807|NCT02688387|64811793|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292808|NCT02688387|64811794|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292809|NCT02688387|64811795|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292810|NCT02688387|64811796|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292811|NCT02688387|64811797|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292812|NCT02688387|64811798|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
23292813|NCT02688387|64811777|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292814|NCT02688387|64811778|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292815|NCT02688387|64811779|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292816|NCT02688387|64811780|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
23292817|NCT02688387|64811781|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292818|NCT02688387|64811782|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292819|NCT02688387|64811783|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292820|NCT02688387|64811784|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292821|NCT02688387|64811785|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292822|NCT02688387|64811786|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292823|NCT02688387|64811787|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292824|NCT02688387|64811788|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292825|NCT02688387|64811789|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292826|NCT02688387|64811790|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292827|NCT02688387|64811791|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292828|NCT02688387|64811792|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292829|NCT02688387|64811793|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292830|NCT02688387|64811794|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292831|NCT02688387|64811795|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292832|NCT02688387|64811796|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292833|NCT02688387|64811797|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292834|NCT02688387|64811798|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292835|NCT02688387|64811777|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292836|NCT02688387|64811778|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
23292837|NCT02688387|64811779|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292838|NCT02688387|64811780|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292839|NCT02688387|64811781|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292840|NCT02688387|64811782|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292841|NCT02688387|64811783|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292842|NCT02688387|64811784|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292843|NCT02688387|64811785|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292844|NCT02688387|64811786|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292845|NCT02688387|64811787|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292846|NCT02688387|64811788|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292847|NCT02688387|64811789|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292848|NCT02688387|64811790|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292849|NCT02688387|64811791|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292850|NCT02688387|64811792|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23493275|NCT01058655|65551432|FG003|Overall Study|Disease Progression|24|||
23493276|NCT01058655|65551429|FG000|Overall Study|Other|0|||
23493277|NCT01058655|65551430|FG001|Overall Study|Other|0|||
23386095|NCT01618708|65158551|FG000|Overall Study|Other than specified above|1|||
23386096|NCT01618708|65158552|FG001|Overall Study|Other than specified above|1|||
23386097|NCT01618708|65158551|FG000|Overall Study|Randomized but not treated|3|||
23386098|NCT01618708|65158552|FG001|Overall Study|Randomized but not treated|2|||
23386099|NCT01835431|65158560|FG000|Overall Study|Adverse Event|1|||
23386100|NCT01835431|65158561|FG001|Overall Study|Adverse Event|0|||
23386101|NCT01835431|65158560|FG000|Overall Study|other|0|||
23386102|NCT01835431|65158561|FG001|Overall Study|other|2|||
23386103|NCT01835431|65158560|FG000|Overall Study|Withdrawal by Subject|6|||
23386104|NCT01835431|65158561|FG001|Overall Study|Withdrawal by Subject|10|||
23386105|NCT01835431|65158560|FG000|Overall Study|Protocol Violation|1|||
23386106|NCT01835431|65158561|FG001|Overall Study|Protocol Violation|0|||
23386107|NCT01666652|65158565|FG000|Overall Study|Serious Adverse Event|0|||
23386108|NCT01666652|65158566|FG001|Overall Study|Serious Adverse Event|0|||
23386109|NCT01666652|65158567|FG002|Overall Study|Serious Adverse Event|0|||
23493278|NCT01058655|65551431|FG002|Overall Study|Other|0|||
23292851|NCT02688387|64811793|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292852|NCT02688387|64811794|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292853|NCT02688387|64811795|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292854|NCT02688387|64811796|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292855|NCT02688387|64811797|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292856|NCT02688387|64811798|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
23292857|NCT02688387|64811777|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292858|NCT02688387|64811778|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292859|NCT02688387|64811779|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
23292860|NCT02688387|64811780|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292861|NCT02688387|64811781|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
23292862|NCT02688387|64811782|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292863|NCT02688387|64811783|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292864|NCT02688387|64811784|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292865|NCT02688387|64811785|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292866|NCT02688387|64811786|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292867|NCT02688387|64811787|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292868|NCT02688387|64811788|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292869|NCT02688387|64811789|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292870|NCT02688387|64811790|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292871|NCT02688387|64811791|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292872|NCT02688387|64811792|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292873|NCT02688387|64811793|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292874|NCT02688387|64811794|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292875|NCT02688387|64811795|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292876|NCT02688387|64811796|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292877|NCT02688387|64811797|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292878|NCT02688387|64811798|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
23292879|NCT02688387|64811777|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
23292880|NCT02688387|64811778|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292881|NCT02688387|64811779|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292882|NCT02688387|64811780|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292883|NCT02688387|64811781|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292884|NCT02688387|64811782|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292885|NCT02688387|64811783|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292886|NCT02688387|64811784|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292887|NCT02688387|64811785|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292888|NCT02688387|64811786|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292889|NCT02688387|64811787|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292890|NCT02688387|64811788|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292891|NCT02688387|64811789|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292892|NCT02688387|64811790|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292893|NCT02688387|64811791|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292894|NCT02688387|64811792|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23386110|NCT01666652|65158568|FG003|Overall Study|Serious Adverse Event|1|||
23386111|NCT01666652|65158569|FG004|Overall Study|Serious Adverse Event|0|||
23386112|NCT01666652|65158565|FG000|Overall Study|Withdrawal by Subject|0|||
23386113|NCT01666652|65158566|FG001|Overall Study|Withdrawal by Subject|0|||
23493279|NCT01058655|65551432|FG003|Overall Study|Other|4|||
23292895|NCT02688387|64811793|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292896|NCT02688387|64811794|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292897|NCT02688387|64811795|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292898|NCT02688387|64811796|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292899|NCT02688387|64811797|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292900|NCT02688387|64811798|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
23292901|NCT02688387|64811777|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292902|NCT02688387|64811778|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292903|NCT02688387|64811779|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292904|NCT02688387|64811780|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292905|NCT02688387|64811781|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292906|NCT02688387|64811782|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292907|NCT02688387|64811783|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292908|NCT02688387|64811784|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292909|NCT02688387|64811785|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292910|NCT02688387|64811786|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292911|NCT02688387|64811787|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
23493280|NCT01752985|65551433|FG000|Treatment Period|Subject request to discontinue treatment|1|||
23292912|NCT02688387|64811788|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292913|NCT02688387|64811789|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23493281|NCT01752985|65551434|FG001|Treatment Period|Subject request to discontinue treatment|0|||
23493282|NCT01752985|65551435|FG002|Treatment Period|Subject request to discontinue treatment|1|||
23292914|NCT02688387|64811790|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292915|NCT02688387|64811791|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292916|NCT02688387|64811792|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23493283|NCT01752985|65551433|FG000|Treatment Period|Subject no longer meets study criteria|0|||
23292917|NCT02688387|64811793|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292918|NCT02688387|64811794|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292919|NCT02688387|64811795|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292920|NCT02688387|64811796|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292921|NCT02688387|64811797|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292922|NCT02688387|64811798|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
23292923|NCT02688387|64811777|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292924|NCT02688387|64811778|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292925|NCT02688387|64811779|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292926|NCT02688387|64811780|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292927|NCT02688387|64811781|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292928|NCT02688387|64811782|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292929|NCT02688387|64811783|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292930|NCT02688387|64811784|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292931|NCT02688387|64811785|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292932|NCT02688387|64811786|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292933|NCT02688387|64811787|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292934|NCT02688387|64811788|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292935|NCT02688387|64811789|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292936|NCT02688387|64811790|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292937|NCT02688387|64811791|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
23292938|NCT02688387|64811792|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292939|NCT02688387|64811793|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292940|NCT02688387|64811794|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292941|NCT02688387|64811795|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292942|NCT02688387|64811796|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23493284|NCT01752985|65551434|FG001|Treatment Period|Subject no longer meets study criteria|1|||
23292943|NCT02688387|64811797|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292944|NCT02688387|64811798|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
23292945|NCT02688387|64811777|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292946|NCT02688387|64811778|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292947|NCT02688387|64811779|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292948|NCT02688387|64811780|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292949|NCT02688387|64811781|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292950|NCT02688387|64811782|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292951|NCT02688387|64811783|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292952|NCT02688387|64811784|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292953|NCT02688387|64811785|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292954|NCT02688387|64811786|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292955|NCT02688387|64811787|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292956|NCT02688387|64811788|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292957|NCT02688387|64811789|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292958|NCT02688387|64811790|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292959|NCT02688387|64811791|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292960|NCT02688387|64811792|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292961|NCT02688387|64811793|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292962|NCT02688387|64811794|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292963|NCT02688387|64811795|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292964|NCT02688387|64811796|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292965|NCT02688387|64811797|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
23292966|NCT02688387|64811798|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
23292967|NCT02688387|64811777|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292968|NCT02688387|64811778|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292969|NCT02688387|64811779|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292970|NCT02688387|64811780|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292971|NCT02688387|64811781|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292972|NCT02688387|64811782|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292973|NCT02688387|64811783|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292974|NCT02688387|64811784|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292975|NCT02688387|64811785|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292976|NCT02688387|64811786|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292977|NCT02688387|64811787|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292978|NCT02688387|64811788|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292979|NCT02688387|64811789|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292980|NCT02688387|64811790|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292981|NCT02688387|64811791|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292982|NCT02688387|64811792|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292983|NCT02688387|64811793|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292984|NCT02688387|64811794|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292985|NCT02688387|64811795|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
23292986|NCT02688387|64811796|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292987|NCT02688387|64811797|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
23292988|NCT02688387|64811798|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
23292989|NCT02688387|64811777|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292990|NCT02688387|64811778|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292991|NCT02688387|64811779|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292992|NCT02688387|64811780|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292993|NCT02688387|64811781|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292994|NCT02688387|64811782|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292995|NCT02688387|64811783|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292996|NCT02688387|64811784|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292997|NCT02688387|64811785|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292998|NCT02688387|64811786|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23292999|NCT02688387|64811787|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293000|NCT02688387|64811788|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293001|NCT02688387|64811789|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293002|NCT02688387|64811790|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293003|NCT02688387|64811791|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293004|NCT02688387|64811792|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293005|NCT02688387|64811793|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293006|NCT02688387|64811794|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293007|NCT02688387|64811795|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293008|NCT02688387|64811796|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
23293009|NCT02688387|64811797|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293010|NCT02688387|64811798|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
23293011|NCT05467982|64811799|FG000|Overall Study|Death|0|||
23293012|NCT05467982|64811800|FG001|Overall Study|Death|1|||
23293013|NCT05467982|64811799|FG000|Overall Study|Lost to Follow-up|3|||
23293014|NCT05467982|64811800|FG001|Overall Study|Lost to Follow-up|1|||
23293015|NCT03086135|64811801|FG000|Overall Study|Adverse Event|1|||
23293016|NCT03086135|64811801|FG000|Overall Study|Lost to Follow-up|2|||
23293017|NCT01731886|64811802|FG000|Overall Study|Death|1|||
23293018|NCT01731886|64811803|FG001|Overall Study|Death|0|||
23293019|NCT01731886|64811802|FG000|Overall Study|Never started treatment|0|||
23293020|NCT01731886|64811803|FG001|Overall Study|Never started treatment|1|||
23293021|NCT01731886|64811802|FG000|Overall Study|Non-compliant|1|||
23293022|NCT01731886|64811803|FG001|Overall Study|Non-compliant|0|||
23293023|NCT03442569|64811804|FG000|Overall Study|Subject was ineligible after enrollment|1|||
23293024|NCT00194792|64811808|FG000|Overall Study|Withdrawal by Subject|1|||
23293025|NCT00889252|64815154|FG000|Overall Study|Adverse Event|2|||
23386114|NCT01666652|65158567|FG002|Overall Study|Withdrawal by Subject|0|||
23386115|NCT01666652|65158568|FG003|Overall Study|Withdrawal by Subject|0|||
23386116|NCT01666652|65158569|FG004|Overall Study|Withdrawal by Subject|1|||
23386117|NCT01666652|65158565|FG000|Overall Study|Moved from study area|1|||
23386118|NCT01666652|65158566|FG001|Overall Study|Moved from study area|0|||
23386119|NCT01666652|65158567|FG002|Overall Study|Moved from study area|0|||
23386120|NCT01666652|65158568|FG003|Overall Study|Moved from study area|2|||
23386121|NCT01666652|65158569|FG004|Overall Study|Moved from study area|0|||
23386122|NCT01666652|65158565|FG000|Overall Study|Lost to Follow-up|1|||
23386123|NCT01666652|65158566|FG001|Overall Study|Lost to Follow-up|1|||
23386124|NCT01666652|65158567|FG002|Overall Study|Lost to Follow-up|1|||
23386125|NCT01666652|65158568|FG003|Overall Study|Lost to Follow-up|1|||
23386126|NCT01666652|65158569|FG004|Overall Study|Lost to Follow-up|0|||
23386127|NCT03073109|65158572|FG000|Overall Study|Adverse Event|0|||
23386128|NCT03073109|65158573|FG001|Overall Study|Adverse Event|1|||
23386129|NCT03073109|65158572|FG000|Overall Study|Other|2|||
23493285|NCT01752985|65551435|FG002|Treatment Period|Subject no longer meets study criteria|1|||
23493286|NCT01752985|65551433|FG000|Treatment Period|Adverse Event|2|||
23493287|NCT01752985|65551434|FG001|Treatment Period|Adverse Event|1|||
23493288|NCT01752985|65551435|FG002|Treatment Period|Adverse Event|2|||
23493289|NCT01752985|65551433|FG000|Treatment Period|Withdrawal by Subject|1|||
23493290|NCT01752985|65551434|FG001|Treatment Period|Withdrawal by Subject|1|||
23493291|NCT01752985|65551435|FG002|Treatment Period|Withdrawal by Subject|0|||
23493292|NCT01752985|65551433|FG000|Treatment Period|Lost to Follow-up|0|||
23493293|NCT01752985|65551434|FG001|Treatment Period|Lost to Follow-up|0|||
23493294|NCT01752985|65551435|FG002|Treatment Period|Lost to Follow-up|1|||
23493295|NCT01328431|65551439|FG000|Baseline|Protocol Violation|0|||
23493296|NCT01328431|65551440|FG001|Baseline|Protocol Violation|2|||
23493297|NCT01328431|65551439|FG000|1 Month (1M)|Lost to Follow-up|55|||
23293026|NCT00889252|64815155|FG001|Overall Study|Adverse Event|4|||
23493298|NCT01328431|65551440|FG001|1 Month (1M)|Lost to Follow-up|58|||
23293027|NCT00889252|64815154|FG000|Overall Study|Withdrawal by Subject|3|||
23386130|NCT03073109|65158573|FG001|Overall Study|Other|0|||
23386131|NCT03073109|65158572|FG000|Overall Study|Lost to Follow-up|8|||
23386132|NCT03073109|65158573|FG001|Overall Study|Lost to Follow-up|1|||
23493299|NCT01328431|65551439|FG000|3 Month (3M)|Death|2|||
23493300|NCT01328431|65551440|FG001|3 Month (3M)|Death|2|||
23293028|NCT00889252|64815155|FG001|Overall Study|Withdrawal by Subject|0|||
23293029|NCT00889252|64815154|FG000|Overall Study|Protocol Violation|2|||
23386133|NCT02369159|65158576|FG000|Overall Study|Adverse Event|0|||
23493301|NCT01328431|65551439|FG000|3 Month (3M)|Lost to Follow-up|75|||
23293030|NCT00889252|64815155|FG001|Overall Study|Protocol Violation|0|||
23293031|NCT02020967|64815156|FG000|Overall Study|Withdrawal by Subject|51|||
23293032|NCT02274558|64815167|FG000|Overall Study|Adverse Event|2|||
23293033|NCT02274558|64815168|FG001|Overall Study|Adverse Event|4|||
23293034|NCT02274558|64815169|FG002|Overall Study|Adverse Event|2|||
23293035|NCT02274558|64815167|FG000|Overall Study|Non-compliance|2|||
23293036|NCT02274558|64815168|FG001|Overall Study|Non-compliance|1|||
23293037|NCT02274558|64815169|FG002|Overall Study|Non-compliance|0|||
23293038|NCT02274558|64815167|FG000|Overall Study|Withdrawal by Subject|1|||
23293039|NCT02274558|64815168|FG001|Overall Study|Withdrawal by Subject|5|||
23293040|NCT02274558|64815169|FG002|Overall Study|Withdrawal by Subject|4|||
23293041|NCT02274558|64815167|FG000|Overall Study|Death|0|||
23293042|NCT02274558|64815168|FG001|Overall Study|Death|0|||
23293043|NCT02274558|64815169|FG002|Overall Study|Death|1|||
23293044|NCT02274558|64815167|FG000|Overall Study|Lost to Follow-up|2|||
23293045|NCT02274558|64815168|FG001|Overall Study|Lost to Follow-up|1|||
23293046|NCT02274558|64815169|FG002|Overall Study|Lost to Follow-up|1|||
23293047|NCT02274558|64815167|FG000|Overall Study|Physician Decision|0|||
23293048|NCT02274558|64815168|FG001|Overall Study|Physician Decision|2|||
23293049|NCT02274558|64815169|FG002|Overall Study|Physician Decision|1|||
23293050|NCT03136406|64815170|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
23293051|NCT04102345|64815171|FG000|Overall Study|Withdrawal by Subject|1|||
23293052|NCT04102345|64815172|FG001|Overall Study|Withdrawal by Subject|0|||
23293053|NCT01546519|64815173|FG000|Overall Study|Adverse Event|0|||
23293054|NCT01546519|64815174|FG001|Overall Study|Adverse Event|0|||
23293055|NCT01546519|64815175|FG002|Overall Study|Adverse Event|1|||
23293056|NCT01546519|64815176|FG003|Overall Study|Adverse Event|1|||
23293057|NCT01546519|64815173|FG000|Overall Study|Death|0|||
23293058|NCT01546519|64815174|FG001|Overall Study|Death|1|||
23293059|NCT01546519|64815175|FG002|Overall Study|Death|3|||
23293060|NCT01546519|64815176|FG003|Overall Study|Death|1|||
23293061|NCT01546519|64815173|FG000|Overall Study|related to disease progression|2|||
23293062|NCT01546519|64815174|FG001|Overall Study|related to disease progression|2|||
23293063|NCT01546519|64815175|FG002|Overall Study|related to disease progression|2|||
23293064|NCT01546519|64815176|FG003|Overall Study|related to disease progression|1|||
23293065|NCT01546519|64815173|FG000|Overall Study|Physician Decision|6|||
23293066|NCT01546519|64815174|FG001|Overall Study|Physician Decision|5|||
23293067|NCT01546519|64815175|FG002|Overall Study|Physician Decision|2|||
23293068|NCT01546519|64815176|FG003|Overall Study|Physician Decision|3|||
23293069|NCT01546519|64815173|FG000|Overall Study|Withdrawal by Subject|1|||
23293070|NCT01546519|64815174|FG001|Overall Study|Withdrawal by Subject|0|||
23293071|NCT01546519|64815175|FG002|Overall Study|Withdrawal by Subject|0|||
23293072|NCT01546519|64815176|FG003|Overall Study|Withdrawal by Subject|0|||
23293073|NCT03554317|64815177|FG000|Overall Study|Withdrawal by Subject|1|||
23293074|NCT03554317|64815177|FG000|Overall Study|PSA Progression|3|||
23293075|NCT03554317|64815177|FG000|Overall Study|Radiographic Progression|4|||
23293076|NCT01294449|64815178|FG000|Overall Study|Death|11|||
23293077|NCT01294449|64815179|FG001|Overall Study|Death|12|||
23293078|NCT01294449|64815178|FG000|Overall Study|Withdrawal by Subject|1|||
23293079|NCT01294449|64815179|FG001|Overall Study|Withdrawal by Subject|3|||
23293080|NCT02853331|64815180|FG000|Overall Study|Death|59|||
23293081|NCT02853331|64815181|FG001|Overall Study|Death|95|||
23293082|NCT02853331|64815180|FG000|Overall Study|Withdrawal by Subject|5|||
23293083|NCT02853331|64815181|FG001|Overall Study|Withdrawal by Subject|9|||
23293084|NCT02853331|64815180|FG000|Overall Study|Ongoing in study|368|||
23293085|NCT02853331|64815181|FG001|Overall Study|Ongoing in study|325|||
23293086|NCT02010255|64815182|FG000|Overall Study|Death|0|||
23293087|NCT02010255|64815183|FG001|Overall Study|Death|1|||
23293088|NCT02010255|64815184|FG002|Overall Study|Death|4|||
23293089|NCT02010255|64815185|FG003|Overall Study|Death|4|||
23293090|NCT02010255|64815186|FG004|Overall Study|Death|2|||
23293091|NCT02010255|64815187|FG005|Overall Study|Death|0|||
23293092|NCT02010255|64815188|FG006|Overall Study|Death|1|||
23293093|NCT02010255|64815189|FG007|Overall Study|Death|1|||
23293094|NCT02010255|64815190|FG008|Overall Study|Death|1|||
23293095|NCT02010255|64815191|FG009|Overall Study|Death|0|||
23293096|NCT02010255|64815192|FG010|Overall Study|Death|1|||
23293097|NCT02010255|64815193|FG011|Overall Study|Death|1|||
23293098|NCT02010255|64815194|FG012|Overall Study|Death|0|||
23293099|NCT02010255|64815195|FG013|Overall Study|Death|0|||
23293100|NCT02010255|64815182|FG000|Overall Study|Lack of Efficacy|4|||
23293101|NCT02010255|64815183|FG001|Overall Study|Lack of Efficacy|1|||
23293102|NCT02010255|64815184|FG002|Overall Study|Lack of Efficacy|2|||
23293103|NCT02010255|64815185|FG003|Overall Study|Lack of Efficacy|1|||
23293104|NCT02010255|64815186|FG004|Overall Study|Lack of Efficacy|1|||
23293105|NCT02010255|64815187|FG005|Overall Study|Lack of Efficacy|0|||
23293106|NCT02010255|64815188|FG006|Overall Study|Lack of Efficacy|0|||
23293107|NCT02010255|64815189|FG007|Overall Study|Lack of Efficacy|0|||
23293108|NCT02010255|64815190|FG008|Overall Study|Lack of Efficacy|0|||
23293109|NCT02010255|64815191|FG009|Overall Study|Lack of Efficacy|0|||
23386134|NCT02369159|65158577|FG001|Overall Study|Adverse Event|1|||
23386135|NCT02369159|65158576|FG000|Overall Study|Lost to Follow-up|1|||
23386136|NCT02369159|65158577|FG001|Overall Study|Lost to Follow-up|1|||
23386137|NCT02369159|65158576|FG000|Overall Study|Withdrawal by Subject|7|||
23386138|NCT02369159|65158577|FG001|Overall Study|Withdrawal by Subject|0|||
23386139|NCT01166945|65158578|FG000|Randomized|diagnosed with Group A strep|4|||
23386140|NCT01166945|65158579|FG001|Randomized|diagnosed with Group A strep|4|||
23386141|NCT01166945|65158578|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
23386142|NCT01166945|65158579|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
23386143|NCT01166945|65158578|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
23386144|NCT01166945|65158579|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
23386145|NCT01166945|65158578|FG000|Day 30|Lost to Follow-up|4|||
23386146|NCT01166945|65158579|FG001|Day 30|Lost to Follow-up|3|||
23386147|NCT03473301|65158580|FG000|Overall Study|Protocol Violation|4|||
23386148|NCT03473301|65158581|FG001|Overall Study|Protocol Violation|0|||
23386149|NCT03473301|65158582|FG002|Overall Study|Protocol Violation|0|||
23386150|NCT03473301|65158580|FG000|Overall Study|Withdrawal by Subject|0|||
23386151|NCT03473301|65158581|FG001|Overall Study|Withdrawal by Subject|1|||
23386152|NCT03473301|65158582|FG002|Overall Study|Withdrawal by Subject|0|||
23386153|NCT03473301|65158580|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
23386154|NCT03473301|65158581|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
23386155|NCT03473301|65158582|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
23386156|NCT02391584|65158583|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
23386157|NCT02391584|65158584|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
23386158|NCT02391584|65158583|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
23386159|NCT02391584|65158584|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
23386160|NCT02391584|65158583|FG000|3 Month|Lost to Follow-up|1|||
23386161|NCT02391584|65158584|FG001|3 Month|Lost to Follow-up|0|||
23386162|NCT02391584|65158583|FG000|6 Month|Withdrawal by Subject|1|||
23386163|NCT02391584|65158584|FG001|6 Month|Withdrawal by Subject|0|||
23386164|NCT02391584|65158583|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
23386165|NCT02391584|65158584|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
23386166|NCT01089543|65158585|FG000|Overall Study|Withdrawal by Subject|2|||
23386167|NCT01089543|65158586|FG001|Overall Study|Withdrawal by Subject|3|||
23386168|NCT01089543|65158587|FG002|Overall Study|Withdrawal by Subject|3|||
23386169|NCT01089543|65158588|FG003|Overall Study|Withdrawal by Subject|1|||
23386170|NCT01089543|65158585|FG000|Overall Study|Physician Decision|1|||
23386171|NCT01089543|65158586|FG001|Overall Study|Physician Decision|0|||
23386172|NCT01089543|65158587|FG002|Overall Study|Physician Decision|0|||
23386173|NCT01089543|65158588|FG003|Overall Study|Physician Decision|1|||
23386174|NCT01089543|65158585|FG000|Overall Study|Adverse Event|0|||
23386175|NCT01089543|65158586|FG001|Overall Study|Adverse Event|1|||
23386176|NCT01089543|65158587|FG002|Overall Study|Adverse Event|0|||
23386177|NCT01089543|65158588|FG003|Overall Study|Adverse Event|0|||
23386178|NCT00376506|65158589|FG000|Overall Study|Death|0|||
23386179|NCT00376506|65158590|FG001|Overall Study|Death|2|||
23293110|NCT02010255|64815192|FG010|Overall Study|Lack of Efficacy|1|||
23293111|NCT02010255|64815193|FG011|Overall Study|Lack of Efficacy|0|||
23293112|NCT02010255|64815194|FG012|Overall Study|Lack of Efficacy|0|||
23293113|NCT02010255|64815195|FG013|Overall Study|Lack of Efficacy|0|||
23293114|NCT02010255|64815182|FG000|Overall Study|Withdrew Consent|1|||
23293115|NCT02010255|64815183|FG001|Overall Study|Withdrew Consent|0|||
23293116|NCT02010255|64815184|FG002|Overall Study|Withdrew Consent|0|||
23293117|NCT02010255|64815185|FG003|Overall Study|Withdrew Consent|1|||
23293118|NCT02010255|64815186|FG004|Overall Study|Withdrew Consent|0|||
23386180|NCT03520569|65158591|FG000|Overall Study|Withdrawal by Subject|1|||
23386181|NCT03760068|65158592|FG000|Overall Study|Withdrawal by Subject|7|||
23293119|NCT02010255|64815187|FG005|Overall Study|Withdrew Consent|0|||
23293120|NCT02010255|64815188|FG006|Overall Study|Withdrew Consent|0|||
23386182|NCT03760068|65158593|FG001|Overall Study|Withdrawal by Subject|8|||
23386183|NCT03760068|65158592|FG000|Overall Study|Adverse Event|1|||
23386184|NCT03760068|65158593|FG001|Overall Study|Adverse Event|2|||
23386185|NCT03760068|65158592|FG000|Overall Study|Administrative Decision by Sponsor|0|||
23386186|NCT03760068|65158593|FG001|Overall Study|Administrative Decision by Sponsor|2|||
23386187|NCT03760068|65158592|FG000|Overall Study|Physician Decision|1|||
23386188|NCT03760068|65158593|FG001|Overall Study|Physician Decision|2|||
23293121|NCT02010255|64815189|FG007|Overall Study|Withdrew Consent|0|||
23293122|NCT02010255|64815190|FG008|Overall Study|Withdrew Consent|0|||
23293123|NCT02010255|64815191|FG009|Overall Study|Withdrew Consent|0|||
23293124|NCT02010255|64815192|FG010|Overall Study|Withdrew Consent|0|||
23293125|NCT02010255|64815193|FG011|Overall Study|Withdrew Consent|0|||
23293126|NCT02010255|64815194|FG012|Overall Study|Withdrew Consent|0|||
23293127|NCT02010255|64815195|FG013|Overall Study|Withdrew Consent|0|||
23293128|NCT02010255|64815182|FG000|Overall Study|Adverse Event|1|||
23293129|NCT02010255|64815183|FG001|Overall Study|Adverse Event|0|||
23293130|NCT02010255|64815184|FG002|Overall Study|Adverse Event|0|||
23293131|NCT02010255|64815185|FG003|Overall Study|Adverse Event|0|||
23293132|NCT02010255|64815186|FG004|Overall Study|Adverse Event|0|||
23293133|NCT02010255|64815187|FG005|Overall Study|Adverse Event|0|||
23293134|NCT02010255|64815188|FG006|Overall Study|Adverse Event|0|||
23293135|NCT02010255|64815189|FG007|Overall Study|Adverse Event|0|||
23293136|NCT02010255|64815190|FG008|Overall Study|Adverse Event|0|||
23293137|NCT02010255|64815191|FG009|Overall Study|Adverse Event|0|||
23293138|NCT02010255|64815192|FG010|Overall Study|Adverse Event|0|||
23293139|NCT02010255|64815193|FG011|Overall Study|Adverse Event|0|||
23293140|NCT02010255|64815194|FG012|Overall Study|Adverse Event|0|||
23293141|NCT02010255|64815195|FG013|Overall Study|Adverse Event|0|||
23293142|NCT02010255|64815182|FG000|Overall Study|Lost to Follow-up|0|||
23293143|NCT02010255|64815183|FG001|Overall Study|Lost to Follow-up|0|||
23293144|NCT02010255|64815184|FG002|Overall Study|Lost to Follow-up|1|||
23293145|NCT02010255|64815185|FG003|Overall Study|Lost to Follow-up|0|||
23293146|NCT02010255|64815186|FG004|Overall Study|Lost to Follow-up|1|||
23293147|NCT02010255|64815187|FG005|Overall Study|Lost to Follow-up|0|||
23293148|NCT02010255|64815188|FG006|Overall Study|Lost to Follow-up|0|||
23293149|NCT02010255|64815189|FG007|Overall Study|Lost to Follow-up|0|||
23293150|NCT02010255|64815190|FG008|Overall Study|Lost to Follow-up|0|||
23293151|NCT02010255|64815191|FG009|Overall Study|Lost to Follow-up|0|||
23293152|NCT02010255|64815192|FG010|Overall Study|Lost to Follow-up|0|||
23293153|NCT02010255|64815193|FG011|Overall Study|Lost to Follow-up|0|||
23293154|NCT02010255|64815194|FG012|Overall Study|Lost to Follow-up|0|||
23293155|NCT02010255|64815195|FG013|Overall Study|Lost to Follow-up|0|||
23293156|NCT02010255|64815182|FG000|Overall Study|Randomized but Not Treated|0|||
23293157|NCT02010255|64815183|FG001|Overall Study|Randomized but Not Treated|0|||
23293158|NCT02010255|64815184|FG002|Overall Study|Randomized but Not Treated|0|||
23293159|NCT02010255|64815185|FG003|Overall Study|Randomized but Not Treated|0|||
23293160|NCT02010255|64815186|FG004|Overall Study|Randomized but Not Treated|0|||
23293161|NCT02010255|64815187|FG005|Overall Study|Randomized but Not Treated|0|||
23293162|NCT02010255|64815188|FG006|Overall Study|Randomized but Not Treated|0|||
23293163|NCT02010255|64815189|FG007|Overall Study|Randomized but Not Treated|0|||
23293164|NCT02010255|64815190|FG008|Overall Study|Randomized but Not Treated|0|||
23293165|NCT02010255|64815191|FG009|Overall Study|Randomized but Not Treated|0|||
23293166|NCT02010255|64815192|FG010|Overall Study|Randomized but Not Treated|0|||
23293167|NCT02010255|64815193|FG011|Overall Study|Randomized but Not Treated|0|||
23293168|NCT02010255|64815194|FG012|Overall Study|Randomized but Not Treated|0|||
23293169|NCT02010255|64815195|FG013|Overall Study|Randomized but Not Treated|1|||
23293170|NCT03635983|64815198|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
23293171|NCT03635983|64815199|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
23293172|NCT03635983|64815198|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
23293173|NCT03635983|64815199|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
23293174|NCT03635983|64815198|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23293175|NCT03635983|64815199|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23293176|NCT03635983|64815198|FG000|Pre-Treatment Period|Other reasons|1|||
23293177|NCT03635983|64815199|FG001|Pre-Treatment Period|Other reasons|2|||
23293178|NCT03635983|64815198|FG000|Pre-Treatment Period|Disease Progression|0|||
23293179|NCT03635983|64815199|FG001|Pre-Treatment Period|Disease Progression|1|||
23293180|NCT03635983|64815198|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
23293181|NCT03635983|64815199|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
23293182|NCT03635983|64815198|FG000|Treatment Period|Completed treatment period|13|||
23293183|NCT03635983|64815199|FG001|Treatment Period|Completed treatment period|20|||
23386189|NCT03760068|65158592|FG000|Overall Study|Lost to Follow-up|4|||
23386190|NCT03760068|65158593|FG001|Overall Study|Lost to Follow-up|9|||
23386191|NCT03760068|65158592|FG000|Overall Study|Subject Moved Out of State|1|||
23386192|NCT03760068|65158593|FG001|Overall Study|Subject Moved Out of State|0|||
23386193|NCT01560988|65158594|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
23386194|NCT01560988|65158595|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
23386195|NCT01560988|65158594|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
23386196|NCT01560988|65158595|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
23386197|NCT01560988|65158594|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
23386198|NCT01560988|65158595|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
23386199|NCT03364686|65158600|FG000|Overall Study|Physician Decision|2|||
23386200|NCT01696214|65158603|FG000|Overall Study|Lost to Follow-up|1|||
23386201|NCT01696214|65158604|FG001|Overall Study|Lost to Follow-up|0|||
23386202|NCT01696214|65158605|FG002|Overall Study|Lost to Follow-up|0|||
23386203|NCT01696214|65158606|FG003|Overall Study|Lost to Follow-up|0|||
23386204|NCT04091438|65158607|FG000|Treatment Period 1 (1 Day)|Other|1|||
23386205|NCT04091438|65158608|FG001|Treatment Period 1 (1 Day)|Other|0|||
23293184|NCT03635983|64815198|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
23293185|NCT03635983|64815199|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
23293186|NCT03635983|64815198|FG000|Treatment Period|Withdrawal by Subject|2|||
23293187|NCT03635983|64815199|FG001|Treatment Period|Withdrawal by Subject|4|||
23293188|NCT03635983|64815198|FG000|Treatment Period|Death|3|||
23293189|NCT03635983|64815199|FG001|Treatment Period|Death|4|||
23293190|NCT03635983|64815198|FG000|Treatment Period|Poor/Non-compliance|1|||
23293191|NCT03635983|64815199|FG001|Treatment Period|Poor/Non-compliance|0|||
23293192|NCT03635983|64815198|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
23293193|NCT03635983|64815199|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
23293194|NCT03635983|64815198|FG000|Treatment Period|Other reasons|5|||
23293195|NCT03635983|64815199|FG001|Treatment Period|Other reasons|2|||
23293196|NCT03635983|64815198|FG000|Treatment Period|Disease progression|184|||
23293197|NCT03635983|64815199|FG001|Treatment Period|Disease progression|168|||
23293198|NCT03635983|64815198|FG000|Treatment Period|Study drug toxicity|26|||
23293199|NCT03635983|64815199|FG001|Treatment Period|Study drug toxicity|29|||
23293200|NCT03635983|64815198|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
23293201|NCT03635983|64815199|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
23293202|NCT03635983|64815198|FG000|Treatment Period|Maximum clinical benefit|3|||
23293203|NCT03635983|64815199|FG001|Treatment Period|Maximum clinical benefit|2|||
23293204|NCT01270620|64815206|FG000|Overall Study|Withdrawal by Subject|1|||
23293205|NCT01270620|64815207|FG001|Overall Study|Withdrawal by Subject|3|||
23293206|NCT01188226|64815212|FG000|Overall Study|Withdrawal by Subject|4|||
23293207|NCT02655224|64815213|FG000|Overall Study|Adverse Event|1|||
23293208|NCT02655224|64815214|FG001|Overall Study|Adverse Event|1|||
23293209|NCT03223909|64815225|FG000|Overall Study|Protocol Violation|48|||
23293210|NCT03223909|64815226|FG001|Overall Study|Protocol Violation|45|||
23293211|NCT03223909|64815227|FG002|Overall Study|Protocol Violation|16|||
23293212|NCT00551616|64815228|FG000|Overall Study|Lost to Follow-up|48|||
23293213|NCT00551616|64815229|FG001|Overall Study|Lost to Follow-up|40|||
23293214|NCT02443324|64815230|FG000|Overall Study|Death|4|||
23293215|NCT02443324|64815231|FG001|Overall Study|Death|1|||
23293216|NCT02443324|64815232|FG002|Overall Study|Death|0|||
23293217|NCT02443324|64815233|FG003|Overall Study|Death|3|||
23293218|NCT02443324|64815234|FG004|Overall Study|Death|1|||
23293219|NCT02443324|64815235|FG005|Overall Study|Death|3|||
23293220|NCT02443324|64815236|FG006|Overall Study|Death|2|||
23293221|NCT02443324|64815230|FG000|Overall Study|Lost to Follow-up|0|||
23293222|NCT02443324|64815231|FG001|Overall Study|Lost to Follow-up|0|||
23293223|NCT02443324|64815232|FG002|Overall Study|Lost to Follow-up|0|||
23293224|NCT02443324|64815233|FG003|Overall Study|Lost to Follow-up|1|||
23293225|NCT02443324|64815234|FG004|Overall Study|Lost to Follow-up|0|||
23293226|NCT02443324|64815235|FG005|Overall Study|Lost to Follow-up|1|||
23293227|NCT02443324|64815236|FG006|Overall Study|Lost to Follow-up|0|||
23293228|NCT02443324|64815230|FG000|Overall Study|Physician Decision|0|||
23293229|NCT02443324|64815231|FG001|Overall Study|Physician Decision|3|||
23293230|NCT02443324|64815232|FG002|Overall Study|Physician Decision|5|||
23293231|NCT02443324|64815233|FG003|Overall Study|Physician Decision|1|||
23293232|NCT02443324|64815234|FG004|Overall Study|Physician Decision|1|||
23293233|NCT02443324|64815235|FG005|Overall Study|Physician Decision|0|||
23293234|NCT02443324|64815236|FG006|Overall Study|Physician Decision|2|||
23293235|NCT02443324|64815230|FG000|Overall Study|Progressive Disease|20|||
23293236|NCT02443324|64815231|FG001|Overall Study|Progressive Disease|20|||
23293237|NCT02443324|64815232|FG002|Overall Study|Progressive Disease|13|||
23293238|NCT02443324|64815233|FG003|Overall Study|Progressive Disease|10|||
23293239|NCT02443324|64815234|FG004|Overall Study|Progressive Disease|13|||
23386206|NCT04091438|65158607|FG000|Washout Period (1 Day)|Protocol deviation|0|||
23386207|NCT04091438|65158608|FG001|Washout Period (1 Day)|Protocol deviation|1|||
23386208|NCT04091438|65158607|FG000|Washout Period (1 Day)|Other|0|||
23293240|NCT02443324|64815235|FG005|Overall Study|Progressive Disease|17|||
23293241|NCT02443324|64815236|FG006|Overall Study|Progressive Disease|10|||
23293242|NCT02443324|64815230|FG000|Overall Study|Withdrawal by Subject|0|||
23293243|NCT02443324|64815231|FG001|Overall Study|Withdrawal by Subject|0|||
23293244|NCT02443324|64815232|FG002|Overall Study|Withdrawal by Subject|3|||
23293245|NCT02443324|64815233|FG003|Overall Study|Withdrawal by Subject|1|||
23293246|NCT02443324|64815234|FG004|Overall Study|Withdrawal by Subject|1|||
23293247|NCT02443324|64815235|FG005|Overall Study|Withdrawal by Subject|0|||
23293248|NCT02443324|64815236|FG006|Overall Study|Withdrawal by Subject|1|||
23293249|NCT02443324|64815230|FG000|Overall Study|Adverse Event|0|||
23293250|NCT02443324|64815231|FG001|Overall Study|Adverse Event|1|||
23293251|NCT02443324|64815232|FG002|Overall Study|Adverse Event|3|||
23293252|NCT02443324|64815233|FG003|Overall Study|Adverse Event|0|||
23293253|NCT02443324|64815234|FG004|Overall Study|Adverse Event|4|||
23293254|NCT02443324|64815235|FG005|Overall Study|Adverse Event|3|||
23293255|NCT02443324|64815236|FG006|Overall Study|Adverse Event|3|||
23293256|NCT02443324|64815230|FG000|Overall Study|Enrolled but Never Treated|0|||
23293257|NCT02443324|64815231|FG001|Overall Study|Enrolled but Never Treated|0|||
23293258|NCT02443324|64815232|FG002|Overall Study|Enrolled but Never Treated|1|||
23293259|NCT02443324|64815233|FG003|Overall Study|Enrolled but Never Treated|0|||
23293260|NCT02443324|64815234|FG004|Overall Study|Enrolled but Never Treated|1|||
23293261|NCT02443324|64815235|FG005|Overall Study|Enrolled but Never Treated|0|||
23293262|NCT02443324|64815236|FG006|Overall Study|Enrolled but Never Treated|1|||
23293263|NCT00388037|64815239|FG000|Overall Study|Protocol Violation|1|||
23293264|NCT02415387|64815240|FG000|Overall Study|Withdrawal by Subject|6|||
23293265|NCT02415387|64815241|FG001|Overall Study|Withdrawal by Subject|1|||
23293266|NCT02415387|64815240|FG000|Overall Study|blood draw problem|0|||
23293267|NCT02415387|64815241|FG001|Overall Study|blood draw problem|1|||
23293268|NCT02415387|64815240|FG000|Overall Study|Protocol Violation|1|||
23293269|NCT02415387|64815241|FG001|Overall Study|Protocol Violation|0|||
23293270|NCT01740427|64815242|FG000|Overall Study|Ongoing|45|||
23293271|NCT01740427|64815243|FG001|Overall Study|Ongoing|5|||
23293272|NCT01740427|64815242|FG000|Overall Study|Objective Progression or Relapse|281|||
23293273|NCT01740427|64815243|FG001|Overall Study|Objective Progression or Relapse|171|||
23293274|NCT01740427|64815242|FG000|Overall Study|Adverse Event|31|||
23293275|NCT01740427|64815243|FG001|Overall Study|Adverse Event|9|||
23293276|NCT01740427|64815242|FG000|Overall Study|Global Deterioration of Health Status|28|||
23293277|NCT01740427|64815243|FG001|Overall Study|Global Deterioration of Health Status|12|||
23293278|NCT01740427|64815242|FG000|Overall Study|Participant Refused Continued Treatment|26|||
23293279|NCT01740427|64815243|FG001|Overall Study|Participant Refused Continued Treatment|15|||
23293280|NCT01740427|64815242|FG000|Overall Study|Unspecified reasons|15|||
23293281|NCT01740427|64815243|FG001|Overall Study|Unspecified reasons|4|||
23293282|NCT01740427|64815242|FG000|Overall Study|Death|10|||
23293283|NCT01740427|64815243|FG001|Overall Study|Death|3|||
23293284|NCT01740427|64815242|FG000|Overall Study|Protocol Violation|5|||
23293285|NCT01740427|64815243|FG001|Overall Study|Protocol Violation|3|||
23293286|NCT01740427|64815242|FG000|Overall Study|Lost to Follow-up|2|||
23293287|NCT01740427|64815243|FG001|Overall Study|Lost to Follow-up|0|||
23293288|NCT01740427|64815242|FG000|Overall Study|Site Terminated by Sponsor|1|||
23293289|NCT01740427|64815243|FG001|Overall Study|Site Terminated by Sponsor|0|||
23293290|NCT01213836|64815244|FG000|Period 1, First Intervention|Adverse Event|2|||
23293291|NCT01213836|64815245|FG001|Period 1, First Intervention|Adverse Event|1|||
23293292|NCT01213836|64815244|FG000|Period 1, First Intervention|Protocol Violation|0|||
23293293|NCT01213836|64815245|FG001|Period 1, First Intervention|Protocol Violation|1|||
23293294|NCT01213836|64815244|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
23293295|NCT01213836|64815245|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
23293296|NCT00413218|64815248|FG000|Overall Study|Randomized but didn't receive study drug|2|||
23293297|NCT00413218|64815249|FG001|Overall Study|Randomized but didn't receive study drug|8|||
23293298|NCT00413218|64815248|FG000|Overall Study|Death|57|||
23293299|NCT00413218|64815249|FG001|Overall Study|Death|56|||
23293300|NCT00413218|64815248|FG000|Overall Study|Lost to Follow-up|14|||
23293301|NCT00413218|64815249|FG001|Overall Study|Lost to Follow-up|17|||
23293302|NCT00413218|64815248|FG000|Overall Study|Admin|20|||
23293303|NCT00413218|64815249|FG001|Overall Study|Admin|14|||
23293304|NCT00413218|64815248|FG000|Overall Study|Missing|1|||
23293305|NCT00413218|64815249|FG001|Overall Study|Missing|0|||
23293306|NCT00413218|64815248|FG000|Overall Study|Withdrawal by Subject|9|||
23293307|NCT00413218|64815249|FG001|Overall Study|Withdrawal by Subject|1|||
23293308|NCT03573817|64815250|FG000|Overall Study|Adverse Event|0|||
23293309|NCT03573817|64815251|FG001|Overall Study|Adverse Event|2|||
23293310|NCT03573817|64815250|FG000|Overall Study|Protocol Violation|0|||
23293311|NCT03573817|64815251|FG001|Overall Study|Protocol Violation|1|||
23293312|NCT03573817|64815250|FG000|Overall Study|Withdrawal by Subject|1|||
23293313|NCT03573817|64815251|FG001|Overall Study|Withdrawal by Subject|1|||
23293314|NCT03381196|64815252|FG000|Overall Study|Withdrawal by Subject|7|||
23293315|NCT03381196|64815253|FG001|Overall Study|Withdrawal by Subject|7|||
23493302|NCT01328431|65551440|FG001|3 Month (3M)|Lost to Follow-up|70|||
23293316|NCT03381196|64815252|FG000|Overall Study|Other|0|||
23293317|NCT03381196|64815253|FG001|Overall Study|Other|1|||
23293318|NCT03381196|64815252|FG000|Overall Study|Lost to Follow-up|5|||
23293319|NCT03381196|64815253|FG001|Overall Study|Lost to Follow-up|4|||
23293320|NCT03381196|64815252|FG000|Overall Study|Death|0|||
23293321|NCT03381196|64815253|FG001|Overall Study|Death|1|||
23293322|NCT03381196|64815252|FG000|Overall Study|Adverse Event|1|||
23386209|NCT04091438|65158608|FG001|Washout Period (1 Day)|Other|1|||
23386210|NCT00924651|65158609|FG000|Overall Study|Chemo started too soon|2|||
23386211|NCT00924651|65158610|FG001|Overall Study|Chemo started too soon|3|||
23386212|NCT00924651|65158609|FG000|Overall Study|No Reason|3|||
23386213|NCT00924651|65158610|FG001|Overall Study|No Reason|7|||
23386214|NCT00924651|65158609|FG000|Overall Study|Overwhelmed|6|||
23386215|NCT00924651|65158610|FG001|Overall Study|Overwhelmed|6|||
23386216|NCT00924651|65158609|FG000|Overall Study|Noncompliant|1|||
23386217|NCT00924651|65158610|FG001|Overall Study|Noncompliant|4|||
23386218|NCT00924651|65158609|FG000|Overall Study|Medical|1|||
23386219|NCT00924651|65158610|FG001|Overall Study|Medical|3|||
23293323|NCT03381196|64815253|FG001|Overall Study|Adverse Event|0|||
23293324|NCT03381196|64815252|FG000|Overall Study|Randomized, not treated|3|||
23293325|NCT03381196|64815253|FG001|Overall Study|Randomized, not treated|6|||
23293326|NCT01848210|64815254|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
23293327|NCT01848210|64815255|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
23293328|NCT01848210|64815254|FG000|Overall Study|Lost to Follow-up|24|||
23293329|NCT01848210|64815255|FG001|Overall Study|Lost to Follow-up|12|||
23293330|NCT01848210|64815254|FG000|Overall Study|Protocol Violation|3|||
23293331|NCT01848210|64815255|FG001|Overall Study|Protocol Violation|5|||
23293332|NCT01848210|64815254|FG000|Overall Study|Use of Forbidden Drugs|9|||
23293333|NCT01848210|64815255|FG001|Overall Study|Use of Forbidden Drugs|10|||
23293334|NCT01848210|64815254|FG000|Overall Study|Impedition Condition|5|||
23293335|NCT01848210|64815255|FG001|Overall Study|Impedition Condition|9|||
23293336|NCT01848210|64815254|FG000|Overall Study|Adverse Event|7|||
23293337|NCT01848210|64815255|FG001|Overall Study|Adverse Event|9|||
23293338|NCT01848210|64815254|FG000|Overall Study|Discontinuation Criterion|5|||
23293339|NCT01848210|64815255|FG001|Overall Study|Discontinuation Criterion|7|||
23293340|NCT01848210|64815254|FG000|Overall Study|Hypesensitivity|1|||
23293341|NCT01848210|64815255|FG001|Overall Study|Hypesensitivity|0|||
23293342|NCT01848210|64815254|FG000|Overall Study|Hepatic Function Alteration|4|||
23293343|NCT01848210|64815255|FG001|Overall Study|Hepatic Function Alteration|0|||
23293344|NCT01848210|64815254|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
23293345|NCT01848210|64815255|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
23293346|NCT01848210|64815254|FG000|Overall Study|Administrative|1|||
23293347|NCT01848210|64815255|FG001|Overall Study|Administrative|0|||
23386220|NCT00924651|65158609|FG000|Overall Study|Changed Mind|10|||
23386221|NCT00924651|65158610|FG001|Overall Study|Changed Mind|1|||
23386222|NCT00924651|65158609|FG000|Overall Study|Incomplete Form|2|||
23293348|NCT00819767|64815256|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23293349|NCT00819767|64815257|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
23293350|NCT03823287|64815261|FG000|Overall Study|Withdrawal by Subject|25|||
23386223|NCT00924651|65158610|FG001|Overall Study|Incomplete Form|1|||
23386224|NCT00800384|65158611|FG000|Overall Study|Withdrawal by Subject|24|||
23386225|NCT00800384|65158612|FG001|Overall Study|Withdrawal by Subject|17|||
23386226|NCT00800384|65158611|FG000|Overall Study|Lost to Follow-up|17|||
23386227|NCT00800384|65158612|FG001|Overall Study|Lost to Follow-up|26|||
23386228|NCT00899847|65158613|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
23386229|NCT00710554|65158615|FG000|Overall Study|Adverse Event|24|||
23386230|NCT00710554|65158616|FG001|Overall Study|Adverse Event|7|||
23386231|NCT00710554|65158615|FG000|Overall Study|Withdrawal by Subject|7|||
23386232|NCT00710554|65158616|FG001|Overall Study|Withdrawal by Subject|3|||
23386233|NCT00710554|65158615|FG000|Overall Study|Lost to Follow-up|7|||
23386234|NCT00710554|65158616|FG001|Overall Study|Lost to Follow-up|1|||
23386235|NCT00710554|65158615|FG000|Overall Study|Lack of Efficacy|11|||
23386236|NCT00710554|65158616|FG001|Overall Study|Lack of Efficacy|12|||
23386237|NCT00710554|65158615|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
23386238|NCT00710554|65158616|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
23386239|NCT01520714|65158617|FG000|Overall Study|Protocol Violation|0|||
23386240|NCT01520714|65158618|FG001|Overall Study|Protocol Violation|3|||
23386241|NCT01520714|65158617|FG000|Overall Study|Adverse Event|0|||
23386242|NCT01520714|65158618|FG001|Overall Study|Adverse Event|2|||
23386243|NCT01520714|65158617|FG000|Overall Study|Lack of Efficacy|0|||
23386244|NCT01520714|65158618|FG001|Overall Study|Lack of Efficacy|1|||
23386245|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
23386246|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
23386247|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
23386248|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
23386249|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
23386250|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
23386251|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
23386252|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23386253|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
23386254|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
23386255|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
23386256|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
23386257|NCT01703221|65158619|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23386258|NCT01703221|65158620|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
23386259|NCT01703221|65158621|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
23386260|NCT01703221|65158619|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
23386261|NCT01703221|65158620|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
23386262|NCT01703221|65158621|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
23386263|NCT01703221|65158619|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
23386264|NCT01703221|65158620|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
23386265|NCT01703221|65158621|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
23386266|NCT01703221|65158619|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
23386267|NCT01703221|65158620|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
23386268|NCT01703221|65158621|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
23386269|NCT03931785|65158622|FG000|Overall Study|Lost to Follow-up|4|||
23386270|NCT03931785|65158623|FG001|Overall Study|Lost to Follow-up|1|||
23386271|NCT03931785|65158624|FG002|Overall Study|Lost to Follow-up|4|||
23386272|NCT03931785|65158625|FG003|Overall Study|Lost to Follow-up|3|||
23386273|NCT03931785|65158622|FG000|Overall Study|Adverse Event|1|||
23386274|NCT03931785|65158623|FG001|Overall Study|Adverse Event|0|||
23386275|NCT03931785|65158624|FG002|Overall Study|Adverse Event|3|||
23386276|NCT03931785|65158625|FG003|Overall Study|Adverse Event|4|||
23386277|NCT03931785|65158622|FG000|Overall Study|Protocol Violation|0|||
23386278|NCT03931785|65158623|FG001|Overall Study|Protocol Violation|1|||
23386279|NCT03931785|65158624|FG002|Overall Study|Protocol Violation|0|||
23386280|NCT03931785|65158625|FG003|Overall Study|Protocol Violation|0|||
23386281|NCT03931785|65158622|FG000|Overall Study|Noncompliance With Study drug|0|||
23386282|NCT03931785|65158623|FG001|Overall Study|Noncompliance With Study drug|1|||
23386283|NCT03931785|65158624|FG002|Overall Study|Noncompliance With Study drug|0|||
23386284|NCT03931785|65158625|FG003|Overall Study|Noncompliance With Study drug|0|||
23386285|NCT03931785|65158622|FG000|Overall Study|Other Not specified|0|||
23386286|NCT03931785|65158623|FG001|Overall Study|Other Not specified|2|||
23386287|NCT03931785|65158624|FG002|Overall Study|Other Not specified|2|||
23386288|NCT03931785|65158625|FG003|Overall Study|Other Not specified|2|||
23493303|NCT01328431|65551439|FG000|12 Month (12M)|Death|2|||
23493304|NCT01328431|65551440|FG001|12 Month (12M)|Death|6|||
23386289|NCT03931785|65158622|FG000|Overall Study|Withdrawal by Subject|0|||
23386290|NCT03931785|65158623|FG001|Overall Study|Withdrawal by Subject|2|||
23493305|NCT01328431|65551439|FG000|12 Month (12M)|Lost to Follow-up|82|||
23493306|NCT01328431|65551440|FG001|12 Month (12M)|Lost to Follow-up|91|||
23386291|NCT03931785|65158624|FG002|Overall Study|Withdrawal by Subject|4|||
23386292|NCT03931785|65158625|FG003|Overall Study|Withdrawal by Subject|1|||
23386293|NCT03931785|65158622|FG000|Overall Study|Pregnancy|0|||
23386294|NCT03931785|65158623|FG001|Overall Study|Pregnancy|0|||
23386295|NCT03931785|65158624|FG002|Overall Study|Pregnancy|0|||
23386296|NCT03931785|65158625|FG003|Overall Study|Pregnancy|1|||
23386297|NCT02571244|65158626|FG000|Overall Study|Lost to Follow-up|0|||
23493307|NCT02180165|65551444|FG000|Overall Study|Not Treated|0|||
23293351|NCT03823287|64815262|FG001|Overall Study|Withdrawal by Subject|17|||
23293352|NCT03823287|64815261|FG000|Overall Study|Death|13|||
23293353|NCT03823287|64815262|FG001|Overall Study|Death|7|||
23293354|NCT03823287|64815261|FG000|Overall Study|Lost to Follow-up|7|||
23293355|NCT03823287|64815262|FG001|Overall Study|Lost to Follow-up|8|||
23293356|NCT03823287|64815261|FG000|Overall Study|Adverse Event|6|||
23293357|NCT03823287|64815262|FG001|Overall Study|Adverse Event|8|||
23293358|NCT03823287|64815261|FG000|Overall Study|Physician Decision|5|||
23293359|NCT03823287|64815262|FG001|Overall Study|Physician Decision|2|||
23293360|NCT03823287|64815261|FG000|Overall Study|Lack of Efficacy|2|||
23293361|NCT03823287|64815262|FG001|Overall Study|Lack of Efficacy|0|||
23293362|NCT03823287|64815261|FG000|Overall Study|Other|2|||
23293363|NCT03823287|64815262|FG001|Overall Study|Other|4|||
23293364|NCT00831233|64815267|FG000|Overall Study|Adverse Event|0|||
23293365|NCT00831233|64815268|FG001|Overall Study|Adverse Event|1|||
23293366|NCT00831233|64815267|FG000|Overall Study|Protocol Violation|1|||
23293367|NCT00831233|64815268|FG001|Overall Study|Protocol Violation|0|||
23293368|NCT00831233|64815267|FG000|Overall Study|Selection Criteria Not Met|2|||
23293369|NCT00831233|64815268|FG001|Overall Study|Selection Criteria Not Met|0|||
23293370|NCT01662024|64815269|FG000|Overall Study|Pregnancy|2|||
23293371|NCT01662024|64815269|FG000|Overall Study|Withdrawal by Subject|3|||
23293372|NCT00784979|64815270|FG000|Overall Study|incomplete data|6|||
23293373|NCT00401245|64815271|FG000|Double Blind Titration Phase|Adverse Event|3|||
23293374|NCT00401245|64815272|FG001|Double Blind Titration Phase|Adverse Event|2|||
23293375|NCT00401245|64815273|FG002|Double Blind Titration Phase|Adverse Event|5|||
23293376|NCT00401245|64815274|FG003|Double Blind Titration Phase|Adverse Event|12|||
23293377|NCT00401245|64815275|FG004|Double Blind Titration Phase|Adverse Event|0|||
23293378|NCT00401245|64815276|FG005|Double Blind Titration Phase|Adverse Event|0|||
23293379|NCT00401245|64815277|FG006|Double Blind Titration Phase|Adverse Event|0|||
23293380|NCT00401245|64815278|FG007|Double Blind Titration Phase|Adverse Event|0|||
23293381|NCT00401245|64815271|FG000|Double Blind Titration Phase|Other|0|||
23293382|NCT00401245|64815272|FG001|Double Blind Titration Phase|Other|0|||
23293383|NCT00401245|64815273|FG002|Double Blind Titration Phase|Other|1|||
23293384|NCT00401245|64815274|FG003|Double Blind Titration Phase|Other|0|||
23293385|NCT00401245|64815275|FG004|Double Blind Titration Phase|Other|0|||
23293386|NCT00401245|64815276|FG005|Double Blind Titration Phase|Other|0|||
23293387|NCT00401245|64815277|FG006|Double Blind Titration Phase|Other|0|||
23293388|NCT00401245|64815278|FG007|Double Blind Titration Phase|Other|0|||
23293389|NCT00401245|64815271|FG000|Double Blind Titration Phase|Protocol Violation|0|||
23293390|NCT00401245|64815272|FG001|Double Blind Titration Phase|Protocol Violation|0|||
23386298|NCT02571244|65158627|FG001|Overall Study|Lost to Follow-up|1|||
23386299|NCT02571244|65158626|FG000|Overall Study|Unable to reach out post discharge|3|||
23386300|NCT02571244|65158627|FG001|Overall Study|Unable to reach out post discharge|0|||
23386301|NCT01152385|65158630|FG000|Overall Study|Withdrawal by Subject|3|||
23386302|NCT01152385|65158631|FG001|Overall Study|Withdrawal by Subject|1|||
23386303|NCT01152385|65158632|FG002|Overall Study|Withdrawal by Subject|1|||
23386304|NCT01152385|65158633|FG003|Overall Study|Withdrawal by Subject|1|||
23386305|NCT01152385|65158630|FG000|Overall Study|Protocol Violation|0|||
23386306|NCT01152385|65158631|FG001|Overall Study|Protocol Violation|0|||
23386307|NCT01152385|65158632|FG002|Overall Study|Protocol Violation|0|||
23386308|NCT01152385|65158633|FG003|Overall Study|Protocol Violation|1|||
23386309|NCT01152385|65158630|FG000|Overall Study|Adverse Event|1|||
23386310|NCT01152385|65158631|FG001|Overall Study|Adverse Event|1|||
23293391|NCT00401245|64815273|FG002|Double Blind Titration Phase|Protocol Violation|0|||
23293392|NCT00401245|64815274|FG003|Double Blind Titration Phase|Protocol Violation|1|||
23293393|NCT00401245|64815275|FG004|Double Blind Titration Phase|Protocol Violation|0|||
23293394|NCT00401245|64815276|FG005|Double Blind Titration Phase|Protocol Violation|0|||
23293395|NCT00401245|64815277|FG006|Double Blind Titration Phase|Protocol Violation|0|||
23293396|NCT00401245|64815278|FG007|Double Blind Titration Phase|Protocol Violation|0|||
23293397|NCT00401245|64815271|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
23386311|NCT01152385|65158632|FG002|Overall Study|Adverse Event|0|||
23386312|NCT01152385|65158633|FG003|Overall Study|Adverse Event|0|||
23386313|NCT01152385|65158630|FG000|Overall Study|Study-specific withdrawal criteria|1|||
23386314|NCT01152385|65158631|FG001|Overall Study|Study-specific withdrawal criteria|1|||
23386315|NCT01152385|65158632|FG002|Overall Study|Study-specific withdrawal criteria|2|||
23386316|NCT01152385|65158633|FG003|Overall Study|Study-specific withdrawal criteria|0|||
23386317|NCT01152385|65158630|FG000|Overall Study|Other|4|||
23386318|NCT01152385|65158631|FG001|Overall Study|Other|3|||
23386319|NCT01152385|65158632|FG002|Overall Study|Other|2|||
23386320|NCT01152385|65158633|FG003|Overall Study|Other|3|||
23386321|NCT00776997|65158634|FG000|Overall Study|Adverse Event|2|||
23386322|NCT02453191|65158635|FG000|Overall Study|Withdrawal by Subject|1|||
23386323|NCT03412890|65158638|FG000|Overall Study|Adverse Event|5|||
23386324|NCT03412890|65158639|FG001|Overall Study|Adverse Event|5|||
23386325|NCT03412890|65158640|FG002|Overall Study|Adverse Event|9|||
23386326|NCT03412890|65158638|FG000|Overall Study|Protocol deviation|2|||
23386327|NCT03412890|65158639|FG001|Overall Study|Protocol deviation|1|||
23386328|NCT03412890|65158640|FG002|Overall Study|Protocol deviation|2|||
23386329|NCT03412890|65158638|FG000|Overall Study|Lost to Follow-up|7|||
23386330|NCT03412890|65158639|FG001|Overall Study|Lost to Follow-up|10|||
23386331|NCT03412890|65158640|FG002|Overall Study|Lost to Follow-up|10|||
23386332|NCT03412890|65158638|FG000|Overall Study|Withdrawal by Subject|9|||
23386333|NCT03412890|65158639|FG001|Overall Study|Withdrawal by Subject|12|||
23386334|NCT03412890|65158640|FG002|Overall Study|Withdrawal by Subject|11|||
23386335|NCT03412890|65158638|FG000|Overall Study|Lack of Efficacy|2|||
23386336|NCT03412890|65158639|FG001|Overall Study|Lack of Efficacy|7|||
23386337|NCT03412890|65158640|FG002|Overall Study|Lack of Efficacy|5|||
23386338|NCT03412890|65158638|FG000|Overall Study|Other|5|||
23386339|NCT03412890|65158639|FG001|Overall Study|Other|6|||
23386340|NCT03412890|65158640|FG002|Overall Study|Other|5|||
23293398|NCT00401245|64815272|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
23293399|NCT00401245|64815273|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
23293400|NCT00401245|64815274|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
23293401|NCT00401245|64815275|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
23293402|NCT00401245|64815276|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
23293403|NCT00401245|64815277|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
23293404|NCT00401245|64815278|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
23293405|NCT00401245|64815271|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23293406|NCT00401245|64815272|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
23293407|NCT00401245|64815273|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23293408|NCT00401245|64815274|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
23293409|NCT00401245|64815275|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23293410|NCT00401245|64815276|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23293411|NCT00401245|64815277|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23293412|NCT00401245|64815278|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
23293413|NCT00401245|64815271|FG000|Open Label Phase|Adverse Event|5|||
23293414|NCT00401245|64815272|FG001|Open Label Phase|Adverse Event|14|||
23293415|NCT00401245|64815273|FG002|Open Label Phase|Adverse Event|6|||
23293416|NCT00401245|64815274|FG003|Open Label Phase|Adverse Event|7|||
23293417|NCT00401245|64815275|FG004|Open Label Phase|Adverse Event|0|||
23293418|NCT00401245|64815276|FG005|Open Label Phase|Adverse Event|0|||
23293419|NCT00401245|64815277|FG006|Open Label Phase|Adverse Event|0|||
23293420|NCT00401245|64815278|FG007|Open Label Phase|Adverse Event|0|||
23293421|NCT00401245|64815271|FG000|Open Label Phase|Lost to Follow-up|5|||
23293422|NCT00401245|64815272|FG001|Open Label Phase|Lost to Follow-up|7|||
23293423|NCT00401245|64815273|FG002|Open Label Phase|Lost to Follow-up|5|||
23386341|NCT03412890|65158638|FG000|Overall Study|Participants who did not receive any study drug|0|||
23386342|NCT03412890|65158639|FG001|Overall Study|Participants who did not receive any study drug|1|||
23386343|NCT03412890|65158640|FG002|Overall Study|Participants who did not receive any study drug|0|||
23386344|NCT01873833|65158641|FG000|Overall Study|Withdrawal by Subject|1|||
23386345|NCT00507507|65158642|FG000|Treatment Period|Lost to Follow-up|0|||
23293424|NCT00401245|64815274|FG003|Open Label Phase|Lost to Follow-up|4|||
23293425|NCT00401245|64815275|FG004|Open Label Phase|Lost to Follow-up|0|||
23293426|NCT00401245|64815276|FG005|Open Label Phase|Lost to Follow-up|0|||
23386346|NCT00507507|65158643|FG001|Treatment Period|Lost to Follow-up|2|||
23386347|NCT00507507|65158642|FG000|Treatment Period|Physician Decision|4|||
23386348|NCT00507507|65158643|FG001|Treatment Period|Physician Decision|1|||
23386349|NCT00507507|65158642|FG000|Treatment Period|Protocol Violation|1|||
23293427|NCT00401245|64815277|FG006|Open Label Phase|Lost to Follow-up|0|||
23293428|NCT00401245|64815278|FG007|Open Label Phase|Lost to Follow-up|0|||
23293429|NCT00401245|64815271|FG000|Open Label Phase|Other|4|||
23293430|NCT00401245|64815272|FG001|Open Label Phase|Other|8|||
23386350|NCT00507507|65158643|FG001|Treatment Period|Protocol Violation|2|||
23386351|NCT00507507|65158642|FG000|Treatment Period|Adverse Event|1|||
23386352|NCT00507507|65158643|FG001|Treatment Period|Adverse Event|1|||
23386353|NCT00507507|65158642|FG000|Treatment Period|Withdrawal by Subject|46|||
23386354|NCT00507507|65158643|FG001|Treatment Period|Withdrawal by Subject|47|||
23386355|NCT00507507|65158642|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
23386356|NCT00507507|65158643|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
23493308|NCT02180165|65551445|FG001|Overall Study|Not Treated|0|||
23293431|NCT00401245|64815273|FG002|Open Label Phase|Other|7|||
23293432|NCT00401245|64815274|FG003|Open Label Phase|Other|8|||
23293433|NCT00401245|64815275|FG004|Open Label Phase|Other|0|||
23293434|NCT00401245|64815276|FG005|Open Label Phase|Other|0|||
23493309|NCT02180165|65551446|FG002|Overall Study|Not Treated|1|||
23493310|NCT02180165|65551447|FG003|Overall Study|Not Treated|0|||
23293435|NCT00401245|64815277|FG006|Open Label Phase|Other|0|||
23293436|NCT00401245|64815278|FG007|Open Label Phase|Other|0|||
23293437|NCT00401245|64815271|FG000|Open Label Phase|Protocol Violation|0|||
23293438|NCT00401245|64815272|FG001|Open Label Phase|Protocol Violation|1|||
23293439|NCT00401245|64815273|FG002|Open Label Phase|Protocol Violation|0|||
23293440|NCT00401245|64815274|FG003|Open Label Phase|Protocol Violation|1|||
23293441|NCT00401245|64815275|FG004|Open Label Phase|Protocol Violation|0|||
23293442|NCT00401245|64815276|FG005|Open Label Phase|Protocol Violation|0|||
23293443|NCT00401245|64815277|FG006|Open Label Phase|Protocol Violation|0|||
23293444|NCT00401245|64815278|FG007|Open Label Phase|Protocol Violation|0|||
23293445|NCT00401245|64815271|FG000|Open Label Phase|Withdrawal by Subject|3|||
23293446|NCT00401245|64815272|FG001|Open Label Phase|Withdrawal by Subject|3|||
23493311|NCT02180165|65551444|FG000|Overall Study|Adverse Event|7|||
23493312|NCT02180165|65551445|FG001|Overall Study|Adverse Event|0|||
23493313|NCT02180165|65551446|FG002|Overall Study|Adverse Event|18|||
23493314|NCT02180165|65551447|FG003|Overall Study|Adverse Event|3|||
23493315|NCT02180165|65551444|FG000|Overall Study|Lack of Efficacy|0|||
23493316|NCT02180165|65551445|FG001|Overall Study|Lack of Efficacy|1|||
23493317|NCT02180165|65551446|FG002|Overall Study|Lack of Efficacy|3|||
23493318|NCT02180165|65551447|FG003|Overall Study|Lack of Efficacy|2|||
23493319|NCT02180165|65551444|FG000|Overall Study|Physician Decision|1|||
23493320|NCT02180165|65551445|FG001|Overall Study|Physician Decision|0|||
23493321|NCT02180165|65551446|FG002|Overall Study|Physician Decision|5|||
23493322|NCT02180165|65551447|FG003|Overall Study|Physician Decision|0|||
23493323|NCT02180165|65551444|FG000|Overall Study|Withdrawal by Subject|3|||
23293447|NCT00401245|64815273|FG002|Open Label Phase|Withdrawal by Subject|2|||
23293448|NCT00401245|64815274|FG003|Open Label Phase|Withdrawal by Subject|1|||
23293449|NCT00401245|64815275|FG004|Open Label Phase|Withdrawal by Subject|0|||
23293450|NCT00401245|64815276|FG005|Open Label Phase|Withdrawal by Subject|0|||
23293451|NCT00401245|64815277|FG006|Open Label Phase|Withdrawal by Subject|0|||
23386357|NCT00507507|65158642|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
23493324|NCT02180165|65551445|FG001|Overall Study|Withdrawal by Subject|0|||
23493325|NCT02180165|65551446|FG002|Overall Study|Withdrawal by Subject|2|||
23493326|NCT02180165|65551447|FG003|Overall Study|Withdrawal by Subject|1|||
23493327|NCT00137631|65551449|FG000|Overall Study|Lost to Follow-up|37|||
23293452|NCT00401245|64815278|FG007|Open Label Phase|Withdrawal by Subject|0|||
23293453|NCT00401245|64815271|FG000|Open Label Phase|Lack of Efficacy|4|||
23293454|NCT00401245|64815272|FG001|Open Label Phase|Lack of Efficacy|2|||
23293455|NCT00401245|64815273|FG002|Open Label Phase|Lack of Efficacy|3|||
23293456|NCT00401245|64815274|FG003|Open Label Phase|Lack of Efficacy|0|||
23293457|NCT00401245|64815275|FG004|Open Label Phase|Lack of Efficacy|0|||
23293458|NCT00401245|64815276|FG005|Open Label Phase|Lack of Efficacy|0|||
23293459|NCT00401245|64815277|FG006|Open Label Phase|Lack of Efficacy|0|||
23293460|NCT00401245|64815278|FG007|Open Label Phase|Lack of Efficacy|0|||
23293461|NCT00401245|64815271|FG000|Double Blind Tapering Phase|Adverse Event|0|||
23293462|NCT00401245|64815272|FG001|Double Blind Tapering Phase|Adverse Event|0|||
23293463|NCT00401245|64815273|FG002|Double Blind Tapering Phase|Adverse Event|0|||
23293464|NCT00401245|64815274|FG003|Double Blind Tapering Phase|Adverse Event|0|||
23293465|NCT00401245|64815275|FG004|Double Blind Tapering Phase|Adverse Event|1|||
23293466|NCT00401245|64815276|FG005|Double Blind Tapering Phase|Adverse Event|1|||
23293467|NCT00401245|64815277|FG006|Double Blind Tapering Phase|Adverse Event|2|||
23293468|NCT00401245|64815278|FG007|Double Blind Tapering Phase|Adverse Event|4|||
23293469|NCT00401245|64815271|FG000|Double Blind Tapering Phase|Investigator request|0|||
23293470|NCT00401245|64815272|FG001|Double Blind Tapering Phase|Investigator request|0|||
23293471|NCT00401245|64815273|FG002|Double Blind Tapering Phase|Investigator request|0|||
23293472|NCT00401245|64815274|FG003|Double Blind Tapering Phase|Investigator request|0|||
23293473|NCT00401245|64815275|FG004|Double Blind Tapering Phase|Investigator request|0|||
23293474|NCT00401245|64815276|FG005|Double Blind Tapering Phase|Investigator request|0|||
23293475|NCT00401245|64815277|FG006|Double Blind Tapering Phase|Investigator request|0|||
23293476|NCT00401245|64815278|FG007|Double Blind Tapering Phase|Investigator request|1|||
23293477|NCT00401245|64815271|FG000|Double Blind Tapering Phase|Other|0|||
23293478|NCT00401245|64815272|FG001|Double Blind Tapering Phase|Other|0|||
23293479|NCT00401245|64815273|FG002|Double Blind Tapering Phase|Other|0|||
23293480|NCT00401245|64815274|FG003|Double Blind Tapering Phase|Other|0|||
23293481|NCT00401245|64815275|FG004|Double Blind Tapering Phase|Other|1|||
23293482|NCT00401245|64815276|FG005|Double Blind Tapering Phase|Other|0|||
23293483|NCT00401245|64815277|FG006|Double Blind Tapering Phase|Other|2|||
23293484|NCT00401245|64815278|FG007|Double Blind Tapering Phase|Other|2|||
23293485|NCT00401245|64815271|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23293486|NCT00401245|64815272|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23293487|NCT00401245|64815273|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23293488|NCT00401245|64815274|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23293489|NCT00401245|64815275|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
23293490|NCT00401245|64815276|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
23293491|NCT00401245|64815277|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
23293492|NCT00401245|64815278|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
23293493|NCT00401245|64815271|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
23293494|NCT00401245|64815272|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
23293495|NCT00401245|64815273|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
23293496|NCT00401245|64815274|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
23293497|NCT00401245|64815275|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
23293498|NCT00401245|64815276|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
23293499|NCT00401245|64815277|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
23293500|NCT00401245|64815278|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
23293501|NCT03539458|64815279|FG000|Overall Study|Death|1|||
23293502|NCT04253236|64815280|FG000|Overall Study|Adverse Event|1|||
23293503|NCT04253236|64815281|FG001|Overall Study|Adverse Event|0|||
23293504|NCT04253236|64815280|FG000|Overall Study|Safety Concerns|1|||
23293505|NCT04253236|64815281|FG001|Overall Study|Safety Concerns|0|||
23386358|NCT00507507|65158643|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
23386359|NCT00507507|65158642|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
23386360|NCT00507507|65158643|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
23386361|NCT00401830|65158646|FG000|Overall Study|Adverse Event|10|||
23386362|NCT00401830|65158647|FG001|Overall Study|Adverse Event|18|||
23386363|NCT00401830|65158646|FG000|Overall Study|Lack of Efficacy|11|||
23386364|NCT00401830|65158647|FG001|Overall Study|Lack of Efficacy|5|||
23386365|NCT00401830|65158646|FG000|Overall Study|Withdrawal by Subject|4|||
23386366|NCT00401830|65158647|FG001|Overall Study|Withdrawal by Subject|3|||
23386367|NCT00401830|65158646|FG000|Overall Study|Protocol Violation|3|||
23386368|NCT00401830|65158647|FG001|Overall Study|Protocol Violation|3|||
23386369|NCT00401830|65158646|FG000|Overall Study|Non-compliance with drug study|1|||
23386370|NCT00401830|65158647|FG001|Overall Study|Non-compliance with drug study|0|||
23386371|NCT00401830|65158646|FG000|Overall Study|Lost to Follow-up|1|||
23386372|NCT00401830|65158647|FG001|Overall Study|Lost to Follow-up|3|||
23386373|NCT00401830|65158646|FG000|Overall Study|Other: Personal / Family problems|1|||
23386374|NCT00401830|65158647|FG001|Overall Study|Other: Personal / Family problems|0|||
23386375|NCT02830087|65158654|FG000|Overall Study|No study staff to follow-up patients|4|||
23386376|NCT02830087|65158655|FG001|Overall Study|No study staff to follow-up patients|4|||
23293506|NCT04253236|64815280|FG000|Overall Study|Study Terminated by Sponsor|1|||
23293507|NCT04253236|64815281|FG001|Overall Study|Study Terminated by Sponsor|0|||
23293508|NCT01376037|64815282|FG000|Overall Study|Lost to Follow-up|0|||
23293509|NCT01376037|64815283|FG001|Overall Study|Lost to Follow-up|2|||
23293510|NCT02447887|64815284|FG000|Overall Study|Study was terminated|3|||
23293511|NCT02001051|64815285|FG000|Overall Study|Deemed not eligible following enrollment|0|||
23293512|NCT02001051|64815286|FG001|Overall Study|Deemed not eligible following enrollment|1|||
23293513|NCT00351351|64815290|FG000|Overall Study|surgical access pbs; device issues|9|||
23293514|NCT00351351|64815291|FG001|Overall Study|surgical access pbs; device issues|4|||
23293515|NCT02056652|64815294|FG000|Overall Study|Withdrawal by Subject|1|||
23386377|NCT02830087|65158656|FG002|Overall Study|No study staff to follow-up patients|4|||
23386378|NCT02830087|65158657|FG003|Overall Study|No study staff to follow-up patients|3|||
23386379|NCT02830087|65158658|FG004|Overall Study|No study staff to follow-up patients|3|||
23386380|NCT02830087|65158659|FG005|Overall Study|No study staff to follow-up patients|3|||
23293516|NCT02056652|64815295|FG001|Overall Study|Withdrawal by Subject|0|||
23293517|NCT02056652|64815294|FG000|Overall Study|Lost to Follow-up|0|||
23293518|NCT02056652|64815295|FG001|Overall Study|Lost to Follow-up|3|||
23293519|NCT03702049|64815296|FG000|Overall Study|Lost to Follow-up|4|||
23293520|NCT03702049|64815296|FG000|Overall Study|Physician Decision|1|||
23293521|NCT01134627|64815297|FG000|Overall Study|Adverse Event|47|||
23386381|NCT01412983|65158660|FG000|1st Period|Ineligible|0|||
23386382|NCT01412983|65158661|FG001|1st Period|Ineligible|1|||
23493328|NCT00137631|65551450|FG001|Overall Study|Lost to Follow-up|41|||
23493329|NCT03082261|65551451|FG000|Overall Study|Death|4|||
23606090|NCT00614614|65947148|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
23606091|NCT00614614|65947149|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
23606092|NCT00614614|65947150|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
23606093|NCT00614614|65947151|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
23606094|NCT00614614|65947152|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
23606095|NCT00614614|65947148|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
23606096|NCT00614614|65947149|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
23606097|NCT00614614|65947150|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
23606098|NCT00614614|65947151|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
23606099|NCT00614614|65947152|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
23606100|NCT00614614|65947148|FG000|Primary Vaccination Phase|Protocol Violation|9|||
23606101|NCT00614614|65947149|FG001|Primary Vaccination Phase|Protocol Violation|3|||
23606102|NCT00614614|65947150|FG002|Primary Vaccination Phase|Protocol Violation|0|||
23606103|NCT00614614|65947151|FG003|Primary Vaccination Phase|Protocol Violation|0|||
23606104|NCT00614614|65947152|FG004|Primary Vaccination Phase|Protocol Violation|0|||
23606105|NCT00614614|65947148|FG000|Primary Vaccination Phase|Other|4|||
23606106|NCT00614614|65947149|FG001|Primary Vaccination Phase|Other|0|||
23606107|NCT00614614|65947150|FG002|Primary Vaccination Phase|Other|0|||
23606108|NCT00614614|65947151|FG003|Primary Vaccination Phase|Other|0|||
23606109|NCT00614614|65947152|FG004|Primary Vaccination Phase|Other|0|||
23606110|NCT00614614|65947148|FG000|Booster Vaccination Phase|Adverse Event|0|||
23606111|NCT00614614|65947149|FG001|Booster Vaccination Phase|Adverse Event|0|||
23606112|NCT00614614|65947150|FG002|Booster Vaccination Phase|Adverse Event|1|||
23606113|NCT00614614|65947151|FG003|Booster Vaccination Phase|Adverse Event|1|||
23293522|NCT01134627|64815298|FG001|Overall Study|Adverse Event|31|||
23293523|NCT01134627|64815297|FG000|Overall Study|Lost to Follow-up|1|||
23293524|NCT01134627|64815298|FG001|Overall Study|Lost to Follow-up|2|||
23293525|NCT01134627|64815297|FG000|Overall Study|Protocol Violation|3|||
23293526|NCT01134627|64815298|FG001|Overall Study|Protocol Violation|5|||
23293527|NCT01134627|64815297|FG000|Overall Study|Lack of Efficacy|2|||
23293528|NCT01134627|64815298|FG001|Overall Study|Lack of Efficacy|12|||
23293529|NCT01134627|64815297|FG000|Overall Study|Withdrawal by Subject|4|||
23293530|NCT01134627|64815298|FG001|Overall Study|Withdrawal by Subject|3|||
23293531|NCT01134627|64815297|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
23293532|NCT01134627|64815298|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
23293533|NCT01134627|64815297|FG000|Overall Study|Other|11|||
23293534|NCT01134627|64815298|FG001|Overall Study|Other|14|||
23293535|NCT02280187|64815299|FG000|Overall Study|Lost to Follow-up|218|||
23293536|NCT01231373|64815300|FG000|Overall Study|Withdrew consent prior to randomization|2|||
23293537|NCT01231373|64815301|FG001|Overall Study|Withdrew consent prior to randomization|1|||
23293538|NCT01231373|64815302|FG002|Overall Study|Withdrew consent prior to randomization|0|||
23293539|NCT01231373|64815303|FG003|Overall Study|Withdrew consent prior to randomization|0|||
23293540|NCT01231373|64815300|FG000|Overall Study|Lost to Follow-up|0|||
23293541|NCT01231373|64815301|FG001|Overall Study|Lost to Follow-up|0|||
23293542|NCT01231373|64815302|FG002|Overall Study|Lost to Follow-up|0|||
23293543|NCT01231373|64815303|FG003|Overall Study|Lost to Follow-up|1|||
23293544|NCT01231373|64815300|FG000|Overall Study|Withdrew Consent|1|||
23293545|NCT01231373|64815301|FG001|Overall Study|Withdrew Consent|0|||
23293546|NCT01231373|64815302|FG002|Overall Study|Withdrew Consent|0|||
23293547|NCT01231373|64815303|FG003|Overall Study|Withdrew Consent|0|||
23293548|NCT00508027|64815304|FG000|Dose Level 1|Lost to Follow-up|4|||
23293549|NCT00508027|64815304|FG000|Dose Level 1|Withdrawal by Subject|2|||
23293550|NCT00508027|64815304|FG000|Dose Level 1|Physician Decision|2|||
23293551|NCT00508027|64815304|FG000|Dose Level 2|Lost to Follow-up|2|||
23293552|NCT00508027|64815304|FG000|Dose Level 2|Withdrawal by Subject|2|||
23293553|NCT00108628|64815309|FG000|Overall Study|Withdrawal by Subject|17|||
23293554|NCT00108628|64815310|FG001|Overall Study|Withdrawal by Subject|9|||
23493330|NCT03082261|65551451|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
23493331|NCT03082261|65551451|FG000|Overall Study|Insurance denial|1|||
23493332|NCT03082261|65551451|FG000|Overall Study|Peripheral lead added|1|||
23493333|NCT03082261|65551451|FG000|Overall Study|Withdrawal by Subject|40|||
23493334|NCT03082261|65551451|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
23493335|NCT03082261|65551451|FG000|Overall Study|Subject implanted with device other than study device|1|||
23493336|NCT03082261|65551451|FG000|Overall Study|Lost to Follow-up|14|||
23493337|NCT03082261|65551451|FG000|Overall Study|Subject moved to a different state|1|||
23493338|NCT03082261|65551451|FG000|Overall Study|Subject non-compliance|2|||
23493339|NCT03082261|65551451|FG000|Overall Study|Subject participation terminated by investigator|9|||
23493340|NCT03082261|65551451|FG000|Overall Study|Subject participation terminated by sponsor|4|||
23493341|NCT03082261|65551451|FG000|Overall Study|System explant|19|||
23493342|NCT03082261|65551451|FG000|Overall Study|Unable to place lead(s)|2|||
23493343|NCT03082261|65551451|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
23493344|NCT00968864|65551452|FG000|Overall Study|Protocol exception/ not evaluable|1|||
23493345|NCT00631696|65551453|FG000|Overall Study|Entered, not randomized to treatment|1|||
23493346|NCT00631696|65551454|FG001|Overall Study|Entered, not randomized to treatment|1|||
23493347|NCT00631696|65551453|FG000|Overall Study|Discontinued after database release date|1|||
23493348|NCT00631696|65551454|FG001|Overall Study|Discontinued after database release date|0|||
23293555|NCT00108628|64815309|FG000|Overall Study|Lack of Efficacy|2|||
23293556|NCT00108628|64815310|FG001|Overall Study|Lack of Efficacy|1|||
23293557|NCT00108628|64815309|FG000|Overall Study|Death|1|||
23293558|NCT00108628|64815310|FG001|Overall Study|Death|0|||
23293559|NCT01517867|64815311|FG000|Overall Study|never started treatment|29|||
23293560|NCT01517867|64815312|FG001|Overall Study|never started treatment|32|||
23293561|NCT01517867|64815311|FG000|Overall Study|Withdrawal by Subject|34|||
23293562|NCT01517867|64815312|FG001|Overall Study|Withdrawal by Subject|30|||
23493349|NCT00631696|65551453|FG000|Overall Study|Follow up after database release date|1|||
23493350|NCT00631696|65551454|FG001|Overall Study|Follow up after database release date|0|||
23493351|NCT00631696|65551453|FG000|Overall Study|Lost to Follow-up|7|||
23493352|NCT00631696|65551454|FG001|Overall Study|Lost to Follow-up|10|||
23493353|NCT00631696|65551453|FG000|Overall Study|Withdrawal by Subject|2|||
23493354|NCT00631696|65551454|FG001|Overall Study|Withdrawal by Subject|9|||
23493355|NCT00631696|65551453|FG000|Overall Study|Other|8|||
23493356|NCT00631696|65551454|FG001|Overall Study|Other|8|||
23493357|NCT00631696|65551453|FG000|Overall Study|Protocol Violation|9|||
23493358|NCT00631696|65551454|FG001|Overall Study|Protocol Violation|9|||
23493359|NCT00631696|65551453|FG000|Overall Study|Study terminated by sponsor|3|||
23493360|NCT00631696|65551454|FG001|Overall Study|Study terminated by sponsor|3|||
23493361|NCT00631696|65551453|FG000|Overall Study|Adverse Event|5|||
23493362|NCT00631696|65551454|FG001|Overall Study|Adverse Event|0|||
23493363|NCT01560403|65551455|FG000|Overall Study|Lost to Follow-up|0|||
23493364|NCT01560403|65551456|FG001|Overall Study|Lost to Follow-up|1|||
23493365|NCT04622306|65551457|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
23493366|NCT04622306|65551458|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
23493367|NCT04622306|65551459|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
23493368|NCT04622306|65551460|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
23493369|NCT04622306|65551461|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
23493370|NCT04622306|65551462|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
23293563|NCT01517867|64815311|FG000|Overall Study|Still in treatment at study end|0|||
23293564|NCT01517867|64815312|FG001|Overall Study|Still in treatment at study end|3|||
23293565|NCT01717040|64815313|FG000|Overall Study|Lost to Follow-up|2|||
23293566|NCT01717040|64815314|FG001|Overall Study|Lost to Follow-up|3|||
23493371|NCT04622306|65551457|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
23493372|NCT04622306|65551458|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
23293567|NCT01717040|64815313|FG000|Overall Study|Lack of Efficacy|1|||
23293568|NCT01717040|64815314|FG001|Overall Study|Lack of Efficacy|1|||
23293569|NCT01717040|64815313|FG000|Overall Study|Adverse Event|1|||
23293570|NCT01717040|64815314|FG001|Overall Study|Adverse Event|0|||
23293571|NCT01717040|64815313|FG000|Overall Study|Required Medication Change|0|||
23293572|NCT01717040|64815314|FG001|Overall Study|Required Medication Change|1|||
23293573|NCT01717040|64815313|FG000|Overall Study|New Substance Use Disorder|1|||
23293574|NCT01717040|64815314|FG001|Overall Study|New Substance Use Disorder|0|||
23293575|NCT00546910|64815315|FG000|Overall Study|Adverse Event|2|||
23293576|NCT00546910|64815316|FG001|Overall Study|Adverse Event|3|||
23293577|NCT00546910|64815315|FG000|Overall Study|Lack of Efficacy|5|||
23293578|NCT00546910|64815316|FG001|Overall Study|Lack of Efficacy|7|||
23293579|NCT00546910|64815315|FG000|Overall Study|Physician Decision|0|||
23293580|NCT00546910|64815316|FG001|Overall Study|Physician Decision|1|||
23293581|NCT00546910|64815315|FG000|Overall Study|Withdrawal by Subject|2|||
23293582|NCT00546910|64815316|FG001|Overall Study|Withdrawal by Subject|0|||
23293583|NCT05317195|64815317|FG000|Randomization|Withdrawal by Subject|1|||
23293584|NCT05317195|64815317|FG000|Randomization|Discontinued|6|||
23293585|NCT05317195|64815317|FG000|Admission|Withdrawal by Subject|2|||
23293586|NCT03310619|64815319|FG000|Pre-Treatment Period|Death|1|||
23293587|NCT03310619|64815320|FG001|Pre-Treatment Period|Death|0|||
23293588|NCT03310619|64815321|FG002|Pre-Treatment Period|Death|0|||
23293589|NCT03310619|64815322|FG003|Pre-Treatment Period|Death|0|||
23293590|NCT03310619|64815323|FG004|Pre-Treatment Period|Death|1|||
23293591|NCT03310619|64815324|FG005|Pre-Treatment Period|Death|0|||
23293592|NCT03310619|64815325|FG006|Pre-Treatment Period|Death|0|||
23293593|NCT03310619|64815326|FG007|Pre-Treatment Period|Death|0|||
23293594|NCT03310619|64815319|FG000|Pre-Treatment Period|Other reasons|2|||
23293595|NCT03310619|64815320|FG001|Pre-Treatment Period|Other reasons|1|||
23293596|NCT03310619|64815321|FG002|Pre-Treatment Period|Other reasons|2|||
23293597|NCT03310619|64815322|FG003|Pre-Treatment Period|Other reasons|0|||
23293598|NCT03310619|64815323|FG004|Pre-Treatment Period|Other reasons|0|||
23293599|NCT03310619|64815324|FG005|Pre-Treatment Period|Other reasons|0|||
23293600|NCT03310619|64815325|FG006|Pre-Treatment Period|Other reasons|2|||
23293601|NCT03310619|64815326|FG007|Pre-Treatment Period|Other reasons|0|||
23293602|NCT03310619|64815319|FG000|Treatment Period|Death|1|||
23293603|NCT03310619|64815320|FG001|Treatment Period|Death|2|||
23293604|NCT03310619|64815321|FG002|Treatment Period|Death|0|||
23293605|NCT03310619|64815322|FG003|Treatment Period|Death|0|||
23293606|NCT03310619|64815323|FG004|Treatment Period|Death|1|||
23293607|NCT03310619|64815324|FG005|Treatment Period|Death|0|||
23293608|NCT03310619|64815325|FG006|Treatment Period|Death|2|||
23293609|NCT03310619|64815326|FG007|Treatment Period|Death|0|||
23293610|NCT03310619|64815319|FG000|Treatment Period|Adverse Event|0|||
23293611|NCT03310619|64815320|FG001|Treatment Period|Adverse Event|1|||
23293612|NCT03310619|64815321|FG002|Treatment Period|Adverse Event|4|||
23293613|NCT03310619|64815322|FG003|Treatment Period|Adverse Event|1|||
23293614|NCT03310619|64815323|FG004|Treatment Period|Adverse Event|0|||
23293615|NCT03310619|64815324|FG005|Treatment Period|Adverse Event|0|||
23293616|NCT03310619|64815325|FG006|Treatment Period|Adverse Event|0|||
23293617|NCT03310619|64815326|FG007|Treatment Period|Adverse Event|0|||
23293618|NCT03310619|64815319|FG000|Treatment Period|Withdrawal by participant|0|||
23293619|NCT03310619|64815320|FG001|Treatment Period|Withdrawal by participant|0|||
23293620|NCT03310619|64815321|FG002|Treatment Period|Withdrawal by participant|1|||
23293621|NCT03310619|64815322|FG003|Treatment Period|Withdrawal by participant|0|||
23293622|NCT03310619|64815323|FG004|Treatment Period|Withdrawal by participant|0|||
23293623|NCT03310619|64815324|FG005|Treatment Period|Withdrawal by participant|0|||
23293624|NCT03310619|64815325|FG006|Treatment Period|Withdrawal by participant|0|||
23293625|NCT03310619|64815326|FG007|Treatment Period|Withdrawal by participant|0|||
23293626|NCT03310619|64815319|FG000|Treatment Period|Lost to Follow-up|0|||
23293627|NCT03310619|64815320|FG001|Treatment Period|Lost to Follow-up|0|||
23293628|NCT03310619|64815321|FG002|Treatment Period|Lost to Follow-up|0|||
23293629|NCT03310619|64815322|FG003|Treatment Period|Lost to Follow-up|0|||
23293630|NCT03310619|64815323|FG004|Treatment Period|Lost to Follow-up|0|||
23293631|NCT03310619|64815324|FG005|Treatment Period|Lost to Follow-up|0|||
23293632|NCT03310619|64815325|FG006|Treatment Period|Lost to Follow-up|0|||
23293633|NCT03310619|64815326|FG007|Treatment Period|Lost to Follow-up|1|||
23293634|NCT03310619|64815319|FG000|Treatment Period|Study terminated by sponsor|0|||
23293635|NCT03310619|64815320|FG001|Treatment Period|Study terminated by sponsor|0|||
23293636|NCT03310619|64815321|FG002|Treatment Period|Study terminated by sponsor|0|||
23293637|NCT03310619|64815322|FG003|Treatment Period|Study terminated by sponsor|0|||
23293638|NCT03310619|64815323|FG004|Treatment Period|Study terminated by sponsor|0|||
23293639|NCT03310619|64815324|FG005|Treatment Period|Study terminated by sponsor|0|||
23293640|NCT03310619|64815325|FG006|Treatment Period|Study terminated by sponsor|0|||
23293641|NCT03310619|64815326|FG007|Treatment Period|Study terminated by sponsor|1|||
23293642|NCT03310619|64815319|FG000|Treatment Period|Physician Decision|0|||
23293643|NCT03310619|64815320|FG001|Treatment Period|Physician Decision|0|||
23293644|NCT03310619|64815321|FG002|Treatment Period|Physician Decision|0|||
23293645|NCT03310619|64815322|FG003|Treatment Period|Physician Decision|0|||
23293646|NCT03310619|64815323|FG004|Treatment Period|Physician Decision|3|||
23293647|NCT03310619|64815324|FG005|Treatment Period|Physician Decision|0|||
23293648|NCT03310619|64815325|FG006|Treatment Period|Physician Decision|0|||
23293649|NCT03310619|64815326|FG007|Treatment Period|Physician Decision|0|||
23293650|NCT03310619|64815319|FG000|Treatment Period|Other reasons|1|||
23293651|NCT03310619|64815320|FG001|Treatment Period|Other reasons|0|||
23293652|NCT03310619|64815321|FG002|Treatment Period|Other reasons|2|||
23293653|NCT03310619|64815322|FG003|Treatment Period|Other reasons|0|||
23293654|NCT03310619|64815323|FG004|Treatment Period|Other reasons|0|||
23293655|NCT03310619|64815324|FG005|Treatment Period|Other reasons|0|||
23293656|NCT03310619|64815325|FG006|Treatment Period|Other reasons|0|||
23293657|NCT03310619|64815326|FG007|Treatment Period|Other reasons|0|||
23293658|NCT01523587|64815327|FG000|Overall Study|Other than listed|5|||
23293659|NCT01523587|64815328|FG001|Overall Study|Other than listed|5|||
23293660|NCT01523587|64815327|FG000|Overall Study|Worsening of underlying cancer disease|19|||
23293661|NCT01523587|64815328|FG001|Overall Study|Worsening of underlying cancer disease|34|||
23293662|NCT01523587|64815327|FG000|Overall Study|Adverse Event|68|||
23293663|NCT01523587|64815328|FG001|Overall Study|Adverse Event|52|||
23293664|NCT01523587|64815327|FG000|Overall Study|Protocol Violation|5|||
23293665|NCT01523587|64815328|FG001|Overall Study|Protocol Violation|3|||
23293666|NCT01523587|64815327|FG000|Overall Study|Lost to Follow-up|2|||
23293667|NCT01523587|64815328|FG001|Overall Study|Lost to Follow-up|2|||
23293668|NCT01523587|64815327|FG000|Overall Study|Withdrawal by Subject|28|||
23293669|NCT01523587|64815328|FG001|Overall Study|Withdrawal by Subject|20|||
23293670|NCT01523587|64815327|FG000|Overall Study|Withdrew due to Progressive disease|265|||
23293671|NCT01523587|64815328|FG001|Overall Study|Withdrew due to Progressive disease|279|||
23293672|NCT01523587|64815327|FG000|Overall Study|Randomised but bot treated|6|||
23293673|NCT01523587|64815328|FG001|Overall Study|Randomised but bot treated|2|||
23293674|NCT00545688|64815329|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
23493373|NCT04622306|65551459|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
23493374|NCT04622306|65551460|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
23493375|NCT04622306|65551461|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
23493376|NCT04622306|65551462|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
23493377|NCT00722800|65551469|FG000|Overall Study|Withdrawal by Subject|1|||
23493378|NCT00722800|65551470|FG001|Overall Study|Withdrawal by Subject|0|||
23493379|NCT00722800|65551469|FG000|Overall Study|Physician Decision|1|||
23493380|NCT00722800|65551470|FG001|Overall Study|Physician Decision|0|||
23493381|NCT00788073|65551471|FG000|STX209 Then Placebo|Adverse Event|1|||
23493382|NCT00788073|65551472|FG001|STX209 Then Placebo|Adverse Event|0|||
23493383|NCT00788073|65551471|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
23493384|NCT00788073|65551472|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
23493385|NCT00788073|65551471|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
23493386|NCT00788073|65551472|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
23493387|NCT00788073|65551471|FG000|STX209 Then Placebo|unable to return due to travel|0|||
23493388|NCT00788073|65551472|FG001|STX209 Then Placebo|unable to return due to travel|1|||
23493389|NCT00788073|65551471|FG000|Placebo Then STX209|Adverse Event|2|||
23493390|NCT00788073|65551472|FG001|Placebo Then STX209|Adverse Event|0|||
23493391|NCT00788073|65551471|FG000|Placebo Then STX209|Protocol Violation|0|||
23493392|NCT00788073|65551472|FG001|Placebo Then STX209|Protocol Violation|1|||
23493393|NCT00285818|65551473|FG000|Overall Study|Withdrawal by Subject|3|||
23493394|NCT00285818|65551474|FG001|Overall Study|Withdrawal by Subject|2|||
23493395|NCT00285818|65551473|FG000|Overall Study|Lost to Follow-up|1|||
23493396|NCT00285818|65551474|FG001|Overall Study|Lost to Follow-up|0|||
23493397|NCT00723398|65551475|FG000|Overall Study|Withdrawal by Subject|2|||
23493398|NCT00723398|65551476|FG001|Overall Study|Withdrawal by Subject|6|||
23493399|NCT00723398|65551477|FG002|Overall Study|Withdrawal by Subject|4|||
23493400|NCT00723398|65551478|FG003|Overall Study|Withdrawal by Subject|4|||
23493401|NCT00723398|65551479|FG004|Overall Study|Withdrawal by Subject|4|||
23493402|NCT00723398|65551475|FG000|Overall Study|Protocol Violation|2|||
23493403|NCT00723398|65551476|FG001|Overall Study|Protocol Violation|1|||
23493404|NCT00723398|65551477|FG002|Overall Study|Protocol Violation|5|||
23493405|NCT00723398|65551478|FG003|Overall Study|Protocol Violation|0|||
23493406|NCT00723398|65551479|FG004|Overall Study|Protocol Violation|0|||
23493407|NCT00723398|65551475|FG000|Overall Study|Physician Decision|2|||
23493408|NCT00723398|65551476|FG001|Overall Study|Physician Decision|2|||
23493409|NCT00723398|65551477|FG002|Overall Study|Physician Decision|5|||
23493410|NCT00723398|65551478|FG003|Overall Study|Physician Decision|0|||
23493411|NCT00723398|65551479|FG004|Overall Study|Physician Decision|1|||
23493412|NCT00723398|65551475|FG000|Overall Study|Adverse Event|0|||
23493413|NCT00723398|65551476|FG001|Overall Study|Adverse Event|5|||
23493414|NCT00723398|65551477|FG002|Overall Study|Adverse Event|3|||
23493415|NCT00723398|65551478|FG003|Overall Study|Adverse Event|1|||
23493416|NCT00723398|65551479|FG004|Overall Study|Adverse Event|4|||
23493417|NCT00723398|65551475|FG000|Overall Study|Lost to Follow-up|0|||
23493418|NCT00723398|65551476|FG001|Overall Study|Lost to Follow-up|1|||
23493419|NCT00723398|65551477|FG002|Overall Study|Lost to Follow-up|0|||
23493420|NCT00723398|65551478|FG003|Overall Study|Lost to Follow-up|0|||
23493421|NCT00723398|65551479|FG004|Overall Study|Lost to Follow-up|0|||
23493422|NCT00691301|65551480|FG000|Overall Study|Adverse Event|10|||
23493423|NCT00691301|65551480|FG000|Overall Study|Death|2|||
23493424|NCT00691301|65551480|FG000|Overall Study|Lack of Efficacy|32|||
23493425|NCT00691301|65551480|FG000|Overall Study|Withdrawal by Subject|4|||
23493426|NCT00691301|65551480|FG000|Overall Study|Concurrent illness|2|||
23493427|NCT00691301|65551480|FG000|Overall Study|other reason|3|||
23293675|NCT00545688|64815330|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
23493428|NCT00691301|65551480|FG000|Overall Study|Did not initiate study treatment|1|||
23293676|NCT00545688|64815331|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
23293677|NCT00545688|64815332|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
23493429|NCT00257608|65551482|FG000|Chemotherapy Phase|Adverse Event|138|||
23493430|NCT00257608|65551483|FG001|Chemotherapy Phase|Adverse Event|0|||
23493431|NCT00257608|65551484|FG002|Chemotherapy Phase|Adverse Event|0|||
23493432|NCT00257608|65551482|FG000|Chemotherapy Phase|Disease progression|139|||
23493433|NCT00257608|65551483|FG001|Chemotherapy Phase|Disease progression|0|||
23493434|NCT00257608|65551484|FG002|Chemotherapy Phase|Disease progression|0|||
23493435|NCT00257608|65551482|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
23493436|NCT00257608|65551483|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
23293678|NCT00545688|64815329|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
23293679|NCT00545688|64815330|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
23293680|NCT00545688|64815331|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
23293681|NCT00545688|64815332|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
23293682|NCT00545688|64815329|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
23293683|NCT00545688|64815330|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
23293684|NCT00545688|64815331|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
23293685|NCT00545688|64815332|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
23293686|NCT00545688|64815329|FG000|Neo-Adjuvant Treatment Period|Death|0|||
23293687|NCT00545688|64815330|FG001|Neo-Adjuvant Treatment Period|Death|1|||
23293688|NCT00545688|64815331|FG002|Neo-Adjuvant Treatment Period|Death|0|||
23293689|NCT00545688|64815332|FG003|Neo-Adjuvant Treatment Period|Death|0|||
23293690|NCT00545688|64815329|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
23293691|NCT00545688|64815330|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
23293692|NCT00545688|64815331|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
23293693|NCT00545688|64815332|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
23293694|NCT00545688|64815329|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
23293695|NCT00545688|64815330|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
23493437|NCT00257608|65551484|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
23493438|NCT00257608|65551482|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
23493439|NCT00257608|65551483|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
23493440|NCT00257608|65551484|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
23493441|NCT00257608|65551482|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
23493442|NCT00257608|65551483|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
23493443|NCT00257608|65551484|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
23493444|NCT00257608|65551482|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
23293696|NCT00545688|64815331|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
23293697|NCT00545688|64815332|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
23493445|NCT00257608|65551483|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
23493446|NCT00257608|65551484|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
23493447|NCT00257608|65551482|FG000|Chemotherapy Phase|Physician Decision|28|||
23293698|NCT00545688|64815329|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
23493448|NCT00257608|65551483|FG001|Chemotherapy Phase|Physician Decision|0|||
23493449|NCT00257608|65551484|FG002|Chemotherapy Phase|Physician Decision|0|||
23493450|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Adverse Event|0|||
23493451|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Adverse Event|34|||
23493452|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Adverse Event|38|||
23493453|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Disease progression|0|||
23493454|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Disease progression|204|||
23493455|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Disease progression|168|||
23493456|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
23493457|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
23493458|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
23493459|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
23493460|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
23493461|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
23493462|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
23493463|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
23493464|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
23493465|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
23493466|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
23493467|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
23493468|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
23493469|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
23493470|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
23493471|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Physician Decision|0|||
23493472|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Physician Decision|8|||
23293699|NCT00545688|64815330|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
23293700|NCT00545688|64815331|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
23293701|NCT00545688|64815332|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
23293702|NCT00545688|64815329|FG000|Adjuvant Treatment Period|Disease Progression|3|||
23293703|NCT00545688|64815330|FG001|Adjuvant Treatment Period|Disease Progression|3|||
23293704|NCT00545688|64815331|FG002|Adjuvant Treatment Period|Disease Progression|0|||
23293705|NCT00545688|64815332|FG003|Adjuvant Treatment Period|Disease Progression|7|||
23293706|NCT00545688|64815329|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
23293707|NCT00545688|64815330|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
23293708|NCT00545688|64815331|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
23293709|NCT00545688|64815332|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
23293710|NCT00545688|64815329|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
23293711|NCT00545688|64815330|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
23293712|NCT00545688|64815331|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
23293713|NCT00545688|64815332|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
23293714|NCT00545688|64815329|FG000|Adjuvant Treatment Period|Adverse Event|0|||
23293715|NCT00545688|64815330|FG001|Adjuvant Treatment Period|Adverse Event|3|||
23493473|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Physician Decision|11|||
23293716|NCT00545688|64815331|FG002|Adjuvant Treatment Period|Adverse Event|2|||
23293717|NCT00545688|64815332|FG003|Adjuvant Treatment Period|Adverse Event|2|||
23293718|NCT00545688|64815329|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
23293719|NCT00545688|64815330|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
23493474|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
23493475|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
23493476|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
23293720|NCT00545688|64815331|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
23293721|NCT00545688|64815332|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
23293722|NCT00545688|64815329|FG000|Follow-Up Period|Death|4|||
23293723|NCT00545688|64815330|FG001|Follow-Up Period|Death|2|||
23293724|NCT00545688|64815331|FG002|Follow-Up Period|Death|2|||
23293725|NCT00545688|64815332|FG003|Follow-Up Period|Death|6|||
23293726|NCT00545688|64815329|FG000|Follow-Up Period|Disease Progression|6|||
23293727|NCT00545688|64815330|FG001|Follow-Up Period|Disease Progression|5|||
23293728|NCT00545688|64815331|FG002|Follow-Up Period|Disease Progression|9|||
23293729|NCT00545688|64815332|FG003|Follow-Up Period|Disease Progression|9|||
23293730|NCT00545688|64815329|FG000|Follow-Up Period|Refused Treatment|6|||
23293731|NCT00545688|64815330|FG001|Follow-Up Period|Refused Treatment|2|||
23293732|NCT00545688|64815331|FG002|Follow-Up Period|Refused Treatment|0|||
23293733|NCT00545688|64815332|FG003|Follow-Up Period|Refused Treatment|2|||
23293734|NCT00545688|64815329|FG000|Follow-Up Period|Lost to Follow-up|3|||
23293735|NCT00545688|64815330|FG001|Follow-Up Period|Lost to Follow-up|3|||
23293736|NCT00545688|64815331|FG002|Follow-Up Period|Lost to Follow-up|3|||
23293737|NCT00545688|64815332|FG003|Follow-Up Period|Lost to Follow-up|1|||
23293738|NCT00545688|64815329|FG000|Follow-Up Period|Unspecified Reason|2|||
23293739|NCT00545688|64815330|FG001|Follow-Up Period|Unspecified Reason|5|||
23293740|NCT00545688|64815331|FG002|Follow-Up Period|Unspecified Reason|6|||
23293741|NCT00545688|64815332|FG003|Follow-Up Period|Unspecified Reason|8|||
23293742|NCT00545688|64815329|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
23293743|NCT00545688|64815330|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
23293744|NCT00545688|64815331|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
23293745|NCT00545688|64815332|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
23293746|NCT02124902|64815333|FG000|Overall Study|Adverse Event|7|||
23293747|NCT02124902|64815334|FG001|Overall Study|Adverse Event|2|||
23493477|NCT00257608|65551482|FG000|Post Chemotherapy Phase|Not treated|0|||
23493478|NCT00257608|65551483|FG001|Post Chemotherapy Phase|Not treated|4|||
23493479|NCT00257608|65551484|FG002|Post Chemotherapy Phase|Not treated|7|||
23493480|NCT03417219|65551485|FG000|Overall Study|Lost to Follow-up|0|||
23493481|NCT03417219|65551486|FG001|Overall Study|Lost to Follow-up|3|||
23493482|NCT02349542|65551492|FG000|Overall Study|Withdrawal by Subject|5|||
23493483|NCT04154930|65551493|FG000|Overall Study|Withdrawal by Subject|15|||
23493484|NCT04154930|65551494|FG001|Overall Study|Withdrawal by Subject|6|||
23493485|NCT04154930|65551493|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
23493486|NCT04154930|65551494|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
23493487|NCT04154930|65551493|FG000|Overall Study|Lost to Follow-up|14|||
23493488|NCT04154930|65551494|FG001|Overall Study|Lost to Follow-up|6|||
23493489|NCT04154930|65551493|FG000|Overall Study|Other|6|||
23493490|NCT04154930|65551494|FG001|Overall Study|Other|0|||
23493491|NCT04195906|65551495|FG000|Part 1|Adverse Event|3|||
23493492|NCT04195906|65551496|FG001|Part 1|Adverse Event|7|||
23493493|NCT04195906|65551495|FG000|Part 1|Withdrawal by Subject|0|||
23493494|NCT04195906|65551496|FG001|Part 1|Withdrawal by Subject|1|||
23493495|NCT04195906|65551495|FG000|Part 2|Adverse Event|1|||
23493496|NCT04195906|65551496|FG001|Part 2|Adverse Event|1|||
23493497|NCT04195906|65551495|FG000|Part 2|Withdrawal by Subject|0|||
23493498|NCT04195906|65551496|FG001|Part 2|Withdrawal by Subject|3|||
23493499|NCT04195906|65551495|FG000|Part 2|Other|1|||
23493500|NCT04195906|65551496|FG001|Part 2|Other|3|||
23493501|NCT02476201|65551497|FG000|Overall Study|Unable to program MPP|9|||
23493502|NCT02476201|65551497|FG000|Overall Study|Study echo not performed|5|||
23493503|NCT02476201|65551497|FG000|Overall Study|Adverse Event|4|||
23493504|NCT02476201|65551497|FG000|Overall Study|Death|2|||
23493505|NCT02476201|65551497|FG000|Overall Study|Lost to Follow-up|2|||
23493506|NCT02476201|65551497|FG000|Overall Study|MPP programmed to OFF|2|||
23493507|NCT02476201|65551497|FG000|Overall Study|Withdrawal by Subject|1|||
23293748|NCT02124902|64815333|FG000|Overall Study|Went to alternative treatment|4|||
23293749|NCT02124902|64815334|FG001|Overall Study|Went to alternative treatment|0|||
23293750|NCT02124902|64815333|FG000|Overall Study|Withdrawal by Subject|2|||
23293751|NCT02124902|64815334|FG001|Overall Study|Withdrawal by Subject|1|||
23293752|NCT02124902|64815333|FG000|Overall Study|Physician Decision|2|||
23293753|NCT02124902|64815334|FG001|Overall Study|Physician Decision|0|||
23293754|NCT02124902|64815333|FG000|Overall Study|Not eligible|1|||
23493508|NCT02476201|65551497|FG000|Overall Study|Unsuccessful implant|1|||
23493509|NCT02486302|65551498|FG000|Overall Study|Discontinued prematurely|410|||
23493510|NCT02486302|65551498|FG000|Overall Study|Documentation not completed|255|||
23493511|NCT02486302|65551498|FG000|Overall Study|Excluded due to legal reasons|8|||
23293755|NCT02124902|64815334|FG001|Overall Study|Not eligible|0|||
23293756|NCT02124902|64815333|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
23293757|NCT02124902|64815334|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
23293758|NCT01117987|64815335|FG000|Overall Study|Protocol deviation|0|||
23293759|NCT01117987|64815336|FG001|Overall Study|Protocol deviation|1|||
23293760|NCT01117987|64815335|FG000|Overall Study|Subject no longer requires study drug|1|||
23293761|NCT01117987|64815336|FG001|Overall Study|Subject no longer requires study drug|0|||
23293762|NCT01117987|64815335|FG000|Overall Study|Lost to Follow-up|1|||
23293763|NCT01117987|64815336|FG001|Overall Study|Lost to Follow-up|1|||
23293764|NCT01117987|64815335|FG000|Overall Study|Abnormal test procedure result|2|||
23293765|NCT01117987|64815336|FG001|Overall Study|Abnormal test procedure result|0|||
23293766|NCT01117987|64815335|FG000|Overall Study|Lack of Efficacy|3|||
23293767|NCT01117987|64815336|FG001|Overall Study|Lack of Efficacy|4|||
23293768|NCT01117987|64815335|FG000|Overall Study|Death|5|||
23386383|NCT01412983|65158660|FG000|1st Period|Positive slit lamp finding|0|||
23386384|NCT01412983|65158661|FG001|1st Period|Positive slit lamp finding|1|||
23386385|NCT01412983|65158660|FG000|1st Period|Unacceptable lens movement|0|||
23386386|NCT01412983|65158661|FG001|1st Period|Unacceptable lens movement|1|||
23386387|NCT01412983|65158660|FG000|1st Period|Inability to maintain wear|0|||
23386388|NCT01412983|65158661|FG001|1st Period|Inability to maintain wear|1|||
23493512|NCT02486302|65551498|FG000|Overall Study|Not treated|3|||
23293769|NCT01117987|64815336|FG001|Overall Study|Death|10|||
23293770|NCT01117987|64815335|FG000|Overall Study|Withdrawal by Subject|5|||
23493513|NCT03330288|65551499|FG000|Overall Study|Other reason|1|||
23293771|NCT01117987|64815336|FG001|Overall Study|Withdrawal by Subject|10|||
23386389|NCT02636283|65158663|FG000|Overall Study|Adverse Event|2|||
23386390|NCT02636283|65158664|FG001|Overall Study|Adverse Event|0|||
23386391|NCT02636283|65158663|FG000|Overall Study|Trial Terminated Prematurely|0|||
23386392|NCT02636283|65158664|FG001|Overall Study|Trial Terminated Prematurely|3|||
23386393|NCT01441414|65158665|FG000|Overall Study|Participant died|9|||
23386394|NCT01441414|65158665|FG000|Overall Study|Other reasons|3|||
23386395|NCT01441414|65158665|FG000|Overall Study|Study terminated by sponsor|2|||
23493514|NCT03330288|65551500|FG001|Overall Study|Other reason|1|||
23386396|NCT01441414|65158665|FG000|Overall Study|Subject refused further follow-up|1|||
23386397|NCT05059080|65158666|FG000|Overall Study|Withdrawal by Subject|3|||
23386398|NCT05059080|65158666|FG000|Overall Study|Study Terminated by Sponsor|64|||
23386399|NCT04648241|65158669|FG000|Overall Study|Lost to Follow-up|1|||
23386400|NCT04648241|65158670|FG001|Overall Study|Lost to Follow-up|0|||
23386401|NCT01160744|65158671|FG000|Overall Study|Withdrawal by Subject|11|||
23386402|NCT01160744|65158672|FG001|Overall Study|Withdrawal by Subject|5|||
23386403|NCT01160744|65158673|FG002|Overall Study|Withdrawal by Subject|6|||
23386404|NCT01160744|65158674|FG003|Overall Study|Withdrawal by Subject|4|||
23386405|NCT01160744|65158671|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
23386406|NCT01160744|65158672|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
23386407|NCT01160744|65158673|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
23386408|NCT01160744|65158674|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
23386409|NCT00471107|65158675|FG000|Overall Study|Technical problems/data loss|3|||
23386410|NCT00471107|65158676|FG001|Overall Study|Technical problems/data loss|1|||
23386411|NCT00471107|65158677|FG002|Overall Study|Technical problems/data loss|3|||
23386412|NCT00303628|65158678|FG000|Overall Study|Disease progression|0|||
23386413|NCT00303628|65158679|FG001|Overall Study|Disease progression|1|||
23386414|NCT00303628|65158678|FG000|Overall Study|Adverse Event|26|||
23386415|NCT00303628|65158679|FG001|Overall Study|Adverse Event|36|||
23386416|NCT00303628|65158678|FG000|Overall Study|Death|0|||
23386417|NCT00303628|65158679|FG001|Overall Study|Death|1|||
23386418|NCT00303628|65158678|FG000|Overall Study|Withdrawal by Subject|11|||
23386419|NCT00303628|65158679|FG001|Overall Study|Withdrawal by Subject|20|||
23386420|NCT00303628|65158678|FG000|Overall Study|Alternative therapy|2|||
23386421|NCT00303628|65158679|FG001|Overall Study|Alternative therapy|0|||
23386422|NCT00303628|65158678|FG000|Overall Study|Other complicating disease|0|||
23386423|NCT00303628|65158679|FG001|Overall Study|Other complicating disease|1|||
23386424|NCT00303628|65158678|FG000|Overall Study|Not start protocol therapy|3|||
23386425|NCT00303628|65158679|FG001|Overall Study|Not start protocol therapy|5|||
23386426|NCT00303628|65158678|FG000|Overall Study|Other|8|||
23386427|NCT00303628|65158679|FG001|Overall Study|Other|9|||
23386428|NCT02441114|65158680|FG000|Washout2|Withdrawal by Subject|4|||
23493515|NCT03330288|65551499|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
23493516|NCT03330288|65551500|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
23493517|NCT03330288|65551499|FG000|Overall Study|Adverse Event|1|||
23493518|NCT03330288|65551500|FG001|Overall Study|Adverse Event|0|||
23493519|NCT03330288|65551499|FG000|Overall Study|Withdrawal by Subject|1|||
23493520|NCT03330288|65551500|FG001|Overall Study|Withdrawal by Subject|0|||
23493521|NCT03330288|65551499|FG000|Overall Study|Lost to Follow-up|26|||
23493522|NCT03330288|65551500|FG001|Overall Study|Lost to Follow-up|7|||
23386429|NCT02366130|65158681|FG000|Overall Study|Withdrawal by Subject|3|||
23386430|NCT02366130|65158681|FG000|Overall Study|Ineligible|6|||
23386431|NCT03158311|65158682|FG000|Overall Study|Subject/Guardian Decision|10|||
23493523|NCT03953820|65551501|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
23493524|NCT03953820|65551502|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
23493525|NCT03953820|65551503|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
23493526|NCT03953820|65551501|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
23493527|NCT03953820|65551502|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
23493528|NCT03953820|65551503|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
23493529|NCT03896165|65551506|FG000|Overall Study|Withdrawal by Subject|2|||
23493530|NCT00066729|65551507|FG000|Overall Study|Lost to Follow-up|1|||
23493531|NCT00066729|65551507|FG000|Overall Study|Disease progression|1|||
23493532|NCT01938573|65551508|FG000|Overall Study|Lack of Efficacy|1|||
23493533|NCT01938573|65551509|FG001|Overall Study|Lack of Efficacy|0|||
23493534|NCT01938573|65551508|FG000|Overall Study|Operation at other hospital|1|||
23386432|NCT03158311|65158683|FG001|Overall Study|Subject/Guardian Decision|6|||
23386433|NCT03158311|65158684|FG002|Overall Study|Subject/Guardian Decision|11|||
23386434|NCT03158311|65158682|FG000|Overall Study|Adverse Event|5|||
23386435|NCT03158311|65158683|FG001|Overall Study|Adverse Event|3|||
23386436|NCT03158311|65158684|FG002|Overall Study|Adverse Event|3|||
23386437|NCT03158311|65158682|FG000|Overall Study|Techinical Problems|3|||
23493535|NCT01938573|65551509|FG001|Overall Study|Operation at other hospital|0|||
23493536|NCT00181155|65551510|FG000|Overall Study|Physician Decision|1|||
23493537|NCT00181155|65551511|FG001|Overall Study|Physician Decision|0|||
23493538|NCT00181155|65551510|FG000|Overall Study|Withdrawal by Subject|1|||
23493539|NCT00181155|65551511|FG001|Overall Study|Withdrawal by Subject|0|||
23293772|NCT01117987|64815335|FG000|Overall Study|Adverse Event|19|||
23293773|NCT01117987|64815336|FG001|Overall Study|Adverse Event|26|||
23293774|NCT01117987|64815335|FG000|Overall Study|Administrative problems|25|||
23293775|NCT01117987|64815336|FG001|Overall Study|Administrative problems|22|||
23293776|NCT01867606|64815337|FG000|Overall Study|Withdrawal by Subject|10|||
23293777|NCT01867606|64815338|FG001|Overall Study|Withdrawal by Subject|14|||
23386438|NCT03158311|65158683|FG001|Overall Study|Techinical Problems|1|||
23386439|NCT03158311|65158684|FG002|Overall Study|Techinical Problems|5|||
23386440|NCT03158311|65158682|FG000|Overall Study|Physician Decision|2|||
23386441|NCT03158311|65158683|FG001|Overall Study|Physician Decision|3|||
23386442|NCT03158311|65158684|FG002|Overall Study|Physician Decision|7|||
23386443|NCT03158311|65158682|FG000|Overall Study|Lost to Follow-up|1|||
23386444|NCT03158311|65158683|FG001|Overall Study|Lost to Follow-up|1|||
23386445|NCT03158311|65158684|FG002|Overall Study|Lost to Follow-up|1|||
23386446|NCT03158311|65158682|FG000|Overall Study|Sponsor decision|1|||
23386447|NCT03158311|65158683|FG001|Overall Study|Sponsor decision|0|||
23386448|NCT03158311|65158684|FG002|Overall Study|Sponsor decision|0|||
23386449|NCT03158311|65158682|FG000|Overall Study|Pregnancy|0|||
23386450|NCT03158311|65158683|FG001|Overall Study|Pregnancy|2|||
23493540|NCT00239590|65551514|FG000|Randomized|Lost to Follow-up|0|||
23493541|NCT00239590|65551515|FG001|Randomized|Lost to Follow-up|1|||
23493542|NCT00239590|65551514|FG000|Randomized|Withdrawal by Subject|0|||
23493543|NCT00239590|65551515|FG001|Randomized|Withdrawal by Subject|1|||
23493544|NCT00239590|65551514|FG000|Completed Study Protocol|Adverse Event|1|||
23493545|NCT00239590|65551515|FG001|Completed Study Protocol|Adverse Event|1|||
23493546|NCT00239590|65551514|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
23493547|NCT00239590|65551515|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
23493548|NCT02906332|65551516|FG000|Overall Study|Withdrawal by Subject|1|||
23493549|NCT02949700|65551523|FG000|Phase I|Withdrawal by Subject|1|||
23386451|NCT03158311|65158684|FG002|Overall Study|Pregnancy|0|||
23386452|NCT03158311|65158682|FG000|Overall Study|Randomized in error|0|||
23386453|NCT03158311|65158683|FG001|Overall Study|Randomized in error|0|||
23386454|NCT03158311|65158684|FG002|Overall Study|Randomized in error|1|||
23386455|NCT00758043|65158685|FG000|Overall Study|Adverse Event|1|||
23386456|NCT00758043|65158686|FG001|Overall Study|Adverse Event|20|||
23386457|NCT00758043|65158687|FG002|Overall Study|Adverse Event|12|||
23493550|NCT02949700|65551524|FG001|Phase I|Withdrawal by Subject|1|||
23386458|NCT00758043|65158688|FG003|Overall Study|Adverse Event|62|||
23386459|NCT00758043|65158685|FG000|Overall Study|Lack of Efficacy|0|||
23386460|NCT00758043|65158686|FG001|Overall Study|Lack of Efficacy|6|||
23386461|NCT00758043|65158687|FG002|Overall Study|Lack of Efficacy|18|||
23386462|NCT00758043|65158688|FG003|Overall Study|Lack of Efficacy|12|||
23293778|NCT01867606|64815337|FG000|Overall Study|Protocol Violation|0|||
23386463|NCT00758043|65158685|FG000|Overall Study|Refused Further Treatment|0|||
23386464|NCT00758043|65158686|FG001|Overall Study|Refused Further Treatment|11|||
23386465|NCT00758043|65158687|FG002|Overall Study|Refused Further Treatment|5|||
23386466|NCT00758043|65158688|FG003|Overall Study|Refused Further Treatment|8|||
23386467|NCT00758043|65158685|FG000|Overall Study|Lost to Follow-up|0|||
23386468|NCT00758043|65158686|FG001|Overall Study|Lost to Follow-up|2|||
23386469|NCT00758043|65158687|FG002|Overall Study|Lost to Follow-up|2|||
23493551|NCT02949700|65551525|FG002|Phase I|Withdrawal by Subject|0|||
23493552|NCT02949700|65551526|FG003|Phase I|Withdrawal by Subject|0|||
23493553|NCT02949700|65551523|FG000|Phase I|Protocol Violation|1|||
23493554|NCT02949700|65551524|FG001|Phase I|Protocol Violation|0|||
23493555|NCT02949700|65551525|FG002|Phase I|Protocol Violation|0|||
23293779|NCT01867606|64815338|FG001|Overall Study|Protocol Violation|1|||
23293780|NCT01315028|64815339|FG000|Overall Study|Lost to Follow-up|1|||
23293781|NCT01315028|64815340|FG001|Overall Study|Lost to Follow-up|0|||
23293782|NCT01315028|64815339|FG000|Overall Study|Death|0|||
23293783|NCT01315028|64815340|FG001|Overall Study|Death|1|||
23293784|NCT01894230|64815343|FG000|Overall Study|Lost to Follow-up|2|||
23293785|NCT01894230|64815344|FG001|Overall Study|Lost to Follow-up|2|||
23293786|NCT01894230|64815343|FG000|Overall Study|Withdrawal by Subject|4|||
23293787|NCT01894230|64815344|FG001|Overall Study|Withdrawal by Subject|4|||
23293788|NCT01894230|64815343|FG000|Overall Study|Non-adherent|0|||
23293789|NCT01894230|64815344|FG001|Overall Study|Non-adherent|1|||
23293790|NCT01894230|64815343|FG000|Overall Study|Death|1|||
23293791|NCT01894230|64815344|FG001|Overall Study|Death|0|||
23293792|NCT00063258|64815355|FG000|Overall Study|Physician Decision|2|||
23293793|NCT00063258|64815356|FG001|Overall Study|Physician Decision|0|||
23293794|NCT00063258|64815355|FG000|Overall Study|Lack of Efficacy|2|||
23293795|NCT00063258|64815356|FG001|Overall Study|Lack of Efficacy|0|||
23293796|NCT02297841|64815357|FG000|Overall Study|Withdrawal by Subject|1|||
23293797|NCT02297841|64815357|FG000|Overall Study|Protocol Violation|7|||
23293798|NCT04252287|64815358|FG000|Overall Study|Death|5|||
23293799|NCT04252287|64815359|FG001|Overall Study|Death|3|||
23493556|NCT02949700|65551526|FG003|Phase I|Protocol Violation|0|||
23493557|NCT02949700|65551523|FG000|Phase II|Withdrawal by Subject|0|||
23493558|NCT02949700|65551524|FG001|Phase II|Withdrawal by Subject|0|||
23493559|NCT02949700|65551525|FG002|Phase II|Withdrawal by Subject|0|||
23493560|NCT02949700|65551526|FG003|Phase II|Withdrawal by Subject|2|||
23493561|NCT02949700|65551523|FG000|Phase II|Protocol Violation|0|||
23493562|NCT02949700|65551524|FG001|Phase II|Protocol Violation|0|||
23293800|NCT04252287|64815358|FG000|Overall Study|Lost to Follow-up|4|||
23493563|NCT02949700|65551525|FG002|Phase II|Protocol Violation|1|||
23493564|NCT02949700|65551526|FG003|Phase II|Protocol Violation|3|||
23293801|NCT04252287|64815359|FG001|Overall Study|Lost to Follow-up|6|||
23493565|NCT02716805|65551531|FG000|Overall Study|Progressive disease|2|||
23493566|NCT02716805|65551532|FG001|Overall Study|Progressive disease|0|||
23293802|NCT04252287|64815358|FG000|Overall Study|Withdrawal by Subject|19|||
23293803|NCT04252287|64815359|FG001|Overall Study|Withdrawal by Subject|16|||
23293804|NCT04252287|64815358|FG000|Overall Study|Protocol Violation|3|||
23293805|NCT04252287|64815359|FG001|Overall Study|Protocol Violation|4|||
23293806|NCT01355302|64815362|FG000|Phase 1b|Death|4|||
23293807|NCT01355302|64815363|FG001|Phase 1b|Death|0|||
23386470|NCT00758043|65158688|FG003|Overall Study|Lost to Follow-up|5|||
23386471|NCT00758043|65158685|FG000|Overall Study|Withdrawal by Subject|0|||
23293808|NCT01355302|64815364|FG002|Phase 1b|Death|0|||
23293809|NCT01355302|64815362|FG000|Phase 1b|Study terminated by sponsor|2|||
23293810|NCT01355302|64815363|FG001|Phase 1b|Study terminated by sponsor|0|||
23293811|NCT01355302|64815364|FG002|Phase 1b|Study terminated by sponsor|0|||
23293812|NCT02260635|64815366|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
23293813|NCT02260635|64815367|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
23293814|NCT02260635|64815366|FG000|Open-Label Extension|Study Termination|25|||
23293815|NCT02260635|64815367|FG001|Open-Label Extension|Study Termination|25|||
23293816|NCT02260635|64815366|FG000|Open-Label Extension|Withdrawal by Subject|1|||
23293817|NCT02260635|64815367|FG001|Open-Label Extension|Withdrawal by Subject|0|||
23293818|NCT01363011|64815368|FG000|Main Study|Adverse Event|2|||
23293819|NCT01363011|64815369|FG001|Main Study|Adverse Event|3|||
23293820|NCT01363011|64815368|FG000|Main Study|Investigator's Discretion|1|||
23293821|NCT01363011|64815369|FG001|Main Study|Investigator's Discretion|1|||
23293822|NCT01363011|64815368|FG000|Main Study|Withdrew Consent|1|||
23293823|NCT01363011|64815369|FG001|Main Study|Withdrew Consent|4|||
23293824|NCT01363011|64815368|FG000|Main Study|Protocol Violation|0|||
23293825|NCT01363011|64815369|FG001|Main Study|Protocol Violation|1|||
23293826|NCT01363011|64815368|FG000|Extension Phase|Adverse Event|1|||
23293827|NCT01363011|64815369|FG001|Extension Phase|Adverse Event|1|||
23293828|NCT01363011|64815368|FG000|Extension Phase|Lack of Efficacy|0|||
23293829|NCT01363011|64815369|FG001|Extension Phase|Lack of Efficacy|1|||
23293830|NCT01363011|64815368|FG000|Extension Phase|Investigator's Discretion|2|||
23293831|NCT01363011|64815369|FG001|Extension Phase|Investigator's Discretion|2|||
23293832|NCT01363011|64815368|FG000|Extension Phase|Withdrew Consent|0|||
23293833|NCT01363011|64815369|FG001|Extension Phase|Withdrew Consent|1|||
23293834|NCT01363011|64815368|FG000|Extension Phase|Lost to Follow-up|0|||
23293835|NCT01363011|64815369|FG001|Extension Phase|Lost to Follow-up|2|||
23293836|NCT01363011|64815368|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
23293837|NCT01363011|64815369|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
23293838|NCT02522780|64815382|FG000|Overall Study|Consent withdrawn by subject|5|||
23293839|NCT02522780|64815383|FG001|Overall Study|Consent withdrawn by subject|7|||
23293840|NCT02522780|64815382|FG000|Overall Study|Protocol deviation|1|||
23293841|NCT02522780|64815383|FG001|Overall Study|Protocol deviation|3|||
23293842|NCT02522780|64815382|FG000|Overall Study|Subject refused endoscopic procedure|0|||
23293843|NCT02522780|64815383|FG001|Overall Study|Subject refused endoscopic procedure|1|||
23293844|NCT02522780|64815382|FG000|Overall Study|Adverse event, non-fatal|11|||
23293845|NCT02522780|64815383|FG001|Overall Study|Adverse event, non-fatal|16|||
23293846|NCT04980456|64815386|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
23293847|NCT04980456|64815387|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
23293848|NCT04980456|64815386|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
23293849|NCT04980456|64815387|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
23293850|NCT04980456|64815386|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
23293851|NCT04980456|64815387|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
23293852|NCT04980456|64815386|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
23293853|NCT04980456|64815387|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
23293854|NCT02408120|64815391|FG000|Overall Study|Withdrawal by Subject|0|||
23293855|NCT02408120|64815392|FG001|Overall Study|Withdrawal by Subject|1|||
23293856|NCT02408120|64815391|FG000|Overall Study|Treatment Refusal|1|||
23293857|NCT02408120|64815392|FG001|Overall Study|Treatment Refusal|0|||
23293858|NCT02408120|64815391|FG000|Overall Study|Received Steroids|1|||
23293859|NCT02408120|64815392|FG001|Overall Study|Received Steroids|1|||
23293860|NCT02408120|64815391|FG000|Overall Study|Discharged same day|1|||
23293861|NCT02408120|64815392|FG001|Overall Study|Discharged same day|1|||
23293862|NCT02408120|64815391|FG000|Overall Study|Did not receive insulin|1|||
23293863|NCT02408120|64815392|FG001|Overall Study|Did not receive insulin|2|||
23293864|NCT00529217|64815393|FG000|Overall Study|Lack of Efficacy|2|||
23293865|NCT00529217|64815393|FG000|Overall Study|Unable to adhere to study schedule|2|||
23293866|NCT01841073|64815394|FG000|Overall Study|Adverse Event|1|||
23293867|NCT01841073|64815395|FG001|Overall Study|Adverse Event|1|||
23293868|NCT01841073|64815394|FG000|Overall Study|Physician Decision|1|||
23293869|NCT01841073|64815395|FG001|Overall Study|Physician Decision|0|||
23293870|NCT01841073|64815394|FG000|Overall Study|Lost to Follow-up|0|||
23293871|NCT01841073|64815395|FG001|Overall Study|Lost to Follow-up|2|||
23293872|NCT01235442|64815396|FG000|Overall Study|Lost to Follow-up|12|||
23293873|NCT01235442|64815397|FG001|Overall Study|Lost to Follow-up|10|||
23493567|NCT02716805|65551533|FG002|Overall Study|Progressive disease|0|||
23293874|NCT01235442|64815396|FG000|Overall Study|Death|0|||
23493568|NCT02716805|65551534|FG003|Overall Study|Progressive disease|0|||
23493569|NCT04729621|65551543|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
23493570|NCT04729621|65551544|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
23493571|NCT04729621|65551545|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
23493572|NCT04729621|65551546|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
23493573|NCT04729621|65551547|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
23493574|NCT04729621|65551543|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
23493575|NCT04729621|65551544|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
23493576|NCT04729621|65551545|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
23493577|NCT04729621|65551546|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
23493578|NCT04729621|65551547|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
23493579|NCT04729621|65551543|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
23493580|NCT04729621|65551544|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
23493581|NCT04729621|65551545|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
23493582|NCT04729621|65551546|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
23493583|NCT04729621|65551547|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
23493584|NCT04729621|65551543|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23493585|NCT04729621|65551544|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
23493586|NCT04729621|65551545|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
23493587|NCT04729621|65551546|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
23293875|NCT01235442|64815397|FG001|Overall Study|Death|2|||
23293876|NCT01235442|64815396|FG000|Overall Study|Pregnancy|1|||
23293877|NCT01235442|64815397|FG001|Overall Study|Pregnancy|1|||
23293878|NCT01235442|64815396|FG000|Overall Study|Ineligibility determined|5|||
23293879|NCT01235442|64815397|FG001|Overall Study|Ineligibility determined|4|||
23293880|NCT01235442|64815396|FG000|Overall Study|Protocol Violation|3|||
23293881|NCT01235442|64815397|FG001|Overall Study|Protocol Violation|3|||
23293882|NCT01235442|64815396|FG000|Overall Study|Adverse Event|4|||
23293883|NCT01235442|64815397|FG001|Overall Study|Adverse Event|6|||
23293884|NCT01235442|64815396|FG000|Overall Study|Withdrawal by Subject|15|||
23386472|NCT00758043|65158686|FG001|Overall Study|Withdrawal by Subject|1|||
23293885|NCT01235442|64815397|FG001|Overall Study|Withdrawal by Subject|9|||
23293886|NCT01235442|64815396|FG000|Overall Study|Lack of Efficacy|1|||
23293887|NCT01235442|64815397|FG001|Overall Study|Lack of Efficacy|3|||
23293888|NCT01235442|64815396|FG000|Overall Study|Noncompliance|1|||
23293889|NCT01235442|64815397|FG001|Overall Study|Noncompliance|2|||
23293890|NCT01235442|64815396|FG000|Overall Study|Administrative decision|1|||
23293891|NCT01235442|64815397|FG001|Overall Study|Administrative decision|2|||
23293892|NCT01235442|64815396|FG000|Overall Study|Other unspecified|1|||
23293893|NCT01235442|64815397|FG001|Overall Study|Other unspecified|2|||
23293894|NCT03078478|64815398|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
23293895|NCT03078478|64815399|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
23293896|NCT03078478|64815398|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
23293897|NCT03078478|64815399|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
23293898|NCT03078478|64815398|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
23293899|NCT03078478|64815399|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
23293900|NCT03078478|64815398|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
23293901|NCT03078478|64815399|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
23293902|NCT03078478|64815398|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
23293903|NCT03078478|64815399|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
23293904|NCT03078478|64815398|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
23293905|NCT03078478|64815399|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
23293906|NCT03078478|64815398|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
23293907|NCT03078478|64815399|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
23293908|NCT03078478|64815398|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
23293909|NCT03078478|64815399|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
23293910|NCT00035555|64815400|FG000|Overall Study|Adverse Event|5|||
23293911|NCT00035555|64815401|FG001|Overall Study|Adverse Event|8|||
23293912|NCT00035555|64815402|FG002|Overall Study|Adverse Event|9|||
23293913|NCT00035555|64815400|FG000|Overall Study|Allograft loss|1|||
23293914|NCT00035555|64815401|FG001|Overall Study|Allograft loss|1|||
23293915|NCT00035555|64815402|FG002|Overall Study|Allograft loss|2|||
23293916|NCT00035555|64815400|FG000|Overall Study|Death|0|||
23293917|NCT00035555|64815401|FG001|Overall Study|Death|0|||
23293918|NCT00035555|64815402|FG002|Overall Study|Death|2|||
23293919|NCT00035555|64815400|FG000|Overall Study|Lost to Follow-up|0|||
23293920|NCT00035555|64815401|FG001|Overall Study|Lost to Follow-up|0|||
23293921|NCT00035555|64815402|FG002|Overall Study|Lost to Follow-up|1|||
23293922|NCT00035555|64815400|FG000|Overall Study|Noncompliance|0|||
23293923|NCT00035555|64815401|FG001|Overall Study|Noncompliance|1|||
23293924|NCT00035555|64815402|FG002|Overall Study|Noncompliance|1|||
23293925|NCT00035555|64815400|FG000|Overall Study|Prohibited medication|1|||
23293926|NCT00035555|64815401|FG001|Overall Study|Prohibited medication|1|||
23293927|NCT00035555|64815402|FG002|Overall Study|Prohibited medication|0|||
23293928|NCT00035555|64815400|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
23386473|NCT00758043|65158687|FG002|Overall Study|Withdrawal by Subject|1|||
23293929|NCT00035555|64815401|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
23386474|NCT00758043|65158688|FG003|Overall Study|Withdrawal by Subject|4|||
23493588|NCT04729621|65551547|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
23493589|NCT04729621|65551543|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
23493590|NCT04729621|65551544|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
23493591|NCT04729621|65551545|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
23493592|NCT04729621|65551546|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
23493593|NCT04729621|65551547|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
23493594|NCT04729621|65551543|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
23493595|NCT04729621|65551544|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
23493596|NCT04729621|65551545|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
23293930|NCT00035555|64815402|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
23293931|NCT00035555|64815400|FG000|Overall Study|Withdrawal by Subject|2|||
23493597|NCT04729621|65551546|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
23493598|NCT04729621|65551547|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
23493599|NCT00734474|65551548|FG000|Overall Study|Entry Criteria Not Met|0|||
23493600|NCT00734474|65551549|FG001|Overall Study|Entry Criteria Not Met|0|||
23493601|NCT00734474|65551550|FG002|Overall Study|Entry Criteria Not Met|5|||
23493602|NCT00734474|65551551|FG003|Overall Study|Entry Criteria Not Met|0|||
23493603|NCT00734474|65551552|FG004|Overall Study|Entry Criteria Not Met|3|||
23493604|NCT00734474|65551553|FG005|Overall Study|Entry Criteria Not Met|1|||
23493605|NCT00734474|65551554|FG006|Overall Study|Entry Criteria Not Met|0|||
23493606|NCT00734474|65551555|FG007|Overall Study|Entry Criteria Not Met|1|||
23493607|NCT00734474|65551556|FG008|Overall Study|Entry Criteria Not Met|1|||
23493608|NCT00734474|65551548|FG000|Overall Study|Lost to Follow-up|1|||
23493609|NCT00734474|65551549|FG001|Overall Study|Lost to Follow-up|0|||
23493610|NCT00734474|65551550|FG002|Overall Study|Lost to Follow-up|13|||
23493611|NCT00734474|65551551|FG003|Overall Study|Lost to Follow-up|0|||
23493612|NCT00734474|65551552|FG004|Overall Study|Lost to Follow-up|11|||
23493613|NCT00734474|65551553|FG005|Overall Study|Lost to Follow-up|1|||
23493614|NCT00734474|65551554|FG006|Overall Study|Lost to Follow-up|0|||
23493615|NCT00734474|65551555|FG007|Overall Study|Lost to Follow-up|9|||
23493616|NCT00734474|65551556|FG008|Overall Study|Lost to Follow-up|4|||
23493617|NCT00734474|65551548|FG000|Overall Study|Withdrawal by Subject|2|||
23493618|NCT00734474|65551549|FG001|Overall Study|Withdrawal by Subject|1|||
23493619|NCT00734474|65551550|FG002|Overall Study|Withdrawal by Subject|18|||
23493620|NCT00734474|65551551|FG003|Overall Study|Withdrawal by Subject|0|||
23493621|NCT00734474|65551552|FG004|Overall Study|Withdrawal by Subject|24|||
23493622|NCT00734474|65551553|FG005|Overall Study|Withdrawal by Subject|2|||
23493623|NCT00734474|65551554|FG006|Overall Study|Withdrawal by Subject|0|||
23493624|NCT00734474|65551555|FG007|Overall Study|Withdrawal by Subject|36|||
23493625|NCT00734474|65551556|FG008|Overall Study|Withdrawal by Subject|21|||
23493626|NCT00734474|65551548|FG000|Overall Study|Physician Decision|0|||
23493627|NCT00734474|65551549|FG001|Overall Study|Physician Decision|0|||
23493628|NCT00734474|65551550|FG002|Overall Study|Physician Decision|4|||
23493629|NCT00734474|65551551|FG003|Overall Study|Physician Decision|1|||
23493630|NCT00734474|65551552|FG004|Overall Study|Physician Decision|11|||
23493631|NCT00734474|65551553|FG005|Overall Study|Physician Decision|0|||
23493632|NCT00734474|65551554|FG006|Overall Study|Physician Decision|0|||
23493633|NCT00734474|65551555|FG007|Overall Study|Physician Decision|9|||
23493634|NCT00734474|65551556|FG008|Overall Study|Physician Decision|9|||
23493635|NCT00734474|65551548|FG000|Overall Study|Adverse Event|4|||
23293932|NCT00035555|64815401|FG001|Overall Study|Withdrawal by Subject|0|||
23293933|NCT00035555|64815402|FG002|Overall Study|Withdrawal by Subject|2|||
23293934|NCT00035555|64815400|FG000|Overall Study|Investigator deemed not a good candidate|0|||
23293935|NCT00035555|64815401|FG001|Overall Study|Investigator deemed not a good candidate|0|||
23293936|NCT00035555|64815402|FG002|Overall Study|Investigator deemed not a good candidate|1|||
23293937|NCT00035555|64815400|FG000|Overall Study|Received cyclosporin in error|0|||
23293938|NCT00035555|64815401|FG001|Overall Study|Received cyclosporin in error|0|||
23293939|NCT00035555|64815402|FG002|Overall Study|Received cyclosporin in error|1|||
23293940|NCT03547635|64815403|FG000|Overall Study|Adverse Event|5|||
23293941|NCT03547635|64815404|FG001|Overall Study|Adverse Event|2|||
23293942|NCT03547635|64815405|FG002|Overall Study|Adverse Event|3|||
23493636|NCT00734474|65551549|FG001|Overall Study|Adverse Event|4|||
23493637|NCT00734474|65551550|FG002|Overall Study|Adverse Event|63|||
23493638|NCT00734474|65551551|FG003|Overall Study|Adverse Event|1|||
23493639|NCT00734474|65551552|FG004|Overall Study|Adverse Event|64|||
23293943|NCT03547635|64815403|FG000|Overall Study|Lost to Follow-up|1|||
23493640|NCT00734474|65551553|FG005|Overall Study|Adverse Event|0|||
23493641|NCT00734474|65551554|FG006|Overall Study|Adverse Event|1|||
23493642|NCT00734474|65551555|FG007|Overall Study|Adverse Event|65|||
23493643|NCT00734474|65551556|FG008|Overall Study|Adverse Event|39|||
23293944|NCT03547635|64815404|FG001|Overall Study|Lost to Follow-up|3|||
23293945|NCT03547635|64815405|FG002|Overall Study|Lost to Follow-up|4|||
23293946|NCT03547635|64815403|FG000|Overall Study|Withdrawal by Subject|1|||
23493644|NCT00734474|65551548|FG000|Overall Study|Protocol Violation|0|||
23493645|NCT00734474|65551549|FG001|Overall Study|Protocol Violation|0|||
23493646|NCT00734474|65551550|FG002|Overall Study|Protocol Violation|4|||
23293947|NCT03547635|64815404|FG001|Overall Study|Withdrawal by Subject|0|||
23293948|NCT03547635|64815405|FG002|Overall Study|Withdrawal by Subject|0|||
23293949|NCT03547635|64815403|FG000|Overall Study|Withdrawal By PI|0|||
23293950|NCT03547635|64815404|FG001|Overall Study|Withdrawal By PI|1|||
23293951|NCT03547635|64815405|FG002|Overall Study|Withdrawal By PI|0|||
23293952|NCT03547635|64815403|FG000|Overall Study|Withdrawal by Sponsor|0|||
23293953|NCT03547635|64815404|FG001|Overall Study|Withdrawal by Sponsor|0|||
23293954|NCT03547635|64815405|FG002|Overall Study|Withdrawal by Sponsor|1|||
23293955|NCT03547635|64815403|FG000|Overall Study|Errant Randomization before Treatment|0|||
23493647|NCT00734474|65551551|FG003|Overall Study|Protocol Violation|0|||
23493648|NCT00734474|65551552|FG004|Overall Study|Protocol Violation|3|||
23493649|NCT00734474|65551553|FG005|Overall Study|Protocol Violation|0|||
23493650|NCT00734474|65551554|FG006|Overall Study|Protocol Violation|0|||
23493651|NCT00734474|65551555|FG007|Overall Study|Protocol Violation|3|||
23493652|NCT00734474|65551556|FG008|Overall Study|Protocol Violation|1|||
23293956|NCT03547635|64815404|FG001|Overall Study|Errant Randomization before Treatment|1|||
23293957|NCT03547635|64815405|FG002|Overall Study|Errant Randomization before Treatment|0|||
23293958|NCT03547635|64815403|FG000|Overall Study|Withdrawal by Subject|1|||
23493653|NCT00734474|65551548|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
23493654|NCT00734474|65551549|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
23493655|NCT00734474|65551550|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
23493656|NCT00734474|65551551|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
23493657|NCT00734474|65551552|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
23493658|NCT00734474|65551553|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
23493659|NCT00734474|65551554|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
23493660|NCT00734474|65551555|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
23493661|NCT00734474|65551556|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
23493662|NCT00734474|65551548|FG000|Overall Study|Sponsor Decision|0|||
23493663|NCT00734474|65551549|FG001|Overall Study|Sponsor Decision|0|||
23493664|NCT00734474|65551550|FG002|Overall Study|Sponsor Decision|0|||
23493665|NCT00734474|65551551|FG003|Overall Study|Sponsor Decision|0|||
23493666|NCT00734474|65551552|FG004|Overall Study|Sponsor Decision|2|||
23493667|NCT00734474|65551553|FG005|Overall Study|Sponsor Decision|0|||
23493668|NCT00734474|65551554|FG006|Overall Study|Sponsor Decision|0|||
23493669|NCT00734474|65551555|FG007|Overall Study|Sponsor Decision|0|||
23493670|NCT00734474|65551556|FG008|Overall Study|Sponsor Decision|0|||
23493671|NCT00734474|65551548|FG000|Overall Study|Death|0|||
23493672|NCT00734474|65551549|FG001|Overall Study|Death|0|||
23493673|NCT00734474|65551550|FG002|Overall Study|Death|1|||
23493674|NCT00734474|65551551|FG003|Overall Study|Death|0|||
23493675|NCT00734474|65551552|FG004|Overall Study|Death|0|||
23386475|NCT00758043|65158685|FG000|Overall Study|Required Prohibited Medication|0|||
23493676|NCT00734474|65551553|FG005|Overall Study|Death|0|||
23493677|NCT00734474|65551554|FG006|Overall Study|Death|0|||
23493678|NCT00734474|65551555|FG007|Overall Study|Death|2|||
23493679|NCT00734474|65551556|FG008|Overall Study|Death|1|||
23493680|NCT00734474|65551548|FG000|Overall Study|Lack of Efficacy|0|||
23493681|NCT00734474|65551549|FG001|Overall Study|Lack of Efficacy|0|||
23493682|NCT00734474|65551550|FG002|Overall Study|Lack of Efficacy|4|||
23493683|NCT00734474|65551551|FG003|Overall Study|Lack of Efficacy|0|||
23493684|NCT00734474|65551552|FG004|Overall Study|Lack of Efficacy|0|||
23493685|NCT00734474|65551553|FG005|Overall Study|Lack of Efficacy|0|||
23493686|NCT00734474|65551554|FG006|Overall Study|Lack of Efficacy|0|||
23493687|NCT00734474|65551555|FG007|Overall Study|Lack of Efficacy|4|||
23493688|NCT00734474|65551556|FG008|Overall Study|Lack of Efficacy|6|||
23493689|NCT03841448|65551557|FG000|Double-blind Treatment (DBT) Period|Death|1|||
23493690|NCT03841448|65551558|FG001|Double-blind Treatment (DBT) Period|Death|1|||
23493691|NCT03841448|65551559|FG002|Double-blind Treatment (DBT) Period|Death|0|||
23493692|NCT03841448|65551560|FG003|Double-blind Treatment (DBT) Period|Death|0|||
23493693|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
23493694|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
23493695|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
23386476|NCT00758043|65158686|FG001|Overall Study|Required Prohibited Medication|0|||
23386477|NCT00758043|65158687|FG002|Overall Study|Required Prohibited Medication|1|||
23386478|NCT00758043|65158688|FG003|Overall Study|Required Prohibited Medication|3|||
23386479|NCT00758043|65158685|FG000|Overall Study|Non-Compliant With study Drug|0|||
23293959|NCT03547635|64815404|FG001|Overall Study|Withdrawal by Subject|0|||
23293960|NCT03547635|64815405|FG002|Overall Study|Withdrawal by Subject|0|||
23293961|NCT00097786|64815406|FG000|Overall Study|lost to follow-up for all-cause death|296|||
23293962|NCT00097786|64815407|FG001|Overall Study|lost to follow-up for all-cause death|292|||
23293963|NCT00097786|64815408|FG002|Overall Study|lost to follow-up for all-cause death|313|||
23293964|NCT00097786|64815409|FG003|Overall Study|lost to follow-up for all-cause death|310|||
23293965|NCT02278718|64815413|FG000|Overall Study|Adverse Event|1|||
23293966|NCT02278718|64815414|FG001|Overall Study|Adverse Event|0|||
23293967|NCT02278718|64815413|FG000|Overall Study|Lost to Follow-up|2|||
23293968|NCT02278718|64815414|FG001|Overall Study|Lost to Follow-up|4|||
23293969|NCT02278718|64815413|FG000|Overall Study|Withdrawal by Subject|1|||
23293970|NCT02278718|64815414|FG001|Overall Study|Withdrawal by Subject|4|||
23293971|NCT02278718|64815413|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
23293972|NCT02278718|64815414|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
23293973|NCT02278718|64815413|FG000|Overall Study|Missing|0|||
23293974|NCT02278718|64815414|FG001|Overall Study|Missing|1|||
23293975|NCT01439724|64815420|FG000|Overall Study|missing consultation|9|||
23293976|NCT01439724|64815421|FG001|Overall Study|missing consultation|8|||
23293977|NCT01937351|64815422|FG000|Overall Study|Withdrawal by Subject|4|||
23386480|NCT00758043|65158686|FG001|Overall Study|Non-Compliant With study Drug|0|||
23386481|NCT00758043|65158687|FG002|Overall Study|Non-Compliant With study Drug|0|||
23386482|NCT00758043|65158688|FG003|Overall Study|Non-Compliant With study Drug|1|||
23493696|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
23293978|NCT01937351|64815423|FG001|Overall Study|Withdrawal by Subject|2|||
23293979|NCT01937351|64815422|FG000|Overall Study|Death|1|||
23293980|NCT01937351|64815423|FG001|Overall Study|Death|0|||
23386483|NCT00758043|65158685|FG000|Overall Study|Other Reasons|0|||
23493697|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Death|0|||
23493698|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Death|0|||
23493699|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Death|0|||
23293981|NCT01937351|64815422|FG000|Overall Study|Not treated w device, per protocol fail|4|||
23386484|NCT00758043|65158686|FG001|Overall Study|Other Reasons|1|||
23386485|NCT00758043|65158687|FG002|Overall Study|Other Reasons|0|||
23386486|NCT00758043|65158688|FG003|Overall Study|Other Reasons|5|||
23386487|NCT01297244|65158689|FG000|Overall Study|Progressive disease|22|||
23386488|NCT01297244|65158690|FG001|Overall Study|Progressive disease|3|||
23386489|NCT01297244|65158689|FG000|Overall Study|Adverse Event|9|||
23386490|NCT01297244|65158690|FG001|Overall Study|Adverse Event|1|||
23386491|NCT01297244|65158689|FG000|Overall Study|Death|1|||
23386492|NCT01297244|65158690|FG001|Overall Study|Death|1|||
23293982|NCT01937351|64815423|FG001|Overall Study|Not treated w device, per protocol fail|0|||
23293983|NCT00784134|64815424|FG000|Overall Study|Lost to Follow-up|3|||
23293984|NCT00784134|64815425|FG001|Overall Study|Lost to Follow-up|6|||
23293985|NCT01009515|64815426|FG000|Overall Study|Withdrawal by Subject|3|||
23293986|NCT04406194|64815427|FG000|Period 1|Withdrawal by Subject|0|||
23293987|NCT04406194|64815428|FG001|Period 1|Withdrawal by Subject|1|||
23293988|NCT01223235|64815435|FG000|Overall Study|Withdrawal by Subject|1|||
23293989|NCT04106817|64815436|FG000|Overall Study|Lost to Follow-up|1|||
23293990|NCT04106817|64815437|FG001|Overall Study|Lost to Follow-up|0|||
23293991|NCT04106817|64815438|FG002|Overall Study|Lost to Follow-up|0|||
23293992|NCT01619579|64815442|FG000|Overall Study|Withdrawal by Subject|0|||
23293993|NCT01619579|64815443|FG001|Overall Study|Withdrawal by Subject|3|||
23293994|NCT02756637|64815444|FG000|Overall Study|Not eligible for initial SWOG study|10|||
23293995|NCT02756637|64815445|FG001|Overall Study|Not eligible for initial SWOG study|10|||
23293996|NCT02756637|64815444|FG000|Overall Study|No available NLR value|44|||
23293997|NCT02756637|64815445|FG001|Overall Study|No available NLR value|44|||
23293998|NCT02756637|64815444|FG000|Overall Study|Did not complete curative therapy|33|||
23293999|NCT02756637|64815445|FG001|Overall Study|Did not complete curative therapy|0|||
23294000|NCT03429049|64815446|FG000|Overall Study|Adverse Event|2|||
23294001|NCT03429049|64815447|FG001|Overall Study|Adverse Event|3|||
23294002|NCT03429049|64815446|FG000|Overall Study|Death|0|||
23294003|NCT03429049|64815447|FG001|Overall Study|Death|1|||
23294004|NCT03429049|64815446|FG000|Overall Study|Lack of Efficacy|4|||
23294005|NCT03429049|64815447|FG001|Overall Study|Lack of Efficacy|2|||
23294006|NCT03429049|64815446|FG000|Overall Study|Lost to Follow-up|9|||
23294007|NCT03429049|64815447|FG001|Overall Study|Lost to Follow-up|8|||
23294008|NCT03429049|64815446|FG000|Overall Study|Physician Decision|1|||
23294009|NCT03429049|64815447|FG001|Overall Study|Physician Decision|0|||
23294010|NCT03429049|64815446|FG000|Overall Study|Protocol Violation|3|||
23294011|NCT03429049|64815447|FG001|Overall Study|Protocol Violation|0|||
23294012|NCT03429049|64815446|FG000|Overall Study|Sponsor Decision|2|||
23294013|NCT03429049|64815447|FG001|Overall Study|Sponsor Decision|0|||
23294014|NCT03429049|64815446|FG000|Overall Study|Withdrawal by Subject|4|||
23294015|NCT03429049|64815447|FG001|Overall Study|Withdrawal by Subject|20|||
23294016|NCT03429049|64815446|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
23294017|NCT03429049|64815447|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
23294018|NCT00939627|64815450|FG000|Overall Study|Disease Progression|16|||
23294019|NCT00939627|64815451|FG001|Overall Study|Disease Progression|12|||
23294020|NCT00939627|64815452|FG002|Overall Study|Disease Progression|0|||
23294021|NCT00939627|64815450|FG000|Overall Study|Adverse Event|6|||
23294022|NCT00939627|64815451|FG001|Overall Study|Adverse Event|7|||
23294023|NCT00939627|64815452|FG002|Overall Study|Adverse Event|0|||
23294024|NCT00939627|64815450|FG000|Overall Study|Death|0|||
23294025|NCT00939627|64815451|FG001|Overall Study|Death|2|||
23294026|NCT00939627|64815452|FG002|Overall Study|Death|0|||
23294027|NCT00939627|64815450|FG000|Overall Study|Withdrawal by Subject|2|||
23294028|NCT00939627|64815451|FG001|Overall Study|Withdrawal by Subject|4|||
23294029|NCT00939627|64815452|FG002|Overall Study|Withdrawal by Subject|0|||
23294030|NCT00939627|64815450|FG000|Overall Study|Other complicating disease|1|||
23294031|NCT00939627|64815451|FG001|Overall Study|Other complicating disease|1|||
23294032|NCT00939627|64815452|FG002|Overall Study|Other complicating disease|0|||
23294033|NCT00939627|64815450|FG000|Overall Study|Not compliant|2|||
23294034|NCT00939627|64815451|FG001|Overall Study|Not compliant|0|||
23294035|NCT00939627|64815452|FG002|Overall Study|Not compliant|0|||
23386493|NCT01297244|65158689|FG000|Overall Study|Clinical progression|1|||
23386494|NCT01297244|65158690|FG001|Overall Study|Clinical progression|1|||
23386495|NCT01297244|65158689|FG000|Overall Study|Withdrawal by Subject|2|||
23386496|NCT01297244|65158690|FG001|Overall Study|Withdrawal by Subject|0|||
23294036|NCT00939627|64815450|FG000|Overall Study|No off-tx reason given|0|||
23294037|NCT00939627|64815451|FG001|Overall Study|No off-tx reason given|2|||
23294038|NCT00939627|64815452|FG002|Overall Study|No off-tx reason given|0|||
23294039|NCT00631007|64815453|FG000|Overall Study|Adverse Event|0|||
23294040|NCT00631007|64815454|FG001|Overall Study|Adverse Event|2|||
23294041|NCT00631007|64815455|FG002|Overall Study|Adverse Event|0|||
23294042|NCT00631007|64815456|FG003|Overall Study|Adverse Event|2|||
23294043|NCT00631007|64815457|FG004|Overall Study|Adverse Event|3|||
23294044|NCT00631007|64815458|FG005|Overall Study|Adverse Event|2|||
23294045|NCT00631007|64815453|FG000|Overall Study|Lost to Follow-up|2|||
23294046|NCT00631007|64815454|FG001|Overall Study|Lost to Follow-up|1|||
23294047|NCT00631007|64815455|FG002|Overall Study|Lost to Follow-up|2|||
23294048|NCT00631007|64815456|FG003|Overall Study|Lost to Follow-up|4|||
23294049|NCT00631007|64815457|FG004|Overall Study|Lost to Follow-up|5|||
23294050|NCT00631007|64815458|FG005|Overall Study|Lost to Follow-up|3|||
23294051|NCT00631007|64815453|FG000|Overall Study|Physician Decision|1|||
23294052|NCT00631007|64815454|FG001|Overall Study|Physician Decision|0|||
23294053|NCT00631007|64815455|FG002|Overall Study|Physician Decision|1|||
23294054|NCT00631007|64815456|FG003|Overall Study|Physician Decision|0|||
23294055|NCT00631007|64815457|FG004|Overall Study|Physician Decision|0|||
23294056|NCT00631007|64815458|FG005|Overall Study|Physician Decision|2|||
23294057|NCT00631007|64815453|FG000|Overall Study|Persistent Hyperglycemia|2|||
23294058|NCT00631007|64815454|FG001|Overall Study|Persistent Hyperglycemia|2|||
23294059|NCT00631007|64815455|FG002|Overall Study|Persistent Hyperglycemia|5|||
23294060|NCT00631007|64815456|FG003|Overall Study|Persistent Hyperglycemia|1|||
23294061|NCT00631007|64815457|FG004|Overall Study|Persistent Hyperglycemia|2|||
23294062|NCT00631007|64815458|FG005|Overall Study|Persistent Hyperglycemia|5|||
23294063|NCT00631007|64815453|FG000|Overall Study|Withdrawal by Subject|4|||
23294064|NCT00631007|64815454|FG001|Overall Study|Withdrawal by Subject|5|||
23294065|NCT00631007|64815455|FG002|Overall Study|Withdrawal by Subject|2|||
23294066|NCT00631007|64815456|FG003|Overall Study|Withdrawal by Subject|2|||
23294067|NCT00631007|64815457|FG004|Overall Study|Withdrawal by Subject|1|||
23294068|NCT00631007|64815458|FG005|Overall Study|Withdrawal by Subject|3|||
23294069|NCT00631007|64815453|FG000|Overall Study|Other|2|||
23294070|NCT00631007|64815454|FG001|Overall Study|Other|1|||
23294071|NCT00631007|64815455|FG002|Overall Study|Other|0|||
23294072|NCT00631007|64815456|FG003|Overall Study|Other|0|||
23294073|NCT00631007|64815457|FG004|Overall Study|Other|1|||
23294074|NCT00631007|64815458|FG005|Overall Study|Other|0|||
23294075|NCT01915940|64818118|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
23294076|NCT01915940|64818119|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
23294077|NCT01915940|64818120|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
23294078|NCT01915940|64818118|FG000|Treatment Period|Decision of Participant|0|||
23294079|NCT01915940|64818119|FG001|Treatment Period|Decision of Participant|1|||
23294080|NCT01915940|64818120|FG002|Treatment Period|Decision of Participant|3|||
23294081|NCT01915940|64818118|FG000|Treatment Period|Adverse Event|0|||
23294082|NCT01915940|64818119|FG001|Treatment Period|Adverse Event|9|||
23294083|NCT01915940|64818120|FG002|Treatment Period|Adverse Event|1|||
23294084|NCT01915940|64818118|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
23294085|NCT01915940|64818119|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
23294086|NCT01915940|64818120|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
23294087|NCT00869440|64818121|FG000|Overall Study|Withdrawal by Subject|1|||
23294088|NCT00869440|64818122|FG001|Overall Study|Withdrawal by Subject|0|||
23294089|NCT00869440|64818123|FG002|Overall Study|Withdrawal by Subject|0|||
23294090|NCT00869440|64818124|FG003|Overall Study|Withdrawal by Subject|0|||
23294091|NCT00869440|64818121|FG000|Overall Study|Physician Decision|1|||
23294092|NCT00869440|64818122|FG001|Overall Study|Physician Decision|1|||
23294093|NCT00869440|64818123|FG002|Overall Study|Physician Decision|0|||
23294094|NCT00869440|64818124|FG003|Overall Study|Physician Decision|0|||
23294095|NCT00602537|64818125|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
23294096|NCT00602537|64818126|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
23294097|NCT00602537|64818125|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
23294098|NCT00602537|64818126|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
23294099|NCT00602537|64818125|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
23386497|NCT00965094|65158692|FG000|Overall Study|Adverse Event|5|||
23386498|NCT00965094|65158693|FG001|Overall Study|Adverse Event|0|||
23386499|NCT00965094|65158692|FG000|Overall Study|Lost to Follow-up|0|||
23386500|NCT00965094|65158693|FG001|Overall Study|Lost to Follow-up|1|||
23386501|NCT01052428|65158694|FG000|Overall Study|Death|1|||
23386502|NCT01052428|65158695|FG001|Overall Study|Death|0|||
23386503|NCT01052428|65158694|FG000|Overall Study|Withdrawal by Subject|0|||
23386504|NCT01052428|65158695|FG001|Overall Study|Withdrawal by Subject|1|||
23386505|NCT00003474|65158699|FG000|Overall Study|Not Evaluable|14|||
23386506|NCT00422461|65158700|FG000|Overall Study|Adverse Event|1|||
23386507|NCT00422461|65158701|FG001|Overall Study|Adverse Event|2|||
23294100|NCT00602537|64818126|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
23294101|NCT00602537|64818125|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
23294102|NCT00602537|64818126|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
23386508|NCT00422461|65158702|FG002|Overall Study|Adverse Event|1|||
23386509|NCT00422461|65158703|FG003|Overall Study|Adverse Event|1|||
23294103|NCT00602537|64818125|FG000|Follow Up Study Comparison|Adverse Event|1|||
23294104|NCT00602537|64818126|FG001|Follow Up Study Comparison|Adverse Event|0|||
23294105|NCT00602537|64818125|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
23294106|NCT00602537|64818126|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
23294107|NCT00602537|64818125|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
23294108|NCT00602537|64818126|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
23294109|NCT04211766|64818127|FG000|Overall Study|Withdrawal by Subject|5|||
23294110|NCT04211766|64818128|FG001|Overall Study|Withdrawal by Subject|1|||
23294111|NCT01074008|64818129|FG000|Overall Study|Adverse Event|0|||
23294112|NCT01074008|64818130|FG001|Overall Study|Adverse Event|1|||
23294113|NCT01074008|64818131|FG002|Overall Study|Adverse Event|0|||
23386510|NCT00422461|65158700|FG000|Overall Study|Other|0|||
23386511|NCT00422461|65158701|FG001|Overall Study|Other|0|||
23386512|NCT00422461|65158702|FG002|Overall Study|Other|0|||
23294114|NCT01074008|64818132|FG003|Overall Study|Adverse Event|0|||
23294115|NCT01074008|64818133|FG004|Overall Study|Adverse Event|0|||
23294116|NCT01074008|64818134|FG005|Overall Study|Adverse Event|0|||
23294117|NCT01074008|64818135|FG006|Overall Study|Adverse Event|0|||
23294118|NCT01074008|64818136|FG007|Overall Study|Adverse Event|0|||
23294119|NCT01074008|64818137|FG008|Overall Study|Adverse Event|0|||
23294120|NCT01074008|64818129|FG000|Overall Study|Withdrawal by Subject|1|||
23294121|NCT01074008|64818130|FG001|Overall Study|Withdrawal by Subject|1|||
23294122|NCT01074008|64818131|FG002|Overall Study|Withdrawal by Subject|1|||
23294123|NCT01074008|64818132|FG003|Overall Study|Withdrawal by Subject|0|||
23294124|NCT01074008|64818133|FG004|Overall Study|Withdrawal by Subject|1|||
23294125|NCT01074008|64818134|FG005|Overall Study|Withdrawal by Subject|0|||
23294126|NCT01074008|64818135|FG006|Overall Study|Withdrawal by Subject|0|||
23294127|NCT01074008|64818136|FG007|Overall Study|Withdrawal by Subject|0|||
23294128|NCT01074008|64818137|FG008|Overall Study|Withdrawal by Subject|0|||
23294129|NCT01074008|64818129|FG000|Overall Study|Lost to Follow-up|0|||
23294130|NCT01074008|64818130|FG001|Overall Study|Lost to Follow-up|1|||
23294131|NCT01074008|64818131|FG002|Overall Study|Lost to Follow-up|1|||
23294132|NCT01074008|64818132|FG003|Overall Study|Lost to Follow-up|1|||
23294133|NCT01074008|64818133|FG004|Overall Study|Lost to Follow-up|1|||
23294134|NCT01074008|64818134|FG005|Overall Study|Lost to Follow-up|0|||
23294135|NCT01074008|64818135|FG006|Overall Study|Lost to Follow-up|1|||
23294136|NCT01074008|64818136|FG007|Overall Study|Lost to Follow-up|0|||
23294137|NCT01074008|64818137|FG008|Overall Study|Lost to Follow-up|4|||
23294138|NCT00761176|64818138|FG000|Overall Study|Death|1|||
23294139|NCT00761176|64818139|FG001|Overall Study|Death|0|||
23294140|NCT00761176|64818138|FG000|Overall Study|Withdrawal by Subject|1|||
23294141|NCT00761176|64818139|FG001|Overall Study|Withdrawal by Subject|1|||
23294142|NCT02999984|64818140|FG000|Overall Study|Treatment Failure|1|||
23294143|NCT00588731|64818141|FG000|Overall Study|Withdrawal by Subject|3|||
23294144|NCT00588731|64818142|FG001|Overall Study|Withdrawal by Subject|2|||
23294145|NCT00251316|64818143|FG000|Overall Study|Physician Decision|2|||
23294146|NCT00251316|64818144|FG001|Overall Study|Physician Decision|3|||
23294147|NCT00438659|64818145|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
23294148|NCT00438659|64818146|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
23294149|NCT00438659|64818145|FG000|Overall Study|Cancel|5|||
23294150|NCT00438659|64818146|FG001|Overall Study|Cancel|2|||
23294151|NCT03401073|64818147|FG000|Overall Study|Lost to Follow-up|1|||
23294152|NCT03401073|64818148|FG001|Overall Study|Lost to Follow-up|2|||
23294153|NCT02563769|64818149|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
23294154|NCT02563769|64818150|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
23294155|NCT02563769|64818151|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
23294156|NCT03785145|64818152|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
23294157|NCT03785145|64818153|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
23294158|NCT03785145|64818152|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
23294159|NCT03785145|64818153|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
23294160|NCT03785145|64818152|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
23294161|NCT03785145|64818153|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
23294162|NCT03785145|64818152|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
23294163|NCT03785145|64818153|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
23294164|NCT03785145|64818152|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
23294165|NCT03785145|64818153|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
23294166|NCT03785145|64818152|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
23294167|NCT03785145|64818153|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
23294168|NCT03785145|64818152|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
23294169|NCT03785145|64818153|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
23294170|NCT03785145|64818152|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
23294171|NCT03785145|64818153|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
23294172|NCT03785145|64818152|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
23294173|NCT03785145|64818153|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
23294174|NCT03785145|64818152|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
23294175|NCT03785145|64818153|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
23386513|NCT00422461|65158703|FG003|Overall Study|Other|2|||
23386514|NCT00422461|65158700|FG000|Overall Study|Participants no longer willing to participate in study|1|||
23294176|NCT03785145|64818152|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
23294177|NCT03785145|64818153|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
23294178|NCT04823130|64818157|FG000|Overall Study|Withdrawal by Subject|2|||
23294179|NCT04823130|64818158|FG001|Overall Study|Withdrawal by Subject|3|||
23294180|NCT04823130|64818157|FG000|Overall Study|Failure to meet inclusion criteria|6|||
23294181|NCT04823130|64818158|FG001|Overall Study|Failure to meet inclusion criteria|4|||
23294182|NCT04823130|64818157|FG000|Overall Study|Other-unspecified|1|||
23294183|NCT04823130|64818158|FG001|Overall Study|Other-unspecified|0|||
23294184|NCT00754052|64818163|FG000|Overall Study|Study terminated by Sponsor|5|||
23294185|NCT00754052|64818164|FG001|Overall Study|Study terminated by Sponsor|3|||
23294186|NCT01301482|64818165|FG000|Overall Study|Withdrawal by Subject|1|||
23294187|NCT02148445|64818166|FG000|Overall Study|Death|1|||
23294188|NCT02148445|64818167|FG001|Overall Study|Death|3|||
23294189|NCT02310789|64818171|FG000|Overall Study|Adverse Event|1|||
23294190|NCT00779402|64818172|FG000|Treatment Phase 1|Disease Progression|1|||
23294191|NCT00779402|64818173|FG001|Treatment Phase 1|Disease Progression|0|||
23294192|NCT00779402|64818172|FG000|Treatment Phase 1|Adverse Event|2|||
23294193|NCT00779402|64818173|FG001|Treatment Phase 1|Adverse Event|0|||
23294194|NCT00779402|64818172|FG000|Treatment Phase 1|Protocol Violation|1|||
23294195|NCT00779402|64818173|FG001|Treatment Phase 1|Protocol Violation|0|||
23294196|NCT00779402|64818172|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
23294197|NCT00779402|64818173|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
23294198|NCT00779402|64818172|FG000|Treatment Phase 1|Lost to Follow-up|0|||
23294199|NCT00779402|64818173|FG001|Treatment Phase 1|Lost to Follow-up|1|||
23294200|NCT00779402|64818172|FG000|Treatment Phase 1|Death|0|||
23294201|NCT00779402|64818173|FG001|Treatment Phase 1|Death|1|||
23294202|NCT00779402|64818172|FG000|Treatment Phase 1|Intercurrent Illness|1|||
23294203|NCT00779402|64818173|FG001|Treatment Phase 1|Intercurrent Illness|1|||
23386515|NCT00422461|65158701|FG001|Overall Study|Participants no longer willing to participate in study|0|||
23386516|NCT00422461|65158702|FG002|Overall Study|Participants no longer willing to participate in study|0|||
23386517|NCT00422461|65158703|FG003|Overall Study|Participants no longer willing to participate in study|0|||
23386518|NCT00422461|65158700|FG000|Overall Study|Randomized but not treated|1|||
23386519|NCT00422461|65158701|FG001|Overall Study|Randomized but not treated|1|||
23386520|NCT00422461|65158702|FG002|Overall Study|Randomized but not treated|0|||
23386521|NCT00422461|65158703|FG003|Overall Study|Randomized but not treated|0|||
23386522|NCT04621760|65158704|FG000|Overall Study|Lost to Follow-up|2|||
23386523|NCT04621760|65158705|FG001|Overall Study|Lost to Follow-up|4|||
23386524|NCT04621760|65158704|FG000|Overall Study|Withdrawal by Subject|1|||
23386525|NCT04621760|65158705|FG001|Overall Study|Withdrawal by Subject|0|||
23386526|NCT00985790|65158706|FG000|Overall Study|Withdrawal by Subject|1|||
23386527|NCT00985790|65158707|FG001|Overall Study|Withdrawal by Subject|1|||
23386528|NCT00985790|65158706|FG000|Overall Study|Lost to Follow-up|6|||
23294204|NCT00779402|64818172|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
23386529|NCT00985790|65158707|FG001|Overall Study|Lost to Follow-up|7|||
23386530|NCT01229111|65158708|FG000|Overall Study|Death|1|||
23294205|NCT00779402|64818173|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
23294206|NCT00779402|64818172|FG000|Treatment Phase 1|Other|4|||
23294207|NCT00779402|64818173|FG001|Treatment Phase 1|Other|2|||
23294208|NCT00779402|64818172|FG000|Treatment Phase 1|Closure of Study|3|||
23294209|NCT00779402|64818173|FG001|Treatment Phase 1|Closure of Study|2|||
23386531|NCT00930176|65158709|FG000|Overall Study|Death|1|||
23386532|NCT01239745|65158710|FG000|Overall Study|Study terminated by sponsor|45|||
23386533|NCT01239745|65158710|FG000|Overall Study|Adverse Event|1|||
23386534|NCT00120874|65158711|FG000|Overall Study|Death|0|||
23386535|NCT00120874|65158712|FG001|Overall Study|Death|1|||
23386536|NCT00362609|65158715|FG000|Overall Study|Withdrawal by Subject|0|||
23386537|NCT00362609|65158716|FG001|Overall Study|Withdrawal by Subject|1|||
23386538|NCT00362609|65158715|FG000|Overall Study|Protocol Violation|0|||
23386539|NCT00362609|65158716|FG001|Overall Study|Protocol Violation|1|||
23386540|NCT03808909|65158720|FG000|Overall Study|Lost to Follow-up|3|||
23386541|NCT03808909|65158721|FG001|Overall Study|Lost to Follow-up|0|||
23386542|NCT03437733|65158723|FG000|Overall Study|Eligibility criteria not met|0|||
23386543|NCT03437733|65158724|FG001|Overall Study|Eligibility criteria not met|3|||
23386544|NCT03436420|65158731|FG000|Overall Study|Lack of Efficacy|3|||
23386545|NCT00609973|65158734|FG000|Overall Study|Adverse Event|2|||
23386546|NCT00609973|65158735|FG001|Overall Study|Adverse Event|1|||
23386547|NCT00609973|65158734|FG000|Overall Study|Protocol Violation|4|||
23386548|NCT00609973|65158735|FG001|Overall Study|Protocol Violation|3|||
23386549|NCT00609973|65158734|FG000|Overall Study|Lost to Follow-up|2|||
23386550|NCT00609973|65158735|FG001|Overall Study|Lost to Follow-up|1|||
23386551|NCT00609973|65158734|FG000|Overall Study|Withdrawal by Subject|0|||
23386552|NCT00609973|65158735|FG001|Overall Study|Withdrawal by Subject|1|||
23386553|NCT00394472|65158736|FG000|Overall Study|Protocol Violation|1|||
23386554|NCT00394472|65158737|FG001|Overall Study|Protocol Violation|3|||
23386555|NCT00394472|65158736|FG000|Overall Study|incorrect enrolment|4|||
23386556|NCT00394472|65158737|FG001|Overall Study|incorrect enrolment|2|||
23386557|NCT00394472|65158736|FG000|Overall Study|Adverse Event|4|||
23386558|NCT00394472|65158737|FG001|Overall Study|Adverse Event|2|||
23386559|NCT00394472|65158736|FG000|Overall Study|Withdrawal by Subject|0|||
23386560|NCT00394472|65158737|FG001|Overall Study|Withdrawal by Subject|2|||
23386561|NCT00394472|65158736|FG000|Overall Study|Physician Decision|0|||
23386562|NCT00394472|65158737|FG001|Overall Study|Physician Decision|1|||
23386563|NCT00394472|65158736|FG000|Overall Study|Lost to Follow-up|0|||
23386564|NCT00394472|65158737|FG001|Overall Study|Lost to Follow-up|1|||
23386565|NCT02175758|65158740|FG000|Treatment Phase|Lost to Follow-up|0|||
23386566|NCT02175758|65158741|FG001|Treatment Phase|Lost to Follow-up|1|||
23386567|NCT02175758|65158742|FG002|Treatment Phase|Lost to Follow-up|0|||
23386568|NCT02175758|65158743|FG003|Treatment Phase|Lost to Follow-up|0|||
23386569|NCT02175758|65158744|FG004|Treatment Phase|Lost to Follow-up|0|||
23386570|NCT02175758|65158745|FG005|Treatment Phase|Lost to Follow-up|0|||
23386571|NCT02175758|65158740|FG000|Treatment Phase|Adverse Event|0|||
23386572|NCT02175758|65158741|FG001|Treatment Phase|Adverse Event|0|||
23386573|NCT02175758|65158742|FG002|Treatment Phase|Adverse Event|0|||
23386574|NCT02175758|65158743|FG003|Treatment Phase|Adverse Event|0|||
23386575|NCT02175758|65158744|FG004|Treatment Phase|Adverse Event|1|||
23386576|NCT02175758|65158745|FG005|Treatment Phase|Adverse Event|0|||
23386577|NCT03174275|65158746|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
23386578|NCT03174275|65158746|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
23386579|NCT03174275|65158746|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
23386580|NCT03174275|65158746|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
23386581|NCT03174275|65158746|FG000|Adjuvant Chemotherapy|Progression|1|||
23386582|NCT03174275|65158746|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
23386583|NCT03174275|65158746|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
23386584|NCT03174275|65158746|FG000|Adjuvant Durvalumab|Progression|1|||
23386585|NCT03174275|65158746|FG000|Adjuvant Durvalumab|Adverse Event|3|||
23386586|NCT03174275|65158746|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
23386587|NCT03174275|65158746|FG000|Adjuvant Radiotherapy|Progression|1|||
23386588|NCT03174275|65158746|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
23386589|NCT01117350|65158749|FG000|Comparative Period|Not Treated|5|||
23386590|NCT01117350|65158750|FG001|Comparative Period|Not Treated|8|||
23386591|NCT01117350|65158749|FG000|Comparative Period|Adverse Event|6|||
23386592|NCT01117350|65158750|FG001|Comparative Period|Adverse Event|33|||
23386593|NCT01117350|65158749|FG000|Comparative Period|Lost to Follow-up|11|||
23386594|NCT01117350|65158750|FG001|Comparative Period|Lost to Follow-up|7|||
23386595|NCT01117350|65158749|FG000|Comparative Period|Withdrawal by Subject|9|||
23386596|NCT01117350|65158750|FG001|Comparative Period|Withdrawal by Subject|13|||
23386597|NCT01117350|65158749|FG000|Comparative Period|Protocol Violation|8|||
23386598|NCT01117350|65158750|FG001|Comparative Period|Protocol Violation|12|||
23386599|NCT01117350|65158749|FG000|Comparative Period|Lack of Efficacy|1|||
23386600|NCT01117350|65158750|FG001|Comparative Period|Lack of Efficacy|0|||
23386601|NCT01117350|65158749|FG000|Comparative Period|Physician Decision|0|||
23386602|NCT01117350|65158750|FG001|Comparative Period|Physician Decision|1|||
23386603|NCT01117350|65158749|FG000|Comparative Period|Move to another city/country|2|||
23386604|NCT01117350|65158750|FG001|Comparative Period|Move to another city/country|1|||
23386605|NCT01117350|65158749|FG000|Extension Period|Not included in extension, not treated|0|||
23386606|NCT01117350|65158750|FG001|Extension Period|Not included in extension, not treated|50|||
23386607|NCT01117350|65158749|FG000|Extension Period|Adverse Event|0|||
23386608|NCT01117350|65158750|FG001|Extension Period|Adverse Event|2|||
23386609|NCT01117350|65158749|FG000|Extension Period|Protocol Violation|0|||
23386610|NCT01117350|65158750|FG001|Extension Period|Protocol Violation|2|||
23386611|NCT01117350|65158749|FG000|Extension Period|Lost to Follow-up|0|||
23386612|NCT01117350|65158750|FG001|Extension Period|Lost to Follow-up|2|||
23294210|NCT00779402|64818172|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
23294211|NCT00779402|64818173|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
23386613|NCT01117350|65158749|FG000|Extension Period|Withdrawal by Subject|0|||
23386614|NCT01117350|65158750|FG001|Extension Period|Withdrawal by Subject|3|||
23386615|NCT01117350|65158749|FG000|Extension Period|Lack of Efficacy|0|||
23386616|NCT01117350|65158750|FG001|Extension Period|Lack of Efficacy|2|||
23386617|NCT01117350|65158749|FG000|Extension Period|Inclusion criteria not respected|0|||
23386618|NCT01117350|65158750|FG001|Extension Period|Inclusion criteria not respected|1|||
23386619|NCT01117350|65158749|FG000|Extension Period|Prohibited medication|0|||
23386620|NCT01117350|65158750|FG001|Extension Period|Prohibited medication|1|||
23386621|NCT04832971|65158753|FG000|Overall Study|Death|1|||
23386622|NCT04832971|65158754|FG001|Overall Study|Death|0|||
23386623|NCT04832971|65158755|FG002|Overall Study|Death|0|||
23386624|NCT04832971|65158756|FG003|Overall Study|Death|0|||
23386625|NCT04832971|65158753|FG000|Overall Study|Lost to Follow-up|1|||
23386626|NCT04832971|65158754|FG001|Overall Study|Lost to Follow-up|1|||
23386627|NCT04832971|65158755|FG002|Overall Study|Lost to Follow-up|1|||
23386628|NCT04832971|65158756|FG003|Overall Study|Lost to Follow-up|0|||
23386629|NCT04832971|65158753|FG000|Overall Study|Withdrawal by Subject|1|||
23386630|NCT04832971|65158754|FG001|Overall Study|Withdrawal by Subject|3|||
23294212|NCT00779402|64818172|FG000|Surveillance Phase|Protocol Violation|0|||
23294213|NCT00779402|64818173|FG001|Surveillance Phase|Protocol Violation|1|||
23294214|NCT00779402|64818172|FG000|Surveillance Phase|Patient refused to continue|22|||
23294215|NCT00779402|64818173|FG001|Surveillance Phase|Patient refused to continue|14|||
23294216|NCT00779402|64818172|FG000|Surveillance Phase|Lost to Follow-up|2|||
23294217|NCT00779402|64818173|FG001|Surveillance Phase|Lost to Follow-up|1|||
23294218|NCT00779402|64818172|FG000|Surveillance Phase|Death|0|||
23294219|NCT00779402|64818173|FG001|Surveillance Phase|Death|1|||
23294220|NCT00779402|64818172|FG000|Surveillance Phase|Intercurrent Illness|2|||
23294221|NCT00779402|64818173|FG001|Surveillance Phase|Intercurrent Illness|0|||
23294222|NCT00779402|64818172|FG000|Surveillance Phase|Other|5|||
23294223|NCT00779402|64818173|FG001|Surveillance Phase|Other|5|||
23294224|NCT00779402|64818172|FG000|Surveillance Phase|Withdrawal by Subject|4|||
23294225|NCT00779402|64818173|FG001|Surveillance Phase|Withdrawal by Subject|1|||
23294226|NCT00779402|64818172|FG000|Surveillance Phase|Closure of study|5|||
23294227|NCT00779402|64818173|FG001|Surveillance Phase|Closure of study|6|||
23294228|NCT00779402|64818172|FG000|Surveillance Phase|Completed Protocol Visits|3|||
23294229|NCT00779402|64818173|FG001|Surveillance Phase|Completed Protocol Visits|2|||
23294230|NCT00779402|64818172|FG000|Long-term Follow-up|Patient refused to continue|2|||
23294231|NCT00779402|64818173|FG001|Long-term Follow-up|Patient refused to continue|0|||
23294232|NCT00779402|64818172|FG000|Long-term Follow-up|Other|5|||
23294233|NCT00779402|64818173|FG001|Long-term Follow-up|Other|0|||
23294234|NCT00779402|64818172|FG000|Long-term Follow-up|Closure of Study|8|||
23294235|NCT00779402|64818173|FG001|Long-term Follow-up|Closure of Study|4|||
23294236|NCT00779402|64818172|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
23294237|NCT00779402|64818173|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
23294238|NCT01258101|64818184|FG000|Overall Study|Adverse Event|5|||
23294239|NCT01258101|64818185|FG001|Overall Study|Adverse Event|6|||
23294240|NCT01258101|64818186|FG002|Overall Study|Adverse Event|0|||
23294241|NCT01258101|64818187|FG003|Overall Study|Adverse Event|0|||
23294242|NCT01258101|64818184|FG000|Overall Study|Extra exclusion criterion amended|2|||
23386631|NCT04832971|65158755|FG002|Overall Study|Withdrawal by Subject|2|||
23386632|NCT04832971|65158756|FG003|Overall Study|Withdrawal by Subject|2|||
23386633|NCT04832971|65158753|FG000|Overall Study|Other, Not Specified|0|||
23386634|NCT04832971|65158754|FG001|Overall Study|Other, Not Specified|0|||
23386635|NCT04832971|65158755|FG002|Overall Study|Other, Not Specified|1|||
23294243|NCT01258101|64818185|FG001|Overall Study|Extra exclusion criterion amended|1|||
23294244|NCT01258101|64818186|FG002|Overall Study|Extra exclusion criterion amended|1|||
23294245|NCT01258101|64818187|FG003|Overall Study|Extra exclusion criterion amended|1|||
23294246|NCT01258101|64818184|FG000|Overall Study|Informed consent has been withdrawn|2|||
23294247|NCT01258101|64818185|FG001|Overall Study|Informed consent has been withdrawn|2|||
23294248|NCT01258101|64818186|FG002|Overall Study|Informed consent has been withdrawn|1|||
23294249|NCT01258101|64818187|FG003|Overall Study|Informed consent has been withdrawn|1|||
23294250|NCT01258101|64818184|FG000|Overall Study|Patient is not able to attend visits|8|||
23294251|NCT01258101|64818185|FG001|Overall Study|Patient is not able to attend visits|9|||
23294252|NCT01258101|64818186|FG002|Overall Study|Patient is not able to attend visits|7|||
23294253|NCT01258101|64818187|FG003|Overall Study|Patient is not able to attend visits|6|||
23294254|NCT01258101|64818184|FG000|Overall Study|Patient´s compliance|4|||
23294255|NCT01258101|64818185|FG001|Overall Study|Patient´s compliance|3|||
23294256|NCT01258101|64818186|FG002|Overall Study|Patient´s compliance|1|||
23294257|NCT01258101|64818187|FG003|Overall Study|Patient´s compliance|2|||
23386636|NCT04832971|65158756|FG003|Overall Study|Other, Not Specified|0|||
23386637|NCT01778985|65158757|FG000|Overall Study|Lost to Follow-up|1|||
23386638|NCT01778985|65158758|FG001|Overall Study|Lost to Follow-up|0|||
23386639|NCT01778985|65158757|FG000|Overall Study|Physician Decision|2|||
23386640|NCT01778985|65158758|FG001|Overall Study|Physician Decision|2|||
23386641|NCT01778985|65158757|FG000|Overall Study|Protocol Violation|4|||
23386642|NCT01778985|65158758|FG001|Overall Study|Protocol Violation|1|||
23386643|NCT02958527|65158763|FG000|Overall Study|Not collected CRFs|12|||
23386644|NCT03315689|65158768|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
23386645|NCT03315689|65158769|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
23386646|NCT03315689|65158768|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
23386647|NCT03315689|65158769|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
23386648|NCT03315689|65158768|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
23386649|NCT03315689|65158769|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
23386650|NCT00974233|65158770|FG000|Induction Chemoimmunotherapy|Death|2|||
23386651|NCT00974233|65158770|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
23386652|NCT00974233|65158770|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
23386653|NCT00974233|65158770|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
23386654|NCT00974233|65158770|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
23386655|NCT00974233|65158770|FG000|Maintenance Lenalidomide|Adverse Event|8|||
23386656|NCT00263562|65158771|FG000|Overall Study|Protocol Violation|3|||
23386657|NCT00263562|65158772|FG001|Overall Study|Protocol Violation|0|||
23386658|NCT00723944|65158773|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
23386659|NCT00723944|65158774|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
23386660|NCT00723944|65158773|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
23386661|NCT00723944|65158774|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
23386662|NCT00723944|65158773|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
23386663|NCT00723944|65158774|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
23386664|NCT01964560|65158777|FG000|Overall Study|Adverse Event|23|||
23386665|NCT01964560|65158777|FG000|Overall Study|Lack of Efficacy|46|||
23386666|NCT01964560|65158777|FG000|Overall Study|Protocol deviation|2|||
23294258|NCT01258101|64818184|FG000|Overall Study|Lost to Follow-up|5|||
23294259|NCT01258101|64818185|FG001|Overall Study|Lost to Follow-up|5|||
23294260|NCT01258101|64818186|FG002|Overall Study|Lost to Follow-up|0|||
23294261|NCT01258101|64818187|FG003|Overall Study|Lost to Follow-up|6|||
23294262|NCT01258101|64818184|FG000|Overall Study|PCR positive at week 24|0|||
23294263|NCT01258101|64818185|FG001|Overall Study|PCR positive at week 24|0|||
23294264|NCT01258101|64818186|FG002|Overall Study|PCR positive at week 24|0|||
23294265|NCT01258101|64818187|FG003|Overall Study|PCR positive at week 24|1|||
23294266|NCT01258101|64818184|FG000|Overall Study|Other reason|7|||
23294267|NCT01258101|64818185|FG001|Overall Study|Other reason|8|||
23294268|NCT01258101|64818186|FG002|Overall Study|Other reason|1|||
23294269|NCT01258101|64818187|FG003|Overall Study|Other reason|8|||
23294270|NCT03756883|64818188|FG000|Overall Study|Adverse Event|2|||
23294271|NCT03756883|64818189|FG001|Overall Study|Adverse Event|2|||
23294272|NCT03756883|64818190|FG002|Overall Study|Adverse Event|2|||
23294273|NCT03756883|64818188|FG000|Overall Study|Lack of Efficacy|0|||
23294274|NCT03756883|64818189|FG001|Overall Study|Lack of Efficacy|1|||
23294275|NCT03756883|64818190|FG002|Overall Study|Lack of Efficacy|2|||
23294276|NCT03756883|64818188|FG000|Overall Study|Lost to Follow-up|3|||
23294277|NCT03756883|64818189|FG001|Overall Study|Lost to Follow-up|3|||
23294278|NCT03756883|64818190|FG002|Overall Study|Lost to Follow-up|0|||
23294279|NCT03756883|64818188|FG000|Overall Study|Protocol Violation|2|||
23294280|NCT03756883|64818189|FG001|Overall Study|Protocol Violation|0|||
23294281|NCT03756883|64818190|FG002|Overall Study|Protocol Violation|1|||
23294282|NCT03756883|64818188|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
23294283|NCT03756883|64818189|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
23294284|NCT03756883|64818190|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
23294285|NCT03756883|64818188|FG000|Overall Study|Withdrawal by Subject|4|||
23294286|NCT03756883|64818189|FG001|Overall Study|Withdrawal by Subject|1|||
23294287|NCT03756883|64818190|FG002|Overall Study|Withdrawal by Subject|0|||
23294288|NCT03756883|64818188|FG000|Overall Study|Other Reasons|2|||
23294289|NCT03756883|64818189|FG001|Overall Study|Other Reasons|4|||
23386667|NCT01964560|65158777|FG000|Overall Study|Lost to Follow-up|4|||
23294290|NCT03756883|64818190|FG002|Overall Study|Other Reasons|0|||
23294291|NCT00612677|64818195|FG000|Overall Study|study closed before treatment started|1|||
23294292|NCT01813435|64818196|FG000|Overall Study|did not finish experimental regimen|1902|||
23294293|NCT01813435|64818197|FG001|Overall Study|did not finish experimental regimen|770|||
23294294|NCT01813435|64818196|FG000|Overall Study|Lost to Follow-up|268|||
23294295|NCT01813435|64818197|FG001|Overall Study|Lost to Follow-up|237|||
23294296|NCT02608476|64818198|FG000|Overall Study|Withdrawal by Subject|30|||
23294297|NCT02608476|64818199|FG001|Overall Study|Withdrawal by Subject|37|||
23386668|NCT01964560|65158777|FG000|Overall Study|Withdrawal by Subject|64|||
23386669|NCT01964560|65158777|FG000|Overall Study|Surgery-hemispherotomy|1|||
23386670|NCT01964560|65158777|FG000|Overall Study|Surgery|1|||
23386671|NCT01964560|65158777|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
23386672|NCT01964560|65158777|FG000|Overall Study|Patient and Investigator choice|1|||
23386673|NCT01964560|65158777|FG000|Overall Study|Patient was prescribed CBD|1|||
23386674|NCT01964560|65158777|FG000|Overall Study|Participant moved to another country|1|||
23386675|NCT02186171|65158778|FG000|Overall Study|Withdrawal by Subject|1|||
23386676|NCT02186171|65158779|FG001|Overall Study|Withdrawal by Subject|9|||
23386677|NCT02186171|65158778|FG000|Overall Study|Lost to Follow-up|2|||
23386678|NCT02186171|65158779|FG001|Overall Study|Lost to Follow-up|2|||
23386679|NCT02186171|65158778|FG000|Overall Study|Death|1|||
23386680|NCT02186171|65158779|FG001|Overall Study|Death|2|||
23386681|NCT02186171|65158778|FG000|Overall Study|Protocol-specified Criteria|0|||
23386682|NCT02186171|65158779|FG001|Overall Study|Protocol-specified Criteria|2|||
23386683|NCT02489773|65158781|FG000|Overall Study|Lost to Follow-up|4|||
23386684|NCT02489773|65158782|FG001|Overall Study|Lost to Follow-up|1|||
23386685|NCT02489773|65158781|FG000|Overall Study|Physician Decision|1|||
23294298|NCT02608476|64818198|FG000|Overall Study|Lost to Follow-up|24|||
23294299|NCT02608476|64818199|FG001|Overall Study|Lost to Follow-up|24|||
23294300|NCT02608476|64818198|FG000|Overall Study|Adverse Event|2|||
23294301|NCT02608476|64818199|FG001|Overall Study|Adverse Event|8|||
23294302|NCT02608476|64818198|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
23294303|NCT02608476|64818199|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
23294304|NCT02608476|64818198|FG000|Overall Study|Noncompliance with treatment|1|||
23294305|NCT02608476|64818199|FG001|Overall Study|Noncompliance with treatment|5|||
23294306|NCT02608476|64818198|FG000|Overall Study|Lack of Efficacy|3|||
23294307|NCT02608476|64818199|FG001|Overall Study|Lack of Efficacy|1|||
23294308|NCT02608476|64818198|FG000|Overall Study|Other|0|||
23294309|NCT02608476|64818199|FG001|Overall Study|Other|1|||
23294310|NCT02608476|64818198|FG000|Overall Study|Physician Decision|1|||
23294311|NCT02608476|64818199|FG001|Overall Study|Physician Decision|0|||
23294312|NCT02608476|64818198|FG000|Overall Study|Pregnancy|0|||
23294313|NCT02608476|64818199|FG001|Overall Study|Pregnancy|1|||
23294314|NCT02608476|64818198|FG000|Overall Study|Progressive disease|1|||
23294315|NCT02608476|64818199|FG001|Overall Study|Progressive disease|0|||
23294316|NCT03449199|64818200|FG000|Overall Study|Lost to Follow-up|1|||
23294317|NCT03449199|64818201|FG001|Overall Study|Lost to Follow-up|1|||
23294318|NCT03449199|64818202|FG002|Overall Study|Lost to Follow-up|0|||
23294319|NCT03449199|64818200|FG000|Overall Study|Protocol Deviation|0|||
23294320|NCT03449199|64818201|FG001|Overall Study|Protocol Deviation|0|||
23294321|NCT03449199|64818202|FG002|Overall Study|Protocol Deviation|1|||
23294322|NCT03449199|64818200|FG000|Overall Study|Withdrawal by Subject|0|||
23294323|NCT03449199|64818201|FG001|Overall Study|Withdrawal by Subject|0|||
23294324|NCT03449199|64818202|FG002|Overall Study|Withdrawal by Subject|1|||
23294325|NCT00407745|64818203|FG000|Overall Study|Lack of Efficacy|1|||
23294326|NCT00407745|64818204|FG001|Overall Study|Lack of Efficacy|2|||
23294327|NCT00407745|64818203|FG000|Overall Study|Withdrawal by Subject|3|||
23294328|NCT00407745|64818204|FG001|Overall Study|Withdrawal by Subject|3|||
23294329|NCT00407745|64818203|FG000|Overall Study|Protocol Violation|5|||
23294330|NCT00407745|64818204|FG001|Overall Study|Protocol Violation|3|||
23294331|NCT00407745|64818203|FG000|Overall Study|Adverse Event|8|||
23294332|NCT00407745|64818204|FG001|Overall Study|Adverse Event|8|||
23294333|NCT00407745|64818203|FG000|Overall Study|Other|2|||
23294334|NCT00407745|64818204|FG001|Overall Study|Other|0|||
23294335|NCT00407745|64818203|FG000|Overall Study|Randomized, unknown if treated|0|||
23294336|NCT00407745|64818204|FG001|Overall Study|Randomized, unknown if treated|1|||
23294337|NCT04569786|64818212|FG000|Overall Study|Lost to Follow-up|1|||
23294338|NCT04569786|64818213|FG001|Overall Study|Lost to Follow-up|0|||
23294339|NCT04569786|64818214|FG002|Overall Study|Lost to Follow-up|4|||
23294340|NCT04569786|64818215|FG003|Overall Study|Lost to Follow-up|1|||
23294341|NCT04569786|64818216|FG004|Overall Study|Lost to Follow-up|0|||
23294342|NCT04569786|64818212|FG000|Overall Study|Withdrawal by Subject|0|||
23294343|NCT04569786|64818213|FG001|Overall Study|Withdrawal by Subject|0|||
23294344|NCT04569786|64818214|FG002|Overall Study|Withdrawal by Subject|0|||
23294345|NCT04569786|64818215|FG003|Overall Study|Withdrawal by Subject|5|||
23294346|NCT04569786|64818216|FG004|Overall Study|Withdrawal by Subject|1|||
23294347|NCT04569786|64818212|FG000|Overall Study|Physician Decision|0|||
23386686|NCT02489773|65158782|FG001|Overall Study|Physician Decision|0|||
23386687|NCT02489773|65158781|FG000|Overall Study|Withdrawal by Subject|1|||
23386688|NCT02489773|65158782|FG001|Overall Study|Withdrawal by Subject|0|||
23386689|NCT02489773|65158781|FG000|Overall Study|Leave the country or the state|1|||
23386690|NCT02489773|65158782|FG001|Overall Study|Leave the country or the state|1|||
23386691|NCT00504231|65158787|FG000|Overall Study|Discrepant chart documentation re route|0|||
23294348|NCT04569786|64818213|FG001|Overall Study|Physician Decision|0|||
23294349|NCT04569786|64818214|FG002|Overall Study|Physician Decision|0|||
23294350|NCT04569786|64818215|FG003|Overall Study|Physician Decision|1|||
23294351|NCT04569786|64818216|FG004|Overall Study|Physician Decision|0|||
23294352|NCT00442351|64818217|FG000|Overall Study|Administrative|6|||
23294353|NCT00442351|64818218|FG001|Overall Study|Administrative|5|||
23294354|NCT00442351|64818217|FG000|Overall Study|Did not meet protocol eligibility|1|||
23386692|NCT00504231|65158788|FG001|Overall Study|Discrepant chart documentation re route|0|||
23386693|NCT00504231|65158789|FG002|Overall Study|Discrepant chart documentation re route|1|||
23386694|NCT00504231|65158790|FG003|Overall Study|Discrepant chart documentation re route|0|||
23386695|NCT01158404|65158791|FG000|Overall Study|Withdrawal by Subject|0|||
23386696|NCT01158404|65158792|FG001|Overall Study|Withdrawal by Subject|1|||
23386697|NCT01158404|65158793|FG002|Overall Study|Withdrawal by Subject|0|||
23386698|NCT01158404|65158794|FG003|Overall Study|Withdrawal by Subject|0|||
23386699|NCT01158404|65158795|FG004|Overall Study|Withdrawal by Subject|3|||
23386700|NCT01158404|65158796|FG005|Overall Study|Withdrawal by Subject|1|||
23386701|NCT01158404|65158797|FG006|Overall Study|Withdrawal by Subject|0|||
23386702|NCT01158404|65158798|FG007|Overall Study|Withdrawal by Subject|1|||
23386703|NCT01158404|65158791|FG000|Overall Study|Physician Decision|0|||
23386704|NCT01158404|65158792|FG001|Overall Study|Physician Decision|0|||
23386705|NCT01158404|65158793|FG002|Overall Study|Physician Decision|0|||
23386706|NCT01158404|65158794|FG003|Overall Study|Physician Decision|0|||
23386707|NCT01158404|65158795|FG004|Overall Study|Physician Decision|0|||
23386708|NCT01158404|65158796|FG005|Overall Study|Physician Decision|0|||
23386709|NCT01158404|65158797|FG006|Overall Study|Physician Decision|0|||
23386710|NCT01158404|65158798|FG007|Overall Study|Physician Decision|1|||
23386711|NCT01158404|65158791|FG000|Overall Study|Progressive Disease|0|||
23386712|NCT01158404|65158792|FG001|Overall Study|Progressive Disease|0|||
23386713|NCT01158404|65158793|FG002|Overall Study|Progressive Disease|0|||
23386714|NCT01158404|65158794|FG003|Overall Study|Progressive Disease|0|||
23294355|NCT00442351|64818218|FG001|Overall Study|Did not meet protocol eligibility|0|||
23386715|NCT01158404|65158795|FG004|Overall Study|Progressive Disease|0|||
23386716|NCT01158404|65158796|FG005|Overall Study|Progressive Disease|0|||
23386717|NCT01158404|65158797|FG006|Overall Study|Progressive Disease|1|||
23386718|NCT01158404|65158798|FG007|Overall Study|Progressive Disease|0|||
23386719|NCT02528305|65158802|FG000|Overall Study|Withdrawal by Subject|1|||
23386720|NCT02528305|65158802|FG000|Overall Study|Adverse Event|1|||
23386721|NCT02528305|65158802|FG000|Overall Study|Physician Decision|1|||
23386722|NCT01263028|65162619|FG000|Overall Study|Withdrawal by Subject|1|||
23386723|NCT01263028|65162619|FG000|Overall Study|Adverse Event|1|||
23386724|NCT01263028|65162619|FG000|Overall Study|Study terminated due to low enrollment.|4|||
23386725|NCT00537082|65162620|FG000|Overall Study|Adverse Event|6|||
23386726|NCT00537082|65162621|FG001|Overall Study|Adverse Event|6|||
23294356|NCT00442351|64818217|FG000|Overall Study|Other|0|||
23294357|NCT00442351|64818218|FG001|Overall Study|Other|1|||
23294358|NCT02419573|64818219|FG000|Overall Study|Lost to Follow-up|3|||
23294359|NCT02419573|64818220|FG001|Overall Study|Lost to Follow-up|0|||
23294360|NCT02419573|64818219|FG000|Overall Study|Withdrawal by Subject|1|||
23294361|NCT02419573|64818220|FG001|Overall Study|Withdrawal by Subject|0|||
23294362|NCT01961687|64818221|FG000|Overall Study|Lost to Follow-up|19|||
23294363|NCT01961687|64818221|FG000|Overall Study|Re-operation|17|||
23294364|NCT01961687|64818221|FG000|Overall Study|Death|7|||
23294365|NCT01961687|64818221|FG000|Overall Study|Withdrawal by Subject|6|||
23294366|NCT01961687|64818221|FG000|Overall Study|Adverse Event|6|||
23294367|NCT01961687|64818221|FG000|Overall Study|Moved to area without study site|2|||
23294368|NCT01961687|64818221|FG000|Overall Study|Sponsor decision|2|||
23294369|NCT01961687|64818221|FG000|Overall Study|Physician Decision|1|||
23294370|NCT01961687|64818221|FG000|Overall Study|Unable to meet follow-up requirements|1|||
23294371|NCT00857818|64818222|FG000|Overall Study|Lack of Efficacy|1|||
23294372|NCT00857818|64818223|FG001|Overall Study|Lack of Efficacy|0|||
23294373|NCT00857818|64818222|FG000|Overall Study|Adverse Event|3|||
23294374|NCT00857818|64818223|FG001|Overall Study|Adverse Event|0|||
23294375|NCT00857818|64818222|FG000|Overall Study|Withdrawal by Subject|0|||
23294376|NCT00857818|64818223|FG001|Overall Study|Withdrawal by Subject|4|||
23294377|NCT00857818|64818222|FG000|Overall Study|Sponsor terminated study|6|||
23294378|NCT00857818|64818223|FG001|Overall Study|Sponsor terminated study|4|||
23294379|NCT00857818|64818222|FG000|Overall Study|Investigator decision|1|||
23294380|NCT00857818|64818223|FG001|Overall Study|Investigator decision|0|||
23294381|NCT04405739|64818229|FG000|Overall Study|Adverse Event|0|||
23294382|NCT04405739|64818230|FG001|Overall Study|Adverse Event|1|||
23294383|NCT04405739|64818231|FG002|Overall Study|Adverse Event|0|||
23294384|NCT04405739|64818232|FG003|Overall Study|Adverse Event|0|||
23386727|NCT00537082|65162622|FG002|Overall Study|Adverse Event|3|||
23386728|NCT00537082|65162620|FG000|Overall Study|Protocol Violation|0|||
23294385|NCT04405739|64818229|FG000|Overall Study|Lost to Follow-up|0|||
23294386|NCT04405739|64818230|FG001|Overall Study|Lost to Follow-up|2|||
23386729|NCT00537082|65162621|FG001|Overall Study|Protocol Violation|2|||
23386730|NCT00537082|65162622|FG002|Overall Study|Protocol Violation|1|||
23386731|NCT00537082|65162620|FG000|Overall Study|Lack of Efficacy|0|||
23386732|NCT00537082|65162621|FG001|Overall Study|Lack of Efficacy|0|||
23386733|NCT00537082|65162622|FG002|Overall Study|Lack of Efficacy|2|||
23294387|NCT04405739|64818231|FG002|Overall Study|Lost to Follow-up|1|||
23294388|NCT04405739|64818232|FG003|Overall Study|Lost to Follow-up|3|||
23294389|NCT04405739|64818229|FG000|Overall Study|Withdrawal by Subject|0|||
23294390|NCT04405739|64818230|FG001|Overall Study|Withdrawal by Subject|2|||
23294391|NCT04405739|64818231|FG002|Overall Study|Withdrawal by Subject|1|||
23294392|NCT04405739|64818232|FG003|Overall Study|Withdrawal by Subject|1|||
23294393|NCT04405739|64818229|FG000|Overall Study|Death|0|||
23294394|NCT04405739|64818230|FG001|Overall Study|Death|0|||
23294395|NCT04405739|64818231|FG002|Overall Study|Death|1|||
23294396|NCT04405739|64818232|FG003|Overall Study|Death|0|||
23294397|NCT04405739|64818229|FG000|Overall Study|Transferred to rehab|0|||
23294398|NCT04405739|64818230|FG001|Overall Study|Transferred to rehab|0|||
23294399|NCT04405739|64818231|FG002|Overall Study|Transferred to rehab|0|||
23294400|NCT04405739|64818232|FG003|Overall Study|Transferred to rehab|1|||
23294401|NCT04405739|64818229|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
23294402|NCT04405739|64818230|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
23294403|NCT04405739|64818231|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
23294404|NCT04405739|64818232|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
23294405|NCT02012452|64818233|FG000|Overall Study|Lost to Follow-up|2|||
23294406|NCT02012452|64818234|FG001|Overall Study|Lost to Follow-up|1|||
23294407|NCT02012452|64818233|FG000|Overall Study|Withdrawal by Subject|4|||
23294408|NCT02012452|64818234|FG001|Overall Study|Withdrawal by Subject|0|||
23294409|NCT04314843|64818235|FG000|Overall Study|Death|2|||
23294410|NCT04314843|64818236|FG001|Overall Study|Death|2|||
23294411|NCT04314843|64818235|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
23294412|NCT04314843|64818236|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
23294413|NCT00941720|64818246|FG000|Overall Study|Withdrawal by Subject|1|||
23294414|NCT00941720|64818246|FG000|Overall Study|Insurance denied participation|11|||
23294415|NCT00941720|64818246|FG000|Overall Study|ineligible|2|||
23294416|NCT03438006|64818251|FG000|Overall Study|Adverse Event|1|||
23294417|NCT03438006|64818251|FG000|Overall Study|Lost to Follow-up|67|||
23294418|NCT03438006|64818251|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
23294419|NCT03438006|64818251|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
23386734|NCT00537082|65162620|FG000|Overall Study|Withdrawal by Subject|0|||
23386735|NCT00537082|65162621|FG001|Overall Study|Withdrawal by Subject|1|||
23386736|NCT00537082|65162622|FG002|Overall Study|Withdrawal by Subject|0|||
23386737|NCT00537082|65162620|FG000|Overall Study|Discontinued before initiating treatment|3|||
23386738|NCT00537082|65162621|FG001|Overall Study|Discontinued before initiating treatment|0|||
23386739|NCT00537082|65162622|FG002|Overall Study|Discontinued before initiating treatment|0|||
23386740|NCT00292370|65162625|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
23386741|NCT00292370|65162626|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
23386742|NCT00292370|65162627|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
23386743|NCT00292370|65162625|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
23386744|NCT00292370|65162626|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
23386745|NCT00292370|65162627|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
23386746|NCT00292370|65162625|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
23386747|NCT00292370|65162626|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
23386748|NCT00292370|65162627|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
23386749|NCT00292370|65162625|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
23386750|NCT00292370|65162626|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
23386751|NCT00292370|65162627|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
23386752|NCT00292370|65162625|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
23386753|NCT00292370|65162626|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
23386754|NCT00292370|65162627|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
23386755|NCT00292370|65162625|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
23386756|NCT00292370|65162626|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
23386757|NCT00292370|65162627|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
23386758|NCT02123511|65162628|FG000|Overall Study|Cancelled treatment|1|||
23386759|NCT02123511|65162629|FG001|Overall Study|Cancelled treatment|0|||
23386760|NCT02123511|65162628|FG000|Overall Study|Incomplete data|1|||
23386761|NCT02123511|65162629|FG001|Overall Study|Incomplete data|3|||
23386762|NCT02123511|65162628|FG000|Overall Study|Ineligible|0|||
23386763|NCT02123511|65162629|FG001|Overall Study|Ineligible|1|||
23493700|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Death|1|||
23493701|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
23294420|NCT02413294|64818258|FG000|Overall Study|Withdrawal by Subject|1|||
23294421|NCT00171340|64818261|FG000|Overall Study|Adverse Event|46|||
23294422|NCT00171340|64818262|FG001|Overall Study|Adverse Event|42|||
23294423|NCT00171340|64818261|FG000|Overall Study|Lack of Efficacy|29|||
23386764|NCT01927861|65162630|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
23386765|NCT01927861|65162631|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
23386766|NCT01927861|65162630|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
23493702|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
23294424|NCT00171340|64818262|FG001|Overall Study|Lack of Efficacy|41|||
23294425|NCT00171340|64818261|FG000|Overall Study|Protocol Violation|7|||
23294426|NCT00171340|64818262|FG001|Overall Study|Protocol Violation|8|||
23294427|NCT00171340|64818261|FG000|Overall Study|Withdrawal by Subject|22|||
23294428|NCT00171340|64818262|FG001|Overall Study|Withdrawal by Subject|19|||
23294429|NCT00171340|64818261|FG000|Overall Study|Lost to Follow-up|0|||
23294430|NCT00171340|64818262|FG001|Overall Study|Lost to Follow-up|5|||
23294431|NCT00171340|64818261|FG000|Overall Study|Abnormal Laboratory Results|2|||
23294432|NCT00171340|64818262|FG001|Overall Study|Abnormal Laboratory Results|0|||
23294433|NCT00171340|64818261|FG000|Overall Study|Abnormal Test Procedure Results|6|||
23294434|NCT00171340|64818262|FG001|Overall Study|Abnormal Test Procedure Results|11|||
23294435|NCT00171340|64818261|FG000|Overall Study|No Longer Required Study Drug|1|||
23294436|NCT00171340|64818262|FG001|Overall Study|No Longer Required Study Drug|1|||
23294437|NCT00171340|64818261|FG000|Overall Study|Administrative Problems|5|||
23294438|NCT00171340|64818262|FG001|Overall Study|Administrative Problems|2|||
23294439|NCT00171340|64818261|FG000|Overall Study|Death|6|||
23294440|NCT00171340|64818262|FG001|Overall Study|Death|6|||
23294441|NCT02972515|64818263|FG000|Overall Study|Lost to Follow-up|78|||
23294442|NCT02013531|64818271|FG000|Overall Study|Lost to Follow-up|3|||
23294443|NCT02013531|64818271|FG000|Overall Study|Met Withdrawal Criteria|1|||
23294444|NCT02013531|64818271|FG000|Overall Study|Withdrawal by Subject|1|||
23294445|NCT00996437|64818272|FG000|Overall Study|Death|1|||
23294446|NCT00996437|64818273|FG001|Overall Study|Death|0|||
23294447|NCT00996437|64818272|FG000|Overall Study|Dropped|2|||
23294448|NCT00996437|64818273|FG001|Overall Study|Dropped|2|||
23294449|NCT00996437|64818272|FG000|Overall Study|Missed|2|||
23294450|NCT00996437|64818273|FG001|Overall Study|Missed|5|||
23294451|NCT03259789|64818274|FG000|Overall Study|Adverse Event|3|||
23294452|NCT03259789|64818275|FG001|Overall Study|Adverse Event|2|||
23294453|NCT03259789|64818276|FG002|Overall Study|Adverse Event|1|||
23294454|NCT03259789|64818274|FG000|Overall Study|Withdrawal by Subject|9|||
23294455|NCT03259789|64818275|FG001|Overall Study|Withdrawal by Subject|5|||
23294456|NCT03259789|64818276|FG002|Overall Study|Withdrawal by Subject|1|||
23294457|NCT03259789|64818274|FG000|Overall Study|Lost to Follow-up|5|||
23294458|NCT03259789|64818275|FG001|Overall Study|Lost to Follow-up|9|||
23294459|NCT03259789|64818276|FG002|Overall Study|Lost to Follow-up|4|||
23294460|NCT03259789|64818274|FG000|Overall Study|Physician Decision|0|||
23294461|NCT03259789|64818275|FG001|Overall Study|Physician Decision|1|||
23386767|NCT01927861|65162631|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
23294462|NCT03259789|64818276|FG002|Overall Study|Physician Decision|0|||
23294463|NCT04126343|64818277|FG000|Overall Study|Adverse Event|0|||
23294464|NCT04126343|64818278|FG001|Overall Study|Adverse Event|0|||
23294465|NCT04126343|64818279|FG002|Overall Study|Adverse Event|0|||
23294466|NCT04126343|64818280|FG003|Overall Study|Adverse Event|0|||
23386768|NCT02184442|65162633|FG000|Overall Study|Death|61|||
23386769|NCT02184442|65162634|FG001|Overall Study|Death|65|||
23386770|NCT02184442|65162633|FG000|Overall Study|Withdrawal by Subject|3|||
23386771|NCT02184442|65162634|FG001|Overall Study|Withdrawal by Subject|11|||
23386772|NCT02583477|65162635|FG000|Overall Study|Adverse Event|0|||
23386773|NCT02583477|65162636|FG001|Overall Study|Adverse Event|2|||
23386774|NCT02583477|65162635|FG000|Overall Study|Death|1|||
23386775|NCT02583477|65162636|FG001|Overall Study|Death|16|||
23386776|NCT02583477|65162635|FG000|Overall Study|Study terminated|2|||
23386777|NCT02583477|65162636|FG001|Overall Study|Study terminated|2|||
23386778|NCT01543503|65162637|FG000|Overall Study|Lost to Follow-up|32|||
23386779|NCT01543503|65162638|FG001|Overall Study|Lost to Follow-up|36|||
23386780|NCT01543503|65162637|FG000|Overall Study|Adverse Event|9|||
23386781|NCT01543503|65162638|FG001|Overall Study|Adverse Event|13|||
23386782|NCT01543503|65162637|FG000|Overall Study|Lack of Efficacy|4|||
23386783|NCT01543503|65162638|FG001|Overall Study|Lack of Efficacy|16|||
23386784|NCT01543503|65162637|FG000|Overall Study|Participant withdrew informed consent|8|||
23386785|NCT01543503|65162638|FG001|Overall Study|Participant withdrew informed consent|10|||
23386786|NCT01543503|65162637|FG000|Overall Study|Change of jobs|0|||
23386787|NCT01543503|65162638|FG001|Overall Study|Change of jobs|1|||
23386788|NCT01543503|65162637|FG000|Overall Study|Intolerance to the biologic treatment|0|||
23386789|NCT01543503|65162638|FG001|Overall Study|Intolerance to the biologic treatment|1|||
23386790|NCT01543503|65162637|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
23386791|NCT01543503|65162638|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
23386792|NCT01543503|65162637|FG000|Overall Study|Participant did not complete last visit|0|||
23386793|NCT01543503|65162638|FG001|Overall Study|Participant did not complete last visit|2|||
23493703|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
23386794|NCT01543503|65162637|FG000|Overall Study|Refused to continue treatment|7|||
23386795|NCT01543503|65162638|FG001|Overall Study|Refused to continue treatment|0|||
23386796|NCT01543503|65162637|FG000|Overall Study|Incorrect medication received|1|||
23386797|NCT01543503|65162638|FG001|Overall Study|Incorrect medication received|0|||
23386798|NCT01543503|65162637|FG000|Overall Study|Participant moved to another city|2|||
23386799|NCT01543503|65162638|FG001|Overall Study|Participant moved to another city|0|||
23386800|NCT01543503|65162637|FG000|Overall Study|Participant will not return for visits|0|||
23386801|NCT01543503|65162638|FG001|Overall Study|Participant will not return for visits|2|||
23386802|NCT01543503|65162637|FG000|Overall Study|Participant transferred to another city|1|||
23386803|NCT01543503|65162638|FG001|Overall Study|Participant transferred to another city|0|||
23386804|NCT01543503|65162637|FG000|Overall Study|Participant moved to Scotland|1|||
23386805|NCT01543503|65162638|FG001|Overall Study|Participant moved to Scotland|0|||
23386806|NCT01543503|65162637|FG000|Overall Study|Participant decision to stop treatment|1|||
23386807|NCT01543503|65162638|FG001|Overall Study|Participant decision to stop treatment|0|||
23386808|NCT01543503|65162637|FG000|Overall Study|Investigator did not wish to participate|1|||
23386809|NCT01543503|65162638|FG001|Overall Study|Investigator did not wish to participate|1|||
23386810|NCT01543503|65162637|FG000|Overall Study|Participant recruited after closing date|0|||
23386811|NCT01543503|65162638|FG001|Overall Study|Participant recruited after closing date|1|||
23386812|NCT01543503|65162637|FG000|Overall Study|Site stopped participation|5|||
23386813|NCT01543503|65162638|FG001|Overall Study|Site stopped participation|1|||
23386814|NCT01543503|65162637|FG000|Overall Study|Participant did not attend a visit|1|||
23386815|NCT01543503|65162638|FG001|Overall Study|Participant did not attend a visit|0|||
23386816|NCT01543503|65162637|FG000|Overall Study|Moved to other rheumatologic site|0|||
23386817|NCT01543503|65162638|FG001|Overall Study|Moved to other rheumatologic site|1|||
23386818|NCT01543503|65162637|FG000|Overall Study|Participant consented to another study|0|||
23386819|NCT01543503|65162638|FG001|Overall Study|Participant consented to another study|2|||
23386820|NCT01543503|65162637|FG000|Overall Study|Participant went to United States|1|||
23386821|NCT01543503|65162638|FG001|Overall Study|Participant went to United States|0|||
23386822|NCT01543503|65162637|FG000|Overall Study|Screen failure|1|||
23386823|NCT01543503|65162638|FG001|Overall Study|Screen failure|0|||
23386824|NCT01096186|65162639|FG000|Overall Study|Adverse Event|16|||
23386825|NCT01096186|65162639|FG000|Overall Study|Death|4|||
23386826|NCT01096186|65162639|FG000|Overall Study|Lack of Efficacy|4|||
23386827|NCT01096186|65162639|FG000|Overall Study|Lost to Follow-up|2|||
23386828|NCT01096186|65162639|FG000|Overall Study|Withdrawal by Subject|22|||
23386829|NCT01096186|65162639|FG000|Overall Study|Physician Decision|1|||
23386830|NCT01096186|65162639|FG000|Overall Study|Noncompliance with study drug|1|||
23386831|NCT04432298|65162641|FG000|Overall Study|Other than specified|1|||
23386832|NCT04432298|65162642|FG001|Overall Study|Other than specified|0|||
23386833|NCT04432298|65162641|FG000|Overall Study|Lost to Follow-up|0|||
23386834|NCT04432298|65162642|FG001|Overall Study|Lost to Follow-up|1|||
23386835|NCT04432298|65162641|FG000|Overall Study|Death|3|||
23386836|NCT04432298|65162642|FG001|Overall Study|Death|2|||
23386837|NCT04432298|65162641|FG000|Overall Study|Withdrawal by Subject|2|||
23386838|NCT04432298|65162642|FG001|Overall Study|Withdrawal by Subject|0|||
23386839|NCT03211832|65162645|FG000|Overall Study|No longer with agency|32|||
23386840|NCT03211832|65162646|FG001|Overall Study|No longer with agency|49|||
23386841|NCT03211832|65162647|FG002|Overall Study|No longer with agency|30|||
23386842|NCT03211832|65162645|FG000|Overall Study|Declined survey|3|||
23386843|NCT03211832|65162646|FG001|Overall Study|Declined survey|3|||
23386844|NCT03211832|65162647|FG002|Overall Study|Declined survey|2|||
23386845|NCT03211832|65162645|FG000|Overall Study|Not available during data collection|1|||
23386846|NCT03211832|65162646|FG001|Overall Study|Not available during data collection|0|||
23386847|NCT03211832|65162647|FG002|Overall Study|Not available during data collection|2|||
23386848|NCT02037984|65162648|FG000|Overall Study|Lack of Efficacy|0|||
23386849|NCT02037984|65162649|FG001|Overall Study|Lack of Efficacy|0|||
23386850|NCT02037984|65162650|FG002|Overall Study|Lack of Efficacy|3|||
23386851|NCT02037984|65162651|FG003|Overall Study|Lack of Efficacy|10|||
23386852|NCT02037984|65162652|FG004|Overall Study|Lack of Efficacy|2|||
23386853|NCT02037984|65162653|FG005|Overall Study|Lack of Efficacy|2|||
23386854|NCT02037984|65162654|FG006|Overall Study|Lack of Efficacy|4|||
23386855|NCT02037984|65162655|FG007|Overall Study|Lack of Efficacy|3|||
23386856|NCT02037984|65162648|FG000|Overall Study|Lost to Follow-up|1|||
23386857|NCT02037984|65162649|FG001|Overall Study|Lost to Follow-up|0|||
23386858|NCT02037984|65162650|FG002|Overall Study|Lost to Follow-up|3|||
23386859|NCT02037984|65162651|FG003|Overall Study|Lost to Follow-up|5|||
23386860|NCT02037984|65162652|FG004|Overall Study|Lost to Follow-up|2|||
23386861|NCT02037984|65162653|FG005|Overall Study|Lost to Follow-up|2|||
23386862|NCT02037984|65162654|FG006|Overall Study|Lost to Follow-up|2|||
23386863|NCT02037984|65162655|FG007|Overall Study|Lost to Follow-up|4|||
23386864|NCT02037984|65162648|FG000|Overall Study|Physician Decision|0|||
23386865|NCT02037984|65162649|FG001|Overall Study|Physician Decision|0|||
23386866|NCT02037984|65162650|FG002|Overall Study|Physician Decision|0|||
23386867|NCT02037984|65162651|FG003|Overall Study|Physician Decision|0|||
23386868|NCT02037984|65162652|FG004|Overall Study|Physician Decision|0|||
23386869|NCT02037984|65162653|FG005|Overall Study|Physician Decision|0|||
23386870|NCT02037984|65162654|FG006|Overall Study|Physician Decision|1|||
23386871|NCT02037984|65162655|FG007|Overall Study|Physician Decision|0|||
23386872|NCT02037984|65162648|FG000|Overall Study|Protocol Violation|0|||
23386873|NCT02037984|65162649|FG001|Overall Study|Protocol Violation|0|||
23386874|NCT02037984|65162650|FG002|Overall Study|Protocol Violation|0|||
23386875|NCT02037984|65162651|FG003|Overall Study|Protocol Violation|0|||
23386876|NCT02037984|65162652|FG004|Overall Study|Protocol Violation|0|||
23386877|NCT02037984|65162653|FG005|Overall Study|Protocol Violation|1|||
23386878|NCT02037984|65162654|FG006|Overall Study|Protocol Violation|2|||
23386879|NCT02037984|65162655|FG007|Overall Study|Protocol Violation|0|||
23386880|NCT02037984|65162648|FG000|Overall Study|Technical Problems|0|||
23386881|NCT02037984|65162649|FG001|Overall Study|Technical Problems|0|||
23386882|NCT02037984|65162650|FG002|Overall Study|Technical Problems|3|||
23386883|NCT02037984|65162651|FG003|Overall Study|Technical Problems|3|||
23386884|NCT02037984|65162652|FG004|Overall Study|Technical Problems|2|||
23386885|NCT02037984|65162653|FG005|Overall Study|Technical Problems|3|||
23386886|NCT02037984|65162654|FG006|Overall Study|Technical Problems|4|||
23386887|NCT02037984|65162655|FG007|Overall Study|Technical Problems|2|||
23386888|NCT02037984|65162648|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
23386889|NCT02037984|65162649|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23386890|NCT02037984|65162650|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
23386891|NCT02037984|65162651|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
23386892|NCT02037984|65162652|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
23294467|NCT04126343|64818281|FG004|Overall Study|Adverse Event|0|||
23294468|NCT04126343|64818282|FG005|Overall Study|Adverse Event|1|||
23294469|NCT04126343|64818277|FG000|Overall Study|Withdrawal by Subject|0|||
23294470|NCT04126343|64818278|FG001|Overall Study|Withdrawal by Subject|0|||
23294471|NCT04126343|64818279|FG002|Overall Study|Withdrawal by Subject|0|||
23294472|NCT04126343|64818280|FG003|Overall Study|Withdrawal by Subject|1|||
23294473|NCT04126343|64818281|FG004|Overall Study|Withdrawal by Subject|0|||
23294474|NCT04126343|64818282|FG005|Overall Study|Withdrawal by Subject|0|||
23386893|NCT02037984|65162653|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
23493704|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
23294475|NCT04126343|64818277|FG000|Overall Study|Related to COVID-19 pandemic|3|||
23294476|NCT04126343|64818278|FG001|Overall Study|Related to COVID-19 pandemic|4|||
23294477|NCT04126343|64818279|FG002|Overall Study|Related to COVID-19 pandemic|3|||
23294478|NCT04126343|64818280|FG003|Overall Study|Related to COVID-19 pandemic|3|||
23294479|NCT04126343|64818281|FG004|Overall Study|Related to COVID-19 pandemic|3|||
23294480|NCT04126343|64818282|FG005|Overall Study|Related to COVID-19 pandemic|3|||
23294481|NCT01350934|64818283|FG000|Base Study|Adverse Event|6|||
23294482|NCT01350934|64818284|FG001|Base Study|Adverse Event|0|||
23294483|NCT01350934|64818283|FG000|Base Study|Lost to Follow-up|1|||
23386894|NCT02037984|65162654|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
23386895|NCT02037984|65162655|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
23386896|NCT02037984|65162648|FG000|Overall Study|Withdrawal by Subject|0|||
23386897|NCT02037984|65162649|FG001|Overall Study|Withdrawal by Subject|0|||
23386898|NCT02037984|65162650|FG002|Overall Study|Withdrawal by Subject|0|||
23386899|NCT02037984|65162651|FG003|Overall Study|Withdrawal by Subject|1|||
23386900|NCT02037984|65162652|FG004|Overall Study|Withdrawal by Subject|1|||
23386901|NCT02037984|65162653|FG005|Overall Study|Withdrawal by Subject|3|||
23386902|NCT02037984|65162654|FG006|Overall Study|Withdrawal by Subject|0|||
23386903|NCT02037984|65162655|FG007|Overall Study|Withdrawal by Subject|1|||
23386904|NCT01392495|65162662|FG000|Overall Study|Death|3|||
23386905|NCT01392495|65162662|FG000|Overall Study|Administrative problems|8|||
23386906|NCT01392495|65162662|FG000|Overall Study|Withdrawal by Subject|2|||
23386907|NCT01392495|65162662|FG000|Overall Study|Adverse Event|3|||
23386908|NCT00215553|65162663|FG000|Overall Study|Adverse Event|0|||
23294484|NCT01350934|64818284|FG001|Base Study|Lost to Follow-up|0|||
23294485|NCT01350934|64818283|FG000|Base Study|Protocol Violation|1|||
23294486|NCT01350934|64818284|FG001|Base Study|Protocol Violation|1|||
23294487|NCT01350934|64818283|FG000|Base Study|Withdrawal by Subject|1|||
23294488|NCT01350934|64818284|FG001|Base Study|Withdrawal by Subject|2|||
23294489|NCT01350934|64818283|FG000|Base Study|Non-Compliance With Study Drug|2|||
23294490|NCT01350934|64818284|FG001|Base Study|Non-Compliance With Study Drug|0|||
23386909|NCT00215553|65162664|FG001|Overall Study|Adverse Event|1|||
23386910|NCT00215553|65162665|FG002|Overall Study|Adverse Event|2|||
23386911|NCT00215553|65162666|FG003|Overall Study|Adverse Event|1|||
23386912|NCT00215553|65162667|FG004|Overall Study|Adverse Event|2|||
23386913|NCT00215553|65162668|FG005|Overall Study|Adverse Event|6|||
23386914|NCT00215553|65162669|FG006|Overall Study|Adverse Event|0|||
23386915|NCT02176525|65162672|FG000|Overall Study|Adverse Event|0|||
23386916|NCT02176525|65162673|FG001|Overall Study|Adverse Event|0|||
23386917|NCT02176525|65162674|FG002|Overall Study|Adverse Event|0|||
23386918|NCT02176525|65162675|FG003|Overall Study|Adverse Event|1|||
23386919|NCT02176525|65162676|FG004|Overall Study|Adverse Event|1|||
23386920|NCT02176525|65162677|FG005|Overall Study|Adverse Event|0|||
23386921|NCT02176525|65162678|FG006|Overall Study|Adverse Event|1|||
23386922|NCT02176525|65162679|FG007|Overall Study|Adverse Event|0|||
23386923|NCT02176525|65162672|FG000|Overall Study|not treated|1|||
23386924|NCT02176525|65162673|FG001|Overall Study|not treated|0|||
23386925|NCT02176525|65162674|FG002|Overall Study|not treated|0|||
23386926|NCT02176525|65162675|FG003|Overall Study|not treated|0|||
23386927|NCT02176525|65162676|FG004|Overall Study|not treated|0|||
23386928|NCT02176525|65162677|FG005|Overall Study|not treated|1|||
23386929|NCT02176525|65162678|FG006|Overall Study|not treated|0|||
23386930|NCT02176525|65162679|FG007|Overall Study|not treated|0|||
23386931|NCT02301429|65162680|FG000|Overall Study|not acceptable vascular anatomy|3|||
23386932|NCT00311168|65162681|FG000|First Intervention|Withdrawal by Subject|2|||
23386933|NCT00311168|65162682|FG001|First Intervention|Withdrawal by Subject|2|||
23386934|NCT00311168|65162681|FG000|First Intervention|Lost to Follow-up|1|||
23386935|NCT00311168|65162682|FG001|First Intervention|Lost to Follow-up|1|||
23386936|NCT00311168|65162681|FG000|First Intervention|Protocol Violation|1|||
23386937|NCT00311168|65162682|FG001|First Intervention|Protocol Violation|1|||
23386938|NCT00311168|65162681|FG000|First Intervention|Adverse Event|1|||
23386939|NCT00311168|65162682|FG001|First Intervention|Adverse Event|0|||
23386940|NCT00311168|65162681|FG000|First Intervention|Other|2|||
23386941|NCT00311168|65162682|FG001|First Intervention|Other|2|||
23386942|NCT00311168|65162681|FG000|Second Intervention|Lost to Follow-up|9|||
23386943|NCT00311168|65162682|FG001|Second Intervention|Lost to Follow-up|2|||
23386944|NCT00311168|65162681|FG000|Second Intervention|Withdrawal by Subject|0|||
23386945|NCT00311168|65162682|FG001|Second Intervention|Withdrawal by Subject|1|||
23386946|NCT00311168|65162681|FG000|Second Intervention|Other|1|||
23386947|NCT00311168|65162682|FG001|Second Intervention|Other|1|||
23386948|NCT03511066|65162684|FG000|Overall Study|Withdrawal by Subject|1|||
23386949|NCT03511066|65162685|FG001|Overall Study|Withdrawal by Subject|2|||
23386950|NCT03511066|65162686|FG002|Overall Study|Withdrawal by Subject|3|||
23386951|NCT03511066|65162684|FG000|Overall Study|Lost to Follow-up|2|||
23386952|NCT03511066|65162685|FG001|Overall Study|Lost to Follow-up|3|||
23294491|NCT01350934|64818283|FG000|Extension Study|Adverse Event|2|||
23386953|NCT03511066|65162686|FG002|Overall Study|Lost to Follow-up|0|||
23294492|NCT01350934|64818284|FG001|Extension Study|Adverse Event|1|||
23386954|NCT01230814|65162687|FG000|Overall Study|Lost to Follow-up|11|||
23386955|NCT01230814|65162688|FG001|Overall Study|Lost to Follow-up|3|||
23386956|NCT01230814|65162687|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
23386957|NCT01230814|65162688|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
23386958|NCT00159874|65162691|FG000|Overall Study|Adverse Event|2|||
23386959|NCT00159874|65162692|FG001|Overall Study|Adverse Event|2|||
23386960|NCT00159874|65162693|FG002|Overall Study|Adverse Event|5|||
23294493|NCT01350934|64818283|FG000|Extension Study|Lost to Follow-up|2|||
23294494|NCT01350934|64818284|FG001|Extension Study|Lost to Follow-up|0|||
23294495|NCT01350934|64818283|FG000|Extension Study|Protocol Violation|1|||
23294496|NCT01350934|64818284|FG001|Extension Study|Protocol Violation|1|||
23294497|NCT01350934|64818283|FG000|Extension Study|Lack of Efficacy|0|||
23294498|NCT01350934|64818284|FG001|Extension Study|Lack of Efficacy|1|||
23294499|NCT01350934|64818283|FG000|Extension Study|Withdrawal by Subject|0|||
23294500|NCT01350934|64818284|FG001|Extension Study|Withdrawal by Subject|1|||
23294501|NCT00199901|64818285|FG000|Overall Study|Protocol Violation|2|||
23294502|NCT00199901|64818286|FG001|Overall Study|Protocol Violation|0|||
23294503|NCT00199901|64818285|FG000|Overall Study|Withdrawal by Subject|1|||
23294504|NCT00199901|64818286|FG001|Overall Study|Withdrawal by Subject|0|||
23294505|NCT00199901|64818285|FG000|Overall Study|Progressive Disease|24|||
23294506|NCT00199901|64818286|FG001|Overall Study|Progressive Disease|24|||
23294507|NCT02674633|64818287|FG000|Overall Study|Lost to Follow-up|3|||
23294508|NCT02674633|64818288|FG001|Overall Study|Lost to Follow-up|2|||
23294509|NCT02674633|64818287|FG000|Overall Study|Physician Decision|1|||
23294510|NCT02674633|64818288|FG001|Overall Study|Physician Decision|0|||
23294511|NCT02674633|64818287|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
23294512|NCT02674633|64818288|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
23294513|NCT00981799|64818289|FG000|Overall Study|Adverse Event|1|||
23294514|NCT00981799|64818290|FG001|Overall Study|Adverse Event|1|||
23294515|NCT00981799|64818291|FG002|Overall Study|Adverse Event|0|||
23294516|NCT00981799|64818292|FG003|Overall Study|Adverse Event|0|||
23294517|NCT01647711|64818293|FG000|Overall Study|Progressive disease|6|||
23294518|NCT01647711|64818294|FG001|Overall Study|Progressive disease|2|||
23294519|NCT01647711|64818295|FG002|Overall Study|Progressive disease|6|||
23294520|NCT01647711|64818296|FG003|Overall Study|Progressive disease|8|||
23294521|NCT01647711|64818297|FG004|Overall Study|Progressive disease|2|||
23294522|NCT01647711|64818293|FG000|Overall Study|Other adverse event|0|||
23294523|NCT01647711|64818294|FG001|Overall Study|Other adverse event|0|||
23294524|NCT01647711|64818295|FG002|Overall Study|Other adverse event|2|||
23294525|NCT01647711|64818296|FG003|Overall Study|Other adverse event|0|||
23294526|NCT01647711|64818297|FG004|Overall Study|Other adverse event|2|||
23294527|NCT01647711|64818293|FG000|Overall Study|Protocol Violation|0|||
23294528|NCT01647711|64818294|FG001|Overall Study|Protocol Violation|0|||
23386961|NCT00159874|65162694|FG003|Overall Study|Adverse Event|1|||
23294529|NCT01647711|64818295|FG002|Overall Study|Protocol Violation|0|||
23294530|NCT01647711|64818296|FG003|Overall Study|Protocol Violation|0|||
23294531|NCT01647711|64818297|FG004|Overall Study|Protocol Violation|1|||
23386962|NCT00159874|65162695|FG004|Overall Study|Adverse Event|1|||
23386963|NCT00159874|65162696|FG005|Overall Study|Adverse Event|2|||
23386964|NCT00159874|65162697|FG006|Overall Study|Adverse Event|0|||
23386965|NCT00159874|65162691|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
23386966|NCT00159874|65162692|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
23386967|NCT00159874|65162693|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
23386968|NCT00159874|65162694|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
23386969|NCT00159874|65162695|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
23386970|NCT00159874|65162696|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
23386971|NCT00159874|65162697|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
23386972|NCT00159874|65162691|FG000|Overall Study|Lack of Efficacy|2|||
23386973|NCT00159874|65162692|FG001|Overall Study|Lack of Efficacy|0|||
23294532|NCT01647711|64818293|FG000|Overall Study|Refused to continue taking medication|0|||
23294533|NCT01647711|64818294|FG001|Overall Study|Refused to continue taking medication|0|||
23294534|NCT01647711|64818295|FG002|Overall Study|Refused to continue taking medication|0|||
23294535|NCT01647711|64818296|FG003|Overall Study|Refused to continue taking medication|2|||
23294536|NCT01647711|64818297|FG004|Overall Study|Refused to continue taking medication|1|||
23294537|NCT01647711|64818293|FG000|Overall Study|Other reason not defined|0|||
23294538|NCT01647711|64818294|FG001|Overall Study|Other reason not defined|1|||
23386974|NCT00159874|65162693|FG002|Overall Study|Lack of Efficacy|1|||
23493705|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
23294539|NCT01647711|64818295|FG002|Overall Study|Other reason not defined|1|||
23386975|NCT00159874|65162694|FG003|Overall Study|Lack of Efficacy|1|||
23386976|NCT00159874|65162695|FG004|Overall Study|Lack of Efficacy|0|||
23386977|NCT00159874|65162696|FG005|Overall Study|Lack of Efficacy|3|||
23386978|NCT00159874|65162697|FG006|Overall Study|Lack of Efficacy|0|||
23386979|NCT00159874|65162691|FG000|Overall Study|Lost to Follow-up|1|||
23386980|NCT00159874|65162692|FG001|Overall Study|Lost to Follow-up|0|||
23386981|NCT00159874|65162693|FG002|Overall Study|Lost to Follow-up|3|||
23386982|NCT00159874|65162694|FG003|Overall Study|Lost to Follow-up|0|||
23294540|NCT01647711|64818296|FG003|Overall Study|Other reason not defined|1|||
23294541|NCT01647711|64818297|FG004|Overall Study|Other reason not defined|0|||
23294542|NCT00823199|64818298|FG000|Overall Study|Withdrawal by Subject|2|||
23294543|NCT03417830|64818299|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
23294544|NCT03417830|64818300|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
23294545|NCT01825837|64818302|FG000|PART I|Withdrawal by Subject|0|||
23294546|NCT01825837|64818303|FG001|PART I|Withdrawal by Subject|0|||
23294547|NCT01825837|64818304|FG002|PART I|Withdrawal by Subject|0|||
23294548|NCT01825837|64818305|FG003|PART I|Withdrawal by Subject|6|||
23294549|NCT01825837|64818302|FG000|PART I|Patient non-compliance|0|||
23294550|NCT01825837|64818303|FG001|PART I|Patient non-compliance|0|||
23294551|NCT01825837|64818304|FG002|PART I|Patient non-compliance|0|||
23294552|NCT01825837|64818305|FG003|PART I|Patient non-compliance|1|||
23294553|NCT01825837|64818302|FG000|PART I|Treatment failure|0|||
23294554|NCT01825837|64818303|FG001|PART I|Treatment failure|0|||
23294555|NCT01825837|64818304|FG002|PART I|Treatment failure|0|||
23294556|NCT01825837|64818305|FG003|PART I|Treatment failure|7|||
23294557|NCT01825837|64818302|FG000|PART I|reason unspecified|0|||
23294558|NCT01825837|64818303|FG001|PART I|reason unspecified|0|||
23294559|NCT01825837|64818304|FG002|PART I|reason unspecified|0|||
23294560|NCT01825837|64818305|FG003|PART I|reason unspecified|3|||
23294561|NCT01825837|64818302|FG000|PART II|Withdrawal by Subject|3|||
23386983|NCT00159874|65162695|FG004|Overall Study|Lost to Follow-up|1|||
23294562|NCT01825837|64818303|FG001|PART II|Withdrawal by Subject|3|||
23294563|NCT01825837|64818304|FG002|PART II|Withdrawal by Subject|7|||
23294564|NCT01825837|64818305|FG003|PART II|Withdrawal by Subject|0|||
23294565|NCT01825837|64818302|FG000|PART II|Patient non-compliance|5|||
23386984|NCT00159874|65162696|FG005|Overall Study|Lost to Follow-up|2|||
23294566|NCT01825837|64818303|FG001|PART II|Patient non-compliance|2|||
23294567|NCT01825837|64818304|FG002|PART II|Patient non-compliance|4|||
23294568|NCT01825837|64818305|FG003|PART II|Patient non-compliance|0|||
23294569|NCT01825837|64818302|FG000|PART II|Adverse Event|3|||
23294570|NCT01825837|64818303|FG001|PART II|Adverse Event|3|||
23294571|NCT01825837|64818304|FG002|PART II|Adverse Event|1|||
23294572|NCT01825837|64818305|FG003|PART II|Adverse Event|0|||
23294573|NCT01825837|64818302|FG000|PART II|Treatment failure|6|||
23294574|NCT01825837|64818303|FG001|PART II|Treatment failure|4|||
23294575|NCT01825837|64818304|FG002|PART II|Treatment failure|5|||
23294576|NCT01825837|64818305|FG003|PART II|Treatment failure|0|||
23294577|NCT01825837|64818302|FG000|PART II|reason unspecified|2|||
23294578|NCT01825837|64818303|FG001|PART II|reason unspecified|2|||
23294579|NCT01825837|64818304|FG002|PART II|reason unspecified|2|||
23294580|NCT01825837|64818305|FG003|PART II|reason unspecified|0|||
23294581|NCT02457611|64818306|FG000|Overall Study|Lost to Follow-up|3|||
23386985|NCT00159874|65162697|FG006|Overall Study|Lost to Follow-up|1|||
23386986|NCT00159874|65162691|FG000|Overall Study|Other|8|||
23386987|NCT00159874|65162692|FG001|Overall Study|Other|8|||
23386988|NCT00159874|65162693|FG002|Overall Study|Other|8|||
23386989|NCT00159874|65162694|FG003|Overall Study|Other|0|||
23386990|NCT00159874|65162695|FG004|Overall Study|Other|2|||
23386991|NCT00159874|65162696|FG005|Overall Study|Other|1|||
23386992|NCT00159874|65162697|FG006|Overall Study|Other|3|||
23386993|NCT00159874|65162691|FG000|Overall Study|Protocol Violation|0|||
23386994|NCT00159874|65162692|FG001|Overall Study|Protocol Violation|5|||
23386995|NCT00159874|65162693|FG002|Overall Study|Protocol Violation|2|||
23386996|NCT00159874|65162694|FG003|Overall Study|Protocol Violation|0|||
23386997|NCT00159874|65162695|FG004|Overall Study|Protocol Violation|0|||
23493706|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
23493707|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
23493708|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
23493709|NCT03841448|65551557|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
23493710|NCT03841448|65551558|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
23493711|NCT03841448|65551559|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
23493712|NCT03841448|65551560|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
23294582|NCT01949116|64818308|FG000|Overall Study|Death|2|||
23294583|NCT01949116|64818309|FG001|Overall Study|Death|0|||
23294584|NCT01949116|64818308|FG000|Overall Study|Lost to Follow-up|1|||
23294585|NCT01949116|64818309|FG001|Overall Study|Lost to Follow-up|3|||
23294586|NCT01949116|64818308|FG000|Overall Study|Withdrawal by Subject|5|||
23294587|NCT01949116|64818309|FG001|Overall Study|Withdrawal by Subject|3|||
23294588|NCT01507090|64818310|FG000|Overall Study|incomplete dataset|18|||
23294589|NCT00830167|64818311|FG000|Overall Study|Lack of Efficacy|26|||
23294590|NCT00830167|64818312|FG001|Overall Study|Lack of Efficacy|10|||
23386998|NCT00159874|65162696|FG005|Overall Study|Protocol Violation|0|||
23386999|NCT00159874|65162697|FG006|Overall Study|Protocol Violation|0|||
23294591|NCT00830167|64818311|FG000|Overall Study|Adverse Event|8|||
23294592|NCT00830167|64818312|FG001|Overall Study|Adverse Event|24|||
23387000|NCT00159874|65162691|FG000|Overall Study|Death|3|||
23387001|NCT00159874|65162692|FG001|Overall Study|Death|8|||
23387002|NCT00159874|65162693|FG002|Overall Study|Death|15|||
23493713|NCT02264639|65551562|FG000|Overall Study|Death (after completing single-dose phase)|1|||
23493714|NCT02264639|65551563|FG001|Overall Study|Death (after completing single-dose phase)|0|||
23493715|NCT02264639|65551564|FG002|Overall Study|Death (after completing single-dose phase)|0|||
23493716|NCT02264639|65551565|FG003|Overall Study|Death (after completing single-dose phase)|0|||
23493717|NCT02264639|65551566|FG004|Overall Study|Death (after completing single-dose phase)|0|||
23493718|NCT02264639|65551562|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
23493719|NCT02264639|65551563|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
23493720|NCT02264639|65551564|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
23493721|NCT02264639|65551565|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
23294593|NCT00830167|64818311|FG000|Overall Study|Not meeting entrance criteria|2|||
23294594|NCT00830167|64818312|FG001|Overall Study|Not meeting entrance criteria|5|||
23294595|NCT00830167|64818311|FG000|Overall Study|Withdrawal by Subject|2|||
23294596|NCT00830167|64818312|FG001|Overall Study|Withdrawal by Subject|0|||
23294597|NCT00830167|64818311|FG000|Overall Study|Lost to Follow-up|0|||
23294598|NCT00830167|64818312|FG001|Overall Study|Lost to Follow-up|1|||
23294599|NCT00830167|64818311|FG000|Overall Study|Protocol Violation|0|||
23294600|NCT00830167|64818312|FG001|Overall Study|Protocol Violation|1|||
23294601|NCT00830167|64818311|FG000|Overall Study|Other|2|||
23294602|NCT00830167|64818312|FG001|Overall Study|Other|2|||
23294603|NCT03701763|64818313|FG000|Placebo-controlled Phase|Adverse Event|1|||
23294604|NCT03701763|64818314|FG001|Placebo-controlled Phase|Adverse Event|5|||
23294605|NCT03701763|64818315|FG002|Placebo-controlled Phase|Adverse Event|0|||
23294606|NCT03701763|64818316|FG003|Placebo-controlled Phase|Adverse Event|0|||
23294607|NCT03701763|64818313|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
23294608|NCT03701763|64818314|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
23294609|NCT03701763|64818315|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
23294610|NCT03701763|64818316|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
23294611|NCT03701763|64818313|FG000|Placebo-controlled Phase|Miscellaneous|2|||
23294612|NCT03701763|64818314|FG001|Placebo-controlled Phase|Miscellaneous|0|||
23294613|NCT03701763|64818315|FG002|Placebo-controlled Phase|Miscellaneous|0|||
23294614|NCT03701763|64818316|FG003|Placebo-controlled Phase|Miscellaneous|0|||
23294615|NCT03701763|64818313|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
23294616|NCT03701763|64818314|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
23294617|NCT03701763|64818315|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
23294618|NCT03701763|64818316|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
23294619|NCT03701763|64818313|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
23294620|NCT03701763|64818314|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
23294621|NCT03701763|64818315|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
23294622|NCT03701763|64818316|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
23294623|NCT03701763|64818313|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
23294624|NCT03701763|64818314|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
23294625|NCT03701763|64818315|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
23294626|NCT03701763|64818316|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
23294627|NCT03701763|64818313|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
23294628|NCT03701763|64818314|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
23294629|NCT03701763|64818315|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
23294630|NCT03701763|64818316|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
23294631|NCT03701763|64818313|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
23294632|NCT03701763|64818314|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
23294633|NCT03701763|64818315|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
23294634|NCT03701763|64818316|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
23294635|NCT03701763|64818313|FG000|Apremilast Extension Phase|Adverse Event|0|||
23387003|NCT00159874|65162694|FG003|Overall Study|Death|0|||
23387004|NCT00159874|65162695|FG004|Overall Study|Death|1|||
23387005|NCT00159874|65162696|FG005|Overall Study|Death|2|||
23387006|NCT00159874|65162697|FG006|Overall Study|Death|0|||
23387007|NCT00159874|65162691|FG000|Overall Study|Withdrawal by Subject|2|||
23387008|NCT00159874|65162692|FG001|Overall Study|Withdrawal by Subject|6|||
23387009|NCT00159874|65162693|FG002|Overall Study|Withdrawal by Subject|8|||
23387010|NCT00159874|65162694|FG003|Overall Study|Withdrawal by Subject|4|||
23387011|NCT00159874|65162695|FG004|Overall Study|Withdrawal by Subject|3|||
23387012|NCT00159874|65162696|FG005|Overall Study|Withdrawal by Subject|2|||
23387013|NCT00159874|65162697|FG006|Overall Study|Withdrawal by Subject|1|||
23387014|NCT00159874|65162691|FG000|Overall Study|Pregnancy|1|||
23387015|NCT00159874|65162692|FG001|Overall Study|Pregnancy|1|||
23387016|NCT00159874|65162693|FG002|Overall Study|Pregnancy|0|||
23387017|NCT00159874|65162694|FG003|Overall Study|Pregnancy|0|||
23387018|NCT00159874|65162695|FG004|Overall Study|Pregnancy|0|||
23387019|NCT00159874|65162696|FG005|Overall Study|Pregnancy|0|||
23387020|NCT00159874|65162697|FG006|Overall Study|Pregnancy|0|||
23294636|NCT03701763|64818314|FG001|Apremilast Extension Phase|Adverse Event|0|||
23387021|NCT01065766|65162700|FG000|Overall Study|Assessed before the contracted date|1|||
23387022|NCT01065766|65162700|FG000|Overall Study|Contraindication to administration|6|||
23387023|NCT01065766|65162700|FG000|Overall Study|Violated dosage/administration|25|||
23387024|NCT01184118|65162701|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
23387025|NCT01184118|65162701|FG000|Overall Study|No physiologic confirmation of asthma|8|||
23387026|NCT01184118|65162701|FG000|Overall Study|FEV1 <60% predicted|2|||
23387027|NCT01184118|65162701|FG000|Overall Study|Exclusionary medical condition|2|||
23387028|NCT01184118|65162701|FG000|Overall Study|Withdrawal by Subject|5|||
23387029|NCT00562861|65162702|FG000|Overall Study|Adverse Event|1|||
23387030|NCT00562861|65162703|FG001|Overall Study|Adverse Event|1|||
23387031|NCT00562861|65162702|FG000|Overall Study|Lack of Efficacy|5|||
23387032|NCT00562861|65162703|FG001|Overall Study|Lack of Efficacy|5|||
23387033|NCT00562861|65162702|FG000|Overall Study|noncompliance, moved|7|||
23387034|NCT00562861|65162703|FG001|Overall Study|noncompliance, moved|2|||
23387035|NCT00562861|65162702|FG000|Overall Study|Lost to Follow-up|7|||
23387036|NCT00562861|65162703|FG001|Overall Study|Lost to Follow-up|3|||
23387037|NCT00896233|65162707|FG000|Overall Study|Claustrophobia during MRI|1|||
23387038|NCT01658735|65162712|FG000|Overall Study|Lack of Efficacy|1|||
23294637|NCT03701763|64818315|FG002|Apremilast Extension Phase|Adverse Event|3|||
23387039|NCT01658735|65162713|FG001|Overall Study|Lack of Efficacy|0|||
23387040|NCT01658735|65162714|FG002|Overall Study|Lack of Efficacy|1|||
23387041|NCT01658735|65162712|FG000|Overall Study|Lost to Follow-up|1|||
23387042|NCT01658735|65162713|FG001|Overall Study|Lost to Follow-up|1|||
23294638|NCT03701763|64818316|FG003|Apremilast Extension Phase|Adverse Event|1|||
23294639|NCT03701763|64818313|FG000|Apremilast Extension Phase|Miscellaneous|0|||
23294640|NCT03701763|64818314|FG001|Apremilast Extension Phase|Miscellaneous|0|||
23294641|NCT03701763|64818315|FG002|Apremilast Extension Phase|Miscellaneous|2|||
23294642|NCT03701763|64818316|FG003|Apremilast Extension Phase|Miscellaneous|1|||
23294643|NCT03701763|64818313|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
23294644|NCT03701763|64818314|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
23294645|NCT03701763|64818315|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
23387043|NCT01658735|65162714|FG002|Overall Study|Lost to Follow-up|0|||
23387044|NCT01658735|65162712|FG000|Overall Study|Protocol Violation|0|||
23387045|NCT01658735|65162713|FG001|Overall Study|Protocol Violation|1|||
23387046|NCT01658735|65162714|FG002|Overall Study|Protocol Violation|0|||
23387047|NCT01658735|65162712|FG000|Overall Study|Withdrawal by Subject|3|||
23387048|NCT01658735|65162713|FG001|Overall Study|Withdrawal by Subject|5|||
23294646|NCT03701763|64818316|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
23294647|NCT03701763|64818313|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
23294648|NCT03701763|64818314|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
23294649|NCT03701763|64818315|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
23294650|NCT03701763|64818316|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
23294651|NCT03701763|64818313|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
23294652|NCT03701763|64818314|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
23294653|NCT03701763|64818315|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
23294654|NCT03701763|64818316|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
23294655|NCT03701763|64818313|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
23294656|NCT03701763|64818314|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
23294657|NCT03701763|64818315|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
23387049|NCT01658735|65162714|FG002|Overall Study|Withdrawal by Subject|3|||
23387050|NCT04560309|65162718|FG000|Overall Study|Meet drop out criteria|1|||
23387051|NCT04560309|65162719|FG001|Overall Study|Meet drop out criteria|1|||
23387052|NCT01694771|65162720|FG000|Overall Study|Adverse Event|18|||
23387053|NCT01694771|65162721|FG001|Overall Study|Adverse Event|16|||
23294658|NCT03701763|64818316|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
23294659|NCT03701763|64818313|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
23294660|NCT03701763|64818314|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
23294661|NCT03701763|64818315|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
23294662|NCT03701763|64818316|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
23294663|NCT03701763|64818313|FG000|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
23294664|NCT03701763|64818314|FG001|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
23294665|NCT03701763|64818315|FG002|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|1|||
23294666|NCT03701763|64818316|FG003|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
23294667|NCT03701763|64818313|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
23294668|NCT03701763|64818314|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
23294669|NCT03701763|64818315|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
23294670|NCT03701763|64818316|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
23294671|NCT03701763|64818313|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
23294672|NCT03701763|64818314|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
23294673|NCT03701763|64818315|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
23294674|NCT03701763|64818316|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
23294675|NCT02344745|64818317|FG000|Overall Study|Data collection sheets were lost|2|||
23294676|NCT02344745|64818318|FG001|Overall Study|Data collection sheets were lost|0|||
23294677|NCT02039063|64818319|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
23294678|NCT02039063|64818320|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
23294679|NCT02039063|64818321|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
23294680|NCT02039063|64818322|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
23294681|NCT02039063|64818319|FG000|Treatment Phase|Progression of disease|0|||
23294682|NCT02039063|64818320|FG001|Treatment Phase|Progression of disease|0|||
23294683|NCT02039063|64818321|FG002|Treatment Phase|Progression of disease|1|||
23294684|NCT02039063|64818322|FG003|Treatment Phase|Progression of disease|1|||
23294685|NCT02039063|64818319|FG000|Extension Phase|Inadequate therapeutic effect|0|||
23294686|NCT02039063|64818320|FG001|Extension Phase|Inadequate therapeutic effect|1|||
23294687|NCT02039063|64818321|FG002|Extension Phase|Inadequate therapeutic effect|2|||
23294688|NCT02039063|64818322|FG003|Extension Phase|Inadequate therapeutic effect|0|||
23294689|NCT02039063|64818319|FG000|Extension Phase|Progression of disease|0|||
23294690|NCT02039063|64818320|FG001|Extension Phase|Progression of disease|0|||
23294691|NCT02039063|64818321|FG002|Extension Phase|Progression of disease|0|||
23294692|NCT02039063|64818322|FG003|Extension Phase|Progression of disease|1|||
23294693|NCT02039063|64818319|FG000|Extension Phase|Adverse Event|0|||
23294694|NCT02039063|64818320|FG001|Extension Phase|Adverse Event|0|||
23294695|NCT02039063|64818321|FG002|Extension Phase|Adverse Event|1|||
23294696|NCT02039063|64818322|FG003|Extension Phase|Adverse Event|0|||
23294697|NCT02576717|64818323|FG000|Overall Study|Other Reasons|16|||
23294698|NCT02576717|64818324|FG001|Overall Study|Other Reasons|18|||
23294699|NCT02576717|64818325|FG002|Overall Study|Other Reasons|15|||
23294700|NCT02576717|64818323|FG000|Overall Study|Covid-19 Pandemic|0|||
23294701|NCT02576717|64818324|FG001|Overall Study|Covid-19 Pandemic|1|||
23294702|NCT02576717|64818325|FG002|Overall Study|Covid-19 Pandemic|1|||
23294703|NCT02576717|64818323|FG000|Overall Study|Sponsor Decision|0|||
23294704|NCT02576717|64818324|FG001|Overall Study|Sponsor Decision|0|||
23294705|NCT02576717|64818325|FG002|Overall Study|Sponsor Decision|1|||
23294706|NCT02576717|64818323|FG000|Overall Study|Physician Decision|3|||
23294707|NCT02576717|64818324|FG001|Overall Study|Physician Decision|8|||
23294708|NCT02576717|64818325|FG002|Overall Study|Physician Decision|9|||
23294709|NCT02576717|64818323|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
23294710|NCT02576717|64818324|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
23294711|NCT02576717|64818325|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
23294712|NCT02576717|64818323|FG000|Overall Study|Death|3|||
23294713|NCT02576717|64818324|FG001|Overall Study|Death|5|||
23294714|NCT02576717|64818325|FG002|Overall Study|Death|3|||
23294715|NCT02576717|64818323|FG000|Overall Study|Lost to Follow-up|9|||
23294716|NCT02576717|64818324|FG001|Overall Study|Lost to Follow-up|10|||
23294717|NCT02576717|64818325|FG002|Overall Study|Lost to Follow-up|19|||
23294718|NCT02576717|64818323|FG000|Overall Study|Protocol Violation|4|||
23294719|NCT02576717|64818324|FG001|Overall Study|Protocol Violation|0|||
23387054|NCT01694771|65162720|FG000|Overall Study|Lack of Efficacy|1|||
23294720|NCT02576717|64818325|FG002|Overall Study|Protocol Violation|5|||
23294721|NCT02576717|64818323|FG000|Overall Study|Lack of Efficacy|24|||
23294722|NCT02576717|64818324|FG001|Overall Study|Lack of Efficacy|28|||
23294723|NCT02576717|64818325|FG002|Overall Study|Lack of Efficacy|20|||
23294724|NCT02576717|64818323|FG000|Overall Study|Adverse Event|26|||
23294725|NCT02576717|64818324|FG001|Overall Study|Adverse Event|32|||
23294726|NCT02576717|64818325|FG002|Overall Study|Adverse Event|26|||
23294727|NCT00894933|64818326|FG000|Overall Study|Lost to Follow-up|2|||
23387055|NCT01694771|65162721|FG001|Overall Study|Lack of Efficacy|0|||
23387056|NCT01694771|65162720|FG000|Overall Study|Non compliance protocol|7|||
23387057|NCT01694771|65162721|FG001|Overall Study|Non compliance protocol|6|||
23387058|NCT01694771|65162720|FG000|Overall Study|Lost to Follow-up|2|||
23387059|NCT01694771|65162721|FG001|Overall Study|Lost to Follow-up|3|||
23387060|NCT01694771|65162720|FG000|Overall Study|Consent withdrawn|7|||
23387061|NCT01694771|65162721|FG001|Overall Study|Consent withdrawn|9|||
23387062|NCT01694771|65162720|FG000|Overall Study|Other reasons|5|||
23387063|NCT01694771|65162721|FG001|Overall Study|Other reasons|6|||
23493722|NCT02264639|65551566|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
23493723|NCT02264639|65551562|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
23493724|NCT02264639|65551563|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
23493725|NCT02264639|65551564|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
23493726|NCT02264639|65551565|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
23493727|NCT02264639|65551566|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
23493728|NCT02264639|65551562|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
23493729|NCT02264639|65551563|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
23493730|NCT02264639|65551564|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
23493731|NCT02264639|65551565|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
23493732|NCT02264639|65551566|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
23493733|NCT05047770|65551568|FG000|Overall Study|Withdrawal by Subject|15|||
23493734|NCT05047770|65551569|FG001|Overall Study|Withdrawal by Subject|10|||
23493735|NCT05047770|65551570|FG002|Overall Study|Withdrawal by Subject|6|||
23493736|NCT05047770|65551571|FG003|Overall Study|Withdrawal by Subject|12|||
23493737|NCT05047770|65551568|FG000|Overall Study|Lost to Follow-up|7|||
23493738|NCT05047770|65551569|FG001|Overall Study|Lost to Follow-up|5|||
23493739|NCT05047770|65551570|FG002|Overall Study|Lost to Follow-up|12|||
23493740|NCT05047770|65551571|FG003|Overall Study|Lost to Follow-up|13|||
23493741|NCT05047770|65551568|FG000|Overall Study|Other|1|||
23493742|NCT05047770|65551569|FG001|Overall Study|Other|0|||
23493743|NCT05047770|65551570|FG002|Overall Study|Other|1|||
23493744|NCT05047770|65551571|FG003|Overall Study|Other|0|||
23493745|NCT02345226|65551572|FG000|Double-Blind Phase|Adverse Event|5|||
23493746|NCT02345226|65551573|FG001|Double-Blind Phase|Adverse Event|6|||
23493747|NCT02345226|65551572|FG000|Double-Blind Phase|Death|3|||
23493748|NCT02345226|65551573|FG001|Double-Blind Phase|Death|0|||
23493749|NCT02345226|65551572|FG000|Double-Blind Phase|Pregnancy|0|||
23493750|NCT02345226|65551573|FG001|Double-Blind Phase|Pregnancy|1|||
23493751|NCT02345226|65551572|FG000|Double-Blind Phase|Lack of Efficacy|1|||
23493752|NCT02345226|65551573|FG001|Double-Blind Phase|Lack of Efficacy|0|||
23493753|NCT02345226|65551572|FG000|Double-Blind Phase|Investigator's Discretion|4|||
23493754|NCT02345226|65551573|FG001|Double-Blind Phase|Investigator's Discretion|3|||
23493755|NCT02345226|65551572|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
23493756|NCT02345226|65551573|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
23493757|NCT02345226|65551572|FG000|Double-Blind Phase|Withdrew Consent|41|||
23493758|NCT02345226|65551573|FG001|Double-Blind Phase|Withdrew Consent|39|||
23493759|NCT02345226|65551572|FG000|Double-Blind Phase|Lost to Follow-up|12|||
23493760|NCT02345226|65551573|FG001|Double-Blind Phase|Lost to Follow-up|16|||
23493761|NCT02345226|65551572|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
23493762|NCT02345226|65551573|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
23493763|NCT02345226|65551572|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
23493764|NCT02345226|65551573|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
23493765|NCT04295772|65551574|FG000|Overall Study|Protocol Violation|1|||
23493766|NCT04295772|65551575|FG001|Overall Study|Protocol Violation|0|||
23493767|NCT04295772|65551574|FG000|Overall Study|Ongoing for safety monitoring|14|||
23493768|NCT04295772|65551575|FG001|Overall Study|Ongoing for safety monitoring|1|||
23493769|NCT04295772|65551574|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
23387064|NCT04233580|65162723|FG000|Overall Study|Adverse Event|3|||
23387065|NCT04233580|65162724|FG001|Overall Study|Adverse Event|3|||
23387066|NCT04233580|65162723|FG000|Overall Study|Withdrawal by Subject|2|||
23493770|NCT04295772|65551575|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
23493771|NCT00241358|65551576|FG000|Overall Study|Determined to be not ineligible|0|||
23493772|NCT00241358|65551577|FG001|Overall Study|Determined to be not ineligible|1|||
23493773|NCT00241358|65551578|FG002|Overall Study|Determined to be not ineligible|1|||
23493774|NCT00451451|65551581|FG000|Overall Study|Adverse Event|11|||
23493775|NCT00451451|65551582|FG001|Overall Study|Adverse Event|21|||
23493776|NCT00451451|65551583|FG002|Overall Study|Adverse Event|26|||
23493777|NCT00451451|65551584|FG003|Overall Study|Adverse Event|10|||
23493778|NCT00451451|65551581|FG000|Overall Study|Lost to Follow-up|11|||
23387067|NCT04233580|65162724|FG001|Overall Study|Withdrawal by Subject|1|||
23387068|NCT03632720|65162725|FG000|Overall Study|Adverse Event|2|||
23493779|NCT00451451|65551582|FG001|Overall Study|Lost to Follow-up|9|||
23493780|NCT00451451|65551583|FG002|Overall Study|Lost to Follow-up|8|||
23493781|NCT00451451|65551584|FG003|Overall Study|Lost to Follow-up|11|||
23493782|NCT00451451|65551581|FG000|Overall Study|Consent Withdrawn|14|||
23493783|NCT00451451|65551582|FG001|Overall Study|Consent Withdrawn|9|||
23493784|NCT00451451|65551583|FG002|Overall Study|Consent Withdrawn|17|||
23493785|NCT00451451|65551584|FG003|Overall Study|Consent Withdrawn|17|||
23493786|NCT00451451|65551581|FG000|Overall Study|Investigator Decision|6|||
23493787|NCT00451451|65551582|FG001|Overall Study|Investigator Decision|2|||
23493788|NCT00451451|65551583|FG002|Overall Study|Investigator Decision|1|||
23493789|NCT00451451|65551584|FG003|Overall Study|Investigator Decision|2|||
23493790|NCT00451451|65551581|FG000|Overall Study|Subject Non-Compliance|8|||
23493791|NCT00451451|65551582|FG001|Overall Study|Subject Non-Compliance|4|||
23493792|NCT00451451|65551583|FG002|Overall Study|Subject Non-Compliance|3|||
23493793|NCT00451451|65551584|FG003|Overall Study|Subject Non-Compliance|3|||
23493794|NCT00451451|65551581|FG000|Overall Study|Death|1|||
23493795|NCT00451451|65551582|FG001|Overall Study|Death|0|||
23493796|NCT00451451|65551583|FG002|Overall Study|Death|0|||
23493797|NCT00451451|65551584|FG003|Overall Study|Death|1|||
23493798|NCT00451451|65551581|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
23493799|NCT00451451|65551582|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
23493800|NCT00451451|65551583|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
23493801|NCT00451451|65551584|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
23493802|NCT00142935|65551588|FG000|Overall Study|Other reason|1|||
23493803|NCT00142935|65551589|FG001|Overall Study|Other reason|1|||
23493804|NCT00142935|65551590|FG002|Overall Study|Other reason|1|||
23493805|NCT00142935|65551588|FG000|Overall Study|Lost to Follow-up|2|||
23493806|NCT00142935|65551589|FG001|Overall Study|Lost to Follow-up|5|||
23493807|NCT00142935|65551590|FG002|Overall Study|Lost to Follow-up|5|||
23493808|NCT00142935|65551588|FG000|Overall Study|Death|0|||
23493809|NCT00142935|65551589|FG001|Overall Study|Death|2|||
23493810|NCT00142935|65551590|FG002|Overall Study|Death|1|||
23493811|NCT00669396|65551591|FG000|Overall Study|Lost to Follow-up|10|||
23493812|NCT00669396|65551592|FG001|Overall Study|Lost to Follow-up|12|||
23493813|NCT01361568|65551593|FG000|Overall Study|Adverse Event|0|||
23294728|NCT00894933|64818326|FG000|Overall Study|Cancelled Procedure|1|||
23493814|NCT01361568|65551594|FG001|Overall Study|Adverse Event|0|||
23493815|NCT01361568|65551595|FG002|Overall Study|Adverse Event|0|||
23493816|NCT01361568|65551596|FG003|Overall Study|Adverse Event|0|||
23493817|NCT01361568|65551597|FG004|Overall Study|Adverse Event|1|||
23493818|NCT01361568|65551598|FG005|Overall Study|Adverse Event|0|||
23493819|NCT01361568|65551593|FG000|Overall Study|Physician Decision|0|||
23493820|NCT01361568|65551594|FG001|Overall Study|Physician Decision|0|||
23493821|NCT01361568|65551595|FG002|Overall Study|Physician Decision|0|||
23493822|NCT01361568|65551596|FG003|Overall Study|Physician Decision|0|||
23493823|NCT01361568|65551597|FG004|Overall Study|Physician Decision|0|||
23493824|NCT01361568|65551598|FG005|Overall Study|Physician Decision|1|||
23493825|NCT01361568|65551593|FG000|Overall Study|Withdrawal by Subject|2|||
23493826|NCT01361568|65551594|FG001|Overall Study|Withdrawal by Subject|1|||
23493827|NCT01361568|65551595|FG002|Overall Study|Withdrawal by Subject|0|||
23493828|NCT01361568|65551596|FG003|Overall Study|Withdrawal by Subject|0|||
23493829|NCT01361568|65551597|FG004|Overall Study|Withdrawal by Subject|0|||
23387069|NCT03632720|65162726|FG001|Overall Study|Adverse Event|0|||
23387070|NCT03632720|65162727|FG002|Overall Study|Adverse Event|0|||
23387071|NCT03632720|65162725|FG000|Overall Study|Lost to Follow-up|0|||
23387072|NCT03632720|65162726|FG001|Overall Study|Lost to Follow-up|1|||
23493830|NCT01361568|65551598|FG005|Overall Study|Withdrawal by Subject|1|||
23493831|NCT00074984|65551606|FG000|Overall Study|Death|1|||
23493832|NCT00074984|65551607|FG001|Overall Study|Death|2|||
23493833|NCT00074984|65551606|FG000|Overall Study|Withdrawal by Subject|2|||
23493834|NCT00074984|65551607|FG001|Overall Study|Withdrawal by Subject|3|||
23493835|NCT00074984|65551606|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
23493836|NCT00074984|65551607|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
23493837|NCT03555435|65551608|FG000|Overall Study|Lost to Follow-up|17|||
23493838|NCT03555435|65551609|FG001|Overall Study|Lost to Follow-up|19|||
23493839|NCT03555435|65551610|FG002|Overall Study|Lost to Follow-up|8|||
23493840|NCT02024555|65551621|FG000|Overall Study|Lost to Follow-up|1|||
23493841|NCT02024555|65551622|FG001|Overall Study|Lost to Follow-up|1|||
23493842|NCT02024555|65551621|FG000|Overall Study|Withdrawal by Subject|5|||
23493843|NCT02024555|65551622|FG001|Overall Study|Withdrawal by Subject|1|||
23493844|NCT03822182|65551623|FG000|Overall Study|Protocol Violation|0|||
23493845|NCT03822182|65551624|FG001|Overall Study|Protocol Violation|1|||
23493846|NCT03822182|65551625|FG002|Overall Study|Protocol Violation|1|||
23493847|NCT00657358|65554819|FG000|Overall Study|Lack of Efficacy|6|||
23493848|NCT01426438|65554820|FG000|Overall Study|Lost to Follow-up|1|||
23493849|NCT01426438|65554821|FG001|Overall Study|Lost to Follow-up|3|||
23493850|NCT01426438|65554820|FG000|Overall Study|Off study Treatment|9|||
23493851|NCT01426438|65554821|FG001|Overall Study|Off study Treatment|3|||
23493852|NCT01426438|65554820|FG000|Overall Study|Poor scan quality|3|||
23493853|NCT01426438|65554821|FG001|Overall Study|Poor scan quality|2|||
23493854|NCT01426438|65554820|FG000|Overall Study|Missed Scan|2|||
23493855|NCT01426438|65554821|FG001|Overall Study|Missed Scan|2|||
23493856|NCT00590135|65554822|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
23493857|NCT00423722|65554826|FG000|Overall Study|Death|4|||
23493858|NCT00423722|65554827|FG001|Overall Study|Death|4|||
23493859|NCT00423722|65554826|FG000|Overall Study|Declined to participate|2|||
23493860|NCT00423722|65554827|FG001|Overall Study|Declined to participate|3|||
23493861|NCT00423722|65554826|FG000|Overall Study|Unable to complete questionnaires|4|||
23493862|NCT00423722|65554827|FG001|Overall Study|Unable to complete questionnaires|4|||
23493863|NCT00423722|65554826|FG000|Overall Study|Withdrawal by Subject|4|||
23493864|NCT00423722|65554827|FG001|Overall Study|Withdrawal by Subject|2|||
23493865|NCT02840721|65554828|FG000|Treatment Period|Adverse Event|1|||
23493866|NCT02840721|65554828|FG000|Follow-Up|Lack of Efficacy|1|||
23493867|NCT02840721|65554828|FG000|Follow-Up|Withdrawal by Subject|4|||
23493868|NCT02840721|65554828|FG000|Follow-Up|Withdrawal of Consent|2|||
23493869|NCT01453725|65554830|FG000|Overall Study|Adverse Event|3|||
23493870|NCT01453725|65554831|FG001|Overall Study|Adverse Event|3|||
23493871|NCT01453725|65554830|FG000|Overall Study|Lost to Follow-up|4|||
23493872|NCT01453725|65554831|FG001|Overall Study|Lost to Follow-up|0|||
23493873|NCT01453725|65554830|FG000|Overall Study|Non-compliance With Protocol|1|||
23493874|NCT01453725|65554831|FG001|Overall Study|Non-compliance With Protocol|2|||
23493875|NCT01453725|65554830|FG000|Overall Study|Protocol Violation|1|||
23493876|NCT01453725|65554831|FG001|Overall Study|Protocol Violation|0|||
23493877|NCT01453725|65554830|FG000|Overall Study|Withdrawal by Subject|2|||
23493878|NCT01453725|65554831|FG001|Overall Study|Withdrawal by Subject|3|||
23493879|NCT01453725|65554830|FG000|Overall Study|Pregnancy Wish|0|||
23493880|NCT01453725|65554831|FG001|Overall Study|Pregnancy Wish|2|||
23493881|NCT01453725|65554830|FG000|Overall Study|Pregnancy|1|||
23493882|NCT01453725|65554831|FG001|Overall Study|Pregnancy|0|||
23493883|NCT01453725|65554830|FG000|Overall Study|Physician Decision|1|||
23493884|NCT01453725|65554831|FG001|Overall Study|Physician Decision|1|||
23493885|NCT01484275|65554832|FG000|Overall Study|Study terminated by sponsor|28|||
23493886|NCT01484275|65554833|FG001|Overall Study|Study terminated by sponsor|32|||
23493887|NCT01484275|65554832|FG000|Overall Study|Other|10|||
23493888|NCT01484275|65554833|FG001|Overall Study|Other|0|||
23493889|NCT01484275|65554832|FG000|Overall Study|Death|3|||
23493890|NCT01484275|65554833|FG001|Overall Study|Death|4|||
23387073|NCT03632720|65162727|FG002|Overall Study|Lost to Follow-up|0|||
23387074|NCT03632720|65162725|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
23493891|NCT01484275|65554832|FG000|Overall Study|Withdrawal by Subject|1|||
23493892|NCT01484275|65554833|FG001|Overall Study|Withdrawal by Subject|5|||
23493893|NCT01484275|65554832|FG000|Overall Study|Lost to Follow-up|1|||
23493894|NCT01484275|65554833|FG001|Overall Study|Lost to Follow-up|1|||
23493895|NCT00066365|65554834|FG000|Overall Study|Adverse Event|1|||
23493896|NCT00066365|65554835|FG001|Overall Study|Adverse Event|0|||
23493897|NCT00066365|65554834|FG000|Overall Study|Lack of Efficacy|15|||
23493898|NCT00066365|65554835|FG001|Overall Study|Lack of Efficacy|12|||
23493899|NCT00066365|65554834|FG000|Overall Study|Physician Decision|1|||
23493900|NCT00066365|65554835|FG001|Overall Study|Physician Decision|0|||
23493901|NCT00066365|65554834|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
23493902|NCT00066365|65554835|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
23493903|NCT00066365|65554834|FG000|Overall Study|Ineligible|4|||
23493904|NCT00066365|65554835|FG001|Overall Study|Ineligible|2|||
23493905|NCT04744831|65554836|FG000|Overall Study|Progressive Disease|31|||
23493906|NCT04744831|65554837|FG001|Overall Study|Progressive Disease|27|||
23493907|NCT04744831|65554838|FG002|Overall Study|Progressive Disease|25|||
23493908|NCT04744831|65554836|FG000|Overall Study|Adverse Event|3|||
23493909|NCT04744831|65554837|FG001|Overall Study|Adverse Event|3|||
23493910|NCT04744831|65554838|FG002|Overall Study|Adverse Event|3|||
23493911|NCT04744831|65554836|FG000|Overall Study|Clinical Progression|3|||
23493912|NCT04744831|65554837|FG001|Overall Study|Clinical Progression|2|||
23493913|NCT04744831|65554838|FG002|Overall Study|Clinical Progression|5|||
23493914|NCT04744831|65554836|FG000|Overall Study|Other|0|||
23493915|NCT04744831|65554837|FG001|Overall Study|Other|2|||
23493916|NCT04744831|65554838|FG002|Overall Study|Other|1|||
23493917|NCT04744831|65554836|FG000|Overall Study|Death|0|||
23493918|NCT04744831|65554837|FG001|Overall Study|Death|2|||
23294729|NCT00894933|64818326|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
23294730|NCT04276935|64818327|FG000|Overall Study|Lost to Follow-up|3|||
23294731|NCT01563237|64818328|FG000|Overall Study|Lost to Follow-up|6|||
23294732|NCT01563237|64818329|FG001|Overall Study|Lost to Follow-up|0|||
23294733|NCT01563237|64818328|FG000|Overall Study|Withdrawal by Subject|1|||
23294734|NCT01563237|64818329|FG001|Overall Study|Withdrawal by Subject|0|||
23294735|NCT01563237|64818328|FG000|Overall Study|Adverse Event|1|||
23294736|NCT01563237|64818329|FG001|Overall Study|Adverse Event|0|||
23294737|NCT01563237|64818328|FG000|Overall Study|Medical Reasons|1|||
23294738|NCT01563237|64818329|FG001|Overall Study|Medical Reasons|0|||
23294739|NCT01563237|64818328|FG000|Overall Study|Death|1|||
23294740|NCT01563237|64818329|FG001|Overall Study|Death|0|||
23387075|NCT03632720|65162726|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
23387076|NCT03632720|65162727|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
23387077|NCT03632720|65162725|FG000|Overall Study|Screen failure|0|||
23387078|NCT03632720|65162726|FG001|Overall Study|Screen failure|1|||
23387079|NCT03632720|65162727|FG002|Overall Study|Screen failure|0|||
23387080|NCT01663987|65162736|FG000|Overall Study|Adverse Event|7|||
23387081|NCT01663987|65162737|FG001|Overall Study|Adverse Event|2|||
23387082|NCT01663987|65162736|FG000|Overall Study|Lost to Follow-up|1|||
23387083|NCT01663987|65162737|FG001|Overall Study|Lost to Follow-up|1|||
23387084|NCT01663987|65162736|FG000|Overall Study|Withdrawal by Subject|2|||
23387085|NCT01663987|65162737|FG001|Overall Study|Withdrawal by Subject|3|||
23387086|NCT01663987|65162736|FG000|Overall Study|Other reason not defined above|3|||
23387087|NCT01663987|65162737|FG001|Overall Study|Other reason not defined above|0|||
23387088|NCT02872142|65162738|FG000|Overall Study|Adverse Event|2|||
23387089|NCT02872142|65162738|FG000|Overall Study|Death|1|||
23387090|NCT02872142|65162738|FG000|Overall Study|Participant Decision|3|||
23387091|NCT00756314|65162751|FG000|Overall Study|Lost to Follow-up|2|||
23387092|NCT00756314|65162752|FG001|Overall Study|Lost to Follow-up|59|||
23387093|NCT02539394|65162753|FG000|Overall Study|Protocol Violation|1|||
23387094|NCT02539394|65162754|FG001|Overall Study|Protocol Violation|3|||
23387095|NCT02539394|65162753|FG000|Overall Study|Lost to Follow-up|1|||
23387096|NCT02539394|65162754|FG001|Overall Study|Lost to Follow-up|2|||
23387097|NCT02539394|65162753|FG000|Overall Study|Incomplete dataset|6|||
23387098|NCT02539394|65162754|FG001|Overall Study|Incomplete dataset|6|||
23387099|NCT04102111|65162761|FG000|Overall Study|Withdrawal by Subject|2|||
23387100|NCT04102111|65162762|FG001|Overall Study|Withdrawal by Subject|3|||
23387101|NCT04102111|65162761|FG000|Overall Study|Adverse Event|1|||
23387102|NCT04102111|65162762|FG001|Overall Study|Adverse Event|1|||
23387103|NCT04102111|65162761|FG000|Overall Study|Study terminated by sponsor|1|||
23387104|NCT04102111|65162762|FG001|Overall Study|Study terminated by sponsor|3|||
23387105|NCT04189588|65162763|FG000|Overall Study|Death|0|||
23387106|NCT04189588|65162764|FG001|Overall Study|Death|1|||
23387107|NCT04189588|65162763|FG000|Overall Study|Lost to Follow-up|0|||
23387108|NCT04189588|65162764|FG001|Overall Study|Lost to Follow-up|1|||
23387109|NCT00063999|65162770|FG000|Overall Study|Withdrawal by Subject|1|||
23387110|NCT00063999|65162771|FG001|Overall Study|Withdrawal by Subject|0|||
23387111|NCT00063999|65162770|FG000|Overall Study|Ineligible|44|||
23387112|NCT00063999|65162771|FG001|Overall Study|Ineligible|24|||
23387113|NCT00862277|65162776|FG000|Overall Study|Protocol Violation|1|||
23387114|NCT00862277|65162777|FG001|Overall Study|Protocol Violation|2|||
23387115|NCT00862277|65162778|FG002|Overall Study|Protocol Violation|5|||
23387116|NCT00300495|65162780|FG000|Overall Study|Protocol Violation|4|||
23387117|NCT00300495|65162781|FG001|Overall Study|Protocol Violation|1|||
23387118|NCT00567112|65162782|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
23387119|NCT00567112|65162783|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
23387120|NCT00567112|65162784|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
23387121|NCT00567112|65162782|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
23387122|NCT00567112|65162783|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
23387123|NCT00567112|65162784|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
23387124|NCT00567112|65162782|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
23387125|NCT00567112|65162783|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
23493919|NCT04744831|65554838|FG002|Overall Study|Death|1|||
23493920|NCT01030536|65554839|FG000|Overall Study|Withdrawal by Subject|0|||
23493921|NCT01030536|65554840|FG001|Overall Study|Withdrawal by Subject|0|||
23387126|NCT00567112|65162784|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
23387127|NCT01346709|65162787|FG000|Overall Study|Protocol Violation|35|||
23387128|NCT01346709|65162787|FG000|Overall Study|Lost to Follow-up|31|||
23387129|NCT01346709|65162787|FG000|Overall Study|Missing data in candidate risk factor|285|||
23387130|NCT00348374|65162788|FG000|Overall Study|Adverse Event|1|||
23294741|NCT00399893|64818331|FG000|Overall Study|Withdrawal by Subject|1|||
23294742|NCT00399893|64818332|FG001|Overall Study|Withdrawal by Subject|0|||
23294743|NCT00732160|64818336|FG000|Overall Study|Adverse Event|1|||
23294744|NCT00732160|64818337|FG001|Overall Study|Adverse Event|0|||
23294745|NCT00732160|64818338|FG002|Overall Study|Adverse Event|1|||
23294746|NCT00732160|64818339|FG003|Overall Study|Adverse Event|1|||
23294747|NCT00732160|64818336|FG000|Overall Study|scheduling|4|||
23294748|NCT00732160|64818337|FG001|Overall Study|scheduling|4|||
23294749|NCT00732160|64818338|FG002|Overall Study|scheduling|2|||
23294750|NCT00732160|64818339|FG003|Overall Study|scheduling|1|||
23294751|NCT00595335|64818342|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
23294752|NCT00595335|64818343|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
23294753|NCT00595335|64818342|FG000|Baseline to Six Months|Disease Progression|1|||
23294754|NCT00595335|64818343|FG001|Baseline to Six Months|Disease Progression|1|||
23294755|NCT00595335|64818342|FG000|Baseline to Six Months|Adverse Event|1|||
23294756|NCT00595335|64818343|FG001|Baseline to Six Months|Adverse Event|0|||
23294757|NCT00595335|64818342|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
23387131|NCT00348374|65162789|FG001|Overall Study|Adverse Event|4|||
23387132|NCT00348374|65162788|FG000|Overall Study|Lost to Follow-up|1|||
23387133|NCT00348374|65162789|FG001|Overall Study|Lost to Follow-up|3|||
23387134|NCT00348374|65162788|FG000|Overall Study|Withdrawal by Subject|5|||
23387135|NCT00348374|65162789|FG001|Overall Study|Withdrawal by Subject|5|||
23387136|NCT00348374|65162788|FG000|Overall Study|Other|11|||
23387137|NCT00348374|65162789|FG001|Overall Study|Other|12|||
23387138|NCT00348374|65162788|FG000|Overall Study|ongoing at date of cutoff|1|||
23387139|NCT00348374|65162789|FG001|Overall Study|ongoing at date of cutoff|1|||
23387140|NCT00348374|65162788|FG000|Overall Study|randomized but did not receive treatment|0|||
23387141|NCT00348374|65162789|FG001|Overall Study|randomized but did not receive treatment|7|||
23387142|NCT00090402|65162790|FG000|Overall Study|Death|1|||
23387143|NCT00090402|65162791|FG001|Overall Study|Death|1|||
23387144|NCT00090402|65162792|FG002|Overall Study|Death|0|||
23387145|NCT00090402|65162790|FG000|Overall Study|subject moved|0|||
23387146|NCT00090402|65162791|FG001|Overall Study|subject moved|1|||
23387147|NCT00090402|65162792|FG002|Overall Study|subject moved|0|||
23387148|NCT00090402|65162790|FG000|Overall Study|stopped taking study medication|1|||
23493922|NCT01030536|65554841|FG002|Overall Study|Withdrawal by Subject|1|||
23294758|NCT00595335|64818343|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
23294759|NCT00595335|64818342|FG000|Six Months to Twelve Months|Disease Progression|1|||
23294760|NCT00595335|64818343|FG001|Six Months to Twelve Months|Disease Progression|0|||
23294761|NCT02274948|64818344|FG000|Overall Study|Lost to Follow-up|28|||
23294762|NCT02274948|64818345|FG001|Overall Study|Lost to Follow-up|25|||
23294763|NCT02274948|64818344|FG000|Overall Study|Withdrawal by Subject|64|||
23387149|NCT00090402|65162791|FG001|Overall Study|stopped taking study medication|0|||
23387150|NCT00090402|65162792|FG002|Overall Study|stopped taking study medication|1|||
23387151|NCT04341662|65162793|FG000|Overall Study|Did not have source-verified blood loss data|423|||
23387152|NCT04341662|65162794|FG001|Overall Study|Did not have source-verified blood loss data|514|||
23387153|NCT00894647|65162797|FG000|Overall Study|Adverse Event|5|||
23387154|NCT00894647|65162798|FG001|Overall Study|Adverse Event|4|||
23387155|NCT00894647|65162797|FG000|Overall Study|Withdrawal by Subject|4|||
23387156|NCT00894647|65162798|FG001|Overall Study|Withdrawal by Subject|4|||
23387157|NCT00894647|65162797|FG000|Overall Study|Lost to Follow-up|0|||
23387158|NCT00894647|65162798|FG001|Overall Study|Lost to Follow-up|2|||
23387159|NCT00894647|65162797|FG000|Overall Study|Non-compliance with study procedures|0|||
23387160|NCT00894647|65162798|FG001|Overall Study|Non-compliance with study procedures|2|||
23387161|NCT00894647|65162797|FG000|Overall Study|Other, not due to AE|1|||
23387162|NCT00894647|65162798|FG001|Overall Study|Other, not due to AE|2|||
23387163|NCT00676689|65162799|FG000|Overall Study|Screen Failure|2|||
23387164|NCT00676689|65162799|FG000|Overall Study|Death|2|||
23387165|NCT00676689|65162799|FG000|Overall Study|Lost to Follow-up|4|||
23387166|NCT00676689|65162799|FG000|Overall Study|Physician Decision|1|||
23387167|NCT00676689|65162799|FG000|Overall Study|Withdrawal by Subject|3|||
23387168|NCT00676689|65162799|FG000|Overall Study|Continuing FU|49|||
23387169|NCT02383173|65162800|FG000|Overall Study|Palliative Care Team withdrew|0|||
23387170|NCT02383173|65162801|FG001|Overall Study|Palliative Care Team withdrew|2|||
23387171|NCT00689052|65162802|FG000|Overall Study|Adverse Event|4|||
23387172|NCT00689052|65162803|FG001|Overall Study|Adverse Event|6|||
23387173|NCT00689052|65162802|FG000|Overall Study|Protocol Violation|1|||
23387174|NCT00689052|65162803|FG001|Overall Study|Protocol Violation|0|||
23387175|NCT00689052|65162802|FG000|Overall Study|Lost to Follow-up|2|||
23387176|NCT00689052|65162803|FG001|Overall Study|Lost to Follow-up|0|||
23387177|NCT00689052|65162802|FG000|Overall Study|Withdrawal by Subject|2|||
23387178|NCT00689052|65162803|FG001|Overall Study|Withdrawal by Subject|0|||
23387179|NCT00689052|65162802|FG000|Overall Study|Early termination of the trial|22|||
23387180|NCT00689052|65162803|FG001|Overall Study|Early termination of the trial|24|||
23387181|NCT03425188|65162804|FG000|Overall Study|Withdrawal by Subject|1|||
23387182|NCT00160615|65162805|FG000|Overall Study|Adverse Event|5|||
23387183|NCT00160615|65162806|FG001|Overall Study|Adverse Event|12|||
23387184|NCT00160615|65162805|FG000|Overall Study|Withdrawal by Subject|0|||
23387185|NCT00160615|65162806|FG001|Overall Study|Withdrawal by Subject|2|||
23387186|NCT00160615|65162805|FG000|Overall Study|Lack of Efficacy|11|||
23387187|NCT00160615|65162806|FG001|Overall Study|Lack of Efficacy|23|||
23387188|NCT00160615|65162805|FG000|Overall Study|Patient decision|1|||
23387189|NCT00160615|65162806|FG001|Overall Study|Patient decision|2|||
23387190|NCT00160615|65162805|FG000|Overall Study|Investigator decision|1|||
23387191|NCT00160615|65162806|FG001|Overall Study|Investigator decision|1|||
23387192|NCT00160615|65162805|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
23387193|NCT00160615|65162806|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
23387194|NCT00160615|65162805|FG000|Overall Study|Switch to surgical treatment|0|||
23387195|NCT00160615|65162806|FG001|Overall Study|Switch to surgical treatment|2|||
23387196|NCT00160615|65162805|FG000|Overall Study|Non-compliance was suspected|0|||
23387197|NCT00160615|65162806|FG001|Overall Study|Non-compliance was suspected|1|||
23387198|NCT00160615|65162805|FG000|Overall Study|Poor compliance|0|||
23387199|NCT00160615|65162806|FG001|Overall Study|Poor compliance|1|||
23387200|NCT01852214|65162807|FG000|Period 1|Adverse Event|1|||
23387201|NCT01852214|65162808|FG001|Period 1|Adverse Event|2|||
23387202|NCT01852214|65162807|FG000|Period 1|Withdrawal by Subject|0|||
23387203|NCT01852214|65162808|FG001|Period 1|Withdrawal by Subject|1|||
23387204|NCT01852214|65162807|FG000|Washout Period|Withdrawal by Subject|0|||
23387205|NCT01852214|65162808|FG001|Washout Period|Withdrawal by Subject|1|||
23387206|NCT00799864|65162813|FG000|Overall Study|Participant reached a virologic endpoint|9|||
23387207|NCT00799864|65162814|FG001|Overall Study|Participant reached a virologic endpoint|2|||
23387208|NCT00799864|65162815|FG002|Overall Study|Participant reached a virologic endpoint|2|||
23387209|NCT00799864|65162816|FG003|Overall Study|Participant reached a virologic endpoint|0|||
23387210|NCT00799864|65162817|FG004|Overall Study|Participant reached a virologic endpoint|0|||
23387211|NCT00799864|65162813|FG000|Overall Study|Other|2|||
23387212|NCT00799864|65162814|FG001|Overall Study|Other|1|||
23387213|NCT00799864|65162815|FG002|Overall Study|Other|0|||
23387214|NCT00799864|65162816|FG003|Overall Study|Other|0|||
23387215|NCT00799864|65162817|FG004|Overall Study|Other|0|||
23387216|NCT00147537|65162818|FG000|Phase 1b|Death|0|||
23387217|NCT00147537|65162819|FG001|Phase 1b|Death|1|||
23387218|NCT00147537|65162820|FG002|Phase 1b|Death|2|||
23387219|NCT00147537|65162821|FG003|Phase 1b|Death|1|||
23387220|NCT00147537|65162822|FG004|Phase 1b|Death|2|||
23387221|NCT00147537|65162823|FG005|Phase 1b|Death|2|||
23387222|NCT00147537|65162824|FG006|Phase 1b|Death|1|||
23387223|NCT00147537|65162825|FG007|Phase 1b|Death|3|||
23387224|NCT00147537|65162826|FG008|Phase 1b|Death|9|||
23387225|NCT00147537|65162827|FG009|Phase 1b|Death|0|||
23387226|NCT00147537|65162828|FG010|Phase 1b|Death|0|||
23387227|NCT00147537|65162818|FG000|Phase 1b|Lost to Follow-up|2|||
23387228|NCT00147537|65162819|FG001|Phase 1b|Lost to Follow-up|1|||
23387229|NCT00147537|65162820|FG002|Phase 1b|Lost to Follow-up|0|||
23387230|NCT00147537|65162821|FG003|Phase 1b|Lost to Follow-up|0|||
23387231|NCT00147537|65162822|FG004|Phase 1b|Lost to Follow-up|0|||
23387232|NCT00147537|65162823|FG005|Phase 1b|Lost to Follow-up|0|||
23387233|NCT00147537|65162824|FG006|Phase 1b|Lost to Follow-up|2|||
23493923|NCT01030536|65554842|FG003|Overall Study|Withdrawal by Subject|0|||
23493924|NCT01030536|65554843|FG004|Overall Study|Withdrawal by Subject|0|||
23493925|NCT01030536|65554839|FG000|Overall Study|undefined|1|||
23493926|NCT01030536|65554840|FG001|Overall Study|undefined|0|||
23493927|NCT01030536|65554841|FG002|Overall Study|undefined|1|||
23493928|NCT01030536|65554842|FG003|Overall Study|undefined|1|||
23493929|NCT01030536|65554843|FG004|Overall Study|undefined|0|||
23493930|NCT01030536|65554839|FG000|Overall Study|Adverse Event|0|||
23493931|NCT01030536|65554840|FG001|Overall Study|Adverse Event|3|||
23493932|NCT01030536|65554841|FG002|Overall Study|Adverse Event|1|||
23493933|NCT01030536|65554842|FG003|Overall Study|Adverse Event|0|||
23493934|NCT01030536|65554843|FG004|Overall Study|Adverse Event|1|||
23493935|NCT01030536|65554839|FG000|Overall Study|Progressive disease|6|||
23493936|NCT01030536|65554840|FG001|Overall Study|Progressive disease|2|||
23493937|NCT01030536|65554841|FG002|Overall Study|Progressive disease|3|||
23493938|NCT01030536|65554842|FG003|Overall Study|Progressive disease|2|||
23493939|NCT01030536|65554843|FG004|Overall Study|Progressive disease|0|||
23493940|NCT01030536|65554839|FG000|Overall Study|Death|0|||
23493941|NCT01030536|65554840|FG001|Overall Study|Death|1|||
23493942|NCT01030536|65554841|FG002|Overall Study|Death|0|||
23493943|NCT01030536|65554842|FG003|Overall Study|Death|0|||
23493944|NCT01030536|65554843|FG004|Overall Study|Death|0|||
23493945|NCT01386008|65554845|FG000|Overall Study|exited w/o incident /study discontinued|17|||
23493946|NCT01386008|65554845|FG000|Overall Study|Adverse Event|3|||
23493947|NCT00961649|65554852|FG000|Overall Study|Adverse Event|4|||
23493948|NCT00961649|65554853|FG001|Overall Study|Adverse Event|0|||
23493949|NCT00961649|65554854|FG002|Overall Study|Adverse Event|0|||
23493950|NCT00961649|65554855|FG003|Overall Study|Adverse Event|2|||
23493951|NCT00961649|65554852|FG000|Overall Study|Inadequate control of IOP|0|||
23493952|NCT00961649|65554853|FG001|Overall Study|Inadequate control of IOP|0|||
23493953|NCT00961649|65554854|FG002|Overall Study|Inadequate control of IOP|0|||
23493954|NCT00961649|65554855|FG003|Overall Study|Inadequate control of IOP|1|||
23493955|NCT00961649|65554852|FG000|Overall Study|Patient has travel plans during holidays|0|||
23294764|NCT02274948|64818345|FG001|Overall Study|Withdrawal by Subject|58|||
23294765|NCT02274948|64818344|FG000|Overall Study|Stopped on family Practitioner advice|2|||
23294766|NCT02274948|64818345|FG001|Overall Study|Stopped on family Practitioner advice|5|||
23294767|NCT02274948|64818344|FG000|Overall Study|Left the area|4|||
23294768|NCT02274948|64818345|FG001|Overall Study|Left the area|3|||
23294769|NCT02466386|64818352|FG000|Overall Study|Adverse Event|5|||
23294770|NCT02466386|64818352|FG000|Overall Study|Protocol Violation|2|||
23294771|NCT02466386|64818352|FG000|Overall Study|Withdrawal by Subject|14|||
23294772|NCT02466386|64818352|FG000|Overall Study|Lost to Follow-up|5|||
23294773|NCT02466386|64818352|FG000|Overall Study|Lack of Efficacy|8|||
23294774|NCT02466386|64818352|FG000|Overall Study|Other|10|||
23294775|NCT01899326|64818354|FG000|Overall Study|Withdrawal by Subject|1|||
23294776|NCT01899326|64818354|FG000|Overall Study|Adverse Event|2|||
23294777|NCT01899326|64818354|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
23294778|NCT01083680|64818355|FG000|Overall Study|Lost to Follow-up|2758|||
23294779|NCT01083680|64818355|FG000|Overall Study|Withdrawal by Subject|1086|||
23294780|NCT00559364|64818356|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
23294781|NCT00559364|64818357|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
23294782|NCT00983476|64818358|FG000|Overall Study|Did not receive intervention|17|||
23294783|NCT00983476|64818359|FG001|Overall Study|Did not receive intervention|22|||
23387234|NCT00147537|65162825|FG007|Phase 1b|Lost to Follow-up|0|||
23387235|NCT00147537|65162826|FG008|Phase 1b|Lost to Follow-up|1|||
23387236|NCT00147537|65162827|FG009|Phase 1b|Lost to Follow-up|0|||
23387237|NCT00147537|65162828|FG010|Phase 1b|Lost to Follow-up|0|||
23387238|NCT00147537|65162818|FG000|Phase 1b|Other|0|||
23493956|NCT00961649|65554853|FG001|Overall Study|Patient has travel plans during holidays|0|||
23493957|NCT00961649|65554854|FG002|Overall Study|Patient has travel plans during holidays|1|||
23387239|NCT00147537|65162819|FG001|Phase 1b|Other|0|||
23387240|NCT00147537|65162820|FG002|Phase 1b|Other|2|||
23387241|NCT00147537|65162821|FG003|Phase 1b|Other|1|||
23387242|NCT00147537|65162822|FG004|Phase 1b|Other|1|||
23387243|NCT00147537|65162823|FG005|Phase 1b|Other|1|||
23387244|NCT00147537|65162824|FG006|Phase 1b|Other|14|||
23387245|NCT00147537|65162825|FG007|Phase 1b|Other|4|||
23387246|NCT00147537|65162826|FG008|Phase 1b|Other|4|||
23387247|NCT00147537|65162827|FG009|Phase 1b|Other|0|||
23387248|NCT00147537|65162828|FG010|Phase 1b|Other|0|||
23387249|NCT00147537|65162818|FG000|Phase 1b|Withdrawal by Subject|0|||
23387250|NCT00147537|65162819|FG001|Phase 1b|Withdrawal by Subject|0|||
23387251|NCT00147537|65162820|FG002|Phase 1b|Withdrawal by Subject|0|||
23387252|NCT00147537|65162821|FG003|Phase 1b|Withdrawal by Subject|0|||
23387253|NCT00147537|65162822|FG004|Phase 1b|Withdrawal by Subject|0|||
23387254|NCT00147537|65162823|FG005|Phase 1b|Withdrawal by Subject|0|||
23387255|NCT00147537|65162824|FG006|Phase 1b|Withdrawal by Subject|0|||
23387256|NCT00147537|65162825|FG007|Phase 1b|Withdrawal by Subject|0|||
23387257|NCT00147537|65162826|FG008|Phase 1b|Withdrawal by Subject|2|||
23387258|NCT00147537|65162827|FG009|Phase 1b|Withdrawal by Subject|0|||
23387259|NCT00147537|65162828|FG010|Phase 1b|Withdrawal by Subject|0|||
23387260|NCT00147537|65162818|FG000|Phase 1b|Randomized but not treated|0|||
23493958|NCT00961649|65554855|FG003|Overall Study|Patient has travel plans during holidays|0|||
23493959|NCT00961649|65554852|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
23493960|NCT00961649|65554853|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
23493961|NCT00961649|65554854|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
23387261|NCT00147537|65162819|FG001|Phase 1b|Randomized but not treated|0|||
23387262|NCT00147537|65162820|FG002|Phase 1b|Randomized but not treated|0|||
23387263|NCT00147537|65162821|FG003|Phase 1b|Randomized but not treated|0|||
23387264|NCT00147537|65162822|FG004|Phase 1b|Randomized but not treated|0|||
23387265|NCT00147537|65162823|FG005|Phase 1b|Randomized but not treated|0|||
23387266|NCT00147537|65162824|FG006|Phase 1b|Randomized but not treated|1|||
23387267|NCT00147537|65162825|FG007|Phase 1b|Randomized but not treated|0|||
23387268|NCT00147537|65162826|FG008|Phase 1b|Randomized but not treated|1|||
23387269|NCT00147537|65162827|FG009|Phase 1b|Randomized but not treated|0|||
23387270|NCT00147537|65162828|FG010|Phase 1b|Randomized but not treated|0|||
23387271|NCT00147537|65162818|FG000|Phase 2|Death|0|||
23387272|NCT00147537|65162819|FG001|Phase 2|Death|0|||
23387273|NCT00147537|65162820|FG002|Phase 2|Death|0|||
23493962|NCT00961649|65554855|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
23493963|NCT00961649|65554852|FG000|Overall Study|Study terminated by sponsor|4|||
23493964|NCT00961649|65554853|FG001|Overall Study|Study terminated by sponsor|4|||
23493965|NCT00961649|65554854|FG002|Overall Study|Study terminated by sponsor|4|||
23493966|NCT00961649|65554855|FG003|Overall Study|Study terminated by sponsor|1|||
23493967|NCT01952145|65554856|FG000|Overall Study|Protocol Violation|2|||
23493968|NCT01952145|65554857|FG001|Overall Study|Protocol Violation|1|||
23493969|NCT01952145|65554856|FG000|Overall Study|Death|0|||
23387274|NCT00147537|65162821|FG003|Phase 2|Death|0|||
23493970|NCT01952145|65554857|FG001|Overall Study|Death|1|||
23493971|NCT01952145|65554856|FG000|Overall Study|Adverse Event|9|||
23493972|NCT01952145|65554857|FG001|Overall Study|Adverse Event|0|||
23387275|NCT00147537|65162822|FG004|Phase 2|Death|0|||
23387276|NCT00147537|65162823|FG005|Phase 2|Death|0|||
23387277|NCT00147537|65162824|FG006|Phase 2|Death|0|||
23387278|NCT00147537|65162825|FG007|Phase 2|Death|0|||
23294784|NCT00983476|64818360|FG002|Overall Study|Did not receive intervention|0|||
23294785|NCT00576303|64818361|FG000|Dose Titration Period|Early withdrawal|17|||
23294786|NCT00576303|64818361|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
23294787|NCT00576303|64818361|FG000|Long Term Safety Period|Early withdrawal|16|||
23294788|NCT02839798|64818362|FG000|Overall Study|Withdrawal by Subject|2|||
23294789|NCT01118117|64818363|FG000|Overall Study|Death|8|||
23294790|NCT01118117|64818364|FG001|Overall Study|Death|0|||
23493973|NCT01952145|65554856|FG000|Overall Study|Withdrawal Criteria|16|||
23493974|NCT01952145|65554857|FG001|Overall Study|Withdrawal Criteria|11|||
23493975|NCT01952145|65554856|FG000|Overall Study|Unclassified|1|||
23493976|NCT01952145|65554857|FG001|Overall Study|Unclassified|1|||
23493977|NCT05447897|65554858|FG000|Overall Study|Did not participate in survey|2|||
23493978|NCT01811225|65554859|FG000|Treatment Period 1|Adverse Event|2|||
23493979|NCT01811225|65554860|FG001|Treatment Period 1|Adverse Event|3|||
23493980|NCT01811225|65554859|FG000|Treatment Period 1|Lost to Follow-up|12|||
23493981|NCT01811225|65554860|FG001|Treatment Period 1|Lost to Follow-up|8|||
23493982|NCT01811225|65554859|FG000|Treatment Period 1|transporation|1|||
23493983|NCT01811225|65554860|FG001|Treatment Period 1|transporation|0|||
23493984|NCT01811225|65554859|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
23493985|NCT01811225|65554860|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
23493986|NCT01811225|65554859|FG000|Treatment Period 2|Lost to Follow-up|1|||
23493987|NCT01811225|65554860|FG001|Treatment Period 2|Lost to Follow-up|2|||
23493988|NCT01811225|65554859|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
23493989|NCT01811225|65554860|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
23493990|NCT00633750|65554863|FG000|Overall Study|Adverse Event|2|||
23493991|NCT00633750|65554863|FG000|Overall Study|Withdrawal by Subject|3|||
23493992|NCT00108433|65554869|FG000|Overall Study|Lack of Efficacy|1|||
23493993|NCT00108433|65554870|FG001|Overall Study|Lack of Efficacy|2|||
23493994|NCT00108433|65554869|FG000|Overall Study|Death|3|||
23493995|NCT00108433|65554870|FG001|Overall Study|Death|0|||
23493996|NCT00108433|65554869|FG000|Overall Study|Adverse Event|3|||
23493997|NCT00108433|65554870|FG001|Overall Study|Adverse Event|1|||
23493998|NCT00108433|65554869|FG000|Overall Study|Other|14|||
23493999|NCT00108433|65554870|FG001|Overall Study|Other|14|||
23494000|NCT03945214|65554871|FG000|Overall Study|Lost to Follow-up|3|||
23494001|NCT03945214|65554872|FG001|Overall Study|Lost to Follow-up|4|||
23494002|NCT03945214|65554873|FG002|Overall Study|Lost to Follow-up|7|||
23494003|NCT03945214|65554874|FG003|Overall Study|Lost to Follow-up|4|||
23494004|NCT01495975|65554875|FG000|Overall Study|Lost to Follow-up|1|||
23494005|NCT01495975|65554876|FG001|Overall Study|Lost to Follow-up|0|||
23294791|NCT01118117|64818363|FG000|Overall Study|Lost to Follow-up|6|||
23294792|NCT01118117|64818364|FG001|Overall Study|Lost to Follow-up|0|||
23494006|NCT00722423|65554884|FG000|Overall Study|Protocol Violation|0|||
23294793|NCT01118117|64818363|FG000|Overall Study|Missed 12 Month Visit|7|||
23494007|NCT00722423|65554885|FG001|Overall Study|Protocol Violation|1|||
23494008|NCT01128842|65554887|FG000|Overall Study|Adverse Event|1|||
23494009|NCT01128842|65554887|FG000|Overall Study|Disease Progression|6|||
23494010|NCT04638660|65554888|FG000|Overall Study|Withdrawal by Subject|2|||
23494011|NCT04638660|65554889|FG001|Overall Study|Withdrawal by Subject|0|||
23494012|NCT04638660|65554888|FG000|Overall Study|Lost to Follow-up|1|||
23494013|NCT04638660|65554889|FG001|Overall Study|Lost to Follow-up|0|||
23494014|NCT03546062|65554890|FG000|Overall Study|Adverse Event|6|||
23494015|NCT03546062|65554891|FG001|Overall Study|Adverse Event|5|||
23494016|NCT03546062|65554892|FG002|Overall Study|Adverse Event|8|||
23494017|NCT02935842|65554893|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
23494018|NCT02935842|65554894|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
23494019|NCT02935842|65554895|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
23494020|NCT02935842|65554896|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
23494021|NCT02935842|65554893|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
23494022|NCT02935842|65554894|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
23494023|NCT02935842|65554895|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
23494024|NCT02935842|65554896|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
23494025|NCT02935842|65554893|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
23494026|NCT02935842|65554894|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
23494027|NCT02935842|65554895|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
23494028|NCT02935842|65554896|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
23494029|NCT02935842|65554893|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
23494030|NCT02935842|65554894|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
23494031|NCT02935842|65554895|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
23494032|NCT02935842|65554896|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
23494033|NCT02935842|65554893|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
23494034|NCT02935842|65554894|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
23494035|NCT02935842|65554895|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
23494036|NCT02935842|65554896|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
23494037|NCT00566111|65554897|FG000|Overall Study|Adverse Event|0|||
23494038|NCT00566111|65554898|FG001|Overall Study|Adverse Event|2|||
23494039|NCT00697788|65554899|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494040|NCT00697788|65554900|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
23494041|NCT00697788|65554901|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494042|NCT00697788|65554902|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494043|NCT00697788|65554903|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494044|NCT00697788|65554904|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494045|NCT00697788|65554905|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494046|NCT00697788|65554906|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
23494047|NCT00697788|65554899|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494048|NCT00697788|65554900|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494049|NCT00697788|65554901|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494050|NCT00697788|65554902|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494051|NCT00697788|65554903|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
23494052|NCT00697788|65554904|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494053|NCT00697788|65554905|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494054|NCT00697788|65554906|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
23494055|NCT01447433|65554907|FG000|Overall Study|Lost to Follow-up|0|||
23494056|NCT01447433|65554908|FG001|Overall Study|Lost to Follow-up|2|||
23494057|NCT01447433|65554907|FG000|Overall Study|Withdrawal by Subject|3|||
23494058|NCT01447433|65554908|FG001|Overall Study|Withdrawal by Subject|3|||
23494059|NCT01447433|65554907|FG000|Overall Study|Protocol Violation|1|||
23494060|NCT01447433|65554908|FG001|Overall Study|Protocol Violation|1|||
23494061|NCT00369824|65554909|FG000|Overall Study|Adverse Event|0|||
23494062|NCT00369824|65554910|FG001|Overall Study|Adverse Event|2|||
23494063|NCT00369824|65554911|FG002|Overall Study|Adverse Event|0|||
23494064|NCT00369824|65554912|FG003|Overall Study|Adverse Event|0|||
23494065|NCT00369824|65554913|FG004|Overall Study|Adverse Event|1|||
23494066|NCT00369824|65554914|FG005|Overall Study|Adverse Event|0|||
23494067|NCT00369824|65554909|FG000|Overall Study|Protocol Violation|0|||
23494068|NCT00369824|65554910|FG001|Overall Study|Protocol Violation|1|||
23494069|NCT00369824|65554911|FG002|Overall Study|Protocol Violation|0|||
23494070|NCT00369824|65554912|FG003|Overall Study|Protocol Violation|1|||
23494071|NCT00369824|65554913|FG004|Overall Study|Protocol Violation|1|||
23494072|NCT00369824|65554914|FG005|Overall Study|Protocol Violation|0|||
23494073|NCT00369824|65554909|FG000|Overall Study|Withdrawal by Subject|9|||
23494074|NCT00369824|65554910|FG001|Overall Study|Withdrawal by Subject|5|||
23494075|NCT00369824|65554911|FG002|Overall Study|Withdrawal by Subject|5|||
23494076|NCT00369824|65554912|FG003|Overall Study|Withdrawal by Subject|4|||
23494077|NCT00369824|65554913|FG004|Overall Study|Withdrawal by Subject|6|||
23494078|NCT00369824|65554914|FG005|Overall Study|Withdrawal by Subject|2|||
23494079|NCT00369824|65554909|FG000|Overall Study|Lost to Follow-up|6|||
23494080|NCT00369824|65554910|FG001|Overall Study|Lost to Follow-up|11|||
23494081|NCT00369824|65554911|FG002|Overall Study|Lost to Follow-up|7|||
23494082|NCT00369824|65554912|FG003|Overall Study|Lost to Follow-up|8|||
23494083|NCT00369824|65554913|FG004|Overall Study|Lost to Follow-up|9|||
23494084|NCT00369824|65554914|FG005|Overall Study|Lost to Follow-up|6|||
23494085|NCT00369824|65554909|FG000|Overall Study|Other|0|||
23494086|NCT00369824|65554910|FG001|Overall Study|Other|0|||
23494087|NCT00369824|65554911|FG002|Overall Study|Other|0|||
23494088|NCT00369824|65554912|FG003|Overall Study|Other|2|||
23494089|NCT00369824|65554913|FG004|Overall Study|Other|1|||
23494090|NCT00369824|65554914|FG005|Overall Study|Other|3|||
23494091|NCT01390649|65554915|FG000|Overall Study|Physician Decision|1|||
23494092|NCT00850070|65554916|FG000|Overall Study|Lack of Efficacy|1|||
23494093|NCT00850070|65554917|FG001|Overall Study|Lack of Efficacy|1|||
23494094|NCT00850070|65554916|FG000|Overall Study|Adverse Event|2|||
23494095|NCT00850070|65554917|FG001|Overall Study|Adverse Event|0|||
23494096|NCT02980783|65554918|FG000|Overall Study|Lost to Follow-up|1|||
23494097|NCT02877134|65554919|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494098|NCT02877134|65554920|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
23494099|NCT02877134|65554921|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494100|NCT02877134|65554922|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494101|NCT02877134|65554923|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494102|NCT02877134|65554924|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
23494103|NCT02877134|65554925|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494104|NCT02877134|65554926|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494105|NCT02877134|65554927|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494106|NCT02877134|65554928|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494107|NCT02877134|65554929|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494108|NCT02877134|65554930|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
23494109|NCT02877134|65554919|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494110|NCT02877134|65554920|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
23494111|NCT02877134|65554921|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494112|NCT02877134|65554922|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
23494113|NCT02877134|65554923|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494114|NCT02877134|65554924|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494115|NCT02877134|65554925|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
23494116|NCT02877134|65554926|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494117|NCT02877134|65554927|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494118|NCT02877134|65554928|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494119|NCT02877134|65554929|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494120|NCT02877134|65554930|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
23494121|NCT02877134|65554919|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
23494122|NCT02877134|65554920|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
23494123|NCT02877134|65554921|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
23494124|NCT02877134|65554922|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
23494125|NCT02877134|65554923|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
23494126|NCT02877134|65554924|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
23494127|NCT02877134|65554925|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
23494128|NCT02877134|65554926|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494129|NCT02877134|65554927|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494130|NCT02877134|65554928|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494131|NCT02877134|65554929|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494132|NCT02877134|65554930|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
23494133|NCT02877134|65554919|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
23494134|NCT02877134|65554920|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
23494135|NCT02877134|65554921|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
23494136|NCT02877134|65554922|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
23494137|NCT02877134|65554923|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
23494138|NCT02877134|65554924|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
23494139|NCT02877134|65554925|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
23494140|NCT02877134|65554926|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494141|NCT02877134|65554927|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494142|NCT02877134|65554928|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494143|NCT02877134|65554929|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494144|NCT02877134|65554930|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
23494145|NCT02877134|65554919|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494146|NCT02877134|65554920|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494147|NCT02877134|65554921|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494148|NCT02877134|65554922|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494149|NCT02877134|65554923|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494150|NCT02877134|65554924|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494151|NCT02877134|65554925|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494152|NCT02877134|65554926|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494153|NCT02877134|65554927|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
23494154|NCT02877134|65554928|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494155|NCT02877134|65554929|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494156|NCT02877134|65554930|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
23494157|NCT02877134|65554919|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494158|NCT02877134|65554920|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494159|NCT02877134|65554921|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494160|NCT02877134|65554922|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494161|NCT02877134|65554923|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494162|NCT02877134|65554924|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494163|NCT02877134|65554925|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
23494164|NCT02877134|65554926|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
23494165|NCT02877134|65554927|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
23494166|NCT02877134|65554928|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
23494167|NCT02877134|65554929|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
23494168|NCT02877134|65554930|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
23494169|NCT02877134|65554919|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494170|NCT02877134|65554920|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494171|NCT02877134|65554921|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494172|NCT02877134|65554922|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494173|NCT02877134|65554923|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494174|NCT02877134|65554924|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494175|NCT02877134|65554925|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494176|NCT02877134|65554926|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
23494177|NCT02877134|65554927|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
23494178|NCT02877134|65554928|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
23494179|NCT02877134|65554929|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23294794|NCT01118117|64818364|FG001|Overall Study|Missed 12 Month Visit|0|||
23294795|NCT02031237|64818365|FG000|Overall Study|Death|1|||
23294796|NCT02031237|64818366|FG001|Overall Study|Death|5|||
23294797|NCT02031237|64818367|FG002|Overall Study|Death|0|||
23294798|NCT02031237|64818365|FG000|Overall Study|Physician Decision|0|||
23294799|NCT02031237|64818366|FG001|Overall Study|Physician Decision|1|||
23294800|NCT02031237|64818367|FG002|Overall Study|Physician Decision|0|||
23294801|NCT02031237|64818365|FG000|Overall Study|Withdrawal by Subject|2|||
23294802|NCT02031237|64818366|FG001|Overall Study|Withdrawal by Subject|2|||
23387279|NCT00147537|65162826|FG008|Phase 2|Death|0|||
23387280|NCT00147537|65162827|FG009|Phase 2|Death|85|||
23294803|NCT02031237|64818367|FG002|Overall Study|Withdrawal by Subject|0|||
23387281|NCT00147537|65162828|FG010|Phase 2|Death|31|||
23494180|NCT02877134|65554930|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
23494181|NCT02877134|65554919|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
23494182|NCT02877134|65554920|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
23494183|NCT02877134|65554921|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
23494184|NCT02877134|65554922|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
23494185|NCT02877134|65554923|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
23494186|NCT02877134|65554924|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
23494187|NCT02877134|65554925|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
23494188|NCT02877134|65554926|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
23494189|NCT02877134|65554927|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
23494190|NCT02877134|65554928|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
23294804|NCT02031237|64818365|FG000|Overall Study|Protocol Violation|2|||
23294805|NCT02031237|64818366|FG001|Overall Study|Protocol Violation|6|||
23294806|NCT02031237|64818367|FG002|Overall Study|Protocol Violation|0|||
23494191|NCT02877134|65554929|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
23494192|NCT02877134|65554930|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
23494193|NCT04447794|65554936|FG000|Overall Study|Lost to Follow-up|2|||
23494194|NCT04447794|65554937|FG001|Overall Study|Lost to Follow-up|3|||
23494195|NCT04447794|65554938|FG002|Overall Study|Lost to Follow-up|8|||
23494196|NCT04447794|65554936|FG000|Overall Study|Withdrawal by Subject|1|||
23494197|NCT04447794|65554937|FG001|Overall Study|Withdrawal by Subject|1|||
23494198|NCT04447794|65554938|FG002|Overall Study|Withdrawal by Subject|0|||
23294807|NCT02031237|64818365|FG000|Overall Study|Alternate Treatment Given|0|||
23294808|NCT02031237|64818366|FG001|Overall Study|Alternate Treatment Given|0|||
23294809|NCT02031237|64818367|FG002|Overall Study|Alternate Treatment Given|3|||
23294810|NCT03840382|64818368|FG000|Overall Study|Lost to Follow-up|11|||
23294811|NCT00763555|64818372|FG000|Overall Study|Adverse Event|2|||
23294812|NCT00763555|64818373|FG001|Overall Study|Adverse Event|1|||
23294813|NCT00763555|64818372|FG000|Overall Study|Withdrawal by Subject|2|||
23294814|NCT00763555|64818373|FG001|Overall Study|Withdrawal by Subject|6|||
23494199|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
23494200|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
23294815|NCT00763555|64818372|FG000|Overall Study|Lost to Follow-up|0|||
23494201|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
23294816|NCT00763555|64818373|FG001|Overall Study|Lost to Follow-up|3|||
23387282|NCT00147537|65162818|FG000|Phase 2|Lost to Follow-up|0|||
23387283|NCT00147537|65162819|FG001|Phase 2|Lost to Follow-up|0|||
23387284|NCT00147537|65162820|FG002|Phase 2|Lost to Follow-up|0|||
23387285|NCT00147537|65162821|FG003|Phase 2|Lost to Follow-up|0|||
23387286|NCT00147537|65162822|FG004|Phase 2|Lost to Follow-up|0|||
23387287|NCT00147537|65162823|FG005|Phase 2|Lost to Follow-up|0|||
23387288|NCT00147537|65162824|FG006|Phase 2|Lost to Follow-up|0|||
23387289|NCT00147537|65162825|FG007|Phase 2|Lost to Follow-up|0|||
23387290|NCT00147537|65162826|FG008|Phase 2|Lost to Follow-up|0|||
23387291|NCT00147537|65162827|FG009|Phase 2|Lost to Follow-up|12|||
23387292|NCT00147537|65162828|FG010|Phase 2|Lost to Follow-up|4|||
23387293|NCT00147537|65162818|FG000|Phase 2|Other|0|||
23387294|NCT00147537|65162819|FG001|Phase 2|Other|0|||
23387295|NCT00147537|65162820|FG002|Phase 2|Other|0|||
23387296|NCT00147537|65162821|FG003|Phase 2|Other|0|||
23387297|NCT00147537|65162822|FG004|Phase 2|Other|0|||
23387298|NCT00147537|65162823|FG005|Phase 2|Other|0|||
23387299|NCT00147537|65162824|FG006|Phase 2|Other|0|||
23494202|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
23494203|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
23494204|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
23494205|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
23494206|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
23494207|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
23494208|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
23494209|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
23494210|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
23494211|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
23494212|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
23494213|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
23494214|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
23494215|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
23387300|NCT00147537|65162825|FG007|Phase 2|Other|0|||
23387301|NCT00147537|65162826|FG008|Phase 2|Other|0|||
23387302|NCT00147537|65162827|FG009|Phase 2|Other|47|||
23387303|NCT00147537|65162828|FG010|Phase 2|Other|12|||
23387304|NCT00147537|65162818|FG000|Phase 2|Withdrawal by Subject|0|||
23387305|NCT00147537|65162819|FG001|Phase 2|Withdrawal by Subject|0|||
23387306|NCT00147537|65162820|FG002|Phase 2|Withdrawal by Subject|0|||
23387307|NCT00147537|65162821|FG003|Phase 2|Withdrawal by Subject|0|||
23387308|NCT00147537|65162822|FG004|Phase 2|Withdrawal by Subject|0|||
23387309|NCT00147537|65162823|FG005|Phase 2|Withdrawal by Subject|0|||
23387310|NCT00147537|65162824|FG006|Phase 2|Withdrawal by Subject|0|||
23387311|NCT00147537|65162825|FG007|Phase 2|Withdrawal by Subject|0|||
23387312|NCT00147537|65162826|FG008|Phase 2|Withdrawal by Subject|0|||
23387313|NCT00147537|65162827|FG009|Phase 2|Withdrawal by Subject|16|||
23387314|NCT00147537|65162828|FG010|Phase 2|Withdrawal by Subject|4|||
23387315|NCT00147537|65162818|FG000|Phase 2|Randomized but not treated|0|||
23387316|NCT00147537|65162819|FG001|Phase 2|Randomized but not treated|0|||
23387317|NCT00147537|65162820|FG002|Phase 2|Randomized but not treated|0|||
23387318|NCT00147537|65162821|FG003|Phase 2|Randomized but not treated|0|||
23387319|NCT00147537|65162822|FG004|Phase 2|Randomized but not treated|0|||
23387320|NCT00147537|65162823|FG005|Phase 2|Randomized but not treated|0|||
23387321|NCT00147537|65162824|FG006|Phase 2|Randomized but not treated|0|||
23387322|NCT00147537|65162825|FG007|Phase 2|Randomized but not treated|0|||
23387323|NCT00147537|65162826|FG008|Phase 2|Randomized but not treated|0|||
23387324|NCT00147537|65162827|FG009|Phase 2|Randomized but not treated|1|||
23387325|NCT00147537|65162828|FG010|Phase 2|Randomized but not treated|1|||
23387326|NCT02639559|65162829|FG000|Overall Study|Mobilization failure|0|||
23494216|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
23387327|NCT02639559|65162830|FG001|Overall Study|Mobilization failure|3|||
23387328|NCT02639559|65162829|FG000|Overall Study|Issues with vascular acess|1|||
23387329|NCT02639559|65162830|FG001|Overall Study|Issues with vascular acess|0|||
23387330|NCT00245570|65162833|FG000|Washout Between Periods III and IV|Adverse Event|0|||
23387331|NCT00245570|65162834|FG001|Washout Between Periods III and IV|Adverse Event|1|||
23387332|NCT00245570|65162835|FG002|Washout Between Periods III and IV|Adverse Event|0|||
23387333|NCT00245570|65162836|FG003|Washout Between Periods III and IV|Adverse Event|0|||
23387334|NCT00245570|65162837|FG004|Washout Between Periods III and IV|Adverse Event|0|||
23387335|NCT00245570|65162838|FG005|Washout Between Periods III and IV|Adverse Event|0|||
23387336|NCT00183391|65162839|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
23387337|NCT00183391|65162840|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
23387338|NCT00183391|65162839|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
23387339|NCT00183391|65162840|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
23387340|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
23387341|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
23387342|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
23387343|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Adverse Event|5|||
23387344|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Adverse Event|1|||
23387345|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Adverse Event|0|||
23387346|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
23387347|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
23387348|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
23387349|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Death|8|||
23387350|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Death|24|||
23387351|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Death|0|||
23387352|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
23387353|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
23387354|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
23387355|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
23387356|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
23387357|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
23387358|NCT02931539|65162841|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
23387359|NCT02931539|65162842|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
23387360|NCT02931539|65162843|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
23387361|NCT02931539|65162841|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
23387362|NCT02931539|65162842|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
23387363|NCT02931539|65162843|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
23387364|NCT01803737|65162844|FG000|Overall Study|Lack of Time|1|||
23387365|NCT01803737|65162845|FG001|Overall Study|Lack of Time|0|||
23387366|NCT01803737|65162844|FG000|Overall Study|Medical Reason|0|||
23387367|NCT01803737|65162845|FG001|Overall Study|Medical Reason|1|||
23387368|NCT01803737|65162844|FG000|Overall Study|Lost to Follow-up|0|||
23387369|NCT01803737|65162845|FG001|Overall Study|Lost to Follow-up|2|||
23387370|NCT02151604|65162846|FG000|Overall Study|Lost to Follow-up|3|||
23387371|NCT02151604|65162846|FG000|Overall Study|Withdrawal by Subject|2|||
23387372|NCT02151604|65162846|FG000|Overall Study|Physician Decision|3|||
23387373|NCT02151604|65162846|FG000|Overall Study|Death|1|||
23387374|NCT01133977|65162847|FG000|Overall Study|Adverse Event|0|||
23387375|NCT01133977|65162848|FG001|Overall Study|Adverse Event|0|||
23387376|NCT01133977|65162849|FG002|Overall Study|Adverse Event|1|||
23387377|NCT01133977|65162850|FG003|Overall Study|Adverse Event|0|||
23387378|NCT01133977|65162851|FG004|Overall Study|Adverse Event|0|||
23387379|NCT01133977|65162847|FG000|Overall Study|Death|1|||
23387380|NCT01133977|65162848|FG001|Overall Study|Death|1|||
23387381|NCT01133977|65162849|FG002|Overall Study|Death|1|||
23387382|NCT01133977|65162850|FG003|Overall Study|Death|7|||
23387383|NCT01133977|65162851|FG004|Overall Study|Death|3|||
23387384|NCT01133977|65162847|FG000|Overall Study|Started a New Line of Therapy|2|||
23387385|NCT01133977|65162848|FG001|Overall Study|Started a New Line of Therapy|6|||
23387386|NCT01133977|65162849|FG002|Overall Study|Started a New Line of Therapy|4|||
23387387|NCT01133977|65162850|FG003|Overall Study|Started a New Line of Therapy|25|||
23387388|NCT01133977|65162851|FG004|Overall Study|Started a New Line of Therapy|33|||
23387389|NCT01133977|65162847|FG000|Overall Study|Lost to Follow-up|0|||
23387390|NCT01133977|65162848|FG001|Overall Study|Lost to Follow-up|0|||
23387391|NCT01133977|65162849|FG002|Overall Study|Lost to Follow-up|0|||
23387392|NCT01133977|65162850|FG003|Overall Study|Lost to Follow-up|2|||
23387393|NCT01133977|65162851|FG004|Overall Study|Lost to Follow-up|1|||
23387394|NCT01133977|65162847|FG000|Overall Study|Withdrawal by Subject|0|||
23387395|NCT01133977|65162848|FG001|Overall Study|Withdrawal by Subject|0|||
23387396|NCT01133977|65162849|FG002|Overall Study|Withdrawal by Subject|0|||
23387397|NCT01133977|65162850|FG003|Overall Study|Withdrawal by Subject|5|||
23387398|NCT01133977|65162851|FG004|Overall Study|Withdrawal by Subject|1|||
23387399|NCT00421733|65162853|FG000|Overall Study|Adverse Event|4|||
23387400|NCT00421733|65162854|FG001|Overall Study|Adverse Event|9|||
23387401|NCT00421733|65162855|FG002|Overall Study|Adverse Event|2|||
23387402|NCT00421733|65162853|FG000|Overall Study|Lost to Follow-up|1|||
23387403|NCT00421733|65162854|FG001|Overall Study|Lost to Follow-up|2|||
23387404|NCT00421733|65162855|FG002|Overall Study|Lost to Follow-up|4|||
23494217|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
23387405|NCT00421733|65162853|FG000|Overall Study|Withdrawal by Subject|1|||
23387406|NCT00421733|65162854|FG001|Overall Study|Withdrawal by Subject|2|||
23387407|NCT00421733|65162855|FG002|Overall Study|Withdrawal by Subject|7|||
23387408|NCT00421733|65162853|FG000|Overall Study|Death|0|||
23387409|NCT00421733|65162854|FG001|Overall Study|Death|3|||
23387410|NCT00421733|65162855|FG002|Overall Study|Death|0|||
23387411|NCT00421733|65162853|FG000|Overall Study|Required dialysis|1|||
23387412|NCT00421733|65162854|FG001|Overall Study|Required dialysis|0|||
23294817|NCT00104247|64818374|FG000|Overall Study|Withdrawal by Subject|1|||
23294818|NCT00104247|64818375|FG001|Overall Study|Withdrawal by Subject|0|||
23294819|NCT00104247|64818374|FG000|Overall Study|Noncompliant with dosing|0|||
23294820|NCT00104247|64818375|FG001|Overall Study|Noncompliant with dosing|1|||
23294821|NCT02710214|64818376|FG000|Overall Study|Lost to Follow-up|1|||
23294822|NCT02710214|64818377|FG001|Overall Study|Lost to Follow-up|0|||
23294823|NCT02710214|64818376|FG000|Overall Study|Lack of Efficacy|0|||
23294824|NCT02710214|64818377|FG001|Overall Study|Lack of Efficacy|1|||
23294825|NCT02710214|64818376|FG000|Overall Study|Death|0|||
23294826|NCT02710214|64818377|FG001|Overall Study|Death|1|||
23294827|NCT03069417|64818381|FG000|Overall Study|Lost to Follow-up|2|||
23294828|NCT03069417|64818382|FG001|Overall Study|Lost to Follow-up|0|||
23294829|NCT03069417|64818381|FG000|Overall Study|Reason Unknown|4|||
23294830|NCT03069417|64818382|FG001|Overall Study|Reason Unknown|7|||
23294831|NCT00517192|64818387|FG000|Overall Study|Adverse Event|1|||
23294832|NCT00517192|64818388|FG001|Overall Study|Adverse Event|1|||
23294833|NCT00517192|64818387|FG000|Overall Study|Lost to Follow-up|1|||
23294834|NCT00517192|64818388|FG001|Overall Study|Lost to Follow-up|1|||
23294835|NCT00517192|64818387|FG000|Overall Study|Withdrawal by Subject|1|||
23294836|NCT00517192|64818388|FG001|Overall Study|Withdrawal by Subject|0|||
23294837|NCT00517192|64818387|FG000|Overall Study|Early termination of the trial|16|||
23387413|NCT00421733|65162855|FG002|Overall Study|Required dialysis|0|||
23494218|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
23494219|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
23494220|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
23494221|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
23294838|NCT00517192|64818388|FG001|Overall Study|Early termination of the trial|18|||
23294839|NCT03135899|64818389|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
23294840|NCT03135899|64818390|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
23294841|NCT03135899|64818391|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
23294842|NCT03135899|64818392|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
23294843|NCT03135899|64818393|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
23294844|NCT03135899|64818394|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
23294845|NCT03135899|64818395|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
23294846|NCT03135899|64818396|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
23294847|NCT03135899|64818389|FG000|Overall Study|Withdrawal by Subject|0|||
23294848|NCT03135899|64818390|FG001|Overall Study|Withdrawal by Subject|0|||
23294849|NCT03135899|64818391|FG002|Overall Study|Withdrawal by Subject|0|||
23294850|NCT03135899|64818392|FG003|Overall Study|Withdrawal by Subject|0|||
23294851|NCT03135899|64818393|FG004|Overall Study|Withdrawal by Subject|0|||
23294852|NCT03135899|64818394|FG005|Overall Study|Withdrawal by Subject|2|||
23294853|NCT03135899|64818395|FG006|Overall Study|Withdrawal by Subject|0|||
23294854|NCT03135899|64818396|FG007|Overall Study|Withdrawal by Subject|0|||
23294855|NCT01115855|64821750|FG000|Overall Study|Adverse Event|16|||
23294856|NCT01115855|64821751|FG001|Overall Study|Adverse Event|18|||
23294857|NCT01115855|64821750|FG000|Overall Study|Death|6|||
23294858|NCT01115855|64821751|FG001|Overall Study|Death|5|||
23294859|NCT01115855|64821750|FG000|Overall Study|Lab Abnormality|1|||
23294860|NCT01115855|64821751|FG001|Overall Study|Lab Abnormality|1|||
23294861|NCT01115855|64821750|FG000|Overall Study|Protocol Violation|0|||
23294862|NCT01115855|64821751|FG001|Overall Study|Protocol Violation|1|||
23294863|NCT01115855|64821750|FG000|Overall Study|Withdrawal by Subject|5|||
23294864|NCT01115855|64821751|FG001|Overall Study|Withdrawal by Subject|5|||
23294865|NCT01115855|64821750|FG000|Overall Study|Other|8|||
23294866|NCT01115855|64821751|FG001|Overall Study|Other|6|||
23294867|NCT02485158|64821752|FG000|Overall Study|Withdrawal by Subject|3|||
23294868|NCT02485158|64821752|FG000|Overall Study|expected drug side effect|1|||
23294869|NCT03864042|64821753|FG000|DDI Phase|Adverse Event|2|||
23294870|NCT03864042|64821754|FG001|DDI Phase|Adverse Event|0|||
23294871|NCT03864042|64821755|FG002|DDI Phase|Adverse Event|0|||
23294872|NCT03864042|64821753|FG000|DDI Phase|Physician Decision|1|||
23294873|NCT03864042|64821754|FG001|DDI Phase|Physician Decision|0|||
23294874|NCT03864042|64821755|FG002|DDI Phase|Physician Decision|0|||
23294875|NCT03864042|64821753|FG000|DDI Phase|Progressive Disease|1|||
23294876|NCT03864042|64821754|FG001|DDI Phase|Progressive Disease|0|||
23294877|NCT03864042|64821755|FG002|DDI Phase|Progressive Disease|0|||
23294878|NCT03864042|64821753|FG000|Post-DDI Phase|Adverse Event|5|||
23294879|NCT03864042|64821754|FG001|Post-DDI Phase|Adverse Event|3|||
23294880|NCT03864042|64821755|FG002|Post-DDI Phase|Adverse Event|2|||
23494222|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
23294881|NCT03864042|64821753|FG000|Post-DDI Phase|Progressive Disease|11|||
23294882|NCT03864042|64821754|FG001|Post-DDI Phase|Progressive Disease|6|||
23294883|NCT03864042|64821755|FG002|Post-DDI Phase|Progressive Disease|13|||
23294884|NCT03864042|64821753|FG000|Post-DDI Phase|Discretion of investigator|1|||
23294885|NCT03864042|64821754|FG001|Post-DDI Phase|Discretion of investigator|1|||
23294886|NCT03864042|64821755|FG002|Post-DDI Phase|Discretion of investigator|0|||
23294887|NCT03864042|64821753|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
23494223|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Death|2|||
23294888|NCT03864042|64821754|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
23294889|NCT03864042|64821755|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
23387414|NCT00421733|65162853|FG000|Overall Study|Administrative|2|||
23387415|NCT00421733|65162854|FG001|Overall Study|Administrative|0|||
23387416|NCT00421733|65162855|FG002|Overall Study|Administrative|0|||
23387417|NCT00421733|65162853|FG000|Overall Study|Did not satisfy entry criteria|1|||
23387418|NCT00421733|65162854|FG001|Overall Study|Did not satisfy entry criteria|3|||
23387419|NCT00421733|65162855|FG002|Overall Study|Did not satisfy entry criteria|2|||
23387420|NCT00421733|65162853|FG000|Overall Study|Sponsor request|1|||
23387421|NCT00421733|65162854|FG001|Overall Study|Sponsor request|0|||
23387422|NCT00421733|65162855|FG002|Overall Study|Sponsor request|3|||
23387423|NCT00421733|65162853|FG000|Overall Study|Protocol deviation|4|||
23387424|NCT00421733|65162854|FG001|Overall Study|Protocol deviation|7|||
23387425|NCT00421733|65162855|FG002|Overall Study|Protocol deviation|2|||
23387426|NCT01769443|65162856|FG000|Overall Study|Study closure|1|||
23387427|NCT01769443|65162857|FG001|Overall Study|Study closure|0|||
23387428|NCT01712074|65162858|FG000|Placebo Run-in Period|Adverse Event|2|||
23387429|NCT01712074|65162859|FG001|Placebo Run-in Period|Adverse Event|0|||
23387430|NCT01712074|65162860|FG002|Placebo Run-in Period|Adverse Event|0|||
23387431|NCT01712074|65162858|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
23387432|NCT01712074|65162859|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
23387433|NCT01712074|65162860|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
23387434|NCT01712074|65162858|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
23387435|NCT01712074|65162859|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
23387436|NCT01712074|65162860|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
23387437|NCT01712074|65162858|FG000|Placebo Run-in Period|Other|1|||
23387438|NCT01712074|65162859|FG001|Placebo Run-in Period|Other|0|||
23387439|NCT01712074|65162860|FG002|Placebo Run-in Period|Other|0|||
23387440|NCT01712074|65162858|FG000|Placebo Run-in Period|No longer willing to participate|1|||
23387441|NCT01712074|65162859|FG001|Placebo Run-in Period|No longer willing to participate|0|||
23387442|NCT01712074|65162860|FG002|Placebo Run-in Period|No longer willing to participate|0|||
23387443|NCT01712074|65162858|FG000|Double Blind Period|Adverse Event|0|||
23387444|NCT01712074|65162859|FG001|Double Blind Period|Adverse Event|2|||
23294890|NCT03864042|64821753|FG000|Post-DDI Phase|Withdrawal of consent|1|||
23294891|NCT03864042|64821754|FG001|Post-DDI Phase|Withdrawal of consent|2|||
23294892|NCT03864042|64821755|FG002|Post-DDI Phase|Withdrawal of consent|0|||
23294893|NCT03718117|64821764|FG000|Overall Study|Death|12|||
23294894|NCT03718117|64821765|FG001|Overall Study|Death|11|||
23294895|NCT03718117|64821766|FG002|Overall Study|Death|0|||
23294896|NCT03718117|64821764|FG000|Overall Study|Other|0|||
23294897|NCT03718117|64821765|FG001|Overall Study|Other|1|||
23294898|NCT03718117|64821766|FG002|Overall Study|Other|0|||
23294899|NCT03718117|64821764|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
23294900|NCT03718117|64821765|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
23294901|NCT03718117|64821766|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
23294902|NCT03718117|64821764|FG000|Overall Study|Participant not met eligibility criteria|0|||
23294903|NCT03718117|64821765|FG001|Overall Study|Participant not met eligibility criteria|0|||
23294904|NCT03718117|64821766|FG002|Overall Study|Participant not met eligibility criteria|2|||
23387445|NCT01712074|65162860|FG002|Double Blind Period|Adverse Event|1|||
23387446|NCT01712074|65162858|FG000|Double Blind Period|No longer willing to participate|0|||
23387447|NCT01712074|65162859|FG001|Double Blind Period|No longer willing to participate|2|||
23294905|NCT00743509|64821767|FG000|Overall Study|Withdrawal by Subject|2|||
23387448|NCT01712074|65162860|FG002|Double Blind Period|No longer willing to participate|4|||
23294906|NCT00544817|64821770|FG000|Combined Modality|Lack of Efficacy|2|||
23294907|NCT00544817|64821770|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
23294908|NCT00544817|64821770|FG000|Combined Modality|Adverse Event|2|||
23294909|NCT00544817|64821770|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
23294910|NCT00544817|64821770|FG000|No Treatment Interval|Lack of Efficacy|8|||
23294911|NCT00544817|64821770|FG000|No Treatment Interval|Physician Decision|3|||
23294912|NCT00544817|64821770|FG000|No Treatment Interval|Adverse Event|1|||
23494224|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Death|1|||
23494225|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Death|0|||
23294913|NCT00544817|64821770|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
23294914|NCT00544817|64821770|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
23387449|NCT01712074|65162858|FG000|Double Blind Period|Death|0|||
23387450|NCT01712074|65162859|FG001|Double Blind Period|Death|1|||
23387451|NCT01712074|65162860|FG002|Double Blind Period|Death|0|||
23387452|NCT01712074|65162858|FG000|Double Blind Period|Lost to Follow-up|0|||
23387453|NCT01712074|65162859|FG001|Double Blind Period|Lost to Follow-up|2|||
23387454|NCT01712074|65162860|FG002|Double Blind Period|Lost to Follow-up|1|||
23387455|NCT01712074|65162858|FG000|Double Blind Period|Other|0|||
23387456|NCT01712074|65162859|FG001|Double Blind Period|Other|4|||
23387457|NCT01712074|65162860|FG002|Double Blind Period|Other|1|||
23387458|NCT01712074|65162858|FG000|Double Blind Period|Protocol Violation|0|||
23387459|NCT01712074|65162859|FG001|Double Blind Period|Protocol Violation|0|||
23387460|NCT01712074|65162860|FG002|Double Blind Period|Protocol Violation|1|||
23387461|NCT01712074|65162858|FG000|Double Blind Period|No longer met eligibility criteria|0|||
23387462|NCT01712074|65162859|FG001|Double Blind Period|No longer met eligibility criteria|3|||
23387463|NCT01712074|65162860|FG002|Double Blind Period|No longer met eligibility criteria|0|||
23387464|NCT01795937|65162867|FG000|Overall Study|Withdrawal by Subject|1|||
23387465|NCT01795937|65162868|FG001|Overall Study|Withdrawal by Subject|0|||
23494226|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Death|0|||
23494227|NCT02607930|65554939|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
23294915|NCT00544817|64821770|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
23294916|NCT01684215|64821771|FG000|Phase 1, Part 1|Adverse Event|1|||
23294917|NCT01684215|64821772|FG001|Phase 1, Part 1|Adverse Event|0|||
23294918|NCT01684215|64821773|FG002|Phase 1, Part 1|Adverse Event|0|||
23294919|NCT01684215|64821774|FG003|Phase 1, Part 1|Adverse Event|0|||
23294920|NCT01684215|64821771|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
23294921|NCT01684215|64821772|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
23294922|NCT01684215|64821773|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
23294923|NCT01684215|64821774|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
23294924|NCT01684215|64821771|FG000|Phase 1, Part 2|Adverse Event|0|||
23294925|NCT01684215|64821772|FG001|Phase 1, Part 2|Adverse Event|0|||
23294926|NCT01684215|64821773|FG002|Phase 1, Part 2|Adverse Event|1|||
23294927|NCT01684215|64821774|FG003|Phase 1, Part 2|Adverse Event|0|||
23294928|NCT01684215|64821771|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
23294929|NCT01684215|64821772|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
23294930|NCT01684215|64821773|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
23294931|NCT01684215|64821774|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
23294932|NCT01684215|64821771|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
23294933|NCT01684215|64821772|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
23294934|NCT01684215|64821773|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
23294935|NCT01684215|64821774|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
23294936|NCT01684215|64821771|FG000|Phase 2|Death|0|||
23294937|NCT01684215|64821772|FG001|Phase 2|Death|0|||
23294938|NCT01684215|64821773|FG002|Phase 2|Death|0|||
23294939|NCT01684215|64821774|FG003|Phase 2|Death|8|||
23294940|NCT01684215|64821771|FG000|Phase 2|Study terminated by sponsor|0|||
23294941|NCT01684215|64821772|FG001|Phase 2|Study terminated by sponsor|0|||
23294942|NCT01684215|64821773|FG002|Phase 2|Study terminated by sponsor|0|||
23294943|NCT01684215|64821774|FG003|Phase 2|Study terminated by sponsor|30|||
23294944|NCT01684215|64821771|FG000|Phase 2|Enrolled but not treated|0|||
23294945|NCT01684215|64821772|FG001|Phase 2|Enrolled but not treated|0|||
23387466|NCT01795937|65162869|FG002|Overall Study|Withdrawal by Subject|0|||
23294946|NCT01684215|64821773|FG002|Phase 2|Enrolled but not treated|0|||
23294947|NCT01684215|64821774|FG003|Phase 2|Enrolled but not treated|1|||
23294948|NCT01684215|64821771|FG000|Phase 2|Lost to Follow-up|0|||
23294949|NCT01684215|64821772|FG001|Phase 2|Lost to Follow-up|0|||
23294950|NCT01684215|64821773|FG002|Phase 2|Lost to Follow-up|0|||
23294951|NCT01684215|64821774|FG003|Phase 2|Lost to Follow-up|4|||
23294952|NCT01803269|64821775|FG000|Overall Study|Withdrawal by Subject|3|||
23294953|NCT01803269|64821776|FG001|Overall Study|Withdrawal by Subject|0|||
23294954|NCT01803269|64821777|FG002|Overall Study|Withdrawal by Subject|0|||
23387467|NCT01795937|65162867|FG000|Overall Study|Physician Decision|0|||
23387468|NCT01795937|65162868|FG001|Overall Study|Physician Decision|1|||
23294955|NCT00931463|64821778|FG000|Overall Study|Death|8|||
23294956|NCT00931463|64821779|FG001|Overall Study|Death|4|||
23387469|NCT01795937|65162869|FG002|Overall Study|Physician Decision|0|||
23387470|NCT00281580|65162870|FG000|Overall Study|Adverse Event|2|||
23387471|NCT00281580|65162871|FG001|Overall Study|Adverse Event|0|||
23387472|NCT00281580|65162872|FG002|Overall Study|Adverse Event|2|||
23387473|NCT00281580|65162873|FG003|Overall Study|Adverse Event|4|||
23387474|NCT00281580|65162874|FG004|Overall Study|Adverse Event|1|||
23387475|NCT00281580|65162875|FG005|Overall Study|Adverse Event|0|||
23387476|NCT00281580|65162876|FG006|Overall Study|Adverse Event|1|||
23387477|NCT00281580|65162877|FG007|Overall Study|Adverse Event|0|||
23387478|NCT00281580|65162878|FG008|Overall Study|Adverse Event|1|||
23387479|NCT00281580|65162879|FG009|Overall Study|Adverse Event|6|||
23387480|NCT00281580|65162880|FG010|Overall Study|Adverse Event|0|||
23387481|NCT00281580|65162881|FG011|Overall Study|Adverse Event|5|||
23387482|NCT00281580|65162882|FG012|Overall Study|Adverse Event|8|||
23387483|NCT00281580|65162883|FG013|Overall Study|Adverse Event|2|||
23387484|NCT00281580|65162884|FG014|Overall Study|Adverse Event|3|||
23387485|NCT00281580|65162885|FG015|Overall Study|Adverse Event|3|||
23294957|NCT00931463|64821778|FG000|Overall Study|Withdrawal by Subject|5|||
23294958|NCT00931463|64821779|FG001|Overall Study|Withdrawal by Subject|0|||
23294959|NCT00931463|64821778|FG000|Overall Study|Lost to Follow-up|4|||
23294960|NCT00931463|64821779|FG001|Overall Study|Lost to Follow-up|1|||
23294961|NCT02808819|64821782|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
23294962|NCT02808819|64821783|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
23294963|NCT02808819|64821782|FG000|Overall Study|Withdrawal by Subject|10|||
23294964|NCT02808819|64821783|FG001|Overall Study|Withdrawal by Subject|13|||
23294965|NCT02808819|64821782|FG000|Overall Study|Site terminated by sponsor|2|||
23294966|NCT02808819|64821783|FG001|Overall Study|Site terminated by sponsor|0|||
23294967|NCT02808819|64821782|FG000|Overall Study|Pregnancy|1|||
23294968|NCT02808819|64821783|FG001|Overall Study|Pregnancy|0|||
23294969|NCT02808819|64821782|FG000|Overall Study|Lost to Follow-up|1|||
23294970|NCT02808819|64821783|FG001|Overall Study|Lost to Follow-up|6|||
23294971|NCT02808819|64821782|FG000|Overall Study|Protocol Violation|0|||
23294972|NCT02808819|64821783|FG001|Overall Study|Protocol Violation|1|||
23294973|NCT02808819|64821782|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
23294974|NCT02808819|64821783|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
23294975|NCT02808819|64821782|FG000|Overall Study|Death|1|||
23294976|NCT02808819|64821783|FG001|Overall Study|Death|0|||
23294977|NCT02808819|64821782|FG000|Overall Study|Adverse Event|3|||
23294978|NCT02808819|64821783|FG001|Overall Study|Adverse Event|4|||
23294979|NCT00115934|64821784|FG000|Overall Study|Lost to Follow-up|1|||
23294980|NCT00115934|64821785|FG001|Overall Study|Lost to Follow-up|0|||
23294981|NCT00115934|64821784|FG000|Overall Study|Did not receive intervention|3|||
23294982|NCT00115934|64821785|FG001|Overall Study|Did not receive intervention|2|||
23294983|NCT02190279|64821786|FG000|Overall Study|Withdrawal consent|1|||
23294984|NCT02190279|64821787|FG001|Overall Study|Withdrawal consent|0|||
23294985|NCT02190279|64821788|FG002|Overall Study|Withdrawal consent|1|||
23294986|NCT02190279|64821786|FG000|Overall Study|Lost to Follow-up|2|||
23294987|NCT02190279|64821787|FG001|Overall Study|Lost to Follow-up|0|||
23294988|NCT02190279|64821788|FG002|Overall Study|Lost to Follow-up|0|||
23294989|NCT02190279|64821786|FG000|Overall Study|Refused further treatment|0|||
23294990|NCT02190279|64821787|FG001|Overall Study|Refused further treatment|0|||
23294991|NCT02190279|64821788|FG002|Overall Study|Refused further treatment|1|||
23294992|NCT02190279|64821786|FG000|Overall Study|Screening failure|0|||
23294993|NCT02190279|64821787|FG001|Overall Study|Screening failure|0|||
23294994|NCT02190279|64821788|FG002|Overall Study|Screening failure|1|||
23387486|NCT00281580|65162870|FG000|Overall Study|Protocol Violation|0|||
23294995|NCT02619682|64821791|FG000|Overall Study|Withdrawal by Subject|3|||
23294996|NCT02619682|64821791|FG000|Overall Study|Lack of Efficacy|8|||
23294997|NCT02619682|64821791|FG000|Overall Study|new secondary cancer|1|||
23294998|NCT02619682|64821791|FG000|Overall Study|post surgery complications|2|||
23387487|NCT00281580|65162871|FG001|Overall Study|Protocol Violation|0|||
23294999|NCT04447287|64821794|FG000|Period 1: Run-in Period|Adverse Event|3|||
23295000|NCT04447287|64821795|FG001|Period 1: Run-in Period|Adverse Event|0|||
23295001|NCT04447287|64821796|FG002|Period 1: Run-in Period|Adverse Event|0|||
23387488|NCT00281580|65162872|FG002|Overall Study|Protocol Violation|1|||
23387489|NCT00281580|65162873|FG003|Overall Study|Protocol Violation|1|||
23387490|NCT00281580|65162874|FG004|Overall Study|Protocol Violation|0|||
23494228|NCT02607930|65554940|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
23494229|NCT02607930|65554941|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
23494230|NCT02607930|65554942|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
23494231|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
23494232|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
23295002|NCT04447287|64821794|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
23387491|NCT00281580|65162875|FG005|Overall Study|Protocol Violation|0|||
23387492|NCT00281580|65162876|FG006|Overall Study|Protocol Violation|1|||
23387493|NCT00281580|65162877|FG007|Overall Study|Protocol Violation|0|||
23387494|NCT00281580|65162878|FG008|Overall Study|Protocol Violation|2|||
23387495|NCT00281580|65162879|FG009|Overall Study|Protocol Violation|0|||
23387496|NCT00281580|65162880|FG010|Overall Study|Protocol Violation|1|||
23387497|NCT00281580|65162881|FG011|Overall Study|Protocol Violation|2|||
23387498|NCT00281580|65162882|FG012|Overall Study|Protocol Violation|0|||
23387499|NCT00281580|65162883|FG013|Overall Study|Protocol Violation|1|||
23387500|NCT00281580|65162884|FG014|Overall Study|Protocol Violation|1|||
23387501|NCT00281580|65162885|FG015|Overall Study|Protocol Violation|3|||
23494233|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
23494234|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
23295003|NCT04447287|64821795|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
23295004|NCT04447287|64821796|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
23295005|NCT04447287|64821794|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
23295006|NCT04447287|64821795|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
23295007|NCT04447287|64821796|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
23295008|NCT00348816|64821804|FG000|Overall Study|Noncompliance with radiation treatment|1|||
23295009|NCT01467479|64821805|FG000|Overall Study|No Study Medication|1|||
23295010|NCT01467479|64821806|FG001|Overall Study|No Study Medication|0|||
23295011|NCT01467479|64821807|FG002|Overall Study|No Study Medication|2|||
23295012|NCT01467479|64821805|FG000|Overall Study|Adverse Event|1|||
23295013|NCT01467479|64821806|FG001|Overall Study|Adverse Event|2|||
23295014|NCT01467479|64821807|FG002|Overall Study|Adverse Event|0|||
23295015|NCT01467479|64821805|FG000|Overall Study|Death|0|||
23295016|NCT01467479|64821806|FG001|Overall Study|Death|0|||
23295017|NCT01467479|64821807|FG002|Overall Study|Death|1|||
23295018|NCT01467479|64821805|FG000|Overall Study|Lost to Follow-up|2|||
23295019|NCT01467479|64821806|FG001|Overall Study|Lost to Follow-up|5|||
23295020|NCT01467479|64821807|FG002|Overall Study|Lost to Follow-up|3|||
23295021|NCT01467479|64821805|FG000|Overall Study|Withdrawal of Consent|3|||
23295022|NCT01467479|64821806|FG001|Overall Study|Withdrawal of Consent|7|||
23295023|NCT01467479|64821807|FG002|Overall Study|Withdrawal of Consent|7|||
23295024|NCT01467479|64821805|FG000|Overall Study|Study Terminated by Sponsor|1|||
23295025|NCT01467479|64821806|FG001|Overall Study|Study Terminated by Sponsor|3|||
23295026|NCT01467479|64821807|FG002|Overall Study|Study Terminated by Sponsor|3|||
23295027|NCT01467479|64821805|FG000|Overall Study|Other|1|||
23295028|NCT01467479|64821806|FG001|Overall Study|Other|0|||
23295029|NCT01467479|64821807|FG002|Overall Study|Other|0|||
23295030|NCT00685035|64821810|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
23295031|NCT00685035|64821811|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
23295032|NCT01740791|64821814|FG000|Overall Study|Randomized but never treated|5|||
23295033|NCT01740791|64821815|FG001|Overall Study|Randomized but never treated|3|||
23295034|NCT01740791|64821816|FG002|Overall Study|Randomized but never treated|2|||
23295035|NCT01740791|64821817|FG003|Overall Study|Randomized but never treated|2|||
23295036|NCT01740791|64821818|FG004|Overall Study|Randomized but never treated|1|||
23295037|NCT01740791|64821819|FG005|Overall Study|Randomized but never treated|3|||
23295038|NCT01740791|64821814|FG000|Overall Study|Lost to Follow-up|2|||
23295039|NCT01740791|64821815|FG001|Overall Study|Lost to Follow-up|0|||
23295040|NCT01740791|64821816|FG002|Overall Study|Lost to Follow-up|2|||
23295041|NCT01740791|64821817|FG003|Overall Study|Lost to Follow-up|3|||
23295042|NCT01740791|64821818|FG004|Overall Study|Lost to Follow-up|2|||
23295043|NCT01740791|64821819|FG005|Overall Study|Lost to Follow-up|3|||
23295044|NCT01740791|64821814|FG000|Overall Study|Withdrew Consent|4|||
23295045|NCT01740791|64821815|FG001|Overall Study|Withdrew Consent|0|||
23295046|NCT01740791|64821816|FG002|Overall Study|Withdrew Consent|1|||
23295047|NCT01740791|64821817|FG003|Overall Study|Withdrew Consent|2|||
23295048|NCT01740791|64821818|FG004|Overall Study|Withdrew Consent|0|||
23295049|NCT01740791|64821819|FG005|Overall Study|Withdrew Consent|3|||
23295050|NCT01740791|64821814|FG000|Overall Study|Investigator's discretion|1|||
23295051|NCT01740791|64821815|FG001|Overall Study|Investigator's discretion|0|||
23295052|NCT01740791|64821816|FG002|Overall Study|Investigator's discretion|1|||
23295053|NCT01740791|64821817|FG003|Overall Study|Investigator's discretion|0|||
23295054|NCT01740791|64821818|FG004|Overall Study|Investigator's discretion|0|||
23387502|NCT00281580|65162870|FG000|Overall Study|Withdrawal by Subject|3|||
23387503|NCT00281580|65162871|FG001|Overall Study|Withdrawal by Subject|0|||
23295055|NCT01740791|64821819|FG005|Overall Study|Investigator's discretion|1|||
23295056|NCT01740791|64821814|FG000|Overall Study|Adverse Event|0|||
23295057|NCT01740791|64821815|FG001|Overall Study|Adverse Event|0|||
23295058|NCT01740791|64821816|FG002|Overall Study|Adverse Event|0|||
23295059|NCT01740791|64821817|FG003|Overall Study|Adverse Event|0|||
23295060|NCT01740791|64821818|FG004|Overall Study|Adverse Event|0|||
23295061|NCT01740791|64821819|FG005|Overall Study|Adverse Event|1|||
23295062|NCT00255151|64821820|FG000|Overall Study|Adverse Event|10|||
23295063|NCT00255151|64821821|FG001|Overall Study|Adverse Event|6|||
23295064|NCT00255151|64821822|FG002|Overall Study|Adverse Event|9|||
23295065|NCT00255151|64821820|FG000|Overall Study|Lost to Follow-up|4|||
23295066|NCT00255151|64821821|FG001|Overall Study|Lost to Follow-up|3|||
23295067|NCT00255151|64821822|FG002|Overall Study|Lost to Follow-up|4|||
23295068|NCT00255151|64821820|FG000|Overall Study|Withdrawal by Subject|18|||
23295069|NCT00255151|64821821|FG001|Overall Study|Withdrawal by Subject|17|||
23295070|NCT00255151|64821822|FG002|Overall Study|Withdrawal by Subject|8|||
23295071|NCT00255151|64821820|FG000|Overall Study|Noncompliance|0|||
23295072|NCT00255151|64821821|FG001|Overall Study|Noncompliance|1|||
23295073|NCT00255151|64821822|FG002|Overall Study|Noncompliance|2|||
23295074|NCT00255151|64821820|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
23295075|NCT00255151|64821821|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
23295076|NCT00255151|64821822|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
23295077|NCT00255151|64821820|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
23295078|NCT00255151|64821821|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
23295079|NCT00255151|64821822|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
23295080|NCT00255151|64821820|FG000|Overall Study|Possible Barrett's Esophagus|1|||
23295081|NCT00255151|64821821|FG001|Overall Study|Possible Barrett's Esophagus|3|||
23295082|NCT00255151|64821822|FG002|Overall Study|Possible Barrett's Esophagus|8|||
23295083|NCT00255151|64821820|FG000|Overall Study|Esophageal Stricture|0|||
23295084|NCT00255151|64821821|FG001|Overall Study|Esophageal Stricture|0|||
23295085|NCT00255151|64821822|FG002|Overall Study|Esophageal Stricture|1|||
23295086|NCT00255151|64821820|FG000|Overall Study|Therapeutic Failure|11|||
23295087|NCT00255151|64821821|FG001|Overall Study|Therapeutic Failure|2|||
23295088|NCT00255151|64821822|FG002|Overall Study|Therapeutic Failure|3|||
23295089|NCT02096588|64821823|FG000|Overall Study|Lack of Efficacy|2|||
23295090|NCT02096588|64821824|FG001|Overall Study|Lack of Efficacy|0|||
23295091|NCT02096588|64821823|FG000|Overall Study|Withdrawal by Subject|0|||
23295092|NCT02096588|64821824|FG001|Overall Study|Withdrawal by Subject|1|||
23295093|NCT02147587|64821825|FG000|Overall Study|Adverse Event|9|||
23295094|NCT02147587|64821826|FG001|Overall Study|Adverse Event|4|||
23295095|NCT02147587|64821825|FG000|Overall Study|Lack of Efficacy|2|||
23295096|NCT02147587|64821826|FG001|Overall Study|Lack of Efficacy|1|||
23295097|NCT03689894|64821827|FG000|Overall Study|Adverse Event|1|||
23295098|NCT03321526|64821828|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
23387504|NCT00281580|65162872|FG002|Overall Study|Withdrawal by Subject|1|||
23295099|NCT03321526|64821829|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
23295100|NCT03321526|64821828|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
23387505|NCT00281580|65162873|FG003|Overall Study|Withdrawal by Subject|1|||
23387506|NCT00281580|65162874|FG004|Overall Study|Withdrawal by Subject|1|||
23387507|NCT00281580|65162875|FG005|Overall Study|Withdrawal by Subject|2|||
23387508|NCT00281580|65162876|FG006|Overall Study|Withdrawal by Subject|2|||
23387509|NCT00281580|65162877|FG007|Overall Study|Withdrawal by Subject|0|||
23295101|NCT03321526|64821829|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
23295102|NCT03321526|64821828|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
23295103|NCT03321526|64821829|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
23295104|NCT03321526|64821828|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
23295105|NCT03321526|64821829|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
23295106|NCT03321526|64821828|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
23295107|NCT03321526|64821829|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
23295108|NCT03321526|64821828|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
23295109|NCT03321526|64821829|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
23387510|NCT00281580|65162878|FG008|Overall Study|Withdrawal by Subject|1|||
23387511|NCT00281580|65162879|FG009|Overall Study|Withdrawal by Subject|4|||
23387512|NCT00281580|65162880|FG010|Overall Study|Withdrawal by Subject|1|||
23387513|NCT00281580|65162881|FG011|Overall Study|Withdrawal by Subject|1|||
23387514|NCT00281580|65162882|FG012|Overall Study|Withdrawal by Subject|2|||
23295110|NCT03321526|64821828|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
23387515|NCT00281580|65162883|FG013|Overall Study|Withdrawal by Subject|2|||
23387516|NCT00281580|65162884|FG014|Overall Study|Withdrawal by Subject|1|||
23387517|NCT00281580|65162885|FG015|Overall Study|Withdrawal by Subject|5|||
23387518|NCT00281580|65162870|FG000|Overall Study|Lack of Efficacy|2|||
23387519|NCT00281580|65162871|FG001|Overall Study|Lack of Efficacy|1|||
23387520|NCT00281580|65162872|FG002|Overall Study|Lack of Efficacy|1|||
23387521|NCT00281580|65162873|FG003|Overall Study|Lack of Efficacy|6|||
23387522|NCT00281580|65162874|FG004|Overall Study|Lack of Efficacy|2|||
23387523|NCT00281580|65162875|FG005|Overall Study|Lack of Efficacy|0|||
23387524|NCT00281580|65162876|FG006|Overall Study|Lack of Efficacy|0|||
23387525|NCT00281580|65162877|FG007|Overall Study|Lack of Efficacy|0|||
23387526|NCT00281580|65162878|FG008|Overall Study|Lack of Efficacy|0|||
23387527|NCT00281580|65162879|FG009|Overall Study|Lack of Efficacy|0|||
23387528|NCT00281580|65162880|FG010|Overall Study|Lack of Efficacy|0|||
23295111|NCT03321526|64821829|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
23295112|NCT03321526|64821828|FG000|Follow-up Phase (2 Weeks)|Other|24|||
23295113|NCT03321526|64821829|FG001|Follow-up Phase (2 Weeks)|Other|24|||
23295114|NCT01610063|64821830|FG000|Overall Study|Lost to Follow-up|42|||
23295115|NCT01610063|64821831|FG001|Overall Study|Lost to Follow-up|20|||
23295116|NCT02994394|64821832|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
23295117|NCT02994394|64821833|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
23295118|NCT02994394|64821834|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
23295119|NCT02994394|64821835|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
23295120|NCT02994394|64821836|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
23295121|NCT02994394|64821837|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
23295122|NCT02994394|64821832|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
23295123|NCT02994394|64821833|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
23295124|NCT02994394|64821834|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
23295125|NCT02994394|64821835|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
23295126|NCT02994394|64821836|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
23295127|NCT02994394|64821837|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
23295128|NCT02733627|64821840|FG000|Overall Study|Adverse Event|0|||
23295129|NCT02733627|64821841|FG001|Overall Study|Adverse Event|1|||
23295130|NCT02733627|64821842|FG002|Overall Study|Adverse Event|1|||
23295131|NCT02733627|64821843|FG003|Overall Study|Adverse Event|0|||
23387529|NCT00281580|65162881|FG011|Overall Study|Lack of Efficacy|1|||
23387530|NCT00281580|65162882|FG012|Overall Study|Lack of Efficacy|0|||
23387531|NCT00281580|65162883|FG013|Overall Study|Lack of Efficacy|2|||
23387532|NCT00281580|65162884|FG014|Overall Study|Lack of Efficacy|1|||
23387533|NCT00281580|65162885|FG015|Overall Study|Lack of Efficacy|0|||
23387534|NCT00281580|65162870|FG000|Overall Study|Lost to Follow-up|0|||
23387535|NCT00281580|65162871|FG001|Overall Study|Lost to Follow-up|0|||
23387536|NCT00281580|65162872|FG002|Overall Study|Lost to Follow-up|0|||
23387537|NCT00281580|65162873|FG003|Overall Study|Lost to Follow-up|3|||
23387538|NCT00281580|65162874|FG004|Overall Study|Lost to Follow-up|0|||
23387539|NCT00281580|65162875|FG005|Overall Study|Lost to Follow-up|1|||
23387540|NCT00281580|65162876|FG006|Overall Study|Lost to Follow-up|0|||
23387541|NCT00281580|65162877|FG007|Overall Study|Lost to Follow-up|1|||
23387542|NCT00281580|65162878|FG008|Overall Study|Lost to Follow-up|2|||
23387543|NCT00281580|65162879|FG009|Overall Study|Lost to Follow-up|1|||
23387544|NCT00281580|65162880|FG010|Overall Study|Lost to Follow-up|1|||
23387545|NCT00281580|65162881|FG011|Overall Study|Lost to Follow-up|0|||
23387546|NCT00281580|65162882|FG012|Overall Study|Lost to Follow-up|1|||
23387547|NCT00281580|65162883|FG013|Overall Study|Lost to Follow-up|0|||
23387548|NCT00281580|65162884|FG014|Overall Study|Lost to Follow-up|0|||
23387549|NCT00281580|65162885|FG015|Overall Study|Lost to Follow-up|0|||
23387550|NCT00281580|65162870|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
23387551|NCT00281580|65162871|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
23387552|NCT00281580|65162872|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
23387553|NCT00281580|65162873|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
23387554|NCT00281580|65162874|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
23387555|NCT00281580|65162875|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
23387556|NCT00281580|65162876|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
23387557|NCT00281580|65162877|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
23387558|NCT00281580|65162878|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
23387559|NCT00281580|65162879|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
23387560|NCT00281580|65162880|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
23387561|NCT00281580|65162881|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
23387562|NCT00281580|65162882|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
23387563|NCT00281580|65162883|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
23387564|NCT00281580|65162884|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
23387565|NCT00281580|65162885|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
23387566|NCT02255279|65162888|FG000|Overall Study|Lost to Follow-up|2|||
23387567|NCT02255279|65162889|FG001|Overall Study|Lost to Follow-up|2|||
23387568|NCT02255279|65162888|FG000|Overall Study|Protocol Violation|0|||
23387569|NCT02255279|65162889|FG001|Overall Study|Protocol Violation|1|||
23387570|NCT02255279|65162888|FG000|Overall Study|Withdrawal by Subject|3|||
23387571|NCT02255279|65162889|FG001|Overall Study|Withdrawal by Subject|6|||
23387572|NCT02191397|65162890|FG000|Overall Study|Adverse Event|28|||
23387573|NCT02191397|65162891|FG001|Overall Study|Adverse Event|17|||
23387574|NCT02191397|65162890|FG000|Overall Study|Lack of Efficacy|10|||
23387575|NCT02191397|65162891|FG001|Overall Study|Lack of Efficacy|5|||
23387576|NCT02191397|65162890|FG000|Overall Study|Protocol Violation|0|||
23387577|NCT02191397|65162891|FG001|Overall Study|Protocol Violation|3|||
23387578|NCT02191397|65162890|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
23494235|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
23387579|NCT02191397|65162891|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
23387580|NCT02191397|65162890|FG000|Overall Study|Lost to Follow-up|10|||
23387581|NCT02191397|65162891|FG001|Overall Study|Lost to Follow-up|11|||
23387582|NCT02191397|65162890|FG000|Overall Study|Physician Decision|8|||
23387583|NCT02191397|65162891|FG001|Overall Study|Physician Decision|3|||
23387584|NCT02191397|65162890|FG000|Overall Study|Withdrawal by Subject|22|||
23295132|NCT02733627|64821840|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
23295133|NCT02733627|64821841|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
23295134|NCT02733627|64821842|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
23295135|NCT02733627|64821843|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
23295136|NCT01478828|64821844|FG000|Overall Study|Adverse Event|1|||
23295137|NCT00794417|64821845|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
23295138|NCT00794417|64821846|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
23494236|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
23295139|NCT00794417|64821847|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
23295140|NCT00794417|64821848|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
23295141|NCT00794417|64821845|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
23295142|NCT00794417|64821846|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
23295143|NCT00794417|64821847|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
23295144|NCT00794417|64821848|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
23295145|NCT00794417|64821845|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
23295146|NCT00794417|64821846|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
23295147|NCT00794417|64821847|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
23387585|NCT02191397|65162891|FG001|Overall Study|Withdrawal by Subject|27|||
23387586|NCT01129284|65162895|FG000|Overall Study|Adverse Event|2|||
23387587|NCT01129284|65162896|FG001|Overall Study|Adverse Event|0|||
23387588|NCT01129284|65162897|FG002|Overall Study|Adverse Event|1|||
23387589|NCT00212355|65162898|FG000|Overall Study|Adverse Event|1|||
23387590|NCT00212355|65162898|FG000|Overall Study|Withdrawal by Subject|1|||
23387591|NCT00212355|65162898|FG000|Overall Study|A change of address|1|||
23387592|NCT00553475|65162906|FG000|Overall Study|Adverse Event|7|||
23387593|NCT00553475|65162907|FG001|Overall Study|Adverse Event|17|||
23387594|NCT00553475|65162908|FG002|Overall Study|Adverse Event|13|||
23387595|NCT00553475|65162906|FG000|Overall Study|Lack of Efficacy|7|||
23387596|NCT00553475|65162907|FG001|Overall Study|Lack of Efficacy|1|||
23387597|NCT00553475|65162908|FG002|Overall Study|Lack of Efficacy|0|||
23387598|NCT00553475|65162906|FG000|Overall Study|Withdrawal by Subject|1|||
23387599|NCT00553475|65162907|FG001|Overall Study|Withdrawal by Subject|1|||
23387600|NCT00553475|65162908|FG002|Overall Study|Withdrawal by Subject|0|||
23387601|NCT00553475|65162906|FG000|Overall Study|Physician Decision|1|||
23387602|NCT00553475|65162907|FG001|Overall Study|Physician Decision|0|||
23387603|NCT00553475|65162908|FG002|Overall Study|Physician Decision|0|||
23387604|NCT00553475|65162906|FG000|Overall Study|Due to moving|0|||
23387605|NCT00553475|65162907|FG001|Overall Study|Due to moving|1|||
23387606|NCT00553475|65162908|FG002|Overall Study|Due to moving|0|||
23387607|NCT01292473|65162909|FG000|Overall Study|Adverse Event|1|||
23387608|NCT01292473|65162910|FG001|Overall Study|Adverse Event|0|||
23387609|NCT01292473|65162911|FG002|Overall Study|Adverse Event|1|||
23387610|NCT01292473|65162912|FG003|Overall Study|Adverse Event|1|||
23387611|NCT01292473|65162909|FG000|Overall Study|Lost to Follow-up|1|||
23387612|NCT01292473|65162910|FG001|Overall Study|Lost to Follow-up|1|||
23295148|NCT00794417|64821848|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
23295149|NCT00794417|64821845|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
23295150|NCT00794417|64821846|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
23295151|NCT00794417|64821847|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
23295152|NCT00794417|64821848|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
23295153|NCT00794417|64821845|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
23295154|NCT00794417|64821846|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
23295155|NCT00794417|64821847|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
23295156|NCT00794417|64821848|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
23295157|NCT00794417|64821845|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
23295158|NCT00794417|64821846|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
23295159|NCT00794417|64821847|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
23295160|NCT00794417|64821848|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
23295161|NCT01662362|64821855|FG000|Overall Study|Lost to Follow-up|38|||
23295162|NCT01957150|64821856|FG000|Overall Study|Adverse Event|23|||
23295163|NCT01957150|64821857|FG001|Overall Study|Adverse Event|20|||
23295164|NCT01957150|64821856|FG000|Overall Study|Withdrawal by Subject|13|||
23295165|NCT01957150|64821857|FG001|Overall Study|Withdrawal by Subject|17|||
23295166|NCT01957150|64821856|FG000|Overall Study|Physician Decision|3|||
23295167|NCT01957150|64821857|FG001|Overall Study|Physician Decision|6|||
23295168|NCT01957150|64821856|FG000|Overall Study|Lost to Follow-up|4|||
23295169|NCT01957150|64821857|FG001|Overall Study|Lost to Follow-up|4|||
23295170|NCT01957150|64821856|FG000|Overall Study|Protocol Violation|1|||
23295171|NCT01957150|64821857|FG001|Overall Study|Protocol Violation|0|||
23295172|NCT01957150|64821856|FG000|Overall Study|Lack of Efficacy|11|||
23295173|NCT01957150|64821857|FG001|Overall Study|Lack of Efficacy|11|||
23295174|NCT00739973|64821858|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
23295175|NCT00739973|64821859|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23295176|NCT00739973|64821860|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23295177|NCT00739973|64821861|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23295178|NCT00739973|64821862|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23295179|NCT00739973|64821863|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23295180|NCT00739973|64821864|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23295181|NCT00739973|64821865|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23295182|NCT00739973|64821866|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
23295183|NCT00739973|64821858|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
23295184|NCT00739973|64821859|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23295185|NCT00739973|64821860|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23295186|NCT00739973|64821861|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23295187|NCT00739973|64821862|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23295188|NCT00739973|64821863|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23295189|NCT00739973|64821864|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23295190|NCT00739973|64821865|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23295191|NCT00739973|64821866|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
23295192|NCT00739973|64821858|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
23295193|NCT00739973|64821859|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23387613|NCT01292473|65162911|FG002|Overall Study|Lost to Follow-up|2|||
23387614|NCT01292473|65162912|FG003|Overall Study|Lost to Follow-up|2|||
23387615|NCT01292473|65162909|FG000|Overall Study|Withdrawal by Subject|3|||
23387616|NCT01292473|65162910|FG001|Overall Study|Withdrawal by Subject|4|||
23387617|NCT01292473|65162911|FG002|Overall Study|Withdrawal by Subject|3|||
23387618|NCT01292473|65162912|FG003|Overall Study|Withdrawal by Subject|3|||
23387619|NCT01292473|65162909|FG000|Overall Study|Physician Decision|0|||
23387620|NCT01292473|65162910|FG001|Overall Study|Physician Decision|1|||
23387621|NCT01292473|65162911|FG002|Overall Study|Physician Decision|0|||
23387622|NCT01292473|65162912|FG003|Overall Study|Physician Decision|0|||
23387623|NCT01292473|65162909|FG000|Overall Study|Disease Progression|0|||
23387624|NCT01292473|65162910|FG001|Overall Study|Disease Progression|1|||
23387625|NCT01292473|65162911|FG002|Overall Study|Disease Progression|3|||
23387626|NCT01292473|65162912|FG003|Overall Study|Disease Progression|6|||
23387627|NCT03681093|65162913|FG000|Overall Study|Subject decision|0|||
23387628|NCT03681093|65162914|FG001|Overall Study|Subject decision|2|||
23387629|NCT03681093|65162915|FG002|Overall Study|Subject decision|1|||
23387630|NCT01898130|65162918|FG000|Treatment|Withdrawal by Subject|2|||
23387631|NCT01898130|65162918|FG000|Treatment|Progressive Disease|4|||
23387632|NCT01898130|65162918|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
23295194|NCT00739973|64821860|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23295195|NCT00739973|64821861|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23295196|NCT00739973|64821862|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23295197|NCT00739973|64821863|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23295198|NCT00739973|64821864|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23295199|NCT00739973|64821865|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23295200|NCT00739973|64821866|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
23295201|NCT00739973|64821858|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
23295202|NCT00739973|64821859|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23295203|NCT00739973|64821860|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23295204|NCT00739973|64821861|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23295205|NCT00739973|64821862|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23295206|NCT00739973|64821863|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23295207|NCT00739973|64821864|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23295208|NCT00739973|64821865|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23295209|NCT00739973|64821866|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
23295210|NCT00739973|64821858|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
23295211|NCT00739973|64821859|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23295212|NCT00739973|64821860|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23295213|NCT00739973|64821861|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23295214|NCT00739973|64821862|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23295215|NCT00739973|64821863|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23295216|NCT00739973|64821864|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23295217|NCT00739973|64821865|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23295218|NCT00739973|64821866|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
23387633|NCT00825175|65162919|FG000|Overall Study|Withdrawal by Subject|0|||
23295219|NCT00739973|64821858|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
23295220|NCT00739973|64821859|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23295221|NCT00739973|64821860|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23295222|NCT00739973|64821861|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23295223|NCT00739973|64821862|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23295224|NCT00739973|64821863|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23295225|NCT00739973|64821864|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23295226|NCT00739973|64821865|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23295227|NCT00739973|64821866|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
23295228|NCT00739973|64821858|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
23295229|NCT00739973|64821859|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23295230|NCT00739973|64821860|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23295231|NCT00739973|64821861|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23295232|NCT00739973|64821862|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23295233|NCT00739973|64821863|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23295234|NCT00739973|64821864|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23387634|NCT00825175|65162920|FG001|Overall Study|Withdrawal by Subject|5|||
23387635|NCT00682435|65162921|FG000|Overall Study|Insufficient data|5|||
23295235|NCT00739973|64821865|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23387636|NCT00682435|65162921|FG000|Overall Study|Erroneously enrolled twice|2|||
23387637|NCT01623154|65162922|FG000|Overall Study|Did not drink Pranactin Citric|4|||
23387638|NCT00887588|65162923|FG000|Core Period|Death|1|||
23387639|NCT00887588|65162924|FG001|Core Period|Death|1|||
23387640|NCT00887588|65162923|FG000|Core Period|Lost to Follow-up|3|||
23387641|NCT00887588|65162924|FG001|Core Period|Lost to Follow-up|1|||
23387642|NCT00887588|65162923|FG000|Core Period|Withdrawal by Subject|6|||
23387643|NCT00887588|65162924|FG001|Core Period|Withdrawal by Subject|8|||
23387644|NCT00887588|65162923|FG000|Core Period|Adverse Event|9|||
23387645|NCT00887588|65162924|FG001|Core Period|Adverse Event|11|||
23387646|NCT00887588|65162923|FG000|Extension Period|Adverse Event|4|||
23387647|NCT00887588|65162924|FG001|Extension Period|Adverse Event|4|||
23295236|NCT00739973|64821866|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
23387648|NCT00887588|65162923|FG000|Extension Period|Death|0|||
23387649|NCT00887588|65162924|FG001|Extension Period|Death|1|||
23387650|NCT00887588|65162923|FG000|Extension Period|Protocol deviation|1|||
23387651|NCT00887588|65162924|FG001|Extension Period|Protocol deviation|0|||
23387652|NCT00887588|65162923|FG000|Extension Period|Lost to Follow-up|1|||
23387653|NCT00887588|65162924|FG001|Extension Period|Lost to Follow-up|0|||
23295237|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
23295238|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
23295239|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
23295240|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
23295241|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
23295242|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
23295243|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
23295244|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
23295245|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
23295246|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23295247|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23295248|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23295249|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23295250|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
23295251|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23295252|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23295253|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
23295254|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
23295255|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
23295256|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
23295257|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23295258|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23295259|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23295260|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23295261|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23295262|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23295263|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
23295264|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
23295265|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
23295266|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
23295267|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
23295268|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
23295269|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
23295270|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
23295271|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
23295272|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
23295273|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23295274|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23295275|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
23295276|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23295277|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23295278|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23295279|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23295280|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23295281|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
23295282|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23295283|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
23295284|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23494237|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
23494238|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
23494239|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
23494240|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
23494241|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
23494242|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
23494243|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
23494244|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
23494245|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
23494246|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
23494247|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
23494248|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
23494249|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
23494250|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
23494251|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
23494252|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
23494253|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
23494254|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
23494255|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
23494256|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
23494257|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
23494258|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
23494259|NCT02607930|65554939|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
23494260|NCT02607930|65554940|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
23494261|NCT02607930|65554941|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
23494262|NCT02607930|65554942|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
23494263|NCT02404220|65554953|FG000|Overall Study|Adverse Event|0|||
23494264|NCT02404220|65554954|FG001|Overall Study|Adverse Event|0|||
23494265|NCT02404220|65554955|FG002|Overall Study|Adverse Event|1|||
23494266|NCT02404220|65554956|FG003|Overall Study|Adverse Event|0|||
23494267|NCT02404220|65554953|FG000|Overall Study|Death|5|||
23494268|NCT02404220|65554954|FG001|Overall Study|Death|5|||
23494269|NCT02404220|65554955|FG002|Overall Study|Death|3|||
23494270|NCT02404220|65554956|FG003|Overall Study|Death|8|||
23494271|NCT02404220|65554953|FG000|Overall Study|Progressive Disease|0|||
23494272|NCT02404220|65554954|FG001|Overall Study|Progressive Disease|0|||
23494273|NCT02404220|65554955|FG002|Overall Study|Progressive Disease|1|||
23494274|NCT02404220|65554956|FG003|Overall Study|Progressive Disease|1|||
23494275|NCT02404220|65554953|FG000|Overall Study|Study Terminated by Sponsor|0|||
23494276|NCT02404220|65554954|FG001|Overall Study|Study Terminated by Sponsor|0|||
23494277|NCT02404220|65554955|FG002|Overall Study|Study Terminated by Sponsor|2|||
23494278|NCT02404220|65554956|FG003|Overall Study|Study Terminated by Sponsor|1|||
23494279|NCT02404220|65554953|FG000|Overall Study|Withdrawal by Subject|0|||
23494280|NCT02404220|65554954|FG001|Overall Study|Withdrawal by Subject|1|||
23494281|NCT02404220|65554955|FG002|Overall Study|Withdrawal by Subject|0|||
23494282|NCT02404220|65554956|FG003|Overall Study|Withdrawal by Subject|0|||
23494283|NCT02404220|65554953|FG000|Overall Study|Enrolled but Never Treated|0|||
23494284|NCT02404220|65554954|FG001|Overall Study|Enrolled but Never Treated|2|||
23494285|NCT02404220|65554955|FG002|Overall Study|Enrolled but Never Treated|0|||
23494286|NCT02404220|65554956|FG003|Overall Study|Enrolled but Never Treated|0|||
23494287|NCT01824875|65554962|FG000|Overall Study|Disease progression|22|||
23494288|NCT01824875|65554963|FG001|Overall Study|Disease progression|15|||
23494289|NCT01824875|65554962|FG000|Overall Study|Withdrawal by Subject|5|||
23494290|NCT01824875|65554963|FG001|Overall Study|Withdrawal by Subject|4|||
23494291|NCT01824875|65554962|FG000|Overall Study|Adverse Event|4|||
23494292|NCT01824875|65554963|FG001|Overall Study|Adverse Event|10|||
23494293|NCT01824875|65554962|FG000|Overall Study|Alternative therapy|3|||
23494294|NCT01824875|65554963|FG001|Overall Study|Alternative therapy|0|||
23494295|NCT01824875|65554962|FG000|Overall Study|Complicating disease|1|||
23494296|NCT01824875|65554963|FG001|Overall Study|Complicating disease|0|||
23494297|NCT01824875|65554962|FG000|Overall Study|Physician Decision|0|||
23494298|NCT01824875|65554963|FG001|Overall Study|Physician Decision|1|||
23494299|NCT01824875|65554962|FG000|Overall Study|Non-compliance|1|||
23494300|NCT01824875|65554963|FG001|Overall Study|Non-compliance|1|||
23494301|NCT01824875|65554962|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
23494302|NCT01824875|65554963|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
23494303|NCT01824875|65554962|FG000|Overall Study|Administrative issues|0|||
23494304|NCT01824875|65554963|FG001|Overall Study|Administrative issues|2|||
23494305|NCT01824875|65554962|FG000|Overall Study|Ineligible or never started treatment|9|||
23494306|NCT01824875|65554963|FG001|Overall Study|Ineligible or never started treatment|5|||
23494307|NCT01824875|65554962|FG000|Overall Study|Other|0|||
23494308|NCT01824875|65554963|FG001|Overall Study|Other|2|||
23494309|NCT02243696|65554965|FG000|Overall Study|Death|282|||
23387654|NCT00669331|65162928|FG000|Randomisation to First Dose|Adverse Event|1|||
23387655|NCT00669331|65162929|FG001|Randomisation to First Dose|Adverse Event|0|||
23387656|NCT00669331|65162928|FG000|Randomisation to First Dose|Protocol Violation|1|||
23387657|NCT00669331|65162929|FG001|Randomisation to First Dose|Protocol Violation|0|||
23387658|NCT00669331|65162928|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
23387659|NCT00669331|65162929|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
23387660|NCT00669331|65162928|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
23387661|NCT00669331|65162929|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
23387662|NCT00669331|65162928|FG000|Randomisation to First Dose|Death|1|||
23295285|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
23295286|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23295287|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23295288|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
23295289|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
23295290|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
23295291|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
23295292|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
23295293|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
23295294|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
23295295|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
23295296|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
23295297|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
23295298|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
23387663|NCT00669331|65162929|FG001|Randomisation to First Dose|Death|0|||
23387664|NCT00669331|65162928|FG000|Randomisation to First Dose|Sponsor decision|0|||
23387665|NCT00669331|65162929|FG001|Randomisation to First Dose|Sponsor decision|1|||
23295299|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
23295300|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23295301|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23295302|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23295303|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23295304|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23295305|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23387666|NCT00669331|65162928|FG000|Randomisation to First Dose|Randomised in error|3|||
23387667|NCT00669331|65162929|FG001|Randomisation to First Dose|Randomised in error|10|||
23295306|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
23295307|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23295308|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
23295309|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
23295310|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
23295311|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
23295312|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
23295313|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
23295314|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
23295315|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
23295316|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
23295317|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
23295318|NCT00739973|64821858|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23295319|NCT00739973|64821859|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
23295320|NCT00739973|64821860|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23295321|NCT00739973|64821861|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23387668|NCT00669331|65162928|FG000|Blinded Treatment Period|Adverse Event|16|||
23387669|NCT00669331|65162929|FG001|Blinded Treatment Period|Adverse Event|10|||
23387670|NCT00669331|65162928|FG000|Blinded Treatment Period|Protocol Violation|1|||
23387671|NCT00669331|65162929|FG001|Blinded Treatment Period|Protocol Violation|1|||
23387672|NCT00669331|65162928|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
23387673|NCT00669331|65162929|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
23387674|NCT00669331|65162928|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
23387675|NCT00669331|65162929|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
23387676|NCT00669331|65162928|FG000|Blinded Treatment Period|Death|0|||
23387677|NCT00669331|65162929|FG001|Blinded Treatment Period|Death|2|||
23494310|NCT02243696|65554965|FG000|Overall Study|Withdrawal by Subject|79|||
23494311|NCT02243696|65554965|FG000|Overall Study|Lost to Follow-up|57|||
23494312|NCT02243696|65554965|FG000|Overall Study|Subject No Longer has Study System|42|||
23494313|NCT02243696|65554965|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
23494314|NCT02243696|65554965|FG000|Overall Study|Study Terminated for EP PASSION|961|||
23494315|NCT03945266|65554966|FG000|Overall Study|Withdrawal by Subject|1|||
23494316|NCT03945266|65554967|FG001|Overall Study|Withdrawal by Subject|0|||
23494317|NCT03945266|65554966|FG000|Overall Study|Miscarriage|0|||
23494318|NCT03945266|65554967|FG001|Overall Study|Miscarriage|2|||
23494319|NCT03945266|65554966|FG000|Overall Study|Lost to Follow-up|1|||
23494320|NCT03945266|65554967|FG001|Overall Study|Lost to Follow-up|0|||
23494321|NCT02191137|65554971|FG000|Treatment|Death|4|||
23494322|NCT02191137|65554971|FG000|Treatment|Withdrawal by Subject|3|||
23494323|NCT02191137|65554971|FG000|Treatment|Adverse Event|2|||
23295322|NCT00739973|64821862|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23387678|NCT00669331|65162928|FG000|Blinded Treatment Period|Physician Decision|3|||
23387679|NCT00669331|65162929|FG001|Blinded Treatment Period|Physician Decision|3|||
23387680|NCT00669331|65162928|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
23387681|NCT00669331|65162929|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
23387682|NCT01653262|65162930|FG000|Overall Study|Lack of Efficacy|1|||
23387683|NCT01653262|65162930|FG000|Overall Study|SAE, non-fatal|1|||
23387684|NCT01653262|65162930|FG000|Overall Study|AE, non-serious non-fatal|1|||
23387685|NCT00345592|65162935|FG000|Overall Study|Death|14|||
23387686|NCT00345592|65162936|FG001|Overall Study|Death|16|||
23387687|NCT00345592|65162935|FG000|Overall Study|Withdrawal by Subject|11|||
23387688|NCT00345592|65162936|FG001|Overall Study|Withdrawal by Subject|8|||
23387689|NCT03467945|65162937|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23387690|NCT03467945|65162938|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23387691|NCT03467945|65162939|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23387692|NCT03467945|65162940|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23387693|NCT03467945|65162937|FG000|Treatment Period 3|Withdrawal by Subject|1|||
23387694|NCT03467945|65162938|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23387695|NCT03467945|65162939|FG002|Treatment Period 3|Withdrawal by Subject|2|||
23387696|NCT03467945|65162940|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23387697|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
23387698|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
23387699|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
23387700|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
23295323|NCT00739973|64821863|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23295324|NCT00739973|64821864|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
23295325|NCT00739973|64821865|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23387701|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
23387702|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
23387703|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
23387704|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
23387705|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
23387706|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
23387707|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
23387708|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
23387709|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Other|6|||
23387710|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Other|3|||
23387711|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Other|0|||
23387712|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
23387713|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23387714|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
23387715|NCT03636269|65165774|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
23387716|NCT03636269|65165775|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
23295326|NCT00739973|64821866|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
23295327|NCT01714739|64821867|FG000|Overall Study|Disease progression|3|||
23295328|NCT01714739|64821868|FG001|Overall Study|Disease progression|5|||
23295329|NCT01714739|64821869|FG002|Overall Study|Disease progression|5|||
23295330|NCT01714739|64821870|FG003|Overall Study|Disease progression|204|||
23295331|NCT01714739|64821871|FG004|Overall Study|Disease progression|1|||
23387717|NCT03636269|65165776|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
23387718|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Adverse Event|0|||
23387719|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Adverse Event|0|||
23387720|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Adverse Event|21|||
23295332|NCT01714739|64821872|FG005|Overall Study|Disease progression|3|||
23295333|NCT01714739|64821873|FG006|Overall Study|Disease progression|5|||
23387721|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
23387722|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
23295334|NCT01714739|64821867|FG000|Overall Study|Study drug toxicity|1|||
23295335|NCT01714739|64821868|FG001|Overall Study|Study drug toxicity|1|||
23295336|NCT01714739|64821869|FG002|Overall Study|Study drug toxicity|1|||
23295337|NCT01714739|64821870|FG003|Overall Study|Study drug toxicity|15|||
23295338|NCT01714739|64821871|FG004|Overall Study|Study drug toxicity|0|||
23295339|NCT01714739|64821872|FG005|Overall Study|Study drug toxicity|0|||
23295340|NCT01714739|64821873|FG006|Overall Study|Study drug toxicity|5|||
23295341|NCT01714739|64821867|FG000|Overall Study|Death|0|||
23295342|NCT01714739|64821868|FG001|Overall Study|Death|0|||
23295343|NCT01714739|64821869|FG002|Overall Study|Death|0|||
23295344|NCT01714739|64821870|FG003|Overall Study|Death|1|||
23295345|NCT01714739|64821871|FG004|Overall Study|Death|0|||
23295346|NCT01714739|64821872|FG005|Overall Study|Death|0|||
23295347|NCT01714739|64821873|FG006|Overall Study|Death|0|||
23295348|NCT01714739|64821867|FG000|Overall Study|Adverse Event unrelated to drug|0|||
23295349|NCT01714739|64821868|FG001|Overall Study|Adverse Event unrelated to drug|0|||
23295350|NCT01714739|64821869|FG002|Overall Study|Adverse Event unrelated to drug|3|||
23387723|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
23387724|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
23387725|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
23387726|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
23387727|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
23387728|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
23387729|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
23494324|NCT02191137|65554971|FG000|Treatment|Other|1|||
23494325|NCT02191137|65554971|FG000|Follow-up|Lost to Follow-up|2|||
23295351|NCT01714739|64821870|FG003|Overall Study|Adverse Event unrelated to drug|21|||
23387730|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Administrative|0|||
23387731|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Administrative|0|||
23494326|NCT02191137|65554971|FG000|Follow-up|Ongoing/unknown|2|||
23494327|NCT02191137|65554971|FG000|Follow-up|Adverse Event|1|||
23494328|NCT02095223|65554975|FG000|Overall Study|Withdrawal by Subject|1|||
23295352|NCT01714739|64821871|FG004|Overall Study|Adverse Event unrelated to drug|0|||
23295353|NCT01714739|64821872|FG005|Overall Study|Adverse Event unrelated to drug|0|||
23295354|NCT01714739|64821873|FG006|Overall Study|Adverse Event unrelated to drug|0|||
23295355|NCT01714739|64821867|FG000|Overall Study|Participant request to stop therapy|0|||
23295356|NCT01714739|64821868|FG001|Overall Study|Participant request to stop therapy|1|||
23295357|NCT01714739|64821869|FG002|Overall Study|Participant request to stop therapy|0|||
23387732|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Administrative|36|||
23387733|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Other|0|||
23387734|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Other|0|||
23387735|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Other|9|||
23387736|NCT03636269|65165774|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
23387737|NCT03636269|65165775|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
23387738|NCT03636269|65165776|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
23387739|NCT00079781|65165777|FG000|Pre-implant Period|Withdrawal by Subject|2|||
23387740|NCT00079781|65165778|FG001|Pre-implant Period|Withdrawal by Subject|0|||
23387741|NCT00079781|65165779|FG002|Pre-implant Period|Withdrawal by Subject|0|||
23387742|NCT00079781|65165777|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
23387743|NCT00079781|65165778|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
23387744|NCT00079781|65165779|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
23387745|NCT00079781|65165777|FG000|Follow-up Period|Withdrawal by Subject|3|||
23387746|NCT00079781|65165778|FG001|Follow-up Period|Withdrawal by Subject|0|||
23387747|NCT00079781|65165779|FG002|Follow-up Period|Withdrawal by Subject|1|||
23387748|NCT00079781|65165777|FG000|Follow-up Period|Lost to Follow-up|1|||
23387749|NCT00079781|65165778|FG001|Follow-up Period|Lost to Follow-up|0|||
23387750|NCT00079781|65165779|FG002|Follow-up Period|Lost to Follow-up|0|||
23387751|NCT00079781|65165777|FG000|Follow-up Period|Death|0|||
23387752|NCT00079781|65165778|FG001|Follow-up Period|Death|0|||
23387753|NCT00079781|65165779|FG002|Follow-up Period|Death|1|||
23387754|NCT02070380|65165780|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
23387755|NCT02070380|65165781|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
23387756|NCT02070380|65165782|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
23387757|NCT02070380|65165783|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
23387758|NCT02070380|65165780|FG000|Second Injection|Image sets missing or technically inadeq|0|||
23387759|NCT02070380|65165781|FG001|Second Injection|Image sets missing or technically inadeq|1|||
23387760|NCT02070380|65165782|FG002|Second Injection|Image sets missing or technically inadeq|0|||
23387761|NCT02070380|65165783|FG003|Second Injection|Image sets missing or technically inadeq|0|||
23387762|NCT02070380|65165780|FG000|Second Injection|Protocol Violation|0|||
23387763|NCT02070380|65165781|FG001|Second Injection|Protocol Violation|1|||
23387764|NCT02070380|65165782|FG002|Second Injection|Protocol Violation|1|||
23387765|NCT02070380|65165783|FG003|Second Injection|Protocol Violation|5|||
23387766|NCT01336972|65165787|FG000|Overall Study|Adverse Event|1|||
23387767|NCT01336972|65165788|FG001|Overall Study|Adverse Event|1|||
23387768|NCT01336972|65165789|FG002|Overall Study|Adverse Event|0|||
23387769|NCT03721107|65165791|FG000|Overall Study|Adverse Event|1|||
23387770|NCT03721107|65165792|FG001|Overall Study|Adverse Event|1|||
23387771|NCT03721107|65165793|FG002|Overall Study|Adverse Event|6|||
23387772|NCT03721107|65165794|FG003|Overall Study|Adverse Event|5|||
23387773|NCT03721107|65165791|FG000|Overall Study|Lost to Follow-up|2|||
23387774|NCT03721107|65165792|FG001|Overall Study|Lost to Follow-up|0|||
23387775|NCT03721107|65165793|FG002|Overall Study|Lost to Follow-up|3|||
23387776|NCT03721107|65165794|FG003|Overall Study|Lost to Follow-up|0|||
23387777|NCT03721107|65165791|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
23387778|NCT03721107|65165792|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
23387779|NCT03721107|65165793|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
23387780|NCT03721107|65165794|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
23387781|NCT03721107|65165791|FG000|Overall Study|Physician Decision|0|||
23387782|NCT03721107|65165792|FG001|Overall Study|Physician Decision|1|||
23387783|NCT03721107|65165793|FG002|Overall Study|Physician Decision|0|||
23387784|NCT03721107|65165794|FG003|Overall Study|Physician Decision|0|||
23387785|NCT03721107|65165791|FG000|Overall Study|Pregnancy|0|||
23387786|NCT03721107|65165792|FG001|Overall Study|Pregnancy|0|||
23387787|NCT03721107|65165793|FG002|Overall Study|Pregnancy|1|||
23387788|NCT03721107|65165794|FG003|Overall Study|Pregnancy|0|||
23387789|NCT03721107|65165791|FG000|Overall Study|Withdrawal by Subject|1|||
23387790|NCT03721107|65165792|FG001|Overall Study|Withdrawal by Subject|1|||
23387791|NCT03721107|65165793|FG002|Overall Study|Withdrawal by Subject|5|||
23387792|NCT03721107|65165794|FG003|Overall Study|Withdrawal by Subject|5|||
23387793|NCT03721107|65165791|FG000|Overall Study|Other|1|||
23387794|NCT03721107|65165792|FG001|Overall Study|Other|0|||
23387795|NCT03721107|65165793|FG002|Overall Study|Other|0|||
23387796|NCT03721107|65165794|FG003|Overall Study|Other|1|||
23387797|NCT03061214|65165795|FG000|Overall Study|Withdrawal by Subject|21|||
23387798|NCT03061214|65165796|FG001|Overall Study|Withdrawal by Subject|26|||
23387799|NCT03061214|65165797|FG002|Overall Study|Withdrawal by Subject|9|||
23387800|NCT03061214|65165795|FG000|Overall Study|Lost to Follow-up|3|||
23387801|NCT03061214|65165796|FG001|Overall Study|Lost to Follow-up|1|||
23387802|NCT03061214|65165797|FG002|Overall Study|Lost to Follow-up|1|||
23387803|NCT03061214|65165795|FG000|Overall Study|Death|1|||
23387804|NCT03061214|65165796|FG001|Overall Study|Death|1|||
23387805|NCT03061214|65165797|FG002|Overall Study|Death|0|||
23387806|NCT03518203|65165798|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
23387807|NCT03518203|65165798|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
23387808|NCT00561821|65165799|FG000|Overall Study|Not treated|0|||
23387809|NCT00561821|65165800|FG001|Overall Study|Not treated|0|||
23387810|NCT00561821|65165801|FG002|Overall Study|Not treated|1|||
23387811|NCT00561821|65165802|FG003|Overall Study|Not treated|0|||
23387812|NCT00561821|65165799|FG000|Overall Study|Withdrawal by Subject|0|||
23387813|NCT00561821|65165800|FG001|Overall Study|Withdrawal by Subject|1|||
23387814|NCT00561821|65165801|FG002|Overall Study|Withdrawal by Subject|0|||
23387815|NCT00561821|65165802|FG003|Overall Study|Withdrawal by Subject|2|||
23387816|NCT00561821|65165799|FG000|Overall Study|Reasons not related to trial|2|||
23387817|NCT00561821|65165800|FG001|Overall Study|Reasons not related to trial|1|||
23387818|NCT00561821|65165801|FG002|Overall Study|Reasons not related to trial|0|||
23387819|NCT00561821|65165802|FG003|Overall Study|Reasons not related to trial|0|||
23387820|NCT00561821|65165799|FG000|Overall Study|Other (reason not specified)|1|||
23387821|NCT00561821|65165800|FG001|Overall Study|Other (reason not specified)|1|||
23387822|NCT00561821|65165801|FG002|Overall Study|Other (reason not specified)|0|||
23387823|NCT00561821|65165802|FG003|Overall Study|Other (reason not specified)|0|||
23387824|NCT00561821|65165799|FG000|Overall Study|Adverse Event|2|||
23387825|NCT00561821|65165800|FG001|Overall Study|Adverse Event|3|||
23494329|NCT02095223|65554976|FG001|Overall Study|Withdrawal by Subject|0|||
23494330|NCT01914757|65554977|FG000|Overall Study|Severe non-compliance to protocol|3|||
23387826|NCT00561821|65165801|FG002|Overall Study|Adverse Event|1|||
23387827|NCT00561821|65165802|FG003|Overall Study|Adverse Event|1|||
23387828|NCT05029362|65165805|FG000|Overall Study|Lost to Follow-up|9|||
23387829|NCT00655356|65165808|FG000|Overall Study|Withdrawal by Subject|3|||
23387830|NCT00655356|65165809|FG001|Overall Study|Withdrawal by Subject|4|||
23387831|NCT00655356|65165808|FG000|Overall Study|Sponsor Request|10|||
23387832|NCT00655356|65165809|FG001|Overall Study|Sponsor Request|4|||
23387833|NCT00655356|65165808|FG000|Overall Study|Adverse Event|1|||
23387834|NCT00655356|65165809|FG001|Overall Study|Adverse Event|1|||
23387835|NCT00655356|65165808|FG000|Overall Study|Protocol Violation|2|||
23387836|NCT00655356|65165809|FG001|Overall Study|Protocol Violation|1|||
23387837|NCT00655356|65165808|FG000|Overall Study|Other Reason|1|||
23387838|NCT00655356|65165809|FG001|Overall Study|Other Reason|0|||
23387839|NCT01478087|65165810|FG000|Overall Study|due to sponsor closing study|1|||
23387840|NCT01529112|65165814|FG000|Overall Study|Adverse Event|2|||
23387841|NCT01529112|65165815|FG001|Overall Study|Adverse Event|0|||
23387842|NCT01529112|65165814|FG000|Overall Study|Death|59|||
23387843|NCT01529112|65165815|FG001|Overall Study|Death|38|||
23387844|NCT01529112|65165814|FG000|Overall Study|Protocol Violation|1|||
23387845|NCT01529112|65165815|FG001|Overall Study|Protocol Violation|0|||
23387846|NCT01529112|65165814|FG000|Overall Study|Withdrawal by Subject|7|||
23387847|NCT01529112|65165815|FG001|Overall Study|Withdrawal by Subject|3|||
23387848|NCT01502072|65165816|FG000|Overall Study|Withdrawal by Subject|1|||
23387849|NCT01502072|65165817|FG001|Overall Study|Withdrawal by Subject|0|||
23387850|NCT01502072|65165818|FG002|Overall Study|Withdrawal by Subject|0|||
23387851|NCT01502072|65165816|FG000|Overall Study|Death|0|||
23387852|NCT01502072|65165817|FG001|Overall Study|Death|1|||
23387853|NCT01502072|65165818|FG002|Overall Study|Death|0|||
23387854|NCT00420407|65165819|FG000|Overall Study|Lost to Follow-up|0|||
23387855|NCT00420407|65165820|FG001|Overall Study|Lost to Follow-up|3|||
23387856|NCT00420407|65165819|FG000|Overall Study|Physician Decision|2|||
23387857|NCT00420407|65165820|FG001|Overall Study|Physician Decision|1|||
23387858|NCT00420407|65165819|FG000|Overall Study|subject identified as detainee|1|||
23387859|NCT00420407|65165820|FG001|Overall Study|subject identified as detainee|0|||
23387860|NCT00420407|65165819|FG000|Overall Study|subject identified as Jehovah's witness|1|||
23387861|NCT00420407|65165820|FG001|Overall Study|subject identified as Jehovah's witness|0|||
23387862|NCT00420407|65165819|FG000|Overall Study|Withdrawal by Subject|0|||
23387863|NCT00420407|65165820|FG001|Overall Study|Withdrawal by Subject|2|||
23387864|NCT02181621|65165821|FG000|Overall Study|Adverse Event|1|||
23387865|NCT02181621|65165822|FG001|Overall Study|Adverse Event|0|||
23387866|NCT02181621|65165821|FG000|Overall Study|Previously Enrolled|0|||
23387867|NCT02181621|65165822|FG001|Overall Study|Previously Enrolled|1|||
23387868|NCT02181621|65165821|FG000|Overall Study|Enrollment Hold|1|||
23387869|NCT02181621|65165822|FG001|Overall Study|Enrollment Hold|1|||
23387870|NCT00960856|65165823|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23387871|NCT00960856|65165824|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
23387872|NCT00960856|65165825|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
23387873|NCT00960856|65165826|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
23387874|NCT00960856|65165823|FG000|Washout Period of 7 Days|Adverse Event|0|||
23387875|NCT00960856|65165824|FG001|Washout Period of 7 Days|Adverse Event|0|||
23387876|NCT00960856|65165825|FG002|Washout Period of 7 Days|Adverse Event|1|||
23387877|NCT00960856|65165826|FG003|Washout Period of 7 Days|Adverse Event|0|||
23387878|NCT01423084|65165830|FG000|Overall Study|Adverse Event|0|||
23387879|NCT01423084|65165831|FG001|Overall Study|Adverse Event|1|||
23387880|NCT01423084|65165830|FG000|Overall Study|Withdrawal by Subject|2|||
23387881|NCT01423084|65165831|FG001|Overall Study|Withdrawal by Subject|3|||
23387882|NCT04821245|65165834|FG000|Overall Study|Withdrawal by Subject|3|||
23387883|NCT04821245|65165834|FG000|Overall Study|Physician Decision|1|||
23387884|NCT04821245|65165834|FG000|Overall Study|Protocol Violation|5|||
23387885|NCT03280615|65165835|FG000|Overall Study|Lost to Follow-up|1|||
23387886|NCT03280615|65165836|FG001|Overall Study|Lost to Follow-up|2|||
23387887|NCT03280615|65165835|FG000|Overall Study|Adverse Event|1|||
23387888|NCT03280615|65165836|FG001|Overall Study|Adverse Event|1|||
23387889|NCT03280615|65165835|FG000|Overall Study|Withdrawal by Subject|2|||
23387890|NCT03280615|65165836|FG001|Overall Study|Withdrawal by Subject|2|||
23387891|NCT04223687|65165847|FG000|Overall Study|Missing primary outcome|1|||
23387892|NCT04223687|65165848|FG001|Overall Study|Missing primary outcome|0|||
23387893|NCT01682720|65165855|FG000|Overall Study|Randomized but Not Treated|0|||
23387894|NCT01682720|65165856|FG001|Overall Study|Randomized but Not Treated|1|||
23387895|NCT01682720|65165857|FG002|Overall Study|Randomized but Not Treated|1|||
23387896|NCT01682720|65165858|FG003|Overall Study|Randomized but Not Treated|0|||
23387897|NCT01682720|65165855|FG000|Overall Study|Terminated by Sponsor|83|||
23387898|NCT01682720|65165856|FG001|Overall Study|Terminated by Sponsor|0|||
23387899|NCT01682720|65165857|FG002|Overall Study|Terminated by Sponsor|0|||
23387900|NCT01682720|65165858|FG003|Overall Study|Terminated by Sponsor|0|||
23387901|NCT01682720|65165855|FG000|Overall Study|Efficacy Failure|0|||
23387902|NCT01682720|65165856|FG001|Overall Study|Efficacy Failure|3|||
23387903|NCT01682720|65165857|FG002|Overall Study|Efficacy Failure|3|||
23387904|NCT01682720|65165858|FG003|Overall Study|Efficacy Failure|30|||
23387905|NCT01682720|65165855|FG000|Overall Study|Lost to Follow-up|1|||
23387906|NCT01682720|65165856|FG001|Overall Study|Lost to Follow-up|1|||
23387907|NCT01682720|65165857|FG002|Overall Study|Lost to Follow-up|0|||
23387908|NCT01682720|65165858|FG003|Overall Study|Lost to Follow-up|6|||
23387909|NCT01682720|65165855|FG000|Overall Study|Subject Withdrew Consent|0|||
23387910|NCT01682720|65165856|FG001|Overall Study|Subject Withdrew Consent|0|||
23387911|NCT01682720|65165857|FG002|Overall Study|Subject Withdrew Consent|2|||
23387912|NCT01682720|65165858|FG003|Overall Study|Subject Withdrew Consent|2|||
23387913|NCT01682720|65165855|FG000|Overall Study|Adverse Event|1|||
23387914|NCT01682720|65165856|FG001|Overall Study|Adverse Event|0|||
23387915|NCT01682720|65165857|FG002|Overall Study|Adverse Event|1|||
23387916|NCT01682720|65165858|FG003|Overall Study|Adverse Event|1|||
23387917|NCT00225758|65165859|FG000|Overall Study|Adverse Event|4|||
23387918|NCT03438656|65165861|FG000|Overall Study|Lost to Follow-up|2|||
23387919|NCT04621786|65165863|FG000|Overall Study|Lost to Follow-up|9|||
23387920|NCT04621786|65165863|FG000|Overall Study|Protocol Violation|3|||
23387921|NCT00378560|65165864|FG000|Overall Study|Adverse Event|1|||
23387922|NCT00378560|65165865|FG001|Overall Study|Adverse Event|0|||
23387923|NCT00378560|65165864|FG000|Overall Study|Lost to Follow-up|24|||
23295358|NCT01714739|64821870|FG003|Overall Study|Participant request to stop therapy|6|||
23295359|NCT01714739|64821871|FG004|Overall Study|Participant request to stop therapy|0|||
23295360|NCT01714739|64821872|FG005|Overall Study|Participant request to stop therapy|0|||
23295361|NCT01714739|64821873|FG006|Overall Study|Participant request to stop therapy|0|||
23295362|NCT01714739|64821867|FG000|Overall Study|Participant withdrew consent|0|||
23295363|NCT01714739|64821868|FG001|Overall Study|Participant withdrew consent|1|||
23295364|NCT01714739|64821869|FG002|Overall Study|Participant withdrew consent|0|||
23295365|NCT01714739|64821870|FG003|Overall Study|Participant withdrew consent|8|||
23295366|NCT01714739|64821871|FG004|Overall Study|Participant withdrew consent|0|||
23295367|NCT01714739|64821872|FG005|Overall Study|Participant withdrew consent|0|||
23295368|NCT01714739|64821873|FG006|Overall Study|Participant withdrew consent|0|||
23295369|NCT01714739|64821867|FG000|Overall Study|Lost to Follow-up|0|||
23295370|NCT01714739|64821868|FG001|Overall Study|Lost to Follow-up|0|||
23295371|NCT01714739|64821869|FG002|Overall Study|Lost to Follow-up|0|||
23295372|NCT01714739|64821870|FG003|Overall Study|Lost to Follow-up|1|||
23295373|NCT01714739|64821871|FG004|Overall Study|Lost to Follow-up|0|||
23295374|NCT01714739|64821872|FG005|Overall Study|Lost to Follow-up|0|||
23295375|NCT01714739|64821873|FG006|Overall Study|Lost to Follow-up|0|||
23295376|NCT01714739|64821867|FG000|Overall Study|Maximum clinical benefit|0|||
23295377|NCT01714739|64821868|FG001|Overall Study|Maximum clinical benefit|1|||
23295378|NCT01714739|64821869|FG002|Overall Study|Maximum clinical benefit|1|||
23295379|NCT01714739|64821870|FG003|Overall Study|Maximum clinical benefit|3|||
23295380|NCT01714739|64821871|FG004|Overall Study|Maximum clinical benefit|0|||
23295381|NCT01714739|64821872|FG005|Overall Study|Maximum clinical benefit|0|||
23295382|NCT01714739|64821873|FG006|Overall Study|Maximum clinical benefit|0|||
23295383|NCT01714739|64821867|FG000|Overall Study|Poor/non-comliance|0|||
23295384|NCT01714739|64821868|FG001|Overall Study|Poor/non-comliance|1|||
23295385|NCT01714739|64821869|FG002|Overall Study|Poor/non-comliance|0|||
23295386|NCT01714739|64821870|FG003|Overall Study|Poor/non-comliance|1|||
23295387|NCT01714739|64821871|FG004|Overall Study|Poor/non-comliance|0|||
23295388|NCT01714739|64821872|FG005|Overall Study|Poor/non-comliance|0|||
23387924|NCT00378560|65165865|FG001|Overall Study|Lost to Follow-up|29|||
23387925|NCT00378560|65165864|FG000|Overall Study|Protocol Violation|2|||
23387926|NCT00378560|65165865|FG001|Overall Study|Protocol Violation|0|||
23387927|NCT00378560|65165864|FG000|Overall Study|Withdrawal by Subject|17|||
23387928|NCT00378560|65165865|FG001|Overall Study|Withdrawal by Subject|21|||
23295389|NCT01714739|64821873|FG006|Overall Study|Poor/non-comliance|0|||
23295390|NCT01714739|64821867|FG000|Overall Study|No longer meets study criteria|0|||
23295391|NCT01714739|64821868|FG001|Overall Study|No longer meets study criteria|0|||
23295392|NCT01714739|64821869|FG002|Overall Study|No longer meets study criteria|0|||
23295393|NCT01714739|64821870|FG003|Overall Study|No longer meets study criteria|1|||
23295394|NCT01714739|64821871|FG004|Overall Study|No longer meets study criteria|0|||
23295395|NCT01714739|64821872|FG005|Overall Study|No longer meets study criteria|0|||
23387929|NCT00378560|65165864|FG000|Overall Study|Moved|4|||
23295396|NCT01714739|64821873|FG006|Overall Study|No longer meets study criteria|0|||
23295397|NCT01714739|64821867|FG000|Overall Study|Other reason|0|||
23295398|NCT01714739|64821868|FG001|Overall Study|Other reason|0|||
23295399|NCT01714739|64821869|FG002|Overall Study|Other reason|0|||
23295400|NCT01714739|64821870|FG003|Overall Study|Other reason|3|||
23295401|NCT01714739|64821871|FG004|Overall Study|Other reason|1|||
23295402|NCT01714739|64821872|FG005|Overall Study|Other reason|0|||
23295403|NCT01714739|64821873|FG006|Overall Study|Other reason|0|||
23295404|NCT01640184|64821877|FG000|Overall Study|Death|1|||
23295405|NCT01640184|64821878|FG001|Overall Study|Death|0|||
23295406|NCT01640184|64821879|FG002|Overall Study|Death|0|||
23295407|NCT01640184|64821877|FG000|Overall Study|Lost to Follow-up|4|||
23295408|NCT01640184|64821878|FG001|Overall Study|Lost to Follow-up|1|||
23295409|NCT01640184|64821879|FG002|Overall Study|Lost to Follow-up|0|||
23387930|NCT00378560|65165865|FG001|Overall Study|Moved|3|||
23387931|NCT00378560|65165864|FG000|Overall Study|Pregnancy|7|||
23387932|NCT00378560|65165865|FG001|Overall Study|Pregnancy|5|||
23387933|NCT00378560|65165864|FG000|Overall Study|Laboratory test values abnormal|1|||
23387934|NCT00378560|65165865|FG001|Overall Study|Laboratory test values abnormal|0|||
23387935|NCT01433978|65165866|FG000|Core Study|Adverse Event, Non-Fatal|0|||
23387936|NCT01433978|65165867|FG001|Core Study|Adverse Event, Non-Fatal|1|||
23387937|NCT01433978|65165868|FG002|Core Study|Adverse Event, Non-Fatal|0|||
23387938|NCT01433978|65165866|FG000|Core Study|Lack of Efficacy|5|||
23387939|NCT01433978|65165867|FG001|Core Study|Lack of Efficacy|1|||
23387940|NCT01433978|65165868|FG002|Core Study|Lack of Efficacy|0|||
23387941|NCT01433978|65165866|FG000|Core Study|Study Terminated by Sponsor|6|||
23387942|NCT01433978|65165867|FG001|Core Study|Study Terminated by Sponsor|9|||
23387943|NCT01433978|65165868|FG002|Core Study|Study Terminated by Sponsor|0|||
23387944|NCT01433978|65165866|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
23387945|NCT01433978|65165867|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
23387946|NCT01433978|65165868|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
23387947|NCT01433978|65165866|FG000|Extension Phase|Lack of Efficacy|0|||
23387948|NCT01433978|65165867|FG001|Extension Phase|Lack of Efficacy|0|||
23387949|NCT01433978|65165868|FG002|Extension Phase|Lack of Efficacy|1|||
23387950|NCT01433978|65165866|FG000|Extension Phase|Study Terminated by Sponsor|0|||
23387951|NCT01433978|65165867|FG001|Extension Phase|Study Terminated by Sponsor|0|||
23387952|NCT01433978|65165868|FG002|Extension Phase|Study Terminated by Sponsor|4|||
23387953|NCT02514746|65165869|FG000|Overall Study|Chronically Ill|1|||
23387954|NCT02514746|65165870|FG001|Overall Study|Chronically Ill|2|||
23387955|NCT02514746|65165869|FG000|Overall Study|Physician Decision|4|||
23387956|NCT02514746|65165870|FG001|Overall Study|Physician Decision|2|||
23387957|NCT02514746|65165869|FG000|Overall Study|Withdrawal by Subject|12|||
23387958|NCT02514746|65165870|FG001|Overall Study|Withdrawal by Subject|10|||
23387959|NCT02514746|65165869|FG000|Overall Study|Other|5|||
23387960|NCT02514746|65165870|FG001|Overall Study|Other|1|||
23387961|NCT01691092|65165871|FG000|Overall Study|Lost to Follow-up|10|||
23387962|NCT01691092|65165871|FG000|Overall Study|Physician Decision|4|||
23387963|NCT01691092|65165871|FG000|Overall Study|Withdrawal by Subject|3|||
23387964|NCT01691092|65165871|FG000|Overall Study|non-compliance|3|||
23387965|NCT01691092|65165871|FG000|Overall Study|used for different study|2|||
23387966|NCT01691092|65165871|FG000|Overall Study|screen fail|19|||
23387967|NCT01975285|65165872|FG000|Overall Study|Failed Block and follow up|2|||
23387968|NCT01975285|65165873|FG001|Overall Study|Failed Block and follow up|2|||
23387969|NCT01210443|65165874|FG000|Overall Study|Study terminated by sponsor|2|||
23387970|NCT01061710|65165881|FG000|Overall Study|Protocol Violation|14|||
23387971|NCT04076579|65165882|FG000|Overall Study|Adverse Event|2|||
23387972|NCT04076579|65165883|FG001|Overall Study|Adverse Event|0|||
23387973|NCT04076579|65165882|FG000|Overall Study|discontinued due to toxicity|1|||
23387974|NCT04076579|65165883|FG001|Overall Study|discontinued due to toxicity|0|||
23387975|NCT04076579|65165882|FG000|Overall Study|Physician Decision|1|||
23295410|NCT01640184|64821877|FG000|Overall Study|Physician Decision|3|||
23295411|NCT01640184|64821878|FG001|Overall Study|Physician Decision|0|||
23295412|NCT01640184|64821879|FG002|Overall Study|Physician Decision|0|||
23295413|NCT01640184|64821877|FG000|Overall Study|Withdrawal by Subject|0|||
23387976|NCT04076579|65165883|FG001|Overall Study|Physician Decision|0|||
23387977|NCT04076579|65165882|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
23387978|NCT04076579|65165883|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
23387979|NCT04076579|65165882|FG000|Overall Study|Noncompliance|0|||
23387980|NCT04076579|65165883|FG001|Overall Study|Noncompliance|1|||
23387981|NCT04076579|65165882|FG000|Overall Study|Withdrawal by Subject|0|||
23387982|NCT04076579|65165883|FG001|Overall Study|Withdrawal by Subject|2|||
23387983|NCT01827943|65165884|FG000|Overall Study|Protocol Violation|8|||
23387984|NCT01827943|65165884|FG000|Overall Study|Never treated because of an rapid progression|1|||
23387985|NCT00276380|65165885|FG000|Overall Study|Adverse Event|5|||
23295414|NCT01640184|64821878|FG001|Overall Study|Withdrawal by Subject|1|||
23295415|NCT01640184|64821879|FG002|Overall Study|Withdrawal by Subject|1|||
23295416|NCT01640184|64821877|FG000|Overall Study|Protocol Violation|0|||
23387986|NCT00276380|65165886|FG001|Overall Study|Adverse Event|3|||
23387987|NCT00276380|65165885|FG000|Overall Study|Lost to Follow-up|1|||
23387988|NCT00276380|65165886|FG001|Overall Study|Lost to Follow-up|1|||
23387989|NCT00276380|65165885|FG000|Overall Study|Withdrawal by Subject|3|||
23387990|NCT00276380|65165886|FG001|Overall Study|Withdrawal by Subject|6|||
23387991|NCT00276380|65165885|FG000|Overall Study|Death|5|||
23387992|NCT00276380|65165886|FG001|Overall Study|Death|3|||
23387993|NCT00276380|65165885|FG000|Overall Study|Abnormal aPPT Levels|0|||
23387994|NCT00276380|65165886|FG001|Overall Study|Abnormal aPPT Levels|1|||
23387995|NCT04146909|65165887|FG000|Overall Study|Withdrawal by Subject|3|||
23387996|NCT04146909|65165887|FG000|Overall Study|Did not qualify after consented|1|||
23387997|NCT00621322|65165888|FG000|Overall Study|Lost to Follow-up|0|||
23387998|NCT00621322|65165889|FG001|Overall Study|Lost to Follow-up|0|||
23387999|NCT00621322|65165890|FG002|Overall Study|Lost to Follow-up|0|||
23388000|NCT00621322|65165891|FG003|Overall Study|Lost to Follow-up|0|||
23388001|NCT00621322|65165892|FG004|Overall Study|Lost to Follow-up|1|||
23388002|NCT00621322|65165893|FG005|Overall Study|Lost to Follow-up|0|||
23388003|NCT00621322|65165888|FG000|Overall Study|Physician Decision|0|||
23388004|NCT00621322|65165889|FG001|Overall Study|Physician Decision|0|||
23388005|NCT00621322|65165890|FG002|Overall Study|Physician Decision|1|||
23388006|NCT00621322|65165891|FG003|Overall Study|Physician Decision|1|||
23388007|NCT00621322|65165892|FG004|Overall Study|Physician Decision|0|||
23388008|NCT00621322|65165893|FG005|Overall Study|Physician Decision|0|||
23388009|NCT00621322|65165888|FG000|Overall Study|Withdrawal by Subject|0|||
23388010|NCT00621322|65165889|FG001|Overall Study|Withdrawal by Subject|0|||
23388011|NCT00621322|65165890|FG002|Overall Study|Withdrawal by Subject|0|||
23388012|NCT00621322|65165891|FG003|Overall Study|Withdrawal by Subject|1|||
23388013|NCT00621322|65165892|FG004|Overall Study|Withdrawal by Subject|0|||
23388014|NCT00621322|65165893|FG005|Overall Study|Withdrawal by Subject|2|||
23388015|NCT00621322|65165888|FG000|Overall Study|Migrated/moved from study area|1|||
23388016|NCT00621322|65165889|FG001|Overall Study|Migrated/moved from study area|0|||
23388017|NCT00621322|65165890|FG002|Overall Study|Migrated/moved from study area|1|||
23388018|NCT00621322|65165891|FG003|Overall Study|Migrated/moved from study area|1|||
23388019|NCT00621322|65165892|FG004|Overall Study|Migrated/moved from study area|0|||
23388020|NCT00621322|65165893|FG005|Overall Study|Migrated/moved from study area|2|||
23388021|NCT00625378|65165894|FG000|Overall Study|Adverse Event|22|||
23388022|NCT00625378|65165895|FG001|Overall Study|Adverse Event|0|||
23388023|NCT00625378|65165894|FG000|Overall Study|Withdrawal by Subject|16|||
23388024|NCT00625378|65165895|FG001|Overall Study|Withdrawal by Subject|0|||
23388025|NCT00625378|65165894|FG000|Overall Study|Death|38|||
23388026|NCT00625378|65165895|FG001|Overall Study|Death|0|||
23388027|NCT00625378|65165894|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
23388028|NCT00625378|65165895|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
23388029|NCT00625378|65165894|FG000|Overall Study|Lost to Follow-up|17|||
23388030|NCT00625378|65165895|FG001|Overall Study|Lost to Follow-up|0|||
23388031|NCT00625378|65165894|FG000|Overall Study|Non-compliant with study medication|3|||
23295417|NCT01640184|64821878|FG001|Overall Study|Protocol Violation|0|||
23295418|NCT01640184|64821879|FG002|Overall Study|Protocol Violation|1|||
23295419|NCT01103479|64821882|FG000|Overall Study|Up to date with CRC screening|1|||
23295420|NCT01103479|64821883|FG001|Overall Study|Up to date with CRC screening|9|||
23295421|NCT01103479|64821884|FG002|Overall Study|Up to date with CRC screening|12|||
23295422|NCT01103479|64821882|FG000|Overall Study|Family history of CRC|1|||
23295423|NCT01103479|64821883|FG001|Overall Study|Family history of CRC|0|||
23295424|NCT01103479|64821884|FG002|Overall Study|Family history of CRC|2|||
23295425|NCT01103479|64821882|FG000|Overall Study|Active cancer|1|||
23295426|NCT01103479|64821883|FG001|Overall Study|Active cancer|0|||
23295427|NCT01103479|64821884|FG002|Overall Study|Active cancer|0|||
23295428|NCT01103479|64821882|FG000|Overall Study|Saw non-study physician|2|||
23295429|NCT01103479|64821883|FG001|Overall Study|Saw non-study physician|0|||
23295430|NCT01103479|64821884|FG002|Overall Study|Saw non-study physician|0|||
23388032|NCT00625378|65165895|FG001|Overall Study|Non-compliant with study medication|0|||
23388033|NCT00625378|65165894|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
23388034|NCT00625378|65165895|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
23388035|NCT00625378|65165894|FG000|Overall Study|Medical decision|1|||
23388036|NCT00625378|65165895|FG001|Overall Study|Medical decision|0|||
23388037|NCT00625378|65165894|FG000|Overall Study|Multiple toxicities|1|||
23388038|NCT00625378|65165895|FG001|Overall Study|Multiple toxicities|0|||
23388039|NCT00625378|65165894|FG000|Overall Study|New cancer|1|||
23388040|NCT00625378|65165895|FG001|Overall Study|New cancer|0|||
23388041|NCT00625378|65165894|FG000|Overall Study|PTA program|2|||
23295431|NCT02339090|64821885|FG000|Overall Study|Adverse Event|1|||
23388042|NCT00625378|65165895|FG001|Overall Study|PTA program|0|||
23388043|NCT00625378|65165894|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
23295432|NCT02339090|64821886|FG001|Overall Study|Adverse Event|0|||
23295433|NCT02339090|64821885|FG000|Overall Study|Lost to Follow-up|0|||
23295434|NCT02339090|64821886|FG001|Overall Study|Lost to Follow-up|1|||
23388044|NCT00625378|65165895|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
23388045|NCT00625378|65165894|FG000|Overall Study|Sponsor decision|1|||
23388046|NCT00625378|65165895|FG001|Overall Study|Sponsor decision|0|||
23388047|NCT00625378|65165894|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
23388048|NCT00625378|65165895|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
23388049|NCT00625378|65165894|FG000|Overall Study|Switch to commercial drug|6|||
23388050|NCT00625378|65165895|FG001|Overall Study|Switch to commercial drug|1|||
23388051|NCT00625378|65165894|FG000|Overall Study|Missing|2|||
23388052|NCT00625378|65165895|FG001|Overall Study|Missing|0|||
23494331|NCT01914757|65554978|FG001|Overall Study|Severe non-compliance to protocol|1|||
23494332|NCT01914757|65554979|FG002|Overall Study|Severe non-compliance to protocol|2|||
23494333|NCT01914757|65554977|FG000|Overall Study|Lost to Follow-up|5|||
23494334|NCT01914757|65554978|FG001|Overall Study|Lost to Follow-up|8|||
23494335|NCT01914757|65554979|FG002|Overall Study|Lost to Follow-up|6|||
23494336|NCT01914757|65554977|FG000|Overall Study|Withdrawal by Subject|15|||
23295435|NCT02339090|64821885|FG000|Overall Study|Non-compliance With Study Drug|0|||
23295436|NCT02339090|64821886|FG001|Overall Study|Non-compliance With Study Drug|1|||
23295437|NCT02339090|64821885|FG000|Overall Study|Withdrawal by Subject|2|||
23295438|NCT02339090|64821886|FG001|Overall Study|Withdrawal by Subject|1|||
23295439|NCT02339090|64821885|FG000|Overall Study|Poor Growth|3|||
23295440|NCT02339090|64821886|FG001|Overall Study|Poor Growth|0|||
23295441|NCT02339090|64821885|FG000|Overall Study|Randomized but not treated|0|||
23295442|NCT02339090|64821886|FG001|Overall Study|Randomized but not treated|2|||
23295443|NCT02443545|64821889|FG000|Overall Study|Adverse Event|1|||
23295444|NCT02443545|64821890|FG001|Overall Study|Adverse Event|1|||
23295445|NCT02443545|64821889|FG000|Overall Study|Lost to Follow-up|0|||
23295446|NCT02443545|64821890|FG001|Overall Study|Lost to Follow-up|2|||
23295447|NCT02443545|64821889|FG000|Overall Study|Physician Decision|3|||
23295448|NCT02443545|64821890|FG001|Overall Study|Physician Decision|0|||
23295449|NCT02443545|64821889|FG000|Overall Study|Protocol Violation|8|||
23295450|NCT02443545|64821890|FG001|Overall Study|Protocol Violation|1|||
23295451|NCT02443545|64821889|FG000|Overall Study|Pregnancy|1|||
23295452|NCT02443545|64821890|FG001|Overall Study|Pregnancy|1|||
23295453|NCT02443545|64821889|FG000|Overall Study|Withdrawal by Subject|6|||
23388053|NCT00625378|65165894|FG000|Overall Study|End of treatment not available|2|||
23388054|NCT00625378|65165895|FG001|Overall Study|End of treatment not available|0|||
23494337|NCT01914757|65554978|FG001|Overall Study|Withdrawal by Subject|27|||
23494338|NCT01914757|65554979|FG002|Overall Study|Withdrawal by Subject|19|||
23295454|NCT02443545|64821890|FG001|Overall Study|Withdrawal by Subject|3|||
23494339|NCT01914757|65554977|FG000|Overall Study|Death|2|||
23295455|NCT02443545|64821889|FG000|Overall Study|Termination of study|20|||
23295456|NCT02443545|64821890|FG001|Overall Study|Termination of study|11|||
23295457|NCT00298740|64821893|FG000|Overall Study|Lack of Efficacy|6|||
23295458|NCT00298740|64821893|FG000|Overall Study|Withdrawal by Subject|3|||
23295459|NCT00808509|64821895|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
23295460|NCT00808509|64821896|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
23295461|NCT00808509|64821895|FG000|Randomized Phase|Reduced methotrexate dose|1|||
23295462|NCT00808509|64821896|FG001|Randomized Phase|Reduced methotrexate dose|2|||
23295463|NCT00808509|64821895|FG000|Randomized Phase|Patient refused rescue therapy|0|||
23295464|NCT00808509|64821896|FG001|Randomized Phase|Patient refused rescue therapy|3|||
23295465|NCT02788513|64821905|FG000|Overall Study|Withdrawal by Subject|3|||
23295466|NCT02788513|64821906|FG001|Overall Study|Withdrawal by Subject|0|||
23295467|NCT02788513|64821907|FG002|Overall Study|Withdrawal by Subject|2|||
23295468|NCT02788513|64821908|FG003|Overall Study|Withdrawal by Subject|3|||
23295469|NCT02788513|64821909|FG004|Overall Study|Withdrawal by Subject|1|||
23295470|NCT02788513|64821905|FG000|Overall Study|Lost to Follow-up|1|||
23295471|NCT02788513|64821906|FG001|Overall Study|Lost to Follow-up|0|||
23295472|NCT02788513|64821907|FG002|Overall Study|Lost to Follow-up|0|||
23295473|NCT02788513|64821908|FG003|Overall Study|Lost to Follow-up|0|||
23295474|NCT02788513|64821909|FG004|Overall Study|Lost to Follow-up|1|||
23295475|NCT02788513|64821905|FG000|Overall Study|Adverse Event|5|||
23295476|NCT02788513|64821906|FG001|Overall Study|Adverse Event|8|||
23388055|NCT00625378|65165894|FG000|Overall Study|Never treated|2|||
23388056|NCT00625378|65165895|FG001|Overall Study|Never treated|0|||
23388057|NCT01654250|65165896|FG000|Overall Study|Lost to Follow-up|1|||
23388058|NCT01654250|65165897|FG001|Overall Study|Lost to Follow-up|0|||
23388059|NCT01259024|65165898|FG000|Overall Study|Physician Decision|1|||
23388060|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
23388061|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
23388062|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
23388063|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
23388064|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
23388065|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
23388066|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
23388067|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
23388068|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
23388069|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
23388070|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
23388071|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
23388072|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
23388073|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
23388074|NCT00976391|65165902|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
23388075|NCT00976391|65165903|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
23388076|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
23388077|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
23388078|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
23388079|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
23388080|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
23388081|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
23388082|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
23388083|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
23388084|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
23388085|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
23388086|NCT00976391|65165902|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
23388087|NCT00976391|65165903|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
23388088|NCT01862029|65165904|FG000|Overall Study|Physician Decision|1|||
23388089|NCT03378635|65165907|FG000|Overall Study|Adverse Event|1|||
23388090|NCT03378635|65165908|FG001|Overall Study|Adverse Event|0|||
23388091|NCT03378635|65165909|FG002|Overall Study|Adverse Event|0|||
23388092|NCT03378635|65165907|FG000|Overall Study|Withdrawal by Subject|1|||
23388093|NCT03378635|65165908|FG001|Overall Study|Withdrawal by Subject|0|||
23388094|NCT03378635|65165909|FG002|Overall Study|Withdrawal by Subject|0|||
23388095|NCT03253627|65165936|FG000|Overall Study|Lost to Follow-up|1|||
23388096|NCT03253627|65165937|FG001|Overall Study|Lost to Follow-up|2|||
23388097|NCT03253627|65165936|FG000|Overall Study|Withdrawal by Subject|0|||
23295477|NCT02788513|64821907|FG002|Overall Study|Adverse Event|4|||
23388098|NCT03253627|65165937|FG001|Overall Study|Withdrawal by Subject|2|||
23494340|NCT01914757|65554978|FG001|Overall Study|Death|2|||
23494341|NCT01914757|65554979|FG002|Overall Study|Death|1|||
23295478|NCT02788513|64821908|FG003|Overall Study|Adverse Event|2|||
23388099|NCT03253627|65165936|FG000|Overall Study|Inability to complete MRI|1|||
23388100|NCT03253627|65165937|FG001|Overall Study|Inability to complete MRI|0|||
23388101|NCT02773537|65165938|FG000|Overall Study|Lost to Follow-up|0|||
23388102|NCT02773537|65165939|FG001|Overall Study|Lost to Follow-up|1|||
23388103|NCT02773537|65165940|FG002|Overall Study|Lost to Follow-up|4|||
23388104|NCT00395447|65165942|FG000|Overall Study|Death|37|||
23388105|NCT00395447|65165943|FG001|Overall Study|Death|32|||
23388106|NCT00395447|65165942|FG000|Overall Study|Lost to Follow-up|52|||
23388107|NCT00395447|65165943|FG001|Overall Study|Lost to Follow-up|43|||
23388108|NCT00395447|65165942|FG000|Overall Study|Withdrawal by Subject|24|||
23388109|NCT00395447|65165943|FG001|Overall Study|Withdrawal by Subject|19|||
23388110|NCT00395447|65165942|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
23388111|NCT00395447|65165943|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
23388112|NCT03211858|65165944|FG000|Overall Study|Adverse Event|8|||
23388113|NCT03211858|65165945|FG001|Overall Study|Adverse Event|6|||
23388114|NCT03211858|65165944|FG000|Overall Study|Lack of Efficacy|0|||
23388115|NCT03211858|65165945|FG001|Overall Study|Lack of Efficacy|4|||
23388116|NCT03211858|65165944|FG000|Overall Study|Poor compliance to protocol|6|||
23388117|NCT03211858|65165945|FG001|Overall Study|Poor compliance to protocol|2|||
23388118|NCT03211858|65165944|FG000|Overall Study|Non-serious Hypoglycemia|1|||
23388119|NCT03211858|65165945|FG001|Overall Study|Non-serious Hypoglycemia|0|||
23388120|NCT03211858|65165944|FG000|Overall Study|Other than specified above|22|||
23388121|NCT03211858|65165945|FG001|Overall Study|Other than specified above|21|||
23388122|NCT02769481|65165946|FG000|Overall Study|Protocol Violation|1|||
23388123|NCT02769481|65165947|FG001|Overall Study|Protocol Violation|0|||
23388124|NCT02769481|65165946|FG000|Overall Study|Adverse Event|3|||
23388125|NCT02769481|65165947|FG001|Overall Study|Adverse Event|6|||
23388126|NCT02769481|65165946|FG000|Overall Study|Entry Criteria Not Met|1|||
23388127|NCT02769481|65165947|FG001|Overall Study|Entry Criteria Not Met|2|||
23388128|NCT02769481|65165946|FG000|Overall Study|Withdrawal by Subject|14|||
23388129|NCT02769481|65165947|FG001|Overall Study|Withdrawal by Subject|16|||
23388130|NCT02769481|65165946|FG000|Overall Study|Lost to Follow-up|9|||
23388131|NCT02769481|65165947|FG001|Overall Study|Lost to Follow-up|9|||
23388132|NCT02769481|65165946|FG000|Overall Study|Physician Decision|0|||
23388133|NCT02769481|65165947|FG001|Overall Study|Physician Decision|1|||
23388134|NCT02769481|65165946|FG000|Overall Study|Terminated by Sponsor|1|||
23388135|NCT02769481|65165947|FG001|Overall Study|Terminated by Sponsor|0|||
23388136|NCT02769481|65165946|FG000|Overall Study|Death|0|||
23388137|NCT02769481|65165947|FG001|Overall Study|Death|1|||
23388138|NCT02769481|65165946|FG000|Overall Study|Undefined|4|||
23388139|NCT02769481|65165947|FG001|Overall Study|Undefined|1|||
23388140|NCT00420056|65165948|FG000|Overall Study|Objective progression or relapse|17|||
23388141|NCT01748552|65165949|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
23388142|NCT01748552|65165950|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
23388143|NCT01748552|65165951|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
23388144|NCT01748552|65165952|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
23388145|NCT01748552|65165953|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
23388146|NCT01748552|65165954|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
23494342|NCT01914757|65554977|FG000|Overall Study|Adverse Event|4|||
23494343|NCT01914757|65554978|FG001|Overall Study|Adverse Event|3|||
23494344|NCT01914757|65554979|FG002|Overall Study|Adverse Event|4|||
23494345|NCT01914757|65554977|FG000|Overall Study|Study specific withdrawal criteria|0|||
23494346|NCT01914757|65554978|FG001|Overall Study|Study specific withdrawal criteria|1|||
23494347|NCT01914757|65554979|FG002|Overall Study|Study specific withdrawal criteria|0|||
23494348|NCT01914757|65554977|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
23494349|NCT01914757|65554978|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
23388147|NCT01748552|65165955|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
23388148|NCT01748552|65165956|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
23494350|NCT01914757|65554979|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
23494351|NCT01914757|65554977|FG000|Overall Study|Other reasons|5|||
23494352|NCT01914757|65554978|FG001|Overall Study|Other reasons|9|||
23494353|NCT01914757|65554979|FG002|Overall Study|Other reasons|4|||
23494354|NCT04218695|65554980|FG000|Overall Study|Adverse Event|1|||
23494355|NCT04218695|65554981|FG001|Overall Study|Adverse Event|0|||
23494356|NCT00347360|65554982|FG000|Overall Study|Adverse Event|1|||
23388149|NCT01748552|65165957|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
23494357|NCT00347360|65554983|FG001|Overall Study|Adverse Event|2|||
23388150|NCT01748552|65165958|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
23494358|NCT00347360|65554984|FG002|Overall Study|Adverse Event|0|||
23494359|NCT00347360|65554985|FG003|Overall Study|Adverse Event|4|||
23494360|NCT00347360|65554986|FG004|Overall Study|Adverse Event|1|||
23494361|NCT00347360|65554987|FG005|Overall Study|Adverse Event|2|||
23494362|NCT00347360|65554988|FG006|Overall Study|Adverse Event|2|||
23494363|NCT00347360|65554989|FG007|Overall Study|Adverse Event|0|||
23494364|NCT00347360|65554990|FG008|Overall Study|Adverse Event|2|||
23494365|NCT00347360|65554991|FG009|Overall Study|Adverse Event|3|||
23494366|NCT00347360|65554992|FG010|Overall Study|Adverse Event|3|||
23494367|NCT00347360|65554993|FG011|Overall Study|Adverse Event|1|||
23494368|NCT00347360|65554994|FG012|Overall Study|Adverse Event|3|||
23494369|NCT00347360|65554995|FG013|Overall Study|Adverse Event|2|||
23494370|NCT00347360|65554996|FG014|Overall Study|Adverse Event|2|||
23494371|NCT00347360|65554982|FG000|Overall Study|Lost to Follow-up|0|||
23494372|NCT00347360|65554983|FG001|Overall Study|Lost to Follow-up|0|||
23494373|NCT00347360|65554984|FG002|Overall Study|Lost to Follow-up|0|||
23494374|NCT00347360|65554985|FG003|Overall Study|Lost to Follow-up|2|||
23494375|NCT00347360|65554986|FG004|Overall Study|Lost to Follow-up|1|||
23494376|NCT00347360|65554987|FG005|Overall Study|Lost to Follow-up|1|||
23494377|NCT00347360|65554988|FG006|Overall Study|Lost to Follow-up|0|||
23494378|NCT00347360|65554989|FG007|Overall Study|Lost to Follow-up|1|||
23494379|NCT00347360|65554990|FG008|Overall Study|Lost to Follow-up|1|||
23494380|NCT00347360|65554991|FG009|Overall Study|Lost to Follow-up|2|||
23494381|NCT00347360|65554992|FG010|Overall Study|Lost to Follow-up|0|||
23494382|NCT00347360|65554993|FG011|Overall Study|Lost to Follow-up|0|||
23494383|NCT00347360|65554994|FG012|Overall Study|Lost to Follow-up|1|||
23494384|NCT00347360|65554995|FG013|Overall Study|Lost to Follow-up|0|||
23494385|NCT00347360|65554996|FG014|Overall Study|Lost to Follow-up|0|||
23295479|NCT02788513|64821909|FG004|Overall Study|Adverse Event|2|||
23295480|NCT02788513|64821905|FG000|Overall Study|Protocol Violation|0|||
23295481|NCT02788513|64821906|FG001|Overall Study|Protocol Violation|0|||
23295482|NCT02788513|64821907|FG002|Overall Study|Protocol Violation|1|||
23295483|NCT02788513|64821908|FG003|Overall Study|Protocol Violation|1|||
23295484|NCT02788513|64821909|FG004|Overall Study|Protocol Violation|0|||
23295485|NCT02788513|64821905|FG000|Overall Study|Subject decided to stop taking treatment|0|||
23295486|NCT02788513|64821906|FG001|Overall Study|Subject decided to stop taking treatment|0|||
23295487|NCT02788513|64821907|FG002|Overall Study|Subject decided to stop taking treatment|1|||
23295488|NCT02788513|64821908|FG003|Overall Study|Subject decided to stop taking treatment|0|||
23295489|NCT02788513|64821909|FG004|Overall Study|Subject decided to stop taking treatment|0|||
23295490|NCT02788513|64821905|FG000|Overall Study|Decision by the study team|0|||
23494386|NCT00347360|65554982|FG000|Overall Study|Protocol Violation|2|||
23494387|NCT00347360|65554983|FG001|Overall Study|Protocol Violation|3|||
23494388|NCT00347360|65554984|FG002|Overall Study|Protocol Violation|1|||
23494389|NCT00347360|65554985|FG003|Overall Study|Protocol Violation|2|||
23494390|NCT00347360|65554986|FG004|Overall Study|Protocol Violation|1|||
23494391|NCT00347360|65554987|FG005|Overall Study|Protocol Violation|2|||
23494392|NCT00347360|65554988|FG006|Overall Study|Protocol Violation|0|||
23494393|NCT00347360|65554989|FG007|Overall Study|Protocol Violation|0|||
23494394|NCT00347360|65554990|FG008|Overall Study|Protocol Violation|1|||
23494395|NCT00347360|65554991|FG009|Overall Study|Protocol Violation|2|||
23494396|NCT00347360|65554992|FG010|Overall Study|Protocol Violation|0|||
23494397|NCT00347360|65554993|FG011|Overall Study|Protocol Violation|0|||
23494398|NCT00347360|65554994|FG012|Overall Study|Protocol Violation|0|||
23494399|NCT00347360|65554995|FG013|Overall Study|Protocol Violation|1|||
23494400|NCT00347360|65554996|FG014|Overall Study|Protocol Violation|0|||
23494401|NCT00347360|65554982|FG000|Overall Study|Withdrawal by Subject|0|||
23494402|NCT00347360|65554983|FG001|Overall Study|Withdrawal by Subject|1|||
23494403|NCT00347360|65554984|FG002|Overall Study|Withdrawal by Subject|2|||
23494404|NCT00347360|65554985|FG003|Overall Study|Withdrawal by Subject|4|||
23494405|NCT00347360|65554986|FG004|Overall Study|Withdrawal by Subject|1|||
23494406|NCT00347360|65554987|FG005|Overall Study|Withdrawal by Subject|2|||
23494407|NCT00347360|65554988|FG006|Overall Study|Withdrawal by Subject|1|||
23494408|NCT00347360|65554989|FG007|Overall Study|Withdrawal by Subject|1|||
23494409|NCT00347360|65554990|FG008|Overall Study|Withdrawal by Subject|1|||
23494410|NCT00347360|65554991|FG009|Overall Study|Withdrawal by Subject|1|||
23494411|NCT00347360|65554992|FG010|Overall Study|Withdrawal by Subject|0|||
23494412|NCT00347360|65554993|FG011|Overall Study|Withdrawal by Subject|3|||
23494413|NCT00347360|65554994|FG012|Overall Study|Withdrawal by Subject|4|||
23494414|NCT00347360|65554995|FG013|Overall Study|Withdrawal by Subject|2|||
23295491|NCT02788513|64821906|FG001|Overall Study|Decision by the study team|0|||
23295492|NCT02788513|64821907|FG002|Overall Study|Decision by the study team|0|||
23295493|NCT02788513|64821908|FG003|Overall Study|Decision by the study team|0|||
23494415|NCT00347360|65554996|FG014|Overall Study|Withdrawal by Subject|1|||
23494416|NCT00347360|65554982|FG000|Overall Study|Lack of Efficacy|1|||
23494417|NCT00347360|65554983|FG001|Overall Study|Lack of Efficacy|1|||
23494418|NCT00347360|65554984|FG002|Overall Study|Lack of Efficacy|3|||
23494419|NCT00347360|65554985|FG003|Overall Study|Lack of Efficacy|1|||
23295494|NCT02788513|64821909|FG004|Overall Study|Decision by the study team|1|||
23295495|NCT00707434|64821910|FG000|Overall Study|Adverse Event|1|||
23295496|NCT01705717|64821915|FG000|Overall Study|Adverse Event|2|||
23295497|NCT01705717|64821916|FG001|Overall Study|Adverse Event|2|||
23295498|NCT01705717|64821915|FG000|Overall Study|Lack of Efficacy|0|||
23295499|NCT01705717|64821916|FG001|Overall Study|Lack of Efficacy|1|||
23295500|NCT01705717|64821915|FG000|Overall Study|Other|0|||
23494420|NCT00347360|65554986|FG004|Overall Study|Lack of Efficacy|0|||
23494421|NCT00347360|65554987|FG005|Overall Study|Lack of Efficacy|1|||
23494422|NCT00347360|65554988|FG006|Overall Study|Lack of Efficacy|0|||
23494423|NCT00347360|65554989|FG007|Overall Study|Lack of Efficacy|1|||
23494424|NCT00347360|65554990|FG008|Overall Study|Lack of Efficacy|1|||
23494425|NCT00347360|65554991|FG009|Overall Study|Lack of Efficacy|0|||
23494426|NCT00347360|65554992|FG010|Overall Study|Lack of Efficacy|0|||
23494427|NCT00347360|65554993|FG011|Overall Study|Lack of Efficacy|0|||
23494428|NCT00347360|65554994|FG012|Overall Study|Lack of Efficacy|0|||
23494429|NCT00347360|65554995|FG013|Overall Study|Lack of Efficacy|0|||
23494430|NCT00347360|65554996|FG014|Overall Study|Lack of Efficacy|0|||
23494431|NCT00347360|65554982|FG000|Overall Study|Reason not listed/blank|1|||
23494432|NCT00347360|65554983|FG001|Overall Study|Reason not listed/blank|0|||
23494433|NCT00347360|65554984|FG002|Overall Study|Reason not listed/blank|0|||
23494434|NCT00347360|65554985|FG003|Overall Study|Reason not listed/blank|0|||
23494435|NCT00347360|65554986|FG004|Overall Study|Reason not listed/blank|0|||
23494436|NCT00347360|65554987|FG005|Overall Study|Reason not listed/blank|0|||
23494437|NCT00347360|65554988|FG006|Overall Study|Reason not listed/blank|1|||
23494438|NCT00347360|65554989|FG007|Overall Study|Reason not listed/blank|0|||
23494439|NCT00347360|65554990|FG008|Overall Study|Reason not listed/blank|0|||
23494440|NCT00347360|65554991|FG009|Overall Study|Reason not listed/blank|0|||
23494441|NCT00347360|65554992|FG010|Overall Study|Reason not listed/blank|0|||
23494442|NCT00347360|65554993|FG011|Overall Study|Reason not listed/blank|0|||
23494443|NCT00347360|65554994|FG012|Overall Study|Reason not listed/blank|0|||
23494444|NCT00347360|65554995|FG013|Overall Study|Reason not listed/blank|1|||
23494445|NCT00347360|65554996|FG014|Overall Study|Reason not listed/blank|0|||
23494446|NCT00347360|65554982|FG000|Overall Study|Per sponsors instruction|0|||
23494447|NCT00347360|65554983|FG001|Overall Study|Per sponsors instruction|1|||
23494448|NCT00347360|65554984|FG002|Overall Study|Per sponsors instruction|0|||
23494449|NCT00347360|65554985|FG003|Overall Study|Per sponsors instruction|0|||
23494450|NCT00347360|65554986|FG004|Overall Study|Per sponsors instruction|0|||
23494451|NCT00347360|65554987|FG005|Overall Study|Per sponsors instruction|0|||
23494452|NCT00347360|65554988|FG006|Overall Study|Per sponsors instruction|0|||
23494453|NCT00347360|65554989|FG007|Overall Study|Per sponsors instruction|0|||
23494454|NCT00347360|65554990|FG008|Overall Study|Per sponsors instruction|0|||
23494455|NCT00347360|65554991|FG009|Overall Study|Per sponsors instruction|0|||
23494456|NCT00347360|65554992|FG010|Overall Study|Per sponsors instruction|0|||
23494457|NCT00347360|65554993|FG011|Overall Study|Per sponsors instruction|0|||
23494458|NCT00347360|65554994|FG012|Overall Study|Per sponsors instruction|0|||
23295501|NCT01705717|64821916|FG001|Overall Study|Other|2|||
23494459|NCT00347360|65554995|FG013|Overall Study|Per sponsors instruction|0|||
23494460|NCT00347360|65554996|FG014|Overall Study|Per sponsors instruction|0|||
23494461|NCT00347360|65554982|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
23295502|NCT04768296|64821928|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
23295503|NCT04768296|64821929|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
23494462|NCT00347360|65554983|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
23494463|NCT00347360|65554984|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
23494464|NCT00347360|65554985|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
23295504|NCT00500318|64821934|FG000|Overall Study|Adverse Event|3|||
23494465|NCT00347360|65554986|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
23494466|NCT00347360|65554987|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
23494467|NCT00347360|65554988|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
23494468|NCT00347360|65554989|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
23494469|NCT00347360|65554990|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
23494470|NCT00347360|65554991|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
23494471|NCT00347360|65554992|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
23494472|NCT00347360|65554993|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
23494473|NCT00347360|65554994|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
23494474|NCT00347360|65554995|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
23494475|NCT00347360|65554996|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
23494476|NCT00347360|65554982|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
23494477|NCT00347360|65554983|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
23494478|NCT00347360|65554984|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
23494479|NCT00347360|65554985|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
23494480|NCT00347360|65554986|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
23494481|NCT00347360|65554987|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
23295505|NCT00500318|64821935|FG001|Overall Study|Adverse Event|8|||
23494482|NCT00347360|65554988|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
23494483|NCT00347360|65554989|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
23494484|NCT00347360|65554990|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
23494485|NCT00347360|65554991|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
23494486|NCT00347360|65554992|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
23494487|NCT00347360|65554993|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
23494488|NCT00347360|65554994|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
23494489|NCT00347360|65554995|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
23494490|NCT00347360|65554996|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
23494491|NCT00347360|65554982|FG000|Overall Study|Abnormal lab values|0|||
23494492|NCT00347360|65554983|FG001|Overall Study|Abnormal lab values|0|||
23494493|NCT00347360|65554984|FG002|Overall Study|Abnormal lab values|0|||
23494494|NCT00347360|65554985|FG003|Overall Study|Abnormal lab values|0|||
23295506|NCT00500318|64821934|FG000|Overall Study|Protocol Violation|1|||
23295507|NCT00500318|64821935|FG001|Overall Study|Protocol Violation|3|||
23295508|NCT00500318|64821934|FG000|Overall Study|Withdrawal by Subject|1|||
23295509|NCT00500318|64821935|FG001|Overall Study|Withdrawal by Subject|2|||
23295510|NCT00500318|64821934|FG000|Overall Study|Lack of Efficacy|0|||
23295511|NCT00500318|64821935|FG001|Overall Study|Lack of Efficacy|3|||
23295512|NCT00500318|64821934|FG000|Overall Study|Other Reason|0|||
23295513|NCT00500318|64821935|FG001|Overall Study|Other Reason|1|||
23295514|NCT00099268|64821940|FG000|Overall Study|Withdrawal by Subject|46|||
23295515|NCT00099268|64821941|FG001|Overall Study|Withdrawal by Subject|28|||
23295516|NCT00099268|64821940|FG000|Overall Study|Adverse Event|19|||
23295517|NCT00099268|64821941|FG001|Overall Study|Adverse Event|19|||
23295518|NCT00099268|64821940|FG000|Overall Study|Protocol Violation|9|||
23295519|NCT00099268|64821941|FG001|Overall Study|Protocol Violation|8|||
23295520|NCT00099268|64821940|FG000|Overall Study|Lost to Follow-up|6|||
23295521|NCT00099268|64821941|FG001|Overall Study|Lost to Follow-up|4|||
23295522|NCT00099268|64821940|FG000|Overall Study|Lack of Efficacy|5|||
23295523|NCT00099268|64821941|FG001|Overall Study|Lack of Efficacy|18|||
23295524|NCT00099268|64821940|FG000|Overall Study|Administrative problems|4|||
23295525|NCT00099268|64821941|FG001|Overall Study|Administrative problems|4|||
23295526|NCT00099268|64821940|FG000|Overall Study|Death|3|||
23295527|NCT00099268|64821941|FG001|Overall Study|Death|1|||
23295528|NCT03062358|64821942|FG000|Overall Study|Death|220|||
23295529|NCT03062358|64821943|FG001|Overall Study|Death|127|||
23295530|NCT03062358|64821942|FG000|Overall Study|Withdrawal by Subject|2|||
23295531|NCT03062358|64821943|FG001|Overall Study|Withdrawal by Subject|1|||
23295532|NCT03062358|64821942|FG000|Overall Study|Ongoing in Trial|78|||
23494495|NCT00347360|65554986|FG004|Overall Study|Abnormal lab values|0|||
23295533|NCT03062358|64821943|FG001|Overall Study|Ongoing in Trial|25|||
23295534|NCT03546647|64821944|FG000|Overall Study|Adverse Event|1|||
23295535|NCT03546647|64821945|FG001|Overall Study|Adverse Event|0|||
23295536|NCT03648879|64821946|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
23295537|NCT01961882|64821947|FG000|Overall Study|Adverse Event|3|||
23295538|NCT01961882|64821948|FG001|Overall Study|Adverse Event|2|||
23295539|NCT01961882|64821947|FG000|Overall Study|Physician Decision|1|||
23494496|NCT00347360|65554987|FG005|Overall Study|Abnormal lab values|0|||
23494497|NCT00347360|65554988|FG006|Overall Study|Abnormal lab values|1|||
23494498|NCT00347360|65554989|FG007|Overall Study|Abnormal lab values|0|||
23494499|NCT00347360|65554990|FG008|Overall Study|Abnormal lab values|0|||
23494500|NCT00347360|65554991|FG009|Overall Study|Abnormal lab values|0|||
23494501|NCT00347360|65554992|FG010|Overall Study|Abnormal lab values|0|||
23494502|NCT00347360|65554993|FG011|Overall Study|Abnormal lab values|0|||
23494503|NCT00347360|65554994|FG012|Overall Study|Abnormal lab values|0|||
23494504|NCT00347360|65554995|FG013|Overall Study|Abnormal lab values|0|||
23494505|NCT00347360|65554996|FG014|Overall Study|Abnormal lab values|0|||
23494506|NCT00347360|65554982|FG000|Overall Study|PI recommended early withdrawal|0|||
23494507|NCT00347360|65554983|FG001|Overall Study|PI recommended early withdrawal|0|||
23494508|NCT00347360|65554984|FG002|Overall Study|PI recommended early withdrawal|0|||
23494509|NCT00347360|65554985|FG003|Overall Study|PI recommended early withdrawal|0|||
23494510|NCT00347360|65554986|FG004|Overall Study|PI recommended early withdrawal|0|||
23494511|NCT00347360|65554987|FG005|Overall Study|PI recommended early withdrawal|0|||
23494512|NCT00347360|65554988|FG006|Overall Study|PI recommended early withdrawal|0|||
23494513|NCT00347360|65554989|FG007|Overall Study|PI recommended early withdrawal|0|||
23295540|NCT01961882|64821948|FG001|Overall Study|Physician Decision|0|||
23295541|NCT01961882|64821947|FG000|Overall Study|Withdrawal by Subject|4|||
23295542|NCT01961882|64821948|FG001|Overall Study|Withdrawal by Subject|1|||
23295543|NCT01961882|64821947|FG000|Overall Study|Relapse of AML|39|||
23295544|NCT01961882|64821948|FG001|Overall Study|Relapse of AML|37|||
23295545|NCT01961882|64821947|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
23295546|NCT01961882|64821948|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
23295547|NCT01961882|64821947|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
23295548|NCT01961882|64821948|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
23494514|NCT00347360|65554990|FG008|Overall Study|PI recommended early withdrawal|0|||
23494515|NCT00347360|65554991|FG009|Overall Study|PI recommended early withdrawal|1|||
23494516|NCT00347360|65554992|FG010|Overall Study|PI recommended early withdrawal|0|||
23494517|NCT00347360|65554993|FG011|Overall Study|PI recommended early withdrawal|0|||
23494518|NCT00347360|65554994|FG012|Overall Study|PI recommended early withdrawal|0|||
23295549|NCT00436917|64821949|FG000|Overall Study|Withdrawal by Subject|13|||
23295550|NCT00436917|64821949|FG000|Overall Study|Adverse Event|2|||
23295551|NCT00436917|64821949|FG000|Overall Study|Physician Decision|1|||
23295552|NCT00436917|64821949|FG000|Overall Study|Death|1|||
23295553|NCT00436917|64821949|FG000|Overall Study|Lost to Follow-up|1|||
23295554|NCT00436917|64821949|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
23295555|NCT00436917|64821949|FG000|Overall Study|Increased creatinine|1|||
23295556|NCT00436917|64821949|FG000|Overall Study|Personal conflicts of patient|1|||
23295557|NCT00476593|64821950|FG000|Overall Study|Lost to Follow-up|10|||
23295558|NCT00476593|64821951|FG001|Overall Study|Lost to Follow-up|2|||
23295559|NCT00476593|64821952|FG002|Overall Study|Lost to Follow-up|8|||
23295560|NCT00476593|64821953|FG003|Overall Study|Lost to Follow-up|22|||
23295561|NCT04287868|64821954|FG000|Overall Study|Screening fail|1|||
23494519|NCT00347360|65554995|FG013|Overall Study|PI recommended early withdrawal|0|||
23295562|NCT04287868|64821955|FG001|Overall Study|Screening fail|0|||
23295563|NCT00942331|64821958|FG000|Overall Study|Did not start treatment|15|||
23295564|NCT00942331|64821959|FG001|Overall Study|Did not start treatment|22|||
23494520|NCT00347360|65554996|FG014|Overall Study|PI recommended early withdrawal|0|||
23494521|NCT00347360|65554982|FG000|Overall Study|Did not meet criteria before ABPM|0|||
23494522|NCT00347360|65554983|FG001|Overall Study|Did not meet criteria before ABPM|0|||
23494523|NCT00347360|65554984|FG002|Overall Study|Did not meet criteria before ABPM|0|||
23494524|NCT00347360|65554985|FG003|Overall Study|Did not meet criteria before ABPM|0|||
23494525|NCT00347360|65554986|FG004|Overall Study|Did not meet criteria before ABPM|0|||
23494526|NCT00347360|65554987|FG005|Overall Study|Did not meet criteria before ABPM|0|||
23494527|NCT00347360|65554988|FG006|Overall Study|Did not meet criteria before ABPM|0|||
23494528|NCT00347360|65554989|FG007|Overall Study|Did not meet criteria before ABPM|0|||
23494529|NCT00347360|65554990|FG008|Overall Study|Did not meet criteria before ABPM|0|||
23494530|NCT00347360|65554991|FG009|Overall Study|Did not meet criteria before ABPM|0|||
23494531|NCT00347360|65554992|FG010|Overall Study|Did not meet criteria before ABPM|1|||
23295565|NCT02000531|64821960|FG000|Overall Study|Lost to Follow-up|1|||
23295566|NCT02000531|64821961|FG001|Overall Study|Lost to Follow-up|0|||
23295567|NCT02000531|64821960|FG000|Overall Study|Discontinued due to data cut-off|3|||
23494532|NCT00347360|65554993|FG011|Overall Study|Did not meet criteria before ABPM|0|||
23494533|NCT00347360|65554994|FG012|Overall Study|Did not meet criteria before ABPM|0|||
23494534|NCT00347360|65554995|FG013|Overall Study|Did not meet criteria before ABPM|0|||
23494535|NCT00347360|65554996|FG014|Overall Study|Did not meet criteria before ABPM|0|||
23494536|NCT00347360|65554982|FG000|Overall Study|Randomized in error|0|||
23494537|NCT00347360|65554983|FG001|Overall Study|Randomized in error|0|||
23494538|NCT00347360|65554984|FG002|Overall Study|Randomized in error|0|||
23494539|NCT00347360|65554985|FG003|Overall Study|Randomized in error|0|||
23295568|NCT02000531|64821961|FG001|Overall Study|Discontinued due to data cut-off|8|||
23295569|NCT00685802|64821962|FG000|Washout Period of 7 Days|Protocol Violation|2|||
23295570|NCT00685802|64821963|FG001|Washout Period of 7 Days|Protocol Violation|0|||
23295571|NCT00685802|64821962|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
23295572|NCT00685802|64821963|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
23295573|NCT00985231|64821965|FG000|Overall Study|ineligible|1|||
23295574|NCT00985231|64821966|FG001|Overall Study|ineligible|0|||
23295575|NCT00985231|64821965|FG000|Overall Study|Protocol Violation|1|||
23295576|NCT00985231|64821966|FG001|Overall Study|Protocol Violation|0|||
23295577|NCT00985231|64821965|FG000|Overall Study|Withdrawal by Subject|1|||
23295578|NCT00985231|64821966|FG001|Overall Study|Withdrawal by Subject|0|||
23295579|NCT00985231|64821965|FG000|Overall Study|Lost to Follow-up|0|||
23295580|NCT00985231|64821966|FG001|Overall Study|Lost to Follow-up|1|||
23295581|NCT00985231|64821965|FG000|Overall Study|Study related symptoms & complaints|0|||
23295582|NCT00985231|64821966|FG001|Overall Study|Study related symptoms & complaints|2|||
23295583|NCT01647958|64821967|FG000|Initial Study|Lost to Follow-up|2|||
23295584|NCT01647958|64821968|FG001|Initial Study|Lost to Follow-up|3|||
23295585|NCT01647958|64821967|FG000|Continuation Phase|treatment received during Overall Study|39|||
23295586|NCT01647958|64821968|FG001|Continuation Phase|treatment received during Overall Study|0|||
23295587|NCT01647958|64821967|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
23295588|NCT01647958|64821968|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
23295589|NCT04117945|64821969|FG000|Overall Study|Death|1|||
23295590|NCT04117945|64821970|FG001|Overall Study|Death|0|||
23295591|NCT04117945|64821969|FG000|Overall Study|Withdrawal by Subject|3|||
23295592|NCT04117945|64821970|FG001|Overall Study|Withdrawal by Subject|1|||
23295593|NCT04117945|64821969|FG000|Overall Study|Disease Progression|0|||
23295594|NCT04117945|64821970|FG001|Overall Study|Disease Progression|2|||
23295595|NCT04117945|64821969|FG000|Overall Study|Ineligible|8|||
23295596|NCT04117945|64821970|FG001|Overall Study|Ineligible|7|||
23295597|NCT01453153|64821973|FG000|Overall Study|Physician Decision|0|||
23295598|NCT01453153|64821974|FG001|Overall Study|Physician Decision|0|||
23295599|NCT01453153|64821975|FG002|Overall Study|Physician Decision|1|||
23295600|NCT01453153|64821973|FG000|Overall Study|Progressive Disease|3|||
23295601|NCT01453153|64821974|FG001|Overall Study|Progressive Disease|2|||
23295602|NCT01453153|64821975|FG002|Overall Study|Progressive Disease|16|||
23295603|NCT01453153|64821973|FG000|Overall Study|Withdrawal by Subject|0|||
23295604|NCT01453153|64821974|FG001|Overall Study|Withdrawal by Subject|1|||
23295605|NCT01453153|64821975|FG002|Overall Study|Withdrawal by Subject|2|||
23295606|NCT01453153|64821973|FG000|Overall Study|Adverse Event|1|||
23295607|NCT01453153|64821974|FG001|Overall Study|Adverse Event|1|||
23295608|NCT01453153|64821975|FG002|Overall Study|Adverse Event|1|||
23295609|NCT02351167|64821977|FG000|Overall Study|Withdrawal by Subject|19|||
23295610|NCT02351167|64821978|FG001|Overall Study|Withdrawal by Subject|18|||
23295611|NCT02351167|64821979|FG002|Overall Study|Withdrawal by Subject|21|||
23295612|NCT03558139|64821980|FG000|Overall Study|Consent Withdrawn|1|||
23295613|NCT03558139|64821981|FG001|Overall Study|Consent Withdrawn|1|||
23295614|NCT03558139|64821982|FG002|Overall Study|Consent Withdrawn|4|||
23295615|NCT03558139|64821980|FG000|Overall Study|Death|5|||
23295616|NCT03558139|64821981|FG001|Overall Study|Death|3|||
23295617|NCT03558139|64821982|FG002|Overall Study|Death|8|||
23295618|NCT03558139|64821980|FG000|Overall Study|Lost to Follow-up|0|||
23295619|NCT03558139|64821981|FG001|Overall Study|Lost to Follow-up|0|||
23295620|NCT03558139|64821982|FG002|Overall Study|Lost to Follow-up|3|||
23295621|NCT03558139|64821980|FG000|Overall Study|Study Ended Per Protocol|0|||
23295622|NCT03558139|64821981|FG001|Overall Study|Study Ended Per Protocol|3|||
23295623|NCT03558139|64821982|FG002|Overall Study|Study Ended Per Protocol|6|||
23295624|NCT01438476|64821983|FG000|Overall Study|Protocol Violation|1|||
23295625|NCT01438476|64821984|FG001|Overall Study|Protocol Violation|0|||
23295626|NCT01438476|64821983|FG000|Overall Study|Withdrawal by Subject|1|||
23295627|NCT01438476|64821984|FG001|Overall Study|Withdrawal by Subject|0|||
23295628|NCT01438476|64821983|FG000|Overall Study|No Surgery- Disease|8|||
23295629|NCT01438476|64821984|FG001|Overall Study|No Surgery- Disease|10|||
23295630|NCT01438476|64821983|FG000|Overall Study|Communication barrier|0|||
23295631|NCT01438476|64821984|FG001|Overall Study|Communication barrier|1|||
23295632|NCT00775528|64821985|FG000|Overall Study|Protocol Violation|1|||
23295633|NCT04046549|64821986|FG000|Overall Study|Adverse Event|1|||
23295634|NCT04046549|64821986|FG000|Overall Study|Physician Decision|1|||
23295635|NCT04046549|64821986|FG000|Overall Study|Withdrawal by Subject|3|||
23295636|NCT04046549|64821986|FG000|Overall Study|Other, Not Specified|5|||
23295637|NCT04974619|64821995|FG000|Overall Study|Lost to Follow-up|0|||
23295638|NCT04974619|64821996|FG001|Overall Study|Lost to Follow-up|0|||
23295639|NCT04974619|64821997|FG002|Overall Study|Lost to Follow-up|1|||
23295640|NCT04974619|64821995|FG000|Overall Study|Withdrawal by Subject|0|||
23295641|NCT04974619|64821996|FG001|Overall Study|Withdrawal by Subject|0|||
23295642|NCT04974619|64821997|FG002|Overall Study|Withdrawal by Subject|1|||
23295643|NCT04974619|64821995|FG000|Overall Study|Protocol Violation|0|||
23295644|NCT04974619|64821996|FG001|Overall Study|Protocol Violation|1|||
23295645|NCT04974619|64821997|FG002|Overall Study|Protocol Violation|0|||
23295646|NCT00129116|64822004|FG000|Primary Phase|Lost to Follow-up|1|||
23295647|NCT00129116|64822005|FG001|Primary Phase|Lost to Follow-up|1|||
23295648|NCT00129116|64822006|FG002|Primary Phase|Lost to Follow-up|0|||
23295649|NCT00129116|64822007|FG003|Primary Phase|Lost to Follow-up|1|||
23295650|NCT00129116|64822008|FG004|Primary Phase|Lost to Follow-up|1|||
23295651|NCT00129116|64822004|FG000|Primary Phase|Protocol Violation|0|||
23295652|NCT00129116|64822005|FG001|Primary Phase|Protocol Violation|1|||
23295653|NCT00129116|64822006|FG002|Primary Phase|Protocol Violation|0|||
23295654|NCT00129116|64822007|FG003|Primary Phase|Protocol Violation|0|||
23295655|NCT00129116|64822008|FG004|Primary Phase|Protocol Violation|0|||
23295656|NCT00129116|64822004|FG000|Primary Phase|Adverse Event|1|||
23295657|NCT00129116|64822005|FG001|Primary Phase|Adverse Event|1|||
23295658|NCT00129116|64822006|FG002|Primary Phase|Adverse Event|0|||
23295659|NCT00129116|64822007|FG003|Primary Phase|Adverse Event|0|||
23295660|NCT00129116|64822008|FG004|Primary Phase|Adverse Event|0|||
23295661|NCT00129116|64822004|FG000|Primary Phase|Withdrawal by Subject|0|||
23295662|NCT00129116|64822005|FG001|Primary Phase|Withdrawal by Subject|1|||
23295663|NCT00129116|64822006|FG002|Primary Phase|Withdrawal by Subject|0|||
23295664|NCT00129116|64822007|FG003|Primary Phase|Withdrawal by Subject|0|||
23295665|NCT00129116|64822008|FG004|Primary Phase|Withdrawal by Subject|0|||
23295666|NCT00129116|64822004|FG000|Primary Phase|Other|0|||
23295667|NCT00129116|64822005|FG001|Primary Phase|Other|0|||
23295668|NCT00129116|64822006|FG002|Primary Phase|Other|1|||
23295669|NCT00129116|64822007|FG003|Primary Phase|Other|0|||
23295670|NCT00129116|64822008|FG004|Primary Phase|Other|0|||
23295671|NCT00129116|64822004|FG000|Booster Phase|Lost to Follow-up|2|||
23494540|NCT00347360|65554986|FG004|Overall Study|Randomized in error|0|||
23494541|NCT00347360|65554987|FG005|Overall Study|Randomized in error|0|||
23494542|NCT00347360|65554988|FG006|Overall Study|Randomized in error|0|||
23494543|NCT00347360|65554989|FG007|Overall Study|Randomized in error|0|||
23494544|NCT00347360|65554990|FG008|Overall Study|Randomized in error|0|||
23295672|NCT00129116|64822005|FG001|Booster Phase|Lost to Follow-up|0|||
23295673|NCT00129116|64822006|FG002|Booster Phase|Lost to Follow-up|0|||
23295674|NCT00129116|64822007|FG003|Booster Phase|Lost to Follow-up|0|||
23295675|NCT00129116|64822008|FG004|Booster Phase|Lost to Follow-up|1|||
23295676|NCT00700817|64824826|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
23295677|NCT00700817|64824827|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
23295678|NCT00700817|64824828|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
23295679|NCT00700817|64824829|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
23295680|NCT00700817|64824830|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
23494545|NCT00347360|65554991|FG009|Overall Study|Randomized in error|0|||
23494546|NCT00347360|65554992|FG010|Overall Study|Randomized in error|0|||
23494547|NCT00347360|65554993|FG011|Overall Study|Randomized in error|1|||
23494548|NCT00347360|65554994|FG012|Overall Study|Randomized in error|0|||
23494549|NCT00347360|65554995|FG013|Overall Study|Randomized in error|0|||
23494550|NCT00347360|65554996|FG014|Overall Study|Randomized in error|0|||
23295681|NCT00700817|64824826|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
23295682|NCT00700817|64824827|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
23295683|NCT00700817|64824828|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
23295684|NCT00700817|64824829|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
23295685|NCT00700817|64824830|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
23295686|NCT00700817|64824826|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
23295687|NCT00700817|64824827|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
23494551|NCT00347360|65554982|FG000|Overall Study|Failed inclusion criteria #4|0|||
23494552|NCT00347360|65554983|FG001|Overall Study|Failed inclusion criteria #4|0|||
23388151|NCT01748552|65165959|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
23388152|NCT01748552|65165960|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
23388153|NCT01748552|65165949|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388154|NCT01748552|65165950|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388155|NCT01748552|65165951|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388156|NCT01748552|65165952|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388157|NCT01748552|65165953|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388158|NCT01748552|65165954|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388159|NCT01748552|65165955|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
23388160|NCT01748552|65165956|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
23295688|NCT00700817|64824828|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
23295689|NCT00700817|64824829|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
23295690|NCT00700817|64824830|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
23295691|NCT00700817|64824826|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
23295692|NCT00700817|64824827|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
23295693|NCT00700817|64824828|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
23295694|NCT00700817|64824829|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
23295695|NCT00700817|64824830|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
23295696|NCT00700817|64824826|FG000|Week 0-26 (Main Period)|Unclassified|14|||
23295697|NCT00700817|64824827|FG001|Week 0-26 (Main Period)|Unclassified|4|||
23295698|NCT00700817|64824828|FG002|Week 0-26 (Main Period)|Unclassified|8|||
23295699|NCT00700817|64824829|FG003|Week 0-26 (Main Period)|Unclassified|0|||
23295700|NCT00700817|64824830|FG004|Week 0-26 (Main Period)|Unclassified|0|||
23295701|NCT00700817|64824826|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
23295702|NCT00700817|64824827|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
23295703|NCT00700817|64824828|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
23295704|NCT00700817|64824829|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
23295705|NCT00700817|64824830|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
23295706|NCT00700817|64824826|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
23295707|NCT00700817|64824827|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
23295708|NCT00700817|64824828|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
23295709|NCT00700817|64824829|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
23295710|NCT00700817|64824830|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
23295711|NCT00700817|64824826|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
23295712|NCT00700817|64824827|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
23295713|NCT00700817|64824828|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
23295714|NCT00700817|64824829|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
23295715|NCT00700817|64824830|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
23295716|NCT00700817|64824826|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
23295717|NCT00700817|64824827|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
23388161|NCT01748552|65165957|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
23295718|NCT00700817|64824828|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
23295719|NCT00700817|64824829|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
23494553|NCT00347360|65554984|FG002|Overall Study|Failed inclusion criteria #4|0|||
23494554|NCT00347360|65554985|FG003|Overall Study|Failed inclusion criteria #4|0|||
23494555|NCT00347360|65554986|FG004|Overall Study|Failed inclusion criteria #4|0|||
23494556|NCT00347360|65554987|FG005|Overall Study|Failed inclusion criteria #4|0|||
23494557|NCT00347360|65554988|FG006|Overall Study|Failed inclusion criteria #4|0|||
23494558|NCT00347360|65554989|FG007|Overall Study|Failed inclusion criteria #4|0|||
23494559|NCT00347360|65554990|FG008|Overall Study|Failed inclusion criteria #4|0|||
23494560|NCT00347360|65554991|FG009|Overall Study|Failed inclusion criteria #4|0|||
23494561|NCT00347360|65554992|FG010|Overall Study|Failed inclusion criteria #4|0|||
23494562|NCT00347360|65554993|FG011|Overall Study|Failed inclusion criteria #4|1|||
23494563|NCT00347360|65554994|FG012|Overall Study|Failed inclusion criteria #4|0|||
23494564|NCT00347360|65554995|FG013|Overall Study|Failed inclusion criteria #4|0|||
23494565|NCT00347360|65554996|FG014|Overall Study|Failed inclusion criteria #4|0|||
23494566|NCT00347360|65554982|FG000|Overall Study|Prolonged duration between visits|0|||
23494567|NCT00347360|65554983|FG001|Overall Study|Prolonged duration between visits|0|||
23494568|NCT00347360|65554984|FG002|Overall Study|Prolonged duration between visits|0|||
23494569|NCT00347360|65554985|FG003|Overall Study|Prolonged duration between visits|0|||
23494570|NCT00347360|65554986|FG004|Overall Study|Prolonged duration between visits|0|||
23494571|NCT00347360|65554987|FG005|Overall Study|Prolonged duration between visits|0|||
23494572|NCT00347360|65554988|FG006|Overall Study|Prolonged duration between visits|0|||
23494573|NCT00347360|65554989|FG007|Overall Study|Prolonged duration between visits|0|||
23494574|NCT00347360|65554990|FG008|Overall Study|Prolonged duration between visits|0|||
23494575|NCT00347360|65554991|FG009|Overall Study|Prolonged duration between visits|0|||
23494576|NCT00347360|65554992|FG010|Overall Study|Prolonged duration between visits|0|||
23494577|NCT00347360|65554993|FG011|Overall Study|Prolonged duration between visits|0|||
23494578|NCT00347360|65554994|FG012|Overall Study|Prolonged duration between visits|1|||
23295720|NCT00700817|64824830|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
23295721|NCT00700817|64824826|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
23295722|NCT00700817|64824827|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
23295723|NCT00700817|64824828|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
23295724|NCT00700817|64824829|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
23295725|NCT00700817|64824830|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
23494579|NCT00347360|65554995|FG013|Overall Study|Prolonged duration between visits|0|||
23494580|NCT00347360|65554996|FG014|Overall Study|Prolonged duration between visits|0|||
23295726|NCT00700817|64824826|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
23295727|NCT00700817|64824827|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
23295728|NCT00700817|64824828|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
23295729|NCT00700817|64824829|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
23295730|NCT00700817|64824830|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
23388162|NCT01748552|65165958|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23494581|NCT00347360|65554982|FG000|Overall Study|Subject left town, ran out of study drug|0|||
23494582|NCT00347360|65554983|FG001|Overall Study|Subject left town, ran out of study drug|0|||
23494583|NCT00347360|65554984|FG002|Overall Study|Subject left town, ran out of study drug|0|||
23295731|NCT00700817|64824826|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
23295732|NCT00700817|64824827|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
23295733|NCT00700817|64824828|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
23295734|NCT00700817|64824829|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
23295735|NCT00700817|64824830|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
23295736|NCT00700817|64824826|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
23295737|NCT00700817|64824827|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
23295738|NCT00700817|64824828|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
23295739|NCT00700817|64824829|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
23295740|NCT00700817|64824830|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
23295741|NCT00700817|64824826|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
23295742|NCT00700817|64824827|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
23295743|NCT00700817|64824828|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
23295744|NCT00700817|64824829|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
23295745|NCT00700817|64824830|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
23295746|NCT00700817|64824826|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
23295747|NCT00700817|64824827|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
23295748|NCT00700817|64824828|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
23295749|NCT00700817|64824829|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
23295750|NCT00700817|64824830|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
23295751|NCT00892281|64824836|FG000|Overall Study|Adverse Event|65|||
23295752|NCT00892281|64824837|FG001|Overall Study|Adverse Event|8|||
23295753|NCT00892281|64824836|FG000|Overall Study|Lost to Follow-up|81|||
23295754|NCT00892281|64824837|FG001|Overall Study|Lost to Follow-up|8|||
23295755|NCT00892281|64824836|FG000|Overall Study|Pregnancy|1|||
23295756|NCT00892281|64824837|FG001|Overall Study|Pregnancy|0|||
23295757|NCT00892281|64824836|FG000|Overall Study|Protocol Violation|7|||
23295758|NCT00892281|64824837|FG001|Overall Study|Protocol Violation|2|||
23295759|NCT00892281|64824836|FG000|Overall Study|Withdrawal by Subject|86|||
23295760|NCT00892281|64824837|FG001|Overall Study|Withdrawal by Subject|14|||
23295761|NCT00892281|64824836|FG000|Overall Study|Subject failed to return for final visit|2|||
23388163|NCT01748552|65165959|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388164|NCT01748552|65165960|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
23388165|NCT02959892|65165961|FG000|Overall Study|PET tracer synthesis failure|1|||
23388166|NCT02959892|65165962|FG001|Overall Study|PET tracer synthesis failure|0|||
23388167|NCT02959892|65165961|FG000|Overall Study|Study termination|0|||
23388168|NCT02959892|65165962|FG001|Overall Study|Study termination|1|||
23388169|NCT01936974|65165963|FG000|Overall Study|Physician Decision|2|||
23388170|NCT01936974|65165964|FG001|Overall Study|Physician Decision|5|||
23494584|NCT00347360|65554985|FG003|Overall Study|Subject left town, ran out of study drug|0|||
23494585|NCT00347360|65554986|FG004|Overall Study|Subject left town, ran out of study drug|0|||
23494586|NCT00347360|65554987|FG005|Overall Study|Subject left town, ran out of study drug|0|||
23494587|NCT00347360|65554988|FG006|Overall Study|Subject left town, ran out of study drug|0|||
23494588|NCT00347360|65554989|FG007|Overall Study|Subject left town, ran out of study drug|0|||
23494589|NCT00347360|65554990|FG008|Overall Study|Subject left town, ran out of study drug|0|||
23494590|NCT00347360|65554991|FG009|Overall Study|Subject left town, ran out of study drug|0|||
23494591|NCT00347360|65554992|FG010|Overall Study|Subject left town, ran out of study drug|0|||
23494592|NCT00347360|65554993|FG011|Overall Study|Subject left town, ran out of study drug|0|||
23494593|NCT00347360|65554994|FG012|Overall Study|Subject left town, ran out of study drug|0|||
23494594|NCT00347360|65554995|FG013|Overall Study|Subject left town, ran out of study drug|1|||
23494595|NCT00347360|65554996|FG014|Overall Study|Subject left town, ran out of study drug|0|||
23494596|NCT00347360|65554982|FG000|Overall Study|Subject refuse to sign updated consent|0|||
23494597|NCT00347360|65554983|FG001|Overall Study|Subject refuse to sign updated consent|0|||
23494598|NCT00347360|65554984|FG002|Overall Study|Subject refuse to sign updated consent|0|||
23494599|NCT00347360|65554985|FG003|Overall Study|Subject refuse to sign updated consent|0|||
23494600|NCT00347360|65554986|FG004|Overall Study|Subject refuse to sign updated consent|0|||
23494601|NCT00347360|65554987|FG005|Overall Study|Subject refuse to sign updated consent|0|||
23494602|NCT00347360|65554988|FG006|Overall Study|Subject refuse to sign updated consent|0|||
23494603|NCT00347360|65554989|FG007|Overall Study|Subject refuse to sign updated consent|0|||
23494604|NCT00347360|65554990|FG008|Overall Study|Subject refuse to sign updated consent|0|||
23494605|NCT00347360|65554991|FG009|Overall Study|Subject refuse to sign updated consent|0|||
23494606|NCT00347360|65554992|FG010|Overall Study|Subject refuse to sign updated consent|0|||
23494607|NCT00347360|65554993|FG011|Overall Study|Subject refuse to sign updated consent|0|||
23494608|NCT00347360|65554994|FG012|Overall Study|Subject refuse to sign updated consent|0|||
23494609|NCT00347360|65554995|FG013|Overall Study|Subject refuse to sign updated consent|0|||
23494610|NCT00347360|65554996|FG014|Overall Study|Subject refuse to sign updated consent|1|||
23494611|NCT00347360|65554982|FG000|Overall Study|Visits conflicted with new job|0|||
23494612|NCT00347360|65554983|FG001|Overall Study|Visits conflicted with new job|0|||
23494613|NCT00347360|65554984|FG002|Overall Study|Visits conflicted with new job|0|||
23494614|NCT00347360|65554985|FG003|Overall Study|Visits conflicted with new job|0|||
23494615|NCT00347360|65554986|FG004|Overall Study|Visits conflicted with new job|0|||
23295762|NCT00892281|64824837|FG001|Overall Study|Subject failed to return for final visit|0|||
23295763|NCT00892281|64824836|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
23295764|NCT00892281|64824837|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
23295765|NCT00892281|64824836|FG000|Overall Study|Final visit completed 4 weeks late|0|||
23295766|NCT00892281|64824837|FG001|Overall Study|Final visit completed 4 weeks late|1|||
23295767|NCT00892281|64824836|FG000|Overall Study|Subject completed day after study closed|1|||
23295768|NCT00892281|64824837|FG001|Overall Study|Subject completed day after study closed|0|||
23295769|NCT00892281|64824836|FG000|Overall Study|Family emergency|1|||
23295770|NCT00892281|64824837|FG001|Overall Study|Family emergency|0|||
23295771|NCT00892281|64824836|FG000|Overall Study|Last visit not done - death in family|1|||
23295772|NCT00892281|64824837|FG001|Overall Study|Last visit not done - death in family|0|||
23295773|NCT00892281|64824836|FG000|Overall Study|Did not meet incl/excl criteria|1|||
23295774|NCT00892281|64824837|FG001|Overall Study|Did not meet incl/excl criteria|0|||
23295775|NCT00892281|64824836|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
23295776|NCT00892281|64824837|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
23388171|NCT03760666|65165967|FG000|Overall Study|Adverse Event|2|||
23388172|NCT03760666|65165968|FG001|Overall Study|Adverse Event|4|||
23388173|NCT03760666|65165969|FG002|Overall Study|Adverse Event|1|||
23388174|NCT03760666|65165967|FG000|Overall Study|AML Disease Progression|3|||
23388175|NCT03760666|65165968|FG001|Overall Study|AML Disease Progression|3|||
23388176|NCT03760666|65165969|FG002|Overall Study|AML Disease Progression|0|||
23388177|NCT03760666|65165967|FG000|Overall Study|Physician Decision|0|||
23388178|NCT03760666|65165968|FG001|Overall Study|Physician Decision|3|||
23388179|NCT03760666|65165969|FG002|Overall Study|Physician Decision|0|||
23388180|NCT03760666|65165967|FG000|Overall Study|Withdrawal by Subject|0|||
23388181|NCT03760666|65165968|FG001|Overall Study|Withdrawal by Subject|1|||
23388182|NCT03760666|65165969|FG002|Overall Study|Withdrawal by Subject|0|||
23295777|NCT00892281|64824836|FG000|Overall Study|Unable to redeem the drug voucher|1|||
23295778|NCT00892281|64824837|FG001|Overall Study|Unable to redeem the drug voucher|0|||
23388183|NCT01903720|65165975|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
23388184|NCT01903720|65165975|FG000|Overall Study|Adverse Event|1|||
23388185|NCT01903720|65165975|FG000|Overall Study|Rescinding of informed consent|2|||
23388186|NCT01903720|65165975|FG000|Overall Study|Lost to Follow-up|2|||
23388187|NCT01903720|65165975|FG000|Overall Study|Treatment with alternative drug|1|||
23388188|NCT00595075|65165980|FG000|Overall Study|Withdrawal by Subject|1|||
23388189|NCT00595075|65165981|FG001|Overall Study|Withdrawal by Subject|0|||
23388190|NCT03302936|65165983|FG000|Overall Study|Protocol Violation|3|||
23388191|NCT03302936|65165984|FG001|Overall Study|Protocol Violation|4|||
23388192|NCT00736476|65165985|FG000|Overall Study|Adverse Event|1|||
23388193|NCT00736476|65165986|FG001|Overall Study|Adverse Event|0|||
23388194|NCT00576407|65165987|FG000|Overall Study|Death|7|||
23388195|NCT00576407|65165987|FG000|Overall Study|Physician Decision|1|||
23388196|NCT00395512|65165988|FG000|Overall Study|Adverse Event|3|||
23388197|NCT00395512|65165989|FG001|Overall Study|Adverse Event|8|||
23388198|NCT00395512|65165990|FG002|Overall Study|Adverse Event|6|||
23388199|NCT00395512|65165991|FG003|Overall Study|Adverse Event|6|||
23388200|NCT00395512|65165988|FG000|Overall Study|Protocol Violation|2|||
23295779|NCT00892281|64824836|FG000|Overall Study|Subject not good candidate for study|1|||
23295780|NCT00892281|64824837|FG001|Overall Study|Subject not good candidate for study|0|||
23295781|NCT00892281|64824836|FG000|Overall Study|Subject did not return for any visits|1|||
23295782|NCT00892281|64824837|FG001|Overall Study|Subject did not return for any visits|0|||
23295783|NCT00892281|64824836|FG000|Overall Study|Subject missed several visits/lost meds|1|||
23295784|NCT00892281|64824837|FG001|Overall Study|Subject missed several visits/lost meds|0|||
23295785|NCT00892281|64824836|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
23295786|NCT00892281|64824837|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
23295787|NCT00892281|64824836|FG000|Overall Study|Scheduled for knee replacement|0|||
23295788|NCT00892281|64824837|FG001|Overall Study|Scheduled for knee replacement|1|||
23295789|NCT00892281|64824836|FG000|Overall Study|PI complained of inadequate compensation|3|||
23295790|NCT00892281|64824837|FG001|Overall Study|PI complained of inadequate compensation|0|||
23295791|NCT00892281|64824836|FG000|Overall Study|Subject lost interest in program|0|||
23295792|NCT00892281|64824837|FG001|Overall Study|Subject lost interest in program|1|||
23295793|NCT00892281|64824836|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
23295794|NCT00892281|64824837|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
23295795|NCT00892281|64824836|FG000|Overall Study|Death in family|1|||
23295796|NCT00892281|64824837|FG001|Overall Study|Death in family|0|||
23295797|NCT00892281|64824836|FG000|Overall Study|Lack of efficacy of study product|2|||
23388201|NCT00395512|65165989|FG001|Overall Study|Protocol Violation|3|||
23388202|NCT00395512|65165990|FG002|Overall Study|Protocol Violation|6|||
23295798|NCT00892281|64824837|FG001|Overall Study|Lack of efficacy of study product|0|||
23295799|NCT00892281|64824836|FG000|Overall Study|Subject not seen by PI at final visit|1|||
23388203|NCT00395512|65165991|FG003|Overall Study|Protocol Violation|7|||
23388204|NCT00395512|65165988|FG000|Overall Study|Lost to Follow-up|2|||
23388205|NCT00395512|65165989|FG001|Overall Study|Lost to Follow-up|6|||
23388206|NCT00395512|65165990|FG002|Overall Study|Lost to Follow-up|5|||
23388207|NCT00395512|65165991|FG003|Overall Study|Lost to Follow-up|5|||
23388208|NCT00395512|65165988|FG000|Overall Study|Withdrawal by Subject|6|||
23388209|NCT00395512|65165989|FG001|Overall Study|Withdrawal by Subject|5|||
23388210|NCT00395512|65165990|FG002|Overall Study|Withdrawal by Subject|5|||
23388211|NCT00395512|65165991|FG003|Overall Study|Withdrawal by Subject|12|||
23388212|NCT00395512|65165988|FG000|Overall Study|Physician Decision|6|||
23388213|NCT00395512|65165989|FG001|Overall Study|Physician Decision|4|||
23388214|NCT00395512|65165990|FG002|Overall Study|Physician Decision|2|||
23388215|NCT00395512|65165991|FG003|Overall Study|Physician Decision|2|||
23388216|NCT00395512|65165988|FG000|Overall Study|Other|1|||
23388217|NCT00395512|65165989|FG001|Overall Study|Other|1|||
23388218|NCT00395512|65165990|FG002|Overall Study|Other|0|||
23388219|NCT00395512|65165991|FG003|Overall Study|Other|0|||
23388220|NCT00395512|65165988|FG000|Overall Study|Hyperglycemic Rescue|18|||
23388221|NCT00395512|65165989|FG001|Overall Study|Hyperglycemic Rescue|10|||
23388222|NCT00395512|65165990|FG002|Overall Study|Hyperglycemic Rescue|4|||
23388223|NCT00395512|65165991|FG003|Overall Study|Hyperglycemic Rescue|6|||
23388224|NCT02143778|65166002|FG000|Overall Study|Withdrawal by Subject|2|||
23388225|NCT02143778|65166002|FG000|Overall Study|Device malfunction|1|||
23388226|NCT02503865|65166003|FG000|Overall Study|Moved out of area|1|||
23388227|NCT02503865|65166004|FG001|Overall Study|Moved out of area|8|||
23388228|NCT02503865|65166005|FG002|Overall Study|Moved out of area|0|||
23388229|NCT02503865|65166003|FG000|Overall Study|Refused treatment|4|||
23388230|NCT02503865|65166004|FG001|Overall Study|Refused treatment|39|||
23388231|NCT02503865|65166005|FG002|Overall Study|Refused treatment|2|||
23388232|NCT00983957|65166006|FG000|Overall Study|Adverse Event|1|||
23388233|NCT00983957|65166006|FG000|Overall Study|Personal Reasons|1|||
23388234|NCT03954938|65166007|FG000|Overall Study|Withdrawal by Subject|2|||
23388235|NCT03954938|65166007|FG000|Overall Study|Adverse Event|1|||
23494616|NCT00347360|65554987|FG005|Overall Study|Visits conflicted with new job|0|||
23494617|NCT00347360|65554988|FG006|Overall Study|Visits conflicted with new job|1|||
23494618|NCT00347360|65554989|FG007|Overall Study|Visits conflicted with new job|0|||
23295800|NCT00892281|64824837|FG001|Overall Study|Subject not seen by PI at final visit|0|||
23295801|NCT00892281|64824836|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
23295802|NCT00892281|64824837|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
23295803|NCT00892281|64824836|FG000|Overall Study|Missed multiple visits|1|||
23295804|NCT00892281|64824837|FG001|Overall Study|Missed multiple visits|0|||
23295805|NCT00892281|64824836|FG000|Overall Study|Missed visits rescheduled out of window|1|||
23295806|NCT00892281|64824837|FG001|Overall Study|Missed visits rescheduled out of window|0|||
23295807|NCT00892281|64824836|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
23295808|NCT00892281|64824837|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
23295809|NCT00892281|64824836|FG000|Overall Study|Subject had history of drug abuse|1|||
23295810|NCT00892281|64824837|FG001|Overall Study|Subject had history of drug abuse|0|||
23295811|NCT00892281|64824836|FG000|Overall Study|Rash on hand|1|||
23295812|NCT00892281|64824837|FG001|Overall Study|Rash on hand|0|||
23295813|NCT00892281|64824836|FG000|Overall Study|Visit 4 date out of window|1|||
23295814|NCT00892281|64824837|FG001|Overall Study|Visit 4 date out of window|0|||
23295815|NCT02400476|64824838|FG000|Overall Study|Adverse Event|57|||
23295816|NCT02400476|64824839|FG001|Overall Study|Adverse Event|10|||
23295817|NCT02400476|64824840|FG002|Overall Study|Adverse Event|22|||
23295818|NCT02400476|64824841|FG003|Overall Study|Adverse Event|19|||
23295819|NCT02400476|64824842|FG004|Overall Study|Adverse Event|5|||
23295820|NCT02400476|64824843|FG005|Overall Study|Adverse Event|8|||
23295821|NCT02400476|64824838|FG000|Overall Study|Withdrawal by Subject|4|||
23295822|NCT02400476|64824839|FG001|Overall Study|Withdrawal by Subject|1|||
23295823|NCT02400476|64824840|FG002|Overall Study|Withdrawal by Subject|12|||
23295824|NCT02400476|64824841|FG003|Overall Study|Withdrawal by Subject|7|||
23295825|NCT02400476|64824842|FG004|Overall Study|Withdrawal by Subject|5|||
23295826|NCT02400476|64824843|FG005|Overall Study|Withdrawal by Subject|5|||
23295827|NCT02400476|64824838|FG000|Overall Study|Lost to Follow-up|0|||
23295828|NCT02400476|64824839|FG001|Overall Study|Lost to Follow-up|0|||
23295829|NCT02400476|64824840|FG002|Overall Study|Lost to Follow-up|0|||
23295830|NCT02400476|64824841|FG003|Overall Study|Lost to Follow-up|1|||
23295831|NCT02400476|64824842|FG004|Overall Study|Lost to Follow-up|3|||
23295832|NCT02400476|64824843|FG005|Overall Study|Lost to Follow-up|1|||
23295833|NCT02400476|64824838|FG000|Overall Study|Physician Decision|0|||
23295834|NCT02400476|64824839|FG001|Overall Study|Physician Decision|0|||
23295835|NCT02400476|64824840|FG002|Overall Study|Physician Decision|1|||
23295836|NCT02400476|64824841|FG003|Overall Study|Physician Decision|1|||
23388236|NCT04829214|65166008|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
23295837|NCT02400476|64824842|FG004|Overall Study|Physician Decision|0|||
23388237|NCT04829214|65166009|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
23295838|NCT02400476|64824843|FG005|Overall Study|Physician Decision|1|||
23295839|NCT02400476|64824838|FG000|Overall Study|Other, Disease Progression|0|||
23295840|NCT02400476|64824839|FG001|Overall Study|Other, Disease Progression|1|||
23388238|NCT04829214|65166008|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
23388239|NCT04829214|65166009|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
23388240|NCT00425854|65166010|FG000|Overall Study|Progressive Disease|19|||
23295841|NCT02400476|64824840|FG002|Overall Study|Other, Disease Progression|2|||
23295842|NCT02400476|64824841|FG003|Overall Study|Other, Disease Progression|1|||
23295843|NCT02400476|64824842|FG004|Overall Study|Other, Disease Progression|2|||
23295844|NCT02400476|64824843|FG005|Overall Study|Other, Disease Progression|1|||
23295845|NCT02400476|64824838|FG000|Overall Study|Other, Decreased Quality of Life|0|||
23494619|NCT00347360|65554990|FG008|Overall Study|Visits conflicted with new job|0|||
23494620|NCT00347360|65554991|FG009|Overall Study|Visits conflicted with new job|0|||
23494621|NCT00347360|65554992|FG010|Overall Study|Visits conflicted with new job|0|||
23494622|NCT00347360|65554993|FG011|Overall Study|Visits conflicted with new job|0|||
23494623|NCT00347360|65554994|FG012|Overall Study|Visits conflicted with new job|0|||
23494624|NCT00347360|65554995|FG013|Overall Study|Visits conflicted with new job|0|||
23494625|NCT00347360|65554996|FG014|Overall Study|Visits conflicted with new job|0|||
23494626|NCT03307785|65554999|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
23494627|NCT03307785|65555000|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
23494628|NCT03307785|65555001|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
23494629|NCT03307785|65555002|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
23494630|NCT03307785|65555003|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
23494631|NCT03307785|65555004|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
23494632|NCT03307785|65555005|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
23494633|NCT03307785|65555006|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
23494634|NCT03307785|65555007|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
23494635|NCT03307785|65555008|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
23494636|NCT03307785|65555009|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
23494637|NCT03307785|65554999|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
23494638|NCT03307785|65555000|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
23494639|NCT03307785|65555001|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494640|NCT03307785|65555002|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494641|NCT03307785|65555003|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494642|NCT03307785|65555004|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494643|NCT03307785|65555005|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494644|NCT03307785|65555006|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494645|NCT03307785|65555007|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494646|NCT03307785|65555008|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494647|NCT03307785|65555009|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
23494648|NCT03307785|65554999|FG000|Part A: Up to 28.5 Months|Death|4|||
23494649|NCT03307785|65555000|FG001|Part A: Up to 28.5 Months|Death|4|||
23494650|NCT03307785|65555001|FG002|Part A: Up to 28.5 Months|Death|0|||
23494651|NCT03307785|65555002|FG003|Part A: Up to 28.5 Months|Death|0|||
23494652|NCT03307785|65555003|FG004|Part A: Up to 28.5 Months|Death|0|||
23494653|NCT03307785|65555004|FG005|Part A: Up to 28.5 Months|Death|0|||
23494654|NCT03307785|65555005|FG006|Part A: Up to 28.5 Months|Death|0|||
23494655|NCT03307785|65555006|FG007|Part A: Up to 28.5 Months|Death|0|||
23494656|NCT03307785|65555007|FG008|Part A: Up to 28.5 Months|Death|0|||
23494657|NCT03307785|65555008|FG009|Part A: Up to 28.5 Months|Death|0|||
23494658|NCT03307785|65555009|FG010|Part A: Up to 28.5 Months|Death|0|||
23494659|NCT03307785|65554999|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
23494660|NCT03307785|65555000|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
23494661|NCT03307785|65555001|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
23494662|NCT03307785|65555002|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
23494663|NCT03307785|65555003|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
23494664|NCT03307785|65555004|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
23494665|NCT03307785|65555005|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
23494666|NCT03307785|65555006|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
23295846|NCT02400476|64824839|FG001|Overall Study|Other, Decreased Quality of Life|0|||
23295847|NCT02400476|64824840|FG002|Overall Study|Other, Decreased Quality of Life|2|||
23295848|NCT02400476|64824841|FG003|Overall Study|Other, Decreased Quality of Life|0|||
23295849|NCT02400476|64824842|FG004|Overall Study|Other, Decreased Quality of Life|0|||
23295850|NCT02400476|64824843|FG005|Overall Study|Other, Decreased Quality of Life|0|||
23295851|NCT02400476|64824838|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
23295852|NCT02400476|64824839|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
23295853|NCT02400476|64824840|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
23295854|NCT02400476|64824841|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
23295855|NCT02400476|64824842|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
23295856|NCT02400476|64824843|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
23494667|NCT03307785|65555007|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
23494668|NCT03307785|65555008|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
23494669|NCT03307785|65555009|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
23295857|NCT03581188|64824846|FG000|Overall Study|Inclusion criteria not met|3|||
23295858|NCT03581188|64824847|FG001|Overall Study|Inclusion criteria not met|2|||
23295859|NCT03581188|64824846|FG000|Overall Study|Lost to Follow-up|5|||
23494670|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
23295860|NCT03581188|64824847|FG001|Overall Study|Lost to Follow-up|5|||
23295861|NCT03581188|64824846|FG000|Overall Study|Discontinued intervention|11|||
23295862|NCT03581188|64824847|FG001|Overall Study|Discontinued intervention|8|||
23295863|NCT01885182|64824849|FG000|Overall Study|Adverse Event|11|||
23295864|NCT01885182|64824850|FG001|Overall Study|Adverse Event|13|||
23295865|NCT01885182|64824849|FG000|Overall Study|Withdrawal by Subject|13|||
23295866|NCT01885182|64824850|FG001|Overall Study|Withdrawal by Subject|6|||
23388241|NCT00425854|65166011|FG001|Overall Study|Progressive Disease|12|||
23388242|NCT00425854|65166010|FG000|Overall Study|Dose reduction toxicity AE|8|||
23388243|NCT00425854|65166011|FG001|Overall Study|Dose reduction toxicity AE|7|||
23388244|NCT00425854|65166010|FG000|Overall Study|Other Adverse Event|2|||
23388245|NCT00425854|65166011|FG001|Overall Study|Other Adverse Event|2|||
23388246|NCT00985192|65166024|FG000|Overall Study|Withdrawal by Subject|1|||
23388247|NCT00985192|65166024|FG000|Overall Study|Disease Progression|1|||
23388248|NCT00985192|65166024|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
23388249|NCT00754559|65166025|FG000|Overall Study|Adverse Event|15|||
23388250|NCT00754559|65166025|FG000|Overall Study|Protocol Violation|11|||
23388251|NCT00754559|65166025|FG000|Overall Study|Lack of Efficacy|10|||
23388252|NCT00754559|65166025|FG000|Overall Study|Lost to Follow-up|2|||
23388253|NCT00754559|65166025|FG000|Overall Study|Administrative reason|1|||
23388254|NCT00754559|65166025|FG000|Overall Study|Other|5|||
23388255|NCT00754559|65166025|FG000|Overall Study|Withdrawal by Subject|3|||
23388256|NCT01454063|65166026|FG000|Randomized|Adverse Event|1|||
23388257|NCT01454063|65166027|FG001|Randomized|Adverse Event|1|||
23388258|NCT01454063|65166026|FG000|Randomized|Protocol Violation|0|||
23388259|NCT01454063|65166027|FG001|Randomized|Protocol Violation|1|||
23388260|NCT00819832|65166028|FG000|Overall Study|Sponsor Termination of Study|3|||
23388261|NCT00819832|65166029|FG001|Overall Study|Sponsor Termination of Study|0|||
23388262|NCT00819832|65166030|FG002|Overall Study|Sponsor Termination of Study|0|||
23388263|NCT00819832|65166031|FG003|Overall Study|Sponsor Termination of Study|0|||
23388264|NCT00819832|65166032|FG004|Overall Study|Sponsor Termination of Study|0|||
23388265|NCT00819832|65166033|FG005|Overall Study|Sponsor Termination of Study|0|||
23388266|NCT03335566|65166034|FG000|Overall Study|Adverse Event|0|||
23388267|NCT03335566|65166035|FG001|Overall Study|Adverse Event|1|||
23388268|NCT03335566|65166034|FG000|Overall Study|Lost to Follow-up|1|||
23388269|NCT03335566|65166035|FG001|Overall Study|Lost to Follow-up|0|||
23388270|NCT03335566|65166034|FG000|Overall Study|Technical Problems|1|||
23388271|NCT03335566|65166035|FG001|Overall Study|Technical Problems|0|||
23388272|NCT03335566|65166034|FG000|Overall Study|Protocol Violation|1|||
23388273|NCT03335566|65166035|FG001|Overall Study|Protocol Violation|0|||
23388274|NCT03335566|65166034|FG000|Overall Study|Other than specified above|1|||
23388275|NCT03335566|65166035|FG001|Overall Study|Other than specified above|2|||
23388276|NCT01189227|65166039|FG000|Overall Study|Study terminated due to low accrual|6|||
23388277|NCT01189227|65166040|FG001|Overall Study|Study terminated due to low accrual|3|||
23388278|NCT01371565|65166041|FG000|Overall Study|Withdrawal by Subject|1|||
23388279|NCT01371565|65166041|FG000|Overall Study|Death|1|||
23388280|NCT01371565|65166041|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
23388281|NCT04191733|65166046|FG000|Overall Study|Withdrawn due to study closure|13|||
23388282|NCT04191733|65166047|FG001|Overall Study|Withdrawn due to study closure|14|||
23388283|NCT04191733|65166046|FG000|Overall Study|Withdrawal by Subject|2|||
23388284|NCT04191733|65166047|FG001|Overall Study|Withdrawal by Subject|4|||
23388285|NCT04191733|65166046|FG000|Overall Study|Physician Decision|1|||
23388286|NCT04191733|65166047|FG001|Overall Study|Physician Decision|1|||
23388287|NCT04191733|65166046|FG000|Overall Study|Lost to Follow-up|5|||
23388288|NCT04191733|65166047|FG001|Overall Study|Lost to Follow-up|6|||
23388289|NCT04191733|65166046|FG000|Overall Study|Death|0|||
23388290|NCT04191733|65166047|FG001|Overall Study|Death|1|||
23388291|NCT04605588|65166048|FG000|Overall Study|Withdrawal by Subject|1|||
23388292|NCT04605588|65166049|FG001|Overall Study|Withdrawal by Subject|0|||
23388293|NCT02642679|65166050|FG000|Overall Study|Withdrawal by Subject|1|||
23388294|NCT02642679|65166050|FG000|Overall Study|Physician Decision|1|||
23388295|NCT02642679|65166050|FG000|Overall Study|Physician Decision|1|||
23388296|NCT00890097|65166053|FG000|Overall Study|Adverse Event|21|||
23388297|NCT00890097|65166054|FG001|Overall Study|Adverse Event|32|||
23388298|NCT00890097|65166055|FG002|Overall Study|Adverse Event|28|||
23388299|NCT00890097|65166053|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
23494671|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
23295867|NCT01885182|64824849|FG000|Overall Study|Lost to Follow-up|2|||
23388300|NCT00890097|65166054|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
23388301|NCT00890097|65166055|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
23388302|NCT00890097|65166053|FG000|Overall Study|Withdrew Consent|9|||
23388303|NCT00890097|65166054|FG001|Overall Study|Withdrew Consent|6|||
23388304|NCT00890097|65166055|FG002|Overall Study|Withdrew Consent|9|||
23295868|NCT01885182|64824850|FG001|Overall Study|Lost to Follow-up|2|||
23388305|NCT00890097|65166053|FG000|Overall Study|Lost to Follow-up|5|||
23388306|NCT00890097|65166054|FG001|Overall Study|Lost to Follow-up|5|||
23388307|NCT00890097|65166055|FG002|Overall Study|Lost to Follow-up|5|||
23388308|NCT00890097|65166053|FG000|Overall Study|Noncompliance|0|||
23388309|NCT00890097|65166054|FG001|Overall Study|Noncompliance|4|||
23388310|NCT00890097|65166055|FG002|Overall Study|Noncompliance|4|||
23388311|NCT00890097|65166053|FG000|Overall Study|Sponsor Decision|7|||
23388312|NCT00890097|65166054|FG001|Overall Study|Sponsor Decision|11|||
23388313|NCT00890097|65166055|FG002|Overall Study|Sponsor Decision|7|||
23388314|NCT00890097|65166053|FG000|Overall Study|Did not attend final visit|2|||
23388315|NCT00890097|65166054|FG001|Overall Study|Did not attend final visit|3|||
23388316|NCT00890097|65166055|FG002|Overall Study|Did not attend final visit|0|||
23388317|NCT00890097|65166053|FG000|Overall Study|Subject Decision|3|||
23388318|NCT00890097|65166054|FG001|Overall Study|Subject Decision|2|||
23388319|NCT00890097|65166055|FG002|Overall Study|Subject Decision|6|||
23388320|NCT00890097|65166053|FG000|Overall Study|Randomization Error|2|||
23388321|NCT00890097|65166054|FG001|Overall Study|Randomization Error|0|||
23388322|NCT00890097|65166055|FG002|Overall Study|Randomization Error|0|||
23388323|NCT00890097|65166053|FG000|Overall Study|Failed inclusion criteria|3|||
23388324|NCT00890097|65166054|FG001|Overall Study|Failed inclusion criteria|4|||
23388325|NCT00890097|65166055|FG002|Overall Study|Failed inclusion criteria|0|||
23388326|NCT00890097|65166053|FG000|Overall Study|Transportation|0|||
23388327|NCT00890097|65166054|FG001|Overall Study|Transportation|2|||
23388328|NCT00890097|65166055|FG002|Overall Study|Transportation|0|||
23388329|NCT00890097|65166053|FG000|Overall Study|Subject Moved|0|||
23388330|NCT00890097|65166054|FG001|Overall Study|Subject Moved|4|||
23388331|NCT00890097|65166055|FG002|Overall Study|Subject Moved|0|||
23388332|NCT00890097|65166053|FG000|Overall Study|Protocol Deviation|1|||
23388333|NCT00890097|65166054|FG001|Overall Study|Protocol Deviation|1|||
23388334|NCT00890097|65166055|FG002|Overall Study|Protocol Deviation|1|||
23388335|NCT00231465|65166056|FG000|Overall Study|Completed only one cycle|1|||
23388336|NCT00231465|65166056|FG000|Overall Study|Did not have follow up CT scans|1|||
23388337|NCT01341990|65166059|FG000|Overall Study|Adverse Event|0|||
23388338|NCT01341990|65166060|FG001|Overall Study|Adverse Event|1|||
23388339|NCT01341990|65166059|FG000|Overall Study|Torn Study Lens|1|||
23388340|NCT01341990|65166060|FG001|Overall Study|Torn Study Lens|0|||
23388341|NCT01341990|65166059|FG000|Overall Study|Withdrawal by Subject|2|||
23295869|NCT01885182|64824849|FG000|Overall Study|Lack of Efficacy|8|||
23295870|NCT01885182|64824850|FG001|Overall Study|Lack of Efficacy|1|||
23295871|NCT00880087|64824851|FG000|Overall Study|Lost to Follow-up|0|||
23295872|NCT00880087|64824852|FG001|Overall Study|Lost to Follow-up|2|||
23295873|NCT02751827|64824853|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
23295874|NCT02751827|64824854|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
23295875|NCT02751827|64824855|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
23295876|NCT01933919|64824856|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
23295877|NCT01933919|64824857|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
23388342|NCT01341990|65166060|FG001|Overall Study|Withdrawal by Subject|0|||
23295878|NCT01933919|64824856|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
23295879|NCT01933919|64824857|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
23388343|NCT02829957|65166063|FG000|Overall Study|Lost to Follow-up|2|||
23388344|NCT02829957|65166064|FG001|Overall Study|Lost to Follow-up|1|||
23388345|NCT00489476|65168704|FG000|Overall Study|Lost to Follow-up|0|||
23388346|NCT00489476|65168705|FG001|Overall Study|Lost to Follow-up|1|||
23388347|NCT00489476|65168706|FG002|Overall Study|Lost to Follow-up|0|||
23295880|NCT01933919|64824856|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
23295881|NCT01933919|64824857|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
23295882|NCT01933919|64824856|FG000|Open-label Long-term Phase|Adverse Event|2|||
23295883|NCT01933919|64824857|FG001|Open-label Long-term Phase|Adverse Event|0|||
23295884|NCT01933919|64824856|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
23295885|NCT01933919|64824857|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
23295886|NCT01933919|64824856|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
23295887|NCT01933919|64824857|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
23295888|NCT01933919|64824856|FG000|Open-label Long-term Phase|Other|1|||
23295889|NCT01933919|64824857|FG001|Open-label Long-term Phase|Other|2|||
23295890|NCT00706992|64824864|FG000|Overall Study|Study termination|5|||
23295891|NCT00706992|64824865|FG001|Overall Study|Study termination|5|||
23295892|NCT00706992|64824866|FG002|Overall Study|Study termination|6|||
23295893|NCT00706992|64824867|FG003|Overall Study|Study termination|2|||
23295894|NCT00706992|64824868|FG004|Overall Study|Study termination|3|||
23295895|NCT00706992|64824869|FG005|Overall Study|Study termination|2|||
23295896|NCT00706992|64824870|FG006|Overall Study|Study termination|3|||
23295897|NCT00706992|64824864|FG000|Overall Study|Disease progression before treatment|0|||
23295898|NCT00706992|64824865|FG001|Overall Study|Disease progression before treatment|0|||
23295899|NCT00706992|64824866|FG002|Overall Study|Disease progression before treatment|0|||
23295900|NCT00706992|64824867|FG003|Overall Study|Disease progression before treatment|0|||
23295901|NCT00706992|64824868|FG004|Overall Study|Disease progression before treatment|1|||
23388348|NCT00489476|65168707|FG003|Overall Study|Lost to Follow-up|0|||
23388349|NCT01362530|65168708|FG000|Base Study (Cycle 1)|Adverse Event|2|||
23388350|NCT01362530|65168709|FG001|Base Study (Cycle 1)|Adverse Event|0|||
23388351|NCT01362530|65168708|FG000|Base Study (Cycle 1)|Physician Decision|0|||
23494672|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
23494673|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
23295902|NCT00706992|64824869|FG005|Overall Study|Disease progression before treatment|0|||
23295903|NCT00706992|64824870|FG006|Overall Study|Disease progression before treatment|0|||
23295904|NCT02695719|64824871|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
23295905|NCT02695719|64824872|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
23295906|NCT02695719|64824871|FG000|Overall Study|Significant Protocol Deviation|0|||
23295907|NCT02695719|64824872|FG001|Overall Study|Significant Protocol Deviation|1|||
23295908|NCT02695719|64824871|FG000|Overall Study|Voluntary Withdrawal|1|||
23295909|NCT02695719|64824872|FG001|Overall Study|Voluntary Withdrawal|0|||
23295910|NCT00412737|64824873|FG000|Overall Study|Death|1|||
23295911|NCT00412737|64824874|FG001|Overall Study|Death|0|||
23295912|NCT00412737|64824873|FG000|Overall Study|Adverse Event|3|||
23295913|NCT00412737|64824874|FG001|Overall Study|Adverse Event|2|||
23295914|NCT00412737|64824873|FG000|Overall Study|Refused Treatment|6|||
23295915|NCT00412737|64824874|FG001|Overall Study|Refused Treatment|2|||
23295916|NCT00412737|64824873|FG000|Overall Study|Failure to Return|6|||
23295917|NCT00412737|64824874|FG001|Overall Study|Failure to Return|2|||
23295918|NCT05069155|64824882|FG000|Overall Study|Withdrawal by Subject|1|||
23295919|NCT05069155|64824883|FG001|Overall Study|Withdrawal by Subject|3|||
23295920|NCT00567476|64824888|FG000|Overall Study|Adverse Event|2|||
23295921|NCT00567476|64824889|FG001|Overall Study|Adverse Event|0|||
23295922|NCT00567476|64824888|FG000|Overall Study|Pregnancy|1|||
23295923|NCT00567476|64824889|FG001|Overall Study|Pregnancy|0|||
23295924|NCT00567476|64824888|FG000|Overall Study|Protocol Violation|4|||
23295925|NCT00567476|64824889|FG001|Overall Study|Protocol Violation|1|||
23295926|NCT00567476|64824888|FG000|Overall Study|Lost to Follow-up|0|||
23295927|NCT00567476|64824889|FG001|Overall Study|Lost to Follow-up|1|||
23295928|NCT00567476|64824888|FG000|Overall Study|Administrative issues|1|||
23295929|NCT00567476|64824889|FG001|Overall Study|Administrative issues|0|||
23295930|NCT00567476|64824888|FG000|Overall Study|Medical Decision|0|||
23295931|NCT00567476|64824889|FG001|Overall Study|Medical Decision|1|||
23295932|NCT00567476|64824888|FG000|Overall Study|Non-adherence to protocol|0|||
23295933|NCT00567476|64824889|FG001|Overall Study|Non-adherence to protocol|1|||
23295938|NCT04403399|64824894|FG000|Period 2|Physician Decision|0|||
23295939|NCT04403399|64824895|FG001|Period 2|Physician Decision|1|||
23295940|NCT01253317|64824896|FG000|Overall Study|Adverse Event|2|||
23295941|NCT00966381|64824898|FG000|Overall Study|Withdrawal by Subject|2|||
23295942|NCT00966381|64824899|FG001|Overall Study|Withdrawal by Subject|2|||
23295943|NCT02792218|64824904|FG000|Overall Study|Patient/guardian decision|15|||
23295944|NCT02792218|64824905|FG001|Overall Study|Patient/guardian decision|42|||
23295945|NCT02792218|64824904|FG000|Overall Study|Adverse Event|15|||
23295946|NCT02792218|64824905|FG001|Overall Study|Adverse Event|14|||
23295947|NCT02792218|64824904|FG000|Overall Study|Lost to Follow-up|10|||
23295948|NCT02792218|64824905|FG001|Overall Study|Lost to Follow-up|5|||
23388352|NCT01362530|65168709|FG001|Base Study (Cycle 1)|Physician Decision|1|||
23494674|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
23494675|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
23494676|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
23295949|NCT02792218|64824904|FG000|Overall Study|Lack of Efficacy|1|||
23295950|NCT02792218|64824905|FG001|Overall Study|Lack of Efficacy|12|||
23295951|NCT02792218|64824904|FG000|Overall Study|Physician Decision|4|||
23295952|NCT02792218|64824905|FG001|Overall Study|Physician Decision|4|||
23295953|NCT02792218|64824904|FG000|Overall Study|Protocol deviation|3|||
23295954|NCT02792218|64824905|FG001|Overall Study|Protocol deviation|2|||
23295955|NCT02792218|64824904|FG000|Overall Study|New therapy for study indication|0|||
23295956|NCT02792218|64824905|FG001|Overall Study|New therapy for study indication|1|||
23388353|NCT01362530|65168708|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
23388354|NCT01362530|65168709|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
23388355|NCT01362530|65168708|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
23388356|NCT01362530|65168709|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
23388357|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
23388358|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
23388359|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
23388360|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
23388361|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
23388362|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
23388363|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
23388364|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
23388365|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
23388366|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
23388367|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
23388368|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
23388369|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
23388370|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
23388371|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
23388372|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
23388373|NCT01362530|65168708|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
23494677|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
23295957|NCT02792218|64824904|FG000|Overall Study|Non-compliance with study treatment|0|||
23295958|NCT02792218|64824905|FG001|Overall Study|Non-compliance with study treatment|1|||
23295959|NCT02792218|64824904|FG000|Overall Study|Pregnancy|1|||
23295960|NCT02792218|64824905|FG001|Overall Study|Pregnancy|0|||
23295961|NCT00865098|64824906|FG000|Overall Study|Progressive disease|1|||
23295962|NCT00977431|64824910|FG000|Overall Study|Other than listed|1|||
23295963|NCT00977431|64824911|FG001|Overall Study|Other than listed|0|||
23295964|NCT00977431|64824912|FG002|Overall Study|Other than listed|0|||
23295965|NCT00977431|64824913|FG003|Overall Study|Other than listed|0|||
23295966|NCT00977431|64824914|FG004|Overall Study|Other than listed|2|||
23295967|NCT00977431|64824910|FG000|Overall Study|Protocol Violation|0|||
23295968|NCT00977431|64824911|FG001|Overall Study|Protocol Violation|0|||
23295969|NCT00977431|64824912|FG002|Overall Study|Protocol Violation|1|||
23295970|NCT00977431|64824913|FG003|Overall Study|Protocol Violation|0|||
23295971|NCT00977431|64824914|FG004|Overall Study|Protocol Violation|0|||
23295972|NCT00977431|64824910|FG000|Overall Study|Adverse Event|3|||
23295973|NCT00977431|64824911|FG001|Overall Study|Adverse Event|0|||
23295974|NCT00977431|64824912|FG002|Overall Study|Adverse Event|4|||
23295975|NCT00977431|64824913|FG003|Overall Study|Adverse Event|0|||
23295976|NCT00977431|64824914|FG004|Overall Study|Adverse Event|6|||
23295977|NCT00977431|64824910|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
23295978|NCT00977431|64824911|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
23295979|NCT00977431|64824912|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
23295980|NCT00977431|64824913|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
23295981|NCT00977431|64824914|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
23295982|NCT00977431|64824910|FG000|Overall Study|Progressive disease|2|||
23295983|NCT00977431|64824911|FG001|Overall Study|Progressive disease|6|||
23295984|NCT00977431|64824912|FG002|Overall Study|Progressive disease|1|||
23295985|NCT00977431|64824913|FG003|Overall Study|Progressive disease|3|||
23295986|NCT00977431|64824914|FG004|Overall Study|Progressive disease|5|||
23295987|NCT01765270|64824926|FG000|Overall Study|Physician Decision|1|||
23388374|NCT01362530|65168709|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
23388375|NCT02633527|65168710|FG000|Overall Study|Failed to meet eligibility|0|||
23388376|NCT02633527|65168711|FG001|Overall Study|Failed to meet eligibility|1|||
23388377|NCT02633527|65168712|FG002|Overall Study|Failed to meet eligibility|1|||
23388378|NCT02633527|65168713|FG003|Overall Study|Failed to meet eligibility|0|||
23388379|NCT02633527|65168714|FG004|Overall Study|Failed to meet eligibility|1|||
23388380|NCT02633527|65168710|FG000|Overall Study|Adverse Event|0|||
23388381|NCT02633527|65168711|FG001|Overall Study|Adverse Event|4|||
23388382|NCT02633527|65168712|FG002|Overall Study|Adverse Event|3|||
23388383|NCT02633527|65168713|FG003|Overall Study|Adverse Event|1|||
23388384|NCT02633527|65168714|FG004|Overall Study|Adverse Event|5|||
23388385|NCT02633527|65168710|FG000|Overall Study|Lost to Follow-up|1|||
23388386|NCT02633527|65168711|FG001|Overall Study|Lost to Follow-up|2|||
23388387|NCT02633527|65168712|FG002|Overall Study|Lost to Follow-up|5|||
23388388|NCT02633527|65168713|FG003|Overall Study|Lost to Follow-up|5|||
23388389|NCT02633527|65168714|FG004|Overall Study|Lost to Follow-up|4|||
23388390|NCT02633527|65168710|FG000|Overall Study|Withdrawal by Subject|0|||
23388391|NCT02633527|65168711|FG001|Overall Study|Withdrawal by Subject|3|||
23388392|NCT02633527|65168712|FG002|Overall Study|Withdrawal by Subject|5|||
23494678|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
23295988|NCT01765270|64824927|FG001|Overall Study|Physician Decision|0|||
23295989|NCT01765270|64824926|FG000|Overall Study|Withdrawal by Subject|0|||
23388393|NCT02633527|65168713|FG003|Overall Study|Withdrawal by Subject|4|||
23388394|NCT02633527|65168714|FG004|Overall Study|Withdrawal by Subject|4|||
23388395|NCT02633527|65168710|FG000|Overall Study|Protocol Violation|0|||
23388396|NCT02633527|65168711|FG001|Overall Study|Protocol Violation|1|||
23388397|NCT02633527|65168712|FG002|Overall Study|Protocol Violation|1|||
23388398|NCT02633527|65168713|FG003|Overall Study|Protocol Violation|1|||
23388399|NCT02633527|65168714|FG004|Overall Study|Protocol Violation|1|||
23388400|NCT02633527|65168710|FG000|Overall Study|Physician Decision|0|||
23388401|NCT02633527|65168711|FG001|Overall Study|Physician Decision|0|||
23388402|NCT02633527|65168712|FG002|Overall Study|Physician Decision|0|||
23388403|NCT02633527|65168713|FG003|Overall Study|Physician Decision|0|||
23388404|NCT02633527|65168714|FG004|Overall Study|Physician Decision|1|||
23388405|NCT02633527|65168710|FG000|Overall Study|Administrative reason|1|||
23388406|NCT02633527|65168711|FG001|Overall Study|Administrative reason|0|||
23388407|NCT02633527|65168712|FG002|Overall Study|Administrative reason|0|||
23388408|NCT02633527|65168713|FG003|Overall Study|Administrative reason|1|||
23388409|NCT02633527|65168714|FG004|Overall Study|Administrative reason|0|||
23388410|NCT02633527|65168710|FG000|Overall Study|Multiple reasons|1|||
23388411|NCT02633527|65168711|FG001|Overall Study|Multiple reasons|0|||
23388412|NCT02633527|65168712|FG002|Overall Study|Multiple reasons|2|||
23388413|NCT02633527|65168713|FG003|Overall Study|Multiple reasons|2|||
23388414|NCT02633527|65168714|FG004|Overall Study|Multiple reasons|1|||
23388415|NCT00107614|65168716|FG000|Overall Study|Physician Decision|10|||
23388416|NCT00107614|65168716|FG000|Overall Study|Death|2|||
23388417|NCT01903733|65168717|FG000|Overall Study|Death|23|||
23295990|NCT01765270|64824927|FG001|Overall Study|Withdrawal by Subject|1|||
23295991|NCT01552369|64824935|FG000|Overall Study|Did not consent to extended follow up|8|||
23295992|NCT01552369|64824936|FG001|Overall Study|Did not consent to extended follow up|9|||
23295993|NCT00605917|64824937|FG000|Overall Study|Protocol Violation|79|||
23295994|NCT00202839|64824944|FG000|Overall Study|Adverse Event|1|||
23295995|NCT00202839|64824945|FG001|Overall Study|Adverse Event|5|||
23295996|NCT00202839|64824944|FG000|Overall Study|Physician Decision|12|||
23295997|NCT00202839|64824945|FG001|Overall Study|Physician Decision|0|||
23295998|NCT00202839|64824944|FG000|Overall Study|Withdrawal by Subject|6|||
23295999|NCT00202839|64824945|FG001|Overall Study|Withdrawal by Subject|2|||
23296000|NCT00202839|64824944|FG000|Overall Study|Protocol Violation|2|||
23296001|NCT00202839|64824945|FG001|Overall Study|Protocol Violation|1|||
23296002|NCT00202839|64824944|FG000|Overall Study|Lost to Follow-up|3|||
23296003|NCT00202839|64824945|FG001|Overall Study|Lost to Follow-up|2|||
23296004|NCT03395639|64824948|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
23296005|NCT03395639|64824949|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
23296006|NCT03395639|64824950|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
23296007|NCT03395639|64824948|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
23296008|NCT03395639|64824949|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
23296009|NCT03395639|64824950|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
23296010|NCT03395639|64824948|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
23296011|NCT03395639|64824949|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
23296012|NCT03395639|64824950|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
23296013|NCT03395639|64824948|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
23296014|NCT03395639|64824949|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
23296015|NCT03395639|64824950|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
23296016|NCT03395639|64824948|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
23296017|NCT03395639|64824949|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
23296018|NCT03395639|64824950|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
23388418|NCT01903733|65168718|FG001|Overall Study|Death|54|||
23388419|NCT01903733|65168719|FG002|Overall Study|Death|30|||
23388420|NCT01903733|65168720|FG003|Overall Study|Death|98|||
23388421|NCT01903733|65168717|FG000|Overall Study|Participant refused further follow-up|35|||
23388422|NCT01903733|65168718|FG001|Overall Study|Participant refused further follow-up|38|||
23388423|NCT01903733|65168719|FG002|Overall Study|Participant refused further follow-up|13|||
23296019|NCT03166124|64824952|FG000|Treatment Period 1|Adverse Event|0|||
23296020|NCT03166124|64824953|FG001|Treatment Period 1|Adverse Event|0|||
23296021|NCT03166124|64824954|FG002|Treatment Period 1|Adverse Event|1|||
23296022|NCT03166124|64824955|FG003|Treatment Period 1|Adverse Event|0|||
23296023|NCT03166124|64824952|FG000|Wash-out Period|Withdrawal by Subject|0|||
23388424|NCT01903733|65168720|FG003|Overall Study|Participant refused further follow-up|9|||
23296024|NCT03166124|64824953|FG001|Wash-out Period|Withdrawal by Subject|1|||
23296025|NCT03166124|64824954|FG002|Wash-out Period|Withdrawal by Subject|0|||
23296026|NCT03166124|64824955|FG003|Wash-out Period|Withdrawal by Subject|1|||
23296027|NCT03166124|64824952|FG000|Wash-out Period|Adverse Event|0|||
23296028|NCT03166124|64824953|FG001|Wash-out Period|Adverse Event|1|||
23296029|NCT03166124|64824954|FG002|Wash-out Period|Adverse Event|1|||
23296030|NCT03166124|64824955|FG003|Wash-out Period|Adverse Event|0|||
23296031|NCT01049412|64824956|FG000|Period I|Withdrawal by Subject|4|||
23296032|NCT01049412|64824957|FG001|Period I|Withdrawal by Subject|6|||
23296033|NCT01049412|64824956|FG000|Period I|Lost to Follow-up|2|||
23296034|NCT01049412|64824957|FG001|Period I|Lost to Follow-up|2|||
23388425|NCT01903733|65168717|FG000|Overall Study|Lost to Follow-up|18|||
23388426|NCT01903733|65168718|FG001|Overall Study|Lost to Follow-up|19|||
23388427|NCT01903733|65168719|FG002|Overall Study|Lost to Follow-up|6|||
23388428|NCT01903733|65168720|FG003|Overall Study|Lost to Follow-up|9|||
23388429|NCT01903733|65168717|FG000|Overall Study|Other|10|||
23388430|NCT01903733|65168718|FG001|Overall Study|Other|15|||
23388431|NCT01903733|65168719|FG002|Overall Study|Other|12|||
23388432|NCT01903733|65168720|FG003|Overall Study|Other|3|||
23388433|NCT01903733|65168717|FG000|Overall Study|Missing|2|||
23296035|NCT01049412|64824956|FG000|Period I|Physician Decision|0|||
23296036|NCT01049412|64824957|FG001|Period I|Physician Decision|3|||
23296037|NCT01049412|64824956|FG000|Period I|Protocol Violation|1|||
23296038|NCT01049412|64824957|FG001|Period I|Protocol Violation|2|||
23296039|NCT01049412|64824956|FG000|Period I|Adverse Event|1|||
23296040|NCT01049412|64824957|FG001|Period I|Adverse Event|0|||
23296041|NCT01049412|64824956|FG000|Period II|Withdrawal by Subject|2|||
23296042|NCT01049412|64824957|FG001|Period II|Withdrawal by Subject|3|||
23296043|NCT01049412|64824956|FG000|Period II|Adverse Event|1|||
23388434|NCT01903733|65168718|FG001|Overall Study|Missing|0|||
23388435|NCT01903733|65168719|FG002|Overall Study|Missing|0|||
23388436|NCT01903733|65168720|FG003|Overall Study|Missing|0|||
23388437|NCT01903733|65168717|FG000|Overall Study|Investigator request|18|||
23388438|NCT01903733|65168718|FG001|Overall Study|Investigator request|0|||
23388439|NCT01903733|65168719|FG002|Overall Study|Investigator request|0|||
23388440|NCT01903733|65168720|FG003|Overall Study|Investigator request|0|||
23388441|NCT00052715|65168722|FG000|Overall Study|wrong histology|1|||
23388442|NCT03721965|65168723|FG000|Overall Study|Death|1|||
23388443|NCT03721965|65168723|FG000|Overall Study|Study Terminated by Sponsor|1|||
23388444|NCT02100644|65168726|FG000|LTG Escalation Phase|Adverse Event|9|||
23388445|NCT02100644|65168727|FG001|LTG Escalation Phase|Adverse Event|0|||
23388446|NCT02100644|65168728|FG002|LTG Escalation Phase|Adverse Event|0|||
23388447|NCT02100644|65168726|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
23388448|NCT02100644|65168727|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
23388449|NCT02100644|65168728|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
23388450|NCT02100644|65168726|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
23388451|NCT02100644|65168727|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
23388452|NCT02100644|65168728|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
23388453|NCT03048019|65168729|FG000|Overall Study|Adverse Event|1|||
23388454|NCT03048019|65168730|FG001|Overall Study|Adverse Event|0|||
23388455|NCT04634331|65168731|FG000|Overall Study|Withdrawal by Subject|2|||
23388456|NCT04634331|65168732|FG001|Overall Study|Withdrawal by Subject|2|||
23388457|NCT02837952|65168734|FG000|Overall Study|Adverse Event|0|||
23388458|NCT02837952|65168735|FG001|Overall Study|Adverse Event|1|||
23388459|NCT02837952|65168734|FG000|Overall Study|Withdrawal by Subject|4|||
23388460|NCT02837952|65168735|FG001|Overall Study|Withdrawal by Subject|5|||
23388461|NCT02837952|65168734|FG000|Overall Study|Medication Error|1|||
23388462|NCT02837952|65168735|FG001|Overall Study|Medication Error|0|||
23388463|NCT01786109|65168736|FG000|Overall Study|fail manometry barostat tube placement|1|||
23388464|NCT01786109|65168737|FG001|Overall Study|fail manometry barostat tube placement|0|||
23388465|NCT01786109|65168738|FG002|Overall Study|fail manometry barostat tube placement|0|||
23494679|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
23494680|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
23296044|NCT01049412|64824957|FG001|Period II|Adverse Event|0|||
23296045|NCT01049412|64824956|FG000|Period II|Lost to Follow-up|1|||
23296046|NCT01049412|64824957|FG001|Period II|Lost to Follow-up|0|||
23296047|NCT00810602|64824958|FG000|Overall Study|Withdrawal by Subject|8|||
23296048|NCT00810602|64824959|FG001|Overall Study|Withdrawal by Subject|3|||
23296049|NCT02846883|64824962|FG000|Overall Study|Death|0|||
23296050|NCT02846883|64824963|FG001|Overall Study|Death|1|||
23296051|NCT02846883|64824964|FG002|Overall Study|Death|1|||
23388466|NCT01786109|65168736|FG000|Overall Study|unrelated illness|0|||
23388467|NCT01786109|65168737|FG001|Overall Study|unrelated illness|0|||
23388468|NCT01786109|65168738|FG002|Overall Study|unrelated illness|1|||
23388469|NCT01786109|65168736|FG000|Overall Study|adverse effects colon preparation|0|||
23388470|NCT01786109|65168737|FG001|Overall Study|adverse effects colon preparation|0|||
23388471|NCT01786109|65168738|FG002|Overall Study|adverse effects colon preparation|1|||
23388472|NCT00236197|65168740|FG000|Overall Study|Withdrawal by Subject|3|||
23388473|NCT00236197|65168741|FG001|Overall Study|Withdrawal by Subject|2|||
23388474|NCT00236197|65168740|FG000|Overall Study|Lost to Follow-up|1|||
23388475|NCT00236197|65168741|FG001|Overall Study|Lost to Follow-up|5|||
23388476|NCT00236197|65168740|FG000|Overall Study|Protocol Violation|0|||
23388477|NCT00236197|65168741|FG001|Overall Study|Protocol Violation|3|||
23388478|NCT00236197|65168740|FG000|Overall Study|Medication non-compliance|1|||
23388479|NCT00236197|65168741|FG001|Overall Study|Medication non-compliance|2|||
23388480|NCT00236197|65168740|FG000|Overall Study|Other|0|||
23388481|NCT00236197|65168741|FG001|Overall Study|Other|2|||
23388482|NCT04065841|65168743|FG000|Overall Study|Adverse Event|4|||
23388483|NCT04065841|65168744|FG001|Overall Study|Adverse Event|2|||
23388484|NCT04065841|65168745|FG002|Overall Study|Adverse Event|10|||
23388485|NCT04065841|65168746|FG003|Overall Study|Adverse Event|1|||
23388486|NCT04065841|65168743|FG000|Overall Study|Lost to Follow-up|1|||
23296052|NCT02846883|64824962|FG000|Overall Study|Lost to Follow-up|0|||
23296053|NCT02846883|64824963|FG001|Overall Study|Lost to Follow-up|0|||
23296054|NCT02846883|64824964|FG002|Overall Study|Lost to Follow-up|1|||
23296055|NCT02846883|64824962|FG000|Overall Study|Withdrawal by Subject|1|||
23296056|NCT02846883|64824963|FG001|Overall Study|Withdrawal by Subject|0|||
23296057|NCT02846883|64824964|FG002|Overall Study|Withdrawal by Subject|0|||
23296058|NCT02846883|64824962|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
23296059|NCT02846883|64824963|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
23296060|NCT02846883|64824964|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
23296061|NCT02846883|64824962|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
23296062|NCT02846883|64824963|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
23296063|NCT02846883|64824964|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
23296064|NCT03176784|64824973|FG000|Overall Study|Lost to Follow-up|77|||
23296065|NCT03176784|64824974|FG001|Overall Study|Lost to Follow-up|79|||
23296066|NCT03176784|64824975|FG002|Overall Study|Lost to Follow-up|79|||
23296067|NCT03176784|64824976|FG003|Overall Study|Lost to Follow-up|49|||
23296068|NCT03176784|64824973|FG000|Overall Study|Withdrawal by Subject|28|||
23296069|NCT03176784|64824974|FG001|Overall Study|Withdrawal by Subject|34|||
23296070|NCT03176784|64824975|FG002|Overall Study|Withdrawal by Subject|34|||
23296071|NCT03176784|64824976|FG003|Overall Study|Withdrawal by Subject|21|||
23296072|NCT04776746|64824979|FG000|Overall Study|Study terminated by sponsor|61|||
23296073|NCT04776746|64824979|FG000|Overall Study|Adverse Event|5|||
23296074|NCT04776746|64824979|FG000|Overall Study|Death|4|||
23296075|NCT04776746|64824979|FG000|Overall Study|Lack of Efficacy|3|||
23296076|NCT04776746|64824979|FG000|Overall Study|Noncompliance with study drug|2|||
23296077|NCT04776746|64824979|FG000|Overall Study|Not related to COVID-19|2|||
23296078|NCT03870477|64824980|FG000|Overall Study|Early Study Termination|1|||
23296079|NCT02244424|64824981|FG000|Overall Study|Lost to Follow-up|20|||
23296080|NCT02244424|64824982|FG001|Overall Study|Lost to Follow-up|10|||
23296081|NCT02418455|64824992|FG000|48-Week Treatment Period|Other- Not Specified|1|||
23296082|NCT02418455|64824992|FG000|Continuation Period|Sponsor Decision|7|||
23296083|NCT01765751|64824993|FG000|Overall Study|Lost to Follow-up|0|||
23296084|NCT01765751|64824994|FG001|Overall Study|Lost to Follow-up|2|||
23296085|NCT01765751|64824995|FG002|Overall Study|Lost to Follow-up|1|||
23296086|NCT01857206|64824996|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
23296087|NCT01857206|64824997|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
23296088|NCT01857206|64824996|FG000|Overall Study|Lost to Follow-up|9|||
23296089|NCT01857206|64824997|FG001|Overall Study|Lost to Follow-up|6|||
23296090|NCT01857206|64824996|FG000|Overall Study|Unclassified|3|||
23296091|NCT01857206|64824997|FG001|Overall Study|Unclassified|3|||
23388487|NCT04065841|65168744|FG001|Overall Study|Lost to Follow-up|2|||
23388488|NCT04065841|65168745|FG002|Overall Study|Lost to Follow-up|2|||
23296092|NCT01857206|64824996|FG000|Overall Study|Withdrawal by Subject|1|||
23296093|NCT01857206|64824997|FG001|Overall Study|Withdrawal by Subject|0|||
23296094|NCT01754376|64824998|FG000|Overall Study|Adverse Event|1|||
23296095|NCT01754376|64824998|FG000|Overall Study|Lack of Efficacy|2|||
23296096|NCT01660022|64824999|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
23296097|NCT01660022|64825000|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
23388489|NCT04065841|65168746|FG003|Overall Study|Lost to Follow-up|2|||
23388490|NCT04065841|65168743|FG000|Overall Study|Physician Decision|1|||
23388491|NCT04065841|65168744|FG001|Overall Study|Physician Decision|0|||
23296098|NCT01660022|64825001|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
23296099|NCT01660022|64825002|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
23296100|NCT01660022|64825003|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
23296101|NCT01660022|64825004|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
23296102|NCT01660022|64824999|FG000|First Sequence (7 Days)|Adverse Event|0|||
23296103|NCT01660022|64825000|FG001|First Sequence (7 Days)|Adverse Event|0|||
23296104|NCT01660022|64825001|FG002|First Sequence (7 Days)|Adverse Event|0|||
23296105|NCT01660022|64825002|FG003|First Sequence (7 Days)|Adverse Event|0|||
23296106|NCT01660022|64825003|FG004|First Sequence (7 Days)|Adverse Event|1|||
23296107|NCT01660022|64825004|FG005|First Sequence (7 Days)|Adverse Event|3|||
23296108|NCT01660022|64824999|FG000|First Sequence (7 Days)|Protocol Violation|0|||
23296109|NCT01660022|64825000|FG001|First Sequence (7 Days)|Protocol Violation|0|||
23296110|NCT01660022|64825001|FG002|First Sequence (7 Days)|Protocol Violation|0|||
23296111|NCT01660022|64825002|FG003|First Sequence (7 Days)|Protocol Violation|0|||
23296112|NCT01660022|64825003|FG004|First Sequence (7 Days)|Protocol Violation|0|||
23296113|NCT01660022|64825004|FG005|First Sequence (7 Days)|Protocol Violation|1|||
23296114|NCT01020526|64825009|FG000|Overall Study|Withdrawal by Subject|5|||
23296115|NCT01020526|64825009|FG000|Overall Study|Other reasons|3|||
23296116|NCT01020526|64825009|FG000|Overall Study|Insufficient clinical response|3|||
23296117|NCT01020526|64825009|FG000|Overall Study|Lost to Follow-up|1|||
23296118|NCT01020526|64825009|FG000|Overall Study|Adverse Event|2|||
23296119|NCT03629028|64825010|FG000|Overall Study|Lost to Follow-up|26|||
23296120|NCT03629028|64825011|FG001|Overall Study|Lost to Follow-up|23|||
23296121|NCT03629028|64825010|FG000|Overall Study|Pregnancy|4|||
23296122|NCT03629028|64825011|FG001|Overall Study|Pregnancy|2|||
23296123|NCT03629028|64825010|FG000|Overall Study|intolerance to examination|2|||
23296124|NCT03629028|64825011|FG001|Overall Study|intolerance to examination|0|||
23296125|NCT04213209|64825013|FG000|Overall Study|Protocol Violation|1|||
23296126|NCT04213209|64825014|FG001|Overall Study|Protocol Violation|0|||
23296127|NCT04213209|64825015|FG002|Overall Study|Protocol Violation|0|||
23296128|NCT04213209|64825016|FG003|Overall Study|Protocol Violation|0|||
23296129|NCT04213209|64825017|FG004|Overall Study|Protocol Violation|0|||
23296130|NCT04213209|64825018|FG005|Overall Study|Protocol Violation|0|||
23296131|NCT04234464|64825021|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
23296132|NCT04234464|64825022|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
23296133|NCT01392326|64825023|FG000|Overall Study|Death|2|||
23296134|NCT01392326|64825024|FG001|Overall Study|Death|0|||
23296135|NCT01392326|64825025|FG002|Overall Study|Death|0|||
23296136|NCT01392326|64825023|FG000|Overall Study|Withdrawal by Subject|12|||
23296137|NCT01392326|64825024|FG001|Overall Study|Withdrawal by Subject|11|||
23296138|NCT01392326|64825025|FG002|Overall Study|Withdrawal by Subject|15|||
23296139|NCT01392326|64825023|FG000|Overall Study|Protocol Violation|2|||
23296140|NCT01392326|64825024|FG001|Overall Study|Protocol Violation|0|||
23296141|NCT01392326|64825025|FG002|Overall Study|Protocol Violation|0|||
23296142|NCT01392326|64825023|FG000|Overall Study|Pregnancy|0|||
23296143|NCT01392326|64825024|FG001|Overall Study|Pregnancy|0|||
23296144|NCT01392326|64825025|FG002|Overall Study|Pregnancy|1|||
23494681|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Death|0|||
23296145|NCT01392326|64825023|FG000|Overall Study|Physician Decision|7|||
23296146|NCT01392326|64825024|FG001|Overall Study|Physician Decision|5|||
23296147|NCT01392326|64825025|FG002|Overall Study|Physician Decision|2|||
23296148|NCT01392326|64825023|FG000|Overall Study|Lost to Follow-up|1|||
23296149|NCT01392326|64825024|FG001|Overall Study|Lost to Follow-up|3|||
23296150|NCT01392326|64825025|FG002|Overall Study|Lost to Follow-up|4|||
23296151|NCT01392326|64825023|FG000|Overall Study|Lack of Efficacy|14|||
23494682|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Death|0|||
23388492|NCT04065841|65168745|FG002|Overall Study|Physician Decision|0|||
23388493|NCT04065841|65168746|FG003|Overall Study|Physician Decision|0|||
23388494|NCT04065841|65168743|FG000|Overall Study|Protocol Violation|0|||
23388495|NCT04065841|65168744|FG001|Overall Study|Protocol Violation|1|||
23388496|NCT04065841|65168745|FG002|Overall Study|Protocol Violation|0|||
23388497|NCT04065841|65168746|FG003|Overall Study|Protocol Violation|0|||
23388498|NCT04065841|65168743|FG000|Overall Study|Study terminated by Sponsor|22|||
23388499|NCT04065841|65168744|FG001|Overall Study|Study terminated by Sponsor|16|||
23388500|NCT04065841|65168745|FG002|Overall Study|Study terminated by Sponsor|28|||
23388501|NCT04065841|65168746|FG003|Overall Study|Study terminated by Sponsor|17|||
23388502|NCT04065841|65168743|FG000|Overall Study|Withdrawal by Subject|1|||
23388503|NCT04065841|65168744|FG001|Overall Study|Withdrawal by Subject|1|||
23388504|NCT04065841|65168745|FG002|Overall Study|Withdrawal by Subject|2|||
23388505|NCT04065841|65168746|FG003|Overall Study|Withdrawal by Subject|0|||
23388506|NCT00101400|65168747|FG000|Survival Follow-Up|Alive|7|||
23388507|NCT01346592|65168748|FG000|Overall Study|Lost to Follow-up|62|||
23388508|NCT01346592|65168749|FG001|Overall Study|Lost to Follow-up|29|||
23388509|NCT01346592|65168750|FG002|Overall Study|Lost to Follow-up|29|||
23388510|NCT01346592|65168748|FG000|Overall Study|Protocol Violation|2|||
23388511|NCT01346592|65168749|FG001|Overall Study|Protocol Violation|1|||
23388512|NCT01346592|65168750|FG002|Overall Study|Protocol Violation|0|||
23494683|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Death|7|||
23494684|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Death|0|||
23494685|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Death|0|||
23494686|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Death|0|||
23494687|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Death|0|||
23494688|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Death|0|||
23494689|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Death|0|||
23494690|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Death|0|||
23494691|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Death|0|||
23494692|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494693|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494694|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
23494695|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494696|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494697|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494698|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494699|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494700|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494701|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494702|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
23494703|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494704|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494705|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
23494706|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494707|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494708|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494709|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494710|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494711|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494712|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494713|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
23494714|NCT03307785|65554999|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23494715|NCT03307785|65555000|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23494716|NCT03307785|65555001|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
23388513|NCT01346592|65168748|FG000|Overall Study|Death|1|||
23388514|NCT01346592|65168749|FG001|Overall Study|Death|3|||
23388515|NCT01346592|65168750|FG002|Overall Study|Death|4|||
23388516|NCT01346592|65168748|FG000|Overall Study|Adverse Event|0|||
23388517|NCT01346592|65168749|FG001|Overall Study|Adverse Event|1|||
23388518|NCT01346592|65168750|FG002|Overall Study|Adverse Event|0|||
23388519|NCT01346592|65168748|FG000|Overall Study|Withdrawal by Subject|77|||
23388520|NCT01346592|65168749|FG001|Overall Study|Withdrawal by Subject|51|||
23388521|NCT01346592|65168750|FG002|Overall Study|Withdrawal by Subject|38|||
23388522|NCT01346592|65168748|FG000|Overall Study|Inappropriate enrollment|3|||
23388523|NCT01346592|65168749|FG001|Overall Study|Inappropriate enrollment|1|||
23388524|NCT01346592|65168750|FG002|Overall Study|Inappropriate enrollment|1|||
23388525|NCT01346592|65168748|FG000|Overall Study|Administrative reason|1|||
23296152|NCT01392326|64825024|FG001|Overall Study|Lack of Efficacy|10|||
23296153|NCT01392326|64825025|FG002|Overall Study|Lack of Efficacy|15|||
23296154|NCT01392326|64825023|FG000|Overall Study|Adverse Event|9|||
23296155|NCT01392326|64825024|FG001|Overall Study|Adverse Event|6|||
23296156|NCT01392326|64825025|FG002|Overall Study|Adverse Event|11|||
23296157|NCT01220609|64825026|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
23296158|NCT01220609|64825026|FG000|Overall Study|Ineligible- Wrong cell type|1|||
23296159|NCT01220609|64825026|FG000|Overall Study|Ineligible-Never treated|1|||
23296160|NCT01909934|64825027|FG000|Overall Study|Ongoing|23|||
23296161|NCT01909934|64825027|FG000|Overall Study|Withdrawal by Subject|3|||
23296162|NCT01909934|64825027|FG000|Overall Study|Lost to Follow-up|1|||
23296163|NCT01909934|64825027|FG000|Overall Study|Withdrawal of Informed Consent|1|||
23296164|NCT01909934|64825027|FG000|Overall Study|Death|22|||
23296165|NCT01257581|64825034|FG000|Overall Study|Early Termination|3|||
23296166|NCT01257581|64825035|FG001|Overall Study|Early Termination|1|||
23296167|NCT01257581|64825036|FG002|Overall Study|Early Termination|2|||
23388526|NCT01346592|65168749|FG001|Overall Study|Administrative reason|0|||
23388527|NCT01346592|65168750|FG002|Overall Study|Administrative reason|0|||
23296168|NCT01257581|64825034|FG000|Overall Study|Death|2|||
23388528|NCT01346592|65168748|FG000|Overall Study|Unable to Classify|7|||
23388529|NCT01346592|65168749|FG001|Overall Study|Unable to Classify|3|||
23388530|NCT01346592|65168750|FG002|Overall Study|Unable to Classify|6|||
23388531|NCT01877278|65168759|FG000|Overall Study|Lost to Follow-up|3|||
23388532|NCT01877278|65168760|FG001|Overall Study|Lost to Follow-up|3|||
23388533|NCT03180138|65168764|FG000|Overall Study|Mobile-phone could not be verified|2|||
23388534|NCT03180138|65168765|FG001|Overall Study|Mobile-phone could not be verified|13|||
23388535|NCT03180138|65168766|FG002|Overall Study|Mobile-phone could not be verified|15|||
23296169|NCT01257581|64825035|FG001|Overall Study|Death|2|||
23296170|NCT01257581|64825036|FG002|Overall Study|Death|4|||
23296171|NCT02985398|64825037|FG000|Overall Study|Adverse Event|1|||
23296172|NCT02985398|64825037|FG000|Overall Study|Lost to Follow-up|4|||
23296173|NCT02985398|64825037|FG000|Overall Study|Withdrawal by Subject|8|||
23296174|NCT02985398|64825037|FG000|Overall Study|Study Burden|9|||
23296175|NCT04798482|64825044|FG000|Overall Study|Physician Decision|1|||
23296176|NCT04798482|64825044|FG000|Overall Study|Lost eligibility|1|||
23296177|NCT01729026|64825045|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
23296178|NCT01729026|64825046|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
23296179|NCT01729026|64825045|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
23296180|NCT01729026|64825046|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
23296181|NCT00384293|64825048|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
23296182|NCT00384293|64825049|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
23296183|NCT00384293|64825050|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
23296184|NCT00384293|64825048|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
23296185|NCT00384293|64825049|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
23388536|NCT03180138|65168764|FG000|Overall Study|No prior immunization records|17|||
23388537|NCT03180138|65168765|FG001|Overall Study|No prior immunization records|0|||
23388538|NCT03180138|65168766|FG002|Overall Study|No prior immunization records|6|||
23388539|NCT03180138|65168764|FG000|Overall Study|Found to be >24 mon after randomization|3|||
23388540|NCT03180138|65168765|FG001|Overall Study|Found to be >24 mon after randomization|0|||
23388541|NCT03180138|65168766|FG002|Overall Study|Found to be >24 mon after randomization|3|||
23388542|NCT02942407|65168772|FG000|Overall Study|Lost to Follow-up|3|||
23388543|NCT02942407|65168773|FG001|Overall Study|Lost to Follow-up|2|||
23388544|NCT02942407|65168772|FG000|Overall Study|Withdrawal by Subject|7|||
23388545|NCT02942407|65168773|FG001|Overall Study|Withdrawal by Subject|9|||
23388546|NCT02942407|65168772|FG000|Overall Study|Death|16|||
23388547|NCT02942407|65168773|FG001|Overall Study|Death|13|||
23296186|NCT00384293|64825050|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
23388548|NCT01385995|65168774|FG000|Period 1, 2 Months|Physician Decision|1|||
23388549|NCT01385995|65168775|FG001|Period 1, 2 Months|Physician Decision|0|||
23388550|NCT00752219|65168776|FG000|Overall Study|Clinical failure|0|||
23388551|NCT00752219|65168777|FG001|Overall Study|Clinical failure|1|||
23388552|NCT00752219|65168776|FG000|Overall Study|Adverse Event|5|||
23388553|NCT00752219|65168777|FG001|Overall Study|Adverse Event|3|||
23388554|NCT00752219|65168776|FG000|Overall Study|Protocol deviation|1|||
23388555|NCT00752219|65168777|FG001|Overall Study|Protocol deviation|0|||
23388556|NCT00752219|65168776|FG000|Overall Study|Lost to Follow-up|1|||
23388557|NCT00752219|65168777|FG001|Overall Study|Lost to Follow-up|2|||
23388558|NCT00752219|65168776|FG000|Overall Study|Randomized but not treated|1|||
23388559|NCT00752219|65168777|FG001|Overall Study|Randomized but not treated|0|||
23388560|NCT00752219|65168776|FG000|Overall Study|Other|3|||
23388561|NCT00752219|65168777|FG001|Overall Study|Other|0|||
23296187|NCT00384293|64825048|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
23296188|NCT00384293|64825049|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
23296189|NCT00384293|64825050|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
23296190|NCT00384293|64825048|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
23296191|NCT00384293|64825049|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
23296192|NCT00384293|64825050|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
23296193|NCT00384293|64825048|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
23296194|NCT00384293|64825049|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
23296195|NCT00384293|64825050|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
23296196|NCT00384293|64825048|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
23388562|NCT02661815|65168778|FG000|Overall Study|Withdrawal by Subject|1|||
23388563|NCT02661815|65168779|FG001|Overall Study|Withdrawal by Subject|0|||
23388564|NCT02661815|65168780|FG002|Overall Study|Withdrawal by Subject|0|||
23388565|NCT02661815|65168781|FG003|Overall Study|Withdrawal by Subject|0|||
23388566|NCT04105725|65168786|FG000|Primary Intervention|Lost to Follow-up|0|||
23388567|NCT04105725|65168787|FG001|Primary Intervention|Lost to Follow-up|2|||
23388568|NCT04105725|65168786|FG000|Primary Intervention|Withdrawal by Subject|0|||
23388569|NCT04105725|65168787|FG001|Primary Intervention|Withdrawal by Subject|1|||
23388570|NCT03715829|65168788|FG000|Dose Ranging Period|Adverse Event|2|||
23388571|NCT03715829|65168789|FG001|Dose Ranging Period|Adverse Event|4|||
23388572|NCT03715829|65168790|FG002|Dose Ranging Period|Adverse Event|5|||
23296197|NCT00384293|64825049|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
23296198|NCT00384293|64825050|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
23296199|NCT00384293|64825048|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
23296200|NCT00384293|64825049|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
23296201|NCT00384293|64825050|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
23296202|NCT00384293|64825048|FG000|Post-randomization Period|Adverse Event|0|||
23296203|NCT00384293|64825049|FG001|Post-randomization Period|Adverse Event|23|||
23296204|NCT00384293|64825050|FG002|Post-randomization Period|Adverse Event|7|||
23296205|NCT00384293|64825048|FG000|Post-randomization Period|Lost to Follow-up|0|||
23296206|NCT00384293|64825049|FG001|Post-randomization Period|Lost to Follow-up|2|||
23296207|NCT00384293|64825050|FG002|Post-randomization Period|Lost to Follow-up|1|||
23296208|NCT00384293|64825048|FG000|Post-randomization Period|Protocol Violation|0|||
23296209|NCT00384293|64825049|FG001|Post-randomization Period|Protocol Violation|1|||
23296210|NCT00384293|64825050|FG002|Post-randomization Period|Protocol Violation|0|||
23296211|NCT00384293|64825048|FG000|Post-randomization Period|Withdrawal by Subject|0|||
23296212|NCT00384293|64825049|FG001|Post-randomization Period|Withdrawal by Subject|8|||
23296213|NCT00384293|64825050|FG002|Post-randomization Period|Withdrawal by Subject|6|||
23296214|NCT00384293|64825048|FG000|Post-randomization Period|Trial Termination|0|||
23296215|NCT00384293|64825049|FG001|Post-randomization Period|Trial Termination|180|||
23296216|NCT00384293|64825050|FG002|Post-randomization Period|Trial Termination|204|||
23296217|NCT00384293|64825048|FG000|Post-randomization Period|Patient Randomized in Error|0|||
23296218|NCT00384293|64825049|FG001|Post-randomization Period|Patient Randomized in Error|0|||
23296219|NCT00384293|64825050|FG002|Post-randomization Period|Patient Randomized in Error|1|||
23296220|NCT00895037|64825051|FG000|Overall Study|Death|0|||
23388573|NCT03715829|65168791|FG003|Dose Ranging Period|Adverse Event|2|||
23388574|NCT03715829|65168792|FG004|Dose Ranging Period|Adverse Event|3|||
23388575|NCT03715829|65168793|FG005|Dose Ranging Period|Adverse Event|3|||
23388576|NCT03715829|65168794|FG006|Dose Ranging Period|Adverse Event|0|||
23388577|NCT03715829|65168795|FG007|Dose Ranging Period|Adverse Event|0|||
23388578|NCT03715829|65168796|FG008|Dose Ranging Period|Adverse Event|0|||
23388579|NCT03715829|65168797|FG009|Dose Ranging Period|Adverse Event|0|||
23388580|NCT03715829|65168798|FG010|Dose Ranging Period|Adverse Event|0|||
23388581|NCT03715829|65168788|FG000|Dose Ranging Period|Lack of Efficacy|0|||
23388582|NCT03715829|65168789|FG001|Dose Ranging Period|Lack of Efficacy|1|||
23388583|NCT03715829|65168790|FG002|Dose Ranging Period|Lack of Efficacy|0|||
23388584|NCT03715829|65168791|FG003|Dose Ranging Period|Lack of Efficacy|1|||
23388585|NCT03715829|65168792|FG004|Dose Ranging Period|Lack of Efficacy|0|||
23388586|NCT03715829|65168793|FG005|Dose Ranging Period|Lack of Efficacy|0|||
23388587|NCT03715829|65168794|FG006|Dose Ranging Period|Lack of Efficacy|0|||
23388588|NCT03715829|65168795|FG007|Dose Ranging Period|Lack of Efficacy|0|||
23388589|NCT03715829|65168796|FG008|Dose Ranging Period|Lack of Efficacy|0|||
23388590|NCT03715829|65168797|FG009|Dose Ranging Period|Lack of Efficacy|0|||
23388591|NCT03715829|65168798|FG010|Dose Ranging Period|Lack of Efficacy|0|||
23388592|NCT03715829|65168788|FG000|Dose Ranging Period|Lost to Follow-up|2|||
23388593|NCT03715829|65168789|FG001|Dose Ranging Period|Lost to Follow-up|0|||
23388594|NCT03715829|65168790|FG002|Dose Ranging Period|Lost to Follow-up|1|||
23388595|NCT03715829|65168791|FG003|Dose Ranging Period|Lost to Follow-up|1|||
23388596|NCT03715829|65168792|FG004|Dose Ranging Period|Lost to Follow-up|1|||
23388597|NCT03715829|65168793|FG005|Dose Ranging Period|Lost to Follow-up|2|||
23388598|NCT03715829|65168794|FG006|Dose Ranging Period|Lost to Follow-up|0|||
23388599|NCT03715829|65168795|FG007|Dose Ranging Period|Lost to Follow-up|0|||
23388600|NCT03715829|65168796|FG008|Dose Ranging Period|Lost to Follow-up|0|||
23388601|NCT03715829|65168797|FG009|Dose Ranging Period|Lost to Follow-up|0|||
23388602|NCT03715829|65168798|FG010|Dose Ranging Period|Lost to Follow-up|0|||
23388603|NCT03715829|65168788|FG000|Dose Ranging Period|Protocol Violation|0|||
23388604|NCT03715829|65168789|FG001|Dose Ranging Period|Protocol Violation|0|||
23388605|NCT03715829|65168790|FG002|Dose Ranging Period|Protocol Violation|0|||
23388606|NCT03715829|65168791|FG003|Dose Ranging Period|Protocol Violation|1|||
23388607|NCT03715829|65168792|FG004|Dose Ranging Period|Protocol Violation|0|||
23388608|NCT03715829|65168793|FG005|Dose Ranging Period|Protocol Violation|0|||
23388609|NCT03715829|65168794|FG006|Dose Ranging Period|Protocol Violation|0|||
23388610|NCT03715829|65168795|FG007|Dose Ranging Period|Protocol Violation|0|||
23388611|NCT03715829|65168796|FG008|Dose Ranging Period|Protocol Violation|0|||
23388612|NCT03715829|65168797|FG009|Dose Ranging Period|Protocol Violation|0|||
23388613|NCT03715829|65168798|FG010|Dose Ranging Period|Protocol Violation|0|||
23388614|NCT03715829|65168788|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
23388615|NCT03715829|65168789|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
23388616|NCT03715829|65168790|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
23388617|NCT03715829|65168791|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
23388618|NCT03715829|65168792|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
23388619|NCT03715829|65168793|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
23388620|NCT03715829|65168794|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
23388621|NCT03715829|65168795|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
23388622|NCT03715829|65168796|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
23388623|NCT03715829|65168797|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
23388624|NCT03715829|65168798|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
23388625|NCT03715829|65168788|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23296221|NCT00895037|64825052|FG001|Overall Study|Death|2|||
23296222|NCT00895037|64825053|FG002|Overall Study|Death|1|||
23296223|NCT00708708|64825057|FG000|Overall Study|Another therapy instead of Enbrel|141|||
23296224|NCT00708708|64825057|FG000|Overall Study|Lost to Follow-up|52|||
23296225|NCT00708708|64825057|FG000|Overall Study|Withdrawal by Subject|51|||
23296226|NCT00708708|64825057|FG000|Overall Study|Intolerance|42|||
23296227|NCT00708708|64825057|FG000|Overall Study|Another therapy along with Enbrel|15|||
23296228|NCT00708708|64825057|FG000|Overall Study|Other unspecified|11|||
23296229|NCT00708708|64825057|FG000|Overall Study|Good effectiveness|9|||
23296230|NCT00708708|64825057|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
23296231|NCT00708708|64825057|FG000|Overall Study|Administrative reasons|7|||
23296232|NCT00708708|64825057|FG000|Overall Study|Lack of effectiveness|4|||
23296233|NCT00708708|64825057|FG000|Overall Study|Lack of compliance|3|||
23296234|NCT00708708|64825057|FG000|Overall Study|Pregnancy|3|||
23296235|NCT00708708|64825057|FG000|Overall Study|Adverse Event|3|||
23296236|NCT00708708|64825057|FG000|Overall Study|Missing values|392|||
23296237|NCT02776553|64825059|FG000|Overall Study|Lost to Follow-up|1|||
23296238|NCT02776553|64825060|FG001|Overall Study|Lost to Follow-up|0|||
23296239|NCT02776553|64825059|FG000|Overall Study|got liver transplant|1|||
23296240|NCT02776553|64825060|FG001|Overall Study|got liver transplant|2|||
23296241|NCT02776553|64825059|FG000|Overall Study|had other surgery|1|||
23296242|NCT02776553|64825060|FG001|Overall Study|had other surgery|0|||
23296243|NCT02776553|64825059|FG000|Overall Study|Protocol Violation|0|||
23296244|NCT02776553|64825060|FG001|Overall Study|Protocol Violation|1|||
23296245|NCT01613378|64825061|FG000|Overall Study|Lack of Efficacy|13|||
23296246|NCT01613378|64825061|FG000|Overall Study|Adverse Event|11|||
23296247|NCT01613378|64825061|FG000|Overall Study|Withdrawal by Subject|8|||
23296248|NCT01613378|64825061|FG000|Overall Study|Death|2|||
23296249|NCT01613378|64825061|FG000|Overall Study|Lost to Follow-up|1|||
23388626|NCT03715829|65168789|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388627|NCT03715829|65168790|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
23296250|NCT01613378|64825061|FG000|Overall Study|Other Reason|4|||
23296251|NCT00084799|64825064|FG000|Overall Study|Disease Progression|1|||
23296252|NCT00084799|64825065|FG001|Overall Study|Disease Progression|0|||
23296253|NCT02148913|64825068|FG000|Overall Study|Death|0|||
23296254|NCT02148913|64825069|FG001|Overall Study|Death|1|||
23296255|NCT02148913|64825070|FG002|Overall Study|Death|0|||
23296256|NCT02148913|64825071|FG003|Overall Study|Death|0|||
23296257|NCT00442546|64825075|FG000|Overall Study|Adverse Event|11|||
23296258|NCT00442546|64825076|FG001|Overall Study|Adverse Event|17|||
23296259|NCT00442546|64825077|FG002|Overall Study|Adverse Event|13|||
23296260|NCT00442546|64825075|FG000|Overall Study|Lost to Follow-up|1|||
23296261|NCT00442546|64825076|FG001|Overall Study|Lost to Follow-up|2|||
23296262|NCT00442546|64825077|FG002|Overall Study|Lost to Follow-up|1|||
23296263|NCT00442546|64825075|FG000|Overall Study|Other|4|||
23296264|NCT00442546|64825076|FG001|Overall Study|Other|9|||
23296265|NCT00442546|64825077|FG002|Overall Study|Other|6|||
23296266|NCT00442546|64825075|FG000|Overall Study|Withdrawal by Subject|5|||
23296267|NCT00442546|64825076|FG001|Overall Study|Withdrawal by Subject|5|||
23296268|NCT00442546|64825077|FG002|Overall Study|Withdrawal by Subject|7|||
23296269|NCT00442546|64825075|FG000|Overall Study|Randomized But Not Treated|5|||
23296270|NCT00442546|64825076|FG001|Overall Study|Randomized But Not Treated|4|||
23296271|NCT00442546|64825077|FG002|Overall Study|Randomized But Not Treated|6|||
23296272|NCT00418522|64825078|FG000|Overall Study|Adverse Event|7|||
23296273|NCT00418522|64825079|FG001|Overall Study|Adverse Event|1|||
23296274|NCT00418522|64825078|FG000|Overall Study|Lack of Efficacy|1|||
23296275|NCT00418522|64825079|FG001|Overall Study|Lack of Efficacy|3|||
23296276|NCT00418522|64825078|FG000|Overall Study|Lost to Follow-up|10|||
23296277|NCT00418522|64825079|FG001|Overall Study|Lost to Follow-up|4|||
23296278|NCT00418522|64825078|FG000|Overall Study|Withdrawal by Subject|31|||
23296279|NCT00418522|64825079|FG001|Overall Study|Withdrawal by Subject|7|||
23296280|NCT00418522|64825078|FG000|Overall Study|Other|27|||
23296281|NCT00418522|64825079|FG001|Overall Study|Other|23|||
23296282|NCT00418522|64825078|FG000|Overall Study|Randomized but did not receive treatment|7|||
23296283|NCT00418522|64825079|FG001|Overall Study|Randomized but did not receive treatment|4|||
23296284|NCT02427984|64825080|FG000|Overall Study|Lost to Follow-up|13|||
23296285|NCT02427984|64825081|FG001|Overall Study|Lost to Follow-up|5|||
23296286|NCT02427984|64825082|FG002|Overall Study|Lost to Follow-up|18|||
23296287|NCT03297294|64825083|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
23296288|NCT03297294|64825084|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
23296289|NCT03297294|64825085|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23296290|NCT03297294|64825086|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23296291|NCT03297294|64825087|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
23296292|NCT03297294|64825083|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
23296293|NCT03297294|64825084|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
23296294|NCT03297294|64825085|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23296295|NCT03297294|64825086|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23296296|NCT03297294|64825087|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
23296297|NCT03297294|64825083|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
23296298|NCT03297294|64825084|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
23296299|NCT03297294|64825085|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23296300|NCT03297294|64825086|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23296301|NCT03297294|64825087|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
23296302|NCT03297294|64825083|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
23296303|NCT03297294|64825084|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
23296304|NCT03297294|64825085|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23296305|NCT03297294|64825086|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23296306|NCT03297294|64825087|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
23296307|NCT03297294|64825083|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
23296308|NCT03297294|64825084|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
23296309|NCT03297294|64825085|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
23296310|NCT03297294|64825086|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
23296311|NCT03297294|64825087|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
23296312|NCT02070757|64825090|FG000|Overall Study|Adverse Event|107|||
23296313|NCT02070757|64825091|FG001|Overall Study|Adverse Event|99|||
23296314|NCT02070757|64825090|FG000|Overall Study|Lost to Follow-up|7|||
23296315|NCT02070757|64825091|FG001|Overall Study|Lost to Follow-up|4|||
23296316|NCT02070757|64825090|FG000|Overall Study|Protocol Violation|0|||
23296317|NCT02070757|64825091|FG001|Overall Study|Protocol Violation|4|||
23296318|NCT02070757|64825090|FG000|Overall Study|Withdrawal by Subject|1|||
23296319|NCT02070757|64825091|FG001|Overall Study|Withdrawal by Subject|3|||
23296320|NCT02070757|64825090|FG000|Overall Study|Investigator Decision|0|||
23296321|NCT02070757|64825091|FG001|Overall Study|Investigator Decision|2|||
23296322|NCT02070757|64825090|FG000|Overall Study|Discharged from Study Hospital|2|||
23296323|NCT02070757|64825091|FG001|Overall Study|Discharged from Study Hospital|2|||
23296324|NCT04291508|64825092|FG000|Overall Study|Withdrawal by Subject|1|||
23296325|NCT04291508|64825093|FG001|Overall Study|Withdrawal by Subject|0|||
23296326|NCT04291508|64825094|FG002|Overall Study|Withdrawal by Subject|1|||
23296327|NCT04291508|64825095|FG003|Overall Study|Withdrawal by Subject|0|||
23296328|NCT04291508|64825092|FG000|Overall Study|lost to follow up|4|||
23296329|NCT04291508|64825093|FG001|Overall Study|lost to follow up|0|||
23296330|NCT04291508|64825094|FG002|Overall Study|lost to follow up|1|||
23296331|NCT04291508|64825095|FG003|Overall Study|lost to follow up|0|||
23296332|NCT01553747|64825097|FG000|Overall Study|Protocol Violation|0|||
23296333|NCT01553747|64825098|FG001|Overall Study|Protocol Violation|2|||
23296334|NCT01553747|64825099|FG002|Overall Study|Protocol Violation|0|||
23296335|NCT01553747|64825097|FG000|Overall Study|Voluntarily withdrew|70|||
23296336|NCT01553747|64825098|FG001|Overall Study|Voluntarily withdrew|66|||
23296337|NCT01553747|64825099|FG002|Overall Study|Voluntarily withdrew|74|||
23296338|NCT01553747|64825097|FG000|Overall Study|Adverse event or SAE|32|||
23296339|NCT01553747|64825098|FG001|Overall Study|Adverse event or SAE|28|||
23296340|NCT01553747|64825099|FG002|Overall Study|Adverse event or SAE|19|||
23296341|NCT01553747|64825097|FG000|Overall Study|Physician decision: other|10|||
23296342|NCT01553747|64825098|FG001|Overall Study|Physician decision: other|8|||
23296343|NCT01553747|64825099|FG002|Overall Study|Physician decision: other|7|||
23296344|NCT01553747|64825097|FG000|Overall Study|Lost to Follow-up|11|||
23296345|NCT01553747|64825098|FG001|Overall Study|Lost to Follow-up|5|||
23296346|NCT01553747|64825099|FG002|Overall Study|Lost to Follow-up|6|||
23296347|NCT01553747|64825097|FG000|Overall Study|Sponsor decision, specify|7|||
23296348|NCT01553747|64825098|FG001|Overall Study|Sponsor decision, specify|5|||
23296349|NCT01553747|64825099|FG002|Overall Study|Sponsor decision, specify|0|||
23296350|NCT01553747|64825097|FG000|Overall Study|Physician decision: lack of efficacy|1|||
23296351|NCT01553747|64825098|FG001|Overall Study|Physician decision: lack of efficacy|5|||
23296352|NCT01553747|64825099|FG002|Overall Study|Physician decision: lack of efficacy|3|||
23296353|NCT02487082|64825100|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
23296354|NCT02487082|64825101|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
23296355|NCT02487082|64825100|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
23296356|NCT02487082|64825101|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
23296357|NCT01701973|64825102|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23296358|NCT01701973|64825103|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
23296359|NCT01701973|64825104|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23296360|NCT01701973|64825105|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23296361|NCT01701973|64825106|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23296362|NCT01701973|64825107|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23296363|NCT01701973|64825108|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23296364|NCT01701973|64825109|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
23296365|NCT00702208|64825110|FG000|Overall Study|Lost to Follow-up|28|||
23296366|NCT00702208|64825110|FG000|Overall Study|Did not self-lavage|1|||
23296367|NCT00702208|64825110|FG000|Overall Study|Unsatisfactory colposcopy|2|||
23296368|NCT01522950|64825114|FG000|Overall Study|Withdrawal by Subject|3|||
23296369|NCT01522950|64825115|FG001|Overall Study|Withdrawal by Subject|2|||
23296370|NCT01522950|64825116|FG002|Overall Study|Withdrawal by Subject|1|||
23388628|NCT03715829|65168791|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388629|NCT03715829|65168792|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388630|NCT03715829|65168793|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388631|NCT03715829|65168794|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388632|NCT03715829|65168795|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23296371|NCT01522950|64825114|FG000|Overall Study|Adverse Event|3|||
23296372|NCT01522950|64825115|FG001|Overall Study|Adverse Event|1|||
23296373|NCT01522950|64825116|FG002|Overall Study|Adverse Event|1|||
23296374|NCT01522950|64825114|FG000|Overall Study|Protocol Violation|0|||
23296375|NCT01522950|64825115|FG001|Overall Study|Protocol Violation|0|||
23296376|NCT01522950|64825116|FG002|Overall Study|Protocol Violation|2|||
23296377|NCT01522950|64825114|FG000|Overall Study|Death|0|||
23296378|NCT01522950|64825115|FG001|Overall Study|Death|1|||
23296379|NCT01522950|64825116|FG002|Overall Study|Death|1|||
23296380|NCT01522950|64825114|FG000|Overall Study|Study Medication Sensitivity|0|||
23296381|NCT01522950|64825115|FG001|Overall Study|Study Medication Sensitivity|1|||
23296382|NCT01522950|64825116|FG002|Overall Study|Study Medication Sensitivity|0|||
23296383|NCT00296491|64827985|FG000|Overall Study|Low Pollen Counts|18|||
23296384|NCT00296491|64827986|FG001|Overall Study|Low Pollen Counts|26|||
23296385|NCT00296491|64827987|FG002|Overall Study|Low Pollen Counts|25|||
23296386|NCT00296491|64827988|FG003|Overall Study|Low Pollen Counts|16|||
23296387|NCT00296491|64827985|FG000|Overall Study|Protocol Violation|4|||
23296388|NCT00296491|64827986|FG001|Overall Study|Protocol Violation|6|||
23296389|NCT00296491|64827987|FG002|Overall Study|Protocol Violation|2|||
23296390|NCT00296491|64827988|FG003|Overall Study|Protocol Violation|3|||
23296391|NCT00296491|64827985|FG000|Overall Study|Adverse Event|1|||
23296392|NCT00296491|64827986|FG001|Overall Study|Adverse Event|3|||
23296393|NCT00296491|64827987|FG002|Overall Study|Adverse Event|1|||
23296394|NCT00296491|64827988|FG003|Overall Study|Adverse Event|4|||
23296395|NCT00296491|64827985|FG000|Overall Study|Withdrawn due to Asthma|0|||
23296396|NCT00296491|64827986|FG001|Overall Study|Withdrawn due to Asthma|0|||
23296397|NCT00296491|64827987|FG002|Overall Study|Withdrawn due to Asthma|0|||
23296398|NCT00296491|64827988|FG003|Overall Study|Withdrawn due to Asthma|4|||
23296399|NCT00296491|64827985|FG000|Overall Study|Withdrawal by Subject|7|||
23296400|NCT00296491|64827986|FG001|Overall Study|Withdrawal by Subject|3|||
23296401|NCT00296491|64827987|FG002|Overall Study|Withdrawal by Subject|3|||
23296402|NCT00296491|64827988|FG003|Overall Study|Withdrawal by Subject|2|||
23296403|NCT00296491|64827985|FG000|Overall Study|Non-Compliance|12|||
23296404|NCT00296491|64827986|FG001|Overall Study|Non-Compliance|13|||
23296405|NCT00296491|64827987|FG002|Overall Study|Non-Compliance|10|||
23296406|NCT00296491|64827988|FG003|Overall Study|Non-Compliance|14|||
23296407|NCT00296491|64827985|FG000|Overall Study|Lost to Follow-up|0|||
23296408|NCT00296491|64827986|FG001|Overall Study|Lost to Follow-up|2|||
23296409|NCT00296491|64827987|FG002|Overall Study|Lost to Follow-up|2|||
23296410|NCT00296491|64827988|FG003|Overall Study|Lost to Follow-up|0|||
23296411|NCT02510014|64827995|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
23296412|NCT02510014|64827996|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
23296413|NCT02510014|64827995|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
23296414|NCT02510014|64827996|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
23296415|NCT02510014|64827995|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
23296416|NCT02510014|64827996|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
23296417|NCT02510014|64827995|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
23296418|NCT02510014|64827996|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
23296419|NCT02510014|64827995|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
23296420|NCT02510014|64827996|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
23296421|NCT02510014|64827995|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
23296422|NCT02510014|64827996|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
23296423|NCT02510014|64827995|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
23296424|NCT02510014|64827996|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
23296425|NCT02510014|64827995|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
23296426|NCT02510014|64827996|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
23296427|NCT02510014|64827995|FG000|Treatment Period|Adverse Event|11|||
23296428|NCT02510014|64827996|FG001|Treatment Period|Adverse Event|4|||
23296429|NCT02510014|64827995|FG000|Treatment Period|Withdrawal symptoms|3|||
23296430|NCT02510014|64827996|FG001|Treatment Period|Withdrawal symptoms|0|||
23296431|NCT02510014|64827995|FG000|Treatment Period|Lost to Follow-up|80|||
23296432|NCT02510014|64827996|FG001|Treatment Period|Lost to Follow-up|19|||
23296433|NCT02510014|64827995|FG000|Treatment Period|Physician Decision|5|||
23296434|NCT02510014|64827996|FG001|Treatment Period|Physician Decision|0|||
23296435|NCT02510014|64827995|FG000|Treatment Period|Withdrawal by Subject|67|||
23296436|NCT02510014|64827996|FG001|Treatment Period|Withdrawal by Subject|24|||
23296437|NCT02510014|64827995|FG000|Treatment Period|Withdrawn by the investigator|7|||
23296438|NCT02510014|64827996|FG001|Treatment Period|Withdrawn by the investigator|1|||
23296439|NCT02510014|64827995|FG000|Treatment Period|Protocol Violation|4|||
23296440|NCT02510014|64827996|FG001|Treatment Period|Protocol Violation|4|||
23296441|NCT02510014|64827995|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
23296442|NCT02510014|64827996|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
23296443|NCT05158140|64827997|FG000|Overall Study|Death|0|||
23296444|NCT05158140|64827998|FG001|Overall Study|Death|0|||
23296445|NCT05158140|64827999|FG002|Overall Study|Death|0|||
23296446|NCT05158140|64828000|FG003|Overall Study|Death|1|||
23296447|NCT05158140|64827997|FG000|Overall Study|Lost to Follow-up|3|||
23296448|NCT05158140|64827998|FG001|Overall Study|Lost to Follow-up|6|||
23296449|NCT05158140|64827999|FG002|Overall Study|Lost to Follow-up|4|||
23296450|NCT05158140|64828000|FG003|Overall Study|Lost to Follow-up|3|||
23296451|NCT05158140|64827997|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23296452|NCT05158140|64827998|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
23296453|NCT05158140|64827999|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
23296454|NCT05158140|64828000|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
23296455|NCT05158140|64827997|FG000|Overall Study|Withdrawal by Subject|3|||
23388633|NCT03715829|65168796|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23296456|NCT05158140|64827998|FG001|Overall Study|Withdrawal by Subject|7|||
23296457|NCT05158140|64827999|FG002|Overall Study|Withdrawal by Subject|3|||
23296458|NCT05158140|64828000|FG003|Overall Study|Withdrawal by Subject|7|||
23296459|NCT02508116|64828007|FG000|Overall Study|Lost to Follow-up|2|||
23296460|NCT02508116|64828008|FG001|Overall Study|Lost to Follow-up|3|||
23296461|NCT02508116|64828007|FG000|Overall Study|Withdrawal by Subject|3|||
23296462|NCT02508116|64828008|FG001|Overall Study|Withdrawal by Subject|2|||
23296463|NCT02508116|64828007|FG000|Overall Study|Protocol Violation|1|||
23296464|NCT02508116|64828008|FG001|Overall Study|Protocol Violation|2|||
23296465|NCT02508116|64828007|FG000|Overall Study|Physician Decision|2|||
23296466|NCT02508116|64828008|FG001|Overall Study|Physician Decision|0|||
23296467|NCT01098110|64828009|FG000|Overall Study|Withdrawal by Subject|14|||
23296468|NCT01098110|64828010|FG001|Overall Study|Withdrawal by Subject|24|||
23296469|NCT01098110|64828011|FG002|Overall Study|Withdrawal by Subject|19|||
23296470|NCT01098110|64828009|FG000|Overall Study|Adverse Event|30|||
23296471|NCT01098110|64828010|FG001|Overall Study|Adverse Event|32|||
23296472|NCT01098110|64828011|FG002|Overall Study|Adverse Event|43|||
23296473|NCT01098110|64828009|FG000|Overall Study|Lack of Efficacy|13|||
23296474|NCT01098110|64828010|FG001|Overall Study|Lack of Efficacy|9|||
23296475|NCT01098110|64828011|FG002|Overall Study|Lack of Efficacy|27|||
23296476|NCT01098110|64828009|FG000|Overall Study|Other|4|||
23296477|NCT01098110|64828010|FG001|Overall Study|Other|7|||
23296478|NCT01098110|64828011|FG002|Overall Study|Other|5|||
23296479|NCT01098110|64828009|FG000|Overall Study|Untreated|1|||
23296480|NCT01098110|64828010|FG001|Overall Study|Untreated|1|||
23296481|NCT01098110|64828011|FG002|Overall Study|Untreated|0|||
23296482|NCT00003531|64828012|FG000|Overall Study|Not evaluable|10|||
23296483|NCT00854373|64828013|FG000|Overall Study|Withdrawal by Subject|1|||
23388634|NCT03715829|65168797|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388635|NCT03715829|65168798|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
23388636|NCT03715829|65168788|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388637|NCT03715829|65168789|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388638|NCT03715829|65168790|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
23388639|NCT03715829|65168791|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388640|NCT03715829|65168792|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
23388641|NCT03715829|65168793|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388642|NCT03715829|65168794|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388643|NCT03715829|65168795|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388644|NCT03715829|65168796|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388645|NCT03715829|65168797|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388646|NCT03715829|65168798|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
23388647|NCT03715829|65168788|FG000|Dose Ranging Period|Other|0|||
23388648|NCT03715829|65168789|FG001|Dose Ranging Period|Other|0|||
23388649|NCT03715829|65168790|FG002|Dose Ranging Period|Other|2|||
23388650|NCT03715829|65168791|FG003|Dose Ranging Period|Other|0|||
23388651|NCT03715829|65168792|FG004|Dose Ranging Period|Other|0|||
23388652|NCT03715829|65168793|FG005|Dose Ranging Period|Other|3|||
23494717|NCT03307785|65555002|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23388653|NCT03715829|65168794|FG006|Dose Ranging Period|Other|0|||
23388654|NCT03715829|65168795|FG007|Dose Ranging Period|Other|0|||
23494718|NCT03307785|65555003|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23494719|NCT03307785|65555004|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23494720|NCT03307785|65555005|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23296484|NCT00854373|64828014|FG001|Overall Study|Withdrawal by Subject|3|||
23296485|NCT00854373|64828013|FG000|Overall Study|Forgot to take study drug|1|||
23388655|NCT03715829|65168796|FG008|Dose Ranging Period|Other|0|||
23388656|NCT03715829|65168797|FG009|Dose Ranging Period|Other|0|||
23388657|NCT03715829|65168798|FG010|Dose Ranging Period|Other|0|||
23296486|NCT00854373|64828014|FG001|Overall Study|Forgot to take study drug|1|||
23388658|NCT03715829|65168788|FG000|Extension Period|Adverse Event|0|||
23296487|NCT00918463|64828015|FG000|Overall Study|Death|1|||
23296488|NCT00918463|64828015|FG000|Overall Study|Lack of Efficacy|1|||
23296489|NCT03005067|64828018|FG000|Overall Study|Withdrawal by Subject|3|||
23296490|NCT03005067|64828019|FG001|Overall Study|Withdrawal by Subject|2|||
23296491|NCT03005067|64828018|FG000|Overall Study|Adverse Event|4|||
23388659|NCT03715829|65168789|FG001|Extension Period|Adverse Event|0|||
23388660|NCT03715829|65168790|FG002|Extension Period|Adverse Event|0|||
23388661|NCT03715829|65168791|FG003|Extension Period|Adverse Event|0|||
23388662|NCT03715829|65168792|FG004|Extension Period|Adverse Event|0|||
23388663|NCT03715829|65168793|FG005|Extension Period|Adverse Event|0|||
23388664|NCT03715829|65168794|FG006|Extension Period|Adverse Event|3|||
23388665|NCT03715829|65168795|FG007|Extension Period|Adverse Event|1|||
23388666|NCT03715829|65168796|FG008|Extension Period|Adverse Event|6|||
23296492|NCT03005067|64828019|FG001|Overall Study|Adverse Event|3|||
23296493|NCT03005067|64828018|FG000|Overall Study|Other (reason not specified)|3|||
23296494|NCT03005067|64828019|FG001|Overall Study|Other (reason not specified)|1|||
23296495|NCT03005067|64828018|FG000|Overall Study|Protocol Violation|0|||
23296496|NCT03005067|64828019|FG001|Overall Study|Protocol Violation|1|||
23296497|NCT03212794|64828020|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
23296498|NCT03212794|64828021|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
23296499|NCT03212794|64828020|FG000|Overall Study|Lost to Follow-up|5|||
23296500|NCT03212794|64828021|FG001|Overall Study|Lost to Follow-up|6|||
23296501|NCT03212794|64828020|FG000|Overall Study|Incarcerated; unable to participate|2|||
23296502|NCT03212794|64828021|FG001|Overall Study|Incarcerated; unable to participate|0|||
23296503|NCT03212794|64828020|FG000|Overall Study|Withdrawal by Subject|1|||
23296504|NCT03212794|64828021|FG001|Overall Study|Withdrawal by Subject|0|||
23388667|NCT03715829|65168797|FG009|Extension Period|Adverse Event|0|||
23388668|NCT03715829|65168798|FG010|Extension Period|Adverse Event|0|||
23388669|NCT03715829|65168788|FG000|Extension Period|Lack of Efficacy|0|||
23388670|NCT03715829|65168789|FG001|Extension Period|Lack of Efficacy|0|||
23388671|NCT03715829|65168790|FG002|Extension Period|Lack of Efficacy|0|||
23388672|NCT03715829|65168791|FG003|Extension Period|Lack of Efficacy|0|||
23388673|NCT03715829|65168792|FG004|Extension Period|Lack of Efficacy|0|||
23388674|NCT03715829|65168793|FG005|Extension Period|Lack of Efficacy|0|||
23388675|NCT03715829|65168794|FG006|Extension Period|Lack of Efficacy|1|||
23388676|NCT03715829|65168795|FG007|Extension Period|Lack of Efficacy|9|||
23388677|NCT03715829|65168796|FG008|Extension Period|Lack of Efficacy|2|||
23296505|NCT03212794|64828020|FG000|Overall Study|Death|0|||
23296506|NCT03212794|64828021|FG001|Overall Study|Death|1|||
23296507|NCT03212794|64828020|FG000|Overall Study|Found to be ineligible after allocation|0|||
23388678|NCT03715829|65168797|FG009|Extension Period|Lack of Efficacy|0|||
23388679|NCT03715829|65168798|FG010|Extension Period|Lack of Efficacy|0|||
23388680|NCT03715829|65168788|FG000|Extension Period|Lost to Follow-up|0|||
23388681|NCT03715829|65168789|FG001|Extension Period|Lost to Follow-up|0|||
23388682|NCT03715829|65168790|FG002|Extension Period|Lost to Follow-up|0|||
23388683|NCT03715829|65168791|FG003|Extension Period|Lost to Follow-up|0|||
23296508|NCT03212794|64828021|FG001|Overall Study|Found to be ineligible after allocation|1|||
23296509|NCT03212794|64828020|FG000|Overall Study|Relocated out of area|2|||
23296510|NCT03212794|64828021|FG001|Overall Study|Relocated out of area|0|||
23296511|NCT02457819|64828022|FG000|Overall Study|reason not given|8|||
23296512|NCT02457819|64828022|FG000|Overall Study|Withdrawal by Subject|24|||
23296513|NCT02457819|64828022|FG000|Overall Study|Protocol Violation|1|||
23296514|NCT02457819|64828022|FG000|Overall Study|non compliance with study drug|4|||
23296515|NCT02457819|64828022|FG000|Overall Study|Lost to Follow-up|10|||
23296516|NCT02457819|64828022|FG000|Overall Study|Lack of Efficacy|19|||
23296517|NCT02457819|64828022|FG000|Overall Study|Adverse Event|33|||
23296518|NCT02663882|64828023|FG000|Overall Study|Lost to Follow-up|4|||
23296519|NCT02663882|64828024|FG001|Overall Study|Lost to Follow-up|2|||
23296520|NCT00303667|64828033|FG000|Overall Study|Death|0|||
23296521|NCT00303667|64828034|FG001|Overall Study|Death|4|||
23296522|NCT00493779|64828037|FG000|Overall Study|Logistical issue at site|1|||
23296523|NCT02458092|64828038|FG000|Overall Study|Withdrawal by Subject|1|||
23296524|NCT02458092|64828039|FG001|Overall Study|Withdrawal by Subject|0|||
23296525|NCT01286558|64828043|FG000|Overall Study|Adverse Event|1|||
23296526|NCT01286558|64828044|FG001|Overall Study|Adverse Event|1|||
23296527|NCT01286558|64828043|FG000|Overall Study|Withdrawal by Subject|0|||
23296528|NCT01286558|64828044|FG001|Overall Study|Withdrawal by Subject|1|||
23296529|NCT02575339|64828046|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
23296530|NCT02575339|64828047|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
23296531|NCT02575339|64828048|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
23296532|NCT02575339|64828046|FG000|Study Treatment|Disease Progression|5|||
23296533|NCT02575339|64828047|FG001|Study Treatment|Disease Progression|2|||
23296534|NCT02575339|64828048|FG002|Study Treatment|Disease Progression|0|||
23296535|NCT02575339|64828046|FG000|Study Treatment|Adverse Event|1|||
23296536|NCT02575339|64828047|FG001|Study Treatment|Adverse Event|2|||
23296537|NCT02575339|64828048|FG002|Study Treatment|Adverse Event|0|||
23296538|NCT02575339|64828046|FG000|Follow up|Death|6|||
23296539|NCT02575339|64828047|FG001|Follow up|Death|2|||
23296540|NCT02575339|64828048|FG002|Follow up|Death|0|||
23296541|NCT02575339|64828046|FG000|Follow up|Study Terminated|0|||
23296542|NCT02575339|64828047|FG001|Follow up|Study Terminated|2|||
23296543|NCT02575339|64828048|FG002|Follow up|Study Terminated|0|||
23296544|NCT02575339|64828046|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
23296545|NCT02575339|64828047|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
23296546|NCT02575339|64828048|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
23296547|NCT00112294|64828050|FG000|Overall Study|Still on study|5|||
23296548|NCT00112294|64828051|FG001|Overall Study|Still on study|0|||
23296549|NCT01730040|64828052|FG000|Overall Study|Randomized but not treated|0|||
23296550|NCT01730040|64828053|FG001|Overall Study|Randomized but not treated|0|||
23296551|NCT01730040|64828054|FG002|Overall Study|Randomized but not treated|0|||
23296552|NCT01730040|64828055|FG003|Overall Study|Randomized but not treated|0|||
23296553|NCT01730040|64828056|FG004|Overall Study|Randomized but not treated|0|||
23296554|NCT01730040|64828057|FG005|Overall Study|Randomized but not treated|1|||
23296555|NCT01730040|64828058|FG006|Overall Study|Randomized but not treated|0|||
23296556|NCT01730040|64828052|FG000|Overall Study|Subject moved|0|||
23296557|NCT01730040|64828053|FG001|Overall Study|Subject moved|0|||
23296558|NCT01730040|64828054|FG002|Overall Study|Subject moved|1|||
23296559|NCT01730040|64828055|FG003|Overall Study|Subject moved|0|||
23296560|NCT01730040|64828056|FG004|Overall Study|Subject moved|0|||
23296561|NCT01730040|64828057|FG005|Overall Study|Subject moved|0|||
23296562|NCT01730040|64828058|FG006|Overall Study|Subject moved|1|||
23296563|NCT01730040|64828052|FG000|Overall Study|Physician Decision|0|||
23296564|NCT01730040|64828053|FG001|Overall Study|Physician Decision|0|||
23296565|NCT01730040|64828054|FG002|Overall Study|Physician Decision|0|||
23296566|NCT01730040|64828055|FG003|Overall Study|Physician Decision|0|||
23296567|NCT01730040|64828056|FG004|Overall Study|Physician Decision|0|||
23296568|NCT01730040|64828057|FG005|Overall Study|Physician Decision|1|||
23296569|NCT01730040|64828058|FG006|Overall Study|Physician Decision|1|||
23296570|NCT01730040|64828052|FG000|Overall Study|Other than specified|7|||
23296571|NCT01730040|64828053|FG001|Overall Study|Other than specified|8|||
23296572|NCT01730040|64828054|FG002|Overall Study|Other than specified|5|||
23296573|NCT01730040|64828055|FG003|Overall Study|Other than specified|5|||
23296574|NCT01730040|64828056|FG004|Overall Study|Other than specified|5|||
23296575|NCT01730040|64828057|FG005|Overall Study|Other than specified|4|||
23296576|NCT01730040|64828058|FG006|Overall Study|Other than specified|4|||
23296577|NCT01730040|64828052|FG000|Overall Study|Adverse Event|4|||
23296578|NCT01730040|64828053|FG001|Overall Study|Adverse Event|3|||
23296579|NCT01730040|64828054|FG002|Overall Study|Adverse Event|5|||
23296580|NCT01730040|64828055|FG003|Overall Study|Adverse Event|3|||
23296581|NCT01730040|64828056|FG004|Overall Study|Adverse Event|1|||
23296582|NCT01730040|64828057|FG005|Overall Study|Adverse Event|1|||
23296583|NCT01730040|64828058|FG006|Overall Study|Adverse Event|2|||
23296584|NCT01730040|64828052|FG000|Overall Study|Poor compliance to protocol|2|||
23296585|NCT01730040|64828053|FG001|Overall Study|Poor compliance to protocol|4|||
23296586|NCT01730040|64828054|FG002|Overall Study|Poor compliance to protocol|0|||
23296587|NCT01730040|64828055|FG003|Overall Study|Poor compliance to protocol|0|||
23296588|NCT01730040|64828056|FG004|Overall Study|Poor compliance to protocol|0|||
23296589|NCT01730040|64828057|FG005|Overall Study|Poor compliance to protocol|0|||
23296590|NCT01730040|64828058|FG006|Overall Study|Poor compliance to protocol|1|||
23296591|NCT00802178|64828059|FG000|Overall Study|Lack of Efficacy|36|||
23388684|NCT03715829|65168792|FG004|Extension Period|Lost to Follow-up|0|||
23388685|NCT03715829|65168793|FG005|Extension Period|Lost to Follow-up|0|||
23388686|NCT03715829|65168794|FG006|Extension Period|Lost to Follow-up|0|||
23296592|NCT00802178|64828059|FG000|Overall Study|Insufficient tolerability (IT)|17|||
23296593|NCT00802178|64828059|FG000|Overall Study|Withdrawal by Subject|18|||
23296594|NCT00802178|64828059|FG000|Overall Study|Other|32|||
23296595|NCT00802178|64828059|FG000|Overall Study|Lack of efficacy and patient wish|1|||
23296596|NCT00802178|64828059|FG000|Overall Study|IT and patient wish|8|||
23296597|NCT00802178|64828059|FG000|Overall Study|Patients wish and other reason|1|||
23296598|NCT01682148|64828060|FG000|Overall Study|Withdrawal by Subject|2|||
23296599|NCT01682148|64828061|FG001|Overall Study|Withdrawal by Subject|0|||
23296600|NCT01682148|64828060|FG000|Overall Study|Lost to Follow-up|1|||
23296601|NCT01682148|64828061|FG001|Overall Study|Lost to Follow-up|2|||
23296602|NCT01682148|64828060|FG000|Overall Study|Protocol Violation|1|||
23296603|NCT01682148|64828061|FG001|Overall Study|Protocol Violation|1|||
23296604|NCT01230892|64828063|FG000|Overall Study|Withdrawal by Subject|1|||
23296605|NCT01230892|64828064|FG001|Overall Study|Withdrawal by Subject|1|||
23296606|NCT01230892|64828063|FG000|Overall Study|Lost to Follow-up|2|||
23296607|NCT01230892|64828064|FG001|Overall Study|Lost to Follow-up|0|||
23296608|NCT00653159|64828065|FG000|Overall Study|Adverse Event|4|||
23296609|NCT00653159|64828066|FG001|Overall Study|Adverse Event|1|||
23296610|NCT00653159|64828065|FG000|Overall Study|Lost to Follow-up|1|||
23296611|NCT00653159|64828066|FG001|Overall Study|Lost to Follow-up|2|||
23296612|NCT05816200|64828069|FG000|Overall Study|Lost to Follow-up|2|||
23296613|NCT05816200|64828070|FG001|Overall Study|Lost to Follow-up|1|||
23296614|NCT02752802|64828071|FG000|Overall Study|Contrast Volume Not Collected|1|||
23296615|NCT02752802|64828072|FG001|Overall Study|Contrast Volume Not Collected|0|||
23296616|NCT01559935|64828073|FG000|Car Phase|Toxicity|4|||
23296617|NCT01559935|64828073|FG000|Car Phase|Death|1|||
23296618|NCT01559935|64828073|FG000|Car Phase|Lack of Efficacy|2|||
23296619|NCT01559935|64828073|FG000|Car Phase|Lost to Follow-up|1|||
23296620|NCT01559935|64828073|FG000|Car Phase|Physician Decision|1|||
23296621|NCT01559935|64828073|FG000|Car Phase|Withdrawal by Subject|2|||
23296622|NCT01559935|64828073|FG000|Car Phase|Per protocol|1|||
23296623|NCT01559935|64828073|FG000|Car Phase|Insurance|1|||
23296624|NCT01559935|64828073|FG000|Car Phase|non-compliance|1|||
23296625|NCT01559935|64828073|FG000|BiRD Phase|Toxicity|1|||
23296626|NCT01559935|64828073|FG000|BiRD Phase|Lack of Efficacy|1|||
23296627|NCT01559935|64828073|FG000|BiRD Phase|Withdrawal by Subject|2|||
23296628|NCT01559935|64828073|FG000|Maintenance Phase|Remains on study|28|||
23296629|NCT01559935|64828073|FG000|Maintenance Phase|Toxicity|1|||
23296630|NCT01559935|64828073|FG000|Maintenance Phase|Lack of Efficacy|18|||
23296631|NCT01559935|64828073|FG000|Maintenance Phase|Withdrawal by Subject|5|||
23296632|NCT01559935|64828073|FG000|Maintenance Phase|Non-compliance|2|||
23296633|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
23296634|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
23296635|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
23388687|NCT03715829|65168795|FG007|Extension Period|Lost to Follow-up|0|||
23388688|NCT03715829|65168796|FG008|Extension Period|Lost to Follow-up|2|||
23388689|NCT03715829|65168797|FG009|Extension Period|Lost to Follow-up|0|||
23296636|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
23296637|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
23296638|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
23296639|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
23296640|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
23296641|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
23296642|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
23296643|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Subject decision|1|||
23296644|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Subject decision|1|||
23296645|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
23388690|NCT03715829|65168798|FG010|Extension Period|Lost to Follow-up|0|||
23388691|NCT03715829|65168788|FG000|Extension Period|Protocol Violation|0|||
23388692|NCT03715829|65168789|FG001|Extension Period|Protocol Violation|0|||
23388693|NCT03715829|65168790|FG002|Extension Period|Protocol Violation|0|||
23388694|NCT03715829|65168791|FG003|Extension Period|Protocol Violation|0|||
23388695|NCT03715829|65168792|FG004|Extension Period|Protocol Violation|0|||
23388696|NCT03715829|65168793|FG005|Extension Period|Protocol Violation|0|||
23388697|NCT03715829|65168794|FG006|Extension Period|Protocol Violation|0|||
23388698|NCT03715829|65168795|FG007|Extension Period|Protocol Violation|0|||
23388699|NCT03715829|65168796|FG008|Extension Period|Protocol Violation|1|||
23388700|NCT03715829|65168797|FG009|Extension Period|Protocol Violation|0|||
23388701|NCT03715829|65168798|FG010|Extension Period|Protocol Violation|0|||
23388702|NCT03715829|65168788|FG000|Extension Period|Withdrawal by Subject|0|||
23494721|NCT03307785|65555006|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23296646|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
23296647|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
23296648|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
23296649|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
23296650|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
23296651|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
23296652|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
23296653|NCT00518882|64828076|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
23388703|NCT03715829|65168789|FG001|Extension Period|Withdrawal by Subject|0|||
23388704|NCT03715829|65168790|FG002|Extension Period|Withdrawal by Subject|0|||
23296654|NCT00518882|64828077|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
23296655|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
23296656|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
23296657|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
23388705|NCT03715829|65168791|FG003|Extension Period|Withdrawal by Subject|0|||
23296658|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
23296659|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
23296660|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
23296661|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
23296662|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
23296663|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
23296664|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
23296665|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
23296666|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
23296667|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
23296668|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
23296669|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
23388706|NCT03715829|65168792|FG004|Extension Period|Withdrawal by Subject|0|||
23296670|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
23296671|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
23296672|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
23296673|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
23296674|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
23296675|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
23296676|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
23296677|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
23296678|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
23296679|NCT00518882|64828076|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
23296680|NCT00518882|64828077|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
23296681|NCT04241133|64828078|FG000|Overall Study|COVID19 Precautions|14|||
23296682|NCT04241133|64828079|FG001|Overall Study|COVID19 Precautions|34|||
23296683|NCT02014441|64828080|FG000|Overall Study|Withdrawal by Subject|12|||
23296684|NCT04034355|64828085|FG000|Overall Study|Study terminated by Sponsor|10|||
23296685|NCT04034355|64828086|FG001|Overall Study|Study terminated by Sponsor|17|||
23296686|NCT04034355|64828085|FG000|Overall Study|Withdrawal by Subject|12|||
23296687|NCT04034355|64828086|FG001|Overall Study|Withdrawal by Subject|11|||
23296688|NCT04034355|64828085|FG000|Overall Study|Site terminated by Sponsor|4|||
23296689|NCT04034355|64828086|FG001|Overall Study|Site terminated by Sponsor|5|||
23296690|NCT04034355|64828085|FG000|Overall Study|Adverse Event|2|||
23296691|NCT04034355|64828086|FG001|Overall Study|Adverse Event|0|||
23296692|NCT04034355|64828085|FG000|Overall Study|Death|1|||
23296693|NCT04034355|64828086|FG001|Overall Study|Death|1|||
23296694|NCT04034355|64828085|FG000|Overall Study|Not reported|2|||
23296695|NCT04034355|64828086|FG001|Overall Study|Not reported|0|||
23296696|NCT04034355|64828085|FG000|Overall Study|Lost to Follow-up|1|||
23388707|NCT03715829|65168793|FG005|Extension Period|Withdrawal by Subject|0|||
23388708|NCT03715829|65168794|FG006|Extension Period|Withdrawal by Subject|3|||
23388709|NCT03715829|65168795|FG007|Extension Period|Withdrawal by Subject|3|||
23388710|NCT03715829|65168796|FG008|Extension Period|Withdrawal by Subject|12|||
23296697|NCT04034355|64828086|FG001|Overall Study|Lost to Follow-up|0|||
23296698|NCT04034355|64828085|FG000|Overall Study|Physician Decision|1|||
23296699|NCT04034355|64828086|FG001|Overall Study|Physician Decision|0|||
23296700|NCT04034355|64828085|FG000|Overall Study|Protocol Violation|0|||
23296701|NCT04034355|64828086|FG001|Overall Study|Protocol Violation|1|||
23296702|NCT04034355|64828085|FG000|Overall Study|Progressive disease|1|||
23296703|NCT04034355|64828086|FG001|Overall Study|Progressive disease|0|||
23296704|NCT02284347|64828087|FG000|Overall Study|Lost to Follow-up|2|||
23296705|NCT02284347|64828087|FG000|Overall Study|Withdrawn prior to treatment|1|||
23296706|NCT01396421|64828088|FG000|Overall Study|Lost to Follow-up|0|||
23296707|NCT01396421|64828089|FG001|Overall Study|Lost to Follow-up|0|||
23296708|NCT01396421|64828090|FG002|Overall Study|Lost to Follow-up|0|||
23296709|NCT01396421|64828091|FG003|Overall Study|Lost to Follow-up|1|||
23296710|NCT01396421|64828088|FG000|Overall Study|Adverse Event|17|||
23388711|NCT03715829|65168797|FG009|Extension Period|Withdrawal by Subject|3|||
23494722|NCT03307785|65555007|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23296711|NCT01396421|64828089|FG001|Overall Study|Adverse Event|15|||
23296712|NCT01396421|64828090|FG002|Overall Study|Adverse Event|12|||
23296713|NCT01396421|64828091|FG003|Overall Study|Adverse Event|32|||
23296714|NCT01396421|64828088|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
23388712|NCT03715829|65168798|FG010|Extension Period|Withdrawal by Subject|0|||
23296715|NCT01396421|64828089|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
23296716|NCT01396421|64828090|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
23296717|NCT01396421|64828091|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
23296718|NCT01396421|64828088|FG000|Overall Study|Physician Decision|1|||
23296719|NCT01396421|64828089|FG001|Overall Study|Physician Decision|1|||
23296720|NCT01396421|64828090|FG002|Overall Study|Physician Decision|0|||
23296721|NCT01396421|64828091|FG003|Overall Study|Physician Decision|3|||
23296722|NCT01396421|64828088|FG000|Overall Study|Withdrawal by Subject|31|||
23296723|NCT01396421|64828089|FG001|Overall Study|Withdrawal by Subject|24|||
23296724|NCT01396421|64828090|FG002|Overall Study|Withdrawal by Subject|13|||
23296725|NCT01396421|64828091|FG003|Overall Study|Withdrawal by Subject|21|||
23296726|NCT01396421|64828088|FG000|Overall Study|Protocol Deviation|2|||
23296727|NCT01396421|64828089|FG001|Overall Study|Protocol Deviation|1|||
23296728|NCT01396421|64828090|FG002|Overall Study|Protocol Deviation|1|||
23296729|NCT01396421|64828091|FG003|Overall Study|Protocol Deviation|0|||
23296730|NCT01396421|64828088|FG000|Overall Study|Lack of Efficacy|7|||
23296731|NCT01396421|64828089|FG001|Overall Study|Lack of Efficacy|17|||
23296732|NCT01396421|64828090|FG002|Overall Study|Lack of Efficacy|7|||
23296733|NCT01396421|64828091|FG003|Overall Study|Lack of Efficacy|18|||
23296734|NCT02747004|64828094|FG000|Overall Study|Withdrawal by Subject|8|||
23296735|NCT02747004|64828095|FG001|Overall Study|Withdrawal by Subject|5|||
23296736|NCT02747004|64828096|FG002|Overall Study|Withdrawal by Subject|4|||
23296737|NCT02747004|64828094|FG000|Overall Study|Lost to Follow-up|1|||
23296738|NCT02747004|64828095|FG001|Overall Study|Lost to Follow-up|2|||
23296739|NCT02747004|64828096|FG002|Overall Study|Lost to Follow-up|2|||
23296740|NCT02747004|64828094|FG000|Overall Study|on study treatment/follow-up|48|||
23296741|NCT02747004|64828095|FG001|Overall Study|on study treatment/follow-up|42|||
23296742|NCT02747004|64828096|FG002|Overall Study|on study treatment/follow-up|41|||
23296743|NCT00766831|64828097|FG000|Overall Study|Withdrawal by Subject|4|||
23296744|NCT00766831|64828097|FG000|Overall Study|Lost to Follow-up|3|||
23296745|NCT00766831|64828097|FG000|Overall Study|Adverse Event|20|||
23296746|NCT00766831|64828097|FG000|Overall Study|Protocol Violation|15|||
23296747|NCT00766831|64828097|FG000|Overall Study|Physician Decision|5|||
23296748|NCT00766831|64828097|FG000|Overall Study|Withdrawal of consent|26|||
23296749|NCT00766831|64828097|FG000|Overall Study|Non cooperation by participants|14|||
23296750|NCT00766831|64828097|FG000|Overall Study|Other|28|||
23296761|NCT04675775|64828108|FG000|Overall Study|Withdrawal by Subject|7|||
23296762|NCT00868296|64828113|FG000|Overall Study|Adverse Event|0|||
23296763|NCT00868296|64828114|FG001|Overall Study|Adverse Event|2|||
23296764|NCT00868296|64828113|FG000|Overall Study|Withdrawal by Subject|0|||
23296765|NCT00868296|64828114|FG001|Overall Study|Withdrawal by Subject|1|||
23296766|NCT01297322|64828118|FG000|Overall Study|Lost to Follow-up|1|||
23296767|NCT01297322|64828119|FG001|Overall Study|Lost to Follow-up|0|||
23296768|NCT01297322|64828118|FG000|Overall Study|Withdrawal by Subject|0|||
23296769|NCT01297322|64828119|FG001|Overall Study|Withdrawal by Subject|1|||
23296770|NCT01297322|64828118|FG000|Overall Study|Protocol Violation|0|||
23296771|NCT01297322|64828119|FG001|Overall Study|Protocol Violation|3|||
23296772|NCT02087176|64828120|FG000|Overall Study|Withdrawal by Subject|1|||
23296773|NCT02087176|64828120|FG000|Overall Study|Death|10|||
23296774|NCT02087176|64828120|FG000|Overall Study|Censored|19|||
23296775|NCT02087176|64828120|FG000|Overall Study|Study Terminated by Sponsor|2|||
23296776|NCT00897949|64828121|FG000|Overall Study|Adverse Event|1|||
23296777|NCT00897949|64828122|FG001|Overall Study|Adverse Event|1|||
23296778|NCT00897949|64828123|FG002|Overall Study|Adverse Event|0|||
23296779|NCT00897949|64828121|FG000|Overall Study|Lost to Follow-up|0|||
23296780|NCT00897949|64828122|FG001|Overall Study|Lost to Follow-up|2|||
23296781|NCT00897949|64828123|FG002|Overall Study|Lost to Follow-up|1|||
23296782|NCT00897949|64828121|FG000|Overall Study|Protocol Violation|6|||
23296783|NCT00897949|64828122|FG001|Overall Study|Protocol Violation|3|||
23296784|NCT00897949|64828123|FG002|Overall Study|Protocol Violation|1|||
23296785|NCT00897949|64828121|FG000|Overall Study|Withdrawal by Subject|1|||
23296786|NCT00897949|64828122|FG001|Overall Study|Withdrawal by Subject|2|||
23296787|NCT00897949|64828123|FG002|Overall Study|Withdrawal by Subject|0|||
23296788|NCT00897949|64828121|FG000|Overall Study|Patient Uncoorperative|0|||
23296789|NCT00897949|64828122|FG001|Overall Study|Patient Uncoorperative|2|||
23296790|NCT00897949|64828123|FG002|Overall Study|Patient Uncoorperative|1|||
23296791|NCT00897949|64828121|FG000|Overall Study|Lost to Follow-up|30|||
23296792|NCT00897949|64828122|FG001|Overall Study|Lost to Follow-up|23|||
23296793|NCT00897949|64828123|FG002|Overall Study|Lost to Follow-up|17|||
23296794|NCT00897949|64828121|FG000|Overall Study|Withdrawal by Subject|24|||
23296795|NCT00897949|64828122|FG001|Overall Study|Withdrawal by Subject|31|||
23296796|NCT00897949|64828123|FG002|Overall Study|Withdrawal by Subject|17|||
23296797|NCT00897949|64828121|FG000|Overall Study|Abnormal Prestudy Labs|2|||
23296798|NCT00897949|64828122|FG001|Overall Study|Abnormal Prestudy Labs|3|||
23296799|NCT00897949|64828123|FG002|Overall Study|Abnormal Prestudy Labs|4|||
23296800|NCT00897949|64828121|FG000|Overall Study|Abnormal Baseline ECG|2|||
23296801|NCT00897949|64828122|FG001|Overall Study|Abnormal Baseline ECG|2|||
23296802|NCT00897949|64828123|FG002|Overall Study|Abnormal Baseline ECG|4|||
23296803|NCT00897949|64828121|FG000|Overall Study|Need for Concom. Med.|0|||
23296804|NCT00897949|64828122|FG001|Overall Study|Need for Concom. Med.|1|||
23296805|NCT00897949|64828123|FG002|Overall Study|Need for Concom. Med.|1|||
23296806|NCT00897949|64828121|FG000|Overall Study|Lack of Migraine Attack|29|||
23296807|NCT00897949|64828122|FG001|Overall Study|Lack of Migraine Attack|30|||
23296808|NCT00897949|64828123|FG002|Overall Study|Lack of Migraine Attack|19|||
23388713|NCT03715829|65168788|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388714|NCT03715829|65168789|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388715|NCT03715829|65168790|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388716|NCT03715829|65168791|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388717|NCT03715829|65168792|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388718|NCT03715829|65168793|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388719|NCT03715829|65168794|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388720|NCT03715829|65168795|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
23494723|NCT03307785|65555008|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23296809|NCT00897949|64828121|FG000|Overall Study|Did not take study drug|9|||
23296810|NCT00897949|64828122|FG001|Overall Study|Did not take study drug|3|||
23296811|NCT00897949|64828123|FG002|Overall Study|Did not take study drug|4|||
23296812|NCT05506358|64828124|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
23296813|NCT05506358|64828125|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
23296814|NCT05506358|64828126|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
23296815|NCT05506358|64828127|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
23296816|NCT05506358|64828128|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
23296817|NCT05506358|64828124|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
23296818|NCT05506358|64828125|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
23296819|NCT05506358|64828126|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
23296820|NCT05506358|64828127|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
23296821|NCT05506358|64828128|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
23296822|NCT05506358|64828124|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
23296823|NCT05506358|64828125|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
23296824|NCT05506358|64828126|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
23296825|NCT05506358|64828127|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
23296826|NCT05506358|64828128|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
23296827|NCT05506358|64828124|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
23296828|NCT05506358|64828125|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
23296829|NCT05506358|64828126|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
23296830|NCT05506358|64828127|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
23296831|NCT05506358|64828128|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
23296832|NCT05506358|64828124|FG000|Overall Study|HbE trait|0|||
23296833|NCT05506358|64828125|FG001|Overall Study|HbE trait|0|||
23296834|NCT05506358|64828126|FG002|Overall Study|HbE trait|0|||
23296835|NCT05506358|64828127|FG003|Overall Study|HbE trait|1|||
23296836|NCT05506358|64828128|FG004|Overall Study|HbE trait|0|||
23296837|NCT00307931|64828129|FG000|Overall Study|Adverse Event|1|||
23296838|NCT03653026|64828140|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
23296839|NCT03653026|64828141|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
23296840|NCT03653026|64828142|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
23296841|NCT03653026|64828143|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
23296842|NCT03653026|64828140|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
23296843|NCT03653026|64828141|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
23296844|NCT03653026|64828142|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23296845|NCT03653026|64828143|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
23296846|NCT03653026|64828140|FG000|Part 1: Placebo-controlled Period|Other|0|||
23296847|NCT03653026|64828141|FG001|Part 1: Placebo-controlled Period|Other|3|||
23296848|NCT03653026|64828142|FG002|Part 1: Placebo-controlled Period|Other|0|||
23296849|NCT03653026|64828143|FG003|Part 1: Placebo-controlled Period|Other|0|||
23296850|NCT03653026|64828140|FG000|Part 2: Open-label Extension|Adverse Event|0|||
23296851|NCT03653026|64828141|FG001|Part 2: Open-label Extension|Adverse Event|0|||
23296852|NCT03653026|64828142|FG002|Part 2: Open-label Extension|Adverse Event|1|||
23296853|NCT03653026|64828143|FG003|Part 2: Open-label Extension|Adverse Event|1|||
23296854|NCT03653026|64828140|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
23296855|NCT03653026|64828141|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
23296856|NCT03653026|64828142|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
23296857|NCT03653026|64828143|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
23296858|NCT03653026|64828140|FG000|Part 2: Open-label Extension|Other|0|||
23296859|NCT03653026|64828141|FG001|Part 2: Open-label Extension|Other|0|||
23296860|NCT03653026|64828142|FG002|Part 2: Open-label Extension|Other|1|||
23296861|NCT03653026|64828143|FG003|Part 2: Open-label Extension|Other|2|||
23296862|NCT00988208|64828144|FG000|Overall Study|Adverse Event|71|||
23296863|NCT00988208|64828145|FG001|Overall Study|Adverse Event|122|||
23296864|NCT00988208|64828144|FG000|Overall Study|Disease Progression|103|||
23296865|NCT00988208|64828145|FG001|Overall Study|Disease Progression|89|||
23296866|NCT00988208|64828144|FG000|Overall Study|Withdrawal by Subject|50|||
23296867|NCT00988208|64828145|FG001|Overall Study|Withdrawal by Subject|57|||
23296868|NCT00988208|64828144|FG000|Overall Study|Death|9|||
23296869|NCT00988208|64828145|FG001|Overall Study|Death|15|||
23296870|NCT00988208|64828144|FG000|Overall Study|Lost to Follow-up|2|||
23296871|NCT00988208|64828145|FG001|Overall Study|Lost to Follow-up|3|||
23296872|NCT00988208|64828144|FG000|Overall Study|Protocol Violation|9|||
23296873|NCT00988208|64828145|FG001|Overall Study|Protocol Violation|2|||
23296874|NCT00988208|64828144|FG000|Overall Study|Sponsor Decision|102|||
23296875|NCT00988208|64828145|FG001|Overall Study|Sponsor Decision|78|||
23296876|NCT00988208|64828144|FG000|Overall Study|Clinical Progression|17|||
23296877|NCT00988208|64828145|FG001|Overall Study|Clinical Progression|16|||
23296878|NCT00988208|64828144|FG000|Overall Study|Biochemical Progression|21|||
23296879|NCT00988208|64828145|FG001|Overall Study|Biochemical Progression|7|||
23296880|NCT00988208|64828144|FG000|Overall Study|Clinical Deterioration|7|||
23296881|NCT00988208|64828145|FG001|Overall Study|Clinical Deterioration|14|||
23296882|NCT00988208|64828144|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
23296883|NCT00988208|64828145|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
23296884|NCT00988208|64828144|FG000|Overall Study|Other|8|||
23296885|NCT00988208|64828145|FG001|Overall Study|Other|3|||
23296886|NCT02843659|64828146|FG000|Overall Study|Subject Withdrew Consent|0|||
23296887|NCT02843659|64828147|FG001|Overall Study|Subject Withdrew Consent|0|||
23296888|NCT02843659|64828148|FG002|Overall Study|Subject Withdrew Consent|1|||
23296889|NCT02843659|64828146|FG000|Overall Study|Administrative Reason by Sponsor|4|||
23296890|NCT02843659|64828147|FG001|Overall Study|Administrative Reason by Sponsor|5|||
23296891|NCT02843659|64828148|FG002|Overall Study|Administrative Reason by Sponsor|4|||
23296892|NCT02843659|64828146|FG000|Overall Study|Adverse Event|0|||
23296893|NCT02843659|64828147|FG001|Overall Study|Adverse Event|1|||
23296894|NCT02843659|64828148|FG002|Overall Study|Adverse Event|0|||
23296895|NCT00684567|64828149|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
23296896|NCT00684567|64828149|FG000|Monotherapy Period|Adverse Event|2|||
23296897|NCT00684567|64828149|FG000|Monotherapy Period|Death|1|||
23296898|NCT00684567|64828149|FG000|Monotherapy Period|Progression of primary disease|11|||
23296899|NCT00515034|64828151|FG000|Overall Study|Adverse Event|2|||
23296900|NCT00515034|64828152|FG001|Overall Study|Adverse Event|0|||
23296901|NCT00515034|64828153|FG002|Overall Study|Adverse Event|1|||
23296902|NCT00515034|64828154|FG003|Overall Study|Adverse Event|0|||
23296903|NCT00515034|64828151|FG000|Overall Study|Death|4|||
23296904|NCT00515034|64828152|FG001|Overall Study|Death|2|||
23296905|NCT00515034|64828153|FG002|Overall Study|Death|1|||
23296906|NCT00515034|64828154|FG003|Overall Study|Death|3|||
23296907|NCT00515034|64828151|FG000|Overall Study|Withdrawal by Subject|1|||
23296908|NCT00515034|64828152|FG001|Overall Study|Withdrawal by Subject|0|||
23296909|NCT00515034|64828153|FG002|Overall Study|Withdrawal by Subject|3|||
23296910|NCT00515034|64828154|FG003|Overall Study|Withdrawal by Subject|0|||
23296911|NCT00515034|64828151|FG000|Overall Study|Physician Decision|0|||
23296912|NCT00515034|64828152|FG001|Overall Study|Physician Decision|0|||
23494724|NCT03307785|65555009|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
23296913|NCT00515034|64828153|FG002|Overall Study|Physician Decision|1|||
23296914|NCT00515034|64828154|FG003|Overall Study|Physician Decision|1|||
23296915|NCT00515034|64828151|FG000|Overall Study|Other|1|||
23494725|NCT03307785|65554999|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23494726|NCT03307785|65555000|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23494727|NCT03307785|65555001|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23296916|NCT00515034|64828152|FG001|Overall Study|Other|0|||
23296917|NCT00515034|64828153|FG002|Overall Study|Other|2|||
23296918|NCT00515034|64828154|FG003|Overall Study|Other|1|||
23296919|NCT00373425|64828157|FG000|Overall Study|Relapse of NSCLC|116|||
23296920|NCT00373425|64828158|FG001|Overall Study|Relapse of NSCLC|104|||
23296921|NCT00373425|64828159|FG002|Overall Study|Relapse of NSCLC|19|||
23296922|NCT00373425|64828160|FG003|Overall Study|Relapse of NSCLC|2|||
23296923|NCT00373425|64828161|FG004|Overall Study|Relapse of NSCLC|26|||
23296924|NCT00373425|64828157|FG000|Overall Study|Adverse Event|191|||
23296925|NCT00373425|64828158|FG001|Overall Study|Adverse Event|22|||
23296926|NCT00373425|64828159|FG002|Overall Study|Adverse Event|59|||
23296927|NCT00373425|64828160|FG003|Overall Study|Adverse Event|0|||
23296928|NCT00373425|64828161|FG004|Overall Study|Adverse Event|34|||
23296929|NCT00373425|64828157|FG000|Overall Study|Patient request|35|||
23296930|NCT00373425|64828158|FG001|Overall Study|Patient request|18|||
23296931|NCT00373425|64828159|FG002|Overall Study|Patient request|43|||
23296932|NCT00373425|64828160|FG003|Overall Study|Patient request|6|||
23296933|NCT00373425|64828161|FG004|Overall Study|Patient request|7|||
23296934|NCT00373425|64828157|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
23296935|NCT00373425|64828158|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
23296936|NCT00373425|64828159|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
23296937|NCT00373425|64828160|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
23296938|NCT00373425|64828161|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
23296939|NCT00373425|64828157|FG000|Overall Study|Death|7|||
23296940|NCT00373425|64828158|FG001|Overall Study|Death|0|||
23296941|NCT00373425|64828159|FG002|Overall Study|Death|3|||
23296942|NCT00373425|64828160|FG003|Overall Study|Death|1|||
23296943|NCT00373425|64828161|FG004|Overall Study|Death|0|||
23296944|NCT01239472|64828170|FG000|Overall Study|Withdrawal by Subject|5|||
23296945|NCT01239472|64828171|FG001|Overall Study|Withdrawal by Subject|1|||
23296946|NCT01239472|64828170|FG000|Overall Study|Adverse Event|0|||
23296947|NCT01239472|64828171|FG001|Overall Study|Adverse Event|1|||
23296948|NCT01239472|64828170|FG000|Overall Study|Lack of Efficacy|0|||
23296949|NCT01239472|64828171|FG001|Overall Study|Lack of Efficacy|1|||
23296950|NCT03253094|64828172|FG000|Overall Study|Adverse Event|2|||
23296951|NCT03253094|64828173|FG001|Overall Study|Adverse Event|0|||
23296952|NCT03253094|64828174|FG002|Overall Study|Adverse Event|0|||
23296953|NCT03253094|64828175|FG003|Overall Study|Adverse Event|0|||
23296954|NCT03253094|64828176|FG004|Overall Study|Adverse Event|0|||
23296955|NCT03253094|64828177|FG005|Overall Study|Adverse Event|0|||
23296956|NCT03253094|64828172|FG000|Overall Study|Lack of Efficacy|0|||
23296957|NCT03253094|64828173|FG001|Overall Study|Lack of Efficacy|0|||
23296958|NCT03253094|64828174|FG002|Overall Study|Lack of Efficacy|2|||
23296959|NCT03253094|64828175|FG003|Overall Study|Lack of Efficacy|1|||
23296960|NCT03253094|64828176|FG004|Overall Study|Lack of Efficacy|2|||
23296961|NCT03253094|64828177|FG005|Overall Study|Lack of Efficacy|1|||
23296962|NCT03253094|64828172|FG000|Overall Study|Lost to Follow-up|0|||
23296963|NCT03253094|64828173|FG001|Overall Study|Lost to Follow-up|0|||
23296964|NCT03253094|64828174|FG002|Overall Study|Lost to Follow-up|1|||
23296965|NCT03253094|64828175|FG003|Overall Study|Lost to Follow-up|1|||
23296966|NCT03253094|64828176|FG004|Overall Study|Lost to Follow-up|0|||
23296967|NCT03253094|64828177|FG005|Overall Study|Lost to Follow-up|1|||
23296968|NCT03253094|64828172|FG000|Overall Study|Physician Decision|1|||
23296969|NCT03253094|64828173|FG001|Overall Study|Physician Decision|0|||
23296970|NCT03253094|64828174|FG002|Overall Study|Physician Decision|0|||
23296971|NCT03253094|64828175|FG003|Overall Study|Physician Decision|1|||
23296972|NCT03253094|64828176|FG004|Overall Study|Physician Decision|0|||
23296973|NCT03253094|64828177|FG005|Overall Study|Physician Decision|2|||
23296974|NCT03253094|64828172|FG000|Overall Study|Withdrawal by Subject|1|||
23296975|NCT03253094|64828173|FG001|Overall Study|Withdrawal by Subject|2|||
23296976|NCT03253094|64828174|FG002|Overall Study|Withdrawal by Subject|1|||
23296977|NCT03253094|64828175|FG003|Overall Study|Withdrawal by Subject|0|||
23296978|NCT03253094|64828176|FG004|Overall Study|Withdrawal by Subject|3|||
23494728|NCT03307785|65555002|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
23296979|NCT03253094|64828177|FG005|Overall Study|Withdrawal by Subject|0|||
23296980|NCT03253094|64828172|FG000|Overall Study|Other|0|||
23296981|NCT03253094|64828173|FG001|Overall Study|Other|1|||
23296982|NCT03253094|64828174|FG002|Overall Study|Other|2|||
23296983|NCT03253094|64828175|FG003|Overall Study|Other|1|||
23296984|NCT03253094|64828176|FG004|Overall Study|Other|0|||
23388721|NCT03715829|65168796|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
23494729|NCT03307785|65555003|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
23296985|NCT03253094|64828177|FG005|Overall Study|Other|0|||
23296986|NCT00114231|64828179|FG000|Overall Study|No consent|2|||
23296987|NCT00114231|64828180|FG001|Overall Study|No consent|0|||
23296988|NCT00114231|64828179|FG000|Overall Study|QARC requirement not met|1|||
23296989|NCT00114231|64828180|FG001|Overall Study|QARC requirement not met|0|||
23296990|NCT00114231|64828179|FG000|Overall Study|Suspected metastatic disease|1|||
23296991|NCT00114231|64828180|FG001|Overall Study|Suspected metastatic disease|0|||
23388722|NCT03715829|65168797|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388723|NCT03715829|65168798|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
23388724|NCT03715829|65168788|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388725|NCT03715829|65168789|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388726|NCT03715829|65168790|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388727|NCT03715829|65168791|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
23296992|NCT00114231|64828179|FG000|Overall Study|No adenocarcinoma|1|||
23296993|NCT00114231|64828180|FG001|Overall Study|No adenocarcinoma|0|||
23296994|NCT00114231|64828179|FG000|Overall Study|Low creatinine clearance|0|||
23296995|NCT00114231|64828180|FG001|Overall Study|Low creatinine clearance|1|||
23296996|NCT00114231|64828179|FG000|Overall Study|Tumor size > 4cm|1|||
23296997|NCT00114231|64828180|FG001|Overall Study|Tumor size > 4cm|0|||
23296998|NCT00114231|64828179|FG000|Overall Study|Tumor fixed on digital exam|0|||
23296999|NCT00114231|64828180|FG001|Overall Study|Tumor fixed on digital exam|1|||
23297000|NCT00114231|64828179|FG000|Overall Study|No Absolute Neutrophil Count|2|||
23297001|NCT00114231|64828180|FG001|Overall Study|No Absolute Neutrophil Count|0|||
23297002|NCT00114231|64828179|FG000|Overall Study|Biopsy done after registration|1|||
23297003|NCT00114231|64828180|FG001|Overall Study|Biopsy done after registration|0|||
23297004|NCT00063882|64828191|FG000|Overall Study|Protocol Violation|3|||
23297005|NCT00063882|64828192|FG001|Overall Study|Protocol Violation|3|||
23297006|NCT00063882|64828191|FG000|Overall Study|Withdrawal by Subject|2|||
23297007|NCT00063882|64828192|FG001|Overall Study|Withdrawal by Subject|1|||
23388728|NCT03715829|65168792|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
23297008|NCT02181296|64828193|FG000|Overall Study|Lost to Follow-up|7|||
23297009|NCT02181296|64828194|FG001|Overall Study|Lost to Follow-up|6|||
23297010|NCT02858726|64828195|FG000|Overall Study|Adverse Event|4|||
23297011|NCT02858726|64828196|FG001|Overall Study|Adverse Event|4|||
23297012|NCT02858726|64828197|FG002|Overall Study|Adverse Event|9|||
23297013|NCT02858726|64828198|FG003|Overall Study|Adverse Event|1|||
23297014|NCT02858726|64828195|FG000|Overall Study|Physician Decision|0|||
23297015|NCT02858726|64828196|FG001|Overall Study|Physician Decision|0|||
23297016|NCT02858726|64828197|FG002|Overall Study|Physician Decision|1|||
23297017|NCT02858726|64828198|FG003|Overall Study|Physician Decision|0|||
23297018|NCT02858726|64828195|FG000|Overall Study|Protocol Violation|0|||
23297019|NCT02858726|64828196|FG001|Overall Study|Protocol Violation|0|||
23297020|NCT02858726|64828197|FG002|Overall Study|Protocol Violation|0|||
23297021|NCT02858726|64828198|FG003|Overall Study|Protocol Violation|1|||
23297022|NCT02858726|64828195|FG000|Overall Study|Study Terminated by Sponsor|0|||
23297023|NCT02858726|64828196|FG001|Overall Study|Study Terminated by Sponsor|0|||
23297024|NCT02858726|64828197|FG002|Overall Study|Study Terminated by Sponsor|0|||
23297025|NCT02858726|64828198|FG003|Overall Study|Study Terminated by Sponsor|1|||
23297026|NCT02858726|64828195|FG000|Overall Study|Withdrawal by Subject|1|||
23297027|NCT02858726|64828196|FG001|Overall Study|Withdrawal by Subject|2|||
23297028|NCT02858726|64828197|FG002|Overall Study|Withdrawal by Subject|1|||
23297029|NCT02858726|64828198|FG003|Overall Study|Withdrawal by Subject|0|||
23297030|NCT02858726|64828195|FG000|Overall Study|Noncompliance|0|||
23297031|NCT02858726|64828196|FG001|Overall Study|Noncompliance|1|||
23297032|NCT02858726|64828197|FG002|Overall Study|Noncompliance|0|||
23297033|NCT02858726|64828198|FG003|Overall Study|Noncompliance|0|||
23297034|NCT02219308|64828199|FG000|Overall Study|Withdrawal by Subject|1|||
23297035|NCT02219308|64828200|FG001|Overall Study|Withdrawal by Subject|2|||
23297036|NCT02220725|64828203|FG000|Overall Study|Lost to Follow-up|0|||
23297037|NCT02220725|64828204|FG001|Overall Study|Lost to Follow-up|0|||
23297038|NCT02220725|64828205|FG002|Overall Study|Lost to Follow-up|0|||
23297039|NCT02220725|64828206|FG003|Overall Study|Lost to Follow-up|1|||
23297040|NCT02220725|64828203|FG000|Overall Study|Withdrawal by Subject|0|||
23297041|NCT02220725|64828204|FG001|Overall Study|Withdrawal by Subject|0|||
23297042|NCT02220725|64828205|FG002|Overall Study|Withdrawal by Subject|0|||
23297043|NCT02220725|64828206|FG003|Overall Study|Withdrawal by Subject|1|||
23297044|NCT00346164|64828207|FG000|Overall Study|Adverse Event|0|||
23297045|NCT00346164|64828208|FG001|Overall Study|Adverse Event|0|||
23297046|NCT00346164|64828209|FG002|Overall Study|Adverse Event|0|||
23297047|NCT00346164|64828210|FG003|Overall Study|Adverse Event|1|||
23297048|NCT00346164|64828207|FG000|Overall Study|Lack of Efficacy|0|||
23297049|NCT00346164|64828208|FG001|Overall Study|Lack of Efficacy|1|||
23297050|NCT00346164|64828209|FG002|Overall Study|Lack of Efficacy|7|||
23297051|NCT00346164|64828210|FG003|Overall Study|Lack of Efficacy|25|||
23297052|NCT00346164|64828207|FG000|Overall Study|Physician Decision|0|||
23297053|NCT00346164|64828208|FG001|Overall Study|Physician Decision|1|||
23297054|NCT00346164|64828209|FG002|Overall Study|Physician Decision|2|||
23297055|NCT00346164|64828210|FG003|Overall Study|Physician Decision|27|||
23297056|NCT00346164|64828207|FG000|Overall Study|Protocol Violation|6|||
23297057|NCT00346164|64828208|FG001|Overall Study|Protocol Violation|2|||
23297058|NCT00346164|64828209|FG002|Overall Study|Protocol Violation|10|||
23297059|NCT00346164|64828210|FG003|Overall Study|Protocol Violation|4|||
23388729|NCT03715829|65168793|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388730|NCT03715829|65168794|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
23297060|NCT00346164|64828207|FG000|Overall Study|Withdrawal by Subject|0|||
23297061|NCT00346164|64828208|FG001|Overall Study|Withdrawal by Subject|0|||
23297062|NCT00346164|64828209|FG002|Overall Study|Withdrawal by Subject|2|||
23297063|NCT00346164|64828210|FG003|Overall Study|Withdrawal by Subject|0|||
23297064|NCT00346164|64828207|FG000|Overall Study|Ineligible|11|||
23297065|NCT00346164|64828208|FG001|Overall Study|Ineligible|2|||
23297066|NCT00346164|64828209|FG002|Overall Study|Ineligible|2|||
23297067|NCT00346164|64828210|FG003|Overall Study|Ineligible|23|||
23297068|NCT00346164|64828207|FG000|Overall Study|Refusal of further protocol therapy|0|||
23297069|NCT00346164|64828208|FG001|Overall Study|Refusal of further protocol therapy|1|||
23297070|NCT00346164|64828209|FG002|Overall Study|Refusal of further protocol therapy|3|||
23297071|NCT00346164|64828210|FG003|Overall Study|Refusal of further protocol therapy|15|||
23297072|NCT00346164|64828207|FG000|Overall Study|Inability to start week 16 tx on time|0|||
23297073|NCT00346164|64828208|FG001|Overall Study|Inability to start week 16 tx on time|0|||
23297074|NCT00346164|64828209|FG002|Overall Study|Inability to start week 16 tx on time|0|||
23297075|NCT00346164|64828210|FG003|Overall Study|Inability to start week 16 tx on time|11|||
23297076|NCT04059549|64828211|FG000|Overall Study|Withdrawal by Subject|2|||
23297077|NCT04059549|64828212|FG001|Overall Study|Withdrawal by Subject|0|||
23297078|NCT02502734|64828214|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
23297079|NCT02502734|64828215|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
23297080|NCT02502734|64828214|FG000|Washout Period|Adverse Event|1|||
23297081|NCT02502734|64828215|FG001|Washout Period|Adverse Event|0|||
23297082|NCT04403763|64828221|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
23297083|NCT04403763|64828222|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
23297084|NCT04403763|64828223|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
23297085|NCT04403763|64828224|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
23297086|NCT04403763|64828225|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
23297087|NCT04403763|64828226|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
23297088|NCT04403763|64828227|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
23297089|NCT04403763|64828221|FG000|Stage 1|Early termination due to PK tube failure|0|||
23297090|NCT04403763|64828222|FG001|Stage 1|Early termination due to PK tube failure|0|||
23297091|NCT04403763|64828223|FG002|Stage 1|Early termination due to PK tube failure|1|||
23297092|NCT04403763|64828224|FG003|Stage 1|Early termination due to PK tube failure|0|||
23297093|NCT04403763|64828225|FG004|Stage 1|Early termination due to PK tube failure|0|||
23297094|NCT04403763|64828226|FG005|Stage 1|Early termination due to PK tube failure|0|||
23297095|NCT04403763|64828227|FG006|Stage 1|Early termination due to PK tube failure|0|||
23297096|NCT04403763|64828221|FG000|Stage 2A|Adverse Event|0|||
23297097|NCT04403763|64828222|FG001|Stage 2A|Adverse Event|0|||
23297098|NCT04403763|64828223|FG002|Stage 2A|Adverse Event|0|||
23297099|NCT04403763|64828224|FG003|Stage 2A|Adverse Event|0|||
23297100|NCT04403763|64828225|FG004|Stage 2A|Adverse Event|0|||
23297101|NCT04403763|64828226|FG005|Stage 2A|Adverse Event|0|||
23297102|NCT04403763|64828227|FG006|Stage 2A|Adverse Event|1|||
23297103|NCT04025684|64828231|FG000|Overall Study|Withdrawal by Subject|1|||
23297104|NCT04025684|64828232|FG001|Overall Study|Withdrawal by Subject|1|||
23297105|NCT04025684|64828233|FG002|Overall Study|Withdrawal by Subject|0|||
23297106|NCT04025684|64828234|FG003|Overall Study|Withdrawal by Subject|0|||
23297107|NCT04025684|64828231|FG000|Overall Study|Multiple reasons|1|||
23297108|NCT04025684|64828232|FG001|Overall Study|Multiple reasons|3|||
23297109|NCT04025684|64828233|FG002|Overall Study|Multiple reasons|0|||
23297110|NCT04025684|64828234|FG003|Overall Study|Multiple reasons|1|||
23297111|NCT03433755|64828238|FG000|Overall Study|Lost to Follow-up|1|||
23297112|NCT03433755|64828239|FG001|Overall Study|Lost to Follow-up|0|||
23297113|NCT03433755|64828240|FG002|Overall Study|Lost to Follow-up|0|||
23297114|NCT03433755|64828241|FG003|Overall Study|Lost to Follow-up|0|||
23297115|NCT03433755|64828238|FG000|Overall Study|Decision by Sponsor|1|||
23297116|NCT03433755|64828239|FG001|Overall Study|Decision by Sponsor|0|||
23297117|NCT03433755|64828240|FG002|Overall Study|Decision by Sponsor|0|||
23297118|NCT03433755|64828241|FG003|Overall Study|Decision by Sponsor|0|||
23297119|NCT02737592|64828242|FG000|Overall Study|Withdrawal by Subject|1|||
23297120|NCT01045707|64833048|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
23297121|NCT01045707|64833049|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
23388731|NCT03715829|65168795|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388732|NCT03715829|65168796|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
23297122|NCT01045707|64833048|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
23388733|NCT03715829|65168797|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
23297123|NCT01045707|64833049|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
23297124|NCT01045707|64833048|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
23297125|NCT01045707|64833049|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
23297126|NCT01045707|64833048|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
23297127|NCT01045707|64833049|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
23297128|NCT01045707|64833048|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
23297129|NCT01045707|64833049|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
23297130|NCT01045707|64833048|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
23297131|NCT01045707|64833049|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
23297132|NCT01045707|64833048|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
23297133|NCT01045707|64833049|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
23297134|NCT01045707|64833048|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
23297135|NCT01045707|64833049|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
23297136|NCT01045707|64833048|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
23297137|NCT01045707|64833049|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
23297138|NCT02459418|64833052|FG000|Overall Study|Exclusion Criteria|4|||
23297139|NCT02459418|64833053|FG001|Overall Study|Exclusion Criteria|0|||
23297140|NCT02459418|64833052|FG000|Overall Study|Protocol Violation|0|||
23297141|NCT02459418|64833053|FG001|Overall Study|Protocol Violation|2|||
23297142|NCT02459418|64833052|FG000|Overall Study|Physician Decision|0|||
23297143|NCT02459418|64833053|FG001|Overall Study|Physician Decision|2|||
23297144|NCT02459418|64833052|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
23297145|NCT02459418|64833053|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
23297146|NCT02459418|64833052|FG000|Overall Study|Adverse Event|0|||
23297147|NCT02459418|64833053|FG001|Overall Study|Adverse Event|1|||
23494730|NCT03307785|65555004|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23297148|NCT02459418|64833052|FG000|Overall Study|Withdrawal by Subject|1|||
23297149|NCT02459418|64833053|FG001|Overall Study|Withdrawal by Subject|1|||
23297150|NCT02459418|64833052|FG000|Overall Study|Elevated Creatine Kinase|1|||
23297151|NCT02459418|64833053|FG001|Overall Study|Elevated Creatine Kinase|0|||
23297152|NCT02459418|64833052|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
23297153|NCT02459418|64833053|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
23297154|NCT01567826|64833054|FG000|Overall Study|Lost to Follow-up|3|||
23297155|NCT01567826|64833055|FG001|Overall Study|Lost to Follow-up|2|||
23297156|NCT00613834|64833056|FG000|Overall Study|Withdrawal by Subject|0|||
23297157|NCT00613834|64833057|FG001|Overall Study|Withdrawal by Subject|3|||
23297158|NCT00094094|64833065|FG000|Overall Study|Death|2|||
23297159|NCT00094094|64833065|FG000|Overall Study|Lack of Efficacy|23|||
23297160|NCT00094094|64833065|FG000|Overall Study|Adverse Event|7|||
23297161|NCT00852917|64833066|FG000|Overall Study|Adverse Event|13|||
23297162|NCT00852917|64833067|FG001|Overall Study|Adverse Event|20|||
23297163|NCT00852917|64833068|FG002|Overall Study|Adverse Event|35|||
23297164|NCT00852917|64833069|FG003|Overall Study|Adverse Event|17|||
23297165|NCT00852917|64833066|FG000|Overall Study|Lack of Efficacy|21|||
23297166|NCT00852917|64833067|FG001|Overall Study|Lack of Efficacy|11|||
23297167|NCT00852917|64833068|FG002|Overall Study|Lack of Efficacy|11|||
23297168|NCT00852917|64833069|FG003|Overall Study|Lack of Efficacy|47|||
23297169|NCT00852917|64833066|FG000|Overall Study|Withdrawal by Subject|4|||
23297170|NCT00852917|64833067|FG001|Overall Study|Withdrawal by Subject|8|||
23297171|NCT00852917|64833068|FG002|Overall Study|Withdrawal by Subject|10|||
23297172|NCT00852917|64833069|FG003|Overall Study|Withdrawal by Subject|9|||
23297173|NCT00852917|64833066|FG000|Overall Study|Physician Decision|6|||
23297174|NCT00852917|64833067|FG001|Overall Study|Physician Decision|7|||
23297175|NCT00852917|64833068|FG002|Overall Study|Physician Decision|2|||
23297176|NCT00852917|64833069|FG003|Overall Study|Physician Decision|19|||
23297177|NCT00852917|64833066|FG000|Overall Study|Death|0|||
23297178|NCT00852917|64833067|FG001|Overall Study|Death|0|||
23297179|NCT00852917|64833068|FG002|Overall Study|Death|0|||
23297180|NCT00852917|64833069|FG003|Overall Study|Death|1|||
23297181|NCT00537199|64833070|FG000|Overall Study|Study Terminated|1|||
23388734|NCT03715829|65168798|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
23388735|NCT03715829|65168788|FG000|Extension Period|Other|0|||
23388736|NCT03715829|65168789|FG001|Extension Period|Other|0|||
23388737|NCT03715829|65168790|FG002|Extension Period|Other|0|||
23388738|NCT03715829|65168791|FG003|Extension Period|Other|0|||
23388739|NCT03715829|65168792|FG004|Extension Period|Other|0|||
23388740|NCT03715829|65168793|FG005|Extension Period|Other|0|||
23388741|NCT03715829|65168794|FG006|Extension Period|Other|1|||
23388742|NCT03715829|65168795|FG007|Extension Period|Other|2|||
23388743|NCT03715829|65168796|FG008|Extension Period|Other|4|||
23388744|NCT03715829|65168797|FG009|Extension Period|Other|0|||
23297182|NCT02021318|64833071|FG000|Overall Study|Adverse Event|2|||
23297183|NCT02021318|64833072|FG001|Overall Study|Adverse Event|1|||
23297184|NCT02021318|64833071|FG000|Overall Study|Death|33|||
23297185|NCT02021318|64833072|FG001|Overall Study|Death|34|||
23297186|NCT02021318|64833071|FG000|Overall Study|Lost to Follow-up|3|||
23297187|NCT02021318|64833072|FG001|Overall Study|Lost to Follow-up|3|||
23297188|NCT02021318|64833071|FG000|Overall Study|Progressive Disease|0|||
23297189|NCT02021318|64833072|FG001|Overall Study|Progressive Disease|1|||
23297190|NCT02021318|64833071|FG000|Overall Study|Withdrawal by Subject|30|||
23297191|NCT02021318|64833072|FG001|Overall Study|Withdrawal by Subject|18|||
23297192|NCT02021318|64833071|FG000|Overall Study|Physician Decision|3|||
23297193|NCT02021318|64833072|FG001|Overall Study|Physician Decision|3|||
23297194|NCT02021318|64833071|FG000|Overall Study|Miscellaneous|2|||
23297195|NCT02021318|64833072|FG001|Overall Study|Miscellaneous|3|||
23297196|NCT05016622|64833073|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
23297197|NCT05016622|64833073|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
23297198|NCT01640873|64833074|FG000|Overall Study|Protocol Violation|2|||
23297199|NCT01640873|64833075|FG001|Overall Study|Protocol Violation|1|||
23297200|NCT00949988|64833080|FG000|Overall Study|Withdrawal by Subject|3|||
23297201|NCT00710749|64833085|FG000|First Intervention|Withdrawal by Subject|1|||
23297202|NCT00710749|64833086|FG001|First Intervention|Withdrawal by Subject|0|||
23297203|NCT01189500|64833087|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
23297204|NCT01189500|64833087|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
23297205|NCT00987831|64833091|FG000|Overall Study|Never flared in 12 months|1|||
23297206|NCT00987831|64833092|FG001|Overall Study|Never flared in 12 months|0|||
23297207|NCT00987831|64833093|FG002|Overall Study|Never flared in 12 months|0|||
23297208|NCT00987831|64833091|FG000|Overall Study|Lost to Follow-up|0|||
23297209|NCT00987831|64833092|FG001|Overall Study|Lost to Follow-up|3|||
23388745|NCT03715829|65168798|FG010|Extension Period|Other|0|||
23388746|NCT02004275|65168799|FG000|Phase 1|Ineligible|0|||
23388747|NCT02004275|65168800|FG001|Phase 1|Ineligible|0|||
23388748|NCT02004275|65168801|FG002|Phase 1|Ineligible|0|||
23388749|NCT02004275|65168802|FG003|Phase 1|Ineligible|1|||
23388750|NCT02004275|65168803|FG004|Phase 1|Ineligible|1|||
23388751|NCT02004275|65168804|FG005|Phase 1|Ineligible|0|||
23388752|NCT02004275|65168799|FG000|Phase 1|Protocol Violation|0|||
23388753|NCT02004275|65168800|FG001|Phase 1|Protocol Violation|0|||
23388754|NCT02004275|65168801|FG002|Phase 1|Protocol Violation|0|||
23388755|NCT02004275|65168802|FG003|Phase 1|Protocol Violation|1|||
23388756|NCT02004275|65168803|FG004|Phase 1|Protocol Violation|0|||
23388757|NCT02004275|65168804|FG005|Phase 1|Protocol Violation|5|||
23388758|NCT02004275|65168799|FG000|Phase 2 Part 1|Ineligible|6|||
23388759|NCT02004275|65168800|FG001|Phase 2 Part 1|Ineligible|9|||
23388760|NCT02004275|65168801|FG002|Phase 2 Part 1|Ineligible|0|||
23388761|NCT02004275|65168802|FG003|Phase 2 Part 1|Ineligible|0|||
23388762|NCT02004275|65168803|FG004|Phase 2 Part 1|Ineligible|0|||
23388763|NCT02004275|65168804|FG005|Phase 2 Part 1|Ineligible|0|||
23388764|NCT02004275|65168799|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
23388765|NCT02004275|65168800|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
23494731|NCT03307785|65555005|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23297210|NCT00987831|64833093|FG002|Overall Study|Lost to Follow-up|0|||
23297211|NCT01132664|64833094|FG000|Phase lb|Adverse Event|0|||
23297212|NCT01132664|64833095|FG001|Phase lb|Adverse Event|1|||
23297213|NCT01132664|64833096|FG002|Phase lb|Adverse Event|0|||
23297214|NCT01132664|64833097|FG003|Phase lb|Adverse Event|0|||
23388766|NCT02004275|65168801|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
23388767|NCT02004275|65168802|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
23388768|NCT02004275|65168803|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
23388769|NCT02004275|65168804|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
23388770|NCT02536339|65168809|FG000|Overall Study|Death|20|||
23388771|NCT02536339|65168809|FG000|Overall Study|Withdrawal by Subject|3|||
23388772|NCT02536339|65168809|FG000|Overall Study|Lost to Follow-up|2|||
23388773|NCT02536339|65168809|FG000|Overall Study|Treatment discontinued|2|||
23388774|NCT02536339|65168809|FG000|Overall Study|Physician Decision|1|||
23388775|NCT02226653|65168812|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
23388776|NCT02226653|65168813|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
23388777|NCT02226653|65168812|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
23297215|NCT01132664|64833098|FG004|Phase lb|Adverse Event|0|||
23297216|NCT01132664|64833094|FG000|Phase lb|Withdrawal by Subject|1|||
23297217|NCT01132664|64833095|FG001|Phase lb|Withdrawal by Subject|2|||
23297218|NCT01132664|64833096|FG002|Phase lb|Withdrawal by Subject|0|||
23297219|NCT01132664|64833097|FG003|Phase lb|Withdrawal by Subject|0|||
23388778|NCT02226653|65168813|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
23388779|NCT02242903|65168814|FG000|Overall Study|Withdrawal by Subject|1|||
23388780|NCT02242903|65168815|FG001|Overall Study|Withdrawal by Subject|0|||
23388781|NCT02242903|65168816|FG002|Overall Study|Withdrawal by Subject|0|||
23388782|NCT02242903|65168817|FG003|Overall Study|Withdrawal by Subject|0|||
23388783|NCT02242903|65168818|FG004|Overall Study|Withdrawal by Subject|0|||
23388784|NCT02242903|65168819|FG005|Overall Study|Withdrawal by Subject|0|||
23388785|NCT02242903|65168820|FG006|Overall Study|Withdrawal by Subject|0|||
23388786|NCT01093573|65168823|FG000|Overall Study|Physician Decision|0|||
23388787|NCT01093573|65168824|FG001|Overall Study|Physician Decision|0|||
23297220|NCT01132664|64833098|FG004|Phase lb|Withdrawal by Subject|0|||
23297221|NCT01132664|64833094|FG000|Phase lb|Disease Progression|4|||
23297222|NCT01132664|64833095|FG001|Phase lb|Disease Progression|9|||
23297223|NCT01132664|64833096|FG002|Phase lb|Disease Progression|0|||
23297224|NCT01132664|64833097|FG003|Phase lb|Disease Progression|0|||
23297225|NCT01132664|64833098|FG004|Phase lb|Disease Progression|0|||
23297226|NCT01132664|64833094|FG000|Phase ll|Death|0|||
23297227|NCT01132664|64833095|FG001|Phase ll|Death|0|||
23297228|NCT01132664|64833096|FG002|Phase ll|Death|2|||
23297229|NCT01132664|64833097|FG003|Phase ll|Death|0|||
23297230|NCT01132664|64833098|FG004|Phase ll|Death|0|||
23297231|NCT01132664|64833094|FG000|Phase ll|Adverse Event|0|||
23297232|NCT01132664|64833095|FG001|Phase ll|Adverse Event|0|||
23297233|NCT01132664|64833096|FG002|Phase ll|Adverse Event|10|||
23297234|NCT01132664|64833097|FG003|Phase ll|Adverse Event|0|||
23297235|NCT01132664|64833098|FG004|Phase ll|Adverse Event|0|||
23297236|NCT01132664|64833094|FG000|Phase ll|Withdrawal by Subject|0|||
23297237|NCT01132664|64833095|FG001|Phase ll|Withdrawal by Subject|0|||
23297238|NCT01132664|64833096|FG002|Phase ll|Withdrawal by Subject|3|||
23297239|NCT01132664|64833097|FG003|Phase ll|Withdrawal by Subject|0|||
23297240|NCT01132664|64833098|FG004|Phase ll|Withdrawal by Subject|0|||
23297241|NCT01132664|64833094|FG000|Phase ll|Disease progression|0|||
23297242|NCT01132664|64833095|FG001|Phase ll|Disease progression|0|||
23297243|NCT01132664|64833096|FG002|Phase ll|Disease progression|35|||
23297244|NCT01132664|64833097|FG003|Phase ll|Disease progression|0|||
23297245|NCT01132664|64833098|FG004|Phase ll|Disease progression|0|||
23297246|NCT01132664|64833094|FG000|BM Cohort|Disease progression|0|||
23297247|NCT01132664|64833095|FG001|BM Cohort|Disease progression|0|||
23297248|NCT01132664|64833096|FG002|BM Cohort|Disease progression|0|||
23297249|NCT01132664|64833097|FG003|BM Cohort|Disease progression|3|||
23297250|NCT01132664|64833098|FG004|BM Cohort|Disease progression|4|||
23297251|NCT01132664|64833094|FG000|BM Cohort|Adverse Event|0|||
23297252|NCT01132664|64833095|FG001|BM Cohort|Adverse Event|0|||
23297253|NCT01132664|64833096|FG002|BM Cohort|Adverse Event|0|||
23297254|NCT01132664|64833097|FG003|BM Cohort|Adverse Event|0|||
23297255|NCT01132664|64833098|FG004|BM Cohort|Adverse Event|1|||
23297256|NCT01132664|64833094|FG000|BM Cohort|Withdrawal by Subject|0|||
23297257|NCT01132664|64833095|FG001|BM Cohort|Withdrawal by Subject|0|||
23297258|NCT01132664|64833096|FG002|BM Cohort|Withdrawal by Subject|0|||
23297259|NCT01132664|64833097|FG003|BM Cohort|Withdrawal by Subject|0|||
23297260|NCT01132664|64833098|FG004|BM Cohort|Withdrawal by Subject|1|||
23297261|NCT02924376|64833103|FG000|Overall Study|Progressive Disease|4|||
23297262|NCT02924376|64833104|FG001|Overall Study|Progressive Disease|0|||
23297263|NCT02924376|64833105|FG002|Overall Study|Progressive Disease|1|||
23297264|NCT02924376|64833106|FG003|Overall Study|Progressive Disease|0|||
23297265|NCT02924376|64833103|FG000|Overall Study|Death|73|||
23297266|NCT02924376|64833104|FG001|Overall Study|Death|18|||
23297267|NCT02924376|64833105|FG002|Overall Study|Death|15|||
23388788|NCT01093573|65168825|FG002|Overall Study|Physician Decision|1|||
23494732|NCT03307785|65555006|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23297268|NCT02924376|64833106|FG003|Overall Study|Death|2|||
23297269|NCT02924376|64833103|FG000|Overall Study|Lost to Follow-up|3|||
23297270|NCT02924376|64833104|FG001|Overall Study|Lost to Follow-up|0|||
23297271|NCT02924376|64833105|FG002|Overall Study|Lost to Follow-up|0|||
23297272|NCT02924376|64833106|FG003|Overall Study|Lost to Follow-up|0|||
23297273|NCT02924376|64833103|FG000|Overall Study|Study Terminated by Sponsor|19|||
23297274|NCT02924376|64833104|FG001|Overall Study|Study Terminated by Sponsor|0|||
23297275|NCT02924376|64833105|FG002|Overall Study|Study Terminated by Sponsor|0|||
23297276|NCT02924376|64833106|FG003|Overall Study|Study Terminated by Sponsor|0|||
23297277|NCT02924376|64833103|FG000|Overall Study|Physician Decision|1|||
23297278|NCT02924376|64833104|FG001|Overall Study|Physician Decision|0|||
23297279|NCT02924376|64833105|FG002|Overall Study|Physician Decision|0|||
23297280|NCT02924376|64833106|FG003|Overall Study|Physician Decision|0|||
23297281|NCT02924376|64833103|FG000|Overall Study|Withdrawal by Subject|7|||
23388789|NCT01093573|65168823|FG000|Overall Study|Insurance Denied|0|||
23388790|NCT01093573|65168824|FG001|Overall Study|Insurance Denied|0|||
23388791|NCT01093573|65168825|FG002|Overall Study|Insurance Denied|1|||
23297282|NCT02924376|64833104|FG001|Overall Study|Withdrawal by Subject|2|||
23297283|NCT02924376|64833105|FG002|Overall Study|Withdrawal by Subject|1|||
23297284|NCT02924376|64833106|FG003|Overall Study|Withdrawal by Subject|0|||
23297285|NCT02924376|64833103|FG000|Overall Study|Rolled Over to Another Study|1|||
23297286|NCT02924376|64833104|FG001|Overall Study|Rolled Over to Another Study|0|||
23297287|NCT02924376|64833105|FG002|Overall Study|Rolled Over to Another Study|0|||
23494733|NCT03307785|65555007|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23297288|NCT02924376|64833106|FG003|Overall Study|Rolled Over to Another Study|0|||
23297289|NCT00977548|64833107|FG000|Overall Study|Ineligible|4|||
23297290|NCT00977548|64833107|FG000|Overall Study|Adverse Event|8|||
23297291|NCT00977548|64833107|FG000|Overall Study|Withdrawal by Subject|1|||
23297292|NCT00396331|64833108|FG000|Overall Study|Failed to mobilize - no transplant|8|||
23297293|NCT00396331|64833108|FG000|Overall Study|Did not go on to transplant|5|||
23297294|NCT00396331|64833108|FG000|Overall Study|Lost to Follow-up|3|||
23297295|NCT00396331|64833108|FG000|Overall Study|Death|16|||
23297296|NCT03827018|64833109|FG000|Overall Study|Adverse Event|1|||
23297297|NCT03827018|64833110|FG001|Overall Study|Adverse Event|0|||
23297298|NCT03827018|64833109|FG000|Overall Study|Withdrawal by Subject|2|||
23297299|NCT03827018|64833110|FG001|Overall Study|Withdrawal by Subject|2|||
23297300|NCT03827018|64833109|FG000|Overall Study|Lack of Efficacy|0|||
23297301|NCT03827018|64833110|FG001|Overall Study|Lack of Efficacy|1|||
23297302|NCT00706355|64833111|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
23297303|NCT00706355|64833112|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
23297304|NCT00706355|64833113|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
23297305|NCT00706355|64833114|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
23297306|NCT00706355|64833111|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
23297307|NCT00706355|64833112|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
23297308|NCT00706355|64833113|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
23297309|NCT00706355|64833114|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
23297310|NCT00706355|64833111|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
23297311|NCT00706355|64833112|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
23297312|NCT00706355|64833113|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
23297313|NCT00706355|64833114|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
23297314|NCT00706355|64833111|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
23297315|NCT00706355|64833112|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
23297316|NCT00706355|64833113|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
23297317|NCT00706355|64833114|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
23297318|NCT00706355|64833111|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
23297319|NCT00706355|64833112|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
23297320|NCT00706355|64833113|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
23297321|NCT00706355|64833114|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
23297322|NCT00706355|64833111|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
23297323|NCT00706355|64833112|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
23297324|NCT00706355|64833113|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
23297325|NCT00706355|64833114|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
23297326|NCT00706355|64833111|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
23297327|NCT00706355|64833112|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
23297328|NCT00706355|64833113|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
23297329|NCT00706355|64833114|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
23297330|NCT00706355|64833111|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
23297331|NCT00706355|64833112|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
23297332|NCT00706355|64833113|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
23297333|NCT00706355|64833114|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
23297334|NCT00706355|64833111|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
23297335|NCT00706355|64833112|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
23297336|NCT00706355|64833113|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
23494734|NCT03307785|65555008|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23494735|NCT03307785|65555009|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
23494736|NCT03307785|65554999|FG000|Part C: Up to Approx. 60 Months|Death|0|||
23494737|NCT03307785|65555000|FG001|Part C: Up to Approx. 60 Months|Death|0|||
23494738|NCT03307785|65555001|FG002|Part C: Up to Approx. 60 Months|Death|0|||
23494739|NCT03307785|65555002|FG003|Part C: Up to Approx. 60 Months|Death|2|||
23494740|NCT03307785|65555003|FG004|Part C: Up to Approx. 60 Months|Death|5|||
23494741|NCT03307785|65555004|FG005|Part C: Up to Approx. 60 Months|Death|0|||
23494742|NCT03307785|65555005|FG006|Part C: Up to Approx. 60 Months|Death|0|||
23388792|NCT00069953|65168826|FG000|Overall Study|Protocol Violation|2|||
23494743|NCT03307785|65555006|FG007|Part C: Up to Approx. 60 Months|Death|0|||
23494744|NCT03307785|65555007|FG008|Part C: Up to Approx. 60 Months|Death|0|||
23494745|NCT03307785|65555008|FG009|Part C: Up to Approx. 60 Months|Death|0|||
23297337|NCT00706355|64833114|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
23297338|NCT02450526|64833121|FG000|DB Period (Cycle 1)|Adverse Event|0|||
23297339|NCT02450526|64833122|FG001|DB Period (Cycle 1)|Adverse Event|0|||
23297340|NCT02450526|64833123|FG002|DB Period (Cycle 1)|Adverse Event|2|||
23297341|NCT02450526|64833124|FG003|DB Period (Cycle 1)|Adverse Event|0|||
23297342|NCT02450526|64833125|FG004|DB Period (Cycle 1)|Adverse Event|0|||
23297343|NCT02450526|64833121|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
23297344|NCT02450526|64833122|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
23297345|NCT02450526|64833123|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
23297346|NCT02450526|64833124|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
23297347|NCT02450526|64833125|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
23297348|NCT02450526|64833121|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
23297349|NCT02450526|64833122|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
23297350|NCT02450526|64833123|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
23297351|NCT02450526|64833124|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
23297352|NCT02450526|64833125|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
23297353|NCT02450526|64833121|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
23297354|NCT02450526|64833122|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
23297355|NCT02450526|64833123|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
23297356|NCT02450526|64833124|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
23297357|NCT02450526|64833125|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
23297358|NCT02450526|64833121|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
23297359|NCT02450526|64833122|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
23297360|NCT02450526|64833123|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
23297361|NCT02450526|64833124|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
23297362|NCT02450526|64833125|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
23297363|NCT02450526|64833121|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
23297364|NCT02450526|64833122|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
23297365|NCT02450526|64833123|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
23297366|NCT02450526|64833124|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
23297367|NCT02450526|64833125|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
23297368|NCT02450526|64833121|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
23297369|NCT02450526|64833122|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
23297370|NCT02450526|64833123|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
23297371|NCT02450526|64833124|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
23297372|NCT02450526|64833125|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
23297373|NCT02450526|64833121|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
23297374|NCT02450526|64833122|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
23297375|NCT02450526|64833123|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
23297376|NCT02450526|64833124|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
23297377|NCT02450526|64833125|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
23297378|NCT01813071|64833126|FG000|Overall Study|Protocol Violation|0|||
23297379|NCT01813071|64833127|FG001|Overall Study|Protocol Violation|0|||
23297380|NCT01813071|64833128|FG002|Overall Study|Protocol Violation|0|||
23297381|NCT01813071|64833129|FG003|Overall Study|Protocol Violation|0|||
23297382|NCT01813071|64833130|FG004|Overall Study|Protocol Violation|1|||
23297383|NCT01813071|64833131|FG005|Overall Study|Protocol Violation|4|||
23388793|NCT01386645|65168828|FG000|Overall Study|Physician Decision|0|||
23388794|NCT01386645|65168829|FG001|Overall Study|Physician Decision|0|||
23388795|NCT01386645|65168830|FG002|Overall Study|Physician Decision|1|||
23388796|NCT01386645|65168828|FG000|Overall Study|Withdrawal by Subject|0|||
23388797|NCT01386645|65168829|FG001|Overall Study|Withdrawal by Subject|1|||
23388798|NCT01386645|65168830|FG002|Overall Study|Withdrawal by Subject|1|||
23388799|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
23388800|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
23388801|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
23388802|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
23388803|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
23388804|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
23388805|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
23297384|NCT01813071|64833132|FG006|Overall Study|Protocol Violation|2|||
23297385|NCT01813071|64833133|FG007|Overall Study|Protocol Violation|4|||
23297386|NCT01813071|64833134|FG008|Overall Study|Protocol Violation|2|||
23297387|NCT01813071|64833126|FG000|Overall Study|Withdrawal by Subject|0|||
23297388|NCT01813071|64833127|FG001|Overall Study|Withdrawal by Subject|0|||
23297389|NCT01813071|64833128|FG002|Overall Study|Withdrawal by Subject|0|||
23297390|NCT01813071|64833129|FG003|Overall Study|Withdrawal by Subject|0|||
23388806|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
23388807|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
23297391|NCT01813071|64833130|FG004|Overall Study|Withdrawal by Subject|0|||
23388808|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
23388809|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
23388810|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
23388811|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
23388812|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
23388813|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
23388814|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
23388815|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
23388816|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
23388817|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
23388818|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
23388819|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
23388820|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
23388821|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
23388822|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
23388823|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
23388824|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
23297392|NCT01813071|64833131|FG005|Overall Study|Withdrawal by Subject|1|||
23297393|NCT01813071|64833132|FG006|Overall Study|Withdrawal by Subject|0|||
23297394|NCT01813071|64833133|FG007|Overall Study|Withdrawal by Subject|0|||
23297395|NCT01813071|64833134|FG008|Overall Study|Withdrawal by Subject|0|||
23297396|NCT01813071|64833126|FG000|Overall Study|Adverse Event|0|||
23297397|NCT01813071|64833127|FG001|Overall Study|Adverse Event|0|||
23297398|NCT01813071|64833128|FG002|Overall Study|Adverse Event|0|||
23297399|NCT01813071|64833129|FG003|Overall Study|Adverse Event|0|||
23297400|NCT01813071|64833130|FG004|Overall Study|Adverse Event|0|||
23494746|NCT03307785|65555009|FG010|Part C: Up to Approx. 60 Months|Death|0|||
23297401|NCT01813071|64833131|FG005|Overall Study|Adverse Event|1|||
23388825|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
23388826|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
23388827|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
23388828|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
23297402|NCT01813071|64833132|FG006|Overall Study|Adverse Event|0|||
23297403|NCT01813071|64833133|FG007|Overall Study|Adverse Event|0|||
23297404|NCT01813071|64833134|FG008|Overall Study|Adverse Event|0|||
23297405|NCT01813071|64833126|FG000|Overall Study|Physician Decision|0|||
23297406|NCT01813071|64833127|FG001|Overall Study|Physician Decision|0|||
23297407|NCT01813071|64833128|FG002|Overall Study|Physician Decision|0|||
23297408|NCT01813071|64833129|FG003|Overall Study|Physician Decision|0|||
23297409|NCT01813071|64833130|FG004|Overall Study|Physician Decision|0|||
23297410|NCT01813071|64833131|FG005|Overall Study|Physician Decision|0|||
23297411|NCT01813071|64833132|FG006|Overall Study|Physician Decision|1|||
23297412|NCT01813071|64833133|FG007|Overall Study|Physician Decision|0|||
23297413|NCT01813071|64833134|FG008|Overall Study|Physician Decision|0|||
23297414|NCT01813071|64833126|FG000|Overall Study|Met inc/exc criteria|0|||
23297415|NCT01813071|64833127|FG001|Overall Study|Met inc/exc criteria|0|||
23297416|NCT01813071|64833128|FG002|Overall Study|Met inc/exc criteria|0|||
23297417|NCT01813071|64833129|FG003|Overall Study|Met inc/exc criteria|0|||
23297418|NCT01813071|64833130|FG004|Overall Study|Met inc/exc criteria|0|||
23297419|NCT01813071|64833131|FG005|Overall Study|Met inc/exc criteria|1|||
23297420|NCT01813071|64833132|FG006|Overall Study|Met inc/exc criteria|0|||
23297421|NCT01813071|64833133|FG007|Overall Study|Met inc/exc criteria|1|||
23297422|NCT01813071|64833134|FG008|Overall Study|Met inc/exc criteria|1|||
23297423|NCT01221090|64833135|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
23297424|NCT01221090|64833136|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
23297425|NCT01221090|64833137|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
23297426|NCT01221090|64833138|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
23297427|NCT01221090|64833135|FG000|Overall Study|Withdrawal by Subject|0|||
23297428|NCT01221090|64833136|FG001|Overall Study|Withdrawal by Subject|22|||
23297429|NCT01221090|64833137|FG002|Overall Study|Withdrawal by Subject|27|||
23297430|NCT01221090|64833138|FG003|Overall Study|Withdrawal by Subject|2|||
23297431|NCT00456495|64833139|FG000|Overall Study|Physician Decision|2|||
23297432|NCT01546649|64833145|FG000|Overall Study|Adverse Event|4|||
23297433|NCT01546649|64833146|FG001|Overall Study|Adverse Event|5|||
23297434|NCT01546649|64833145|FG000|Overall Study|Protocol Violation|1|||
23297435|NCT01546649|64833146|FG001|Overall Study|Protocol Violation|0|||
23297436|NCT01546649|64833145|FG000|Overall Study|Lack of Efficacy|1|||
23297437|NCT01546649|64833146|FG001|Overall Study|Lack of Efficacy|0|||
23297438|NCT01546649|64833145|FG000|Overall Study|Recurrence|1|||
23297439|NCT01546649|64833146|FG001|Overall Study|Recurrence|1|||
23297440|NCT01546649|64833145|FG000|Overall Study|Discovery of secondary cancer|0|||
23297441|NCT01546649|64833146|FG001|Overall Study|Discovery of secondary cancer|1|||
23297442|NCT01546649|64833145|FG000|Overall Study|Withdrawal by Subject|1|||
23297443|NCT01546649|64833146|FG001|Overall Study|Withdrawal by Subject|2|||
23297444|NCT00733369|64833147|FG000|Overall Study|Lost to Follow-up|2|||
23297445|NCT00733369|64833148|FG001|Overall Study|Lost to Follow-up|1|||
23297446|NCT00733369|64833147|FG000|Overall Study|Adverse Event|4|||
23297447|NCT00733369|64833148|FG001|Overall Study|Adverse Event|4|||
23297448|NCT00733369|64833147|FG000|Overall Study|Protocol Violation|4|||
23297449|NCT00733369|64833148|FG001|Overall Study|Protocol Violation|4|||
23297450|NCT03165955|64833149|FG000|Treatment|Withdrawal by Subject|3|||
23297451|NCT03165955|64833149|FG000|Treatment|Death|1|||
23297452|NCT03165955|64833149|FG000|Treatment|Adverse Event|1|||
23297453|NCT03165955|64833149|FG000|Treatment|Progressive disease|3|||
23297454|NCT02429934|64833151|FG000|Overall Study|Withdrawal by Subject|0|||
23297455|NCT02429934|64833152|FG001|Overall Study|Withdrawal by Subject|2|||
23297456|NCT02429934|64833151|FG000|Overall Study|Adverse Event|2|||
23297457|NCT02429934|64833152|FG001|Overall Study|Adverse Event|0|||
23297458|NCT02429934|64833151|FG000|Overall Study|Lost to Follow-up|1|||
23297459|NCT02429934|64833152|FG001|Overall Study|Lost to Follow-up|1|||
23297460|NCT02429934|64833151|FG000|Overall Study|Physician Decision|1|||
23297461|NCT02429934|64833152|FG001|Overall Study|Physician Decision|0|||
23297462|NCT02631876|64833153|FG000|Overall Study|Death|96|||
23297463|NCT02631876|64833154|FG001|Overall Study|Death|50|||
23297464|NCT02631876|64833153|FG000|Overall Study|Investigator's discretion|1|||
23297465|NCT02631876|64833154|FG001|Overall Study|Investigator's discretion|0|||
23388829|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
23297466|NCT02631876|64833153|FG000|Overall Study|Lost to Follow-up|2|||
23297467|NCT02631876|64833154|FG001|Overall Study|Lost to Follow-up|0|||
23297468|NCT02631876|64833153|FG000|Overall Study|Withdrawal by Subject|16|||
23297469|NCT02631876|64833154|FG001|Overall Study|Withdrawal by Subject|9|||
23297470|NCT02631876|64833153|FG000|Overall Study|Other than specified|4|||
23297471|NCT02631876|64833154|FG001|Overall Study|Other than specified|4|||
23388830|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
23388831|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
23388832|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
23388833|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
23388834|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
23388835|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
23388836|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
23297472|NCT03686150|64833162|FG000|Overall Study|Withdrawal by Subject|1|||
23297473|NCT03686150|64833163|FG001|Overall Study|Withdrawal by Subject|1|||
23297474|NCT03686150|64833164|FG002|Overall Study|Withdrawal by Subject|1|||
23297475|NCT03686150|64833165|FG003|Overall Study|Withdrawal by Subject|0|||
23297476|NCT03686150|64833166|FG004|Overall Study|Withdrawal by Subject|1|||
23297477|NCT03686150|64833167|FG005|Overall Study|Withdrawal by Subject|2|||
23297478|NCT03686150|64833162|FG000|Overall Study|Physician Decision|1|||
23388837|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
23388838|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
23297479|NCT03686150|64833163|FG001|Overall Study|Physician Decision|0|||
23297480|NCT03686150|64833164|FG002|Overall Study|Physician Decision|0|||
23388839|NCT02596893|65168831|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
23388840|NCT02596893|65168832|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
23388841|NCT02596893|65168833|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
23388842|NCT02596893|65168834|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
23388843|NCT04439357|65168835|FG000|Overall Study|Disease Progression|4|||
23297481|NCT03686150|64833165|FG003|Overall Study|Physician Decision|0|||
23297482|NCT03686150|64833166|FG004|Overall Study|Physician Decision|0|||
23297483|NCT03686150|64833167|FG005|Overall Study|Physician Decision|1|||
23297484|NCT03686150|64833162|FG000|Overall Study|Lost to Follow-up|0|||
23297485|NCT03686150|64833163|FG001|Overall Study|Lost to Follow-up|1|||
23297486|NCT03686150|64833164|FG002|Overall Study|Lost to Follow-up|0|||
23297487|NCT03686150|64833165|FG003|Overall Study|Lost to Follow-up|0|||
23297488|NCT03686150|64833166|FG004|Overall Study|Lost to Follow-up|0|||
23297489|NCT03686150|64833167|FG005|Overall Study|Lost to Follow-up|0|||
23297490|NCT01684878|64833172|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
23297491|NCT01684878|64833173|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
23494747|NCT03307785|65554999|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494748|NCT03307785|65555000|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23297492|NCT01684878|64833174|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
23297493|NCT01684878|64833175|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
23297494|NCT01684878|64833172|FG000|Part 1: Safety Run in Phase|Death|15|||
23297495|NCT01684878|64833173|FG001|Part 1: Safety Run in Phase|Death|20|||
23297496|NCT01684878|64833174|FG002|Part 1: Safety Run in Phase|Death|0|||
23297497|NCT01684878|64833175|FG003|Part 1: Safety Run in Phase|Death|0|||
23297498|NCT01684878|64833172|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
23297499|NCT01684878|64833173|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
23297500|NCT01684878|64833174|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
23297501|NCT01684878|64833175|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
23297502|NCT01684878|64833172|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
23297503|NCT01684878|64833173|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
23297504|NCT01684878|64833174|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
23297505|NCT01684878|64833175|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
23297506|NCT01684878|64833172|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
23297507|NCT01684878|64833173|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
23297508|NCT01684878|64833174|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
23297509|NCT01684878|64833175|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
23297510|NCT01684878|64833172|FG000|Part 2: Randomized Phase|Death|0|||
23297511|NCT01684878|64833173|FG001|Part 2: Randomized Phase|Death|0|||
23297512|NCT01684878|64833174|FG002|Part 2: Randomized Phase|Death|62|||
23297513|NCT01684878|64833175|FG003|Part 2: Randomized Phase|Death|68|||
23297514|NCT01684878|64833172|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
23297515|NCT01684878|64833173|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
23297516|NCT01684878|64833174|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
23297517|NCT01684878|64833175|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
23297518|NCT01684878|64833172|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
23297519|NCT01684878|64833173|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
23297520|NCT01684878|64833174|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
23297521|NCT01684878|64833175|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
23297522|NCT01010750|64833176|FG000|Second Intervention|Adverse Event|0|||
23297523|NCT01010750|64833177|FG001|Second Intervention|Adverse Event|1|||
23297524|NCT01010750|64833178|FG002|Second Intervention|Adverse Event|0|||
23297525|NCT01010750|64833179|FG003|Second Intervention|Adverse Event|0|||
23297526|NCT01010750|64833180|FG004|Second Intervention|Adverse Event|0|||
23297527|NCT01010750|64833181|FG005|Second Intervention|Adverse Event|0|||
23297528|NCT03227224|64833182|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
23297529|NCT03227224|64833183|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
23297530|NCT03227224|64833184|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
23297531|NCT03227224|64833185|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
23297532|NCT03227224|64833182|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
23297533|NCT03227224|64833183|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
23297534|NCT03227224|64833184|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
23297535|NCT03227224|64833185|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
23297536|NCT03227224|64833182|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
23297537|NCT03227224|64833183|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
23297538|NCT03227224|64833184|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
23297539|NCT03227224|64833185|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
23297540|NCT03227224|64833182|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
23297541|NCT03227224|64833183|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23297542|NCT03227224|64833184|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23297543|NCT03227224|64833185|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
23297544|NCT03227224|64833182|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
23297545|NCT03227224|64833183|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
23297546|NCT03227224|64833184|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
23297547|NCT03227224|64833185|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
23297548|NCT03227224|64833182|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
23297549|NCT03227224|64833183|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
23297550|NCT03227224|64833184|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
23297551|NCT03227224|64833185|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
23297552|NCT03227224|64833182|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
23297553|NCT03227224|64833183|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
23297554|NCT03227224|64833184|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
23297555|NCT03227224|64833185|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
23297556|NCT03227224|64833182|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
23297557|NCT03227224|64833183|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
23297558|NCT03227224|64833184|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
23297559|NCT03227224|64833185|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
23297560|NCT03227224|64833182|FG000|Follow-up Phase (2 Weeks)|Other|4|||
23297561|NCT03227224|64833183|FG001|Follow-up Phase (2 Weeks)|Other|4|||
23297562|NCT03227224|64833184|FG002|Follow-up Phase (2 Weeks)|Other|6|||
23297563|NCT03227224|64833185|FG003|Follow-up Phase (2 Weeks)|Other|3|||
23297564|NCT04039919|64833186|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23297565|NCT04039919|64833187|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23297566|NCT04039919|64833188|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23297567|NCT04039919|64833189|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23297568|NCT04039919|64833190|FG004|Treatment Period 1|Withdrawal by Subject|0|||
23297569|NCT04039919|64833186|FG000|Treatment Period 1|Sponsor's decision|0|||
23297570|NCT04039919|64833187|FG001|Treatment Period 1|Sponsor's decision|0|||
23297571|NCT04039919|64833188|FG002|Treatment Period 1|Sponsor's decision|0|||
23297572|NCT04039919|64833189|FG003|Treatment Period 1|Sponsor's decision|0|||
23297573|NCT04039919|64833190|FG004|Treatment Period 1|Sponsor's decision|16|||
23297574|NCT04039919|64833186|FG000|Treatment Period 5|Withdrawal by Subject|1|||
23297575|NCT04039919|64833187|FG001|Treatment Period 5|Withdrawal by Subject|0|||
23297576|NCT04039919|64833188|FG002|Treatment Period 5|Withdrawal by Subject|0|||
23297577|NCT04039919|64833189|FG003|Treatment Period 5|Withdrawal by Subject|0|||
23297578|NCT04039919|64833190|FG004|Treatment Period 5|Withdrawal by Subject|0|||
23297579|NCT03891329|64833191|FG000|Overall Study|Death|5|||
23297580|NCT03891329|64833191|FG000|Overall Study|Lost to Follow-up|4|||
23297581|NCT03891329|64833191|FG000|Overall Study|Physician Decision|4|||
23297582|NCT03891329|64833191|FG000|Overall Study|Device explanted|3|||
23297583|NCT03891329|64833191|FG000|Overall Study|No study device implanted|3|||
23297584|NCT04364737|64833192|FG000|Overall Study|Withdrawal by Subject|4|||
23297585|NCT04364737|64833193|FG001|Overall Study|Withdrawal by Subject|9|||
23297586|NCT04364737|64833192|FG000|Overall Study|Lost to Follow-up|1|||
23297587|NCT04364737|64833193|FG001|Overall Study|Lost to Follow-up|1|||
23297588|NCT01232491|64833194|FG000|Overall Study|Adverse Event|13|||
23297589|NCT01232491|64833195|FG001|Overall Study|Adverse Event|8|||
23297590|NCT01232491|64833194|FG000|Overall Study|Lack of Efficacy|1|||
23297591|NCT01232491|64833195|FG001|Overall Study|Lack of Efficacy|5|||
23297592|NCT01232491|64833194|FG000|Overall Study|Protocol Violation|13|||
23297593|NCT01232491|64833195|FG001|Overall Study|Protocol Violation|11|||
23297594|NCT01232491|64833194|FG000|Overall Study|Withdrawal Criteria|12|||
23297595|NCT01232491|64833195|FG001|Overall Study|Withdrawal Criteria|21|||
23297596|NCT01232491|64833194|FG000|Overall Study|Other|21|||
23388844|NCT00504556|65168836|FG000|Overall Study|Adverse Event|11|||
23297597|NCT01232491|64833195|FG001|Overall Study|Other|18|||
23297598|NCT01316419|64833196|FG000|Overall Study|Not treated|103|||
23297599|NCT01316419|64833196|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
23297600|NCT01316419|64833196|FG000|Overall Study|Lost to Follow-up|19|||
23297601|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
23297602|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
23297603|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
23297604|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
23297605|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
23297606|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
23297607|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
23297608|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
23297609|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
23297610|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
23297611|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
23494749|NCT03307785|65555001|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23388845|NCT00504556|65168837|FG001|Overall Study|Adverse Event|11|||
23388846|NCT00504556|65168838|FG002|Overall Study|Adverse Event|14|||
23388847|NCT00504556|65168839|FG003|Overall Study|Adverse Event|13|||
23388848|NCT00504556|65168840|FG004|Overall Study|Adverse Event|5|||
23388849|NCT00504556|65168836|FG000|Overall Study|Death|3|||
23388850|NCT00504556|65168837|FG001|Overall Study|Death|3|||
23388851|NCT00504556|65168838|FG002|Overall Study|Death|1|||
23388852|NCT00504556|65168839|FG003|Overall Study|Death|0|||
23388853|NCT00504556|65168840|FG004|Overall Study|Death|2|||
23388854|NCT00504556|65168836|FG000|Overall Study|Protocol Violation|1|||
23388855|NCT00504556|65168837|FG001|Overall Study|Protocol Violation|3|||
23388856|NCT00504556|65168838|FG002|Overall Study|Protocol Violation|2|||
23388857|NCT00504556|65168839|FG003|Overall Study|Protocol Violation|1|||
23388858|NCT00504556|65168840|FG004|Overall Study|Protocol Violation|2|||
23297612|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
23297613|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23297614|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23297615|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
23297616|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
23297617|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
23297618|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
23297619|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
23297620|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
23297621|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
23297622|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
23297623|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
23297624|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
23297625|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
23297626|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
23297627|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
23297628|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
23297629|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Death|0|||
23297630|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Death|1|||
23297631|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Death|0|||
23297632|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Death|0|||
23297633|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
23297634|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
23297635|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
23297636|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
23297637|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
23297638|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
23297639|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
23297640|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
23297641|NCT02990806|64833198|FG000|Stage 1 (22 Weeks)|Other|1|||
23297642|NCT02990806|64833199|FG001|Stage 1 (22 Weeks)|Other|3|||
23297643|NCT02990806|64833200|FG002|Stage 1 (22 Weeks)|Other|0|||
23297644|NCT02990806|64833201|FG003|Stage 1 (22 Weeks)|Other|0|||
23297645|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
23297646|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
23297647|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
23297648|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
23297649|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Death|1|||
23297650|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Death|0|||
23297651|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Death|0|||
23297652|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Death|0|||
23297653|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
23297654|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
23297655|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
23297656|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
23297657|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
23297658|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
23297659|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
23297660|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
23388859|NCT00504556|65168836|FG000|Overall Study|Lost to Follow-up|0|||
23297661|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
23388860|NCT00504556|65168837|FG001|Overall Study|Lost to Follow-up|0|||
23388861|NCT00504556|65168838|FG002|Overall Study|Lost to Follow-up|1|||
23297662|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
23297663|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
23297664|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
23388862|NCT00504556|65168839|FG003|Overall Study|Lost to Follow-up|1|||
23388863|NCT00504556|65168840|FG004|Overall Study|Lost to Follow-up|1|||
23388864|NCT00504556|65168836|FG000|Overall Study|Withdrawal by Subject|16|||
23388865|NCT00504556|65168837|FG001|Overall Study|Withdrawal by Subject|16|||
23297665|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
23297666|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
23297667|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
23297668|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
23297669|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23297670|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
23297671|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
23297672|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
23297673|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
23297674|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
23297675|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
23297676|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
23297677|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
23297678|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
23297679|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
23297680|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
23297681|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
23297682|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
23297683|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
23388866|NCT00504556|65168838|FG002|Overall Study|Withdrawal by Subject|7|||
23494750|NCT03307785|65555002|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
23297684|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
23297685|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
23297686|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
23388867|NCT00504556|65168839|FG003|Overall Study|Withdrawal by Subject|8|||
23388868|NCT00504556|65168840|FG004|Overall Study|Withdrawal by Subject|12|||
23388869|NCT00504556|65168836|FG000|Overall Study|administrative reasons|0|||
23388870|NCT00504556|65168837|FG001|Overall Study|administrative reasons|2|||
23388871|NCT00504556|65168838|FG002|Overall Study|administrative reasons|2|||
23388872|NCT00504556|65168839|FG003|Overall Study|administrative reasons|1|||
23388873|NCT00504556|65168840|FG004|Overall Study|administrative reasons|2|||
23297687|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
23297688|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
23297689|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Other|3|||
23297690|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Other|0|||
23297691|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Other|4|||
23297692|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Other|1|||
23297693|NCT02990806|64833198|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
23297694|NCT02990806|64833199|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
23297695|NCT02990806|64833200|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
23297696|NCT02990806|64833201|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
23297697|NCT02990806|64833198|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
23297698|NCT02990806|64833199|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
23297699|NCT02990806|64833200|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
23297700|NCT02990806|64833201|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
23297701|NCT02990806|64833198|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
23297702|NCT02990806|64833199|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
23388874|NCT00504556|65168836|FG000|Overall Study|did not meet entry criteria|2|||
23388875|NCT00504556|65168837|FG001|Overall Study|did not meet entry criteria|0|||
23297703|NCT02990806|64833200|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
23297704|NCT02990806|64833201|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
23297705|NCT02990806|64833198|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23388876|NCT00504556|65168838|FG002|Overall Study|did not meet entry criteria|1|||
23297706|NCT02990806|64833199|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
23297707|NCT02990806|64833200|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23297708|NCT02990806|64833201|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
23297709|NCT02990806|64833198|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
23297710|NCT02990806|64833199|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
23297711|NCT02990806|64833200|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
23297712|NCT02990806|64833201|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
23297713|NCT02990806|64833198|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
23297714|NCT02990806|64833199|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
23297715|NCT02990806|64833200|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
23297716|NCT02990806|64833201|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
23297717|NCT02990806|64833198|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
23297718|NCT02990806|64833199|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
23297719|NCT02990806|64833200|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
23297720|NCT02990806|64833201|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
23297721|NCT02990806|64833198|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
23297722|NCT02990806|64833199|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
23297723|NCT02990806|64833200|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
23297724|NCT02990806|64833201|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
23297725|NCT02990806|64833198|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
23297726|NCT02990806|64833199|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
23297727|NCT02990806|64833200|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
23297728|NCT02990806|64833201|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
23297729|NCT00890552|64833202|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
23297730|NCT00890552|64833202|FG000|On-treatment|Early prog disease/ death|10|||
23297731|NCT02709486|64833203|FG000|Overall Study|Adverse Event|2|||
23297732|NCT02709486|64833204|FG001|Overall Study|Adverse Event|5|||
23297733|NCT02709486|64833205|FG002|Overall Study|Adverse Event|3|||
23297734|NCT02709486|64833203|FG000|Overall Study|Death|0|||
23297735|NCT02709486|64833204|FG001|Overall Study|Death|0|||
23297736|NCT02709486|64833205|FG002|Overall Study|Death|2|||
23297737|NCT02709486|64833203|FG000|Overall Study|Insufficient clinical response|7|||
23297738|NCT02709486|64833204|FG001|Overall Study|Insufficient clinical response|3|||
23297739|NCT02709486|64833205|FG002|Overall Study|Insufficient clinical response|3|||
23297740|NCT02709486|64833203|FG000|Overall Study|Lost to Follow-up|3|||
23297741|NCT02709486|64833204|FG001|Overall Study|Lost to Follow-up|2|||
23297742|NCT02709486|64833205|FG002|Overall Study|Lost to Follow-up|2|||
23297743|NCT02709486|64833203|FG000|Overall Study|Other|0|||
23297744|NCT02709486|64833204|FG001|Overall Study|Other|2|||
23297745|NCT02709486|64833205|FG002|Overall Study|Other|3|||
23297746|NCT02709486|64833203|FG000|Overall Study|Withdrawal by Subject|32|||
23297747|NCT02709486|64833204|FG001|Overall Study|Withdrawal by Subject|22|||
23297748|NCT02709486|64833205|FG002|Overall Study|Withdrawal by Subject|32|||
23297749|NCT01138826|64833210|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
23297750|NCT01138826|64833211|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
23297751|NCT01138826|64833212|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
23297752|NCT01138826|64833213|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
23297753|NCT01138826|64833214|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
23297754|NCT01138826|64833215|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
23297755|NCT00484419|64833216|FG000|Overall Study|Adverse Event|3|||
23297756|NCT00484419|64833217|FG001|Overall Study|Adverse Event|0|||
23297757|NCT00484419|64833218|FG002|Overall Study|Adverse Event|0|||
23297758|NCT00484419|64833216|FG000|Overall Study|Lost to Follow-up|1|||
23297759|NCT00484419|64833217|FG001|Overall Study|Lost to Follow-up|0|||
23297760|NCT00484419|64833218|FG002|Overall Study|Lost to Follow-up|2|||
23297761|NCT00484419|64833216|FG000|Overall Study|Withdrawal by Subject|3|||
23297762|NCT00484419|64833217|FG001|Overall Study|Withdrawal by Subject|1|||
23297763|NCT00484419|64833218|FG002|Overall Study|Withdrawal by Subject|1|||
23494751|NCT03307785|65555003|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494752|NCT03307785|65555004|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494753|NCT03307785|65555005|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494754|NCT03307785|65555006|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23297764|NCT00484419|64833216|FG000|Overall Study|subject met discontinuation criteria|2|||
23388877|NCT00504556|65168839|FG003|Overall Study|did not meet entry criteria|1|||
23297765|NCT00484419|64833217|FG001|Overall Study|subject met discontinuation criteria|2|||
23297766|NCT00484419|64833218|FG002|Overall Study|subject met discontinuation criteria|4|||
23297767|NCT00484419|64833216|FG000|Overall Study|required restricted medication|1|||
23297768|NCT00484419|64833217|FG001|Overall Study|required restricted medication|0|||
23297769|NCT00484419|64833218|FG002|Overall Study|required restricted medication|1|||
23297770|NCT00484419|64833216|FG000|Overall Study|Physician Decision|1|||
23297771|NCT00484419|64833217|FG001|Overall Study|Physician Decision|1|||
23297772|NCT00484419|64833218|FG002|Overall Study|Physician Decision|1|||
23297773|NCT00484419|64833216|FG000|Overall Study|subject unable to receive medication|1|||
23494755|NCT03307785|65555007|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494756|NCT03307785|65555008|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494757|NCT03307785|65555009|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
23494758|NCT03307785|65554999|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494759|NCT03307785|65555000|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494760|NCT03307785|65555001|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494761|NCT03307785|65555002|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494762|NCT03307785|65555003|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
23494763|NCT03307785|65555004|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494764|NCT03307785|65555005|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494765|NCT03307785|65555006|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494766|NCT03307785|65555007|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494767|NCT03307785|65555008|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494768|NCT03307785|65555009|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
23494769|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494770|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494771|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494772|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494773|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494774|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
23494775|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494776|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494777|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494778|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494779|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
23494780|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
23494781|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
23494782|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
23494783|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
23494784|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
23494785|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
23494786|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
23494787|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
23494788|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
23494789|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
23494790|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
23494791|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494792|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494793|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494794|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494795|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494796|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
23494797|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494798|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494799|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494800|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494801|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
23494802|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494803|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494804|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494805|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494806|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494807|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
23494808|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494809|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23297774|NCT00484419|64833217|FG001|Overall Study|subject unable to receive medication|0|||
23297775|NCT00484419|64833218|FG002|Overall Study|subject unable to receive medication|0|||
23297776|NCT00484419|64833216|FG000|Overall Study|subject relocated|0|||
23297777|NCT00484419|64833217|FG001|Overall Study|subject relocated|1|||
23297778|NCT00484419|64833218|FG002|Overall Study|subject relocated|0|||
23297779|NCT00484419|64833216|FG000|Overall Study|sponsor decision, randomized in error|0|||
23297780|NCT00484419|64833217|FG001|Overall Study|sponsor decision, randomized in error|0|||
23297781|NCT00484419|64833218|FG002|Overall Study|sponsor decision, randomized in error|2|||
23297782|NCT01844531|64833219|FG000|Overall Study|Withdrawal by Subject|0|||
23297783|NCT01844531|64833220|FG001|Overall Study|Withdrawal by Subject|1|||
23297784|NCT01844531|64833221|FG002|Overall Study|Withdrawal by Subject|0|||
23297785|NCT01844531|64833222|FG003|Overall Study|Withdrawal by Subject|0|||
23297786|NCT01302847|64833223|FG000|Overall Study|Ongoing|0|||
23297787|NCT01302847|64833224|FG001|Overall Study|Ongoing|0|||
23297788|NCT01302847|64833225|FG002|Overall Study|Ongoing|0|||
23297789|NCT01302847|64833226|FG003|Overall Study|Ongoing|0|||
23297790|NCT01302847|64833227|FG004|Overall Study|Ongoing|0|||
23297791|NCT01302847|64833228|FG005|Overall Study|Ongoing|27|||
23297792|NCT01302847|64833229|FG006|Overall Study|Ongoing|22|||
23297793|NCT01302847|64833230|FG007|Overall Study|Ongoing|17|||
23297794|NCT01302847|64833223|FG000|Overall Study|Death|0|||
23297795|NCT01302847|64833224|FG001|Overall Study|Death|1|||
23297796|NCT01302847|64833225|FG002|Overall Study|Death|0|||
23297797|NCT01302847|64833226|FG003|Overall Study|Death|0|||
23297798|NCT01302847|64833227|FG004|Overall Study|Death|0|||
23297799|NCT01302847|64833228|FG005|Overall Study|Death|1|||
23297800|NCT01302847|64833229|FG006|Overall Study|Death|1|||
23297801|NCT01302847|64833230|FG007|Overall Study|Death|0|||
23297802|NCT01302847|64833223|FG000|Overall Study|Pregnancy|2|||
23297803|NCT01302847|64833224|FG001|Overall Study|Pregnancy|0|||
23297804|NCT01302847|64833225|FG002|Overall Study|Pregnancy|0|||
23297805|NCT01302847|64833226|FG003|Overall Study|Pregnancy|0|||
23297806|NCT01302847|64833227|FG004|Overall Study|Pregnancy|0|||
23297807|NCT01302847|64833228|FG005|Overall Study|Pregnancy|0|||
23297808|NCT01302847|64833229|FG006|Overall Study|Pregnancy|0|||
23297809|NCT01302847|64833230|FG007|Overall Study|Pregnancy|0|||
23297810|NCT01302847|64833223|FG000|Overall Study|Virologic failure|0|||
23297811|NCT01302847|64833224|FG001|Overall Study|Virologic failure|2|||
23297812|NCT01302847|64833225|FG002|Overall Study|Virologic failure|2|||
23297813|NCT01302847|64833226|FG003|Overall Study|Virologic failure|0|||
23297814|NCT01302847|64833227|FG004|Overall Study|Virologic failure|1|||
23297815|NCT01302847|64833228|FG005|Overall Study|Virologic failure|1|||
23297816|NCT01302847|64833229|FG006|Overall Study|Virologic failure|0|||
23297817|NCT01302847|64833230|FG007|Overall Study|Virologic failure|2|||
23297818|NCT01302847|64833223|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23297819|NCT01302847|64833224|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23297820|NCT01302847|64833225|FG002|Overall Study|Severe debilitation, unable to continue|0|||
23297821|NCT01302847|64833226|FG003|Overall Study|Severe debilitation, unable to continue|0|||
23297822|NCT01302847|64833227|FG004|Overall Study|Severe debilitation, unable to continue|0|||
23297823|NCT01302847|64833228|FG005|Overall Study|Severe debilitation, unable to continue|1|||
23297824|NCT01302847|64833229|FG006|Overall Study|Severe debilitation, unable to continue|1|||
23297825|NCT01302847|64833230|FG007|Overall Study|Severe debilitation, unable to continue|0|||
23297826|NCT01302847|64833223|FG000|Overall Study|Not able to get to clinic|1|||
23297827|NCT01302847|64833224|FG001|Overall Study|Not able to get to clinic|1|||
23297828|NCT01302847|64833225|FG002|Overall Study|Not able to get to clinic|0|||
23297829|NCT01302847|64833226|FG003|Overall Study|Not able to get to clinic|0|||
23297830|NCT01302847|64833227|FG004|Overall Study|Not able to get to clinic|0|||
23297831|NCT01302847|64833228|FG005|Overall Study|Not able to get to clinic|0|||
23297832|NCT01302847|64833229|FG006|Overall Study|Not able to get to clinic|0|||
23297833|NCT01302847|64833230|FG007|Overall Study|Not able to get to clinic|0|||
23297834|NCT01302847|64833223|FG000|Overall Study|Site closing|2|||
23297835|NCT01302847|64833224|FG001|Overall Study|Site closing|2|||
23297836|NCT01302847|64833225|FG002|Overall Study|Site closing|0|||
23297837|NCT01302847|64833226|FG003|Overall Study|Site closing|0|||
23494810|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23297838|NCT01302847|64833227|FG004|Overall Study|Site closing|0|||
23494811|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23297839|NCT01302847|64833228|FG005|Overall Study|Site closing|0|||
23297840|NCT01302847|64833229|FG006|Overall Study|Site closing|0|||
23297841|NCT01302847|64833230|FG007|Overall Study|Site closing|0|||
23297842|NCT01302847|64833223|FG000|Overall Study|Withdrawal by Subject|1|||
23297843|NCT01302847|64833224|FG001|Overall Study|Withdrawal by Subject|0|||
23297844|NCT01302847|64833225|FG002|Overall Study|Withdrawal by Subject|0|||
23297845|NCT01302847|64833226|FG003|Overall Study|Withdrawal by Subject|0|||
23297846|NCT01302847|64833227|FG004|Overall Study|Withdrawal by Subject|1|||
23297847|NCT01302847|64833228|FG005|Overall Study|Withdrawal by Subject|0|||
23297848|NCT01302847|64833229|FG006|Overall Study|Withdrawal by Subject|0|||
23297849|NCT01302847|64833230|FG007|Overall Study|Withdrawal by Subject|1|||
23297850|NCT01302847|64833223|FG000|Overall Study|Not willing to adhere to requirements|5|||
23297851|NCT01302847|64833224|FG001|Overall Study|Not willing to adhere to requirements|0|||
23297852|NCT01302847|64833225|FG002|Overall Study|Not willing to adhere to requirements|0|||
23297853|NCT01302847|64833226|FG003|Overall Study|Not willing to adhere to requirements|1|||
23297854|NCT01302847|64833227|FG004|Overall Study|Not willing to adhere to requirements|0|||
23297855|NCT01302847|64833228|FG005|Overall Study|Not willing to adhere to requirements|0|||
23297856|NCT01302847|64833229|FG006|Overall Study|Not willing to adhere to requirements|0|||
23297857|NCT01302847|64833230|FG007|Overall Study|Not willing to adhere to requirements|2|||
23297858|NCT01302847|64833223|FG000|Overall Study|Site unable to contact participant|2|||
23297859|NCT01302847|64833224|FG001|Overall Study|Site unable to contact participant|1|||
23297860|NCT01302847|64833225|FG002|Overall Study|Site unable to contact participant|0|||
23297861|NCT01302847|64833226|FG003|Overall Study|Site unable to contact participant|0|||
23297862|NCT01302847|64833227|FG004|Overall Study|Site unable to contact participant|0|||
23297863|NCT01302847|64833228|FG005|Overall Study|Site unable to contact participant|0|||
23297864|NCT01302847|64833229|FG006|Overall Study|Site unable to contact participant|2|||
23297865|NCT01302847|64833230|FG007|Overall Study|Site unable to contact participant|0|||
23297866|NCT00969124|64833232|FG000|Overall Study|Protocol Violation|2|||
23297867|NCT00969124|64833232|FG000|Overall Study|Inadequate bowel preparation|15|||
23297868|NCT00969124|64833232|FG000|Overall Study|Inability to reach cecum|9|||
23297869|NCT00969124|64833232|FG000|Overall Study|Previously unrecognized disease|3|||
23297870|NCT00969124|64833232|FG000|Overall Study|Technical error|1|||
23297871|NCT00611884|64833234|FG000|Overall Study|Adverse Event|1|||
23297872|NCT00611884|64833235|FG001|Overall Study|Adverse Event|0|||
23297873|NCT00611884|64833236|FG002|Overall Study|Adverse Event|0|||
23297874|NCT00611884|64833237|FG003|Overall Study|Adverse Event|1|||
23297875|NCT00611884|64833234|FG000|Overall Study|Non-Compliance|1|||
23297876|NCT00611884|64833235|FG001|Overall Study|Non-Compliance|4|||
23297877|NCT00611884|64833236|FG002|Overall Study|Non-Compliance|2|||
23297878|NCT00611884|64833237|FG003|Overall Study|Non-Compliance|2|||
23297879|NCT00611884|64833234|FG000|Overall Study|Lack of Efficacy|0|||
23297880|NCT00611884|64833235|FG001|Overall Study|Lack of Efficacy|1|||
23297881|NCT00611884|64833236|FG002|Overall Study|Lack of Efficacy|0|||
23297882|NCT00611884|64833237|FG003|Overall Study|Lack of Efficacy|0|||
23297883|NCT00611884|64833234|FG000|Overall Study|Unclassified|7|||
23297884|NCT00611884|64833235|FG001|Overall Study|Unclassified|4|||
23297885|NCT00611884|64833236|FG002|Overall Study|Unclassified|2|||
23297886|NCT00611884|64833237|FG003|Overall Study|Unclassified|3|||
23297887|NCT01010126|64833238|FG000|Overall Study|Withdrawal by Subject|1|||
23297888|NCT01010126|64833239|FG001|Overall Study|Withdrawal by Subject|0|||
23297889|NCT01010126|64833240|FG002|Overall Study|Withdrawal by Subject|1|||
23297890|NCT01010126|64833241|FG003|Overall Study|Withdrawal by Subject|0|||
23297891|NCT01010126|64833242|FG004|Overall Study|Withdrawal by Subject|3|||
23297892|NCT01010126|64833243|FG005|Overall Study|Withdrawal by Subject|0|||
23297893|NCT01131299|64833244|FG000|Overall Study|Withdrawal by Subject|4|||
23297894|NCT01131299|64833245|FG001|Overall Study|Withdrawal by Subject|7|||
23297895|NCT00206102|64833251|FG000|Overall Study|Adverse Event|119|||
23297896|NCT00206102|64833252|FG001|Overall Study|Adverse Event|82|||
23297897|NCT00206102|64833251|FG000|Overall Study|Protocol Violation|0|||
23297898|NCT00206102|64833252|FG001|Overall Study|Protocol Violation|2|||
23297899|NCT00206102|64833251|FG000|Overall Study|Lack of therapeutic response|16|||
23297900|NCT00206102|64833252|FG001|Overall Study|Lack of therapeutic response|11|||
23297901|NCT00206102|64833251|FG000|Overall Study|Lost to Follow-up|95|||
23297902|NCT00206102|64833252|FG001|Overall Study|Lost to Follow-up|66|||
23297903|NCT00206102|64833251|FG000|Overall Study|Withdrawal by Subject|118|||
23297904|NCT00206102|64833252|FG001|Overall Study|Withdrawal by Subject|101|||
23297905|NCT00206102|64833251|FG000|Overall Study|Study-specific discontinuation criteria|18|||
23297906|NCT00206102|64833252|FG001|Overall Study|Study-specific discontinuation criteria|17|||
23297907|NCT00206102|64833251|FG000|Overall Study|None of those categories|42|||
23297908|NCT00206102|64833252|FG001|Overall Study|None of those categories|36|||
23297909|NCT02985879|64833253|FG000|Overall Study|Adverse Event|7|||
23297910|NCT02985879|64833254|FG001|Overall Study|Adverse Event|9|||
23297911|NCT02985879|64833255|FG002|Overall Study|Adverse Event|7|||
23297912|NCT02985879|64833253|FG000|Overall Study|Withdrew consent|6|||
23297913|NCT02985879|64833254|FG001|Overall Study|Withdrew consent|8|||
23297914|NCT02985879|64833255|FG002|Overall Study|Withdrew consent|10|||
23297915|NCT02985879|64833253|FG000|Overall Study|Lost to Follow-up|1|||
23297916|NCT02985879|64833254|FG001|Overall Study|Lost to Follow-up|0|||
23297917|NCT02985879|64833255|FG002|Overall Study|Lost to Follow-up|2|||
23297918|NCT02985879|64833253|FG000|Overall Study|Other, not specified|62|||
23297919|NCT02985879|64833254|FG001|Overall Study|Other, not specified|58|||
23297920|NCT02985879|64833255|FG002|Overall Study|Other, not specified|58|||
23297921|NCT02744755|64833262|FG000|Study Period 1|Protocol Violation|2|||
23297922|NCT02744755|64833263|FG001|Study Period 1|Protocol Violation|1|||
23297923|NCT02744755|64833262|FG000|Study Period 1|not defined|0|||
23297924|NCT02744755|64833263|FG001|Study Period 1|not defined|1|||
23297925|NCT02744755|64833262|FG000|Study Period 1|Pregnancy|1|||
23297926|NCT02744755|64833263|FG001|Study Period 1|Pregnancy|0|||
23297927|NCT02744755|64833262|FG000|Study Period 1|Adverse Event|1|||
23297928|NCT02744755|64833263|FG001|Study Period 1|Adverse Event|1|||
23297929|NCT02744755|64833262|FG000|Study Period 1|Lost to Follow-up|1|||
23297930|NCT02744755|64833263|FG001|Study Period 1|Lost to Follow-up|1|||
23297931|NCT02744755|64833262|FG000|Study Period 1|Lack of Efficacy|1|||
23297932|NCT02744755|64833263|FG001|Study Period 1|Lack of Efficacy|0|||
23297933|NCT02744755|64833262|FG000|Study Period 1|Withdrawal by Subject|8|||
23297934|NCT02744755|64833263|FG001|Study Period 1|Withdrawal by Subject|4|||
23297935|NCT02744755|64833262|FG000|Study Period 2|Adverse Event|5|||
23297936|NCT02744755|64833263|FG001|Study Period 2|Adverse Event|0|||
23297937|NCT02744755|64833262|FG000|Study Period 2|Protocol Violation|1|||
23297938|NCT02744755|64833263|FG001|Study Period 2|Protocol Violation|0|||
23297939|NCT02744755|64833262|FG000|Study Period 2|not defined|3|||
23297940|NCT02744755|64833263|FG001|Study Period 2|not defined|2|||
23297941|NCT02744755|64833262|FG000|Study Period 2|Lost to Follow-up|0|||
23297942|NCT02744755|64833263|FG001|Study Period 2|Lost to Follow-up|2|||
23297943|NCT02744755|64833262|FG000|Study Period 2|Withdrawal by Subject|2|||
23297944|NCT02744755|64833263|FG001|Study Period 2|Withdrawal by Subject|2|||
23297945|NCT02744755|64833262|FG000|Study Period 2|Lack of Efficacy|3|||
23297946|NCT02744755|64833263|FG001|Study Period 2|Lack of Efficacy|2|||
23297947|NCT00369382|64833268|FG000|Overall Study|Death|0|||
23297948|NCT00369382|64833269|FG001|Overall Study|Death|2|||
23297949|NCT00369382|64833268|FG000|Overall Study|Physician Decision|2|||
23297950|NCT00369382|64833269|FG001|Overall Study|Physician Decision|1|||
23297951|NCT00369382|64833268|FG000|Overall Study|Withdrawal by Subject|5|||
23297952|NCT00369382|64833269|FG001|Overall Study|Withdrawal by Subject|0|||
23297953|NCT00369382|64833268|FG000|Overall Study|Randomized, not treated|2|||
23297954|NCT00369382|64833269|FG001|Overall Study|Randomized, not treated|0|||
23297955|NCT00369382|64833268|FG000|Overall Study|Other|1|||
23297956|NCT00369382|64833269|FG001|Overall Study|Other|0|||
23297957|NCT01042535|64833275|FG000|Overall Study|disease progression prior to treatment|3|||
23297958|NCT01042535|64833275|FG000|Overall Study|disease progression during treatment|3|||
23297959|NCT01042535|64833275|FG000|Overall Study|complications from other disease|2|||
23297960|NCT00848042|64833281|FG000|Overall Study|Death|1|||
23297961|NCT00848042|64833282|FG001|Overall Study|Death|2|||
23297962|NCT00848042|64833283|FG002|Overall Study|Death|0|||
23297963|NCT00848042|64833281|FG000|Overall Study|Other Therapy|3|||
23297964|NCT00848042|64833282|FG001|Overall Study|Other Therapy|0|||
23297965|NCT00848042|64833283|FG002|Overall Study|Other Therapy|0|||
23297966|NCT01652729|64833286|FG000|Overall Study|Withdrawal by Subject|14|||
23297967|NCT01652729|64833287|FG001|Overall Study|Withdrawal by Subject|7|||
23297968|NCT01652729|64833288|FG002|Overall Study|Withdrawal by Subject|7|||
23297969|NCT01652729|64833286|FG000|Overall Study|Adverse Event|4|||
23297970|NCT01652729|64833287|FG001|Overall Study|Adverse Event|0|||
23297971|NCT01652729|64833288|FG002|Overall Study|Adverse Event|3|||
23297972|NCT01652729|64833286|FG000|Overall Study|Physician Decision|1|||
23297973|NCT01652729|64833287|FG001|Overall Study|Physician Decision|0|||
23297974|NCT01652729|64833288|FG002|Overall Study|Physician Decision|1|||
23297975|NCT01652729|64833286|FG000|Overall Study|Protocol Violation|1|||
23297976|NCT01652729|64833287|FG001|Overall Study|Protocol Violation|0|||
23297977|NCT01652729|64833288|FG002|Overall Study|Protocol Violation|0|||
23297978|NCT01652729|64833286|FG000|Overall Study|Lost to Follow-up|6|||
23297979|NCT01652729|64833287|FG001|Overall Study|Lost to Follow-up|6|||
23297980|NCT01652729|64833288|FG002|Overall Study|Lost to Follow-up|3|||
23297981|NCT01652729|64833286|FG000|Overall Study|Administrative|1|||
23297982|NCT01652729|64833287|FG001|Overall Study|Administrative|0|||
23297983|NCT01652729|64833288|FG002|Overall Study|Administrative|0|||
23297984|NCT00483548|64833291|FG000|Overall Study|Randomized; not treated with study drug|1|||
23297985|NCT00483548|64833292|FG001|Overall Study|Randomized; not treated with study drug|3|||
23297986|NCT00483548|64833291|FG000|Overall Study|Adverse Event|25|||
23297987|NCT00483548|64833292|FG001|Overall Study|Adverse Event|14|||
23297988|NCT00483548|64833291|FG000|Overall Study|Laboratory abnormality|1|||
23297989|NCT00483548|64833292|FG001|Overall Study|Laboratory abnormality|2|||
23297990|NCT00483548|64833291|FG000|Overall Study|Lack of Efficacy|4|||
23297991|NCT00483548|64833292|FG001|Overall Study|Lack of Efficacy|8|||
23297992|NCT00483548|64833291|FG000|Overall Study|Protocol Violation|11|||
23297993|NCT00483548|64833292|FG001|Overall Study|Protocol Violation|7|||
23297994|NCT00483548|64833291|FG000|Overall Study|Pregnancy|1|||
23297995|NCT00483548|64833292|FG001|Overall Study|Pregnancy|0|||
23297996|NCT00483548|64833291|FG000|Overall Study|Protocol required discontinuation|6|||
23297997|NCT00483548|64833292|FG001|Overall Study|Protocol required discontinuation|6|||
23297998|NCT00483548|64833291|FG000|Overall Study|Unable to comply with protocol schedule|1|||
23297999|NCT00483548|64833292|FG001|Overall Study|Unable to comply with protocol schedule|0|||
23298000|NCT00483548|64833291|FG000|Overall Study|Non-compliance with medication|2|||
23298001|NCT00483548|64833292|FG001|Overall Study|Non-compliance with medication|0|||
23298002|NCT00483548|64833291|FG000|Overall Study|Lost to Follow-up|3|||
23298003|NCT00483548|64833292|FG001|Overall Study|Lost to Follow-up|4|||
23298004|NCT00483548|64833291|FG000|Overall Study|Withdrawal by Subject|5|||
23298005|NCT00483548|64833292|FG001|Overall Study|Withdrawal by Subject|2|||
23298006|NCT02953678|64833295|FG000|Overall Study|Adverse Event|20|||
23298007|NCT02953678|64833295|FG000|Overall Study|Death|7|||
23298008|NCT02953678|64833295|FG000|Overall Study|Physician Decision|23|||
23298009|NCT02953678|64833295|FG000|Overall Study|Progressive Disease of GVHD|7|||
23298010|NCT02953678|64833295|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
23298011|NCT02953678|64833295|FG000|Overall Study|Withdrawal by participant|3|||
23298012|NCT02953678|64833295|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
23298013|NCT02953678|64833295|FG000|Overall Study|Participants were transferred to commercial product.|3|||
23298014|NCT02039414|64833298|FG000|Overall Study|Delivered|1|||
23298015|NCT02039414|64833299|FG001|Overall Study|Delivered|1|||
23298016|NCT02039414|64833298|FG000|Overall Study|Lost to Follow-up|2|||
23298017|NCT02039414|64833299|FG001|Overall Study|Lost to Follow-up|0|||
23298018|NCT02039414|64833298|FG000|Overall Study|Protocol Violation|3|||
23298019|NCT02039414|64833299|FG001|Overall Study|Protocol Violation|1|||
23298020|NCT03739138|64833300|FG000|Overall Study|Death|0|||
23388878|NCT00504556|65168840|FG004|Overall Study|did not meet entry criteria|0|||
23298021|NCT03739138|64833301|FG001|Overall Study|Death|7|||
23298022|NCT03739138|64833302|FG002|Overall Study|Death|4|||
23298023|NCT03739138|64833303|FG003|Overall Study|Death|13|||
23388879|NCT00504556|65168836|FG000|Overall Study|data monitor committee decision|0|||
23298024|NCT03739138|64833304|FG004|Overall Study|Death|0|||
23298025|NCT03739138|64833300|FG000|Overall Study|Lost to Follow-up|0|||
23298026|NCT03739138|64833301|FG001|Overall Study|Lost to Follow-up|0|||
23298027|NCT03739138|64833302|FG002|Overall Study|Lost to Follow-up|1|||
23388880|NCT00504556|65168837|FG001|Overall Study|data monitor committee decision|0|||
23298028|NCT03739138|64833303|FG003|Overall Study|Lost to Follow-up|0|||
23298029|NCT03739138|64833304|FG004|Overall Study|Lost to Follow-up|0|||
23298030|NCT03739138|64833300|FG000|Overall Study|Study Terminated By Sponsor|0|||
23298031|NCT03739138|64833301|FG001|Overall Study|Study Terminated By Sponsor|0|||
23298032|NCT03739138|64833302|FG002|Overall Study|Study Terminated By Sponsor|0|||
23298033|NCT03739138|64833303|FG003|Overall Study|Study Terminated By Sponsor|4|||
23298034|NCT03739138|64833304|FG004|Overall Study|Study Terminated By Sponsor|0|||
23298035|NCT03739138|64833300|FG000|Overall Study|Withdrawal by Subject|0|||
23298036|NCT03739138|64833301|FG001|Overall Study|Withdrawal by Subject|0|||
23298037|NCT03739138|64833302|FG002|Overall Study|Withdrawal by Subject|0|||
23298038|NCT03739138|64833303|FG003|Overall Study|Withdrawal by Subject|1|||
23298039|NCT03739138|64833304|FG004|Overall Study|Withdrawal by Subject|0|||
23298040|NCT02315066|64833305|FG000|Overall Study|Lost to Follow-up|0|||
23298041|NCT02315066|64833306|FG001|Overall Study|Lost to Follow-up|1|||
23298042|NCT02315066|64833307|FG002|Overall Study|Lost to Follow-up|1|||
23298043|NCT02315066|64833308|FG003|Overall Study|Lost to Follow-up|0|||
23298044|NCT02315066|64833309|FG004|Overall Study|Lost to Follow-up|1|||
23298045|NCT02315066|64833310|FG005|Overall Study|Lost to Follow-up|0|||
23298046|NCT02315066|64833311|FG006|Overall Study|Lost to Follow-up|2|||
23298047|NCT02315066|64833312|FG007|Overall Study|Lost to Follow-up|1|||
23298048|NCT02315066|64833313|FG008|Overall Study|Lost to Follow-up|0|||
23298049|NCT02315066|64833314|FG009|Overall Study|Lost to Follow-up|0|||
23298050|NCT02315066|64833315|FG010|Overall Study|Lost to Follow-up|1|||
23298051|NCT02315066|64833316|FG011|Overall Study|Lost to Follow-up|2|||
23298052|NCT02315066|64833317|FG012|Overall Study|Lost to Follow-up|0|||
23298053|NCT02315066|64833318|FG013|Overall Study|Lost to Follow-up|4|||
23298054|NCT02315066|64833305|FG000|Overall Study|Death|2|||
23298055|NCT02315066|64833306|FG001|Overall Study|Death|7|||
23298056|NCT02315066|64833307|FG002|Overall Study|Death|6|||
23298057|NCT02315066|64833308|FG003|Overall Study|Death|11|||
23298058|NCT02315066|64833309|FG004|Overall Study|Death|10|||
23298059|NCT02315066|64833310|FG005|Overall Study|Death|3|||
23298060|NCT02315066|64833311|FG006|Overall Study|Death|9|||
23298061|NCT02315066|64833312|FG007|Overall Study|Death|9|||
23298062|NCT02315066|64833313|FG008|Overall Study|Death|10|||
23298063|NCT02315066|64833314|FG009|Overall Study|Death|8|||
23298064|NCT02315066|64833315|FG010|Overall Study|Death|10|||
23298065|NCT02315066|64833316|FG011|Overall Study|Death|7|||
23298066|NCT02315066|64833317|FG012|Overall Study|Death|8|||
23298067|NCT02315066|64833318|FG013|Overall Study|Death|21|||
23298068|NCT02315066|64833305|FG000|Overall Study|Other|0|||
23298069|NCT02315066|64833306|FG001|Overall Study|Other|0|||
23298070|NCT02315066|64833307|FG002|Overall Study|Other|0|||
23494812|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
23494813|NCT03307785|65554999|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494814|NCT03307785|65555000|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494815|NCT03307785|65555001|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494816|NCT03307785|65555002|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494817|NCT03307785|65555003|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494818|NCT03307785|65555004|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
23494819|NCT03307785|65555005|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23298071|NCT02315066|64833308|FG003|Overall Study|Other|0|||
23298072|NCT02315066|64833309|FG004|Overall Study|Other|0|||
23298073|NCT02315066|64833310|FG005|Overall Study|Other|0|||
23298074|NCT02315066|64833311|FG006|Overall Study|Other|0|||
23298075|NCT02315066|64833312|FG007|Overall Study|Other|1|||
23298076|NCT02315066|64833313|FG008|Overall Study|Other|1|||
23298077|NCT02315066|64833314|FG009|Overall Study|Other|2|||
23298078|NCT02315066|64833315|FG010|Overall Study|Other|0|||
23298079|NCT02315066|64833316|FG011|Overall Study|Other|0|||
23298080|NCT02315066|64833317|FG012|Overall Study|Other|0|||
23298081|NCT02315066|64833318|FG013|Overall Study|Other|0|||
23298082|NCT02315066|64833305|FG000|Overall Study|Subject refused further follow-up|0|||
23298083|NCT02315066|64833306|FG001|Overall Study|Subject refused further follow-up|2|||
23298084|NCT02315066|64833307|FG002|Overall Study|Subject refused further follow-up|2|||
23298085|NCT02315066|64833308|FG003|Overall Study|Subject refused further follow-up|0|||
23298086|NCT02315066|64833309|FG004|Overall Study|Subject refused further follow-up|0|||
23298087|NCT02315066|64833310|FG005|Overall Study|Subject refused further follow-up|0|||
23298088|NCT02315066|64833311|FG006|Overall Study|Subject refused further follow-up|2|||
23298089|NCT02315066|64833312|FG007|Overall Study|Subject refused further follow-up|3|||
23298090|NCT02315066|64833313|FG008|Overall Study|Subject refused further follow-up|0|||
23298091|NCT02315066|64833314|FG009|Overall Study|Subject refused further follow-up|1|||
23298092|NCT02315066|64833315|FG010|Overall Study|Subject refused further follow-up|1|||
23298093|NCT02315066|64833316|FG011|Overall Study|Subject refused further follow-up|2|||
23298094|NCT02315066|64833317|FG012|Overall Study|Subject refused further follow-up|2|||
23298095|NCT02315066|64833318|FG013|Overall Study|Subject refused further follow-up|4|||
23298096|NCT02315066|64833305|FG000|Overall Study|Study ongoing at date of cut-off|0|||
23298097|NCT02315066|64833306|FG001|Overall Study|Study ongoing at date of cut-off|0|||
23298098|NCT02315066|64833307|FG002|Overall Study|Study ongoing at date of cut-off|0|||
23298099|NCT02315066|64833308|FG003|Overall Study|Study ongoing at date of cut-off|0|||
23298100|NCT02315066|64833309|FG004|Overall Study|Study ongoing at date of cut-off|0|||
23298101|NCT02315066|64833310|FG005|Overall Study|Study ongoing at date of cut-off|0|||
23298102|NCT02315066|64833311|FG006|Overall Study|Study ongoing at date of cut-off|0|||
23298103|NCT02315066|64833312|FG007|Overall Study|Study ongoing at date of cut-off|0|||
23298104|NCT02315066|64833313|FG008|Overall Study|Study ongoing at date of cut-off|0|||
23298105|NCT02315066|64833314|FG009|Overall Study|Study ongoing at date of cut-off|0|||
23298106|NCT02315066|64833315|FG010|Overall Study|Study ongoing at date of cut-off|0|||
23298107|NCT02315066|64833316|FG011|Overall Study|Study ongoing at date of cut-off|0|||
23298108|NCT02315066|64833317|FG012|Overall Study|Study ongoing at date of cut-off|0|||
23298109|NCT02315066|64833318|FG013|Overall Study|Study ongoing at date of cut-off|1|||
23298110|NCT02674386|64833319|FG000|Overall Study|Lost to Follow-up|0|||
23298111|NCT02674386|64833320|FG001|Overall Study|Lost to Follow-up|1|||
23494820|NCT03307785|65555006|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494821|NCT03307785|65555007|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494822|NCT03307785|65555008|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494823|NCT03307785|65555009|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
23494824|NCT03307785|65554999|FG000|Part E: Up to 4.4 Months|Death|0|||
23494825|NCT03307785|65555000|FG001|Part E: Up to 4.4 Months|Death|0|||
23494826|NCT03307785|65555001|FG002|Part E: Up to 4.4 Months|Death|0|||
23494827|NCT03307785|65555002|FG003|Part E: Up to 4.4 Months|Death|0|||
23494828|NCT03307785|65555003|FG004|Part E: Up to 4.4 Months|Death|0|||
23494829|NCT03307785|65555004|FG005|Part E: Up to 4.4 Months|Death|0|||
23494830|NCT03307785|65555005|FG006|Part E: Up to 4.4 Months|Death|1|||
23298112|NCT02674386|64833321|FG002|Overall Study|Lost to Follow-up|1|||
23298113|NCT02674386|64833319|FG000|Overall Study|Withdrawal by Subject|0|||
23494831|NCT03307785|65555006|FG007|Part E: Up to 4.4 Months|Death|0|||
23298114|NCT02674386|64833320|FG001|Overall Study|Withdrawal by Subject|4|||
23298115|NCT02674386|64833321|FG002|Overall Study|Withdrawal by Subject|0|||
23298116|NCT02674386|64833319|FG000|Overall Study|Other|0|||
23298117|NCT02674386|64833320|FG001|Overall Study|Other|1|||
23298118|NCT02674386|64833321|FG002|Overall Study|Other|0|||
23298119|NCT02674386|64833319|FG000|Overall Study|Enrolled but not evaluated|0|||
23298120|NCT02674386|64833320|FG001|Overall Study|Enrolled but not evaluated|4|||
23298121|NCT02674386|64833321|FG002|Overall Study|Enrolled but not evaluated|0|||
23298122|NCT03336242|64833322|FG000|Overall Study|Adverse Event|0|||
23298123|NCT03336242|64833323|FG001|Overall Study|Adverse Event|1|||
23298124|NCT00767520|64833327|FG000|Overall Study|Participants still on treatment|11|||
23298125|NCT00767520|64833328|FG001|Overall Study|Participants still on treatment|15|||
23298126|NCT00767520|64833327|FG000|Overall Study|Randomized in error and Never treated|0|||
23298127|NCT00767520|64833328|FG001|Overall Study|Randomized in error and Never treated|2|||
23298128|NCT01796964|64833331|FG000|Overall Study|Adverse Event|1|||
23298129|NCT01796964|64833332|FG001|Overall Study|Adverse Event|1|||
23298130|NCT01796964|64833331|FG000|Overall Study|Death|1|||
23298131|NCT01796964|64833332|FG001|Overall Study|Death|0|||
23298132|NCT01796964|64833331|FG000|Overall Study|Protocol Violation|0|||
23298133|NCT01796964|64833332|FG001|Overall Study|Protocol Violation|1|||
23298134|NCT01796964|64833331|FG000|Overall Study|Withdrawal by Subject|1|||
23298135|NCT01796964|64833332|FG001|Overall Study|Withdrawal by Subject|1|||
23298136|NCT02340221|64833333|FG000|Overall Study|Death|100|||
23298137|NCT02340221|64833334|FG001|Overall Study|Death|197|||
23298138|NCT02340221|64833333|FG000|Overall Study|Withdrawal by Participant|24|||
23298139|NCT02340221|64833334|FG001|Overall Study|Withdrawal by Participant|37|||
23298140|NCT02340221|64833333|FG000|Overall Study|Lost to Follow-up|4|||
23298141|NCT02340221|64833334|FG001|Overall Study|Lost to Follow-up|15|||
23298142|NCT02340221|64833333|FG000|Overall Study|Reason Not Specified|85|||
23298143|NCT02340221|64833334|FG001|Overall Study|Reason Not Specified|165|||
23298144|NCT02340221|64833333|FG000|Overall Study|Study Terminated by Sponsor|1|||
23298145|NCT02340221|64833334|FG001|Overall Study|Study Terminated by Sponsor|3|||
23298146|NCT00319046|64833336|FG000|Overall Study|withdrawal of subject's consent|7|||
23298147|NCT00319046|64833336|FG000|Overall Study|administrative reason|1|||
23298148|NCT01998243|64833337|FG000|Overall Study|Pregnancy|0|||
23298149|NCT01998243|64833338|FG001|Overall Study|Pregnancy|1|||
23298150|NCT01998243|64833337|FG000|Overall Study|Protocol Violation|5|||
23298151|NCT01998243|64833338|FG001|Overall Study|Protocol Violation|2|||
23298152|NCT01998243|64833337|FG000|Overall Study|Withdrawal by Subject|3|||
23298153|NCT01998243|64833338|FG001|Overall Study|Withdrawal by Subject|4|||
23298154|NCT00792623|64833339|FG000|Overall Study|Adverse Event|2|||
23298155|NCT00792623|64833339|FG000|Overall Study|Withdrawal by Subject|5|||
23298156|NCT03330236|64833345|FG000|Overall Study|Death|2|||
23298157|NCT03330236|64833346|FG001|Overall Study|Death|1|||
23298158|NCT03330236|64833345|FG000|Overall Study|Withdrawal by Subject|2|||
23298159|NCT03330236|64833346|FG001|Overall Study|Withdrawal by Subject|4|||
23298160|NCT03330236|64833345|FG000|Overall Study|Lost to Follow-up|0|||
23298161|NCT03330236|64833346|FG001|Overall Study|Lost to Follow-up|2|||
23298162|NCT03330236|64833345|FG000|Overall Study|Physician Decision|2|||
23298163|NCT03330236|64833346|FG001|Overall Study|Physician Decision|0|||
23298164|NCT03330236|64833345|FG000|Overall Study|Protocol Violation|4|||
23298165|NCT03330236|64833346|FG001|Overall Study|Protocol Violation|3|||
23298166|NCT03330236|64833345|FG000|Overall Study|SedLine malfunction/blinding|19|||
23298167|NCT03330236|64833346|FG001|Overall Study|SedLine malfunction/blinding|14|||
23298168|NCT03330236|64833345|FG000|Overall Study|Volatile anesthetics used|11|||
23298169|NCT03330236|64833346|FG001|Overall Study|Volatile anesthetics used|8|||
23298170|NCT03330236|64833345|FG000|Overall Study|Surgery aborted/converted to open|60|||
23298171|NCT03330236|64833346|FG001|Overall Study|Surgery aborted/converted to open|52|||
23298172|NCT00285584|64833347|FG000|Month 3|Lost to Follow-up|3|||
23298173|NCT00285584|64833348|FG001|Month 3|Lost to Follow-up|3|||
23298174|NCT00285584|64833347|FG000|Month 3|Withdrawal by Subject|1|||
23298175|NCT00285584|64833348|FG001|Month 3|Withdrawal by Subject|0|||
23298176|NCT00285584|64833347|FG000|Month 6|Lost to Follow-up|0|||
23298177|NCT00285584|64833348|FG001|Month 6|Lost to Follow-up|1|||
23298178|NCT03235479|64833349|FG000|Overall Study|Lost to Follow-up|8|||
23298179|NCT03235479|64833350|FG001|Overall Study|Lost to Follow-up|11|||
23298180|NCT03235479|64833349|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
23298181|NCT03235479|64833350|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
23298182|NCT03235479|64833349|FG000|Overall Study|Pregnancy|1|||
23298183|NCT03235479|64833350|FG001|Overall Study|Pregnancy|0|||
23298184|NCT03235479|64833349|FG000|Overall Study|Protocol Deviation|1|||
23298185|NCT03235479|64833350|FG001|Overall Study|Protocol Deviation|3|||
23298186|NCT03235479|64833349|FG000|Overall Study|Technical Problems|3|||
23298187|NCT03235479|64833350|FG001|Overall Study|Technical Problems|2|||
23298188|NCT03235479|64833349|FG000|Overall Study|Withdrawal by Subject|2|||
23494832|NCT03307785|65555007|FG008|Part E: Up to 4.4 Months|Death|0|||
23298189|NCT03235479|64833350|FG001|Overall Study|Withdrawal by Subject|2|||
23298190|NCT03235479|64833349|FG000|Overall Study|Other Reasons|3|||
23298191|NCT03235479|64833350|FG001|Overall Study|Other Reasons|5|||
23298192|NCT00873119|64833351|FG000|Overall Study|Patient request|4|||
23298193|NCT00873119|64833352|FG001|Overall Study|Patient request|2|||
23298194|NCT00873119|64833351|FG000|Overall Study|Adverse Event|8|||
23298195|NCT00873119|64833352|FG001|Overall Study|Adverse Event|0|||
23298196|NCT00873119|64833351|FG000|Overall Study|Progressive disease|26|||
23298197|NCT00873119|64833352|FG001|Overall Study|Progressive disease|18|||
23298198|NCT00873119|64833351|FG000|Overall Study|Death|2|||
23298199|NCT00873119|64833352|FG001|Overall Study|Death|1|||
23298200|NCT00873119|64833351|FG000|Overall Study|Other|2|||
23298201|NCT00873119|64833352|FG001|Overall Study|Other|5|||
23298202|NCT00873119|64833351|FG000|Overall Study|Not treated|2|||
23298203|NCT00873119|64833352|FG001|Overall Study|Not treated|0|||
23298204|NCT02746627|64833355|FG000|Overall Study|Withdrawal by Subject|1|||
23298205|NCT02746627|64833356|FG001|Overall Study|Withdrawal by Subject|1|||
23298206|NCT02746627|64833357|FG002|Overall Study|Withdrawal by Subject|1|||
23298207|NCT03087786|64833362|FG000|Overall Study|Withdrawal by Subject|2|||
23298208|NCT03087786|64833363|FG001|Overall Study|Withdrawal by Subject|0|||
23298209|NCT01056640|64833364|FG000|Overall Study|Withdrawal by Subject|11|||
23298210|NCT01056640|64833365|FG001|Overall Study|Withdrawal by Subject|8|||
23298211|NCT01056640|64833364|FG000|Overall Study|Death|15|||
23298212|NCT01056640|64833365|FG001|Overall Study|Death|4|||
23298213|NCT00108082|64833366|FG000|Overall Study|Adverse Event|14|||
23298214|NCT00108082|64833367|FG001|Overall Study|Adverse Event|12|||
23298215|NCT00108082|64833368|FG002|Overall Study|Adverse Event|17|||
23298216|NCT00108082|64833366|FG000|Overall Study|Lost to Follow-up|6|||
23298217|NCT00108082|64833367|FG001|Overall Study|Lost to Follow-up|3|||
23298218|NCT00108082|64833368|FG002|Overall Study|Lost to Follow-up|7|||
23298219|NCT00108082|64833366|FG000|Overall Study|Consent Withdrawn|3|||
23298220|NCT00108082|64833367|FG001|Overall Study|Consent Withdrawn|3|||
23298221|NCT00108082|64833368|FG002|Overall Study|Consent Withdrawn|5|||
23298222|NCT00108082|64833366|FG000|Overall Study|Protocol Violation|1|||
23298223|NCT00108082|64833367|FG001|Overall Study|Protocol Violation|2|||
23298224|NCT00108082|64833368|FG002|Overall Study|Protocol Violation|0|||
23298225|NCT00108082|64833366|FG000|Overall Study|Lack of Efficacy|3|||
23298226|NCT00108082|64833367|FG001|Overall Study|Lack of Efficacy|1|||
23298227|NCT00108082|64833368|FG002|Overall Study|Lack of Efficacy|2|||
23298228|NCT00108082|64833366|FG000|Overall Study|Amendment 4: > Month 12|5|||
23298229|NCT00108082|64833367|FG001|Overall Study|Amendment 4: > Month 12|7|||
23298230|NCT00108082|64833368|FG002|Overall Study|Amendment 4: > Month 12|5|||
23298231|NCT00108082|64833366|FG000|Overall Study|Woman of Child-bearing Potential|2|||
23298232|NCT00108082|64833367|FG001|Overall Study|Woman of Child-bearing Potential|0|||
23298233|NCT00108082|64833368|FG002|Overall Study|Woman of Child-bearing Potential|2|||
23298234|NCT00108082|64833366|FG000|Overall Study|Incorrectly Randomized|0|||
23298235|NCT00108082|64833367|FG001|Overall Study|Incorrectly Randomized|0|||
23298236|NCT00108082|64833368|FG002|Overall Study|Incorrectly Randomized|2|||
23298237|NCT00108082|64833366|FG000|Overall Study|Non-compliance|1|||
23298238|NCT00108082|64833367|FG001|Overall Study|Non-compliance|0|||
23298239|NCT00108082|64833368|FG002|Overall Study|Non-compliance|2|||
23298240|NCT00108082|64833366|FG000|Overall Study|Stopped Study Medication|0|||
23298241|NCT00108082|64833367|FG001|Overall Study|Stopped Study Medication|0|||
23298242|NCT00108082|64833368|FG002|Overall Study|Stopped Study Medication|1|||
23298243|NCT00108082|64833366|FG000|Overall Study|Site Closed Study|0|||
23298244|NCT00108082|64833367|FG001|Overall Study|Site Closed Study|2|||
23298245|NCT00108082|64833368|FG002|Overall Study|Site Closed Study|0|||
23298246|NCT00108082|64833366|FG000|Overall Study|Protocol Amendment|0|||
23298247|NCT00108082|64833367|FG001|Overall Study|Protocol Amendment|1|||
23298248|NCT00108082|64833368|FG002|Overall Study|Protocol Amendment|0|||
23298249|NCT00108082|64833366|FG000|Overall Study|Study Medication Not Tapered|0|||
23298250|NCT00108082|64833367|FG001|Overall Study|Study Medication Not Tapered|1|||
23298251|NCT00108082|64833368|FG002|Overall Study|Study Medication Not Tapered|0|||
23298252|NCT00108082|64833366|FG000|Overall Study|Subject Left Site Location|1|||
23298253|NCT00108082|64833367|FG001|Overall Study|Subject Left Site Location|0|||
23298254|NCT00108082|64833368|FG002|Overall Study|Subject Left Site Location|0|||
23298255|NCT00108082|64833366|FG000|Overall Study|Investigator Not at Site|1|||
23388881|NCT00504556|65168838|FG002|Overall Study|data monitor committee decision|0|||
23298256|NCT00108082|64833367|FG001|Overall Study|Investigator Not at Site|0|||
23298257|NCT00108082|64833368|FG002|Overall Study|Investigator Not at Site|0|||
23298258|NCT00108082|64833366|FG000|Overall Study|Blood Pressure Not Controlled|1|||
23298259|NCT00108082|64833367|FG001|Overall Study|Blood Pressure Not Controlled|0|||
23298260|NCT00108082|64833368|FG002|Overall Study|Blood Pressure Not Controlled|0|||
23298261|NCT04932941|64833369|FG000|Overall Study|Lost to Follow-up|3|||
23298262|NCT04932941|64833370|FG001|Overall Study|Lost to Follow-up|1|||
23298263|NCT04932941|64833369|FG000|Overall Study|Withdrawal by Subject|7|||
23298264|NCT04932941|64833370|FG001|Overall Study|Withdrawal by Subject|4|||
23298265|NCT04932941|64833369|FG000|Overall Study|Other|4|||
23298266|NCT04932941|64833370|FG001|Overall Study|Other|2|||
23298267|NCT01546142|64833371|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
23298268|NCT01546142|64833372|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
23298269|NCT01546142|64833371|FG000|Overall Study|Subject Noncompliance|1|||
23494833|NCT03307785|65555008|FG009|Part E: Up to 4.4 Months|Death|0|||
23298270|NCT01546142|64833372|FG001|Overall Study|Subject Noncompliance|1|||
23298271|NCT01546142|64833371|FG000|Overall Study|Adverse Event|6|||
23298272|NCT01546142|64833372|FG001|Overall Study|Adverse Event|3|||
23298273|NCT01546142|64833371|FG000|Overall Study|Lost to Follow-up|20|||
23298274|NCT01546142|64833372|FG001|Overall Study|Lost to Follow-up|15|||
23298275|NCT01546142|64833371|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
23298276|NCT01546142|64833372|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
23298277|NCT01546142|64833371|FG000|Overall Study|Subject Randomized but Not Treated|1|||
23298278|NCT01546142|64833372|FG001|Overall Study|Subject Randomized but Not Treated|0|||
23298279|NCT01546922|64833373|FG000|First Period of 10 Weeks|Protocol Violation|3|||
23298280|NCT01546922|64833374|FG001|First Period of 10 Weeks|Protocol Violation|1|||
23298281|NCT01546922|64833373|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
23298282|NCT01546922|64833374|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
23298283|NCT01546922|64833373|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
23298284|NCT01546922|64833374|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
23298285|NCT01546922|64833373|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
23298286|NCT01546922|64833374|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
23298287|NCT01546922|64833373|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
23298288|NCT01546922|64833374|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
23298289|NCT04223778|64833375|FG000|Overall Study|Ongoing|322|||
23298290|NCT04223778|64833376|FG001|Overall Study|Ongoing|326|||
23298291|NCT04223778|64833375|FG000|Overall Study|Death|0|||
23298292|NCT04223778|64833376|FG001|Overall Study|Death|1|||
23298293|NCT04223778|64833375|FG000|Overall Study|Lost to Follow-up|1|||
23298294|NCT04223778|64833376|FG001|Overall Study|Lost to Follow-up|5|||
23298295|NCT04223778|64833375|FG000|Overall Study|Physician Decision|3|||
23298296|NCT04223778|64833376|FG001|Overall Study|Physician Decision|1|||
23298297|NCT04223778|64833375|FG000|Overall Study|Withdrawal by Subject|10|||
23298298|NCT04223778|64833376|FG001|Overall Study|Withdrawal by Subject|1|||
23298299|NCT04223778|64833375|FG000|Overall Study|Lack of Efficacy|0|||
23298300|NCT04223778|64833376|FG001|Overall Study|Lack of Efficacy|2|||
23298301|NCT00330460|64833379|FG000|Overall Study|Physician Decision|1|||
23298302|NCT00330460|64833380|FG001|Overall Study|Physician Decision|0|||
23298303|NCT00330460|64833379|FG000|Overall Study|Adverse Event|10|||
23298304|NCT00330460|64833380|FG001|Overall Study|Adverse Event|8|||
23298305|NCT00330460|64833379|FG000|Overall Study|Withdrawal by Subject|18|||
23298306|NCT00330460|64833380|FG001|Overall Study|Withdrawal by Subject|17|||
23298307|NCT00330460|64833379|FG000|Overall Study|Death|1|||
23298308|NCT00330460|64833380|FG001|Overall Study|Death|1|||
23298309|NCT00330460|64833379|FG000|Overall Study|Ineligibility determined|1|||
23298310|NCT00330460|64833380|FG001|Overall Study|Ineligibility determined|3|||
23298311|NCT00330460|64833379|FG000|Overall Study|Lost to Follow-up|8|||
23298312|NCT00330460|64833380|FG001|Overall Study|Lost to Follow-up|3|||
23298313|NCT00330460|64833379|FG000|Overall Study|Noncompliance|2|||
23298314|NCT00330460|64833380|FG001|Overall Study|Noncompliance|1|||
23298315|NCT00330460|64833379|FG000|Overall Study|Other|1|||
23298316|NCT00330460|64833380|FG001|Overall Study|Other|0|||
23298317|NCT01807117|64833381|FG000|Overall Study|Physician Decision|2|||
23298318|NCT01807117|64833381|FG000|Overall Study|Disease diagnosis not a study disease|1|||
23298319|NCT03341000|64833385|FG000|Overall Study|Adverse Event|1|||
23298320|NCT00955721|64833388|FG000|Overall Study|Physician Decision|1|||
23298321|NCT00955721|64833389|FG001|Overall Study|Physician Decision|0|||
23298322|NCT00955721|64833388|FG000|Overall Study|Death|1|||
23298323|NCT00955721|64833389|FG001|Overall Study|Death|0|||
23298324|NCT00955721|64833388|FG000|Overall Study|Withdrawal by Subject|1|||
23298325|NCT00955721|64833389|FG001|Overall Study|Withdrawal by Subject|0|||
23298326|NCT01615263|64833390|FG000|Overall Study|Post-randomization exclusion|0|||
23298327|NCT01615263|64833391|FG001|Overall Study|Post-randomization exclusion|2|||
23298328|NCT03451006|64833392|FG000|Overall Study|Withdrawal by Subject|2|||
23298329|NCT03451006|64833393|FG001|Overall Study|Withdrawal by Subject|2|||
23298330|NCT00824369|64833394|FG000|Overall Study|Nolonger willing to participate in study|1|||
23298331|NCT00824369|64833395|FG001|Overall Study|Nolonger willing to participate in study|0|||
23298332|NCT00824369|64833396|FG002|Overall Study|Nolonger willing to participate in study|1|||
23298333|NCT00824369|64833397|FG003|Overall Study|Nolonger willing to participate in study|2|||
23298334|NCT00824369|64833398|FG004|Overall Study|Nolonger willing to participate in study|0|||
23298335|NCT00824369|64833399|FG005|Overall Study|Nolonger willing to participate in study|1|||
23298336|NCT00824369|64833394|FG000|Overall Study|Lost to Follow-up|0|||
23298337|NCT00824369|64833395|FG001|Overall Study|Lost to Follow-up|0|||
23298338|NCT00824369|64833396|FG002|Overall Study|Lost to Follow-up|0|||
23298339|NCT00824369|64833397|FG003|Overall Study|Lost to Follow-up|0|||
23298340|NCT00824369|64833398|FG004|Overall Study|Lost to Follow-up|1|||
23298341|NCT00824369|64833399|FG005|Overall Study|Lost to Follow-up|0|||
23298342|NCT00885677|64833400|FG000|Overall Study|Death|40|||
23298343|NCT00885677|64833401|FG001|Overall Study|Death|34|||
23298344|NCT00885677|64833400|FG000|Overall Study|Lost to Follow-up|15|||
23298345|NCT00885677|64833401|FG001|Overall Study|Lost to Follow-up|13|||
23298346|NCT00885677|64833400|FG000|Overall Study|Protocol Violation|54|||
23298347|NCT00885677|64833401|FG001|Overall Study|Protocol Violation|54|||
23298348|NCT00885677|64833400|FG000|Overall Study|premature study closure|41|||
23298349|NCT00885677|64833401|FG001|Overall Study|premature study closure|44|||
23298350|NCT00885677|64833400|FG000|Overall Study|device/lead revision or replacement|7|||
23298351|NCT00885677|64833401|FG001|Overall Study|device/lead revision or replacement|6|||
23298352|NCT00885677|64833400|FG000|Overall Study|Heart transplantation|1|||
23298353|NCT00885677|64833401|FG001|Overall Study|Heart transplantation|0|||
23298354|NCT00885677|64833400|FG000|Overall Study|Inclusion/exclusion not met|25|||
23298355|NCT00885677|64833401|FG001|Overall Study|Inclusion/exclusion not met|27|||
23298356|NCT00466726|64833402|FG000|Overall Study|Not evaluable for response|14|||
23298357|NCT00991510|64833403|FG000|Period I (Days 1-14)|Adverse Event|1|||
23298358|NCT00991510|64833404|FG001|Period I (Days 1-14)|Adverse Event|0|||
23298359|NCT00991510|64833403|FG000|Period III (Days 29-112)|Adverse Event|1|||
23298360|NCT00991510|64833404|FG001|Period III (Days 29-112)|Adverse Event|1|||
23388882|NCT00504556|65168839|FG003|Overall Study|data monitor committee decision|100|||
23388883|NCT00504556|65168840|FG004|Overall Study|data monitor committee decision|0|||
23388884|NCT00504556|65168836|FG000|Overall Study|Other|2|||
23388885|NCT00504556|65168837|FG001|Overall Study|Other|2|||
23388886|NCT00504556|65168838|FG002|Overall Study|Other|2|||
23388887|NCT00504556|65168839|FG003|Overall Study|Other|3|||
23388888|NCT00504556|65168840|FG004|Overall Study|Other|0|||
23388889|NCT00504556|65168836|FG000|Overall Study|not in safety analysis set|0|||
23388890|NCT00504556|65168837|FG001|Overall Study|not in safety analysis set|1|||
23388891|NCT00504556|65168838|FG002|Overall Study|not in safety analysis set|1|||
23388892|NCT00504556|65168839|FG003|Overall Study|not in safety analysis set|0|||
23388893|NCT00504556|65168840|FG004|Overall Study|not in safety analysis set|1|||
23388894|NCT02244957|65168841|FG000|Overall Study|Lack of Efficacy|1|||
23388895|NCT02244957|65168842|FG001|Overall Study|Lack of Efficacy|0|||
23388896|NCT01379937|65168846|FG000|Overall Study|Protocol Violation|0|||
23388897|NCT01379937|65168847|FG001|Overall Study|Protocol Violation|0|||
23388898|NCT01379937|65168848|FG002|Overall Study|Protocol Violation|0|||
23388899|NCT01379937|65168849|FG003|Overall Study|Protocol Violation|1|||
23388900|NCT01379937|65168846|FG000|Overall Study|Consent withdrawal|0|||
23388901|NCT01379937|65168847|FG001|Overall Study|Consent withdrawal|1|||
23388902|NCT01379937|65168848|FG002|Overall Study|Consent withdrawal|0|||
23388903|NCT01379937|65168849|FG003|Overall Study|Consent withdrawal|0|||
23388904|NCT01379937|65168846|FG000|Overall Study|Lost to Follow-up|1|||
23388905|NCT01379937|65168847|FG001|Overall Study|Lost to Follow-up|2|||
23494834|NCT03307785|65555009|FG010|Part E: Up to 4.4 Months|Death|0|||
23298361|NCT00479388|64836651|FG000|Overall Study|Adverse Event|90|||
23298362|NCT00479388|64836652|FG001|Overall Study|Adverse Event|45|||
23298363|NCT00479388|64836651|FG000|Overall Study|Lost to Follow-up|0|||
23298364|NCT00479388|64836652|FG001|Overall Study|Lost to Follow-up|2|||
23298365|NCT00479388|64836651|FG000|Overall Study|Protocol Violation|10|||
23298366|NCT00479388|64836652|FG001|Overall Study|Protocol Violation|9|||
23298367|NCT00479388|64836651|FG000|Overall Study|Withdrawal by Subject|32|||
23298368|NCT00479388|64836652|FG001|Overall Study|Withdrawal by Subject|17|||
23298369|NCT03545191|64836653|FG000|Overall Study|Death|1|||
23298370|NCT03545191|64836654|FG001|Overall Study|Death|0|||
23298371|NCT03545191|64836655|FG002|Overall Study|Death|0|||
23298372|NCT03545191|64836653|FG000|Overall Study|Adverse Event|4|||
23298373|NCT03545191|64836654|FG001|Overall Study|Adverse Event|2|||
23298374|NCT03545191|64836655|FG002|Overall Study|Adverse Event|7|||
23298375|NCT03545191|64836653|FG000|Overall Study|Other reasons|3|||
23298376|NCT03545191|64836654|FG001|Overall Study|Other reasons|11|||
23298377|NCT03545191|64836655|FG002|Overall Study|Other reasons|8|||
23298378|NCT03545191|64836653|FG000|Overall Study|Withdrawal by Subject|13|||
23298379|NCT03545191|64836654|FG001|Overall Study|Withdrawal by Subject|10|||
23298380|NCT03545191|64836655|FG002|Overall Study|Withdrawal by Subject|12|||
23298381|NCT03545191|64836653|FG000|Overall Study|Lost to Follow-up|1|||
23298382|NCT03545191|64836654|FG001|Overall Study|Lost to Follow-up|2|||
23298383|NCT03545191|64836655|FG002|Overall Study|Lost to Follow-up|3|||
23298384|NCT01048502|64836659|FG000|Overall Study|Lost to Follow-up|2|||
23298385|NCT01048502|64836660|FG001|Overall Study|Lost to Follow-up|0|||
23298386|NCT01048502|64836661|FG002|Overall Study|Lost to Follow-up|0|||
23298387|NCT01048502|64836662|FG003|Overall Study|Lost to Follow-up|0|||
23298388|NCT01048502|64836659|FG000|Overall Study|Adverse Event|1|||
23298389|NCT01048502|64836660|FG001|Overall Study|Adverse Event|0|||
23298390|NCT01048502|64836661|FG002|Overall Study|Adverse Event|0|||
23298391|NCT01048502|64836662|FG003|Overall Study|Adverse Event|0|||
23298392|NCT01048502|64836659|FG000|Overall Study|Withdrawal by Subject|1|||
23298393|NCT01048502|64836660|FG001|Overall Study|Withdrawal by Subject|4|||
23298394|NCT01048502|64836661|FG002|Overall Study|Withdrawal by Subject|5|||
23298395|NCT01048502|64836662|FG003|Overall Study|Withdrawal by Subject|3|||
23298396|NCT01048502|64836659|FG000|Overall Study|Physician Decision|0|||
23298397|NCT01048502|64836660|FG001|Overall Study|Physician Decision|3|||
23298398|NCT01048502|64836661|FG002|Overall Study|Physician Decision|0|||
23298399|NCT01048502|64836662|FG003|Overall Study|Physician Decision|1|||
23298400|NCT00103402|64836663|FG000|Overall Study|Adverse Event|3|||
23298401|NCT00103402|64836664|FG001|Overall Study|Adverse Event|4|||
23298402|NCT00103402|64836663|FG000|Overall Study|Lost to Follow-up|8|||
23298403|NCT00103402|64836664|FG001|Overall Study|Lost to Follow-up|7|||
23298404|NCT00103402|64836663|FG000|Overall Study|Dissatisfied/No longer interested|6|||
23298405|NCT00103402|64836664|FG001|Overall Study|Dissatisfied/No longer interested|6|||
23298406|NCT00103402|64836663|FG000|Overall Study|Personal constraints/Other|5|||
23298407|NCT00103402|64836664|FG001|Overall Study|Personal constraints/Other|0|||
23298408|NCT02037165|64836665|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
23298409|NCT02037165|64836666|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
23298410|NCT02037165|64836667|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
23298411|NCT02037165|64836668|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
23298412|NCT02037165|64836669|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
23298413|NCT02075606|64836670|FG000|Overall Study|Adverse Event|5|||
23298414|NCT02075606|64836670|FG000|Overall Study|Withdrawal by Subject|1|||
23298415|NCT02075606|64836670|FG000|Overall Study|Death|1|||
23298416|NCT02075606|64836670|FG000|Overall Study|Investigator's decision|1|||
23298417|NCT02075606|64836670|FG000|Overall Study|Symptom management|1|||
23298418|NCT02075606|64836670|FG000|Overall Study|Increasing Symptoms|1|||
23298419|NCT02492841|64836671|FG000|Overall Study|Lost to Follow-up|34|||
23298420|NCT02492841|64836672|FG001|Overall Study|Lost to Follow-up|31|||
23298421|NCT02492841|64836673|FG002|Overall Study|Lost to Follow-up|35|||
23298422|NCT01491035|64836674|FG000|Overall Study|Lost to Follow-up|0|||
23298423|NCT01491035|64836675|FG001|Overall Study|Lost to Follow-up|0|||
23298424|NCT01491035|64836676|FG002|Overall Study|Lost to Follow-up|0|||
23298425|NCT01491035|64836677|FG003|Overall Study|Lost to Follow-up|0|||
23298426|NCT01491035|64836678|FG004|Overall Study|Lost to Follow-up|1|||
23298427|NCT01491035|64836679|FG005|Overall Study|Lost to Follow-up|0|||
23298428|NCT01491035|64836680|FG006|Overall Study|Lost to Follow-up|0|||
23298429|NCT01491035|64836681|FG007|Overall Study|Lost to Follow-up|0|||
23298430|NCT02938520|64836682|FG000|Overall Study|On-going at the time of analysis|258|||
23298431|NCT02938520|64836683|FG001|Overall Study|On-going at the time of analysis|261|||
23298432|NCT02938520|64836682|FG000|Overall Study|Physician Decision|2|||
23298433|NCT02938520|64836683|FG001|Overall Study|Physician Decision|5|||
23298434|NCT02938520|64836682|FG000|Overall Study|Lost to Follow-up|2|||
23298435|NCT02938520|64836683|FG001|Overall Study|Lost to Follow-up|2|||
23298436|NCT02938520|64836682|FG000|Overall Study|Withdrawal by Subject|7|||
23298437|NCT02938520|64836683|FG001|Overall Study|Withdrawal by Subject|7|||
23298438|NCT02938520|64836682|FG000|Overall Study|Protocol Violation|0|||
23606114|NCT00614614|65947152|FG004|Booster Vaccination Phase|Adverse Event|0|||
23606115|NCT00614614|65947148|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
23606116|NCT00614614|65947149|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
23606117|NCT00614614|65947150|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
23606118|NCT00614614|65947151|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
23606119|NCT00614614|65947152|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
23606120|NCT00614614|65947148|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
23606121|NCT00614614|65947149|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
23606122|NCT00614614|65947150|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
23606123|NCT00614614|65947151|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
23298439|NCT02938520|64836683|FG001|Overall Study|Protocol Violation|1|||
23606124|NCT00614614|65947152|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
23606125|NCT00614614|65947148|FG000|Booster Vaccination Phase|Protocol Violation|0|||
23606126|NCT00614614|65947149|FG001|Booster Vaccination Phase|Protocol Violation|0|||
23606127|NCT00614614|65947150|FG002|Booster Vaccination Phase|Protocol Violation|2|||
23298440|NCT02938520|64836682|FG000|Overall Study|Lack of Efficacy|5|||
23298441|NCT02938520|64836683|FG001|Overall Study|Lack of Efficacy|3|||
23298442|NCT02938520|64836682|FG000|Overall Study|Adverse Event|9|||
23298443|NCT02938520|64836683|FG001|Overall Study|Adverse Event|4|||
23298444|NCT00725621|64836688|FG000|Overall Study|Adverse Event|25|||
23298445|NCT00725621|64836688|FG000|Overall Study|Lack of Efficacy|46|||
23298446|NCT00725621|64836688|FG000|Overall Study|Withdrawal by Subject|57|||
23298447|NCT00725621|64836688|FG000|Overall Study|Physician Decision|19|||
23298448|NCT00725621|64836688|FG000|Overall Study|Lost to Follow-up|52|||
23298449|NCT00725621|64836688|FG000|Overall Study|Non-compliance|8|||
23298450|NCT00725621|64836688|FG000|Overall Study|Continued treatment by other physician|6|||
23298451|NCT00725621|64836688|FG000|Overall Study|Switched to other study|1|||
23298452|NCT00725621|64836688|FG000|Overall Study|Switched to other drug|1|||
23298453|NCT00725621|64836688|FG000|Overall Study|Prepared for elective surgery|1|||
23298454|NCT00725621|64836688|FG000|Overall Study|Reason not specified|55|||
23298455|NCT00268892|64836689|FG000|Overall Study|Adverse Event|14|||
23298456|NCT00268892|64836690|FG001|Overall Study|Adverse Event|17|||
23298457|NCT00268892|64836691|FG002|Overall Study|Adverse Event|20|||
23298458|NCT00268892|64836689|FG000|Overall Study|Lack of Efficacy|1|||
23298459|NCT00268892|64836690|FG001|Overall Study|Lack of Efficacy|3|||
23298460|NCT00268892|64836691|FG002|Overall Study|Lack of Efficacy|0|||
23298461|NCT00268892|64836689|FG000|Overall Study|Withdrawal by Subject|14|||
23298462|NCT00268892|64836690|FG001|Overall Study|Withdrawal by Subject|15|||
23298463|NCT00268892|64836691|FG002|Overall Study|Withdrawal by Subject|13|||
23298464|NCT00268892|64836689|FG000|Overall Study|Physician Decision|0|||
23298465|NCT00268892|64836690|FG001|Overall Study|Physician Decision|1|||
23298466|NCT00268892|64836691|FG002|Overall Study|Physician Decision|0|||
23298467|NCT00268892|64836689|FG000|Overall Study|Lost to Follow-up|5|||
23298468|NCT00268892|64836690|FG001|Overall Study|Lost to Follow-up|2|||
23298469|NCT00268892|64836691|FG002|Overall Study|Lost to Follow-up|4|||
23298470|NCT00268892|64836689|FG000|Overall Study|Protocol Violation|0|||
23298471|NCT00268892|64836690|FG001|Overall Study|Protocol Violation|1|||
23298472|NCT00268892|64836691|FG002|Overall Study|Protocol Violation|0|||
23298473|NCT00268892|64836689|FG000|Overall Study|Disease Progression|1|||
23298474|NCT00268892|64836690|FG001|Overall Study|Disease Progression|1|||
23298475|NCT00268892|64836691|FG002|Overall Study|Disease Progression|0|||
23298476|NCT00268892|64836689|FG000|Overall Study|Trial Site Closed|4|||
23298477|NCT00268892|64836690|FG001|Overall Study|Trial Site Closed|2|||
23298478|NCT00268892|64836691|FG002|Overall Study|Trial Site Closed|2|||
23298479|NCT00293202|64836692|FG000|Overall Study|Withdrawal by Subject|1|||
23298480|NCT00293202|64836693|FG001|Overall Study|Withdrawal by Subject|2|||
23298481|NCT00293202|64836692|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
23298482|NCT00293202|64836693|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
23298483|NCT00293202|64836692|FG000|Overall Study|on-hold due to fistula maturation time|1|||
23298484|NCT00293202|64836693|FG001|Overall Study|on-hold due to fistula maturation time|0|||
23298485|NCT00834899|64836694|FG000|Overall Study|Withdrawal by Subject|1|||
23298486|NCT00834899|64836695|FG001|Overall Study|Withdrawal by Subject|1|||
23298487|NCT03585959|64836696|FG000|Overall Study|Physician Decision|1|||
23298488|NCT03585959|64836696|FG000|Overall Study|Unsuccessful Procedure|2|||
23298489|NCT00653991|64836701|FG000|3 Month Follow-up|Participant would not respond|150|||
23298490|NCT00653991|64836702|FG001|3 Month Follow-up|Participant would not respond|157|||
23298491|NCT00653991|64836701|FG000|6 Month Follow-up|Participant would not respond|133|||
23298492|NCT00653991|64836702|FG001|6 Month Follow-up|Participant would not respond|141|||
23388906|NCT01379937|65168848|FG002|Overall Study|Lost to Follow-up|2|||
23388907|NCT01379937|65168849|FG003|Overall Study|Lost to Follow-up|0|||
23388908|NCT01217047|65168852|FG000|Overall Study|Lost to Follow-up|0|||
23298493|NCT01194973|64836703|FG000|Screening Period|Screen Failure|3|||
23298494|NCT01194973|64836703|FG000|26 Week Treatment Period|Adverse Event|1|||
23298495|NCT01194973|64836703|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
23298496|NCT01194973|64836703|FG000|26 Week Treatment Period|Pregnancy|1|||
23298497|NCT00359788|64836707|FG000|Overall Study|Adverse Event|11|||
23298498|NCT00359788|64836708|FG001|Overall Study|Adverse Event|10|||
23298499|NCT00359788|64836707|FG000|Overall Study|Lack of Efficacy|1|||
23298500|NCT00359788|64836708|FG001|Overall Study|Lack of Efficacy|2|||
23298501|NCT00359788|64836707|FG000|Overall Study|Lost to Follow-up|3|||
23298502|NCT00359788|64836708|FG001|Overall Study|Lost to Follow-up|2|||
23298503|NCT00359788|64836707|FG000|Overall Study|Withdrawal by Subject|4|||
23298504|NCT00359788|64836708|FG001|Overall Study|Withdrawal by Subject|1|||
23298505|NCT00359788|64836707|FG000|Overall Study|Protocol Violation|4|||
23298506|NCT00359788|64836708|FG001|Overall Study|Protocol Violation|2|||
23388909|NCT01217047|65168853|FG001|Overall Study|Lost to Follow-up|1|||
23388910|NCT01217047|65168854|FG002|Overall Study|Lost to Follow-up|0|||
23298507|NCT04233879|64836709|FG000|Overall Study|Death|2|||
23298508|NCT04233879|64836710|FG001|Overall Study|Death|0|||
23298509|NCT04233879|64836709|FG000|Overall Study|Lost to Follow-up|3|||
23298510|NCT04233879|64836710|FG001|Overall Study|Lost to Follow-up|8|||
23298511|NCT04233879|64836709|FG000|Overall Study|Physician Decision|4|||
23298512|NCT04233879|64836710|FG001|Overall Study|Physician Decision|4|||
23388911|NCT01796470|65168855|FG000|Overall Study|Adverse Event|4|||
23388912|NCT01796470|65168856|FG001|Overall Study|Adverse Event|2|||
23388913|NCT01796470|65168857|FG002|Overall Study|Adverse Event|2|||
23388914|NCT01796470|65168858|FG003|Overall Study|Adverse Event|1|||
23388915|NCT01796470|65168859|FG004|Overall Study|Adverse Event|3|||
23388916|NCT01796470|65168855|FG000|Overall Study|Death|2|||
23494835|NCT03307785|65554999|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
23494836|NCT03307785|65555000|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
23494837|NCT03307785|65555001|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
23494838|NCT03307785|65555002|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
23494839|NCT03307785|65555003|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
23494840|NCT03307785|65555004|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
23494841|NCT03307785|65555005|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
23494842|NCT03307785|65555006|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
23298513|NCT04233879|64836709|FG000|Overall Study|Withdrawal by Subject|7|||
23388917|NCT01796470|65168856|FG001|Overall Study|Death|0|||
23388918|NCT01796470|65168857|FG002|Overall Study|Death|0|||
23494843|NCT03307785|65555007|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
23388919|NCT01796470|65168858|FG003|Overall Study|Death|0|||
23388920|NCT01796470|65168859|FG004|Overall Study|Death|1|||
23298514|NCT04233879|64836710|FG001|Overall Study|Withdrawal by Subject|10|||
23298515|NCT04233879|64836709|FG000|Overall Study|Other|281|||
23388921|NCT01796470|65168855|FG000|Overall Study|Initiated New Therapy|9|||
23388922|NCT01796470|65168856|FG001|Overall Study|Initiated New Therapy|0|||
23388923|NCT01796470|65168857|FG002|Overall Study|Initiated New Therapy|0|||
23494844|NCT03307785|65555008|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
23494845|NCT03307785|65555009|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
23494846|NCT03307785|65554999|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
23494847|NCT03307785|65555000|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
23298516|NCT04233879|64836710|FG001|Overall Study|Other|279|||
23298517|NCT00720226|64836711|FG000|Overall Study|Withdrawal by Subject|7|||
23494848|NCT03307785|65555001|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
23298518|NCT00720226|64836712|FG001|Overall Study|Withdrawal by Subject|4|||
23298519|NCT01207440|64836713|FG000|Overall Study|Adverse Event|46|||
23298520|NCT01207440|64836714|FG001|Overall Study|Adverse Event|11|||
23298521|NCT01207440|64836715|FG002|Overall Study|Adverse Event|7|||
23298522|NCT01207440|64836716|FG003|Overall Study|Adverse Event|2|||
23298523|NCT01207440|64836717|FG004|Overall Study|Adverse Event|6|||
23298524|NCT01207440|64836718|FG005|Overall Study|Adverse Event|6|||
23298525|NCT01207440|64836719|FG006|Overall Study|Adverse Event|2|||
23298526|NCT01207440|64836713|FG000|Overall Study|Death|6|||
23298527|NCT01207440|64836714|FG001|Overall Study|Death|3|||
23298528|NCT01207440|64836715|FG002|Overall Study|Death|2|||
23298529|NCT01207440|64836716|FG003|Overall Study|Death|2|||
23298530|NCT01207440|64836717|FG004|Overall Study|Death|7|||
23298531|NCT01207440|64836718|FG005|Overall Study|Death|5|||
23298532|NCT01207440|64836719|FG006|Overall Study|Death|1|||
23298533|NCT01207440|64836713|FG000|Overall Study|Lack of Efficacy|13|||
23298534|NCT01207440|64836714|FG001|Overall Study|Lack of Efficacy|2|||
23298535|NCT01207440|64836715|FG002|Overall Study|Lack of Efficacy|5|||
23298536|NCT01207440|64836716|FG003|Overall Study|Lack of Efficacy|1|||
23298537|NCT01207440|64836717|FG004|Overall Study|Lack of Efficacy|2|||
23298538|NCT01207440|64836718|FG005|Overall Study|Lack of Efficacy|3|||
23298539|NCT01207440|64836719|FG006|Overall Study|Lack of Efficacy|0|||
23298540|NCT01207440|64836713|FG000|Overall Study|Lost to Follow-up|0|||
23298541|NCT01207440|64836714|FG001|Overall Study|Lost to Follow-up|0|||
23298542|NCT01207440|64836715|FG002|Overall Study|Lost to Follow-up|2|||
23298543|NCT01207440|64836716|FG003|Overall Study|Lost to Follow-up|1|||
23298544|NCT01207440|64836717|FG004|Overall Study|Lost to Follow-up|0|||
23298545|NCT01207440|64836718|FG005|Overall Study|Lost to Follow-up|0|||
23298546|NCT01207440|64836719|FG006|Overall Study|Lost to Follow-up|0|||
23298547|NCT01207440|64836713|FG000|Overall Study|Non-compliance with Study Drug|3|||
23298548|NCT01207440|64836714|FG001|Overall Study|Non-compliance with Study Drug|0|||
23298549|NCT01207440|64836715|FG002|Overall Study|Non-compliance with Study Drug|1|||
23298550|NCT01207440|64836716|FG003|Overall Study|Non-compliance with Study Drug|0|||
23298551|NCT01207440|64836717|FG004|Overall Study|Non-compliance with Study Drug|0|||
23298552|NCT01207440|64836718|FG005|Overall Study|Non-compliance with Study Drug|0|||
23298553|NCT01207440|64836719|FG006|Overall Study|Non-compliance with Study Drug|0|||
23298554|NCT01207440|64836713|FG000|Overall Study|Physician Decision|6|||
23298555|NCT01207440|64836714|FG001|Overall Study|Physician Decision|5|||
23298556|NCT01207440|64836715|FG002|Overall Study|Physician Decision|5|||
23298557|NCT01207440|64836716|FG003|Overall Study|Physician Decision|0|||
23298558|NCT01207440|64836717|FG004|Overall Study|Physician Decision|1|||
23298559|NCT01207440|64836718|FG005|Overall Study|Physician Decision|0|||
23298560|NCT01207440|64836719|FG006|Overall Study|Physician Decision|0|||
23298561|NCT01207440|64836713|FG000|Overall Study|Progressive Disease|19|||
23298562|NCT01207440|64836714|FG001|Overall Study|Progressive Disease|10|||
23298563|NCT01207440|64836715|FG002|Overall Study|Progressive Disease|19|||
23298564|NCT01207440|64836716|FG003|Overall Study|Progressive Disease|7|||
23298565|NCT01207440|64836717|FG004|Overall Study|Progressive Disease|23|||
23298566|NCT01207440|64836718|FG005|Overall Study|Progressive Disease|27|||
23298567|NCT01207440|64836719|FG006|Overall Study|Progressive Disease|0|||
23298568|NCT01207440|64836713|FG000|Overall Study|Protocol Violation|2|||
23298569|NCT01207440|64836714|FG001|Overall Study|Protocol Violation|0|||
23298570|NCT01207440|64836715|FG002|Overall Study|Protocol Violation|0|||
23298571|NCT01207440|64836716|FG003|Overall Study|Protocol Violation|0|||
23298572|NCT01207440|64836717|FG004|Overall Study|Protocol Violation|0|||
23298573|NCT01207440|64836718|FG005|Overall Study|Protocol Violation|0|||
23298574|NCT01207440|64836719|FG006|Overall Study|Protocol Violation|0|||
23298575|NCT01207440|64836713|FG000|Overall Study|Site Terminated by Sponsor|69|||
23298576|NCT01207440|64836714|FG001|Overall Study|Site Terminated by Sponsor|19|||
23298577|NCT01207440|64836715|FG002|Overall Study|Site Terminated by Sponsor|12|||
23298578|NCT01207440|64836716|FG003|Overall Study|Site Terminated by Sponsor|2|||
23298579|NCT01207440|64836717|FG004|Overall Study|Site Terminated by Sponsor|3|||
23298580|NCT01207440|64836718|FG005|Overall Study|Site Terminated by Sponsor|0|||
23298581|NCT01207440|64836719|FG006|Overall Study|Site Terminated by Sponsor|2|||
23298582|NCT01207440|64836713|FG000|Overall Study|Withdrawal by Subject|29|||
23298583|NCT01207440|64836714|FG001|Overall Study|Withdrawal by Subject|4|||
23298584|NCT01207440|64836715|FG002|Overall Study|Withdrawal by Subject|5|||
23298585|NCT01207440|64836716|FG003|Overall Study|Withdrawal by Subject|3|||
23298586|NCT01207440|64836717|FG004|Overall Study|Withdrawal by Subject|2|||
23298587|NCT01207440|64836718|FG005|Overall Study|Withdrawal by Subject|2|||
23298588|NCT01207440|64836719|FG006|Overall Study|Withdrawal by Subject|0|||
23494849|NCT03307785|65555002|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
23494850|NCT03307785|65555003|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
23298589|NCT01207440|64836713|FG000|Overall Study|Reason Not Specified|10|||
23298590|NCT01207440|64836714|FG001|Overall Study|Reason Not Specified|10|||
23298591|NCT01207440|64836715|FG002|Overall Study|Reason Not Specified|7|||
23298592|NCT01207440|64836716|FG003|Overall Study|Reason Not Specified|0|||
23298593|NCT01207440|64836717|FG004|Overall Study|Reason Not Specified|4|||
23298594|NCT01207440|64836718|FG005|Overall Study|Reason Not Specified|3|||
23298595|NCT01207440|64836719|FG006|Overall Study|Reason Not Specified|0|||
23298596|NCT01673698|64836720|FG000|Overall Study|Lost to Follow-up|51|||
23298597|NCT01673698|64836721|FG001|Overall Study|Lost to Follow-up|13|||
23298598|NCT00257920|64836724|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
23298599|NCT00257920|64836725|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
23298600|NCT00257920|64836724|FG000|Period: Second Intervention|Other|2|||
23298601|NCT00257920|64836725|FG001|Period: Second Intervention|Other|1|||
23298602|NCT00359632|64836726|FG000|Overall Study|Death|2|||
23298603|NCT00359632|64836727|FG001|Overall Study|Death|0|||
23298604|NCT00359632|64836726|FG000|Overall Study|Adverse Event|1|||
23298605|NCT00359632|64836727|FG001|Overall Study|Adverse Event|0|||
23298606|NCT00359632|64836726|FG000|Overall Study|Non-compliance with visit schedule|1|||
23298607|NCT00359632|64836727|FG001|Overall Study|Non-compliance with visit schedule|0|||
23298608|NCT02356211|64836728|FG000|Overall Study|Withdrawal by Subject|2|||
23298609|NCT02356211|64836729|FG001|Overall Study|Withdrawal by Subject|2|||
23298610|NCT02356211|64836728|FG000|Overall Study|ineligible|1|||
23298611|NCT02356211|64836729|FG001|Overall Study|ineligible|8|||
23298612|NCT00502801|64836730|FG000|Treatment Period|Withdrawal by Subject|3|||
23298613|NCT00502801|64836730|FG000|Treatment Period|Adverse Event|7|||
23298614|NCT00502801|64836730|FG000|Treatment Period|Death|14|||
23298615|NCT00502801|64836730|FG000|Treatment Period|OTHER|30|||
23298616|NCT00502801|64836730|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
23298617|NCT00502801|64836730|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
23298618|NCT00502801|64836730|FG000|End of Therapy to Test of Cure|Death|3|||
23298619|NCT00502801|64836730|FG000|End of Therapy to Test of Cure|OTHER|2|||
23298620|NCT03978091|64836743|FG000|Overall Study|Lost to Follow-up|0|||
23298621|NCT03978091|64836744|FG001|Overall Study|Lost to Follow-up|0|||
23298622|NCT03978091|64836745|FG002|Overall Study|Lost to Follow-up|1|||
23298623|NCT03978091|64836746|FG003|Overall Study|Lost to Follow-up|0|||
23298624|NCT03978091|64836747|FG004|Overall Study|Lost to Follow-up|0|||
23298625|NCT03978091|64836748|FG005|Overall Study|Lost to Follow-up|0|||
23298626|NCT03978091|64836743|FG000|Overall Study|Withdrawal by Subject|0|||
23298627|NCT03978091|64836744|FG001|Overall Study|Withdrawal by Subject|0|||
23298628|NCT03978091|64836745|FG002|Overall Study|Withdrawal by Subject|0|||
23298629|NCT03978091|64836746|FG003|Overall Study|Withdrawal by Subject|1|||
23298630|NCT03978091|64836747|FG004|Overall Study|Withdrawal by Subject|1|||
23298631|NCT03978091|64836748|FG005|Overall Study|Withdrawal by Subject|0|||
23298632|NCT01557582|64836753|FG000|Overall Study|Protocol Violation|4|||
23298633|NCT01557582|64836753|FG000|Overall Study|Operator error|2|||
23298634|NCT02224573|64836754|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
23298635|NCT02224573|64836755|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
23298636|NCT02224573|64836754|FG000|Treatment Phase|Started on Other IMP|1|||
23298637|NCT02224573|64836755|FG001|Treatment Phase|Started on Other IMP|0|||
23298638|NCT02224573|64836754|FG000|Treatment Phase|Participant Discontinued IMP|0|||
23298639|NCT02224573|64836755|FG001|Treatment Phase|Participant Discontinued IMP|1|||
23298640|NCT02224573|64836754|FG000|Treatment Phase|Lack of Efficacy|15|||
23298641|NCT02224573|64836755|FG001|Treatment Phase|Lack of Efficacy|8|||
23298642|NCT02224573|64836754|FG000|Treatment Phase|Began Commercial Product|1|||
23298643|NCT02224573|64836755|FG001|Treatment Phase|Began Commercial Product|0|||
23298644|NCT02224573|64836754|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
23298645|NCT02224573|64836755|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
23298646|NCT02224573|64836754|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
23298647|NCT02224573|64836755|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
23298648|NCT02224573|64836754|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
23298649|NCT02224573|64836755|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
23494851|NCT03307785|65555004|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
23494852|NCT03307785|65555005|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
23494853|NCT03307785|65555006|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
23298650|NCT02224573|64836754|FG000|Treatment Phase|Continued Compassionate Use|1|||
23298651|NCT02224573|64836755|FG001|Treatment Phase|Continued Compassionate Use|0|||
23298652|NCT02224573|64836754|FG000|Treatment Phase|Lack of Efficiency|2|||
23298653|NCT02224573|64836755|FG001|Treatment Phase|Lack of Efficiency|1|||
23298654|NCT02224573|64836754|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
23298655|NCT02224573|64836755|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
23298656|NCT02224573|64836754|FG000|Treatment Phase|Participant Moved|2|||
23298657|NCT02224573|64836755|FG001|Treatment Phase|Participant Moved|0|||
23298658|NCT02224573|64836754|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
23298659|NCT02224573|64836755|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
23298660|NCT02224573|64836754|FG000|Treatment Phase|Refused Medication|1|||
23298661|NCT02224573|64836755|FG001|Treatment Phase|Refused Medication|1|||
23298662|NCT02224573|64836754|FG000|Treatment Phase|Adverse Event|26|||
23298663|NCT02224573|64836755|FG001|Treatment Phase|Adverse Event|38|||
23298664|NCT02224573|64836754|FG000|Treatment Phase|Placed in Group Home|0|||
23298665|NCT02224573|64836755|FG001|Treatment Phase|Placed in Group Home|1|||
23298666|NCT02224573|64836754|FG000|Treatment Phase|Pursued Other Trials|1|||
23298667|NCT02224573|64836755|FG001|Treatment Phase|Pursued Other Trials|0|||
23298668|NCT02224573|64836754|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
23298669|NCT02224573|64836755|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
23298670|NCT02224573|64836754|FG000|Treatment Phase|Lost to Follow-up|2|||
23298671|NCT02224573|64836755|FG001|Treatment Phase|Lost to Follow-up|1|||
23298672|NCT02224573|64836754|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
23298673|NCT02224573|64836755|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
23298674|NCT02224573|64836754|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
23298675|NCT02224573|64836755|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
23298676|NCT02224573|64836754|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
23298677|NCT02224573|64836755|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
23298678|NCT02224573|64836754|FG000|Taper Phase|Adverse Event|1|||
23298679|NCT02224573|64836755|FG001|Taper Phase|Adverse Event|1|||
23298680|NCT00690482|64836758|FG000|Overall Study|Adverse Event|2|||
23298681|NCT00690482|64836759|FG001|Overall Study|Adverse Event|1|||
23298682|NCT00690482|64836758|FG000|Overall Study|Incorrect enrolment|0|||
23298683|NCT00690482|64836759|FG001|Overall Study|Incorrect enrolment|1|||
23298684|NCT00690482|64836758|FG000|Overall Study|Study-specific discontinuation criteria|1|||
23298685|NCT00690482|64836759|FG001|Overall Study|Study-specific discontinuation criteria|0|||
23298686|NCT00690482|64836758|FG000|Overall Study|Intake of prohibited medicine|1|||
23298687|NCT00690482|64836759|FG001|Overall Study|Intake of prohibited medicine|0|||
23298688|NCT00690482|64836758|FG000|Overall Study|withdrew consent at rand.day|0|||
23298689|NCT00690482|64836759|FG001|Overall Study|withdrew consent at rand.day|1|||
23298690|NCT02104817|64836762|FG000|Overall Study|Death|363|||
23298691|NCT02104817|64836763|FG001|Overall Study|Death|330|||
23298692|NCT02104817|64836762|FG000|Overall Study|Lost to Follow-up|3|||
23298693|NCT02104817|64836763|FG001|Overall Study|Lost to Follow-up|2|||
23298694|NCT02104817|64836762|FG000|Overall Study|Protocol Violation|0|||
23298695|NCT02104817|64836763|FG001|Overall Study|Protocol Violation|1|||
23298696|NCT02104817|64836762|FG000|Overall Study|Study terminated by sponsor|5854|||
23298697|NCT02104817|64836763|FG001|Overall Study|Study terminated by sponsor|5901|||
23298698|NCT02104817|64836762|FG000|Overall Study|Withdrawal by Subject|111|||
23298699|NCT02104817|64836763|FG001|Overall Study|Withdrawal by Subject|78|||
23298700|NCT02104817|64836762|FG000|Overall Study|Other reasons|128|||
23298701|NCT02104817|64836763|FG001|Overall Study|Other reasons|135|||
23298702|NCT03903159|64836764|FG000|Overall Study|Discharged with Staff Approval|2|||
23298703|NCT03903159|64836764|FG000|Overall Study|Discharged at Staff Request|2|||
23298704|NCT03903159|64836764|FG000|Overall Study|Discharged Against Staff Advice|1|||
23298705|NCT01345318|64836765|FG000|Overall Study|Adverse Event|16|||
23298706|NCT01345318|64836765|FG000|Overall Study|Lack of Efficacy|17|||
23298707|NCT01345318|64836765|FG000|Overall Study|Lost to Follow-up|2|||
23298708|NCT01345318|64836765|FG000|Overall Study|Protocol Violation|1|||
23298709|NCT01345318|64836765|FG000|Overall Study|Withdrawal by Subject|41|||
23298710|NCT01345318|64836765|FG000|Overall Study|Other|3|||
23298711|NCT02083926|64836766|FG000|Overall Study|Withdrawal by Subject|1|||
23298712|NCT02083926|64836767|FG001|Overall Study|Withdrawal by Subject|0|||
23298713|NCT00058214|64836771|FG000|Overall Study|Adverse Event|1|||
23298714|NCT01376310|64836776|FG000|Overall Study|Study closed/terminated|1|||
23298715|NCT01376310|64836777|FG001|Overall Study|Study closed/terminated|2|||
23298716|NCT01376310|64836776|FG000|Overall Study|Withdrawal by Subject|8|||
23298717|NCT01376310|64836777|FG001|Overall Study|Withdrawal by Subject|2|||
23298718|NCT01376310|64836776|FG000|Overall Study|Physician Decision|26|||
23298719|NCT01376310|64836777|FG001|Overall Study|Physician Decision|7|||
23298720|NCT01376310|64836776|FG000|Overall Study|Lost to Follow-up|1|||
23298721|NCT01376310|64836777|FG001|Overall Study|Lost to Follow-up|0|||
23298722|NCT02954159|64836778|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
23298723|NCT02954159|64836779|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
23298724|NCT02954159|64836778|FG000|Overall Study|Withdrawal by Subject|0|||
23298725|NCT02954159|64836779|FG001|Overall Study|Withdrawal by Subject|1|||
23298726|NCT04349631|64836783|FG000|Overall Study|Lost to Follow-up|3|||
23298727|NCT04349631|64836783|FG000|Overall Study|Withdrawal by Subject|7|||
23298728|NCT00467831|64836786|FG000|Overall Study|Death|2|||
23298729|NCT00467831|64836786|FG000|Overall Study|Withdrawal by Subject|1|||
23298730|NCT00493246|64836787|FG000|Overall Study|Withdrawal by Subject|0|||
23298731|NCT00493246|64836788|FG001|Overall Study|Withdrawal by Subject|0|||
23298732|NCT00493246|64836789|FG002|Overall Study|Withdrawal by Subject|0|||
23298733|NCT00493246|64836790|FG003|Overall Study|Withdrawal by Subject|0|||
23298734|NCT00493246|64836791|FG004|Overall Study|Withdrawal by Subject|1|||
23298735|NCT00493246|64836792|FG005|Overall Study|Withdrawal by Subject|0|||
23298736|NCT00493246|64836793|FG006|Overall Study|Withdrawal by Subject|0|||
23298737|NCT00493246|64836794|FG007|Overall Study|Withdrawal by Subject|0|||
23298738|NCT00493246|64836787|FG000|Overall Study|No access to draw blood|0|||
23298739|NCT00493246|64836788|FG001|Overall Study|No access to draw blood|0|||
23298740|NCT00493246|64836789|FG002|Overall Study|No access to draw blood|0|||
23298741|NCT00493246|64836790|FG003|Overall Study|No access to draw blood|0|||
23298742|NCT00493246|64836791|FG004|Overall Study|No access to draw blood|0|||
23298743|NCT00493246|64836792|FG005|Overall Study|No access to draw blood|1|||
23298744|NCT00493246|64836793|FG006|Overall Study|No access to draw blood|0|||
23298745|NCT00493246|64836794|FG007|Overall Study|No access to draw blood|0|||
23298746|NCT00493246|64836787|FG000|Overall Study|Lost to Follow-up|0|||
23298747|NCT00493246|64836788|FG001|Overall Study|Lost to Follow-up|0|||
23298748|NCT00493246|64836789|FG002|Overall Study|Lost to Follow-up|0|||
23298749|NCT00493246|64836790|FG003|Overall Study|Lost to Follow-up|0|||
23298750|NCT00493246|64836791|FG004|Overall Study|Lost to Follow-up|0|||
23298751|NCT00493246|64836792|FG005|Overall Study|Lost to Follow-up|0|||
23298752|NCT00493246|64836793|FG006|Overall Study|Lost to Follow-up|1|||
23298753|NCT00493246|64836794|FG007|Overall Study|Lost to Follow-up|0|||
23298754|NCT03921151|64836797|FG000|Overall Study|Withdrawal by Subject|11|||
23298755|NCT03921151|64836798|FG001|Overall Study|Withdrawal by Subject|16|||
23298756|NCT04142242|64836799|FG000|Stage I|Non-compliance with the protocol|1|||
23298757|NCT04142242|64836800|FG001|Stage I|Non-compliance with the protocol|0|||
23298758|NCT04142242|64836801|FG002|Stage I|Non-compliance with the protocol|0|||
23298759|NCT04142242|64836802|FG003|Stage I|Non-compliance with the protocol|0|||
23298760|NCT04142242|64836803|FG004|Stage I|Non-compliance with the protocol|0|||
23298761|NCT04142242|64836804|FG005|Stage I|Non-compliance with the protocol|1|||
23298762|NCT04142242|64836799|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23298763|NCT04142242|64836800|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
23298764|NCT04142242|64836801|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23298765|NCT04142242|64836802|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23298766|NCT04142242|64836803|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23298767|NCT04142242|64836804|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
23298768|NCT04142242|64836799|FG000|Stage II|Non-compliance with the protocol|0|||
23298769|NCT04142242|64836800|FG001|Stage II|Non-compliance with the protocol|0|||
23298770|NCT04142242|64836801|FG002|Stage II|Non-compliance with the protocol|0|||
23298771|NCT04142242|64836802|FG003|Stage II|Non-compliance with the protocol|2|||
23298772|NCT04142242|64836803|FG004|Stage II|Non-compliance with the protocol|0|||
23298773|NCT04142242|64836804|FG005|Stage II|Non-compliance with the protocol|0|||
23298774|NCT04142242|64836799|FG000|Stage II|Lost to Follow-up|0|||
23298775|NCT04142242|64836800|FG001|Stage II|Lost to Follow-up|0|||
23298776|NCT04142242|64836801|FG002|Stage II|Lost to Follow-up|1|||
23298777|NCT04142242|64836802|FG003|Stage II|Lost to Follow-up|2|||
23298778|NCT04142242|64836803|FG004|Stage II|Lost to Follow-up|0|||
23298779|NCT04142242|64836804|FG005|Stage II|Lost to Follow-up|0|||
23298780|NCT04142242|64836799|FG000|Stage II|Withdrawal by Subject|0|||
23298781|NCT04142242|64836800|FG001|Stage II|Withdrawal by Subject|0|||
23298782|NCT04142242|64836801|FG002|Stage II|Withdrawal by Subject|5|||
23298783|NCT04142242|64836802|FG003|Stage II|Withdrawal by Subject|9|||
23298784|NCT04142242|64836803|FG004|Stage II|Withdrawal by Subject|0|||
23298785|NCT04142242|64836804|FG005|Stage II|Withdrawal by Subject|0|||
23298786|NCT03042468|64836807|FG000|Overall Study|Death|0|||
23298787|NCT03042468|64836808|FG001|Overall Study|Death|1|||
23298788|NCT03042468|64836809|FG002|Overall Study|Death|1|||
23298789|NCT03042468|64836810|FG003|Overall Study|Death|0|||
23298790|NCT03042468|64836811|FG004|Overall Study|Death|0|||
23298791|NCT03042468|64836812|FG005|Overall Study|Death|0|||
23298792|NCT03042468|64836807|FG000|Overall Study|Withdrawal by Subject|0|||
23298793|NCT03042468|64836808|FG001|Overall Study|Withdrawal by Subject|0|||
23298794|NCT03042468|64836809|FG002|Overall Study|Withdrawal by Subject|0|||
23298795|NCT03042468|64836810|FG003|Overall Study|Withdrawal by Subject|0|||
23298796|NCT03042468|64836811|FG004|Overall Study|Withdrawal by Subject|0|||
23298797|NCT03042468|64836812|FG005|Overall Study|Withdrawal by Subject|1|||
23298798|NCT03042468|64836807|FG000|Overall Study|Lost to Follow-up|0|||
23298799|NCT03042468|64836808|FG001|Overall Study|Lost to Follow-up|0|||
23298800|NCT03042468|64836809|FG002|Overall Study|Lost to Follow-up|0|||
23388924|NCT01796470|65168858|FG003|Overall Study|Initiated New Therapy|0|||
23298801|NCT03042468|64836810|FG003|Overall Study|Lost to Follow-up|0|||
23298802|NCT03042468|64836811|FG004|Overall Study|Lost to Follow-up|1|||
23298803|NCT03042468|64836812|FG005|Overall Study|Lost to Follow-up|1|||
23388925|NCT01796470|65168859|FG004|Overall Study|Initiated New Therapy|2|||
23388926|NCT01796470|65168855|FG000|Overall Study|Lost to Follow-up|0|||
23298804|NCT01976728|64836815|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
23298805|NCT01976728|64836816|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
23298806|NCT01976728|64836817|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
23298807|NCT01976728|64836818|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
23298808|NCT01534078|64836819|FG000|Overall Study|Death|1|||
23298809|NCT01534078|64836819|FG000|Overall Study|Withdrawal by Subject|1|||
23298810|NCT01371994|64836821|FG000|Overall Study|Adverse Event|3|||
23298811|NCT01371994|64836822|FG001|Overall Study|Adverse Event|6|||
23298812|NCT01371994|64836821|FG000|Overall Study|Lack of Efficacy|3|||
23298813|NCT01371994|64836822|FG001|Overall Study|Lack of Efficacy|0|||
23298814|NCT01371994|64836821|FG000|Overall Study|Withdrawal by Subject|13|||
23298815|NCT01371994|64836822|FG001|Overall Study|Withdrawal by Subject|7|||
23298816|NCT01371994|64836821|FG000|Overall Study|Lost to Follow-up|1|||
23298817|NCT01371994|64836822|FG001|Overall Study|Lost to Follow-up|1|||
23298818|NCT01371994|64836821|FG000|Overall Study|Protocol Violation|24|||
23298819|NCT01371994|64836822|FG001|Overall Study|Protocol Violation|17|||
23298820|NCT01371994|64836821|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
23298821|NCT01371994|64836822|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
23298822|NCT01371994|64836821|FG000|Overall Study|Physician Decision|1|||
23298823|NCT01371994|64836822|FG001|Overall Study|Physician Decision|1|||
23298824|NCT01371994|64836821|FG000|Overall Study|Miscellaneous Reasons|6|||
23298825|NCT01371994|64836822|FG001|Overall Study|Miscellaneous Reasons|4|||
23298826|NCT02696031|64836823|FG000|Up to Week 24|Adverse Event|2|||
23298827|NCT02696031|64836824|FG001|Up to Week 24|Adverse Event|4|||
23298828|NCT02696031|64836825|FG002|Up to Week 24|Adverse Event|2|||
23298829|NCT02696031|64836826|FG003|Up to Week 24|Adverse Event|0|||
23298830|NCT02696031|64836827|FG004|Up to Week 24|Adverse Event|0|||
23298831|NCT02696031|64836828|FG005|Up to Week 24|Adverse Event|0|||
23298832|NCT02696031|64836823|FG000|Up to Week 24|Lack of Efficacy|2|||
23298833|NCT02696031|64836824|FG001|Up to Week 24|Lack of Efficacy|1|||
23298834|NCT02696031|64836825|FG002|Up to Week 24|Lack of Efficacy|2|||
23298835|NCT02696031|64836826|FG003|Up to Week 24|Lack of Efficacy|0|||
23298836|NCT02696031|64836827|FG004|Up to Week 24|Lack of Efficacy|0|||
23298837|NCT02696031|64836828|FG005|Up to Week 24|Lack of Efficacy|0|||
23298838|NCT02696031|64836823|FG000|Up to Week 24|Lost to Follow-up|0|||
23298839|NCT02696031|64836824|FG001|Up to Week 24|Lost to Follow-up|1|||
23298840|NCT02696031|64836825|FG002|Up to Week 24|Lost to Follow-up|1|||
23298841|NCT02696031|64836826|FG003|Up to Week 24|Lost to Follow-up|0|||
23298842|NCT02696031|64836827|FG004|Up to Week 24|Lost to Follow-up|0|||
23298843|NCT02696031|64836828|FG005|Up to Week 24|Lost to Follow-up|0|||
23298844|NCT02696031|64836823|FG000|Up to Week 24|Physician Decision|1|||
23298845|NCT02696031|64836824|FG001|Up to Week 24|Physician Decision|0|||
23298846|NCT02696031|64836825|FG002|Up to Week 24|Physician Decision|1|||
23298847|NCT02696031|64836826|FG003|Up to Week 24|Physician Decision|0|||
23298848|NCT02696031|64836827|FG004|Up to Week 24|Physician Decision|0|||
23298849|NCT02696031|64836828|FG005|Up to Week 24|Physician Decision|0|||
23298850|NCT02696031|64836823|FG000|Up to Week 24|Protocol Violation|1|||
23298851|NCT02696031|64836824|FG001|Up to Week 24|Protocol Violation|0|||
23298852|NCT02696031|64836825|FG002|Up to Week 24|Protocol Violation|0|||
23298853|NCT02696031|64836826|FG003|Up to Week 24|Protocol Violation|0|||
23298854|NCT02696031|64836827|FG004|Up to Week 24|Protocol Violation|0|||
23298855|NCT02696031|64836828|FG005|Up to Week 24|Protocol Violation|0|||
23298856|NCT02696031|64836823|FG000|Up to Week 24|Withdrawal by Subject|4|||
23298857|NCT02696031|64836824|FG001|Up to Week 24|Withdrawal by Subject|1|||
23298858|NCT02696031|64836825|FG002|Up to Week 24|Withdrawal by Subject|5|||
23298859|NCT02696031|64836826|FG003|Up to Week 24|Withdrawal by Subject|0|||
23298860|NCT02696031|64836827|FG004|Up to Week 24|Withdrawal by Subject|0|||
23298861|NCT02696031|64836828|FG005|Up to Week 24|Withdrawal by Subject|0|||
23298862|NCT02696031|64836823|FG000|Up to Week 52|Adverse Event|4|||
23298863|NCT02696031|64836824|FG001|Up to Week 52|Adverse Event|5|||
23298864|NCT02696031|64836825|FG002|Up to Week 52|Adverse Event|3|||
23298865|NCT02696031|64836826|FG003|Up to Week 52|Adverse Event|0|||
23298866|NCT02696031|64836827|FG004|Up to Week 52|Adverse Event|0|||
23298867|NCT02696031|64836828|FG005|Up to Week 52|Adverse Event|0|||
23298868|NCT02696031|64836823|FG000|Up to Week 52|Lack of Efficacy|10|||
23298869|NCT02696031|64836824|FG001|Up to Week 52|Lack of Efficacy|7|||
23298870|NCT02696031|64836825|FG002|Up to Week 52|Lack of Efficacy|11|||
23298871|NCT02696031|64836826|FG003|Up to Week 52|Lack of Efficacy|0|||
23298872|NCT02696031|64836827|FG004|Up to Week 52|Lack of Efficacy|0|||
23298873|NCT02696031|64836828|FG005|Up to Week 52|Lack of Efficacy|0|||
23298874|NCT02696031|64836823|FG000|Up to Week 52|Lost to Follow-up|1|||
23298875|NCT02696031|64836824|FG001|Up to Week 52|Lost to Follow-up|1|||
23298876|NCT02696031|64836825|FG002|Up to Week 52|Lost to Follow-up|1|||
23298877|NCT02696031|64836826|FG003|Up to Week 52|Lost to Follow-up|0|||
23298878|NCT02696031|64836827|FG004|Up to Week 52|Lost to Follow-up|0|||
23298879|NCT02696031|64836828|FG005|Up to Week 52|Lost to Follow-up|0|||
23298880|NCT02696031|64836823|FG000|Up to Week 52|Physician Decision|1|||
23298881|NCT02696031|64836824|FG001|Up to Week 52|Physician Decision|1|||
23298882|NCT02696031|64836825|FG002|Up to Week 52|Physician Decision|2|||
23298883|NCT02696031|64836826|FG003|Up to Week 52|Physician Decision|0|||
23298884|NCT02696031|64836827|FG004|Up to Week 52|Physician Decision|0|||
23298885|NCT02696031|64836828|FG005|Up to Week 52|Physician Decision|0|||
23298886|NCT02696031|64836823|FG000|Up to Week 52|Pregnancy|0|||
23298887|NCT02696031|64836824|FG001|Up to Week 52|Pregnancy|2|||
23298888|NCT02696031|64836825|FG002|Up to Week 52|Pregnancy|0|||
23298889|NCT02696031|64836826|FG003|Up to Week 52|Pregnancy|0|||
23298890|NCT02696031|64836827|FG004|Up to Week 52|Pregnancy|0|||
23298891|NCT02696031|64836828|FG005|Up to Week 52|Pregnancy|0|||
23298892|NCT02696031|64836823|FG000|Up to Week 52|Protocol Violation|1|||
23298893|NCT02696031|64836824|FG001|Up to Week 52|Protocol Violation|0|||
23298894|NCT02696031|64836825|FG002|Up to Week 52|Protocol Violation|0|||
23298895|NCT02696031|64836826|FG003|Up to Week 52|Protocol Violation|0|||
23298896|NCT02696031|64836827|FG004|Up to Week 52|Protocol Violation|0|||
23298897|NCT02696031|64836828|FG005|Up to Week 52|Protocol Violation|0|||
23298898|NCT02696031|64836823|FG000|Up to Week 52|Withdrawal by Subject|12|||
23298899|NCT02696031|64836824|FG001|Up to Week 52|Withdrawal by Subject|3|||
23298900|NCT02696031|64836825|FG002|Up to Week 52|Withdrawal by Subject|9|||
23298901|NCT02696031|64836826|FG003|Up to Week 52|Withdrawal by Subject|0|||
23298902|NCT02696031|64836827|FG004|Up to Week 52|Withdrawal by Subject|0|||
23298903|NCT02696031|64836828|FG005|Up to Week 52|Withdrawal by Subject|0|||
23298904|NCT02696031|64836823|FG000|Up to Week 104|Pregnancy|0|||
23298905|NCT02696031|64836824|FG001|Up to Week 104|Pregnancy|2|||
23298906|NCT02696031|64836825|FG002|Up to Week 104|Pregnancy|1|||
23298907|NCT02696031|64836826|FG003|Up to Week 104|Pregnancy|0|||
23298908|NCT02696031|64836827|FG004|Up to Week 104|Pregnancy|0|||
23298909|NCT02696031|64836828|FG005|Up to Week 104|Pregnancy|0|||
23298910|NCT02696031|64836823|FG000|Up to Week 104|Withdrawal by Subject|15|||
23298911|NCT02696031|64836824|FG001|Up to Week 104|Withdrawal by Subject|10|||
23298912|NCT02696031|64836825|FG002|Up to Week 104|Withdrawal by Subject|16|||
23298913|NCT02696031|64836826|FG003|Up to Week 104|Withdrawal by Subject|0|||
23298914|NCT02696031|64836827|FG004|Up to Week 104|Withdrawal by Subject|0|||
23298915|NCT02696031|64836828|FG005|Up to Week 104|Withdrawal by Subject|0|||
23298916|NCT02696031|64836823|FG000|Up to Week 104|Protocol Violation|1|||
23298917|NCT02696031|64836824|FG001|Up to Week 104|Protocol Violation|0|||
23298918|NCT02696031|64836825|FG002|Up to Week 104|Protocol Violation|0|||
23298919|NCT02696031|64836826|FG003|Up to Week 104|Protocol Violation|0|||
23298920|NCT02696031|64836827|FG004|Up to Week 104|Protocol Violation|0|||
23298921|NCT02696031|64836828|FG005|Up to Week 104|Protocol Violation|0|||
23298922|NCT02696031|64836823|FG000|Up to Week 104|Physician Decision|1|||
23298923|NCT02696031|64836824|FG001|Up to Week 104|Physician Decision|2|||
23298924|NCT02696031|64836825|FG002|Up to Week 104|Physician Decision|3|||
23298925|NCT02696031|64836826|FG003|Up to Week 104|Physician Decision|0|||
23298926|NCT02696031|64836827|FG004|Up to Week 104|Physician Decision|0|||
23298927|NCT02696031|64836828|FG005|Up to Week 104|Physician Decision|0|||
23298928|NCT02696031|64836823|FG000|Up to Week 104|Lost to Follow-up|2|||
23298929|NCT02696031|64836824|FG001|Up to Week 104|Lost to Follow-up|3|||
23298930|NCT02696031|64836825|FG002|Up to Week 104|Lost to Follow-up|1|||
23298931|NCT02696031|64836826|FG003|Up to Week 104|Lost to Follow-up|0|||
23298932|NCT02696031|64836827|FG004|Up to Week 104|Lost to Follow-up|0|||
23298933|NCT02696031|64836828|FG005|Up to Week 104|Lost to Follow-up|0|||
23298934|NCT02696031|64836823|FG000|Up to Week 104|Lack of Efficacy|13|||
23298935|NCT02696031|64836824|FG001|Up to Week 104|Lack of Efficacy|12|||
23298936|NCT02696031|64836825|FG002|Up to Week 104|Lack of Efficacy|11|||
23298937|NCT02696031|64836826|FG003|Up to Week 104|Lack of Efficacy|0|||
23298938|NCT02696031|64836827|FG004|Up to Week 104|Lack of Efficacy|0|||
23298939|NCT02696031|64836828|FG005|Up to Week 104|Lack of Efficacy|0|||
23298940|NCT02696031|64836823|FG000|Up to Week 104|Adverse Event|7|||
23298941|NCT02696031|64836824|FG001|Up to Week 104|Adverse Event|11|||
23298942|NCT02696031|64836825|FG002|Up to Week 104|Adverse Event|5|||
23298943|NCT02696031|64836826|FG003|Up to Week 104|Adverse Event|0|||
23298944|NCT02696031|64836827|FG004|Up to Week 104|Adverse Event|0|||
23298945|NCT02696031|64836828|FG005|Up to Week 104|Adverse Event|0|||
23298946|NCT02696031|64836823|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23298947|NCT02696031|64836824|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
23298948|NCT02696031|64836825|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23298949|NCT02696031|64836826|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23298950|NCT02696031|64836827|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23298951|NCT02696031|64836828|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
23298952|NCT02696031|64836823|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
23298953|NCT02696031|64836824|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
23298954|NCT02696031|64836825|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
23298955|NCT02696031|64836826|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
23298956|NCT02696031|64836827|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
23298957|NCT02696031|64836828|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
23298958|NCT02696031|64836823|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
23298959|NCT02696031|64836824|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
23298960|NCT02696031|64836825|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
23298961|NCT02696031|64836826|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
23298962|NCT02696031|64836827|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
23298963|NCT02696031|64836828|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
23298964|NCT02696031|64836823|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23298965|NCT02696031|64836824|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23298966|NCT02696031|64836825|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23298967|NCT02696031|64836826|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
23298968|NCT02696031|64836827|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23298969|NCT02696031|64836828|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
23298970|NCT02696031|64836823|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23298971|NCT02696031|64836824|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23298972|NCT02696031|64836825|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23298973|NCT02696031|64836826|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23298974|NCT02696031|64836827|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
23298975|NCT02696031|64836828|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
23298976|NCT02696031|64836823|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
23298977|NCT02696031|64836824|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
23298978|NCT02696031|64836825|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
23298979|NCT02696031|64836826|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
23298980|NCT02696031|64836827|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
23298981|NCT02696031|64836828|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
23298982|NCT02696031|64836823|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
23298983|NCT02696031|64836824|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
23298984|NCT02696031|64836825|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
23298985|NCT02696031|64836826|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
23298986|NCT02696031|64836827|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
23298987|NCT02696031|64836828|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
23298988|NCT02326974|64836829|FG000|Overall Study|Withdrawal by Subject|2|||
23298989|NCT02326974|64836829|FG000|Overall Study|failed heterogenity evaluation|5|||
23298990|NCT03856593|64836830|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
23298991|NCT03856593|64836831|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
23298992|NCT04412057|64836835|FG000|Overall Study|Death|3|||
23298993|NCT04412057|64836836|FG001|Overall Study|Death|7|||
23298994|NCT04412057|64836835|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
23298995|NCT04412057|64836836|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
23298996|NCT00233987|64836839|FG000|Overall Study|Withdrawal by Subject|1|||
23298997|NCT00233987|64836839|FG000|Overall Study|Lack of Efficacy|2|||
23298998|NCT00233987|64836839|FG000|Overall Study|Reason Under Review|1|||
23298999|NCT00233987|64836839|FG000|Overall Study|Other - Not Protocol Specified|5|||
23299000|NCT00233987|64836839|FG000|Overall Study|Eligible but No Treatment Received|2|||
23299001|NCT00233987|64836839|FG000|Overall Study|Ineligible|4|||
23299002|NCT01715896|64836840|FG000|Overall Study|Lost to Follow-up|0|||
23299003|NCT01715896|64836841|FG001|Overall Study|Lost to Follow-up|2|||
23299004|NCT01715896|64836840|FG000|Overall Study|Withdrawal by Subject|1|||
23299005|NCT01715896|64836841|FG001|Overall Study|Withdrawal by Subject|4|||
23299006|NCT01715896|64836840|FG000|Overall Study|Other|2|||
23299007|NCT01715896|64836841|FG001|Overall Study|Other|5|||
23299008|NCT01832402|64836842|FG000|Overall Study|Lost to Follow-up|2|||
23299009|NCT01832402|64836843|FG001|Overall Study|Lost to Follow-up|0|||
23299010|NCT01832402|64836842|FG000|Overall Study|Withdrawal by Subject|3|||
23299011|NCT01832402|64836843|FG001|Overall Study|Withdrawal by Subject|3|||
23299012|NCT01832402|64836842|FG000|Overall Study|Declining Performance status|2|||
23299013|NCT01832402|64836843|FG001|Overall Study|Declining Performance status|1|||
23299014|NCT01583218|64836845|FG000|Overall Study|Withdrawal by Subject|43|||
23299015|NCT01583218|64836846|FG001|Overall Study|Withdrawal by Subject|29|||
23299016|NCT01583218|64836845|FG000|Overall Study|Death|206|||
23299017|NCT01583218|64836846|FG001|Overall Study|Death|211|||
23299018|NCT01583218|64836845|FG000|Overall Study|Lost to Follow-up|11|||
23299019|NCT01583218|64836846|FG001|Overall Study|Lost to Follow-up|17|||
23299020|NCT01583218|64836845|FG000|Overall Study|Adverse event or serious adverse event|3|||
23299021|NCT01583218|64836846|FG001|Overall Study|Adverse event or serious adverse event|3|||
23299022|NCT01583218|64836845|FG000|Overall Study|Patient /Family decision|3|||
23299023|NCT01583218|64836846|FG001|Overall Study|Patient /Family decision|0|||
23299024|NCT01583218|64836845|FG000|Overall Study|Cannot contact patient directly|1|||
23299025|NCT01583218|64836846|FG001|Overall Study|Cannot contact patient directly|2|||
23299026|NCT01583218|64836845|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
23299027|NCT01583218|64836846|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
23299028|NCT01583218|64836845|FG000|Overall Study|Patient did not wish to attend visits|0|||
23299029|NCT01583218|64836846|FG001|Overall Study|Patient did not wish to attend visits|1|||
23299030|NCT01583218|64836845|FG000|Overall Study|Patient randomized but not dosed|17|||
23299031|NCT01583218|64836846|FG001|Overall Study|Patient randomized but not dosed|16|||
23299032|NCT01583218|64836845|FG000|Overall Study|Patient was assessed via phone in person|1|||
23299033|NCT01583218|64836846|FG001|Overall Study|Patient was assessed via phone in person|0|||
23299034|NCT01583218|64836845|FG000|Overall Study|Patient deemed ineligible after random|2|||
23299035|NCT01583218|64836846|FG001|Overall Study|Patient deemed ineligible after random|0|||
23299036|NCT01583218|64836845|FG000|Overall Study|Patient was early terminated from study|0|||
23299037|NCT01583218|64836846|FG001|Overall Study|Patient was early terminated from study|1|||
23299038|NCT01583218|64836845|FG000|Overall Study|Patient was randomized due to mistake|1|||
23299039|NCT01583218|64836846|FG001|Overall Study|Patient was randomized due to mistake|0|||
23299040|NCT01583218|64836845|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
23299041|NCT01583218|64836846|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
23299042|NCT01583218|64836845|FG000|Overall Study|Withdraw of consent on day of random|1|||
23299043|NCT01583218|64836846|FG001|Overall Study|Withdraw of consent on day of random|0|||
23299044|NCT04553913|64836847|FG000|Overall Study|patient's block resolved prior to PACU|1|||
23299045|NCT04553913|64836847|FG000|Overall Study|did not use the device properly|5|||
23299046|NCT03832738|64836848|FG000|Overall Study|Withdrawal by Subject|6|||
23299047|NCT03832738|64836849|FG001|Overall Study|Withdrawal by Subject|7|||
23299048|NCT03832738|64836850|FG002|Overall Study|Withdrawal by Subject|16|||
23299049|NCT03832738|64836848|FG000|Overall Study|Physician Decision|0|||
23299050|NCT03832738|64836849|FG001|Overall Study|Physician Decision|1|||
23299051|NCT03832738|64836850|FG002|Overall Study|Physician Decision|2|||
23299052|NCT03832738|64836848|FG000|Overall Study|Adverse Event|2|||
23299053|NCT03832738|64836849|FG001|Overall Study|Adverse Event|3|||
23299054|NCT03832738|64836850|FG002|Overall Study|Adverse Event|1|||
23299055|NCT03832738|64836848|FG000|Overall Study|Pregnancy|0|||
23299056|NCT03832738|64836849|FG001|Overall Study|Pregnancy|1|||
23299057|NCT03832738|64836850|FG002|Overall Study|Pregnancy|0|||
23299058|NCT02701413|64836856|FG000|Overall Study|Withdrawal by Subject|7|||
23299059|NCT02701413|64836857|FG001|Overall Study|Withdrawal by Subject|11|||
23299060|NCT00532935|64836858|FG000|Overall Study|Adverse Event|11|||
23299061|NCT00532935|64836859|FG001|Overall Study|Adverse Event|12|||
23299062|NCT00532935|64836858|FG000|Overall Study|Lack of Efficacy|0|||
23299063|NCT00532935|64836859|FG001|Overall Study|Lack of Efficacy|3|||
23299064|NCT00532935|64836858|FG000|Overall Study|Lost to Follow-up|10|||
23299065|NCT00532935|64836859|FG001|Overall Study|Lost to Follow-up|6|||
23299066|NCT00532935|64836858|FG000|Overall Study|Physician Decision|4|||
23299067|NCT00532935|64836859|FG001|Overall Study|Physician Decision|5|||
23299068|NCT00532935|64836858|FG000|Overall Study|Pregnancy|1|||
23299069|NCT00532935|64836859|FG001|Overall Study|Pregnancy|0|||
23299070|NCT00532935|64836858|FG000|Overall Study|Protocol Violation|4|||
23299071|NCT00532935|64836859|FG001|Overall Study|Protocol Violation|2|||
23299072|NCT00532935|64836858|FG000|Overall Study|Withdrawal by Subject|10|||
23299073|NCT00532935|64836859|FG001|Overall Study|Withdrawal by Subject|9|||
23299074|NCT00532935|64836858|FG000|Overall Study|Protocol Specific Criteria|11|||
23299075|NCT00532935|64836859|FG001|Overall Study|Protocol Specific Criteria|15|||
23299076|NCT00857259|64836860|FG000|Overall Study|Protocol Violation|1|||
23299077|NCT00857259|64836861|FG001|Overall Study|Protocol Violation|0|||
23299078|NCT00857259|64836862|FG002|Overall Study|Protocol Violation|1|||
23299079|NCT04086641|64836870|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
23299080|NCT04086641|64836871|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
23299081|NCT03407118|64836874|FG000|Period 2|Withdrawal by Subject|1|||
23299082|NCT03407118|64836875|FG001|Period 2|Withdrawal by Subject|0|||
23299083|NCT03201211|64836876|FG000|Overall Study|Adverse Event|1|||
23299084|NCT03201211|64836877|FG001|Overall Study|Adverse Event|0|||
23299085|NCT03201211|64836878|FG002|Overall Study|Adverse Event|0|||
23299086|NCT03201211|64836876|FG000|Overall Study|Protocol Violation|1|||
23299087|NCT03201211|64836877|FG001|Overall Study|Protocol Violation|0|||
23299088|NCT03201211|64836878|FG002|Overall Study|Protocol Violation|0|||
23299089|NCT03201211|64836876|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23299090|NCT03201211|64836877|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
23299091|NCT03201211|64836878|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
23299092|NCT03201211|64836876|FG000|Overall Study|OTHER unknown reasons|0|||
23299093|NCT03201211|64836877|FG001|Overall Study|OTHER unknown reasons|1|||
23299094|NCT03201211|64836878|FG002|Overall Study|OTHER unknown reasons|0|||
23299095|NCT00337428|64836879|FG000|Overall Study|Withdrawal by Subject|1|||
23299096|NCT00337428|64836880|FG001|Overall Study|Withdrawal by Subject|2|||
23299097|NCT00337428|64836879|FG000|Overall Study|Lack of Time|1|||
23299098|NCT00337428|64836880|FG001|Overall Study|Lack of Time|1|||
23299099|NCT00337428|64836879|FG000|Overall Study|Unwilling to Continue|1|||
23299100|NCT00337428|64836880|FG001|Overall Study|Unwilling to Continue|0|||
23299101|NCT00337428|64836879|FG000|Overall Study|Anorexia|1|||
23299102|NCT00337428|64836880|FG001|Overall Study|Anorexia|0|||
23299103|NCT03123783|64836881|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23299104|NCT03123783|64836882|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
23299105|NCT03123783|64836883|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23299106|NCT03123783|64836884|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23299107|NCT03123783|64836885|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23299108|NCT03123783|64836886|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23299109|NCT03123783|64836887|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
23299110|NCT03123783|64836881|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
23299111|NCT03123783|64836882|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
23299112|NCT03123783|64836883|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
23299113|NCT03123783|64836884|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
23299114|NCT03123783|64836885|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
23299115|NCT03123783|64836886|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
23299116|NCT03123783|64836887|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
23299117|NCT03123783|64836881|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
23299118|NCT03123783|64836882|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
23299119|NCT03123783|64836883|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
23299120|NCT03123783|64836884|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
23299121|NCT03123783|64836885|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
23299122|NCT03123783|64836886|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
23299123|NCT03123783|64836887|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
23299124|NCT03123783|64836881|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23299125|NCT03123783|64836882|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23299126|NCT03123783|64836883|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23299127|NCT03123783|64836884|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23299128|NCT03123783|64836885|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
23299129|NCT03123783|64836886|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23299130|NCT03123783|64836887|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
23299131|NCT00094458|64836888|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
23299132|NCT00094458|64836889|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
23299133|NCT00094458|64836890|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
23299134|NCT00094458|64836891|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
23299135|NCT00094458|64836892|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
23299136|NCT00094458|64836893|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
23299137|NCT00094458|64836888|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
23299138|NCT00094458|64836889|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
23299139|NCT00094458|64836890|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
23299140|NCT00094458|64836891|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
23299141|NCT00094458|64836892|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
23299142|NCT00094458|64836893|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
23299143|NCT00094458|64836888|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
23299144|NCT00094458|64836889|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
23299145|NCT00094458|64836890|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
23299146|NCT00094458|64836891|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
23299147|NCT00094458|64836892|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
23299148|NCT00094458|64836893|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
23299149|NCT00094458|64836888|FG000|Main Study: Through Week 30|Adverse Event|38|||
23299150|NCT00094458|64836889|FG001|Main Study: Through Week 30|Adverse Event|20|||
23299151|NCT00094458|64836890|FG002|Main Study: Through Week 30|Adverse Event|28|||
23299152|NCT00094458|64836891|FG003|Main Study: Through Week 30|Adverse Event|0|||
23299153|NCT00094458|64836892|FG004|Main Study: Through Week 30|Adverse Event|0|||
23299154|NCT00094458|64836893|FG005|Main Study: Through Week 30|Adverse Event|0|||
23299155|NCT00094458|64836888|FG000|Main Study: Through Week 30|Death|1|||
23299156|NCT00094458|64836889|FG001|Main Study: Through Week 30|Death|0|||
23299157|NCT00094458|64836890|FG002|Main Study: Through Week 30|Death|0|||
23299158|NCT00094458|64836891|FG003|Main Study: Through Week 30|Death|0|||
23299159|NCT00094458|64836892|FG004|Main Study: Through Week 30|Death|0|||
23299160|NCT00094458|64836893|FG005|Main Study: Through Week 30|Death|0|||
23299161|NCT00094458|64836888|FG000|Main Study: Through Week 30|Other|19|||
23299162|NCT00094458|64836889|FG001|Main Study: Through Week 30|Other|16|||
23299163|NCT00094458|64836890|FG002|Main Study: Through Week 30|Other|9|||
23299164|NCT00094458|64836891|FG003|Main Study: Through Week 30|Other|0|||
23299165|NCT00094458|64836892|FG004|Main Study: Through Week 30|Other|0|||
23299166|NCT00094458|64836893|FG005|Main Study: Through Week 30|Other|0|||
23299167|NCT00094458|64836888|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
23299168|NCT00094458|64836889|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
23388927|NCT01796470|65168856|FG001|Overall Study|Lost to Follow-up|1|||
23388928|NCT01796470|65168857|FG002|Overall Study|Lost to Follow-up|0|||
23388929|NCT01796470|65168858|FG003|Overall Study|Lost to Follow-up|0|||
23299169|NCT00094458|64836890|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
23299170|NCT00094458|64836891|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
23299171|NCT00094458|64836892|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
23299172|NCT00094458|64836893|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
23299173|NCT00094458|64836888|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
23299174|NCT00094458|64836889|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
23299175|NCT00094458|64836890|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
23299176|NCT00094458|64836891|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
23299177|NCT00094458|64836892|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
23299178|NCT00094458|64836893|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
23299179|NCT00094458|64836888|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
23299180|NCT00094458|64836889|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
23299181|NCT00094458|64836890|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
23299182|NCT00094458|64836891|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
23299183|NCT00094458|64836892|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
23299184|NCT00094458|64836893|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
23299185|NCT00094458|64836888|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
23299186|NCT00094458|64836889|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
23299187|NCT00094458|64836890|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
23299188|NCT00094458|64836891|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
23299189|NCT00094458|64836892|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
23299190|NCT00094458|64836893|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
23299191|NCT00094458|64836888|FG000|OLE: Open-Label Extension|Adverse Event|0|||
23299192|NCT00094458|64836889|FG001|OLE: Open-Label Extension|Adverse Event|0|||
23299193|NCT00094458|64836890|FG002|OLE: Open-Label Extension|Adverse Event|0|||
23299194|NCT00094458|64836891|FG003|OLE: Open-Label Extension|Adverse Event|0|||
23299195|NCT00094458|64836892|FG004|OLE: Open-Label Extension|Adverse Event|3|||
23299196|NCT00094458|64836893|FG005|OLE: Open-Label Extension|Adverse Event|4|||
23299197|NCT00094458|64836888|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
23299198|NCT00094458|64836889|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
23299199|NCT00094458|64836890|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
23299200|NCT00094458|64836891|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
23299201|NCT00094458|64836892|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
23299202|NCT00094458|64836893|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
23299203|NCT00094458|64836888|FG000|OLE: Open-Label Extension|Patient decision|0|||
23299204|NCT00094458|64836889|FG001|OLE: Open-Label Extension|Patient decision|0|||
23299205|NCT00094458|64836890|FG002|OLE: Open-Label Extension|Patient decision|0|||
23299206|NCT00094458|64836891|FG003|OLE: Open-Label Extension|Patient decision|0|||
23299207|NCT00094458|64836892|FG004|OLE: Open-Label Extension|Patient decision|1|||
23299208|NCT00094458|64836893|FG005|OLE: Open-Label Extension|Patient decision|0|||
23299209|NCT01929395|64836894|FG000|Overall Study|Did not complete - non-related toxicity|1|||
23299210|NCT01929395|64836895|FG001|Overall Study|Did not complete - non-related toxicity|0|||
23299211|NCT01929395|64836896|FG002|Overall Study|Did not complete - non-related toxicity|0|||
23299212|NCT01929395|64836894|FG000|Overall Study|Withdrawal by Subject|0|||
23299213|NCT01929395|64836895|FG001|Overall Study|Withdrawal by Subject|1|||
23299214|NCT01929395|64836896|FG002|Overall Study|Withdrawal by Subject|0|||
23299215|NCT01929395|64836894|FG000|Overall Study|Screen Fail|0|||
23299216|NCT01929395|64836895|FG001|Overall Study|Screen Fail|0|||
23299217|NCT01929395|64836896|FG002|Overall Study|Screen Fail|1|||
23299218|NCT02777918|64836897|FG000|Overall Study|Medical reasons|1|||
23299219|NCT02777918|64836898|FG001|Overall Study|Medical reasons|2|||
23299220|NCT02777918|64836897|FG000|Overall Study|Too busy / stressed|1|||
23299221|NCT02777918|64836898|FG001|Overall Study|Too busy / stressed|1|||
23299222|NCT02777918|64836897|FG000|Overall Study|Withdrawal by Subject|1|||
23299223|NCT02777918|64836898|FG001|Overall Study|Withdrawal by Subject|1|||
23299224|NCT00290251|64836899|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23299225|NCT00290251|64836900|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23299226|NCT00290251|64836901|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23299227|NCT00290251|64836902|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23299228|NCT00290251|64836903|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
23299229|NCT00290251|64836904|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
23299230|NCT00290251|64836899|FG000|Treatment 1 (Months 2-4)|headache|0|||
23299231|NCT00290251|64836900|FG001|Treatment 1 (Months 2-4)|headache|0|||
23299232|NCT00290251|64836901|FG002|Treatment 1 (Months 2-4)|headache|0|||
23299233|NCT00290251|64836902|FG003|Treatment 1 (Months 2-4)|headache|0|||
23299234|NCT00290251|64836903|FG004|Treatment 1 (Months 2-4)|headache|1|||
23299235|NCT00290251|64836904|FG005|Treatment 1 (Months 2-4)|headache|0|||
23299236|NCT00290251|64836899|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
23299237|NCT00290251|64836900|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
23299238|NCT00290251|64836901|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
23299239|NCT00290251|64836902|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
23299240|NCT00290251|64836903|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
23299241|NCT00290251|64836904|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
23299242|NCT01663727|64836905|FG000|Overall Study|Death|161|||
23299243|NCT01663727|64836906|FG001|Overall Study|Death|155|||
23299244|NCT01663727|64836905|FG000|Overall Study|Lost to Follow-up|10|||
23299245|NCT01663727|64836906|FG001|Overall Study|Lost to Follow-up|8|||
23299246|NCT01663727|64836905|FG000|Overall Study|Withdrawal by Subject|18|||
23299247|NCT01663727|64836906|FG001|Overall Study|Withdrawal by Subject|25|||
23299248|NCT01663727|64836905|FG000|Overall Study|Study Terminated|51|||
23299249|NCT01663727|64836906|FG001|Overall Study|Study Terminated|50|||
23299250|NCT01663727|64836905|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
23299251|NCT01663727|64836906|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
23299252|NCT01663727|64836905|FG000|Overall Study|Withdrawal prior to dosing.|1|||
23299253|NCT01663727|64836906|FG001|Overall Study|Withdrawal prior to dosing.|0|||
23299254|NCT01272921|64836909|FG000|Overall Study|Protocol Violation|2|||
23299255|NCT01272921|64836910|FG001|Overall Study|Protocol Violation|1|||
23299256|NCT00995085|64836911|FG000|Overall Study|Withdrawal by Subject|5|||
23299257|NCT01351350|64836913|FG000|Overall Study|Disease Progression|5|||
23299258|NCT01351350|64836914|FG001|Overall Study|Disease Progression|13|||
23299259|NCT01351350|64836915|FG002|Overall Study|Disease Progression|6|||
23299260|NCT01351350|64836916|FG003|Overall Study|Disease Progression|8|||
23299261|NCT01351350|64836917|FG004|Overall Study|Disease Progression|5|||
23299262|NCT01351350|64836913|FG000|Overall Study|Adverse Event|1|||
23299263|NCT01351350|64836914|FG001|Overall Study|Adverse Event|10|||
23299264|NCT01351350|64836915|FG002|Overall Study|Adverse Event|1|||
23299265|NCT01351350|64836916|FG003|Overall Study|Adverse Event|2|||
23299266|NCT01351350|64836917|FG004|Overall Study|Adverse Event|0|||
23299267|NCT01351350|64836913|FG000|Overall Study|Participant Decision|2|||
23299268|NCT01351350|64836914|FG001|Overall Study|Participant Decision|6|||
23299269|NCT01351350|64836915|FG002|Overall Study|Participant Decision|3|||
23299270|NCT01351350|64836916|FG003|Overall Study|Participant Decision|3|||
23299271|NCT01351350|64836917|FG004|Overall Study|Participant Decision|2|||
23299272|NCT01351350|64836913|FG000|Overall Study|Enrolled but not Treated|0|||
23299273|NCT01351350|64836914|FG001|Overall Study|Enrolled but not Treated|0|||
23299274|NCT01351350|64836915|FG002|Overall Study|Enrolled but not Treated|1|||
23299275|NCT01351350|64836916|FG003|Overall Study|Enrolled but not Treated|0|||
23299276|NCT01351350|64836917|FG004|Overall Study|Enrolled but not Treated|0|||
23299277|NCT01299805|64836920|FG000|Overall Study|Adverse Event|2|||
23299278|NCT01299805|64836921|FG001|Overall Study|Adverse Event|0|||
23299279|NCT00831623|64836922|FG000|Overall Study|Withdrawal by Subject|9|||
23299280|NCT00831623|64836922|FG000|Overall Study|Lost to Follow-up|1|||
23299281|NCT00831623|64836922|FG000|Overall Study|Not 2 years post-treatment|12|||
23299282|NCT05212883|64836923|FG000|Overall Study|Invalid test result|125|||
23299283|NCT03499119|64836929|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
23299284|NCT03499119|64836930|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
23299285|NCT03499119|64836931|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
23299286|NCT03499119|64836932|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
23299287|NCT03499119|64836929|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
23299288|NCT03499119|64836930|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
23299289|NCT03499119|64836931|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
23299290|NCT03499119|64836932|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
23299291|NCT03499119|64836929|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
23299292|NCT03499119|64836930|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
23299293|NCT03499119|64836931|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
23299294|NCT03499119|64836932|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
23299295|NCT03499119|64836929|FG000|Optional Extension Phase|Lost to Follow-up|0|||
23299296|NCT03499119|64836930|FG001|Optional Extension Phase|Lost to Follow-up|0|||
23299297|NCT03499119|64836931|FG002|Optional Extension Phase|Lost to Follow-up|0|||
23299298|NCT03499119|64836932|FG003|Optional Extension Phase|Lost to Follow-up|1|||
23299299|NCT03499119|64836929|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
23299300|NCT03499119|64836930|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
23299301|NCT03499119|64836931|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
23299302|NCT03499119|64836932|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
23299303|NCT03499119|64836929|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
23299304|NCT03499119|64836930|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
23299305|NCT03499119|64836931|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
23299306|NCT03499119|64836932|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
23299307|NCT02133001|64839804|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
23299308|NCT02133001|64839805|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
23299309|NCT02133001|64839804|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
23299310|NCT02133001|64839805|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
23299311|NCT02133001|64839804|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
23388930|NCT01796470|65168859|FG004|Overall Study|Lost to Follow-up|0|||
23299312|NCT02133001|64839805|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
23299313|NCT02133001|64839804|FG000|Double Blind (Day 1-25)|Other|2|||
23299314|NCT02133001|64839805|FG001|Double Blind (Day 1-25)|Other|2|||
23299315|NCT02133001|64839804|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
23299316|NCT02133001|64839805|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
23299317|NCT02133001|64839804|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
23299318|NCT02133001|64839805|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
23299319|NCT02133001|64839804|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
23299320|NCT02133001|64839805|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
23299321|NCT02133001|64839804|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
23299322|NCT02133001|64839805|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
23299323|NCT00430950|64839813|FG000|Overall Study|Adverse Event|7|||
23299324|NCT00430950|64839814|FG001|Overall Study|Adverse Event|6|||
23299325|NCT00430950|64839813|FG000|Overall Study|Withdrawal by Subject|1|||
23299326|NCT00430950|64839814|FG001|Overall Study|Withdrawal by Subject|0|||
23299327|NCT00430950|64839813|FG000|Overall Study|concomitant medication,etc.|5|||
23299328|NCT00430950|64839814|FG001|Overall Study|concomitant medication,etc.|7|||
23299329|NCT01045421|64839819|FG000|Phase 1|Progressive Disease|0|||
23299330|NCT01045421|64839820|FG001|Phase 1|Progressive Disease|0|||
23299331|NCT01045421|64839821|FG002|Phase 1|Progressive Disease|0|||
23299332|NCT01045421|64839822|FG003|Phase 1|Progressive Disease|0|||
23299333|NCT01045421|64839823|FG004|Phase 1|Progressive Disease|1|||
23299334|NCT01045421|64839824|FG005|Phase 1|Progressive Disease|0|||
23299335|NCT01045421|64839825|FG006|Phase 1|Progressive Disease|0|||
23299336|NCT01045421|64839826|FG007|Phase 1|Progressive Disease|0|||
23299337|NCT01045421|64839827|FG008|Phase 1|Progressive Disease|0|||
23299338|NCT01045421|64839828|FG009|Phase 1|Progressive Disease|0|||
23299339|NCT01045421|64839829|FG010|Phase 1|Progressive Disease|0|||
23299340|NCT01045421|64839819|FG000|Phase 1|Withdrawal by Subject|0|||
23299341|NCT01045421|64839820|FG001|Phase 1|Withdrawal by Subject|0|||
23299342|NCT01045421|64839821|FG002|Phase 1|Withdrawal by Subject|0|||
23299343|NCT01045421|64839822|FG003|Phase 1|Withdrawal by Subject|1|||
23299344|NCT01045421|64839823|FG004|Phase 1|Withdrawal by Subject|0|||
23299345|NCT01045421|64839824|FG005|Phase 1|Withdrawal by Subject|0|||
23299346|NCT01045421|64839825|FG006|Phase 1|Withdrawal by Subject|0|||
23299347|NCT01045421|64839826|FG007|Phase 1|Withdrawal by Subject|0|||
23299348|NCT01045421|64839827|FG008|Phase 1|Withdrawal by Subject|0|||
23299349|NCT01045421|64839828|FG009|Phase 1|Withdrawal by Subject|0|||
23299350|NCT01045421|64839829|FG010|Phase 1|Withdrawal by Subject|0|||
23299351|NCT01045421|64839819|FG000|Phase 2|Progressive Disease|0|||
23299352|NCT01045421|64839820|FG001|Phase 2|Progressive Disease|0|||
23299353|NCT01045421|64839821|FG002|Phase 2|Progressive Disease|0|||
23299354|NCT01045421|64839822|FG003|Phase 2|Progressive Disease|0|||
23299355|NCT01045421|64839823|FG004|Phase 2|Progressive Disease|0|||
23299356|NCT01045421|64839824|FG005|Phase 2|Progressive Disease|0|||
23299357|NCT01045421|64839825|FG006|Phase 2|Progressive Disease|0|||
23299358|NCT01045421|64839826|FG007|Phase 2|Progressive Disease|1|||
23299359|NCT01045421|64839827|FG008|Phase 2|Progressive Disease|1|||
23299360|NCT01045421|64839828|FG009|Phase 2|Progressive Disease|1|||
23299361|NCT01045421|64839829|FG010|Phase 2|Progressive Disease|1|||
23299362|NCT01045421|64839819|FG000|Phase 2|Death|0|||
23299363|NCT01045421|64839820|FG001|Phase 2|Death|0|||
23299364|NCT01045421|64839821|FG002|Phase 2|Death|0|||
23299365|NCT01045421|64839822|FG003|Phase 2|Death|0|||
23299366|NCT01045421|64839823|FG004|Phase 2|Death|0|||
23299367|NCT01045421|64839824|FG005|Phase 2|Death|0|||
23299368|NCT01045421|64839825|FG006|Phase 2|Death|0|||
23299369|NCT01045421|64839826|FG007|Phase 2|Death|1|||
23299370|NCT01045421|64839827|FG008|Phase 2|Death|1|||
23299371|NCT01045421|64839828|FG009|Phase 2|Death|2|||
23299372|NCT01045421|64839829|FG010|Phase 2|Death|0|||
23299373|NCT01045421|64839819|FG000|Phase 2|Other|0|||
23299374|NCT01045421|64839820|FG001|Phase 2|Other|0|||
23299375|NCT01045421|64839821|FG002|Phase 2|Other|0|||
23299376|NCT01045421|64839822|FG003|Phase 2|Other|0|||
23299377|NCT01045421|64839823|FG004|Phase 2|Other|0|||
23299378|NCT01045421|64839824|FG005|Phase 2|Other|0|||
23299379|NCT01045421|64839825|FG006|Phase 2|Other|0|||
23494854|NCT03307785|65555007|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
23299380|NCT01045421|64839826|FG007|Phase 2|Other|3|||
23299381|NCT01045421|64839827|FG008|Phase 2|Other|0|||
23299382|NCT01045421|64839828|FG009|Phase 2|Other|0|||
23299383|NCT01045421|64839829|FG010|Phase 2|Other|1|||
23299384|NCT01091103|64839832|FG000|Overall Study|Adverse Event|1|||
23299385|NCT01091103|64839832|FG000|Overall Study|Progressive Disease|3|||
23494855|NCT03307785|65555008|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
23494856|NCT03307785|65555009|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
23494857|NCT04553679|65555010|FG000|Overall Study|Withdrawal by Subject|2|||
23494858|NCT04553679|65555011|FG001|Overall Study|Withdrawal by Subject|0|||
23494859|NCT04553679|65555010|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
23494860|NCT04553679|65555011|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
23494861|NCT02171065|65555012|FG000|Overall Study|Withdrawal by Subject|1|||
23494862|NCT02171065|65555013|FG001|Overall Study|Withdrawal by Subject|0|||
23494863|NCT02171065|65555014|FG002|Overall Study|Withdrawal by Subject|0|||
23494864|NCT02171065|65555012|FG000|Overall Study|Lost to Follow-up|0|||
23494865|NCT02171065|65555013|FG001|Overall Study|Lost to Follow-up|0|||
23494866|NCT02171065|65555014|FG002|Overall Study|Lost to Follow-up|1|||
23494867|NCT01890746|65555015|FG000|Overall Study|Death|39|||
23494868|NCT01890746|65555016|FG001|Overall Study|Death|30|||
23494869|NCT01890746|65555015|FG000|Overall Study|Adverse Event|1|||
23494870|NCT01890746|65555016|FG001|Overall Study|Adverse Event|0|||
23494871|NCT01890746|65555015|FG000|Overall Study|Lost to Follow-up|4|||
23494872|NCT01890746|65555016|FG001|Overall Study|Lost to Follow-up|1|||
23494873|NCT01890746|65555015|FG000|Overall Study|Physician Decision|3|||
23494874|NCT01890746|65555016|FG001|Overall Study|Physician Decision|2|||
23494875|NCT01890746|65555015|FG000|Overall Study|Withdrawal by Subject|5|||
23494876|NCT01890746|65555016|FG001|Overall Study|Withdrawal by Subject|8|||
23494877|NCT00085709|65555017|FG000|Overall Study|Adverse Event|8|||
23494878|NCT00085709|65555018|FG001|Overall Study|Adverse Event|0|||
23494879|NCT00085709|65555017|FG000|Overall Study|Death|8|||
23494880|NCT00085709|65555018|FG001|Overall Study|Death|2|||
23494881|NCT00085709|65555017|FG000|Overall Study|Refusal unrelated to adverse events|1|||
23494882|NCT00085709|65555018|FG001|Overall Study|Refusal unrelated to adverse events|2|||
23494883|NCT00085709|65555017|FG000|Overall Study|Progression|3|||
23494884|NCT00085709|65555018|FG001|Overall Study|Progression|4|||
23494885|NCT00085709|65555017|FG000|Overall Study|Not protocol specified|12|||
23494886|NCT00085709|65555018|FG001|Overall Study|Not protocol specified|22|||
23299386|NCT03710590|64839833|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
23299387|NCT03710590|64839834|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
23299388|NCT02221037|64839835|FG000|Overall Study|Physician Decision|0|||
23299389|NCT02221037|64839836|FG001|Overall Study|Physician Decision|0|||
23494887|NCT00085709|65555017|FG000|Overall Study|Not eligible|19|||
23494888|NCT00085709|65555018|FG001|Overall Study|Not eligible|19|||
23494889|NCT00085709|65555017|FG000|Overall Study|Withdrawal by Subject|2|||
23299390|NCT02221037|64839837|FG002|Overall Study|Physician Decision|1|||
23494890|NCT00085709|65555018|FG001|Overall Study|Withdrawal by Subject|1|||
23494891|NCT00754065|65555020|FG000|Overall Study|Never received treatment|12|||
23299391|NCT02221037|64839838|FG003|Overall Study|Physician Decision|0|||
23299392|NCT01787279|64839839|FG000|Overall Study|Lost to Follow-up|2|||
23299393|NCT01787279|64839839|FG000|Overall Study|Lack of Efficacy|1|||
23299394|NCT00248170|64839840|FG000|Overall Study|Withdrawal by Subject|71|||
23299395|NCT00248170|64839841|FG001|Overall Study|Withdrawal by Subject|79|||
23299396|NCT00248170|64839840|FG000|Overall Study|Protocol Violation|35|||
23299397|NCT00248170|64839841|FG001|Overall Study|Protocol Violation|30|||
23299398|NCT00248170|64839840|FG000|Overall Study|Lost to Follow-up|28|||
23299399|NCT00248170|64839841|FG001|Overall Study|Lost to Follow-up|35|||
23299400|NCT00248170|64839840|FG000|Overall Study|Disease progression|196|||
23299401|NCT00248170|64839841|FG001|Overall Study|Disease progression|216|||
23299402|NCT00248170|64839840|FG000|Overall Study|Death|28|||
23299403|NCT00248170|64839841|FG001|Overall Study|Death|47|||
23299404|NCT00248170|64839840|FG000|Overall Study|Adverse Event|311|||
23299405|NCT00248170|64839841|FG001|Overall Study|Adverse Event|296|||
23299406|NCT00248170|64839840|FG000|Overall Study|Administrative problems|22|||
23299407|NCT00248170|64839841|FG001|Overall Study|Administrative problems|25|||
23299408|NCT00248170|64839840|FG000|Overall Study|Abnormal test procedure(s) result|49|||
23299409|NCT00248170|64839841|FG001|Overall Study|Abnormal test procedure(s) result|61|||
23299410|NCT00248170|64839840|FG000|Overall Study|Abnormal laboratory values|4|||
23299411|NCT00248170|64839841|FG001|Overall Study|Abnormal laboratory values|0|||
23299412|NCT00248170|64839840|FG000|Overall Study|Protocol deviation|17|||
23299413|NCT00248170|64839841|FG001|Overall Study|Protocol deviation|19|||
23299414|NCT00841906|64839845|FG000|Overall Study|Withdrawal by Subject|2|||
23299415|NCT00841906|64839846|FG001|Overall Study|Withdrawal by Subject|0|||
23299416|NCT01674647|64839850|FG000|Treatment Period|Death|4|||
23299417|NCT01674647|64839851|FG001|Treatment Period|Death|1|||
23299418|NCT01674647|64839850|FG000|Treatment Period|Efficacy outcome reached|0|||
23299419|NCT01674647|64839851|FG001|Treatment Period|Efficacy outcome reached|1|||
23388931|NCT01796470|65168855|FG000|Overall Study|Physician Decision|5|||
23388932|NCT01796470|65168856|FG001|Overall Study|Physician Decision|4|||
23388933|NCT01796470|65168857|FG002|Overall Study|Physician Decision|1|||
23388934|NCT01796470|65168858|FG003|Overall Study|Physician Decision|0|||
23388935|NCT01796470|65168859|FG004|Overall Study|Physician Decision|1|||
23388936|NCT01796470|65168855|FG000|Overall Study|Progressive Disease|7|||
23388937|NCT01796470|65168856|FG001|Overall Study|Progressive Disease|7|||
23388938|NCT01796470|65168857|FG002|Overall Study|Progressive Disease|3|||
23388939|NCT01796470|65168858|FG003|Overall Study|Progressive Disease|2|||
23388940|NCT01796470|65168859|FG004|Overall Study|Progressive Disease|0|||
23388941|NCT01796470|65168855|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
23388942|NCT01796470|65168856|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
23388943|NCT01796470|65168857|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
23388944|NCT01796470|65168858|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
23388945|NCT01796470|65168859|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
23388946|NCT01796470|65168855|FG000|Overall Study|Withdrawal by Subject|7|||
23388947|NCT01796470|65168856|FG001|Overall Study|Withdrawal by Subject|0|||
23388948|NCT01796470|65168857|FG002|Overall Study|Withdrawal by Subject|0|||
23388949|NCT01796470|65168858|FG003|Overall Study|Withdrawal by Subject|0|||
23388950|NCT01796470|65168859|FG004|Overall Study|Withdrawal by Subject|1|||
23388951|NCT01348490|65168860|FG000|Overall Study|Death|1|||
23388952|NCT01348490|65168860|FG000|Overall Study|Adverse Event|3|||
23388953|NCT01348490|65168860|FG000|Overall Study|Consent withdrawn|7|||
23388954|NCT01348490|65168860|FG000|Overall Study|Disease progression|3|||
23388955|NCT01348490|65168860|FG000|Overall Study|Lost to Follow-up|1|||
23388956|NCT01348490|65168860|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
23388957|NCT01348490|65168860|FG000|Overall Study|Other Unspecified|8|||
23388958|NCT02057666|65168861|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
23388959|NCT02057666|65168862|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
23388960|NCT02057666|65168861|FG000|Double Blind Treatment Period|Poor tolerability|7|||
23388961|NCT02057666|65168862|FG001|Double Blind Treatment Period|Poor tolerability|2|||
23388962|NCT02057666|65168861|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
23388963|NCT02057666|65168862|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
23388964|NCT02057666|65168861|FG000|Double Blind Treatment Period|Physician Decision|1|||
23388965|NCT02057666|65168862|FG001|Double Blind Treatment Period|Physician Decision|0|||
23388966|NCT02057666|65168861|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
23388967|NCT02057666|65168862|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
23388968|NCT02057666|65168861|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
23299420|NCT01674647|64839850|FG000|Treatment Period|Physician Decision|3|||
23388969|NCT02057666|65168862|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
23388970|NCT02057666|65168861|FG000|Double Blind Treatment Period|Sponsor's request|70|||
23388971|NCT02057666|65168862|FG001|Double Blind Treatment Period|Sponsor's request|34|||
23299421|NCT01674647|64839851|FG001|Treatment Period|Physician Decision|1|||
23299422|NCT01674647|64839850|FG000|Treatment Period|Adverse Event|60|||
23299423|NCT01674647|64839851|FG001|Treatment Period|Adverse Event|22|||
23388972|NCT02057666|65168861|FG000|Open-Label Treatment Period|Poor tolerability|0|||
23388973|NCT02057666|65168862|FG001|Open-Label Treatment Period|Poor tolerability|1|||
23388974|NCT02057666|65168861|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
23388975|NCT02057666|65168862|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
23388976|NCT02057666|65168861|FG000|Open-Label Treatment Period|Sponsor's request|0|||
23388977|NCT02057666|65168862|FG001|Open-Label Treatment Period|Sponsor's request|4|||
23388978|NCT01539525|65168865|FG000|Overall Study|Lost to Follow-up|19|||
23388979|NCT01539525|65168866|FG001|Overall Study|Lost to Follow-up|12|||
23388980|NCT01539525|65168867|FG002|Overall Study|Lost to Follow-up|11|||
23388981|NCT01539525|65168865|FG000|Overall Study|Withdrawal by Subject|0|||
23388982|NCT01539525|65168866|FG001|Overall Study|Withdrawal by Subject|3|||
23388983|NCT01539525|65168867|FG002|Overall Study|Withdrawal by Subject|2|||
23388984|NCT01539525|65168865|FG000|Overall Study|Protocol Violation|1|||
23388985|NCT01539525|65168866|FG001|Overall Study|Protocol Violation|1|||
23388986|NCT01539525|65168867|FG002|Overall Study|Protocol Violation|4|||
23388987|NCT02489045|65168869|FG000|Overall Study|unable to collect usable data|53|||
23388988|NCT02489045|65168869|FG000|Follow-up|Lost to Follow-up|10|||
23388989|NCT02766478|65168872|FG000|Overall Study|Withdrawal by Subject|1|||
23388990|NCT02766478|65168873|FG001|Overall Study|Withdrawal by Subject|1|||
23388991|NCT00912509|65168876|FG000|Overall Study|Lost to Follow-up|1|||
23388992|NCT00912509|65168877|FG001|Overall Study|Lost to Follow-up|0|||
23388993|NCT00912509|65168876|FG000|Overall Study|Lack of Efficacy|4|||
23388994|NCT00912509|65168877|FG001|Overall Study|Lack of Efficacy|3|||
23388995|NCT02365064|65168878|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
23388996|NCT02365064|65168879|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
23388997|NCT02365064|65168878|FG000|Overall Study|Withdrawal by Subject|6|||
23388998|NCT02365064|65168879|FG001|Overall Study|Withdrawal by Subject|9|||
23388999|NCT02365064|65168878|FG000|Overall Study|Treatment intolerance|2|||
23389000|NCT02365064|65168879|FG001|Overall Study|Treatment intolerance|4|||
23389001|NCT05122143|65168880|FG000|Overall Study|Adverse Event|1|||
23389002|NCT05122143|65168881|FG001|Overall Study|Adverse Event|0|||
23389003|NCT05122143|65168882|FG002|Overall Study|Adverse Event|0|||
23389004|NCT05122143|65168883|FG003|Overall Study|Adverse Event|0|||
23389005|NCT05122143|65168884|FG004|Overall Study|Adverse Event|1|||
23389006|NCT05122143|65168885|FG005|Overall Study|Adverse Event|0|||
23389007|NCT05122143|65168880|FG000|Overall Study|Protocol non-compliance|0|||
23389008|NCT05122143|65168881|FG001|Overall Study|Protocol non-compliance|0|||
23389009|NCT05122143|65168882|FG002|Overall Study|Protocol non-compliance|1|||
23389010|NCT05122143|65168883|FG003|Overall Study|Protocol non-compliance|0|||
23389011|NCT05122143|65168884|FG004|Overall Study|Protocol non-compliance|0|||
23389012|NCT05122143|65168885|FG005|Overall Study|Protocol non-compliance|0|||
23389013|NCT05122143|65168880|FG000|Overall Study|Covid contact|0|||
23389014|NCT05122143|65168881|FG001|Overall Study|Covid contact|0|||
23389015|NCT05122143|65168882|FG002|Overall Study|Covid contact|0|||
23389016|NCT05122143|65168883|FG003|Overall Study|Covid contact|0|||
23299424|NCT01674647|64839850|FG000|Treatment Period|Non-compliance with study drug|3|||
23299425|NCT01674647|64839851|FG001|Treatment Period|Non-compliance with study drug|0|||
23299426|NCT01674647|64839850|FG000|Treatment Period|Lost to Follow-up|1|||
23299427|NCT01674647|64839851|FG001|Treatment Period|Lost to Follow-up|1|||
23299428|NCT01674647|64839850|FG000|Treatment Period|Withdrawal by Subject|19|||
23389017|NCT05122143|65168884|FG004|Overall Study|Covid contact|1|||
23299429|NCT01674647|64839851|FG001|Treatment Period|Withdrawal by Subject|16|||
23299430|NCT01674647|64839850|FG000|Treatment Period|Switching to other therapy|5|||
23299431|NCT01674647|64839851|FG001|Treatment Period|Switching to other therapy|2|||
23299432|NCT01674647|64839850|FG000|Treatment Period|Logistical difficulties|5|||
23299433|NCT01674647|64839851|FG001|Treatment Period|Logistical difficulties|8|||
23299434|NCT01674647|64839850|FG000|Treatment Period|Treatment failure|0|||
23299435|NCT01674647|64839851|FG001|Treatment Period|Treatment failure|14|||
23299436|NCT01674647|64839850|FG000|Treatment Period|Protocol Violation|56|||
23299437|NCT01674647|64839851|FG001|Treatment Period|Protocol Violation|36|||
23299438|NCT01674647|64839850|FG000|30-day Safety Follow-up Period|Death|3|||
23299439|NCT01674647|64839851|FG001|30-day Safety Follow-up Period|Death|2|||
23299440|NCT01674647|64839850|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
23299441|NCT01674647|64839851|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
23299442|NCT01674647|64839850|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
23299443|NCT01674647|64839851|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
23299444|NCT01674647|64839850|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
23299445|NCT01674647|64839851|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
23299446|NCT01674647|64839850|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
23299447|NCT01674647|64839851|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
23299448|NCT01674647|64839850|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
23299449|NCT01674647|64839851|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
23299450|NCT01782482|64839852|FG000|Overall Study|Adverse Event|2|||
23299451|NCT01782482|64839853|FG001|Overall Study|Adverse Event|1|||
23299452|NCT01782482|64839852|FG000|Overall Study|Lost to Follow-up|2|||
23299453|NCT01782482|64839853|FG001|Overall Study|Lost to Follow-up|3|||
23299454|NCT01782482|64839852|FG000|Overall Study|Physician Decision|1|||
23299455|NCT01782482|64839853|FG001|Overall Study|Physician Decision|0|||
23299456|NCT01782482|64839852|FG000|Overall Study|Protocol Violation|1|||
23299457|NCT01782482|64839853|FG001|Overall Study|Protocol Violation|0|||
23299458|NCT01782482|64839852|FG000|Overall Study|Withdrawal by Subject|2|||
23299459|NCT01782482|64839853|FG001|Overall Study|Withdrawal by Subject|3|||
23299460|NCT01782482|64839852|FG000|Overall Study|Randomized in Error|2|||
23299461|NCT01782482|64839853|FG001|Overall Study|Randomized in Error|2|||
23299462|NCT01782482|64839852|FG000|Overall Study|Habitually wearing toric lens OS|0|||
23299463|NCT01782482|64839853|FG001|Overall Study|Habitually wearing toric lens OS|1|||
23299464|NCT04740931|64839854|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
23299465|NCT04740931|64839855|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
23299466|NCT04740931|64839854|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
23299467|NCT04740931|64839855|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
23299468|NCT04740931|64839854|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
23299469|NCT04740931|64839855|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
23389018|NCT05122143|65168885|FG005|Overall Study|Covid contact|0|||
23389019|NCT02451007|65168887|FG000|Overall Study|Withdrawal by Subject|4|||
23389020|NCT02451007|65168887|FG000|Overall Study|Adverse Event|1|||
23389021|NCT02451007|65168887|FG000|Overall Study|Disease Progression|2|||
23389022|NCT00803049|65168889|FG000|Overall Study|Adverse Event|21|||
23389023|NCT00803049|65168890|FG001|Overall Study|Adverse Event|33|||
23389024|NCT00803049|65168891|FG002|Overall Study|Adverse Event|13|||
23389025|NCT00803049|65168892|FG003|Overall Study|Adverse Event|27|||
23389026|NCT00803049|65168889|FG000|Overall Study|Lack of Efficacy|10|||
23389027|NCT00803049|65168890|FG001|Overall Study|Lack of Efficacy|19|||
23389028|NCT00803049|65168891|FG002|Overall Study|Lack of Efficacy|6|||
23389029|NCT00803049|65168892|FG003|Overall Study|Lack of Efficacy|13|||
23389030|NCT00803049|65168889|FG000|Overall Study|Lost to Follow-up|0|||
23389031|NCT00803049|65168890|FG001|Overall Study|Lost to Follow-up|2|||
23389032|NCT00803049|65168891|FG002|Overall Study|Lost to Follow-up|0|||
23389033|NCT00803049|65168892|FG003|Overall Study|Lost to Follow-up|3|||
23389034|NCT00803049|65168889|FG000|Overall Study|Death|2|||
23389035|NCT00803049|65168890|FG001|Overall Study|Death|1|||
23389036|NCT00803049|65168891|FG002|Overall Study|Death|0|||
23389037|NCT00803049|65168892|FG003|Overall Study|Death|2|||
23389038|NCT00803049|65168889|FG000|Overall Study|Progressive Disease|6|||
23389039|NCT00803049|65168890|FG001|Overall Study|Progressive Disease|10|||
23389040|NCT00803049|65168891|FG002|Overall Study|Progressive Disease|6|||
23389041|NCT00803049|65168892|FG003|Overall Study|Progressive Disease|6|||
23389042|NCT00803049|65168889|FG000|Overall Study|Withdrawal by Subject|19|||
23389043|NCT00803049|65168890|FG001|Overall Study|Withdrawal by Subject|43|||
23389044|NCT00803049|65168891|FG002|Overall Study|Withdrawal by Subject|16|||
23389045|NCT00803049|65168892|FG003|Overall Study|Withdrawal by Subject|44|||
23389046|NCT00803049|65168889|FG000|Overall Study|Protocol Violation|0|||
23389047|NCT00803049|65168890|FG001|Overall Study|Protocol Violation|1|||
23389048|NCT00803049|65168891|FG002|Overall Study|Protocol Violation|1|||
23389049|NCT00803049|65168892|FG003|Overall Study|Protocol Violation|0|||
23389050|NCT00803049|65168889|FG000|Overall Study|Randomized and Not Treated|0|||
23389051|NCT00803049|65168890|FG001|Overall Study|Randomized and Not Treated|0|||
23389052|NCT00803049|65168891|FG002|Overall Study|Randomized and Not Treated|0|||
23389053|NCT00803049|65168892|FG003|Overall Study|Randomized and Not Treated|2|||
23389054|NCT00803049|65168889|FG000|Overall Study|Other than Specified Above|3|||
23389055|NCT00803049|65168890|FG001|Overall Study|Other than Specified Above|9|||
23389056|NCT00803049|65168891|FG002|Overall Study|Other than Specified Above|2|||
23389057|NCT00803049|65168892|FG003|Overall Study|Other than Specified Above|5|||
23389058|NCT01093534|65168893|FG000|Overall Study|Adverse Event|2|||
23389059|NCT01093534|65168894|FG001|Overall Study|Adverse Event|5|||
23389060|NCT01093534|65168895|FG002|Overall Study|Adverse Event|2|||
23389061|NCT01093534|65168893|FG000|Overall Study|Lack of Efficacy|2|||
23389062|NCT01093534|65168894|FG001|Overall Study|Lack of Efficacy|1|||
23389063|NCT01093534|65168895|FG002|Overall Study|Lack of Efficacy|1|||
23389064|NCT01093534|65168893|FG000|Overall Study|Withdrawal by Subject|5|||
23389065|NCT01093534|65168894|FG001|Overall Study|Withdrawal by Subject|7|||
23389066|NCT01093534|65168895|FG002|Overall Study|Withdrawal by Subject|2|||
23389067|NCT01093534|65168893|FG000|Overall Study|Other|1|||
23389068|NCT01093534|65168894|FG001|Overall Study|Other|3|||
23389069|NCT01093534|65168895|FG002|Overall Study|Other|4|||
23389070|NCT03021005|65168902|FG000|Overall Study|Lost to Follow-up|39|||
23389071|NCT03021005|65168903|FG001|Overall Study|Lost to Follow-up|26|||
23389072|NCT02904265|65168904|FG000|Overall Study|Physician Decision|1|||
23389073|NCT02904265|65168905|FG001|Overall Study|Physician Decision|2|||
23389074|NCT02565186|65168913|FG000|Overall Study|Adverse Event|113|||
23389075|NCT02565186|65168914|FG001|Overall Study|Adverse Event|148|||
23389076|NCT02565186|65168913|FG000|Overall Study|Lost to Follow-up|102|||
23389077|NCT02565186|65168914|FG001|Overall Study|Lost to Follow-up|93|||
23389078|NCT02565186|65168913|FG000|Overall Study|Non-Compliance|57|||
23389079|NCT02565186|65168914|FG001|Overall Study|Non-Compliance|55|||
23389080|NCT02565186|65168913|FG000|Overall Study|Withdrawal by Subject|229|||
23389081|NCT02565186|65168914|FG001|Overall Study|Withdrawal by Subject|214|||
23389082|NCT02565186|65168913|FG000|Overall Study|Physician Decision|18|||
23494892|NCT00754065|65555021|FG001|Overall Study|Never received treatment|2|||
23389083|NCT02565186|65168914|FG001|Overall Study|Physician Decision|16|||
23389084|NCT02565186|65168913|FG000|Overall Study|Sponsor Request|5|||
23494893|NCT00754065|65555020|FG000|Overall Study|Adverse Event|19|||
23494894|NCT00754065|65555021|FG001|Overall Study|Adverse Event|25|||
23494895|NCT00754065|65555020|FG000|Overall Study|Lost to Follow-up|7|||
23494896|NCT00754065|65555021|FG001|Overall Study|Lost to Follow-up|11|||
23494897|NCT00754065|65555020|FG000|Overall Study|Protocol Violation|12|||
23494898|NCT00754065|65555021|FG001|Overall Study|Protocol Violation|10|||
23494899|NCT00754065|65555020|FG000|Overall Study|Withdrawal by Subject|4|||
23494900|NCT00754065|65555021|FG001|Overall Study|Withdrawal by Subject|5|||
23494901|NCT00754065|65555020|FG000|Overall Study|Pregnancy|6|||
23389085|NCT02565186|65168914|FG001|Overall Study|Sponsor Request|9|||
23389086|NCT02565186|65168913|FG000|Overall Study|Missing|1|||
23389087|NCT02565186|65168914|FG001|Overall Study|Missing|0|||
23389088|NCT02565186|65168913|FG000|Overall Study|Did Not Receive Study Drug|55|||
23389089|NCT02565186|65168914|FG001|Overall Study|Did Not Receive Study Drug|86|||
23389090|NCT00421408|65168917|FG000|Overall Study|Lost to Follow-up|30|||
23389091|NCT00421408|65168918|FG001|Overall Study|Lost to Follow-up|20|||
23389092|NCT00421408|65168917|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
23389093|NCT00421408|65168918|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
23389094|NCT01034657|65168921|FG000|Core Phase|Withdrawal by Subject|1|||
23389095|NCT01034657|65168922|FG001|Core Phase|Withdrawal by Subject|0|||
23389096|NCT01034657|65168923|FG002|Core Phase|Withdrawal by Subject|0|||
23389097|NCT01034657|65168921|FG000|Core Phase|Lack of Efficacy|2|||
23389098|NCT01034657|65168922|FG001|Core Phase|Lack of Efficacy|0|||
23389099|NCT01034657|65168923|FG002|Core Phase|Lack of Efficacy|0|||
23389100|NCT01034657|65168921|FG000|Core Phase|Abnormal laboratory value|1|||
23389101|NCT01034657|65168922|FG001|Core Phase|Abnormal laboratory value|0|||
23389102|NCT01034657|65168923|FG002|Core Phase|Abnormal laboratory value|0|||
23389103|NCT01034657|65168921|FG000|Core Phase|Adverse Event|8|||
23389104|NCT01034657|65168922|FG001|Core Phase|Adverse Event|0|||
23389105|NCT01034657|65168923|FG002|Core Phase|Adverse Event|0|||
23389106|NCT01034657|65168921|FG000|Core Phase|Protocol Violation|2|||
23389107|NCT01034657|65168922|FG001|Core Phase|Protocol Violation|0|||
23389108|NCT01034657|65168923|FG002|Core Phase|Protocol Violation|0|||
23389109|NCT01034657|65168921|FG000|Randomized Phase|Withdrawal by Subject|0|||
23389110|NCT01034657|65168922|FG001|Randomized Phase|Withdrawal by Subject|2|||
23389111|NCT01034657|65168923|FG002|Randomized Phase|Withdrawal by Subject|0|||
23389112|NCT01034657|65168921|FG000|Randomized Phase|Lack of Efficacy|5|||
23389113|NCT01034657|65168922|FG001|Randomized Phase|Lack of Efficacy|1|||
23389114|NCT01034657|65168923|FG002|Randomized Phase|Lack of Efficacy|0|||
23389115|NCT01034657|65168921|FG000|Randomized Phase|Abnormal laboratory value|0|||
23389116|NCT01034657|65168922|FG001|Randomized Phase|Abnormal laboratory value|1|||
23389117|NCT01034657|65168923|FG002|Randomized Phase|Abnormal laboratory value|0|||
23389118|NCT01034657|65168921|FG000|Randomized Phase|Adverse Event|0|||
23389119|NCT01034657|65168922|FG001|Randomized Phase|Adverse Event|2|||
23389120|NCT01034657|65168923|FG002|Randomized Phase|Adverse Event|1|||
23389121|NCT00432991|65168928|FG000|Overall Study|Protocol Violation|7|||
23389122|NCT00432991|65168929|FG001|Overall Study|Protocol Violation|12|||
23389123|NCT04691115|65168934|FG000|Overall Study|Withdrawal by Subject|0|||
23389124|NCT04691115|65168935|FG001|Overall Study|Withdrawal by Subject|0|||
23389125|NCT04691115|65168936|FG002|Overall Study|Withdrawal by Subject|0|||
23389126|NCT04691115|65168937|FG003|Overall Study|Withdrawal by Subject|0|||
23389127|NCT04691115|65168938|FG004|Overall Study|Withdrawal by Subject|0|||
23389128|NCT04691115|65168939|FG005|Overall Study|Withdrawal by Subject|1|||
23389129|NCT04691115|65168940|FG006|Overall Study|Withdrawal by Subject|0|||
23389130|NCT04691115|65168941|FG007|Overall Study|Withdrawal by Subject|0|||
23389131|NCT04691115|65168942|FG008|Overall Study|Withdrawal by Subject|0|||
23389132|NCT04691115|65168943|FG009|Overall Study|Withdrawal by Subject|0|||
23389133|NCT04691115|65168944|FG010|Overall Study|Withdrawal by Subject|0|||
23389134|NCT04691115|65168945|FG011|Overall Study|Withdrawal by Subject|0|||
23389135|NCT04691115|65168946|FG012|Overall Study|Withdrawal by Subject|0|||
23389136|NCT04691115|65168947|FG013|Overall Study|Withdrawal by Subject|0|||
23389137|NCT02412436|65168948|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
23389138|NCT02412436|65168948|FG000|Overall Study|Lost to Follow-up|6|||
23389139|NCT02412436|65168948|FG000|Overall Study|Unable to get to clinic|3|||
23389140|NCT02412436|65168948|FG000|Overall Study|Death|1|||
23389141|NCT02412436|65168948|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
23389142|NCT02852005|65168956|FG000|Overall Study|Lost to Follow-up|0|||
23389143|NCT02852005|65168957|FG001|Overall Study|Lost to Follow-up|0|||
23389144|NCT02852005|65168958|FG002|Overall Study|Lost to Follow-up|0|||
23389145|NCT02852005|65168959|FG003|Overall Study|Lost to Follow-up|0|||
23389146|NCT02852005|65168960|FG004|Overall Study|Lost to Follow-up|1|||
23389147|NCT02852005|65168956|FG000|Overall Study|Withdrawal by Subject|1|||
23389148|NCT02852005|65168957|FG001|Overall Study|Withdrawal by Subject|0|||
23389149|NCT02852005|65168958|FG002|Overall Study|Withdrawal by Subject|0|||
23389150|NCT02852005|65168959|FG003|Overall Study|Withdrawal by Subject|0|||
23389151|NCT02852005|65168960|FG004|Overall Study|Withdrawal by Subject|0|||
23389152|NCT00933166|65168961|FG000|Overall Study|Lost to Follow-up|4|||
23389153|NCT00933166|65168961|FG000|Overall Study|Lack of Efficacy|9|||
23389154|NCT00933166|65168961|FG000|Overall Study|Unavailable|4|||
23389155|NCT00933166|65168961|FG000|Overall Study|Withdrawal by Subject|1|||
23389156|NCT01848457|65168965|FG000|Overall Study|Death|1|||
23389157|NCT01848457|65168966|FG001|Overall Study|Death|0|||
23389158|NCT01848457|65168967|FG002|Overall Study|Death|0|||
23389159|NCT01848457|65168968|FG003|Overall Study|Death|0|||
23389160|NCT01682603|65168969|FG000|Overall Study|Lost to Follow-up|3|||
23389161|NCT02965456|65168973|FG000|Overall Study|Lost to Follow-up|40|||
23389162|NCT02965456|65168974|FG001|Overall Study|Lost to Follow-up|18|||
23389163|NCT02965456|65168973|FG000|Overall Study|Subject Request|22|||
23389164|NCT02965456|65168974|FG001|Overall Study|Subject Request|13|||
23389165|NCT02965456|65168973|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
23389166|NCT02965456|65168974|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
23389167|NCT02965456|65168973|FG000|Overall Study|Adverse Event|3|||
23389168|NCT02965456|65168974|FG001|Overall Study|Adverse Event|0|||
23389169|NCT02965456|65168973|FG000|Overall Study|Noncompliance with Study Drug|1|||
23389170|NCT02965456|65168974|FG001|Overall Study|Noncompliance with Study Drug|1|||
23389171|NCT02965456|65168973|FG000|Overall Study|Worsening Condition|0|||
23389172|NCT02965456|65168974|FG001|Overall Study|Worsening Condition|2|||
23389173|NCT02965456|65168973|FG000|Overall Study|Lack of Efficacy|1|||
23389174|NCT02965456|65168974|FG001|Overall Study|Lack of Efficacy|0|||
23389175|NCT02965456|65168973|FG000|Overall Study|Physician Decision|0|||
23389176|NCT02965456|65168974|FG001|Overall Study|Physician Decision|1|||
23389177|NCT02965456|65168973|FG000|Overall Study|Pregnancy|1|||
23389178|NCT02965456|65168974|FG001|Overall Study|Pregnancy|0|||
23389179|NCT02965456|65168973|FG000|Overall Study|Protocol Violation|0|||
23389180|NCT02965456|65168974|FG001|Overall Study|Protocol Violation|1|||
23389181|NCT02965456|65168973|FG000|Overall Study|Participant ran out of study drug|0|||
23389182|NCT02965456|65168974|FG001|Overall Study|Participant ran out of study drug|1|||
23389183|NCT00527748|65168977|FG000|Overall Study|Other|3|||
23389184|NCT03787212|65168978|FG000|Period 1|Study Termination|2|||
23389185|NCT03787212|65168979|FG001|Period 1|Study Termination|2|||
23389186|NCT03193437|65168980|FG000|Overall Study|Adverse Event|4|||
23389187|NCT03193437|65168980|FG000|Overall Study|Withdrawal by Subject|2|||
23389188|NCT03193437|65168980|FG000|Overall Study|Disease Progression|2|||
23389189|NCT04126174|65171643|FG000|Overall Study|Lost to Follow-up|3|||
23389190|NCT04126174|65171644|FG001|Overall Study|Lost to Follow-up|3|||
23389191|NCT01517178|65171645|FG000|Period 1|Adverse Event|1|||
23389192|NCT01517178|65171646|FG001|Period 1|Adverse Event|2|||
23389193|NCT01517178|65171645|FG000|Period 1|Lack of Efficacy|0|||
23389194|NCT01517178|65171646|FG001|Period 1|Lack of Efficacy|1|||
23389195|NCT01517178|65171645|FG000|Period 1|E.g. study termination|3|||
23389196|NCT01517178|65171646|FG001|Period 1|E.g. study termination|1|||
23389197|NCT01517178|65171645|FG000|Period 1|Withdrawal by Subject|0|||
23389198|NCT01517178|65171646|FG001|Period 1|Withdrawal by Subject|1|||
23389199|NCT01517178|65171645|FG000|Period 2|Adverse Event|1|||
23389200|NCT01517178|65171646|FG001|Period 2|Adverse Event|0|||
23389201|NCT01517178|65171645|FG000|Period 2|Withdrawal by Subject|3|||
23389202|NCT01517178|65171646|FG001|Period 2|Withdrawal by Subject|0|||
23389203|NCT01517178|65171645|FG000|Period 2|E.g. study termination|2|||
23389204|NCT01517178|65171646|FG001|Period 2|E.g. study termination|2|||
23389205|NCT05451329|65171647|FG000|Overall Study|Adverse Event|1|||
23389206|NCT05451329|65171648|FG001|Overall Study|Adverse Event|1|||
23494902|NCT00754065|65555021|FG001|Overall Study|Pregnancy|0|||
23389207|NCT05451329|65171649|FG002|Overall Study|Adverse Event|0|||
23389208|NCT05451329|65171647|FG000|Overall Study|Withdrawal by Subject|1|||
23389209|NCT05451329|65171648|FG001|Overall Study|Withdrawal by Subject|0|||
23389210|NCT05451329|65171649|FG002|Overall Study|Withdrawal by Subject|0|||
23389211|NCT05451329|65171647|FG000|Overall Study|Investigational Product Lot exchange|1|||
23389212|NCT05451329|65171648|FG001|Overall Study|Investigational Product Lot exchange|1|||
23389213|NCT05451329|65171649|FG002|Overall Study|Investigational Product Lot exchange|0|||
23389214|NCT00866775|65171650|FG000|Overall Study|Adverse Event|5|||
23389215|NCT00866775|65171651|FG001|Overall Study|Adverse Event|19|||
23389216|NCT00866775|65171650|FG000|Overall Study|Death|1|||
23389217|NCT00866775|65171651|FG001|Overall Study|Death|0|||
23389218|NCT00866775|65171650|FG000|Overall Study|Lost to Follow-up|0|||
23389219|NCT00866775|65171651|FG001|Overall Study|Lost to Follow-up|4|||
23389220|NCT00866775|65171650|FG000|Overall Study|Physician Decision|0|||
23389221|NCT00866775|65171651|FG001|Overall Study|Physician Decision|3|||
23389222|NCT00866775|65171650|FG000|Overall Study|Protocol Violation|3|||
23389223|NCT00866775|65171651|FG001|Overall Study|Protocol Violation|4|||
23389224|NCT00866775|65171650|FG000|Overall Study|Withdrawal by Subject|4|||
23389225|NCT00866775|65171651|FG001|Overall Study|Withdrawal by Subject|4|||
23389226|NCT00866775|65171650|FG000|Overall Study|met exit criteria|23|||
23389227|NCT00866775|65171651|FG001|Overall Study|met exit criteria|17|||
23389228|NCT00866775|65171650|FG000|Overall Study|discontinued due to communication error|0|||
23389229|NCT00866775|65171651|FG001|Overall Study|discontinued due to communication error|1|||
23389230|NCT01550965|65171652|FG000|Overall Study|Adverse Event|26|||
23389231|NCT01550965|65171652|FG000|Overall Study|Withdrawal by Subject|10|||
23389232|NCT01550965|65171652|FG000|Overall Study|Lost to Follow-up|2|||
23389233|NCT01550965|65171652|FG000|Overall Study|Lack of Efficacy|59|||
23389234|NCT01550965|65171652|FG000|Overall Study|Other|13|||
23389235|NCT03633058|65171653|FG000|Overall Study|Adverse Event|0|||
23389236|NCT03633058|65171654|FG001|Overall Study|Adverse Event|0|||
23389237|NCT03633058|65171655|FG002|Overall Study|Adverse Event|1|||
23389238|NCT03633058|65171656|FG003|Overall Study|Adverse Event|0|||
23389239|NCT00289978|65171657|FG000|Overall Study|Withdrawal by Subject|31|||
23389240|NCT00289978|65171658|FG001|Overall Study|Withdrawal by Subject|17|||
23389241|NCT00289978|65171659|FG002|Overall Study|Withdrawal by Subject|28|||
23389242|NCT00289978|65171657|FG000|Overall Study|Adverse Event|22|||
23389243|NCT00289978|65171658|FG001|Overall Study|Adverse Event|13|||
23389244|NCT00289978|65171659|FG002|Overall Study|Adverse Event|18|||
23389245|NCT00289978|65171657|FG000|Overall Study|Lack of Efficacy|13|||
23389246|NCT00289978|65171658|FG001|Overall Study|Lack of Efficacy|6|||
23389247|NCT00289978|65171659|FG002|Overall Study|Lack of Efficacy|25|||
23389248|NCT00289978|65171657|FG000|Overall Study|Abnormal laboratory value(s)|20|||
23299470|NCT04740931|64839854|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
23299471|NCT04740931|64839855|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
23299472|NCT04740931|64839854|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
23299473|NCT04740931|64839855|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
23299474|NCT04740931|64839854|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
23299475|NCT04740931|64839855|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
23299476|NCT04740931|64839854|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
23299477|NCT04740931|64839855|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
23299478|NCT04740931|64839854|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
23299479|NCT04740931|64839855|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
23299480|NCT04740931|64839854|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
23299481|NCT04740931|64839855|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
23299482|NCT04740931|64839854|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
23299483|NCT04740931|64839855|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
23299484|NCT04740931|64839854|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
23299485|NCT04740931|64839855|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
23299486|NCT04740931|64839854|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
23299487|NCT04740931|64839855|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
23299488|NCT04740931|64839854|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
23299489|NCT04740931|64839855|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
23299490|NCT04740931|64839854|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
23299491|NCT04740931|64839855|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
23299492|NCT04740931|64839854|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
23299493|NCT04740931|64839855|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
23299494|NCT04633642|64839858|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
23299495|NCT04633642|64839859|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
23299496|NCT00107042|64839860|FG000|Overall Study|Lost to Follow-up|9|||
23299497|NCT00107042|64839861|FG001|Overall Study|Lost to Follow-up|7|||
23299498|NCT00107042|64839860|FG000|Overall Study|Withdrawal by Subject|6|||
23299499|NCT00107042|64839861|FG001|Overall Study|Withdrawal by Subject|1|||
23299500|NCT00107042|64839860|FG000|Overall Study|Moved out of area|5|||
23299501|NCT00107042|64839861|FG001|Overall Study|Moved out of area|3|||
23389249|NCT00289978|65171658|FG001|Overall Study|Abnormal laboratory value(s)|9|||
23389250|NCT00289978|65171659|FG002|Overall Study|Abnormal laboratory value(s)|1|||
23389251|NCT00289978|65171657|FG000|Overall Study|Lost to Follow-up|3|||
23389252|NCT00289978|65171658|FG001|Overall Study|Lost to Follow-up|5|||
23389253|NCT00289978|65171659|FG002|Overall Study|Lost to Follow-up|7|||
23389254|NCT00289978|65171657|FG000|Overall Study|Protocol Violation|5|||
23389255|NCT00289978|65171658|FG001|Overall Study|Protocol Violation|5|||
23389256|NCT00289978|65171659|FG002|Overall Study|Protocol Violation|4|||
23389257|NCT00289978|65171657|FG000|Overall Study|Abnormal test procedure result(s)|2|||
23389258|NCT00289978|65171658|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23389259|NCT00289978|65171659|FG002|Overall Study|Abnormal test procedure result(s)|1|||
23389260|NCT00289978|65171657|FG000|Overall Study|Death|1|||
23389261|NCT00289978|65171658|FG001|Overall Study|Death|0|||
23389262|NCT00289978|65171659|FG002|Overall Study|Death|2|||
23389263|NCT00266032|65171663|FG000|Treatment|Adverse Event|42|||
23389264|NCT00266032|65171664|FG001|Treatment|Adverse Event|26|||
23389265|NCT00266032|65171665|FG002|Treatment|Adverse Event|10|||
23389266|NCT00266032|65171663|FG000|Treatment|Lost to Follow-up|19|||
23389267|NCT00266032|65171664|FG001|Treatment|Lost to Follow-up|4|||
23389268|NCT00266032|65171665|FG002|Treatment|Lost to Follow-up|2|||
23389269|NCT00266032|65171663|FG000|Treatment|Pregnancy|3|||
23389270|NCT00266032|65171664|FG001|Treatment|Pregnancy|2|||
23389271|NCT00266032|65171665|FG002|Treatment|Pregnancy|2|||
23389272|NCT00266032|65171663|FG000|Treatment|Protocol Violation|6|||
23389273|NCT00266032|65171664|FG001|Treatment|Protocol Violation|14|||
23389274|NCT00266032|65171665|FG002|Treatment|Protocol Violation|13|||
23389275|NCT00266032|65171663|FG000|Treatment|Withdrawal by Subject|28|||
23389276|NCT00266032|65171664|FG001|Treatment|Withdrawal by Subject|13|||
23389277|NCT00266032|65171665|FG002|Treatment|Withdrawal by Subject|12|||
23389278|NCT00266032|65171663|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
23389279|NCT00266032|65171664|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
23389280|NCT00266032|65171665|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
23389281|NCT00266032|65171663|FG000|Open-label Safety Extension|Adverse Event|5|||
23389282|NCT00266032|65171664|FG001|Open-label Safety Extension|Adverse Event|0|||
23389283|NCT00266032|65171665|FG002|Open-label Safety Extension|Adverse Event|4|||
23389284|NCT00266032|65171663|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
23389285|NCT00266032|65171664|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
23389286|NCT00266032|65171665|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
23389287|NCT00266032|65171663|FG000|Open-label Safety Extension|Pregnancy|4|||
23389288|NCT00266032|65171664|FG001|Open-label Safety Extension|Pregnancy|1|||
23389289|NCT00266032|65171665|FG002|Open-label Safety Extension|Pregnancy|2|||
23389290|NCT00266032|65171663|FG000|Open-label Safety Extension|Protocol Violation|1|||
23389291|NCT00266032|65171664|FG001|Open-label Safety Extension|Protocol Violation|3|||
23389292|NCT00266032|65171665|FG002|Open-label Safety Extension|Protocol Violation|2|||
23389293|NCT00266032|65171663|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
23389294|NCT00266032|65171664|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
23389295|NCT00266032|65171665|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
23389296|NCT00266032|65171663|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
23389297|NCT00266032|65171664|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
23389298|NCT00266032|65171665|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
23389299|NCT00545948|65171666|FG000|Overall Study|Not Treated|1|||
23389300|NCT00545948|65171667|FG001|Overall Study|Not Treated|1|||
23389301|NCT00545948|65171668|FG002|Overall Study|Not Treated|7|||
23389302|NCT05805150|65171672|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
23389303|NCT05805150|65171673|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
23389304|NCT03301415|65171677|FG000|Overall Study|Lost to Follow-up|2|||
23389305|NCT03301415|65171677|FG000|Overall Study|Unable to comply with visit schedule|2|||
23389306|NCT01421459|65171680|FG000|Overall Study|Adverse Event|6|||
23389307|NCT01421459|65171681|FG001|Overall Study|Adverse Event|10|||
23389308|NCT01421459|65171680|FG000|Overall Study|Death|1|||
23389309|NCT01421459|65171681|FG001|Overall Study|Death|1|||
23389310|NCT01421459|65171680|FG000|Overall Study|Lack of Efficacy|1|||
23389311|NCT01421459|65171681|FG001|Overall Study|Lack of Efficacy|2|||
23389312|NCT01421459|65171680|FG000|Overall Study|Lost to Follow-up|8|||
23389313|NCT01421459|65171681|FG001|Overall Study|Lost to Follow-up|9|||
23389314|NCT01421459|65171680|FG000|Overall Study|Physician Decision|9|||
23389315|NCT01421459|65171681|FG001|Overall Study|Physician Decision|9|||
23389316|NCT01421459|65171680|FG000|Overall Study|Protocol Violation|8|||
23389317|NCT01421459|65171681|FG001|Overall Study|Protocol Violation|5|||
23389318|NCT01421459|65171680|FG000|Overall Study|Withdrawal by Subject|12|||
23389319|NCT01421459|65171681|FG001|Overall Study|Withdrawal by Subject|16|||
23389320|NCT00392288|65171682|FG000|Overall Study|Adverse Event|17|||
23389321|NCT00392288|65171683|FG001|Overall Study|Adverse Event|7|||
23389322|NCT00392288|65171684|FG002|Overall Study|Adverse Event|8|||
23389323|NCT00392288|65171682|FG000|Overall Study|Lack of Efficacy|8|||
23389324|NCT00392288|65171683|FG001|Overall Study|Lack of Efficacy|5|||
23389325|NCT00392288|65171684|FG002|Overall Study|Lack of Efficacy|3|||
23389326|NCT00392288|65171682|FG000|Overall Study|Protocol Violation|1|||
23389327|NCT00392288|65171683|FG001|Overall Study|Protocol Violation|3|||
23389328|NCT00392288|65171684|FG002|Overall Study|Protocol Violation|1|||
23389329|NCT00392288|65171682|FG000|Overall Study|Lost to Follow-up|1|||
23389330|NCT00392288|65171683|FG001|Overall Study|Lost to Follow-up|1|||
23389331|NCT00392288|65171684|FG002|Overall Study|Lost to Follow-up|1|||
23389332|NCT00392288|65171682|FG000|Overall Study|Withdrawal by Subject|1|||
23389333|NCT00392288|65171683|FG001|Overall Study|Withdrawal by Subject|0|||
23389334|NCT00392288|65171684|FG002|Overall Study|Withdrawal by Subject|2|||
23389335|NCT00392288|65171682|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
23389336|NCT00392288|65171683|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
23389337|NCT00392288|65171684|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
23389338|NCT00392288|65171682|FG000|Overall Study|Other|3|||
23389339|NCT00392288|65171683|FG001|Overall Study|Other|4|||
23389340|NCT00392288|65171684|FG002|Overall Study|Other|1|||
23389341|NCT00003907|65171685|FG000|Overall Study|Adverse Event|2|||
23389342|NCT00003907|65171686|FG001|Overall Study|Adverse Event|11|||
23389343|NCT00003907|65171685|FG000|Overall Study|Death|2|||
23389344|NCT00003907|65171686|FG001|Overall Study|Death|0|||
23389345|NCT00003907|65171685|FG000|Overall Study|Withdrawal by Subject|1|||
23389346|NCT00003907|65171686|FG001|Overall Study|Withdrawal by Subject|3|||
23389347|NCT00003907|65171685|FG000|Overall Study|Progressive disease|4|||
23389348|NCT00003907|65171686|FG001|Overall Study|Progressive disease|4|||
23389349|NCT00003907|65171685|FG000|Overall Study|Complicating disease|1|||
23389350|NCT00003907|65171686|FG001|Overall Study|Complicating disease|0|||
23389351|NCT00003907|65171685|FG000|Overall Study|Other|1|||
23389352|NCT00003907|65171686|FG001|Overall Study|Other|3|||
23389353|NCT00003907|65171685|FG000|Overall Study|ineligible or not treated|2|||
23389354|NCT00003907|65171686|FG001|Overall Study|ineligible or not treated|2|||
23389355|NCT01773889|65171692|FG000|Overall Study|lack of funding|2|||
23389356|NCT01260311|65171693|FG000|Overall Study|Adverse Event|11|||
23389357|NCT01260311|65171693|FG000|Overall Study|Lack of Efficacy|4|||
23389358|NCT01260311|65171693|FG000|Overall Study|Lost to Follow-up|25|||
23389359|NCT01260311|65171693|FG000|Overall Study|Withdrawal by Subject|6|||
23389360|NCT01260311|65171693|FG000|Overall Study|Financial Constraints|77|||
23389361|NCT01260311|65171693|FG000|Overall Study|Gone to Province|2|||
23389362|NCT01260311|65171693|FG000|Overall Study|Medication Stopped|1|||
23389363|NCT01260311|65171693|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
23389364|NCT00461812|65171695|FG000|Overall Study|study terminated|10|||
23389365|NCT02715856|65171696|FG000|Overall Study|Software Issues|12|||
23494903|NCT00754065|65555020|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
23494904|NCT00754065|65555021|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
23389366|NCT02715856|65171697|FG001|Overall Study|Software Issues|7|||
23389367|NCT02715856|65171696|FG000|Overall Study|Death|6|||
23389368|NCT02715856|65171697|FG001|Overall Study|Death|5|||
23389369|NCT02715856|65171696|FG000|Overall Study|Non- Compliant|0|||
23389370|NCT02715856|65171697|FG001|Overall Study|Non- Compliant|40|||
23389371|NCT03382873|65171698|FG000|Overall Study|Lost to Follow-up|9|||
23389372|NCT03382873|65171699|FG001|Overall Study|Lost to Follow-up|10|||
23389373|NCT03382873|65171698|FG000|Overall Study|Withdrawal by Subject|6|||
23494905|NCT00668707|65555029|FG000|Overall Study|Cancer Recurrence|58|||
23389374|NCT03382873|65171699|FG001|Overall Study|Withdrawal by Subject|11|||
23389375|NCT03382873|65171698|FG000|Overall Study|Visit not completed due to pandemic|16|||
23389376|NCT03382873|65171699|FG001|Overall Study|Visit not completed due to pandemic|41|||
23389377|NCT03247673|65171700|FG000|Overall Study|Withdrawal by Subject|1|||
23389378|NCT03247673|65171701|FG001|Overall Study|Withdrawal by Subject|0|||
23389379|NCT03247673|65171702|FG002|Overall Study|Withdrawal by Subject|3|||
23389380|NCT03247673|65171700|FG000|Overall Study|Lost to Follow-up|0|||
23389381|NCT03247673|65171701|FG001|Overall Study|Lost to Follow-up|0|||
23389382|NCT03247673|65171702|FG002|Overall Study|Lost to Follow-up|1|||
23389383|NCT02544763|65171703|FG000|Overall Study|Adverse Event|8|||
23389384|NCT02544763|65171704|FG001|Overall Study|Adverse Event|8|||
23389385|NCT02544763|65171705|FG002|Overall Study|Adverse Event|0|||
23389386|NCT02544763|65171703|FG000|Overall Study|Withdrawn by parent/guardian|1|||
23389387|NCT02544763|65171704|FG001|Overall Study|Withdrawn by parent/guardian|1|||
23389388|NCT02544763|65171705|FG002|Overall Study|Withdrawn by parent/guardian|1|||
23389389|NCT02544763|65171703|FG000|Overall Study|Met withdrawal criteria|0|||
23389390|NCT02544763|65171704|FG001|Overall Study|Met withdrawal criteria|2|||
23389391|NCT02544763|65171705|FG002|Overall Study|Met withdrawal criteria|0|||
23389392|NCT02544763|65171703|FG000|Overall Study|Physician Decision|0|||
23389393|NCT02544763|65171704|FG001|Overall Study|Physician Decision|1|||
23389394|NCT02544763|65171705|FG002|Overall Study|Physician Decision|0|||
23389395|NCT02544763|65171703|FG000|Overall Study|Difficulties taking IMP|1|||
23389396|NCT02544763|65171704|FG001|Overall Study|Difficulties taking IMP|0|||
23389397|NCT02544763|65171705|FG002|Overall Study|Difficulties taking IMP|0|||
23389398|NCT00309946|65171711|FG000|Overall Study|Withdrawal by Subject|1|||
23389399|NCT02336555|65171718|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
23389400|NCT02336555|65171719|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
23389401|NCT02336555|65171718|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
23389402|NCT02336555|65171719|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
23389403|NCT02336555|65171718|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
23389404|NCT02336555|65171719|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
23389405|NCT01104870|65171720|FG000|Overall Study|Adverse Event|1|||
23389406|NCT01104870|65171721|FG001|Overall Study|Adverse Event|1|||
23389407|NCT01104870|65171722|FG002|Overall Study|Adverse Event|0|||
23389408|NCT01104870|65171720|FG000|Overall Study|Death|0|||
23389409|NCT01104870|65171721|FG001|Overall Study|Death|0|||
23389410|NCT01104870|65171722|FG002|Overall Study|Death|1|||
23389411|NCT01104870|65171720|FG000|Overall Study|Withdrawal by Subject|0|||
23389412|NCT01104870|65171721|FG001|Overall Study|Withdrawal by Subject|0|||
23389413|NCT01104870|65171722|FG002|Overall Study|Withdrawal by Subject|1|||
23389414|NCT05069415|65171725|FG000|Overall Study|Withdrawal by Subject|2|||
23389415|NCT05069415|65171726|FG001|Overall Study|Withdrawal by Subject|0|||
23389416|NCT05069415|65171725|FG000|Overall Study|Adverse Event|2|||
23389417|NCT05069415|65171726|FG001|Overall Study|Adverse Event|0|||
23389418|NCT00480025|65171727|FG000|Overall Study|Protocol Violation|12|||
23389419|NCT00480025|65171728|FG001|Overall Study|Protocol Violation|7|||
23389420|NCT00480025|65171727|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
23389421|NCT00480025|65171728|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
23389422|NCT00480025|65171727|FG000|Overall Study|Disease Progression / Recurrence|449|||
23389423|NCT00480025|65171728|FG001|Overall Study|Disease Progression / Recurrence|224|||
23389424|NCT00480025|65171727|FG000|Overall Study|Adverse Event|44|||
23389425|NCT00480025|65171728|FG001|Overall Study|Adverse Event|12|||
23389426|NCT00480025|65171727|FG000|Overall Study|Other|70|||
23389427|NCT00480025|65171728|FG001|Overall Study|Other|29|||
23389428|NCT00480025|65171727|FG000|Overall Study|SAE including intercurrent illness|76|||
23389429|NCT00480025|65171728|FG001|Overall Study|SAE including intercurrent illness|42|||
23389430|NCT02904096|65171729|FG000|Overall Study|Adverse Event|1|||
23389431|NCT02904096|65171730|FG001|Overall Study|Adverse Event|0|||
23389432|NCT02904096|65171729|FG000|Overall Study|Withdrawal by Subject|4|||
23389433|NCT02904096|65171730|FG001|Overall Study|Withdrawal by Subject|3|||
23389434|NCT02904096|65171729|FG000|Overall Study|Lost to Follow-up|10|||
23389435|NCT02904096|65171730|FG001|Overall Study|Lost to Follow-up|17|||
23389436|NCT02904096|65171729|FG000|Overall Study|Non-compliant|3|||
23389437|NCT02904096|65171730|FG001|Overall Study|Non-compliant|1|||
23389438|NCT02904096|65171729|FG000|Overall Study|Sponsor instructed|1|||
23389439|NCT02904096|65171730|FG001|Overall Study|Sponsor instructed|0|||
23389440|NCT00397046|65171731|FG000|Overall Study|Disease Progression|3|||
23389441|NCT00397046|65171732|FG001|Overall Study|Disease Progression|3|||
23389442|NCT00397046|65171733|FG002|Overall Study|Disease Progression|10|||
23389443|NCT00397046|65171734|FG003|Overall Study|Disease Progression|5|||
23389444|NCT00692237|65171735|FG000|Overall Study|Withdrawal by Subject|1|||
23389445|NCT00692237|65171736|FG001|Overall Study|Withdrawal by Subject|3|||
23389446|NCT00692237|65171735|FG000|Overall Study|Adverse Event|0|||
23389447|NCT00692237|65171736|FG001|Overall Study|Adverse Event|1|||
23389448|NCT02217982|65171737|FG000|Overall Study|Trial discontinued|1|||
23389449|NCT02217982|65171738|FG001|Overall Study|Trial discontinued|0|||
23389450|NCT02217982|65171737|FG000|Overall Study|Adverse Event|0|||
23389451|NCT02217982|65171738|FG001|Overall Study|Adverse Event|1|||
23389452|NCT01027754|65171746|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
23389453|NCT01027754|65171747|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
23389454|NCT01027754|65171746|FG000|Overall Study|Withdrawal by Subject|0|||
23389455|NCT01027754|65171747|FG001|Overall Study|Withdrawal by Subject|5|||
23389456|NCT05524948|65171748|FG000|Overall Study|Withdrawal by Subject|1|||
23389457|NCT05524948|65171749|FG001|Overall Study|Withdrawal by Subject|0|||
23389458|NCT05524948|65171748|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
23389459|NCT05524948|65171749|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
23389460|NCT00773461|65171750|FG000|Overall Study|Adverse Event|1|||
23389461|NCT00773461|65171751|FG001|Overall Study|Adverse Event|3|||
23389462|NCT00773461|65171750|FG000|Overall Study|Withdrawal by Subject|4|||
23389463|NCT00773461|65171751|FG001|Overall Study|Withdrawal by Subject|1|||
23389464|NCT01608308|65171752|FG000|Overall Study|pretreatment medical and billing reasons|0|||
23389465|NCT01608308|65171753|FG001|Overall Study|pretreatment medical and billing reasons|2|||
23389466|NCT01832038|65171756|FG000|Overall Study|Death|5|||
23389467|NCT01832038|65171756|FG000|Overall Study|Adverse Event|50|||
23389468|NCT01832038|65171756|FG000|Overall Study|Lack of Efficacy|81|||
23389469|NCT01832038|65171756|FG000|Overall Study|Protocol Violation|7|||
23389470|NCT01832038|65171756|FG000|Overall Study|Lost to Follow-up|10|||
23389471|NCT01832038|65171756|FG000|Overall Study|Withdrawal by Subject|49|||
23389472|NCT01832038|65171756|FG000|Overall Study|Visit non-compliance|2|||
23389473|NCT01832038|65171756|FG000|Overall Study|Subject refused to return visit|2|||
23389474|NCT01832038|65171756|FG000|Overall Study|Not convenient to come back to site|2|||
23389475|NCT01832038|65171756|FG000|Overall Study|Participant was asked to quit|5|||
23389476|NCT01832038|65171756|FG000|Overall Study|Back home|1|||
23389477|NCT01832038|65171756|FG000|Overall Study|Pregnancy|1|||
23389478|NCT01832038|65171756|FG000|Overall Study|Low compliance|3|||
23389479|NCT01832038|65171756|FG000|Overall Study|Prohibit procedure|2|||
23389480|NCT01832038|65171756|FG000|Overall Study|Not possible to visit the hospital|1|||
23389481|NCT01832038|65171756|FG000|Overall Study|Changes of implementation system|3|||
23389482|NCT01832038|65171756|FG000|Overall Study|Plan to pregnancy|7|||
23389483|NCT01832038|65171756|FG000|Overall Study|Bad mood and has suicidal thought|1|||
23389484|NCT01832038|65171756|FG000|Overall Study|Prohibited concomitant medication|1|||
23389485|NCT01832038|65171756|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
23389486|NCT01832038|65171756|FG000|Overall Study|Subject considered the efficacy was poor|1|||
23389487|NCT01629563|65171757|FG000|Overall Study|Adverse Event|16|||
23389488|NCT01629563|65171758|FG001|Overall Study|Adverse Event|16|||
23389489|NCT01629563|65171757|FG000|Overall Study|Death|2|||
23389490|NCT01629563|65171758|FG001|Overall Study|Death|0|||
23389491|NCT01629563|65171757|FG000|Overall Study|Lack of Efficacy|2|||
23389492|NCT01629563|65171758|FG001|Overall Study|Lack of Efficacy|3|||
23389493|NCT01629563|65171757|FG000|Overall Study|Lost to Follow-up|1|||
23389494|NCT01629563|65171758|FG001|Overall Study|Lost to Follow-up|0|||
23389495|NCT01629563|65171757|FG000|Overall Study|Pregnancy|1|||
23389496|NCT01629563|65171758|FG001|Overall Study|Pregnancy|2|||
23389497|NCT01629563|65171757|FG000|Overall Study|Protocol Violation|0|||
23389498|NCT01629563|65171758|FG001|Overall Study|Protocol Violation|1|||
23389499|NCT01629563|65171757|FG000|Overall Study|Withdrawal by Subject|27|||
23389500|NCT01629563|65171758|FG001|Overall Study|Withdrawal by Subject|20|||
23389501|NCT01629563|65171757|FG000|Overall Study|surgery|0|||
23389502|NCT01629563|65171758|FG001|Overall Study|surgery|3|||
23389503|NCT01629563|65171757|FG000|Overall Study|Lack of return of menses|12|||
23389504|NCT01629563|65171758|FG001|Overall Study|Lack of return of menses|7|||
23389505|NCT01629563|65171757|FG000|Overall Study|Protocol Violation|0|||
23389506|NCT01629563|65171758|FG001|Overall Study|Protocol Violation|1|||
23389507|NCT00903344|65171760|FG000|Overall Study|Pregnancy|2|||
23389508|NCT00903344|65171761|FG001|Overall Study|Pregnancy|3|||
23389509|NCT00903344|65171760|FG000|Overall Study|Lost to Follow-up|3|||
23389510|NCT00903344|65171761|FG001|Overall Study|Lost to Follow-up|0|||
23389511|NCT01248468|65171762|FG000|Overall Study|Administrative problem|1|||
23389512|NCT01248468|65171763|FG001|Overall Study|Administrative problem|0|||
23389513|NCT01248468|65171764|FG002|Overall Study|Administrative problem|0|||
23389514|NCT01248468|65171762|FG000|Overall Study|Lost to Follow-up|9|||
23389515|NCT01248468|65171763|FG001|Overall Study|Lost to Follow-up|12|||
23389516|NCT01248468|65171764|FG002|Overall Study|Lost to Follow-up|4|||
23389517|NCT01248468|65171762|FG000|Overall Study|Pregnancy|1|||
23389518|NCT01248468|65171763|FG001|Overall Study|Pregnancy|0|||
23389519|NCT01248468|65171764|FG002|Overall Study|Pregnancy|0|||
23389520|NCT01248468|65171762|FG000|Overall Study|Withdrawal by Subject|4|||
23389521|NCT01248468|65171763|FG001|Overall Study|Withdrawal by Subject|2|||
23389522|NCT01248468|65171764|FG002|Overall Study|Withdrawal by Subject|0|||
23389523|NCT02093520|65171765|FG000|Overall Study|Not treated|6|||
23389524|NCT02093520|65171766|FG001|Overall Study|Not treated|22|||
23389525|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
23389526|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
23389527|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
23389528|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
23389529|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
23389530|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
23389531|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
23389532|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
23389533|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
23389534|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
23389535|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
23389536|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
23389537|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
23389538|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
23389539|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
23389540|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
23389541|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
23389542|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
23389543|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
23389544|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
23389545|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
23389546|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
23389547|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
23389548|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
23389549|NCT01272219|65171767|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
23389550|NCT01272219|65171768|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
23389551|NCT01272219|65171769|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
23389552|NCT01272219|65171770|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
23389553|NCT01272219|65171771|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
23389554|NCT01272219|65171772|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
23389555|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
23389556|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
23389557|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
23389558|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
23389559|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
23389560|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
23389561|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23389562|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23299502|NCT00107042|64839860|FG000|Overall Study|Pregnancy|1|||
23299503|NCT00107042|64839861|FG001|Overall Study|Pregnancy|1|||
23299504|NCT00107042|64839860|FG000|Overall Study|Inadvertent enrollment|0|||
23389563|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23389564|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
23389565|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23389566|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
23389567|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
23389568|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
23389569|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
23389570|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
23389571|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
23389572|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
23389573|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
23389574|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
23389575|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
23389576|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
23389577|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
23389578|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
23389579|NCT01272219|65171767|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
23389580|NCT01272219|65171768|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
23389581|NCT01272219|65171769|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
23389582|NCT01272219|65171770|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
23389583|NCT01272219|65171771|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
23389584|NCT01272219|65171772|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
23389585|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
23389586|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
23389587|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
23389588|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
23389589|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
23389590|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
23389591|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
23389592|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
23389593|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
23389594|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
23389595|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
23389596|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
23389597|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
23389598|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
23389599|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
23389600|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
23389601|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
23389602|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
23389603|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
23389604|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
23389605|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
23389606|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
23389607|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
23299505|NCT00107042|64839861|FG001|Overall Study|Inadvertent enrollment|1|||
23299506|NCT00107042|64839860|FG000|Overall Study|vaccinated outside window|1|||
23299507|NCT00107042|64839861|FG001|Overall Study|vaccinated outside window|1|||
23299508|NCT00107042|64839860|FG000|Overall Study|Disallowed medications|0|||
23299509|NCT00107042|64839861|FG001|Overall Study|Disallowed medications|2|||
23299510|NCT01568866|64839862|FG000|Overall Study|Disease Progression|208|||
23299511|NCT01568866|64839863|FG001|Overall Study|Disease Progression|183|||
23299512|NCT01568866|64839862|FG000|Overall Study|Adverse Event|94|||
23299513|NCT01568866|64839863|FG001|Overall Study|Adverse Event|96|||
23299514|NCT01568866|64839862|FG000|Overall Study|Patient Request|55|||
23299515|NCT01568866|64839863|FG001|Overall Study|Patient Request|71|||
23299516|NCT01568866|64839862|FG000|Overall Study|Physician Decision|40|||
23299517|NCT01568866|64839863|FG001|Overall Study|Physician Decision|32|||
23299518|NCT01568866|64839862|FG000|Overall Study|Withdrawal by Subject|19|||
23299519|NCT01568866|64839863|FG001|Overall Study|Withdrawal by Subject|11|||
23299520|NCT01568866|64839862|FG000|Overall Study|Death|10|||
23389608|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
23389609|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
23389610|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
23389611|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
23389612|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
23389613|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
23389614|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
23389615|NCT01272219|65171767|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
23389616|NCT01272219|65171768|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
23389617|NCT01272219|65171769|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
23389618|NCT01272219|65171770|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
23389619|NCT01272219|65171771|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
23389620|NCT01272219|65171772|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
23389621|NCT02579759|65171774|FG000|Overall Study|Protocol Violation|2|||
23389622|NCT02579759|65171775|FG001|Overall Study|Protocol Violation|0|||
23389623|NCT02579759|65171776|FG002|Overall Study|Protocol Violation|0|||
23389624|NCT02579759|65171774|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
23389625|NCT02579759|65171775|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
23389626|NCT02579759|65171776|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
23299521|NCT01568866|64839863|FG001|Overall Study|Death|18|||
23299522|NCT01568866|64839862|FG000|Overall Study|Protocol Non-compliance|2|||
23299523|NCT01568866|64839863|FG001|Overall Study|Protocol Non-compliance|4|||
23299524|NCT01568866|64839862|FG000|Overall Study|Lost to Follow-up|1|||
23299525|NCT01568866|64839863|FG001|Overall Study|Lost to Follow-up|0|||
23299526|NCT01568866|64839862|FG000|Overall Study|Randomized but Not Dosed|9|||
23299527|NCT01568866|64839863|FG001|Overall Study|Randomized but Not Dosed|1|||
23389627|NCT02579759|65171774|FG000|Overall Study|BfArM hold|13|||
23389628|NCT02579759|65171775|FG001|Overall Study|BfArM hold|12|||
23389629|NCT02579759|65171776|FG002|Overall Study|BfArM hold|12|||
23389630|NCT02579759|65171774|FG000|Overall Study|Sponsor stopped Dose 2|0|||
23389631|NCT02579759|65171775|FG001|Overall Study|Sponsor stopped Dose 2|41|||
23389632|NCT02579759|65171776|FG002|Overall Study|Sponsor stopped Dose 2|0|||
23389633|NCT02579759|65171774|FG000|Overall Study|Non compliance|0|||
23389634|NCT02579759|65171775|FG001|Overall Study|Non compliance|1|||
23389635|NCT02579759|65171776|FG002|Overall Study|Non compliance|0|||
23389636|NCT02579759|65171774|FG000|Overall Study|Pregnancy|0|||
23389637|NCT02579759|65171775|FG001|Overall Study|Pregnancy|1|||
23389638|NCT02579759|65171776|FG002|Overall Study|Pregnancy|0|||
23389639|NCT02579759|65171774|FG000|Overall Study|Inclusion/exclusion criteria|0|||
23389640|NCT02579759|65171775|FG001|Overall Study|Inclusion/exclusion criteria|0|||
23389641|NCT02579759|65171776|FG002|Overall Study|Inclusion/exclusion criteria|1|||
23389642|NCT02579759|65171774|FG000|Overall Study|Adverse Event|4|||
23389643|NCT02579759|65171775|FG001|Overall Study|Adverse Event|3|||
23389644|NCT02579759|65171776|FG002|Overall Study|Adverse Event|1|||
23389645|NCT02579759|65171774|FG000|Overall Study|Withdrawal by Subject|3|||
23389646|NCT02579759|65171775|FG001|Overall Study|Withdrawal by Subject|3|||
23389647|NCT02579759|65171776|FG002|Overall Study|Withdrawal by Subject|5|||
23389648|NCT02579759|65171774|FG000|Overall Study|Lost to Follow-up|2|||
23389649|NCT02579759|65171775|FG001|Overall Study|Lost to Follow-up|2|||
23389650|NCT02579759|65171776|FG002|Overall Study|Lost to Follow-up|2|||
23389651|NCT00449787|65171777|FG000|Overall Study|Lost to Follow-up|10|||
23389652|NCT00449787|65171778|FG001|Overall Study|Lost to Follow-up|8|||
23389653|NCT00449787|65171777|FG000|Overall Study|Did not require medication|95|||
23389654|NCT00449787|65171778|FG001|Overall Study|Did not require medication|92|||
23389655|NCT01546987|65171779|FG000|Overall Study|Protocol Violation|3|||
23389656|NCT01546987|65171780|FG001|Overall Study|Protocol Violation|4|||
23389657|NCT01309100|65171781|FG000|Overall Study|Protocol Violation|1|||
23389658|NCT01309100|65171781|FG000|Overall Study|Positive Slit lamp finding|1|||
23389659|NCT02038647|65171783|FG000|Overall Study|Progressive Disease|50|||
23389660|NCT02038647|65171784|FG001|Overall Study|Progressive Disease|59|||
23389661|NCT02038647|65171783|FG000|Overall Study|Adverse Event|18|||
23389662|NCT02038647|65171784|FG001|Overall Study|Adverse Event|10|||
23389663|NCT02038647|65171783|FG000|Overall Study|Symptomatic Deterioration|7|||
23389664|NCT02038647|65171784|FG001|Overall Study|Symptomatic Deterioration|7|||
23389665|NCT02038647|65171783|FG000|Overall Study|Withdrawal by Subject|5|||
23389666|NCT02038647|65171784|FG001|Overall Study|Withdrawal by Subject|2|||
23389667|NCT02038647|65171783|FG000|Overall Study|Not Reported|0|||
23389668|NCT02038647|65171784|FG001|Overall Study|Not Reported|1|||
23389669|NCT02038647|65171783|FG000|Overall Study|Ongoing at Datacut|9|||
23389670|NCT02038647|65171784|FG001|Overall Study|Ongoing at Datacut|10|||
23389671|NCT05626686|65171785|FG000|Overall Study|Protocol Violation|3|||
23299528|NCT01790113|64839865|FG000|Overall Study|Adverse Event|2|||
23299529|NCT01790113|64839866|FG001|Overall Study|Adverse Event|7|||
23299530|NCT01790113|64839865|FG000|Overall Study|Study ended due to FDA clearance|1|||
23299531|NCT01790113|64839866|FG001|Overall Study|Study ended due to FDA clearance|68|||
23299532|NCT04920916|64839867|FG000|Phase IIa 60 Day Study|Death|2|||
23389672|NCT05626686|65171785|FG000|Overall Study|Withdrawal by Subject|3|||
23389673|NCT00128492|65171791|FG000|Overall Study|AE unrelated to study|2|||
23299533|NCT04920916|64839868|FG001|Phase IIa 60 Day Study|Death|5|||
23299534|NCT04920916|64839867|FG000|1 Year Follow up (Phone Call)|Death|1|||
23299535|NCT04920916|64839868|FG001|1 Year Follow up (Phone Call)|Death|3|||
23299536|NCT04920916|64839867|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
23389674|NCT00128492|65171792|FG001|Overall Study|AE unrelated to study|9|||
23389675|NCT00128492|65171791|FG000|Overall Study|Study drug intolerance (AE)|2|||
23389676|NCT00128492|65171792|FG001|Overall Study|Study drug intolerance (AE)|8|||
23389677|NCT00128492|65171791|FG000|Overall Study|AE related to study|1|||
23389678|NCT00128492|65171792|FG001|Overall Study|AE related to study|4|||
23389679|NCT00128492|65171791|FG000|Overall Study|Death|1|||
23389680|NCT00128492|65171792|FG001|Overall Study|Death|0|||
23389681|NCT00128492|65171791|FG000|Overall Study|Lost to Follow-up|1|||
23389682|NCT00128492|65171792|FG001|Overall Study|Lost to Follow-up|5|||
23389683|NCT00128492|65171791|FG000|Overall Study|Noncompliance|0|||
23389684|NCT00128492|65171792|FG001|Overall Study|Noncompliance|5|||
23389685|NCT00128492|65171791|FG000|Overall Study|Personal or administrative|10|||
23389686|NCT00128492|65171792|FG001|Overall Study|Personal or administrative|22|||
23389687|NCT00128492|65171791|FG000|Overall Study|Withdrawal by Subject|3|||
23389688|NCT00128492|65171792|FG001|Overall Study|Withdrawal by Subject|5|||
23389689|NCT00128492|65171791|FG000|Overall Study|Pregnancy|0|||
23389690|NCT00128492|65171792|FG001|Overall Study|Pregnancy|1|||
23494906|NCT00668707|65555030|FG001|Overall Study|Cancer Recurrence|58|||
23494907|NCT00668707|65555029|FG000|Overall Study|Withdrawal by Subject|117|||
23494908|NCT00668707|65555030|FG001|Overall Study|Withdrawal by Subject|100|||
23494909|NCT00668707|65555029|FG000|Overall Study|Lost to Follow-up|3|||
23494910|NCT00668707|65555030|FG001|Overall Study|Lost to Follow-up|6|||
23494911|NCT00668707|65555029|FG000|Overall Study|Protocol Violation|10|||
23494912|NCT00668707|65555030|FG001|Overall Study|Protocol Violation|12|||
23494913|NCT00668707|65555029|FG000|Overall Study|Death|11|||
23494914|NCT00668707|65555030|FG001|Overall Study|Death|4|||
23494915|NCT03758443|65555031|FG000|Induction Period|Adverse Event|2|||
23494916|NCT03758443|65555032|FG001|Induction Period|Adverse Event|4|||
23494917|NCT03758443|65555033|FG002|Induction Period|Adverse Event|2|||
23494918|NCT03758443|65555034|FG003|Induction Period|Adverse Event|3|||
23494919|NCT03758443|65555031|FG000|Induction Period|Physician Decision|1|||
23494920|NCT03758443|65555032|FG001|Induction Period|Physician Decision|1|||
23389691|NCT03111108|65171793|FG000|Overall Study|Death|0|||
23389692|NCT03111108|65171794|FG001|Overall Study|Death|1|||
23389693|NCT03111108|65171793|FG000|Overall Study|Withdrawal by Subject|1|||
23494921|NCT03758443|65555033|FG002|Induction Period|Physician Decision|3|||
23494922|NCT03758443|65555034|FG003|Induction Period|Physician Decision|0|||
23494923|NCT03758443|65555031|FG000|Induction Period|Protocol Violation|0|||
23494924|NCT03758443|65555032|FG001|Induction Period|Protocol Violation|0|||
23494925|NCT03758443|65555033|FG002|Induction Period|Protocol Violation|0|||
23494926|NCT03758443|65555034|FG003|Induction Period|Protocol Violation|1|||
23299537|NCT04920916|64839868|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
23299538|NCT00731549|64839869|FG000|Overall Study|Lost to Follow-up|19|||
23299539|NCT00731549|64839869|FG000|Overall Study|Met withdrawal criteria|24|||
23299540|NCT00731549|64839869|FG000|Overall Study|Physician Decision|16|||
23299541|NCT00731549|64839869|FG000|Overall Study|Withdrawal by Subject|89|||
23299542|NCT00731549|64839869|FG000|Overall Study|Protocol deviation|1|||
23299543|NCT00731549|64839869|FG000|Overall Study|Adverse Event|31|||
23299544|NCT00731549|64839869|FG000|Overall Study|Lack of efficacy with AE|37|||
23299545|NCT00731549|64839869|FG000|Overall Study|Lack of efficacy without AE|6|||
23299546|NCT02201290|64839872|FG000|Overall Study|Withdrawal by Subject|2|||
23299547|NCT02201290|64839872|FG000|Overall Study|Lack of Efficacy|2|||
23299548|NCT02201290|64839872|FG000|Overall Study|Adverse Event|1|||
23299549|NCT00573170|64839873|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
23299550|NCT00573170|64839874|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
23299551|NCT00573170|64839875|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
23299552|NCT00573170|64839876|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
23299553|NCT00573170|64839877|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
23389694|NCT03111108|65171794|FG001|Overall Study|Withdrawal by Subject|0|||
23494927|NCT03758443|65555031|FG000|Induction Period|Withdrawal by Subject|3|||
23494928|NCT03758443|65555032|FG001|Induction Period|Withdrawal by Subject|2|||
23494929|NCT03758443|65555033|FG002|Induction Period|Withdrawal by Subject|2|||
23299554|NCT00573170|64839878|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
23299555|NCT00573170|64839873|FG000|First Washout Period|Adverse Event|1|||
23494930|NCT03758443|65555034|FG003|Induction Period|Withdrawal by Subject|4|||
23494931|NCT03758443|65555031|FG000|Extended Induction Period|Adverse Event|1|||
23494932|NCT03758443|65555032|FG001|Extended Induction Period|Adverse Event|1|||
23494933|NCT03758443|65555033|FG002|Extended Induction Period|Adverse Event|0|||
23494934|NCT03758443|65555034|FG003|Extended Induction Period|Adverse Event|1|||
23494935|NCT03758443|65555031|FG000|Extended Induction Period|Lost to Follow-up|1|||
23494936|NCT03758443|65555032|FG001|Extended Induction Period|Lost to Follow-up|0|||
23494937|NCT03758443|65555033|FG002|Extended Induction Period|Lost to Follow-up|0|||
23494938|NCT03758443|65555034|FG003|Extended Induction Period|Lost to Follow-up|0|||
23494939|NCT03758443|65555031|FG000|Extended Induction Period|Physician Decision|2|||
23494940|NCT03758443|65555032|FG001|Extended Induction Period|Physician Decision|1|||
23494941|NCT03758443|65555033|FG002|Extended Induction Period|Physician Decision|2|||
23494942|NCT03758443|65555034|FG003|Extended Induction Period|Physician Decision|2|||
23494943|NCT03758443|65555031|FG000|Extended Induction Period|Protocol Violation|0|||
23494944|NCT03758443|65555032|FG001|Extended Induction Period|Protocol Violation|0|||
23494945|NCT03758443|65555033|FG002|Extended Induction Period|Protocol Violation|0|||
23494946|NCT03758443|65555034|FG003|Extended Induction Period|Protocol Violation|1|||
23494947|NCT03758443|65555031|FG000|Extended Induction Period|Withdrawal by Subject|8|||
23389695|NCT00203242|65171795|FG000|Overall Study|Lost to Follow-up|1|||
23389696|NCT01959919|65171797|FG000|Overall Study|Did not meet the eligibility criteria|2|||
23389697|NCT02741193|65171798|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
23389698|NCT02741193|65171798|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
23389699|NCT02011542|65171800|FG000|Overall Study|Physician Decision|1|||
23389700|NCT04309500|65171801|FG000|Overall Study|Lost to Follow-up|1|||
23389701|NCT04309500|65171802|FG001|Overall Study|Lost to Follow-up|0|||
23389702|NCT04309500|65171803|FG002|Overall Study|Lost to Follow-up|0|||
23389703|NCT04309500|65171804|FG003|Overall Study|Lost to Follow-up|0|||
23389704|NCT02940223|65171805|FG000|Overall Study|Failed Requirement|2|||
23389705|NCT02940223|65171806|FG001|Overall Study|Failed Requirement|0|||
23389706|NCT00004228|65171807|FG000|Overall Study|Adverse Event|0|||
23389707|NCT00004228|65171808|FG001|Overall Study|Adverse Event|1|||
23389708|NCT00004228|65171809|FG002|Overall Study|Adverse Event|0|||
23389709|NCT00004228|65171810|FG003|Overall Study|Adverse Event|0|||
23389710|NCT00004228|65171811|FG004|Overall Study|Adverse Event|1|||
23389711|NCT00004228|65171812|FG005|Overall Study|Adverse Event|0|||
23389712|NCT00004228|65171813|FG006|Overall Study|Adverse Event|0|||
23389713|NCT00004228|65171807|FG000|Overall Study|Death|0|||
23389714|NCT00004228|65171808|FG001|Overall Study|Death|1|||
23389715|NCT00004228|65171809|FG002|Overall Study|Death|2|||
23389716|NCT00004228|65171810|FG003|Overall Study|Death|0|||
23389717|NCT00004228|65171811|FG004|Overall Study|Death|1|||
23389718|NCT00004228|65171812|FG005|Overall Study|Death|0|||
23389719|NCT00004228|65171813|FG006|Overall Study|Death|0|||
23389720|NCT00004228|65171807|FG000|Overall Study|Lack of Efficacy|1|||
23389721|NCT00004228|65171808|FG001|Overall Study|Lack of Efficacy|6|||
23389722|NCT00004228|65171809|FG002|Overall Study|Lack of Efficacy|5|||
23389723|NCT00004228|65171810|FG003|Overall Study|Lack of Efficacy|3|||
23389724|NCT00004228|65171811|FG004|Overall Study|Lack of Efficacy|9|||
23389725|NCT00004228|65171812|FG005|Overall Study|Lack of Efficacy|8|||
23389726|NCT00004228|65171813|FG006|Overall Study|Lack of Efficacy|4|||
23389727|NCT00004228|65171807|FG000|Overall Study|Lost to Follow-up|0|||
23389728|NCT00004228|65171808|FG001|Overall Study|Lost to Follow-up|0|||
23389729|NCT00004228|65171809|FG002|Overall Study|Lost to Follow-up|1|||
23389730|NCT00004228|65171810|FG003|Overall Study|Lost to Follow-up|0|||
23389731|NCT00004228|65171811|FG004|Overall Study|Lost to Follow-up|0|||
23389732|NCT00004228|65171812|FG005|Overall Study|Lost to Follow-up|0|||
23389733|NCT00004228|65171813|FG006|Overall Study|Lost to Follow-up|0|||
23389734|NCT00004228|65171807|FG000|Overall Study|Physician Decision|1|||
23389735|NCT00004228|65171808|FG001|Overall Study|Physician Decision|0|||
23389736|NCT00004228|65171809|FG002|Overall Study|Physician Decision|3|||
23494948|NCT03758443|65555032|FG001|Extended Induction Period|Withdrawal by Subject|1|||
23494949|NCT03758443|65555033|FG002|Extended Induction Period|Withdrawal by Subject|7|||
23494950|NCT03758443|65555034|FG003|Extended Induction Period|Withdrawal by Subject|3|||
23494951|NCT03758443|65555031|FG000|Extended Induction Period|Miscellaneous|1|||
23494952|NCT03758443|65555032|FG001|Extended Induction Period|Miscellaneous|0|||
23494953|NCT03758443|65555033|FG002|Extended Induction Period|Miscellaneous|0|||
23389737|NCT00004228|65171810|FG003|Overall Study|Physician Decision|2|||
23389738|NCT00004228|65171811|FG004|Overall Study|Physician Decision|1|||
23389739|NCT00004228|65171812|FG005|Overall Study|Physician Decision|1|||
23389740|NCT00004228|65171813|FG006|Overall Study|Physician Decision|1|||
23389741|NCT00004228|65171807|FG000|Overall Study|Protocol Violation|0|||
23389742|NCT00004228|65171808|FG001|Overall Study|Protocol Violation|5|||
23389743|NCT00004228|65171809|FG002|Overall Study|Protocol Violation|2|||
23389744|NCT00004228|65171810|FG003|Overall Study|Protocol Violation|1|||
23389745|NCT00004228|65171811|FG004|Overall Study|Protocol Violation|1|||
23494954|NCT03758443|65555034|FG003|Extended Induction Period|Miscellaneous|0|||
23494955|NCT03758443|65555031|FG000|Maintenance Period|Adverse Event|1|||
23494956|NCT03758443|65555032|FG001|Maintenance Period|Adverse Event|2|||
23389746|NCT00004228|65171812|FG005|Overall Study|Protocol Violation|2|||
23389747|NCT00004228|65171813|FG006|Overall Study|Protocol Violation|0|||
23389748|NCT00004228|65171807|FG000|Overall Study|Withdrawal by Subject|3|||
23389749|NCT00004228|65171808|FG001|Overall Study|Withdrawal by Subject|0|||
23389750|NCT00004228|65171809|FG002|Overall Study|Withdrawal by Subject|1|||
23389751|NCT00004228|65171810|FG003|Overall Study|Withdrawal by Subject|0|||
23389752|NCT00004228|65171811|FG004|Overall Study|Withdrawal by Subject|2|||
23389753|NCT00004228|65171812|FG005|Overall Study|Withdrawal by Subject|1|||
23389754|NCT00004228|65171813|FG006|Overall Study|Withdrawal by Subject|2|||
23389755|NCT00004228|65171807|FG000|Overall Study|Other|0|||
23389756|NCT00004228|65171808|FG001|Overall Study|Other|0|||
23389757|NCT00004228|65171809|FG002|Overall Study|Other|1|||
23389758|NCT00004228|65171810|FG003|Overall Study|Other|0|||
23389759|NCT00004228|65171811|FG004|Overall Study|Other|0|||
23389760|NCT00004228|65171812|FG005|Overall Study|Other|0|||
23299556|NCT00573170|64839874|FG001|First Washout Period|Adverse Event|1|||
23299557|NCT00573170|64839875|FG002|First Washout Period|Adverse Event|0|||
23299558|NCT00573170|64839876|FG003|First Washout Period|Adverse Event|0|||
23299559|NCT00573170|64839877|FG004|First Washout Period|Adverse Event|0|||
23299560|NCT00573170|64839878|FG005|First Washout Period|Adverse Event|1|||
23299561|NCT00573170|64839873|FG000|First Washout Period|Lack of Efficacy|0|||
23299562|NCT00573170|64839874|FG001|First Washout Period|Lack of Efficacy|0|||
23299563|NCT00573170|64839875|FG002|First Washout Period|Lack of Efficacy|0|||
23299564|NCT00573170|64839876|FG003|First Washout Period|Lack of Efficacy|0|||
23299565|NCT00573170|64839877|FG004|First Washout Period|Lack of Efficacy|0|||
23299566|NCT00573170|64839878|FG005|First Washout Period|Lack of Efficacy|1|||
23299567|NCT00573170|64839873|FG000|First Washout Period|Lost to Follow-up|1|||
23299568|NCT00573170|64839874|FG001|First Washout Period|Lost to Follow-up|1|||
23299569|NCT00573170|64839875|FG002|First Washout Period|Lost to Follow-up|0|||
23299570|NCT00573170|64839876|FG003|First Washout Period|Lost to Follow-up|2|||
23299571|NCT00573170|64839877|FG004|First Washout Period|Lost to Follow-up|0|||
23299572|NCT00573170|64839878|FG005|First Washout Period|Lost to Follow-up|2|||
23299573|NCT00573170|64839873|FG000|First Washout Period|Withdrawal by Subject|2|||
23299574|NCT00573170|64839874|FG001|First Washout Period|Withdrawal by Subject|0|||
23299575|NCT00573170|64839875|FG002|First Washout Period|Withdrawal by Subject|0|||
23299576|NCT00573170|64839876|FG003|First Washout Period|Withdrawal by Subject|2|||
23299577|NCT00573170|64839877|FG004|First Washout Period|Withdrawal by Subject|3|||
23299578|NCT00573170|64839878|FG005|First Washout Period|Withdrawal by Subject|3|||
23299579|NCT00573170|64839873|FG000|First Washout Period|Other|4|||
23299580|NCT00573170|64839874|FG001|First Washout Period|Other|0|||
23299581|NCT00573170|64839875|FG002|First Washout Period|Other|1|||
23299582|NCT00573170|64839876|FG003|First Washout Period|Other|1|||
23299583|NCT00573170|64839877|FG004|First Washout Period|Other|0|||
23299584|NCT00573170|64839878|FG005|First Washout Period|Other|0|||
23299585|NCT00573170|64839873|FG000|Second Washout Period|Adverse Event|1|||
23299586|NCT00573170|64839874|FG001|Second Washout Period|Adverse Event|0|||
23299587|NCT00573170|64839875|FG002|Second Washout Period|Adverse Event|0|||
23299588|NCT00573170|64839876|FG003|Second Washout Period|Adverse Event|0|||
23299589|NCT00573170|64839877|FG004|Second Washout Period|Adverse Event|1|||
23299590|NCT00573170|64839878|FG005|Second Washout Period|Adverse Event|0|||
23299591|NCT00573170|64839873|FG000|Second Washout Period|Protocol Violation|2|||
23299592|NCT00573170|64839874|FG001|Second Washout Period|Protocol Violation|1|||
23299593|NCT00573170|64839875|FG002|Second Washout Period|Protocol Violation|1|||
23299594|NCT00573170|64839876|FG003|Second Washout Period|Protocol Violation|0|||
23299595|NCT00573170|64839877|FG004|Second Washout Period|Protocol Violation|0|||
23299596|NCT00573170|64839878|FG005|Second Washout Period|Protocol Violation|0|||
23299597|NCT00573170|64839873|FG000|Second Washout Period|Withdrawal by Subject|1|||
23299598|NCT00573170|64839874|FG001|Second Washout Period|Withdrawal by Subject|1|||
23299599|NCT00573170|64839875|FG002|Second Washout Period|Withdrawal by Subject|2|||
23299600|NCT00573170|64839876|FG003|Second Washout Period|Withdrawal by Subject|0|||
23299601|NCT00573170|64839877|FG004|Second Washout Period|Withdrawal by Subject|1|||
23299602|NCT00573170|64839878|FG005|Second Washout Period|Withdrawal by Subject|0|||
23299603|NCT00573170|64839873|FG000|Second Washout Period|Lost to Follow-up|0|||
23299604|NCT00573170|64839874|FG001|Second Washout Period|Lost to Follow-up|0|||
23299605|NCT00573170|64839875|FG002|Second Washout Period|Lost to Follow-up|0|||
23299606|NCT00573170|64839876|FG003|Second Washout Period|Lost to Follow-up|1|||
23299607|NCT00573170|64839877|FG004|Second Washout Period|Lost to Follow-up|0|||
23389761|NCT00004228|65171813|FG006|Overall Study|Other|0|||
23389762|NCT00004228|65171807|FG000|Overall Study|ineligible|4|||
23494957|NCT03758443|65555033|FG002|Maintenance Period|Adverse Event|0|||
23494958|NCT03758443|65555034|FG003|Maintenance Period|Adverse Event|0|||
23494959|NCT03758443|65555031|FG000|Maintenance Period|Lost to Follow-up|0|||
23494960|NCT03758443|65555032|FG001|Maintenance Period|Lost to Follow-up|0|||
23494961|NCT03758443|65555033|FG002|Maintenance Period|Lost to Follow-up|0|||
23494962|NCT03758443|65555034|FG003|Maintenance Period|Lost to Follow-up|1|||
23494963|NCT03758443|65555031|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
23494964|NCT03758443|65555032|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
23494965|NCT03758443|65555033|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
23494966|NCT03758443|65555034|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
23494967|NCT03758443|65555031|FG000|Maintenance Period|Protocol Violation|0|||
23494968|NCT03758443|65555032|FG001|Maintenance Period|Protocol Violation|1|||
23494969|NCT03758443|65555033|FG002|Maintenance Period|Protocol Violation|0|||
23494970|NCT03758443|65555034|FG003|Maintenance Period|Protocol Violation|0|||
23494971|NCT03758443|65555031|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
23494972|NCT03758443|65555032|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
23389763|NCT00004228|65171808|FG001|Overall Study|ineligible|2|||
23389764|NCT00004228|65171809|FG002|Overall Study|ineligible|4|||
23389765|NCT00004228|65171810|FG003|Overall Study|ineligible|1|||
23389766|NCT00004228|65171811|FG004|Overall Study|ineligible|1|||
23389767|NCT00004228|65171812|FG005|Overall Study|ineligible|2|||
23389768|NCT00004228|65171813|FG006|Overall Study|ineligible|5|||
23389769|NCT03810365|65171816|FG000|Overall Study|Lost to Follow-up|2|||
23389770|NCT03810365|65171817|FG001|Overall Study|Lost to Follow-up|2|||
23389771|NCT03810365|65171816|FG000|Overall Study|Withdrawal by Subject|4|||
23389772|NCT03810365|65171817|FG001|Overall Study|Withdrawal by Subject|5|||
23389773|NCT01044459|65171818|FG000|Overall Study|Withdrawal by Subject|21|||
23389774|NCT01044459|65171819|FG001|Overall Study|Withdrawal by Subject|28|||
23389775|NCT01044459|65171818|FG000|Overall Study|Terminated by Sponsor|22|||
23389776|NCT01044459|65171819|FG001|Overall Study|Terminated by Sponsor|21|||
23389777|NCT01044459|65171818|FG000|Overall Study|Adverse Event|22|||
23389778|NCT01044459|65171819|FG001|Overall Study|Adverse Event|20|||
23389779|NCT01044459|65171818|FG000|Overall Study|Lack of Efficacy|23|||
23389780|NCT01044459|65171819|FG001|Overall Study|Lack of Efficacy|12|||
23389781|NCT01044459|65171818|FG000|Overall Study|Protocol Violation|11|||
23389782|NCT01044459|65171819|FG001|Overall Study|Protocol Violation|16|||
23389783|NCT01044459|65171818|FG000|Overall Study|Other Reason|7|||
23389784|NCT01044459|65171819|FG001|Overall Study|Other Reason|14|||
23389785|NCT01044459|65171818|FG000|Overall Study|COPD exacerbation|9|||
23389786|NCT01044459|65171819|FG001|Overall Study|COPD exacerbation|8|||
23494973|NCT03758443|65555033|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
23494974|NCT03758443|65555034|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
23299608|NCT00573170|64839878|FG005|Second Washout Period|Lost to Follow-up|0|||
23299609|NCT00573170|64839873|FG000|Second Washout Period|Other|1|||
23299610|NCT00573170|64839874|FG001|Second Washout Period|Other|2|||
23299611|NCT00573170|64839875|FG002|Second Washout Period|Other|1|||
23299612|NCT00573170|64839876|FG003|Second Washout Period|Other|4|||
23299613|NCT00573170|64839877|FG004|Second Washout Period|Other|6|||
23299614|NCT00573170|64839878|FG005|Second Washout Period|Other|2|||
23299615|NCT00573170|64839873|FG000|Third Treatment Period|Withdrawal by Subject|1|||
23299616|NCT00573170|64839874|FG001|Third Treatment Period|Withdrawal by Subject|0|||
23299617|NCT00573170|64839875|FG002|Third Treatment Period|Withdrawal by Subject|0|||
23299618|NCT00573170|64839876|FG003|Third Treatment Period|Withdrawal by Subject|0|||
23494975|NCT03758443|65555031|FG000|Maintenance Period|Withdrawal by Subject|1|||
23494976|NCT03758443|65555032|FG001|Maintenance Period|Withdrawal by Subject|0|||
23299619|NCT00573170|64839877|FG004|Third Treatment Period|Withdrawal by Subject|0|||
23389787|NCT01044459|65171818|FG000|Overall Study|Lost to Follow-up|18|||
23389788|NCT01044459|65171819|FG001|Overall Study|Lost to Follow-up|12|||
23389789|NCT00787800|65171820|FG000|Overall Study|Withdrawal by Subject|3|||
23389790|NCT00787800|65171821|FG001|Overall Study|Withdrawal by Subject|5|||
23389791|NCT00787800|65171820|FG000|Overall Study|Death|0|||
23389792|NCT00787800|65171821|FG001|Overall Study|Death|2|||
23389793|NCT03160573|65171822|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
23389794|NCT03160573|65171823|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
23389795|NCT03160573|65171824|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
23389796|NCT03160573|65171825|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
23389797|NCT00124657|65171826|FG000|Overall Study|Toxicity|0|||
23389798|NCT00124657|65171827|FG001|Overall Study|Toxicity|0|||
23389799|NCT00124657|65171828|FG002|Overall Study|Toxicity|1|||
23389800|NCT00124657|65171826|FG000|Overall Study|Non-compliance|1|||
23389801|NCT00124657|65171827|FG001|Overall Study|Non-compliance|0|||
23389802|NCT00124657|65171828|FG002|Overall Study|Non-compliance|4|||
23389803|NCT00124657|65171826|FG000|Overall Study|Progressive disease|14|||
23389804|NCT00124657|65171827|FG001|Overall Study|Progressive disease|5|||
23389805|NCT00124657|65171828|FG002|Overall Study|Progressive disease|27|||
23389806|NCT00124657|65171826|FG000|Overall Study|Intercurrent illness|1|||
23389807|NCT00124657|65171827|FG001|Overall Study|Intercurrent illness|0|||
23389808|NCT00124657|65171828|FG002|Overall Study|Intercurrent illness|0|||
23389809|NCT04204902|65171829|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
23389810|NCT04204902|65171830|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
23389811|NCT04642079|65171833|FG000|Overall Study|Lost to Follow-up|2|||
23389812|NCT04642079|65171834|FG001|Overall Study|Lost to Follow-up|5|||
23389813|NCT04642079|65171835|FG002|Overall Study|Lost to Follow-up|2|||
23389814|NCT04642079|65171836|FG003|Overall Study|Lost to Follow-up|0|||
23389815|NCT04642079|65171833|FG000|Overall Study|Withdrawal by Subject|0|||
23389816|NCT04642079|65171834|FG001|Overall Study|Withdrawal by Subject|4|||
23389817|NCT04642079|65171835|FG002|Overall Study|Withdrawal by Subject|1|||
23389818|NCT04642079|65171836|FG003|Overall Study|Withdrawal by Subject|2|||
23389819|NCT04642079|65171833|FG000|Overall Study|Other|0|||
23389820|NCT04642079|65171834|FG001|Overall Study|Other|0|||
23389821|NCT04642079|65171835|FG002|Overall Study|Other|0|||
23389822|NCT04642079|65171836|FG003|Overall Study|Other|1|||
23389823|NCT04642079|65171833|FG000|Overall Study|No longer met eligibility criteria|1|||
23389824|NCT04642079|65171834|FG001|Overall Study|No longer met eligibility criteria|0|||
23389825|NCT04642079|65171835|FG002|Overall Study|No longer met eligibility criteria|1|||
23389826|NCT04642079|65171836|FG003|Overall Study|No longer met eligibility criteria|1|||
23389827|NCT01687595|65171837|FG000|Overall Study|Withdrawal by Subject|8|||
23389828|NCT01687595|65171838|FG001|Overall Study|Withdrawal by Subject|0|||
23389829|NCT01687595|65171837|FG000|Overall Study|Lost to Follow-up|3|||
23389830|NCT01687595|65171838|FG001|Overall Study|Lost to Follow-up|1|||
23389831|NCT01687595|65171837|FG000|Overall Study|Investigator's decision|1|||
23389832|NCT01687595|65171838|FG001|Overall Study|Investigator's decision|0|||
23389833|NCT01687595|65171837|FG000|Overall Study|Sponsor's decision|1|||
23389834|NCT01687595|65171838|FG001|Overall Study|Sponsor's decision|0|||
23389835|NCT01687595|65171837|FG000|Overall Study|Noncompliance|1|||
23389836|NCT01687595|65171838|FG001|Overall Study|Noncompliance|2|||
23389837|NCT01687595|65171837|FG000|Overall Study|Other than specified|56|||
23389838|NCT01687595|65171838|FG001|Overall Study|Other than specified|7|||
23389839|NCT01084135|65171839|FG000|20 Week|Physician Decision|0|||
23389840|NCT01084135|65171840|FG001|20 Week|Physician Decision|1|||
23389841|NCT02595437|65171841|FG000|Triferic Via IV|Withdrawal by Subject|1|||
23389842|NCT02094885|65171842|FG000|Overall Study|Death|1|||
23389843|NCT02094885|65171843|FG001|Overall Study|Death|5|||
23389844|NCT02094885|65171842|FG000|Overall Study|Withdrawn due to age|1|||
23389845|NCT02094885|65171843|FG001|Overall Study|Withdrawn due to age|0|||
23389846|NCT05333965|65171856|FG000|First Intervention|Adverse Event|0|||
23389847|NCT05333965|65171857|FG001|First Intervention|Adverse Event|1|||
23389848|NCT05333965|65171856|FG000|First Intervention|Withdrawal by Subject|0|||
23494977|NCT03758443|65555033|FG002|Maintenance Period|Withdrawal by Subject|1|||
23494978|NCT03758443|65555034|FG003|Maintenance Period|Withdrawal by Subject|1|||
23299620|NCT00573170|64839878|FG005|Third Treatment Period|Withdrawal by Subject|0|||
23299621|NCT00573170|64839873|FG000|Third Treatment Period|Lost to Follow-up|0|||
23299622|NCT00573170|64839874|FG001|Third Treatment Period|Lost to Follow-up|0|||
23299623|NCT00573170|64839875|FG002|Third Treatment Period|Lost to Follow-up|0|||
23299624|NCT00573170|64839876|FG003|Third Treatment Period|Lost to Follow-up|0|||
23299625|NCT00573170|64839877|FG004|Third Treatment Period|Lost to Follow-up|0|||
23299626|NCT00573170|64839878|FG005|Third Treatment Period|Lost to Follow-up|2|||
23299627|NCT01005329|64839880|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
23299628|NCT04568031|64839881|FG000|Overall Study|Lost to Follow-up|1|||
23299629|NCT04568031|64839882|FG001|Overall Study|Lost to Follow-up|0|||
23299630|NCT04568031|64839883|FG002|Overall Study|Lost to Follow-up|0|||
23299631|NCT04568031|64839884|FG003|Overall Study|Lost to Follow-up|0|||
23299632|NCT04568031|64839881|FG000|Overall Study|Physician Decision|1|||
23299633|NCT04568031|64839882|FG001|Overall Study|Physician Decision|0|||
23299634|NCT04568031|64839883|FG002|Overall Study|Physician Decision|1|||
23299635|NCT04568031|64839884|FG003|Overall Study|Physician Decision|0|||
23299636|NCT04568031|64839881|FG000|Overall Study|Withdrawal by Subject|1|||
23299637|NCT04568031|64839882|FG001|Overall Study|Withdrawal by Subject|0|||
23299638|NCT04568031|64839883|FG002|Overall Study|Withdrawal by Subject|4|||
23299639|NCT04568031|64839884|FG003|Overall Study|Withdrawal by Subject|1|||
23299640|NCT02370914|64839891|FG000|Overall Study|Protocol Violation|2|||
23299641|NCT02556307|64839892|FG000|Overall Study|Premature treatment interruption|11|||
23299642|NCT02556307|64839892|FG000|Overall Study|Lost to Follow-up|36|||
23299643|NCT02556307|64839892|FG000|Overall Study|Change to triple therapy|4|||
23299644|NCT02556307|64839892|FG000|Overall Study|Enrolled but not treated|2|||
23299645|NCT01560507|64839893|FG000|Overall Study|Lost to Follow-up|3|||
23299646|NCT01560507|64839894|FG001|Overall Study|Lost to Follow-up|1|||
23299647|NCT01560507|64839895|FG002|Overall Study|Lost to Follow-up|2|||
23299648|NCT01560507|64839893|FG000|Overall Study|Withdrawal by Subject|1|||
23299649|NCT01560507|64839894|FG001|Overall Study|Withdrawal by Subject|1|||
23299650|NCT01560507|64839895|FG002|Overall Study|Withdrawal by Subject|0|||
23299651|NCT03827564|64839900|FG000|Overall Study|Discontinued due to Study Termination|1|||
23299652|NCT03827564|64839901|FG001|Overall Study|Discontinued due to Study Termination|0|||
23299653|NCT01917968|64839907|FG000|Overall Study|Death|3|||
23299654|NCT01917968|64839908|FG001|Overall Study|Death|2|||
23299655|NCT01917968|64839907|FG000|Overall Study|Lost to Follow-up|21|||
23299656|NCT01917968|64839908|FG001|Overall Study|Lost to Follow-up|39|||
23494979|NCT03758443|65555031|FG000|Maintenance Period|Miscellaneous|0|||
23494980|NCT03758443|65555032|FG001|Maintenance Period|Miscellaneous|0|||
23299657|NCT01917968|64839907|FG000|Overall Study|Physician Decision|1|||
23494981|NCT03758443|65555033|FG002|Maintenance Period|Miscellaneous|1|||
23299658|NCT01917968|64839908|FG001|Overall Study|Physician Decision|2|||
23299659|NCT01917968|64839907|FG000|Overall Study|Withdrawal by Subject|20|||
23299660|NCT01917968|64839908|FG001|Overall Study|Withdrawal by Subject|35|||
23299661|NCT01917968|64839907|FG000|Overall Study|Subject Relocation|5|||
23299662|NCT01917968|64839908|FG001|Overall Study|Subject Relocation|1|||
23299663|NCT01917968|64839907|FG000|Overall Study|36M Missed Visit|3|||
23299664|NCT01917968|64839908|FG001|Overall Study|36M Missed Visit|2|||
23299665|NCT01917968|64839907|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
23299666|NCT01917968|64839908|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
23299667|NCT01917968|64839907|FG000|Overall Study|Change in Family Circumstances|0|||
23299668|NCT01917968|64839908|FG001|Overall Study|Change in Family Circumstances|1|||
23299669|NCT01917968|64839907|FG000|Overall Study|No Data Available|0|||
23299670|NCT01917968|64839908|FG001|Overall Study|No Data Available|2|||
23299671|NCT01124695|64839909|FG000|Overall Study|Disease progression|77|||
23299672|NCT01124695|64839909|FG000|Overall Study|Adverse Event|11|||
23299673|NCT01124695|64839909|FG000|Overall Study|Death|1|||
23299674|NCT01124695|64839909|FG000|Overall Study|Withdrawal by Subject|7|||
23299675|NCT01124695|64839909|FG000|Overall Study|Physician Decision|3|||
23299676|NCT01124695|64839909|FG000|Overall Study|Alternative therapy|9|||
23299677|NCT01124695|64839909|FG000|Overall Study|No documentation that patient went off treatment|4|||
23389849|NCT05333965|65171857|FG001|First Intervention|Withdrawal by Subject|1|||
23389850|NCT02771145|65171858|FG000|Overall Study|Adverse Event|3|||
23389851|NCT02771145|65171858|FG000|Overall Study|Lost to Follow-up|1|||
23389852|NCT04157738|65171861|FG000|Overall Study|Moved out of state|0|||
23389853|NCT04157738|65171862|FG001|Overall Study|Moved out of state|2|||
23389854|NCT04157738|65171861|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
23389855|NCT04157738|65171862|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
23606128|NCT00614614|65947151|FG003|Booster Vaccination Phase|Protocol Violation|3|||
23389857|NCT00564070|65171866|FG000|Overall Study|Lost to Follow-up|9|||
23389858|NCT00564070|65171867|FG001|Overall Study|Lost to Follow-up|7|||
23389859|NCT00564070|65171866|FG000|Overall Study|Worsening depression, referred to care|3|||
23389860|NCT00564070|65171867|FG001|Overall Study|Worsening depression, referred to care|0|||
23389861|NCT00756444|65171874|FG000|Overall Study|Adverse Event|1|||
23389862|NCT00756444|65171875|FG001|Overall Study|Adverse Event|1|||
23389863|NCT00756444|65171874|FG000|Overall Study|Withdrawal by Subject|6|||
23389864|NCT00756444|65171875|FG001|Overall Study|Withdrawal by Subject|8|||
23389865|NCT00756444|65171874|FG000|Overall Study|Lost to Follow-up|0|||
23389866|NCT00756444|65171875|FG001|Overall Study|Lost to Follow-up|1|||
23389867|NCT00756444|65171874|FG000|Overall Study|Death|5|||
23389868|NCT00756444|65171875|FG001|Overall Study|Death|4|||
23389869|NCT00756444|65171874|FG000|Overall Study|Disease Progression|2|||
23389870|NCT00756444|65171875|FG001|Overall Study|Disease Progression|7|||
23389871|NCT00756444|65171874|FG000|Overall Study|Ineligibility Determined|1|||
23389872|NCT00756444|65171875|FG001|Overall Study|Ineligibility Determined|0|||
23389873|NCT02991859|65171876|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389874|NCT02991859|65171877|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
23389875|NCT02991859|65171878|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389876|NCT02991859|65171879|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389877|NCT02991859|65171880|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
23389878|NCT02991859|65171881|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389879|NCT02991859|65171882|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389880|NCT02991859|65171883|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389881|NCT02991859|65171884|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389882|NCT02991859|65171885|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389883|NCT02991859|65171886|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389884|NCT02991859|65171887|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389885|NCT02991859|65171888|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389886|NCT02991859|65171889|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389887|NCT02991859|65171890|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389888|NCT02991859|65171891|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389889|NCT02991859|65171892|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
23389890|NCT02991859|65171876|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389891|NCT02991859|65171877|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23606129|NCT00614614|65947152|FG004|Booster Vaccination Phase|Protocol Violation|0|||
23606130|NCT00614614|65947148|FG000|Booster Vaccination Phase|Other|0|||
23606131|NCT00614614|65947149|FG001|Booster Vaccination Phase|Other|1|||
23606132|NCT00614614|65947150|FG002|Booster Vaccination Phase|Other|3|||
23606133|NCT00614614|65947151|FG003|Booster Vaccination Phase|Other|2|||
23606134|NCT00614614|65947152|FG004|Booster Vaccination Phase|Other|1|||
23606135|NCT00641537|65947155|FG000|96-week Period|Adverse Event|0|||
23606136|NCT00641537|65947156|FG001|96-week Period|Adverse Event|1|||
23606137|NCT00641537|65947157|FG002|96-week Period|Adverse Event|3|||
23606138|NCT00641537|65947158|FG003|96-week Period|Adverse Event|0|||
23606139|NCT00641537|65947159|FG004|96-week Period|Adverse Event|2|||
23606140|NCT00641537|65947160|FG005|96-week Period|Adverse Event|0|||
23606141|NCT00641537|65947161|FG006|96-week Period|Adverse Event|0|||
23606142|NCT00641537|65947162|FG007|96-week Period|Adverse Event|0|||
23606143|NCT00641537|65947155|FG000|96-week Period|Lost to Follow-up|3|||
23606144|NCT00641537|65947156|FG001|96-week Period|Lost to Follow-up|1|||
23606145|NCT00641537|65947157|FG002|96-week Period|Lost to Follow-up|2|||
23606146|NCT00641537|65947158|FG003|96-week Period|Lost to Follow-up|2|||
23606147|NCT00641537|65947159|FG004|96-week Period|Lost to Follow-up|4|||
23606148|NCT00641537|65947160|FG005|96-week Period|Lost to Follow-up|0|||
23606149|NCT00641537|65947161|FG006|96-week Period|Lost to Follow-up|1|||
23494982|NCT03758443|65555034|FG003|Maintenance Period|Miscellaneous|0|||
23494983|NCT00983437|65555035|FG000|Overall Study|Adverse Event|9|||
23494984|NCT00983437|65555035|FG000|Overall Study|Lack of Efficacy|1|||
23494985|NCT00983437|65555035|FG000|Overall Study|Withdrawal by Subject|8|||
23494986|NCT00983437|65555035|FG000|Overall Study|Noncompliance to Study Procedures|1|||
23494987|NCT00983437|65555035|FG000|Overall Study|Lost to Follow-up|2|||
23494988|NCT00983437|65555035|FG000|Overall Study|Other Reason|26|||
23494989|NCT00287365|65555036|FG000|Overall Study|sample not acquired|13|||
23299678|NCT01124695|64839909|FG000|Overall Study|Ineligible|9|||
23299679|NCT01124695|64839909|FG000|Overall Study|Ineligible and never start treatment|2|||
23299680|NCT01298778|64839919|FG000|Overall Study|Lost to Follow-up|2|||
23299681|NCT01298778|64839920|FG001|Overall Study|Lost to Follow-up|3|||
23299682|NCT01298778|64839919|FG000|Overall Study|Incorrect use of VAS|1|||
23299683|NCT01298778|64839920|FG001|Overall Study|Incorrect use of VAS|0|||
23299684|NCT01298778|64839919|FG000|Overall Study|Withdrawal by Subject|0|||
23299685|NCT01298778|64839920|FG001|Overall Study|Withdrawal by Subject|1|||
23299686|NCT01298778|64839919|FG000|Overall Study|Protocol Violation|0|||
23299687|NCT01298778|64839920|FG001|Overall Study|Protocol Violation|1|||
23299688|NCT01298778|64839919|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
23299689|NCT01298778|64839920|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
23299690|NCT02470091|64839924|FG000|Overall Study|Withdrawal by Subject|1|||
23299691|NCT02470091|64839925|FG001|Overall Study|Withdrawal by Subject|0|||
23299692|NCT02470091|64839924|FG000|Overall Study|Ineligible|0|||
23299693|NCT02470091|64839925|FG001|Overall Study|Ineligible|2|||
23299694|NCT00788593|64839926|FG000|Placebo Run-in Phase|Adverse Event|2|||
23299695|NCT00788593|64839927|FG001|Placebo Run-in Phase|Adverse Event|0|||
23299696|NCT00788593|64839928|FG002|Placebo Run-in Phase|Adverse Event|0|||
23299697|NCT00788593|64839926|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
23299698|NCT00788593|64839927|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
23299699|NCT00788593|64839928|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
23299700|NCT00788593|64839926|FG000|Placebo Run-in Phase|Protocol Violation|2|||
23299701|NCT00788593|64839927|FG001|Placebo Run-in Phase|Protocol Violation|0|||
23299702|NCT00788593|64839928|FG002|Placebo Run-in Phase|Protocol Violation|0|||
23299703|NCT00788593|64839926|FG000|First Intervention Period|Adverse Event|0|||
23494990|NCT01788046|65555037|FG000|Overall Study|Withdrawal by Subject|12|||
23494991|NCT01788046|65555038|FG001|Overall Study|Withdrawal by Subject|12|||
23299704|NCT00788593|64839927|FG001|First Intervention Period|Adverse Event|1|||
23389892|NCT02991859|65171878|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389893|NCT02991859|65171879|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389894|NCT02991859|65171880|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389895|NCT02991859|65171881|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389896|NCT02991859|65171882|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389897|NCT02991859|65171883|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389898|NCT02991859|65171884|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389899|NCT02991859|65171885|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389900|NCT02991859|65171886|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389901|NCT02991859|65171887|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389902|NCT02991859|65171888|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
23389903|NCT02991859|65171889|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
23389904|NCT02991859|65171890|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389905|NCT02991859|65171891|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389906|NCT02991859|65171892|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
23389907|NCT02991859|65171876|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389908|NCT02991859|65171877|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389909|NCT02991859|65171878|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389910|NCT02991859|65171879|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389911|NCT02991859|65171880|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389912|NCT02991859|65171881|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
23389913|NCT02991859|65171882|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389914|NCT02991859|65171883|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389915|NCT02991859|65171884|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389916|NCT02991859|65171885|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389917|NCT02991859|65171886|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389918|NCT02991859|65171887|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389919|NCT02991859|65171888|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389920|NCT02991859|65171889|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389921|NCT02991859|65171890|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389922|NCT02991859|65171891|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389923|NCT02991859|65171892|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
23389924|NCT02991859|65171876|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389925|NCT02991859|65171877|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389926|NCT02991859|65171878|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389927|NCT02991859|65171879|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389928|NCT02991859|65171880|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389929|NCT02991859|65171881|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389930|NCT02991859|65171882|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389931|NCT02991859|65171883|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389932|NCT02991859|65171884|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389933|NCT02991859|65171885|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
23389934|NCT02991859|65171886|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389935|NCT02991859|65171887|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389936|NCT02991859|65171888|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389937|NCT02991859|65171889|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389938|NCT02991859|65171890|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389939|NCT02991859|65171891|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389940|NCT02991859|65171892|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
23389941|NCT02991859|65171876|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389942|NCT02991859|65171877|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389943|NCT02991859|65171878|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389944|NCT02991859|65171879|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389945|NCT02991859|65171880|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389946|NCT02991859|65171881|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389947|NCT02991859|65171882|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389948|NCT02991859|65171883|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389949|NCT02991859|65171884|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
23389950|NCT02991859|65171885|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389951|NCT02991859|65171886|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389952|NCT02991859|65171887|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389953|NCT02991859|65171888|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389954|NCT02991859|65171889|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389955|NCT02991859|65171890|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389956|NCT02991859|65171891|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389957|NCT02991859|65171892|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
23389958|NCT02554474|65171894|FG000|Overall Study|Protocol Violation|1|||
23389959|NCT02554474|65171895|FG001|Overall Study|Protocol Violation|1|||
23389960|NCT02554474|65171894|FG000|Overall Study|Health issue not related to the study|1|||
23389961|NCT02554474|65171895|FG001|Overall Study|Health issue not related to the study|0|||
23389962|NCT02554474|65171894|FG000|Overall Study|Withdrawal by Subject|1|||
23389963|NCT02554474|65171895|FG001|Overall Study|Withdrawal by Subject|1|||
23389964|NCT02727699|65171896|FG000|Overall Study|Adverse Event|2|||
23389965|NCT02727699|65171897|FG001|Overall Study|Adverse Event|0|||
23389966|NCT02727699|65171896|FG000|Overall Study|Withdrawal by Subject|5|||
23389967|NCT02727699|65171897|FG001|Overall Study|Withdrawal by Subject|3|||
23389968|NCT02727699|65171896|FG000|Overall Study|Protocol Violation|0|||
23389969|NCT02727699|65171897|FG001|Overall Study|Protocol Violation|1|||
23389970|NCT02727699|65171896|FG000|Overall Study|Physician Decision|0|||
23389971|NCT02727699|65171897|FG001|Overall Study|Physician Decision|1|||
23389972|NCT02727699|65171896|FG000|Overall Study|Lost to Follow-up|1|||
23389973|NCT02727699|65171897|FG001|Overall Study|Lost to Follow-up|0|||
23389974|NCT02727699|65171896|FG000|Overall Study|Sponsor Decision|1|||
23389975|NCT02727699|65171897|FG001|Overall Study|Sponsor Decision|0|||
23389976|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
23389977|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
23389978|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
23389979|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
23389980|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
23389981|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
23389982|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
23389983|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
23389984|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
23389985|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
23389986|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
23389987|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
23389988|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
23389989|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
23389990|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
23389991|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
23389992|NCT01755156|65171898|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
23389993|NCT01755156|65171899|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
23389994|NCT01755156|65171898|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
23389995|NCT01755156|65171899|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
23389996|NCT01755156|65171898|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
23389997|NCT01755156|65171899|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
23389998|NCT04755231|65171905|FG000|Overall Study|Lost to Follow-up|5|||
23389999|NCT04755231|65171905|FG000|Overall Study|Withdrawal by Subject|5|||
23299705|NCT00788593|64839928|FG002|First Intervention Period|Adverse Event|0|||
23390000|NCT01897896|65171906|FG000|Overall Study|Death|1|||
23390001|NCT01897896|65171907|FG001|Overall Study|Death|0|||
23390002|NCT01897896|65171906|FG000|Overall Study|Adverse Event|11|||
23390003|NCT01897896|65171907|FG001|Overall Study|Adverse Event|1|||
23390004|NCT01897896|65171906|FG000|Overall Study|Lost to Follow-up|1|||
23299706|NCT00788593|64839926|FG000|Second Intervention Period|Lost to Follow-up|0|||
23390005|NCT01897896|65171907|FG001|Overall Study|Lost to Follow-up|0|||
23390006|NCT01897896|65171906|FG000|Overall Study|Non-compliance with study drug dosing|1|||
23299707|NCT00788593|64839927|FG001|Second Intervention Period|Lost to Follow-up|1|||
23299708|NCT00788593|64839928|FG002|Second Intervention Period|Lost to Follow-up|0|||
23299709|NCT00788593|64839926|FG000|Second Intervention Period|Other|0|||
23299710|NCT00788593|64839927|FG001|Second Intervention Period|Other|0|||
23299711|NCT00788593|64839928|FG002|Second Intervention Period|Other|1|||
23299712|NCT00754442|64839932|FG000|Overall Study|Withdrawal by Subject|5|||
23299713|NCT00754442|64839933|FG001|Overall Study|Withdrawal by Subject|3|||
23299714|NCT02357342|64839934|FG000|First 6 Months|Death|2|||
23299715|NCT02357342|64839935|FG001|First 6 Months|Death|0|||
23299716|NCT03919448|64839936|FG000|Overall Study|Withdrawal by Subject|1|||
23299717|NCT03919448|64839937|FG001|Overall Study|Withdrawal by Subject|0|||
23299718|NCT03919448|64839938|FG002|Overall Study|Withdrawal by Subject|0|||
23299719|NCT00140413|64839939|FG000|Overall Study|Lost to Follow-up|1|||
23299720|NCT00140413|64839940|FG001|Overall Study|Lost to Follow-up|0|||
23299721|NCT00140413|64839939|FG000|Overall Study|Withdrawal by Subject|2|||
23299722|NCT00140413|64839940|FG001|Overall Study|Withdrawal by Subject|0|||
23299723|NCT01901848|64839941|FG000|Randomized and Treated|Lost to Follow-up|3|||
23299724|NCT01901848|64839942|FG001|Randomized and Treated|Lost to Follow-up|6|||
23299725|NCT01901848|64839941|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
23299726|NCT01901848|64839942|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
23299727|NCT02610816|64839943|FG000|Phase 1|Withdrawal by Subject|2|||
23299728|NCT02610816|64839944|FG001|Phase 1|Withdrawal by Subject|6|||
23299729|NCT02610816|64839945|FG002|Phase 1|Withdrawal by Subject|0|||
23299730|NCT02610816|64839946|FG003|Phase 1|Withdrawal by Subject|0|||
23299731|NCT02610816|64839943|FG000|Phase 1|Lost to Follow-up|2|||
23299732|NCT02610816|64839944|FG001|Phase 1|Lost to Follow-up|1|||
23299733|NCT02610816|64839945|FG002|Phase 1|Lost to Follow-up|0|||
23299734|NCT02610816|64839946|FG003|Phase 1|Lost to Follow-up|0|||
23299735|NCT02610816|64839943|FG000|Phase 1|Physician Decision|0|||
23299736|NCT02610816|64839944|FG001|Phase 1|Physician Decision|1|||
23299737|NCT02610816|64839945|FG002|Phase 1|Physician Decision|0|||
23299738|NCT02610816|64839946|FG003|Phase 1|Physician Decision|0|||
23299739|NCT02610816|64839943|FG000|Phase 2|Withdrawal by Subject|0|||
23299740|NCT02610816|64839944|FG001|Phase 2|Withdrawal by Subject|0|||
23299741|NCT02610816|64839945|FG002|Phase 2|Withdrawal by Subject|9|||
23299742|NCT02610816|64839946|FG003|Phase 2|Withdrawal by Subject|3|||
23299743|NCT02610816|64839943|FG000|Phase 2|Lost to Follow-up|0|||
23299744|NCT02610816|64839944|FG001|Phase 2|Lost to Follow-up|0|||
23299745|NCT02610816|64839945|FG002|Phase 2|Lost to Follow-up|2|||
23299746|NCT02610816|64839946|FG003|Phase 2|Lost to Follow-up|0|||
23299747|NCT02610816|64839943|FG000|Phase 2|Physician Decision|0|||
23299748|NCT02610816|64839944|FG001|Phase 2|Physician Decision|0|||
23299749|NCT02610816|64839945|FG002|Phase 2|Physician Decision|0|||
23299750|NCT02610816|64839946|FG003|Phase 2|Physician Decision|2|||
23299751|NCT02610816|64839943|FG000|Phase 2|Pregnancy|0|||
23299752|NCT02610816|64839944|FG001|Phase 2|Pregnancy|0|||
23299753|NCT02610816|64839945|FG002|Phase 2|Pregnancy|0|||
23299754|NCT02610816|64839946|FG003|Phase 2|Pregnancy|1|||
23299755|NCT00407758|64839949|FG000|Overall Study|ineligible -improper prior treatment|1|||
23299756|NCT00588640|64839950|FG000|Overall Study|Physician Decision|1|||
23299757|NCT00588640|64839950|FG000|Overall Study|Ineligible Patient|1|||
23299758|NCT01333072|64839951|FG000|Overall Study|Lost to Follow-up|3|||
23299759|NCT01333072|64839952|FG001|Overall Study|Lost to Follow-up|0|||
23299760|NCT01333072|64839951|FG000|Overall Study|Adverse Event|2|||
23299761|NCT01333072|64839952|FG001|Overall Study|Adverse Event|4|||
23299762|NCT01333072|64839951|FG000|Overall Study|Physician Decision|1|||
23299763|NCT01333072|64839952|FG001|Overall Study|Physician Decision|0|||
23299764|NCT00402025|64839953|FG000|Overall Study|Adverse Event|0|||
23299765|NCT00402025|64839954|FG001|Overall Study|Adverse Event|0|||
23299766|NCT00402025|64839955|FG002|Overall Study|Adverse Event|2|||
23299767|NCT00402025|64839953|FG000|Overall Study|Death|0|||
23299768|NCT00402025|64839954|FG001|Overall Study|Death|1|||
23390007|NCT01897896|65171907|FG001|Overall Study|Non-compliance with study drug dosing|1|||
23390008|NCT01897896|65171906|FG000|Overall Study|Withdrawal by Subject|7|||
23390009|NCT01897896|65171907|FG001|Overall Study|Withdrawal by Subject|1|||
23390010|NCT01897896|65171906|FG000|Overall Study|Require drug that interfere with study|1|||
23390011|NCT01897896|65171907|FG001|Overall Study|Require drug that interfere with study|4|||
23390012|NCT01897896|65171906|FG000|Overall Study|Protocol Violation|1|||
23390013|NCT01897896|65171907|FG001|Overall Study|Protocol Violation|1|||
23390014|NCT01897896|65171906|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
23390015|NCT01897896|65171907|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
23390016|NCT01897896|65171906|FG000|Overall Study|Caregiver can no longer participate|0|||
23390017|NCT01897896|65171907|FG001|Overall Study|Caregiver can no longer participate|2|||
23494992|NCT01788046|65555037|FG000|Overall Study|Lost to Follow-up|12|||
23494993|NCT01788046|65555038|FG001|Overall Study|Lost to Follow-up|19|||
23494994|NCT01788046|65555037|FG000|Overall Study|Death|7|||
23494995|NCT01788046|65555038|FG001|Overall Study|Death|5|||
23494996|NCT01788046|65555037|FG000|Overall Study|Protocol Specified Criteria|25|||
23494997|NCT01788046|65555038|FG001|Overall Study|Protocol Specified Criteria|1|||
23494998|NCT00491764|65555039|FG000|Overall Study|Adverse Event|1|||
23494999|NCT00491764|65555040|FG001|Overall Study|Adverse Event|2|||
23495000|NCT00491764|65555041|FG002|Overall Study|Adverse Event|4|||
23495001|NCT00491764|65555042|FG003|Overall Study|Adverse Event|4|||
23495002|NCT00491764|65555043|FG004|Overall Study|Adverse Event|0|||
23495003|NCT00491764|65555044|FG005|Overall Study|Adverse Event|1|||
23495004|NCT00491764|65555039|FG000|Overall Study|Lost to Follow-up|0|||
23495005|NCT00491764|65555040|FG001|Overall Study|Lost to Follow-up|1|||
23495006|NCT00491764|65555041|FG002|Overall Study|Lost to Follow-up|0|||
23495007|NCT00491764|65555042|FG003|Overall Study|Lost to Follow-up|1|||
23495008|NCT00491764|65555043|FG004|Overall Study|Lost to Follow-up|0|||
23495009|NCT00491764|65555044|FG005|Overall Study|Lost to Follow-up|3|||
23495010|NCT00491764|65555039|FG000|Overall Study|Withdrawal by Subject|2|||
23495011|NCT00491764|65555040|FG001|Overall Study|Withdrawal by Subject|3|||
23495012|NCT00491764|65555041|FG002|Overall Study|Withdrawal by Subject|1|||
23495013|NCT00491764|65555042|FG003|Overall Study|Withdrawal by Subject|2|||
23495014|NCT00491764|65555043|FG004|Overall Study|Withdrawal by Subject|2|||
23495015|NCT00491764|65555044|FG005|Overall Study|Withdrawal by Subject|4|||
23495016|NCT00491764|65555039|FG000|Overall Study|Non Compliance with the Protocol|1|||
23495017|NCT00491764|65555040|FG001|Overall Study|Non Compliance with the Protocol|0|||
23495018|NCT00491764|65555041|FG002|Overall Study|Non Compliance with the Protocol|0|||
23495019|NCT00491764|65555042|FG003|Overall Study|Non Compliance with the Protocol|0|||
23495020|NCT00491764|65555043|FG004|Overall Study|Non Compliance with the Protocol|0|||
23495021|NCT00491764|65555044|FG005|Overall Study|Non Compliance with the Protocol|0|||
23495022|NCT00491764|65555039|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
23495023|NCT00491764|65555040|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
23299769|NCT00402025|64839955|FG002|Overall Study|Death|5|||
23299770|NCT00402025|64839953|FG000|Overall Study|Disease Progression|1|||
23299771|NCT00402025|64839954|FG001|Overall Study|Disease Progression|1|||
23299772|NCT00402025|64839955|FG002|Overall Study|Disease Progression|2|||
23299773|NCT00402025|64839953|FG000|Overall Study|Physician Decision|1|||
23299774|NCT00402025|64839954|FG001|Overall Study|Physician Decision|1|||
23299775|NCT00402025|64839955|FG002|Overall Study|Physician Decision|0|||
23299776|NCT00402025|64839953|FG000|Overall Study|Participant Decision|0|||
23299777|NCT00402025|64839954|FG001|Overall Study|Participant Decision|0|||
23299778|NCT00402025|64839955|FG002|Overall Study|Participant Decision|1|||
23299779|NCT00952276|64839956|FG000|Overall Study|Withdrawal by Subject|1|||
23299780|NCT00952276|64839957|FG001|Overall Study|Withdrawal by Subject|0|||
23299781|NCT00952276|64839958|FG002|Overall Study|Withdrawal by Subject|0|||
23299782|NCT00952276|64839959|FG003|Overall Study|Withdrawal by Subject|1|||
23495024|NCT00491764|65555041|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
23299783|NCT00952276|64839960|FG004|Overall Study|Withdrawal by Subject|0|||
23495025|NCT00491764|65555042|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
23495026|NCT00491764|65555043|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
23390018|NCT01897896|65171906|FG000|Overall Study|Other than specified|2|||
23390019|NCT01897896|65171907|FG001|Overall Study|Other than specified|1|||
23390020|NCT00993473|65171909|FG000|Overall Study|Adverse Event|0|||
23390021|NCT00993473|65171910|FG001|Overall Study|Adverse Event|2|||
23390022|NCT00993473|65171909|FG000|Overall Study|Protocol Violation|1|||
23390023|NCT00993473|65171910|FG001|Overall Study|Protocol Violation|2|||
23390024|NCT00993473|65171909|FG000|Overall Study|Lost to Follow-up|1|||
23390025|NCT00993473|65171910|FG001|Overall Study|Lost to Follow-up|0|||
23390026|NCT00993473|65171909|FG000|Overall Study|Withdrawal by Subject|1|||
23390027|NCT00993473|65171910|FG001|Overall Study|Withdrawal by Subject|5|||
23390028|NCT00993473|65171909|FG000|Overall Study|Technical problem with CGM device|0|||
23390029|NCT00993473|65171910|FG001|Overall Study|Technical problem with CGM device|1|||
23390030|NCT00993473|65171909|FG000|Overall Study|Family event|1|||
23390031|NCT00993473|65171910|FG001|Overall Study|Family event|0|||
23390032|NCT00617903|65171911|FG000|Overall Study|Withdrawal by Subject|2|||
23390033|NCT00617903|65171912|FG001|Overall Study|Withdrawal by Subject|3|||
23390034|NCT00617903|65171911|FG000|Overall Study|Lost to Follow-up|1|||
23390035|NCT00617903|65171912|FG001|Overall Study|Lost to Follow-up|1|||
23390036|NCT00617903|65171911|FG000|Overall Study|Lack of Efficacy|0|||
23390037|NCT00617903|65171912|FG001|Overall Study|Lack of Efficacy|1|||
23390038|NCT00617903|65171911|FG000|Overall Study|Adverse Event|0|||
23390039|NCT00617903|65171912|FG001|Overall Study|Adverse Event|1|||
23390040|NCT00617903|65171911|FG000|Overall Study|noncompliance|0|||
23390041|NCT00617903|65171912|FG001|Overall Study|noncompliance|1|||
23390042|NCT01633112|65171915|FG000|Overall Study|Lack of Efficacy|1|||
23390043|NCT01633112|65171916|FG001|Overall Study|Lack of Efficacy|6|||
23390044|NCT01633112|65171917|FG002|Overall Study|Lack of Efficacy|13|||
23390045|NCT01633112|65171915|FG000|Overall Study|Abnormal laboratory value(s)|3|||
23390046|NCT01633112|65171916|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23390047|NCT01633112|65171917|FG002|Overall Study|Abnormal laboratory value(s)|0|||
23390048|NCT01633112|65171915|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23390049|NCT01633112|65171916|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23390050|NCT01633112|65171917|FG002|Overall Study|Abnormal test procedure result(s)|0|||
23390051|NCT01633112|65171915|FG000|Overall Study|Administrative problems|1|||
23390052|NCT01633112|65171916|FG001|Overall Study|Administrative problems|2|||
23390053|NCT01633112|65171917|FG002|Overall Study|Administrative problems|5|||
23495027|NCT00491764|65555044|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
23495028|NCT00491764|65555039|FG000|Overall Study|Administrative|1|||
23390054|NCT01633112|65171915|FG000|Overall Study|Adverse Event|16|||
23495029|NCT00491764|65555040|FG001|Overall Study|Administrative|0|||
23390055|NCT01633112|65171916|FG001|Overall Study|Adverse Event|18|||
23390056|NCT01633112|65171917|FG002|Overall Study|Adverse Event|20|||
23390057|NCT01633112|65171915|FG000|Overall Study|Lost to Follow-up|7|||
23390058|NCT01633112|65171916|FG001|Overall Study|Lost to Follow-up|19|||
23390059|NCT01633112|65171917|FG002|Overall Study|Lost to Follow-up|6|||
23390060|NCT01633112|65171915|FG000|Overall Study|Protocol Violation|4|||
23390061|NCT01633112|65171916|FG001|Overall Study|Protocol Violation|0|||
23390062|NCT01633112|65171917|FG002|Overall Study|Protocol Violation|2|||
23390063|NCT01633112|65171915|FG000|Overall Study|Subject no longer requires study drug|0|||
23390064|NCT01633112|65171916|FG001|Overall Study|Subject no longer requires study drug|0|||
23390065|NCT01633112|65171917|FG002|Overall Study|Subject no longer requires study drug|1|||
23390066|NCT01633112|65171915|FG000|Overall Study|Withdrawal by Subject|20|||
23390067|NCT01633112|65171916|FG001|Overall Study|Withdrawal by Subject|12|||
23390068|NCT01633112|65171917|FG002|Overall Study|Withdrawal by Subject|41|||
23390069|NCT01633112|65171915|FG000|Overall Study|missing Study Completion CRF|1|||
23390070|NCT01633112|65171916|FG001|Overall Study|missing Study Completion CRF|1|||
23390071|NCT01633112|65171917|FG002|Overall Study|missing Study Completion CRF|4|||
23390072|NCT02605967|65171921|FG000|Overall Study|subject / guardian decision|1|||
23390073|NCT02605967|65171922|FG001|Overall Study|subject / guardian decision|2|||
23390074|NCT02605967|65171921|FG000|Overall Study|Physician Decision|10|||
23390075|NCT02605967|65171922|FG001|Overall Study|Physician Decision|1|||
23390076|NCT02605967|65171921|FG000|Overall Study|Death|4|||
23390077|NCT02605967|65171922|FG001|Overall Study|Death|2|||
23390078|NCT02605967|65171921|FG000|Overall Study|Adverse Event|1|||
23390079|NCT02605967|65171922|FG001|Overall Study|Adverse Event|0|||
23495030|NCT00491764|65555041|FG002|Overall Study|Administrative|2|||
23390080|NCT02605967|65171921|FG000|Overall Study|progressive disease|66|||
23390081|NCT02605967|65171922|FG001|Overall Study|progressive disease|35|||
23390082|NCT01050218|65171923|FG000|Overall Study|Adverse Event|37|||
23390083|NCT01050218|65171923|FG000|Overall Study|Lack of Efficacy|8|||
23390084|NCT01050218|65171923|FG000|Overall Study|Protocol Violation|3|||
23390085|NCT01050218|65171923|FG000|Overall Study|Withdrawal by Subject|18|||
23390086|NCT01050218|65171923|FG000|Overall Study|Discontinued by sponsor|18|||
23390087|NCT01050218|65171923|FG000|Overall Study|Compliance|2|||
23390088|NCT01050218|65171923|FG000|Overall Study|Failed to return|7|||
23390089|NCT01050218|65171923|FG000|Overall Study|Serious Adverse Event|1|||
23390090|NCT01050218|65171923|FG000|Overall Study|Family emergency|1|||
23390091|NCT02829918|65175133|FG000|Overall Study|Death|2|||
23390092|NCT02829918|65175133|FG000|Overall Study|Withdrawal by Subject|4|||
23390093|NCT02829918|65175133|FG000|Overall Study|Adverse Event|1|||
23299784|NCT02694549|64839961|FG000|Overall Study|screen failures|2|||
23299785|NCT04440449|64839962|FG000|Overall Study|Lost to Follow-up|2|||
23299786|NCT04440449|64839963|FG001|Overall Study|Lost to Follow-up|0|||
23299787|NCT02697773|64839964|FG000|Overall Study|Adverse Event|2|||
23299788|NCT02697773|64839965|FG001|Overall Study|Adverse Event|1|||
23299789|NCT02697773|64839966|FG002|Overall Study|Adverse Event|2|||
23299790|NCT02697773|64839964|FG000|Overall Study|Death|0|||
23299791|NCT02697773|64839965|FG001|Overall Study|Death|0|||
23299792|NCT02697773|64839966|FG002|Overall Study|Death|2|||
23299793|NCT02697773|64839964|FG000|Overall Study|Lack of Efficacy|4|||
23299794|NCT02697773|64839965|FG001|Overall Study|Lack of Efficacy|6|||
23299795|NCT02697773|64839966|FG002|Overall Study|Lack of Efficacy|6|||
23299796|NCT02697773|64839964|FG000|Overall Study|Lost to Follow-up|5|||
23299797|NCT02697773|64839965|FG001|Overall Study|Lost to Follow-up|5|||
23299798|NCT02697773|64839966|FG002|Overall Study|Lost to Follow-up|7|||
23299799|NCT02697773|64839964|FG000|Overall Study|Other|15|||
23299800|NCT02697773|64839965|FG001|Overall Study|Other|11|||
23299801|NCT02697773|64839966|FG002|Overall Study|Other|10|||
23299802|NCT02697773|64839964|FG000|Overall Study|Protocol Violation|1|||
23299803|NCT02697773|64839965|FG001|Overall Study|Protocol Violation|1|||
23299804|NCT02697773|64839966|FG002|Overall Study|Protocol Violation|0|||
23299805|NCT02697773|64839964|FG000|Overall Study|Withdrawal by Subject|10|||
23299806|NCT02697773|64839965|FG001|Overall Study|Withdrawal by Subject|13|||
23299807|NCT02697773|64839966|FG002|Overall Study|Withdrawal by Subject|13|||
23390094|NCT02829918|65175133|FG000|Overall Study|Progression|1|||
23299808|NCT02697773|64839964|FG000|Overall Study|Randomized but not treated|1|||
23299809|NCT02697773|64839965|FG001|Overall Study|Randomized but not treated|1|||
23390095|NCT00215657|65175136|FG000|Overall Study|Adverse Event|5|||
23390096|NCT00215657|65175137|FG001|Overall Study|Adverse Event|1|||
23299810|NCT02697773|64839966|FG002|Overall Study|Randomized but not treated|0|||
23299811|NCT03487848|64839969|FG000|Overall Study|Lost to Follow-up|1|||
23299812|NCT01557842|64839970|FG000|Overall Study|Lost to Follow-up|0|||
23299813|NCT01557842|64839971|FG001|Overall Study|Lost to Follow-up|1|||
23390097|NCT00215657|65175138|FG002|Overall Study|Adverse Event|3|||
23299814|NCT01557842|64839970|FG000|Overall Study|Death|1|||
23390098|NCT00215657|65175139|FG003|Overall Study|Adverse Event|0|||
23390099|NCT00215657|65175140|FG004|Overall Study|Adverse Event|3|||
23390100|NCT00215657|65175141|FG005|Overall Study|Adverse Event|1|||
23390101|NCT00215657|65175142|FG006|Overall Study|Adverse Event|0|||
23390102|NCT00215657|65175143|FG007|Overall Study|Adverse Event|3|||
23390103|NCT00215657|65175136|FG000|Overall Study|Withdrawal by Subject|6|||
23390104|NCT00215657|65175137|FG001|Overall Study|Withdrawal by Subject|3|||
23390105|NCT00215657|65175138|FG002|Overall Study|Withdrawal by Subject|3|||
23390106|NCT00215657|65175139|FG003|Overall Study|Withdrawal by Subject|1|||
23390107|NCT00215657|65175140|FG004|Overall Study|Withdrawal by Subject|6|||
23390108|NCT00215657|65175141|FG005|Overall Study|Withdrawal by Subject|1|||
23390109|NCT00215657|65175142|FG006|Overall Study|Withdrawal by Subject|10|||
23390110|NCT00215657|65175143|FG007|Overall Study|Withdrawal by Subject|3|||
23390111|NCT00215657|65175136|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
23390112|NCT00215657|65175137|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
23390113|NCT00215657|65175138|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
23390114|NCT00215657|65175139|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
23390115|NCT00215657|65175140|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
23390116|NCT00215657|65175141|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
23390117|NCT00215657|65175142|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
23390118|NCT00215657|65175143|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
23390119|NCT00215657|65175136|FG000|Overall Study|Insufficient testosterone response|5|||
23390120|NCT00215657|65175137|FG001|Overall Study|Insufficient testosterone response|4|||
23390121|NCT00215657|65175138|FG002|Overall Study|Insufficient testosterone response|1|||
23390122|NCT00215657|65175139|FG003|Overall Study|Insufficient testosterone response|12|||
23390123|NCT00215657|65175140|FG004|Overall Study|Insufficient testosterone response|8|||
23390124|NCT00215657|65175141|FG005|Overall Study|Insufficient testosterone response|12|||
23390125|NCT00215657|65175142|FG006|Overall Study|Insufficient testosterone response|4|||
23390126|NCT00215657|65175143|FG007|Overall Study|Insufficient testosterone response|7|||
23390127|NCT00215657|65175136|FG000|Overall Study|Other|3|||
23390128|NCT00215657|65175137|FG001|Overall Study|Other|1|||
23390129|NCT00215657|65175138|FG002|Overall Study|Other|2|||
23390130|NCT00215657|65175139|FG003|Overall Study|Other|3|||
23390131|NCT00215657|65175140|FG004|Overall Study|Other|5|||
23390132|NCT00215657|65175141|FG005|Overall Study|Other|4|||
23390133|NCT00215657|65175142|FG006|Overall Study|Other|6|||
23390134|NCT00215657|65175143|FG007|Overall Study|Other|1|||
23390135|NCT01308788|65175144|FG000|2-year Treatment|medication change by treating physician|4|||
23390136|NCT01308788|65175145|FG001|2-year Treatment|medication change by treating physician|11|||
23390137|NCT02003898|65175148|FG000|Overall Study|Death|3|||
23390138|NCT02003898|65175148|FG000|Overall Study|Lost to Follow-up|12|||
23390139|NCT02003898|65175148|FG000|Overall Study|Withdrawal by Subject|52|||
23495031|NCT00491764|65555042|FG003|Overall Study|Administrative|1|||
23495032|NCT00491764|65555043|FG004|Overall Study|Administrative|0|||
23495033|NCT00491764|65555044|FG005|Overall Study|Administrative|0|||
23390140|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
23390141|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
23390142|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
23390143|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
23390144|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
23390145|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
23390146|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Other|2|||
23390147|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Other|1|||
23390148|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Other|1|||
23390149|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
23390150|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
23390151|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
23390152|NCT02691494|65175149|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
23390153|NCT02691494|65175150|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
23390154|NCT02691494|65175151|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
23390155|NCT04507269|65175152|FG000|Overall Study|Withdrawal by Subject|1|||
23390156|NCT04507269|65175153|FG001|Overall Study|Withdrawal by Subject|1|||
23390157|NCT04507269|65175154|FG002|Overall Study|Withdrawal by Subject|0|||
23390158|NCT04507269|65175155|FG003|Overall Study|Withdrawal by Subject|0|||
23390159|NCT04507269|65175156|FG004|Overall Study|Withdrawal by Subject|0|||
23390160|NCT04507269|65175157|FG005|Overall Study|Withdrawal by Subject|0|||
23390161|NCT04507269|65175152|FG000|Overall Study|Lost to Follow-up|0|||
23299815|NCT01557842|64839971|FG001|Overall Study|Death|0|||
23299816|NCT01557842|64839970|FG000|Overall Study|Lack of Efficacy|0|||
23299817|NCT01557842|64839971|FG001|Overall Study|Lack of Efficacy|1|||
23299818|NCT01557842|64839970|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
23299819|NCT01557842|64839971|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
23299820|NCT01557842|64839970|FG000|Overall Study|Study Terminated by Sponsor|3|||
23299821|NCT01557842|64839971|FG001|Overall Study|Study Terminated by Sponsor|4|||
23299822|NCT01557842|64839970|FG000|Overall Study|Not Ablated|2|||
23299823|NCT01557842|64839971|FG001|Overall Study|Not Ablated|0|||
23390162|NCT04507269|65175153|FG001|Overall Study|Lost to Follow-up|0|||
23390163|NCT04507269|65175154|FG002|Overall Study|Lost to Follow-up|0|||
23390164|NCT04507269|65175155|FG003|Overall Study|Lost to Follow-up|0|||
23390165|NCT04507269|65175156|FG004|Overall Study|Lost to Follow-up|1|||
23390166|NCT04507269|65175157|FG005|Overall Study|Lost to Follow-up|0|||
23390167|NCT03829683|65175158|FG000|Overall Study|Lost to Follow-up|1|||
23390168|NCT03829683|65175159|FG001|Overall Study|Lost to Follow-up|0|||
23390169|NCT03829683|65175158|FG000|Overall Study|Physician Decision|3|||
23390170|NCT03829683|65175159|FG001|Overall Study|Physician Decision|1|||
23390171|NCT03829683|65175158|FG000|Overall Study|Withdrawal by Subject|0|||
23390172|NCT03829683|65175159|FG001|Overall Study|Withdrawal by Subject|1|||
23390173|NCT03829683|65175158|FG000|Overall Study|Discharge from hospital|1|||
23390174|NCT03829683|65175159|FG001|Overall Study|Discharge from hospital|0|||
23390175|NCT01569763|65175160|FG000|Overall Study|Lack of Efficacy|2|||
23390176|NCT01569763|65175161|FG001|Overall Study|Lack of Efficacy|7|||
23390177|NCT01569763|65175160|FG000|Overall Study|Adverse Event|1|||
23390178|NCT01569763|65175161|FG001|Overall Study|Adverse Event|0|||
23390179|NCT02363283|65175162|FG000|Overall Study|Withdrawal by Subject|1|||
23390180|NCT02363283|65175162|FG000|Overall Study|Not eligible due to transaminitis|1|||
23390181|NCT01592747|65175163|FG000|Overall Study|Loss of Therapeutic Response|107|||
23390182|NCT01592747|65175164|FG001|Overall Study|Loss of Therapeutic Response|108|||
23390183|NCT01592747|65175165|FG002|Overall Study|Loss of Therapeutic Response|100|||
23390184|NCT01592747|65175163|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
23495034|NCT00216476|65555051|FG000|Overall Study|Withdrawal by Subject|59|||
23495035|NCT00216476|65555052|FG001|Overall Study|Withdrawal by Subject|72|||
23390185|NCT01592747|65175164|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
23390186|NCT01592747|65175165|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
23606150|NCT00641537|65947162|FG007|96-week Period|Lost to Follow-up|0|||
23606151|NCT00641537|65947155|FG000|96-week Period|Protocol Violation|0|||
23606152|NCT00641537|65947156|FG001|96-week Period|Protocol Violation|1|||
23606153|NCT00641537|65947157|FG002|96-week Period|Protocol Violation|0|||
23606154|NCT00641537|65947158|FG003|96-week Period|Protocol Violation|1|||
23606155|NCT00641537|65947159|FG004|96-week Period|Protocol Violation|0|||
23606156|NCT00641537|65947160|FG005|96-week Period|Protocol Violation|1|||
23606157|NCT00641537|65947161|FG006|96-week Period|Protocol Violation|0|||
23606158|NCT00641537|65947162|FG007|96-week Period|Protocol Violation|0|||
23606159|NCT00641537|65947155|FG000|96-week Period|Death|2|||
23606160|NCT00641537|65947156|FG001|96-week Period|Death|0|||
23606161|NCT00641537|65947157|FG002|96-week Period|Death|1|||
23606162|NCT00641537|65947158|FG003|96-week Period|Death|0|||
23606163|NCT00641537|65947159|FG004|96-week Period|Death|0|||
23606164|NCT00641537|65947160|FG005|96-week Period|Death|0|||
23606165|NCT00641537|65947161|FG006|96-week Period|Death|0|||
23606166|NCT00641537|65947162|FG007|96-week Period|Death|0|||
23606167|NCT00641537|65947155|FG000|96-week Period|Other|4|||
23606168|NCT00641537|65947156|FG001|96-week Period|Other|7|||
23606169|NCT00641537|65947157|FG002|96-week Period|Other|14|||
23606170|NCT00641537|65947158|FG003|96-week Period|Other|9|||
23606171|NCT00641537|65947159|FG004|96-week Period|Other|11|||
23606172|NCT00641537|65947160|FG005|96-week Period|Other|6|||
23606173|NCT00641537|65947161|FG006|96-week Period|Other|4|||
23606174|NCT00641537|65947162|FG007|96-week Period|Other|6|||
23606175|NCT00641537|65947155|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
23606176|NCT00641537|65947156|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
23606177|NCT00641537|65947157|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
23606178|NCT00641537|65947158|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
23606179|NCT00641537|65947159|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
23606180|NCT00641537|65947160|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
23606181|NCT00641537|65947161|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
23606182|NCT00641537|65947162|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
23606183|NCT00641537|65947155|FG000|24-Week Supplemental Follow-up Period|Other|0|||
23606184|NCT00641537|65947156|FG001|24-Week Supplemental Follow-up Period|Other|2|||
23606185|NCT00641537|65947157|FG002|24-Week Supplemental Follow-up Period|Other|2|||
23495036|NCT00216476|65555053|FG002|Overall Study|Withdrawal by Subject|9|||
23390187|NCT01592747|65175163|FG000|Overall Study|Adverse Event|1|||
23390188|NCT01592747|65175164|FG001|Overall Study|Adverse Event|0|||
23390189|NCT01592747|65175165|FG002|Overall Study|Adverse Event|0|||
23390190|NCT01592747|65175163|FG000|Overall Study|Protocol Violation|4|||
23390191|NCT01592747|65175164|FG001|Overall Study|Protocol Violation|0|||
23390192|NCT01592747|65175165|FG002|Overall Study|Protocol Violation|4|||
23390193|NCT01592747|65175163|FG000|Overall Study|Lack of Efficacy|0|||
23390194|NCT01592747|65175164|FG001|Overall Study|Lack of Efficacy|1|||
23390195|NCT01592747|65175165|FG002|Overall Study|Lack of Efficacy|0|||
23390196|NCT01592747|65175163|FG000|Overall Study|Withdrawal by Subject|2|||
23390197|NCT01592747|65175164|FG001|Overall Study|Withdrawal by Subject|0|||
23390198|NCT01592747|65175165|FG002|Overall Study|Withdrawal by Subject|2|||
23390199|NCT01592747|65175163|FG000|Overall Study|Lost to Follow-up|1|||
23390200|NCT01592747|65175164|FG001|Overall Study|Lost to Follow-up|0|||
23390201|NCT01592747|65175165|FG002|Overall Study|Lost to Follow-up|1|||
23390202|NCT01592747|65175163|FG000|Overall Study|Other Reasons|1|||
23390203|NCT01592747|65175164|FG001|Overall Study|Other Reasons|1|||
23390204|NCT01592747|65175165|FG002|Overall Study|Other Reasons|0|||
23390205|NCT02144337|65175168|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
23390206|NCT02144337|65175169|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
23495037|NCT00216476|65555051|FG000|Overall Study|Lost to Follow-up|10|||
23495038|NCT00216476|65555052|FG001|Overall Study|Lost to Follow-up|9|||
23495039|NCT00216476|65555053|FG002|Overall Study|Lost to Follow-up|1|||
23495040|NCT00216476|65555051|FG000|Overall Study|Adverse Event|6|||
23495041|NCT00216476|65555052|FG001|Overall Study|Adverse Event|10|||
23495042|NCT00216476|65555053|FG002|Overall Study|Adverse Event|1|||
23495043|NCT00216476|65555051|FG000|Overall Study|Lack of Efficacy|4|||
23495044|NCT00216476|65555052|FG001|Overall Study|Lack of Efficacy|3|||
23495045|NCT00216476|65555053|FG002|Overall Study|Lack of Efficacy|0|||
23390207|NCT02144337|65175168|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
23390208|NCT02144337|65175169|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
23390209|NCT02144337|65175168|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
23495046|NCT00216476|65555051|FG000|Overall Study|Death|2|||
23495047|NCT00216476|65555052|FG001|Overall Study|Death|0|||
23299824|NCT00126126|64839972|FG000|Overall Study|Lost to Follow-up|0|||
23299825|NCT00126126|64839973|FG001|Overall Study|Lost to Follow-up|2|||
23299826|NCT01000610|64839974|FG000|Overall Study|Adverse Event|1|||
23390210|NCT02144337|65175169|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
23390211|NCT02144337|65175168|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
23390212|NCT02144337|65175169|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
23390213|NCT02144337|65175168|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
23390214|NCT02144337|65175169|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
23390215|NCT04985682|65175177|FG000|Overall Study|Withdrawal by Subject|1|||
23390216|NCT05346640|65175181|FG000|Overall Study|Lack of Efficacy|2|||
23390217|NCT05346640|65175181|FG000|Overall Study|Lost to Follow-up|14|||
23390218|NCT05346640|65175181|FG000|Overall Study|Protocol Violation|4|||
23390219|NCT05346640|65175181|FG000|Overall Study|Withdrawal by Subject|2|||
23390220|NCT05346640|65175181|FG000|Overall Study|Physiological Complications|3|||
23390221|NCT05346640|65175181|FG000|Overall Study|Other Reason|3|||
23390222|NCT02936323|65175182|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390223|NCT02936323|65175183|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
23390224|NCT02936323|65175184|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390225|NCT02936323|65175185|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
23390226|NCT02936323|65175186|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
23390227|NCT02936323|65175187|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
23390228|NCT02936323|65175188|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390229|NCT02936323|65175189|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390230|NCT02936323|65175190|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390231|NCT02936323|65175191|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
23390232|NCT02936323|65175182|FG000|Phase 1 Dose Escalation|Death|2|||
23390233|NCT02936323|65175183|FG001|Phase 1 Dose Escalation|Death|1|||
23390234|NCT02936323|65175184|FG002|Phase 1 Dose Escalation|Death|3|||
23390235|NCT02936323|65175185|FG003|Phase 1 Dose Escalation|Death|1|||
23390236|NCT02936323|65175186|FG004|Phase 1 Dose Escalation|Death|2|||
23390237|NCT02936323|65175187|FG005|Phase 1 Dose Escalation|Death|3|||
23390238|NCT02936323|65175188|FG006|Phase 1 Dose Escalation|Death|3|||
23390239|NCT02936323|65175189|FG007|Phase 1 Dose Escalation|Death|0|||
23390240|NCT02936323|65175190|FG008|Phase 1 Dose Escalation|Death|0|||
23390241|NCT02936323|65175191|FG009|Phase 1 Dose Escalation|Death|0|||
23390242|NCT02936323|65175182|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390243|NCT02936323|65175183|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23495048|NCT00216476|65555053|FG002|Overall Study|Death|0|||
23495049|NCT00216476|65555051|FG000|Overall Study|Pregnancy|0|||
23390244|NCT02936323|65175184|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390245|NCT02936323|65175185|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390246|NCT02936323|65175186|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390247|NCT02936323|65175187|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
23390248|NCT02936323|65175188|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390249|NCT02936323|65175189|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390250|NCT02936323|65175190|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390251|NCT02936323|65175191|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
23390252|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390253|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390254|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390255|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390256|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390257|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390258|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
23390259|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
23390260|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
23390261|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
23390262|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
23390263|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
23390264|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
23390265|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
23390266|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
23390267|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
23390268|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
23390269|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
23390270|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
23390271|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
23390272|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390273|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390274|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390275|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390276|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390277|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390278|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390279|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
23390280|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
23390281|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
23390282|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390283|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390284|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390285|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390286|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390287|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390288|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390289|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390290|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
23390291|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
23390292|NCT02936323|65175182|FG000|Phase 2a Dose Expansion|Death|0|||
23390293|NCT02936323|65175183|FG001|Phase 2a Dose Expansion|Death|0|||
23390294|NCT02936323|65175184|FG002|Phase 2a Dose Expansion|Death|0|||
23390295|NCT02936323|65175185|FG003|Phase 2a Dose Expansion|Death|0|||
23390296|NCT02936323|65175186|FG004|Phase 2a Dose Expansion|Death|0|||
23495050|NCT00216476|65555052|FG001|Overall Study|Pregnancy|1|||
23390297|NCT02936323|65175187|FG005|Phase 2a Dose Expansion|Death|0|||
23390298|NCT02936323|65175188|FG006|Phase 2a Dose Expansion|Death|0|||
23390299|NCT02936323|65175189|FG007|Phase 2a Dose Expansion|Death|4|||
23390300|NCT02936323|65175190|FG008|Phase 2a Dose Expansion|Death|8|||
23390301|NCT02936323|65175191|FG009|Phase 2a Dose Expansion|Death|10|||
23390302|NCT01335685|65175192|FG000|Overall Study|Study Terminated by Sponsor|2|||
23390303|NCT01335685|65175193|FG001|Overall Study|Study Terminated by Sponsor|1|||
23390304|NCT01335685|65175194|FG002|Overall Study|Study Terminated by Sponsor|1|||
23390305|NCT01335685|65175195|FG003|Overall Study|Study Terminated by Sponsor|10|||
23390306|NCT01335685|65175196|FG004|Overall Study|Study Terminated by Sponsor|0|||
23390307|NCT01335685|65175197|FG005|Overall Study|Study Terminated by Sponsor|4|||
23390308|NCT01335685|65175198|FG006|Overall Study|Study Terminated by Sponsor|2|||
23390309|NCT01335685|65175199|FG007|Overall Study|Study Terminated by Sponsor|3|||
23390310|NCT01335685|65175192|FG000|Overall Study|Withdrawal by Subject|1|||
23390311|NCT01335685|65175193|FG001|Overall Study|Withdrawal by Subject|0|||
23390312|NCT01335685|65175194|FG002|Overall Study|Withdrawal by Subject|0|||
23390313|NCT01335685|65175195|FG003|Overall Study|Withdrawal by Subject|1|||
23299827|NCT01000610|64839974|FG000|Overall Study|Lost to Follow-up|4|||
23495051|NCT00216476|65555053|FG002|Overall Study|Pregnancy|1|||
23299828|NCT01000610|64839974|FG000|Overall Study|Treatment failure|1|||
23299829|NCT03078582|64839976|FG000|Overall Study|Adverse Event|0|||
23495052|NCT00216476|65555051|FG000|Overall Study|Other|0|||
23299830|NCT03078582|64839977|FG001|Overall Study|Adverse Event|8|||
23390314|NCT01335685|65175196|FG004|Overall Study|Withdrawal by Subject|0|||
23390315|NCT01335685|65175197|FG005|Overall Study|Withdrawal by Subject|0|||
23390316|NCT01335685|65175198|FG006|Overall Study|Withdrawal by Subject|0|||
23390317|NCT01335685|65175199|FG007|Overall Study|Withdrawal by Subject|0|||
23390318|NCT01335685|65175192|FG000|Overall Study|Reason not Specified|0|||
23390319|NCT01335685|65175193|FG001|Overall Study|Reason not Specified|0|||
23390320|NCT01335685|65175194|FG002|Overall Study|Reason not Specified|1|||
23390321|NCT01335685|65175195|FG003|Overall Study|Reason not Specified|0|||
23390322|NCT01335685|65175196|FG004|Overall Study|Reason not Specified|0|||
23390323|NCT01335685|65175197|FG005|Overall Study|Reason not Specified|1|||
23390324|NCT01335685|65175198|FG006|Overall Study|Reason not Specified|0|||
23495053|NCT00216476|65555052|FG001|Overall Study|Other|0|||
23495054|NCT00216476|65555053|FG002|Overall Study|Other|1|||
23495055|NCT00216476|65555051|FG000|Overall Study|Refuses Injection|11|||
23495056|NCT00216476|65555052|FG001|Overall Study|Refuses Injection|0|||
23495057|NCT00216476|65555053|FG002|Overall Study|Refuses Injection|0|||
23495058|NCT00216476|65555051|FG000|Overall Study|No Further Need for Treatment|3|||
23495059|NCT00216476|65555052|FG001|Overall Study|No Further Need for Treatment|4|||
23495060|NCT00216476|65555053|FG002|Overall Study|No Further Need for Treatment|1|||
23390325|NCT01335685|65175199|FG007|Overall Study|Reason not Specified|0|||
23390326|NCT00987935|65175200|FG000|Overall Study|Progressive disease|3|||
23390327|NCT00987935|65175201|FG001|Overall Study|Progressive disease|2|||
23390328|NCT00987935|65175202|FG002|Overall Study|Progressive disease|3|||
23390329|NCT00987935|65175203|FG003|Overall Study|Progressive disease|2|||
23390330|NCT00987935|65175204|FG004|Overall Study|Progressive disease|5|||
23390331|NCT00987935|65175205|FG005|Overall Study|Progressive disease|3|||
23390332|NCT00987935|65175206|FG006|Overall Study|Progressive disease|9|||
23390333|NCT00987935|65175207|FG007|Overall Study|Progressive disease|48|||
23390334|NCT00987935|65175208|FG008|Overall Study|Progressive disease|23|||
23390335|NCT00987935|65175200|FG000|Overall Study|Adverse Event|0|||
23390336|NCT00987935|65175201|FG001|Overall Study|Adverse Event|1|||
23390337|NCT00987935|65175202|FG002|Overall Study|Adverse Event|0|||
23390338|NCT00987935|65175203|FG003|Overall Study|Adverse Event|1|||
23390339|NCT00987935|65175204|FG004|Overall Study|Adverse Event|1|||
23390340|NCT00987935|65175205|FG005|Overall Study|Adverse Event|0|||
23390341|NCT00987935|65175206|FG006|Overall Study|Adverse Event|2|||
23390342|NCT00987935|65175207|FG007|Overall Study|Adverse Event|10|||
23390343|NCT00987935|65175208|FG008|Overall Study|Adverse Event|6|||
23390344|NCT00987935|65175200|FG000|Overall Study|Refused to continue taking trial med.|1|||
23390345|NCT00987935|65175201|FG001|Overall Study|Refused to continue taking trial med.|0|||
23390346|NCT00987935|65175202|FG002|Overall Study|Refused to continue taking trial med.|0|||
23390347|NCT00987935|65175203|FG003|Overall Study|Refused to continue taking trial med.|0|||
23390348|NCT00987935|65175204|FG004|Overall Study|Refused to continue taking trial med.|1|||
23390349|NCT00987935|65175205|FG005|Overall Study|Refused to continue taking trial med.|0|||
23390350|NCT00987935|65175206|FG006|Overall Study|Refused to continue taking trial med.|4|||
23390351|NCT00987935|65175207|FG007|Overall Study|Refused to continue taking trial med.|4|||
23390352|NCT00987935|65175208|FG008|Overall Study|Refused to continue taking trial med.|2|||
23390353|NCT00987935|65175200|FG000|Overall Study|Reason other than those specified above|0|||
23390354|NCT00987935|65175201|FG001|Overall Study|Reason other than those specified above|0|||
23390355|NCT00987935|65175202|FG002|Overall Study|Reason other than those specified above|0|||
23390356|NCT00987935|65175203|FG003|Overall Study|Reason other than those specified above|0|||
23390357|NCT00987935|65175204|FG004|Overall Study|Reason other than those specified above|0|||
23390358|NCT00987935|65175205|FG005|Overall Study|Reason other than those specified above|0|||
23390359|NCT00987935|65175206|FG006|Overall Study|Reason other than those specified above|0|||
23495061|NCT00216476|65555051|FG000|Overall Study|Non-compliance|0|||
23495062|NCT00216476|65555052|FG001|Overall Study|Non-compliance|4|||
23495063|NCT00216476|65555053|FG002|Overall Study|Non-compliance|1|||
23390360|NCT00987935|65175207|FG007|Overall Study|Reason other than those specified above|0|||
23390361|NCT00987935|65175208|FG008|Overall Study|Reason other than those specified above|1|||
23390362|NCT02272985|65175209|FG000|Overall Study|Withdrawal by Subject|1|||
23390363|NCT02272985|65175209|FG000|Overall Study|hip fracture|1|||
23390364|NCT02272985|65175209|FG000|Overall Study|kidney transplantation|1|||
23390365|NCT00913835|65175211|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
23390366|NCT00913835|65175212|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
23390367|NCT00913835|65175211|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
23390368|NCT00913835|65175212|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
23390369|NCT00913835|65175211|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
23390370|NCT00913835|65175212|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
23390371|NCT00913835|65175211|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
23390372|NCT00913835|65175212|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
23390373|NCT00913835|65175211|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
23390374|NCT00913835|65175212|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
23390375|NCT00468546|65175213|FG000|Week 24 Analysis|Lack of Efficacy|83|||
23390376|NCT00468546|65175214|FG001|Week 24 Analysis|Lack of Efficacy|37|||
23495064|NCT00216476|65555051|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
23495065|NCT00216476|65555052|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
23495066|NCT00216476|65555053|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
23495067|NCT00216476|65555051|FG000|Overall Study|Administrative Reasons|1|||
23390377|NCT00468546|65175213|FG000|Week 24 Analysis|Refused treatment|5|||
23390378|NCT00468546|65175214|FG001|Week 24 Analysis|Refused treatment|5|||
23390379|NCT00468546|65175213|FG000|Week 24 Analysis|Adverse Event|1|||
23390380|NCT00468546|65175214|FG001|Week 24 Analysis|Adverse Event|8|||
23390381|NCT00468546|65175213|FG000|Week 24 Analysis|Failure to return|3|||
23390382|NCT00468546|65175214|FG001|Week 24 Analysis|Failure to return|4|||
23390383|NCT00468546|65175213|FG000|Week 24 Analysis|Rescue therapy|2|||
23390384|NCT00468546|65175214|FG001|Week 24 Analysis|Rescue therapy|0|||
23390385|NCT00468546|65175213|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
23390386|NCT00468546|65175214|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
23390387|NCT00468546|65175213|FG000|Week 24 Analysis|Due to clinical hold|1|||
23390388|NCT00468546|65175214|FG001|Week 24 Analysis|Due to clinical hold|0|||
23390389|NCT00468546|65175213|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
23390390|NCT00468546|65175214|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
23495068|NCT00216476|65555052|FG001|Overall Study|Administrative Reasons|1|||
23390391|NCT00468546|65175213|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
23390392|NCT00468546|65175214|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
23390393|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
23390394|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
23390395|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Death|1|||
23390396|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Death|0|||
23390397|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
23390398|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
23390399|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
23390400|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
23390401|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
23390402|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
23390403|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
23390404|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
23390405|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
23390406|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
23390407|NCT00468546|65175213|FG000|Week 24 to Week 104 Analysis|Other|17|||
23390408|NCT00468546|65175214|FG001|Week 24 to Week 104 Analysis|Other|14|||
23390409|NCT02971137|65175217|FG000|Overall Study|Lost to Follow-up|44|||
23390410|NCT02971137|65175218|FG001|Overall Study|Lost to Follow-up|56|||
23390411|NCT02402907|65175222|FG000|Overall Study|Delivered vaginally|9|||
23390412|NCT02402907|65175223|FG001|Overall Study|Delivered vaginally|3|||
23390413|NCT02402907|65175222|FG000|Overall Study|Delivered outside of Sinai|1|||
23390414|NCT02402907|65175223|FG001|Overall Study|Delivered outside of Sinai|1|||
23390415|NCT02402907|65175222|FG000|Overall Study|Lost to follow up after C-Section|10|||
23390416|NCT02402907|65175223|FG001|Overall Study|Lost to follow up after C-Section|23|||
23390417|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
23390418|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23495069|NCT00216476|65555053|FG002|Overall Study|Administrative Reasons|0|||
23495070|NCT00216476|65555051|FG000|Overall Study|Protocol Deviation|5|||
23495071|NCT00216476|65555052|FG001|Overall Study|Protocol Deviation|1|||
23495072|NCT00216476|65555053|FG002|Overall Study|Protocol Deviation|0|||
23495073|NCT00216476|65555051|FG000|Overall Study|Patient Moved|2|||
23495074|NCT00216476|65555052|FG001|Overall Study|Patient Moved|2|||
23495075|NCT00216476|65555053|FG002|Overall Study|Patient Moved|0|||
23495076|NCT01846104|65555062|FG000|Overall Study|Withdrawal by Subject|1|||
23495077|NCT02959983|65555067|FG000|Overall Study|Protocol Violation|0|||
23495078|NCT02959983|65555068|FG001|Overall Study|Protocol Violation|1|||
23390419|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23390420|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23390421|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
23390422|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
23390423|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23495079|NCT02959983|65555067|FG000|Overall Study|Lack of Efficacy|0|||
23495080|NCT02959983|65555068|FG001|Overall Study|Lack of Efficacy|1|||
23495081|NCT02959983|65555067|FG000|Overall Study|Lost to Follow-up|12|||
23390424|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23390425|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23390426|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
23390427|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
23390428|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23390429|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23390430|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23390431|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
23390432|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
23390433|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
23390434|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
23390435|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
23390436|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
23390437|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
23390438|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
23390439|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
23390440|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
23390441|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
23390442|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
23390443|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
23390444|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
23390445|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
23390446|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
23390447|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
23495082|NCT02959983|65555068|FG001|Overall Study|Lost to Follow-up|9|||
23495083|NCT02959983|65555067|FG000|Overall Study|Other|1|||
23495084|NCT02959983|65555068|FG001|Overall Study|Other|1|||
23495085|NCT02959983|65555067|FG000|Overall Study|Physician Decision|1|||
23495086|NCT02959983|65555068|FG001|Overall Study|Physician Decision|0|||
23495087|NCT02959983|65555067|FG000|Overall Study|Adverse Event|5|||
23495088|NCT02959983|65555068|FG001|Overall Study|Adverse Event|1|||
23495089|NCT02959983|65555067|FG000|Overall Study|Withdrawal by Subject|7|||
23495090|NCT02959983|65555068|FG001|Overall Study|Withdrawal by Subject|12|||
23495091|NCT00785928|65555069|FG000|Treatment Phase|Adverse Event|1|||
23495092|NCT00785928|65555070|FG001|Treatment Phase|Adverse Event|1|||
23495093|NCT00785928|65555071|FG002|Treatment Phase|Adverse Event|2|||
23495094|NCT00785928|65555072|FG003|Treatment Phase|Adverse Event|0|||
23495095|NCT00785928|65555073|FG004|Treatment Phase|Adverse Event|0|||
23495096|NCT00785928|65555074|FG005|Treatment Phase|Adverse Event|0|||
23495097|NCT00785928|65555075|FG006|Treatment Phase|Adverse Event|2|||
23495098|NCT00785928|65555069|FG000|Treatment Phase|Inadequate Response|0|||
23495099|NCT00785928|65555070|FG001|Treatment Phase|Inadequate Response|1|||
23495100|NCT00785928|65555071|FG002|Treatment Phase|Inadequate Response|0|||
23495101|NCT00785928|65555072|FG003|Treatment Phase|Inadequate Response|0|||
23495102|NCT00785928|65555073|FG004|Treatment Phase|Inadequate Response|0|||
23495103|NCT00785928|65555074|FG005|Treatment Phase|Inadequate Response|0|||
23495104|NCT00785928|65555075|FG006|Treatment Phase|Inadequate Response|0|||
23495105|NCT00785928|65555069|FG000|Treatment Phase|Lack of Efficacy|0|||
23390448|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23390449|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23390450|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23390451|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
23390452|NCT01111552|65175224|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
23495106|NCT00785928|65555070|FG001|Treatment Phase|Lack of Efficacy|1|||
23495107|NCT00785928|65555071|FG002|Treatment Phase|Lack of Efficacy|1|||
23390453|NCT01111552|65175225|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
23495108|NCT00785928|65555072|FG003|Treatment Phase|Lack of Efficacy|0|||
23495109|NCT00785928|65555073|FG004|Treatment Phase|Lack of Efficacy|0|||
23495110|NCT00785928|65555074|FG005|Treatment Phase|Lack of Efficacy|0|||
23495111|NCT00785928|65555075|FG006|Treatment Phase|Lack of Efficacy|0|||
23495112|NCT00785928|65555069|FG000|Treatment Phase|Physician Decision|0|||
23495113|NCT00785928|65555070|FG001|Treatment Phase|Physician Decision|0|||
23495114|NCT00785928|65555071|FG002|Treatment Phase|Physician Decision|0|||
23495115|NCT00785928|65555072|FG003|Treatment Phase|Physician Decision|0|||
23495116|NCT00785928|65555073|FG004|Treatment Phase|Physician Decision|1|||
23495117|NCT00785928|65555074|FG005|Treatment Phase|Physician Decision|0|||
23495118|NCT00785928|65555075|FG006|Treatment Phase|Physician Decision|0|||
23495119|NCT00785928|65555069|FG000|Treatment Phase|Sponsor Decision|1|||
23495120|NCT00785928|65555070|FG001|Treatment Phase|Sponsor Decision|0|||
23495121|NCT00785928|65555071|FG002|Treatment Phase|Sponsor Decision|0|||
23495122|NCT00785928|65555072|FG003|Treatment Phase|Sponsor Decision|0|||
23495123|NCT00785928|65555073|FG004|Treatment Phase|Sponsor Decision|0|||
23495124|NCT00785928|65555074|FG005|Treatment Phase|Sponsor Decision|0|||
23495125|NCT00785928|65555075|FG006|Treatment Phase|Sponsor Decision|1|||
23495126|NCT00785928|65555069|FG000|Treatment Phase|Withdrawal by Subject|1|||
23495127|NCT00785928|65555070|FG001|Treatment Phase|Withdrawal by Subject|2|||
23495128|NCT00785928|65555071|FG002|Treatment Phase|Withdrawal by Subject|0|||
23495129|NCT00785928|65555072|FG003|Treatment Phase|Withdrawal by Subject|0|||
23495130|NCT00785928|65555073|FG004|Treatment Phase|Withdrawal by Subject|1|||
23495131|NCT00785928|65555074|FG005|Treatment Phase|Withdrawal by Subject|0|||
23495132|NCT00785928|65555075|FG006|Treatment Phase|Withdrawal by Subject|0|||
23390454|NCT01111552|65175226|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
23390455|NCT01111552|65175227|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
23495133|NCT02058693|65555077|FG000|Phase 1|Withdrawal by Subject|3|||
23495134|NCT02058693|65555078|FG001|Phase 1|Withdrawal by Subject|2|||
23495135|NCT02058693|65555077|FG000|Phase 1|Adverse Event|0|||
23495136|NCT02058693|65555078|FG001|Phase 1|Adverse Event|1|||
23495137|NCT02058693|65555077|FG000|Phase 1|Lack of Efficacy|1|||
23495138|NCT02058693|65555078|FG001|Phase 1|Lack of Efficacy|0|||
23495139|NCT02058693|65555077|FG000|Phase 1|Physician Decision|1|||
23495140|NCT02058693|65555078|FG001|Phase 1|Physician Decision|1|||
23495141|NCT02058693|65555077|FG000|Phase 2|Withdrawal by Subject|0|||
23495142|NCT02058693|65555078|FG001|Phase 2|Withdrawal by Subject|2|||
23495143|NCT01268150|65555079|FG000|Treatment Phase|Progression of disease|18|||
23495144|NCT01268150|65555079|FG000|Treatment Phase|Adverse Event|3|||
23495145|NCT01268150|65555079|FG000|Treatment Phase|Withdrawal by Subject|3|||
23495146|NCT01268150|65555079|FG000|Treatment Phase|Other|4|||
23495147|NCT01268150|65555079|FG000|Extension Phase|Adverse Event|3|||
23495148|NCT01268150|65555079|FG000|Extension Phase|Disease progression|18|||
23495149|NCT01268150|65555079|FG000|Extension Phase|Other|6|||
23390456|NCT01111552|65175228|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
23390457|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23390458|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23390459|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23390460|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
23390461|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
23390462|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
23390463|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
23390464|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
23390465|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
23390466|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
23390467|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
23390468|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
23390469|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
23390470|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
23390471|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
23390472|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
23390473|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
23390474|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
23390475|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
23390476|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
23390477|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
23495150|NCT01193530|65555080|FG000|Overall Study|Withdrawal by Subject|2|||
23495151|NCT01193530|65555081|FG001|Overall Study|Withdrawal by Subject|2|||
23495152|NCT01193530|65555080|FG000|Overall Study|Began Contraindicated Therapy|1|||
23495153|NCT01193530|65555081|FG001|Overall Study|Began Contraindicated Therapy|0|||
23495154|NCT01193530|65555080|FG000|Overall Study|Lost Light Box|0|||
23495155|NCT01193530|65555081|FG001|Overall Study|Lost Light Box|1|||
23495156|NCT01193530|65555080|FG000|Overall Study|Returned home - out of state|0|||
23495157|NCT01193530|65555081|FG001|Overall Study|Returned home - out of state|1|||
23495158|NCT01193530|65555080|FG000|Overall Study|Non-Compliance|0|||
23495159|NCT01193530|65555081|FG001|Overall Study|Non-Compliance|1|||
23495160|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Adverse Event|3|||
23495161|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Adverse Event|0|||
23495162|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
23495163|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
23495164|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
23495165|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
23495166|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Physician Decision|0|||
23495167|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Physician Decision|2|||
23495168|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
23495169|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
23495170|NCT02110238|65555084|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
23495171|NCT02110238|65555085|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
23495172|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
23495173|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
23495174|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
23495175|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
23495176|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
23495177|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
23495178|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
23495179|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
23495180|NCT02110238|65555084|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
23299831|NCT02531594|64839978|FG000|Overall Study|Withdrawal by Subject|7|||
23299832|NCT02531594|64839979|FG001|Overall Study|Withdrawal by Subject|8|||
23299833|NCT00983918|64839980|FG000|Overall Study|conversion to open cholecystectomy|0|||
23299834|NCT00983918|64839981|FG001|Overall Study|conversion to open cholecystectomy|2|||
23299835|NCT00983918|64839982|FG002|Overall Study|conversion to open cholecystectomy|2|||
23299836|NCT00983918|64839983|FG003|Overall Study|conversion to open cholecystectomy|2|||
23299837|NCT02691741|64839986|FG000|Overall Study|Adverse Event|0|||
23299838|NCT02691741|64839987|FG001|Overall Study|Adverse Event|2|||
23299839|NCT02691741|64839986|FG000|Overall Study|Lost to Follow-up|1|||
23299840|NCT02691741|64839987|FG001|Overall Study|Lost to Follow-up|0|||
23299841|NCT02691741|64839986|FG000|Overall Study|Physician Decision|0|||
23299842|NCT02691741|64839987|FG001|Overall Study|Physician Decision|1|||
23299843|NCT02691741|64839986|FG000|Overall Study|Withdrawal by Subject|0|||
23299844|NCT02691741|64839987|FG001|Overall Study|Withdrawal by Subject|4|||
23299845|NCT00865514|64839988|FG000|Overall Study|Infusion cost exceeded funding|2|||
23299846|NCT00869024|64839989|FG000|Overall Study|Death|2|||
23299847|NCT00869024|64839990|FG001|Overall Study|Death|3|||
23299848|NCT00869024|64839989|FG000|Overall Study|Lost to Follow-up|0|||
23299849|NCT00869024|64839990|FG001|Overall Study|Lost to Follow-up|1|||
23299850|NCT00869024|64839989|FG000|Overall Study|Protocol Violation|0|||
23299851|NCT00869024|64839990|FG001|Overall Study|Protocol Violation|1|||
23299852|NCT01014624|64839991|FG000|Overall Study|Adverse Event|0|||
23299853|NCT01014624|64839992|FG001|Overall Study|Adverse Event|1|||
23299854|NCT01014624|64839991|FG000|Overall Study|Protocol Violation|1|||
23299855|NCT01014624|64839992|FG001|Overall Study|Protocol Violation|0|||
23299856|NCT01014624|64839991|FG000|Overall Study|Withdrawal by Subject|1|||
23299857|NCT01014624|64839992|FG001|Overall Study|Withdrawal by Subject|0|||
23299858|NCT00536484|64839993|FG000|Overall Study|Adverse Event|21|||
23299859|NCT00536484|64839994|FG001|Overall Study|Adverse Event|34|||
23299860|NCT00536484|64839993|FG000|Overall Study|Withdrawal by Subject|11|||
23299861|NCT00536484|64839994|FG001|Overall Study|Withdrawal by Subject|11|||
23390478|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
23495181|NCT02110238|65555085|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
23299862|NCT00536484|64839993|FG000|Overall Study|Lost to Follow-up|8|||
23299863|NCT00536484|64839994|FG001|Overall Study|Lost to Follow-up|6|||
23299864|NCT00536484|64839993|FG000|Overall Study|Lack of Efficacy|16|||
23299865|NCT00536484|64839994|FG001|Overall Study|Lack of Efficacy|5|||
23299866|NCT00536484|64839993|FG000|Overall Study|Other|4|||
23299867|NCT00536484|64839994|FG001|Overall Study|Other|0|||
23299868|NCT02960438|64839996|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
23390479|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
23390480|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
23390481|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
23390482|NCT01111552|65175224|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23390483|NCT01111552|65175225|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23390484|NCT01111552|65175226|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
23390485|NCT01111552|65175227|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23390486|NCT01111552|65175228|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
23390487|NCT04008069|65175234|FG000|Open-Label Period|Adverse Event|1|||
23390488|NCT04008069|65175235|FG001|Open-Label Period|Adverse Event|0|||
23390489|NCT04008069|65175236|FG002|Open-Label Period|Adverse Event|0|||
23390490|NCT04008069|65175234|FG000|Open-Label Period|Lack of Efficacy|4|||
23390491|NCT04008069|65175235|FG001|Open-Label Period|Lack of Efficacy|0|||
23390492|NCT04008069|65175236|FG002|Open-Label Period|Lack of Efficacy|0|||
23390493|NCT04008069|65175234|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
23390494|NCT04008069|65175235|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
23390495|NCT04008069|65175236|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
23390496|NCT04008069|65175234|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
23390497|NCT04008069|65175235|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
23390498|NCT04008069|65175236|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
23390499|NCT00050011|65175237|FG000|Overall Study|Adverse Event|41|||
23390500|NCT00050011|65175238|FG001|Overall Study|Adverse Event|46|||
23390501|NCT00050011|65175237|FG000|Overall Study|Abnormal laboratory value(s)|1|||
23390502|NCT00050011|65175238|FG001|Overall Study|Abnormal laboratory value(s)|1|||
23390503|NCT00050011|65175237|FG000|Overall Study|Abnormal test procedure results|0|||
23390504|NCT00050011|65175238|FG001|Overall Study|Abnormal test procedure results|1|||
23390505|NCT00050011|65175237|FG000|Overall Study|Lack of Efficacy|16|||
23390506|NCT00050011|65175238|FG001|Overall Study|Lack of Efficacy|21|||
23390507|NCT00050011|65175237|FG000|Overall Study|Participant condition no longer required|1|||
23390508|NCT00050011|65175238|FG001|Overall Study|Participant condition no longer required|0|||
23390509|NCT00050011|65175237|FG000|Overall Study|Protocol Violation|4|||
23390510|NCT00050011|65175238|FG001|Overall Study|Protocol Violation|10|||
23390511|NCT00050011|65175237|FG000|Overall Study|Withdrawal by Subject|34|||
23390512|NCT00050011|65175238|FG001|Overall Study|Withdrawal by Subject|26|||
23390513|NCT00050011|65175237|FG000|Overall Study|Lost to Follow-up|7|||
23390514|NCT00050011|65175238|FG001|Overall Study|Lost to Follow-up|9|||
23390515|NCT00050011|65175237|FG000|Overall Study|Administrative problems|10|||
23390516|NCT00050011|65175238|FG001|Overall Study|Administrative problems|6|||
23390517|NCT00050011|65175237|FG000|Overall Study|Death|7|||
23390518|NCT00050011|65175238|FG001|Overall Study|Death|4|||
23390519|NCT00050011|65175237|FG000|Overall Study|Unknown - Reason is missing|0|||
23390520|NCT00050011|65175238|FG001|Overall Study|Unknown - Reason is missing|2|||
23390521|NCT00458705|65175243|FG000|Overall Study|Adverse Event|4|||
23390522|NCT00458705|65175243|FG000|Overall Study|Not Treated|1|||
23390523|NCT03773562|65175247|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
23390524|NCT03773562|65175247|FG000|Overall Study|Lost to Follow-up|10|||
23390525|NCT03773562|65175247|FG000|Overall Study|Withdrawal by Subject|1|||
23390526|NCT00908141|65175248|FG000|Overall Study|Withdrawal by Subject|0|||
23390527|NCT00908141|65175249|FG001|Overall Study|Withdrawal by Subject|1|||
23390528|NCT03052608|65175255|FG000|Treatment Phase|Adverse Event|10|||
23390529|NCT03052608|65175256|FG001|Treatment Phase|Adverse Event|12|||
23390530|NCT03052608|65175255|FG000|Treatment Phase|Death|6|||
23390531|NCT03052608|65175256|FG001|Treatment Phase|Death|4|||
23390532|NCT03052608|65175255|FG000|Treatment Phase|Withdrawal by Subject|4|||
23390533|NCT03052608|65175256|FG001|Treatment Phase|Withdrawal by Subject|12|||
23390534|NCT03052608|65175255|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
23390535|NCT03052608|65175256|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
23390536|NCT03052608|65175255|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
23390537|NCT03052608|65175256|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
23390538|NCT03052608|65175255|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
23390539|NCT03052608|65175256|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
23495182|NCT02083081|65555086|FG000|Overall Study|Lost to Follow-up|31|||
23495183|NCT02083081|65555087|FG001|Overall Study|Lost to Follow-up|9|||
23495184|NCT00875979|65555088|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
23495185|NCT00875979|65555089|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
23495186|NCT00875979|65555088|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
23495187|NCT00875979|65555089|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
23495188|NCT00875979|65555088|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
23495189|NCT00875979|65555089|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
23495190|NCT00875979|65555088|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
23495191|NCT00875979|65555089|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
23495192|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
23495193|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
23495194|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
23495195|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
23495196|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
23299869|NCT02960438|64839997|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
23299870|NCT02960438|64839998|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
23299871|NCT02960438|64839999|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
23299872|NCT02960438|64839996|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
23299873|NCT02960438|64839997|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
23299874|NCT02960438|64839998|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
23299875|NCT02960438|64839999|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
23299876|NCT02960438|64839996|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
23299877|NCT02960438|64839997|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
23299878|NCT02960438|64839998|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
23299879|NCT02960438|64839999|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
23299880|NCT02960438|64839996|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
23299881|NCT02960438|64839997|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
23299882|NCT02960438|64839998|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
23299883|NCT02960438|64839999|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
23299884|NCT02960438|64839996|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
23299885|NCT02960438|64839997|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
23299886|NCT02960438|64839998|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
23299887|NCT02960438|64839999|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
23299888|NCT02960438|64839996|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
23299889|NCT02960438|64839997|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
23299890|NCT02960438|64839998|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
23299891|NCT02960438|64839999|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
23299892|NCT02960438|64839996|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
23299893|NCT02960438|64839997|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
23299894|NCT02960438|64839998|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
23299895|NCT02960438|64839999|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
23299896|NCT02960438|64839996|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
23299897|NCT02960438|64839997|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
23299898|NCT02960438|64839998|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
23299899|NCT02960438|64839999|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
23299900|NCT02960438|64839996|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
23299901|NCT02960438|64839997|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
23299902|NCT02960438|64839998|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
23299903|NCT02960438|64839999|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
23299904|NCT02960438|64839996|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
23299905|NCT02960438|64839997|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
23299906|NCT02960438|64839998|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
23299907|NCT02960438|64839999|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
23299908|NCT02960438|64839996|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
23299909|NCT02960438|64839997|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
23299910|NCT02960438|64839998|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
23299911|NCT02960438|64839999|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
23299912|NCT02960438|64839996|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
23299913|NCT02960438|64839997|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
23299914|NCT02960438|64839998|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
23299915|NCT02960438|64839999|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
23495197|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
23495198|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
23495199|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
23390540|NCT03052608|65175255|FG000|Treatment Phase|Ongoing|103|||
23390541|NCT03052608|65175256|FG001|Treatment Phase|Ongoing|31|||
23390542|NCT03052608|65175255|FG000|Long-Term Follow-up Phase|Death|23|||
23390543|NCT03052608|65175256|FG001|Long-Term Follow-up Phase|Death|28|||
23390544|NCT03052608|65175255|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
23390545|NCT03052608|65175256|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
23390546|NCT03052608|65175255|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
23390547|NCT03052608|65175256|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
23390548|NCT03052608|65175255|FG000|Long-Term Follow-up Phase|Ongoing|122|||
23390549|NCT03052608|65175256|FG001|Long-Term Follow-up Phase|Ongoing|99|||
23390550|NCT04551053|65175257|FG000|Overall Study|Death|9|||
23390551|NCT04551053|65175258|FG001|Overall Study|Death|9|||
23390552|NCT04551053|65175257|FG000|Overall Study|Lost to Follow-up|0|||
23390553|NCT04551053|65175258|FG001|Overall Study|Lost to Follow-up|2|||
23390554|NCT04551053|65175257|FG000|Overall Study|Study Terminated by Sponsor|53|||
23390555|NCT04551053|65175258|FG001|Overall Study|Study Terminated by Sponsor|63|||
23390556|NCT04551053|65175257|FG000|Overall Study|Withdrawal by Subject|12|||
23390557|NCT04551053|65175258|FG001|Overall Study|Withdrawal by Subject|5|||
23390558|NCT04551053|65175257|FG000|Overall Study|Adverse Event|1|||
23390559|NCT04551053|65175258|FG001|Overall Study|Adverse Event|0|||
23390560|NCT04551053|65175257|FG000|Overall Study|Lack of Efficacy|2|||
23390561|NCT04551053|65175258|FG001|Overall Study|Lack of Efficacy|0|||
23390562|NCT04551053|65175257|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
23390563|NCT04551053|65175258|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
23495200|NCT00875979|65555088|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
23495201|NCT00875979|65555089|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
23495202|NCT00492531|65555097|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
23495203|NCT00492531|65555098|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
23495204|NCT02124161|65555099|FG000|Overall Study|Other unspecified|0|||
23495205|NCT02124161|65555100|FG001|Overall Study|Other unspecified|1|||
23495206|NCT02124161|65555099|FG000|Overall Study|Death|1|||
23495207|NCT02124161|65555100|FG001|Overall Study|Death|0|||
23495208|NCT02124161|65555099|FG000|Overall Study|Protocol Violation|2|||
23495209|NCT02124161|65555100|FG001|Overall Study|Protocol Violation|1|||
23495210|NCT02124161|65555099|FG000|Overall Study|Withdrawal by Subject|1|||
23495211|NCT02124161|65555100|FG001|Overall Study|Withdrawal by Subject|2|||
23495212|NCT02124161|65555099|FG000|Overall Study|Adverse Event|2|||
23495213|NCT02124161|65555100|FG001|Overall Study|Adverse Event|0|||
23495214|NCT02124161|65555099|FG000|Overall Study|Does not meet entrance criteria|2|||
23495215|NCT02124161|65555100|FG001|Overall Study|Does not meet entrance criteria|3|||
23495216|NCT02124161|65555099|FG000|Overall Study|No longer meets eligibility criteria|5|||
23495217|NCT02124161|65555100|FG001|Overall Study|No longer meets eligibility criteria|4|||
23495218|NCT02124161|65555099|FG000|Overall Study|Lost to Follow-up|3|||
23495219|NCT02124161|65555100|FG001|Overall Study|Lost to Follow-up|4|||
23495220|NCT00892047|65555101|FG000|Overall Study|Adverse Event|2|||
23495221|NCT00892047|65555102|FG001|Overall Study|Adverse Event|2|||
23495222|NCT00892047|65555101|FG000|Overall Study|subject burden|2|||
23495223|NCT00892047|65555102|FG001|Overall Study|subject burden|3|||
23495224|NCT00892047|65555101|FG000|Overall Study|Lack of Efficacy|0|||
23495225|NCT00892047|65555102|FG001|Overall Study|Lack of Efficacy|2|||
23495226|NCT01034631|65555103|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
23495227|NCT01034631|65555104|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
23495228|NCT01034631|65555105|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
23495229|NCT01034631|65555103|FG000|Phase II|Not Evaluable per protocol|0|||
23495230|NCT01034631|65555104|FG001|Phase II|Not Evaluable per protocol|0|||
23495231|NCT01034631|65555105|FG002|Phase II|Not Evaluable per protocol|2|||
23495232|NCT01034631|65555103|FG000|Phase II|Determined Ineligible per protocol|0|||
23495233|NCT01034631|65555104|FG001|Phase II|Determined Ineligible per protocol|1|||
23495234|NCT01034631|65555105|FG002|Phase II|Determined Ineligible per protocol|0|||
23495235|NCT03934684|65555106|FG000|Overall Study|Participants continuing in study|11|||
23495236|NCT03934684|65555107|FG001|Overall Study|Participants continuing in study|4|||
23495237|NCT03934684|65555106|FG000|Overall Study|Discontinuation of carfilzomib|20|||
23390564|NCT04551053|65175257|FG000|Overall Study|Splenapendectomi|1|||
23495238|NCT03934684|65555107|FG001|Overall Study|Discontinuation of carfilzomib|30|||
23495239|NCT03934684|65555106|FG000|Overall Study|Death|2|||
23495240|NCT03934684|65555107|FG001|Overall Study|Death|2|||
23495241|NCT03934684|65555106|FG000|Overall Study|Lost to Follow-up|2|||
23495242|NCT03934684|65555107|FG001|Overall Study|Lost to Follow-up|5|||
23390565|NCT04551053|65175258|FG001|Overall Study|Splenapendectomi|0|||
23390566|NCT04551053|65175257|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
23390567|NCT04551053|65175258|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
23390568|NCT04551053|65175257|FG000|Overall Study|Medical Decision|0|||
23390569|NCT04551053|65175258|FG001|Overall Study|Medical Decision|1|||
23390570|NCT04551053|65175257|FG000|Overall Study|Ongoing|6|||
23390571|NCT04551053|65175258|FG001|Overall Study|Ongoing|4|||
23390572|NCT01916226|65175261|FG000|Overall Study|Adverse Event|1|||
23390573|NCT01916226|65175262|FG001|Overall Study|Adverse Event|0|||
23390574|NCT01916226|65175263|FG002|Overall Study|Adverse Event|1|||
23390575|NCT01916226|65175264|FG003|Overall Study|Adverse Event|1|||
23390576|NCT01916226|65175261|FG000|Overall Study|Lack of Efficacy|0|||
23390577|NCT01916226|65175262|FG001|Overall Study|Lack of Efficacy|0|||
23390578|NCT01916226|65175263|FG002|Overall Study|Lack of Efficacy|2|||
23390579|NCT01916226|65175264|FG003|Overall Study|Lack of Efficacy|1|||
23390580|NCT01916226|65175261|FG000|Overall Study|Protocol Violation|0|||
23390581|NCT01916226|65175262|FG001|Overall Study|Protocol Violation|1|||
23390582|NCT01916226|65175263|FG002|Overall Study|Protocol Violation|0|||
23390583|NCT01916226|65175264|FG003|Overall Study|Protocol Violation|1|||
23390584|NCT01916226|65175261|FG000|Overall Study|Physician Decision|0|||
23390585|NCT01916226|65175262|FG001|Overall Study|Physician Decision|0|||
23390586|NCT01916226|65175263|FG002|Overall Study|Physician Decision|0|||
23390587|NCT01916226|65175264|FG003|Overall Study|Physician Decision|1|||
23390588|NCT00635050|65175265|FG000|Overall Study|Withdrawal by Subject|1|||
23390589|NCT00720083|65175269|FG000|Overall Study|Ineligible|1|||
23390590|NCT00720083|65175270|FG001|Overall Study|Ineligible|2|||
23390591|NCT03627468|65175271|FG000|Overall Study|Adverse Event|5|||
23390592|NCT03627468|65175272|FG001|Overall Study|Adverse Event|33|||
23390593|NCT03627468|65175271|FG000|Overall Study|Withdrawal by Subject|13|||
23390594|NCT03627468|65175272|FG001|Overall Study|Withdrawal by Subject|23|||
23390595|NCT03627468|65175271|FG000|Overall Study|Physician Decision|1|||
23390596|NCT03627468|65175272|FG001|Overall Study|Physician Decision|0|||
23390597|NCT03627468|65175271|FG000|Overall Study|Protocol Violation|0|||
23390598|NCT03627468|65175272|FG001|Overall Study|Protocol Violation|2|||
23390599|NCT03627468|65175271|FG000|Overall Study|Lost to Follow-up|10|||
23390600|NCT03627468|65175272|FG001|Overall Study|Lost to Follow-up|16|||
23390601|NCT03627468|65175271|FG000|Overall Study|Death|1|||
23390602|NCT03627468|65175272|FG001|Overall Study|Death|0|||
23390603|NCT03627468|65175271|FG000|Overall Study|Pregnancy|1|||
23390604|NCT03627468|65175272|FG001|Overall Study|Pregnancy|1|||
23390605|NCT03627468|65175271|FG000|Overall Study|Lack of Efficacy|0|||
23390606|NCT03627468|65175272|FG001|Overall Study|Lack of Efficacy|2|||
23390607|NCT03627468|65175271|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
23390608|NCT03627468|65175272|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
23390609|NCT01347086|65175295|FG000|Overall Study|failed screening visit|0|||
23390610|NCT01347086|65175296|FG001|Overall Study|failed screening visit|0|||
23390611|NCT01347086|65175297|FG002|Overall Study|failed screening visit|1|||
23390612|NCT01347086|65175298|FG003|Overall Study|failed screening visit|0|||
23390613|NCT01347086|65175299|FG004|Overall Study|failed screening visit|0|||
23390614|NCT01347086|65175300|FG005|Overall Study|failed screening visit|0|||
23390615|NCT01347086|65175301|FG006|Overall Study|failed screening visit|1|||
23390616|NCT01347086|65175302|FG007|Overall Study|failed screening visit|1|||
23390617|NCT01347086|65175303|FG008|Overall Study|failed screening visit|0|||
23390618|NCT01347086|65175304|FG009|Overall Study|failed screening visit|1|||
23390619|NCT01013870|65175305|FG000|Overall Study|Lost to Follow-up|1|||
23390620|NCT01013870|65175306|FG001|Overall Study|Lost to Follow-up|3|||
23390621|NCT01674062|65175307|FG000|Overall Study|Insufficient Therapeutic Response|56|||
23390622|NCT01674062|65175308|FG001|Overall Study|Insufficient Therapeutic Response|26|||
23390623|NCT01674062|65175307|FG000|Overall Study|Other|8|||
23390624|NCT01674062|65175308|FG001|Overall Study|Other|1|||
23390625|NCT01674062|65175307|FG000|Overall Study|Adverse Event|1|||
23390626|NCT01674062|65175308|FG001|Overall Study|Adverse Event|1|||
23390627|NCT01674062|65175307|FG000|Overall Study|Death|0|||
23390628|NCT01674062|65175308|FG001|Overall Study|Death|1|||
23390629|NCT01674062|65175307|FG000|Overall Study|Programming Error|1|||
23390630|NCT01674062|65175308|FG001|Overall Study|Programming Error|0|||
23390631|NCT02502383|65175320|FG000|Overall Study|Lost to Follow-up|130|||
23390632|NCT02502383|65175321|FG001|Overall Study|Lost to Follow-up|131|||
23390633|NCT02502383|65175320|FG000|Overall Study|Withdrawal by Subject|31|||
23390634|NCT02502383|65175321|FG001|Overall Study|Withdrawal by Subject|24|||
23390635|NCT02410200|65175322|FG000|Overall Study|Adverse Event|2|||
23390636|NCT01903863|65175323|FG000|Overall Study|Physician Decision|2|||
23390637|NCT01903863|65175324|FG001|Overall Study|Physician Decision|0|||
23390638|NCT01472185|65175329|FG000|Overall Study|Randomized but Not Treated|0|||
23390639|NCT01472185|65175330|FG001|Overall Study|Randomized but Not Treated|1|||
23390640|NCT01472185|65175329|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
23390641|NCT01472185|65175330|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
23390642|NCT01472185|65175329|FG000|Overall Study|Hyperglycemia|5|||
23390643|NCT01472185|65175330|FG001|Overall Study|Hyperglycemia|2|||
23390644|NCT01472185|65175329|FG000|Overall Study|Investigator's Discretion|3|||
23390645|NCT01472185|65175330|FG001|Overall Study|Investigator's Discretion|1|||
23390646|NCT01472185|65175329|FG000|Overall Study|Lost to Follow-up|4|||
23390647|NCT01472185|65175330|FG001|Overall Study|Lost to Follow-up|1|||
23390648|NCT01472185|65175329|FG000|Overall Study|Protocol Violation|5|||
23390649|NCT01472185|65175330|FG001|Overall Study|Protocol Violation|1|||
23390650|NCT01472185|65175329|FG000|Overall Study|Subject Noncompliance|8|||
23390651|NCT01472185|65175330|FG001|Overall Study|Subject Noncompliance|15|||
23390652|NCT01472185|65175329|FG000|Overall Study|Subject Withdrew Consent|6|||
23390653|NCT01472185|65175330|FG001|Overall Study|Subject Withdrew Consent|3|||
23390654|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
23390655|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Adverse Event|1|||
23390656|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
23390657|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Physician Decision|1|||
23390658|NCT00088881|65175335|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
23390659|NCT00088881|65175335|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
23390660|NCT00088881|65175335|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
23390661|NCT00089583|65175337|FG000|Overall Study|Adverse Event|0|||
23390662|NCT00089583|65175338|FG001|Overall Study|Adverse Event|3|||
23299916|NCT01688726|64840000|FG000|Overall Study|Adverse Event|1|||
23299917|NCT01688726|64840001|FG001|Overall Study|Adverse Event|0|||
23299918|NCT01688726|64840000|FG000|Overall Study|Relocated abroad|0|||
23299919|NCT01688726|64840001|FG001|Overall Study|Relocated abroad|1|||
23299920|NCT00904748|64840002|FG000|Overall Study|Withdrawal by Subject|1|||
23299921|NCT00904748|64840003|FG001|Overall Study|Withdrawal by Subject|1|||
23299922|NCT00904748|64840004|FG002|Overall Study|Withdrawal by Subject|1|||
23299923|NCT00904748|64840005|FG003|Overall Study|Withdrawal by Subject|2|||
23299924|NCT00904748|64840006|FG004|Overall Study|Withdrawal by Subject|0|||
23299925|NCT00904748|64840007|FG005|Overall Study|Withdrawal by Subject|0|||
23299926|NCT00904748|64840002|FG000|Overall Study|Adverse Event|0|||
23299927|NCT00904748|64840003|FG001|Overall Study|Adverse Event|0|||
23299928|NCT00904748|64840004|FG002|Overall Study|Adverse Event|0|||
23299929|NCT00904748|64840005|FG003|Overall Study|Adverse Event|0|||
23299930|NCT00904748|64840006|FG004|Overall Study|Adverse Event|1|||
23299931|NCT00904748|64840007|FG005|Overall Study|Adverse Event|0|||
23299932|NCT00493454|64840010|FG000|Overall Study|Withdrawal by Subject|1|||
23299933|NCT00518622|64840011|FG000|Overall Study|Lost to Follow-up|0|||
23299934|NCT00518622|64840012|FG001|Overall Study|Lost to Follow-up|0|||
23299935|NCT00518622|64840013|FG002|Overall Study|Lost to Follow-up|1|||
23299936|NCT00518622|64840014|FG003|Overall Study|Lost to Follow-up|0|||
23299937|NCT00518622|64840015|FG004|Overall Study|Lost to Follow-up|0|||
23299938|NCT00518622|64840016|FG005|Overall Study|Lost to Follow-up|0|||
23299939|NCT00518622|64840017|FG006|Overall Study|Lost to Follow-up|0|||
23299940|NCT00518622|64840018|FG007|Overall Study|Lost to Follow-up|0|||
23299941|NCT00518622|64840011|FG000|Overall Study|Study medication taken incorrectly|0|||
23299942|NCT00518622|64840012|FG001|Overall Study|Study medication taken incorrectly|1|||
23299943|NCT00518622|64840013|FG002|Overall Study|Study medication taken incorrectly|0|||
23299944|NCT00518622|64840014|FG003|Overall Study|Study medication taken incorrectly|0|||
23299945|NCT00518622|64840015|FG004|Overall Study|Study medication taken incorrectly|0|||
23299946|NCT00518622|64840016|FG005|Overall Study|Study medication taken incorrectly|0|||
23299947|NCT00518622|64840017|FG006|Overall Study|Study medication taken incorrectly|0|||
23299948|NCT00518622|64840018|FG007|Overall Study|Study medication taken incorrectly|0|||
23390663|NCT00089583|65175337|FG000|Overall Study|Insufficient Viral Load Response|5|||
23390664|NCT00089583|65175338|FG001|Overall Study|Insufficient Viral Load Response|5|||
23390665|NCT00089583|65175337|FG000|Overall Study|Withdrawal by Subject|0|||
23390666|NCT00089583|65175338|FG001|Overall Study|Withdrawal by Subject|4|||
23390667|NCT00089583|65175337|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
23299949|NCT00606502|64840019|FG000|Randomization|Randomized but not treated|3|||
23299950|NCT00606502|64840020|FG001|Randomization|Randomized but not treated|0|||
23299951|NCT00606502|64840019|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
23299952|NCT00606502|64840020|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
23390668|NCT00089583|65175338|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
23390669|NCT00089583|65175337|FG000|Overall Study|Participant Refused Study Medication|0|||
23299953|NCT02377921|64840021|FG000|Overall Study|Subject non-compliance|1|||
23299954|NCT02377921|64840022|FG001|Overall Study|Subject non-compliance|1|||
23299955|NCT01884688|64840023|FG000|Overall Study|Screen Failure|2|||
23299956|NCT00619359|64840024|FG000|Overall Study|Adverse Event|32|||
23299957|NCT00619359|64840025|FG001|Overall Study|Adverse Event|36|||
23299958|NCT00619359|64840024|FG000|Overall Study|Lost to Follow-up|12|||
23390670|NCT00089583|65175338|FG001|Overall Study|Participant Refused Study Medication|2|||
23390671|NCT00089583|65175337|FG000|Overall Study|Non-Compliance|0|||
23390672|NCT00089583|65175338|FG001|Overall Study|Non-Compliance|4|||
23390673|NCT00089583|65175337|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
23390674|NCT00089583|65175338|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
23390675|NCT00089583|65175337|FG000|Overall Study|Participant Management Criteria Met|0|||
23390676|NCT00089583|65175338|FG001|Overall Study|Participant Management Criteria Met|1|||
23390677|NCT00089583|65175337|FG000|Overall Study|Reason Not Provided|0|||
23390678|NCT00089583|65175338|FG001|Overall Study|Reason Not Provided|1|||
23390679|NCT00089583|65175337|FG000|Overall Study|Protocol Violation|0|||
23390680|NCT00089583|65175338|FG001|Overall Study|Protocol Violation|3|||
23390681|NCT00089583|65175337|FG000|Overall Study|Principal Investigator Decision|0|||
23390682|NCT00089583|65175338|FG001|Overall Study|Principal Investigator Decision|10|||
23390683|NCT00089583|65175337|FG000|Overall Study|Start of Disallowed Medication|0|||
23390684|NCT00089583|65175338|FG001|Overall Study|Start of Disallowed Medication|1|||
23390685|NCT00089583|65175337|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
23390686|NCT00089583|65175338|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
23390687|NCT00089583|65175337|FG000|Overall Study|Participant Incarcerated|0|||
23390688|NCT00089583|65175338|FG001|Overall Study|Participant Incarcerated|1|||
23390689|NCT04650893|65175339|FG000|Overall Study|Lost to Follow-up|11|||
23390690|NCT04650893|65175340|FG001|Overall Study|Lost to Follow-up|10|||
23390691|NCT04650893|65175341|FG002|Overall Study|Lost to Follow-up|11|||
23390692|NCT00855166|65175342|FG000|Overall Study|Adverse Event|0|||
23390693|NCT00855166|65175343|FG001|Overall Study|Adverse Event|2|||
23390694|NCT00855166|65175342|FG000|Overall Study|Death|0|||
23390695|NCT00855166|65175343|FG001|Overall Study|Death|1|||
23390696|NCT00855166|65175342|FG000|Overall Study|Withdrawal by Subject|1|||
23390697|NCT00855166|65175343|FG001|Overall Study|Withdrawal by Subject|4|||
23390698|NCT00855166|65175342|FG000|Overall Study|Poor/non-compliance|2|||
23390699|NCT00855166|65175343|FG001|Overall Study|Poor/non-compliance|0|||
23390700|NCT00855166|65175342|FG000|Overall Study|Administrative reasons by sponsor|1|||
23390701|NCT00855166|65175343|FG001|Overall Study|Administrative reasons by sponsor|0|||
23390702|NCT00855166|65175342|FG000|Overall Study|Subject no longer meets study criteria|1|||
23390703|NCT00855166|65175343|FG001|Overall Study|Subject no longer meets study criteria|1|||
23390704|NCT02529488|65175344|FG000|Overall Study|Adverse Event|1|||
23390705|NCT02529488|65175344|FG000|Overall Study|Death|3|||
23390706|NCT01908699|65175345|FG000|Overall Study|Adverse Event|8|||
23390707|NCT01908699|65175346|FG001|Overall Study|Adverse Event|12|||
23390708|NCT01908699|65175345|FG000|Overall Study|Lack of Efficacy|2|||
23495243|NCT03934684|65555106|FG000|Overall Study|Withdrawal by Subject|7|||
23495244|NCT03934684|65555107|FG001|Overall Study|Withdrawal by Subject|8|||
23495245|NCT01254292|65555108|FG000|Comparative Phase|Adverse Event|25|||
23495246|NCT01254292|65555109|FG001|Comparative Phase|Adverse Event|25|||
23390709|NCT01908699|65175346|FG001|Overall Study|Lack of Efficacy|2|||
23390710|NCT01908699|65175345|FG000|Overall Study|Lost to Follow-up|2|||
23390711|NCT01908699|65175346|FG001|Overall Study|Lost to Follow-up|4|||
23390712|NCT01908699|65175345|FG000|Overall Study|Physician Decision|8|||
23390713|NCT01908699|65175346|FG001|Overall Study|Physician Decision|8|||
23495247|NCT01254292|65555108|FG000|Comparative Phase|Lost to Follow-up|3|||
23495248|NCT01254292|65555109|FG001|Comparative Phase|Lost to Follow-up|21|||
23495249|NCT01254292|65555108|FG000|Comparative Phase|Pregnancy|2|||
23495250|NCT01254292|65555109|FG001|Comparative Phase|Pregnancy|6|||
23495251|NCT01254292|65555108|FG000|Comparative Phase|Withdrawal by Subject|20|||
23390714|NCT01908699|65175345|FG000|Overall Study|Withdrawal by Subject|15|||
23390715|NCT01908699|65175346|FG001|Overall Study|Withdrawal by Subject|10|||
23390716|NCT01908699|65175345|FG000|Overall Study|Pregnancy|0|||
23299959|NCT00619359|64840025|FG001|Overall Study|Lost to Follow-up|16|||
23299960|NCT00619359|64840024|FG000|Overall Study|Physician Decision|0|||
23495252|NCT01254292|65555109|FG001|Comparative Phase|Withdrawal by Subject|21|||
23495253|NCT01254292|65555108|FG000|Comparative Phase|Protocol Violation|1|||
23495254|NCT01254292|65555109|FG001|Comparative Phase|Protocol Violation|2|||
23495255|NCT01254292|65555108|FG000|Comparative Phase|Wish for pregnancy|4|||
23495256|NCT01254292|65555109|FG001|Comparative Phase|Wish for pregnancy|6|||
23495257|NCT01254292|65555108|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
23495258|NCT01254292|65555109|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
23495259|NCT01254292|65555108|FG000|LCS12 Extension Phase|Adverse Event|9|||
23495260|NCT01254292|65555109|FG001|LCS12 Extension Phase|Adverse Event|0|||
23495261|NCT01254292|65555108|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
23299961|NCT00619359|64840025|FG001|Overall Study|Physician Decision|7|||
23495262|NCT01254292|65555109|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
23390717|NCT01908699|65175346|FG001|Overall Study|Pregnancy|1|||
23390718|NCT01908699|65175345|FG000|Overall Study|Randomized in Error|1|||
23390719|NCT01908699|65175346|FG001|Overall Study|Randomized in Error|0|||
23495263|NCT01254292|65555108|FG000|LCS12 Extension Phase|Other unknown|4|||
23495264|NCT01254292|65555109|FG001|LCS12 Extension Phase|Other unknown|0|||
23495265|NCT01254292|65555108|FG000|LCS12 Extension Phase|Pregnancy|2|||
23495266|NCT01254292|65555109|FG001|LCS12 Extension Phase|Pregnancy|0|||
23495267|NCT01254292|65555108|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
23495268|NCT01254292|65555109|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
23495269|NCT03080454|65555115|FG000|Baseline|Adverse Event|2|||
23390720|NCT01908699|65175345|FG000|Overall Study|Death|9|||
23299962|NCT00619359|64840024|FG000|Overall Study|Protocol Violation|1|||
23299963|NCT00619359|64840025|FG001|Overall Study|Protocol Violation|1|||
23299964|NCT00619359|64840024|FG000|Overall Study|Withdrawal by Subject|19|||
23299965|NCT00619359|64840025|FG001|Overall Study|Withdrawal by Subject|20|||
23299966|NCT00619359|64840024|FG000|Overall Study|Progressive Disease|3|||
23299967|NCT00619359|64840025|FG001|Overall Study|Progressive Disease|1|||
23299968|NCT00389831|64840026|FG000|Overall Study|Lack of Efficacy|0|||
23390721|NCT01908699|65175346|FG001|Overall Study|Death|12|||
23390722|NCT01908699|65175345|FG000|Overall Study|Progressive Disease|30|||
23390723|NCT01908699|65175346|FG001|Overall Study|Progressive Disease|29|||
23390724|NCT02799043|65175353|FG000|Overall Study|Adverse Event|0|||
23390725|NCT02799043|65175354|FG001|Overall Study|Adverse Event|1|||
23390726|NCT02799043|65175353|FG000|Overall Study|Death|1|||
23390727|NCT02799043|65175354|FG001|Overall Study|Death|1|||
23390728|NCT02799043|65175353|FG000|Overall Study|Lost to Follow-up|3|||
23390729|NCT02799043|65175354|FG001|Overall Study|Lost to Follow-up|6|||
23390730|NCT02799043|65175353|FG000|Overall Study|Withdrawal by Subject|4|||
23390731|NCT02799043|65175354|FG001|Overall Study|Withdrawal by Subject|4|||
23390732|NCT02799043|65175353|FG000|Overall Study|Moved to different country|0|||
23390733|NCT02799043|65175354|FG001|Overall Study|Moved to different country|1|||
23390734|NCT02799043|65175353|FG000|Overall Study|Trial Screen Failure|1|||
23390735|NCT02799043|65175354|FG001|Overall Study|Trial Screen Failure|0|||
23390736|NCT02799043|65175353|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
23390737|NCT02799043|65175354|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
23390738|NCT01813357|65175355|FG000|Overall Study|Lost to Follow-up|5|||
23390739|NCT01813357|65175356|FG001|Overall Study|Lost to Follow-up|6|||
23390740|NCT02496156|65175361|FG000|Overall Study|Lost to Follow-up|5|||
23390741|NCT02496156|65175362|FG001|Overall Study|Lost to Follow-up|0|||
23390742|NCT02496156|65175361|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
23390743|NCT02496156|65175362|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
23390744|NCT02255656|65175363|FG000|Overall Study|Adverse Event|11|||
23390745|NCT02255656|65175363|FG000|Overall Study|Poor compliance to protocol|3|||
23390746|NCT02255656|65175363|FG000|Overall Study|Lost to Follow-up|30|||
23390747|NCT02255656|65175363|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
23390748|NCT02255656|65175363|FG000|Overall Study|Other|126|||
23390749|NCT01840163|65175368|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
23495270|NCT03080454|65555115|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
23495271|NCT03080454|65555115|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
23495272|NCT00913380|65555116|FG000|Clinical Outcomes|Lost to Follow-up|6|||
23299969|NCT00389831|64840027|FG001|Overall Study|Lack of Efficacy|2|||
23299970|NCT00389831|64840026|FG000|Overall Study|Did not receive treatment.|0|||
23299971|NCT00389831|64840027|FG001|Overall Study|Did not receive treatment.|2|||
23299972|NCT00389831|64840026|FG000|Overall Study|Other reasons|0|||
23299973|NCT00389831|64840027|FG001|Overall Study|Other reasons|2|||
23299974|NCT00389831|64840026|FG000|Overall Study|Lost to Follow-up|0|||
23299975|NCT00389831|64840027|FG001|Overall Study|Lost to Follow-up|1|||
23299976|NCT00614822|64840032|FG000|Overall Study|Adverse Event|3|||
23299977|NCT00573157|64840034|FG000|Overall Study|Adverse Event|3|||
23299978|NCT00573157|64840035|FG001|Overall Study|Adverse Event|1|||
23299979|NCT00573157|64840034|FG000|Overall Study|Other|1|||
23299980|NCT00573157|64840035|FG001|Overall Study|Other|1|||
23299981|NCT01725282|64840036|FG000|Overall Study|Adverse Event|1|||
23299982|NCT01725282|64840037|FG001|Overall Study|Adverse Event|3|||
23299983|NCT01725282|64840038|FG002|Overall Study|Adverse Event|6|||
23299984|NCT01725282|64840039|FG003|Overall Study|Adverse Event|4|||
23299985|NCT01725282|64840036|FG000|Overall Study|Exacerbation of Target Disease|1|||
23299986|NCT01725282|64840037|FG001|Overall Study|Exacerbation of Target Disease|0|||
23299987|NCT01725282|64840038|FG002|Overall Study|Exacerbation of Target Disease|0|||
23299988|NCT01725282|64840039|FG003|Overall Study|Exacerbation of Target Disease|1|||
23299989|NCT01725282|64840036|FG000|Overall Study|Met Exclusion Criteria|0|||
23299990|NCT01725282|64840037|FG001|Overall Study|Met Exclusion Criteria|0|||
23299991|NCT01725282|64840038|FG002|Overall Study|Met Exclusion Criteria|1|||
23299992|NCT01725282|64840039|FG003|Overall Study|Met Exclusion Criteria|0|||
23299993|NCT01725282|64840036|FG000|Overall Study|Study Site Withdrawal|0|||
23299994|NCT01725282|64840037|FG001|Overall Study|Study Site Withdrawal|1|||
23299995|NCT01725282|64840038|FG002|Overall Study|Study Site Withdrawal|0|||
23299996|NCT01725282|64840039|FG003|Overall Study|Study Site Withdrawal|0|||
23299997|NCT01725282|64840036|FG000|Overall Study|Withdrawal by Subject|0|||
23299998|NCT01725282|64840037|FG001|Overall Study|Withdrawal by Subject|0|||
23299999|NCT01725282|64840038|FG002|Overall Study|Withdrawal by Subject|1|||
23300000|NCT01725282|64840039|FG003|Overall Study|Withdrawal by Subject|1|||
23300001|NCT01725282|64840036|FG000|Overall Study|Lack of Efficacy|0|||
23300002|NCT01725282|64840037|FG001|Overall Study|Lack of Efficacy|1|||
23300003|NCT01725282|64840038|FG002|Overall Study|Lack of Efficacy|0|||
23300004|NCT01725282|64840039|FG003|Overall Study|Lack of Efficacy|1|||
23300005|NCT02225665|64840042|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
23300006|NCT02225665|64840043|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
23300007|NCT02225665|64840042|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
23300008|NCT02225665|64840043|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
23300009|NCT01564459|64840045|FG000|Run-In|Adverse Event|7|||
23300010|NCT01564459|64840046|FG001|Run-In|Adverse Event|0|||
23390750|NCT01840163|65175369|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
23390751|NCT01840163|65175368|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
23390752|NCT01840163|65175369|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
23300011|NCT01564459|64840047|FG002|Run-In|Adverse Event|0|||
23300012|NCT01564459|64840045|FG000|Run-In|Lost to Follow-up|1|||
23300013|NCT01564459|64840046|FG001|Run-In|Lost to Follow-up|0|||
23300014|NCT01564459|64840047|FG002|Run-In|Lost to Follow-up|0|||
23300015|NCT01564459|64840045|FG000|Run-In|Non-compliance with study drug|2|||
23300016|NCT01564459|64840046|FG001|Run-In|Non-compliance with study drug|0|||
23300017|NCT01564459|64840047|FG002|Run-In|Non-compliance with study drug|0|||
23300018|NCT01564459|64840045|FG000|Run-In|Protocol Violation|1|||
23300019|NCT01564459|64840046|FG001|Run-In|Protocol Violation|0|||
23390753|NCT01840163|65175368|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
23390754|NCT01840163|65175369|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
23390755|NCT01767857|65175370|FG000|Overall Study|Adverse Event|27|||
23390756|NCT01767857|65175371|FG001|Overall Study|Adverse Event|7|||
23390757|NCT01767857|65175370|FG000|Overall Study|Death|28|||
23390758|NCT01767857|65175371|FG001|Overall Study|Death|13|||
23390759|NCT01767857|65175370|FG000|Overall Study|Lack of Efficacy|299|||
23390760|NCT01767857|65175371|FG001|Overall Study|Lack of Efficacy|151|||
23390761|NCT01767857|65175370|FG000|Overall Study|Lost to Follow-up|1|||
23390762|NCT01767857|65175371|FG001|Overall Study|Lost to Follow-up|1|||
23390763|NCT01767857|65175370|FG000|Overall Study|Withdrawal by Subject|38|||
23390764|NCT01767857|65175371|FG001|Overall Study|Withdrawal by Subject|18|||
23390765|NCT01767857|65175370|FG000|Overall Study|Physician Decision|17|||
23390766|NCT01767857|65175371|FG001|Overall Study|Physician Decision|10|||
23390767|NCT01767857|65175370|FG000|Overall Study|Protocol Terminated|1|||
23390768|NCT01767857|65175371|FG001|Overall Study|Protocol Terminated|0|||
23390769|NCT01767857|65175370|FG000|Overall Study|Randomized But Never Treated|19|||
23390770|NCT01767857|65175371|FG001|Overall Study|Randomized But Never Treated|13|||
23390771|NCT01122680|65175375|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
23390772|NCT01122680|65175376|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
23390773|NCT01122680|65175377|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
23390774|NCT01122680|65175378|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
23390775|NCT01122680|65175375|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
23390776|NCT01122680|65175376|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
23390777|NCT01122680|65175377|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
23390778|NCT01122680|65175378|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
23390779|NCT01122680|65175375|FG000|Period 1 (4 Weeks)|Other|1|||
23390780|NCT01122680|65175376|FG001|Period 1 (4 Weeks)|Other|1|||
23390781|NCT01122680|65175377|FG002|Period 1 (4 Weeks)|Other|0|||
23390782|NCT01122680|65175378|FG003|Period 1 (4 Weeks)|Other|0|||
23390783|NCT01122680|65175375|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
23300020|NCT01564459|64840047|FG002|Run-In|Protocol Violation|0|||
23300021|NCT01564459|64840045|FG000|Run-In|Withdrawal by Subject|1|||
23300022|NCT01564459|64840046|FG001|Run-In|Withdrawal by Subject|0|||
23300023|NCT01564459|64840047|FG002|Run-In|Withdrawal by Subject|0|||
23300024|NCT01564459|64840045|FG000|Double-blind Treatment|Adverse Event|0|||
23300025|NCT01564459|64840046|FG001|Double-blind Treatment|Adverse Event|0|||
23300026|NCT01564459|64840047|FG002|Double-blind Treatment|Adverse Event|1|||
23300027|NCT00062751|64840048|FG000|Overall Study|Disease progression|24|||
23300028|NCT00062751|64840049|FG001|Overall Study|Disease progression|17|||
23300029|NCT00062751|64840050|FG002|Overall Study|Disease progression|24|||
23300030|NCT00062751|64840051|FG003|Overall Study|Disease progression|2|||
23300031|NCT00062751|64840052|FG004|Overall Study|Disease progression|2|||
23300032|NCT00062751|64840048|FG000|Overall Study|Adverse Event|4|||
23300033|NCT00062751|64840049|FG001|Overall Study|Adverse Event|7|||
23300034|NCT00062751|64840050|FG002|Overall Study|Adverse Event|2|||
23300035|NCT00062751|64840051|FG003|Overall Study|Adverse Event|2|||
23300036|NCT00062751|64840052|FG004|Overall Study|Adverse Event|2|||
23300037|NCT00062751|64840048|FG000|Overall Study|Other|2|||
23300038|NCT00062751|64840049|FG001|Overall Study|Other|3|||
23300039|NCT00062751|64840050|FG002|Overall Study|Other|1|||
23300040|NCT00062751|64840051|FG003|Overall Study|Other|0|||
23300041|NCT00062751|64840052|FG004|Overall Study|Other|1|||
23300042|NCT00062751|64840048|FG000|Overall Study|Withdrawal by Subject|1|||
23390784|NCT01122680|65175376|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
23390785|NCT01122680|65175377|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
23390786|NCT01122680|65175378|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
23390787|NCT01122680|65175375|FG000|Period 2 (4 Weeks)|Other|1|||
23390788|NCT01122680|65175376|FG001|Period 2 (4 Weeks)|Other|0|||
23390789|NCT01122680|65175377|FG002|Period 2 (4 Weeks)|Other|0|||
23390790|NCT01122680|65175378|FG003|Period 2 (4 Weeks)|Other|0|||
23300043|NCT00062751|64840049|FG001|Overall Study|Withdrawal by Subject|2|||
23300044|NCT00062751|64840050|FG002|Overall Study|Withdrawal by Subject|2|||
23300045|NCT00062751|64840051|FG003|Overall Study|Withdrawal by Subject|1|||
23300046|NCT00062751|64840052|FG004|Overall Study|Withdrawal by Subject|0|||
23390791|NCT01122680|65175375|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
23390792|NCT01122680|65175376|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
23390793|NCT01122680|65175377|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
23390794|NCT01122680|65175378|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
23390795|NCT01122680|65175375|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23390796|NCT01122680|65175376|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
23390797|NCT01122680|65175377|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23390798|NCT01122680|65175378|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
23390799|NCT03186378|65175379|FG000|Overall Study|Lost to Follow-up|1|||
23390800|NCT03186378|65175380|FG001|Overall Study|Lost to Follow-up|0|||
23390801|NCT00663260|65175381|FG000|Overall Study|Lack of Efficacy|2|||
23300047|NCT00062751|64840048|FG000|Overall Study|Symptomatic deterioration|1|||
23300048|NCT00062751|64840049|FG001|Overall Study|Symptomatic deterioration|1|||
23300049|NCT00062751|64840050|FG002|Overall Study|Symptomatic deterioration|0|||
23300050|NCT00062751|64840051|FG003|Overall Study|Symptomatic deterioration|0|||
23300051|NCT00062751|64840052|FG004|Overall Study|Symptomatic deterioration|1|||
23300052|NCT00062751|64840048|FG000|Overall Study|Death|1|||
23300053|NCT00062751|64840049|FG001|Overall Study|Death|0|||
23300054|NCT00062751|64840050|FG002|Overall Study|Death|1|||
23300055|NCT00062751|64840051|FG003|Overall Study|Death|0|||
23300056|NCT00062751|64840052|FG004|Overall Study|Death|0|||
23300057|NCT01425723|64840053|FG000|Overall Study|Lack of Efficacy|0|||
23300058|NCT01425723|64840054|FG001|Overall Study|Lack of Efficacy|1|||
23300059|NCT01425723|64840053|FG000|Overall Study|Withdrawal by Subject|1|||
23300060|NCT01425723|64840054|FG001|Overall Study|Withdrawal by Subject|4|||
23300061|NCT01425723|64840053|FG000|Overall Study|Lost to Follow-up|0|||
23300062|NCT01425723|64840054|FG001|Overall Study|Lost to Follow-up|3|||
23300063|NCT01425723|64840053|FG000|Overall Study|Physician Decision|2|||
23300064|NCT01425723|64840054|FG001|Overall Study|Physician Decision|0|||
23300065|NCT01425723|64840053|FG000|Overall Study|Other|1|||
23300066|NCT01425723|64840054|FG001|Overall Study|Other|10|||
23300067|NCT02100319|64840057|FG000|Overall Study|Case Report Forms Uncollected|11|||
23300068|NCT02100319|64840057|FG000|Overall Study|Protocol Deviation|5|||
23300069|NCT01366443|64840058|FG000|Overall Study|Lost to Follow-up|2|||
23300070|NCT01366443|64840058|FG000|Overall Study|Under 18 yo|1|||
23300071|NCT01311557|64840059|FG000|Overall Study|Serious adverse event|0|||
23300072|NCT01311557|64840060|FG001|Overall Study|Serious adverse event|1|||
23300073|NCT01311557|64840059|FG000|Overall Study|Protocol Violation|4|||
23300074|NCT01311557|64840060|FG001|Overall Study|Protocol Violation|2|||
23300075|NCT01311557|64840059|FG000|Overall Study|Lost to Follow-up|0|||
23300076|NCT01311557|64840060|FG001|Overall Study|Lost to Follow-up|1|||
23300077|NCT01311557|64840059|FG000|Overall Study|Withdrawal by Subject|1|||
23300078|NCT01311557|64840060|FG001|Overall Study|Withdrawal by Subject|2|||
23300079|NCT01201759|64840063|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
23300080|NCT01201759|64840064|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
23300081|NCT01201759|64840063|FG000|Visit 3 - Washout|Adverse Event|0|||
23300082|NCT01201759|64840064|FG001|Visit 3 - Washout|Adverse Event|3|||
23300083|NCT01201759|64840063|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
23300084|NCT01201759|64840064|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
23300085|NCT01201759|64840063|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
23300086|NCT01201759|64840064|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
23300087|NCT00842530|64840065|FG000|Overall Study|Serious adverse event|0|||
23300088|NCT00842530|64840066|FG001|Overall Study|Serious adverse event|6|||
23300089|NCT00842530|64840065|FG000|Overall Study|Other adverse event|6|||
23300090|NCT00842530|64840066|FG001|Overall Study|Other adverse event|1|||
23300091|NCT00842530|64840065|FG000|Overall Study|Protocol Violation|32|||
23300092|NCT00842530|64840066|FG001|Overall Study|Protocol Violation|14|||
23300093|NCT00842530|64840065|FG000|Overall Study|Lost to Follow-up|6|||
23300094|NCT00842530|64840066|FG001|Overall Study|Lost to Follow-up|8|||
23300095|NCT00842530|64840065|FG000|Overall Study|Withdrawal by Subject|73|||
23300096|NCT00842530|64840066|FG001|Overall Study|Withdrawal by Subject|28|||
23300097|NCT02676284|64840067|FG000|Overall Study|Withdrawal by Subject|1|||
23390802|NCT00663260|65175382|FG001|Overall Study|Lack of Efficacy|0|||
23300098|NCT01791153|64840068|FG000|Part 1: Blinded Period|Adverse Event|7|||
23300099|NCT01791153|64840069|FG001|Part 1: Blinded Period|Adverse Event|3|||
23390803|NCT00663260|65175383|FG002|Overall Study|Lack of Efficacy|0|||
23390804|NCT00663260|65175381|FG000|Overall Study|Adverse Event|12|||
23390805|NCT00663260|65175382|FG001|Overall Study|Adverse Event|7|||
23390806|NCT00663260|65175383|FG002|Overall Study|Adverse Event|6|||
23390807|NCT00663260|65175381|FG000|Overall Study|Withdrawal by Subject|3|||
23390808|NCT00663260|65175382|FG001|Overall Study|Withdrawal by Subject|1|||
23390809|NCT00663260|65175383|FG002|Overall Study|Withdrawal by Subject|6|||
23390810|NCT00663260|65175381|FG000|Overall Study|Death|1|||
23390811|NCT00663260|65175382|FG001|Overall Study|Death|0|||
23390812|NCT00663260|65175383|FG002|Overall Study|Death|1|||
23390813|NCT00663260|65175381|FG000|Overall Study|Lost to Follow-up|0|||
23390814|NCT00663260|65175382|FG001|Overall Study|Lost to Follow-up|1|||
23390815|NCT00663260|65175383|FG002|Overall Study|Lost to Follow-up|0|||
23390816|NCT00663260|65175381|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
23390817|NCT00663260|65175382|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
23390818|NCT00663260|65175383|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
23390819|NCT02951819|65175384|FG000|Overall Study|Death|9|||
23390820|NCT02951819|65175385|FG001|Overall Study|Death|7|||
23390821|NCT02951819|65175384|FG000|Overall Study|Withdrawal by Subject|3|||
23390822|NCT02951819|65175385|FG001|Overall Study|Withdrawal by Subject|0|||
23390823|NCT02951819|65175384|FG000|Overall Study|Adverse Event|1|||
23390824|NCT02951819|65175385|FG001|Overall Study|Adverse Event|0|||
23390825|NCT02951819|65175384|FG000|Overall Study|Lack of Efficacy|4|||
23390826|NCT02951819|65175385|FG001|Overall Study|Lack of Efficacy|0|||
23390827|NCT02951819|65175384|FG000|Overall Study|Lost to Follow-up|1|||
23390828|NCT02951819|65175385|FG001|Overall Study|Lost to Follow-up|0|||
23390829|NCT02951819|65175384|FG000|Overall Study|Progressive Disease|1|||
23390830|NCT02951819|65175385|FG001|Overall Study|Progressive Disease|0|||
23390831|NCT02951819|65175384|FG000|Overall Study|Other|9|||
23390832|NCT02951819|65175385|FG001|Overall Study|Other|0|||
23390833|NCT01714063|65175386|FG000|Overall Study|Equipment malfunction|2|||
23390834|NCT00500331|65175387|FG000|Overall Study|Adverse Event|0|||
23390835|NCT00500331|65175388|FG001|Overall Study|Adverse Event|2|||
23390836|NCT00500331|65175389|FG002|Overall Study|Adverse Event|0|||
23390837|NCT00500331|65175390|FG003|Overall Study|Adverse Event|1|||
23390838|NCT00500331|65175391|FG004|Overall Study|Adverse Event|2|||
23390839|NCT00500331|65175392|FG005|Overall Study|Adverse Event|2|||
23390840|NCT00500331|65175393|FG006|Overall Study|Adverse Event|0|||
23390841|NCT00500331|65175387|FG000|Overall Study|Lost to Follow-up|1|||
23390842|NCT00500331|65175388|FG001|Overall Study|Lost to Follow-up|1|||
23390843|NCT00500331|65175389|FG002|Overall Study|Lost to Follow-up|1|||
23390844|NCT00500331|65175390|FG003|Overall Study|Lost to Follow-up|2|||
23390845|NCT00500331|65175391|FG004|Overall Study|Lost to Follow-up|1|||
23390846|NCT00500331|65175392|FG005|Overall Study|Lost to Follow-up|0|||
23390847|NCT00500331|65175393|FG006|Overall Study|Lost to Follow-up|0|||
23390848|NCT00500331|65175387|FG000|Overall Study|Protocol Violation|3|||
23390849|NCT00500331|65175388|FG001|Overall Study|Protocol Violation|1|||
23390850|NCT00500331|65175389|FG002|Overall Study|Protocol Violation|1|||
23390851|NCT00500331|65175390|FG003|Overall Study|Protocol Violation|0|||
23390852|NCT00500331|65175391|FG004|Overall Study|Protocol Violation|1|||
23390853|NCT00500331|65175392|FG005|Overall Study|Protocol Violation|1|||
23390854|NCT00500331|65175393|FG006|Overall Study|Protocol Violation|1|||
23390855|NCT00500331|65175387|FG000|Overall Study|Withdrawal by Subject|4|||
23390856|NCT00500331|65175388|FG001|Overall Study|Withdrawal by Subject|0|||
23390857|NCT00500331|65175389|FG002|Overall Study|Withdrawal by Subject|1|||
23390858|NCT00500331|65175390|FG003|Overall Study|Withdrawal by Subject|5|||
23390859|NCT00500331|65175391|FG004|Overall Study|Withdrawal by Subject|0|||
23390860|NCT00500331|65175392|FG005|Overall Study|Withdrawal by Subject|1|||
23390861|NCT00500331|65175393|FG006|Overall Study|Withdrawal by Subject|1|||
23390862|NCT00500331|65175387|FG000|Overall Study|Lack of Efficacy|3|||
23390863|NCT00500331|65175388|FG001|Overall Study|Lack of Efficacy|1|||
23390864|NCT00500331|65175389|FG002|Overall Study|Lack of Efficacy|0|||
23390865|NCT00500331|65175390|FG003|Overall Study|Lack of Efficacy|0|||
23390866|NCT00500331|65175391|FG004|Overall Study|Lack of Efficacy|0|||
23390867|NCT00500331|65175392|FG005|Overall Study|Lack of Efficacy|0|||
23390868|NCT00500331|65175393|FG006|Overall Study|Lack of Efficacy|0|||
23390869|NCT00500331|65175387|FG000|Overall Study|Liver function test abnormality|0|||
23390870|NCT00500331|65175388|FG001|Overall Study|Liver function test abnormality|0|||
23390871|NCT00500331|65175389|FG002|Overall Study|Liver function test abnormality|1|||
23300100|NCT01791153|64840070|FG002|Part 1: Blinded Period|Adverse Event|2|||
23300101|NCT01791153|64840071|FG003|Part 1: Blinded Period|Adverse Event|0|||
23300102|NCT01791153|64840072|FG004|Part 1: Blinded Period|Adverse Event|0|||
23300103|NCT01791153|64840073|FG005|Part 1: Blinded Period|Adverse Event|0|||
23300104|NCT01791153|64840074|FG006|Part 1: Blinded Period|Adverse Event|0|||
23300105|NCT01791153|64840075|FG007|Part 1: Blinded Period|Adverse Event|0|||
23300106|NCT01791153|64840068|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
23300107|NCT01791153|64840069|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
23300108|NCT01791153|64840070|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
23300109|NCT01791153|64840071|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
23300110|NCT01791153|64840072|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
23300111|NCT01791153|64840073|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
23300112|NCT01791153|64840074|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
23300113|NCT01791153|64840075|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
23300114|NCT01791153|64840068|FG000|Part 1: Blinded Period|Non-Compliance|1|||
23300115|NCT01791153|64840069|FG001|Part 1: Blinded Period|Non-Compliance|0|||
23300116|NCT01791153|64840070|FG002|Part 1: Blinded Period|Non-Compliance|0|||
23300117|NCT01791153|64840071|FG003|Part 1: Blinded Period|Non-Compliance|0|||
23300118|NCT01791153|64840072|FG004|Part 1: Blinded Period|Non-Compliance|0|||
23300119|NCT01791153|64840073|FG005|Part 1: Blinded Period|Non-Compliance|0|||
23300120|NCT01791153|64840074|FG006|Part 1: Blinded Period|Non-Compliance|0|||
23300121|NCT01791153|64840075|FG007|Part 1: Blinded Period|Non-Compliance|0|||
23495273|NCT00913380|65555117|FG001|Clinical Outcomes|Lost to Follow-up|6|||
23495274|NCT01145625|65558751|FG000|Overall Study|Lost to Follow-up|8|||
23495275|NCT01145625|65558752|FG001|Overall Study|Lost to Follow-up|9|||
23495276|NCT01145625|65558751|FG000|Overall Study|Adverse Event|6|||
23495277|NCT01145625|65558752|FG001|Overall Study|Adverse Event|4|||
23300122|NCT01791153|64840068|FG000|Part 1: Blinded Period|Physician Decision|0|||
23300123|NCT01791153|64840069|FG001|Part 1: Blinded Period|Physician Decision|0|||
23300124|NCT01791153|64840070|FG002|Part 1: Blinded Period|Physician Decision|0|||
23300125|NCT01791153|64840071|FG003|Part 1: Blinded Period|Physician Decision|1|||
23300126|NCT01791153|64840072|FG004|Part 1: Blinded Period|Physician Decision|0|||
23300127|NCT01791153|64840073|FG005|Part 1: Blinded Period|Physician Decision|0|||
23300128|NCT01791153|64840074|FG006|Part 1: Blinded Period|Physician Decision|0|||
23300129|NCT01791153|64840075|FG007|Part 1: Blinded Period|Physician Decision|0|||
23300130|NCT01791153|64840068|FG000|Part 1: Blinded Period|Protocol Violation|0|||
23300131|NCT01791153|64840069|FG001|Part 1: Blinded Period|Protocol Violation|0|||
23300132|NCT01791153|64840070|FG002|Part 1: Blinded Period|Protocol Violation|0|||
23300133|NCT01791153|64840071|FG003|Part 1: Blinded Period|Protocol Violation|1|||
23300134|NCT01791153|64840072|FG004|Part 1: Blinded Period|Protocol Violation|0|||
23300135|NCT01791153|64840073|FG005|Part 1: Blinded Period|Protocol Violation|0|||
23300136|NCT01791153|64840074|FG006|Part 1: Blinded Period|Protocol Violation|0|||
23300137|NCT01791153|64840075|FG007|Part 1: Blinded Period|Protocol Violation|0|||
23495278|NCT01145625|65558751|FG000|Overall Study|Protocol Violation|3|||
23495279|NCT01145625|65558752|FG001|Overall Study|Protocol Violation|1|||
23495280|NCT01145625|65558751|FG000|Overall Study|Withdrawal by Subject|7|||
23495281|NCT01145625|65558752|FG001|Overall Study|Withdrawal by Subject|16|||
23495282|NCT01145625|65558751|FG000|Overall Study|Pregnancy|0|||
23495283|NCT01145625|65558752|FG001|Overall Study|Pregnancy|1|||
23495284|NCT04696055|65558753|FG000|Overall Study|Adverse Event|10|||
23495285|NCT04696055|65558754|FG001|Overall Study|Adverse Event|0|||
23495286|NCT04696055|65558753|FG000|Overall Study|Death|2|||
23495287|NCT04696055|65558754|FG001|Overall Study|Death|1|||
23495288|NCT04696055|65558753|FG000|Overall Study|Other|4|||
23495289|NCT04696055|65558754|FG001|Overall Study|Other|0|||
23495290|NCT04696055|65558753|FG000|Overall Study|Physician Decision|1|||
23495291|NCT04696055|65558754|FG001|Overall Study|Physician Decision|0|||
23495292|NCT04696055|65558753|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
23495293|NCT04696055|65558754|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
23390872|NCT00500331|65175390|FG003|Overall Study|Liver function test abnormality|0|||
23390873|NCT00500331|65175391|FG004|Overall Study|Liver function test abnormality|0|||
23390874|NCT00500331|65175392|FG005|Overall Study|Liver function test abnormality|0|||
23390875|NCT00500331|65175393|FG006|Overall Study|Liver function test abnormality|0|||
23390876|NCT00500331|65175387|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
23390877|NCT00500331|65175388|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
23390878|NCT00500331|65175389|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
23390879|NCT00500331|65175390|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
23390880|NCT00500331|65175391|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
23390881|NCT00500331|65175392|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
23390882|NCT00500331|65175393|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
23390883|NCT00500331|65175387|FG000|Overall Study|Didn't return for continuation of study|1|||
23390884|NCT00500331|65175388|FG001|Overall Study|Didn't return for continuation of study|0|||
23390885|NCT00500331|65175389|FG002|Overall Study|Didn't return for continuation of study|0|||
23390886|NCT00500331|65175390|FG003|Overall Study|Didn't return for continuation of study|0|||
23390887|NCT00500331|65175391|FG004|Overall Study|Didn't return for continuation of study|0|||
23390888|NCT00500331|65175392|FG005|Overall Study|Didn't return for continuation of study|0|||
23390889|NCT00500331|65175393|FG006|Overall Study|Didn't return for continuation of study|0|||
23390890|NCT00500331|65175387|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
23390891|NCT00500331|65175388|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390892|NCT00500331|65175389|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390893|NCT00500331|65175390|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390894|NCT00500331|65175391|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390895|NCT00500331|65175392|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390896|NCT00500331|65175393|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
23390897|NCT00500331|65175387|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
23390898|NCT00500331|65175388|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
23390899|NCT00500331|65175389|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
23390900|NCT00500331|65175390|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
23390901|NCT00500331|65175391|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
23390902|NCT00500331|65175392|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
23390903|NCT00500331|65175393|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
23390904|NCT00500331|65175387|FG000|Overall Study|Participant was randomized by mistake|1|||
23390905|NCT00500331|65175388|FG001|Overall Study|Participant was randomized by mistake|0|||
23390906|NCT00500331|65175389|FG002|Overall Study|Participant was randomized by mistake|0|||
23390907|NCT00500331|65175390|FG003|Overall Study|Participant was randomized by mistake|0|||
23390908|NCT00500331|65175391|FG004|Overall Study|Participant was randomized by mistake|0|||
23390909|NCT00500331|65175392|FG005|Overall Study|Participant was randomized by mistake|0|||
23390910|NCT00500331|65175393|FG006|Overall Study|Participant was randomized by mistake|0|||
23390911|NCT00500331|65175387|FG000|Overall Study|Diabetologist nurse in the study|0|||
23390912|NCT00500331|65175388|FG001|Overall Study|Diabetologist nurse in the study|0|||
23390913|NCT00500331|65175389|FG002|Overall Study|Diabetologist nurse in the study|1|||
23390914|NCT00500331|65175390|FG003|Overall Study|Diabetologist nurse in the study|0|||
23495294|NCT04696055|65558753|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
23495295|NCT04696055|65558754|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
23495296|NCT04696055|65558753|FG000|Overall Study|Subject Decision|1|||
23495297|NCT04696055|65558754|FG001|Overall Study|Subject Decision|2|||
23390915|NCT00500331|65175391|FG004|Overall Study|Diabetologist nurse in the study|0|||
23390916|NCT00500331|65175392|FG005|Overall Study|Diabetologist nurse in the study|0|||
23390917|NCT00500331|65175393|FG006|Overall Study|Diabetologist nurse in the study|0|||
23390918|NCT00500331|65175387|FG000|Overall Study|State ban of biological samples export|0|||
23390919|NCT00500331|65175388|FG001|Overall Study|State ban of biological samples export|0|||
23390920|NCT00500331|65175389|FG002|Overall Study|State ban of biological samples export|0|||
23390921|NCT00500331|65175390|FG003|Overall Study|State ban of biological samples export|1|||
23390922|NCT00500331|65175391|FG004|Overall Study|State ban of biological samples export|0|||
23390923|NCT00500331|65175392|FG005|Overall Study|State ban of biological samples export|0|||
23390924|NCT00500331|65175393|FG006|Overall Study|State ban of biological samples export|0|||
23390925|NCT00500331|65175387|FG000|Overall Study|Protocol violated|0|||
23390926|NCT00500331|65175388|FG001|Overall Study|Protocol violated|0|||
23390927|NCT00500331|65175389|FG002|Overall Study|Protocol violated|0|||
23390928|NCT00500331|65175390|FG003|Overall Study|Protocol violated|1|||
23390929|NCT00500331|65175391|FG004|Overall Study|Protocol violated|0|||
23495298|NCT04696055|65558753|FG000|Overall Study|Ongoing with study treatment|13|||
23495299|NCT04696055|65558754|FG001|Overall Study|Ongoing with study treatment|10|||
23495300|NCT03198078|65558756|FG000|Overall Study|Adverse Event|0|||
23495301|NCT03198078|65558757|FG001|Overall Study|Adverse Event|1|||
23495302|NCT03198078|65558758|FG002|Overall Study|Adverse Event|2|||
23495303|NCT03198078|65558756|FG000|Overall Study|Lack of Efficacy|0|||
23495304|NCT03198078|65558757|FG001|Overall Study|Lack of Efficacy|0|||
23495305|NCT03198078|65558758|FG002|Overall Study|Lack of Efficacy|3|||
23495306|NCT03198078|65558756|FG000|Overall Study|Lost to Follow-up|1|||
23390930|NCT00500331|65175392|FG005|Overall Study|Protocol violated|0|||
23390931|NCT00500331|65175393|FG006|Overall Study|Protocol violated|0|||
23390932|NCT03436732|65175394|FG000|Overall Study|Not treated-enrolled in different study|1|||
23390933|NCT03436732|65175395|FG001|Overall Study|Not treated-enrolled in different study|0|||
23390934|NCT03436732|65175394|FG000|Overall Study|Off study after cycle 1|1|||
23390935|NCT03436732|65175395|FG001|Overall Study|Off study after cycle 1|0|||
23390936|NCT03436732|65175394|FG000|Overall Study|Adverse Event|2|||
23390937|NCT03436732|65175395|FG001|Overall Study|Adverse Event|0|||
23390938|NCT03436732|65175394|FG000|Overall Study|Death|0|||
23390939|NCT03436732|65175395|FG001|Overall Study|Death|1|||
23495307|NCT03198078|65558757|FG001|Overall Study|Lost to Follow-up|0|||
23495308|NCT03198078|65558758|FG002|Overall Study|Lost to Follow-up|0|||
23495309|NCT03198078|65558756|FG000|Overall Study|Pregnancy|0|||
23495310|NCT03198078|65558757|FG001|Overall Study|Pregnancy|1|||
23495311|NCT03198078|65558758|FG002|Overall Study|Pregnancy|0|||
23495312|NCT03198078|65558756|FG000|Overall Study|Withdrawal by Subject|1|||
23495313|NCT03198078|65558757|FG001|Overall Study|Withdrawal by Subject|0|||
23495314|NCT03198078|65558758|FG002|Overall Study|Withdrawal by Subject|2|||
23495315|NCT03198078|65558756|FG000|Overall Study|Withdrawal by Caregiver|1|||
23495316|NCT03198078|65558757|FG001|Overall Study|Withdrawal by Caregiver|3|||
23495317|NCT03198078|65558758|FG002|Overall Study|Withdrawal by Caregiver|5|||
23495318|NCT00400764|65558763|FG000|Phase Ib|Adverse Event|1|||
23495319|NCT00400764|65558764|FG001|Phase Ib|Adverse Event|0|||
23495320|NCT00400764|65558765|FG002|Phase Ib|Adverse Event|0|||
23495321|NCT00400764|65558766|FG003|Phase Ib|Adverse Event|0|||
23495322|NCT00400764|65558767|FG004|Phase Ib|Adverse Event|0|||
23495323|NCT00400764|65558763|FG000|Phase Ib|Death|1|||
23495324|NCT00400764|65558764|FG001|Phase Ib|Death|0|||
23495325|NCT00400764|65558765|FG002|Phase Ib|Death|0|||
23495326|NCT00400764|65558766|FG003|Phase Ib|Death|0|||
23495327|NCT00400764|65558767|FG004|Phase Ib|Death|0|||
23495328|NCT00400764|65558763|FG000|Phase Ib|Disease Progression|4|||
23495329|NCT00400764|65558764|FG001|Phase Ib|Disease Progression|4|||
23495330|NCT00400764|65558765|FG002|Phase Ib|Disease Progression|0|||
23495331|NCT00400764|65558766|FG003|Phase Ib|Disease Progression|0|||
23495332|NCT00400764|65558767|FG004|Phase Ib|Disease Progression|0|||
23495333|NCT00400764|65558763|FG000|Phase II|Death|0|||
23495334|NCT00400764|65558764|FG001|Phase II|Death|0|||
23495335|NCT00400764|65558765|FG002|Phase II|Death|1|||
23495336|NCT00400764|65558766|FG003|Phase II|Death|2|||
23495337|NCT00400764|65558767|FG004|Phase II|Death|0|||
23495338|NCT00400764|65558763|FG000|Phase II|Lost to Follow-up|0|||
23390940|NCT02698787|65175396|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
23390941|NCT02698787|65175397|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
23390942|NCT00814983|65175402|FG000|Overall Study|Screen failure|1|||
23390943|NCT00814983|65175403|FG001|Overall Study|Screen failure|0|||
23390944|NCT00814983|65175402|FG000|Overall Study|Withdrawal by Subject|1|||
23390945|NCT00814983|65175403|FG001|Overall Study|Withdrawal by Subject|0|||
23495339|NCT00400764|65558764|FG001|Phase II|Lost to Follow-up|0|||
23495340|NCT00400764|65558765|FG002|Phase II|Lost to Follow-up|1|||
23495341|NCT00400764|65558766|FG003|Phase II|Lost to Follow-up|0|||
23495342|NCT00400764|65558767|FG004|Phase II|Lost to Follow-up|0|||
23495343|NCT00400764|65558763|FG000|Phase II|Physician Decision|0|||
23495344|NCT00400764|65558764|FG001|Phase II|Physician Decision|0|||
23495345|NCT00400764|65558765|FG002|Phase II|Physician Decision|1|||
23390946|NCT00814983|65175402|FG000|Overall Study|Graft failure|1|||
23390947|NCT00814983|65175403|FG001|Overall Study|Graft failure|0|||
23390948|NCT01697501|65175407|FG000|Overall Study|Protocol Violation|2|||
23390949|NCT04629521|65175408|FG000|Overall Study|Death|1|||
23390950|NCT04629521|65175408|FG000|Overall Study|Lost to Follow-up|3|||
23390951|NCT04629521|65175408|FG000|Overall Study|Subject withdrew consent|3|||
23390952|NCT04629521|65175408|FG000|Overall Study|Enrolled in error|1|||
23390953|NCT02462057|65175409|FG000|Overall Study|Left Vitality|32|||
23390954|NCT02462057|65175410|FG001|Overall Study|Left Vitality|27|||
23390955|NCT02462057|65175411|FG002|Overall Study|Left Vitality|23|||
23390956|NCT02462057|65175412|FG003|Overall Study|Left Vitality|35|||
23390957|NCT02462057|65175413|FG004|Overall Study|Left Vitality|33|||
23390958|NCT02462057|65175409|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
23390959|NCT02462057|65175410|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
23390960|NCT02462057|65175411|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
23390961|NCT02462057|65175412|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
23390962|NCT02462057|65175413|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
23390963|NCT01681849|65175414|FG000|Overall Study|Protocol Violation|2|||
23390964|NCT01681849|65175415|FG001|Overall Study|Protocol Violation|0|||
23390965|NCT01681849|65175416|FG002|Overall Study|Protocol Violation|0|||
23390966|NCT01681849|65175414|FG000|Overall Study|Withdrawal by Subject|3|||
23390967|NCT01681849|65175415|FG001|Overall Study|Withdrawal by Subject|5|||
23390968|NCT01681849|65175416|FG002|Overall Study|Withdrawal by Subject|33|||
23390969|NCT01681849|65175414|FG000|Overall Study|Lost to Follow-up|3|||
23390970|NCT01681849|65175415|FG001|Overall Study|Lost to Follow-up|2|||
23390971|NCT01681849|65175416|FG002|Overall Study|Lost to Follow-up|6|||
23390972|NCT01491919|65175417|FG000|Overall Study|Insufficient PK sampling|1|||
23390973|NCT01491919|65175418|FG001|Overall Study|Insufficient PK sampling|2|||
23390974|NCT01491919|65175419|FG002|Overall Study|Insufficient PK sampling|1|||
23390975|NCT04535362|65175420|FG000|Overall Study|Lost to Follow-up|3|||
23390976|NCT04535362|65175421|FG001|Overall Study|Lost to Follow-up|1|||
23390977|NCT00680914|65175422|FG000|Overall Study|Consent withdrawal|6|||
23390978|NCT00680914|65175423|FG001|Overall Study|Consent withdrawal|3|||
23390979|NCT00680914|65175422|FG000|Overall Study|Lost to Follow-up|4|||
23390980|NCT00680914|65175423|FG001|Overall Study|Lost to Follow-up|0|||
23390981|NCT00680914|65175422|FG000|Overall Study|serious adverse event (SAE)|0|||
23390982|NCT00680914|65175423|FG001|Overall Study|serious adverse event (SAE)|1|||
23390983|NCT00530257|65175424|FG000|Overall Study|Lost to Follow-up|1|||
23390984|NCT02105012|65175427|FG000|Overall Study|Withdrawal by Subject|11|||
23390985|NCT02105012|65175427|FG000|Overall Study|Protocol Specified Criteria|9|||
23390986|NCT02105012|65175427|FG000|Overall Study|Lost to Follow-up|4|||
23390987|NCT02105012|65175427|FG000|Overall Study|Protocol Violation|4|||
23390988|NCT02105012|65175427|FG000|Overall Study|Physician Decision|3|||
23390989|NCT02105012|65175427|FG000|Overall Study|Adverse Event|1|||
23390990|NCT02105012|65175427|FG000|Overall Study|Lack of Efficacy|1|||
23390991|NCT03766906|65175428|FG000|Overall Study|Withdrawal by Subject|6|||
23390992|NCT01791205|65175434|FG000|Phase II|Lack of Efficacy|6|||
23390993|NCT01791205|65175435|FG001|Phase II|Lack of Efficacy|0|||
23390994|NCT01791205|65175434|FG000|Phase II|Adverse Event|2|||
23390995|NCT01791205|65175435|FG001|Phase II|Adverse Event|0|||
23390996|NCT01791205|65175434|FG000|Phase II|Safety|1|||
23390997|NCT01791205|65175435|FG001|Phase II|Safety|0|||
23390998|NCT01791205|65175434|FG000|Phase II|Lost to Follow-up|1|||
23390999|NCT01791205|65175435|FG001|Phase II|Lost to Follow-up|0|||
23391000|NCT01791205|65175434|FG000|Phase II|Remission of disease|1|||
23391001|NCT01791205|65175435|FG001|Phase II|Remission of disease|0|||
23391002|NCT01791205|65175434|FG000|Phase II|Physician's decision|1|||
23391003|NCT01791205|65175435|FG001|Phase II|Physician's decision|0|||
23391004|NCT01514422|65175436|FG000|Overall Study|Lost to Follow-up|1|||
23391005|NCT01922895|65175440|FG000|Overall Study|Death|0|||
23391006|NCT01922895|65175441|FG001|Overall Study|Death|1|||
23391007|NCT01922895|65175440|FG000|Overall Study|Withdrawal by Subject|1|||
23391008|NCT01922895|65175441|FG001|Overall Study|Withdrawal by Subject|2|||
23391009|NCT01922895|65175440|FG000|Overall Study|Lost to Follow-up|5|||
23391010|NCT01922895|65175441|FG001|Overall Study|Lost to Follow-up|11|||
23391011|NCT01475825|65175447|FG000|Overall Study|Adverse Event|41|||
23391012|NCT01475825|65175448|FG001|Overall Study|Adverse Event|15|||
23391013|NCT01475825|65175449|FG002|Overall Study|Adverse Event|27|||
23391014|NCT01475825|65175450|FG003|Overall Study|Adverse Event|11|||
23391015|NCT01475825|65175447|FG000|Overall Study|Death|1|||
23391016|NCT01475825|65175448|FG001|Overall Study|Death|0|||
23391017|NCT01475825|65175449|FG002|Overall Study|Death|1|||
23391018|NCT01475825|65175450|FG003|Overall Study|Death|0|||
23391019|NCT01475825|65175447|FG000|Overall Study|Lack of Efficacy|0|||
23391020|NCT01475825|65175448|FG001|Overall Study|Lack of Efficacy|0|||
23391021|NCT01475825|65175449|FG002|Overall Study|Lack of Efficacy|1|||
23391022|NCT01475825|65175450|FG003|Overall Study|Lack of Efficacy|0|||
23391023|NCT01475825|65175447|FG000|Overall Study|Lost to Follow-up|0|||
23391024|NCT01475825|65175448|FG001|Overall Study|Lost to Follow-up|0|||
23391025|NCT01475825|65175449|FG002|Overall Study|Lost to Follow-up|3|||
23391026|NCT01475825|65175450|FG003|Overall Study|Lost to Follow-up|1|||
23391027|NCT01475825|65175447|FG000|Overall Study|Non-compliance with Study Drug|1|||
23391028|NCT01475825|65175448|FG001|Overall Study|Non-compliance with Study Drug|2|||
23391029|NCT01475825|65175449|FG002|Overall Study|Non-compliance with Study Drug|4|||
23391030|NCT01475825|65175450|FG003|Overall Study|Non-compliance with Study Drug|0|||
23391031|NCT01475825|65175447|FG000|Overall Study|Other: Not available|0|||
23391032|NCT01475825|65175448|FG001|Overall Study|Other: Not available|0|||
23391033|NCT01475825|65175449|FG002|Overall Study|Other: Not available|2|||
23391034|NCT01475825|65175450|FG003|Overall Study|Other: Not available|0|||
23391035|NCT01475825|65175447|FG000|Overall Study|Protocol Violation|1|||
23391036|NCT01475825|65175448|FG001|Overall Study|Protocol Violation|0|||
23391037|NCT01475825|65175449|FG002|Overall Study|Protocol Violation|0|||
23391038|NCT01475825|65175450|FG003|Overall Study|Protocol Violation|0|||
23391039|NCT01475825|65175447|FG000|Overall Study|Physician Decision|0|||
23391040|NCT01475825|65175448|FG001|Overall Study|Physician Decision|1|||
23391041|NCT01475825|65175449|FG002|Overall Study|Physician Decision|0|||
23391042|NCT01475825|65175450|FG003|Overall Study|Physician Decision|0|||
23391043|NCT01475825|65175447|FG000|Overall Study|Withdrawal by Subject|8|||
23391044|NCT01475825|65175448|FG001|Overall Study|Withdrawal by Subject|3|||
23391045|NCT01475825|65175449|FG002|Overall Study|Withdrawal by Subject|11|||
23495346|NCT00400764|65558766|FG003|Phase II|Physician Decision|1|||
23495347|NCT00400764|65558767|FG004|Phase II|Physician Decision|0|||
23495348|NCT00400764|65558763|FG000|Phase II|Sponsor's decision to terminate|0|||
23495349|NCT00400764|65558764|FG001|Phase II|Sponsor's decision to terminate|0|||
23495350|NCT00400764|65558765|FG002|Phase II|Sponsor's decision to terminate|18|||
23495351|NCT00400764|65558766|FG003|Phase II|Sponsor's decision to terminate|22|||
23495352|NCT00400764|65558767|FG004|Phase II|Sponsor's decision to terminate|11|||
23495353|NCT00400764|65558763|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
23495354|NCT00400764|65558764|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
23495355|NCT00400764|65558765|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
23391046|NCT01475825|65175450|FG003|Overall Study|Withdrawal by Subject|7|||
23391047|NCT01475825|65175447|FG000|Overall Study|Did not enter OLC|15|||
23391048|NCT01475825|65175448|FG001|Overall Study|Did not enter OLC|11|||
23391049|NCT01475825|65175449|FG002|Overall Study|Did not enter OLC|15|||
23391050|NCT01475825|65175450|FG003|Overall Study|Did not enter OLC|11|||
23391051|NCT03359395|65175451|FG000|First Intervention A / B|Withdrawal by Subject|1|||
23391052|NCT03359395|65175452|FG001|First Intervention A / B|Withdrawal by Subject|0|||
23391053|NCT03359395|65175451|FG000|First Intervention A / B|Lost to Follow-up|2|||
23391054|NCT03359395|65175452|FG001|First Intervention A / B|Lost to Follow-up|3|||
23391055|NCT03359395|65175451|FG000|Second Intervention B/A|Exclusion criteria|0|||
23391056|NCT03359395|65175452|FG001|Second Intervention B/A|Exclusion criteria|1|||
23391057|NCT03359395|65175451|FG000|Second Intervention B/A|Lost to Follow-up|3|||
23495356|NCT00400764|65558766|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
23495357|NCT00400764|65558767|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
23495358|NCT00400764|65558763|FG000|Phase II|Withdrawal by Subject|0|||
23391058|NCT03359395|65175452|FG001|Second Intervention B/A|Lost to Follow-up|2|||
23300138|NCT01791153|64840068|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
23495359|NCT00400764|65558764|FG001|Phase II|Withdrawal by Subject|0|||
23495360|NCT00400764|65558765|FG002|Phase II|Withdrawal by Subject|1|||
23495361|NCT00400764|65558766|FG003|Phase II|Withdrawal by Subject|1|||
23300139|NCT01791153|64840069|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
23495362|NCT00400764|65558767|FG004|Phase II|Withdrawal by Subject|0|||
23495363|NCT02187744|65558768|FG000|Study|Participant refused further follow-up|1|||
23495364|NCT02187744|65558769|FG001|Study|Participant refused further follow-up|0|||
23495365|NCT02187744|65558768|FG000|Study|Other|2|||
23495366|NCT02187744|65558769|FG001|Study|Other|1|||
23495367|NCT02187744|65558768|FG000|Study|Lost to Follow-up|0|||
23495368|NCT02187744|65558769|FG001|Study|Lost to Follow-up|2|||
23495369|NCT02187744|65558768|FG000|Study|Related adverse event, not serious|0|||
23495370|NCT02187744|65558769|FG001|Study|Related adverse event, not serious|2|||
23495371|NCT02187744|65558768|FG000|Study|Death|1|||
23495372|NCT02187744|65558769|FG001|Study|Death|0|||
23495373|NCT02187744|65558768|FG000|Study|Related adverse event, serious non-fatal|0|||
23495374|NCT02187744|65558769|FG001|Study|Related adverse event, serious non-fatal|1|||
23495375|NCT02187744|65558768|FG000|Treatment|Death|1|||
23495376|NCT02187744|65558769|FG001|Treatment|Death|0|||
23495377|NCT02187744|65558768|FG000|Treatment|Related adverse event, serious non-fatal|0|||
23495378|NCT02187744|65558769|FG001|Treatment|Related adverse event, serious non-fatal|1|||
23495379|NCT02187744|65558768|FG000|Treatment|Related adverse event, not serious|0|||
23495380|NCT02187744|65558769|FG001|Treatment|Related adverse event, not serious|2|||
23495381|NCT02187744|65558768|FG000|Treatment|Lost to Follow-up|0|||
23495382|NCT02187744|65558769|FG001|Treatment|Lost to Follow-up|1|||
23495383|NCT02187744|65558768|FG000|Treatment|Other|2|||
23495384|NCT02187744|65558769|FG001|Treatment|Other|0|||
23495385|NCT02187744|65558768|FG000|Treatment|Participant refused continued treatment|1|||
23495386|NCT02187744|65558769|FG001|Treatment|Participant refused continued treatment|1|||
23495387|NCT04032652|65558770|FG000|Overall Study|The study was terminated and the PI has|1|||
23495388|NCT04032652|65558771|FG001|Overall Study|The study was terminated and the PI has|1|||
23495389|NCT03320057|65558773|FG000|Overall Study|Lost to Follow-up|4|||
23495390|NCT03320057|65558774|FG001|Overall Study|Lost to Follow-up|17|||
23495391|NCT03320057|65558773|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
23495392|NCT03320057|65558774|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
23495393|NCT00191269|65558775|FG000|Overall Study|Protocol Violation|0|||
23495394|NCT00191269|65558776|FG001|Overall Study|Protocol Violation|2|||
23495395|NCT00191269|65558775|FG000|Overall Study|Adverse Event|1|||
23495396|NCT00191269|65558776|FG001|Overall Study|Adverse Event|4|||
23495397|NCT00191269|65558775|FG000|Overall Study|Progression of Disease|4|||
23495398|NCT00191269|65558776|FG001|Overall Study|Progression of Disease|42|||
23495399|NCT00191269|65558775|FG000|Overall Study|Lack of Efficacy|1|||
23495400|NCT00191269|65558776|FG001|Overall Study|Lack of Efficacy|5|||
23300140|NCT01791153|64840070|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
23300141|NCT01791153|64840071|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
23300142|NCT01791153|64840072|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
23300143|NCT01791153|64840073|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
23300144|NCT01791153|64840074|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
23300145|NCT01791153|64840075|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
23300146|NCT01791153|64840068|FG000|Part 2: Open-label Period|Adverse Event|0|||
23300147|NCT01791153|64840069|FG001|Part 2: Open-label Period|Adverse Event|0|||
23300148|NCT01791153|64840070|FG002|Part 2: Open-label Period|Adverse Event|0|||
23300149|NCT01791153|64840071|FG003|Part 2: Open-label Period|Adverse Event|0|||
23300150|NCT01791153|64840072|FG004|Part 2: Open-label Period|Adverse Event|0|||
23300151|NCT01791153|64840073|FG005|Part 2: Open-label Period|Adverse Event|1|||
23300152|NCT01791153|64840074|FG006|Part 2: Open-label Period|Adverse Event|1|||
23495401|NCT00191269|65558775|FG000|Overall Study|Withdrawal by Subject|0|||
23495402|NCT00191269|65558776|FG001|Overall Study|Withdrawal by Subject|1|||
23391059|NCT01028560|65175453|FG000|Overall Study|Lack of Efficacy|3|||
23391060|NCT01028560|65175454|FG001|Overall Study|Lack of Efficacy|6|||
23391061|NCT01028560|65175453|FG000|Overall Study|Withdrawal by Subject|7|||
23391062|NCT01028560|65175454|FG001|Overall Study|Withdrawal by Subject|12|||
23391063|NCT00836901|65175455|FG000|First Intervention|Withdrawal by Subject|1|||
23391064|NCT00836901|65175456|FG001|First Intervention|Withdrawal by Subject|0|||
23391065|NCT00911157|65175457|FG000|Overall Study|Adverse Event|4|||
23391066|NCT00911157|65175458|FG001|Overall Study|Adverse Event|1|||
23391067|NCT00911157|65175457|FG000|Overall Study|Withdrawal by Subject|1|||
23391068|NCT00911157|65175458|FG001|Overall Study|Withdrawal by Subject|1|||
23391069|NCT00911157|65175457|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
23391070|NCT00911157|65175458|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
23391071|NCT00911157|65175457|FG000|Overall Study|Need to treat for lung cancer|1|||
23391072|NCT00911157|65175458|FG001|Overall Study|Need to treat for lung cancer|0|||
23391073|NCT02180672|65175459|FG000|Overall Study|Lost to Follow-up|5|||
23391074|NCT02180672|65175460|FG001|Overall Study|Lost to Follow-up|7|||
23391075|NCT00637156|65178459|FG000|Overall Study|Withdrawal by Subject|0|||
23391076|NCT00637156|65178460|FG001|Overall Study|Withdrawal by Subject|7|||
23391077|NCT00637156|65178459|FG000|Overall Study|Death|0|||
23391078|NCT00637156|65178460|FG001|Overall Study|Death|1|||
23391079|NCT00637156|65178459|FG000|Overall Study|Lost to Follow-up|10|||
23391080|NCT00637156|65178460|FG001|Overall Study|Lost to Follow-up|16|||
23391081|NCT02624687|65178465|FG000|Overall Study|Withdrawal by Subject|1|||
23391082|NCT02624687|65178466|FG001|Overall Study|Withdrawal by Subject|1|||
23391083|NCT02624687|65178465|FG000|Overall Study|medical leave from work|0|||
23391084|NCT02624687|65178466|FG001|Overall Study|medical leave from work|1|||
23391085|NCT02231580|65178467|FG000|Overall Study|Adverse Event|5|||
23391086|NCT02231580|65178468|FG001|Overall Study|Adverse Event|0|||
23391087|NCT03701074|65178469|FG000|Overall Study|Physician Decision|1|||
23391088|NCT03701074|65178470|FG001|Overall Study|Physician Decision|0|||
23391089|NCT00023595|65178471|FG000|5 Year Follow up|Lost to Follow-up|2|||
23391090|NCT00023595|65178472|FG001|5 Year Follow up|Lost to Follow-up|2|||
23391091|NCT00023595|65178473|FG002|5 Year Follow up|Lost to Follow-up|1|||
23391092|NCT00023595|65178474|FG003|5 Year Follow up|Lost to Follow-up|7|||
23391093|NCT00023595|65178475|FG004|5 Year Follow up|Lost to Follow-up|3|||
23391094|NCT00023595|65178471|FG000|10 Year Follow up|Lost to Follow-up|12|||
23391095|NCT00023595|65178472|FG001|10 Year Follow up|Lost to Follow-up|10|||
23391096|NCT00023595|65178473|FG002|10 Year Follow up|Lost to Follow-up|3|||
23391097|NCT00023595|65178474|FG003|10 Year Follow up|Lost to Follow-up|0|||
23391098|NCT00023595|65178475|FG004|10 Year Follow up|Lost to Follow-up|0|||
23495403|NCT00191269|65558775|FG000|Overall Study|Pathologic Aggrevation|0|||
23495404|NCT00191269|65558776|FG001|Overall Study|Pathologic Aggrevation|1|||
23495405|NCT00191269|65558775|FG000|Overall Study|Physician Decision|0|||
23495406|NCT00191269|65558776|FG001|Overall Study|Physician Decision|3|||
23495407|NCT00115739|65558779|FG000|Overall Study|Lost to Follow-up|3|||
23495408|NCT04203797|65558787|FG000|Overall Study|Adverse Event|1|||
23495409|NCT04203797|65558788|FG001|Overall Study|Adverse Event|0|||
23495410|NCT04203797|65558787|FG000|Overall Study|Did not complete End of Study follow-up|1|||
23495411|NCT04203797|65558788|FG001|Overall Study|Did not complete End of Study follow-up|0|||
23495412|NCT01696695|65558790|FG000|Overall Study|Disease progression|373|||
23495413|NCT01696695|65558790|FG000|Overall Study|Death|29|||
23495414|NCT01696695|65558790|FG000|Overall Study|Adverse Event|74|||
23495415|NCT01696695|65558790|FG000|Overall Study|Withdrawal by Subject|92|||
23391099|NCT01149460|65178479|FG000|Overall Study|Withdrawal by Subject|0|||
23391100|NCT01149460|65178480|FG001|Overall Study|Withdrawal by Subject|2|||
23495416|NCT01696695|65558790|FG000|Overall Study|Lost to Follow-up|48|||
23495417|NCT01696695|65558790|FG000|Overall Study|Other|74|||
23495418|NCT01696695|65558790|FG000|Overall Study|Major Protocol Violation|192|||
23495419|NCT01950169|65558791|FG000|Overall Study|Withdrawal by Subject|2|||
23495420|NCT01950169|65558792|FG001|Overall Study|Withdrawal by Subject|8|||
23495421|NCT01950169|65558793|FG002|Overall Study|Withdrawal by Subject|1|||
23495422|NCT01950169|65558791|FG000|Overall Study|Death|1|||
23495423|NCT01950169|65558792|FG001|Overall Study|Death|0|||
23495424|NCT01950169|65558793|FG002|Overall Study|Death|0|||
23495425|NCT02158975|65558794|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
23495426|NCT03641339|65558795|FG000|Overall Study|Physician Decision|1|||
23495427|NCT03641339|65558796|FG001|Overall Study|Physician Decision|0|||
23495428|NCT03641339|65558797|FG002|Overall Study|Physician Decision|0|||
23495429|NCT03641339|65558798|FG003|Overall Study|Physician Decision|0|||
23495430|NCT03641339|65558799|FG004|Overall Study|Physician Decision|0|||
23495431|NCT03641339|65558800|FG005|Overall Study|Physician Decision|0|||
23495432|NCT03641339|65558795|FG000|Overall Study|Withdrawal by Subject|0|||
23495433|NCT03641339|65558796|FG001|Overall Study|Withdrawal by Subject|2|||
23495434|NCT03641339|65558797|FG002|Overall Study|Withdrawal by Subject|0|||
23495435|NCT03641339|65558798|FG003|Overall Study|Withdrawal by Subject|2|||
23495436|NCT03641339|65558799|FG004|Overall Study|Withdrawal by Subject|0|||
23495437|NCT03641339|65558800|FG005|Overall Study|Withdrawal by Subject|1|||
23495438|NCT01739309|65558802|FG000|Overall Study|Adverse Event|1|||
23495439|NCT01739309|65558802|FG000|Overall Study|Withdrawal by Subject|1|||
23495440|NCT01449539|65558806|FG000|Overall Study|Withdrawal by Subject|3|||
23495441|NCT01449539|65558806|FG000|Overall Study|Toxicity not study related|1|||
23495442|NCT00516074|65558808|FG000|Overall Study|Adverse Event|0|||
23495443|NCT00516074|65558809|FG001|Overall Study|Adverse Event|1|||
23495444|NCT00516074|65558808|FG000|Overall Study|Subject Decision|4|||
23495445|NCT00516074|65558809|FG001|Overall Study|Subject Decision|2|||
23495446|NCT00516074|65558808|FG000|Overall Study|Loss of Glucose Control|2|||
23391101|NCT01299961|65178481|FG000|Overall Study|Adverse Event|3|||
23391102|NCT01299961|65178481|FG000|Overall Study|Lack of Efficacy|2|||
23391103|NCT01299961|65178481|FG000|Overall Study|Lost to Follow-up|1|||
23391104|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
23391105|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
23391106|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
23391107|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
23391108|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
23391109|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
23391110|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
23391111|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
23391112|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
23391113|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
23391114|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
23495447|NCT00516074|65558809|FG001|Overall Study|Loss of Glucose Control|0|||
23495448|NCT05306977|65558814|FG000|Overall Study|Withdrawal by Subject|1|||
23495449|NCT04057365|65558820|FG000|Overall Study|Withdrawal by Subject|2|||
23495450|NCT04057365|65558821|FG001|Overall Study|Withdrawal by Subject|0|||
23495451|NCT04545385|65558822|FG000|Overall Study|Withdrawal by Subject|2|||
23495452|NCT04545385|65558823|FG001|Overall Study|Withdrawal by Subject|0|||
23495453|NCT04545385|65558822|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
23495454|NCT04545385|65558823|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
23495455|NCT04545385|65558822|FG000|Overall Study|Study termination|10|||
23495456|NCT04545385|65558823|FG001|Overall Study|Study termination|10|||
23495457|NCT04545385|65558822|FG000|Overall Study|Sponsor decision|2|||
23495458|NCT04545385|65558823|FG001|Overall Study|Sponsor decision|2|||
23495459|NCT04545385|65558822|FG000|Overall Study|Other than specified|1|||
23495460|NCT04545385|65558823|FG001|Overall Study|Other than specified|0|||
23495461|NCT00246753|65558824|FG000|Overall Study|Withdrawal by Subject|2|||
23495462|NCT00246753|65558824|FG000|Overall Study|Physician Decision|2|||
23391115|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
23391116|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
23391117|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
23495463|NCT00246753|65558824|FG000|Overall Study|Adverse Event|2|||
23495464|NCT00246753|65558824|FG000|Overall Study|Unacceptable toxicity|2|||
23495465|NCT00319501|65558825|FG000|Double-blind Period|Withdrawal by Subject|0|||
23495466|NCT00319501|65558826|FG001|Double-blind Period|Withdrawal by Subject|3|||
23495467|NCT00319501|65558825|FG000|Double-blind Period|Sponsor Request|1|||
23495468|NCT00319501|65558826|FG001|Double-blind Period|Sponsor Request|0|||
23495469|NCT00319501|65558825|FG000|Double-blind Period|Did not receive treatment|42|||
23495470|NCT00319501|65558826|FG001|Double-blind Period|Did not receive treatment|29|||
23495471|NCT00319501|65558825|FG000|Open-label Period|Adverse Event|5|||
23495472|NCT00319501|65558826|FG001|Open-label Period|Adverse Event|0|||
23495473|NCT00319501|65558825|FG000|Open-label Period|Protocol Violation|6|||
23495474|NCT00319501|65558826|FG001|Open-label Period|Protocol Violation|0|||
23495475|NCT00319501|65558825|FG000|Open-label Period|Withdrawal by Subject|38|||
23495476|NCT00319501|65558826|FG001|Open-label Period|Withdrawal by Subject|0|||
23495477|NCT00319501|65558825|FG000|Open-label Period|Principal Investigator decision|6|||
23495478|NCT00319501|65558826|FG001|Open-label Period|Principal Investigator decision|0|||
23495479|NCT00319501|65558825|FG000|Open-label Period|Sponsor request|12|||
23495480|NCT00319501|65558826|FG001|Open-label Period|Sponsor request|0|||
23495481|NCT00319501|65558825|FG000|Open-label Period|Lost to Follow-up|5|||
23495482|NCT00319501|65558826|FG001|Open-label Period|Lost to Follow-up|0|||
23495483|NCT00319501|65558825|FG000|Open-label Period|Did not receive treatment|33|||
23495484|NCT00319501|65558826|FG001|Open-label Period|Did not receive treatment|0|||
23495485|NCT00319501|65558825|FG000|Open-label Period|Other|11|||
23391118|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
23391119|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
23495486|NCT00319501|65558826|FG001|Open-label Period|Other|0|||
23495487|NCT00319501|65558825|FG000|Open-label Extension Period|Adverse Event|2|||
23495488|NCT00319501|65558826|FG001|Open-label Extension Period|Adverse Event|0|||
23495489|NCT00319501|65558825|FG000|Open-label Extension Period|Did not receive treatment|18|||
23495490|NCT00319501|65558826|FG001|Open-label Extension Period|Did not receive treatment|0|||
23495491|NCT00319501|65558825|FG000|Open-label Extension Period|Other|1|||
23495492|NCT00319501|65558826|FG001|Open-label Extension Period|Other|0|||
23495493|NCT00319501|65558825|FG000|Open-label Extension Period|Principal investigator decision|2|||
23495494|NCT00319501|65558826|FG001|Open-label Extension Period|Principal investigator decision|0|||
23495495|NCT00319501|65558825|FG000|Open-label Extension Period|Sponsor request|26|||
23495496|NCT00319501|65558826|FG001|Open-label Extension Period|Sponsor request|0|||
23391120|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
23391121|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
23495497|NCT00319501|65558825|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
23495498|NCT00319501|65558826|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
23495499|NCT02083965|65558827|FG000|Treatment Period|Other|1|||
23495500|NCT02083965|65558828|FG001|Treatment Period|Other|0|||
23495501|NCT01414608|65558829|FG000|Overall Study|Ineligible|5|||
23495502|NCT01414608|65558830|FG001|Overall Study|Ineligible|2|||
23495503|NCT00615108|65558836|FG000|Overall Study|Adverse Event|122|||
23495504|NCT00615108|65558836|FG000|Overall Study|Other|370|||
23495505|NCT00615108|65558836|FG000|Overall Study|Lost to Follow-up|15|||
23391122|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
23391123|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
23391124|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
23391125|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
23391126|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
23391127|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
23495506|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
23495507|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
23495508|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
23495509|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
23495510|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
23495511|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
23495512|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Death|6|||
23495513|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Death|0|||
23495514|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Death|0|||
23495515|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
23495516|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
23495517|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
23495518|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
23495519|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
23495520|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
23495521|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
23495522|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
23495523|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
23495524|NCT01539083|65558840|FG000|Before Randomization (VCD Induction)|Other|5|||
23495525|NCT01539083|65558841|FG001|Before Randomization (VCD Induction)|Other|0|||
23495526|NCT01539083|65558842|FG002|Before Randomization (VCD Induction)|Other|0|||
23495527|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
23495528|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
23495529|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
23495530|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Other|0|||
23495531|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Other|1|||
23495532|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Other|1|||
23495533|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
23495534|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
23495535|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
23495536|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
23495537|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
23495538|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
23495539|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
23495540|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
23495541|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
23495542|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
23495543|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
23495544|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
23495545|NCT01539083|65558840|FG000|After Randomization (TP and VTP)|Death|0|||
23495546|NCT01539083|65558841|FG001|After Randomization (TP and VTP)|Death|6|||
23495547|NCT01539083|65558842|FG002|After Randomization (TP and VTP)|Death|11|||
23495548|NCT03855228|65558845|FG000|Overall Study|Adverse Event|2|||
23495549|NCT03855228|65558846|FG001|Overall Study|Adverse Event|4|||
23495550|NCT03855228|65558847|FG002|Overall Study|Adverse Event|4|||
23495551|NCT03855228|65558848|FG003|Overall Study|Adverse Event|8|||
23495552|NCT03855228|65558845|FG000|Overall Study|Treatment Failure|1|||
23495553|NCT03855228|65558846|FG001|Overall Study|Treatment Failure|2|||
23495554|NCT03855228|65558847|FG002|Overall Study|Treatment Failure|1|||
23495555|NCT03855228|65558848|FG003|Overall Study|Treatment Failure|8|||
23495556|NCT03855228|65558845|FG000|Overall Study|Lost to Follow-up|0|||
23495557|NCT03855228|65558846|FG001|Overall Study|Lost to Follow-up|0|||
23495558|NCT03855228|65558847|FG002|Overall Study|Lost to Follow-up|0|||
23495559|NCT03855228|65558848|FG003|Overall Study|Lost to Follow-up|1|||
23495560|NCT03855228|65558845|FG000|Overall Study|Protocol Violation|0|||
23495561|NCT03855228|65558846|FG001|Overall Study|Protocol Violation|1|||
23495562|NCT03855228|65558847|FG002|Overall Study|Protocol Violation|2|||
23495563|NCT03855228|65558848|FG003|Overall Study|Protocol Violation|1|||
23495564|NCT03855228|65558845|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
23495565|NCT03855228|65558846|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
23495566|NCT03855228|65558847|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
23495567|NCT03855228|65558848|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
23495568|NCT00408629|65558852|FG000|Overall Study|Adverse Event|13|||
23495569|NCT00408629|65558853|FG001|Overall Study|Adverse Event|27|||
23495570|NCT00408629|65558852|FG000|Overall Study|Withdrawal by Subject|8|||
23495571|NCT00408629|65558853|FG001|Overall Study|Withdrawal by Subject|4|||
23495572|NCT00408629|65558852|FG000|Overall Study|Lost to Follow-up|1|||
23495573|NCT00408629|65558853|FG001|Overall Study|Lost to Follow-up|1|||
23495574|NCT00408629|65558852|FG000|Overall Study|Lack of Efficacy|63|||
23495575|NCT00408629|65558853|FG001|Overall Study|Lack of Efficacy|73|||
23495576|NCT00408629|65558852|FG000|Overall Study|Protocol Violation|1|||
23495577|NCT00408629|65558853|FG001|Overall Study|Protocol Violation|5|||
23495578|NCT00408629|65558852|FG000|Overall Study|Miscellaneous|11|||
23495579|NCT00408629|65558853|FG001|Overall Study|Miscellaneous|15|||
23495580|NCT00586625|65558854|FG000|Overall Study|Adverse Event|6|||
23495581|NCT00586625|65558855|FG001|Overall Study|Adverse Event|6|||
23495582|NCT00586625|65558854|FG000|Overall Study|Protocol Violation|3|||
23495583|NCT00586625|65558855|FG001|Overall Study|Protocol Violation|0|||
23495584|NCT00586625|65558854|FG000|Overall Study|Withdrawal by Subject|32|||
23495585|NCT00586625|65558855|FG001|Overall Study|Withdrawal by Subject|10|||
23495586|NCT00586625|65558854|FG000|Overall Study|Subject non-compliance|0|||
23495587|NCT00586625|65558855|FG001|Overall Study|Subject non-compliance|1|||
23495588|NCT00586625|65558854|FG000|Overall Study|Subject unable to return for visit|2|||
23495589|NCT00586625|65558855|FG001|Overall Study|Subject unable to return for visit|0|||
23495590|NCT00866788|65558858|FG000|Overall Study|Adverse Event|0|||
23495591|NCT00866788|65558859|FG001|Overall Study|Adverse Event|2|||
23495592|NCT00866788|65558860|FG002|Overall Study|Adverse Event|0|||
23495593|NCT00866788|65558861|FG003|Overall Study|Adverse Event|1|||
23495594|NCT00866788|65558858|FG000|Overall Study|Lost to Follow-up|1|||
23495595|NCT00866788|65558859|FG001|Overall Study|Lost to Follow-up|1|||
23495596|NCT00866788|65558860|FG002|Overall Study|Lost to Follow-up|0|||
23495597|NCT00866788|65558861|FG003|Overall Study|Lost to Follow-up|2|||
23495598|NCT00866788|65558858|FG000|Overall Study|Withdrawal by Subject|2|||
23495599|NCT00866788|65558859|FG001|Overall Study|Withdrawal by Subject|1|||
23495600|NCT00866788|65558860|FG002|Overall Study|Withdrawal by Subject|0|||
23495601|NCT00866788|65558861|FG003|Overall Study|Withdrawal by Subject|1|||
23495602|NCT00866788|65558858|FG000|Overall Study|Pregnancy|0|||
23495603|NCT00866788|65558859|FG001|Overall Study|Pregnancy|1|||
23495604|NCT00866788|65558860|FG002|Overall Study|Pregnancy|0|||
23495605|NCT00866788|65558861|FG003|Overall Study|Pregnancy|0|||
23495606|NCT00866788|65558858|FG000|Overall Study|Disease progression|3|||
23495607|NCT00866788|65558859|FG001|Overall Study|Disease progression|1|||
23495608|NCT00866788|65558860|FG002|Overall Study|Disease progression|1|||
23495609|NCT00866788|65558861|FG003|Overall Study|Disease progression|0|||
23495610|NCT00866788|65558858|FG000|Overall Study|Physician Decision|0|||
23495611|NCT00866788|65558859|FG001|Overall Study|Physician Decision|0|||
23495612|NCT00866788|65558860|FG002|Overall Study|Physician Decision|1|||
23495613|NCT00866788|65558861|FG003|Overall Study|Physician Decision|1|||
23495614|NCT02002091|65558862|FG000|Screening|Lost to Follow-up|10|||
23495615|NCT02002091|65558863|FG001|Screening|Lost to Follow-up|12|||
23495616|NCT02002091|65558862|FG000|Screening|Death|3|||
23495617|NCT02002091|65558863|FG001|Screening|Death|2|||
23495618|NCT01235689|65558864|FG000|Overall Study|Adverse Event|12|||
23495619|NCT01235689|65558865|FG001|Overall Study|Adverse Event|16|||
23495620|NCT01235689|65558864|FG000|Overall Study|Lack of Efficacy|12|||
23495621|NCT01235689|65558865|FG001|Overall Study|Lack of Efficacy|5|||
23495622|NCT01235689|65558864|FG000|Overall Study|Withdrawal by Subject|3|||
23495623|NCT01235689|65558865|FG001|Overall Study|Withdrawal by Subject|4|||
23495624|NCT01235689|65558864|FG000|Overall Study|Lost to Follow-up|1|||
23495625|NCT01235689|65558865|FG001|Overall Study|Lost to Follow-up|2|||
23495626|NCT01235689|65558864|FG000|Overall Study|Miscellaneous|1|||
23495627|NCT01235689|65558865|FG001|Overall Study|Miscellaneous|5|||
23495628|NCT00508755|65558868|FG000|Overall Study|Withdrawal by Subject|1|||
23495629|NCT03583697|65558869|FG000|Overall Study|Withdrawal by Subject|0|||
23495630|NCT03583697|65558870|FG001|Overall Study|Withdrawal by Subject|0|||
23495631|NCT03583697|65558871|FG002|Overall Study|Withdrawal by Subject|1|||
23495632|NCT03583697|65558869|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
23495633|NCT03583697|65558870|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
23495634|NCT03583697|65558871|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
23495635|NCT00799383|65558872|FG000|Overall Study|Protocol Violation|1|||
23495636|NCT00799383|65558873|FG001|Overall Study|Protocol Violation|1|||
23495637|NCT00799383|65558872|FG000|Overall Study|Adverse Event|0|||
23495638|NCT00799383|65558873|FG001|Overall Study|Adverse Event|1|||
23495639|NCT00799383|65558872|FG000|Overall Study|Lost to Follow-up|1|||
23495640|NCT00799383|65558873|FG001|Overall Study|Lost to Follow-up|2|||
23495641|NCT00799383|65558872|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
23495642|NCT00799383|65558873|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
23495643|NCT00799383|65558872|FG000|Overall Study|Withdrawal by Subject|0|||
23495644|NCT00799383|65558873|FG001|Overall Study|Withdrawal by Subject|1|||
23495645|NCT00398411|65558874|FG000|Overall Study|Death|0|||
23495646|NCT00398411|65558875|FG001|Overall Study|Death|1|||
23495647|NCT01849783|65558878|FG000|Overall Study|Adverse Event|5|||
23495648|NCT01849783|65558878|FG000|Overall Study|Death|2|||
23495649|NCT01849783|65558878|FG000|Overall Study|Physician Decision|1|||
23495650|NCT01849783|65558878|FG000|Overall Study|Withdrawal by Subject|1|||
23495651|NCT01849783|65558878|FG000|Overall Study|Unable to comply|2|||
23495652|NCT01849783|65558878|FG000|Overall Study|Disease progression|11|||
23495653|NCT02008318|65558879|FG000|Overall Study|Adverse Event|4|||
23495654|NCT02008318|65558880|FG001|Overall Study|Adverse Event|0|||
23495655|NCT02008318|65558879|FG000|Overall Study|Physician Decision|2|||
23495656|NCT02008318|65558880|FG001|Overall Study|Physician Decision|0|||
23495657|NCT02008318|65558879|FG000|Overall Study|Progressive Disease|2|||
23495658|NCT02008318|65558880|FG001|Overall Study|Progressive Disease|0|||
23495659|NCT02008318|65558879|FG000|Overall Study|Protocol Violation|1|||
23495660|NCT02008318|65558880|FG001|Overall Study|Protocol Violation|1|||
23495661|NCT02008318|65558879|FG000|Overall Study|Withdrawal by Subject|3|||
23495662|NCT02008318|65558880|FG001|Overall Study|Withdrawal by Subject|0|||
23495663|NCT02728596|65558881|FG000|Overall Study|Refusal unrelated to adverse event|3|||
23495664|NCT02728596|65558882|FG001|Overall Study|Refusal unrelated to adverse event|6|||
23495665|NCT02728596|65558883|FG002|Overall Study|Refusal unrelated to adverse event|7|||
23495666|NCT02728596|65558884|FG003|Overall Study|Refusal unrelated to adverse event|7|||
23495667|NCT02728596|65558881|FG000|Overall Study|Death|44|||
23495668|NCT02728596|65558882|FG001|Overall Study|Death|42|||
23495669|NCT02728596|65558883|FG002|Overall Study|Death|123|||
23495670|NCT02728596|65558884|FG003|Overall Study|Death|68|||
23495671|NCT02248701|65558887|FG000|Overall Study|Withdrawal by Subject|2|||
23495672|NCT02248701|65558888|FG001|Overall Study|Withdrawal by Subject|1|||
23495673|NCT02248701|65558887|FG000|Overall Study|Physician Decision|0|||
23495674|NCT02248701|65558888|FG001|Overall Study|Physician Decision|1|||
23495675|NCT02248701|65558887|FG000|Overall Study|Adverse Event|1|||
23495676|NCT02248701|65558888|FG001|Overall Study|Adverse Event|0|||
23495677|NCT02248701|65558887|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
23495678|NCT02248701|65558888|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
23495679|NCT00392015|65558891|FG000|Overall Study|Lost to Follow-up|2|||
23495680|NCT00392015|65558892|FG001|Overall Study|Lost to Follow-up|0|||
23495681|NCT00392015|65558893|FG002|Overall Study|Lost to Follow-up|2|||
23495682|NCT00392015|65558894|FG003|Overall Study|Lost to Follow-up|1|||
23495683|NCT00392015|65558895|FG004|Overall Study|Lost to Follow-up|1|||
23495684|NCT00392015|65558896|FG005|Overall Study|Lost to Follow-up|0|||
23495685|NCT00392015|65558891|FG000|Overall Study|Withdrawal by Subject|0|||
23495686|NCT00392015|65558892|FG001|Overall Study|Withdrawal by Subject|0|||
23495687|NCT00392015|65558893|FG002|Overall Study|Withdrawal by Subject|2|||
23495688|NCT00392015|65558894|FG003|Overall Study|Withdrawal by Subject|0|||
23495689|NCT00392015|65558895|FG004|Overall Study|Withdrawal by Subject|0|||
23495690|NCT00392015|65558896|FG005|Overall Study|Withdrawal by Subject|0|||
23495691|NCT00392015|65558891|FG000|Overall Study|Adverse Event|0|||
23495692|NCT00392015|65558892|FG001|Overall Study|Adverse Event|0|||
23495693|NCT00392015|65558893|FG002|Overall Study|Adverse Event|0|||
23495694|NCT00392015|65558894|FG003|Overall Study|Adverse Event|0|||
23495695|NCT00392015|65558895|FG004|Overall Study|Adverse Event|1|||
23495696|NCT00392015|65558896|FG005|Overall Study|Adverse Event|0|||
23495697|NCT00392015|65558891|FG000|Overall Study|Previous trial recipient|0|||
23495698|NCT00392015|65558892|FG001|Overall Study|Previous trial recipient|0|||
23495699|NCT00392015|65558893|FG002|Overall Study|Previous trial recipient|0|||
23495700|NCT00392015|65558894|FG003|Overall Study|Previous trial recipient|0|||
23300153|NCT01791153|64840075|FG007|Part 2: Open-label Period|Adverse Event|2|||
23495701|NCT00392015|65558895|FG004|Overall Study|Previous trial recipient|1|||
23495702|NCT00392015|65558896|FG005|Overall Study|Previous trial recipient|0|||
23495703|NCT01522248|65558899|FG000|Overall Study|Lost to Follow-up|1|||
23495704|NCT01522248|65558900|FG001|Overall Study|Lost to Follow-up|0|||
23495705|NCT01031381|65558901|FG000|Overall Study|Physician Decision|3|||
23495706|NCT01031381|65558901|FG000|Overall Study|Withdrawal by Subject|6|||
23495707|NCT01816074|65558902|FG000|Phase 1|Time commitment issues|0|||
23495708|NCT01816074|65558903|FG001|Phase 1|Time commitment issues|0|||
23495709|NCT01816074|65558904|FG002|Phase 1|Time commitment issues|1|||
23495710|NCT01816074|65558905|FG003|Phase 1|Time commitment issues|0|||
23300154|NCT01791153|64840068|FG000|Part 2: Open-label Period|Death|0|||
23300155|NCT01791153|64840069|FG001|Part 2: Open-label Period|Death|0|||
23495711|NCT01816074|65558902|FG000|Phase 2|Time commitment Issues|0|||
23495712|NCT01816074|65558903|FG001|Phase 2|Time commitment Issues|2|||
23495713|NCT01816074|65558904|FG002|Phase 2|Time commitment Issues|0|||
23495714|NCT01816074|65558905|FG003|Phase 2|Time commitment Issues|0|||
23495715|NCT01816074|65558902|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
23495716|NCT01816074|65558903|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
23495717|NCT01816074|65558904|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
23495718|NCT01816074|65558905|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
23495719|NCT01816074|65558902|FG000|Phase 2|Physician Decision|0|||
23495720|NCT01816074|65558903|FG001|Phase 2|Physician Decision|0|||
23495721|NCT01816074|65558904|FG002|Phase 2|Physician Decision|0|||
23495722|NCT01816074|65558905|FG003|Phase 2|Physician Decision|1|||
23495723|NCT01816074|65558902|FG000|Phase 2|Withdrawal by Subject|1|||
23495724|NCT01816074|65558903|FG001|Phase 2|Withdrawal by Subject|0|||
23495725|NCT01816074|65558904|FG002|Phase 2|Withdrawal by Subject|0|||
23495726|NCT01816074|65558905|FG003|Phase 2|Withdrawal by Subject|0|||
23495727|NCT00676338|65558906|FG000|Overall Study|Adverse Event|6|||
23495728|NCT00676338|65558907|FG001|Overall Study|Adverse Event|6|||
23495729|NCT00676338|65558908|FG002|Overall Study|Adverse Event|5|||
23495730|NCT00676338|65558909|FG003|Overall Study|Adverse Event|1|||
23495731|NCT00676338|65558906|FG000|Overall Study|Lost to Follow-up|4|||
23495732|NCT00676338|65558907|FG001|Overall Study|Lost to Follow-up|1|||
23495733|NCT00676338|65558908|FG002|Overall Study|Lost to Follow-up|3|||
23495734|NCT00676338|65558909|FG003|Overall Study|Lost to Follow-up|4|||
23495735|NCT00676338|65558906|FG000|Overall Study|Physician Decision|3|||
23495736|NCT00676338|65558907|FG001|Overall Study|Physician Decision|3|||
23495737|NCT00676338|65558908|FG002|Overall Study|Physician Decision|2|||
23495738|NCT00676338|65558909|FG003|Overall Study|Physician Decision|3|||
23300156|NCT01791153|64840070|FG002|Part 2: Open-label Period|Death|0|||
23495739|NCT00676338|65558906|FG000|Overall Study|Protocol Violation|5|||
23391128|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
23391129|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
23391130|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
23391131|NCT03093415|65178482|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
23391132|NCT03093415|65178483|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
23391133|NCT03093415|65178484|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
23391134|NCT03093415|65178482|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
23391135|NCT03093415|65178483|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
23391136|NCT03093415|65178484|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
23391137|NCT02402647|65178489|FG000|Overall Study|Lost to Follow-up|13|||
23391138|NCT02402647|65178490|FG001|Overall Study|Lost to Follow-up|7|||
23391139|NCT02402647|65178489|FG000|Overall Study|Protocol Violation|1|||
23391140|NCT02402647|65178490|FG001|Overall Study|Protocol Violation|1|||
23391141|NCT02402647|65178489|FG000|Overall Study|scheduled and timed out|2|||
23391142|NCT02402647|65178490|FG001|Overall Study|scheduled and timed out|1|||
23391143|NCT02402647|65178489|FG000|Overall Study|medical illness|2|||
23391144|NCT02402647|65178490|FG001|Overall Study|medical illness|4|||
23391145|NCT02402647|65178489|FG000|Overall Study|Moved|2|||
23391146|NCT02402647|65178490|FG001|Overall Study|Moved|0|||
23391147|NCT02402647|65178489|FG000|Overall Study|loved one illness|1|||
23391148|NCT02402647|65178490|FG001|Overall Study|loved one illness|0|||
23391149|NCT02402647|65178489|FG000|Overall Study|deceased preexisting condition|2|||
23391150|NCT02402647|65178490|FG001|Overall Study|deceased preexisting condition|0|||
23391151|NCT02402647|65178489|FG000|Overall Study|Other|2|||
23391152|NCT02402647|65178490|FG001|Overall Study|Other|1|||
23391153|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
23391154|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391155|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391156|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391157|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391158|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
23391159|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
23391160|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
23391161|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391162|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
23391163|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391164|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391165|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391166|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
23391167|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
23391168|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391169|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391170|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391171|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391172|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391173|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
23391174|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
23391175|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23391176|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23391177|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23391178|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23391179|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
23391180|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
23402832|NCT02185534|65220020|FG003|First Washout Period|Protocol Violation|0|||
23391181|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391182|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
23391183|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391184|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391185|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391186|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391187|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
23391188|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391189|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391190|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391191|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391192|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
23391193|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
23391194|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
23391195|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
23391196|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
23391197|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
23391198|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
23391199|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
23391200|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
23391201|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
23391202|NCT01557244|65178491|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
23391203|NCT01557244|65178492|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391204|NCT01557244|65178493|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
23391205|NCT01557244|65178494|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391206|NCT01557244|65178495|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391207|NCT01557244|65178496|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391208|NCT01557244|65178497|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
23391209|NCT01557244|65178491|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
23391210|NCT01557244|65178492|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
23391211|NCT01557244|65178493|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
23391212|NCT01557244|65178494|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
23391213|NCT01557244|65178495|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
23391214|NCT01557244|65178496|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
23391215|NCT01557244|65178497|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
23391216|NCT01557244|65178491|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
23391217|NCT01557244|65178492|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
23391218|NCT01557244|65178493|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391219|NCT01557244|65178494|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391220|NCT01557244|65178495|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391221|NCT01557244|65178496|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391222|NCT01557244|65178497|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
23391223|NCT01557244|65178491|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391224|NCT01557244|65178492|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391225|NCT01557244|65178493|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391226|NCT01557244|65178494|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
23391227|NCT01557244|65178495|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391228|NCT01557244|65178496|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391229|NCT01557244|65178497|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
23391230|NCT01557244|65178491|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
23391231|NCT01557244|65178492|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
23391232|NCT01557244|65178493|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391233|NCT01557244|65178494|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391234|NCT01557244|65178495|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391235|NCT01557244|65178496|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391236|NCT01557244|65178497|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
23391237|NCT03977155|65178498|FG000|Overall Study|Adverse Event|3|||
23391238|NCT03977155|65178499|FG001|Overall Study|Adverse Event|0|||
23391239|NCT03977155|65178500|FG002|Overall Study|Adverse Event|0|||
23391240|NCT03977155|65178498|FG000|Overall Study|Lost to Follow-up|0|||
23391241|NCT03977155|65178499|FG001|Overall Study|Lost to Follow-up|1|||
23391242|NCT03977155|65178500|FG002|Overall Study|Lost to Follow-up|0|||
23391243|NCT03977155|65178498|FG000|Overall Study|Withdrawal by Subject|1|||
23391244|NCT03977155|65178499|FG001|Overall Study|Withdrawal by Subject|1|||
23391245|NCT03977155|65178500|FG002|Overall Study|Withdrawal by Subject|2|||
23391246|NCT03977155|65178498|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
23391247|NCT03977155|65178499|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
23391248|NCT03977155|65178500|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
23391249|NCT02202577|65178501|FG000|Overall Study|Lost to Follow-up|6|||
23391250|NCT02202577|65178502|FG001|Overall Study|Lost to Follow-up|16|||
23391251|NCT02202577|65178501|FG000|Overall Study|Protocol Violation|7|||
23391252|NCT02202577|65178502|FG001|Overall Study|Protocol Violation|3|||
23391253|NCT00605657|65178505|FG000|Overall Study|Adverse Event|1|||
23391254|NCT00605657|65178505|FG000|Overall Study|Protocol Violation|1|||
23391255|NCT05185453|65178506|FG000|Overall Study|Lost to Follow-up|13|||
23391256|NCT05185453|65178507|FG001|Overall Study|Lost to Follow-up|3|||
23391257|NCT02254460|65178508|FG000|Overall Study|Adverse Event|1|||
23391258|NCT02254460|65178509|FG001|Overall Study|Adverse Event|0|||
23391259|NCT01882829|65178510|FG000|Overall Study|Adverse Event|4|||
23391260|NCT01882829|65178510|FG000|Overall Study|Protocol Violation|1|||
23391261|NCT01882829|65178510|FG000|Overall Study|Withdrawal by Subject|1|||
23391262|NCT03921528|65178511|FG000|Overall Study|Withdrawal by Subject|0|||
23391263|NCT03921528|65178512|FG001|Overall Study|Withdrawal by Subject|1|||
23391264|NCT03921528|65178513|FG002|Overall Study|Withdrawal by Subject|0|||
23391265|NCT03921528|65178514|FG003|Overall Study|Withdrawal by Subject|0|||
23391266|NCT03921528|65178515|FG004|Overall Study|Withdrawal by Subject|0|||
23391267|NCT00456365|65178518|FG000|Overall Study|Lost to Follow-up|1|||
23391268|NCT00456365|65178519|FG001|Overall Study|Lost to Follow-up|3|||
23391269|NCT00456365|65178518|FG000|Overall Study|Withdrawal by Subject|4|||
23391270|NCT00456365|65178519|FG001|Overall Study|Withdrawal by Subject|7|||
23391271|NCT00456365|65178518|FG000|Overall Study|Pregnancy|1|||
23391272|NCT00456365|65178519|FG001|Overall Study|Pregnancy|1|||
23495740|NCT00676338|65558907|FG001|Overall Study|Protocol Violation|9|||
23495741|NCT00676338|65558908|FG002|Overall Study|Protocol Violation|2|||
23495742|NCT00676338|65558909|FG003|Overall Study|Protocol Violation|5|||
23495743|NCT00676338|65558906|FG000|Overall Study|Withdrawal by Subject|17|||
23495744|NCT00676338|65558907|FG001|Overall Study|Withdrawal by Subject|9|||
23495745|NCT00676338|65558908|FG002|Overall Study|Withdrawal by Subject|12|||
23495746|NCT00676338|65558909|FG003|Overall Study|Withdrawal by Subject|6|||
23300157|NCT01791153|64840071|FG003|Part 2: Open-label Period|Death|0|||
23300158|NCT01791153|64840072|FG004|Part 2: Open-label Period|Death|0|||
23300159|NCT01791153|64840073|FG005|Part 2: Open-label Period|Death|1|||
23300160|NCT01791153|64840074|FG006|Part 2: Open-label Period|Death|1|||
23300161|NCT01791153|64840075|FG007|Part 2: Open-label Period|Death|1|||
23391273|NCT00456365|65178518|FG000|Overall Study|oncologic diagnosis|1|||
23391274|NCT00456365|65178519|FG001|Overall Study|oncologic diagnosis|1|||
23391275|NCT02679274|65178520|FG000|Overall Study|Withdrawal by Subject|1|||
23391276|NCT02679274|65178521|FG001|Overall Study|Withdrawal by Subject|0|||
23391277|NCT01730729|65178527|FG000|Overall Study|Adverse Event|1|||
23391278|NCT01730729|65178527|FG000|Overall Study|Death|1|||
23391279|NCT01730729|65178527|FG000|Overall Study|Progressive Disease|12|||
23391280|NCT00959049|65178534|FG000|Overall Study|Adverse Event|1|||
23391281|NCT00959049|65178535|FG001|Overall Study|Adverse Event|0|||
23391282|NCT00959049|65178536|FG002|Overall Study|Adverse Event|0|||
23495747|NCT00676338|65558906|FG000|Overall Study|Entry Criteria Not Met|0|||
23495748|NCT00676338|65558907|FG001|Overall Study|Entry Criteria Not Met|2|||
23495749|NCT00676338|65558908|FG002|Overall Study|Entry Criteria Not Met|1|||
23495750|NCT00676338|65558909|FG003|Overall Study|Entry Criteria Not Met|1|||
23495751|NCT00676338|65558906|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
23495752|NCT00676338|65558907|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
23495753|NCT00676338|65558908|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
23495754|NCT00676338|65558909|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
23495755|NCT00622284|65558910|FG000|Overall Study|Lack of Efficacy|45|||
23495756|NCT00622284|65558911|FG001|Overall Study|Lack of Efficacy|15|||
23495757|NCT00622284|65558910|FG000|Overall Study|Adverse Event|61|||
23495758|NCT00622284|65558911|FG001|Overall Study|Adverse Event|90|||
23495759|NCT00622284|65558910|FG000|Overall Study|Protocol Violation|12|||
23495760|NCT00622284|65558911|FG001|Overall Study|Protocol Violation|5|||
23495761|NCT00622284|65558910|FG000|Overall Study|Lost to Follow-up|11|||
23495762|NCT00622284|65558911|FG001|Overall Study|Lost to Follow-up|13|||
23495763|NCT00622284|65558910|FG000|Overall Study|Withdrawal by Subject|27|||
23495764|NCT00622284|65558911|FG001|Overall Study|Withdrawal by Subject|24|||
23495765|NCT00622284|65558910|FG000|Overall Study|Other reason (not specified)|33|||
23495766|NCT00622284|65558911|FG001|Overall Study|Other reason (not specified)|24|||
23495767|NCT03095612|65558912|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23495768|NCT03095612|65558913|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
23495769|NCT03095612|65558914|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23391283|NCT00959049|65178537|FG003|Overall Study|Adverse Event|0|||
23495770|NCT03095612|65558915|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23495771|NCT03095612|65558916|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23495772|NCT03095612|65558917|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23495773|NCT03095612|65558918|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
23300162|NCT01791153|64840068|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
23300163|NCT01791153|64840069|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
23300164|NCT01791153|64840070|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
23391284|NCT00959049|65178538|FG004|Overall Study|Adverse Event|0|||
23495774|NCT00809354|65558920|FG000|Overall Study|Adverse Event|32|||
23391285|NCT00959049|65178539|FG005|Overall Study|Adverse Event|0|||
23391286|NCT00959049|65178534|FG000|Overall Study|Lost to Follow-up|17|||
23391287|NCT00959049|65178535|FG001|Overall Study|Lost to Follow-up|5|||
23391288|NCT00959049|65178536|FG002|Overall Study|Lost to Follow-up|1|||
23391289|NCT00959049|65178537|FG003|Overall Study|Lost to Follow-up|10|||
23391290|NCT00959049|65178538|FG004|Overall Study|Lost to Follow-up|9|||
23391291|NCT00959049|65178539|FG005|Overall Study|Lost to Follow-up|1|||
23391292|NCT00959049|65178534|FG000|Overall Study|Contraindicated medication|0|||
23391293|NCT00959049|65178535|FG001|Overall Study|Contraindicated medication|0|||
23391294|NCT00959049|65178536|FG002|Overall Study|Contraindicated medication|0|||
23391295|NCT00959049|65178537|FG003|Overall Study|Contraindicated medication|1|||
23391296|NCT00959049|65178538|FG004|Overall Study|Contraindicated medication|0|||
23391297|NCT00959049|65178539|FG005|Overall Study|Contraindicated medication|0|||
23391298|NCT00959049|65178534|FG000|Overall Study|Withdrawal by Subject|0|||
23391299|NCT00959049|65178535|FG001|Overall Study|Withdrawal by Subject|2|||
23391300|NCT00959049|65178536|FG002|Overall Study|Withdrawal by Subject|0|||
23391301|NCT00959049|65178537|FG003|Overall Study|Withdrawal by Subject|0|||
23391302|NCT00959049|65178538|FG004|Overall Study|Withdrawal by Subject|0|||
23391303|NCT00959049|65178539|FG005|Overall Study|Withdrawal by Subject|0|||
23391304|NCT03647137|65178540|FG000|Overall Study|Scan Limitation|2|||
23391305|NCT03647137|65178541|FG001|Overall Study|Scan Limitation|1|||
23391306|NCT03647137|65178542|FG002|Overall Study|Scan Limitation|1|||
23391307|NCT03647137|65178543|FG003|Overall Study|Scan Limitation|2|||
23391308|NCT04976855|65178550|FG000|Part I|Withdrawal by Subject|0|||
23391309|NCT04976855|65178551|FG001|Part I|Withdrawal by Subject|1|||
23391310|NCT04976855|65178552|FG002|Part I|Withdrawal by Subject|0|||
23391311|NCT04976855|65178553|FG003|Part I|Withdrawal by Subject|0|||
23391312|NCT04976855|65178554|FG004|Part I|Withdrawal by Subject|0|||
23391313|NCT04976855|65178555|FG005|Part I|Withdrawal by Subject|0|||
23391314|NCT04976855|65178556|FG006|Part I|Withdrawal by Subject|0|||
23391315|NCT04976855|65178550|FG000|Part II|Adverse Event|0|||
23391316|NCT04976855|65178551|FG001|Part II|Adverse Event|0|||
23391317|NCT04976855|65178552|FG002|Part II|Adverse Event|0|||
23391318|NCT04976855|65178553|FG003|Part II|Adverse Event|1|||
23391319|NCT04976855|65178554|FG004|Part II|Adverse Event|0|||
23391320|NCT04976855|65178555|FG005|Part II|Adverse Event|0|||
23391321|NCT04976855|65178556|FG006|Part II|Adverse Event|0|||
23391322|NCT04976855|65178550|FG000|Part II|Withdrawal by Subject|0|||
23391323|NCT04976855|65178551|FG001|Part II|Withdrawal by Subject|0|||
23391324|NCT04976855|65178552|FG002|Part II|Withdrawal by Subject|0|||
23391325|NCT04976855|65178553|FG003|Part II|Withdrawal by Subject|0|||
23391326|NCT04976855|65178554|FG004|Part II|Withdrawal by Subject|1|||
23391327|NCT04976855|65178555|FG005|Part II|Withdrawal by Subject|0|||
23391328|NCT04976855|65178556|FG006|Part II|Withdrawal by Subject|0|||
23391329|NCT04976855|65178550|FG000|Part II|Lost to Follow-up|0|||
23391330|NCT04976855|65178551|FG001|Part II|Lost to Follow-up|0|||
23391331|NCT04976855|65178552|FG002|Part II|Lost to Follow-up|0|||
23391332|NCT04976855|65178553|FG003|Part II|Lost to Follow-up|0|||
23391333|NCT04976855|65178554|FG004|Part II|Lost to Follow-up|0|||
23391334|NCT04976855|65178555|FG005|Part II|Lost to Follow-up|1|||
23391335|NCT04976855|65178556|FG006|Part II|Lost to Follow-up|0|||
23495775|NCT00809354|65558921|FG001|Overall Study|Adverse Event|45|||
23300165|NCT01791153|64840071|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
23495776|NCT00809354|65558922|FG002|Overall Study|Adverse Event|37|||
23495777|NCT00809354|65558923|FG003|Overall Study|Adverse Event|53|||
23495778|NCT00809354|65558924|FG004|Overall Study|Adverse Event|26|||
23495779|NCT00809354|65558925|FG005|Overall Study|Adverse Event|33|||
23495780|NCT00809354|65558926|FG006|Overall Study|Adverse Event|44|||
23495781|NCT00809354|65558927|FG007|Overall Study|Adverse Event|40|||
23495782|NCT00809354|65558928|FG008|Overall Study|Adverse Event|46|||
23495783|NCT00809354|65558929|FG009|Overall Study|Adverse Event|26|||
23495784|NCT00809354|65558920|FG000|Overall Study|Lack of Efficacy|23|||
23495785|NCT00809354|65558921|FG001|Overall Study|Lack of Efficacy|23|||
23495786|NCT00809354|65558922|FG002|Overall Study|Lack of Efficacy|22|||
23495787|NCT00809354|65558923|FG003|Overall Study|Lack of Efficacy|15|||
23391336|NCT00661687|65178557|FG000|Overall Study|Study related symptoms and complaints|5|||
23391337|NCT00661687|65178557|FG000|Overall Study|Positive slit lamp findings|4|||
23391338|NCT00661687|65178557|FG000|Overall Study|Inability to maintain wearing schedule|3|||
23391339|NCT00661687|65178557|FG000|Overall Study|Physician Decision|1|||
23391340|NCT00661687|65178557|FG000|Overall Study|Adverse Event|2|||
23391341|NCT00662038|65178558|FG000|Overall Study|Reason not specified|3|||
23391342|NCT00662038|65178558|FG000|Overall Study|Withdrawn consent|22|||
23391343|NCT00662038|65178558|FG000|Overall Study|Withdrawal by Subject|83|||
23495788|NCT00809354|65558924|FG004|Overall Study|Lack of Efficacy|40|||
23495789|NCT00809354|65558925|FG005|Overall Study|Lack of Efficacy|19|||
23495790|NCT00809354|65558926|FG006|Overall Study|Lack of Efficacy|21|||
23495791|NCT00809354|65558927|FG007|Overall Study|Lack of Efficacy|15|||
23495792|NCT00809354|65558928|FG008|Overall Study|Lack of Efficacy|18|||
23391344|NCT00662038|65178558|FG000|Overall Study|Sponsor decision|1|||
23391345|NCT00662038|65178558|FG000|Overall Study|Physician Decision|19|||
23391346|NCT00662038|65178558|FG000|Overall Study|Lung transplantation|44|||
23391347|NCT00662038|65178558|FG000|Overall Study|Lost to Follow-up|1|||
23391348|NCT00662038|65178558|FG000|Overall Study|Death|95|||
23391349|NCT00662038|65178558|FG000|Overall Study|Adverse Event|358|||
23391350|NCT00662038|65178558|FG000|Overall Study|Continued treatment|5|||
23391351|NCT00979407|65178561|FG000|Overall Study|Withdrawal by Subject|3|||
23391352|NCT00979407|65178562|FG001|Overall Study|Withdrawal by Subject|4|||
23391353|NCT00979407|65178561|FG000|Overall Study|Lost to Follow-up|3|||
23495793|NCT00809354|65558929|FG009|Overall Study|Lack of Efficacy|38|||
23495794|NCT00809354|65558920|FG000|Overall Study|Lost to Follow-up|10|||
23495795|NCT00809354|65558921|FG001|Overall Study|Lost to Follow-up|11|||
23495796|NCT00809354|65558922|FG002|Overall Study|Lost to Follow-up|8|||
23495797|NCT00809354|65558923|FG003|Overall Study|Lost to Follow-up|13|||
23495798|NCT00809354|65558924|FG004|Overall Study|Lost to Follow-up|6|||
23495799|NCT00809354|65558925|FG005|Overall Study|Lost to Follow-up|2|||
23495800|NCT00809354|65558926|FG006|Overall Study|Lost to Follow-up|0|||
23495801|NCT00809354|65558927|FG007|Overall Study|Lost to Follow-up|5|||
23495802|NCT00809354|65558928|FG008|Overall Study|Lost to Follow-up|4|||
23495803|NCT00809354|65558929|FG009|Overall Study|Lost to Follow-up|0|||
23495804|NCT00809354|65558920|FG000|Overall Study|Protocol Violation|7|||
23495805|NCT00809354|65558921|FG001|Overall Study|Protocol Violation|14|||
23495806|NCT00809354|65558922|FG002|Overall Study|Protocol Violation|14|||
23495807|NCT00809354|65558923|FG003|Overall Study|Protocol Violation|12|||
23495808|NCT00809354|65558924|FG004|Overall Study|Protocol Violation|14|||
23495809|NCT00809354|65558925|FG005|Overall Study|Protocol Violation|6|||
23391354|NCT00979407|65178562|FG001|Overall Study|Lost to Follow-up|3|||
23391355|NCT00322218|65178563|FG000|Overall Study|Death|3|||
23391356|NCT00322218|65178564|FG001|Overall Study|Death|6|||
23391357|NCT00879398|65178570|FG000|Overall Study|Visit Stop|399|||
23391358|NCT00879398|65178570|FG000|Overall Study|Lack of Efficacy|64|||
23391359|NCT00879398|65178570|FG000|Overall Study|Adverse Event|41|||
23495810|NCT00809354|65558926|FG006|Overall Study|Protocol Violation|4|||
23495811|NCT00809354|65558927|FG007|Overall Study|Protocol Violation|6|||
23495812|NCT00809354|65558928|FG008|Overall Study|Protocol Violation|9|||
23495813|NCT00809354|65558929|FG009|Overall Study|Protocol Violation|3|||
23391360|NCT00879398|65178570|FG000|Overall Study|Other Reasons|171|||
23391361|NCT03757715|65178571|FG000|Overall Study|Lost to Follow-up|4|||
23391362|NCT03757715|65178572|FG001|Overall Study|Lost to Follow-up|9|||
23495814|NCT00809354|65558920|FG000|Overall Study|Withdrawal by Subject|32|||
23495815|NCT00809354|65558921|FG001|Overall Study|Withdrawal by Subject|27|||
23495816|NCT00809354|65558922|FG002|Overall Study|Withdrawal by Subject|31|||
23495817|NCT00809354|65558923|FG003|Overall Study|Withdrawal by Subject|33|||
23495818|NCT00809354|65558924|FG004|Overall Study|Withdrawal by Subject|34|||
23495819|NCT00809354|65558925|FG005|Overall Study|Withdrawal by Subject|29|||
23495820|NCT00809354|65558926|FG006|Overall Study|Withdrawal by Subject|27|||
23495821|NCT00809354|65558927|FG007|Overall Study|Withdrawal by Subject|19|||
23300166|NCT01791153|64840072|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
23300167|NCT01791153|64840073|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
23300168|NCT01791153|64840074|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
23300169|NCT01791153|64840075|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
23300170|NCT01791153|64840068|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
23300171|NCT01791153|64840069|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
23300172|NCT01791153|64840070|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
23300173|NCT01791153|64840071|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
23300174|NCT01791153|64840072|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
23300175|NCT01791153|64840073|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
23300176|NCT01791153|64840074|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
23300177|NCT01791153|64840075|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
23300178|NCT01791153|64840068|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
23300179|NCT01791153|64840069|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
23300180|NCT01791153|64840070|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
23300181|NCT01791153|64840071|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
23300182|NCT01791153|64840072|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
23300183|NCT01791153|64840073|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
23300184|NCT01791153|64840074|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
23300185|NCT01791153|64840075|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
23300186|NCT01791153|64840068|FG000|Part 2: Open-label Period|Physician Decision|0|||
23300187|NCT01791153|64840069|FG001|Part 2: Open-label Period|Physician Decision|0|||
23300188|NCT01791153|64840070|FG002|Part 2: Open-label Period|Physician Decision|0|||
23300189|NCT01791153|64840071|FG003|Part 2: Open-label Period|Physician Decision|0|||
23300190|NCT01791153|64840072|FG004|Part 2: Open-label Period|Physician Decision|1|||
23300191|NCT01791153|64840073|FG005|Part 2: Open-label Period|Physician Decision|1|||
23300192|NCT01791153|64840074|FG006|Part 2: Open-label Period|Physician Decision|0|||
23300193|NCT01791153|64840075|FG007|Part 2: Open-label Period|Physician Decision|0|||
23300194|NCT02243293|64840076|FG000|Overall Study|Adverse Event|1|||
23300195|NCT02243293|64840077|FG001|Overall Study|Adverse Event|0|||
23495822|NCT00809354|65558928|FG008|Overall Study|Withdrawal by Subject|18|||
23495823|NCT00809354|65558929|FG009|Overall Study|Withdrawal by Subject|20|||
23391363|NCT03757715|65178571|FG000|Overall Study|Withdrawal by Subject|1|||
23391364|NCT03757715|65178572|FG001|Overall Study|Withdrawal by Subject|1|||
23391365|NCT01772693|65178573|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
23391366|NCT01772693|65178574|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
23391367|NCT01772693|65178573|FG000|Overall Study|Withdrawal by Subject|2|||
23391368|NCT01772693|65178574|FG001|Overall Study|Withdrawal by Subject|0|||
23391369|NCT01772693|65178573|FG000|Overall Study|Alternative Treatment|2|||
23391370|NCT01772693|65178574|FG001|Overall Study|Alternative Treatment|0|||
23391371|NCT00382863|65178575|FG000|Overall Study|Death|9|||
23391372|NCT00382863|65178576|FG001|Overall Study|Death|9|||
23391373|NCT00382863|65178575|FG000|Overall Study|Lost to Follow-up|1|||
23391374|NCT00382863|65178576|FG001|Overall Study|Lost to Follow-up|2|||
23391375|NCT00382863|65178575|FG000|Overall Study|Withdrawal by Subject|5|||
23391376|NCT00382863|65178576|FG001|Overall Study|Withdrawal by Subject|25|||
23391377|NCT03449147|65178577|FG000|52-week Treatment Period|Death|0|||
23391378|NCT03449147|65178578|FG001|52-week Treatment Period|Death|1|||
23391379|NCT03449147|65178579|FG002|52-week Treatment Period|Death|0|||
23391380|NCT03449147|65178577|FG000|52-week Treatment Period|Lost to Follow-up|6|||
23391381|NCT03449147|65178578|FG001|52-week Treatment Period|Lost to Follow-up|2|||
23495824|NCT00809354|65558920|FG000|Overall Study|Other|10|||
23495825|NCT00809354|65558921|FG001|Overall Study|Other|2|||
23495826|NCT00809354|65558922|FG002|Overall Study|Other|7|||
23495827|NCT00809354|65558923|FG003|Overall Study|Other|10|||
23495828|NCT00809354|65558924|FG004|Overall Study|Other|5|||
23495829|NCT00809354|65558925|FG005|Overall Study|Other|3|||
23495830|NCT00809354|65558926|FG006|Overall Study|Other|2|||
23495831|NCT00809354|65558927|FG007|Overall Study|Other|3|||
23495832|NCT00809354|65558928|FG008|Overall Study|Other|4|||
23495833|NCT00809354|65558929|FG009|Overall Study|Other|3|||
23495834|NCT00809354|65558920|FG000|Overall Study|Study terminated by sponsor|138|||
23495835|NCT00809354|65558921|FG001|Overall Study|Study terminated by sponsor|134|||
23495836|NCT00809354|65558922|FG002|Overall Study|Study terminated by sponsor|129|||
23495837|NCT00809354|65558923|FG003|Overall Study|Study terminated by sponsor|120|||
23495838|NCT00809354|65558924|FG004|Overall Study|Study terminated by sponsor|126|||
23495839|NCT00809354|65558925|FG005|Overall Study|Study terminated by sponsor|133|||
23391382|NCT03449147|65178579|FG002|52-week Treatment Period|Lost to Follow-up|5|||
23391383|NCT03449147|65178577|FG000|52-week Treatment Period|Other|0|||
23391384|NCT03449147|65178578|FG001|52-week Treatment Period|Other|1|||
23391385|NCT03449147|65178579|FG002|52-week Treatment Period|Other|2|||
23391386|NCT03449147|65178577|FG000|52-week Treatment Period|Physician Decision|1|||
23391387|NCT03449147|65178578|FG001|52-week Treatment Period|Physician Decision|0|||
23391388|NCT03449147|65178579|FG002|52-week Treatment Period|Physician Decision|3|||
23391389|NCT03449147|65178577|FG000|52-week Treatment Period|Screen Failure|1|||
23391390|NCT03449147|65178578|FG001|52-week Treatment Period|Screen Failure|2|||
23391391|NCT03449147|65178579|FG002|52-week Treatment Period|Screen Failure|0|||
23391392|NCT03449147|65178577|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
23391393|NCT03449147|65178578|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
23391394|NCT03449147|65178579|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
23391395|NCT03449147|65178577|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
23391396|NCT03449147|65178578|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
23391397|NCT03449147|65178579|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
23391398|NCT03449147|65178577|FG000|12-Week Off-Treatment Durability Period|Other|0|||
23391399|NCT03449147|65178578|FG001|12-Week Off-Treatment Durability Period|Other|1|||
23391400|NCT03449147|65178579|FG002|12-Week Off-Treatment Durability Period|Other|0|||
23391401|NCT00944645|65178584|FG000|Period 2|Adverse Event|1|||
23391402|NCT00944645|65178585|FG001|Period 2|Adverse Event|0|||
23391403|NCT00944645|65178584|FG000|Period 2|Lost to Follow-up|0|||
23391404|NCT00944645|65178585|FG001|Period 2|Lost to Follow-up|3|||
23391405|NCT00944645|65178584|FG000|Period 2|Withdrawal by Subject|7|||
23391406|NCT00944645|65178585|FG001|Period 2|Withdrawal by Subject|6|||
23391407|NCT01926509|65178586|FG000|Overall Study|vital sign met discontinuation criteria|1|||
23391408|NCT01926509|65178587|FG001|Overall Study|vital sign met discontinuation criteria|0|||
23391409|NCT01926509|65178588|FG002|Overall Study|vital sign met discontinuation criteria|0|||
23391410|NCT01926509|65178589|FG003|Overall Study|vital sign met discontinuation criteria|0|||
23391411|NCT03034044|65178595|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
23495840|NCT00809354|65558926|FG006|Overall Study|Study terminated by sponsor|124|||
23495841|NCT00809354|65558927|FG007|Overall Study|Study terminated by sponsor|148|||
23391412|NCT00563316|65178598|FG000|Overall Study|Adverse Event|2|||
23391413|NCT00563316|65178598|FG000|Overall Study|Physician Decision|1|||
23391414|NCT00563316|65178598|FG000|Overall Study|Lost to Follow-up|2|||
23495842|NCT00809354|65558928|FG008|Overall Study|Study terminated by sponsor|127|||
23495843|NCT00809354|65558929|FG009|Overall Study|Study terminated by sponsor|135|||
23495844|NCT00809354|65558920|FG000|Overall Study|Withdrawn due to pregnancy|0|||
23391415|NCT00563316|65178598|FG000|Overall Study|Death|1|||
23391416|NCT00563316|65178598|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
23391417|NCT00563316|65178598|FG000|Overall Study|Other|1|||
23391418|NCT02757963|65178599|FG000|Overall Study|Adverse Event|3|||
23391419|NCT02757963|65178599|FG000|Overall Study|Reached Stopping Criteria|1054|||
23391420|NCT02757963|65178599|FG000|Overall Study|Lost to Follow-up|5|||
23391421|NCT02757963|65178599|FG000|Overall Study|Physician Decision|1|||
23391422|NCT02757963|65178599|FG000|Overall Study|Withdrawal by Subject|34|||
23391423|NCT02414841|65178600|FG000|Overall Study|Withdrawal by Subject|7|||
23391424|NCT02414841|65178601|FG001|Overall Study|Withdrawal by Subject|5|||
23391425|NCT02414841|65178600|FG000|Overall Study|Lost to Follow-up|13|||
23300196|NCT02243293|64840078|FG002|Overall Study|Adverse Event|0|||
23300197|NCT02243293|64840079|FG003|Overall Study|Adverse Event|0|||
23300198|NCT02243293|64840080|FG004|Overall Study|Adverse Event|0|||
23300199|NCT02243293|64840081|FG005|Overall Study|Adverse Event|0|||
23300200|NCT02243293|64840082|FG006|Overall Study|Adverse Event|0|||
23300201|NCT02243293|64840083|FG007|Overall Study|Adverse Event|0|||
23300202|NCT02243293|64840084|FG008|Overall Study|Adverse Event|0|||
23300203|NCT02243293|64840085|FG009|Overall Study|Adverse Event|0|||
23300204|NCT02243293|64840086|FG010|Overall Study|Adverse Event|0|||
23300205|NCT02243293|64840087|FG011|Overall Study|Adverse Event|0|||
23300206|NCT02243293|64840088|FG012|Overall Study|Adverse Event|0|||
23300207|NCT02243293|64840089|FG013|Overall Study|Adverse Event|0|||
23300208|NCT02243293|64840090|FG014|Overall Study|Adverse Event|0|||
23300209|NCT02243293|64840091|FG015|Overall Study|Adverse Event|1|||
23300210|NCT02243293|64840092|FG016|Overall Study|Adverse Event|0|||
23391426|NCT02414841|65178601|FG001|Overall Study|Lost to Follow-up|6|||
23391427|NCT02414841|65178600|FG000|Overall Study|Death|17|||
23391428|NCT02414841|65178601|FG001|Overall Study|Death|14|||
23300211|NCT02243293|64840093|FG017|Overall Study|Adverse Event|0|||
23300212|NCT02243293|64840094|FG018|Overall Study|Adverse Event|0|||
23391429|NCT02414841|65178600|FG000|Overall Study|Received a Kidney Transplant|13|||
23391430|NCT02414841|65178601|FG001|Overall Study|Received a Kidney Transplant|4|||
23391431|NCT02414841|65178600|FG000|Overall Study|Randomized But Not Treated|6|||
23391432|NCT02414841|65178601|FG001|Overall Study|Randomized But Not Treated|4|||
23391433|NCT00185614|65178602|FG000|Inter-treatment Period|Physician Decision|1|||
23391434|NCT00185614|65178602|FG000|Inter-treatment Period|Relapse|2|||
23391435|NCT00185614|65178602|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
23391436|NCT03906071|65178607|FG000|Overall Study|Death|180|||
23391437|NCT03906071|65178608|FG001|Overall Study|Death|185|||
23391438|NCT03906071|65178607|FG000|Overall Study|Lost to Follow-up|3|||
23391439|NCT03906071|65178608|FG001|Overall Study|Lost to Follow-up|3|||
23391440|NCT03906071|65178607|FG000|Overall Study|Withdrawal by Subject|15|||
23391441|NCT03906071|65178608|FG001|Overall Study|Withdrawal by Subject|27|||
23391442|NCT03906071|65178607|FG000|Overall Study|Other|2|||
23391443|NCT03906071|65178608|FG001|Overall Study|Other|1|||
23495845|NCT00809354|65558921|FG001|Overall Study|Withdrawn due to pregnancy|1|||
23495846|NCT00809354|65558922|FG002|Overall Study|Withdrawn due to pregnancy|0|||
23495847|NCT00809354|65558923|FG003|Overall Study|Withdrawn due to pregnancy|0|||
23495848|NCT00809354|65558924|FG004|Overall Study|Withdrawn due to pregnancy|0|||
23495849|NCT00809354|65558925|FG005|Overall Study|Withdrawn due to pregnancy|0|||
23495850|NCT00809354|65558926|FG006|Overall Study|Withdrawn due to pregnancy|0|||
23495851|NCT00809354|65558927|FG007|Overall Study|Withdrawn due to pregnancy|0|||
23495852|NCT00809354|65558928|FG008|Overall Study|Withdrawn due to pregnancy|0|||
23495853|NCT00809354|65558929|FG009|Overall Study|Withdrawn due to pregnancy|0|||
23495854|NCT00809354|65558920|FG000|Overall Study|Randomized but not Treated|3|||
23495855|NCT00809354|65558921|FG001|Overall Study|Randomized but not Treated|1|||
23495856|NCT00809354|65558922|FG002|Overall Study|Randomized but not Treated|6|||
23495857|NCT00809354|65558923|FG003|Overall Study|Randomized but not Treated|0|||
23495858|NCT00809354|65558924|FG004|Overall Study|Randomized but not Treated|5|||
23495859|NCT00809354|65558925|FG005|Overall Study|Randomized but not Treated|0|||
23495860|NCT00809354|65558926|FG006|Overall Study|Randomized but not Treated|1|||
23495861|NCT00809354|65558927|FG007|Overall Study|Randomized but not Treated|1|||
23495862|NCT00809354|65558928|FG008|Overall Study|Randomized but not Treated|2|||
23495863|NCT00809354|65558929|FG009|Overall Study|Randomized but not Treated|1|||
23495864|NCT00809354|65558920|FG000|Overall Study|Death|0|||
23495865|NCT00809354|65558921|FG001|Overall Study|Death|0|||
23495866|NCT00809354|65558922|FG002|Overall Study|Death|0|||
23495867|NCT00809354|65558923|FG003|Overall Study|Death|0|||
23495868|NCT00809354|65558924|FG004|Overall Study|Death|0|||
23300213|NCT02243293|64840095|FG019|Overall Study|Adverse Event|0|||
23300214|NCT02243293|64840096|FG020|Overall Study|Adverse Event|1|||
23300215|NCT02243293|64840097|FG021|Overall Study|Adverse Event|0|||
23300216|NCT02243293|64840076|FG000|Overall Study|Withdrawal by Subject|1|||
23300217|NCT02243293|64840077|FG001|Overall Study|Withdrawal by Subject|0|||
23300218|NCT02243293|64840078|FG002|Overall Study|Withdrawal by Subject|0|||
23300219|NCT02243293|64840079|FG003|Overall Study|Withdrawal by Subject|0|||
23300220|NCT02243293|64840080|FG004|Overall Study|Withdrawal by Subject|0|||
23300221|NCT02243293|64840081|FG005|Overall Study|Withdrawal by Subject|0|||
23300222|NCT02243293|64840082|FG006|Overall Study|Withdrawal by Subject|0|||
23300223|NCT02243293|64840083|FG007|Overall Study|Withdrawal by Subject|0|||
23391444|NCT04887285|65178614|FG000|Overall Study|Lost to Follow-up|0|||
23391445|NCT04887285|65178615|FG001|Overall Study|Lost to Follow-up|2|||
23391446|NCT04887285|65178616|FG002|Overall Study|Lost to Follow-up|3|||
23495869|NCT00809354|65558925|FG005|Overall Study|Death|0|||
23391447|NCT04641975|65178623|FG000|Overall Study|Protocol Violation|1|||
23391448|NCT04641975|65178624|FG001|Overall Study|Protocol Violation|2|||
23391449|NCT04641975|65178625|FG002|Overall Study|Protocol Violation|0|||
23391450|NCT04641975|65178626|FG003|Overall Study|Protocol Violation|0|||
23391451|NCT04641975|65178623|FG000|Overall Study|Adverse Event|0|||
23391452|NCT04641975|65178624|FG001|Overall Study|Adverse Event|0|||
23391453|NCT04641975|65178625|FG002|Overall Study|Adverse Event|1|||
23391454|NCT04641975|65178626|FG003|Overall Study|Adverse Event|1|||
23391455|NCT04641975|65178623|FG000|Overall Study|Withdrawal by Subject|1|||
23391456|NCT04641975|65178624|FG001|Overall Study|Withdrawal by Subject|0|||
23391457|NCT04641975|65178625|FG002|Overall Study|Withdrawal by Subject|0|||
23391458|NCT04641975|65178626|FG003|Overall Study|Withdrawal by Subject|0|||
23391459|NCT01487161|65178633|FG000|Overall Study|Adverse Event|1|||
23391460|NCT01487161|65178634|FG001|Overall Study|Adverse Event|0|||
23391461|NCT01487161|65178635|FG002|Overall Study|Adverse Event|0|||
23391462|NCT01487161|65178636|FG003|Overall Study|Adverse Event|0|||
23495870|NCT00809354|65558926|FG006|Overall Study|Death|0|||
23300224|NCT02243293|64840084|FG008|Overall Study|Withdrawal by Subject|0|||
23391463|NCT01487161|65178633|FG000|Overall Study|Withdrawal by Subject|1|||
23391464|NCT01487161|65178634|FG001|Overall Study|Withdrawal by Subject|1|||
23391465|NCT01487161|65178635|FG002|Overall Study|Withdrawal by Subject|1|||
23495871|NCT00809354|65558927|FG007|Overall Study|Death|1|||
23391466|NCT01487161|65178636|FG003|Overall Study|Withdrawal by Subject|2|||
23391467|NCT01487161|65178633|FG000|Overall Study|missing data|0|||
23391468|NCT01487161|65178634|FG001|Overall Study|missing data|1|||
23391469|NCT01487161|65178635|FG002|Overall Study|missing data|0|||
23391470|NCT01487161|65178636|FG003|Overall Study|missing data|0|||
23391471|NCT02264821|65178637|FG000|Overall Study|Protocol Violation|1|||
23391472|NCT02264821|65178638|FG001|Overall Study|Protocol Violation|3|||
23391473|NCT02264821|65178639|FG002|Overall Study|Protocol Violation|6|||
23391474|NCT02367885|65178642|FG000|Overall Study|Lost to Follow-up|1|||
23391475|NCT02367885|65178643|FG001|Overall Study|Lost to Follow-up|0|||
23391476|NCT02367885|65178644|FG002|Overall Study|Lost to Follow-up|0|||
23391477|NCT02367885|65178642|FG000|Overall Study|Withdrawal by Subject|1|||
23391478|NCT02367885|65178643|FG001|Overall Study|Withdrawal by Subject|0|||
23391479|NCT02367885|65178644|FG002|Overall Study|Withdrawal by Subject|0|||
23391480|NCT03766399|65178645|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391481|NCT03766399|65178646|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391482|NCT03766399|65178647|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391483|NCT03766399|65178648|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391484|NCT03766399|65178649|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391485|NCT03766399|65178650|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391486|NCT03766399|65178651|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391487|NCT03766399|65178652|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391488|NCT03766399|65178653|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391489|NCT03766399|65178654|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391490|NCT03766399|65178655|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391491|NCT03766399|65178656|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391492|NCT03766399|65178657|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391493|NCT03766399|65178658|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
23391494|NCT03766399|65178659|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391495|NCT03766399|65178660|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391496|NCT03766399|65178661|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391497|NCT03766399|65178662|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
23391498|NCT02298946|65178665|FG000|Overall Study|Did not receive treatment|2|||
23391499|NCT02298946|65178666|FG001|Overall Study|Did not receive treatment|0|||
23495872|NCT00809354|65558928|FG008|Overall Study|Death|0|||
23495873|NCT00809354|65558929|FG009|Overall Study|Death|0|||
23495874|NCT02762578|65558930|FG000|Overall Study|Adverse Event|1|||
23495875|NCT02762578|65558931|FG001|Overall Study|Adverse Event|6|||
23495876|NCT02762578|65558930|FG000|Overall Study|Protocol Violation|4|||
23495877|NCT02762578|65558931|FG001|Overall Study|Protocol Violation|2|||
23495878|NCT02762578|65558930|FG000|Overall Study|Withdrawal by Subject|4|||
23495879|NCT02762578|65558931|FG001|Overall Study|Withdrawal by Subject|2|||
23495880|NCT02762578|65558930|FG000|Overall Study|Unclassified|6|||
23495881|NCT02762578|65558931|FG001|Overall Study|Unclassified|0|||
23495882|NCT00781274|65558933|FG000|Overall Study|Withdrawal by Subject|2|||
23495883|NCT01201785|65558942|FG000|Overall Study|Lost to Follow-up|16|||
23495884|NCT00289016|65558943|FG000|Overall Study|Disease Progression|29|||
23495885|NCT00289016|65558943|FG000|Overall Study|Death|2|||
23495886|NCT00289016|65558943|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
23495887|NCT00289016|65558943|FG000|Overall Study|Withdrawal by Subject|2|||
23495888|NCT00289016|65558943|FG000|Overall Study|Adverse Event|1|||
23495889|NCT00289016|65558943|FG000|Overall Study|Other|1|||
23495890|NCT01218113|65558947|FG000|Overall Study|Withdrawal by Subject|1|||
23391500|NCT02298946|65178665|FG000|Overall Study|Unevaluable|2|||
23495891|NCT01218113|65558948|FG001|Overall Study|Withdrawal by Subject|0|||
23495892|NCT01218113|65558949|FG002|Overall Study|Withdrawal by Subject|1|||
23495893|NCT01218113|65558947|FG000|Overall Study|Lost to Follow-up|4|||
23495894|NCT01218113|65558948|FG001|Overall Study|Lost to Follow-up|1|||
23391501|NCT02298946|65178666|FG001|Overall Study|Unevaluable|1|||
23495895|NCT01218113|65558949|FG002|Overall Study|Lost to Follow-up|4|||
23391502|NCT02457546|65178667|FG000|Overall Study|Other reasons|4|||
23391503|NCT02457546|65178668|FG001|Overall Study|Other reasons|1|||
23391504|NCT02457546|65178667|FG000|Overall Study|Refused to complete study/procedures|1|||
23391505|NCT02457546|65178668|FG001|Overall Study|Refused to complete study/procedures|1|||
23391506|NCT02457546|65178667|FG000|Overall Study|Lost to Follow-up|4|||
23391507|NCT02457546|65178668|FG001|Overall Study|Lost to Follow-up|1|||
23391508|NCT02457546|65178667|FG000|Overall Study|Adverse Event|0|||
23391509|NCT02457546|65178668|FG001|Overall Study|Adverse Event|1|||
23391510|NCT01428713|65178669|FG000|Overall Study|Non-compliance|2|||
23391511|NCT01428713|65178670|FG001|Overall Study|Non-compliance|2|||
23391512|NCT01428713|65178669|FG000|Overall Study|Withdrawal by Subject|1|||
23391513|NCT01428713|65178670|FG001|Overall Study|Withdrawal by Subject|1|||
23391514|NCT01428713|65178669|FG000|Overall Study|Adverse Event|0|||
23391515|NCT01428713|65178670|FG001|Overall Study|Adverse Event|2|||
23391516|NCT02913326|65178671|FG000|Overall Study|Reason not listed|0|||
23391517|NCT02913326|65178672|FG001|Overall Study|Reason not listed|1|||
23391518|NCT02913326|65178671|FG000|Overall Study|Lost to Follow-up|0|||
23391519|NCT02913326|65178672|FG001|Overall Study|Lost to Follow-up|1|||
23391520|NCT02913326|65178671|FG000|Overall Study|Adverse Event|1|||
23391521|NCT02913326|65178672|FG001|Overall Study|Adverse Event|0|||
23391522|NCT01213251|65178673|FG000|Overall Study|Death|2|||
23495896|NCT01218113|65558947|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
23495897|NCT01218113|65558948|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
23495898|NCT01218113|65558949|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
23495899|NCT01893203|65558950|FG000|Overall Study|Withdrawal by Subject|1|||
23495900|NCT01387932|65558951|FG000|Randomized and Treated|Physician Decision|3|||
23495901|NCT01387932|65558952|FG001|Randomized and Treated|Physician Decision|2|||
23495902|NCT01387932|65558951|FG000|Randomized and Treated|Withdrawal by Subject|4|||
23495903|NCT01387932|65558952|FG001|Randomized and Treated|Withdrawal by Subject|2|||
23495904|NCT01387932|65558951|FG000|Survival Follow-up|Liver Transplant|24|||
23495905|NCT01387932|65558952|FG001|Survival Follow-up|Liver Transplant|28|||
23495906|NCT01387932|65558951|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
23495907|NCT01387932|65558952|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
23495908|NCT01387932|65558951|FG000|Survival Follow-up|Withdrawal by Subject|2|||
23495909|NCT01387932|65558952|FG001|Survival Follow-up|Withdrawal by Subject|4|||
23495910|NCT01387932|65558951|FG000|Survival Follow-up|Lost to Follow-up|6|||
23495911|NCT01387932|65558952|FG001|Survival Follow-up|Lost to Follow-up|5|||
23495912|NCT01797731|65558953|FG000|Overall Study|Didn't have proper radiographs required|3|||
23391523|NCT01213251|65178674|FG001|Overall Study|Death|1|||
23391524|NCT01213251|65178675|FG002|Overall Study|Death|2|||
23391525|NCT01213251|65178673|FG000|Overall Study|Exit|3|||
23495913|NCT01797731|65558954|FG001|Overall Study|Didn't have proper radiographs required|3|||
23495914|NCT03846804|65558955|FG000|Overall Study|Refused blood draw|1|||
23495915|NCT03846804|65558955|FG000|Overall Study|Protocol Violation|1|||
23495916|NCT02598960|65558957|FG000|Treatment Period|Disease Progression|4|||
23495917|NCT02598960|65558958|FG001|Treatment Period|Disease Progression|4|||
23391526|NCT01213251|65178674|FG001|Overall Study|Exit|2|||
23391527|NCT01213251|65178675|FG002|Overall Study|Exit|8|||
23391528|NCT01213251|65178673|FG000|Overall Study|Protocol Violation|1|||
23391529|NCT01213251|65178674|FG001|Overall Study|Protocol Violation|1|||
23391530|NCT01213251|65178675|FG002|Overall Study|Protocol Violation|0|||
23391531|NCT01213251|65178673|FG000|Overall Study|Missed 18-Month Follow-up|0|||
23300225|NCT02243293|64840085|FG009|Overall Study|Withdrawal by Subject|1|||
23300226|NCT02243293|64840086|FG010|Overall Study|Withdrawal by Subject|0|||
23300227|NCT02243293|64840087|FG011|Overall Study|Withdrawal by Subject|1|||
23300228|NCT02243293|64840088|FG012|Overall Study|Withdrawal by Subject|0|||
23391532|NCT01213251|65178674|FG001|Overall Study|Missed 18-Month Follow-up|0|||
23391533|NCT01213251|65178675|FG002|Overall Study|Missed 18-Month Follow-up|1|||
23391534|NCT00488293|65178676|FG000|Overall Study|Lost to Follow-up|28|||
23391535|NCT00488293|65178677|FG001|Overall Study|Lost to Follow-up|25|||
23391536|NCT00488293|65178676|FG000|Overall Study|Withdrawal by Subject|5|||
23391537|NCT00488293|65178677|FG001|Overall Study|Withdrawal by Subject|3|||
23391538|NCT00488293|65178676|FG000|Overall Study|Death|2|||
23391539|NCT00488293|65178677|FG001|Overall Study|Death|1|||
23391540|NCT00488293|65178676|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
23391541|NCT00488293|65178677|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
23391542|NCT03510715|65178678|FG000|Overall Study|Adverse Event|1|||
23391543|NCT03510715|65178679|FG001|Overall Study|Adverse Event|0|||
23495918|NCT02598960|65558959|FG002|Treatment Period|Disease Progression|4|||
23300229|NCT02243293|64840089|FG013|Overall Study|Withdrawal by Subject|0|||
23300230|NCT02243293|64840090|FG014|Overall Study|Withdrawal by Subject|0|||
23300231|NCT02243293|64840091|FG015|Overall Study|Withdrawal by Subject|0|||
23300232|NCT02243293|64840092|FG016|Overall Study|Withdrawal by Subject|0|||
23300233|NCT02243293|64840093|FG017|Overall Study|Withdrawal by Subject|0|||
23300234|NCT02243293|64840094|FG018|Overall Study|Withdrawal by Subject|0|||
23300235|NCT02243293|64840095|FG019|Overall Study|Withdrawal by Subject|0|||
23300236|NCT02243293|64840096|FG020|Overall Study|Withdrawal by Subject|0|||
23300237|NCT02243293|64840097|FG021|Overall Study|Withdrawal by Subject|1|||
23300238|NCT02243293|64840076|FG000|Overall Study|Lost to Follow-up|0|||
23300239|NCT02243293|64840077|FG001|Overall Study|Lost to Follow-up|1|||
23300240|NCT02243293|64840078|FG002|Overall Study|Lost to Follow-up|1|||
23300241|NCT02243293|64840079|FG003|Overall Study|Lost to Follow-up|1|||
23300242|NCT02243293|64840080|FG004|Overall Study|Lost to Follow-up|0|||
23300243|NCT02243293|64840081|FG005|Overall Study|Lost to Follow-up|0|||
23300244|NCT02243293|64840082|FG006|Overall Study|Lost to Follow-up|3|||
23300245|NCT02243293|64840083|FG007|Overall Study|Lost to Follow-up|0|||
23300246|NCT02243293|64840084|FG008|Overall Study|Lost to Follow-up|0|||
23300247|NCT02243293|64840085|FG009|Overall Study|Lost to Follow-up|0|||
23300248|NCT02243293|64840086|FG010|Overall Study|Lost to Follow-up|0|||
23300249|NCT02243293|64840087|FG011|Overall Study|Lost to Follow-up|2|||
23300250|NCT02243293|64840088|FG012|Overall Study|Lost to Follow-up|0|||
23300251|NCT02243293|64840089|FG013|Overall Study|Lost to Follow-up|0|||
23300252|NCT02243293|64840090|FG014|Overall Study|Lost to Follow-up|0|||
23391544|NCT00721110|65178681|FG000|Overall Study|Ultram use|1|||
23391545|NCT00721110|65178682|FG001|Overall Study|Ultram use|0|||
23391546|NCT00721110|65178683|FG002|Overall Study|Ultram use|0|||
23391547|NCT00721110|65178684|FG003|Overall Study|Ultram use|0|||
23391548|NCT00721110|65178681|FG000|Overall Study|vertical incision|0|||
23391549|NCT00721110|65178682|FG001|Overall Study|vertical incision|0|||
23391550|NCT00721110|65178683|FG002|Overall Study|vertical incision|1|||
23391551|NCT00721110|65178684|FG003|Overall Study|vertical incision|0|||
23391552|NCT01443026|65178685|FG000|Overall Study|Physician Decision|1|||
23391553|NCT01443026|65178686|FG001|Overall Study|Physician Decision|0|||
23391554|NCT01443026|65178685|FG000|Overall Study|Death|0|||
23391555|NCT01443026|65178686|FG001|Overall Study|Death|1|||
23391556|NCT01443026|65178685|FG000|Overall Study|Withdrawal by Subject|0|||
23391557|NCT01443026|65178686|FG001|Overall Study|Withdrawal by Subject|3|||
23391558|NCT01443026|65178685|FG000|Overall Study|Lost to Follow-up|2|||
23391559|NCT01443026|65178686|FG001|Overall Study|Lost to Follow-up|1|||
23495919|NCT02598960|65558960|FG003|Treatment Period|Disease Progression|6|||
23495920|NCT02598960|65558961|FG004|Treatment Period|Disease Progression|8|||
23300253|NCT02243293|64840091|FG015|Overall Study|Lost to Follow-up|0|||
23391560|NCT00489359|65178687|FG000|Overall Study|Death|0|||
23391561|NCT00489359|65178688|FG001|Overall Study|Death|2|||
23495921|NCT02598960|65558962|FG005|Treatment Period|Disease Progression|2|||
23391562|NCT00489359|65178687|FG000|Overall Study|Progressive Disease|5|||
23391563|NCT00489359|65178688|FG001|Overall Study|Progressive Disease|6|||
23391564|NCT00489359|65178687|FG000|Overall Study|Lost to Follow-up|1|||
23391565|NCT00489359|65178688|FG001|Overall Study|Lost to Follow-up|0|||
23391566|NCT00489359|65178687|FG000|Overall Study|Withdrawal by Subject|1|||
23391567|NCT00489359|65178688|FG001|Overall Study|Withdrawal by Subject|5|||
23391568|NCT00489359|65178687|FG000|Overall Study|Adverse Event|0|||
23391569|NCT00489359|65178688|FG001|Overall Study|Adverse Event|16|||
23391570|NCT01892189|65178689|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
23391571|NCT01892189|65178690|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
23391572|NCT01892189|65178691|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
23391573|NCT01892189|65178692|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
23391574|NCT01892189|65178693|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
23391575|NCT01892189|65178694|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
23391576|NCT01892189|65178695|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
23391577|NCT01892189|65178696|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
23391578|NCT01892189|65178697|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
23391579|NCT01892189|65178689|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23391580|NCT01892189|65178690|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23391581|NCT01892189|65178691|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
23391582|NCT01892189|65178692|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23391583|NCT01892189|65178693|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23391584|NCT01892189|65178694|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23391585|NCT01892189|65178695|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23391586|NCT01892189|65178696|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23391587|NCT01892189|65178697|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23391588|NCT01892189|65178689|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391589|NCT01892189|65178690|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391590|NCT01892189|65178691|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391591|NCT01892189|65178692|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391592|NCT01892189|65178693|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391593|NCT01892189|65178694|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
23495922|NCT02598960|65558963|FG006|Treatment Period|Disease Progression|2|||
23495923|NCT02598960|65558964|FG007|Treatment Period|Disease Progression|3|||
23495924|NCT02598960|65558965|FG008|Treatment Period|Disease Progression|7|||
23495925|NCT02598960|65558966|FG009|Treatment Period|Disease Progression|9|||
23495926|NCT02598960|65558967|FG010|Treatment Period|Disease Progression|7|||
23495927|NCT02598960|65558968|FG011|Treatment Period|Disease Progression|143|||
23495928|NCT02598960|65558969|FG012|Treatment Period|Disease Progression|23|||
23495929|NCT02598960|65558957|FG000|Treatment Period|Study drug toxicity|0|||
23495930|NCT02598960|65558958|FG001|Treatment Period|Study drug toxicity|0|||
23495931|NCT02598960|65558959|FG002|Treatment Period|Study drug toxicity|0|||
23495932|NCT02598960|65558960|FG003|Treatment Period|Study drug toxicity|0|||
23495933|NCT02598960|65558961|FG004|Treatment Period|Study drug toxicity|0|||
23391594|NCT01892189|65178695|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23495934|NCT02598960|65558962|FG005|Treatment Period|Study drug toxicity|0|||
23495935|NCT02598960|65558963|FG006|Treatment Period|Study drug toxicity|0|||
23495936|NCT02598960|65558964|FG007|Treatment Period|Study drug toxicity|0|||
23391595|NCT01892189|65178696|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391596|NCT01892189|65178697|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
23391597|NCT02150863|65178711|FG000|Overall Study|Lost to Follow-up|0|||
23391598|NCT02150863|65178712|FG001|Overall Study|Lost to Follow-up|1|||
23391599|NCT02150863|65178713|FG002|Overall Study|Lost to Follow-up|0|||
23391600|NCT03791060|65178714|FG000|Overall Study|Withdrawal by Subject|1|||
23391601|NCT01027351|65178715|FG000|Overall Study|Withdrawal by Subject|1|||
23391602|NCT01027351|65178716|FG001|Overall Study|Withdrawal by Subject|0|||
23391603|NCT01027351|65178717|FG002|Overall Study|Withdrawal by Subject|1|||
23391604|NCT01027351|65178718|FG003|Overall Study|Withdrawal by Subject|0|||
23495937|NCT02598960|65558965|FG008|Treatment Period|Study drug toxicity|0|||
23495938|NCT02598960|65558966|FG009|Treatment Period|Study drug toxicity|1|||
23391605|NCT01027351|65178719|FG004|Overall Study|Withdrawal by Subject|3|||
23391606|NCT01027351|65178720|FG005|Overall Study|Withdrawal by Subject|5|||
23391607|NCT01027351|65178715|FG000|Overall Study|Lost to Follow-up|1|||
23391608|NCT01027351|65178716|FG001|Overall Study|Lost to Follow-up|1|||
23391609|NCT01027351|65178717|FG002|Overall Study|Lost to Follow-up|0|||
23391610|NCT01027351|65178718|FG003|Overall Study|Lost to Follow-up|1|||
23391611|NCT01027351|65178719|FG004|Overall Study|Lost to Follow-up|6|||
23391612|NCT01027351|65178720|FG005|Overall Study|Lost to Follow-up|0|||
23391613|NCT01027351|65178715|FG000|Overall Study|Inappropriate enrollment|0|||
23391614|NCT01027351|65178716|FG001|Overall Study|Inappropriate enrollment|0|||
23391615|NCT01027351|65178717|FG002|Overall Study|Inappropriate enrollment|0|||
23391616|NCT01027351|65178718|FG003|Overall Study|Inappropriate enrollment|0|||
23391617|NCT01027351|65178719|FG004|Overall Study|Inappropriate enrollment|1|||
23391618|NCT01027351|65178720|FG005|Overall Study|Inappropriate enrollment|0|||
23391619|NCT01027351|65178715|FG000|Overall Study|Protocol Violation|1|||
23391620|NCT01027351|65178716|FG001|Overall Study|Protocol Violation|0|||
23391621|NCT01027351|65178717|FG002|Overall Study|Protocol Violation|0|||
23391622|NCT01027351|65178718|FG003|Overall Study|Protocol Violation|1|||
23495939|NCT02598960|65558967|FG010|Treatment Period|Study drug toxicity|0|||
23495940|NCT02598960|65558968|FG011|Treatment Period|Study drug toxicity|3|||
23495941|NCT02598960|65558969|FG012|Treatment Period|Study drug toxicity|0|||
23495942|NCT02598960|65558957|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
23495943|NCT02598960|65558958|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
23495944|NCT02598960|65558959|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
23495945|NCT02598960|65558960|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
23495946|NCT02598960|65558961|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
23391623|NCT01027351|65178719|FG004|Overall Study|Protocol Violation|1|||
23391624|NCT01027351|65178720|FG005|Overall Study|Protocol Violation|0|||
23391625|NCT02067156|65178727|FG000|Overall Study|Lost to Follow-up|4|||
23495947|NCT02598960|65558962|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
23495948|NCT02598960|65558963|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
23495949|NCT02598960|65558964|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
23495950|NCT02598960|65558965|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
23495951|NCT02598960|65558966|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
23495952|NCT02598960|65558967|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
23495953|NCT02598960|65558968|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
23495954|NCT02598960|65558969|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
23495955|NCT02598960|65558957|FG000|Treatment Period|participant request to discontinue|0|||
23495956|NCT02598960|65558958|FG001|Treatment Period|participant request to discontinue|1|||
23495957|NCT02598960|65558959|FG002|Treatment Period|participant request to discontinue|0|||
23495958|NCT02598960|65558960|FG003|Treatment Period|participant request to discontinue|0|||
23495959|NCT02598960|65558961|FG004|Treatment Period|participant request to discontinue|1|||
23300254|NCT02243293|64840092|FG016|Overall Study|Lost to Follow-up|3|||
23300255|NCT02243293|64840093|FG017|Overall Study|Lost to Follow-up|1|||
23300256|NCT02243293|64840094|FG018|Overall Study|Lost to Follow-up|0|||
23300257|NCT02243293|64840095|FG019|Overall Study|Lost to Follow-up|0|||
23300258|NCT02243293|64840096|FG020|Overall Study|Lost to Follow-up|1|||
23300259|NCT02243293|64840097|FG021|Overall Study|Lost to Follow-up|2|||
23300260|NCT02243293|64840076|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
23300261|NCT02243293|64840077|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
23300262|NCT02243293|64840078|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
23300263|NCT02243293|64840079|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
23300264|NCT02243293|64840080|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
23300265|NCT02243293|64840081|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
23300266|NCT02243293|64840082|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
23300267|NCT02243293|64840083|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
23300268|NCT02243293|64840084|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
23300269|NCT02243293|64840085|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
23300270|NCT02243293|64840086|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
23300271|NCT02243293|64840087|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
23300272|NCT02243293|64840088|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
23300273|NCT02243293|64840089|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
23300274|NCT02243293|64840090|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
23300275|NCT02243293|64840091|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
23300276|NCT02243293|64840092|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
23300277|NCT02243293|64840093|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
23300278|NCT02243293|64840094|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
23300279|NCT02243293|64840095|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
23300280|NCT02243293|64840096|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
23300281|NCT02243293|64840097|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
23300282|NCT02243293|64840076|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
23300283|NCT02243293|64840077|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
23300284|NCT02243293|64840078|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
23300285|NCT02243293|64840079|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
23300286|NCT02243293|64840080|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
23300287|NCT02243293|64840081|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
23300288|NCT02243293|64840082|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
23300289|NCT02243293|64840083|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
23495960|NCT02598960|65558962|FG005|Treatment Period|participant request to discontinue|0|||
23495961|NCT02598960|65558963|FG006|Treatment Period|participant request to discontinue|0|||
23495962|NCT02598960|65558964|FG007|Treatment Period|participant request to discontinue|0|||
23495963|NCT02598960|65558965|FG008|Treatment Period|participant request to discontinue|0|||
23391626|NCT01416831|65178730|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
23391627|NCT01416831|65178731|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
23391628|NCT04620668|65178750|FG000|Overall Study|Withdrawal by Subject|2|||
23391629|NCT04620668|65178751|FG001|Overall Study|Withdrawal by Subject|0|||
23391630|NCT04620668|65178750|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
23391631|NCT04620668|65178751|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
23391632|NCT04620668|65178750|FG000|Overall Study|Removed before analysis: missing data|2|||
23391633|NCT04620668|65178751|FG001|Overall Study|Removed before analysis: missing data|0|||
23391634|NCT04620668|65178750|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
23391635|NCT04620668|65178751|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
23391636|NCT04620668|65178750|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
23391637|NCT04620668|65178751|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
23391638|NCT03460704|65178752|FG000|Overall Study|Withdrawal by Subject|11|||
23391639|NCT03460704|65178753|FG001|Overall Study|Withdrawal by Subject|14|||
23391640|NCT03460704|65178752|FG000|Overall Study|Study terminated by the Sponsor|29|||
23391641|NCT03460704|65178753|FG001|Overall Study|Study terminated by the Sponsor|19|||
23391642|NCT03460704|65178752|FG000|Overall Study|Adverse Event|10|||
23391643|NCT03460704|65178753|FG001|Overall Study|Adverse Event|5|||
23391644|NCT03460704|65178752|FG000|Overall Study|Death|3|||
23391645|NCT03460704|65178753|FG001|Overall Study|Death|2|||
23391646|NCT03460704|65178752|FG000|Overall Study|Non-Compliance with Study Drug|3|||
23391647|NCT03460704|65178753|FG001|Overall Study|Non-Compliance with Study Drug|0|||
23391648|NCT03460704|65178752|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
23391649|NCT03460704|65178753|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
23391650|NCT03460704|65178752|FG000|Overall Study|Other|2|||
23391651|NCT03460704|65178753|FG001|Overall Study|Other|1|||
23391652|NCT03412591|65178754|FG000|Overall Study|Withdrawal by Subject|1|||
23391653|NCT03412591|65178755|FG001|Overall Study|Withdrawal by Subject|8|||
23391654|NCT03412591|65178754|FG000|Overall Study|Adverse Event|0|||
23391655|NCT03412591|65178755|FG001|Overall Study|Adverse Event|1|||
23391656|NCT03163667|65178756|FG000|Overall Study|Death|15|||
23391657|NCT03163667|65178757|FG001|Overall Study|Death|27|||
23391658|NCT03163667|65178756|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
23391659|NCT03163667|65178757|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
23391660|NCT02743221|65180804|FG000|Overall Study|Progressive disease|29|||
23391661|NCT02743221|65180805|FG001|Overall Study|Progressive disease|38|||
23391662|NCT02743221|65180804|FG000|Overall Study|Adverse Event|17|||
23391663|NCT02743221|65180805|FG001|Overall Study|Adverse Event|14|||
23391664|NCT02743221|65180804|FG000|Overall Study|non medical reason|8|||
23391665|NCT02743221|65180805|FG001|Overall Study|non medical reason|2|||
23391666|NCT02743221|65180804|FG000|Overall Study|Physician Decision|2|||
23391667|NCT02743221|65180805|FG001|Overall Study|Physician Decision|5|||
23391668|NCT02743221|65180804|FG000|Overall Study|Patient not eligible, not treated|0|||
23391669|NCT02743221|65180805|FG001|Overall Study|Patient not eligible, not treated|1|||
23606186|NCT00641537|65947158|FG003|24-Week Supplemental Follow-up Period|Other|1|||
23606187|NCT00641537|65947159|FG004|24-Week Supplemental Follow-up Period|Other|3|||
23606188|NCT00641537|65947160|FG005|24-Week Supplemental Follow-up Period|Other|0|||
23606189|NCT00641537|65947161|FG006|24-Week Supplemental Follow-up Period|Other|1|||
23606190|NCT00641537|65947162|FG007|24-Week Supplemental Follow-up Period|Other|1|||
23606191|NCT00704340|65947164|FG000|Overall Study|Lost to Follow-up|2|||
23606192|NCT00704340|65947165|FG001|Overall Study|Lost to Follow-up|1|||
23606193|NCT00704340|65947164|FG000|Overall Study|Death|0|||
23606194|NCT00704340|65947165|FG001|Overall Study|Death|1|||
23606195|NCT01009645|65947166|FG000|Overall Study|Lost to Follow-up|2|||
23391680|NCT01506726|65180810|FG000|Overall Study|Adverse Event|1|||
23391681|NCT01506726|65180811|FG001|Overall Study|Adverse Event|2|||
23495964|NCT02598960|65558966|FG009|Treatment Period|participant request to discontinue|0|||
23495965|NCT02598960|65558967|FG010|Treatment Period|participant request to discontinue|1|||
23495966|NCT02598960|65558968|FG011|Treatment Period|participant request to discontinue|4|||
23495967|NCT02598960|65558969|FG012|Treatment Period|participant request to discontinue|0|||
23391682|NCT03345550|65180812|FG000|Overall Study|Withdrawal by Subject|1|||
23391683|NCT03345550|65180813|FG001|Overall Study|Withdrawal by Subject|0|||
23391684|NCT03345550|65180812|FG000|Overall Study|Lost to Follow-up|4|||
23391685|NCT03345550|65180813|FG001|Overall Study|Lost to Follow-up|5|||
23391686|NCT03312543|65180816|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
23391687|NCT03312543|65180817|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
23391688|NCT03312543|65180816|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
23391689|NCT03312543|65180817|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
23391690|NCT03312543|65180816|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
23391691|NCT03312543|65180817|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
23391692|NCT03312543|65180816|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
23391693|NCT03312543|65180817|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
23391694|NCT03312543|65180816|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
23391695|NCT03312543|65180817|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
23391696|NCT03312543|65180816|FG000|Regression (Week 12 to Week 24)|Death|0|||
23391697|NCT03312543|65180817|FG001|Regression (Week 12 to Week 24)|Death|1|||
23391698|NCT02034565|65180818|FG000|Overall Study|Adverse Event|1|||
23495968|NCT02598960|65558957|FG000|Treatment Period|participant withdrew consent|0|||
23495969|NCT02598960|65558958|FG001|Treatment Period|participant withdrew consent|0|||
23391699|NCT02034565|65180819|FG001|Overall Study|Adverse Event|0|||
23391700|NCT00493285|65180826|FG000|Overall Study|Lost to Follow-up|0|||
23391701|NCT00493285|65180827|FG001|Overall Study|Lost to Follow-up|0|||
23391702|NCT00493285|65180828|FG002|Overall Study|Lost to Follow-up|0|||
23391703|NCT00493285|65180829|FG003|Overall Study|Lost to Follow-up|0|||
23391704|NCT00493285|65180830|FG004|Overall Study|Lost to Follow-up|1|||
23391705|NCT00493285|65180831|FG005|Overall Study|Lost to Follow-up|0|||
23391706|NCT03502200|65180832|FG000|Overall Study|Adverse Event|1|||
23391707|NCT03502200|65180833|FG001|Overall Study|Adverse Event|0|||
23391708|NCT03502200|65180832|FG000|Overall Study|Lost to Follow-up|36|||
23391709|NCT03502200|65180833|FG001|Overall Study|Lost to Follow-up|38|||
23391710|NCT03502200|65180832|FG000|Overall Study|Study Team Decision|1|||
23391711|NCT03502200|65180833|FG001|Overall Study|Study Team Decision|1|||
23391712|NCT03502200|65180832|FG000|Overall Study|Withdrawal by Subject|5|||
23391713|NCT03502200|65180833|FG001|Overall Study|Withdrawal by Subject|7|||
23391714|NCT03502200|65180832|FG000|Overall Study|Death|0|||
23391715|NCT03502200|65180833|FG001|Overall Study|Death|2|||
23391716|NCT01767987|65180834|FG000|Overall Study|Physician Decision|4|||
23391717|NCT01767987|65180835|FG001|Overall Study|Physician Decision|1|||
23495970|NCT02598960|65558959|FG002|Treatment Period|participant withdrew consent|0|||
23495971|NCT02598960|65558960|FG003|Treatment Period|participant withdrew consent|0|||
23495972|NCT02598960|65558961|FG004|Treatment Period|participant withdrew consent|0|||
23495973|NCT02598960|65558962|FG005|Treatment Period|participant withdrew consent|0|||
23495974|NCT02598960|65558963|FG006|Treatment Period|participant withdrew consent|0|||
23495975|NCT02598960|65558964|FG007|Treatment Period|participant withdrew consent|0|||
23300290|NCT02243293|64840084|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
23495976|NCT02598960|65558965|FG008|Treatment Period|participant withdrew consent|0|||
23495977|NCT02598960|65558966|FG009|Treatment Period|participant withdrew consent|0|||
23495978|NCT02598960|65558967|FG010|Treatment Period|participant withdrew consent|0|||
23495979|NCT02598960|65558968|FG011|Treatment Period|participant withdrew consent|3|||
23495980|NCT02598960|65558969|FG012|Treatment Period|participant withdrew consent|0|||
23495981|NCT02598960|65558957|FG000|Treatment Period|No longer meets study criteria|0|||
23495982|NCT02598960|65558958|FG001|Treatment Period|No longer meets study criteria|0|||
23495983|NCT02598960|65558959|FG002|Treatment Period|No longer meets study criteria|0|||
23495984|NCT02598960|65558960|FG003|Treatment Period|No longer meets study criteria|0|||
23495985|NCT02598960|65558961|FG004|Treatment Period|No longer meets study criteria|0|||
23495986|NCT02598960|65558962|FG005|Treatment Period|No longer meets study criteria|0|||
23495987|NCT02598960|65558963|FG006|Treatment Period|No longer meets study criteria|0|||
23300291|NCT02243293|64840085|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
23300292|NCT02243293|64840086|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
23300293|NCT02243293|64840087|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
23300294|NCT02243293|64840088|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
23300295|NCT02243293|64840089|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
23300296|NCT02243293|64840090|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
23300297|NCT02243293|64840091|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
23391718|NCT01381679|65180836|FG000|Overall Study|Adverse Event|3|||
23391719|NCT01381679|65180836|FG000|Overall Study|Lost to Follow-up|885|||
23391720|NCT03559530|65180838|FG000|Overall Study|non-location of medical records|44|||
23391721|NCT03559530|65180839|FG001|Overall Study|non-location of medical records|0|||
23391722|NCT03559530|65180838|FG000|Overall Study|culture results not considered for treat|29|||
23391723|NCT03559530|65180839|FG001|Overall Study|culture results not considered for treat|0|||
23391724|NCT03559530|65180838|FG000|Overall Study|duplicate cases|8|||
23391725|NCT03559530|65180839|FG001|Overall Study|duplicate cases|0|||
23300298|NCT02243293|64840092|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
23300299|NCT02243293|64840093|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
23300300|NCT02243293|64840094|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
23300301|NCT02243293|64840095|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
23300302|NCT02243293|64840096|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
23300303|NCT02243293|64840097|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
23300304|NCT00227266|64840098|FG000|Overall Study|Withdrawal by Subject|0|||
23300305|NCT00227266|64840099|FG001|Overall Study|Withdrawal by Subject|0|||
23300306|NCT00227266|64840100|FG002|Overall Study|Withdrawal by Subject|1|||
23300307|NCT00227266|64840098|FG000|Overall Study|Protocol Violation|1|||
23300308|NCT00227266|64840099|FG001|Overall Study|Protocol Violation|0|||
23300309|NCT00227266|64840100|FG002|Overall Study|Protocol Violation|1|||
23300310|NCT00227266|64840098|FG000|Overall Study|Excessive weight gain|0|||
23391726|NCT03559530|65180838|FG000|Overall Study|other species of Acinetobacte|7|||
23391727|NCT03559530|65180839|FG001|Overall Study|other species of Acinetobacte|0|||
23391728|NCT03559530|65180838|FG000|Overall Study|contamination / colonization|3|||
23391729|NCT03559530|65180839|FG001|Overall Study|contamination / colonization|0|||
23391730|NCT00539500|65180840|FG000|Overall Study|Disease Progression|1|||
23391731|NCT00539500|65180840|FG000|Overall Study|Lost to Follow-up|2|||
23391732|NCT01557569|65180845|FG000|Overall Study|Adverse Event|2|||
23391733|NCT01557569|65180846|FG001|Overall Study|Adverse Event|0|||
23391734|NCT01557569|65180845|FG000|Overall Study|high blood pressure|0|||
23391735|NCT01557569|65180846|FG001|Overall Study|high blood pressure|1|||
23391736|NCT01557569|65180845|FG000|Overall Study|Withdrawal by Subject|3|||
23391737|NCT01557569|65180846|FG001|Overall Study|Withdrawal by Subject|5|||
23391738|NCT01557569|65180845|FG000|Overall Study|noncompliance with rules of residential|0|||
23391739|NCT01557569|65180846|FG001|Overall Study|noncompliance with rules of residential|1|||
23391740|NCT03777020|65180847|FG000|Overall Study|Withdrawal by Subject|4|||
23391741|NCT03777020|65180848|FG001|Overall Study|Withdrawal by Subject|4|||
23391742|NCT03777020|65180847|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
23391743|NCT03777020|65180848|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
23391744|NCT03847519|65180849|FG000|Overall Study|Death|5|||
23391745|NCT03847519|65180850|FG001|Overall Study|Death|8|||
23391746|NCT03847519|65180851|FG002|Overall Study|Death|1|||
23391747|NCT03847519|65180849|FG000|Overall Study|Lost to Follow-up|1|||
23391748|NCT03847519|65180850|FG001|Overall Study|Lost to Follow-up|2|||
23391749|NCT03847519|65180851|FG002|Overall Study|Lost to Follow-up|0|||
23391750|NCT03847519|65180849|FG000|Overall Study|Study Terminated by Sponsor|0|||
23391751|NCT03847519|65180850|FG001|Overall Study|Study Terminated by Sponsor|3|||
23391752|NCT03847519|65180851|FG002|Overall Study|Study Terminated by Sponsor|2|||
23391753|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
23391754|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
23391755|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
23391756|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
23391757|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
23391758|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
23391759|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
23391760|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
23391761|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
23391762|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
23391763|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391764|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391765|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391766|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391767|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391768|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391769|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391770|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
23391771|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23391772|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
23606196|NCT01009645|65947167|FG001|Overall Study|Lost to Follow-up|8|||
23391773|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391774|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391775|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391776|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391777|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391778|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
23391779|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391780|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391781|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391782|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
23391783|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391784|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391785|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391786|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391787|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
23391788|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
23391789|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
23391790|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
23391791|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
23391792|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
23391793|NCT02082977|65180852|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391794|NCT02082977|65180853|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391795|NCT02082977|65180854|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391796|NCT02082977|65180855|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391797|NCT02082977|65180856|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391798|NCT02082977|65180857|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391799|NCT02082977|65180858|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391800|NCT02082977|65180859|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
23391801|NCT02082977|65180860|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391802|NCT02082977|65180861|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
23391803|NCT01946880|65180862|FG000|Overall Study|Lost to Follow-up|1|||
23391804|NCT01946880|65180863|FG001|Overall Study|Lost to Follow-up|0|||
23391805|NCT01946880|65180862|FG000|Overall Study|Physician Decision|1|||
23391806|NCT01946880|65180863|FG001|Overall Study|Physician Decision|1|||
23391807|NCT01946880|65180862|FG000|Overall Study|Withdrawal by Subject|3|||
23391808|NCT01946880|65180863|FG001|Overall Study|Withdrawal by Subject|2|||
23391809|NCT01946880|65180862|FG000|Overall Study|Met Primary Endpoint|1|||
23391810|NCT01946880|65180863|FG001|Overall Study|Met Primary Endpoint|0|||
23391811|NCT01946880|65180862|FG000|Overall Study|Personal and Family Issues|1|||
23391812|NCT01946880|65180863|FG001|Overall Study|Personal and Family Issues|0|||
23391813|NCT05752487|65180864|FG000|Overall Study|Randomized, not treated|9|||
23391814|NCT05752487|65180864|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
23495988|NCT02598960|65558964|FG007|Treatment Period|No longer meets study criteria|0|||
23495989|NCT02598960|65558965|FG008|Treatment Period|No longer meets study criteria|0|||
23495990|NCT02598960|65558966|FG009|Treatment Period|No longer meets study criteria|0|||
23495991|NCT02598960|65558967|FG010|Treatment Period|No longer meets study criteria|0|||
23495992|NCT02598960|65558968|FG011|Treatment Period|No longer meets study criteria|1|||
23495993|NCT02598960|65558969|FG012|Treatment Period|No longer meets study criteria|0|||
23495994|NCT02598960|65558957|FG000|Treatment Period|Other Reasons|0|||
23495995|NCT02598960|65558958|FG001|Treatment Period|Other Reasons|0|||
23495996|NCT02598960|65558959|FG002|Treatment Period|Other Reasons|0|||
23495997|NCT02598960|65558960|FG003|Treatment Period|Other Reasons|0|||
23495998|NCT02598960|65558961|FG004|Treatment Period|Other Reasons|0|||
23495999|NCT02598960|65558962|FG005|Treatment Period|Other Reasons|0|||
23496000|NCT02598960|65558963|FG006|Treatment Period|Other Reasons|0|||
23496001|NCT02598960|65558964|FG007|Treatment Period|Other Reasons|0|||
23496002|NCT02598960|65558965|FG008|Treatment Period|Other Reasons|0|||
23496003|NCT02598960|65558966|FG009|Treatment Period|Other Reasons|0|||
23496004|NCT02598960|65558967|FG010|Treatment Period|Other Reasons|0|||
23496005|NCT02598960|65558968|FG011|Treatment Period|Other Reasons|0|||
23496006|NCT02598960|65558969|FG012|Treatment Period|Other Reasons|1|||
23496007|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|Death|1|||
23496008|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|Death|0|||
23391815|NCT05752487|65180864|FG000|Overall Study|Withdrawal by Subject|2|||
23391816|NCT05752487|65180864|FG000|Overall Study|Ongoing|137|||
23391817|NCT00833703|65180865|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
23391818|NCT00833703|65180866|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
23391819|NCT05543174|65180867|FG000|Overall Study|Ongoing|7|||
23391820|NCT02967692|65180868|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
23496009|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|Death|0|||
23391821|NCT02967692|65180869|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
23496010|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|Death|0|||
23606197|NCT01009645|65947168|FG002|Overall Study|Lost to Follow-up|4|||
23606198|NCT01009645|65947169|FG003|Overall Study|Lost to Follow-up|5|||
23606199|NCT01867307|65947170|FG000|Overall Study|Protocol Violation|2|||
23606200|NCT01867307|65947171|FG001|Overall Study|Protocol Violation|0|||
23606201|NCT01867307|65947170|FG000|Overall Study|Other Adverse Event|1|||
23606202|NCT01867307|65947171|FG001|Overall Study|Other Adverse Event|3|||
23606203|NCT01536093|65947172|FG000|Overall Study|Death|1|||
23606204|NCT01536093|65947173|FG001|Overall Study|Death|2|||
23606205|NCT01536093|65947172|FG000|Overall Study|absence of maternal colostrum|2|||
23606206|NCT01536093|65947173|FG001|Overall Study|absence of maternal colostrum|0|||
23606207|NCT01536093|65947172|FG000|Overall Study|Withdrawal by Subject|0|||
23606208|NCT01536093|65947173|FG001|Overall Study|Withdrawal by Subject|1|||
23606209|NCT00985088|65947178|FG000|Overall Study|Serious Adverse Event|1|||
23606210|NCT00985088|65947179|FG001|Overall Study|Serious Adverse Event|1|||
23606211|NCT00985088|65947180|FG002|Overall Study|Serious Adverse Event|0|||
23391822|NCT02967692|65180870|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
23391823|NCT02967692|65180871|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
23391824|NCT02967692|65180868|FG000|Overall Study|Progressive disease|3|||
23391825|NCT02967692|65180869|FG001|Overall Study|Progressive disease|15|||
23391826|NCT02967692|65180870|FG002|Overall Study|Progressive disease|99|||
23391827|NCT02967692|65180871|FG003|Overall Study|Progressive disease|128|||
23391828|NCT02967692|65180868|FG000|Overall Study|Subject/guardian decision|1|||
23391829|NCT02967692|65180869|FG001|Overall Study|Subject/guardian decision|1|||
23391830|NCT02967692|65180870|FG002|Overall Study|Subject/guardian decision|6|||
23391831|NCT02967692|65180871|FG003|Overall Study|Subject/guardian decision|13|||
23391832|NCT02967692|65180868|FG000|Overall Study|Death|0|||
23391833|NCT02967692|65180869|FG001|Overall Study|Death|1|||
23391834|NCT02967692|65180870|FG002|Overall Study|Death|10|||
23391835|NCT02967692|65180871|FG003|Overall Study|Death|9|||
23391836|NCT02967692|65180868|FG000|Overall Study|Protocol deviation|1|||
23391837|NCT02967692|65180869|FG001|Overall Study|Protocol deviation|0|||
23391838|NCT02967692|65180870|FG002|Overall Study|Protocol deviation|1|||
23606212|NCT00985088|65947181|FG003|Overall Study|Serious Adverse Event|0|||
23606213|NCT00985088|65947182|FG004|Overall Study|Serious Adverse Event|0|||
23606214|NCT00985088|65947183|FG005|Overall Study|Serious Adverse Event|0|||
23606215|NCT00985088|65947184|FG006|Overall Study|Serious Adverse Event|0|||
23606216|NCT00985088|65947185|FG007|Overall Study|Serious Adverse Event|1|||
23606217|NCT00985088|65947178|FG000|Overall Study|Adverse Event|0|||
23606218|NCT00985088|65947179|FG001|Overall Study|Adverse Event|0|||
23606219|NCT00985088|65947180|FG002|Overall Study|Adverse Event|1|||
23606220|NCT00985088|65947181|FG003|Overall Study|Adverse Event|0|||
23606221|NCT00985088|65947182|FG004|Overall Study|Adverse Event|0|||
23606222|NCT00985088|65947183|FG005|Overall Study|Adverse Event|0|||
23606223|NCT00985088|65947184|FG006|Overall Study|Adverse Event|0|||
23606224|NCT00985088|65947185|FG007|Overall Study|Adverse Event|0|||
23606225|NCT00985088|65947178|FG000|Overall Study|Withdrawal by Subject|4|||
23606226|NCT00985088|65947179|FG001|Overall Study|Withdrawal by Subject|0|||
23606227|NCT00985088|65947180|FG002|Overall Study|Withdrawal by Subject|0|||
23606228|NCT00985088|65947181|FG003|Overall Study|Withdrawal by Subject|1|||
23606229|NCT00985088|65947182|FG004|Overall Study|Withdrawal by Subject|3|||
23606230|NCT00985088|65947183|FG005|Overall Study|Withdrawal by Subject|2|||
23606231|NCT00985088|65947184|FG006|Overall Study|Withdrawal by Subject|1|||
23606232|NCT00985088|65947185|FG007|Overall Study|Withdrawal by Subject|2|||
23606233|NCT00985088|65947178|FG000|Overall Study|Migrated/moved from study area|0|||
23606234|NCT00985088|65947179|FG001|Overall Study|Migrated/moved from study area|0|||
23606235|NCT00985088|65947180|FG002|Overall Study|Migrated/moved from study area|1|||
23606236|NCT00985088|65947181|FG003|Overall Study|Migrated/moved from study area|0|||
23606237|NCT00985088|65947182|FG004|Overall Study|Migrated/moved from study area|0|||
23606238|NCT00985088|65947183|FG005|Overall Study|Migrated/moved from study area|0|||
23606239|NCT00985088|65947184|FG006|Overall Study|Migrated/moved from study area|0|||
23606240|NCT00985088|65947185|FG007|Overall Study|Migrated/moved from study area|1|||
23606241|NCT00985088|65947178|FG000|Overall Study|Lost to Follow-up|6|||
23606242|NCT00985088|65947179|FG001|Overall Study|Lost to Follow-up|1|||
23606243|NCT00985088|65947180|FG002|Overall Study|Lost to Follow-up|2|||
23606244|NCT00985088|65947181|FG003|Overall Study|Lost to Follow-up|6|||
23606245|NCT00985088|65947182|FG004|Overall Study|Lost to Follow-up|6|||
23606246|NCT00985088|65947183|FG005|Overall Study|Lost to Follow-up|5|||
23606247|NCT00985088|65947184|FG006|Overall Study|Lost to Follow-up|3|||
23606248|NCT00985088|65947185|FG007|Overall Study|Lost to Follow-up|2|||
23606249|NCT03692871|65947186|FG000|Overall Study|Death|1|||
23606250|NCT03692871|65947187|FG001|Overall Study|Death|1|||
23391839|NCT02967692|65180871|FG003|Overall Study|Protocol deviation|1|||
23391840|NCT02967692|65180868|FG000|Overall Study|Lost to Follow-up|0|||
23391841|NCT02967692|65180869|FG001|Overall Study|Lost to Follow-up|0|||
23391842|NCT02967692|65180870|FG002|Overall Study|Lost to Follow-up|1|||
23391843|NCT02967692|65180871|FG003|Overall Study|Lost to Follow-up|0|||
23496011|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|Death|0|||
23391844|NCT02967692|65180868|FG000|Overall Study|Physician Decision|0|||
23391845|NCT02967692|65180869|FG001|Overall Study|Physician Decision|0|||
23391846|NCT02967692|65180870|FG002|Overall Study|Physician Decision|13|||
23391847|NCT02967692|65180871|FG003|Overall Study|Physician Decision|9|||
23391848|NCT02967692|65180868|FG000|Overall Study|Adverse Event|1|||
23391849|NCT02967692|65180869|FG001|Overall Study|Adverse Event|9|||
23391850|NCT02967692|65180870|FG002|Overall Study|Adverse Event|51|||
23391851|NCT02967692|65180871|FG003|Overall Study|Adverse Event|23|||
23391852|NCT02758626|65180872|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
23391853|NCT02758626|65180873|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
23391854|NCT02758626|65180872|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
23391855|NCT02758626|65180873|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
23391856|NCT02758626|65180872|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
23391857|NCT02758626|65180873|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
23391858|NCT02758626|65180872|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
23391859|NCT02758626|65180873|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
23391860|NCT03443401|65180874|FG000|Overall Study|Lost to Follow-up|13|||
23391861|NCT03443401|65180874|FG000|Overall Study|Influential outlier|1|||
23391862|NCT02457793|65180884|FG000|Overall Study|Reason not specified|0|||
23391863|NCT02457793|65180885|FG001|Overall Study|Reason not specified|0|||
23391864|NCT02457793|65180886|FG002|Overall Study|Reason not specified|0|||
23391865|NCT02457793|65180887|FG003|Overall Study|Reason not specified|1|||
23391866|NCT02457793|65180888|FG004|Overall Study|Reason not specified|1|||
23391867|NCT02457793|65180889|FG005|Overall Study|Reason not specified|1|||
23391868|NCT02457793|65180884|FG000|Overall Study|Withdrawal by Subject|0|||
23391869|NCT02457793|65180885|FG001|Overall Study|Withdrawal by Subject|4|||
23391870|NCT02457793|65180886|FG002|Overall Study|Withdrawal by Subject|2|||
23391871|NCT02457793|65180887|FG003|Overall Study|Withdrawal by Subject|2|||
23391872|NCT02457793|65180888|FG004|Overall Study|Withdrawal by Subject|2|||
23391873|NCT02457793|65180889|FG005|Overall Study|Withdrawal by Subject|2|||
23391874|NCT02457793|65180884|FG000|Overall Study|Adverse Event|0|||
23391875|NCT02457793|65180885|FG001|Overall Study|Adverse Event|0|||
23391876|NCT02457793|65180886|FG002|Overall Study|Adverse Event|0|||
23391877|NCT02457793|65180887|FG003|Overall Study|Adverse Event|1|||
23391878|NCT02457793|65180888|FG004|Overall Study|Adverse Event|0|||
23391879|NCT02457793|65180889|FG005|Overall Study|Adverse Event|0|||
23391880|NCT02457793|65180884|FG000|Overall Study|Physician Decision|1|||
23391881|NCT02457793|65180885|FG001|Overall Study|Physician Decision|0|||
23391882|NCT02457793|65180886|FG002|Overall Study|Physician Decision|1|||
23391883|NCT02457793|65180887|FG003|Overall Study|Physician Decision|1|||
23391884|NCT02457793|65180888|FG004|Overall Study|Physician Decision|1|||
23391885|NCT02457793|65180889|FG005|Overall Study|Physician Decision|3|||
23391886|NCT01889251|65180891|FG000|Overall Study|Adverse Event|1|||
23391887|NCT01889251|65180892|FG001|Overall Study|Adverse Event|0|||
23391888|NCT02395627|65180899|FG000|Overall Study|Withdrawal by Subject|0|||
23391889|NCT02395627|65180900|FG001|Overall Study|Withdrawal by Subject|2|||
23391890|NCT02395627|65180901|FG002|Overall Study|Withdrawal by Subject|0|||
23391891|NCT02395627|65180899|FG000|Overall Study|Did not receive pembrolizumab|3|||
23391892|NCT02395627|65180900|FG001|Overall Study|Did not receive pembrolizumab|1|||
23391893|NCT02395627|65180901|FG002|Overall Study|Did not receive pembrolizumab|0|||
23391894|NCT03439072|65180902|FG000|Overall Study|Withdrawal by Subject|2|||
23391895|NCT03439072|65180903|FG001|Overall Study|Withdrawal by Subject|3|||
23391896|NCT03439072|65180902|FG000|Overall Study|Physician Decision|0|||
23391897|NCT03439072|65180903|FG001|Overall Study|Physician Decision|1|||
23391898|NCT04349098|65180904|FG000|Overall Study|Death|16|||
23391899|NCT04349098|65180905|FG001|Overall Study|Death|8|||
23391900|NCT04349098|65180904|FG000|Overall Study|Lost to Follow-up|11|||
23391901|NCT04349098|65180905|FG001|Overall Study|Lost to Follow-up|8|||
23391902|NCT04349098|65180904|FG000|Overall Study|Withdrawal by Subject|8|||
23391903|NCT04349098|65180905|FG001|Overall Study|Withdrawal by Subject|5|||
23391904|NCT04349098|65180904|FG000|Overall Study|Other|3|||
23391905|NCT04349098|65180905|FG001|Overall Study|Other|5|||
23391906|NCT02014103|65180907|FG000|Overall Study|Protocol Violation|7|||
23391907|NCT02014103|65180908|FG001|Overall Study|Protocol Violation|7|||
23391908|NCT02014103|65180907|FG000|Overall Study|Adverse Event|1|||
23391909|NCT02014103|65180908|FG001|Overall Study|Adverse Event|0|||
23391910|NCT02014103|65180907|FG000|Overall Study|Lost venous access|1|||
23391911|NCT02014103|65180908|FG001|Overall Study|Lost venous access|0|||
23391912|NCT02014103|65180907|FG000|Overall Study|Withdrawal by Subject|0|||
23391913|NCT02014103|65180908|FG001|Overall Study|Withdrawal by Subject|2|||
23391914|NCT00835042|65180911|FG000|First Intervention|Withdrawal by Subject|3|||
23391915|NCT00835042|65180912|FG001|First Intervention|Withdrawal by Subject|0|||
23391916|NCT00835042|65180911|FG000|First Intervention|Adverse Event|1|||
23391917|NCT00835042|65180912|FG001|First Intervention|Adverse Event|2|||
23391918|NCT00835042|65180911|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
23391919|NCT00835042|65180912|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
23391920|NCT00642759|65180918|FG000|Overall Study|Protocol Violation|1|||
23391921|NCT03400787|65180919|FG000|Overall Study|Lost to Follow-up|1|||
23391922|NCT03400787|65180920|FG001|Overall Study|Lost to Follow-up|0|||
23391923|NCT03400787|65180919|FG000|Overall Study|Death|1|||
23391924|NCT03400787|65180920|FG001|Overall Study|Death|0|||
23391925|NCT03400787|65180919|FG000|Overall Study|Protocol Violation|0|||
23391926|NCT03400787|65180920|FG001|Overall Study|Protocol Violation|2|||
23391927|NCT03400787|65180919|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
23391928|NCT03400787|65180920|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
23391929|NCT04115293|65180921|FG000|Overall Study|Adverse Event|0|||
23391930|NCT04115293|65180922|FG001|Overall Study|Adverse Event|2|||
23391931|NCT04115293|65180921|FG000|Overall Study|Withdrawal by Subject|2|||
23391932|NCT04115293|65180922|FG001|Overall Study|Withdrawal by Subject|1|||
23391933|NCT04115293|65180921|FG000|Overall Study|Physician Decision|1|||
23391934|NCT04115293|65180922|FG001|Overall Study|Physician Decision|0|||
23391935|NCT04115293|65180921|FG000|Overall Study|Death|1|||
23496012|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|Death|0|||
23391936|NCT04115293|65180922|FG001|Overall Study|Death|1|||
23391937|NCT00980798|65180926|FG000|Overall Study|Adverse Event|7|||
23391938|NCT00980798|65180927|FG001|Overall Study|Adverse Event|36|||
23391939|NCT00980798|65180926|FG000|Overall Study|Lack of Efficacy|16|||
23496013|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|Death|0|||
23391940|NCT00980798|65180927|FG001|Overall Study|Lack of Efficacy|5|||
23391941|NCT00980798|65180926|FG000|Overall Study|Lost to Follow-up|0|||
23391942|NCT00980798|65180927|FG001|Overall Study|Lost to Follow-up|1|||
23391943|NCT00980798|65180926|FG000|Overall Study|Physician Decision|2|||
23391944|NCT00980798|65180927|FG001|Overall Study|Physician Decision|1|||
23391945|NCT00980798|65180926|FG000|Overall Study|Withdrawal by Subject|8|||
23391946|NCT00980798|65180927|FG001|Overall Study|Withdrawal by Subject|11|||
23391947|NCT00980798|65180926|FG000|Overall Study|Other|0|||
23391948|NCT00980798|65180927|FG001|Overall Study|Other|1|||
23391949|NCT03794544|65180928|FG000|Overall Study|Withdrawal by Subject|1|||
23391950|NCT03794544|65180929|FG001|Overall Study|Withdrawal by Subject|1|||
23391951|NCT03794544|65180930|FG002|Overall Study|Withdrawal by Subject|0|||
23391952|NCT03794544|65180931|FG003|Overall Study|Withdrawal by Subject|0|||
23391953|NCT03794544|65180928|FG000|Overall Study|Death|0|||
23391954|NCT03794544|65180929|FG001|Overall Study|Death|0|||
23391955|NCT03794544|65180930|FG002|Overall Study|Death|0|||
23391956|NCT03794544|65180931|FG003|Overall Study|Death|1|||
23391957|NCT03794544|65180928|FG000|Overall Study|Lost to Follow-up|0|||
23391958|NCT03794544|65180929|FG001|Overall Study|Lost to Follow-up|1|||
23300311|NCT00227266|64840099|FG001|Overall Study|Excessive weight gain|0|||
23300312|NCT00227266|64840100|FG002|Overall Study|Excessive weight gain|2|||
23300313|NCT01355159|64840104|FG000|Overall Study|Withdrew consent|39|||
23300314|NCT01355159|64840105|FG001|Overall Study|Withdrew consent|47|||
23300315|NCT01355159|64840104|FG000|Overall Study|No primary outcome data|17|||
23300316|NCT01355159|64840105|FG001|Overall Study|No primary outcome data|11|||
23300317|NCT01355159|64840104|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
23300318|NCT01355159|64840105|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
23300319|NCT01355159|64840104|FG000|Overall Study|Early intrauterine fetal death|6|||
23300320|NCT01355159|64840105|FG001|Overall Study|Early intrauterine fetal death|6|||
23300321|NCT02940730|64840106|FG000|Intervention 2|Physician Decision|7|||
23300322|NCT02940730|64840107|FG001|Intervention 2|Physician Decision|0|||
23300323|NCT00652028|64842766|FG000|Overall Study|Adverse Event|1|||
23300324|NCT00652028|64842767|FG001|Overall Study|Adverse Event|0|||
23300325|NCT00652028|64842768|FG002|Overall Study|Adverse Event|0|||
23300326|NCT00652028|64842769|FG003|Overall Study|Adverse Event|0|||
23391959|NCT03794544|65180930|FG002|Overall Study|Lost to Follow-up|1|||
23391960|NCT03794544|65180931|FG003|Overall Study|Lost to Follow-up|0|||
23391961|NCT03794544|65180928|FG000|Overall Study|Other|0|||
23391962|NCT03794544|65180929|FG001|Overall Study|Other|1|||
23391963|NCT03794544|65180930|FG002|Overall Study|Other|0|||
23391964|NCT03794544|65180931|FG003|Overall Study|Other|0|||
23391965|NCT02249949|65180932|FG000|Overall Study|Cancelled prior to treatment|2|||
23391966|NCT03101267|65180934|FG000|Primary Study Period|Withdrawal by Subject|1|||
23391967|NCT03101267|65180935|FG001|Primary Study Period|Withdrawal by Subject|2|||
23391968|NCT03101267|65180936|FG002|Primary Study Period|Withdrawal by Subject|3|||
23391969|NCT03101267|65180934|FG000|Primary Study Period|Miscellaneous|2|||
23391970|NCT03101267|65180935|FG001|Primary Study Period|Miscellaneous|0|||
23496014|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|Death|0|||
23496015|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|Death|0|||
23391971|NCT03101267|65180936|FG002|Primary Study Period|Miscellaneous|0|||
23391972|NCT03004183|65180944|FG000|Overall Study|Adverse Event|7|||
23391973|NCT03004183|65180944|FG000|Overall Study|Lost to Follow-up|1|||
23391974|NCT03004183|65180944|FG000|Overall Study|Physician Decision|40|||
23391975|NCT03004183|65180944|FG000|Overall Study|Withdrawal by Subject|1|||
23391976|NCT03004183|65180944|FG000|Overall Study|COVID-19|1|||
23391977|NCT00267488|65180950|FG000|Overall Study|Sponsor Terminated Study|9|||
23391978|NCT00267488|65180950|FG000|Overall Study|Protocol Violation|1|||
23391979|NCT00267488|65180950|FG000|Overall Study|Other (Disease Progression)|1|||
23391980|NCT01904279|65180952|FG000|Overall Study|Lack of Efficacy|2|||
23391981|NCT01904279|65180953|FG001|Overall Study|Lack of Efficacy|3|||
23391982|NCT01904279|65180952|FG000|Overall Study|Withdrawal by Subject|1|||
23391983|NCT01904279|65180953|FG001|Overall Study|Withdrawal by Subject|0|||
23391984|NCT03474107|65180954|FG000|Overall Study|Adverse Event|42|||
23391985|NCT03474107|65180955|FG001|Overall Study|Adverse Event|46|||
23391986|NCT03474107|65180954|FG000|Overall Study|Death|2|||
23391987|NCT03474107|65180955|FG001|Overall Study|Death|2|||
23391988|NCT03474107|65180954|FG000|Overall Study|Lost to Follow-up|0|||
23391989|NCT03474107|65180955|FG001|Overall Study|Lost to Follow-up|1|||
23391990|NCT03474107|65180954|FG000|Overall Study|Progressive Disease|177|||
23391991|NCT03474107|65180955|FG001|Overall Study|Progressive Disease|180|||
23391992|NCT03474107|65180954|FG000|Overall Study|Protocol Violation|1|||
23391993|NCT03474107|65180955|FG001|Overall Study|Protocol Violation|1|||
23391994|NCT03474107|65180954|FG000|Overall Study|Withdrawal by Subject|15|||
23391995|NCT03474107|65180955|FG001|Overall Study|Withdrawal by Subject|27|||
23391996|NCT03474107|65180954|FG000|Overall Study|Physician Decision|7|||
23391997|NCT03474107|65180955|FG001|Overall Study|Physician Decision|22|||
23391998|NCT03474107|65180954|FG000|Overall Study|Miscellaneous|1|||
23391999|NCT03474107|65180955|FG001|Overall Study|Miscellaneous|6|||
23392000|NCT02607722|65182652|FG000|Overall Study|No data reliability|1|||
23392001|NCT02607722|65182652|FG000|Overall Study|no patient visit|18|||
23392002|NCT02607722|65182652|FG000|Overall Study|missing info in CRF|13|||
23392003|NCT02607722|65182652|FG000|Overall Study|Withdrawal by Subject|616|||
23392004|NCT02607722|65182652|FG000|Overall Study|Lost to Follow-up|312|||
23392005|NCT02607722|65182652|FG000|Overall Study|Improved|22|||
23392006|NCT02607722|65182652|FG000|Overall Study|Lack of Efficacy|316|||
23496016|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|Death|1|||
23496017|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|Death|0|||
23496018|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|Death|11|||
23496019|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|Death|2|||
23496020|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496021|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496022|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496023|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496024|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496025|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496026|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496027|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
23392007|NCT02607722|65182652|FG000|Overall Study|Adverse Event|2553|||
23392008|NCT02607722|65182652|FG000|Overall Study|Not treated|1|||
23392009|NCT02607722|65182652|FG000|Overall Study|No CRF collected|138|||
23392010|NCT02607722|65182652|FG000|Overall Study|without CRF|4225|||
23392011|NCT02607722|65182652|FG000|Overall Study|Physician Decision|367|||
23392012|NCT03880019|65182655|FG000|Overall Study|Competing disease|1|||
23392013|NCT04034927|65182661|FG000|Overall Study|Adverse Event|4|||
23392014|NCT04034927|65182662|FG001|Overall Study|Adverse Event|9|||
23392015|NCT04034927|65182661|FG000|Overall Study|Death|0|||
23392016|NCT04034927|65182662|FG001|Overall Study|Death|1|||
23392017|NCT04034927|65182661|FG000|Overall Study|Withdrawal by Subject|0|||
23392018|NCT04034927|65182662|FG001|Overall Study|Withdrawal by Subject|3|||
23496028|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
23300327|NCT00652028|64842766|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
23300328|NCT00652028|64842767|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
23300329|NCT00652028|64842768|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
23300330|NCT00652028|64842769|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
23300331|NCT00652028|64842766|FG000|Overall Study|Physician Decision|0|||
23392019|NCT04034927|65182661|FG000|Overall Study|Still on Treatment|2|||
23392020|NCT04034927|65182662|FG001|Overall Study|Still on Treatment|1|||
23392021|NCT04034927|65182661|FG000|Overall Study|Other|1|||
23392022|NCT04034927|65182662|FG001|Overall Study|Other|1|||
23392023|NCT03038672|65182667|FG000|Initial Treatment|Unacceptable chemistry|0|||
23392024|NCT03038672|65182668|FG001|Initial Treatment|Unacceptable chemistry|1|||
23392025|NCT03038672|65182667|FG000|Initial Treatment|Progression prior to treatment|1|||
23300332|NCT00652028|64842767|FG001|Overall Study|Physician Decision|0|||
23300333|NCT00652028|64842768|FG002|Overall Study|Physician Decision|1|||
23300334|NCT00652028|64842769|FG003|Overall Study|Physician Decision|0|||
23300335|NCT00775606|64842770|FG000|Overall Study|Study sponsor terminated funding|3|||
23300336|NCT00775606|64842771|FG001|Overall Study|Study sponsor terminated funding|0|||
23300337|NCT02384850|64842772|FG000|Overall Study|Withdrawal by Subject|2|||
23300338|NCT02384850|64842773|FG001|Overall Study|Withdrawal by Subject|2|||
23300339|NCT03180801|64842774|FG000|Overall Study|Physician Decision|3|||
23300340|NCT03180801|64842775|FG001|Overall Study|Physician Decision|3|||
23300341|NCT03180801|64842776|FG002|Overall Study|Physician Decision|1|||
23300342|NCT03180801|64842774|FG000|Overall Study|Non-compliance|1|||
23300343|NCT03180801|64842775|FG001|Overall Study|Non-compliance|4|||
23300344|NCT03180801|64842776|FG002|Overall Study|Non-compliance|0|||
23300345|NCT03180801|64842774|FG000|Overall Study|Inoculation Target Reached|1|||
23300346|NCT03180801|64842775|FG001|Overall Study|Inoculation Target Reached|1|||
23300347|NCT03180801|64842776|FG002|Overall Study|Inoculation Target Reached|3|||
23300348|NCT03180801|64842774|FG000|Overall Study|Adverse Event|1|||
23300349|NCT03180801|64842775|FG001|Overall Study|Adverse Event|0|||
23300350|NCT03180801|64842776|FG002|Overall Study|Adverse Event|2|||
23300351|NCT03180801|64842774|FG000|Overall Study|Withdrawal by Subject|2|||
23300352|NCT03180801|64842775|FG001|Overall Study|Withdrawal by Subject|2|||
23300353|NCT03180801|64842776|FG002|Overall Study|Withdrawal by Subject|1|||
23300354|NCT03180801|64842774|FG000|Overall Study|Lost to Follow-up|0|||
23300355|NCT03180801|64842775|FG001|Overall Study|Lost to Follow-up|2|||
23300356|NCT03180801|64842776|FG002|Overall Study|Lost to Follow-up|3|||
23300357|NCT01280617|64842781|FG000|Overall Study|Adverse Event|0|||
23300358|NCT01280617|64842782|FG001|Overall Study|Adverse Event|1|||
23300359|NCT01360866|64842783|FG000|Overall Study|Lost to Follow-up|11|||
23392026|NCT03038672|65182668|FG001|Initial Treatment|Progression prior to treatment|0|||
23392027|NCT03038672|65182667|FG000|Initial Treatment|No treatment per protocol|1|||
23392028|NCT03038672|65182668|FG001|Initial Treatment|No treatment per protocol|0|||
23392029|NCT02088554|65182671|FG000|Overall Study|Exited before procedure|130|||
23392030|NCT02088554|65182671|FG000|Overall Study|Attempted but not implanted|31|||
23392031|NCT02088554|65182671|FG000|Overall Study|Implant not attempted|19|||
23392032|NCT02088554|65182671|FG000|Overall Study|Pending next visit|532|||
23392033|NCT02088554|65182671|FG000|Overall Study|Death|170|||
23392034|NCT02088554|65182671|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
23392035|NCT02088554|65182671|FG000|Overall Study|Lost to Follow-up|23|||
23392036|NCT02088554|65182671|FG000|Overall Study|Explanted|32|||
23392037|NCT02088554|65182671|FG000|Overall Study|Any other reason not covered by previous categories|11|||
23392038|NCT05418426|65182679|FG000|Overall Study|Adverse Event|0|||
23392039|NCT05418426|65182680|FG001|Overall Study|Adverse Event|1|||
23392040|NCT05418426|65182681|FG002|Overall Study|Adverse Event|0|||
23392041|NCT05418426|65182679|FG000|Overall Study|Withdrawal by Subject|0|||
23392042|NCT05418426|65182680|FG001|Overall Study|Withdrawal by Subject|1|||
23392043|NCT05418426|65182681|FG002|Overall Study|Withdrawal by Subject|0|||
23392044|NCT05418426|65182679|FG000|Overall Study|Protocol Violation|0|||
23392045|NCT05418426|65182680|FG001|Overall Study|Protocol Violation|0|||
23392046|NCT05418426|65182681|FG002|Overall Study|Protocol Violation|1|||
23392047|NCT03338790|65182694|FG000|Overall Study|Disease Progression|65|||
23392048|NCT03338790|65182695|FG001|Overall Study|Disease Progression|43|||
23392049|NCT03338790|65182696|FG002|Overall Study|Disease Progression|50|||
23392050|NCT03338790|65182697|FG003|Overall Study|Disease Progression|37|||
23392051|NCT03338790|65182694|FG000|Overall Study|Study Drug Toxicity|9|||
23392052|NCT03338790|65182695|FG001|Overall Study|Study Drug Toxicity|8|||
23392053|NCT03338790|65182696|FG002|Overall Study|Study Drug Toxicity|15|||
23392054|NCT03338790|65182697|FG003|Overall Study|Study Drug Toxicity|0|||
23392055|NCT03338790|65182694|FG000|Overall Study|Death|1|||
23392056|NCT03338790|65182695|FG001|Overall Study|Death|1|||
23392057|NCT03338790|65182696|FG002|Overall Study|Death|1|||
23392058|NCT03338790|65182697|FG003|Overall Study|Death|0|||
23392059|NCT03338790|65182694|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
23392060|NCT03338790|65182695|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
23392061|NCT03338790|65182696|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
23392062|NCT03338790|65182697|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
23392063|NCT03338790|65182694|FG000|Overall Study|Participant request to discontinue study treatment|3|||
23392064|NCT03338790|65182695|FG001|Overall Study|Participant request to discontinue study treatment|3|||
23392065|NCT03338790|65182696|FG002|Overall Study|Participant request to discontinue study treatment|2|||
23392066|NCT03338790|65182697|FG003|Overall Study|Participant request to discontinue study treatment|1|||
23392067|NCT03338790|65182694|FG000|Overall Study|Poor/non-compliance|0|||
23392068|NCT03338790|65182695|FG001|Overall Study|Poor/non-compliance|1|||
23392069|NCT03338790|65182696|FG002|Overall Study|Poor/non-compliance|0|||
23392070|NCT03338790|65182697|FG003|Overall Study|Poor/non-compliance|0|||
23392071|NCT03338790|65182694|FG000|Overall Study|Participant withdrew consent|1|||
23392072|NCT03338790|65182695|FG001|Overall Study|Participant withdrew consent|0|||
23392073|NCT03338790|65182696|FG002|Overall Study|Participant withdrew consent|1|||
23392074|NCT03338790|65182697|FG003|Overall Study|Participant withdrew consent|1|||
23392075|NCT03338790|65182694|FG000|Overall Study|Other reasons|0|||
23392076|NCT03338790|65182695|FG001|Overall Study|Other reasons|5|||
23392077|NCT03338790|65182696|FG002|Overall Study|Other reasons|0|||
23392078|NCT03338790|65182697|FG003|Overall Study|Other reasons|2|||
23392079|NCT03338790|65182694|FG000|Overall Study|Not reported|0|||
23392080|NCT03338790|65182695|FG001|Overall Study|Not reported|0|||
23392081|NCT03338790|65182696|FG002|Overall Study|Not reported|1|||
23392082|NCT03338790|65182697|FG003|Overall Study|Not reported|0|||
23392083|NCT03338790|65182694|FG000|Overall Study|Completed treatment period|1|||
23392084|NCT03338790|65182695|FG001|Overall Study|Completed treatment period|2|||
23392085|NCT03338790|65182696|FG002|Overall Study|Completed treatment period|0|||
23392086|NCT03338790|65182697|FG003|Overall Study|Completed treatment period|0|||
23392087|NCT02507934|65182698|FG000|Overall Study|Lost to Follow-up|2|||
23392088|NCT02507934|65182699|FG001|Overall Study|Lost to Follow-up|0|||
23392089|NCT02507934|65182698|FG000|Overall Study|Withdrawal by Subject|2|||
23392090|NCT02507934|65182699|FG001|Overall Study|Withdrawal by Subject|0|||
23392091|NCT05473715|65182700|FG000|Overall Study|Trial terminate|2|||
23392092|NCT05473715|65182701|FG001|Overall Study|Trial terminate|1|||
23392093|NCT05878067|65182706|FG000|Overall Study|Lost to Follow-up|2|||
23392094|NCT04730271|65182707|FG000|Overall Study|Adverse Event|0|||
23392095|NCT04730271|65182708|FG001|Overall Study|Adverse Event|2|||
23392096|NCT04730271|65182707|FG000|Overall Study|Withdrawal by Subject|1|||
23392097|NCT04730271|65182708|FG001|Overall Study|Withdrawal by Subject|1|||
23392098|NCT04730271|65182707|FG000|Overall Study|Protocol Violation|7|||
23392099|NCT04730271|65182708|FG001|Overall Study|Protocol Violation|13|||
23392100|NCT04730271|65182707|FG000|Overall Study|Lost to Follow-up|3|||
23392101|NCT04730271|65182708|FG001|Overall Study|Lost to Follow-up|3|||
23392102|NCT04730271|65182707|FG000|Overall Study|Death|1|||
23392103|NCT04730271|65182708|FG001|Overall Study|Death|0|||
23392104|NCT06582732|65182710|FG000|Initial Study Period|Adverse Event|0|||
23392105|NCT06582732|65182711|FG001|Initial Study Period|Adverse Event|0|||
23392106|NCT06582732|65182712|FG002|Initial Study Period|Adverse Event|0|||
23392107|NCT06582732|65182713|FG003|Initial Study Period|Adverse Event|2|||
23392108|NCT06582732|65182714|FG004|Initial Study Period|Adverse Event|0|||
23392109|NCT06582732|65182715|FG005|Initial Study Period|Adverse Event|0|||
23392110|NCT06582732|65182716|FG006|Initial Study Period|Adverse Event|0|||
23392111|NCT06582732|65182710|FG000|Initial Study Period|Death|1|||
23392112|NCT06582732|65182711|FG001|Initial Study Period|Death|0|||
23392113|NCT06582732|65182712|FG002|Initial Study Period|Death|0|||
23392114|NCT06582732|65182713|FG003|Initial Study Period|Death|0|||
23392115|NCT06582732|65182714|FG004|Initial Study Period|Death|1|||
23392116|NCT06582732|65182715|FG005|Initial Study Period|Death|0|||
23392117|NCT06582732|65182716|FG006|Initial Study Period|Death|0|||
23392118|NCT06582732|65182710|FG000|Initial Study Period|Lost to Follow-up|0|||
23392119|NCT06582732|65182711|FG001|Initial Study Period|Lost to Follow-up|0|||
23392120|NCT06582732|65182712|FG002|Initial Study Period|Lost to Follow-up|2|||
23392121|NCT06582732|65182713|FG003|Initial Study Period|Lost to Follow-up|0|||
23392122|NCT06582732|65182714|FG004|Initial Study Period|Lost to Follow-up|0|||
23392123|NCT06582732|65182715|FG005|Initial Study Period|Lost to Follow-up|0|||
23392124|NCT06582732|65182716|FG006|Initial Study Period|Lost to Follow-up|0|||
23392125|NCT06582732|65182710|FG000|Initial Study Period|Withdrawal by Subject|0|||
23392126|NCT06582732|65182711|FG001|Initial Study Period|Withdrawal by Subject|1|||
23392127|NCT06582732|65182712|FG002|Initial Study Period|Withdrawal by Subject|0|||
23392128|NCT06582732|65182713|FG003|Initial Study Period|Withdrawal by Subject|1|||
23392129|NCT06582732|65182714|FG004|Initial Study Period|Withdrawal by Subject|3|||
23392130|NCT06582732|65182715|FG005|Initial Study Period|Withdrawal by Subject|1|||
23392131|NCT06582732|65182716|FG006|Initial Study Period|Withdrawal by Subject|2|||
23392132|NCT06582732|65182710|FG000|Initial Study Period|Moved Away|0|||
23392133|NCT06582732|65182711|FG001|Initial Study Period|Moved Away|0|||
23392134|NCT06582732|65182712|FG002|Initial Study Period|Moved Away|0|||
23392135|NCT06582732|65182713|FG003|Initial Study Period|Moved Away|0|||
23392136|NCT06582732|65182714|FG004|Initial Study Period|Moved Away|1|||
23392137|NCT06582732|65182715|FG005|Initial Study Period|Moved Away|0|||
23392138|NCT06582732|65182716|FG006|Initial Study Period|Moved Away|0|||
23392139|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23392140|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
23392141|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23392142|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
23392143|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
23392144|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
23392145|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
23392146|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
23392147|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
23392148|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
23392149|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
23392150|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
23392151|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23392152|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
23392153|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23392154|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
23392155|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
23392156|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
23392157|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
23392158|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
23392159|NCT02836249|65182718|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
23392160|NCT02836249|65182719|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
23392161|NCT02836249|65182720|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
23392162|NCT02836249|65182721|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
23392163|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
23392164|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
23392165|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
23392166|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
23392167|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
23392168|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
23392169|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
23392170|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
23392171|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Death|0|||
23392172|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Death|0|||
23392173|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Death|1|||
23392174|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Death|0|||
23392175|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
23392176|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
23392177|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
23392178|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
23392179|NCT02836249|65182718|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
23392180|NCT02836249|65182719|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
23392181|NCT02836249|65182720|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
23392182|NCT02836249|65182721|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
23392183|NCT02595879|65182722|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
23392184|NCT02595879|65182723|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
23392185|NCT02168439|65182725|FG000|Overall Study|Protocol Violation|0|||
23392186|NCT02168439|65182726|FG001|Overall Study|Protocol Violation|2|||
23392187|NCT02562235|65182727|FG000|Overall Study|Adverse Event|3|||
23392188|NCT03579719|65182729|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
23392189|NCT00552279|65182730|FG000|Overall Study|Adverse Event|0|||
23392190|NCT00552279|65182731|FG001|Overall Study|Adverse Event|1|||
23392191|NCT00552279|65182730|FG000|Overall Study|Withdrawal by Subject|12|||
23392192|NCT00552279|65182731|FG001|Overall Study|Withdrawal by Subject|1|||
23392193|NCT00552279|65182730|FG000|Overall Study|Lost to Follow-up|1|||
23392194|NCT00552279|65182731|FG001|Overall Study|Lost to Follow-up|0|||
23392195|NCT00552279|65182730|FG000|Overall Study|Other|1|||
23392196|NCT00552279|65182731|FG001|Overall Study|Other|1|||
23392197|NCT03878602|65182732|FG000|Overall Study|cord blood donation|7|||
23392198|NCT03878602|65182733|FG001|Overall Study|cord blood donation|1|||
23606251|NCT03692871|65947186|FG000|Overall Study|Lost to Follow-up|24|||
23392199|NCT03878602|65182732|FG000|Overall Study|incomplete data collection|2|||
23606252|NCT03692871|65947187|FG001|Overall Study|Lost to Follow-up|9|||
23606253|NCT03692871|65947186|FG000|Overall Study|Physician Decision|22|||
23606254|NCT03692871|65947187|FG001|Overall Study|Physician Decision|7|||
23606255|NCT03692871|65947186|FG000|Overall Study|Protocol Deviation|1|||
23606256|NCT03692871|65947187|FG001|Overall Study|Protocol Deviation|0|||
23606257|NCT03692871|65947186|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
23606258|NCT03692871|65947187|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
23606259|NCT02671266|65947188|FG000|Overall Study|Withdrawal by Subject|1|||
23606260|NCT02671266|65947189|FG001|Overall Study|Withdrawal by Subject|1|||
23606261|NCT03019289|65947190|FG000|Overall Study|Adverse Event|1|||
23606262|NCT03019289|65947191|FG001|Overall Study|Adverse Event|0|||
23606263|NCT03019289|65947192|FG002|Overall Study|Adverse Event|0|||
23606264|NCT03019289|65947193|FG003|Overall Study|Adverse Event|0|||
23606265|NCT03019289|65947194|FG004|Overall Study|Adverse Event|0|||
23606266|NCT03019289|65947195|FG005|Overall Study|Adverse Event|0|||
23496029|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496030|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496031|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
23496032|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
23496033|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
23496034|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
23496035|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
23496036|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
23496037|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
23496038|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
23496039|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
23496040|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
23496041|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
23496042|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
23496043|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
23496044|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
23496045|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
23496046|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496047|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496048|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23300360|NCT01360866|64842784|FG001|Overall Study|Lost to Follow-up|28|||
23300361|NCT01360866|64842785|FG002|Overall Study|Lost to Follow-up|41|||
23496049|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496050|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496051|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496052|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496053|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496054|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496055|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496056|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496057|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
23496058|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
23496059|NCT02598960|65558957|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
23496060|NCT02598960|65558958|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
23496061|NCT02598960|65558959|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
23496062|NCT02598960|65558960|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
23496063|NCT02598960|65558961|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
23496064|NCT02598960|65558962|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
23496065|NCT02598960|65558963|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
23496066|NCT02598960|65558964|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
23496067|NCT02598960|65558965|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
23496068|NCT02598960|65558966|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
23496069|NCT02598960|65558967|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
23496070|NCT02598960|65558968|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
23496071|NCT02598960|65558969|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
23496072|NCT01622231|65558970|FG000|Overall Study|Physician Decision|1|||
23496073|NCT01622231|65558970|FG000|Overall Study|Withdrawal by Subject|1|||
23496074|NCT01980940|65558972|FG000|Overall Study|Protocol Violation|0|||
23496075|NCT01980940|65558973|FG001|Overall Study|Protocol Violation|0|||
23496076|NCT01980940|65558974|FG002|Overall Study|Protocol Violation|0|||
23496077|NCT01980940|65558975|FG003|Overall Study|Protocol Violation|0|||
23496078|NCT01980940|65558976|FG004|Overall Study|Protocol Violation|0|||
23496079|NCT01980940|65558977|FG005|Overall Study|Protocol Violation|2|||
23496080|NCT01980940|65558978|FG006|Overall Study|Protocol Violation|0|||
23496081|NCT01980940|65558979|FG007|Overall Study|Protocol Violation|0|||
23496082|NCT01719783|65558982|FG000|Dose 2|Physician Decision|1|||
23496083|NCT01719783|65558983|FG001|Dose 2|Physician Decision|0|||
23496084|NCT00385762|65558986|FG000|Overall Study|Adverse Event|1|||
23496085|NCT00385762|65558986|FG000|Overall Study|Lost to Follow-up|1|||
23496086|NCT00434954|65558988|FG000|Overall Study|Adverse Event|17|||
23496087|NCT00434954|65558989|FG001|Overall Study|Adverse Event|2|||
23496088|NCT00434954|65558988|FG000|Overall Study|Entry criteria not met|14|||
23496089|NCT00434954|65558989|FG001|Overall Study|Entry criteria not met|16|||
23496090|NCT00434954|65558988|FG000|Overall Study|Lost to Follow-up|0|||
23496091|NCT00434954|65558989|FG001|Overall Study|Lost to Follow-up|1|||
23496092|NCT00434954|65558988|FG000|Overall Study|Physician Decision|6|||
23496093|NCT00434954|65558989|FG001|Overall Study|Physician Decision|3|||
23496094|NCT00434954|65558988|FG000|Overall Study|Protocol Violation|36|||
23496095|NCT00434954|65558989|FG001|Overall Study|Protocol Violation|27|||
23496096|NCT00434954|65558988|FG000|Overall Study|Sponsor decision|1|||
23496097|NCT00434954|65558989|FG001|Overall Study|Sponsor decision|0|||
23496098|NCT00434954|65558988|FG000|Overall Study|Subject decision|8|||
23496099|NCT00434954|65558989|FG001|Overall Study|Subject decision|22|||
23496100|NCT01611155|65558995|FG000|Overall Study|Adverse Event|1|||
23496101|NCT01611155|65558996|FG001|Overall Study|Adverse Event|1|||
23496102|NCT01611155|65558995|FG000|Overall Study|Refused further treatment|6|||
23496103|NCT01611155|65558996|FG001|Overall Study|Refused further treatment|4|||
23496104|NCT01611155|65558995|FG000|Overall Study|Disease progression|1|||
23496105|NCT01611155|65558996|FG001|Overall Study|Disease progression|0|||
23496106|NCT01611155|65558995|FG000|Overall Study|Withdrawal by Subject|1|||
23496107|NCT01611155|65558996|FG001|Overall Study|Withdrawal by Subject|0|||
23496108|NCT01611155|65558995|FG000|Overall Study|Alternative treatment|0|||
23496109|NCT01611155|65558996|FG001|Overall Study|Alternative treatment|1|||
23496110|NCT01611155|65558995|FG000|Overall Study|Ineligible patient|0|||
23496111|NCT01611155|65558996|FG001|Overall Study|Ineligible patient|1|||
23496112|NCT00761631|65558999|FG000|Overall Study|Parent/legal guardian request|8|||
23496113|NCT00761631|65559000|FG001|Overall Study|Parent/legal guardian request|3|||
23496114|NCT00761631|65559001|FG002|Overall Study|Parent/legal guardian request|8|||
23496115|NCT00761631|65559002|FG003|Overall Study|Parent/legal guardian request|0|||
23496116|NCT00761631|65559003|FG004|Overall Study|Parent/legal guardian request|5|||
23496117|NCT00761631|65559004|FG005|Overall Study|Parent/legal guardian request|0|||
23496118|NCT00761631|65558999|FG000|Overall Study|Lost to Follow-up|2|||
23496119|NCT00761631|65559000|FG001|Overall Study|Lost to Follow-up|4|||
23496120|NCT00761631|65559001|FG002|Overall Study|Lost to Follow-up|7|||
23496121|NCT00761631|65559002|FG003|Overall Study|Lost to Follow-up|1|||
23496122|NCT00761631|65559003|FG004|Overall Study|Lost to Follow-up|6|||
23496123|NCT00761631|65559004|FG005|Overall Study|Lost to Follow-up|1|||
23496124|NCT00761631|65558999|FG000|Overall Study|Protocol Violation|2|||
23496125|NCT00761631|65559000|FG001|Overall Study|Protocol Violation|0|||
23496126|NCT00761631|65559001|FG002|Overall Study|Protocol Violation|0|||
23496127|NCT00761631|65559002|FG003|Overall Study|Protocol Violation|1|||
23496128|NCT00761631|65559003|FG004|Overall Study|Protocol Violation|5|||
23496129|NCT00761631|65559004|FG005|Overall Study|Protocol Violation|1|||
23496130|NCT00761631|65558999|FG000|Overall Study|Randomized, not treated|1|||
23496131|NCT00761631|65559000|FG001|Overall Study|Randomized, not treated|0|||
23496132|NCT00761631|65559001|FG002|Overall Study|Randomized, not treated|0|||
23496133|NCT00761631|65559002|FG003|Overall Study|Randomized, not treated|0|||
23496134|NCT00761631|65559003|FG004|Overall Study|Randomized, not treated|0|||
23496135|NCT00761631|65559004|FG005|Overall Study|Randomized, not treated|0|||
23496136|NCT00761631|65558999|FG000|Overall Study|Failed to return|1|||
23496137|NCT00761631|65559000|FG001|Overall Study|Failed to return|0|||
23496138|NCT00761631|65559001|FG002|Overall Study|Failed to return|1|||
23496139|NCT00761631|65559002|FG003|Overall Study|Failed to return|1|||
23496140|NCT00761631|65559003|FG004|Overall Study|Failed to return|5|||
23496141|NCT00761631|65559004|FG005|Overall Study|Failed to return|2|||
23496142|NCT00761631|65558999|FG000|Overall Study|Physician Decision|1|||
23496143|NCT00761631|65559000|FG001|Overall Study|Physician Decision|0|||
23496144|NCT00761631|65559001|FG002|Overall Study|Physician Decision|0|||
23496145|NCT00761631|65559002|FG003|Overall Study|Physician Decision|0|||
23496146|NCT00761631|65559003|FG004|Overall Study|Physician Decision|0|||
23496147|NCT00761631|65559004|FG005|Overall Study|Physician Decision|0|||
23496148|NCT00761631|65558999|FG000|Overall Study|Other|0|||
23496149|NCT00761631|65559000|FG001|Overall Study|Other|0|||
23496150|NCT00761631|65559001|FG002|Overall Study|Other|0|||
23496151|NCT00761631|65559002|FG003|Overall Study|Other|0|||
23496152|NCT00761631|65559003|FG004|Overall Study|Other|1|||
23496153|NCT00761631|65559004|FG005|Overall Study|Other|1|||
23496154|NCT05350410|65559005|FG000|Overall Study|Withdrawal by Subject|1|||
23496155|NCT01976338|65559006|FG000|Overall Study|Physician Decision|0|||
23496156|NCT01976338|65559007|FG001|Overall Study|Physician Decision|1|||
23496157|NCT01976338|65559006|FG000|Overall Study|Lost to Follow-up|3|||
23496158|NCT01976338|65559007|FG001|Overall Study|Lost to Follow-up|0|||
23496159|NCT01976338|65559006|FG000|Overall Study|Withdrawal by Subject|5|||
23496160|NCT01976338|65559007|FG001|Overall Study|Withdrawal by Subject|2|||
23496161|NCT01976338|65559006|FG000|Overall Study|Adverse Event|5|||
23496162|NCT01976338|65559007|FG001|Overall Study|Adverse Event|1|||
23496163|NCT02925117|65559008|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
23496164|NCT02925117|65559009|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
23496165|NCT02925117|65559010|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
23392200|NCT03878602|65182733|FG001|Overall Study|incomplete data collection|0|||
23402833|NCT02185534|65220021|FG004|First Washout Period|Protocol Violation|0|||
23496166|NCT02925117|65559011|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
23496167|NCT02925117|65559012|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496168|NCT02925117|65559013|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496169|NCT02925117|65559014|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496170|NCT02925117|65559015|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23402834|NCT02185534|65220022|FG005|First Washout Period|Protocol Violation|1|||
23402835|NCT04245709|65220023|FG000|Overall Study|Adverse Event|13|||
23402836|NCT04245709|65220023|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
23402837|NCT03782064|65220024|FG000|Overall Study|Lack of Efficacy|2|||
23402838|NCT03782064|65220024|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
23402839|NCT02927795|65220025|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
23402840|NCT02927795|65220025|FG000|Overall Study|Not Treated|4|||
23496171|NCT02925117|65559016|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496172|NCT02925117|65559017|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496173|NCT02925117|65559018|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496174|NCT02925117|65559019|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
23496175|NCT02925117|65559008|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
23496176|NCT02925117|65559009|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
23496177|NCT02925117|65559010|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
23496178|NCT02925117|65559011|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496179|NCT02925117|65559012|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496180|NCT02925117|65559013|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496181|NCT02925117|65559014|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496182|NCT02925117|65559015|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496183|NCT02925117|65559016|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496184|NCT02925117|65559017|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496185|NCT02925117|65559018|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496186|NCT02925117|65559019|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
23496187|NCT02925117|65559008|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
23496188|NCT02925117|65559009|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
23496189|NCT02925117|65559010|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496190|NCT02925117|65559011|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496191|NCT02925117|65559012|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496192|NCT02925117|65559013|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496193|NCT02925117|65559014|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496194|NCT02925117|65559015|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496195|NCT02925117|65559016|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496196|NCT02925117|65559017|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496197|NCT02925117|65559018|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496198|NCT02925117|65559019|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
23496199|NCT02925117|65559008|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
23496200|NCT02925117|65559009|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
23496201|NCT02925117|65559010|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
23496202|NCT02925117|65559011|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
23496203|NCT02925117|65559012|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
23496204|NCT02925117|65559013|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
23496205|NCT02925117|65559014|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
23496206|NCT02925117|65559015|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
23496207|NCT02925117|65559016|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
23496208|NCT02925117|65559017|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
23496209|NCT02925117|65559018|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
23496210|NCT02925117|65559019|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
23496211|NCT02925117|65559008|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496212|NCT02925117|65559009|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496213|NCT02925117|65559010|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496214|NCT02925117|65559011|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496215|NCT02925117|65559012|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496216|NCT02925117|65559013|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
23496217|NCT02925117|65559014|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496218|NCT02925117|65559015|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496219|NCT02925117|65559016|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496220|NCT02925117|65559017|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
23496221|NCT02925117|65559018|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
23496222|NCT02925117|65559019|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
23496223|NCT02925117|65559008|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496224|NCT02925117|65559009|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496225|NCT02925117|65559010|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496226|NCT02925117|65559011|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496227|NCT02925117|65559012|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
23496228|NCT02925117|65559013|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
23496229|NCT02925117|65559014|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
23496230|NCT02925117|65559015|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
23496231|NCT02925117|65559016|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
23496232|NCT02925117|65559017|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
23392201|NCT04152200|65182736|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
23496233|NCT02925117|65559018|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
23496234|NCT02925117|65559019|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
23496235|NCT02925117|65559008|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496236|NCT02925117|65559009|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496237|NCT02925117|65559010|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496238|NCT02925117|65559011|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23300362|NCT01360866|64842786|FG003|Overall Study|Lost to Follow-up|0|||
23496239|NCT02925117|65559012|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496240|NCT02925117|65559013|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
23496241|NCT02925117|65559014|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496242|NCT02925117|65559015|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496243|NCT02925117|65559016|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496244|NCT02925117|65559017|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496245|NCT02925117|65559018|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
23496246|NCT02925117|65559019|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
23496247|NCT02925117|65559008|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
23496248|NCT02925117|65559009|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
23392202|NCT04152200|65182737|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
23392203|NCT00855335|65182738|FG000|Overall Study|Lost to Follow-up|0|||
23392204|NCT00855335|65182739|FG001|Overall Study|Lost to Follow-up|0|||
23392205|NCT00855335|65182740|FG002|Overall Study|Lost to Follow-up|3|||
23392206|NCT00855335|65182741|FG003|Overall Study|Lost to Follow-up|1|||
23392207|NCT00855335|65182742|FG004|Overall Study|Lost to Follow-up|0|||
23392208|NCT00855335|65182738|FG000|Overall Study|Withdrawal by Subject|0|||
23392209|NCT00855335|65182739|FG001|Overall Study|Withdrawal by Subject|0|||
23392210|NCT00855335|65182740|FG002|Overall Study|Withdrawal by Subject|0|||
23392211|NCT00855335|65182741|FG003|Overall Study|Withdrawal by Subject|1|||
23392212|NCT00855335|65182742|FG004|Overall Study|Withdrawal by Subject|0|||
23392213|NCT00855335|65182738|FG000|Overall Study|Adverse Event|2|||
23392214|NCT00855335|65182739|FG001|Overall Study|Adverse Event|0|||
23392215|NCT00855335|65182740|FG002|Overall Study|Adverse Event|0|||
23392216|NCT00855335|65182741|FG003|Overall Study|Adverse Event|0|||
23392217|NCT00855335|65182742|FG004|Overall Study|Adverse Event|0|||
23392218|NCT00855335|65182738|FG000|Overall Study|Physician Decision|1|||
23392219|NCT00855335|65182739|FG001|Overall Study|Physician Decision|1|||
23392220|NCT00855335|65182740|FG002|Overall Study|Physician Decision|0|||
23392221|NCT00855335|65182741|FG003|Overall Study|Physician Decision|0|||
23392222|NCT00855335|65182742|FG004|Overall Study|Physician Decision|0|||
23392223|NCT00855335|65182738|FG000|Overall Study|Other|2|||
23392224|NCT00855335|65182739|FG001|Overall Study|Other|1|||
23392225|NCT00855335|65182740|FG002|Overall Study|Other|2|||
23392226|NCT00855335|65182741|FG003|Overall Study|Other|5|||
23392227|NCT00855335|65182742|FG004|Overall Study|Other|1|||
23392228|NCT03896581|65182743|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
23392229|NCT03896581|65182744|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
23392230|NCT03896581|65182743|FG000|Overall Study|Withdrawal by Subject|4|||
23392231|NCT03896581|65182744|FG001|Overall Study|Withdrawal by Subject|1|||
23392232|NCT03896581|65182743|FG000|Overall Study|Lost to Follow-up|1|||
23392233|NCT03896581|65182744|FG001|Overall Study|Lost to Follow-up|0|||
23392234|NCT03896581|65182743|FG000|Overall Study|Lack of Efficacy|2|||
23392235|NCT03896581|65182744|FG001|Overall Study|Lack of Efficacy|1|||
23392236|NCT03896581|65182743|FG000|Overall Study|Adverse event, non-fatal|0|||
23392237|NCT03896581|65182744|FG001|Overall Study|Adverse event, non-fatal|2|||
23392238|NCT03404960|65182745|FG000|Overall Study|Adverse Event|0|||
23392239|NCT03404960|65182746|FG001|Overall Study|Adverse Event|2|||
23392240|NCT03404960|65182745|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
23392241|NCT03404960|65182746|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
23392242|NCT03404960|65182745|FG000|Overall Study|Bowel obstruction|0|||
23392243|NCT03404960|65182746|FG001|Overall Study|Bowel obstruction|1|||
23392244|NCT03404960|65182745|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
23392245|NCT03404960|65182746|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
23392246|NCT02657343|65182747|FG000|Overall Study|Death|0|||
23392247|NCT02657343|65182748|FG001|Overall Study|Death|2|||
23392248|NCT02657343|65182749|FG002|Overall Study|Death|0|||
23392249|NCT02657343|65182750|FG003|Overall Study|Death|0|||
23392250|NCT02657343|65182751|FG004|Overall Study|Death|0|||
23392251|NCT02657343|65182752|FG005|Overall Study|Death|0|||
23392252|NCT02657343|65182747|FG000|Overall Study|Patient went to hospice|1|||
23392253|NCT02657343|65182748|FG001|Overall Study|Patient went to hospice|0|||
23392254|NCT02657343|65182749|FG002|Overall Study|Patient went to hospice|0|||
23392255|NCT02657343|65182750|FG003|Overall Study|Patient went to hospice|0|||
23392256|NCT02657343|65182751|FG004|Overall Study|Patient went to hospice|0|||
23392257|NCT02657343|65182752|FG005|Overall Study|Patient went to hospice|0|||
23392258|NCT02657343|65182747|FG000|Overall Study|Withdrawal by Subject|0|||
23392259|NCT02657343|65182748|FG001|Overall Study|Withdrawal by Subject|0|||
23392260|NCT02657343|65182749|FG002|Overall Study|Withdrawal by Subject|0|||
23392261|NCT02657343|65182750|FG003|Overall Study|Withdrawal by Subject|0|||
23496249|NCT02925117|65559010|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
23496250|NCT02925117|65559011|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
23496251|NCT02925117|65559012|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
23496252|NCT02925117|65559013|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
23392262|NCT02657343|65182751|FG004|Overall Study|Withdrawal by Subject|1|||
23392263|NCT02657343|65182752|FG005|Overall Study|Withdrawal by Subject|0|||
23392264|NCT01197300|65182762|FG000|Overall Study|Lost to Follow-up|0|||
23392265|NCT01197300|65182763|FG001|Overall Study|Lost to Follow-up|1|||
23392266|NCT01197300|65182762|FG000|Overall Study|Protocol Violation|0|||
23392267|NCT01197300|65182763|FG001|Overall Study|Protocol Violation|1|||
23392268|NCT02284893|65182766|FG000|26 Week (Short Term)|Adverse Event|1|||
23392269|NCT02284893|65182767|FG001|26 Week (Short Term)|Adverse Event|9|||
23392270|NCT02284893|65182766|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
23392271|NCT02284893|65182767|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
23392272|NCT02284893|65182766|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
23392273|NCT02284893|65182767|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
23392274|NCT02284893|65182766|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
23392275|NCT02284893|65182767|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
23392276|NCT02284893|65182766|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
23392277|NCT02284893|65182767|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
23392278|NCT02284893|65182766|FG000|26 Week (Short Term)|Other|1|||
23392279|NCT02284893|65182767|FG001|26 Week (Short Term)|Other|1|||
23392280|NCT02284893|65182766|FG000|52 Week (Long Term)|Adverse Event|3|||
23392281|NCT02284893|65182767|FG001|52 Week (Long Term)|Adverse Event|1|||
23392282|NCT02284893|65182766|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
23392283|NCT02284893|65182767|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
23392284|NCT02284893|65182766|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
23392285|NCT02284893|65182767|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
23392286|NCT02284893|65182766|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
23392287|NCT02284893|65182767|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
23392288|NCT02284893|65182766|FG000|52 Week (Long Term)|Non-Compliance|2|||
23392289|NCT02284893|65182767|FG001|52 Week (Long Term)|Non-Compliance|3|||
23392290|NCT03537508|65182768|FG000|Overall Study|Adverse Event|2|||
23392291|NCT03537508|65182769|FG001|Overall Study|Adverse Event|1|||
23392292|NCT03537508|65182768|FG000|Overall Study|Protocol Violation|65|||
23392293|NCT03537508|65182769|FG001|Overall Study|Protocol Violation|48|||
23392294|NCT03537508|65182768|FG000|Overall Study|Lost to Follow-up|86|||
23392295|NCT03537508|65182769|FG001|Overall Study|Lost to Follow-up|60|||
23392296|NCT03537508|65182768|FG000|Overall Study|Withdrawal by parent/guardian|263|||
23392297|NCT03537508|65182769|FG001|Overall Study|Withdrawal by parent/guardian|149|||
23392298|NCT02720094|65182774|FG000|Overall Study|Scheduled exit visit/end of study|2|||
23392299|NCT02720094|65182775|FG001|Overall Study|Scheduled exit visit/end of study|1|||
23392300|NCT02720094|65182774|FG000|Overall Study|Death|4|||
23392301|NCT02720094|65182775|FG001|Overall Study|Death|7|||
23392302|NCT02720094|65182774|FG000|Overall Study|Withdrawal by Subject|55|||
23392303|NCT02720094|65182775|FG001|Overall Study|Withdrawal by Subject|56|||
23392304|NCT02720094|65182774|FG000|Overall Study|Lost to Follow-up|2|||
23496253|NCT02925117|65559014|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
23496254|NCT02925117|65559015|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
23496255|NCT02925117|65559016|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
23496256|NCT02925117|65559017|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
23392305|NCT02720094|65182775|FG001|Overall Study|Lost to Follow-up|7|||
23392306|NCT02720094|65182774|FG000|Overall Study|Physician Decision|1|||
23392307|NCT02720094|65182775|FG001|Overall Study|Physician Decision|3|||
23392308|NCT02720094|65182774|FG000|Overall Study|Inappropriate enrollment|1|||
23392309|NCT02720094|65182775|FG001|Overall Study|Inappropriate enrollment|3|||
23392310|NCT02720094|65182774|FG000|Overall Study|Ongoing|2210|||
23392311|NCT02720094|65182775|FG001|Overall Study|Ongoing|2203|||
23392312|NCT02720094|65182774|FG000|Overall Study|Relocation|1|||
23392313|NCT02720094|65182775|FG001|Overall Study|Relocation|1|||
23392314|NCT02302222|65182776|FG000|Overall Study|Physician Decision|0|||
23392315|NCT02302222|65182777|FG001|Overall Study|Physician Decision|4|||
23496257|NCT02925117|65559018|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
23496258|NCT02925117|65559019|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
23496259|NCT03519178|65559026|FG000|PF-06873600 Treatment|Adverse Event|0|||
23496260|NCT03519178|65559027|FG001|PF-06873600 Treatment|Adverse Event|0|||
23496261|NCT03519178|65559028|FG002|PF-06873600 Treatment|Adverse Event|0|||
23496262|NCT03519178|65559029|FG003|PF-06873600 Treatment|Adverse Event|0|||
23496263|NCT03519178|65559030|FG004|PF-06873600 Treatment|Adverse Event|0|||
23392316|NCT02302222|65182776|FG000|Overall Study|Lost to Follow-up|1|||
23392317|NCT02302222|65182777|FG001|Overall Study|Lost to Follow-up|0|||
23392318|NCT02302222|65182776|FG000|Overall Study|Treatment discontinued before day 5|0|||
23392319|NCT02302222|65182777|FG001|Overall Study|Treatment discontinued before day 5|1|||
23496264|NCT03519178|65559031|FG005|PF-06873600 Treatment|Adverse Event|0|||
23392320|NCT02302222|65182776|FG000|Overall Study|Withdrawn prior to any treatment|0|||
23392321|NCT02302222|65182777|FG001|Overall Study|Withdrawn prior to any treatment|1|||
23392322|NCT04909801|65182778|FG000|Overall Study|Lack of Efficacy|2|||
23496265|NCT03519178|65559032|FG006|PF-06873600 Treatment|Adverse Event|0|||
23496266|NCT03519178|65559033|FG007|PF-06873600 Treatment|Adverse Event|2|||
23496267|NCT03519178|65559034|FG008|PF-06873600 Treatment|Adverse Event|1|||
23496268|NCT03519178|65559035|FG009|PF-06873600 Treatment|Adverse Event|0|||
23496269|NCT03519178|65559036|FG010|PF-06873600 Treatment|Adverse Event|0|||
23496270|NCT03519178|65559037|FG011|PF-06873600 Treatment|Adverse Event|0|||
23496271|NCT03519178|65559038|FG012|PF-06873600 Treatment|Adverse Event|1|||
23496272|NCT03519178|65559039|FG013|PF-06873600 Treatment|Adverse Event|3|||
23496273|NCT03519178|65559040|FG014|PF-06873600 Treatment|Adverse Event|2|||
23496274|NCT03519178|65559026|FG000|PF-06873600 Treatment|Death|0|||
23496275|NCT03519178|65559027|FG001|PF-06873600 Treatment|Death|0|||
23496276|NCT03519178|65559028|FG002|PF-06873600 Treatment|Death|0|||
23496277|NCT03519178|65559029|FG003|PF-06873600 Treatment|Death|0|||
23496278|NCT03519178|65559030|FG004|PF-06873600 Treatment|Death|0|||
23496279|NCT03519178|65559031|FG005|PF-06873600 Treatment|Death|0|||
23496280|NCT03519178|65559032|FG006|PF-06873600 Treatment|Death|0|||
23496281|NCT03519178|65559033|FG007|PF-06873600 Treatment|Death|0|||
23496282|NCT03519178|65559034|FG008|PF-06873600 Treatment|Death|1|||
23496283|NCT03519178|65559035|FG009|PF-06873600 Treatment|Death|1|||
23496284|NCT03519178|65559036|FG010|PF-06873600 Treatment|Death|0|||
23496285|NCT03519178|65559037|FG011|PF-06873600 Treatment|Death|0|||
23496286|NCT03519178|65559038|FG012|PF-06873600 Treatment|Death|0|||
23496287|NCT03519178|65559039|FG013|PF-06873600 Treatment|Death|0|||
23496288|NCT03519178|65559040|FG014|PF-06873600 Treatment|Death|1|||
23496289|NCT03519178|65559026|FG000|PF-06873600 Treatment|Physician Decision|0|||
23496290|NCT03519178|65559027|FG001|PF-06873600 Treatment|Physician Decision|0|||
23496291|NCT03519178|65559028|FG002|PF-06873600 Treatment|Physician Decision|0|||
23496292|NCT03519178|65559029|FG003|PF-06873600 Treatment|Physician Decision|0|||
23496293|NCT03519178|65559030|FG004|PF-06873600 Treatment|Physician Decision|0|||
23496294|NCT03519178|65559031|FG005|PF-06873600 Treatment|Physician Decision|0|||
23496295|NCT03519178|65559032|FG006|PF-06873600 Treatment|Physician Decision|0|||
23496296|NCT03519178|65559033|FG007|PF-06873600 Treatment|Physician Decision|1|||
23496297|NCT03519178|65559034|FG008|PF-06873600 Treatment|Physician Decision|0|||
23496298|NCT03519178|65559035|FG009|PF-06873600 Treatment|Physician Decision|0|||
23496299|NCT03519178|65559036|FG010|PF-06873600 Treatment|Physician Decision|1|||
23496300|NCT03519178|65559037|FG011|PF-06873600 Treatment|Physician Decision|0|||
23496301|NCT03519178|65559038|FG012|PF-06873600 Treatment|Physician Decision|0|||
23496302|NCT03519178|65559039|FG013|PF-06873600 Treatment|Physician Decision|4|||
23496303|NCT03519178|65559040|FG014|PF-06873600 Treatment|Physician Decision|1|||
23496304|NCT03519178|65559026|FG000|PF-06873600 Treatment|Progressive disease|1|||
23496305|NCT03519178|65559027|FG001|PF-06873600 Treatment|Progressive disease|1|||
23496306|NCT03519178|65559028|FG002|PF-06873600 Treatment|Progressive disease|1|||
23496307|NCT03519178|65559029|FG003|PF-06873600 Treatment|Progressive disease|1|||
23496308|NCT03519178|65559030|FG004|PF-06873600 Treatment|Progressive disease|6|||
23496309|NCT03519178|65559031|FG005|PF-06873600 Treatment|Progressive disease|7|||
23496310|NCT03519178|65559032|FG006|PF-06873600 Treatment|Progressive disease|3|||
23496311|NCT03519178|65559033|FG007|PF-06873600 Treatment|Progressive disease|7|||
23496312|NCT03519178|65559034|FG008|PF-06873600 Treatment|Progressive disease|3|||
23496313|NCT03519178|65559035|FG009|PF-06873600 Treatment|Progressive disease|5|||
23496314|NCT03519178|65559036|FG010|PF-06873600 Treatment|Progressive disease|4|||
23496315|NCT03519178|65559037|FG011|PF-06873600 Treatment|Progressive disease|3|||
23496316|NCT03519178|65559038|FG012|PF-06873600 Treatment|Progressive disease|4|||
23496317|NCT03519178|65559039|FG013|PF-06873600 Treatment|Progressive disease|28|||
23496318|NCT03519178|65559040|FG014|PF-06873600 Treatment|Progressive disease|7|||
23496319|NCT03519178|65559026|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496320|NCT03519178|65559027|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496321|NCT03519178|65559028|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
23496322|NCT03519178|65559029|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496323|NCT03519178|65559030|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
23496324|NCT03519178|65559031|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496325|NCT03519178|65559032|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496326|NCT03519178|65559033|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
23496327|NCT03519178|65559034|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
23496328|NCT03519178|65559035|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
23496329|NCT03519178|65559036|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
23496330|NCT03519178|65559037|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
23496331|NCT03519178|65559038|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
23496332|NCT03519178|65559039|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
23496333|NCT03519178|65559040|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
23496334|NCT03519178|65559026|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
23496335|NCT03519178|65559027|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
23496336|NCT03519178|65559028|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
23606267|NCT03019289|65947196|FG006|Overall Study|Adverse Event|0|||
23496337|NCT03519178|65559029|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
23496338|NCT03519178|65559030|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
23496339|NCT03519178|65559031|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
23496340|NCT03519178|65559032|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
23496341|NCT03519178|65559033|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
23496342|NCT03519178|65559034|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
23496343|NCT03519178|65559035|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
23496344|NCT03519178|65559036|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
23496345|NCT03519178|65559037|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
23496346|NCT03519178|65559038|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
23496347|NCT03519178|65559039|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
23496348|NCT03519178|65559040|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
23496349|NCT03519178|65559026|FG000|PF-06873600 Treatment|Refused further treatment|0|||
23496350|NCT03519178|65559027|FG001|PF-06873600 Treatment|Refused further treatment|1|||
23496351|NCT03519178|65559028|FG002|PF-06873600 Treatment|Refused further treatment|0|||
23496352|NCT03519178|65559029|FG003|PF-06873600 Treatment|Refused further treatment|0|||
23496353|NCT03519178|65559030|FG004|PF-06873600 Treatment|Refused further treatment|1|||
23496354|NCT03519178|65559031|FG005|PF-06873600 Treatment|Refused further treatment|0|||
23496355|NCT03519178|65559032|FG006|PF-06873600 Treatment|Refused further treatment|0|||
23496356|NCT03519178|65559033|FG007|PF-06873600 Treatment|Refused further treatment|0|||
23496357|NCT03519178|65559034|FG008|PF-06873600 Treatment|Refused further treatment|0|||
23496358|NCT03519178|65559035|FG009|PF-06873600 Treatment|Refused further treatment|0|||
23496359|NCT03519178|65559036|FG010|PF-06873600 Treatment|Refused further treatment|0|||
23496360|NCT03519178|65559037|FG011|PF-06873600 Treatment|Refused further treatment|0|||
23496361|NCT03519178|65559038|FG012|PF-06873600 Treatment|Refused further treatment|0|||
23496362|NCT03519178|65559039|FG013|PF-06873600 Treatment|Refused further treatment|0|||
23496363|NCT03519178|65559040|FG014|PF-06873600 Treatment|Refused further treatment|1|||
23496364|NCT03519178|65559026|FG000|PF-06873600 Treatment|Other|0|||
23496365|NCT03519178|65559027|FG001|PF-06873600 Treatment|Other|0|||
23496366|NCT03519178|65559028|FG002|PF-06873600 Treatment|Other|0|||
23496367|NCT03519178|65559029|FG003|PF-06873600 Treatment|Other|0|||
23496368|NCT03519178|65559030|FG004|PF-06873600 Treatment|Other|0|||
23496369|NCT03519178|65559031|FG005|PF-06873600 Treatment|Other|0|||
23496370|NCT03519178|65559032|FG006|PF-06873600 Treatment|Other|0|||
23496371|NCT03519178|65559033|FG007|PF-06873600 Treatment|Other|0|||
23496372|NCT03519178|65559034|FG008|PF-06873600 Treatment|Other|1|||
23496373|NCT03519178|65559035|FG009|PF-06873600 Treatment|Other|0|||
23496374|NCT03519178|65559036|FG010|PF-06873600 Treatment|Other|0|||
23496375|NCT03519178|65559037|FG011|PF-06873600 Treatment|Other|0|||
23496376|NCT03519178|65559038|FG012|PF-06873600 Treatment|Other|0|||
23496377|NCT03519178|65559039|FG013|PF-06873600 Treatment|Other|1|||
23496378|NCT03519178|65559040|FG014|PF-06873600 Treatment|Other|3|||
23496379|NCT03519178|65559026|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
23496380|NCT03519178|65559027|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
23496381|NCT03519178|65559028|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
23496382|NCT03519178|65559029|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
23496383|NCT03519178|65559030|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
23496384|NCT03519178|65559031|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
23496385|NCT03519178|65559032|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
23496386|NCT03519178|65559033|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
23496387|NCT03519178|65559034|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
23496388|NCT03519178|65559035|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
23496389|NCT03519178|65559036|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
23392323|NCT04909801|65182779|FG001|Overall Study|Lack of Efficacy|1|||
23392324|NCT04909801|65182778|FG000|Overall Study|Adverse Event|1|||
23392325|NCT04909801|65182779|FG001|Overall Study|Adverse Event|2|||
23392326|NCT04909801|65182778|FG000|Overall Study|Participant request to discontinue study treatment|1|||
23392327|NCT04909801|65182779|FG001|Overall Study|Participant request to discontinue study treatment|2|||
23392328|NCT04909801|65182778|FG000|Overall Study|Withdrawal by Subject|2|||
23392329|NCT04909801|65182779|FG001|Overall Study|Withdrawal by Subject|1|||
23392330|NCT04909801|65182778|FG000|Overall Study|other reasons|1|||
23496390|NCT03519178|65559037|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
23496391|NCT03519178|65559038|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
23496392|NCT03519178|65559039|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
23496393|NCT03519178|65559040|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
23496394|NCT03519178|65559026|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496395|NCT03519178|65559027|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496396|NCT03519178|65559028|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496397|NCT03519178|65559029|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
23392331|NCT04909801|65182779|FG001|Overall Study|other reasons|1|||
23496398|NCT03519178|65559030|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496399|NCT03519178|65559031|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496400|NCT03519178|65559032|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496401|NCT03519178|65559033|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496402|NCT03519178|65559034|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496403|NCT03519178|65559035|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496404|NCT03519178|65559036|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
23392332|NCT04918771|65182781|FG000|Overall Study|Withdrawal by Subject|4|||
23392333|NCT04918771|65182782|FG001|Overall Study|Withdrawal by Subject|5|||
23392334|NCT04918771|65182781|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
23392335|NCT04918771|65182782|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
23392336|NCT04893811|65182783|FG000|Vaccination Phase|Death|1|||
23392337|NCT04893811|65182784|FG001|Vaccination Phase|Death|0|||
23392338|NCT04893811|65182783|FG000|Vaccination Phase|Lost to Follow-up|1|||
23392339|NCT04893811|65182784|FG001|Vaccination Phase|Lost to Follow-up|1|||
23392340|NCT04893811|65182783|FG000|Vaccination Phase|Protocol Violation|2|||
23392341|NCT04893811|65182784|FG001|Vaccination Phase|Protocol Violation|0|||
23392342|NCT04893811|65182783|FG000|Vaccination Phase|Withdrawal by Subject|2|||
23392343|NCT04893811|65182784|FG001|Vaccination Phase|Withdrawal by Subject|1|||
23392344|NCT04893811|65182783|FG000|Vaccination Phase|Other|0|||
23392345|NCT04893811|65182784|FG001|Vaccination Phase|Other|1|||
23392346|NCT04893811|65182783|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
23392347|NCT04893811|65182784|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
23392348|NCT04893811|65182783|FG000|Follow-up Phase|Lost to Follow-up|0|||
23392349|NCT04893811|65182784|FG001|Follow-up Phase|Lost to Follow-up|1|||
23392350|NCT03374254|65182785|FG000|Overall Study|Death|5|||
23392351|NCT03374254|65182786|FG001|Overall Study|Death|16|||
23392352|NCT03374254|65182787|FG002|Overall Study|Death|13|||
23392353|NCT03374254|65182788|FG003|Overall Study|Death|11|||
23392354|NCT03374254|65182789|FG004|Overall Study|Death|9|||
23392355|NCT03374254|65182790|FG005|Overall Study|Death|12|||
23392356|NCT03374254|65182791|FG006|Overall Study|Death|11|||
23392357|NCT03374254|65182792|FG007|Overall Study|Death|6|||
23392358|NCT03374254|65182793|FG008|Overall Study|Death|7|||
23392359|NCT03374254|65182785|FG000|Overall Study|Lost to Follow-up|0|||
23392360|NCT03374254|65182786|FG001|Overall Study|Lost to Follow-up|0|||
23392361|NCT03374254|65182787|FG002|Overall Study|Lost to Follow-up|0|||
23392362|NCT03374254|65182788|FG003|Overall Study|Lost to Follow-up|0|||
23392363|NCT03374254|65182789|FG004|Overall Study|Lost to Follow-up|0|||
23392364|NCT03374254|65182790|FG005|Overall Study|Lost to Follow-up|0|||
23392365|NCT03374254|65182791|FG006|Overall Study|Lost to Follow-up|2|||
23392366|NCT03374254|65182792|FG007|Overall Study|Lost to Follow-up|0|||
23392367|NCT03374254|65182793|FG008|Overall Study|Lost to Follow-up|0|||
23392368|NCT03374254|65182785|FG000|Overall Study|Sponsor Decision|1|||
23392369|NCT03374254|65182786|FG001|Overall Study|Sponsor Decision|0|||
23392370|NCT03374254|65182787|FG002|Overall Study|Sponsor Decision|2|||
23392371|NCT03374254|65182788|FG003|Overall Study|Sponsor Decision|3|||
23496405|NCT03519178|65559037|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496406|NCT03519178|65559038|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
23496407|NCT03519178|65559039|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
23496408|NCT03519178|65559040|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
23496409|NCT03519178|65559026|FG000|PF-06873600 Treatment|Ongoing|0|||
23496410|NCT03519178|65559027|FG001|PF-06873600 Treatment|Ongoing|0|||
23496411|NCT03519178|65559028|FG002|PF-06873600 Treatment|Ongoing|0|||
23392372|NCT03374254|65182789|FG004|Overall Study|Sponsor Decision|2|||
23392373|NCT03374254|65182790|FG005|Overall Study|Sponsor Decision|3|||
23392374|NCT03374254|65182791|FG006|Overall Study|Sponsor Decision|3|||
23392375|NCT03374254|65182792|FG007|Overall Study|Sponsor Decision|3|||
23392376|NCT03374254|65182793|FG008|Overall Study|Sponsor Decision|4|||
23392377|NCT03374254|65182785|FG000|Overall Study|Withdrawal by Subject|0|||
23392378|NCT03374254|65182786|FG001|Overall Study|Withdrawal by Subject|0|||
23392379|NCT03374254|65182787|FG002|Overall Study|Withdrawal by Subject|0|||
23392380|NCT03374254|65182788|FG003|Overall Study|Withdrawal by Subject|2|||
23392381|NCT03374254|65182789|FG004|Overall Study|Withdrawal by Subject|0|||
23392382|NCT03374254|65182790|FG005|Overall Study|Withdrawal by Subject|1|||
23392383|NCT03374254|65182791|FG006|Overall Study|Withdrawal by Subject|0|||
23392384|NCT03374254|65182792|FG007|Overall Study|Withdrawal by Subject|0|||
23392385|NCT03374254|65182793|FG008|Overall Study|Withdrawal by Subject|0|||
23392386|NCT05852340|65182795|FG000|Period 5|Not completing the meal|0|||
23392387|NCT05852340|65182796|FG001|Period 5|Not completing the meal|1|||
23392388|NCT05852340|65182797|FG002|Period 5|Not completing the meal|0|||
23392389|NCT05852340|65182798|FG003|Period 5|Not completing the meal|0|||
23392390|NCT05852340|65182795|FG000|Period 5|Adverse Event|0|||
23392391|NCT05852340|65182796|FG001|Period 5|Adverse Event|0|||
23496412|NCT03519178|65559029|FG003|PF-06873600 Treatment|Ongoing|0|||
23392392|NCT05852340|65182797|FG002|Period 5|Adverse Event|0|||
23392393|NCT05852340|65182798|FG003|Period 5|Adverse Event|1|||
23392394|NCT00605189|65182799|FG000|Overall Study|Adverse Event|1|||
23392395|NCT00605189|65182800|FG001|Overall Study|Adverse Event|0|||
23392396|NCT00605189|65182801|FG002|Overall Study|Adverse Event|0|||
23392397|NCT00605189|65182799|FG000|Overall Study|Other|2|||
23392398|NCT00605189|65182800|FG001|Overall Study|Other|2|||
23392399|NCT00605189|65182801|FG002|Overall Study|Other|0|||
23392400|NCT01698905|65182802|FG000|Overall Study|Adverse Event|4|||
23392401|NCT01698905|65182802|FG000|Overall Study|Physician Decision|2|||
23392402|NCT01698905|65182802|FG000|Overall Study|Pregnancy|1|||
23392403|NCT01698905|65182802|FG000|Overall Study|Protocol Violation|1|||
23392404|NCT01698905|65182802|FG000|Overall Study|Subject/guardian decision|2|||
23392405|NCT01698905|65182802|FG000|Overall Study|Death|1|||
23392406|NCT04770285|65184678|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
23392407|NCT04770285|65184679|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
23392408|NCT04770285|65184678|FG000|Overall Study|Lack of Efficacy|0|||
23392409|NCT04770285|65184679|FG001|Overall Study|Lack of Efficacy|1|||
23392410|NCT04770285|65184678|FG000|Overall Study|Lost to Follow-up|11|||
23392411|NCT04770285|65184679|FG001|Overall Study|Lost to Follow-up|8|||
23392412|NCT04770285|65184678|FG000|Overall Study|Protocol Deviation|6|||
23392413|NCT04770285|65184679|FG001|Overall Study|Protocol Deviation|6|||
23392414|NCT04770285|65184678|FG000|Overall Study|Technical Problem|0|||
23392415|NCT04770285|65184679|FG001|Overall Study|Technical Problem|1|||
23392416|NCT04770285|65184678|FG000|Overall Study|Withdrawal by Subject|9|||
23392417|NCT04770285|65184679|FG001|Overall Study|Withdrawal by Subject|8|||
23392418|NCT04770285|65184678|FG000|Overall Study|Reason Not Specified|0|||
23392419|NCT04770285|65184679|FG001|Overall Study|Reason Not Specified|1|||
23392420|NCT02960893|65184682|FG000|Randomization Phase (8-week)|Adverse Event|5|||
23392421|NCT02960893|65184683|FG001|Randomization Phase (8-week)|Adverse Event|0|||
23392422|NCT02960893|65184682|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
23392423|NCT02960893|65184683|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
23392424|NCT02960893|65184682|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
23392425|NCT02960893|65184683|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
23392426|NCT02960893|65184682|FG000|Extension Phase (48-week)|Adverse Event|2|||
23392427|NCT02960893|65184683|FG001|Extension Phase (48-week)|Adverse Event|3|||
23392428|NCT02960893|65184682|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
23392429|NCT02960893|65184683|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
23392430|NCT02960893|65184682|FG000|Extension Phase (48-week)|Other Reason|2|||
23392431|NCT02960893|65184683|FG001|Extension Phase (48-week)|Other Reason|1|||
23392432|NCT02960893|65184682|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
23392433|NCT02960893|65184683|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
23392434|NCT02960893|65184682|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
23392435|NCT02960893|65184683|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
23392436|NCT05130281|65184688|FG000|Overall Study|Withdrawal by Subject|0|||
23392437|NCT05130281|65184689|FG001|Overall Study|Withdrawal by Subject|0|||
23392438|NCT05130281|65184690|FG002|Overall Study|Withdrawal by Subject|1|||
23392439|NCT04487080|65184691|FG000|Overall Study|Withdrawal by Subject|19|||
23392440|NCT04487080|65184692|FG001|Overall Study|Withdrawal by Subject|18|||
23392441|NCT04487080|65184693|FG002|Overall Study|Withdrawal by Subject|13|||
23392442|NCT04487080|65184691|FG000|Overall Study|Lost to Follow-up|3|||
23392443|NCT04487080|65184692|FG001|Overall Study|Lost to Follow-up|1|||
23392444|NCT04487080|65184693|FG002|Overall Study|Lost to Follow-up|0|||
23392445|NCT04487080|65184691|FG000|Overall Study|Ongoing|313|||
23392446|NCT04487080|65184692|FG001|Overall Study|Ongoing|297|||
23392447|NCT04487080|65184693|FG002|Overall Study|Ongoing|149|||
23392448|NCT03738228|65184694|FG000|Overall Study|Never received study treatment|2|||
23392449|NCT03738228|65184695|FG001|Overall Study|Never received study treatment|2|||
23392450|NCT02592863|65184698|FG000|Overall Study|Withdrawal by Subject|2|||
23392451|NCT02592863|65184699|FG001|Overall Study|Withdrawal by Subject|2|||
23392452|NCT02592863|65184698|FG000|Overall Study|Lost to Follow-up|1|||
23392453|NCT02592863|65184699|FG001|Overall Study|Lost to Follow-up|1|||
23392454|NCT02097225|65184700|FG000|Dose Level 4|Adverse Event|0|||
23392455|NCT02097225|65184701|FG001|Dose Level 4|Adverse Event|0|||
23392456|NCT02097225|65184702|FG002|Dose Level 4|Adverse Event|0|||
23392457|NCT02097225|65184703|FG003|Dose Level 4|Adverse Event|0|||
23392458|NCT02097225|65184704|FG004|Dose Level 4|Adverse Event|1|||
23392459|NCT05602727|65184705|FG000|Overall Study|Physician Decision|0|||
23496413|NCT03519178|65559030|FG004|PF-06873600 Treatment|Ongoing|0|||
23392460|NCT05602727|65184706|FG001|Overall Study|Physician Decision|1|||
23392461|NCT05602727|65184707|FG002|Overall Study|Physician Decision|0|||
23392462|NCT05602727|65184705|FG000|Overall Study|Randomized by mistake without study medication|1|||
23392463|NCT05602727|65184706|FG001|Overall Study|Randomized by mistake without study medication|0|||
23392464|NCT05602727|65184707|FG002|Overall Study|Randomized by mistake without study medication|0|||
23392465|NCT05602727|65184705|FG000|Overall Study|Study termination by Sponsor|18|||
23392466|NCT05602727|65184706|FG001|Overall Study|Study termination by Sponsor|15|||
23392467|NCT05602727|65184707|FG002|Overall Study|Study termination by Sponsor|19|||
23392468|NCT05602727|65184705|FG000|Overall Study|Withdrawal by Subject|2|||
23392469|NCT05602727|65184706|FG001|Overall Study|Withdrawal by Subject|1|||
23392470|NCT05602727|65184707|FG002|Overall Study|Withdrawal by Subject|1|||
23392471|NCT05602727|65184705|FG000|Overall Study|Various reasons|1|||
23392472|NCT05602727|65184706|FG001|Overall Study|Various reasons|6|||
23392473|NCT05602727|65184707|FG002|Overall Study|Various reasons|1|||
23392478|NCT05837481|65184710|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
23392479|NCT05837481|65184711|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
23392480|NCT03228537|65184712|FG000|Neoadjuvant|Adverse Event|2|||
23392481|NCT03228537|65184712|FG000|Neoadjuvant|Progression/Relapse|4|||
23392482|NCT03228537|65184712|FG000|Neoadjuvant|Death|1|||
23392483|NCT03228537|65184712|FG000|Surgery|Death|1|||
23392484|NCT03228537|65184712|FG000|Surgery|Other - Not Protocol Specified|2|||
23392485|NCT03228537|65184712|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
23392486|NCT03228537|65184712|FG000|Maintenance|Progression/Relapse|10|||
23392487|NCT04134936|65184716|FG000|Overall Study|Adverse Event|3|||
23392488|NCT04134936|65184717|FG001|Overall Study|Adverse Event|2|||
23392489|NCT04134936|65184716|FG000|Overall Study|Withdrawal by Subject|2|||
23392490|NCT04134936|65184717|FG001|Overall Study|Withdrawal by Subject|3|||
23392491|NCT04134936|65184716|FG000|Overall Study|Physician Decision|0|||
23392492|NCT04134936|65184717|FG001|Overall Study|Physician Decision|1|||
23392493|NCT04134936|65184716|FG000|Overall Study|Progressive disease, joined another trial|1|||
23392494|NCT04134936|65184717|FG001|Overall Study|Progressive disease, joined another trial|0|||
23392495|NCT04134936|65184716|FG000|Overall Study|Progressive disease|1|||
23392496|NCT04134936|65184717|FG001|Overall Study|Progressive disease|0|||
23392497|NCT01065454|65184718|FG000|Treatment|Adverse Event|7|||
23392498|NCT01065454|65184719|FG001|Treatment|Adverse Event|4|||
23392499|NCT01065454|65184720|FG002|Treatment|Adverse Event|3|||
23392500|NCT01065454|65184721|FG003|Treatment|Adverse Event|6|||
23392501|NCT01065454|65184718|FG000|Treatment|Death|1|||
23392502|NCT01065454|65184719|FG001|Treatment|Death|0|||
23392503|NCT01065454|65184720|FG002|Treatment|Death|0|||
23392504|NCT01065454|65184721|FG003|Treatment|Death|0|||
23392505|NCT01065454|65184718|FG000|Treatment|Non-compliance|1|||
23392506|NCT01065454|65184719|FG001|Treatment|Non-compliance|0|||
23392507|NCT01065454|65184720|FG002|Treatment|Non-compliance|0|||
23392508|NCT01065454|65184721|FG003|Treatment|Non-compliance|1|||
23392509|NCT01065454|65184718|FG000|Treatment|Protocol Decision|0|||
23392510|NCT01065454|65184719|FG001|Treatment|Protocol Decision|0|||
23392511|NCT01065454|65184720|FG002|Treatment|Protocol Decision|3|||
23392512|NCT01065454|65184721|FG003|Treatment|Protocol Decision|2|||
23392513|NCT01065454|65184718|FG000|Treatment|Protocol Violation|1|||
23392514|NCT01065454|65184719|FG001|Treatment|Protocol Violation|0|||
23392515|NCT01065454|65184720|FG002|Treatment|Protocol Violation|1|||
23392516|NCT01065454|65184721|FG003|Treatment|Protocol Violation|0|||
23392517|NCT01065454|65184718|FG000|Treatment|Withdrawal by Subject|3|||
23392518|NCT01065454|65184719|FG001|Treatment|Withdrawal by Subject|1|||
23392519|NCT01065454|65184720|FG002|Treatment|Withdrawal by Subject|2|||
23392520|NCT01065454|65184721|FG003|Treatment|Withdrawal by Subject|3|||
23392521|NCT01065454|65184718|FG000|Follow up|Adverse Event|1|||
23392522|NCT01065454|65184719|FG001|Follow up|Adverse Event|0|||
23392523|NCT01065454|65184720|FG002|Follow up|Adverse Event|0|||
23392524|NCT01065454|65184721|FG003|Follow up|Adverse Event|1|||
23392525|NCT01065454|65184718|FG000|Follow up|Death|0|||
23392526|NCT01065454|65184719|FG001|Follow up|Death|1|||
23392527|NCT01065454|65184720|FG002|Follow up|Death|1|||
23392528|NCT01065454|65184721|FG003|Follow up|Death|0|||
23392529|NCT01065454|65184718|FG000|Follow up|Lost to Follow-up|0|||
23392530|NCT01065454|65184719|FG001|Follow up|Lost to Follow-up|0|||
23392531|NCT01065454|65184720|FG002|Follow up|Lost to Follow-up|0|||
23392532|NCT01065454|65184721|FG003|Follow up|Lost to Follow-up|1|||
23392533|NCT01065454|65184718|FG000|Follow up|Progressive disease|0|||
23392534|NCT01065454|65184719|FG001|Follow up|Progressive disease|0|||
23392535|NCT01065454|65184720|FG002|Follow up|Progressive disease|0|||
23392536|NCT01065454|65184721|FG003|Follow up|Progressive disease|1|||
23392537|NCT01065454|65184718|FG000|Follow up|Withdrawal by Subject|1|||
23392538|NCT01065454|65184719|FG001|Follow up|Withdrawal by Subject|1|||
23392539|NCT01065454|65184720|FG002|Follow up|Withdrawal by Subject|1|||
23496414|NCT03519178|65559031|FG005|PF-06873600 Treatment|Ongoing|0|||
23392540|NCT01065454|65184721|FG003|Follow up|Withdrawal by Subject|0|||
23392541|NCT01065454|65184718|FG000|Follow up|study ongoing|37|||
23392542|NCT01065454|65184719|FG001|Follow up|study ongoing|22|||
23392543|NCT01065454|65184720|FG002|Follow up|study ongoing|15|||
23496415|NCT03519178|65559032|FG006|PF-06873600 Treatment|Ongoing|0|||
23496416|NCT03519178|65559033|FG007|PF-06873600 Treatment|Ongoing|0|||
23496417|NCT03519178|65559034|FG008|PF-06873600 Treatment|Ongoing|0|||
23496418|NCT03519178|65559035|FG009|PF-06873600 Treatment|Ongoing|0|||
23496419|NCT03519178|65559036|FG010|PF-06873600 Treatment|Ongoing|0|||
23392544|NCT01065454|65184721|FG003|Follow up|study ongoing|41|||
23392545|NCT04116489|65184722|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
23392546|NCT04116489|65184722|FG000|Overall Study|Withdrawal by Subject|1|||
23392547|NCT04197583|65184724|FG000|Overall Study|Study Stent Replacement|34|||
23392548|NCT04197583|65184725|FG001|Overall Study|Study Stent Replacement|8|||
23392549|NCT04197583|65184724|FG000|Overall Study|Lost to Follow-up|14|||
23392550|NCT04197583|65184725|FG001|Overall Study|Lost to Follow-up|3|||
23392551|NCT04197583|65184724|FG000|Overall Study|Death|3|||
23392552|NCT04197583|65184725|FG001|Overall Study|Death|0|||
23392553|NCT04197583|65184724|FG000|Overall Study|Physician Decision|1|||
23392554|NCT04197583|65184725|FG001|Overall Study|Physician Decision|0|||
23392555|NCT04197583|65184724|FG000|Overall Study|Withdrawal by Subject|1|||
23392556|NCT04197583|65184725|FG001|Overall Study|Withdrawal by Subject|1|||
23392557|NCT04197583|65184724|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
23392558|NCT04197583|65184725|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
23392559|NCT04197583|65184724|FG000|Overall Study|Screen Failure|0|||
23392560|NCT04197583|65184725|FG001|Overall Study|Screen Failure|20|||
23392561|NCT01587196|65184726|FG000|Overall Study|Lost to Follow-up|50|||
23392562|NCT01587196|65184726|FG000|Overall Study|Withdrawal by Subject|4|||
23392563|NCT01380080|65184729|FG000|Overall Study|Death|36|||
23392564|NCT01380080|65184730|FG001|Overall Study|Death|44|||
23392565|NCT01380080|65184729|FG000|Overall Study|Site is closing|28|||
23392566|NCT01380080|65184730|FG001|Overall Study|Site is closing|31|||
23392567|NCT01380080|65184729|FG000|Overall Study|Not able to get to clinic|7|||
23392568|NCT01380080|65184730|FG001|Overall Study|Not able to get to clinic|1|||
23392569|NCT01380080|65184729|FG000|Overall Study|Not willing to adhere to requirements|6|||
23392570|NCT01380080|65184730|FG001|Overall Study|Not willing to adhere to requirements|2|||
23392571|NCT01380080|65184729|FG000|Overall Study|Withdrawal by Subject|5|||
23392572|NCT01380080|65184730|FG001|Overall Study|Withdrawal by Subject|2|||
23496420|NCT03519178|65559037|FG011|PF-06873600 Treatment|Ongoing|0|||
23496421|NCT03519178|65559038|FG012|PF-06873600 Treatment|Ongoing|0|||
23496422|NCT03519178|65559039|FG013|PF-06873600 Treatment|Ongoing|1|||
23496423|NCT03519178|65559040|FG014|PF-06873600 Treatment|Ongoing|6|||
23496424|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496425|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496426|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496427|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496428|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496429|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496430|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496431|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496432|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496433|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496434|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496435|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496436|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496437|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
23496438|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
23496439|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Death|0|||
23496440|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Death|0|||
23496441|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Death|0|||
23496442|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Death|0|||
23496443|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Death|0|||
23392573|NCT01380080|65184729|FG000|Overall Study|Lost to Follow-up|3|||
23392574|NCT01380080|65184730|FG001|Overall Study|Lost to Follow-up|3|||
23392575|NCT04144517|65184734|FG000|Overall Study|Physician Decision|0|||
23392576|NCT04144517|65184735|FG001|Overall Study|Physician Decision|1|||
23392577|NCT04144517|65184734|FG000|Overall Study|Other|2|||
23392578|NCT04144517|65184735|FG001|Overall Study|Other|2|||
23496444|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Death|0|||
23496445|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Death|0|||
23496446|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Death|0|||
23496447|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Death|0|||
23496448|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Death|1|||
23392579|NCT04144517|65184734|FG000|Overall Study|Death|6|||
23392580|NCT04144517|65184735|FG001|Overall Study|Death|3|||
23392581|NCT02763566|65184738|FG000|Overall Study|Lost to Follow-up|1|||
23392582|NCT02763566|65184739|FG001|Overall Study|Lost to Follow-up|4|||
23392583|NCT02763566|65184740|FG002|Overall Study|Lost to Follow-up|0|||
23392584|NCT02763566|65184741|FG003|Overall Study|Lost to Follow-up|1|||
23392585|NCT02763566|65184738|FG000|Overall Study|On study treatment at study conclusion|114|||
23392586|NCT02763566|65184739|FG001|Overall Study|On study treatment at study conclusion|34|||
23392587|NCT02763566|65184740|FG002|Overall Study|On study treatment at study conclusion|54|||
23392588|NCT02763566|65184741|FG003|Overall Study|On study treatment at study conclusion|13|||
23392589|NCT02763566|65184738|FG000|Overall Study|Withdrawal by Subject|3|||
23392590|NCT02763566|65184739|FG001|Overall Study|Withdrawal by Subject|1|||
23392591|NCT02763566|65184740|FG002|Overall Study|Withdrawal by Subject|0|||
23392592|NCT02763566|65184741|FG003|Overall Study|Withdrawal by Subject|0|||
23392593|NCT02879695|65184750|FG000|Overall Study|Did not start study treatment|2|||
23392594|NCT02879695|65184751|FG001|Overall Study|Did not start study treatment|0|||
23392595|NCT02879695|65184752|FG002|Overall Study|Did not start study treatment|3|||
23392596|NCT02879695|65184753|FG003|Overall Study|Did not start study treatment|0|||
23392597|NCT00847730|65184754|FG000|Overall Study|Multiple interruptions in therapy|8|||
23392598|NCT02420314|65184757|FG000|Overall Study|Withdrawal by Subject|1|||
23392599|NCT02420314|65184757|FG000|Overall Study|Protocol Violation|1|||
23392600|NCT03913130|65184758|FG000|Overall Study|Sponsor Decision|1|||
23392601|NCT03952559|65184763|FG000|Double Blind Treatment Period|Adverse Event|0|||
23392602|NCT03952559|65184764|FG001|Double Blind Treatment Period|Adverse Event|2|||
23392603|NCT03952559|65184765|FG002|Double Blind Treatment Period|Adverse Event|1|||
23392604|NCT03952559|65184766|FG003|Double Blind Treatment Period|Adverse Event|0|||
23392605|NCT03952559|65184767|FG004|Double Blind Treatment Period|Adverse Event|1|||
23392606|NCT03952559|65184763|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
23392607|NCT03952559|65184764|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
23392608|NCT03952559|65184765|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
23392609|NCT03952559|65184766|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
23392610|NCT03952559|65184767|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
23392611|NCT03952559|65184763|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
23392612|NCT03952559|65184764|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
23392613|NCT03952559|65184765|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
23392614|NCT03952559|65184766|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
23392615|NCT03952559|65184767|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
23392616|NCT03952559|65184763|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
23392617|NCT03952559|65184764|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
23392618|NCT03952559|65184765|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
23392619|NCT03952559|65184766|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
23392620|NCT03952559|65184767|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
23392621|NCT04347538|65184768|FG000|Overall Study|Lost to Follow-up|4|||
23392622|NCT04347538|65184769|FG001|Overall Study|Lost to Follow-up|5|||
23392623|NCT04347538|65184770|FG002|Overall Study|Lost to Follow-up|7|||
23392624|NCT02367040|65184771|FG000|Overall Study|Lost to Follow-up|1|||
23392625|NCT02367040|65184772|FG001|Overall Study|Lost to Follow-up|1|||
23392626|NCT02367040|65184771|FG000|Overall Study|Lack of Efficacy|1|||
23392627|NCT02367040|65184772|FG001|Overall Study|Lack of Efficacy|0|||
23392628|NCT02367040|65184771|FG000|Overall Study|Additional primary malignancy|0|||
23392629|NCT02367040|65184772|FG001|Overall Study|Additional primary malignancy|1|||
23392630|NCT02367040|65184771|FG000|Overall Study|AE not associated with clinical disease progression|114|||
23392631|NCT02367040|65184772|FG001|Overall Study|AE not associated with clinical disease progression|11|||
23392632|NCT02367040|65184771|FG000|Overall Study|AE associated with clinical disease progression|1|||
23392633|NCT02367040|65184772|FG001|Overall Study|AE associated with clinical disease progression|3|||
23392634|NCT02367040|65184771|FG000|Overall Study|Physician Decision|2|||
23392635|NCT02367040|65184772|FG001|Overall Study|Physician Decision|8|||
23392636|NCT02367040|65184771|FG000|Overall Study|Non-compliance with study drug|1|||
23392637|NCT02367040|65184772|FG001|Overall Study|Non-compliance with study drug|0|||
23392638|NCT02367040|65184771|FG000|Overall Study|Failure to meet continuation criteria|1|||
23392639|NCT02367040|65184772|FG001|Overall Study|Failure to meet continuation criteria|0|||
23392640|NCT02367040|65184771|FG000|Overall Study|Switching to other therapy|2|||
23392641|NCT02367040|65184772|FG001|Overall Study|Switching to other therapy|0|||
23392642|NCT02367040|65184771|FG000|Overall Study|Withdrawal by Subject|46|||
23392643|NCT02367040|65184772|FG001|Overall Study|Withdrawal by Subject|16|||
23392644|NCT02367040|65184771|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
23392645|NCT02367040|65184772|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
23392646|NCT02367040|65184771|FG000|Overall Study|Patient decision|39|||
23392647|NCT02367040|65184772|FG001|Overall Study|Patient decision|14|||
23392648|NCT02367040|65184771|FG000|Overall Study|Required procedure failed|1|||
23392649|NCT02367040|65184772|FG001|Overall Study|Required procedure failed|0|||
23300363|NCT01360866|64842783|FG000|Overall Study|Adverse Event|56|||
23300364|NCT01360866|64842784|FG001|Overall Study|Adverse Event|61|||
23392650|NCT02367040|65184771|FG000|Overall Study|Randomized by mistake with study treatment|1|||
23392651|NCT02367040|65184772|FG001|Overall Study|Randomized by mistake with study treatment|0|||
23392652|NCT02367040|65184771|FG000|Overall Study|Protocol Violation|1|||
23392653|NCT02367040|65184772|FG001|Overall Study|Protocol Violation|0|||
23392654|NCT02367040|65184771|FG000|Overall Study|Progressive disease - radiological progression|51|||
23392655|NCT02367040|65184772|FG001|Overall Study|Progressive disease - radiological progression|78|||
23496449|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Death|0|||
23496450|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Death|0|||
23496451|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Death|0|||
23496452|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Death|0|||
23496453|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Death|1|||
23496454|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496455|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496456|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496457|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496458|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496459|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496460|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496461|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496462|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496463|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496464|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496465|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496466|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496467|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
23496468|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
23496469|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496470|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496471|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496472|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496473|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496474|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496475|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23392656|NCT02367040|65184771|FG000|Overall Study|Progressive disease - clinical progression|6|||
23392657|NCT02367040|65184772|FG001|Overall Study|Progressive disease - clinical progression|6|||
23392658|NCT02367040|65184771|FG000|Overall Study|Drug not administered|3|||
23496476|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23606268|NCT03019289|65947197|FG007|Overall Study|Adverse Event|0|||
23606269|NCT03019289|65947198|FG008|Overall Study|Adverse Event|1|||
23606270|NCT03019289|65947190|FG000|Overall Study|Other|1|||
23496477|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496478|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496479|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496480|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496481|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
23496482|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
23496483|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
23496484|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496485|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496486|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496487|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496488|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496489|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496490|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496491|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496492|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496493|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
23496494|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496495|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496496|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
23496497|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
23496498|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
23496499|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496500|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496501|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496502|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496503|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496504|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496505|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23606271|NCT03019289|65947191|FG001|Overall Study|Other|0|||
23606272|NCT03019289|65947192|FG002|Overall Study|Other|0|||
23606273|NCT03019289|65947193|FG003|Overall Study|Other|0|||
23606274|NCT03019289|65947194|FG004|Overall Study|Other|0|||
23392659|NCT02367040|65184772|FG001|Overall Study|Drug not administered|2|||
23392660|NCT02367040|65184771|FG000|Overall Study|Progressive disease|0|||
23496506|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496507|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496508|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496509|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496510|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496511|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
23496512|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
23496513|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
23606275|NCT03019289|65947195|FG005|Overall Study|Other|0|||
23606276|NCT03019289|65947196|FG006|Overall Study|Other|0|||
23392661|NCT02367040|65184772|FG001|Overall Study|Progressive disease|1|||
23392662|NCT02367040|65184771|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
23392663|NCT02367040|65184772|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
23392664|NCT02367040|65184771|FG000|Overall Study|Death|2|||
23392665|NCT02367040|65184772|FG001|Overall Study|Death|0|||
23392666|NCT03770286|65184773|FG000|Overall Study|Lost to Follow-up|6|||
23392667|NCT03770286|65184774|FG001|Overall Study|Lost to Follow-up|4|||
23392668|NCT03770286|65184775|FG002|Overall Study|Lost to Follow-up|3|||
23392669|NCT03770286|65184773|FG000|Overall Study|Protocol Violation|1|||
23392670|NCT03770286|65184774|FG001|Overall Study|Protocol Violation|0|||
23392671|NCT03770286|65184775|FG002|Overall Study|Protocol Violation|2|||
23392672|NCT04573881|65184776|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
23392673|NCT01969058|65184777|FG000|Overall Study|Withdrawal by Subject|2|||
23392674|NCT01969058|65184778|FG001|Overall Study|Withdrawal by Subject|0|||
23392675|NCT01969058|65184777|FG000|Overall Study|Adverse Event|1|||
23392676|NCT01969058|65184778|FG001|Overall Study|Adverse Event|0|||
23392677|NCT03735121|65184779|FG000|Overall Study|Death|3|||
23392678|NCT03735121|65184780|FG001|Overall Study|Death|6|||
23392679|NCT03735121|65184781|FG002|Overall Study|Death|8|||
23392680|NCT03735121|65184782|FG003|Overall Study|Death|37|||
23392681|NCT03735121|65184783|FG004|Overall Study|Death|86|||
23392682|NCT03735121|65184779|FG000|Overall Study|Withdrawal by Subject|1|||
23392683|NCT03735121|65184780|FG001|Overall Study|Withdrawal by Subject|1|||
23392684|NCT03735121|65184781|FG002|Overall Study|Withdrawal by Subject|3|||
23392685|NCT03735121|65184782|FG003|Overall Study|Withdrawal by Subject|4|||
23392686|NCT03735121|65184783|FG004|Overall Study|Withdrawal by Subject|2|||
23392687|NCT03735121|65184779|FG000|Overall Study|Progressive Disease|0|||
23392688|NCT03735121|65184780|FG001|Overall Study|Progressive Disease|0|||
23392689|NCT03735121|65184781|FG002|Overall Study|Progressive Disease|1|||
23392690|NCT03735121|65184782|FG003|Overall Study|Progressive Disease|0|||
23392691|NCT03735121|65184783|FG004|Overall Study|Progressive Disease|0|||
23392692|NCT03735121|65184779|FG000|Overall Study|Lost to Follow-up|0|||
23392693|NCT03735121|65184780|FG001|Overall Study|Lost to Follow-up|0|||
23392694|NCT03735121|65184781|FG002|Overall Study|Lost to Follow-up|0|||
23392695|NCT03735121|65184782|FG003|Overall Study|Lost to Follow-up|0|||
23392696|NCT03735121|65184783|FG004|Overall Study|Lost to Follow-up|1|||
23392697|NCT03735121|65184779|FG000|Overall Study|Ongoing|3|||
23392698|NCT03735121|65184780|FG001|Overall Study|Ongoing|3|||
23392699|NCT03735121|65184781|FG002|Overall Study|Ongoing|26|||
23392700|NCT03735121|65184782|FG003|Overall Study|Ongoing|83|||
23392701|NCT03735121|65184783|FG004|Overall Study|Ongoing|158|||
23392702|NCT02135133|65184785|FG000|Overall Study|Adverse Event|10|||
23392703|NCT02135133|65184785|FG000|Overall Study|regulatory mandate|5|||
23392704|NCT03822468|65184786|FG000|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|110|||
23392705|NCT03822468|65184787|FG001|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|107|||
23392706|NCT03822468|65184786|FG000|Treatment Period|Progressive disease|50|||
23392707|NCT03822468|65184787|FG001|Treatment Period|Progressive disease|51|||
23392708|NCT03822468|65184786|FG000|Treatment Period|Adverse Event|16|||
23392709|NCT03822468|65184787|FG001|Treatment Period|Adverse Event|18|||
23392710|NCT03822468|65184786|FG000|Treatment Period|Patient decision|4|||
23392711|NCT03822468|65184787|FG001|Treatment Period|Patient decision|5|||
23392712|NCT03822468|65184786|FG000|Treatment Period|Physician Decision|4|||
23392713|NCT03822468|65184787|FG001|Treatment Period|Physician Decision|5|||
23392714|NCT03822468|65184786|FG000|Treatment Period|Protocol deviation|2|||
23606277|NCT03019289|65947197|FG007|Overall Study|Other|0|||
23392715|NCT03822468|65184787|FG001|Treatment Period|Protocol deviation|1|||
23392716|NCT03822468|65184786|FG000|Treatment Period|Death|1|||
23392717|NCT03822468|65184787|FG001|Treatment Period|Death|1|||
23392718|NCT03822468|65184786|FG000|Treatment Period|Lost to Follow-up|1|||
23392719|NCT03822468|65184787|FG001|Treatment Period|Lost to Follow-up|0|||
23392720|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|12|||
23402841|NCT01349673|65220031|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
23392721|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|13|||
23392722|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Progressive disease|3|||
23392723|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
23392724|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Patient decision|3|||
23392725|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Patient decision|1|||
23392726|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Death|1|||
23392727|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Death|0|||
23392728|NCT03822468|65184786|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
23392729|NCT03822468|65184787|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
23392730|NCT06351371|65184788|FG000|Overall Study|Mutation Status Not Confirmed|9|||
23392731|NCT06351371|65184788|FG000|Overall Study|Ineligible|1|||
23496514|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496515|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496516|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496517|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496518|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496519|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496520|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496521|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496522|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496523|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
23496524|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496525|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496526|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
23496527|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
23496528|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
23496529|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496530|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496531|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496532|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496533|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496534|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496535|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496536|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496537|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496538|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
23496539|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496540|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496541|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496542|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
23496543|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
23496544|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496545|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496546|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496547|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496548|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496549|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496550|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496551|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496552|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496553|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496554|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496555|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496556|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496557|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
23496558|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
23496559|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Other|0|||
23496560|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Other|0|||
23392732|NCT06351371|65184788|FG000|Overall Study|Adverse Event|4|||
23392733|NCT06351371|65184788|FG000|Overall Study|Death|1|||
23496561|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Other|0|||
23496562|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Other|0|||
23496563|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Other|0|||
23496564|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Other|0|||
23496565|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Other|0|||
23496566|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Other|0|||
23496567|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Other|0|||
23496568|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Other|0|||
23496569|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Other|0|||
23496570|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Other|0|||
23496571|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Other|0|||
23496572|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Other|1|||
23496573|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Other|3|||
23496574|NCT03519178|65559026|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496575|NCT03519178|65559027|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496576|NCT03519178|65559028|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496577|NCT03519178|65559029|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496578|NCT03519178|65559030|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496579|NCT03519178|65559031|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496580|NCT03519178|65559032|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496581|NCT03519178|65559033|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496582|NCT03519178|65559034|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496583|NCT03519178|65559035|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496584|NCT03519178|65559036|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496585|NCT03519178|65559037|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496586|NCT03519178|65559038|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
23496587|NCT03519178|65559039|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
23496588|NCT03519178|65559040|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
23496589|NCT03519178|65559026|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
23496590|NCT03519178|65559027|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
23496591|NCT03519178|65559028|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
23496592|NCT03519178|65559029|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
23392734|NCT06351371|65184788|FG000|Overall Study|Disease progression|14|||
23392735|NCT06351371|65184788|FG000|Overall Study|Withdrawal by Subject|3|||
23392736|NCT06351371|65184788|FG000|Overall Study|Physician Decision|3|||
23392737|NCT01107496|65184789|FG000|Overall Study|Adverse Event|1|||
23392738|NCT01107496|65184790|FG001|Overall Study|Adverse Event|0|||
23392739|NCT01107496|65184789|FG000|Overall Study|Lack of Efficacy|1|||
23392740|NCT01107496|65184790|FG001|Overall Study|Lack of Efficacy|0|||
23392741|NCT01107496|65184789|FG000|Overall Study|Protocol Violation|0|||
23496593|NCT03519178|65559030|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
23496594|NCT03519178|65559031|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
23300365|NCT01360866|64842785|FG002|Overall Study|Adverse Event|134|||
23300366|NCT01360866|64842786|FG003|Overall Study|Adverse Event|6|||
23300367|NCT01360866|64842783|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
23300368|NCT01360866|64842784|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
23300369|NCT01360866|64842785|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
23300370|NCT01360866|64842786|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
23300371|NCT01360866|64842783|FG000|Overall Study|Withdrawn by Investigator|9|||
23300372|NCT01360866|64842784|FG001|Overall Study|Withdrawn by Investigator|8|||
23300373|NCT01360866|64842785|FG002|Overall Study|Withdrawn by Investigator|31|||
23300374|NCT01360866|64842786|FG003|Overall Study|Withdrawn by Investigator|2|||
23300375|NCT01360866|64842783|FG000|Overall Study|Withdrawal by participant|79|||
23300376|NCT01360866|64842784|FG001|Overall Study|Withdrawal by participant|89|||
23300377|NCT01360866|64842785|FG002|Overall Study|Withdrawal by participant|168|||
23300378|NCT01360866|64842786|FG003|Overall Study|Withdrawal by participant|8|||
23300379|NCT01360866|64842783|FG000|Overall Study|Protocol Deviation|25|||
23300380|NCT01360866|64842784|FG001|Overall Study|Protocol Deviation|33|||
23300381|NCT01360866|64842785|FG002|Overall Study|Protocol Deviation|61|||
23300382|NCT01360866|64842786|FG003|Overall Study|Protocol Deviation|2|||
23300383|NCT01360866|64842783|FG000|Overall Study|Lack of Efficacy|30|||
23300384|NCT01360866|64842784|FG001|Overall Study|Lack of Efficacy|40|||
23300385|NCT01360866|64842785|FG002|Overall Study|Lack of Efficacy|30|||
23300386|NCT01360866|64842786|FG003|Overall Study|Lack of Efficacy|4|||
23300387|NCT00804141|64842787|FG000|Overall Study|Adverse Event|157|||
23300388|NCT00804141|64842787|FG000|Overall Study|Death|4|||
23300389|NCT00804141|64842787|FG000|Overall Study|Failed to return|96|||
23300390|NCT00804141|64842787|FG000|Overall Study|Investigator request|8|||
23300391|NCT00804141|64842787|FG000|Overall Study|Protocol Violation|85|||
23300392|NCT00804141|64842787|FG000|Overall Study|Withdrawal by Subject|131|||
23300393|NCT00804141|64842787|FG000|Overall Study|Lack of Efficacy|46|||
23300394|NCT00804141|64842787|FG000|Overall Study|Other than specified|30|||
23300395|NCT00804141|64842787|FG000|Overall Study|Enrolled but not treated|6|||
23300396|NCT00375492|64842788|FG000|Overall Study|Adverse Event|4|||
23496595|NCT03519178|65559032|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
23496596|NCT03519178|65559033|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
23496597|NCT03519178|65559034|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
23496598|NCT03519178|65559035|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
23496599|NCT03519178|65559036|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
23496600|NCT03519178|65559037|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
23496601|NCT03519178|65559038|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
23496602|NCT03519178|65559039|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
23496603|NCT03519178|65559040|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
23496604|NCT03519178|65559026|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
23496605|NCT03519178|65559027|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
23496606|NCT03519178|65559028|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
23496607|NCT03519178|65559029|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
23496608|NCT03519178|65559030|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
23496609|NCT03519178|65559031|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
23392742|NCT01107496|65184790|FG001|Overall Study|Protocol Violation|1|||
23392743|NCT01107496|65184789|FG000|Overall Study|Lost to Follow-up|0|||
23392744|NCT01107496|65184790|FG001|Overall Study|Lost to Follow-up|1|||
23392745|NCT03518060|65184793|FG000|Overall Study|Death|1|||
23392746|NCT03518060|65184793|FG000|Overall Study|Poor adherence|1|||
23392747|NCT03518060|65184793|FG000|Overall Study|Withdrawal of informed consent|2|||
23392748|NCT03518060|65184793|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
23392749|NCT03518060|65184793|FG000|Overall Study|Physician Decision|7|||
23392750|NCT03518060|65184793|FG000|Overall Study|Adverse drug reactions|23|||
23392751|NCT03518060|65184793|FG000|Overall Study|Withdrawal by Subject|25|||
23392752|NCT03518060|65184793|FG000|Overall Study|Lost to Follow-up|13|||
23392753|NCT05810597|65184802|FG000|Period 1|Adverse Event|2|||
23392754|NCT05810597|65184803|FG001|Period 1|Adverse Event|0|||
23392755|NCT05810597|65184802|FG000|Period 1|Physician Decision|1|||
23392756|NCT05810597|65184803|FG001|Period 1|Physician Decision|0|||
23392757|NCT04756531|65184804|FG000|Overall Study|Adverse Event|0|||
23392758|NCT04756531|65184805|FG001|Overall Study|Adverse Event|0|||
23392759|NCT04756531|65184806|FG002|Overall Study|Adverse Event|0|||
23392760|NCT04756531|65184807|FG003|Overall Study|Adverse Event|0|||
23392761|NCT04756531|65184808|FG004|Overall Study|Adverse Event|1|||
23392762|NCT04756531|65184809|FG005|Overall Study|Adverse Event|0|||
23392763|NCT04756531|65184810|FG006|Overall Study|Adverse Event|0|||
23392764|NCT04756531|65184811|FG007|Overall Study|Adverse Event|0|||
23392765|NCT04756531|65184812|FG008|Overall Study|Adverse Event|0|||
23392766|NCT04756531|65184813|FG009|Overall Study|Adverse Event|0|||
23392767|NCT04756531|65184814|FG010|Overall Study|Adverse Event|0|||
23392768|NCT04756531|65184815|FG011|Overall Study|Adverse Event|0|||
23392769|NCT04756531|65184816|FG012|Overall Study|Adverse Event|0|||
23392770|NCT04756531|65184817|FG013|Overall Study|Adverse Event|0|||
23392771|NCT04756531|65184818|FG014|Overall Study|Adverse Event|0|||
23392772|NCT04756531|65184819|FG015|Overall Study|Adverse Event|0|||
23392773|NCT04756531|65184820|FG016|Overall Study|Adverse Event|0|||
23392774|NCT04756531|65184821|FG017|Overall Study|Adverse Event|0|||
23392775|NCT04756531|65184804|FG000|Overall Study|Withdrawal by Subject|0|||
23392776|NCT04756531|65184805|FG001|Overall Study|Withdrawal by Subject|0|||
23392777|NCT04756531|65184806|FG002|Overall Study|Withdrawal by Subject|0|||
23392778|NCT04756531|65184807|FG003|Overall Study|Withdrawal by Subject|0|||
23392779|NCT04756531|65184808|FG004|Overall Study|Withdrawal by Subject|0|||
23392780|NCT04756531|65184809|FG005|Overall Study|Withdrawal by Subject|0|||
23392781|NCT04756531|65184810|FG006|Overall Study|Withdrawal by Subject|1|||
23392782|NCT04756531|65184811|FG007|Overall Study|Withdrawal by Subject|0|||
23392783|NCT04756531|65184812|FG008|Overall Study|Withdrawal by Subject|0|||
23392784|NCT04756531|65184813|FG009|Overall Study|Withdrawal by Subject|0|||
23392785|NCT04756531|65184814|FG010|Overall Study|Withdrawal by Subject|0|||
23392786|NCT04756531|65184815|FG011|Overall Study|Withdrawal by Subject|0|||
23392787|NCT04756531|65184816|FG012|Overall Study|Withdrawal by Subject|0|||
23392788|NCT04756531|65184817|FG013|Overall Study|Withdrawal by Subject|0|||
23392789|NCT04756531|65184818|FG014|Overall Study|Withdrawal by Subject|0|||
23392790|NCT04756531|65184819|FG015|Overall Study|Withdrawal by Subject|0|||
23392791|NCT04756531|65184820|FG016|Overall Study|Withdrawal by Subject|0|||
23392792|NCT04756531|65184821|FG017|Overall Study|Withdrawal by Subject|0|||
23392793|NCT04035486|65184826|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
23392794|NCT04035486|65184827|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
23392795|NCT04035486|65184828|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
23496610|NCT03519178|65559032|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
23392796|NCT04035486|65184829|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
23392797|NCT04035486|65184826|FG000|Overall Study|Death|6|||
23392798|NCT04035486|65184827|FG001|Overall Study|Death|3|||
23392799|NCT04035486|65184828|FG002|Overall Study|Death|70|||
23392800|NCT04035486|65184829|FG003|Overall Study|Death|77|||
23496611|NCT03519178|65559033|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
23496612|NCT03519178|65559034|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
23496613|NCT03519178|65559035|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
23496614|NCT03519178|65559036|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
23496615|NCT03519178|65559037|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
23496616|NCT03519178|65559038|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
23496617|NCT03519178|65559039|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
23496618|NCT03519178|65559040|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
23496619|NCT03519178|65559026|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496620|NCT03519178|65559027|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496621|NCT03519178|65559028|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496622|NCT03519178|65559029|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496623|NCT03519178|65559030|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496624|NCT03519178|65559031|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496625|NCT03519178|65559032|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496626|NCT03519178|65559033|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496627|NCT03519178|65559034|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496628|NCT03519178|65559035|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496629|NCT03519178|65559036|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
23496630|NCT03519178|65559037|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496631|NCT03519178|65559038|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496632|NCT03519178|65559039|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496633|NCT03519178|65559040|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
23496634|NCT03519178|65559026|FG000|Follow-Up|Death|0|||
23496635|NCT03519178|65559027|FG001|Follow-Up|Death|0|||
23496636|NCT03519178|65559028|FG002|Follow-Up|Death|1|||
23496637|NCT03519178|65559029|FG003|Follow-Up|Death|0|||
23496638|NCT03519178|65559030|FG004|Follow-Up|Death|0|||
23496639|NCT03519178|65559031|FG005|Follow-Up|Death|0|||
23496640|NCT03519178|65559032|FG006|Follow-Up|Death|0|||
23496641|NCT03519178|65559033|FG007|Follow-Up|Death|0|||
23496642|NCT03519178|65559034|FG008|Follow-Up|Death|3|||
23496643|NCT03519178|65559035|FG009|Follow-Up|Death|1|||
23496644|NCT03519178|65559036|FG010|Follow-Up|Death|0|||
23496645|NCT03519178|65559037|FG011|Follow-Up|Death|0|||
23496646|NCT03519178|65559038|FG012|Follow-Up|Death|2|||
23496647|NCT03519178|65559039|FG013|Follow-Up|Death|0|||
23496648|NCT03519178|65559040|FG014|Follow-Up|Death|0|||
23496649|NCT03519178|65559026|FG000|Follow-Up|Lost to Follow-up|0|||
23496650|NCT03519178|65559027|FG001|Follow-Up|Lost to Follow-up|0|||
23496651|NCT03519178|65559028|FG002|Follow-Up|Lost to Follow-up|0|||
23496652|NCT03519178|65559029|FG003|Follow-Up|Lost to Follow-up|0|||
23496653|NCT03519178|65559030|FG004|Follow-Up|Lost to Follow-up|0|||
23496654|NCT03519178|65559031|FG005|Follow-Up|Lost to Follow-up|3|||
23496655|NCT03519178|65559032|FG006|Follow-Up|Lost to Follow-up|1|||
23496656|NCT03519178|65559033|FG007|Follow-Up|Lost to Follow-up|4|||
23496657|NCT03519178|65559034|FG008|Follow-Up|Lost to Follow-up|1|||
23496658|NCT03519178|65559035|FG009|Follow-Up|Lost to Follow-up|0|||
23496659|NCT03519178|65559036|FG010|Follow-Up|Lost to Follow-up|0|||
23496660|NCT03519178|65559037|FG011|Follow-Up|Lost to Follow-up|0|||
23496661|NCT03519178|65559038|FG012|Follow-Up|Lost to Follow-up|0|||
23496662|NCT03519178|65559039|FG013|Follow-Up|Lost to Follow-up|0|||
23496663|NCT03519178|65559040|FG014|Follow-Up|Lost to Follow-up|0|||
23496664|NCT03519178|65559026|FG000|Follow-Up|Withdrawal by Subject|1|||
23496665|NCT03519178|65559027|FG001|Follow-Up|Withdrawal by Subject|2|||
23496666|NCT03519178|65559028|FG002|Follow-Up|Withdrawal by Subject|2|||
23496667|NCT03519178|65559029|FG003|Follow-Up|Withdrawal by Subject|3|||
23496668|NCT03519178|65559030|FG004|Follow-Up|Withdrawal by Subject|5|||
23496669|NCT03519178|65559031|FG005|Follow-Up|Withdrawal by Subject|1|||
23496670|NCT03519178|65559032|FG006|Follow-Up|Withdrawal by Subject|2|||
23496671|NCT03519178|65559033|FG007|Follow-Up|Withdrawal by Subject|6|||
23496672|NCT03519178|65559034|FG008|Follow-Up|Withdrawal by Subject|5|||
23496673|NCT03519178|65559035|FG009|Follow-Up|Withdrawal by Subject|2|||
23496674|NCT03519178|65559036|FG010|Follow-Up|Withdrawal by Subject|3|||
23496675|NCT03519178|65559037|FG011|Follow-Up|Withdrawal by Subject|5|||
23300397|NCT00375492|64842789|FG001|Overall Study|Adverse Event|5|||
23392801|NCT04035486|65184826|FG000|Overall Study|Screen Failure|0|||
23496676|NCT03519178|65559038|FG012|Follow-Up|Withdrawal by Subject|2|||
23496677|NCT03519178|65559039|FG013|Follow-Up|Withdrawal by Subject|0|||
23496678|NCT03519178|65559040|FG014|Follow-Up|Withdrawal by Subject|0|||
23496679|NCT03519178|65559026|FG000|Follow-Up|Other|0|||
23496680|NCT03519178|65559027|FG001|Follow-Up|Other|0|||
23496681|NCT03519178|65559028|FG002|Follow-Up|Other|0|||
23496682|NCT03519178|65559029|FG003|Follow-Up|Other|0|||
23496683|NCT03519178|65559030|FG004|Follow-Up|Other|0|||
23496684|NCT03519178|65559031|FG005|Follow-Up|Other|0|||
23496685|NCT03519178|65559032|FG006|Follow-Up|Other|0|||
23496686|NCT03519178|65559033|FG007|Follow-Up|Other|1|||
23496687|NCT03519178|65559034|FG008|Follow-Up|Other|0|||
23496688|NCT03519178|65559035|FG009|Follow-Up|Other|0|||
23496689|NCT03519178|65559036|FG010|Follow-Up|Other|0|||
23496690|NCT03519178|65559037|FG011|Follow-Up|Other|0|||
23496691|NCT03519178|65559038|FG012|Follow-Up|Other|0|||
23496692|NCT03519178|65559039|FG013|Follow-Up|Other|0|||
23496693|NCT03519178|65559040|FG014|Follow-Up|Other|0|||
23496694|NCT03519178|65559026|FG000|Long-term Follow-up|Death|0|||
23496695|NCT03519178|65559027|FG001|Long-term Follow-up|Death|0|||
23496696|NCT03519178|65559028|FG002|Long-term Follow-up|Death|0|||
23496697|NCT03519178|65559029|FG003|Long-term Follow-up|Death|0|||
23392802|NCT04035486|65184827|FG001|Overall Study|Screen Failure|0|||
23392803|NCT04035486|65184828|FG002|Overall Study|Screen Failure|1|||
23392804|NCT04035486|65184829|FG003|Overall Study|Screen Failure|1|||
23392805|NCT04035486|65184826|FG000|Overall Study|Withdrawal by Subject|1|||
23496698|NCT03519178|65559030|FG004|Long-term Follow-up|Death|0|||
23496699|NCT03519178|65559031|FG005|Long-term Follow-up|Death|0|||
23496700|NCT03519178|65559032|FG006|Long-term Follow-up|Death|0|||
23496701|NCT03519178|65559033|FG007|Long-term Follow-up|Death|0|||
23496702|NCT03519178|65559034|FG008|Long-term Follow-up|Death|0|||
23496703|NCT03519178|65559035|FG009|Long-term Follow-up|Death|0|||
23496704|NCT03519178|65559036|FG010|Long-term Follow-up|Death|0|||
23496705|NCT03519178|65559037|FG011|Long-term Follow-up|Death|0|||
23496706|NCT03519178|65559038|FG012|Long-term Follow-up|Death|0|||
23496707|NCT03519178|65559039|FG013|Long-term Follow-up|Death|4|||
23496708|NCT03519178|65559040|FG014|Long-term Follow-up|Death|4|||
23496709|NCT03519178|65559026|FG000|Long-term Follow-up|Lost to Follow-up|0|||
23496710|NCT03519178|65559027|FG001|Long-term Follow-up|Lost to Follow-up|0|||
23496711|NCT03519178|65559028|FG002|Long-term Follow-up|Lost to Follow-up|0|||
23496712|NCT03519178|65559029|FG003|Long-term Follow-up|Lost to Follow-up|0|||
23496713|NCT03519178|65559030|FG004|Long-term Follow-up|Lost to Follow-up|0|||
23496714|NCT03519178|65559031|FG005|Long-term Follow-up|Lost to Follow-up|0|||
23496715|NCT03519178|65559032|FG006|Long-term Follow-up|Lost to Follow-up|0|||
23496716|NCT03519178|65559033|FG007|Long-term Follow-up|Lost to Follow-up|0|||
23496717|NCT03519178|65559034|FG008|Long-term Follow-up|Lost to Follow-up|0|||
23496718|NCT03519178|65559035|FG009|Long-term Follow-up|Lost to Follow-up|0|||
23496719|NCT03519178|65559036|FG010|Long-term Follow-up|Lost to Follow-up|0|||
23496720|NCT03519178|65559037|FG011|Long-term Follow-up|Lost to Follow-up|0|||
23496721|NCT03519178|65559038|FG012|Long-term Follow-up|Lost to Follow-up|0|||
23496722|NCT03519178|65559039|FG013|Long-term Follow-up|Lost to Follow-up|1|||
23496723|NCT03519178|65559040|FG014|Long-term Follow-up|Lost to Follow-up|1|||
23496724|NCT03519178|65559026|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
23496725|NCT03519178|65559027|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
23496726|NCT03519178|65559028|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
23496727|NCT03519178|65559029|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
23496728|NCT03519178|65559030|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
23496729|NCT03519178|65559031|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
23496730|NCT03519178|65559032|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
23496731|NCT03519178|65559033|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
23496732|NCT03519178|65559034|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
23496733|NCT03519178|65559035|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
23496734|NCT03519178|65559036|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
23496735|NCT03519178|65559037|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
23496736|NCT03519178|65559038|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
23496737|NCT03519178|65559039|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
23496738|NCT03519178|65559040|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
23496739|NCT03519178|65559026|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
23496740|NCT03519178|65559027|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
23496741|NCT03519178|65559028|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
23496742|NCT03519178|65559029|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
23496743|NCT03519178|65559030|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
23496744|NCT03519178|65559031|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
23496745|NCT03519178|65559032|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
23496746|NCT03519178|65559033|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
23496747|NCT03519178|65559034|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
23496748|NCT03519178|65559035|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
23606278|NCT03019289|65947198|FG008|Overall Study|Other|0|||
23392806|NCT04035486|65184827|FG001|Overall Study|Withdrawal by Subject|1|||
23392807|NCT04035486|65184828|FG002|Overall Study|Withdrawal by Subject|11|||
23392808|NCT04035486|65184829|FG003|Overall Study|Withdrawal by Subject|9|||
23392809|NCT01355627|65184830|FG000|Overall Study|Request By the Patient to Discontinue|5|||
23392810|NCT01355627|65184831|FG001|Overall Study|Request By the Patient to Discontinue|7|||
23392811|NCT01355627|65184830|FG000|Overall Study|Lost to Follow-up|8|||
23392812|NCT01355627|65184831|FG001|Overall Study|Lost to Follow-up|7|||
23392813|NCT01355627|65184830|FG000|Overall Study|Fatal Adverse Event|19|||
23392814|NCT01355627|65184831|FG001|Overall Study|Fatal Adverse Event|23|||
23392815|NCT01355627|65184830|FG000|Overall Study|Other|1|||
23392816|NCT01355627|65184831|FG001|Overall Study|Other|1|||
23392817|NCT01854775|65184832|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
23392818|NCT01854775|65184833|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
23392819|NCT01854775|65184834|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
23392820|NCT01854775|65184832|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
23392821|NCT01854775|65184833|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
23392822|NCT01854775|65184834|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
23392823|NCT01854775|65184832|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
23392824|NCT01854775|65184833|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
23392825|NCT01854775|65184834|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
23392826|NCT01854775|65184832|FG000|Extension Phase|Pregnancy|3|||
23392827|NCT01854775|65184833|FG001|Extension Phase|Pregnancy|0|||
23392828|NCT01854775|65184834|FG002|Extension Phase|Pregnancy|0|||
23392829|NCT01854775|65184832|FG000|Extension Phase|Investigator's Discretion|1|||
23392830|NCT01854775|65184833|FG001|Extension Phase|Investigator's Discretion|0|||
23392831|NCT01854775|65184834|FG002|Extension Phase|Investigator's Discretion|0|||
23392832|NCT01854775|65184832|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
23392833|NCT01854775|65184833|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
23392834|NCT01854775|65184834|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
23392835|NCT01854775|65184832|FG000|Extension Phase|Lost to Follow-up|2|||
23392836|NCT01854775|65184833|FG001|Extension Phase|Lost to Follow-up|0|||
23392837|NCT01854775|65184834|FG002|Extension Phase|Lost to Follow-up|0|||
23392838|NCT01854775|65184832|FG000|Extension Phase|Still on Study|32|||
23392839|NCT01854775|65184833|FG001|Extension Phase|Still on Study|47|||
23392840|NCT01854775|65184834|FG002|Extension Phase|Still on Study|18|||
23392841|NCT05305651|65184835|FG000|Overall Study|Death|1|||
23392842|NCT05305651|65184835|FG000|Overall Study|Withdrawal by Subject|4|||
23392843|NCT05305651|65184835|FG000|Overall Study|Lost to Follow-up|4|||
23392844|NCT02721732|65184836|FG000|Overall Study|Adverse Event|2|||
23392845|NCT02721732|65184837|FG001|Overall Study|Adverse Event|0|||
23392846|NCT02721732|65184838|FG002|Overall Study|Adverse Event|2|||
23392847|NCT02721732|65184839|FG003|Overall Study|Adverse Event|0|||
23392848|NCT02721732|65184840|FG004|Overall Study|Adverse Event|1|||
23392849|NCT02721732|65184841|FG005|Overall Study|Adverse Event|0|||
23392850|NCT02721732|65184842|FG006|Overall Study|Adverse Event|1|||
23392851|NCT02721732|65184843|FG007|Overall Study|Adverse Event|0|||
23392852|NCT02721732|65184844|FG008|Overall Study|Adverse Event|1|||
23392853|NCT02721732|65184845|FG009|Overall Study|Adverse Event|1|||
23392854|NCT02721732|65184836|FG000|Overall Study|Death|0|||
23392855|NCT02721732|65184837|FG001|Overall Study|Death|0|||
23392856|NCT02721732|65184838|FG002|Overall Study|Death|0|||
23392857|NCT02721732|65184839|FG003|Overall Study|Death|0|||
23392858|NCT02721732|65184840|FG004|Overall Study|Death|1|||
23392859|NCT02721732|65184841|FG005|Overall Study|Death|0|||
23392860|NCT02721732|65184842|FG006|Overall Study|Death|1|||
23392861|NCT02721732|65184843|FG007|Overall Study|Death|0|||
23392862|NCT02721732|65184844|FG008|Overall Study|Death|0|||
23392863|NCT02721732|65184845|FG009|Overall Study|Death|1|||
23392864|NCT02721732|65184836|FG000|Overall Study|Lack of Efficacy|12|||
23392865|NCT02721732|65184837|FG001|Overall Study|Lack of Efficacy|11|||
23392866|NCT02721732|65184838|FG002|Overall Study|Lack of Efficacy|18|||
23496749|NCT03519178|65559036|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
23392867|NCT02721732|65184839|FG003|Overall Study|Lack of Efficacy|5|||
23392868|NCT02721732|65184840|FG004|Overall Study|Lack of Efficacy|21|||
23392869|NCT02721732|65184841|FG005|Overall Study|Lack of Efficacy|2|||
23392870|NCT02721732|65184842|FG006|Overall Study|Lack of Efficacy|8|||
23392871|NCT02721732|65184843|FG007|Overall Study|Lack of Efficacy|11|||
23392872|NCT02721732|65184844|FG008|Overall Study|Lack of Efficacy|10|||
23392873|NCT02721732|65184845|FG009|Overall Study|Lack of Efficacy|20|||
23392874|NCT02721732|65184836|FG000|Overall Study|Physician Decision|0|||
23392875|NCT02721732|65184837|FG001|Overall Study|Physician Decision|0|||
23392876|NCT02721732|65184838|FG002|Overall Study|Physician Decision|1|||
23392877|NCT02721732|65184839|FG003|Overall Study|Physician Decision|0|||
23392878|NCT02721732|65184840|FG004|Overall Study|Physician Decision|0|||
23392879|NCT02721732|65184841|FG005|Overall Study|Physician Decision|0|||
23392880|NCT02721732|65184842|FG006|Overall Study|Physician Decision|0|||
23392881|NCT02721732|65184843|FG007|Overall Study|Physician Decision|0|||
23392882|NCT02721732|65184844|FG008|Overall Study|Physician Decision|0|||
23392883|NCT02721732|65184845|FG009|Overall Study|Physician Decision|0|||
23392884|NCT02721732|65184836|FG000|Overall Study|Withdrawal by Subject|1|||
23392885|NCT02721732|65184837|FG001|Overall Study|Withdrawal by Subject|0|||
23392886|NCT02721732|65184838|FG002|Overall Study|Withdrawal by Subject|0|||
23392887|NCT02721732|65184839|FG003|Overall Study|Withdrawal by Subject|0|||
23392888|NCT02721732|65184840|FG004|Overall Study|Withdrawal by Subject|3|||
23392889|NCT02721732|65184841|FG005|Overall Study|Withdrawal by Subject|0|||
23392890|NCT02721732|65184842|FG006|Overall Study|Withdrawal by Subject|1|||
23392891|NCT02721732|65184843|FG007|Overall Study|Withdrawal by Subject|1|||
23392892|NCT02721732|65184844|FG008|Overall Study|Withdrawal by Subject|0|||
23392893|NCT02721732|65184845|FG009|Overall Study|Withdrawal by Subject|1|||
23392894|NCT02721732|65184836|FG000|Overall Study|Participant Choice|1|||
23392895|NCT02721732|65184837|FG001|Overall Study|Participant Choice|0|||
23392896|NCT02721732|65184838|FG002|Overall Study|Participant Choice|0|||
23392897|NCT02721732|65184839|FG003|Overall Study|Participant Choice|0|||
23392898|NCT02721732|65184840|FG004|Overall Study|Participant Choice|0|||
23392899|NCT02721732|65184841|FG005|Overall Study|Participant Choice|0|||
23392900|NCT02721732|65184842|FG006|Overall Study|Participant Choice|0|||
23392901|NCT02721732|65184843|FG007|Overall Study|Participant Choice|0|||
23392902|NCT02721732|65184844|FG008|Overall Study|Participant Choice|0|||
23392903|NCT02721732|65184845|FG009|Overall Study|Participant Choice|1|||
23392904|NCT02721732|65184836|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392905|NCT02721732|65184837|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392906|NCT02721732|65184838|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
23392907|NCT02721732|65184839|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392908|NCT02721732|65184840|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392909|NCT02721732|65184841|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392910|NCT02721732|65184842|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392911|NCT02721732|65184843|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23496750|NCT03519178|65559037|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
23496751|NCT03519178|65559038|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
23496752|NCT03519178|65559039|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
23496753|NCT03519178|65559040|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
23496754|NCT03519178|65559026|FG000|Long-term Follow-up|Other|0|||
23496755|NCT03519178|65559027|FG001|Long-term Follow-up|Other|0|||
23496756|NCT03519178|65559028|FG002|Long-term Follow-up|Other|0|||
23496757|NCT03519178|65559029|FG003|Long-term Follow-up|Other|0|||
23496758|NCT03519178|65559030|FG004|Long-term Follow-up|Other|0|||
23496759|NCT03519178|65559031|FG005|Long-term Follow-up|Other|0|||
23496760|NCT03519178|65559032|FG006|Long-term Follow-up|Other|0|||
23496761|NCT03519178|65559033|FG007|Long-term Follow-up|Other|0|||
23496762|NCT03519178|65559034|FG008|Long-term Follow-up|Other|0|||
23496763|NCT03519178|65559035|FG009|Long-term Follow-up|Other|0|||
23496764|NCT03519178|65559036|FG010|Long-term Follow-up|Other|0|||
23496765|NCT03519178|65559037|FG011|Long-term Follow-up|Other|0|||
23496766|NCT03519178|65559038|FG012|Long-term Follow-up|Other|0|||
23496767|NCT03519178|65559039|FG013|Long-term Follow-up|Other|0|||
23496768|NCT03519178|65559040|FG014|Long-term Follow-up|Other|1|||
23496769|NCT03519178|65559026|FG000|Long-term Follow-up|Ongoing|0|||
23496770|NCT03519178|65559027|FG001|Long-term Follow-up|Ongoing|0|||
23496771|NCT03519178|65559028|FG002|Long-term Follow-up|Ongoing|0|||
23496772|NCT03519178|65559029|FG003|Long-term Follow-up|Ongoing|0|||
23496773|NCT03519178|65559030|FG004|Long-term Follow-up|Ongoing|0|||
23496774|NCT03519178|65559031|FG005|Long-term Follow-up|Ongoing|0|||
23496775|NCT03519178|65559032|FG006|Long-term Follow-up|Ongoing|0|||
23496776|NCT03519178|65559033|FG007|Long-term Follow-up|Ongoing|0|||
23496777|NCT03519178|65559034|FG008|Long-term Follow-up|Ongoing|0|||
23496778|NCT03519178|65559035|FG009|Long-term Follow-up|Ongoing|0|||
23496779|NCT03519178|65559036|FG010|Long-term Follow-up|Ongoing|0|||
23496780|NCT03519178|65559037|FG011|Long-term Follow-up|Ongoing|0|||
23496781|NCT03519178|65559038|FG012|Long-term Follow-up|Ongoing|0|||
23496782|NCT03519178|65559039|FG013|Long-term Follow-up|Ongoing|1|||
23496783|NCT03519178|65559040|FG014|Long-term Follow-up|Ongoing|0|||
23496784|NCT03685123|65562464|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
23496785|NCT03685123|65562465|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
23496786|NCT03685123|65562466|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
23496787|NCT03685123|65562464|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
23496788|NCT03685123|65562465|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
23496789|NCT03685123|65562466|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
23496790|NCT03685123|65562464|FG000|Weight Loss Phase|Lost to Follow-up|1|||
23496791|NCT03685123|65562465|FG001|Weight Loss Phase|Lost to Follow-up|0|||
23496792|NCT03685123|65562466|FG002|Weight Loss Phase|Lost to Follow-up|0|||
23496793|NCT03685123|65562464|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
23496794|NCT03685123|65562465|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
23496795|NCT03685123|65562466|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
23496796|NCT03685123|65562464|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
23496797|NCT03685123|65562465|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
23496798|NCT03685123|65562466|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
23496799|NCT03685123|65562464|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
23496800|NCT03685123|65562465|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
23496801|NCT03685123|65562466|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
23496802|NCT03724032|65562470|FG000|Overall Study|Physician Decision|1|||
23496803|NCT03724032|65562471|FG001|Overall Study|Physician Decision|0|||
23496804|NCT03724032|65562472|FG002|Overall Study|Physician Decision|0|||
23496805|NCT03724032|65562470|FG000|Overall Study|Protocol Violation|2|||
23496806|NCT03724032|65562471|FG001|Overall Study|Protocol Violation|2|||
23496807|NCT03724032|65562472|FG002|Overall Study|Protocol Violation|1|||
23496808|NCT01548287|65562474|FG000|Screening|No reason provided|0|||
23496809|NCT01548287|65562475|FG001|Screening|No reason provided|0|||
23496810|NCT01548287|65562476|FG002|Screening|No reason provided|0|||
23496811|NCT01548287|65562477|FG003|Screening|No reason provided|0|||
23496812|NCT01548287|65562478|FG004|Screening|No reason provided|9|||
23496813|NCT01548287|65562474|FG000|Screening|Did not meet eligibility criteria|0|||
23496814|NCT01548287|65562475|FG001|Screening|Did not meet eligibility criteria|0|||
23496815|NCT01548287|65562476|FG002|Screening|Did not meet eligibility criteria|0|||
23496816|NCT01548287|65562477|FG003|Screening|Did not meet eligibility criteria|0|||
23496817|NCT01548287|65562478|FG004|Screening|Did not meet eligibility criteria|74|||
23496818|NCT01548287|65562474|FG000|Randomized Period|Did not meet inclusion criteria|0|||
23496819|NCT01548287|65562475|FG001|Randomized Period|Did not meet inclusion criteria|0|||
23496820|NCT01548287|65562476|FG002|Randomized Period|Did not meet inclusion criteria|2|||
23496821|NCT01548287|65562477|FG003|Randomized Period|Did not meet inclusion criteria|0|||
23496822|NCT01548287|65562478|FG004|Randomized Period|Did not meet inclusion criteria|0|||
23496823|NCT01548287|65562474|FG000|Randomized Period|Adverse Event|0|||
23496824|NCT01548287|65562475|FG001|Randomized Period|Adverse Event|2|||
23496825|NCT01548287|65562476|FG002|Randomized Period|Adverse Event|5|||
23496826|NCT01548287|65562477|FG003|Randomized Period|Adverse Event|0|||
23496827|NCT01548287|65562478|FG004|Randomized Period|Adverse Event|0|||
23496828|NCT02229383|65562479|FG000|Overall Study|Adverse Event|7|||
23496829|NCT02229383|65562480|FG001|Overall Study|Adverse Event|4|||
23496830|NCT02229383|65562479|FG000|Overall Study|Death|0|||
23496831|NCT02229383|65562480|FG001|Overall Study|Death|1|||
23496832|NCT02229383|65562479|FG000|Overall Study|Lost to Follow-up|5|||
23496833|NCT02229383|65562480|FG001|Overall Study|Lost to Follow-up|3|||
23496834|NCT02229383|65562479|FG000|Overall Study|Withdrawal by Subject|4|||
23496835|NCT02229383|65562480|FG001|Overall Study|Withdrawal by Subject|6|||
23496836|NCT02229383|65562479|FG000|Overall Study|Did not receive treatment|1|||
23496837|NCT02229383|65562480|FG001|Overall Study|Did not receive treatment|0|||
23496838|NCT02229383|65562479|FG000|Overall Study|Other|3|||
23496839|NCT02229383|65562480|FG001|Overall Study|Other|8|||
23496840|NCT05213481|65562481|FG000|Overall Study|Adverse Event|3|||
23496841|NCT05213481|65562481|FG000|Overall Study|Lost to Follow-up|1|||
23496842|NCT00894166|65562484|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
23496843|NCT00894166|65562485|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
23496844|NCT00894166|65562486|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
23496845|NCT00894166|65562487|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
23496846|NCT00894166|65562488|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
23496847|NCT00894166|65562489|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
23496848|NCT00894166|65562490|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
23496849|NCT00894166|65562491|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
23496850|NCT00894166|65562484|FG000|Overall Study|Death|0|||
23496851|NCT00894166|65562485|FG001|Overall Study|Death|0|||
23496852|NCT00894166|65562486|FG002|Overall Study|Death|0|||
23496853|NCT00894166|65562487|FG003|Overall Study|Death|1|||
23496854|NCT00894166|65562488|FG004|Overall Study|Death|0|||
23496855|NCT00894166|65562489|FG005|Overall Study|Death|0|||
23496856|NCT00894166|65562490|FG006|Overall Study|Death|0|||
23496857|NCT00894166|65562491|FG007|Overall Study|Death|0|||
23496858|NCT02217878|65562494|FG000|Overall Study|required morphine due to chest pain|1|||
23496859|NCT02217878|65562495|FG001|Overall Study|required morphine due to chest pain|2|||
23496860|NCT02217878|65562494|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
23496861|NCT02217878|65562495|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
23496862|NCT00880542|65562499|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
23496863|NCT00880542|65562499|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
23496864|NCT00880542|65562499|FG000|REP: Surgical Resection|progressive disease|1|||
23496865|NCT01651039|65562500|FG000|Overall Study|Non-evaluables|5|||
23496866|NCT01651039|65562500|FG000|Overall Study|Physician Decision|2|||
23496867|NCT01651039|65562500|FG000|Overall Study|Withdrawal by Subject|1|||
23496868|NCT01651039|65562500|FG000|Overall Study|Progressive Disease|22|||
23496869|NCT03673046|65562501|FG000|Overall Study|Adverse Event|1|||
23496870|NCT03673046|65562502|FG001|Overall Study|Adverse Event|1|||
23496871|NCT03673046|65562501|FG000|Overall Study|Withdrawal by Subject|8|||
23496872|NCT03673046|65562502|FG001|Overall Study|Withdrawal by Subject|2|||
23496873|NCT00446251|65562506|FG000|Overall Study|On-study Transplants|2|||
23496874|NCT00446251|65562506|FG000|Overall Study|Rituximab Infusion Reaction|2|||
23496875|NCT00446251|65562506|FG000|Overall Study|Lost to Follow-up|1|||
23496876|NCT03087643|65562507|FG000|Overall Study|Withdrawal by Subject|2|||
23496877|NCT03087643|65562508|FG001|Overall Study|Withdrawal by Subject|4|||
23496878|NCT03087643|65562507|FG000|Overall Study|Death|2|||
23496879|NCT03087643|65562508|FG001|Overall Study|Death|2|||
23496880|NCT04674644|65562509|FG000|Overall Study|with missing data|37|||
23496881|NCT02699593|65562510|FG000|Period 1|Unsatisfactory Visual Response|0|||
23496882|NCT02699593|65562511|FG001|Period 1|Unsatisfactory Visual Response|1|||
23496883|NCT02699593|65562510|FG000|Period 1|Torn Contact Len|4|||
23496884|NCT02699593|65562511|FG001|Period 1|Torn Contact Len|3|||
23496885|NCT02699593|65562510|FG000|Period 1|Protocol Violation|0|||
23496886|NCT02699593|65562511|FG001|Period 1|Protocol Violation|1|||
23496887|NCT02699593|65562510|FG000|Period 1|Withdrawal by Subject|0|||
23496888|NCT02699593|65562511|FG001|Period 1|Withdrawal by Subject|1|||
23496889|NCT02699593|65562510|FG000|Period 1|Adverse Event|1|||
23496890|NCT02699593|65562511|FG001|Period 1|Adverse Event|1|||
23496891|NCT02699593|65562510|FG000|Period 2|Adverse Event|1|||
23496892|NCT02699593|65562511|FG001|Period 2|Adverse Event|1|||
23496893|NCT02699593|65562510|FG000|Period 2|Lost Contact Lens|0|||
23496894|NCT02699593|65562511|FG001|Period 2|Lost Contact Lens|1|||
23496895|NCT02699593|65562510|FG000|Period 2|Torn Contact Lens|1|||
23496896|NCT02699593|65562511|FG001|Period 2|Torn Contact Lens|0|||
23496897|NCT00150709|65562514|FG000|Overall Study|Protocol Violation|7|||
23496898|NCT00150709|65562515|FG001|Overall Study|Protocol Violation|8|||
23496899|NCT00150709|65562516|FG002|Overall Study|Protocol Violation|3|||
23496900|NCT00150709|65562517|FG003|Overall Study|Protocol Violation|1|||
23496901|NCT00150709|65562514|FG000|Overall Study|Adverse Event|8|||
23496902|NCT00150709|65562515|FG001|Overall Study|Adverse Event|2|||
23496903|NCT00150709|65562516|FG002|Overall Study|Adverse Event|2|||
23496904|NCT00150709|65562517|FG003|Overall Study|Adverse Event|3|||
23496905|NCT00150709|65562514|FG000|Overall Study|Lack of Efficacy|6|||
23496906|NCT00150709|65562515|FG001|Overall Study|Lack of Efficacy|11|||
23496907|NCT00150709|65562516|FG002|Overall Study|Lack of Efficacy|9|||
23496908|NCT00150709|65562517|FG003|Overall Study|Lack of Efficacy|0|||
23496909|NCT00150709|65562514|FG000|Overall Study|Withdrawal by Subject|7|||
23496910|NCT00150709|65562515|FG001|Overall Study|Withdrawal by Subject|10|||
23496911|NCT00150709|65562516|FG002|Overall Study|Withdrawal by Subject|5|||
23496912|NCT00150709|65562517|FG003|Overall Study|Withdrawal by Subject|0|||
23496913|NCT00150709|65562514|FG000|Overall Study|Lost to Follow-up|3|||
23496914|NCT00150709|65562515|FG001|Overall Study|Lost to Follow-up|2|||
23496915|NCT00150709|65562516|FG002|Overall Study|Lost to Follow-up|0|||
23496916|NCT00150709|65562517|FG003|Overall Study|Lost to Follow-up|0|||
23496917|NCT00150709|65562514|FG000|Overall Study|Sponsor decision|0|||
23496918|NCT00150709|65562515|FG001|Overall Study|Sponsor decision|0|||
23496919|NCT00150709|65562516|FG002|Overall Study|Sponsor decision|0|||
23496920|NCT00150709|65562517|FG003|Overall Study|Sponsor decision|1|||
23496921|NCT00150709|65562514|FG000|Overall Study|Site/Investigator discontinued the study|5|||
23496922|NCT00150709|65562515|FG001|Overall Study|Site/Investigator discontinued the study|5|||
23496923|NCT00150709|65562516|FG002|Overall Study|Site/Investigator discontinued the study|2|||
23496924|NCT00150709|65562517|FG003|Overall Study|Site/Investigator discontinued the study|0|||
23496925|NCT00150709|65562514|FG000|Overall Study|Decision of parent(s)|1|||
23496926|NCT00150709|65562515|FG001|Overall Study|Decision of parent(s)|2|||
23496927|NCT00150709|65562516|FG002|Overall Study|Decision of parent(s)|0|||
23496928|NCT00150709|65562517|FG003|Overall Study|Decision of parent(s)|0|||
23496929|NCT00150709|65562514|FG000|Overall Study|Decision of parent(s) and investigator|3|||
23496930|NCT00150709|65562515|FG001|Overall Study|Decision of parent(s) and investigator|0|||
23496931|NCT00150709|65562516|FG002|Overall Study|Decision of parent(s) and investigator|0|||
23496932|NCT00150709|65562517|FG003|Overall Study|Decision of parent(s) and investigator|0|||
23496933|NCT00150709|65562514|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
23496934|NCT00150709|65562515|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
23496935|NCT00150709|65562516|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
23496936|NCT00150709|65562517|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
23496937|NCT00150709|65562514|FG000|Overall Study|Investigator decision|1|||
23496938|NCT00150709|65562515|FG001|Overall Study|Investigator decision|0|||
23496939|NCT00150709|65562516|FG002|Overall Study|Investigator decision|0|||
23496940|NCT00150709|65562517|FG003|Overall Study|Investigator decision|1|||
23496941|NCT00150709|65562514|FG000|Overall Study|Subject relocated|2|||
23496942|NCT00150709|65562515|FG001|Overall Study|Subject relocated|2|||
23496943|NCT00150709|65562516|FG002|Overall Study|Subject relocated|1|||
23496944|NCT00150709|65562517|FG003|Overall Study|Subject relocated|0|||
23496945|NCT00150709|65562514|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
23496946|NCT00150709|65562515|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
23496947|NCT00150709|65562516|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
23496948|NCT00150709|65562517|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
23496949|NCT00150709|65562514|FG000|Overall Study|Convenience|0|||
23496950|NCT00150709|65562515|FG001|Overall Study|Convenience|1|||
23496951|NCT00150709|65562516|FG002|Overall Study|Convenience|0|||
23496952|NCT00150709|65562517|FG003|Overall Study|Convenience|0|||
23496953|NCT00150709|65562514|FG000|Overall Study|Subject entered new drug study|0|||
23496954|NCT00150709|65562515|FG001|Overall Study|Subject entered new drug study|1|||
23496955|NCT00150709|65562516|FG002|Overall Study|Subject entered new drug study|0|||
23496956|NCT00150709|65562517|FG003|Overall Study|Subject entered new drug study|0|||
23496957|NCT00150709|65562514|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
23496958|NCT00150709|65562515|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
23496959|NCT00150709|65562516|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
23496960|NCT00150709|65562517|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
23496961|NCT00150709|65562514|FG000|Overall Study|Lack of ease of swallowing|0|||
23496962|NCT00150709|65562515|FG001|Overall Study|Lack of ease of swallowing|1|||
23496963|NCT00150709|65562516|FG002|Overall Study|Lack of ease of swallowing|0|||
23496964|NCT00150709|65562517|FG003|Overall Study|Lack of ease of swallowing|0|||
23496965|NCT03342963|65562518|FG000|Overall Study|Adverse Event|1|||
23496966|NCT03342963|65562519|FG001|Overall Study|Adverse Event|2|||
23496967|NCT03342963|65562520|FG002|Overall Study|Adverse Event|0|||
23496968|NCT03342963|65562521|FG003|Overall Study|Adverse Event|0|||
23496969|NCT03342963|65562518|FG000|Overall Study|Withdrawal by Subject|1|||
23496970|NCT03342963|65562519|FG001|Overall Study|Withdrawal by Subject|0|||
23496971|NCT03342963|65562520|FG002|Overall Study|Withdrawal by Subject|0|||
23496972|NCT03342963|65562521|FG003|Overall Study|Withdrawal by Subject|0|||
23496973|NCT01453361|65562522|FG000|Overall Study|Disease Progression|6|||
23496974|NCT01453361|65562522|FG000|Overall Study|Screen-Failures|10|||
23496975|NCT00957580|65562523|FG000|Overall Study|Ongoing at data cut-off|0|||
23496976|NCT00957580|65562524|FG001|Overall Study|Ongoing at data cut-off|1|||
23496977|NCT00957580|65562525|FG002|Overall Study|Ongoing at data cut-off|0|||
23496978|NCT00957580|65562523|FG000|Overall Study|Enrolled but not treated|0|||
23496979|NCT00957580|65562524|FG001|Overall Study|Enrolled but not treated|1|||
23496980|NCT00957580|65562525|FG002|Overall Study|Enrolled but not treated|0|||
23496981|NCT00621582|65562526|FG000|Overall Study|Adverse Event|7|||
23496982|NCT00621582|65562526|FG000|Overall Study|Protocol Violation|57|||
23496983|NCT00621582|65562526|FG000|Overall Study|Lost to Follow-up|24|||
23496984|NCT00621582|65562526|FG000|Overall Study|issues not identified by investigators|18|||
23496985|NCT00457301|65562527|FG000|Overall Study|Withdrawal by Subject|3|||
23392912|NCT02721732|65184844|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392913|NCT02721732|65184845|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
23392914|NCT02721732|65184836|FG000|Overall Study|Progression and withdrew consent|1|||
23392915|NCT02721732|65184837|FG001|Overall Study|Progression and withdrew consent|1|||
23392916|NCT02721732|65184838|FG002|Overall Study|Progression and withdrew consent|0|||
23392917|NCT02721732|65184839|FG003|Overall Study|Progression and withdrew consent|0|||
23392918|NCT02721732|65184840|FG004|Overall Study|Progression and withdrew consent|0|||
23392919|NCT02721732|65184841|FG005|Overall Study|Progression and withdrew consent|0|||
23392920|NCT02721732|65184842|FG006|Overall Study|Progression and withdrew consent|0|||
23392921|NCT02721732|65184843|FG007|Overall Study|Progression and withdrew consent|0|||
23392922|NCT02721732|65184844|FG008|Overall Study|Progression and withdrew consent|0|||
23392923|NCT02721732|65184845|FG009|Overall Study|Progression and withdrew consent|1|||
23392924|NCT02721732|65184836|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
23392925|NCT02721732|65184837|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
23392926|NCT02721732|65184838|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
23392927|NCT02721732|65184839|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
23392928|NCT02721732|65184840|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
23392929|NCT02721732|65184841|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
23392930|NCT02721732|65184842|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
23392931|NCT02721732|65184843|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
23392932|NCT02721732|65184844|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
23392933|NCT02721732|65184845|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
23392934|NCT02096354|65184846|FG000|Overall Study|Physician Decision|4|||
23392935|NCT02096354|65184847|FG001|Overall Study|Physician Decision|5|||
23392936|NCT02096354|65184848|FG002|Overall Study|Physician Decision|0|||
23392937|NCT02096354|65184846|FG000|Overall Study|Withdrawal by Subject|3|||
23392938|NCT02096354|65184847|FG001|Overall Study|Withdrawal by Subject|1|||
23392939|NCT02096354|65184848|FG002|Overall Study|Withdrawal by Subject|0|||
23392940|NCT02096354|65184846|FG000|Overall Study|Adverse Event|7|||
23392941|NCT02096354|65184847|FG001|Overall Study|Adverse Event|4|||
23392942|NCT02096354|65184848|FG002|Overall Study|Adverse Event|0|||
23392943|NCT02096354|65184846|FG000|Overall Study|Ineligible|0|||
23392944|NCT02096354|65184847|FG001|Overall Study|Ineligible|0|||
23392945|NCT02096354|65184848|FG002|Overall Study|Ineligible|11|||
23392946|NCT00645658|65184854|FG000|Overall Study|Withdrawal by Subject|1|||
23392947|NCT00645658|65184855|FG001|Overall Study|Withdrawal by Subject|0|||
23392948|NCT00645658|65184854|FG000|Overall Study|Did not complete all assesments|0|||
23392949|NCT00645658|65184855|FG001|Overall Study|Did not complete all assesments|2|||
23392950|NCT03569891|65184856|FG000|Lead-in|Ineligible during lead-in|8|||
23392951|NCT03569891|65184856|FG000|Lead-in|Withdrawal by Subject|3|||
23392952|NCT03569891|65184856|FG000|Lead-in|Risks related to COVID-19|2|||
23392953|NCT03569891|65184856|FG000|AMT-061|Adverse Event|1|||
23392954|NCT03423979|65184857|FG000|Overall Study|Death|1|||
23392955|NCT03692052|65184860|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
23392956|NCT03692052|65184860|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
23392957|NCT03692052|65184860|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
23392958|NCT03692052|65184860|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
23392959|NCT01500135|65184871|FG000|Overall Study|Withdrawal of Consent|4|||
23392960|NCT01500135|65184872|FG001|Overall Study|Withdrawal of Consent|0|||
23496986|NCT00457301|65562528|FG001|Overall Study|Withdrawal by Subject|3|||
23496987|NCT00457301|65562527|FG000|Overall Study|Censored out of the study|15|||
23496988|NCT00457301|65562528|FG001|Overall Study|Censored out of the study|14|||
23496989|NCT00457301|65562527|FG000|Overall Study|Death|5|||
23496990|NCT00457301|65562528|FG001|Overall Study|Death|7|||
23496991|NCT03000569|65562529|FG000|Overall Study|Withdrawal by Subject|1|||
23496992|NCT03000569|65562530|FG001|Overall Study|Withdrawal by Subject|0|||
23496993|NCT00165984|65562531|FG000|Overall Study|Death|15|||
23496994|NCT02059408|65562532|FG000|Overall Study|Did not get tested|0|||
23496995|NCT02059408|65562533|FG001|Overall Study|Did not get tested|330|||
23496996|NCT02059408|65562534|FG002|Overall Study|Did not get tested|358|||
23496997|NCT01706146|65562535|FG000|Overall Study|Withdrawal by Subject|1|||
23496998|NCT01706146|65562535|FG000|Overall Study|Adverse Event|3|||
23496999|NCT01706146|65562535|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
23497000|NCT02202980|65562539|FG000|Overall Study|Lack of Efficacy|1|||
23497001|NCT02202980|65562540|FG001|Overall Study|Lack of Efficacy|0|||
23497002|NCT02202980|65562541|FG002|Overall Study|Lack of Efficacy|7|||
23497003|NCT02202980|65562542|FG003|Overall Study|Lack of Efficacy|0|||
23497004|NCT02202980|65562543|FG004|Overall Study|Lack of Efficacy|3|||
23497005|NCT02202980|65562544|FG005|Overall Study|Lack of Efficacy|1|||
23497006|NCT02202980|65562545|FG006|Overall Study|Lack of Efficacy|11|||
23497007|NCT02202980|65562546|FG007|Overall Study|Lack of Efficacy|2|||
23497008|NCT02202980|65562547|FG008|Overall Study|Lack of Efficacy|2|||
23497009|NCT02202980|65562548|FG009|Overall Study|Lack of Efficacy|0|||
23497010|NCT02202980|65562549|FG010|Overall Study|Lack of Efficacy|0|||
23497011|NCT02202980|65562550|FG011|Overall Study|Lack of Efficacy|3|||
23497012|NCT02202980|65562551|FG012|Overall Study|Lack of Efficacy|10|||
23497013|NCT02202980|65562552|FG013|Overall Study|Lack of Efficacy|0|||
23497014|NCT02202980|65562539|FG000|Overall Study|Protocol Violation|0|||
23497015|NCT02202980|65562540|FG001|Overall Study|Protocol Violation|0|||
23497016|NCT02202980|65562541|FG002|Overall Study|Protocol Violation|0|||
23497017|NCT02202980|65562542|FG003|Overall Study|Protocol Violation|3|||
23497018|NCT02202980|65562543|FG004|Overall Study|Protocol Violation|3|||
23497019|NCT02202980|65562544|FG005|Overall Study|Protocol Violation|0|||
23497020|NCT02202980|65562545|FG006|Overall Study|Protocol Violation|0|||
23497021|NCT02202980|65562546|FG007|Overall Study|Protocol Violation|0|||
23497022|NCT02202980|65562547|FG008|Overall Study|Protocol Violation|0|||
23497023|NCT02202980|65562548|FG009|Overall Study|Protocol Violation|0|||
23497024|NCT02202980|65562549|FG010|Overall Study|Protocol Violation|0|||
23497025|NCT02202980|65562550|FG011|Overall Study|Protocol Violation|0|||
23497026|NCT02202980|65562551|FG012|Overall Study|Protocol Violation|0|||
23497027|NCT02202980|65562552|FG013|Overall Study|Protocol Violation|0|||
23497028|NCT02202980|65562539|FG000|Overall Study|Lost to Follow-up|0|||
23497029|NCT02202980|65562540|FG001|Overall Study|Lost to Follow-up|1|||
23497030|NCT02202980|65562541|FG002|Overall Study|Lost to Follow-up|1|||
23497031|NCT02202980|65562542|FG003|Overall Study|Lost to Follow-up|1|||
23497032|NCT02202980|65562543|FG004|Overall Study|Lost to Follow-up|0|||
23497033|NCT02202980|65562544|FG005|Overall Study|Lost to Follow-up|0|||
23497034|NCT02202980|65562545|FG006|Overall Study|Lost to Follow-up|0|||
23497035|NCT02202980|65562546|FG007|Overall Study|Lost to Follow-up|1|||
23497036|NCT02202980|65562547|FG008|Overall Study|Lost to Follow-up|1|||
23497037|NCT02202980|65562548|FG009|Overall Study|Lost to Follow-up|0|||
23497038|NCT02202980|65562549|FG010|Overall Study|Lost to Follow-up|0|||
23497039|NCT02202980|65562550|FG011|Overall Study|Lost to Follow-up|0|||
23497040|NCT02202980|65562551|FG012|Overall Study|Lost to Follow-up|1|||
23497041|NCT02202980|65562552|FG013|Overall Study|Lost to Follow-up|0|||
23497042|NCT02202980|65562539|FG000|Overall Study|Withdrew Consent|0|||
23497043|NCT02202980|65562540|FG001|Overall Study|Withdrew Consent|1|||
23497044|NCT02202980|65562541|FG002|Overall Study|Withdrew Consent|2|||
23497045|NCT02202980|65562542|FG003|Overall Study|Withdrew Consent|0|||
23497046|NCT02202980|65562543|FG004|Overall Study|Withdrew Consent|0|||
23497047|NCT02202980|65562544|FG005|Overall Study|Withdrew Consent|0|||
23497048|NCT02202980|65562545|FG006|Overall Study|Withdrew Consent|0|||
23497049|NCT02202980|65562546|FG007|Overall Study|Withdrew Consent|0|||
23497050|NCT02202980|65562547|FG008|Overall Study|Withdrew Consent|1|||
23497051|NCT02202980|65562548|FG009|Overall Study|Withdrew Consent|0|||
23497052|NCT02202980|65562549|FG010|Overall Study|Withdrew Consent|0|||
23497053|NCT02202980|65562550|FG011|Overall Study|Withdrew Consent|0|||
23497054|NCT02202980|65562551|FG012|Overall Study|Withdrew Consent|0|||
23497055|NCT02202980|65562552|FG013|Overall Study|Withdrew Consent|0|||
23497056|NCT00736944|65562557|FG000|Induction|Death|1|||
23497057|NCT00736944|65562557|FG000|Definitive Treatment|Physician Decision|1|||
23497058|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
23497059|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
23497060|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
23497061|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
23497062|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
23497063|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
23392961|NCT01500135|65184871|FG000|Overall Study|Lost to Follow-up|6|||
23497064|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
23497065|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
23497066|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
23497067|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
23497068|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
23497069|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
23497070|NCT00044083|65562559|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
23497071|NCT00044083|65562560|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
23497072|NCT00044083|65562559|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
23497073|NCT00044083|65562560|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
23497074|NCT00044083|65562559|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
23497075|NCT00044083|65562560|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
23497076|NCT00044083|65562559|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
23497077|NCT00044083|65562560|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
23497078|NCT01330030|65562564|FG000|Overall Study|Lost to Follow-up|16|||
23497079|NCT01330030|65562565|FG001|Overall Study|Lost to Follow-up|17|||
23497080|NCT03113071|65562568|FG000|Overall Study|Withdrawal by Subject|1|||
23497081|NCT03113071|65562569|FG001|Overall Study|Withdrawal by Subject|0|||
23497082|NCT01409434|65562570|FG000|Overall Study|Protocol Violation|4|||
23497083|NCT00369707|65562571|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
23497084|NCT00369707|65562571|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
23497085|NCT00369707|65562571|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
23497086|NCT00369707|65562571|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
23497087|NCT00369707|65562571|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
23497088|NCT00369707|65562571|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
23497089|NCT00369707|65562571|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
23497090|NCT00369707|65562571|FG000|Follow up for 2 Years After Treatment|Death|1|||
23497091|NCT00369707|65562571|FG000|Follow up for 2 Years After Treatment|Other|2|||
23497092|NCT02564796|65562574|FG000|Overall Study|Physician Decision|2|||
23497093|NCT02564796|65562575|FG001|Overall Study|Physician Decision|2|||
23497094|NCT01558739|65562576|FG000|Overall Study|Adverse Event|7|||
23497095|NCT01558739|65562576|FG000|Overall Study|Withdrawal by Subject|2|||
23497096|NCT01558739|65562576|FG000|Overall Study|Death|3|||
23497097|NCT01558739|65562576|FG000|Overall Study|Disease Progression|4|||
23497098|NCT01558739|65562576|FG000|Overall Study|Protocol Violation|1|||
23497099|NCT03068455|65562579|FG000|Pre-treatment Period|Disease progression|0|||
23497100|NCT03068455|65562580|FG001|Pre-treatment Period|Disease progression|1|||
23497101|NCT03068455|65562579|FG000|Pre-treatment Period|Participant withdrew consent|1|||
23497102|NCT03068455|65562580|FG001|Pre-treatment Period|Participant withdrew consent|1|||
23497103|NCT03068455|65562579|FG000|Pre-treatment Period|Poor/non-compliance|0|||
23497104|NCT03068455|65562580|FG001|Pre-treatment Period|Poor/non-compliance|1|||
23497105|NCT03068455|65562579|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
23497106|NCT03068455|65562580|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
23497107|NCT03068455|65562579|FG000|Pre-treatment Period|Not reported|2|||
23497108|NCT03068455|65562580|FG001|Pre-treatment Period|Not reported|1|||
23497109|NCT03068455|65562579|FG000|Treatment Period|Disease progression|166|||
23497110|NCT03068455|65562580|FG001|Treatment Period|Disease progression|208|||
23497111|NCT03068455|65562579|FG000|Treatment Period|Study drug toxicity|317|||
23497112|NCT03068455|65562580|FG001|Treatment Period|Study drug toxicity|104|||
23497113|NCT03068455|65562579|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
23497114|NCT03068455|65562580|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
23497115|NCT03068455|65562579|FG000|Treatment Period|Participant request to stop therapy|33|||
23497116|NCT03068455|65562580|FG001|Treatment Period|Participant request to stop therapy|20|||
23497117|NCT03068455|65562579|FG000|Treatment Period|Participant withdrew consent|5|||
23497118|NCT03068455|65562580|FG001|Treatment Period|Participant withdrew consent|10|||
23497119|NCT03068455|65562579|FG000|Treatment Period|Poor/non-compliance|3|||
23497120|NCT03068455|65562580|FG001|Treatment Period|Poor/non-compliance|0|||
23497121|NCT03068455|65562579|FG000|Treatment Period|Participant no longer meets study criteria|1|||
23497122|NCT03068455|65562580|FG001|Treatment Period|Participant no longer meets study criteria|3|||
23497123|NCT03068455|65562579|FG000|Treatment Period|Other reasons|12|||
23497124|NCT03068455|65562580|FG001|Treatment Period|Other reasons|4|||
23497125|NCT03344796|65562582|FG000|Overall Study|Lost to Follow-up|0|||
23497126|NCT03344796|65562583|FG001|Overall Study|Lost to Follow-up|0|||
23497127|NCT03344796|65562584|FG002|Overall Study|Lost to Follow-up|0|||
23497128|NCT03344796|65562585|FG003|Overall Study|Lost to Follow-up|0|||
23497129|NCT03344796|65562586|FG004|Overall Study|Lost to Follow-up|0|||
23497130|NCT03344796|65562587|FG005|Overall Study|Lost to Follow-up|2|||
23497131|NCT00851630|65562594|FG000|Overall Study|Death|2|||
23497132|NCT00851630|65562595|FG001|Overall Study|Death|1|||
23497133|NCT00851630|65562594|FG000|Overall Study|Clinical failure|0|||
23497134|NCT00851630|65562595|FG001|Overall Study|Clinical failure|1|||
23497135|NCT00751933|65562596|FG000|Overall Study|Withdrawal by Subject|0|||
23497136|NCT00751933|65562597|FG001|Overall Study|Withdrawal by Subject|1|||
23497137|NCT00751933|65562598|FG002|Overall Study|Withdrawal by Subject|0|||
23497138|NCT00751933|65562599|FG003|Overall Study|Withdrawal by Subject|0|||
23497139|NCT00751933|65562596|FG000|Overall Study|Physician Decision|0|||
23497140|NCT00751933|65562597|FG001|Overall Study|Physician Decision|0|||
23497141|NCT00751933|65562598|FG002|Overall Study|Physician Decision|1|||
23497142|NCT00751933|65562599|FG003|Overall Study|Physician Decision|1|||
23497143|NCT05085730|65562600|FG000|Overall Study|Withdrawal by Subject|4|||
23497144|NCT05085730|65562600|FG000|Overall Study|Physician Decision|1|||
23497145|NCT01488370|65562605|FG000|Overall Study|Protocol Violation|0|||
23497146|NCT01488370|65562606|FG001|Overall Study|Protocol Violation|1|||
23497147|NCT01488370|65562607|FG002|Overall Study|Protocol Violation|1|||
23497148|NCT00306189|65562609|FG000|Overall Study|Physician Decision|0|||
23497149|NCT00306189|65562610|FG001|Overall Study|Physician Decision|0|||
23497150|NCT00306189|65562611|FG002|Overall Study|Physician Decision|0|||
23497151|NCT00306189|65562612|FG003|Overall Study|Physician Decision|1|||
23497152|NCT00306189|65562609|FG000|Overall Study|Adverse Event|3|||
23497153|NCT00306189|65562610|FG001|Overall Study|Adverse Event|3|||
23497154|NCT00306189|65562611|FG002|Overall Study|Adverse Event|2|||
23497155|NCT00306189|65562612|FG003|Overall Study|Adverse Event|2|||
23497156|NCT00306189|65562609|FG000|Overall Study|Withdrawal by Subject|4|||
23497157|NCT00306189|65562610|FG001|Overall Study|Withdrawal by Subject|2|||
23300398|NCT00375492|64842788|FG000|Overall Study|Entry Criteria Not Met|0|||
23497158|NCT00306189|65562611|FG002|Overall Study|Withdrawal by Subject|8|||
23497159|NCT00306189|65562612|FG003|Overall Study|Withdrawal by Subject|1|||
23497160|NCT00306189|65562609|FG000|Overall Study|Ineligibility determined|1|||
23497161|NCT00306189|65562610|FG001|Overall Study|Ineligibility determined|1|||
23497162|NCT00306189|65562611|FG002|Overall Study|Ineligibility determined|1|||
23497163|NCT00306189|65562612|FG003|Overall Study|Ineligibility determined|1|||
23497164|NCT00306189|65562609|FG000|Overall Study|Other|1|||
23497165|NCT00306189|65562610|FG001|Overall Study|Other|0|||
23497166|NCT00306189|65562611|FG002|Overall Study|Other|0|||
23392962|NCT01500135|65184872|FG001|Overall Study|Lost to Follow-up|4|||
23392963|NCT01500135|65184871|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
23392964|NCT01500135|65184872|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
23392965|NCT01500135|65184871|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
23392966|NCT01500135|65184872|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
23392967|NCT01500135|65184871|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
23392968|NCT01500135|65184872|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
23392969|NCT01500135|65184871|FG000|Overall Study|Participant was a Safety Concern|1|||
23392970|NCT01500135|65184872|FG001|Overall Study|Participant was a Safety Concern|0|||
23392971|NCT01500135|65184871|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
23392972|NCT01500135|65184872|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
23392973|NCT03274466|65184873|FG000|Overall Study|Withdrawal by Subject|7|||
23392974|NCT03274466|65184874|FG001|Overall Study|Withdrawal by Subject|3|||
23392975|NCT03274466|65184873|FG000|Overall Study|Protocol Specified Withdrawal|5|||
23392976|NCT03274466|65184874|FG001|Overall Study|Protocol Specified Withdrawal|11|||
23392977|NCT03274466|65184873|FG000|Overall Study|Lost to Follow-up|5|||
23392978|NCT03274466|65184874|FG001|Overall Study|Lost to Follow-up|7|||
23392979|NCT03274466|65184873|FG000|Overall Study|Subject Non-compliance|0|||
23392980|NCT03274466|65184874|FG001|Overall Study|Subject Non-compliance|1|||
23392981|NCT03274466|65184873|FG000|Overall Study|Adverse Event|3|||
23392982|NCT03274466|65184874|FG001|Overall Study|Adverse Event|3|||
23392983|NCT03274466|65184873|FG000|Overall Study|Physician Decision|0|||
23392984|NCT03274466|65184874|FG001|Overall Study|Physician Decision|1|||
23392985|NCT03274466|65184873|FG000|Overall Study|Protocol Violation|3|||
23392986|NCT03274466|65184874|FG001|Overall Study|Protocol Violation|3|||
23392987|NCT01979185|65184875|FG000|Period 2|Other|0|||
23392988|NCT01979185|65184876|FG001|Period 2|Other|1|||
23392989|NCT01911260|65184877|FG000|Supplementation Period|transference or evasion of school|7|||
23392990|NCT01911260|65184878|FG001|Supplementation Period|transference or evasion of school|9|||
23392991|NCT01911260|65184879|FG002|Supplementation Period|transference or evasion of school|7|||
23392992|NCT01911260|65184880|FG003|Supplementation Period|transference or evasion of school|6|||
23392993|NCT01911260|65184877|FG000|Supplementation Period|Adverse Event|2|||
23392994|NCT01911260|65184878|FG001|Supplementation Period|Adverse Event|0|||
23392995|NCT01911260|65184879|FG002|Supplementation Period|Adverse Event|1|||
23392996|NCT01911260|65184880|FG003|Supplementation Period|Adverse Event|0|||
23392997|NCT01911260|65184877|FG000|Supplementation Period|refused to receive supplement|1|||
23392998|NCT01911260|65184878|FG001|Supplementation Period|refused to receive supplement|0|||
23392999|NCT01911260|65184879|FG002|Supplementation Period|refused to receive supplement|1|||
23393000|NCT01911260|65184880|FG003|Supplementation Period|refused to receive supplement|0|||
23393001|NCT01911260|65184877|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
23393002|NCT01911260|65184878|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
23393003|NCT01911260|65184879|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
23393004|NCT01911260|65184880|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
23393005|NCT01911260|65184877|FG000|Follow-up Period|transference or evasion of school|13|||
23393006|NCT01911260|65184878|FG001|Follow-up Period|transference or evasion of school|20|||
23393007|NCT01911260|65184879|FG002|Follow-up Period|transference or evasion of school|15|||
23393008|NCT01911260|65184880|FG003|Follow-up Period|transference or evasion of school|12|||
23393009|NCT03997383|65186711|FG000|Double-blind Treatment Period|Adverse Event|4|||
23393010|NCT03997383|65186712|FG001|Double-blind Treatment Period|Adverse Event|3|||
23393011|NCT03997383|65186711|FG000|Double-blind Treatment Period|Death|4|||
23393012|NCT03997383|65186712|FG001|Double-blind Treatment Period|Death|4|||
23393013|NCT03997383|65186711|FG000|Double-blind Treatment Period|Physician Decision|2|||
23393014|NCT03997383|65186712|FG001|Double-blind Treatment Period|Physician Decision|0|||
23393015|NCT03997383|65186711|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
23393016|NCT03997383|65186712|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
23393017|NCT03997383|65186711|FG000|Open-label Extension Period|Ongoing|148|||
23393018|NCT03997383|65186712|FG001|Open-label Extension Period|Ongoing|151|||
23393019|NCT03997383|65186711|FG000|Open-label Extension Period|Adverse Event|4|||
23393020|NCT03997383|65186712|FG001|Open-label Extension Period|Adverse Event|1|||
23393021|NCT03997383|65186711|FG000|Open-label Extension Period|Death|8|||
23393022|NCT03997383|65186712|FG001|Open-label Extension Period|Death|9|||
23393023|NCT03997383|65186711|FG000|Open-label Extension Period|Physician Decision|1|||
23497167|NCT00306189|65562612|FG003|Overall Study|Other|0|||
23497168|NCT03948581|65562617|FG000|Overall Study|Lost to Follow-up|0|||
23497169|NCT03948581|65562618|FG001|Overall Study|Lost to Follow-up|1|||
23497170|NCT01649804|65562622|FG000|Overall Study|Administrative/Other|8|||
23497171|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
23497172|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
23497173|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
23497174|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
23497175|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
23497176|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
23497177|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
23497178|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
23497179|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
23497180|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497181|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497182|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497183|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497184|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497185|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497186|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
23497187|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
23497188|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497189|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497190|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497191|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497192|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497193|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497194|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
23497195|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
23497196|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497197|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497198|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497199|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497200|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497201|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497202|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
23497203|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
23497204|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497205|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497206|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497207|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497208|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497209|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497210|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
23497211|NCT00533897|65562627|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
23497212|NCT00533897|65562628|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497213|NCT00533897|65562629|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497214|NCT00533897|65562630|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497215|NCT00533897|65562631|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497216|NCT00533897|65562632|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497217|NCT00533897|65562633|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497218|NCT00533897|65562634|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
23497219|NCT00533897|65562627|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497220|NCT00533897|65562628|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
23393024|NCT03997383|65186712|FG001|Open-label Extension Period|Physician Decision|1|||
23393025|NCT03997383|65186711|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
23393026|NCT03997383|65186712|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
23497221|NCT00533897|65562629|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
23497222|NCT00533897|65562630|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497223|NCT00533897|65562631|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497224|NCT00533897|65562632|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497225|NCT00533897|65562633|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497226|NCT00533897|65562634|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
23497227|NCT00533897|65562627|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497228|NCT00533897|65562628|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497229|NCT00533897|65562629|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
23497230|NCT00533897|65562630|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497231|NCT00533897|65562631|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497232|NCT00533897|65562632|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497233|NCT00533897|65562633|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497234|NCT00533897|65562634|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
23497235|NCT00533897|65562627|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497236|NCT00533897|65562628|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497237|NCT00533897|65562629|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497238|NCT00533897|65562630|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497239|NCT00533897|65562631|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497240|NCT00533897|65562632|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
23497241|NCT00533897|65562633|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497242|NCT00533897|65562634|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
23497243|NCT00533897|65562627|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497244|NCT00533897|65562628|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497245|NCT00533897|65562629|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497246|NCT00533897|65562630|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497247|NCT00533897|65562631|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497248|NCT00533897|65562632|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
23497249|NCT00533897|65562633|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497250|NCT00533897|65562634|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
23497251|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497252|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497253|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497254|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497255|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497256|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
23497257|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
23497258|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
23497259|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Death|0|||
23497260|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Death|0|||
23497261|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Death|0|||
23497262|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Death|0|||
23497263|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Death|0|||
23497264|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Death|0|||
23497265|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Death|1|||
23497266|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Death|3|||
23497267|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497268|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497269|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497270|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497271|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497272|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
23497273|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
23497274|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
23497275|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497276|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497277|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497278|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497279|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497280|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497281|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
23497282|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
23497283|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Adverse Event|0|||
23497284|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Adverse Event|0|||
23497285|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Adverse Event|0|||
23497286|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Adverse Event|0|||
23497287|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Adverse Event|0|||
23497288|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Adverse Event|0|||
23497289|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Adverse Event|2|||
23497290|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Adverse Event|5|||
23497291|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Pregnancy|0|||
23497292|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Pregnancy|0|||
23497293|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Pregnancy|0|||
23497294|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Pregnancy|0|||
23497295|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Pregnancy|0|||
23497296|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Pregnancy|0|||
23497297|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Pregnancy|0|||
23497298|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Pregnancy|2|||
23497299|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497300|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497301|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497302|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497303|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497304|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
23497305|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
23497306|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
23497307|NCT00533897|65562627|FG000|Long Term Extension (LTE)|Other|0|||
23497308|NCT00533897|65562628|FG001|Long Term Extension (LTE)|Other|0|||
23497309|NCT00533897|65562629|FG002|Long Term Extension (LTE)|Other|0|||
23497310|NCT00533897|65562630|FG003|Long Term Extension (LTE)|Other|0|||
23497311|NCT00533897|65562631|FG004|Long Term Extension (LTE)|Other|0|||
23497312|NCT00533897|65562632|FG005|Long Term Extension (LTE)|Other|0|||
23497313|NCT00533897|65562633|FG006|Long Term Extension (LTE)|Other|1|||
23497314|NCT00533897|65562634|FG007|Long Term Extension (LTE)|Other|6|||
23497315|NCT01930123|65562635|FG000|Overall Study|Adverse Event|1|||
23497316|NCT01930123|65562636|FG001|Overall Study|Adverse Event|0|||
23497317|NCT01930123|65562635|FG000|Overall Study|Physician Decision|21|||
23497318|NCT01930123|65562636|FG001|Overall Study|Physician Decision|8|||
23497319|NCT01930123|65562635|FG000|Overall Study|Withdrawal by Subject|1|||
23497320|NCT01930123|65562636|FG001|Overall Study|Withdrawal by Subject|0|||
23497321|NCT02015754|65562645|FG000|Overall Study|Disease progression|5|||
23497322|NCT02015754|65562645|FG000|Overall Study|Change in treatment modality|5|||
23497323|NCT02015754|65562645|FG000|Overall Study|Lost to Follow-up|1|||
23497324|NCT04515394|65562657|FG000|Overall Study|Participant did not receive treatment|1|||
23497325|NCT00094172|65562660|FG000|Overall Study|Adverse Event|0|||
23497326|NCT00094172|65562661|FG001|Overall Study|Adverse Event|1|||
23497327|NCT00094172|65562660|FG000|Overall Study|Lost to Follow-up|2|||
23497328|NCT00094172|65562661|FG001|Overall Study|Lost to Follow-up|0|||
23393027|NCT03997383|65186711|FG000|Open-label Extension Period|Reason Not Specified|2|||
23393028|NCT03997383|65186712|FG001|Open-label Extension Period|Reason Not Specified|0|||
23393029|NCT02185768|65186713|FG000|Overall Study|Patients were not treated|2|||
23393030|NCT01356940|65186715|FG000|First Intervention (28 Days)|Adverse Event|1|||
23393031|NCT01356940|65186716|FG001|First Intervention (28 Days)|Adverse Event|0|||
23393032|NCT01356940|65186715|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
23393033|NCT01356940|65186716|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
23393034|NCT03599713|65186719|FG000|Overall Study|Death|26|||
23393035|NCT03599713|65186720|FG001|Overall Study|Death|3|||
23393036|NCT03599713|65186719|FG000|Overall Study|Withdrawal by Subject|6|||
23393037|NCT03599713|65186720|FG001|Overall Study|Withdrawal by Subject|0|||
23393038|NCT03599713|65186719|FG000|Overall Study|Ongoing|69|||
23393039|NCT03599713|65186720|FG001|Overall Study|Ongoing|3|||
23393040|NCT00432965|65186721|FG000|Overall Study|Lost to Follow-up|22|||
23393041|NCT00432965|65186722|FG001|Overall Study|Lost to Follow-up|19|||
23393042|NCT00432965|65186721|FG000|Overall Study|Withdrawal by Subject|13|||
23393043|NCT00432965|65186722|FG001|Overall Study|Withdrawal by Subject|13|||
23393044|NCT00432965|65186721|FG000|Overall Study|Physician Decision|14|||
23393045|NCT00432965|65186722|FG001|Overall Study|Physician Decision|13|||
23393046|NCT00432965|65186721|FG000|Overall Study|Lack of Efficacy|8|||
23393047|NCT00432965|65186722|FG001|Overall Study|Lack of Efficacy|13|||
23393048|NCT00432965|65186721|FG000|Overall Study|Non-compliance|7|||
23393049|NCT00432965|65186722|FG001|Overall Study|Non-compliance|0|||
23393050|NCT00432965|65186721|FG000|Overall Study|Adverse Event|22|||
23393051|NCT00432965|65186722|FG001|Overall Study|Adverse Event|19|||
23393052|NCT00432965|65186721|FG000|Overall Study|Death|3|||
23393053|NCT00432965|65186722|FG001|Overall Study|Death|4|||
23393054|NCT00432965|65186721|FG000|Overall Study|Exclusionary Methods|1|||
23393055|NCT00432965|65186722|FG001|Overall Study|Exclusionary Methods|2|||
23393056|NCT00432965|65186721|FG000|Overall Study|Incomplete Data|4|||
23393057|NCT00432965|65186722|FG001|Overall Study|Incomplete Data|3|||
23393058|NCT00425555|65186723|FG000|Overall Study|Withdrawal by Subject|11|||
23393059|NCT00425555|65186724|FG001|Overall Study|Withdrawal by Subject|8|||
23393060|NCT00425555|65186723|FG000|Overall Study|Lost to Follow-up|0|||
23393061|NCT00425555|65186724|FG001|Overall Study|Lost to Follow-up|1|||
23393062|NCT00425555|65186723|FG000|Overall Study|Administrative problems|3|||
23393063|NCT00425555|65186724|FG001|Overall Study|Administrative problems|0|||
23393064|NCT00425555|65186723|FG000|Overall Study|Death|1|||
23393065|NCT00425555|65186724|FG001|Overall Study|Death|2|||
23393066|NCT00425555|65186723|FG000|Overall Study|New cancer therapy|2|||
23393067|NCT00425555|65186724|FG001|Overall Study|New cancer therapy|1|||
23393068|NCT00425555|65186723|FG000|Overall Study|Disease progression|36|||
23393069|NCT00425555|65186724|FG001|Overall Study|Disease progression|33|||
23393070|NCT00425555|65186723|FG000|Overall Study|Adverse Event|25|||
23393071|NCT00425555|65186724|FG001|Overall Study|Adverse Event|15|||
23393072|NCT00425555|65186723|FG000|Overall Study|Protocol Violation|1|||
23393073|NCT00425555|65186724|FG001|Overall Study|Protocol Violation|0|||
23393074|NCT05270863|65186725|FG000|Visit 2 First Intervention|Randomization error|0|||
23393075|NCT05270863|65186726|FG001|Visit 2 First Intervention|Randomization error|0|||
23393076|NCT05270863|65186727|FG002|Visit 2 First Intervention|Randomization error|0|||
23393077|NCT05270863|65186728|FG003|Visit 2 First Intervention|Randomization error|1|||
23393078|NCT05270863|65186729|FG004|Visit 2 First Intervention|Randomization error|0|||
23497329|NCT00094172|65562660|FG000|Overall Study|Protocol Violation|0|||
23497330|NCT00094172|65562661|FG001|Overall Study|Protocol Violation|1|||
23497331|NCT00094172|65562660|FG000|Overall Study|Withdrawal by Subject|10|||
23497332|NCT00094172|65562661|FG001|Overall Study|Withdrawal by Subject|5|||
23497333|NCT00094172|65562660|FG000|Overall Study|Primary endpoint met.|1|||
23497334|NCT00094172|65562661|FG001|Overall Study|Primary endpoint met.|0|||
23497335|NCT00094172|65562660|FG000|Overall Study|Started other MS therapy due to disease|1|||
23497336|NCT00094172|65562661|FG001|Overall Study|Started other MS therapy due to disease|0|||
23497337|NCT04478266|65562662|FG000|Overall Study|Adverse Event|20|||
23497338|NCT04478266|65562663|FG001|Overall Study|Adverse Event|21|||
23497339|NCT04478266|65562662|FG000|Overall Study|Progressive disease|146|||
23497340|NCT04478266|65562663|FG001|Overall Study|Progressive disease|168|||
23497341|NCT04478266|65562662|FG000|Overall Study|Poor compliance to protocol|1|||
23497342|NCT04478266|65562663|FG001|Overall Study|Poor compliance to protocol|0|||
23497343|NCT04478266|65562662|FG000|Overall Study|Withdrawal by Subject|19|||
23497344|NCT04478266|65562663|FG001|Overall Study|Withdrawal by Subject|16|||
23497345|NCT04478266|65562662|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
23497346|NCT04478266|65562663|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
23497347|NCT04478266|65562662|FG000|Overall Study|Study terminated by sponsor|33|||
23497348|NCT04478266|65562663|FG001|Overall Study|Study terminated by sponsor|35|||
23497349|NCT04478266|65562662|FG000|Overall Study|Other: unspecified|5|||
23497350|NCT04478266|65562663|FG001|Overall Study|Other: unspecified|7|||
23497351|NCT04478266|65562662|FG000|Overall Study|Randomized but not treated|1|||
23497352|NCT04478266|65562663|FG001|Overall Study|Randomized but not treated|1|||
23393079|NCT05270863|65186730|FG005|Visit 2 First Intervention|Randomization error|0|||
23393080|NCT05270863|65186725|FG000|First Washout|Withdrawal by Subject|0|||
23393081|NCT05270863|65186726|FG001|First Washout|Withdrawal by Subject|0|||
23393082|NCT05270863|65186727|FG002|First Washout|Withdrawal by Subject|0|||
23393083|NCT05270863|65186728|FG003|First Washout|Withdrawal by Subject|0|||
23393084|NCT05270863|65186729|FG004|First Washout|Withdrawal by Subject|1|||
23393085|NCT05270863|65186730|FG005|First Washout|Withdrawal by Subject|1|||
23393086|NCT05270863|65186725|FG000|First Washout|Lost to Follow-up|0|||
23393087|NCT05270863|65186726|FG001|First Washout|Lost to Follow-up|0|||
23393088|NCT05270863|65186727|FG002|First Washout|Lost to Follow-up|0|||
23393089|NCT05270863|65186728|FG003|First Washout|Lost to Follow-up|0|||
23393090|NCT05270863|65186729|FG004|First Washout|Lost to Follow-up|0|||
23393091|NCT05270863|65186730|FG005|First Washout|Lost to Follow-up|1|||
23393092|NCT05270863|65186725|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
23393093|NCT05270863|65186726|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
23393094|NCT05270863|65186727|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
23393095|NCT05270863|65186728|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
23393096|NCT05270863|65186729|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
23393097|NCT05270863|65186730|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
23393098|NCT05270863|65186725|FG000|Second Washout|Withdrawal by Subject|1|||
23393099|NCT05270863|65186726|FG001|Second Washout|Withdrawal by Subject|1|||
23393100|NCT05270863|65186727|FG002|Second Washout|Withdrawal by Subject|0|||
23393101|NCT05270863|65186728|FG003|Second Washout|Withdrawal by Subject|0|||
23393102|NCT05270863|65186729|FG004|Second Washout|Withdrawal by Subject|0|||
23393103|NCT05270863|65186730|FG005|Second Washout|Withdrawal by Subject|0|||
23393104|NCT05270863|65186725|FG000|Second Washout|Lost to Follow-up|0|||
23393105|NCT05270863|65186726|FG001|Second Washout|Lost to Follow-up|0|||
23393106|NCT05270863|65186727|FG002|Second Washout|Lost to Follow-up|0|||
23393107|NCT05270863|65186728|FG003|Second Washout|Lost to Follow-up|1|||
23393108|NCT05270863|65186729|FG004|Second Washout|Lost to Follow-up|0|||
23393109|NCT05270863|65186730|FG005|Second Washout|Lost to Follow-up|0|||
23393110|NCT00939185|65186732|FG000|Overall Study|Adverse Event|3|||
23393111|NCT00939185|65186732|FG000|Overall Study|Lack of Efficacy|1|||
23393112|NCT00939185|65186732|FG000|Overall Study|Lost to Follow-up|6|||
23393113|NCT00939185|65186732|FG000|Overall Study|Other|3|||
23393114|NCT00939185|65186732|FG000|Overall Study|Withdrawal by Subject|2|||
23393115|NCT00939185|65186732|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
23393116|NCT04100018|65186733|FG000|Pre-Treatment Period|Not Reported|0|||
23497353|NCT00365508|65562664|FG000|Overall Study|Lost to Follow-up|139|||
23497354|NCT00365508|65562665|FG001|Overall Study|Lost to Follow-up|154|||
23393117|NCT04100018|65186734|FG001|Pre-Treatment Period|Not Reported|4|||
23497355|NCT01788228|65562666|FG000|Overall Study|Migrated/moved from study area|1|||
23497356|NCT01788228|65562667|FG001|Overall Study|Migrated/moved from study area|0|||
23497357|NCT03840174|65562668|FG000|Overall Study|Withdrawal by Subject|1|||
23497358|NCT03840174|65562669|FG001|Overall Study|Withdrawal by Subject|0|||
23497359|NCT03840174|65562670|FG002|Overall Study|Withdrawal by Subject|0|||
23497360|NCT03840174|65562671|FG003|Overall Study|Withdrawal by Subject|0|||
23497361|NCT01387789|65562672|FG000|Overall Study|Adverse Event|5|||
23497362|NCT01387789|65562672|FG000|Overall Study|Lack of Efficacy|2|||
23497363|NCT01387789|65562672|FG000|Overall Study|Lost to Follow-up|1|||
23497364|NCT01773733|65562673|FG000|Overall Study|Adverse Event|3286|||
23497365|NCT01773733|65562674|FG001|Overall Study|Adverse Event|540|||
23497366|NCT01773733|65562673|FG000|Overall Study|Pregnancy|28|||
23497367|NCT01773733|65562674|FG001|Overall Study|Pregnancy|0|||
23497368|NCT01773733|65562673|FG000|Overall Study|Other different categories of not compl|55415|||
23497369|NCT01773733|65562674|FG001|Overall Study|Other different categories of not compl|7781|||
23497370|NCT01890473|65562675|FG000|Overall Study|Lost to Follow-up|1|||
23497371|NCT01890473|65562676|FG001|Overall Study|Lost to Follow-up|0|||
23497372|NCT01890473|65562675|FG000|Overall Study|Poor/non-compliance|1|||
23497373|NCT01890473|65562676|FG001|Overall Study|Poor/non-compliance|0|||
23497374|NCT00282412|65562677|FG000|Overall Study|Death|2|||
23497375|NCT01197560|65562678|FG000|Overall Study|Adverse Event|6|||
23497376|NCT01197560|65562679|FG001|Overall Study|Adverse Event|8|||
23497377|NCT01197560|65562678|FG000|Overall Study|Death|3|||
23497378|NCT01197560|65562679|FG001|Overall Study|Death|5|||
23497379|NCT01197560|65562678|FG000|Overall Study|Withdrawal by Subject|1|||
23497380|NCT01197560|65562679|FG001|Overall Study|Withdrawal by Subject|1|||
23393118|NCT04100018|65186733|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
23393119|NCT04100018|65186734|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
23393120|NCT04100018|65186733|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
23393121|NCT04100018|65186734|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
23393122|NCT04100018|65186733|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
23393123|NCT04100018|65186734|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23393124|NCT04100018|65186733|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
23393125|NCT04100018|65186734|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
23393126|NCT04100018|65186733|FG000|Treatment Period|Ongoing Treatment as of clinical cut off date|58|||
23393127|NCT04100018|65186734|FG001|Treatment Period|Ongoing Treatment as of clinical cut off date|52|||
23393128|NCT04100018|65186733|FG000|Treatment Period|Other Reason|18|||
23393129|NCT04100018|65186734|FG001|Treatment Period|Other Reason|29|||
23393130|NCT04100018|65186733|FG000|Treatment Period|Completed treatment as per protocol|0|||
23393131|NCT04100018|65186734|FG001|Treatment Period|Completed treatment as per protocol|1|||
23393132|NCT04100018|65186733|FG000|Treatment Period|Maximum clinical benefit|3|||
23393133|NCT04100018|65186734|FG001|Treatment Period|Maximum clinical benefit|0|||
23393134|NCT04100018|65186733|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
23393135|NCT04100018|65186734|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
23393136|NCT04100018|65186733|FG000|Treatment Period|Study drug toxicity|67|||
23393137|NCT04100018|65186734|FG001|Treatment Period|Study drug toxicity|28|||
23393138|NCT04100018|65186733|FG000|Treatment Period|Disease Progression|269|||
23393139|NCT04100018|65186734|FG001|Treatment Period|Disease Progression|318|||
23393140|NCT04100018|65186733|FG000|Treatment Period|Administrative reasons by sponsor|1|||
23393141|NCT04100018|65186734|FG001|Treatment Period|Administrative reasons by sponsor|1|||
23393142|NCT04100018|65186733|FG000|Treatment Period|Poor/Non-Compliance|1|||
23393143|NCT04100018|65186734|FG001|Treatment Period|Poor/Non-Compliance|0|||
23393144|NCT04100018|65186733|FG000|Treatment Period|Lost to Follow-up|2|||
23393145|NCT04100018|65186734|FG001|Treatment Period|Lost to Follow-up|2|||
23393146|NCT04100018|65186733|FG000|Treatment Period|Death|14|||
23393147|NCT04100018|65186734|FG001|Treatment Period|Death|11|||
23393148|NCT04100018|65186733|FG000|Treatment Period|Participant withdrew consent|8|||
23393149|NCT04100018|65186734|FG001|Treatment Period|Participant withdrew consent|10|||
23393150|NCT04100018|65186733|FG000|Treatment Period|Participant request to discontinue study treatment|32|||
23393151|NCT04100018|65186734|FG001|Treatment Period|Participant request to discontinue study treatment|31|||
23393152|NCT04100018|65186733|FG000|Treatment Period|Adverse Event|12|||
23393153|NCT04100018|65186734|FG001|Treatment Period|Adverse Event|6|||
23393154|NCT04100018|65186733|FG000|Treatment Period|Lack of Efficacy|4|||
23393155|NCT04100018|65186734|FG001|Treatment Period|Lack of Efficacy|2|||
23393156|NCT01400412|65186735|FG000|Overall Study|Lost to Follow-up|4|||
23393157|NCT01400412|65186736|FG001|Overall Study|Lost to Follow-up|7|||
23393158|NCT01400412|65186735|FG000|Overall Study|Withdrawal by Subject|3|||
23393159|NCT01400412|65186736|FG001|Overall Study|Withdrawal by Subject|4|||
23497381|NCT01197560|65562678|FG000|Overall Study|Disease progression|40|||
23497382|NCT01197560|65562679|FG001|Overall Study|Disease progression|35|||
23497383|NCT01197560|65562678|FG000|Overall Study|Miscellaneous|4|||
23393160|NCT01400412|65186735|FG000|Overall Study|Unable to complete|3|||
23393161|NCT01400412|65186736|FG001|Overall Study|Unable to complete|3|||
23497384|NCT01197560|65562679|FG001|Overall Study|Miscellaneous|3|||
23497385|NCT01197560|65562678|FG000|Overall Study|Missing|0|||
23497386|NCT01197560|65562679|FG001|Overall Study|Missing|1|||
23497387|NCT01817530|65562680|FG000|Overall Study|Exclusionary Medication Received|0|||
23497388|NCT01817530|65562681|FG001|Overall Study|Exclusionary Medication Received|0|||
23497389|NCT01817530|65562682|FG002|Overall Study|Exclusionary Medication Received|0|||
23497390|NCT01817530|65562683|FG003|Overall Study|Exclusionary Medication Received|0|||
23497391|NCT01817530|65562684|FG004|Overall Study|Exclusionary Medication Received|1|||
23497392|NCT01817530|65562685|FG005|Overall Study|Exclusionary Medication Received|0|||
23497393|NCT01817530|65562686|FG006|Overall Study|Exclusionary Medication Received|0|||
23497394|NCT01817530|65562687|FG007|Overall Study|Exclusionary Medication Received|0|||
23497395|NCT01817530|65562680|FG000|Overall Study|Adverse Event|6|||
23497396|NCT01817530|65562681|FG001|Overall Study|Adverse Event|3|||
23497397|NCT01817530|65562682|FG002|Overall Study|Adverse Event|2|||
23497398|NCT01817530|65562683|FG003|Overall Study|Adverse Event|5|||
23497399|NCT01817530|65562684|FG004|Overall Study|Adverse Event|0|||
23497400|NCT01817530|65562685|FG005|Overall Study|Adverse Event|10|||
23497401|NCT01817530|65562686|FG006|Overall Study|Adverse Event|5|||
23497402|NCT01817530|65562687|FG007|Overall Study|Adverse Event|8|||
23497403|NCT01817530|65562680|FG000|Overall Study|Subject Noncompliant|3|||
23497404|NCT01817530|65562681|FG001|Overall Study|Subject Noncompliant|1|||
23497405|NCT01817530|65562682|FG002|Overall Study|Subject Noncompliant|0|||
23497406|NCT01817530|65562683|FG003|Overall Study|Subject Noncompliant|4|||
23497407|NCT01817530|65562684|FG004|Overall Study|Subject Noncompliant|0|||
23497408|NCT01817530|65562685|FG005|Overall Study|Subject Noncompliant|1|||
23497409|NCT01817530|65562686|FG006|Overall Study|Subject Noncompliant|1|||
23497410|NCT01817530|65562687|FG007|Overall Study|Subject Noncompliant|1|||
23497411|NCT01817530|65562680|FG000|Overall Study|Lack of Efficacy|1|||
23497412|NCT01817530|65562681|FG001|Overall Study|Lack of Efficacy|0|||
23497413|NCT01817530|65562682|FG002|Overall Study|Lack of Efficacy|0|||
23497414|NCT01817530|65562683|FG003|Overall Study|Lack of Efficacy|0|||
23393162|NCT01400412|65186735|FG000|Overall Study|Never started study treatment|0|||
23393163|NCT01400412|65186736|FG001|Overall Study|Never started study treatment|3|||
23393164|NCT03331354|65186740|FG000|Overall Study|Withdrawal by Subject|1|||
23393165|NCT03331354|65186741|FG001|Overall Study|Withdrawal by Subject|3|||
23393166|NCT03331354|65186740|FG000|Overall Study|Lost to Follow-up|3|||
23393167|NCT03331354|65186741|FG001|Overall Study|Lost to Follow-up|3|||
23393168|NCT03331354|65186740|FG000|Overall Study|Found employment before initiated active intervention|0|||
23393169|NCT03331354|65186741|FG001|Overall Study|Found employment before initiated active intervention|4|||
23393170|NCT03557931|65186742|FG000|Overall Study|Adverse Event|4|||
23393171|NCT03557931|65186743|FG001|Overall Study|Adverse Event|6|||
23393172|NCT03557931|65186744|FG002|Overall Study|Adverse Event|1|||
23393173|NCT03557931|65186742|FG000|Overall Study|Lost to Follow-up|4|||
23393174|NCT03557931|65186743|FG001|Overall Study|Lost to Follow-up|4|||
23393175|NCT03557931|65186744|FG002|Overall Study|Lost to Follow-up|1|||
23393176|NCT03557931|65186742|FG000|Overall Study|Protocol Violation|1|||
23393177|NCT03557931|65186743|FG001|Overall Study|Protocol Violation|4|||
23393178|NCT03557931|65186744|FG002|Overall Study|Protocol Violation|1|||
23393179|NCT03557931|65186742|FG000|Overall Study|Withdrawal by Subject|14|||
23393180|NCT03557931|65186743|FG001|Overall Study|Withdrawal by Subject|0|||
23393181|NCT03557931|65186744|FG002|Overall Study|Withdrawal by Subject|7|||
23393182|NCT03557931|65186742|FG000|Overall Study|Miscellaneous|8|||
23393183|NCT03557931|65186743|FG001|Overall Study|Miscellaneous|5|||
23393184|NCT03557931|65186744|FG002|Overall Study|Miscellaneous|3|||
23393185|NCT00112385|65186745|FG000|Overall Study|Lost to Follow-up|1|||
23393186|NCT00112385|65186746|FG001|Overall Study|Lost to Follow-up|0|||
23393187|NCT00112385|65186745|FG000|Overall Study|Withdrawal by Subject|0|||
23393188|NCT00112385|65186746|FG001|Overall Study|Withdrawal by Subject|1|||
23393189|NCT03384966|65186747|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
23393190|NCT03384966|65186748|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
23393191|NCT03384966|65186749|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
23393192|NCT03384966|65186747|FG000|Follow-up Period|Adverse Event|1|||
23393193|NCT03384966|65186748|FG001|Follow-up Period|Adverse Event|0|||
23393194|NCT03384966|65186749|FG002|Follow-up Period|Adverse Event|0|||
23393195|NCT01585025|65186754|FG000|Overall Study|Withdrawal by Subject|0|||
23393196|NCT01585025|65186755|FG001|Overall Study|Withdrawal by Subject|3|||
23393197|NCT01585025|65186756|FG002|Overall Study|Withdrawal by Subject|4|||
23497415|NCT01817530|65562684|FG004|Overall Study|Lack of Efficacy|0|||
23497416|NCT01817530|65562685|FG005|Overall Study|Lack of Efficacy|1|||
23497417|NCT01817530|65562686|FG006|Overall Study|Lack of Efficacy|0|||
23497418|NCT01817530|65562687|FG007|Overall Study|Lack of Efficacy|1|||
23393198|NCT01649869|65186759|FG000|Overall Study|Family member illness|1|||
23393199|NCT01649869|65186760|FG001|Overall Study|Family member illness|0|||
23393200|NCT01649869|65186759|FG000|Overall Study|Required treatment outside protocol|1|||
23393201|NCT01649869|65186760|FG001|Overall Study|Required treatment outside protocol|0|||
23497419|NCT01817530|65562680|FG000|Overall Study|Pregnancy|0|||
23497420|NCT01817530|65562681|FG001|Overall Study|Pregnancy|0|||
23497421|NCT01817530|65562682|FG002|Overall Study|Pregnancy|0|||
23497422|NCT01817530|65562683|FG003|Overall Study|Pregnancy|0|||
23497423|NCT01817530|65562684|FG004|Overall Study|Pregnancy|0|||
23497424|NCT01817530|65562685|FG005|Overall Study|Pregnancy|1|||
23497425|NCT01817530|65562686|FG006|Overall Study|Pregnancy|0|||
23497426|NCT01817530|65562687|FG007|Overall Study|Pregnancy|0|||
23497427|NCT01817530|65562680|FG000|Overall Study|Other|0|||
23497428|NCT01817530|65562681|FG001|Overall Study|Other|1|||
23497429|NCT01817530|65562682|FG002|Overall Study|Other|0|||
23497430|NCT01817530|65562683|FG003|Overall Study|Other|0|||
23497431|NCT01817530|65562684|FG004|Overall Study|Other|1|||
23497432|NCT01817530|65562685|FG005|Overall Study|Other|0|||
23497433|NCT01817530|65562686|FG006|Overall Study|Other|5|||
23497434|NCT01817530|65562687|FG007|Overall Study|Other|0|||
23497435|NCT01817530|65562680|FG000|Overall Study|Surgery or Invasive Intervention|1|||
23497436|NCT01817530|65562681|FG001|Overall Study|Surgery or Invasive Intervention|0|||
23497437|NCT01817530|65562682|FG002|Overall Study|Surgery or Invasive Intervention|0|||
23497438|NCT01817530|65562683|FG003|Overall Study|Surgery or Invasive Intervention|0|||
23497439|NCT01817530|65562684|FG004|Overall Study|Surgery or Invasive Intervention|1|||
23497440|NCT01817530|65562685|FG005|Overall Study|Surgery or Invasive Intervention|1|||
23497441|NCT01817530|65562686|FG006|Overall Study|Surgery or Invasive Intervention|1|||
23497442|NCT01817530|65562687|FG007|Overall Study|Surgery or Invasive Intervention|0|||
23497443|NCT01817530|65562680|FG000|Overall Study|Consent Withdrawn by Subject|3|||
23497444|NCT01817530|65562681|FG001|Overall Study|Consent Withdrawn by Subject|4|||
23497445|NCT01817530|65562682|FG002|Overall Study|Consent Withdrawn by Subject|7|||
23497446|NCT01817530|65562683|FG003|Overall Study|Consent Withdrawn by Subject|3|||
23497447|NCT01817530|65562684|FG004|Overall Study|Consent Withdrawn by Subject|5|||
23497448|NCT01817530|65562685|FG005|Overall Study|Consent Withdrawn by Subject|3|||
23497449|NCT01817530|65562686|FG006|Overall Study|Consent Withdrawn by Subject|3|||
23497450|NCT01817530|65562687|FG007|Overall Study|Consent Withdrawn by Subject|10|||
23497451|NCT01817530|65562680|FG000|Overall Study|Lost to Follow-up|1|||
23497452|NCT01817530|65562681|FG001|Overall Study|Lost to Follow-up|4|||
23497453|NCT01817530|65562682|FG002|Overall Study|Lost to Follow-up|2|||
23497454|NCT01817530|65562683|FG003|Overall Study|Lost to Follow-up|1|||
23497455|NCT01817530|65562684|FG004|Overall Study|Lost to Follow-up|3|||
23497456|NCT01817530|65562685|FG005|Overall Study|Lost to Follow-up|2|||
23497457|NCT01817530|65562686|FG006|Overall Study|Lost to Follow-up|8|||
23497458|NCT01817530|65562687|FG007|Overall Study|Lost to Follow-up|4|||
23497459|NCT00560105|65562690|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
23497460|NCT00560105|65562691|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
23393202|NCT01649869|65186759|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
23393203|NCT01649869|65186760|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
23393204|NCT01422382|65186761|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
23393205|NCT03232567|65186762|FG000|Overall Study|Withdrawal by Subject|0|||
23393206|NCT03232567|65186763|FG001|Overall Study|Withdrawal by Subject|1|||
23393207|NCT03232567|65186764|FG002|Overall Study|Withdrawal by Subject|0|||
23393208|NCT03232567|65186765|FG003|Overall Study|Withdrawal by Subject|0|||
23393209|NCT03636022|65186770|FG000|Overall Study|Withdrawal by Subject|1|||
23393210|NCT03636022|65186771|FG001|Overall Study|Withdrawal by Subject|3|||
23393211|NCT03802396|65186773|FG000|Overall Study|Withdrawal by Subject|2|||
23393212|NCT03802396|65186774|FG001|Overall Study|Withdrawal by Subject|0|||
23393213|NCT03802396|65186773|FG000|Overall Study|Surgery Cancelled|1|||
23393214|NCT03802396|65186774|FG001|Overall Study|Surgery Cancelled|0|||
23393215|NCT01088906|65186777|FG000|Overall Study|Inclusion error|1|||
23393216|NCT01088906|65186777|FG000|Overall Study|Did not receive study treatment|3|||
23393217|NCT01088906|65186777|FG000|Overall Study|Missing data|1|||
23393218|NCT00492050|65186778|FG000|Overall Study|Adverse Event|1|||
23393219|NCT00492050|65186778|FG000|Overall Study|Lack of Efficacy|1|||
23393220|NCT00492050|65186778|FG000|Overall Study|Withdrawal by Subject|3|||
23393221|NCT00492050|65186778|FG000|Overall Study|Unable to collect SCT|2|||
23497461|NCT00478231|65562692|FG000|Overall Study|Death|7|||
23497462|NCT00478231|65562692|FG000|Overall Study|Lack of Efficacy|47|||
23497463|NCT00478231|65562692|FG000|Overall Study|Lost to Follow-up|7|||
23393222|NCT00492050|65186778|FG000|Overall Study|Progressive Disease|2|||
23393223|NCT01052779|65186779|FG000|Overall Study|Adverse Event|1|||
23393224|NCT01052779|65186780|FG001|Overall Study|Adverse Event|4|||
23497464|NCT00478231|65562692|FG000|Overall Study|Withdrawal by Subject|6|||
23497465|NCT00478231|65562692|FG000|Overall Study|Other|9|||
23497466|NCT00478231|65562692|FG000|Overall Study|Adverse Event|5|||
23393225|NCT01052779|65186779|FG000|Overall Study|Withdrawal by Subject|1|||
23393226|NCT01052779|65186780|FG001|Overall Study|Withdrawal by Subject|2|||
23393227|NCT01052779|65186779|FG000|Overall Study|Other-Protocol Violation|1|||
23393228|NCT01052779|65186780|FG001|Overall Study|Other-Protocol Violation|1|||
23393229|NCT01052779|65186779|FG000|Overall Study|Other-Surgery|0|||
23393230|NCT01052779|65186780|FG001|Overall Study|Other-Surgery|2|||
23393231|NCT01052779|65186779|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
23393232|NCT01052779|65186780|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
23393233|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
23393234|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
23393235|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
23393236|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
23393237|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
23393238|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
23497467|NCT00478231|65562692|FG000|Overall Study|Randomized, not treated|3|||
23497468|NCT00850343|65562693|FG000|Overall Study|Withdrawal by Subject|11|||
23497469|NCT00850343|65562694|FG001|Overall Study|Withdrawal by Subject|0|||
23497470|NCT00850343|65562695|FG002|Overall Study|Withdrawal by Subject|3|||
23497471|NCT00850343|65562696|FG003|Overall Study|Withdrawal by Subject|2|||
23497472|NCT00850343|65562693|FG000|Overall Study|Adverse Event|15|||
23497473|NCT00850343|65562694|FG001|Overall Study|Adverse Event|2|||
23497474|NCT00850343|65562695|FG002|Overall Study|Adverse Event|6|||
23497475|NCT00850343|65562696|FG003|Overall Study|Adverse Event|6|||
23497476|NCT00850343|65562693|FG000|Overall Study|Pregnancy|0|||
23497477|NCT00850343|65562694|FG001|Overall Study|Pregnancy|0|||
23497478|NCT00850343|65562695|FG002|Overall Study|Pregnancy|0|||
23497479|NCT00850343|65562696|FG003|Overall Study|Pregnancy|1|||
23497480|NCT00850343|65562693|FG000|Overall Study|Lack of Efficacy|17|||
23497481|NCT00850343|65562694|FG001|Overall Study|Lack of Efficacy|0|||
23497482|NCT00850343|65562695|FG002|Overall Study|Lack of Efficacy|3|||
23497483|NCT00850343|65562696|FG003|Overall Study|Lack of Efficacy|2|||
23497484|NCT00850343|65562693|FG000|Overall Study|Non-compliance with Study Procedures|1|||
23497485|NCT00850343|65562694|FG001|Overall Study|Non-compliance with Study Procedures|0|||
23497486|NCT00850343|65562695|FG002|Overall Study|Non-compliance with Study Procedures|1|||
23497487|NCT00850343|65562696|FG003|Overall Study|Non-compliance with Study Procedures|1|||
23497488|NCT00850343|65562693|FG000|Overall Study|Physician Decision|2|||
23497489|NCT00850343|65562694|FG001|Overall Study|Physician Decision|1|||
23497490|NCT00850343|65562695|FG002|Overall Study|Physician Decision|1|||
23497491|NCT00850343|65562696|FG003|Overall Study|Physician Decision|1|||
23497492|NCT00231842|65562697|FG000|Overall Study|Withdrawal by Subject|3|||
23497493|NCT00231842|65562697|FG000|Overall Study|Did not complete the last 3 cycle|8|||
23497494|NCT03780543|65562698|FG000|Overall Study|Adverse Event|1|||
23497495|NCT03780543|65562699|FG001|Overall Study|Adverse Event|0|||
23497496|NCT03780543|65562700|FG002|Overall Study|Adverse Event|2|||
23497497|NCT03780543|65562698|FG000|Overall Study|Lost to Follow-up|2|||
23497498|NCT03780543|65562699|FG001|Overall Study|Lost to Follow-up|0|||
23497499|NCT03780543|65562700|FG002|Overall Study|Lost to Follow-up|1|||
23393239|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
23393240|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
23393241|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
23393242|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
23393243|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
23393244|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
23393245|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
23393246|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
23393247|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
23393248|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
23393249|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
23393250|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
23393251|NCT00086515|65186781|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
23393252|NCT00086515|65186782|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
23393253|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
23393254|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
23393255|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
23497500|NCT03780543|65562698|FG000|Overall Study|Study terminated by Sponsor|8|||
23497501|NCT03780543|65562699|FG001|Overall Study|Study terminated by Sponsor|7|||
23497502|NCT03780543|65562700|FG002|Overall Study|Study terminated by Sponsor|13|||
23497503|NCT03780543|65562698|FG000|Overall Study|Withdrawal by Subject|1|||
23393256|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
23393257|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
23497504|NCT03780543|65562699|FG001|Overall Study|Withdrawal by Subject|8|||
23497505|NCT03780543|65562700|FG002|Overall Study|Withdrawal by Subject|1|||
23497506|NCT03780543|65562698|FG000|Overall Study|Noncompliance with study drug|1|||
23497507|NCT03780543|65562699|FG001|Overall Study|Noncompliance with study drug|0|||
23497508|NCT03780543|65562700|FG002|Overall Study|Noncompliance with study drug|0|||
23393258|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
23393259|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
23393260|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
23497509|NCT00705289|65562704|FG000|Overall Study|Subject or treating physician's choice|131|||
23497510|NCT00259610|65562705|FG000|Overall Study|Withdrawal by Subject|33|||
23497511|NCT00259610|65562706|FG001|Overall Study|Withdrawal by Subject|25|||
23497512|NCT00259610|65562707|FG002|Overall Study|Withdrawal by Subject|29|||
23497513|NCT00259610|65562708|FG003|Overall Study|Withdrawal by Subject|19|||
23497514|NCT00259610|65562705|FG000|Overall Study|Lost to Follow-up|19|||
23497515|NCT00259610|65562706|FG001|Overall Study|Lost to Follow-up|8|||
23497516|NCT00259610|65562707|FG002|Overall Study|Lost to Follow-up|18|||
23300399|NCT00375492|64842789|FG001|Overall Study|Entry Criteria Not Met|1|||
23300400|NCT00375492|64842788|FG000|Overall Study|Loss of Glucose Control|0|||
23300401|NCT00375492|64842789|FG001|Overall Study|Loss of Glucose Control|1|||
23497517|NCT00259610|65562708|FG003|Overall Study|Lost to Follow-up|15|||
23497518|NCT00259610|65562705|FG000|Overall Study|Physician Decision|6|||
23497519|NCT00259610|65562706|FG001|Overall Study|Physician Decision|4|||
23300402|NCT00375492|64842788|FG000|Overall Study|Lost to Follow-up|10|||
23300403|NCT00375492|64842789|FG001|Overall Study|Lost to Follow-up|5|||
23300404|NCT00375492|64842788|FG000|Overall Study|Physician Decision|0|||
23300405|NCT00375492|64842789|FG001|Overall Study|Physician Decision|4|||
23300406|NCT00375492|64842788|FG000|Overall Study|Protocol Violation|6|||
23300407|NCT00375492|64842789|FG001|Overall Study|Protocol Violation|3|||
23300408|NCT00375492|64842788|FG000|Overall Study|Sponsor Decision|0|||
23300409|NCT00375492|64842789|FG001|Overall Study|Sponsor Decision|1|||
23300410|NCT00375492|64842788|FG000|Overall Study|Withdrawal by Subject|6|||
23300411|NCT00375492|64842789|FG001|Overall Study|Withdrawal by Subject|6|||
23300412|NCT03346070|64842790|FG000|Overall Study|Death|0|||
23300413|NCT03346070|64842791|FG001|Overall Study|Death|0|||
23300414|NCT03346070|64842792|FG002|Overall Study|Death|0|||
23300415|NCT03346070|64842793|FG003|Overall Study|Death|0|||
23300416|NCT03346070|64842794|FG004|Overall Study|Death|1|||
23300417|NCT03346070|64842790|FG000|Overall Study|Lost to Follow-up|0|||
23300418|NCT03346070|64842791|FG001|Overall Study|Lost to Follow-up|1|||
23300419|NCT03346070|64842792|FG002|Overall Study|Lost to Follow-up|2|||
23300420|NCT03346070|64842793|FG003|Overall Study|Lost to Follow-up|0|||
23300421|NCT03346070|64842794|FG004|Overall Study|Lost to Follow-up|0|||
23300422|NCT03346070|64842790|FG000|Overall Study|Physician Decision|0|||
23300423|NCT03346070|64842791|FG001|Overall Study|Physician Decision|0|||
23300424|NCT03346070|64842792|FG002|Overall Study|Physician Decision|0|||
23300425|NCT03346070|64842793|FG003|Overall Study|Physician Decision|1|||
23300426|NCT03346070|64842794|FG004|Overall Study|Physician Decision|1|||
23300427|NCT03346070|64842790|FG000|Overall Study|Withdrawal by Subject|1|||
23300428|NCT03346070|64842791|FG001|Overall Study|Withdrawal by Subject|0|||
23300429|NCT03346070|64842792|FG002|Overall Study|Withdrawal by Subject|0|||
23300430|NCT03346070|64842793|FG003|Overall Study|Withdrawal by Subject|1|||
23300431|NCT03346070|64842794|FG004|Overall Study|Withdrawal by Subject|0|||
23300432|NCT03346070|64842790|FG000|Overall Study|Study medication not received as planned|2|||
23300433|NCT03346070|64842791|FG001|Overall Study|Study medication not received as planned|3|||
23300434|NCT03346070|64842792|FG002|Overall Study|Study medication not received as planned|2|||
23300435|NCT03346070|64842793|FG003|Overall Study|Study medication not received as planned|3|||
23300436|NCT03346070|64842794|FG004|Overall Study|Study medication not received as planned|2|||
23300437|NCT03346070|64842790|FG000|Overall Study|Screen Failure|0|||
23300438|NCT03346070|64842791|FG001|Overall Study|Screen Failure|0|||
23300439|NCT03346070|64842792|FG002|Overall Study|Screen Failure|0|||
23300440|NCT03346070|64842793|FG003|Overall Study|Screen Failure|1|||
23300441|NCT03346070|64842794|FG004|Overall Study|Screen Failure|1|||
23300442|NCT00251641|64842795|FG000|Overall Study|Adverse Event|80|||
23300443|NCT00251641|64842796|FG001|Overall Study|Adverse Event|8|||
23300444|NCT00251641|64842795|FG000|Overall Study|Lack of Efficacy|2|||
23393261|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
23393262|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
23393263|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
23393264|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
23393265|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
23393266|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
23393267|NCT00086515|65186781|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
23393268|NCT00086515|65186782|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
23393269|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
23393270|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
23393271|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
23393272|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
23393273|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
23393274|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
23393275|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
23393276|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
23497520|NCT00259610|65562707|FG002|Overall Study|Physician Decision|7|||
23497521|NCT00259610|65562708|FG003|Overall Study|Physician Decision|2|||
23497522|NCT00259610|65562705|FG000|Overall Study|Death|1|||
23497523|NCT00259610|65562706|FG001|Overall Study|Death|1|||
23497524|NCT00259610|65562707|FG002|Overall Study|Death|2|||
23497525|NCT00259610|65562708|FG003|Overall Study|Death|0|||
23497526|NCT00259610|65562705|FG000|Overall Study|non medical reason|6|||
23497527|NCT00259610|65562706|FG001|Overall Study|non medical reason|2|||
23497528|NCT00259610|65562707|FG002|Overall Study|non medical reason|10|||
23300445|NCT00251641|64842796|FG001|Overall Study|Lack of Efficacy|1|||
23300446|NCT00251641|64842795|FG000|Overall Study|Progression of Disease|0|||
23300447|NCT00251641|64842796|FG001|Overall Study|Progression of Disease|2|||
23300448|NCT00251641|64842795|FG000|Overall Study|Lost to Follow-up|3|||
23300449|NCT00251641|64842796|FG001|Overall Study|Lost to Follow-up|3|||
23300450|NCT00251641|64842795|FG000|Overall Study|Withdrawal by Subject|6|||
23300451|NCT00251641|64842796|FG001|Overall Study|Withdrawal by Subject|8|||
23300452|NCT00251641|64842795|FG000|Overall Study|Protocol Violation|10|||
23300453|NCT00251641|64842796|FG001|Overall Study|Protocol Violation|2|||
23300454|NCT00251641|64842795|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
23300455|NCT00251641|64842796|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
23497529|NCT00259610|65562708|FG003|Overall Study|non medical reason|3|||
23497530|NCT00259610|65562705|FG000|Overall Study|Adverse Event|3|||
23497531|NCT00259610|65562706|FG001|Overall Study|Adverse Event|4|||
23497532|NCT00259610|65562707|FG002|Overall Study|Adverse Event|5|||
23497533|NCT00259610|65562708|FG003|Overall Study|Adverse Event|2|||
23497534|NCT00259610|65562705|FG000|Overall Study|Serious Adverse Event|8|||
23497535|NCT00259610|65562706|FG001|Overall Study|Serious Adverse Event|2|||
23497536|NCT00259610|65562707|FG002|Overall Study|Serious Adverse Event|2|||
23497537|NCT00259610|65562708|FG003|Overall Study|Serious Adverse Event|2|||
23497538|NCT04289623|65562710|FG000|Wave 1 Emails|Email was not delivered|268|||
23497539|NCT04289623|65562711|FG001|Wave 1 Emails|Email was not delivered|257|||
23497540|NCT04289623|65562712|FG002|Wave 1 Emails|Email was not delivered|0|||
23497541|NCT04289623|65562713|FG003|Wave 1 Emails|Email was not delivered|0|||
23497542|NCT04289623|65562714|FG004|Wave 1 Emails|Email was not delivered|0|||
23497543|NCT04289623|65562715|FG005|Wave 1 Emails|Email was not delivered|0|||
23497544|NCT00939640|65562716|FG000|Overall Study|Physician Decision|1|||
23497545|NCT02693119|65562719|FG000|Open-Label Period|Withdrawal by Subject|0|||
23497546|NCT02693119|65562720|FG001|Open-Label Period|Withdrawal by Subject|1|||
23393277|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
23393278|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
23393279|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
23393280|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
23393281|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
23393282|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
23393283|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
23393284|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
23393285|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
23393286|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
23393287|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
23393288|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
23393289|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
23393290|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
23393291|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
23393292|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
23393293|NCT00086515|65186781|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
23393294|NCT00086515|65186782|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
23393295|NCT00581919|65186786|FG000|Overall Study|Adverse Event|8|||
23393296|NCT00581919|65186786|FG000|Overall Study|Death|1|||
23393297|NCT00581919|65186786|FG000|Overall Study|Disease Progression|10|||
23393298|NCT00581919|65186786|FG000|Overall Study|Physician Decision|1|||
23393299|NCT00581919|65186786|FG000|Overall Study|Other Complicating Disease|1|||
23393300|NCT00581919|65186786|FG000|Overall Study|Started Non-Protocol Therapy|2|||
23393301|NCT00581919|65186786|FG000|Overall Study|Withdrawal by Subject|1|||
23393302|NCT05788991|65186787|FG000|Overall Study|Not treated with study medication|1|||
23393303|NCT05788991|65186788|FG001|Overall Study|Not treated with study medication|3|||
23393304|NCT05788991|65186787|FG000|Overall Study|Withdrawal by Subject|1|||
23393305|NCT05788991|65186788|FG001|Overall Study|Withdrawal by Subject|0|||
23393306|NCT05788991|65186787|FG000|Overall Study|Lack of Efficacy|0|||
23393307|NCT05788991|65186788|FG001|Overall Study|Lack of Efficacy|1|||
23393308|NCT05788991|65186787|FG000|Overall Study|Protocol Violation|1|||
23393309|NCT05788991|65186788|FG001|Overall Study|Protocol Violation|2|||
23393310|NCT03189719|65186789|FG000|Overall Study|Death|325|||
23393311|NCT03189719|65186790|FG001|Overall Study|Death|361|||
23393312|NCT03189719|65186789|FG000|Overall Study|Physician Decision|1|||
23393313|NCT03189719|65186790|FG001|Overall Study|Physician Decision|0|||
23393314|NCT03189719|65186789|FG000|Overall Study|Sponsor Decision|40|||
23497547|NCT00573183|65562723|FG000|Overall Study|Lost to Follow-up|52|||
23497548|NCT00573183|65562724|FG001|Overall Study|Lost to Follow-up|50|||
23393315|NCT03189719|65186790|FG001|Overall Study|Sponsor Decision|12|||
23497549|NCT00573183|65562723|FG000|Overall Study|Withdrawal by Subject|8|||
23497550|NCT00573183|65562724|FG001|Overall Study|Withdrawal by Subject|2|||
23497551|NCT00573183|65562723|FG000|Overall Study|Death|0|||
23497552|NCT00573183|65562724|FG001|Overall Study|Death|1|||
23497553|NCT00573183|65562723|FG000|Overall Study|Adverse Event|2|||
23497554|NCT00573183|65562724|FG001|Overall Study|Adverse Event|0|||
23497555|NCT00573183|65562723|FG000|Overall Study|Incarceration|5|||
23497556|NCT00573183|65562724|FG001|Overall Study|Incarceration|8|||
23497557|NCT00573183|65562723|FG000|Overall Study|Other|5|||
23497558|NCT00573183|65562724|FG001|Overall Study|Other|2|||
23497559|NCT00293033|65562725|FG000|Open-label Titration Period|Adverse Event|10|||
23497560|NCT00293033|65562725|FG000|Open-label Titration Period|Death|3|||
23497561|NCT00293033|65562725|FG000|Open-label Titration Period|Lack of Efficacy|5|||
23497562|NCT00293033|65562725|FG000|Open-label Titration Period|Protocol Violation|2|||
23497563|NCT00293033|65562725|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
23497564|NCT00293033|65562725|FG000|Open-label Titration Period|Noncompliance and other|27|||
23497565|NCT00293033|65562725|FG000|Double-blind Treatment Period|Adverse Event|3|||
23497566|NCT00293033|65562725|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
23497567|NCT00293033|65562725|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
23497568|NCT00293033|65562725|FG000|Double-blind Treatment Period|Noncompliance|4|||
23497569|NCT01443078|65562726|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
23497570|NCT01443078|65562726|FG000|Overall Study|Withdrawal by Subject|1|||
23497571|NCT01443078|65562726|FG000|Overall Study|Patient had brain mets|1|||
23497572|NCT00799422|65562734|FG000|First Week of Wear|Lost to Follow-up|0|||
23497573|NCT00799422|65562735|FG001|First Week of Wear|Lost to Follow-up|0|||
23497574|NCT00799422|65562736|FG002|First Week of Wear|Lost to Follow-up|1|||
23497575|NCT00799422|65562737|FG003|First Week of Wear|Lost to Follow-up|0|||
23497576|NCT00799422|65562738|FG004|First Week of Wear|Lost to Follow-up|0|||
23497577|NCT00799422|65562739|FG005|First Week of Wear|Lost to Follow-up|0|||
23497578|NCT00799422|65562734|FG000|First Week of Wear|Adverse Event|0|||
23497579|NCT00799422|65562735|FG001|First Week of Wear|Adverse Event|0|||
23497580|NCT00799422|65562736|FG002|First Week of Wear|Adverse Event|0|||
23497581|NCT00799422|65562737|FG003|First Week of Wear|Adverse Event|1|||
23497582|NCT00799422|65562738|FG004|First Week of Wear|Adverse Event|0|||
23497583|NCT00799422|65562739|FG005|First Week of Wear|Adverse Event|0|||
23497584|NCT01790932|65562740|FG000|Overall Study|Disease Progression|41|||
23497585|NCT01790932|65562740|FG000|Overall Study|Adverse Event|7|||
23497586|NCT01790932|65562740|FG000|Overall Study|Physician Decision|1|||
23497587|NCT01790932|65562740|FG000|Overall Study|Withdrawal by Subject|1|||
23497588|NCT02336373|65562741|FG000|Overall Study|Protocol closed early|4|||
23497589|NCT02336373|65562741|FG000|Overall Study|Physician Decision|14|||
23497590|NCT03750955|65562743|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
23497591|NCT03750955|65562744|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
23497592|NCT03750955|65562743|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
23497593|NCT03750955|65562744|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
23497594|NCT00644228|65562745|FG000|Randomization & Eligibility|Ineligible|31|||
23497595|NCT00644228|65562746|FG001|Randomization & Eligibility|Ineligible|21|||
23497596|NCT00644228|65562745|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
23497597|NCT00644228|65562746|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
23497598|NCT00644228|65562745|FG000|Randomization & Eligibility|Invalid Consent|0|||
23497599|NCT00644228|65562746|FG001|Randomization & Eligibility|Invalid Consent|1|||
23497600|NCT00644228|65562745|FG000|Induction Therapy|Adverse Event|22|||
23497601|NCT00644228|65562746|FG001|Induction Therapy|Adverse Event|55|||
23497602|NCT00644228|65562745|FG000|Induction Therapy|Withdrawal by Subject|10|||
23497603|NCT00644228|65562746|FG001|Induction Therapy|Withdrawal by Subject|3|||
23497604|NCT00644228|65562745|FG000|Induction Therapy|Progression/Relapse|24|||
23497605|NCT00644228|65562746|FG001|Induction Therapy|Progression/Relapse|12|||
23497606|NCT00644228|65562745|FG000|Induction Therapy|Death|3|||
23497607|NCT00644228|65562746|FG001|Induction Therapy|Death|7|||
23497608|NCT00644228|65562745|FG000|Induction Therapy|Not Protocol-Specified|24|||
23497609|NCT00644228|65562746|FG001|Induction Therapy|Not Protocol-Specified|28|||
23497610|NCT00644228|65562745|FG000|Maintenance|Adverse Event|27|||
23497611|NCT00644228|65562746|FG001|Maintenance|Adverse Event|31|||
23497612|NCT00644228|65562745|FG000|Maintenance|Withdrawal by Subject|6|||
23497613|NCT00644228|65562746|FG001|Maintenance|Withdrawal by Subject|4|||
23497614|NCT00644228|65562745|FG000|Maintenance|Progression/Relapse|67|||
23497615|NCT00644228|65562746|FG001|Maintenance|Progression/Relapse|42|||
23497616|NCT00644228|65562745|FG000|Maintenance|Death|3|||
23497617|NCT00644228|65562746|FG001|Maintenance|Death|3|||
23497618|NCT00644228|65562745|FG000|Maintenance|Not Protocol-Specified|14|||
23497619|NCT00644228|65562746|FG001|Maintenance|Not Protocol-Specified|15|||
23497620|NCT00644228|65562745|FG000|Maintenance|On Treatment|26|||
23497621|NCT00644228|65562746|FG001|Maintenance|On Treatment|40|||
23497622|NCT04528732|65562750|FG000|Overall Study|Death|1|||
23497623|NCT04528732|65562751|FG001|Overall Study|Death|0|||
23497624|NCT04528732|65562752|FG002|Overall Study|Death|1|||
23497625|NCT04528732|65562750|FG000|Overall Study|Lost to Follow-up|0|||
23497626|NCT04528732|65562751|FG001|Overall Study|Lost to Follow-up|1|||
23497627|NCT04528732|65562752|FG002|Overall Study|Lost to Follow-up|2|||
23497628|NCT03817879|65562756|FG000|Overall Study|Drop out|5|||
23497629|NCT03817879|65562757|FG001|Overall Study|Drop out|12|||
23497630|NCT03817879|65562756|FG000|Overall Study|Withdrawal by Subject|0|||
23497631|NCT03817879|65562757|FG001|Overall Study|Withdrawal by Subject|1|||
23497632|NCT03606512|65562758|FG000|Overall Study|Lost to Follow-up|0|||
23497633|NCT03606512|65562759|FG001|Overall Study|Lost to Follow-up|1|||
23497634|NCT03606512|65562758|FG000|Overall Study|'moved from study area|0|||
23497635|NCT03606512|65562759|FG001|Overall Study|'moved from study area|1|||
23497636|NCT03334539|65566143|FG000|Overall Study|Adverse Event|3|||
23497637|NCT03334539|65566144|FG001|Overall Study|Adverse Event|5|||
23497638|NCT03334539|65566145|FG002|Overall Study|Adverse Event|0|||
23497639|NCT03334539|65566143|FG000|Overall Study|Withdrawal by Subject|0|||
23497640|NCT03334539|65566144|FG001|Overall Study|Withdrawal by Subject|1|||
23497641|NCT03334539|65566145|FG002|Overall Study|Withdrawal by Subject|1|||
23497642|NCT03334539|65566143|FG000|Overall Study|Administrative Reasons|1|||
23497643|NCT03334539|65566144|FG001|Overall Study|Administrative Reasons|0|||
23497644|NCT03334539|65566145|FG002|Overall Study|Administrative Reasons|0|||
23497645|NCT03334539|65566143|FG000|Overall Study|Hypertension Not Controlled|0|||
23497646|NCT03334539|65566144|FG001|Overall Study|Hypertension Not Controlled|1|||
23497647|NCT03334539|65566145|FG002|Overall Study|Hypertension Not Controlled|0|||
23497648|NCT00816595|65566146|FG000|Overall Study|Withdrawal by Subject|2|||
23497649|NCT00816595|65566147|FG001|Overall Study|Withdrawal by Subject|0|||
23497650|NCT01602120|65566148|FG000|Overall Study|Adverse Event|3|||
23497651|NCT01602120|65566149|FG001|Overall Study|Adverse Event|6|||
23497652|NCT01602120|65566150|FG002|Overall Study|Adverse Event|0|||
23497653|NCT01602120|65566151|FG003|Overall Study|Adverse Event|2|||
23497654|NCT01602120|65566148|FG000|Overall Study|Death|0|||
23497655|NCT01602120|65566149|FG001|Overall Study|Death|4|||
23497656|NCT01602120|65566150|FG002|Overall Study|Death|0|||
23497657|NCT01602120|65566151|FG003|Overall Study|Death|0|||
23497658|NCT01602120|65566148|FG000|Overall Study|Lost to Follow-up|0|||
23497659|NCT01602120|65566149|FG001|Overall Study|Lost to Follow-up|1|||
23497660|NCT01602120|65566150|FG002|Overall Study|Lost to Follow-up|0|||
23497661|NCT01602120|65566151|FG003|Overall Study|Lost to Follow-up|1|||
23497662|NCT01602120|65566148|FG000|Overall Study|Protocol Violation|1|||
23497663|NCT01602120|65566149|FG001|Overall Study|Protocol Violation|1|||
23497664|NCT01602120|65566150|FG002|Overall Study|Protocol Violation|0|||
23497665|NCT01602120|65566151|FG003|Overall Study|Protocol Violation|0|||
23497666|NCT01602120|65566148|FG000|Overall Study|Non-compliance|0|||
23497667|NCT01602120|65566149|FG001|Overall Study|Non-compliance|3|||
23497668|NCT01602120|65566150|FG002|Overall Study|Non-compliance|0|||
23497669|NCT01602120|65566151|FG003|Overall Study|Non-compliance|1|||
23497670|NCT01602120|65566148|FG000|Overall Study|Withdrawal by Subject|8|||
23497671|NCT01602120|65566149|FG001|Overall Study|Withdrawal by Subject|17|||
23497672|NCT01602120|65566150|FG002|Overall Study|Withdrawal by Subject|0|||
23497673|NCT01602120|65566151|FG003|Overall Study|Withdrawal by Subject|3|||
23497674|NCT01602120|65566148|FG000|Overall Study|Study Terminated by Sponsor|12|||
23497675|NCT01602120|65566149|FG001|Overall Study|Study Terminated by Sponsor|24|||
23497676|NCT01602120|65566150|FG002|Overall Study|Study Terminated by Sponsor|17|||
23497677|NCT01602120|65566151|FG003|Overall Study|Study Terminated by Sponsor|44|||
23497678|NCT01602120|65566148|FG000|Overall Study|Physician Decision|2|||
23497679|NCT01602120|65566149|FG001|Overall Study|Physician Decision|3|||
23497680|NCT01602120|65566150|FG002|Overall Study|Physician Decision|0|||
23497681|NCT01602120|65566151|FG003|Overall Study|Physician Decision|0|||
23497682|NCT01602120|65566148|FG000|Overall Study|Unspecified Reason|3|||
23497683|NCT01602120|65566149|FG001|Overall Study|Unspecified Reason|1|||
23497684|NCT01602120|65566150|FG002|Overall Study|Unspecified Reason|0|||
23497685|NCT01602120|65566151|FG003|Overall Study|Unspecified Reason|2|||
23497686|NCT00289133|65566152|FG000|Overall Study|Non-study device implanted|12|||
23497687|NCT00289133|65566153|FG001|Overall Study|Non-study device implanted|0|||
23497688|NCT00289133|65566152|FG000|Overall Study|Protocol Violation|32|||
23497689|NCT00289133|65566153|FG001|Overall Study|Protocol Violation|38|||
23497690|NCT00289133|65566152|FG000|Overall Study|Withdrawal by Subject|9|||
23497691|NCT00289133|65566153|FG001|Overall Study|Withdrawal by Subject|10|||
23497692|NCT00289133|65566152|FG000|Overall Study|Death|5|||
23497693|NCT00289133|65566153|FG001|Overall Study|Death|10|||
23497694|NCT00289133|65566152|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
23497695|NCT00289133|65566153|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
23497696|NCT00289133|65566152|FG000|Overall Study|Physician Decision|41|||
23497697|NCT00289133|65566153|FG001|Overall Study|Physician Decision|45|||
23497698|NCT00289133|65566152|FG000|Overall Study|Revision|8|||
23497699|NCT00289133|65566153|FG001|Overall Study|Revision|6|||
23497700|NCT00289133|65566152|FG000|Overall Study|Lost to Follow-up|92|||
23497701|NCT00289133|65566153|FG001|Overall Study|Lost to Follow-up|115|||
23497702|NCT00412542|65566162|FG000|Overall Study|Withdrawal by Subject|0|||
23497703|NCT00412542|65566163|FG001|Overall Study|Withdrawal by Subject|2|||
23497704|NCT00412542|65566162|FG000|Overall Study|Not Eligible|0|||
23497705|NCT00412542|65566163|FG001|Overall Study|Not Eligible|1|||
23497706|NCT01534962|65566164|FG000|Overall Study|Randomized but did not start treatment|2|||
23497707|NCT01534962|65566165|FG001|Overall Study|Randomized but did not start treatment|0|||
23497708|NCT01534962|65566166|FG002|Overall Study|Randomized but did not start treatment|0|||
23497709|NCT01534962|65566167|FG003|Overall Study|Randomized but did not start treatment|1|||
23393316|NCT03189719|65186789|FG000|Overall Study|Withdrawal by Subject|7|||
23393317|NCT03189719|65186790|FG001|Overall Study|Withdrawal by Subject|3|||
23393318|NCT03884101|65186791|FG000|Overall Study|Participant Ongoing in Study|202|||
23393319|NCT03884101|65186792|FG001|Overall Study|Participant Ongoing in Study|186|||
23393320|NCT03884101|65186791|FG000|Overall Study|Death|212|||
23393321|NCT03884101|65186792|FG001|Overall Study|Death|224|||
23393322|NCT03884101|65186791|FG000|Overall Study|Lost to Follow-up|0|||
23393323|NCT03884101|65186792|FG001|Overall Study|Lost to Follow-up|1|||
23393324|NCT03884101|65186791|FG000|Overall Study|Withdrawal by Subject|6|||
23393325|NCT03884101|65186792|FG001|Overall Study|Withdrawal by Subject|11|||
23393326|NCT02310321|65186806|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
23393327|NCT02310321|65186807|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
23393328|NCT02310321|65186808|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
23393329|NCT02310321|65186806|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
23393330|NCT02310321|65186807|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
23393331|NCT02310321|65186808|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
23393332|NCT02310321|65186806|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
23497710|NCT01534962|65566164|FG000|Overall Study|Discontinued at AF recurrence|35|||
23497711|NCT01534962|65566165|FG001|Overall Study|Discontinued at AF recurrence|26|||
23497712|NCT01534962|65566166|FG002|Overall Study|Discontinued at AF recurrence|24|||
23497713|NCT01534962|65566167|FG003|Overall Study|Discontinued at AF recurrence|31|||
23497714|NCT00091442|65566168|FG000|Overall Study|Progressive Disease|220|||
23497715|NCT00091442|65566169|FG001|Overall Study|Progressive Disease|189|||
23497716|NCT00091442|65566168|FG000|Overall Study|Physician Decision|61|||
23497717|NCT00091442|65566169|FG001|Overall Study|Physician Decision|58|||
23497718|NCT00091442|65566168|FG000|Overall Study|Withdrawal by Subject|38|||
23497719|NCT00091442|65566169|FG001|Overall Study|Withdrawal by Subject|46|||
23497720|NCT00091442|65566168|FG000|Overall Study|Adverse Event|29|||
23497721|NCT00091442|65566169|FG001|Overall Study|Adverse Event|48|||
23393333|NCT02310321|65186807|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
23393334|NCT02310321|65186808|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
23497722|NCT00091442|65566168|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
23497723|NCT00091442|65566169|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
23497724|NCT00091442|65566168|FG000|Overall Study|Death|9|||
23497725|NCT00091442|65566169|FG001|Overall Study|Death|7|||
23497726|NCT00091442|65566168|FG000|Overall Study|Lost to Follow-up|1|||
23497727|NCT00091442|65566169|FG001|Overall Study|Lost to Follow-up|3|||
23497728|NCT00091442|65566168|FG000|Overall Study|Other|2|||
23497729|NCT00091442|65566169|FG001|Overall Study|Other|6|||
23497730|NCT01889238|65566172|FG000|Overall Study|Treatment ongoing|9|||
23497731|NCT04431453|65566173|FG000|Overall Study|Withdrew Consent|0|||
23497732|NCT04431453|65566174|FG001|Overall Study|Withdrew Consent|1|||
23497733|NCT04431453|65566175|FG002|Overall Study|Withdrew Consent|0|||
23497734|NCT04431453|65566176|FG003|Overall Study|Withdrew Consent|2|||
23497735|NCT04431453|65566177|FG004|Overall Study|Withdrew Consent|0|||
23497736|NCT04431453|65566178|FG005|Overall Study|Withdrew Consent|0|||
23497737|NCT04431453|65566179|FG006|Overall Study|Withdrew Consent|0|||
23497738|NCT04431453|65566180|FG007|Overall Study|Withdrew Consent|0|||
23497739|NCT04431453|65566173|FG000|Overall Study|Death|1|||
23393335|NCT02310321|65186806|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
23497740|NCT04431453|65566174|FG001|Overall Study|Death|0|||
23497741|NCT04431453|65566175|FG002|Overall Study|Death|0|||
23497742|NCT04431453|65566176|FG003|Overall Study|Death|0|||
23497743|NCT04431453|65566177|FG004|Overall Study|Death|0|||
23497744|NCT04431453|65566178|FG005|Overall Study|Death|0|||
23497745|NCT04431453|65566179|FG006|Overall Study|Death|0|||
23497746|NCT04431453|65566180|FG007|Overall Study|Death|1|||
23393336|NCT02310321|65186807|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
23497747|NCT04431453|65566173|FG000|Overall Study|Lost to Follow-up|0|||
23497748|NCT04431453|65566174|FG001|Overall Study|Lost to Follow-up|0|||
23497749|NCT04431453|65566175|FG002|Overall Study|Lost to Follow-up|1|||
23497750|NCT04431453|65566176|FG003|Overall Study|Lost to Follow-up|1|||
23497751|NCT04431453|65566177|FG004|Overall Study|Lost to Follow-up|0|||
23497752|NCT04431453|65566178|FG005|Overall Study|Lost to Follow-up|0|||
23497753|NCT04431453|65566179|FG006|Overall Study|Lost to Follow-up|0|||
23497754|NCT04431453|65566180|FG007|Overall Study|Lost to Follow-up|0|||
23497755|NCT04431453|65566173|FG000|Overall Study|Enrolled but Never Treated|0|||
23497756|NCT04431453|65566174|FG001|Overall Study|Enrolled but Never Treated|0|||
23497757|NCT04431453|65566175|FG002|Overall Study|Enrolled but Never Treated|0|||
23497758|NCT04431453|65566176|FG003|Overall Study|Enrolled but Never Treated|0|||
23497759|NCT04431453|65566177|FG004|Overall Study|Enrolled but Never Treated|1|||
23497760|NCT04431453|65566178|FG005|Overall Study|Enrolled but Never Treated|0|||
23497761|NCT04431453|65566179|FG006|Overall Study|Enrolled but Never Treated|0|||
23497762|NCT04431453|65566180|FG007|Overall Study|Enrolled but Never Treated|0|||
23497763|NCT03689530|65566181|FG000|Overall Study|Withdrawal by Subject|53|||
23497764|NCT03689530|65566182|FG001|Overall Study|Withdrawal by Subject|16|||
23497765|NCT01083485|65566184|FG000|Overall Study|Adverse Event|0|||
23497766|NCT01083485|65566185|FG001|Overall Study|Adverse Event|1|||
23497767|NCT01083485|65566184|FG000|Overall Study|Protocol Violation|1|||
23497768|NCT01083485|65566185|FG001|Overall Study|Protocol Violation|0|||
23497769|NCT01083485|65566184|FG000|Overall Study|Withdrawal by Subject|5|||
23497770|NCT01083485|65566185|FG001|Overall Study|Withdrawal by Subject|2|||
23497771|NCT01083485|65566184|FG000|Overall Study|Other|1|||
23497772|NCT01083485|65566185|FG001|Overall Study|Other|0|||
23497773|NCT00843856|65566187|FG000|Overall Study|Lost to Follow-up|1|||
23497774|NCT00843856|65566188|FG001|Overall Study|Lost to Follow-up|2|||
23497775|NCT04138810|65566189|FG000|Overall Study|Withdrawal by Subject|0|||
23497776|NCT04138810|65566190|FG001|Overall Study|Withdrawal by Subject|1|||
23497777|NCT04138810|65566189|FG000|Overall Study|Subject cancelled surgery|1|||
23497778|NCT04138810|65566190|FG001|Overall Study|Subject cancelled surgery|0|||
23497779|NCT00493025|65566191|FG000|Overall Study|Physician Decision|19|||
23497780|NCT02369016|65566194|FG000|Overall Study|AE associated with clinical disease progression|2|||
23497781|NCT02369016|65566195|FG001|Overall Study|AE associated with clinical disease progression|1|||
23497782|NCT02369016|65566194|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
23497783|NCT02369016|65566195|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
23497784|NCT02369016|65566194|FG000|Overall Study|Progressive disease - clinical progression|1|||
23497785|NCT02369016|65566195|FG001|Overall Study|Progressive disease - clinical progression|4|||
23497786|NCT02369016|65566194|FG000|Overall Study|withdrawal by patient|4|||
23497787|NCT02369016|65566195|FG001|Overall Study|withdrawal by patient|0|||
23497788|NCT02369016|65566194|FG000|Overall Study|Progressive disease - radiological progression|6|||
23497789|NCT02369016|65566195|FG001|Overall Study|Progressive disease - radiological progression|2|||
23497790|NCT02378961|65566197|FG000|Overall Study|Lack of Efficacy|4|||
23497791|NCT02378961|65566198|FG001|Overall Study|Lack of Efficacy|2|||
23497792|NCT02378961|65566199|FG002|Overall Study|Lack of Efficacy|0|||
23497793|NCT02378961|65566200|FG003|Overall Study|Lack of Efficacy|1|||
23497794|NCT02378961|65566197|FG000|Overall Study|Death|0|||
23497795|NCT02378961|65566198|FG001|Overall Study|Death|0|||
23497796|NCT02378961|65566199|FG002|Overall Study|Death|1|||
23497797|NCT02378961|65566200|FG003|Overall Study|Death|0|||
23497798|NCT01189604|65566201|FG000|Overall Study|Impossible to visit|0|||
23497799|NCT01189604|65566202|FG001|Overall Study|Impossible to visit|0|||
23497800|NCT01189604|65566203|FG002|Overall Study|Impossible to visit|0|||
23497801|NCT01189604|65566204|FG003|Overall Study|Impossible to visit|0|||
23497802|NCT01189604|65566205|FG004|Overall Study|Impossible to visit|0|||
23497803|NCT01189604|65566206|FG005|Overall Study|Impossible to visit|1|||
23497804|NCT01189604|65566207|FG006|Overall Study|Impossible to visit|0|||
23497805|NCT01189604|65566201|FG000|Overall Study|Adverse Event|0|||
23497806|NCT01189604|65566202|FG001|Overall Study|Adverse Event|1|||
23497807|NCT01189604|65566203|FG002|Overall Study|Adverse Event|0|||
23497808|NCT01189604|65566204|FG003|Overall Study|Adverse Event|0|||
23497809|NCT01189604|65566205|FG004|Overall Study|Adverse Event|2|||
23497810|NCT01189604|65566206|FG005|Overall Study|Adverse Event|0|||
23497811|NCT01189604|65566207|FG006|Overall Study|Adverse Event|1|||
23497812|NCT01189604|65566201|FG000|Overall Study|Withdrawal by Subject|1|||
23497813|NCT01189604|65566202|FG001|Overall Study|Withdrawal by Subject|0|||
23497814|NCT01189604|65566203|FG002|Overall Study|Withdrawal by Subject|0|||
23497815|NCT01189604|65566204|FG003|Overall Study|Withdrawal by Subject|0|||
23497816|NCT01189604|65566205|FG004|Overall Study|Withdrawal by Subject|0|||
23497817|NCT01189604|65566206|FG005|Overall Study|Withdrawal by Subject|0|||
23497818|NCT01189604|65566207|FG006|Overall Study|Withdrawal by Subject|0|||
23497819|NCT00675948|65566208|FG000|Overall Study|Adverse Event|23|||
23497820|NCT00675948|65566209|FG001|Overall Study|Adverse Event|1|||
23497821|NCT00675948|65566208|FG000|Overall Study|Lack of Efficacy|3|||
23497822|NCT00675948|65566209|FG001|Overall Study|Lack of Efficacy|0|||
23497823|NCT00675948|65566208|FG000|Overall Study|Withdrawal by Subject|7|||
23497824|NCT00675948|65566209|FG001|Overall Study|Withdrawal by Subject|0|||
23497825|NCT00675948|65566208|FG000|Overall Study|Lost to Follow-up|2|||
23497826|NCT00675948|65566209|FG001|Overall Study|Lost to Follow-up|0|||
23497827|NCT00675948|65566208|FG000|Overall Study|Protocol Violation|1|||
23497828|NCT00675948|65566209|FG001|Overall Study|Protocol Violation|0|||
23497829|NCT00675948|65566208|FG000|Overall Study|Pain under control|1|||
23497830|NCT00675948|65566209|FG001|Overall Study|Pain under control|0|||
23497831|NCT00675948|65566208|FG000|Overall Study|Sponsor decision|0|||
23497832|NCT00675948|65566209|FG001|Overall Study|Sponsor decision|1|||
23497833|NCT00675948|65566208|FG000|Overall Study|Patient died|1|||
23497834|NCT00675948|65566209|FG001|Overall Study|Patient died|0|||
23497835|NCT00675948|65566208|FG000|Overall Study|Patient unable to comply with diaries|1|||
23497836|NCT00675948|65566209|FG001|Overall Study|Patient unable to comply with diaries|0|||
23497837|NCT00675948|65566208|FG000|Overall Study|Patient feels unable to take medication|0|||
23497838|NCT00675948|65566209|FG001|Overall Study|Patient feels unable to take medication|1|||
23497839|NCT02339285|65566211|FG000|Overall Study|Withdrawal by Subject|0|||
23497840|NCT02339285|65566212|FG001|Overall Study|Withdrawal by Subject|1|||
23497841|NCT02339285|65566213|FG002|Overall Study|Withdrawal by Subject|1|||
23497842|NCT02339285|65566211|FG000|Overall Study|Lost to Follow-up|1|||
23497843|NCT02339285|65566212|FG001|Overall Study|Lost to Follow-up|1|||
23497844|NCT02339285|65566213|FG002|Overall Study|Lost to Follow-up|1|||
23497845|NCT02339285|65566211|FG000|Overall Study|Protocol Deviation|0|||
23497846|NCT02339285|65566212|FG001|Overall Study|Protocol Deviation|1|||
23497847|NCT02339285|65566213|FG002|Overall Study|Protocol Deviation|0|||
23497848|NCT04502433|65566214|FG000|Overall Study|Death|2|||
23497849|NCT04502433|65566215|FG001|Overall Study|Death|4|||
23497850|NCT04502433|65566214|FG000|Overall Study|Lost to Follow-up|1|||
23497851|NCT04502433|65566215|FG001|Overall Study|Lost to Follow-up|0|||
23497852|NCT04502433|65566214|FG000|Overall Study|Physician Decision|0|||
23497853|NCT04502433|65566215|FG001|Overall Study|Physician Decision|1|||
23497854|NCT05439941|65566216|FG000|Overall Study|Lack of Efficacy|8|||
23497855|NCT05439941|65566217|FG001|Overall Study|Lack of Efficacy|5|||
23497856|NCT05439941|65566218|FG002|Overall Study|Lack of Efficacy|3|||
23497857|NCT05439941|65566216|FG000|Overall Study|Treatment Failure|0|||
23497858|NCT05439941|65566217|FG001|Overall Study|Treatment Failure|1|||
23497859|NCT05439941|65566218|FG002|Overall Study|Treatment Failure|0|||
23497860|NCT05439941|65566216|FG000|Overall Study|Adverse Event|1|||
23497861|NCT05439941|65566217|FG001|Overall Study|Adverse Event|3|||
23497862|NCT05439941|65566218|FG002|Overall Study|Adverse Event|0|||
23497863|NCT05439941|65566216|FG000|Overall Study|Adverse Event - Parent Study|1|||
23497864|NCT05439941|65566217|FG001|Overall Study|Adverse Event - Parent Study|0|||
23497865|NCT05439941|65566218|FG002|Overall Study|Adverse Event - Parent Study|0|||
23497866|NCT05439941|65566216|FG000|Overall Study|Pregnancy|1|||
23497867|NCT05439941|65566217|FG001|Overall Study|Pregnancy|0|||
23497868|NCT05439941|65566218|FG002|Overall Study|Pregnancy|0|||
23497869|NCT05439941|65566216|FG000|Overall Study|Withdrawal by Subject|9|||
23497870|NCT05439941|65566217|FG001|Overall Study|Withdrawal by Subject|6|||
23497871|NCT05439941|65566218|FG002|Overall Study|Withdrawal by Subject|10|||
23497872|NCT05439941|65566216|FG000|Overall Study|Non-Compliance|1|||
23497873|NCT05439941|65566217|FG001|Overall Study|Non-Compliance|1|||
23497874|NCT05439941|65566218|FG002|Overall Study|Non-Compliance|1|||
23497875|NCT05439941|65566216|FG000|Overall Study|Lost to Follow-up|2|||
23497876|NCT05439941|65566217|FG001|Overall Study|Lost to Follow-up|2|||
23497877|NCT05439941|65566218|FG002|Overall Study|Lost to Follow-up|0|||
23497878|NCT05439941|65566216|FG000|Overall Study|Physician Decision|1|||
23497879|NCT05439941|65566217|FG001|Overall Study|Physician Decision|0|||
23497880|NCT05439941|65566218|FG002|Overall Study|Physician Decision|0|||
23497881|NCT05439941|65566216|FG000|Overall Study|Trial Termination by Sponsor|78|||
23497882|NCT05439941|65566217|FG001|Overall Study|Trial Termination by Sponsor|83|||
23497883|NCT05439941|65566218|FG002|Overall Study|Trial Termination by Sponsor|65|||
23497884|NCT05439941|65566216|FG000|Overall Study|Other than Reasons Listed|2|||
23497885|NCT05439941|65566217|FG001|Overall Study|Other than Reasons Listed|1|||
23497886|NCT05439941|65566218|FG002|Overall Study|Other than Reasons Listed|0|||
23497887|NCT04401423|65566223|FG000|Overall Study|Withdrawal by Subject|3|||
23497888|NCT04401423|65566224|FG001|Overall Study|Withdrawal by Subject|1|||
23497889|NCT04401423|65566223|FG000|Overall Study|Physician Decision|2|||
23497890|NCT04401423|65566224|FG001|Overall Study|Physician Decision|1|||
23497891|NCT00087607|65566225|FG000|Overall Study|Adverse Event|14|||
23497892|NCT00087607|65566226|FG001|Overall Study|Adverse Event|24|||
23497893|NCT00087607|65566225|FG000|Overall Study|Death|0|||
23497894|NCT00087607|65566226|FG001|Overall Study|Death|1|||
23497895|NCT00087607|65566225|FG000|Overall Study|Insufficient Therapeutic Response|53|||
23497896|NCT00087607|65566226|FG001|Overall Study|Insufficient Therapeutic Response|42|||
23497897|NCT00087607|65566225|FG000|Overall Study|Failure to return|21|||
23497898|NCT00087607|65566226|FG001|Overall Study|Failure to return|17|||
23497899|NCT00087607|65566225|FG000|Overall Study|Withdrew Consent|12|||
23497900|NCT00087607|65566226|FG001|Overall Study|Withdrew Consent|16|||
23497901|NCT00087607|65566225|FG000|Overall Study|Administrative|12|||
23497902|NCT00087607|65566226|FG001|Overall Study|Administrative|12|||
23497903|NCT00087607|65566225|FG000|Overall Study|Refused Treatment|5|||
23497904|NCT00087607|65566226|FG001|Overall Study|Refused Treatment|7|||
23497905|NCT00087607|65566225|FG000|Overall Study|Other Protocol Violation|5|||
23497906|NCT00087607|65566226|FG001|Overall Study|Other Protocol Violation|2|||
23497907|NCT00087607|65566225|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
23497908|NCT00087607|65566226|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
23497909|NCT00134082|65566227|FG000|Overall Study|Adverse Event|2|||
23497910|NCT00134082|65566227|FG000|Overall Study|Death|1|||
23497911|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
23497912|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
23497913|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
23497914|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
23497915|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
23497916|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
23497917|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
23497918|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
23497919|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
23497920|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
23497921|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
23497922|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
23497923|NCT02349061|65566230|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
23497924|NCT02349061|65566231|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
23497925|NCT02349061|65566232|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
23497926|NCT02349061|65566230|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
23497927|NCT02349061|65566231|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
23497928|NCT02349061|65566232|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
23497929|NCT02349061|65566230|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
23497930|NCT02349061|65566231|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
23497931|NCT02349061|65566232|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
23497932|NCT02349061|65566230|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
23497933|NCT02349061|65566231|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
23393337|NCT02310321|65186808|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
23393338|NCT02310321|65186806|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
23393339|NCT02310321|65186807|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
23393340|NCT02310321|65186808|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
23393341|NCT02310321|65186806|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
23393342|NCT02310321|65186807|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
23393343|NCT02310321|65186808|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
23393344|NCT02310321|65186806|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
23393345|NCT02310321|65186807|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
23393346|NCT02310321|65186808|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
23393347|NCT02310321|65186806|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
23393348|NCT02310321|65186807|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
23393349|NCT02310321|65186808|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
23393350|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
23393351|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
23393352|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
23393353|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
23393354|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
23393355|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
23393356|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
23393357|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
23497934|NCT02349061|65566232|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
23497935|NCT02349061|65566230|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
23497936|NCT02349061|65566231|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
23497937|NCT02349061|65566232|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
23497938|NCT02349061|65566230|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
23497939|NCT02349061|65566231|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
23497940|NCT02349061|65566232|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
23393358|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
23393359|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
23393360|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
23497941|NCT02349061|65566230|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
23497942|NCT02349061|65566231|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
23497943|NCT02349061|65566232|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
23497944|NCT02349061|65566230|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
23497945|NCT02349061|65566231|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
23497946|NCT02349061|65566232|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
23393361|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
23393362|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
23393363|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
23393364|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
23393365|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
23497947|NCT02349061|65566230|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
23497948|NCT02349061|65566231|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
23497949|NCT02349061|65566232|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
23497950|NCT03386448|65566233|FG000|Overall Study|Adverse Event|0|||
23497951|NCT03386448|65566234|FG001|Overall Study|Adverse Event|2|||
23497952|NCT00702923|65566235|FG000|Overall Study|Adverse Event|1|||
23497953|NCT03988088|65566236|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
23497954|NCT03988088|65566237|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
23497955|NCT03988088|65566238|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
23497956|NCT03988088|65566239|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
23497957|NCT03988088|65566236|FG000|Open-Label Addendum|Lost to Follow-up|0|||
23497958|NCT03988088|65566237|FG001|Open-Label Addendum|Lost to Follow-up|0|||
23497959|NCT03988088|65566238|FG002|Open-Label Addendum|Lost to Follow-up|1|||
23497960|NCT03988088|65566239|FG003|Open-Label Addendum|Lost to Follow-up|0|||
23497961|NCT02130297|65566240|FG000|Overall Study|Lost to Follow-up|4|||
23497962|NCT00334958|65566244|FG000|Overall Study|Medication Noncompliance|0|||
23497963|NCT00334958|65566245|FG001|Overall Study|Medication Noncompliance|3|||
23497964|NCT00334958|65566244|FG000|Overall Study|Protocol Violation|2|||
23497965|NCT00334958|65566245|FG001|Overall Study|Protocol Violation|2|||
23497966|NCT00334958|65566244|FG000|Overall Study|Request of the investigator or sponsor|0|||
23497967|NCT00334958|65566245|FG001|Overall Study|Request of the investigator or sponsor|1|||
23497968|NCT00334958|65566244|FG000|Overall Study|Withdrawal by Subject|7|||
23497969|NCT00334958|65566245|FG001|Overall Study|Withdrawal by Subject|4|||
23497970|NCT00334958|65566244|FG000|Overall Study|Adverse Event|27|||
23497971|NCT00334958|65566245|FG001|Overall Study|Adverse Event|12|||
23497972|NCT00334958|65566244|FG000|Overall Study|Other|1|||
23497973|NCT00334958|65566245|FG001|Overall Study|Other|2|||
23497974|NCT01543958|65566246|FG000|Overall Study|Loss to follow-up|3|||
23497975|NCT01543958|65566246|FG000|Overall Study|ART initiation|1|||
23497976|NCT01065597|65566247|FG000|Overall Study|Adverse Event|1|||
23497977|NCT01972568|65566248|FG000|Overall Study|Other events|3|||
23497978|NCT01972568|65566249|FG001|Overall Study|Other events|0|||
23497979|NCT01972568|65566250|FG002|Overall Study|Other events|0|||
23497980|NCT01972568|65566248|FG000|Overall Study|Lack of Efficacy|0|||
23497981|NCT01972568|65566249|FG001|Overall Study|Lack of Efficacy|1|||
23497982|NCT01972568|65566250|FG002|Overall Study|Lack of Efficacy|2|||
23497983|NCT01972568|65566248|FG000|Overall Study|Protocol Violation|1|||
23497984|NCT01972568|65566249|FG001|Overall Study|Protocol Violation|2|||
23497985|NCT01972568|65566250|FG002|Overall Study|Protocol Violation|2|||
23497986|NCT01972568|65566248|FG000|Overall Study|Withdrawal by Subject|6|||
23497987|NCT01972568|65566249|FG001|Overall Study|Withdrawal by Subject|3|||
23497988|NCT01972568|65566250|FG002|Overall Study|Withdrawal by Subject|7|||
23393366|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
23497989|NCT01972568|65566248|FG000|Overall Study|Lost to Follow-up|1|||
23497990|NCT01972568|65566249|FG001|Overall Study|Lost to Follow-up|0|||
23497991|NCT01972568|65566250|FG002|Overall Study|Lost to Follow-up|0|||
23497992|NCT01972568|65566248|FG000|Overall Study|Adverse Event|5|||
23497993|NCT01972568|65566249|FG001|Overall Study|Adverse Event|6|||
23497994|NCT01972568|65566250|FG002|Overall Study|Adverse Event|5|||
23497995|NCT03719586|65566255|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
23497996|NCT03719586|65566256|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
23497997|NCT03719586|65566257|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
23497998|NCT03719586|65566258|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
23497999|NCT03137537|65566259|FG000|Overall Study|Adverse Event|0|||
23498000|NCT03137537|65566260|FG001|Overall Study|Adverse Event|1|||
23393367|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
23393368|NCT02310321|65186806|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
23393369|NCT02310321|65186807|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
23393370|NCT02310321|65186808|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
23393371|NCT02310321|65186806|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
23393372|NCT02310321|65186807|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
23393373|NCT02310321|65186808|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|16|||
23393374|NCT02310321|65186806|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
23393375|NCT02310321|65186807|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
23393376|NCT02310321|65186808|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|3|||
23393377|NCT02310321|65186806|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
23393378|NCT02310321|65186807|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
23393379|NCT02310321|65186808|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|3|||
23498001|NCT00075218|65566263|FG000|Double-Blind Treatment|Adverse Event|23|||
23498002|NCT00075218|65566264|FG001|Double-Blind Treatment|Adverse Event|4|||
23498003|NCT00075218|65566265|FG002|Double-Blind Treatment|Adverse Event|0|||
23498004|NCT00075218|65566263|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
23300456|NCT00251641|64842795|FG000|Overall Study|Switched Treatment|9|||
23300457|NCT00251641|64842796|FG001|Overall Study|Switched Treatment|63|||
23300458|NCT03097588|64842797|FG000|Overall Study|Adverse Event|1|||
23300459|NCT02692482|64842798|FG000|Overall Study|Death|2|||
23300460|NCT02692482|64842799|FG001|Overall Study|Death|2|||
23300461|NCT02692482|64842798|FG000|Overall Study|Withdrawal by Subject|1|||
23300462|NCT02692482|64842799|FG001|Overall Study|Withdrawal by Subject|2|||
23300463|NCT03351231|64842800|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
23300464|NCT03351231|64842800|FG000|Combination Therapy Period|Disease progression|2|||
23300465|NCT03351231|64842800|FG000|Combination Therapy Period|Study drug toxicity|1|||
23300466|NCT03351231|64842800|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
23300467|NCT03351231|64842800|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
23300468|NCT03351231|64842800|FG000|Safety Follow-Up Period|Other reason|2|||
23300469|NCT02065713|64842801|FG000|Overall Study|Adverse Event|0|||
23300470|NCT02065713|64842802|FG001|Overall Study|Adverse Event|1|||
23300471|NCT02065713|64842801|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23300472|NCT02065713|64842802|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23300473|NCT03438227|64842803|FG000|Overall Study|Withdrawal by Subject|10|||
23300474|NCT03438227|64842804|FG001|Overall Study|Withdrawal by Subject|5|||
23300475|NCT00925301|64842807|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
23300476|NCT00925301|64842808|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
23300477|NCT00925301|64842809|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
23300478|NCT00925301|64842810|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
23300479|NCT00925301|64842807|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
23300480|NCT00925301|64842808|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
23300481|NCT00925301|64842809|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
23300482|NCT00925301|64842810|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
23300483|NCT00925301|64842807|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
23300484|NCT00925301|64842808|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
23300485|NCT00925301|64842809|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
23300486|NCT00925301|64842810|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
23300487|NCT00925301|64842807|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
23300488|NCT00925301|64842808|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
23300489|NCT00925301|64842809|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
23498005|NCT00075218|65566264|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
23498006|NCT00075218|65566265|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
23498007|NCT00075218|65566263|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
23498008|NCT00075218|65566264|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
23498009|NCT00075218|65566265|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
23498010|NCT00075218|65566263|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
23498011|NCT00075218|65566264|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
23498012|NCT00075218|65566265|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
23498013|NCT00075218|65566263|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
23498014|NCT00075218|65566264|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
23498015|NCT00075218|65566265|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
23498016|NCT00075218|65566263|FG000|Double-Blind Treatment|No study medication taken|2|||
23498017|NCT00075218|65566264|FG001|Double-Blind Treatment|No study medication taken|0|||
23498018|NCT00075218|65566265|FG002|Double-Blind Treatment|No study medication taken|0|||
23498019|NCT00075218|65566263|FG000|Open-Label Treatment|Lack of Efficacy|0|||
23498020|NCT00075218|65566264|FG001|Open-Label Treatment|Lack of Efficacy|0|||
23498021|NCT00075218|65566265|FG002|Open-Label Treatment|Lack of Efficacy|174|||
23498022|NCT00075218|65566263|FG000|Open-Label Treatment|Adverse Event|0|||
23498023|NCT00075218|65566264|FG001|Open-Label Treatment|Adverse Event|0|||
23498024|NCT00075218|65566265|FG002|Open-Label Treatment|Adverse Event|51|||
23498025|NCT00075218|65566263|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
23498026|NCT00075218|65566264|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
23498027|NCT00075218|65566265|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
23498028|NCT00075218|65566263|FG000|Open-Label Treatment|Decision of Sponsor|0|||
23498029|NCT00075218|65566264|FG001|Open-Label Treatment|Decision of Sponsor|0|||
23498030|NCT00075218|65566265|FG002|Open-Label Treatment|Decision of Sponsor|8|||
23498031|NCT00075218|65566263|FG000|Open-Label Treatment|Protocol Violation|0|||
23498032|NCT00075218|65566264|FG001|Open-Label Treatment|Protocol Violation|0|||
23498033|NCT00075218|65566265|FG002|Open-Label Treatment|Protocol Violation|1|||
23498034|NCT00075218|65566263|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
23498035|NCT00075218|65566264|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
23498036|NCT00075218|65566265|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
23498037|NCT00142298|65566266|FG000|Overall Study|Adverse Event|10|||
23498038|NCT00142298|65566267|FG001|Overall Study|Adverse Event|10|||
23498039|NCT00142298|65566268|FG002|Overall Study|Adverse Event|1|||
23498040|NCT00142298|65566269|FG003|Overall Study|Adverse Event|5|||
23498041|NCT00142298|65566270|FG004|Overall Study|Adverse Event|2|||
23498042|NCT00142298|65566271|FG005|Overall Study|Adverse Event|2|||
23498043|NCT00142298|65566272|FG006|Overall Study|Adverse Event|0|||
23498044|NCT00142298|65566273|FG007|Overall Study|Adverse Event|0|||
23498045|NCT00142298|65566274|FG008|Overall Study|Adverse Event|0|||
23498046|NCT00142298|65566275|FG009|Overall Study|Adverse Event|0|||
23498047|NCT00142298|65566266|FG000|Overall Study|Clinical disease progression|1|||
23498048|NCT00142298|65566267|FG001|Overall Study|Clinical disease progression|0|||
23498049|NCT00142298|65566268|FG002|Overall Study|Clinical disease progression|0|||
23498050|NCT00142298|65566269|FG003|Overall Study|Clinical disease progression|0|||
23498051|NCT00142298|65566270|FG004|Overall Study|Clinical disease progression|0|||
23498052|NCT00142298|65566271|FG005|Overall Study|Clinical disease progression|0|||
23498053|NCT00142298|65566272|FG006|Overall Study|Clinical disease progression|0|||
23498054|NCT00142298|65566273|FG007|Overall Study|Clinical disease progression|0|||
23498055|NCT00142298|65566274|FG008|Overall Study|Clinical disease progression|0|||
23498056|NCT00142298|65566275|FG009|Overall Study|Clinical disease progression|0|||
23498057|NCT00142298|65566266|FG000|Overall Study|Death|1|||
23498058|NCT00142298|65566267|FG001|Overall Study|Death|1|||
23498059|NCT00142298|65566268|FG002|Overall Study|Death|1|||
23498060|NCT00142298|65566269|FG003|Overall Study|Death|0|||
23498061|NCT00142298|65566270|FG004|Overall Study|Death|0|||
23498062|NCT00142298|65566271|FG005|Overall Study|Death|6|||
23498063|NCT00142298|65566272|FG006|Overall Study|Death|0|||
23498064|NCT00142298|65566273|FG007|Overall Study|Death|0|||
23498065|NCT00142298|65566274|FG008|Overall Study|Death|0|||
23498066|NCT00142298|65566275|FG009|Overall Study|Death|0|||
23498067|NCT00142298|65566266|FG000|Overall Study|Lack of Efficacy|44|||
23498068|NCT00142298|65566267|FG001|Overall Study|Lack of Efficacy|62|||
23498069|NCT00142298|65566268|FG002|Overall Study|Lack of Efficacy|9|||
23498070|NCT00142298|65566269|FG003|Overall Study|Lack of Efficacy|12|||
23498071|NCT00142298|65566270|FG004|Overall Study|Lack of Efficacy|1|||
23498072|NCT00142298|65566271|FG005|Overall Study|Lack of Efficacy|0|||
23300490|NCT00925301|64842810|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
23498073|NCT00142298|65566272|FG006|Overall Study|Lack of Efficacy|0|||
23498074|NCT00142298|65566273|FG007|Overall Study|Lack of Efficacy|1|||
23498075|NCT00142298|65566274|FG008|Overall Study|Lack of Efficacy|0|||
23498076|NCT00142298|65566275|FG009|Overall Study|Lack of Efficacy|0|||
23498077|NCT00142298|65566266|FG000|Overall Study|Non-compliance|15|||
23498078|NCT00142298|65566267|FG001|Overall Study|Non-compliance|13|||
23498079|NCT00142298|65566268|FG002|Overall Study|Non-compliance|0|||
23498080|NCT00142298|65566269|FG003|Overall Study|Non-compliance|6|||
23498081|NCT00142298|65566270|FG004|Overall Study|Non-compliance|1|||
23498082|NCT00142298|65566271|FG005|Overall Study|Non-compliance|0|||
23498083|NCT00142298|65566272|FG006|Overall Study|Non-compliance|0|||
23498084|NCT00142298|65566273|FG007|Overall Study|Non-compliance|3|||
23498085|NCT00142298|65566274|FG008|Overall Study|Non-compliance|3|||
23393380|NCT02310321|65186806|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
23393381|NCT02310321|65186807|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
23393382|NCT02310321|65186808|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|3|||
23393383|NCT02310321|65186806|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
23393384|NCT02310321|65186807|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
23393385|NCT02310321|65186808|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|26|||
23393386|NCT02310321|65186806|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
23393387|NCT02310321|65186807|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
23393388|NCT02310321|65186808|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|1|||
23393389|NCT02310321|65186806|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
23393390|NCT02310321|65186807|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
23393391|NCT02310321|65186808|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|1|||
23393392|NCT05309291|65186811|FG000|Overall Study|Adverse Event|0|||
23393393|NCT05309291|65186812|FG001|Overall Study|Adverse Event|1|||
23393394|NCT01435356|65186814|FG000|Overall Study|Adverse Event|2|||
23393395|NCT01435356|65186815|FG001|Overall Study|Adverse Event|0|||
23393396|NCT01435356|65186814|FG000|Overall Study|Disease progression/recurrence|17|||
23393397|NCT01435356|65186815|FG001|Overall Study|Disease progression/recurrence|10|||
23393398|NCT01435356|65186814|FG000|Overall Study|Protocol Violation|0|||
23393399|NCT01435356|65186815|FG001|Overall Study|Protocol Violation|1|||
23393400|NCT01435356|65186814|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
23393401|NCT01435356|65186815|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
23393402|NCT01435356|65186814|FG000|Overall Study|Withdrawal by Subject|1|||
23393403|NCT01435356|65186815|FG001|Overall Study|Withdrawal by Subject|1|||
23393404|NCT01435356|65186814|FG000|Overall Study|Facial palsy|1|||
23393405|NCT01435356|65186815|FG001|Overall Study|Facial palsy|0|||
23393406|NCT01435356|65186814|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
23393407|NCT01435356|65186815|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
23393408|NCT01435356|65186814|FG000|Overall Study|Physician Decision|1|||
23393409|NCT01435356|65186815|FG001|Overall Study|Physician Decision|0|||
23393410|NCT01435356|65186814|FG000|Overall Study|Patient decision|3|||
23393411|NCT01435356|65186815|FG001|Overall Study|Patient decision|0|||
23393412|NCT01435356|65186814|FG000|Overall Study|Patient moved to another city|1|||
23393413|NCT01435356|65186815|FG001|Overall Study|Patient moved to another city|1|||
23393414|NCT00734032|65186816|FG000|Overall Study|Adverse Event|0|||
23393415|NCT00734032|65186817|FG001|Overall Study|Adverse Event|1|||
23393416|NCT00734032|65186818|FG002|Overall Study|Adverse Event|0|||
23393417|NCT00734032|65186819|FG003|Overall Study|Adverse Event|0|||
23393418|NCT02776735|65186824|FG000|Overall Study|Adverse Event|0|||
23393419|NCT02776735|65186825|FG001|Overall Study|Adverse Event|0|||
23393420|NCT02776735|65186826|FG002|Overall Study|Adverse Event|0|||
23393421|NCT02776735|65186827|FG003|Overall Study|Adverse Event|1|||
23393422|NCT02776735|65186828|FG004|Overall Study|Adverse Event|0|||
23393423|NCT02776735|65186829|FG005|Overall Study|Adverse Event|1|||
23393424|NCT02776735|65186824|FG000|Overall Study|Lost to Follow-up|0|||
23393425|NCT02776735|65186825|FG001|Overall Study|Lost to Follow-up|0|||
23393426|NCT02776735|65186826|FG002|Overall Study|Lost to Follow-up|0|||
23393427|NCT02776735|65186827|FG003|Overall Study|Lost to Follow-up|1|||
23393428|NCT02776735|65186828|FG004|Overall Study|Lost to Follow-up|0|||
23393429|NCT02776735|65186829|FG005|Overall Study|Lost to Follow-up|0|||
23393430|NCT02776735|65186824|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23393431|NCT02776735|65186825|FG001|Overall Study|Withdrawal by parent/guardian|0|||
23393432|NCT02776735|65186826|FG002|Overall Study|Withdrawal by parent/guardian|2|||
23393433|NCT02776735|65186827|FG003|Overall Study|Withdrawal by parent/guardian|2|||
23393434|NCT02776735|65186828|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23393435|NCT02776735|65186829|FG005|Overall Study|Withdrawal by parent/guardian|0|||
23393436|NCT02776735|65186824|FG000|Overall Study|Withdrawal by Subject|1|||
23393437|NCT02776735|65186825|FG001|Overall Study|Withdrawal by Subject|0|||
23393438|NCT02776735|65186826|FG002|Overall Study|Withdrawal by Subject|0|||
23393439|NCT02776735|65186827|FG003|Overall Study|Withdrawal by Subject|0|||
23393440|NCT02776735|65186828|FG004|Overall Study|Withdrawal by Subject|0|||
23393441|NCT02776735|65186829|FG005|Overall Study|Withdrawal by Subject|1|||
23498086|NCT00142298|65566275|FG009|Overall Study|Non-compliance|0|||
23498087|NCT00142298|65566266|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
23393442|NCT02776735|65186824|FG000|Overall Study|Other|0|||
23393443|NCT02776735|65186825|FG001|Overall Study|Other|0|||
23498088|NCT00142298|65566267|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
23498089|NCT00142298|65566268|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
23498090|NCT00142298|65566269|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
23498091|NCT00142298|65566270|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
23498092|NCT00142298|65566271|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
23498093|NCT00142298|65566272|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
23498094|NCT00142298|65566273|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
23498095|NCT00142298|65566274|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
23498096|NCT00142298|65566275|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
23498097|NCT00142298|65566266|FG000|Overall Study|Pregnancy|4|||
23498098|NCT00142298|65566267|FG001|Overall Study|Pregnancy|4|||
23498099|NCT00142298|65566268|FG002|Overall Study|Pregnancy|2|||
23498100|NCT00142298|65566269|FG003|Overall Study|Pregnancy|3|||
23498101|NCT00142298|65566270|FG004|Overall Study|Pregnancy|0|||
23498102|NCT00142298|65566271|FG005|Overall Study|Pregnancy|0|||
23498103|NCT00142298|65566272|FG006|Overall Study|Pregnancy|0|||
23498104|NCT00142298|65566273|FG007|Overall Study|Pregnancy|0|||
23498105|NCT00142298|65566274|FG008|Overall Study|Pregnancy|1|||
23498106|NCT00142298|65566275|FG009|Overall Study|Pregnancy|0|||
23498107|NCT00142298|65566266|FG000|Overall Study|Virologic breakthrough|19|||
23498108|NCT00142298|65566267|FG001|Overall Study|Virologic breakthrough|23|||
23498109|NCT00142298|65566268|FG002|Overall Study|Virologic breakthrough|9|||
23498110|NCT00142298|65566269|FG003|Overall Study|Virologic breakthrough|7|||
23498111|NCT00142298|65566270|FG004|Overall Study|Virologic breakthrough|2|||
23498112|NCT00142298|65566271|FG005|Overall Study|Virologic breakthrough|3|||
23498113|NCT00142298|65566272|FG006|Overall Study|Virologic breakthrough|3|||
23498114|NCT00142298|65566273|FG007|Overall Study|Virologic breakthrough|0|||
23498115|NCT00142298|65566274|FG008|Overall Study|Virologic breakthrough|0|||
23498116|NCT00142298|65566275|FG009|Overall Study|Virologic breakthrough|0|||
23498117|NCT00142298|65566266|FG000|Overall Study|Other- not specified|0|||
23498118|NCT00142298|65566267|FG001|Overall Study|Other- not specified|3|||
23498119|NCT00142298|65566268|FG002|Overall Study|Other- not specified|0|||
23498120|NCT00142298|65566269|FG003|Overall Study|Other- not specified|1|||
23498121|NCT00142298|65566270|FG004|Overall Study|Other- not specified|0|||
23300491|NCT00925301|64842807|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
23300492|NCT00925301|64842808|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
23300493|NCT00925301|64842809|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
23300494|NCT00925301|64842810|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
23300495|NCT00925301|64842807|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
23300496|NCT00925301|64842808|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
23300497|NCT00925301|64842809|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
23393444|NCT02776735|65186826|FG002|Overall Study|Other|3|||
23498122|NCT00142298|65566271|FG005|Overall Study|Other- not specified|0|||
23498123|NCT00142298|65566272|FG006|Overall Study|Other- not specified|0|||
23498124|NCT00142298|65566273|FG007|Overall Study|Other- not specified|0|||
23498125|NCT00142298|65566274|FG008|Overall Study|Other- not specified|0|||
23498126|NCT00142298|65566275|FG009|Overall Study|Other- not specified|0|||
23498127|NCT00142298|65566266|FG000|Overall Study|Lost to Follow-up|0|||
23498128|NCT00142298|65566267|FG001|Overall Study|Lost to Follow-up|0|||
23498129|NCT00142298|65566268|FG002|Overall Study|Lost to Follow-up|0|||
23498130|NCT00142298|65566269|FG003|Overall Study|Lost to Follow-up|0|||
23498131|NCT00142298|65566270|FG004|Overall Study|Lost to Follow-up|0|||
23498132|NCT00142298|65566271|FG005|Overall Study|Lost to Follow-up|0|||
23498133|NCT00142298|65566272|FG006|Overall Study|Lost to Follow-up|2|||
23498134|NCT00142298|65566273|FG007|Overall Study|Lost to Follow-up|0|||
23498135|NCT00142298|65566274|FG008|Overall Study|Lost to Follow-up|0|||
23498136|NCT00142298|65566275|FG009|Overall Study|Lost to Follow-up|0|||
23498137|NCT00142298|65566266|FG000|Overall Study|Treatment Failure|0|||
23498138|NCT00142298|65566267|FG001|Overall Study|Treatment Failure|0|||
23498139|NCT00142298|65566268|FG002|Overall Study|Treatment Failure|0|||
23498140|NCT00142298|65566269|FG003|Overall Study|Treatment Failure|0|||
23498141|NCT00142298|65566270|FG004|Overall Study|Treatment Failure|0|||
23498142|NCT00142298|65566271|FG005|Overall Study|Treatment Failure|2|||
23498143|NCT00142298|65566272|FG006|Overall Study|Treatment Failure|2|||
23498144|NCT00142298|65566273|FG007|Overall Study|Treatment Failure|0|||
23498145|NCT00142298|65566274|FG008|Overall Study|Treatment Failure|0|||
23498146|NCT00142298|65566275|FG009|Overall Study|Treatment Failure|0|||
23498147|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
23498148|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
23498149|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
23498150|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
23498151|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
23498152|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
23498153|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
23498154|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
23498155|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
23498156|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
23498157|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
23498158|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
23498159|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
23498160|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
23498161|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
23498162|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
23498163|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
23498164|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
23498165|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
23498166|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
23498167|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
23498168|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
23498169|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
23498170|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
23498171|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
23498172|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
23498173|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
23498174|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
23498175|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
23498176|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
23498177|NCT00313300|65566276|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
23498178|NCT00313300|65566277|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
23498179|NCT00313300|65566278|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
23498180|NCT00313300|65566279|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
23498181|NCT00313300|65566280|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
23498182|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
23498183|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
23498184|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
23498185|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
23498186|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
23498187|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
23498188|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
23498189|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
23498190|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
23498191|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
23498192|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
23498193|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
23498194|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
23498195|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
23498196|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
23498197|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
23498198|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
23498199|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
23498200|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
23498201|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
23498202|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
23498203|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
23498204|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
23498205|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
23498206|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
23498207|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
23498208|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
23498209|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
23498210|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
23498211|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
23498212|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
23498213|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
23498214|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
23498215|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
23498216|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
23498217|NCT00313300|65566276|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
23498218|NCT00313300|65566277|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
23498219|NCT00313300|65566278|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
23498220|NCT00313300|65566279|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
23498221|NCT00313300|65566280|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
23498222|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
23498223|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
23498224|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
23498225|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
23498226|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
23498227|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
23498228|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
23498229|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
23498230|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
23498231|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
23498232|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
23498233|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
23498234|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
23498235|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
23300498|NCT00925301|64842810|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
23498236|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
23498237|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
23498238|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
23498239|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
23498240|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
23498241|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
23498242|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
23498243|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
23498244|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
23498245|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
23498246|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
23498247|NCT00313300|65566276|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
23498248|NCT00313300|65566277|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
23498249|NCT00313300|65566278|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
23498250|NCT00313300|65566279|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
23498251|NCT00313300|65566280|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
23498252|NCT02004522|65566281|FG000|Overall Study|Adverse Event|55|||
23498253|NCT02004522|65566282|FG001|Overall Study|Adverse Event|6|||
23498254|NCT02004522|65566281|FG000|Overall Study|Withdrawal by Subject|13|||
23498255|NCT02004522|65566282|FG001|Overall Study|Withdrawal by Subject|7|||
23498256|NCT02004522|65566281|FG000|Overall Study|Death|12|||
23498257|NCT02004522|65566282|FG001|Overall Study|Death|3|||
23498258|NCT02004522|65566281|FG000|Overall Study|Physician Decision|3|||
23498259|NCT02004522|65566282|FG001|Overall Study|Physician Decision|4|||
23498260|NCT02004522|65566281|FG000|Overall Study|Protocol Violation|1|||
23498261|NCT02004522|65566282|FG001|Overall Study|Protocol Violation|0|||
23498262|NCT02004522|65566281|FG000|Overall Study|Other is reason listed by PI|4|||
23498263|NCT02004522|65566282|FG001|Overall Study|Other is reason listed by PI|1|||
23498264|NCT02004522|65566281|FG000|Overall Study|Never Dosed|2|||
23498265|NCT02004522|65566282|FG001|Overall Study|Never Dosed|4|||
23498266|NCT02004522|65566281|FG000|Overall Study|Disease Progression|35|||
23393445|NCT02776735|65186827|FG003|Overall Study|Other|0|||
23393446|NCT02776735|65186828|FG004|Overall Study|Other|0|||
23393447|NCT02776735|65186829|FG005|Overall Study|Other|0|||
23393448|NCT05293717|65186830|FG000|Overall Study|Physician Decision|1|||
23393449|NCT02321514|65186843|FG000|Overall Study|Death|15|||
23393450|NCT02321514|65186843|FG000|Overall Study|Missed Visit|7|||
23393451|NCT02321514|65186843|FG000|Overall Study|Study Exit|3|||
23393452|NCT03379870|65186855|FG000|Overall Study|Lost to Follow-up|1|||
23393453|NCT03379870|65186856|FG001|Overall Study|Lost to Follow-up|0|||
23393454|NCT03379870|65186855|FG000|Overall Study|Protocol Violation|1|||
23393455|NCT03379870|65186856|FG001|Overall Study|Protocol Violation|1|||
23393456|NCT03814044|65186859|FG000|Overall Study|Protocol deviation|1|||
23393457|NCT03559556|65186860|FG000|Overall Study|Withdrawal by Subject|1|||
23393458|NCT01450631|65186861|FG000|Overall Study|Lost to Follow-up|2|||
23393459|NCT01450631|65186862|FG001|Overall Study|Lost to Follow-up|4|||
23393460|NCT01450631|65186861|FG000|Overall Study|Withdrawal by Subject|1|||
23393461|NCT01450631|65186862|FG001|Overall Study|Withdrawal by Subject|0|||
23393462|NCT02730169|65186863|FG000|Overall Study|Protocol Violation|1|||
23393463|NCT02730169|65186864|FG001|Overall Study|Protocol Violation|0|||
23393464|NCT02730169|65186865|FG002|Overall Study|Protocol Violation|0|||
23393465|NCT02730169|65186866|FG003|Overall Study|Protocol Violation|1|||
23393466|NCT02730169|65186863|FG000|Overall Study|Adverse Event|2|||
23393467|NCT02730169|65186864|FG001|Overall Study|Adverse Event|3|||
23393468|NCT02730169|65186865|FG002|Overall Study|Adverse Event|3|||
23393469|NCT02730169|65186866|FG003|Overall Study|Adverse Event|0|||
23393470|NCT02730169|65186863|FG000|Overall Study|Adverse Event of Special Interest|0|||
23393471|NCT02730169|65186864|FG001|Overall Study|Adverse Event of Special Interest|1|||
23393472|NCT02730169|65186865|FG002|Overall Study|Adverse Event of Special Interest|2|||
23393473|NCT02730169|65186866|FG003|Overall Study|Adverse Event of Special Interest|0|||
23393474|NCT02730169|65186863|FG000|Overall Study|Withdrawal by Subject|6|||
23393475|NCT02730169|65186864|FG001|Overall Study|Withdrawal by Subject|11|||
23393476|NCT02730169|65186865|FG002|Overall Study|Withdrawal by Subject|6|||
23393477|NCT02730169|65186866|FG003|Overall Study|Withdrawal by Subject|8|||
23393478|NCT02730169|65186863|FG000|Overall Study|Lost to Follow-up|5|||
23393479|NCT02730169|65186864|FG001|Overall Study|Lost to Follow-up|6|||
23498267|NCT02004522|65566282|FG001|Overall Study|Disease Progression|31|||
23498268|NCT02004522|65566281|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
23498269|NCT02004522|65566282|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
23498270|NCT01854658|65566283|FG000|Overall Study|Protocol Violation|6|||
23498271|NCT01854658|65566284|FG001|Overall Study|Protocol Violation|2|||
23498272|NCT01854658|65566285|FG002|Overall Study|Protocol Violation|2|||
23393480|NCT02730169|65186865|FG002|Overall Study|Lost to Follow-up|5|||
23393481|NCT02730169|65186866|FG003|Overall Study|Lost to Follow-up|6|||
23393482|NCT02730169|65186863|FG000|Overall Study|Other|0|||
23393483|NCT02730169|65186864|FG001|Overall Study|Other|0|||
23393484|NCT02730169|65186865|FG002|Overall Study|Other|1|||
23393485|NCT02730169|65186866|FG003|Overall Study|Other|1|||
23393486|NCT05375929|65186870|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
23393487|NCT05375929|65186871|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
23393488|NCT05375929|65186872|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
23393489|NCT05375929|65186873|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
23393490|NCT05375929|65186870|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
23393491|NCT05375929|65186871|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
23393492|NCT05375929|65186872|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23393493|NCT05375929|65186873|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
23393494|NCT05375929|65186870|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
23393495|NCT05375929|65186871|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
23393496|NCT05375929|65186872|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
23393497|NCT05375929|65186873|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
23393498|NCT05375929|65186870|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
23393499|NCT05375929|65186871|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
23393500|NCT05375929|65186872|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
23393501|NCT05375929|65186873|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
23393502|NCT05375929|65186870|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
23393503|NCT05375929|65186871|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
23393504|NCT05375929|65186872|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
23393505|NCT05375929|65186873|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
23393506|NCT05375929|65186870|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
23498273|NCT01854658|65566286|FG003|Overall Study|Protocol Violation|1|||
23498274|NCT01854658|65566283|FG000|Overall Study|Physician Decision|7|||
23498275|NCT01854658|65566284|FG001|Overall Study|Physician Decision|5|||
23498276|NCT01854658|65566285|FG002|Overall Study|Physician Decision|2|||
23498277|NCT01854658|65566286|FG003|Overall Study|Physician Decision|4|||
23498278|NCT01854658|65566283|FG000|Overall Study|Lost to Follow-up|8|||
23498279|NCT01854658|65566284|FG001|Overall Study|Lost to Follow-up|9|||
23498280|NCT01854658|65566285|FG002|Overall Study|Lost to Follow-up|8|||
23498281|NCT01854658|65566286|FG003|Overall Study|Lost to Follow-up|4|||
23393507|NCT05375929|65186871|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
23393508|NCT05375929|65186872|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
23393509|NCT05375929|65186873|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
23393510|NCT05375929|65186870|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
23393511|NCT05375929|65186871|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
23393512|NCT05375929|65186872|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
23393513|NCT05375929|65186873|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
23393514|NCT05375929|65186870|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
23393515|NCT05375929|65186871|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
23393516|NCT05375929|65186872|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
23393517|NCT05375929|65186873|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
23393518|NCT05375929|65186870|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
23393519|NCT05375929|65186871|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
23393520|NCT05375929|65186872|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
23393521|NCT05375929|65186873|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
23393522|NCT05375929|65186870|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
23393523|NCT05375929|65186871|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
23393524|NCT05375929|65186872|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
23393525|NCT05375929|65186873|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
23393526|NCT00835549|65186874|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
23393527|NCT00835549|65186875|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
23393528|NCT02781558|65186885|FG000|Overall Study|Lost to Follow-up|2|||
23498282|NCT01854658|65566283|FG000|Overall Study|Withdrawal by Subject|28|||
23498283|NCT01854658|65566284|FG001|Overall Study|Withdrawal by Subject|21|||
23498284|NCT01854658|65566285|FG002|Overall Study|Withdrawal by Subject|29|||
23498285|NCT01854658|65566286|FG003|Overall Study|Withdrawal by Subject|15|||
23498286|NCT01854658|65566283|FG000|Overall Study|Protocol-specified criteria|15|||
23498287|NCT01854658|65566284|FG001|Overall Study|Protocol-specified criteria|15|||
23498288|NCT01854658|65566285|FG002|Overall Study|Protocol-specified criteria|10|||
23498289|NCT01854658|65566286|FG003|Overall Study|Protocol-specified criteria|7|||
23498290|NCT01854658|65566283|FG000|Overall Study|Lack of Efficacy|3|||
23498291|NCT01854658|65566284|FG001|Overall Study|Lack of Efficacy|8|||
23498292|NCT01854658|65566285|FG002|Overall Study|Lack of Efficacy|4|||
23393529|NCT02781558|65186886|FG001|Overall Study|Lost to Follow-up|2|||
23393530|NCT02781558|65186885|FG000|Overall Study|Adverse Event|1|||
23393531|NCT02781558|65186886|FG001|Overall Study|Adverse Event|0|||
23393532|NCT04938427|65186887|FG000|Overall Study|Adverse Event|5|||
23393533|NCT04938427|65186888|FG001|Overall Study|Adverse Event|19|||
23393534|NCT04938427|65186887|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23393535|NCT04938427|65186888|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23393536|NCT04938427|65186887|FG000|Overall Study|Withdrawal by Subject|1|||
23393537|NCT04938427|65186888|FG001|Overall Study|Withdrawal by Subject|0|||
23393538|NCT04938427|65186887|FG000|Overall Study|Reason Not Specified|2|||
23393539|NCT04938427|65186888|FG001|Overall Study|Reason Not Specified|1|||
23393540|NCT02697448|65186891|FG000|Overall Study|Protocol Violation|2|||
23393541|NCT02697448|65186892|FG001|Overall Study|Protocol Violation|4|||
23393542|NCT02697448|65186891|FG000|Overall Study|Clinical concerns during ablation|1|||
23393543|NCT02697448|65186892|FG001|Overall Study|Clinical concerns during ablation|1|||
23393544|NCT02697448|65186891|FG000|Overall Study|No data collected|2|||
23393545|NCT02697448|65186892|FG001|Overall Study|No data collected|0|||
23393546|NCT03900650|65186894|FG000|Overall Study|Withdrawal by Subject|1|||
23393547|NCT03900650|65186895|FG001|Overall Study|Withdrawal by Subject|1|||
23393548|NCT03900650|65186896|FG002|Overall Study|Withdrawal by Subject|0|||
23393549|NCT03900650|65186897|FG003|Overall Study|Withdrawal by Subject|0|||
23393550|NCT03900650|65186894|FG000|Overall Study|Withdrawn by staff|1|||
23393551|NCT03900650|65186895|FG001|Overall Study|Withdrawn by staff|0|||
23393552|NCT03900650|65186896|FG002|Overall Study|Withdrawn by staff|0|||
23393553|NCT03900650|65186897|FG003|Overall Study|Withdrawn by staff|0|||
23393562|NCT03729609|65186907|FG000|Overall Study|Protocol Violation|1|||
23393563|NCT01166646|65186910|FG000|Overall Study|Protocol Violation|0|||
23393564|NCT01166646|65186911|FG001|Overall Study|Protocol Violation|1|||
23393565|NCT01166646|65186910|FG000|Overall Study|Adverse Event|1|||
23498293|NCT01854658|65566286|FG003|Overall Study|Lack of Efficacy|7|||
23498294|NCT01854658|65566283|FG000|Overall Study|Adverse Event|21|||
23498295|NCT01854658|65566284|FG001|Overall Study|Adverse Event|14|||
23498296|NCT01854658|65566285|FG002|Overall Study|Adverse Event|23|||
23498297|NCT01854658|65566286|FG003|Overall Study|Adverse Event|19|||
23498298|NCT01854658|65566283|FG000|Overall Study|Administrative reasons|5|||
23498299|NCT01854658|65566284|FG001|Overall Study|Administrative reasons|1|||
23498300|NCT01854658|65566285|FG002|Overall Study|Administrative reasons|2|||
23498301|NCT01854658|65566286|FG003|Overall Study|Administrative reasons|2|||
23498302|NCT00934089|65566289|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
23498303|NCT00934089|65566290|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
23498304|NCT00934089|65566289|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
23498305|NCT00934089|65566290|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
23498306|NCT02021773|65566291|FG000|Overall Study|Adverse Event|1|||
23498307|NCT02021773|65566292|FG001|Overall Study|Adverse Event|4|||
23498308|NCT02021773|65566293|FG002|Overall Study|Adverse Event|3|||
23498309|NCT02021773|65566291|FG000|Overall Study|Lack of Efficacy|2|||
23498310|NCT02021773|65566292|FG001|Overall Study|Lack of Efficacy|2|||
23498311|NCT02021773|65566293|FG002|Overall Study|Lack of Efficacy|2|||
23498312|NCT02021773|65566291|FG000|Overall Study|Protocol Violation|2|||
23498313|NCT02021773|65566292|FG001|Overall Study|Protocol Violation|3|||
23498314|NCT02021773|65566293|FG002|Overall Study|Protocol Violation|1|||
23498315|NCT02021773|65566291|FG000|Overall Study|Withdrawal by Subject|3|||
23498316|NCT02021773|65566292|FG001|Overall Study|Withdrawal by Subject|4|||
23498317|NCT02021773|65566293|FG002|Overall Study|Withdrawal by Subject|5|||
23498318|NCT02021773|65566291|FG000|Overall Study|Lost to Follow-up|1|||
23498319|NCT02021773|65566292|FG001|Overall Study|Lost to Follow-up|3|||
23498320|NCT02021773|65566293|FG002|Overall Study|Lost to Follow-up|0|||
23498321|NCT02021773|65566291|FG000|Overall Study|Reason not specified|3|||
23498322|NCT02021773|65566292|FG001|Overall Study|Reason not specified|0|||
23498323|NCT02021773|65566293|FG002|Overall Study|Reason not specified|0|||
23498324|NCT00178633|65566294|FG000|Overall Study|Lost to Follow-up|6|||
23498325|NCT01702961|65566300|FG000|Overall Study|Additional treatment|3|||
23498326|NCT01702961|65566300|FG000|Overall Study|Progressive disease|5|||
23498327|NCT01702961|65566300|FG000|Overall Study|Relapse|20|||
23498328|NCT01702961|65566300|FG000|Overall Study|Death|6|||
23498329|NCT01702961|65566300|FG000|Overall Study|Lost to Follow-up|2|||
23498330|NCT01702961|65566300|FG000|Overall Study|Ongoing|11|||
23498331|NCT04377620|65566303|FG000|Overall Study|Death|42|||
23498332|NCT04377620|65566304|FG001|Overall Study|Death|48|||
23498333|NCT04377620|65566305|FG002|Overall Study|Death|36|||
23498334|NCT04377620|65566303|FG000|Overall Study|Withdrawal by Subject|0|||
23498335|NCT04377620|65566304|FG001|Overall Study|Withdrawal by Subject|2|||
23498336|NCT04377620|65566305|FG002|Overall Study|Withdrawal by Subject|0|||
23498337|NCT00437983|65566308|FG000|Overall Study|Adverse Event|6|||
23498338|NCT00437983|65566309|FG001|Overall Study|Adverse Event|6|||
23498339|NCT00437983|65566308|FG000|Overall Study|Protocol Violation|2|||
23498340|NCT00437983|65566309|FG001|Overall Study|Protocol Violation|1|||
23498341|NCT00437983|65566308|FG000|Overall Study|Withdrawal by Subject|5|||
23498342|NCT00437983|65566309|FG001|Overall Study|Withdrawal by Subject|6|||
23498343|NCT00926328|65566312|FG000|Overall Study|Lost to Follow-up|12|||
23498344|NCT00926328|65566313|FG001|Overall Study|Lost to Follow-up|14|||
23498345|NCT00003473|65566315|FG000|Overall Study|Three patients were not evaluable.|3|||
23498346|NCT01999868|65566316|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
23498347|NCT01999868|65566317|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
23498348|NCT01999868|65566318|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
23498349|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
23498350|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
23498351|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
23498352|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
23498353|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
23498354|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
23498355|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
23498356|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
23498357|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
23498358|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
23498359|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
23498360|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
23393566|NCT01166646|65186911|FG001|Overall Study|Adverse Event|0|||
23498361|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
23498362|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
23498363|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
23498364|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
23498365|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
23498366|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
23498367|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
23393567|NCT01992757|65189343|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
23498368|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
23498369|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
23498370|NCT01999868|65566316|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
23498371|NCT01999868|65566317|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
23498372|NCT01999868|65566318|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
23498373|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
23498374|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
23498375|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
23498376|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
23393568|NCT05261126|65189344|FG000|Overall Study|Death|0|||
23393569|NCT05261126|65189345|FG001|Overall Study|Death|0|||
23393570|NCT05261126|65189346|FG002|Overall Study|Death|1|||
23393571|NCT05261126|65189347|FG003|Overall Study|Death|0|||
23393572|NCT05261126|65189348|FG004|Overall Study|Death|0|||
23393573|NCT05261126|65189344|FG000|Overall Study|Lost to Follow-up|0|||
23393574|NCT05261126|65189345|FG001|Overall Study|Lost to Follow-up|0|||
23393575|NCT05261126|65189346|FG002|Overall Study|Lost to Follow-up|0|||
23393576|NCT05261126|65189347|FG003|Overall Study|Lost to Follow-up|0|||
23393577|NCT05261126|65189348|FG004|Overall Study|Lost to Follow-up|1|||
23393578|NCT05261126|65189344|FG000|Overall Study|Physician Decision|1|||
23393579|NCT05261126|65189345|FG001|Overall Study|Physician Decision|0|||
23393580|NCT05261126|65189346|FG002|Overall Study|Physician Decision|0|||
23393581|NCT05261126|65189347|FG003|Overall Study|Physician Decision|0|||
23393582|NCT05261126|65189348|FG004|Overall Study|Physician Decision|0|||
23393583|NCT05261126|65189344|FG000|Overall Study|Screen Failure|0|||
23393584|NCT05261126|65189345|FG001|Overall Study|Screen Failure|0|||
23393585|NCT05261126|65189346|FG002|Overall Study|Screen Failure|0|||
23393586|NCT05261126|65189347|FG003|Overall Study|Screen Failure|0|||
23393587|NCT05261126|65189348|FG004|Overall Study|Screen Failure|1|||
23393588|NCT05261126|65189344|FG000|Overall Study|Withdrawal by Subject|1|||
23393589|NCT05261126|65189345|FG001|Overall Study|Withdrawal by Subject|0|||
23393590|NCT05261126|65189346|FG002|Overall Study|Withdrawal by Subject|1|||
23393591|NCT05261126|65189347|FG003|Overall Study|Withdrawal by Subject|1|||
23393592|NCT05261126|65189348|FG004|Overall Study|Withdrawal by Subject|0|||
23393593|NCT05261126|65189344|FG000|Overall Study|Not Recorded|0|||
23393594|NCT05261126|65189345|FG001|Overall Study|Not Recorded|0|||
23393595|NCT05261126|65189346|FG002|Overall Study|Not Recorded|0|||
23393596|NCT05261126|65189347|FG003|Overall Study|Not Recorded|1|||
23393597|NCT05261126|65189348|FG004|Overall Study|Not Recorded|0|||
23393598|NCT02496000|65189352|FG000|Overall Study|Withdrawal by Subject|1|||
23393599|NCT02496000|65189353|FG001|Overall Study|Withdrawal by Subject|2|||
23393600|NCT02496000|65189354|FG002|Overall Study|Withdrawal by Subject|0|||
23393601|NCT02496000|65189352|FG000|Overall Study|Lost to Follow-up|1|||
23393602|NCT02496000|65189353|FG001|Overall Study|Lost to Follow-up|0|||
23393603|NCT02496000|65189354|FG002|Overall Study|Lost to Follow-up|1|||
23393604|NCT02496000|65189352|FG000|Overall Study|Protocol Violation|0|||
23393605|NCT02496000|65189353|FG001|Overall Study|Protocol Violation|0|||
23393606|NCT02496000|65189354|FG002|Overall Study|Protocol Violation|1|||
23393607|NCT02496000|65189352|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
23393608|NCT02496000|65189353|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
23393609|NCT02496000|65189354|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
23393610|NCT02496000|65189352|FG000|Overall Study|undetermined|0|||
23393611|NCT02496000|65189353|FG001|Overall Study|undetermined|1|||
23393612|NCT02496000|65189354|FG002|Overall Study|undetermined|0|||
23393613|NCT02734004|65189355|FG000|Overall Study|Death|36|||
23393614|NCT02734004|65189356|FG001|Overall Study|Death|24|||
23498377|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
23498378|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
23393615|NCT02734004|65189357|FG002|Overall Study|Death|26|||
23393616|NCT02734004|65189358|FG003|Overall Study|Death|35|||
23393617|NCT02734004|65189359|FG004|Overall Study|Death|13|||
23393618|NCT02734004|65189360|FG005|Overall Study|Death|17|||
23393619|NCT02734004|65189361|FG006|Overall Study|Death|20|||
23393620|NCT02734004|65189355|FG000|Overall Study|Lost to Follow-up|1|||
23393621|NCT02734004|65189356|FG001|Overall Study|Lost to Follow-up|1|||
23393622|NCT02734004|65189357|FG002|Overall Study|Lost to Follow-up|0|||
23393623|NCT02734004|65189358|FG003|Overall Study|Lost to Follow-up|0|||
23393624|NCT02734004|65189359|FG004|Overall Study|Lost to Follow-up|1|||
23393625|NCT02734004|65189360|FG005|Overall Study|Lost to Follow-up|0|||
23393626|NCT02734004|65189361|FG006|Overall Study|Lost to Follow-up|0|||
23393627|NCT02734004|65189355|FG000|Overall Study|Withdrawal by Subject|3|||
23393628|NCT02734004|65189356|FG001|Overall Study|Withdrawal by Subject|1|||
23393629|NCT02734004|65189357|FG002|Overall Study|Withdrawal by Subject|1|||
23393630|NCT02734004|65189358|FG003|Overall Study|Withdrawal by Subject|1|||
23393631|NCT02734004|65189359|FG004|Overall Study|Withdrawal by Subject|3|||
23393632|NCT02734004|65189360|FG005|Overall Study|Withdrawal by Subject|0|||
23393633|NCT02734004|65189361|FG006|Overall Study|Withdrawal by Subject|2|||
23498379|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
23498380|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
23498381|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
23498382|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
23498383|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
23498384|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
23498385|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
23498386|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
23498387|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
23498388|NCT01999868|65566316|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
23498389|NCT01999868|65566317|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
23393634|NCT02734004|65189355|FG000|Overall Study|Other|0|||
23393635|NCT02734004|65189356|FG001|Overall Study|Other|8|||
23393636|NCT02734004|65189357|FG002|Overall Study|Other|7|||
23393637|NCT02734004|65189358|FG003|Overall Study|Other|4|||
23393638|NCT02734004|65189359|FG004|Overall Study|Other|34|||
23393639|NCT02734004|65189360|FG005|Overall Study|Other|14|||
23498390|NCT01999868|65566318|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
23393640|NCT02734004|65189361|FG006|Overall Study|Other|10|||
23393641|NCT01313676|65189370|FG000|Overall Study|Adverse Event|395|||
23393642|NCT01313676|65189371|FG001|Overall Study|Adverse Event|365|||
23393643|NCT01313676|65189372|FG002|Overall Study|Adverse Event|372|||
23393644|NCT01313676|65189373|FG003|Overall Study|Adverse Event|333|||
23498391|NCT03385564|65566319|FG000|Overall Study|Adverse Event|0|||
23393645|NCT01313676|65189370|FG000|Overall Study|Lack of Efficacy|98|||
23498392|NCT03385564|65566320|FG001|Overall Study|Adverse Event|0|||
23498393|NCT03385564|65566321|FG002|Overall Study|Adverse Event|3|||
23498394|NCT03385564|65566322|FG003|Overall Study|Adverse Event|3|||
23498395|NCT03385564|65566319|FG000|Overall Study|Other than listed|0|||
23498396|NCT03385564|65566320|FG001|Overall Study|Other than listed|0|||
23498397|NCT03385564|65566321|FG002|Overall Study|Other than listed|0|||
23498398|NCT03385564|65566322|FG003|Overall Study|Other than listed|5|||
23498399|NCT03385564|65566319|FG000|Overall Study|Withdrawal by Subject|0|||
23498400|NCT03385564|65566320|FG001|Overall Study|Withdrawal by Subject|1|||
23498401|NCT03385564|65566321|FG002|Overall Study|Withdrawal by Subject|1|||
23498402|NCT03385564|65566322|FG003|Overall Study|Withdrawal by Subject|0|||
23498403|NCT03385564|65566319|FG000|Overall Study|Lack of Efficacy|0|||
23498404|NCT03385564|65566320|FG001|Overall Study|Lack of Efficacy|0|||
23498405|NCT03385564|65566321|FG002|Overall Study|Lack of Efficacy|0|||
23498406|NCT03385564|65566322|FG003|Overall Study|Lack of Efficacy|1|||
23498407|NCT03385564|65566319|FG000|Overall Study|Death|0|||
23498408|NCT03385564|65566320|FG001|Overall Study|Death|0|||
23498409|NCT03385564|65566321|FG002|Overall Study|Death|1|||
23498410|NCT03385564|65566322|FG003|Overall Study|Death|0|||
23498411|NCT00428792|65566323|FG000|Overall Study|Lack of Efficacy|1|||
23498412|NCT00428792|65566324|FG001|Overall Study|Lack of Efficacy|3|||
23498413|NCT00428792|65566323|FG000|Overall Study|Lost to Follow-up|0|||
23498414|NCT00428792|65566324|FG001|Overall Study|Lost to Follow-up|1|||
23498415|NCT00191139|65566325|FG000|Overall Study|Adverse Event|2|||
23498416|NCT00191139|65566326|FG001|Overall Study|Adverse Event|6|||
23498417|NCT00191139|65566325|FG000|Overall Study|Death|2|||
23498418|NCT00191139|65566326|FG001|Overall Study|Death|0|||
23498419|NCT00191139|65566325|FG000|Overall Study|Withdrawal by Subject|0|||
23498420|NCT00191139|65566326|FG001|Overall Study|Withdrawal by Subject|3|||
23498421|NCT00191139|65566325|FG000|Overall Study|Disease Progression|0|||
23498422|NCT00191139|65566326|FG001|Overall Study|Disease Progression|1|||
23498423|NCT00191139|65566325|FG000|Overall Study|Other|1|||
23498424|NCT00191139|65566326|FG001|Overall Study|Other|2|||
23498425|NCT01539538|65566329|FG000|Overall Study|Adverse Event|13|||
23498426|NCT01539538|65566330|FG001|Overall Study|Adverse Event|18|||
23498427|NCT01539538|65566329|FG000|Overall Study|Lack of Efficacy|13|||
23498428|NCT01539538|65566330|FG001|Overall Study|Lack of Efficacy|16|||
23498429|NCT01539538|65566329|FG000|Overall Study|Withdrawal by Subject|2|||
23498430|NCT01539538|65566330|FG001|Overall Study|Withdrawal by Subject|3|||
23498431|NCT01539538|65566329|FG000|Overall Study|PCA no longer required or PCA problem|3|||
23498432|NCT01539538|65566330|FG001|Overall Study|PCA no longer required or PCA problem|7|||
23498433|NCT00371826|65566333|FG000|Core Phase (12 Months)|Adverse Event|15|||
23498434|NCT00371826|65566334|FG001|Core Phase (12 Months)|Adverse Event|4|||
23498435|NCT00371826|65566335|FG002|Core Phase (12 Months)|Adverse Event|9|||
23498436|NCT00371826|65566333|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
23498437|NCT00371826|65566334|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
23498438|NCT00371826|65566335|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
23498439|NCT00371826|65566333|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
23498440|NCT00371826|65566334|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
23498441|NCT00371826|65566335|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
23498442|NCT00371826|65566333|FG000|Core Phase (12 Months)|Protocol Violation|1|||
23498443|NCT00371826|65566334|FG001|Core Phase (12 Months)|Protocol Violation|0|||
23498444|NCT00371826|65566335|FG002|Core Phase (12 Months)|Protocol Violation|1|||
23498445|NCT00371826|65566333|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
23498446|NCT00371826|65566334|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
23498447|NCT00371826|65566335|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
23498448|NCT00371826|65566333|FG000|Core Phase (12 Months)|Administrative problems|1|||
23498449|NCT00371826|65566334|FG001|Core Phase (12 Months)|Administrative problems|0|||
23498450|NCT00371826|65566335|FG002|Core Phase (12 Months)|Administrative problems|8|||
23498451|NCT00371826|65566333|FG000|Core Phase (12 Months)|Graft Loss|0|||
23498452|NCT00371826|65566334|FG001|Core Phase (12 Months)|Graft Loss|1|||
23498453|NCT00371826|65566335|FG002|Core Phase (12 Months)|Graft Loss|0|||
23498454|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Adverse Event|4|||
23498455|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Adverse Event|5|||
23498456|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Adverse Event|0|||
23498457|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
23498458|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
23498459|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
23498460|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
23498461|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
23393646|NCT01313676|65189371|FG001|Overall Study|Lack of Efficacy|90|||
23393647|NCT01313676|65189372|FG002|Overall Study|Lack of Efficacy|65|||
23393648|NCT01313676|65189373|FG003|Overall Study|Lack of Efficacy|46|||
23393649|NCT01313676|65189370|FG000|Overall Study|Protocol Violation|37|||
23393650|NCT01313676|65189371|FG001|Overall Study|Protocol Violation|44|||
23393651|NCT01313676|65189372|FG002|Overall Study|Protocol Violation|46|||
23393652|NCT01313676|65189373|FG003|Overall Study|Protocol Violation|44|||
23393653|NCT01313676|65189370|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
23393654|NCT01313676|65189371|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
23393655|NCT01313676|65189372|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
23393656|NCT01313676|65189373|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
23393657|NCT01313676|65189370|FG000|Overall Study|Study Closed/terminated|7|||
23393658|NCT01313676|65189371|FG001|Overall Study|Study Closed/terminated|6|||
23393659|NCT01313676|65189372|FG002|Overall Study|Study Closed/terminated|9|||
23393660|NCT01313676|65189373|FG003|Overall Study|Study Closed/terminated|9|||
23393661|NCT01313676|65189370|FG000|Overall Study|Lost to Follow-up|0|||
23393662|NCT01313676|65189371|FG001|Overall Study|Lost to Follow-up|0|||
23393663|NCT01313676|65189372|FG002|Overall Study|Lost to Follow-up|1|||
23393664|NCT01313676|65189373|FG003|Overall Study|Lost to Follow-up|0|||
23393665|NCT01313676|65189370|FG000|Overall Study|Physician Decision|53|||
23393666|NCT01313676|65189371|FG001|Overall Study|Physician Decision|64|||
23393667|NCT01313676|65189372|FG002|Overall Study|Physician Decision|62|||
23393668|NCT01313676|65189373|FG003|Overall Study|Physician Decision|48|||
23393669|NCT01313676|65189370|FG000|Overall Study|Decision by Participant or Proxy|643|||
23393670|NCT01313676|65189371|FG001|Overall Study|Decision by Participant or Proxy|527|||
23393671|NCT01313676|65189372|FG002|Overall Study|Decision by Participant or Proxy|515|||
23393672|NCT01313676|65189373|FG003|Overall Study|Decision by Participant or Proxy|492|||
23393673|NCT01313676|65189370|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
23393674|NCT01313676|65189371|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
23393675|NCT01313676|65189372|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
23393676|NCT01313676|65189373|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
23393677|NCT01313676|65189370|FG000|Overall Study|Investigator Site Closed|12|||
23393678|NCT01313676|65189371|FG001|Overall Study|Investigator Site Closed|11|||
23393679|NCT01313676|65189372|FG002|Overall Study|Investigator Site Closed|15|||
23393680|NCT01313676|65189373|FG003|Overall Study|Investigator Site Closed|10|||
23393681|NCT01313676|65189370|FG000|Overall Study|Missing|1|||
23393682|NCT01313676|65189371|FG001|Overall Study|Missing|1|||
23393683|NCT01313676|65189372|FG002|Overall Study|Missing|1|||
23393684|NCT01313676|65189373|FG003|Overall Study|Missing|0|||
23393685|NCT01554904|65189374|FG000|Overall Study|Withdrawal by Subject|3|||
23393686|NCT01554904|65189374|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
23393687|NCT00137449|65189377|FG000|Overall Study|Disease Progression|8|||
23393688|NCT00137449|65189378|FG001|Overall Study|Disease Progression|13|||
23393689|NCT00137449|65189377|FG000|Overall Study|Death|4|||
23393690|NCT00137449|65189378|FG001|Overall Study|Death|3|||
23393691|NCT00137449|65189377|FG000|Overall Study|Adverse Event|3|||
23393692|NCT00137449|65189378|FG001|Overall Study|Adverse Event|1|||
23393693|NCT00137449|65189377|FG000|Overall Study|Withdrawal by Subject|1|||
23393694|NCT00137449|65189378|FG001|Overall Study|Withdrawal by Subject|1|||
23393695|NCT00567580|65189383|FG000|Overall Study|Protocol Violation|28|||
23393696|NCT00567580|65189384|FG001|Overall Study|Protocol Violation|24|||
23393697|NCT00567580|65189385|FG002|Overall Study|Protocol Violation|24|||
23393698|NCT00835354|65189388|FG000|First Intervention|Adverse Event|0|||
23393699|NCT00835354|65189389|FG001|First Intervention|Adverse Event|1|||
23393700|NCT02251041|65189394|FG000|Overall Study|Did not receive intervention|15|||
23393701|NCT02251041|65189395|FG001|Overall Study|Did not receive intervention|4|||
23393702|NCT02276040|65189396|FG000|Overall Study|Physician Decision|15|||
23393703|NCT02022202|65189403|FG000|Overall Study|Withdrawal by Subject|2|||
23393704|NCT02022202|65189403|FG000|Overall Study|Disease Progression|3|||
23393705|NCT02022202|65189403|FG000|Overall Study|Desire go to immediately to surgery|3|||
23393706|NCT03204812|65189404|FG000|Overall Study|Adverse Event|3|||
23393707|NCT00526799|65189410|FG000|Overall Study|Withdrawal by Subject|1|||
23393708|NCT00526799|65189411|FG001|Overall Study|Withdrawal by Subject|0|||
23393709|NCT00526799|65189410|FG000|Overall Study|Intercurrent Complicating Disease|0|||
23393710|NCT00526799|65189411|FG001|Overall Study|Intercurrent Complicating Disease|1|||
23393711|NCT01661595|65189413|FG000|Phase 1: Week 0-4|Adverse Event|1|||
23393712|NCT01661595|65189414|FG001|Phase 1: Week 0-4|Adverse Event|0|||
23393713|NCT01661595|65189415|FG002|Phase 1: Week 0-4|Adverse Event|0|||
23393714|NCT01661595|65189416|FG003|Phase 1: Week 0-4|Adverse Event|0|||
23393715|NCT01661595|65189413|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
23393716|NCT01661595|65189414|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
23393717|NCT01661595|65189415|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
23393718|NCT01661595|65189416|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
23393719|NCT00265122|65189419|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
23393720|NCT00265122|65189420|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
23393721|NCT00265122|65189421|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
23393722|NCT00265122|65189422|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
23393723|NCT00265122|65189423|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
23393724|NCT00265122|65189424|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
23393725|NCT00265122|65189419|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
23393726|NCT00265122|65189420|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
23393727|NCT00265122|65189421|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
23393728|NCT00265122|65189422|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
23393729|NCT00265122|65189423|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
23393730|NCT00265122|65189424|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
23393731|NCT00265122|65189419|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
23393732|NCT00265122|65189420|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
23393733|NCT00265122|65189421|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
23393734|NCT00265122|65189422|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
23393735|NCT00265122|65189423|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
23393736|NCT00265122|65189424|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
23393737|NCT00265122|65189419|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
23393738|NCT00265122|65189420|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
23393739|NCT00265122|65189421|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
23393740|NCT00265122|65189422|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
23393741|NCT00265122|65189423|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
23393742|NCT00265122|65189424|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
23393743|NCT00265122|65189419|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
23393744|NCT00265122|65189420|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
23393745|NCT00265122|65189421|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
23393746|NCT00265122|65189422|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
23393747|NCT00265122|65189423|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
23393748|NCT00265122|65189424|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
23393749|NCT00265122|65189419|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
23393750|NCT00265122|65189420|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
23393751|NCT00265122|65189421|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
23393752|NCT00265122|65189422|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
23393753|NCT00265122|65189423|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
23393754|NCT00265122|65189424|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
23393755|NCT03332056|65189429|FG000|Overall Study|Incomplete questionnaires|8|||
23393756|NCT03332056|65189430|FG001|Overall Study|Incomplete questionnaires|9|||
23393757|NCT03332056|65189429|FG000|Overall Study|Passed stone prior to surgery date|1|||
23393758|NCT03332056|65189430|FG001|Overall Study|Passed stone prior to surgery date|0|||
23393759|NCT03332056|65189429|FG000|Overall Study|Did not require a ureteral stent|0|||
23393760|NCT03332056|65189430|FG001|Overall Study|Did not require a ureteral stent|1|||
23393761|NCT01150357|65189431|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
23393762|NCT01150357|65189432|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
23393763|NCT01150357|65189433|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
23393764|NCT01150357|65189431|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
23393765|NCT01150357|65189432|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
23393766|NCT01150357|65189433|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
23393767|NCT01150357|65189431|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
23393768|NCT01150357|65189432|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
23393769|NCT01150357|65189433|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
23393770|NCT01150357|65189431|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
23393771|NCT01150357|65189432|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
23393772|NCT01150357|65189433|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
23393773|NCT01150357|65189431|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
23393774|NCT01150357|65189432|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
23393775|NCT01150357|65189433|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
23393776|NCT01150357|65189431|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
23393777|NCT01150357|65189432|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
23393778|NCT01150357|65189433|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
23393779|NCT01150357|65189431|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
23393780|NCT01150357|65189432|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
23393781|NCT01150357|65189433|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
23393782|NCT00511199|65189437|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
23393783|NCT00511199|65189438|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
23393784|NCT00511199|65189437|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
23393785|NCT00511199|65189438|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
23393786|NCT00511199|65189437|FG000|Overall Study|Withdrawal of Informed Consent|19|||
23393787|NCT00511199|65189438|FG001|Overall Study|Withdrawal of Informed Consent|4|||
23393788|NCT00511199|65189437|FG000|Overall Study|Pregnancy|6|||
23393789|NCT00511199|65189438|FG001|Overall Study|Pregnancy|3|||
23393790|NCT00511199|65189437|FG000|Overall Study|Pregnancy Wish|16|||
23393791|NCT00511199|65189438|FG001|Overall Study|Pregnancy Wish|8|||
23393792|NCT00511199|65189437|FG000|Overall Study|Lost to Follow-up|40|||
23393793|NCT00511199|65189438|FG001|Overall Study|Lost to Follow-up|17|||
23393794|NCT00511199|65189437|FG000|Overall Study|Other Reason|78|||
23393795|NCT00511199|65189438|FG001|Overall Study|Other Reason|37|||
23393796|NCT03440411|65189444|FG000|Overall Study|Adverse Event|0|||
23393797|NCT03440411|65189445|FG001|Overall Study|Adverse Event|0|||
23393798|NCT03440411|65189446|FG002|Overall Study|Adverse Event|1|||
23393799|NCT03440411|65189447|FG003|Overall Study|Adverse Event|0|||
23393800|NCT03440411|65189444|FG000|Overall Study|PD|2|||
23393801|NCT03440411|65189445|FG001|Overall Study|PD|1|||
23393802|NCT03440411|65189446|FG002|Overall Study|PD|1|||
23393803|NCT03440411|65189447|FG003|Overall Study|PD|1|||
23393804|NCT03440411|65189444|FG000|Overall Study|Withdrawal by Subject|1|||
23393805|NCT03440411|65189445|FG001|Overall Study|Withdrawal by Subject|0|||
23393806|NCT03440411|65189446|FG002|Overall Study|Withdrawal by Subject|0|||
23393807|NCT03440411|65189447|FG003|Overall Study|Withdrawal by Subject|0|||
23393808|NCT03440411|65189444|FG000|Overall Study|Closed study by sponsor|0|||
23393809|NCT03440411|65189445|FG001|Overall Study|Closed study by sponsor|0|||
23393810|NCT03440411|65189446|FG002|Overall Study|Closed study by sponsor|0|||
23393811|NCT03440411|65189447|FG003|Overall Study|Closed study by sponsor|1|||
23393812|NCT03787615|65189449|FG000|Overall Study|Withdrawal by Subject|2|||
23393813|NCT03787615|65189449|FG000|Overall Study|Lost to Follow-up|2|||
23393814|NCT03468998|65189453|FG000|Overall Study|Withdrawal by Subject|1|||
23393815|NCT03468998|65189454|FG001|Overall Study|Withdrawal by Subject|1|||
23393816|NCT03468998|65189455|FG002|Overall Study|Withdrawal by Subject|0|||
23393817|NCT03468998|65189456|FG003|Overall Study|Withdrawal by Subject|4|||
23393818|NCT03468998|65189457|FG004|Overall Study|Withdrawal by Subject|1|||
23393819|NCT03468998|65189458|FG005|Overall Study|Withdrawal by Subject|0|||
23393820|NCT02943473|65189459|FG000|Overall Study|enrolled but not dosed|1|||
23393821|NCT02943473|65189459|FG000|Overall Study|screen failure|1|||
23393822|NCT02943473|65189459|FG000|Overall Study|Physician Decision|4|||
23393823|NCT05360784|65189460|FG000|Overall Study|Discontinued|25|||
23393824|NCT05360784|65189461|FG001|Overall Study|Discontinued|11|||
23393825|NCT05538728|65189462|FG000|Overall Study|Withdrawal by Subject|1|||
23393826|NCT05538728|65189463|FG001|Overall Study|Withdrawal by Subject|1|||
23393827|NCT04890509|65189464|FG000|Overall Study|Death|4|||
23393828|NCT04890509|65189465|FG001|Overall Study|Death|4|||
23393829|NCT00553254|65189474|FG000|Overall Study|Death|3|||
23393830|NCT00553254|65189475|FG001|Overall Study|Death|6|||
23393831|NCT00553254|65189476|FG002|Overall Study|Death|25|||
23393832|NCT00553254|65189474|FG000|Overall Study|Lost to Follow-up|0|||
23393833|NCT00553254|65189475|FG001|Overall Study|Lost to Follow-up|0|||
23393834|NCT00553254|65189476|FG002|Overall Study|Lost to Follow-up|2|||
23393835|NCT00553254|65189474|FG000|Overall Study|Withdrawal by Subject|2|||
23393836|NCT00553254|65189475|FG001|Overall Study|Withdrawal by Subject|0|||
23393837|NCT00553254|65189476|FG002|Overall Study|Withdrawal by Subject|2|||
23393838|NCT00553254|65189474|FG000|Overall Study|Study terminated by Sponsor|0|||
23393839|NCT00553254|65189475|FG001|Overall Study|Study terminated by Sponsor|0|||
23393840|NCT00553254|65189476|FG002|Overall Study|Study terminated by Sponsor|1|||
23393841|NCT00553254|65189474|FG000|Overall Study|Other|1|||
23393842|NCT00553254|65189475|FG001|Overall Study|Other|0|||
23393843|NCT00553254|65189476|FG002|Overall Study|Other|13|||
23393844|NCT03257657|65189479|FG000|Overall Study|Lost to Follow-up|0|||
23393845|NCT03257657|65189480|FG001|Overall Study|Lost to Follow-up|3|||
23393846|NCT03257657|65189479|FG000|Overall Study|Withdrawn|0|||
23393847|NCT03257657|65189480|FG001|Overall Study|Withdrawn|1|||
23393848|NCT03257657|65189479|FG000|Overall Study|Noted not eligible right after enrolled|0|||
23393849|NCT03257657|65189480|FG001|Overall Study|Noted not eligible right after enrolled|1|||
23393850|NCT03058952|65189482|FG000|Overall Study|Adverse Event|1|||
23393851|NCT03058952|65189483|FG001|Overall Study|Adverse Event|0|||
23393852|NCT03058952|65189482|FG000|Overall Study|Lost to Follow-up|15|||
23393853|NCT03058952|65189483|FG001|Overall Study|Lost to Follow-up|15|||
23393854|NCT03058952|65189482|FG000|Overall Study|Withdrawal by Subject|7|||
23393855|NCT03058952|65189483|FG001|Overall Study|Withdrawal by Subject|11|||
23393856|NCT00415636|65189484|FG000|Overall Study|Symptomatic deterioration|1|||
23393857|NCT00415636|65189485|FG001|Overall Study|Symptomatic deterioration|0|||
23393858|NCT00415636|65189486|FG002|Overall Study|Symptomatic deterioration|1|||
23393859|NCT00415636|65189487|FG003|Overall Study|Symptomatic deterioration|2|||
23393860|NCT00415636|65189488|FG004|Overall Study|Symptomatic deterioration|0|||
23393861|NCT00415636|65189489|FG005|Overall Study|Symptomatic deterioration|1|||
23393862|NCT00415636|65189484|FG000|Overall Study|Adverse Event|0|||
23393863|NCT00415636|65189485|FG001|Overall Study|Adverse Event|0|||
23393864|NCT00415636|65189486|FG002|Overall Study|Adverse Event|0|||
23393865|NCT00415636|65189487|FG003|Overall Study|Adverse Event|1|||
23393866|NCT00415636|65189488|FG004|Overall Study|Adverse Event|1|||
23393867|NCT00415636|65189489|FG005|Overall Study|Adverse Event|0|||
23393868|NCT00415636|65189484|FG000|Overall Study|Withdrawal by Subject|0|||
23393869|NCT00415636|65189485|FG001|Overall Study|Withdrawal by Subject|0|||
23393870|NCT00415636|65189486|FG002|Overall Study|Withdrawal by Subject|0|||
23393871|NCT00415636|65189487|FG003|Overall Study|Withdrawal by Subject|0|||
23393872|NCT00415636|65189488|FG004|Overall Study|Withdrawal by Subject|1|||
23393873|NCT00415636|65189489|FG005|Overall Study|Withdrawal by Subject|0|||
23393874|NCT00415636|65189484|FG000|Overall Study|Disease progression|0|||
23393875|NCT00415636|65189485|FG001|Overall Study|Disease progression|0|||
23393876|NCT00415636|65189486|FG002|Overall Study|Disease progression|0|||
23393877|NCT00415636|65189487|FG003|Overall Study|Disease progression|3|||
23393878|NCT00415636|65189488|FG004|Overall Study|Disease progression|0|||
23393879|NCT00415636|65189489|FG005|Overall Study|Disease progression|1|||
23393880|NCT02014467|65189490|FG000|Overall Study|Adverse Event|4|||
23393881|NCT02014467|65189491|FG001|Overall Study|Adverse Event|0|||
23393882|NCT02014467|65189490|FG000|Overall Study|Protocol Violation|3|||
23393883|NCT02014467|65189491|FG001|Overall Study|Protocol Violation|0|||
23393884|NCT02014467|65189490|FG000|Overall Study|Physician Decision|2|||
23393885|NCT02014467|65189491|FG001|Overall Study|Physician Decision|3|||
23393886|NCT02014467|65189490|FG000|Overall Study|Withdrawal by Subject|16|||
23393887|NCT02014467|65189491|FG001|Overall Study|Withdrawal by Subject|4|||
23393888|NCT00522379|65189492|FG000|Overall Study|Adverse Event|12|||
23393889|NCT00522379|65189493|FG001|Overall Study|Adverse Event|15|||
23393890|NCT00522379|65189494|FG002|Overall Study|Adverse Event|12|||
23393891|NCT00522379|65189495|FG003|Overall Study|Adverse Event|5|||
23393892|NCT00522379|65189496|FG004|Overall Study|Adverse Event|17|||
23393893|NCT00522379|65189492|FG000|Overall Study|Lack of Efficacy|3|||
23393894|NCT00522379|65189493|FG001|Overall Study|Lack of Efficacy|0|||
23393895|NCT00522379|65189494|FG002|Overall Study|Lack of Efficacy|2|||
23393896|NCT00522379|65189495|FG003|Overall Study|Lack of Efficacy|2|||
23393897|NCT00522379|65189496|FG004|Overall Study|Lack of Efficacy|7|||
23393898|NCT00522379|65189492|FG000|Overall Study|Withdrawal by Subject|2|||
23393899|NCT00522379|65189493|FG001|Overall Study|Withdrawal by Subject|3|||
23393900|NCT00522379|65189494|FG002|Overall Study|Withdrawal by Subject|1|||
23393901|NCT00522379|65189495|FG003|Overall Study|Withdrawal by Subject|2|||
23393902|NCT00522379|65189496|FG004|Overall Study|Withdrawal by Subject|0|||
23393903|NCT00522379|65189492|FG000|Overall Study|Protocol Violation|1|||
23393904|NCT00522379|65189493|FG001|Overall Study|Protocol Violation|1|||
23393905|NCT00522379|65189494|FG002|Overall Study|Protocol Violation|2|||
23393906|NCT00522379|65189495|FG003|Overall Study|Protocol Violation|0|||
23393907|NCT00522379|65189496|FG004|Overall Study|Protocol Violation|0|||
23393908|NCT00522379|65189492|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
23393909|NCT00522379|65189493|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
23393910|NCT00522379|65189494|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
23393911|NCT00522379|65189495|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
23393912|NCT00522379|65189496|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
23393913|NCT00522379|65189492|FG000|Overall Study|Lost to Follow-up|1|||
23393914|NCT00522379|65189493|FG001|Overall Study|Lost to Follow-up|0|||
23393915|NCT00522379|65189494|FG002|Overall Study|Lost to Follow-up|4|||
23393916|NCT00522379|65189495|FG003|Overall Study|Lost to Follow-up|2|||
23393917|NCT00522379|65189496|FG004|Overall Study|Lost to Follow-up|2|||
23393918|NCT00522379|65189492|FG000|Overall Study|Randomization error|0|||
23393919|NCT00522379|65189493|FG001|Overall Study|Randomization error|0|||
23393920|NCT00522379|65189494|FG002|Overall Study|Randomization error|0|||
23393921|NCT00522379|65189495|FG003|Overall Study|Randomization error|0|||
23393922|NCT00522379|65189496|FG004|Overall Study|Randomization error|1|||
23393923|NCT00522379|65189492|FG000|Overall Study|Dispensing error|1|||
23393924|NCT00522379|65189493|FG001|Overall Study|Dispensing error|0|||
23393925|NCT00522379|65189494|FG002|Overall Study|Dispensing error|0|||
23393926|NCT00522379|65189495|FG003|Overall Study|Dispensing error|1|||
23393927|NCT00522379|65189496|FG004|Overall Study|Dispensing error|0|||
23393928|NCT00522379|65189492|FG000|Overall Study|Subject Moved|1|||
23393929|NCT00522379|65189493|FG001|Overall Study|Subject Moved|1|||
23393930|NCT00522379|65189494|FG002|Overall Study|Subject Moved|0|||
23393931|NCT00522379|65189495|FG003|Overall Study|Subject Moved|0|||
23393932|NCT00522379|65189496|FG004|Overall Study|Subject Moved|0|||
23393933|NCT00522379|65189492|FG000|Overall Study|Sponsor Request|0|||
23393934|NCT00522379|65189493|FG001|Overall Study|Sponsor Request|1|||
23393935|NCT00522379|65189494|FG002|Overall Study|Sponsor Request|0|||
23393936|NCT00522379|65189495|FG003|Overall Study|Sponsor Request|0|||
23393937|NCT00522379|65189496|FG004|Overall Study|Sponsor Request|0|||
23393938|NCT00522379|65189492|FG000|Overall Study|Family Problem|0|||
23393939|NCT00522379|65189493|FG001|Overall Study|Family Problem|0|||
23393940|NCT00522379|65189494|FG002|Overall Study|Family Problem|1|||
23393941|NCT00522379|65189495|FG003|Overall Study|Family Problem|0|||
23393942|NCT00522379|65189496|FG004|Overall Study|Family Problem|0|||
23393943|NCT00522379|65189492|FG000|Overall Study|Site Closed|0|||
23393944|NCT00522379|65189493|FG001|Overall Study|Site Closed|0|||
23393945|NCT00522379|65189494|FG002|Overall Study|Site Closed|0|||
23393946|NCT00522379|65189495|FG003|Overall Study|Site Closed|1|||
23393947|NCT00522379|65189496|FG004|Overall Study|Site Closed|0|||
23393948|NCT00522379|65189492|FG000|Overall Study|Subject Withdrawal|0|||
23393949|NCT00522379|65189493|FG001|Overall Study|Subject Withdrawal|0|||
23393950|NCT00522379|65189494|FG002|Overall Study|Subject Withdrawal|0|||
23393951|NCT00522379|65189495|FG003|Overall Study|Subject Withdrawal|1|||
23393952|NCT00522379|65189496|FG004|Overall Study|Subject Withdrawal|0|||
23393953|NCT04237584|65189497|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
23393954|NCT04237584|65189498|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
23393955|NCT04237584|65189499|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
23393956|NCT04237584|65189500|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
23393957|NCT04237584|65189497|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
23393958|NCT04237584|65189498|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
23393959|NCT04237584|65189499|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
23393960|NCT04237584|65189500|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
23393961|NCT04237584|65189497|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
23393962|NCT04237584|65189498|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
23393963|NCT04237584|65189499|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
23393964|NCT04237584|65189500|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
23393965|NCT04237584|65189497|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
23393966|NCT04237584|65189498|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
23393967|NCT04237584|65189499|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
23393968|NCT04237584|65189500|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
23393969|NCT04237584|65189497|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
23393970|NCT04237584|65189498|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
23393971|NCT04237584|65189499|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
23393972|NCT04237584|65189500|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
23393973|NCT00759395|65189509|FG000|Overall Study|Adverse Event|1|||
23393974|NCT00759395|65189510|FG001|Overall Study|Adverse Event|0|||
23393975|NCT00759395|65189509|FG000|Overall Study|Withdrawal by Subject|1|||
23393976|NCT00759395|65189510|FG001|Overall Study|Withdrawal by Subject|0|||
23393977|NCT00759395|65189509|FG000|Overall Study|Lack of Efficacy|0|||
23393978|NCT00759395|65189510|FG001|Overall Study|Lack of Efficacy|2|||
23393979|NCT03553836|65189511|FG000|Overall Study|Ongoing in Study|460|||
23393980|NCT03553836|65189512|FG001|Overall Study|Ongoing in Study|459|||
23393981|NCT03553836|65189511|FG000|Overall Study|Withdrawal by Subject|9|||
23393982|NCT03553836|65189512|FG001|Overall Study|Withdrawal by Subject|10|||
23393983|NCT03553836|65189511|FG000|Overall Study|Lost to Follow-up|1|||
23393984|NCT03553836|65189512|FG001|Overall Study|Lost to Follow-up|3|||
23393985|NCT03553836|65189511|FG000|Overall Study|Death|17|||
23393986|NCT03553836|65189512|FG001|Overall Study|Death|17|||
23393987|NCT03681678|65189513|FG000|Overall Study|Lost to Follow-up|20|||
23393988|NCT00835367|65189515|FG000|Washout|Adverse Event|2|||
23393989|NCT00835367|65189516|FG001|Washout|Adverse Event|0|||
23393990|NCT00835367|65189515|FG000|Washout|Withdrawal by Subject|1|||
23393991|NCT00835367|65189516|FG001|Washout|Withdrawal by Subject|0|||
23393992|NCT00835367|65189515|FG000|Second Intervention|Adverse Event|1|||
23393993|NCT00835367|65189516|FG001|Second Intervention|Adverse Event|1|||
23393994|NCT05166902|65189517|FG000|First Intervention|Lost to Follow-up|0|||
23393995|NCT05166902|65189518|FG001|First Intervention|Lost to Follow-up|1|||
23393996|NCT03682367|65189521|FG000|Overall Study|Protocol Violation|2|||
23393997|NCT03682367|65189522|FG001|Overall Study|Protocol Violation|1|||
23393998|NCT03682367|65189521|FG000|Overall Study|Closed Study Early|0|||
23393999|NCT03682367|65189522|FG001|Overall Study|Closed Study Early|3|||
23394000|NCT00863304|65189523|FG000|Overall Study|Adverse Event|10|||
23394001|NCT00863304|65189524|FG001|Overall Study|Adverse Event|4|||
23394002|NCT00863304|65189525|FG002|Overall Study|Adverse Event|14|||
23394003|NCT00863304|65189526|FG003|Overall Study|Adverse Event|16|||
23394004|NCT00863304|65189523|FG000|Overall Study|Lost to Follow-up|1|||
23394005|NCT00863304|65189524|FG001|Overall Study|Lost to Follow-up|5|||
23394006|NCT00863304|65189525|FG002|Overall Study|Lost to Follow-up|4|||
23394007|NCT00863304|65189526|FG003|Overall Study|Lost to Follow-up|2|||
23394008|NCT00863304|65189523|FG000|Overall Study|Lack of Efficacy|57|||
23394009|NCT00863304|65189524|FG001|Overall Study|Lack of Efficacy|26|||
23394010|NCT00863304|65189525|FG002|Overall Study|Lack of Efficacy|30|||
23394011|NCT00863304|65189526|FG003|Overall Study|Lack of Efficacy|28|||
23394012|NCT00863304|65189523|FG000|Overall Study|Withdrawal by Subject|19|||
23394013|NCT00863304|65189524|FG001|Overall Study|Withdrawal by Subject|14|||
23394014|NCT00863304|65189525|FG002|Overall Study|Withdrawal by Subject|20|||
23394015|NCT00863304|65189526|FG003|Overall Study|Withdrawal by Subject|18|||
23394016|NCT00863304|65189523|FG000|Overall Study|Other|1|||
23394017|NCT00863304|65189524|FG001|Overall Study|Other|0|||
23394018|NCT00863304|65189525|FG002|Overall Study|Other|0|||
23394019|NCT00863304|65189526|FG003|Overall Study|Other|1|||
23394020|NCT00863304|65189523|FG000|Overall Study|Protocol Violation|2|||
23394021|NCT00863304|65189524|FG001|Overall Study|Protocol Violation|6|||
23394022|NCT00863304|65189525|FG002|Overall Study|Protocol Violation|2|||
23394023|NCT00863304|65189526|FG003|Overall Study|Protocol Violation|0|||
23394024|NCT00863304|65189523|FG000|Overall Study|Randomized, but not Treated|3|||
23394025|NCT00863304|65189524|FG001|Overall Study|Randomized, but not Treated|1|||
23394026|NCT00863304|65189525|FG002|Overall Study|Randomized, but not Treated|4|||
23394027|NCT00863304|65189526|FG003|Overall Study|Randomized, but not Treated|1|||
23394028|NCT00863304|65189523|FG000|Overall Study|Entered extension study|101|||
23394029|NCT00863304|65189524|FG001|Overall Study|Entered extension study|129|||
23394030|NCT00863304|65189525|FG002|Overall Study|Entered extension study|113|||
23394031|NCT00863304|65189526|FG003|Overall Study|Entered extension study|125|||
23394032|NCT04164901|65189527|FG000|Overall Study|Withdrawal by Subject|4|||
23394033|NCT04164901|65189528|FG001|Overall Study|Withdrawal by Subject|4|||
23394034|NCT00581100|65189532|FG000|Overall Study|Death|1|||
23394035|NCT00581100|65189533|FG001|Overall Study|Death|0|||
23394036|NCT00581100|65189532|FG000|Overall Study|Adverse Event|2|||
23394037|NCT00581100|65189533|FG001|Overall Study|Adverse Event|1|||
23394038|NCT00581100|65189532|FG000|Overall Study|Withdrawal by Subject|1|||
23394039|NCT00581100|65189533|FG001|Overall Study|Withdrawal by Subject|4|||
23394040|NCT00581100|65189532|FG000|Overall Study|Other|3|||
23394041|NCT00581100|65189533|FG001|Overall Study|Other|0|||
23394042|NCT00323622|65189534|FG000|Overall Study|Other|30|||
23394043|NCT00323622|65189535|FG001|Overall Study|Other|91|||
23394044|NCT00323622|65189536|FG002|Overall Study|Other|4|||
23394045|NCT00323622|65189537|FG003|Overall Study|Other|12|||
23394046|NCT00323622|65189538|FG004|Overall Study|Other|32|||
23394047|NCT00323622|65189539|FG005|Overall Study|Other|74|||
23394048|NCT00323622|65189540|FG006|Overall Study|Other|5|||
23394049|NCT00323622|65189541|FG007|Overall Study|Other|13|||
23394050|NCT00323622|65189534|FG000|Overall Study|Death|1|||
23394051|NCT00323622|65189535|FG001|Overall Study|Death|1|||
23394052|NCT00323622|65189536|FG002|Overall Study|Death|0|||
23394053|NCT00323622|65189537|FG003|Overall Study|Death|0|||
23394054|NCT00323622|65189538|FG004|Overall Study|Death|7|||
23394055|NCT00323622|65189539|FG005|Overall Study|Death|0|||
23394056|NCT00323622|65189540|FG006|Overall Study|Death|0|||
23394057|NCT00323622|65189541|FG007|Overall Study|Death|2|||
23394058|NCT03556891|65189543|FG000|Overall Study|Adverse Event|4|||
23394059|NCT03556891|65189543|FG000|Overall Study|MRI Need|3|||
23394060|NCT03556891|65189543|FG000|Overall Study|Device Failure|1|||
23394061|NCT03556891|65189543|FG000|Overall Study|Death|1|||
23394062|NCT03556891|65189543|FG000|Overall Study|Lost to Follow-up|1|||
23394063|NCT03556891|65189543|FG000|Overall Study|Missing at random|1|||
23394064|NCT03556891|65189543|FG000|Overall Study|Missing due to COVID|1|||
23394065|NCT03556891|65189543|FG000|Overall Study|Protocol Violation|1|||
23394066|NCT03524157|65189551|FG000|Overall Study|cytology not readable|0|||
23394067|NCT03524157|65189552|FG001|Overall Study|cytology not readable|0|||
23394068|NCT03524157|65189553|FG002|Overall Study|cytology not readable|1|||
23394069|NCT00656370|65189557|FG000|Overall Study|Screen Failures|7|||
23394070|NCT00656370|65189557|FG000|Overall Study|Alternates|3|||
23394071|NCT01437189|65189558|FG000|Overall Study|Adverse Event|3|||
23394072|NCT01437189|65189558|FG000|Overall Study|Lack of Efficacy|4|||
23394073|NCT01437189|65189558|FG000|Overall Study|Withdrawal by Subject|8|||
23394074|NCT01702298|65189560|FG000|Overall Study|Withdrawal by Subject|1|||
23394075|NCT02706392|65189561|FG000|Overall Study|Death|1|||
23394076|NCT02706392|65189562|FG001|Overall Study|Death|0|||
23394077|NCT02706392|65189563|FG002|Overall Study|Death|2|||
23394078|NCT02706392|65189564|FG003|Overall Study|Death|2|||
23394079|NCT02706392|65189565|FG004|Overall Study|Death|5|||
23394080|NCT02706392|65189566|FG005|Overall Study|Death|2|||
23394081|NCT00867035|65189567|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
23394082|NCT00867035|65189568|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
23394083|NCT00867035|65189567|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
23394084|NCT00867035|65189568|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
23394085|NCT03514134|65189569|FG000|Overall Study|Lost to Follow-up|0|||
23394086|NCT03514134|65189570|FG001|Overall Study|Lost to Follow-up|1|||
23394087|NCT01405196|65189571|FG000|Overall Study|Study Terminated by Sponsor|0|||
23394088|NCT01405196|65189572|FG001|Overall Study|Study Terminated by Sponsor|0|||
23498462|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
23498463|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
23498464|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
23498465|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
23498466|NCT00371826|65566333|FG000|Extension Phase (24 Months)|Administrative problems|0|||
23498467|NCT00371826|65566334|FG001|Extension Phase (24 Months)|Administrative problems|0|||
23498468|NCT00371826|65566335|FG002|Extension Phase (24 Months)|Administrative problems|2|||
23498469|NCT00709761|65566336|FG000|Overall Study|Withdrawal by Subject|8|||
23498470|NCT00709761|65566336|FG000|Overall Study|study closed/terminated|17|||
23498471|NCT00709761|65566336|FG000|Overall Study|Lost to Follow-up|2|||
23498472|NCT05209360|65566337|FG000|Overall Study|Withdrawal by Subject|0|||
23498473|NCT05209360|65566338|FG001|Overall Study|Withdrawal by Subject|0|||
23498474|NCT05209360|65566339|FG002|Overall Study|Withdrawal by Subject|1|||
23498475|NCT05209360|65566340|FG003|Overall Study|Withdrawal by Subject|0|||
23498476|NCT05209360|65566341|FG004|Overall Study|Withdrawal by Subject|0|||
23498477|NCT05209360|65566342|FG005|Overall Study|Withdrawal by Subject|0|||
23498478|NCT01686828|65566343|FG000|Overall Study|Physician Decision|1|||
23498479|NCT01686828|65566344|FG001|Overall Study|Physician Decision|0|||
23498480|NCT01686828|65566345|FG002|Overall Study|Physician Decision|0|||
23498481|NCT01686828|65566346|FG003|Overall Study|Physician Decision|0|||
23498482|NCT01686828|65566343|FG000|Overall Study|New Job|0|||
23498483|NCT01686828|65566344|FG001|Overall Study|New Job|1|||
23498484|NCT01686828|65566345|FG002|Overall Study|New Job|0|||
23498485|NCT01686828|65566346|FG003|Overall Study|New Job|0|||
23498486|NCT01686828|65566343|FG000|Overall Study|Weight Loss|0|||
23498487|NCT01686828|65566344|FG001|Overall Study|Weight Loss|0|||
23498488|NCT01686828|65566345|FG002|Overall Study|Weight Loss|1|||
23498489|NCT01686828|65566346|FG003|Overall Study|Weight Loss|0|||
23498490|NCT00036270|65566348|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
23498491|NCT00036270|65566349|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
23498492|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
23498493|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
23498494|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
23498495|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
23498496|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
23498497|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
23498498|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Other|277|||
23498499|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Other|288|||
23498500|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
23498501|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
23498502|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
23498503|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
23498504|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
23498505|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
23498506|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
23498507|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
23394089|NCT01405196|65189573|FG002|Overall Study|Study Terminated by Sponsor|9|||
23394090|NCT01405196|65189574|FG003|Overall Study|Study Terminated by Sponsor|0|||
23394091|NCT01405196|65189571|FG000|Overall Study|Other|2|||
23394092|NCT01405196|65189572|FG001|Overall Study|Other|2|||
23394093|NCT01405196|65189573|FG002|Overall Study|Other|5|||
23394094|NCT01405196|65189574|FG003|Overall Study|Other|0|||
23394095|NCT01405196|65189571|FG000|Overall Study|Withdrawal by Subject|4|||
23394096|NCT01405196|65189572|FG001|Overall Study|Withdrawal by Subject|6|||
23394097|NCT01405196|65189573|FG002|Overall Study|Withdrawal by Subject|3|||
23394098|NCT01405196|65189574|FG003|Overall Study|Withdrawal by Subject|6|||
23394099|NCT01405196|65189571|FG000|Overall Study|Adverse Event|2|||
23394100|NCT01405196|65189572|FG001|Overall Study|Adverse Event|2|||
23394101|NCT01405196|65189573|FG002|Overall Study|Adverse Event|0|||
23394102|NCT01405196|65189574|FG003|Overall Study|Adverse Event|2|||
23394103|NCT01405196|65189571|FG000|Overall Study|Death|1|||
23394104|NCT01405196|65189572|FG001|Overall Study|Death|0|||
23394105|NCT01405196|65189573|FG002|Overall Study|Death|3|||
23394106|NCT01405196|65189574|FG003|Overall Study|Death|0|||
23394107|NCT01405196|65189571|FG000|Overall Study|Lost to Follow-up|2|||
23394108|NCT01405196|65189572|FG001|Overall Study|Lost to Follow-up|2|||
23394109|NCT01405196|65189573|FG002|Overall Study|Lost to Follow-up|3|||
23394110|NCT01405196|65189574|FG003|Overall Study|Lost to Follow-up|1|||
23394111|NCT00480532|65189575|FG000|Overall Study|Withdrawal by Subject|2|||
23394112|NCT00480532|65189576|FG001|Overall Study|Withdrawal by Subject|4|||
23394113|NCT00480532|65189577|FG002|Overall Study|Withdrawal by Subject|3|||
23394114|NCT00480532|65189578|FG003|Overall Study|Withdrawal by Subject|1|||
23394115|NCT00480532|65189575|FG000|Overall Study|Protocol Violation|0|||
23394116|NCT00480532|65189576|FG001|Overall Study|Protocol Violation|0|||
23394117|NCT00480532|65189577|FG002|Overall Study|Protocol Violation|1|||
23394118|NCT00480532|65189578|FG003|Overall Study|Protocol Violation|0|||
23394119|NCT01174563|65189579|FG000|Overall Study|Progressive Disease|45|||
23394120|NCT01174563|65189579|FG000|Overall Study|Death|5|||
23394121|NCT01174563|65189579|FG000|Overall Study|Investigator's Discretion|5|||
23498508|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
23498509|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
23394122|NCT01174563|65189579|FG000|Overall Study|Participant Withdrew Consent|3|||
23394123|NCT01174563|65189579|FG000|Overall Study|Rash Adverse Event|1|||
23394124|NCT01174563|65189579|FG000|Overall Study|Sponsor's decision|1|||
23606279|NCT01916109|65947199|FG000|Overall Study|Withdrawal by Subject|1|||
23606280|NCT04748341|65947201|FG000|Overall Study|Lost to Follow-up|1|||
23606281|NCT04748341|65947202|FG001|Overall Study|Lost to Follow-up|1|||
23606282|NCT02060487|65947203|FG000|Overall Study|Other|1|||
23606283|NCT02060487|65947204|FG001|Overall Study|Other|2|||
23606284|NCT02060487|65947205|FG002|Overall Study|Other|1|||
23606285|NCT02060487|65947203|FG000|Overall Study|Lack of Efficacy|0|||
23606286|NCT02060487|65947204|FG001|Overall Study|Lack of Efficacy|1|||
23606287|NCT02060487|65947205|FG002|Overall Study|Lack of Efficacy|0|||
23606288|NCT02060487|65947203|FG000|Overall Study|Withdrawal by Subject|3|||
23606289|NCT02060487|65947204|FG001|Overall Study|Withdrawal by Subject|10|||
23606290|NCT02060487|65947205|FG002|Overall Study|Withdrawal by Subject|4|||
23394137|NCT02971163|65189588|FG000|Overall Study|Lost to Follow-up|4|||
23394138|NCT02971163|65189589|FG001|Overall Study|Lost to Follow-up|2|||
23394139|NCT03110562|65189591|FG000|Initial Treatment Period|Disease Progression|1|||
23394140|NCT03110562|65189592|FG001|Initial Treatment Period|Disease Progression|1|||
23394141|NCT03110562|65189593|FG002|Initial Treatment Period|Disease Progression|0|||
23394142|NCT03110562|65189594|FG003|Initial Treatment Period|Disease Progression|0|||
23394143|NCT03110562|65189591|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
23394144|NCT03110562|65189592|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
23394145|NCT03110562|65189593|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
23394146|NCT03110562|65189594|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
23394147|NCT03110562|65189591|FG000|Initial Treatment Period|Adverse Event|1|||
23394148|NCT03110562|65189592|FG001|Initial Treatment Period|Adverse Event|0|||
23394149|NCT03110562|65189593|FG002|Initial Treatment Period|Adverse Event|0|||
23394150|NCT03110562|65189594|FG003|Initial Treatment Period|Adverse Event|0|||
23394151|NCT03110562|65189591|FG000|Initial Treatment Period|Death|74|||
23394152|NCT03110562|65189592|FG001|Initial Treatment Period|Death|82|||
23394153|NCT03110562|65189593|FG002|Initial Treatment Period|Death|0|||
23394154|NCT03110562|65189594|FG003|Initial Treatment Period|Death|0|||
23394155|NCT03110562|65189591|FG000|Initial Treatment Period|Lost to Follow-up|13|||
23394156|NCT03110562|65189592|FG001|Initial Treatment Period|Lost to Follow-up|8|||
23394157|NCT03110562|65189593|FG002|Initial Treatment Period|Lost to Follow-up|0|||
23394158|NCT03110562|65189594|FG003|Initial Treatment Period|Lost to Follow-up|0|||
23394159|NCT03110562|65189591|FG000|Initial Treatment Period|Protocol Deviation|1|||
23394160|NCT03110562|65189592|FG001|Initial Treatment Period|Protocol Deviation|0|||
23394161|NCT03110562|65189593|FG002|Initial Treatment Period|Protocol Deviation|0|||
23394162|NCT03110562|65189594|FG003|Initial Treatment Period|Protocol Deviation|0|||
23394163|NCT03110562|65189591|FG000|Initial Treatment Period|Physician Decision|2|||
23394164|NCT03110562|65189592|FG001|Initial Treatment Period|Physician Decision|1|||
23394165|NCT03110562|65189593|FG002|Initial Treatment Period|Physician Decision|0|||
23394166|NCT03110562|65189594|FG003|Initial Treatment Period|Physician Decision|0|||
23394167|NCT03110562|65189591|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
23394168|NCT03110562|65189592|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
23394169|NCT03110562|65189593|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
23394170|NCT03110562|65189594|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
23394171|NCT03110562|65189591|FG000|Initial Treatment Period|Other|5|||
23394172|NCT03110562|65189592|FG001|Initial Treatment Period|Other|4|||
23394173|NCT03110562|65189593|FG002|Initial Treatment Period|Other|0|||
23394174|NCT03110562|65189594|FG003|Initial Treatment Period|Other|0|||
23394175|NCT03110562|65189591|FG000|Initial Treatment Period|Randomized but never treated|0|||
23394176|NCT03110562|65189592|FG001|Initial Treatment Period|Randomized but never treated|3|||
23394177|NCT03110562|65189593|FG002|Initial Treatment Period|Randomized but never treated|0|||
23394178|NCT03110562|65189594|FG003|Initial Treatment Period|Randomized but never treated|0|||
23394179|NCT03110562|65189591|FG000|Crossover Period|Disease Progression|0|||
23394180|NCT03110562|65189592|FG001|Crossover Period|Disease Progression|0|||
23394181|NCT03110562|65189593|FG002|Crossover Period|Disease Progression|1|||
23394182|NCT03110562|65189594|FG003|Crossover Period|Disease Progression|0|||
23394183|NCT03110562|65189591|FG000|Crossover Period|Withdrawal by Subject|0|||
23394184|NCT03110562|65189592|FG001|Crossover Period|Withdrawal by Subject|0|||
23394185|NCT03110562|65189593|FG002|Crossover Period|Withdrawal by Subject|8|||
23394186|NCT03110562|65189594|FG003|Crossover Period|Withdrawal by Subject|6|||
23394187|NCT03110562|65189591|FG000|Crossover Period|Death|0|||
23394188|NCT03110562|65189592|FG001|Crossover Period|Death|0|||
23394189|NCT03110562|65189593|FG002|Crossover Period|Death|37|||
23394190|NCT03110562|65189594|FG003|Crossover Period|Death|3|||
23394191|NCT03110562|65189591|FG000|Crossover Period|Lost to Follow-up|0|||
23394192|NCT03110562|65189592|FG001|Crossover Period|Lost to Follow-up|0|||
23394193|NCT03110562|65189593|FG002|Crossover Period|Lost to Follow-up|0|||
23394194|NCT03110562|65189594|FG003|Crossover Period|Lost to Follow-up|1|||
23394195|NCT03110562|65189591|FG000|Crossover Period|Other|0|||
23606291|NCT02060487|65947203|FG000|Overall Study|Study Terminated By Sponsor|87|||
23606292|NCT02060487|65947204|FG001|Overall Study|Study Terminated By Sponsor|89|||
23606293|NCT02060487|65947205|FG002|Overall Study|Study Terminated By Sponsor|100|||
23606294|NCT02060487|65947203|FG000|Overall Study|Randomized in error|1|||
23606295|NCT02060487|65947204|FG001|Overall Study|Randomized in error|0|||
23606296|NCT02060487|65947205|FG002|Overall Study|Randomized in error|0|||
23606297|NCT02060487|65947203|FG000|Overall Study|Protocol Violation|0|||
23606298|NCT02060487|65947204|FG001|Overall Study|Protocol Violation|1|||
23606299|NCT02060487|65947205|FG002|Overall Study|Protocol Violation|1|||
23606300|NCT02060487|65947203|FG000|Overall Study|Lost to Follow-up|3|||
23606301|NCT02060487|65947204|FG001|Overall Study|Lost to Follow-up|0|||
23606302|NCT02060487|65947205|FG002|Overall Study|Lost to Follow-up|2|||
23606303|NCT02060487|65947203|FG000|Overall Study|Death|34|||
23606304|NCT02060487|65947204|FG001|Overall Study|Death|25|||
23606305|NCT02060487|65947205|FG002|Overall Study|Death|19|||
23606306|NCT02060487|65947203|FG000|Overall Study|Adverse Event|0|||
23394196|NCT03110562|65189592|FG001|Crossover Period|Other|0|||
23394197|NCT03110562|65189593|FG002|Crossover Period|Other|1|||
23394198|NCT03110562|65189594|FG003|Crossover Period|Other|1|||
23606307|NCT02060487|65947204|FG001|Overall Study|Adverse Event|0|||
23394199|NCT03110562|65189591|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
23394200|NCT03110562|65189592|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
23394201|NCT03110562|65189593|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
23394202|NCT03110562|65189594|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
23394203|NCT02467270|65189596|FG000|Overall Study|Participants Never Treated|0|||
23394204|NCT02467270|65189597|FG001|Overall Study|Participants Never Treated|1|||
23394205|NCT02467270|65189598|FG002|Overall Study|Participants Never Treated|0|||
23394206|NCT02467270|65189596|FG000|Overall Study|Ongoing|50|||
23394207|NCT02467270|65189597|FG001|Overall Study|Ongoing|41|||
23394208|NCT02467270|65189598|FG002|Overall Study|Ongoing|43|||
23394209|NCT02467270|65189596|FG000|Overall Study|Adverse Event|16|||
23394210|NCT02467270|65189597|FG001|Overall Study|Adverse Event|15|||
23394211|NCT02467270|65189598|FG002|Overall Study|Adverse Event|14|||
23394212|NCT02467270|65189596|FG000|Overall Study|Progressive Disease|7|||
23394213|NCT02467270|65189597|FG001|Overall Study|Progressive Disease|7|||
23394214|NCT02467270|65189598|FG002|Overall Study|Progressive Disease|4|||
23394215|NCT02467270|65189596|FG000|Overall Study|Death|2|||
23394216|NCT02467270|65189597|FG001|Overall Study|Death|0|||
23394217|NCT02467270|65189598|FG002|Overall Study|Death|2|||
23394218|NCT02467270|65189596|FG000|Overall Study|Lack of Efficacy|12|||
23394219|NCT02467270|65189597|FG001|Overall Study|Lack of Efficacy|18|||
23394220|NCT02467270|65189598|FG002|Overall Study|Lack of Efficacy|23|||
23394221|NCT02467270|65189596|FG000|Overall Study|Non-compliance With Study Drug|0|||
23394222|NCT02467270|65189597|FG001|Overall Study|Non-compliance With Study Drug|2|||
23394223|NCT02467270|65189598|FG002|Overall Study|Non-compliance With Study Drug|1|||
23394224|NCT02467270|65189596|FG000|Overall Study|Lost to Follow-up|2|||
23394225|NCT02467270|65189597|FG001|Overall Study|Lost to Follow-up|1|||
23394226|NCT02467270|65189598|FG002|Overall Study|Lost to Follow-up|0|||
23394227|NCT02467270|65189596|FG000|Overall Study|Pregnancy|0|||
23394228|NCT02467270|65189597|FG001|Overall Study|Pregnancy|1|||
23394229|NCT02467270|65189598|FG002|Overall Study|Pregnancy|0|||
23394230|NCT02467270|65189596|FG000|Overall Study|Physician Decision|0|||
23394231|NCT02467270|65189597|FG001|Overall Study|Physician Decision|4|||
23394232|NCT02467270|65189598|FG002|Overall Study|Physician Decision|1|||
23394233|NCT02467270|65189596|FG000|Overall Study|Withdrawal by Subject|4|||
23394234|NCT02467270|65189597|FG001|Overall Study|Withdrawal by Subject|3|||
23394235|NCT02467270|65189598|FG002|Overall Study|Withdrawal by Subject|5|||
23394236|NCT02467270|65189596|FG000|Overall Study|Reason not Specified|1|||
23394237|NCT02467270|65189597|FG001|Overall Study|Reason not Specified|2|||
23394238|NCT02467270|65189598|FG002|Overall Study|Reason not Specified|1|||
23394239|NCT04110145|65189602|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
23394240|NCT04110145|65189603|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
23394241|NCT04110145|65189604|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
23394242|NCT04110145|65189605|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
23394243|NCT04110145|65189606|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
23394244|NCT02263547|65189609|FG000|Overall Study|Adverse Event|1|||
23394245|NCT02263547|65189609|FG000|Overall Study|Lost to Follow-up|2|||
23394246|NCT01969409|65192555|FG000|Overall Study|Death|2|||
23394247|NCT01969409|65192556|FG001|Overall Study|Death|2|||
23394248|NCT01969409|65192555|FG000|Overall Study|Transplant|1|||
23394249|NCT01969409|65192556|FG001|Overall Study|Transplant|1|||
23394250|NCT01969409|65192555|FG000|Overall Study|Withdrawal by Subject|0|||
23394251|NCT01969409|65192556|FG001|Overall Study|Withdrawal by Subject|1|||
23394252|NCT01948427|65192559|FG000|Overall Study|Serious Adverse Event|3|||
23394253|NCT01948427|65192560|FG001|Overall Study|Serious Adverse Event|0|||
23394254|NCT01948427|65192561|FG002|Overall Study|Serious Adverse Event|0|||
23394255|NCT01948427|65192562|FG003|Overall Study|Serious Adverse Event|0|||
23394256|NCT01948427|65192563|FG004|Overall Study|Serious Adverse Event|1|||
23394257|NCT01948427|65192559|FG000|Overall Study|Investigator Request|0|||
23394258|NCT01948427|65192560|FG001|Overall Study|Investigator Request|8|||
23394259|NCT01948427|65192561|FG002|Overall Study|Investigator Request|0|||
23394260|NCT01948427|65192562|FG003|Overall Study|Investigator Request|0|||
23394261|NCT01948427|65192563|FG004|Overall Study|Investigator Request|6|||
23498510|NCT00036270|65566348|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
23498511|NCT00036270|65566349|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
23394262|NCT01948427|65192559|FG000|Overall Study|Lost to Follow-up|1|||
23394263|NCT01948427|65192560|FG001|Overall Study|Lost to Follow-up|0|||
23394264|NCT01948427|65192561|FG002|Overall Study|Lost to Follow-up|0|||
23394265|NCT01948427|65192562|FG003|Overall Study|Lost to Follow-up|0|||
23394266|NCT01948427|65192563|FG004|Overall Study|Lost to Follow-up|4|||
23394267|NCT01948427|65192559|FG000|Overall Study|Withdrawal by Subject|2|||
23394268|NCT01948427|65192560|FG001|Overall Study|Withdrawal by Subject|0|||
23394269|NCT01948427|65192561|FG002|Overall Study|Withdrawal by Subject|0|||
23394270|NCT01948427|65192562|FG003|Overall Study|Withdrawal by Subject|0|||
23394271|NCT01948427|65192563|FG004|Overall Study|Withdrawal by Subject|1|||
23394272|NCT01948427|65192559|FG000|Overall Study|Other, Not Specified|1|||
23394273|NCT01948427|65192560|FG001|Overall Study|Other, Not Specified|9|||
23394274|NCT01948427|65192561|FG002|Overall Study|Other, Not Specified|0|||
23394275|NCT01948427|65192562|FG003|Overall Study|Other, Not Specified|0|||
23394276|NCT01948427|65192563|FG004|Overall Study|Other, Not Specified|2|||
23394277|NCT03639935|65192566|FG000|Overall Study|Death|3|||
23394278|NCT03639935|65192566|FG000|Overall Study|Adverse Event|1|||
23394279|NCT02038036|65192567|FG000|Core Study|Adverse Event|7|||
23394280|NCT02038036|65192568|FG001|Core Study|Adverse Event|7|||
23394281|NCT02038036|65192567|FG000|Core Study|Death|1|||
23394282|NCT02038036|65192568|FG001|Core Study|Death|1|||
23394283|NCT02038036|65192567|FG000|Core Study|Disease progression|2|||
23394284|NCT02038036|65192568|FG001|Core Study|Disease progression|2|||
23498512|NCT01365052|65566350|FG000|Overall Study|Adverse Event|4|||
23394285|NCT02038036|65192567|FG000|Core Study|Lost to Follow-up|0|||
23394286|NCT02038036|65192568|FG001|Core Study|Lost to Follow-up|1|||
23394287|NCT02038036|65192567|FG000|Core Study|Physician Decision|2|||
23394288|NCT02038036|65192568|FG001|Core Study|Physician Decision|1|||
23394289|NCT02038036|65192567|FG000|Core Study|Subject/guardian decision|0|||
23394290|NCT02038036|65192568|FG001|Core Study|Subject/guardian decision|1|||
23394291|NCT02038036|65192567|FG000|Core Study|Withdrawal by Subject|3|||
23394292|NCT02038036|65192568|FG001|Core Study|Withdrawal by Subject|1|||
23394293|NCT02038036|65192567|FG000|Crossover Period|Withdrawal by Subject|0|||
23394294|NCT02038036|65192568|FG001|Crossover Period|Withdrawal by Subject|3|||
23394295|NCT02038036|65192567|FG000|Crossover Period|Adverse Event|0|||
23394296|NCT02038036|65192568|FG001|Crossover Period|Adverse Event|9|||
23394297|NCT02038036|65192567|FG000|Crossover Period|Death|0|||
23394298|NCT02038036|65192568|FG001|Crossover Period|Death|2|||
23394299|NCT02038036|65192567|FG000|Crossover Period|Disease progression|0|||
23394300|NCT02038036|65192568|FG001|Crossover Period|Disease progression|3|||
23394301|NCT02038036|65192567|FG000|Crossover Period|Lost to Follow-up|0|||
23394302|NCT02038036|65192568|FG001|Crossover Period|Lost to Follow-up|1|||
23394303|NCT02038036|65192567|FG000|Crossover Period|Physician Decision|0|||
23394304|NCT02038036|65192568|FG001|Crossover Period|Physician Decision|2|||
23394305|NCT00836706|65192571|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
23394306|NCT00836706|65192572|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
23394307|NCT00113373|65192573|FG000|Overall Study|Ineligible: wrong primary|1|||
23394308|NCT00113373|65192573|FG000|Overall Study|Ineligible: second primary|1|||
23394309|NCT00113373|65192573|FG000|Overall Study|Never Treated|1|||
23394310|NCT02919618|65192590|FG000|Overall Study|Death|1|||
23394311|NCT03131479|65192591|FG000|Overall Study|Adverse Event|0|||
23394312|NCT03131479|65192592|FG001|Overall Study|Adverse Event|0|||
23394313|NCT03131479|65192593|FG002|Overall Study|Adverse Event|1|||
23394314|NCT03131479|65192594|FG003|Overall Study|Adverse Event|1|||
23394315|NCT03131479|65192595|FG004|Overall Study|Adverse Event|0|||
23394316|NCT03131479|65192591|FG000|Overall Study|Subject/Guardian Decision|0|||
23394317|NCT03131479|65192592|FG001|Overall Study|Subject/Guardian Decision|0|||
23394318|NCT03131479|65192593|FG002|Overall Study|Subject/Guardian Decision|0|||
23394319|NCT03131479|65192594|FG003|Overall Study|Subject/Guardian Decision|1|||
23394320|NCT03131479|65192595|FG004|Overall Study|Subject/Guardian Decision|0|||
23394321|NCT01538199|65192596|FG000|Overall Study|Lost to Follow-up|1|||
23394322|NCT01538199|65192597|FG001|Overall Study|Lost to Follow-up|2|||
23394323|NCT01538199|65192598|FG002|Overall Study|Lost to Follow-up|1|||
23394324|NCT01538199|65192599|FG003|Overall Study|Lost to Follow-up|0|||
23394325|NCT01538199|65192596|FG000|Overall Study|participant did not have time|1|||
23394326|NCT01538199|65192597|FG001|Overall Study|participant did not have time|0|||
23394327|NCT01538199|65192598|FG002|Overall Study|participant did not have time|0|||
23394328|NCT01538199|65192599|FG003|Overall Study|participant did not have time|2|||
23394329|NCT01538199|65192596|FG000|Overall Study|Lack of Efficacy|0|||
23394330|NCT01538199|65192597|FG001|Overall Study|Lack of Efficacy|1|||
23394331|NCT01538199|65192598|FG002|Overall Study|Lack of Efficacy|0|||
23394332|NCT01538199|65192599|FG003|Overall Study|Lack of Efficacy|0|||
23394333|NCT03132467|65192600|FG000|Overall Study|Adverse Event|2|||
23498513|NCT01365052|65566351|FG001|Overall Study|Adverse Event|4|||
23498514|NCT00005044|65566352|FG000|Overall Study|Protocol Violation|37|||
23394334|NCT03132467|65192600|FG000|Overall Study|Withdrawal by Subject|2|||
23394335|NCT00668642|65192601|FG000|First Off-cycle|Cancer progression|1|||
23394336|NCT00668642|65192602|FG001|First Off-cycle|Cancer progression|0|||
23394337|NCT00668642|65192601|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
23394338|NCT00668642|65192602|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
23394339|NCT02314923|65192603|FG000|Overall Study|Death|0|||
23394340|NCT02314923|65192604|FG001|Overall Study|Death|0|||
23394341|NCT02314923|65192605|FG002|Overall Study|Death|0|||
23394342|NCT02314923|65192606|FG003|Overall Study|Death|1|||
23394343|NCT02314923|65192607|FG004|Overall Study|Death|0|||
23394344|NCT02314923|65192608|FG005|Overall Study|Death|0|||
23394345|NCT02314923|65192609|FG006|Overall Study|Death|0|||
23394346|NCT02314923|65192610|FG007|Overall Study|Death|0|||
23394347|NCT02314923|65192611|FG008|Overall Study|Death|0|||
23394348|NCT02314923|65192612|FG009|Overall Study|Death|0|||
23394349|NCT02314923|65192603|FG000|Overall Study|Lost to Follow-up|2|||
23394350|NCT02314923|65192604|FG001|Overall Study|Lost to Follow-up|3|||
23394351|NCT02314923|65192605|FG002|Overall Study|Lost to Follow-up|1|||
23394352|NCT02314923|65192606|FG003|Overall Study|Lost to Follow-up|0|||
23394353|NCT02314923|65192607|FG004|Overall Study|Lost to Follow-up|0|||
23394354|NCT02314923|65192608|FG005|Overall Study|Lost to Follow-up|0|||
23394355|NCT02314923|65192609|FG006|Overall Study|Lost to Follow-up|3|||
23394356|NCT02314923|65192610|FG007|Overall Study|Lost to Follow-up|4|||
23394357|NCT02314923|65192611|FG008|Overall Study|Lost to Follow-up|2|||
23394358|NCT02314923|65192612|FG009|Overall Study|Lost to Follow-up|0|||
23394359|NCT02314923|65192603|FG000|Overall Study|Withdrawal by Subject|0|||
23394360|NCT02314923|65192604|FG001|Overall Study|Withdrawal by Subject|0|||
23394361|NCT02314923|65192605|FG002|Overall Study|Withdrawal by Subject|1|||
23394362|NCT02314923|65192606|FG003|Overall Study|Withdrawal by Subject|0|||
23394363|NCT02314923|65192607|FG004|Overall Study|Withdrawal by Subject|1|||
23394364|NCT02314923|65192608|FG005|Overall Study|Withdrawal by Subject|0|||
23394365|NCT02314923|65192609|FG006|Overall Study|Withdrawal by Subject|1|||
23394366|NCT02314923|65192610|FG007|Overall Study|Withdrawal by Subject|0|||
23394367|NCT02314923|65192611|FG008|Overall Study|Withdrawal by Subject|0|||
23394368|NCT02314923|65192612|FG009|Overall Study|Withdrawal by Subject|0|||
23394369|NCT02314923|65192603|FG000|Overall Study|Physician Decision|0|||
23394370|NCT02314923|65192604|FG001|Overall Study|Physician Decision|1|||
23394371|NCT02314923|65192605|FG002|Overall Study|Physician Decision|0|||
23394372|NCT02314923|65192606|FG003|Overall Study|Physician Decision|0|||
23394373|NCT02314923|65192607|FG004|Overall Study|Physician Decision|0|||
23394374|NCT02314923|65192608|FG005|Overall Study|Physician Decision|0|||
23394375|NCT02314923|65192609|FG006|Overall Study|Physician Decision|0|||
23394376|NCT02314923|65192610|FG007|Overall Study|Physician Decision|0|||
23394377|NCT02314923|65192611|FG008|Overall Study|Physician Decision|0|||
23394378|NCT02314923|65192612|FG009|Overall Study|Physician Decision|0|||
23394379|NCT02314923|65192603|FG000|Overall Study|Participant unavailable|0|||
23394380|NCT02314923|65192604|FG001|Overall Study|Participant unavailable|0|||
23394381|NCT02314923|65192605|FG002|Overall Study|Participant unavailable|0|||
23394382|NCT02314923|65192606|FG003|Overall Study|Participant unavailable|0|||
23394383|NCT02314923|65192607|FG004|Overall Study|Participant unavailable|0|||
23394384|NCT02314923|65192608|FG005|Overall Study|Participant unavailable|1|||
23394385|NCT02314923|65192609|FG006|Overall Study|Participant unavailable|0|||
23394386|NCT02314923|65192610|FG007|Overall Study|Participant unavailable|0|||
23394387|NCT02314923|65192611|FG008|Overall Study|Participant unavailable|0|||
23394388|NCT02314923|65192612|FG009|Overall Study|Participant unavailable|0|||
23394389|NCT02314923|65192603|FG000|Overall Study|Screen failure|0|||
23394390|NCT02314923|65192604|FG001|Overall Study|Screen failure|0|||
23394391|NCT02314923|65192605|FG002|Overall Study|Screen failure|0|||
23394392|NCT02314923|65192606|FG003|Overall Study|Screen failure|0|||
23394393|NCT02314923|65192607|FG004|Overall Study|Screen failure|0|||
23394394|NCT02314923|65192608|FG005|Overall Study|Screen failure|0|||
23394395|NCT02314923|65192609|FG006|Overall Study|Screen failure|1|||
23394396|NCT02314923|65192610|FG007|Overall Study|Screen failure|0|||
23394397|NCT02314923|65192611|FG008|Overall Study|Screen failure|0|||
23394398|NCT02314923|65192612|FG009|Overall Study|Screen failure|0|||
23394399|NCT02314923|65192603|FG000|Overall Study|Participant relocation|1|||
23394400|NCT02314923|65192604|FG001|Overall Study|Participant relocation|0|||
23394401|NCT02314923|65192605|FG002|Overall Study|Participant relocation|0|||
23394402|NCT02314923|65192606|FG003|Overall Study|Participant relocation|0|||
23394403|NCT02314923|65192607|FG004|Overall Study|Participant relocation|0|||
23394404|NCT02314923|65192608|FG005|Overall Study|Participant relocation|0|||
23394405|NCT02314923|65192609|FG006|Overall Study|Participant relocation|0|||
23394406|NCT02314923|65192610|FG007|Overall Study|Participant relocation|1|||
23394407|NCT02314923|65192611|FG008|Overall Study|Participant relocation|0|||
23394408|NCT02314923|65192612|FG009|Overall Study|Participant relocation|0|||
23394409|NCT01394185|65192613|FG000|Overall Study|Withdrawal by Subject|2|||
23394410|NCT01394185|65192614|FG001|Overall Study|Withdrawal by Subject|0|||
23394411|NCT01394185|65192615|FG002|Overall Study|Withdrawal by Subject|0|||
23394412|NCT01394185|65192616|FG003|Overall Study|Withdrawal by Subject|0|||
23394413|NCT01394185|65192617|FG004|Overall Study|Withdrawal by Subject|1|||
23394414|NCT01394185|65192618|FG005|Overall Study|Withdrawal by Subject|0|||
23394415|NCT01394185|65192613|FG000|Overall Study|Change in protocol|3|||
23394416|NCT01394185|65192614|FG001|Overall Study|Change in protocol|0|||
23394417|NCT01394185|65192615|FG002|Overall Study|Change in protocol|0|||
23394418|NCT01394185|65192616|FG003|Overall Study|Change in protocol|0|||
23394419|NCT01394185|65192617|FG004|Overall Study|Change in protocol|3|||
23394420|NCT01394185|65192618|FG005|Overall Study|Change in protocol|0|||
23394421|NCT01394185|65192613|FG000|Overall Study|Protocol Violation|1|||
23394422|NCT01394185|65192614|FG001|Overall Study|Protocol Violation|0|||
23394423|NCT01394185|65192615|FG002|Overall Study|Protocol Violation|0|||
23394424|NCT01394185|65192616|FG003|Overall Study|Protocol Violation|1|||
23394425|NCT01394185|65192617|FG004|Overall Study|Protocol Violation|0|||
23394426|NCT01394185|65192618|FG005|Overall Study|Protocol Violation|1|||
23394427|NCT04576455|65192619|FG000|Overall Study|Ongoing in the Study|122|||
23394428|NCT04576455|65192620|FG001|Overall Study|Ongoing in the Study|135|||
23394429|NCT04576455|65192619|FG000|Overall Study|Death|18|||
23394430|NCT04576455|65192620|FG001|Overall Study|Death|12|||
23394431|NCT04576455|65192619|FG000|Overall Study|Lost to Follow-up|1|||
23394432|NCT04576455|65192620|FG001|Overall Study|Lost to Follow-up|0|||
23394433|NCT04576455|65192619|FG000|Overall Study|Withdrawal by Subject|10|||
23394434|NCT04576455|65192620|FG001|Overall Study|Withdrawal by Subject|5|||
23394435|NCT02495883|65192621|FG000|Overall Study|Excessive head motion|1|||
23394436|NCT02495883|65192622|FG001|Overall Study|Excessive head motion|0|||
23394437|NCT01344356|65192624|FG000|Overall Study|Physician Decision|0|||
23394438|NCT01344356|65192625|FG001|Overall Study|Physician Decision|3|||
23394439|NCT01344356|65192624|FG000|Overall Study|Lost to Follow-up|0|||
23394440|NCT01344356|65192625|FG001|Overall Study|Lost to Follow-up|6|||
23394441|NCT03312114|65192628|FG000|Overall Study|All the five enrolled dropped out of the|5|||
23394442|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Adverse Event|3|||
23394443|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Adverse Event|0|||
23394444|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Adverse Event|0|||
23394445|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
23394446|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
23394447|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
23394448|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
23394449|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
23394450|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
23394451|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
23394452|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
23300499|NCT00925301|64842807|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
23300500|NCT00925301|64842808|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
23394453|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
23498515|NCT00005044|65566353|FG001|Overall Study|Protocol Violation|46|||
23394454|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
23606308|NCT02060487|65947205|FG002|Overall Study|Adverse Event|1|||
23606309|NCT00089609|65947207|FG000|Overall Study|Withdrawal by Subject|3|||
23606310|NCT00089609|65947208|FG001|Overall Study|Withdrawal by Subject|1|||
23606311|NCT05445557|65947209|FG000|Double Blind Part|Lost to Follow-up|1|||
23606312|NCT01005602|65947210|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
23606313|NCT01005602|65947211|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
23606314|NCT00088166|65947212|FG000|Overall Study|Adverse Event|11|||
23606315|NCT00088166|65947213|FG001|Overall Study|Adverse Event|9|||
23606316|NCT00088166|65947212|FG000|Overall Study|Death|3|||
23606317|NCT00088166|65947213|FG001|Overall Study|Death|1|||
23606318|NCT00088166|65947212|FG000|Overall Study|Lost to Follow-up|0|||
23606319|NCT00088166|65947213|FG001|Overall Study|Lost to Follow-up|1|||
23606320|NCT00088166|65947212|FG000|Overall Study|Physician Decision|4|||
23606321|NCT00088166|65947213|FG001|Overall Study|Physician Decision|1|||
23606322|NCT00088166|65947212|FG000|Overall Study|Protocol Violation|1|||
23606323|NCT00088166|65947213|FG001|Overall Study|Protocol Violation|5|||
23606324|NCT00088166|65947212|FG000|Overall Study|Patient deterioration|29|||
23606325|NCT00088166|65947213|FG001|Overall Study|Patient deterioration|39|||
23606326|NCT00088166|65947212|FG000|Overall Study|Withdrawal by Subject|5|||
23606327|NCT00088166|65947213|FG001|Overall Study|Withdrawal by Subject|5|||
23606328|NCT03265132|65947214|FG000|Overall Study|Adverse Event|0|||
23606329|NCT03265132|65947215|FG001|Overall Study|Adverse Event|1|||
23606330|NCT03265132|65947214|FG000|Overall Study|Lack of Efficacy|0|||
23606331|NCT03265132|65947215|FG001|Overall Study|Lack of Efficacy|2|||
23606332|NCT03265132|65947214|FG000|Overall Study|Progressive disease|0|||
23606333|NCT03265132|65947215|FG001|Overall Study|Progressive disease|2|||
23606334|NCT03265132|65947214|FG000|Overall Study|Withdrawal by Subject|0|||
23606335|NCT03265132|65947215|FG001|Overall Study|Withdrawal by Subject|1|||
23606336|NCT02332824|65947216|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
23606337|NCT02332824|65947217|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
23606338|NCT02332824|65947218|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
23606339|NCT02332824|65947219|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
23606340|NCT02332824|65947220|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
23394455|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
23394456|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
23394457|NCT04380142|65192629|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
23394458|NCT04380142|65192630|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
23394459|NCT04380142|65192631|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
23394460|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23394461|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23394462|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Adverse Event|14|||
23394463|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
23394464|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
23394465|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
23394466|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
23394467|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
23394468|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
23394469|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
23394470|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
23394471|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
23394472|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
23394473|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
23394474|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
23394475|NCT04380142|65192629|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
23394476|NCT04380142|65192630|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
23394477|NCT04380142|65192631|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
23394478|NCT00518180|65192633|FG000|Overall Study|Withdrawal by Subject|29|||
23394479|NCT00518180|65192634|FG001|Overall Study|Withdrawal by Subject|30|||
23394480|NCT00518180|65192635|FG002|Overall Study|Withdrawal by Subject|42|||
23394481|NCT00518180|65192633|FG000|Overall Study|Lost to Follow-up|30|||
23394482|NCT00518180|65192634|FG001|Overall Study|Lost to Follow-up|28|||
23394483|NCT00518180|65192635|FG002|Overall Study|Lost to Follow-up|34|||
23394484|NCT00518180|65192633|FG000|Overall Study|Administrative reason|0|||
23394485|NCT00518180|65192634|FG001|Overall Study|Administrative reason|2|||
23498516|NCT00005044|65566352|FG000|Overall Study|Withdrawal by Subject|1|||
23498517|NCT00005044|65566353|FG001|Overall Study|Withdrawal by Subject|5|||
23498518|NCT00005044|65566352|FG000|Overall Study|No protocol treatment|0|||
23498519|NCT00005044|65566353|FG001|Overall Study|No protocol treatment|1|||
23498520|NCT00293215|65566354|FG000|Overall Study|Progressive disease|3|||
23498521|NCT00293215|65566355|FG001|Overall Study|Progressive disease|1|||
23498522|NCT00293215|65566354|FG000|Overall Study|Adverse Event|2|||
23498523|NCT00293215|65566355|FG001|Overall Study|Adverse Event|2|||
23498524|NCT04066023|65566358|FG000|Overall Study|Adverse Event|0|||
23498525|NCT04066023|65566359|FG001|Overall Study|Adverse Event|0|||
23394486|NCT00518180|65192635|FG002|Overall Study|Administrative reason|2|||
23394487|NCT00518180|65192633|FG000|Overall Study|Protocol Violation|5|||
23498526|NCT04066023|65566360|FG002|Overall Study|Adverse Event|1|||
23498527|NCT04066023|65566358|FG000|Overall Study|Sponsor decision|3|||
23498528|NCT04066023|65566359|FG001|Overall Study|Sponsor decision|6|||
23498529|NCT04066023|65566360|FG002|Overall Study|Sponsor decision|2|||
23394488|NCT00518180|65192634|FG001|Overall Study|Protocol Violation|7|||
23394489|NCT00518180|65192635|FG002|Overall Study|Protocol Violation|4|||
23394490|NCT00518180|65192633|FG000|Overall Study|Unable to classify|0|||
23394491|NCT00518180|65192634|FG001|Overall Study|Unable to classify|2|||
23394492|NCT00518180|65192635|FG002|Overall Study|Unable to classify|0|||
23394493|NCT00518180|65192633|FG000|Overall Study|Adverse Event|1|||
23394494|NCT00518180|65192634|FG001|Overall Study|Adverse Event|0|||
23394495|NCT00518180|65192635|FG002|Overall Study|Adverse Event|0|||
23394496|NCT00862940|65192636|FG000|Overall Study|Adverse Event|15|||
23394497|NCT00862940|65192637|FG001|Overall Study|Adverse Event|12|||
23394498|NCT00862940|65192636|FG000|Overall Study|Lack of Efficacy|1|||
23394499|NCT00862940|65192637|FG001|Overall Study|Lack of Efficacy|3|||
23394500|NCT00862940|65192636|FG000|Overall Study|Protocol Violation|2|||
23394501|NCT00862940|65192637|FG001|Overall Study|Protocol Violation|5|||
23394502|NCT00862940|65192636|FG000|Overall Study|Withdrawal by Subject|4|||
23394503|NCT00862940|65192637|FG001|Overall Study|Withdrawal by Subject|6|||
23394504|NCT00862940|65192636|FG000|Overall Study|Non-compliance|4|||
23394505|NCT00862940|65192637|FG001|Overall Study|Non-compliance|0|||
23394506|NCT00862940|65192636|FG000|Overall Study|Lost to Follow-up|0|||
23394507|NCT00862940|65192637|FG001|Overall Study|Lost to Follow-up|1|||
23394508|NCT00862940|65192636|FG000|Overall Study|Administrative or other reason(s)|4|||
23394509|NCT00862940|65192637|FG001|Overall Study|Administrative or other reason(s)|3|||
23394510|NCT04581395|65192640|FG000|Overall Study|Protocol Violation|4|||
23394511|NCT04581395|65192641|FG001|Overall Study|Protocol Violation|3|||
23394512|NCT04581395|65192642|FG002|Overall Study|Protocol Violation|2|||
23394513|NCT04581395|65192640|FG000|Overall Study|Physician Decision|0|||
23394514|NCT04581395|65192641|FG001|Overall Study|Physician Decision|1|||
23394515|NCT04581395|65192642|FG002|Overall Study|Physician Decision|0|||
23394516|NCT03014089|65192648|FG000|Overall Study|Withdrawal by Subject|0|||
23394517|NCT03014089|65192649|FG001|Overall Study|Withdrawal by Subject|1|||
23394518|NCT03014089|65192650|FG002|Overall Study|Withdrawal by Subject|1|||
23394519|NCT03014089|65192651|FG003|Overall Study|Withdrawal by Subject|1|||
23394520|NCT03014089|65192648|FG000|Overall Study|Lost to Follow-up|1|||
23394521|NCT03014089|65192649|FG001|Overall Study|Lost to Follow-up|0|||
23394522|NCT03014089|65192650|FG002|Overall Study|Lost to Follow-up|0|||
23394523|NCT03014089|65192651|FG003|Overall Study|Lost to Follow-up|0|||
23498530|NCT04066023|65566358|FG000|Overall Study|Physician Decision|0|||
23300501|NCT00925301|64842809|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
23300502|NCT00925301|64842810|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
23300503|NCT02549573|64842811|FG000|Overall Study|Withdrawal by Subject|0|||
23300504|NCT02549573|64842812|FG001|Overall Study|Withdrawal by Subject|2|||
23394524|NCT03014089|65192648|FG000|Overall Study|Adverse Event|1|||
23394525|NCT03014089|65192649|FG001|Overall Study|Adverse Event|0|||
23394526|NCT03014089|65192650|FG002|Overall Study|Adverse Event|1|||
23394527|NCT03014089|65192651|FG003|Overall Study|Adverse Event|0|||
23394528|NCT02801578|65192654|FG000|Overall Study|Adverse Event|2|||
23394529|NCT00397540|65192655|FG000|Overall Study|short follow-up duration < 12 months|1|||
23394530|NCT00397540|65192656|FG001|Overall Study|short follow-up duration < 12 months|0|||
23394531|NCT04442269|65192659|FG000|Overall Study|Adverse Event|1|||
23394532|NCT04442269|65192660|FG001|Overall Study|Adverse Event|0|||
23394533|NCT04442269|65192659|FG000|Overall Study|Death|0|||
23394534|NCT04442269|65192660|FG001|Overall Study|Death|1|||
23394535|NCT04442269|65192659|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
23394536|NCT04442269|65192660|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
23394537|NCT04442269|65192659|FG000|Overall Study|Lost to Follow-up|1|||
23394538|NCT04442269|65192660|FG001|Overall Study|Lost to Follow-up|0|||
23394539|NCT04442269|65192659|FG000|Overall Study|Withdrawal by Subject|3|||
23394540|NCT04442269|65192660|FG001|Overall Study|Withdrawal by Subject|2|||
23394541|NCT04442269|65192659|FG000|Overall Study|Protocol Deviation|0|||
23394542|NCT04442269|65192660|FG001|Overall Study|Protocol Deviation|1|||
23394543|NCT04442269|65192659|FG000|Overall Study|Travel Limitations|1|||
23394544|NCT04442269|65192660|FG001|Overall Study|Travel Limitations|1|||
23394545|NCT01514357|65192665|FG000|Overall Study|Screen failure|2|||
23394546|NCT01514357|65192666|FG001|Overall Study|Screen failure|0|||
23394547|NCT01514357|65192665|FG000|Overall Study|Withdrawal by Subject|2|||
23394548|NCT01514357|65192666|FG001|Overall Study|Withdrawal by Subject|0|||
23394549|NCT00830336|65192671|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
23394550|NCT00830336|65192672|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
23394551|NCT00071032|65192673|FG000|Overall Study|Lost to Follow-up|1|||
23394552|NCT00071032|65192674|FG001|Overall Study|Lost to Follow-up|1|||
23394553|NCT00071032|65192673|FG000|Overall Study|Withdrawal by Subject|8|||
23394554|NCT00071032|65192674|FG001|Overall Study|Withdrawal by Subject|6|||
23394555|NCT00071032|65192673|FG000|Overall Study|Missing Primary Outcome|0|||
23394556|NCT00071032|65192674|FG001|Overall Study|Missing Primary Outcome|1|||
23394557|NCT03773484|65192676|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
23394558|NCT03289039|65192684|FG000|Overall Study|Withdrawal by Subject|0|||
23394559|NCT03289039|65192685|FG001|Overall Study|Withdrawal by Subject|1|||
23394560|NCT03289039|65192684|FG000|Overall Study|Became ineligible prior to treatment start|0|||
23394561|NCT03289039|65192685|FG001|Overall Study|Became ineligible prior to treatment start|1|||
23394562|NCT03289039|65192684|FG000|Overall Study|progressed before treatment start|1|||
23394563|NCT03289039|65192685|FG001|Overall Study|progressed before treatment start|0|||
23394564|NCT00095576|65192688|FG000|Overall Study|Adverse Event|5|||
23394565|NCT00095576|65192689|FG001|Overall Study|Adverse Event|3|||
23394566|NCT00095576|65192688|FG000|Overall Study|Lost to Follow-up|233|||
23394567|NCT00095576|65192689|FG001|Overall Study|Lost to Follow-up|229|||
23394568|NCT00095576|65192688|FG000|Overall Study|Protocol Violation|1|||
23394569|NCT00095576|65192689|FG001|Overall Study|Protocol Violation|0|||
23394570|NCT00095576|65192688|FG000|Overall Study|Withdrawal by Subject|34|||
23394571|NCT00095576|65192689|FG001|Overall Study|Withdrawal by Subject|47|||
23394572|NCT00095576|65192688|FG000|Overall Study|Option to switch to a rollover study|1097|||
23394573|NCT00095576|65192689|FG001|Overall Study|Option to switch to a rollover study|1099|||
23394574|NCT00095576|65192688|FG000|Overall Study|Site terminated|75|||
23394575|NCT00095576|65192689|FG001|Overall Study|Site terminated|67|||
23394576|NCT00095576|65192688|FG000|Overall Study|Subject moved|30|||
23394577|NCT00095576|65192689|FG001|Overall Study|Subject moved|36|||
23394578|NCT00643279|65192692|FG000|Overall Study|Death|13|||
23394579|NCT00643279|65192693|FG001|Overall Study|Death|11|||
23394580|NCT00643279|65192692|FG000|Overall Study|Withdrawal by Subject|3|||
23394581|NCT00643279|65192693|FG001|Overall Study|Withdrawal by Subject|0|||
23394582|NCT00643279|65192692|FG000|Overall Study|Lost to Follow-up|0|||
23394583|NCT00643279|65192693|FG001|Overall Study|Lost to Follow-up|1|||
23394584|NCT00643279|65192692|FG000|Overall Study|Physician Decision|0|||
23394585|NCT00643279|65192693|FG001|Overall Study|Physician Decision|1|||
23394586|NCT02296125|65192698|FG000|Overall Study|Withdrawal by Subject|18|||
23394587|NCT02296125|65192699|FG001|Overall Study|Withdrawal by Subject|8|||
23394588|NCT02296125|65192700|FG002|Overall Study|Withdrawal by Subject|6|||
23394589|NCT02296125|65192701|FG003|Overall Study|Withdrawal by Subject|2|||
23394590|NCT02296125|65192698|FG000|Overall Study|Adverse Event|41|||
23394591|NCT02296125|65192699|FG001|Overall Study|Adverse Event|52|||
23394592|NCT02296125|65192700|FG002|Overall Study|Adverse Event|9|||
23394593|NCT02296125|65192701|FG003|Overall Study|Adverse Event|4|||
23394594|NCT02296125|65192698|FG000|Overall Study|Severe non-compliance to protocol|0|||
23394595|NCT02296125|65192699|FG001|Overall Study|Severe non-compliance to protocol|1|||
23394596|NCT02296125|65192700|FG002|Overall Study|Severe non-compliance to protocol|0|||
23394597|NCT02296125|65192701|FG003|Overall Study|Severe non-compliance to protocol|0|||
23394598|NCT02296125|65192698|FG000|Overall Study|Condition under investigation worsened|153|||
23394599|NCT02296125|65192699|FG001|Overall Study|Condition under investigation worsened|199|||
23394600|NCT02296125|65192700|FG002|Overall Study|Condition under investigation worsened|39|||
23394601|NCT02296125|65192701|FG003|Overall Study|Condition under investigation worsened|56|||
23394602|NCT02296125|65192698|FG000|Overall Study|Any reason not specifically recorded|6|||
23394603|NCT02296125|65192699|FG001|Overall Study|Any reason not specifically recorded|4|||
23394604|NCT02296125|65192700|FG002|Overall Study|Any reason not specifically recorded|2|||
23394605|NCT02296125|65192701|FG003|Overall Study|Any reason not specifically recorded|0|||
23394606|NCT02743962|65192709|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
23394607|NCT02743962|65192710|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
23394608|NCT00329420|65192715|FG000|Re-induction Phase|Lack of Efficacy|0|||
23394609|NCT00329420|65192716|FG001|Re-induction Phase|Lack of Efficacy|1|||
23394610|NCT00329420|65192717|FG002|Re-induction Phase|Lack of Efficacy|0|||
23394611|NCT00329420|65192715|FG000|Re-induction Phase|Withdrawal of Consent|0|||
23394612|NCT00329420|65192716|FG001|Re-induction Phase|Withdrawal of Consent|0|||
23394613|NCT00329420|65192717|FG002|Re-induction Phase|Withdrawal of Consent|1|||
23394614|NCT00329420|65192715|FG000|Re-induction Phase|Did not respond to re-induction|6|||
23394615|NCT00329420|65192716|FG001|Re-induction Phase|Did not respond to re-induction|5|||
23394616|NCT00329420|65192717|FG002|Re-induction Phase|Did not respond to re-induction|7|||
23394617|NCT00329420|65192715|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
23394618|NCT00329420|65192716|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
23394619|NCT00329420|65192717|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
23394620|NCT00329420|65192715|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
23394621|NCT00329420|65192716|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
23394622|NCT00329420|65192717|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
23394623|NCT00329420|65192715|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
23394624|NCT00329420|65192716|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
23394625|NCT00329420|65192717|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
23394626|NCT02526290|65192718|FG000|Overall Study|Adverse Event|3|||
23394627|NCT02526290|65192718|FG000|Overall Study|Withdrawal by Subject|4|||
23394628|NCT02526290|65192718|FG000|Overall Study|Physician Decision|1|||
23394629|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394630|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
23394631|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394632|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
23394633|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
23394634|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
23394635|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
23394636|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394637|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394638|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394639|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394640|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394641|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394642|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394643|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394644|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
23394645|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
23394646|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
23394647|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
23394648|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
23394649|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
23394650|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
23394651|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
23394652|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
23394653|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
23394654|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
23394655|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
23394656|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
23394657|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
23394658|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
23394659|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
23394660|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
23394661|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
23394662|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
23394663|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394664|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394665|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394666|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394667|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394668|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394669|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394670|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394671|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394672|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394673|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394674|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394675|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394676|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
23394677|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
23394678|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394679|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
23394680|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
23394681|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
23394682|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
23394683|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
23394684|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394685|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394686|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394687|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394688|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394689|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394690|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394691|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394692|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23394693|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394694|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394695|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394696|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
23394697|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394698|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394699|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
23394700|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394701|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394702|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394703|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394704|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394705|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394706|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394707|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394708|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
23394709|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394710|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394711|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
23394712|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394713|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394714|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394715|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394716|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394717|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394718|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394719|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394720|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394721|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394722|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394723|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394724|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
23394725|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
23394726|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
23394727|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
23394728|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394729|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394730|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394731|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394732|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394733|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394734|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394735|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394736|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394737|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394738|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394739|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394740|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23394741|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
23394742|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
23394743|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
23394744|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
23394745|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
23394746|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
23394747|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
23394748|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
23394749|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
23394750|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
23394751|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
23394752|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
23394753|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
23394754|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
23394755|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
23394756|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
23394757|NCT02958865|65192725|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394758|NCT02958865|65192726|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394759|NCT02958865|65192727|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394760|NCT02958865|65192728|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394761|NCT02958865|65192729|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
23394762|NCT02958865|65192730|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394763|NCT02958865|65192731|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23498531|NCT04066023|65566359|FG001|Overall Study|Physician Decision|0|||
23394764|NCT02958865|65192732|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394765|NCT02958865|65192733|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394766|NCT02958865|65192734|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394767|NCT02958865|65192735|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394768|NCT02958865|65192736|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394769|NCT02958865|65192737|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394770|NCT02958865|65192738|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394771|NCT02958865|65192739|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394772|NCT02958865|65192740|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23394773|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394774|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394775|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394776|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394777|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394778|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394779|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394780|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23394781|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23394782|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
23394783|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
23394784|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23394785|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
23394786|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23394787|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
23394788|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
23394789|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394790|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394791|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394792|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394793|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394794|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394795|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394796|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394797|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
23394798|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
23394799|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394800|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
23394801|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394802|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
23394803|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
23394804|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
23394805|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394806|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394807|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394808|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394809|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394810|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394811|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394812|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394813|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394814|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
23394815|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394816|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394817|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394818|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394819|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
23394820|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
23394821|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394822|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394823|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394824|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394825|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394826|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394827|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394828|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394829|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394830|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394831|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
23394832|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
23394833|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
23394834|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
23394835|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
23394836|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
23394837|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
23394838|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
23394839|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
23394840|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
23394841|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
23394842|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
23394843|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
23394844|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
23394845|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
23394846|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
23394847|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
23394848|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
23394849|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
23394850|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
23394851|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
23394852|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
23394853|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394854|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394855|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394856|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394857|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394858|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394859|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394860|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394861|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394862|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23498532|NCT04066023|65566360|FG002|Overall Study|Physician Decision|1|||
23394863|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394864|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394865|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394866|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
23394867|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394868|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
23394869|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394870|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394871|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394872|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394873|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394874|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394875|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394876|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394877|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394878|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394879|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394880|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394881|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394882|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
23394883|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394884|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
23394885|NCT02958865|65192725|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394886|NCT02958865|65192726|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394887|NCT02958865|65192727|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394888|NCT02958865|65192728|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394889|NCT02958865|65192729|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394890|NCT02958865|65192730|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394891|NCT02958865|65192731|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394892|NCT02958865|65192732|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394893|NCT02958865|65192733|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394894|NCT02958865|65192734|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
23394895|NCT02958865|65192735|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394896|NCT02958865|65192736|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394897|NCT02958865|65192737|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394898|NCT02958865|65192738|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394899|NCT02958865|65192739|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394900|NCT02958865|65192740|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
23394901|NCT00654732|65192743|FG000|Overall Study|Adverse Event|4|||
23394902|NCT00654732|65192744|FG001|Overall Study|Adverse Event|6|||
23394903|NCT00851084|65192745|FG000|Overall Study|Randomized but not treated|1|||
23394904|NCT00851084|65192746|FG001|Overall Study|Randomized but not treated|0|||
23394905|NCT00851084|65192745|FG000|Overall Study|Adverse Event|26|||
23394906|NCT00851084|65192746|FG001|Overall Study|Adverse Event|36|||
23394907|NCT00851084|65192745|FG000|Overall Study|Disease progression|52|||
23394908|NCT00851084|65192746|FG001|Overall Study|Disease progression|47|||
23394909|NCT00851084|65192745|FG000|Overall Study|Poor compliance to protocol|1|||
23394910|NCT00851084|65192746|FG001|Overall Study|Poor compliance to protocol|1|||
23394911|NCT00851084|65192745|FG000|Overall Study|Physician Decision|13|||
23394912|NCT00851084|65192746|FG001|Overall Study|Physician Decision|14|||
23300505|NCT02549573|64842811|FG000|Overall Study|Protocol Violation|0|||
23394913|NCT00851084|65192745|FG000|Overall Study|Consent withdrawn|0|||
23394914|NCT00851084|65192746|FG001|Overall Study|Consent withdrawn|2|||
23394915|NCT00851084|65192745|FG000|Overall Study|Withdrawal by Subject|11|||
23394916|NCT00851084|65192746|FG001|Overall Study|Withdrawal by Subject|12|||
23394917|NCT00851084|65192745|FG000|Overall Study|Metastatic surgery|6|||
23394918|NCT00851084|65192746|FG001|Overall Study|Metastatic surgery|6|||
23394919|NCT00851084|65192745|FG000|Overall Study|Other|7|||
23394920|NCT00851084|65192746|FG001|Overall Study|Other|1|||
23394921|NCT01651208|65192751|FG000|Overall Study|Lost to Follow-up|14|||
23394922|NCT01651208|65192752|FG001|Overall Study|Lost to Follow-up|16|||
23394923|NCT00829868|65192755|FG000|Washout|Physician Decision|1|||
23394924|NCT00829868|65192756|FG001|Washout|Physician Decision|0|||
23394925|NCT03242434|65192757|FG000|Overall Study|Death|0|||
23394926|NCT03242434|65192758|FG001|Overall Study|Death|2|||
23394927|NCT01358734|65192759|FG000|Overall Study|Adverse Event|4|||
23394928|NCT01358734|65192760|FG001|Overall Study|Adverse Event|7|||
23394929|NCT01358734|65192761|FG002|Overall Study|Adverse Event|3|||
23394930|NCT01358734|65192759|FG000|Overall Study|Lack of Efficacy|0|||
23394931|NCT01358734|65192760|FG001|Overall Study|Lack of Efficacy|1|||
23394932|NCT01358734|65192761|FG002|Overall Study|Lack of Efficacy|3|||
23394933|NCT01358734|65192759|FG000|Overall Study|Withdrawal by Subject|1|||
23394934|NCT01358734|65192760|FG001|Overall Study|Withdrawal by Subject|6|||
23394935|NCT01358734|65192761|FG002|Overall Study|Withdrawal by Subject|3|||
23394936|NCT01358734|65192759|FG000|Overall Study|Death|3|||
23394937|NCT01358734|65192760|FG001|Overall Study|Death|7|||
23394938|NCT01358734|65192761|FG002|Overall Study|Death|2|||
23394939|NCT01358734|65192759|FG000|Overall Study|Progressive Disease|5|||
23394940|NCT01358734|65192760|FG001|Overall Study|Progressive Disease|13|||
23394941|NCT01358734|65192761|FG002|Overall Study|Progressive Disease|16|||
23394942|NCT01358734|65192759|FG000|Overall Study|Non-compliance with study drug|0|||
23394943|NCT01358734|65192760|FG001|Overall Study|Non-compliance with study drug|0|||
23394944|NCT01358734|65192761|FG002|Overall Study|Non-compliance with study drug|1|||
23394945|NCT01358734|65192759|FG000|Overall Study|Other|2|||
23394946|NCT01358734|65192760|FG001|Overall Study|Other|5|||
23394947|NCT01358734|65192761|FG002|Overall Study|Other|4|||
23394948|NCT01358734|65192759|FG000|Overall Study|Protocol Violation|0|||
23394949|NCT01358734|65192760|FG001|Overall Study|Protocol Violation|0|||
23394950|NCT01358734|65192761|FG002|Overall Study|Protocol Violation|2|||
23394951|NCT02448381|65192763|FG000|Overall Study|Adverse Event|2|||
23394952|NCT02448381|65192764|FG001|Overall Study|Adverse Event|0|||
23394953|NCT02448381|65192763|FG000|Overall Study|Lost to Follow-up|16|||
23394954|NCT02448381|65192764|FG001|Overall Study|Lost to Follow-up|9|||
23394955|NCT02448381|65192763|FG000|Overall Study|Physician Decision|1|||
23394956|NCT02448381|65192764|FG001|Overall Study|Physician Decision|1|||
23394957|NCT02448381|65192763|FG000|Overall Study|Pregnancy|1|||
23394958|NCT02448381|65192764|FG001|Overall Study|Pregnancy|0|||
23394959|NCT02448381|65192763|FG000|Overall Study|Withdrawal by Subject|13|||
23394960|NCT02448381|65192764|FG001|Overall Study|Withdrawal by Subject|9|||
23394961|NCT02448381|65192763|FG000|Overall Study|Noncompliance with Study Procedures|2|||
23394962|NCT02448381|65192764|FG001|Overall Study|Noncompliance with Study Procedures|0|||
23394963|NCT00982280|65192767|FG000|Observation Period|Not eligible to be dosed|19|||
23394964|NCT00982280|65192767|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
23394965|NCT00982280|65192767|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
23394966|NCT00982280|65192767|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
23394967|NCT00982280|65192767|FG000|Maintenance Period|Adverse Event|1|||
23394968|NCT03078868|65192768|FG000|Overall Study|Physician Decision|3|||
23394969|NCT04123704|65192769|FG000|Overall Study|Disease progression|2|||
23394970|NCT00321932|65192770|FG000|Overall Study|Death|3|||
23394971|NCT00321932|65192771|FG001|Overall Study|Death|6|||
23394972|NCT00321932|65192770|FG000|Overall Study|Withdrawal by Subject|3|||
23394973|NCT00321932|65192771|FG001|Overall Study|Withdrawal by Subject|6|||
23394974|NCT00321932|65192770|FG000|Overall Study|Early relapse|2|||
23394975|NCT00321932|65192771|FG001|Overall Study|Early relapse|8|||
23394976|NCT00321932|65192770|FG000|Overall Study|Missing data|2|||
23394977|NCT00321932|65192771|FG001|Overall Study|Missing data|1|||
23394978|NCT03427619|65192772|FG000|Overall Study|Physician Decision|3|||
23394979|NCT03427619|65192772|FG000|Overall Study|Withdrawal by Subject|4|||
23394980|NCT03427619|65192772|FG000|Overall Study|Lost to Follow-up|5|||
23394981|NCT03427619|65192772|FG000|Overall Study|Administrative|4|||
23394982|NCT03427619|65192772|FG000|Overall Study|Other|2|||
23394983|NCT03427619|65192772|FG000|Overall Study|Unknown or Missing Completion Status|48|||
23394984|NCT02552225|65192773|FG000|Overall Study|Withdrawal by Subject|1|||
23394985|NCT02552225|65192774|FG001|Overall Study|Withdrawal by Subject|0|||
23394986|NCT03033784|65192775|FG000|Overall Study|Anxiety related to MRI scanner|0|||
23394987|NCT03033784|65192776|FG001|Overall Study|Anxiety related to MRI scanner|1|||
23394988|NCT03033784|65192777|FG002|Overall Study|Anxiety related to MRI scanner|0|||
23394989|NCT03033784|65192778|FG003|Overall Study|Anxiety related to MRI scanner|0|||
23394990|NCT03033784|65192779|FG004|Overall Study|Anxiety related to MRI scanner|0|||
23394991|NCT03033784|65192780|FG005|Overall Study|Anxiety related to MRI scanner|0|||
23394992|NCT03033784|65192781|FG006|Overall Study|Anxiety related to MRI scanner|0|||
23394993|NCT03033784|65192782|FG007|Overall Study|Anxiety related to MRI scanner|0|||
23394994|NCT03033784|65192783|FG008|Overall Study|Anxiety related to MRI scanner|0|||
23394995|NCT03033784|65192784|FG009|Overall Study|Anxiety related to MRI scanner|0|||
23394996|NCT03033784|65192785|FG010|Overall Study|Anxiety related to MRI scanner|0|||
23394997|NCT03033784|65192786|FG011|Overall Study|Anxiety related to MRI scanner|0|||
23394998|NCT03033784|65192787|FG012|Overall Study|Anxiety related to MRI scanner|0|||
23394999|NCT03033784|65192775|FG000|Overall Study|Withdrawal by Subject|0|||
23395000|NCT03033784|65192776|FG001|Overall Study|Withdrawal by Subject|0|||
23395001|NCT03033784|65192777|FG002|Overall Study|Withdrawal by Subject|0|||
23395002|NCT03033784|65192778|FG003|Overall Study|Withdrawal by Subject|0|||
23395003|NCT03033784|65192779|FG004|Overall Study|Withdrawal by Subject|0|||
23395004|NCT03033784|65192780|FG005|Overall Study|Withdrawal by Subject|0|||
23395005|NCT03033784|65192781|FG006|Overall Study|Withdrawal by Subject|0|||
23395006|NCT03033784|65192782|FG007|Overall Study|Withdrawal by Subject|0|||
23395007|NCT03033784|65192783|FG008|Overall Study|Withdrawal by Subject|0|||
23395008|NCT03033784|65192784|FG009|Overall Study|Withdrawal by Subject|0|||
23395009|NCT03033784|65192785|FG010|Overall Study|Withdrawal by Subject|0|||
23395010|NCT03033784|65192786|FG011|Overall Study|Withdrawal by Subject|0|||
23395011|NCT03033784|65192787|FG012|Overall Study|Withdrawal by Subject|2|||
23395012|NCT03456076|65192788|FG000|Overall Study|Withdrawal by Subject|5|||
23395013|NCT03456076|65192789|FG001|Overall Study|Withdrawal by Subject|9|||
23395014|NCT03456076|65192788|FG000|Overall Study|Protocol deviation|0|||
23395015|NCT03456076|65192789|FG001|Overall Study|Protocol deviation|1|||
23395016|NCT03456076|65192788|FG000|Overall Study|Lost to Follow-up|0|||
23395017|NCT03456076|65192789|FG001|Overall Study|Lost to Follow-up|1|||
23395018|NCT03456076|65192788|FG000|Overall Study|Death|2|||
23395019|NCT03456076|65192789|FG001|Overall Study|Death|5|||
23395020|NCT03456076|65192788|FG000|Overall Study|Study ongoing|123|||
23395021|NCT03456076|65192789|FG001|Overall Study|Study ongoing|111|||
23395022|NCT00730327|65192790|FG000|Overall Study|Lost to Follow-up|14|||
23395023|NCT00730327|65192791|FG001|Overall Study|Lost to Follow-up|16|||
23395024|NCT00730327|65192790|FG000|Overall Study|Adverse Event|8|||
23395025|NCT00730327|65192791|FG001|Overall Study|Adverse Event|1|||
23395026|NCT00730327|65192790|FG000|Overall Study|Withdrawal by Subject|3|||
23395027|NCT00730327|65192791|FG001|Overall Study|Withdrawal by Subject|13|||
23395028|NCT00730327|65192790|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
23395029|NCT00730327|65192791|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
23395030|NCT03895372|65192792|FG000|Investigational Treatment Period|Adverse Event|1|||
23395031|NCT03895372|65192793|FG001|Investigational Treatment Period|Adverse Event|0|||
23395032|NCT03895372|65192794|FG002|Investigational Treatment Period|Adverse Event|0|||
23395033|NCT03895372|65192795|FG003|Investigational Treatment Period|Adverse Event|0|||
23395034|NCT03895372|65192796|FG004|Investigational Treatment Period|Adverse Event|0|||
23395035|NCT03895372|65192797|FG005|Investigational Treatment Period|Adverse Event|0|||
23395036|NCT03895372|65192798|FG006|Investigational Treatment Period|Adverse Event|4|||
23395037|NCT03895372|65192799|FG007|Investigational Treatment Period|Adverse Event|3|||
23395038|NCT03895372|65192792|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
23395039|NCT03895372|65192793|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
23395040|NCT03895372|65192794|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
23395041|NCT03895372|65192795|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
23395042|NCT03895372|65192796|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
23395043|NCT03895372|65192797|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
23395044|NCT03895372|65192798|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
23395045|NCT03895372|65192799|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
23395046|NCT03895372|65192792|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
23395047|NCT03895372|65192793|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
23395048|NCT03895372|65192794|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
23395049|NCT03895372|65192795|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
23395050|NCT03895372|65192796|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
23395051|NCT03895372|65192797|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
23395052|NCT03895372|65192798|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
23395053|NCT03895372|65192799|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
23395054|NCT03895372|65192792|FG000|Investigational Treatment Period|Other|0|||
23395055|NCT03895372|65192793|FG001|Investigational Treatment Period|Other|0|||
23395056|NCT03895372|65192794|FG002|Investigational Treatment Period|Other|0|||
23395057|NCT03895372|65192795|FG003|Investigational Treatment Period|Other|0|||
23395058|NCT03895372|65192796|FG004|Investigational Treatment Period|Other|0|||
23395059|NCT03895372|65192797|FG005|Investigational Treatment Period|Other|1|||
23395060|NCT03895372|65192798|FG006|Investigational Treatment Period|Other|0|||
23395061|NCT03895372|65192799|FG007|Investigational Treatment Period|Other|2|||
23395062|NCT03895372|65192792|FG000|Investigational Treatment Period|Protocol Violation|0|||
23395063|NCT03895372|65192793|FG001|Investigational Treatment Period|Protocol Violation|0|||
23395064|NCT03895372|65192794|FG002|Investigational Treatment Period|Protocol Violation|0|||
23395065|NCT03895372|65192795|FG003|Investigational Treatment Period|Protocol Violation|1|||
23395066|NCT03895372|65192796|FG004|Investigational Treatment Period|Protocol Violation|0|||
23395067|NCT03895372|65192797|FG005|Investigational Treatment Period|Protocol Violation|0|||
23395068|NCT03895372|65192798|FG006|Investigational Treatment Period|Protocol Violation|0|||
23395069|NCT03895372|65192799|FG007|Investigational Treatment Period|Protocol Violation|0|||
23395070|NCT03895372|65192792|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
23395071|NCT03895372|65192793|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
23395072|NCT03895372|65192794|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
23606341|NCT02332824|65947221|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
23606342|NCT02332824|65947216|FG000|Overall Study|Voluntary Withdrawal|1|||
23606343|NCT02332824|65947217|FG001|Overall Study|Voluntary Withdrawal|0|||
23606344|NCT02332824|65947218|FG002|Overall Study|Voluntary Withdrawal|0|||
23606345|NCT02332824|65947219|FG003|Overall Study|Voluntary Withdrawal|0|||
23606346|NCT02332824|65947220|FG004|Overall Study|Voluntary Withdrawal|0|||
23606347|NCT02332824|65947221|FG005|Overall Study|Voluntary Withdrawal|0|||
23606348|NCT02332824|65947216|FG000|Overall Study|Inconvenient schedule|1|||
23606349|NCT02332824|65947217|FG001|Overall Study|Inconvenient schedule|1|||
23606350|NCT02332824|65947218|FG002|Overall Study|Inconvenient schedule|0|||
23606351|NCT02332824|65947219|FG003|Overall Study|Inconvenient schedule|0|||
23606352|NCT02332824|65947220|FG004|Overall Study|Inconvenient schedule|0|||
23606353|NCT02332824|65947221|FG005|Overall Study|Inconvenient schedule|0|||
23606354|NCT02332824|65947216|FG000|Overall Study|Transfer|0|||
23606355|NCT02332824|65947217|FG001|Overall Study|Transfer|0|||
23606356|NCT02332824|65947218|FG002|Overall Study|Transfer|1|||
23606357|NCT02332824|65947219|FG003|Overall Study|Transfer|1|||
23606358|NCT02332824|65947220|FG004|Overall Study|Transfer|0|||
23606359|NCT02332824|65947221|FG005|Overall Study|Transfer|0|||
23606360|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
23606361|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
23606362|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Death|2|||
23606363|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
23606364|NCT01698918|65947222|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
23606365|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
23606366|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
23606367|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Death|1|||
23606368|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
23606369|NCT01698918|65947222|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
23606370|NCT02833948|65947223|FG000|Overall Study|Death|2|||
23606371|NCT02833948|65947224|FG001|Overall Study|Death|3|||
23606372|NCT02833948|65947223|FG000|Overall Study|were not scanned|8|||
23606373|NCT02833948|65947224|FG001|Overall Study|were not scanned|13|||
23606374|NCT02833948|65947223|FG000|Overall Study|scans could not be evaluated|5|||
23606375|NCT02833948|65947224|FG001|Overall Study|scans could not be evaluated|2|||
23606376|NCT00659373|65947232|FG000|Overall Study|Withdrawal by Subject|3|||
23606377|NCT00659373|65947233|FG001|Overall Study|Withdrawal by Subject|5|||
23606378|NCT00659373|65947232|FG000|Overall Study|Assessment Missed|2|||
23606379|NCT00659373|65947233|FG001|Overall Study|Assessment Missed|2|||
23606380|NCT02958553|65947235|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
23606381|NCT02958553|65947235|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
23606382|NCT00551421|65947236|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
23606383|NCT02309892|65947237|FG000|Overall Study|Physician Decision|1|||
23395073|NCT03895372|65192795|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
23395074|NCT03895372|65192796|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
23395075|NCT03895372|65192797|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
23395076|NCT03895372|65192798|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
23395077|NCT03895372|65192799|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
23395078|NCT03895372|65192792|FG000|Extension Treatment Period|Adverse Event|0|||
23395079|NCT03895372|65192793|FG001|Extension Treatment Period|Adverse Event|1|||
23395080|NCT03895372|65192794|FG002|Extension Treatment Period|Adverse Event|0|||
23395081|NCT03895372|65192795|FG003|Extension Treatment Period|Adverse Event|1|||
23395082|NCT03895372|65192796|FG004|Extension Treatment Period|Adverse Event|0|||
23395083|NCT03895372|65192797|FG005|Extension Treatment Period|Adverse Event|0|||
23395084|NCT03895372|65192798|FG006|Extension Treatment Period|Adverse Event|3|||
23395085|NCT03895372|65192799|FG007|Extension Treatment Period|Adverse Event|3|||
23395086|NCT03895372|65192792|FG000|Extension Treatment Period|Other|1|||
23395087|NCT03895372|65192793|FG001|Extension Treatment Period|Other|3|||
23395088|NCT03895372|65192794|FG002|Extension Treatment Period|Other|0|||
23395089|NCT03895372|65192795|FG003|Extension Treatment Period|Other|0|||
23395090|NCT03895372|65192796|FG004|Extension Treatment Period|Other|1|||
23395091|NCT03895372|65192797|FG005|Extension Treatment Period|Other|0|||
23395092|NCT03895372|65192798|FG006|Extension Treatment Period|Other|0|||
23395093|NCT03895372|65192799|FG007|Extension Treatment Period|Other|2|||
23395094|NCT03895372|65192792|FG000|Extension Treatment Period|Pregnancy|0|||
23395095|NCT03895372|65192793|FG001|Extension Treatment Period|Pregnancy|0|||
23395096|NCT03895372|65192794|FG002|Extension Treatment Period|Pregnancy|0|||
23395097|NCT03895372|65192795|FG003|Extension Treatment Period|Pregnancy|0|||
23395098|NCT03895372|65192796|FG004|Extension Treatment Period|Pregnancy|1|||
23395099|NCT03895372|65192797|FG005|Extension Treatment Period|Pregnancy|0|||
23395100|NCT03895372|65192798|FG006|Extension Treatment Period|Pregnancy|0|||
23395101|NCT03895372|65192799|FG007|Extension Treatment Period|Pregnancy|0|||
23395102|NCT03895372|65192792|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
23395103|NCT03895372|65192793|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
23395104|NCT03895372|65192794|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
23395105|NCT03895372|65192795|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
23395106|NCT03895372|65192796|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
23395107|NCT03895372|65192797|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
23395108|NCT03895372|65192798|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
23395109|NCT03895372|65192799|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
23395110|NCT02989857|65192801|FG000|Randomization Phase|Not Treated|3|||
23395111|NCT02989857|65192802|FG001|Randomization Phase|Not Treated|2|||
23498533|NCT04066023|65566358|FG000|Overall Study|Lost to Follow-up|0|||
23395112|NCT02989857|65192803|FG002|Randomization Phase|Not Treated|0|||
23395113|NCT03552029|65192804|FG000|Overall Study|Death|3|||
23395114|NCT03552029|65192805|FG001|Overall Study|Death|0|||
23300506|NCT02549573|64842812|FG001|Overall Study|Protocol Violation|1|||
23300507|NCT00292188|64842818|FG000|Single-Blind|Adverse Event|14|||
23395115|NCT03552029|65192804|FG000|Overall Study|Adverse Event|1|||
23498534|NCT04066023|65566359|FG001|Overall Study|Lost to Follow-up|1|||
23300508|NCT00292188|64842819|FG001|Single-Blind|Adverse Event|0|||
23300509|NCT00292188|64842820|FG002|Single-Blind|Adverse Event|0|||
23300510|NCT00292188|64842818|FG000|Single-Blind|Lack of Efficacy|2|||
23300511|NCT00292188|64842819|FG001|Single-Blind|Lack of Efficacy|0|||
23300512|NCT00292188|64842820|FG002|Single-Blind|Lack of Efficacy|0|||
23300513|NCT00292188|64842818|FG000|Single-Blind|Laboratory Abnormality|5|||
23300514|NCT00292188|64842819|FG001|Single-Blind|Laboratory Abnormality|0|||
23300515|NCT00292188|64842820|FG002|Single-Blind|Laboratory Abnormality|0|||
23300516|NCT00292188|64842818|FG000|Single-Blind|Lost to Follow-up|3|||
23300517|NCT00292188|64842819|FG001|Single-Blind|Lost to Follow-up|0|||
23300518|NCT00292188|64842820|FG002|Single-Blind|Lost to Follow-up|0|||
23300519|NCT00292188|64842818|FG000|Single-Blind|Other|77|||
23300520|NCT00292188|64842819|FG001|Single-Blind|Other|0|||
23300521|NCT00292188|64842820|FG002|Single-Blind|Other|0|||
23300522|NCT00292188|64842818|FG000|Single-Blind|Withdrawal by Subject|12|||
23300523|NCT00292188|64842819|FG001|Single-Blind|Withdrawal by Subject|0|||
23300524|NCT00292188|64842820|FG002|Single-Blind|Withdrawal by Subject|0|||
23300525|NCT00292188|64842818|FG000|Single-Blind|Did not receive treatment|1|||
23300526|NCT00292188|64842819|FG001|Single-Blind|Did not receive treatment|0|||
23300527|NCT00292188|64842820|FG002|Single-Blind|Did not receive treatment|0|||
23300528|NCT00292188|64842818|FG000|Double-Blind|Adverse Event|0|||
23300529|NCT00292188|64842819|FG001|Double-Blind|Adverse Event|25|||
23300530|NCT00292188|64842820|FG002|Double-Blind|Adverse Event|9|||
23300531|NCT00292188|64842818|FG000|Double-Blind|Lack of Efficacy|0|||
23300532|NCT00292188|64842819|FG001|Double-Blind|Lack of Efficacy|2|||
23300533|NCT00292188|64842820|FG002|Double-Blind|Lack of Efficacy|12|||
23300534|NCT00292188|64842818|FG000|Double-Blind|Lost to Follow-up|0|||
23300535|NCT00292188|64842819|FG001|Double-Blind|Lost to Follow-up|1|||
23300536|NCT00292188|64842820|FG002|Double-Blind|Lost to Follow-up|0|||
23300537|NCT00292188|64842818|FG000|Double-Blind|Other|0|||
23300538|NCT00292188|64842819|FG001|Double-Blind|Other|3|||
23300539|NCT00292188|64842820|FG002|Double-Blind|Other|4|||
23300540|NCT00292188|64842818|FG000|Double-Blind|Withdrawal by Subject|0|||
23300541|NCT00292188|64842819|FG001|Double-Blind|Withdrawal by Subject|0|||
23300542|NCT00292188|64842820|FG002|Double-Blind|Withdrawal by Subject|3|||
23300543|NCT00292188|64842818|FG000|Double-Blind|Laboratory Abnormality|0|||
23300544|NCT00292188|64842819|FG001|Double-Blind|Laboratory Abnormality|0|||
23300545|NCT00292188|64842820|FG002|Double-Blind|Laboratory Abnormality|1|||
23300546|NCT01481324|64842821|FG000|Overall Study|Missing Data|0|||
23300547|NCT01481324|64842822|FG001|Overall Study|Missing Data|2|||
23300548|NCT01481324|64842823|FG002|Overall Study|Missing Data|2|||
23300549|NCT02041091|64842824|FG000|Treatment|Adverse Event|3|||
23300550|NCT02041091|64842825|FG001|Treatment|Adverse Event|3|||
23395116|NCT03552029|65192805|FG001|Overall Study|Adverse Event|0|||
23395117|NCT03552029|65192804|FG000|Overall Study|Lack of Efficacy|0|||
23395118|NCT03552029|65192805|FG001|Overall Study|Lack of Efficacy|2|||
23395119|NCT03552029|65192804|FG000|Overall Study|Physician Decision|0|||
23395120|NCT03552029|65192805|FG001|Overall Study|Physician Decision|1|||
23395121|NCT03552029|65192804|FG000|Overall Study|Study terminated by Sponsor|0|||
23395122|NCT03552029|65192805|FG001|Overall Study|Study terminated by Sponsor|1|||
23395123|NCT03552029|65192804|FG000|Overall Study|Other|0|||
23395124|NCT03552029|65192805|FG001|Overall Study|Other|2|||
23395125|NCT00829244|65192806|FG000|Overall Study|Adverse Event|1|||
23395126|NCT00829244|65192807|FG001|Overall Study|Adverse Event|3|||
23395127|NCT00829244|65192806|FG000|Overall Study|Protocol Violation|1|||
23395128|NCT00829244|65192807|FG001|Overall Study|Protocol Violation|0|||
23395129|NCT00829244|65192806|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
23395130|NCT00829244|65192807|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
23395131|NCT00829244|65192806|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
23395132|NCT00829244|65192807|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
23395133|NCT00829244|65192806|FG000|Overall Study|No fertilization|2|||
23395134|NCT00829244|65192807|FG001|Overall Study|No fertilization|2|||
23395135|NCT00829244|65192806|FG000|Overall Study|All embryos discarded|0|||
23395136|NCT00829244|65192807|FG001|Overall Study|All embryos discarded|3|||
23395137|NCT00829244|65192806|FG000|Overall Study|No embryo cleavage|0|||
23395138|NCT00829244|65192807|FG001|Overall Study|No embryo cleavage|2|||
23395139|NCT00105066|65192816|FG000|Overall Study|Adverse Event|2|||
23395140|NCT00105066|65192817|FG001|Overall Study|Adverse Event|5|||
23395141|NCT00936936|65192818|FG000|Overall Study|Adverse Event|7|||
23395142|NCT00936936|65192819|FG001|Overall Study|Adverse Event|1|||
23395143|NCT00936936|65192818|FG000|Overall Study|Disease Progression|2|||
23395144|NCT00936936|65192819|FG001|Overall Study|Disease Progression|2|||
23395145|NCT00936936|65192818|FG000|Overall Study|Unrelated|3|||
23395146|NCT00936936|65192819|FG001|Overall Study|Unrelated|1|||
23395147|NCT02213926|65192822|FG000|Overall Study|Death|59|||
23395148|NCT02213926|65192822|FG000|Overall Study|Withdrawal by Subject|10|||
23395149|NCT02213926|65192822|FG000|Overall Study|study terminated by sponsor|51|||
23395150|NCT02213926|65192822|FG000|Overall Study|Lost to Follow-up|3|||
23395151|NCT02213926|65192822|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
23395152|NCT04016714|65192825|FG000|Overall Study|Death|1|||
23395153|NCT04016714|65192826|FG001|Overall Study|Death|0|||
23395154|NCT04016714|65192825|FG000|Overall Study|Lost to Follow-up|3|||
23395155|NCT04016714|65192826|FG001|Overall Study|Lost to Follow-up|1|||
23395156|NCT04016714|65192825|FG000|Overall Study|Physician Decision|3|||
23395157|NCT04016714|65192826|FG001|Overall Study|Physician Decision|3|||
23395158|NCT04016714|65192825|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
23395159|NCT04016714|65192826|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
23395160|NCT00381641|65192827|FG000|Overall Study|Withdrawal by Subject|0|||
23395161|NCT00381641|65192828|FG001|Overall Study|Withdrawal by Subject|2|||
23395162|NCT00835172|65192832|FG000|Washout|Protocol Violation|0|||
23395163|NCT00835172|65192833|FG001|Washout|Protocol Violation|1|||
23395164|NCT00618787|65192836|FG000|Overall Study|Adverse Event|0|||
23395165|NCT00618787|65192837|FG001|Overall Study|Adverse Event|1|||
23395166|NCT00618787|65192836|FG000|Overall Study|Withdrawal by Subject|2|||
23395167|NCT00618787|65192837|FG001|Overall Study|Withdrawal by Subject|1|||
23395168|NCT00618787|65192836|FG000|Overall Study|Lost to Follow-up|1|||
23395169|NCT00618787|65192837|FG001|Overall Study|Lost to Follow-up|0|||
23395170|NCT03802916|65192841|FG000|Overall Study|Adverse Event|0|||
23395171|NCT03802916|65192842|FG001|Overall Study|Adverse Event|1|||
23395172|NCT03802916|65192841|FG000|Overall Study|Withdrawal by Subject|0|||
23395173|NCT03802916|65192842|FG001|Overall Study|Withdrawal by Subject|1|||
23395174|NCT00457626|65192849|FG000|Overall Study|Adverse Event|3|||
23395175|NCT00457626|65192849|FG000|Overall Study|Administrative Problems|2|||
23498535|NCT04066023|65566360|FG002|Overall Study|Lost to Follow-up|1|||
23395176|NCT00457626|65192849|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
23395177|NCT00652834|65192850|FG000|Overall Study|Withdrawal by Subject|3|||
23395178|NCT00652834|65192850|FG000|Overall Study|Lost to Follow-up|2|||
23395179|NCT03685149|65192852|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
23395180|NCT03685149|65192853|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
23395181|NCT03685149|65192852|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
23395182|NCT03685149|65192853|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
23395183|NCT03685149|65192852|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
23395184|NCT03685149|65192853|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
23395185|NCT02374255|65192854|FG000|Overall Study|Withdrawal by Subject|2|||
23395186|NCT02374255|65192855|FG001|Overall Study|Withdrawal by Subject|0|||
23395187|NCT02374255|65192856|FG002|Overall Study|Withdrawal by Subject|0|||
23395188|NCT02374255|65192857|FG003|Overall Study|Withdrawal by Subject|0|||
23498536|NCT04066023|65566358|FG000|Overall Study|Noncompliance|0|||
23395189|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Adverse Event|6|||
23395190|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Adverse Event|15|||
23395191|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Adverse Event|0|||
23395192|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Death|0|||
23395193|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Death|2|||
23395194|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Death|0|||
23395195|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
23395196|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
23395197|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
23395198|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
23395199|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
23395200|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
23395201|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Physician Decision|1|||
23395202|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Physician Decision|1|||
23395203|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Physician Decision|0|||
23395204|NCT02921256|65192863|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
23395205|NCT02921256|65192864|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
23395206|NCT02921256|65192865|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
23395207|NCT02921256|65192863|FG000|Arm Ib v Arm III|Adverse Event|9|||
23395208|NCT02921256|65192864|FG001|Arm Ib v Arm III|Adverse Event|0|||
23395209|NCT02921256|65192865|FG002|Arm Ib v Arm III|Adverse Event|4|||
23395210|NCT02921256|65192863|FG000|Arm Ib v Arm III|Death|1|||
23395211|NCT02921256|65192864|FG001|Arm Ib v Arm III|Death|0|||
23395212|NCT02921256|65192865|FG002|Arm Ib v Arm III|Death|1|||
23395213|NCT02921256|65192863|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
23395214|NCT02921256|65192864|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
23395215|NCT02921256|65192865|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
23395216|NCT02921256|65192863|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
23395217|NCT02921256|65192864|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
23395218|NCT02921256|65192865|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
23395219|NCT02921256|65192863|FG000|Arm Ib v Arm III|Physician Decision|4|||
23395220|NCT02921256|65192864|FG001|Arm Ib v Arm III|Physician Decision|0|||
23395221|NCT02921256|65192865|FG002|Arm Ib v Arm III|Physician Decision|1|||
23300551|NCT02041091|64842824|FG000|Treatment|Withdrawal by Subject|2|||
23300552|NCT02041091|64842825|FG001|Treatment|Withdrawal by Subject|4|||
23395222|NCT02921256|65192863|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
23395223|NCT02921256|65192864|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
23395224|NCT02921256|65192865|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
23395225|NCT02014376|65192866|FG000|Overall Study|Adverse Event|1|||
23395226|NCT02014376|65192867|FG001|Overall Study|Adverse Event|1|||
23395227|NCT02014376|65192868|FG002|Overall Study|Adverse Event|0|||
23395228|NCT02014376|65192866|FG000|Overall Study|Lost to Follow-up|2|||
23395229|NCT02014376|65192867|FG001|Overall Study|Lost to Follow-up|0|||
23395230|NCT02014376|65192868|FG002|Overall Study|Lost to Follow-up|0|||
23395231|NCT00829998|65192872|FG000|Washout|Adverse Event|0|||
23395232|NCT00829998|65192873|FG001|Washout|Adverse Event|1|||
23395233|NCT03360344|65192874|FG000|Overall Study|Withdrawal by Subject|0|||
23395234|NCT03360344|65192875|FG001|Overall Study|Withdrawal by Subject|1|||
23395235|NCT03360344|65192876|FG002|Overall Study|Withdrawal by Subject|1|||
23395236|NCT01107886|65195577|FG000|Overall Study|Lost to Follow-up|15|||
23395237|NCT01107886|65195578|FG001|Overall Study|Lost to Follow-up|13|||
23395238|NCT01107886|65195577|FG000|Overall Study|Withdrawal by Subject|180|||
23395239|NCT01107886|65195578|FG001|Overall Study|Withdrawal by Subject|196|||
23395240|NCT01107886|65195577|FG000|Overall Study|Administrative withdrawal of consent|7|||
23395241|NCT01107886|65195578|FG001|Overall Study|Administrative withdrawal of consent|5|||
23395242|NCT04507204|65195582|FG000|Overall Study|Adverse Event|8|||
23395243|NCT04507204|65195583|FG001|Overall Study|Adverse Event|13|||
23395244|NCT04507204|65195582|FG000|Overall Study|Death|0|||
23395245|NCT04507204|65195583|FG001|Overall Study|Death|1|||
23395246|NCT04507204|65195582|FG000|Overall Study|Lost to Follow-up|15|||
23395247|NCT04507204|65195583|FG001|Overall Study|Lost to Follow-up|14|||
23395248|NCT04507204|65195582|FG000|Overall Study|Poor Compliance with Protocol|2|||
23395249|NCT04507204|65195583|FG001|Overall Study|Poor Compliance with Protocol|4|||
23395250|NCT04507204|65195582|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
23395251|NCT04507204|65195583|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
23395252|NCT04507204|65195582|FG000|Overall Study|Withdrawal of Patient Consent|21|||
23395253|NCT04507204|65195583|FG001|Overall Study|Withdrawal of Patient Consent|13|||
23395254|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
23395255|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395256|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395257|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395258|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395259|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395260|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
23395261|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
23395262|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
23395263|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
23395264|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
23395265|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
23395266|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
23395267|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
23395268|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
23395269|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
23395270|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
23395271|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
23395272|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
23395273|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
23395274|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
23395275|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
23395276|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
23395277|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
23395278|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
23395279|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
23395280|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
23395281|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
23395282|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
23395283|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
23395284|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
23395285|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
23395286|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
23395287|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
23395288|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
23395289|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
23395290|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
23395291|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
23395292|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
23395293|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
23395294|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
23395295|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
23395296|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
23395297|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395298|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395299|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395300|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395301|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395302|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
23395303|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395304|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
23395305|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395306|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23498537|NCT04066023|65566359|FG001|Overall Study|Noncompliance|1|||
23498538|NCT04066023|65566360|FG002|Overall Study|Noncompliance|1|||
23498539|NCT01313858|65566361|FG000|Overall Study|Premature Treatment Termination|251|||
23498540|NCT01313858|65566362|FG001|Overall Study|Premature Treatment Termination|219|||
23300553|NCT02041091|64842824|FG000|Treatment|Physician Decision|1|||
23395307|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395308|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395309|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
23395310|NCT01362790|65195584|FG000|Pilot Phase & Phase 2|Death on study|0|||
23395311|NCT01362790|65195585|FG001|Pilot Phase & Phase 2|Death on study|0|||
23395312|NCT01362790|65195586|FG002|Pilot Phase & Phase 2|Death on study|0|||
23395313|NCT01362790|65195587|FG003|Pilot Phase & Phase 2|Death on study|1|||
23395314|NCT01362790|65195588|FG004|Pilot Phase & Phase 2|Death on study|0|||
23395315|NCT01362790|65195589|FG005|Pilot Phase & Phase 2|Death on study|0|||
23395316|NCT01362790|65195590|FG006|Pilot Phase & Phase 2|Death on study|0|||
23395317|NCT01362790|65195584|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
23395318|NCT01362790|65195585|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
23395319|NCT01362790|65195586|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
23498541|NCT01313858|65566363|FG002|Overall Study|Premature Treatment Termination|191|||
23498542|NCT01313858|65566361|FG000|Overall Study|Lost to Follow-up|35|||
23300554|NCT02041091|64842825|FG001|Treatment|Physician Decision|0|||
23395320|NCT01362790|65195587|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
23395321|NCT01362790|65195588|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
23395322|NCT01362790|65195589|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
23395323|NCT01362790|65195590|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
23395324|NCT01362790|65195584|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395325|NCT01362790|65195585|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395326|NCT01362790|65195586|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395327|NCT01362790|65195587|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395328|NCT01362790|65195588|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
23395329|NCT01362790|65195589|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395330|NCT01362790|65195590|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
23395331|NCT01362790|65195584|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
23395332|NCT01362790|65195585|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
23395333|NCT01362790|65195586|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
23395334|NCT01362790|65195587|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
23395335|NCT01362790|65195588|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
23395336|NCT01362790|65195589|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
23395337|NCT01362790|65195590|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
23395338|NCT00688740|65195594|FG000|Overall Study|Adverse Event|45|||
23395339|NCT00688740|65195595|FG001|Overall Study|Adverse Event|8|||
23395340|NCT00688740|65195594|FG000|Overall Study|Death|2|||
23395341|NCT00688740|65195595|FG001|Overall Study|Death|2|||
23395342|NCT00688740|65195594|FG000|Overall Study|Lost to Follow-up|0|||
23395343|NCT00688740|65195595|FG001|Overall Study|Lost to Follow-up|1|||
23395344|NCT00688740|65195594|FG000|Overall Study|Consent Withdrawn|17|||
23395345|NCT00688740|65195595|FG001|Overall Study|Consent Withdrawn|17|||
23395346|NCT00688740|65195594|FG000|Overall Study|Breast Cancer Relapse|1|||
23395347|NCT00688740|65195595|FG001|Overall Study|Breast Cancer Relapse|4|||
23395348|NCT00688740|65195594|FG000|Overall Study|Violation of Inclusion Criteria|1|||
23395349|NCT00688740|65195595|FG001|Overall Study|Violation of Inclusion Criteria|3|||
23395350|NCT01121757|65195596|FG000|First Drug|Death|1|||
23395351|NCT01121757|65195597|FG001|First Drug|Death|0|||
23395352|NCT01121757|65195596|FG000|First Drug|Disease Progression|0|||
23395353|NCT01121757|65195597|FG001|First Drug|Disease Progression|2|||
23395354|NCT01121757|65195596|FG000|Combination|Physician Decision|0|||
23395355|NCT01121757|65195597|FG001|Combination|Physician Decision|1|||
23395356|NCT01121757|65195596|FG000|Combination|Disease Progression|2|||
23395357|NCT01121757|65195597|FG001|Combination|Disease Progression|0|||
23395358|NCT00163189|65195599|FG000|Overall Study|Other|6|||
23395359|NCT00163189|65195599|FG000|Overall Study|Lost to Follow-up|1|||
23395360|NCT00163189|65195599|FG000|Overall Study|Protocol Violation|2|||
23395361|NCT00163189|65195599|FG000|Overall Study|Death|3|||
23395362|NCT00163189|65195599|FG000|Overall Study|Adverse Event|6|||
23395363|NCT00163189|65195599|FG000|Overall Study|Lack of Efficacy|7|||
23395364|NCT00163189|65195599|FG000|Overall Study|Study terminated by sponsor|11|||
23395365|NCT00163189|65195599|FG000|Overall Study|Withdrawal by Subject|11|||
23395366|NCT00163189|65195599|FG000|Overall Study|Did not meet continuation criterion|16|||
23395367|NCT02629861|65195601|FG000|Overall Study|Adverse Event|7|||
23395368|NCT02629861|65195602|FG001|Overall Study|Adverse Event|5|||
23395369|NCT02629861|65195603|FG002|Overall Study|Adverse Event|4|||
23395370|NCT02629861|65195601|FG000|Overall Study|Withdrawal by Subject|5|||
23395371|NCT02629861|65195602|FG001|Overall Study|Withdrawal by Subject|8|||
23395372|NCT02629861|65195603|FG002|Overall Study|Withdrawal by Subject|13|||
23395373|NCT02629861|65195601|FG000|Overall Study|Protocol Violation|2|||
23395374|NCT02629861|65195602|FG001|Overall Study|Protocol Violation|3|||
23395375|NCT02629861|65195603|FG002|Overall Study|Protocol Violation|7|||
23395376|NCT02629861|65195601|FG000|Overall Study|Lost to Follow-up|12|||
23395377|NCT02629861|65195602|FG001|Overall Study|Lost to Follow-up|9|||
23395378|NCT02629861|65195603|FG002|Overall Study|Lost to Follow-up|4|||
23395379|NCT02629861|65195601|FG000|Overall Study|Other|1|||
23395380|NCT02629861|65195602|FG001|Overall Study|Other|1|||
23395381|NCT02629861|65195603|FG002|Overall Study|Other|0|||
23395382|NCT02629861|65195601|FG000|Overall Study|Pregnancy|2|||
23395383|NCT02629861|65195602|FG001|Overall Study|Pregnancy|1|||
23395384|NCT02629861|65195603|FG002|Overall Study|Pregnancy|0|||
23395385|NCT02546323|65195611|FG000|Overall Study|Withdrawal by Subject|36|||
23395386|NCT02546323|65195612|FG001|Overall Study|Withdrawal by Subject|33|||
23395387|NCT02546323|65195611|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
23395388|NCT02546323|65195612|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
23395389|NCT02546323|65195611|FG000|Overall Study|Adverse Event|17|||
23395390|NCT02546323|65195612|FG001|Overall Study|Adverse Event|11|||
23395391|NCT02546323|65195611|FG000|Overall Study|Patient Specific Reasons|1|||
23395392|NCT02546323|65195612|FG001|Overall Study|Patient Specific Reasons|2|||
23395393|NCT02546323|65195611|FG000|Overall Study|Lost to Follow-up|2|||
23395394|NCT02546323|65195612|FG001|Overall Study|Lost to Follow-up|3|||
23395395|NCT02546323|65195611|FG000|Overall Study|Non-compliance with Study Drug|2|||
23395396|NCT02546323|65195612|FG001|Overall Study|Non-compliance with Study Drug|2|||
23395397|NCT02546323|65195611|FG000|Overall Study|Met Withdrawal Criteria|2|||
23395398|NCT02546323|65195612|FG001|Overall Study|Met Withdrawal Criteria|14|||
23395399|NCT02993263|65195615|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
23395400|NCT00567502|65195616|FG000|Overall Study|Lost to Follow-up|91|||
23395401|NCT00567502|65195617|FG001|Overall Study|Lost to Follow-up|14|||
23395402|NCT00567502|65195618|FG002|Overall Study|Lost to Follow-up|351|||
23395403|NCT00567502|65195619|FG003|Overall Study|Lost to Follow-up|2|||
23395404|NCT00567502|65195616|FG000|Overall Study|Death|65|||
23395405|NCT00567502|65195617|FG001|Overall Study|Death|16|||
23395406|NCT00567502|65195618|FG002|Overall Study|Death|360|||
23395407|NCT00567502|65195619|FG003|Overall Study|Death|5|||
23395408|NCT00567502|65195616|FG000|Overall Study|Other|64|||
23395409|NCT00567502|65195617|FG001|Overall Study|Other|2|||
23395410|NCT00567502|65195618|FG002|Overall Study|Other|134|||
23395411|NCT00567502|65195619|FG003|Overall Study|Other|6|||
23395412|NCT00567502|65195616|FG000|Overall Study|Participant request|12|||
23395413|NCT00567502|65195617|FG001|Overall Study|Participant request|1|||
23395414|NCT00567502|65195618|FG002|Overall Study|Participant request|33|||
23395415|NCT00567502|65195619|FG003|Overall Study|Participant request|1|||
23395416|NCT00567502|65195616|FG000|Overall Study|Sponsor request|9|||
23395417|NCT00567502|65195617|FG001|Overall Study|Sponsor request|0|||
23395418|NCT00567502|65195618|FG002|Overall Study|Sponsor request|30|||
23395419|NCT00567502|65195619|FG003|Overall Study|Sponsor request|1|||
23395420|NCT00567502|65195616|FG000|Overall Study|Never Initiated Treatment|0|||
23395421|NCT00567502|65195617|FG001|Overall Study|Never Initiated Treatment|0|||
23395422|NCT00567502|65195618|FG002|Overall Study|Never Initiated Treatment|0|||
23395423|NCT00567502|65195619|FG003|Overall Study|Never Initiated Treatment|72|||
23395424|NCT01148771|65195620|FG000|Washout Period|Withdrawal by Subject|0|||
23395425|NCT01148771|65195621|FG001|Washout Period|Withdrawal by Subject|1|||
23395426|NCT03122184|65195622|FG000|Overall Study|Lost to Follow-up|4|||
23395427|NCT03122184|65195623|FG001|Overall Study|Lost to Follow-up|6|||
23395428|NCT03122184|65195622|FG000|Overall Study|Withdrawal by Subject|3|||
23395429|NCT03122184|65195623|FG001|Overall Study|Withdrawal by Subject|0|||
23395430|NCT03122184|65195622|FG000|Overall Study|Terminated due to cognitive problem|1|||
23395431|NCT03122184|65195623|FG001|Overall Study|Terminated due to cognitive problem|0|||
23395432|NCT00404248|65195624|FG000|Overall Study|pts declining status|0|||
23395433|NCT00404248|65195625|FG001|Overall Study|pts declining status|1|||
23395434|NCT00404248|65195626|FG002|Overall Study|pts declining status|0|||
23395435|NCT00404248|65195627|FG003|Overall Study|pts declining status|0|||
23395436|NCT00404248|65195628|FG004|Overall Study|pts declining status|0|||
23395437|NCT00404248|65195629|FG005|Overall Study|pts declining status|0|||
23395438|NCT00404248|65195630|FG006|Overall Study|pts declining status|0|||
23395439|NCT00404248|65195631|FG007|Overall Study|pts declining status|0|||
23395440|NCT00404248|65195632|FG008|Overall Study|pts declining status|0|||
23395441|NCT03391882|65195635|FG000|Study Overall|Adverse Event|3|||
23395442|NCT03391882|65195636|FG001|Study Overall|Adverse Event|6|||
23395443|NCT03391882|65195637|FG002|Study Overall|Adverse Event|1|||
23395444|NCT03391882|65195638|FG003|Study Overall|Adverse Event|1|||
23395445|NCT03391882|65195639|FG004|Study Overall|Adverse Event|3|||
23395446|NCT03391882|65195640|FG005|Study Overall|Adverse Event|1|||
23395447|NCT03391882|65195635|FG000|Study Overall|Lack of Efficacy|13|||
23395448|NCT03391882|65195636|FG001|Study Overall|Lack of Efficacy|9|||
23395449|NCT03391882|65195637|FG002|Study Overall|Lack of Efficacy|0|||
23395450|NCT03391882|65195638|FG003|Study Overall|Lack of Efficacy|0|||
23395451|NCT03391882|65195639|FG004|Study Overall|Lack of Efficacy|0|||
23395452|NCT03391882|65195640|FG005|Study Overall|Lack of Efficacy|0|||
23395453|NCT03391882|65195635|FG000|Study Overall|Withdrawal by Subject|3|||
23395454|NCT03391882|65195636|FG001|Study Overall|Withdrawal by Subject|3|||
23395455|NCT03391882|65195637|FG002|Study Overall|Withdrawal by Subject|2|||
23395456|NCT03391882|65195638|FG003|Study Overall|Withdrawal by Subject|2|||
23395457|NCT03391882|65195639|FG004|Study Overall|Withdrawal by Subject|1|||
23395458|NCT03391882|65195640|FG005|Study Overall|Withdrawal by Subject|3|||
23395459|NCT03391882|65195635|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23498543|NCT01313858|65566362|FG001|Overall Study|Lost to Follow-up|51|||
23498544|NCT01313858|65566363|FG002|Overall Study|Lost to Follow-up|47|||
23395460|NCT03391882|65195636|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
23395461|NCT03391882|65195637|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23395462|NCT03391882|65195638|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23395463|NCT03391882|65195639|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23395464|NCT03391882|65195640|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
23395465|NCT03391882|65195635|FG000|Study Overall|Protocol Violation|1|||
23395466|NCT03391882|65195636|FG001|Study Overall|Protocol Violation|0|||
23395467|NCT03391882|65195637|FG002|Study Overall|Protocol Violation|0|||
23395468|NCT03391882|65195638|FG003|Study Overall|Protocol Violation|0|||
23395469|NCT03391882|65195639|FG004|Study Overall|Protocol Violation|0|||
23395470|NCT03391882|65195640|FG005|Study Overall|Protocol Violation|0|||
23395471|NCT03391882|65195635|FG000|Part A - Titration Phase|Adverse Event|3|||
23395472|NCT03391882|65195636|FG001|Part A - Titration Phase|Adverse Event|6|||
23395473|NCT03391882|65195637|FG002|Part A - Titration Phase|Adverse Event|0|||
23395474|NCT03391882|65195638|FG003|Part A - Titration Phase|Adverse Event|0|||
23498545|NCT00389597|65566364|FG000|Overall Study|Lost to Follow-up|8|||
23498546|NCT00389597|65566365|FG001|Overall Study|Lost to Follow-up|6|||
23395475|NCT03391882|65195639|FG004|Part A - Titration Phase|Adverse Event|0|||
23395476|NCT03391882|65195640|FG005|Part A - Titration Phase|Adverse Event|0|||
23395477|NCT03391882|65195635|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
23395478|NCT03391882|65195636|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
23498547|NCT00389597|65566366|FG002|Overall Study|Lost to Follow-up|4|||
23395479|NCT03391882|65195637|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
23395480|NCT03391882|65195638|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
23395481|NCT03391882|65195639|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
23395482|NCT03391882|65195640|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
23395483|NCT03391882|65195635|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
23395484|NCT03391882|65195636|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
23395485|NCT03391882|65195637|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
23395486|NCT03391882|65195638|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
23395487|NCT03391882|65195639|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
23395488|NCT03391882|65195640|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
23395489|NCT03391882|65195635|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395490|NCT03391882|65195636|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
23395491|NCT03391882|65195637|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395492|NCT03391882|65195638|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395493|NCT03391882|65195639|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395494|NCT03391882|65195640|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
23395495|NCT03391882|65195635|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
23395496|NCT03391882|65195636|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
23395497|NCT03391882|65195637|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
23395498|NCT03391882|65195638|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
23395499|NCT03391882|65195639|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
23395500|NCT03391882|65195640|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
23395501|NCT03391882|65195635|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
23395502|NCT03391882|65195636|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
23395503|NCT03391882|65195637|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
23395504|NCT03391882|65195638|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
23395505|NCT03391882|65195639|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
23395506|NCT03391882|65195640|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
23395507|NCT03391882|65195635|FG000|Part B - Treatment Phase|Adverse Event|0|||
23395508|NCT03391882|65195636|FG001|Part B - Treatment Phase|Adverse Event|0|||
23395509|NCT03391882|65195637|FG002|Part B - Treatment Phase|Adverse Event|1|||
23395510|NCT03391882|65195638|FG003|Part B - Treatment Phase|Adverse Event|1|||
23395511|NCT03391882|65195639|FG004|Part B - Treatment Phase|Adverse Event|3|||
23395512|NCT03391882|65195640|FG005|Part B - Treatment Phase|Adverse Event|1|||
23395513|NCT03391882|65195635|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
23395514|NCT03391882|65195636|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
23395515|NCT03391882|65195637|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
23395516|NCT03391882|65195638|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
23395517|NCT03391882|65195639|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
23395518|NCT03391882|65195640|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
23395519|NCT02257684|65195641|FG000|Overall Study|Adverse Event|2|||
23395520|NCT02257684|65195641|FG000|Overall Study|Lack of Efficacy|1|||
23395521|NCT02257684|65195641|FG000|Overall Study|Sponsor's Decision|1|||
23395522|NCT04549454|65195642|FG000|T1 to T2|Lost to Follow-up|22|||
23395523|NCT04549454|65195643|FG001|T1 to T2|Lost to Follow-up|26|||
23395524|NCT04549454|65195642|FG000|T1 to T3|Lost to Follow-up|31|||
23395525|NCT04549454|65195643|FG001|T1 to T3|Lost to Follow-up|36|||
23395526|NCT00779909|65195646|FG000|Overall Study|Lost to Follow-up|1|||
23395527|NCT00779909|65195647|FG001|Overall Study|Lost to Follow-up|0|||
23395528|NCT00779909|65195648|FG002|Overall Study|Lost to Follow-up|0|||
23395529|NCT00779909|65195649|FG003|Overall Study|Lost to Follow-up|1|||
23395530|NCT00779909|65195646|FG000|Overall Study|Withdrawal by Subject|0|||
23395531|NCT00779909|65195647|FG001|Overall Study|Withdrawal by Subject|1|||
23395532|NCT00779909|65195648|FG002|Overall Study|Withdrawal by Subject|0|||
23395533|NCT00779909|65195649|FG003|Overall Study|Withdrawal by Subject|0|||
23395534|NCT00565747|65195654|FG000|Overall Study|No embryo transfer|67|||
23395535|NCT00565747|65195655|FG001|Overall Study|No embryo transfer|73|||
23395536|NCT00800735|65195658|FG000|Overall Study|Administrative/Other|2|||
23395537|NCT00800735|65195658|FG000|Overall Study|Insufficient Therapeutic Response|2|||
23395538|NCT00800735|65195658|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
23395539|NCT00800735|65195658|FG000|Overall Study|Withdrew Consent|3|||
23395540|NCT04282148|65195660|FG000|Overall Study|Death|1|||
23395541|NCT04282148|65195660|FG000|Overall Study|Withdrawal by Subject|1|||
23395542|NCT04282148|65195660|FG000|Overall Study|Physician Decision|1|||
23395543|NCT00209131|65195662|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
23395544|NCT00209131|65195663|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
23395545|NCT00760552|65195664|FG000|Overall Study|Death|2|||
23395546|NCT00760552|65195665|FG001|Overall Study|Death|0|||
23395547|NCT00760552|65195664|FG000|Overall Study|Lost to Follow-up|11|||
23395548|NCT00760552|65195665|FG001|Overall Study|Lost to Follow-up|10|||
23395549|NCT03612570|65195666|FG000|Overall Study|Lost to Follow-up|1|||
23395550|NCT04064905|65195667|FG000|Overall Study|Lost to Follow-up|0|||
23395551|NCT04064905|65195668|FG001|Overall Study|Lost to Follow-up|3|||
23395552|NCT04064905|65195669|FG002|Overall Study|Lost to Follow-up|1|||
23498548|NCT00389597|65566367|FG003|Overall Study|Lost to Follow-up|6|||
23606384|NCT02309892|65947238|FG001|Overall Study|Physician Decision|0|||
23395553|NCT04064905|65195670|FG003|Overall Study|Lost to Follow-up|4|||
23395554|NCT04064905|65195671|FG004|Overall Study|Lost to Follow-up|2|||
23395555|NCT00666263|65195672|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
23395556|NCT00666263|65195673|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
23395557|NCT00666263|65195672|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
23395558|NCT00666263|65195673|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
23395559|NCT00666263|65195672|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
23395560|NCT00666263|65195673|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
23395561|NCT01285102|65195674|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
23395562|NCT01972659|65195675|FG000|Overall Study|Protocol Violation|2|||
23395563|NCT01972659|65195676|FG001|Overall Study|Protocol Violation|2|||
23395564|NCT01972659|65195675|FG000|Overall Study|problems realted to acceleromyograph|2|||
23395565|NCT01972659|65195676|FG001|Overall Study|problems realted to acceleromyograph|1|||
23395566|NCT01928433|65195690|FG000|Overall Study|Adverse Event|5|||
23395567|NCT01928433|65195691|FG001|Overall Study|Adverse Event|2|||
23395568|NCT01928433|65195692|FG002|Overall Study|Adverse Event|5|||
23498549|NCT03338010|65566373|FG000|Overall Study|Withdrawal by Subject|14|||
23498550|NCT03338010|65566374|FG001|Overall Study|Withdrawal by Subject|8|||
23498551|NCT03338010|65566373|FG000|Overall Study|Lost to Follow-up|4|||
23498552|NCT03338010|65566374|FG001|Overall Study|Lost to Follow-up|2|||
23498553|NCT03338010|65566373|FG000|Overall Study|Adverse Event|3|||
23498554|NCT03338010|65566374|FG001|Overall Study|Adverse Event|2|||
23498555|NCT03338010|65566373|FG000|Overall Study|Physician Decision|2|||
23498556|NCT03338010|65566374|FG001|Overall Study|Physician Decision|2|||
23498557|NCT03338010|65566373|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23498558|NCT03338010|65566374|FG001|Overall Study|Non-Compliance with Study Drug|3|||
23498559|NCT03338010|65566373|FG000|Overall Study|Protocol Violation|0|||
23498560|NCT03338010|65566374|FG001|Overall Study|Protocol Violation|1|||
23498561|NCT02899299|65566375|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
23498562|NCT02899299|65566376|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
23498563|NCT02899299|65566375|FG000|Pre-treatment|Participant withdrew consent|1|||
23498564|NCT02899299|65566376|FG001|Pre-treatment|Participant withdrew consent|11|||
23498565|NCT02899299|65566375|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
23498566|NCT02899299|65566376|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
23498567|NCT02899299|65566375|FG000|Pre-treatment|Not reported|0|||
23498568|NCT02899299|65566376|FG001|Pre-treatment|Not reported|1|||
23498569|NCT02899299|65566375|FG000|Treatment|Disease Progression|182|||
23498570|NCT02899299|65566376|FG001|Treatment|Disease Progression|43|||
23498571|NCT02899299|65566375|FG000|Treatment|Study Drug Toxicity|60|||
23498572|NCT02899299|65566376|FG001|Treatment|Study Drug Toxicity|24|||
23498573|NCT02899299|65566375|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
23498574|NCT02899299|65566376|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
23498575|NCT02899299|65566375|FG000|Treatment|Participant request to discontinue Study treatment|4|||
23498576|NCT02899299|65566376|FG001|Treatment|Participant request to discontinue Study treatment|10|||
23498577|NCT02899299|65566375|FG000|Treatment|Participant withdrew consent|6|||
23498578|NCT02899299|65566376|FG001|Treatment|Participant withdrew consent|3|||
23498579|NCT02899299|65566375|FG000|Treatment|Lost to Follow-up|0|||
23395569|NCT01928433|65195690|FG000|Overall Study|Protocol Violation|0|||
23395570|NCT01928433|65195691|FG001|Overall Study|Protocol Violation|0|||
23395571|NCT01928433|65195692|FG002|Overall Study|Protocol Violation|2|||
23498580|NCT02899299|65566376|FG001|Treatment|Lost to Follow-up|2|||
23498581|NCT02899299|65566375|FG000|Treatment|Maximum Clinical Benefit|11|||
23498582|NCT02899299|65566376|FG001|Treatment|Maximum Clinical Benefit|2|||
23498583|NCT02899299|65566375|FG000|Treatment|Poor/Non-compliance|1|||
23498584|NCT02899299|65566376|FG001|Treatment|Poor/Non-compliance|0|||
23395572|NCT01928433|65195690|FG000|Overall Study|Lack of Efficacy|5|||
23395573|NCT01928433|65195691|FG001|Overall Study|Lack of Efficacy|4|||
23395574|NCT01928433|65195692|FG002|Overall Study|Lack of Efficacy|4|||
23498585|NCT02899299|65566375|FG000|Treatment|Participant no longer meets Study criteria|4|||
23498586|NCT02899299|65566376|FG001|Treatment|Participant no longer meets Study criteria|0|||
23606385|NCT02309892|65947239|FG002|Overall Study|Physician Decision|0|||
23395575|NCT01928433|65195690|FG000|Overall Study|Withdrawal by Subject|0|||
23395576|NCT01928433|65195691|FG001|Overall Study|Withdrawal by Subject|4|||
23395577|NCT01928433|65195692|FG002|Overall Study|Withdrawal by Subject|0|||
23395578|NCT01928433|65195690|FG000|Overall Study|Negative screening urine culture|7|||
23395579|NCT01928433|65195691|FG001|Overall Study|Negative screening urine culture|6|||
23395580|NCT01928433|65195692|FG002|Overall Study|Negative screening urine culture|10|||
23395581|NCT01928433|65195690|FG000|Overall Study|Lost to Follow-up|0|||
23395582|NCT01928433|65195691|FG001|Overall Study|Lost to Follow-up|2|||
23395583|NCT01928433|65195692|FG002|Overall Study|Lost to Follow-up|3|||
23395584|NCT01928433|65195690|FG000|Overall Study|Other reasons|3|||
23395585|NCT01928433|65195691|FG001|Overall Study|Other reasons|3|||
23395586|NCT01928433|65195692|FG002|Overall Study|Other reasons|4|||
23395587|NCT01155050|65195693|FG000|Overall Study|Lost to Follow-up|15|||
23395588|NCT01155050|65195694|FG001|Overall Study|Lost to Follow-up|20|||
23395589|NCT01155050|65195695|FG002|Overall Study|Lost to Follow-up|19|||
23395590|NCT01155050|65195696|FG003|Overall Study|Lost to Follow-up|22|||
23395591|NCT00505687|65195697|FG000|Overall Study|Important protocol violation|2|||
23395592|NCT00505687|65195697|FG000|Overall Study|Lack of Efficacy|15|||
23395593|NCT00505687|65195697|FG000|Overall Study|Adverse Event|48|||
23395594|NCT00505687|65195697|FG000|Overall Study|Subject withdrew consent|15|||
23395595|NCT00505687|65195697|FG000|Overall Study|Lost to Follow-up|1|||
23395596|NCT00505687|65195697|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
23395597|NCT00505687|65195697|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
23395598|NCT00505687|65195697|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
23395599|NCT00505687|65195697|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
23395600|NCT00505687|65195697|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
23395601|NCT00505687|65195697|FG000|Overall Study|Other: Disease Progression|1|||
23395602|NCT00505687|65195697|FG000|Overall Study|Other: As Per Sponsor|8|||
23395603|NCT02853136|65195698|FG000|Wash-out|Adverse Event|0|||
23395604|NCT02853136|65195699|FG001|Wash-out|Adverse Event|0|||
23395605|NCT02853136|65195700|FG002|Wash-out|Adverse Event|0|||
23395606|NCT02853136|65195701|FG003|Wash-out|Adverse Event|1|||
23395607|NCT00443456|65195704|FG000|Overall Study|Adverse Event|16|||
23395608|NCT00443456|65195704|FG000|Overall Study|Move|1|||
23395609|NCT00443456|65195704|FG000|Overall Study|Withdrawal by Subject|1|||
23395610|NCT02796651|65195706|FG000|Overall Study|Adverse Event|6|||
23395611|NCT02796651|65195706|FG000|Overall Study|Lost to Follow-up|1|||
23395612|NCT02796651|65195706|FG000|Overall Study|Withdrawal by Subject|4|||
23395613|NCT02796651|65195706|FG000|Overall Study|Protocol Violation|4|||
23395614|NCT02796651|65195706|FG000|Overall Study|Lack of Efficacy|1|||
23395615|NCT02796651|65195706|FG000|Overall Study|Other|10|||
23395616|NCT00427700|65195707|FG000|Overall Study|Lost to Follow-up|2|||
23395617|NCT00427700|65195708|FG001|Overall Study|Lost to Follow-up|5|||
23395618|NCT00427700|65195707|FG000|Overall Study|no induction of menses|1|||
23395619|NCT00427700|65195708|FG001|Overall Study|no induction of menses|4|||
23395620|NCT00427700|65195707|FG000|Overall Study|Pregnancy|0|||
23395621|NCT00427700|65195708|FG001|Overall Study|Pregnancy|2|||
23395622|NCT03801525|65195709|FG000|Overall Study|Adverse Event|17|||
23395623|NCT03801525|65195710|FG001|Overall Study|Adverse Event|1|||
23395624|NCT03801525|65195711|FG002|Overall Study|Adverse Event|0|||
23395625|NCT03801525|65195709|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
23395626|NCT03801525|65195710|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
23395627|NCT03801525|65195711|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
23395628|NCT03801525|65195709|FG000|Overall Study|Death|29|||
23395629|NCT03801525|65195710|FG001|Overall Study|Death|1|||
23395630|NCT03801525|65195711|FG002|Overall Study|Death|4|||
23395631|NCT03801525|65195709|FG000|Overall Study|Disease Progression|6|||
23395632|NCT03801525|65195710|FG001|Overall Study|Disease Progression|0|||
23395633|NCT03801525|65195711|FG002|Overall Study|Disease Progression|1|||
23395634|NCT03801525|65195709|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
23395635|NCT03801525|65195710|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
23395636|NCT03801525|65195711|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
23395637|NCT03801525|65195709|FG000|Overall Study|Investigator Decision|18|||
23395638|NCT03801525|65195710|FG001|Overall Study|Investigator Decision|1|||
23395639|NCT03801525|65195711|FG002|Overall Study|Investigator Decision|0|||
23395640|NCT03801525|65195709|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
23395641|NCT03801525|65195710|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
23395642|NCT03801525|65195711|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
23395643|NCT03801525|65195709|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
23395644|NCT03801525|65195710|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
23395645|NCT03801525|65195711|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
23395646|NCT03801525|65195709|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
23395647|NCT03801525|65195710|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
23395648|NCT03801525|65195711|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
23395649|NCT03801525|65195709|FG000|Overall Study|Withdrawal of Subject Consent|38|||
23395650|NCT03801525|65195710|FG001|Overall Study|Withdrawal of Subject Consent|2|||
23395651|NCT03801525|65195711|FG002|Overall Study|Withdrawal of Subject Consent|1|||
23395652|NCT03801525|65195709|FG000|Overall Study|Reason not Specified|4|||
23395653|NCT03801525|65195710|FG001|Overall Study|Reason not Specified|0|||
23395654|NCT03801525|65195711|FG002|Overall Study|Reason not Specified|4|||
23395655|NCT01188967|65195712|FG000|Overall Study|Withdrawal by Subject|1|||
23395656|NCT01188967|65195713|FG001|Overall Study|Withdrawal by Subject|1|||
23395657|NCT01188967|65195712|FG000|Overall Study|Physician Decision|1|||
23395658|NCT01188967|65195713|FG001|Overall Study|Physician Decision|1|||
23395659|NCT01188967|65195712|FG000|Overall Study|Lost to Follow-up|3|||
23395660|NCT01188967|65195713|FG001|Overall Study|Lost to Follow-up|2|||
23395661|NCT00654355|65195716|FG000|Overall Study|Lost to Follow-up|2|||
23395662|NCT00654355|65195717|FG001|Overall Study|Lost to Follow-up|2|||
23395663|NCT01168596|65195720|FG000|Overall Study|Withdrawal by Subject|3|||
23395664|NCT01168596|65195721|FG001|Overall Study|Withdrawal by Subject|1|||
23395665|NCT02106832|65195722|FG000|Overall Study|Adverse Event|1|||
23395666|NCT02106832|65195723|FG001|Overall Study|Adverse Event|2|||
23395667|NCT02106832|65195724|FG002|Overall Study|Adverse Event|3|||
23395668|NCT02106832|65195725|FG003|Overall Study|Adverse Event|0|||
23395669|NCT02106832|65195722|FG000|Overall Study|Death|4|||
23395670|NCT02106832|65195723|FG001|Overall Study|Death|4|||
23395671|NCT02106832|65195724|FG002|Overall Study|Death|1|||
23395672|NCT02106832|65195725|FG003|Overall Study|Death|4|||
23395673|NCT02106832|65195722|FG000|Overall Study|Deterioration of general conditions|0|||
23395674|NCT02106832|65195723|FG001|Overall Study|Deterioration of general conditions|0|||
23395675|NCT02106832|65195724|FG002|Overall Study|Deterioration of general conditions|1|||
23395676|NCT02106832|65195725|FG003|Overall Study|Deterioration of general conditions|0|||
23395677|NCT02106832|65195722|FG000|Overall Study|Lost to Follow-up|0|||
23395678|NCT02106832|65195723|FG001|Overall Study|Lost to Follow-up|1|||
23395679|NCT02106832|65195724|FG002|Overall Study|Lost to Follow-up|1|||
23395680|NCT02106832|65195725|FG003|Overall Study|Lost to Follow-up|3|||
23395681|NCT02106832|65195722|FG000|Overall Study|Physician Decision|1|||
23395682|NCT02106832|65195723|FG001|Overall Study|Physician Decision|0|||
23395683|NCT02106832|65195724|FG002|Overall Study|Physician Decision|0|||
23395684|NCT02106832|65195725|FG003|Overall Study|Physician Decision|0|||
23395685|NCT02106832|65195722|FG000|Overall Study|Protocol Violation|0|||
23395686|NCT02106832|65195723|FG001|Overall Study|Protocol Violation|0|||
23395687|NCT02106832|65195724|FG002|Overall Study|Protocol Violation|0|||
23395688|NCT02106832|65195725|FG003|Overall Study|Protocol Violation|1|||
23395689|NCT02106832|65195722|FG000|Overall Study|Withdrawal by Subject|17|||
23395690|NCT02106832|65195723|FG001|Overall Study|Withdrawal by Subject|17|||
23395691|NCT02106832|65195724|FG002|Overall Study|Withdrawal by Subject|10|||
23395692|NCT02106832|65195725|FG003|Overall Study|Withdrawal by Subject|7|||
23395693|NCT02106832|65195722|FG000|Overall Study|Technical problems|0|||
23395694|NCT02106832|65195723|FG001|Overall Study|Technical problems|1|||
23395695|NCT02106832|65195724|FG002|Overall Study|Technical problems|0|||
23395696|NCT02106832|65195725|FG003|Overall Study|Technical problems|0|||
23395697|NCT02090764|65195726|FG000|Overall Study|Adverse Event|1|||
23395698|NCT02090764|65195727|FG001|Overall Study|Adverse Event|3|||
23395699|NCT02090764|65195726|FG000|Overall Study|Lack of Efficacy|0|||
23395700|NCT02090764|65195727|FG001|Overall Study|Lack of Efficacy|13|||
23395701|NCT02090764|65195726|FG000|Overall Study|Withdrawal by Subject|2|||
23395702|NCT02090764|65195727|FG001|Overall Study|Withdrawal by Subject|1|||
23395703|NCT02090764|65195726|FG000|Overall Study|Intercurrent illness and other|1|||
23606386|NCT02309892|65947240|FG003|Overall Study|Physician Decision|0|||
23395704|NCT02090764|65195727|FG001|Overall Study|Intercurrent illness and other|1|||
23395705|NCT02090764|65195726|FG000|Overall Study|Lost to Follow-up|2|||
23395706|NCT02090764|65195727|FG001|Overall Study|Lost to Follow-up|2|||
23395707|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
23395708|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
23395709|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
23395710|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
23395711|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
23395712|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
23395713|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
23395714|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
23395715|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
23395716|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
23395717|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
23395718|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
23395719|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
23395720|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
23395721|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
23395722|NCT05014919|65195728|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
23395723|NCT05014919|65195729|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
23395724|NCT05014919|65195730|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
23395725|NCT05014919|65195728|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
23395726|NCT05014919|65195729|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
23395727|NCT05014919|65195730|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
23395728|NCT05014919|65195728|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
23395729|NCT05014919|65195729|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
23395730|NCT05014919|65195730|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
23395731|NCT00129974|65195731|FG000|Overall Study|Other|1|||
23395732|NCT01537432|65195734|FG000|Overall Study|Lost to Follow-up|3|||
23395733|NCT01537432|65195735|FG001|Overall Study|Lost to Follow-up|1|||
23395734|NCT01537432|65195734|FG000|Overall Study|Withdrawal by Subject|0|||
23395735|NCT01537432|65195735|FG001|Overall Study|Withdrawal by Subject|1|||
23395736|NCT01537432|65195734|FG000|Overall Study|Administrative problems|1|||
23395737|NCT01537432|65195735|FG001|Overall Study|Administrative problems|0|||
23395738|NCT01537432|65195734|FG000|Overall Study|Adverse Event|1|||
23395739|NCT01537432|65195735|FG001|Overall Study|Adverse Event|0|||
23395740|NCT01537432|65195734|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
23395741|NCT01537432|65195735|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
23395742|NCT03498716|65195736|FG000|Overall Study|Withdrawal by Subject|88|||
23395743|NCT03498716|65195737|FG001|Overall Study|Withdrawal by Subject|73|||
23395744|NCT03498716|65195736|FG000|Overall Study|Study Terminated By Sponsor|933|||
23395745|NCT03498716|65195737|FG001|Overall Study|Study Terminated By Sponsor|927|||
23395746|NCT03498716|65195736|FG000|Overall Study|Lost to Follow-up|15|||
23395747|NCT03498716|65195737|FG001|Overall Study|Lost to Follow-up|26|||
23395748|NCT03498716|65195736|FG000|Overall Study|Disease Relapse|0|||
23395749|NCT03498716|65195737|FG001|Overall Study|Disease Relapse|1|||
23395750|NCT03498716|65195736|FG000|Overall Study|Death|58|||
23395751|NCT03498716|65195737|FG001|Overall Study|Death|72|||
23395752|NCT03498716|65195736|FG000|Overall Study|Physician Decision|4|||
23395753|NCT03498716|65195737|FG001|Overall Study|Physician Decision|2|||
23395754|NCT04617860|65195741|FG000|Overall Study|Adverse Event|0|||
23395755|NCT04617860|65195742|FG001|Overall Study|Adverse Event|2|||
23395756|NCT04617860|65195743|FG002|Overall Study|Adverse Event|2|||
23395757|NCT04617860|65195741|FG000|Overall Study|Withdrawal by Subject|0|||
23395758|NCT04617860|65195742|FG001|Overall Study|Withdrawal by Subject|0|||
23395759|NCT04617860|65195743|FG002|Overall Study|Withdrawal by Subject|2|||
23395760|NCT04617860|65195741|FG000|Overall Study|Physician Decision|0|||
23395761|NCT04617860|65195742|FG001|Overall Study|Physician Decision|1|||
23395762|NCT04617860|65195743|FG002|Overall Study|Physician Decision|0|||
23395763|NCT04617860|65195741|FG000|Overall Study|Sponsor Decision|0|||
23395764|NCT04617860|65195742|FG001|Overall Study|Sponsor Decision|3|||
23395765|NCT04617860|65195743|FG002|Overall Study|Sponsor Decision|1|||
23395766|NCT04617860|65195741|FG000|Overall Study|Termination of Study by Sponsor|8|||
23395767|NCT04617860|65195742|FG001|Overall Study|Termination of Study by Sponsor|4|||
23395768|NCT04617860|65195743|FG002|Overall Study|Termination of Study by Sponsor|13|||
23395769|NCT01448616|65195756|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
23395770|NCT01448616|65195757|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
23395771|NCT01448616|65195758|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
23395772|NCT01448616|65195759|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
23395773|NCT01448616|65195756|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
23395774|NCT01448616|65195757|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
23395775|NCT01448616|65195758|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
23395776|NCT01448616|65195759|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
23395777|NCT01448616|65195756|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
23395778|NCT01448616|65195757|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
23395779|NCT01448616|65195758|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
23395780|NCT01448616|65195759|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
23498587|NCT02899299|65566375|FG000|Treatment|Administrative reason by Sponsor|2|||
23498588|NCT02899299|65566376|FG001|Treatment|Administrative reason by Sponsor|0|||
23498589|NCT02899299|65566375|FG000|Treatment|Other reasons|12|||
23395781|NCT01448616|65195756|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
23395782|NCT01448616|65195757|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
23395783|NCT01448616|65195758|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
23395784|NCT01448616|65195759|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
23395785|NCT01448616|65195756|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
23395786|NCT01448616|65195757|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
23498590|NCT02899299|65566376|FG001|Treatment|Other reasons|2|||
23395787|NCT01448616|65195758|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
23395788|NCT01448616|65195759|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
23395789|NCT02371889|65195760|FG000|Overall Study|Adverse medication effect|11|||
23395790|NCT02371889|65195761|FG001|Overall Study|Adverse medication effect|2|||
23395791|NCT02371889|65195760|FG000|Overall Study|Lost to Follow-up|6|||
23395792|NCT02371889|65195761|FG001|Overall Study|Lost to Follow-up|5|||
23395793|NCT02371889|65195760|FG000|Overall Study|Personal time constraints|2|||
23395794|NCT02371889|65195761|FG001|Overall Study|Personal time constraints|4|||
23395795|NCT02371889|65195760|FG000|Overall Study|Lack of Efficacy|0|||
23395796|NCT02371889|65195761|FG001|Overall Study|Lack of Efficacy|2|||
23395797|NCT02371889|65195760|FG000|Overall Study|Relapse|0|||
23395798|NCT02371889|65195761|FG001|Overall Study|Relapse|1|||
23395799|NCT03309202|65195762|FG000|Overall Study|Lost to Follow-up|1|||
23395800|NCT03309202|65195763|FG001|Overall Study|Lost to Follow-up|0|||
23395801|NCT03309202|65195764|FG002|Overall Study|Lost to Follow-up|0|||
23395802|NCT03309202|65195765|FG003|Overall Study|Lost to Follow-up|0|||
23606387|NCT02309892|65947241|FG004|Overall Study|Physician Decision|0|||
23606388|NCT02309892|65947242|FG005|Overall Study|Physician Decision|0|||
23606389|NCT02309892|65947243|FG006|Overall Study|Physician Decision|0|||
23606390|NCT02309892|65947237|FG000|Overall Study|Adverse Event|1|||
23606391|NCT02309892|65947238|FG001|Overall Study|Adverse Event|0|||
23606392|NCT02309892|65947239|FG002|Overall Study|Adverse Event|1|||
23606393|NCT02309892|65947240|FG003|Overall Study|Adverse Event|0|||
23606394|NCT02309892|65947241|FG004|Overall Study|Adverse Event|0|||
23606395|NCT02309892|65947242|FG005|Overall Study|Adverse Event|0|||
23606396|NCT02309892|65947243|FG006|Overall Study|Adverse Event|0|||
23606397|NCT02309892|65947237|FG000|Overall Study|Progressive Disease|0|||
23606398|NCT02309892|65947238|FG001|Overall Study|Progressive Disease|1|||
23606399|NCT02309892|65947239|FG002|Overall Study|Progressive Disease|0|||
23606400|NCT02309892|65947240|FG003|Overall Study|Progressive Disease|0|||
23606401|NCT02309892|65947241|FG004|Overall Study|Progressive Disease|1|||
23606402|NCT02309892|65947242|FG005|Overall Study|Progressive Disease|0|||
23606403|NCT02309892|65947243|FG006|Overall Study|Progressive Disease|0|||
23606404|NCT02309892|65947237|FG000|Overall Study|Death|0|||
23606405|NCT02309892|65947238|FG001|Overall Study|Death|0|||
23606406|NCT02309892|65947239|FG002|Overall Study|Death|0|||
23606407|NCT02309892|65947240|FG003|Overall Study|Death|0|||
23606408|NCT02309892|65947241|FG004|Overall Study|Death|0|||
23606409|NCT02309892|65947242|FG005|Overall Study|Death|1|||
23395803|NCT04129398|65195771|FG000|Overall Study|Physician Decision|2|||
23395804|NCT00954447|65195772|FG000|Overall Study|Adverse Event|33|||
23395805|NCT00954447|65195773|FG001|Overall Study|Adverse Event|25|||
23395806|NCT00954447|65195772|FG000|Overall Study|Lack of Efficacy|17|||
23395807|NCT00954447|65195773|FG001|Overall Study|Lack of Efficacy|3|||
23395808|NCT00954447|65195772|FG000|Overall Study|Protocol Violation|5|||
23395809|NCT00954447|65195773|FG001|Overall Study|Protocol Violation|7|||
23498591|NCT02899299|65566375|FG000|Treatment|Not reported|7|||
23300555|NCT02041091|64842824|FG000|Treatment|Sponsor Decision|15|||
23498592|NCT02899299|65566376|FG001|Treatment|Not reported|0|||
23498593|NCT01332331|65566377|FG000|Overall Study|Lost to Follow-up|0|||
23498594|NCT01332331|65566378|FG001|Overall Study|Lost to Follow-up|1|||
23395810|NCT00954447|65195772|FG000|Overall Study|Lost to Follow-up|8|||
23395811|NCT00954447|65195773|FG001|Overall Study|Lost to Follow-up|14|||
23395812|NCT00954447|65195772|FG000|Overall Study|Withdrawal by Subject|26|||
23395813|NCT00954447|65195773|FG001|Overall Study|Withdrawal by Subject|21|||
23395814|NCT00954447|65195772|FG000|Overall Study|Other|21|||
23395815|NCT00954447|65195773|FG001|Overall Study|Other|18|||
23395816|NCT03038087|65195774|FG000|Overall Study|lost data|1|||
23395817|NCT04103450|65195778|FG000|Overall Study|Adverse Event|4|||
23395818|NCT04103450|65195779|FG001|Overall Study|Adverse Event|2|||
23395819|NCT04103450|65195778|FG000|Overall Study|Lack of Efficacy|3|||
23395820|NCT04103450|65195779|FG001|Overall Study|Lack of Efficacy|0|||
23395821|NCT04103450|65195778|FG000|Overall Study|Withdrawal by Subject|5|||
23395822|NCT04103450|65195779|FG001|Overall Study|Withdrawal by Subject|3|||
23395823|NCT04103450|65195778|FG000|Overall Study|Lost to Follow-up|1|||
23395824|NCT04103450|65195779|FG001|Overall Study|Lost to Follow-up|2|||
23395825|NCT04103450|65195778|FG000|Overall Study|Physician Decision|1|||
23395826|NCT04103450|65195779|FG001|Overall Study|Physician Decision|2|||
23395827|NCT04103450|65195778|FG000|Overall Study|Protocol Violation|1|||
23395828|NCT04103450|65195779|FG001|Overall Study|Protocol Violation|0|||
23300556|NCT02041091|64842825|FG001|Treatment|Sponsor Decision|16|||
23395829|NCT04103450|65195778|FG000|Overall Study|Other|1|||
23395830|NCT04103450|65195779|FG001|Overall Study|Other|1|||
23395831|NCT01153516|65195780|FG000|Overall Study|Both subjects refused surgery|2|||
23395832|NCT01153516|65195781|FG001|Overall Study|Both subjects refused surgery|0|||
23395833|NCT01156844|65195782|FG000|Overall Study|Adverse Event|0|||
23498595|NCT01332331|65566377|FG000|Overall Study|Adverse Event|1|||
23498596|NCT01332331|65566378|FG001|Overall Study|Adverse Event|1|||
23395834|NCT01156844|65195783|FG001|Overall Study|Adverse Event|0|||
23395835|NCT01156844|65195784|FG002|Overall Study|Adverse Event|1|||
23395836|NCT01156844|65195785|FG003|Overall Study|Adverse Event|1|||
23395837|NCT01156844|65195782|FG000|Overall Study|Abnormal test procedure result(s)|0|||
23395838|NCT01156844|65195783|FG001|Overall Study|Abnormal test procedure result(s)|1|||
23395839|NCT01156844|65195784|FG002|Overall Study|Abnormal test procedure result(s)|2|||
23395840|NCT01156844|65195785|FG003|Overall Study|Abnormal test procedure result(s)|2|||
23395841|NCT01156844|65195782|FG000|Overall Study|Withdrawal by Subject|0|||
23395842|NCT01156844|65195783|FG001|Overall Study|Withdrawal by Subject|0|||
23498597|NCT01332331|65566377|FG000|Overall Study|Physician Decision|1|||
23395843|NCT01156844|65195784|FG002|Overall Study|Withdrawal by Subject|2|||
23395844|NCT01156844|65195785|FG003|Overall Study|Withdrawal by Subject|2|||
23395845|NCT01156844|65195782|FG000|Overall Study|Lost to Follow-up|0|||
23395846|NCT01156844|65195783|FG001|Overall Study|Lost to Follow-up|0|||
23395847|NCT01156844|65195784|FG002|Overall Study|Lost to Follow-up|1|||
23395848|NCT01156844|65195785|FG003|Overall Study|Lost to Follow-up|0|||
23395849|NCT01156844|65195782|FG000|Overall Study|Administrative problems|0|||
23395850|NCT01156844|65195783|FG001|Overall Study|Administrative problems|1|||
23395851|NCT01156844|65195784|FG002|Overall Study|Administrative problems|0|||
23395852|NCT01156844|65195785|FG003|Overall Study|Administrative problems|1|||
23395853|NCT01156844|65195782|FG000|Overall Study|Protocol deviation|2|||
23395854|NCT01156844|65195783|FG001|Overall Study|Protocol deviation|0|||
23395855|NCT01156844|65195784|FG002|Overall Study|Protocol deviation|0|||
23395856|NCT01156844|65195785|FG003|Overall Study|Protocol deviation|0|||
23395857|NCT01605097|65195786|FG000|Overall Study|Protocol Violation|1|||
23395858|NCT02746809|65195788|FG000|Enrollment|Inclusion Exclusion not met|9|||
23395859|NCT02746809|65195788|FG000|Enrollment|Withdrawal by Subject|1|||
23395860|NCT02746809|65195788|FG000|Enrollment|Expected Enrollment Met|2|||
23395861|NCT02746809|65195788|FG000|Procedure|Death|1|||
23395862|NCT02746809|65195788|FG000|1-Month|Death|5|||
23395863|NCT02746809|65195788|FG000|6-Month|Death|2|||
23395864|NCT02746809|65195788|FG000|6-Month|Withdrawal by Subject|1|||
23395865|NCT02746809|65195788|FG000|12-Month|Death|3|||
23395866|NCT02746809|65195788|FG000|12-Month|Withdrawal by Subject|2|||
23395867|NCT02746809|65195788|FG000|24-Month|Death|1|||
23395868|NCT02746809|65195788|FG000|24-Month|Withdrawal by Subject|1|||
23395869|NCT02746809|65195788|FG000|36-Month|Death|8|||
23395870|NCT02746809|65195788|FG000|36-Month|Withdrawal by Subject|1|||
23395871|NCT02746809|65195788|FG000|48-Month|Death|7|||
23395872|NCT02746809|65195788|FG000|48-Month|Withdrawal by Subject|1|||
23395873|NCT02746809|65195788|FG000|60-Month|Death|1|||
23395874|NCT02746809|65195788|FG000|60-Month|Lost to Follow-up|2|||
23395875|NCT01217892|65195791|FG000|Overall Study|Adverse Event|1|||
23395876|NCT01217892|65195792|FG001|Overall Study|Adverse Event|1|||
23395877|NCT01217892|65195793|FG002|Overall Study|Adverse Event|1|||
23395878|NCT01217892|65195794|FG003|Overall Study|Adverse Event|0|||
23395879|NCT01217892|65195791|FG000|Overall Study|Withdrawal by Subject|0|||
23395880|NCT01217892|65195792|FG001|Overall Study|Withdrawal by Subject|2|||
23395881|NCT01217892|65195793|FG002|Overall Study|Withdrawal by Subject|1|||
23395882|NCT01217892|65195794|FG003|Overall Study|Withdrawal by Subject|0|||
23395883|NCT01217892|65195791|FG000|Overall Study|Lab value|1|||
23395884|NCT01217892|65195792|FG001|Overall Study|Lab value|0|||
23395885|NCT01217892|65195793|FG002|Overall Study|Lab value|1|||
23395886|NCT01217892|65195794|FG003|Overall Study|Lab value|0|||
23395887|NCT01217892|65195791|FG000|Overall Study|Subject no longer meets study criteria|5|||
23395888|NCT01217892|65195792|FG001|Overall Study|Subject no longer meets study criteria|2|||
23395889|NCT01217892|65195793|FG002|Overall Study|Subject no longer meets study criteria|4|||
23395890|NCT01217892|65195794|FG003|Overall Study|Subject no longer meets study criteria|8|||
23395891|NCT01217892|65195791|FG000|Overall Study|Incorrect enrollment|0|||
23395892|NCT01217892|65195792|FG001|Overall Study|Incorrect enrollment|1|||
23395893|NCT01217892|65195793|FG002|Overall Study|Incorrect enrollment|1|||
23395894|NCT01217892|65195794|FG003|Overall Study|Incorrect enrollment|0|||
23395895|NCT01217892|65195791|FG000|Overall Study|Poor/Non-Compliance|0|||
23395896|NCT01217892|65195792|FG001|Overall Study|Poor/Non-Compliance|0|||
23395897|NCT01217892|65195793|FG002|Overall Study|Poor/Non-Compliance|1|||
23395898|NCT01217892|65195794|FG003|Overall Study|Poor/Non-Compliance|0|||
23395899|NCT00437073|65195806|FG000|Overall Study|Sponsor Terminated Study|1|||
23395900|NCT00437073|65195807|FG001|Overall Study|Sponsor Terminated Study|0|||
23395901|NCT00437073|65195806|FG000|Overall Study|Physician Decision|0|||
23395902|NCT00437073|65195807|FG001|Overall Study|Physician Decision|1|||
23395903|NCT02997202|65195814|FG000|Overall Study|Miscellaneous|2|||
23395904|NCT02997202|65195815|FG001|Overall Study|Miscellaneous|2|||
23395905|NCT02997202|65195814|FG000|Overall Study|Withdrawal by Subject|8|||
23395906|NCT02997202|65195815|FG001|Overall Study|Withdrawal by Subject|12|||
23395907|NCT02997202|65195814|FG000|Overall Study|Lost to Follow-up|5|||
23395908|NCT02997202|65195815|FG001|Overall Study|Lost to Follow-up|3|||
23395909|NCT02997202|65195814|FG000|Overall Study|Death|41|||
23395910|NCT02997202|65195815|FG001|Overall Study|Death|45|||
23395911|NCT02439957|65195818|FG000|Overall Study|Study Terminated|3|||
23395912|NCT02439957|65195819|FG001|Overall Study|Study Terminated|3|||
23395913|NCT01817777|65195820|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
23395914|NCT01817777|65195821|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
23395915|NCT01817777|65195822|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
23395916|NCT01817777|65195820|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
23395917|NCT01817777|65195821|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
23395918|NCT01817777|65195822|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
23395919|NCT01817777|65195820|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
23395920|NCT01817777|65195821|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
23395921|NCT01817777|65195822|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
23395922|NCT01817777|65195820|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
23395923|NCT01817777|65195821|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
23395924|NCT01817777|65195822|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
23395925|NCT01817777|65195820|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
23395926|NCT01817777|65195821|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
23395927|NCT01817777|65195822|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
23395928|NCT00363298|65195823|FG000|First Study Week|Lack of Efficacy|6|||
23395929|NCT00363298|65195824|FG001|First Study Week|Lack of Efficacy|5|||
23395930|NCT00363298|65195823|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
23395931|NCT00363298|65195824|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
23395932|NCT01634152|65195825|FG000|Overall Study|Adverse Event|2|||
23395933|NCT01634152|65195826|FG001|Overall Study|Adverse Event|0|||
23395934|NCT01634152|65195827|FG002|Overall Study|Adverse Event|2|||
23395935|NCT01634152|65195825|FG000|Overall Study|Consent withdrawn not due to AE|1|||
23395936|NCT01634152|65195826|FG001|Overall Study|Consent withdrawn not due to AE|0|||
23395937|NCT01634152|65195827|FG002|Overall Study|Consent withdrawn not due to AE|1|||
23395938|NCT01634152|65195825|FG000|Overall Study|Not treated|0|||
23498598|NCT01332331|65566378|FG001|Overall Study|Physician Decision|0|||
23395939|NCT01634152|65195826|FG001|Overall Study|Not treated|1|||
23498599|NCT01681472|65566380|FG000|Overall Study|Adverse Event|0|||
23498600|NCT01681472|65566381|FG001|Overall Study|Adverse Event|1|||
23498601|NCT01681472|65566382|FG002|Overall Study|Adverse Event|0|||
23395940|NCT01634152|65195827|FG002|Overall Study|Not treated|0|||
23395941|NCT01634152|65195825|FG000|Overall Study|Other reason not defined above|1|||
23395942|NCT01634152|65195826|FG001|Overall Study|Other reason not defined above|0|||
23395943|NCT01634152|65195827|FG002|Overall Study|Other reason not defined above|1|||
23395944|NCT00754572|65195828|FG000|Overall Study|Adverse Event|19|||
23395945|NCT00754572|65195828|FG000|Overall Study|Other|39|||
23395946|NCT00754572|65195828|FG000|Overall Study|Protocol Violation|3|||
23395947|NCT00754572|65195828|FG000|Overall Study|Withdrawal by Subject|3|||
23300557|NCT02041091|64842824|FG000|Treatment|Lost to Follow-up|1|||
23395948|NCT00754572|65195828|FG000|Overall Study|Lack of Efficacy|2|||
23395949|NCT00754572|65195828|FG000|Overall Study|Death|1|||
23395950|NCT00754572|65195828|FG000|Overall Study|Administrative Reason|3|||
23395951|NCT00754572|65195828|FG000|Overall Study|Lost to Follow-up|1|||
23395952|NCT01542788|65195829|FG000|Overall Study|Randomized but Not Treated|2|||
23300558|NCT02041091|64842825|FG001|Treatment|Lost to Follow-up|0|||
23395953|NCT01542788|65195830|FG001|Overall Study|Randomized but Not Treated|0|||
23395954|NCT01542788|65195829|FG000|Overall Study|Lack of Efficacy|41|||
23395955|NCT01542788|65195830|FG001|Overall Study|Lack of Efficacy|71|||
23395956|NCT01542788|65195829|FG000|Overall Study|Lost to Follow-up|5|||
23395957|NCT01542788|65195830|FG001|Overall Study|Lost to Follow-up|0|||
23395958|NCT01542788|65195829|FG000|Overall Study|Death|3|||
23395959|NCT01542788|65195830|FG001|Overall Study|Death|0|||
23395960|NCT01542788|65195829|FG000|Overall Study|Protocol Violation|2|||
23395961|NCT01542788|65195830|FG001|Overall Study|Protocol Violation|0|||
23395962|NCT01542788|65195829|FG000|Overall Study|Physician Decision|1|||
23395963|NCT01542788|65195830|FG001|Overall Study|Physician Decision|0|||
23395964|NCT01542788|65195829|FG000|Overall Study|Withdrawal by Subject|1|||
23498602|NCT01681472|65566383|FG003|Overall Study|Adverse Event|0|||
23498603|NCT00717093|65566387|FG000|Overall Study|Adverse Event|19|||
23300559|NCT02041091|64842824|FG000|Optional Safety Extension Period|Adverse Event|4|||
23395965|NCT01542788|65195830|FG001|Overall Study|Withdrawal by Subject|0|||
23395966|NCT04992273|65195833|FG000|Overall Study|Lost to Follow-up|0|||
23395967|NCT04992273|65195834|FG001|Overall Study|Lost to Follow-up|1|||
23395968|NCT04724837|65195840|FG000|Overall Study|Other|4|||
23395969|NCT04724837|65195841|FG001|Overall Study|Other|16|||
23395970|NCT04724837|65195842|FG002|Overall Study|Other|0|||
23395971|NCT04724837|65195840|FG000|Overall Study|Withdrawal by Subject|2|||
23395972|NCT04724837|65195841|FG001|Overall Study|Withdrawal by Subject|9|||
23395973|NCT04724837|65195842|FG002|Overall Study|Withdrawal by Subject|9|||
23395974|NCT04724837|65195840|FG000|Overall Study|Adverse Event|2|||
23395975|NCT04724837|65195841|FG001|Overall Study|Adverse Event|7|||
23395976|NCT04724837|65195842|FG002|Overall Study|Adverse Event|4|||
23395977|NCT04724837|65195840|FG000|Overall Study|Lost to Follow-up|0|||
23395978|NCT04724837|65195841|FG001|Overall Study|Lost to Follow-up|1|||
23395979|NCT04724837|65195842|FG002|Overall Study|Lost to Follow-up|3|||
23395980|NCT04724837|65195840|FG000|Overall Study|Physician Decision|1|||
23395981|NCT04724837|65195841|FG001|Overall Study|Physician Decision|2|||
23395982|NCT04724837|65195842|FG002|Overall Study|Physician Decision|0|||
23395983|NCT04724837|65195840|FG000|Overall Study|Death|0|||
23395984|NCT04724837|65195841|FG001|Overall Study|Death|0|||
23395985|NCT04724837|65195842|FG002|Overall Study|Death|1|||
23395986|NCT04724837|65195840|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
23395987|NCT04724837|65195841|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
23395988|NCT04724837|65195842|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
23395989|NCT04724837|65195840|FG000|Overall Study|Study Terminated by Sponsor|0|||
23395990|NCT04724837|65195841|FG001|Overall Study|Study Terminated by Sponsor|1|||
23395991|NCT04724837|65195842|FG002|Overall Study|Study Terminated by Sponsor|0|||
23395992|NCT03958331|65195844|FG000|Overall Study|Withdrawal by Subject|3|||
23395993|NCT03958331|65195845|FG001|Overall Study|Withdrawal by Subject|1|||
23395994|NCT03958331|65195846|FG002|Overall Study|Withdrawal by Subject|5|||
23395995|NCT03958331|65195844|FG000|Overall Study|Weaned from medicine|2|||
23395996|NCT03958331|65195845|FG001|Overall Study|Weaned from medicine|0|||
23395997|NCT03958331|65195846|FG002|Overall Study|Weaned from medicine|0|||
23395998|NCT03958331|65195844|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
23395999|NCT03958331|65195845|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
23396000|NCT03958331|65195846|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
23396001|NCT03032484|65195847|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
23396002|NCT03032484|65195848|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
23396003|NCT03032484|65195847|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
23396004|NCT03032484|65195848|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
23396005|NCT03386773|65195849|FG000|Overall Study|Lost to Follow-up|24|||
23396006|NCT03386773|65195850|FG001|Overall Study|Lost to Follow-up|33|||
23396007|NCT03386773|65195849|FG000|Overall Study|Withdrawal by Subject|3|||
23396008|NCT03386773|65195850|FG001|Overall Study|Withdrawal by Subject|2|||
23396009|NCT00347269|65195851|FG000|Overall Study|Lost to Follow-up|74|||
23396010|NCT00347269|65195852|FG001|Overall Study|Lost to Follow-up|65|||
23396011|NCT00347269|65195851|FG000|Overall Study|Withdrawal by Subject|18|||
23498604|NCT00717093|65566388|FG001|Overall Study|Adverse Event|9|||
23396012|NCT00347269|65195852|FG001|Overall Study|Withdrawal by Subject|38|||
23396013|NCT00347269|65195851|FG000|Overall Study|Death|2|||
23396014|NCT00347269|65195852|FG001|Overall Study|Death|3|||
23396015|NCT01344226|65195853|FG000|Overall Study|Protocol Violation|2|||
23396016|NCT01344226|65195853|FG000|Overall Study|Withdrawal by Subject|3|||
23396017|NCT01344226|65195853|FG000|Overall Study|Lack of Efficacy|3|||
23396018|NCT02216526|65195854|FG000|Overall Study|Adverse Event|1|||
23498605|NCT00717093|65566387|FG000|Overall Study|Lack of Efficacy|3|||
23498606|NCT00717093|65566388|FG001|Overall Study|Lack of Efficacy|13|||
23498607|NCT00717093|65566387|FG000|Overall Study|Lost to Follow-up|9|||
23396019|NCT02216526|65195855|FG001|Overall Study|Adverse Event|1|||
23396020|NCT02216526|65195856|FG002|Overall Study|Adverse Event|0|||
23396021|NCT02216526|65195854|FG000|Overall Study|Death|0|||
23396022|NCT02216526|65195855|FG001|Overall Study|Death|1|||
23396023|NCT02216526|65195856|FG002|Overall Study|Death|3|||
23396024|NCT02216526|65195854|FG000|Overall Study|Protocol Violation|2|||
23396025|NCT02216526|65195855|FG001|Overall Study|Protocol Violation|0|||
23396026|NCT02216526|65195856|FG002|Overall Study|Protocol Violation|2|||
23396027|NCT02216526|65195854|FG000|Overall Study|Hospitalization|2|||
23396028|NCT02216526|65195855|FG001|Overall Study|Hospitalization|1|||
23396029|NCT02216526|65195856|FG002|Overall Study|Hospitalization|3|||
23396030|NCT01722669|65195861|FG000|Overall Study|Withdrawal by Subject|0|||
23396031|NCT01722669|65195862|FG001|Overall Study|Withdrawal by Subject|0|||
23396032|NCT01722669|65195863|FG002|Overall Study|Withdrawal by Subject|0|||
23396033|NCT01722669|65195864|FG003|Overall Study|Withdrawal by Subject|0|||
23396034|NCT01722669|65195865|FG004|Overall Study|Withdrawal by Subject|0|||
23396035|NCT01722669|65195866|FG005|Overall Study|Withdrawal by Subject|2|||
23396036|NCT00770679|65195867|FG000|Overall Study|Lost to Follow-up|3|||
23396037|NCT00770679|65195867|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
23396038|NCT01959932|65195868|FG000|Overall Study|Withdrawal by Subject|1|||
23396039|NCT01959932|65195869|FG001|Overall Study|Withdrawal by Subject|0|||
23396040|NCT01959932|65195870|FG002|Overall Study|Withdrawal by Subject|0|||
23396041|NCT03610048|65195871|FG000|Overall Study|Study terminated by sponsor|84|||
23396042|NCT03610048|65195871|FG000|Overall Study|Adverse Event|32|||
23396043|NCT03610048|65195871|FG000|Overall Study|Withdrawal by Subject|31|||
23396044|NCT03610048|65195871|FG000|Overall Study|Lost to Follow-up|8|||
23396045|NCT03610048|65195871|FG000|Overall Study|Other|4|||
23396046|NCT03610048|65195871|FG000|Overall Study|Physician Decision|1|||
23396047|NCT03610048|65195871|FG000|Overall Study|Pregnancy|1|||
23396048|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Adverse Event|20|||
23396049|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Adverse Event|10|||
23396050|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Adverse Event|5|||
23396051|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Adverse Event|0|||
23396052|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Adverse Event|0|||
23396053|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Adverse Event|0|||
23396054|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Adverse Event|0|||
23396055|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Adverse Event|0|||
23396056|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Adverse Event|0|||
23396057|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Adverse Event|0|||
23396058|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Adverse Event|0|||
23396059|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Adverse Event|0|||
23396060|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396061|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396062|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
23396063|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396064|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396065|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396066|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396067|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396068|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396069|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396070|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396071|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
23396072|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
23396073|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
23396074|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
23396075|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
23396076|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
23396077|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
23396078|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
23396079|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
23396080|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
23498608|NCT00717093|65566388|FG001|Overall Study|Lost to Follow-up|6|||
23498609|NCT00717093|65566387|FG000|Overall Study|Withdrawal by Subject|12|||
23396081|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
23396082|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
23396083|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
23396084|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
23396085|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
23396086|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
23396087|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
23396088|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
23396089|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
23396090|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
23396091|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
23396092|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
23396093|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
23396094|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
23396095|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
23396096|NCT00725985|65198880|FG000|ITP- Treatment Disposition|Other|50|||
23396097|NCT00725985|65198881|FG001|ITP- Treatment Disposition|Other|38|||
23396098|NCT00725985|65198882|FG002|ITP- Treatment Disposition|Other|24|||
23396099|NCT00725985|65198883|FG003|ITP- Treatment Disposition|Other|0|||
23396100|NCT00725985|65198884|FG004|ITP- Treatment Disposition|Other|0|||
23396101|NCT00725985|65198885|FG005|ITP- Treatment Disposition|Other|0|||
23396102|NCT00725985|65198886|FG006|ITP- Treatment Disposition|Other|0|||
23396103|NCT00725985|65198887|FG007|ITP- Treatment Disposition|Other|0|||
23396104|NCT00725985|65198888|FG008|ITP- Treatment Disposition|Other|0|||
23396105|NCT00725985|65198889|FG009|ITP- Treatment Disposition|Other|0|||
23396106|NCT00725985|65198890|FG010|ITP- Treatment Disposition|Other|0|||
23396107|NCT00725985|65198891|FG011|ITP- Treatment Disposition|Other|0|||
23396108|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396109|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396110|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396111|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
23396112|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
23396113|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
23396114|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396115|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396116|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396117|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396118|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396119|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
23396120|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Death|0|||
23396121|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Death|0|||
23396122|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Death|0|||
23396123|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Death|0|||
23396124|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Death|1|||
23396125|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Death|0|||
23396126|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Death|0|||
23396127|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Death|0|||
23396128|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Death|0|||
23396129|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Death|0|||
23396130|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Death|0|||
23396131|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Death|0|||
23396132|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396133|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396134|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396135|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
23396136|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396137|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396138|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396139|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396140|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396141|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396142|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396143|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
23396144|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
23498610|NCT00717093|65566388|FG001|Overall Study|Withdrawal by Subject|19|||
23396145|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396146|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396147|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396148|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396149|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
23396150|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
23498611|NCT00717093|65566387|FG000|Overall Study|Other|0|||
23498612|NCT00717093|65566388|FG001|Overall Study|Other|1|||
23396151|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396152|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396153|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396154|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396155|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
23396156|NCT00725985|65198880|FG000|OLMP (Up to 96 Weeks)|Other|0|||
23396157|NCT00725985|65198881|FG001|OLMP (Up to 96 Weeks)|Other|0|||
23396158|NCT00725985|65198882|FG002|OLMP (Up to 96 Weeks)|Other|0|||
23396159|NCT00725985|65198883|FG003|OLMP (Up to 96 Weeks)|Other|15|||
23396160|NCT00725985|65198884|FG004|OLMP (Up to 96 Weeks)|Other|20|||
23396161|NCT00725985|65198885|FG005|OLMP (Up to 96 Weeks)|Other|44|||
23396162|NCT00725985|65198886|FG006|OLMP (Up to 96 Weeks)|Other|0|||
23396163|NCT00725985|65198887|FG007|OLMP (Up to 96 Weeks)|Other|0|||
23396164|NCT00725985|65198888|FG008|OLMP (Up to 96 Weeks)|Other|0|||
23396165|NCT00725985|65198889|FG009|OLMP (Up to 96 Weeks)|Other|0|||
23396166|NCT00725985|65198890|FG010|OLMP (Up to 96 Weeks)|Other|0|||
23396167|NCT00725985|65198891|FG011|OLMP (Up to 96 Weeks)|Other|0|||
23396168|NCT00725985|65198880|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396169|NCT00725985|65198881|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396170|NCT00725985|65198882|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396171|NCT00725985|65198883|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396172|NCT00725985|65198884|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396173|NCT00725985|65198885|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396174|NCT00725985|65198886|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396175|NCT00725985|65198887|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
23396176|NCT00725985|65198888|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396177|NCT00725985|65198889|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396178|NCT00725985|65198890|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396179|NCT00725985|65198891|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
23396180|NCT00725985|65198880|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396181|NCT00725985|65198881|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396182|NCT00725985|65198882|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396183|NCT00725985|65198883|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396184|NCT00725985|65198884|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396185|NCT00725985|65198885|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396186|NCT00725985|65198886|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396187|NCT00725985|65198887|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396188|NCT00725985|65198888|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
23396189|NCT00725985|65198889|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396190|NCT00725985|65198890|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396191|NCT00725985|65198891|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
23396192|NCT00725985|65198880|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396193|NCT00725985|65198881|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396194|NCT00725985|65198882|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396195|NCT00725985|65198883|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396196|NCT00725985|65198884|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23498613|NCT00717093|65566387|FG000|Overall Study|Randomized but not treated|1|||
23498614|NCT00717093|65566388|FG001|Overall Study|Randomized but not treated|0|||
23498615|NCT00986830|65566391|FG000|Overall Study|Death|1|||
23498616|NCT00986830|65566391|FG000|Overall Study|Lost to Follow-up|1|||
23396197|NCT00725985|65198885|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396198|NCT00725985|65198886|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
23396199|NCT00725985|65198887|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
23396200|NCT00725985|65198888|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
23396201|NCT00725985|65198889|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396202|NCT00725985|65198890|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396203|NCT00725985|65198891|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
23396204|NCT00725985|65198880|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396205|NCT00725985|65198881|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396206|NCT00725985|65198882|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396207|NCT00725985|65198883|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396208|NCT00725985|65198884|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396209|NCT00725985|65198885|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396210|NCT00725985|65198886|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396211|NCT00725985|65198887|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396212|NCT00725985|65198888|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
23396213|NCT00725985|65198889|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
23396214|NCT00725985|65198890|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
23396215|NCT00725985|65198891|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
23396216|NCT01230060|65198892|FG000|Overall Study|Withdrawal by Subject|1|||
23396217|NCT02457065|65198893|FG000|Overall Study|Lost to Follow-up|9|||
23396218|NCT02457065|65198894|FG001|Overall Study|Lost to Follow-up|11|||
23396219|NCT02112656|65198900|FG000|Overall Study|Death|78|||
23396220|NCT02112656|65198901|FG001|Overall Study|Death|82|||
23396221|NCT02112656|65198900|FG000|Overall Study|Withdrawal by Subject|9|||
23396222|NCT02112656|65198901|FG001|Overall Study|Withdrawal by Subject|11|||
23396223|NCT02112656|65198900|FG000|Overall Study|Lost to Follow-up|2|||
23396224|NCT02112656|65198901|FG001|Overall Study|Lost to Follow-up|4|||
23396225|NCT02112656|65198900|FG000|Overall Study|Noncompliance|1|||
23396226|NCT02112656|65198901|FG001|Overall Study|Noncompliance|2|||
23396227|NCT00791648|65198902|FG000|Overall Study|Physician Decision|0|||
23396228|NCT00791648|65198903|FG001|Overall Study|Physician Decision|1|||
23396229|NCT00791648|65198902|FG000|Overall Study|Withdrawal by Subject|0|||
23396230|NCT00791648|65198903|FG001|Overall Study|Withdrawal by Subject|1|||
23396231|NCT02278003|65198904|FG000|Overall Study|Withdrawal by Subject|11|||
23396232|NCT02278003|65198905|FG001|Overall Study|Withdrawal by Subject|0|||
23396233|NCT02278003|65198904|FG000|Overall Study|Not Treated|1|||
23396234|NCT02278003|65198905|FG001|Overall Study|Not Treated|0|||
23396235|NCT02278003|65198904|FG000|Overall Study|Recognition task improperly completed|7|||
23396236|NCT02278003|65198905|FG001|Overall Study|Recognition task improperly completed|0|||
23396237|NCT02284191|65198910|FG000|Overall Study|Withdrawal by Subject|1|||
23396238|NCT02284191|65198911|FG001|Overall Study|Withdrawal by Subject|3|||
23396239|NCT02284191|65198910|FG000|Overall Study|Lost to Follow-up|1|||
23396240|NCT02284191|65198911|FG001|Overall Study|Lost to Follow-up|0|||
23396241|NCT02724839|65198912|FG000|Overall Study|Withdrawal by Subject|1|||
23396242|NCT02724839|65198913|FG001|Overall Study|Withdrawal by Subject|1|||
23396243|NCT02724839|65198914|FG002|Overall Study|Withdrawal by Subject|0|||
23396244|NCT02724839|65198912|FG000|Overall Study|Lost to Follow-up|0|||
23396245|NCT02724839|65198913|FG001|Overall Study|Lost to Follow-up|3|||
23396246|NCT02724839|65198914|FG002|Overall Study|Lost to Follow-up|2|||
23396247|NCT02724839|65198912|FG000|Overall Study|Physician Decision|0|||
23396248|NCT02724839|65198913|FG001|Overall Study|Physician Decision|0|||
23396249|NCT02724839|65198914|FG002|Overall Study|Physician Decision|3|||
23396250|NCT01038323|65198915|FG000|Overall Study|Withdrawal by Subject|3|||
23396251|NCT01038323|65198916|FG001|Overall Study|Withdrawal by Subject|2|||
23396252|NCT01038323|65198917|FG002|Overall Study|Withdrawal by Subject|4|||
23396253|NCT03674281|65198918|FG000|Overall Study|screen failure|2|||
23396254|NCT03674281|65198919|FG001|Overall Study|screen failure|0|||
23396255|NCT03674281|65198920|FG002|Overall Study|screen failure|0|||
23396256|NCT03674281|65198918|FG000|Overall Study|Withdrawal by Subject|1|||
23396257|NCT03674281|65198919|FG001|Overall Study|Withdrawal by Subject|3|||
23396258|NCT03674281|65198920|FG002|Overall Study|Withdrawal by Subject|3|||
23396259|NCT02271880|65198921|FG000|Overall Study|Premature discontinuation of study|3|||
23396260|NCT02271880|65198922|FG001|Overall Study|Premature discontinuation of study|4|||
23396261|NCT03707821|65198923|FG000|Overall Study|Protocol Violation|0|||
23396262|NCT03707821|65198924|FG001|Overall Study|Protocol Violation|1|||
23396263|NCT03707821|65198923|FG000|Overall Study|Unsatisfactory Visual Response|1|||
23396264|NCT03707821|65198924|FG001|Overall Study|Unsatisfactory Visual Response|0|||
23396265|NCT03707821|65198923|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
23396266|NCT03707821|65198924|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
23396267|NCT02006927|65198925|FG000|Overall Study|Adverse Event|2|||
23396268|NCT02006927|65198925|FG000|Overall Study|Withdrawal by Subject|1|||
23396269|NCT02390076|65198926|FG000|Overall Study|Lost to Follow-up|2|||
23396270|NCT02390076|65198927|FG001|Overall Study|Lost to Follow-up|1|||
23396271|NCT02390076|65198928|FG002|Overall Study|Lost to Follow-up|4|||
23396272|NCT01728246|65198929|FG000|Overall Study|Participant needed rescue medication|1|||
23396273|NCT01728246|65198930|FG001|Overall Study|Participant needed rescue medication|5|||
23396274|NCT01728246|65198929|FG000|Overall Study|Protocol Violation|1|||
23396275|NCT01728246|65198930|FG001|Overall Study|Protocol Violation|0|||
23396276|NCT01728246|65198929|FG000|Overall Study|Withdrawal by Subject|2|||
23396277|NCT01728246|65198930|FG001|Overall Study|Withdrawal by Subject|3|||
23396278|NCT01728246|65198929|FG000|Overall Study|Lost to Follow-up|23|||
23396279|NCT01728246|65198930|FG001|Overall Study|Lost to Follow-up|22|||
23396280|NCT01728246|65198929|FG000|Overall Study|Lack of Efficacy|1|||
23396281|NCT01728246|65198930|FG001|Overall Study|Lack of Efficacy|1|||
23396282|NCT01728246|65198929|FG000|Overall Study|Adverse Event|8|||
23396283|NCT01728246|65198930|FG001|Overall Study|Adverse Event|5|||
23396284|NCT01365455|65198932|FG000|Induction Period|Adverse Event|5|||
23396285|NCT01365455|65198933|FG001|Induction Period|Adverse Event|3|||
23396286|NCT01365455|65198934|FG002|Induction Period|Adverse Event|4|||
23396287|NCT01365455|65198935|FG003|Induction Period|Adverse Event|0|||
23396288|NCT01365455|65198936|FG004|Induction Period|Adverse Event|0|||
23396289|NCT01365455|65198932|FG000|Induction Period|Lack of Efficacy|1|||
23396290|NCT01365455|65198933|FG001|Induction Period|Lack of Efficacy|1|||
23300560|NCT02041091|64842825|FG001|Optional Safety Extension Period|Adverse Event|2|||
23300561|NCT02041091|64842824|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
23300562|NCT02041091|64842825|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
23300563|NCT02041091|64842824|FG000|Optional Safety Extension Period|Protocol Violation|2|||
23300564|NCT02041091|64842825|FG001|Optional Safety Extension Period|Protocol Violation|0|||
23300565|NCT02041091|64842824|FG000|Optional Safety Extension Period|Physician Decision|2|||
23396291|NCT01365455|65198934|FG002|Induction Period|Lack of Efficacy|0|||
23396292|NCT01365455|65198935|FG003|Induction Period|Lack of Efficacy|0|||
23396293|NCT01365455|65198936|FG004|Induction Period|Lack of Efficacy|0|||
23396294|NCT01365455|65198932|FG000|Induction Period|Pregnancy|0|||
23396295|NCT01365455|65198933|FG001|Induction Period|Pregnancy|1|||
23396296|NCT01365455|65198934|FG002|Induction Period|Pregnancy|0|||
23396297|NCT01365455|65198935|FG003|Induction Period|Pregnancy|0|||
23396298|NCT01365455|65198936|FG004|Induction Period|Pregnancy|0|||
23396299|NCT01365455|65198932|FG000|Induction Period|Protocol deviation|0|||
23396300|NCT01365455|65198933|FG001|Induction Period|Protocol deviation|1|||
23396301|NCT01365455|65198934|FG002|Induction Period|Protocol deviation|1|||
23396302|NCT01365455|65198935|FG003|Induction Period|Protocol deviation|0|||
23396303|NCT01365455|65198936|FG004|Induction Period|Protocol deviation|0|||
23396304|NCT01365455|65198932|FG000|Induction Period|Subject/guardian decision|9|||
23396305|NCT01365455|65198933|FG001|Induction Period|Subject/guardian decision|1|||
23396306|NCT01365455|65198934|FG002|Induction Period|Subject/guardian decision|8|||
23396307|NCT01365455|65198935|FG003|Induction Period|Subject/guardian decision|0|||
23396308|NCT01365455|65198936|FG004|Induction Period|Subject/guardian decision|0|||
23396309|NCT01365455|65198932|FG000|Induction Period|Lost to Follow-up|0|||
23396310|NCT01365455|65198933|FG001|Induction Period|Lost to Follow-up|0|||
23396311|NCT01365455|65198934|FG002|Induction Period|Lost to Follow-up|3|||
23396312|NCT01365455|65198935|FG003|Induction Period|Lost to Follow-up|0|||
23396313|NCT01365455|65198936|FG004|Induction Period|Lost to Follow-up|0|||
23396314|NCT01365455|65198932|FG000|Maintenance Period|Adverse Event|12|||
23396315|NCT01365455|65198933|FG001|Maintenance Period|Adverse Event|5|||
23396316|NCT01365455|65198934|FG002|Maintenance Period|Adverse Event|1|||
23396317|NCT01365455|65198935|FG003|Maintenance Period|Adverse Event|2|||
23498617|NCT00986830|65566391|FG000|Overall Study|Lack of Efficacy|1|||
23396318|NCT01365455|65198936|FG004|Maintenance Period|Adverse Event|4|||
23396319|NCT01365455|65198932|FG000|Maintenance Period|Lack of Efficacy|10|||
23396320|NCT01365455|65198933|FG001|Maintenance Period|Lack of Efficacy|2|||
23396321|NCT01365455|65198934|FG002|Maintenance Period|Lack of Efficacy|0|||
23396322|NCT01365455|65198935|FG003|Maintenance Period|Lack of Efficacy|2|||
23396323|NCT01365455|65198936|FG004|Maintenance Period|Lack of Efficacy|2|||
23396324|NCT01365455|65198932|FG000|Maintenance Period|Lost to Follow-up|2|||
23396325|NCT01365455|65198933|FG001|Maintenance Period|Lost to Follow-up|4|||
23396326|NCT01365455|65198934|FG002|Maintenance Period|Lost to Follow-up|0|||
23396327|NCT01365455|65198935|FG003|Maintenance Period|Lost to Follow-up|0|||
23396328|NCT01365455|65198936|FG004|Maintenance Period|Lost to Follow-up|3|||
23396329|NCT01365455|65198932|FG000|Maintenance Period|Non-compliance with study treatment|0|||
23396330|NCT01365455|65198933|FG001|Maintenance Period|Non-compliance with study treatment|0|||
23396331|NCT01365455|65198934|FG002|Maintenance Period|Non-compliance with study treatment|0|||
23396332|NCT01365455|65198935|FG003|Maintenance Period|Non-compliance with study treatment|1|||
23396333|NCT01365455|65198936|FG004|Maintenance Period|Non-compliance with study treatment|0|||
23396334|NCT01365455|65198932|FG000|Maintenance Period|Physician Decision|0|||
23396335|NCT01365455|65198933|FG001|Maintenance Period|Physician Decision|1|||
23498618|NCT00986830|65566391|FG000|Overall Study|Unable to access sinus with device|5|||
23396336|NCT01365455|65198934|FG002|Maintenance Period|Physician Decision|0|||
23396337|NCT01365455|65198935|FG003|Maintenance Period|Physician Decision|0|||
23396338|NCT01365455|65198936|FG004|Maintenance Period|Physician Decision|1|||
23396339|NCT01365455|65198932|FG000|Maintenance Period|Pregnancy|0|||
23396340|NCT01365455|65198933|FG001|Maintenance Period|Pregnancy|4|||
23396341|NCT01365455|65198934|FG002|Maintenance Period|Pregnancy|0|||
23396342|NCT01365455|65198935|FG003|Maintenance Period|Pregnancy|0|||
23396343|NCT01365455|65198936|FG004|Maintenance Period|Pregnancy|2|||
23396344|NCT01365455|65198932|FG000|Maintenance Period|Protocol deviation|1|||
23396345|NCT01365455|65198933|FG001|Maintenance Period|Protocol deviation|1|||
23396346|NCT01365455|65198934|FG002|Maintenance Period|Protocol deviation|0|||
23396347|NCT01365455|65198935|FG003|Maintenance Period|Protocol deviation|0|||
23396348|NCT01365455|65198936|FG004|Maintenance Period|Protocol deviation|0|||
23396349|NCT01365455|65198932|FG000|Maintenance Period|Subject/guardian decision|4|||
23396350|NCT01365455|65198933|FG001|Maintenance Period|Subject/guardian decision|6|||
23396351|NCT01365455|65198934|FG002|Maintenance Period|Subject/guardian decision|2|||
23396352|NCT01365455|65198935|FG003|Maintenance Period|Subject/guardian decision|4|||
23396353|NCT01365455|65198936|FG004|Maintenance Period|Subject/guardian decision|1|||
23396354|NCT03663582|65198937|FG000|Overall Study|Physician Decision|1|||
23396355|NCT00431964|65198938|FG000|Overall Study|Adverse Event|1|||
23396356|NCT00431964|65198939|FG001|Overall Study|Adverse Event|0|||
23396357|NCT00431964|65198938|FG000|Overall Study|Lost to Follow-up|1|||
23396358|NCT00431964|65198939|FG001|Overall Study|Lost to Follow-up|2|||
23396359|NCT00431964|65198938|FG000|Overall Study|Physician Decision|2|||
23396360|NCT00431964|65198939|FG001|Overall Study|Physician Decision|2|||
23396361|NCT00431964|65198938|FG000|Overall Study|Withdrawal by Subject|2|||
23396362|NCT00431964|65198939|FG001|Overall Study|Withdrawal by Subject|1|||
23396363|NCT00431964|65198938|FG000|Overall Study|Parental Consent Withdrawn|0|||
23396364|NCT00431964|65198939|FG001|Overall Study|Parental Consent Withdrawn|2|||
23396365|NCT00431964|65198938|FG000|Overall Study|Due to Unstable Health|0|||
23300566|NCT02041091|64842825|FG001|Optional Safety Extension Period|Physician Decision|1|||
23300567|NCT02041091|64842824|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
23300568|NCT02041091|64842825|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
23396366|NCT00431964|65198939|FG001|Overall Study|Due to Unstable Health|1|||
23396367|NCT00789555|65198943|FG000|Overall Study|Protocol Amendment|78|||
23396368|NCT00789555|65198944|FG001|Overall Study|Protocol Amendment|76|||
23396369|NCT00789555|65198945|FG002|Overall Study|Protocol Amendment|80|||
23396370|NCT00789555|65198943|FG000|Overall Study|Adverse Event|17|||
23396371|NCT00789555|65198944|FG001|Overall Study|Adverse Event|7|||
23396372|NCT00789555|65198945|FG002|Overall Study|Adverse Event|10|||
23396373|NCT00789555|65198943|FG000|Overall Study|Lost to Follow-up|9|||
23396374|NCT00789555|65198944|FG001|Overall Study|Lost to Follow-up|10|||
23396375|NCT00789555|65198945|FG002|Overall Study|Lost to Follow-up|18|||
23396376|NCT00789555|65198943|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
23396377|NCT00789555|65198944|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
23396378|NCT00789555|65198945|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
23396379|NCT00789555|65198943|FG000|Overall Study|Treatment failure|11|||
23396380|NCT00789555|65198944|FG001|Overall Study|Treatment failure|8|||
23300569|NCT02041091|64842824|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
23300570|NCT02041091|64842825|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
23300571|NCT00608517|64842826|FG000|Overall Study|Death|1|||
23300572|NCT00608517|64842827|FG001|Overall Study|Death|0|||
23300573|NCT00608517|64842828|FG002|Overall Study|Death|0|||
23300574|NCT00103038|64842832|FG000|Overall Study|Withdrawal by Subject|8|||
23300575|NCT00103038|64842832|FG000|Overall Study|Screen failure|3|||
23396381|NCT00789555|65198945|FG002|Overall Study|Treatment failure|12|||
23396382|NCT00789555|65198943|FG000|Overall Study|Protocol Violation|6|||
23396383|NCT00789555|65198944|FG001|Overall Study|Protocol Violation|9|||
23396384|NCT00789555|65198945|FG002|Overall Study|Protocol Violation|13|||
23396385|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
23396386|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
23396387|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
23396388|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396389|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23300576|NCT00103038|64842832|FG000|Overall Study|Death|1|||
23300577|NCT00103038|64842832|FG000|Overall Study|Physician Decision|1|||
23300578|NCT00513682|64842833|FG000|Washout Phase|Adverse Event|2|||
23396390|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396391|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396392|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396393|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396394|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396395|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396396|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396397|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396398|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396399|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396400|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
23396401|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
23396402|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
23396403|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23300579|NCT03465436|64842834|FG000|Period 1|Protocol Violation|0|||
23396404|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396405|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396406|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396407|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396408|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396409|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396410|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396411|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396412|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396413|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396414|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396415|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396416|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
23396417|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396418|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396419|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396420|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
23396421|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396422|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396423|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396424|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396425|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396426|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396427|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396428|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396429|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396430|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396431|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396432|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
23396433|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23300580|NCT03465436|64842835|FG001|Period 1|Protocol Violation|0|||
23396434|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396435|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
23396436|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396437|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396438|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396439|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396440|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396441|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396442|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396443|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396444|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396445|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396446|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396447|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396448|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
23396449|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396450|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396451|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396452|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
23396453|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396454|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396455|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396456|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396457|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396458|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396459|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396460|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396461|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396462|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396463|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396464|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
23396465|NCT02891226|65198950|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396466|NCT02891226|65198951|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396467|NCT02891226|65198952|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396468|NCT02891226|65198953|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
23396469|NCT02891226|65198954|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396470|NCT02891226|65198955|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23498619|NCT00945893|65566392|FG000|Overall Study|Lost to Follow-up|2|||
23498620|NCT00945893|65566393|FG001|Overall Study|Lost to Follow-up|8|||
23396471|NCT02891226|65198956|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23300581|NCT03465436|64842836|FG002|Period 1|Protocol Violation|1|||
23396472|NCT02891226|65198957|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396473|NCT02891226|65198958|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396474|NCT02891226|65198959|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396475|NCT02891226|65198960|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396476|NCT02891226|65198961|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396477|NCT02891226|65198962|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396478|NCT02891226|65198963|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396479|NCT02891226|65198964|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396480|NCT02891226|65198965|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
23396481|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396482|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396483|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23606410|NCT02309892|65947243|FG006|Overall Study|Death|0|||
23606411|NCT03345407|65947244|FG000|Overall Study|Withdrawal by Subject|11|||
23606412|NCT03345407|65947245|FG001|Overall Study|Withdrawal by Subject|1|||
23606413|NCT03345407|65947246|FG002|Overall Study|Withdrawal by Subject|5|||
23606414|NCT03345407|65947247|FG003|Overall Study|Withdrawal by Subject|6|||
23606415|NCT03345407|65947248|FG004|Overall Study|Withdrawal by Subject|3|||
23606416|NCT03345407|65947249|FG005|Overall Study|Withdrawal by Subject|6|||
23606417|NCT03345407|65947250|FG006|Overall Study|Withdrawal by Subject|16|||
23606418|NCT03345407|65947244|FG000|Overall Study|Physician Decision|3|||
23606419|NCT03345407|65947245|FG001|Overall Study|Physician Decision|1|||
23606420|NCT03345407|65947246|FG002|Overall Study|Physician Decision|0|||
23606421|NCT03345407|65947247|FG003|Overall Study|Physician Decision|0|||
23606422|NCT03345407|65947248|FG004|Overall Study|Physician Decision|1|||
23396484|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396485|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396486|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396487|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
23396488|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
23396489|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
23396490|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
23396491|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396492|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396493|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396494|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396495|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396496|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
23396497|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396498|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396499|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396500|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396501|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396502|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
23396503|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396504|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396505|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396506|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
23396507|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396508|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396509|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396510|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396511|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396512|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
23396513|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396514|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396515|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396516|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396517|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396518|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396519|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
23396520|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
23396521|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
23396522|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
23396523|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396524|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396525|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396526|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396527|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396528|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
23396529|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396530|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396531|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396532|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396533|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
23396534|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396535|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396536|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396537|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396538|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396539|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396540|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396541|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396542|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396543|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396544|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
23396545|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396546|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396547|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396548|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23402842|NCT01349673|65220031|FG000|Overall Study|No Longer Qualified For Study|1|||
23498621|NCT00945893|65566392|FG000|Overall Study|Withdrawal of consent|1|||
23402843|NCT01349673|65220031|FG000|Overall Study|Site Closure|10|||
23396549|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396550|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396551|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
23396552|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396553|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396554|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396555|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396556|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396557|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396558|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396559|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396560|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
23396561|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396562|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396563|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396564|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396565|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396566|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396567|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396568|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
23396569|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
23396570|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
23396571|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396572|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396573|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396574|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396575|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396576|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
23396577|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396578|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396579|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396580|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396581|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396582|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396583|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396584|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
23606423|NCT03345407|65947249|FG005|Overall Study|Physician Decision|2|||
23300582|NCT03465436|64842837|FG003|Period 1|Protocol Violation|0|||
23300583|NCT03465436|64842834|FG000|Period 2|Protocol Violation|0|||
23300584|NCT03465436|64842835|FG001|Period 2|Protocol Violation|1|||
23300585|NCT03465436|64842836|FG002|Period 2|Protocol Violation|0|||
23300586|NCT03465436|64842837|FG003|Period 2|Protocol Violation|0|||
23300587|NCT03465436|64842834|FG000|Period 3|Protocol Violation|1|||
23300588|NCT03465436|64842835|FG001|Period 3|Protocol Violation|1|||
23300589|NCT03465436|64842836|FG002|Period 3|Protocol Violation|0|||
23300590|NCT03465436|64842837|FG003|Period 3|Protocol Violation|0|||
23300591|NCT03465436|64842834|FG000|Period 4|Protocol Violation|0|||
23300592|NCT03465436|64842835|FG001|Period 4|Protocol Violation|0|||
23300593|NCT03465436|64842836|FG002|Period 4|Protocol Violation|1|||
23300594|NCT03465436|64842837|FG003|Period 4|Protocol Violation|0|||
23300595|NCT04647383|64842838|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
23300596|NCT04647383|64842839|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
23300597|NCT04647383|64842840|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
23300598|NCT04647383|64842841|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
23300599|NCT03977701|64842847|FG000|Overall Study|COVID-19 pandemic|0|||
23300600|NCT03977701|64842848|FG001|Overall Study|COVID-19 pandemic|0|||
23300601|NCT03977701|64842849|FG002|Overall Study|COVID-19 pandemic|0|||
23300602|NCT03977701|64842850|FG003|Overall Study|COVID-19 pandemic|0|||
23300603|NCT03977701|64842851|FG004|Overall Study|COVID-19 pandemic|0|||
23300604|NCT03977701|64842852|FG005|Overall Study|COVID-19 pandemic|1|||
23300605|NCT03977701|64842853|FG006|Overall Study|COVID-19 pandemic|0|||
23300606|NCT03977701|64842854|FG007|Overall Study|COVID-19 pandemic|1|||
23300607|NCT03977701|64842855|FG008|Overall Study|COVID-19 pandemic|0|||
23300608|NCT03977701|64842856|FG009|Overall Study|COVID-19 pandemic|0|||
23300609|NCT01157897|64842857|FG000|Overall Study|Lost to Follow-up|2|||
23300610|NCT01157897|64842858|FG001|Overall Study|Lost to Follow-up|0|||
23300611|NCT01157897|64842859|FG002|Overall Study|Lost to Follow-up|0|||
23300612|NCT01157897|64842860|FG003|Overall Study|Lost to Follow-up|1|||
23300613|NCT01157897|64842857|FG000|Overall Study|Relocated|0|||
23300614|NCT01157897|64842858|FG001|Overall Study|Relocated|2|||
23396585|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396586|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396587|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396588|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396589|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396590|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396591|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396592|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
23396593|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396594|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396595|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396596|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396597|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396598|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396599|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396600|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396601|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
23396602|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396603|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396604|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396605|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396606|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396607|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396608|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
23396609|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396610|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396611|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396612|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396613|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23606424|NCT03345407|65947250|FG006|Overall Study|Physician Decision|3|||
23300615|NCT01157897|64842859|FG002|Overall Study|Relocated|0|||
23300616|NCT01157897|64842860|FG003|Overall Study|Relocated|0|||
23300617|NCT02903238|64842861|FG000|Overall Study|Lost to Follow-up|4|||
23300618|NCT02129647|64842862|FG000|Overall Study|Adverse Event|2|||
23300619|NCT02129647|64842862|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
23300620|NCT00724373|64842866|FG000|Overall Study|Adverse Event|41|||
23300621|NCT00724373|64842866|FG000|Overall Study|Lack of Efficacy|82|||
23300622|NCT00724373|64842866|FG000|Overall Study|Lost to Follow-up|7|||
23300623|NCT00724373|64842866|FG000|Overall Study|Non-compliance|2|||
23300624|NCT00724373|64842866|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
23300625|NCT00724373|64842866|FG000|Overall Study|Participant moved away|1|||
23300626|NCT00724373|64842866|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
23300627|NCT00724373|64842866|FG000|Overall Study|Only to have 24 week regimen|1|||
23300628|NCT00724373|64842866|FG000|Overall Study|Viral Relapse|1|||
23300629|NCT00724373|64842866|FG000|Overall Study|Acute HCV infection|1|||
23300630|NCT00724373|64842866|FG000|Overall Study|Drug Relapse|1|||
23300631|NCT00724373|64842866|FG000|Overall Study|Tolerability|23|||
23300632|NCT05132569|64842867|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
23300633|NCT05132569|64842868|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
23300634|NCT05132569|64842867|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
23300635|NCT05132569|64842868|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
23300636|NCT05132569|64842867|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
23396614|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396615|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396616|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396617|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396618|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
23396619|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396620|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396621|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396622|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396623|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396624|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
23396625|NCT02891226|65198950|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396626|NCT02891226|65198951|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396627|NCT02891226|65198952|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396628|NCT02891226|65198953|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396629|NCT02891226|65198954|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396630|NCT02891226|65198955|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396631|NCT02891226|65198956|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396632|NCT02891226|65198957|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396633|NCT02891226|65198958|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396634|NCT02891226|65198959|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
23396635|NCT02891226|65198960|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396636|NCT02891226|65198961|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396637|NCT02891226|65198962|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396638|NCT02891226|65198963|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396639|NCT02891226|65198964|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396640|NCT02891226|65198965|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
23396641|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396642|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396643|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396644|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396645|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396646|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396647|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396648|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396649|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23498622|NCT00945893|65566393|FG001|Overall Study|Withdrawal of consent|2|||
23498623|NCT02296320|65566394|FG000|Overall Study|Withdrawal by Subject|4|||
23498624|NCT02296320|65566395|FG001|Overall Study|Withdrawal by Subject|0|||
23396650|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396651|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
23396652|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396653|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396654|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396655|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396656|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
23396657|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396658|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396659|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396660|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396661|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396662|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396663|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396664|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396665|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396666|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396667|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
23396668|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396669|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396670|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396671|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396672|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
23396673|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396674|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396675|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396676|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396677|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396678|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396679|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396680|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396681|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396682|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396683|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
23396684|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396685|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396686|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396687|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396688|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
23396689|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396690|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396691|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396692|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396693|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396694|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396695|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396696|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396697|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396698|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396699|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
23396700|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396701|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396702|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396703|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396704|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
23396705|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396706|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396707|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396708|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396709|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396710|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396711|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396712|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396713|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396714|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396715|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
23396716|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396717|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396718|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396719|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396720|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
23396721|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396722|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396723|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396724|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396725|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396726|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396727|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396728|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396729|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396730|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396731|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
23396732|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396733|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396734|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396735|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396736|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
23396737|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396738|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396739|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396740|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396741|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396742|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396743|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396744|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396745|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396746|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396747|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
23396748|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396749|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396750|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396751|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396752|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
23396753|NCT02891226|65198950|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396754|NCT02891226|65198951|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396755|NCT02891226|65198952|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396756|NCT02891226|65198953|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396757|NCT02891226|65198954|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396758|NCT02891226|65198955|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396759|NCT02891226|65198956|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396760|NCT02891226|65198957|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396761|NCT02891226|65198958|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396762|NCT02891226|65198959|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396763|NCT02891226|65198960|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
23396764|NCT02891226|65198961|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396765|NCT02891226|65198962|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23300637|NCT05132569|64842868|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
23300638|NCT01475253|64842869|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
23300639|NCT01475253|64842870|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
23300640|NCT01475253|64842871|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
23300641|NCT01475253|64842872|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
23300642|NCT01475253|64842869|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
23300643|NCT01475253|64842870|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
23300644|NCT01475253|64842871|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
23300645|NCT01475253|64842872|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
23300646|NCT01435031|64842875|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
23300647|NCT01435031|64842875|FG000|ITT at 1 Month|Death|1|||
23300648|NCT01435031|64842875|FG000|ITT at 1 Month|Lost to Follow-up|4|||
23300649|NCT01435031|64842875|FG000|ITT at 6 Months|Death|2|||
23300650|NCT01435031|64842875|FG000|ITT at 6 Months|Lost to Follow-up|3|||
23300651|NCT01435031|64842875|FG000|ITT at 1 Year|Death|1|||
23300652|NCT01435031|64842875|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
23300653|NCT01435031|64842875|FG000|ITT at 1 Year|Lost to Follow-up|6|||
23396766|NCT02891226|65198963|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396767|NCT02891226|65198964|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396768|NCT02891226|65198965|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
23396769|NCT02891226|65198950|FG000|Follow-up Period|Withdrawal by Subject|0|||
23396770|NCT02891226|65198951|FG001|Follow-up Period|Withdrawal by Subject|0|||
23396771|NCT02891226|65198952|FG002|Follow-up Period|Withdrawal by Subject|0|||
23300654|NCT01435031|64842875|FG000|ITT at 2 Years|Death|7|||
23300655|NCT01435031|64842875|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
23300656|NCT01435031|64842875|FG000|ITT at 2 Years|Lost to Follow-up|4|||
23300657|NCT01435031|64842875|FG000|ITT at 3 Years|Death|5|||
23300658|NCT01435031|64842875|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
23300659|NCT01435031|64842875|FG000|ITT at 3 Years|Lost to Follow-up|4|||
23300660|NCT01435031|64842875|FG000|ITT at 4 Years|Death|4|||
23300661|NCT01435031|64842875|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
23300662|NCT01435031|64842875|FG000|ITT at 4 Years|Lost to Follow-up|1|||
23300663|NCT01408563|64842877|FG000|Overall Study|Ineligible after consent/ registration|2|||
23300664|NCT00355472|64842878|FG000|Overall Study|Physician Decision|1|||
23300665|NCT01930175|64842879|FG000|Core Study|Lost to Follow-up|0|||
23300666|NCT01930175|64842880|FG001|Core Study|Lost to Follow-up|1|||
23300667|NCT01930175|64842881|FG002|Core Study|Lost to Follow-up|0|||
23300668|NCT01930175|64842879|FG000|Core Study|Adverse Event|0|||
23396772|NCT02891226|65198953|FG003|Follow-up Period|Withdrawal by Subject|0|||
23396773|NCT02891226|65198954|FG004|Follow-up Period|Withdrawal by Subject|0|||
23396774|NCT02891226|65198955|FG005|Follow-up Period|Withdrawal by Subject|0|||
23300669|NCT01930175|64842880|FG001|Core Study|Adverse Event|0|||
23300670|NCT01930175|64842881|FG002|Core Study|Adverse Event|1|||
23300671|NCT05855616|64842882|FG000|Overall Study|Lost to Follow-up|1|||
23300672|NCT05855616|64842883|FG001|Overall Study|Lost to Follow-up|2|||
23300673|NCT00317642|64842890|FG000|Overall Study|Not Received Either Study Drug|1|||
23300674|NCT00317642|64842891|FG001|Overall Study|Not Received Either Study Drug|3|||
23396775|NCT02891226|65198956|FG006|Follow-up Period|Withdrawal by Subject|0|||
23396776|NCT02891226|65198957|FG007|Follow-up Period|Withdrawal by Subject|0|||
23396777|NCT02891226|65198958|FG008|Follow-up Period|Withdrawal by Subject|0|||
23396778|NCT02891226|65198959|FG009|Follow-up Period|Withdrawal by Subject|0|||
23396779|NCT02891226|65198960|FG010|Follow-up Period|Withdrawal by Subject|0|||
23396780|NCT02891226|65198961|FG011|Follow-up Period|Withdrawal by Subject|1|||
23396781|NCT02891226|65198962|FG012|Follow-up Period|Withdrawal by Subject|0|||
23396782|NCT02891226|65198963|FG013|Follow-up Period|Withdrawal by Subject|0|||
23396783|NCT02891226|65198964|FG014|Follow-up Period|Withdrawal by Subject|1|||
23396784|NCT02891226|65198965|FG015|Follow-up Period|Withdrawal by Subject|1|||
23396785|NCT00815633|65198966|FG000|Overall Study|study terminated|1|||
23396786|NCT00787150|65198967|FG000|Overall Study|Adverse Event|4|||
23396787|NCT00787150|65198968|FG001|Overall Study|Adverse Event|4|||
23396788|NCT00787150|65198969|FG002|Overall Study|Adverse Event|4|||
23396789|NCT00787150|65198967|FG000|Overall Study|Physician Decision|1|||
23396790|NCT00787150|65198968|FG001|Overall Study|Physician Decision|2|||
23300675|NCT00317642|64842890|FG000|Overall Study|Physician Decision|15|||
23396791|NCT00787150|65198969|FG002|Overall Study|Physician Decision|1|||
23396792|NCT00787150|65198967|FG000|Overall Study|Withdrawal by Subject|2|||
23396793|NCT00787150|65198968|FG001|Overall Study|Withdrawal by Subject|1|||
23396794|NCT00787150|65198969|FG002|Overall Study|Withdrawal by Subject|0|||
23396795|NCT00787150|65198967|FG000|Overall Study|Dosing incorrect study durg|2|||
23396796|NCT00787150|65198968|FG001|Overall Study|Dosing incorrect study durg|0|||
23396797|NCT00787150|65198969|FG002|Overall Study|Dosing incorrect study durg|0|||
23396798|NCT04618471|65198970|FG000|Overall Study|Screen Failure|62|||
23396799|NCT04618471|65198970|FG000|Overall Study|Withdrawal by Subject|6|||
23396800|NCT04618471|65198970|FG000|Overall Study|Physician Decision|2|||
23396801|NCT04618471|65198970|FG000|Overall Study|Lost to Follow-up|1|||
23396802|NCT04618471|65198970|FG000|Overall Study|Various other reasons|2|||
23396803|NCT04618471|65198970|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
23396804|NCT01998477|65198971|FG000|Overall Study|Lost to Follow-up|4|||
23396805|NCT01998477|65198972|FG001|Overall Study|Lost to Follow-up|5|||
23396806|NCT01998477|65198971|FG000|Overall Study|Withdrawal by Subject|6|||
23396807|NCT01998477|65198972|FG001|Overall Study|Withdrawal by Subject|0|||
23396808|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
23396809|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
23396810|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
23396811|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
23396812|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
23396813|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
23396814|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
23396815|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
23396816|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
23396817|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
23396818|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
23396819|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
23396820|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
23396821|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
23396822|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
23396823|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
23396824|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
23396825|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
23396826|NCT01432444|65198973|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
23396827|NCT01432444|65198974|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
23396828|NCT01432444|65198975|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
23396829|NCT01432444|65198973|FG000|Treatment Phase|Lost to Follow-up|0|||
23396830|NCT01432444|65198974|FG001|Treatment Phase|Lost to Follow-up|33|||
23396831|NCT01432444|65198975|FG002|Treatment Phase|Lost to Follow-up|0|||
23396832|NCT01432444|65198973|FG000|Treatment Phase|Adverse Event|0|||
23396833|NCT01432444|65198974|FG001|Treatment Phase|Adverse Event|37|||
23396834|NCT01432444|65198975|FG002|Treatment Phase|Adverse Event|0|||
23396835|NCT01432444|65198973|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
23498625|NCT02296320|65566396|FG002|Overall Study|Withdrawal by Subject|2|||
23498626|NCT02296320|65566394|FG000|Overall Study|Death|24|||
23396836|NCT01432444|65198974|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
23396837|NCT01432444|65198975|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
23498627|NCT02296320|65566395|FG001|Overall Study|Death|3|||
23396838|NCT01432444|65198973|FG000|Treatment Phase|Physician Decision|0|||
23396839|NCT01432444|65198974|FG001|Treatment Phase|Physician Decision|5|||
23396840|NCT01432444|65198975|FG002|Treatment Phase|Physician Decision|0|||
23396841|NCT01432444|65198973|FG000|Treatment Phase|Withdrawal by Subject|0|||
23396842|NCT01432444|65198974|FG001|Treatment Phase|Withdrawal by Subject|41|||
23396843|NCT01432444|65198975|FG002|Treatment Phase|Withdrawal by Subject|0|||
23396844|NCT01432444|65198973|FG000|Treatment Phase|Protocol Deviation|0|||
23396845|NCT01432444|65198974|FG001|Treatment Phase|Protocol Deviation|3|||
23396846|NCT01432444|65198975|FG002|Treatment Phase|Protocol Deviation|0|||
23396847|NCT01432444|65198973|FG000|Treatment Phase|Lack of Efficacy|0|||
23396848|NCT01432444|65198974|FG001|Treatment Phase|Lack of Efficacy|10|||
23396849|NCT01432444|65198975|FG002|Treatment Phase|Lack of Efficacy|0|||
23396850|NCT01432444|65198973|FG000|Extension Phase|Lost to Follow-up|0|||
23396851|NCT01432444|65198974|FG001|Extension Phase|Lost to Follow-up|0|||
23396852|NCT01432444|65198975|FG002|Extension Phase|Lost to Follow-up|17|||
23396853|NCT01432444|65198973|FG000|Extension Phase|Adverse Event|0|||
23396854|NCT01432444|65198974|FG001|Extension Phase|Adverse Event|0|||
23396855|NCT01432444|65198975|FG002|Extension Phase|Adverse Event|10|||
23396856|NCT01432444|65198973|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
23396857|NCT01432444|65198974|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
23396858|NCT01432444|65198975|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
23396859|NCT01432444|65198973|FG000|Extension Phase|Met Withdrawal Criteria|0|||
23396860|NCT01432444|65198974|FG001|Extension Phase|Met Withdrawal Criteria|0|||
23396861|NCT01432444|65198975|FG002|Extension Phase|Met Withdrawal Criteria|144|||
23396862|NCT01432444|65198973|FG000|Extension Phase|Physician Decision|0|||
23396863|NCT01432444|65198974|FG001|Extension Phase|Physician Decision|0|||
23396864|NCT01432444|65198975|FG002|Extension Phase|Physician Decision|1|||
23396865|NCT01432444|65198973|FG000|Extension Phase|Withdrawal by Subject|0|||
23396866|NCT01432444|65198974|FG001|Extension Phase|Withdrawal by Subject|0|||
23396867|NCT01432444|65198975|FG002|Extension Phase|Withdrawal by Subject|13|||
23396868|NCT00543985|65198976|FG000|Overall Study|Withdrawal by Subject|4|||
23396869|NCT03069716|65198977|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
23396870|NCT03069716|65198978|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
23396871|NCT03069716|65198979|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
23396872|NCT03069716|65198977|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
23396873|NCT03069716|65198978|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
23396874|NCT03069716|65198979|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
23396875|NCT03069716|65198977|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
23396876|NCT03069716|65198978|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
23396877|NCT03069716|65198979|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
23396878|NCT03069716|65198977|FG000|Randomized Treatment|Withdrawal by Subject|0|||
23396879|NCT03069716|65198978|FG001|Randomized Treatment|Withdrawal by Subject|2|||
23396880|NCT03069716|65198979|FG002|Randomized Treatment|Withdrawal by Subject|0|||
23396881|NCT00949533|65198980|FG000|Overall Study|Lost to Follow-up|0|||
23396882|NCT00949533|65198981|FG001|Overall Study|Lost to Follow-up|1|||
23396883|NCT00841815|65198984|FG000|Washout|Withdrawal by Subject|0|||
23396884|NCT00841815|65198985|FG001|Washout|Withdrawal by Subject|1|||
23396885|NCT03950856|65198986|FG000|Overall Study|Death|1|||
23396886|NCT03950856|65198987|FG001|Overall Study|Death|2|||
23396887|NCT03950856|65198988|FG002|Overall Study|Death|0|||
23396888|NCT03950856|65198989|FG003|Overall Study|Death|0|||
23396889|NCT03950856|65198986|FG000|Overall Study|Lost to Follow-up|5|||
23396890|NCT03950856|65198987|FG001|Overall Study|Lost to Follow-up|6|||
23396891|NCT03950856|65198988|FG002|Overall Study|Lost to Follow-up|8|||
23396892|NCT03950856|65198989|FG003|Overall Study|Lost to Follow-up|2|||
23396893|NCT03950856|65198986|FG000|Overall Study|Protocol Violation|2|||
23396894|NCT03950856|65198987|FG001|Overall Study|Protocol Violation|0|||
23396895|NCT03950856|65198988|FG002|Overall Study|Protocol Violation|0|||
23396896|NCT03950856|65198989|FG003|Overall Study|Protocol Violation|1|||
23396897|NCT03950856|65198986|FG000|Overall Study|Withdrawal by Subject|4|||
23396898|NCT03950856|65198987|FG001|Overall Study|Withdrawal by Subject|1|||
23396899|NCT03950856|65198988|FG002|Overall Study|Withdrawal by Subject|3|||
23396900|NCT03950856|65198989|FG003|Overall Study|Withdrawal by Subject|1|||
23396901|NCT03950856|65198986|FG000|Overall Study|Unable to phone|7|||
23396902|NCT03950856|65198987|FG001|Overall Study|Unable to phone|6|||
23396903|NCT03950856|65198988|FG002|Overall Study|Unable to phone|7|||
23396904|NCT03950856|65198989|FG003|Overall Study|Unable to phone|2|||
23396905|NCT02259114|65198990|FG000|Overall Study|Progressive Disease|14|||
23396906|NCT02259114|65198991|FG001|Overall Study|Progressive Disease|2|||
23396907|NCT02259114|65198992|FG002|Overall Study|Progressive Disease|10|||
23396908|NCT02259114|65198993|FG003|Overall Study|Progressive Disease|2|||
23396909|NCT02259114|65198994|FG004|Overall Study|Progressive Disease|5|||
23396910|NCT02259114|65198990|FG000|Overall Study|Adverse Event|2|||
23396911|NCT02259114|65198991|FG001|Overall Study|Adverse Event|1|||
23396912|NCT02259114|65198992|FG002|Overall Study|Adverse Event|0|||
23396913|NCT02259114|65198993|FG003|Overall Study|Adverse Event|0|||
23396914|NCT02259114|65198994|FG004|Overall Study|Adverse Event|1|||
23396915|NCT02259114|65198990|FG000|Overall Study|Death|3|||
23396916|NCT02259114|65198991|FG001|Overall Study|Death|0|||
23396917|NCT02259114|65198992|FG002|Overall Study|Death|1|||
23396918|NCT02259114|65198993|FG003|Overall Study|Death|0|||
23396919|NCT02259114|65198994|FG004|Overall Study|Death|0|||
23396920|NCT02259114|65198990|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
23396921|NCT02259114|65198991|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
23396922|NCT02259114|65198992|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
23396923|NCT02259114|65198993|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
23396924|NCT02259114|65198994|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
23396925|NCT02259114|65198990|FG000|Overall Study|Withdrawal by Subject|0|||
23396926|NCT02259114|65198991|FG001|Overall Study|Withdrawal by Subject|0|||
23396927|NCT02259114|65198992|FG002|Overall Study|Withdrawal by Subject|1|||
23396928|NCT02259114|65198993|FG003|Overall Study|Withdrawal by Subject|1|||
23396929|NCT02259114|65198994|FG004|Overall Study|Withdrawal by Subject|0|||
23396930|NCT02259114|65198990|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
23396931|NCT02259114|65198991|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
23396932|NCT02259114|65198992|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
23396933|NCT02259114|65198993|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
23396934|NCT02259114|65198994|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
23396935|NCT02259114|65198990|FG000|Overall Study|Not Treated|1|||
23396936|NCT02259114|65198991|FG001|Overall Study|Not Treated|0|||
23396937|NCT02259114|65198992|FG002|Overall Study|Not Treated|0|||
23396938|NCT02259114|65198993|FG003|Overall Study|Not Treated|0|||
23396939|NCT02259114|65198994|FG004|Overall Study|Not Treated|0|||
23396940|NCT04540367|65199002|FG000|Overall Study|Withdrawal by Subject|0|||
23396941|NCT04540367|65199003|FG001|Overall Study|Withdrawal by Subject|0|||
23396942|NCT04540367|65199004|FG002|Overall Study|Withdrawal by Subject|0|||
23396943|NCT04540367|65199005|FG003|Overall Study|Withdrawal by Subject|2|||
23396944|NCT04540367|65199002|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
23396945|NCT04540367|65199003|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
23396946|NCT04540367|65199004|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
23396947|NCT04540367|65199005|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
23396948|NCT04540367|65199002|FG000|Overall Study|Adverse Event|0|||
23396949|NCT04540367|65199003|FG001|Overall Study|Adverse Event|0|||
23396950|NCT04540367|65199004|FG002|Overall Study|Adverse Event|1|||
23396951|NCT04540367|65199005|FG003|Overall Study|Adverse Event|1|||
23396952|NCT00967499|65199008|FG000|Overall Study|Adverse Event|0|||
23396953|NCT00967499|65199009|FG001|Overall Study|Adverse Event|1|||
23396954|NCT00967499|65199008|FG000|Overall Study|Protocol Violation|1|||
23396955|NCT00967499|65199009|FG001|Overall Study|Protocol Violation|0|||
23396956|NCT00967499|65199008|FG000|Overall Study|Sponsor Decision|1|||
23396957|NCT00967499|65199009|FG001|Overall Study|Sponsor Decision|0|||
23396958|NCT00967499|65199008|FG000|Overall Study|Randomized but not treated|63|||
23396959|NCT00967499|65199009|FG001|Overall Study|Randomized but not treated|59|||
23396960|NCT02757430|65199010|FG000|Overall Study|Physician Decision|6|||
23396961|NCT02757430|65199010|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
23396962|NCT02757430|65199010|FG000|Overall Study|No informed consent|1|||
23396963|NCT02757430|65199010|FG000|Overall Study|No procedure performed|2|||
23396964|NCT00485173|65199024|FG000|Overall Study|Death|4|||
23396965|NCT00485173|65199025|FG001|Overall Study|Death|3|||
23396966|NCT00485173|65199024|FG000|Overall Study|Lost to Follow-up|32|||
23396967|NCT00485173|65199025|FG001|Overall Study|Lost to Follow-up|61|||
23396968|NCT03402841|65199027|FG000|Overall Study|Withdrawal by Subject|3|||
23396969|NCT03402841|65199027|FG000|Overall Study|Lost to Follow-up|2|||
23396970|NCT03402841|65199027|FG000|Overall Study|Death|146|||
23396971|NCT01734902|65199029|FG000|Overall Study|Other than listed|0|||
23396972|NCT01734902|65199030|FG001|Overall Study|Other than listed|2|||
23396973|NCT02511106|65199031|FG000|Overall Study|Lost to Follow-up|6|||
23396974|NCT02511106|65199032|FG001|Overall Study|Lost to Follow-up|4|||
23396975|NCT02511106|65199031|FG000|Overall Study|Withdrawal by Subject|24|||
23396976|NCT02511106|65199032|FG001|Overall Study|Withdrawal by Subject|21|||
23396977|NCT02511106|65199031|FG000|Overall Study|Death|42|||
23396978|NCT02511106|65199032|FG001|Overall Study|Death|82|||
23396979|NCT02511106|65199031|FG000|Overall Study|Ongoing study at data cut-off|3|||
23396980|NCT02511106|65199032|FG001|Overall Study|Ongoing study at data cut-off|2|||
23396981|NCT02511106|65199031|FG000|Overall Study|Without specified reason|3|||
23396982|NCT02511106|65199032|FG001|Overall Study|Without specified reason|0|||
23396983|NCT04614324|65199035|FG000|Overall Study|Lost to Follow-up|3|||
23396984|NCT04614324|65199035|FG000|Overall Study|Physician Decision|1|||
23396985|NCT04614324|65199035|FG000|Overall Study|Withdrawal by Subject|2|||
23396986|NCT04614324|65199035|FG000|Overall Study|Remaining in Follow up|123|||
23396987|NCT00776230|65199038|FG000|Overall Study|Lost to Follow-up|2|||
23396988|NCT00776230|65199039|FG001|Overall Study|Lost to Follow-up|1|||
23396989|NCT00776230|65199040|FG002|Overall Study|Lost to Follow-up|5|||
23396990|NCT00776230|65199038|FG000|Overall Study|Not vaccinated at Day 0|1|||
23396991|NCT00776230|65199039|FG001|Overall Study|Not vaccinated at Day 0|0|||
23396992|NCT00776230|65199040|FG002|Overall Study|Not vaccinated at Day 0|0|||
23396993|NCT00776230|65199038|FG000|Overall Study|Withdrawal by Subject|0|||
23396994|NCT00776230|65199039|FG001|Overall Study|Withdrawal by Subject|1|||
23396995|NCT00776230|65199040|FG002|Overall Study|Withdrawal by Subject|0|||
23498628|NCT02296320|65566396|FG002|Overall Study|Death|27|||
23498629|NCT02296320|65566394|FG000|Overall Study|Lost to Follow-up|5|||
23396996|NCT00776230|65199038|FG000|Overall Study|Subject missed Visit 4|0|||
23396997|NCT00776230|65199039|FG001|Overall Study|Subject missed Visit 4|1|||
23396998|NCT00776230|65199040|FG002|Overall Study|Subject missed Visit 4|0|||
23396999|NCT04138056|65199043|FG000|Primary Study|Lost to Follow-up|3|||
23397000|NCT04138056|65199044|FG001|Primary Study|Lost to Follow-up|4|||
23397001|NCT04138056|65199045|FG002|Primary Study|Lost to Follow-up|1|||
23397002|NCT04138056|65199046|FG003|Primary Study|Lost to Follow-up|1|||
23397003|NCT04138056|65199047|FG004|Primary Study|Lost to Follow-up|4|||
23397004|NCT04138056|65199043|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
23397005|NCT04138056|65199044|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
23397006|NCT04138056|65199045|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
23397007|NCT04138056|65199046|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
23397008|NCT04138056|65199047|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
23498630|NCT02296320|65566395|FG001|Overall Study|Lost to Follow-up|2|||
23397009|NCT04138056|65199043|FG000|Extension Study|Lost to Follow-up|1|||
23397010|NCT04138056|65199044|FG001|Extension Study|Lost to Follow-up|2|||
23397011|NCT04138056|65199045|FG002|Extension Study|Lost to Follow-up|1|||
23397012|NCT04138056|65199046|FG003|Extension Study|Lost to Follow-up|0|||
23397013|NCT04138056|65199047|FG004|Extension Study|Lost to Follow-up|1|||
23498631|NCT02296320|65566396|FG002|Overall Study|Lost to Follow-up|7|||
23397014|NCT03485157|65199048|FG000|Double Blind Phase|Lost to Follow-up|4|||
23397015|NCT03485157|65199049|FG001|Double Blind Phase|Lost to Follow-up|4|||
23397016|NCT03485157|65199048|FG000|Double Blind Phase|Adverse Event|2|||
23397017|NCT03485157|65199049|FG001|Double Blind Phase|Adverse Event|1|||
23397018|NCT03485157|65199048|FG000|Double Blind Phase|Withdrawal by Subject|6|||
23397019|NCT03485157|65199049|FG001|Double Blind Phase|Withdrawal by Subject|9|||
23397020|NCT03485157|65199048|FG000|Double Blind Phase|Removal by PI|3|||
23397021|NCT03485157|65199049|FG001|Double Blind Phase|Removal by PI|7|||
23397022|NCT03485157|65199048|FG000|Open Label Phase|Lost to Follow-up|1|||
23397023|NCT03485157|65199049|FG001|Open Label Phase|Lost to Follow-up|2|||
23397024|NCT03485157|65199048|FG000|Open Label Phase|Adverse Event|0|||
23397025|NCT03485157|65199049|FG001|Open Label Phase|Adverse Event|1|||
23397026|NCT03485157|65199048|FG000|Open Label Phase|Withdrawal by Subject|1|||
23397027|NCT03485157|65199049|FG001|Open Label Phase|Withdrawal by Subject|2|||
23397028|NCT03485157|65199048|FG000|Open Label Phase|Removal by PI|2|||
23397029|NCT03485157|65199049|FG001|Open Label Phase|Removal by PI|0|||
23397030|NCT00523978|65199054|FG000|Overall Study|Withdrawal by Subject|3|||
23397031|NCT00523978|65199055|FG001|Overall Study|Withdrawal by Subject|7|||
23397032|NCT00523978|65199054|FG000|Overall Study|Screen Failures|5|||
23397033|NCT00523978|65199055|FG001|Overall Study|Screen Failures|1|||
23397034|NCT00523978|65199054|FG000|Overall Study|Death|1|||
23397035|NCT00523978|65199055|FG001|Overall Study|Death|0|||
23397036|NCT02037529|65199056|FG000|Overall Study|Withdrawal by Subject|1|||
23397037|NCT02037529|65199057|FG001|Overall Study|Withdrawal by Subject|3|||
23397038|NCT02037529|65199056|FG000|Overall Study|Adverse Event|0|||
23397039|NCT02037529|65199057|FG001|Overall Study|Adverse Event|1|||
23397040|NCT00027560|65199060|FG000|Overall Study|Withdrawal by Subject|1|||
23397041|NCT00619866|65199061|FG000|Weeks 1 - 12|Adverse Event|0|||
23397042|NCT00619866|65199062|FG001|Weeks 1 - 12|Adverse Event|1|||
23397043|NCT00619866|65199063|FG002|Weeks 1 - 12|Adverse Event|2|||
23397044|NCT00619866|65199064|FG003|Weeks 1 - 12|Adverse Event|0|||
23397045|NCT00619866|65199065|FG004|Weeks 1 - 12|Adverse Event|0|||
23397046|NCT00619866|65199061|FG000|Weeks 1 - 12|Non-compliance|0|||
23397047|NCT00619866|65199062|FG001|Weeks 1 - 12|Non-compliance|0|||
23397048|NCT00619866|65199063|FG002|Weeks 1 - 12|Non-compliance|1|||
23498632|NCT02296320|65566394|FG000|Overall Study|Not treated|2|||
23498633|NCT02296320|65566395|FG001|Overall Study|Not treated|0|||
23498634|NCT02296320|65566396|FG002|Overall Study|Not treated|0|||
23397049|NCT00619866|65199064|FG003|Weeks 1 - 12|Non-compliance|0|||
23397050|NCT00619866|65199065|FG004|Weeks 1 - 12|Non-compliance|0|||
23397051|NCT00619866|65199061|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
23397052|NCT00619866|65199062|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
23397053|NCT00619866|65199063|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
23397054|NCT00619866|65199064|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
23397055|NCT00619866|65199065|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
23397056|NCT00619866|65199061|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
23498635|NCT02296320|65566394|FG000|Overall Study|Not - specified|0|||
23397057|NCT00619866|65199062|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
23397058|NCT00619866|65199063|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
23397059|NCT00619866|65199064|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
23397060|NCT00619866|65199065|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
23397061|NCT00619866|65199061|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
23397062|NCT00619866|65199062|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
23397063|NCT00619866|65199063|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
23397064|NCT00619866|65199064|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
23397065|NCT00619866|65199065|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
23397066|NCT00619866|65199061|FG000|Weeks 1 - 12|Sponsor Decision|0|||
23397067|NCT00619866|65199062|FG001|Weeks 1 - 12|Sponsor Decision|1|||
23397068|NCT00619866|65199063|FG002|Weeks 1 - 12|Sponsor Decision|0|||
23397069|NCT00619866|65199064|FG003|Weeks 1 - 12|Sponsor Decision|0|||
23397070|NCT00619866|65199065|FG004|Weeks 1 - 12|Sponsor Decision|0|||
23397071|NCT00619866|65199061|FG000|Weeks 13 - 24|Adverse Event|0|||
23397072|NCT00619866|65199062|FG001|Weeks 13 - 24|Adverse Event|0|||
23397073|NCT00619866|65199063|FG002|Weeks 13 - 24|Adverse Event|2|||
23397074|NCT00619866|65199064|FG003|Weeks 13 - 24|Adverse Event|1|||
23397075|NCT00619866|65199065|FG004|Weeks 13 - 24|Adverse Event|0|||
23397076|NCT00619866|65199061|FG000|Weeks 13 - 24|Protocol Deviation|0|||
23397077|NCT00619866|65199062|FG001|Weeks 13 - 24|Protocol Deviation|0|||
23397078|NCT00619866|65199063|FG002|Weeks 13 - 24|Protocol Deviation|0|||
23397079|NCT00619866|65199064|FG003|Weeks 13 - 24|Protocol Deviation|1|||
23397080|NCT00619866|65199065|FG004|Weeks 13 - 24|Protocol Deviation|0|||
23397081|NCT00619866|65199061|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
23397082|NCT00619866|65199062|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
23397083|NCT00619866|65199063|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
23397084|NCT00619866|65199064|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
23397085|NCT00619866|65199065|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
23397086|NCT00619866|65199061|FG000|Weeks 13 - 24|Non-compliance|0|||
23397087|NCT00619866|65199062|FG001|Weeks 13 - 24|Non-compliance|1|||
23397088|NCT00619866|65199063|FG002|Weeks 13 - 24|Non-compliance|1|||
23397089|NCT00619866|65199064|FG003|Weeks 13 - 24|Non-compliance|0|||
23397090|NCT00619866|65199065|FG004|Weeks 13 - 24|Non-compliance|0|||
23397091|NCT00619866|65199061|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
23397092|NCT00619866|65199062|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
23397093|NCT00619866|65199063|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
23397094|NCT00619866|65199064|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
23397095|NCT00619866|65199065|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
23397096|NCT00474903|65199066|FG000|Overall Study|Protocol Violation|1|||
23397097|NCT00474903|65199067|FG001|Overall Study|Protocol Violation|5|||
23397098|NCT00474903|65199068|FG002|Overall Study|Protocol Violation|2|||
23397099|NCT01073293|65199071|FG000|Overall Study|Lost to Follow-up|0|||
23397100|NCT01073293|65199072|FG001|Overall Study|Lost to Follow-up|1|||
23397101|NCT01073293|65199071|FG000|Overall Study|Withdrawal by Subject|5|||
23397102|NCT01073293|65199072|FG001|Overall Study|Withdrawal by Subject|10|||
23397103|NCT02367456|65199073|FG000|Overall Study|Death|8|||
23397104|NCT02367456|65199074|FG001|Overall Study|Death|24|||
23397105|NCT02367456|65199075|FG002|Overall Study|Death|17|||
23300676|NCT00317642|64842891|FG001|Overall Study|Physician Decision|7|||
23397106|NCT02367456|65199073|FG000|Overall Study|Lost to Follow-up|1|||
23397107|NCT02367456|65199074|FG001|Overall Study|Lost to Follow-up|3|||
23498636|NCT02296320|65566395|FG001|Overall Study|Not - specified|0|||
23397108|NCT02367456|65199075|FG002|Overall Study|Lost to Follow-up|1|||
23397109|NCT02367456|65199073|FG000|Overall Study|Other reason|3|||
23397110|NCT02367456|65199074|FG001|Overall Study|Other reason|3|||
23397111|NCT02367456|65199075|FG002|Overall Study|Other reason|9|||
23397112|NCT02367456|65199073|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
23397113|NCT02367456|65199074|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
23397114|NCT02367456|65199075|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
23397115|NCT01936831|65199084|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397116|NCT01936831|65199085|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397117|NCT01936831|65199086|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397118|NCT01936831|65199087|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397119|NCT01936831|65199088|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23498637|NCT02296320|65566396|FG002|Overall Study|Not - specified|1|||
23498638|NCT03607487|65566401|FG000|Overall Study|Withdrawal by Subject|2|||
23498639|NCT03607487|65566402|FG001|Overall Study|Withdrawal by Subject|0|||
23498640|NCT03607487|65566403|FG002|Overall Study|Withdrawal by Subject|0|||
23397120|NCT01936831|65199089|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
23498641|NCT03607487|65566404|FG003|Overall Study|Withdrawal by Subject|1|||
23498642|NCT00724932|65566409|FG000|Overall Study|Lost to Follow-up|1|||
23498643|NCT00724932|65566410|FG001|Overall Study|Lost to Follow-up|0|||
23397121|NCT01936831|65199090|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397122|NCT01936831|65199091|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397123|NCT01936831|65199092|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
23397124|NCT02489279|65199093|FG000|Overall Study|Lost to Follow-up|12|||
23397125|NCT02489279|65199094|FG001|Overall Study|Lost to Follow-up|10|||
23397126|NCT02297516|65199095|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
23397127|NCT02297516|65199096|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
23397128|NCT02297516|65199095|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
23397129|NCT02297516|65199096|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
23397130|NCT02297516|65199095|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
23397131|NCT02297516|65199096|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
23397132|NCT00399529|65199097|FG000|Overall Study|Off Study Prior to Treatment|2|||
23397133|NCT05201807|65199098|FG000|Overall Study|Adverse Event|1|||
23397134|NCT05201807|65199098|FG000|Overall Study|COVID-19 Related|1|||
23397135|NCT02164864|65199101|FG000|Overall Study|Trial disease worsening|7|||
23397136|NCT02164864|65199102|FG001|Overall Study|Trial disease worsening|5|||
23397137|NCT02164864|65199103|FG002|Overall Study|Trial disease worsening|1|||
23397138|NCT02164864|65199101|FG000|Overall Study|Other pre-existing disease worsening|6|||
23397139|NCT02164864|65199102|FG001|Overall Study|Other pre-existing disease worsening|4|||
23397140|NCT02164864|65199103|FG002|Overall Study|Other pre-existing disease worsening|9|||
23498644|NCT00724932|65566409|FG000|Overall Study|Not treated|4|||
23397141|NCT02164864|65199101|FG000|Overall Study|Other Adverse Event (AE)|52|||
23397142|NCT02164864|65199102|FG001|Overall Study|Other Adverse Event (AE)|32|||
23397143|NCT02164864|65199103|FG002|Overall Study|Other Adverse Event (AE)|49|||
23397144|NCT02164864|65199101|FG000|Overall Study|Protocol Violation|2|||
23397145|NCT02164864|65199102|FG001|Overall Study|Protocol Violation|4|||
23397146|NCT02164864|65199103|FG002|Overall Study|Protocol Violation|1|||
23397147|NCT02164864|65199101|FG000|Overall Study|Lost to Follow-up|4|||
23397148|NCT02164864|65199102|FG001|Overall Study|Lost to Follow-up|3|||
23397149|NCT02164864|65199103|FG002|Overall Study|Lost to Follow-up|2|||
23397150|NCT02164864|65199101|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
23397151|NCT02164864|65199102|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
23397152|NCT02164864|65199103|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
23397153|NCT02164864|65199101|FG000|Overall Study|Other than stated|3|||
23397154|NCT02164864|65199102|FG001|Overall Study|Other than stated|4|||
23397155|NCT02164864|65199103|FG002|Overall Study|Other than stated|14|||
23397156|NCT02317627|65199106|FG000|Overall Study|Withdrawal by Subject|0|||
23397157|NCT02317627|65199107|FG001|Overall Study|Withdrawal by Subject|1|||
23397158|NCT02317627|65199108|FG002|Overall Study|Withdrawal by Subject|1|||
23397159|NCT02317627|65199106|FG000|Overall Study|Lost to Follow-up|2|||
23397160|NCT02317627|65199107|FG001|Overall Study|Lost to Follow-up|0|||
23397161|NCT02317627|65199108|FG002|Overall Study|Lost to Follow-up|0|||
23397162|NCT02317627|65199106|FG000|Overall Study|Stopped by Investigator|0|||
23397163|NCT02317627|65199107|FG001|Overall Study|Stopped by Investigator|1|||
23397164|NCT02317627|65199108|FG002|Overall Study|Stopped by Investigator|0|||
23397165|NCT02317627|65199106|FG000|Overall Study|Adverse Event|0|||
23397166|NCT02317627|65199107|FG001|Overall Study|Adverse Event|2|||
23397167|NCT02317627|65199108|FG002|Overall Study|Adverse Event|3|||
23397168|NCT02317627|65199106|FG000|Overall Study|Non-compliance with study drug|0|||
23397169|NCT02317627|65199107|FG001|Overall Study|Non-compliance with study drug|1|||
23397170|NCT02317627|65199108|FG002|Overall Study|Non-compliance with study drug|0|||
23397171|NCT01475721|65199109|FG000|Overall Study|Death|3|||
23397172|NCT01475721|65199110|FG001|Overall Study|Death|6|||
23397173|NCT01475721|65199109|FG000|Overall Study|Withdrawal by Subject|8|||
23397174|NCT01475721|65199110|FG001|Overall Study|Withdrawal by Subject|8|||
23397175|NCT02471144|65199111|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
23397176|NCT02471144|65199112|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
23397177|NCT02471144|65199113|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
23397178|NCT02471144|65199114|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
23397179|NCT02471144|65199115|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
23397180|NCT02471144|65199116|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
23397181|NCT02471144|65199117|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
23397182|NCT02471144|65199118|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
23397183|NCT02471144|65199119|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
23397184|NCT02471144|65199120|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
23397185|NCT02471144|65199121|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
23397186|NCT02471144|65199111|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397187|NCT02471144|65199112|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397188|NCT02471144|65199113|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397189|NCT02471144|65199114|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
23397190|NCT02471144|65199115|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397191|NCT02471144|65199116|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397192|NCT02471144|65199117|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397193|NCT02471144|65199118|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397194|NCT02471144|65199119|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397195|NCT02471144|65199120|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397196|NCT02471144|65199121|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
23397197|NCT02471144|65199111|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397198|NCT02471144|65199112|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397199|NCT02471144|65199113|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
23397200|NCT02471144|65199114|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397201|NCT02471144|65199115|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397202|NCT02471144|65199116|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397203|NCT02471144|65199117|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397204|NCT02471144|65199118|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397205|NCT02471144|65199119|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397206|NCT02471144|65199120|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397207|NCT02471144|65199121|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
23397208|NCT02471144|65199111|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
23397209|NCT02471144|65199112|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
23397210|NCT02471144|65199113|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397211|NCT02471144|65199114|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397212|NCT02471144|65199115|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397213|NCT02471144|65199116|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397214|NCT02471144|65199117|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397215|NCT02471144|65199118|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397216|NCT02471144|65199119|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23300677|NCT00317642|64842890|FG000|Overall Study|Participant declined treatment|14|||
23300678|NCT00317642|64842891|FG001|Overall Study|Participant declined treatment|3|||
23300679|NCT00317642|64842890|FG000|Overall Study|Adverse Event|17|||
23300680|NCT00317642|64842891|FG001|Overall Study|Adverse Event|5|||
23300681|NCT00317642|64842890|FG000|Overall Study|Treatment Failure|56|||
23397217|NCT02471144|65199120|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397218|NCT02471144|65199121|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
23397219|NCT02471144|65199111|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397220|NCT02471144|65199112|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397221|NCT02471144|65199113|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397222|NCT02471144|65199114|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397223|NCT02471144|65199115|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
23397224|NCT02471144|65199116|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397225|NCT02471144|65199117|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
23397226|NCT02471144|65199118|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397227|NCT02471144|65199119|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
23397228|NCT02471144|65199120|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397229|NCT02471144|65199121|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
23397230|NCT02471144|65199111|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397231|NCT02471144|65199112|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397232|NCT02471144|65199113|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397233|NCT02471144|65199114|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397234|NCT02471144|65199115|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397235|NCT02471144|65199116|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
23397236|NCT02471144|65199117|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397237|NCT02471144|65199118|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397238|NCT02471144|65199119|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
23397239|NCT02471144|65199120|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397240|NCT02471144|65199121|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
23397241|NCT02471144|65199111|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397242|NCT02471144|65199112|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397243|NCT02471144|65199113|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23498645|NCT00724932|65566410|FG001|Overall Study|Not treated|3|||
23498646|NCT02538029|65566422|FG000|Overall Study|unable to complete cognitive assessments|1|||
23397244|NCT02471144|65199114|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397245|NCT02471144|65199115|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397246|NCT02471144|65199116|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23606425|NCT03345407|65947244|FG000|Overall Study|Lost to Follow-up|2|||
23498647|NCT02538029|65566423|FG001|Overall Study|unable to complete cognitive assessments|0|||
23397247|NCT02471144|65199117|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397248|NCT02471144|65199118|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397249|NCT02471144|65199119|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
23397250|NCT02471144|65199120|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397251|NCT02471144|65199121|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
23397252|NCT02471144|65199111|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397253|NCT02471144|65199112|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397254|NCT02471144|65199113|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397255|NCT02471144|65199114|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397256|NCT02471144|65199115|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397257|NCT02471144|65199116|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397258|NCT02471144|65199117|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397259|NCT02471144|65199118|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
23397260|NCT02471144|65199119|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
23397261|NCT02471144|65199120|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23606426|NCT03345407|65947245|FG001|Overall Study|Lost to Follow-up|0|||
23300682|NCT00317642|64842891|FG001|Overall Study|Treatment Failure|102|||
23606427|NCT03345407|65947246|FG002|Overall Study|Lost to Follow-up|1|||
23606428|NCT03345407|65947247|FG003|Overall Study|Lost to Follow-up|0|||
23606429|NCT03345407|65947248|FG004|Overall Study|Lost to Follow-up|1|||
23606430|NCT03345407|65947249|FG005|Overall Study|Lost to Follow-up|2|||
23606431|NCT03345407|65947250|FG006|Overall Study|Lost to Follow-up|3|||
23606432|NCT03345407|65947244|FG000|Overall Study|Protocol-defined stopping criteria|9|||
23606433|NCT03345407|65947245|FG001|Overall Study|Protocol-defined stopping criteria|0|||
23606434|NCT03345407|65947246|FG002|Overall Study|Protocol-defined stopping criteria|0|||
23606435|NCT03345407|65947247|FG003|Overall Study|Protocol-defined stopping criteria|0|||
23606436|NCT03345407|65947248|FG004|Overall Study|Protocol-defined stopping criteria|2|||
23606437|NCT03345407|65947249|FG005|Overall Study|Protocol-defined stopping criteria|1|||
23606438|NCT03345407|65947250|FG006|Overall Study|Protocol-defined stopping criteria|1|||
23606439|NCT03345407|65947244|FG000|Overall Study|Protocol Violation|2|||
23606440|NCT03345407|65947245|FG001|Overall Study|Protocol Violation|0|||
23606441|NCT03345407|65947246|FG002|Overall Study|Protocol Violation|0|||
23606442|NCT03345407|65947247|FG003|Overall Study|Protocol Violation|0|||
23606443|NCT03345407|65947248|FG004|Overall Study|Protocol Violation|1|||
23606444|NCT03345407|65947249|FG005|Overall Study|Protocol Violation|0|||
23606445|NCT03345407|65947250|FG006|Overall Study|Protocol Violation|3|||
23606446|NCT03345407|65947244|FG000|Overall Study|Lack of Efficacy|1|||
23606447|NCT03345407|65947245|FG001|Overall Study|Lack of Efficacy|1|||
23606448|NCT03345407|65947246|FG002|Overall Study|Lack of Efficacy|1|||
23606449|NCT03345407|65947247|FG003|Overall Study|Lack of Efficacy|1|||
23606450|NCT03345407|65947248|FG004|Overall Study|Lack of Efficacy|1|||
23606451|NCT03345407|65947249|FG005|Overall Study|Lack of Efficacy|0|||
23606452|NCT03345407|65947250|FG006|Overall Study|Lack of Efficacy|3|||
23606453|NCT03345407|65947244|FG000|Overall Study|Adverse Event|4|||
23606454|NCT03345407|65947245|FG001|Overall Study|Adverse Event|0|||
23606455|NCT03345407|65947246|FG002|Overall Study|Adverse Event|5|||
23606456|NCT03345407|65947247|FG003|Overall Study|Adverse Event|4|||
23606457|NCT03345407|65947248|FG004|Overall Study|Adverse Event|6|||
23606458|NCT03345407|65947249|FG005|Overall Study|Adverse Event|5|||
23606459|NCT03345407|65947250|FG006|Overall Study|Adverse Event|16|||
23606460|NCT00624377|65947251|FG000|Overall Study|Lost to Follow-up|355|||
23606461|NCT00624377|65947251|FG000|Overall Study|Withdrawal by Subject|100|||
23606462|NCT00624377|65947251|FG000|Overall Study|Adverse Event|14|||
23606463|NCT00624377|65947251|FG000|Overall Study|Other|91|||
23606464|NCT00624377|65947251|FG000|Overall Study|Non-evaluable population|84|||
23606465|NCT01777932|65947254|FG000|Overall Study|Disease progression|136|||
23606466|NCT01777932|65947254|FG000|Overall Study|Death|3|||
23606467|NCT01777932|65947254|FG000|Overall Study|Adverse Event|34|||
23606468|NCT01777932|65947254|FG000|Overall Study|Lost to Follow-up|3|||
23606469|NCT01777932|65947254|FG000|Overall Study|Investigator decision|10|||
23606470|NCT01777932|65947254|FG000|Overall Study|Reimbursement limit|9|||
23606471|NCT01777932|65947254|FG000|Overall Study|Patient refused further treatment|10|||
23606472|NCT00378898|65947257|FG000|Overall Study|Withdrawal by Subject|10|||
23606473|NCT00378898|65947258|FG001|Overall Study|Withdrawal by Subject|5|||
23606474|NCT00378898|65947257|FG000|Overall Study|Protocol Violation|1|||
23606475|NCT00378898|65947258|FG001|Overall Study|Protocol Violation|1|||
23606476|NCT02446015|65947259|FG000|Overall Study|Adverse Event|0|||
23606477|NCT02446015|65947260|FG001|Overall Study|Adverse Event|1|||
23397262|NCT02471144|65199121|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
23397263|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397264|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397265|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23300683|NCT00317642|64842890|FG000|Overall Study|Disease Recurrence|1|||
23397266|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397267|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397268|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397269|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397270|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397271|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
23397272|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
23397273|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
23397274|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397275|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397276|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397277|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397278|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397279|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397280|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397281|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397282|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397283|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
23300684|NCT00317642|64842891|FG001|Overall Study|Disease Recurrence|2|||
23397284|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
23397285|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397286|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397287|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397288|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397289|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397290|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397291|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397292|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397293|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397294|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
23397295|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
23397296|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397297|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397298|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397299|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397300|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397301|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397302|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397303|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397304|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
23397305|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
23397306|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
23397307|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397308|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397309|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397310|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397311|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397312|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397313|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397314|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397315|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397316|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
23397317|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
23397318|NCT02471144|65199111|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397319|NCT02471144|65199112|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397320|NCT02471144|65199113|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397321|NCT02471144|65199114|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397322|NCT02471144|65199115|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397323|NCT02471144|65199116|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397324|NCT02471144|65199117|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397325|NCT02471144|65199118|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397326|NCT02471144|65199119|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
23397327|NCT02471144|65199120|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
23397328|NCT02471144|65199121|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
23397329|NCT04573972|65199122|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
23397330|NCT04573972|65199123|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
23397331|NCT00928668|65199130|FG000|Overall Study|Adverse Event|1|||
23397332|NCT00928668|65199131|FG001|Overall Study|Adverse Event|0|||
23397333|NCT00928668|65199132|FG002|Overall Study|Adverse Event|0|||
23397334|NCT00928668|65199133|FG003|Overall Study|Adverse Event|0|||
23397335|NCT00928668|65199134|FG004|Overall Study|Adverse Event|0|||
23397336|NCT00928668|65199130|FG000|Overall Study|Protocol Violation|0|||
23397337|NCT00928668|65199131|FG001|Overall Study|Protocol Violation|0|||
23397338|NCT00928668|65199132|FG002|Overall Study|Protocol Violation|0|||
23397339|NCT00928668|65199133|FG003|Overall Study|Protocol Violation|0|||
23397340|NCT00928668|65199134|FG004|Overall Study|Protocol Violation|1|||
23397341|NCT00928668|65199130|FG000|Overall Study|Withdrawal by Subject|0|||
23397342|NCT00928668|65199131|FG001|Overall Study|Withdrawal by Subject|1|||
23397343|NCT00928668|65199132|FG002|Overall Study|Withdrawal by Subject|1|||
23397344|NCT00928668|65199133|FG003|Overall Study|Withdrawal by Subject|0|||
23397345|NCT00928668|65199134|FG004|Overall Study|Withdrawal by Subject|0|||
23397346|NCT00928668|65199130|FG000|Overall Study|Other reasons not listed above|0|||
23397347|NCT00928668|65199131|FG001|Overall Study|Other reasons not listed above|0|||
23498648|NCT02538029|65566424|FG002|Overall Study|unable to complete cognitive assessments|1|||
23397348|NCT00928668|65199132|FG002|Overall Study|Other reasons not listed above|0|||
23397349|NCT00928668|65199133|FG003|Overall Study|Other reasons not listed above|1|||
23397350|NCT00928668|65199134|FG004|Overall Study|Other reasons not listed above|0|||
23397351|NCT01085214|65199135|FG000|Overall Study|Alternate treatment required|1|||
23397352|NCT02327169|65199136|FG000|Overall Study|Progressive Disease|1|||
23397353|NCT02327169|65199137|FG001|Overall Study|Progressive Disease|3|||
23397354|NCT02327169|65199138|FG002|Overall Study|Progressive Disease|4|||
23397355|NCT02327169|65199139|FG003|Overall Study|Progressive Disease|3|||
23397356|NCT02327169|65199140|FG004|Overall Study|Progressive Disease|4|||
23397357|NCT02327169|65199141|FG005|Overall Study|Progressive Disease|3|||
23397358|NCT02327169|65199142|FG006|Overall Study|Progressive Disease|3|||
23397359|NCT02327169|65199143|FG007|Overall Study|Progressive Disease|3|||
23397360|NCT02327169|65199144|FG008|Overall Study|Progressive Disease|4|||
23397361|NCT02327169|65199145|FG009|Overall Study|Progressive Disease|4|||
23397362|NCT02327169|65199146|FG010|Overall Study|Progressive Disease|4|||
23397363|NCT02327169|65199147|FG011|Overall Study|Progressive Disease|3|||
23397364|NCT02327169|65199148|FG012|Overall Study|Progressive Disease|1|||
23397365|NCT02327169|65199149|FG013|Overall Study|Progressive Disease|3|||
23397366|NCT02327169|65199150|FG014|Overall Study|Progressive Disease|3|||
23397367|NCT02327169|65199136|FG000|Overall Study|Adverse Event|2|||
23397368|NCT02327169|65199137|FG001|Overall Study|Adverse Event|0|||
23397369|NCT02327169|65199138|FG002|Overall Study|Adverse Event|1|||
23397370|NCT02327169|65199139|FG003|Overall Study|Adverse Event|0|||
23397371|NCT02327169|65199140|FG004|Overall Study|Adverse Event|1|||
23397372|NCT02327169|65199141|FG005|Overall Study|Adverse Event|0|||
23300685|NCT00317642|64842890|FG000|Overall Study|Death|14|||
23397373|NCT02327169|65199142|FG006|Overall Study|Adverse Event|0|||
23397374|NCT02327169|65199143|FG007|Overall Study|Adverse Event|0|||
23397375|NCT02327169|65199144|FG008|Overall Study|Adverse Event|0|||
23397376|NCT02327169|65199145|FG009|Overall Study|Adverse Event|2|||
23397377|NCT02327169|65199146|FG010|Overall Study|Adverse Event|0|||
23397378|NCT02327169|65199147|FG011|Overall Study|Adverse Event|3|||
23397379|NCT02327169|65199148|FG012|Overall Study|Adverse Event|0|||
23397380|NCT02327169|65199149|FG013|Overall Study|Adverse Event|2|||
23397381|NCT02327169|65199150|FG014|Overall Study|Adverse Event|1|||
23397382|NCT02327169|65199136|FG000|Overall Study|Symptomatic Deterioration|0|||
23397383|NCT02327169|65199137|FG001|Overall Study|Symptomatic Deterioration|0|||
23397384|NCT02327169|65199138|FG002|Overall Study|Symptomatic Deterioration|1|||
23397385|NCT02327169|65199139|FG003|Overall Study|Symptomatic Deterioration|0|||
23397386|NCT02327169|65199140|FG004|Overall Study|Symptomatic Deterioration|1|||
23397387|NCT02327169|65199141|FG005|Overall Study|Symptomatic Deterioration|1|||
23397388|NCT02327169|65199142|FG006|Overall Study|Symptomatic Deterioration|0|||
23397389|NCT02327169|65199143|FG007|Overall Study|Symptomatic Deterioration|0|||
23397390|NCT02327169|65199144|FG008|Overall Study|Symptomatic Deterioration|2|||
23397391|NCT02327169|65199145|FG009|Overall Study|Symptomatic Deterioration|1|||
23397392|NCT02327169|65199146|FG010|Overall Study|Symptomatic Deterioration|0|||
23397393|NCT02327169|65199147|FG011|Overall Study|Symptomatic Deterioration|0|||
23397394|NCT02327169|65199148|FG012|Overall Study|Symptomatic Deterioration|0|||
23397395|NCT02327169|65199149|FG013|Overall Study|Symptomatic Deterioration|2|||
23397396|NCT02327169|65199150|FG014|Overall Study|Symptomatic Deterioration|1|||
23397397|NCT02327169|65199136|FG000|Overall Study|Reason Not Specified|0|||
23397398|NCT02327169|65199137|FG001|Overall Study|Reason Not Specified|0|||
23397399|NCT02327169|65199138|FG002|Overall Study|Reason Not Specified|1|||
23397400|NCT02327169|65199139|FG003|Overall Study|Reason Not Specified|0|||
23397401|NCT02327169|65199140|FG004|Overall Study|Reason Not Specified|0|||
23397402|NCT02327169|65199141|FG005|Overall Study|Reason Not Specified|0|||
23397403|NCT02327169|65199142|FG006|Overall Study|Reason Not Specified|0|||
23397404|NCT02327169|65199143|FG007|Overall Study|Reason Not Specified|0|||
23397405|NCT02327169|65199144|FG008|Overall Study|Reason Not Specified|0|||
23397406|NCT02327169|65199145|FG009|Overall Study|Reason Not Specified|1|||
23397407|NCT02327169|65199146|FG010|Overall Study|Reason Not Specified|2|||
23397408|NCT02327169|65199147|FG011|Overall Study|Reason Not Specified|1|||
23397409|NCT02327169|65199148|FG012|Overall Study|Reason Not Specified|0|||
23397410|NCT02327169|65199149|FG013|Overall Study|Reason Not Specified|0|||
23397411|NCT02327169|65199150|FG014|Overall Study|Reason Not Specified|2|||
23397412|NCT02327169|65199136|FG000|Overall Study|Withdrawal by Subject|1|||
23397413|NCT02327169|65199137|FG001|Overall Study|Withdrawal by Subject|0|||
23397414|NCT02327169|65199138|FG002|Overall Study|Withdrawal by Subject|0|||
23397415|NCT02327169|65199139|FG003|Overall Study|Withdrawal by Subject|0|||
23397416|NCT02327169|65199140|FG004|Overall Study|Withdrawal by Subject|1|||
23397417|NCT02327169|65199141|FG005|Overall Study|Withdrawal by Subject|0|||
23397418|NCT02327169|65199142|FG006|Overall Study|Withdrawal by Subject|0|||
23397419|NCT02327169|65199143|FG007|Overall Study|Withdrawal by Subject|1|||
23397420|NCT02327169|65199144|FG008|Overall Study|Withdrawal by Subject|0|||
23397421|NCT02327169|65199145|FG009|Overall Study|Withdrawal by Subject|0|||
23397422|NCT02327169|65199146|FG010|Overall Study|Withdrawal by Subject|0|||
23397423|NCT02327169|65199147|FG011|Overall Study|Withdrawal by Subject|0|||
23397424|NCT02327169|65199148|FG012|Overall Study|Withdrawal by Subject|0|||
23397425|NCT02327169|65199149|FG013|Overall Study|Withdrawal by Subject|0|||
23397426|NCT02327169|65199150|FG014|Overall Study|Withdrawal by Subject|3|||
23397427|NCT02327169|65199136|FG000|Overall Study|Lost to Follow-up|0|||
23397428|NCT02327169|65199137|FG001|Overall Study|Lost to Follow-up|0|||
23397429|NCT02327169|65199138|FG002|Overall Study|Lost to Follow-up|0|||
23397430|NCT02327169|65199139|FG003|Overall Study|Lost to Follow-up|0|||
23397431|NCT02327169|65199140|FG004|Overall Study|Lost to Follow-up|1|||
23397432|NCT02327169|65199141|FG005|Overall Study|Lost to Follow-up|0|||
23397433|NCT02327169|65199142|FG006|Overall Study|Lost to Follow-up|0|||
23397434|NCT02327169|65199143|FG007|Overall Study|Lost to Follow-up|0|||
23397435|NCT02327169|65199144|FG008|Overall Study|Lost to Follow-up|0|||
23397436|NCT02327169|65199145|FG009|Overall Study|Lost to Follow-up|0|||
23397437|NCT02327169|65199146|FG010|Overall Study|Lost to Follow-up|0|||
23397438|NCT02327169|65199147|FG011|Overall Study|Lost to Follow-up|0|||
23397439|NCT02327169|65199148|FG012|Overall Study|Lost to Follow-up|0|||
23397440|NCT02327169|65199149|FG013|Overall Study|Lost to Follow-up|0|||
23397441|NCT02327169|65199150|FG014|Overall Study|Lost to Follow-up|0|||
23397442|NCT02191618|65199151|FG000|Overall Study|Withdrawal by Subject|3|||
23397443|NCT02191618|65199151|FG000|Overall Study|Missed Visit|4|||
23397444|NCT02415556|65199152|FG000|Overall Study|Adverse Event|3|||
23397445|NCT02415556|65199153|FG001|Overall Study|Adverse Event|4|||
23397446|NCT02415556|65199154|FG002|Overall Study|Adverse Event|2|||
23397447|NCT02415556|65199155|FG003|Overall Study|Adverse Event|4|||
23397448|NCT02415556|65199152|FG000|Overall Study|Lost to Follow-up|4|||
23397449|NCT02415556|65199153|FG001|Overall Study|Lost to Follow-up|5|||
23397450|NCT02415556|65199154|FG002|Overall Study|Lost to Follow-up|4|||
23397451|NCT02415556|65199155|FG003|Overall Study|Lost to Follow-up|1|||
23397452|NCT02415556|65199152|FG000|Overall Study|Withdrawal by Subject|13|||
23397453|NCT02415556|65199153|FG001|Overall Study|Withdrawal by Subject|4|||
23397454|NCT02415556|65199154|FG002|Overall Study|Withdrawal by Subject|14|||
23397455|NCT02415556|65199155|FG003|Overall Study|Withdrawal by Subject|12|||
23397456|NCT02415556|65199152|FG000|Overall Study|Physician Decision|1|||
23397457|NCT02415556|65199153|FG001|Overall Study|Physician Decision|3|||
23397458|NCT02415556|65199154|FG002|Overall Study|Physician Decision|1|||
23397459|NCT02415556|65199155|FG003|Overall Study|Physician Decision|2|||
23397460|NCT02415556|65199152|FG000|Overall Study|Censored - study completion|4|||
23397461|NCT02415556|65199153|FG001|Overall Study|Censored - study completion|5|||
23397462|NCT02415556|65199154|FG002|Overall Study|Censored - study completion|1|||
23397463|NCT02415556|65199155|FG003|Overall Study|Censored - study completion|0|||
23397464|NCT02415556|65199152|FG000|Overall Study|Family-related issues|0|||
23397465|NCT02415556|65199153|FG001|Overall Study|Family-related issues|0|||
23397466|NCT02415556|65199154|FG002|Overall Study|Family-related issues|0|||
23397467|NCT02415556|65199155|FG003|Overall Study|Family-related issues|1|||
23397468|NCT00332696|65199156|FG000|Overall Study|Death|24|||
23397469|NCT00332696|65199157|FG001|Overall Study|Death|14|||
23397470|NCT00332696|65199156|FG000|Overall Study|Insufficient therapeutic effect|4|||
23397471|NCT00332696|65199157|FG001|Overall Study|Insufficient therapeutic effect|11|||
23397472|NCT00332696|65199156|FG000|Overall Study|Adverse Event|1|||
23397473|NCT00332696|65199157|FG001|Overall Study|Adverse Event|2|||
23397474|NCT00332696|65199156|FG000|Overall Study|Condition does not justify treatment|0|||
23397475|NCT00332696|65199157|FG001|Overall Study|Condition does not justify treatment|2|||
23397476|NCT00332696|65199156|FG000|Overall Study|Lost to Follow-up|0|||
23397477|NCT00332696|65199157|FG001|Overall Study|Lost to Follow-up|1|||
23397478|NCT00332696|65199156|FG000|Overall Study|Withdrawal by Subject|1|||
23397479|NCT00332696|65199157|FG001|Overall Study|Withdrawal by Subject|0|||
23397480|NCT01570387|65199160|FG000|Overall Study|Adverse Event|1|||
23498649|NCT01146665|65566427|FG000|Overall Study|Withdrawal by Subject|10|||
23397481|NCT01570387|65199161|FG001|Overall Study|Adverse Event|0|||
23397482|NCT01570387|65199162|FG002|Overall Study|Adverse Event|0|||
23397483|NCT01570387|65199163|FG003|Overall Study|Adverse Event|0|||
23397484|NCT01570387|65199160|FG000|Overall Study|Death|0|||
23397485|NCT01570387|65199161|FG001|Overall Study|Death|0|||
23397486|NCT01570387|65199162|FG002|Overall Study|Death|0|||
23397487|NCT01570387|65199163|FG003|Overall Study|Death|1|||
23498650|NCT01146665|65566428|FG001|Overall Study|Withdrawal by Subject|16|||
23397488|NCT01570387|65199160|FG000|Overall Study|Withdrawal by Subject|0|||
23397489|NCT01570387|65199161|FG001|Overall Study|Withdrawal by Subject|0|||
23397490|NCT01570387|65199162|FG002|Overall Study|Withdrawal by Subject|0|||
23397491|NCT01570387|65199163|FG003|Overall Study|Withdrawal by Subject|1|||
23397492|NCT03931330|65199164|FG000|Overall Study|Physician Decision|1|||
23397493|NCT04068922|65199165|FG000|Overall Study|Lost to Follow-up|5|||
23397494|NCT04068922|65199165|FG000|Overall Study|Withdrawal by Subject|7|||
23397495|NCT04068922|65199165|FG000|Overall Study|Adverse Event|1|||
23397496|NCT00856557|65199166|FG000|Overall Study|No patients with contextual flags|12|||
23498651|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
23397497|NCT00856557|65199167|FG001|Overall Study|No patients with contextual flags|16|||
23397498|NCT01133847|65203239|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
23397499|NCT01133847|65203240|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
23498652|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
23397500|NCT01133847|65203241|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
23397501|NCT01133847|65203239|FG000|Follow-Up Phase|Lost to Follow-up|1|||
23397502|NCT01133847|65203240|FG001|Follow-Up Phase|Lost to Follow-up|3|||
23397503|NCT01133847|65203241|FG002|Follow-Up Phase|Lost to Follow-up|7|||
23397504|NCT00133705|65203245|FG000|Overall Study|Withdrawal by Subject|2|||
23397505|NCT00133705|65203246|FG001|Overall Study|Withdrawal by Subject|3|||
23397506|NCT04976777|65203247|FG000|Overall Study|COVID-19 Infection|1|||
23397507|NCT04976777|65203248|FG001|Overall Study|COVID-19 Infection|0|||
23397508|NCT00478257|65203249|FG000|Overall Study|Withdrawal by Subject|8|||
23397509|NCT00478257|65203250|FG001|Overall Study|Withdrawal by Subject|3|||
23397510|NCT00573768|65203251|FG000|Overall Study|Adverse Event|1|||
23397511|NCT00573768|65203252|FG001|Overall Study|Adverse Event|1|||
23397512|NCT00573768|65203253|FG002|Overall Study|Adverse Event|2|||
23397513|NCT00573768|65203251|FG000|Overall Study|Protocol Violation|1|||
23397514|NCT00573768|65203252|FG001|Overall Study|Protocol Violation|0|||
23397515|NCT00573768|65203253|FG002|Overall Study|Protocol Violation|1|||
23397516|NCT00573768|65203251|FG000|Overall Study|Withdrawal by Subject|0|||
23397517|NCT00573768|65203252|FG001|Overall Study|Withdrawal by Subject|1|||
23397518|NCT00573768|65203253|FG002|Overall Study|Withdrawal by Subject|0|||
23397519|NCT00573768|65203251|FG000|Overall Study|Lost to Follow-up|0|||
23397520|NCT00573768|65203252|FG001|Overall Study|Lost to Follow-up|0|||
23397521|NCT00573768|65203253|FG002|Overall Study|Lost to Follow-up|1|||
23397522|NCT01055028|65203256|FG000|Screening|Screen Failure|1|||
23397523|NCT01055028|65203257|FG001|Screening|Screen Failure|1|||
23397524|NCT01055028|65203256|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
23397525|NCT01055028|65203257|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
23397526|NCT01055028|65203256|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
23397527|NCT01055028|65203257|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
23397528|NCT01055028|65203256|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
23397529|NCT01055028|65203257|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
23397530|NCT03341936|65203258|FG000|Overall Study|Ineligible|1|||
23397531|NCT03341936|65203258|FG000|Overall Study|Disease Progression|2|||
23397532|NCT03341936|65203258|FG000|Overall Study|Withdrew Consent|4|||
23397533|NCT03341936|65203258|FG000|Overall Study|Non-Compliance|1|||
23397534|NCT03341936|65203258|FG000|Overall Study|Physician Decision|1|||
23397535|NCT03341936|65203258|FG000|Overall Study|Withdrawal by Subject|1|||
23397536|NCT03341936|65203258|FG000|Overall Study|Other|1|||
23397537|NCT01047540|65203264|FG000|Overall Study|Protocol Violation|1|||
23397538|NCT01047540|65203265|FG001|Overall Study|Protocol Violation|0|||
23397539|NCT01047540|65203266|FG002|Overall Study|Protocol Violation|0|||
23397540|NCT01047540|65203267|FG003|Overall Study|Protocol Violation|0|||
23397541|NCT01047540|65203268|FG004|Overall Study|Protocol Violation|0|||
23397542|NCT01047540|65203264|FG000|Overall Study|Lost to Follow-up|1|||
23397543|NCT01047540|65203265|FG001|Overall Study|Lost to Follow-up|0|||
23397544|NCT01047540|65203266|FG002|Overall Study|Lost to Follow-up|0|||
23397545|NCT01047540|65203267|FG003|Overall Study|Lost to Follow-up|0|||
23397546|NCT01047540|65203268|FG004|Overall Study|Lost to Follow-up|0|||
23397547|NCT01047540|65203264|FG000|Overall Study|Withdrawal by Subject|1|||
23397548|NCT01047540|65203265|FG001|Overall Study|Withdrawal by Subject|0|||
23397549|NCT01047540|65203266|FG002|Overall Study|Withdrawal by Subject|3|||
23397550|NCT01047540|65203267|FG003|Overall Study|Withdrawal by Subject|0|||
23397551|NCT01047540|65203268|FG004|Overall Study|Withdrawal by Subject|1|||
23397552|NCT01047540|65203264|FG000|Overall Study|Pregnancy|1|||
23397553|NCT01047540|65203265|FG001|Overall Study|Pregnancy|0|||
23397554|NCT01047540|65203266|FG002|Overall Study|Pregnancy|0|||
23397555|NCT01047540|65203267|FG003|Overall Study|Pregnancy|0|||
23397556|NCT01047540|65203268|FG004|Overall Study|Pregnancy|0|||
23397557|NCT01047540|65203264|FG000|Overall Study|Adverse Event|1|||
23397558|NCT01047540|65203265|FG001|Overall Study|Adverse Event|0|||
23397559|NCT01047540|65203266|FG002|Overall Study|Adverse Event|0|||
23397560|NCT01047540|65203267|FG003|Overall Study|Adverse Event|0|||
23397561|NCT01047540|65203268|FG004|Overall Study|Adverse Event|0|||
23397562|NCT04749914|65203269|FG000|Period 1|Adverse Event|1|||
23397563|NCT04749914|65203270|FG001|Period 1|Adverse Event|0|||
23397564|NCT04749914|65203271|FG002|Period 1|Adverse Event|0|||
23397565|NCT04749914|65203272|FG003|Period 1|Adverse Event|0|||
23397566|NCT04749914|65203269|FG000|Period 1|Withdrawal by Subject|1|||
23397567|NCT04749914|65203270|FG001|Period 1|Withdrawal by Subject|0|||
23397568|NCT04749914|65203271|FG002|Period 1|Withdrawal by Subject|1|||
23397569|NCT04749914|65203272|FG003|Period 1|Withdrawal by Subject|0|||
23397570|NCT04856527|65203273|FG000|Overall Study|Unable to complete experimental task|2|||
23397571|NCT04856527|65203274|FG001|Overall Study|Unable to complete experimental task|0|||
23397572|NCT02670473|65203275|FG000|Overall Study|Withdrawal by Subject|1|||
23397573|NCT01209767|65203279|FG000|Overall Study|Withdrawal by Subject|1|||
23397574|NCT01209767|65203279|FG000|Overall Study|Lost to Follow-up|3|||
23397575|NCT00016354|65203280|FG000|Overall Study|Lack of Efficacy|0|||
23397576|NCT00016354|65203281|FG001|Overall Study|Lack of Efficacy|0|||
23397577|NCT00016354|65203282|FG002|Overall Study|Lack of Efficacy|0|||
23397578|NCT00016354|65203283|FG003|Overall Study|Lack of Efficacy|0|||
23397579|NCT00016354|65203284|FG004|Overall Study|Lack of Efficacy|0|||
23397580|NCT00016354|65203285|FG005|Overall Study|Lack of Efficacy|0|||
23397581|NCT00016354|65203286|FG006|Overall Study|Lack of Efficacy|0|||
23397582|NCT00016354|65203287|FG007|Overall Study|Lack of Efficacy|1|||
23397583|NCT02081586|65203288|FG000|Overall Study|Lost to Follow-up|0|||
23397584|NCT02081586|65203289|FG001|Overall Study|Lost to Follow-up|1|||
23397585|NCT02081586|65203290|FG002|Overall Study|Lost to Follow-up|0|||
23397586|NCT02081586|65203291|FG003|Overall Study|Lost to Follow-up|1|||
23397587|NCT02081586|65203288|FG000|Overall Study|Head injury not related to study|0|||
23397588|NCT02081586|65203289|FG001|Overall Study|Head injury not related to study|0|||
23397589|NCT02081586|65203290|FG002|Overall Study|Head injury not related to study|1|||
23397590|NCT02081586|65203291|FG003|Overall Study|Head injury not related to study|0|||
23397591|NCT02735200|65203292|FG000|Overall Study|Lost to Follow-up|0|||
23397592|NCT02735200|65203293|FG001|Overall Study|Lost to Follow-up|5|||
23397593|NCT02735200|65203292|FG000|Overall Study|Withdrawal by Subject|8|||
23397594|NCT02735200|65203293|FG001|Overall Study|Withdrawal by Subject|0|||
23397595|NCT01280968|65203298|FG000|Overall Study|Lost to Follow-up|8|||
23397596|NCT01280968|65203299|FG001|Overall Study|Lost to Follow-up|2|||
23397597|NCT01280968|65203298|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
23397598|NCT01280968|65203299|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
23397599|NCT01280968|65203298|FG000|Overall Study|Commuting Problems|2|||
23397600|NCT01280968|65203299|FG001|Overall Study|Commuting Problems|0|||
23397601|NCT01280968|65203298|FG000|Overall Study|Anxiety|2|||
23397602|NCT01280968|65203299|FG001|Overall Study|Anxiety|0|||
23397603|NCT01280968|65203298|FG000|Overall Study|Adverse Event|1|||
23397604|NCT01280968|65203299|FG001|Overall Study|Adverse Event|0|||
23397605|NCT01280968|65203298|FG000|Overall Study|Scheduling Conflicts|1|||
23397606|NCT01280968|65203299|FG001|Overall Study|Scheduling Conflicts|1|||
23397607|NCT01280968|65203298|FG000|Overall Study|Pre-existing Neurological Condition|1|||
23397608|NCT01280968|65203299|FG001|Overall Study|Pre-existing Neurological Condition|0|||
23397609|NCT01280968|65203298|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
23397610|NCT01280968|65203299|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
23397611|NCT04507763|65203300|FG000|Overall Study|Participants did not meet entrance criteria|201|||
23397612|NCT01853280|65203303|FG000|Overall Study|Lack of Efficacy|2|||
23397613|NCT01853280|65203304|FG001|Overall Study|Lack of Efficacy|2|||
23397614|NCT01853280|65203303|FG000|Overall Study|Lost to Follow-up|0|||
23397615|NCT01853280|65203304|FG001|Overall Study|Lost to Follow-up|1|||
23397616|NCT01853280|65203303|FG000|Overall Study|Physician Decision|0|||
23397617|NCT01853280|65203304|FG001|Overall Study|Physician Decision|1|||
23397618|NCT01853280|65203303|FG000|Overall Study|Withdrawal by Subject|0|||
23397619|NCT01853280|65203304|FG001|Overall Study|Withdrawal by Subject|1|||
23397620|NCT01853280|65203303|FG000|Overall Study|Ineligible|0|||
23397621|NCT01853280|65203304|FG001|Overall Study|Ineligible|1|||
23397622|NCT00492557|65203305|FG000|Overall Study|Subject request|12|||
23397623|NCT00492557|65203306|FG001|Overall Study|Subject request|11|||
23397624|NCT00492557|65203305|FG000|Overall Study|Protocol Violation|7|||
23397625|NCT00492557|65203306|FG001|Overall Study|Protocol Violation|8|||
23397626|NCT00492557|65203305|FG000|Overall Study|Other|2|||
23397627|NCT00492557|65203306|FG001|Overall Study|Other|2|||
23397628|NCT00492557|65203305|FG000|Overall Study|Death|1|||
23397629|NCT00492557|65203306|FG001|Overall Study|Death|1|||
23397630|NCT00492557|65203305|FG000|Overall Study|Adverse Event|1|||
23397631|NCT00492557|65203306|FG001|Overall Study|Adverse Event|0|||
23397632|NCT00492557|65203305|FG000|Overall Study|Failed to return|1|||
23397633|NCT00492557|65203306|FG001|Overall Study|Failed to return|0|||
23397634|NCT00492557|65203305|FG000|Overall Study|Lost to Follow-up|0|||
23397635|NCT00492557|65203306|FG001|Overall Study|Lost to Follow-up|1|||
23397636|NCT02806414|65203307|FG000|Overall Study|Lost to Follow-up|2|||
23397637|NCT01152437|65203308|FG000|Overall Study|Other Adverse Event|8|||
23397638|NCT01152437|65203309|FG001|Overall Study|Other Adverse Event|1|||
23397639|NCT01152437|65203310|FG002|Overall Study|Other Adverse Event|7|||
23397640|NCT01152437|65203308|FG000|Overall Study|Not treated|0|||
23397641|NCT01152437|65203309|FG001|Overall Study|Not treated|1|||
23397642|NCT01152437|65203310|FG002|Overall Study|Not treated|2|||
23397643|NCT01152437|65203308|FG000|Overall Study|Progressive disease|27|||
23397644|NCT01152437|65203309|FG001|Overall Study|Progressive disease|13|||
23397645|NCT01152437|65203310|FG002|Overall Study|Progressive disease|32|||
23397646|NCT01152437|65203308|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
23397647|NCT01152437|65203309|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
23397648|NCT01152437|65203310|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
23397649|NCT01441960|65203311|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
23397650|NCT01441960|65203312|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
23397651|NCT01441960|65203311|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
23397652|NCT01441960|65203312|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
23397653|NCT01441960|65203311|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
23397654|NCT01441960|65203312|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
23397655|NCT03435380|65203313|FG000|Overall Study|Death|1|||
23397656|NCT03435380|65203314|FG001|Overall Study|Death|2|||
23397657|NCT03435380|65203315|FG002|Overall Study|Death|1|||
23397658|NCT03435380|65203313|FG000|Overall Study|Lost to Follow-up|12|||
23397659|NCT03435380|65203314|FG001|Overall Study|Lost to Follow-up|8|||
23397660|NCT03435380|65203315|FG002|Overall Study|Lost to Follow-up|6|||
23397661|NCT03435380|65203313|FG000|Overall Study|Physician Decision|1|||
23397662|NCT03435380|65203314|FG001|Overall Study|Physician Decision|0|||
23397663|NCT03435380|65203315|FG002|Overall Study|Physician Decision|0|||
23397664|NCT03435380|65203313|FG000|Overall Study|Withdrawal by Subject|0|||
23397665|NCT03435380|65203314|FG001|Overall Study|Withdrawal by Subject|1|||
23397666|NCT03435380|65203315|FG002|Overall Study|Withdrawal by Subject|1|||
23397667|NCT03435380|65203313|FG000|Overall Study|Ineligible|0|||
23397668|NCT03435380|65203314|FG001|Overall Study|Ineligible|1|||
23397669|NCT03435380|65203315|FG002|Overall Study|Ineligible|1|||
23397670|NCT00104884|65203319|FG000|Overall Study|Disease progression|4|||
23397671|NCT04388826|65203320|FG000|Overall Study|Lost to Follow-up|3|||
23397672|NCT04388826|65203321|FG001|Overall Study|Lost to Follow-up|2|||
23397673|NCT04388826|65203320|FG000|Overall Study|Adverse Event|1|||
23397674|NCT04388826|65203321|FG001|Overall Study|Adverse Event|0|||
23397675|NCT00462826|65203322|FG000|Overall Study|Ineligible - second primary|1|||
23397676|NCT00462826|65203322|FG000|Overall Study|Ineligible - wrong cell type|1|||
23397677|NCT00462826|65203322|FG000|Overall Study|Ineligible - wrong primary|2|||
23397678|NCT00462826|65203322|FG000|Overall Study|Never treated|1|||
23397679|NCT00557440|65203323|FG000|Treatment Period 1|Adverse Event|0|||
23397680|NCT00557440|65203324|FG001|Treatment Period 1|Adverse Event|0|||
23397681|NCT00557440|65203325|FG002|Treatment Period 1|Adverse Event|1|||
23397682|NCT04704193|65203329|FG000|Overall Study|Withdrawal by Subject|1|||
23397683|NCT00889005|65203330|FG000|Overall Study|Lost to Follow-up|4|||
23397684|NCT00889005|65203331|FG001|Overall Study|Lost to Follow-up|2|||
23397685|NCT00889005|65203330|FG000|Overall Study|Withdrawal by Subject|4|||
23397686|NCT00889005|65203331|FG001|Overall Study|Withdrawal by Subject|0|||
23397687|NCT02157610|65203338|FG000|Overall Study|Death|4|||
23397688|NCT02157610|65203339|FG001|Overall Study|Death|4|||
23397689|NCT00718315|65203344|FG000|Overall Study|Adverse Event|1|||
23397690|NCT00718315|65203345|FG001|Overall Study|Adverse Event|2|||
23397691|NCT00718315|65203346|FG002|Overall Study|Adverse Event|3|||
23397692|NCT00718315|65203344|FG000|Overall Study|Death|6|||
23397693|NCT00718315|65203345|FG001|Overall Study|Death|6|||
23397694|NCT00718315|65203346|FG002|Overall Study|Death|5|||
23397695|NCT00718315|65203344|FG000|Overall Study|Lost to Follow-up|2|||
23397696|NCT00718315|65203345|FG001|Overall Study|Lost to Follow-up|3|||
23397697|NCT00718315|65203346|FG002|Overall Study|Lost to Follow-up|4|||
23397698|NCT00718315|65203344|FG000|Overall Study|Protocol Violation|5|||
23397699|NCT00718315|65203345|FG001|Overall Study|Protocol Violation|5|||
23397700|NCT00718315|65203346|FG002|Overall Study|Protocol Violation|3|||
23397701|NCT00718315|65203344|FG000|Overall Study|Erlotinib dose decreased|4|||
23397702|NCT00718315|65203345|FG001|Overall Study|Erlotinib dose decreased|3|||
23397703|NCT00718315|65203346|FG002|Overall Study|Erlotinib dose decreased|1|||
23397704|NCT00718315|65203344|FG000|Overall Study|Use of Minocyclin|1|||
23397705|NCT00718315|65203345|FG001|Overall Study|Use of Minocyclin|1|||
23397706|NCT00718315|65203346|FG002|Overall Study|Use of Minocyclin|1|||
23397707|NCT00718315|65203344|FG000|Overall Study|Disease progression|0|||
23498653|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
23498654|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
23397708|NCT00718315|65203345|FG001|Overall Study|Disease progression|1|||
23397709|NCT00718315|65203346|FG002|Overall Study|Disease progression|1|||
23498655|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
23397710|NCT00718315|65203344|FG000|Overall Study|Other|0|||
23397711|NCT00718315|65203345|FG001|Overall Study|Other|0|||
23397712|NCT00718315|65203346|FG002|Overall Study|Other|1|||
23397713|NCT00718315|65203344|FG000|Overall Study|Use of ATB and Corticoids|0|||
23397714|NCT00718315|65203345|FG001|Overall Study|Use of ATB and Corticoids|1|||
23397715|NCT00718315|65203346|FG002|Overall Study|Use of ATB and Corticoids|2|||
23397716|NCT02684461|65203347|FG000|Overall Study|Adverse Event|1|||
23397717|NCT02684461|65203348|FG001|Overall Study|Adverse Event|0|||
23397718|NCT02684461|65203349|FG002|Overall Study|Adverse Event|0|||
23397719|NCT02684461|65203347|FG000|Overall Study|Lack of Efficacy|1|||
23397720|NCT02684461|65203348|FG001|Overall Study|Lack of Efficacy|2|||
23397721|NCT02684461|65203349|FG002|Overall Study|Lack of Efficacy|0|||
23397722|NCT02154061|65203353|FG000|Overall Study|Pregnancy|1|||
23397723|NCT02154061|65203354|FG001|Overall Study|Pregnancy|0|||
23397724|NCT02154061|65203353|FG000|Overall Study|enrolled but not vaccinated|1|||
23397725|NCT02154061|65203354|FG001|Overall Study|enrolled but not vaccinated|0|||
23397726|NCT04023487|65203355|FG000|Overall Study|Lost to Follow-up|5|||
23397727|NCT04023487|65203356|FG001|Overall Study|Lost to Follow-up|4|||
23397728|NCT04023487|65203355|FG000|Overall Study|Pregnancy|1|||
23397729|NCT04023487|65203356|FG001|Overall Study|Pregnancy|2|||
23397730|NCT04023487|65203355|FG000|Overall Study|Withdrawal by Subject|4|||
23397731|NCT04023487|65203356|FG001|Overall Study|Withdrawal by Subject|5|||
23397732|NCT04023487|65203355|FG000|Overall Study|Partially completed testing|8|||
23397733|NCT04023487|65203356|FG001|Overall Study|Partially completed testing|4|||
23397734|NCT01784029|65203361|FG000|Overall Study|Lost to Follow-up|19|||
23397735|NCT01784029|65203362|FG001|Overall Study|Lost to Follow-up|20|||
23397736|NCT01784029|65203363|FG002|Overall Study|Lost to Follow-up|22|||
23397737|NCT01994876|65203375|FG000|Test Period 1|Withdrawal by Subject|0|||
23397738|NCT01994876|65203376|FG001|Test Period 1|Withdrawal by Subject|1|||
23397739|NCT01994876|65203375|FG000|Test Period 1|Adverse Event|0|||
23397740|NCT01994876|65203376|FG001|Test Period 1|Adverse Event|1|||
23397741|NCT01994876|65203375|FG000|Test Period 2|Adverse Event|1|||
23397742|NCT01994876|65203376|FG001|Test Period 2|Adverse Event|0|||
23397743|NCT01994876|65203375|FG000|Test Period 2|Protocol Violation|0|||
23397744|NCT01994876|65203376|FG001|Test Period 2|Protocol Violation|1|||
23397745|NCT01198587|65203377|FG000|Overall Study|Lost to Follow-up|8|||
23397746|NCT01198587|65203378|FG001|Overall Study|Lost to Follow-up|0|||
23397747|NCT01198587|65203379|FG002|Overall Study|Lost to Follow-up|9|||
23397748|NCT01198587|65203380|FG003|Overall Study|Lost to Follow-up|0|||
23397749|NCT01246960|65203383|FG000|Overall Study|Lost to Follow-up|3|||
23397750|NCT01246960|65203384|FG001|Overall Study|Lost to Follow-up|1|||
23397751|NCT01246960|65203383|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
23397752|NCT01246960|65203384|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
23397753|NCT02604511|65203385|FG000|Overall Study|Adverse Event|3|||
23397754|NCT02604511|65203385|FG000|Overall Study|Disease Progression|4|||
23397755|NCT02604511|65203385|FG000|Overall Study|Withdrawal by Subject|3|||
23397756|NCT02604511|65203385|FG000|Overall Study|Participant ineligible|1|||
23397757|NCT02604511|65203385|FG000|Overall Study|Intercurrent illness|1|||
23397758|NCT04570384|65203386|FG000|Overall Study|Adverse Event|2|||
23397759|NCT04570384|65203387|FG001|Overall Study|Adverse Event|1|||
23397760|NCT04570384|65203386|FG000|Overall Study|Death|2|||
23397761|NCT04570384|65203387|FG001|Overall Study|Death|5|||
23397762|NCT04570384|65203386|FG000|Overall Study|Lost to Follow-up|1|||
23397763|NCT04570384|65203387|FG001|Overall Study|Lost to Follow-up|0|||
23397764|NCT04570384|65203386|FG000|Overall Study|Other|1|||
23397765|NCT04570384|65203387|FG001|Overall Study|Other|0|||
23397766|NCT04570384|65203386|FG000|Overall Study|Protocol Violation|0|||
23397767|NCT04570384|65203387|FG001|Overall Study|Protocol Violation|1|||
23397768|NCT04570384|65203386|FG000|Overall Study|Sponsor Decision|1|||
23397769|NCT04570384|65203387|FG001|Overall Study|Sponsor Decision|0|||
23397770|NCT04570384|65203386|FG000|Overall Study|Withdrawal by Subject|4|||
23397771|NCT04570384|65203387|FG001|Overall Study|Withdrawal by Subject|2|||
23397772|NCT01832727|65203388|FG000|Overall Study|Adverse Event|4|||
23397773|NCT01832727|65203389|FG001|Overall Study|Adverse Event|6|||
23397774|NCT01832727|65203390|FG002|Overall Study|Adverse Event|1|||
23397775|NCT01832727|65203391|FG003|Overall Study|Adverse Event|0|||
23397776|NCT01832727|65203392|FG004|Overall Study|Adverse Event|1|||
23397777|NCT01832727|65203393|FG005|Overall Study|Adverse Event|1|||
23397778|NCT01832727|65203394|FG006|Overall Study|Adverse Event|2|||
23397779|NCT01832727|65203395|FG007|Overall Study|Adverse Event|1|||
23397780|NCT01832727|65203396|FG008|Overall Study|Adverse Event|9|||
23397781|NCT01832727|65203388|FG000|Overall Study|Disease progression|3|||
23397782|NCT01832727|65203389|FG001|Overall Study|Disease progression|0|||
23397783|NCT01832727|65203390|FG002|Overall Study|Disease progression|2|||
23397784|NCT01832727|65203391|FG003|Overall Study|Disease progression|1|||
23397785|NCT01832727|65203392|FG004|Overall Study|Disease progression|3|||
23397786|NCT01832727|65203393|FG005|Overall Study|Disease progression|3|||
23397787|NCT01832727|65203394|FG006|Overall Study|Disease progression|6|||
23397788|NCT01832727|65203395|FG007|Overall Study|Disease progression|2|||
23397789|NCT01832727|65203396|FG008|Overall Study|Disease progression|7|||
23397790|NCT01832727|65203388|FG000|Overall Study|Lost to Follow-up|0|||
23397791|NCT01832727|65203389|FG001|Overall Study|Lost to Follow-up|0|||
23397792|NCT01832727|65203390|FG002|Overall Study|Lost to Follow-up|0|||
23397793|NCT01832727|65203391|FG003|Overall Study|Lost to Follow-up|1|||
23397794|NCT01832727|65203392|FG004|Overall Study|Lost to Follow-up|0|||
23397795|NCT01832727|65203393|FG005|Overall Study|Lost to Follow-up|0|||
23397796|NCT01832727|65203394|FG006|Overall Study|Lost to Follow-up|0|||
23397797|NCT01832727|65203395|FG007|Overall Study|Lost to Follow-up|0|||
23397798|NCT01832727|65203396|FG008|Overall Study|Lost to Follow-up|0|||
23397799|NCT01832727|65203388|FG000|Overall Study|Physician Decision|1|||
23397800|NCT01832727|65203389|FG001|Overall Study|Physician Decision|0|||
23397801|NCT01832727|65203390|FG002|Overall Study|Physician Decision|0|||
23397802|NCT01832727|65203391|FG003|Overall Study|Physician Decision|1|||
23397803|NCT01832727|65203392|FG004|Overall Study|Physician Decision|0|||
23397804|NCT01832727|65203393|FG005|Overall Study|Physician Decision|1|||
23397805|NCT01832727|65203394|FG006|Overall Study|Physician Decision|0|||
23397806|NCT01832727|65203395|FG007|Overall Study|Physician Decision|0|||
23397807|NCT01832727|65203396|FG008|Overall Study|Physician Decision|0|||
23397808|NCT01832727|65203388|FG000|Overall Study|Withdrawal by Subject|1|||
23397809|NCT01832727|65203389|FG001|Overall Study|Withdrawal by Subject|1|||
23397810|NCT01832727|65203390|FG002|Overall Study|Withdrawal by Subject|0|||
23397811|NCT01832727|65203391|FG003|Overall Study|Withdrawal by Subject|1|||
23397812|NCT01832727|65203392|FG004|Overall Study|Withdrawal by Subject|0|||
23397813|NCT01832727|65203393|FG005|Overall Study|Withdrawal by Subject|1|||
23397814|NCT01832727|65203394|FG006|Overall Study|Withdrawal by Subject|0|||
23397815|NCT01832727|65203395|FG007|Overall Study|Withdrawal by Subject|2|||
23397816|NCT01832727|65203396|FG008|Overall Study|Withdrawal by Subject|1|||
23397817|NCT01832727|65203388|FG000|Overall Study|Study terminated by sponsor|0|||
23397818|NCT01832727|65203389|FG001|Overall Study|Study terminated by sponsor|0|||
23397819|NCT01832727|65203390|FG002|Overall Study|Study terminated by sponsor|0|||
23397820|NCT01832727|65203391|FG003|Overall Study|Study terminated by sponsor|0|||
23397821|NCT01832727|65203392|FG004|Overall Study|Study terminated by sponsor|0|||
23397822|NCT01832727|65203393|FG005|Overall Study|Study terminated by sponsor|0|||
23397823|NCT01832727|65203394|FG006|Overall Study|Study terminated by sponsor|0|||
23397824|NCT01832727|65203395|FG007|Overall Study|Study terminated by sponsor|1|||
23397825|NCT01832727|65203396|FG008|Overall Study|Study terminated by sponsor|1|||
23397826|NCT03235050|65203397|FG000|Overall Study|Adverse Event|0|||
23397827|NCT03235050|65203398|FG001|Overall Study|Adverse Event|0|||
23397828|NCT03235050|65203399|FG002|Overall Study|Adverse Event|1|||
23397829|NCT03235050|65203400|FG003|Overall Study|Adverse Event|4|||
23397830|NCT03235050|65203401|FG004|Overall Study|Adverse Event|1|||
23397831|NCT03235050|65203397|FG000|Overall Study|Death|0|||
23397832|NCT03235050|65203398|FG001|Overall Study|Death|0|||
23397833|NCT03235050|65203399|FG002|Overall Study|Death|0|||
23397834|NCT03235050|65203400|FG003|Overall Study|Death|2|||
23397835|NCT03235050|65203401|FG004|Overall Study|Death|1|||
23397836|NCT03235050|65203397|FG000|Overall Study|Lost to Follow-up|1|||
23397837|NCT03235050|65203398|FG001|Overall Study|Lost to Follow-up|2|||
23397838|NCT03235050|65203399|FG002|Overall Study|Lost to Follow-up|1|||
23397839|NCT03235050|65203400|FG003|Overall Study|Lost to Follow-up|2|||
23397840|NCT03235050|65203401|FG004|Overall Study|Lost to Follow-up|0|||
23397841|NCT03235050|65203397|FG000|Overall Study|Withdrawal by Subject|3|||
23397842|NCT03235050|65203398|FG001|Overall Study|Withdrawal by Subject|2|||
23397843|NCT03235050|65203399|FG002|Overall Study|Withdrawal by Subject|2|||
23397844|NCT03235050|65203400|FG003|Overall Study|Withdrawal by Subject|5|||
23397845|NCT03235050|65203401|FG004|Overall Study|Withdrawal by Subject|7|||
23397846|NCT03235050|65203397|FG000|Overall Study|Other reasons|0|||
23397847|NCT03235050|65203398|FG001|Overall Study|Other reasons|1|||
23397848|NCT03235050|65203399|FG002|Overall Study|Other reasons|0|||
23397849|NCT03235050|65203400|FG003|Overall Study|Other reasons|1|||
23397850|NCT03235050|65203401|FG004|Overall Study|Other reasons|2|||
23397851|NCT04436744|65203406|FG000|Overall Study|Adverse Event|1|||
23397852|NCT04436744|65203407|FG001|Overall Study|Adverse Event|1|||
23397853|NCT04436744|65203406|FG000|Overall Study|Death|1|||
23397854|NCT04436744|65203407|FG001|Overall Study|Death|0|||
23397855|NCT04436744|65203406|FG000|Overall Study|Lost to Follow-up|0|||
23397856|NCT04436744|65203407|FG001|Overall Study|Lost to Follow-up|2|||
23397857|NCT04436744|65203406|FG000|Overall Study|Physician Decision|0|||
23397858|NCT04436744|65203407|FG001|Overall Study|Physician Decision|1|||
23397859|NCT04436744|65203406|FG000|Overall Study|Progressive Disease|0|||
23397860|NCT04436744|65203407|FG001|Overall Study|Progressive Disease|4|||
23397861|NCT04436744|65203406|FG000|Overall Study|Protocol Deviation|1|||
23397862|NCT04436744|65203407|FG001|Overall Study|Protocol Deviation|1|||
23397863|NCT04436744|65203406|FG000|Overall Study|Withdrawal by Subject|1|||
23397864|NCT04436744|65203407|FG001|Overall Study|Withdrawal by Subject|2|||
23397865|NCT02704208|65203408|FG000|Overall Study|Lost to Follow-up|42|||
23397866|NCT02704208|65203409|FG001|Overall Study|Lost to Follow-up|37|||
23397867|NCT01677988|65203410|FG000|Overall Study|Lack of Efficacy|2|||
23397868|NCT04476784|65203414|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
23397869|NCT04476784|65203415|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
23397870|NCT02437318|65203416|FG000|Overall Study|Progressive disease|173|||
23397871|NCT02437318|65203417|FG001|Overall Study|Progressive disease|208|||
23397872|NCT02437318|65203416|FG000|Overall Study|Subject/guardian decision|22|||
23397873|NCT02437318|65203417|FG001|Overall Study|Subject/guardian decision|10|||
23397874|NCT02437318|65203416|FG000|Overall Study|Physician Decision|11|||
23397875|NCT02437318|65203417|FG001|Overall Study|Physician Decision|10|||
23397876|NCT02437318|65203416|FG000|Overall Study|Adverse Event|14|||
23397877|NCT02437318|65203417|FG001|Overall Study|Adverse Event|3|||
23397878|NCT02437318|65203416|FG000|Overall Study|Death|4|||
23397879|NCT02437318|65203417|FG001|Overall Study|Death|4|||
23397880|NCT02437318|65203416|FG000|Overall Study|Protocol Violation|5|||
23397881|NCT02437318|65203417|FG001|Overall Study|Protocol Violation|6|||
23397882|NCT02437318|65203416|FG000|Overall Study|Untreated|0|||
23397883|NCT02437318|65203417|FG001|Overall Study|Untreated|1|||
23397884|NCT00448448|65203419|FG000|Overall Study|Withdrawal by Subject|13|||
23397885|NCT00448448|65203420|FG001|Overall Study|Withdrawal by Subject|2|||
23397886|NCT00448448|65203419|FG000|Overall Study|On protocol when study ended|83|||
23397887|NCT00448448|65203420|FG001|Overall Study|On protocol when study ended|36|||
23397888|NCT00448448|65203419|FG000|Overall Study|Lost to Follow-up|2|||
23397889|NCT00448448|65203420|FG001|Overall Study|Lost to Follow-up|1|||
23397890|NCT00448448|65203419|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
23397891|NCT00448448|65203420|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
23397892|NCT00448448|65203419|FG000|Overall Study|Signed consent lost|0|||
23397893|NCT00448448|65203420|FG001|Overall Study|Signed consent lost|1|||
23397894|NCT02378480|65203421|FG000|Overall Study|Physician Decision|1|||
23397895|NCT02378480|65203422|FG001|Overall Study|Physician Decision|1|||
23397896|NCT02378480|65203421|FG000|Overall Study|Death|1|||
23397897|NCT02378480|65203422|FG001|Overall Study|Death|2|||
23397898|NCT02378480|65203421|FG000|Overall Study|Randomized, but Not Treated|6|||
23397899|NCT02378480|65203422|FG001|Overall Study|Randomized, but Not Treated|4|||
23397900|NCT02378480|65203421|FG000|Overall Study|Adverse Event|0|||
23397901|NCT02378480|65203422|FG001|Overall Study|Adverse Event|1|||
23397902|NCT02378480|65203421|FG000|Overall Study|Missed EOT/PTE Visit|1|||
23397903|NCT02378480|65203422|FG001|Overall Study|Missed EOT/PTE Visit|2|||
23397904|NCT02378480|65203421|FG000|Overall Study|Withdrawal by Subject|9|||
23397905|NCT02378480|65203422|FG001|Overall Study|Withdrawal by Subject|4|||
23397906|NCT02378480|65203421|FG000|Overall Study|Lost to Follow-up|10|||
23397907|NCT02378480|65203422|FG001|Overall Study|Lost to Follow-up|18|||
23397908|NCT02441218|65203425|FG000|Overall Study|Death|503|||
23397909|NCT02441218|65203426|FG001|Overall Study|Death|553|||
23397910|NCT02441218|65203425|FG000|Overall Study|Withdrawal by Subject|73|||
23397911|NCT02441218|65203426|FG001|Overall Study|Withdrawal by Subject|58|||
23397912|NCT02441218|65203425|FG000|Overall Study|Lost to Follow-up|2|||
23397913|NCT02441218|65203426|FG001|Overall Study|Lost to Follow-up|1|||
23397914|NCT01373281|65203427|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
23397915|NCT01373281|65203428|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
23397916|NCT01373281|65203427|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
23397917|NCT01373281|65203428|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
23397918|NCT01373281|65203427|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
23397919|NCT01373281|65203428|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
23397920|NCT01373281|65203427|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
23397921|NCT01373281|65203428|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
23397922|NCT01373281|65203427|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
23397923|NCT01373281|65203428|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
23397924|NCT01373281|65203427|FG000|Surveillance Expansion Period|Protocol Violation|9|||
23397925|NCT01373281|65203428|FG001|Surveillance Expansion Period|Protocol Violation|1|||
23397926|NCT01373281|65203427|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
23397927|NCT01373281|65203428|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
23397928|NCT01373281|65203427|FG000|Surveillance Expansion Period|Serious adverse event|3|||
23397929|NCT01373281|65203428|FG001|Surveillance Expansion Period|Serious adverse event|4|||
23397930|NCT02133573|65203434|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
23397931|NCT02133573|65203435|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
23397932|NCT02133573|65203434|FG000|Overall Study|Child Deaths|3|||
23397933|NCT02133573|65203435|FG001|Overall Study|Child Deaths|5|||
23397934|NCT02133573|65203434|FG000|Overall Study|Child Declined Follow Ups|2|||
23397935|NCT02133573|65203435|FG001|Overall Study|Child Declined Follow Ups|1|||
23397936|NCT02133573|65203434|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
23397937|NCT02133573|65203435|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
23397938|NCT01693367|65203438|FG000|Overall Study|Withdrawal by Subject|1|||
23397939|NCT01693367|65203439|FG001|Overall Study|Withdrawal by Subject|1|||
23397940|NCT01693367|65203438|FG000|Overall Study|Physician Decision|0|||
23397941|NCT01693367|65203439|FG001|Overall Study|Physician Decision|1|||
23397942|NCT00582907|65203440|FG000|1st Course|Withdrawal by Subject|1|||
23397943|NCT00582907|65203441|FG001|1st Course|Withdrawal by Subject|0|||
23397944|NCT00582907|65203442|FG002|1st Course|Withdrawal by Subject|0|||
23397945|NCT00582907|65203443|FG003|1st Course|Withdrawal by Subject|0|||
23397946|NCT00582907|65203440|FG000|1st Course|Lost to Follow-up|0|||
23397947|NCT00582907|65203441|FG001|1st Course|Lost to Follow-up|0|||
23397948|NCT00582907|65203442|FG002|1st Course|Lost to Follow-up|0|||
23397949|NCT00582907|65203443|FG003|1st Course|Lost to Follow-up|1|||
23498656|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
23498657|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
23397950|NCT00582907|65203440|FG000|2nd Course|Lack of Efficacy|1|||
23397951|NCT00582907|65203441|FG001|2nd Course|Lack of Efficacy|0|||
23397952|NCT00582907|65203442|FG002|2nd Course|Lack of Efficacy|0|||
23397953|NCT00582907|65203443|FG003|2nd Course|Lack of Efficacy|0|||
23397954|NCT04290624|65203444|FG000|Overall Study|Adverse Event|1|||
23397955|NCT04290624|65203445|FG001|Overall Study|Adverse Event|0|||
23397956|NCT00833690|65203446|FG000|Overall Study|Withdrawal by Subject|1|||
23397957|NCT00833690|65203447|FG001|Overall Study|Withdrawal by Subject|0|||
23397958|NCT00833690|65203448|FG002|Overall Study|Withdrawal by Subject|0|||
23397959|NCT00833690|65203446|FG000|Overall Study|Discontinued study drug|3|||
23397960|NCT00833690|65203447|FG001|Overall Study|Discontinued study drug|2|||
23397961|NCT00833690|65203448|FG002|Overall Study|Discontinued study drug|0|||
23397962|NCT00127855|65203453|FG000|Primary Vaccination Course|Adverse Event|0|||
23397963|NCT00127855|65203454|FG001|Primary Vaccination Course|Adverse Event|0|||
23397964|NCT00127855|65203455|FG002|Primary Vaccination Course|Adverse Event|1|||
23397965|NCT00127855|65203456|FG003|Primary Vaccination Course|Adverse Event|0|||
23397966|NCT00127855|65203457|FG004|Primary Vaccination Course|Adverse Event|0|||
23397967|NCT00127855|65203453|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
23397968|NCT00127855|65203454|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
23397969|NCT00127855|65203455|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
23397970|NCT00127855|65203456|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
23397971|NCT00127855|65203457|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
23397972|NCT00127855|65203453|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
23397973|NCT00127855|65203454|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
23397974|NCT00127855|65203455|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
23397975|NCT00127855|65203456|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
23397976|NCT00127855|65203457|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
23397977|NCT00127855|65203453|FG000|Primary Vaccination Course|Other|0|||
23397978|NCT00127855|65203454|FG001|Primary Vaccination Course|Other|0|||
23397979|NCT00127855|65203455|FG002|Primary Vaccination Course|Other|0|||
23397980|NCT00127855|65203456|FG003|Primary Vaccination Course|Other|0|||
23397981|NCT00127855|65203457|FG004|Primary Vaccination Course|Other|1|||
23397982|NCT01849276|65203459|FG000|Followed for Survival for 5 Years|Death|1|||
23397983|NCT01849276|65203459|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
23397984|NCT03383666|65203460|FG000|Overall Study|Withdrawal by Subject|2|||
23300686|NCT00317642|64842891|FG001|Overall Study|Death|7|||
23397985|NCT03383666|65203460|FG000|Overall Study|Lost to Follow-up|2|||
23397986|NCT01561976|65203461|FG000|Period 1|Adverse Event|0|||
23397987|NCT01561976|65203462|FG001|Period 1|Adverse Event|0|||
23397988|NCT01561976|65203463|FG002|Period 1|Adverse Event|1|||
23397989|NCT01561976|65203464|FG003|Period 1|Adverse Event|0|||
23397990|NCT01561976|65203465|FG004|Period 1|Adverse Event|0|||
23397991|NCT01561976|65203466|FG005|Period 1|Adverse Event|0|||
23397992|NCT01561976|65203461|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
23397993|NCT01561976|65203462|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
23397994|NCT01561976|65203463|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
23397995|NCT01561976|65203464|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
23397996|NCT01561976|65203465|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
23397997|NCT01561976|65203466|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
23397998|NCT01561976|65203461|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23397999|NCT01561976|65203462|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23398000|NCT01561976|65203463|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23398001|NCT01561976|65203464|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23398002|NCT01561976|65203465|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
23398003|NCT01561976|65203466|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
23398004|NCT01561976|65203461|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
23398005|NCT01561976|65203462|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
23398006|NCT01561976|65203463|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
23398007|NCT01561976|65203464|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
23398008|NCT01561976|65203465|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
23398009|NCT01561976|65203466|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
23398010|NCT00575666|65203467|FG000|Overall Study|Withdrawal by Subject|3|||
23398011|NCT00575666|65203468|FG001|Overall Study|Withdrawal by Subject|2|||
23398012|NCT00575666|65203467|FG000|Overall Study|Physician Decision|1|||
23398013|NCT00575666|65203468|FG001|Overall Study|Physician Decision|1|||
23398014|NCT02519842|65203469|FG000|Base Study: Cycle 1|Screening Failure|1|||
23398015|NCT02519842|65203470|FG001|Base Study: Cycle 1|Screening Failure|1|||
23398016|NCT02519842|65203471|FG002|Base Study: Cycle 1|Screening Failure|0|||
23398017|NCT02519842|65203469|FG000|Base Study: Cycle 1|Adverse Event|1|||
23398018|NCT02519842|65203470|FG001|Base Study: Cycle 1|Adverse Event|0|||
23398019|NCT02519842|65203471|FG002|Base Study: Cycle 1|Adverse Event|0|||
23398020|NCT02519842|65203469|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
23398021|NCT02519842|65203470|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
23398022|NCT02519842|65203471|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
23398023|NCT02519842|65203469|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
23398024|NCT02519842|65203470|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
23398025|NCT02519842|65203471|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
23398026|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
23398027|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
23398028|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
23398029|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
23398030|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
23398031|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
23398032|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23398033|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
23398034|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
23398035|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
23398036|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
23398037|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
23398038|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Death|0|||
23398039|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Death|0|||
23398040|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Death|1|||
23398041|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
23398042|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
23398043|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
23398044|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
23398045|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
23398046|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
23398047|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
23398048|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
23398049|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
23398050|NCT02519842|65203469|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
23398051|NCT02519842|65203470|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
23398052|NCT02519842|65203471|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
23398053|NCT02287610|65203472|FG000|Overall Study|Lost to Follow-up|3|||
23398054|NCT02287610|65203472|FG000|Overall Study|Withdrawal by Subject|8|||
23398055|NCT02287610|65203472|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
23398056|NCT04466891|65203474|FG000|Overall Study|Death|52|||
23398057|NCT04466891|65203475|FG001|Overall Study|Death|5|||
23398058|NCT04466891|65203474|FG000|Overall Study|Withdrawal by Subject|8|||
23398059|NCT04466891|65203475|FG001|Overall Study|Withdrawal by Subject|1|||
23398060|NCT00419744|65203476|FG000|Overall Study|Adverse Event|39|||
23398061|NCT00419744|65203477|FG001|Overall Study|Adverse Event|40|||
23398062|NCT00419744|65203478|FG002|Overall Study|Adverse Event|50|||
23398063|NCT00419744|65203476|FG000|Overall Study|Withdrawal by Subject|45|||
23398064|NCT00419744|65203477|FG001|Overall Study|Withdrawal by Subject|49|||
23398065|NCT00419744|65203478|FG002|Overall Study|Withdrawal by Subject|52|||
23398066|NCT00419744|65203476|FG000|Overall Study|Lost to Follow-up|8|||
23398067|NCT00419744|65203477|FG001|Overall Study|Lost to Follow-up|10|||
23398068|NCT00419744|65203478|FG002|Overall Study|Lost to Follow-up|6|||
23398069|NCT00419744|65203476|FG000|Overall Study|Protocol Violation|4|||
23398070|NCT00419744|65203477|FG001|Overall Study|Protocol Violation|7|||
23398071|NCT00419744|65203478|FG002|Overall Study|Protocol Violation|8|||
23398072|NCT00419744|65203476|FG000|Overall Study|Randomized in error|9|||
23398073|NCT00419744|65203477|FG001|Overall Study|Randomized in error|6|||
23398074|NCT00419744|65203478|FG002|Overall Study|Randomized in error|7|||
23398075|NCT00419744|65203476|FG000|Overall Study|Moving out of state|2|||
23398076|NCT00419744|65203477|FG001|Overall Study|Moving out of state|0|||
23398077|NCT00419744|65203478|FG002|Overall Study|Moving out of state|1|||
23398078|NCT00419744|65203476|FG000|Overall Study|Physician Decision|10|||
23398079|NCT00419744|65203477|FG001|Overall Study|Physician Decision|5|||
23398080|NCT00419744|65203478|FG002|Overall Study|Physician Decision|6|||
23398081|NCT00419744|65203476|FG000|Overall Study|Spirometry mouthpiece issues|0|||
23398082|NCT00419744|65203477|FG001|Overall Study|Spirometry mouthpiece issues|1|||
23398083|NCT00419744|65203478|FG002|Overall Study|Spirometry mouthpiece issues|2|||
23398084|NCT00419744|65203476|FG000|Overall Study|Incorrect medication kit dispensed|0|||
23398085|NCT00419744|65203477|FG001|Overall Study|Incorrect medication kit dispensed|0|||
23398086|NCT00419744|65203478|FG002|Overall Study|Incorrect medication kit dispensed|1|||
23398087|NCT00557193|65203479|FG000|Induction|Adverse Event|2|||
23398088|NCT00557193|65203480|FG001|Induction|Adverse Event|0|||
23398089|NCT00557193|65203481|FG002|Induction|Adverse Event|0|||
23398090|NCT00557193|65203482|FG003|Induction|Adverse Event|0|||
23398091|NCT00557193|65203483|FG004|Induction|Adverse Event|0|||
23398092|NCT00557193|65203484|FG005|Induction|Adverse Event|0|||
23398093|NCT00557193|65203479|FG000|Induction|Death|6|||
23398094|NCT00557193|65203480|FG001|Induction|Death|0|||
23398095|NCT00557193|65203481|FG002|Induction|Death|0|||
23398096|NCT00557193|65203482|FG003|Induction|Death|0|||
23398097|NCT00557193|65203483|FG004|Induction|Death|0|||
23398098|NCT00557193|65203484|FG005|Induction|Death|0|||
23398099|NCT00557193|65203479|FG000|Induction|Physician Decision|3|||
23398100|NCT00557193|65203480|FG001|Induction|Physician Decision|0|||
23398101|NCT00557193|65203481|FG002|Induction|Physician Decision|0|||
23398102|NCT00557193|65203482|FG003|Induction|Physician Decision|0|||
23398103|NCT00557193|65203483|FG004|Induction|Physician Decision|0|||
23398104|NCT00557193|65203484|FG005|Induction|Physician Decision|0|||
23398105|NCT00557193|65203479|FG000|Induction|Withdrawal by Subject|1|||
23398106|NCT00557193|65203480|FG001|Induction|Withdrawal by Subject|0|||
23398107|NCT00557193|65203481|FG002|Induction|Withdrawal by Subject|0|||
23398108|NCT00557193|65203482|FG003|Induction|Withdrawal by Subject|0|||
23398109|NCT00557193|65203483|FG004|Induction|Withdrawal by Subject|0|||
23398110|NCT00557193|65203484|FG005|Induction|Withdrawal by Subject|0|||
23398111|NCT00557193|65203479|FG000|Induction|Refusal of Further Protocol Therapy|2|||
23398112|NCT00557193|65203480|FG001|Induction|Refusal of Further Protocol Therapy|0|||
23398113|NCT00557193|65203481|FG002|Induction|Refusal of Further Protocol Therapy|0|||
23398114|NCT00557193|65203482|FG003|Induction|Refusal of Further Protocol Therapy|0|||
23398115|NCT00557193|65203483|FG004|Induction|Refusal of Further Protocol Therapy|0|||
23398116|NCT00557193|65203484|FG005|Induction|Refusal of Further Protocol Therapy|0|||
23398117|NCT00557193|65203479|FG000|Induction|Ineligible|8|||
23398118|NCT00557193|65203480|FG001|Induction|Ineligible|0|||
23398119|NCT00557193|65203481|FG002|Induction|Ineligible|0|||
23398120|NCT00557193|65203482|FG003|Induction|Ineligible|0|||
23398121|NCT00557193|65203483|FG004|Induction|Ineligible|0|||
23398122|NCT00557193|65203484|FG005|Induction|Ineligible|0|||
23398123|NCT00557193|65203479|FG000|Induction|Inevaluable for post Induction|2|||
23398124|NCT00557193|65203480|FG001|Induction|Inevaluable for post Induction|0|||
23398125|NCT00557193|65203481|FG002|Induction|Inevaluable for post Induction|0|||
23398126|NCT00557193|65203482|FG003|Induction|Inevaluable for post Induction|0|||
23398127|NCT00557193|65203483|FG004|Induction|Inevaluable for post Induction|0|||
23398128|NCT00557193|65203484|FG005|Induction|Inevaluable for post Induction|0|||
23398129|NCT00557193|65203479|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
23398130|NCT00557193|65203480|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398131|NCT00557193|65203481|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398132|NCT00557193|65203482|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398133|NCT00557193|65203483|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398134|NCT00557193|65203484|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
23398135|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23398136|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
23398137|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
23398138|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
23398139|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
23398140|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
23398141|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
23398142|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
23398143|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
23398144|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
23398145|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
23398146|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
23398147|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
23398148|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
23398149|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
23398150|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
23398151|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
23398152|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
23398153|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
23398154|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
23398155|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
23398156|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
23398157|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
23398158|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
23398159|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
23398160|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
23398161|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
23398162|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
23398163|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
23398164|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
23398165|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23398166|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23398167|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
23398168|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23398169|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23398170|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
23398171|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23498658|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
23498659|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498660|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
23498661|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498662|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498663|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498664|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498665|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
23498666|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
23498667|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498668|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498669|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
23498670|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498671|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498672|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498673|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498674|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498675|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Other|0|||
23498676|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Other|0|||
23498677|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Other|1|||
23498678|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Other|1|||
23498679|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Other|2|||
23498680|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Other|0|||
23498681|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Other|0|||
23498682|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Other|0|||
23498683|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
23498684|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
23498685|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
23498686|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
23498687|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
23498688|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
23398172|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23398173|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
23398174|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23398175|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23398176|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
23398177|NCT00557193|65203479|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
23398178|NCT00557193|65203480|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
23398179|NCT00557193|65203481|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
23398180|NCT00557193|65203482|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
23398181|NCT00557193|65203483|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
23398182|NCT00557193|65203484|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
23398183|NCT03837509|65203489|FG000|Phase 1|Death|5|||
23398184|NCT03837509|65203490|FG001|Phase 1|Death|2|||
23398185|NCT03837509|65203491|FG002|Phase 1|Death|0|||
23398186|NCT03837509|65203492|FG003|Phase 1|Death|0|||
23398187|NCT03837509|65203493|FG004|Phase 1|Death|0|||
23398188|NCT03837509|65203489|FG000|Phase 2|Death|0|||
23398189|NCT03837509|65203490|FG001|Phase 2|Death|0|||
23398190|NCT03837509|65203491|FG002|Phase 2|Death|0|||
23398191|NCT03837509|65203492|FG003|Phase 2|Death|1|||
23398192|NCT03837509|65203493|FG004|Phase 2|Death|1|||
23398193|NCT03937479|65203496|FG000|Overall Study|Adverse Event|2|||
23398194|NCT03937479|65203497|FG001|Overall Study|Adverse Event|3|||
23398195|NCT03937479|65203498|FG002|Overall Study|Adverse Event|0|||
23398196|NCT03937479|65203499|FG003|Overall Study|Adverse Event|0|||
23398197|NCT03937479|65203500|FG004|Overall Study|Adverse Event|1|||
23398198|NCT03937479|65203496|FG000|Overall Study|Withdrawal by Subject|3|||
23398199|NCT03937479|65203497|FG001|Overall Study|Withdrawal by Subject|5|||
23398200|NCT03937479|65203498|FG002|Overall Study|Withdrawal by Subject|2|||
23398201|NCT03937479|65203499|FG003|Overall Study|Withdrawal by Subject|2|||
23398202|NCT03937479|65203500|FG004|Overall Study|Withdrawal by Subject|1|||
23398203|NCT03937479|65203496|FG000|Overall Study|Protocol Violation|5|||
23398204|NCT03937479|65203497|FG001|Overall Study|Protocol Violation|6|||
23398205|NCT03937479|65203498|FG002|Overall Study|Protocol Violation|4|||
23398206|NCT03937479|65203499|FG003|Overall Study|Protocol Violation|3|||
23398207|NCT03937479|65203500|FG004|Overall Study|Protocol Violation|2|||
23398208|NCT03937479|65203496|FG000|Overall Study|Lost to Follow-up|0|||
23398209|NCT03937479|65203497|FG001|Overall Study|Lost to Follow-up|1|||
23398210|NCT03937479|65203498|FG002|Overall Study|Lost to Follow-up|0|||
23398211|NCT03937479|65203499|FG003|Overall Study|Lost to Follow-up|1|||
23398212|NCT03937479|65203500|FG004|Overall Study|Lost to Follow-up|0|||
23398213|NCT03937479|65203496|FG000|Overall Study|Physician Decision|0|||
23398214|NCT03937479|65203497|FG001|Overall Study|Physician Decision|0|||
23398215|NCT03937479|65203498|FG002|Overall Study|Physician Decision|1|||
23398216|NCT03937479|65203499|FG003|Overall Study|Physician Decision|0|||
23398217|NCT03937479|65203500|FG004|Overall Study|Physician Decision|1|||
23398218|NCT03038620|65203501|FG000|Overall Study|Lost to Follow-up|18|||
23398219|NCT03038620|65203502|FG001|Overall Study|Lost to Follow-up|23|||
23398220|NCT03038620|65203501|FG000|Overall Study|Withdrawal by Subject|0|||
23398221|NCT03038620|65203502|FG001|Overall Study|Withdrawal by Subject|15|||
23398222|NCT03038620|65203501|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
23398223|NCT03038620|65203502|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
23398224|NCT04567524|65203503|FG000|Overall Study|Adverse Event|1|||
23398225|NCT04567524|65203504|FG001|Overall Study|Adverse Event|1|||
23398226|NCT04567524|65203505|FG002|Overall Study|Adverse Event|0|||
23398227|NCT04567524|65203506|FG003|Overall Study|Adverse Event|0|||
23398228|NCT04567524|65203503|FG000|Overall Study|Withdrawal by Subject|2|||
23398229|NCT04567524|65203504|FG001|Overall Study|Withdrawal by Subject|0|||
23398230|NCT04567524|65203505|FG002|Overall Study|Withdrawal by Subject|0|||
23398231|NCT04567524|65203506|FG003|Overall Study|Withdrawal by Subject|1|||
23398232|NCT00622726|65203507|FG000|March, 2008 to August, 2010|Death|5|||
23398233|NCT00622726|65203508|FG001|March, 2008 to August, 2010|Death|2|||
23398234|NCT00622726|65203507|FG000|August, 2010 to April, 2013|Death|1|||
23398235|NCT00622726|65203508|FG001|August, 2010 to April, 2013|Death|5|||
23398236|NCT00907621|65203510|FG000|Overall Study|Lost to Follow-up|6|||
23398237|NCT00907621|65203511|FG001|Overall Study|Lost to Follow-up|3|||
23398238|NCT00907621|65203510|FG000|Overall Study|intercurrent febrile illness|1|||
23398239|NCT00907621|65203511|FG001|Overall Study|intercurrent febrile illness|1|||
23498689|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
23398240|NCT04339062|65203512|FG000|Overall Study|Death|0|||
23398241|NCT04339062|65203513|FG001|Overall Study|Death|1|||
23398242|NCT00876447|65203514|FG000|Overall Study|Other miscellaneous reasons|3|||
23398243|NCT00876447|65203515|FG001|Overall Study|Other miscellaneous reasons|8|||
23398244|NCT00876447|65203514|FG000|Overall Study|Site closure|19|||
23398245|NCT00876447|65203515|FG001|Overall Study|Site closure|14|||
23398246|NCT00876447|65203514|FG000|Overall Study|Protocol Violation|9|||
23398247|NCT00876447|65203515|FG001|Overall Study|Protocol Violation|3|||
23398248|NCT00876447|65203514|FG000|Overall Study|Personal reasons|30|||
23398249|NCT00876447|65203515|FG001|Overall Study|Personal reasons|28|||
23398250|NCT00876447|65203514|FG000|Overall Study|Lost to Follow-up|6|||
23398251|NCT00876447|65203515|FG001|Overall Study|Lost to Follow-up|15|||
23398252|NCT00876447|65203514|FG000|Overall Study|Pregnancy|4|||
23398253|NCT00876447|65203515|FG001|Overall Study|Pregnancy|2|||
23398254|NCT00876447|65203514|FG000|Overall Study|Lack of Efficacy|5|||
23398255|NCT00876447|65203515|FG001|Overall Study|Lack of Efficacy|3|||
23398256|NCT00876447|65203514|FG000|Overall Study|Adverse Event|4|||
23398257|NCT00876447|65203515|FG001|Overall Study|Adverse Event|8|||
23398258|NCT04881760|65203516|FG000|Overall Study|Adverse Event|0|||
23398259|NCT04881760|65203517|FG001|Overall Study|Adverse Event|1|||
23398260|NCT04881760|65203518|FG002|Overall Study|Adverse Event|1|||
23398261|NCT04881760|65203519|FG003|Overall Study|Adverse Event|0|||
23398262|NCT04881760|65203520|FG004|Overall Study|Adverse Event|1|||
23398263|NCT04881760|65203521|FG005|Overall Study|Adverse Event|1|||
23398264|NCT04881760|65203522|FG006|Overall Study|Adverse Event|2|||
23398265|NCT04881760|65203516|FG000|Overall Study|Death|0|||
23398266|NCT04881760|65203517|FG001|Overall Study|Death|0|||
23398267|NCT04881760|65203518|FG002|Overall Study|Death|0|||
23398268|NCT04881760|65203519|FG003|Overall Study|Death|1|||
23398269|NCT04881760|65203520|FG004|Overall Study|Death|0|||
23398270|NCT04881760|65203521|FG005|Overall Study|Death|0|||
23398271|NCT04881760|65203522|FG006|Overall Study|Death|0|||
23398272|NCT04881760|65203516|FG000|Overall Study|Lost to Follow-up|5|||
23398273|NCT04881760|65203517|FG001|Overall Study|Lost to Follow-up|7|||
23398274|NCT04881760|65203518|FG002|Overall Study|Lost to Follow-up|5|||
23398275|NCT04881760|65203519|FG003|Overall Study|Lost to Follow-up|1|||
23398276|NCT04881760|65203520|FG004|Overall Study|Lost to Follow-up|2|||
23398277|NCT04881760|65203521|FG005|Overall Study|Lost to Follow-up|4|||
23398278|NCT04881760|65203522|FG006|Overall Study|Lost to Follow-up|4|||
23398279|NCT04881760|65203516|FG000|Overall Study|Withdrawal by Subject|13|||
23398280|NCT04881760|65203517|FG001|Overall Study|Withdrawal by Subject|1|||
23398281|NCT04881760|65203518|FG002|Overall Study|Withdrawal by Subject|1|||
23398282|NCT04881760|65203519|FG003|Overall Study|Withdrawal by Subject|4|||
23300687|NCT00317642|64842890|FG000|Overall Study|Not Continue to Consolidation|2|||
23300688|NCT00317642|64842891|FG001|Overall Study|Not Continue to Consolidation|0|||
23300689|NCT00317642|64842890|FG000|Overall Study|Withdrawal by Subject|0|||
23300690|NCT00317642|64842891|FG001|Overall Study|Withdrawal by Subject|1|||
23300691|NCT00317642|64842890|FG000|Overall Study|Referred For Transplantation|1|||
23300692|NCT00317642|64842891|FG001|Overall Study|Referred For Transplantation|0|||
23300693|NCT00317642|64842890|FG000|Overall Study|AML Not Centrally Confirmed|1|||
23300694|NCT00317642|64842891|FG001|Overall Study|AML Not Centrally Confirmed|5|||
23300695|NCT03438539|64842892|FG000|Overall Study|Lost to Follow-up|8|||
23398283|NCT04881760|65203520|FG004|Overall Study|Withdrawal by Subject|2|||
23398284|NCT04881760|65203521|FG005|Overall Study|Withdrawal by Subject|1|||
23398285|NCT04881760|65203522|FG006|Overall Study|Withdrawal by Subject|2|||
23398286|NCT04881760|65203516|FG000|Overall Study|Randomized but Never Treated|0|||
23398287|NCT04881760|65203517|FG001|Overall Study|Randomized but Never Treated|0|||
23398288|NCT04881760|65203518|FG002|Overall Study|Randomized but Never Treated|0|||
23398289|NCT04881760|65203519|FG003|Overall Study|Randomized but Never Treated|1|||
23398290|NCT04881760|65203520|FG004|Overall Study|Randomized but Never Treated|0|||
23398291|NCT04881760|65203521|FG005|Overall Study|Randomized but Never Treated|0|||
23398292|NCT04881760|65203522|FG006|Overall Study|Randomized but Never Treated|0|||
23398293|NCT04881760|65203516|FG000|Overall Study|Inadvertent Enrollment|2|||
23398294|NCT04881760|65203517|FG001|Overall Study|Inadvertent Enrollment|0|||
23398295|NCT04881760|65203518|FG002|Overall Study|Inadvertent Enrollment|0|||
23398296|NCT04881760|65203519|FG003|Overall Study|Inadvertent Enrollment|0|||
23398297|NCT04881760|65203520|FG004|Overall Study|Inadvertent Enrollment|0|||
23398298|NCT04881760|65203521|FG005|Overall Study|Inadvertent Enrollment|0|||
23398299|NCT04881760|65203522|FG006|Overall Study|Inadvertent Enrollment|0|||
23398300|NCT04881760|65203516|FG000|Overall Study|Site Closure|0|||
23398301|NCT04881760|65203517|FG001|Overall Study|Site Closure|0|||
23398302|NCT04881760|65203518|FG002|Overall Study|Site Closure|0|||
23398303|NCT04881760|65203519|FG003|Overall Study|Site Closure|1|||
23398304|NCT04881760|65203520|FG004|Overall Study|Site Closure|0|||
23398305|NCT04881760|65203521|FG005|Overall Study|Site Closure|0|||
23398306|NCT04881760|65203522|FG006|Overall Study|Site Closure|0|||
23398307|NCT00183248|65203523|FG000|Overall Study|Lost to Follow-up|0|||
23398308|NCT00183248|65203524|FG001|Overall Study|Lost to Follow-up|1|||
23398309|NCT00183248|65203523|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
23398310|NCT00183248|65203524|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
23398311|NCT04047446|65203526|FG000|Overall Study|Physician Decision|1|||
23398312|NCT04047446|65203527|FG001|Overall Study|Physician Decision|0|||
23398313|NCT00189423|65203530|FG000|Overall Study|Death|746|||
23398314|NCT00189423|65203531|FG001|Overall Study|Death|747|||
23398315|NCT00189423|65203530|FG000|Overall Study|Withdrawal by Subject|9|||
23398316|NCT00189423|65203531|FG001|Overall Study|Withdrawal by Subject|9|||
23398317|NCT00189423|65203530|FG000|Overall Study|Lost to Follow-up|10|||
23398318|NCT00189423|65203531|FG001|Overall Study|Lost to Follow-up|10|||
23398319|NCT00402987|65203534|FG000|Overall Study|Lack of Efficacy|0|||
23398320|NCT00402987|65203535|FG001|Overall Study|Lack of Efficacy|0|||
23398321|NCT00402987|65203536|FG002|Overall Study|Lack of Efficacy|1|||
23398322|NCT00402987|65203537|FG003|Overall Study|Lack of Efficacy|0|||
23398323|NCT01696643|65203538|FG000|Overall Study|Adverse Event|15|||
23398324|NCT01696643|65203539|FG001|Overall Study|Adverse Event|7|||
23398325|NCT01696643|65203538|FG000|Overall Study|Death|1|||
23398326|NCT01696643|65203539|FG001|Overall Study|Death|2|||
23398327|NCT01696643|65203538|FG000|Overall Study|Lack of Efficacy|3|||
23398328|NCT01696643|65203539|FG001|Overall Study|Lack of Efficacy|0|||
23398329|NCT01696643|65203538|FG000|Overall Study|Lost to Follow-up|67|||
23398330|NCT01696643|65203539|FG001|Overall Study|Lost to Follow-up|67|||
23398331|NCT01696643|65203538|FG000|Overall Study|Physician Decision|3|||
23498690|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
23398332|NCT01696643|65203539|FG001|Overall Study|Physician Decision|2|||
23398333|NCT01696643|65203538|FG000|Overall Study|Pregnancy|0|||
23398334|NCT01696643|65203539|FG001|Overall Study|Pregnancy|1|||
23398335|NCT01696643|65203538|FG000|Overall Study|Protocol Violation|7|||
23398336|NCT01696643|65203539|FG001|Overall Study|Protocol Violation|7|||
23398337|NCT01696643|65203538|FG000|Overall Study|Study Terminated by Sponsor|286|||
23398338|NCT01696643|65203539|FG001|Overall Study|Study Terminated by Sponsor|294|||
23398339|NCT01696643|65203538|FG000|Overall Study|Withdrawal by Subject|142|||
23398340|NCT01696643|65203539|FG001|Overall Study|Withdrawal by Subject|149|||
23398341|NCT01696643|65203538|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
23398342|NCT01696643|65203539|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
23398343|NCT01696643|65203538|FG000|Overall Study|Site Error|2|||
23398344|NCT01696643|65203539|FG001|Overall Study|Site Error|1|||
23398345|NCT01696643|65203538|FG000|Overall Study|Participant Incarcerated|0|||
23398346|NCT01696643|65203539|FG001|Overall Study|Participant Incarcerated|1|||
23398347|NCT01696643|65203538|FG000|Overall Study|Medical Monitor Decision|0|||
23398348|NCT01696643|65203539|FG001|Overall Study|Medical Monitor Decision|2|||
23398349|NCT01696643|65203538|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
23398350|NCT01696643|65203539|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
23398351|NCT00508482|65203541|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
23398352|NCT00508482|65203542|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
23398353|NCT00508482|65203543|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
23398354|NCT00508482|65203541|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
23398355|NCT00508482|65203542|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
23300696|NCT03438539|64842893|FG001|Overall Study|Lost to Follow-up|4|||
23398356|NCT00508482|65203543|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
23398357|NCT00508482|65203541|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
23398358|NCT00508482|65203542|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
23398359|NCT00508482|65203543|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
23398360|NCT03283241|65203544|FG000|Overall Study|Adverse Event|4|||
23398361|NCT03283241|65203545|FG001|Overall Study|Adverse Event|1|||
23398362|NCT03283241|65203544|FG000|Overall Study|Withdrawal by Subject|0|||
23398363|NCT03283241|65203545|FG001|Overall Study|Withdrawal by Subject|1|||
23398364|NCT03283241|65203544|FG000|Overall Study|Subject relocated to Finland|0|||
23398365|NCT03283241|65203545|FG001|Overall Study|Subject relocated to Finland|1|||
23398366|NCT01602484|65203546|FG000|Overall Study|Airway issues unrelated to study|0|||
23398367|NCT01602484|65203547|FG001|Overall Study|Airway issues unrelated to study|1|||
23398368|NCT02561962|65203548|FG000|Overall Study|Withdrawal by Subject|1|||
23398369|NCT02561962|65203549|FG001|Overall Study|Withdrawal by Subject|0|||
23398370|NCT02561962|65203550|FG002|Overall Study|Withdrawal by Subject|0|||
23398371|NCT02561962|65203551|FG003|Overall Study|Withdrawal by Subject|0|||
23398372|NCT02561962|65203552|FG004|Overall Study|Withdrawal by Subject|1|||
23398373|NCT02561962|65203553|FG005|Overall Study|Withdrawal by Subject|1|||
23398374|NCT02561962|65203554|FG006|Overall Study|Withdrawal by Subject|2|||
23398375|NCT02561962|65203555|FG007|Overall Study|Withdrawal by Subject|1|||
23398376|NCT02561962|65203556|FG008|Overall Study|Withdrawal by Subject|0|||
23398377|NCT02561962|65203548|FG000|Overall Study|Decision by sponsor|0|||
23398378|NCT02561962|65203549|FG001|Overall Study|Decision by sponsor|0|||
23398379|NCT02561962|65203550|FG002|Overall Study|Decision by sponsor|0|||
23398380|NCT02561962|65203551|FG003|Overall Study|Decision by sponsor|0|||
23398381|NCT02561962|65203552|FG004|Overall Study|Decision by sponsor|1|||
23398382|NCT02561962|65203553|FG005|Overall Study|Decision by sponsor|1|||
23398383|NCT02561962|65203554|FG006|Overall Study|Decision by sponsor|0|||
23398384|NCT02561962|65203555|FG007|Overall Study|Decision by sponsor|3|||
23398385|NCT02561962|65203556|FG008|Overall Study|Decision by sponsor|0|||
23398386|NCT02561962|65203548|FG000|Overall Study|Lost to Follow-up|0|||
23398387|NCT02561962|65203549|FG001|Overall Study|Lost to Follow-up|0|||
23398388|NCT02561962|65203550|FG002|Overall Study|Lost to Follow-up|0|||
23398389|NCT02561962|65203551|FG003|Overall Study|Lost to Follow-up|0|||
23398390|NCT02561962|65203552|FG004|Overall Study|Lost to Follow-up|0|||
23398391|NCT02561962|65203553|FG005|Overall Study|Lost to Follow-up|1|||
23398392|NCT02561962|65203554|FG006|Overall Study|Lost to Follow-up|0|||
23398393|NCT02561962|65203555|FG007|Overall Study|Lost to Follow-up|0|||
23398394|NCT02561962|65203556|FG008|Overall Study|Lost to Follow-up|0|||
23398395|NCT01463033|65203557|FG000|Overall Study|Lost to Follow-up|4|||
23398396|NCT01463033|65203558|FG001|Overall Study|Lost to Follow-up|4|||
23398397|NCT01463033|65203557|FG000|Overall Study|Death|3|||
23398398|NCT01463033|65203558|FG001|Overall Study|Death|2|||
23398399|NCT00337168|65203563|FG000|Overall Study|Death|5|||
23398400|NCT00337168|65203563|FG000|Overall Study|Not protocol specified|2|||
23398401|NCT00337168|65203563|FG000|Overall Study|Did not start therapy|1|||
23398402|NCT01170663|65203564|FG000|Overall Study|Lost to Follow-up|3|||
23398403|NCT01170663|65203565|FG001|Overall Study|Lost to Follow-up|9|||
23398404|NCT01170663|65203564|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
23398405|NCT01170663|65203565|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
23398406|NCT00542178|65203566|FG000|Overall Study|did not complete year 4 follow-up|75|||
23398407|NCT00542178|65203567|FG001|Overall Study|did not complete year 4 follow-up|80|||
23398408|NCT00542178|65203568|FG002|Overall Study|did not complete year 4 follow-up|74|||
23498691|NCT01090492|65566429|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
23398409|NCT00542178|65203569|FG003|Overall Study|did not complete year 4 follow-up|62|||
23398410|NCT00542178|65203570|FG004|Overall Study|did not complete year 4 follow-up|64|||
23398411|NCT00542178|65203571|FG005|Overall Study|did not complete year 4 follow-up|89|||
23398412|NCT00542178|65203572|FG006|Overall Study|did not complete year 4 follow-up|87|||
23398413|NCT00542178|65203573|FG007|Overall Study|did not complete year 4 follow-up|85|||
23398414|NCT00867334|65203574|FG000|Overall Study|Withdrawal by Subject|0|||
23398415|NCT00867334|65203575|FG001|Overall Study|Withdrawal by Subject|1|||
23398416|NCT00867334|65203574|FG000|Overall Study|Withdrawal by Subject|1|||
23398417|NCT00867334|65203575|FG001|Overall Study|Withdrawal by Subject|0|||
23398418|NCT00867334|65203574|FG000|Overall Study|Withdrawal by Subject|1|||
23398419|NCT00867334|65203575|FG001|Overall Study|Withdrawal by Subject|0|||
23398420|NCT00444106|65203576|FG000|Overall Study|Lost to Follow-up|2|||
23398421|NCT00444106|65203577|FG001|Overall Study|Lost to Follow-up|1|||
23398422|NCT00444106|65203578|FG002|Overall Study|Lost to Follow-up|0|||
23398423|NCT00444106|65203576|FG000|Overall Study|Abnormal Test Procedure Results|0|||
23398424|NCT00444106|65203577|FG001|Overall Study|Abnormal Test Procedure Results|0|||
23398425|NCT00444106|65203578|FG002|Overall Study|Abnormal Test Procedure Results|1|||
23398426|NCT00806585|65203587|FG000|Overall Study|Study terminated by Sponsor|0|||
23398427|NCT00806585|65203588|FG001|Overall Study|Study terminated by Sponsor|0|||
23398428|NCT00806585|65203589|FG002|Overall Study|Study terminated by Sponsor|1|||
23398429|NCT00806585|65203590|FG003|Overall Study|Study terminated by Sponsor|2|||
23398430|NCT00806585|65203591|FG004|Overall Study|Study terminated by Sponsor|0|||
23398431|NCT00806585|65203587|FG000|Overall Study|Protocol Violation|3|||
23398432|NCT00806585|65203588|FG001|Overall Study|Protocol Violation|1|||
23398433|NCT00806585|65203589|FG002|Overall Study|Protocol Violation|2|||
23398434|NCT00806585|65203590|FG003|Overall Study|Protocol Violation|0|||
23398435|NCT00806585|65203591|FG004|Overall Study|Protocol Violation|0|||
23398436|NCT00806585|65203587|FG000|Overall Study|Physician Decision|0|||
23398437|NCT00806585|65203588|FG001|Overall Study|Physician Decision|2|||
23398438|NCT00806585|65203589|FG002|Overall Study|Physician Decision|3|||
23398439|NCT00806585|65203590|FG003|Overall Study|Physician Decision|0|||
23398440|NCT00806585|65203591|FG004|Overall Study|Physician Decision|1|||
23398441|NCT00806585|65203587|FG000|Overall Study|Lost to Follow-up|2|||
23398442|NCT00806585|65203588|FG001|Overall Study|Lost to Follow-up|1|||
23398443|NCT00806585|65203589|FG002|Overall Study|Lost to Follow-up|2|||
23398444|NCT00806585|65203590|FG003|Overall Study|Lost to Follow-up|2|||
23398445|NCT00806585|65203591|FG004|Overall Study|Lost to Follow-up|5|||
23498692|NCT01090492|65566430|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
23398446|NCT00806585|65203587|FG000|Overall Study|Lack of Efficacy|1|||
23398447|NCT00806585|65203588|FG001|Overall Study|Lack of Efficacy|0|||
23398448|NCT00806585|65203589|FG002|Overall Study|Lack of Efficacy|0|||
23398449|NCT00806585|65203590|FG003|Overall Study|Lack of Efficacy|0|||
23398450|NCT00806585|65203591|FG004|Overall Study|Lack of Efficacy|0|||
23398451|NCT00806585|65203587|FG000|Overall Study|Adverse Event|1|||
23398452|NCT00806585|65203588|FG001|Overall Study|Adverse Event|5|||
23398453|NCT00806585|65203589|FG002|Overall Study|Adverse Event|3|||
23398454|NCT00806585|65203590|FG003|Overall Study|Adverse Event|4|||
23398455|NCT00806585|65203591|FG004|Overall Study|Adverse Event|2|||
23398456|NCT00806585|65203587|FG000|Overall Study|Withdrawal by Subject|10|||
23398457|NCT00806585|65203588|FG001|Overall Study|Withdrawal by Subject|8|||
23398458|NCT00806585|65203589|FG002|Overall Study|Withdrawal by Subject|9|||
23398459|NCT00806585|65203590|FG003|Overall Study|Withdrawal by Subject|3|||
23398460|NCT00806585|65203591|FG004|Overall Study|Withdrawal by Subject|11|||
23398461|NCT00806585|65203587|FG000|Overall Study|Completion status unknown|15|||
23398462|NCT00806585|65203588|FG001|Overall Study|Completion status unknown|14|||
23398463|NCT00806585|65203589|FG002|Overall Study|Completion status unknown|12|||
23398464|NCT00806585|65203590|FG003|Overall Study|Completion status unknown|4|||
23398465|NCT00806585|65203591|FG004|Overall Study|Completion status unknown|12|||
23398466|NCT02835690|65203604|FG000|Overall Study|Death|12|||
23398467|NCT02835690|65203605|FG001|Overall Study|Death|11|||
23398468|NCT02835690|65203606|FG002|Overall Study|Death|13|||
23398469|NCT02835690|65203604|FG000|Overall Study|Transferred to Extension Study|2|||
23398470|NCT02835690|65203605|FG001|Overall Study|Transferred to Extension Study|2|||
23398471|NCT02835690|65203606|FG002|Overall Study|Transferred to Extension Study|1|||
23398472|NCT02835690|65203604|FG000|Overall Study|Did Not Continue on Extension Study|0|||
23398473|NCT02835690|65203605|FG001|Overall Study|Did Not Continue on Extension Study|0|||
23398474|NCT02835690|65203606|FG002|Overall Study|Did Not Continue on Extension Study|1|||
23398475|NCT02835690|65203604|FG000|Overall Study|Not Treated|0|||
23398476|NCT02835690|65203605|FG001|Overall Study|Not Treated|2|||
23398477|NCT02835690|65203606|FG002|Overall Study|Not Treated|0|||
23398478|NCT00902330|65203607|FG000|Overall Study|Too overwhelmed by treatment|2|||
23398479|NCT00902330|65203608|FG001|Overall Study|Too overwhelmed by treatment|5|||
23398480|NCT00902330|65203607|FG000|Overall Study|Adverse Event|1|||
23398481|NCT00902330|65203608|FG001|Overall Study|Adverse Event|0|||
23300697|NCT03438539|64842894|FG002|Overall Study|Lost to Follow-up|10|||
23300698|NCT03438539|64842895|FG003|Overall Study|Lost to Follow-up|9|||
23398482|NCT00902330|65203607|FG000|Overall Study|No post baseline data|1|||
23398483|NCT00902330|65203608|FG001|Overall Study|No post baseline data|0|||
23398484|NCT00160563|65203609|FG000|Overall Study|Adverse Event|1|||
23398485|NCT00160563|65203610|FG001|Overall Study|Adverse Event|1|||
23398486|NCT00160563|65203611|FG002|Overall Study|Adverse Event|1|||
23398487|NCT00160563|65203609|FG000|Overall Study|Lost to Follow-up|1|||
23398488|NCT00160563|65203610|FG001|Overall Study|Lost to Follow-up|1|||
23398489|NCT00160563|65203611|FG002|Overall Study|Lost to Follow-up|2|||
23398490|NCT00160563|65203609|FG000|Overall Study|Protocol Violation|0|||
23398491|NCT00160563|65203610|FG001|Overall Study|Protocol Violation|0|||
23398492|NCT00160563|65203611|FG002|Overall Study|Protocol Violation|3|||
23398493|NCT00160563|65203609|FG000|Overall Study|Withdrawal by Subject|1|||
23398494|NCT00160563|65203610|FG001|Overall Study|Withdrawal by Subject|2|||
23398495|NCT00160563|65203611|FG002|Overall Study|Withdrawal by Subject|3|||
23398496|NCT00160563|65203609|FG000|Overall Study|Other (listed in the study report)|48|||
23398497|NCT00160563|65203610|FG001|Overall Study|Other (listed in the study report)|40|||
23398498|NCT00160563|65203611|FG002|Overall Study|Other (listed in the study report)|81|||
23398499|NCT00160563|65203609|FG000|Overall Study|Missing reason|0|||
23398500|NCT00160563|65203610|FG001|Overall Study|Missing reason|1|||
23398501|NCT00160563|65203611|FG002|Overall Study|Missing reason|0|||
23398502|NCT04622592|65203612|FG000|Overall Study|Death|0|||
23398503|NCT04622592|65203613|FG001|Overall Study|Death|0|||
23398504|NCT04622592|65203614|FG002|Overall Study|Death|1|||
23398505|NCT04622592|65203615|FG003|Overall Study|Death|0|||
23398506|NCT04622592|65203616|FG004|Overall Study|Death|0|||
23398507|NCT04622592|65203617|FG005|Overall Study|Death|0|||
23398508|NCT04622592|65203618|FG006|Overall Study|Death|0|||
23398509|NCT04622592|65203619|FG007|Overall Study|Death|1|||
23398510|NCT04622592|65203612|FG000|Overall Study|Lost to Follow-up|0|||
23398511|NCT04622592|65203613|FG001|Overall Study|Lost to Follow-up|0|||
23398512|NCT04622592|65203614|FG002|Overall Study|Lost to Follow-up|0|||
23498693|NCT01090492|65566431|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
23498694|NCT01090492|65566432|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
23498695|NCT01090492|65566433|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
23498696|NCT01090492|65566434|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
23498697|NCT01090492|65566435|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
23498698|NCT01090492|65566436|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
23498699|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
23498700|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
23498701|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
23498702|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
23498703|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
23498704|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
23498705|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
23498706|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
23300699|NCT03438539|64842896|FG004|Overall Study|Lost to Follow-up|3|||
23300700|NCT03438539|64842897|FG005|Overall Study|Lost to Follow-up|8|||
23398513|NCT04622592|65203615|FG003|Overall Study|Lost to Follow-up|3|||
23398514|NCT04622592|65203616|FG004|Overall Study|Lost to Follow-up|1|||
23398515|NCT04622592|65203617|FG005|Overall Study|Lost to Follow-up|0|||
23398516|NCT04622592|65203618|FG006|Overall Study|Lost to Follow-up|2|||
23398517|NCT04622592|65203619|FG007|Overall Study|Lost to Follow-up|2|||
23498707|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498708|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
23498709|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498710|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498711|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498712|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498713|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498714|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
23498715|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Other|0|||
23498716|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Other|1|||
23498717|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Other|1|||
23498718|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Other|0|||
23498719|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Other|0|||
23498720|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Other|0|||
23498721|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Other|0|||
23498722|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Other|0|||
23498723|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
23498724|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
23498725|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
23498726|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
23498727|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
23498728|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
23498729|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
23498730|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
23498731|NCT01090492|65566429|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498732|NCT01090492|65566430|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498733|NCT01090492|65566431|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498734|NCT01090492|65566432|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498735|NCT01090492|65566433|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498736|NCT01090492|65566434|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498737|NCT01090492|65566435|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
23498738|NCT01090492|65566436|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
23498739|NCT00199875|65566437|FG000|Overall Study|Withdrawal by Subject|0|||
23498740|NCT00199875|65566438|FG001|Overall Study|Withdrawal by Subject|0|||
23498741|NCT00199875|65566439|FG002|Overall Study|Withdrawal by Subject|0|||
23498742|NCT00199875|65566440|FG003|Overall Study|Withdrawal by Subject|0|||
23498743|NCT00199875|65566441|FG004|Overall Study|Withdrawal by Subject|1|||
23498744|NCT01500031|65566442|FG000|Overall Study|Death|1|||
23498745|NCT01500031|65566442|FG000|Overall Study|Withdrawal by Subject|4|||
23498746|NCT01020981|65566443|FG000|Overall Study|Did not return mailed survey|74|||
23498747|NCT01020981|65566444|FG001|Overall Study|Did not return mailed survey|58|||
23498748|NCT01020981|65566443|FG000|Overall Study|Survey returned undeliverable|8|||
23498749|NCT01020981|65566444|FG001|Overall Study|Survey returned undeliverable|32|||
23498750|NCT01020981|65566443|FG000|Overall Study|Participant declined to complete survey|2|||
23498751|NCT01020981|65566444|FG001|Overall Study|Participant declined to complete survey|0|||
23398518|NCT04622592|65203612|FG000|Overall Study|Physician Decision|0|||
23498752|NCT01180985|65566445|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
23498753|NCT01180985|65566446|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
23498754|NCT00415168|65566448|FG000|Overall Study|Death|26|||
23498755|NCT00415168|65566448|FG000|Overall Study|Lost to Follow-up|3|||
23498756|NCT00415168|65566448|FG000|Overall Study|Physician Decision|13|||
23498757|NCT00415168|65566448|FG000|Overall Study|Sponsor Decision|4|||
23498758|NCT00415168|65566448|FG000|Overall Study|Withdrawal by Subject|6|||
23498759|NCT02465515|65566449|FG000|Overall Study|Investigator site closed|4|||
23498760|NCT02465515|65566450|FG001|Overall Study|Investigator site closed|5|||
23498761|NCT02465515|65566449|FG000|Overall Study|Withdrawal by Subject|74|||
23498762|NCT02465515|65566450|FG001|Overall Study|Withdrawal by Subject|43|||
23498763|NCT02465515|65566449|FG000|Overall Study|Physician Decision|8|||
23498764|NCT02465515|65566450|FG001|Overall Study|Physician Decision|12|||
23498765|NCT02465515|65566449|FG000|Overall Study|Lost to Follow-up|68|||
23498766|NCT02465515|65566450|FG001|Overall Study|Lost to Follow-up|51|||
23498767|NCT01964430|65566451|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
23498768|NCT01964430|65566452|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
23498769|NCT01964430|65566451|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
23498770|NCT01964430|65566452|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
23498771|NCT01964430|65566451|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
23498772|NCT01964430|65566452|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
23498773|NCT01964430|65566451|FG000|Treatment Period|Adverse Event|71|||
23498774|NCT01964430|65566452|FG001|Treatment Period|Adverse Event|37|||
23498775|NCT01964430|65566451|FG000|Treatment Period|Withdrawal by Subject|36|||
23498776|NCT01964430|65566452|FG001|Treatment Period|Withdrawal by Subject|27|||
23498777|NCT01964430|65566451|FG000|Treatment Period|Death|1|||
23498778|NCT01964430|65566452|FG001|Treatment Period|Death|3|||
23498779|NCT01964430|65566451|FG000|Treatment Period|Protocol Deviation|0|||
23498780|NCT01964430|65566452|FG001|Treatment Period|Protocol Deviation|1|||
23498781|NCT01964430|65566451|FG000|Treatment Period|Physician Decision|5|||
23498782|NCT01964430|65566452|FG001|Treatment Period|Physician Decision|4|||
23498783|NCT01964430|65566451|FG000|Treatment Period|Disease Relapse|28|||
23498784|NCT01964430|65566452|FG001|Treatment Period|Disease Relapse|38|||
23498785|NCT01964430|65566451|FG000|Treatment Period|Other reasons|1|||
23498786|NCT01964430|65566452|FG001|Treatment Period|Other reasons|3|||
23498787|NCT01999114|65566453|FG000|Overall Study|Adverse Event|8|||
23498788|NCT01999114|65566454|FG001|Overall Study|Adverse Event|7|||
23498789|NCT01999114|65566455|FG002|Overall Study|Adverse Event|2|||
23498790|NCT01999114|65566456|FG003|Overall Study|Adverse Event|2|||
23498791|NCT01999114|65566457|FG004|Overall Study|Adverse Event|1|||
23498792|NCT01999114|65566453|FG000|Overall Study|Withdrawal by Subject|0|||
23498793|NCT01999114|65566454|FG001|Overall Study|Withdrawal by Subject|0|||
23498794|NCT01999114|65566455|FG002|Overall Study|Withdrawal by Subject|1|||
23498795|NCT01999114|65566456|FG003|Overall Study|Withdrawal by Subject|0|||
23498796|NCT01999114|65566457|FG004|Overall Study|Withdrawal by Subject|1|||
23498797|NCT01999114|65566453|FG000|Overall Study|Lost to Follow-up|0|||
23498798|NCT01999114|65566454|FG001|Overall Study|Lost to Follow-up|0|||
23498799|NCT01999114|65566455|FG002|Overall Study|Lost to Follow-up|1|||
23498800|NCT01999114|65566456|FG003|Overall Study|Lost to Follow-up|0|||
23498801|NCT01999114|65566457|FG004|Overall Study|Lost to Follow-up|0|||
23498802|NCT01999114|65566453|FG000|Overall Study|Administrative|0|||
23498803|NCT01999114|65566454|FG001|Overall Study|Administrative|0|||
23498804|NCT01999114|65566455|FG002|Overall Study|Administrative|1|||
23498805|NCT01999114|65566456|FG003|Overall Study|Administrative|1|||
23498806|NCT01999114|65566457|FG004|Overall Study|Administrative|2|||
23498807|NCT01604408|65566460|FG000|Treatment Period 1|Protocol Violation|0|||
23498808|NCT01604408|65566461|FG001|Treatment Period 1|Protocol Violation|1|||
23498809|NCT01604408|65566460|FG000|Treatment Period 2|Withdrawal by Subject|1|||
23498810|NCT01604408|65566461|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23498811|NCT01604408|65566460|FG000|Treatment Period 2|Protocol Violation|1|||
23498812|NCT01604408|65566461|FG001|Treatment Period 2|Protocol Violation|0|||
23498813|NCT01604408|65566460|FG000|Treatment Period 2|Adverse Event|0|||
23498814|NCT01604408|65566461|FG001|Treatment Period 2|Adverse Event|1|||
23498815|NCT01604408|65566460|FG000|Treatment Period 3|Protocol Violation|1|||
23498816|NCT01604408|65566461|FG001|Treatment Period 3|Protocol Violation|1|||
23498817|NCT01604408|65566460|FG000|Treatment Period 3|Adverse Event|0|||
23498818|NCT01604408|65566461|FG001|Treatment Period 3|Adverse Event|3|||
23498819|NCT01604408|65566460|FG000|Treatment Period 3|Withdrawal by Subject|3|||
23498820|NCT01604408|65566461|FG001|Treatment Period 3|Withdrawal by Subject|1|||
23498821|NCT01604408|65566460|FG000|Treatment Period 3|Sponsor Decision|1|||
23498822|NCT01604408|65566461|FG001|Treatment Period 3|Sponsor Decision|0|||
23498823|NCT01604408|65566460|FG000|Treatment Period 4|Death|1|||
23498824|NCT01604408|65566461|FG001|Treatment Period 4|Death|0|||
23498825|NCT01604408|65566460|FG000|Treatment Period 4|Withdrawal by Subject|2|||
23498826|NCT01604408|65566461|FG001|Treatment Period 4|Withdrawal by Subject|1|||
23498827|NCT01604408|65566460|FG000|Treatment Period 4|Adverse Event|0|||
23498828|NCT01604408|65566461|FG001|Treatment Period 4|Adverse Event|1|||
23498829|NCT01604408|65566460|FG000|Treatment Period 5|Adverse Event|4|||
23498830|NCT01604408|65566461|FG001|Treatment Period 5|Adverse Event|0|||
23498831|NCT01604408|65566460|FG000|Treatment Period 6|Lost to Follow-up|0|||
23498832|NCT01604408|65566461|FG001|Treatment Period 6|Lost to Follow-up|1|||
23498833|NCT01604408|65566460|FG000|Treatment Period 6|Adverse Event|2|||
23498834|NCT01604408|65566461|FG001|Treatment Period 6|Adverse Event|0|||
23498835|NCT01604408|65566460|FG000|Treatment Period 6|Sponsor decision|0|||
23498836|NCT01604408|65566461|FG001|Treatment Period 6|Sponsor decision|1|||
23498837|NCT01604408|65566460|FG000|Observation Period|Adverse Event|1|||
23498838|NCT01604408|65566461|FG001|Observation Period|Adverse Event|1|||
23498839|NCT01604408|65566460|FG000|Observation Period|Withdrawal by Subject|0|||
23498840|NCT01604408|65566461|FG001|Observation Period|Withdrawal by Subject|2|||
23498841|NCT01921387|65566462|FG000|Overall Study|Adverse Event|1|||
23498842|NCT02628938|65566463|FG000|Overall Study|Did not attend the follow up recall|2|||
23300701|NCT01846273|64842898|FG000|Overall Study|Adverse Event|9|||
23498843|NCT02628938|65566464|FG001|Overall Study|Did not attend the follow up recall|2|||
23498844|NCT02628938|65566465|FG002|Overall Study|Did not attend the follow up recall|1|||
23498845|NCT02628938|65566463|FG000|Overall Study|Failure to comply with the instructions|3|||
23498846|NCT02628938|65566464|FG001|Overall Study|Failure to comply with the instructions|0|||
23498847|NCT02628938|65566465|FG002|Overall Study|Failure to comply with the instructions|3|||
23498848|NCT00450255|65566468|FG000|Overall Study|Prior RFA ablation of liver|1|||
23498849|NCT00806351|65566469|FG000|Overall Study|Death|5|||
23498850|NCT00806351|65566470|FG001|Overall Study|Death|4|||
23498851|NCT03307967|65566472|FG000|Overall Study|Lost to Follow-up|4|||
23498852|NCT01441180|65566474|FG000|Overall Study|Lost to Follow-up|1|||
23498853|NCT01441180|65566475|FG001|Overall Study|Lost to Follow-up|1|||
23498854|NCT01441180|65566476|FG002|Overall Study|Lost to Follow-up|1|||
23498855|NCT01441180|65566474|FG000|Overall Study|Discontinued|0|||
23498856|NCT01441180|65566475|FG001|Overall Study|Discontinued|0|||
23498857|NCT01441180|65566476|FG002|Overall Study|Discontinued|2|||
23498858|NCT01945281|65566478|FG000|Overall Study|Adverse Event|1|||
23498859|NCT01945281|65566479|FG001|Overall Study|Adverse Event|0|||
23498860|NCT01945281|65566478|FG000|Overall Study|Death|3|||
23498861|NCT01945281|65566479|FG001|Overall Study|Death|3|||
23498862|NCT01945281|65566478|FG000|Overall Study|Physician Decision|1|||
23498863|NCT01945281|65566479|FG001|Overall Study|Physician Decision|1|||
23498864|NCT01945281|65566478|FG000|Overall Study|Technical Problems|1|||
23498865|NCT01945281|65566479|FG001|Overall Study|Technical Problems|0|||
23498866|NCT00395304|65566481|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23498867|NCT00395304|65566482|FG001|Treatment Period 1|Withdrawal by Subject|3|||
23498868|NCT00395304|65566483|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23498869|NCT00395304|65566484|FG003|Treatment Period 1|Withdrawal by Subject|2|||
23498870|NCT00395304|65566485|FG004|Treatment Period 1|Withdrawal by Subject|1|||
23498871|NCT00395304|65566486|FG005|Treatment Period 1|Withdrawal by Subject|1|||
23498872|NCT00395304|65566481|FG000|Treatment Period 1|Lost to Follow-up|1|||
23498873|NCT00395304|65566482|FG001|Treatment Period 1|Lost to Follow-up|0|||
23498874|NCT00395304|65566483|FG002|Treatment Period 1|Lost to Follow-up|0|||
23498875|NCT00395304|65566484|FG003|Treatment Period 1|Lost to Follow-up|1|||
23498876|NCT00395304|65566485|FG004|Treatment Period 1|Lost to Follow-up|0|||
23498877|NCT00395304|65566486|FG005|Treatment Period 1|Lost to Follow-up|1|||
23498878|NCT00395304|65566481|FG000|Treatment Period 1|Physician Decision|0|||
23498879|NCT00395304|65566482|FG001|Treatment Period 1|Physician Decision|1|||
23498880|NCT00395304|65566483|FG002|Treatment Period 1|Physician Decision|0|||
23498881|NCT00395304|65566484|FG003|Treatment Period 1|Physician Decision|0|||
23498882|NCT00395304|65566485|FG004|Treatment Period 1|Physician Decision|0|||
23498883|NCT00395304|65566486|FG005|Treatment Period 1|Physician Decision|0|||
23498884|NCT00395304|65566481|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23498885|NCT00395304|65566482|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23498886|NCT00395304|65566483|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23498887|NCT00395304|65566484|FG003|Treatment Period 2|Withdrawal by Subject|1|||
23498888|NCT00395304|65566485|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23498889|NCT00395304|65566486|FG005|Treatment Period 2|Withdrawal by Subject|2|||
23498890|NCT00395304|65566481|FG000|Treatment Period 2|Lost to Follow-up|0|||
23498891|NCT00395304|65566482|FG001|Treatment Period 2|Lost to Follow-up|3|||
23498892|NCT00395304|65566483|FG002|Treatment Period 2|Lost to Follow-up|0|||
23498893|NCT00395304|65566484|FG003|Treatment Period 2|Lost to Follow-up|0|||
23498894|NCT00395304|65566485|FG004|Treatment Period 2|Lost to Follow-up|0|||
23498895|NCT00395304|65566486|FG005|Treatment Period 2|Lost to Follow-up|0|||
23498896|NCT00395304|65566481|FG000|Treatment Period 2|Physician Decision|0|||
23498897|NCT00395304|65566482|FG001|Treatment Period 2|Physician Decision|0|||
23498898|NCT00395304|65566483|FG002|Treatment Period 2|Physician Decision|1|||
23498899|NCT00395304|65566484|FG003|Treatment Period 2|Physician Decision|0|||
23498900|NCT00395304|65566485|FG004|Treatment Period 2|Physician Decision|0|||
23498901|NCT00395304|65566486|FG005|Treatment Period 2|Physician Decision|0|||
23498902|NCT00395304|65566481|FG000|Treatment Period 2|Other|0|||
23498903|NCT00395304|65566482|FG001|Treatment Period 2|Other|1|||
23498904|NCT00395304|65566483|FG002|Treatment Period 2|Other|0|||
23498905|NCT00395304|65566484|FG003|Treatment Period 2|Other|0|||
23498906|NCT00395304|65566485|FG004|Treatment Period 2|Other|0|||
23498907|NCT00395304|65566486|FG005|Treatment Period 2|Other|0|||
23498908|NCT00395304|65566481|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23498909|NCT00395304|65566482|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23498910|NCT00395304|65566483|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23498911|NCT00395304|65566484|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23498912|NCT00395304|65566485|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23498913|NCT00395304|65566486|FG005|Treatment Period 3|Withdrawal by Subject|1|||
23498914|NCT00395304|65566481|FG000|Treatment Period 3|Lost to Follow-up|1|||
23498915|NCT00395304|65566482|FG001|Treatment Period 3|Lost to Follow-up|1|||
23498916|NCT00395304|65566483|FG002|Treatment Period 3|Lost to Follow-up|0|||
23498917|NCT00395304|65566484|FG003|Treatment Period 3|Lost to Follow-up|0|||
23498918|NCT00395304|65566485|FG004|Treatment Period 3|Lost to Follow-up|0|||
23498919|NCT00395304|65566486|FG005|Treatment Period 3|Lost to Follow-up|0|||
23498920|NCT00395304|65566481|FG000|Treatment Period 3|Physician Decision|0|||
23498921|NCT00395304|65566482|FG001|Treatment Period 3|Physician Decision|1|||
23498922|NCT00395304|65566483|FG002|Treatment Period 3|Physician Decision|0|||
23498923|NCT00395304|65566484|FG003|Treatment Period 3|Physician Decision|0|||
23498924|NCT00395304|65566485|FG004|Treatment Period 3|Physician Decision|0|||
23498925|NCT00395304|65566486|FG005|Treatment Period 3|Physician Decision|0|||
23498926|NCT00395304|65566481|FG000|Treatment Period 3|Other|0|||
23498927|NCT00395304|65566482|FG001|Treatment Period 3|Other|0|||
23498928|NCT00395304|65566483|FG002|Treatment Period 3|Other|0|||
23498929|NCT00395304|65566484|FG003|Treatment Period 3|Other|1|||
23498930|NCT00395304|65566485|FG004|Treatment Period 3|Other|0|||
23498931|NCT00395304|65566486|FG005|Treatment Period 3|Other|0|||
23498932|NCT00825682|65566487|FG000|Overall Study|personal reasons/ inconvenience|13|||
23498933|NCT00825682|65566488|FG001|Overall Study|personal reasons/ inconvenience|5|||
23498934|NCT00496470|65569733|FG000|Overall Study|Adverse Event|8|||
23498935|NCT00496470|65569734|FG001|Overall Study|Adverse Event|10|||
23498936|NCT00496470|65569733|FG000|Overall Study|Withdrawal by Subject|5|||
23498937|NCT00496470|65569734|FG001|Overall Study|Withdrawal by Subject|12|||
23498938|NCT00496470|65569733|FG000|Overall Study|Incorrectly enrolled|13|||
23498939|NCT00496470|65569734|FG001|Overall Study|Incorrectly enrolled|5|||
23498940|NCT00496470|65569733|FG000|Overall Study|Other reason|0|||
23498941|NCT00496470|65569734|FG001|Overall Study|Other reason|2|||
23498942|NCT00531934|65569737|FG000|Overall Study|Adverse Event|4|||
23498943|NCT00531934|65569738|FG001|Overall Study|Adverse Event|8|||
23498944|NCT00531934|65569737|FG000|Overall Study|Progression|52|||
23498945|NCT00531934|65569738|FG001|Overall Study|Progression|42|||
23498946|NCT00531934|65569737|FG000|Overall Study|Death|7|||
23498947|NCT00531934|65569738|FG001|Overall Study|Death|10|||
23498948|NCT00531934|65569737|FG000|Overall Study|Withdrawal by Subject|1|||
23498949|NCT00531934|65569738|FG001|Overall Study|Withdrawal by Subject|1|||
23498950|NCT00531934|65569737|FG000|Overall Study|Other|2|||
23498951|NCT00531934|65569738|FG001|Overall Study|Other|2|||
23498952|NCT01768286|65569747|FG000|Overall Study|Randomized But Not Treated|0|||
23498953|NCT01768286|65569748|FG001|Overall Study|Randomized But Not Treated|0|||
23498954|NCT01768286|65569749|FG002|Overall Study|Randomized But Not Treated|1|||
23498955|NCT01768286|65569750|FG003|Overall Study|Randomized But Not Treated|0|||
23498956|NCT01768286|65569747|FG000|Overall Study|Lack of Efficacy|7|||
23498957|NCT01768286|65569748|FG001|Overall Study|Lack of Efficacy|4|||
23498958|NCT01768286|65569749|FG002|Overall Study|Lack of Efficacy|0|||
23498959|NCT01768286|65569750|FG003|Overall Study|Lack of Efficacy|1|||
23498960|NCT01768286|65569747|FG000|Overall Study|Withdrew Consent|0|||
23498961|NCT01768286|65569748|FG001|Overall Study|Withdrew Consent|0|||
23498962|NCT01768286|65569749|FG002|Overall Study|Withdrew Consent|1|||
23498963|NCT01768286|65569750|FG003|Overall Study|Withdrew Consent|0|||
23498964|NCT00518687|65569751|FG000|Overall Study|Adverse Event|201|||
23300702|NCT01846273|64842899|FG001|Overall Study|Adverse Event|7|||
23498965|NCT00518687|65569752|FG001|Overall Study|Adverse Event|177|||
23300703|NCT01846273|64842900|FG002|Overall Study|Adverse Event|0|||
23498966|NCT00518687|65569751|FG000|Overall Study|Lost to Follow-up|144|||
23498967|NCT00518687|65569752|FG001|Overall Study|Lost to Follow-up|155|||
23498968|NCT00518687|65569751|FG000|Overall Study|Physician Decision|42|||
23498969|NCT00518687|65569752|FG001|Overall Study|Physician Decision|48|||
23498970|NCT00518687|65569751|FG000|Overall Study|Progressive disease|2|||
23498971|NCT00518687|65569752|FG001|Overall Study|Progressive disease|2|||
23498972|NCT00518687|65569751|FG000|Overall Study|Protocol Violation|8|||
23498973|NCT00518687|65569752|FG001|Overall Study|Protocol Violation|10|||
23498974|NCT00518687|65569751|FG000|Overall Study|Study terminated by sponsor|930|||
23498975|NCT00518687|65569752|FG001|Overall Study|Study terminated by sponsor|918|||
23498976|NCT00518687|65569751|FG000|Overall Study|Withdrawal by Subject|110|||
23498977|NCT00518687|65569752|FG001|Overall Study|Withdrawal by Subject|110|||
23498978|NCT00915278|65569753|FG000|Overall Study|Death|1|||
23498979|NCT00915278|65569754|FG001|Overall Study|Death|0|||
23498980|NCT00915278|65569755|FG002|Overall Study|Death|0|||
23498981|NCT00915278|65569756|FG003|Overall Study|Death|0|||
23498982|NCT00915278|65569757|FG004|Overall Study|Death|0|||
23498983|NCT00915278|65569758|FG005|Overall Study|Death|0|||
23498984|NCT00915278|65569753|FG000|Overall Study|Lost to Follow-up|0|||
23498985|NCT00915278|65569754|FG001|Overall Study|Lost to Follow-up|1|||
23498986|NCT00915278|65569755|FG002|Overall Study|Lost to Follow-up|0|||
23498987|NCT00915278|65569756|FG003|Overall Study|Lost to Follow-up|0|||
23498988|NCT00915278|65569757|FG004|Overall Study|Lost to Follow-up|0|||
23498989|NCT00915278|65569758|FG005|Overall Study|Lost to Follow-up|0|||
23498990|NCT00915278|65569753|FG000|Overall Study|Withdrawal by Subject|0|||
23498991|NCT00915278|65569754|FG001|Overall Study|Withdrawal by Subject|1|||
23498992|NCT00915278|65569755|FG002|Overall Study|Withdrawal by Subject|0|||
23498993|NCT00915278|65569756|FG003|Overall Study|Withdrawal by Subject|0|||
23498994|NCT00915278|65569757|FG004|Overall Study|Withdrawal by Subject|1|||
23498995|NCT00915278|65569758|FG005|Overall Study|Withdrawal by Subject|4|||
23498996|NCT00915278|65569753|FG000|Overall Study|Adverse Event|4|||
23498997|NCT00915278|65569754|FG001|Overall Study|Adverse Event|1|||
23498998|NCT00915278|65569755|FG002|Overall Study|Adverse Event|0|||
23498999|NCT00915278|65569756|FG003|Overall Study|Adverse Event|0|||
23499000|NCT00915278|65569757|FG004|Overall Study|Adverse Event|0|||
23499001|NCT00915278|65569758|FG005|Overall Study|Adverse Event|0|||
23499002|NCT00915278|65569753|FG000|Overall Study|Progressive disease/clinical progression|0|||
23499003|NCT00915278|65569754|FG001|Overall Study|Progressive disease/clinical progression|0|||
23499004|NCT00915278|65569755|FG002|Overall Study|Progressive disease/clinical progression|0|||
23499005|NCT00915278|65569756|FG003|Overall Study|Progressive disease/clinical progression|3|||
23499006|NCT00915278|65569757|FG004|Overall Study|Progressive disease/clinical progression|1|||
23499007|NCT00915278|65569758|FG005|Overall Study|Progressive disease/clinical progression|2|||
23499008|NCT00915278|65569753|FG000|Overall Study|Infusion related AEs|0|||
23499009|NCT00915278|65569754|FG001|Overall Study|Infusion related AEs|0|||
23499010|NCT00915278|65569755|FG002|Overall Study|Infusion related AEs|0|||
23499011|NCT00915278|65569756|FG003|Overall Study|Infusion related AEs|0|||
23499012|NCT00915278|65569757|FG004|Overall Study|Infusion related AEs|0|||
23499013|NCT00915278|65569758|FG005|Overall Study|Infusion related AEs|2|||
23499014|NCT00915278|65569753|FG000|Overall Study|Admission to hospice|0|||
23499015|NCT00915278|65569754|FG001|Overall Study|Admission to hospice|0|||
23499016|NCT00915278|65569755|FG002|Overall Study|Admission to hospice|1|||
23499017|NCT00915278|65569756|FG003|Overall Study|Admission to hospice|0|||
23499018|NCT00915278|65569757|FG004|Overall Study|Admission to hospice|0|||
23499019|NCT00915278|65569758|FG005|Overall Study|Admission to hospice|0|||
23499020|NCT00530946|65569762|FG000|Overall Study|Adverse Event|1|||
23499021|NCT00530946|65569763|FG001|Overall Study|Adverse Event|2|||
23499022|NCT00530946|65569764|FG002|Overall Study|Adverse Event|1|||
23499023|NCT00530946|65569765|FG003|Overall Study|Adverse Event|1|||
23499024|NCT00530946|65569762|FG000|Overall Study|Protocol Violation|0|||
23499025|NCT00530946|65569763|FG001|Overall Study|Protocol Violation|0|||
23499026|NCT00530946|65569764|FG002|Overall Study|Protocol Violation|0|||
23499027|NCT00530946|65569765|FG003|Overall Study|Protocol Violation|1|||
23499028|NCT00530946|65569762|FG000|Overall Study|Noncompliance|1|||
23499029|NCT00530946|65569763|FG001|Overall Study|Noncompliance|0|||
23499030|NCT00530946|65569764|FG002|Overall Study|Noncompliance|0|||
23499031|NCT00530946|65569765|FG003|Overall Study|Noncompliance|0|||
23499032|NCT05399641|65569766|FG000|Overall Study|Adverse Event|0|||
23499033|NCT05399641|65569767|FG001|Overall Study|Adverse Event|1|||
23499034|NCT05399641|65569768|FG002|Overall Study|Adverse Event|1|||
23499035|NCT05399641|65569766|FG000|Overall Study|Lost to Follow-up|1|||
23499036|NCT05399641|65569767|FG001|Overall Study|Lost to Follow-up|2|||
23499037|NCT05399641|65569768|FG002|Overall Study|Lost to Follow-up|2|||
23499038|NCT05399641|65569766|FG000|Overall Study|Physician Decision|1|||
23499039|NCT05399641|65569767|FG001|Overall Study|Physician Decision|3|||
23499040|NCT05399641|65569768|FG002|Overall Study|Physician Decision|3|||
23499041|NCT05399641|65569766|FG000|Overall Study|Withdrawal by Subject|4|||
23499042|NCT05399641|65569767|FG001|Overall Study|Withdrawal by Subject|11|||
23499043|NCT05399641|65569768|FG002|Overall Study|Withdrawal by Subject|7|||
23499044|NCT05399641|65569766|FG000|Overall Study|Reason not defined|3|||
23499045|NCT05399641|65569767|FG001|Overall Study|Reason not defined|5|||
23499046|NCT05399641|65569768|FG002|Overall Study|Reason not defined|6|||
23499047|NCT03334630|65569770|FG000|Overall Study|Withdrawal by Subject|7|||
23499048|NCT03334630|65569771|FG001|Overall Study|Withdrawal by Subject|7|||
23499049|NCT03334630|65569770|FG000|Overall Study|Lost to Follow-up|3|||
23499050|NCT03334630|65569771|FG001|Overall Study|Lost to Follow-up|1|||
23499051|NCT03334630|65569770|FG000|Overall Study|Adverse Event|0|||
23499052|NCT03334630|65569771|FG001|Overall Study|Adverse Event|1|||
23499053|NCT03334630|65569770|FG000|Overall Study|Physician Decision|1|||
23499054|NCT03334630|65569771|FG001|Overall Study|Physician Decision|1|||
23499055|NCT03334630|65569770|FG000|Overall Study|Enrollment closed|2|||
23499056|NCT03334630|65569771|FG001|Overall Study|Enrollment closed|1|||
23499057|NCT03334630|65569770|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
23499058|NCT03334630|65569771|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
23499059|NCT03334630|65569770|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
23499060|NCT03334630|65569771|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
23499061|NCT00660699|65569772|FG000|Overall Study|Withdrawal by Subject|2|||
23499062|NCT00570765|65569773|FG000|DB Phase|Withdrawal by Subject|1|||
23499063|NCT00570765|65569774|FG001|DB Phase|Withdrawal by Subject|0|||
23499064|NCT00570765|65569775|FG002|DB Phase|Withdrawal by Subject|0|||
23499065|NCT00570765|65569776|FG003|DB Phase|Withdrawal by Subject|0|||
23499066|NCT00570765|65569773|FG000|DB Phase|Protocol Violation|0|||
23499067|NCT00570765|65569774|FG001|DB Phase|Protocol Violation|1|||
23499068|NCT00570765|65569775|FG002|DB Phase|Protocol Violation|0|||
23499069|NCT00570765|65569776|FG003|DB Phase|Protocol Violation|0|||
23499070|NCT00570765|65569773|FG000|DB Phase|Adverse Event|3|||
23499071|NCT00570765|65569774|FG001|DB Phase|Adverse Event|6|||
23499072|NCT00570765|65569775|FG002|DB Phase|Adverse Event|0|||
23499073|NCT00570765|65569776|FG003|DB Phase|Adverse Event|0|||
23499074|NCT00570765|65569773|FG000|DB Phase|Did Not Receive Study Drug|0|||
23499075|NCT00570765|65569774|FG001|DB Phase|Did Not Receive Study Drug|0|||
23499076|NCT00570765|65569775|FG002|DB Phase|Did Not Receive Study Drug|1|||
23499077|NCT00570765|65569776|FG003|DB Phase|Did Not Receive Study Drug|0|||
23499078|NCT00570765|65569773|FG000|LTSE Phase|Withdrawal by Subject|0|||
23499079|NCT00570765|65569774|FG001|LTSE Phase|Withdrawal by Subject|0|||
23499080|NCT00570765|65569775|FG002|LTSE Phase|Withdrawal by Subject|0|||
23499081|NCT00570765|65569776|FG003|LTSE Phase|Withdrawal by Subject|1|||
23499082|NCT00570765|65569773|FG000|LTSE Phase|Adverse Event|0|||
23499083|NCT00570765|65569774|FG001|LTSE Phase|Adverse Event|0|||
23499084|NCT00570765|65569775|FG002|LTSE Phase|Adverse Event|0|||
23499085|NCT00570765|65569776|FG003|LTSE Phase|Adverse Event|7|||
23499086|NCT00570765|65569773|FG000|LTSE Phase|Physician Decision|0|||
23499087|NCT00570765|65569774|FG001|LTSE Phase|Physician Decision|0|||
23499088|NCT00570765|65569775|FG002|LTSE Phase|Physician Decision|0|||
23499089|NCT00570765|65569776|FG003|LTSE Phase|Physician Decision|4|||
23499090|NCT02362269|65569777|FG000|Overall Study|Moved|1|||
23499091|NCT02362269|65569778|FG001|Overall Study|Moved|0|||
23499092|NCT02362269|65569777|FG000|Overall Study|Lost to Follow-up|0|||
23499093|NCT02362269|65569778|FG001|Overall Study|Lost to Follow-up|6|||
23499094|NCT00762229|65569781|FG000|Overall Study|Lost to Follow-up|1|||
23499095|NCT00762229|65569782|FG001|Overall Study|Lost to Follow-up|1|||
23499096|NCT00762229|65569781|FG000|Overall Study|did not recveive intervention|0|||
23499097|NCT00762229|65569782|FG001|Overall Study|did not recveive intervention|1|||
23499098|NCT01683383|65569784|FG000|Overall Study|Infant was not transported|1|||
23499099|NCT01683383|65569785|FG001|Overall Study|Infant was not transported|0|||
23499100|NCT00001880|65569790|FG000|Overall Study|Death|14|||
23499101|NCT01393301|65569796|FG000|Overall Study|Lost to Follow-up|5|||
23499102|NCT01393301|65569797|FG001|Overall Study|Lost to Follow-up|3|||
23499103|NCT01393301|65569796|FG000|Overall Study|Withdrawal by Subject|2|||
23499104|NCT01393301|65569797|FG001|Overall Study|Withdrawal by Subject|0|||
23499105|NCT01393301|65569796|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
23499106|NCT01393301|65569797|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
23499107|NCT03741062|65569800|FG000|Overall Study|Protocol Violation|1|||
23499108|NCT03741062|65569801|FG001|Overall Study|Protocol Violation|0|||
23499109|NCT05248867|65569802|FG000|Double-blind Period|Lost to Follow-up|0|||
23499110|NCT05248867|65569803|FG001|Double-blind Period|Lost to Follow-up|3|||
23499111|NCT05248867|65569804|FG002|Double-blind Period|Lost to Follow-up|0|||
23499112|NCT05248867|65569805|FG003|Double-blind Period|Lost to Follow-up|0|||
23499113|NCT05248867|65569806|FG004|Double-blind Period|Lost to Follow-up|0|||
23499114|NCT05248867|65569807|FG005|Double-blind Period|Lost to Follow-up|0|||
23499115|NCT05248867|65569802|FG000|Double-blind Period|Withdrawal by Subject|5|||
23499116|NCT05248867|65569803|FG001|Double-blind Period|Withdrawal by Subject|14|||
23499117|NCT05248867|65569804|FG002|Double-blind Period|Withdrawal by Subject|0|||
23499118|NCT05248867|65569805|FG003|Double-blind Period|Withdrawal by Subject|0|||
23499119|NCT05248867|65569806|FG004|Double-blind Period|Withdrawal by Subject|0|||
23300704|NCT01846273|64842898|FG000|Overall Study|Subject withdrew consent|5|||
23499120|NCT05248867|65569807|FG005|Double-blind Period|Withdrawal by Subject|0|||
23499121|NCT05248867|65569802|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499122|NCT05248867|65569803|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
23499123|NCT05248867|65569804|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499124|NCT05248867|65569805|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499125|NCT05248867|65569806|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499126|NCT05248867|65569807|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
23499127|NCT05248867|65569802|FG000|Double-blind Period|Other, not specified|3|||
23499128|NCT05248867|65569803|FG001|Double-blind Period|Other, not specified|8|||
23499129|NCT05248867|65569804|FG002|Double-blind Period|Other, not specified|0|||
23499130|NCT05248867|65569805|FG003|Double-blind Period|Other, not specified|0|||
23499131|NCT05248867|65569806|FG004|Double-blind Period|Other, not specified|0|||
23499132|NCT05248867|65569807|FG005|Double-blind Period|Other, not specified|0|||
23499133|NCT05248867|65569802|FG000|Open-label Period|Withdrawal by Subject|0|||
23499134|NCT05248867|65569803|FG001|Open-label Period|Withdrawal by Subject|0|||
23499135|NCT05248867|65569804|FG002|Open-label Period|Withdrawal by Subject|3|||
23499136|NCT05248867|65569805|FG003|Open-label Period|Withdrawal by Subject|1|||
23499137|NCT05248867|65569806|FG004|Open-label Period|Withdrawal by Subject|7|||
23499138|NCT05248867|65569807|FG005|Open-label Period|Withdrawal by Subject|9|||
23499139|NCT05248867|65569802|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499140|NCT05248867|65569803|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499141|NCT05248867|65569804|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499142|NCT05248867|65569805|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
23499143|NCT05248867|65569806|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499144|NCT05248867|65569807|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
23499145|NCT05248867|65569802|FG000|Open-label Period|Lost to Follow-up|0|||
23499146|NCT05248867|65569803|FG001|Open-label Period|Lost to Follow-up|0|||
23499147|NCT05248867|65569804|FG002|Open-label Period|Lost to Follow-up|0|||
23499148|NCT05248867|65569805|FG003|Open-label Period|Lost to Follow-up|0|||
23499149|NCT05248867|65569806|FG004|Open-label Period|Lost to Follow-up|5|||
23499150|NCT05248867|65569807|FG005|Open-label Period|Lost to Follow-up|2|||
23499151|NCT05248867|65569802|FG000|Open-label Period|COVID-19 Infection|0|||
23499152|NCT05248867|65569803|FG001|Open-label Period|COVID-19 Infection|0|||
23499153|NCT05248867|65569804|FG002|Open-label Period|COVID-19 Infection|0|||
23499154|NCT05248867|65569805|FG003|Open-label Period|COVID-19 Infection|0|||
23499155|NCT05248867|65569806|FG004|Open-label Period|COVID-19 Infection|1|||
23499156|NCT05248867|65569807|FG005|Open-label Period|COVID-19 Infection|0|||
23499157|NCT05248867|65569802|FG000|Open-label Period|Other, not specified|0|||
23499158|NCT05248867|65569803|FG001|Open-label Period|Other, not specified|0|||
23499159|NCT05248867|65569804|FG002|Open-label Period|Other, not specified|0|||
23499160|NCT05248867|65569805|FG003|Open-label Period|Other, not specified|0|||
23499161|NCT05248867|65569806|FG004|Open-label Period|Other, not specified|4|||
23499162|NCT05248867|65569807|FG005|Open-label Period|Other, not specified|0|||
23499163|NCT02582983|65569809|FG000|Overall Study|Death|3|||
23499164|NCT02582983|65569809|FG000|Overall Study|Withdrawal by Subject|2|||
23499165|NCT02582983|65569809|FG000|Overall Study|Adverse Event|1|||
23499166|NCT02339584|65569810|FG000|Overall Study|Adverse Event|11|||
23499167|NCT02339584|65569811|FG001|Overall Study|Adverse Event|7|||
23499168|NCT02339584|65569810|FG000|Overall Study|Lack of Efficacy|0|||
23499169|NCT02339584|65569811|FG001|Overall Study|Lack of Efficacy|1|||
23499170|NCT02339584|65569810|FG000|Overall Study|Physician Decision|1|||
23499171|NCT02339584|65569811|FG001|Overall Study|Physician Decision|2|||
23499172|NCT02339584|65569810|FG000|Overall Study|Protocol Violation|1|||
23499173|NCT02339584|65569811|FG001|Overall Study|Protocol Violation|1|||
23499174|NCT02339584|65569810|FG000|Overall Study|Withdrawal by Subject|2|||
23499175|NCT02339584|65569811|FG001|Overall Study|Withdrawal by Subject|4|||
23499176|NCT03478657|65569816|FG000|Overall Study|Withdrawal by Subject|0|||
23499177|NCT03478657|65569817|FG001|Overall Study|Withdrawal by Subject|1|||
23499178|NCT00868608|65569818|FG000|Overall Study|Withdrawal by Subject|3|||
23499179|NCT00868608|65569819|FG001|Overall Study|Withdrawal by Subject|1|||
23499180|NCT00868608|65569820|FG002|Overall Study|Withdrawal by Subject|0|||
23499181|NCT00868608|65569818|FG000|Overall Study|Lost to Follow-up|3|||
23499182|NCT00868608|65569819|FG001|Overall Study|Lost to Follow-up|0|||
23499183|NCT00868608|65569820|FG002|Overall Study|Lost to Follow-up|1|||
23499184|NCT00868608|65569818|FG000|Overall Study|Death|16|||
23499185|NCT00868608|65569819|FG001|Overall Study|Death|2|||
23499186|NCT00868608|65569820|FG002|Overall Study|Death|4|||
23499187|NCT00868608|65569818|FG000|Overall Study|Other - Unspecified|1|||
23499188|NCT00868608|65569819|FG001|Overall Study|Other - Unspecified|0|||
23499189|NCT00868608|65569820|FG002|Overall Study|Other - Unspecified|0|||
23499190|NCT01909674|65569821|FG000|Overall Study|Withdrawal by Subject|5|||
23499191|NCT01909674|65569822|FG001|Overall Study|Withdrawal by Subject|2|||
23499192|NCT01926015|65569823|FG000|Overall Study|Withdrawal by parent/guardian|0|||
23499193|NCT01926015|65569824|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23499194|NCT01926015|65569823|FG000|Overall Study|Randomized not treated|2|||
23499195|NCT01926015|65569824|FG001|Overall Study|Randomized not treated|0|||
23499196|NCT03345914|65569825|FG000|Overall Study|Transition to another study at week 16|80|||
23499197|NCT03345914|65569826|FG001|Overall Study|Transition to another study at week 16|86|||
23499198|NCT03345914|65569827|FG002|Overall Study|Transition to another study at week 16|78|||
23499199|NCT03345914|65569825|FG000|Overall Study|Transition to OLE during follow-up|37|||
23398519|NCT04622592|65203613|FG001|Overall Study|Physician Decision|0|||
23398520|NCT04622592|65203614|FG002|Overall Study|Physician Decision|0|||
23398521|NCT04622592|65203615|FG003|Overall Study|Physician Decision|0|||
23398522|NCT04622592|65203616|FG004|Overall Study|Physician Decision|1|||
23398523|NCT04622592|65203617|FG005|Overall Study|Physician Decision|0|||
23398524|NCT04622592|65203618|FG006|Overall Study|Physician Decision|0|||
23398525|NCT04622592|65203619|FG007|Overall Study|Physician Decision|0|||
23398526|NCT04622592|65203612|FG000|Overall Study|Withdrawal by Subject|1|||
23398527|NCT04622592|65203613|FG001|Overall Study|Withdrawal by Subject|0|||
23398528|NCT04622592|65203614|FG002|Overall Study|Withdrawal by Subject|2|||
23398529|NCT04622592|65203615|FG003|Overall Study|Withdrawal by Subject|0|||
23398530|NCT04622592|65203616|FG004|Overall Study|Withdrawal by Subject|0|||
23398531|NCT04622592|65203617|FG005|Overall Study|Withdrawal by Subject|0|||
23398532|NCT04622592|65203618|FG006|Overall Study|Withdrawal by Subject|1|||
23398533|NCT04622592|65203619|FG007|Overall Study|Withdrawal by Subject|4|||
23398534|NCT04622592|65203612|FG000|Overall Study|Other than specified above|0|||
23398535|NCT04622592|65203613|FG001|Overall Study|Other than specified above|0|||
23398536|NCT04622592|65203614|FG002|Overall Study|Other than specified above|1|||
23398537|NCT04622592|65203615|FG003|Overall Study|Other than specified above|0|||
23398538|NCT04622592|65203616|FG004|Overall Study|Other than specified above|0|||
23398539|NCT04622592|65203617|FG005|Overall Study|Other than specified above|0|||
23398540|NCT04622592|65203618|FG006|Overall Study|Other than specified above|0|||
23398541|NCT04622592|65203619|FG007|Overall Study|Other than specified above|0|||
23398542|NCT03673176|65207081|FG000|Overall Study|Death prior to intervention|1|||
23398543|NCT03673176|65207081|FG000|Overall Study|Death following intervention|3|||
23398544|NCT03673176|65207081|FG000|Overall Study|Withdrawal by Subject|1|||
23398545|NCT00370292|65207082|FG000|Overall Study|Disease Progression|4|||
23398546|NCT00370292|65207082|FG000|Overall Study|Adverse Event|7|||
23398547|NCT00370292|65207082|FG000|Overall Study|Physician Decision|2|||
23398548|NCT00256126|65207083|FG000|Overall Study|Adverse Event|1|||
23398549|NCT00256126|65207084|FG001|Overall Study|Adverse Event|0|||
23398550|NCT00256126|65207083|FG000|Overall Study|Other|1|||
23398551|NCT00256126|65207084|FG001|Overall Study|Other|2|||
23398552|NCT01276704|65207085|FG000|Overall Study|Lost to Follow-up|2|||
23398553|NCT01276704|65207086|FG001|Overall Study|Lost to Follow-up|3|||
23398554|NCT01276704|65207085|FG000|Overall Study|Non-compliant|2|||
23398555|NCT01276704|65207086|FG001|Overall Study|Non-compliant|2|||
23398556|NCT01276704|65207085|FG000|Overall Study|Withdrawal by Subject|7|||
23398557|NCT01276704|65207086|FG001|Overall Study|Withdrawal by Subject|1|||
23398558|NCT01276704|65207085|FG000|Overall Study|Physician Decision|3|||
23398559|NCT01276704|65207086|FG001|Overall Study|Physician Decision|5|||
23398560|NCT03247829|65207087|FG000|Overall Study|Death|3|||
23398561|NCT03247829|65207088|FG001|Overall Study|Death|4|||
23398562|NCT03247829|65207087|FG000|Overall Study|Enter Hospice Care|1|||
23398563|NCT03247829|65207088|FG001|Overall Study|Enter Hospice Care|0|||
23398564|NCT03247829|65207087|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
23398565|NCT03247829|65207088|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
23398566|NCT03247829|65207087|FG000|Overall Study|LVAD Explant|1|||
23398567|NCT03247829|65207088|FG001|Overall Study|LVAD Explant|1|||
23398568|NCT03247829|65207087|FG000|Overall Study|Transplant|1|||
23398569|NCT03247829|65207088|FG001|Overall Study|Transplant|1|||
23398570|NCT01767909|65207089|FG000|Overall Study|Withdrawal by Subject|4|||
23398571|NCT01767909|65207090|FG001|Overall Study|Withdrawal by Subject|7|||
23398572|NCT01767909|65207089|FG000|Overall Study|Adverse Event|3|||
23398573|NCT01767909|65207090|FG001|Overall Study|Adverse Event|1|||
23398574|NCT01767909|65207089|FG000|Overall Study|Withdrawal by Study Partner|3|||
23398575|NCT01767909|65207090|FG001|Overall Study|Withdrawal by Study Partner|1|||
23398576|NCT01767909|65207089|FG000|Overall Study|Non-Compliance|2|||
23398577|NCT01767909|65207090|FG001|Overall Study|Non-Compliance|0|||
23398578|NCT01767909|65207089|FG000|Overall Study|Perceived Lack of Efficacy|1|||
23398579|NCT01767909|65207090|FG001|Overall Study|Perceived Lack of Efficacy|0|||
23398580|NCT01767909|65207089|FG000|Overall Study|Investigator Recommendation|0|||
23398581|NCT01767909|65207090|FG001|Overall Study|Investigator Recommendation|1|||
23398582|NCT01767909|65207089|FG000|Overall Study|Lost to Follow-up|0|||
23398583|NCT01767909|65207090|FG001|Overall Study|Lost to Follow-up|1|||
23398584|NCT01767909|65207089|FG000|Overall Study|LP uncessessful|0|||
23398585|NCT01767909|65207090|FG001|Overall Study|LP uncessessful|1|||
23398586|NCT00399035|65207091|FG000|Overall Study|Death|289|||
23398587|NCT00399035|65207092|FG001|Overall Study|Death|141|||
23398588|NCT00399035|65207093|FG002|Overall Study|Death|234|||
23398589|NCT00399035|65207091|FG000|Overall Study|Lost to Follow-up|2|||
23398590|NCT00399035|65207092|FG001|Overall Study|Lost to Follow-up|1|||
23398591|NCT00399035|65207093|FG002|Overall Study|Lost to Follow-up|5|||
23398592|NCT00399035|65207091|FG000|Overall Study|Withdrawal by Subject|19|||
23398593|NCT00399035|65207092|FG001|Overall Study|Withdrawal by Subject|15|||
23499200|NCT03345914|65569826|FG001|Overall Study|Transition to OLE during follow-up|33|||
23499201|NCT03345914|65569827|FG002|Overall Study|Transition to OLE during follow-up|39|||
23499202|NCT03345914|65569825|FG000|Overall Study|Physician Decision|0|||
23499203|NCT03345914|65569826|FG001|Overall Study|Physician Decision|1|||
23499204|NCT03345914|65569827|FG002|Overall Study|Physician Decision|1|||
23499205|NCT03345914|65569825|FG000|Overall Study|Withdrawal by Subject|5|||
23499206|NCT03345914|65569826|FG001|Overall Study|Withdrawal by Subject|1|||
23499207|NCT03345914|65569827|FG002|Overall Study|Withdrawal by Subject|2|||
23499208|NCT03345914|65569825|FG000|Overall Study|Other|1|||
23499209|NCT03345914|65569826|FG001|Overall Study|Other|1|||
23499210|NCT03345914|65569827|FG002|Overall Study|Other|1|||
23499211|NCT03345914|65569825|FG000|Overall Study|Ongoing|0|||
23499212|NCT03345914|65569826|FG001|Overall Study|Ongoing|0|||
23499213|NCT03345914|65569827|FG002|Overall Study|Ongoing|1|||
23499214|NCT00345839|65569828|FG000|Overall Study|Withdrawal by Subject|91|||
23499215|NCT00345839|65569829|FG001|Overall Study|Withdrawal by Subject|98|||
23499216|NCT00345839|65569828|FG000|Overall Study|Lost to Follow-up|58|||
23499217|NCT00345839|65569829|FG001|Overall Study|Lost to Follow-up|61|||
23499218|NCT01218243|65569832|FG000|Overall Study|Lack of Efficacy|1|||
23499219|NCT01218243|65569833|FG001|Overall Study|Lack of Efficacy|1|||
23499220|NCT01218243|65569832|FG000|Overall Study|Lost to Follow-up|3|||
23499221|NCT01218243|65569833|FG001|Overall Study|Lost to Follow-up|3|||
23499222|NCT01218243|65569832|FG000|Overall Study|Protocol Violation|5|||
23499223|NCT01218243|65569833|FG001|Overall Study|Protocol Violation|10|||
23499224|NCT01201850|65569836|FG000|Overall Study|Tumor progression|4|||
23499225|NCT01896050|65569837|FG000|Overall Study|Adverse Event|37|||
23499226|NCT01896050|65569838|FG001|Overall Study|Adverse Event|2|||
23499227|NCT01896050|65569837|FG000|Overall Study|Death|1|||
23499228|NCT01896050|65569838|FG001|Overall Study|Death|0|||
23499229|NCT02099708|65569840|FG000|Overall Study|Data Not Available|30|||
23499230|NCT02099708|65569840|FG000|Overall Study|Lost to Follow-up|141|||
23499231|NCT02099708|65569840|FG000|Overall Study|Other|29|||
23499232|NCT02091960|65569841|FG000|Overall Study|Death|7|||
23499233|NCT02091960|65569841|FG000|Overall Study|Withdrawal by Subject|1|||
23499234|NCT02091960|65569841|FG000|Overall Study|Miscellaneous Reasons|31|||
23499235|NCT02091960|65569841|FG000|Overall Study|On Study at Data Cut-off|12|||
23499236|NCT02571777|65569842|FG000|Overall Study|Subject/guardian decision|34|||
23499237|NCT02571777|65569843|FG001|Overall Study|Subject/guardian decision|26|||
23499238|NCT02571777|65569844|FG002|Overall Study|Subject/guardian decision|26|||
23499239|NCT02571777|65569845|FG003|Overall Study|Subject/guardian decision|25|||
23499240|NCT02571777|65569846|FG004|Overall Study|Subject/guardian decision|27|||
23499241|NCT02571777|65569842|FG000|Overall Study|Protocol Deviation|2|||
23499242|NCT02571777|65569843|FG001|Overall Study|Protocol Deviation|3|||
23499243|NCT02571777|65569844|FG002|Overall Study|Protocol Deviation|4|||
23499244|NCT02571777|65569845|FG003|Overall Study|Protocol Deviation|8|||
23499245|NCT02571777|65569846|FG004|Overall Study|Protocol Deviation|4|||
23499246|NCT02571777|65569842|FG000|Overall Study|Death|1|||
23499247|NCT02571777|65569843|FG001|Overall Study|Death|1|||
23499248|NCT02571777|65569844|FG002|Overall Study|Death|4|||
23499249|NCT02571777|65569845|FG003|Overall Study|Death|0|||
23499250|NCT02571777|65569846|FG004|Overall Study|Death|0|||
23499251|NCT02571777|65569842|FG000|Overall Study|Lost to Follow-up|1|||
23499252|NCT02571777|65569843|FG001|Overall Study|Lost to Follow-up|1|||
23499253|NCT02571777|65569844|FG002|Overall Study|Lost to Follow-up|2|||
23499254|NCT02571777|65569845|FG003|Overall Study|Lost to Follow-up|0|||
23499255|NCT02571777|65569846|FG004|Overall Study|Lost to Follow-up|1|||
23499256|NCT02571777|65569842|FG000|Overall Study|Physician Decision|1|||
23499257|NCT02571777|65569843|FG001|Overall Study|Physician Decision|7|||
23499258|NCT02571777|65569844|FG002|Overall Study|Physician Decision|5|||
23499259|NCT02571777|65569845|FG003|Overall Study|Physician Decision|2|||
23499260|NCT02571777|65569846|FG004|Overall Study|Physician Decision|4|||
23499261|NCT02571777|65569842|FG000|Overall Study|Pregnancy|0|||
23499262|NCT02571777|65569843|FG001|Overall Study|Pregnancy|0|||
23499263|NCT02571777|65569844|FG002|Overall Study|Pregnancy|0|||
23499264|NCT02571777|65569845|FG003|Overall Study|Pregnancy|2|||
23499265|NCT02571777|65569846|FG004|Overall Study|Pregnancy|0|||
23499266|NCT02570074|65569847|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
23499267|NCT02570074|65569848|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
23499268|NCT02925923|65569850|FG000|Overall Study|blood samples hemolyzed|0|||
23499269|NCT02925923|65569851|FG001|Overall Study|blood samples hemolyzed|2|||
23499270|NCT03228433|65569853|FG000|Overall Study|Lost to Follow-up|1|||
23499271|NCT03228433|65569854|FG001|Overall Study|Lost to Follow-up|0|||
23499272|NCT03228433|65569855|FG002|Overall Study|Lost to Follow-up|0|||
23300705|NCT01846273|64842899|FG001|Overall Study|Subject withdrew consent|8|||
23499273|NCT03228433|65569856|FG003|Overall Study|Lost to Follow-up|0|||
23499274|NCT03228433|65569857|FG004|Overall Study|Lost to Follow-up|0|||
23499275|NCT03228433|65569858|FG005|Overall Study|Lost to Follow-up|0|||
23499276|NCT03228433|65569853|FG000|Overall Study|Positive alcohol test|0|||
23499277|NCT03228433|65569854|FG001|Overall Study|Positive alcohol test|0|||
23499278|NCT03228433|65569855|FG002|Overall Study|Positive alcohol test|0|||
23499279|NCT03228433|65569856|FG003|Overall Study|Positive alcohol test|1|||
23499280|NCT03228433|65569857|FG004|Overall Study|Positive alcohol test|0|||
23499281|NCT03228433|65569858|FG005|Overall Study|Positive alcohol test|0|||
23499282|NCT03600818|65569862|FG000|Overall Study|Adverse Event|4|||
23499283|NCT03600818|65569863|FG001|Overall Study|Adverse Event|7|||
23499284|NCT03600818|65569862|FG000|Overall Study|Lack of Efficacy|9|||
23499285|NCT03600818|65569863|FG001|Overall Study|Lack of Efficacy|4|||
23499286|NCT03600818|65569862|FG000|Overall Study|Withdrawal by Subject|4|||
23499287|NCT03600818|65569863|FG001|Overall Study|Withdrawal by Subject|3|||
23499288|NCT03600818|65569862|FG000|Overall Study|Other-unspecified|5|||
23499289|NCT03600818|65569863|FG001|Overall Study|Other-unspecified|3|||
23499290|NCT03600818|65569862|FG000|Overall Study|Randomized and not treated|0|||
23499291|NCT03600818|65569863|FG001|Overall Study|Randomized and not treated|1|||
23499292|NCT02850965|65569867|FG000|Overall Study|Other than listed|3|||
23499293|NCT02850965|65569868|FG001|Overall Study|Other than listed|4|||
23499294|NCT02850965|65569867|FG000|Overall Study|Protocol Violation|0|||
23499295|NCT02850965|65569868|FG001|Overall Study|Protocol Violation|2|||
23499296|NCT02850965|65569867|FG000|Overall Study|Lost to Follow-up|5|||
23499297|NCT02850965|65569868|FG001|Overall Study|Lost to Follow-up|3|||
23499298|NCT02850965|65569867|FG000|Overall Study|Lack of Efficacy|4|||
23499299|NCT02850965|65569868|FG001|Overall Study|Lack of Efficacy|8|||
23499300|NCT02850965|65569867|FG000|Overall Study|Adverse Event|3|||
23499301|NCT02850965|65569868|FG001|Overall Study|Adverse Event|2|||
23499302|NCT02850965|65569867|FG000|Overall Study|Withdrawal by Subject|3|||
23499303|NCT02850965|65569868|FG001|Overall Study|Withdrawal by Subject|4|||
23499304|NCT02850965|65569867|FG000|Overall Study|Physician Decision|0|||
23499305|NCT02850965|65569868|FG001|Overall Study|Physician Decision|1|||
23499306|NCT02850965|65569867|FG000|Overall Study|Randomized but not treated|0|||
23499307|NCT02850965|65569868|FG001|Overall Study|Randomized but not treated|1|||
23499308|NCT03758066|65569869|FG000|Overall Study|Lost to Follow-up|14|||
23499309|NCT02572401|65569876|FG000|Overall Study|Lost to Follow-up|5|||
23499310|NCT02572401|65569877|FG001|Overall Study|Lost to Follow-up|8|||
23499311|NCT02572401|65569878|FG002|Overall Study|Lost to Follow-up|9|||
23499312|NCT02572401|65569879|FG003|Overall Study|Lost to Follow-up|9|||
23499313|NCT02572401|65569876|FG000|Overall Study|Death|0|||
23499314|NCT02572401|65569877|FG001|Overall Study|Death|0|||
23499315|NCT02572401|65569878|FG002|Overall Study|Death|0|||
23499316|NCT02572401|65569879|FG003|Overall Study|Death|1|||
23499317|NCT00847379|65569885|FG000|Overall Study|Study terminated by Sponsor|59|||
23499318|NCT00847379|65569886|FG001|Overall Study|Study terminated by Sponsor|57|||
23499319|NCT00847379|65569887|FG002|Overall Study|Study terminated by Sponsor|57|||
23499320|NCT00242216|65569890|FG000|Overall Study|Lost to Follow-up|12|||
23499321|NCT00242216|65569891|FG001|Overall Study|Lost to Follow-up|17|||
23499322|NCT00242216|65569890|FG000|Overall Study|Death|4|||
23499323|NCT00242216|65569891|FG001|Overall Study|Death|2|||
23499324|NCT00242216|65569890|FG000|Overall Study|Lack of Efficacy|1|||
23499325|NCT00242216|65569891|FG001|Overall Study|Lack of Efficacy|2|||
23499326|NCT00242216|65569890|FG000|Overall Study|no medicaiton dispensed|1|||
23499327|NCT00242216|65569891|FG001|Overall Study|no medicaiton dispensed|1|||
23499328|NCT01217801|65569892|FG000|Period 1|Protocol Violation|1|||
23499329|NCT01217801|65569893|FG001|Period 1|Protocol Violation|1|||
23499330|NCT01217801|65569892|FG000|Period 1|Withdrawal by Subject|0|||
23499331|NCT01217801|65569893|FG001|Period 1|Withdrawal by Subject|1|||
23499332|NCT01233258|65569897|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
23499333|NCT01233258|65569898|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
23499334|NCT01233258|65569899|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
23499335|NCT01233258|65569900|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
23499336|NCT01233258|65569901|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
23499337|NCT01233258|65569902|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
23499338|NCT01233258|65569897|FG000|First Intervention (6 Months)|Protocol Violation|0|||
23499339|NCT01233258|65569898|FG001|First Intervention (6 Months)|Protocol Violation|0|||
23499340|NCT01233258|65569899|FG002|First Intervention (6 Months)|Protocol Violation|1|||
23499341|NCT01233258|65569900|FG003|First Intervention (6 Months)|Protocol Violation|0|||
23499342|NCT01233258|65569901|FG004|First Intervention (6 Months)|Protocol Violation|0|||
23499343|NCT01233258|65569902|FG005|First Intervention (6 Months)|Protocol Violation|0|||
23499344|NCT01233258|65569897|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
23499345|NCT01233258|65569898|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
23499346|NCT01233258|65569899|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
23499347|NCT01233258|65569900|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
23499348|NCT01233258|65569901|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
23499349|NCT01233258|65569902|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
23499350|NCT00696800|65569909|FG000|Overall Study|Adverse Event|16|||
23499351|NCT00696800|65569910|FG001|Overall Study|Adverse Event|3|||
23499352|NCT00696800|65569909|FG000|Overall Study|Insufficient compliance with medication|2|||
23499353|NCT00696800|65569910|FG001|Overall Study|Insufficient compliance with medication|1|||
23499354|NCT00696800|65569909|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
23499355|NCT00696800|65569910|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
23499356|NCT00696800|65569909|FG000|Overall Study|Insufficient ovarian response|4|||
23499357|NCT00696800|65569910|FG001|Overall Study|Insufficient ovarian response|1|||
23499358|NCT00696800|65569909|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
23499359|NCT00696800|65569910|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
23499360|NCT00696800|65569909|FG000|Overall Study|Too high ovarian response|6|||
23499361|NCT00696800|65569910|FG001|Overall Study|Too high ovarian response|1|||
23499362|NCT00696800|65569909|FG000|Overall Study|No/too few/bad quality oocytes|4|||
23499363|NCT00696800|65569910|FG001|Overall Study|No/too few/bad quality oocytes|3|||
23499364|NCT00696800|65569909|FG000|Overall Study|No/abnormal fertilization|11|||
23499365|NCT00696800|65569910|FG001|Overall Study|No/abnormal fertilization|13|||
23499366|NCT00696800|65569909|FG000|Overall Study|No/too few/bad quality embryos|24|||
23499367|NCT00696800|65569910|FG001|Overall Study|No/too few/bad quality embryos|18|||
23499368|NCT00696800|65569909|FG000|Overall Study|Other Reasons|5|||
23499369|NCT00696800|65569910|FG001|Overall Study|Other Reasons|3|||
23499370|NCT00696800|65569909|FG000|Overall Study|Not treated|1|||
23499371|NCT00696800|65569910|FG001|Overall Study|Not treated|2|||
23499372|NCT02422303|65569915|FG000|Overall Study|Lost to Follow-up|1|||
23499373|NCT02422303|65569916|FG001|Overall Study|Lost to Follow-up|1|||
23499374|NCT01970397|65569917|FG000|Overall Study|Adverse Event|0|||
23499375|NCT01970397|65569918|FG001|Overall Study|Adverse Event|1|||
23499376|NCT01970397|65569917|FG000|Overall Study|Lost to Follow-up|0|||
23499377|NCT01970397|65569918|FG001|Overall Study|Lost to Follow-up|1|||
23499378|NCT01970397|65569917|FG000|Overall Study|Personal Reasons|1|||
23499379|NCT01970397|65569918|FG001|Overall Study|Personal Reasons|2|||
23499380|NCT01970397|65569917|FG000|Overall Study|Protocol Violation|1|||
23499381|NCT01970397|65569918|FG001|Overall Study|Protocol Violation|1|||
23499382|NCT02610725|65569919|FG000|Overall Study|Lost to Follow-up|197|||
23499383|NCT02610725|65569919|FG000|Overall Study|self-reported contraindication|9|||
23499384|NCT03408483|65569920|FG000|Overall Study|Physician Decision|3|||
23499385|NCT03408483|65569921|FG001|Overall Study|Physician Decision|3|||
23499386|NCT03408483|65569920|FG000|Overall Study|Lost to Follow-up|3|||
23499387|NCT03408483|65569921|FG001|Overall Study|Lost to Follow-up|0|||
23499388|NCT01397162|65569924|FG000|Overall Study|Adverse Event|4|||
23499389|NCT01397162|65569925|FG001|Overall Study|Adverse Event|0|||
23499390|NCT01397162|65569926|FG002|Overall Study|Adverse Event|0|||
23499391|NCT01397162|65569927|FG003|Overall Study|Adverse Event|0|||
23499392|NCT01397162|65569928|FG004|Overall Study|Adverse Event|0|||
23499393|NCT01397162|65569924|FG000|Overall Study|Not yet defined|3|||
23499394|NCT01397162|65569925|FG001|Overall Study|Not yet defined|4|||
23499395|NCT01397162|65569926|FG002|Overall Study|Not yet defined|3|||
23499396|NCT01397162|65569927|FG003|Overall Study|Not yet defined|5|||
23499397|NCT01397162|65569928|FG004|Overall Study|Not yet defined|3|||
23499398|NCT01397890|65569938|FG000|Overall Study|Withdrawal by Subject|7|||
23499399|NCT01397890|65569939|FG001|Overall Study|Withdrawal by Subject|11|||
23499400|NCT01397890|65569938|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
23499401|NCT01397890|65569939|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
23499402|NCT01397890|65569938|FG000|Overall Study|Death|2|||
23499403|NCT01397890|65569939|FG001|Overall Study|Death|3|||
23499404|NCT01397890|65569938|FG000|Overall Study|Lost to Follow-up|1|||
23499405|NCT01397890|65569939|FG001|Overall Study|Lost to Follow-up|4|||
23499406|NCT01397890|65569938|FG000|Overall Study|Condition under Investigation Worsened|1|||
23499407|NCT01397890|65569939|FG001|Overall Study|Condition under Investigation Worsened|3|||
23499408|NCT01397890|65569938|FG000|Overall Study|Adverse Event|1|||
23499409|NCT01397890|65569939|FG001|Overall Study|Adverse Event|2|||
23499410|NCT01397890|65569938|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
23499411|NCT01397890|65569939|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
23499412|NCT01397890|65569938|FG000|Overall Study|Others|2|||
23499413|NCT01397890|65569939|FG001|Overall Study|Others|1|||
23499414|NCT01402011|65569940|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
23499415|NCT01402011|65569941|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
23499416|NCT01402011|65569942|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
23499417|NCT01402011|65569940|FG000|Active Treatment Period|Withdrawal by Subject|1|||
23499418|NCT01402011|65569941|FG001|Active Treatment Period|Withdrawal by Subject|3|||
23499419|NCT01402011|65569942|FG002|Active Treatment Period|Withdrawal by Subject|0|||
23499420|NCT01402011|65569940|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
23499421|NCT01402011|65569941|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
23499422|NCT01402011|65569942|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
23499423|NCT02657369|65569943|FG000|Overall Study|Death|27|||
23499424|NCT02657369|65569943|FG000|Overall Study|Study terminated by sponsor|7|||
23499425|NCT02605824|65569946|FG000|Overall Study|Physician Decision|1|||
23499426|NCT02605824|65569947|FG001|Overall Study|Physician Decision|0|||
23499427|NCT02993757|65569950|FG000|Overall Study|Non compliance with the protocol|155|||
23499428|NCT02993757|65569951|FG001|Overall Study|Non compliance with the protocol|170|||
23499429|NCT02993757|65569950|FG000|Overall Study|Lost to Follow-up|1|||
23499430|NCT02993757|65569951|FG001|Overall Study|Lost to Follow-up|0|||
23499431|NCT02993757|65569950|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
23499432|NCT02993757|65569951|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
23499433|NCT03797014|65569954|FG000|Overall Study|Withdrawal by Subject|1|||
23499434|NCT03797014|65569954|FG000|Overall Study|Lost to Follow-up|1|||
23499435|NCT03797014|65569954|FG000|Overall Study|Protocol Violation|1|||
23499436|NCT04390191|65569957|FG000|Overall Study|Withdrawal by Subject|1|||
23499437|NCT04390191|65569958|FG001|Overall Study|Withdrawal by Subject|0|||
23499438|NCT01999179|65569961|FG000|Overall Study|Adverse Event|1|||
23499439|NCT01999179|65569961|FG000|Overall Study|Lost to Follow-up|1|||
23499440|NCT01999179|65569961|FG000|Overall Study|Change in Therapy|3|||
23499441|NCT01999179|65569961|FG000|Overall Study|New catheter|2|||
23499442|NCT01300650|65569964|FG000|Overall Study|Adverse Event|1|||
23499443|NCT02083783|65569965|FG000|Overall Study|Withdrawal by Subject|1|||
23499444|NCT02083783|65569966|FG001|Overall Study|Withdrawal by Subject|0|||
23499445|NCT00674362|65569967|FG000|Double Blind|Adverse Event|6|||
23499446|NCT00674362|65569968|FG001|Double Blind|Adverse Event|6|||
23499447|NCT00674362|65569967|FG000|Double Blind|Lack of Efficacy|2|||
23499448|NCT00674362|65569968|FG001|Double Blind|Lack of Efficacy|6|||
23499449|NCT00674362|65569967|FG000|Double Blind|Loss of efficacy|0|||
23499450|NCT00674362|65569968|FG001|Double Blind|Loss of efficacy|1|||
23499451|NCT00674362|65569967|FG000|Double Blind|Withdrawal by Subject|4|||
23499452|NCT00674362|65569968|FG001|Double Blind|Withdrawal by Subject|3|||
23499453|NCT00674362|65569967|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
23499454|NCT00674362|65569968|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
23499455|NCT00674362|65569967|FG000|Double Blind|Other: Surgery|0|||
23499456|NCT00674362|65569968|FG001|Double Blind|Other: Surgery|1|||
23499457|NCT00674362|65569967|FG000|Open Label|Adverse Event|1|||
23499458|NCT00674362|65569968|FG001|Open Label|Adverse Event|0|||
23499459|NCT00674362|65569967|FG000|Open Label|Other: Subject moved to extension study|1|||
23499460|NCT00674362|65569968|FG001|Open Label|Other: Subject moved to extension study|0|||
23499461|NCT00639678|65569969|FG000|Overall Study|Withdrawal by Subject|3|||
23499462|NCT00639678|65569970|FG001|Overall Study|Withdrawal by Subject|0|||
23499463|NCT00639678|65569971|FG002|Overall Study|Withdrawal by Subject|4|||
23499464|NCT00639678|65569972|FG003|Overall Study|Withdrawal by Subject|0|||
23499465|NCT00639678|65569969|FG000|Overall Study|Lost to Follow-up|1|||
23499466|NCT00639678|65569970|FG001|Overall Study|Lost to Follow-up|0|||
23499467|NCT00639678|65569971|FG002|Overall Study|Lost to Follow-up|6|||
23499468|NCT00639678|65569972|FG003|Overall Study|Lost to Follow-up|0|||
23499469|NCT00639678|65569969|FG000|Overall Study|Adverse Event|0|||
23499470|NCT00639678|65569970|FG001|Overall Study|Adverse Event|1|||
23499471|NCT00639678|65569971|FG002|Overall Study|Adverse Event|0|||
23499472|NCT00639678|65569972|FG003|Overall Study|Adverse Event|0|||
23499473|NCT00639678|65569969|FG000|Overall Study|Lack of Compliance|0|||
23499474|NCT00639678|65569970|FG001|Overall Study|Lack of Compliance|0|||
23499475|NCT00639678|65569971|FG002|Overall Study|Lack of Compliance|1|||
23499476|NCT00639678|65569972|FG003|Overall Study|Lack of Compliance|0|||
23499477|NCT00622401|65569973|FG000|Overall Study|Disease progression prior to treatment|3|||
23499478|NCT00622401|65569974|FG001|Overall Study|Disease progression prior to treatment|2|||
23499479|NCT00622401|65569975|FG002|Overall Study|Disease progression prior to treatment|0|||
23499480|NCT00404235|65569978|FG000|Overall Study|Withdrawal by Subject|1|||
23499481|NCT00404235|65569979|FG001|Overall Study|Withdrawal by Subject|2|||
23499482|NCT00911547|65569982|FG000|Overall Study|Adverse Event|8|||
23499483|NCT00911547|65569983|FG001|Overall Study|Adverse Event|27|||
23499484|NCT00911547|65569984|FG002|Overall Study|Adverse Event|11|||
23499485|NCT00911547|65569985|FG003|Overall Study|Adverse Event|6|||
23499486|NCT00911547|65569982|FG000|Overall Study|Lost to Follow-up|0|||
23499487|NCT00911547|65569983|FG001|Overall Study|Lost to Follow-up|0|||
23499488|NCT00911547|65569984|FG002|Overall Study|Lost to Follow-up|2|||
23499489|NCT00911547|65569985|FG003|Overall Study|Lost to Follow-up|1|||
23499490|NCT00911547|65569982|FG000|Overall Study|Protocol Violation|0|||
23499491|NCT00911547|65569983|FG001|Overall Study|Protocol Violation|5|||
23499492|NCT00911547|65569984|FG002|Overall Study|Protocol Violation|5|||
23499493|NCT00911547|65569985|FG003|Overall Study|Protocol Violation|1|||
23499494|NCT00911547|65569982|FG000|Overall Study|Withdrawal by Subject|3|||
23499495|NCT00911547|65569983|FG001|Overall Study|Withdrawal by Subject|10|||
23499496|NCT00911547|65569984|FG002|Overall Study|Withdrawal by Subject|4|||
23499497|NCT00911547|65569985|FG003|Overall Study|Withdrawal by Subject|8|||
23499498|NCT01253408|65569988|FG000|Overall Study|Adverse Event|0|||
23499499|NCT01253408|65569989|FG001|Overall Study|Adverse Event|1|||
23499500|NCT01253408|65569990|FG002|Overall Study|Adverse Event|0|||
23499501|NCT00316719|65569991|FG000|Overall Study|Adverse Event|0|||
23499502|NCT00316719|65569992|FG001|Overall Study|Adverse Event|6|||
23499503|NCT00316719|65569991|FG000|Overall Study|Consent withdrawn|2|||
23499504|NCT00316719|65569992|FG001|Overall Study|Consent withdrawn|0|||
23499505|NCT01552694|65569995|FG000|Overall Study|Lost to Follow-up|0|||
23499506|NCT01552694|65569996|FG001|Overall Study|Lost to Follow-up|1|||
23499507|NCT01552694|65569995|FG000|Overall Study|Protocol Violation|0|||
23499508|NCT01552694|65569996|FG001|Overall Study|Protocol Violation|1|||
23499509|NCT01466153|65569997|FG000|Overall Study|Disease Progression|2|||
23499510|NCT01466153|65569998|FG001|Overall Study|Disease Progression|2|||
23499511|NCT01466153|65569999|FG002|Overall Study|Disease Progression|0|||
23499512|NCT01466153|65569997|FG000|Overall Study|Adverse Event|14|||
23499513|NCT01466153|65569998|FG001|Overall Study|Adverse Event|13|||
23499514|NCT01466153|65569999|FG002|Overall Study|Adverse Event|17|||
23499515|NCT01466153|65569997|FG000|Overall Study|Withdrawal of Consent|2|||
23499516|NCT01466153|65569998|FG001|Overall Study|Withdrawal of Consent|0|||
23499517|NCT01466153|65569999|FG002|Overall Study|Withdrawal of Consent|0|||
23499518|NCT01466153|65569997|FG000|Overall Study|Investigator Discretion|3|||
23499519|NCT01466153|65569998|FG001|Overall Study|Investigator Discretion|2|||
23499520|NCT01466153|65569999|FG002|Overall Study|Investigator Discretion|2|||
23499521|NCT01466153|65569997|FG000|Overall Study|Randomized-Not Treated|2|||
23499522|NCT01466153|65569998|FG001|Overall Study|Randomized-Not Treated|3|||
23499523|NCT01466153|65569999|FG002|Overall Study|Randomized-Not Treated|4|||
23499524|NCT01466153|65569997|FG000|Overall Study|Other-Unspecified|6|||
23499525|NCT01466153|65569998|FG001|Overall Study|Other-Unspecified|4|||
23499526|NCT01466153|65569999|FG002|Overall Study|Other-Unspecified|2|||
23499527|NCT03469934|65570000|FG000|Overall Study|Withdrawal by Subject|0|||
23499528|NCT03469934|65570001|FG001|Overall Study|Withdrawal by Subject|1|||
23499529|NCT01203098|65570003|FG000|Overall Study|Adverse Event|3|||
23499530|NCT01203098|65570004|FG001|Overall Study|Adverse Event|1|||
23499531|NCT01203098|65570005|FG002|Overall Study|Adverse Event|7|||
23499532|NCT01203098|65570003|FG000|Overall Study|Lost to Follow-up|0|||
23499533|NCT01203098|65570004|FG001|Overall Study|Lost to Follow-up|0|||
23499534|NCT01203098|65570005|FG002|Overall Study|Lost to Follow-up|1|||
23499535|NCT01203098|65570003|FG000|Overall Study|Physician Decision|2|||
23499536|NCT01203098|65570004|FG001|Overall Study|Physician Decision|2|||
23499537|NCT01203098|65570005|FG002|Overall Study|Physician Decision|0|||
23499538|NCT01203098|65570003|FG000|Overall Study|Withdrawal by Subject|1|||
23499539|NCT01203098|65570004|FG001|Overall Study|Withdrawal by Subject|1|||
23499540|NCT01203098|65570005|FG002|Overall Study|Withdrawal by Subject|3|||
23499541|NCT00968201|65570008|FG000|Base Study - (Period II)|Adverse Event|8|||
23499542|NCT00968201|65570009|FG001|Base Study - (Period II)|Adverse Event|0|||
23499543|NCT00968201|65570010|FG002|Base Study - (Period II)|Adverse Event|16|||
23499544|NCT00968201|65570008|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
23499545|NCT00968201|65570009|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
23499546|NCT00968201|65570010|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
23499547|NCT00968201|65570008|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
23499548|NCT00968201|65570009|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
23499549|NCT00968201|65570010|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
23499550|NCT00968201|65570008|FG000|Base Study - (Period II)|Protocol Violation|12|||
23499551|NCT00968201|65570009|FG001|Base Study - (Period II)|Protocol Violation|0|||
23499552|NCT00968201|65570010|FG002|Base Study - (Period II)|Protocol Violation|12|||
23499553|NCT00968201|65570008|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
23499554|NCT00968201|65570009|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
23499555|NCT00968201|65570010|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
23499556|NCT00968201|65570008|FG000|Base Study - (Period II)|Site Error|0|||
23499557|NCT00968201|65570009|FG001|Base Study - (Period II)|Site Error|0|||
23499558|NCT00968201|65570010|FG002|Base Study - (Period II)|Site Error|1|||
23499559|NCT00968201|65570008|FG000|Extension Study - (Period III)|Adverse Event|0|||
23499560|NCT00968201|65570009|FG001|Extension Study - (Period III)|Adverse Event|5|||
23499561|NCT00968201|65570010|FG002|Extension Study - (Period III)|Adverse Event|22|||
23499562|NCT00968201|65570008|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
23499563|NCT00968201|65570009|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
23499564|NCT00968201|65570010|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
23499565|NCT00968201|65570008|FG000|Extension Study - (Period III)|Protocol Violation|0|||
23499566|NCT00968201|65570009|FG001|Extension Study - (Period III)|Protocol Violation|17|||
23499567|NCT00968201|65570010|FG002|Extension Study - (Period III)|Protocol Violation|14|||
23499568|NCT00968201|65570008|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
23499569|NCT00968201|65570009|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
23499570|NCT00968201|65570010|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
23499571|NCT00968201|65570008|FG000|Extension Study - (Period III)|Patient Relocated|0|||
23499572|NCT00968201|65570009|FG001|Extension Study - (Period III)|Patient Relocated|1|||
23499573|NCT00968201|65570010|FG002|Extension Study - (Period III)|Patient Relocated|1|||
23499574|NCT00968201|65570008|FG000|Extension Study - (Period III)|Noncompliance|0|||
23499575|NCT00968201|65570009|FG001|Extension Study - (Period III)|Noncompliance|0|||
23499576|NCT00968201|65570010|FG002|Extension Study - (Period III)|Noncompliance|3|||
23499577|NCT00968201|65570008|FG000|Extension Study - (Period III)|Other|0|||
23499578|NCT00968201|65570009|FG001|Extension Study - (Period III)|Other|0|||
23499579|NCT00968201|65570010|FG002|Extension Study - (Period III)|Other|2|||
23499580|NCT00968201|65570008|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
23499581|NCT00968201|65570009|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
23499582|NCT00968201|65570010|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
23499583|NCT00040365|65570011|FG000|Overall Study|Death|1|||
23499584|NCT00040365|65570011|FG000|Overall Study|Progressive disease|7|||
23499585|NCT00040365|65570011|FG000|Overall Study|Lost to Follow-up|3|||
23499586|NCT00003487|65570012|FG000|Overall Study|Not evaluable|2|||
23499587|NCT04092582|65573142|FG000|Overall Study|Death|1|||
23499588|NCT04092582|65573143|FG001|Overall Study|Death|1|||
23499589|NCT04092582|65573142|FG000|Overall Study|Withdrawal by Subject|4|||
23499590|NCT04092582|65573143|FG001|Overall Study|Withdrawal by Subject|1|||
23499591|NCT04092582|65573142|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
23499592|NCT04092582|65573143|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
23499593|NCT01781975|65573144|FG000|Overall Study|Death|1|||
23499594|NCT01781975|65573145|FG001|Overall Study|Death|0|||
23499595|NCT01781975|65573144|FG000|Overall Study|Withdrawal by Subject|1|||
23499596|NCT01781975|65573145|FG001|Overall Study|Withdrawal by Subject|1|||
23499597|NCT03128411|65573146|FG000|Treatment Phase|Adverse Event|21|||
23499598|NCT03128411|65573146|FG000|Treatment Phase|Physician Decision|1|||
23499599|NCT03128411|65573146|FG000|Treatment Phase|Other|2|||
23499600|NCT03128411|65573146|FG000|Long Term Follow-up Phase|Death|2|||
23499601|NCT02639065|65573147|FG000|Study Treatment|Disease Progression|13|||
23499602|NCT02639065|65573147|FG000|Study Treatment|Adverse Event|9|||
23499603|NCT02639065|65573147|FG000|Study Treatment|Withdrawal by Subject|1|||
23499604|NCT02639065|65573147|FG000|Follow up|Subject refused to follow up|1|||
23499605|NCT02639065|65573147|FG000|Follow up|Symptomatic Deterioration|2|||
23398594|NCT00399035|65207093|FG002|Overall Study|Withdrawal by Subject|12|||
23398595|NCT00399035|65207091|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
23398596|NCT00399035|65207092|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
23398597|NCT00399035|65207093|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
23398598|NCT00399035|65207091|FG000|Overall Study|Severe non-compliance with protocol|2|||
23398599|NCT00399035|65207092|FG001|Overall Study|Severe non-compliance with protocol|1|||
23398600|NCT00399035|65207093|FG002|Overall Study|Severe non-compliance with protocol|0|||
23398601|NCT00940602|65207094|FG000|Overall Study|Administrative problems|1|||
23398602|NCT00940602|65207095|FG001|Overall Study|Administrative problems|1|||
23398603|NCT00940602|65207094|FG000|Overall Study|Patient/guardian decision|13|||
23398604|NCT00940602|65207095|FG001|Overall Study|Patient/guardian decision|28|||
23398605|NCT00940602|65207094|FG000|Overall Study|Physician Decision|8|||
23398606|NCT00940602|65207095|FG001|Overall Study|Physician Decision|5|||
23398607|NCT00940602|65207094|FG000|Overall Study|Pregnancy|1|||
23398608|NCT00940602|65207095|FG001|Overall Study|Pregnancy|0|||
23398609|NCT00940602|65207094|FG000|Overall Study|Protocol Deviation (untreated)|1|||
23398610|NCT00940602|65207095|FG001|Overall Study|Protocol Deviation (untreated)|0|||
23398611|NCT00940602|65207094|FG000|Overall Study|Disease progression|8|||
23398612|NCT00940602|65207095|FG001|Overall Study|Disease progression|2|||
23398613|NCT00940602|65207094|FG000|Overall Study|Death|38|||
23398614|NCT00940602|65207095|FG001|Overall Study|Death|19|||
23398615|NCT00940602|65207094|FG000|Overall Study|Lost to Follow-up|3|||
23398616|NCT00940602|65207095|FG001|Overall Study|Lost to Follow-up|1|||
23398617|NCT00940602|65207094|FG000|Overall Study|Patient withdrew consent|26|||
23398618|NCT00940602|65207095|FG001|Overall Study|Patient withdrew consent|13|||
23398619|NCT00940602|65207094|FG000|Overall Study|Adverse Event|7|||
23398620|NCT00940602|65207095|FG001|Overall Study|Adverse Event|2|||
23398621|NCT00940602|65207094|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
23398622|NCT00940602|65207095|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
23398623|NCT01593917|65207098|FG000|Overall Study|Death|67|||
23398624|NCT01593917|65207098|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
23398625|NCT01593917|65207098|FG000|Overall Study|Withdrawal by Subject|23|||
23398626|NCT01593917|65207098|FG000|Overall Study|Lost to Follow-up|12|||
23398627|NCT01593917|65207098|FG000|Overall Study|Protocol Violation|5|||
23398628|NCT01593917|65207098|FG000|Overall Study|Physician Decision|3|||
23398629|NCT01729039|65207102|FG000|Overall Study|disqualified|2|||
23398630|NCT01729039|65207103|FG001|Overall Study|disqualified|5|||
23499606|NCT02639065|65573147|FG000|Follow up|Death|2|||
23499607|NCT02639065|65573147|FG000|Follow up|Study Terminated|1|||
23499608|NCT02639065|65573147|FG000|Follow up|Disease Progression|3|||
23499609|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
23499610|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
23398631|NCT01729039|65207102|FG000|Overall Study|Withdrawal by Subject|8|||
23398632|NCT01729039|65207103|FG001|Overall Study|Withdrawal by Subject|7|||
23398633|NCT02660229|65207106|FG000|Overall Study|Adverse Event|2|||
23398634|NCT02660229|65207107|FG001|Overall Study|Adverse Event|0|||
23398635|NCT02660229|65207106|FG000|Overall Study|Withdrawal by Subject|0|||
23398636|NCT02660229|65207107|FG001|Overall Study|Withdrawal by Subject|1|||
23398637|NCT03412929|65207108|FG000|Overall Study|Protocol Violation|3|||
23398638|NCT04577781|65207109|FG000|Overall Study|Adverse Event|2|||
23398639|NCT04577781|65207110|FG001|Overall Study|Adverse Event|2|||
23398640|NCT04577781|65207109|FG000|Overall Study|Physician Decision|1|||
23398641|NCT04577781|65207110|FG001|Overall Study|Physician Decision|0|||
23398642|NCT00366457|65207111|FG000|Overall Study|never began study therapy|2|||
23398643|NCT03243084|65207112|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
23398644|NCT03243084|65207113|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
23398645|NCT00744861|65207117|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
23398646|NCT00744861|65207118|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
23398647|NCT00744861|65207119|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
23398648|NCT00744861|65207120|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
23398649|NCT00744861|65207117|FG000|Feasibility Stage 1|Pregnancy|0|||
23398650|NCT00744861|65207118|FG001|Feasibility Stage 1|Pregnancy|1|||
23398651|NCT00744861|65207119|FG002|Feasibility Stage 1|Pregnancy|0|||
23398652|NCT00744861|65207120|FG003|Feasibility Stage 1|Pregnancy|0|||
23398653|NCT00744861|65207117|FG000|Pivotal Stage 2|Adverse Event|0|||
23398654|NCT00744861|65207118|FG001|Pivotal Stage 2|Adverse Event|0|||
23398655|NCT00744861|65207119|FG002|Pivotal Stage 2|Adverse Event|6|||
23398656|NCT00744861|65207120|FG003|Pivotal Stage 2|Adverse Event|11|||
23398657|NCT00744861|65207117|FG000|Pivotal Stage 2|Death|0|||
23398658|NCT00744861|65207118|FG001|Pivotal Stage 2|Death|0|||
23398659|NCT00744861|65207119|FG002|Pivotal Stage 2|Death|0|||
23398660|NCT00744861|65207120|FG003|Pivotal Stage 2|Death|1|||
23398661|NCT00744861|65207117|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
23398662|NCT00744861|65207118|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
23398663|NCT00744861|65207119|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
23398664|NCT00744861|65207120|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
23398665|NCT00744861|65207117|FG000|Pivotal Stage 2|Physician Decision|0|||
23398666|NCT00744861|65207118|FG001|Pivotal Stage 2|Physician Decision|0|||
23398667|NCT00744861|65207119|FG002|Pivotal Stage 2|Physician Decision|3|||
23398668|NCT00744861|65207120|FG003|Pivotal Stage 2|Physician Decision|1|||
23398669|NCT00744861|65207117|FG000|Pivotal Stage 2|Protocol Violation|0|||
23398670|NCT00744861|65207118|FG001|Pivotal Stage 2|Protocol Violation|0|||
23398671|NCT00744861|65207119|FG002|Pivotal Stage 2|Protocol Violation|0|||
23398672|NCT00744861|65207120|FG003|Pivotal Stage 2|Protocol Violation|1|||
23398673|NCT00744861|65207117|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
23398674|NCT00744861|65207118|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
23398675|NCT00744861|65207119|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
23398676|NCT00744861|65207120|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
23398677|NCT00744861|65207117|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
23398678|NCT00744861|65207118|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
23398679|NCT00744861|65207119|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
23398680|NCT00744861|65207120|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
23398681|NCT02862574|65207124|FG000|Double-Blind Treatment Period|Adverse Event|0|||
23398682|NCT02862574|65207125|FG001|Double-Blind Treatment Period|Adverse Event|1|||
23398683|NCT02862574|65207126|FG002|Double-Blind Treatment Period|Adverse Event|0|||
23398684|NCT02862574|65207124|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
23398685|NCT02862574|65207125|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
23398686|NCT02862574|65207126|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
23398687|NCT02862574|65207124|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
23499611|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
23499612|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
23499613|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499614|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499615|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499616|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499617|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499618|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499619|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
23499620|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
23499621|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
23398688|NCT02862574|65207125|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
23398689|NCT02862574|65207126|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
23398690|NCT01816984|65207127|FG000|Overall Study|declining health status|1|||
23398691|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Death|2|||
23499622|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
23499623|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
23499624|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499625|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499626|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499627|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499628|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499629|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499630|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
23499631|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
23499632|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
23499633|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
23499634|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
23499635|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499636|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499637|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499638|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499639|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499640|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499641|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
23499642|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499643|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499644|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499645|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
23499646|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499647|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499648|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499649|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499650|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499651|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499652|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
23499653|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
23499654|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
23499655|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
23499656|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
23499657|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499658|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499659|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499660|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499661|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499662|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499663|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
23499664|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
23499665|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
23499666|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
23499667|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
23499668|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499669|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499670|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499671|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499672|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499673|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499674|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
23499675|NCT01847274|65573154|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
23499676|NCT01847274|65573155|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
23499677|NCT01847274|65573156|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
23499678|NCT01847274|65573157|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
23499679|NCT01847274|65573158|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499680|NCT01847274|65573159|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499681|NCT01847274|65573160|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499682|NCT01847274|65573161|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499683|NCT01847274|65573162|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499684|NCT01847274|65573163|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499685|NCT01847274|65573164|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
23499686|NCT01847274|65573154|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499687|NCT01847274|65573155|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499688|NCT01847274|65573156|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499689|NCT01847274|65573157|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499690|NCT01847274|65573158|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499691|NCT01847274|65573159|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
23499692|NCT01847274|65573160|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499693|NCT01847274|65573161|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499694|NCT01847274|65573162|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499695|NCT01847274|65573163|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499696|NCT01847274|65573164|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
23499697|NCT01847274|65573154|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499698|NCT01847274|65573155|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499699|NCT01847274|65573156|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499700|NCT01847274|65573157|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499701|NCT01847274|65573158|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
23499702|NCT01847274|65573159|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499703|NCT01847274|65573160|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499704|NCT01847274|65573161|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499705|NCT01847274|65573162|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499706|NCT01847274|65573163|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499707|NCT01847274|65573164|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
23499708|NCT01847274|65573154|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499709|NCT01847274|65573155|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499710|NCT01847274|65573156|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499711|NCT01847274|65573157|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499712|NCT01847274|65573158|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499713|NCT01847274|65573159|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499714|NCT01847274|65573160|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
23499715|NCT01847274|65573161|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499716|NCT01847274|65573162|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499717|NCT01847274|65573163|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499718|NCT01847274|65573164|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
23499719|NCT01847274|65573154|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499720|NCT01847274|65573155|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499721|NCT01847274|65573156|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499722|NCT01847274|65573157|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499723|NCT01847274|65573158|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499724|NCT01847274|65573159|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499725|NCT01847274|65573160|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
23499726|NCT01847274|65573161|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499727|NCT01847274|65573162|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499728|NCT01847274|65573163|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499729|NCT01847274|65573164|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
23499730|NCT01847274|65573154|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499731|NCT01847274|65573155|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499732|NCT01847274|65573156|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499733|NCT01847274|65573157|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499734|NCT01847274|65573158|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499735|NCT01847274|65573159|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499736|NCT01847274|65573160|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
23499737|NCT01847274|65573161|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499738|NCT01847274|65573162|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499739|NCT01847274|65573163|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499740|NCT01847274|65573164|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
23499741|NCT01847274|65573154|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499742|NCT01847274|65573155|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499743|NCT01847274|65573156|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499744|NCT01847274|65573157|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499745|NCT01847274|65573158|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499746|NCT01847274|65573159|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499747|NCT01847274|65573160|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
23499748|NCT01847274|65573161|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
23499749|NCT01847274|65573162|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
23499750|NCT01847274|65573163|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
23499751|NCT01847274|65573164|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
23499752|NCT01847274|65573154|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499753|NCT01847274|65573155|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499754|NCT01847274|65573156|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499755|NCT01847274|65573157|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499756|NCT01847274|65573158|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499757|NCT01847274|65573159|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499758|NCT01847274|65573160|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499759|NCT01847274|65573161|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
23499760|NCT01847274|65573162|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499761|NCT01847274|65573163|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
23499762|NCT01847274|65573164|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
23499763|NCT01847274|65573154|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499764|NCT01847274|65573155|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499765|NCT01847274|65573156|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499766|NCT01847274|65573157|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499767|NCT01847274|65573158|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499768|NCT01847274|65573159|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499769|NCT01847274|65573160|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499770|NCT01847274|65573161|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
23499771|NCT01847274|65573162|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
23499772|NCT01847274|65573163|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
23499773|NCT01847274|65573164|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
23499774|NCT01847274|65573154|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499775|NCT01847274|65573155|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499776|NCT01847274|65573156|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499777|NCT01847274|65573157|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499778|NCT01847274|65573158|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499779|NCT01847274|65573159|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499780|NCT01847274|65573160|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499781|NCT01847274|65573161|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499782|NCT01847274|65573162|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499783|NCT01847274|65573163|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
23499784|NCT01847274|65573164|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
23499785|NCT00190671|65573168|FG000|Overall Study|Satisfactory Response|4|||
23499786|NCT00190671|65573169|FG001|Overall Study|Satisfactory Response|7|||
23499787|NCT00190671|65573168|FG000|Overall Study|Lack of Efficacy|19|||
23499788|NCT00190671|65573169|FG001|Overall Study|Lack of Efficacy|24|||
23499789|NCT00190671|65573168|FG000|Overall Study|Death from Study Disease|1|||
23499790|NCT00190671|65573169|FG001|Overall Study|Death from Study Disease|1|||
23499791|NCT00190671|65573168|FG000|Overall Study|Adverse Event|3|||
23499792|NCT00190671|65573169|FG001|Overall Study|Adverse Event|2|||
23499793|NCT00190671|65573168|FG000|Overall Study|Clinical Relapse|0|||
23499794|NCT00190671|65573169|FG001|Overall Study|Clinical Relapse|1|||
23499795|NCT00190671|65573168|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
23499796|NCT00190671|65573169|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
23499797|NCT00190671|65573168|FG000|Overall Study|Death from Other Causes|0|||
23499798|NCT00190671|65573169|FG001|Overall Study|Death from Other Causes|2|||
23499799|NCT00190671|65573168|FG000|Overall Study|Protocol Violation|0|||
23499800|NCT00190671|65573169|FG001|Overall Study|Protocol Violation|1|||
23499801|NCT00190671|65573168|FG000|Overall Study|Withdrawal by Subject|0|||
23499802|NCT00190671|65573169|FG001|Overall Study|Withdrawal by Subject|2|||
23499803|NCT03727230|65573170|FG000|Overall Study|Lost to Follow-up|12|||
23398692|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
23398693|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
23398694|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Physician Decision|1|||
23398695|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
23398696|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
23499804|NCT00126191|65573176|FG000|Overall Study|Physician Decision|0|||
23499805|NCT00126191|65573177|FG001|Overall Study|Physician Decision|1|||
23499806|NCT00126191|65573176|FG000|Overall Study|Death|0|||
23499807|NCT00126191|65573177|FG001|Overall Study|Death|1|||
23499808|NCT00378378|65573178|FG000|Overall Study|Withdrawal by Subject|0|||
23499809|NCT00378378|65573179|FG001|Overall Study|Withdrawal by Subject|1|||
23499810|NCT00378378|65573180|FG002|Overall Study|Withdrawal by Subject|0|||
23499811|NCT00378378|65573178|FG000|Overall Study|Treatment Failure|0|||
23499812|NCT00378378|65573179|FG001|Overall Study|Treatment Failure|0|||
23499813|NCT00378378|65573180|FG002|Overall Study|Treatment Failure|1|||
23499814|NCT00378378|65573178|FG000|Overall Study|Non-compliance with protocol|0|||
23499815|NCT00378378|65573179|FG001|Overall Study|Non-compliance with protocol|0|||
23499816|NCT00378378|65573180|FG002|Overall Study|Non-compliance with protocol|1|||
23499817|NCT00074152|65573181|FG000|Overall Study|Death|21|||
23499818|NCT00074152|65573182|FG001|Overall Study|Death|9|||
23499819|NCT00074152|65573181|FG000|Overall Study|Lack of Efficacy|34|||
23499820|NCT00074152|65573182|FG001|Overall Study|Lack of Efficacy|24|||
23499821|NCT04545060|65573183|FG000|Overall Study|Adverse Event|0|||
23499822|NCT04545060|65573184|FG001|Overall Study|Adverse Event|1|||
23499823|NCT04545060|65573183|FG000|Overall Study|Death|0|||
23499824|NCT04545060|65573184|FG001|Overall Study|Death|5|||
23499825|NCT04545060|65573183|FG000|Overall Study|Lost to Follow-up|10|||
23499826|NCT04545060|65573184|FG001|Overall Study|Lost to Follow-up|13|||
23499827|NCT04545060|65573183|FG000|Overall Study|Physician Decision|3|||
23499828|NCT04545060|65573184|FG001|Overall Study|Physician Decision|0|||
23499829|NCT04545060|65573183|FG000|Overall Study|Withdrawal by Subject|17|||
23499830|NCT04545060|65573184|FG001|Overall Study|Withdrawal by Subject|22|||
23499831|NCT03166735|65573185|FG000|Overall Study|Not Treated|1|||
23499832|NCT03166735|65573186|FG001|Overall Study|Not Treated|0|||
23499833|NCT03166735|65573187|FG002|Overall Study|Not Treated|0|||
23499834|NCT03166735|65573188|FG003|Overall Study|Not Treated|0|||
23499835|NCT03166735|65573189|FG004|Overall Study|Not Treated|0|||
23499836|NCT03166735|65573185|FG000|Overall Study|follow-up not completed as planned|0|||
23499837|NCT03166735|65573186|FG001|Overall Study|follow-up not completed as planned|1|||
23499838|NCT03166735|65573187|FG002|Overall Study|follow-up not completed as planned|1|||
23499839|NCT03166735|65573188|FG003|Overall Study|follow-up not completed as planned|0|||
23499840|NCT03166735|65573189|FG004|Overall Study|follow-up not completed as planned|1|||
23499841|NCT03166735|65573185|FG000|Overall Study|Withdrawal by Subject|0|||
23499842|NCT03166735|65573186|FG001|Overall Study|Withdrawal by Subject|0|||
23499843|NCT03166735|65573187|FG002|Overall Study|Withdrawal by Subject|1|||
23499844|NCT03166735|65573188|FG003|Overall Study|Withdrawal by Subject|1|||
23499845|NCT03166735|65573189|FG004|Overall Study|Withdrawal by Subject|2|||
23499846|NCT03166735|65573185|FG000|Overall Study|Lost to Follow-up|0|||
23499847|NCT03166735|65573186|FG001|Overall Study|Lost to Follow-up|2|||
23499848|NCT03166735|65573187|FG002|Overall Study|Lost to Follow-up|1|||
23499849|NCT03166735|65573188|FG003|Overall Study|Lost to Follow-up|0|||
23499850|NCT03166735|65573189|FG004|Overall Study|Lost to Follow-up|1|||
23499851|NCT01727297|65573190|FG000|Overall Study|Death|13|||
23499852|NCT01727297|65573191|FG001|Overall Study|Death|0|||
23499853|NCT01727297|65573190|FG000|Overall Study|Protocol Violation|1|||
23499854|NCT01727297|65573191|FG001|Overall Study|Protocol Violation|10|||
23499855|NCT01727297|65573190|FG000|Overall Study|Adverse Event|3|||
23499856|NCT01727297|65573191|FG001|Overall Study|Adverse Event|1|||
23499857|NCT01727297|65573190|FG000|Overall Study|Lost to Follow-up|11|||
23499858|NCT01727297|65573191|FG001|Overall Study|Lost to Follow-up|0|||
23499859|NCT01727297|65573190|FG000|Overall Study|Withdrawal by Subject|26|||
23499860|NCT01727297|65573191|FG001|Overall Study|Withdrawal by Subject|27|||
23499861|NCT01727297|65573190|FG000|Overall Study|Physician Decision|19|||
23499862|NCT01727297|65573191|FG001|Overall Study|Physician Decision|5|||
23499863|NCT01727297|65573190|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
23499864|NCT01727297|65573191|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
23499865|NCT00880009|65573192|FG000|Overall Study|Study terminated by sponsor|14|||
23499866|NCT00880009|65573192|FG000|Overall Study|Withdrawal by Subject|1|||
23499867|NCT00880009|65573192|FG000|Overall Study|Protocol Violation|1|||
23499868|NCT03322631|65573193|FG000|Overall Study|Withdrawal by Subject|0|||
23499869|NCT03322631|65573194|FG001|Overall Study|Withdrawal by Subject|1|||
23499870|NCT03322631|65573195|FG002|Overall Study|Withdrawal by Subject|0|||
23499871|NCT03322631|65573196|FG003|Overall Study|Withdrawal by Subject|0|||
23499872|NCT03322631|65573193|FG000|Overall Study|Adverse Event|0|||
23499873|NCT03322631|65573194|FG001|Overall Study|Adverse Event|0|||
23499874|NCT03322631|65573195|FG002|Overall Study|Adverse Event|1|||
23499875|NCT03322631|65573196|FG003|Overall Study|Adverse Event|0|||
23499876|NCT00282984|65573197|FG000|Overall Study|Death|2|||
23499877|NCT00282984|65573198|FG001|Overall Study|Death|5|||
23499878|NCT00282984|65573197|FG000|Overall Study|Adverse Event|8|||
23499879|NCT00282984|65573198|FG001|Overall Study|Adverse Event|5|||
23499880|NCT00282984|65573197|FG000|Overall Study|Lack of Efficacy|0|||
23499881|NCT00282984|65573198|FG001|Overall Study|Lack of Efficacy|2|||
23499882|NCT00282984|65573197|FG000|Overall Study|Lost to Follow-up|14|||
23499883|NCT00282984|65573198|FG001|Overall Study|Lost to Follow-up|10|||
23499884|NCT00282984|65573197|FG000|Overall Study|Withdrawal by Participant|22|||
23499885|NCT00282984|65573198|FG001|Overall Study|Withdrawal by Participant|34|||
23499886|NCT00282984|65573197|FG000|Overall Study|Participant stopped study medication|2|||
23499887|NCT00282984|65573198|FG001|Overall Study|Participant stopped study medication|2|||
23499888|NCT00282984|65573197|FG000|Overall Study|Participant only allowed phone follow-up|0|||
23499889|NCT00282984|65573198|FG001|Overall Study|Participant only allowed phone follow-up|1|||
23499890|NCT00282984|65573197|FG000|Overall Study|Participant used antipsychosis meds|0|||
23499891|NCT00282984|65573198|FG001|Overall Study|Participant used antipsychosis meds|1|||
23499892|NCT00282984|65573197|FG000|Overall Study|lack of motivation|1|||
23499893|NCT00282984|65573198|FG001|Overall Study|lack of motivation|0|||
23499894|NCT00282984|65573197|FG000|Overall Study|in prison|0|||
23499895|NCT00282984|65573198|FG001|Overall Study|in prison|1|||
23499896|NCT00282984|65573197|FG000|Overall Study|Protocol Violation|2|||
23499897|NCT00282984|65573198|FG001|Overall Study|Protocol Violation|0|||
23499898|NCT02527161|65573199|FG000|Overall Study|Failed MRI|52|||
23499899|NCT02527161|65573199|FG000|Overall Study|Withdrawal by Subject|19|||
23499900|NCT02527161|65573199|FG000|Overall Study|Delay in or unfit for surgery|16|||
23499901|NCT02527161|65573199|FG000|Overall Study|MRI contraindication|6|||
23499902|NCT02527161|65573199|FG000|Overall Study|Consent violation|4|||
23499903|NCT02527161|65573199|FG000|Overall Study|Only Recruited to Part A|27|||
23499904|NCT02527161|65573199|FG000|Overall Study|Physician Decision|1|||
23499905|NCT02527161|65573199|FG000|Overall Study|Adverse Event|1|||
23499906|NCT02527161|65573199|FG000|Overall Study|Lost to Follow-up|6|||
23499907|NCT02166905|65573202|FG000|Overall Study|Withdrawal by Subject|1|||
23499908|NCT02166905|65573203|FG001|Overall Study|Withdrawal by Subject|0|||
23499909|NCT02166905|65573204|FG002|Overall Study|Withdrawal by Subject|0|||
23499910|NCT02166905|65573205|FG003|Overall Study|Withdrawal by Subject|0|||
23499911|NCT02969369|65573206|FG000|Study|Adverse Event|1|||
23499912|NCT02969369|65573207|FG001|Study|Adverse Event|6|||
23499913|NCT02969369|65573206|FG000|Study|Lack of Efficacy|0|||
23499914|NCT02969369|65573207|FG001|Study|Lack of Efficacy|1|||
23499915|NCT02969369|65573206|FG000|Study|Lost to Follow-up|0|||
23499916|NCT02969369|65573207|FG001|Study|Lost to Follow-up|1|||
23499917|NCT02969369|65573206|FG000|Study|Withdrawal by Subject|3|||
23499918|NCT02969369|65573207|FG001|Study|Withdrawal by Subject|5|||
23499919|NCT02969369|65573206|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
23499920|NCT02969369|65573207|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
23499921|NCT02969369|65573206|FG000|Double-blind Period|Adverse Event|1|||
23499922|NCT02969369|65573207|FG001|Double-blind Period|Adverse Event|5|||
23499923|NCT02969369|65573206|FG000|Double-blind Period|Lost to Follow-up|0|||
23499924|NCT02969369|65573207|FG001|Double-blind Period|Lost to Follow-up|1|||
23499925|NCT02969369|65573206|FG000|Double-blind Period|Withdrawal by Subject|2|||
23499926|NCT02969369|65573207|FG001|Double-blind Period|Withdrawal by Subject|3|||
23499927|NCT02969369|65573206|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
23499928|NCT02969369|65573207|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
23499929|NCT02969369|65573206|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
23499930|NCT02969369|65573207|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
23499931|NCT02969369|65573206|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
23499932|NCT02969369|65573207|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
23499933|NCT02969369|65573206|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
23499934|NCT02969369|65573207|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
23499935|NCT01637272|65573208|FG000|Overall Study|Adverse Event|6|||
23499936|NCT01637272|65573208|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
23499937|NCT01637272|65573208|FG000|Overall Study|Withdrawal by Subject|3|||
23499938|NCT01637272|65573208|FG000|Overall Study|Lost to Follow-up|2|||
23499939|NCT01637272|65573208|FG000|Overall Study|completed core, did not enter ext. phase|4|||
23499940|NCT01637272|65573208|FG000|Overall Study|Administrative problems|1|||
23499941|NCT01637272|65573208|FG000|Overall Study|Protocol Violation|2|||
23499942|NCT01496612|65573209|FG000|1st Intervention|Adverse Event|1|||
23499943|NCT01496612|65573210|FG001|1st Intervention|Adverse Event|0|||
23499944|NCT01496612|65573209|FG000|1st Intervention|Withdrawal by Subject|1|||
23499945|NCT01496612|65573210|FG001|1st Intervention|Withdrawal by Subject|0|||
23499946|NCT01269463|65573212|FG000|First Intervention|Withdrawal by Subject|1|||
23499947|NCT01269463|65573213|FG001|First Intervention|Withdrawal by Subject|0|||
23499948|NCT01269463|65573212|FG000|First Intervention|Adverse Event|1|||
23499949|NCT01269463|65573213|FG001|First Intervention|Adverse Event|0|||
23499950|NCT01269463|65573212|FG000|First Intervention|Lack of Efficacy|0|||
23499951|NCT01269463|65573213|FG001|First Intervention|Lack of Efficacy|1|||
23499952|NCT01269463|65573212|FG000|First Intervention|Physician Decision|0|||
23499953|NCT01269463|65573213|FG001|First Intervention|Physician Decision|1|||
23499954|NCT01787331|65573214|FG000|Overall Study|Physician Decision|1|||
23499955|NCT01787331|65573214|FG000|Overall Study|Withdrawal by Subject|1|||
23499956|NCT00261807|65573220|FG000|Overall Study|Lost to Follow-up|2|||
23499957|NCT00261807|65573220|FG000|Overall Study|Adverse Event|2|||
23499958|NCT00261807|65573220|FG000|Overall Study|Death|1|||
23499959|NCT00261807|65573220|FG000|Overall Study|Protocol Violation|2|||
23499960|NCT00129272|65573230|FG000|Overall Study|Lost to Follow-up|12|||
23499961|NCT00129272|65573231|FG001|Overall Study|Lost to Follow-up|11|||
23499962|NCT00129272|65573230|FG000|Overall Study|Withdrawal by Subject|5|||
23499963|NCT00129272|65573231|FG001|Overall Study|Withdrawal by Subject|11|||
23499964|NCT01348165|65573232|FG000|Overall Study|Adverse Event|0|||
23499965|NCT01348165|65573233|FG001|Overall Study|Adverse Event|0|||
23499966|NCT01348165|65573234|FG002|Overall Study|Adverse Event|0|||
23499967|NCT01348165|65573235|FG003|Overall Study|Adverse Event|0|||
23499968|NCT01348165|65573236|FG004|Overall Study|Adverse Event|0|||
23499969|NCT01348165|65573237|FG005|Overall Study|Adverse Event|0|||
23499970|NCT01348165|65573238|FG006|Overall Study|Adverse Event|1|||
23499971|NCT02302807|65573239|FG000|Overall Study|Withdrawal by Subject|28|||
23499972|NCT02302807|65573240|FG001|Overall Study|Withdrawal by Subject|11|||
23499973|NCT02302807|65573239|FG000|Overall Study|Lost to Follow-up|4|||
23499974|NCT02302807|65573240|FG001|Overall Study|Lost to Follow-up|6|||
23499975|NCT02302807|65573239|FG000|Overall Study|Death|397|||
23499976|NCT02302807|65573240|FG001|Overall Study|Death|385|||
23499977|NCT02302807|65573239|FG000|Overall Study|Study Terminated By Sponsor|35|||
23499978|NCT02302807|65573240|FG001|Overall Study|Study Terminated By Sponsor|64|||
23499979|NCT02302807|65573239|FG000|Overall Study|Physician Decision|0|||
23499980|NCT02302807|65573240|FG001|Overall Study|Physician Decision|1|||
23499981|NCT00300274|65573241|FG000|Overall Study|Withdrawal by Subject|12|||
23499982|NCT00300274|65573242|FG001|Overall Study|Withdrawal by Subject|3|||
23499983|NCT00300274|65573243|FG002|Overall Study|Withdrawal by Subject|14|||
23499984|NCT00300274|65573241|FG000|Overall Study|Lost to Follow-up|3|||
23499985|NCT00300274|65573242|FG001|Overall Study|Lost to Follow-up|4|||
23499986|NCT00300274|65573243|FG002|Overall Study|Lost to Follow-up|5|||
23499987|NCT00300274|65573241|FG000|Overall Study|Death|31|||
23499988|NCT00300274|65573242|FG001|Overall Study|Death|20|||
23499989|NCT00300274|65573243|FG002|Overall Study|Death|25|||
23499990|NCT00300274|65573241|FG000|Overall Study|Re-transplant|0|||
23499991|NCT00300274|65573242|FG001|Overall Study|Re-transplant|0|||
23499992|NCT00300274|65573243|FG002|Overall Study|Re-transplant|1|||
23499993|NCT02200211|65573244|FG000|Overall Study|Lost to Follow-up|7|||
23499994|NCT02200211|65573245|FG001|Overall Study|Lost to Follow-up|7|||
23499995|NCT02200211|65573246|FG002|Overall Study|Lost to Follow-up|1|||
23499996|NCT02200211|65573247|FG003|Overall Study|Lost to Follow-up|2|||
23499997|NCT02200211|65573244|FG000|Overall Study|Withdrawal by Subject|1|||
23499998|NCT02200211|65573245|FG001|Overall Study|Withdrawal by Subject|0|||
23499999|NCT02200211|65573246|FG002|Overall Study|Withdrawal by Subject|0|||
23500000|NCT02200211|65573247|FG003|Overall Study|Withdrawal by Subject|0|||
23500001|NCT01786668|65573250|FG000|Overall Study|Adverse Event|0|||
23500002|NCT01786668|65573251|FG001|Overall Study|Adverse Event|1|||
23500003|NCT01786668|65573252|FG002|Overall Study|Adverse Event|1|||
23500004|NCT01786668|65573253|FG003|Overall Study|Adverse Event|2|||
23500005|NCT01786668|65573250|FG000|Overall Study|Withdrawal by Subject|0|||
23500006|NCT01786668|65573251|FG001|Overall Study|Withdrawal by Subject|0|||
23500007|NCT01786668|65573252|FG002|Overall Study|Withdrawal by Subject|3|||
23500008|NCT01786668|65573253|FG003|Overall Study|Withdrawal by Subject|1|||
23500009|NCT01786668|65573250|FG000|Overall Study|Pregnancy|0|||
23500010|NCT01786668|65573251|FG001|Overall Study|Pregnancy|0|||
23500011|NCT01786668|65573252|FG002|Overall Study|Pregnancy|0|||
23500012|NCT01786668|65573253|FG003|Overall Study|Pregnancy|1|||
23500013|NCT01786668|65573250|FG000|Overall Study|Lost to Follow-up|1|||
23500014|NCT01786668|65573251|FG001|Overall Study|Lost to Follow-up|0|||
23500015|NCT01786668|65573252|FG002|Overall Study|Lost to Follow-up|1|||
23500016|NCT01786668|65573253|FG003|Overall Study|Lost to Follow-up|0|||
23500017|NCT00221403|65573254|FG000|Overall Study|Protocol Violation|1|||
23500018|NCT00221403|65573255|FG001|Overall Study|Protocol Violation|0|||
23500019|NCT00221403|65573256|FG002|Overall Study|Protocol Violation|0|||
23500020|NCT00221403|65573254|FG000|Overall Study|Physician Decision|1|||
23500021|NCT00221403|65573255|FG001|Overall Study|Physician Decision|0|||
23500022|NCT00221403|65573256|FG002|Overall Study|Physician Decision|0|||
23500023|NCT00221403|65573254|FG000|Overall Study|Withdrawal by Subject|0|||
23500024|NCT00221403|65573255|FG001|Overall Study|Withdrawal by Subject|3|||
23500025|NCT00221403|65573256|FG002|Overall Study|Withdrawal by Subject|0|||
23500026|NCT00221403|65573254|FG000|Overall Study|Lack of Efficacy|0|||
23500027|NCT00221403|65573255|FG001|Overall Study|Lack of Efficacy|1|||
23500028|NCT00221403|65573256|FG002|Overall Study|Lack of Efficacy|0|||
23500029|NCT00221403|65573254|FG000|Overall Study|Adverse Event|0|||
23500030|NCT00221403|65573255|FG001|Overall Study|Adverse Event|1|||
23500031|NCT00221403|65573256|FG002|Overall Study|Adverse Event|0|||
23500032|NCT03230097|65573257|FG000|Overall Study|Adverse Event|2|||
23500033|NCT03230097|65573258|FG001|Overall Study|Adverse Event|1|||
23500034|NCT03230097|65573257|FG000|Overall Study|non-compliance|0|||
23500035|NCT03230097|65573258|FG001|Overall Study|non-compliance|1|||
23500036|NCT03230097|65573257|FG000|Overall Study|Lost to Follow-up|2|||
23500037|NCT03230097|65573258|FG001|Overall Study|Lost to Follow-up|4|||
23500038|NCT03230097|65573257|FG000|Overall Study|Withdrawal by Subject|7|||
23500039|NCT03230097|65573258|FG001|Overall Study|Withdrawal by Subject|3|||
23500040|NCT03230097|65573257|FG000|Overall Study|Trial termination|4|||
23500041|NCT03230097|65573258|FG001|Overall Study|Trial termination|5|||
23500042|NCT03230097|65573257|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
23500043|NCT03230097|65573258|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
23500044|NCT03230097|65573257|FG000|Overall Study|outcome event|0|||
23500045|NCT03230097|65573258|FG001|Overall Study|outcome event|1|||
23500046|NCT00299104|65573261|FG000|Treatment Period|Adverse Event|14|||
23500047|NCT00299104|65573262|FG001|Treatment Period|Adverse Event|9|||
23500048|NCT00299104|65573263|FG002|Treatment Period|Adverse Event|7|||
23500049|NCT00299104|65573261|FG000|Treatment Period|Death|1|||
23500050|NCT00299104|65573262|FG001|Treatment Period|Death|1|||
23500051|NCT00299104|65573263|FG002|Treatment Period|Death|1|||
23500052|NCT00299104|65573261|FG000|Treatment Period|Insufficient therapeutic response|34|||
23500053|NCT00299104|65573262|FG001|Treatment Period|Insufficient therapeutic response|13|||
23500054|NCT00299104|65573263|FG002|Treatment Period|Insufficient therapeutic response|8|||
23500055|NCT00299104|65573261|FG000|Treatment Period|Failure to return|9|||
23500056|NCT00299104|65573262|FG001|Treatment Period|Failure to return|8|||
23500057|NCT00299104|65573263|FG002|Treatment Period|Failure to return|8|||
23500058|NCT00299104|65573261|FG000|Treatment Period|Violation of selection criteria|1|||
23500059|NCT00299104|65573262|FG001|Treatment Period|Violation of selection criteria|2|||
23500060|NCT00299104|65573263|FG002|Treatment Period|Violation of selection criteria|0|||
23500061|NCT00299104|65573261|FG000|Treatment Period|Protocol Violation|1|||
23500062|NCT00299104|65573262|FG001|Treatment Period|Protocol Violation|1|||
23500063|NCT00299104|65573263|FG002|Treatment Period|Protocol Violation|0|||
23500064|NCT00299104|65573261|FG000|Treatment Period|Refused treatment|9|||
23500065|NCT00299104|65573262|FG001|Treatment Period|Refused treatment|2|||
23500066|NCT00299104|65573263|FG002|Treatment Period|Refused treatment|2|||
23500067|NCT00299104|65573261|FG000|Treatment Period|Withdrew consent|14|||
23500068|NCT00299104|65573262|FG001|Treatment Period|Withdrew consent|19|||
23500069|NCT00299104|65573263|FG002|Treatment Period|Withdrew consent|9|||
23500070|NCT00299104|65573261|FG000|Treatment Period|Administrative reasons|106|||
23500071|NCT00299104|65573262|FG001|Treatment Period|Administrative reasons|120|||
23500072|NCT00299104|65573263|FG002|Treatment Period|Administrative reasons|137|||
23500073|NCT00299104|65573261|FG000|Safety Follow-Up (SFU) Period|Death|3|||
23500074|NCT00299104|65573262|FG001|Safety Follow-Up (SFU) Period|Death|2|||
23500075|NCT00299104|65573263|FG002|Safety Follow-Up (SFU) Period|Death|1|||
23500076|NCT00299104|65573261|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
23500077|NCT00299104|65573262|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
23500078|NCT00299104|65573263|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
23500079|NCT00299104|65573261|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
23500080|NCT00299104|65573262|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
23500081|NCT00299104|65573263|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
23500082|NCT00299104|65573261|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
23500083|NCT00299104|65573262|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
23500084|NCT00299104|65573263|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
23500085|NCT00299104|65573261|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
23500086|NCT00299104|65573262|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
23500087|NCT00299104|65573263|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
23500088|NCT00299104|65573261|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
23500089|NCT00299104|65573262|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
23500090|NCT00299104|65573263|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
23500091|NCT00299104|65573261|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
23500092|NCT00299104|65573262|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
23500093|NCT00299104|65573263|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
23500094|NCT00299104|65573261|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
23500095|NCT00299104|65573262|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
23500096|NCT00299104|65573263|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
23500097|NCT01273597|65573264|FG000|Overall Study|Adverse Event|5|||
23500098|NCT01273597|65573264|FG000|Overall Study|Underwent Kidney Transplantation|2|||
23500099|NCT01273597|65573264|FG000|Overall Study|Reason Not Reported|1|||
23500100|NCT01281865|65573265|FG000|Overall Study|Adverse Event|1|||
23500101|NCT01281865|65573266|FG001|Overall Study|Adverse Event|1|||
23500102|NCT01281865|65573265|FG000|Overall Study|Withdrawal by Subject|1|||
23500103|NCT01281865|65573266|FG001|Overall Study|Withdrawal by Subject|0|||
23500104|NCT01281865|65573265|FG000|Overall Study|Lack of Efficacy|1|||
23500105|NCT01281865|65573266|FG001|Overall Study|Lack of Efficacy|0|||
23500106|NCT00259649|65573267|FG000|Overall Study|Lost to Follow-up|7|||
23500107|NCT00259649|65573267|FG000|Overall Study|irregular menses|3|||
23500108|NCT03602482|65573269|FG000|Overall Study|Withdrawal by Subject|6|||
23500109|NCT03602482|65573270|FG001|Overall Study|Withdrawal by Subject|7|||
23500110|NCT03602482|65573271|FG002|Overall Study|Withdrawal by Subject|0|||
23500111|NCT03602482|65573272|FG003|Overall Study|Withdrawal by Subject|0|||
23500112|NCT00256750|65573276|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
23500113|NCT00256750|65573277|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
23500114|NCT00256750|65573278|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
23500115|NCT00256750|65573276|FG000|Transplanted Pre-Treatment|Other|2|||
23500116|NCT00256750|65573277|FG001|Transplanted Pre-Treatment|Other|0|||
23500117|NCT00256750|65573278|FG002|Transplanted Pre-Treatment|Other|0|||
23500118|NCT00256750|65573276|FG000|Transplanted Pre-Treatment|Death|1|||
23500119|NCT00256750|65573277|FG001|Transplanted Pre-Treatment|Death|0|||
23500120|NCT00256750|65573278|FG002|Transplanted Pre-Treatment|Death|0|||
23500121|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
23500122|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
23500123|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
23500124|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Death|3|||
23500125|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Death|2|||
23500126|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Death|4|||
23500127|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
23500128|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
23500129|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
23500130|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
23500131|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
23500132|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
23500133|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Other|5|||
23500134|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Other|4|||
23500135|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Other|2|||
23500136|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
23500137|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
23500138|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
23500139|NCT00256750|65573276|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
23500140|NCT00256750|65573277|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
23500141|NCT00256750|65573278|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
23500142|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
23500143|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
23500144|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
23500145|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
23500146|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
23500147|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
23500148|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Death|3|||
23500149|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Death|0|||
23500150|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Death|0|||
23500151|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
23500152|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
23500153|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
23500154|NCT00256750|65573276|FG000|Post-Transplant Treated (24 Months)|Other|2|||
23500155|NCT00256750|65573277|FG001|Post-Transplant Treated (24 Months)|Other|0|||
23500156|NCT00256750|65573278|FG002|Post-Transplant Treated (24 Months)|Other|1|||
23500157|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
23500158|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
23500159|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
23500160|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
23500161|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
23500162|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
23500163|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Death|0|||
23500164|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Death|2|||
23500165|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Death|1|||
23500166|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
23500167|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
23500168|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
23500169|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
23500170|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
23500171|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
23500172|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
23500173|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
23500174|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
23300706|NCT01846273|64842900|FG002|Overall Study|Subject withdrew consent|0|||
23500175|NCT00256750|65573276|FG000|Post-Transplant Treated (36 Months)|Other|0|||
23500176|NCT00256750|65573277|FG001|Post-Transplant Treated (36 Months)|Other|1|||
23500177|NCT00256750|65573278|FG002|Post-Transplant Treated (36 Months)|Other|1|||
23500178|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
23500179|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
23500180|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
23500181|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
23500182|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
23500183|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
23500184|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
23500185|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
23500186|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
23500187|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
23500188|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
23500189|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
23500190|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
23500191|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
23500192|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
23500193|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
23500194|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
23500195|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
23500196|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
23500197|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
23500198|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
23500199|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
23500200|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
23500201|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
23500202|NCT00256750|65573276|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
23500203|NCT00256750|65573277|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
23500204|NCT00256750|65573278|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
23500205|NCT04523220|65573279|FG000|Main Treatment Period|Physician Decision|1|||
23500206|NCT04523220|65573280|FG001|Main Treatment Period|Physician Decision|1|||
23500207|NCT04523220|65573281|FG002|Main Treatment Period|Physician Decision|0|||
23500208|NCT04523220|65573279|FG000|Main Treatment Period|Other|5|||
23500209|NCT04523220|65573280|FG001|Main Treatment Period|Other|2|||
23500210|NCT04523220|65573281|FG002|Main Treatment Period|Other|4|||
23500211|NCT04523220|65573279|FG000|Main Treatment Period|Subject Decision|5|||
23500212|NCT04523220|65573280|FG001|Main Treatment Period|Subject Decision|7|||
23500213|NCT04523220|65573281|FG002|Main Treatment Period|Subject Decision|3|||
23500214|NCT04523220|65573279|FG000|Main Treatment Period|Death|5|||
23500215|NCT04523220|65573280|FG001|Main Treatment Period|Death|11|||
23500216|NCT04523220|65573281|FG002|Main Treatment Period|Death|4|||
23500217|NCT04523220|65573279|FG000|Main Treatment Period|Adverse Event|11|||
23500218|NCT04523220|65573280|FG001|Main Treatment Period|Adverse Event|9|||
23500219|NCT04523220|65573281|FG002|Main Treatment Period|Adverse Event|9|||
23500220|NCT04523220|65573279|FG000|Main Treatment Period|Withdrawal by Subject|3|||
23500221|NCT04523220|65573280|FG001|Main Treatment Period|Withdrawal by Subject|3|||
23500222|NCT04523220|65573281|FG002|Main Treatment Period|Withdrawal by Subject|4|||
23500223|NCT04523220|65573279|FG000|Main Treatment Period|Study drug never adminstered|10|||
23500224|NCT04523220|65573280|FG001|Main Treatment Period|Study drug never adminstered|3|||
23500225|NCT04523220|65573281|FG002|Main Treatment Period|Study drug never adminstered|5|||
23500226|NCT04523220|65573279|FG000|Extension Treatment Period|Physician Decision|1|||
23500227|NCT04523220|65573280|FG001|Extension Treatment Period|Physician Decision|0|||
23500228|NCT04523220|65573281|FG002|Extension Treatment Period|Physician Decision|3|||
23500229|NCT04523220|65573279|FG000|Extension Treatment Period|Other|2|||
23500230|NCT04523220|65573280|FG001|Extension Treatment Period|Other|6|||
23500231|NCT04523220|65573281|FG002|Extension Treatment Period|Other|6|||
23500232|NCT04523220|65573279|FG000|Extension Treatment Period|Subject Decision|5|||
23500233|NCT04523220|65573280|FG001|Extension Treatment Period|Subject Decision|2|||
23500234|NCT04523220|65573281|FG002|Extension Treatment Period|Subject Decision|4|||
23500235|NCT04523220|65573279|FG000|Extension Treatment Period|Death|6|||
23500236|NCT04523220|65573280|FG001|Extension Treatment Period|Death|4|||
23500237|NCT04523220|65573281|FG002|Extension Treatment Period|Death|7|||
23500238|NCT04523220|65573279|FG000|Extension Treatment Period|Adverse Event|6|||
23500239|NCT04523220|65573280|FG001|Extension Treatment Period|Adverse Event|7|||
23500240|NCT04523220|65573281|FG002|Extension Treatment Period|Adverse Event|9|||
23500241|NCT04523220|65573279|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
23500242|NCT04523220|65573280|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
23500243|NCT04523220|65573281|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
23500244|NCT04523220|65573279|FG000|Extension Treatment Period|Study drug never administered|0|||
23500245|NCT04523220|65573280|FG001|Extension Treatment Period|Study drug never administered|1|||
23500246|NCT04523220|65573281|FG002|Extension Treatment Period|Study drug never administered|0|||
23500247|NCT01876420|65573282|FG000|Overall Study|Missed 30 day visit|1|||
23500248|NCT00114530|65573285|FG000|Overall Study|Death|3|||
23500249|NCT00114530|65573286|FG001|Overall Study|Death|11|||
23500250|NCT00114530|65573285|FG000|Overall Study|Lost to Follow-up|1|||
23500251|NCT00114530|65573286|FG001|Overall Study|Lost to Follow-up|1|||
23500252|NCT00114530|65573285|FG000|Overall Study|Physician Decision|1|||
23500253|NCT00114530|65573286|FG001|Overall Study|Physician Decision|1|||
23500254|NCT00114530|65573285|FG000|Overall Study|Withdrawal by Subject|2|||
23500255|NCT00114530|65573286|FG001|Overall Study|Withdrawal by Subject|6|||
23500256|NCT00114530|65573285|FG000|Overall Study|Breast Cancer|1|||
23500257|NCT00114530|65573286|FG001|Overall Study|Breast Cancer|0|||
23500258|NCT00114530|65573285|FG000|Overall Study|Subject decision after endpoint failure|0|||
23500259|NCT00114530|65573286|FG001|Overall Study|Subject decision after endpoint failure|1|||
23500260|NCT00114530|65573285|FG000|Overall Study|Ineligible|1|||
23500261|NCT00114530|65573286|FG001|Overall Study|Ineligible|0|||
23500262|NCT01392443|65573287|FG000|Overall Study|Disease progression|30|||
23500263|NCT01392443|65573287|FG000|Overall Study|Adverse Event|24|||
23500264|NCT01392443|65573287|FG000|Overall Study|Death|7|||
23500265|NCT01392443|65573287|FG000|Overall Study|Withdrawal by Subject|5|||
23500266|NCT01392443|65573287|FG000|Overall Study|Lost to Follow-up|1|||
23500267|NCT01392443|65573287|FG000|Overall Study|Protocol Violation|1|||
23500268|NCT03298867|65573288|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
23500269|NCT03298867|65573289|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
23500270|NCT03298867|65573288|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
23500271|NCT03298867|65573289|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
23500272|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
23500273|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
23500274|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
23500275|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
23500276|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
23500277|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
23500278|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
23500279|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
23500280|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
23500281|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
23500282|NCT03298867|65573288|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
23500283|NCT03298867|65573289|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
23500284|NCT03298867|65573288|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
23500285|NCT03298867|65573289|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
23500286|NCT02795832|65573290|FG000|Overall Study|Adverse Event|0|||
23500287|NCT02795832|65573291|FG001|Overall Study|Adverse Event|0|||
23500288|NCT02795832|65573292|FG002|Overall Study|Adverse Event|0|||
23500289|NCT02795832|65573293|FG003|Overall Study|Adverse Event|0|||
23500290|NCT02795832|65573294|FG004|Overall Study|Adverse Event|0|||
23500291|NCT02795832|65573295|FG005|Overall Study|Adverse Event|3|||
23500292|NCT01133522|65573298|FG000|Overall Study|Withdrawal by Subject|0|||
23500293|NCT01133522|65573299|FG001|Overall Study|Withdrawal by Subject|1|||
23500294|NCT01133522|65573300|FG002|Overall Study|Withdrawal by Subject|0|||
23500295|NCT01133522|65573301|FG003|Overall Study|Withdrawal by Subject|1|||
23500296|NCT01133522|65573302|FG004|Overall Study|Withdrawal by Subject|0|||
23500297|NCT01133522|65573303|FG005|Overall Study|Withdrawal by Subject|0|||
23500298|NCT01133522|65573304|FG006|Overall Study|Withdrawal by Subject|0|||
23500299|NCT01133522|65573305|FG007|Overall Study|Withdrawal by Subject|0|||
23500300|NCT01133522|65573306|FG008|Overall Study|Withdrawal by Subject|0|||
23500301|NCT01133522|65573307|FG009|Overall Study|Withdrawal by Subject|0|||
23500302|NCT01133522|65573298|FG000|Overall Study|Physician Decision|0|||
23500303|NCT01133522|65573299|FG001|Overall Study|Physician Decision|0|||
23500304|NCT01133522|65573300|FG002|Overall Study|Physician Decision|0|||
23500305|NCT01133522|65573301|FG003|Overall Study|Physician Decision|0|||
23500306|NCT01133522|65573302|FG004|Overall Study|Physician Decision|1|||
23500307|NCT01133522|65573303|FG005|Overall Study|Physician Decision|0|||
23500308|NCT01133522|65573304|FG006|Overall Study|Physician Decision|0|||
23500309|NCT01133522|65573305|FG007|Overall Study|Physician Decision|0|||
23500310|NCT01133522|65573306|FG008|Overall Study|Physician Decision|0|||
23500311|NCT01133522|65573307|FG009|Overall Study|Physician Decision|0|||
23500312|NCT03478930|65573314|FG000|Overall Study|Adverse Event|0|||
23500313|NCT03478930|65573315|FG001|Overall Study|Adverse Event|1|||
23500314|NCT03478930|65573314|FG000|Overall Study|Lack of Efficacy|3|||
23500315|NCT03478930|65573315|FG001|Overall Study|Lack of Efficacy|3|||
23500316|NCT03478930|65573314|FG000|Overall Study|Withdrawal by Subject|6|||
23500317|NCT03478930|65573315|FG001|Overall Study|Withdrawal by Subject|5|||
23500318|NCT00672646|65573316|FG000|Overall Study|Lost to Follow-up|0|||
23500319|NCT00672646|65573317|FG001|Overall Study|Lost to Follow-up|1|||
23500320|NCT00672646|65573318|FG002|Overall Study|Lost to Follow-up|2|||
23500321|NCT00672646|65573316|FG000|Overall Study|Withdrawal by Subject|0|||
23500322|NCT00672646|65573317|FG001|Overall Study|Withdrawal by Subject|0|||
23500323|NCT00672646|65573318|FG002|Overall Study|Withdrawal by Subject|1|||
23500324|NCT00814164|65573319|FG000|Overall Study|Progression|7|||
23500325|NCT00814164|65573319|FG000|Overall Study|not stated|7|||
23500326|NCT00814164|65573319|FG000|Overall Study|Death|5|||
23500327|NCT02289417|65573321|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
23500328|NCT02289417|65573322|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500329|NCT02289417|65573323|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
23500330|NCT02289417|65573324|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500331|NCT02289417|65573325|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500332|NCT02289417|65573326|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500333|NCT02289417|65573327|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500334|NCT02289417|65573328|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500335|NCT02289417|65573329|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
23500336|NCT02289417|65573321|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
23500337|NCT02289417|65573322|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
23500338|NCT02289417|65573323|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
23500339|NCT02289417|65573324|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500340|NCT02289417|65573325|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500341|NCT02289417|65573326|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500342|NCT02289417|65573327|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500343|NCT02289417|65573328|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500344|NCT02289417|65573329|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
23500345|NCT02289417|65573321|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500346|NCT02289417|65573322|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
23500347|NCT02289417|65573323|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500348|NCT02289417|65573324|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500349|NCT02289417|65573325|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500350|NCT02289417|65573326|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500351|NCT02289417|65573327|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500352|NCT02289417|65573328|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500353|NCT02289417|65573329|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
23500354|NCT02289417|65573321|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
23500355|NCT02289417|65573322|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500356|NCT02289417|65573323|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500357|NCT02289417|65573324|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500358|NCT02289417|65573325|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500359|NCT02289417|65573326|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500360|NCT02289417|65573327|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500361|NCT02289417|65573328|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500362|NCT02289417|65573329|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
23500363|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
23500364|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
23500365|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
23500366|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
23500367|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
23500368|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
23500369|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
23500370|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
23500371|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
23500372|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500373|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500374|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
23500375|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500376|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500377|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500378|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500379|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500380|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
23500381|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
23500382|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
23500383|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
23500384|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
23500385|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
23500386|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
23500387|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
23500388|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
23500389|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
23500390|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500391|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500392|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
23500393|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500394|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
23500395|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
23500396|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500397|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500398|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
23500399|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500400|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500401|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500402|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500403|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500404|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500405|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
23500406|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500407|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
23500408|NCT02289417|65573321|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500409|NCT02289417|65573322|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500410|NCT02289417|65573323|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500411|NCT02289417|65573324|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
23500412|NCT02289417|65573325|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500413|NCT02289417|65573326|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500414|NCT02289417|65573327|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
23500415|NCT02289417|65573328|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500416|NCT02289417|65573329|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
23500417|NCT02289417|65573321|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
23500418|NCT02289417|65573322|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
23500419|NCT02289417|65573323|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
23500420|NCT02289417|65573324|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
23500421|NCT02289417|65573325|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
23500422|NCT02289417|65573326|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
23500423|NCT02289417|65573327|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
23500424|NCT02289417|65573328|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
23500425|NCT02289417|65573329|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
23500426|NCT02289417|65573321|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500427|NCT02289417|65573322|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500428|NCT02289417|65573323|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500429|NCT02289417|65573324|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500430|NCT02289417|65573325|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500431|NCT02289417|65573326|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500432|NCT02289417|65573327|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
23500433|NCT02289417|65573328|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
23500434|NCT02289417|65573329|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
23500435|NCT02289417|65573321|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500436|NCT02289417|65573322|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500437|NCT02289417|65573323|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500438|NCT02289417|65573324|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500439|NCT02289417|65573325|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500440|NCT02289417|65573326|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500441|NCT02289417|65573327|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
23500442|NCT02289417|65573328|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
23500443|NCT02289417|65573329|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
23500444|NCT02289417|65573321|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500445|NCT02289417|65573322|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500446|NCT02289417|65573323|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500447|NCT02289417|65573324|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500448|NCT02289417|65573325|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500449|NCT02289417|65573326|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500450|NCT02289417|65573327|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500451|NCT02289417|65573328|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
23500452|NCT02289417|65573329|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
23500453|NCT02985957|65573330|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500454|NCT02985957|65573331|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500455|NCT02985957|65573332|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500456|NCT02985957|65573333|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500457|NCT02985957|65573334|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
23500458|NCT02985957|65573335|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500459|NCT02985957|65573336|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
23500460|NCT02985957|65573330|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
23500461|NCT02985957|65573331|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
23500462|NCT02985957|65573332|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
23500463|NCT02985957|65573333|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
23500464|NCT02985957|65573334|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
23500465|NCT02985957|65573335|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
23500466|NCT02985957|65573336|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
23500467|NCT02985957|65573330|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500468|NCT02985957|65573331|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500469|NCT02985957|65573332|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500470|NCT02985957|65573333|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500471|NCT02985957|65573334|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500472|NCT02985957|65573335|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
23500473|NCT02985957|65573336|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
23500474|NCT02985957|65573330|FG000|Treatment Period|Death|0|||
23500475|NCT02985957|65573331|FG001|Treatment Period|Death|0|||
23500476|NCT02985957|65573332|FG002|Treatment Period|Death|0|||
23500477|NCT02985957|65573333|FG003|Treatment Period|Death|0|||
23500478|NCT02985957|65573334|FG004|Treatment Period|Death|1|||
23500479|NCT02985957|65573335|FG005|Treatment Period|Death|0|||
23500480|NCT02985957|65573336|FG006|Treatment Period|Death|0|||
23500481|NCT02985957|65573330|FG000|Treatment Period|Participant withdrew consent|0|||
23500482|NCT02985957|65573331|FG001|Treatment Period|Participant withdrew consent|0|||
23500483|NCT02985957|65573332|FG002|Treatment Period|Participant withdrew consent|0|||
23500484|NCT02985957|65573333|FG003|Treatment Period|Participant withdrew consent|1|||
23500485|NCT02985957|65573334|FG004|Treatment Period|Participant withdrew consent|3|||
23500486|NCT02985957|65573335|FG005|Treatment Period|Participant withdrew consent|0|||
23500487|NCT02985957|65573336|FG006|Treatment Period|Participant withdrew consent|1|||
23500488|NCT02985957|65573330|FG000|Treatment Period|Lost to Follow-up|0|||
23500489|NCT02985957|65573331|FG001|Treatment Period|Lost to Follow-up|0|||
23500490|NCT02985957|65573332|FG002|Treatment Period|Lost to Follow-up|0|||
23500491|NCT02985957|65573333|FG003|Treatment Period|Lost to Follow-up|0|||
23500492|NCT02985957|65573334|FG004|Treatment Period|Lost to Follow-up|1|||
23500493|NCT02985957|65573335|FG005|Treatment Period|Lost to Follow-up|0|||
23500494|NCT02985957|65573336|FG006|Treatment Period|Lost to Follow-up|0|||
23500495|NCT02985957|65573330|FG000|Treatment Period|Other reasons|0|||
23500496|NCT02985957|65573331|FG001|Treatment Period|Other reasons|0|||
23500497|NCT02985957|65573332|FG002|Treatment Period|Other reasons|1|||
23500498|NCT02985957|65573333|FG003|Treatment Period|Other reasons|3|||
23500499|NCT02985957|65573334|FG004|Treatment Period|Other reasons|6|||
23500500|NCT02985957|65573335|FG005|Treatment Period|Other reasons|0|||
23500501|NCT02985957|65573336|FG006|Treatment Period|Other reasons|1|||
23500502|NCT02985957|65573330|FG000|Treatment Period|Not reported|0|||
23500503|NCT02985957|65573331|FG001|Treatment Period|Not reported|1|||
23500504|NCT02985957|65573332|FG002|Treatment Period|Not reported|2|||
23500505|NCT02985957|65573333|FG003|Treatment Period|Not reported|5|||
23500506|NCT02985957|65573334|FG004|Treatment Period|Not reported|0|||
23500507|NCT02985957|65573335|FG005|Treatment Period|Not reported|0|||
23500508|NCT02985957|65573336|FG006|Treatment Period|Not reported|0|||
23500509|NCT02985957|65573330|FG000|Treatment Period|Maximum clinical benefit|0|||
23500510|NCT02985957|65573331|FG001|Treatment Period|Maximum clinical benefit|0|||
23500511|NCT02985957|65573332|FG002|Treatment Period|Maximum clinical benefit|1|||
23500512|NCT02985957|65573333|FG003|Treatment Period|Maximum clinical benefit|1|||
23500513|NCT02985957|65573334|FG004|Treatment Period|Maximum clinical benefit|0|||
23500514|NCT02985957|65573335|FG005|Treatment Period|Maximum clinical benefit|0|||
23500515|NCT02985957|65573336|FG006|Treatment Period|Maximum clinical benefit|2|||
23500516|NCT02985957|65573330|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
23500517|NCT02985957|65573331|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
23500518|NCT02985957|65573332|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
23500519|NCT02985957|65573333|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
23500520|NCT02985957|65573334|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
23500521|NCT02985957|65573335|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
23500522|NCT02985957|65573336|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
23500523|NCT02985957|65573330|FG000|Treatment Period|Study drug toxicity|1|||
23500524|NCT02985957|65573331|FG001|Treatment Period|Study drug toxicity|23|||
23500525|NCT02985957|65573332|FG002|Treatment Period|Study drug toxicity|20|||
23500526|NCT02985957|65573333|FG003|Treatment Period|Study drug toxicity|11|||
23500527|NCT02985957|65573334|FG004|Treatment Period|Study drug toxicity|19|||
23500528|NCT02985957|65573335|FG005|Treatment Period|Study drug toxicity|3|||
23500529|NCT02985957|65573336|FG006|Treatment Period|Study drug toxicity|5|||
23500530|NCT02985957|65573330|FG000|Treatment Period|Disease progression|0|||
23500531|NCT02985957|65573331|FG001|Treatment Period|Disease progression|16|||
23500532|NCT02985957|65573332|FG002|Treatment Period|Disease progression|20|||
23500533|NCT02985957|65573333|FG003|Treatment Period|Disease progression|39|||
23500534|NCT02985957|65573334|FG004|Treatment Period|Disease progression|29|||
23500535|NCT02985957|65573335|FG005|Treatment Period|Disease progression|11|||
23500536|NCT02985957|65573336|FG006|Treatment Period|Disease progression|28|||
23500537|NCT02985957|65573330|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
23500538|NCT02985957|65573331|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
23500539|NCT02985957|65573332|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
23500540|NCT02985957|65573333|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
23500541|NCT02985957|65573334|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
23500542|NCT02985957|65573335|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
23500543|NCT02985957|65573336|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
23500544|NCT02985957|65573330|FG000|Treatment Period|Poor/Non-Compliance|0|||
23500545|NCT02985957|65573331|FG001|Treatment Period|Poor/Non-Compliance|0|||
23500546|NCT02985957|65573332|FG002|Treatment Period|Poor/Non-Compliance|0|||
23500547|NCT02985957|65573333|FG003|Treatment Period|Poor/Non-Compliance|0|||
23500548|NCT02985957|65573334|FG004|Treatment Period|Poor/Non-Compliance|1|||
23500549|NCT02985957|65573335|FG005|Treatment Period|Poor/Non-Compliance|1|||
23500550|NCT02985957|65573336|FG006|Treatment Period|Poor/Non-Compliance|0|||
23500551|NCT02985957|65573330|FG000|Treatment Period|Continuing in Treatment Period|0|||
23500552|NCT02985957|65573331|FG001|Treatment Period|Continuing in Treatment Period|1|||
23500553|NCT02985957|65573332|FG002|Treatment Period|Continuing in Treatment Period|0|||
23500554|NCT02985957|65573333|FG003|Treatment Period|Continuing in Treatment Period|4|||
23500555|NCT02985957|65573334|FG004|Treatment Period|Continuing in Treatment Period|4|||
23500556|NCT02985957|65573335|FG005|Treatment Period|Continuing in Treatment Period|0|||
23500557|NCT02985957|65573336|FG006|Treatment Period|Continuing in Treatment Period|0|||
23500558|NCT01318993|65573338|FG000|Overall Study|Adverse Event|53|||
23500559|NCT01318993|65573338|FG000|Overall Study|Lack of Efficacy|121|||
23500560|NCT01318993|65573338|FG000|Overall Study|Protocol Violation|3|||
23500561|NCT01318993|65573338|FG000|Overall Study|Protocol based stopping criteria|6|||
23500562|NCT01318993|65573338|FG000|Overall Study|Study closed or terminated|174|||
23500563|NCT01318993|65573338|FG000|Overall Study|Lost to Follow-up|4|||
23500564|NCT01318993|65573338|FG000|Overall Study|Physician Decision|13|||
23500565|NCT01318993|65573338|FG000|Overall Study|Withdrawal by Subject|24|||
23500566|NCT02747875|65573339|FG000|Overall Study|Physician Decision|1|||
23500567|NCT02747875|65573340|FG001|Overall Study|Physician Decision|0|||
23500568|NCT02747875|65573339|FG000|Overall Study|Adverse Event|0|||
23500569|NCT02747875|65573340|FG001|Overall Study|Adverse Event|1|||
23500570|NCT01606800|65573343|FG000|Overall Study|Adverse Event|3|||
23500571|NCT01606800|65573344|FG001|Overall Study|Adverse Event|1|||
23500572|NCT01606800|65573343|FG000|Overall Study|Participant withdrew consent|0|||
23500573|NCT01606800|65573344|FG001|Overall Study|Participant withdrew consent|1|||
23500574|NCT01606800|65573343|FG000|Overall Study|Missing completion status|2|||
23500575|NCT01606800|65573344|FG001|Overall Study|Missing completion status|0|||
23500576|NCT00679432|65573345|FG000|Overall Study|Adverse Event|5|||
23500577|NCT00679432|65573346|FG001|Overall Study|Adverse Event|6|||
23500578|NCT00679432|65573347|FG002|Overall Study|Adverse Event|10|||
23500579|NCT00679432|65573348|FG003|Overall Study|Adverse Event|7|||
23500580|NCT00679432|65573345|FG000|Overall Study|Protocol Violation|1|||
23500581|NCT00679432|65573346|FG001|Overall Study|Protocol Violation|1|||
23500582|NCT00679432|65573347|FG002|Overall Study|Protocol Violation|2|||
23500583|NCT00679432|65573348|FG003|Overall Study|Protocol Violation|1|||
23500584|NCT00679432|65573345|FG000|Overall Study|Withdrawal by Subject|8|||
23500585|NCT00679432|65573346|FG001|Overall Study|Withdrawal by Subject|11|||
23500586|NCT00679432|65573347|FG002|Overall Study|Withdrawal by Subject|10|||
23500587|NCT00679432|65573348|FG003|Overall Study|Withdrawal by Subject|9|||
23500588|NCT00679432|65573345|FG000|Overall Study|Lost to Follow-up|1|||
23500589|NCT00679432|65573346|FG001|Overall Study|Lost to Follow-up|5|||
23500590|NCT00679432|65573347|FG002|Overall Study|Lost to Follow-up|4|||
23500591|NCT00679432|65573348|FG003|Overall Study|Lost to Follow-up|2|||
23500592|NCT00679432|65573345|FG000|Overall Study|Physician Decision|3|||
23500593|NCT00679432|65573346|FG001|Overall Study|Physician Decision|2|||
23500594|NCT00679432|65573347|FG002|Overall Study|Physician Decision|2|||
23500595|NCT00679432|65573348|FG003|Overall Study|Physician Decision|2|||
23500596|NCT00679432|65573345|FG000|Overall Study|Sponsor decision|1|||
23500597|NCT00679432|65573346|FG001|Overall Study|Sponsor decision|0|||
23500598|NCT00679432|65573347|FG002|Overall Study|Sponsor decision|0|||
23500599|NCT00679432|65573348|FG003|Overall Study|Sponsor decision|0|||
23500600|NCT00679432|65573345|FG000|Overall Study|Lack of Efficacy|13|||
23500601|NCT00679432|65573346|FG001|Overall Study|Lack of Efficacy|9|||
23500602|NCT00679432|65573347|FG002|Overall Study|Lack of Efficacy|14|||
23500603|NCT00679432|65573348|FG003|Overall Study|Lack of Efficacy|8|||
23500604|NCT00679432|65573345|FG000|Overall Study|Infectious colitis, normal histology|5|||
23500605|NCT00679432|65573346|FG001|Overall Study|Infectious colitis, normal histology|4|||
23500606|NCT00679432|65573347|FG002|Overall Study|Infectious colitis, normal histology|8|||
23500607|NCT00679432|65573348|FG003|Overall Study|Infectious colitis, normal histology|3|||
23500608|NCT00679432|65573345|FG000|Overall Study|Randomization error, return to prior Rx|0|||
23398697|NCT00786422|65207137|FG000|Rivaroxaban Treatment|Adverse Event|2|||
23500609|NCT00679432|65573346|FG001|Overall Study|Randomization error, return to prior Rx|0|||
23500610|NCT00679432|65573347|FG002|Overall Study|Randomization error, return to prior Rx|3|||
23500611|NCT00679432|65573348|FG003|Overall Study|Randomization error, return to prior Rx|0|||
23500612|NCT02742441|65573349|FG000|Overall Study|Lost to Follow-up|4|||
23500613|NCT02742441|65573350|FG001|Overall Study|Lost to Follow-up|4|||
23500614|NCT02742441|65573349|FG000|Overall Study|Withdrawal by Subject|2|||
23500615|NCT02742441|65573350|FG001|Overall Study|Withdrawal by Subject|2|||
23500616|NCT02742441|65573349|FG000|Overall Study|Adverse Event|0|||
23500617|NCT02742441|65573350|FG001|Overall Study|Adverse Event|2|||
23500618|NCT04094883|65573353|FG000|Overall Study|Withdrawal by Subject|1|||
23500619|NCT00705484|65573360|FG000|Overall Study|Adverse Event|28|||
23500620|NCT00705484|65573361|FG001|Overall Study|Adverse Event|27|||
23500621|NCT00705484|65573360|FG000|Overall Study|Lost to Follow-up|169|||
23500622|NCT00705484|65573361|FG001|Overall Study|Lost to Follow-up|250|||
23500623|NCT00705484|65573360|FG000|Overall Study|Withdrawal by Subject|96|||
23500624|NCT00705484|65573361|FG001|Overall Study|Withdrawal by Subject|72|||
23500625|NCT00705484|65573360|FG000|Overall Study|Administrative|89|||
23500626|NCT00705484|65573361|FG001|Overall Study|Administrative|59|||
23500627|NCT00401531|65573363|FG000|Overall Study|Adverse Event|2|||
23500628|NCT00401531|65573364|FG001|Overall Study|Adverse Event|0|||
23500629|NCT00401531|65573363|FG000|Overall Study|Protocol Violation|3|||
23500630|NCT00401531|65573364|FG001|Overall Study|Protocol Violation|7|||
23500631|NCT00401531|65573363|FG000|Overall Study|Lost to Follow-up|1|||
23500632|NCT00401531|65573364|FG001|Overall Study|Lost to Follow-up|1|||
23500633|NCT00401531|65573363|FG000|Overall Study|Withdrawal by Subject|3|||
23500634|NCT00401531|65573364|FG001|Overall Study|Withdrawal by Subject|2|||
23500635|NCT00996307|65573365|FG000|Overall Study|Adverse Event|0|||
23500636|NCT00996307|65573366|FG001|Overall Study|Adverse Event|1|||
23500637|NCT00996307|65573367|FG002|Overall Study|Adverse Event|0|||
23500638|NCT00996307|65573368|FG003|Overall Study|Adverse Event|0|||
23500639|NCT00996307|65573365|FG000|Overall Study|Withdrawal by Subject|3|||
23500640|NCT00996307|65573366|FG001|Overall Study|Withdrawal by Subject|2|||
23500641|NCT00996307|65573367|FG002|Overall Study|Withdrawal by Subject|5|||
23500642|NCT00996307|65573368|FG003|Overall Study|Withdrawal by Subject|5|||
23500643|NCT00996307|65573365|FG000|Overall Study|Lost to Follow-up|13|||
23500644|NCT00996307|65573366|FG001|Overall Study|Lost to Follow-up|13|||
23500645|NCT00996307|65573367|FG002|Overall Study|Lost to Follow-up|7|||
23500646|NCT00996307|65573368|FG003|Overall Study|Lost to Follow-up|15|||
23500647|NCT00996307|65573365|FG000|Overall Study|Administrative reason|0|||
23500648|NCT00996307|65573366|FG001|Overall Study|Administrative reason|1|||
23500649|NCT00996307|65573367|FG002|Overall Study|Administrative reason|0|||
23500650|NCT00996307|65573368|FG003|Overall Study|Administrative reason|0|||
23398698|NCT00786422|65207137|FG000|Follow-up Period|Death|1|||
23398699|NCT00786422|65207137|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
23398700|NCT03639610|65207141|FG000|Overall Study|Adverse Event|7|||
23398701|NCT03639610|65207142|FG001|Overall Study|Adverse Event|1|||
23398702|NCT03639610|65207143|FG002|Overall Study|Adverse Event|0|||
23398703|NCT03639610|65207141|FG000|Overall Study|Physician Decision|3|||
23398704|NCT03639610|65207142|FG001|Overall Study|Physician Decision|1|||
23398705|NCT03639610|65207143|FG002|Overall Study|Physician Decision|0|||
23398706|NCT03639610|65207141|FG000|Overall Study|Disease progression|8|||
23398707|NCT03639610|65207142|FG001|Overall Study|Disease progression|5|||
23398708|NCT03639610|65207143|FG002|Overall Study|Disease progression|3|||
23398709|NCT03639610|65207141|FG000|Overall Study|Study terminated by sponsor|2|||
23398710|NCT03639610|65207142|FG001|Overall Study|Study terminated by sponsor|1|||
23398711|NCT03639610|65207143|FG002|Overall Study|Study terminated by sponsor|1|||
23398712|NCT03639610|65207141|FG000|Overall Study|Patient request to stop treatment|1|||
23398713|NCT03639610|65207142|FG001|Overall Study|Patient request to stop treatment|2|||
23398714|NCT03639610|65207143|FG002|Overall Study|Patient request to stop treatment|0|||
23398715|NCT01215851|65207144|FG000|Treatment Period|Adverse Event|1|||
23398716|NCT01215851|65207145|FG001|Treatment Period|Adverse Event|1|||
23398717|NCT01215851|65207146|FG002|Treatment Period|Adverse Event|1|||
23398718|NCT01215851|65207147|FG003|Treatment Period|Adverse Event|3|||
23398719|NCT01215851|65207148|FG004|Treatment Period|Adverse Event|0|||
23398720|NCT01215851|65207149|FG005|Treatment Period|Adverse Event|1|||
23398721|NCT01215851|65207144|FG000|Follow up Period|Lost to Follow-up|0|||
23398722|NCT01215851|65207145|FG001|Follow up Period|Lost to Follow-up|0|||
23500651|NCT00996307|65573365|FG000|Overall Study|Unable to classify|4|||
23500652|NCT00996307|65573366|FG001|Overall Study|Unable to classify|0|||
23500653|NCT00996307|65573367|FG002|Overall Study|Unable to classify|2|||
23500654|NCT00996307|65573368|FG003|Overall Study|Unable to classify|1|||
23500655|NCT00453063|65573371|FG000|Overall Study|Adverse Event|1|||
23500656|NCT00453063|65573372|FG001|Overall Study|Adverse Event|2|||
23500657|NCT00453063|65573371|FG000|Overall Study|Withdrawal by Subject|1|||
23500658|NCT00453063|65573372|FG001|Overall Study|Withdrawal by Subject|1|||
23500659|NCT00453063|65573371|FG000|Overall Study|Protocol Violation|1|||
23500660|NCT00453063|65573372|FG001|Overall Study|Protocol Violation|0|||
23500661|NCT00443261|65573373|FG000|Overall Study|Death|1|||
23500662|NCT02590003|65573385|FG000|Overall Study|Death|1|||
23500663|NCT02590003|65573386|FG001|Overall Study|Death|2|||
23500664|NCT01064310|65573387|FG000|Period 1|Adverse Event|7|||
23500665|NCT01064310|65573388|FG001|Period 1|Adverse Event|10|||
23500666|NCT01064310|65573389|FG002|Period 1|Adverse Event|0|||
23500667|NCT01064310|65573387|FG000|Period 1|Physician Decision|1|||
23500668|NCT01064310|65573388|FG001|Period 1|Physician Decision|0|||
23500669|NCT01064310|65573389|FG002|Period 1|Physician Decision|0|||
23500670|NCT01064310|65573387|FG000|Period 1|Withdrawal by Subject|2|||
23500671|NCT01064310|65573388|FG001|Period 1|Withdrawal by Subject|2|||
23500672|NCT01064310|65573389|FG002|Period 1|Withdrawal by Subject|0|||
23500673|NCT01064310|65573387|FG000|Period 1|Lack of Efficacy|3|||
23500674|NCT01064310|65573388|FG001|Period 1|Lack of Efficacy|5|||
23500675|NCT01064310|65573389|FG002|Period 1|Lack of Efficacy|0|||
23500676|NCT01064310|65573387|FG000|Period 1|Entered Open-label Period|1|||
23500677|NCT01064310|65573388|FG001|Period 1|Entered Open-label Period|1|||
23500678|NCT01064310|65573389|FG002|Period 1|Entered Open-label Period|0|||
23500679|NCT01064310|65573387|FG000|Period 2|Adverse Event|2|||
23500680|NCT01064310|65573388|FG001|Period 2|Adverse Event|1|||
23500681|NCT01064310|65573389|FG002|Period 2|Adverse Event|0|||
23500682|NCT01064310|65573387|FG000|Period 2|Physician Decision|0|||
23500683|NCT01064310|65573388|FG001|Period 2|Physician Decision|1|||
23500684|NCT01064310|65573389|FG002|Period 2|Physician Decision|0|||
23500685|NCT01064310|65573387|FG000|Period 2|Entered Open-label Period|1|||
23500686|NCT01064310|65573388|FG001|Period 2|Entered Open-label Period|0|||
23500687|NCT01064310|65573389|FG002|Period 2|Entered Open-label Period|0|||
23500688|NCT01064310|65573387|FG000|Period 2|Lack of Efficacy|1|||
23500689|NCT01064310|65573388|FG001|Period 2|Lack of Efficacy|4|||
23500690|NCT01064310|65573389|FG002|Period 2|Lack of Efficacy|0|||
23500691|NCT01064310|65573387|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
23500692|NCT01064310|65573388|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
23500693|NCT01064310|65573389|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
23500694|NCT01064310|65573387|FG000|Open Label Pazopinib|Adverse Event|0|||
23500695|NCT01064310|65573388|FG001|Open Label Pazopinib|Adverse Event|0|||
23500696|NCT01064310|65573389|FG002|Open Label Pazopinib|Adverse Event|12|||
23500697|NCT01064310|65573387|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
23500698|NCT01064310|65573388|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
23500699|NCT01064310|65573389|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
23500700|NCT01064310|65573387|FG000|Open Label Pazopinib|Physician Decision|0|||
23500701|NCT01064310|65573388|FG001|Open Label Pazopinib|Physician Decision|0|||
23500702|NCT01064310|65573389|FG002|Open Label Pazopinib|Physician Decision|20|||
23500703|NCT02571075|65573399|FG000|Overall Study|Lost to Follow-up|20|||
23500704|NCT02571075|65573400|FG001|Overall Study|Lost to Follow-up|24|||
23500705|NCT04749615|65573405|FG000|Overall Study|Lost to Follow-up|6|||
23500706|NCT04749615|65573406|FG001|Overall Study|Lost to Follow-up|10|||
23500707|NCT04502693|65573407|FG000|Overall Study|Adverse Event|7|||
23500708|NCT04502693|65573408|FG001|Overall Study|Adverse Event|6|||
23500709|NCT04502693|65573409|FG002|Overall Study|Adverse Event|11|||
23500710|NCT04502693|65573410|FG003|Overall Study|Adverse Event|1|||
23500711|NCT04502693|65573407|FG000|Overall Study|Lost to Follow-up|32|||
23500712|NCT04502693|65573408|FG001|Overall Study|Lost to Follow-up|36|||
23500713|NCT04502693|65573409|FG002|Overall Study|Lost to Follow-up|69|||
23500714|NCT04502693|65573410|FG003|Overall Study|Lost to Follow-up|4|||
23500715|NCT04502693|65573407|FG000|Overall Study|Protocol Violation|8|||
23500716|NCT04502693|65573408|FG001|Overall Study|Protocol Violation|8|||
23500717|NCT04502693|65573409|FG002|Overall Study|Protocol Violation|16|||
23500718|NCT04502693|65573410|FG003|Overall Study|Protocol Violation|1|||
23500719|NCT04502693|65573407|FG000|Overall Study|Withdrawal by Subject|46|||
23500720|NCT04502693|65573408|FG001|Overall Study|Withdrawal by Subject|38|||
23500721|NCT04502693|65573409|FG002|Overall Study|Withdrawal by Subject|54|||
23500722|NCT04502693|65573410|FG003|Overall Study|Withdrawal by Subject|7|||
23500723|NCT04502693|65573407|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
23500724|NCT04502693|65573408|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
23500725|NCT04502693|65573409|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
23500726|NCT04502693|65573410|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
23500727|NCT04502693|65573407|FG000|Overall Study|Other|1|||
23500728|NCT04502693|65573408|FG001|Overall Study|Other|0|||
23500729|NCT04502693|65573409|FG002|Overall Study|Other|1|||
23500730|NCT04502693|65573410|FG003|Overall Study|Other|1|||
23500731|NCT00538291|65573411|FG000|Overall Study|Adverse Event|2|||
23500732|NCT00538291|65573411|FG000|Overall Study|Withdrawal by Subject|1|||
23500733|NCT04930965|65573412|FG000|Overall Study|Lost to Follow-up|7|||
23500734|NCT04930965|65573413|FG001|Overall Study|Lost to Follow-up|5|||
23500735|NCT02763462|65573414|FG000|Overall Study|Protocol Violation|6|||
23500736|NCT02030041|65573420|FG000|Overall Study|Withdrawal by Subject|2|||
23500737|NCT02030041|65573421|FG001|Overall Study|Withdrawal by Subject|2|||
23500738|NCT02030041|65573422|FG002|Overall Study|Withdrawal by Subject|1|||
23500739|NCT03681405|65573426|FG000|Overall Study|Found to be ineligible after randomized|1|||
23500740|NCT03681405|65573427|FG001|Overall Study|Found to be ineligible after randomized|0|||
23500741|NCT03302234|65573434|FG000|Overall Study|Death|191|||
23500742|NCT03302234|65573435|FG001|Overall Study|Death|192|||
23500743|NCT03302234|65573434|FG000|Overall Study|Withdrawal by Subject|2|||
23500744|NCT03302234|65573435|FG001|Overall Study|Withdrawal by Subject|2|||
23500745|NCT03302234|65573434|FG000|Overall Study|Sponsor Decision|90|||
23500746|NCT03302234|65573435|FG001|Overall Study|Sponsor Decision|89|||
23500747|NCT03302234|65573434|FG000|Overall Study|Laryngeal carcinoma|0|||
23500748|NCT03302234|65573435|FG001|Overall Study|Laryngeal carcinoma|1|||
23500749|NCT03302234|65573434|FG000|Overall Study|Not Reported|1|||
23500750|NCT03302234|65573435|FG001|Overall Study|Not Reported|0|||
23500751|NCT00762385|65573436|FG000|First Intervention|Lens Issue|1|||
23500752|NCT00762385|65573437|FG001|First Intervention|Lens Issue|1|||
23500753|NCT00762385|65573436|FG000|First Intervention|Lost to Follow-up|0|||
23500754|NCT00762385|65573437|FG001|First Intervention|Lost to Follow-up|2|||
23500755|NCT00762385|65573436|FG000|First Intervention|Ineligible|1|||
23500756|NCT00762385|65573437|FG001|First Intervention|Ineligible|0|||
23500757|NCT00762385|65573436|FG000|First Intervention|Protocol Violation|0|||
23500758|NCT00762385|65573437|FG001|First Intervention|Protocol Violation|1|||
23500759|NCT00762385|65573436|FG000|Second Intervention|Protocol Violation|3|||
23500760|NCT00762385|65573437|FG001|Second Intervention|Protocol Violation|3|||
23500761|NCT01364649|65573438|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
23500762|NCT01364649|65573439|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
23500763|NCT01364649|65573438|FG000|Overall Study|Lack of Efficacy|6|||
23500764|NCT01364649|65573439|FG001|Overall Study|Lack of Efficacy|0|||
23500765|NCT01364649|65573438|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
23500766|NCT01364649|65573439|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
23500767|NCT01364649|65573438|FG000|Overall Study|Protocol Deviations|4|||
23500768|NCT01364649|65573439|FG001|Overall Study|Protocol Deviations|8|||
23500769|NCT01364649|65573438|FG000|Overall Study|Withdrawal of Consent|9|||
23500770|NCT01364649|65573439|FG001|Overall Study|Withdrawal of Consent|7|||
23500771|NCT01364649|65573438|FG000|Overall Study|Lost to Follow-up|12|||
23500772|NCT01364649|65573439|FG001|Overall Study|Lost to Follow-up|13|||
23500773|NCT01364649|65573438|FG000|Overall Study|Other|4|||
23500774|NCT01364649|65573439|FG001|Overall Study|Other|1|||
23500775|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
23500776|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
23500777|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
23500778|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
23500779|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
23500780|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
23500781|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
23500782|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
23500783|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
23500784|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
23500785|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
23500786|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
23500787|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
23500788|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
23500789|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
23500790|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
23500791|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
23500792|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
23500793|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
23500794|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
23500795|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
23500796|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
23500797|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
23500798|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
23500799|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
23500800|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
23500801|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
23500802|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
23500803|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
23500804|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
23500805|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500806|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
23500807|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500808|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500809|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500810|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
23500811|NCT00843024|65573440|FG000|Single-blind Placebo Run-In Phase|Other|0|||
23500812|NCT00843024|65573441|FG001|Single-blind Placebo Run-In Phase|Other|1|||
23500813|NCT00843024|65573442|FG002|Single-blind Placebo Run-In Phase|Other|0|||
23500814|NCT00843024|65573443|FG003|Single-blind Placebo Run-In Phase|Other|0|||
23500815|NCT00843024|65573444|FG004|Single-blind Placebo Run-In Phase|Other|0|||
23500816|NCT00843024|65573445|FG005|Single-blind Placebo Run-In Phase|Other|0|||
23500817|NCT00843024|65573440|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
23500818|NCT00843024|65573441|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
23500819|NCT00843024|65573442|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
23500820|NCT00843024|65573443|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
23500821|NCT00843024|65573444|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
23500822|NCT00843024|65573445|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
23500823|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
23500824|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
23500825|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
23500826|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
23500827|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
23500828|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
23500829|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23500830|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23500831|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23500832|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
23500833|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
23500834|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
23500835|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
23500836|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
23500837|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
23500838|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
23500839|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
23500840|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
23500841|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Physician Decision|0|||
23500842|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Physician Decision|0|||
23500843|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Physician Decision|0|||
23500844|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Physician Decision|3|||
23500845|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Physician Decision|1|||
23500846|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Physician Decision|1|||
23500847|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Adverse Event|0|||
23500848|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Adverse Event|0|||
23500849|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Adverse Event|0|||
23500850|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Adverse Event|0|||
23500851|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Adverse Event|1|||
23500852|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Adverse Event|1|||
23500853|NCT00843024|65573440|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500854|NCT00843024|65573441|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500855|NCT00843024|65573442|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500856|NCT00843024|65573443|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500857|NCT00843024|65573444|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
23500858|NCT00843024|65573445|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
23500859|NCT01081678|65576435|FG000|Overall Study|Ineligibility Determined|0|||
23500860|NCT01081678|65576436|FG001|Overall Study|Ineligibility Determined|0|||
23500861|NCT01081678|65576437|FG002|Overall Study|Ineligibility Determined|1|||
23500862|NCT01081678|65576438|FG003|Overall Study|Ineligibility Determined|1|||
23500863|NCT01081678|65576435|FG000|Overall Study|Noncompliance|3|||
23500864|NCT01081678|65576436|FG001|Overall Study|Noncompliance|4|||
23500865|NCT01081678|65576437|FG002|Overall Study|Noncompliance|5|||
23500866|NCT01081678|65576438|FG003|Overall Study|Noncompliance|2|||
23500867|NCT01081678|65576435|FG000|Overall Study|Adverse Event|2|||
23500868|NCT01081678|65576436|FG001|Overall Study|Adverse Event|1|||
23500869|NCT01081678|65576437|FG002|Overall Study|Adverse Event|2|||
23500870|NCT01081678|65576438|FG003|Overall Study|Adverse Event|2|||
23500871|NCT01081678|65576435|FG000|Overall Study|Withdrawal by Subject|15|||
23500872|NCT01081678|65576436|FG001|Overall Study|Withdrawal by Subject|7|||
23500873|NCT01081678|65576437|FG002|Overall Study|Withdrawal by Subject|17|||
23500874|NCT01081678|65576438|FG003|Overall Study|Withdrawal by Subject|14|||
23500875|NCT01081678|65576435|FG000|Overall Study|Administrative Decision|1|||
23500876|NCT01081678|65576436|FG001|Overall Study|Administrative Decision|0|||
23500877|NCT01081678|65576437|FG002|Overall Study|Administrative Decision|0|||
23500878|NCT01081678|65576438|FG003|Overall Study|Administrative Decision|1|||
23500879|NCT01081678|65576435|FG000|Overall Study|Lost to Follow-up|4|||
23500880|NCT01081678|65576436|FG001|Overall Study|Lost to Follow-up|1|||
23500881|NCT01081678|65576437|FG002|Overall Study|Lost to Follow-up|4|||
23500882|NCT01081678|65576438|FG003|Overall Study|Lost to Follow-up|3|||
23500883|NCT01081678|65576435|FG000|Overall Study|Death|2|||
23500884|NCT01081678|65576436|FG001|Overall Study|Death|2|||
23500885|NCT01081678|65576437|FG002|Overall Study|Death|2|||
23500886|NCT01081678|65576438|FG003|Overall Study|Death|6|||
23500887|NCT01081678|65576435|FG000|Overall Study|Other|0|||
23500888|NCT01081678|65576436|FG001|Overall Study|Other|1|||
23500889|NCT01081678|65576437|FG002|Overall Study|Other|0|||
23500890|NCT01081678|65576438|FG003|Overall Study|Other|0|||
23500891|NCT00939770|65576442|FG000|Overall Study|Adverse Event|1|||
23500892|NCT00939770|65576443|FG001|Overall Study|Adverse Event|1|||
23500893|NCT00939770|65576444|FG002|Overall Study|Adverse Event|0|||
23500894|NCT00939770|65576445|FG003|Overall Study|Adverse Event|0|||
23500895|NCT00939770|65576446|FG004|Overall Study|Adverse Event|6|||
23500896|NCT00939770|65576447|FG005|Overall Study|Adverse Event|2|||
23500897|NCT00939770|65576448|FG006|Overall Study|Adverse Event|1|||
23500898|NCT00939770|65576449|FG007|Overall Study|Adverse Event|1|||
23500899|NCT00939770|65576442|FG000|Overall Study|Lack of Efficacy|4|||
23500900|NCT00939770|65576443|FG001|Overall Study|Lack of Efficacy|6|||
23500901|NCT00939770|65576444|FG002|Overall Study|Lack of Efficacy|13|||
23500902|NCT00939770|65576445|FG003|Overall Study|Lack of Efficacy|9|||
23500903|NCT00939770|65576446|FG004|Overall Study|Lack of Efficacy|16|||
23500904|NCT00939770|65576447|FG005|Overall Study|Lack of Efficacy|8|||
23500905|NCT00939770|65576448|FG006|Overall Study|Lack of Efficacy|11|||
23500906|NCT00939770|65576449|FG007|Overall Study|Lack of Efficacy|1|||
23500907|NCT00939770|65576442|FG000|Overall Study|Lost to Follow-up|0|||
23500908|NCT00939770|65576443|FG001|Overall Study|Lost to Follow-up|0|||
23500909|NCT00939770|65576444|FG002|Overall Study|Lost to Follow-up|0|||
23500910|NCT00939770|65576445|FG003|Overall Study|Lost to Follow-up|0|||
23500911|NCT00939770|65576446|FG004|Overall Study|Lost to Follow-up|1|||
23500912|NCT00939770|65576447|FG005|Overall Study|Lost to Follow-up|0|||
23500913|NCT00939770|65576448|FG006|Overall Study|Lost to Follow-up|0|||
23500914|NCT00939770|65576449|FG007|Overall Study|Lost to Follow-up|0|||
23500915|NCT00939770|65576442|FG000|Overall Study|Physician Decision|0|||
23500916|NCT00939770|65576443|FG001|Overall Study|Physician Decision|0|||
23500917|NCT00939770|65576444|FG002|Overall Study|Physician Decision|2|||
23500918|NCT00939770|65576445|FG003|Overall Study|Physician Decision|0|||
23500919|NCT00939770|65576446|FG004|Overall Study|Physician Decision|7|||
23500920|NCT00939770|65576447|FG005|Overall Study|Physician Decision|1|||
23500921|NCT00939770|65576448|FG006|Overall Study|Physician Decision|0|||
23500922|NCT00939770|65576449|FG007|Overall Study|Physician Decision|6|||
23500923|NCT00939770|65576442|FG000|Overall Study|Protocol Violation|0|||
23500924|NCT00939770|65576443|FG001|Overall Study|Protocol Violation|0|||
23500925|NCT00939770|65576444|FG002|Overall Study|Protocol Violation|0|||
23500926|NCT00939770|65576445|FG003|Overall Study|Protocol Violation|0|||
23500927|NCT00939770|65576446|FG004|Overall Study|Protocol Violation|1|||
23500928|NCT00939770|65576447|FG005|Overall Study|Protocol Violation|0|||
23500929|NCT00939770|65576448|FG006|Overall Study|Protocol Violation|0|||
23500930|NCT00939770|65576449|FG007|Overall Study|Protocol Violation|0|||
23500931|NCT00939770|65576442|FG000|Overall Study|Withdrawal by Subject|0|||
23500932|NCT00939770|65576443|FG001|Overall Study|Withdrawal by Subject|1|||
23500933|NCT00939770|65576444|FG002|Overall Study|Withdrawal by Subject|5|||
23500934|NCT00939770|65576445|FG003|Overall Study|Withdrawal by Subject|2|||
23500935|NCT00939770|65576446|FG004|Overall Study|Withdrawal by Subject|6|||
23500936|NCT00939770|65576447|FG005|Overall Study|Withdrawal by Subject|0|||
23500937|NCT00939770|65576448|FG006|Overall Study|Withdrawal by Subject|2|||
23500938|NCT00939770|65576449|FG007|Overall Study|Withdrawal by Subject|2|||
23500939|NCT02591290|65576452|FG000|Overall Study|Withdrawal by Subject|2|||
23500940|NCT02784431|65576463|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
23500941|NCT02784431|65576463|FG000|Overall Study|Early Study Termination|19|||
23500942|NCT03733470|65576466|FG000|Overall Study|PI Decision|1|||
23500943|NCT03733470|65576467|FG001|Overall Study|PI Decision|1|||
23500944|NCT05229406|65576469|FG000|Overall Study|Withdrawal by Subject|1|||
23500945|NCT05229406|65576470|FG001|Overall Study|Withdrawal by Subject|2|||
23500946|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
23500947|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
23500948|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
23500949|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
23500950|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
23500951|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
23500952|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
23500953|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
23500954|NCT03943147|65576477|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
23500955|NCT03943147|65576478|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
23500956|NCT03943147|65576477|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
23500957|NCT03943147|65576478|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
23500958|NCT02151110|65576479|FG000|Overall Study|Withdrawal by Subject|0|||
23500959|NCT02151110|65576480|FG001|Overall Study|Withdrawal by Subject|0|||
23500960|NCT02151110|65576481|FG002|Overall Study|Withdrawal by Subject|0|||
23500961|NCT02151110|65576482|FG003|Overall Study|Withdrawal by Subject|0|||
23500962|NCT02151110|65576483|FG004|Overall Study|Withdrawal by Subject|0|||
23500963|NCT02151110|65576484|FG005|Overall Study|Withdrawal by Subject|0|||
23500964|NCT02151110|65576485|FG006|Overall Study|Withdrawal by Subject|0|||
23500965|NCT02151110|65576486|FG007|Overall Study|Withdrawal by Subject|1|||
23500966|NCT02151110|65576479|FG000|Overall Study|Lost to Follow-up|0|||
23500967|NCT02151110|65576480|FG001|Overall Study|Lost to Follow-up|0|||
23500968|NCT02151110|65576481|FG002|Overall Study|Lost to Follow-up|0|||
23500969|NCT02151110|65576482|FG003|Overall Study|Lost to Follow-up|0|||
23500970|NCT02151110|65576483|FG004|Overall Study|Lost to Follow-up|0|||
23500971|NCT02151110|65576484|FG005|Overall Study|Lost to Follow-up|0|||
23500972|NCT02151110|65576485|FG006|Overall Study|Lost to Follow-up|0|||
23500973|NCT02151110|65576486|FG007|Overall Study|Lost to Follow-up|2|||
23500974|NCT01896102|65576487|FG000|Overall Study|Death|1|||
23500975|NCT01896102|65576487|FG000|Overall Study|Participant to receive allogenic transplant|2|||
23500976|NCT00566995|65576488|FG000|Overall Study|Toxicity|4|||
23500977|NCT00566995|65576488|FG000|Overall Study|Withdrew consent|3|||
23500978|NCT01084083|65576489|FG000|Overall Study|Adverse Event|5|||
23500979|NCT01084083|65576489|FG000|Overall Study|Death|1|||
23500980|NCT01084083|65576489|FG000|Overall Study|Withdrawal by Subject|2|||
23500981|NCT01084083|65576489|FG000|Overall Study|Complicating disease|1|||
23500982|NCT01084083|65576489|FG000|Overall Study|Other|2|||
23500983|NCT01084083|65576489|FG000|Overall Study|Never started assigned therapy|1|||
23500984|NCT02915016|65576490|FG000|Overall Study|Lost to Follow-up|4|||
23500985|NCT02915016|65576491|FG001|Overall Study|Lost to Follow-up|2|||
23500986|NCT02915016|65576492|FG002|Overall Study|Lost to Follow-up|5|||
23500987|NCT02915016|65576493|FG003|Overall Study|Lost to Follow-up|3|||
23500988|NCT02915016|65576494|FG004|Overall Study|Lost to Follow-up|5|||
23500989|NCT02915016|65576495|FG005|Overall Study|Lost to Follow-up|2|||
23500990|NCT02915016|65576496|FG006|Overall Study|Lost to Follow-up|8|||
23500991|NCT02915016|65576497|FG007|Overall Study|Lost to Follow-up|2|||
23500992|NCT02915016|65576490|FG000|Overall Study|Physician Decision|0|||
23500993|NCT02915016|65576491|FG001|Overall Study|Physician Decision|0|||
23500994|NCT02915016|65576492|FG002|Overall Study|Physician Decision|1|||
23500995|NCT02915016|65576493|FG003|Overall Study|Physician Decision|0|||
23500996|NCT02915016|65576494|FG004|Overall Study|Physician Decision|0|||
23500997|NCT02915016|65576495|FG005|Overall Study|Physician Decision|1|||
23500998|NCT02915016|65576496|FG006|Overall Study|Physician Decision|2|||
23500999|NCT02915016|65576497|FG007|Overall Study|Physician Decision|0|||
23501000|NCT02915016|65576490|FG000|Overall Study|Withdrawal by Subject|2|||
23501001|NCT02915016|65576491|FG001|Overall Study|Withdrawal by Subject|0|||
23501002|NCT02915016|65576492|FG002|Overall Study|Withdrawal by Subject|1|||
23501003|NCT02915016|65576493|FG003|Overall Study|Withdrawal by Subject|0|||
23501004|NCT02915016|65576494|FG004|Overall Study|Withdrawal by Subject|1|||
23501005|NCT02915016|65576495|FG005|Overall Study|Withdrawal by Subject|3|||
23501006|NCT02915016|65576496|FG006|Overall Study|Withdrawal by Subject|1|||
23501007|NCT02915016|65576497|FG007|Overall Study|Withdrawal by Subject|1|||
23501008|NCT02915016|65576490|FG000|Overall Study|Elected not to continue|0|||
23501009|NCT02915016|65576491|FG001|Overall Study|Elected not to continue|0|||
23501010|NCT02915016|65576492|FG002|Overall Study|Elected not to continue|0|||
23501011|NCT02915016|65576493|FG003|Overall Study|Elected not to continue|1|||
23501012|NCT02915016|65576494|FG004|Overall Study|Elected not to continue|0|||
23501013|NCT02915016|65576495|FG005|Overall Study|Elected not to continue|0|||
23501014|NCT02915016|65576496|FG006|Overall Study|Elected not to continue|1|||
23501015|NCT02915016|65576497|FG007|Overall Study|Elected not to continue|0|||
23501016|NCT02915016|65576490|FG000|Overall Study|HIV infection|1|||
23501017|NCT02915016|65576491|FG001|Overall Study|HIV infection|1|||
23501018|NCT02915016|65576492|FG002|Overall Study|HIV infection|1|||
23501019|NCT02915016|65576493|FG003|Overall Study|HIV infection|0|||
23501020|NCT02915016|65576494|FG004|Overall Study|HIV infection|1|||
23398723|NCT01215851|65207146|FG002|Follow up Period|Lost to Follow-up|0|||
23501021|NCT02915016|65576495|FG005|Overall Study|HIV infection|0|||
23501022|NCT02915016|65576496|FG006|Overall Study|HIV infection|0|||
23501023|NCT02915016|65576497|FG007|Overall Study|HIV infection|0|||
23501024|NCT02915016|65576490|FG000|Overall Study|Participant unable to adhere|0|||
23501025|NCT02915016|65576491|FG001|Overall Study|Participant unable to adhere|0|||
23501026|NCT02915016|65576492|FG002|Overall Study|Participant unable to adhere|0|||
23501027|NCT02915016|65576493|FG003|Overall Study|Participant unable to adhere|0|||
23501028|NCT02915016|65576494|FG004|Overall Study|Participant unable to adhere|0|||
23501029|NCT02915016|65576495|FG005|Overall Study|Participant unable to adhere|0|||
23501030|NCT02915016|65576496|FG006|Overall Study|Participant unable to adhere|0|||
23501031|NCT02915016|65576497|FG007|Overall Study|Participant unable to adhere|1|||
23501032|NCT01866293|65576501|FG000|Overall Study|Adverse Event|2|||
23501033|NCT02192359|65576502|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
23501034|NCT02192359|65576503|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
23501035|NCT02192359|65576504|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
23501036|NCT02192359|65576505|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
23501037|NCT02192359|65576502|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
23501038|NCT02192359|65576503|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
23501039|NCT02192359|65576504|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
23501040|NCT02192359|65576505|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
23501041|NCT02192359|65576502|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
23501042|NCT02192359|65576503|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
23501043|NCT02192359|65576504|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
23501044|NCT02192359|65576505|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
23501045|NCT01546883|65576508|FG000|Overall Study|Withdrawal by Subject|3|||
23501046|NCT01546883|65576508|FG000|Overall Study|Adverse Event|4|||
23501047|NCT01546883|65576508|FG000|Overall Study|Lost to Follow-up|2|||
23501048|NCT01546883|65576508|FG000|Overall Study|early closure of study|2|||
23501049|NCT01546883|65576508|FG000|Overall Study|other unrelated illness|1|||
23501050|NCT01578187|65576509|FG000|Usability Phase|Withdrawal by Subject|1|||
23501051|NCT01350492|65576510|FG000|Intervention|Lost to Follow-up|2|||
23501052|NCT01350492|65576511|FG001|Intervention|Lost to Follow-up|5|||
23501053|NCT01350492|65576510|FG000|Intervention|Withdrawal by Subject|3|||
23501054|NCT01350492|65576511|FG001|Intervention|Withdrawal by Subject|1|||
23501055|NCT01350492|65576510|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
23501056|NCT01350492|65576511|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
23501057|NCT01350492|65576510|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
23501058|NCT01350492|65576511|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
23501059|NCT04786990|65576513|FG000|Overall Study|Withdrawal by Subject|1|||
23501060|NCT04786990|65576513|FG000|Overall Study|Adverse Event|1|||
23501061|NCT04786990|65576513|FG000|Overall Study|Lost to Follow-up|1|||
23501062|NCT04786990|65576513|FG000|Overall Study|Noncompliance|1|||
23501063|NCT04786990|65576513|FG000|Overall Study|Unable to complete site visits|1|||
23501064|NCT04786990|65576513|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
23501065|NCT03725852|65576516|FG000|Overall Study|Death|1|||
23501066|NCT03725852|65576517|FG001|Overall Study|Death|0|||
23501067|NCT03725852|65576516|FG000|Overall Study|Withdrawal by Subject|1|||
23501068|NCT03725852|65576517|FG001|Overall Study|Withdrawal by Subject|0|||
23501069|NCT03725852|65576516|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
23501070|NCT03725852|65576517|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
23398724|NCT01215851|65207147|FG003|Follow up Period|Lost to Follow-up|0|||
23398725|NCT01215851|65207148|FG004|Follow up Period|Lost to Follow-up|0|||
23398726|NCT01215851|65207149|FG005|Follow up Period|Lost to Follow-up|1|||
23398727|NCT00673920|65207150|FG000|Baseline up to Week 48|Withdrew consent|1|||
23398728|NCT00673920|65207151|FG001|Baseline up to Week 48|Withdrew consent|0|||
23398729|NCT00673920|65207152|FG002|Baseline up to Week 48|Withdrew consent|2|||
23398730|NCT00673920|65207153|FG003|Baseline up to Week 48|Withdrew consent|0|||
23398731|NCT00673920|65207154|FG004|Baseline up to Week 48|Withdrew consent|0|||
23398732|NCT00673920|65207155|FG005|Baseline up to Week 48|Withdrew consent|0|||
23398733|NCT00673920|65207156|FG006|Baseline up to Week 48|Withdrew consent|0|||
23398734|NCT00673920|65207157|FG007|Baseline up to Week 48|Withdrew consent|0|||
23398735|NCT00673920|65207150|FG000|Baseline up to Week 48|Refused treatment|1|||
23398736|NCT00673920|65207151|FG001|Baseline up to Week 48|Refused treatment|0|||
23398737|NCT00673920|65207152|FG002|Baseline up to Week 48|Refused treatment|0|||
23398738|NCT00673920|65207153|FG003|Baseline up to Week 48|Refused treatment|0|||
23398739|NCT00673920|65207154|FG004|Baseline up to Week 48|Refused treatment|0|||
23398740|NCT00673920|65207155|FG005|Baseline up to Week 48|Refused treatment|0|||
23398741|NCT00673920|65207156|FG006|Baseline up to Week 48|Refused treatment|0|||
23398742|NCT00673920|65207157|FG007|Baseline up to Week 48|Refused treatment|0|||
23398743|NCT00673920|65207150|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
23398744|NCT00673920|65207151|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
23398745|NCT00673920|65207152|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398746|NCT00673920|65207153|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398747|NCT00673920|65207154|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398748|NCT00673920|65207155|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398749|NCT00673920|65207156|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
23501071|NCT00845858|65576519|FG000|Overall Study|Withdrawal by Subject|5|||
23501072|NCT00845858|65576520|FG001|Overall Study|Withdrawal by Subject|1|||
23501073|NCT00845858|65576521|FG002|Overall Study|Withdrawal by Subject|1|||
23501074|NCT00845858|65576519|FG000|Overall Study|Adverse Event|3|||
23501075|NCT00845858|65576520|FG001|Overall Study|Adverse Event|8|||
23501076|NCT00845858|65576521|FG002|Overall Study|Adverse Event|4|||
23501077|NCT00845858|65576519|FG000|Overall Study|Protocol Violation|0|||
23501078|NCT00845858|65576520|FG001|Overall Study|Protocol Violation|0|||
23501079|NCT00845858|65576521|FG002|Overall Study|Protocol Violation|1|||
23501080|NCT00845858|65576519|FG000|Overall Study|not eligible|0|||
23501081|NCT00845858|65576520|FG001|Overall Study|not eligible|3|||
23501082|NCT00845858|65576521|FG002|Overall Study|not eligible|2|||
23501083|NCT00824720|65576522|FG000|Overall Study|failed plug insertion|3|||
23501084|NCT00824720|65576523|FG001|Overall Study|failed plug insertion|1|||
23501085|NCT00824720|65576524|FG002|Overall Study|failed plug insertion|0|||
23501086|NCT00824720|65576522|FG000|Overall Study|Protocol Violation|0|||
23501087|NCT00824720|65576523|FG001|Overall Study|Protocol Violation|0|||
23501088|NCT00824720|65576524|FG002|Overall Study|Protocol Violation|1|||
23501089|NCT02725710|65576527|FG000|Overall Study|Lost to Follow-up|1|||
23501090|NCT02725710|65576528|FG001|Overall Study|Lost to Follow-up|0|||
23501091|NCT00458211|65576529|FG000|Overall Study|Lack of Efficacy|12|||
23501092|NCT00458211|65576529|FG000|Overall Study|Withdrawal by Subject|2|||
23501093|NCT00458211|65576529|FG000|Overall Study|Protocol Violation|2|||
23501094|NCT00361569|65576535|FG000|Overall Study|Protocol Violation|3|||
23501095|NCT00361569|65576536|FG001|Overall Study|Protocol Violation|2|||
23501096|NCT00361569|65576537|FG002|Overall Study|Protocol Violation|4|||
23501097|NCT00361569|65576538|FG003|Overall Study|Protocol Violation|2|||
23501098|NCT00361569|65576535|FG000|Overall Study|Withdrawal by Subject|2|||
23501099|NCT00361569|65576536|FG001|Overall Study|Withdrawal by Subject|1|||
23501100|NCT00361569|65576537|FG002|Overall Study|Withdrawal by Subject|9|||
23501101|NCT00361569|65576538|FG003|Overall Study|Withdrawal by Subject|14|||
23501102|NCT00361569|65576535|FG000|Overall Study|Adverse Event|3|||
23501103|NCT00361569|65576536|FG001|Overall Study|Adverse Event|5|||
23501104|NCT00361569|65576537|FG002|Overall Study|Adverse Event|2|||
23501105|NCT00361569|65576538|FG003|Overall Study|Adverse Event|2|||
23501106|NCT00361569|65576535|FG000|Overall Study|Lost to Follow-up|2|||
23501107|NCT00361569|65576536|FG001|Overall Study|Lost to Follow-up|3|||
23501108|NCT00361569|65576537|FG002|Overall Study|Lost to Follow-up|3|||
23501109|NCT00361569|65576538|FG003|Overall Study|Lost to Follow-up|2|||
23501110|NCT00361569|65576535|FG000|Overall Study|Not specified by investigator|2|||
23501111|NCT00361569|65576536|FG001|Overall Study|Not specified by investigator|0|||
23501112|NCT00361569|65576537|FG002|Overall Study|Not specified by investigator|0|||
23501113|NCT00361569|65576538|FG003|Overall Study|Not specified by investigator|1|||
23501114|NCT01606007|65576539|FG000|Overall Study|Reason 'Other' in the protocol|0|||
23501115|NCT01606007|65576540|FG001|Overall Study|Reason 'Other' in the protocol|1|||
23501116|NCT01606007|65576541|FG002|Overall Study|Reason 'Other' in the protocol|1|||
23501117|NCT01606007|65576539|FG000|Overall Study|Pregnancy|0|||
23501118|NCT01606007|65576540|FG001|Overall Study|Pregnancy|1|||
23501119|NCT01606007|65576541|FG002|Overall Study|Pregnancy|1|||
23501120|NCT01606007|65576539|FG000|Overall Study|Withdrawal by Subject|8|||
23501121|NCT01606007|65576540|FG001|Overall Study|Withdrawal by Subject|6|||
23501122|NCT01606007|65576541|FG002|Overall Study|Withdrawal by Subject|1|||
23501123|NCT01606007|65576539|FG000|Overall Study|Adverse Event|0|||
23501124|NCT01606007|65576540|FG001|Overall Study|Adverse Event|1|||
23501125|NCT01606007|65576541|FG002|Overall Study|Adverse Event|1|||
23501126|NCT01606007|65576539|FG000|Overall Study|discontinue study treatment|0|||
23501127|NCT01606007|65576540|FG001|Overall Study|discontinue study treatment|2|||
23501128|NCT01606007|65576541|FG002|Overall Study|discontinue study treatment|1|||
23501129|NCT01606007|65576539|FG000|Overall Study|Lost to Follow-up|6|||
23501130|NCT01606007|65576540|FG001|Overall Study|Lost to Follow-up|8|||
23501131|NCT01606007|65576541|FG002|Overall Study|Lost to Follow-up|5|||
23501132|NCT01606007|65576539|FG000|Overall Study|Poor/Non-compliance|1|||
23501133|NCT01606007|65576540|FG001|Overall Study|Poor/Non-compliance|0|||
23501134|NCT01606007|65576541|FG002|Overall Study|Poor/Non-compliance|0|||
23501135|NCT00851747|65576542|FG000|Overall Study|Physician Decision|6|||
23501136|NCT00851747|65576543|FG001|Overall Study|Physician Decision|6|||
23501137|NCT00851747|65576544|FG002|Overall Study|Physician Decision|6|||
23501138|NCT02100514|65576545|FG000|Treatment Period|Adverse Event|0|||
23501139|NCT02100514|65576546|FG001|Treatment Period|Adverse Event|5|||
23501140|NCT02100514|65576547|FG002|Treatment Period|Adverse Event|0|||
23501141|NCT02100514|65576548|FG003|Treatment Period|Adverse Event|0|||
23501142|NCT02100514|65576549|FG004|Treatment Period|Adverse Event|0|||
23501143|NCT02100514|65576545|FG000|Treatment Period|Death|2|||
23501144|NCT02100514|65576546|FG001|Treatment Period|Death|2|||
23501145|NCT02100514|65576547|FG002|Treatment Period|Death|0|||
23501146|NCT02100514|65576548|FG003|Treatment Period|Death|0|||
23300707|NCT01846273|64842898|FG000|Overall Study|Lost to Follow-up|2|||
23501147|NCT02100514|65576549|FG004|Treatment Period|Death|0|||
23501148|NCT02100514|65576545|FG000|Treatment Period|Lost to Follow-up|5|||
23501149|NCT02100514|65576546|FG001|Treatment Period|Lost to Follow-up|17|||
23501150|NCT02100514|65576547|FG002|Treatment Period|Lost to Follow-up|0|||
23501151|NCT02100514|65576548|FG003|Treatment Period|Lost to Follow-up|0|||
23501152|NCT02100514|65576549|FG004|Treatment Period|Lost to Follow-up|0|||
23501153|NCT02100514|65576545|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
23501154|NCT02100514|65576546|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
23501155|NCT02100514|65576547|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
23501156|NCT02100514|65576548|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
23501157|NCT02100514|65576549|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
23501158|NCT02100514|65576545|FG000|Treatment Period|Protocol Violation|1|||
23501159|NCT02100514|65576546|FG001|Treatment Period|Protocol Violation|1|||
23501160|NCT02100514|65576547|FG002|Treatment Period|Protocol Violation|0|||
23501161|NCT02100514|65576548|FG003|Treatment Period|Protocol Violation|0|||
23501162|NCT02100514|65576549|FG004|Treatment Period|Protocol Violation|0|||
23501163|NCT02100514|65576545|FG000|Treatment Period|Withdrawal by Subject|12|||
23501164|NCT02100514|65576546|FG001|Treatment Period|Withdrawal by Subject|37|||
23501165|NCT02100514|65576547|FG002|Treatment Period|Withdrawal by Subject|0|||
23501166|NCT02100514|65576548|FG003|Treatment Period|Withdrawal by Subject|0|||
23501167|NCT02100514|65576549|FG004|Treatment Period|Withdrawal by Subject|0|||
23501168|NCT02100514|65576545|FG000|Treatment Period|Other|9|||
23501169|NCT02100514|65576546|FG001|Treatment Period|Other|11|||
23501170|NCT02100514|65576547|FG002|Treatment Period|Other|0|||
23501171|NCT02100514|65576548|FG003|Treatment Period|Other|0|||
23501172|NCT02100514|65576549|FG004|Treatment Period|Other|0|||
23501173|NCT02100514|65576545|FG000|Extension Period|Withdrew consent|0|||
23501174|NCT02100514|65576546|FG001|Extension Period|Withdrew consent|0|||
23501175|NCT02100514|65576547|FG002|Extension Period|Withdrew consent|2|||
23501176|NCT02100514|65576548|FG003|Extension Period|Withdrew consent|0|||
23501177|NCT02100514|65576549|FG004|Extension Period|Withdrew consent|0|||
23501178|NCT01962896|65576558|FG000|Overall Study|Lack of Efficacy|4|||
23501179|NCT01325584|65576561|FG000|Overall Study|Death|1|||
23501180|NCT01370356|65576563|FG000|Overall Study|Death|1|||
23501181|NCT01370356|65576564|FG001|Overall Study|Death|0|||
23501182|NCT01370356|65576563|FG000|Overall Study|Lack of Efficacy|6|||
23501183|NCT01370356|65576564|FG001|Overall Study|Lack of Efficacy|28|||
23501184|NCT01370356|65576563|FG000|Overall Study|Lost to Follow-up|76|||
23501185|NCT01370356|65576564|FG001|Overall Study|Lost to Follow-up|81|||
23501186|NCT01370356|65576563|FG000|Overall Study|Withdrawal by Subject|54|||
23501187|NCT01370356|65576564|FG001|Overall Study|Withdrawal by Subject|59|||
23398750|NCT00673920|65207157|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
23398751|NCT00673920|65207150|FG000|Baseline up to Week 48|Protocol Violation|0|||
23398752|NCT00673920|65207151|FG001|Baseline up to Week 48|Protocol Violation|0|||
23398753|NCT00673920|65207152|FG002|Baseline up to Week 48|Protocol Violation|1|||
23398754|NCT00673920|65207153|FG003|Baseline up to Week 48|Protocol Violation|0|||
23398755|NCT00673920|65207154|FG004|Baseline up to Week 48|Protocol Violation|0|||
23398756|NCT00673920|65207155|FG005|Baseline up to Week 48|Protocol Violation|0|||
23398757|NCT00673920|65207156|FG006|Baseline up to Week 48|Protocol Violation|0|||
23398758|NCT00673920|65207157|FG007|Baseline up to Week 48|Protocol Violation|0|||
23398759|NCT00673920|65207150|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398760|NCT00673920|65207151|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398761|NCT00673920|65207152|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
23398762|NCT00673920|65207153|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398763|NCT00673920|65207154|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398764|NCT00673920|65207155|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398765|NCT00673920|65207156|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398766|NCT00673920|65207157|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
23398767|NCT00673920|65207150|FG000|Baseline up to Week 48|Administrative/Other|0|||
23398768|NCT00673920|65207151|FG001|Baseline up to Week 48|Administrative/Other|1|||
23398769|NCT00673920|65207152|FG002|Baseline up to Week 48|Administrative/Other|2|||
23398770|NCT00673920|65207153|FG003|Baseline up to Week 48|Administrative/Other|0|||
23398771|NCT00673920|65207154|FG004|Baseline up to Week 48|Administrative/Other|0|||
23398772|NCT00673920|65207155|FG005|Baseline up to Week 48|Administrative/Other|0|||
23398773|NCT00673920|65207156|FG006|Baseline up to Week 48|Administrative/Other|0|||
23398774|NCT00673920|65207157|FG007|Baseline up to Week 48|Administrative/Other|0|||
23398775|NCT00673920|65207150|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398776|NCT00673920|65207151|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
23398777|NCT00673920|65207152|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
23398778|NCT00673920|65207153|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398779|NCT00673920|65207154|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398780|NCT00673920|65207155|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398781|NCT00673920|65207156|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398782|NCT00673920|65207157|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
23398783|NCT00673920|65207150|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23501188|NCT01370356|65576563|FG000|Overall Study|Reason not specified|39|||
23501189|NCT01370356|65576564|FG001|Overall Study|Reason not specified|43|||
23501190|NCT01370356|65576563|FG000|Overall Study|Protocol Violation|3|||
23501191|NCT01370356|65576564|FG001|Overall Study|Protocol Violation|3|||
23501192|NCT01370356|65576563|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
23501193|NCT01370356|65576564|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
23501194|NCT01370356|65576563|FG000|Overall Study|AE Not Related to Study Drug|1|||
23501195|NCT01370356|65576564|FG001|Overall Study|AE Not Related to Study Drug|4|||
23501196|NCT02516163|65576565|FG000|Overall Study|Withdrawal by Subject|1|||
23501197|NCT02516163|65576565|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
23501198|NCT02516163|65576565|FG000|Overall Study|Unfit/delay in surgery|3|||
23501199|NCT02516163|65576565|FG000|Overall Study|Use of incorrect measurement technique|5|||
23501200|NCT02516163|65576565|FG000|Overall Study|Data not recorded|2|||
23501201|NCT02516163|65576565|FG000|Overall Study|MRI contraindication exclusion|6|||
23501202|NCT02400333|65576566|FG000|Overall Study|Withdrawal by Subject|0|||
23501203|NCT02400333|65576567|FG001|Overall Study|Withdrawal by Subject|1|||
23501204|NCT02400333|65576568|FG002|Overall Study|Withdrawal by Subject|0|||
23501205|NCT02400333|65576569|FG003|Overall Study|Withdrawal by Subject|1|||
23501206|NCT02400333|65576566|FG000|Overall Study|Protocol Violation|1|||
23501207|NCT02400333|65576567|FG001|Overall Study|Protocol Violation|0|||
23501208|NCT02400333|65576568|FG002|Overall Study|Protocol Violation|2|||
23501209|NCT02400333|65576569|FG003|Overall Study|Protocol Violation|1|||
23501210|NCT01091974|65576585|FG000|Overall Study|Did not start intervention|3|||
23501211|NCT01091974|65576586|FG001|Overall Study|Did not start intervention|1|||
23501212|NCT01091974|65576587|FG002|Overall Study|Did not start intervention|3|||
23501213|NCT01091974|65576588|FG003|Overall Study|Did not start intervention|1|||
23501214|NCT01091974|65576585|FG000|Overall Study|resumed sleep medication|0|||
23501215|NCT01091974|65576586|FG001|Overall Study|resumed sleep medication|0|||
23501216|NCT01091974|65576587|FG002|Overall Study|resumed sleep medication|1|||
23501217|NCT01091974|65576588|FG003|Overall Study|resumed sleep medication|2|||
23501218|NCT01091974|65576585|FG000|Overall Study|Withdrawal by Subject|1|||
23501219|NCT01091974|65576586|FG001|Overall Study|Withdrawal by Subject|3|||
23501220|NCT01091974|65576587|FG002|Overall Study|Withdrawal by Subject|2|||
23501221|NCT01091974|65576588|FG003|Overall Study|Withdrawal by Subject|2|||
23501222|NCT01091974|65576585|FG000|Overall Study|side-effects|1|||
23501223|NCT01091974|65576586|FG001|Overall Study|side-effects|1|||
23501224|NCT01091974|65576587|FG002|Overall Study|side-effects|0|||
23501225|NCT01091974|65576588|FG003|Overall Study|side-effects|2|||
23501226|NCT00289783|65576589|FG000|Primary Phase|Adverse Event|10|||
23501227|NCT00289783|65576590|FG001|Primary Phase|Adverse Event|1|||
23501228|NCT00289783|65576589|FG000|Primary Phase|Protocol Violation|27|||
23501229|NCT00289783|65576590|FG001|Primary Phase|Protocol Violation|6|||
23501230|NCT00289783|65576589|FG000|Primary Phase|Withdrawal by Subject|93|||
23501231|NCT00289783|65576590|FG001|Primary Phase|Withdrawal by Subject|40|||
23501232|NCT00289783|65576589|FG000|Primary Phase|Lost to Follow-up|60|||
23501233|NCT00289783|65576590|FG001|Primary Phase|Lost to Follow-up|14|||
23501234|NCT00289783|65576589|FG000|Primary Phase|Migration from the study area|26|||
23501235|NCT00289783|65576590|FG001|Primary Phase|Migration from the study area|10|||
23501236|NCT00289783|65576589|FG000|Primary Phase|Other|32|||
23501237|NCT00289783|65576590|FG001|Primary Phase|Other|12|||
23501238|NCT00289783|65576589|FG000|Fourth Dose Phase|Adverse Event|1|||
23501239|NCT00289783|65576590|FG001|Fourth Dose Phase|Adverse Event|0|||
23501240|NCT00289783|65576589|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
23501241|NCT00289783|65576590|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
23501242|NCT00289783|65576589|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
23501243|NCT00289783|65576590|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
23501244|NCT00289783|65576589|FG000|Fourth Dose Phase|Migration from the study area|1|||
23501245|NCT00289783|65576590|FG001|Fourth Dose Phase|Migration from the study area|1|||
23501246|NCT00289783|65576589|FG000|Fourth Dose Phase|Other|22|||
23501247|NCT00289783|65576590|FG001|Fourth Dose Phase|Other|10|||
23501248|NCT01049308|65576595|FG000|Pill Counts|Withdrawal by Subject|83|||
23501249|NCT00205881|65576596|FG000|Overall Study|Withdrawal by Subject|16|||
23501250|NCT00844896|65576597|FG000|Overall Study|Lost to Follow-up|12|||
23501251|NCT00844896|65576598|FG001|Overall Study|Lost to Follow-up|16|||
23501252|NCT00844896|65576597|FG000|Overall Study|Parents did not have time to complete|0|||
23501253|NCT00844896|65576598|FG001|Overall Study|Parents did not have time to complete|1|||
23501254|NCT02195583|65576599|FG000|Overall Study|Lost to Follow-up|1|||
23501255|NCT02195583|65576599|FG000|Overall Study|Withdrawal by Subject|4|||
23501256|NCT02195583|65576599|FG000|Overall Study|Adverse Event|2|||
23501257|NCT02195583|65576599|FG000|Overall Study|Other Reason|2|||
23501258|NCT03616600|65576600|FG000|Overall Study|Withdrawal by Subject|1|||
23501259|NCT03616600|65576601|FG001|Overall Study|Withdrawal by Subject|0|||
23501260|NCT00319553|65576604|FG000|Overall Study|Protocol Violation|1|||
23501261|NCT00319553|65576605|FG001|Overall Study|Protocol Violation|2|||
23501262|NCT00319553|65576604|FG000|Overall Study|Lost to Follow-up|2|||
23501263|NCT00319553|65576605|FG001|Overall Study|Lost to Follow-up|1|||
23501264|NCT00319553|65576604|FG000|Overall Study|Withdrawal by Subject|1|||
23501265|NCT00319553|65576605|FG001|Overall Study|Withdrawal by Subject|1|||
23501266|NCT00211510|65576606|FG000|Overall Study|Physician Decision|3|||
23501267|NCT00211510|65576607|FG001|Overall Study|Physician Decision|1|||
23501268|NCT00211510|65576606|FG000|Overall Study|Withdrawal by Subject|3|||
23501269|NCT00211510|65576607|FG001|Overall Study|Withdrawal by Subject|1|||
23501270|NCT01256008|65576608|FG000|Overall Study|Lost to Follow-up|6|||
23501271|NCT01256008|65576609|FG001|Overall Study|Lost to Follow-up|4|||
23501272|NCT01256008|65576610|FG002|Overall Study|Lost to Follow-up|11|||
23501273|NCT01256008|65576608|FG000|Overall Study|Withdrawal by Subject|2|||
23501274|NCT01256008|65576609|FG001|Overall Study|Withdrawal by Subject|3|||
23501275|NCT01256008|65576610|FG002|Overall Study|Withdrawal by Subject|10|||
23501276|NCT01774968|65576612|FG000|Overall Study|Adverse Event|4|||
23501277|NCT01774968|65576613|FG001|Overall Study|Adverse Event|4|||
23501278|NCT01774968|65576612|FG000|Overall Study|Death|0|||
23501279|NCT01774968|65576613|FG001|Overall Study|Death|1|||
23501280|NCT01774968|65576612|FG000|Overall Study|Lost to Follow-up|1|||
23501281|NCT01774968|65576613|FG001|Overall Study|Lost to Follow-up|3|||
23501282|NCT01774968|65576612|FG000|Overall Study|Physician Decision|5|||
23501283|NCT01774968|65576613|FG001|Overall Study|Physician Decision|1|||
23501284|NCT01774968|65576612|FG000|Overall Study|Protocol Violation|14|||
23501285|NCT01774968|65576613|FG001|Overall Study|Protocol Violation|13|||
23501286|NCT01774968|65576612|FG000|Overall Study|Sponsor Decision|0|||
23501287|NCT01774968|65576613|FG001|Overall Study|Sponsor Decision|2|||
23501288|NCT01774968|65576612|FG000|Overall Study|Withdrawal by Subject|6|||
23501289|NCT01774968|65576613|FG001|Overall Study|Withdrawal by Subject|11|||
23501290|NCT03173313|65576614|FG000|Overall Study|Lost to Follow-up|2|||
23501291|NCT03173313|65576615|FG001|Overall Study|Lost to Follow-up|3|||
23501292|NCT03173313|65576614|FG000|Overall Study|Withdrawal by Subject|0|||
23501293|NCT03173313|65576615|FG001|Overall Study|Withdrawal by Subject|1|||
23501294|NCT03173313|65576614|FG000|Overall Study|Death|5|||
23501295|NCT03173313|65576615|FG001|Overall Study|Death|0|||
23501296|NCT03173313|65576614|FG000|Overall Study|Physician Decision|1|||
23501297|NCT03173313|65576615|FG001|Overall Study|Physician Decision|0|||
23501298|NCT03173313|65576614|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
23501299|NCT03173313|65576615|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
23501300|NCT03173313|65576614|FG000|Overall Study|Bone Fracture|1|||
23501301|NCT03173313|65576615|FG001|Overall Study|Bone Fracture|0|||
23501302|NCT01416272|65576616|FG000|Overall Study|Unacceptable distance visual acuity|2|||
23501303|NCT01416272|65576616|FG000|Overall Study|Lost to Follow-up|1|||
23501304|NCT01416272|65576616|FG000|Overall Study|Study related complaints|1|||
23501305|NCT04112784|65576617|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
23501306|NCT04112784|65576617|FG000|Overall Study|Screen Failures|4|||
23501307|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501308|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
23501309|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501310|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
23501311|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
23501312|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501313|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501314|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501315|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501316|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501317|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501318|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501319|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501320|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501321|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
23501322|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
23501323|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
23501324|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
23501325|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501326|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501327|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501328|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501329|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501330|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501331|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501332|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501333|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501334|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501335|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501336|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
23501337|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501338|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501339|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501340|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
23501341|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501342|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501343|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501344|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501345|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501346|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501347|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501348|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501349|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501350|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501351|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
23501352|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501353|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
23501354|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501355|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501356|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501357|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501358|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501359|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501360|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501361|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501362|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501363|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501364|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501365|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501366|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
23501367|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501368|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501369|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501370|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501371|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
23501372|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501373|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501374|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501375|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501376|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501377|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501378|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501379|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501380|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501381|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
23501382|NCT01737697|65576620|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501383|NCT01737697|65576621|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
23501384|NCT01737697|65576622|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
23501385|NCT01737697|65576623|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
23501386|NCT01737697|65576624|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
23501387|NCT01737697|65576625|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501388|NCT01737697|65576626|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501389|NCT01737697|65576627|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501390|NCT01737697|65576628|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501391|NCT01737697|65576629|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501392|NCT01737697|65576630|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501393|NCT01737697|65576631|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501394|NCT01737697|65576632|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501395|NCT01737697|65576633|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501396|NCT01737697|65576634|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
23501397|NCT01737697|65576620|FG000|Subacute Phase|Adverse Event|0|||
23501398|NCT01737697|65576621|FG001|Subacute Phase|Adverse Event|0|||
23501399|NCT01737697|65576622|FG002|Subacute Phase|Adverse Event|0|||
23501400|NCT01737697|65576623|FG003|Subacute Phase|Adverse Event|0|||
23501401|NCT01737697|65576624|FG004|Subacute Phase|Adverse Event|0|||
23501402|NCT01737697|65576625|FG005|Subacute Phase|Adverse Event|1|||
23501403|NCT01737697|65576626|FG006|Subacute Phase|Adverse Event|1|||
23501404|NCT01737697|65576627|FG007|Subacute Phase|Adverse Event|1|||
23501405|NCT01737697|65576628|FG008|Subacute Phase|Adverse Event|1|||
23501406|NCT01737697|65576629|FG009|Subacute Phase|Adverse Event|1|||
23501407|NCT01737697|65576630|FG010|Subacute Phase|Adverse Event|4|||
23501408|NCT01737697|65576631|FG011|Subacute Phase|Adverse Event|1|||
23501409|NCT01737697|65576632|FG012|Subacute Phase|Adverse Event|1|||
23501410|NCT01737697|65576633|FG013|Subacute Phase|Adverse Event|0|||
23501411|NCT01737697|65576634|FG014|Subacute Phase|Adverse Event|0|||
23501412|NCT01737697|65576620|FG000|Subacute Phase|Withdrawal by Subject|0|||
23501413|NCT01737697|65576621|FG001|Subacute Phase|Withdrawal by Subject|0|||
23501414|NCT01737697|65576622|FG002|Subacute Phase|Withdrawal by Subject|0|||
23501415|NCT01737697|65576623|FG003|Subacute Phase|Withdrawal by Subject|0|||
23501416|NCT01737697|65576624|FG004|Subacute Phase|Withdrawal by Subject|0|||
23501417|NCT01737697|65576625|FG005|Subacute Phase|Withdrawal by Subject|1|||
23501418|NCT01737697|65576626|FG006|Subacute Phase|Withdrawal by Subject|0|||
23501419|NCT01737697|65576627|FG007|Subacute Phase|Withdrawal by Subject|2|||
23501420|NCT01737697|65576628|FG008|Subacute Phase|Withdrawal by Subject|0|||
23501421|NCT01737697|65576629|FG009|Subacute Phase|Withdrawal by Subject|1|||
23501422|NCT01737697|65576630|FG010|Subacute Phase|Withdrawal by Subject|0|||
23501423|NCT01737697|65576631|FG011|Subacute Phase|Withdrawal by Subject|1|||
23501424|NCT01737697|65576632|FG012|Subacute Phase|Withdrawal by Subject|1|||
23501425|NCT01737697|65576633|FG013|Subacute Phase|Withdrawal by Subject|1|||
23501426|NCT01737697|65576634|FG014|Subacute Phase|Withdrawal by Subject|0|||
23501427|NCT01737697|65576620|FG000|Subacute Phase|Lost to Follow-up|0|||
23501428|NCT01737697|65576621|FG001|Subacute Phase|Lost to Follow-up|0|||
23501429|NCT01737697|65576622|FG002|Subacute Phase|Lost to Follow-up|0|||
23501430|NCT01737697|65576623|FG003|Subacute Phase|Lost to Follow-up|0|||
23501431|NCT01737697|65576624|FG004|Subacute Phase|Lost to Follow-up|0|||
23501432|NCT01737697|65576625|FG005|Subacute Phase|Lost to Follow-up|0|||
23501433|NCT01737697|65576626|FG006|Subacute Phase|Lost to Follow-up|0|||
23501434|NCT01737697|65576627|FG007|Subacute Phase|Lost to Follow-up|0|||
23501435|NCT01737697|65576628|FG008|Subacute Phase|Lost to Follow-up|0|||
23501436|NCT01737697|65576629|FG009|Subacute Phase|Lost to Follow-up|0|||
23501437|NCT01737697|65576630|FG010|Subacute Phase|Lost to Follow-up|0|||
23501438|NCT01737697|65576631|FG011|Subacute Phase|Lost to Follow-up|0|||
23501439|NCT01737697|65576632|FG012|Subacute Phase|Lost to Follow-up|0|||
23501440|NCT01737697|65576633|FG013|Subacute Phase|Lost to Follow-up|0|||
23501441|NCT01737697|65576634|FG014|Subacute Phase|Lost to Follow-up|1|||
23501442|NCT01737697|65576620|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
23501443|NCT01737697|65576621|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
23501444|NCT01737697|65576622|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
23501445|NCT01737697|65576623|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
23501446|NCT01737697|65576624|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
23501447|NCT01737697|65576625|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
23501448|NCT01737697|65576626|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
23501449|NCT01737697|65576627|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
23501450|NCT01737697|65576628|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
23501451|NCT01737697|65576629|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
23398784|NCT00673920|65207151|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398785|NCT00673920|65207152|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398786|NCT00673920|65207153|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398787|NCT00673920|65207154|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398788|NCT00673920|65207155|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398789|NCT00673920|65207156|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
23398790|NCT00673920|65207157|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
23398791|NCT00673920|65207150|FG000|Week 24 to Week 48|Failure to return|0|||
23398792|NCT00673920|65207151|FG001|Week 24 to Week 48|Failure to return|0|||
23398793|NCT00673920|65207152|FG002|Week 24 to Week 48|Failure to return|0|||
23398794|NCT00673920|65207153|FG003|Week 24 to Week 48|Failure to return|0|||
23398795|NCT00673920|65207154|FG004|Week 24 to Week 48|Failure to return|0|||
23398796|NCT00673920|65207155|FG005|Week 24 to Week 48|Failure to return|1|||
23398797|NCT00673920|65207156|FG006|Week 24 to Week 48|Failure to return|0|||
23398798|NCT00673920|65207157|FG007|Week 24 to Week 48|Failure to return|0|||
23398799|NCT00673920|65207150|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398800|NCT00673920|65207151|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398801|NCT00673920|65207152|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398802|NCT00673920|65207153|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398803|NCT00673920|65207154|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398804|NCT00673920|65207155|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
23398805|NCT00673920|65207156|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398806|NCT00673920|65207157|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
23398807|NCT00673920|65207150|FG000|Week 24 to Week 48|Death|0|||
23398808|NCT00673920|65207151|FG001|Week 24 to Week 48|Death|0|||
23398809|NCT00673920|65207152|FG002|Week 24 to Week 48|Death|0|||
23398810|NCT00673920|65207153|FG003|Week 24 to Week 48|Death|0|||
23398811|NCT00673920|65207154|FG004|Week 24 to Week 48|Death|0|||
23398812|NCT00673920|65207155|FG005|Week 24 to Week 48|Death|1|||
23398813|NCT00673920|65207156|FG006|Week 24 to Week 48|Death|0|||
23398814|NCT00673920|65207157|FG007|Week 24 to Week 48|Death|0|||
23398815|NCT00673920|65207150|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
23398816|NCT00673920|65207151|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
23501452|NCT01737697|65576630|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
23501453|NCT01737697|65576631|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
23501454|NCT01737697|65576632|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
23501455|NCT01737697|65576633|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
23501456|NCT01737697|65576634|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
23501457|NCT01737697|65576620|FG000|Subacute Phase|Protocol Violation|0|||
23501458|NCT01737697|65576621|FG001|Subacute Phase|Protocol Violation|0|||
23501459|NCT01737697|65576622|FG002|Subacute Phase|Protocol Violation|0|||
23501460|NCT01737697|65576623|FG003|Subacute Phase|Protocol Violation|0|||
23501461|NCT01737697|65576624|FG004|Subacute Phase|Protocol Violation|0|||
23501462|NCT01737697|65576625|FG005|Subacute Phase|Protocol Violation|1|||
23501463|NCT01737697|65576626|FG006|Subacute Phase|Protocol Violation|0|||
23501464|NCT01737697|65576627|FG007|Subacute Phase|Protocol Violation|0|||
23501465|NCT01737697|65576628|FG008|Subacute Phase|Protocol Violation|0|||
23501466|NCT01737697|65576629|FG009|Subacute Phase|Protocol Violation|0|||
23501467|NCT01737697|65576630|FG010|Subacute Phase|Protocol Violation|1|||
23501468|NCT01737697|65576631|FG011|Subacute Phase|Protocol Violation|0|||
23501469|NCT01737697|65576632|FG012|Subacute Phase|Protocol Violation|0|||
23501470|NCT01737697|65576633|FG013|Subacute Phase|Protocol Violation|0|||
23501471|NCT01737697|65576634|FG014|Subacute Phase|Protocol Violation|0|||
23501472|NCT01737697|65576620|FG000|Subacute Phase|Physician Decision|0|||
23501473|NCT01737697|65576621|FG001|Subacute Phase|Physician Decision|0|||
23501474|NCT01737697|65576622|FG002|Subacute Phase|Physician Decision|0|||
23501475|NCT01737697|65576623|FG003|Subacute Phase|Physician Decision|0|||
23501476|NCT01737697|65576624|FG004|Subacute Phase|Physician Decision|0|||
23501477|NCT01737697|65576625|FG005|Subacute Phase|Physician Decision|0|||
23501478|NCT01737697|65576626|FG006|Subacute Phase|Physician Decision|0|||
23501479|NCT01737697|65576627|FG007|Subacute Phase|Physician Decision|0|||
23501480|NCT01737697|65576628|FG008|Subacute Phase|Physician Decision|1|||
23501481|NCT01737697|65576629|FG009|Subacute Phase|Physician Decision|0|||
23501482|NCT01737697|65576630|FG010|Subacute Phase|Physician Decision|0|||
23501483|NCT01737697|65576631|FG011|Subacute Phase|Physician Decision|0|||
23501484|NCT01737697|65576632|FG012|Subacute Phase|Physician Decision|0|||
23501485|NCT01737697|65576633|FG013|Subacute Phase|Physician Decision|0|||
23501486|NCT01737697|65576634|FG014|Subacute Phase|Physician Decision|0|||
23501487|NCT01737697|65576620|FG000|Subacute Phase|Death|0|||
23501488|NCT01737697|65576621|FG001|Subacute Phase|Death|0|||
23501489|NCT01737697|65576622|FG002|Subacute Phase|Death|0|||
23501490|NCT01737697|65576623|FG003|Subacute Phase|Death|0|||
23501491|NCT01737697|65576624|FG004|Subacute Phase|Death|0|||
23501492|NCT01737697|65576625|FG005|Subacute Phase|Death|0|||
23501493|NCT01737697|65576626|FG006|Subacute Phase|Death|0|||
23501494|NCT01737697|65576627|FG007|Subacute Phase|Death|0|||
23501495|NCT01737697|65576628|FG008|Subacute Phase|Death|0|||
23501496|NCT01737697|65576629|FG009|Subacute Phase|Death|0|||
23501497|NCT01737697|65576630|FG010|Subacute Phase|Death|1|||
23501498|NCT01737697|65576631|FG011|Subacute Phase|Death|0|||
23501499|NCT01737697|65576632|FG012|Subacute Phase|Death|0|||
23501500|NCT01737697|65576633|FG013|Subacute Phase|Death|0|||
23501501|NCT01737697|65576634|FG014|Subacute Phase|Death|0|||
23501502|NCT00558558|65576635|FG000|Overall Study|Unable to swallow|1|||
23501503|NCT00558558|65576635|FG000|Overall Study|Withdrawal by Subject|1|||
23501504|NCT00558558|65576635|FG000|Overall Study|Lack of Efficacy|4|||
23501505|NCT00279305|65576636|FG000|Overall Study|Pregnancy|1|||
23501506|NCT00279305|65576637|FG001|Overall Study|Pregnancy|0|||
23501507|NCT00279305|65576636|FG000|Overall Study|Withdrawal by Subject|2|||
23501508|NCT00279305|65576637|FG001|Overall Study|Withdrawal by Subject|0|||
23501509|NCT00279305|65576636|FG000|Overall Study|Dificulting establishing IV|1|||
23501510|NCT00279305|65576637|FG001|Overall Study|Dificulting establishing IV|0|||
23501511|NCT00279305|65576636|FG000|Overall Study|FDA Safety Alert|4|||
23501512|NCT00279305|65576637|FG001|Overall Study|FDA Safety Alert|1|||
23501513|NCT01546207|65576640|FG000|Overall Study|Death|1|||
23501514|NCT02695329|65576641|FG000|Overall Study|Adverse Event|1|||
23501515|NCT02695329|65576642|FG001|Overall Study|Adverse Event|0|||
23501516|NCT02695329|65576641|FG000|Overall Study|Poor X-ray quality for measurement|4|||
23501517|NCT02695329|65576642|FG001|Overall Study|Poor X-ray quality for measurement|5|||
23501518|NCT01169493|65576643|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
23501519|NCT01169493|65576644|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
23501520|NCT01169493|65576645|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
23501521|NCT01169493|65576646|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
23501522|NCT01169493|65576647|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
23501523|NCT01169493|65576648|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
23501524|NCT01169493|65576643|FG000|Period 3 (6 Months)|Adverse Event|0|||
23501525|NCT01169493|65576644|FG001|Period 3 (6 Months)|Adverse Event|1|||
23501526|NCT01169493|65576645|FG002|Period 3 (6 Months)|Adverse Event|0|||
23300708|NCT01846273|64842899|FG001|Overall Study|Lost to Follow-up|1|||
23501527|NCT01169493|65576646|FG003|Period 3 (6 Months)|Adverse Event|0|||
23501528|NCT01169493|65576647|FG004|Period 3 (6 Months)|Adverse Event|0|||
23501529|NCT01169493|65576648|FG005|Period 3 (6 Months)|Adverse Event|0|||
23501530|NCT01169493|65576643|FG000|Period 3 (6 Months)|Physician Decision|0|||
23501531|NCT01169493|65576644|FG001|Period 3 (6 Months)|Physician Decision|1|||
23501532|NCT01169493|65576645|FG002|Period 3 (6 Months)|Physician Decision|1|||
23501533|NCT01169493|65576646|FG003|Period 3 (6 Months)|Physician Decision|0|||
23501534|NCT01169493|65576647|FG004|Period 3 (6 Months)|Physician Decision|0|||
23501535|NCT01169493|65576648|FG005|Period 3 (6 Months)|Physician Decision|0|||
23501536|NCT02499783|65576649|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
23501537|NCT02499783|65576650|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
23501538|NCT02499783|65576651|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
23501539|NCT02499783|65576649|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
23501540|NCT02499783|65576650|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
23501541|NCT02499783|65576651|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
23501542|NCT02499783|65576649|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
23501543|NCT02499783|65576650|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
23501544|NCT02499783|65576651|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
23501545|NCT02499783|65576649|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
23501546|NCT02499783|65576650|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
23501547|NCT02499783|65576651|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
23501548|NCT02499783|65576649|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
23501549|NCT02499783|65576650|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
23501550|NCT02499783|65576651|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
23501551|NCT02499783|65576649|FG000|DB Period: Weeks 0-8|Other|1|||
23501552|NCT02499783|65576650|FG001|DB Period: Weeks 0-8|Other|1|||
23501553|NCT02499783|65576651|FG002|DB Period: Weeks 0-8|Other|0|||
23501554|NCT02499783|65576649|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
23501555|NCT02499783|65576650|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
23501556|NCT02499783|65576651|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
23501557|NCT02499783|65576649|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
23501558|NCT02499783|65576650|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
23501559|NCT02499783|65576651|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
23501560|NCT02499783|65576649|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
23501561|NCT02499783|65576650|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
23501562|NCT02499783|65576651|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
23501563|NCT02499783|65576649|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
23501564|NCT02499783|65576650|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
23501565|NCT02499783|65576651|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
23501566|NCT02854631|65576654|FG000|Overall Study|Adverse Event|1|||
23501567|NCT02854631|65576655|FG001|Overall Study|Adverse Event|2|||
23501568|NCT02854631|65576654|FG000|Overall Study|Withdrew Consent|3|||
23501569|NCT02854631|65576655|FG001|Overall Study|Withdrew Consent|2|||
23501570|NCT02854631|65576654|FG000|Overall Study|Investigator's Discretion|2|||
23501571|NCT02854631|65576655|FG001|Overall Study|Investigator's Discretion|0|||
23501572|NCT02854631|65576654|FG000|Overall Study|Death|12|||
23501573|NCT02854631|65576655|FG001|Overall Study|Death|8|||
23501574|NCT02854631|65576654|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
23501575|NCT02854631|65576655|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
23501576|NCT02854631|65576654|FG000|Overall Study|Protocol Violation|0|||
23501577|NCT02854631|65576655|FG001|Overall Study|Protocol Violation|1|||
23501578|NCT02854631|65576654|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
23501579|NCT02854631|65576655|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
23501580|NCT02854631|65576654|FG000|Overall Study|Lost to Follow-up|4|||
23501581|NCT02854631|65576655|FG001|Overall Study|Lost to Follow-up|2|||
23501582|NCT01010061|65576656|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
23501583|NCT01010061|65576657|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
23501584|NCT01010061|65576656|FG000|Overall Study|Disease Progression|2|||
23501585|NCT01010061|65576657|FG001|Overall Study|Disease Progression|8|||
23501586|NCT01010061|65576656|FG000|Overall Study|Withdrew Consent|5|||
23501587|NCT01010061|65576657|FG001|Overall Study|Withdrew Consent|1|||
23501588|NCT01010061|65576656|FG000|Overall Study|Death|3|||
23501589|NCT01010061|65576657|FG001|Overall Study|Death|6|||
23501590|NCT01010061|65576656|FG000|Overall Study|Administrative/Other|0|||
23501591|NCT01010061|65576657|FG001|Overall Study|Administrative/Other|1|||
23501592|NCT01010061|65576656|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
23501593|NCT01010061|65576657|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
23501594|NCT01010061|65576656|FG000|Overall Study|Insufficient Therapeutic Response|1|||
23501595|NCT01010061|65576657|FG001|Overall Study|Insufficient Therapeutic Response|5|||
23501596|NCT01010061|65576656|FG000|Overall Study|Violation of Selection Criteria|0|||
23501597|NCT01010061|65576657|FG001|Overall Study|Violation of Selection Criteria|1|||
23501598|NCT01010061|65576656|FG000|Overall Study|Did Not Receive Treatment|2|||
23501599|NCT01010061|65576657|FG001|Overall Study|Did Not Receive Treatment|2|||
23501600|NCT02469298|65576669|FG000|Overall Study|Protocol Violation|0|||
23501601|NCT02469298|65576670|FG001|Overall Study|Protocol Violation|1|||
23501602|NCT02469298|65576671|FG002|Overall Study|Protocol Violation|1|||
23501603|NCT02469298|65576672|FG003|Overall Study|Protocol Violation|0|||
23501604|NCT02469298|65576669|FG000|Overall Study|Lost to Follow-up|1|||
23501605|NCT02469298|65576670|FG001|Overall Study|Lost to Follow-up|0|||
23501606|NCT02469298|65576671|FG002|Overall Study|Lost to Follow-up|1|||
23501607|NCT02469298|65576672|FG003|Overall Study|Lost to Follow-up|0|||
23501608|NCT02469298|65576669|FG000|Overall Study|Physician Decision|0|||
23501609|NCT02469298|65576670|FG001|Overall Study|Physician Decision|0|||
23501610|NCT02469298|65576671|FG002|Overall Study|Physician Decision|0|||
23501611|NCT02469298|65576672|FG003|Overall Study|Physician Decision|1|||
23501612|NCT02469298|65576669|FG000|Overall Study|Withdrawal by Subject|0|||
23501613|NCT02469298|65576670|FG001|Overall Study|Withdrawal by Subject|0|||
23501614|NCT02469298|65576671|FG002|Overall Study|Withdrawal by Subject|0|||
23501615|NCT02469298|65576672|FG003|Overall Study|Withdrawal by Subject|1|||
23501616|NCT01389817|65576673|FG000|Overall Study|Physician Decision|1|||
23501617|NCT01389817|65576674|FG001|Overall Study|Physician Decision|0|||
23501618|NCT01389817|65576673|FG000|Overall Study|Lost to Follow-up|1|||
23501619|NCT01389817|65576674|FG001|Overall Study|Lost to Follow-up|0|||
23501620|NCT01389817|65576673|FG000|Overall Study|Withdrawal by Subject|2|||
23501621|NCT01389817|65576674|FG001|Overall Study|Withdrawal by Subject|0|||
23501622|NCT05570500|65576676|FG000|Overall Study|Lost to Follow-up|7|||
23501623|NCT05570500|65576677|FG001|Overall Study|Lost to Follow-up|5|||
23501624|NCT00481078|65576680|FG000|Overall Study|Progression of disease|11|||
23501625|NCT00481078|65576681|FG001|Overall Study|Progression of disease|11|||
23501626|NCT00481078|65576680|FG000|Overall Study|Adverse Event|15|||
23501627|NCT00481078|65576681|FG001|Overall Study|Adverse Event|3|||
23501628|NCT00481078|65576680|FG000|Overall Study|Death|5|||
23501629|NCT00481078|65576681|FG001|Overall Study|Death|3|||
23501630|NCT00481078|65576680|FG000|Overall Study|Intercurrent illness|1|||
23501631|NCT00481078|65576681|FG001|Overall Study|Intercurrent illness|0|||
23501632|NCT00481078|65576680|FG000|Overall Study|Withdrawal by Subject|7|||
23501633|NCT00481078|65576681|FG001|Overall Study|Withdrawal by Subject|1|||
23501634|NCT00481078|65576680|FG000|Overall Study|Information not available|1|||
23501635|NCT00481078|65576681|FG001|Overall Study|Information not available|0|||
23501636|NCT00481078|65576680|FG000|Overall Study|Received other treatment|2|||
23501637|NCT00481078|65576681|FG001|Overall Study|Received other treatment|1|||
23501638|NCT00481078|65576680|FG000|Overall Study|Brain metastasis|0|||
23501639|NCT00481078|65576681|FG001|Overall Study|Brain metastasis|1|||
23501640|NCT00713323|65576682|FG000|Overall Study|Adverse Event|75|||
23501641|NCT00713323|65576682|FG000|Overall Study|Withdrawal by Subject|15|||
23501642|NCT00713323|65576682|FG000|Overall Study|Lost to Follow-up|11|||
23501643|NCT00713323|65576682|FG000|Overall Study|Lack of Efficacy|36|||
23501644|NCT00713323|65576682|FG000|Overall Study|Low creatine clearance at screening|1|||
23501645|NCT00713323|65576682|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
23501646|NCT00713323|65576682|FG000|Overall Study|Surgery cured allodynic pain|1|||
23501647|NCT00713323|65576682|FG000|Overall Study|Pain free|1|||
23501648|NCT00713323|65576682|FG000|Overall Study|Non-compliance|1|||
23501649|NCT00713323|65576682|FG000|Overall Study|Pain resolved|1|||
23501650|NCT00713323|65576682|FG000|Overall Study|Subject travelling to USA|1|||
23501651|NCT00713323|65576682|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
23501652|NCT00713323|65576682|FG000|Overall Study|Treatment that may interact with Sativex|1|||
23501653|NCT02021331|65576685|FG000|Overall Study|Adverse Event|0|||
23501654|NCT02021331|65576686|FG001|Overall Study|Adverse Event|2|||
23501655|NCT01513343|65576691|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
23501656|NCT01513343|65576692|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
23501657|NCT01513343|65576691|FG000|Post Data Collection|Dropped/withdrew from study|7|||
23501658|NCT01513343|65576692|FG001|Post Data Collection|Dropped/withdrew from study|1|||
23501659|NCT01513343|65576691|FG000|Post Data Collection|Lost to Follow-up|10|||
23501660|NCT01513343|65576692|FG001|Post Data Collection|Lost to Follow-up|23|||
23501661|NCT01513343|65576691|FG000|6-month Follow-up|Lost to Follow-up|28|||
23501662|NCT01513343|65576692|FG001|6-month Follow-up|Lost to Follow-up|17|||
23501663|NCT01513343|65576691|FG000|12-month Follow-up|Lost to Follow-up|10|||
23501664|NCT01513343|65576692|FG001|12-month Follow-up|Lost to Follow-up|3|||
23501665|NCT04661839|65576693|FG000|Overall Study|Not Treated|0|||
23501666|NCT04661839|65576694|FG001|Overall Study|Not Treated|0|||
23501667|NCT04661839|65576695|FG002|Overall Study|Not Treated|1|||
23501668|NCT04661839|65576696|FG003|Overall Study|Not Treated|0|||
23501669|NCT04661839|65576693|FG000|Overall Study|Lost to Follow-up|1|||
23501670|NCT04661839|65576694|FG001|Overall Study|Lost to Follow-up|0|||
23501671|NCT04661839|65576695|FG002|Overall Study|Lost to Follow-up|0|||
23501672|NCT04661839|65576696|FG003|Overall Study|Lost to Follow-up|1|||
23501673|NCT04752475|65576701|FG000|Overall Study|Withdrawal by Subject|1|||
23501674|NCT04752475|65576702|FG001|Overall Study|Withdrawal by Subject|1|||
23501675|NCT01858389|65576704|FG000|Overall Study|Death|1|||
23501676|NCT01858389|65576705|FG001|Overall Study|Death|3|||
23501677|NCT01858389|65576704|FG000|Overall Study|Study terminated by sponsor|0|||
23501678|NCT01858389|65576705|FG001|Overall Study|Study terminated by sponsor|2|||
23501679|NCT01858389|65576704|FG000|Overall Study|Withdrawal by Subject|0|||
23501680|NCT01858389|65576705|FG001|Overall Study|Withdrawal by Subject|1|||
23501681|NCT01858389|65576704|FG000|Overall Study|Progressive disease|10|||
23501682|NCT01858389|65576705|FG001|Overall Study|Progressive disease|11|||
23501683|NCT01858389|65576704|FG000|Overall Study|Other|2|||
23501684|NCT01858389|65576705|FG001|Overall Study|Other|4|||
23501685|NCT01858389|65576704|FG000|Overall Study|Adverse Event|3|||
23501686|NCT01858389|65576705|FG001|Overall Study|Adverse Event|1|||
23501687|NCT01858389|65576704|FG000|Overall Study|Did not receive treatment|0|||
23501688|NCT01858389|65576705|FG001|Overall Study|Did not receive treatment|3|||
23501689|NCT00640601|65576709|FG000|Overall Study|Adverse Event|43|||
23501690|NCT00640601|65576709|FG000|Overall Study|Withdrawal by Subject|20|||
23501691|NCT00640601|65576709|FG000|Overall Study|Protocol Violation|6|||
23501692|NCT00640601|65576709|FG000|Overall Study|Lack of Efficacy|16|||
23501693|NCT00640601|65576709|FG000|Overall Study|Lost to Follow-up|9|||
23501694|NCT00640601|65576709|FG000|Overall Study|Physician Decision|8|||
23501695|NCT00640601|65576709|FG000|Overall Study|treatment naive, combination therapy|10|||
23501696|NCT02321800|65576712|FG000|Overall Study|Withdrawal by Subject|3|||
23501697|NCT02321800|65576713|FG001|Overall Study|Withdrawal by Subject|3|||
23501698|NCT02321800|65576712|FG000|Overall Study|Death|1|||
23501699|NCT02321800|65576713|FG001|Overall Study|Death|0|||
23501700|NCT02321800|65576712|FG000|Overall Study|Protocol Violation|1|||
23501701|NCT02321800|65576713|FG001|Overall Study|Protocol Violation|0|||
23501702|NCT02321800|65576712|FG000|Overall Study|Lost to Follow-up|10|||
23501703|NCT02321800|65576713|FG001|Overall Study|Lost to Follow-up|4|||
23501704|NCT02321800|65576712|FG000|Overall Study|Adverse Event|2|||
23501705|NCT02321800|65576713|FG001|Overall Study|Adverse Event|3|||
23501706|NCT02321800|65576712|FG000|Overall Study|Other, Miscellaneous|3|||
23501707|NCT02321800|65576713|FG001|Overall Study|Other, Miscellaneous|1|||
23501708|NCT02059395|65576714|FG000|Overall Study|Lost to Follow-up|2|||
23501709|NCT02059395|65576715|FG001|Overall Study|Lost to Follow-up|4|||
23501710|NCT01708161|65576716|FG000|Overall Study|Adverse Event|1|||
23501711|NCT01708161|65576717|FG001|Overall Study|Adverse Event|3|||
23501712|NCT01708161|65576718|FG002|Overall Study|Adverse Event|4|||
23501713|NCT01708161|65576719|FG003|Overall Study|Adverse Event|2|||
23501714|NCT01708161|65576720|FG004|Overall Study|Adverse Event|3|||
23501715|NCT01708161|65576721|FG005|Overall Study|Adverse Event|0|||
23501716|NCT01708161|65576716|FG000|Overall Study|Death|0|||
23501717|NCT01708161|65576717|FG001|Overall Study|Death|0|||
23501718|NCT01708161|65576718|FG002|Overall Study|Death|0|||
23501719|NCT01708161|65576719|FG003|Overall Study|Death|1|||
23501720|NCT01708161|65576720|FG004|Overall Study|Death|0|||
23501721|NCT01708161|65576721|FG005|Overall Study|Death|1|||
23501722|NCT01708161|65576716|FG000|Overall Study|Withdrawal by Subject|0|||
23501723|NCT01708161|65576717|FG001|Overall Study|Withdrawal by Subject|1|||
23501724|NCT01708161|65576718|FG002|Overall Study|Withdrawal by Subject|1|||
23501725|NCT01708161|65576719|FG003|Overall Study|Withdrawal by Subject|0|||
23501726|NCT01708161|65576720|FG004|Overall Study|Withdrawal by Subject|0|||
23501727|NCT01708161|65576721|FG005|Overall Study|Withdrawal by Subject|0|||
23501728|NCT01708161|65576716|FG000|Overall Study|Administrative problems|0|||
23501729|NCT01708161|65576717|FG001|Overall Study|Administrative problems|1|||
23501730|NCT01708161|65576718|FG002|Overall Study|Administrative problems|0|||
23501731|NCT01708161|65576719|FG003|Overall Study|Administrative problems|0|||
23501732|NCT01708161|65576720|FG004|Overall Study|Administrative problems|0|||
23501733|NCT01708161|65576721|FG005|Overall Study|Administrative problems|0|||
23501734|NCT01708161|65576716|FG000|Overall Study|Disease progression|3|||
23501735|NCT01708161|65576717|FG001|Overall Study|Disease progression|5|||
23501736|NCT01708161|65576718|FG002|Overall Study|Disease progression|5|||
23501737|NCT01708161|65576719|FG003|Overall Study|Disease progression|13|||
23501738|NCT01708161|65576720|FG004|Overall Study|Disease progression|3|||
23501739|NCT01708161|65576721|FG005|Overall Study|Disease progression|0|||
23501740|NCT03868124|65576722|FG000|Overall Study|Withdrawal by Subject|4|||
23501741|NCT03868124|65576723|FG001|Overall Study|Withdrawal by Subject|0|||
23501742|NCT03868124|65576724|FG002|Overall Study|Withdrawal by Subject|1|||
23501743|NCT03868124|65576722|FG000|Overall Study|Physician Decision|1|||
23501744|NCT03868124|65576723|FG001|Overall Study|Physician Decision|0|||
23501745|NCT03868124|65576724|FG002|Overall Study|Physician Decision|1|||
23501746|NCT03868124|65576722|FG000|Overall Study|Lost to Follow-up|1|||
23501747|NCT03868124|65576723|FG001|Overall Study|Lost to Follow-up|1|||
23501748|NCT03868124|65576724|FG002|Overall Study|Lost to Follow-up|2|||
23501749|NCT03868124|65576722|FG000|Overall Study|Death|1|||
23501750|NCT03868124|65576723|FG001|Overall Study|Death|1|||
23501751|NCT03868124|65576724|FG002|Overall Study|Death|2|||
23501752|NCT03868124|65576722|FG000|Overall Study|Adverse Event|0|||
23501753|NCT03868124|65576723|FG001|Overall Study|Adverse Event|0|||
23501754|NCT03868124|65576724|FG002|Overall Study|Adverse Event|3|||
23501755|NCT03868124|65576722|FG000|Overall Study|Explanted|2|||
23501756|NCT03868124|65576723|FG001|Overall Study|Explanted|1|||
23501757|NCT03868124|65576724|FG002|Overall Study|Explanted|0|||
23501758|NCT03868124|65576722|FG000|Overall Study|Ongoing in study|176|||
23501759|NCT03868124|65576723|FG001|Overall Study|Ongoing in study|180|||
23501760|NCT03868124|65576724|FG002|Overall Study|Ongoing in study|183|||
23501761|NCT01782222|65576725|FG000|Overall Study|Adverse Event|4|||
23501762|NCT01782222|65576726|FG001|Overall Study|Adverse Event|5|||
23501763|NCT01782222|65576727|FG002|Overall Study|Adverse Event|3|||
23501764|NCT01782222|65576725|FG000|Overall Study|Lack of Efficacy|2|||
23501765|NCT01782222|65576726|FG001|Overall Study|Lack of Efficacy|1|||
23501766|NCT01782222|65576727|FG002|Overall Study|Lack of Efficacy|0|||
23501767|NCT01782222|65576725|FG000|Overall Study|Protocol Violation|1|||
23501768|NCT01782222|65576726|FG001|Overall Study|Protocol Violation|0|||
23501769|NCT01782222|65576727|FG002|Overall Study|Protocol Violation|0|||
23501770|NCT01782222|65576725|FG000|Overall Study|Withdrawal by Subject|1|||
23501771|NCT01782222|65576726|FG001|Overall Study|Withdrawal by Subject|4|||
23501772|NCT01782222|65576727|FG002|Overall Study|Withdrawal by Subject|1|||
23501773|NCT01782222|65576725|FG000|Overall Study|Moved to other state|0|||
23501774|NCT01782222|65576726|FG001|Overall Study|Moved to other state|1|||
23501775|NCT01782222|65576727|FG002|Overall Study|Moved to other state|0|||
23501776|NCT00923156|65576728|FG000|Overall Study|Adverse Event|0|||
23501777|NCT00923156|65576729|FG001|Overall Study|Adverse Event|2|||
23501778|NCT00923156|65576730|FG002|Overall Study|Adverse Event|1|||
23501779|NCT00923156|65576728|FG000|Overall Study|Abnormal laboratory values|0|||
23501780|NCT00923156|65576729|FG001|Overall Study|Abnormal laboratory values|0|||
23501781|NCT00923156|65576730|FG002|Overall Study|Abnormal laboratory values|1|||
23501782|NCT00923156|65576728|FG000|Overall Study|Withdrawal by Subject|0|||
23501783|NCT00923156|65576729|FG001|Overall Study|Withdrawal by Subject|1|||
23501784|NCT00923156|65576730|FG002|Overall Study|Withdrawal by Subject|0|||
23501785|NCT00923156|65576728|FG000|Overall Study|Death|0|||
23501786|NCT00923156|65576729|FG001|Overall Study|Death|1|||
23501787|NCT00923156|65576730|FG002|Overall Study|Death|0|||
23501788|NCT00923156|65576728|FG000|Overall Study|Lack of Efficacy|0|||
23501789|NCT00923156|65576729|FG001|Overall Study|Lack of Efficacy|0|||
23501790|NCT00923156|65576730|FG002|Overall Study|Lack of Efficacy|1|||
23501791|NCT00873015|65576731|FG000|Overall Study|Withdrawal by Subject|0|||
23501792|NCT00873015|65576732|FG001|Overall Study|Withdrawal by Subject|1|||
23501793|NCT00873015|65576733|FG002|Overall Study|Withdrawal by Subject|0|||
23501794|NCT00873015|65576734|FG003|Overall Study|Withdrawal by Subject|0|||
23606478|NCT02446015|65947259|FG000|Overall Study|Withdrawal by Subject|1|||
23606479|NCT02446015|65947260|FG001|Overall Study|Withdrawal by Subject|0|||
23606480|NCT03052517|65947261|FG000|Overall Study|Study Terminated By Sponsor|928|||
23606481|NCT03052517|65947262|FG001|Overall Study|Study Terminated By Sponsor|938|||
23606482|NCT03052517|65947263|FG002|Overall Study|Study Terminated By Sponsor|296|||
23606483|NCT03052517|65947261|FG000|Overall Study|Subject/Guardian Decision|50|||
23606484|NCT03052517|65947262|FG001|Overall Study|Subject/Guardian Decision|45|||
23606485|NCT03052517|65947263|FG002|Overall Study|Subject/Guardian Decision|22|||
23606486|NCT03052517|65947261|FG000|Overall Study|Lack of Efficacy|23|||
23606487|NCT03052517|65947262|FG001|Overall Study|Lack of Efficacy|14|||
23606488|NCT03052517|65947263|FG002|Overall Study|Lack of Efficacy|7|||
23606489|NCT03052517|65947261|FG000|Overall Study|Adverse Event|6|||
23606490|NCT03052517|65947262|FG001|Overall Study|Adverse Event|5|||
23606491|NCT03052517|65947263|FG002|Overall Study|Adverse Event|0|||
23606492|NCT03052517|65947261|FG000|Overall Study|Physician Decision|4|||
23606493|NCT03052517|65947262|FG001|Overall Study|Physician Decision|5|||
23606494|NCT03052517|65947263|FG002|Overall Study|Physician Decision|1|||
23606495|NCT03052517|65947261|FG000|Overall Study|Death|3|||
23606496|NCT03052517|65947262|FG001|Overall Study|Death|0|||
23606497|NCT03052517|65947263|FG002|Overall Study|Death|1|||
23606498|NCT03052517|65947261|FG000|Overall Study|Lost to Follow-up|2|||
23606499|NCT03052517|65947262|FG001|Overall Study|Lost to Follow-up|4|||
23606500|NCT03052517|65947263|FG002|Overall Study|Lost to Follow-up|0|||
23606501|NCT03052517|65947261|FG000|Overall Study|Pregnancy|1|||
23606502|NCT03052517|65947262|FG001|Overall Study|Pregnancy|0|||
23606503|NCT03052517|65947263|FG002|Overall Study|Pregnancy|1|||
23606504|NCT03052517|65947261|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
23606505|NCT03052517|65947262|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
23606506|NCT03052517|65947263|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
23606507|NCT03052517|65947261|FG000|Overall Study|Technical Problems|0|||
23606508|NCT03052517|65947262|FG001|Overall Study|Technical Problems|1|||
23606509|NCT03052517|65947263|FG002|Overall Study|Technical Problems|0|||
23606510|NCT00657709|65947266|FG000|Overall Study|AE or Death|7|||
23606511|NCT00657709|65947267|FG001|Overall Study|AE or Death|7|||
23606512|NCT00657709|65947268|FG002|Overall Study|AE or Death|6|||
23606513|NCT00657709|65947269|FG003|Overall Study|AE or Death|7|||
23606514|NCT00657709|65947270|FG004|Overall Study|AE or Death|1|||
23606515|NCT00657709|65947266|FG000|Overall Study|Withdrawal by Subject|7|||
23606516|NCT00657709|65947267|FG001|Overall Study|Withdrawal by Subject|15|||
23606517|NCT00657709|65947268|FG002|Overall Study|Withdrawal by Subject|15|||
23606518|NCT00657709|65947269|FG003|Overall Study|Withdrawal by Subject|5|||
23606519|NCT00657709|65947270|FG004|Overall Study|Withdrawal by Subject|9|||
23606520|NCT00657709|65947266|FG000|Overall Study|Lost to Follow-up|9|||
23606521|NCT00657709|65947267|FG001|Overall Study|Lost to Follow-up|9|||
23606522|NCT00657709|65947268|FG002|Overall Study|Lost to Follow-up|7|||
23501795|NCT02256631|65580043|FG000|Overall Study|Lost to Follow-up|1|||
23501796|NCT02256631|65580044|FG001|Overall Study|Lost to Follow-up|1|||
23501797|NCT02256631|65580045|FG002|Overall Study|Lost to Follow-up|0|||
23501798|NCT02256631|65580046|FG003|Overall Study|Lost to Follow-up|2|||
23501799|NCT02256631|65580047|FG004|Overall Study|Lost to Follow-up|0|||
23501800|NCT02256631|65580048|FG005|Overall Study|Lost to Follow-up|4|||
23501801|NCT02256631|65580049|FG006|Overall Study|Lost to Follow-up|1|||
23501802|NCT02256631|65580043|FG000|Overall Study|Withdrawal by Subject|0|||
23501803|NCT02256631|65580044|FG001|Overall Study|Withdrawal by Subject|0|||
23501804|NCT02256631|65580045|FG002|Overall Study|Withdrawal by Subject|0|||
23501805|NCT02256631|65580046|FG003|Overall Study|Withdrawal by Subject|1|||
23501806|NCT02256631|65580047|FG004|Overall Study|Withdrawal by Subject|1|||
23501807|NCT02256631|65580048|FG005|Overall Study|Withdrawal by Subject|0|||
23501808|NCT02256631|65580049|FG006|Overall Study|Withdrawal by Subject|1|||
23501809|NCT02256631|65580043|FG000|Overall Study|Unable to get to clinic|0|||
23501810|NCT02256631|65580044|FG001|Overall Study|Unable to get to clinic|2|||
23501811|NCT02256631|65580045|FG002|Overall Study|Unable to get to clinic|0|||
23501812|NCT02256631|65580046|FG003|Overall Study|Unable to get to clinic|1|||
23501813|NCT02256631|65580047|FG004|Overall Study|Unable to get to clinic|0|||
23501814|NCT02256631|65580048|FG005|Overall Study|Unable to get to clinic|1|||
23501815|NCT02256631|65580049|FG006|Overall Study|Unable to get to clinic|2|||
23501816|NCT00039130|65580050|FG000|Overall Study|Adverse Event|11|||
23501817|NCT00039130|65580050|FG000|Overall Study|Death|9|||
23501818|NCT00039130|65580050|FG000|Overall Study|Withdrawal by Subject|3|||
23501819|NCT00039130|65580050|FG000|Overall Study|Progression|2|||
23501820|NCT00039130|65580050|FG000|Overall Study|Subsequent treatment|2|||
23501821|NCT00039130|65580050|FG000|Overall Study|Physician Decision|3|||
23501822|NCT03845985|65580053|FG000|Overall Study|Lost to Follow-up|2|||
23501823|NCT03845985|65580054|FG001|Overall Study|Lost to Follow-up|1|||
23501824|NCT03845985|65580053|FG000|Overall Study|Physician Decision|1|||
23501825|NCT03845985|65580054|FG001|Overall Study|Physician Decision|0|||
23501826|NCT03845985|65580053|FG000|Overall Study|Withdrawal by Subject|4|||
23501827|NCT03845985|65580054|FG001|Overall Study|Withdrawal by Subject|1|||
23501828|NCT02521870|65580062|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501829|NCT02521870|65580063|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
23501830|NCT02521870|65580064|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501831|NCT02521870|65580065|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501832|NCT02521870|65580066|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501833|NCT02521870|65580067|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501834|NCT02521870|65580068|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501835|NCT02521870|65580069|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501836|NCT02521870|65580070|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501837|NCT02521870|65580071|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501838|NCT02521870|65580072|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501839|NCT02521870|65580073|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
23501840|NCT02521870|65580062|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
23501841|NCT02521870|65580063|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
23501842|NCT02521870|65580064|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
23501843|NCT02521870|65580065|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
23501844|NCT02521870|65580066|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
23501845|NCT02521870|65580067|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
23501846|NCT02521870|65580068|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
23501847|NCT02521870|65580069|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
23501848|NCT02521870|65580070|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
23501849|NCT02521870|65580071|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
23501850|NCT02521870|65580072|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
23501851|NCT02521870|65580073|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
23501852|NCT02521870|65580062|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
23501853|NCT02521870|65580063|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
23501854|NCT02521870|65580064|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
23501855|NCT02521870|65580065|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
23501856|NCT02521870|65580066|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
23501857|NCT02521870|65580067|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
23501858|NCT02521870|65580068|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
23501859|NCT02521870|65580069|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
23501860|NCT02521870|65580070|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
23501861|NCT02521870|65580071|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
23501862|NCT02521870|65580072|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
23501863|NCT02521870|65580073|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
23501864|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501865|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501866|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501867|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501868|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
23501869|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
23501870|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
23501871|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501872|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
23501873|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
23501874|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
23501875|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
23501876|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
23501877|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
23501878|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
23501879|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
23501880|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
23501881|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
23501882|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
23501883|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
23501884|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
23501885|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
23501886|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
23501887|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
23501888|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
23501889|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
23501890|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
23501891|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
23501892|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
23501893|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
23501894|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
23501895|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
23501896|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
23501897|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
23501898|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
23501899|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
23501900|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Death|0|||
23501901|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Death|0|||
23501902|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Death|0|||
23501903|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Death|0|||
23501904|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Death|1|||
23501905|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Death|1|||
23501906|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Death|3|||
23501907|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Death|1|||
23501908|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Death|1|||
23501909|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Death|5|||
23501910|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Death|2|||
23501911|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Death|2|||
23501912|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Other|0|||
23501913|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Other|0|||
23501914|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Other|0|||
23501915|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Other|0|||
23501916|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Other|10|||
23501917|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Other|3|||
23501918|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Other|2|||
23501919|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Other|0|||
23501920|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Other|10|||
23501921|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Other|5|||
23501922|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Other|1|||
23501923|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Other|7|||
23501924|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501925|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501926|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501927|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501928|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
23501929|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501930|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501931|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501932|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501933|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501934|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501935|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
23501936|NCT02521870|65580062|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501937|NCT02521870|65580063|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501938|NCT02521870|65580064|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501939|NCT02521870|65580065|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501940|NCT02521870|65580066|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
23501941|NCT02521870|65580067|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501942|NCT02521870|65580068|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23606523|NCT00657709|65947269|FG003|Overall Study|Lost to Follow-up|1|||
23501943|NCT02521870|65580069|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501944|NCT02521870|65580070|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501945|NCT02521870|65580071|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501946|NCT02521870|65580072|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501947|NCT02521870|65580073|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
23501948|NCT02165215|65580074|FG000|Induction Phase|Adverse Event|1|||
23501949|NCT02165215|65580075|FG001|Induction Phase|Adverse Event|0|||
23501950|NCT02165215|65580076|FG002|Induction Phase|Adverse Event|0|||
23501951|NCT02165215|65580074|FG000|Induction Phase|Withdrawal by Subject|10|||
23501952|NCT02165215|65580075|FG001|Induction Phase|Withdrawal by Subject|0|||
23501953|NCT02165215|65580076|FG002|Induction Phase|Withdrawal by Subject|0|||
23501954|NCT02165215|65580074|FG000|Induction Phase|Protocol Violation|1|||
23501955|NCT02165215|65580075|FG001|Induction Phase|Protocol Violation|0|||
23501956|NCT02165215|65580076|FG002|Induction Phase|Protocol Violation|0|||
23501957|NCT02165215|65580074|FG000|Induction Phase|Physician Decision|1|||
23501958|NCT02165215|65580075|FG001|Induction Phase|Physician Decision|0|||
23501959|NCT02165215|65580076|FG002|Induction Phase|Physician Decision|0|||
23501960|NCT02165215|65580074|FG000|Induction Phase|Lack of Efficacy|2|||
23501961|NCT02165215|65580075|FG001|Induction Phase|Lack of Efficacy|0|||
23501962|NCT02165215|65580076|FG002|Induction Phase|Lack of Efficacy|0|||
23501963|NCT02165215|65580074|FG000|Induction Phase|Non-Compliance|2|||
23501964|NCT02165215|65580075|FG001|Induction Phase|Non-Compliance|0|||
23501965|NCT02165215|65580076|FG002|Induction Phase|Non-Compliance|0|||
23501966|NCT02165215|65580074|FG000|Induction Phase|Lost to Follow-up|6|||
23501967|NCT02165215|65580075|FG001|Induction Phase|Lost to Follow-up|0|||
23501968|NCT02165215|65580076|FG002|Induction Phase|Lost to Follow-up|0|||
23501969|NCT02165215|65580074|FG000|Maintenance Phase|Withdrawal by Subject|0|||
23501970|NCT02165215|65580075|FG001|Maintenance Phase|Withdrawal by Subject|7|||
23501971|NCT02165215|65580076|FG002|Maintenance Phase|Withdrawal by Subject|3|||
23501972|NCT02165215|65580074|FG000|Maintenance Phase|Multiple reasons|0|||
23501973|NCT02165215|65580075|FG001|Maintenance Phase|Multiple reasons|2|||
23501974|NCT02165215|65580076|FG002|Maintenance Phase|Multiple reasons|1|||
23501975|NCT02165215|65580074|FG000|Maintenance Phase|Lost to Follow-up|0|||
23501976|NCT02165215|65580075|FG001|Maintenance Phase|Lost to Follow-up|2|||
23501977|NCT02165215|65580076|FG002|Maintenance Phase|Lost to Follow-up|0|||
23501978|NCT02165215|65580074|FG000|Maintenance Phase|Adverse Event|0|||
23501979|NCT02165215|65580075|FG001|Maintenance Phase|Adverse Event|1|||
23501980|NCT02165215|65580076|FG002|Maintenance Phase|Adverse Event|1|||
23501981|NCT00660309|65580080|FG000|Overall Study|Adverse Event|2|||
23501982|NCT00660309|65580081|FG001|Overall Study|Adverse Event|0|||
23501983|NCT00660309|65580080|FG000|Overall Study|Withdrawal by Subject|0|||
23501984|NCT00660309|65580081|FG001|Overall Study|Withdrawal by Subject|3|||
23501985|NCT02619175|65580082|FG000|Overall Study|Withdrawal by Subject|1|||
23501986|NCT02619175|65580083|FG001|Overall Study|Withdrawal by Subject|0|||
23501987|NCT02619175|65580082|FG000|Overall Study|foot pain|1|||
23501988|NCT02619175|65580083|FG001|Overall Study|foot pain|0|||
23501989|NCT03167411|65580084|FG000|Overall Study|Adverse Event|0|||
23501990|NCT03167411|65580085|FG001|Overall Study|Adverse Event|1|||
23501991|NCT02853604|65580094|FG000|Overall Study|Withdrawal by Subject|12|||
23501992|NCT02853604|65580095|FG001|Overall Study|Withdrawal by Subject|35|||
23501993|NCT02853604|65580094|FG000|Overall Study|Lost to Follow-up|4|||
23501994|NCT02853604|65580095|FG001|Overall Study|Lost to Follow-up|8|||
23501995|NCT02853604|65580094|FG000|Overall Study|Death|1|||
23501996|NCT02853604|65580095|FG001|Overall Study|Death|5|||
23501997|NCT02853604|65580094|FG000|Overall Study|Miscellaneous|11|||
23501998|NCT02853604|65580095|FG001|Overall Study|Miscellaneous|2|||
23501999|NCT02853604|65580094|FG000|Overall Study|Progressive Disease|0|||
23502000|NCT02853604|65580095|FG001|Overall Study|Progressive Disease|2|||
23502001|NCT01032837|65580098|FG000|Overall Study|Adverse event/internal illness|0|||
23502002|NCT01032837|65580099|FG001|Overall Study|Adverse event/internal illness|1|||
23502003|NCT01032837|65580100|FG002|Overall Study|Adverse event/internal illness|0|||
23502004|NCT01032837|65580101|FG003|Overall Study|Adverse event/internal illness|1|||
23502005|NCT01032837|65580098|FG000|Overall Study|Withdrew consent|0|||
23502006|NCT01032837|65580099|FG001|Overall Study|Withdrew consent|2|||
23502007|NCT01032837|65580100|FG002|Overall Study|Withdrew consent|0|||
23502008|NCT01032837|65580101|FG003|Overall Study|Withdrew consent|1|||
23502009|NCT01032837|65580098|FG000|Overall Study|Failed to return|0|||
23502010|NCT01032837|65580099|FG001|Overall Study|Failed to return|0|||
23502011|NCT01032837|65580100|FG002|Overall Study|Failed to return|1|||
23502012|NCT01032837|65580101|FG003|Overall Study|Failed to return|0|||
23502013|NCT01032837|65580098|FG000|Overall Study|Refused treatment|0|||
23502014|NCT01032837|65580099|FG001|Overall Study|Refused treatment|0|||
23502015|NCT01032837|65580100|FG002|Overall Study|Refused treatment|0|||
23502016|NCT01032837|65580101|FG003|Overall Study|Refused treatment|1|||
23502017|NCT00582166|65580102|FG000|Overall Study|Death|1|||
23502018|NCT00582166|65580102|FG000|Overall Study|Ineligible pathology|1|||
23502019|NCT00288054|65580103|FG000|Overall Study|Protocol Violation|2|||
23502020|NCT00288054|65580103|FG000|Overall Study|Lack of Efficacy|16|||
23502021|NCT00288054|65580103|FG000|Overall Study|Adverse Event|3|||
23502022|NCT00288054|65580103|FG000|Overall Study|Withdrawal by Subject|1|||
23502023|NCT00288054|65580103|FG000|Overall Study|Not protocol specified|2|||
23502024|NCT01471171|65580106|FG000|Treatment Period 1|Adverse Event|4|||
23502025|NCT01471171|65580107|FG001|Treatment Period 1|Adverse Event|1|||
23502026|NCT01471171|65580106|FG000|Treatment Period 2|Adverse Event|1|||
23398817|NCT00673920|65207152|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
23398818|NCT00673920|65207153|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
23398819|NCT00673920|65207154|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
23398820|NCT00673920|65207155|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
23398821|NCT00673920|65207156|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
23398822|NCT00673920|65207157|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
23398823|NCT01645176|65207158|FG000|Overall Study|Lack of Efficacy|4|||
23398824|NCT01645176|65207158|FG000|Overall Study|did not complete final MRI|1|||
23398825|NCT03342560|65207159|FG000|Overall Study|Lost to Follow-up|2|||
23398826|NCT01664624|65207163|FG000|Overall Study|Adverse Event|0|||
23398827|NCT01664624|65207164|FG001|Overall Study|Adverse Event|1|||
23398828|NCT01664624|65207165|FG002|Overall Study|Adverse Event|0|||
23398829|NCT01664624|65207166|FG003|Overall Study|Adverse Event|0|||
23398830|NCT04490278|65207170|FG000|Overall Study|Lost to Follow-up|6|||
23398831|NCT01346176|65207179|FG000|Recruited|Protocol Violation|1|||
23398832|NCT01346176|65207180|FG001|Recruited|Protocol Violation|0|||
23398833|NCT01346176|65207181|FG002|Recruited|Protocol Violation|0|||
23398834|NCT01346176|65207179|FG000|Completed Advance Directive|Death|3|||
23398835|NCT01346176|65207180|FG001|Completed Advance Directive|Death|2|||
23398836|NCT01346176|65207181|FG002|Completed Advance Directive|Death|2|||
23398837|NCT01346176|65207179|FG000|Completed Advance Directive|Became Ineligible|3|||
23398838|NCT01346176|65207180|FG001|Completed Advance Directive|Became Ineligible|0|||
23398839|NCT01346176|65207181|FG002|Completed Advance Directive|Became Ineligible|1|||
23398840|NCT01346176|65207179|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
23398841|NCT01346176|65207180|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
23398842|NCT01346176|65207181|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
23398843|NCT01346176|65207179|FG000|Completed Satisfaction Survey|Death|3|||
23398844|NCT01346176|65207180|FG001|Completed Satisfaction Survey|Death|0|||
23398845|NCT01346176|65207181|FG002|Completed Satisfaction Survey|Death|2|||
23398846|NCT01346176|65207179|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
23398847|NCT01346176|65207180|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
23398848|NCT01346176|65207181|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
23398849|NCT01263119|65207182|FG000|Period 1|Protocol Violation|2|||
23398850|NCT01263119|65207182|FG000|Period 2|Adverse Event|2|||
23398851|NCT03586973|65207183|FG000|Overall Study|Death|15|||
23398852|NCT03586973|65207184|FG001|Overall Study|Death|8|||
23398853|NCT03586973|65207183|FG000|Overall Study|Site Terminated by Sponsor|3|||
23398854|NCT03586973|65207184|FG001|Overall Study|Site Terminated by Sponsor|6|||
23398855|NCT03586973|65207183|FG000|Overall Study|Withdrawal by Subject|1|||
23398856|NCT03586973|65207184|FG001|Overall Study|Withdrawal by Subject|0|||
23398857|NCT03586973|65207183|FG000|Overall Study|Lost to Follow-up|1|||
23398858|NCT03586973|65207184|FG001|Overall Study|Lost to Follow-up|0|||
23398859|NCT00335829|65207185|FG000|Overall Study|Withdrawal by Subject|1|||
23398860|NCT00335829|65207185|FG000|Overall Study|Lost to Follow-up|1|||
23398861|NCT00335829|65207185|FG000|Overall Study|Adverse Event|1|||
23398862|NCT03580044|65207186|FG000|Overall Study|Death|2|||
23398863|NCT03580044|65207187|FG001|Overall Study|Death|1|||
23398864|NCT03580044|65207186|FG000|Overall Study|Withdrawal by Subject|1|||
23398865|NCT03580044|65207187|FG001|Overall Study|Withdrawal by Subject|1|||
23398866|NCT03139448|65207188|FG000|Overall Study|Lack of Efficacy|6|||
23398867|NCT03139448|65207189|FG001|Overall Study|Lack of Efficacy|7|||
23398868|NCT03139448|65207188|FG000|Overall Study|Location of procedure changed|2|||
23398869|NCT03139448|65207189|FG001|Overall Study|Location of procedure changed|8|||
23398870|NCT03139448|65207188|FG000|Overall Study|Withdrawal by Subject|3|||
23502027|NCT01471171|65580107|FG001|Treatment Period 2|Adverse Event|0|||
23502028|NCT03486223|65580114|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
23502029|NCT03486223|65580115|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
23502030|NCT01929343|65580118|FG000|Overall Study|Physician Decision|0|||
23502031|NCT01929343|65580119|FG001|Overall Study|Physician Decision|2|||
23502032|NCT01929343|65580120|FG002|Overall Study|Physician Decision|0|||
23502033|NCT01929343|65580118|FG000|Overall Study|Withdrawal by Subject|1|||
23502034|NCT01929343|65580119|FG001|Overall Study|Withdrawal by Subject|0|||
23502035|NCT01929343|65580120|FG002|Overall Study|Withdrawal by Subject|0|||
23502036|NCT00393029|65580123|FG000|Overall Study|Not treated|0|||
23502037|NCT00393029|65580124|FG001|Overall Study|Not treated|1|||
23502038|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
23502039|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
23502040|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
23502041|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
23502042|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
23502043|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
23502044|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
23502045|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
23398871|NCT03139448|65207189|FG001|Overall Study|Withdrawal by Subject|6|||
23398872|NCT03139448|65207188|FG000|Overall Study|Screen fail|1|||
23398873|NCT03139448|65207189|FG001|Overall Study|Screen fail|3|||
23398874|NCT03139448|65207188|FG000|Overall Study|Physician Decision|0|||
23398875|NCT03139448|65207189|FG001|Overall Study|Physician Decision|2|||
23398876|NCT00320606|65207190|FG000|Overall Study|Adverse Event|1|||
23398877|NCT00320606|65207190|FG000|Overall Study|Protocol Violation|1|||
23398878|NCT00320606|65207190|FG000|Overall Study|Withdrawal by Subject|1|||
23398879|NCT01917318|65207191|FG000|First Treatment|Withdrawal by Subject|0|||
23398880|NCT01917318|65207192|FG001|First Treatment|Withdrawal by Subject|1|||
23398881|NCT02095106|65207193|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
23398882|NCT02095106|65207194|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
23398883|NCT02234362|65207195|FG000|Overall Study|Not eligible after first screening visit|17|||
23398884|NCT02234362|65207195|FG000|Overall Study|Lost to Follow-up|6|||
23398885|NCT02234362|65207195|FG000|Overall Study|Withdrawal by Subject|3|||
23398886|NCT00529633|65207200|FG000|Overall Study|Withdrawal by Subject|1|||
23398887|NCT00529633|65207201|FG001|Overall Study|Withdrawal by Subject|1|||
23398888|NCT01464879|65207202|FG000|Overall Study|Physician Decision|1|||
23398889|NCT01464879|65207202|FG000|Overall Study|Non-compliance|1|||
23398890|NCT01900665|65207207|FG000|Placebo Controlled Period|Death|9|||
23398891|NCT01900665|65207208|FG001|Placebo Controlled Period|Death|16|||
23398892|NCT01900665|65207207|FG000|Placebo Controlled Period|Adverse Event|48|||
23398893|NCT01900665|65207208|FG001|Placebo Controlled Period|Adverse Event|39|||
23398894|NCT01900665|65207207|FG000|Placebo Controlled Period|Protocol Violation|1|||
23398895|NCT01900665|65207208|FG001|Placebo Controlled Period|Protocol Violation|7|||
23398896|NCT01900665|65207207|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
23398897|NCT01900665|65207208|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
23398898|NCT01900665|65207207|FG000|Placebo Controlled Period|Physician Decision|11|||
23502046|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
23502047|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
23502048|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
23502049|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
23502050|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
23502051|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
23502052|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
23502053|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
23502054|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
23502055|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
23502056|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
23502057|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
23502058|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
23502059|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
23502060|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
23502061|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
23502062|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
23502063|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
23502064|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
23502065|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
23502066|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
23502067|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
23502068|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
23502069|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
23502070|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
23502071|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
23502072|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
23502073|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
23502074|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
23398899|NCT01900665|65207208|FG001|Placebo Controlled Period|Physician Decision|7|||
23398900|NCT01900665|65207207|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
23398901|NCT01900665|65207208|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
23398902|NCT01900665|65207207|FG000|Placebo Controlled Period|Caregiver Decision|33|||
23502075|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
23502076|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
23502077|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
23502078|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
23502079|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
23502080|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
23502081|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
23502082|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
23502083|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
23502084|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
23502085|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
23502086|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
23502087|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
23502088|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
23502089|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
23502090|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
23502091|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
23502092|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
23502093|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
23502094|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
23502095|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
23502096|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
23502097|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
23502098|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
23502099|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
23502100|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
23502101|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
23502102|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
23502103|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
23502104|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
23502105|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
23502106|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
23502107|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
23502108|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Change of location|0|||
23502109|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Change of location|0|||
23606524|NCT00657709|65947270|FG004|Overall Study|Lost to Follow-up|21|||
23606525|NCT00657709|65947266|FG000|Overall Study|Protocol Violation|0|||
23606526|NCT00657709|65947267|FG001|Overall Study|Protocol Violation|2|||
23606527|NCT00657709|65947268|FG002|Overall Study|Protocol Violation|0|||
23606528|NCT00657709|65947269|FG003|Overall Study|Protocol Violation|1|||
23300709|NCT01846273|64842900|FG002|Overall Study|Lost to Follow-up|0|||
23300710|NCT01846273|64842898|FG000|Overall Study|Administrative problems|1|||
23300711|NCT01846273|64842899|FG001|Overall Study|Administrative problems|0|||
23300712|NCT01846273|64842900|FG002|Overall Study|Administrative problems|0|||
23300713|NCT01846273|64842898|FG000|Overall Study|Death|2|||
23300714|NCT01846273|64842899|FG001|Overall Study|Death|1|||
23300715|NCT01846273|64842900|FG002|Overall Study|Death|0|||
23300716|NCT01846273|64842898|FG000|Overall Study|Disease Progression|0|||
23300717|NCT01846273|64842899|FG001|Overall Study|Disease Progression|4|||
23300718|NCT01846273|64842900|FG002|Overall Study|Disease Progression|0|||
23300719|NCT01846273|64842898|FG000|Overall Study|Protocol Deviation|2|||
23300720|NCT01846273|64842899|FG001|Overall Study|Protocol Deviation|3|||
23300721|NCT01846273|64842900|FG002|Overall Study|Protocol Deviation|0|||
23300722|NCT01846273|64842898|FG000|Overall Study|Physician Decision|1|||
23300723|NCT01846273|64842899|FG001|Overall Study|Physician Decision|2|||
23300724|NCT01846273|64842900|FG002|Overall Study|Physician Decision|0|||
23300725|NCT00059787|64842903|FG000|Overall Study|Adverse Event|13|||
23300726|NCT00059787|64842903|FG000|Overall Study|disease progression|2|||
23300727|NCT00059787|64842903|FG000|Overall Study|ineligible|1|||
23300728|NCT00059787|64842903|FG000|Overall Study|Other|4|||
23300729|NCT04109313|64842912|FG000|Overall Study|Pregnancy|1|||
23300730|NCT04109313|64842912|FG000|Overall Study|Adverse Event|11|||
23300731|NCT04109313|64842912|FG000|Overall Study|Lack of Efficacy|11|||
23300732|NCT04109313|64842912|FG000|Overall Study|Lost to Follow-up|1|||
23300733|NCT04109313|64842912|FG000|Overall Study|Physician Decision|2|||
23300734|NCT04109313|64842912|FG000|Overall Study|Subject Decision|13|||
23300735|NCT04109313|64842912|FG000|Overall Study|Covid-19 situation|2|||
23300736|NCT02072824|64842913|FG000|Overall Study|Insufficient clinical response|1|||
23300737|NCT02072824|64842914|FG001|Overall Study|Insufficient clinical response|0|||
23300738|NCT02072824|64842915|FG002|Overall Study|Insufficient clinical response|1|||
23300739|NCT02072824|64842913|FG000|Overall Study|No longer willing to participate|1|||
23300740|NCT02072824|64842914|FG001|Overall Study|No longer willing to participate|0|||
23300741|NCT02072824|64842915|FG002|Overall Study|No longer willing to participate|1|||
23300742|NCT02072824|64842913|FG000|Overall Study|Medication error|0|||
23300743|NCT02072824|64842914|FG001|Overall Study|Medication error|1|||
23300744|NCT02072824|64842915|FG002|Overall Study|Medication error|0|||
23300745|NCT02072824|64842913|FG000|Overall Study|Adverse Event|0|||
23300746|NCT02072824|64842914|FG001|Overall Study|Adverse Event|0|||
23300747|NCT02072824|64842915|FG002|Overall Study|Adverse Event|1|||
23300748|NCT01020799|64842917|FG000|Overall Study|Adverse Event|4|||
23300749|NCT01020799|64842918|FG001|Overall Study|Adverse Event|3|||
23300750|NCT01020799|64842919|FG002|Overall Study|Adverse Event|2|||
23300751|NCT01020799|64842917|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
23300752|NCT01020799|64842918|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
23300753|NCT01020799|64842919|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
23300754|NCT01020799|64842917|FG000|Overall Study|Protocol Violation|3|||
23300755|NCT01020799|64842918|FG001|Overall Study|Protocol Violation|2|||
23300756|NCT01020799|64842919|FG002|Overall Study|Protocol Violation|0|||
23300757|NCT01020799|64842917|FG000|Overall Study|Withdrawal by Subject|2|||
23300758|NCT01020799|64842918|FG001|Overall Study|Withdrawal by Subject|2|||
23300759|NCT01020799|64842919|FG002|Overall Study|Withdrawal by Subject|3|||
23300760|NCT01020799|64842917|FG000|Overall Study|Lost to Follow-up|6|||
23300761|NCT01020799|64842918|FG001|Overall Study|Lost to Follow-up|4|||
23300762|NCT01020799|64842919|FG002|Overall Study|Lost to Follow-up|2|||
23300763|NCT02017860|64842920|FG000|Overall Study|Adverse Event|1|||
23300764|NCT02017860|64842920|FG000|Overall Study|Withdrawal by Subject|1|||
23300765|NCT01843348|64842923|FG000|Overall Study|Withdrawal by Subject|4|||
23300766|NCT01843348|64842924|FG001|Overall Study|Withdrawal by Subject|16|||
23300767|NCT01843348|64842925|FG002|Overall Study|Withdrawal by Subject|18|||
23300768|NCT01843348|64842923|FG000|Overall Study|Lost to Follow-up|5|||
23300769|NCT01843348|64842924|FG001|Overall Study|Lost to Follow-up|4|||
23300770|NCT01843348|64842925|FG002|Overall Study|Lost to Follow-up|2|||
23300771|NCT01843348|64842923|FG000|Overall Study|Death|5|||
23300772|NCT01843348|64842924|FG001|Overall Study|Death|3|||
23300773|NCT01843348|64842925|FG002|Overall Study|Death|4|||
23300774|NCT01843348|64842923|FG000|Overall Study|Graft loss/retransplantation|5|||
23300775|NCT01843348|64842924|FG001|Overall Study|Graft loss/retransplantation|8|||
23606529|NCT00657709|65947270|FG004|Overall Study|Protocol Violation|2|||
23606530|NCT02400749|65947271|FG000|Week 0 -16|Withdrawal by Subject|5|||
23606531|NCT02400749|65947272|FG001|Week 0 -16|Withdrawal by Subject|5|||
23606532|NCT02400749|65947271|FG000|Week 0 -16|Adverse Event|3|||
23606533|NCT02400749|65947272|FG001|Week 0 -16|Adverse Event|1|||
23606534|NCT02400749|65947271|FG000|Week 0 -16|Lost to Follow-up|2|||
23606535|NCT02400749|65947272|FG001|Week 0 -16|Lost to Follow-up|0|||
23606536|NCT02400749|65947271|FG000|Week 0 -16|Protocol Violation|1|||
23606537|NCT02400749|65947272|FG001|Week 0 -16|Protocol Violation|0|||
23606538|NCT02400749|65947271|FG000|Week 17 - 32|Withdrawal by Subject|3|||
23606539|NCT02400749|65947272|FG001|Week 17 - 32|Withdrawal by Subject|2|||
23606540|NCT02400749|65947271|FG000|Week 17 - 32|Adverse Event|2|||
23606541|NCT02400749|65947272|FG001|Week 17 - 32|Adverse Event|1|||
23502110|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Change of location|0|||
23502111|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Change of location|1|||
23502112|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Change of location|0|||
23502113|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
23502114|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
23502115|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
23502116|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
23502117|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
23502118|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
23502119|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
23502120|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
23502121|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
23502122|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
23502123|NCT00730405|65580125|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
23502124|NCT00730405|65580126|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
23502125|NCT00730405|65580127|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
23502126|NCT00730405|65580128|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
23502127|NCT00730405|65580129|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
23502128|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
23502129|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
23502130|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
23502131|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
23502132|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
23502133|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
23502134|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
23502135|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
23502136|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
23502137|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
23502138|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
23502139|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
23502140|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
23502141|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
23502142|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
23502143|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Death|0|||
23502144|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Death|1|||
23502145|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Death|0|||
23502146|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Death|1|||
23502147|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Death|0|||
23502148|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Change of location|1|||
23502149|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Change of location|1|||
23502150|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Change of location|0|||
23502151|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Change of location|1|||
23502152|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Change of location|0|||
23502153|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
23502154|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
23502155|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
23502156|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
23502157|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
23502158|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
23502159|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
23502160|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
23502161|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
23502162|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
23502163|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
23502164|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
23502165|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
23502166|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
23502167|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
23502168|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
23502169|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
23502170|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
23502171|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
23502172|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
23502173|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
23502174|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
23502175|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
23502176|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
23502177|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
23502178|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
23502179|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
23502180|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
23502181|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
23502182|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
23502183|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
23502184|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
23502185|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
23502186|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
23502187|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
23502188|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
23502189|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
23502190|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
23502191|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
23502192|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
23502193|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
23502194|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
23502195|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
23502196|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
23502197|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
23502198|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
23502199|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
23502200|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
23502201|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
23502202|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
23502203|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Missing|0|||
23502204|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Missing|0|||
23502205|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Missing|2|||
23502206|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Missing|0|||
23502207|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Missing|0|||
23502208|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
23502209|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
23502210|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
23502211|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
23502212|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
23502213|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
23502214|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
23502215|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
23502216|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
23502217|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
23502218|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
23502219|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
23502220|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
23502221|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
23502222|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
23502223|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
23502224|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
23502225|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
23502226|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
23502227|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
23502228|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
23502229|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
23502230|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
23502231|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
23502232|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
23502233|NCT00730405|65580125|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
23502234|NCT00730405|65580126|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
23502235|NCT00730405|65580127|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
23502236|NCT00730405|65580128|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
23502237|NCT00730405|65580129|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
23502238|NCT02197520|65580132|FG000|Period 1|Withdrawal by Subject|1|||
23502239|NCT02197520|65580133|FG001|Period 1|Withdrawal by Subject|0|||
23502240|NCT02197520|65580132|FG000|Period 2|Adverse Event|0|||
23502241|NCT02197520|65580133|FG001|Period 2|Adverse Event|2|||
23502242|NCT02197520|65580132|FG000|Period 2|Withdrawal by Subject|1|||
23502243|NCT02197520|65580133|FG001|Period 2|Withdrawal by Subject|0|||
23502244|NCT01487200|65580134|FG000|Overall Study|Withdrawal by Subject|0|||
23502245|NCT01487200|65580135|FG001|Overall Study|Withdrawal by Subject|1|||
23502246|NCT01487200|65580136|FG002|Overall Study|Withdrawal by Subject|0|||
23502247|NCT01487200|65580137|FG003|Overall Study|Withdrawal by Subject|0|||
23502248|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Adverse Event|16|||
23502249|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Adverse Event|17|||
23502250|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Adverse Event|13|||
23502251|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Adverse Event|18|||
23502252|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Adverse Event|0|||
23502253|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Adverse Event|0|||
23502254|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Adverse Event|0|||
23502255|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Adverse Event|0|||
23502256|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
23502257|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
23502258|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
23502259|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
23502260|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
23502261|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
23502262|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
23502263|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
23502264|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
23502265|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
23502266|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
23502267|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
23502268|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
23502269|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
23502270|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
23502271|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
23502272|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
23502273|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
23502274|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
23502275|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
23502276|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
23502277|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
23502278|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
23502279|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
23502280|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
23502281|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502282|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
23502283|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
23502284|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502285|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502286|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502287|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
23502288|NCT02975336|65580138|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
23502289|NCT02975336|65580139|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
23502290|NCT02975336|65580140|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
23502291|NCT02975336|65580141|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
23398903|NCT01900665|65207208|FG001|Placebo Controlled Period|Caregiver Decision|41|||
23398904|NCT01900665|65207207|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
23502292|NCT02975336|65580142|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
23502293|NCT02975336|65580143|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
23502294|NCT02975336|65580144|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
23502295|NCT02975336|65580145|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
23502296|NCT02975336|65580138|FG000|LTE (104 Weeks)|Adverse Event|0|||
23502297|NCT02975336|65580139|FG001|LTE (104 Weeks)|Adverse Event|0|||
23502298|NCT02975336|65580140|FG002|LTE (104 Weeks)|Adverse Event|0|||
23502299|NCT02975336|65580141|FG003|LTE (104 Weeks)|Adverse Event|0|||
23502300|NCT02975336|65580142|FG004|LTE (104 Weeks)|Adverse Event|7|||
23502301|NCT02975336|65580143|FG005|LTE (104 Weeks)|Adverse Event|4|||
23502302|NCT02975336|65580144|FG006|LTE (104 Weeks)|Adverse Event|2|||
23502303|NCT02975336|65580145|FG007|LTE (104 Weeks)|Adverse Event|0|||
23502304|NCT02975336|65580138|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
23502305|NCT02975336|65580139|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
23502306|NCT02975336|65580140|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
23502307|NCT02975336|65580141|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
23502308|NCT02975336|65580142|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
23502309|NCT02975336|65580143|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
23502310|NCT02975336|65580144|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
23502311|NCT02975336|65580145|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
23502312|NCT02975336|65580138|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
23502313|NCT02975336|65580139|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
23502314|NCT02975336|65580140|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
23502315|NCT02975336|65580141|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
23502316|NCT02975336|65580142|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
23502317|NCT02975336|65580143|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
23502318|NCT02975336|65580144|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
23502319|NCT02975336|65580145|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
23502320|NCT02975336|65580138|FG000|LTE (104 Weeks)|Other|0|||
23502321|NCT02975336|65580139|FG001|LTE (104 Weeks)|Other|0|||
23502322|NCT02975336|65580140|FG002|LTE (104 Weeks)|Other|0|||
23502323|NCT02975336|65580141|FG003|LTE (104 Weeks)|Other|0|||
23502324|NCT02975336|65580142|FG004|LTE (104 Weeks)|Other|55|||
23502325|NCT02975336|65580143|FG005|LTE (104 Weeks)|Other|63|||
23502326|NCT02975336|65580144|FG006|LTE (104 Weeks)|Other|76|||
23502327|NCT02975336|65580145|FG007|LTE (104 Weeks)|Other|72|||
23502328|NCT03926169|65580146|FG000|Period A|Adverse Event|2|||
23502329|NCT03926169|65580147|FG001|Period A|Adverse Event|2|||
23502330|NCT03926169|65580148|FG002|Period A|Adverse Event|1|||
23502331|NCT03926169|65580146|FG000|Period A|Withdrawal by Subject|2|||
23502332|NCT03926169|65580147|FG001|Period A|Withdrawal by Subject|2|||
23502333|NCT03926169|65580148|FG002|Period A|Withdrawal by Subject|2|||
23502334|NCT03926169|65580146|FG000|Period A|Lost to Follow-up|3|||
23502335|NCT03926169|65580147|FG001|Period A|Lost to Follow-up|1|||
23502336|NCT03926169|65580148|FG002|Period A|Lost to Follow-up|0|||
23502337|NCT03926169|65580146|FG000|Period A|Lack of Efficacy|0|||
23502338|NCT03926169|65580147|FG001|Period A|Lack of Efficacy|2|||
23502339|NCT03926169|65580148|FG002|Period A|Lack of Efficacy|2|||
23502340|NCT03926169|65580146|FG000|Period A|COVID-19 Infection|0|||
23502341|NCT03926169|65580147|FG001|Period A|COVID-19 Infection|1|||
23502342|NCT03926169|65580148|FG002|Period A|COVID-19 Infection|0|||
23502343|NCT03926169|65580146|FG000|Period A|COVID-19 Logistical Restrictions|0|||
23502344|NCT03926169|65580147|FG001|Period A|COVID-19 Logistical Restrictions|2|||
23502345|NCT03926169|65580148|FG002|Period A|COVID-19 Logistical Restrictions|1|||
23502346|NCT03926169|65580146|FG000|Period A|Other, Not Specified|1|||
23502347|NCT03926169|65580147|FG001|Period A|Other, Not Specified|0|||
23502348|NCT03926169|65580148|FG002|Period A|Other, Not Specified|0|||
23502349|NCT03926169|65580146|FG000|Period B|Adverse Event|3|||
23502350|NCT03926169|65580147|FG001|Period B|Adverse Event|1|||
23502351|NCT03926169|65580148|FG002|Period B|Adverse Event|1|||
23502352|NCT03926169|65580146|FG000|Period B|Withdrawal by Subject|1|||
23502353|NCT03926169|65580147|FG001|Period B|Withdrawal by Subject|3|||
23502354|NCT03926169|65580148|FG002|Period B|Withdrawal by Subject|0|||
23502355|NCT03926169|65580146|FG000|Period B|Lack of Efficacy|3|||
23502356|NCT03926169|65580147|FG001|Period B|Lack of Efficacy|1|||
23502357|NCT03926169|65580148|FG002|Period B|Lack of Efficacy|1|||
23502358|NCT03926169|65580146|FG000|Period B|Lost to Follow-up|1|||
23502359|NCT03926169|65580147|FG001|Period B|Lost to Follow-up|1|||
23502360|NCT03926169|65580148|FG002|Period B|Lost to Follow-up|4|||
23502361|NCT03926169|65580146|FG000|Period B|Other, Not Specified|62|||
23502362|NCT03926169|65580147|FG001|Period B|Other, Not Specified|57|||
23502363|NCT03926169|65580148|FG002|Period B|Other, Not Specified|65|||
23502364|NCT03715530|65580149|FG000|Overall Study|Lost to Follow-up|3|||
23502365|NCT03715530|65580150|FG001|Overall Study|Lost to Follow-up|1|||
23502366|NCT03715530|65580151|FG002|Overall Study|Lost to Follow-up|2|||
23502367|NCT02412618|65580152|FG000|Overall Study|Withdrawal by Subject|1|||
23502368|NCT02412618|65580153|FG001|Overall Study|Withdrawal by Subject|1|||
23502369|NCT02412618|65580152|FG000|Overall Study|Expulsion|1|||
23502370|NCT02412618|65580153|FG001|Overall Study|Expulsion|1|||
23502371|NCT02549937|65580154|FG000|Overall Study|Death|0|||
23502372|NCT02549937|65580155|FG001|Overall Study|Death|1|||
23502373|NCT02549937|65580156|FG002|Overall Study|Death|0|||
23502374|NCT02549937|65580157|FG003|Overall Study|Death|1|||
23502375|NCT02549937|65580158|FG004|Overall Study|Death|0|||
23502376|NCT02549937|65580159|FG005|Overall Study|Death|8|||
23502377|NCT02549937|65580160|FG006|Overall Study|Death|0|||
23502378|NCT02549937|65580161|FG007|Overall Study|Death|0|||
23502379|NCT02549937|65580162|FG008|Overall Study|Death|19|||
23502380|NCT02549937|65580154|FG000|Overall Study|No follow up required|3|||
23502381|NCT02549937|65580155|FG001|Overall Study|No follow up required|6|||
23502382|NCT02549937|65580156|FG002|Overall Study|No follow up required|3|||
23502383|NCT02549937|65580157|FG003|Overall Study|No follow up required|8|||
23502384|NCT02549937|65580158|FG004|Overall Study|No follow up required|12|||
23502385|NCT02549937|65580159|FG005|Overall Study|No follow up required|21|||
23502386|NCT02549937|65580160|FG006|Overall Study|No follow up required|9|||
23502387|NCT02549937|65580161|FG007|Overall Study|No follow up required|11|||
23502388|NCT02549937|65580162|FG008|Overall Study|No follow up required|0|||
23502389|NCT02549937|65580154|FG000|Overall Study|Other|0|||
23502390|NCT02549937|65580155|FG001|Overall Study|Other|0|||
23502391|NCT02549937|65580156|FG002|Overall Study|Other|0|||
23502392|NCT02549937|65580157|FG003|Overall Study|Other|0|||
23502393|NCT02549937|65580158|FG004|Overall Study|Other|1|||
23502394|NCT02549937|65580159|FG005|Overall Study|Other|0|||
23502395|NCT02549937|65580160|FG006|Overall Study|Other|3|||
23502396|NCT02549937|65580161|FG007|Overall Study|Other|2|||
23502397|NCT02549937|65580162|FG008|Overall Study|Other|3|||
23502398|NCT02549937|65580154|FG000|Overall Study|Lost to Follow-up|0|||
23502399|NCT02549937|65580155|FG001|Overall Study|Lost to Follow-up|0|||
23502400|NCT02549937|65580156|FG002|Overall Study|Lost to Follow-up|0|||
23502401|NCT02549937|65580157|FG003|Overall Study|Lost to Follow-up|0|||
23502402|NCT02549937|65580158|FG004|Overall Study|Lost to Follow-up|0|||
23502403|NCT02549937|65580159|FG005|Overall Study|Lost to Follow-up|0|||
23502404|NCT02549937|65580160|FG006|Overall Study|Lost to Follow-up|0|||
23502405|NCT02549937|65580161|FG007|Overall Study|Lost to Follow-up|0|||
23502406|NCT02549937|65580162|FG008|Overall Study|Lost to Follow-up|3|||
23502407|NCT02549937|65580154|FG000|Overall Study|Withdrawal by Subject|0|||
23502408|NCT02549937|65580155|FG001|Overall Study|Withdrawal by Subject|0|||
23502409|NCT02549937|65580156|FG002|Overall Study|Withdrawal by Subject|0|||
23502410|NCT02549937|65580157|FG003|Overall Study|Withdrawal by Subject|0|||
23502411|NCT02549937|65580158|FG004|Overall Study|Withdrawal by Subject|0|||
23502412|NCT02549937|65580159|FG005|Overall Study|Withdrawal by Subject|1|||
23502413|NCT02549937|65580160|FG006|Overall Study|Withdrawal by Subject|4|||
23502414|NCT02549937|65580161|FG007|Overall Study|Withdrawal by Subject|3|||
23502415|NCT02549937|65580162|FG008|Overall Study|Withdrawal by Subject|2|||
23502416|NCT02549937|65580154|FG000|Overall Study|Sponsor Decision|0|||
23502417|NCT02549937|65580155|FG001|Overall Study|Sponsor Decision|0|||
23502418|NCT02549937|65580156|FG002|Overall Study|Sponsor Decision|0|||
23502419|NCT02549937|65580157|FG003|Overall Study|Sponsor Decision|0|||
23502420|NCT02549937|65580158|FG004|Overall Study|Sponsor Decision|0|||
23502421|NCT02549937|65580159|FG005|Overall Study|Sponsor Decision|0|||
23502422|NCT02549937|65580160|FG006|Overall Study|Sponsor Decision|0|||
23502423|NCT02549937|65580161|FG007|Overall Study|Sponsor Decision|0|||
23502424|NCT02549937|65580162|FG008|Overall Study|Sponsor Decision|6|||
23502425|NCT01051323|65580163|FG000|Overall Study|Discontinuation of treatment|103|||
23502426|NCT01051323|65580163|FG000|Overall Study|Transplantation|28|||
23502427|NCT01051323|65580163|FG000|Overall Study|Dialysis dependency|22|||
23502428|NCT01051323|65580163|FG000|Overall Study|Withdrawal by Subject|13|||
23502429|NCT01051323|65580163|FG000|Overall Study|Lost to Follow-up|31|||
23502430|NCT01051323|65580163|FG000|Overall Study|Death|129|||
23502431|NCT01051323|65580163|FG000|Overall Study|Hospitalization|28|||
23502432|NCT01051323|65580163|FG000|Overall Study|Other|148|||
23502433|NCT01051323|65580163|FG000|Overall Study|Missing|37|||
23502434|NCT00555971|65580164|FG000|Overall Study|Adverse Event|1|||
23502435|NCT00555971|65580165|FG001|Overall Study|Adverse Event|1|||
23502436|NCT00667875|65580166|FG000|Overall Study|Adverse Event|0|||
23502437|NCT00667875|65580167|FG001|Overall Study|Adverse Event|2|||
23502438|NCT00667875|65580168|FG002|Overall Study|Adverse Event|6|||
23502439|NCT00667875|65580166|FG000|Overall Study|Withdrawal by Subject|10|||
23502440|NCT00667875|65580167|FG001|Overall Study|Withdrawal by Subject|9|||
23502441|NCT00667875|65580168|FG002|Overall Study|Withdrawal by Subject|7|||
23502442|NCT00006237|65580170|FG000|Overall Study|Adverse Event|39|||
23502443|NCT00006237|65580171|FG001|Overall Study|Adverse Event|29|||
23502444|NCT00006237|65580170|FG000|Overall Study|Death|1|||
23502445|NCT00006237|65580171|FG001|Overall Study|Death|0|||
23502446|NCT00006237|65580170|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
23502447|NCT00006237|65580171|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
23502448|NCT00006237|65580170|FG000|Overall Study|Progression/relapse|54|||
23502449|NCT00006237|65580171|FG001|Overall Study|Progression/relapse|2|||
23502450|NCT00006237|65580170|FG000|Overall Study|Not eligible|9|||
23502451|NCT00006237|65580171|FG001|Overall Study|Not eligible|20|||
23502452|NCT00006237|65580170|FG000|Overall Study|Withdrawal by Subject|0|||
23502453|NCT00006237|65580171|FG001|Overall Study|Withdrawal by Subject|1|||
23502454|NCT00006237|65580170|FG000|Overall Study|Not protocol specified|14|||
23502455|NCT00006237|65580171|FG001|Overall Study|Not protocol specified|5|||
23502456|NCT03693300|65580172|FG000|Overall Study|Withdrawal by Subject|6|||
23502457|NCT03693300|65580173|FG001|Overall Study|Withdrawal by Subject|0|||
23502458|NCT03693300|65580172|FG000|Overall Study|Death|50|||
23502459|NCT03693300|65580173|FG001|Overall Study|Death|2|||
23502460|NCT03693300|65580172|FG000|Overall Study|Lost to Follow-up|2|||
23502461|NCT03693300|65580173|FG001|Overall Study|Lost to Follow-up|0|||
23502462|NCT01217814|65580177|FG000|Overall Study|Adverse Event|1|||
23502463|NCT01217814|65580178|FG001|Overall Study|Adverse Event|1|||
23502464|NCT01217814|65580179|FG002|Overall Study|Adverse Event|0|||
23502465|NCT01217814|65580177|FG000|Overall Study|Lack of Efficacy|0|||
23502466|NCT01217814|65580178|FG001|Overall Study|Lack of Efficacy|0|||
23502467|NCT01217814|65580179|FG002|Overall Study|Lack of Efficacy|1|||
23502468|NCT02756013|65580180|FG000|Overall Study|Adverse Event|1|||
23502469|NCT02756013|65580180|FG000|Overall Study|Hypersensitivity|1|||
23502470|NCT00353262|65580185|FG000|Overall Study|Adverse Event|8|||
23502471|NCT00353262|65580185|FG000|Overall Study|Withdrawal by Subject|2|||
23502472|NCT00353262|65580185|FG000|Overall Study|Insufficient Therapeutic Response|13|||
23502473|NCT00353262|65580185|FG000|Overall Study|Progression|1|||
23502474|NCT00353262|65580185|FG000|Overall Study|Surgery|4|||
23502475|NCT00353262|65580185|FG000|Overall Study|Break from Chemotherapy|1|||
23502476|NCT00283400|65580186|FG000|Overall Study|Withdrawal by Subject|1|||
23502477|NCT00283400|65580187|FG001|Overall Study|Withdrawal by Subject|1|||
23502478|NCT00283400|65580188|FG002|Overall Study|Withdrawal by Subject|0|||
23502479|NCT00283400|65580189|FG003|Overall Study|Withdrawal by Subject|0|||
23502480|NCT00283400|65580186|FG000|Overall Study|Death|1|||
23502481|NCT00283400|65580187|FG001|Overall Study|Death|0|||
23502482|NCT00283400|65580188|FG002|Overall Study|Death|1|||
23502483|NCT00283400|65580189|FG003|Overall Study|Death|0|||
23502484|NCT00519831|65580190|FG000|Overall Study|Adverse Event|3|||
23502485|NCT00777608|65580191|FG000|Overall Study|Lost to Follow-up|1|||
23502486|NCT00777608|65580192|FG001|Overall Study|Lost to Follow-up|1|||
23502487|NCT00777608|65580191|FG000|Overall Study|Withdrawal by Subject|1|||
23502488|NCT00777608|65580192|FG001|Overall Study|Withdrawal by Subject|3|||
23502489|NCT00777608|65580191|FG000|Overall Study|Protocol Violation|1|||
23502490|NCT00777608|65580192|FG001|Overall Study|Protocol Violation|0|||
23502491|NCT00777608|65580191|FG000|Overall Study|Investigator Decision|1|||
23502492|NCT00777608|65580192|FG001|Overall Study|Investigator Decision|2|||
23502493|NCT02197247|65580193|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
23502494|NCT02197247|65580193|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
23502495|NCT02197247|65580193|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
23502496|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
23502497|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
23502498|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
23502499|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
23502500|NCT02197247|65580193|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
23502501|NCT03521934|65580197|FG000|Overall Study|Death|65|||
23502502|NCT03521934|65580198|FG001|Overall Study|Death|73|||
23502503|NCT03521934|65580197|FG000|Overall Study|Withdrawal by Subject|18|||
23502504|NCT03521934|65580198|FG001|Overall Study|Withdrawal by Subject|23|||
23502505|NCT03521934|65580197|FG000|Overall Study|Site Terminated by Sponsor|39|||
23502506|NCT03521934|65580198|FG001|Overall Study|Site Terminated by Sponsor|35|||
23502507|NCT03521934|65580197|FG000|Overall Study|Study Terminated by Sponsor|483|||
23502508|NCT03521934|65580198|FG001|Overall Study|Study Terminated by Sponsor|477|||
23502509|NCT03521934|65580197|FG000|Overall Study|Reason not Specified|3|||
23502510|NCT03521934|65580198|FG001|Overall Study|Reason not Specified|6|||
23502511|NCT03372096|65580199|FG000|Overall Study|Study Closed|8|||
23502512|NCT01063868|65580202|FG000|Overall Study|Adverse Event|9|||
23502513|NCT01063868|65580203|FG001|Overall Study|Adverse Event|7|||
23502514|NCT01063868|65580202|FG000|Overall Study|Withdrawal by Subject|3|||
23502515|NCT01063868|65580203|FG001|Overall Study|Withdrawal by Subject|1|||
23502516|NCT01063868|65580202|FG000|Overall Study|Study Terminated By Sponsor|23|||
23502517|NCT01063868|65580203|FG001|Overall Study|Study Terminated By Sponsor|4|||
23502518|NCT01619423|65580204|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
23502519|NCT01619423|65580205|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
23502520|NCT01619423|65580206|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
23502521|NCT01619423|65580207|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
23502522|NCT00743483|65580212|FG000|Baseline Period|Physician Decision|1|||
23502523|NCT00743483|65580212|FG000|Treatment Period|Adverse Event|1|||
23502524|NCT00119106|65580216|FG000|Overall Study|HIV infected at baseline|179|||
23502525|NCT00119106|65580217|FG001|Overall Study|HIV infected at baseline|178|||
23502526|NCT02430311|65580218|FG000|Part A|Adverse Event|0|||
23502527|NCT02430311|65580219|FG001|Part A|Adverse Event|1|||
23502528|NCT02430311|65580218|FG000|Part A|Withdrawal by Subject|1|||
23502529|NCT02430311|65580219|FG001|Part A|Withdrawal by Subject|0|||
23502530|NCT02430311|65580218|FG000|Part B|Meet study-specific withdrawal criteria|6|||
23502531|NCT02430311|65580219|FG001|Part B|Meet study-specific withdrawal criteria|6|||
23502532|NCT02430311|65580218|FG000|Part B|Withdrawal by Subject|2|||
23502533|NCT02430311|65580219|FG001|Part B|Withdrawal by Subject|2|||
23502534|NCT02430311|65580218|FG000|Part B|Adverse Event|1|||
23502535|NCT02430311|65580219|FG001|Part B|Adverse Event|0|||
23502536|NCT02430311|65580218|FG000|Part B|Death|1|||
23502537|NCT02430311|65580219|FG001|Part B|Death|0|||
23502538|NCT00963937|65580220|FG000|Overall Study|Protocol Violation|1|||
23502539|NCT00963937|65580221|FG001|Overall Study|Protocol Violation|1|||
23502540|NCT00963937|65580222|FG002|Overall Study|Protocol Violation|0|||
23502541|NCT00963937|65580220|FG000|Overall Study|Physician Decision|18|||
23502542|NCT00963937|65580221|FG001|Overall Study|Physician Decision|10|||
23502543|NCT00963937|65580222|FG002|Overall Study|Physician Decision|4|||
23502544|NCT02587234|65580225|FG000|Overall Study|Withdrawal by Subject|1|||
23502545|NCT02587234|65580226|FG001|Overall Study|Withdrawal by Subject|1|||
23502546|NCT02587234|65580225|FG000|Overall Study|Lost to Follow-up|0|||
23300776|NCT01843348|64842925|FG002|Overall Study|Graft loss/retransplantation|11|||
23502547|NCT02587234|65580226|FG001|Overall Study|Lost to Follow-up|2|||
23502548|NCT03310775|65580230|FG000|Overall Study|Lost to Follow-up|2|||
23502549|NCT03310775|65580231|FG001|Overall Study|Lost to Follow-up|3|||
23502550|NCT03310775|65580230|FG000|Overall Study|aggravation of depression|0|||
23502551|NCT03310775|65580231|FG001|Overall Study|aggravation of depression|1|||
23398905|NCT01900665|65207208|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
23398906|NCT01900665|65207207|FG000|Open Label Period|Adverse Event|16|||
23398907|NCT01900665|65207208|FG001|Open Label Period|Adverse Event|20|||
23398908|NCT01900665|65207207|FG000|Open Label Period|Death|5|||
23398909|NCT01900665|65207208|FG001|Open Label Period|Death|6|||
23398910|NCT01900665|65207207|FG000|Open Label Period|Lost to Follow-up|1|||
23398911|NCT01900665|65207208|FG001|Open Label Period|Lost to Follow-up|1|||
23398912|NCT01900665|65207207|FG000|Open Label Period|Parent/Caregiver Decision|33|||
23398913|NCT01900665|65207208|FG001|Open Label Period|Parent/Caregiver Decision|34|||
23398914|NCT01900665|65207207|FG000|Open Label Period|Physician Decision|4|||
23398915|NCT01900665|65207208|FG001|Open Label Period|Physician Decision|4|||
23398916|NCT01900665|65207207|FG000|Open Label Period|Protocol Violation|0|||
23398917|NCT01900665|65207208|FG001|Open Label Period|Protocol Violation|1|||
23398918|NCT01900665|65207207|FG000|Open Label Period|Sponsor Decision|802|||
23398919|NCT01900665|65207208|FG001|Open Label Period|Sponsor Decision|765|||
23398920|NCT01900665|65207207|FG000|Open Label Period|Withdrawal by Subject|20|||
23398921|NCT01900665|65207208|FG001|Open Label Period|Withdrawal by Subject|28|||
23398922|NCT00457392|65207209|FG000|Overall Study|Objective Progression or Relapse|229|||
23398923|NCT00457392|65207210|FG001|Overall Study|Objective Progression or Relapse|296|||
23398924|NCT00457392|65207209|FG000|Overall Study|Death|106|||
23398925|NCT00457392|65207210|FG001|Overall Study|Death|106|||
23502552|NCT01405456|65580237|FG000|Overall Study|Lost to Follow-up|2|||
23502553|NCT01405456|65580238|FG001|Overall Study|Lost to Follow-up|1|||
23398926|NCT00457392|65207209|FG000|Overall Study|Adverse Event|84|||
23398927|NCT00457392|65207210|FG001|Overall Study|Adverse Event|41|||
23502554|NCT01405456|65580237|FG000|Overall Study|Physician Decision|1|||
23502555|NCT01405456|65580238|FG001|Overall Study|Physician Decision|0|||
23502556|NCT01317160|65580239|FG000|Overall Study|Incorrect inclusion|1|||
23502557|NCT01317160|65580240|FG001|Overall Study|Incorrect inclusion|1|||
23502558|NCT01317160|65580239|FG000|Overall Study|Lost to Follow-up|3|||
23502559|NCT01317160|65580240|FG001|Overall Study|Lost to Follow-up|3|||
23398928|NCT00457392|65207209|FG000|Overall Study|Global Deterioration of Health Status|22|||
23398929|NCT00457392|65207210|FG001|Overall Study|Global Deterioration of Health Status|8|||
23398930|NCT00457392|65207209|FG000|Overall Study|Withdrawal by Subject|14|||
23398931|NCT00457392|65207210|FG001|Overall Study|Withdrawal by Subject|8|||
23398932|NCT00457392|65207209|FG000|Overall Study|Lost to Follow-up|6|||
23398933|NCT00457392|65207210|FG001|Overall Study|Lost to Follow-up|7|||
23398934|NCT00457392|65207209|FG000|Overall Study|Protocol Violation|4|||
23398935|NCT00457392|65207210|FG001|Overall Study|Protocol Violation|3|||
23398936|NCT00457392|65207209|FG000|Overall Study|Other|7|||
23398937|NCT00457392|65207210|FG001|Overall Study|Other|4|||
23398938|NCT00457392|65207209|FG000|Overall Study|Study Terminated by Sponsor|1|||
23398939|NCT00457392|65207210|FG001|Overall Study|Study Terminated by Sponsor|4|||
23398940|NCT00457392|65207209|FG000|Overall Study|Randomized, Not Treated|7|||
23398941|NCT00457392|65207210|FG001|Overall Study|Randomized, Not Treated|3|||
23398942|NCT02394561|65207212|FG000|CORE Phase|Adverse Event|7|||
23398943|NCT02394561|65207213|FG001|CORE Phase|Adverse Event|9|||
23398944|NCT02394561|65207212|FG000|CORE Phase|Death|0|||
23398945|NCT02394561|65207213|FG001|CORE Phase|Death|1|||
23398946|NCT02394561|65207212|FG000|CORE Phase|Pregnancy|1|||
23398947|NCT02394561|65207213|FG001|CORE Phase|Pregnancy|0|||
23398948|NCT02394561|65207212|FG000|CORE Phase|Lost to Follow-up|1|||
23398949|NCT02394561|65207213|FG001|CORE Phase|Lost to Follow-up|0|||
23398950|NCT02394561|65207212|FG000|CORE Phase|Physician Decision|1|||
23398951|NCT02394561|65207213|FG001|CORE Phase|Physician Decision|1|||
23398952|NCT02394561|65207212|FG000|CORE Phase|Withdrawal by Subject|2|||
23398953|NCT02394561|65207213|FG001|CORE Phase|Withdrawal by Subject|2|||
23398954|NCT02394561|65207212|FG000|CORE Phase|Lack of Efficacy|1|||
23398955|NCT02394561|65207213|FG001|CORE Phase|Lack of Efficacy|6|||
23398956|NCT02394561|65207212|FG000|Extension Phase|Adverse Event|6|||
23398957|NCT02394561|65207213|FG001|Extension Phase|Adverse Event|1|||
23398958|NCT02394561|65207212|FG000|Extension Phase|Death|0|||
23398959|NCT02394561|65207213|FG001|Extension Phase|Death|1|||
23398960|NCT02394561|65207212|FG000|Extension Phase|Protocol Violation|1|||
23398961|NCT02394561|65207213|FG001|Extension Phase|Protocol Violation|0|||
23398962|NCT02394561|65207212|FG000|Extension Phase|Lost to Follow-up|1|||
23398963|NCT02394561|65207213|FG001|Extension Phase|Lost to Follow-up|0|||
23398964|NCT02394561|65207212|FG000|Extension Phase|Physician Decision|0|||
23398965|NCT02394561|65207213|FG001|Extension Phase|Physician Decision|2|||
23398966|NCT02394561|65207212|FG000|Extension Phase|Withdrawal by Subject|0|||
23398967|NCT02394561|65207213|FG001|Extension Phase|Withdrawal by Subject|5|||
23398968|NCT02394561|65207212|FG000|Extension Phase|Lack of Efficacy|3|||
23398969|NCT02394561|65207213|FG001|Extension Phase|Lack of Efficacy|3|||
23398970|NCT01646827|65207215|FG000|Overall Study|Lost to Follow-up|0|||
23398971|NCT01646827|65207216|FG001|Overall Study|Lost to Follow-up|3|||
23398972|NCT01646827|65207215|FG000|Overall Study|Physician Decision|1|||
23398973|NCT01646827|65207216|FG001|Overall Study|Physician Decision|2|||
23398974|NCT01646827|65207215|FG000|Overall Study|Withdrawal by Subject|1|||
23398975|NCT01646827|65207216|FG001|Overall Study|Withdrawal by Subject|0|||
23398976|NCT01051661|65207217|FG000|Overall Study|Adverse Event|1|||
23398977|NCT01051661|65207218|FG001|Overall Study|Adverse Event|1|||
23398978|NCT01051661|65207219|FG002|Overall Study|Adverse Event|1|||
23398979|NCT01051661|65207220|FG003|Overall Study|Adverse Event|1|||
23398980|NCT01051661|65207221|FG004|Overall Study|Adverse Event|0|||
23398981|NCT01051661|65207222|FG005|Overall Study|Adverse Event|0|||
23398982|NCT01051661|65207217|FG000|Overall Study|Lost to Follow-up|13|||
23398983|NCT01051661|65207218|FG001|Overall Study|Lost to Follow-up|22|||
23398984|NCT01051661|65207219|FG002|Overall Study|Lost to Follow-up|15|||
23398985|NCT01051661|65207220|FG003|Overall Study|Lost to Follow-up|17|||
23398986|NCT01051661|65207221|FG004|Overall Study|Lost to Follow-up|10|||
23398987|NCT01051661|65207222|FG005|Overall Study|Lost to Follow-up|24|||
23398988|NCT01051661|65207217|FG000|Overall Study|Migrated/moved from study area|1|||
23398989|NCT01051661|65207218|FG001|Overall Study|Migrated/moved from study area|6|||
23398990|NCT01051661|65207219|FG002|Overall Study|Migrated/moved from study area|6|||
23398991|NCT01051661|65207220|FG003|Overall Study|Migrated/moved from study area|8|||
23398992|NCT01051661|65207221|FG004|Overall Study|Migrated/moved from study area|7|||
23398993|NCT01051661|65207222|FG005|Overall Study|Migrated/moved from study area|3|||
23398994|NCT01051661|65207217|FG000|Overall Study|Refused blood sampling|0|||
23398995|NCT01051661|65207218|FG001|Overall Study|Refused blood sampling|0|||
23398996|NCT01051661|65207219|FG002|Overall Study|Refused blood sampling|0|||
23398997|NCT01051661|65207220|FG003|Overall Study|Refused blood sampling|0|||
23398998|NCT01051661|65207221|FG004|Overall Study|Refused blood sampling|0|||
23398999|NCT01051661|65207222|FG005|Overall Study|Refused blood sampling|1|||
23399000|NCT01051661|65207217|FG000|Overall Study|Data not reliable|1|||
23399001|NCT01051661|65207218|FG001|Overall Study|Data not reliable|0|||
23399002|NCT01051661|65207219|FG002|Overall Study|Data not reliable|0|||
23399003|NCT01051661|65207220|FG003|Overall Study|Data not reliable|0|||
23399004|NCT01051661|65207221|FG004|Overall Study|Data not reliable|0|||
23502560|NCT01317160|65580239|FG000|Overall Study|Withdrawal by Subject|0|||
23502561|NCT01317160|65580240|FG001|Overall Study|Withdrawal by Subject|2|||
23502562|NCT01866930|65580241|FG000|Treatment Period|Other|1|||
23502563|NCT01866930|65580242|FG001|Treatment Period|Other|0|||
23502564|NCT01866930|65580241|FG000|Treatment Period|Death|0|||
23502565|NCT01866930|65580242|FG001|Treatment Period|Death|2|||
23502566|NCT01866930|65580241|FG000|Treatment Period|Poor/non compliance|0|||
23502567|NCT01866930|65580242|FG001|Treatment Period|Poor/non compliance|2|||
23502568|NCT01866930|65580241|FG000|Treatment Period|No longer meets study criteria|0|||
23502569|NCT01866930|65580242|FG001|Treatment Period|No longer meets study criteria|1|||
23502570|NCT01866930|65580241|FG000|Treatment Period|Withdrawal by Subject|2|||
23502571|NCT01866930|65580242|FG001|Treatment Period|Withdrawal by Subject|8|||
23502572|NCT01866930|65580241|FG000|Treatment Period|Lack of Efficacy|1|||
23399005|NCT01051661|65207222|FG005|Overall Study|Data not reliable|1|||
23399006|NCT01051661|65207217|FG000|Overall Study|Unable to attend visit(s)|2|||
23399007|NCT01051661|65207218|FG001|Overall Study|Unable to attend visit(s)|4|||
23399008|NCT01051661|65207219|FG002|Overall Study|Unable to attend visit(s)|2|||
23399009|NCT01051661|65207220|FG003|Overall Study|Unable to attend visit(s)|1|||
23399010|NCT01051661|65207221|FG004|Overall Study|Unable to attend visit(s)|3|||
23399011|NCT01051661|65207222|FG005|Overall Study|Unable to attend visit(s)|2|||
23399012|NCT01051661|65207217|FG000|Overall Study|Consent not received from both parents|0|||
23399013|NCT01051661|65207218|FG001|Overall Study|Consent not received from both parents|0|||
23399014|NCT01051661|65207219|FG002|Overall Study|Consent not received from both parents|0|||
23399015|NCT01051661|65207220|FG003|Overall Study|Consent not received from both parents|0|||
23399016|NCT01051661|65207221|FG004|Overall Study|Consent not received from both parents|0|||
23300777|NCT01843348|64842923|FG000|Overall Study|Various reasons|4|||
23399017|NCT01051661|65207222|FG005|Overall Study|Consent not received from both parents|1|||
23502573|NCT01866930|65580242|FG001|Treatment Period|Lack of Efficacy|9|||
23502574|NCT01866930|65580241|FG000|Treatment Period|Adverse Event|4|||
23502575|NCT01866930|65580242|FG001|Treatment Period|Adverse Event|12|||
23502576|NCT01866930|65580241|FG000|Treatment Period|Lost to Follow-up|1|||
23502577|NCT01866930|65580242|FG001|Treatment Period|Lost to Follow-up|1|||
23502578|NCT01866930|65580241|FG000|Follow-up Period|Lost to Follow-up|1|||
23502579|NCT01866930|65580242|FG001|Follow-up Period|Lost to Follow-up|1|||
23399018|NCT01051661|65207217|FG000|Overall Study|Failure to comply with protocol|0|||
23399019|NCT01051661|65207218|FG001|Overall Study|Failure to comply with protocol|0|||
23399020|NCT01051661|65207219|FG002|Overall Study|Failure to comply with protocol|2|||
23399021|NCT01051661|65207220|FG003|Overall Study|Failure to comply with protocol|0|||
23399022|NCT01051661|65207221|FG004|Overall Study|Failure to comply with protocol|0|||
23399023|NCT01051661|65207222|FG005|Overall Study|Failure to comply with protocol|0|||
23399024|NCT01051661|65207217|FG000|Overall Study|Subject lost legal representation|0|||
23399025|NCT01051661|65207218|FG001|Overall Study|Subject lost legal representation|0|||
23399026|NCT01051661|65207219|FG002|Overall Study|Subject lost legal representation|0|||
23399027|NCT01051661|65207220|FG003|Overall Study|Subject lost legal representation|0|||
23399028|NCT01051661|65207221|FG004|Overall Study|Subject lost legal representation|1|||
23399029|NCT01051661|65207222|FG005|Overall Study|Subject lost legal representation|0|||
23399030|NCT01051661|65207217|FG000|Overall Study|Protocol Violation|0|||
23399031|NCT01051661|65207218|FG001|Overall Study|Protocol Violation|0|||
23399032|NCT01051661|65207219|FG002|Overall Study|Protocol Violation|0|||
23399033|NCT01051661|65207220|FG003|Overall Study|Protocol Violation|1|||
23399034|NCT01051661|65207221|FG004|Overall Study|Protocol Violation|2|||
23399035|NCT01051661|65207222|FG005|Overall Study|Protocol Violation|1|||
23399036|NCT01051661|65207217|FG000|Overall Study|Withdrawal by Subject|16|||
23399037|NCT01051661|65207218|FG001|Overall Study|Withdrawal by Subject|30|||
23399038|NCT01051661|65207219|FG002|Overall Study|Withdrawal by Subject|13|||
23399039|NCT01051661|65207220|FG003|Overall Study|Withdrawal by Subject|28|||
23399040|NCT01051661|65207221|FG004|Overall Study|Withdrawal by Subject|12|||
23399041|NCT01051661|65207222|FG005|Overall Study|Withdrawal by Subject|34|||
23399042|NCT05223673|65207227|FG000|Overall Study|Protocol Violation|1|||
23399043|NCT05223673|65207227|FG000|Overall Study|Study termination|6|||
23399044|NCT04484857|65207228|FG000|Overall Study|Adverse Event|2|||
23399045|NCT04484857|65207228|FG000|Overall Study|Death|10|||
23399046|NCT04484857|65207228|FG000|Overall Study|Withdrawal by Subject|3|||
23399047|NCT04484857|65207228|FG000|Overall Study|Transferred/Relocation|5|||
23399048|NCT04484857|65207228|FG000|Overall Study|Kidney Transplant|7|||
23399049|NCT04484857|65207228|FG000|Overall Study|Other than specified|4|||
23399050|NCT04484857|65207228|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
23399051|NCT01342094|65207233|FG000|Overall Study|Adverse Event|5|||
23399052|NCT01342094|65207234|FG001|Overall Study|Adverse Event|0|||
23399053|NCT01342094|65207233|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
23399054|NCT01342094|65207234|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
23399055|NCT01342094|65207233|FG000|Overall Study|Withdrawal by Subject|0|||
23399056|NCT01342094|65207234|FG001|Overall Study|Withdrawal by Subject|2|||
23399057|NCT00805389|65207242|FG000|Overall Study|Adverse Event|0|||
23399058|NCT00805389|65207243|FG001|Overall Study|Adverse Event|0|||
23399059|NCT00805389|65207244|FG002|Overall Study|Adverse Event|1|||
23399060|NCT00805389|65207245|FG003|Overall Study|Adverse Event|2|||
23399061|NCT00805389|65207246|FG004|Overall Study|Adverse Event|0|||
23399062|NCT00805389|65207242|FG000|Overall Study|Lost to Follow-up|4|||
23399063|NCT00805389|65207243|FG001|Overall Study|Lost to Follow-up|3|||
23399064|NCT00805389|65207244|FG002|Overall Study|Lost to Follow-up|6|||
23399065|NCT00805389|65207245|FG003|Overall Study|Lost to Follow-up|10|||
23399066|NCT00805389|65207246|FG004|Overall Study|Lost to Follow-up|9|||
23399067|NCT00805389|65207242|FG000|Overall Study|Protocol Violation|0|||
23399068|NCT00805389|65207243|FG001|Overall Study|Protocol Violation|0|||
23399069|NCT00805389|65207244|FG002|Overall Study|Protocol Violation|1|||
23399070|NCT00805389|65207245|FG003|Overall Study|Protocol Violation|0|||
23399071|NCT00805389|65207246|FG004|Overall Study|Protocol Violation|0|||
23399072|NCT00805389|65207242|FG000|Overall Study|Withdrawal by Subject|3|||
23399073|NCT00805389|65207243|FG001|Overall Study|Withdrawal by Subject|2|||
23399074|NCT00805389|65207244|FG002|Overall Study|Withdrawal by Subject|4|||
23399075|NCT00805389|65207245|FG003|Overall Study|Withdrawal by Subject|5|||
23399076|NCT00805389|65207246|FG004|Overall Study|Withdrawal by Subject|4|||
23399077|NCT01968980|65207247|FG000|Overall Study|Death|0|||
23502580|NCT01866930|65580241|FG000|Follow-up Period|Other|1|||
23502581|NCT01866930|65580242|FG001|Follow-up Period|Other|5|||
23399078|NCT01968980|65207248|FG001|Overall Study|Death|1|||
23399079|NCT01968980|65207247|FG000|Overall Study|Adverse Event|1|||
23399080|NCT01968980|65207248|FG001|Overall Study|Adverse Event|3|||
23399081|NCT01968980|65207247|FG000|Overall Study|Does not meet entry criteria|1|||
23399082|NCT01968980|65207248|FG001|Overall Study|Does not meet entry criteria|3|||
23399083|NCT01968980|65207247|FG000|Overall Study|Withdrawal by Subject|13|||
23399084|NCT01968980|65207248|FG001|Overall Study|Withdrawal by Subject|5|||
23399085|NCT01968980|65207247|FG000|Overall Study|Other unspecified|1|||
23399086|NCT01968980|65207248|FG001|Overall Study|Other unspecified|2|||
23399087|NCT02536664|65207253|FG000|Overall Study|Inadequate completion of documentation|2|||
23399088|NCT02536664|65207254|FG001|Overall Study|Inadequate completion of documentation|4|||
23399089|NCT02536664|65207253|FG000|Overall Study|Progression|13|||
23399090|NCT02536664|65207254|FG001|Overall Study|Progression|18|||
23399091|NCT02536664|65207253|FG000|Overall Study|Death due to lymphoma|2|||
23399092|NCT02536664|65207254|FG001|Overall Study|Death due to lymphoma|1|||
23399093|NCT02536664|65207253|FG000|Overall Study|Death due to other reason|3|||
23399094|NCT02536664|65207254|FG001|Overall Study|Death due to other reason|2|||
23399095|NCT02536664|65207253|FG000|Overall Study|Intolerability|8|||
23399096|NCT02536664|65207254|FG001|Overall Study|Intolerability|6|||
23399097|NCT02536664|65207253|FG000|Overall Study|Withdrawal by Subject|8|||
23399098|NCT02536664|65207254|FG001|Overall Study|Withdrawal by Subject|5|||
23399099|NCT02536664|65207253|FG000|Overall Study|Other|18|||
23399100|NCT02536664|65207254|FG001|Overall Study|Other|24|||
23399101|NCT02536664|65207253|FG000|Overall Study|Missing|53|||
23399102|NCT02536664|65207254|FG001|Overall Study|Missing|20|||
23399103|NCT02951780|65207255|FG000|Period 1|Adverse Event|0|||
23399104|NCT02951780|65207256|FG001|Period 1|Adverse Event|0|||
23399105|NCT02951780|65207257|FG002|Period 1|Adverse Event|0|||
23399106|NCT02951780|65207258|FG003|Period 1|Adverse Event|1|||
23399107|NCT02951780|65207259|FG004|Period 1|Adverse Event|0|||
23399108|NCT02951780|65207260|FG005|Period 1|Adverse Event|0|||
23399109|NCT02951780|65207261|FG006|Period 1|Adverse Event|0|||
23399110|NCT02951780|65207262|FG007|Period 1|Adverse Event|0|||
23399111|NCT02951780|65207263|FG008|Period 1|Adverse Event|0|||
23399112|NCT02951780|65207255|FG000|Period 1|Scheduling Conflicts|0|||
23399113|NCT02951780|65207256|FG001|Period 1|Scheduling Conflicts|0|||
23399114|NCT02951780|65207257|FG002|Period 1|Scheduling Conflicts|0|||
23399115|NCT02951780|65207258|FG003|Period 1|Scheduling Conflicts|0|||
23399116|NCT02951780|65207259|FG004|Period 1|Scheduling Conflicts|0|||
23399117|NCT02951780|65207260|FG005|Period 1|Scheduling Conflicts|0|||
23399118|NCT02951780|65207261|FG006|Period 1|Scheduling Conflicts|0|||
23399119|NCT02951780|65207262|FG007|Period 1|Scheduling Conflicts|1|||
23399120|NCT02951780|65207263|FG008|Period 1|Scheduling Conflicts|0|||
23399121|NCT02951780|65207255|FG000|Period 2|Scheduling Conflicts|0|||
23399122|NCT02951780|65207256|FG001|Period 2|Scheduling Conflicts|0|||
23399123|NCT02951780|65207257|FG002|Period 2|Scheduling Conflicts|0|||
23399124|NCT02951780|65207258|FG003|Period 2|Scheduling Conflicts|0|||
23399125|NCT02951780|65207259|FG004|Period 2|Scheduling Conflicts|0|||
23399126|NCT02951780|65207260|FG005|Period 2|Scheduling Conflicts|0|||
23399127|NCT02951780|65207261|FG006|Period 2|Scheduling Conflicts|0|||
23399128|NCT02951780|65207262|FG007|Period 2|Scheduling Conflicts|1|||
23399129|NCT02951780|65207263|FG008|Period 2|Scheduling Conflicts|0|||
23399130|NCT01323192|65207267|FG000|Overall Study|Adverse Event|6|||
23399131|NCT01323192|65207268|FG001|Overall Study|Adverse Event|1|||
23399132|NCT01323192|65207267|FG000|Overall Study|Withdrawal by Subject|3|||
23399133|NCT01323192|65207268|FG001|Overall Study|Withdrawal by Subject|1|||
23399134|NCT01323192|65207267|FG000|Overall Study|Noncompliance with study medication|0|||
23399135|NCT01323192|65207268|FG001|Overall Study|Noncompliance with study medication|3|||
23399136|NCT01323192|65207267|FG000|Overall Study|Nonmedical reasons|0|||
23399137|NCT01323192|65207268|FG001|Overall Study|Nonmedical reasons|1|||
23399138|NCT00746811|65207269|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
23399139|NCT00746811|65207270|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
23399140|NCT02805790|65207271|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
23399141|NCT02805790|65207272|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
23399142|NCT01880957|65207275|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
23399143|NCT01880957|65207276|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
23399144|NCT01880957|65207275|FG000|Overall Study|Lost to Follow-up|11|||
23399145|NCT01880957|65207276|FG001|Overall Study|Lost to Follow-up|0|||
23399146|NCT01880957|65207275|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
23399147|NCT01880957|65207276|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
23399148|NCT00545779|65207277|FG000|Overall Study|Violation of selection criteria at entry|8|||
23399149|NCT00545779|65207277|FG000|Overall Study|Other protocol violation|1|||
23399150|NCT00545779|65207277|FG000|Overall Study|Did not cooperate|7|||
23399151|NCT00545779|65207277|FG000|Overall Study|Withdrawal by Subject|20|||
23399152|NCT00545779|65207277|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
23399153|NCT00545779|65207277|FG000|Overall Study|Failure to return|3|||
23399154|NCT01049373|65207278|FG000|Overall Study|Protocol Violation|9|||
23399155|NCT01049373|65207279|FG001|Overall Study|Protocol Violation|9|||
23399156|NCT01049373|65207278|FG000|Overall Study|Withdrawal by Subject|8|||
23399157|NCT01049373|65207279|FG001|Overall Study|Withdrawal by Subject|5|||
23399158|NCT01049373|65207278|FG000|Overall Study|Adverse Event|3|||
23399159|NCT01049373|65207279|FG001|Overall Study|Adverse Event|3|||
23399160|NCT01049373|65207278|FG000|Overall Study|Lost to Follow-up|9|||
23399161|NCT01049373|65207279|FG001|Overall Study|Lost to Follow-up|4|||
23399162|NCT01049373|65207278|FG000|Overall Study|no evaluable study values|9|||
23399163|NCT01049373|65207279|FG001|Overall Study|no evaluable study values|21|||
23399164|NCT01049373|65207278|FG000|Overall Study|Other|1|||
23399165|NCT01049373|65207279|FG001|Overall Study|Other|1|||
23399166|NCT01049373|65207278|FG000|Overall Study|Non-cooperation|0|||
23399167|NCT01049373|65207279|FG001|Overall Study|Non-cooperation|1|||
23399168|NCT00590967|65207280|FG000|Overall Study|Withdrawal by Subject|1|||
23399169|NCT00590967|65207281|FG001|Overall Study|Withdrawal by Subject|1|||
23399170|NCT00590967|65207280|FG000|Overall Study|Ineligible|1|||
23399171|NCT00590967|65207281|FG001|Overall Study|Ineligible|0|||
23399172|NCT00590967|65207280|FG000|Overall Study|Poor performance status|0|||
23399173|NCT00590967|65207281|FG001|Overall Study|Poor performance status|1|||
23399174|NCT00590967|65207280|FG000|Overall Study|Non-compliant|0|||
23399175|NCT00590967|65207281|FG001|Overall Study|Non-compliant|2|||
23399176|NCT00590967|65207280|FG000|Overall Study|Did not sign consent form|0|||
23399177|NCT00590967|65207281|FG001|Overall Study|Did not sign consent form|1|||
23399178|NCT00590967|65207280|FG000|Overall Study|Did not receive chemo per protocol|1|||
23399179|NCT00590967|65207281|FG001|Overall Study|Did not receive chemo per protocol|0|||
23399180|NCT00730886|65207284|FG000|Overall Study|Lost to Follow-up|1|||
23399181|NCT00730886|65207285|FG001|Overall Study|Lost to Follow-up|0|||
23399182|NCT00730886|65207284|FG000|Overall Study|Physician Decision|1|||
23399183|NCT00730886|65207285|FG001|Overall Study|Physician Decision|0|||
23399184|NCT02538614|65207286|FG000|Overall Study|Progressive Disease|2|||
23399185|NCT00279214|65207287|FG000|Overall Study|Physician Decision|3|||
23399186|NCT00279214|65207288|FG001|Overall Study|Physician Decision|2|||
23399187|NCT00980044|65207292|FG000|Overall Study|Withdrawal by Subject|5|||
23399188|NCT00980044|65207293|FG001|Overall Study|Withdrawal by Subject|7|||
23399189|NCT00980044|65207294|FG002|Overall Study|Withdrawal by Subject|3|||
23399190|NCT00980044|65207292|FG000|Overall Study|Protocol Violation|0|||
23399191|NCT00980044|65207293|FG001|Overall Study|Protocol Violation|0|||
23399192|NCT00980044|65207294|FG002|Overall Study|Protocol Violation|2|||
23399193|NCT03443687|65207295|FG000|Overall Study|Lost to Follow-up|3|||
23399194|NCT03443687|65207296|FG001|Overall Study|Lost to Follow-up|5|||
23399195|NCT03443687|65207295|FG000|Overall Study|Withdrawal by Subject|1|||
23399196|NCT03443687|65207296|FG001|Overall Study|Withdrawal by Subject|0|||
23399197|NCT03443687|65207295|FG000|Overall Study|Discontinued intervention|1|||
23399198|NCT03443687|65207296|FG001|Overall Study|Discontinued intervention|1|||
23399199|NCT01378195|65207298|FG000|Overall Study|Lost to Follow-up|29|||
23399200|NCT01378195|65207299|FG001|Overall Study|Lost to Follow-up|18|||
23399201|NCT00461708|65207300|FG000|Overall Study|Adverse Event|17|||
23399202|NCT00461708|65207301|FG001|Overall Study|Adverse Event|7|||
23399203|NCT00461708|65207300|FG000|Overall Study|Lack of Efficacy|68|||
23399204|NCT00461708|65207301|FG001|Overall Study|Lack of Efficacy|20|||
23399205|NCT00461708|65207300|FG000|Overall Study|Physician Decision|10|||
23399206|NCT00461708|65207301|FG001|Overall Study|Physician Decision|4|||
23399207|NCT00461708|65207300|FG000|Overall Study|Withdrawal by Subject|8|||
23399208|NCT00461708|65207301|FG001|Overall Study|Withdrawal by Subject|2|||
23399209|NCT00461708|65207300|FG000|Overall Study|Other|4|||
23399210|NCT00461708|65207301|FG001|Overall Study|Other|4|||
23399211|NCT00461708|65207300|FG000|Overall Study|Death|8|||
23399212|NCT00461708|65207301|FG001|Overall Study|Death|1|||
23399213|NCT00506142|65207302|FG000|Overall Study|Adverse Event|8|||
23399214|NCT00506142|65207303|FG001|Overall Study|Adverse Event|7|||
23399215|NCT00506142|65207302|FG000|Overall Study|Lack of Efficacy|21|||
23399216|NCT00506142|65207303|FG001|Overall Study|Lack of Efficacy|7|||
23399217|NCT00506142|65207302|FG000|Overall Study|Withdrawal by Subject|4|||
23399218|NCT00506142|65207303|FG001|Overall Study|Withdrawal by Subject|5|||
23399219|NCT00506142|65207302|FG000|Overall Study|Physician Decision|1|||
23399220|NCT00506142|65207303|FG001|Overall Study|Physician Decision|0|||
23399221|NCT00506142|65207302|FG000|Overall Study|New health condition|1|||
23399222|NCT00506142|65207303|FG001|Overall Study|New health condition|0|||
23399223|NCT00261833|65207304|FG000|Overall Study|Death|1|||
23399224|NCT00261833|65207305|FG001|Overall Study|Death|3|||
23399225|NCT00261833|65207304|FG000|Overall Study|Adverse Event|1|||
23399226|NCT00261833|65207305|FG001|Overall Study|Adverse Event|4|||
23399227|NCT00261833|65207304|FG000|Overall Study|Withdrawal by Subject|5|||
23399228|NCT00261833|65207305|FG001|Overall Study|Withdrawal by Subject|7|||
23399229|NCT00261833|65207304|FG000|Overall Study|Protocol Violation|0|||
23399230|NCT00261833|65207305|FG001|Overall Study|Protocol Violation|1|||
23399231|NCT00261833|65207304|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
23399232|NCT00261833|65207305|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
23399233|NCT00261833|65207304|FG000|Overall Study|Lung transplantation|1|||
23399234|NCT00261833|65207305|FG001|Overall Study|Lung transplantation|1|||
23399235|NCT00261833|65207304|FG000|Overall Study|Missing reason|1|||
23399236|NCT00261833|65207305|FG001|Overall Study|Missing reason|0|||
23399237|NCT00261833|65207304|FG000|Overall Study|Not interested in being participant|0|||
23399238|NCT00261833|65207305|FG001|Overall Study|Not interested in being participant|1|||
23502582|NCT01866930|65580241|FG000|Follow-up Period|No longer required per protocol|1|||
23399239|NCT00698841|65207306|FG000|Overall Study|Withdrawal by Subject|2|||
23399240|NCT00698841|65207306|FG000|Overall Study|Adverse Event|3|||
23399241|NCT00698841|65207306|FG000|Overall Study|Disease progression|7|||
23502583|NCT01866930|65580242|FG001|Follow-up Period|No longer required per protocol|0|||
23399242|NCT00698841|65207306|FG000|Overall Study|Failure to meet eligibility criteria|2|||
23399243|NCT00698841|65207306|FG000|Overall Study|Study drug toxicity|2|||
23399244|NCT00698841|65207306|FG000|Overall Study|Other|2|||
23399245|NCT01802788|65207307|FG000|Overall Study|Withdrawal by Subject|102|||
23399246|NCT01802788|65207308|FG001|Overall Study|Withdrawal by Subject|5|||
23399247|NCT01802788|65207307|FG000|Overall Study|Death|382|||
23399248|NCT01802788|65207308|FG001|Overall Study|Death|18|||
23399249|NCT01802788|65207307|FG000|Overall Study|Lost to Follow-up|31|||
23399250|NCT01802788|65207308|FG001|Overall Study|Lost to Follow-up|2|||
23399251|NCT01802788|65207307|FG000|Overall Study|Physician Decision|3|||
23399252|NCT01802788|65207308|FG001|Overall Study|Physician Decision|0|||
23399253|NCT01802788|65207307|FG000|Overall Study|Patient Non-Compliance|1|||
23399254|NCT01802788|65207308|FG001|Overall Study|Patient Non-Compliance|0|||
23399255|NCT01802788|65207307|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
23399256|NCT01802788|65207308|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
23399257|NCT01802788|65207307|FG000|Overall Study|Other Reasons|19|||
23399258|NCT01802788|65207308|FG001|Overall Study|Other Reasons|0|||
23399259|NCT00077974|65207311|FG000|Overall Study|Adverse Event|22|||
23399260|NCT00077974|65207311|FG000|Overall Study|Protocol Violation|1|||
23399261|NCT00077974|65207311|FG000|Overall Study|Withdrawal by Subject|3|||
23399262|NCT00077974|65207311|FG000|Overall Study|Lack of Efficacy|76|||
23399263|NCT00077974|65207311|FG000|Overall Study|Decision of Sponsor|2|||
23399264|NCT00831389|65207312|FG000|Overall Study|Withdrawal by Subject|0|||
23399265|NCT00831389|65207313|FG001|Overall Study|Withdrawal by Subject|1|||
23399266|NCT00454116|65207314|FG000|Overall Study|Adverse Event|5|||
23399267|NCT00454116|65207315|FG001|Overall Study|Adverse Event|11|||
23399268|NCT00454116|65207316|FG002|Overall Study|Adverse Event|9|||
23399269|NCT00454116|65207314|FG000|Overall Study|Condition under investigation worsened|17|||
23399270|NCT00454116|65207315|FG001|Overall Study|Condition under investigation worsened|13|||
23399271|NCT00454116|65207316|FG002|Overall Study|Condition under investigation worsened|18|||
23399272|NCT00454116|65207314|FG000|Overall Study|Withdrawal by Subject|3|||
23399273|NCT00454116|65207315|FG001|Overall Study|Withdrawal by Subject|3|||
23399274|NCT00454116|65207316|FG002|Overall Study|Withdrawal by Subject|1|||
23399275|NCT00454116|65207314|FG000|Overall Study|Other|2|||
23399276|NCT00454116|65207315|FG001|Overall Study|Other|2|||
23399277|NCT00454116|65207316|FG002|Overall Study|Other|0|||
23399278|NCT03728933|65207317|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
23399279|NCT03728933|65207318|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
23399280|NCT03728933|65207319|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
23399281|NCT03728933|65207317|FG000|Overall Study|Withdrawal by Subject|0|||
23399282|NCT03728933|65207318|FG001|Overall Study|Withdrawal by Subject|0|||
23399283|NCT03728933|65207319|FG002|Overall Study|Withdrawal by Subject|1|||
23399284|NCT03728933|65207317|FG000|Overall Study|Lost to Follow-up|0|||
23399285|NCT03728933|65207318|FG001|Overall Study|Lost to Follow-up|1|||
23399286|NCT03728933|65207319|FG002|Overall Study|Lost to Follow-up|0|||
23399287|NCT03728933|65207317|FG000|Overall Study|Adverse Event|1|||
23399288|NCT03728933|65207318|FG001|Overall Study|Adverse Event|0|||
23399289|NCT03728933|65207319|FG002|Overall Study|Adverse Event|0|||
23399290|NCT01983111|65207320|FG000|Overall Study|Withdrawal by Subject|8|||
23399291|NCT01983111|65207321|FG001|Overall Study|Withdrawal by Subject|6|||
23399292|NCT01983111|65207320|FG000|Overall Study|Adverse Event|4|||
23399293|NCT01983111|65207321|FG001|Overall Study|Adverse Event|0|||
23399294|NCT01983111|65207320|FG000|Overall Study|Protocol Violation|0|||
23399295|NCT01983111|65207321|FG001|Overall Study|Protocol Violation|1|||
23399296|NCT01990742|65207322|FG000|Overall Study|Withdrawal by facility|407|||
23399297|NCT01990742|65207323|FG001|Overall Study|Withdrawal by facility|1083|||
23399298|NCT01990742|65207322|FG000|Overall Study|Facility closed|0|||
23399299|NCT01990742|65207323|FG001|Overall Study|Facility closed|270|||
23399300|NCT00501644|65207326|FG000|Overall Study|Adverse Event|4|||
23399301|NCT00501644|65207326|FG000|Overall Study|Withdrawal by Subject|1|||
23399302|NCT03510273|65207331|FG000|Overall Study|Withdrawal by Subject|2|||
23399303|NCT03510273|65207331|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
23399304|NCT03510273|65207331|FG000|Overall Study|Moved away from study area|4|||
23399305|NCT00271544|65207336|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
23399306|NCT00271544|65207336|FG000|Overall Study|Model 4196 lead not attempted|9|||
23399307|NCT00271544|65207336|FG000|Overall Study|Implant not attempted|4|||
23399308|NCT02712788|65207337|FG000|Overall Study|Physician Decision|1|||
23399309|NCT02712788|65207338|FG001|Overall Study|Physician Decision|0|||
23399310|NCT02712788|65207337|FG000|Overall Study|Protocol Violation|1|||
23399311|NCT02712788|65207338|FG001|Overall Study|Protocol Violation|0|||
23399312|NCT03323164|65207339|FG000|Overall Study|Poor quality imaging/scans|2|||
23399313|NCT03323164|65207340|FG001|Overall Study|Poor quality imaging/scans|2|||
23399314|NCT01493089|65207341|FG000|Overall Study|Protocol Violation|2|||
23399315|NCT01493089|65207342|FG001|Overall Study|Protocol Violation|2|||
23399316|NCT01493089|65207341|FG000|Overall Study|Withdrawal by Subject|1|||
23399317|NCT01493089|65207342|FG001|Overall Study|Withdrawal by Subject|0|||
23399318|NCT01493089|65207341|FG000|Overall Study|Physician Decision|0|||
23399319|NCT01493089|65207342|FG001|Overall Study|Physician Decision|1|||
23399320|NCT01905540|65207347|FG000|Period 3|Other|1|||
23399321|NCT01905540|65207348|FG001|Period 3|Other|0|||
23399322|NCT01905540|65207349|FG002|Period 3|Other|1|||
23399323|NCT01905540|65207350|FG003|Period 3|Other|1|||
23399324|NCT00657267|65207351|FG000|Overall Study|Progressive disease|45|||
23399325|NCT00657267|65207351|FG000|Overall Study|Adverse Event|9|||
23399326|NCT01876381|65207352|FG000|Overall Study|Lack of Efficacy|5|||
23399327|NCT01876381|65207352|FG000|Overall Study|Physician Decision|1|||
23399328|NCT01876381|65207352|FG000|Overall Study|Withdrawal by Subject|1|||
23399329|NCT01740687|65207355|FG000|Overall Study|Lost to Follow-up|11|||
23399330|NCT01740687|65207355|FG000|Overall Study|Withdrawal by Subject|2|||
23399331|NCT01740687|65207355|FG000|Overall Study|other reason|22|||
23399332|NCT01740687|65207355|FG000|Overall Study|treatment not received|2|||
23399333|NCT03781414|65207360|FG000|Overall Study|Study terminated by sponsor|39|||
23399334|NCT03781414|65207361|FG001|Overall Study|Study terminated by sponsor|34|||
23399335|NCT03781414|65207362|FG002|Overall Study|Study terminated by sponsor|25|||
23399336|NCT03781414|65207360|FG000|Overall Study|Adverse Event|3|||
23399337|NCT03781414|65207361|FG001|Overall Study|Adverse Event|6|||
23399338|NCT03781414|65207362|FG002|Overall Study|Adverse Event|3|||
23399339|NCT03781414|65207360|FG000|Overall Study|Physician Decision|2|||
23399340|NCT03781414|65207361|FG001|Overall Study|Physician Decision|0|||
23399341|NCT03781414|65207362|FG002|Overall Study|Physician Decision|1|||
23399342|NCT03781414|65207360|FG000|Overall Study|Withdrawal by Subject|2|||
23399343|NCT03781414|65207361|FG001|Overall Study|Withdrawal by Subject|3|||
23399344|NCT03781414|65207362|FG002|Overall Study|Withdrawal by Subject|3|||
23399345|NCT03781414|65207360|FG000|Overall Study|Death|1|||
23399346|NCT03781414|65207361|FG001|Overall Study|Death|4|||
23399347|NCT03781414|65207362|FG002|Overall Study|Death|0|||
23399348|NCT03781414|65207360|FG000|Overall Study|Lost to Follow-up|1|||
23399349|NCT03781414|65207361|FG001|Overall Study|Lost to Follow-up|1|||
23399350|NCT03781414|65207362|FG002|Overall Study|Lost to Follow-up|0|||
23399351|NCT01567722|65207365|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
23399352|NCT01567722|65207366|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
23399353|NCT01567722|65207367|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
23399354|NCT01567722|65207365|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
23399355|NCT01567722|65207366|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
23399356|NCT01567722|65207367|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
23399357|NCT01567722|65207365|FG000|Overall Study|Protocol closure by the OCG|2|||
23399358|NCT01567722|65207366|FG001|Overall Study|Protocol closure by the OCG|0|||
23399359|NCT01567722|65207367|FG002|Overall Study|Protocol closure by the OCG|0|||
23399360|NCT01567722|65207365|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
23399361|NCT01567722|65207366|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
23399362|NCT01567722|65207367|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
23399363|NCT00710593|65207368|FG000|Overall Study|Incarceration|1|||
23399364|NCT00710593|65207369|FG001|Overall Study|Incarceration|0|||
23399365|NCT00710593|65207368|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
23399366|NCT00710593|65207369|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
23399367|NCT00710593|65207368|FG000|Overall Study|Lost to Follow-up|3|||
23399368|NCT00710593|65207369|FG001|Overall Study|Lost to Follow-up|1|||
23399369|NCT00710593|65207368|FG000|Overall Study|Moved out of area|1|||
23399370|NCT00710593|65207369|FG001|Overall Study|Moved out of area|0|||
23399371|NCT00710593|65207368|FG000|Overall Study|Failure to adhere or complete study eval|1|||
23399372|NCT00710593|65207369|FG001|Overall Study|Failure to adhere or complete study eval|1|||
23399373|NCT00710593|65207368|FG000|Overall Study|Protocol Violation|1|||
23399374|NCT00710593|65207369|FG001|Overall Study|Protocol Violation|1|||
23399375|NCT00710593|65207368|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
23399376|NCT00710593|65207369|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
23399377|NCT00659425|65207372|FG000|Overall Study|Disease progression|1|||
23399378|NCT00659425|65207373|FG001|Overall Study|Disease progression|0|||
23399379|NCT00659425|65207374|FG002|Overall Study|Disease progression|0|||
23399380|NCT00659425|65207375|FG003|Overall Study|Disease progression|1|||
23399381|NCT00659425|65207376|FG004|Overall Study|Disease progression|0|||
23399382|NCT00659425|65207377|FG005|Overall Study|Disease progression|2|||
23399383|NCT00659425|65207378|FG006|Overall Study|Disease progression|4|||
23399384|NCT00659425|65207379|FG007|Overall Study|Disease progression|3|||
23399385|NCT00659425|65207380|FG008|Overall Study|Disease progression|5|||
23399386|NCT00659425|65207381|FG009|Overall Study|Disease progression|3|||
23399387|NCT00659425|65207372|FG000|Overall Study|Death|0|||
23399388|NCT00659425|65207373|FG001|Overall Study|Death|0|||
23399389|NCT00659425|65207374|FG002|Overall Study|Death|0|||
23399390|NCT00659425|65207375|FG003|Overall Study|Death|1|||
23399391|NCT00659425|65207376|FG004|Overall Study|Death|0|||
23399392|NCT00659425|65207377|FG005|Overall Study|Death|0|||
23399393|NCT00659425|65207378|FG006|Overall Study|Death|1|||
23399394|NCT00659425|65207379|FG007|Overall Study|Death|0|||
23399395|NCT00659425|65207380|FG008|Overall Study|Death|0|||
23399396|NCT00659425|65207381|FG009|Overall Study|Death|0|||
23399397|NCT00659425|65207372|FG000|Overall Study|Adverse Event|0|||
23399398|NCT00659425|65207373|FG001|Overall Study|Adverse Event|0|||
23399399|NCT00659425|65207374|FG002|Overall Study|Adverse Event|0|||
23399400|NCT00659425|65207375|FG003|Overall Study|Adverse Event|0|||
23399401|NCT00659425|65207376|FG004|Overall Study|Adverse Event|0|||
23399402|NCT00659425|65207377|FG005|Overall Study|Adverse Event|1|||
23399403|NCT00659425|65207378|FG006|Overall Study|Adverse Event|0|||
23399404|NCT00659425|65207379|FG007|Overall Study|Adverse Event|3|||
23399405|NCT00659425|65207380|FG008|Overall Study|Adverse Event|1|||
23399406|NCT00659425|65207381|FG009|Overall Study|Adverse Event|4|||
23399407|NCT00659425|65207372|FG000|Overall Study|Investigator Discretion|0|||
23399408|NCT00659425|65207373|FG001|Overall Study|Investigator Discretion|0|||
23399409|NCT00659425|65207374|FG002|Overall Study|Investigator Discretion|0|||
23399410|NCT00659425|65207375|FG003|Overall Study|Investigator Discretion|0|||
23399411|NCT00659425|65207376|FG004|Overall Study|Investigator Discretion|0|||
23399412|NCT00659425|65207377|FG005|Overall Study|Investigator Discretion|1|||
23399413|NCT00659425|65207378|FG006|Overall Study|Investigator Discretion|0|||
23399414|NCT00659425|65207379|FG007|Overall Study|Investigator Discretion|3|||
23399415|NCT00659425|65207380|FG008|Overall Study|Investigator Discretion|0|||
23399416|NCT00659425|65207381|FG009|Overall Study|Investigator Discretion|0|||
23399417|NCT00659425|65207372|FG000|Overall Study|Other|0|||
23399418|NCT00659425|65207373|FG001|Overall Study|Other|1|||
23399419|NCT00659425|65207374|FG002|Overall Study|Other|1|||
23399420|NCT00659425|65207375|FG003|Overall Study|Other|2|||
23399421|NCT00659425|65207376|FG004|Overall Study|Other|4|||
23399422|NCT00659425|65207377|FG005|Overall Study|Other|0|||
23399423|NCT00659425|65207378|FG006|Overall Study|Other|3|||
23399424|NCT00659425|65207379|FG007|Overall Study|Other|2|||
23399425|NCT00659425|65207380|FG008|Overall Study|Other|0|||
23399426|NCT00659425|65207381|FG009|Overall Study|Other|6|||
23399427|NCT00854360|65207382|FG000|Overall Study|Adverse Event|0|||
23399428|NCT00854360|65207383|FG001|Overall Study|Adverse Event|1|||
23399429|NCT00854360|65207384|FG002|Overall Study|Adverse Event|2|||
23399430|NCT00854360|65207385|FG003|Overall Study|Adverse Event|6|||
23399431|NCT00854360|65207382|FG000|Overall Study|Withdrawal by Subject|0|||
23399432|NCT00854360|65207383|FG001|Overall Study|Withdrawal by Subject|0|||
23399433|NCT00854360|65207384|FG002|Overall Study|Withdrawal by Subject|0|||
23399434|NCT00854360|65207385|FG003|Overall Study|Withdrawal by Subject|1|||
23399435|NCT00854360|65207382|FG000|Overall Study|Pregnancy|0|||
23399436|NCT00854360|65207383|FG001|Overall Study|Pregnancy|1|||
23399437|NCT00854360|65207384|FG002|Overall Study|Pregnancy|0|||
23399438|NCT00854360|65207385|FG003|Overall Study|Pregnancy|0|||
23399439|NCT00854360|65207382|FG000|Overall Study|Lack of Efficacy|2|||
23399440|NCT00854360|65207383|FG001|Overall Study|Lack of Efficacy|1|||
23399441|NCT00854360|65207384|FG002|Overall Study|Lack of Efficacy|0|||
23399442|NCT00854360|65207385|FG003|Overall Study|Lack of Efficacy|0|||
23399443|NCT00854360|65207382|FG000|Overall Study|Other|0|||
23399444|NCT00854360|65207383|FG001|Overall Study|Other|0|||
23399445|NCT00854360|65207384|FG002|Overall Study|Other|0|||
23399446|NCT00854360|65207385|FG003|Overall Study|Other|3|||
23399447|NCT04194450|65207387|FG000|Overall Study|not eligible|1|||
23399448|NCT04194450|65207388|FG001|Overall Study|not eligible|0|||
23399449|NCT01656161|65207392|FG000|Overall Study|Death|3|||
23399450|NCT01656161|65207392|FG000|Overall Study|Adverse Event|2|||
23399451|NCT01656161|65207392|FG000|Overall Study|Protocol Violation|1|||
23399452|NCT01656161|65207392|FG000|Overall Study|Withdrawal by Subject|1|||
23399453|NCT01823289|65210577|FG000|Overall Study|Lost to Follow-up|5|||
23399454|NCT01823289|65210577|FG000|Overall Study|Adverse Event|5|||
23399455|NCT01823289|65210577|FG000|Overall Study|Lack of Efficacy|1|||
23399456|NCT01823289|65210577|FG000|Overall Study|Physician Decision|9|||
23399457|NCT01823289|65210577|FG000|Overall Study|Administered contraindicated medicine|1|||
23399458|NCT01823289|65210577|FG000|Overall Study|Transaminase increased more than 3 times|1|||
23399459|NCT01823289|65210577|FG000|Overall Study|Drug affected efficacy and safety|1|||
23399460|NCT01823289|65210577|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
23399461|NCT02434081|65210578|FG000|Overall Study|Death (never started treatment)|2|||
23399462|NCT02434081|65210578|FG000|Overall Study|Death|2|||
23399463|NCT02434081|65210578|FG000|Overall Study|Progression|20|||
23399464|NCT02434081|65210578|FG000|Overall Study|Adverse Event|20|||
23399465|NCT02434081|65210578|FG000|Overall Study|Physician Decision|2|||
23399466|NCT02434081|65210578|FG000|Overall Study|Withdrawal by Subject|1|||
23399467|NCT02434081|65210578|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
23399468|NCT01854528|65210579|FG000|Overall Study|Adverse Event|0|||
23399469|NCT01854528|65210580|FG001|Overall Study|Adverse Event|4|||
23399470|NCT01854528|65210579|FG000|Overall Study|Withdrawal by Subject|0|||
23399471|NCT01854528|65210580|FG001|Overall Study|Withdrawal by Subject|2|||
23399472|NCT01854528|65210579|FG000|Overall Study|Virologic Failure|0|||
23399473|NCT01854528|65210580|FG001|Overall Study|Virologic Failure|9|||
23399474|NCT01492088|65210585|FG000|Overall Study|Withdrawal by Patient|0|||
23399475|NCT01492088|65210586|FG001|Overall Study|Withdrawal by Patient|2|||
23399476|NCT01492088|65210587|FG002|Overall Study|Withdrawal by Patient|0|||
23399477|NCT01492088|65210585|FG000|Overall Study|Death|1|||
23399478|NCT01492088|65210586|FG001|Overall Study|Death|6|||
23399479|NCT01492088|65210587|FG002|Overall Study|Death|2|||
23399480|NCT01492088|65210585|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
23399481|NCT01492088|65210586|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
23399482|NCT01492088|65210587|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
23399483|NCT01492088|65210585|FG000|Overall Study|Alive at Last Follow-up|0|||
23399484|NCT01492088|65210586|FG001|Overall Study|Alive at Last Follow-up|6|||
23399485|NCT01492088|65210587|FG002|Overall Study|Alive at Last Follow-up|11|||
23399486|NCT03186638|65210588|FG000|Overall Study|Withdrawal by Subject|4|||
23399487|NCT03186638|65210589|FG001|Overall Study|Withdrawal by Subject|4|||
23399488|NCT03186638|65210588|FG000|Overall Study|Withdrawn due to medical problem|3|||
23399489|NCT03186638|65210589|FG001|Overall Study|Withdrawn due to medical problem|2|||
23399490|NCT03186638|65210588|FG000|Overall Study|Lost to Follow-up|1|||
23399491|NCT03186638|65210589|FG001|Overall Study|Lost to Follow-up|0|||
23399492|NCT03904147|65210592|FG000|Overall Study|Death|15|||
23399493|NCT03904147|65210593|FG001|Overall Study|Death|13|||
23399494|NCT03904147|65210594|FG002|Overall Study|Death|15|||
23399495|NCT03904147|65210592|FG000|Overall Study|Withdrawal by Subject|7|||
23399496|NCT03904147|65210593|FG001|Overall Study|Withdrawal by Subject|12|||
23399497|NCT03904147|65210594|FG002|Overall Study|Withdrawal by Subject|1|||
23399498|NCT03904147|65210592|FG000|Overall Study|1Y visit completed after 365 days|1|||
23399499|NCT03904147|65210593|FG001|Overall Study|1Y visit completed after 365 days|1|||
23399500|NCT03904147|65210594|FG002|Overall Study|1Y visit completed after 365 days|0|||
23399501|NCT03984825|65210597|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
23399502|NCT03984825|65210597|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
23399503|NCT03984825|65210597|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
23399504|NCT00967616|65210598|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
23399505|NCT00967616|65210599|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
23399506|NCT00967616|65210598|FG000|Overall Study|Death|0|||
23399507|NCT00967616|65210599|FG001|Overall Study|Death|3|||
23399508|NCT00967616|65210598|FG000|Overall Study|Withdrawal by Subject|8|||
23399509|NCT00967616|65210599|FG001|Overall Study|Withdrawal by Subject|4|||
23399510|NCT00967616|65210598|FG000|Overall Study|Progressive Disease|31|||
23399511|NCT00967616|65210599|FG001|Overall Study|Progressive Disease|18|||
23399512|NCT00967616|65210598|FG000|Overall Study|Other|8|||
23399513|NCT00967616|65210599|FG001|Overall Study|Other|8|||
23399514|NCT00967616|65210598|FG000|Overall Study|Protocol Violation|1|||
23399515|NCT00967616|65210599|FG001|Overall Study|Protocol Violation|0|||
23399516|NCT01225952|65210600|FG000|Overall Study|Lost to Follow-up|1|||
23399517|NCT01225952|65210601|FG001|Overall Study|Lost to Follow-up|0|||
23399518|NCT01225952|65210602|FG002|Overall Study|Lost to Follow-up|0|||
23399519|NCT01225952|65210600|FG000|Overall Study|Study Eye Explanted|0|||
23399520|NCT01225952|65210601|FG001|Overall Study|Study Eye Explanted|0|||
23399521|NCT01225952|65210602|FG002|Overall Study|Study Eye Explanted|1|||
23399522|NCT01225952|65210600|FG000|Overall Study|Withdrawal by Subject|4|||
23399523|NCT01225952|65210601|FG001|Overall Study|Withdrawal by Subject|4|||
23399524|NCT01225952|65210602|FG002|Overall Study|Withdrawal by Subject|5|||
23399525|NCT01225952|65210600|FG000|Overall Study|Surgical complications|1|||
23399526|NCT01225952|65210601|FG001|Overall Study|Surgical complications|0|||
23399527|NCT01225952|65210602|FG002|Overall Study|Surgical complications|0|||
23399528|NCT01541371|65210603|FG000|Overall Study|Withdrawal by Subject|14|||
23399529|NCT01541371|65210603|FG000|Overall Study|Lost to Follow-up|21|||
23399530|NCT01541371|65210603|FG000|Overall Study|Adverse Event|15|||
23399531|NCT01541371|65210603|FG000|Overall Study|Lack of Efficacy|12|||
23399532|NCT01541371|65210603|FG000|Overall Study|Protocol Violation|6|||
23399533|NCT01541371|65210603|FG000|Overall Study|Study medication non-compliance|3|||
23399534|NCT01541371|65210603|FG000|Overall Study|Other|6|||
23399535|NCT01657305|65210604|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
23399536|NCT01657305|65210604|FG000|Overall Study|Withdrawal by Subject|4|||
23399537|NCT01657305|65210604|FG000|Overall Study|Adverse Event|1|||
23399538|NCT01657305|65210604|FG000|Overall Study|Lost to Follow-up|1|||
23399539|NCT01657305|65210604|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
23399540|NCT04046939|65210605|FG000|Primary Assessment Period|Adverse Event|1|||
23399541|NCT04046939|65210606|FG001|Primary Assessment Period|Adverse Event|0|||
23399542|NCT04046939|65210607|FG002|Primary Assessment Period|Adverse Event|0|||
23399543|NCT04046939|65210608|FG003|Primary Assessment Period|Adverse Event|0|||
23399544|NCT04046939|65210605|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
23399545|NCT04046939|65210606|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
23399546|NCT04046939|65210607|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
23399547|NCT04046939|65210608|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
23399548|NCT04046939|65210605|FG000|Primary Assessment Period|Physician Decision|0|||
23399549|NCT04046939|65210606|FG001|Primary Assessment Period|Physician Decision|0|||
23399550|NCT04046939|65210607|FG002|Primary Assessment Period|Physician Decision|1|||
23399551|NCT04046939|65210608|FG003|Primary Assessment Period|Physician Decision|0|||
23399552|NCT04046939|65210605|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
23399553|NCT04046939|65210606|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
23399554|NCT04046939|65210607|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
23399555|NCT04046939|65210608|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
23399556|NCT00565409|65210609|FG000|Period 1 Open Label|Adverse Event|17|||
23399557|NCT00565409|65210610|FG001|Period 1 Open Label|Adverse Event|0|||
23399558|NCT00565409|65210611|FG002|Period 1 Open Label|Adverse Event|0|||
23399559|NCT00565409|65210612|FG003|Period 1 Open Label|Adverse Event|0|||
23399560|NCT00565409|65210609|FG000|Period 1 Open Label|Death|2|||
23399561|NCT00565409|65210610|FG001|Period 1 Open Label|Death|0|||
23399562|NCT00565409|65210611|FG002|Period 1 Open Label|Death|0|||
23399563|NCT00565409|65210612|FG003|Period 1 Open Label|Death|0|||
23399564|NCT00565409|65210609|FG000|Period 1 Open Label|Lost to Follow-up|1|||
23399565|NCT00565409|65210610|FG001|Period 1 Open Label|Lost to Follow-up|0|||
23399566|NCT00565409|65210611|FG002|Period 1 Open Label|Lost to Follow-up|0|||
23399567|NCT00565409|65210612|FG003|Period 1 Open Label|Lost to Follow-up|0|||
23399568|NCT00565409|65210609|FG000|Period 1 Open Label|Other|21|||
23399569|NCT00565409|65210610|FG001|Period 1 Open Label|Other|0|||
23399570|NCT00565409|65210611|FG002|Period 1 Open Label|Other|0|||
23399571|NCT00565409|65210612|FG003|Period 1 Open Label|Other|0|||
23399572|NCT00565409|65210609|FG000|Period 1 Open Label|Protocol Violation|14|||
23399573|NCT00565409|65210610|FG001|Period 1 Open Label|Protocol Violation|0|||
23399574|NCT00565409|65210611|FG002|Period 1 Open Label|Protocol Violation|0|||
23399575|NCT00565409|65210612|FG003|Period 1 Open Label|Protocol Violation|0|||
23399576|NCT00565409|65210609|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
23399577|NCT00565409|65210610|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
23399578|NCT00565409|65210611|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
23399579|NCT00565409|65210612|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
23399580|NCT00565409|65210609|FG000|Period 1 Open Label|no conclusion of participation record|1|||
23399581|NCT00565409|65210610|FG001|Period 1 Open Label|no conclusion of participation record|0|||
23399582|NCT00565409|65210611|FG002|Period 1 Open Label|no conclusion of participation record|0|||
23399583|NCT00565409|65210612|FG003|Period 1 Open Label|no conclusion of participation record|0|||
23399584|NCT00565409|65210609|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
23399585|NCT00565409|65210610|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
23399586|NCT00565409|65210611|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
23399587|NCT00565409|65210612|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
23399588|NCT00565409|65210609|FG000|Period 2 Double-Blind|Adverse Event|0|||
23399589|NCT00565409|65210610|FG001|Period 2 Double-Blind|Adverse Event|7|||
23399590|NCT00565409|65210611|FG002|Period 2 Double-Blind|Adverse Event|4|||
23399591|NCT00565409|65210612|FG003|Period 2 Double-Blind|Adverse Event|5|||
23399592|NCT00565409|65210609|FG000|Period 2 Double-Blind|Death|0|||
23399593|NCT00565409|65210610|FG001|Period 2 Double-Blind|Death|2|||
23399594|NCT00565409|65210611|FG002|Period 2 Double-Blind|Death|0|||
23399595|NCT00565409|65210612|FG003|Period 2 Double-Blind|Death|0|||
23399596|NCT00565409|65210609|FG000|Period 2 Double-Blind|Protocol Violation|0|||
23399597|NCT00565409|65210610|FG001|Period 2 Double-Blind|Protocol Violation|4|||
23399598|NCT00565409|65210611|FG002|Period 2 Double-Blind|Protocol Violation|6|||
23399599|NCT00565409|65210612|FG003|Period 2 Double-Blind|Protocol Violation|2|||
23399600|NCT00565409|65210609|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
23399601|NCT00565409|65210610|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
23399602|NCT00565409|65210611|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
23399603|NCT00565409|65210612|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
23399604|NCT00565409|65210609|FG000|Period 2 Double-Blind|Other|0|||
23399605|NCT00565409|65210610|FG001|Period 2 Double-Blind|Other|4|||
23399606|NCT00565409|65210611|FG002|Period 2 Double-Blind|Other|5|||
23399607|NCT00565409|65210612|FG003|Period 2 Double-Blind|Other|9|||
23399608|NCT00565409|65210609|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
23399609|NCT00565409|65210610|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
23399610|NCT00565409|65210611|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
23399611|NCT00565409|65210612|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
23399612|NCT01627691|65210613|FG000|Overall Study|Death|11|||
23399613|NCT01627691|65210613|FG000|Overall Study|Lost to Follow-up|3|||
23399614|NCT01627691|65210613|FG000|Overall Study|Withdrawal by Subject|1|||
23399615|NCT01627691|65210613|FG000|Overall Study|Missed the visit|3|||
23399616|NCT02569853|65210614|FG000|Overall Study|Adverse Event|2|||
23399617|NCT02569853|65210615|FG001|Overall Study|Adverse Event|0|||
23399618|NCT02569853|65210614|FG000|Overall Study|Withdrawal by Subject|3|||
23399619|NCT02569853|65210615|FG001|Overall Study|Withdrawal by Subject|2|||
23399620|NCT02569853|65210614|FG000|Overall Study|Lost to Follow-up|3|||
23399621|NCT02569853|65210615|FG001|Overall Study|Lost to Follow-up|3|||
23399622|NCT02569853|65210614|FG000|Overall Study|Protocol Violation|1|||
23399623|NCT02569853|65210615|FG001|Overall Study|Protocol Violation|1|||
23399624|NCT02569853|65210614|FG000|Overall Study|Did not experience migraine attack|10|||
23399625|NCT02569853|65210615|FG001|Overall Study|Did not experience migraine attack|7|||
23399626|NCT02569853|65210614|FG000|Overall Study|Physician Decision|1|||
23399627|NCT02569853|65210615|FG001|Overall Study|Physician Decision|1|||
23399628|NCT03322566|65210617|FG000|Overall Study|Death|34|||
23399629|NCT03322566|65210618|FG001|Overall Study|Death|35|||
23399630|NCT03322566|65210619|FG002|Overall Study|Death|23|||
23399631|NCT03322566|65210617|FG000|Overall Study|Physician Decision|6|||
23399632|NCT03322566|65210618|FG001|Overall Study|Physician Decision|7|||
23399633|NCT03322566|65210619|FG002|Overall Study|Physician Decision|2|||
23399634|NCT03322566|65210617|FG000|Overall Study|Withdrawal by Subject|4|||
23399635|NCT03322566|65210618|FG001|Overall Study|Withdrawal by Subject|3|||
23399636|NCT03322566|65210619|FG002|Overall Study|Withdrawal by Subject|6|||
23399637|NCT03322566|65210617|FG000|Overall Study|Lost to Follow-up|0|||
23399638|NCT03322566|65210618|FG001|Overall Study|Lost to Follow-up|0|||
23399639|NCT03322566|65210619|FG002|Overall Study|Lost to Follow-up|1|||
23399640|NCT03322566|65210617|FG000|Overall Study|Study terminated by sponsor|1|||
23399641|NCT03322566|65210618|FG001|Overall Study|Study terminated by sponsor|0|||
23399642|NCT03322566|65210619|FG002|Overall Study|Study terminated by sponsor|1|||
23399643|NCT01397253|65210621|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
23399644|NCT01397253|65210622|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
23399645|NCT01307449|65210623|FG000|Overall Study|Adverse Event|1|||
23399646|NCT01307449|65210624|FG001|Overall Study|Adverse Event|0|||
23399647|NCT01307449|65210625|FG002|Overall Study|Adverse Event|0|||
23399648|NCT01307449|65210626|FG003|Overall Study|Adverse Event|0|||
23399649|NCT01887717|65210627|FG000|Overall Study|Withdrawal by Subject|1|||
23399650|NCT01887717|65210628|FG001|Overall Study|Withdrawal by Subject|7|||
23399651|NCT01887717|65210627|FG000|Overall Study|Physician Decision|0|||
23399652|NCT01887717|65210628|FG001|Overall Study|Physician Decision|2|||
23399653|NCT01887717|65210627|FG000|Overall Study|Administrative reasons|5|||
23399654|NCT01887717|65210628|FG001|Overall Study|Administrative reasons|2|||
23399655|NCT03502681|65210629|FG000|Overall Study|Adverse Event|1|||
23399656|NCT03502681|65210630|FG001|Overall Study|Adverse Event|1|||
23399657|NCT03502681|65210629|FG000|Overall Study|Disease Progression|2|||
23399658|NCT03502681|65210630|FG001|Overall Study|Disease Progression|1|||
23399659|NCT03983421|65210631|FG000|Overall Study|Lost to Follow-up|1|||
23399660|NCT00276419|65210633|FG000|First Intervention|Adverse Event|1|||
23399661|NCT00276419|65210634|FG001|First Intervention|Adverse Event|0|||
23399662|NCT00276419|65210633|FG000|First Intervention|Withdrawal by Subject|0|||
23399663|NCT00276419|65210634|FG001|First Intervention|Withdrawal by Subject|2|||
23399664|NCT00590317|65210639|FG000|Overall Study|Lack of Efficacy|1|||
23399665|NCT00590317|65210640|FG001|Overall Study|Lack of Efficacy|5|||
23399666|NCT00943761|65210641|FG000|Overall Study|Lost to Follow-up|2|||
23399667|NCT00943761|65210642|FG001|Overall Study|Lost to Follow-up|0|||
23399668|NCT00943761|65210641|FG000|Overall Study|Withdrawal by Subject|2|||
23399669|NCT00943761|65210642|FG001|Overall Study|Withdrawal by Subject|1|||
23399670|NCT00503984|65210643|FG000|Overall Study|Protocol Violation|0|||
23399671|NCT00503984|65210644|FG001|Overall Study|Protocol Violation|1|||
23399672|NCT00503984|65210645|FG002|Overall Study|Protocol Violation|0|||
23399673|NCT00503984|65210646|FG003|Overall Study|Protocol Violation|0|||
23399674|NCT00503984|65210647|FG004|Overall Study|Protocol Violation|0|||
23399675|NCT00503984|65210648|FG005|Overall Study|Protocol Violation|0|||
23399676|NCT00503984|65210643|FG000|Overall Study|Adverse Event|0|||
23399677|NCT00503984|65210644|FG001|Overall Study|Adverse Event|1|||
23399678|NCT00503984|65210645|FG002|Overall Study|Adverse Event|0|||
23399679|NCT00503984|65210646|FG003|Overall Study|Adverse Event|0|||
23399680|NCT00503984|65210647|FG004|Overall Study|Adverse Event|0|||
23399681|NCT00503984|65210648|FG005|Overall Study|Adverse Event|0|||
23399682|NCT00503984|65210643|FG000|Overall Study|Death|0|||
23399683|NCT00503984|65210644|FG001|Overall Study|Death|0|||
23399684|NCT00503984|65210645|FG002|Overall Study|Death|0|||
23399685|NCT00503984|65210646|FG003|Overall Study|Death|0|||
23399686|NCT00503984|65210647|FG004|Overall Study|Death|1|||
23399687|NCT00503984|65210648|FG005|Overall Study|Death|0|||
23399688|NCT02639390|65210649|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
23399689|NCT02639390|65210650|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
23399690|NCT02332928|65210651|FG000|Overall Study|Withdrawal by Subject|0|||
23399691|NCT02332928|65210652|FG001|Overall Study|Withdrawal by Subject|2|||
23399692|NCT02332928|65210651|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
23399693|NCT02332928|65210652|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
23399694|NCT01164007|65210660|FG000|Overall Study|Adverse Event|5|||
23399695|NCT01164007|65210660|FG000|Overall Study|Progression of Disease|30|||
23399696|NCT01164007|65210660|FG000|Overall Study|Protocol Violation|1|||
23399697|NCT01164007|65210660|FG000|Overall Study|Withdrawal by Subject|1|||
23399698|NCT01164007|65210660|FG000|Overall Study|Medical Decision|3|||
23399699|NCT01392573|65210661|FG000|Overall Study|Adverse Event|1|||
23399700|NCT01392573|65210662|FG001|Overall Study|Adverse Event|3|||
23399701|NCT01392573|65210661|FG000|Overall Study|Lack of Efficacy|1|||
23399702|NCT01392573|65210662|FG001|Overall Study|Lack of Efficacy|2|||
23399703|NCT01392573|65210661|FG000|Overall Study|Protocol Violation|0|||
23399704|NCT01392573|65210662|FG001|Overall Study|Protocol Violation|2|||
23399705|NCT01392573|65210661|FG000|Overall Study|Withdrawal Criteria|13|||
23399706|NCT01392573|65210662|FG001|Overall Study|Withdrawal Criteria|15|||
23399707|NCT01392573|65210661|FG000|Overall Study|Site closure|8|||
23399708|NCT01392573|65210662|FG001|Overall Study|Site closure|7|||
23399709|NCT01392573|65210661|FG000|Overall Study|Unclassified|9|||
23399710|NCT01392573|65210662|FG001|Overall Study|Unclassified|6|||
23399711|NCT02803203|65210663|FG000|Overall Study|Adverse Event|4|||
23399712|NCT02803203|65210663|FG000|Overall Study|Death|4|||
23399713|NCT02803203|65210663|FG000|Overall Study|Progressive disease|29|||
23399714|NCT02803203|65210663|FG000|Overall Study|Withdrawal by Subject|8|||
23399715|NCT02803203|65210663|FG000|Overall Study|Complete resection of target disease|2|||
23399716|NCT02803203|65210663|FG000|Overall Study|Switched to commercial Osi|1|||
23399717|NCT02803203|65210663|FG000|Overall Study|Participant moved away|1|||
23399718|NCT01985022|65210668|FG000|Overall Study|Lost to Follow-up|0|||
23399719|NCT01985022|65210669|FG001|Overall Study|Lost to Follow-up|1|||
23399720|NCT01985022|65210668|FG000|Overall Study|Protocol Violation|0|||
23399721|NCT01985022|65210669|FG001|Overall Study|Protocol Violation|1|||
23399722|NCT01985022|65210668|FG000|Overall Study|Withdrawal by Subject|4|||
23399723|NCT01985022|65210669|FG001|Overall Study|Withdrawal by Subject|1|||
23399724|NCT04079738|65210670|FG000|Study Treatment|Death|1|||
23399725|NCT04079738|65210671|FG001|Study Treatment|Death|0|||
23399726|NCT04079738|65210672|FG002|Study Treatment|Death|0|||
23399727|NCT04079738|65210673|FG003|Study Treatment|Death|0|||
23399728|NCT04079738|65210670|FG000|Study Treatment|Adverse Event|2|||
23399729|NCT04079738|65210671|FG001|Study Treatment|Adverse Event|0|||
23399730|NCT04079738|65210672|FG002|Study Treatment|Adverse Event|0|||
23399731|NCT04079738|65210673|FG003|Study Treatment|Adverse Event|0|||
23399732|NCT04079738|65210670|FG000|Study Treatment|withdrawal before treatment|1|||
23399733|NCT04079738|65210671|FG001|Study Treatment|withdrawal before treatment|0|||
23399734|NCT04079738|65210672|FG002|Study Treatment|withdrawal before treatment|0|||
23399735|NCT04079738|65210673|FG003|Study Treatment|withdrawal before treatment|0|||
23399736|NCT04079738|65210670|FG000|Study Treatment|symptomatic deterioration|2|||
23399737|NCT04079738|65210671|FG001|Study Treatment|symptomatic deterioration|0|||
23399738|NCT04079738|65210672|FG002|Study Treatment|symptomatic deterioration|0|||
23399739|NCT04079738|65210673|FG003|Study Treatment|symptomatic deterioration|0|||
23399740|NCT04079738|65210670|FG000|Study Treatment|Disease Progression|1|||
23399741|NCT04079738|65210671|FG001|Study Treatment|Disease Progression|0|||
23399742|NCT04079738|65210672|FG002|Study Treatment|Disease Progression|0|||
23399743|NCT04079738|65210673|FG003|Study Treatment|Disease Progression|0|||
23399744|NCT04079738|65210670|FG000|Study Treatment|withdrawal after treatment|1|||
23399745|NCT04079738|65210671|FG001|Study Treatment|withdrawal after treatment|0|||
23399746|NCT04079738|65210672|FG002|Study Treatment|withdrawal after treatment|0|||
23399747|NCT04079738|65210673|FG003|Study Treatment|withdrawal after treatment|0|||
23399748|NCT04079738|65210670|FG000|Follow up|Withdrawal by Subject|3|||
23399749|NCT04079738|65210671|FG001|Follow up|Withdrawal by Subject|0|||
23399750|NCT04079738|65210672|FG002|Follow up|Withdrawal by Subject|0|||
23399751|NCT04079738|65210673|FG003|Follow up|Withdrawal by Subject|0|||
23399752|NCT04079738|65210670|FG000|Follow up|Death|5|||
23399753|NCT04079738|65210671|FG001|Follow up|Death|0|||
23399754|NCT04079738|65210672|FG002|Follow up|Death|0|||
23399755|NCT04079738|65210673|FG003|Follow up|Death|0|||
23399756|NCT01987557|65210675|FG000|Overall Study|Protocol Violation|1|||
23399757|NCT01987557|65210676|FG001|Overall Study|Protocol Violation|0|||
23399758|NCT01987557|65210677|FG002|Overall Study|Protocol Violation|1|||
23399759|NCT01987557|65210675|FG000|Overall Study|Withdrawal by Subject|2|||
23399760|NCT01987557|65210676|FG001|Overall Study|Withdrawal by Subject|1|||
23399761|NCT01987557|65210677|FG002|Overall Study|Withdrawal by Subject|2|||
23399762|NCT01987557|65210675|FG000|Overall Study|Adverse Event|0|||
23399763|NCT01987557|65210676|FG001|Overall Study|Adverse Event|2|||
23399764|NCT01987557|65210677|FG002|Overall Study|Adverse Event|0|||
23399765|NCT01404234|65210679|FG000|Overall Study|Withdrawal by Subject|2|||
23399766|NCT00560417|65210683|FG000|Overall Study|Adverse Event|3|||
23399767|NCT00560417|65210684|FG001|Overall Study|Adverse Event|2|||
23502584|NCT01866930|65580241|FG000|Follow-up Period|Withdrawal by Subject|3|||
23502585|NCT01866930|65580242|FG001|Follow-up Period|Withdrawal by Subject|3|||
23502586|NCT04974697|65580247|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
23502587|NCT04974697|65580247|FG000|Overall Study|Lens discomfort|1|||
23502588|NCT04444895|65580248|FG000|Overall Study|Adverse Event|2|||
23399768|NCT00560417|65210683|FG000|Overall Study|Entry Criteria Not Met|1|||
23399769|NCT00560417|65210684|FG001|Overall Study|Entry Criteria Not Met|0|||
23399770|NCT00560417|65210683|FG000|Overall Study|Lost to Follow-up|0|||
23399771|NCT00560417|65210684|FG001|Overall Study|Lost to Follow-up|1|||
23399772|NCT00560417|65210683|FG000|Overall Study|Physician Decision|2|||
23399773|NCT00560417|65210684|FG001|Overall Study|Physician Decision|6|||
23399774|NCT00560417|65210683|FG000|Overall Study|Protocol Violation|6|||
23399775|NCT00560417|65210684|FG001|Overall Study|Protocol Violation|5|||
23399776|NCT00560417|65210683|FG000|Overall Study|Sponsor Decision|2|||
23399777|NCT00560417|65210684|FG001|Overall Study|Sponsor Decision|0|||
23399778|NCT00560417|65210683|FG000|Overall Study|Withdrawal by Subject|3|||
23399779|NCT00560417|65210684|FG001|Overall Study|Withdrawal by Subject|3|||
23399780|NCT01359956|65210685|FG000|Overall Study|Death|58|||
23399781|NCT01359956|65210686|FG001|Overall Study|Death|60|||
23399782|NCT01359956|65210687|FG002|Overall Study|Death|66|||
23399783|NCT01359956|65210688|FG003|Overall Study|Death|57|||
23399784|NCT01359956|65210685|FG000|Overall Study|Lost to Follow-up|3|||
23399785|NCT01359956|65210686|FG001|Overall Study|Lost to Follow-up|4|||
23399786|NCT01359956|65210687|FG002|Overall Study|Lost to Follow-up|1|||
23399787|NCT01359956|65210688|FG003|Overall Study|Lost to Follow-up|1|||
23399788|NCT05489328|65210689|FG000|Overall Study|Lost to Follow-up|0|||
23399789|NCT05489328|65210690|FG001|Overall Study|Lost to Follow-up|0|||
23399790|NCT05489328|65210691|FG002|Overall Study|Lost to Follow-up|1|||
23399791|NCT05489328|65210692|FG003|Overall Study|Lost to Follow-up|0|||
23399792|NCT05489328|65210693|FG004|Overall Study|Lost to Follow-up|2|||
23399793|NCT05489328|65210694|FG005|Overall Study|Lost to Follow-up|0|||
23399794|NCT05489328|65210695|FG006|Overall Study|Lost to Follow-up|0|||
23399795|NCT05489328|65210696|FG007|Overall Study|Lost to Follow-up|1|||
23399796|NCT05489328|65210697|FG008|Overall Study|Lost to Follow-up|0|||
23399797|NCT05489328|65210689|FG000|Overall Study|Withdrawal by Subject|0|||
23399798|NCT05489328|65210690|FG001|Overall Study|Withdrawal by Subject|0|||
23399799|NCT05489328|65210691|FG002|Overall Study|Withdrawal by Subject|0|||
23399800|NCT05489328|65210692|FG003|Overall Study|Withdrawal by Subject|0|||
23399801|NCT05489328|65210693|FG004|Overall Study|Withdrawal by Subject|0|||
23399802|NCT05489328|65210694|FG005|Overall Study|Withdrawal by Subject|0|||
23399803|NCT05489328|65210695|FG006|Overall Study|Withdrawal by Subject|1|||
23399804|NCT05489328|65210696|FG007|Overall Study|Withdrawal by Subject|1|||
23399805|NCT05489328|65210697|FG008|Overall Study|Withdrawal by Subject|0|||
23399806|NCT05489328|65210689|FG000|Overall Study|Other|0|||
23399807|NCT05489328|65210690|FG001|Overall Study|Other|0|||
23399808|NCT05489328|65210691|FG002|Overall Study|Other|0|||
23399809|NCT05489328|65210692|FG003|Overall Study|Other|0|||
23399810|NCT05489328|65210693|FG004|Overall Study|Other|0|||
23399811|NCT05489328|65210694|FG005|Overall Study|Other|0|||
23399812|NCT05489328|65210695|FG006|Overall Study|Other|0|||
23399813|NCT05489328|65210696|FG007|Overall Study|Other|1|||
23399814|NCT05489328|65210697|FG008|Overall Study|Other|1|||
23399815|NCT01143402|65210710|FG000|Overall Study|Rapid clinical decline|1|||
23399816|NCT01143402|65210711|FG001|Overall Study|Rapid clinical decline|1|||
23399817|NCT01143402|65210712|FG002|Overall Study|Rapid clinical decline|0|||
23399818|NCT01143402|65210710|FG000|Overall Study|Not Treated|0|||
23399819|NCT01143402|65210711|FG001|Overall Study|Not Treated|0|||
23399820|NCT01143402|65210712|FG002|Overall Study|Not Treated|1|||
23399821|NCT01214837|65210714|FG000|Overall Study|Death|0|||
23399822|NCT01214837|65210715|FG001|Overall Study|Death|0|||
23399823|NCT01214837|65210716|FG002|Overall Study|Death|1|||
23399824|NCT01214837|65210714|FG000|Overall Study|Adverse Event|1|||
23399825|NCT01214837|65210715|FG001|Overall Study|Adverse Event|2|||
23399826|NCT01214837|65210716|FG002|Overall Study|Adverse Event|1|||
23399827|NCT01214837|65210714|FG000|Overall Study|Withdrawal by Subject|27|||
23399828|NCT01214837|65210715|FG001|Overall Study|Withdrawal by Subject|36|||
23399829|NCT01214837|65210716|FG002|Overall Study|Withdrawal by Subject|28|||
23399830|NCT01214837|65210714|FG000|Overall Study|Lost to Follow-up|20|||
23399831|NCT01214837|65210715|FG001|Overall Study|Lost to Follow-up|15|||
23399832|NCT01214837|65210716|FG002|Overall Study|Lost to Follow-up|21|||
23399833|NCT01214837|65210714|FG000|Overall Study|Inappropriate Enrolment|0|||
23399834|NCT01214837|65210715|FG001|Overall Study|Inappropriate Enrolment|1|||
23399835|NCT01214837|65210716|FG002|Overall Study|Inappropriate Enrolment|2|||
23399836|NCT01214837|65210714|FG000|Overall Study|Administrative Reason|2|||
23399837|NCT01214837|65210715|FG001|Overall Study|Administrative Reason|6|||
23502589|NCT04444895|65580248|FG000|Overall Study|Lost to Follow-up|2|||
23502590|NCT04444895|65580248|FG000|Overall Study|Withdrawal by Subject|5|||
23502591|NCT01749137|65580249|FG000|Overall Study|Adverse Event|4|||
23502592|NCT01749137|65580250|FG001|Overall Study|Adverse Event|4|||
23502593|NCT01749137|65580249|FG000|Overall Study|Lost to Follow-up|2|||
23502594|NCT01749137|65580250|FG001|Overall Study|Lost to Follow-up|3|||
23502595|NCT01749137|65580249|FG000|Overall Study|Physician Decision|1|||
23399838|NCT01214837|65210716|FG002|Overall Study|Administrative Reason|4|||
23399839|NCT01214837|65210714|FG000|Overall Study|Protocol Violation|3|||
23399840|NCT01214837|65210715|FG001|Overall Study|Protocol Violation|1|||
23399841|NCT01214837|65210716|FG002|Overall Study|Protocol Violation|5|||
23399842|NCT01214837|65210714|FG000|Overall Study|Unable to Classify|1|||
23399843|NCT01214837|65210715|FG001|Overall Study|Unable to Classify|3|||
23399844|NCT01214837|65210716|FG002|Overall Study|Unable to Classify|0|||
23399845|NCT02493764|65210718|FG000|Overall Study|Adverse Event|2|||
23399846|NCT02493764|65210719|FG001|Overall Study|Adverse Event|2|||
23502596|NCT01749137|65580250|FG001|Overall Study|Physician Decision|0|||
23502597|NCT01749137|65580249|FG000|Overall Study|Withdrawal by Subject|8|||
23502598|NCT01749137|65580250|FG001|Overall Study|Withdrawal by Subject|4|||
23502599|NCT04659161|65580253|FG000|Overall Study|Adverse Event|10|||
23399847|NCT02493764|65210718|FG000|Overall Study|Death|44|||
23399848|NCT02493764|65210719|FG001|Overall Study|Death|58|||
23399849|NCT02493764|65210718|FG000|Overall Study|Lost to Follow-up|2|||
23399850|NCT02493764|65210719|FG001|Overall Study|Lost to Follow-up|1|||
23399851|NCT02493764|65210718|FG000|Overall Study|Protocol Violation|6|||
23399852|NCT02493764|65210719|FG001|Overall Study|Protocol Violation|7|||
23399853|NCT02493764|65210718|FG000|Overall Study|Physician Decision|1|||
23399854|NCT02493764|65210719|FG001|Overall Study|Physician Decision|1|||
23399855|NCT02493764|65210718|FG000|Overall Study|Participant moved|17|||
23399856|NCT02493764|65210719|FG001|Overall Study|Participant moved|5|||
23399857|NCT02493764|65210718|FG000|Overall Study|Withdrawal parent/guardian|0|||
23399858|NCT02493764|65210719|FG001|Overall Study|Withdrawal parent/guardian|1|||
23399859|NCT02493764|65210718|FG000|Overall Study|Withdrawal by Subject|11|||
23399860|NCT02493764|65210719|FG001|Overall Study|Withdrawal by Subject|7|||
23399861|NCT01368614|65210722|FG000|Screening Period|Screen Failure|58|||
23399862|NCT01368614|65210723|FG001|Screening Period|Screen Failure|0|||
23399863|NCT01368614|65210724|FG002|Screening Period|Screen Failure|0|||
23399864|NCT01368614|65210725|FG003|Screening Period|Screen Failure|0|||
23399865|NCT01368614|65210722|FG000|Study Period|Withdrawal by Subject|0|||
23399866|NCT01368614|65210723|FG001|Study Period|Withdrawal by Subject|1|||
23399867|NCT01368614|65210724|FG002|Study Period|Withdrawal by Subject|1|||
23399868|NCT01368614|65210725|FG003|Study Period|Withdrawal by Subject|3|||
23399869|NCT01368614|65210722|FG000|Study Period|Lost to Follow-up|0|||
23399870|NCT01368614|65210723|FG001|Study Period|Lost to Follow-up|0|||
23399871|NCT01368614|65210724|FG002|Study Period|Lost to Follow-up|1|||
23399872|NCT01368614|65210725|FG003|Study Period|Lost to Follow-up|0|||
23399873|NCT00639457|65210733|FG000|Overall Study|Withdrawal by Subject|2|||
23399874|NCT00639457|65210734|FG001|Overall Study|Withdrawal by Subject|3|||
23399875|NCT00387088|65210735|FG000|Overall Study|Adverse Event|143|||
23399876|NCT00387088|65210736|FG001|Overall Study|Adverse Event|156|||
23399877|NCT00387088|65210735|FG000|Overall Study|Protocol Violation|47|||
23399878|NCT00387088|65210736|FG001|Overall Study|Protocol Violation|35|||
23399879|NCT00387088|65210735|FG000|Overall Study|Withdrawal by Subject|20|||
23399880|NCT00387088|65210736|FG001|Overall Study|Withdrawal by Subject|35|||
23399881|NCT00387088|65210735|FG000|Overall Study|Lack of Efficacy|28|||
23399882|NCT00387088|65210736|FG001|Overall Study|Lack of Efficacy|67|||
23399883|NCT00387088|65210735|FG000|Overall Study|Lost to Follow-up|22|||
23399884|NCT00387088|65210736|FG001|Overall Study|Lost to Follow-up|28|||
23399885|NCT00387088|65210735|FG000|Overall Study|Other|58|||
23399886|NCT00387088|65210736|FG001|Overall Study|Other|52|||
23399887|NCT00237042|65210737|FG000|Treatment|Became ineligible post-randomization|0|||
23399888|NCT00237042|65210738|FG001|Treatment|Became ineligible post-randomization|1|||
23399889|NCT00237042|65210739|FG002|Treatment|Became ineligible post-randomization|16|||
23399890|NCT00237042|65210737|FG000|Treatment|Moved out of state|1|||
23399891|NCT00237042|65210738|FG001|Treatment|Moved out of state|1|||
23502600|NCT04659161|65580254|FG001|Overall Study|Adverse Event|6|||
23502601|NCT04659161|65580253|FG000|Overall Study|Withdrawal by Subject|13|||
23399892|NCT00237042|65210739|FG002|Treatment|Moved out of state|1|||
23399893|NCT00237042|65210737|FG000|Treatment|Completed no treatment|5|||
23399894|NCT00237042|65210738|FG001|Treatment|Completed no treatment|5|||
23399895|NCT00237042|65210739|FG002|Treatment|Completed no treatment|21|||
23399896|NCT00237042|65210737|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
23399897|NCT00237042|65210738|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
23399898|NCT00237042|65210739|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
23399899|NCT00237042|65210737|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
23399900|NCT00237042|65210738|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
23399901|NCT00237042|65210739|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
23399902|NCT02300233|65210740|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
23399903|NCT02300233|65210741|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
23399904|NCT02300233|65210742|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
23399905|NCT02300233|65210740|FG000|Overall Study|Withdrawal by Subject|1|||
23399906|NCT02300233|65210741|FG001|Overall Study|Withdrawal by Subject|0|||
23399907|NCT02300233|65210742|FG002|Overall Study|Withdrawal by Subject|3|||
23399908|NCT02300233|65210740|FG000|Overall Study|Investigator Judgement|0|||
23399909|NCT02300233|65210741|FG001|Overall Study|Investigator Judgement|0|||
23399910|NCT02300233|65210742|FG002|Overall Study|Investigator Judgement|1|||
23399911|NCT02300233|65210740|FG000|Overall Study|Reason Not Specified|0|||
23399912|NCT02300233|65210741|FG001|Overall Study|Reason Not Specified|0|||
23399913|NCT02300233|65210742|FG002|Overall Study|Reason Not Specified|5|||
23399914|NCT01193101|65210743|FG000|Overall Study|Adverse Event|0|||
23399915|NCT01193101|65210744|FG001|Overall Study|Adverse Event|1|||
23399916|NCT01193101|65210745|FG002|Overall Study|Adverse Event|1|||
23399917|NCT01193101|65210746|FG003|Overall Study|Adverse Event|3|||
23399918|NCT01193101|65210743|FG000|Overall Study|Lack of Efficacy|3|||
23399919|NCT01193101|65210744|FG001|Overall Study|Lack of Efficacy|1|||
23399920|NCT01193101|65210745|FG002|Overall Study|Lack of Efficacy|0|||
23399921|NCT01193101|65210746|FG003|Overall Study|Lack of Efficacy|8|||
23399922|NCT01193101|65210743|FG000|Overall Study|Withdrawal by Subject|2|||
23399923|NCT01193101|65210744|FG001|Overall Study|Withdrawal by Subject|4|||
23399924|NCT01193101|65210745|FG002|Overall Study|Withdrawal by Subject|1|||
23399925|NCT01193101|65210746|FG003|Overall Study|Withdrawal by Subject|1|||
23502602|NCT04659161|65580254|FG001|Overall Study|Withdrawal by Subject|12|||
23502603|NCT04659161|65580253|FG000|Overall Study|Other|9|||
23502604|NCT04659161|65580254|FG001|Overall Study|Other|8|||
23502605|NCT03288129|65580258|FG000|Overall Study|Adverse Event|10|||
23502606|NCT03288129|65580258|FG000|Overall Study|Lost to Follow-up|3|||
23502607|NCT03288129|65580258|FG000|Overall Study|Withdrawal by Subject|3|||
23502608|NCT03288129|65580258|FG000|Overall Study|Withdrawal of consent/assent|1|||
23502609|NCT03288129|65580258|FG000|Overall Study|Other|5|||
23502610|NCT04439110|65580259|FG000|Overall Study|Ineligible|2|||
23502611|NCT04439110|65580259|FG000|Overall Study|Adverse Event|4|||
23502612|NCT04439110|65580259|FG000|Overall Study|Death|2|||
23502613|NCT04439110|65580259|FG000|Overall Study|Disease proression|25|||
23502614|NCT04439110|65580259|FG000|Overall Study|Withdrawal by Subject|1|||
23502615|NCT04439110|65580259|FG000|Overall Study|Alternative therapy|1|||
23502616|NCT04439110|65580259|FG000|Overall Study|Other complicating disease|1|||
23502617|NCT04439110|65580259|FG000|Overall Study|Personal reasons|1|||
23502618|NCT04439110|65580259|FG000|Overall Study|Still on treatment|1|||
23502619|NCT01550289|65580263|FG000|Overall Study|Protocol Violation|1|||
23502620|NCT01550289|65580264|FG001|Overall Study|Protocol Violation|0|||
23502621|NCT01550289|65580263|FG000|Overall Study|Lost to Follow-up|1|||
23502622|NCT01550289|65580264|FG001|Overall Study|Lost to Follow-up|1|||
23502623|NCT01550289|65580263|FG000|Overall Study|Withdrawal by Subject|11|||
23502624|NCT01550289|65580264|FG001|Overall Study|Withdrawal by Subject|3|||
23502625|NCT00826943|65580265|FG000|Overall Study|Withdrawal by Subject|0|||
23300778|NCT01843348|64842924|FG001|Overall Study|Various reasons|9|||
23399926|NCT01193101|65210743|FG000|Overall Study|Administrative problems|0|||
23399927|NCT01193101|65210744|FG001|Overall Study|Administrative problems|0|||
23399928|NCT01193101|65210745|FG002|Overall Study|Administrative problems|1|||
23399929|NCT01193101|65210746|FG003|Overall Study|Administrative problems|0|||
23399930|NCT01193101|65210743|FG000|Overall Study|Abnormal test procedure results|0|||
23399931|NCT01193101|65210744|FG001|Overall Study|Abnormal test procedure results|1|||
23399932|NCT01193101|65210745|FG002|Overall Study|Abnormal test procedure results|0|||
23399933|NCT01193101|65210746|FG003|Overall Study|Abnormal test procedure results|0|||
23399934|NCT03692403|65210747|FG000|Overall Study|Withdrawal by Subject|1|||
23399935|NCT03692403|65210748|FG001|Overall Study|Withdrawal by Subject|0|||
23399936|NCT03692403|65210749|FG002|Overall Study|Withdrawal by Subject|1|||
23399937|NCT03692403|65210750|FG003|Overall Study|Withdrawal by Subject|0|||
23399938|NCT03692403|65210747|FG000|Overall Study|Adverse Event|0|||
23399939|NCT03692403|65210748|FG001|Overall Study|Adverse Event|0|||
23399940|NCT03692403|65210749|FG002|Overall Study|Adverse Event|0|||
23399941|NCT03692403|65210750|FG003|Overall Study|Adverse Event|1|||
23399942|NCT03692403|65210747|FG000|Overall Study|Pregnancy|0|||
23399943|NCT03692403|65210748|FG001|Overall Study|Pregnancy|1|||
23399944|NCT03692403|65210749|FG002|Overall Study|Pregnancy|0|||
23502626|NCT00826943|65580266|FG001|Overall Study|Withdrawal by Subject|0|||
23502627|NCT00826943|65580267|FG002|Overall Study|Withdrawal by Subject|0|||
23502628|NCT00826943|65580268|FG003|Overall Study|Withdrawal by Subject|0|||
23502629|NCT00826943|65580269|FG004|Overall Study|Withdrawal by Subject|1|||
23300779|NCT01843348|64842925|FG002|Overall Study|Various reasons|6|||
23300780|NCT02972502|64842926|FG000|Overall Study|Lost to Follow-up|3|||
23502630|NCT00826943|65580270|FG005|Overall Study|Withdrawal by Subject|0|||
23502631|NCT00042289|65580271|FG000|Overall Study|Lost to Follow-up|3|||
23502632|NCT00042289|65580272|FG001|Overall Study|Lost to Follow-up|0|||
23502633|NCT00042289|65580273|FG002|Overall Study|Lost to Follow-up|0|||
23502634|NCT00042289|65580274|FG003|Overall Study|Lost to Follow-up|1|||
23502635|NCT00042289|65580275|FG004|Overall Study|Lost to Follow-up|3|||
23502636|NCT00042289|65580276|FG005|Overall Study|Lost to Follow-up|3|||
23502637|NCT00042289|65580277|FG006|Overall Study|Lost to Follow-up|6|||
23502638|NCT00042289|65580278|FG007|Overall Study|Lost to Follow-up|1|||
23502639|NCT00042289|65580279|FG008|Overall Study|Lost to Follow-up|1|||
23502640|NCT00042289|65580280|FG009|Overall Study|Lost to Follow-up|0|||
23502641|NCT00042289|65580281|FG010|Overall Study|Lost to Follow-up|0|||
23502642|NCT00042289|65580282|FG011|Overall Study|Lost to Follow-up|0|||
23502643|NCT00042289|65580283|FG012|Overall Study|Lost to Follow-up|0|||
23502644|NCT00042289|65580284|FG013|Overall Study|Lost to Follow-up|0|||
23502645|NCT00042289|65580285|FG014|Overall Study|Lost to Follow-up|0|||
23502646|NCT00042289|65580286|FG015|Overall Study|Lost to Follow-up|1|||
23502647|NCT00042289|65580287|FG016|Overall Study|Lost to Follow-up|1|||
23502648|NCT00042289|65580288|FG017|Overall Study|Lost to Follow-up|0|||
23502649|NCT00042289|65580289|FG018|Overall Study|Lost to Follow-up|3|||
23502650|NCT00042289|65580290|FG019|Overall Study|Lost to Follow-up|2|||
23502651|NCT00042289|65580291|FG020|Overall Study|Lost to Follow-up|0|||
23502652|NCT00042289|65580292|FG021|Overall Study|Lost to Follow-up|0|||
23502653|NCT00042289|65580293|FG022|Overall Study|Lost to Follow-up|0|||
23502654|NCT00042289|65580294|FG023|Overall Study|Lost to Follow-up|0|||
23502655|NCT00042289|65580295|FG024|Overall Study|Lost to Follow-up|0|||
23502656|NCT00042289|65580296|FG025|Overall Study|Lost to Follow-up|0|||
23502657|NCT00042289|65580297|FG026|Overall Study|Lost to Follow-up|2|||
23502658|NCT00042289|65580298|FG027|Overall Study|Lost to Follow-up|2|||
23502659|NCT00042289|65580299|FG028|Overall Study|Lost to Follow-up|2|||
23502660|NCT00042289|65580300|FG029|Overall Study|Lost to Follow-up|0|||
23502661|NCT00042289|65580301|FG030|Overall Study|Lost to Follow-up|0|||
23502662|NCT00042289|65580302|FG031|Overall Study|Lost to Follow-up|2|||
23502663|NCT00042289|65580303|FG032|Overall Study|Lost to Follow-up|1|||
23502664|NCT00042289|65580304|FG033|Overall Study|Lost to Follow-up|1|||
23502665|NCT00042289|65580305|FG034|Overall Study|Lost to Follow-up|1|||
23502666|NCT00042289|65580306|FG035|Overall Study|Lost to Follow-up|2|||
23502667|NCT00042289|65580307|FG036|Overall Study|Lost to Follow-up|1|||
23502668|NCT00042289|65580308|FG037|Overall Study|Lost to Follow-up|1|||
23502669|NCT00042289|65580309|FG038|Overall Study|Lost to Follow-up|0|||
23502670|NCT00042289|65580310|FG039|Overall Study|Lost to Follow-up|5|||
23502671|NCT00042289|65580311|FG040|Overall Study|Lost to Follow-up|0|||
23502672|NCT00042289|65580312|FG041|Overall Study|Lost to Follow-up|2|||
23502673|NCT00042289|65580313|FG042|Overall Study|Lost to Follow-up|2|||
23502674|NCT00042289|65580314|FG043|Overall Study|Lost to Follow-up|0|||
23502675|NCT00042289|65580315|FG044|Overall Study|Lost to Follow-up|0|||
23502676|NCT00042289|65580316|FG045|Overall Study|Lost to Follow-up|1|||
23502677|NCT00042289|65580317|FG046|Overall Study|Lost to Follow-up|0|||
23502678|NCT00042289|65580271|FG000|Overall Study|Other reason|0|||
23502679|NCT00042289|65580272|FG001|Overall Study|Other reason|0|||
23502680|NCT00042289|65580273|FG002|Overall Study|Other reason|0|||
23502681|NCT00042289|65580274|FG003|Overall Study|Other reason|2|||
23502682|NCT00042289|65580275|FG004|Overall Study|Other reason|0|||
23502683|NCT00042289|65580276|FG005|Overall Study|Other reason|0|||
23502684|NCT00042289|65580277|FG006|Overall Study|Other reason|0|||
23502685|NCT00042289|65580278|FG007|Overall Study|Other reason|0|||
23502686|NCT00042289|65580279|FG008|Overall Study|Other reason|0|||
23502687|NCT00042289|65580280|FG009|Overall Study|Other reason|0|||
23502688|NCT00042289|65580281|FG010|Overall Study|Other reason|0|||
23502689|NCT00042289|65580282|FG011|Overall Study|Other reason|0|||
23502690|NCT00042289|65580283|FG012|Overall Study|Other reason|0|||
23502691|NCT00042289|65580284|FG013|Overall Study|Other reason|0|||
23502692|NCT00042289|65580285|FG014|Overall Study|Other reason|0|||
23502693|NCT00042289|65580286|FG015|Overall Study|Other reason|0|||
23502694|NCT00042289|65580287|FG016|Overall Study|Other reason|0|||
23502695|NCT00042289|65580288|FG017|Overall Study|Other reason|0|||
23502696|NCT00042289|65580289|FG018|Overall Study|Other reason|1|||
23502697|NCT00042289|65580290|FG019|Overall Study|Other reason|0|||
23502698|NCT00042289|65580291|FG020|Overall Study|Other reason|0|||
23502699|NCT00042289|65580292|FG021|Overall Study|Other reason|0|||
23502700|NCT00042289|65580293|FG022|Overall Study|Other reason|0|||
23502701|NCT00042289|65580294|FG023|Overall Study|Other reason|1|||
23502702|NCT00042289|65580295|FG024|Overall Study|Other reason|0|||
23502703|NCT00042289|65580296|FG025|Overall Study|Other reason|0|||
23502704|NCT00042289|65580297|FG026|Overall Study|Other reason|1|||
23502705|NCT00042289|65580298|FG027|Overall Study|Other reason|0|||
23502706|NCT00042289|65580299|FG028|Overall Study|Other reason|3|||
23502707|NCT00042289|65580300|FG029|Overall Study|Other reason|0|||
23502708|NCT00042289|65580301|FG030|Overall Study|Other reason|0|||
23502709|NCT00042289|65580302|FG031|Overall Study|Other reason|1|||
23502710|NCT00042289|65580303|FG032|Overall Study|Other reason|0|||
23502711|NCT00042289|65580304|FG033|Overall Study|Other reason|1|||
23502712|NCT00042289|65580305|FG034|Overall Study|Other reason|0|||
23502713|NCT00042289|65580306|FG035|Overall Study|Other reason|2|||
23502714|NCT00042289|65580307|FG036|Overall Study|Other reason|0|||
23502715|NCT00042289|65580308|FG037|Overall Study|Other reason|0|||
23502716|NCT00042289|65580309|FG038|Overall Study|Other reason|0|||
23502717|NCT00042289|65580310|FG039|Overall Study|Other reason|0|||
23502718|NCT00042289|65580311|FG040|Overall Study|Other reason|0|||
23502719|NCT00042289|65580312|FG041|Overall Study|Other reason|0|||
23502720|NCT00042289|65580313|FG042|Overall Study|Other reason|0|||
23502721|NCT00042289|65580314|FG043|Overall Study|Other reason|1|||
23502722|NCT00042289|65580315|FG044|Overall Study|Other reason|0|||
23502723|NCT00042289|65580316|FG045|Overall Study|Other reason|0|||
23502724|NCT00042289|65580317|FG046|Overall Study|Other reason|0|||
23502725|NCT00042289|65580271|FG000|Overall Study|Severe debilitation, unable to continue|0|||
23502726|NCT00042289|65580272|FG001|Overall Study|Severe debilitation, unable to continue|0|||
23502727|NCT00042289|65580273|FG002|Overall Study|Severe debilitation, unable to continue|0|||
23502728|NCT00042289|65580274|FG003|Overall Study|Severe debilitation, unable to continue|0|||
23502729|NCT00042289|65580275|FG004|Overall Study|Severe debilitation, unable to continue|0|||
23502730|NCT00042289|65580276|FG005|Overall Study|Severe debilitation, unable to continue|0|||
23502731|NCT00042289|65580277|FG006|Overall Study|Severe debilitation, unable to continue|0|||
23502732|NCT00042289|65580278|FG007|Overall Study|Severe debilitation, unable to continue|0|||
23502733|NCT00042289|65580279|FG008|Overall Study|Severe debilitation, unable to continue|0|||
23502734|NCT00042289|65580280|FG009|Overall Study|Severe debilitation, unable to continue|0|||
23502735|NCT00042289|65580281|FG010|Overall Study|Severe debilitation, unable to continue|0|||
23502736|NCT00042289|65580282|FG011|Overall Study|Severe debilitation, unable to continue|0|||
23502737|NCT00042289|65580283|FG012|Overall Study|Severe debilitation, unable to continue|0|||
23502738|NCT00042289|65580284|FG013|Overall Study|Severe debilitation, unable to continue|0|||
23502739|NCT00042289|65580285|FG014|Overall Study|Severe debilitation, unable to continue|0|||
23502740|NCT00042289|65580286|FG015|Overall Study|Severe debilitation, unable to continue|0|||
23502741|NCT00042289|65580287|FG016|Overall Study|Severe debilitation, unable to continue|0|||
23502742|NCT00042289|65580288|FG017|Overall Study|Severe debilitation, unable to continue|0|||
23502743|NCT00042289|65580289|FG018|Overall Study|Severe debilitation, unable to continue|0|||
23502744|NCT00042289|65580290|FG019|Overall Study|Severe debilitation, unable to continue|0|||
23502745|NCT00042289|65580291|FG020|Overall Study|Severe debilitation, unable to continue|0|||
23502746|NCT00042289|65580292|FG021|Overall Study|Severe debilitation, unable to continue|1|||
23502747|NCT00042289|65580293|FG022|Overall Study|Severe debilitation, unable to continue|0|||
23502748|NCT00042289|65580294|FG023|Overall Study|Severe debilitation, unable to continue|1|||
23502749|NCT00042289|65580295|FG024|Overall Study|Severe debilitation, unable to continue|0|||
23502750|NCT00042289|65580296|FG025|Overall Study|Severe debilitation, unable to continue|0|||
23502751|NCT00042289|65580297|FG026|Overall Study|Severe debilitation, unable to continue|0|||
23502752|NCT00042289|65580298|FG027|Overall Study|Severe debilitation, unable to continue|1|||
23502753|NCT00042289|65580299|FG028|Overall Study|Severe debilitation, unable to continue|0|||
23502754|NCT00042289|65580300|FG029|Overall Study|Severe debilitation, unable to continue|0|||
23502755|NCT00042289|65580301|FG030|Overall Study|Severe debilitation, unable to continue|0|||
23502756|NCT00042289|65580302|FG031|Overall Study|Severe debilitation, unable to continue|1|||
23502757|NCT00042289|65580303|FG032|Overall Study|Severe debilitation, unable to continue|1|||
23502758|NCT00042289|65580304|FG033|Overall Study|Severe debilitation, unable to continue|0|||
23502759|NCT00042289|65580305|FG034|Overall Study|Severe debilitation, unable to continue|0|||
23502760|NCT00042289|65580306|FG035|Overall Study|Severe debilitation, unable to continue|0|||
23502761|NCT00042289|65580307|FG036|Overall Study|Severe debilitation, unable to continue|0|||
23502762|NCT00042289|65580308|FG037|Overall Study|Severe debilitation, unable to continue|0|||
23502763|NCT00042289|65580309|FG038|Overall Study|Severe debilitation, unable to continue|0|||
23502764|NCT00042289|65580310|FG039|Overall Study|Severe debilitation, unable to continue|0|||
23502765|NCT00042289|65580311|FG040|Overall Study|Severe debilitation, unable to continue|0|||
23502766|NCT00042289|65580312|FG041|Overall Study|Severe debilitation, unable to continue|0|||
23502767|NCT00042289|65580313|FG042|Overall Study|Severe debilitation, unable to continue|0|||
23502768|NCT00042289|65580314|FG043|Overall Study|Severe debilitation, unable to continue|0|||
23502769|NCT00042289|65580315|FG044|Overall Study|Severe debilitation, unable to continue|0|||
23502770|NCT00042289|65580316|FG045|Overall Study|Severe debilitation, unable to continue|0|||
23502771|NCT00042289|65580317|FG046|Overall Study|Severe debilitation, unable to continue|0|||
23502772|NCT00042289|65580271|FG000|Overall Study|Site closed|0|||
23502773|NCT00042289|65580272|FG001|Overall Study|Site closed|0|||
23502774|NCT00042289|65580273|FG002|Overall Study|Site closed|0|||
23502775|NCT00042289|65580274|FG003|Overall Study|Site closed|0|||
23502776|NCT00042289|65580275|FG004|Overall Study|Site closed|0|||
23502777|NCT00042289|65580276|FG005|Overall Study|Site closed|0|||
23502778|NCT00042289|65580277|FG006|Overall Study|Site closed|0|||
23502779|NCT00042289|65580278|FG007|Overall Study|Site closed|0|||
23502780|NCT00042289|65580279|FG008|Overall Study|Site closed|0|||
23502781|NCT00042289|65580280|FG009|Overall Study|Site closed|0|||
23502782|NCT00042289|65580281|FG010|Overall Study|Site closed|0|||
23502783|NCT00042289|65580282|FG011|Overall Study|Site closed|0|||
23502784|NCT00042289|65580283|FG012|Overall Study|Site closed|0|||
23502785|NCT00042289|65580284|FG013|Overall Study|Site closed|0|||
23502786|NCT00042289|65580285|FG014|Overall Study|Site closed|0|||
23502787|NCT00042289|65580286|FG015|Overall Study|Site closed|0|||
23502788|NCT00042289|65580287|FG016|Overall Study|Site closed|0|||
23502789|NCT00042289|65580288|FG017|Overall Study|Site closed|0|||
23502790|NCT00042289|65580289|FG018|Overall Study|Site closed|0|||
23502791|NCT00042289|65580290|FG019|Overall Study|Site closed|0|||
23502792|NCT00042289|65580291|FG020|Overall Study|Site closed|0|||
23502793|NCT00042289|65580292|FG021|Overall Study|Site closed|0|||
23502794|NCT00042289|65580293|FG022|Overall Study|Site closed|0|||
23502795|NCT00042289|65580294|FG023|Overall Study|Site closed|0|||
23502796|NCT00042289|65580295|FG024|Overall Study|Site closed|0|||
23502797|NCT00042289|65580296|FG025|Overall Study|Site closed|0|||
23502798|NCT00042289|65580297|FG026|Overall Study|Site closed|0|||
23502799|NCT00042289|65580298|FG027|Overall Study|Site closed|0|||
23502800|NCT00042289|65580299|FG028|Overall Study|Site closed|0|||
23502801|NCT00042289|65580300|FG029|Overall Study|Site closed|0|||
23502802|NCT00042289|65580301|FG030|Overall Study|Site closed|0|||
23502803|NCT00042289|65580302|FG031|Overall Study|Site closed|3|||
23502804|NCT00042289|65580303|FG032|Overall Study|Site closed|0|||
23502805|NCT00042289|65580304|FG033|Overall Study|Site closed|0|||
23502806|NCT00042289|65580305|FG034|Overall Study|Site closed|0|||
23502807|NCT00042289|65580306|FG035|Overall Study|Site closed|0|||
23502808|NCT00042289|65580307|FG036|Overall Study|Site closed|1|||
23502809|NCT00042289|65580308|FG037|Overall Study|Site closed|0|||
23502810|NCT00042289|65580309|FG038|Overall Study|Site closed|0|||
23502811|NCT00042289|65580310|FG039|Overall Study|Site closed|0|||
23502812|NCT00042289|65580311|FG040|Overall Study|Site closed|0|||
23502813|NCT00042289|65580312|FG041|Overall Study|Site closed|0|||
23502814|NCT00042289|65580313|FG042|Overall Study|Site closed|1|||
23502815|NCT00042289|65580314|FG043|Overall Study|Site closed|0|||
23502816|NCT00042289|65580315|FG044|Overall Study|Site closed|0|||
23502817|NCT00042289|65580316|FG045|Overall Study|Site closed|0|||
23502818|NCT00042289|65580317|FG046|Overall Study|Site closed|0|||
23502819|NCT00042289|65580271|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
23502820|NCT00042289|65580272|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
23502821|NCT00042289|65580273|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
23502822|NCT00042289|65580274|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
23502823|NCT00042289|65580275|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
23502824|NCT00042289|65580276|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
23502825|NCT00042289|65580277|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
23502826|NCT00042289|65580278|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
23502827|NCT00042289|65580279|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
23502828|NCT00042289|65580280|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
23502829|NCT00042289|65580281|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
23502830|NCT00042289|65580282|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
23502831|NCT00042289|65580283|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
23502832|NCT00042289|65580284|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
23502833|NCT00042289|65580285|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
23502834|NCT00042289|65580286|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
23502835|NCT00042289|65580287|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
23502836|NCT00042289|65580288|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
23502837|NCT00042289|65580289|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
23502838|NCT00042289|65580290|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
23502839|NCT00042289|65580291|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
23502840|NCT00042289|65580292|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
23502841|NCT00042289|65580293|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
23502842|NCT00042289|65580294|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
23502843|NCT00042289|65580295|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
23502844|NCT00042289|65580296|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
23502845|NCT00042289|65580297|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
23502846|NCT00042289|65580298|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
23502847|NCT00042289|65580299|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
23502848|NCT00042289|65580300|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
23502849|NCT00042289|65580301|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
23502850|NCT00042289|65580302|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
23502851|NCT00042289|65580303|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
23502852|NCT00042289|65580304|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
23502853|NCT00042289|65580305|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
23502854|NCT00042289|65580306|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
23502855|NCT00042289|65580307|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
23502856|NCT00042289|65580308|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
23502857|NCT00042289|65580309|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
23502858|NCT00042289|65580310|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
23502859|NCT00042289|65580311|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
23502860|NCT00042289|65580312|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
23502861|NCT00042289|65580313|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
23502862|NCT00042289|65580314|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
23502863|NCT00042289|65580315|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
23502864|NCT00042289|65580316|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
23502865|NCT00042289|65580317|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
23502866|NCT00042289|65580271|FG000|Overall Study|Protocol Violation|0|||
23502867|NCT00042289|65580272|FG001|Overall Study|Protocol Violation|0|||
23502868|NCT00042289|65580273|FG002|Overall Study|Protocol Violation|0|||
23502869|NCT00042289|65580274|FG003|Overall Study|Protocol Violation|0|||
23502870|NCT00042289|65580275|FG004|Overall Study|Protocol Violation|0|||
23502871|NCT00042289|65580276|FG005|Overall Study|Protocol Violation|1|||
23502872|NCT00042289|65580277|FG006|Overall Study|Protocol Violation|0|||
23502873|NCT00042289|65580278|FG007|Overall Study|Protocol Violation|1|||
23502874|NCT00042289|65580279|FG008|Overall Study|Protocol Violation|0|||
23502875|NCT00042289|65580280|FG009|Overall Study|Protocol Violation|0|||
23502876|NCT00042289|65580281|FG010|Overall Study|Protocol Violation|0|||
23502877|NCT00042289|65580282|FG011|Overall Study|Protocol Violation|0|||
23502878|NCT00042289|65580283|FG012|Overall Study|Protocol Violation|0|||
23502879|NCT00042289|65580284|FG013|Overall Study|Protocol Violation|0|||
23502880|NCT00042289|65580285|FG014|Overall Study|Protocol Violation|0|||
23502881|NCT00042289|65580286|FG015|Overall Study|Protocol Violation|0|||
23502882|NCT00042289|65580287|FG016|Overall Study|Protocol Violation|0|||
23502883|NCT00042289|65580288|FG017|Overall Study|Protocol Violation|0|||
23502884|NCT00042289|65580289|FG018|Overall Study|Protocol Violation|0|||
23502885|NCT00042289|65580290|FG019|Overall Study|Protocol Violation|0|||
23502886|NCT00042289|65580291|FG020|Overall Study|Protocol Violation|0|||
23502887|NCT00042289|65580292|FG021|Overall Study|Protocol Violation|0|||
23502888|NCT00042289|65580293|FG022|Overall Study|Protocol Violation|0|||
23502889|NCT00042289|65580294|FG023|Overall Study|Protocol Violation|1|||
23502890|NCT00042289|65580295|FG024|Overall Study|Protocol Violation|1|||
23502891|NCT00042289|65580296|FG025|Overall Study|Protocol Violation|0|||
23502892|NCT00042289|65580297|FG026|Overall Study|Protocol Violation|2|||
23502893|NCT00042289|65580298|FG027|Overall Study|Protocol Violation|0|||
23502894|NCT00042289|65580299|FG028|Overall Study|Protocol Violation|0|||
23502895|NCT00042289|65580300|FG029|Overall Study|Protocol Violation|0|||
23502896|NCT00042289|65580301|FG030|Overall Study|Protocol Violation|1|||
23502897|NCT00042289|65580302|FG031|Overall Study|Protocol Violation|0|||
23502898|NCT00042289|65580303|FG032|Overall Study|Protocol Violation|0|||
23502899|NCT00042289|65580304|FG033|Overall Study|Protocol Violation|0|||
23502900|NCT00042289|65580305|FG034|Overall Study|Protocol Violation|0|||
23502901|NCT00042289|65580306|FG035|Overall Study|Protocol Violation|0|||
23502902|NCT00042289|65580307|FG036|Overall Study|Protocol Violation|0|||
23502903|NCT00042289|65580308|FG037|Overall Study|Protocol Violation|0|||
23502904|NCT00042289|65580309|FG038|Overall Study|Protocol Violation|0|||
23502905|NCT00042289|65580310|FG039|Overall Study|Protocol Violation|0|||
23502906|NCT00042289|65580311|FG040|Overall Study|Protocol Violation|0|||
23502907|NCT00042289|65580312|FG041|Overall Study|Protocol Violation|1|||
23502908|NCT00042289|65580313|FG042|Overall Study|Protocol Violation|1|||
23502909|NCT00042289|65580314|FG043|Overall Study|Protocol Violation|1|||
23502910|NCT00042289|65580315|FG044|Overall Study|Protocol Violation|0|||
23502911|NCT00042289|65580316|FG045|Overall Study|Protocol Violation|0|||
23502912|NCT00042289|65580317|FG046|Overall Study|Protocol Violation|0|||
23502913|NCT00042289|65580271|FG000|Overall Study|Withdrawal by Subject|4|||
23502914|NCT00042289|65580272|FG001|Overall Study|Withdrawal by Subject|1|||
23502915|NCT00042289|65580273|FG002|Overall Study|Withdrawal by Subject|0|||
23502916|NCT00042289|65580274|FG003|Overall Study|Withdrawal by Subject|2|||
23502917|NCT00042289|65580275|FG004|Overall Study|Withdrawal by Subject|0|||
23502918|NCT00042289|65580276|FG005|Overall Study|Withdrawal by Subject|2|||
23502919|NCT00042289|65580277|FG006|Overall Study|Withdrawal by Subject|0|||
23502920|NCT00042289|65580278|FG007|Overall Study|Withdrawal by Subject|0|||
23502921|NCT00042289|65580279|FG008|Overall Study|Withdrawal by Subject|0|||
23502922|NCT00042289|65580280|FG009|Overall Study|Withdrawal by Subject|1|||
23502923|NCT00042289|65580281|FG010|Overall Study|Withdrawal by Subject|0|||
23502924|NCT00042289|65580282|FG011|Overall Study|Withdrawal by Subject|0|||
23502925|NCT00042289|65580283|FG012|Overall Study|Withdrawal by Subject|2|||
23502926|NCT00042289|65580284|FG013|Overall Study|Withdrawal by Subject|0|||
23502927|NCT00042289|65580285|FG014|Overall Study|Withdrawal by Subject|0|||
23502928|NCT00042289|65580286|FG015|Overall Study|Withdrawal by Subject|0|||
23502929|NCT00042289|65580287|FG016|Overall Study|Withdrawal by Subject|0|||
23502930|NCT00042289|65580288|FG017|Overall Study|Withdrawal by Subject|0|||
23502931|NCT00042289|65580289|FG018|Overall Study|Withdrawal by Subject|0|||
23502932|NCT00042289|65580290|FG019|Overall Study|Withdrawal by Subject|0|||
23502933|NCT00042289|65580291|FG020|Overall Study|Withdrawal by Subject|0|||
23502934|NCT00042289|65580292|FG021|Overall Study|Withdrawal by Subject|1|||
23502935|NCT00042289|65580293|FG022|Overall Study|Withdrawal by Subject|1|||
23502936|NCT00042289|65580294|FG023|Overall Study|Withdrawal by Subject|1|||
23502937|NCT00042289|65580295|FG024|Overall Study|Withdrawal by Subject|0|||
23502938|NCT00042289|65580296|FG025|Overall Study|Withdrawal by Subject|0|||
23502939|NCT00042289|65580297|FG026|Overall Study|Withdrawal by Subject|1|||
23502940|NCT00042289|65580298|FG027|Overall Study|Withdrawal by Subject|0|||
23399945|NCT03692403|65210750|FG003|Overall Study|Pregnancy|0|||
23399946|NCT03692403|65210747|FG000|Overall Study|Other|0|||
23399947|NCT03692403|65210748|FG001|Overall Study|Other|0|||
23399948|NCT03692403|65210749|FG002|Overall Study|Other|1|||
23399949|NCT03692403|65210750|FG003|Overall Study|Other|0|||
23399950|NCT00060944|65210751|FG000|Overall Study|Adverse Event|12|||
23399951|NCT00060944|65210752|FG001|Overall Study|Adverse Event|10|||
23399952|NCT00060944|65210751|FG000|Overall Study|Death|2|||
23399953|NCT00060944|65210752|FG001|Overall Study|Death|3|||
23399954|NCT00060944|65210751|FG000|Overall Study|Withdrawal by Subject|18|||
23399955|NCT00060944|65210752|FG001|Overall Study|Withdrawal by Subject|5|||
23399956|NCT00060944|65210751|FG000|Overall Study|Disease Progression|93|||
23399957|NCT00060944|65210752|FG001|Overall Study|Disease Progression|94|||
23399958|NCT00060944|65210751|FG000|Overall Study|Lost to Follow-up|1|||
23399959|NCT00060944|65210752|FG001|Overall Study|Lost to Follow-up|0|||
23399960|NCT00060944|65210751|FG000|Overall Study|Subject Ineligible To Continue|2|||
23399961|NCT00060944|65210752|FG001|Overall Study|Subject Ineligible To Continue|1|||
23399962|NCT00060944|65210751|FG000|Overall Study|Treatment Switch|0|||
23399963|NCT00060944|65210752|FG001|Overall Study|Treatment Switch|13|||
23399964|NCT00060944|65210751|FG000|Overall Study|Other|2|||
23502941|NCT00042289|65580299|FG028|Overall Study|Withdrawal by Subject|2|||
23502942|NCT00042289|65580300|FG029|Overall Study|Withdrawal by Subject|0|||
23502943|NCT00042289|65580301|FG030|Overall Study|Withdrawal by Subject|0|||
23502944|NCT00042289|65580302|FG031|Overall Study|Withdrawal by Subject|1|||
23502945|NCT00042289|65580303|FG032|Overall Study|Withdrawal by Subject|2|||
23502946|NCT00042289|65580304|FG033|Overall Study|Withdrawal by Subject|1|||
23502947|NCT00042289|65580305|FG034|Overall Study|Withdrawal by Subject|0|||
23502948|NCT00042289|65580306|FG035|Overall Study|Withdrawal by Subject|0|||
23502949|NCT00042289|65580307|FG036|Overall Study|Withdrawal by Subject|0|||
23502950|NCT00042289|65580308|FG037|Overall Study|Withdrawal by Subject|1|||
23502951|NCT00042289|65580309|FG038|Overall Study|Withdrawal by Subject|0|||
23502952|NCT00042289|65580310|FG039|Overall Study|Withdrawal by Subject|0|||
23502953|NCT00042289|65580311|FG040|Overall Study|Withdrawal by Subject|0|||
23502954|NCT00042289|65580312|FG041|Overall Study|Withdrawal by Subject|0|||
23502955|NCT00042289|65580313|FG042|Overall Study|Withdrawal by Subject|1|||
23502956|NCT00042289|65580314|FG043|Overall Study|Withdrawal by Subject|0|||
23502957|NCT00042289|65580315|FG044|Overall Study|Withdrawal by Subject|0|||
23502958|NCT00042289|65580316|FG045|Overall Study|Withdrawal by Subject|0|||
23502959|NCT00042289|65580317|FG046|Overall Study|Withdrawal by Subject|0|||
23502960|NCT00833794|65580330|FG000|Open-label Phase|Adverse Event|225|||
23502961|NCT00833794|65580331|FG001|Open-label Phase|Adverse Event|0|||
23502962|NCT00833794|65580330|FG000|Open-label Phase|Lack of Efficacy|28|||
23502963|NCT00833794|65580331|FG001|Open-label Phase|Lack of Efficacy|0|||
23502964|NCT00833794|65580330|FG000|Open-label Phase|Withdrawal by Subject|48|||
23502965|NCT00833794|65580331|FG001|Open-label Phase|Withdrawal by Subject|0|||
23502966|NCT00833794|65580330|FG000|Open-label Phase|Physician Decision|20|||
23502967|NCT00833794|65580331|FG001|Open-label Phase|Physician Decision|0|||
23502968|NCT00833794|65580330|FG000|Open-label Phase|Administrative reason|1|||
23502969|NCT00833794|65580331|FG001|Open-label Phase|Administrative reason|0|||
23502970|NCT00833794|65580330|FG000|Open-label Phase|Protocol Violation|47|||
23502971|NCT00833794|65580331|FG001|Open-label Phase|Protocol Violation|0|||
23502972|NCT00833794|65580330|FG000|Open-label Phase|Did not complete wash-out period|12|||
23502973|NCT00833794|65580331|FG001|Open-label Phase|Did not complete wash-out period|0|||
23502974|NCT00833794|65580330|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
23502975|NCT00833794|65580331|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
23502976|NCT00833794|65580330|FG000|Double-blind Phase|Adverse Event|44|||
23502977|NCT00833794|65580331|FG001|Double-blind Phase|Adverse Event|11|||
23502978|NCT00833794|65580330|FG000|Double-blind Phase|Lack of Efficacy|34|||
23502979|NCT00833794|65580331|FG001|Double-blind Phase|Lack of Efficacy|22|||
23502980|NCT00833794|65580330|FG000|Double-blind Phase|Withdrawal by Subject|23|||
23502981|NCT00833794|65580331|FG001|Double-blind Phase|Withdrawal by Subject|6|||
23502982|NCT00833794|65580330|FG000|Double-blind Phase|Physician Decision|4|||
23399965|NCT00060944|65210752|FG001|Overall Study|Other|4|||
23399966|NCT00060944|65210751|FG000|Overall Study|randomized but not treated|6|||
23399967|NCT00060944|65210752|FG001|Overall Study|randomized but not treated|4|||
23399968|NCT01668004|65210757|FG000|Overall Study|Adverse Event|7|||
23502983|NCT00833794|65580331|FG001|Double-blind Phase|Physician Decision|7|||
23502984|NCT00833794|65580330|FG000|Double-blind Phase|Administrative reason|1|||
23502985|NCT00833794|65580331|FG001|Double-blind Phase|Administrative reason|3|||
23502986|NCT01434667|65580334|FG000|Overall Study|Lost to Follow-up|5|||
23502987|NCT01434667|65580335|FG001|Overall Study|Lost to Follow-up|10|||
23502988|NCT01540838|65580338|FG000|Overall Study|Open nasogastric tube|9|||
23502989|NCT01540838|65580339|FG001|Overall Study|Open nasogastric tube|7|||
23502990|NCT01540838|65580338|FG000|Overall Study|Treatment doses missing|8|||
23502991|NCT01540838|65580339|FG001|Overall Study|Treatment doses missing|12|||
23502992|NCT01540838|65580338|FG000|Overall Study|Additional antibiotic treatment|1|||
23502993|NCT01540838|65580339|FG001|Overall Study|Additional antibiotic treatment|2|||
23502994|NCT01540838|65580338|FG000|Overall Study|Died before treatment initiation|1|||
23502995|NCT01540838|65580339|FG001|Overall Study|Died before treatment initiation|1|||
23502996|NCT01540838|65580338|FG000|Overall Study|Not BM. Other treatment|3|||
23502997|NCT01540838|65580339|FG001|Overall Study|Not BM. Other treatment|1|||
23502998|NCT00521014|65580340|FG000|Overall Study|Inevaluable, not treated|1|||
23502999|NCT01845831|65580341|FG000|Inpatient Phase|Withdrawal by Subject|1|||
23503000|NCT01845831|65580342|FG001|Inpatient Phase|Withdrawal by Subject|1|||
23503001|NCT01845831|65580343|FG002|Inpatient Phase|Withdrawal by Subject|0|||
23503002|NCT01845831|65580344|FG003|Inpatient Phase|Withdrawal by Subject|0|||
23503003|NCT01845831|65580345|FG004|Inpatient Phase|Withdrawal by Subject|0|||
23503004|NCT01744197|65580346|FG000|Overall Study|Received 1 patch|2|||
23503005|NCT01744197|65580347|FG001|Overall Study|Received 1 patch|1|||
23503006|NCT01744197|65580346|FG000|Overall Study|No patch received|2|||
23503007|NCT01744197|65580347|FG001|Overall Study|No patch received|2|||
23503008|NCT05048784|65580348|FG000|Period 1|Adverse Event|3|||
23503009|NCT05048784|65580349|FG001|Period 1|Adverse Event|1|||
23503010|NCT05048784|65580350|FG002|Period 1|Adverse Event|0|||
23503011|NCT05048784|65580351|FG003|Period 1|Adverse Event|0|||
23503012|NCT05048784|65580348|FG000|Period 2|Lost to Follow-up|0|||
23503013|NCT05048784|65580349|FG001|Period 2|Lost to Follow-up|1|||
23503014|NCT05048784|65580350|FG002|Period 2|Lost to Follow-up|0|||
23503015|NCT05048784|65580351|FG003|Period 2|Lost to Follow-up|0|||
23503016|NCT00873912|65580359|FG000|Overall Study|Withdrawal by Subject|1|||
23503017|NCT00873912|65580360|FG001|Overall Study|Withdrawal by Subject|0|||
23503018|NCT00873912|65580359|FG000|Overall Study|Lost to Follow-up|2|||
23503019|NCT00873912|65580360|FG001|Overall Study|Lost to Follow-up|0|||
23503020|NCT02862171|65580362|FG000|Overall Study|Death|1|||
23503021|NCT02862171|65580362|FG000|Overall Study|Lost to Follow-up|13|||
23503022|NCT02862171|65580362|FG000|Overall Study|Withdrawal by Subject|57|||
23503023|NCT02862171|65580362|FG000|Overall Study|Non-compliance|4|||
23503024|NCT02862171|65580362|FG000|Overall Study|HIV-1 seroconversion|18|||
23503025|NCT00444912|65580365|FG000|Overall Study|Death|1|||
23503026|NCT00444912|65580366|FG001|Overall Study|Death|2|||
23503027|NCT00444912|65580365|FG000|Overall Study|Lost to Follow-up|1|||
23503028|NCT00444912|65580366|FG001|Overall Study|Lost to Follow-up|0|||
23503029|NCT00444912|65580365|FG000|Overall Study|Participant Failed Mobilization|1|||
23503030|NCT00444912|65580366|FG001|Overall Study|Participant Failed Mobilization|0|||
23503031|NCT03305575|65580369|FG000|Overall Study|Physician Decision|1|||
23503032|NCT03305575|65580370|FG001|Overall Study|Physician Decision|0|||
23503033|NCT02555683|65580373|FG000|Overall Study|Physician Decision|1|||
23503034|NCT02555683|65580374|FG001|Overall Study|Physician Decision|0|||
23503035|NCT02555683|65580375|FG002|Overall Study|Physician Decision|2|||
23503036|NCT02555683|65580373|FG000|Overall Study|Lost to Follow-up|2|||
23503037|NCT02555683|65580374|FG001|Overall Study|Lost to Follow-up|1|||
23503038|NCT02555683|65580375|FG002|Overall Study|Lost to Follow-up|2|||
23503039|NCT02555683|65580373|FG000|Overall Study|Technical Problems|1|||
23503040|NCT02555683|65580374|FG001|Overall Study|Technical Problems|1|||
23503041|NCT02555683|65580375|FG002|Overall Study|Technical Problems|0|||
23503042|NCT02555683|65580373|FG000|Overall Study|Protocol deviation|0|||
23503043|NCT02555683|65580374|FG001|Overall Study|Protocol deviation|1|||
23503044|NCT02555683|65580375|FG002|Overall Study|Protocol deviation|0|||
23503045|NCT02555683|65580373|FG000|Overall Study|Lack of Efficacy|2|||
23503046|NCT02555683|65580374|FG001|Overall Study|Lack of Efficacy|0|||
23503047|NCT02555683|65580375|FG002|Overall Study|Lack of Efficacy|0|||
23503048|NCT02555683|65580373|FG000|Overall Study|Death|0|||
23503049|NCT02555683|65580374|FG001|Overall Study|Death|1|||
23503050|NCT02555683|65580375|FG002|Overall Study|Death|2|||
23503051|NCT02555683|65580373|FG000|Overall Study|Adverse Event|1|||
23503052|NCT02555683|65580374|FG001|Overall Study|Adverse Event|0|||
23503053|NCT02555683|65580375|FG002|Overall Study|Adverse Event|1|||
23503054|NCT02555683|65580373|FG000|Overall Study|Subject/guardian decision|12|||
23503055|NCT02555683|65580374|FG001|Overall Study|Subject/guardian decision|12|||
23503056|NCT02555683|65580375|FG002|Overall Study|Subject/guardian decision|22|||
23503057|NCT02555683|65580373|FG000|Overall Study|Death post Treatment/safety period|0|||
23503058|NCT02555683|65580374|FG001|Overall Study|Death post Treatment/safety period|1|||
23503059|NCT02555683|65580375|FG002|Overall Study|Death post Treatment/safety period|0|||
23503060|NCT02955602|65580377|FG000|Overall Study|Adverse Event|0|||
23503061|NCT02955602|65580378|FG001|Overall Study|Adverse Event|3|||
23503062|NCT02955602|65580379|FG002|Overall Study|Adverse Event|0|||
23503063|NCT02955602|65580377|FG000|Overall Study|Withdrawal of informed consent|1|||
23503064|NCT02955602|65580378|FG001|Overall Study|Withdrawal of informed consent|3|||
23503065|NCT02955602|65580379|FG002|Overall Study|Withdrawal of informed consent|2|||
23503066|NCT02955602|65580377|FG000|Overall Study|Lost to Follow-up|0|||
23503067|NCT02955602|65580378|FG001|Overall Study|Lost to Follow-up|0|||
23503068|NCT02955602|65580379|FG002|Overall Study|Lost to Follow-up|1|||
23503069|NCT02955602|65580377|FG000|Overall Study|Other|0|||
23503070|NCT02955602|65580378|FG001|Overall Study|Other|1|||
23503071|NCT02955602|65580379|FG002|Overall Study|Other|3|||
23503072|NCT00518284|65580384|FG000|Overall Study|Adverse Event|0|||
23503073|NCT00518284|65580385|FG001|Overall Study|Adverse Event|1|||
23503074|NCT00518284|65580386|FG002|Overall Study|Adverse Event|0|||
23503075|NCT00518284|65580387|FG003|Overall Study|Adverse Event|0|||
23503076|NCT00518284|65580384|FG000|Overall Study|Study Termination|0|||
23503077|NCT00518284|65580385|FG001|Overall Study|Study Termination|2|||
23503078|NCT00518284|65580386|FG002|Overall Study|Study Termination|1|||
23503079|NCT00518284|65580387|FG003|Overall Study|Study Termination|2|||
23503080|NCT00726986|65580388|FG000|Induction Phase|Adverse Event|4|||
23503081|NCT00726986|65580388|FG000|Induction Phase|Withdrawal by Subject|2|||
23503082|NCT00726986|65580388|FG000|Induction Phase|Death|2|||
23503083|NCT00726986|65580388|FG000|Induction Phase|Lack of Efficacy|5|||
23503084|NCT00726986|65580388|FG000|Induction Phase|Secondary Disease|2|||
23503085|NCT00726986|65580388|FG000|Maintenance Phase|Adverse Event|1|||
23503086|NCT00726986|65580388|FG000|Maintenance Phase|Lack of Efficacy|2|||
23503087|NCT01061177|65580389|FG000|Overall Study|Adverse Event|117|||
23503088|NCT01061177|65580389|FG000|Overall Study|Withdrawal by Subject|27|||
23503089|NCT01061177|65580389|FG000|Overall Study|Disease progression|17|||
23503090|NCT01061177|65580389|FG000|Overall Study|Protocol Violation|11|||
23503091|NCT01061177|65580389|FG000|Overall Study|Lost to Follow-up|9|||
23503092|NCT01061177|65580389|FG000|Overall Study|New cancer therapy|9|||
23503093|NCT01061177|65580389|FG000|Overall Study|Abnormal laboratory values|6|||
23503094|NCT01061177|65580389|FG000|Overall Study|Abnormal test procedure results|4|||
23503095|NCT01061177|65580389|FG000|Overall Study|Administratie problems|4|||
23503096|NCT01061177|65580389|FG000|Overall Study|Death|4|||
23503097|NCT02094677|65580390|FG000|Overall Study|Screening|3|||
23503098|NCT02094677|65580391|FG001|Overall Study|Screening|1|||
23503099|NCT01427972|65580393|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503100|NCT01427972|65580394|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503101|NCT01427972|65580395|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503102|NCT01427972|65580396|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503103|NCT01427972|65580397|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503104|NCT01427972|65580398|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503105|NCT01427972|65580399|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503106|NCT01427972|65580400|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
23503107|NCT01427972|65580401|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503108|NCT01427972|65580402|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503109|NCT01427972|65580403|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503110|NCT01427972|65580404|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
23503111|NCT01427972|65580393|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503112|NCT01427972|65580394|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503113|NCT01427972|65580395|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503114|NCT01427972|65580396|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503115|NCT01427972|65580397|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503116|NCT01427972|65580398|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
23503117|NCT01427972|65580399|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503118|NCT01427972|65580400|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503119|NCT01427972|65580401|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503120|NCT01427972|65580402|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503121|NCT01427972|65580403|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503122|NCT01427972|65580404|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
23503123|NCT01427972|65580393|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503124|NCT01427972|65580394|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
23503125|NCT01427972|65580395|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503126|NCT01427972|65580396|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503127|NCT01427972|65580397|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503128|NCT01427972|65580398|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503129|NCT01427972|65580399|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503130|NCT01427972|65580400|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503131|NCT01427972|65580401|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503132|NCT01427972|65580402|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503133|NCT01427972|65580403|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503134|NCT01427972|65580404|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
23503135|NCT02197130|65580405|FG000|Overall Study|Adverse Event|13|||
23503136|NCT02197130|65580406|FG001|Overall Study|Adverse Event|4|||
23503137|NCT02197130|65580407|FG002|Overall Study|Adverse Event|23|||
23503138|NCT02197130|65580405|FG000|Overall Study|Death|0|||
23503139|NCT02197130|65580406|FG001|Overall Study|Death|1|||
23503140|NCT02197130|65580407|FG002|Overall Study|Death|0|||
23503141|NCT02197130|65580405|FG000|Overall Study|Lost to Follow-up|2|||
23503142|NCT02197130|65580406|FG001|Overall Study|Lost to Follow-up|0|||
23503143|NCT02197130|65580407|FG002|Overall Study|Lost to Follow-up|1|||
23503144|NCT02197130|65580405|FG000|Overall Study|Does not meet entrance criteria|0|||
23503145|NCT02197130|65580406|FG001|Overall Study|Does not meet entrance criteria|0|||
23503146|NCT02197130|65580407|FG002|Overall Study|Does not meet entrance criteria|1|||
23503147|NCT02197130|65580405|FG000|Overall Study|Withdrawal by Subject|0|||
23503148|NCT02197130|65580406|FG001|Overall Study|Withdrawal by Subject|3|||
23503149|NCT02197130|65580407|FG002|Overall Study|Withdrawal by Subject|4|||
23503150|NCT02197130|65580405|FG000|Overall Study|Other|1|||
23503151|NCT02197130|65580406|FG001|Overall Study|Other|0|||
23503152|NCT02197130|65580407|FG002|Overall Study|Other|3|||
23503153|NCT01382212|65580409|FG000|Overall Study|Kidney transplant|1|||
23503154|NCT01382212|65580409|FG000|Overall Study|Withdrew consent|1|||
23503155|NCT02439138|65580411|FG000|Overall Study|Adverse Event|1|||
23503156|NCT02439138|65580411|FG000|Overall Study|PI decision to terminate the study|2|||
23503157|NCT02801396|65580412|FG000|Period 1|Withdrawal by Subject|0|||
23503158|NCT02801396|65580413|FG001|Period 1|Withdrawal by Subject|0|||
23503159|NCT02801396|65580414|FG002|Period 1|Withdrawal by Subject|0|||
23503160|NCT02801396|65580415|FG003|Period 1|Withdrawal by Subject|0|||
23503161|NCT02801396|65580416|FG004|Period 1|Withdrawal by Subject|1|||
23503162|NCT02801396|65580417|FG005|Period 1|Withdrawal by Subject|0|||
23503163|NCT02794883|65580418|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
23503164|NCT02794883|65580419|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
23503165|NCT02794883|65580420|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
23503166|NCT02794883|65580418|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
23503167|NCT02794883|65580419|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
23503168|NCT02794883|65580420|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
23503169|NCT02794883|65580418|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
23503170|NCT02794883|65580419|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
23503171|NCT02794883|65580420|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
23503172|NCT02794883|65580418|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
23503173|NCT02794883|65580419|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
23503174|NCT02794883|65580420|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
23503175|NCT02794883|65580418|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
23503176|NCT02794883|65580419|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
23503177|NCT02794883|65580420|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
23503178|NCT02794883|65580418|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
23503179|NCT02794883|65580419|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
23503180|NCT02794883|65580420|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
23503181|NCT02794883|65580418|FG000|Follow-up Period (up to 2 Years)|Death|12|||
23503182|NCT02794883|65580419|FG001|Follow-up Period (up to 2 Years)|Death|10|||
23503183|NCT02794883|65580420|FG002|Follow-up Period (up to 2 Years)|Death|10|||
23503184|NCT05074667|65580421|FG000|Overall Study|Death|1|||
23503185|NCT05074667|65580421|FG000|Overall Study|Withdrawal by Subject|4|||
23503186|NCT05074667|65580421|FG000|Overall Study|Lost to Follow-up|10|||
23503187|NCT00224042|65580432|FG000|Overall Study|Adverse Event|2|||
23503188|NCT00224042|65580433|FG001|Overall Study|Adverse Event|1|||
23503189|NCT00224042|65580432|FG000|Overall Study|Protocol Violation|0|||
23399969|NCT01668004|65210757|FG000|Overall Study|Withdrawal by Subject|2|||
23399970|NCT01668004|65210757|FG000|Overall Study|Lost to Follow-up|5|||
23399971|NCT01668004|65210757|FG000|Overall Study|Lack of Efficacy|9|||
23399972|NCT01668004|65210757|FG000|Overall Study|Non-compliance with treatment|2|||
23399973|NCT01378117|65210758|FG000|Overall Study|withdrawal|2|||
23399974|NCT01378117|65210759|FG001|Overall Study|withdrawal|1|||
23399975|NCT01378117|65210760|FG002|Overall Study|withdrawal|2|||
23399976|NCT01378117|65210758|FG000|Overall Study|discharged before med given|2|||
23399977|NCT01378117|65210759|FG001|Overall Study|discharged before med given|0|||
23503190|NCT00224042|65580433|FG001|Overall Study|Protocol Violation|1|||
23503191|NCT00224042|65580432|FG000|Overall Study|Physician Decision|0|||
23503192|NCT00224042|65580433|FG001|Overall Study|Physician Decision|1|||
23503193|NCT00224042|65580432|FG000|Overall Study|Did not meet lab incusion criteria|2|||
23503194|NCT00224042|65580433|FG001|Overall Study|Did not meet lab incusion criteria|3|||
23399978|NCT01378117|65210760|FG002|Overall Study|discharged before med given|1|||
23503195|NCT00224042|65580432|FG000|Overall Study|Other|2|||
23503196|NCT00224042|65580433|FG001|Overall Study|Other|0|||
23503197|NCT05201703|65583771|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
23503198|NCT05201703|65583772|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
23503199|NCT05201703|65583771|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
23503200|NCT05201703|65583772|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
23503201|NCT03003390|65583773|FG000|Overall Study|Physician Decision|2|||
23503202|NCT03003390|65583774|FG001|Overall Study|Physician Decision|0|||
23503203|NCT03003390|65583773|FG000|Overall Study|Parent refused intervention|2|||
23503204|NCT03003390|65583774|FG001|Overall Study|Parent refused intervention|0|||
23399979|NCT01152788|65210763|FG000|Overall Study|Withdrawal by Subject|0|||
23399980|NCT01152788|65210764|FG001|Overall Study|Withdrawal by Subject|3|||
23399981|NCT01152788|65210763|FG000|Overall Study|No treatment|0|||
23399982|NCT01152788|65210764|FG001|Overall Study|No treatment|1|||
23399983|NCT01959529|65210765|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
23503205|NCT00105469|65583777|FG000|Overall Study|Adverse Event|9|||
23503206|NCT00105469|65583778|FG001|Overall Study|Adverse Event|8|||
23503207|NCT00105469|65583777|FG000|Overall Study|Protocol Violation|4|||
23503208|NCT00105469|65583778|FG001|Overall Study|Protocol Violation|0|||
23503209|NCT00105469|65583777|FG000|Overall Study|Withdrawal by Subject|2|||
23503210|NCT00105469|65583778|FG001|Overall Study|Withdrawal by Subject|3|||
23503211|NCT00105469|65583777|FG000|Overall Study|Lost to Follow-up|1|||
23503212|NCT00105469|65583778|FG001|Overall Study|Lost to Follow-up|0|||
23503213|NCT00105469|65583777|FG000|Overall Study|Lack of Efficacy|2|||
23503214|NCT00105469|65583778|FG001|Overall Study|Lack of Efficacy|0|||
23399984|NCT01959529|65210766|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
23399985|NCT01959529|65210765|FG000|Overall Study|Lost to Follow-up|4|||
23399986|NCT01959529|65210766|FG001|Overall Study|Lost to Follow-up|1|||
23399987|NCT01959529|65210765|FG000|Overall Study|Other|70|||
23399988|NCT01959529|65210766|FG001|Overall Study|Other|68|||
23399989|NCT01959529|65210765|FG000|Overall Study|Hypoglycaemia|1|||
23399990|NCT01959529|65210766|FG001|Overall Study|Hypoglycaemia|1|||
23399991|NCT01959529|65210765|FG000|Overall Study|Lack of glycaemic control|1|||
23399992|NCT01959529|65210766|FG001|Overall Study|Lack of glycaemic control|1|||
23503215|NCT00105469|65583777|FG000|Overall Study|Other Reason|4|||
23503216|NCT00105469|65583778|FG001|Overall Study|Other Reason|0|||
23399993|NCT01882465|65210767|FG000|Period 1|Lens Discomfort|0|||
23399994|NCT01882465|65210768|FG001|Period 1|Lens Discomfort|0|||
23399995|NCT01882465|65210769|FG002|Period 1|Lens Discomfort|0|||
23503217|NCT01666782|65583780|FG000|Overall Study|Received 2 doses of vaccine|0|||
23503218|NCT01666782|65583781|FG001|Overall Study|Received 2 doses of vaccine|1|||
23503219|NCT01666782|65583780|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
23503220|NCT01666782|65583781|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
23503221|NCT00594659|65583782|FG000|Overall Study|Lost to Follow-up|13|||
23503222|NCT00594659|65583783|FG001|Overall Study|Lost to Follow-up|9|||
23503223|NCT00594659|65583784|FG002|Overall Study|Lost to Follow-up|7|||
23503224|NCT01756898|65583785|FG000|Overall Study|Adverse Event|7|||
23503225|NCT01756898|65583786|FG001|Overall Study|Adverse Event|1|||
23503226|NCT01756898|65583787|FG002|Overall Study|Adverse Event|0|||
23503227|NCT01756898|65583788|FG003|Overall Study|Adverse Event|0|||
23503228|NCT01756898|65583785|FG000|Overall Study|Lack of Efficacy|4|||
23503229|NCT01756898|65583786|FG001|Overall Study|Lack of Efficacy|7|||
23503230|NCT01756898|65583787|FG002|Overall Study|Lack of Efficacy|6|||
23503231|NCT01756898|65583788|FG003|Overall Study|Lack of Efficacy|6|||
23503232|NCT01756898|65583785|FG000|Overall Study|Lost to Follow-up|2|||
23503233|NCT01756898|65583786|FG001|Overall Study|Lost to Follow-up|4|||
23503234|NCT01756898|65583787|FG002|Overall Study|Lost to Follow-up|2|||
23503235|NCT01756898|65583788|FG003|Overall Study|Lost to Follow-up|3|||
23503236|NCT01756898|65583785|FG000|Overall Study|Protocol Violation|1|||
23503237|NCT01756898|65583786|FG001|Overall Study|Protocol Violation|2|||
23503238|NCT01756898|65583787|FG002|Overall Study|Protocol Violation|2|||
23503239|NCT01756898|65583788|FG003|Overall Study|Protocol Violation|1|||
23503240|NCT01756898|65583785|FG000|Overall Study|Withdrew Consent|5|||
23503241|NCT01756898|65583786|FG001|Overall Study|Withdrew Consent|3|||
23503242|NCT01756898|65583787|FG002|Overall Study|Withdrew Consent|5|||
23503243|NCT01756898|65583788|FG003|Overall Study|Withdrew Consent|6|||
23503244|NCT01756898|65583785|FG000|Overall Study|Other|0|||
23503245|NCT01756898|65583786|FG001|Overall Study|Other|2|||
23503246|NCT01756898|65583787|FG002|Overall Study|Other|2|||
23503247|NCT01756898|65583788|FG003|Overall Study|Other|0|||
23503248|NCT01644565|65583790|FG000|Overall Study|Undisclosed Medical History|1|||
23503249|NCT01644565|65583791|FG001|Overall Study|Undisclosed Medical History|0|||
23503250|NCT01644565|65583792|FG002|Overall Study|Undisclosed Medical History|0|||
23503251|NCT01644565|65583793|FG003|Overall Study|Undisclosed Medical History|0|||
23503252|NCT01644565|65583794|FG004|Overall Study|Undisclosed Medical History|0|||
23503253|NCT01644565|65583795|FG005|Overall Study|Undisclosed Medical History|0|||
23503254|NCT01644565|65583796|FG006|Overall Study|Undisclosed Medical History|0|||
23503255|NCT01644565|65583797|FG007|Overall Study|Undisclosed Medical History|0|||
23503256|NCT01644565|65583798|FG008|Overall Study|Undisclosed Medical History|0|||
23503257|NCT01644565|65583790|FG000|Overall Study|Lost to Follow-up|0|||
23503258|NCT01644565|65583791|FG001|Overall Study|Lost to Follow-up|0|||
23503259|NCT01644565|65583792|FG002|Overall Study|Lost to Follow-up|0|||
23503260|NCT01644565|65583793|FG003|Overall Study|Lost to Follow-up|1|||
23503261|NCT01644565|65583794|FG004|Overall Study|Lost to Follow-up|0|||
23503262|NCT01644565|65583795|FG005|Overall Study|Lost to Follow-up|0|||
23503263|NCT01644565|65583796|FG006|Overall Study|Lost to Follow-up|0|||
23503264|NCT01644565|65583797|FG007|Overall Study|Lost to Follow-up|2|||
23503265|NCT01644565|65583798|FG008|Overall Study|Lost to Follow-up|0|||
23503266|NCT01644565|65583790|FG000|Overall Study|Family emergency|0|||
23503267|NCT01644565|65583791|FG001|Overall Study|Family emergency|0|||
23503268|NCT01644565|65583792|FG002|Overall Study|Family emergency|0|||
23503269|NCT01644565|65583793|FG003|Overall Study|Family emergency|0|||
23503270|NCT01644565|65583794|FG004|Overall Study|Family emergency|1|||
23503271|NCT01644565|65583795|FG005|Overall Study|Family emergency|0|||
23503272|NCT01644565|65583796|FG006|Overall Study|Family emergency|0|||
23503273|NCT01644565|65583797|FG007|Overall Study|Family emergency|0|||
23503274|NCT01644565|65583798|FG008|Overall Study|Family emergency|0|||
23503275|NCT01644565|65583790|FG000|Overall Study|Relocation|0|||
23503276|NCT01644565|65583791|FG001|Overall Study|Relocation|0|||
23503277|NCT01644565|65583792|FG002|Overall Study|Relocation|0|||
23503278|NCT01644565|65583793|FG003|Overall Study|Relocation|0|||
23503279|NCT01644565|65583794|FG004|Overall Study|Relocation|0|||
23503280|NCT01644565|65583795|FG005|Overall Study|Relocation|0|||
23503281|NCT01644565|65583796|FG006|Overall Study|Relocation|0|||
23503282|NCT01644565|65583797|FG007|Overall Study|Relocation|0|||
23503283|NCT01644565|65583798|FG008|Overall Study|Relocation|1|||
23503284|NCT01785069|65583803|FG000|Overall Study|Implanted with nonstudy device|1|||
23503285|NCT01785069|65583804|FG001|Overall Study|Implanted with nonstudy device|2|||
23503286|NCT01785069|65583805|FG002|Overall Study|Implanted with nonstudy device|1|||
23503287|NCT01785069|65583806|FG003|Overall Study|Implanted with nonstudy device|0|||
23503288|NCT01785069|65583803|FG000|Overall Study|Death|0|||
23503289|NCT01785069|65583804|FG001|Overall Study|Death|0|||
23503290|NCT01785069|65583805|FG002|Overall Study|Death|2|||
23503291|NCT01785069|65583806|FG003|Overall Study|Death|0|||
23503292|NCT01785069|65583803|FG000|Overall Study|Subject choice|2|||
23503293|NCT01785069|65583804|FG001|Overall Study|Subject choice|2|||
23503294|NCT01785069|65583805|FG002|Overall Study|Subject choice|0|||
23503295|NCT01785069|65583806|FG003|Overall Study|Subject choice|1|||
23503296|NCT01785069|65583803|FG000|Overall Study|Lost to Follow-up|1|||
23503297|NCT01785069|65583804|FG001|Overall Study|Lost to Follow-up|2|||
23503298|NCT01785069|65583805|FG002|Overall Study|Lost to Follow-up|4|||
23503299|NCT01785069|65583806|FG003|Overall Study|Lost to Follow-up|1|||
23503300|NCT01785069|65583803|FG000|Overall Study|Reason not Specified|1|||
23503301|NCT01785069|65583804|FG001|Overall Study|Reason not Specified|2|||
23503302|NCT01785069|65583805|FG002|Overall Study|Reason not Specified|1|||
23503303|NCT01785069|65583806|FG003|Overall Study|Reason not Specified|4|||
23503304|NCT01785069|65583803|FG000|Overall Study|Not evaluable|7|||
23503305|NCT01785069|65583804|FG001|Overall Study|Not evaluable|4|||
23503306|NCT01785069|65583805|FG002|Overall Study|Not evaluable|5|||
23503307|NCT01785069|65583806|FG003|Overall Study|Not evaluable|8|||
23503308|NCT00717197|65583811|FG000|Overall Study|Unable to purchase study drug|5|||
23503309|NCT00717197|65583811|FG000|Overall Study|Tumor Progression|1|||
23503310|NCT00717197|65583811|FG000|Overall Study|Physician Decision|1|||
23503311|NCT00602797|65583814|FG000|Overall Study|Adverse Event|1|||
23503312|NCT01898806|65583817|FG000|Overall Study|Withdrawal by Subject|2|||
23503313|NCT01898806|65583817|FG000|Overall Study|Physician Decision|1|||
23399996|NCT01882465|65210770|FG003|Period 1|Lens Discomfort|1|||
23399997|NCT01882465|65210771|FG004|Period 1|Lens Discomfort|0|||
23399998|NCT01882465|65210772|FG005|Period 1|Lens Discomfort|0|||
23399999|NCT01882465|65210773|FG006|Period 1|Lens Discomfort|0|||
23400000|NCT01882465|65210767|FG000|Period 1|Withdrawal by Subject|0|||
23400001|NCT01882465|65210768|FG001|Period 1|Withdrawal by Subject|0|||
23400002|NCT01882465|65210769|FG002|Period 1|Withdrawal by Subject|0|||
23400003|NCT01882465|65210770|FG003|Period 1|Withdrawal by Subject|0|||
23400004|NCT01882465|65210771|FG004|Period 1|Withdrawal by Subject|0|||
23400005|NCT01882465|65210772|FG005|Period 1|Withdrawal by Subject|0|||
23400006|NCT01882465|65210773|FG006|Period 1|Withdrawal by Subject|1|||
23400007|NCT01882465|65210767|FG000|Period 2|Protocol Violation|0|||
23400008|NCT01882465|65210768|FG001|Period 2|Protocol Violation|0|||
23400009|NCT01882465|65210769|FG002|Period 2|Protocol Violation|0|||
23400010|NCT01882465|65210770|FG003|Period 2|Protocol Violation|0|||
23400011|NCT01882465|65210771|FG004|Period 2|Protocol Violation|1|||
23400012|NCT01882465|65210772|FG005|Period 2|Protocol Violation|0|||
23400013|NCT01882465|65210773|FG006|Period 2|Protocol Violation|0|||
23400014|NCT01114737|65210774|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
23400015|NCT01114737|65210775|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
23400016|NCT01114737|65210774|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
23400017|NCT01114737|65210775|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
23400018|NCT01114737|65210774|FG000|Randomized Treatment Period|Pregnancy|1|||
23400019|NCT01114737|65210775|FG001|Randomized Treatment Period|Pregnancy|0|||
23400020|NCT01114737|65210774|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
23400021|NCT01114737|65210775|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
23400022|NCT01114737|65210774|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
23400023|NCT01114737|65210775|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
23400024|NCT01114737|65210774|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
23400025|NCT01114737|65210775|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
23400026|NCT02343302|65210780|FG000|Overall Study|Physician Decision|1|||
23400027|NCT02343302|65210781|FG001|Overall Study|Physician Decision|1|||
23400028|NCT01935947|65210782|FG000|Overall Study|Adverse Event|0|||
23400029|NCT01935947|65210783|FG001|Overall Study|Adverse Event|2|||
23400030|NCT01935947|65210784|FG002|Overall Study|Adverse Event|0|||
23400031|NCT01935947|65210782|FG000|Overall Study|Diease Progression|2|||
23400032|NCT01935947|65210783|FG001|Overall Study|Diease Progression|2|||
23400033|NCT01935947|65210784|FG002|Overall Study|Diease Progression|2|||
23400034|NCT01935947|65210782|FG000|Overall Study|Death|1|||
23400035|NCT01935947|65210783|FG001|Overall Study|Death|0|||
23400036|NCT01935947|65210784|FG002|Overall Study|Death|0|||
23400037|NCT01071954|65210797|FG000|Overall Study|Noncompliance|4|||
23400038|NCT01071954|65210797|FG000|Overall Study|Adverse Event|1|||
23400039|NCT01071954|65210797|FG000|Overall Study|Withdrawal by Subject|11|||
23400040|NCT01071954|65210797|FG000|Overall Study|Requirement for Alternative Therapy|5|||
23400041|NCT01071954|65210797|FG000|Overall Study|Administrative Decision|5|||
23400042|NCT01071954|65210797|FG000|Overall Study|Protocol Specified Criteria|1|||
23400043|NCT03508050|65210798|FG000|Overall Study|Pleural adhesions|1|||
23400044|NCT03508050|65210799|FG001|Overall Study|Pleural adhesions|0|||
23400045|NCT03508050|65210798|FG000|Overall Study|Mucus plug|1|||
23400046|NCT03508050|65210799|FG001|Overall Study|Mucus plug|0|||
23400047|NCT03508050|65210798|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
23400048|NCT03508050|65210799|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
23400049|NCT03508050|65210798|FG000|Overall Study|Sustained desaturation|0|||
23400050|NCT03508050|65210799|FG001|Overall Study|Sustained desaturation|1|||
23400051|NCT03047135|65210803|FG000|Overall Study|Still being treated|3|||
23400052|NCT00140140|65210804|FG000|Overall Study|Unacceptable toxicity|1|||
23400053|NCT00140140|65210805|FG001|Overall Study|Unacceptable toxicity|1|||
23400054|NCT00140140|65210806|FG002|Overall Study|Unacceptable toxicity|2|||
23400055|NCT00140140|65210804|FG000|Overall Study|Physician Decision|1|||
23400056|NCT00140140|65210805|FG001|Overall Study|Physician Decision|1|||
23400057|NCT00140140|65210806|FG002|Overall Study|Physician Decision|0|||
23400058|NCT01517984|65210807|FG000|Overall Study|Lost to Follow-up|0|||
23503314|NCT02578316|65583818|FG000|Extension Phase|Progression of disease|6|||
23503315|NCT01235351|65583820|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
23503316|NCT01235351|65583821|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
23503317|NCT01088997|65583822|FG000|Overall Study|Physician Decision|1|||
23503318|NCT01088997|65583823|FG001|Overall Study|Physician Decision|1|||
23503319|NCT01088997|65583822|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
23503320|NCT01088997|65583823|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
23503321|NCT01088997|65583822|FG000|Overall Study|Excluded prior to receiving drug|1|||
23503322|NCT01088997|65583823|FG001|Overall Study|Excluded prior to receiving drug|1|||
23503323|NCT01691781|65583824|FG000|Overall Study|Withdrawal by Subject|4|||
23503324|NCT01691781|65583825|FG001|Overall Study|Withdrawal by Subject|3|||
23503325|NCT01691781|65583824|FG000|Overall Study|Physician Decision|1|||
23503326|NCT01691781|65583825|FG001|Overall Study|Physician Decision|1|||
23503327|NCT01691781|65583824|FG000|Overall Study|Protocol Violation|2|||
23503328|NCT01691781|65583825|FG001|Overall Study|Protocol Violation|2|||
23503329|NCT01691781|65583824|FG000|Overall Study|Adverse Event|0|||
23503330|NCT01691781|65583825|FG001|Overall Study|Adverse Event|1|||
23503331|NCT02871297|65583826|FG000|Overall Study|Adverse Event|34|||
23503332|NCT02871297|65583826|FG000|Overall Study|Lack of Efficacy|10|||
23503333|NCT02871297|65583826|FG000|Overall Study|Non-compliance with study drug|15|||
23503334|NCT02871297|65583826|FG000|Overall Study|Protocol Violation|3|||
23503335|NCT02871297|65583826|FG000|Overall Study|Withdrawal by Subject|20|||
23503336|NCT02871297|65583826|FG000|Overall Study|Lost to Follow-up|13|||
23503337|NCT02871297|65583826|FG000|Overall Study|Rolled over to 13546A|2|||
23503338|NCT02871297|65583826|FG000|Overall Study|Other than specified|39|||
23503339|NCT01587001|65583827|FG000|Overall Study|Lost to Follow-up|2|||
23503340|NCT01587001|65583828|FG001|Overall Study|Lost to Follow-up|0|||
23503341|NCT01587001|65583827|FG000|Overall Study|Insufficient samples to complete testing|4|||
23503342|NCT01587001|65583828|FG001|Overall Study|Insufficient samples to complete testing|1|||
23503343|NCT02228460|65583829|FG000|Overall Study|Adverse Event|1|||
23503344|NCT02228460|65583829|FG000|Overall Study|Lost to Follow-up|1|||
23503345|NCT01367002|65583830|FG000|Overall Study|Withdrawal by Subject|1|||
23503346|NCT01367002|65583831|FG001|Overall Study|Withdrawal by Subject|0|||
23503347|NCT01367002|65583830|FG000|Overall Study|Physician Decision|0|||
23503348|NCT01367002|65583831|FG001|Overall Study|Physician Decision|2|||
23503349|NCT03310021|65583835|FG000|Overall Study|Withdrawal by Subject|0|||
23503350|NCT03310021|65583836|FG001|Overall Study|Withdrawal by Subject|0|||
23503351|NCT03310021|65583837|FG002|Overall Study|Withdrawal by Subject|0|||
23503352|NCT03310021|65583838|FG003|Overall Study|Withdrawal by Subject|0|||
23503353|NCT03310021|65583839|FG004|Overall Study|Withdrawal by Subject|0|||
23503354|NCT03310021|65583840|FG005|Overall Study|Withdrawal by Subject|0|||
23503355|NCT03310021|65583841|FG006|Overall Study|Withdrawal by Subject|1|||
23503356|NCT03310021|65583842|FG007|Overall Study|Withdrawal by Subject|0|||
23503357|NCT03310021|65583843|FG008|Overall Study|Withdrawal by Subject|0|||
23503358|NCT03310021|65583844|FG009|Overall Study|Withdrawal by Subject|0|||
23503359|NCT03310021|65583845|FG010|Overall Study|Withdrawal by Subject|0|||
23503360|NCT03310021|65583846|FG011|Overall Study|Withdrawal by Subject|0|||
23503361|NCT03310021|65583847|FG012|Overall Study|Withdrawal by Subject|0|||
23503362|NCT03310021|65583848|FG013|Overall Study|Withdrawal by Subject|0|||
23503363|NCT03310021|65583849|FG014|Overall Study|Withdrawal by Subject|0|||
23503364|NCT03310021|65583850|FG015|Overall Study|Withdrawal by Subject|0|||
23503365|NCT03310021|65583851|FG016|Overall Study|Withdrawal by Subject|0|||
23503366|NCT03310021|65583852|FG017|Overall Study|Withdrawal by Subject|0|||
23503367|NCT03310021|65583853|FG018|Overall Study|Withdrawal by Subject|0|||
23503368|NCT03310021|65583854|FG019|Overall Study|Withdrawal by Subject|0|||
23503369|NCT03310021|65583835|FG000|Overall Study|Lost to Follow-up|0|||
23503370|NCT03310021|65583836|FG001|Overall Study|Lost to Follow-up|0|||
23503371|NCT03310021|65583837|FG002|Overall Study|Lost to Follow-up|0|||
23503372|NCT03310021|65583838|FG003|Overall Study|Lost to Follow-up|0|||
23503373|NCT03310021|65583839|FG004|Overall Study|Lost to Follow-up|0|||
23503374|NCT03310021|65583840|FG005|Overall Study|Lost to Follow-up|0|||
23503375|NCT03310021|65583841|FG006|Overall Study|Lost to Follow-up|0|||
23503376|NCT03310021|65583842|FG007|Overall Study|Lost to Follow-up|0|||
23503377|NCT03310021|65583843|FG008|Overall Study|Lost to Follow-up|0|||
23503378|NCT03310021|65583844|FG009|Overall Study|Lost to Follow-up|0|||
23503379|NCT03310021|65583845|FG010|Overall Study|Lost to Follow-up|1|||
23503380|NCT03310021|65583846|FG011|Overall Study|Lost to Follow-up|0|||
23503381|NCT03310021|65583847|FG012|Overall Study|Lost to Follow-up|0|||
23503382|NCT03310021|65583848|FG013|Overall Study|Lost to Follow-up|0|||
23503383|NCT03310021|65583849|FG014|Overall Study|Lost to Follow-up|0|||
23503384|NCT03310021|65583850|FG015|Overall Study|Lost to Follow-up|0|||
23503385|NCT03310021|65583851|FG016|Overall Study|Lost to Follow-up|0|||
23503386|NCT03310021|65583852|FG017|Overall Study|Lost to Follow-up|0|||
23503387|NCT03310021|65583853|FG018|Overall Study|Lost to Follow-up|0|||
23503388|NCT03310021|65583854|FG019|Overall Study|Lost to Follow-up|0|||
23503389|NCT01243892|65583855|FG000|Overall Study|Did not meet eligibility criteria|2|||
23503390|NCT01243892|65583856|FG001|Overall Study|Did not meet eligibility criteria|0|||
23503391|NCT00228384|65583857|FG000|Overall Study|Death|9|||
23503392|NCT00228384|65583858|FG001|Overall Study|Death|3|||
23503393|NCT00228384|65583857|FG000|Overall Study|Lost to Follow-up|6|||
23503394|NCT00228384|65583858|FG001|Overall Study|Lost to Follow-up|10|||
23503395|NCT00228384|65583857|FG000|Overall Study|Surgical Intervention (bypass)|5|||
23503396|NCT00228384|65583858|FG001|Overall Study|Surgical Intervention (bypass)|5|||
23503397|NCT00228384|65583857|FG000|Overall Study|Withdrawal by Subject|9|||
23503398|NCT00228384|65583858|FG001|Overall Study|Withdrawal by Subject|10|||
23503399|NCT00228384|65583857|FG000|Overall Study|Physician Decision|0|||
23503400|NCT00228384|65583858|FG001|Overall Study|Physician Decision|1|||
23503401|NCT02036294|65583863|FG000|Overall Study|Death|7|||
23503402|NCT02036294|65583864|FG001|Overall Study|Death|8|||
23503403|NCT02036294|65583863|FG000|Overall Study|Withdrawal by Subject|2|||
23503404|NCT02036294|65583864|FG001|Overall Study|Withdrawal by Subject|3|||
23503405|NCT02849678|65583865|FG000|Overall Study|Protocol Violation|3|||
23503406|NCT02849678|65583866|FG001|Overall Study|Protocol Violation|6|||
23503407|NCT01950741|65583867|FG000|Overall Study|Lost to Follow-up|1|||
23503408|NCT01950741|65583867|FG000|Overall Study|Death|1|||
23503409|NCT01950741|65583867|FG000|Overall Study|Withdrawal by Subject|1|||
23503410|NCT02879305|65583869|FG000|Overall Study|Investigator Site Closed|55|||
23503411|NCT02879305|65583870|FG001|Overall Study|Investigator Site Closed|57|||
23503412|NCT02879305|65583869|FG000|Overall Study|Withdrawal by Subject|44|||
23503413|NCT02879305|65583870|FG001|Overall Study|Withdrawal by Subject|42|||
23503414|NCT02879305|65583869|FG000|Overall Study|Lost to Follow-up|17|||
23503415|NCT02879305|65583870|FG001|Overall Study|Lost to Follow-up|12|||
23503416|NCT02879305|65583869|FG000|Overall Study|Other|1|||
23503417|NCT02879305|65583870|FG001|Overall Study|Other|0|||
23503418|NCT03808545|65583872|FG000|Overall Study|Withdrawal by Subject|1|||
23503419|NCT03808545|65583873|FG001|Overall Study|Withdrawal by Subject|1|||
23503420|NCT01702805|65583879|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
23503421|NCT01702805|65583880|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
23503422|NCT01702805|65583879|FG000|Overall Study|Incomplete Follow-up|18|||
23503423|NCT01702805|65583880|FG001|Overall Study|Incomplete Follow-up|15|||
23503424|NCT01702805|65583879|FG000|Overall Study|Vital Status Assessment Only|40|||
23503425|NCT01702805|65583880|FG001|Overall Study|Vital Status Assessment Only|39|||
23503426|NCT01702805|65583879|FG000|Overall Study|Lost to Follow-up|5|||
23503427|NCT01702805|65583880|FG001|Overall Study|Lost to Follow-up|5|||
23503428|NCT00885846|65583883|FG000|Overall Study|Withdrawal by Subject|2|||
23503429|NCT00885846|65583884|FG001|Overall Study|Withdrawal by Subject|5|||
23503430|NCT00885846|65583885|FG002|Overall Study|Withdrawal by Subject|2|||
23503431|NCT00629707|65583886|FG000|Overall Study|Withdrawal by Subject|0|||
23503432|NCT00629707|65583887|FG001|Overall Study|Withdrawal by Subject|1|||
23503433|NCT00629707|65583886|FG000|Overall Study|Physician Decision|0|||
23503434|NCT00629707|65583887|FG001|Overall Study|Physician Decision|1|||
23503435|NCT00329238|65583891|FG000|Overall Study|Adverse Event|147|||
23503436|NCT00329238|65583892|FG001|Overall Study|Adverse Event|129|||
23503437|NCT00329238|65583891|FG000|Overall Study|Protocol Violation|23|||
23503438|NCT00329238|65583892|FG001|Overall Study|Protocol Violation|34|||
23503439|NCT00329238|65583891|FG000|Overall Study|Lost to Follow-up|2|||
23503440|NCT00329238|65583892|FG001|Overall Study|Lost to Follow-up|6|||
23503441|NCT00329238|65583891|FG000|Overall Study|Withdrawal by Subject|64|||
23503442|NCT00329238|65583892|FG001|Overall Study|Withdrawal by Subject|58|||
23503443|NCT00329238|65583891|FG000|Overall Study|Other reason (not specified)|40|||
23503444|NCT00329238|65583892|FG001|Overall Study|Other reason (not specified)|54|||
23503445|NCT02280304|65583893|FG000|Overall Study|Lost to Follow-up|7|||
23503446|NCT02280304|65583894|FG001|Overall Study|Lost to Follow-up|8|||
23503447|NCT01086033|65583895|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
23503448|NCT01086033|65583895|FG000|Overall Study|Lost to Follow-up|86|||
23503449|NCT01086033|65583895|FG000|Overall Study|Adverse Event|42|||
23503450|NCT01086033|65583895|FG000|Overall Study|Withdrawal by Subject|41|||
23503451|NCT01086033|65583895|FG000|Overall Study|Other|14|||
23503452|NCT01086033|65583895|FG000|Overall Study|Other|13|||
23503453|NCT01086033|65583895|FG000|Overall Study|AE and Withdrew Consent|5|||
23503454|NCT01086033|65583895|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
23503455|NCT01086033|65583895|FG000|Overall Study|Withdrew consent and Other Reason|4|||
23503456|NCT01086033|65583895|FG000|Overall Study|AE and Lack of Efficacy|4|||
23503457|NCT01086033|65583895|FG000|Overall Study|Death|1|||
23503458|NCT01086033|65583895|FG000|Overall Study|AE and Lost to Follow-up|1|||
23503459|NCT01086033|65583895|FG000|Overall Study|AE and Other Reason|1|||
23503460|NCT01086033|65583895|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
23503461|NCT03039283|65583900|FG000|Overall Study|Protocol Violation|2|||
23503462|NCT02634320|65583901|FG000|Overall Study|Adverse Event|2|||
23503463|NCT02634320|65583901|FG000|Overall Study|Lost to Follow-up|3|||
23503464|NCT02634320|65583901|FG000|Overall Study|Moved out of area|2|||
23503465|NCT02634320|65583901|FG000|Overall Study|Out of window for study visits|1|||
23503466|NCT02634320|65583901|FG000|Overall Study|Protocol Violation|1|||
23503467|NCT02634320|65583901|FG000|Overall Study|Withdrawal by Subject|5|||
23503468|NCT02634320|65583901|FG000|Overall Study|Lack of Efficacy|2|||
23503469|NCT01507298|65583907|FG000|Overall Study|Protocol Violation|0|||
23503470|NCT01507298|65583908|FG001|Overall Study|Protocol Violation|6|||
23503471|NCT00407797|65583909|FG000|Overall Study|Lost to Follow-up|2|||
23503472|NCT00407797|65583909|FG000|Overall Study|Adverse Event|6|||
23503473|NCT00407797|65583909|FG000|Overall Study|Other|7|||
23503474|NCT00407797|65583909|FG000|Overall Study|Withdrawal by Subject|3|||
23503475|NCT03736447|65583913|FG000|Overall Study|Adverse Event|5|||
23503476|NCT03736447|65583914|FG001|Overall Study|Adverse Event|1|||
23503477|NCT03736447|65583913|FG000|Overall Study|Withdrawal by Subject|5|||
23503478|NCT03736447|65583914|FG001|Overall Study|Withdrawal by Subject|1|||
23503479|NCT03736447|65583913|FG000|Overall Study|Lost to Follow-up|1|||
23503480|NCT03736447|65583914|FG001|Overall Study|Lost to Follow-up|0|||
23503481|NCT03736447|65583913|FG000|Overall Study|Physician Decision|1|||
23503482|NCT03736447|65583914|FG001|Overall Study|Physician Decision|0|||
23503483|NCT03736447|65583913|FG000|Overall Study|Continued commitment to study treatment|3|||
23503484|NCT03736447|65583914|FG001|Overall Study|Continued commitment to study treatment|0|||
23503485|NCT03736447|65583913|FG000|Overall Study|Taste aversion to study product|0|||
23503486|NCT03736447|65583914|FG001|Overall Study|Taste aversion to study product|1|||
23503487|NCT02944968|65583915|FG000|Overall Study|Subject excluded before study procedure|1|||
23503488|NCT02944968|65583915|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
23503489|NCT03200860|65583919|FG000|Overall Study|Withdrawal by Subject|1|||
23503490|NCT03200860|65583920|FG001|Overall Study|Withdrawal by Subject|0|||
23503491|NCT04189081|65583921|FG000|Overall Study|Lost to Follow-up|1|||
23503492|NCT04189081|65583922|FG001|Overall Study|Lost to Follow-up|0|||
23503493|NCT04189081|65583923|FG002|Overall Study|Lost to Follow-up|0|||
23503494|NCT04189081|65583921|FG000|Overall Study|Withdrawal by Subject|0|||
23503495|NCT04189081|65583922|FG001|Overall Study|Withdrawal by Subject|0|||
23503496|NCT04189081|65583923|FG002|Overall Study|Withdrawal by Subject|1|||
23503497|NCT03311724|65583924|FG000|Overall Study|Physician Decision|0|||
23503498|NCT03311724|65583925|FG001|Overall Study|Physician Decision|0|||
23503499|NCT03311724|65583926|FG002|Overall Study|Physician Decision|0|||
23503500|NCT03311724|65583927|FG003|Overall Study|Physician Decision|1|||
23503501|NCT03311724|65583924|FG000|Overall Study|Protocol Violation|1|||
23503502|NCT03311724|65583925|FG001|Overall Study|Protocol Violation|0|||
23503503|NCT03311724|65583926|FG002|Overall Study|Protocol Violation|1|||
23503504|NCT03311724|65583927|FG003|Overall Study|Protocol Violation|0|||
23503505|NCT03311724|65583924|FG000|Overall Study|Withdrawal by Subject|1|||
23503506|NCT03311724|65583925|FG001|Overall Study|Withdrawal by Subject|1|||
23503507|NCT03311724|65583926|FG002|Overall Study|Withdrawal by Subject|0|||
23503508|NCT03311724|65583927|FG003|Overall Study|Withdrawal by Subject|0|||
23503509|NCT03311724|65583924|FG000|Overall Study|Lost to Follow-up|1|||
23503510|NCT03311724|65583925|FG001|Overall Study|Lost to Follow-up|0|||
23503511|NCT03311724|65583926|FG002|Overall Study|Lost to Follow-up|0|||
23503512|NCT03311724|65583927|FG003|Overall Study|Lost to Follow-up|0|||
23503513|NCT03311724|65583924|FG000|Overall Study|Sponsor Decision|0|||
23503514|NCT03311724|65583925|FG001|Overall Study|Sponsor Decision|0|||
23503515|NCT03311724|65583926|FG002|Overall Study|Sponsor Decision|1|||
23503516|NCT03311724|65583927|FG003|Overall Study|Sponsor Decision|0|||
23503517|NCT02206048|65583941|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
23503518|NCT02468232|65583942|FG000|Core Part of Study|Adverse Event|0|||
23503519|NCT02468232|65583943|FG001|Core Part of Study|Adverse Event|1|||
23503520|NCT02468232|65583944|FG002|Core Part of Study|Adverse Event|0|||
23503521|NCT02468232|65583945|FG003|Core Part of Study|Adverse Event|0|||
23503522|NCT02468232|65583942|FG000|Core Part of Study|Death|20|||
23503523|NCT02468232|65583943|FG001|Core Part of Study|Death|17|||
23503524|NCT02468232|65583944|FG002|Core Part of Study|Death|0|||
23503525|NCT02468232|65583945|FG003|Core Part of Study|Death|0|||
23503526|NCT02468232|65583942|FG000|Core Part of Study|Technical Problems|1|||
23503527|NCT02468232|65583943|FG001|Core Part of Study|Technical Problems|1|||
23300781|NCT02972502|64842927|FG001|Overall Study|Lost to Follow-up|1|||
23503528|NCT02468232|65583944|FG002|Core Part of Study|Technical Problems|0|||
23503529|NCT02468232|65583945|FG003|Core Part of Study|Technical Problems|0|||
23503530|NCT02468232|65583942|FG000|OLE Part of Study|Adverse Event|0|||
23503531|NCT02468232|65583943|FG001|OLE Part of Study|Adverse Event|0|||
23400059|NCT01517984|65210808|FG001|Overall Study|Lost to Follow-up|1|||
23400060|NCT01517984|65210809|FG002|Overall Study|Lost to Follow-up|0|||
23400061|NCT01517984|65210810|FG003|Overall Study|Lost to Follow-up|0|||
23400062|NCT01517984|65210807|FG000|Overall Study|Withdrawal by Subject|1|||
23400063|NCT01517984|65210808|FG001|Overall Study|Withdrawal by Subject|8|||
23400064|NCT01517984|65210809|FG002|Overall Study|Withdrawal by Subject|4|||
23400065|NCT01517984|65210810|FG003|Overall Study|Withdrawal by Subject|1|||
23400066|NCT01517984|65210807|FG000|Overall Study|Screen Failure|4|||
23400067|NCT01517984|65210808|FG001|Overall Study|Screen Failure|0|||
23400068|NCT01517984|65210809|FG002|Overall Study|Screen Failure|0|||
23400069|NCT01517984|65210810|FG003|Overall Study|Screen Failure|0|||
23400070|NCT01517984|65210807|FG000|Overall Study|Ineligible for randomization|0|||
23400071|NCT01517984|65210808|FG001|Overall Study|Ineligible for randomization|14|||
23400072|NCT01517984|65210809|FG002|Overall Study|Ineligible for randomization|0|||
23400073|NCT01517984|65210810|FG003|Overall Study|Ineligible for randomization|0|||
23400074|NCT01673126|65210811|FG000|Overall Study|change of diagnosis|4|||
23400075|NCT01673126|65210812|FG001|Overall Study|change of diagnosis|3|||
23400076|NCT00688597|65210813|FG000|Overall Study|Adverse Event|2|||
23400077|NCT00688597|65210814|FG001|Overall Study|Adverse Event|0|||
23400078|NCT00688597|65210815|FG002|Overall Study|Adverse Event|0|||
23400079|NCT00688597|65210813|FG000|Overall Study|Physician Decision|1|||
23400080|NCT00688597|65210814|FG001|Overall Study|Physician Decision|0|||
23400081|NCT00688597|65210815|FG002|Overall Study|Physician Decision|0|||
23400082|NCT02553629|65210821|FG000|Overall Study|Logistic reasons|3|||
23400083|NCT02553629|65210822|FG001|Overall Study|Logistic reasons|6|||
23400084|NCT02935192|65210823|FG000|Overall Study|Withdrawal by Subject|8|||
23400085|NCT02935192|65210824|FG001|Overall Study|Withdrawal by Subject|4|||
23400086|NCT02268383|65210827|FG000|Overall Study|Death|12|||
23400087|NCT02268383|65210827|FG000|Overall Study|Lost to Follow-up|2|||
23400088|NCT02268383|65210827|FG000|Overall Study|Withdrawal by Subject|9|||
23400089|NCT02268383|65210827|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
23400090|NCT02268383|65210827|FG000|Overall Study|Protocol deviation|3|||
23400091|NCT02268383|65210827|FG000|Overall Study|Sponsor decision|22|||
23400092|NCT02268383|65210827|FG000|Overall Study|Not reported|12|||
23400093|NCT04108273|65210841|FG000|Overall Study|COVID Pandemic|1|||
23400094|NCT04108273|65210842|FG001|Overall Study|COVID Pandemic|0|||
23400095|NCT03366337|65210845|FG000|Overall Study|Lost to Follow-up|1|||
23400096|NCT03366337|65210846|FG001|Overall Study|Lost to Follow-up|0|||
23400097|NCT03366337|65210847|FG002|Overall Study|Lost to Follow-up|1|||
23400098|NCT03366337|65210848|FG003|Overall Study|Lost to Follow-up|0|||
23400099|NCT03366337|65210845|FG000|Overall Study|Withdrawal by Subject|2|||
23400100|NCT03366337|65210846|FG001|Overall Study|Withdrawal by Subject|0|||
23400101|NCT03366337|65210847|FG002|Overall Study|Withdrawal by Subject|1|||
23503532|NCT02468232|65583944|FG002|OLE Part of Study|Adverse Event|4|||
23503533|NCT02468232|65583945|FG003|OLE Part of Study|Adverse Event|5|||
23503534|NCT02468232|65583942|FG000|OLE Part of Study|Death|0|||
23503535|NCT02468232|65583943|FG001|OLE Part of Study|Death|0|||
23503536|NCT02468232|65583944|FG002|OLE Part of Study|Death|4|||
23503537|NCT02468232|65583945|FG003|OLE Part of Study|Death|2|||
23503538|NCT02468232|65583942|FG000|OLE Part of Study|Physician Decision|0|||
23503539|NCT02468232|65583943|FG001|OLE Part of Study|Physician Decision|0|||
23503540|NCT02468232|65583944|FG002|OLE Part of Study|Physician Decision|4|||
23503541|NCT02468232|65583945|FG003|OLE Part of Study|Physician Decision|0|||
23503542|NCT02468232|65583942|FG000|OLE Part of Study|Subject/Guardian decision|0|||
23503543|NCT02468232|65583943|FG001|OLE Part of Study|Subject/Guardian decision|0|||
23503544|NCT02468232|65583944|FG002|OLE Part of Study|Subject/Guardian decision|2|||
23503545|NCT02468232|65583945|FG003|OLE Part of Study|Subject/Guardian decision|5|||
23503546|NCT02612727|65583947|FG000|Overall Study|Parent request|4|||
23503547|NCT02612727|65583948|FG001|Overall Study|Parent request|1|||
23503548|NCT02612727|65583947|FG000|Overall Study|Needed treatment incompatible with PT|1|||
23503549|NCT02612727|65583948|FG001|Overall Study|Needed treatment incompatible with PT|1|||
23503550|NCT02612727|65583947|FG000|Overall Study|Direct hyperbilirubinemia|0|||
23503551|NCT02612727|65583948|FG001|Overall Study|Direct hyperbilirubinemia|2|||
23503552|NCT00729651|65583949|FG000|Overall Study|Withdrawal by Subject|5|||
23503553|NCT00729651|65583950|FG001|Overall Study|Withdrawal by Subject|6|||
23503554|NCT00729651|65583949|FG000|Overall Study|Lost to Follow-up|5|||
23503555|NCT00729651|65583950|FG001|Overall Study|Lost to Follow-up|4|||
23503556|NCT00729651|65583949|FG000|Overall Study|Protocol Violation|0|||
23503557|NCT00729651|65583950|FG001|Overall Study|Protocol Violation|1|||
23503558|NCT00729651|65583949|FG000|Overall Study|Adverse Event|7|||
23503559|NCT00729651|65583950|FG001|Overall Study|Adverse Event|3|||
23503560|NCT00729651|65583949|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
23503561|NCT00729651|65583950|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
23503562|NCT00729651|65583949|FG000|Overall Study|Subject's private reason|2|||
23503563|NCT00729651|65583950|FG001|Overall Study|Subject's private reason|0|||
23503564|NCT03060629|65583952|FG000|Overall Study|Death|4|||
23503565|NCT03060629|65583953|FG001|Overall Study|Death|5|||
23503566|NCT03060629|65583952|FG000|Overall Study|Withdrawal by Subject|50|||
23503567|NCT03060629|65583953|FG001|Overall Study|Withdrawal by Subject|35|||
23503568|NCT03060629|65583952|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
23503569|NCT03060629|65583953|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
23503570|NCT03060629|65583952|FG000|Overall Study|Participant Relocate|15|||
23503571|NCT03060629|65583953|FG001|Overall Study|Participant Relocate|15|||
23503572|NCT03060629|65583952|FG000|Overall Study|Unable to Contact Participant|34|||
23503573|NCT03060629|65583953|FG001|Overall Study|Unable to Contact Participant|23|||
23503574|NCT03060629|65583952|FG000|Overall Study|Investigator Decision|7|||
23503575|NCT03060629|65583953|FG001|Overall Study|Investigator Decision|7|||
23503576|NCT03060629|65583952|FG000|Overall Study|Study Terminated by Sponsor|1100|||
23503577|NCT03060629|65583953|FG001|Overall Study|Study Terminated by Sponsor|1123|||
23503578|NCT03060629|65583952|FG000|Overall Study|Other|4|||
23503579|NCT03060629|65583953|FG001|Overall Study|Other|4|||
23503580|NCT02244606|65583954|FG000|Overall Study|Adverse Event|0|||
23503581|NCT02244606|65583955|FG001|Overall Study|Adverse Event|1|||
23503582|NCT02244606|65583956|FG002|Overall Study|Adverse Event|1|||
23503583|NCT02244606|65583957|FG003|Overall Study|Adverse Event|0|||
23503584|NCT02244606|65583954|FG000|Overall Study|Lost to Follow-up|2|||
23503585|NCT02244606|65583955|FG001|Overall Study|Lost to Follow-up|2|||
23503586|NCT02244606|65583956|FG002|Overall Study|Lost to Follow-up|1|||
23503587|NCT02244606|65583957|FG003|Overall Study|Lost to Follow-up|0|||
23503588|NCT02244606|65583954|FG000|Overall Study|Protocol Violation|0|||
23503589|NCT02244606|65583955|FG001|Overall Study|Protocol Violation|0|||
23503590|NCT02244606|65583956|FG002|Overall Study|Protocol Violation|0|||
23503591|NCT02244606|65583957|FG003|Overall Study|Protocol Violation|1|||
23503592|NCT02244606|65583954|FG000|Overall Study|Withdrawal by Subject|1|||
23503593|NCT02244606|65583955|FG001|Overall Study|Withdrawal by Subject|1|||
23503594|NCT02244606|65583956|FG002|Overall Study|Withdrawal by Subject|0|||
23503595|NCT02244606|65583957|FG003|Overall Study|Withdrawal by Subject|0|||
23503596|NCT02244606|65583954|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
23503597|NCT02244606|65583955|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
23503598|NCT02244606|65583956|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
23503599|NCT02244606|65583957|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
23503600|NCT01626391|65583958|FG000|Overall Study|Physician Decision|1|||
23503601|NCT01626391|65583959|FG001|Overall Study|Physician Decision|0|||
23503602|NCT01626391|65583958|FG000|Overall Study|Withdrawal by Subject|1|||
23503603|NCT01626391|65583959|FG001|Overall Study|Withdrawal by Subject|0|||
23503604|NCT01862874|65583960|FG000|Overall Study|Randomized not treated|1|||
23503605|NCT01862874|65583961|FG001|Overall Study|Randomized not treated|0|||
23503606|NCT01862874|65583960|FG000|Overall Study|Adverse Event|0|||
23503607|NCT01862874|65583961|FG001|Overall Study|Adverse Event|3|||
23503608|NCT01862874|65583960|FG000|Overall Study|Lost to Follow-up|26|||
23503609|NCT01862874|65583961|FG001|Overall Study|Lost to Follow-up|29|||
23503610|NCT01862874|65583960|FG000|Overall Study|Physician Decision|5|||
23503611|NCT01862874|65583961|FG001|Overall Study|Physician Decision|3|||
23503612|NCT01862874|65583960|FG000|Overall Study|Withdrawn by parent/guardian|1|||
23503613|NCT01862874|65583961|FG001|Overall Study|Withdrawn by parent/guardian|1|||
23503614|NCT01862874|65583960|FG000|Overall Study|Withdrawal by Subject|46|||
23503615|NCT01862874|65583961|FG001|Overall Study|Withdrawal by Subject|40|||
23503616|NCT01862874|65583960|FG000|Overall Study|Death|0|||
23503617|NCT01862874|65583961|FG001|Overall Study|Death|1|||
23503618|NCT00506662|65583962|FG000|Overall Study|Adverse Event|0|||
23503619|NCT00506662|65583963|FG001|Overall Study|Adverse Event|2|||
23503620|NCT00506662|65583962|FG000|Overall Study|Lack of Efficacy|1|||
23503621|NCT00506662|65583963|FG001|Overall Study|Lack of Efficacy|0|||
23503622|NCT00506662|65583962|FG000|Overall Study|Protocol Violation|2|||
23503623|NCT00506662|65583963|FG001|Overall Study|Protocol Violation|4|||
23503624|NCT00506662|65583962|FG000|Overall Study|Trial terminated|10|||
23503625|NCT00506662|65583963|FG001|Overall Study|Trial terminated|16|||
23503626|NCT00506662|65583962|FG000|Overall Study|Not recorded|4|||
23503627|NCT00506662|65583963|FG001|Overall Study|Not recorded|6|||
23503628|NCT04805541|65583966|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
23503629|NCT00913497|65583967|FG000|Overall Study|Adverse Event|1|||
23503630|NCT00913497|65583967|FG000|Overall Study|Withdrawal by Subject|2|||
23503631|NCT02340975|65583968|FG000|Overall Study|Death|6|||
23503632|NCT02340975|65583969|FG001|Overall Study|Death|23|||
23503633|NCT02340975|65583970|FG002|Overall Study|Death|21|||
23503634|NCT02340975|65583971|FG003|Overall Study|Death|7|||
23503635|NCT02340975|65583972|FG004|Overall Study|Death|21|||
23503636|NCT02340975|65583973|FG005|Overall Study|Death|13|||
23503637|NCT02340975|65583968|FG000|Overall Study|Lost to Follow-up|0|||
23503638|NCT02340975|65583969|FG001|Overall Study|Lost to Follow-up|0|||
23503639|NCT02340975|65583970|FG002|Overall Study|Lost to Follow-up|0|||
23503640|NCT02340975|65583971|FG003|Overall Study|Lost to Follow-up|0|||
23503641|NCT02340975|65583972|FG004|Overall Study|Lost to Follow-up|2|||
23503642|NCT02340975|65583973|FG005|Overall Study|Lost to Follow-up|0|||
23503643|NCT02340975|65583968|FG000|Overall Study|Withdrawal by Subject|0|||
23503644|NCT02340975|65583969|FG001|Overall Study|Withdrawal by Subject|0|||
23503645|NCT02340975|65583970|FG002|Overall Study|Withdrawal by Subject|3|||
23503646|NCT02340975|65583971|FG003|Overall Study|Withdrawal by Subject|3|||
23503647|NCT02340975|65583972|FG004|Overall Study|Withdrawal by Subject|2|||
23503648|NCT02340975|65583973|FG005|Overall Study|Withdrawal by Subject|0|||
23503649|NCT02340975|65583968|FG000|Overall Study|Other|0|||
23503650|NCT02340975|65583969|FG001|Overall Study|Other|4|||
23503651|NCT02340975|65583970|FG002|Overall Study|Other|0|||
23503652|NCT02340975|65583971|FG003|Overall Study|Other|2|||
23503653|NCT02340975|65583972|FG004|Overall Study|Other|0|||
23503654|NCT02340975|65583973|FG005|Overall Study|Other|6|||
23503655|NCT00571948|65583974|FG000|Overall Study|Lost to Follow-up|2|||
23503656|NCT00571948|65583975|FG001|Overall Study|Lost to Follow-up|0|||
23503657|NCT00571948|65583974|FG000|Overall Study|Withdrawal by Subject|1|||
23503658|NCT00571948|65583975|FG001|Overall Study|Withdrawal by Subject|2|||
23503659|NCT00571948|65583974|FG000|Overall Study|Protocol Violation|3|||
23503660|NCT00571948|65583975|FG001|Overall Study|Protocol Violation|3|||
23503661|NCT00571948|65583974|FG000|Overall Study|infant refused study meal|3|||
23503662|NCT00571948|65583975|FG001|Overall Study|infant refused study meal|4|||
23503663|NCT00571948|65583974|FG000|Overall Study|Parent were afraid of blood colection|2|||
23503664|NCT00571948|65583975|FG001|Overall Study|Parent were afraid of blood colection|5|||
23503665|NCT03338998|65583977|FG000|Treatment Period|Withdrawal by Subject|1|||
23503666|NCT03338998|65583978|FG001|Treatment Period|Withdrawal by Subject|1|||
23503667|NCT03338998|65583977|FG000|Treatment Period|Adverse Event|0|||
23503668|NCT03338998|65583978|FG001|Treatment Period|Adverse Event|2|||
23503669|NCT03338998|65583977|FG000|Treatment Period|Protocol deviation|1|||
23503670|NCT03338998|65583978|FG001|Treatment Period|Protocol deviation|0|||
23503671|NCT03338998|65583977|FG000|Treatment Period|Physician Decision|2|||
23503672|NCT03338998|65583978|FG001|Treatment Period|Physician Decision|0|||
23503673|NCT03338998|65583977|FG000|Treatment Period|Subject failed swallow test|4|||
23503674|NCT03338998|65583978|FG001|Treatment Period|Subject failed swallow test|0|||
23503675|NCT03338998|65583977|FG000|Safety Follow-Up Period|Adverse Event|0|||
23503676|NCT03338998|65583978|FG001|Safety Follow-Up Period|Adverse Event|1|||
23503677|NCT03338998|65583977|FG000|Safety Follow-Up Period|Protocol deviation|1|||
23503678|NCT03338998|65583978|FG001|Safety Follow-Up Period|Protocol deviation|0|||
23503679|NCT03338998|65583977|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
23503680|NCT03338998|65583978|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
23503681|NCT02478632|65583980|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
23503682|NCT02478632|65583981|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
23503683|NCT02478632|65583980|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
23503684|NCT02478632|65583981|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
23503685|NCT02478632|65583980|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
23503686|NCT02478632|65583981|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
23503687|NCT02006719|65583982|FG000|Overall Study|Withdrawal by Subject|10|||
23503688|NCT02006719|65583983|FG001|Overall Study|Withdrawal by Subject|2|||
23503689|NCT02006719|65583982|FG000|Overall Study|Lost to Follow-up|5|||
23503690|NCT02006719|65583983|FG001|Overall Study|Lost to Follow-up|1|||
23503691|NCT02006719|65583982|FG000|Overall Study|Protocol Violation|2|||
23503692|NCT02006719|65583983|FG001|Overall Study|Protocol Violation|0|||
23503693|NCT02006719|65583982|FG000|Overall Study|Adverse Event|1|||
23503694|NCT02006719|65583983|FG001|Overall Study|Adverse Event|1|||
23503695|NCT02006719|65583982|FG000|Overall Study|Other/Unknown|0|||
23503696|NCT02006719|65583983|FG001|Overall Study|Other/Unknown|1|||
23503697|NCT00621153|65583984|FG000|Overall Study|Safety Reason|8|||
23503698|NCT00621153|65583985|FG001|Overall Study|Safety Reason|7|||
23503699|NCT00621153|65583984|FG000|Overall Study|Adverse Event|3|||
23503700|NCT00621153|65583985|FG001|Overall Study|Adverse Event|2|||
23503701|NCT00621153|65583984|FG000|Overall Study|Lost to Follow-up|5|||
23503702|NCT00621153|65583985|FG001|Overall Study|Lost to Follow-up|1|||
23503703|NCT00621153|65583984|FG000|Overall Study|Withdrawal by Subject|4|||
23503704|NCT00621153|65583985|FG001|Overall Study|Withdrawal by Subject|5|||
23503705|NCT01678911|65583986|FG000|Second Intervention|Lost to Follow-up|2|||
23503706|NCT01678911|65583987|FG001|Second Intervention|Lost to Follow-up|0|||
23503707|NCT00536198|65583988|FG000|Overall Study|Lost to Follow-up|15|||
23503708|NCT00536198|65583989|FG001|Overall Study|Lost to Follow-up|14|||
23503709|NCT00536198|65583988|FG000|Overall Study|Withdrawal by Subject|16|||
23503710|NCT00536198|65583989|FG001|Overall Study|Withdrawal by Subject|12|||
23503711|NCT00536198|65583988|FG000|Overall Study|Adverse Event|2|||
23503712|NCT00536198|65583989|FG001|Overall Study|Adverse Event|2|||
23503713|NCT00536198|65583988|FG000|Overall Study|Rescue|3|||
23503714|NCT00536198|65583989|FG001|Overall Study|Rescue|9|||
23503715|NCT00536198|65583988|FG000|Overall Study|Pregnancy|1|||
23503716|NCT00536198|65583989|FG001|Overall Study|Pregnancy|1|||
23503717|NCT00536198|65583988|FG000|Overall Study|Protocol Violation|0|||
23503718|NCT00536198|65583989|FG001|Overall Study|Protocol Violation|1|||
23503719|NCT01626456|65583990|FG000|Overall Study|Withdrawal by Subject|21|||
23503720|NCT01626456|65583991|FG001|Overall Study|Withdrawal by Subject|46|||
23503721|NCT01626456|65583990|FG000|Overall Study|Adverse Event|2|||
23503722|NCT01626456|65583991|FG001|Overall Study|Adverse Event|27|||
23503723|NCT01626456|65583990|FG000|Overall Study|Lost to Follow-up|2|||
23503724|NCT01626456|65583991|FG001|Overall Study|Lost to Follow-up|27|||
23503725|NCT01626456|65583990|FG000|Overall Study|Lack of Efficacy|6|||
23503726|NCT01626456|65583991|FG001|Overall Study|Lack of Efficacy|7|||
23503727|NCT01626456|65583990|FG000|Overall Study|Physician Decision|1|||
23503728|NCT01626456|65583991|FG001|Overall Study|Physician Decision|4|||
23503729|NCT01626456|65583990|FG000|Overall Study|Protocol Violation|1|||
23503730|NCT01626456|65583991|FG001|Overall Study|Protocol Violation|1|||
23503731|NCT01626456|65583990|FG000|Overall Study|Site Closure|2|||
23503732|NCT01626456|65583991|FG001|Overall Study|Site Closure|3|||
23503733|NCT01626456|65583990|FG000|Overall Study|Incarceration|0|||
23503734|NCT01626456|65583991|FG001|Overall Study|Incarceration|2|||
23503735|NCT01446289|65583992|FG000|Overall Study|Withdrawal by Subject|1|||
23503736|NCT01446289|65583993|FG001|Overall Study|Withdrawal by Subject|0|||
23503737|NCT01446289|65583994|FG002|Overall Study|Withdrawal by Subject|1|||
23503738|NCT01446289|65583995|FG003|Overall Study|Withdrawal by Subject|0|||
23503739|NCT03572062|65584000|FG000|Overall Study|Adverse Event|0|||
23503740|NCT03572062|65584001|FG001|Overall Study|Adverse Event|0|||
23503741|NCT03572062|65584002|FG002|Overall Study|Adverse Event|0|||
23503742|NCT03572062|65584003|FG003|Overall Study|Adverse Event|0|||
23503743|NCT03572062|65584004|FG004|Overall Study|Adverse Event|0|||
23503744|NCT03572062|65584005|FG005|Overall Study|Adverse Event|0|||
23503745|NCT03572062|65584006|FG006|Overall Study|Adverse Event|0|||
23503746|NCT03572062|65584007|FG007|Overall Study|Adverse Event|0|||
23503747|NCT03572062|65584008|FG008|Overall Study|Adverse Event|1|||
23503748|NCT03572062|65584009|FG009|Overall Study|Adverse Event|3|||
23503749|NCT03572062|65584000|FG000|Overall Study|Death|0|||
23503750|NCT03572062|65584001|FG001|Overall Study|Death|0|||
23503751|NCT03572062|65584002|FG002|Overall Study|Death|0|||
23503752|NCT03572062|65584003|FG003|Overall Study|Death|0|||
23503753|NCT03572062|65584004|FG004|Overall Study|Death|0|||
23503754|NCT03572062|65584005|FG005|Overall Study|Death|1|||
23503755|NCT03572062|65584006|FG006|Overall Study|Death|0|||
23503756|NCT03572062|65584007|FG007|Overall Study|Death|0|||
23503757|NCT03572062|65584008|FG008|Overall Study|Death|0|||
23503758|NCT03572062|65584009|FG009|Overall Study|Death|0|||
23503759|NCT03572062|65584000|FG000|Overall Study|Lost to Follow-up|0|||
23503760|NCT03572062|65584001|FG001|Overall Study|Lost to Follow-up|0|||
23503761|NCT03572062|65584002|FG002|Overall Study|Lost to Follow-up|0|||
23503762|NCT03572062|65584003|FG003|Overall Study|Lost to Follow-up|0|||
23503763|NCT03572062|65584004|FG004|Overall Study|Lost to Follow-up|0|||
23503764|NCT03572062|65584005|FG005|Overall Study|Lost to Follow-up|1|||
23503765|NCT03572062|65584006|FG006|Overall Study|Lost to Follow-up|1|||
23503766|NCT03572062|65584007|FG007|Overall Study|Lost to Follow-up|0|||
23503767|NCT03572062|65584008|FG008|Overall Study|Lost to Follow-up|0|||
23503768|NCT03572062|65584009|FG009|Overall Study|Lost to Follow-up|0|||
23503769|NCT03572062|65584000|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503770|NCT03572062|65584001|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503771|NCT03572062|65584002|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503772|NCT03572062|65584003|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503773|NCT03572062|65584004|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503774|NCT03572062|65584005|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503775|NCT03572062|65584006|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503776|NCT03572062|65584007|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503777|NCT03572062|65584008|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
23503778|NCT03572062|65584009|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
23503779|NCT03572062|65584000|FG000|Overall Study|Study Terminated By Sponsor|0|||
23503780|NCT03572062|65584001|FG001|Overall Study|Study Terminated By Sponsor|0|||
23503781|NCT03572062|65584002|FG002|Overall Study|Study Terminated By Sponsor|0|||
23503782|NCT03572062|65584003|FG003|Overall Study|Study Terminated By Sponsor|0|||
23503783|NCT03572062|65584004|FG004|Overall Study|Study Terminated By Sponsor|0|||
23503784|NCT03572062|65584005|FG005|Overall Study|Study Terminated By Sponsor|0|||
23503785|NCT03572062|65584006|FG006|Overall Study|Study Terminated By Sponsor|0|||
23503786|NCT03572062|65584007|FG007|Overall Study|Study Terminated By Sponsor|0|||
23503787|NCT03572062|65584008|FG008|Overall Study|Study Terminated By Sponsor|29|||
23503788|NCT03572062|65584009|FG009|Overall Study|Study Terminated By Sponsor|27|||
23503789|NCT03572062|65584000|FG000|Overall Study|Physician Decision|0|||
23503790|NCT03572062|65584001|FG001|Overall Study|Physician Decision|0|||
23503791|NCT03572062|65584002|FG002|Overall Study|Physician Decision|0|||
23503792|NCT03572062|65584003|FG003|Overall Study|Physician Decision|0|||
23503793|NCT03572062|65584004|FG004|Overall Study|Physician Decision|0|||
23503794|NCT03572062|65584005|FG005|Overall Study|Physician Decision|0|||
23503795|NCT03572062|65584006|FG006|Overall Study|Physician Decision|0|||
23503796|NCT03572062|65584007|FG007|Overall Study|Physician Decision|0|||
23503797|NCT03572062|65584008|FG008|Overall Study|Physician Decision|1|||
23503798|NCT03572062|65584009|FG009|Overall Study|Physician Decision|0|||
23503799|NCT03572062|65584000|FG000|Overall Study|Withdrawal by Subject|0|||
23503800|NCT03572062|65584001|FG001|Overall Study|Withdrawal by Subject|0|||
23503801|NCT03572062|65584002|FG002|Overall Study|Withdrawal by Subject|0|||
23503802|NCT03572062|65584003|FG003|Overall Study|Withdrawal by Subject|0|||
23503803|NCT03572062|65584004|FG004|Overall Study|Withdrawal by Subject|0|||
23503804|NCT03572062|65584005|FG005|Overall Study|Withdrawal by Subject|0|||
23503805|NCT03572062|65584006|FG006|Overall Study|Withdrawal by Subject|0|||
23503806|NCT03572062|65584007|FG007|Overall Study|Withdrawal by Subject|0|||
23503807|NCT03572062|65584008|FG008|Overall Study|Withdrawal by Subject|0|||
23503808|NCT03572062|65584009|FG009|Overall Study|Withdrawal by Subject|1|||
23503809|NCT03572062|65584000|FG000|Overall Study|Randomized But Not Treated|0|||
23503810|NCT03572062|65584001|FG001|Overall Study|Randomized But Not Treated|0|||
23503811|NCT03572062|65584002|FG002|Overall Study|Randomized But Not Treated|0|||
23503812|NCT03572062|65584003|FG003|Overall Study|Randomized But Not Treated|0|||
23503813|NCT03572062|65584004|FG004|Overall Study|Randomized But Not Treated|1|||
23503814|NCT03572062|65584005|FG005|Overall Study|Randomized But Not Treated|2|||
23503815|NCT03572062|65584006|FG006|Overall Study|Randomized But Not Treated|0|||
23503816|NCT03572062|65584007|FG007|Overall Study|Randomized But Not Treated|1|||
23503817|NCT03572062|65584008|FG008|Overall Study|Randomized But Not Treated|0|||
23503818|NCT03572062|65584009|FG009|Overall Study|Randomized But Not Treated|0|||
23503819|NCT03648983|65584010|FG000|Overall Study|Study was terminated due to PI departure|95|||
23503820|NCT00745823|65584013|FG000|Overall Study|Adverse Event|5|||
23503821|NCT00745823|65584014|FG001|Overall Study|Adverse Event|3|||
23503822|NCT00745823|65584013|FG000|Overall Study|Lack of Efficacy|20|||
23503823|NCT00745823|65584014|FG001|Overall Study|Lack of Efficacy|6|||
23503824|NCT00745823|65584013|FG000|Overall Study|Lost to Follow-up|10|||
23503825|NCT00745823|65584014|FG001|Overall Study|Lost to Follow-up|11|||
23503826|NCT00745823|65584013|FG000|Overall Study|Physician Decision|10|||
23503827|NCT00745823|65584014|FG001|Overall Study|Physician Decision|5|||
23503828|NCT00745823|65584013|FG000|Overall Study|Pregnancy|0|||
23503829|NCT00745823|65584014|FG001|Overall Study|Pregnancy|4|||
23503830|NCT00745823|65584013|FG000|Overall Study|Withdrawal by Subject|14|||
23503831|NCT00745823|65584014|FG001|Overall Study|Withdrawal by Subject|8|||
23503832|NCT00745823|65584013|FG000|Overall Study|Study Terminated by Sponsor|326|||
23503833|NCT00745823|65584014|FG001|Overall Study|Study Terminated by Sponsor|349|||
23503834|NCT01405742|65584015|FG000|Overall Study|Lost to Follow-up|1|||
23503835|NCT01405742|65584016|FG001|Overall Study|Lost to Follow-up|0|||
23503836|NCT03919799|65584020|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
23503837|NCT03919799|65584021|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
23503838|NCT03919799|65584022|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
23503839|NCT03919799|65584023|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
23503840|NCT03919799|65584024|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
23503841|NCT03919799|65584020|FG000|DB Period (28 Weeks)|Adverse Event|1|||
23503842|NCT03919799|65584021|FG001|DB Period (28 Weeks)|Adverse Event|1|||
23503843|NCT03919799|65584022|FG002|DB Period (28 Weeks)|Adverse Event|1|||
23503844|NCT03919799|65584023|FG003|DB Period (28 Weeks)|Adverse Event|0|||
23503845|NCT03919799|65584024|FG004|DB Period (28 Weeks)|Adverse Event|0|||
23503846|NCT03919799|65584020|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
23503847|NCT03919799|65584021|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
23503848|NCT03919799|65584022|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
23503849|NCT03919799|65584023|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
23503850|NCT03919799|65584024|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
23503851|NCT03919799|65584020|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
23503852|NCT03919799|65584021|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
23503853|NCT03919799|65584022|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
23503854|NCT03919799|65584023|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
23503855|NCT03919799|65584024|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
23503856|NCT03919799|65584020|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
23503857|NCT03919799|65584021|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
23503858|NCT03919799|65584022|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
23503859|NCT03919799|65584023|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
23503860|NCT03919799|65584024|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
23503861|NCT03978832|65584030|FG000|Overall Study|Adverse Event|1|||
23503862|NCT03978832|65584030|FG000|Overall Study|Lost to Follow-up|1|||
23503863|NCT03978832|65584030|FG000|Overall Study|Withdrawal by Subject|6|||
23503864|NCT03978832|65584030|FG000|Overall Study|Physician Decision|2|||
23503865|NCT03978832|65584030|FG000|Overall Study|did not pass screening criteria|44|||
23503866|NCT02859454|65584031|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
23503867|NCT01687998|65584032|FG000|Overall Study|Withdrawal by Subject|49|||
23503868|NCT01687998|65584033|FG001|Overall Study|Withdrawal by Subject|51|||
23503869|NCT01687998|65584032|FG000|Overall Study|Known to be Alive at Study End|54|||
23503870|NCT01687998|65584033|FG001|Overall Study|Known to be Alive at Study End|62|||
23503871|NCT01687998|65584032|FG000|Overall Study|Lost to Follow-up|9|||
23503872|NCT01687998|65584033|FG001|Overall Study|Lost to Follow-up|7|||
23503873|NCT00963547|65584038|FG000|Overall Study|Adverse Event|0|||
23503874|NCT00963547|65584039|FG001|Overall Study|Adverse Event|1|||
23503875|NCT00963547|65584040|FG002|Overall Study|Adverse Event|0|||
23503876|NCT00963547|65584041|FG003|Overall Study|Adverse Event|1|||
23503877|NCT00963547|65584042|FG004|Overall Study|Adverse Event|0|||
23503878|NCT00963547|65584043|FG005|Overall Study|Adverse Event|0|||
23503879|NCT00963547|65584044|FG006|Overall Study|Adverse Event|0|||
23503880|NCT00963547|65584038|FG000|Overall Study|Physician Decision|1|||
23503881|NCT00963547|65584039|FG001|Overall Study|Physician Decision|1|||
23503882|NCT00963547|65584040|FG002|Overall Study|Physician Decision|0|||
23503883|NCT00963547|65584041|FG003|Overall Study|Physician Decision|0|||
23503884|NCT00963547|65584042|FG004|Overall Study|Physician Decision|0|||
23503885|NCT00963547|65584043|FG005|Overall Study|Physician Decision|0|||
23503886|NCT00963547|65584044|FG006|Overall Study|Physician Decision|0|||
23503887|NCT00963547|65584038|FG000|Overall Study|Progressive Disease|3|||
23503888|NCT00963547|65584039|FG001|Overall Study|Progressive Disease|8|||
23503889|NCT00963547|65584040|FG002|Overall Study|Progressive Disease|9|||
23503890|NCT00963547|65584041|FG003|Overall Study|Progressive Disease|5|||
23503891|NCT00963547|65584042|FG004|Overall Study|Progressive Disease|0|||
23503892|NCT00963547|65584043|FG005|Overall Study|Progressive Disease|0|||
23503893|NCT00963547|65584044|FG006|Overall Study|Progressive Disease|0|||
23503894|NCT00963547|65584038|FG000|Overall Study|Withdrawal by Subject|0|||
23503895|NCT00963547|65584039|FG001|Overall Study|Withdrawal by Subject|0|||
23503896|NCT00963547|65584040|FG002|Overall Study|Withdrawal by Subject|3|||
23503897|NCT00963547|65584041|FG003|Overall Study|Withdrawal by Subject|0|||
23503898|NCT00963547|65584042|FG004|Overall Study|Withdrawal by Subject|0|||
23503899|NCT00963547|65584043|FG005|Overall Study|Withdrawal by Subject|0|||
23503900|NCT00963547|65584044|FG006|Overall Study|Withdrawal by Subject|0|||
23503901|NCT00963547|65584038|FG000|Overall Study|Reason Unknown|0|||
23503902|NCT00963547|65584039|FG001|Overall Study|Reason Unknown|1|||
23503903|NCT00963547|65584040|FG002|Overall Study|Reason Unknown|0|||
23503904|NCT00963547|65584041|FG003|Overall Study|Reason Unknown|0|||
23503905|NCT00963547|65584042|FG004|Overall Study|Reason Unknown|0|||
23503906|NCT00963547|65584043|FG005|Overall Study|Reason Unknown|0|||
23503907|NCT00963547|65584044|FG006|Overall Study|Reason Unknown|0|||
23503908|NCT02468674|65584045|FG000|Overall Study|Adverse Event|0|||
23503909|NCT02468674|65584046|FG001|Overall Study|Adverse Event|0|||
23503910|NCT02468674|65584047|FG002|Overall Study|Adverse Event|0|||
23503911|NCT02468674|65584048|FG003|Overall Study|Adverse Event|1|||
23503912|NCT02468674|65584049|FG004|Overall Study|Adverse Event|0|||
23503913|NCT02468674|65584050|FG005|Overall Study|Adverse Event|1|||
23503914|NCT02468674|65584051|FG006|Overall Study|Adverse Event|0|||
23503915|NCT02468674|65584052|FG007|Overall Study|Adverse Event|0|||
23503916|NCT02468674|65584053|FG008|Overall Study|Adverse Event|0|||
23503917|NCT02468674|65584045|FG000|Overall Study|Lost to Follow-up|1|||
23503918|NCT02468674|65584046|FG001|Overall Study|Lost to Follow-up|0|||
23503919|NCT02468674|65584047|FG002|Overall Study|Lost to Follow-up|0|||
23503920|NCT02468674|65584048|FG003|Overall Study|Lost to Follow-up|0|||
23503921|NCT02468674|65584049|FG004|Overall Study|Lost to Follow-up|0|||
23503922|NCT02468674|65584050|FG005|Overall Study|Lost to Follow-up|0|||
23503923|NCT02468674|65584051|FG006|Overall Study|Lost to Follow-up|0|||
23503924|NCT02468674|65584052|FG007|Overall Study|Lost to Follow-up|1|||
23503925|NCT02468674|65584053|FG008|Overall Study|Lost to Follow-up|1|||
23503926|NCT02468674|65584045|FG000|Overall Study|Physician Decision|0|||
23503927|NCT02468674|65584046|FG001|Overall Study|Physician Decision|0|||
23503928|NCT02468674|65584047|FG002|Overall Study|Physician Decision|0|||
23503929|NCT02468674|65584048|FG003|Overall Study|Physician Decision|0|||
23503930|NCT02468674|65584049|FG004|Overall Study|Physician Decision|0|||
23503931|NCT02468674|65584050|FG005|Overall Study|Physician Decision|0|||
23503932|NCT02468674|65584051|FG006|Overall Study|Physician Decision|1|||
23503933|NCT02468674|65584052|FG007|Overall Study|Physician Decision|0|||
23503934|NCT02468674|65584053|FG008|Overall Study|Physician Decision|0|||
23503935|NCT02468674|65584045|FG000|Overall Study|Patient/Guardian Decision|0|||
23503936|NCT02468674|65584046|FG001|Overall Study|Patient/Guardian Decision|0|||
23503937|NCT02468674|65584047|FG002|Overall Study|Patient/Guardian Decision|0|||
23503938|NCT02468674|65584048|FG003|Overall Study|Patient/Guardian Decision|0|||
23503939|NCT02468674|65584049|FG004|Overall Study|Patient/Guardian Decision|1|||
23503940|NCT02468674|65584050|FG005|Overall Study|Patient/Guardian Decision|0|||
23503941|NCT02468674|65584051|FG006|Overall Study|Patient/Guardian Decision|0|||
23503942|NCT02468674|65584052|FG007|Overall Study|Patient/Guardian Decision|2|||
23503943|NCT02468674|65584053|FG008|Overall Study|Patient/Guardian Decision|1|||
23503944|NCT02468674|65584045|FG000|Overall Study|Protocol Deviation|0|||
23503945|NCT02468674|65584046|FG001|Overall Study|Protocol Deviation|0|||
23503946|NCT02468674|65584047|FG002|Overall Study|Protocol Deviation|0|||
23503947|NCT02468674|65584048|FG003|Overall Study|Protocol Deviation|0|||
23503948|NCT02468674|65584049|FG004|Overall Study|Protocol Deviation|0|||
23503949|NCT02468674|65584050|FG005|Overall Study|Protocol Deviation|0|||
23503950|NCT02468674|65584051|FG006|Overall Study|Protocol Deviation|0|||
23503951|NCT02468674|65584052|FG007|Overall Study|Protocol Deviation|1|||
23503952|NCT02468674|65584053|FG008|Overall Study|Protocol Deviation|1|||
23503953|NCT00680017|65584054|FG000|Overall Study|Adverse Event|13|||
23503954|NCT00680017|65584055|FG001|Overall Study|Adverse Event|7|||
23503955|NCT00680017|65584054|FG000|Overall Study|Withdrawal by Subject|2|||
23503956|NCT00680017|65584055|FG001|Overall Study|Withdrawal by Subject|5|||
23503957|NCT00680017|65584054|FG000|Overall Study|Lost to Follow-up|2|||
23503958|NCT00680017|65584055|FG001|Overall Study|Lost to Follow-up|0|||
23503959|NCT00967668|65584063|FG000|Overall Study|Withdrawal by Subject|13|||
23503960|NCT00967668|65584064|FG001|Overall Study|Withdrawal by Subject|8|||
23503961|NCT00967668|65584065|FG002|Overall Study|Withdrawal by Subject|8|||
23503962|NCT00967668|65584063|FG000|Overall Study|Death|0|||
23503963|NCT00967668|65584064|FG001|Overall Study|Death|2|||
23503964|NCT00967668|65584065|FG002|Overall Study|Death|4|||
23503965|NCT00967668|65584063|FG000|Overall Study|Removed due to behavior|1|||
23503966|NCT00967668|65584064|FG001|Overall Study|Removed due to behavior|1|||
23503967|NCT00967668|65584065|FG002|Overall Study|Removed due to behavior|2|||
23503968|NCT00967668|65584063|FG000|Overall Study|Refused Year 2|11|||
23503969|NCT00967668|65584064|FG001|Overall Study|Refused Year 2|6|||
23503970|NCT00967668|65584065|FG002|Overall Study|Refused Year 2|4|||
23503971|NCT00967668|65584063|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
23503972|NCT00967668|65584064|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
23503973|NCT00967668|65584065|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
23503974|NCT00967668|65584063|FG000|Overall Study|Lost to Follow-up|15|||
23503975|NCT00967668|65584064|FG001|Overall Study|Lost to Follow-up|9|||
23503976|NCT00967668|65584065|FG002|Overall Study|Lost to Follow-up|16|||
23503977|NCT00967668|65584063|FG000|Overall Study|Refused 12-mo assessment|3|||
23503978|NCT00967668|65584064|FG001|Overall Study|Refused 12-mo assessment|1|||
23503979|NCT00967668|65584065|FG002|Overall Study|Refused 12-mo assessment|9|||
23503980|NCT00967668|65584063|FG000|Overall Study|Pregnancy|1|||
23503981|NCT00967668|65584064|FG001|Overall Study|Pregnancy|0|||
23503982|NCT00967668|65584065|FG002|Overall Study|Pregnancy|0|||
23503983|NCT03706079|65584066|FG000|Predecessor Study|Death|0|||
23503984|NCT03706079|65584067|FG001|Predecessor Study|Death|2|||
23503985|NCT03706079|65584068|FG002|Predecessor Study|Death|0|||
23503986|NCT03706079|65584069|FG003|Predecessor Study|Death|1|||
23503987|NCT03706079|65584070|FG004|Predecessor Study|Death|0|||
23503988|NCT03706079|65584071|FG005|Predecessor Study|Death|0|||
23503989|NCT03706079|65584066|FG000|Predecessor Study|Lost to Follow-up|5|||
23503990|NCT03706079|65584067|FG001|Predecessor Study|Lost to Follow-up|2|||
23503991|NCT03706079|65584068|FG002|Predecessor Study|Lost to Follow-up|0|||
23503992|NCT03706079|65584069|FG003|Predecessor Study|Lost to Follow-up|0|||
23503993|NCT03706079|65584070|FG004|Predecessor Study|Lost to Follow-up|1|||
23503994|NCT03706079|65584071|FG005|Predecessor Study|Lost to Follow-up|0|||
23503995|NCT03706079|65584066|FG000|Predecessor Study|Withdrawal by Subject|8|||
23503996|NCT03706079|65584067|FG001|Predecessor Study|Withdrawal by Subject|15|||
23503997|NCT03706079|65584068|FG002|Predecessor Study|Withdrawal by Subject|0|||
23503998|NCT03706079|65584069|FG003|Predecessor Study|Withdrawal by Subject|5|||
23503999|NCT03706079|65584070|FG004|Predecessor Study|Withdrawal by Subject|2|||
23504000|NCT03706079|65584071|FG005|Predecessor Study|Withdrawal by Subject|0|||
23504001|NCT03706079|65584066|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
23504002|NCT03706079|65584067|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
23504003|NCT03706079|65584068|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
23504004|NCT03706079|65584069|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
23504005|NCT03706079|65584070|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
23504006|NCT03706079|65584071|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
23504007|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504008|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504009|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504010|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504011|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
23504012|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
23504013|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
23504014|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
23504015|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
23504016|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
23504017|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
23504018|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
23504019|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
23504020|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504021|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504022|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504023|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504024|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
23504025|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
23504026|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
23504027|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
23504028|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
23504029|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
23504030|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
23504031|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
23504032|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
23504033|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
23504034|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
23504035|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
23504036|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
23400102|NCT03366337|65210848|FG003|Overall Study|Withdrawal by Subject|1|||
23400103|NCT02138825|65210849|FG000|Main Study Treatment|Adverse Event|11|||
23400104|NCT02138825|65210850|FG001|Main Study Treatment|Adverse Event|3|||
23400105|NCT02138825|65210849|FG000|Main Study Treatment|Death|1|||
23400106|NCT02138825|65210850|FG001|Main Study Treatment|Death|2|||
23400107|NCT02138825|65210849|FG000|Main Study Treatment|Protocol Violation|2|||
23400108|NCT02138825|65210850|FG001|Main Study Treatment|Protocol Violation|2|||
23400109|NCT02138825|65210849|FG000|Main Study Treatment|Sponsor decision|12|||
23400110|NCT02138825|65210850|FG001|Main Study Treatment|Sponsor decision|18|||
23400111|NCT02138825|65210849|FG000|Main Study Treatment|Study terminated by sponsor|10|||
23400112|NCT02138825|65210850|FG001|Main Study Treatment|Study terminated by sponsor|9|||
23400113|NCT02138825|65210849|FG000|Main Study Treatment|Withdrawal by Subject|3|||
23400114|NCT02138825|65210850|FG001|Main Study Treatment|Withdrawal by Subject|1|||
23400115|NCT02138825|65210849|FG000|Main Study Treatment|Medical decision|1|||
23400116|NCT02138825|65210850|FG001|Main Study Treatment|Medical decision|0|||
23400117|NCT02138825|65210849|FG000|Long-term Extension|Study termination by sponsor|32|||
23400118|NCT02138825|65210850|FG001|Long-term Extension|Study termination by sponsor|38|||
23400119|NCT02138825|65210849|FG000|Safety Follow-up|Adverse Event|4|||
23400120|NCT02138825|65210850|FG001|Safety Follow-up|Adverse Event|3|||
23400121|NCT02138825|65210849|FG000|Safety Follow-up|Death|11|||
23400122|NCT02138825|65210850|FG001|Safety Follow-up|Death|5|||
23400123|NCT02138825|65210849|FG000|Safety Follow-up|Withdrawal by Subject|5|||
23400124|NCT02138825|65210850|FG001|Safety Follow-up|Withdrawal by Subject|3|||
23400125|NCT02138825|65210849|FG000|Safety Follow-up|clinic worsening|1|||
23400126|NCT02138825|65210850|FG001|Safety Follow-up|clinic worsening|0|||
23400127|NCT02138825|65210849|FG000|Safety Follow-up|withdrawal by PI|1|||
23400128|NCT02138825|65210850|FG001|Safety Follow-up|withdrawal by PI|0|||
23400129|NCT02138825|65210849|FG000|Safety Follow-up|logistical difficulties|0|||
23400130|NCT02138825|65210850|FG001|Safety Follow-up|logistical difficulties|1|||
23400131|NCT02138825|65210849|FG000|Safety Follow-up|progressive disease|0|||
23400132|NCT02138825|65210850|FG001|Safety Follow-up|progressive disease|2|||
23400133|NCT02138825|65210849|FG000|Safety Follow-up|too unwell to attend the visit|0|||
23400134|NCT02138825|65210850|FG001|Safety Follow-up|too unwell to attend the visit|1|||
23400135|NCT02138825|65210849|FG000|Safety Follow-up|treatment unblinded|0|||
23400136|NCT02138825|65210850|FG001|Safety Follow-up|treatment unblinded|1|||
23400137|NCT02138825|65210849|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
23400138|NCT02138825|65210850|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
23400139|NCT00325143|65210851|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
23400140|NCT00325143|65210851|FG000|Overall Study|Migrated/moved from study area|1|||
23400141|NCT00325143|65210851|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
23400142|NCT00325143|65210851|FG000|Overall Study|Withdrawal by Subject|8|||
23400143|NCT03434834|65210852|FG000|Overall Study|unable to swallow OCT probe|16|||
23400144|NCT00633126|65210853|FG000|Overall Study|Did not receive full dose|1|||
23400145|NCT01932788|65210856|FG000|Overall Study|Protocol Violation|18|||
23400146|NCT01932788|65210857|FG001|Overall Study|Protocol Violation|0|||
23400147|NCT01932788|65210856|FG000|Overall Study|Lost to Follow-up|18|||
23400148|NCT01932788|65210857|FG001|Overall Study|Lost to Follow-up|46|||
23400149|NCT01932788|65210856|FG000|Overall Study|Lack of Efficacy|2|||
23400150|NCT01932788|65210857|FG001|Overall Study|Lack of Efficacy|0|||
23400151|NCT01932788|65210856|FG000|Overall Study|Withdrawal by Subject|0|||
23400152|NCT01932788|65210857|FG001|Overall Study|Withdrawal by Subject|5|||
23400153|NCT01816048|65210858|FG000|Overall Study|Adverse Event|1|||
23400154|NCT01816048|65210858|FG000|Overall Study|Death|1|||
23400155|NCT01816048|65210858|FG000|Overall Study|Withdrawal by Subject|1|||
23400156|NCT01816048|65210858|FG000|Overall Study|Disease Progression|3|||
23400157|NCT00002766|65210865|FG000|Overall Study|Withdrawal by Subject|0|||
23400158|NCT00002766|65210866|FG001|Overall Study|Withdrawal by Subject|1|||
23400159|NCT00002766|65210865|FG000|Overall Study|Patient Not Treated|1|||
23400160|NCT00002766|65210866|FG001|Overall Study|Patient Not Treated|2|||
23400161|NCT00002766|65210865|FG000|Overall Study|Adverse Event|1|||
23400162|NCT00002766|65210866|FG001|Overall Study|Adverse Event|1|||
23400163|NCT00002766|65210865|FG000|Overall Study|Protocol Violation|1|||
23400164|NCT00002766|65210866|FG001|Overall Study|Protocol Violation|0|||
23400165|NCT03358030|65210867|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
23400166|NCT03358030|65210868|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
23400167|NCT03358030|65210869|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
23400168|NCT03358030|65210870|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
23400169|NCT03358030|65210867|FG000|Overall Study|Ineligibility|0|||
23400170|NCT03358030|65210868|FG001|Overall Study|Ineligibility|0|||
23400171|NCT03358030|65210869|FG002|Overall Study|Ineligibility|0|||
23400172|NCT03358030|65210870|FG003|Overall Study|Ineligibility|2|||
23400173|NCT03358030|65210867|FG000|Overall Study|Voluntary Withdrawal|1|||
23400174|NCT03358030|65210868|FG001|Overall Study|Voluntary Withdrawal|1|||
23400175|NCT03358030|65210869|FG002|Overall Study|Voluntary Withdrawal|3|||
23400176|NCT03358030|65210870|FG003|Overall Study|Voluntary Withdrawal|1|||
23400177|NCT03358030|65210867|FG000|Overall Study|Other|0|||
23400178|NCT03358030|65210868|FG001|Overall Study|Other|0|||
23400179|NCT03358030|65210869|FG002|Overall Study|Other|1|||
23400180|NCT03358030|65210870|FG003|Overall Study|Other|0|||
23400181|NCT00145626|65210871|FG000|Overall Study|Did not have NK infusions|2|||
23400182|NCT00145626|65210871|FG000|Overall Study|Turned 2 years old before treatment|1|||
23400183|NCT00145626|65210871|FG000|Overall Study|Death|1|||
23400184|NCT00145626|65210871|FG000|Overall Study|Withdrawal by Subject|1|||
23400185|NCT02115321|65210872|FG000|Overall Study|Death|1|||
23400186|NCT02115321|65210873|FG001|Overall Study|Death|0|||
23402844|NCT01349673|65220031|FG000|Overall Study|Withdrawal by Subject|21|||
23402845|NCT01349673|65220031|FG000|Overall Study|Lost to Follow-up|6|||
23402846|NCT01349673|65220031|FG000|Overall Study|Adverse Event|17|||
23402847|NCT01349673|65220031|FG000|Overall Study|Study Terminated By Sponsor|50|||
23402848|NCT01349673|65220031|FG000|Overall Study|Lack of Efficacy|8|||
23402849|NCT01130337|65220034|FG000|Overall Study|Withdrawal by Subject|3|||
23402850|NCT01130337|65220034|FG000|Overall Study|Principal investigator decision|1|||
23402851|NCT01130337|65220034|FG000|Overall Study|Death|1|||
23402852|NCT01130337|65220034|FG000|Overall Study|Disease progression|1|||
23402853|NCT01130337|65220034|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
23402854|NCT01130337|65220034|FG000|Overall Study|Surgical resection (R2)|1|||
23402855|NCT03089047|65220035|FG000|Overall Study|Lost to Follow-up|1|||
23402856|NCT03089047|65220036|FG001|Overall Study|Lost to Follow-up|0|||
23402857|NCT04422431|65220037|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
23402858|NCT04422431|65220037|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
23400187|NCT01076010|65214042|FG000|Overall Study|Death|15|||
23400188|NCT01076010|65214043|FG001|Overall Study|Death|1|||
23400189|NCT01076010|65214044|FG002|Overall Study|Death|0|||
23400190|NCT01076010|65214042|FG000|Overall Study|Adverse Event|7|||
23400191|NCT01076010|65214043|FG001|Overall Study|Adverse Event|2|||
23400192|NCT01076010|65214044|FG002|Overall Study|Adverse Event|0|||
23400193|NCT01076010|65214042|FG000|Overall Study|Progressive disease|90|||
23400194|NCT01076010|65214043|FG001|Overall Study|Progressive disease|30|||
23400195|NCT01076010|65214044|FG002|Overall Study|Progressive disease|1|||
23400196|NCT01076010|65214042|FG000|Overall Study|Lack of Efficacy|4|||
23400197|NCT01076010|65214043|FG001|Overall Study|Lack of Efficacy|0|||
23400198|NCT01076010|65214044|FG002|Overall Study|Lack of Efficacy|0|||
23400199|NCT01076010|65214042|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
23400200|NCT01076010|65214043|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
23400201|NCT01076010|65214044|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
23400202|NCT01076010|65214042|FG000|Overall Study|Significant Surgical Procedure|0|||
23400203|NCT01076010|65214043|FG001|Overall Study|Significant Surgical Procedure|1|||
23400204|NCT01076010|65214044|FG002|Overall Study|Significant Surgical Procedure|0|||
23400205|NCT01076010|65214042|FG000|Overall Study|Protocol Violation|0|||
23400206|NCT01076010|65214043|FG001|Overall Study|Protocol Violation|1|||
23400207|NCT01076010|65214044|FG002|Overall Study|Protocol Violation|0|||
23400208|NCT01076010|65214042|FG000|Overall Study|Noncompliance|1|||
23400209|NCT01076010|65214043|FG001|Overall Study|Noncompliance|1|||
23400210|NCT01076010|65214044|FG002|Overall Study|Noncompliance|0|||
23400211|NCT01076010|65214042|FG000|Overall Study|Withdrawal by Subject|3|||
23400212|NCT01076010|65214043|FG001|Overall Study|Withdrawal by Subject|0|||
23400213|NCT01076010|65214044|FG002|Overall Study|Withdrawal by Subject|1|||
23400214|NCT01076010|65214042|FG000|Overall Study|Other|5|||
23400215|NCT01076010|65214043|FG001|Overall Study|Other|2|||
23400216|NCT01076010|65214044|FG002|Overall Study|Other|0|||
23400217|NCT00959907|65214050|FG000|Overall Study|Protocol Violation|0|||
23400218|NCT00959907|65214051|FG001|Overall Study|Protocol Violation|1|||
23400219|NCT00959907|65214050|FG000|Overall Study|Adverse Event|1|||
23400220|NCT00959907|65214051|FG001|Overall Study|Adverse Event|0|||
23400221|NCT00959907|65214050|FG000|Overall Study|Withdrawal by Subject|2|||
23400222|NCT00959907|65214051|FG001|Overall Study|Withdrawal by Subject|0|||
23400223|NCT01171677|65214052|FG000|Overall Study|Withdrawal by Subject|0|||
23400224|NCT01171677|65214053|FG001|Overall Study|Withdrawal by Subject|3|||
23400225|NCT01171677|65214052|FG000|Overall Study|Adverse Event|1|||
23400226|NCT01171677|65214053|FG001|Overall Study|Adverse Event|0|||
23400227|NCT01171677|65214052|FG000|Overall Study|completed <70% IntenSati classes|5|||
23400228|NCT01171677|65214053|FG001|Overall Study|completed <70% IntenSati classes|0|||
23400229|NCT01904721|65214054|FG000|Overall Study|Other Reasons|0|||
23400230|NCT01904721|65214055|FG001|Overall Study|Other Reasons|0|||
23400231|NCT01904721|65214056|FG002|Overall Study|Other Reasons|1|||
23400232|NCT01904721|65214057|FG003|Overall Study|Other Reasons|1|||
23400233|NCT01904721|65214058|FG004|Overall Study|Other Reasons|2|||
23400234|NCT01904721|65214059|FG005|Overall Study|Other Reasons|2|||
23400235|NCT01904721|65214060|FG006|Overall Study|Other Reasons|2|||
23400236|NCT01904721|65214054|FG000|Overall Study|Personal Reasons|0|||
23400237|NCT01904721|65214055|FG001|Overall Study|Personal Reasons|0|||
23400238|NCT01904721|65214056|FG002|Overall Study|Personal Reasons|0|||
23400239|NCT01904721|65214057|FG003|Overall Study|Personal Reasons|0|||
23400240|NCT01904721|65214058|FG004|Overall Study|Personal Reasons|2|||
23400241|NCT01904721|65214059|FG005|Overall Study|Personal Reasons|3|||
23400242|NCT01904721|65214060|FG006|Overall Study|Personal Reasons|3|||
23400243|NCT01904721|65214054|FG000|Overall Study|Lost to Follow-up|0|||
23400244|NCT01904721|65214055|FG001|Overall Study|Lost to Follow-up|0|||
23400245|NCT01904721|65214056|FG002|Overall Study|Lost to Follow-up|0|||
23400246|NCT01904721|65214057|FG003|Overall Study|Lost to Follow-up|0|||
23400247|NCT01904721|65214058|FG004|Overall Study|Lost to Follow-up|1|||
23400248|NCT01904721|65214059|FG005|Overall Study|Lost to Follow-up|3|||
23400249|NCT01904721|65214060|FG006|Overall Study|Lost to Follow-up|1|||
23400250|NCT01904721|65214054|FG000|Overall Study|Lack of Efficacy|0|||
23400251|NCT01904721|65214055|FG001|Overall Study|Lack of Efficacy|0|||
23400252|NCT01904721|65214056|FG002|Overall Study|Lack of Efficacy|0|||
23400253|NCT01904721|65214057|FG003|Overall Study|Lack of Efficacy|0|||
23400254|NCT01904721|65214058|FG004|Overall Study|Lack of Efficacy|0|||
23400255|NCT01904721|65214059|FG005|Overall Study|Lack of Efficacy|0|||
23400256|NCT01904721|65214060|FG006|Overall Study|Lack of Efficacy|1|||
23400257|NCT01904721|65214054|FG000|Overall Study|Adverse Event|0|||
23400258|NCT01904721|65214055|FG001|Overall Study|Adverse Event|0|||
23400259|NCT01904721|65214056|FG002|Overall Study|Adverse Event|0|||
23400260|NCT01904721|65214057|FG003|Overall Study|Adverse Event|0|||
23400261|NCT01904721|65214058|FG004|Overall Study|Adverse Event|3|||
23400262|NCT01904721|65214059|FG005|Overall Study|Adverse Event|1|||
23400263|NCT01904721|65214060|FG006|Overall Study|Adverse Event|0|||
23400264|NCT01881789|65214061|FG000|Overall Study|Withdrawal by Subject|0|||
23400265|NCT01881789|65214062|FG001|Overall Study|Withdrawal by Subject|2|||
23400266|NCT01881789|65214063|FG002|Overall Study|Withdrawal by Subject|1|||
23400267|NCT01881789|65214064|FG003|Overall Study|Withdrawal by Subject|0|||
23400268|NCT01881789|65214065|FG004|Overall Study|Withdrawal by Subject|1|||
23400269|NCT01881789|65214066|FG005|Overall Study|Withdrawal by Subject|1|||
23400270|NCT01881789|65214061|FG000|Overall Study|Study Terminated by Sponsor|0|||
23400271|NCT01881789|65214062|FG001|Overall Study|Study Terminated by Sponsor|0|||
23400272|NCT01881789|65214063|FG002|Overall Study|Study Terminated by Sponsor|0|||
23400273|NCT01881789|65214064|FG003|Overall Study|Study Terminated by Sponsor|0|||
23400274|NCT01881789|65214065|FG004|Overall Study|Study Terminated by Sponsor|0|||
23400275|NCT01881789|65214066|FG005|Overall Study|Study Terminated by Sponsor|1|||
23400276|NCT01881789|65214061|FG000|Overall Study|Other|3|||
23400277|NCT01881789|65214062|FG001|Overall Study|Other|5|||
23400278|NCT01881789|65214063|FG002|Overall Study|Other|2|||
23400279|NCT01881789|65214064|FG003|Overall Study|Other|3|||
23400280|NCT01881789|65214065|FG004|Overall Study|Other|1|||
23400281|NCT01881789|65214066|FG005|Overall Study|Other|1|||
23400282|NCT03376516|65214067|FG000|Overall Study|Not treated|1|||
23400283|NCT03376516|65214067|FG000|Overall Study|Consent withdrawn|1|||
23400284|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
23400285|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400286|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400287|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400288|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400289|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
23400290|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
23400291|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
23400292|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
23400293|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
23400294|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
23400295|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
23400296|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
23400297|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400298|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400299|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400300|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400301|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
23400302|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
23400303|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
23400304|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
23400305|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
23400306|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
23400307|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
23400308|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
23400309|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
23400310|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
23400311|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
23400312|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
23400313|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
23400314|NCT00716274|65214068|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400315|NCT00716274|65214069|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
23400316|NCT00716274|65214070|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400317|NCT00716274|65214071|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400318|NCT00716274|65214072|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400319|NCT00716274|65214073|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
23400320|NCT00716274|65214068|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400321|NCT00716274|65214069|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400322|NCT00716274|65214070|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
23400323|NCT00716274|65214071|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400324|NCT00716274|65214072|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400325|NCT00716274|65214073|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
23400326|NCT00716274|65214068|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
23400327|NCT00716274|65214069|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
23400328|NCT00716274|65214070|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
23400329|NCT00716274|65214071|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
23400330|NCT00716274|65214072|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
23400331|NCT00716274|65214073|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
23400332|NCT00716274|65214068|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
23400333|NCT00716274|65214069|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
23400334|NCT00716274|65214070|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
23400335|NCT00716274|65214071|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
23400336|NCT00716274|65214072|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
23402992|NCT03314935|65220064|FG009|Phase 1|Withdrawal by Subject|0|||
23400337|NCT00716274|65214073|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
23400338|NCT00716274|65214068|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
23400339|NCT00716274|65214069|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
23400340|NCT00716274|65214070|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
23400341|NCT00716274|65214071|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
23400342|NCT00716274|65214072|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
23400343|NCT00716274|65214073|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
23400344|NCT01074931|65214076|FG000|Overall Study|Economic reasons|1|||
23400345|NCT01074931|65214076|FG000|Overall Study|Death|5|||
23504037|NCT03706079|65584066|FG000|Long Term Extension (DESTINATION)|Death|8|||
23504038|NCT03706079|65584067|FG001|Long Term Extension (DESTINATION)|Death|2|||
23504039|NCT03706079|65584068|FG002|Long Term Extension (DESTINATION)|Death|2|||
23504040|NCT03706079|65584069|FG003|Long Term Extension (DESTINATION)|Death|1|||
23504041|NCT03706079|65584070|FG004|Long Term Extension (DESTINATION)|Death|0|||
23504042|NCT03706079|65584071|FG005|Long Term Extension (DESTINATION)|Death|0|||
23504043|NCT04678661|65584072|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
23504044|NCT04678661|65584073|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
23504045|NCT04678661|65584072|FG000|Overall Study|Protocol Violation|2|||
23504046|NCT04678661|65584073|FG001|Overall Study|Protocol Violation|0|||
23504047|NCT04678661|65584072|FG000|Overall Study|Withdrawal by Subject|1|||
23504048|NCT04678661|65584073|FG001|Overall Study|Withdrawal by Subject|0|||
23504049|NCT04678661|65584072|FG000|Overall Study|Lost to Follow-up|2|||
23504050|NCT04678661|65584073|FG001|Overall Study|Lost to Follow-up|0|||
23504051|NCT04678661|65584072|FG000|Overall Study|Death|2|||
23504052|NCT04678661|65584073|FG001|Overall Study|Death|0|||
23504053|NCT00619177|65584074|FG000|Overall Study|Adverse Event|18|||
23504054|NCT00619177|65584074|FG000|Overall Study|Lost to Follow-up|2|||
23504055|NCT00619177|65584074|FG000|Overall Study|Lack of Efficacy|1|||
23504056|NCT00619177|65584074|FG000|Overall Study|Missing termination information|481|||
23504057|NCT00619177|65584074|FG000|Overall Study|Not specified reasons|6|||
23504058|NCT03706456|65584075|FG000|Overall Study|Adverse Event|1|||
23504059|NCT03706456|65584075|FG000|Overall Study|Lack of Efficacy|2|||
23504060|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
23504061|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
23504062|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Progression|3|||
23504063|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
23504064|NCT00064337|65584078|FG000|PBSCC or Induction/PBSCC|Death|2|||
23504065|NCT00064337|65584078|FG000|Transplant|Adverse Event|9|||
23504066|NCT00064337|65584078|FG000|Transplant|Not protocol-specified|5|||
23504067|NCT00064337|65584078|FG000|Transplant|Death|3|||
23504068|NCT00064337|65584078|FG000|Transplant|Patient Refusal|2|||
23504069|NCT00064337|65584078|FG000|Transplant|Progression|2|||
23504070|NCT00064337|65584078|FG000|Maintenance|Adverse Event|3|||
23504071|NCT00064337|65584078|FG000|Maintenance|Progression|2|||
23504072|NCT00064337|65584078|FG000|Maintenance|On treatment at time of analysis|2|||
23504073|NCT00064337|65584078|FG000|Maintenance|Not protocol-specified|2|||
23504074|NCT00064337|65584078|FG000|Maintenance|Death|1|||
23504075|NCT03782792|65584079|FG000|Overall Study|Patient left the country|0|||
23504076|NCT03782792|65584080|FG001|Overall Study|Patient left the country|1|||
23504077|NCT03782792|65584079|FG000|Overall Study|Withdrawal by Subject|1|||
23504078|NCT03782792|65584080|FG001|Overall Study|Withdrawal by Subject|2|||
23504079|NCT01306942|65584081|FG000|Phase I|Adverse Event|2|||
23504080|NCT01306942|65584082|FG001|Phase I|Adverse Event|2|||
23504081|NCT01306942|65584083|FG002|Phase I|Adverse Event|0|||
23504082|NCT01306942|65584084|FG003|Phase I|Adverse Event|0|||
23504083|NCT01306942|65584081|FG000|Phase I|Physician Decision|3|||
23504084|NCT01306942|65584082|FG001|Phase I|Physician Decision|1|||
23504085|NCT01306942|65584083|FG002|Phase I|Physician Decision|0|||
23504086|NCT01306942|65584084|FG003|Phase I|Physician Decision|0|||
23504087|NCT01306942|65584081|FG000|Phase II|Adverse Event|0|||
23504088|NCT01306942|65584082|FG001|Phase II|Adverse Event|0|||
23504089|NCT01306942|65584083|FG002|Phase II|Adverse Event|0|||
23504090|NCT01306942|65584084|FG003|Phase II|Adverse Event|6|||
23504091|NCT01306942|65584081|FG000|Phase II|Physician Decision|2|||
23504092|NCT01306942|65584082|FG001|Phase II|Physician Decision|0|||
23504093|NCT01306942|65584083|FG002|Phase II|Physician Decision|0|||
23504094|NCT01306942|65584084|FG003|Phase II|Physician Decision|5|||
23504095|NCT01306942|65584081|FG000|Phase II|Withdrawal by Subject|0|||
23504096|NCT01306942|65584082|FG001|Phase II|Withdrawal by Subject|0|||
23504097|NCT01306942|65584083|FG002|Phase II|Withdrawal by Subject|0|||
23504098|NCT01306942|65584084|FG003|Phase II|Withdrawal by Subject|2|||
23504099|NCT01306942|65584081|FG000|Phase II|Death|0|||
23504100|NCT01306942|65584082|FG001|Phase II|Death|0|||
23504101|NCT01306942|65584083|FG002|Phase II|Death|0|||
23504102|NCT01306942|65584084|FG003|Phase II|Death|1|||
23400346|NCT02114177|65214077|FG000|Overall Study|Lost to Follow-up|1|||
23504103|NCT01306942|65584081|FG000|Phase II|Not finished treatment|0|||
23504104|NCT01306942|65584082|FG001|Phase II|Not finished treatment|0|||
23504105|NCT01306942|65584083|FG002|Phase II|Not finished treatment|0|||
23504106|NCT01306942|65584084|FG003|Phase II|Not finished treatment|1|||
23504107|NCT01306942|65584081|FG000|Phase II|Protocol Violation|0|||
23504108|NCT01306942|65584082|FG001|Phase II|Protocol Violation|0|||
23504109|NCT01306942|65584083|FG002|Phase II|Protocol Violation|0|||
23504110|NCT01306942|65584084|FG003|Phase II|Protocol Violation|1|||
23504111|NCT00753415|65584085|FG000|Part A|Disease progression|1|||
23504112|NCT00753415|65584086|FG001|Part A|Disease progression|0|||
23504113|NCT00753415|65584087|FG002|Part A|Disease progression|1|||
23504114|NCT00753415|65584088|FG003|Part A|Disease progression|2|||
23504115|NCT00753415|65584089|FG004|Part A|Disease progression|0|||
23504116|NCT00753415|65584090|FG005|Part A|Disease progression|0|||
23504117|NCT00753415|65584091|FG006|Part A|Disease progression|0|||
23504118|NCT00753415|65584092|FG007|Part A|Disease progression|0|||
23504119|NCT00753415|65584093|FG008|Part A|Disease progression|0|||
23504120|NCT00753415|65584094|FG009|Part A|Disease progression|0|||
23504121|NCT00753415|65584085|FG000|Part A|Withdrawal by Subject|0|||
23504122|NCT00753415|65584086|FG001|Part A|Withdrawal by Subject|0|||
23504123|NCT00753415|65584087|FG002|Part A|Withdrawal by Subject|1|||
23504124|NCT00753415|65584088|FG003|Part A|Withdrawal by Subject|0|||
23504125|NCT00753415|65584089|FG004|Part A|Withdrawal by Subject|0|||
23504126|NCT00753415|65584090|FG005|Part A|Withdrawal by Subject|0|||
23504127|NCT00753415|65584091|FG006|Part A|Withdrawal by Subject|0|||
23504128|NCT00753415|65584092|FG007|Part A|Withdrawal by Subject|0|||
23504129|NCT00753415|65584093|FG008|Part A|Withdrawal by Subject|0|||
23504130|NCT00753415|65584094|FG009|Part A|Withdrawal by Subject|0|||
23504131|NCT00753415|65584085|FG000|Part B|Lost to Follow-up|0|||
23504132|NCT00753415|65584086|FG001|Part B|Lost to Follow-up|0|||
23504133|NCT00753415|65584087|FG002|Part B|Lost to Follow-up|0|||
23504134|NCT00753415|65584088|FG003|Part B|Lost to Follow-up|0|||
23504135|NCT00753415|65584089|FG004|Part B|Lost to Follow-up|0|||
23504136|NCT00753415|65584090|FG005|Part B|Lost to Follow-up|0|||
23504137|NCT00753415|65584091|FG006|Part B|Lost to Follow-up|0|||
23504138|NCT00753415|65584092|FG007|Part B|Lost to Follow-up|1|||
23504139|NCT00753415|65584093|FG008|Part B|Lost to Follow-up|1|||
23504140|NCT00753415|65584094|FG009|Part B|Lost to Follow-up|0|||
23504141|NCT00753415|65584085|FG000|Part B|Disease progression|0|||
23504142|NCT00753415|65584086|FG001|Part B|Disease progression|0|||
23504143|NCT00753415|65584087|FG002|Part B|Disease progression|0|||
23504144|NCT00753415|65584088|FG003|Part B|Disease progression|0|||
23504145|NCT00753415|65584089|FG004|Part B|Disease progression|0|||
23504146|NCT00753415|65584090|FG005|Part B|Disease progression|0|||
23504147|NCT00753415|65584091|FG006|Part B|Disease progression|0|||
23504148|NCT00753415|65584092|FG007|Part B|Disease progression|0|||
23504149|NCT00753415|65584093|FG008|Part B|Disease progression|2|||
23504150|NCT00753415|65584094|FG009|Part B|Disease progression|1|||
23504151|NCT04213079|65584098|FG000|Overall Study|Lost to Follow-up|0|||
23504152|NCT04213079|65584099|FG001|Overall Study|Lost to Follow-up|2|||
23504153|NCT01918774|65584100|FG000|Overall Study|Lost prior to first CBTw session|4|||
23504154|NCT01918774|65584100|FG000|Overall Study|Lost to Follow-up|1|||
23504155|NCT03727347|65584101|FG000|Overall Study|Withdrawal by Subject|2|||
23504156|NCT03727347|65584101|FG000|Overall Study|Lost to Follow-up|1|||
23504157|NCT01751178|65584102|FG000|Overall Study|Adverse Event|2|||
23504158|NCT01751178|65584103|FG001|Overall Study|Adverse Event|0|||
23504159|NCT01751178|65584104|FG002|Overall Study|Adverse Event|0|||
23504160|NCT01751178|65584102|FG000|Overall Study|Other Reason (unknown)|1|||
23504161|NCT01751178|65584103|FG001|Overall Study|Other Reason (unknown)|0|||
23504162|NCT01751178|65584104|FG002|Overall Study|Other Reason (unknown)|2|||
23504163|NCT02042183|65584105|FG000|Overall Study|Physician Decision|7|||
23504164|NCT02042183|65584106|FG001|Overall Study|Physician Decision|2|||
23504165|NCT02042183|65584105|FG000|Overall Study|Lack of Efficacy|4|||
23504166|NCT02042183|65584106|FG001|Overall Study|Lack of Efficacy|3|||
23504167|NCT02042183|65584105|FG000|Overall Study|Non-compliance with Study Drug|2|||
23504168|NCT02042183|65584106|FG001|Overall Study|Non-compliance with Study Drug|3|||
23504169|NCT02042183|65584105|FG000|Overall Study|Adverse Event|17|||
23504170|NCT02042183|65584106|FG001|Overall Study|Adverse Event|6|||
23504171|NCT02042183|65584105|FG000|Overall Study|Other|3|||
23504172|NCT02042183|65584106|FG001|Overall Study|Other|3|||
23504173|NCT02042183|65584105|FG000|Overall Study|Withdrawal by Subject|21|||
23504174|NCT02042183|65584106|FG001|Overall Study|Withdrawal by Subject|16|||
23504175|NCT02042183|65584105|FG000|Overall Study|Site Terminated by Sponsor|2|||
23504176|NCT02042183|65584106|FG001|Overall Study|Site Terminated by Sponsor|1|||
23504177|NCT02042183|65584105|FG000|Overall Study|Lost to Follow-up|9|||
23504178|NCT02042183|65584106|FG001|Overall Study|Lost to Follow-up|2|||
23504179|NCT00133952|65584107|FG000|Overall Study|Adverse Event|1|||
23504180|NCT00133952|65584108|FG001|Overall Study|Adverse Event|2|||
23504181|NCT00133952|65584107|FG000|Overall Study|Death|3|||
23504182|NCT00133952|65584108|FG001|Overall Study|Death|2|||
23504183|NCT00133952|65584107|FG000|Overall Study|Lost to Follow-up|9|||
23504184|NCT00133952|65584108|FG001|Overall Study|Lost to Follow-up|14|||
23504185|NCT00133952|65584107|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
23504186|NCT00133952|65584108|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
23504187|NCT00133952|65584107|FG000|Overall Study|Protocol Violation|1|||
23504188|NCT00133952|65584108|FG001|Overall Study|Protocol Violation|1|||
23504189|NCT00133952|65584107|FG000|Overall Study|Withdrawal by Subject|20|||
23504190|NCT00133952|65584108|FG001|Overall Study|Withdrawal by Subject|4|||
23504191|NCT00133952|65584107|FG000|Overall Study|Physician Decision|4|||
23504192|NCT00133952|65584108|FG001|Overall Study|Physician Decision|3|||
23504193|NCT00133952|65584107|FG000|Overall Study|Sponsor Decision|0|||
23504194|NCT00133952|65584108|FG001|Overall Study|Sponsor Decision|1|||
23504195|NCT02397278|65584109|FG000|Overall Study|Withdrawal by Subject|0|||
23504196|NCT02397278|65584110|FG001|Overall Study|Withdrawal by Subject|2|||
23504197|NCT02397278|65584109|FG000|Overall Study|Deemed ineligible following surgery|1|||
23504198|NCT02397278|65584110|FG001|Overall Study|Deemed ineligible following surgery|1|||
23504199|NCT02864498|65584120|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
23504200|NCT02864498|65584121|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
23504201|NCT02864498|65584122|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
23504202|NCT02864498|65584120|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
23504203|NCT02864498|65584121|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
23504204|NCT02864498|65584122|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
23504205|NCT02864498|65584120|FG000|Overall Study|Investigator Discretion|0|||
23504206|NCT02864498|65584121|FG001|Overall Study|Investigator Discretion|2|||
23504207|NCT02864498|65584122|FG002|Overall Study|Investigator Discretion|1|||
23504208|NCT02864498|65584120|FG000|Overall Study|Lost to Follow-up|8|||
23504209|NCT02864498|65584121|FG001|Overall Study|Lost to Follow-up|6|||
23504210|NCT02864498|65584122|FG002|Overall Study|Lost to Follow-up|3|||
23504211|NCT02864498|65584120|FG000|Overall Study|Lack of Efficacy|5|||
23504212|NCT02864498|65584121|FG001|Overall Study|Lack of Efficacy|3|||
23504213|NCT02864498|65584122|FG002|Overall Study|Lack of Efficacy|3|||
23504214|NCT02864498|65584120|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
23504215|NCT02864498|65584121|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
23504216|NCT02864498|65584122|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
23504217|NCT02864498|65584120|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
23504218|NCT02864498|65584121|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
23504219|NCT02864498|65584122|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
23504220|NCT02864498|65584120|FG000|Overall Study|Subject moved out of the country.|0|||
23504221|NCT02864498|65584121|FG001|Overall Study|Subject moved out of the country.|0|||
23504222|NCT02864498|65584122|FG002|Overall Study|Subject moved out of the country.|1|||
23400347|NCT02114177|65214078|FG001|Overall Study|Lost to Follow-up|2|||
23402993|NCT03314935|65220065|FG010|Phase 1|Withdrawal by Subject|0|||
23402994|NCT03314935|65220066|FG011|Phase 1|Withdrawal by Subject|0|||
23402995|NCT03314935|65220067|FG012|Phase 1|Withdrawal by Subject|0|||
23402996|NCT03314935|65220068|FG013|Phase 1|Withdrawal by Subject|0|||
23402997|NCT03314935|65220069|FG014|Phase 1|Withdrawal by Subject|0|||
23402998|NCT03314935|65220055|FG000|Phase 1|Progressive Disease|2|||
23402999|NCT03314935|65220056|FG001|Phase 1|Progressive Disease|0|||
23403000|NCT03314935|65220057|FG002|Phase 1|Progressive Disease|0|||
23403001|NCT03314935|65220058|FG003|Phase 1|Progressive Disease|1|||
23403002|NCT03314935|65220059|FG004|Phase 1|Progressive Disease|0|||
23403003|NCT03314935|65220060|FG005|Phase 1|Progressive Disease|0|||
23403004|NCT03314935|65220061|FG006|Phase 1|Progressive Disease|0|||
23403005|NCT03314935|65220062|FG007|Phase 1|Progressive Disease|0|||
23403006|NCT03314935|65220063|FG008|Phase 1|Progressive Disease|0|||
23403007|NCT03314935|65220064|FG009|Phase 1|Progressive Disease|0|||
23403008|NCT03314935|65220065|FG010|Phase 1|Progressive Disease|0|||
23403009|NCT03314935|65220066|FG011|Phase 1|Progressive Disease|0|||
23403010|NCT03314935|65220067|FG012|Phase 1|Progressive Disease|0|||
23403011|NCT03314935|65220068|FG013|Phase 1|Progressive Disease|0|||
23403012|NCT03314935|65220069|FG014|Phase 1|Progressive Disease|0|||
23403013|NCT03314935|65220055|FG000|Phase 1|Study Terminated by Sponsor|0|||
23403014|NCT03314935|65220056|FG001|Phase 1|Study Terminated by Sponsor|1|||
23403015|NCT03314935|65220057|FG002|Phase 1|Study Terminated by Sponsor|0|||
23403016|NCT03314935|65220058|FG003|Phase 1|Study Terminated by Sponsor|0|||
23403017|NCT03314935|65220059|FG004|Phase 1|Study Terminated by Sponsor|0|||
23403018|NCT03314935|65220060|FG005|Phase 1|Study Terminated by Sponsor|0|||
23403019|NCT03314935|65220061|FG006|Phase 1|Study Terminated by Sponsor|0|||
23403020|NCT03314935|65220062|FG007|Phase 1|Study Terminated by Sponsor|0|||
23403021|NCT03314935|65220063|FG008|Phase 1|Study Terminated by Sponsor|1|||
23403022|NCT03314935|65220064|FG009|Phase 1|Study Terminated by Sponsor|0|||
23403023|NCT03314935|65220065|FG010|Phase 1|Study Terminated by Sponsor|0|||
23403024|NCT03314935|65220066|FG011|Phase 1|Study Terminated by Sponsor|0|||
23403025|NCT03314935|65220067|FG012|Phase 1|Study Terminated by Sponsor|0|||
23403026|NCT03314935|65220068|FG013|Phase 1|Study Terminated by Sponsor|0|||
23403027|NCT03314935|65220069|FG014|Phase 1|Study Terminated by Sponsor|0|||
23403028|NCT03314935|65220055|FG000|Phase 1|"Captured as Other in Database"|0|||
23300782|NCT02972502|64842926|FG000|Overall Study|Withdrawal by Subject|1|||
23300783|NCT02972502|64842927|FG001|Overall Study|Withdrawal by Subject|1|||
23300784|NCT00679913|64842928|FG000|Overall Study|Protocol Violation|18|||
23300785|NCT00679913|64842929|FG001|Overall Study|Protocol Violation|13|||
23300786|NCT02333487|64842930|FG000|Overall Study|Adverse Event|0|||
23300787|NCT02333487|64842931|FG001|Overall Study|Adverse Event|2|||
23300788|NCT02333487|64842932|FG002|Overall Study|Adverse Event|0|||
23300789|NCT00594646|64842933|FG000|Overall Study|Withdrawal by Subject|1|||
23300790|NCT00594646|64842933|FG000|Overall Study|Lost to Follow-up|15|||
23400348|NCT02114177|65214077|FG000|Overall Study|Withdrawal by Subject|6|||
23400349|NCT02114177|65214078|FG001|Overall Study|Withdrawal by Subject|1|||
23400350|NCT02114177|65214077|FG000|Overall Study|Other|2|||
23400351|NCT02114177|65214078|FG001|Overall Study|Other|1|||
23400352|NCT03768427|65214079|FG000|Overall Study|Death|0|||
23400353|NCT03768427|65214080|FG001|Overall Study|Death|0|||
23400354|NCT03768427|65214081|FG002|Overall Study|Death|1|||
23400355|NCT03768427|65214082|FG003|Overall Study|Death|0|||
23400356|NCT03768427|65214079|FG000|Overall Study|Lost to Follow-up|2|||
23400357|NCT03768427|65214080|FG001|Overall Study|Lost to Follow-up|0|||
23400358|NCT03768427|65214081|FG002|Overall Study|Lost to Follow-up|0|||
23400359|NCT03768427|65214082|FG003|Overall Study|Lost to Follow-up|0|||
23400360|NCT03768427|65214079|FG000|Overall Study|Physician Decision|3|||
23400361|NCT03768427|65214080|FG001|Overall Study|Physician Decision|2|||
23400362|NCT03768427|65214081|FG002|Overall Study|Physician Decision|4|||
23400363|NCT03768427|65214082|FG003|Overall Study|Physician Decision|4|||
23400364|NCT03768427|65214079|FG000|Overall Study|Withdrawal by Subject|7|||
23400365|NCT03768427|65214080|FG001|Overall Study|Withdrawal by Subject|2|||
23400366|NCT03768427|65214081|FG002|Overall Study|Withdrawal by Subject|6|||
23400367|NCT03768427|65214082|FG003|Overall Study|Withdrawal by Subject|7|||
23400368|NCT01822925|65214083|FG000|Overall Study|Adverse Event|1|||
23400369|NCT01822925|65214084|FG001|Overall Study|Adverse Event|1|||
23400370|NCT01822925|65214085|FG002|Overall Study|Adverse Event|1|||
23400371|NCT01822925|65214086|FG003|Overall Study|Adverse Event|1|||
23400372|NCT01822925|65214083|FG000|Overall Study|Lost to Follow-up|0|||
23400373|NCT01822925|65214084|FG001|Overall Study|Lost to Follow-up|1|||
23400374|NCT01822925|65214085|FG002|Overall Study|Lost to Follow-up|0|||
23400375|NCT01822925|65214086|FG003|Overall Study|Lost to Follow-up|0|||
23400376|NCT01822925|65214083|FG000|Overall Study|Protocol Violation|1|||
23400377|NCT01822925|65214084|FG001|Overall Study|Protocol Violation|0|||
23400378|NCT01822925|65214085|FG002|Overall Study|Protocol Violation|0|||
23400379|NCT01822925|65214086|FG003|Overall Study|Protocol Violation|1|||
23400380|NCT01822925|65214083|FG000|Overall Study|Withdrawal by Subject|2|||
23400381|NCT01822925|65214084|FG001|Overall Study|Withdrawal by Subject|0|||
23400382|NCT01822925|65214085|FG002|Overall Study|Withdrawal by Subject|2|||
23400383|NCT01822925|65214086|FG003|Overall Study|Withdrawal by Subject|2|||
23400384|NCT01822925|65214083|FG000|Overall Study|Taking prohibited medication|2|||
23400385|NCT01822925|65214084|FG001|Overall Study|Taking prohibited medication|0|||
23400386|NCT01822925|65214085|FG002|Overall Study|Taking prohibited medication|0|||
23400387|NCT01822925|65214086|FG003|Overall Study|Taking prohibited medication|1|||
23400388|NCT01029535|65214091|FG000|Overall Study|Lost to Follow-up|24|||
23400389|NCT01029535|65214091|FG000|Overall Study|Protocol Violation|2|||
23400390|NCT01029535|65214091|FG000|Overall Study|Participant Withdrew Consent|2|||
23400391|NCT01029535|65214091|FG000|Overall Study|Adverse Event|1|||
23400392|NCT01029535|65214091|FG000|Overall Study|Use of Another Treatment|1|||
23400393|NCT01029535|65214091|FG000|Overall Study|Death|1|||
23400394|NCT02379052|65214092|FG000|Overall Study|Protocol Violation|0|||
23400395|NCT02379052|65214093|FG001|Overall Study|Protocol Violation|1|||
23400396|NCT02379052|65214092|FG000|Overall Study|Adverse Event|0|||
23400397|NCT02379052|65214093|FG001|Overall Study|Adverse Event|1|||
23400398|NCT02379052|65214092|FG000|Overall Study|Physician Decision|1|||
23400399|NCT02379052|65214093|FG001|Overall Study|Physician Decision|1|||
23400400|NCT02379052|65214092|FG000|Overall Study|Withdrawal by Subject|2|||
23400401|NCT02379052|65214093|FG001|Overall Study|Withdrawal by Subject|0|||
23400402|NCT02379052|65214092|FG000|Overall Study|Lost to Follow-up|2|||
23400403|NCT02379052|65214093|FG001|Overall Study|Lost to Follow-up|1|||
23400404|NCT02379052|65214092|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
23400405|NCT02379052|65214093|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
23400406|NCT02379052|65214092|FG000|Overall Study|Subject was Incarcerated|0|||
23400407|NCT02379052|65214093|FG001|Overall Study|Subject was Incarcerated|1|||
23400408|NCT02329743|65214094|FG000|Overall Study|Adverse Event|1|||
23300791|NCT00680186|64842934|FG000|Overall Study|Adverse Event|47|||
23300792|NCT00680186|64842935|FG001|Overall Study|Adverse Event|44|||
23300793|NCT00680186|64842934|FG000|Overall Study|Protocol Violation|31|||
23400409|NCT02329743|65214095|FG001|Overall Study|Adverse Event|1|||
23400410|NCT02329743|65214096|FG002|Overall Study|Adverse Event|3|||
23400411|NCT02329743|65214094|FG000|Overall Study|Lost to Follow-up|1|||
23400412|NCT02329743|65214095|FG001|Overall Study|Lost to Follow-up|0|||
23400413|NCT02329743|65214096|FG002|Overall Study|Lost to Follow-up|1|||
23400414|NCT02329743|65214094|FG000|Overall Study|Withdrawal by Subject|4|||
23400415|NCT02329743|65214095|FG001|Overall Study|Withdrawal by Subject|4|||
23400416|NCT02329743|65214096|FG002|Overall Study|Withdrawal by Subject|1|||
23400417|NCT02329743|65214094|FG000|Overall Study|Other|0|||
23400418|NCT02329743|65214095|FG001|Overall Study|Other|2|||
23400419|NCT02329743|65214096|FG002|Overall Study|Other|3|||
23400420|NCT01812057|65214097|FG000|Overall Study|Protocol Violation|1|||
23400421|NCT01812057|65214098|FG001|Overall Study|Protocol Violation|0|||
23400422|NCT01812057|65214097|FG000|Overall Study|Physician Decision|1|||
23400423|NCT01812057|65214098|FG001|Overall Study|Physician Decision|0|||
23400424|NCT00329030|65214099|FG000|Overall Study|Withdrawal by Subject|1|||
23400425|NCT00329030|65214100|FG001|Overall Study|Withdrawal by Subject|3|||
23400426|NCT00329030|65214099|FG000|Overall Study|Progressive Disease|6|||
23400427|NCT00329030|65214100|FG001|Overall Study|Progressive Disease|2|||
23400428|NCT00329030|65214099|FG000|Overall Study|Ineligible Pathology|1|||
23400429|NCT00329030|65214100|FG001|Overall Study|Ineligible Pathology|1|||
23400430|NCT02296476|65214101|FG000|Overall Study|Disease Progression|6|||
23400431|NCT02296476|65214102|FG001|Overall Study|Disease Progression|4|||
23400432|NCT02296476|65214103|FG002|Overall Study|Disease Progression|2|||
23400433|NCT01644643|65214104|FG000|Overall Study|Death|1|||
23400434|NCT01644643|65214105|FG001|Overall Study|Death|0|||
23400435|NCT01644643|65214106|FG002|Overall Study|Death|3|||
23400436|NCT01644643|65214107|FG003|Overall Study|Death|3|||
23400437|NCT01644643|65214104|FG000|Overall Study|Lost to Follow-up|0|||
23400438|NCT01644643|65214105|FG001|Overall Study|Lost to Follow-up|0|||
23400439|NCT01644643|65214106|FG002|Overall Study|Lost to Follow-up|0|||
23400440|NCT01644643|65214107|FG003|Overall Study|Lost to Follow-up|4|||
23400441|NCT01644643|65214104|FG000|Overall Study|Withdrawal by Subject|1|||
23400442|NCT01644643|65214105|FG001|Overall Study|Withdrawal by Subject|0|||
23400443|NCT01644643|65214106|FG002|Overall Study|Withdrawal by Subject|2|||
23400444|NCT01644643|65214107|FG003|Overall Study|Withdrawal by Subject|1|||
23400445|NCT01644643|65214104|FG000|Overall Study|Other Eligibility criteria|0|||
23400446|NCT01644643|65214105|FG001|Overall Study|Other Eligibility criteria|0|||
23400447|NCT01644643|65214106|FG002|Overall Study|Other Eligibility criteria|0|||
23400448|NCT01644643|65214107|FG003|Overall Study|Other Eligibility criteria|2|||
23400449|NCT03545672|65214108|FG000|Overall Study|Uncertain diagnosis|2|||
23400450|NCT03545672|65214109|FG001|Overall Study|Uncertain diagnosis|1|||
23400451|NCT03545672|65214108|FG000|Overall Study|Protocol Violation|2|||
23400452|NCT03545672|65214109|FG001|Overall Study|Protocol Violation|2|||
23400453|NCT02750514|65214112|FG000|Track 1|Disease progression|20|||
23400454|NCT02750514|65214113|FG001|Track 1|Disease progression|1|||
23400455|NCT02750514|65214114|FG002|Track 1|Disease progression|0|||
23400456|NCT02750514|65214115|FG003|Track 1|Disease progression|1|||
23400457|NCT02750514|65214116|FG004|Track 1|Disease progression|0|||
23400458|NCT02750514|65214112|FG000|Track 1|Adverse event unrelated to study drug|1|||
23400459|NCT02750514|65214113|FG001|Track 1|Adverse event unrelated to study drug|0|||
23400460|NCT02750514|65214114|FG002|Track 1|Adverse event unrelated to study drug|0|||
23400461|NCT02750514|65214115|FG003|Track 1|Adverse event unrelated to study drug|0|||
23400462|NCT02750514|65214116|FG004|Track 1|Adverse event unrelated to study drug|0|||
23400463|NCT02750514|65214112|FG000|Track 1|Study drug toxicity|4|||
23400464|NCT02750514|65214113|FG001|Track 1|Study drug toxicity|1|||
23400465|NCT02750514|65214114|FG002|Track 1|Study drug toxicity|0|||
23400466|NCT02750514|65214115|FG003|Track 1|Study drug toxicity|1|||
23400467|NCT02750514|65214116|FG004|Track 1|Study drug toxicity|0|||
23400468|NCT02750514|65214112|FG000|Track 1|Participant request to discontinue|1|||
23400469|NCT02750514|65214113|FG001|Track 1|Participant request to discontinue|0|||
23400470|NCT02750514|65214114|FG002|Track 1|Participant request to discontinue|0|||
23400471|NCT02750514|65214115|FG003|Track 1|Participant request to discontinue|0|||
23400472|NCT02750514|65214116|FG004|Track 1|Participant request to discontinue|0|||
23400473|NCT02750514|65214112|FG000|Track 1|Other reasons|1|||
23400474|NCT02750514|65214113|FG001|Track 1|Other reasons|0|||
23400475|NCT02750514|65214114|FG002|Track 1|Other reasons|0|||
23400476|NCT02750514|65214115|FG003|Track 1|Other reasons|0|||
23400477|NCT02750514|65214116|FG004|Track 1|Other reasons|0|||
23400478|NCT02750514|65214112|FG000|Track 2|Disease progression|4|||
23400479|NCT02750514|65214113|FG001|Track 2|Disease progression|5|||
23400480|NCT02750514|65214114|FG002|Track 2|Disease progression|2|||
23400481|NCT02750514|65214115|FG003|Track 2|Disease progression|5|||
23400482|NCT02750514|65214116|FG004|Track 2|Disease progression|0|||
23400483|NCT02750514|65214112|FG000|Track 2|Adverse event unrelated to study drug|1|||
23400484|NCT02750514|65214113|FG001|Track 2|Adverse event unrelated to study drug|0|||
23400485|NCT02750514|65214114|FG002|Track 2|Adverse event unrelated to study drug|0|||
23400486|NCT02750514|65214115|FG003|Track 2|Adverse event unrelated to study drug|0|||
23400487|NCT02750514|65214116|FG004|Track 2|Adverse event unrelated to study drug|0|||
23400488|NCT02750514|65214112|FG000|Track 2|Study drug toxicity|1|||
23400489|NCT02750514|65214113|FG001|Track 2|Study drug toxicity|2|||
23400490|NCT02750514|65214114|FG002|Track 2|Study drug toxicity|0|||
23400491|NCT02750514|65214115|FG003|Track 2|Study drug toxicity|2|||
23400492|NCT02750514|65214116|FG004|Track 2|Study drug toxicity|0|||
23400493|NCT02750514|65214112|FG000|Track 2|Participant withdrew consent|0|||
23400494|NCT02750514|65214113|FG001|Track 2|Participant withdrew consent|1|||
23400495|NCT02750514|65214114|FG002|Track 2|Participant withdrew consent|0|||
23400496|NCT02750514|65214115|FG003|Track 2|Participant withdrew consent|0|||
23400497|NCT02750514|65214116|FG004|Track 2|Participant withdrew consent|0|||
23400498|NCT02750514|65214112|FG000|Track 3|Disease progression|0|||
23400499|NCT02750514|65214113|FG001|Track 3|Disease progression|24|||
23400500|NCT02750514|65214114|FG002|Track 3|Disease progression|13|||
23400501|NCT02750514|65214115|FG003|Track 3|Disease progression|14|||
23400502|NCT02750514|65214116|FG004|Track 3|Disease progression|0|||
23400503|NCT02750514|65214112|FG000|Track 3|Adverse event unrelated to study drug|0|||
23400504|NCT02750514|65214113|FG001|Track 3|Adverse event unrelated to study drug|1|||
23400505|NCT02750514|65214114|FG002|Track 3|Adverse event unrelated to study drug|1|||
23400506|NCT02750514|65214115|FG003|Track 3|Adverse event unrelated to study drug|1|||
23400507|NCT02750514|65214116|FG004|Track 3|Adverse event unrelated to study drug|0|||
23400508|NCT02750514|65214112|FG000|Track 3|Study drug toxicity|0|||
23400509|NCT02750514|65214113|FG001|Track 3|Study drug toxicity|3|||
23400510|NCT02750514|65214114|FG002|Track 3|Study drug toxicity|0|||
23400511|NCT02750514|65214115|FG003|Track 3|Study drug toxicity|1|||
23400512|NCT02750514|65214116|FG004|Track 3|Study drug toxicity|0|||
23400513|NCT02750514|65214112|FG000|Track 3|Participant request to discontinue|0|||
23400514|NCT02750514|65214113|FG001|Track 3|Participant request to discontinue|2|||
23400515|NCT02750514|65214114|FG002|Track 3|Participant request to discontinue|0|||
23400516|NCT02750514|65214115|FG003|Track 3|Participant request to discontinue|0|||
23400517|NCT02750514|65214116|FG004|Track 3|Participant request to discontinue|0|||
23400518|NCT02750514|65214112|FG000|Track 3|Participant withdrew consent|0|||
23400519|NCT02750514|65214113|FG001|Track 3|Participant withdrew consent|3|||
23400520|NCT02750514|65214114|FG002|Track 3|Participant withdrew consent|1|||
23400521|NCT02750514|65214115|FG003|Track 3|Participant withdrew consent|0|||
23400522|NCT02750514|65214116|FG004|Track 3|Participant withdrew consent|0|||
23400523|NCT02750514|65214112|FG000|Track 3|Other reasons|0|||
23400524|NCT02750514|65214113|FG001|Track 3|Other reasons|3|||
23400525|NCT02750514|65214114|FG002|Track 3|Other reasons|0|||
23400526|NCT02750514|65214115|FG003|Track 3|Other reasons|0|||
23400527|NCT02750514|65214116|FG004|Track 3|Other reasons|0|||
23400528|NCT02750514|65214112|FG000|Track 4|Study drug toxicity|0|||
23400529|NCT02750514|65214113|FG001|Track 4|Study drug toxicity|6|||
23400530|NCT02750514|65214114|FG002|Track 4|Study drug toxicity|0|||
23400531|NCT02750514|65214115|FG003|Track 4|Study drug toxicity|5|||
23400532|NCT02750514|65214116|FG004|Track 4|Study drug toxicity|0|||
23400533|NCT02750514|65214112|FG000|Track 4|Participant request to discontinue|0|||
23400534|NCT02750514|65214113|FG001|Track 4|Participant request to discontinue|1|||
23400535|NCT02750514|65214114|FG002|Track 4|Participant request to discontinue|0|||
23400536|NCT02750514|65214115|FG003|Track 4|Participant request to discontinue|1|||
23400537|NCT02750514|65214116|FG004|Track 4|Participant request to discontinue|0|||
23400538|NCT02750514|65214112|FG000|Track 4|Participant withdrew consent|0|||
23400539|NCT02750514|65214113|FG001|Track 4|Participant withdrew consent|1|||
23400540|NCT02750514|65214114|FG002|Track 4|Participant withdrew consent|0|||
23400541|NCT02750514|65214115|FG003|Track 4|Participant withdrew consent|0|||
23400542|NCT02750514|65214116|FG004|Track 4|Participant withdrew consent|0|||
23400543|NCT02750514|65214112|FG000|Track 4|Other reasons|0|||
23400544|NCT02750514|65214113|FG001|Track 4|Other reasons|5|||
23400545|NCT02750514|65214114|FG002|Track 4|Other reasons|0|||
23400546|NCT02750514|65214115|FG003|Track 4|Other reasons|3|||
23400547|NCT02750514|65214116|FG004|Track 4|Other reasons|0|||
23400548|NCT02750514|65214112|FG000|Track 4|Disease progression|0|||
23400549|NCT02750514|65214113|FG001|Track 4|Disease progression|33|||
23400550|NCT02750514|65214114|FG002|Track 4|Disease progression|0|||
23400551|NCT02750514|65214115|FG003|Track 4|Disease progression|32|||
23400552|NCT02750514|65214116|FG004|Track 4|Disease progression|0|||
23400553|NCT02750514|65214112|FG000|Track 4|Adverse event unrelated to study drug|0|||
23400554|NCT02750514|65214113|FG001|Track 4|Adverse event unrelated to study drug|5|||
23400555|NCT02750514|65214114|FG002|Track 4|Adverse event unrelated to study drug|0|||
23400556|NCT02750514|65214115|FG003|Track 4|Adverse event unrelated to study drug|0|||
23400557|NCT02750514|65214116|FG004|Track 4|Adverse event unrelated to study drug|0|||
23400558|NCT02750514|65214112|FG000|Track 4|Death|0|||
23400559|NCT02750514|65214113|FG001|Track 4|Death|0|||
23400560|NCT02750514|65214114|FG002|Track 4|Death|0|||
23400561|NCT02750514|65214115|FG003|Track 4|Death|1|||
23400562|NCT02750514|65214116|FG004|Track 4|Death|0|||
23400563|NCT02750514|65214112|FG000|Track 5|Disease progression|0|||
23400564|NCT02750514|65214113|FG001|Track 5|Disease progression|0|||
23400565|NCT02750514|65214114|FG002|Track 5|Disease progression|0|||
23400566|NCT02750514|65214115|FG003|Track 5|Disease progression|0|||
23400567|NCT02750514|65214116|FG004|Track 5|Disease progression|34|||
23400568|NCT02750514|65214112|FG000|Track 5|Adverse event unrelated to study drug|0|||
23400569|NCT02750514|65214113|FG001|Track 5|Adverse event unrelated to study drug|0|||
23400570|NCT02750514|65214114|FG002|Track 5|Adverse event unrelated to study drug|0|||
23400571|NCT02750514|65214115|FG003|Track 5|Adverse event unrelated to study drug|0|||
23400572|NCT02750514|65214116|FG004|Track 5|Adverse event unrelated to study drug|2|||
23400573|NCT02750514|65214112|FG000|Track 5|Study drug toxicity|0|||
23400574|NCT02750514|65214113|FG001|Track 5|Study drug toxicity|0|||
23400575|NCT02750514|65214114|FG002|Track 5|Study drug toxicity|0|||
23400576|NCT02750514|65214115|FG003|Track 5|Study drug toxicity|0|||
23400577|NCT02750514|65214116|FG004|Track 5|Study drug toxicity|2|||
23400578|NCT02750514|65214112|FG000|Track 5|Participant request to discontinue|0|||
23400579|NCT02750514|65214113|FG001|Track 5|Participant request to discontinue|0|||
23400580|NCT02750514|65214114|FG002|Track 5|Participant request to discontinue|0|||
23400581|NCT02750514|65214115|FG003|Track 5|Participant request to discontinue|0|||
23400582|NCT02750514|65214116|FG004|Track 5|Participant request to discontinue|3|||
23400583|NCT02750514|65214112|FG000|Track 5|Other reasons|0|||
23400584|NCT02750514|65214113|FG001|Track 5|Other reasons|0|||
23400585|NCT02750514|65214114|FG002|Track 5|Other reasons|0|||
23400586|NCT02750514|65214115|FG003|Track 5|Other reasons|0|||
23400587|NCT02750514|65214116|FG004|Track 5|Other reasons|2|||
23400588|NCT00110214|65214122|FG000|Overall Study|Never started treatment|21|||
23400589|NCT00110214|65214123|FG001|Overall Study|Never started treatment|20|||
23400590|NCT00110214|65214122|FG000|Overall Study|Disease progression or death|260|||
23400591|NCT00110214|65214123|FG001|Overall Study|Disease progression or death|151|||
23400592|NCT00110214|65214122|FG000|Overall Study|Adverse Event|115|||
23400593|NCT00110214|65214123|FG001|Overall Study|Adverse Event|192|||
23400594|NCT00110214|65214122|FG000|Overall Study|Refused further treatment|52|||
23400595|NCT00110214|65214123|FG001|Overall Study|Refused further treatment|65|||
23400596|NCT00110214|65214122|FG000|Overall Study|Other (not specified)|61|||
23400597|NCT00110214|65214123|FG001|Overall Study|Other (not specified)|75|||
23400598|NCT00442702|65214126|FG000|Titration Period|Adverse Event|2|||
23400599|NCT00442702|65214127|FG001|Titration Period|Adverse Event|0|||
23400600|NCT00442702|65214126|FG000|Titration Period|Death|3|||
23400601|NCT00442702|65214127|FG001|Titration Period|Death|2|||
23400602|NCT00442702|65214126|FG000|Titration Period|Insufficient Therapeutic Response|1|||
23400603|NCT00442702|65214127|FG001|Titration Period|Insufficient Therapeutic Response|0|||
23400604|NCT00442702|65214126|FG000|Titration Period|Refused Treatment|4|||
23400605|NCT00442702|65214127|FG001|Titration Period|Refused Treatment|1|||
23400606|NCT00442702|65214126|FG000|Titration Period|Failure to return|1|||
23400607|NCT00442702|65214127|FG001|Titration Period|Failure to return|0|||
23400608|NCT00442702|65214126|FG000|Titration Period|Hospitalized in another hospital|1|||
23400609|NCT00442702|65214127|FG001|Titration Period|Hospitalized in another hospital|0|||
23400610|NCT00442702|65214126|FG000|Evaluation Period|Adverse Event|1|||
23400611|NCT00442702|65214127|FG001|Evaluation Period|Adverse Event|0|||
23400612|NCT00442702|65214126|FG000|Evaluation Period|Death|1|||
23400613|NCT00442702|65214127|FG001|Evaluation Period|Death|1|||
23400614|NCT00442702|65214126|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
23400615|NCT00442702|65214127|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
23400616|NCT00442702|65214126|FG000|Evaluation Period|Refused treatment|1|||
23400617|NCT00442702|65214127|FG001|Evaluation Period|Refused treatment|1|||
23400618|NCT00442702|65214126|FG000|Evaluation Period|Renal transplant|0|||
23400619|NCT00442702|65214127|FG001|Evaluation Period|Renal transplant|1|||
23400620|NCT00442702|65214126|FG000|Evaluation Period|Failure to return|1|||
23400621|NCT00442702|65214127|FG001|Evaluation Period|Failure to return|0|||
23400622|NCT00442702|65214126|FG000|Evaluation Period|Site closure|0|||
23400623|NCT00442702|65214127|FG001|Evaluation Period|Site closure|1|||
23400624|NCT02505425|65214128|FG000|Overall Study|Lost to Follow-up|41|||
23400625|NCT02505425|65214129|FG001|Overall Study|Lost to Follow-up|61|||
23400626|NCT02505425|65214130|FG002|Overall Study|Lost to Follow-up|31|||
23400627|NCT02505425|65214131|FG003|Overall Study|Lost to Follow-up|19|||
23400628|NCT02505425|65214128|FG000|Overall Study|Withdrawal by Subject|39|||
23400629|NCT02505425|65214129|FG001|Overall Study|Withdrawal by Subject|9|||
23400630|NCT02505425|65214130|FG002|Overall Study|Withdrawal by Subject|19|||
23400631|NCT02505425|65214131|FG003|Overall Study|Withdrawal by Subject|7|||
23400632|NCT02505425|65214128|FG000|Overall Study|Death|8|||
23400633|NCT02505425|65214129|FG001|Overall Study|Death|12|||
23400634|NCT02505425|65214130|FG002|Overall Study|Death|0|||
23400635|NCT02505425|65214131|FG003|Overall Study|Death|0|||
23400636|NCT00920556|65214132|FG000|Overall Study|Adverse Event|16|||
23400637|NCT00920556|65214132|FG000|Overall Study|Physician Decision|7|||
23400638|NCT00920556|65214132|FG000|Overall Study|Withdrawal by Subject|1|||
23400639|NCT03423121|65214133|FG000|Overall Study|Lost to Follow-up|2|||
23400640|NCT03423121|65214134|FG001|Overall Study|Lost to Follow-up|6|||
23400641|NCT03423121|65214133|FG000|Overall Study|Adverse Event|1|||
23400642|NCT03423121|65214134|FG001|Overall Study|Adverse Event|0|||
23400643|NCT00100802|65214138|FG000|Overall Study|Adverse Event|9|||
23400644|NCT00100802|65214138|FG000|Overall Study|Death|1|||
23400645|NCT00100802|65214138|FG000|Overall Study|Lack of Efficacy|47|||
23400646|NCT00100802|65214138|FG000|Overall Study|Physician Decision|5|||
23400647|NCT00100802|65214138|FG000|Overall Study|Protocol Violation|1|||
23300794|NCT00680186|64842935|FG001|Overall Study|Protocol Violation|26|||
23400648|NCT00100802|65214138|FG000|Overall Study|Withdrawal by Subject|5|||
23400649|NCT00100802|65214138|FG000|Overall Study|Ineligible|12|||
23400650|NCT01822665|65214142|FG000|Overall Study|Adverse Event|3|||
23400651|NCT01822665|65214142|FG000|Overall Study|Other Reason|5|||
23400652|NCT03213509|65214143|FG000|Overall Study|Did not consent for verbal autopsy|4|||
23400653|NCT03213509|65214144|FG001|Overall Study|Did not consent for verbal autopsy|5|||
23400654|NCT01374425|65214147|FG000|Overall Study|Radiographic Disease Progression|86|||
23400655|NCT01374425|65214148|FG001|Overall Study|Radiographic Disease Progression|81|||
23400656|NCT01374425|65214147|FG000|Overall Study|Clinical Disease Progression|9|||
23400657|NCT01374425|65214148|FG001|Overall Study|Clinical Disease Progression|6|||
23400658|NCT01374425|65214147|FG000|Overall Study|Adverse Event|29|||
23400659|NCT01374425|65214148|FG001|Overall Study|Adverse Event|18|||
23400660|NCT01374425|65214147|FG000|Overall Study|Death (Progression of Disease)|1|||
23400661|NCT01374425|65214148|FG001|Overall Study|Death (Progression of Disease)|0|||
23400662|NCT01374425|65214147|FG000|Overall Study|Death (Adverse Event)|2|||
23400663|NCT01374425|65214148|FG001|Overall Study|Death (Adverse Event)|4|||
23400664|NCT01374425|65214147|FG000|Overall Study|Withdrawal by Subject|6|||
23400665|NCT01374425|65214148|FG001|Overall Study|Withdrawal by Subject|7|||
23400666|NCT01374425|65214147|FG000|Overall Study|Refused Treatment|10|||
23400667|NCT01374425|65214148|FG001|Overall Study|Refused Treatment|24|||
23400668|NCT01374425|65214147|FG000|Overall Study|Protocol Violation|2|||
23400669|NCT01374425|65214148|FG001|Overall Study|Protocol Violation|3|||
23400670|NCT01374425|65214147|FG000|Overall Study|Sponsor Decision|0|||
23400671|NCT01374425|65214148|FG001|Overall Study|Sponsor Decision|1|||
23400672|NCT01374425|65214147|FG000|Overall Study|Lost to Follow-up|2|||
23400673|NCT01374425|65214148|FG001|Overall Study|Lost to Follow-up|1|||
23400674|NCT01374425|65214147|FG000|Overall Study|Other|41|||
23400675|NCT01374425|65214148|FG001|Overall Study|Other|43|||
23400676|NCT01242514|65214149|FG000|Overall Study|e.g., project closure|1042|||
23400677|NCT01242514|65214150|FG001|Overall Study|e.g., project closure|305|||
23400678|NCT01242514|65214151|FG002|Overall Study|e.g., project closure|171|||
23400679|NCT01242514|65214149|FG000|Overall Study|Subject decision|33|||
23400680|NCT01242514|65214150|FG001|Overall Study|Subject decision|8|||
23400681|NCT01242514|65214151|FG002|Overall Study|Subject decision|2|||
23400682|NCT01242514|65214149|FG000|Overall Study|Severe non-compliance to protocol|5|||
23400683|NCT01242514|65214150|FG001|Overall Study|Severe non-compliance to protocol|2|||
23400684|NCT01242514|65214151|FG002|Overall Study|Severe non-compliance to protocol|1|||
23400685|NCT01242514|65214149|FG000|Overall Study|Lack of therapeutic response|99|||
23400686|NCT01242514|65214150|FG001|Overall Study|Lack of therapeutic response|16|||
23400687|NCT01242514|65214151|FG002|Overall Study|Lack of therapeutic response|10|||
23400688|NCT01242514|65214149|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
23400689|NCT01242514|65214150|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
23400690|NCT01242514|65214151|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
23400691|NCT01242514|65214149|FG000|Overall Study|Lost to Follow-up|14|||
23400692|NCT01242514|65214150|FG001|Overall Study|Lost to Follow-up|5|||
23400693|NCT01242514|65214151|FG002|Overall Study|Lost to Follow-up|4|||
23400694|NCT01242514|65214149|FG000|Overall Study|Adverse Event|129|||
23400695|NCT01242514|65214150|FG001|Overall Study|Adverse Event|18|||
23400696|NCT01242514|65214151|FG002|Overall Study|Adverse Event|19|||
23400697|NCT00069641|65214152|FG000|Overall Study|Death|1|||
23400698|NCT00069641|65214153|FG001|Overall Study|Death|0|||
23400699|NCT00069641|65214154|FG002|Overall Study|Death|1|||
23400700|NCT02170064|65214165|FG000|Overall Study|Withdrawal by Subject|5|||
23400701|NCT02170064|65214166|FG001|Overall Study|Withdrawal by Subject|1|||
23400702|NCT02170064|65214167|FG002|Overall Study|Withdrawal by Subject|1|||
23400703|NCT02170064|65214165|FG000|Overall Study|Physician Decision|1|||
23400704|NCT02170064|65214166|FG001|Overall Study|Physician Decision|1|||
23400705|NCT02170064|65214167|FG002|Overall Study|Physician Decision|0|||
23400706|NCT02239926|65214169|FG000|Overall Study|Withdrawal by Subject|0|||
23400707|NCT02239926|65214170|FG001|Overall Study|Withdrawal by Subject|1|||
23400708|NCT01870869|65214171|FG000|Overall Study|Implanted with nonstudy device|1|||
23400709|NCT01870869|65214172|FG001|Overall Study|Implanted with nonstudy device|3|||
23400710|NCT01870869|65214173|FG002|Overall Study|Implanted with nonstudy device|14|||
23400711|NCT01870869|65214174|FG003|Overall Study|Implanted with nonstudy device|4|||
23400712|NCT01870869|65214171|FG000|Overall Study|Death|0|||
23400713|NCT01870869|65214172|FG001|Overall Study|Death|0|||
23400714|NCT01870869|65214173|FG002|Overall Study|Death|7|||
23400715|NCT01870869|65214174|FG003|Overall Study|Death|1|||
23400716|NCT01870869|65214171|FG000|Overall Study|Subject choice|6|||
23400717|NCT01870869|65214172|FG001|Overall Study|Subject choice|2|||
23400718|NCT01870869|65214173|FG002|Overall Study|Subject choice|22|||
23400719|NCT01870869|65214174|FG003|Overall Study|Subject choice|8|||
23400720|NCT01870869|65214171|FG000|Overall Study|Lost to Follow-up|10|||
23400721|NCT01870869|65214172|FG001|Overall Study|Lost to Follow-up|2|||
23400722|NCT01870869|65214173|FG002|Overall Study|Lost to Follow-up|25|||
23400723|NCT01870869|65214174|FG003|Overall Study|Lost to Follow-up|3|||
23400724|NCT01870869|65214171|FG000|Overall Study|Reason not Specified|1|||
23400725|NCT01870869|65214172|FG001|Overall Study|Reason not Specified|2|||
23400726|NCT01870869|65214173|FG002|Overall Study|Reason not Specified|20|||
23400727|NCT01870869|65214174|FG003|Overall Study|Reason not Specified|4|||
23400728|NCT01870869|65214171|FG000|Overall Study|Not evaluable|10|||
23400729|NCT01870869|65214172|FG001|Overall Study|Not evaluable|5|||
23400730|NCT01870869|65214173|FG002|Overall Study|Not evaluable|42|||
23400731|NCT01870869|65214174|FG003|Overall Study|Not evaluable|10|||
23400732|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
23400733|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
23400734|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
23400735|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
23400736|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
23400737|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
23400738|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
23400739|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
23400740|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
23400741|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
23400742|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
23400743|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
23400744|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
23400745|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
23400746|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
23400747|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
23400748|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
23400749|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
23400750|NCT03789292|65214175|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
23400751|NCT03789292|65214176|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
23400752|NCT03789292|65214177|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
23400753|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
23400754|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
23400755|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
23400756|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
23400757|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
23400758|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
23400759|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
23400760|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
23400761|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
23400762|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
23400763|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
23400764|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
23400765|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
23400766|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
23400767|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
23400768|NCT03789292|65214175|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
23400769|NCT03789292|65214176|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
23400770|NCT03789292|65214177|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
23400771|NCT01979614|65214178|FG000|Overall Study|Adverse Event|1|||
23400772|NCT01979614|65214179|FG001|Overall Study|Adverse Event|1|||
23400773|NCT01783444|65214185|FG000|Treatment Phase|Adverse Event|9|||
23400774|NCT01783444|65214186|FG001|Treatment Phase|Adverse Event|20|||
23400775|NCT01783444|65214187|FG002|Treatment Phase|Adverse Event|19|||
23400776|NCT01783444|65214185|FG000|Treatment Phase|Disease Progression|76|||
23400777|NCT01783444|65214186|FG001|Treatment Phase|Disease Progression|66|||
23400778|NCT01783444|65214187|FG002|Treatment Phase|Disease Progression|64|||
23400779|NCT01783444|65214185|FG000|Treatment Phase|Death|2|||
23400780|NCT01783444|65214186|FG001|Treatment Phase|Death|2|||
23400781|NCT01783444|65214187|FG002|Treatment Phase|Death|2|||
23400782|NCT01783444|65214185|FG000|Treatment Phase|Protocol Violation|1|||
23400783|NCT01783444|65214186|FG001|Treatment Phase|Protocol Violation|1|||
23400784|NCT01783444|65214187|FG002|Treatment Phase|Protocol Violation|2|||
23400785|NCT01783444|65214185|FG000|Treatment Phase|Withdrawal by Subject|6|||
23400786|NCT01783444|65214186|FG001|Treatment Phase|Withdrawal by Subject|8|||
23400787|NCT01783444|65214187|FG002|Treatment Phase|Withdrawal by Subject|9|||
23400788|NCT01783444|65214185|FG000|Treatment Phase|Administrative problems|2|||
23400789|NCT01783444|65214186|FG001|Treatment Phase|Administrative problems|0|||
23400790|NCT01783444|65214187|FG002|Treatment Phase|Administrative problems|1|||
23400791|NCT01783444|65214185|FG000|Treatment Phase|Physician Decision|8|||
23400792|NCT01783444|65214186|FG001|Treatment Phase|Physician Decision|6|||
23400793|NCT01783444|65214187|FG002|Treatment Phase|Physician Decision|5|||
23400794|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
23400795|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
23400796|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
23400797|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
23400798|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
23400799|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
23400800|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
23400801|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
23400802|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
23400803|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
23400804|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
23400805|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
23400806|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
23400807|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
23400808|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
23400809|NCT01783444|65214185|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
23400810|NCT01783444|65214186|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
23400811|NCT01783444|65214187|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
23400812|NCT00976456|65214188|FG000|Overall Study|Adverse Event|17|||
23400813|NCT00976456|65214189|FG001|Overall Study|Adverse Event|22|||
23400814|NCT00976456|65214188|FG000|Overall Study|Death|7|||
23400815|NCT00976456|65214189|FG001|Overall Study|Death|9|||
23400816|NCT00976456|65214188|FG000|Overall Study|Lack of Efficacy|5|||
23400817|NCT00976456|65214189|FG001|Overall Study|Lack of Efficacy|2|||
23400818|NCT00976456|65214188|FG000|Overall Study|Withdrawal by Subject|3|||
23400819|NCT00976456|65214189|FG001|Overall Study|Withdrawal by Subject|1|||
23400820|NCT00976456|65214188|FG000|Overall Study|screening failure, unknown|11|||
23400821|NCT00976456|65214189|FG001|Overall Study|screening failure, unknown|4|||
23400822|NCT04102007|65214190|FG000|Overall Study|Adverse Event|4|||
23400823|NCT04102007|65214190|FG000|Overall Study|Lost to Follow-up|3|||
23400824|NCT04102007|65214190|FG000|Overall Study|Withdrawal by Subject|12|||
23400825|NCT04102007|65214190|FG000|Overall Study|Eligibility Violation|5|||
23400826|NCT04102007|65214190|FG000|Overall Study|Lack of Efficacy|6|||
23400827|NCT04102007|65214190|FG000|Overall Study|Protocol Deviation|5|||
23400828|NCT04102007|65214190|FG000|Overall Study|Protocol Compliance|1|||
23400829|NCT04102007|65214190|FG000|Overall Study|Withdrew Treatment|2|||
23400830|NCT04102007|65214190|FG000|Overall Study|Pregnancy|1|||
23400831|NCT02655887|65214196|FG000|Overall Study|Lost to Follow-up|3|||
23400832|NCT02655887|65214196|FG000|Overall Study|Death|4|||
23400833|NCT02655887|65214196|FG000|Overall Study|Withdrawal by Subject|3|||
23400834|NCT02655887|65214196|FG000|Overall Study|Missed 12-month follow-up visit|4|||
23400835|NCT01816295|65214200|FG000|Double Blind Phase|Adverse Event|11|||
23400836|NCT01816295|65214201|FG001|Double Blind Phase|Adverse Event|8|||
23400837|NCT01816295|65214200|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
23400838|NCT01816295|65214201|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
23400839|NCT01816295|65214200|FG000|Double Blind Phase|Lost to Follow-up|3|||
23400840|NCT01816295|65214201|FG001|Double Blind Phase|Lost to Follow-up|5|||
23400841|NCT01816295|65214200|FG000|Double Blind Phase|Physician Decision|2|||
23400842|NCT01816295|65214201|FG001|Double Blind Phase|Physician Decision|2|||
23400843|NCT01816295|65214200|FG000|Double Blind Phase|Protocol Violation|17|||
23400844|NCT01816295|65214201|FG001|Double Blind Phase|Protocol Violation|11|||
23400845|NCT01816295|65214200|FG000|Double Blind Phase|Sponsor Decision|8|||
23400846|NCT01816295|65214201|FG001|Double Blind Phase|Sponsor Decision|8|||
23400847|NCT01816295|65214200|FG000|Double Blind Phase|Withdrawal by Subject|22|||
23400848|NCT01816295|65214201|FG001|Double Blind Phase|Withdrawal by Subject|20|||
23400849|NCT01816295|65214200|FG000|OLE Phase|Adverse Event|17|||
23400850|NCT01816295|65214201|FG001|OLE Phase|Adverse Event|15|||
23400851|NCT01816295|65214200|FG000|OLE Phase|Death|1|||
23400852|NCT01816295|65214201|FG001|OLE Phase|Death|0|||
23400853|NCT01816295|65214200|FG000|OLE Phase|Entry Criteria Not Met|3|||
23400854|NCT01816295|65214201|FG001|OLE Phase|Entry Criteria Not Met|5|||
23400855|NCT01816295|65214200|FG000|OLE Phase|Lost to Follow-up|5|||
23400856|NCT01816295|65214201|FG001|OLE Phase|Lost to Follow-up|5|||
23400857|NCT01816295|65214200|FG000|OLE Phase|Physician Decision|3|||
23400858|NCT01816295|65214201|FG001|OLE Phase|Physician Decision|1|||
23400859|NCT01816295|65214200|FG000|OLE Phase|Protocol Violation|4|||
23400860|NCT01816295|65214201|FG001|OLE Phase|Protocol Violation|4|||
23400861|NCT01816295|65214200|FG000|OLE Phase|Sponsor Decision|7|||
23400862|NCT01816295|65214201|FG001|OLE Phase|Sponsor Decision|9|||
23400863|NCT01816295|65214200|FG000|OLE Phase|Withdrawal by Subject|10|||
23400864|NCT01816295|65214201|FG001|OLE Phase|Withdrawal by Subject|10|||
23400865|NCT01816295|65214200|FG000|OLE Phase|Lack of Efficacy|3|||
23400866|NCT01816295|65214201|FG001|OLE Phase|Lack of Efficacy|7|||
23400867|NCT01128569|65214204|FG000|Washout Period 1|Adverse Event|0|||
23400868|NCT01128569|65214205|FG001|Washout Period 1|Adverse Event|0|||
23400869|NCT01128569|65214206|FG002|Washout Period 1|Adverse Event|1|||
23400870|NCT01128569|65214207|FG003|Washout Period 1|Adverse Event|0|||
23400871|NCT01128569|65214208|FG004|Washout Period 1|Adverse Event|0|||
23400872|NCT01128569|65214209|FG005|Washout Period 1|Adverse Event|0|||
23400873|NCT01128569|65214204|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23400874|NCT01128569|65214205|FG001|Treatment Period 2|Withdrawal by Subject|1|||
23400875|NCT01128569|65214206|FG002|Treatment Period 2|Withdrawal by Subject|0|||
23400876|NCT01128569|65214207|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23400877|NCT01128569|65214208|FG004|Treatment Period 2|Withdrawal by Subject|0|||
23400878|NCT01128569|65214209|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23400879|NCT01126190|65214212|FG000|Double-Blind Phase|Death|0|||
23400880|NCT01126190|65214213|FG001|Double-Blind Phase|Death|1|||
23400881|NCT01126190|65214214|FG002|Double-Blind Phase|Death|0|||
23400882|NCT01126190|65214212|FG000|Double-Blind Phase|Adverse Event|1|||
23400883|NCT01126190|65214213|FG001|Double-Blind Phase|Adverse Event|2|||
23400884|NCT01126190|65214214|FG002|Double-Blind Phase|Adverse Event|0|||
23400885|NCT01126190|65214212|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
23400886|NCT01126190|65214213|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
23400887|NCT01126190|65214214|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
23400888|NCT01126190|65214212|FG000|Double-Blind Phase|Request of Investigator|1|||
23400889|NCT01126190|65214213|FG001|Double-Blind Phase|Request of Investigator|0|||
23400890|NCT01126190|65214214|FG002|Double-Blind Phase|Request of Investigator|0|||
23400891|NCT01126190|65214212|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
23400892|NCT01126190|65214213|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
23400893|NCT01126190|65214214|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
23400894|NCT01126190|65214212|FG000|Double-Blind Phase|Non-compliance|1|||
23400895|NCT01126190|65214213|FG001|Double-Blind Phase|Non-compliance|0|||
23400896|NCT01126190|65214214|FG002|Double-Blind Phase|Non-compliance|0|||
23400897|NCT01126190|65214212|FG000|Double-Blind Phase|Lost to Follow-up|1|||
23400898|NCT01126190|65214213|FG001|Double-Blind Phase|Lost to Follow-up|3|||
23400899|NCT01126190|65214214|FG002|Double-Blind Phase|Lost to Follow-up|0|||
23400900|NCT01126190|65214212|FG000|Open-Label Phase|Death|0|||
23400901|NCT01126190|65214213|FG001|Open-Label Phase|Death|0|||
23400902|NCT01126190|65214214|FG002|Open-Label Phase|Death|1|||
23400903|NCT01126190|65214212|FG000|Open-Label Phase|Adverse Event|0|||
23400904|NCT01126190|65214213|FG001|Open-Label Phase|Adverse Event|0|||
23400905|NCT01126190|65214214|FG002|Open-Label Phase|Adverse Event|4|||
23400906|NCT01126190|65214212|FG000|Open-Label Phase|Withdrawal by Subject|0|||
23400907|NCT01126190|65214213|FG001|Open-Label Phase|Withdrawal by Subject|0|||
23400908|NCT01126190|65214214|FG002|Open-Label Phase|Withdrawal by Subject|6|||
23400909|NCT02301897|65214219|FG000|Treatment Course 1|Non-Compliance|0|||
23400910|NCT02301897|65214220|FG001|Treatment Course 1|Non-Compliance|0|||
23400911|NCT02301897|65214221|FG002|Treatment Course 1|Non-Compliance|1|||
23400912|NCT02301897|65214219|FG000|Treatment Course 1|Adverse Event|1|||
23400913|NCT02301897|65214220|FG001|Treatment Course 1|Adverse Event|1|||
23400914|NCT02301897|65214221|FG002|Treatment Course 1|Adverse Event|0|||
23400915|NCT02301897|65214219|FG000|Treatment Course 1|Lost to Follow-up|1|||
23400916|NCT02301897|65214220|FG001|Treatment Course 1|Lost to Follow-up|2|||
23400917|NCT02301897|65214221|FG002|Treatment Course 1|Lost to Follow-up|1|||
23400918|NCT02301897|65214219|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
23400919|NCT02301897|65214220|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
23400920|NCT02301897|65214221|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
23400921|NCT02301897|65214219|FG000|Treatment Course 1|Withdrawal by Subject|0|||
23400922|NCT02301897|65214220|FG001|Treatment Course 1|Withdrawal by Subject|0|||
23400923|NCT02301897|65214221|FG002|Treatment Course 1|Withdrawal by Subject|2|||
23400924|NCT02301897|65214219|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
23400925|NCT02301897|65214220|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
23400926|NCT02301897|65214221|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
23300795|NCT00680186|64842934|FG000|Overall Study|Lost to Follow-up|11|||
23400927|NCT02301897|65214219|FG000|Treatment Course 2|Lost to Follow-up|0|||
23400928|NCT02301897|65214220|FG001|Treatment Course 2|Lost to Follow-up|2|||
23400929|NCT02301897|65214221|FG002|Treatment Course 2|Lost to Follow-up|0|||
23400930|NCT02301897|65214219|FG000|Treatment Course 2|Pregnancy|0|||
23400931|NCT02301897|65214220|FG001|Treatment Course 2|Pregnancy|1|||
23400932|NCT02301897|65214221|FG002|Treatment Course 2|Pregnancy|1|||
23400933|NCT02301897|65214219|FG000|Treatment Course 2|Withdrawal by Subject|0|||
23400934|NCT02301897|65214220|FG001|Treatment Course 2|Withdrawal by Subject|2|||
23400935|NCT02301897|65214221|FG002|Treatment Course 2|Withdrawal by Subject|0|||
23400936|NCT02301897|65214219|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
23400937|NCT02301897|65214220|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
23400938|NCT02301897|65214221|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
23400939|NCT03097289|65214222|FG000|Overall Study|Adverse Event|1|||
23400940|NCT03097289|65214222|FG000|Overall Study|Equipment failure|2|||
23400941|NCT03097289|65214222|FG000|Overall Study|Collected platelet product unusable|3|||
23400942|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
23400943|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
23400944|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
23400945|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
23400946|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
23400947|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
23400948|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
23400949|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
23400950|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
23400951|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
23400952|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
23400953|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
23400954|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
23400955|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
23400956|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
23400957|NCT00546481|65214225|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
23400958|NCT00546481|65214226|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
23400959|NCT00546481|65214227|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
23400960|NCT00546481|65214225|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
23400961|NCT00546481|65214226|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
23400962|NCT00546481|65214227|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
23400963|NCT00546481|65214225|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
23400964|NCT00546481|65214226|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
23400965|NCT00546481|65214227|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
23400966|NCT00546481|65214225|FG000|Maintenance Phase (CERA)|Other Reason|0|||
23400967|NCT00546481|65214226|FG001|Maintenance Phase (CERA)|Other Reason|0|||
23400968|NCT00546481|65214227|FG002|Maintenance Phase (CERA)|Other Reason|1|||
23400969|NCT02286895|65214232|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
23400970|NCT02286895|65214233|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
23400971|NCT02286895|65214232|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
23400972|NCT02286895|65214233|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
23400973|NCT02286895|65214232|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
23400974|NCT02286895|65214233|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
23400975|NCT04409834|65214234|FG000|Overall Study|Death|55|||
23400976|NCT04409834|65214235|FG001|Overall Study|Death|62|||
23400977|NCT00904371|65214239|FG000|Overall Study|Adverse Event|2|||
23400978|NCT00904371|65214239|FG000|Overall Study|Lost to Follow-up|4|||
23400979|NCT00904371|65214239|FG000|Overall Study|Discontinued at target blood pressure|2|||
23400980|NCT00904371|65214239|FG000|Overall Study|Continued with Tritace|1|||
23400981|NCT00613106|65214240|FG000|Overall Study|Adverse Event|3|||
23400982|NCT00613106|65214241|FG001|Overall Study|Adverse Event|1|||
23400983|NCT00613106|65214240|FG000|Overall Study|Withdrawal by Subject|6|||
23400984|NCT00613106|65214241|FG001|Overall Study|Withdrawal by Subject|3|||
23400985|NCT00613106|65214240|FG000|Overall Study|Lost to Follow-up|7|||
23400986|NCT00613106|65214241|FG001|Overall Study|Lost to Follow-up|2|||
23400987|NCT00613106|65214240|FG000|Overall Study|misc|4|||
23400988|NCT00613106|65214241|FG001|Overall Study|misc|3|||
23400989|NCT02412670|65214243|FG000|Overall Study|Adverse Event|4|||
23400990|NCT02412670|65214244|FG001|Overall Study|Adverse Event|1|||
23400991|NCT02412670|65214243|FG000|Overall Study|Physician Decision|1|||
23400992|NCT02412670|65214244|FG001|Overall Study|Physician Decision|0|||
23400993|NCT02412670|65214243|FG000|Overall Study|Withdrawal by Subject|1|||
23400994|NCT02412670|65214244|FG001|Overall Study|Withdrawal by Subject|0|||
23400995|NCT02412670|65214243|FG000|Overall Study|Ineligible|1|||
23400996|NCT02412670|65214244|FG001|Overall Study|Ineligible|0|||
23400997|NCT00403130|65214245|FG000|2 Years From Start of Treatment|Not Eligible|3|||
23400998|NCT00403130|65214245|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
23400999|NCT00403130|65214245|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
23401000|NCT00403130|65214245|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
23401001|NCT00382174|65214246|FG000|Overall Study|Lost to Follow-up|1|||
23401002|NCT00382174|65214247|FG001|Overall Study|Lost to Follow-up|4|||
23401003|NCT00382174|65214248|FG002|Overall Study|Lost to Follow-up|5|||
23401004|NCT00382174|65214246|FG000|Overall Study|Adverse Event|1|||
23401005|NCT00382174|65214247|FG001|Overall Study|Adverse Event|4|||
23401006|NCT00382174|65214248|FG002|Overall Study|Adverse Event|5|||
23401007|NCT00382174|65214246|FG000|Overall Study|Withdrawal by Subject|1|||
23401008|NCT00382174|65214247|FG001|Overall Study|Withdrawal by Subject|4|||
23401009|NCT00382174|65214248|FG002|Overall Study|Withdrawal by Subject|5|||
23401010|NCT00382174|65214246|FG000|Overall Study|Non compliance|1|||
23401011|NCT00382174|65214247|FG001|Overall Study|Non compliance|0|||
23401012|NCT00382174|65214248|FG002|Overall Study|Non compliance|1|||
23401013|NCT00382174|65214246|FG000|Overall Study|Physician Decision|0|||
23401014|NCT00382174|65214247|FG001|Overall Study|Physician Decision|2|||
23401015|NCT00382174|65214248|FG002|Overall Study|Physician Decision|2|||
23401016|NCT00382174|65214246|FG000|Overall Study|Failed to meet criteria|0|||
23401017|NCT00382174|65214247|FG001|Overall Study|Failed to meet criteria|1|||
23401018|NCT00382174|65214248|FG002|Overall Study|Failed to meet criteria|1|||
23401019|NCT00382174|65214246|FG000|Overall Study|Wounds merged|0|||
23401020|NCT00382174|65214247|FG001|Overall Study|Wounds merged|2|||
23401021|NCT00382174|65214248|FG002|Overall Study|Wounds merged|2|||
23401022|NCT01732536|65214249|FG000|Overall Study|Withdrawal by Subject|1|||
23401023|NCT01732536|65214250|FG001|Overall Study|Withdrawal by Subject|1|||
23401024|NCT02701764|65214251|FG000|Overall Study|Lost to Follow-up|0|||
23401025|NCT02701764|65214252|FG001|Overall Study|Lost to Follow-up|1|||
23401026|NCT01736917|65214253|FG000|Overall Study|Adverse Event|1|||
23401027|NCT01736917|65214253|FG000|Overall Study|Protocol Violation|10|||
23401028|NCT04211363|65214254|FG000|Overall Study|Adverse Event|5|||
23401029|NCT04211363|65214255|FG001|Overall Study|Adverse Event|2|||
23401030|NCT04211363|65214254|FG000|Overall Study|Physician Decision|0|||
23401031|NCT04211363|65214255|FG001|Overall Study|Physician Decision|1|||
23401032|NCT04211363|65214254|FG000|Overall Study|Protocol Violation|1|||
23401033|NCT04211363|65214255|FG001|Overall Study|Protocol Violation|0|||
23401034|NCT04211363|65214254|FG000|Overall Study|Pregnancy|1|||
23401035|NCT04211363|65214255|FG001|Overall Study|Pregnancy|0|||
23401036|NCT04211363|65214254|FG000|Overall Study|Lost to Follow-up|12|||
23401037|NCT04211363|65214255|FG001|Overall Study|Lost to Follow-up|4|||
23401038|NCT04211363|65214254|FG000|Overall Study|Withdrawal by Subject|11|||
23401039|NCT04211363|65214255|FG001|Overall Study|Withdrawal by Subject|11|||
23401040|NCT04211363|65214254|FG000|Overall Study|Other|1|||
23401041|NCT04211363|65214255|FG001|Overall Study|Other|2|||
23401042|NCT01425814|65214256|FG000|Period 1|Stability criteria not fulfilled|0|||
23401043|NCT01425814|65214257|FG001|Period 1|Stability criteria not fulfilled|1|||
23401044|NCT01425814|65214258|FG002|Period 1|Stability criteria not fulfilled|0|||
23401045|NCT01425814|65214259|FG003|Period 1|Stability criteria not fulfilled|0|||
23401046|NCT01425814|65214260|FG004|Period 1|Stability criteria not fulfilled|0|||
23401047|NCT01425814|65214261|FG005|Period 1|Stability criteria not fulfilled|0|||
23401048|NCT01425814|65214256|FG000|Period 2|Stability criteria not fulfilled|0|||
23401049|NCT01425814|65214257|FG001|Period 2|Stability criteria not fulfilled|1|||
23401050|NCT01425814|65214258|FG002|Period 2|Stability criteria not fulfilled|0|||
23401051|NCT01425814|65214259|FG003|Period 2|Stability criteria not fulfilled|0|||
23401052|NCT01425814|65214260|FG004|Period 2|Stability criteria not fulfilled|0|||
23401053|NCT01425814|65214261|FG005|Period 2|Stability criteria not fulfilled|0|||
23401054|NCT01425814|65214256|FG000|Period 3|Adverse Event|0|||
23401055|NCT01425814|65214257|FG001|Period 3|Adverse Event|0|||
23401056|NCT01425814|65214258|FG002|Period 3|Adverse Event|0|||
23401057|NCT01425814|65214259|FG003|Period 3|Adverse Event|0|||
23401058|NCT01425814|65214260|FG004|Period 3|Adverse Event|0|||
23401059|NCT01425814|65214261|FG005|Period 3|Adverse Event|1|||
23401060|NCT01425814|65214256|FG000|Period 4|Adverse Event|1|||
23401061|NCT01425814|65214257|FG001|Period 4|Adverse Event|0|||
23401062|NCT01425814|65214258|FG002|Period 4|Adverse Event|1|||
23401063|NCT01425814|65214259|FG003|Period 4|Adverse Event|0|||
23401064|NCT01425814|65214260|FG004|Period 4|Adverse Event|0|||
23401065|NCT01425814|65214261|FG005|Period 4|Adverse Event|0|||
23401066|NCT01425814|65214256|FG000|Period 5|Stability criteria not fulfilled|0|||
23401067|NCT01425814|65214257|FG001|Period 5|Stability criteria not fulfilled|0|||
23401068|NCT01425814|65214258|FG002|Period 5|Stability criteria not fulfilled|1|||
23401069|NCT01425814|65214259|FG003|Period 5|Stability criteria not fulfilled|0|||
23401070|NCT01425814|65214260|FG004|Period 5|Stability criteria not fulfilled|0|||
23401071|NCT01425814|65214261|FG005|Period 5|Stability criteria not fulfilled|1|||
23401072|NCT01847755|65214264|FG000|Overall Study|Adverse Event|2|||
23401073|NCT01847755|65214264|FG000|Overall Study|Withdrawal by Subject|2|||
23401074|NCT01847755|65214264|FG000|Overall Study|Physician Decision|1|||
23401075|NCT00049543|65214265|FG000|Overall Study|still on treatment|2|||
23401076|NCT00049543|65214266|FG001|Overall Study|still on treatment|9|||
23401077|NCT02612311|65214269|FG000|Overall Study|Adverse Event|16|||
23401078|NCT02612311|65214270|FG001|Overall Study|Adverse Event|12|||
23401079|NCT02612311|65214271|FG002|Overall Study|Adverse Event|7|||
23401080|NCT02612311|65214272|FG003|Overall Study|Adverse Event|13|||
23401081|NCT02612311|65214269|FG000|Overall Study|Death|29|||
23401082|NCT02612311|65214270|FG001|Overall Study|Death|10|||
23401083|NCT02612311|65214271|FG002|Overall Study|Death|11|||
23401084|NCT02612311|65214272|FG003|Overall Study|Death|11|||
23401085|NCT02612311|65214269|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
23401086|NCT02612311|65214270|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
23401087|NCT02612311|65214271|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
23401088|NCT02612311|65214272|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
23401089|NCT02612311|65214269|FG000|Overall Study|Investigator's Decision|11|||
23401090|NCT02612311|65214270|FG001|Overall Study|Investigator's Decision|15|||
23401091|NCT02612311|65214271|FG002|Overall Study|Investigator's Decision|6|||
23401092|NCT02612311|65214272|FG003|Overall Study|Investigator's Decision|6|||
23401093|NCT02612311|65214269|FG000|Overall Study|Lack of Efficacy|0|||
23401094|NCT02612311|65214270|FG001|Overall Study|Lack of Efficacy|0|||
23401095|NCT02612311|65214271|FG002|Overall Study|Lack of Efficacy|1|||
23401096|NCT02612311|65214272|FG003|Overall Study|Lack of Efficacy|1|||
23401097|NCT02612311|65214269|FG000|Overall Study|Lost to Follow-up|2|||
23401098|NCT02612311|65214270|FG001|Overall Study|Lost to Follow-up|2|||
23401099|NCT02612311|65214271|FG002|Overall Study|Lost to Follow-up|1|||
23401100|NCT02612311|65214272|FG003|Overall Study|Lost to Follow-up|2|||
23401101|NCT02612311|65214269|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
23401102|NCT02612311|65214270|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
23401103|NCT02612311|65214271|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
23401104|NCT02612311|65214272|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
23401105|NCT02612311|65214269|FG000|Overall Study|Site Terminated by Sponsor|29|||
23401106|NCT02612311|65214270|FG001|Overall Study|Site Terminated by Sponsor|12|||
23401107|NCT02612311|65214271|FG002|Overall Study|Site Terminated by Sponsor|13|||
23401108|NCT02612311|65214272|FG003|Overall Study|Site Terminated by Sponsor|5|||
23401109|NCT02612311|65214269|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
23401110|NCT02612311|65214270|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
23401111|NCT02612311|65214271|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
23401112|NCT02612311|65214272|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
23401113|NCT02612311|65214269|FG000|Overall Study|Reason Not Specified|3|||
23401114|NCT02612311|65214270|FG001|Overall Study|Reason Not Specified|7|||
23401115|NCT02612311|65214271|FG002|Overall Study|Reason Not Specified|4|||
23401116|NCT02612311|65214272|FG003|Overall Study|Reason Not Specified|5|||
23401117|NCT02612311|65214269|FG000|Overall Study|Unknown/Missing|10|||
23401118|NCT02612311|65214270|FG001|Overall Study|Unknown/Missing|13|||
23401119|NCT02612311|65214271|FG002|Overall Study|Unknown/Missing|4|||
23401120|NCT02612311|65214272|FG003|Overall Study|Unknown/Missing|0|||
23401121|NCT02612311|65214269|FG000|Overall Study|Non-Compliance with Study|1|||
23401122|NCT02612311|65214270|FG001|Overall Study|Non-Compliance with Study|0|||
23401123|NCT02612311|65214271|FG002|Overall Study|Non-Compliance with Study|0|||
23401124|NCT02612311|65214272|FG003|Overall Study|Non-Compliance with Study|0|||
23401125|NCT01865487|65214275|FG000|Overall Study|Lost to Follow-up|0|||
23401126|NCT01865487|65214276|FG001|Overall Study|Lost to Follow-up|0|||
23401127|NCT01865487|65214277|FG002|Overall Study|Lost to Follow-up|0|||
23401128|NCT01865487|65214278|FG003|Overall Study|Lost to Follow-up|1|||
23401129|NCT01865487|65214279|FG004|Overall Study|Lost to Follow-up|0|||
23401130|NCT01865487|65214280|FG005|Overall Study|Lost to Follow-up|0|||
23401131|NCT01865487|65214281|FG006|Overall Study|Lost to Follow-up|1|||
23401132|NCT01865487|65214282|FG007|Overall Study|Lost to Follow-up|0|||
23401133|NCT01865487|65214283|FG008|Overall Study|Lost to Follow-up|0|||
23401134|NCT01865487|65214284|FG009|Overall Study|Lost to Follow-up|0|||
23401135|NCT01865487|65214275|FG000|Overall Study|Withdrawal by Subject|0|||
23401136|NCT01865487|65214276|FG001|Overall Study|Withdrawal by Subject|0|||
23401137|NCT01865487|65214277|FG002|Overall Study|Withdrawal by Subject|0|||
23401138|NCT01865487|65214278|FG003|Overall Study|Withdrawal by Subject|0|||
23401139|NCT01865487|65214279|FG004|Overall Study|Withdrawal by Subject|1|||
23401140|NCT01865487|65214280|FG005|Overall Study|Withdrawal by Subject|0|||
23401141|NCT01865487|65214281|FG006|Overall Study|Withdrawal by Subject|0|||
23401142|NCT01865487|65214282|FG007|Overall Study|Withdrawal by Subject|0|||
23401143|NCT01865487|65214283|FG008|Overall Study|Withdrawal by Subject|0|||
23401144|NCT01865487|65214284|FG009|Overall Study|Withdrawal by Subject|0|||
23401145|NCT01463527|65214285|FG000|Overall Study|Protocol Violation|1|||
23401146|NCT01463527|65214286|FG001|Overall Study|Protocol Violation|1|||
23401147|NCT01463527|65214285|FG000|Overall Study|Crying >20% of sedation|5|||
23401148|NCT01463527|65214286|FG001|Overall Study|Crying >20% of sedation|6|||
23401149|NCT03961308|65214288|FG000|Overall Study|Withdrawal by Subject|1|||
23401150|NCT03961308|65214289|FG001|Overall Study|Withdrawal by Subject|0|||
23401151|NCT03961308|65214288|FG000|Overall Study|Other|1|||
23401152|NCT03961308|65214289|FG001|Overall Study|Other|0|||
23401153|NCT03961308|65214288|FG000|Overall Study|Lost to Follow-up|0|||
23401154|NCT03961308|65214289|FG001|Overall Study|Lost to Follow-up|1|||
23401155|NCT03961308|65214288|FG000|Overall Study|Adverse Event|0|||
23401156|NCT03961308|65214289|FG001|Overall Study|Adverse Event|1|||
23401157|NCT00105534|65214290|FG000|Overall Study|Adverse Event|2|||
23401158|NCT00105534|65214291|FG001|Overall Study|Adverse Event|5|||
23401159|NCT00105534|65214290|FG000|Overall Study|Protocol Violation|1|||
23401160|NCT00105534|65214291|FG001|Overall Study|Protocol Violation|4|||
23401161|NCT00105534|65214290|FG000|Overall Study|Withdrawal by Subject|6|||
23401162|NCT00105534|65214291|FG001|Overall Study|Withdrawal by Subject|6|||
23401163|NCT00105534|65214290|FG000|Overall Study|Lost to Follow-up|5|||
23401164|NCT00105534|65214291|FG001|Overall Study|Lost to Follow-up|1|||
23401165|NCT00105534|65214290|FG000|Overall Study|Lack of Efficacy|7|||
23401166|NCT00105534|65214291|FG001|Overall Study|Lack of Efficacy|15|||
23401167|NCT00105534|65214290|FG000|Overall Study|Treatment unmasked|1|||
23401168|NCT00105534|65214291|FG001|Overall Study|Treatment unmasked|0|||
23401169|NCT00105534|65214290|FG000|Overall Study|Other Reason|0|||
23401170|NCT00105534|65214291|FG001|Overall Study|Other Reason|2|||
23401171|NCT01445847|65214292|FG000|Overall Study|Protocol Violation|13|||
23401172|NCT01445847|65214293|FG001|Overall Study|Protocol Violation|14|||
23401173|NCT01445847|65214292|FG000|Overall Study|Missed Data|1|||
23401174|NCT01445847|65214293|FG001|Overall Study|Missed Data|0|||
23401175|NCT02573948|65214299|FG000|Longitudinal Cohort|Death|9|||
23401176|NCT02573948|65214299|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
23401177|NCT02573948|65214299|FG000|Longitudinal Cohort|Incarcerated|25|||
23401178|NCT00328172|65214304|FG000|Overall Study|Adverse Event|3|||
23401179|NCT00328172|65214305|FG001|Overall Study|Adverse Event|2|||
23401180|NCT00328172|65214306|FG002|Overall Study|Adverse Event|1|||
23401181|NCT00328172|65214307|FG003|Overall Study|Adverse Event|2|||
23401182|NCT00328172|65214308|FG004|Overall Study|Adverse Event|1|||
23401183|NCT00328172|65214304|FG000|Overall Study|Protocol Violation|0|||
23401184|NCT00328172|65214305|FG001|Overall Study|Protocol Violation|1|||
23401185|NCT00328172|65214306|FG002|Overall Study|Protocol Violation|1|||
23401186|NCT00328172|65214307|FG003|Overall Study|Protocol Violation|0|||
23401187|NCT00328172|65214308|FG004|Overall Study|Protocol Violation|0|||
23401188|NCT00328172|65214304|FG000|Overall Study|Lost to Follow-up|1|||
23401189|NCT00328172|65214305|FG001|Overall Study|Lost to Follow-up|1|||
23401190|NCT00328172|65214306|FG002|Overall Study|Lost to Follow-up|2|||
23401191|NCT00328172|65214307|FG003|Overall Study|Lost to Follow-up|1|||
23401192|NCT00328172|65214308|FG004|Overall Study|Lost to Follow-up|1|||
23401193|NCT00328172|65214304|FG000|Overall Study|Withdrawal by Subject|1|||
23401194|NCT00328172|65214305|FG001|Overall Study|Withdrawal by Subject|1|||
23401195|NCT00328172|65214306|FG002|Overall Study|Withdrawal by Subject|1|||
23401196|NCT00328172|65214307|FG003|Overall Study|Withdrawal by Subject|6|||
23401197|NCT00328172|65214308|FG004|Overall Study|Withdrawal by Subject|0|||
23401198|NCT00328172|65214304|FG000|Overall Study|Lack of Efficacy|14|||
23401199|NCT00328172|65214305|FG001|Overall Study|Lack of Efficacy|9|||
23401200|NCT00328172|65214306|FG002|Overall Study|Lack of Efficacy|4|||
23401201|NCT00328172|65214307|FG003|Overall Study|Lack of Efficacy|4|||
23401202|NCT00328172|65214308|FG004|Overall Study|Lack of Efficacy|3|||
23401203|NCT00328172|65214304|FG000|Overall Study|Other reason (not specified)|3|||
23401204|NCT00328172|65214305|FG001|Overall Study|Other reason (not specified)|0|||
23401205|NCT00328172|65214306|FG002|Overall Study|Other reason (not specified)|1|||
23401206|NCT00328172|65214307|FG003|Overall Study|Other reason (not specified)|0|||
23401207|NCT00328172|65214308|FG004|Overall Study|Other reason (not specified)|0|||
23401208|NCT00533429|65214309|FG000|Overall Study|Adverse Event|3|||
23401209|NCT00533429|65214310|FG001|Overall Study|Adverse Event|1|||
23401210|NCT00533429|65214309|FG000|Overall Study|Death|1|||
23401211|NCT00533429|65214310|FG001|Overall Study|Death|0|||
23401212|NCT00533429|65214309|FG000|Overall Study|Withdrawal by Subject|2|||
23401213|NCT00533429|65214310|FG001|Overall Study|Withdrawal by Subject|0|||
23401214|NCT00533429|65214309|FG000|Overall Study|Progressive Disease|12|||
23401215|NCT00533429|65214310|FG001|Overall Study|Progressive Disease|13|||
23401216|NCT00533429|65214309|FG000|Overall Study|Symptomatic deterioration|1|||
23401217|NCT00533429|65214310|FG001|Overall Study|Symptomatic deterioration|2|||
23401218|NCT01957865|65214315|FG000|Overall Study|Found HIV negative|0|||
23401219|NCT01957865|65214316|FG001|Overall Study|Found HIV negative|0|||
23401220|NCT01957865|65214317|FG002|Overall Study|Found HIV negative|1|||
23401221|NCT01957865|65214315|FG000|Overall Study|Lost to Follow-up|0|||
23401222|NCT01957865|65214316|FG001|Overall Study|Lost to Follow-up|2|||
23401223|NCT01957865|65214317|FG002|Overall Study|Lost to Follow-up|2|||
23401224|NCT02013609|65214322|FG000|Overall Study|Withdrawal by Subject|9|||
23401225|NCT02013609|65214322|FG000|Overall Study|Lost to Follow-up|3|||
23401226|NCT02013609|65214322|FG000|Overall Study|Adverse Event|3|||
23401227|NCT02013609|65214322|FG000|Overall Study|Met Withdrawal Criteria|3|||
23401228|NCT02359903|65214323|FG000|Overall Study|Adverse Event|0|||
23401229|NCT02359903|65214324|FG001|Overall Study|Adverse Event|2|||
23401230|NCT01077063|65214327|FG000|Overall Study|Adverse Event|3|||
23401231|NCT01077063|65214328|FG001|Overall Study|Adverse Event|0|||
23300796|NCT00680186|64842935|FG001|Overall Study|Lost to Follow-up|6|||
23401232|NCT01077063|65214327|FG000|Overall Study|Death|1|||
23401233|NCT01077063|65214328|FG001|Overall Study|Death|1|||
23401234|NCT01077063|65214327|FG000|Overall Study|Withdrawal by Subject|0|||
23401235|NCT01077063|65214328|FG001|Overall Study|Withdrawal by Subject|2|||
23401236|NCT01182350|65214332|FG000|Overall Study|Adverse Event|5|||
23401237|NCT01182350|65214333|FG001|Overall Study|Adverse Event|0|||
23401238|NCT01182350|65214334|FG002|Overall Study|Adverse Event|0|||
23401239|NCT01182350|65214335|FG003|Overall Study|Adverse Event|0|||
23401240|NCT01182350|65214336|FG004|Overall Study|Adverse Event|0|||
23401241|NCT01182350|65214332|FG000|Overall Study|Disease Progression|15|||
23401242|NCT01182350|65214333|FG001|Overall Study|Disease Progression|12|||
23401243|NCT01182350|65214334|FG002|Overall Study|Disease Progression|0|||
23401244|NCT01182350|65214335|FG003|Overall Study|Disease Progression|1|||
23401245|NCT01182350|65214336|FG004|Overall Study|Disease Progression|0|||
23401246|NCT01182350|65214332|FG000|Overall Study|Death|0|||
23401247|NCT01182350|65214333|FG001|Overall Study|Death|1|||
23401248|NCT01182350|65214334|FG002|Overall Study|Death|1|||
23401249|NCT01182350|65214335|FG003|Overall Study|Death|0|||
23401250|NCT01182350|65214336|FG004|Overall Study|Death|0|||
23401251|NCT01182350|65214332|FG000|Overall Study|Withdrawal by Subject|3|||
23401252|NCT01182350|65214333|FG001|Overall Study|Withdrawal by Subject|1|||
23401253|NCT01182350|65214334|FG002|Overall Study|Withdrawal by Subject|0|||
23401254|NCT01182350|65214335|FG003|Overall Study|Withdrawal by Subject|1|||
23401255|NCT01182350|65214336|FG004|Overall Study|Withdrawal by Subject|0|||
23401256|NCT01182350|65214332|FG000|Overall Study|Alternative Therapy|2|||
23401257|NCT01182350|65214333|FG001|Overall Study|Alternative Therapy|0|||
23401258|NCT01182350|65214334|FG002|Overall Study|Alternative Therapy|1|||
23401259|NCT01182350|65214335|FG003|Overall Study|Alternative Therapy|0|||
23401260|NCT01182350|65214336|FG004|Overall Study|Alternative Therapy|0|||
23401261|NCT01182350|65214332|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
23401262|NCT01182350|65214333|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
23401263|NCT01182350|65214334|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
23401264|NCT01182350|65214335|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
23401265|NCT01182350|65214336|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
23401266|NCT01182350|65214332|FG000|Overall Study|Unevaluable for Biopsy|0|||
23401267|NCT01182350|65214333|FG001|Overall Study|Unevaluable for Biopsy|0|||
23401268|NCT01182350|65214334|FG002|Overall Study|Unevaluable for Biopsy|0|||
23401269|NCT01182350|65214335|FG003|Overall Study|Unevaluable for Biopsy|0|||
23401270|NCT01182350|65214336|FG004|Overall Study|Unevaluable for Biopsy|3|||
23401271|NCT01154452|65216746|FG000|Phase Ib|Not Treated|1|||
23401272|NCT01154452|65216747|FG001|Phase Ib|Not Treated|0|||
23401273|NCT01154452|65216748|FG002|Phase Ib|Not Treated|0|||
23401274|NCT01154452|65216749|FG003|Phase Ib|Not Treated|0|||
23401275|NCT01154452|65216746|FG000|Phase Ib|Adverse Event|2|||
23401276|NCT01154452|65216747|FG001|Phase Ib|Adverse Event|1|||
23401277|NCT01154452|65216748|FG002|Phase Ib|Adverse Event|0|||
23401278|NCT01154452|65216749|FG003|Phase Ib|Adverse Event|0|||
23401279|NCT01154452|65216746|FG000|Phase II|Withdrawal by Subject|0|||
23401280|NCT01154452|65216747|FG001|Phase II|Withdrawal by Subject|0|||
23401281|NCT01154452|65216748|FG002|Phase II|Withdrawal by Subject|1|||
23401282|NCT01154452|65216749|FG003|Phase II|Withdrawal by Subject|2|||
23401283|NCT01154452|65216746|FG000|Phase II|Adverse Event|0|||
23401284|NCT01154452|65216747|FG001|Phase II|Adverse Event|0|||
23401285|NCT01154452|65216748|FG002|Phase II|Adverse Event|4|||
23401286|NCT01154452|65216749|FG003|Phase II|Adverse Event|4|||
23401287|NCT02015039|65216750|FG000|Overall Study|Not eligible|0|||
23401288|NCT02015039|65216751|FG001|Overall Study|Not eligible|1|||
23401289|NCT01576783|65216752|FG000|Overall Study|Change in Medical Care|1|||
23401290|NCT01576783|65216753|FG001|Overall Study|Change in Medical Care|0|||
23401291|NCT01576783|65216752|FG000|Overall Study|Lost to Follow-up|14|||
23401292|NCT01576783|65216753|FG001|Overall Study|Lost to Follow-up|16|||
23401293|NCT01576783|65216752|FG000|Overall Study|Withdrawal by Subject|5|||
23401294|NCT01576783|65216753|FG001|Overall Study|Withdrawal by Subject|1|||
23401295|NCT01299389|65216754|FG000|Double-blind|Adverse Event|45|||
23401296|NCT01299389|65216755|FG001|Double-blind|Adverse Event|27|||
23401297|NCT01299389|65216756|FG002|Double-blind|Adverse Event|0|||
23401298|NCT01299389|65216757|FG003|Double-blind|Adverse Event|0|||
23401299|NCT01299389|65216754|FG000|Double-blind|Lack of Efficacy|45|||
23401300|NCT01299389|65216755|FG001|Double-blind|Lack of Efficacy|21|||
23401301|NCT01299389|65216756|FG002|Double-blind|Lack of Efficacy|0|||
23401302|NCT01299389|65216757|FG003|Double-blind|Lack of Efficacy|0|||
23401303|NCT01299389|65216754|FG000|Double-blind|Lost to Follow-up|2|||
23401304|NCT01299389|65216755|FG001|Double-blind|Lost to Follow-up|1|||
23401305|NCT01299389|65216756|FG002|Double-blind|Lost to Follow-up|0|||
23401306|NCT01299389|65216757|FG003|Double-blind|Lost to Follow-up|0|||
23401307|NCT01299389|65216754|FG000|Double-blind|Withdrawal by Subject|16|||
23401308|NCT01299389|65216755|FG001|Double-blind|Withdrawal by Subject|13|||
23401309|NCT01299389|65216756|FG002|Double-blind|Withdrawal by Subject|0|||
23401310|NCT01299389|65216757|FG003|Double-blind|Withdrawal by Subject|0|||
23401311|NCT01299389|65216754|FG000|Double-blind|Other|1|||
23401312|NCT01299389|65216755|FG001|Double-blind|Other|1|||
23401313|NCT01299389|65216756|FG002|Double-blind|Other|0|||
23401314|NCT01299389|65216757|FG003|Double-blind|Other|0|||
23401315|NCT01299389|65216754|FG000|Double-blind|"fail to meet study population criteria"|0|||
23401316|NCT01299389|65216755|FG001|Double-blind|"fail to meet study population criteria"|1|||
23401317|NCT01299389|65216756|FG002|Double-blind|"fail to meet study population criteria"|0|||
23401318|NCT01299389|65216757|FG003|Double-blind|"fail to meet study population criteria"|0|||
23401319|NCT01299389|65216754|FG000|Post-observational|Other|0|||
23401320|NCT01299389|65216755|FG001|Post-observational|Other|0|||
23401321|NCT01299389|65216756|FG002|Post-observational|Other|12|||
23401322|NCT01299389|65216757|FG003|Post-observational|Other|6|||
23401323|NCT02289469|65216760|FG000|Overall Study|Unable to match a control|6|||
23401324|NCT02289469|65216761|FG001|Overall Study|Unable to match a control|0|||
23401325|NCT01248793|65216767|FG000|Overall Study|Lost to Follow-up|0|||
23401326|NCT01248793|65216768|FG001|Overall Study|Lost to Follow-up|1|||
23401327|NCT01248793|65216767|FG000|Overall Study|Adverse Event|1|||
23401328|NCT01248793|65216768|FG001|Overall Study|Adverse Event|1|||
23401329|NCT01248793|65216767|FG000|Overall Study|Protocol Violation|0|||
23401330|NCT01248793|65216768|FG001|Overall Study|Protocol Violation|1|||
23401331|NCT01248793|65216767|FG000|Overall Study|Withdrawal by Subject|3|||
23401332|NCT01248793|65216768|FG001|Overall Study|Withdrawal by Subject|3|||
23401333|NCT01016132|65216770|FG000|Overall Study|Discomfort|1|||
23401334|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
23401335|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
23401336|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
23401337|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Death|0|||
23401338|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Death|0|||
23401339|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Death|1|||
23401340|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
23401341|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
23401342|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
23401343|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
23401344|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
23401345|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
23401346|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
23401347|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
23401348|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
23401349|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Graft loss|0|||
23401350|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Graft loss|0|||
23401351|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Graft loss|7|||
23401352|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
23401353|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
23401354|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
23401355|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
23401356|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
23401357|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
23401358|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
23401359|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
23401360|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
23401361|NCT00956293|65216771|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
23401362|NCT00956293|65216772|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
23401363|NCT00956293|65216773|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
23401364|NCT00956293|65216771|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
23401365|NCT00956293|65216772|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
23401366|NCT00956293|65216773|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
23401367|NCT00956293|65216771|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
23401368|NCT00956293|65216772|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
23401369|NCT00956293|65216773|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
23401370|NCT00956293|65216771|FG000|Main Period (Randomization)|Adverse Event|0|||
23401371|NCT00956293|65216772|FG001|Main Period (Randomization)|Adverse Event|15|||
23401372|NCT00956293|65216773|FG002|Main Period (Randomization)|Adverse Event|0|||
23401373|NCT00956293|65216771|FG000|Follow-up Period|Follow-up period was terminated.|20|||
23401374|NCT00956293|65216772|FG001|Follow-up Period|Follow-up period was terminated.|32|||
23401375|NCT00956293|65216773|FG002|Follow-up Period|Follow-up period was terminated.|0|||
23401376|NCT01497197|65216774|FG000|Overall Study|Lost to Follow-up|1|||
23401377|NCT01497197|65216775|FG001|Overall Study|Lost to Follow-up|0|||
23401378|NCT01497197|65216774|FG000|Overall Study|Protocol Violation|0|||
23401379|NCT01497197|65216775|FG001|Overall Study|Protocol Violation|2|||
23401380|NCT01497197|65216774|FG000|Overall Study|Withdrawal by Subject|2|||
23401381|NCT01497197|65216775|FG001|Overall Study|Withdrawal by Subject|1|||
23401382|NCT01497197|65216774|FG000|Overall Study|Excessive/lack of response to treatment|1|||
23401383|NCT01497197|65216775|FG001|Overall Study|Excessive/lack of response to treatment|0|||
23401384|NCT01497197|65216774|FG000|Overall Study|Risk of OHSS|1|||
23401385|NCT01497197|65216775|FG001|Overall Study|Risk of OHSS|0|||
23401386|NCT01497197|65216774|FG000|Overall Study|No oocytes retrieved|3|||
23401387|NCT01497197|65216775|FG001|Overall Study|No oocytes retrieved|2|||
23401388|NCT01497197|65216774|FG000|Overall Study|No fertilisation|6|||
23401389|NCT01497197|65216775|FG001|Overall Study|No fertilisation|5|||
23401390|NCT01497197|65216774|FG000|Overall Study|Intention to freeze all embryos|0|||
23401391|NCT01497197|65216775|FG001|Overall Study|Intention to freeze all embryos|1|||
23401392|NCT01497197|65216774|FG000|Overall Study|All embryos discarded|0|||
23401393|NCT01497197|65216775|FG001|Overall Study|All embryos discarded|3|||
23401394|NCT01497197|65216774|FG000|Overall Study|Other|3|||
23401395|NCT01497197|65216775|FG001|Overall Study|Other|1|||
23401396|NCT03092479|65216777|FG000|Overall Study|Lost to Follow-up|3|||
23401397|NCT03092479|65216778|FG001|Overall Study|Lost to Follow-up|2|||
23401398|NCT03092479|65216777|FG000|Overall Study|Withdrawal by Subject|4|||
23401399|NCT03092479|65216778|FG001|Overall Study|Withdrawal by Subject|0|||
23401400|NCT01061385|65216779|FG000|Overall Study|Lost to Follow-up|1|||
23401401|NCT01061385|65216780|FG001|Overall Study|Lost to Follow-up|0|||
23401402|NCT01061385|65216779|FG000|Overall Study|subject decision not related to AE|0|||
23401403|NCT01061385|65216780|FG001|Overall Study|subject decision not related to AE|1|||
23300797|NCT00680186|64842934|FG000|Overall Study|Withdrawal by Subject|32|||
23300798|NCT00680186|64842935|FG001|Overall Study|Withdrawal by Subject|39|||
23300799|NCT00680186|64842934|FG000|Overall Study|Other|4|||
23300800|NCT00680186|64842935|FG001|Overall Study|Other|1|||
23300801|NCT01202877|64842938|FG000|Overall Study|Disease Progression|0|||
23300802|NCT01202877|64842939|FG001|Overall Study|Disease Progression|1|||
23300803|NCT01202877|64842940|FG002|Overall Study|Disease Progression|2|||
23300804|NCT01202877|64842938|FG000|Overall Study|Adverse Event|0|||
23300805|NCT01202877|64842939|FG001|Overall Study|Adverse Event|0|||
23300806|NCT01202877|64842940|FG002|Overall Study|Adverse Event|2|||
23300807|NCT01202877|64842938|FG000|Overall Study|Withdrawal by Subject|0|||
23300808|NCT01202877|64842939|FG001|Overall Study|Withdrawal by Subject|0|||
23300809|NCT01202877|64842940|FG002|Overall Study|Withdrawal by Subject|1|||
23300810|NCT01202877|64842938|FG000|Overall Study|Death|0|||
23300811|NCT01202877|64842939|FG001|Overall Study|Death|0|||
23300812|NCT01202877|64842940|FG002|Overall Study|Death|1|||
23300813|NCT02080832|64842941|FG000|Overall Study|Excluded from analysis by MRI|9|||
23300814|NCT02080832|64842942|FG001|Overall Study|Excluded from analysis by MRI|10|||
23300815|NCT02080832|64842943|FG002|Overall Study|Excluded from analysis by MRI|14|||
23300816|NCT02080832|64842941|FG000|Overall Study|Lost to Follow-up|0|||
23300817|NCT02080832|64842942|FG001|Overall Study|Lost to Follow-up|2|||
23300818|NCT02080832|64842943|FG002|Overall Study|Lost to Follow-up|2|||
23300819|NCT02211014|64842944|FG000|Overall Study|Adverse Event|0|||
23300820|NCT02211014|64842945|FG001|Overall Study|Adverse Event|2|||
23300821|NCT02211014|64842944|FG000|Overall Study|Physician Decision|1|||
23300822|NCT02211014|64842945|FG001|Overall Study|Physician Decision|2|||
23300823|NCT02211014|64842944|FG000|Overall Study|Started another cancer therapy|1|||
23300824|NCT02211014|64842945|FG001|Overall Study|Started another cancer therapy|0|||
23300825|NCT02211014|64842944|FG000|Overall Study|Withdrawal by Subject|0|||
23300826|NCT02211014|64842945|FG001|Overall Study|Withdrawal by Subject|1|||
23300827|NCT02211014|64842944|FG000|Overall Study|In agreement with patient, no benefit|0|||
23300828|NCT02211014|64842945|FG001|Overall Study|In agreement with patient, no benefit|1|||
23300829|NCT02668822|64842946|FG000|Overall Study|Protocol Violation|2|||
23300830|NCT02668822|64842947|FG001|Overall Study|Protocol Violation|0|||
23300831|NCT02668822|64842946|FG000|Overall Study|Study Terminated by Sponsor|7|||
23300832|NCT02668822|64842947|FG001|Overall Study|Study Terminated by Sponsor|9|||
23300833|NCT01382251|64842950|FG000|Overall Study|Surgeries cancelled or delayed|16|||
23300834|NCT01382251|64842951|FG001|Overall Study|Surgeries cancelled or delayed|16|||
23300835|NCT01382251|64842950|FG000|Overall Study|Lost to Follow-up|4|||
23300836|NCT01382251|64842951|FG001|Overall Study|Lost to Follow-up|4|||
23300837|NCT01382251|64842950|FG000|Overall Study|Contacted after study closed|1|||
23300838|NCT01382251|64842951|FG001|Overall Study|Contacted after study closed|1|||
23300839|NCT00958126|64842954|FG000|Overall Study|Serious Adverse Event|0|||
23300840|NCT00958126|64842955|FG001|Overall Study|Serious Adverse Event|2|||
23300841|NCT00958126|64842956|FG002|Overall Study|Serious Adverse Event|0|||
23300842|NCT00958126|64842957|FG003|Overall Study|Serious Adverse Event|0|||
23300843|NCT00958126|64842958|FG004|Overall Study|Serious Adverse Event|0|||
23300844|NCT00958126|64842959|FG005|Overall Study|Serious Adverse Event|0|||
23300845|NCT00958126|64842960|FG006|Overall Study|Serious Adverse Event|1|||
23300846|NCT00958126|64842961|FG007|Overall Study|Serious Adverse Event|0|||
23300847|NCT00958126|64842954|FG000|Overall Study|Withdrawal by Subject|0|||
23300848|NCT00958126|64842955|FG001|Overall Study|Withdrawal by Subject|2|||
23300849|NCT00958126|64842956|FG002|Overall Study|Withdrawal by Subject|0|||
23300850|NCT00958126|64842957|FG003|Overall Study|Withdrawal by Subject|0|||
23300851|NCT00958126|64842958|FG004|Overall Study|Withdrawal by Subject|0|||
23300852|NCT00958126|64842959|FG005|Overall Study|Withdrawal by Subject|0|||
23300853|NCT00958126|64842960|FG006|Overall Study|Withdrawal by Subject|0|||
23300854|NCT00958126|64842961|FG007|Overall Study|Withdrawal by Subject|0|||
23300855|NCT00958126|64842954|FG000|Overall Study|Moved away from study area|0|||
23300856|NCT00958126|64842955|FG001|Overall Study|Moved away from study area|0|||
23300857|NCT00958126|64842956|FG002|Overall Study|Moved away from study area|1|||
23300858|NCT00958126|64842957|FG003|Overall Study|Moved away from study area|1|||
23300859|NCT00958126|64842958|FG004|Overall Study|Moved away from study area|0|||
23300860|NCT00958126|64842959|FG005|Overall Study|Moved away from study area|0|||
23300861|NCT00958126|64842960|FG006|Overall Study|Moved away from study area|0|||
23300862|NCT00958126|64842961|FG007|Overall Study|Moved away from study area|0|||
23300863|NCT00958126|64842954|FG000|Overall Study|Lost to Follow-up|1|||
23300864|NCT00958126|64842955|FG001|Overall Study|Lost to Follow-up|5|||
23300865|NCT00958126|64842956|FG002|Overall Study|Lost to Follow-up|9|||
23300866|NCT00958126|64842957|FG003|Overall Study|Lost to Follow-up|8|||
23300867|NCT00958126|64842958|FG004|Overall Study|Lost to Follow-up|0|||
23300868|NCT00958126|64842959|FG005|Overall Study|Lost to Follow-up|0|||
23300869|NCT00958126|64842960|FG006|Overall Study|Lost to Follow-up|0|||
23300870|NCT00958126|64842961|FG007|Overall Study|Lost to Follow-up|0|||
23300871|NCT00958126|64842954|FG000|Overall Study|Sponsor/Investigator decision|0|||
23300872|NCT00958126|64842955|FG001|Overall Study|Sponsor/Investigator decision|0|||
23300873|NCT00958126|64842956|FG002|Overall Study|Sponsor/Investigator decision|0|||
23300874|NCT00958126|64842957|FG003|Overall Study|Sponsor/Investigator decision|1|||
23300875|NCT00958126|64842958|FG004|Overall Study|Sponsor/Investigator decision|0|||
23300876|NCT00958126|64842959|FG005|Overall Study|Sponsor/Investigator decision|0|||
23300877|NCT00958126|64842960|FG006|Overall Study|Sponsor/Investigator decision|0|||
23300878|NCT00958126|64842961|FG007|Overall Study|Sponsor/Investigator decision|0|||
23300879|NCT00958126|64842954|FG000|Overall Study|Other Reason|0|||
23300880|NCT00958126|64842955|FG001|Overall Study|Other Reason|0|||
23300881|NCT00958126|64842956|FG002|Overall Study|Other Reason|0|||
23300882|NCT00958126|64842957|FG003|Overall Study|Other Reason|1|||
23300883|NCT00958126|64842958|FG004|Overall Study|Other Reason|0|||
23300884|NCT00958126|64842959|FG005|Overall Study|Other Reason|1|||
23300885|NCT00958126|64842960|FG006|Overall Study|Other Reason|0|||
23300886|NCT00958126|64842961|FG007|Overall Study|Other Reason|0|||
23300887|NCT03276780|64842966|FG000|Overall Study|Withdrawal by Subject|5|||
23300888|NCT03276780|64842967|FG001|Overall Study|Withdrawal by Subject|3|||
23300889|NCT03276780|64842966|FG000|Overall Study|Lost to Follow-up|3|||
23300890|NCT03276780|64842967|FG001|Overall Study|Lost to Follow-up|5|||
23300891|NCT03276780|64842966|FG000|Overall Study|Moved out of state|1|||
23300892|NCT03276780|64842967|FG001|Overall Study|Moved out of state|1|||
23300893|NCT03276780|64842966|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
23300894|NCT03276780|64842967|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
23300895|NCT03276780|64842966|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
23300896|NCT03276780|64842967|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
23300897|NCT02522403|64842968|FG000|Overall Study|Lost to Follow-up|2|||
23300898|NCT02522403|64842969|FG001|Overall Study|Lost to Follow-up|2|||
23300899|NCT02522403|64842968|FG000|Overall Study|Withdrawal by Subject|2|||
23300900|NCT02522403|64842969|FG001|Overall Study|Withdrawal by Subject|4|||
23300901|NCT03510182|64842972|FG000|Overall Study|Withdrawal by Subject|2|||
23300902|NCT03656874|64842973|FG000|Overall Study|Lost to Follow-up|3|||
23300903|NCT03656874|64842974|FG001|Overall Study|Lost to Follow-up|17|||
23300904|NCT03401450|64842975|FG000|Overall Study|Lost to Follow-up|4|||
23300905|NCT03401450|64842976|FG001|Overall Study|Lost to Follow-up|6|||
23300906|NCT03401450|64842975|FG000|Overall Study|Anesthesia plan changed|2|||
23300907|NCT03401450|64842976|FG001|Overall Study|Anesthesia plan changed|2|||
23300908|NCT03401450|64842975|FG000|Overall Study|Did not complete medication diary|4|||
23300909|NCT03401450|64842976|FG001|Overall Study|Did not complete medication diary|2|||
23300910|NCT03401450|64842975|FG000|Overall Study|post surgery medication change|2|||
23300911|NCT03401450|64842976|FG001|Overall Study|post surgery medication change|1|||
23300912|NCT03401450|64842975|FG000|Overall Study|Cancelled surgery|0|||
23300913|NCT03401450|64842976|FG001|Overall Study|Cancelled surgery|2|||
23300914|NCT02459665|64842977|FG000|Overall Study|Withdrawal by Subject|0|||
23300915|NCT02459665|64842978|FG001|Overall Study|Withdrawal by Subject|1|||
23300916|NCT02459665|64842979|FG002|Overall Study|Withdrawal by Subject|1|||
23300917|NCT02459665|64842980|FG003|Overall Study|Withdrawal by Subject|2|||
23300918|NCT01534637|64842982|FG000|Overall Study|Physician Decision|3|||
23300919|NCT01534637|64842982|FG000|Overall Study|Lack of Efficacy|3|||
23300920|NCT01534637|64842982|FG000|Overall Study|Withdrawal by Subject|1|||
23300921|NCT01534637|64842982|FG000|Overall Study|Adverse Event|1|||
23300922|NCT01534637|64842982|FG000|Overall Study|Liver Mets before treatment|1|||
23300923|NCT01506908|64842983|FG000|Overall Study|Adverse Event|1|||
23300924|NCT01506908|64842984|FG001|Overall Study|Adverse Event|0|||
23300925|NCT00906373|64842987|FG000|Overall Study|Withdrawal by Subject|0|||
23300926|NCT00906373|64842988|FG001|Overall Study|Withdrawal by Subject|5|||
23300927|NCT00906373|64842987|FG000|Overall Study|Other|0|||
23300928|NCT00906373|64842988|FG001|Overall Study|Other|1|||
23300929|NCT00906373|64842987|FG000|Overall Study|Still on treatment at cutoff date|0|||
23300930|NCT00906373|64842988|FG001|Overall Study|Still on treatment at cutoff date|2|||
23300931|NCT00049842|64842989|FG000|Treatment Phase|Adverse Event|47|||
23300932|NCT00049842|64842990|FG001|Treatment Phase|Adverse Event|12|||
23300933|NCT00049842|64842989|FG000|Treatment Phase|Withdrawal by Subject|35|||
23300934|NCT00049842|64842990|FG001|Treatment Phase|Withdrawal by Subject|46|||
23300935|NCT00049842|64842989|FG000|Treatment Phase|Non-compliance with protocol|7|||
23300936|NCT00049842|64842990|FG001|Treatment Phase|Non-compliance with protocol|8|||
23300937|NCT00049842|64842989|FG000|Treatment Phase|Lost to Follow-up|4|||
23300938|NCT00049842|64842990|FG001|Treatment Phase|Lost to Follow-up|8|||
23300939|NCT00049842|64842989|FG000|Treatment Phase|Administrative|0|||
23300940|NCT00049842|64842990|FG001|Treatment Phase|Administrative|3|||
23300941|NCT00049842|64842989|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
23300942|NCT00049842|64842990|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
23300943|NCT00049842|64842989|FG000|Follow-up Phase|Adverse Event|6|||
23300944|NCT00049842|64842990|FG001|Follow-up Phase|Adverse Event|1|||
23300945|NCT00049842|64842989|FG000|Follow-up Phase|Other|1|||
23300946|NCT00049842|64842990|FG001|Follow-up Phase|Other|4|||
23300947|NCT00911807|64842991|FG000|Overall Study|Adverse Event|2|||
23300948|NCT00911807|64842992|FG001|Overall Study|Adverse Event|1|||
23300949|NCT00911807|64842993|FG002|Overall Study|Adverse Event|5|||
23300950|NCT00911807|64842991|FG000|Overall Study|Death|0|||
23300951|NCT00911807|64842992|FG001|Overall Study|Death|0|||
23300952|NCT00911807|64842993|FG002|Overall Study|Death|1|||
23300953|NCT00911807|64842991|FG000|Overall Study|Protocol Violation|6|||
23300954|NCT00911807|64842992|FG001|Overall Study|Protocol Violation|4|||
23300955|NCT00911807|64842993|FG002|Overall Study|Protocol Violation|9|||
23300956|NCT00911807|64842991|FG000|Overall Study|Withdrawal by Subject|8|||
23300957|NCT00911807|64842992|FG001|Overall Study|Withdrawal by Subject|10|||
23300958|NCT00911807|64842993|FG002|Overall Study|Withdrawal by Subject|7|||
23300959|NCT00911807|64842991|FG000|Overall Study|Organizational reasons|1|||
23300960|NCT00911807|64842992|FG001|Overall Study|Organizational reasons|3|||
23300961|NCT00911807|64842993|FG002|Overall Study|Organizational reasons|1|||
23300962|NCT00620659|64842994|FG000|Treatment Period 1|Adverse Event|1|||
23300963|NCT00620659|64842995|FG001|Treatment Period 1|Adverse Event|0|||
23300964|NCT00620659|64842996|FG002|Treatment Period 1|Adverse Event|0|||
23300965|NCT00620659|64842997|FG003|Treatment Period 1|Adverse Event|3|||
23300966|NCT00620659|64842998|FG004|Treatment Period 1|Adverse Event|0|||
23300967|NCT00620659|64842999|FG005|Treatment Period 1|Adverse Event|0|||
23300968|NCT00620659|64842994|FG000|Treatment Period 1|Protocol Violation|1|||
23300969|NCT00620659|64842995|FG001|Treatment Period 1|Protocol Violation|0|||
23300970|NCT00620659|64842996|FG002|Treatment Period 1|Protocol Violation|0|||
23300971|NCT00620659|64842997|FG003|Treatment Period 1|Protocol Violation|0|||
23300972|NCT00620659|64842998|FG004|Treatment Period 1|Protocol Violation|0|||
23300973|NCT00620659|64842999|FG005|Treatment Period 1|Protocol Violation|0|||
23300974|NCT00620659|64842994|FG000|Treatment Period 1|Withdrawal by Subject|1|||
23300975|NCT00620659|64842995|FG001|Treatment Period 1|Withdrawal by Subject|0|||
23300976|NCT00620659|64842996|FG002|Treatment Period 1|Withdrawal by Subject|1|||
23300977|NCT00620659|64842997|FG003|Treatment Period 1|Withdrawal by Subject|0|||
23300978|NCT00620659|64842998|FG004|Treatment Period 1|Withdrawal by Subject|1|||
23300979|NCT00620659|64842999|FG005|Treatment Period 1|Withdrawal by Subject|0|||
23300980|NCT00620659|64842994|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
23300981|NCT00620659|64842995|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
23300982|NCT00620659|64842996|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
23300983|NCT00620659|64842997|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
23300984|NCT00620659|64842998|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
23300985|NCT00620659|64842999|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
23300986|NCT00620659|64842994|FG000|Treatment Period 2|Adverse Event|0|||
23300987|NCT00620659|64842995|FG001|Treatment Period 2|Adverse Event|3|||
23300988|NCT00620659|64842996|FG002|Treatment Period 2|Adverse Event|0|||
23300989|NCT00620659|64842997|FG003|Treatment Period 2|Adverse Event|0|||
23300990|NCT00620659|64842998|FG004|Treatment Period 2|Adverse Event|2|||
23300991|NCT00620659|64842999|FG005|Treatment Period 2|Adverse Event|0|||
23300992|NCT00620659|64842994|FG000|Treatment Period 2|Withdrawal by Subject|0|||
23300993|NCT00620659|64842995|FG001|Treatment Period 2|Withdrawal by Subject|0|||
23300994|NCT00620659|64842996|FG002|Treatment Period 2|Withdrawal by Subject|1|||
23300995|NCT00620659|64842997|FG003|Treatment Period 2|Withdrawal by Subject|0|||
23300996|NCT00620659|64842998|FG004|Treatment Period 2|Withdrawal by Subject|3|||
23300997|NCT00620659|64842999|FG005|Treatment Period 2|Withdrawal by Subject|0|||
23300998|NCT00620659|64842994|FG000|Placebo Washout Period 2|Adverse Event|2|||
23300999|NCT00620659|64842995|FG001|Placebo Washout Period 2|Adverse Event|0|||
23301000|NCT00620659|64842996|FG002|Placebo Washout Period 2|Adverse Event|0|||
23301001|NCT00620659|64842997|FG003|Placebo Washout Period 2|Adverse Event|0|||
23301002|NCT00620659|64842998|FG004|Placebo Washout Period 2|Adverse Event|0|||
23301003|NCT00620659|64842999|FG005|Placebo Washout Period 2|Adverse Event|0|||
23301004|NCT00620659|64842994|FG000|Treatment Period 3|Adverse Event|0|||
23301005|NCT00620659|64842995|FG001|Treatment Period 3|Adverse Event|2|||
23301006|NCT00620659|64842996|FG002|Treatment Period 3|Adverse Event|0|||
23301007|NCT00620659|64842997|FG003|Treatment Period 3|Adverse Event|0|||
23301008|NCT00620659|64842998|FG004|Treatment Period 3|Adverse Event|0|||
23301009|NCT00620659|64842999|FG005|Treatment Period 3|Adverse Event|0|||
23301010|NCT00620659|64842994|FG000|Treatment Period 3|Withdrawal by Subject|0|||
23301011|NCT00620659|64842995|FG001|Treatment Period 3|Withdrawal by Subject|0|||
23301012|NCT00620659|64842996|FG002|Treatment Period 3|Withdrawal by Subject|0|||
23301013|NCT00620659|64842997|FG003|Treatment Period 3|Withdrawal by Subject|1|||
23301014|NCT00620659|64842998|FG004|Treatment Period 3|Withdrawal by Subject|0|||
23301015|NCT00620659|64842999|FG005|Treatment Period 3|Withdrawal by Subject|0|||
23301016|NCT05020249|64843003|FG000|Overall Study|Protocol Violation|1|||
23301017|NCT05020249|64843004|FG001|Overall Study|Protocol Violation|0|||
23301018|NCT00109837|64843010|FG000|Overall Study|Adverse Event|2|||
23301019|NCT00109837|64843010|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
23301020|NCT00109837|64843010|FG000|Overall Study|Death|1|||
23301021|NCT00109837|64843010|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
23301022|NCT00109837|64843010|FG000|Overall Study|Not treated|1|||
23301023|NCT00109837|64843010|FG000|Overall Study|Ineligible|1|||
23301024|NCT00507546|64843011|FG000|Overall Study|Withdrawal by Subject|1|||
23301025|NCT00507546|64843012|FG001|Overall Study|Withdrawal by Subject|0|||
23301026|NCT00507546|64843011|FG000|Overall Study|Protocol Violation|1|||
23301027|NCT00507546|64843012|FG001|Overall Study|Protocol Violation|0|||
23301028|NCT00507546|64843011|FG000|Overall Study|Physician Decision|0|||
23301029|NCT00507546|64843012|FG001|Overall Study|Physician Decision|1|||
23301030|NCT01045993|64843013|FG000|Overall Study|Treated-later found eligibility not met|0|||
23301031|NCT01045993|64843014|FG001|Overall Study|Treated-later found eligibility not met|1|||
23301032|NCT01045993|64843015|FG002|Overall Study|Treated-later found eligibility not met|0|||
23301033|NCT01045993|64843016|FG003|Overall Study|Treated-later found eligibility not met|0|||
23301034|NCT00693225|64843017|FG000|Overall Study|Lost to Follow-up|1|||
23301035|NCT00693225|64843018|FG001|Overall Study|Lost to Follow-up|2|||
23301036|NCT00693225|64843017|FG000|Overall Study|Adverse Event|1|||
23301037|NCT00693225|64843018|FG001|Overall Study|Adverse Event|3|||
23301038|NCT02792959|64843027|FG000|Overall Study|Protocol Violation|1|||
23301039|NCT01901874|64843028|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
23301040|NCT01901874|64843028|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
23301041|NCT01901874|64843028|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
23301042|NCT01901874|64843028|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
23301043|NCT01901874|64843028|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
23301044|NCT01901874|64843028|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
23301045|NCT03438396|64843029|FG000|Overall Study|Reason Not Specified|9|||
23301046|NCT03438396|64843029|FG000|Overall Study|Withdrawal by Subject|5|||
23301047|NCT03438396|64843029|FG000|Overall Study|Lost to Follow-up|2|||
23301048|NCT03438396|64843029|FG000|Overall Study|Death|85|||
23301049|NCT03438396|64843029|FG000|Overall Study|Not treated|1|||
23301050|NCT03812991|64843030|FG000|Overall Study|Lost to Follow-up|3|||
23301051|NCT03812991|64843031|FG001|Overall Study|Lost to Follow-up|1|||
23301052|NCT00891371|64843032|FG000|Pre-assignment|Inclusion/exclusion|5|||
23301053|NCT00891371|64843032|FG000|Pre-assignment|Consent withdrawal|1|||
23301054|NCT00891371|64843032|FG000|Treatment|Lack of Efficacy|5|||
23301055|NCT00891371|64843032|FG000|Treatment|Adverse Event|2|||
23301056|NCT00891371|64843032|FG000|Treatment|Death|1|||
23301057|NCT00891371|64843032|FG000|Treatment|Lost to Follow-up|1|||
23301058|NCT03604341|64843035|FG000|Overall Study|Withdrawal by Subject|1|||
23301059|NCT03604341|64843036|FG001|Overall Study|Withdrawal by Subject|1|||
23301060|NCT03604341|64843035|FG000|Overall Study|Adverse Event|1|||
23301061|NCT03604341|64843036|FG001|Overall Study|Adverse Event|0|||
23301062|NCT03604341|64843035|FG000|Overall Study|Protocol Violation|0|||
23301063|NCT03604341|64843036|FG001|Overall Study|Protocol Violation|1|||
23301064|NCT02698865|64843039|FG000|Overall Study|Other|11|||
23301065|NCT02698865|64843040|FG001|Overall Study|Other|11|||
23301066|NCT02698865|64843039|FG000|Overall Study|Withdrawal by Subject|20|||
23301067|NCT02698865|64843040|FG001|Overall Study|Withdrawal by Subject|16|||
23301068|NCT02698865|64843039|FG000|Overall Study|Physician Decision|0|||
23301069|NCT02698865|64843040|FG001|Overall Study|Physician Decision|4|||
23301070|NCT02698865|64843039|FG000|Overall Study|Lost to Follow-up|4|||
23301071|NCT02698865|64843040|FG001|Overall Study|Lost to Follow-up|2|||
23301072|NCT01206816|64846789|FG000|Overall Study|Protocol Violation|0|||
23301073|NCT01206816|64846790|FG001|Overall Study|Protocol Violation|0|||
23301074|NCT01206816|64846791|FG002|Overall Study|Protocol Violation|1|||
23301075|NCT01206816|64846792|FG003|Overall Study|Protocol Violation|0|||
23301076|NCT01206816|64846793|FG004|Overall Study|Protocol Violation|0|||
23301077|NCT01206816|64846794|FG005|Overall Study|Protocol Violation|0|||
23301078|NCT01206816|64846795|FG006|Overall Study|Protocol Violation|0|||
23301079|NCT01206816|64846789|FG000|Overall Study|Withdrawal by Subject|0|||
23301080|NCT01206816|64846790|FG001|Overall Study|Withdrawal by Subject|0|||
23301081|NCT01206816|64846791|FG002|Overall Study|Withdrawal by Subject|1|||
23301082|NCT01206816|64846792|FG003|Overall Study|Withdrawal by Subject|0|||
23301083|NCT01206816|64846793|FG004|Overall Study|Withdrawal by Subject|0|||
23301084|NCT01206816|64846794|FG005|Overall Study|Withdrawal by Subject|0|||
23301085|NCT01206816|64846795|FG006|Overall Study|Withdrawal by Subject|0|||
23301086|NCT01206816|64846789|FG000|Overall Study|Progressive disease|3|||
23301087|NCT01206816|64846790|FG001|Overall Study|Progressive disease|3|||
23301088|NCT01206816|64846791|FG002|Overall Study|Progressive disease|13|||
23301089|NCT01206816|64846792|FG003|Overall Study|Progressive disease|3|||
23301090|NCT01206816|64846793|FG004|Overall Study|Progressive disease|3|||
23301091|NCT01206816|64846794|FG005|Overall Study|Progressive disease|16|||
23301092|NCT01206816|64846795|FG006|Overall Study|Progressive disease|3|||
23301093|NCT01206816|64846789|FG000|Overall Study|Other AE|0|||
23301094|NCT01206816|64846790|FG001|Overall Study|Other AE|0|||
23301095|NCT01206816|64846791|FG002|Overall Study|Other AE|4|||
23301096|NCT01206816|64846792|FG003|Overall Study|Other AE|0|||
23301097|NCT01206816|64846793|FG004|Overall Study|Other AE|0|||
23401404|NCT03783780|65216781|FG000|Overall Study|Withdrawn prior to completion|1|||
23401405|NCT00714948|65216786|FG000|Overall Study|Adverse Event|2|||
23401406|NCT03108521|65216787|FG000|Overall Study|Lost to Follow-up|3|||
23401407|NCT03108521|65216788|FG001|Overall Study|Lost to Follow-up|0|||
23401408|NCT03108521|65216787|FG000|Overall Study|Lack of Efficacy|2|||
23401409|NCT03108521|65216788|FG001|Overall Study|Lack of Efficacy|0|||
23401410|NCT03108521|65216787|FG000|Overall Study|Physician Decision|4|||
23401411|NCT03108521|65216788|FG001|Overall Study|Physician Decision|0|||
23401412|NCT03108521|65216787|FG000|Overall Study|Adverse Event|3|||
23401413|NCT03108521|65216788|FG001|Overall Study|Adverse Event|0|||
23401414|NCT04592341|65216789|FG000|Overall Study|Physician Decision|5|||
23401415|NCT04592341|65216789|FG000|Overall Study|Study Terminated by Sponsor|5|||
23401416|NCT04592341|65216789|FG000|Overall Study|Withdrawal by Subject|53|||
23401417|NCT04592341|65216789|FG000|Overall Study|Lost to Follow-up|3|||
23401418|NCT04592341|65216789|FG000|Overall Study|Death|1|||
23401419|NCT04592341|65216789|FG000|Overall Study|Adverse Event|5|||
23401420|NCT04592341|65216789|FG000|Overall Study|other|4|||
23301098|NCT01206816|64846794|FG005|Overall Study|Other AE|3|||
23301099|NCT01206816|64846795|FG006|Overall Study|Other AE|2|||
23301100|NCT01206816|64846789|FG000|Overall Study|other than stated above|0|||
23301101|NCT01206816|64846790|FG001|Overall Study|other than stated above|0|||
23301102|NCT01206816|64846791|FG002|Overall Study|other than stated above|1|||
23301103|NCT01206816|64846792|FG003|Overall Study|other than stated above|0|||
23301104|NCT01206816|64846793|FG004|Overall Study|other than stated above|0|||
23301105|NCT01206816|64846794|FG005|Overall Study|other than stated above|0|||
23301106|NCT01206816|64846795|FG006|Overall Study|other than stated above|1|||
23301107|NCT03095118|64846796|FG000|Overall Study|Adverse Event|1|||
23301108|NCT03095118|64846796|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
23301109|NCT01859130|64846799|FG000|Overall Study|Death|4|||
23301110|NCT01859130|64846799|FG000|Overall Study|Lost to Follow-up|16|||
23301111|NCT01859130|64846799|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
23301112|NCT01859130|64846799|FG000|Overall Study|Physician Decision|6|||
23301113|NCT01859130|64846799|FG000|Overall Study|Withdrawal by Subject|17|||
23301114|NCT01859130|64846799|FG000|Overall Study|Adverse Event|11|||
23301115|NCT00546572|64846800|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
23301116|NCT00546572|64846801|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
23301117|NCT00546572|64846800|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
23301118|NCT00546572|64846801|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
23301119|NCT00546572|64846800|FG000|Vax 1 / Year 0|Protocol Violation|3|||
23301120|NCT00546572|64846801|FG001|Vax 1 / Year 0|Protocol Violation|4|||
23301121|NCT00546572|64846800|FG000|Vax 1 / Year 0|Death|2|||
23301122|NCT00546572|64846801|FG001|Vax 1 / Year 0|Death|2|||
23301123|NCT00546572|64846800|FG000|Vax 1 / Year 0|Adverse Event|0|||
23301124|NCT00546572|64846801|FG001|Vax 1 / Year 0|Adverse Event|1|||
23301125|NCT00546572|64846800|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
23301126|NCT00546572|64846801|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
23301127|NCT00546572|64846800|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
23301128|NCT00546572|64846801|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
23301129|NCT00546572|64846800|FG000|Vax 2 / Year 1|Other|1|||
23301130|NCT00546572|64846801|FG001|Vax 2 / Year 1|Other|1|||
23301131|NCT00546572|64846800|FG000|Vax 2 / Year 1|Adverse Event|1|||
23301132|NCT00546572|64846801|FG001|Vax 2 / Year 1|Adverse Event|0|||
23301133|NCT00546572|64846800|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
23301134|NCT00546572|64846801|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
23301135|NCT04146363|64846805|FG000|Induction Period|Adverse Event|1|||
23301136|NCT04146363|64846806|FG001|Induction Period|Adverse Event|2|||
23301137|NCT04146363|64846807|FG002|Induction Period|Adverse Event|0|||
23301138|NCT04146363|64846808|FG003|Induction Period|Adverse Event|0|||
23301139|NCT04146363|64846809|FG004|Induction Period|Adverse Event|0|||
23301140|NCT04146363|64846810|FG005|Induction Period|Adverse Event|0|||
23301141|NCT04146363|64846811|FG006|Induction Period|Adverse Event|0|||
23301142|NCT04146363|64846812|FG007|Induction Period|Adverse Event|0|||
23301143|NCT04146363|64846813|FG008|Induction Period|Adverse Event|0|||
23301144|NCT04146363|64846814|FG009|Induction Period|Adverse Event|0|||
23301145|NCT04146363|64846815|FG010|Induction Period|Adverse Event|0|||
23301146|NCT04146363|64846805|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
23301147|NCT04146363|64846806|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
23301148|NCT04146363|64846807|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
23301149|NCT04146363|64846808|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
23301150|NCT04146363|64846809|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
23301151|NCT04146363|64846810|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
23301152|NCT04146363|64846811|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
23301153|NCT04146363|64846812|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
23301154|NCT04146363|64846813|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
23301155|NCT04146363|64846814|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
23301156|NCT04146363|64846815|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
23401421|NCT01444781|65216790|FG000|Overall Study|Lost to Follow-up|0|||
23401422|NCT01444781|65216791|FG001|Overall Study|Lost to Follow-up|3|||
23401423|NCT01444781|65216792|FG002|Overall Study|Lost to Follow-up|1|||
23401424|NCT01444781|65216790|FG000|Overall Study|Withdrawal by Subject|3|||
23401425|NCT01444781|65216791|FG001|Overall Study|Withdrawal by Subject|1|||
23401426|NCT01444781|65216792|FG002|Overall Study|Withdrawal by Subject|2|||
23401427|NCT02750930|65216796|FG000|Overall Study|Study closed/terminated|8|||
23401428|NCT02131766|65216799|FG000|Overall Study|Withdrawal by Subject|4|||
23401429|NCT00527618|65216802|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
23401430|NCT00527618|65216803|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
23401431|NCT00527618|65216802|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
23401432|NCT00527618|65216803|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
23401433|NCT00527618|65216802|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
23401434|NCT00527618|65216803|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
23401435|NCT00527618|65216802|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
23401436|NCT00527618|65216803|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
23401437|NCT00527618|65216802|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
23401438|NCT00527618|65216803|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
23401439|NCT00527618|65216802|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
23401440|NCT00527618|65216803|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
23401441|NCT01250054|65216805|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
23401442|NCT01250054|65216806|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
23401443|NCT01342926|65216807|FG000|Overall Study|Adverse Event|5|||
23401444|NCT01342926|65216808|FG001|Overall Study|Adverse Event|8|||
23401445|NCT01342926|65216809|FG002|Overall Study|Adverse Event|10|||
23401446|NCT01342926|65216810|FG003|Overall Study|Adverse Event|7|||
23401447|NCT01342926|65216807|FG000|Overall Study|Lost to Follow-up|0|||
23401448|NCT01342926|65216808|FG001|Overall Study|Lost to Follow-up|1|||
23401449|NCT01342926|65216809|FG002|Overall Study|Lost to Follow-up|1|||
23401450|NCT01342926|65216810|FG003|Overall Study|Lost to Follow-up|0|||
23401451|NCT01342926|65216807|FG000|Overall Study|Investigator Discretion|2|||
23401452|NCT01342926|65216808|FG001|Overall Study|Investigator Discretion|2|||
23401453|NCT01342926|65216809|FG002|Overall Study|Investigator Discretion|0|||
23401454|NCT01342926|65216810|FG003|Overall Study|Investigator Discretion|0|||
23401455|NCT01342926|65216807|FG000|Overall Study|Withdrawal by Subject|2|||
23401456|NCT01342926|65216808|FG001|Overall Study|Withdrawal by Subject|4|||
23401457|NCT01342926|65216809|FG002|Overall Study|Withdrawal by Subject|3|||
23401458|NCT01342926|65216810|FG003|Overall Study|Withdrawal by Subject|5|||
23401459|NCT02122380|65216815|FG000|First Intervention (30 Days)|Adverse Event|1|||
23401460|NCT02122380|65216816|FG001|First Intervention (30 Days)|Adverse Event|0|||
23401461|NCT02122380|65216815|FG000|First Intervention (30 Days)|Physician Decision|0|||
23401462|NCT02122380|65216816|FG001|First Intervention (30 Days)|Physician Decision|1|||
23401463|NCT02122380|65216815|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
23401464|NCT02122380|65216816|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
23401465|NCT02122380|65216815|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
23401466|NCT02122380|65216816|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
23401467|NCT02122380|65216815|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
23401468|NCT02122380|65216816|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
23401469|NCT00812955|65216819|FG000|Overall Study|Adverse Event|7|||
23401470|NCT00812955|65216820|FG001|Overall Study|Adverse Event|6|||
23401471|NCT00812955|65216821|FG002|Overall Study|Adverse Event|3|||
23401472|NCT00812955|65216822|FG003|Overall Study|Adverse Event|4|||
23401473|NCT00812955|65216819|FG000|Overall Study|Lost to Follow-up|2|||
23401474|NCT00812955|65216820|FG001|Overall Study|Lost to Follow-up|1|||
23401475|NCT00812955|65216821|FG002|Overall Study|Lost to Follow-up|1|||
23401476|NCT00812955|65216822|FG003|Overall Study|Lost to Follow-up|2|||
23401477|NCT00812955|65216819|FG000|Overall Study|Withdrawal by Subject|1|||
23401478|NCT00812955|65216820|FG001|Overall Study|Withdrawal by Subject|0|||
23401479|NCT00812955|65216821|FG002|Overall Study|Withdrawal by Subject|1|||
23401480|NCT00812955|65216822|FG003|Overall Study|Withdrawal by Subject|2|||
23401481|NCT00812955|65216819|FG000|Overall Study|randomized in error|0|||
23401482|NCT00812955|65216820|FG001|Overall Study|randomized in error|0|||
23401483|NCT00812955|65216821|FG002|Overall Study|randomized in error|1|||
23401484|NCT00812955|65216822|FG003|Overall Study|randomized in error|0|||
23401485|NCT01493414|65216823|FG000|Overall Study|Adverse Event|405|||
23401486|NCT01493414|65216823|FG000|Overall Study|Disease progression|204|||
23401487|NCT01493414|65216823|FG000|Overall Study|Death|101|||
23401488|NCT01493414|65216823|FG000|Overall Study|Physician Decision|93|||
23401489|NCT01493414|65216823|FG000|Overall Study|Withdrawal by Subject|79|||
23401490|NCT01493414|65216823|FG000|Overall Study|Protocol deviation|27|||
23401491|NCT01493414|65216823|FG000|Overall Study|Administrative problems|25|||
23401492|NCT01493414|65216823|FG000|Overall Study|Lost to Follow-up|16|||
23401493|NCT01343888|65216826|FG000|Overall Study|Adverse Event|12|||
23401494|NCT01343888|65216827|FG001|Overall Study|Adverse Event|22|||
23401495|NCT01343888|65216828|FG002|Overall Study|Adverse Event|5|||
23401496|NCT01343888|65216826|FG000|Overall Study|Lack of Efficacy|9|||
23401497|NCT01343888|65216827|FG001|Overall Study|Lack of Efficacy|9|||
23401498|NCT01343888|65216828|FG002|Overall Study|Lack of Efficacy|13|||
23401499|NCT01343888|65216826|FG000|Overall Study|Lost to Follow-up|0|||
23401500|NCT01343888|65216827|FG001|Overall Study|Lost to Follow-up|2|||
23401501|NCT01343888|65216828|FG002|Overall Study|Lost to Follow-up|1|||
23401502|NCT01343888|65216826|FG000|Overall Study|Protocol Violation|0|||
23401503|NCT01343888|65216827|FG001|Overall Study|Protocol Violation|2|||
23401504|NCT01343888|65216828|FG002|Overall Study|Protocol Violation|0|||
23401505|NCT01343888|65216826|FG000|Overall Study|Withdrawal by Subject|4|||
23401506|NCT01343888|65216827|FG001|Overall Study|Withdrawal by Subject|4|||
23301157|NCT04146363|64846805|FG000|Induction Period|Lack of Efficacy|7|||
23301158|NCT04146363|64846806|FG001|Induction Period|Lack of Efficacy|2|||
23401507|NCT01343888|65216828|FG002|Overall Study|Withdrawal by Subject|2|||
23301159|NCT04146363|64846807|FG002|Induction Period|Lack of Efficacy|0|||
23301160|NCT04146363|64846808|FG003|Induction Period|Lack of Efficacy|0|||
23301161|NCT04146363|64846809|FG004|Induction Period|Lack of Efficacy|0|||
23301162|NCT04146363|64846810|FG005|Induction Period|Lack of Efficacy|0|||
23301163|NCT04146363|64846811|FG006|Induction Period|Lack of Efficacy|0|||
23301164|NCT04146363|64846812|FG007|Induction Period|Lack of Efficacy|0|||
23301165|NCT04146363|64846813|FG008|Induction Period|Lack of Efficacy|0|||
23301166|NCT04146363|64846814|FG009|Induction Period|Lack of Efficacy|0|||
23301167|NCT04146363|64846815|FG010|Induction Period|Lack of Efficacy|0|||
23301168|NCT04146363|64846805|FG000|Induction Period|Lost to Follow-up|1|||
23301169|NCT04146363|64846806|FG001|Induction Period|Lost to Follow-up|4|||
23301170|NCT04146363|64846807|FG002|Induction Period|Lost to Follow-up|0|||
23301171|NCT04146363|64846808|FG003|Induction Period|Lost to Follow-up|0|||
23301172|NCT04146363|64846809|FG004|Induction Period|Lost to Follow-up|0|||
23301173|NCT04146363|64846810|FG005|Induction Period|Lost to Follow-up|0|||
23301174|NCT04146363|64846811|FG006|Induction Period|Lost to Follow-up|0|||
23301175|NCT04146363|64846812|FG007|Induction Period|Lost to Follow-up|0|||
23301176|NCT04146363|64846813|FG008|Induction Period|Lost to Follow-up|0|||
23301177|NCT04146363|64846814|FG009|Induction Period|Lost to Follow-up|0|||
23301178|NCT04146363|64846815|FG010|Induction Period|Lost to Follow-up|0|||
23301179|NCT04146363|64846805|FG000|Induction Period|Positive quantiferon test|0|||
23301180|NCT04146363|64846806|FG001|Induction Period|Positive quantiferon test|1|||
23301181|NCT04146363|64846807|FG002|Induction Period|Positive quantiferon test|0|||
23301182|NCT04146363|64846808|FG003|Induction Period|Positive quantiferon test|0|||
23301183|NCT04146363|64846809|FG004|Induction Period|Positive quantiferon test|0|||
23301184|NCT04146363|64846810|FG005|Induction Period|Positive quantiferon test|0|||
23301185|NCT04146363|64846811|FG006|Induction Period|Positive quantiferon test|0|||
23301186|NCT04146363|64846812|FG007|Induction Period|Positive quantiferon test|0|||
23301187|NCT04146363|64846813|FG008|Induction Period|Positive quantiferon test|0|||
23301188|NCT04146363|64846814|FG009|Induction Period|Positive quantiferon test|0|||
23301189|NCT04146363|64846815|FG010|Induction Period|Positive quantiferon test|0|||
23301190|NCT04146363|64846805|FG000|Induction Period|Protocol Deviation|5|||
23301191|NCT04146363|64846806|FG001|Induction Period|Protocol Deviation|6|||
23301192|NCT04146363|64846807|FG002|Induction Period|Protocol Deviation|0|||
23301193|NCT04146363|64846808|FG003|Induction Period|Protocol Deviation|0|||
23301194|NCT04146363|64846809|FG004|Induction Period|Protocol Deviation|0|||
23301195|NCT04146363|64846810|FG005|Induction Period|Protocol Deviation|0|||
23301196|NCT04146363|64846811|FG006|Induction Period|Protocol Deviation|0|||
23301197|NCT04146363|64846812|FG007|Induction Period|Protocol Deviation|0|||
23301198|NCT04146363|64846813|FG008|Induction Period|Protocol Deviation|0|||
23301199|NCT04146363|64846814|FG009|Induction Period|Protocol Deviation|0|||
23301200|NCT04146363|64846815|FG010|Induction Period|Protocol Deviation|0|||
23301201|NCT04146363|64846805|FG000|Induction Period|Withdrawal by Subject|6|||
23301202|NCT04146363|64846806|FG001|Induction Period|Withdrawal by Subject|3|||
23301203|NCT04146363|64846807|FG002|Induction Period|Withdrawal by Subject|0|||
23301204|NCT04146363|64846808|FG003|Induction Period|Withdrawal by Subject|0|||
23301205|NCT04146363|64846809|FG004|Induction Period|Withdrawal by Subject|0|||
23301206|NCT04146363|64846810|FG005|Induction Period|Withdrawal by Subject|0|||
23301207|NCT04146363|64846811|FG006|Induction Period|Withdrawal by Subject|0|||
23301208|NCT04146363|64846812|FG007|Induction Period|Withdrawal by Subject|0|||
23301209|NCT04146363|64846813|FG008|Induction Period|Withdrawal by Subject|0|||
23301210|NCT04146363|64846814|FG009|Induction Period|Withdrawal by Subject|0|||
23301211|NCT04146363|64846815|FG010|Induction Period|Withdrawal by Subject|0|||
23301212|NCT04146363|64846805|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
23301213|NCT04146363|64846806|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
23301214|NCT04146363|64846807|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
23301215|NCT04146363|64846808|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
23301216|NCT04146363|64846809|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
23301217|NCT04146363|64846810|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
23301218|NCT04146363|64846811|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
23301219|NCT04146363|64846812|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
23301220|NCT04146363|64846813|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
23301221|NCT04146363|64846814|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
23301222|NCT04146363|64846815|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
23301223|NCT04146363|64846805|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301224|NCT04146363|64846806|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301225|NCT04146363|64846807|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301226|NCT04146363|64846808|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301227|NCT04146363|64846809|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301228|NCT04146363|64846810|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301229|NCT04146363|64846811|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301230|NCT04146363|64846812|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
23301231|NCT04146363|64846813|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301232|NCT04146363|64846814|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301233|NCT04146363|64846815|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
23301234|NCT04146363|64846805|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23301235|NCT04146363|64846806|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23301236|NCT04146363|64846807|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23301237|NCT04146363|64846808|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23301238|NCT04146363|64846809|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23301239|NCT04146363|64846810|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23301240|NCT04146363|64846811|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
23301241|NCT04146363|64846812|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
23301242|NCT04146363|64846813|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23301243|NCT04146363|64846814|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23301244|NCT04146363|64846815|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
23301245|NCT04146363|64846805|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
23301246|NCT04146363|64846806|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
23301247|NCT04146363|64846807|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
23301248|NCT04146363|64846808|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
23301249|NCT04146363|64846809|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
23301250|NCT04146363|64846810|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
23301251|NCT04146363|64846811|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
23301252|NCT04146363|64846812|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
23301253|NCT04146363|64846813|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
23301254|NCT04146363|64846814|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
23301255|NCT04146363|64846815|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
23301256|NCT04146363|64846805|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23301257|NCT04146363|64846806|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23301258|NCT04146363|64846807|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23301259|NCT04146363|64846808|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23301260|NCT04146363|64846809|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
23301261|NCT04146363|64846810|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
23301262|NCT04146363|64846811|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
23301263|NCT04146363|64846812|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
23301264|NCT04146363|64846813|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23301265|NCT04146363|64846814|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23301266|NCT04146363|64846815|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
23301267|NCT04146363|64846805|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23301268|NCT04146363|64846806|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23301269|NCT04146363|64846807|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
23301270|NCT04146363|64846808|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23301271|NCT04146363|64846809|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23301272|NCT04146363|64846810|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
23301273|NCT04146363|64846811|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
23301274|NCT04146363|64846812|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
23301275|NCT04146363|64846813|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23301276|NCT04146363|64846814|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23301277|NCT04146363|64846815|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
23301278|NCT04146363|64846805|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
23301279|NCT04146363|64846806|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
23301280|NCT04146363|64846807|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
23301281|NCT04146363|64846808|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
23301282|NCT04146363|64846809|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
23301283|NCT04146363|64846810|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
23301284|NCT04146363|64846811|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
23301285|NCT04146363|64846812|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
23301286|NCT04146363|64846813|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
23301287|NCT04146363|64846814|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
23301288|NCT04146363|64846815|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
23301289|NCT04146363|64846805|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23301290|NCT04146363|64846806|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23301291|NCT04146363|64846807|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23301292|NCT04146363|64846808|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23301293|NCT04146363|64846809|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23301294|NCT04146363|64846810|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23301295|NCT04146363|64846811|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23301296|NCT04146363|64846812|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
23301297|NCT04146363|64846813|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
23301298|NCT04146363|64846814|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
23301299|NCT04146363|64846815|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
23301300|NCT04146363|64846805|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23401508|NCT01343888|65216826|FG000|Overall Study|other than stated above|0|||
23401509|NCT01343888|65216827|FG001|Overall Study|other than stated above|0|||
23301301|NCT04146363|64846806|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23301302|NCT04146363|64846807|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23301303|NCT04146363|64846808|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23301304|NCT04146363|64846809|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23301305|NCT04146363|64846810|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23301306|NCT04146363|64846811|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23301307|NCT04146363|64846812|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23301308|NCT04146363|64846813|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
23301309|NCT04146363|64846814|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
23301310|NCT04146363|64846815|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
23301311|NCT04146363|64846805|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
23301312|NCT04146363|64846806|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
23301313|NCT04146363|64846807|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
23301314|NCT04146363|64846808|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
23301315|NCT04146363|64846809|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
23301316|NCT04146363|64846810|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
23301317|NCT04146363|64846811|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
23301318|NCT04146363|64846812|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
23301319|NCT04146363|64846813|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
23301320|NCT04146363|64846814|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
23301321|NCT04146363|64846815|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
23301322|NCT04146363|64846805|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23301323|NCT04146363|64846806|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23301324|NCT04146363|64846807|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23301325|NCT04146363|64846808|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23301326|NCT04146363|64846809|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23301327|NCT04146363|64846810|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23301328|NCT04146363|64846811|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23301329|NCT04146363|64846812|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
23301330|NCT04146363|64846813|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
23301331|NCT04146363|64846814|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
23301332|NCT04146363|64846815|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
23301333|NCT04146363|64846805|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301334|NCT04146363|64846806|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301335|NCT04146363|64846807|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301336|NCT04146363|64846808|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301337|NCT04146363|64846809|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301338|NCT04146363|64846810|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301339|NCT04146363|64846811|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301340|NCT04146363|64846812|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301341|NCT04146363|64846813|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301342|NCT04146363|64846814|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
23301343|NCT04146363|64846815|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
23301344|NCT04146363|64846805|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301345|NCT04146363|64846806|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301346|NCT04146363|64846807|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301347|NCT04146363|64846808|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301348|NCT04146363|64846809|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301349|NCT04146363|64846810|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301350|NCT04146363|64846811|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301351|NCT04146363|64846812|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301352|NCT04146363|64846813|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301353|NCT04146363|64846814|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
23301354|NCT04146363|64846815|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
23301355|NCT01301508|64846816|FG000|Overall Study|Withdrawal by Subject|1|||
23301356|NCT01301508|64846817|FG001|Overall Study|Withdrawal by Subject|2|||
23301357|NCT01301508|64846816|FG000|Overall Study|Lost to Follow-up|0|||
23301358|NCT01301508|64846817|FG001|Overall Study|Lost to Follow-up|1|||
23301359|NCT02562482|64846820|FG000|Overall Study|Enrolled, but did not receive product|4|||
23301360|NCT02562482|64846821|FG001|Overall Study|Enrolled, but did not receive product|0|||
23301361|NCT02562482|64846820|FG000|Overall Study|Lost to Follow-up|9|||
23301362|NCT02562482|64846821|FG001|Overall Study|Lost to Follow-up|6|||
23301363|NCT02562482|64846820|FG000|Overall Study|Moved from area|2|||
23301364|NCT02562482|64846821|FG001|Overall Study|Moved from area|3|||
23301365|NCT02562482|64846820|FG000|Overall Study|Withdrawal by Subject|5|||
23301366|NCT02562482|64846821|FG001|Overall Study|Withdrawal by Subject|3|||
23301367|NCT02562482|64846820|FG000|Overall Study|Physician Decision|1|||
23301368|NCT02562482|64846821|FG001|Overall Study|Physician Decision|3|||
23301369|NCT02562482|64846820|FG000|Overall Study|Illness/Injury unrelated to product|0|||
23301370|NCT02562482|64846821|FG001|Overall Study|Illness/Injury unrelated to product|1|||
23301371|NCT00821873|64846830|FG000|Overall Study|Lost to Follow-up|4|||
23301372|NCT01064531|64846833|FG000|Overall Study|Lost to Follow-up|0|||
23301373|NCT01064531|64846834|FG001|Overall Study|Lost to Follow-up|2|||
23301374|NCT01064531|64846833|FG000|Overall Study|Physician Decision|0|||
23301375|NCT01064531|64846834|FG001|Overall Study|Physician Decision|1|||
23301376|NCT01064531|64846833|FG000|Overall Study|Withdrawal by Subject|2|||
23301377|NCT01064531|64846834|FG001|Overall Study|Withdrawal by Subject|2|||
23301378|NCT01064531|64846833|FG000|Overall Study|Revision due to femoral stem loosening|1|||
23301379|NCT01064531|64846834|FG001|Overall Study|Revision due to femoral stem loosening|0|||
23301380|NCT01064531|64846833|FG000|Overall Study|Revision due to dislocation|0|||
23301381|NCT01064531|64846834|FG001|Overall Study|Revision due to dislocation|1|||
23301382|NCT01064531|64846833|FG000|Overall Study|Death|0|||
23301383|NCT01064531|64846834|FG001|Overall Study|Death|1|||
23301384|NCT02132754|64846840|FG000|Overall Study|Adverse Event|0|||
23301385|NCT02132754|64846841|FG001|Overall Study|Adverse Event|0|||
23301386|NCT02132754|64846842|FG002|Overall Study|Adverse Event|0|||
23301387|NCT02132754|64846843|FG003|Overall Study|Adverse Event|0|||
23301388|NCT02132754|64846844|FG004|Overall Study|Adverse Event|0|||
23301389|NCT02132754|64846845|FG005|Overall Study|Adverse Event|0|||
23301390|NCT02132754|64846846|FG006|Overall Study|Adverse Event|0|||
23301391|NCT02132754|64846847|FG007|Overall Study|Adverse Event|0|||
23301392|NCT02132754|64846848|FG008|Overall Study|Adverse Event|0|||
23301393|NCT02132754|64846849|FG009|Overall Study|Adverse Event|0|||
23301394|NCT02132754|64846850|FG010|Overall Study|Adverse Event|0|||
23301395|NCT02132754|64846851|FG011|Overall Study|Adverse Event|0|||
23301396|NCT02132754|64846852|FG012|Overall Study|Adverse Event|0|||
23301397|NCT02132754|64846853|FG013|Overall Study|Adverse Event|0|||
23301398|NCT02132754|64846854|FG014|Overall Study|Adverse Event|0|||
23301399|NCT02132754|64846855|FG015|Overall Study|Adverse Event|0|||
23301400|NCT02132754|64846856|FG016|Overall Study|Adverse Event|0|||
23301401|NCT02132754|64846857|FG017|Overall Study|Adverse Event|1|||
23301402|NCT02132754|64846858|FG018|Overall Study|Adverse Event|0|||
23301403|NCT02132754|64846859|FG019|Overall Study|Adverse Event|0|||
23301404|NCT02132754|64846860|FG020|Overall Study|Adverse Event|0|||
23301405|NCT02132754|64846861|FG021|Overall Study|Adverse Event|0|||
23301406|NCT02132754|64846862|FG022|Overall Study|Adverse Event|0|||
23301407|NCT02132754|64846863|FG023|Overall Study|Adverse Event|0|||
23301408|NCT02132754|64846864|FG024|Overall Study|Adverse Event|0|||
23301409|NCT02132754|64846865|FG025|Overall Study|Adverse Event|1|||
23301410|NCT02132754|64846866|FG026|Overall Study|Adverse Event|1|||
23301411|NCT02132754|64846867|FG027|Overall Study|Adverse Event|0|||
23301412|NCT02132754|64846868|FG028|Overall Study|Adverse Event|0|||
23301413|NCT02132754|64846869|FG029|Overall Study|Adverse Event|0|||
23301414|NCT02132754|64846870|FG030|Overall Study|Adverse Event|1|||
23301415|NCT02132754|64846871|FG031|Overall Study|Adverse Event|0|||
23301416|NCT02132754|64846872|FG032|Overall Study|Adverse Event|1|||
23301417|NCT02132754|64846873|FG033|Overall Study|Adverse Event|1|||
23301418|NCT02132754|64846840|FG000|Overall Study|Clinical Progression|0|||
23301419|NCT02132754|64846841|FG001|Overall Study|Clinical Progression|0|||
23301420|NCT02132754|64846842|FG002|Overall Study|Clinical Progression|0|||
23301421|NCT02132754|64846843|FG003|Overall Study|Clinical Progression|0|||
23301422|NCT02132754|64846844|FG004|Overall Study|Clinical Progression|0|||
23301423|NCT02132754|64846845|FG005|Overall Study|Clinical Progression|0|||
23301424|NCT02132754|64846846|FG006|Overall Study|Clinical Progression|0|||
23301425|NCT02132754|64846847|FG007|Overall Study|Clinical Progression|0|||
23301426|NCT02132754|64846848|FG008|Overall Study|Clinical Progression|0|||
23301427|NCT02132754|64846849|FG009|Overall Study|Clinical Progression|1|||
23301428|NCT02132754|64846850|FG010|Overall Study|Clinical Progression|0|||
23301429|NCT02132754|64846851|FG011|Overall Study|Clinical Progression|0|||
23301430|NCT02132754|64846852|FG012|Overall Study|Clinical Progression|0|||
23301431|NCT02132754|64846853|FG013|Overall Study|Clinical Progression|0|||
23301432|NCT02132754|64846854|FG014|Overall Study|Clinical Progression|0|||
23301433|NCT02132754|64846855|FG015|Overall Study|Clinical Progression|0|||
23301434|NCT02132754|64846856|FG016|Overall Study|Clinical Progression|1|||
23301435|NCT02132754|64846857|FG017|Overall Study|Clinical Progression|1|||
23301436|NCT02132754|64846858|FG018|Overall Study|Clinical Progression|0|||
23301437|NCT02132754|64846859|FG019|Overall Study|Clinical Progression|1|||
23301438|NCT02132754|64846860|FG020|Overall Study|Clinical Progression|0|||
23301439|NCT02132754|64846861|FG021|Overall Study|Clinical Progression|0|||
23301440|NCT02132754|64846862|FG022|Overall Study|Clinical Progression|1|||
23301441|NCT02132754|64846863|FG023|Overall Study|Clinical Progression|0|||
23301442|NCT02132754|64846864|FG024|Overall Study|Clinical Progression|1|||
23301443|NCT02132754|64846865|FG025|Overall Study|Clinical Progression|1|||
23301444|NCT02132754|64846866|FG026|Overall Study|Clinical Progression|0|||
23301445|NCT02132754|64846867|FG027|Overall Study|Clinical Progression|1|||
23301446|NCT02132754|64846868|FG028|Overall Study|Clinical Progression|1|||
23301447|NCT02132754|64846869|FG029|Overall Study|Clinical Progression|0|||
23301448|NCT02132754|64846870|FG030|Overall Study|Clinical Progression|1|||
23301449|NCT02132754|64846871|FG031|Overall Study|Clinical Progression|0|||
23301450|NCT02132754|64846872|FG032|Overall Study|Clinical Progression|0|||
23301451|NCT02132754|64846873|FG033|Overall Study|Clinical Progression|2|||
23301452|NCT02132754|64846840|FG000|Overall Study|Death|0|||
23301453|NCT02132754|64846841|FG001|Overall Study|Death|0|||
23301454|NCT02132754|64846842|FG002|Overall Study|Death|0|||
23301455|NCT02132754|64846843|FG003|Overall Study|Death|0|||
23301456|NCT02132754|64846844|FG004|Overall Study|Death|0|||
23301457|NCT02132754|64846845|FG005|Overall Study|Death|0|||
23301458|NCT02132754|64846846|FG006|Overall Study|Death|0|||
23301459|NCT02132754|64846847|FG007|Overall Study|Death|0|||
23301460|NCT02132754|64846848|FG008|Overall Study|Death|0|||
23301461|NCT02132754|64846849|FG009|Overall Study|Death|0|||
23301462|NCT02132754|64846850|FG010|Overall Study|Death|0|||
23301463|NCT02132754|64846851|FG011|Overall Study|Death|0|||
23301464|NCT02132754|64846852|FG012|Overall Study|Death|0|||
23301465|NCT02132754|64846853|FG013|Overall Study|Death|0|||
23301466|NCT02132754|64846854|FG014|Overall Study|Death|0|||
23301467|NCT02132754|64846855|FG015|Overall Study|Death|1|||
23301468|NCT02132754|64846856|FG016|Overall Study|Death|0|||
23301469|NCT02132754|64846857|FG017|Overall Study|Death|0|||
23301470|NCT02132754|64846858|FG018|Overall Study|Death|0|||
23301471|NCT02132754|64846859|FG019|Overall Study|Death|1|||
23301472|NCT02132754|64846860|FG020|Overall Study|Death|0|||
23301473|NCT02132754|64846861|FG021|Overall Study|Death|1|||
23301474|NCT02132754|64846862|FG022|Overall Study|Death|0|||
23301475|NCT02132754|64846863|FG023|Overall Study|Death|0|||
23301476|NCT02132754|64846864|FG024|Overall Study|Death|0|||
23301477|NCT02132754|64846865|FG025|Overall Study|Death|0|||
23301478|NCT02132754|64846866|FG026|Overall Study|Death|1|||
23301479|NCT02132754|64846867|FG027|Overall Study|Death|0|||
23301480|NCT02132754|64846868|FG028|Overall Study|Death|0|||
23301481|NCT02132754|64846869|FG029|Overall Study|Death|0|||
23301482|NCT02132754|64846870|FG030|Overall Study|Death|0|||
23301483|NCT02132754|64846871|FG031|Overall Study|Death|0|||
23301484|NCT02132754|64846872|FG032|Overall Study|Death|0|||
23301485|NCT02132754|64846873|FG033|Overall Study|Death|2|||
23301486|NCT02132754|64846840|FG000|Overall Study|Excluded Medication|0|||
23301487|NCT02132754|64846841|FG001|Overall Study|Excluded Medication|0|||
23301488|NCT02132754|64846842|FG002|Overall Study|Excluded Medication|0|||
23301489|NCT02132754|64846843|FG003|Overall Study|Excluded Medication|0|||
23301490|NCT02132754|64846844|FG004|Overall Study|Excluded Medication|0|||
23301491|NCT02132754|64846845|FG005|Overall Study|Excluded Medication|0|||
23301492|NCT02132754|64846846|FG006|Overall Study|Excluded Medication|0|||
23301493|NCT02132754|64846847|FG007|Overall Study|Excluded Medication|0|||
23301494|NCT02132754|64846848|FG008|Overall Study|Excluded Medication|0|||
23301495|NCT02132754|64846849|FG009|Overall Study|Excluded Medication|0|||
23301496|NCT02132754|64846850|FG010|Overall Study|Excluded Medication|0|||
23301497|NCT02132754|64846851|FG011|Overall Study|Excluded Medication|0|||
23301498|NCT02132754|64846852|FG012|Overall Study|Excluded Medication|0|||
23301499|NCT02132754|64846853|FG013|Overall Study|Excluded Medication|0|||
23301500|NCT02132754|64846854|FG014|Overall Study|Excluded Medication|0|||
23301501|NCT02132754|64846855|FG015|Overall Study|Excluded Medication|0|||
23301502|NCT02132754|64846856|FG016|Overall Study|Excluded Medication|0|||
23301503|NCT02132754|64846857|FG017|Overall Study|Excluded Medication|0|||
23301504|NCT02132754|64846858|FG018|Overall Study|Excluded Medication|0|||
23301505|NCT02132754|64846859|FG019|Overall Study|Excluded Medication|0|||
23301506|NCT02132754|64846860|FG020|Overall Study|Excluded Medication|1|||
23301507|NCT02132754|64846861|FG021|Overall Study|Excluded Medication|0|||
23301508|NCT02132754|64846862|FG022|Overall Study|Excluded Medication|0|||
23301509|NCT02132754|64846863|FG023|Overall Study|Excluded Medication|0|||
23301510|NCT02132754|64846864|FG024|Overall Study|Excluded Medication|0|||
23301511|NCT02132754|64846865|FG025|Overall Study|Excluded Medication|0|||
23301512|NCT02132754|64846866|FG026|Overall Study|Excluded Medication|0|||
23301513|NCT02132754|64846867|FG027|Overall Study|Excluded Medication|0|||
23301514|NCT02132754|64846868|FG028|Overall Study|Excluded Medication|0|||
23301515|NCT02132754|64846869|FG029|Overall Study|Excluded Medication|0|||
23301516|NCT02132754|64846870|FG030|Overall Study|Excluded Medication|0|||
23301517|NCT02132754|64846871|FG031|Overall Study|Excluded Medication|0|||
23301518|NCT02132754|64846872|FG032|Overall Study|Excluded Medication|0|||
23301519|NCT02132754|64846873|FG033|Overall Study|Excluded Medication|1|||
23301520|NCT02132754|64846840|FG000|Overall Study|Physician Decision|0|||
23301521|NCT02132754|64846841|FG001|Overall Study|Physician Decision|0|||
23301522|NCT02132754|64846842|FG002|Overall Study|Physician Decision|0|||
23301523|NCT02132754|64846843|FG003|Overall Study|Physician Decision|0|||
23301524|NCT02132754|64846844|FG004|Overall Study|Physician Decision|0|||
23301525|NCT02132754|64846845|FG005|Overall Study|Physician Decision|0|||
23301526|NCT02132754|64846846|FG006|Overall Study|Physician Decision|0|||
23301527|NCT02132754|64846847|FG007|Overall Study|Physician Decision|0|||
23301528|NCT02132754|64846848|FG008|Overall Study|Physician Decision|0|||
23301529|NCT02132754|64846849|FG009|Overall Study|Physician Decision|1|||
23301530|NCT02132754|64846850|FG010|Overall Study|Physician Decision|0|||
23301531|NCT02132754|64846851|FG011|Overall Study|Physician Decision|1|||
23301532|NCT02132754|64846852|FG012|Overall Study|Physician Decision|1|||
23301533|NCT02132754|64846853|FG013|Overall Study|Physician Decision|0|||
23301534|NCT02132754|64846854|FG014|Overall Study|Physician Decision|0|||
23301535|NCT02132754|64846855|FG015|Overall Study|Physician Decision|1|||
23301536|NCT02132754|64846856|FG016|Overall Study|Physician Decision|0|||
23301537|NCT02132754|64846857|FG017|Overall Study|Physician Decision|0|||
23301538|NCT02132754|64846858|FG018|Overall Study|Physician Decision|0|||
23301539|NCT02132754|64846859|FG019|Overall Study|Physician Decision|0|||
23301540|NCT02132754|64846860|FG020|Overall Study|Physician Decision|0|||
23301541|NCT02132754|64846861|FG021|Overall Study|Physician Decision|0|||
23301542|NCT02132754|64846862|FG022|Overall Study|Physician Decision|0|||
23301543|NCT02132754|64846863|FG023|Overall Study|Physician Decision|0|||
23301544|NCT02132754|64846864|FG024|Overall Study|Physician Decision|1|||
23301545|NCT02132754|64846865|FG025|Overall Study|Physician Decision|0|||
23301546|NCT02132754|64846866|FG026|Overall Study|Physician Decision|0|||
23301547|NCT02132754|64846867|FG027|Overall Study|Physician Decision|0|||
23301548|NCT02132754|64846868|FG028|Overall Study|Physician Decision|0|||
23301549|NCT02132754|64846869|FG029|Overall Study|Physician Decision|0|||
23301550|NCT02132754|64846870|FG030|Overall Study|Physician Decision|0|||
23301551|NCT02132754|64846871|FG031|Overall Study|Physician Decision|1|||
23301552|NCT02132754|64846872|FG032|Overall Study|Physician Decision|0|||
23301553|NCT02132754|64846873|FG033|Overall Study|Physician Decision|3|||
23301554|NCT02132754|64846840|FG000|Overall Study|Progressive Disease|1|||
23301555|NCT02132754|64846841|FG001|Overall Study|Progressive Disease|1|||
23301556|NCT02132754|64846842|FG002|Overall Study|Progressive Disease|1|||
23301557|NCT02132754|64846843|FG003|Overall Study|Progressive Disease|1|||
23301558|NCT02132754|64846844|FG004|Overall Study|Progressive Disease|1|||
23301559|NCT02132754|64846845|FG005|Overall Study|Progressive Disease|1|||
23301560|NCT02132754|64846846|FG006|Overall Study|Progressive Disease|1|||
23301561|NCT02132754|64846847|FG007|Overall Study|Progressive Disease|1|||
23301562|NCT02132754|64846848|FG008|Overall Study|Progressive Disease|1|||
23301563|NCT02132754|64846849|FG009|Overall Study|Progressive Disease|3|||
23301564|NCT02132754|64846850|FG010|Overall Study|Progressive Disease|3|||
23301565|NCT02132754|64846851|FG011|Overall Study|Progressive Disease|2|||
23301566|NCT02132754|64846852|FG012|Overall Study|Progressive Disease|2|||
23301567|NCT02132754|64846853|FG013|Overall Study|Progressive Disease|3|||
23301568|NCT02132754|64846854|FG014|Overall Study|Progressive Disease|2|||
23301569|NCT02132754|64846855|FG015|Overall Study|Progressive Disease|1|||
23301570|NCT02132754|64846856|FG016|Overall Study|Progressive Disease|2|||
23301571|NCT02132754|64846857|FG017|Overall Study|Progressive Disease|1|||
23301572|NCT02132754|64846858|FG018|Overall Study|Progressive Disease|3|||
23301573|NCT02132754|64846859|FG019|Overall Study|Progressive Disease|1|||
23301574|NCT02132754|64846860|FG020|Overall Study|Progressive Disease|1|||
23301575|NCT02132754|64846861|FG021|Overall Study|Progressive Disease|3|||
23301576|NCT02132754|64846862|FG022|Overall Study|Progressive Disease|2|||
23301577|NCT02132754|64846863|FG023|Overall Study|Progressive Disease|3|||
23301578|NCT02132754|64846864|FG024|Overall Study|Progressive Disease|0|||
23301579|NCT02132754|64846865|FG025|Overall Study|Progressive Disease|1|||
23301580|NCT02132754|64846866|FG026|Overall Study|Progressive Disease|2|||
23301581|NCT02132754|64846867|FG027|Overall Study|Progressive Disease|1|||
23301582|NCT02132754|64846868|FG028|Overall Study|Progressive Disease|2|||
23301583|NCT02132754|64846869|FG029|Overall Study|Progressive Disease|3|||
23301584|NCT02132754|64846870|FG030|Overall Study|Progressive Disease|1|||
23301585|NCT02132754|64846871|FG031|Overall Study|Progressive Disease|1|||
23301586|NCT02132754|64846872|FG032|Overall Study|Progressive Disease|3|||
23301587|NCT02132754|64846873|FG033|Overall Study|Progressive Disease|6|||
23301588|NCT02132754|64846840|FG000|Overall Study|Screen Failure|0|||
23301589|NCT02132754|64846841|FG001|Overall Study|Screen Failure|0|||
23301590|NCT02132754|64846842|FG002|Overall Study|Screen Failure|0|||
23301591|NCT02132754|64846843|FG003|Overall Study|Screen Failure|0|||
23301592|NCT02132754|64846844|FG004|Overall Study|Screen Failure|0|||
23301593|NCT02132754|64846845|FG005|Overall Study|Screen Failure|0|||
23301594|NCT02132754|64846846|FG006|Overall Study|Screen Failure|0|||
23301595|NCT02132754|64846847|FG007|Overall Study|Screen Failure|0|||
23301596|NCT02132754|64846848|FG008|Overall Study|Screen Failure|0|||
23301597|NCT02132754|64846849|FG009|Overall Study|Screen Failure|0|||
23301598|NCT02132754|64846850|FG010|Overall Study|Screen Failure|0|||
23301599|NCT02132754|64846851|FG011|Overall Study|Screen Failure|0|||
23301600|NCT02132754|64846852|FG012|Overall Study|Screen Failure|0|||
23301601|NCT02132754|64846853|FG013|Overall Study|Screen Failure|0|||
23301602|NCT02132754|64846854|FG014|Overall Study|Screen Failure|0|||
23301603|NCT02132754|64846855|FG015|Overall Study|Screen Failure|0|||
23301604|NCT02132754|64846856|FG016|Overall Study|Screen Failure|0|||
23301605|NCT02132754|64846857|FG017|Overall Study|Screen Failure|0|||
23301606|NCT02132754|64846858|FG018|Overall Study|Screen Failure|0|||
23301607|NCT02132754|64846859|FG019|Overall Study|Screen Failure|1|||
23301608|NCT02132754|64846860|FG020|Overall Study|Screen Failure|0|||
23301609|NCT02132754|64846861|FG021|Overall Study|Screen Failure|1|||
23301610|NCT02132754|64846862|FG022|Overall Study|Screen Failure|0|||
23301611|NCT02132754|64846863|FG023|Overall Study|Screen Failure|0|||
23301612|NCT02132754|64846864|FG024|Overall Study|Screen Failure|0|||
23301613|NCT02132754|64846865|FG025|Overall Study|Screen Failure|0|||
23301614|NCT02132754|64846866|FG026|Overall Study|Screen Failure|0|||
23301615|NCT02132754|64846867|FG027|Overall Study|Screen Failure|0|||
23301616|NCT02132754|64846868|FG028|Overall Study|Screen Failure|0|||
23301617|NCT02132754|64846869|FG029|Overall Study|Screen Failure|0|||
23301618|NCT02132754|64846870|FG030|Overall Study|Screen Failure|0|||
23301619|NCT02132754|64846871|FG031|Overall Study|Screen Failure|0|||
23301620|NCT02132754|64846872|FG032|Overall Study|Screen Failure|0|||
23301621|NCT02132754|64846873|FG033|Overall Study|Screen Failure|0|||
23301622|NCT02132754|64846840|FG000|Overall Study|Transferred to Extension Study|0|||
23301623|NCT02132754|64846841|FG001|Overall Study|Transferred to Extension Study|0|||
23301624|NCT02132754|64846842|FG002|Overall Study|Transferred to Extension Study|0|||
23301625|NCT02132754|64846843|FG003|Overall Study|Transferred to Extension Study|0|||
23301626|NCT02132754|64846844|FG004|Overall Study|Transferred to Extension Study|0|||
23301627|NCT02132754|64846845|FG005|Overall Study|Transferred to Extension Study|0|||
23301628|NCT02132754|64846846|FG006|Overall Study|Transferred to Extension Study|0|||
23301629|NCT02132754|64846847|FG007|Overall Study|Transferred to Extension Study|0|||
23301630|NCT02132754|64846848|FG008|Overall Study|Transferred to Extension Study|0|||
23301631|NCT02132754|64846849|FG009|Overall Study|Transferred to Extension Study|0|||
23301632|NCT02132754|64846850|FG010|Overall Study|Transferred to Extension Study|0|||
23301633|NCT02132754|64846851|FG011|Overall Study|Transferred to Extension Study|0|||
23301634|NCT02132754|64846852|FG012|Overall Study|Transferred to Extension Study|0|||
23301635|NCT02132754|64846853|FG013|Overall Study|Transferred to Extension Study|0|||
23301636|NCT02132754|64846854|FG014|Overall Study|Transferred to Extension Study|0|||
23301637|NCT02132754|64846855|FG015|Overall Study|Transferred to Extension Study|0|||
23301638|NCT02132754|64846856|FG016|Overall Study|Transferred to Extension Study|0|||
23301639|NCT02132754|64846857|FG017|Overall Study|Transferred to Extension Study|0|||
23301640|NCT02132754|64846858|FG018|Overall Study|Transferred to Extension Study|0|||
23301641|NCT02132754|64846859|FG019|Overall Study|Transferred to Extension Study|0|||
23301642|NCT02132754|64846860|FG020|Overall Study|Transferred to Extension Study|0|||
23301643|NCT02132754|64846861|FG021|Overall Study|Transferred to Extension Study|0|||
23301644|NCT02132754|64846862|FG022|Overall Study|Transferred to Extension Study|0|||
23301645|NCT02132754|64846863|FG023|Overall Study|Transferred to Extension Study|0|||
23301646|NCT02132754|64846864|FG024|Overall Study|Transferred to Extension Study|0|||
23301647|NCT02132754|64846865|FG025|Overall Study|Transferred to Extension Study|0|||
23301648|NCT02132754|64846866|FG026|Overall Study|Transferred to Extension Study|0|||
23301649|NCT02132754|64846867|FG027|Overall Study|Transferred to Extension Study|0|||
23301650|NCT02132754|64846868|FG028|Overall Study|Transferred to Extension Study|0|||
23301651|NCT02132754|64846869|FG029|Overall Study|Transferred to Extension Study|0|||
23301652|NCT02132754|64846870|FG030|Overall Study|Transferred to Extension Study|0|||
23301653|NCT02132754|64846871|FG031|Overall Study|Transferred to Extension Study|0|||
23301654|NCT02132754|64846872|FG032|Overall Study|Transferred to Extension Study|0|||
23301655|NCT02132754|64846873|FG033|Overall Study|Transferred to Extension Study|6|||
23301656|NCT02132754|64846840|FG000|Overall Study|Withdrawal by Subject|0|||
23301657|NCT02132754|64846841|FG001|Overall Study|Withdrawal by Subject|0|||
23301658|NCT02132754|64846842|FG002|Overall Study|Withdrawal by Subject|0|||
23301659|NCT02132754|64846843|FG003|Overall Study|Withdrawal by Subject|0|||
23301660|NCT02132754|64846844|FG004|Overall Study|Withdrawal by Subject|0|||
23301661|NCT02132754|64846845|FG005|Overall Study|Withdrawal by Subject|0|||
23301662|NCT02132754|64846846|FG006|Overall Study|Withdrawal by Subject|0|||
23301663|NCT02132754|64846847|FG007|Overall Study|Withdrawal by Subject|0|||
23301664|NCT02132754|64846848|FG008|Overall Study|Withdrawal by Subject|0|||
23301665|NCT02132754|64846849|FG009|Overall Study|Withdrawal by Subject|1|||
23301666|NCT02132754|64846850|FG010|Overall Study|Withdrawal by Subject|0|||
23301667|NCT02132754|64846851|FG011|Overall Study|Withdrawal by Subject|0|||
23301668|NCT02132754|64846852|FG012|Overall Study|Withdrawal by Subject|1|||
23301669|NCT02132754|64846853|FG013|Overall Study|Withdrawal by Subject|0|||
23301670|NCT02132754|64846854|FG014|Overall Study|Withdrawal by Subject|1|||
23301671|NCT02132754|64846855|FG015|Overall Study|Withdrawal by Subject|2|||
23301672|NCT02132754|64846856|FG016|Overall Study|Withdrawal by Subject|1|||
23301673|NCT02132754|64846857|FG017|Overall Study|Withdrawal by Subject|0|||
23301674|NCT02132754|64846858|FG018|Overall Study|Withdrawal by Subject|0|||
23301675|NCT02132754|64846859|FG019|Overall Study|Withdrawal by Subject|0|||
23301676|NCT02132754|64846860|FG020|Overall Study|Withdrawal by Subject|1|||
23301677|NCT02132754|64846861|FG021|Overall Study|Withdrawal by Subject|0|||
23301678|NCT02132754|64846862|FG022|Overall Study|Withdrawal by Subject|0|||
23301679|NCT02132754|64846863|FG023|Overall Study|Withdrawal by Subject|0|||
23301680|NCT02132754|64846864|FG024|Overall Study|Withdrawal by Subject|1|||
23301681|NCT02132754|64846865|FG025|Overall Study|Withdrawal by Subject|0|||
23301682|NCT02132754|64846866|FG026|Overall Study|Withdrawal by Subject|0|||
23301683|NCT02132754|64846867|FG027|Overall Study|Withdrawal by Subject|1|||
23301684|NCT02132754|64846868|FG028|Overall Study|Withdrawal by Subject|0|||
23301685|NCT02132754|64846869|FG029|Overall Study|Withdrawal by Subject|0|||
23301686|NCT02132754|64846870|FG030|Overall Study|Withdrawal by Subject|0|||
23301687|NCT02132754|64846871|FG031|Overall Study|Withdrawal by Subject|1|||
23301688|NCT02132754|64846872|FG032|Overall Study|Withdrawal by Subject|0|||
23301689|NCT02132754|64846873|FG033|Overall Study|Withdrawal by Subject|2|||
23301690|NCT02478320|64846874|FG000|Overall Study|Adverse Event|2|||
23301691|NCT02478320|64846875|FG001|Overall Study|Adverse Event|0|||
23301692|NCT02478320|64846874|FG000|Overall Study|Death|1|||
23301693|NCT02478320|64846875|FG001|Overall Study|Death|0|||
23301694|NCT02478320|64846874|FG000|Overall Study|Lack of Efficacy|4|||
23301695|NCT02478320|64846875|FG001|Overall Study|Lack of Efficacy|0|||
23301696|NCT02478320|64846874|FG000|Overall Study|Withdrawal by Subject|2|||
23301697|NCT02478320|64846875|FG001|Overall Study|Withdrawal by Subject|0|||
23301698|NCT02478320|64846874|FG000|Overall Study|Screen Failure|3|||
23301699|NCT02478320|64846875|FG001|Overall Study|Screen Failure|0|||
23301700|NCT02865395|64846876|FG000|Overall Study|Physician Decision|6|||
23301701|NCT02865395|64846877|FG001|Overall Study|Physician Decision|10|||
23301702|NCT02865395|64846878|FG002|Overall Study|Physician Decision|7|||
23301703|NCT01763918|64846879|FG000|Overall Study|Withdrawal by Subject|2|||
23301704|NCT01763918|64846880|FG001|Overall Study|Withdrawal by Subject|1|||
23301705|NCT01763918|64846881|FG002|Overall Study|Withdrawal by Subject|1|||
23301706|NCT01763918|64846882|FG003|Overall Study|Withdrawal by Subject|2|||
23301707|NCT01763918|64846879|FG000|Overall Study|Sponsor Decision|4|||
23301708|NCT01763918|64846880|FG001|Overall Study|Sponsor Decision|0|||
23301709|NCT01763918|64846881|FG002|Overall Study|Sponsor Decision|9|||
23301710|NCT01763918|64846882|FG003|Overall Study|Sponsor Decision|0|||
23301711|NCT02813421|64846883|FG000|Overall Study|Withdrawal by Subject|1|||
23301712|NCT02813421|64846884|FG001|Overall Study|Withdrawal by Subject|2|||
23301713|NCT02813421|64846883|FG000|Overall Study|Lost to Follow-up|1|||
23301714|NCT02813421|64846884|FG001|Overall Study|Lost to Follow-up|1|||
23301715|NCT00446199|64846885|FG000|Overall Study|Adverse Event|7|||
23301716|NCT00446199|64846886|FG001|Overall Study|Adverse Event|4|||
23301717|NCT00446199|64846887|FG002|Overall Study|Adverse Event|6|||
23301718|NCT00446199|64846888|FG003|Overall Study|Adverse Event|4|||
23301719|NCT00446199|64846885|FG000|Overall Study|Lost to Follow-up|4|||
23301720|NCT00446199|64846886|FG001|Overall Study|Lost to Follow-up|5|||
23301721|NCT00446199|64846887|FG002|Overall Study|Lost to Follow-up|2|||
23301722|NCT00446199|64846888|FG003|Overall Study|Lost to Follow-up|6|||
23301723|NCT00446199|64846885|FG000|Overall Study|Protocol Violation|1|||
23301724|NCT00446199|64846886|FG001|Overall Study|Protocol Violation|2|||
23301725|NCT00446199|64846887|FG002|Overall Study|Protocol Violation|1|||
23301726|NCT00446199|64846888|FG003|Overall Study|Protocol Violation|3|||
23301727|NCT00446199|64846885|FG000|Overall Study|Withdrawal by Subject|2|||
23301728|NCT00446199|64846886|FG001|Overall Study|Withdrawal by Subject|5|||
23301729|NCT00446199|64846887|FG002|Overall Study|Withdrawal by Subject|9|||
23301730|NCT00446199|64846888|FG003|Overall Study|Withdrawal by Subject|10|||
23301731|NCT00446199|64846885|FG000|Overall Study|Site termination|2|||
23301732|NCT00446199|64846886|FG001|Overall Study|Site termination|0|||
23301733|NCT00446199|64846887|FG002|Overall Study|Site termination|0|||
23301734|NCT00446199|64846888|FG003|Overall Study|Site termination|1|||
23301735|NCT00446199|64846885|FG000|Overall Study|Randomization in Error|2|||
23301736|NCT00446199|64846886|FG001|Overall Study|Randomization in Error|0|||
23301737|NCT00446199|64846887|FG002|Overall Study|Randomization in Error|1|||
23301738|NCT00446199|64846888|FG003|Overall Study|Randomization in Error|1|||
23301739|NCT00446199|64846885|FG000|Overall Study|Lack of Efficacy|1|||
23301740|NCT00446199|64846886|FG001|Overall Study|Lack of Efficacy|0|||
23301741|NCT00446199|64846887|FG002|Overall Study|Lack of Efficacy|0|||
23301742|NCT00446199|64846888|FG003|Overall Study|Lack of Efficacy|1|||
23301743|NCT00446199|64846885|FG000|Overall Study|Non-compliant with study drug|1|||
23301744|NCT00446199|64846886|FG001|Overall Study|Non-compliant with study drug|0|||
23301745|NCT00446199|64846887|FG002|Overall Study|Non-compliant with study drug|5|||
23301746|NCT00446199|64846888|FG003|Overall Study|Non-compliant with study drug|0|||
23301747|NCT00446199|64846885|FG000|Overall Study|Non-compliant with visit schedule|1|||
23301748|NCT00446199|64846886|FG001|Overall Study|Non-compliant with visit schedule|1|||
23301749|NCT00446199|64846887|FG002|Overall Study|Non-compliant with visit schedule|1|||
23301750|NCT00446199|64846888|FG003|Overall Study|Non-compliant with visit schedule|2|||
23301751|NCT00446199|64846885|FG000|Overall Study|Hormone fear|0|||
23301752|NCT00446199|64846886|FG001|Overall Study|Hormone fear|0|||
23301753|NCT00446199|64846887|FG002|Overall Study|Hormone fear|0|||
23301754|NCT00446199|64846888|FG003|Overall Study|Hormone fear|1|||
23301755|NCT00446199|64846885|FG000|Overall Study|Lost interest in study participation|0|||
23301756|NCT00446199|64846886|FG001|Overall Study|Lost interest in study participation|1|||
23301757|NCT00446199|64846887|FG002|Overall Study|Lost interest in study participation|0|||
23301758|NCT00446199|64846888|FG003|Overall Study|Lost interest in study participation|0|||
23301759|NCT00446199|64846885|FG000|Overall Study|In-/Exclusion criterion violated|2|||
23301760|NCT00446199|64846886|FG001|Overall Study|In-/Exclusion criterion violated|1|||
23301761|NCT00446199|64846887|FG002|Overall Study|In-/Exclusion criterion violated|2|||
23301762|NCT00446199|64846888|FG003|Overall Study|In-/Exclusion criterion violated|1|||
23301763|NCT00446199|64846885|FG000|Overall Study|Move|0|||
23301764|NCT00446199|64846886|FG001|Overall Study|Move|1|||
23301765|NCT00446199|64846887|FG002|Overall Study|Move|0|||
23301766|NCT00446199|64846888|FG003|Overall Study|Move|0|||
23301767|NCT02780167|64846890|FG000|Overall Study|Adverse Event|9|||
23301768|NCT02780167|64846891|FG001|Overall Study|Adverse Event|8|||
23301769|NCT02780167|64846892|FG002|Overall Study|Adverse Event|8|||
23301770|NCT02780167|64846893|FG003|Overall Study|Adverse Event|12|||
23301771|NCT02780167|64846894|FG004|Overall Study|Adverse Event|8|||
23301772|NCT02780167|64846890|FG000|Overall Study|Lack of Efficacy|6|||
23301773|NCT02780167|64846891|FG001|Overall Study|Lack of Efficacy|5|||
23301774|NCT02780167|64846892|FG002|Overall Study|Lack of Efficacy|6|||
23301775|NCT02780167|64846893|FG003|Overall Study|Lack of Efficacy|1|||
23301776|NCT02780167|64846894|FG004|Overall Study|Lack of Efficacy|0|||
23301777|NCT02780167|64846890|FG000|Overall Study|Lost to Follow-up|2|||
23301778|NCT02780167|64846891|FG001|Overall Study|Lost to Follow-up|0|||
23301779|NCT02780167|64846892|FG002|Overall Study|Lost to Follow-up|1|||
23301780|NCT02780167|64846893|FG003|Overall Study|Lost to Follow-up|0|||
23301781|NCT02780167|64846894|FG004|Overall Study|Lost to Follow-up|0|||
23301782|NCT02780167|64846890|FG000|Overall Study|Does not meet entrance criteria|0|||
23301783|NCT02780167|64846891|FG001|Overall Study|Does not meet entrance criteria|0|||
23301784|NCT02780167|64846892|FG002|Overall Study|Does not meet entrance criteria|1|||
23301785|NCT02780167|64846893|FG003|Overall Study|Does not meet entrance criteria|0|||
23301786|NCT02780167|64846894|FG004|Overall Study|Does not meet entrance criteria|0|||
23301787|NCT02780167|64846890|FG000|Overall Study|No longer meets eligibility criteria|0|||
23301788|NCT02780167|64846891|FG001|Overall Study|No longer meets eligibility criteria|0|||
23301789|NCT02780167|64846892|FG002|Overall Study|No longer meets eligibility criteria|0|||
23301790|NCT02780167|64846893|FG003|Overall Study|No longer meets eligibility criteria|1|||
23301791|NCT02780167|64846894|FG004|Overall Study|No longer meets eligibility criteria|1|||
23301792|NCT02780167|64846890|FG000|Overall Study|Protocol Violation|5|||
23301793|NCT02780167|64846891|FG001|Overall Study|Protocol Violation|5|||
23301794|NCT02780167|64846892|FG002|Overall Study|Protocol Violation|1|||
23301795|NCT02780167|64846893|FG003|Overall Study|Protocol Violation|1|||
23301796|NCT02780167|64846894|FG004|Overall Study|Protocol Violation|2|||
23301797|NCT02780167|64846890|FG000|Overall Study|Withdrawal by Subject|6|||
23301798|NCT02780167|64846891|FG001|Overall Study|Withdrawal by Subject|4|||
23301799|NCT02780167|64846892|FG002|Overall Study|Withdrawal by Subject|4|||
23301800|NCT02780167|64846893|FG003|Overall Study|Withdrawal by Subject|3|||
23301801|NCT02780167|64846894|FG004|Overall Study|Withdrawal by Subject|4|||
23301802|NCT02780167|64846890|FG000|Overall Study|Other|0|||
23301803|NCT02780167|64846891|FG001|Overall Study|Other|0|||
23301804|NCT02780167|64846892|FG002|Overall Study|Other|3|||
23301805|NCT02780167|64846893|FG003|Overall Study|Other|1|||
23301806|NCT02780167|64846894|FG004|Overall Study|Other|2|||
23301807|NCT00350402|64846895|FG000|Overall Study|Lost to Follow-up|1|||
23301808|NCT00350402|64846896|FG001|Overall Study|Lost to Follow-up|1|||
23301809|NCT01277718|64846897|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
23301810|NCT01277718|64846898|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
23301811|NCT01277718|64846897|FG000|Period 2 - Second Intervention|Physician Decision|0|||
23301812|NCT01277718|64846898|FG001|Period 2 - Second Intervention|Physician Decision|2|||
23301813|NCT01138111|64846899|FG000|Overall Study|Withdrawal by Subject|5|||
23301814|NCT01138111|64846899|FG000|Overall Study|Adverse Event|1|||
23301815|NCT01138111|64846899|FG000|Overall Study|Death|1|||
23301816|NCT01138111|64846899|FG000|Overall Study|Lost to Follow-up|2|||
23301817|NCT04551911|64846902|FG000|Overall Study|Lost to Follow-up|2|||
23301818|NCT04551911|64846903|FG001|Overall Study|Lost to Follow-up|1|||
23301819|NCT04551911|64846902|FG000|Overall Study|Withdrawal by Subject|10|||
23301820|NCT04551911|64846903|FG001|Overall Study|Withdrawal by Subject|10|||
23301821|NCT04551911|64846902|FG000|Overall Study|Did not receive the study drug|3|||
23301822|NCT04551911|64846903|FG001|Overall Study|Did not receive the study drug|4|||
23301823|NCT01462318|64846904|FG000|Main Study / TP-DI Study|Other|2|||
23301824|NCT01462318|64846905|FG001|Main Study / TP-DI Study|Other|0|||
23301825|NCT01462318|64846906|FG002|Main Study / TP-DI Study|Other|0|||
23301826|NCT01462318|64846904|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
23301827|NCT01462318|64846905|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
23301828|NCT01462318|64846906|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
23301829|NCT01462318|64846904|FG000|Main Study / TP-DI Study|Adverse Event|4|||
23301830|NCT01462318|64846905|FG001|Main Study / TP-DI Study|Adverse Event|0|||
23301831|NCT01462318|64846906|FG002|Main Study / TP-DI Study|Adverse Event|0|||
23301832|NCT01462318|64846904|FG000|Extension Phase|Lost to Follow-up|0|||
23301833|NCT01462318|64846905|FG001|Extension Phase|Lost to Follow-up|0|||
23301834|NCT01462318|64846906|FG002|Extension Phase|Lost to Follow-up|1|||
23301835|NCT01462318|64846904|FG000|Extension Phase|Other|0|||
23301836|NCT01462318|64846905|FG001|Extension Phase|Other|0|||
23301837|NCT01462318|64846906|FG002|Extension Phase|Other|1|||
23301838|NCT01462318|64846904|FG000|Extension Phase|Disease Progression|0|||
23301839|NCT01462318|64846905|FG001|Extension Phase|Disease Progression|0|||
23301840|NCT01462318|64846906|FG002|Extension Phase|Disease Progression|1|||
23301841|NCT01462318|64846904|FG000|Extension Phase|Withdrawal by Subject|0|||
23301842|NCT01462318|64846905|FG001|Extension Phase|Withdrawal by Subject|0|||
23301843|NCT01462318|64846906|FG002|Extension Phase|Withdrawal by Subject|15|||
23301844|NCT01462318|64846904|FG000|Extension Phase|Investigator Decision|0|||
23301845|NCT01462318|64846905|FG001|Extension Phase|Investigator Decision|0|||
23301846|NCT01462318|64846906|FG002|Extension Phase|Investigator Decision|5|||
23301847|NCT01462318|64846904|FG000|Extension Phase|Adverse Event|0|||
23301848|NCT01462318|64846905|FG001|Extension Phase|Adverse Event|0|||
23301849|NCT01462318|64846906|FG002|Extension Phase|Adverse Event|22|||
23301850|NCT01833533|64846907|FG000|Overall Study|Adverse Event|0|||
23301851|NCT01833533|64846908|FG001|Overall Study|Adverse Event|1|||
23301852|NCT01833533|64846907|FG000|Overall Study|Lost to Follow-up|4|||
23301853|NCT01833533|64846908|FG001|Overall Study|Lost to Follow-up|9|||
23301854|NCT01833533|64846907|FG000|Overall Study|To Enter an Extension Study|0|||
23301855|NCT01833533|64846908|FG001|Overall Study|To Enter an Extension Study|4|||
23301856|NCT01833533|64846907|FG000|Overall Study|Other|2|||
23301857|NCT01833533|64846908|FG001|Overall Study|Other|7|||
23301858|NCT02310646|64846909|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
23301859|NCT02310646|64846910|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
23301860|NCT02310646|64846909|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
23301861|NCT02310646|64846910|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
23301862|NCT01659736|64846911|FG000|Treatment Period|Adverse Event|1|||
23301863|NCT01659736|64846912|FG001|Treatment Period|Adverse Event|1|||
23301864|NCT01659736|64846911|FG000|Treatment Period|Protocol Violation|3|||
23301865|NCT01659736|64846912|FG001|Treatment Period|Protocol Violation|1|||
23301866|NCT01659736|64846911|FG000|Treatment Period|Withdrawal by Subject|1|||
23301867|NCT01659736|64846912|FG001|Treatment Period|Withdrawal by Subject|0|||
23301868|NCT01659736|64846911|FG000|3-month Follow-up|Lost to Follow-up|0|||
23301869|NCT01659736|64846912|FG001|3-month Follow-up|Lost to Follow-up|1|||
23301870|NCT03185013|64846915|FG000|Overall Study|Withdrawal by Subject|5|||
23301871|NCT03185013|64846916|FG001|Overall Study|Withdrawal by Subject|3|||
23301872|NCT03185013|64846915|FG000|Overall Study|Adverse Event|1|||
23301873|NCT03185013|64846916|FG001|Overall Study|Adverse Event|0|||
23301874|NCT03185013|64846915|FG000|Overall Study|Progressive Disease|1|||
23301875|NCT03185013|64846916|FG001|Overall Study|Progressive Disease|0|||
23301876|NCT03185013|64846915|FG000|Overall Study|Lost to Follow-up|8|||
23301877|NCT03185013|64846916|FG001|Overall Study|Lost to Follow-up|2|||
23301878|NCT03185013|64846915|FG000|Overall Study|Physician Decision|1|||
23301879|NCT03185013|64846916|FG001|Overall Study|Physician Decision|0|||
23301880|NCT03185013|64846915|FG000|Overall Study|Protocol Deviation|2|||
23301881|NCT03185013|64846916|FG001|Overall Study|Protocol Deviation|0|||
23301882|NCT03185013|64846915|FG000|Overall Study|Reason not Specified|3|||
23301883|NCT03185013|64846916|FG001|Overall Study|Reason not Specified|2|||
23301884|NCT03185013|64846915|FG000|Overall Study|Death|1|||
23301885|NCT03185013|64846916|FG001|Overall Study|Death|0|||
23301886|NCT00809965|64846917|FG000|Overall Study|Death|194|||
23301887|NCT00809965|64846918|FG001|Overall Study|Death|147|||
23301888|NCT00809965|64846919|FG002|Overall Study|Death|196|||
23301889|NCT00809965|64846917|FG000|Overall Study|Lost to Follow-up|17|||
23301890|NCT00809965|64846918|FG001|Overall Study|Lost to Follow-up|10|||
23301891|NCT00809965|64846919|FG002|Overall Study|Lost to Follow-up|18|||
23301892|NCT00809965|64846917|FG000|Overall Study|Withdrawal by Subject|405|||
23301893|NCT00809965|64846918|FG001|Overall Study|Withdrawal by Subject|448|||
23301894|NCT00809965|64846919|FG002|Overall Study|Withdrawal by Subject|441|||
23301895|NCT00809965|64846917|FG000|Overall Study|Other Reason|167|||
23301896|NCT00809965|64846918|FG001|Overall Study|Other Reason|170|||
23301897|NCT00809965|64846919|FG002|Overall Study|Other Reason|189|||
23301898|NCT00307034|64846920|FG000|Overall Study|Adverse Event|1|||
23301899|NCT00307034|64846921|FG001|Overall Study|Adverse Event|2|||
23301900|NCT00307034|64846920|FG000|Overall Study|Withdrawal by Subject|1|||
23301901|NCT00307034|64846921|FG001|Overall Study|Withdrawal by Subject|2|||
23301902|NCT00307034|64846920|FG000|Overall Study|Lost to Follow-up|0|||
23301903|NCT00307034|64846921|FG001|Overall Study|Lost to Follow-up|3|||
23301904|NCT04965389|64846922|FG000|Overall Study|Other reasons|1|||
23301905|NCT04965389|64846923|FG001|Overall Study|Other reasons|0|||
23301906|NCT04965389|64846924|FG002|Overall Study|Other reasons|0|||
23301907|NCT04965389|64846925|FG003|Overall Study|Other reasons|0|||
23301908|NCT04965389|64846922|FG000|Overall Study|Participant withdrew consent|0|||
23301909|NCT04965389|64846923|FG001|Overall Study|Participant withdrew consent|1|||
23301910|NCT04965389|64846924|FG002|Overall Study|Participant withdrew consent|0|||
23301911|NCT04965389|64846925|FG003|Overall Study|Participant withdrew consent|0|||
23301912|NCT04965389|64846922|FG000|Overall Study|Poor/Non-compliance|0|||
23301913|NCT04965389|64846923|FG001|Overall Study|Poor/Non-compliance|1|||
23301914|NCT04965389|64846924|FG002|Overall Study|Poor/Non-compliance|0|||
23301915|NCT04965389|64846925|FG003|Overall Study|Poor/Non-compliance|0|||
23301916|NCT02621034|64846926|FG000|Overall Study|Lost to Follow-up|3|||
23301917|NCT02621034|64846927|FG001|Overall Study|Lost to Follow-up|2|||
23301918|NCT02621034|64846928|FG002|Overall Study|Lost to Follow-up|5|||
23301919|NCT01366092|64846929|FG000|Overall Study|Progressive cGVHD|2|||
23301920|NCT01366092|64846929|FG000|Overall Study|Physician Decision|1|||
23301921|NCT01366092|64846929|FG000|Overall Study|Withdrawal by Subject|1|||
23301922|NCT03043560|64846930|FG000|Overall Study|Discontinued Intervention|1|||
23301923|NCT03043560|64846931|FG001|Overall Study|Discontinued Intervention|2|||
23301924|NCT03043560|64846930|FG000|Overall Study|Lost to Follow-up|0|||
23301925|NCT03043560|64846931|FG001|Overall Study|Lost to Follow-up|1|||
23301926|NCT03979820|64846934|FG000|Overall Study|Protocol Violation|1|||
23301927|NCT03979820|64846935|FG001|Overall Study|Protocol Violation|0|||
23301928|NCT03979820|64846936|FG002|Overall Study|Protocol Violation|0|||
23301929|NCT03979820|64846937|FG003|Overall Study|Protocol Violation|0|||
23301930|NCT03979820|64846934|FG000|Overall Study|Withdrawal by Subject|0|||
23301931|NCT03979820|64846935|FG001|Overall Study|Withdrawal by Subject|0|||
23301932|NCT03979820|64846936|FG002|Overall Study|Withdrawal by Subject|1|||
23301933|NCT03979820|64846937|FG003|Overall Study|Withdrawal by Subject|0|||
23301934|NCT03979820|64846934|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
23301935|NCT03979820|64846935|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
23301936|NCT03979820|64846936|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
23301937|NCT03979820|64846937|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
23301938|NCT02916693|64846938|FG000|Overall Study|Lost to Follow-up|7|||
23301939|NCT00770692|64846939|FG000|Overall Study|Withdrawal by Subject|7|||
23301940|NCT00770692|64846940|FG001|Overall Study|Withdrawal by Subject|9|||
23301941|NCT00770692|64846941|FG002|Overall Study|Withdrawal by Subject|9|||
23301942|NCT00770692|64846942|FG003|Overall Study|Withdrawal by Subject|6|||
23301943|NCT00770692|64846939|FG000|Overall Study|Adverse Event|3|||
23301944|NCT00770692|64846940|FG001|Overall Study|Adverse Event|0|||
23301945|NCT00770692|64846941|FG002|Overall Study|Adverse Event|4|||
23301946|NCT00770692|64846942|FG003|Overall Study|Adverse Event|4|||
23301947|NCT00770692|64846939|FG000|Overall Study|Investigator judgment|2|||
23301948|NCT00770692|64846940|FG001|Overall Study|Investigator judgment|0|||
23301949|NCT00770692|64846941|FG002|Overall Study|Investigator judgment|1|||
23301950|NCT00770692|64846942|FG003|Overall Study|Investigator judgment|1|||
23301951|NCT04209205|64846949|FG000|Overall Study|Adverse Event|2|||
23301952|NCT04209205|64846950|FG001|Overall Study|Adverse Event|3|||
23301953|NCT04209205|64846949|FG000|Overall Study|Lost to Follow-up|3|||
23301954|NCT04209205|64846950|FG001|Overall Study|Lost to Follow-up|1|||
23301955|NCT04209205|64846949|FG000|Overall Study|Physician Decision|1|||
23301956|NCT04209205|64846950|FG001|Overall Study|Physician Decision|1|||
23301957|NCT04209205|64846949|FG000|Overall Study|Subject decision|10|||
23301958|NCT04209205|64846950|FG001|Overall Study|Subject decision|10|||
23301959|NCT04209205|64846949|FG000|Overall Study|Progressive disease|1|||
23301960|NCT04209205|64846950|FG001|Overall Study|Progressive disease|0|||
23301961|NCT04209205|64846949|FG000|Overall Study|Protocol deviation|0|||
23301962|NCT04209205|64846950|FG001|Overall Study|Protocol deviation|1|||
23301963|NCT04209205|64846949|FG000|Overall Study|New therapy for study indication|1|||
23301964|NCT04209205|64846950|FG001|Overall Study|New therapy for study indication|0|||
23301965|NCT04209205|64846949|FG000|Overall Study|Adverse event - placebo not switched|0|||
23301966|NCT04209205|64846950|FG001|Overall Study|Adverse event - placebo not switched|1|||
23301967|NCT04209205|64846949|FG000|Overall Study|Subject decision - placebo not switched|0|||
23301968|NCT04209205|64846950|FG001|Overall Study|Subject decision - placebo not switched|5|||
23301969|NCT04209205|64846949|FG000|Overall Study|Death - placebo not switched|0|||
23301970|NCT04209205|64846950|FG001|Overall Study|Death - placebo not switched|1|||
23301971|NCT01300923|64846951|FG000|Overall Study|Physician Decision|0|||
23301972|NCT01300923|64846952|FG001|Overall Study|Physician Decision|2|||
23301973|NCT03188718|64846958|FG000|Overall Study|Participant noncompliance|4|||
23301974|NCT03188718|64846958|FG000|Overall Study|Withdrawal by Subject|1|||
23301975|NCT03188718|64846958|FG000|Overall Study|Device failure|3|||
23301976|NCT01338987|64846959|FG000|Overall Study|enrolled on new protocol|0|||
23301977|NCT01338987|64846960|FG001|Overall Study|enrolled on new protocol|0|||
23301978|NCT01338987|64846961|FG002|Overall Study|enrolled on new protocol|1|||
23301979|NCT01338987|64846962|FG003|Overall Study|enrolled on new protocol|0|||
23301980|NCT01338987|64846963|FG004|Overall Study|enrolled on new protocol|0|||
23301981|NCT01338987|64846959|FG000|Overall Study|Disease progression on study|2|||
23301982|NCT01338987|64846960|FG001|Overall Study|Disease progression on study|1|||
23301983|NCT01338987|64846961|FG002|Overall Study|Disease progression on study|1|||
23301984|NCT01338987|64846962|FG003|Overall Study|Disease progression on study|0|||
23301985|NCT01338987|64846963|FG004|Overall Study|Disease progression on study|0|||
23301986|NCT00597116|64846964|FG000|Overall Study|Adverse Event|2|||
23301987|NCT00597116|64846965|FG001|Overall Study|Adverse Event|1|||
23301988|NCT00597116|64846964|FG000|Overall Study|Withdrawal by Subject|0|||
23301989|NCT00597116|64846965|FG001|Overall Study|Withdrawal by Subject|2|||
23301990|NCT00597116|64846964|FG000|Overall Study|Physician Decision|0|||
23301991|NCT00597116|64846965|FG001|Overall Study|Physician Decision|1|||
23401510|NCT01343888|65216828|FG002|Overall Study|other than stated above|1|||
23301992|NCT00597116|64846964|FG000|Overall Study|Death|0|||
23301993|NCT00597116|64846965|FG001|Overall Study|Death|1|||
23301994|NCT00597116|64846964|FG000|Overall Study|Lost to Follow-up|1|||
23301995|NCT00597116|64846965|FG001|Overall Study|Lost to Follow-up|0|||
23301996|NCT00597116|64846964|FG000|Overall Study|Progressive disease|11|||
23301997|NCT00597116|64846965|FG001|Overall Study|Progressive disease|6|||
23301998|NCT03407430|64846966|FG000|Washout|Protocol Violation|1|||
23301999|NCT03407430|64846967|FG001|Washout|Protocol Violation|0|||
23302000|NCT03852459|64846970|FG000|Overall Study|Adverse Event|2|||
23302001|NCT03852459|64846971|FG001|Overall Study|Adverse Event|2|||
23302002|NCT03852459|64846970|FG000|Overall Study|Withdrawal by Subject|1|||
23302003|NCT03852459|64846971|FG001|Overall Study|Withdrawal by Subject|1|||
23302004|NCT04718194|64846977|FG000|Overall Study|Withdrawal by Subject|3|||
23302005|NCT04718194|64846978|FG001|Overall Study|Withdrawal by Subject|0|||
23302006|NCT04718194|64846977|FG000|Overall Study|Lost to Follow-up|3|||
23302007|NCT04718194|64846978|FG001|Overall Study|Lost to Follow-up|0|||
23302008|NCT02442271|64846983|FG000|Overall Study|Adverse Event|1|||
23302009|NCT02442271|64846983|FG000|Overall Study|Withdrew Consent|1|||
23302010|NCT02442271|64846983|FG000|Overall Study|Lost to Follow-up|1|||
23302011|NCT02442271|64846983|FG000|Overall Study|Other|1|||
23302012|NCT04969861|64846984|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
23302013|NCT04969861|64846985|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
23302014|NCT00136318|64846995|FG000|Overall Study|Adverse Event|5|||
23302015|NCT00136318|64846996|FG001|Overall Study|Adverse Event|5|||
23302016|NCT00136318|64846995|FG000|Overall Study|Withdrawal by Subject|2|||
23302017|NCT00136318|64846996|FG001|Overall Study|Withdrawal by Subject|2|||
23302018|NCT02547766|64846997|FG000|Overall Study|Withdrawal by Subject|1|||
23302019|NCT04132336|64846998|FG000|Overall Study|Investigator Decision|0|||
23302020|NCT04132336|64846999|FG001|Overall Study|Investigator Decision|1|||
23302021|NCT04132336|64847000|FG002|Overall Study|Investigator Decision|0|||
23302022|NCT04132336|64847001|FG003|Overall Study|Investigator Decision|0|||
23302023|NCT04132336|64847002|FG004|Overall Study|Investigator Decision|0|||
23302024|NCT04132336|64847003|FG005|Overall Study|Investigator Decision|0|||
23302025|NCT04132336|64847004|FG006|Overall Study|Investigator Decision|0|||
23302026|NCT04317599|64847005|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
23302027|NCT04317599|64847005|FG000|Overall Study|treatment outside standard of care|4|||
23302028|NCT01421342|64847009|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
23302029|NCT01421342|64847010|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
23302030|NCT01421342|64847011|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
23302031|NCT01421342|64847009|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
23302032|NCT01421342|64847010|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
23302033|NCT01421342|64847011|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
23302034|NCT01421342|64847009|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
23302035|NCT01421342|64847010|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
23302036|NCT01421342|64847011|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
23302037|NCT01421342|64847009|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
23302038|NCT01421342|64847010|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
23302039|NCT01421342|64847011|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
23302040|NCT01421342|64847009|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
23302041|NCT01421342|64847010|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
23302042|NCT01421342|64847011|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
23302043|NCT01421342|64847009|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
23302044|NCT01421342|64847010|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
23302045|NCT01421342|64847011|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
23302046|NCT01421342|64847009|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
23302047|NCT01421342|64847010|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
23302048|NCT01421342|64847011|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
23302049|NCT01421342|64847009|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
23302050|NCT01421342|64847010|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
23302051|NCT01421342|64847011|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
23302052|NCT01421342|64847009|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
23302053|NCT01421342|64847010|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
23302054|NCT01421342|64847011|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
23302055|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
23302056|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
23302057|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
23302058|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
23302059|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
23302060|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
23302061|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
23302062|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
23302063|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
23302064|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
23302065|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
23302066|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
23302067|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
23302068|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
23302069|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
23302070|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
23302071|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
23302072|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
23302073|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
23302074|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
23302075|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
23302076|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
23302077|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
23302078|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
23302079|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
23302080|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
23302081|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
23302082|NCT01421342|64847009|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
23302083|NCT01421342|64847010|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
23302084|NCT01421342|64847011|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
23401511|NCT03218917|65216831|FG000|Overall Study|Adverse Event|3|||
23401512|NCT03218917|65216832|FG001|Overall Study|Adverse Event|3|||
23401513|NCT03218917|65216833|FG002|Overall Study|Adverse Event|2|||
23401514|NCT03218917|65216831|FG000|Overall Study|Subject withdrew consent|2|||
23401515|NCT03218917|65216832|FG001|Overall Study|Subject withdrew consent|4|||
23401516|NCT03218917|65216833|FG002|Overall Study|Subject withdrew consent|10|||
23401517|NCT03218917|65216831|FG000|Overall Study|Physician Decision|0|||
23401518|NCT03218917|65216832|FG001|Overall Study|Physician Decision|1|||
23401519|NCT03218917|65216833|FG002|Overall Study|Physician Decision|1|||
23401520|NCT03218917|65216831|FG000|Overall Study|Lost to Follow-up|1|||
23401521|NCT03218917|65216832|FG001|Overall Study|Lost to Follow-up|0|||
23401522|NCT03218917|65216833|FG002|Overall Study|Lost to Follow-up|0|||
23401523|NCT03218917|65216831|FG000|Overall Study|Reason Missing|0|||
23401524|NCT03218917|65216832|FG001|Overall Study|Reason Missing|2|||
23401525|NCT03218917|65216833|FG002|Overall Study|Reason Missing|0|||
23401526|NCT03218917|65216831|FG000|Overall Study|Death|0|||
23401527|NCT03218917|65216832|FG001|Overall Study|Death|1|||
23401528|NCT03218917|65216833|FG002|Overall Study|Death|0|||
23401529|NCT03218917|65216831|FG000|Overall Study|Non-Compliance with Study Drug|0|||
23401530|NCT03218917|65216832|FG001|Overall Study|Non-Compliance with Study Drug|1|||
23401531|NCT03218917|65216833|FG002|Overall Study|Non-Compliance with Study Drug|0|||
23401532|NCT02030821|65216834|FG000|Overall Study|Physician Decision|2|||
23401533|NCT02030821|65216835|FG001|Overall Study|Physician Decision|2|||
23401534|NCT02030821|65216836|FG002|Overall Study|Physician Decision|5|||
23401535|NCT02030821|65216837|FG003|Overall Study|Physician Decision|2|||
23401536|NCT02986074|65216838|FG000|First Trial Period|Adverse Event|1|||
23401537|NCT02986074|65216839|FG001|First Trial Period|Adverse Event|0|||
23401538|NCT02986074|65216840|FG002|First Trial Period|Adverse Event|0|||
23401539|NCT02986074|65216841|FG003|First Trial Period|Adverse Event|0|||
23401540|NCT02986074|65216838|FG000|Follow up Period|system explant|0|||
23401541|NCT02986074|65216839|FG001|Follow up Period|system explant|0|||
23401542|NCT02986074|65216840|FG002|Follow up Period|system explant|1|||
23401543|NCT02986074|65216841|FG003|Follow up Period|system explant|2|||
23401544|NCT02986074|65216838|FG000|Follow up Period|Physician Decision|0|||
23401545|NCT02986074|65216839|FG001|Follow up Period|Physician Decision|0|||
23401546|NCT02986074|65216840|FG002|Follow up Period|Physician Decision|0|||
23401547|NCT02986074|65216841|FG003|Follow up Period|Physician Decision|1|||
23401548|NCT01788943|65216842|FG000|Overall Study|Withdrawal by Subject|1|||
23401549|NCT01788943|65216843|FG001|Overall Study|Withdrawal by Subject|0|||
23401550|NCT00894387|65216846|FG000|Overall Study|Adverse Event|44|||
23401551|NCT00894387|65216847|FG001|Overall Study|Adverse Event|45|||
23401552|NCT00894387|65216846|FG000|Overall Study|Abnormal Laboratory values|2|||
23401553|NCT00894387|65216847|FG001|Overall Study|Abnormal Laboratory values|2|||
23401554|NCT00894387|65216846|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
23401555|NCT00894387|65216847|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
23401556|NCT00894387|65216846|FG000|Overall Study|Lost to Follow-up|3|||
23401557|NCT00894387|65216847|FG001|Overall Study|Lost to Follow-up|5|||
23401558|NCT00894387|65216846|FG000|Overall Study|Administrative problems|2|||
23401559|NCT00894387|65216847|FG001|Overall Study|Administrative problems|2|||
23401560|NCT00894387|65216846|FG000|Overall Study|Death|77|||
23401561|NCT00894387|65216847|FG001|Overall Study|Death|76|||
23401562|NCT00894387|65216846|FG000|Overall Study|Protocol Deviation|4|||
23401563|NCT00894387|65216847|FG001|Overall Study|Protocol Deviation|0|||
23401564|NCT00894387|65216846|FG000|Overall Study|Patient's request|25|||
23401565|NCT00894387|65216847|FG001|Overall Study|Patient's request|30|||
23401566|NCT00894387|65216846|FG000|Overall Study|Other (Missing)|5|||
23401567|NCT00894387|65216847|FG001|Overall Study|Other (Missing)|3|||
23401568|NCT00894387|65216846|FG000|Overall Study|Mis-randomized|13|||
23401569|NCT00894387|65216847|FG001|Overall Study|Mis-randomized|9|||
23401570|NCT00894387|65216846|FG000|Overall Study|GCP non-compliance|0|||
23401571|NCT00894387|65216847|FG001|Overall Study|GCP non-compliance|2|||
23401572|NCT00776789|65216848|FG000|Overall Study|Consent refusal|2|||
23401573|NCT00776789|65216849|FG001|Overall Study|Consent refusal|2|||
23401574|NCT00776789|65216848|FG000|Overall Study|Poor quality video|1|||
23401575|NCT00776789|65216849|FG001|Overall Study|Poor quality video|1|||
23401576|NCT01657370|65216858|FG000|Overall Study|Withdrawal by Subject|0|||
23401577|NCT01657370|65216859|FG001|Overall Study|Withdrawal by Subject|0|||
23401578|NCT01657370|65216860|FG002|Overall Study|Withdrawal by Subject|1|||
23401579|NCT01657370|65216861|FG003|Overall Study|Withdrawal by Subject|0|||
23401580|NCT01657370|65216862|FG004|Overall Study|Withdrawal by Subject|0|||
23401581|NCT01657370|65216863|FG005|Overall Study|Withdrawal by Subject|1|||
23401582|NCT01657370|65216858|FG000|Overall Study|Physician Decision|2|||
23401583|NCT01657370|65216859|FG001|Overall Study|Physician Decision|3|||
23401584|NCT01657370|65216860|FG002|Overall Study|Physician Decision|1|||
23401585|NCT01657370|65216861|FG003|Overall Study|Physician Decision|2|||
23401586|NCT01657370|65216862|FG004|Overall Study|Physician Decision|5|||
23401587|NCT01657370|65216863|FG005|Overall Study|Physician Decision|0|||
23401588|NCT01657370|65216858|FG000|Overall Study|Lack of Qualifying Event|1|||
23401589|NCT01657370|65216859|FG001|Overall Study|Lack of Qualifying Event|0|||
23401590|NCT01657370|65216860|FG002|Overall Study|Lack of Qualifying Event|3|||
23401591|NCT01657370|65216861|FG003|Overall Study|Lack of Qualifying Event|2|||
23401592|NCT01657370|65216862|FG004|Overall Study|Lack of Qualifying Event|1|||
23401593|NCT01657370|65216863|FG005|Overall Study|Lack of Qualifying Event|2|||
23401594|NCT01657370|65216858|FG000|Overall Study|Adverse Event|0|||
23401595|NCT01657370|65216859|FG001|Overall Study|Adverse Event|0|||
23401596|NCT01657370|65216860|FG002|Overall Study|Adverse Event|0|||
23401597|NCT01657370|65216861|FG003|Overall Study|Adverse Event|0|||
23401598|NCT01657370|65216862|FG004|Overall Study|Adverse Event|1|||
23401599|NCT01657370|65216863|FG005|Overall Study|Adverse Event|0|||
23401600|NCT01657370|65216858|FG000|Overall Study|Protocol Violation|1|||
23401601|NCT01657370|65216859|FG001|Overall Study|Protocol Violation|1|||
23401602|NCT01657370|65216860|FG002|Overall Study|Protocol Violation|1|||
23401603|NCT01657370|65216861|FG003|Overall Study|Protocol Violation|1|||
23401604|NCT01657370|65216862|FG004|Overall Study|Protocol Violation|0|||
23401605|NCT01657370|65216863|FG005|Overall Study|Protocol Violation|0|||
23401606|NCT01657370|65216858|FG000|Overall Study|Lost to Follow-up|2|||
23401607|NCT01657370|65216859|FG001|Overall Study|Lost to Follow-up|0|||
23401608|NCT01657370|65216860|FG002|Overall Study|Lost to Follow-up|1|||
23401609|NCT01657370|65216861|FG003|Overall Study|Lost to Follow-up|0|||
23401610|NCT01657370|65216862|FG004|Overall Study|Lost to Follow-up|0|||
23401611|NCT01657370|65216863|FG005|Overall Study|Lost to Follow-up|1|||
23401612|NCT02756403|65216864|FG000|Overall Study|Unable to swallow medication|0|||
23401613|NCT02756403|65216865|FG001|Overall Study|Unable to swallow medication|1|||
23401614|NCT02756403|65216866|FG002|Overall Study|Unable to swallow medication|1|||
23401615|NCT02756403|65216867|FG003|Overall Study|Unable to swallow medication|1|||
23401616|NCT02756403|65216864|FG000|Overall Study|Did not complete Procedure|0|||
23401617|NCT02756403|65216865|FG001|Overall Study|Did not complete Procedure|1|||
23401618|NCT02756403|65216866|FG002|Overall Study|Did not complete Procedure|0|||
23401619|NCT02756403|65216867|FG003|Overall Study|Did not complete Procedure|0|||
23401620|NCT02756403|65216864|FG000|Overall Study|Changed Mind About Procedure|0|||
23401621|NCT02756403|65216865|FG001|Overall Study|Changed Mind About Procedure|0|||
23401622|NCT02756403|65216866|FG002|Overall Study|Changed Mind About Procedure|1|||
23401623|NCT02756403|65216867|FG003|Overall Study|Changed Mind About Procedure|0|||
23401624|NCT02756403|65216864|FG000|Overall Study|Protocol Violation|0|||
23401625|NCT02756403|65216865|FG001|Overall Study|Protocol Violation|1|||
23401626|NCT02756403|65216866|FG002|Overall Study|Protocol Violation|0|||
23401627|NCT02756403|65216867|FG003|Overall Study|Protocol Violation|1|||
23401628|NCT00698828|65216869|FG000|Overall Study|Adverse Event|3|||
23401629|NCT00698828|65216870|FG001|Overall Study|Adverse Event|4|||
23401630|NCT00698828|65216871|FG002|Overall Study|Adverse Event|4|||
23401631|NCT00698828|65216869|FG000|Overall Study|Death|0|||
23401632|NCT00698828|65216870|FG001|Overall Study|Death|0|||
23401633|NCT00698828|65216871|FG002|Overall Study|Death|1|||
23401634|NCT00698828|65216869|FG000|Overall Study|Exacerbation of COPD|1|||
23401635|NCT00698828|65216870|FG001|Overall Study|Exacerbation of COPD|3|||
23401636|NCT00698828|65216871|FG002|Overall Study|Exacerbation of COPD|0|||
23401637|NCT00698828|65216869|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
23401638|NCT00698828|65216870|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
23401639|NCT00698828|65216871|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
23401640|NCT00698828|65216869|FG000|Overall Study|Investigator/Sponsor decision|1|||
23401641|NCT00698828|65216870|FG001|Overall Study|Investigator/Sponsor decision|0|||
23401642|NCT00698828|65216871|FG002|Overall Study|Investigator/Sponsor decision|2|||
23401643|NCT00698828|65216869|FG000|Overall Study|Lost to Follow-up|1|||
23401644|NCT00698828|65216870|FG001|Overall Study|Lost to Follow-up|1|||
23401645|NCT00698828|65216871|FG002|Overall Study|Lost to Follow-up|0|||
23401646|NCT00698828|65216869|FG000|Overall Study|Withdrew consent|0|||
23401647|NCT00698828|65216870|FG001|Overall Study|Withdrew consent|7|||
23401648|NCT00698828|65216871|FG002|Overall Study|Withdrew consent|4|||
23401649|NCT00698828|65216869|FG000|Overall Study|Withdrew consent (not treated)|2|||
23401650|NCT00698828|65216870|FG001|Overall Study|Withdrew consent (not treated)|0|||
23401651|NCT00698828|65216871|FG002|Overall Study|Withdrew consent (not treated)|0|||
23401652|NCT01757665|65216872|FG000|Overall Study|Still on Study - Visit Completed|240|||
23401653|NCT01757665|65216873|FG001|Overall Study|Still on Study - Visit Completed|30|||
23401654|NCT01757665|65216872|FG000|Overall Study|Still on Study - Visit Pending|398|||
23401655|NCT01757665|65216873|FG001|Overall Study|Still on Study - Visit Pending|40|||
23401656|NCT01757665|65216872|FG000|Overall Study|Still on Study - Missed Visit|14|||
23401657|NCT01757665|65216873|FG001|Overall Study|Still on Study - Missed Visit|1|||
23401658|NCT01757665|65216872|FG000|Overall Study|Death|25|||
23401659|NCT01757665|65216873|FG001|Overall Study|Death|8|||
23401660|NCT01757665|65216872|FG000|Overall Study|Explant|1|||
23401661|NCT01757665|65216873|FG001|Overall Study|Explant|2|||
23401662|NCT01757665|65216872|FG000|Overall Study|Withdrawal by Subject|10|||
23401663|NCT01757665|65216873|FG001|Overall Study|Withdrawal by Subject|0|||
23401664|NCT01757665|65216872|FG000|Overall Study|Lost to Follow-up|1|||
23401665|NCT01757665|65216873|FG001|Overall Study|Lost to Follow-up|1|||
23302085|NCT01421342|64847009|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
23302086|NCT01421342|64847010|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
23302087|NCT01421342|64847011|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
23302088|NCT01421342|64847009|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
23302089|NCT01421342|64847010|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
23302090|NCT01421342|64847011|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
23302091|NCT01421342|64847009|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
23302092|NCT01421342|64847010|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
23302093|NCT01421342|64847011|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
23302094|NCT01421342|64847009|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
23302095|NCT01421342|64847010|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
23302096|NCT01421342|64847011|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
23302097|NCT01421342|64847009|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
23302098|NCT01421342|64847010|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
23302099|NCT01421342|64847011|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
23302100|NCT01421342|64847009|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
23302101|NCT01421342|64847010|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
23302102|NCT01421342|64847011|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
23302103|NCT01421342|64847009|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
23302104|NCT01421342|64847010|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
23302105|NCT01421342|64847011|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
23302106|NCT01421342|64847009|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
23302107|NCT01421342|64847010|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
23302108|NCT01421342|64847011|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
23302109|NCT01421342|64847009|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
23302110|NCT01421342|64847010|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
23302111|NCT01421342|64847011|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
23302112|NCT01370213|64847012|FG000|Overall Study|Early Death|1|||
23302113|NCT01370213|64847013|FG001|Overall Study|Early Death|0|||
23302114|NCT01370213|64847014|FG002|Overall Study|Early Death|0|||
23302115|NCT01370213|64847012|FG000|Overall Study|Not evaluable|0|||
23302116|NCT01370213|64847013|FG001|Overall Study|Not evaluable|2|||
23302117|NCT01370213|64847014|FG002|Overall Study|Not evaluable|0|||
23302118|NCT01432574|64847015|FG000|Overall Study|Moved|2|||
23302119|NCT01432574|64847015|FG000|Overall Study|Not interested|1|||
23302120|NCT00973765|64847016|FG000|Overall Study|Lost to Follow-up|8|||
23302121|NCT00973765|64847017|FG001|Overall Study|Lost to Follow-up|14|||
23302122|NCT03314662|64847019|FG000|Overall Study|Withdrawal by Subject|1|||
23302123|NCT03314662|64847020|FG001|Overall Study|Withdrawal by Subject|1|||
23302124|NCT03314662|64847021|FG002|Overall Study|Withdrawal by Subject|1|||
23302125|NCT03314662|64847019|FG000|Overall Study|Lost to Follow-up|5|||
23302126|NCT03314662|64847020|FG001|Overall Study|Lost to Follow-up|4|||
23302127|NCT03314662|64847021|FG002|Overall Study|Lost to Follow-up|4|||
23302128|NCT03314662|64847019|FG000|Overall Study|Death|2|||
23302129|NCT03314662|64847020|FG001|Overall Study|Death|0|||
23302130|NCT03314662|64847021|FG002|Overall Study|Death|0|||
23302131|NCT03001219|64847022|FG000|Proof of Concept|Study Termination by Sponsor|0|||
23302132|NCT03001219|64847023|FG001|Proof of Concept|Study Termination by Sponsor|1|||
23302133|NCT03001219|64847022|FG000|Proof of Concept|Withdrawal by Subject|0|||
23302134|NCT03001219|64847023|FG001|Proof of Concept|Withdrawal by Subject|4|||
23302135|NCT03001219|64847022|FG000|Proof of Concept|Protocol Deviation|0|||
23302136|NCT03001219|64847023|FG001|Proof of Concept|Protocol Deviation|1|||
23302137|NCT03001219|64847022|FG000|Proof of Concept|Adverse Event|1|||
23302138|NCT03001219|64847023|FG001|Proof of Concept|Adverse Event|1|||
23302139|NCT03001219|64847022|FG000|Proof of Concept|Physician Decision|1|||
23302140|NCT03001219|64847023|FG001|Proof of Concept|Physician Decision|0|||
23302141|NCT03001219|64847022|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
23302142|NCT03001219|64847023|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
23302143|NCT03001219|64847022|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
23302144|NCT03001219|64847023|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
23302145|NCT03001219|64847022|FG000|Extension Period Analysis|Physician Decision|0|||
23302146|NCT03001219|64847023|FG001|Extension Period Analysis|Physician Decision|1|||
23302147|NCT03001219|64847022|FG000|Extension Period Analysis|Adverse Event|1|||
23302148|NCT03001219|64847023|FG001|Extension Period Analysis|Adverse Event|1|||
23302149|NCT03001219|64847022|FG000|Extension Period Analysis|Protocol Deviation|0|||
23302150|NCT03001219|64847023|FG001|Extension Period Analysis|Protocol Deviation|1|||
23302151|NCT03001219|64847022|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
23302152|NCT03001219|64847023|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
23302153|NCT02595008|64847026|FG000|Overall Study|Enrolled In Error|1|||
23302154|NCT02595008|64847027|FG001|Overall Study|Enrolled In Error|0|||
23302155|NCT01621191|64847028|FG000|Overall Study|Adverse Event|9|||
23302156|NCT01621191|64847028|FG000|Overall Study|Withdrawal by Subject|8|||
23302157|NCT01621191|64847028|FG000|Overall Study|Lack of Efficacy|6|||
23302158|NCT01621191|64847028|FG000|Overall Study|Lost to Follow-up|1|||
23302159|NCT01621191|64847028|FG000|Overall Study|Site Removed From Study|1|||
23302160|NCT03064438|64847029|FG000|Overall Study|Lost to Follow-up|1|||
23302161|NCT03064438|64847030|FG001|Overall Study|Lost to Follow-up|0|||
23302162|NCT03064438|64847029|FG000|Overall Study|Withdrawal by Subject|0|||
23302163|NCT03064438|64847030|FG001|Overall Study|Withdrawal by Subject|1|||
23302164|NCT02939014|64847033|FG000|Overall Study|Lost to Follow-up|1|||
23302165|NCT02939014|64847034|FG001|Overall Study|Lost to Follow-up|0|||
23302166|NCT02939014|64847033|FG000|Overall Study|Death|4|||
23302167|NCT02939014|64847034|FG001|Overall Study|Death|3|||
23302168|NCT02138136|64847041|FG000|Overall Study|Protocol Violation|4|||
23302169|NCT02138136|64847041|FG000|Overall Study|Physician Decision|7|||
23302170|NCT02138136|64847041|FG000|Overall Study|Lack of Efficacy|35|||
23302171|NCT02138136|64847041|FG000|Overall Study|Pregnancy|2|||
23302172|NCT02138136|64847041|FG000|Overall Study|Adverse Event|18|||
23302173|NCT02138136|64847041|FG000|Overall Study|Withdrawal by Subject|36|||
23302174|NCT02138136|64847041|FG000|Overall Study|Lost to Follow-up|32|||
23302175|NCT02138136|64847041|FG000|Overall Study|Withdrawn by Sponsor|5|||
23302176|NCT01386684|64847043|FG000|Overall Study|Lost to Follow-up|51|||
23302177|NCT01386684|64847043|FG000|Overall Study|Other|51|||
23302178|NCT01386684|64847043|FG000|Overall Study|Death|47|||
23302179|NCT01386684|64847043|FG000|Overall Study|Withdrawal of Consent|44|||
23302180|NCT01386684|64847043|FG000|Overall Study|Alternative Therapy Required|37|||
23302181|NCT01386684|64847043|FG000|Overall Study|Disease Progression|28|||
23302182|NCT01386684|64847043|FG000|Overall Study|Adverse Event|20|||
23302183|NCT01386684|64847043|FG000|Overall Study|Noncompliance|8|||
23302184|NCT01386684|64847043|FG000|Overall Study|Protocol Violation|4|||
23302185|NCT01386684|64847043|FG000|Overall Study|Missing|3|||
23302186|NCT02025751|64847054|FG000|Overall Study|Lost to Follow-up|1|||
23302187|NCT02025751|64847055|FG001|Overall Study|Lost to Follow-up|0|||
23302188|NCT02025751|64847054|FG000|Overall Study|Adverse Event|0|||
23302189|NCT02025751|64847055|FG001|Overall Study|Adverse Event|1|||
23302190|NCT02025751|64847054|FG000|Overall Study|Physician Decision|0|||
23302191|NCT02025751|64847055|FG001|Overall Study|Physician Decision|1|||
23302192|NCT02025751|64847054|FG000|Overall Study|Withdrawal by Subject|0|||
23302193|NCT02025751|64847055|FG001|Overall Study|Withdrawal by Subject|1|||
23302194|NCT03036839|64847065|FG000|Overall Study|Adverse Event|0|||
23302195|NCT03036839|64847066|FG001|Overall Study|Adverse Event|0|||
23302196|NCT03036839|64847067|FG002|Overall Study|Adverse Event|1|||
23302197|NCT03036839|64847065|FG000|Overall Study|Death|3|||
23302198|NCT03036839|64847066|FG001|Overall Study|Death|0|||
23302199|NCT03036839|64847067|FG002|Overall Study|Death|3|||
23302200|NCT03036839|64847065|FG000|Overall Study|Withdrew Consent|0|||
23302201|NCT03036839|64847066|FG001|Overall Study|Withdrew Consent|0|||
23401666|NCT01757665|65216872|FG000|Overall Study|Not Implanted with Device|5|||
23401667|NCT01757665|65216873|FG001|Overall Study|Not Implanted with Device|1|||
23401668|NCT02393859|65216874|FG000|Overall Study|Decision by Sponsor|2|||
23401669|NCT02393859|65216875|FG001|Overall Study|Decision by Sponsor|4|||
23401670|NCT02393859|65216874|FG000|Overall Study|Withdrawal by Subject|11|||
23401671|NCT02393859|65216875|FG001|Overall Study|Withdrawal by Subject|6|||
23401672|NCT02393859|65216874|FG000|Overall Study|Death|27|||
23401673|NCT02393859|65216875|FG001|Overall Study|Death|10|||
23401674|NCT02393859|65216874|FG000|Overall Study|Lost to Follow-up|1|||
23401675|NCT02393859|65216875|FG001|Overall Study|Lost to Follow-up|1|||
23401676|NCT00066690|65216876|FG000|Overall Study|Adverse Event|145|||
23401677|NCT00066690|65216877|FG001|Overall Study|Adverse Event|58|||
23401678|NCT00066690|65216878|FG002|Overall Study|Adverse Event|126|||
23401679|NCT00066690|65216876|FG000|Overall Study|Death|3|||
23401680|NCT00066690|65216877|FG001|Overall Study|Death|0|||
23401681|NCT00066690|65216878|FG002|Overall Study|Death|2|||
23401682|NCT00066690|65216876|FG000|Overall Study|Lack of Efficacy|114|||
23401683|NCT00066690|65216877|FG001|Overall Study|Lack of Efficacy|110|||
23401684|NCT00066690|65216878|FG002|Overall Study|Lack of Efficacy|76|||
23401685|NCT00066690|65216876|FG000|Overall Study|Lost to Follow-up|40|||
23401686|NCT00066690|65216877|FG001|Overall Study|Lost to Follow-up|21|||
23401687|NCT00066690|65216878|FG002|Overall Study|Lost to Follow-up|29|||
23401688|NCT00066690|65216876|FG000|Overall Study|Withdrawal by Subject|50|||
23302202|NCT03036839|64847067|FG002|Overall Study|Withdrew Consent|1|||
23302203|NCT01875471|64847068|FG000|Overall Study|Adverse Event|0|||
23302204|NCT01875471|64847069|FG001|Overall Study|Adverse Event|1|||
23302205|NCT01875471|64847068|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
23302206|NCT01875471|64847069|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
23302207|NCT03463993|64847070|FG000|Overall Study|Lost to Follow-up|7|||
23302208|NCT03463993|64847071|FG001|Overall Study|Lost to Follow-up|8|||
23302209|NCT03463993|64847070|FG000|Overall Study|Withdrawal by Subject|2|||
23302210|NCT03463993|64847071|FG001|Overall Study|Withdrawal by Subject|0|||
23401689|NCT00066690|65216877|FG001|Overall Study|Withdrawal by Subject|55|||
23401690|NCT00066690|65216878|FG002|Overall Study|Withdrawal by Subject|49|||
23401691|NCT00066690|65216876|FG000|Overall Study|Treatment Ongoing|246|||
23401692|NCT00066690|65216877|FG001|Overall Study|Treatment Ongoing|278|||
23401693|NCT00066690|65216878|FG002|Overall Study|Treatment Ongoing|282|||
23401694|NCT05142306|65216879|FG000|Overall Study|Withdrawal by Subject|0|||
23401695|NCT05142306|65216880|FG001|Overall Study|Withdrawal by Subject|0|||
23401696|NCT05142306|65216881|FG002|Overall Study|Withdrawal by Subject|1|||
23401697|NCT04716894|65216882|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
23401698|NCT04716894|65216882|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
23401699|NCT01173679|65216883|FG000|Overall Study|Death|1|||
23401700|NCT04778592|65216884|FG000|Overall Study|Adverse Event|1|||
23401701|NCT04778592|65216885|FG001|Overall Study|Adverse Event|2|||
23401702|NCT04778592|65216884|FG000|Overall Study|Withdrawal by Subject|1|||
23401703|NCT04778592|65216885|FG001|Overall Study|Withdrawal by Subject|2|||
23401704|NCT00692003|65216886|FG000|Overall Study|Sponsor Decision|5|||
23401705|NCT00692003|65216887|FG001|Overall Study|Sponsor Decision|1|||
23401706|NCT04781816|65216888|FG000|Overall Study|Adverse Event|0|||
23401707|NCT04781816|65216889|FG001|Overall Study|Adverse Event|1|||
23401708|NCT04781816|65216888|FG000|Overall Study|Withdrawal by Subject|1|||
23401709|NCT04781816|65216889|FG001|Overall Study|Withdrawal by Subject|1|||
23401710|NCT04781816|65216888|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
23401711|NCT04781816|65216889|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
23401712|NCT01819272|65216892|FG000|Overall Study|Adverse Event|1|||
23401713|NCT01819272|65216893|FG001|Overall Study|Adverse Event|0|||
23401714|NCT01819272|65216894|FG002|Overall Study|Adverse Event|0|||
23401715|NCT01819272|65216895|FG003|Overall Study|Adverse Event|2|||
23401716|NCT01819272|65216896|FG004|Overall Study|Adverse Event|0|||
23401717|NCT01819272|65216897|FG005|Overall Study|Adverse Event|0|||
23401718|NCT01819272|65216892|FG000|Overall Study|Lost to Follow-up|3|||
23401719|NCT01819272|65216893|FG001|Overall Study|Lost to Follow-up|0|||
23401720|NCT01819272|65216894|FG002|Overall Study|Lost to Follow-up|1|||
23401721|NCT01819272|65216895|FG003|Overall Study|Lost to Follow-up|0|||
23401722|NCT01819272|65216896|FG004|Overall Study|Lost to Follow-up|0|||
23401723|NCT01819272|65216897|FG005|Overall Study|Lost to Follow-up|3|||
23401724|NCT01819272|65216892|FG000|Overall Study|Protocol Violation|0|||
23401725|NCT01819272|65216893|FG001|Overall Study|Protocol Violation|0|||
23401726|NCT01819272|65216894|FG002|Overall Study|Protocol Violation|0|||
23401727|NCT01819272|65216895|FG003|Overall Study|Protocol Violation|1|||
23401728|NCT01819272|65216896|FG004|Overall Study|Protocol Violation|2|||
23401729|NCT01819272|65216897|FG005|Overall Study|Protocol Violation|3|||
23401730|NCT01819272|65216892|FG000|Overall Study|Physician Decision|0|||
23401731|NCT01819272|65216893|FG001|Overall Study|Physician Decision|1|||
23401732|NCT01819272|65216894|FG002|Overall Study|Physician Decision|0|||
23401733|NCT01819272|65216895|FG003|Overall Study|Physician Decision|0|||
23401734|NCT01819272|65216896|FG004|Overall Study|Physician Decision|0|||
23401735|NCT01819272|65216897|FG005|Overall Study|Physician Decision|0|||
23401736|NCT01819272|65216892|FG000|Overall Study|Withdrawal of Consent|0|||
23401737|NCT01819272|65216893|FG001|Overall Study|Withdrawal of Consent|1|||
23401738|NCT01819272|65216894|FG002|Overall Study|Withdrawal of Consent|2|||
23401739|NCT01819272|65216895|FG003|Overall Study|Withdrawal of Consent|1|||
23401740|NCT01819272|65216896|FG004|Overall Study|Withdrawal of Consent|0|||
23401741|NCT01819272|65216897|FG005|Overall Study|Withdrawal of Consent|1|||
23401742|NCT01819272|65216892|FG000|Overall Study|Loss of Glucose Control|2|||
23401743|NCT01819272|65216893|FG001|Overall Study|Loss of Glucose Control|1|||
23401744|NCT01819272|65216894|FG002|Overall Study|Loss of Glucose Control|0|||
23401745|NCT01819272|65216895|FG003|Overall Study|Loss of Glucose Control|1|||
23401746|NCT01819272|65216896|FG004|Overall Study|Loss of Glucose Control|2|||
23401747|NCT01819272|65216897|FG005|Overall Study|Loss of Glucose Control|0|||
23401748|NCT01088503|65216899|FG000|Overall Study|Withdrawal by Subject|118|||
23401749|NCT01088503|65216900|FG001|Overall Study|Withdrawal by Subject|327|||
23401750|NCT01088503|65216901|FG002|Overall Study|Withdrawal by Subject|10|||
23401751|NCT01088503|65216899|FG000|Overall Study|Death|64|||
23401752|NCT01088503|65216900|FG001|Overall Study|Death|358|||
23401753|NCT01088503|65216901|FG002|Overall Study|Death|7|||
23401754|NCT02761642|65216902|FG000|Overall Study|Did not Receive Study Treatment|3|||
23401755|NCT02761642|65216902|FG000|Overall Study|Adverse Event|13|||
23401756|NCT02761642|65216902|FG000|Overall Study|Withdrawal by Subject|2|||
23401757|NCT02761642|65216902|FG000|Overall Study|Non-compliant|7|||
23401758|NCT02761642|65216902|FG000|Overall Study|Death|3|||
23401759|NCT02761642|65216902|FG000|Overall Study|Lack of Efficacy|20|||
23401760|NCT02761642|65216902|FG000|Overall Study|Physician Decision|1|||
23401761|NCT02761642|65216902|FG000|Overall Study|Reason Unspecified|21|||
23401762|NCT02121509|65216908|FG000|Washout Period (35 Days)|Adverse Event|1|||
23401763|NCT02121509|65216909|FG001|Washout Period (35 Days)|Adverse Event|1|||
23401764|NCT02121509|65216910|FG002|Washout Period (35 Days)|Adverse Event|0|||
23401765|NCT02121509|65216911|FG003|Washout Period (35 Days)|Adverse Event|0|||
23401766|NCT02121509|65216908|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
23401767|NCT02121509|65216909|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
23401768|NCT02121509|65216910|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
23401769|NCT02121509|65216911|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
23401770|NCT02121509|65216908|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
23401771|NCT02121509|65216909|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
23401772|NCT02121509|65216910|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
23401773|NCT02121509|65216911|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
23401774|NCT03423602|65216916|FG000|Overall Study|Death|1|||
23401775|NCT03423602|65216916|FG000|Overall Study|Lost to Follow-up|6|||
23401776|NCT03423602|65216916|FG000|Overall Study|Protocol Violation|1|||
23401777|NCT03423602|65216916|FG000|Overall Study|Withdrawal by Subject|4|||
23401778|NCT03559270|65216917|FG000|Overall Study|Adverse Event|6|||
23401779|NCT03559270|65216918|FG001|Overall Study|Adverse Event|5|||
23401780|NCT03559270|65216919|FG002|Overall Study|Adverse Event|3|||
23401781|NCT03559270|65216920|FG003|Overall Study|Adverse Event|0|||
23401782|NCT03559270|65216917|FG000|Overall Study|Lack of Efficacy|34|||
23401783|NCT03559270|65216918|FG001|Overall Study|Lack of Efficacy|52|||
23401784|NCT03559270|65216919|FG002|Overall Study|Lack of Efficacy|37|||
23401785|NCT03559270|65216920|FG003|Overall Study|Lack of Efficacy|2|||
23401786|NCT03559270|65216917|FG000|Overall Study|Death|0|||
23401787|NCT03559270|65216918|FG001|Overall Study|Death|2|||
23401788|NCT03559270|65216919|FG002|Overall Study|Death|0|||
23401789|NCT03559270|65216920|FG003|Overall Study|Death|0|||
23401790|NCT03559270|65216917|FG000|Overall Study|Lost to Follow-up|16|||
23401791|NCT03559270|65216918|FG001|Overall Study|Lost to Follow-up|4|||
23401792|NCT03559270|65216919|FG002|Overall Study|Lost to Follow-up|12|||
23401793|NCT03559270|65216920|FG003|Overall Study|Lost to Follow-up|3|||
23401794|NCT03559270|65216917|FG000|Overall Study|Sponsor Decision|38|||
23401795|NCT03559270|65216918|FG001|Overall Study|Sponsor Decision|31|||
23401796|NCT03559270|65216919|FG002|Overall Study|Sponsor Decision|35|||
23401797|NCT03559270|65216920|FG003|Overall Study|Sponsor Decision|18|||
23401798|NCT03559270|65216917|FG000|Overall Study|Withdrawal by Subject|19|||
23401799|NCT03559270|65216918|FG001|Overall Study|Withdrawal by Subject|21|||
23401800|NCT03559270|65216919|FG002|Overall Study|Withdrawal by Subject|18|||
23401801|NCT03559270|65216920|FG003|Overall Study|Withdrawal by Subject|7|||
23401802|NCT03559270|65216917|FG000|Overall Study|Physician Decision|3|||
23401803|NCT03559270|65216918|FG001|Overall Study|Physician Decision|2|||
23401804|NCT03559270|65216919|FG002|Overall Study|Physician Decision|1|||
23401805|NCT03559270|65216920|FG003|Overall Study|Physician Decision|0|||
23401806|NCT03559270|65216917|FG000|Overall Study|Pregnancy|0|||
23401807|NCT03559270|65216918|FG001|Overall Study|Pregnancy|1|||
23401808|NCT03559270|65216919|FG002|Overall Study|Pregnancy|0|||
23401809|NCT03559270|65216920|FG003|Overall Study|Pregnancy|0|||
23401810|NCT03559270|65216917|FG000|Overall Study|Protocol Violation|1|||
23401811|NCT03559270|65216918|FG001|Overall Study|Protocol Violation|0|||
23401812|NCT03559270|65216919|FG002|Overall Study|Protocol Violation|2|||
23401813|NCT03559270|65216920|FG003|Overall Study|Protocol Violation|0|||
23401814|NCT02197572|65216921|FG000|Overall Study|Progressive Disease|28|||
23401815|NCT02197572|65216921|FG000|Overall Study|Withdrawal by Subject|9|||
23401816|NCT02197572|65216921|FG000|Overall Study|Adverse Event|3|||
23401817|NCT02197572|65216921|FG000|Overall Study|Reason Not Specified|4|||
23401818|NCT03507127|65216922|FG000|Overall Study|Withdrawal by Subject|1|||
23401819|NCT03507127|65216923|FG001|Overall Study|Withdrawal by Subject|0|||
23401820|NCT03507127|65216922|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
23401821|NCT03507127|65216923|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
23401822|NCT00707993|65216924|FG000|Overall Study|Adverse Event|16|||
23401823|NCT00707993|65216925|FG001|Overall Study|Adverse Event|20|||
23401824|NCT00707993|65216924|FG000|Overall Study|Protocol Violation|4|||
23401825|NCT00707993|65216925|FG001|Overall Study|Protocol Violation|7|||
23401826|NCT00707993|65216924|FG000|Overall Study|Lost to Follow-up|0|||
23401827|NCT00707993|65216925|FG001|Overall Study|Lost to Follow-up|4|||
23401828|NCT00707993|65216924|FG000|Overall Study|Withdrawal by Subject|12|||
23401829|NCT00707993|65216925|FG001|Overall Study|Withdrawal by Subject|16|||
23401830|NCT00707993|65216924|FG000|Overall Study|Hyperglycemic Rescue|55|||
23401831|NCT00707993|65216925|FG001|Overall Study|Hyperglycemic Rescue|47|||
23401832|NCT00707993|65216924|FG000|Overall Study|Other|2|||
23401833|NCT00707993|65216925|FG001|Overall Study|Other|0|||
23401834|NCT01500317|65216926|FG000|Overall Study|Withdrawal by Subject|3|||
23401835|NCT01500317|65216927|FG001|Overall Study|Withdrawal by Subject|2|||
23401836|NCT01500317|65216928|FG002|Overall Study|Withdrawal by Subject|0|||
23401837|NCT02431325|65216929|FG000|Overall Study|Adverse Event|3|||
23401838|NCT02431325|65216930|FG001|Overall Study|Adverse Event|0|||
23401839|NCT02431325|65216929|FG000|Overall Study|Lost to Follow-up|0|||
23401840|NCT02431325|65216930|FG001|Overall Study|Lost to Follow-up|1|||
23401841|NCT02431325|65216929|FG000|Overall Study|Withdrawal by Subject|1|||
23401842|NCT02431325|65216930|FG001|Overall Study|Withdrawal by Subject|2|||
23401843|NCT02431325|65216929|FG000|Overall Study|Declined to take study medication|1|||
23401844|NCT02431325|65216930|FG001|Overall Study|Declined to take study medication|0|||
23401845|NCT02431325|65216929|FG000|Overall Study|Withdrew before starting study medication|1|||
23401846|NCT02431325|65216930|FG001|Overall Study|Withdrew before starting study medication|0|||
23401847|NCT02431325|65216929|FG000|Overall Study|Placebo shortage|2|||
23401848|NCT02431325|65216930|FG001|Overall Study|Placebo shortage|0|||
23401849|NCT03698279|65216931|FG000|Overall Study|Withdrawal by parent/guardian|1|||
23401850|NCT03698279|65216932|FG001|Overall Study|Withdrawal by parent/guardian|1|||
23401851|NCT03698279|65216933|FG002|Overall Study|Withdrawal by parent/guardian|1|||
23401852|NCT03698279|65216934|FG003|Overall Study|Withdrawal by parent/guardian|1|||
23401853|NCT03698279|65216935|FG004|Overall Study|Withdrawal by parent/guardian|0|||
23401854|NCT03698279|65216936|FG005|Overall Study|Withdrawal by parent/guardian|0|||
23401855|NCT03698279|65216931|FG000|Overall Study|Protocol deviation|1|||
23401856|NCT03698279|65216932|FG001|Overall Study|Protocol deviation|0|||
23401857|NCT03698279|65216933|FG002|Overall Study|Protocol deviation|1|||
23401858|NCT03698279|65216934|FG003|Overall Study|Protocol deviation|0|||
23401859|NCT03698279|65216935|FG004|Overall Study|Protocol deviation|0|||
23401860|NCT03698279|65216936|FG005|Overall Study|Protocol deviation|0|||
23401861|NCT03698279|65216931|FG000|Overall Study|Withdrawal by Subject|0|||
23401862|NCT03698279|65216932|FG001|Overall Study|Withdrawal by Subject|0|||
23401863|NCT03698279|65216933|FG002|Overall Study|Withdrawal by Subject|1|||
23401864|NCT03698279|65216934|FG003|Overall Study|Withdrawal by Subject|0|||
23401865|NCT03698279|65216935|FG004|Overall Study|Withdrawal by Subject|0|||
23401866|NCT03698279|65216936|FG005|Overall Study|Withdrawal by Subject|0|||
23401867|NCT03698279|65216931|FG000|Overall Study|Lost to Follow-up|3|||
23401868|NCT03698279|65216932|FG001|Overall Study|Lost to Follow-up|1|||
23401869|NCT03698279|65216933|FG002|Overall Study|Lost to Follow-up|4|||
23401870|NCT03698279|65216934|FG003|Overall Study|Lost to Follow-up|5|||
23401871|NCT03698279|65216935|FG004|Overall Study|Lost to Follow-up|0|||
23401872|NCT03698279|65216936|FG005|Overall Study|Lost to Follow-up|0|||
23401873|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
23401874|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
23401875|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
23401876|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
23401877|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
23401878|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
23401879|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
23401880|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
23401881|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
23401882|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
23401883|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
23401884|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
23401885|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
23401886|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
23401887|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
23401888|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
23401889|NCT00953706|65216940|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
23401890|NCT00953706|65216941|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
23401891|NCT00953706|65216942|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
23401892|NCT00953706|65216943|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
23401893|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
23401894|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
23401895|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
23401896|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
23401897|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
23401898|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
23401899|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
23401900|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
23401901|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
23401902|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
23401903|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
23401904|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
23401905|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
23401906|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
23401907|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
23401908|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
23401909|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
23401910|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
23401911|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
23401912|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
23401913|NCT00953706|65216940|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
23401914|NCT00953706|65216941|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
23401915|NCT00953706|65216942|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
23401916|NCT00953706|65216943|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
23401917|NCT00586157|65216946|FG000|First Intervention|Worsening behavior|1|||
23401918|NCT00586157|65216947|FG001|First Intervention|Worsening behavior|0|||
23401919|NCT00586157|65216946|FG000|Second Intervention|Withdrawal by Subject|1|||
23401920|NCT00586157|65216947|FG001|Second Intervention|Withdrawal by Subject|0|||
23401921|NCT00586157|65216946|FG000|Second Intervention|Worsening behavior|1|||
23401922|NCT00586157|65216947|FG001|Second Intervention|Worsening behavior|0|||
23401923|NCT00586157|65216946|FG000|Second Intervention|Adverse Event|0|||
23401924|NCT00586157|65216947|FG001|Second Intervention|Adverse Event|1|||
23401925|NCT00244621|65216948|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
23401926|NCT00244621|65216949|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
23401927|NCT00244621|65216950|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
23401928|NCT00244621|65216948|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
23401929|NCT00244621|65216949|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
23401930|NCT00244621|65216950|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
23401931|NCT00244621|65216948|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
23401932|NCT00244621|65216949|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
23401933|NCT00244621|65216950|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
23401934|NCT00244621|65216948|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
23401935|NCT00244621|65216949|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
23401936|NCT00244621|65216950|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
23401937|NCT00244621|65216948|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
23401938|NCT00244621|65216949|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
23401939|NCT00244621|65216950|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
23401940|NCT00244621|65216948|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
23401941|NCT00244621|65216949|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
23401942|NCT00244621|65216950|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
23401943|NCT00244621|65216948|FG000|Open-label Treatment Period|Adverse Event|0|||
23302211|NCT03463993|64847070|FG000|Overall Study|Protocol Violation|4|||
23302212|NCT03463993|64847071|FG001|Overall Study|Protocol Violation|1|||
23302213|NCT03463993|64847070|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
23401944|NCT00244621|65216949|FG001|Open-label Treatment Period|Adverse Event|0|||
23401945|NCT00244621|65216950|FG002|Open-label Treatment Period|Adverse Event|1|||
23401946|NCT00244621|65216948|FG000|Open-label Treatment Period|Moved abroad|0|||
23401947|NCT00244621|65216949|FG001|Open-label Treatment Period|Moved abroad|0|||
23401948|NCT00244621|65216950|FG002|Open-label Treatment Period|Moved abroad|1|||
23401949|NCT01083602|65216951|FG000|Overall Study|Adverse Event|11|||
23401950|NCT01083602|65216951|FG000|Overall Study|New Cancer Therapy|2|||
23401951|NCT01083602|65216951|FG000|Overall Study|Death|1|||
23401952|NCT01083602|65216951|FG000|Overall Study|Withdrawal by Subject|5|||
23401953|NCT01083602|65216951|FG000|Overall Study|Lack of Efficacy|36|||
23401954|NCT01897532|65216955|FG000|Discontinuation From Treatment|Not Treated|7|||
23401955|NCT01897532|65216956|FG001|Discontinuation From Treatment|Not Treated|5|||
23401956|NCT01897532|65216955|FG000|Discontinuation From Treatment|Other reason than specified|196|||
23401957|NCT01897532|65216956|FG001|Discontinuation From Treatment|Other reason than specified|176|||
23401958|NCT01897532|65216955|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
23401959|NCT01897532|65216956|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
23401960|NCT01897532|65216955|FG000|Discontinuation From Treatment|Non compliance|24|||
23401961|NCT01897532|65216956|FG001|Discontinuation From Treatment|Non compliance|15|||
23401962|NCT01897532|65216955|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
23401963|NCT01897532|65216956|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
23401964|NCT01897532|65216955|FG000|Discontinuation From Trial|Not Treated|7|||
23401965|NCT01897532|65216956|FG001|Discontinuation From Trial|Not Treated|5|||
23401966|NCT01897532|65216955|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
23401967|NCT01897532|65216956|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
23401968|NCT00278161|65216957|FG000|Overall Study|Death|11|||
23401969|NCT02297412|65216958|FG000|Overall Study|Canceled|1|||
23401970|NCT02297412|65216959|FG001|Overall Study|Canceled|1|||
23401971|NCT00487981|65216960|FG000|Overall Study|Hypothyroidism diagnosis|1|||
23401972|NCT00696878|65216961|FG000|Overall Study|Adverse Event|8|||
23401973|NCT00696878|65216961|FG000|Overall Study|Withdrawal by Subject|87|||
23401974|NCT00696878|65216961|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
23302214|NCT03463993|64847071|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
23302215|NCT03463993|64847070|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
23302216|NCT03463993|64847071|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
23302217|NCT00186043|64847084|FG000|Overall Study|Lack of Efficacy|1|||
23302218|NCT00186043|64847085|FG001|Overall Study|Lack of Efficacy|3|||
23302219|NCT00186043|64847084|FG000|Overall Study|Lost to Follow-up|4|||
23302220|NCT00186043|64847085|FG001|Overall Study|Lost to Follow-up|6|||
23302221|NCT00186043|64847084|FG000|Overall Study|Withdrawal by Subject|1|||
23302222|NCT00186043|64847085|FG001|Overall Study|Withdrawal by Subject|0|||
23302223|NCT00186043|64847084|FG000|Overall Study|Adverse Event|7|||
23302224|NCT00186043|64847085|FG001|Overall Study|Adverse Event|3|||
23302225|NCT00186043|64847084|FG000|Overall Study|Protocol Violation|2|||
23302226|NCT00186043|64847085|FG001|Overall Study|Protocol Violation|1|||
23302227|NCT02302859|64847086|FG000|Overall Study|Lost Phone|1|||
23302228|NCT02302859|64847087|FG001|Overall Study|Lost Phone|1|||
23302229|NCT02302859|64847086|FG000|Overall Study|Withdrawal by Subject|0|||
23302230|NCT02302859|64847087|FG001|Overall Study|Withdrawal by Subject|1|||
23302231|NCT02991430|64847091|FG000|Treatment Period 1|Adverse Event|1|||
23302232|NCT02991430|64847092|FG001|Treatment Period 1|Adverse Event|0|||
23302233|NCT02991430|64847093|FG002|Treatment Period 1|Adverse Event|2|||
23302234|NCT02991430|64847091|FG000|Treatment Period 1|Withdrawal by Subject|0|||
23302235|NCT02991430|64847092|FG001|Treatment Period 1|Withdrawal by Subject|4|||
23302236|NCT02991430|64847093|FG002|Treatment Period 1|Withdrawal by Subject|0|||
23302237|NCT02991430|64847091|FG000|Treatment Period 2|Study Termination|6|||
23302238|NCT02991430|64847092|FG001|Treatment Period 2|Study Termination|3|||
23302239|NCT02991430|64847093|FG002|Treatment Period 2|Study Termination|3|||
23302240|NCT02991430|64847091|FG000|Treatment Period 2|Lost to Follow-up|0|||
23302241|NCT02991430|64847092|FG001|Treatment Period 2|Lost to Follow-up|0|||
23302242|NCT02991430|64847093|FG002|Treatment Period 2|Lost to Follow-up|1|||
23302243|NCT02991430|64847091|FG000|Post-treatment Observation Period|Study Termination|3|||
23302244|NCT02991430|64847092|FG001|Post-treatment Observation Period|Study Termination|6|||
23302245|NCT02991430|64847093|FG002|Post-treatment Observation Period|Study Termination|5|||
23302246|NCT02615171|64847094|FG000|Overall Study|Lost to Follow-up|2|||
23302247|NCT02615171|64847095|FG001|Overall Study|Lost to Follow-up|1|||
23302248|NCT00252174|64847098|FG000|Overall Study|Withdrawal by Subject|0|||
23302249|NCT00252174|64847099|FG001|Overall Study|Withdrawal by Subject|1|||
23302250|NCT00252174|64847100|FG002|Overall Study|Withdrawal by Subject|0|||
23302251|NCT03456960|64847101|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23302252|NCT03456960|64847102|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23302253|NCT03456960|64847103|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
23302254|NCT03456960|64847104|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
23302255|NCT03456960|64847105|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23302256|NCT03456960|64847106|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
23302257|NCT03456960|64847101|FG000|Period 2 (1 Day)|Adverse Event|1|||
23302258|NCT03456960|64847102|FG001|Period 2 (1 Day)|Adverse Event|0|||
23302259|NCT03456960|64847103|FG002|Period 2 (1 Day)|Adverse Event|0|||
23302260|NCT03456960|64847104|FG003|Period 2 (1 Day)|Adverse Event|1|||
23302261|NCT03456960|64847105|FG004|Period 2 (1 Day)|Adverse Event|0|||
23302262|NCT03456960|64847106|FG005|Period 2 (1 Day)|Adverse Event|0|||
23302263|NCT02622113|64847111|FG000|Overall Study|Adverse Event|4|||
23302264|NCT02622113|64847112|FG001|Overall Study|Adverse Event|4|||
23302265|NCT02622113|64847111|FG000|Overall Study|Physician Decision|0|||
23302266|NCT02622113|64847112|FG001|Overall Study|Physician Decision|1|||
23302267|NCT02622113|64847111|FG000|Overall Study|Withdrawal by Subject|0|||
23302268|NCT02622113|64847112|FG001|Overall Study|Withdrawal by Subject|2|||
23302269|NCT02622113|64847111|FG000|Overall Study|Stopping Criteria|1|||
23302270|NCT02622113|64847112|FG001|Overall Study|Stopping Criteria|3|||
23302271|NCT03250299|64847113|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
23302272|NCT03250299|64847114|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
23302273|NCT03250299|64847115|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
23302274|NCT03250299|64847116|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
23302275|NCT03250299|64847117|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
23302276|NCT03250299|64847113|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
23302277|NCT03250299|64847114|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
23302278|NCT03250299|64847115|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
23302279|NCT03250299|64847116|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
23302280|NCT03250299|64847117|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
23302281|NCT03250299|64847113|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
23302282|NCT03250299|64847114|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
23302283|NCT03250299|64847115|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
23302284|NCT03250299|64847116|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
23302285|NCT03250299|64847117|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
23302286|NCT03250299|64847113|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
23302287|NCT03250299|64847114|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
23302288|NCT03250299|64847115|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
23302289|NCT03250299|64847116|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
23302290|NCT03250299|64847117|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
23302291|NCT03254602|64847118|FG000|Overall Study|Lost to Follow-up|4|||
23302292|NCT00876018|64847119|FG000|Overall Study|Lost to Follow-up|0|||
23302293|NCT00876018|64847120|FG001|Overall Study|Lost to Follow-up|1|||
23302294|NCT00876018|64847121|FG002|Overall Study|Lost to Follow-up|1|||
23302295|NCT00876018|64847119|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
23302296|NCT00876018|64847120|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
23302297|NCT00876018|64847121|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
23302298|NCT00003138|64847124|FG000|Step 1|Reasons off treatment not documented|60|||
23302299|NCT00003138|64847125|FG001|Step 1|Reasons off treatment not documented|57|||
23302300|NCT00003138|64847124|FG000|Step 1|Never started treatment|1|||
23302301|NCT00003138|64847125|FG001|Step 1|Never started treatment|0|||
23302302|NCT00003138|64847124|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
23302303|NCT00003138|64847125|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
23302304|NCT00003138|64847124|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
23302305|NCT00003138|64847125|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
23302306|NCT00003138|64847124|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
23302307|NCT00003138|64847125|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
23302308|NCT00003138|64847124|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
23302309|NCT00003138|64847125|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
23302310|NCT01244061|64847128|FG000|Overall Study|Death|1|||
23302311|NCT01244061|64847129|FG001|Overall Study|Death|0|||
23302312|NCT01244061|64847128|FG000|Overall Study|Did not meet entrance criteria|1|||
23302313|NCT01244061|64847129|FG001|Overall Study|Did not meet entrance criteria|0|||
23302314|NCT01244061|64847128|FG000|Overall Study|Lack of Efficacy|1|||
23302315|NCT01244061|64847129|FG001|Overall Study|Lack of Efficacy|3|||
23302316|NCT01244061|64847128|FG000|Overall Study|Lost to Follow-up|34|||
23302317|NCT01244061|64847129|FG001|Overall Study|Lost to Follow-up|30|||
23302318|NCT01244061|64847128|FG000|Overall Study|Withdrawal by Subject|29|||
23302319|NCT01244061|64847129|FG001|Overall Study|Withdrawal by Subject|46|||
23302320|NCT01244061|64847128|FG000|Overall Study|Other|8|||
23302321|NCT01244061|64847129|FG001|Overall Study|Other|19|||
23302322|NCT01244061|64847128|FG000|Overall Study|Protocol Violation|1|||
23302323|NCT01244061|64847129|FG001|Overall Study|Protocol Violation|1|||
23302324|NCT01244061|64847128|FG000|Overall Study|Adverse Event|5|||
23302325|NCT01244061|64847129|FG001|Overall Study|Adverse Event|2|||
23302326|NCT01244061|64847128|FG000|Overall Study|Randomized but not treated|2|||
23302327|NCT01244061|64847129|FG001|Overall Study|Randomized but not treated|2|||
23302328|NCT02013375|64847130|FG000|Overall Study|Did not engraft|1|||
23302329|NCT02013375|64847130|FG000|Overall Study|Did not engraft|1|||
23302330|NCT01079832|64847134|FG000|Overall Study|Withdrawal by Subject|1|||
23401975|NCT00696878|65216961|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
23401976|NCT00696878|65216961|FG000|Overall Study|Trial stopped|32|||
23401977|NCT00696878|65216961|FG000|Overall Study|Other reason (not specified)|55|||
23401978|NCT01897493|65216964|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
23401979|NCT02834819|65216966|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
23401980|NCT02834819|65216967|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
23401981|NCT02136914|65216971|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
23401982|NCT02136914|65216972|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
23401983|NCT02136914|65216971|FG000|Overall Study|Withdrawal by Subject|3|||
23401984|NCT02136914|65216972|FG001|Overall Study|Withdrawal by Subject|10|||
23401985|NCT02136914|65216971|FG000|Overall Study|Subject Unwilling to Proceed|7|||
23401986|NCT02136914|65216972|FG001|Overall Study|Subject Unwilling to Proceed|2|||
23401987|NCT02136914|65216971|FG000|Overall Study|Lost to Follow-up|1|||
23401988|NCT02136914|65216972|FG001|Overall Study|Lost to Follow-up|1|||
23401989|NCT02136914|65216971|FG000|Overall Study|Did Not Receive Study Drug|2|||
23401990|NCT02136914|65216972|FG001|Overall Study|Did Not Receive Study Drug|0|||
23401991|NCT02136914|65216971|FG000|Overall Study|Lack of Efficacy|1|||
23401992|NCT02136914|65216972|FG001|Overall Study|Lack of Efficacy|0|||
23401993|NCT02136914|65216971|FG000|Overall Study|Death|0|||
23401994|NCT02136914|65216972|FG001|Overall Study|Death|1|||
23401995|NCT02303262|65216973|FG000|Overall Study|Withdrawal by Subject|2|||
23401996|NCT03012334|65216977|FG000|Period 1|Withdrawal by Subject|0|||
23401997|NCT03012334|65216978|FG001|Period 1|Withdrawal by Subject|0|||
23401998|NCT03012334|65216979|FG002|Period 1|Withdrawal by Subject|0|||
23401999|NCT03012334|65216980|FG003|Period 1|Withdrawal by Subject|0|||
23402000|NCT03012334|65216981|FG004|Period 1|Withdrawal by Subject|0|||
23402001|NCT03012334|65216982|FG005|Period 1|Withdrawal by Subject|0|||
23402002|NCT03012334|65216983|FG006|Period 1|Withdrawal by Subject|0|||
23402003|NCT03012334|65216984|FG007|Period 1|Withdrawal by Subject|0|||
23402004|NCT03012334|65216985|FG008|Period 1|Withdrawal by Subject|0|||
23402005|NCT03012334|65216986|FG009|Period 1|Withdrawal by Subject|1|||
23402006|NCT03012334|65216977|FG000|Period 2|Withdrawal by Subject|0|||
23402007|NCT03012334|65216978|FG001|Period 2|Withdrawal by Subject|1|||
23402008|NCT03012334|65216979|FG002|Period 2|Withdrawal by Subject|0|||
23402009|NCT03012334|65216980|FG003|Period 2|Withdrawal by Subject|0|||
23402010|NCT03012334|65216981|FG004|Period 2|Withdrawal by Subject|0|||
23402011|NCT03012334|65216982|FG005|Period 2|Withdrawal by Subject|0|||
23402012|NCT03012334|65216983|FG006|Period 2|Withdrawal by Subject|0|||
23402013|NCT03012334|65216984|FG007|Period 2|Withdrawal by Subject|0|||
23402014|NCT03012334|65216985|FG008|Period 2|Withdrawal by Subject|0|||
23402015|NCT03012334|65216986|FG009|Period 2|Withdrawal by Subject|0|||
23402016|NCT03012334|65216977|FG000|Period 2|Protocol Violation|0|||
23402017|NCT03012334|65216978|FG001|Period 2|Protocol Violation|0|||
23402018|NCT03012334|65216979|FG002|Period 2|Protocol Violation|1|||
23402019|NCT03012334|65216980|FG003|Period 2|Protocol Violation|0|||
23402020|NCT03012334|65216981|FG004|Period 2|Protocol Violation|0|||
23402021|NCT03012334|65216982|FG005|Period 2|Protocol Violation|0|||
23402022|NCT03012334|65216983|FG006|Period 2|Protocol Violation|0|||
23402023|NCT03012334|65216984|FG007|Period 2|Protocol Violation|1|||
23402024|NCT03012334|65216985|FG008|Period 2|Protocol Violation|0|||
23402025|NCT03012334|65216986|FG009|Period 2|Protocol Violation|0|||
23402026|NCT03012334|65216977|FG000|Period 4|Non-Compliance|0|||
23402027|NCT03012334|65216978|FG001|Period 4|Non-Compliance|0|||
23402028|NCT03012334|65216979|FG002|Period 4|Non-Compliance|0|||
23402029|NCT03012334|65216980|FG003|Period 4|Non-Compliance|0|||
23402030|NCT03012334|65216981|FG004|Period 4|Non-Compliance|0|||
23402031|NCT03012334|65216982|FG005|Period 4|Non-Compliance|0|||
23402032|NCT03012334|65216983|FG006|Period 4|Non-Compliance|1|||
23402033|NCT03012334|65216984|FG007|Period 4|Non-Compliance|0|||
23402034|NCT03012334|65216985|FG008|Period 4|Non-Compliance|0|||
23402035|NCT03012334|65216986|FG009|Period 4|Non-Compliance|0|||
23402036|NCT03012334|65216977|FG000|Period 4|Adverse Event|0|||
23402037|NCT03012334|65216978|FG001|Period 4|Adverse Event|0|||
23402038|NCT03012334|65216979|FG002|Period 4|Adverse Event|0|||
23402039|NCT03012334|65216980|FG003|Period 4|Adverse Event|0|||
23402040|NCT03012334|65216981|FG004|Period 4|Adverse Event|0|||
23402041|NCT03012334|65216982|FG005|Period 4|Adverse Event|0|||
23402042|NCT03012334|65216983|FG006|Period 4|Adverse Event|0|||
23402043|NCT03012334|65216984|FG007|Period 4|Adverse Event|0|||
23402044|NCT03012334|65216985|FG008|Period 4|Adverse Event|1|||
23402045|NCT03012334|65216986|FG009|Period 4|Adverse Event|0|||
23402046|NCT00532844|65216988|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
23402047|NCT00532844|65216989|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
23402048|NCT00532844|65216988|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
23402049|NCT00532844|65216989|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
23402050|NCT00532844|65216988|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
23402051|NCT00532844|65216989|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
23402052|NCT00532844|65216988|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
23402053|NCT00532844|65216989|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
23402054|NCT00532844|65216988|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
23402055|NCT00532844|65216989|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
23402056|NCT03192137|65216995|FG000|Overall Study|Adverse Event|10|||
23402057|NCT03192137|65216996|FG001|Overall Study|Adverse Event|11|||
23402058|NCT03192137|65216995|FG000|Overall Study|Physician Decision|1|||
23402059|NCT03192137|65216996|FG001|Overall Study|Physician Decision|0|||
23402060|NCT03192137|65216995|FG000|Overall Study|Lack of Efficacy|20|||
23402061|NCT03192137|65216996|FG001|Overall Study|Lack of Efficacy|37|||
23402062|NCT03192137|65216995|FG000|Overall Study|Withdrawal by Subject|3|||
23402063|NCT03192137|65216996|FG001|Overall Study|Withdrawal by Subject|3|||
23402064|NCT03192137|65216995|FG000|Overall Study|Protocol Violation|4|||
23402065|NCT03192137|65216996|FG001|Overall Study|Protocol Violation|3|||
23402066|NCT03192137|65216995|FG000|Overall Study|Surgery Cancelled|4|||
23402067|NCT03192137|65216996|FG001|Overall Study|Surgery Cancelled|1|||
23402068|NCT03192137|65216995|FG000|Overall Study|Other - Various Administrative Reasons|8|||
23402069|NCT03192137|65216996|FG001|Overall Study|Other - Various Administrative Reasons|3|||
23402070|NCT02254291|65216997|FG000|Overall Study|Withdrawal by Subject|0|||
23402071|NCT02254291|65216998|FG001|Overall Study|Withdrawal by Subject|3|||
23402072|NCT02254291|65216999|FG002|Overall Study|Withdrawal by Subject|1|||
23402073|NCT02254291|65216997|FG000|Overall Study|Missing follow-up information|0|||
23402074|NCT02254291|65216998|FG001|Overall Study|Missing follow-up information|0|||
23402075|NCT02254291|65216999|FG002|Overall Study|Missing follow-up information|1|||
23402076|NCT01913327|65217000|FG000|Overall Study|Withdrawal by Subject|0|||
23402077|NCT01913327|65217001|FG001|Overall Study|Withdrawal by Subject|1|||
23402078|NCT03500211|65217002|FG000|Overall Study|Withdrawal by Subject|1|||
23402079|NCT03500211|65217003|FG001|Overall Study|Withdrawal by Subject|1|||
23402080|NCT01213082|65219749|FG000|Overall Study|Lost to Follow-up|6|||
23402081|NCT01213082|65219750|FG001|Overall Study|Lost to Follow-up|7|||
23402082|NCT01213082|65219751|FG002|Overall Study|Lost to Follow-up|4|||
23402083|NCT01213082|65219749|FG000|Overall Study|Physician Decision|0|||
23402084|NCT01213082|65219750|FG001|Overall Study|Physician Decision|0|||
23402085|NCT01213082|65219751|FG002|Overall Study|Physician Decision|1|||
23402086|NCT01334554|65219752|FG000|Overall Study|Adverse Event|4|||
23402087|NCT01334554|65219753|FG001|Overall Study|Adverse Event|2|||
23402088|NCT01847443|65219754|FG000|Study Period 1|Withdrawal by Subject|0|||
23402089|NCT01847443|65219755|FG001|Study Period 1|Withdrawal by Subject|1|||
23402090|NCT01847443|65219756|FG002|Study Period 1|Withdrawal by Subject|0|||
23402091|NCT01847443|65219757|FG003|Study Period 1|Withdrawal by Subject|0|||
23402092|NCT01847443|65219754|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
23402093|NCT01847443|65219755|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
23402094|NCT01847443|65219756|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
23402095|NCT01847443|65219757|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
23402096|NCT01847443|65219754|FG000|Washout Period Before Study Period 2|Other reason|1|||
23402097|NCT01847443|65219755|FG001|Washout Period Before Study Period 2|Other reason|0|||
23402098|NCT01847443|65219756|FG002|Washout Period Before Study Period 2|Other reason|0|||
23402099|NCT01847443|65219757|FG003|Washout Period Before Study Period 2|Other reason|0|||
23402100|NCT01847443|65219754|FG000|Washout Period Before Study Period 3|Other reason|1|||
23402101|NCT01847443|65219755|FG001|Washout Period Before Study Period 3|Other reason|0|||
23402102|NCT01847443|65219756|FG002|Washout Period Before Study Period 3|Other reason|0|||
23402103|NCT01847443|65219757|FG003|Washout Period Before Study Period 3|Other reason|0|||
23402104|NCT01847443|65219754|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
23402105|NCT01847443|65219755|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
23402106|NCT01847443|65219756|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
23402107|NCT01847443|65219757|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
23402108|NCT01847443|65219754|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
23402109|NCT01847443|65219755|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
23402110|NCT01847443|65219756|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
23402111|NCT01847443|65219757|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
23402112|NCT00948688|65219760|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
23402113|NCT00948688|65219761|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
23402114|NCT00948688|65219760|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
23402115|NCT00948688|65219761|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
23402116|NCT00948688|65219760|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
23402117|NCT00948688|65219761|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
23402118|NCT02332187|65219763|FG000|Overall Study|Withdrawal by Subject|2|||
23402119|NCT02332187|65219764|FG001|Overall Study|Withdrawal by Subject|2|||
23402120|NCT02332187|65219763|FG000|Overall Study|Adverse Event|0|||
23402121|NCT02332187|65219764|FG001|Overall Study|Adverse Event|1|||
23402122|NCT00305448|65219765|FG000|Overall Study|Protocol Violation|0|||
23402123|NCT00305448|65219766|FG001|Overall Study|Protocol Violation|1|||
23402124|NCT00305448|65219767|FG002|Overall Study|Protocol Violation|0|||
23402125|NCT00305448|65219765|FG000|Overall Study|Withdrawal by Subject|2|||
23402126|NCT00305448|65219766|FG001|Overall Study|Withdrawal by Subject|0|||
23402127|NCT00305448|65219767|FG002|Overall Study|Withdrawal by Subject|1|||
23402128|NCT00305448|65219765|FG000|Overall Study|Adverse Event|1|||
23402129|NCT00305448|65219766|FG001|Overall Study|Adverse Event|0|||
23402130|NCT00305448|65219767|FG002|Overall Study|Adverse Event|1|||
23402131|NCT00305448|65219765|FG000|Overall Study|Disease Progression|27|||
23402132|NCT00305448|65219766|FG001|Overall Study|Disease Progression|31|||
23402133|NCT00305448|65219767|FG002|Overall Study|Disease Progression|28|||
23402134|NCT00305448|65219765|FG000|Overall Study|Subjective Disease Progression|1|||
23402135|NCT00305448|65219766|FG001|Overall Study|Subjective Disease Progression|2|||
23402136|NCT00305448|65219767|FG002|Overall Study|Subjective Disease Progression|2|||
23402137|NCT00305448|65219765|FG000|Overall Study|Tumor Marker Elevation|0|||
23402138|NCT00305448|65219766|FG001|Overall Study|Tumor Marker Elevation|0|||
23402139|NCT00305448|65219767|FG002|Overall Study|Tumor Marker Elevation|1|||
23402140|NCT00436436|65219769|FG000|Overall Study|Progression|4|||
23402141|NCT00436436|65219769|FG000|Overall Study|Adverse Event|2|||
23402142|NCT00436436|65219769|FG000|Overall Study|Death|6|||
23402143|NCT04568603|65219770|FG000|Overall Study|Physician Decision|1|||
23402144|NCT01977222|65219784|FG000|Overall Study|Withdrawal by Subject|1|||
23402145|NCT00441272|65219787|FG000|Overall Study|Study terminated prior to enrollment|25|||
23402146|NCT00441272|65219788|FG001|Overall Study|Study terminated prior to enrollment|25|||
23402147|NCT02465931|65219789|FG000|Overall Study|Lost to Follow-up|9|||
23402148|NCT02465931|65219790|FG001|Overall Study|Lost to Follow-up|11|||
23402149|NCT02465931|65219789|FG000|Overall Study|Protocol Violation|1|||
23402150|NCT02465931|65219790|FG001|Overall Study|Protocol Violation|0|||
23402151|NCT02465931|65219789|FG000|Overall Study|Withdrawal by Subject|1|||
23402152|NCT02465931|65219790|FG001|Overall Study|Withdrawal by Subject|0|||
23402153|NCT04460183|65219791|FG000|Overall Study|Lost to Follow-up|3|||
23402154|NCT04460183|65219792|FG001|Overall Study|Lost to Follow-up|1|||
23402155|NCT04460183|65219791|FG000|Overall Study|Withdrawal by Subject|1|||
23402156|NCT04460183|65219792|FG001|Overall Study|Withdrawal by Subject|0|||
23402157|NCT01240863|65219793|FG000|Open-label Titration Period|Adverse Event|47|||
23402158|NCT01240863|65219794|FG001|Open-label Titration Period|Adverse Event|0|||
23402159|NCT01240863|65219795|FG002|Open-label Titration Period|Adverse Event|0|||
23402160|NCT01240863|65219793|FG000|Open-label Titration Period|Lack of Efficacy|19|||
23402161|NCT01240863|65219794|FG001|Open-label Titration Period|Lack of Efficacy|0|||
23402162|NCT01240863|65219795|FG002|Open-label Titration Period|Lack of Efficacy|0|||
23402163|NCT01240863|65219793|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
23402164|NCT01240863|65219794|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
23402165|NCT01240863|65219795|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
23402166|NCT01240863|65219793|FG000|Open-label Titration Period|Protocol Violation|7|||
23402167|NCT01240863|65219794|FG001|Open-label Titration Period|Protocol Violation|0|||
23402168|NCT01240863|65219795|FG002|Open-label Titration Period|Protocol Violation|0|||
23402169|NCT01240863|65219793|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
23402170|NCT01240863|65219794|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
23402171|NCT01240863|65219795|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
23402172|NCT01240863|65219793|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
23402173|NCT01240863|65219794|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
23402174|NCT01240863|65219795|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
23402175|NCT01240863|65219793|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
23402176|NCT01240863|65219794|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
23402177|NCT01240863|65219795|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
23402178|NCT01240863|65219793|FG000|Open-label Titration Period|Other|7|||
23402179|NCT01240863|65219794|FG001|Open-label Titration Period|Other|0|||
23402180|NCT01240863|65219795|FG002|Open-label Titration Period|Other|0|||
23402181|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
23402182|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
23402183|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
23402184|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
23402185|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
23402186|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
23402187|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
23402188|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
23402189|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
23402190|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
23402191|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
23402192|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
23402193|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
23402194|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
23402195|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
23402196|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
23402197|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
23402198|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
23402199|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
23402200|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
23402201|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
23402202|NCT01240863|65219793|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
23402203|NCT01240863|65219794|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
23402204|NCT01240863|65219795|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
23402205|NCT01428219|65219796|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
23402206|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
23402207|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
23402208|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
23402209|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
23402210|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
23402211|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
23402212|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
23402213|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
23402214|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
23402215|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
23402216|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
23402217|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
23402218|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
23402219|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
23402220|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
23402221|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
23402222|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
23402223|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
23402224|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
23402225|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
23402226|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
23402227|NCT04021290|65219797|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
23402228|NCT04021290|65219798|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
23402229|NCT04021290|65219799|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
23402230|NCT04021290|65219797|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
23402231|NCT04021290|65219798|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
23402232|NCT04021290|65219799|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
23402233|NCT04021290|65219797|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
23402234|NCT04021290|65219798|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
23402235|NCT04021290|65219799|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
23402236|NCT04021290|65219797|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
23402237|NCT04021290|65219798|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
23402238|NCT04021290|65219799|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
23402239|NCT04021290|65219797|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
23402240|NCT04021290|65219798|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
23402241|NCT04021290|65219799|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
23402242|NCT00806260|65219802|FG000|Period 1 (1 Day)|Adverse Event|0|||
23402243|NCT00806260|65219803|FG001|Period 1 (1 Day)|Adverse Event|0|||
23402244|NCT00806260|65219804|FG002|Period 1 (1 Day)|Adverse Event|0|||
23402245|NCT00806260|65219805|FG003|Period 1 (1 Day)|Adverse Event|0|||
23402246|NCT00806260|65219806|FG004|Period 1 (1 Day)|Adverse Event|3|||
23402247|NCT00806260|65219807|FG005|Period 1 (1 Day)|Adverse Event|0|||
23402248|NCT00806260|65219802|FG000|Period 2|Adverse Event|0|||
23402249|NCT00806260|65219803|FG001|Period 2|Adverse Event|0|||
23402250|NCT00806260|65219804|FG002|Period 2|Adverse Event|0|||
23402251|NCT00806260|65219805|FG003|Period 2|Adverse Event|1|||
23402252|NCT00806260|65219806|FG004|Period 2|Adverse Event|0|||
23402253|NCT00806260|65219807|FG005|Period 2|Adverse Event|0|||
23402254|NCT00806260|65219802|FG000|Period 2|Protocol Violation|1|||
23402255|NCT00806260|65219803|FG001|Period 2|Protocol Violation|0|||
23402256|NCT00806260|65219804|FG002|Period 2|Protocol Violation|1|||
23402257|NCT00806260|65219805|FG003|Period 2|Protocol Violation|0|||
23402258|NCT00806260|65219806|FG004|Period 2|Protocol Violation|0|||
23402259|NCT00806260|65219807|FG005|Period 2|Protocol Violation|0|||
23402260|NCT00806260|65219802|FG000|Period 2|Need to take concomitant medication|1|||
23402261|NCT00806260|65219803|FG001|Period 2|Need to take concomitant medication|0|||
23402262|NCT00806260|65219804|FG002|Period 2|Need to take concomitant medication|0|||
23402263|NCT00806260|65219805|FG003|Period 2|Need to take concomitant medication|0|||
23402264|NCT00806260|65219806|FG004|Period 2|Need to take concomitant medication|0|||
23402265|NCT00806260|65219807|FG005|Period 2|Need to take concomitant medication|0|||
23402266|NCT00806260|65219802|FG000|Period 2|sponsor request|0|||
23402267|NCT00806260|65219803|FG001|Period 2|sponsor request|0|||
23402268|NCT00806260|65219804|FG002|Period 2|sponsor request|1|||
23402269|NCT00806260|65219805|FG003|Period 2|sponsor request|1|||
23402270|NCT00806260|65219806|FG004|Period 2|sponsor request|0|||
23402271|NCT00806260|65219807|FG005|Period 2|sponsor request|0|||
23402272|NCT00806260|65219802|FG000|Period 3|Protocol Violation|0|||
23402273|NCT00806260|65219803|FG001|Period 3|Protocol Violation|1|||
23402274|NCT00806260|65219804|FG002|Period 3|Protocol Violation|1|||
23402275|NCT00806260|65219805|FG003|Period 3|Protocol Violation|0|||
23402276|NCT00806260|65219806|FG004|Period 3|Protocol Violation|0|||
23402277|NCT00806260|65219807|FG005|Period 3|Protocol Violation|0|||
23402278|NCT00806260|65219802|FG000|Period 3|Pregnancy|1|||
23402279|NCT00806260|65219803|FG001|Period 3|Pregnancy|0|||
23402280|NCT00806260|65219804|FG002|Period 3|Pregnancy|0|||
23402281|NCT00806260|65219805|FG003|Period 3|Pregnancy|0|||
23402282|NCT00806260|65219806|FG004|Period 3|Pregnancy|0|||
23402283|NCT00806260|65219807|FG005|Period 3|Pregnancy|0|||
23402284|NCT02031302|65219808|FG000|Overall Study|Death|115|||
23402285|NCT02031302|65219809|FG001|Overall Study|Death|0|||
23402286|NCT02031302|65219808|FG000|Overall Study|Not treated with study valve system|18|||
23402287|NCT02031302|65219809|FG001|Overall Study|Not treated with study valve system|0|||
23402288|NCT02031302|65219808|FG000|Overall Study|Missed Follow Up|27|||
23402289|NCT02031302|65219809|FG001|Overall Study|Missed Follow Up|0|||
23402290|NCT02031302|65219808|FG000|Overall Study|Lost to Follow-up|4|||
23402291|NCT02031302|65219809|FG001|Overall Study|Lost to Follow-up|0|||
23402292|NCT01976299|65219810|FG000|Overall Study|Withdrawal by Subject|3|||
23402293|NCT01976299|65219811|FG001|Overall Study|Withdrawal by Subject|1|||
23402294|NCT01976299|65219810|FG000|Overall Study|Death|4|||
23402295|NCT01976299|65219811|FG001|Overall Study|Death|2|||
23402296|NCT01976299|65219810|FG000|Overall Study|Lost to Follow-up|7|||
23402297|NCT01976299|65219811|FG001|Overall Study|Lost to Follow-up|1|||
23402298|NCT01976299|65219810|FG000|Overall Study|See clarification above in comments|9|||
23402299|NCT01976299|65219811|FG001|Overall Study|See clarification above in comments|2|||
23402300|NCT00583219|65219814|FG000|Phase 2|Withdrawal by Subject|1|||
23402301|NCT00742625|65219815|FG000|Remission Induction|Progression|6|||
23402302|NCT00742625|65219815|FG000|Remission Induction|Failed induction|8|||
23402303|NCT00742625|65219815|FG000|Remission Induction|Adverse Event|3|||
23402304|NCT00742625|65219815|FG000|Remission Induction|Death|10|||
23402305|NCT00742625|65219815|FG000|Remission Induction|Refusal|5|||
23402306|NCT00742625|65219815|FG000|Remission Induction|Non protocol treatment|17|||
23402307|NCT00742625|65219815|FG000|Remission Induction|Other, not specified|5|||
23402308|NCT00742625|65219815|FG000|Consolidation|Progression|5|||
23402309|NCT00742625|65219815|FG000|Consolidation|Adverse Event|1|||
23402310|NCT00742625|65219815|FG000|Consolidation|Death|1|||
23402311|NCT00742625|65219815|FG000|Consolidation|Refused|1|||
23402312|NCT00742625|65219815|FG000|Consolidation|Non protocol therapy|13|||
23402313|NCT02896257|65219830|FG000|Providers|Without eligible patients|21|||
23402314|NCT02896257|65219831|FG001|Providers|Without eligible patients|28|||
23402315|NCT02896257|65219830|FG000|Patients|PFT entry criteria not met|43|||
23402316|NCT02896257|65219831|FG001|Patients|PFT entry criteria not met|50|||
23402317|NCT02896257|65219830|FG000|Patients|No capacity to review|8|||
23402318|NCT02896257|65219831|FG001|Patients|No capacity to review|11|||
23402319|NCT02896257|65219830|FG000|Patients|Appointment rescheduled/cancelled|5|||
23402320|NCT02896257|65219831|FG001|Patients|Appointment rescheduled/cancelled|7|||
23402321|NCT02896257|65219830|FG000|Patients|PCP not assigned a clinic|4|||
23402322|NCT02896257|65219831|FG001|Patients|PCP not assigned a clinic|0|||
23402323|NCT02896257|65219830|FG000|Patients|No history of COPD|0|||
23402324|NCT02896257|65219831|FG001|Patients|No history of COPD|1|||
23402325|NCT02896257|65219830|FG000|Patients|Deceased between review and index date|0|||
23402326|NCT02896257|65219831|FG001|Patients|Deceased between review and index date|1|||
23402327|NCT02896257|65219830|FG000|Patients|No ICS Rx upon review|1|||
23402328|NCT02896257|65219831|FG001|Patients|No ICS Rx upon review|1|||
23402329|NCT02896257|65219830|FG000|Patients|Protocol Violation|2|||
23402330|NCT02896257|65219831|FG001|Patients|Protocol Violation|1|||
23402331|NCT02896257|65219830|FG000|Patients|Hospice care|0|||
23402332|NCT02896257|65219831|FG001|Patients|Hospice care|1|||
23402333|NCT04846231|65219832|FG000|Overall Study|Lost to Follow-up|1|||
23402334|NCT04846231|65219833|FG001|Overall Study|Lost to Follow-up|0|||
23402335|NCT04846231|65219834|FG002|Overall Study|Lost to Follow-up|0|||
23402336|NCT04846231|65219835|FG003|Overall Study|Lost to Follow-up|0|||
23402337|NCT04846231|65219836|FG004|Overall Study|Lost to Follow-up|0|||
23402338|NCT04846231|65219837|FG005|Overall Study|Lost to Follow-up|0|||
23402339|NCT04846231|65219838|FG006|Overall Study|Lost to Follow-up|0|||
23402340|NCT04846231|65219839|FG007|Overall Study|Lost to Follow-up|1|||
23402341|NCT04846231|65219832|FG000|Overall Study|Withdrawal by Subject|0|||
23402342|NCT04846231|65219833|FG001|Overall Study|Withdrawal by Subject|1|||
23402343|NCT04846231|65219834|FG002|Overall Study|Withdrawal by Subject|2|||
23402344|NCT04846231|65219835|FG003|Overall Study|Withdrawal by Subject|1|||
23402345|NCT04846231|65219836|FG004|Overall Study|Withdrawal by Subject|0|||
23402346|NCT04846231|65219837|FG005|Overall Study|Withdrawal by Subject|0|||
23402347|NCT04846231|65219838|FG006|Overall Study|Withdrawal by Subject|0|||
23402348|NCT04846231|65219839|FG007|Overall Study|Withdrawal by Subject|0|||
23402349|NCT04846231|65219832|FG000|Overall Study|Protocol Violation|0|||
23402350|NCT04846231|65219833|FG001|Overall Study|Protocol Violation|1|||
23402351|NCT04846231|65219834|FG002|Overall Study|Protocol Violation|0|||
23402352|NCT04846231|65219835|FG003|Overall Study|Protocol Violation|0|||
23402353|NCT04846231|65219836|FG004|Overall Study|Protocol Violation|0|||
23402354|NCT04846231|65219837|FG005|Overall Study|Protocol Violation|0|||
23402355|NCT04846231|65219838|FG006|Overall Study|Protocol Violation|0|||
23402356|NCT04846231|65219839|FG007|Overall Study|Protocol Violation|0|||
23402357|NCT04846231|65219832|FG000|Overall Study|Adverse Event|0|||
23402358|NCT04846231|65219833|FG001|Overall Study|Adverse Event|0|||
23402359|NCT04846231|65219834|FG002|Overall Study|Adverse Event|0|||
23402360|NCT04846231|65219835|FG003|Overall Study|Adverse Event|0|||
23402361|NCT04846231|65219836|FG004|Overall Study|Adverse Event|0|||
23402362|NCT04846231|65219837|FG005|Overall Study|Adverse Event|0|||
23402363|NCT04846231|65219838|FG006|Overall Study|Adverse Event|1|||
23402364|NCT04846231|65219839|FG007|Overall Study|Adverse Event|1|||
23402365|NCT04154605|65219840|FG000|Overall Study|Procedure Canceled|1|||
23402366|NCT04154605|65219841|FG001|Overall Study|Procedure Canceled|1|||
23402367|NCT04154605|65219840|FG000|Overall Study|Missed follow up|1|||
23402368|NCT04154605|65219841|FG001|Overall Study|Missed follow up|1|||
23402369|NCT04154605|65219840|FG000|Overall Study|Withdrawal by Subject|1|||
23402370|NCT04154605|65219841|FG001|Overall Study|Withdrawal by Subject|0|||
23402371|NCT02961244|65219842|FG000|Overall Study|Protocol Violation|0|||
23402372|NCT02961244|65219843|FG001|Overall Study|Protocol Violation|1|||
23402373|NCT02961244|65219842|FG000|Overall Study|Withdrawal by Subject|1|||
23402374|NCT02961244|65219843|FG001|Overall Study|Withdrawal by Subject|2|||
23402375|NCT02961244|65219842|FG000|Overall Study|Surgery plan change after study approval|0|||
23402376|NCT02961244|65219843|FG001|Overall Study|Surgery plan change after study approval|2|||
23402377|NCT02961244|65219842|FG000|Overall Study|Lost to Follow-up|0|||
23402378|NCT02961244|65219843|FG001|Overall Study|Lost to Follow-up|2|||
23402379|NCT02961244|65219842|FG000|Overall Study|İnadequate data|0|||
23402380|NCT02961244|65219843|FG001|Overall Study|İnadequate data|2|||
23402381|NCT02808429|65219844|FG000|Overall Study|Lost to Follow-up|1|||
23402382|NCT02808429|65219845|FG001|Overall Study|Lost to Follow-up|0|||
23402383|NCT02808429|65219846|FG002|Overall Study|Lost to Follow-up|0|||
23402384|NCT02808429|65219844|FG000|Overall Study|Protocol Violation|0|||
23402385|NCT02808429|65219845|FG001|Overall Study|Protocol Violation|1|||
23402386|NCT02808429|65219846|FG002|Overall Study|Protocol Violation|0|||
23402387|NCT02808429|65219844|FG000|Overall Study|Premature study termination by sponsor|2|||
23402388|NCT02808429|65219845|FG001|Overall Study|Premature study termination by sponsor|0|||
23402389|NCT02808429|65219846|FG002|Overall Study|Premature study termination by sponsor|1|||
23402390|NCT02808429|65219844|FG000|Overall Study|Relocation|0|||
23402391|NCT02808429|65219845|FG001|Overall Study|Relocation|0|||
23402392|NCT02808429|65219846|FG002|Overall Study|Relocation|1|||
23402393|NCT00552071|65219847|FG000|Overall Study|Adverse Event|1|||
23402394|NCT00552071|65219848|FG001|Overall Study|Adverse Event|0|||
23402395|NCT00552071|65219847|FG000|Overall Study|Lack of Efficacy|1|||
23402396|NCT00552071|65219848|FG001|Overall Study|Lack of Efficacy|0|||
23402397|NCT00552071|65219847|FG000|Overall Study|Physician Decision|1|||
23402398|NCT00552071|65219848|FG001|Overall Study|Physician Decision|0|||
23402399|NCT00552071|65219847|FG000|Overall Study|Pregnancy|1|||
23402400|NCT00552071|65219848|FG001|Overall Study|Pregnancy|0|||
23402401|NCT00552071|65219847|FG000|Overall Study|Death|0|||
23402402|NCT00552071|65219848|FG001|Overall Study|Death|1|||
23402403|NCT00552071|65219847|FG000|Overall Study|Withdrawal by Subject|0|||
23402404|NCT00552071|65219848|FG001|Overall Study|Withdrawal by Subject|1|||
23402405|NCT02829996|65219849|FG000|Overall Study|Withdrawal by Subject|1|||
23402406|NCT02829996|65219850|FG001|Overall Study|Withdrawal by Subject|0|||
23402407|NCT02829996|65219851|FG002|Overall Study|Withdrawal by Subject|0|||
23402408|NCT02829996|65219852|FG003|Overall Study|Withdrawal by Subject|0|||
23402409|NCT02829996|65219853|FG004|Overall Study|Withdrawal by Subject|0|||
23402410|NCT03965403|65219854|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
23402411|NCT02479880|65219861|FG000|Overall Study|Study Terminated by Sponsor|13|||
23402412|NCT02479880|65219862|FG001|Overall Study|Study Terminated by Sponsor|12|||
23402413|NCT02479880|65219861|FG000|Overall Study|Pregnancy|0|||
23402414|NCT02479880|65219862|FG001|Overall Study|Pregnancy|1|||
23402415|NCT02712996|65219863|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
23402416|NCT02712996|65219864|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
23402417|NCT03110029|65219867|FG000|Overall Study|Withdrawal by Subject|1|||
23402418|NCT03110029|65219868|FG001|Overall Study|Withdrawal by Subject|1|||
23402419|NCT02737501|65219869|FG000|Randomized Phase|Died|41|||
23402420|NCT02737501|65219870|FG001|Randomized Phase|Died|29|||
23402421|NCT02737501|65219871|FG002|Randomized Phase|Died|0|||
23402422|NCT02737501|65219869|FG000|Randomized Phase|Withdrawal by Subject|16|||
23402423|NCT02737501|65219870|FG001|Randomized Phase|Withdrawal by Subject|6|||
23402424|NCT02737501|65219871|FG002|Randomized Phase|Withdrawal by Subject|0|||
23402425|NCT02737501|65219869|FG000|Randomized Phase|Lost to Follow-up|0|||
23402426|NCT02737501|65219870|FG001|Randomized Phase|Lost to Follow-up|1|||
23402427|NCT02737501|65219871|FG002|Randomized Phase|Lost to Follow-up|0|||
23402428|NCT02737501|65219869|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
23402429|NCT02737501|65219870|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
23402430|NCT02737501|65219871|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
23402431|NCT02737501|65219869|FG000|Randomized Phase|Reason not Specified|1|||
23402432|NCT02737501|65219870|FG001|Randomized Phase|Reason not Specified|1|||
23402433|NCT02737501|65219871|FG002|Randomized Phase|Reason not Specified|0|||
23402434|NCT02737501|65219869|FG000|Randomized Phase|Never Treated|1|||
23402435|NCT02737501|65219870|FG001|Randomized Phase|Never Treated|1|||
23402436|NCT02737501|65219871|FG002|Randomized Phase|Never Treated|0|||
23402437|NCT02737501|65219869|FG000|Crossover Phase|Died|0|||
23402438|NCT02737501|65219870|FG001|Crossover Phase|Died|0|||
23402439|NCT02737501|65219871|FG002|Crossover Phase|Died|22|||
23402440|NCT02737501|65219869|FG000|Crossover Phase|Withdrew Consent|0|||
23402441|NCT02737501|65219870|FG001|Crossover Phase|Withdrew Consent|0|||
23402442|NCT02737501|65219871|FG002|Crossover Phase|Withdrew Consent|9|||
23402443|NCT02737501|65219869|FG000|Crossover Phase|Physician Decision|0|||
23402444|NCT02737501|65219870|FG001|Crossover Phase|Physician Decision|0|||
23402445|NCT02737501|65219871|FG002|Crossover Phase|Physician Decision|1|||
23402446|NCT02737501|65219869|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
23402447|NCT02737501|65219870|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
23402448|NCT02737501|65219871|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
23402449|NCT01944020|65219872|FG000|Overall Study|Withdrawal by Subject|5|||
23402450|NCT01944020|65219873|FG001|Overall Study|Withdrawal by Subject|0|||
23402451|NCT04099277|65219874|FG000|Overall Study|Physician Decision|1|||
23402452|NCT04099277|65219874|FG000|Overall Study|Withdrawal by Subject|1|||
23402453|NCT02709720|65219879|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
23402454|NCT02709720|65219879|FG000|Overall Study|Protocol Violation|1|||
23402455|NCT02709720|65219879|FG000|Overall Study|Not take study medication|1|||
23402456|NCT02071771|65219880|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
23402457|NCT02071771|65219881|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
23402458|NCT02071771|65219880|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
23402459|NCT02071771|65219881|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
23402460|NCT02026011|65219884|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
23402461|NCT02026011|65219885|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
23402462|NCT02026011|65219884|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
23402463|NCT02026011|65219885|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
23402464|NCT02026011|65219884|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
23402465|NCT02026011|65219885|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
23402466|NCT02026011|65219884|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
23402467|NCT02026011|65219885|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
23402468|NCT03637491|65219886|FG000|Overall Study|Death|9|||
23402469|NCT03637491|65219887|FG001|Overall Study|Death|9|||
23402470|NCT03637491|65219888|FG002|Overall Study|Death|5|||
23402471|NCT03637491|65219889|FG003|Overall Study|Death|3|||
23402472|NCT03637491|65219886|FG000|Overall Study|Lost to Follow-up|0|||
23402473|NCT03637491|65219887|FG001|Overall Study|Lost to Follow-up|1|||
23402474|NCT03637491|65219888|FG002|Overall Study|Lost to Follow-up|0|||
23402475|NCT03637491|65219889|FG003|Overall Study|Lost to Follow-up|1|||
23402476|NCT03637491|65219886|FG000|Overall Study|Study Terminated By Sponsor|0|||
23402477|NCT03637491|65219887|FG001|Overall Study|Study Terminated By Sponsor|2|||
23402478|NCT03637491|65219888|FG002|Overall Study|Study Terminated By Sponsor|1|||
23402479|NCT03637491|65219889|FG003|Overall Study|Study Terminated By Sponsor|0|||
23402480|NCT03637491|65219886|FG000|Overall Study|Withdrawal by Subject|1|||
23402481|NCT03637491|65219887|FG001|Overall Study|Withdrawal by Subject|0|||
23402482|NCT03637491|65219888|FG002|Overall Study|Withdrawal by Subject|1|||
23402483|NCT03637491|65219889|FG003|Overall Study|Withdrawal by Subject|2|||
23402484|NCT04819113|65219890|FG000|Overall Study|Withdrawal by parent/guardian|3|||
23402485|NCT04819113|65219890|FG000|Overall Study|Lost to Follow-up|1|||
23402486|NCT04819113|65219890|FG000|Overall Study|Withdrawn before vaccination|2|||
23402487|NCT01282866|65219891|FG000|Overall Study|Adverse Event|1|||
23402488|NCT01612676|65219896|FG000|Overall Study|Adverse Event|2|||
23402489|NCT01612676|65219897|FG001|Overall Study|Adverse Event|3|||
23402490|NCT01612676|65219898|FG002|Overall Study|Adverse Event|1|||
23402491|NCT01612676|65219899|FG003|Overall Study|Adverse Event|3|||
23402492|NCT01612676|65219896|FG000|Overall Study|Protocol Violation|0|||
23402493|NCT01612676|65219897|FG001|Overall Study|Protocol Violation|1|||
23402494|NCT01612676|65219898|FG002|Overall Study|Protocol Violation|0|||
23402495|NCT01612676|65219899|FG003|Overall Study|Protocol Violation|0|||
23402496|NCT05111145|65219902|FG000|Overall Study|Commercial drug is available for participant|76|||
23402497|NCT05111145|65219902|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
23402498|NCT00598650|65219903|FG000|Overall Study|Withdrawal by Subject|3|||
23402499|NCT00598650|65219903|FG000|Overall Study|Adverse Event|18|||
23402500|NCT00598650|65219903|FG000|Overall Study|No treatment for 3 weeks|1|||
23402501|NCT00598650|65219903|FG000|Overall Study|Not eligible|1|||
23402502|NCT00598650|65219903|FG000|Overall Study|Prohibited Concomitant Medication|2|||
23402503|NCT00598650|65219903|FG000|Overall Study|Physician Decision|2|||
23402504|NCT00558636|65219904|FG000|Treatment|Adverse Event|9|||
23402505|NCT00558636|65219905|FG001|Treatment|Adverse Event|2|||
23402506|NCT00558636|65219904|FG000|Treatment|Withdrawal by Subject|2|||
23402507|NCT00558636|65219905|FG001|Treatment|Withdrawal by Subject|0|||
23402508|NCT00558636|65219904|FG000|Treatment|Premature termination of the study|35|||
23402509|NCT00558636|65219905|FG001|Treatment|Premature termination of the study|37|||
23402510|NCT00558636|65219904|FG000|Treatment|Disease progression|1|||
23402511|NCT00558636|65219905|FG001|Treatment|Disease progression|5|||
23402512|NCT00558636|65219904|FG000|Follow-up|Premature termination of the study|12|||
23402513|NCT00558636|65219905|FG001|Follow-up|Premature termination of the study|7|||
23402514|NCT01541865|65219909|FG000|Overall Study|Lost to Follow-up|11|||
23402515|NCT01541865|65219909|FG000|Overall Study|Withdrawal by Subject|9|||
23402516|NCT01541865|65219909|FG000|Overall Study|Adverse Event|1|||
23402517|NCT01541865|65219909|FG000|Overall Study|Protocol Violation|1|||
23402518|NCT00648037|65219910|FG000|Overall Study|Not Treated|1|||
23402519|NCT00648037|65219910|FG000|Overall Study|Withdrawal by Subject|1|||
23402520|NCT00648037|65219910|FG000|Overall Study|Adverse Event|11|||
23402521|NCT00648037|65219910|FG000|Overall Study|Relapse|2|||
23402522|NCT00648037|65219910|FG000|Overall Study|Other|1|||
23402523|NCT00939107|65219920|FG000|Overall Study|Lost to Follow-up|14|||
23402524|NCT00939107|65219921|FG001|Overall Study|Lost to Follow-up|12|||
23402525|NCT01434654|65219922|FG000|Overall Study|Withdrawal by Subject|1|||
23402526|NCT01434654|65219923|FG001|Overall Study|Withdrawal by Subject|0|||
23402527|NCT01434654|65219922|FG000|Overall Study|Lost to Follow-up|1|||
23402528|NCT01434654|65219923|FG001|Overall Study|Lost to Follow-up|0|||
23402529|NCT00775268|65219924|FG000|Baseline|Drug not synthesize dose|1|||
23402530|NCT00775268|65219925|FG001|Baseline|Drug not synthesize dose|0|||
23402531|NCT00775268|65219924|FG000|Baseline|Not treated-ineligible per CT|0|||
23402532|NCT00775268|65219925|FG001|Baseline|Not treated-ineligible per CT|1|||
23402533|NCT00775268|65219924|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
23402534|NCT00775268|65219925|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
23402535|NCT00775268|65219924|FG000|After Completion|Participant missed scan appointment|1|||
23402536|NCT00775268|65219925|FG001|After Completion|Participant missed scan appointment|0|||
23402537|NCT05173974|65219926|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
23402538|NCT05173974|65219927|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
23402539|NCT05173974|65219928|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
23402540|NCT05173974|65219929|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
23402541|NCT05173974|65219926|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
23402542|NCT05173974|65219927|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
23402543|NCT05173974|65219928|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
23402544|NCT05173974|65219929|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
23402545|NCT04067492|65219930|FG000|Overall Study|Lost to Follow-up|0|||
23402546|NCT04067492|65219931|FG001|Overall Study|Lost to Follow-up|0|||
23402547|NCT04067492|65219932|FG002|Overall Study|Lost to Follow-up|0|||
23402548|NCT04067492|65219933|FG003|Overall Study|Lost to Follow-up|0|||
23402549|NCT04067492|65219934|FG004|Overall Study|Lost to Follow-up|0|||
23402550|NCT04067492|65219935|FG005|Overall Study|Lost to Follow-up|1|||
23402551|NCT04067492|65219930|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402552|NCT04067492|65219931|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
23402553|NCT04067492|65219932|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402554|NCT04067492|65219933|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402555|NCT04067492|65219934|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402556|NCT04067492|65219935|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
23402557|NCT04067492|65219930|FG000|Overall Study|COVID-19 epidemiological situation|0|||
23402558|NCT04067492|65219931|FG001|Overall Study|COVID-19 epidemiological situation|0|||
23402559|NCT04067492|65219932|FG002|Overall Study|COVID-19 epidemiological situation|0|||
23402560|NCT04067492|65219933|FG003|Overall Study|COVID-19 epidemiological situation|1|||
23402561|NCT04067492|65219934|FG004|Overall Study|COVID-19 epidemiological situation|0|||
23402562|NCT04067492|65219935|FG005|Overall Study|COVID-19 epidemiological situation|0|||
23402563|NCT01273038|65219936|FG000|Second Intervention (14 Days)|Adverse Event|0|||
23402564|NCT01273038|65219937|FG001|Second Intervention (14 Days)|Adverse Event|1|||
23402565|NCT01273038|65219936|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
23402566|NCT01273038|65219937|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
23402567|NCT02651116|65219938|FG000|Overall Study|Adverse Event|0|||
23402568|NCT02651116|65219939|FG001|Overall Study|Adverse Event|1|||
23402569|NCT02651116|65219938|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
23402570|NCT02651116|65219939|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
23402571|NCT03281629|65219940|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
23402572|NCT03281629|65219941|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
23402573|NCT03281629|65219940|FG000|Overall Study|Death|0|||
23402574|NCT03281629|65219941|FG001|Overall Study|Death|1|||
23402575|NCT03281629|65219940|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
23402576|NCT03281629|65219941|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
23402577|NCT04940130|65219942|FG000|Overall Study|Travel|1|||
23402578|NCT04940130|65219943|FG001|Overall Study|Travel|0|||
23402579|NCT04940130|65219944|FG002|Overall Study|Travel|2|||
23402580|NCT04940130|65219942|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
23402581|NCT04940130|65219943|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
23402582|NCT04940130|65219944|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
23402583|NCT04940130|65219942|FG000|Overall Study|Adverse Event|0|||
23402584|NCT04940130|65219943|FG001|Overall Study|Adverse Event|0|||
23402585|NCT04940130|65219944|FG002|Overall Study|Adverse Event|2|||
23402586|NCT04940130|65219942|FG000|Overall Study|Disease progression/treatment failure|0|||
23402587|NCT04940130|65219943|FG001|Overall Study|Disease progression/treatment failure|0|||
23402588|NCT04940130|65219944|FG002|Overall Study|Disease progression/treatment failure|1|||
23402589|NCT04940130|65219942|FG000|Overall Study|Participant refusal|0|||
23402590|NCT04940130|65219943|FG001|Overall Study|Participant refusal|0|||
23402591|NCT04940130|65219944|FG002|Overall Study|Participant refusal|1|||
23402592|NCT01639469|65219945|FG000|Overall Study|Death|4|||
23402593|NCT01639469|65219946|FG001|Overall Study|Death|2|||
23402594|NCT01639469|65219945|FG000|Overall Study|Lost to Follow-up|1|||
23402595|NCT01639469|65219946|FG001|Overall Study|Lost to Follow-up|1|||
23402596|NCT01082614|65219947|FG000|Overall Study|Adverse Event|1|||
23402597|NCT01082614|65219948|FG001|Overall Study|Adverse Event|4|||
23402598|NCT01082614|65219947|FG000|Overall Study|Equipment Malfunction|0|||
23402599|NCT01082614|65219948|FG001|Overall Study|Equipment Malfunction|1|||
23402600|NCT01082614|65219947|FG000|Overall Study|Physician Decision|2|||
23402601|NCT01082614|65219948|FG001|Overall Study|Physician Decision|0|||
23402602|NCT01276106|65219952|FG000|Overall Study|Adverse Event|3|||
23402603|NCT01276106|65219953|FG001|Overall Study|Adverse Event|3|||
23402604|NCT01276106|65219954|FG002|Overall Study|Adverse Event|11|||
23402605|NCT01276106|65219955|FG003|Overall Study|Adverse Event|3|||
23402606|NCT01276106|65219952|FG000|Overall Study|Withdrawal by Subject|6|||
23402607|NCT01276106|65219953|FG001|Overall Study|Withdrawal by Subject|3|||
23402608|NCT01276106|65219954|FG002|Overall Study|Withdrawal by Subject|1|||
23402609|NCT01276106|65219955|FG003|Overall Study|Withdrawal by Subject|6|||
23402610|NCT01276106|65219952|FG000|Overall Study|Lack of Efficacy|0|||
23402611|NCT01276106|65219953|FG001|Overall Study|Lack of Efficacy|1|||
23402612|NCT01276106|65219954|FG002|Overall Study|Lack of Efficacy|0|||
23402613|NCT01276106|65219955|FG003|Overall Study|Lack of Efficacy|1|||
23402614|NCT01276106|65219952|FG000|Overall Study|Lost to Follow-up|2|||
23402615|NCT01276106|65219953|FG001|Overall Study|Lost to Follow-up|1|||
23402616|NCT01276106|65219954|FG002|Overall Study|Lost to Follow-up|1|||
23402617|NCT01276106|65219955|FG003|Overall Study|Lost to Follow-up|0|||
23402618|NCT01276106|65219952|FG000|Overall Study|Physician Decision|0|||
23402619|NCT01276106|65219953|FG001|Overall Study|Physician Decision|0|||
23402620|NCT01276106|65219954|FG002|Overall Study|Physician Decision|1|||
23402621|NCT01276106|65219955|FG003|Overall Study|Physician Decision|1|||
23402622|NCT01276106|65219952|FG000|Overall Study|Protocol Violation|1|||
23402623|NCT01276106|65219953|FG001|Overall Study|Protocol Violation|1|||
23402624|NCT01276106|65219954|FG002|Overall Study|Protocol Violation|0|||
23402625|NCT01276106|65219955|FG003|Overall Study|Protocol Violation|2|||
23402626|NCT01276106|65219952|FG000|Overall Study|Insufficient therapeutic effects|0|||
23402627|NCT01276106|65219953|FG001|Overall Study|Insufficient therapeutic effects|0|||
23402628|NCT01276106|65219954|FG002|Overall Study|Insufficient therapeutic effects|2|||
23402629|NCT01276106|65219955|FG003|Overall Study|Insufficient therapeutic effects|0|||
23402630|NCT03605693|65219956|FG000|Overall Study|Lost to Follow-up|4|||
23402631|NCT03605693|65219957|FG001|Overall Study|Lost to Follow-up|0|||
23402632|NCT03605693|65219956|FG000|Overall Study|Physician Decision|1|||
23402633|NCT03605693|65219957|FG001|Overall Study|Physician Decision|0|||
23402634|NCT04834726|65219958|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
23402635|NCT04834726|65219959|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
23402636|NCT04834726|65219960|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
23402637|NCT04834726|65219961|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
23402638|NCT04834726|65219962|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
23402639|NCT04834726|65219963|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
23402640|NCT04834726|65219964|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
23402641|NCT04834726|65219965|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
23402642|NCT04834726|65219966|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
23402643|NCT02848092|65219979|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
23402644|NCT02848092|65219980|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
23402645|NCT02848092|65219979|FG000|1-month Post-training Follow-up|Adverse Event|2|||
23402646|NCT02848092|65219980|FG001|1-month Post-training Follow-up|Adverse Event|1|||
23402647|NCT02848092|65219979|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
23402648|NCT02848092|65219980|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
23402649|NCT02848092|65219979|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
23402650|NCT02848092|65219980|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
23402651|NCT02848092|65219979|FG000|1-month Post-training Follow-up|fatigue|0|||
23402652|NCT02848092|65219980|FG001|1-month Post-training Follow-up|fatigue|1|||
23402653|NCT02848092|65219979|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
23402654|NCT02848092|65219980|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
23402655|NCT02848092|65219979|FG000|6-month Post-training Follow-up|Adverse Event|1|||
23402656|NCT02848092|65219980|FG001|6-month Post-training Follow-up|Adverse Event|1|||
23402657|NCT02848092|65219979|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
23402658|NCT02848092|65219980|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
23402659|NCT02848092|65219979|FG000|6-month Post-training Follow-up|frustrated with task|1|||
23402660|NCT02848092|65219980|FG001|6-month Post-training Follow-up|frustrated with task|0|||
23402661|NCT02848092|65219979|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
23402662|NCT02848092|65219980|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
23402663|NCT02848092|65219979|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
23402664|NCT02848092|65219980|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
23402665|NCT03289143|65219983|FG000|Overall Study|Caregiver Unavailability|1|||
23402666|NCT03289143|65219984|FG001|Overall Study|Caregiver Unavailability|1|||
23402667|NCT03289143|65219985|FG002|Overall Study|Caregiver Unavailability|0|||
23402668|NCT03289143|65219986|FG003|Overall Study|Caregiver Unavailability|0|||
23402669|NCT03289143|65219983|FG000|Overall Study|Research Department Closure|0|||
23402670|NCT03289143|65219984|FG001|Overall Study|Research Department Closure|0|||
23402671|NCT03289143|65219985|FG002|Overall Study|Research Department Closure|1|||
23402672|NCT03289143|65219986|FG003|Overall Study|Research Department Closure|0|||
23402673|NCT03289143|65219983|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
23402674|NCT03289143|65219984|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
23402675|NCT03289143|65219985|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
23402676|NCT03289143|65219986|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
23402677|NCT03289143|65219983|FG000|Overall Study|Medical Monitor Decision|1|||
23402678|NCT03289143|65219984|FG001|Overall Study|Medical Monitor Decision|0|||
23402679|NCT03289143|65219985|FG002|Overall Study|Medical Monitor Decision|0|||
23402680|NCT03289143|65219986|FG003|Overall Study|Medical Monitor Decision|0|||
23402681|NCT03289143|65219983|FG000|Overall Study|Participant Non-Compliance|0|||
23402682|NCT03289143|65219984|FG001|Overall Study|Participant Non-Compliance|0|||
23402683|NCT03289143|65219985|FG002|Overall Study|Participant Non-Compliance|1|||
23402684|NCT03289143|65219986|FG003|Overall Study|Participant Non-Compliance|0|||
23402685|NCT03289143|65219983|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
23402686|NCT03289143|65219984|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
23402687|NCT03289143|65219985|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
23402688|NCT03289143|65219986|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
23402689|NCT03289143|65219983|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
23402690|NCT03289143|65219984|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
23402691|NCT03289143|65219985|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
23402692|NCT03289143|65219986|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
23402693|NCT03289143|65219983|FG000|Overall Study|Caregiver Passed Away|1|||
23402694|NCT03289143|65219984|FG001|Overall Study|Caregiver Passed Away|0|||
23402695|NCT03289143|65219985|FG002|Overall Study|Caregiver Passed Away|0|||
23402696|NCT03289143|65219986|FG003|Overall Study|Caregiver Passed Away|0|||
23402697|NCT03289143|65219983|FG000|Overall Study|Physician Decision|0|||
23402698|NCT03289143|65219984|FG001|Overall Study|Physician Decision|2|||
23402699|NCT03289143|65219985|FG002|Overall Study|Physician Decision|2|||
23402700|NCT03289143|65219986|FG003|Overall Study|Physician Decision|2|||
23402701|NCT03289143|65219983|FG000|Overall Study|Protocol Deviation|2|||
23402859|NCT04422431|65220037|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
23402860|NCT04422431|65220037|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
23402861|NCT04422431|65220037|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
23402862|NCT04422431|65220037|FG000|Extension Period (48 Weeks)|Other than specified|2|||
23402863|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
23402864|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
23402865|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
23402866|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23402867|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23402868|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23402869|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
23402870|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
23402871|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402872|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402873|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402874|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402875|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402876|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
23402877|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
23402878|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
23402879|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
23402880|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23402881|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23402882|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23402883|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
23402884|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
23402885|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
23402886|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402887|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402888|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402889|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402890|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
23402891|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
23402892|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402893|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402894|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402895|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402896|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402897|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
23402898|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402899|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
23402900|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402901|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402902|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402903|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402904|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
23402905|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
23402906|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
23402907|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
23402908|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23402909|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23402910|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23402911|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
23402912|NCT03745638|65220040|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
23402913|NCT03745638|65220041|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
23402914|NCT03745638|65220042|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402915|NCT03745638|65220043|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402916|NCT03745638|65220044|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402917|NCT03745638|65220045|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402918|NCT03745638|65220046|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
23402919|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23402920|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23402921|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23402922|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23402923|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
23402924|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
23402925|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
23402926|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23402927|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23402928|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23402929|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
23402930|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
23402931|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
23402932|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
23402933|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23402934|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23402935|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
23402936|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
23402937|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
23402938|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
23402939|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
23402940|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402941|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402942|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402943|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402944|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
23402945|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
23402946|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
23402947|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402948|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402949|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402950|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402951|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402952|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
23402953|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
23402954|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23402955|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23402956|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
23402957|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
23402958|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
23402959|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
23402960|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
23402961|NCT03745638|65220040|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402962|NCT03745638|65220041|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402963|NCT03745638|65220042|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402964|NCT03745638|65220043|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402965|NCT03745638|65220044|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
23402966|NCT03745638|65220045|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
23402967|NCT03745638|65220046|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
23402968|NCT03314935|65220055|FG000|Phase 1|Death|4|||
23402969|NCT03314935|65220056|FG001|Phase 1|Death|2|||
23402970|NCT03314935|65220057|FG002|Phase 1|Death|5|||
23402971|NCT03314935|65220058|FG003|Phase 1|Death|4|||
23402972|NCT03314935|65220059|FG004|Phase 1|Death|3|||
23402973|NCT03314935|65220060|FG005|Phase 1|Death|4|||
23402974|NCT03314935|65220061|FG006|Phase 1|Death|5|||
23402975|NCT03314935|65220062|FG007|Phase 1|Death|4|||
23402976|NCT03314935|65220063|FG008|Phase 1|Death|3|||
23402977|NCT03314935|65220064|FG009|Phase 1|Death|0|||
23402978|NCT03314935|65220065|FG010|Phase 1|Death|0|||
23402979|NCT03314935|65220066|FG011|Phase 1|Death|0|||
23402980|NCT03314935|65220067|FG012|Phase 1|Death|0|||
23402981|NCT03314935|65220068|FG013|Phase 1|Death|0|||
23402982|NCT03314935|65220069|FG014|Phase 1|Death|0|||
23402983|NCT03314935|65220055|FG000|Phase 1|Withdrawal by Subject|2|||
23402984|NCT03314935|65220056|FG001|Phase 1|Withdrawal by Subject|1|||
23402985|NCT03314935|65220057|FG002|Phase 1|Withdrawal by Subject|1|||
23402986|NCT03314935|65220058|FG003|Phase 1|Withdrawal by Subject|2|||
23402987|NCT03314935|65220059|FG004|Phase 1|Withdrawal by Subject|1|||
23402988|NCT03314935|65220060|FG005|Phase 1|Withdrawal by Subject|0|||
23402989|NCT03314935|65220061|FG006|Phase 1|Withdrawal by Subject|1|||
23402990|NCT03314935|65220062|FG007|Phase 1|Withdrawal by Subject|0|||
23402991|NCT03314935|65220063|FG008|Phase 1|Withdrawal by Subject|1|||
23403029|NCT03314935|65220056|FG001|Phase 1|"Captured as Other in Database"|2|||
23403030|NCT03314935|65220057|FG002|Phase 1|"Captured as Other in Database"|0|||
23403031|NCT03314935|65220058|FG003|Phase 1|"Captured as Other in Database"|0|||
23403032|NCT03314935|65220059|FG004|Phase 1|"Captured as Other in Database"|0|||
23403033|NCT03314935|65220060|FG005|Phase 1|"Captured as Other in Database"|0|||
23403034|NCT03314935|65220061|FG006|Phase 1|"Captured as Other in Database"|1|||
23403035|NCT03314935|65220062|FG007|Phase 1|"Captured as Other in Database"|1|||
23403036|NCT03314935|65220063|FG008|Phase 1|"Captured as Other in Database"|1|||
23403037|NCT03314935|65220064|FG009|Phase 1|"Captured as Other in Database"|0|||
23403038|NCT03314935|65220065|FG010|Phase 1|"Captured as Other in Database"|0|||
23403039|NCT03314935|65220066|FG011|Phase 1|"Captured as Other in Database"|0|||
23403040|NCT03314935|65220067|FG012|Phase 1|"Captured as Other in Database"|0|||
23403041|NCT03314935|65220068|FG013|Phase 1|"Captured as Other in Database"|0|||
23403042|NCT03314935|65220069|FG014|Phase 1|"Captured as Other in Database"|0|||
23403043|NCT03314935|65220055|FG000|Phase 1|Lost to Follow-up|0|||
23403044|NCT03314935|65220056|FG001|Phase 1|Lost to Follow-up|0|||
23403045|NCT03314935|65220057|FG002|Phase 1|Lost to Follow-up|0|||
23403046|NCT03314935|65220058|FG003|Phase 1|Lost to Follow-up|0|||
23403047|NCT03314935|65220059|FG004|Phase 1|Lost to Follow-up|0|||
23403048|NCT03314935|65220060|FG005|Phase 1|Lost to Follow-up|0|||
23403049|NCT03314935|65220061|FG006|Phase 1|Lost to Follow-up|0|||
23403050|NCT03314935|65220062|FG007|Phase 1|Lost to Follow-up|0|||
23403051|NCT03314935|65220063|FG008|Phase 1|Lost to Follow-up|1|||
23403052|NCT03314935|65220064|FG009|Phase 1|Lost to Follow-up|0|||
23403053|NCT03314935|65220065|FG010|Phase 1|Lost to Follow-up|0|||
23403054|NCT03314935|65220066|FG011|Phase 1|Lost to Follow-up|0|||
23403055|NCT03314935|65220067|FG012|Phase 1|Lost to Follow-up|0|||
23403056|NCT03314935|65220068|FG013|Phase 1|Lost to Follow-up|0|||
23403057|NCT03314935|65220069|FG014|Phase 1|Lost to Follow-up|0|||
23403058|NCT03314935|65220055|FG000|Phase 2|Death|0|||
23403059|NCT03314935|65220056|FG001|Phase 2|Death|0|||
23403060|NCT03314935|65220057|FG002|Phase 2|Death|0|||
23403061|NCT03314935|65220058|FG003|Phase 2|Death|0|||
23403062|NCT03314935|65220059|FG004|Phase 2|Death|0|||
23403063|NCT03314935|65220060|FG005|Phase 2|Death|0|||
23403064|NCT03314935|65220061|FG006|Phase 2|Death|0|||
23403065|NCT03314935|65220062|FG007|Phase 2|Death|0|||
23403066|NCT03314935|65220063|FG008|Phase 2|Death|0|||
23403067|NCT03314935|65220064|FG009|Phase 2|Death|5|||
23403068|NCT03314935|65220065|FG010|Phase 2|Death|20|||
23403069|NCT03314935|65220066|FG011|Phase 2|Death|6|||
23403070|NCT03314935|65220067|FG012|Phase 2|Death|7|||
23403071|NCT03314935|65220068|FG013|Phase 2|Death|6|||
23403072|NCT03314935|65220069|FG014|Phase 2|Death|17|||
23403073|NCT03314935|65220055|FG000|Phase 2|Withdrawal by Subject|0|||
23403074|NCT03314935|65220056|FG001|Phase 2|Withdrawal by Subject|0|||
23403075|NCT03314935|65220057|FG002|Phase 2|Withdrawal by Subject|0|||
23403076|NCT03314935|65220058|FG003|Phase 2|Withdrawal by Subject|0|||
23403077|NCT03314935|65220059|FG004|Phase 2|Withdrawal by Subject|0|||
23403078|NCT03314935|65220060|FG005|Phase 2|Withdrawal by Subject|0|||
23403079|NCT03314935|65220061|FG006|Phase 2|Withdrawal by Subject|0|||
23403080|NCT03314935|65220062|FG007|Phase 2|Withdrawal by Subject|0|||
23403081|NCT03314935|65220063|FG008|Phase 2|Withdrawal by Subject|0|||
23403082|NCT03314935|65220064|FG009|Phase 2|Withdrawal by Subject|1|||
23403083|NCT03314935|65220065|FG010|Phase 2|Withdrawal by Subject|4|||
23403084|NCT03314935|65220066|FG011|Phase 2|Withdrawal by Subject|0|||
23403085|NCT03314935|65220067|FG012|Phase 2|Withdrawal by Subject|1|||
23403086|NCT03314935|65220068|FG013|Phase 2|Withdrawal by Subject|0|||
23403087|NCT03314935|65220069|FG014|Phase 2|Withdrawal by Subject|1|||
23403088|NCT03314935|65220055|FG000|Phase 2|Progressive Disease|0|||
23403089|NCT03314935|65220056|FG001|Phase 2|Progressive Disease|0|||
23403090|NCT03314935|65220057|FG002|Phase 2|Progressive Disease|0|||
23403091|NCT03314935|65220058|FG003|Phase 2|Progressive Disease|0|||
23403092|NCT03314935|65220059|FG004|Phase 2|Progressive Disease|0|||
23403093|NCT03314935|65220060|FG005|Phase 2|Progressive Disease|0|||
23403094|NCT03314935|65220061|FG006|Phase 2|Progressive Disease|0|||
23403095|NCT03314935|65220062|FG007|Phase 2|Progressive Disease|0|||
23403096|NCT03314935|65220063|FG008|Phase 2|Progressive Disease|0|||
23403097|NCT03314935|65220064|FG009|Phase 2|Progressive Disease|1|||
23403098|NCT03314935|65220065|FG010|Phase 2|Progressive Disease|1|||
23403099|NCT03314935|65220066|FG011|Phase 2|Progressive Disease|1|||
23403100|NCT03314935|65220067|FG012|Phase 2|Progressive Disease|2|||
23403101|NCT03314935|65220068|FG013|Phase 2|Progressive Disease|0|||
23403102|NCT03314935|65220069|FG014|Phase 2|Progressive Disease|1|||
23403103|NCT03314935|65220055|FG000|Phase 2|Study Terminated by Sponsor|0|||
23403104|NCT03314935|65220056|FG001|Phase 2|Study Terminated by Sponsor|0|||
23403105|NCT03314935|65220057|FG002|Phase 2|Study Terminated by Sponsor|0|||
23403106|NCT03314935|65220058|FG003|Phase 2|Study Terminated by Sponsor|0|||
23403107|NCT03314935|65220059|FG004|Phase 2|Study Terminated by Sponsor|0|||
23403108|NCT03314935|65220060|FG005|Phase 2|Study Terminated by Sponsor|0|||
23403109|NCT03314935|65220061|FG006|Phase 2|Study Terminated by Sponsor|0|||
23403110|NCT03314935|65220062|FG007|Phase 2|Study Terminated by Sponsor|0|||
23403111|NCT03314935|65220063|FG008|Phase 2|Study Terminated by Sponsor|0|||
23403112|NCT03314935|65220064|FG009|Phase 2|Study Terminated by Sponsor|0|||
23403113|NCT03314935|65220065|FG010|Phase 2|Study Terminated by Sponsor|7|||
23403114|NCT03314935|65220066|FG011|Phase 2|Study Terminated by Sponsor|2|||
23403115|NCT03314935|65220067|FG012|Phase 2|Study Terminated by Sponsor|1|||
23403116|NCT03314935|65220068|FG013|Phase 2|Study Terminated by Sponsor|4|||
23403117|NCT03314935|65220069|FG014|Phase 2|Study Terminated by Sponsor|4|||
23403118|NCT03314935|65220055|FG000|Phase 2|Lost to Follow-up|0|||
23403119|NCT03314935|65220056|FG001|Phase 2|Lost to Follow-up|0|||
23403120|NCT03314935|65220057|FG002|Phase 2|Lost to Follow-up|0|||
23403121|NCT03314935|65220058|FG003|Phase 2|Lost to Follow-up|0|||
23403122|NCT03314935|65220059|FG004|Phase 2|Lost to Follow-up|0|||
23403123|NCT03314935|65220060|FG005|Phase 2|Lost to Follow-up|0|||
23403124|NCT03314935|65220061|FG006|Phase 2|Lost to Follow-up|0|||
23403125|NCT03314935|65220062|FG007|Phase 2|Lost to Follow-up|0|||
23403126|NCT03314935|65220063|FG008|Phase 2|Lost to Follow-up|0|||
23403127|NCT03314935|65220064|FG009|Phase 2|Lost to Follow-up|1|||
23403128|NCT03314935|65220065|FG010|Phase 2|Lost to Follow-up|0|||
23403129|NCT03314935|65220066|FG011|Phase 2|Lost to Follow-up|0|||
23403130|NCT03314935|65220067|FG012|Phase 2|Lost to Follow-up|0|||
23403131|NCT03314935|65220068|FG013|Phase 2|Lost to Follow-up|0|||
23403132|NCT03314935|65220069|FG014|Phase 2|Lost to Follow-up|1|||
23403133|NCT03314935|65220055|FG000|Phase 2|Physician Decision|0|||
23403134|NCT03314935|65220056|FG001|Phase 2|Physician Decision|0|||
23403135|NCT03314935|65220057|FG002|Phase 2|Physician Decision|0|||
23403136|NCT03314935|65220058|FG003|Phase 2|Physician Decision|0|||
23403137|NCT03314935|65220059|FG004|Phase 2|Physician Decision|0|||
23403138|NCT03314935|65220060|FG005|Phase 2|Physician Decision|0|||
23403139|NCT03314935|65220061|FG006|Phase 2|Physician Decision|0|||
23403140|NCT03314935|65220062|FG007|Phase 2|Physician Decision|0|||
23403141|NCT03314935|65220063|FG008|Phase 2|Physician Decision|0|||
23403142|NCT03314935|65220064|FG009|Phase 2|Physician Decision|0|||
23403143|NCT03314935|65220065|FG010|Phase 2|Physician Decision|1|||
23403144|NCT03314935|65220066|FG011|Phase 2|Physician Decision|0|||
23403145|NCT03314935|65220067|FG012|Phase 2|Physician Decision|0|||
23403146|NCT03314935|65220068|FG013|Phase 2|Physician Decision|0|||
23403147|NCT03314935|65220069|FG014|Phase 2|Physician Decision|0|||
